id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
259350|NCT03125031|623570|P1|NOT COMPLETED|Overall Study||0
259351|NCT03125031|623570|P1|COMPLETED|Overall Study||44
259352|NCT03125031|623570|P1|STARTED|Overall Study||44
259353|NCT03125005|623575|P1|NOT COMPLETED|Overall Study||0
259354|NCT03125005|623575|P1|COMPLETED|Overall Study||51
259355|NCT03125005|623575|P1|STARTED|Overall Study||51
259356|NCT03124966|623579|P1|NOT COMPLETED|Overall Study||0
259357|NCT03124966|623579|P1|COMPLETED|Overall Study||118
259358|NCT03124966|623579|P1|STARTED|Overall Study||118
259359|NCT03124927|623583|P1|NOT COMPLETED|Overall Study||0
259360|NCT03124927|623583|P1|COMPLETED|Overall Study||25
259361|NCT03124927|623583|P1|STARTED|Overall Study||25
259362|NCT03124901|623587|P1|NOT COMPLETED|Overall Study||0
259363|NCT03124901|623587|P1|COMPLETED|Overall Study||147
259364|NCT03124901|623587|P1|STARTED|Overall Study||147
259365|NCT03124771|623591|P1|NOT COMPLETED|Overall Study||0
259366|NCT03124771|623591|P1|COMPLETED|Overall Study||132
259367|NCT03124771|623591|P1|STARTED|Overall Study||132
259368|NCT03124758|623595|P1|NOT COMPLETED|Overall Study||0
259369|NCT03124758|623595|P1|COMPLETED|Overall Study||354
259370|NCT03124758|623595|P1|STARTED|Overall Study||354
259371|NCT03124693|623599|P1|NOT COMPLETED|Overall Study||0
259372|NCT03124693|623599|P1|COMPLETED|Overall Study||90
259373|NCT03124693|623599|P1|STARTED|Overall Study||90
259374|NCT03106870|623605|P2|NOT COMPLETED|Overall Study||0
259375|NCT03106870|623606|P1|NOT COMPLETED|Overall Study||0
259376|NCT03106870|623605|P2|COMPLETED|Overall Study||31
259377|NCT03106870|623606|P1|COMPLETED|Overall Study||31
259378|NCT03106870|623605|P2|STARTED|Overall Study||31
259379|NCT03106870|623606|P1|STARTED|Overall Study||31
259380|NCT03106337|623616|P1|NOT COMPLETED|Overall Study||0
259381|NCT03106337|623616|P1|COMPLETED|Overall Study||35
259382|NCT03106337|623616|P1|STARTED|Overall Study||35
259383|NCT03072719|623623|P2|NOT COMPLETED|Overall Study||1
259384|NCT03072719|623624|P1|NOT COMPLETED|Overall Study||1
259385|NCT03072719|623623|P2|COMPLETED|Overall Study||59
259386|NCT03072719|623624|P1|COMPLETED|Overall Study||59
259387|NCT03072719|623623|P2|STARTED|Overall Study||60
259388|NCT03072719|623624|P1|STARTED|Overall Study||60
259389|NCT03070730|623637|P3|NOT COMPLETED|Overall Study||0
259390|NCT03070730|623638|P2|NOT COMPLETED|Overall Study||0
259391|NCT03070730|623639|P1|NOT COMPLETED|Overall Study||0
259392|NCT03070730|623637|P3|COMPLETED|Overall Study||0
259393|NCT03070730|623638|P2|COMPLETED|Overall Study||0
259394|NCT03070730|623639|P1|COMPLETED|Overall Study||0
259395|NCT03070730|623637|P3|STARTED|Overall Study||0
259396|NCT03070730|623638|P2|STARTED|Overall Study||0
259397|NCT03070730|623639|P1|STARTED|Overall Study||0
259398|NCT03065933|623770|P1|NOT COMPLETED|Overall Study||5
259399|NCT03065933|623770|P1|COMPLETED|Overall Study||0
259400|NCT03065933|623770|P1|STARTED|Overall Study||5
259401|NCT03061513|623776|P2|NOT COMPLETED|Overall Study||1
259402|NCT03061513|623777|P1|NOT COMPLETED|Overall Study||0
259403|NCT03061513|623776|P2|COMPLETED|Overall Study||4
259404|NCT03061513|623777|P1|COMPLETED|Overall Study||6
259405|NCT03061513|623776|P2|STARTED|Overall Study||5
259406|NCT03061513|623777|P1|STARTED|Overall Study||6
259407|NCT03048006|623785|P1|NOT COMPLETED|Overall Study||0
259408|NCT03048006|623785|P1|COMPLETED|Overall Study||44456
259409|NCT03048006|623785|P1|STARTED|Overall Study||44456
259410|NCT03047447|623794|P3|NOT COMPLETED|Overall Study||0
259411|NCT03047447|623795|P2|NOT COMPLETED|Overall Study||0
259412|NCT03047447|623796|P1|NOT COMPLETED|Overall Study||0
259413|NCT03047447|623794|P3|COMPLETED|Overall Study||10
259414|NCT03047447|623795|P2|COMPLETED|Overall Study||10
259415|NCT03047447|623796|P1|COMPLETED|Overall Study||10
259416|NCT03047447|623794|P3|STARTED|Overall Study||10
259417|NCT03047447|623795|P2|STARTED|Overall Study||10
259418|NCT03047447|623796|P1|STARTED|Overall Study||10
259419|NCT03041298|623816|P1|NOT COMPLETED|Overall Study||0
259420|NCT03041298|623816|P1|COMPLETED|Overall Study||1537
259421|NCT03041298|623816|P1|STARTED|Overall Study||1537
259422|NCT03039179|623826|P2|NOT COMPLETED|Overall Study||0
259423|NCT03039179|623827|P1|NOT COMPLETED|Overall Study||0
259424|NCT03039179|623826|P2|COMPLETED|Overall Study||42
259425|NCT03039179|623827|P1|COMPLETED|Overall Study||38
259426|NCT03039179|623826|P2|STARTED|Overall Study||42
259427|NCT03039179|623827|P1|STARTED|Overall Study||38
259428|NCT03037541|623837|P2|NOT COMPLETED|Overall Study||0
259429|NCT03037541|623838|P1|NOT COMPLETED|Overall Study||0
259430|NCT03037541|623837|P2|COMPLETED|Overall Study||30
259431|NCT03037541|623838|P1|COMPLETED|Overall Study||30
259432|NCT03037541|623837|P2|STARTED|Overall Study||30
259433|NCT03037541|623838|P1|STARTED|Overall Study||30
259434|NCT03035955|623848|P2|NOT COMPLETED|Overall Study||1
259435|NCT03035955|623849|P1|NOT COMPLETED|Overall Study||1
259436|NCT03035955|623848|P2|COMPLETED|Overall Study||9
259437|NCT03035955|623849|P1|COMPLETED|Overall Study||9
259438|NCT03035955|623848|P2|STARTED|Overall Study||10
259439|NCT03035955|623849|P1|STARTED|Overall Study||10
259440|NCT03026803|623855|P1|NOT COMPLETED|Overall Study||0
259441|NCT03026803|623855|P1|COMPLETED|Overall Study||4
259442|NCT03026803|623855|P1|STARTED|Overall Study||4
259443|NCT03023709|623861|P2|NOT COMPLETED|Overall Study||0
259444|NCT03023709|623862|P1|NOT COMPLETED|Overall Study||0
259445|NCT03023709|623861|P2|COMPLETED|Overall Study||0
259446|NCT03023709|623862|P1|COMPLETED|Overall Study||3
259447|NCT03023709|623861|P2|STARTED|Overall Study||0
259448|NCT03023709|623862|P1|STARTED|Overall Study||3
259449|NCT03023683|623872|P2|NOT COMPLETED|Overall Study||1
259450|NCT03023683|623873|P1|NOT COMPLETED|Overall Study||0
259451|NCT03023683|623872|P2|COMPLETED|Overall Study||17
259452|NCT03023683|623873|P1|COMPLETED|Overall Study||0
259453|NCT03023683|623872|P2|STARTED|Overall Study||18
259454|NCT03023683|623873|P1|STARTED|Overall Study||0
259455|NCT03023553|623883|P2|NOT COMPLETED|Overall Study||1
259456|NCT03023553|623884|P1|NOT COMPLETED|Overall Study||0
259457|NCT03023553|623883|P2|COMPLETED|Overall Study||8
259458|NCT03023553|623884|P1|COMPLETED|Overall Study||4
259459|NCT03023553|623883|P2|STARTED|Overall Study||9
259460|NCT03023553|623884|P1|STARTED|Overall Study||4
259461|NCT03023488|623892|P1|NOT COMPLETED|Overall Study||0
259462|NCT03023488|623892|P1|COMPLETED|Overall Study||46
259463|NCT03023488|623892|P1|STARTED|Overall Study||46
259464|NCT03023176|623905|P1|NOT COMPLETED|Overall Study||0
259465|NCT03023176|623905|P1|COMPLETED|Overall Study||20
259466|NCT03023176|623905|P1|STARTED|Overall Study||20
259467|NCT03023137|623912|P2|NOT COMPLETED|Overall Study||9
259468|NCT03023137|623913|P1|NOT COMPLETED|Overall Study||4
259469|NCT03023137|623912|P2|COMPLETED|Overall Study||162
259470|NCT03023137|623913|P1|COMPLETED|Overall Study||174
259471|NCT03023137|623912|P2|STARTED|Overall Study||171
259472|NCT03023137|623913|P1|STARTED|Overall Study||178
259473|NCT03022435|623944|P5|NOT COMPLETED|Overall Study||0
259474|NCT03022435|623945|P4|NOT COMPLETED|Overall Study||0
259475|NCT03022435|623946|P3|NOT COMPLETED|Overall Study||0
259476|NCT03022435|623947|P2|NOT COMPLETED|Overall Study||0
259477|NCT03022435|623948|P1|NOT COMPLETED|Overall Study||0
259478|NCT03022435|623944|P5|COMPLETED|Overall Study||3
259479|NCT03022435|623945|P4|COMPLETED|Overall Study||3
259480|NCT03022435|623946|P3|COMPLETED|Overall Study||6
259481|NCT03022435|623947|P2|COMPLETED|Overall Study||5
259482|NCT03022435|623948|P1|COMPLETED|Overall Study||5
259483|NCT03022435|623944|P5|STARTED|Overall Study||3
259484|NCT03022435|623945|P4|STARTED|Overall Study||3
259485|NCT03022435|623946|P3|STARTED|Overall Study||6
259486|NCT03022435|623947|P2|STARTED|Overall Study||5
259487|NCT03022435|623948|P1|STARTED|Overall Study||5
259488|NCT03022422|623971|P6|NOT COMPLETED|Overall Study||0
259489|NCT03022422|623972|P5|NOT COMPLETED|Overall Study||0
259490|NCT03022422|623973|P4|NOT COMPLETED|Overall Study||0
259491|NCT03022422|623974|P3|NOT COMPLETED|Overall Study||3
259492|NCT03022422|623975|P2|NOT COMPLETED|Overall Study||0
259493|NCT03022422|623976|P1|NOT COMPLETED|Overall Study||0
259494|NCT03022422|623971|P6|COMPLETED|Overall Study||5
259495|NCT03022422|623972|P5|COMPLETED|Overall Study||5
259496|NCT03022422|623973|P4|COMPLETED|Overall Study||12
259497|NCT03022422|623974|P3|COMPLETED|Overall Study||20
259498|NCT03022422|623975|P2|COMPLETED|Overall Study||10
259499|NCT03022422|623976|P1|COMPLETED|Overall Study||8
259500|NCT03022422|623971|P6|STARTED|Overall Study||5
259501|NCT03022422|623972|P5|STARTED|Overall Study||5
259502|NCT03022422|623973|P4|STARTED|Overall Study||12
259503|NCT03022422|623974|P3|STARTED|Overall Study||23
259504|NCT03022422|623975|P2|STARTED|Overall Study||10
259505|NCT03022422|623976|P1|STARTED|Overall Study||8
259506|NCT03020537|623998|P2|NOT COMPLETED|Overall Study||0
259507|NCT03020537|623999|P1|NOT COMPLETED|Overall Study||0
259508|NCT03020537|623998|P2|COMPLETED|Overall Study||7
259509|NCT03020537|623999|P1|COMPLETED|Overall Study||1
259510|NCT03020537|623998|P2|STARTED|Overall Study||7
259511|NCT03020537|623999|P1|STARTED|Overall Study||1
259512|NCT03020498|624010|P3|NOT COMPLETED|Overall Study||0
259513|NCT03020498|624011|P2|NOT COMPLETED|Overall Study||3
259514|NCT03020498|624012|P1|NOT COMPLETED|Overall Study||0
259515|NCT03020498|624010|P3|COMPLETED|Overall Study||36
259516|NCT03020498|624011|P2|COMPLETED|Overall Study||38
259517|NCT03020498|624012|P1|COMPLETED|Overall Study||14
259518|NCT03020498|624010|P3|STARTED|Overall Study||36
259519|NCT03020498|624011|P2|STARTED|Overall Study||41
259520|NCT03020498|624012|P1|STARTED|Overall Study||14
259521|NCT03020472|624023|P1|NOT COMPLETED|Overall Study||0
259522|NCT03020472|624023|P1|COMPLETED|Overall Study||6
259523|NCT03020472|624023|P1|STARTED|Overall Study||6
259524|NCT03019783|624031|P2|NOT COMPLETED|Overall Study||0
259525|NCT03019783|624032|P1|NOT COMPLETED|Overall Study||0
259526|NCT03019783|624031|P2|COMPLETED|Overall Study||31
259527|NCT03019783|624032|P1|COMPLETED|Overall Study||29
259528|NCT03019783|624031|P2|STARTED|Overall Study||31
259529|NCT03019783|624032|P1|STARTED|Overall Study||29
259530|NCT03001674|624042|P2|NOT COMPLETED|Overall Study||0
259531|NCT03001674|624043|P1|NOT COMPLETED|Overall Study||0
259532|NCT03001674|624042|P2|COMPLETED|Overall Study||5
259533|NCT03001674|624043|P1|COMPLETED|Overall Study||10
259534|NCT03001674|624042|P2|STARTED|Overall Study||5
259535|NCT03001674|624043|P1|STARTED|Overall Study||10
259536|NCT03001258|624052|P3|NOT COMPLETED|Overall Study||0
259537|NCT03001258|624053|P2|NOT COMPLETED|Overall Study||0
259538|NCT03001258|624054|P1|NOT COMPLETED|Overall Study||0
259539|NCT03001258|624052|P3|COMPLETED|Overall Study||485
259540|NCT03001258|624053|P2|COMPLETED|Overall Study||751
259541|NCT03001258|624054|P1|COMPLETED|Overall Study||765
259542|NCT03001258|624052|P3|STARTED|Overall Study||485
259543|NCT03001258|624053|P2|STARTED|Overall Study||751
259544|NCT03001258|624054|P1|STARTED|Overall Study||765
259545|NCT03000088|624064|P2|NOT COMPLETED|Overall Study||0
259546|NCT03000088|624065|P1|NOT COMPLETED|Overall Study||0
259547|NCT03000088|624064|P2|COMPLETED|Overall Study||70
259548|NCT03000088|624065|P1|COMPLETED|Overall Study||70
259549|NCT03000088|624064|P2|STARTED|Overall Study||70
259550|NCT03000088|624065|P1|STARTED|Overall Study||70
259551|NCT02988219|624073|P2|NOT COMPLETED|Overall Study||3
259552|NCT02988219|624074|P1|NOT COMPLETED|Overall Study||1
259553|NCT02988219|624073|P2|COMPLETED|Overall Study||22
259554|NCT02988219|624074|P1|COMPLETED|Overall Study||24
259555|NCT02988219|624073|P2|STARTED|Overall Study||25
259556|NCT02988219|624074|P1|STARTED|Overall Study||25
259557|NCT02987374|624082|P1|NOT COMPLETED|Overall Study||0
259558|NCT02987374|624082|P1|COMPLETED|Overall Study||10
259559|NCT02987374|624082|P1|STARTED|Overall Study||10
259560|NCT02974543|624089|P2|NOT COMPLETED|Overall Study||0
259561|NCT02974543|624090|P1|NOT COMPLETED|Overall Study||1
259562|NCT02974543|624089|P2|COMPLETED|Overall Study||10
259563|NCT02974543|624090|P1|COMPLETED|Overall Study||10
259564|NCT02974543|624089|P2|Began Crossover Assignment|Overall Study||10
259565|NCT02974543|624090|P1|Began Crossover Assignment|Overall Study||10
259566|NCT02974543|624089|P2|Began Washout Period|Overall Study||10
259567|NCT02974543|624090|P1|Began Washout Period|Overall Study||10
259568|NCT02974543|624089|P2|STARTED|Overall Study||10
259569|NCT02974543|624090|P1|STARTED|Overall Study||11
259570|NCT02971670|624114|P4|NOT COMPLETED|Overall Study||2
259571|NCT02971670|624115|P3|NOT COMPLETED|Overall Study||1
259572|NCT02971670|624116|P2|NOT COMPLETED|Overall Study||1
259573|NCT02971670|624117|P1|NOT COMPLETED|Overall Study||4
259574|NCT02971670|624114|P4|COMPLETED|Overall Study||1
259575|NCT02971670|624115|P3|COMPLETED|Overall Study||4
259576|NCT02971670|624116|P2|COMPLETED|Overall Study||1
259577|NCT02971670|624117|P1|COMPLETED|Overall Study||9
259578|NCT02971670|624114|P4|STARTED|Overall Study||3
259579|NCT02971670|624115|P3|STARTED|Overall Study||5
259580|NCT02971670|624116|P2|STARTED|Overall Study||2
259581|NCT02971670|624117|P1|STARTED|Overall Study||13
259582|NCT02961244|624137|P2|NOT COMPLETED|Overall Study||9
259583|NCT02961244|624138|P1|NOT COMPLETED|Overall Study||1
259584|NCT02961244|624137|P2|COMPLETED|Overall Study||55
259585|NCT02961244|624138|P1|COMPLETED|Overall Study||63
259586|NCT02961244|624137|P2|Patients Excluded During Randomization|Overall Study||1
259587|NCT02961244|624138|P1|Patients Excluded During Randomization|Overall Study||0
259588|NCT02961244|624137|P2|STARTED|Overall Study||64
259589|NCT02961244|624138|P1|STARTED|Overall Study||64
259590|NCT02958995|624148|P2|NOT COMPLETED|Overall Study||0
259591|NCT02958995|624149|P1|NOT COMPLETED|Overall Study||0
259592|NCT02958995|624148|P2|COMPLETED|Overall Study||107495
259593|NCT02958995|624149|P1|COMPLETED|Overall Study||2630666
259594|NCT02958995|624148|P2|STARTED|Overall Study||107495
259595|NCT02958995|624149|P1|STARTED|Overall Study||2630666
259596|NCT02958956|624159|P2|NOT COMPLETED|Overall Study||0
259597|NCT02958956|624160|P1|NOT COMPLETED|Overall Study||0
259598|NCT02958956|624159|P2|COMPLETED|Overall Study||198317
259599|NCT02958956|624160|P1|COMPLETED|Overall Study||38190
259600|NCT02958956|624159|P2|STARTED|Overall Study||198317
259601|NCT02958956|624160|P1|STARTED|Overall Study||38190
259602|NCT02951767|624173|P1|NOT COMPLETED|Overall Study||119
259603|NCT02951767|624173|P1|COMPLETED|Overall Study||0
259604|NCT02951767|624173|P1|STARTED|Overall Study||119
259605|NCT02947984|624192|P2|NOT COMPLETED|Overall Study||0
259606|NCT02947984|624193|P1|NOT COMPLETED|Overall Study||0
259607|NCT02947984|624192|P2|COMPLETED|Overall Study||22
259608|NCT02947984|624193|P1|COMPLETED|Overall Study||22
259609|NCT02947984|624192|P2|STARTED|Overall Study||22
259610|NCT02947984|624193|P1|STARTED|Overall Study||22
259611|NCT02941640|624209|P4|NOT COMPLETED|Overall Study||0
259612|NCT02941640|624210|P3|NOT COMPLETED|Overall Study||0
259613|NCT02941640|624211|P2|NOT COMPLETED|Overall Study||0
259614|NCT02941640|624212|P1|NOT COMPLETED|Overall Study||0
259615|NCT02941640|624209|P4|COMPLETED|Overall Study||30
259616|NCT02941640|624210|P3|COMPLETED|Overall Study||30
259617|NCT02941640|624211|P2|COMPLETED|Overall Study||30
259618|NCT02941640|624212|P1|COMPLETED|Overall Study||30
259619|NCT02941640|624209|P4|STARTED|Overall Study||30
259620|NCT02941640|624210|P3|STARTED|Overall Study||30
259621|NCT02941640|624211|P2|STARTED|Overall Study||30
259622|NCT02941640|624212|P1|STARTED|Overall Study||30
259623|NCT02934347|624244|P2|NOT COMPLETED|Overall Study||0
259624|NCT02934347|624245|P1|NOT COMPLETED|Overall Study||0
259625|NCT02934347|624244|P2|COMPLETED|Overall Study||407
259626|NCT02934347|624245|P1|COMPLETED|Overall Study||374
259627|NCT02934347|624244|P2|STARTED|Overall Study||407
259628|NCT02934347|624245|P1|STARTED|Overall Study||374
259629|NCT02920749|624261|P4|NOT COMPLETED|Overall Study||0
259630|NCT02920749|624262|P3|NOT COMPLETED|Overall Study||0
259631|NCT02920749|624263|P2|NOT COMPLETED|Overall Study||0
259632|NCT02920749|624264|P1|NOT COMPLETED|Overall Study||0
259633|NCT02920749|624261|P4|COMPLETED|Overall Study||30
259634|NCT02920749|624262|P3|COMPLETED|Overall Study||30
259635|NCT02920749|624263|P2|COMPLETED|Overall Study||30
259636|NCT02920749|624264|P1|COMPLETED|Overall Study||30
259637|NCT02920749|624261|P4|STARTED|Overall Study||30
259638|NCT02920749|624262|P3|STARTED|Overall Study||30
259639|NCT02920749|624263|P2|STARTED|Overall Study||30
259640|NCT02920749|624264|P1|STARTED|Overall Study||30
259641|NCT02919657|624278|P2|NOT COMPLETED|Overall Study||0
259642|NCT02919657|624279|P1|NOT COMPLETED|Overall Study||0
259643|NCT02919657|624278|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
259644|NCT02919657|624279|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
259645|NCT02919657|624278|P2|STARTED|Overall Study|10 Participants|10
259646|NCT02919657|624279|P1|STARTED|Overall Study|10 Participants|10
259647|NCT02903238|624285|P1|NOT COMPLETED|Overall Study||4
259648|NCT02903238|624285|P1|COMPLETED|Overall Study||17
259649|NCT02903238|624285|P1|STARTED|Overall Study||21
259650|NCT02895347|624296|P2|NOT COMPLETED|Overall Study||1
259651|NCT02895347|624297|P1|NOT COMPLETED|Overall Study||3
259652|NCT02895347|624296|P2|COMPLETED|Overall Study||19
259653|NCT02895347|624297|P1|COMPLETED|Overall Study||17
259654|NCT02895347|624296|P2|STARTED|Overall Study||20
259655|NCT02895347|624297|P1|STARTED|Overall Study||20
259656|NCT02889289|624306|P1|NOT COMPLETED|Overall Study||0
259657|NCT02889289|624306|P1|COMPLETED|Overall Study||1
259658|NCT02889289|624306|P1|STARTED|Overall Study||1
259659|NCT02882152|624317|P2|NOT COMPLETED|Overall Study||0
259660|NCT02882152|624318|P1|NOT COMPLETED|Overall Study||1
259661|NCT02882152|624317|P2|COMPLETED|Overall Study||20
259662|NCT02882152|624318|P1|COMPLETED|Overall Study||19
259663|NCT02882152|624317|P2|STARTED|Overall Study||20
259664|NCT02882152|624318|P1|STARTED|Overall Study||20
259665|NCT02863198|624328|P2|NOT COMPLETED|Overall Study||0
259666|NCT02863198|624329|P1|NOT COMPLETED|Overall Study||0
259667|NCT02863198|624328|P2|COMPLETED|Overall Study||60
259668|NCT02863198|624329|P1|COMPLETED|Overall Study||60
259669|NCT02863198|624328|P2|STARTED|Overall Study||60
259670|NCT02863198|624329|P1|STARTED|Overall Study||60
259671|NCT02862106|624351|P2|NOT COMPLETED|Overall Study||6
259672|NCT02862106|624352|P1|NOT COMPLETED|Overall Study||38
259673|NCT02862106|624351|P2|COMPLETED|Overall Study||20
259674|NCT02862106|624352|P1|COMPLETED|Overall Study||145
259675|NCT02862106|624351|P2|STARTED|Overall Study||26
259676|NCT02862106|624352|P1|STARTED|Overall Study||183
259677|NCT02856880|624410|P1|NOT COMPLETED|Overall Study||1
259678|NCT02856880|624410|P1|COMPLETED|Overall Study||44
259679|NCT02856880|624410|P1|Received SLS Negative Control|Overall Study||44
259680|NCT02856880|624410|P1|Received Non-SLS Negative Control|Overall Study||44
259681|NCT02856880|624410|P1|Received Positive Control|Overall Study||45
259682|NCT02856880|624410|P1|Received Test Zinc Non-IPMP|Overall Study||44
259683|NCT02856880|624410|P1|Received Test Zinc-IPMP|Overall Study||44
259684|NCT02856880|624410|P1|STARTED|Overall Study||45
259685|NCT02849678|624436|P2|NOT COMPLETED|Overall Study||6
259686|NCT02849678|624437|P1|NOT COMPLETED|Overall Study||6
259687|NCT02849678|624436|P2|COMPLETED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|18
259688|NCT02849678|624437|P1|COMPLETED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|17
259689|NCT02849678|624436|P2|STARTED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|24
259690|NCT02849678|624437|P1|STARTED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|23
259691|NCT02847169|624443|P2|NOT COMPLETED|Second Intervention (1 Week)||0
259692|NCT02847169|624444|P1|NOT COMPLETED|Second Intervention (1 Week)||0
259693|NCT02847169|624443|P2|COMPLETED|Second Intervention (1 Week)||15
259694|NCT02847169|624444|P1|COMPLETED|Second Intervention (1 Week)||15
259695|NCT02847169|624443|P2|STARTED|Second Intervention (1 Week)||15
259696|NCT02847169|624444|P1|STARTED|Second Intervention (1 Week)||15
259697|NCT02847169|624443|P2|NOT COMPLETED|First Intervention (1 Week)||0
259698|NCT02847169|624444|P1|NOT COMPLETED|First Intervention (1 Week)||0
259699|NCT02847169|624443|P2|COMPLETED|First Intervention (1 Week)||15
259700|NCT02847169|624444|P1|COMPLETED|First Intervention (1 Week)||15
259701|NCT02847169|624443|P2|STARTED|First Intervention (1 Week)||15
259702|NCT02847169|624444|P1|STARTED|First Intervention (1 Week)||15
259703|NCT02840916|624480|P2|NOT COMPLETED|Overall Study||3
259704|NCT02840916|624481|P1|NOT COMPLETED|Overall Study||1
259705|NCT02840916|624480|P2|COMPLETED|Overall Study||30
259706|NCT02840916|624481|P1|COMPLETED|Overall Study||32
259707|NCT02840916|624480|P2|STARTED|Overall Study||33
259708|NCT02840916|624481|P1|STARTED|Overall Study||33
259709|NCT02839772|624493|P2|NOT COMPLETED|Overall Study||0
259710|NCT02839772|624494|P1|NOT COMPLETED|Overall Study||1
259711|NCT02839772|624493|P2|COMPLETED|Overall Study||96
259712|NCT02839772|624494|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
259713|NCT02839772|624493|P2|STARTED|Overall Study||96
259714|NCT02839772|624494|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
259715|NCT02834624|624533|P2|NOT COMPLETED|Overall Study||0
259716|NCT02834624|624534|P1|NOT COMPLETED|Overall Study||0
259717|NCT02834624|624533|P2|COMPLETED|Overall Study||15
259718|NCT02834624|624534|P1|COMPLETED|Overall Study||15
259719|NCT02834624|624533|P2|STARTED|Overall Study||15
259720|NCT02834624|624534|P1|STARTED|Overall Study||15
259721|NCT02832375|624546|P2|NOT COMPLETED|Overall Study||0
259722|NCT02832375|624547|P1|NOT COMPLETED|Overall Study||2
259723|NCT02832375|624546|P2|COMPLETED|Overall Study||121
259724|NCT02832375|624547|P1|COMPLETED|Overall Study||119
259725|NCT02832375|624546|P2|STARTED|Overall Study||121
259726|NCT02832375|624547|P1|STARTED|Overall Study||121
259727|NCT02829775|624557|P1|NOT COMPLETED|Overall Study||5
259728|NCT02829775|624557|P1|COMPLETED|Overall Study||4
259729|NCT02829775|624557|P1|STARTED|Overall Study||9
259730|NCT02829463|624564|P2|NOT COMPLETED|Overall Study||0
259731|NCT02829463|624565|P1|NOT COMPLETED|Overall Study||0
259732|NCT02829463|624564|P2|COMPLETED|Overall Study||62
259733|NCT02829463|624565|P1|COMPLETED|Overall Study||59
259734|NCT02829463|624564|P2|STARTED|Overall Study||62
259735|NCT02829463|624565|P1|STARTED|Overall Study||59
259736|NCT02828137|624574|P3|NOT COMPLETED|Overall Study||0
259737|NCT02828137|624575|P2|NOT COMPLETED|Overall Study||0
259738|NCT02828137|624576|P1|NOT COMPLETED|Overall Study||0
259739|NCT02828137|624574|P3|COMPLETED|Overall Study||41
259740|NCT02828137|624575|P2|COMPLETED|Overall Study||41
259741|NCT02828137|624576|P1|COMPLETED|Overall Study||41
259742|NCT02828137|624574|P3|STARTED|Overall Study||41
259743|NCT02828137|624575|P2|STARTED|Overall Study||41
259744|NCT02828137|624576|P1|STARTED|Overall Study||41
259745|NCT02823080|624586|P2|NOT COMPLETED|Overall Study||0
259746|NCT02823080|624587|P1|NOT COMPLETED|Overall Study||0
259747|NCT02823080|624586|P2|COMPLETED|Overall Study||24
259748|NCT02823080|624587|P1|COMPLETED|Overall Study||24
259749|NCT02823080|624586|P2|STARTED|Overall Study||24
259750|NCT02823080|624587|P1|STARTED|Overall Study||24
259751|NCT02822885|624605|P1|NOT COMPLETED|Overall Study||0
259752|NCT02822885|624605|P1|COMPLETED|Overall Study||70
259753|NCT02822885|624605|P1|STARTED|Overall Study||70
259754|NCT02822287|624613|P1|NOT COMPLETED|Overall Study||0
259755|NCT02822287|624613|P1|COMPLETED|Overall Study||57
259756|NCT02822287|624613|P1|STARTED|Overall Study||57
259757|NCT02821403|624625|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
259758|NCT02821403|624626|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
259759|NCT02821403|624625|P2|COMPLETED|"Third Intervention (1 Month)"||40
259760|NCT02821403|624626|P1|COMPLETED|"Third Intervention (1 Month)"||40
259761|NCT02821403|624625|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
259762|NCT02821403|624626|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
259763|NCT02821403|624625|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
259764|NCT02821403|624626|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
259765|NCT02821403|624625|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
259766|NCT02821403|624626|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
259767|NCT02821403|624625|P2|STARTED|"Third Intervention (1 Month)"||40
259768|NCT02821403|624626|P1|STARTED|"Third Intervention (1 Month)"||40
259769|NCT02821403|624625|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
259770|NCT02821403|624626|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
259771|NCT02821403|624625|P2|COMPLETED|"Second Intervention (1 Month)"||40
259772|NCT02821403|624626|P1|COMPLETED|"Second Intervention (1 Month)"||40
259773|NCT02821403|624625|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
259774|NCT02821403|624626|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
259775|NCT02821403|624625|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
259776|NCT02821403|624626|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
259777|NCT02821403|624625|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
259778|NCT02821403|624626|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
259779|NCT02821403|624625|P2|STARTED|"Second Intervention (1 Month)"||40
259780|NCT02821403|624626|P1|STARTED|"Second Intervention (1 Month)"||40
259781|NCT02821403|624625|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
259782|NCT02821403|624626|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
259783|NCT02821403|624625|P2|COMPLETED|"First Intervention (1 Month)"||40
259784|NCT02821403|624626|P1|COMPLETED|"First Intervention (1 Month)"||40
259785|NCT02821403|624625|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
259786|NCT02821403|624626|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
259787|NCT02821403|624625|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
259788|NCT02821403|624626|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
259789|NCT02821403|624625|P2|Used Clear Lens|"First Intervention (1 Month)"||13
259790|NCT02821403|624626|P1|Used Clear Lens|"First Intervention (1 Month)"||13
259791|NCT02821403|624625|P2|STARTED|"First Intervention (1 Month)"||40
259792|NCT02821403|624626|P1|STARTED|"First Intervention (1 Month)"||40
259793|NCT02817763|624646|P2|NOT COMPLETED|Overall Study||0
259794|NCT02817763|624647|P1|NOT COMPLETED|Overall Study||0
259795|NCT02817763|624646|P2|COMPLETED|Overall Study||20
259796|NCT02817763|624647|P1|COMPLETED|Overall Study||20
259797|NCT02817763|624646|P2|STARTED|Overall Study||20
259798|NCT02817763|624647|P1|STARTED|Overall Study||20
259799|NCT02815735|624655|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
259800|NCT02815735|624656|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
259801|NCT02815735|624655|P2|COMPLETED|Second Intervention (4 Weeks)||37
259802|NCT02815735|624656|P1|COMPLETED|Second Intervention (4 Weeks)||33
259803|NCT02815735|624655|P2|STARTED|Second Intervention (4 Weeks)||37
259804|NCT02815735|624656|P1|STARTED|Second Intervention (4 Weeks)||34
259805|NCT02815735|624655|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
259806|NCT02815735|624656|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
259807|NCT02815735|624655|P2|COMPLETED|First Intervention (4 Weeks)||37
259808|NCT02815735|624656|P1|COMPLETED|First Intervention (4 Weeks)||34
259809|NCT02815735|624655|P2|STARTED|First Intervention (4 Weeks)||38
259810|NCT02815735|624656|P1|STARTED|First Intervention (4 Weeks)||36
259811|NCT02814279|624673|P2|NOT COMPLETED|Overall Study||0
259812|NCT02814279|624674|P1|NOT COMPLETED|Overall Study||0
259813|NCT02814279|624673|P2|COMPLETED|Overall Study||21
259814|NCT02814279|624674|P1|COMPLETED|Overall Study||21
259815|NCT02814279|624673|P2|STARTED|Overall Study||21
259816|NCT02814279|624674|P1|STARTED|Overall Study||21
259817|NCT02813070|624685|P3|NOT COMPLETED|Overall Study||11
259818|NCT02813070|624686|P2|NOT COMPLETED|Overall Study||3
259819|NCT02813070|624687|P1|NOT COMPLETED|Overall Study||3
259820|NCT02813070|624685|P3|COMPLETED|Overall Study||25
259821|NCT02813070|624686|P2|COMPLETED|Overall Study||20
259822|NCT02813070|624687|P1|COMPLETED|Overall Study||25
259823|NCT02813070|624685|P3|Treated (Safety Population)|Overall Study||25
259824|NCT02813070|624686|P2|Treated (Safety Population)|Overall Study||20
259825|NCT02813070|624687|P1|Treated (Safety Population)|Overall Study||25
259826|NCT02813070|624685|P3|STARTED|Overall Study||36
259827|NCT02813070|624686|P2|STARTED|Overall Study||23
259828|NCT02813070|624687|P1|STARTED|Overall Study||28
259829|NCT02809911|624698|P2|NOT COMPLETED|Overall Study||0
259830|NCT02809911|624699|P1|NOT COMPLETED|Overall Study||0
259831|NCT02809911|624698|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
259832|NCT02809911|624699|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
259833|NCT02809911|624698|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
259834|NCT02809911|624699|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
259835|NCT02809833|624707|P1|NOT COMPLETED|Overall Study||300
259836|NCT02809833|624707|P1|COMPLETED|Overall Study||550
259837|NCT02809833|624707|P1|STARTED|Overall Study||850
259838|NCT02808130|624787|P6|NOT COMPLETED|Overall Study||0
259839|NCT02808130|624788|P5|NOT COMPLETED|Overall Study||0
259840|NCT02808130|624789|P4|NOT COMPLETED|Overall Study||0
259841|NCT02808130|624790|P3|NOT COMPLETED|Overall Study||0
259842|NCT02808130|624791|P2|NOT COMPLETED|Overall Study||0
259843|NCT02808130|624792|P1|NOT COMPLETED|Overall Study||0
259844|NCT02808130|624787|P6|COMPLETED|Overall Study||15
259845|NCT02808130|624788|P5|COMPLETED|Overall Study||15
259846|NCT02808130|624789|P4|COMPLETED|Overall Study||15
259847|NCT02808130|624790|P3|COMPLETED|Overall Study||15
259848|NCT02808130|624791|P2|COMPLETED|Overall Study||15
259849|NCT02808130|624792|P1|COMPLETED|Overall Study||15
259850|NCT02808130|624787|P6|STARTED|Overall Study||15
259851|NCT02808130|624788|P5|STARTED|Overall Study||15
259852|NCT02808130|624789|P4|STARTED|Overall Study||15
259853|NCT02808130|624790|P3|STARTED|Overall Study||15
259854|NCT02808130|624791|P2|STARTED|Overall Study||15
259855|NCT02808130|624792|P1|STARTED|Overall Study||15
259856|NCT02806544|624818|P1|NOT COMPLETED|Overall Study||4
259857|NCT02806544|624818|P1|COMPLETED|Overall Study||31
259858|NCT02806544|624818|P1|STARTED|Overall Study||35
259859|NCT02806505|624829|P2|NOT COMPLETED|Overall Study||11
259860|NCT02806505|624830|P1|NOT COMPLETED|Overall Study||10
259861|NCT02806505|624829|P2|COMPLETED|Overall Study||32
259862|NCT02806505|624830|P1|COMPLETED|Overall Study||28
259863|NCT02806505|624829|P2|STARTED|Overall Study||43
259864|NCT02806505|624830|P1|STARTED|Overall Study||38
259865|NCT02805907|624842|P2|NOT COMPLETED|Overall Study||3
259866|NCT02805907|624843|P1|NOT COMPLETED|Overall Study||3
259867|NCT02805907|624842|P2|COMPLETED|Overall Study||53
259868|NCT02805907|624843|P1|COMPLETED|Overall Study||53
259869|NCT02805907|624842|P2|STARTED|Overall Study||56
259870|NCT02805907|624843|P1|STARTED|Overall Study||56
259871|NCT02801396|624855|P6|NOT COMPLETED|Period 3||0
259872|NCT02801396|624856|P5|NOT COMPLETED|Period 3||0
259873|NCT02801396|624857|P4|NOT COMPLETED|Period 3||0
259874|NCT02801396|624858|P3|NOT COMPLETED|Period 3||0
259875|NCT02801396|624859|P2|NOT COMPLETED|Period 3||0
259876|NCT02801396|624860|P1|NOT COMPLETED|Period 3||0
259877|NCT02801396|624855|P6|COMPLETED|Period 3||17
259878|NCT02801396|624856|P5|COMPLETED|Period 3||16
259879|NCT02801396|624857|P4|COMPLETED|Period 3||16
259880|NCT02801396|624858|P3|COMPLETED|Period 3||17
259881|NCT02801396|624859|P2|COMPLETED|Period 3||17
259882|NCT02801396|624860|P1|COMPLETED|Period 3||17
259883|NCT02801396|624855|P6|STARTED|Period 3||17
259884|NCT02801396|624856|P5|STARTED|Period 3||16
259885|NCT02801396|624857|P4|STARTED|Period 3||16
259886|NCT02801396|624858|P3|STARTED|Period 3||17
259887|NCT02801396|624859|P2|STARTED|Period 3||17
259888|NCT02801396|624860|P1|STARTED|Period 3||17
259889|NCT02801396|624855|P6|NOT COMPLETED|Period 2||0
259890|NCT02801396|624856|P5|NOT COMPLETED|Period 2||0
259891|NCT02801396|624857|P4|NOT COMPLETED|Period 2||0
259892|NCT02801396|624858|P3|NOT COMPLETED|Period 2||0
259893|NCT02801396|624859|P2|NOT COMPLETED|Period 2||0
259894|NCT02801396|624860|P1|NOT COMPLETED|Period 2||0
259895|NCT02801396|624855|P6|COMPLETED|Period 2||17
259896|NCT02801396|624856|P5|COMPLETED|Period 2||16
259897|NCT02801396|624857|P4|COMPLETED|Period 2||16
259898|NCT02801396|624858|P3|COMPLETED|Period 2||17
259899|NCT02801396|624859|P2|COMPLETED|Period 2||17
259900|NCT02801396|624860|P1|COMPLETED|Period 2||17
259901|NCT02801396|624855|P6|STARTED|Period 2||17
259902|NCT02801396|624856|P5|STARTED|Period 2||16
259903|NCT02801396|624857|P4|STARTED|Period 2||16
259904|NCT02801396|624858|P3|STARTED|Period 2||17
259905|NCT02801396|624859|P2|STARTED|Period 2||17
259906|NCT02801396|624860|P1|STARTED|Period 2||17
259907|NCT02801396|624855|P6|NOT COMPLETED|Period 1||0
259908|NCT02801396|624856|P5|NOT COMPLETED|Period 1||1
259909|NCT02801396|624857|P4|NOT COMPLETED|Period 1||0
259910|NCT02801396|624858|P3|NOT COMPLETED|Period 1||0
259911|NCT02801396|624859|P2|NOT COMPLETED|Period 1||0
259912|NCT02801396|624860|P1|NOT COMPLETED|Period 1||0
259913|NCT02801396|624855|P6|COMPLETED|Period 1||17
259914|NCT02801396|624856|P5|COMPLETED|Period 1||16
259915|NCT02801396|624857|P4|COMPLETED|Period 1||16
259916|NCT02801396|624858|P3|COMPLETED|Period 1||17
259917|NCT02801396|624859|P2|COMPLETED|Period 1||17
259918|NCT02801396|624860|P1|COMPLETED|Period 1||17
259919|NCT02801396|624855|P6|STARTED|Period 1||17
259920|NCT02801396|624856|P5|STARTED|Period 1||17
259921|NCT02801396|624857|P4|STARTED|Period 1||16
259922|NCT02801396|624858|P3|STARTED|Period 1||17
259923|NCT02801396|624859|P2|STARTED|Period 1||17
259924|NCT02801396|624860|P1|STARTED|Period 1||17
259925|NCT02799082|624879|P2|NOT COMPLETED|Overall Study||4
259926|NCT02799082|624880|P1|NOT COMPLETED|Overall Study||4
259927|NCT02799082|624879|P2|COMPLETED|Overall Study||77
259928|NCT02799082|624880|P1|COMPLETED|Overall Study||37
259929|NCT02799082|624879|P2|STARTED|Overall Study||81
259930|NCT02799082|624880|P1|STARTED|Overall Study||41
259931|NCT02799069|624917|P3|NOT COMPLETED|Overall Study||7
259932|NCT02799069|624918|P2|NOT COMPLETED|Overall Study||7
259933|NCT02799069|624919|P1|NOT COMPLETED|Overall Study||8
259934|NCT02799069|624917|P3|COMPLETED|Overall Study||240
259935|NCT02799069|624918|P2|COMPLETED|Overall Study||241
259936|NCT02799069|624919|P1|COMPLETED|Overall Study||68
259937|NCT02799069|624917|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
259938|NCT02799069|624918|P2|ITT/Safety|Overall Study||248
259939|NCT02799069|624919|P1|ITT/Safety|Overall Study||76
259940|NCT02799069|624917|P3|STARTED|Overall Study||247
259941|NCT02799069|624918|P2|STARTED|Overall Study||248
259942|NCT02799069|624919|P1|STARTED|Overall Study||76
259943|NCT02796092|625031|P2|NOT COMPLETED|Overall Study||0
259944|NCT02796092|625032|P1|NOT COMPLETED|Overall Study||0
259945|NCT02796092|625031|P2|COMPLETED|Overall Study||50
259946|NCT02796092|625032|P1|COMPLETED|Overall Study||50
259947|NCT02796092|625031|P2|STARTED|Overall Study||50
259948|NCT02796092|625032|P1|STARTED|Overall Study||50
259949|NCT02792049|625066|P2|NOT COMPLETED|Overall Study||0
259950|NCT02792049|625067|P1|NOT COMPLETED|Overall Study||0
259951|NCT02792049|625066|P2|COMPLETED|Overall Study||35
259952|NCT02792049|625067|P1|COMPLETED|Overall Study||35
259953|NCT02792049|625066|P2|STARTED|Overall Study||35
259954|NCT02792049|625067|P1|STARTED|Overall Study||35
259955|NCT02791659|625083|P2|NOT COMPLETED|Overall Study||1
259956|NCT02791659|625084|P1|NOT COMPLETED|Overall Study||0
259957|NCT02791659|625083|P2|COMPLETED|Overall Study||27
259958|NCT02791659|625084|P1|COMPLETED|Overall Study||27
259959|NCT02791659|625083|P2|STARTED|Overall Study||28
259960|NCT02791659|625084|P1|STARTED|Overall Study||27
259961|NCT02791269|625092|P2|NOT COMPLETED|Overall Study||1
259962|NCT02791269|625093|P1|NOT COMPLETED|Overall Study||0
259963|NCT02791269|625092|P2|COMPLETED|Overall Study||19
259964|NCT02791269|625093|P1|COMPLETED|Overall Study||4
259965|NCT02791269|625092|P2|STARTED|Overall Study||20
259966|NCT02791269|625093|P1|STARTED|Overall Study||4
259967|NCT02790281|625107|P1|NOT COMPLETED|Overall Study||0
259968|NCT02790281|625107|P1|COMPLETED|Overall Study||33
259969|NCT02790281|625107|P1|STARTED|Overall Study||33
259970|NCT02788097|625115|P2|NOT COMPLETED|Overall Study||0
259971|NCT02788097|625116|P1|NOT COMPLETED|Overall Study||0
259972|NCT02788097|625115|P2|COMPLETED|Overall Study||69
259973|NCT02788097|625116|P1|COMPLETED|Overall Study||61
259974|NCT02788097|625115|P2|STARTED|Overall Study||69
259975|NCT02788097|625116|P1|STARTED|Overall Study||61
259976|NCT02780622|625122|P2|NOT COMPLETED|Treatment Period 2||0
259977|NCT02780622|625123|P1|NOT COMPLETED|Treatment Period 2||0
259978|NCT02780622|625122|P2|COMPLETED|Treatment Period 2||10
259979|NCT02780622|625123|P1|COMPLETED|Treatment Period 2||10
259980|NCT02780622|625122|P2|STARTED|Treatment Period 2||10
259981|NCT02780622|625123|P1|STARTED|Treatment Period 2||10
259982|NCT02780622|625122|P2|NOT COMPLETED|Treatment Period 1||0
259983|NCT02780622|625123|P1|NOT COMPLETED|Treatment Period 1||0
259984|NCT02780622|625122|P2|COMPLETED|Treatment Period 1||10
259985|NCT02780622|625123|P1|COMPLETED|Treatment Period 1||10
259986|NCT02780622|625122|P2|STARTED|Treatment Period 1||10
259987|NCT02780622|625123|P1|STARTED|Treatment Period 1||10
259988|NCT02774278|625161|P1|NOT COMPLETED|Overall Study||264
259989|NCT02774278|625161|P1|COMPLETED|Overall Study||0
259990|NCT02774278|625161|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
259991|NCT02774278|625161|P1|STARTED|Overall Study||264
259992|NCT02773758|625171|P2|NOT COMPLETED|Overall Study||0
259993|NCT02773758|625172|P1|NOT COMPLETED|Overall Study||0
259994|NCT02773758|625171|P2|COMPLETED|Overall Study||70
259995|NCT02773758|625172|P1|COMPLETED|Overall Study||71
259996|NCT02773758|625171|P2|STARTED|Overall Study||70
259997|NCT02773758|625172|P1|STARTED|Overall Study||71
259998|NCT02772666|625182|P1|NOT COMPLETED|SFT Then O-Glass||0
259999|NCT02772666|625182|P1|COMPLETED|SFT Then O-Glass||44
260000|NCT02772666|625182|P1|STARTED|SFT Then O-Glass||44
260001|NCT02772666|625182|P1|NOT COMPLETED|O-Glas Then SFT||0
260002|NCT02772666|625182|P1|COMPLETED|O-Glas Then SFT||44
260003|NCT02772666|625182|P1|STARTED|O-Glas Then SFT||44
260004|NCT02767843|625187|P1|NOT COMPLETED|Overall Study||0
260005|NCT02767843|625187|P1|COMPLETED|Overall Study||4
260006|NCT02767843|625187|P1|STARTED|Overall Study||4
260007|NCT02767765|625193|P1|NOT COMPLETED|Overall Study||11
260008|NCT02767765|625193|P1|COMPLETED|Overall Study||50
260009|NCT02767765|625193|P1|STARTED|Overall Study||61
260010|NCT02766400|625204|P2|NOT COMPLETED|Overall Study||2
260011|NCT02766400|625205|P1|NOT COMPLETED|Overall Study||2
260012|NCT02766400|625204|P2|COMPLETED|Overall Study||20
260013|NCT02766400|625205|P1|COMPLETED|Overall Study||19
260014|NCT02766400|625204|P2|STARTED|Overall Study||22
260015|NCT02766400|625205|P1|STARTED|Overall Study||21
260016|NCT02766244|625211|P1|NOT COMPLETED|Overall Study||0
260017|NCT02766244|625211|P1|COMPLETED|Overall Study||3
260018|NCT02766244|625211|P1|STARTED|Overall Study||3
260019|NCT02765269|625222|P2|NOT COMPLETED|Overall Study||0
260020|NCT02765269|625223|P1|NOT COMPLETED|Overall Study||0
260021|NCT02765269|625222|P2|COMPLETED|Overall Study||21
260022|NCT02765269|625223|P1|COMPLETED|Overall Study||25
260023|NCT02765269|625222|P2|STARTED|Overall Study||21
260024|NCT02765269|625223|P1|STARTED|Overall Study||25
260025|NCT02763189|625237|P2|NOT COMPLETED|Overall Study||2
260026|NCT02763189|625238|P1|NOT COMPLETED|Overall Study||0
260027|NCT02763189|625237|P2|COMPLETED|Overall Study||2
260028|NCT02763189|625238|P1|COMPLETED|Overall Study||4
260029|NCT02763189|625237|P2|STARTED|Overall Study||4
260030|NCT02763189|625238|P1|STARTED|Overall Study||4
260031|NCT02761733|625250|P4|NOT COMPLETED|Overall Study||15
260032|NCT02761733|625251|P3|NOT COMPLETED|Overall Study||27
260033|NCT02761733|625252|P2|NOT COMPLETED|Overall Study||21
260034|NCT02761733|625253|P1|NOT COMPLETED|Overall Study||30
260035|NCT02761733|625250|P4|COMPLETED|Overall Study||45
260036|NCT02761733|625251|P3|COMPLETED|Overall Study||33
260037|NCT02761733|625252|P2|COMPLETED|Overall Study||39
260038|NCT02761733|625253|P1|COMPLETED|Overall Study||30
260039|NCT02761733|625250|P4|9/30/2015|Overall Study||50
260040|NCT02761733|625251|P3|9/30/2015|Overall Study||33
260041|NCT02761733|625252|P2|9/30/2015|Overall Study||44
260042|NCT02761733|625253|P1|9/30/2015|Overall Study||40
260043|NCT02761733|625250|P4|3/31/2015|Overall Study||50
260044|NCT02761733|625251|P3|3/31/2015|Overall Study||43
260045|NCT02761733|625252|P2|3/31/2015|Overall Study||47
260046|NCT02761733|625253|P1|3/31/2015|Overall Study||48
260047|NCT02761733|625250|P4|9/30/2014|Overall Study||55
260048|NCT02761733|625251|P3|9/30/2014|Overall Study||48
260049|NCT02761733|625252|P2|9/30/2014|Overall Study||56
260050|NCT02761733|625253|P1|9/30/2014|Overall Study||53
260051|NCT02761733|625250|P4|STARTED|Overall Study||60
260052|NCT02761733|625251|P3|STARTED|Overall Study||60
260053|NCT02761733|625252|P2|STARTED|Overall Study||60
260054|NCT02761733|625253|P1|STARTED|Overall Study||60
260055|NCT02761629|625285|P2|NOT COMPLETED|Overall Study||32
260056|NCT02761629|625286|P1|NOT COMPLETED|Overall Study||27
260057|NCT02761629|625285|P2|COMPLETED|Overall Study||58
260058|NCT02761629|625286|P1|COMPLETED|Overall Study||63
260059|NCT02761629|625285|P2|Treated|Overall Study||86
260060|NCT02761629|625286|P1|Treated|Overall Study||82
260061|NCT02761629|625285|P2|STARTED|Overall Study||90
260062|NCT02761629|625286|P1|STARTED|Overall Study||90
260063|NCT02760654|625308|P2|NOT COMPLETED|Overall Study||6
260064|NCT02760654|625309|P1|NOT COMPLETED|Overall Study||7
260065|NCT02760654|625308|P2|COMPLETED|Overall Study||24
260066|NCT02760654|625309|P1|COMPLETED|Overall Study||23
260067|NCT02760654|625308|P2|STARTED|Overall Study||30
260068|NCT02760654|625309|P1|STARTED|Overall Study||30
260069|NCT02759471|625333|P1|NOT COMPLETED|Overall Study||2
260070|NCT02759471|625333|P1|COMPLETED|Overall Study||52
260071|NCT02759471|625333|P1|STARTED|Overall Study||54
260072|NCT02756637|625345|P2|NOT COMPLETED|Overall Study||54
260073|NCT02756637|625346|P1|NOT COMPLETED|Overall Study||87
260074|NCT02756637|625345|P2|COMPLETED|Overall Study||263
260075|NCT02756637|625346|P1|COMPLETED|Overall Study||230
260076|NCT02756637|625345|P2|Completed Curative Treatment|Overall Study||0
260077|NCT02756637|625346|P1|Completed Curative Treatment|Overall Study||230
260078|NCT02756637|625345|P2|Had NLR Value|Overall Study||263
260079|NCT02756637|625346|P1|Had NLR Value|Overall Study||263
260080|NCT02756637|625345|P2|Eligible for SWOG 8710|Overall Study||307
260081|NCT02756637|625346|P1|Eligible for SWOG 8710|Overall Study||307
260082|NCT02756637|625345|P2|STARTED|Overall Study||317
260083|NCT02756637|625346|P1|STARTED|Overall Study||317
260084|NCT02756351|625354|P2|NOT COMPLETED|Overall Study||0
260085|NCT02756351|625355|P1|NOT COMPLETED|Overall Study||0
260086|NCT02756351|625354|P2|COMPLETED|Overall Study||24
260087|NCT02756351|625355|P1|COMPLETED|Overall Study||24
260088|NCT02756351|625354|P2|STARTED|Overall Study||24
260089|NCT02756351|625355|P1|STARTED|Overall Study||24
260090|NCT02755805|625365|P2|NOT COMPLETED|Overall Study||4
260091|NCT02755805|625366|P1|NOT COMPLETED|Overall Study||2
260092|NCT02755805|625365|P2|COMPLETED|Overall Study||11
260093|NCT02755805|625366|P1|COMPLETED|Overall Study||13
260094|NCT02755805|625365|P2|STARTED|Overall Study||15
260095|NCT02755805|625366|P1|STARTED|Overall Study||15
260096|NCT02753699|625381|P3|NOT COMPLETED|Overall Study||23
260097|NCT02753699|625382|P2|NOT COMPLETED|Overall Study||43
260098|NCT02753699|625383|P1|NOT COMPLETED|Overall Study||14
260099|NCT02753699|625381|P3|COMPLETED|Overall Study||139
260100|NCT02753699|625382|P2|COMPLETED|Overall Study||354
260101|NCT02753699|625383|P1|COMPLETED|Overall Study||150
260102|NCT02753699|625381|P3|STARTED|Overall Study||162
260103|NCT02753699|625382|P2|STARTED|Overall Study||397
260104|NCT02753699|625383|P1|STARTED|Overall Study||164
260105|NCT02753075|625400|P3|NOT COMPLETED|Overall Study||3
260106|NCT02753075|625401|P2|NOT COMPLETED|Overall Study||3
260107|NCT02753075|625402|P1|NOT COMPLETED|Overall Study||8
260108|NCT02753075|625400|P3|COMPLETED|Overall Study||78
260109|NCT02753075|625401|P2|COMPLETED|Overall Study||77
260110|NCT02753075|625402|P1|COMPLETED|Overall Study||71
260111|NCT02753075|625400|P3|STARTED|Overall Study||81
260112|NCT02753075|625401|P2|STARTED|Overall Study||80
260113|NCT02753075|625402|P1|STARTED|Overall Study||79
260114|NCT02752802|625429|P2|NOT COMPLETED|Overall Study||0
260115|NCT02752802|625430|P1|NOT COMPLETED|Overall Study||1
260116|NCT02752802|625429|P2|COMPLETED|Overall Study||48
260117|NCT02752802|625430|P1|COMPLETED|Overall Study||47
260118|NCT02752802|625429|P2|STARTED|Overall Study||48
260119|NCT02752802|625430|P1|STARTED|Overall Study||48
260120|NCT02751450|625441|P2|NOT COMPLETED|Overall Study||0
260121|NCT02751450|625442|P1|NOT COMPLETED|Overall Study||1
260122|NCT02751450|625441|P2|COMPLETED|Overall Study||116
260123|NCT02751450|625442|P1|COMPLETED|Overall Study||116
260124|NCT02751450|625441|P2|STARTED|Overall Study||116
260125|NCT02751450|625442|P1|STARTED|Overall Study||117
260126|NCT02750943|625456|P2|NOT COMPLETED|Overall Study||9
260127|NCT02750943|625457|P1|NOT COMPLETED|Overall Study||6
260128|NCT02750943|625456|P2|COMPLETED|Overall Study||119
260129|NCT02750943|625457|P1|COMPLETED|Overall Study||119
260130|NCT02750943|625456|P2|STARTED|Overall Study||128
260131|NCT02750943|625457|P1|STARTED|Overall Study||125
260132|NCT02750709|625471|P6|NOT COMPLETED|Treatment Period 3||0
260133|NCT02750709|625472|P5|NOT COMPLETED|Treatment Period 3||0
260134|NCT02750709|625473|P4|NOT COMPLETED|Treatment Period 3||0
260135|NCT02750709|625474|P3|NOT COMPLETED|Treatment Period 3||0
260136|NCT02750709|625475|P2|NOT COMPLETED|Treatment Period 3||0
260137|NCT02750709|625476|P1|NOT COMPLETED|Treatment Period 3||0
260138|NCT02750709|625471|P6|COMPLETED|Treatment Period 3||3
260139|NCT02750709|625472|P5|COMPLETED|Treatment Period 3||4
260140|NCT02750709|625473|P4|COMPLETED|Treatment Period 3||4
260141|NCT02750709|625474|P3|COMPLETED|Treatment Period 3||4
260142|NCT02750709|625475|P2|COMPLETED|Treatment Period 3||4
260143|NCT02750709|625476|P1|COMPLETED|Treatment Period 3||4
260144|NCT02750709|625471|P6|STARTED|Treatment Period 3||3
260145|NCT02750709|625472|P5|STARTED|Treatment Period 3||4
260146|NCT02750709|625473|P4|STARTED|Treatment Period 3||4
260147|NCT02750709|625474|P3|STARTED|Treatment Period 3||4
260148|NCT02750709|625475|P2|STARTED|Treatment Period 3||4
260149|NCT02750709|625476|P1|STARTED|Treatment Period 3||4
260150|NCT02750709|625471|P6|NOT COMPLETED|Treatment Period 2||0
260151|NCT02750709|625472|P5|NOT COMPLETED|Treatment Period 2||0
260152|NCT02750709|625473|P4|NOT COMPLETED|Treatment Period 2||0
260153|NCT02750709|625474|P3|NOT COMPLETED|Treatment Period 2||0
260154|NCT02750709|625475|P2|NOT COMPLETED|Treatment Period 2||0
260155|NCT02750709|625476|P1|NOT COMPLETED|Treatment Period 2||0
260156|NCT02750709|625471|P6|COMPLETED|Treatment Period 2||3
260157|NCT02750709|625472|P5|COMPLETED|Treatment Period 2||4
260158|NCT02750709|625473|P4|COMPLETED|Treatment Period 2||4
260159|NCT02750709|625474|P3|COMPLETED|Treatment Period 2||4
260160|NCT02750709|625475|P2|COMPLETED|Treatment Period 2||4
260161|NCT02750709|625476|P1|COMPLETED|Treatment Period 2||4
260162|NCT02750709|625471|P6|STARTED|Treatment Period 2||3
260163|NCT02750709|625472|P5|STARTED|Treatment Period 2||4
260164|NCT02750709|625473|P4|STARTED|Treatment Period 2||4
260165|NCT02750709|625474|P3|STARTED|Treatment Period 2||4
260166|NCT02750709|625475|P2|STARTED|Treatment Period 2||4
260167|NCT02750709|625476|P1|STARTED|Treatment Period 2||4
260168|NCT02750709|625471|P6|NOT COMPLETED|Treatment Period 1||1
260169|NCT02750709|625472|P5|NOT COMPLETED|Treatment Period 1||0
260170|NCT02750709|625473|P4|NOT COMPLETED|Treatment Period 1||0
260171|NCT02750709|625474|P3|NOT COMPLETED|Treatment Period 1||0
260172|NCT02750709|625475|P2|NOT COMPLETED|Treatment Period 1||0
260173|NCT02750709|625476|P1|NOT COMPLETED|Treatment Period 1||0
260174|NCT02750709|625471|P6|COMPLETED|Treatment Period 1||3
260175|NCT02750709|625472|P5|COMPLETED|Treatment Period 1||4
260176|NCT02750709|625473|P4|COMPLETED|Treatment Period 1||4
260177|NCT02750709|625474|P3|COMPLETED|Treatment Period 1||4
260178|NCT02750709|625475|P2|COMPLETED|Treatment Period 1||4
260179|NCT02750709|625476|P1|COMPLETED|Treatment Period 1||4
260180|NCT02750709|625471|P6|STARTED|Treatment Period 1||4
260181|NCT02750709|625472|P5|STARTED|Treatment Period 1||4
260182|NCT02750709|625473|P4|STARTED|Treatment Period 1||4
260183|NCT02750709|625474|P3|STARTED|Treatment Period 1||4
260184|NCT02750709|625475|P2|STARTED|Treatment Period 1||4
260185|NCT02750709|625476|P1|STARTED|Treatment Period 1||4
260186|NCT02750345|625502|P6|NOT COMPLETED|Intervention 3||0
260187|NCT02750345|625503|P5|NOT COMPLETED|Intervention 3||0
260188|NCT02750345|625504|P4|NOT COMPLETED|Intervention 3||0
260189|NCT02750345|625505|P3|NOT COMPLETED|Intervention 3||0
260190|NCT02750345|625506|P2|NOT COMPLETED|Intervention 3||0
260191|NCT02750345|625507|P1|NOT COMPLETED|Intervention 3||0
260192|NCT02750345|625502|P6|COMPLETED|Intervention 3||4
260193|NCT02750345|625503|P5|COMPLETED|Intervention 3||3
260194|NCT02750345|625504|P4|COMPLETED|Intervention 3||4
260195|NCT02750345|625505|P3|COMPLETED|Intervention 3||4
260196|NCT02750345|625506|P2|COMPLETED|Intervention 3||4
260197|NCT02750345|625507|P1|COMPLETED|Intervention 3||4
260198|NCT02750345|625502|P6|STARTED|Intervention 3||4
260199|NCT02750345|625503|P5|STARTED|Intervention 3||3
260200|NCT02750345|625504|P4|STARTED|Intervention 3||4
260201|NCT02750345|625505|P3|STARTED|Intervention 3||4
260202|NCT02750345|625506|P2|STARTED|Intervention 3||4
260203|NCT02750345|625507|P1|STARTED|Intervention 3||4
260204|NCT02750345|625502|P6|NOT COMPLETED|Intervention 2||0
260205|NCT02750345|625503|P5|NOT COMPLETED|Intervention 2||0
260206|NCT02750345|625504|P4|NOT COMPLETED|Intervention 2||0
260207|NCT02750345|625505|P3|NOT COMPLETED|Intervention 2||0
260208|NCT02750345|625506|P2|NOT COMPLETED|Intervention 2||0
260209|NCT02750345|625507|P1|NOT COMPLETED|Intervention 2||0
260210|NCT02750345|625502|P6|COMPLETED|Intervention 2||4
260211|NCT02750345|625503|P5|COMPLETED|Intervention 2||3
260212|NCT02750345|625504|P4|COMPLETED|Intervention 2||4
260213|NCT02750345|625505|P3|COMPLETED|Intervention 2||4
260214|NCT02750345|625506|P2|COMPLETED|Intervention 2||4
260215|NCT02750345|625507|P1|COMPLETED|Intervention 2||4
260216|NCT02750345|625502|P6|STARTED|Intervention 2||4
260217|NCT02750345|625503|P5|STARTED|Intervention 2||3
260218|NCT02750345|625504|P4|STARTED|Intervention 2||4
260219|NCT02750345|625505|P3|STARTED|Intervention 2||4
260220|NCT02750345|625506|P2|STARTED|Intervention 2||4
260221|NCT02750345|625507|P1|STARTED|Intervention 2||4
260222|NCT02750345|625502|P6|NOT COMPLETED|Intervention 1||0
260223|NCT02750345|625503|P5|NOT COMPLETED|Intervention 1||1
260224|NCT02750345|625504|P4|NOT COMPLETED|Intervention 1||0
260225|NCT02750345|625505|P3|NOT COMPLETED|Intervention 1||0
260226|NCT02750345|625506|P2|NOT COMPLETED|Intervention 1||0
260227|NCT02750345|625507|P1|NOT COMPLETED|Intervention 1||0
260228|NCT02750345|625502|P6|COMPLETED|Intervention 1||4
260229|NCT02750345|625503|P5|COMPLETED|Intervention 1||3
260230|NCT02750345|625504|P4|COMPLETED|Intervention 1||4
260231|NCT02750345|625505|P3|COMPLETED|Intervention 1||4
260232|NCT02750345|625506|P2|COMPLETED|Intervention 1||4
260233|NCT02750345|625507|P1|COMPLETED|Intervention 1||4
260234|NCT02750345|625502|P6|STARTED|Intervention 1||4
260235|NCT02750345|625503|P5|STARTED|Intervention 1||4
260236|NCT02750345|625504|P4|STARTED|Intervention 1||4
260237|NCT02750345|625505|P3|STARTED|Intervention 1||4
260238|NCT02750345|625506|P2|STARTED|Intervention 1||4
260239|NCT02750345|625507|P1|STARTED|Intervention 1||4
260240|NCT02750332|625533|P2|NOT COMPLETED|Treatment Period 2||0
260241|NCT02750332|625534|P1|NOT COMPLETED|Treatment Period 2||0
260242|NCT02750332|625533|P2|COMPLETED|Treatment Period 2||9
260243|NCT02750332|625534|P1|COMPLETED|Treatment Period 2||10
260244|NCT02750332|625533|P2|STARTED|Treatment Period 2||9
260245|NCT02750332|625534|P1|STARTED|Treatment Period 2||10
260246|NCT02750332|625533|P2|NOT COMPLETED|Treatment Period 1||1
260247|NCT02750332|625534|P1|NOT COMPLETED|Treatment Period 1||0
260248|NCT02750332|625533|P2|COMPLETED|Treatment Period 1||9
260249|NCT02750332|625534|P1|COMPLETED|Treatment Period 1||10
260250|NCT02750332|625533|P2|STARTED|Treatment Period 1||10
260251|NCT02750332|625534|P1|STARTED|Treatment Period 1||10
260252|NCT02748213|625554|P2|NOT COMPLETED|Overall Study||112
260253|NCT02748213|625555|P1|NOT COMPLETED|Overall Study||113
260254|NCT02748213|625554|P2|COMPLETED|Overall Study||0
260255|NCT02748213|625555|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
260256|NCT02748213|625554|P2|Treated|Overall Study||110
260257|NCT02748213|625555|P1|Treated|Overall Study||112
260258|NCT02748213|625554|P2|STARTED|Overall Study||112
260259|NCT02748213|625555|P1|STARTED|Overall Study||113
260260|NCT02746679|625573|P2|NOT COMPLETED|Overall Study||6
260261|NCT02746679|625574|P1|NOT COMPLETED|Overall Study||4
260262|NCT02746679|625573|P2|COMPLETED|Overall Study||75
260263|NCT02746679|625574|P1|COMPLETED|Overall Study||76
260264|NCT02746679|625573|P2|STARTED|Overall Study||81
260265|NCT02746679|625574|P1|STARTED|Overall Study||80
260266|NCT02746406|625604|P1|NOT COMPLETED|Overall Study||0
260267|NCT02746406|625604|P1|COMPLETED|Overall Study||5
260268|NCT02746406|625604|P1|STARTED|Overall Study||5
260269|NCT02746107|625608|P1|NOT COMPLETED|Overall Study||0
260270|NCT02746107|625608|P1|COMPLETED|Overall Study||968
260271|NCT02746107|625608|P1|CHA2DS2-VASC Score = 5|Overall Study||192
260272|NCT02746107|625608|P1|CHA2DS2-VASC Score = 4|Overall Study||197
260273|NCT02746107|625608|P1|CHA2DS2-VASC Score = 3|Overall Study||195
260274|NCT02746107|625608|P1|CHA2DS2-VASC Score = 2|Overall Study||189
260275|NCT02746107|625608|P1|CHA2DS2-VASC Score = 1|Overall Study||195
260276|NCT02746107|625608|P1|Target=Physician|Overall Study||482
260277|NCT02746107|625608|P1|Target=Patient|Overall Study||486
260278|NCT02746107|625608|P1|5year Risk Estimate|Overall Study||485
260279|NCT02746107|625608|P1|1year Risk Estimate|Overall Study||483
260280|NCT02746107|625608|P1|1 Diagram DA|Overall Study||486
260281|NCT02746107|625608|P1|2 Diagrams DA|Overall Study||482
260282|NCT02746107|625608|P1|STARTED|Overall Study||968
260283|NCT02745626|625626|P3|NOT COMPLETED|Overall Study||3
260284|NCT02745626|625627|P2|NOT COMPLETED|Overall Study||6
260285|NCT02745626|625628|P1|NOT COMPLETED|Overall Study||3
260286|NCT02745626|625626|P3|COMPLETED|Overall Study||19
260287|NCT02745626|625627|P2|COMPLETED|Overall Study||16
260288|NCT02745626|625628|P1|COMPLETED|Overall Study||21
260289|NCT02745626|625626|P3|STARTED|Overall Study||22
260290|NCT02745626|625627|P2|STARTED|Overall Study||22
260291|NCT02745626|625628|P1|STARTED|Overall Study||24
260292|NCT02743702|625656|P2|NOT COMPLETED|Overall Study||0
260293|NCT02743702|625657|P1|NOT COMPLETED|Overall Study||0
260294|NCT02743702|625656|P2|COMPLETED|Overall Study||10
260295|NCT02743702|625657|P1|COMPLETED|Overall Study||11
260296|NCT02743702|625656|P2|STARTED|Overall Study||10
260297|NCT02743702|625657|P1|STARTED|Overall Study||11
260298|NCT02743936|625665|P2|NOT COMPLETED|Overall Study||0
260299|NCT02743936|625666|P1|NOT COMPLETED|Overall Study||0
260300|NCT02743936|625665|P2|COMPLETED|Overall Study||32
260301|NCT02743936|625666|P1|COMPLETED|Overall Study||32
260302|NCT02743936|625665|P2|STARTED|Overall Study||32
260303|NCT02743936|625666|P1|STARTED|Overall Study||32
260304|NCT02739594|625676|P2|NOT COMPLETED|Overall Study||28
260305|NCT02739594|625677|P1|NOT COMPLETED|Overall Study||25
260306|NCT02739594|625676|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
260307|NCT02739594|625677|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
260308|NCT02739594|625676|P2|Completed at Week 96|Overall Study||10
260309|NCT02739594|625677|P1|Completed at Week 96|Overall Study||10
260310|NCT02739594|625676|P2|Completed at Week 44|Overall Study||5
260311|NCT02739594|625677|P1|Completed at Week 44|Overall Study||11
260312|NCT02739594|625676|P2|STARTED|Overall Study||43
260313|NCT02739594|625677|P1|STARTED|Overall Study||46
260314|NCT02737592|625707|P1|NOT COMPLETED|Overall Study||1
260315|NCT02737592|625707|P1|COMPLETED|Overall Study||33
260316|NCT02737592|625707|P1|STARTED|Overall Study||34
260317|NCT02736721|625712|P1|NOT COMPLETED|Overall Study||16
260318|NCT02736721|625712|P1|COMPLETED|Overall Study||25
260319|NCT02736721|625712|P1|STARTED|Overall Study||41
260320|NCT02735200|625723|P2|NOT COMPLETED|Overall Study||5
260321|NCT02735200|625724|P1|NOT COMPLETED|Overall Study||8
260322|NCT02735200|625723|P2|COMPLETED|Overall Study||345
260323|NCT02735200|625724|P1|COMPLETED|Overall Study||192
260324|NCT02735200|625723|P2|STARTED|Overall Study||350
260325|NCT02735200|625724|P1|STARTED|Overall Study||200
260326|NCT02734355|625732|P2|NOT COMPLETED|Overall Study||0
260327|NCT02734355|625733|P1|NOT COMPLETED|Overall Study||0
260328|NCT02734355|625732|P2|COMPLETED|Overall Study||30
260329|NCT02734355|625733|P1|COMPLETED|Overall Study||34
260330|NCT02734355|625732|P2|STARTED|Overall Study||30
260331|NCT02734355|625733|P1|STARTED|Overall Study||34
260332|NCT02734056|625765|P2|NOT COMPLETED|Overall Study||1
260333|NCT02734056|625766|P1|NOT COMPLETED|Overall Study||0
260334|NCT02734056|625765|P2|COMPLETED|Overall Study||49
260335|NCT02734056|625766|P1|COMPLETED|Overall Study||50
260336|NCT02734056|625765|P2|STARTED|Overall Study||50
260337|NCT02734056|625766|P1|STARTED|Overall Study||50
260338|NCT02732639|625772|P1|NOT COMPLETED|Overall Study||1
260339|NCT02732639|625772|P1|COMPLETED|Overall Study||30
260340|NCT02732639|625772|P1|STARTED|Overall Study||31
260341|NCT02732561|625785|P2|NOT COMPLETED|Overall Study||1
260342|NCT02732561|625786|P1|NOT COMPLETED|Overall Study||2
260343|NCT02732561|625785|P2|COMPLETED|Overall Study||4
260344|NCT02732561|625786|P1|COMPLETED|Overall Study||3
260345|NCT02732561|625785|P2|STARTED|Overall Study||5
260346|NCT02732561|625786|P1|STARTED|Overall Study||5
260347|NCT02732210|625796|P2|NOT COMPLETED|Overall Study||294
260348|NCT02732210|625797|P1|NOT COMPLETED|Overall Study||85
260349|NCT02732210|625796|P2|COMPLETED|Overall Study||338
260350|NCT02732210|625797|P1|COMPLETED|Overall Study||218
260351|NCT02732210|625796|P2|STARTED|Overall Study||632
260352|NCT02732210|625797|P1|STARTED|Overall Study||303
260353|NCT02731833|625815|P2|NOT COMPLETED|Overall Study||0
260354|NCT02731833|625816|P1|NOT COMPLETED|Overall Study||0
260355|NCT02731833|625815|P2|COMPLETED|Overall Study||111
260356|NCT02731833|625816|P1|COMPLETED|Overall Study||111
260357|NCT02731833|625815|P2|STARTED|Overall Study||111
260358|NCT02731833|625816|P1|STARTED|Overall Study||111
260359|NCT02731313|625828|P1|NOT COMPLETED|Overall Study||0
260360|NCT02731313|625828|P1|COMPLETED|Overall Study||367
260361|NCT02731313|625828|P1|STARTED|Overall Study||367
260362|NCT02731300|625838|P2|NOT COMPLETED|Overall Study||0
260363|NCT02731300|625839|P1|NOT COMPLETED|Overall Study||0
260364|NCT02731300|625838|P2|COMPLETED|Overall Study||7
260365|NCT02731300|625839|P1|COMPLETED|Overall Study||15
260366|NCT02731300|625838|P2|STARTED|Overall Study||7
260367|NCT02731300|625839|P1|STARTED|Overall Study||15
260368|NCT02731131|625849|P2|NOT COMPLETED|Overall Study||2
260369|NCT02731131|625850|P1|NOT COMPLETED|Overall Study||0
260370|NCT02731131|625849|P2|COMPLETED|Overall Study||4
260371|NCT02731131|625850|P1|COMPLETED|Overall Study||6
260372|NCT02731131|625849|P2|STARTED|Overall Study||6
260373|NCT02731131|625850|P1|STARTED|Overall Study||6
260374|NCT02730260|625868|P2|NOT COMPLETED|Overall Study||75
260375|NCT02730260|625869|P1|NOT COMPLETED|Overall Study||82
260376|NCT02730260|625868|P2|COMPLETED|Overall Study||185
260377|NCT02730260|625869|P1|COMPLETED|Overall Study||176
260378|NCT02730260|625868|P2|STARTED|Overall Study||260
260379|NCT02730260|625869|P1|STARTED|Overall Study||258
260380|NCT02726971|625877|P2|NOT COMPLETED|Overall Study||9
260381|NCT02726971|625878|P1|NOT COMPLETED|Overall Study||11
260382|NCT02726971|625877|P2|COMPLETED|Overall Study||62
260383|NCT02726971|625878|P1|COMPLETED|Overall Study||59
260384|NCT02726971|625877|P2|STARTED|Overall Study||71
260385|NCT02726971|625878|P1|STARTED|Overall Study||70
260386|NCT02726178|625890|P2|NOT COMPLETED|Overall Study||0
260387|NCT02726178|625891|P1|NOT COMPLETED|Overall Study||0
260388|NCT02726178|625890|P2|COMPLETED|Overall Study||28
260389|NCT02726178|625891|P1|COMPLETED|Overall Study||28
260390|NCT02726178|625890|P2|STARTED|Overall Study||28
260391|NCT02726178|625891|P1|STARTED|Overall Study||28
260392|NCT02726022|625897|P1|NOT COMPLETED|Overall Study||36
260393|NCT02726022|625897|P1|COMPLETED|Overall Study||78
260394|NCT02726022|625897|P1|STARTED|Overall Study||114
260395|NCT02725788|625908|P2|NOT COMPLETED|Overall Study||2
260396|NCT02725788|625909|P1|NOT COMPLETED|Overall Study||1
260397|NCT02725788|625908|P2|COMPLETED|Overall Study||122
260398|NCT02725788|625909|P1|COMPLETED|Overall Study||122
260399|NCT02725788|625908|P2|STARTED|Overall Study||124
260400|NCT02725788|625909|P1|STARTED|Overall Study||123
260401|NCT02724449|625915|P1|NOT COMPLETED|Overall Study||0
260402|NCT02724449|625915|P1|COMPLETED|Overall Study||16
260403|NCT02724449|625915|P1|STARTED|Overall Study||16
260404|NCT02723188|625922|P3|NOT COMPLETED|Overall Study||0
260405|NCT02723188|625923|P2|NOT COMPLETED|Overall Study||0
260406|NCT02723188|625924|P1|NOT COMPLETED|Overall Study||1
260407|NCT02723188|625922|P3|COMPLETED|Overall Study||15
260408|NCT02723188|625923|P2|COMPLETED|Overall Study||15
260409|NCT02723188|625924|P1|COMPLETED|Overall Study||14
260410|NCT02723188|625922|P3|STARTED|Overall Study||15
260411|NCT02723188|625923|P2|STARTED|Overall Study||15
260412|NCT02723188|625924|P1|STARTED|Overall Study||15
260413|NCT02722564|625935|P1|NOT COMPLETED|Overall Study||0
260414|NCT02722564|625935|P1|COMPLETED|Overall Study||55
260415|NCT02722564|625935|P1|STARTED|Overall Study||55
260416|NCT02721641|625939|P1|NOT COMPLETED|Overall Study||0
260417|NCT02721641|625939|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
260418|NCT02721641|625939|P1|STARTED|Overall Study||69
260419|NCT02721277|625945|P1|NOT COMPLETED|Overall Study||0
260420|NCT02721277|625945|P1|COMPLETED|Overall Study||2
260421|NCT02721277|625945|P1|STARTED|Overall Study||2
260422|NCT02720952|625974|P1|NOT COMPLETED|Overall Study||0
260423|NCT02720952|625974|P1|COMPLETED|Overall Study||24
260424|NCT02720952|625974|P1|STARTED|Overall Study||24
260425|NCT02717754|625989|P6|NOT COMPLETED|Overall Study||20
260426|NCT02717754|625990|P5|NOT COMPLETED|Overall Study||20
260427|NCT02717754|625991|P4|NOT COMPLETED|Overall Study||10
260428|NCT02717754|625992|P3|NOT COMPLETED|Overall Study||0
260429|NCT02717754|625993|P2|NOT COMPLETED|Overall Study||0
260430|NCT02717754|625994|P1|NOT COMPLETED|Overall Study||0
260431|NCT02717754|625989|P6|COMPLETED|Overall Study||0
260432|NCT02717754|625990|P5|COMPLETED|Overall Study||0
260433|NCT02717754|625991|P4|COMPLETED|Overall Study||0
260434|NCT02717754|625992|P3|COMPLETED|Overall Study||20
260435|NCT02717754|625993|P2|COMPLETED|Overall Study||19
260436|NCT02717754|625994|P1|COMPLETED|Overall Study||10
260437|NCT02717754|625989|P6|STARTED|Overall Study||20
260438|NCT02717754|625990|P5|STARTED|Overall Study||20
260439|NCT02717754|625991|P4|STARTED|Overall Study||10
260440|NCT02717754|625992|P3|STARTED|Overall Study||20
260441|NCT02717754|625993|P2|STARTED|Overall Study||19
260442|NCT02717754|625994|P1|STARTED|Overall Study||10
260443|NCT02716779|626025|P3|NOT COMPLETED|Combination Therapy||1
260444|NCT02716779|626026|P2|NOT COMPLETED|Combination Therapy||2
260445|NCT02716779|626027|P1|NOT COMPLETED|Combination Therapy||0
260446|NCT02716779|626025|P3|COMPLETED|Combination Therapy||25
260447|NCT02716779|626026|P2|COMPLETED|Combination Therapy||23
260448|NCT02716779|626027|P1|COMPLETED|Combination Therapy||14
260449|NCT02716779|626025|P3|STARTED|Combination Therapy||26
260450|NCT02716779|626026|P2|STARTED|Combination Therapy||25
260451|NCT02716779|626027|P1|STARTED|Combination Therapy||14
260452|NCT02716779|626025|P3|NOT COMPLETED|Monotherapy||1
260453|NCT02716779|626026|P2|NOT COMPLETED|Monotherapy||1
260454|NCT02716779|626027|P1|NOT COMPLETED|Monotherapy||0
260455|NCT02716779|626025|P3|COMPLETED|Monotherapy||26
260456|NCT02716779|626026|P2|COMPLETED|Monotherapy||25
260457|NCT02716779|626027|P1|COMPLETED|Monotherapy||14
260458|NCT02716779|626025|P3|STARTED|Monotherapy||27
260459|NCT02716779|626026|P2|STARTED|Monotherapy||26
260460|NCT02716779|626027|P1|STARTED|Monotherapy||14
260461|NCT02716298|626071|P2|NOT COMPLETED|Second Intervention (1 Month)||0
260462|NCT02716298|626072|P1|NOT COMPLETED|Second Intervention (1 Month)||0
260463|NCT02716298|626071|P2|COMPLETED|Second Intervention (1 Month)||23
260464|NCT02716298|626072|P1|COMPLETED|Second Intervention (1 Month)||24
260465|NCT02716298|626071|P2|STARTED|Second Intervention (1 Month)||23
260466|NCT02716298|626072|P1|STARTED|Second Intervention (1 Month)||24
260467|NCT02716298|626071|P2|NOT COMPLETED|First Intervention (1 Month)||1
260468|NCT02716298|626072|P1|NOT COMPLETED|First Intervention (1 Month)||1
260469|NCT02716298|626071|P2|COMPLETED|First Intervention (1 Month)||23
260470|NCT02716298|626072|P1|COMPLETED|First Intervention (1 Month)||24
260471|NCT02716298|626071|P2|STARTED|First Intervention (1 Month)||24
260472|NCT02716298|626072|P1|STARTED|First Intervention (1 Month)||25
260473|NCT02713594|626089|P2|NOT COMPLETED|Overall Study||396
260474|NCT02713594|626090|P1|NOT COMPLETED|Overall Study||390
260475|NCT02713594|626089|P2|COMPLETED|Overall Study||552
260476|NCT02713594|626090|P1|COMPLETED|Overall Study||562
260477|NCT02713594|626089|P2|STARTED|Overall Study||948
260478|NCT02713594|626090|P1|STARTED|Overall Study||952
260479|NCT02712099|626102|P2|NOT COMPLETED|Overall Study||0
260480|NCT02712099|626103|P1|NOT COMPLETED|Overall Study||0
260481|NCT02712099|626102|P2|COMPLETED|Overall Study||20
260482|NCT02712099|626103|P1|COMPLETED|Overall Study||30
260483|NCT02712099|626102|P2|STARTED|Overall Study||20
260484|NCT02712099|626103|P1|STARTED|Overall Study||30
260485|NCT02709577|626121|P4|NOT COMPLETED|Overall Study||0
260486|NCT02709577|626122|P3|NOT COMPLETED|Overall Study||2
260487|NCT02709577|626123|P2|NOT COMPLETED|Overall Study||5
260488|NCT02709577|626124|P1|NOT COMPLETED|Overall Study||2
260489|NCT02709577|626121|P4|COMPLETED|Overall Study||5
260490|NCT02709577|626122|P3|COMPLETED|Overall Study||4
260491|NCT02709577|626123|P2|COMPLETED|Overall Study||8
260492|NCT02709577|626124|P1|COMPLETED|Overall Study||10
260493|NCT02709577|626121|P4|STARTED|Overall Study||5
260494|NCT02709577|626122|P3|STARTED|Overall Study||6
260495|NCT02709577|626123|P2|STARTED|Overall Study||13
260496|NCT02709577|626124|P1|STARTED|Overall Study||12
260497|NCT02708524|626140|P4|NOT COMPLETED|Overall Study||0
260498|NCT02708524|626141|P3|NOT COMPLETED|Overall Study||3
260499|NCT02708524|626142|P2|NOT COMPLETED|Overall Study||6
260500|NCT02708524|626143|P1|NOT COMPLETED|Overall Study||4
260501|NCT02708524|626140|P4|COMPLETED|Overall Study||136
260502|NCT02708524|626141|P3|COMPLETED|Overall Study||134
260503|NCT02708524|626142|P2|COMPLETED|Overall Study||130
260504|NCT02708524|626143|P1|COMPLETED|Overall Study||135
260505|NCT02708524|626140|P4|STARTED|Overall Study||136
260506|NCT02708524|626141|P3|STARTED|Overall Study||137
260507|NCT02708524|626142|P2|STARTED|Overall Study||136
260508|NCT02708524|626143|P1|STARTED|Overall Study||139
260509|NCT02708355|626192|P3|NOT COMPLETED|Overall Study||0
260510|NCT02708355|626193|P2|NOT COMPLETED|Overall Study||0
260511|NCT02708355|626194|P1|NOT COMPLETED|Overall Study||1
260512|NCT02708355|626192|P3|COMPLETED|Overall Study||12
260513|NCT02708355|626193|P2|COMPLETED|Overall Study||22
260514|NCT02708355|626194|P1|COMPLETED|Overall Study||20
260515|NCT02708355|626192|P3|STARTED|Overall Study||12
260516|NCT02708355|626193|P2|STARTED|Overall Study||22
260517|NCT02708355|626194|P1|STARTED|Overall Study||21
260518|NCT02708277|626207|P2|NOT COMPLETED|Overall Study||4
260519|NCT02708277|626208|P1|NOT COMPLETED|Overall Study||7
260520|NCT02708277|626207|P2|COMPLETED|Overall Study||39
260521|NCT02708277|626208|P1|COMPLETED|Overall Study||43
260522|NCT02708277|626207|P2|STARTED|Overall Study||43
260523|NCT02708277|626208|P1|STARTED|Overall Study||50
260524|NCT02708238|626223|P3|NOT COMPLETED|Overall Study||3
260525|NCT02708238|626224|P2|NOT COMPLETED|Overall Study||1
260526|NCT02708238|626225|P1|NOT COMPLETED|Overall Study||0
260527|NCT02708238|626223|P3|COMPLETED|Overall Study||57
260528|NCT02708238|626224|P2|COMPLETED|Overall Study||59
260529|NCT02708238|626225|P1|COMPLETED|Overall Study||60
260530|NCT02708238|626223|P3|STARTED|Overall Study||60
260531|NCT02708238|626224|P2|STARTED|Overall Study||60
260532|NCT02708238|626225|P1|STARTED|Overall Study||60
260533|NCT02708212|626238|P2|NOT COMPLETED|Overall Study||0
260534|NCT02708212|626239|P1|NOT COMPLETED|Overall Study||0
260535|NCT02708212|626238|P2|COMPLETED|Overall Study||60
260536|NCT02708212|626239|P1|COMPLETED|Overall Study||60
260537|NCT02708212|626238|P2|STARTED|Overall Study||60
260538|NCT02708212|626239|P1|STARTED|Overall Study||60
260539|NCT02707640|626251|P2|NOT COMPLETED|Overall Study||7
260540|NCT02707640|626252|P1|NOT COMPLETED|Overall Study||9
260541|NCT02707640|626251|P2|COMPLETED|Overall Study||55
260542|NCT02707640|626252|P1|COMPLETED|Overall Study||52
260543|NCT02707640|626251|P2|STARTED|Overall Study||62
260544|NCT02707640|626252|P1|STARTED|Overall Study||61
260545|NCT02707172|626270|P1|NOT COMPLETED|2nd Set of Experiment||0
260546|NCT02707172|626270|P1|COMPLETED|2nd Set of Experiment||28
260547|NCT02707172|626270|P1|STARTED|2nd Set of Experiment||28
260548|NCT02707172|626270|P1|NOT COMPLETED|Wash Out||0
260549|NCT02707172|626270|P1|COMPLETED|Wash Out||28
260550|NCT02707172|626270|P1|STARTED|Wash Out||28
260551|NCT02707172|626270|P1|NOT COMPLETED|1st Set of Experiment||0
260552|NCT02707172|626270|P1|COMPLETED|1st Set of Experiment||28
260553|NCT02707172|626270|P1|STARTED|1st Set of Experiment||28
260554|NCT02705807|626275|P1|NOT COMPLETED|Overall Study||0
260555|NCT02705807|626275|P1|COMPLETED|Overall Study||10
260556|NCT02705807|626275|P1|STARTED|Overall Study||10
260557|NCT02705716|626307|P2|NOT COMPLETED|Overall Study||2
260558|NCT02705716|626308|P1|NOT COMPLETED|Overall Study||4
260559|NCT02705716|626307|P2|COMPLETED|Overall Study||68
260560|NCT02705716|626308|P1|COMPLETED|Overall Study||68
260561|NCT02705716|626307|P2|STARTED|Overall Study||70
260562|NCT02705716|626308|P1|STARTED|Overall Study||72
260563|NCT02701556|626320|P2|NOT COMPLETED|Overall Study||20
260564|NCT02701556|626321|P1|NOT COMPLETED|Overall Study||22
260565|NCT02701556|626320|P2|COMPLETED|Overall Study||178
260566|NCT02701556|626321|P1|COMPLETED|Overall Study||175
260567|NCT02701556|626320|P2|STARTED|Overall Study||198
260568|NCT02701556|626321|P1|STARTED|Overall Study||197
260569|NCT02701387|626327|P1|NOT COMPLETED|Overall Study||0
260570|NCT02701387|626327|P1|COMPLETED|Overall Study||7
260571|NCT02701387|626327|P1|STARTED|Overall Study||7
260572|NCT02701296|626334|P2|NOT COMPLETED|Overall Study||2
260573|NCT02701296|626335|P1|NOT COMPLETED|Overall Study||0
260574|NCT02701296|626334|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
260575|NCT02701296|626335|P1|COMPLETED|Overall Study||42
260576|NCT02701296|626334|P2|STARTED|Overall Study||38
260577|NCT02701296|626335|P1|STARTED|Overall Study||42
260578|NCT02701270|626351|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
260579|NCT02701270|626352|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
260580|NCT02701270|626353|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
260581|NCT02701270|626354|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
260582|NCT02701270|626351|P4|COMPLETED|Fourth Intervention at Visit 4||3
260583|NCT02701270|626352|P3|COMPLETED|Fourth Intervention at Visit 4||3
260584|NCT02701270|626353|P2|COMPLETED|Fourth Intervention at Visit 4||3
260585|NCT02701270|626354|P1|COMPLETED|Fourth Intervention at Visit 4||2
260586|NCT02701270|626351|P4|STARTED|Fourth Intervention at Visit 4||3
260587|NCT02701270|626352|P3|STARTED|Fourth Intervention at Visit 4||3
260588|NCT02701270|626353|P2|STARTED|Fourth Intervention at Visit 4||3
260589|NCT02701270|626354|P1|STARTED|Fourth Intervention at Visit 4||2
260590|NCT02701270|626351|P4|NOT COMPLETED|Third Intervention at Visit 3||0
260591|NCT02701270|626352|P3|NOT COMPLETED|Third Intervention at Visit 3||0
260592|NCT02701270|626353|P2|NOT COMPLETED|Third Intervention at Visit 3||0
260593|NCT02701270|626354|P1|NOT COMPLETED|Third Intervention at Visit 3||0
260594|NCT02701270|626351|P4|COMPLETED|Third Intervention at Visit 3||3
260595|NCT02701270|626352|P3|COMPLETED|Third Intervention at Visit 3||3
260596|NCT02701270|626353|P2|COMPLETED|Third Intervention at Visit 3||3
260597|NCT02701270|626354|P1|COMPLETED|Third Intervention at Visit 3||2
260598|NCT02701270|626351|P4|STARTED|Third Intervention at Visit 3||3
260599|NCT02701270|626352|P3|STARTED|Third Intervention at Visit 3||3
260600|NCT02701270|626353|P2|STARTED|Third Intervention at Visit 3||3
260601|NCT02701270|626354|P1|STARTED|Third Intervention at Visit 3||2
260602|NCT02701270|626351|P4|NOT COMPLETED|Second Intervention at Visit 2||0
260603|NCT02701270|626352|P3|NOT COMPLETED|Second Intervention at Visit 2||0
260604|NCT02701270|626353|P2|NOT COMPLETED|Second Intervention at Visit 2||0
260605|NCT02701270|626354|P1|NOT COMPLETED|Second Intervention at Visit 2||0
260606|NCT02701270|626351|P4|COMPLETED|Second Intervention at Visit 2||3
260607|NCT02701270|626352|P3|COMPLETED|Second Intervention at Visit 2||3
260608|NCT02701270|626353|P2|COMPLETED|Second Intervention at Visit 2||3
260609|NCT02701270|626354|P1|COMPLETED|Second Intervention at Visit 2||2
260610|NCT02701270|626351|P4|STARTED|Second Intervention at Visit 2||3
260611|NCT02701270|626352|P3|STARTED|Second Intervention at Visit 2||3
260612|NCT02701270|626353|P2|STARTED|Second Intervention at Visit 2||3
260613|NCT02701270|626354|P1|STARTED|Second Intervention at Visit 2||2
260614|NCT02701270|626351|P4|NOT COMPLETED|First Intervention at Visit 1||0
260615|NCT02701270|626352|P3|NOT COMPLETED|First Intervention at Visit 1||0
260616|NCT02701270|626353|P2|NOT COMPLETED|First Intervention at Visit 1||0
260617|NCT02701270|626354|P1|NOT COMPLETED|First Intervention at Visit 1||0
260618|NCT02701270|626351|P4|COMPLETED|First Intervention at Visit 1||3
260619|NCT02701270|626352|P3|COMPLETED|First Intervention at Visit 1||3
260620|NCT02701270|626353|P2|COMPLETED|First Intervention at Visit 1||3
260621|NCT02701270|626354|P1|COMPLETED|First Intervention at Visit 1||2
260622|NCT02701270|626351|P4|STARTED|First Intervention at Visit 1||3
260623|NCT02701270|626352|P3|STARTED|First Intervention at Visit 1||3
260624|NCT02701270|626353|P2|STARTED|First Intervention at Visit 1||3
260625|NCT02701270|626354|P1|STARTED|First Intervention at Visit 1||2
260626|NCT02699892|626368|P1|NOT COMPLETED|Overall Study||36
260627|NCT02699892|626368|P1|COMPLETED|Overall Study||94
260628|NCT02699892|626368|P1|STARTED|Overall Study||130
260629|NCT02699593|626373|P2|NOT COMPLETED|Period 2||2
260630|NCT02699593|626374|P1|NOT COMPLETED|Period 2||2
260631|NCT02699593|626373|P2|COMPLETED|Period 2||60
260632|NCT02699593|626374|P1|COMPLETED|Period 2||65
260633|NCT02699593|626373|P2|STARTED|Period 2||62
260634|NCT02699593|626374|P1|STARTED|Period 2||67
260635|NCT02699593|626373|P2|NOT COMPLETED|Period 1||7
260636|NCT02699593|626374|P1|NOT COMPLETED|Period 1||5
260637|NCT02699593|626373|P2|COMPLETED|Period 1||62
260638|NCT02699593|626374|P1|COMPLETED|Period 1||67
260639|NCT02699593|626373|P2|STARTED|Period 1||69
260640|NCT02699593|626374|P1|STARTED|Period 1||72
260641|NCT02697890|626384|P2|NOT COMPLETED|Overall Study||0
260642|NCT02697890|626385|P1|NOT COMPLETED|Overall Study||0
260643|NCT02697890|626384|P2|COMPLETED|Overall Study||14
260644|NCT02697890|626385|P1|COMPLETED|Overall Study||14
260645|NCT02697890|626384|P2|STARTED|Overall Study||14
260646|NCT02697890|626385|P1|STARTED|Overall Study||14
260647|NCT02694718|626397|P1|NOT COMPLETED|Overall Study||2
260648|NCT02694718|626397|P1|COMPLETED|Overall Study||58
260649|NCT02694718|626397|P1|STARTED|Overall Study||60
260650|NCT02694536|626407|P1|NOT COMPLETED|Overall Study||80
260651|NCT02694536|626407|P1|COMPLETED|Overall Study||0
260652|NCT02694536|626407|P1|STARTED|Overall Study||80
260653|NCT02694315|626416|P1|NOT COMPLETED|Overall Study||0
260654|NCT02694315|626416|P1|COMPLETED|Overall Study||200
260655|NCT02694315|626416|P1|STARTED|Overall Study||200
260656|NCT02694198|626421|P1|NOT COMPLETED|Overall Study||0
260657|NCT02694198|626421|P1|COMPLETED|Overall Study||135
260658|NCT02694198|626421|P1|STARTED|Overall Study||135
260659|NCT02693704|626430|P4|NOT COMPLETED|Overall Study||0
260660|NCT02693704|626431|P3|NOT COMPLETED|Overall Study||0
260661|NCT02693704|626432|P2|NOT COMPLETED|Overall Study||0
260662|NCT02693704|626433|P1|NOT COMPLETED|Overall Study||0
260663|NCT02693704|626430|P4|COMPLETED|Overall Study||10
260664|NCT02693704|626431|P3|COMPLETED|Overall Study||10
260665|NCT02693704|626432|P2|COMPLETED|Overall Study||10
260666|NCT02693704|626433|P1|COMPLETED|Overall Study||10
260667|NCT02693704|626430|P4|STARTED|Overall Study||10
260668|NCT02693704|626431|P3|STARTED|Overall Study||10
260669|NCT02693704|626432|P2|STARTED|Overall Study||10
260670|NCT02693704|626433|P1|STARTED|Overall Study||10
260671|NCT02691507|626453|P2|NOT COMPLETED|Overall Study||1
260672|NCT02691507|626454|P1|NOT COMPLETED|Overall Study||0
260673|NCT02691507|626453|P2|COMPLETED|Overall Study||12
260674|NCT02691507|626454|P1|COMPLETED|Overall Study||40
260675|NCT02691507|626453|P2|STARTED|Overall Study||13
260676|NCT02691507|626454|P1|STARTED|Overall Study||40
260677|NCT02691416|626586|P2|NOT COMPLETED|Overall Study||0
260678|NCT02691416|626587|P1|NOT COMPLETED|Overall Study||0
260679|NCT02691416|626586|P2|COMPLETED|Overall Study||30
260680|NCT02691416|626587|P1|COMPLETED|Overall Study||30
260681|NCT02691416|626586|P2|STARTED|Overall Study||30
260682|NCT02691416|626587|P1|STARTED|Overall Study||30
260683|NCT02691143|626609|P2|NOT COMPLETED|Overall Study||0
260684|NCT02691143|626610|P1|NOT COMPLETED|Overall Study||0
260685|NCT02691143|626609|P2|COMPLETED|Overall Study||23
260686|NCT02691143|626610|P1|COMPLETED|Overall Study||27
260687|NCT02691143|626609|P2|STARTED|Overall Study||23
260688|NCT02691143|626610|P1|STARTED|Overall Study||27
260689|NCT02690727|626618|P2|NOT COMPLETED|Overall Study||2
260690|NCT02690727|626619|P1|NOT COMPLETED|Overall Study||2
260691|NCT02690727|626618|P2|COMPLETED|Overall Study|2 subjects withdrawn from the study|7
260692|NCT02690727|626619|P1|COMPLETED|Overall Study|2 subjects withdrawn from the study|7
260693|NCT02690727|626618|P2|STARTED|Overall Study||9
260694|NCT02690727|626619|P1|STARTED|Overall Study||9
260695|NCT02687217|626629|P2|NOT COMPLETED|Overall Study||0
260696|NCT02687217|626630|P1|NOT COMPLETED|Overall Study||0
260697|NCT02687217|626629|P2|COMPLETED|Overall Study||30
260698|NCT02687217|626630|P1|COMPLETED|Overall Study||30
260699|NCT02687217|626629|P2|STARTED|Overall Study||30
260700|NCT02687217|626630|P1|STARTED|Overall Study||30
260701|NCT02687126|626640|P1|NOT COMPLETED|Data Analysis||0
260702|NCT02687126|626640|P1|COMPLETED|Data Analysis||106
260703|NCT02687126|626640|P1|STARTED|Data Analysis||106
260704|NCT02687126|626640|P1|NOT COMPLETED|Data Collection||0
260705|NCT02687126|626640|P1|COMPLETED|Data Collection||106
260706|NCT02687126|626640|P1|STARTED|Data Collection||106
260707|NCT02684942|626647|P6|NOT COMPLETED|Overall Study||0
260708|NCT02684942|626648|P5|NOT COMPLETED|Overall Study||0
260709|NCT02684942|626649|P4|NOT COMPLETED|Overall Study||0
260710|NCT02684942|626650|P3|NOT COMPLETED|Overall Study||0
260711|NCT02684942|626651|P2|NOT COMPLETED|Overall Study||0
260712|NCT02684942|626652|P1|NOT COMPLETED|Overall Study||0
260713|NCT02684942|626647|P6|COMPLETED|Overall Study||6
260714|NCT02684942|626648|P5|COMPLETED|Overall Study||6
260715|NCT02684942|626649|P4|COMPLETED|Overall Study||7
260716|NCT02684942|626650|P3|COMPLETED|Overall Study||7
260717|NCT02684942|626651|P2|COMPLETED|Overall Study||7
260718|NCT02684942|626652|P1|COMPLETED|Overall Study||7
260719|NCT02684942|626647|P6|STARTED|Overall Study||6
260720|NCT02684942|626648|P5|STARTED|Overall Study||6
260721|NCT02684942|626649|P4|STARTED|Overall Study||7
260722|NCT02684942|626650|P3|STARTED|Overall Study||7
260723|NCT02684942|626651|P2|STARTED|Overall Study||7
260724|NCT02684942|626652|P1|STARTED|Overall Study||7
260725|NCT02684630|626668|P2|NOT COMPLETED|Overall Study||3
260726|NCT02684630|626669|P1|NOT COMPLETED|Overall Study||5
260727|NCT02684630|626668|P2|COMPLETED|Overall Study||60
260728|NCT02684630|626669|P1|COMPLETED|Overall Study||60
260729|NCT02684630|626668|P2|STARTED|Overall Study||63
260730|NCT02684630|626669|P1|STARTED|Overall Study||65
260731|NCT02684604|626679|P2|NOT COMPLETED|Overall Study||0
260732|NCT02684604|626680|P1|NOT COMPLETED|Overall Study||0
260733|NCT02684604|626679|P2|COMPLETED|Overall Study||44
260734|NCT02684604|626680|P1|COMPLETED|Overall Study||44
260735|NCT02684604|626679|P2|STARTED|Overall Study||44
260736|NCT02684604|626680|P1|STARTED|Overall Study||44
260737|NCT02684396|626692|P6|NOT COMPLETED|Overall Study||0
260738|NCT02684396|626693|P5|NOT COMPLETED|Overall Study||0
260739|NCT02684396|626694|P4|NOT COMPLETED|Overall Study||0
260740|NCT02684396|626695|P3|NOT COMPLETED|Overall Study||0
260741|NCT02684396|626696|P2|NOT COMPLETED|Overall Study||0
260742|NCT02684396|626697|P1|NOT COMPLETED|Overall Study||0
260743|NCT02684396|626692|P6|COMPLETED|Overall Study||10
260744|NCT02684396|626693|P5|COMPLETED|Overall Study||5
260745|NCT02684396|626694|P4|COMPLETED|Overall Study||6
260746|NCT02684396|626695|P3|COMPLETED|Overall Study||6
260747|NCT02684396|626696|P2|COMPLETED|Overall Study||6
260748|NCT02684396|626697|P1|COMPLETED|Overall Study||6
260749|NCT02684396|626692|P6|STARTED|Overall Study||10
260750|NCT02684396|626693|P5|STARTED|Overall Study||5
260751|NCT02684396|626694|P4|STARTED|Overall Study||6
260752|NCT02684396|626695|P3|STARTED|Overall Study||6
260753|NCT02684396|626696|P2|STARTED|Overall Study||6
260754|NCT02684396|626697|P1|STARTED|Overall Study||6
260755|NCT02683954|626751|P2|NOT COMPLETED|Overall Study||0
260756|NCT02683954|626752|P1|NOT COMPLETED|Overall Study||0
260757|NCT02683954|626751|P2|COMPLETED|Overall Study||30
260758|NCT02683954|626752|P1|COMPLETED|Overall Study||30
260759|NCT02683954|626751|P2|STARTED|Overall Study||30
260760|NCT02683954|626752|P1|STARTED|Overall Study||30
260761|NCT02681458|626760|P2|NOT COMPLETED|Overall Study||656
260762|NCT02681458|626761|P1|NOT COMPLETED|Overall Study||645
260763|NCT02681458|626760|P2|COMPLETED|Overall Study||62
260764|NCT02681458|626761|P1|COMPLETED|Overall Study||73
260765|NCT02681458|626760|P2|STARTED|Overall Study||718
260766|NCT02681458|626761|P1|STARTED|Overall Study||718
260767|NCT02679976|626767|P1|NOT COMPLETED|Overall Study||0
260768|NCT02679976|626767|P1|COMPLETED|Overall Study||30
260769|NCT02679976|626767|P1|Myopes|Overall Study||14
260770|NCT02679976|626767|P1|Hyperopes|Overall Study||16
260771|NCT02679976|626767|P1|STARTED|Overall Study||30
260772|NCT02679469|626776|P1|NOT COMPLETED|Overall Study||0
260773|NCT02679469|626776|P1|COMPLETED|Overall Study||7
260774|NCT02679469|626776|P1|STARTED|Overall Study||7
260775|NCT02678676|626784|P2|NOT COMPLETED|Overall Study||872
260776|NCT02678676|626785|P1|NOT COMPLETED|Overall Study||888
260777|NCT02678676|626784|P2|COMPLETED|Overall Study||907
260778|NCT02678676|626785|P1|COMPLETED|Overall Study||932
260779|NCT02678676|626784|P2|STARTED|Overall Study||1779
260780|NCT02678676|626785|P1|STARTED|Overall Study||1820
260781|NCT02677779|626795|P2|NOT COMPLETED|Overall Study||0
260782|NCT02677779|626796|P1|NOT COMPLETED|Overall Study||0
260783|NCT02677779|626795|P2|COMPLETED|Overall Study||10
260784|NCT02677779|626796|P1|COMPLETED|Overall Study||10
260785|NCT02677779|626795|P2|STARTED|Overall Study||10
260786|NCT02677779|626796|P1|STARTED|Overall Study||10
260787|NCT02677493|626813|P3|NOT COMPLETED|Overall Study||3
260788|NCT02677493|626814|P2|NOT COMPLETED|Overall Study||2
260789|NCT02677493|626815|P1|NOT COMPLETED|Overall Study||11
260790|NCT02677493|626813|P3|COMPLETED|Overall Study||296
260791|NCT02677493|626814|P2|COMPLETED|Overall Study||296
260792|NCT02677493|626815|P1|COMPLETED|Overall Study||1186
260793|NCT02677493|626813|P3|STARTED|Overall Study||299
260794|NCT02677493|626814|P2|STARTED|Overall Study||298
260795|NCT02677493|626815|P1|STARTED|Overall Study||1197
260796|NCT02675543|626828|P2|NOT COMPLETED|Overall Study||0
260797|NCT02675543|626829|P1|NOT COMPLETED|Overall Study||0
260798|NCT02675543|626828|P2|COMPLETED|Overall Study||20
260799|NCT02675543|626829|P1|COMPLETED|Overall Study||15
260800|NCT02675543|626828|P2|STARTED|Overall Study||20
260801|NCT02675543|626829|P1|STARTED|Overall Study||15
260802|NCT02673944|626835|P1|NOT COMPLETED|Overall Study||0
260803|NCT02673944|626835|P1|COMPLETED|Overall Study||10
260804|NCT02673944|626835|P1|STARTED|Overall Study||10
260805|NCT02672514|626842|P2|NOT COMPLETED|Overall Study||0
260806|NCT02672514|626843|P1|NOT COMPLETED|Overall Study||0
260807|NCT02672514|626842|P2|COMPLETED|Overall Study||51
260808|NCT02672514|626843|P1|COMPLETED|Overall Study||53
260809|NCT02672514|626842|P2|STARTED|Overall Study||51
260810|NCT02672514|626843|P1|STARTED|Overall Study||53
260811|NCT02670811|626851|P2|NOT COMPLETED|Overall Study||0
260812|NCT02670811|626852|P1|NOT COMPLETED|Overall Study||1
260813|NCT02670811|626851|P2|COMPLETED|Overall Study||18
260814|NCT02670811|626852|P1|COMPLETED|Overall Study||17
260815|NCT02670811|626851|P2|STARTED|Overall Study||18
260816|NCT02670811|626852|P1|STARTED|Overall Study||18
260817|NCT02670473|626868|P1|NOT COMPLETED|Overall Study||1
260818|NCT02670473|626868|P1|COMPLETED|Overall Study||34
260819|NCT02670473|626868|P1|STARTED|Overall Study||35
260820|NCT02669095|626923|P2|NOT COMPLETED|Overall Study||3
260821|NCT02669095|626924|P1|NOT COMPLETED|Overall Study||1
260822|NCT02669095|626923|P2|COMPLETED|Overall Study||72
260823|NCT02669095|626924|P1|COMPLETED|Overall Study||74
260824|NCT02669095|626923|P2|STARTED|Overall Study||75
260825|NCT02669095|626924|P1|STARTED|Overall Study||75
260826|NCT02669043|626932|P1|NOT COMPLETED|Overall Study||4
260827|NCT02669043|626932|P1|COMPLETED|Overall Study||4
260828|NCT02669043|626932|P1|STARTED|Overall Study||8
260829|NCT02667704|626936|P1|NOT COMPLETED|Treatment Period 2||0
260830|NCT02667704|626936|P1|COMPLETED|Treatment Period 2||13
260831|NCT02667704|626936|P1|STARTED|Treatment Period 2||13
260832|NCT02667704|626936|P1|NOT COMPLETED|Treatment Period 1||0
260833|NCT02667704|626936|P1|COMPLETED|Treatment Period 1||13
260834|NCT02667704|626936|P1|STARTED|Treatment Period 1||13
260835|NCT02666560|626947|P2|NOT COMPLETED|Condition 2 (1 Day)||0
260836|NCT02666560|626948|P1|NOT COMPLETED|Condition 2 (1 Day)||0
260837|NCT02666560|626947|P2|COMPLETED|Condition 2 (1 Day)||11
260838|NCT02666560|626948|P1|COMPLETED|Condition 2 (1 Day)||8
260839|NCT02666560|626947|P2|STARTED|Condition 2 (1 Day)||11
260840|NCT02666560|626948|P1|STARTED|Condition 2 (1 Day)||8
260841|NCT02666560|626947|P2|NOT COMPLETED|Condition 1 (1 Day)||0
260842|NCT02666560|626948|P1|NOT COMPLETED|Condition 1 (1 Day)||0
260843|NCT02666560|626947|P2|COMPLETED|Condition 1 (1 Day)||11
260844|NCT02666560|626948|P1|COMPLETED|Condition 1 (1 Day)||8
260845|NCT02666560|626947|P2|STARTED|Condition 1 (1 Day)||11
260846|NCT02666560|626948|P1|STARTED|Condition 1 (1 Day)||8
260847|NCT02666222|626964|P1|NOT COMPLETED|Overall Study||2
260848|NCT02666222|626964|P1|COMPLETED|Overall Study||49
260849|NCT02666222|626964|P1|STARTED|Overall Study||51
260850|NCT02665260|626976|P4|NOT COMPLETED|Overall Study||1
260851|NCT02665260|626977|P3|NOT COMPLETED|Overall Study||4
260852|NCT02665260|626978|P2|NOT COMPLETED|Overall Study||1
260853|NCT02665260|626979|P1|NOT COMPLETED|Overall Study||2
260854|NCT02665260|626976|P4|COMPLETED|Overall Study||21
260855|NCT02665260|626977|P3|COMPLETED|Overall Study||21
260856|NCT02665260|626978|P2|COMPLETED|Overall Study||22
260857|NCT02665260|626979|P1|COMPLETED|Overall Study||22
260858|NCT02665260|626976|P4|STARTED|Overall Study||22
260859|NCT02665260|626977|P3|STARTED|Overall Study||25
260860|NCT02665260|626978|P2|STARTED|Overall Study||23
260861|NCT02665260|626979|P1|STARTED|Overall Study||24
260862|NCT02664987|626993|P1|NOT COMPLETED|Overall Study||0
260863|NCT02664987|626993|P1|COMPLETED|Overall Study||462
260864|NCT02664987|626993|P1|STARTED|Overall Study||462
260865|NCT02664532|627004|P2|NOT COMPLETED|Overall Study||0
260866|NCT02664532|627005|P1|NOT COMPLETED|Overall Study||0
260867|NCT02664532|627004|P2|COMPLETED|Overall Study||75
260868|NCT02664532|627005|P1|COMPLETED|Overall Study||75
260869|NCT02664532|627004|P2|STARTED|Overall Study||75
260870|NCT02664532|627005|P1|STARTED|Overall Study||75
260871|NCT02664311|627019|P2|NOT COMPLETED|Overall Study||0
260872|NCT02664311|627020|P1|NOT COMPLETED|Overall Study||0
260873|NCT02664311|627019|P2|COMPLETED|Overall Study||3
260874|NCT02664311|627020|P1|COMPLETED|Overall Study||6
260875|NCT02664311|627019|P2|STARTED|Overall Study||3
260876|NCT02664311|627020|P1|STARTED|Overall Study||6
260877|NCT02663453|627032|P2|NOT COMPLETED|Overall Study||4
260878|NCT02663453|627033|P1|NOT COMPLETED|Overall Study||5
260879|NCT02663453|627032|P2|COMPLETED|Overall Study||18
260880|NCT02663453|627033|P1|COMPLETED|Overall Study||17
260881|NCT02663453|627032|P2|STARTED|Overall Study||22
260882|NCT02663453|627033|P1|STARTED|Overall Study||22
260883|NCT02663232|627055|P1|NOT COMPLETED|Overall Study||0
260884|NCT02663232|627055|P1|COMPLETED|Overall Study||264
260885|NCT02663232|627055|P1|STARTED|Overall Study||264
260886|NCT02662608|627076|P1|NOT COMPLETED|Overall Study||0
260887|NCT02662608|627076|P1|COMPLETED|Overall Study||1
260888|NCT02662608|627076|P1|STARTED|Overall Study||1
260889|NCT02662556|627080|P1|NOT COMPLETED|Overall Study||8
260890|NCT02662556|627080|P1|COMPLETED|Overall Study||132
260891|NCT02662556|627080|P1|STARTED|Overall Study||140
260892|NCT02658461|627090|P3|NOT COMPLETED|Overall Study||0
260893|NCT02658461|627091|P2|NOT COMPLETED|Overall Study||0
260894|NCT02658461|627092|P1|NOT COMPLETED|Overall Study||0
260895|NCT02658461|627090|P3|COMPLETED|Overall Study||12
260896|NCT02658461|627091|P2|COMPLETED|Overall Study||12
260897|NCT02658461|627092|P1|COMPLETED|Overall Study||12
260898|NCT02658461|627090|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
260899|NCT02658461|627091|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
260900|NCT02658461|627092|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
260901|NCT02657629|627120|P2|NOT COMPLETED|Overall Study||0
260902|NCT02657629|627121|P1|NOT COMPLETED|Overall Study||2
260903|NCT02657629|627120|P2|COMPLETED|Overall Study||14
260904|NCT02657629|627121|P1|COMPLETED|Overall Study||12
260905|NCT02657629|627120|P2|STARTED|Overall Study||14
260906|NCT02657629|627121|P1|STARTED|Overall Study||14
260907|NCT02657538|627127|P1|NOT COMPLETED|Overall Study||4
260908|NCT02657538|627127|P1|COMPLETED|Overall Study||31
260909|NCT02657538|627127|P1|Received Visual Caries Detection + Bite|Overall Study||35
260910|NCT02657538|627127|P1|Received Near Infrared Transillumination|Overall Study||35
260911|NCT02657538|627127|P1|STARTED|Overall Study||35
260912|NCT02656485|627138|P4|NOT COMPLETED|Overall Study||2
260913|NCT02656485|627139|P3|NOT COMPLETED|Overall Study||2
260914|NCT02656485|627140|P2|NOT COMPLETED|Overall Study||3
260915|NCT02656485|627141|P1|NOT COMPLETED|Overall Study||2
260916|NCT02656485|627138|P4|COMPLETED|Overall Study||7
260917|NCT02656485|627139|P3|COMPLETED|Overall Study||7
260918|NCT02656485|627140|P2|COMPLETED|Overall Study||6
260919|NCT02656485|627141|P1|COMPLETED|Overall Study||7
260920|NCT02656485|627138|P4|STARTED|Overall Study||9
260921|NCT02656485|627139|P3|STARTED|Overall Study||9
260922|NCT02656485|627140|P2|STARTED|Overall Study||9
260923|NCT02656485|627141|P1|STARTED|Overall Study||9
260924|NCT02656160|627153|P2|NOT COMPLETED|Second Study Night||0
260925|NCT02656160|627154|P1|NOT COMPLETED|Second Study Night||0
260926|NCT02656160|627153|P2|COMPLETED|Second Study Night||6
260927|NCT02656160|627154|P1|COMPLETED|Second Study Night||4
260928|NCT02656160|627153|P2|STARTED|Second Study Night||6
260929|NCT02656160|627154|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
260930|NCT02656160|627153|P2|NOT COMPLETED|First Study Night||0
260931|NCT02656160|627154|P1|NOT COMPLETED|First Study Night||0
260932|NCT02656160|627153|P2|COMPLETED|First Study Night||6
260933|NCT02656160|627154|P1|COMPLETED|First Study Night||7
260934|NCT02656160|627153|P2|STARTED|First Study Night||6
260935|NCT02656160|627154|P1|STARTED|First Study Night||7
260936|NCT02653560|627162|P4|NOT COMPLETED|Placebo Phase||0
260937|NCT02653560|627163|P3|NOT COMPLETED|Placebo Phase||0
260938|NCT02653560|627164|P2|NOT COMPLETED|Placebo Phase||0
260939|NCT02653560|627165|P1|NOT COMPLETED|Placebo Phase||0
260940|NCT02653560|627162|P4|COMPLETED|Placebo Phase||30
260941|NCT02653560|627163|P3|COMPLETED|Placebo Phase||0
260942|NCT02653560|627164|P2|COMPLETED|Placebo Phase||0
260943|NCT02653560|627165|P1|COMPLETED|Placebo Phase||0
260944|NCT02653560|627162|P4|STARTED|Placebo Phase||30
260945|NCT02653560|627163|P3|STARTED|Placebo Phase||0
260946|NCT02653560|627164|P2|STARTED|Placebo Phase||0
260947|NCT02653560|627165|P1|STARTED|Placebo Phase||0
260948|NCT02653560|627162|P4|NOT COMPLETED|KCl Phase||0
260949|NCT02653560|627163|P3|NOT COMPLETED|KCl Phase||0
260950|NCT02653560|627164|P2|NOT COMPLETED|KCl Phase||0
260951|NCT02653560|627165|P1|NOT COMPLETED|KCl Phase||0
260952|NCT02653560|627162|P4|COMPLETED|KCl Phase||0
260953|NCT02653560|627163|P3|COMPLETED|KCl Phase||30
260954|NCT02653560|627164|P2|COMPLETED|KCl Phase||0
260955|NCT02653560|627165|P1|COMPLETED|KCl Phase||0
260956|NCT02653560|627162|P4|STARTED|KCl Phase||0
260957|NCT02653560|627163|P3|STARTED|KCl Phase||30
260958|NCT02653560|627164|P2|STARTED|KCl Phase||0
260959|NCT02653560|627165|P1|STARTED|KCl Phase||0
260960|NCT02653560|627162|P4|NOT COMPLETED|K Citrate Phase||0
260961|NCT02653560|627163|P3|NOT COMPLETED|K Citrate Phase||0
260962|NCT02653560|627164|P2|NOT COMPLETED|K Citrate Phase||0
260963|NCT02653560|627165|P1|NOT COMPLETED|K Citrate Phase||0
260964|NCT02653560|627162|P4|COMPLETED|K Citrate Phase||0
260965|NCT02653560|627163|P3|COMPLETED|K Citrate Phase||0
260966|NCT02653560|627164|P2|COMPLETED|K Citrate Phase||30
260967|NCT02653560|627165|P1|COMPLETED|K Citrate Phase||0
260968|NCT02653560|627162|P4|STARTED|K Citrate Phase||0
260969|NCT02653560|627163|P3|STARTED|K Citrate Phase||0
260970|NCT02653560|627164|P2|STARTED|K Citrate Phase||30
260971|NCT02653560|627165|P1|STARTED|K Citrate Phase||0
260972|NCT02653560|627162|P4|NOT COMPLETED|KMgCit Phase||0
260973|NCT02653560|627163|P3|NOT COMPLETED|KMgCit Phase||0
260974|NCT02653560|627164|P2|NOT COMPLETED|KMgCit Phase||0
260975|NCT02653560|627165|P1|NOT COMPLETED|KMgCit Phase||0
260976|NCT02653560|627162|P4|COMPLETED|KMgCit Phase||0
260977|NCT02653560|627163|P3|COMPLETED|KMgCit Phase||0
260978|NCT02653560|627164|P2|COMPLETED|KMgCit Phase||0
260979|NCT02653560|627165|P1|COMPLETED|KMgCit Phase||30
260980|NCT02653560|627162|P4|STARTED|KMgCit Phase||0
260981|NCT02653560|627163|P3|STARTED|KMgCit Phase||0
260982|NCT02653560|627164|P2|STARTED|KMgCit Phase||0
260983|NCT02653560|627165|P1|STARTED|KMgCit Phase||30
260984|NCT02651467|627178|P3|NOT COMPLETED|Overall Study||4
260985|NCT02651467|627179|P2|NOT COMPLETED|Overall Study||0
260986|NCT02651467|627180|P1|NOT COMPLETED|Overall Study||1
260987|NCT02651467|627178|P3|COMPLETED|Overall Study||69
260988|NCT02651467|627179|P2|COMPLETED|Overall Study||74
260989|NCT02651467|627180|P1|COMPLETED|Overall Study||73
260990|NCT02651467|627178|P3|STARTED|Overall Study||73
260991|NCT02651467|627179|P2|STARTED|Overall Study||74
260992|NCT02651467|627180|P1|STARTED|Overall Study||74
260993|NCT02650219|627201|P2|NOT COMPLETED|Overall Study||0
260994|NCT02650219|627202|P1|NOT COMPLETED|Overall Study||0
260995|NCT02650219|627201|P2|COMPLETED|Overall Study||20
260996|NCT02650219|627202|P1|COMPLETED|Overall Study||40
260997|NCT02650219|627201|P2|STARTED|Overall Study||20
260998|NCT02650219|627202|P1|STARTED|Overall Study||40
260999|NCT02649634|627214|P2|NOT COMPLETED|Overall Study||6
261000|NCT02649634|627215|P1|NOT COMPLETED|Overall Study||3
261001|NCT02649634|627214|P2|COMPLETED|Overall Study||60
261002|NCT02649634|627215|P1|COMPLETED|Overall Study||66
261003|NCT02649634|627214|P2|STARTED|Overall Study||66
261004|NCT02649634|627215|P1|STARTED|Overall Study||69
261005|NCT02648438|627274|P3|NOT COMPLETED|Overall Study||0
261006|NCT02648438|627275|P2|NOT COMPLETED|Overall Study||3
261007|NCT02648438|627276|P1|NOT COMPLETED|Overall Study||3
261008|NCT02648438|627274|P3|COMPLETED|Overall Study||6
261009|NCT02648438|627275|P2|COMPLETED|Overall Study||9
261010|NCT02648438|627276|P1|COMPLETED|Overall Study||9
261011|NCT02648438|627274|P3|STARTED|Overall Study||6
261012|NCT02648438|627275|P2|STARTED|Overall Study||12
261013|NCT02648438|627276|P1|STARTED|Overall Study||12
261014|NCT02648022|627318|P2|NOT COMPLETED|Overall Study||0
261015|NCT02648022|627319|P1|NOT COMPLETED|Overall Study||0
261016|NCT02648022|627318|P2|COMPLETED|Overall Study||39
261017|NCT02648022|627319|P1|COMPLETED|Overall Study||40
261018|NCT02648022|627318|P2|STARTED|Overall Study||39
261019|NCT02648022|627319|P1|STARTED|Overall Study||40
261020|NCT02646449|627331|P2|NOT COMPLETED|Overall Study||0
261021|NCT02646449|627332|P1|NOT COMPLETED|Overall Study||0
261022|NCT02646449|627331|P2|COMPLETED|Overall Study||3
261023|NCT02646449|627332|P1|COMPLETED|Overall Study||4
261024|NCT02646449|627331|P2|STARTED|Overall Study||3
261025|NCT02646449|627332|P1|STARTED|Overall Study||4
261026|NCT02645760|627342|P2|NOT COMPLETED|Overall Study||0
261027|NCT02645760|627343|P1|NOT COMPLETED|Overall Study||0
261028|NCT02645760|627342|P2|COMPLETED|Overall Study||19
261029|NCT02645760|627343|P1|COMPLETED|Overall Study||19
261030|NCT02645760|627342|P2|STARTED|Overall Study||19
261031|NCT02645760|627343|P1|STARTED|Overall Study||19
261032|NCT02645123|627358|P3|NOT COMPLETED|Overall Study||0
261033|NCT02645123|627359|P2|NOT COMPLETED|Overall Study||0
261034|NCT02645123|627360|P1|NOT COMPLETED|Overall Study||0
261035|NCT02645123|627358|P3|COMPLETED|Overall Study||25
261036|NCT02645123|627359|P2|COMPLETED|Overall Study||25
261037|NCT02645123|627360|P1|COMPLETED|Overall Study||25
261038|NCT02645123|627358|P3|STARTED|Overall Study||25
261039|NCT02645123|627359|P2|STARTED|Overall Study||25
261040|NCT02645123|627360|P1|STARTED|Overall Study||25
261041|NCT02644356|627377|P1|NOT COMPLETED|Overall Study||2
261042|NCT02644356|627377|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
261043|NCT02644356|627377|P1|STARTED|Overall Study||51
261044|NCT02644109|627389|P2|NOT COMPLETED|Overall Study||4
261045|NCT02644109|627390|P1|NOT COMPLETED|Overall Study||0
261046|NCT02644109|627389|P2|COMPLETED|Overall Study||24
261047|NCT02644109|627390|P1|COMPLETED|Overall Study||24
261048|NCT02644109|627389|P2|STARTED|Overall Study||28
261049|NCT02644109|627390|P1|STARTED|Overall Study||24
261050|NCT02644096|627398|P2|NOT COMPLETED|Overall Study||25
261051|NCT02644096|627399|P1|NOT COMPLETED|Overall Study||28
261052|NCT02644096|627398|P2|COMPLETED|Overall Study||57
261053|NCT02644096|627399|P1|COMPLETED|Overall Study||65
261054|NCT02644096|627398|P2|9 Month SF-36 Questionnaire|Overall Study||57
261055|NCT02644096|627399|P1|9 Month SF-36 Questionnaire|Overall Study||65
261056|NCT02644096|627398|P2|12 Week SF-36 Questionnaire|Overall Study||59
261057|NCT02644096|627399|P1|12 Week SF-36 Questionnaire|Overall Study||68
261058|NCT02644096|627398|P2|10 Week Interview|Overall Study||59
261059|NCT02644096|627399|P1|10 Week Interview|Overall Study|Not done in control group|0
261060|NCT02644096|627398|P2|2 Week Interview|Overall Study||68
261061|NCT02644096|627399|P1|2 Week Interview|Overall Study|Not done in control group|0
261062|NCT02644096|627398|P2|STARTED|Overall Study||82
261063|NCT02644096|627399|P1|STARTED|Overall Study||93
261064|NCT02643225|627407|P2|NOT COMPLETED|Overall Study||0
261065|NCT02643225|627408|P1|NOT COMPLETED|Overall Study||0
261066|NCT02643225|627407|P2|COMPLETED|Overall Study||40
261067|NCT02643225|627408|P1|COMPLETED|Overall Study||40
261068|NCT02643225|627407|P2|STARTED|Overall Study||40
261069|NCT02643225|627408|P1|STARTED|Overall Study||40
261070|NCT02643199|627420|P1|NOT COMPLETED|Overall Study||0
261071|NCT02643199|627420|P1|COMPLETED|Overall Study||90
261072|NCT02643199|627420|P1|STARTED|Overall Study||90
261073|NCT02643004|627425|P2|NOT COMPLETED|Second Intervention (One Week)||0
261074|NCT02643004|627426|P1|NOT COMPLETED|Second Intervention (One Week)||0
261075|NCT02643004|627425|P2|COMPLETED|Second Intervention (One Week)||35
261076|NCT02643004|627426|P1|COMPLETED|Second Intervention (One Week)||35
261077|NCT02643004|627425|P2|STARTED|Second Intervention (One Week)||35
261078|NCT02643004|627426|P1|STARTED|Second Intervention (One Week)||35
261079|NCT02643004|627425|P2|NOT COMPLETED|First Intervention (One Week)||0
261080|NCT02643004|627426|P1|NOT COMPLETED|First Intervention (One Week)||0
261081|NCT02643004|627425|P2|COMPLETED|First Intervention (One Week)||35
261082|NCT02643004|627426|P1|COMPLETED|First Intervention (One Week)||35
261083|NCT02643004|627425|P2|STARTED|First Intervention (One Week)||35
261084|NCT02643004|627426|P1|STARTED|First Intervention (One Week)||35
261085|NCT02642575|627466|P1|NOT COMPLETED|Overall Study||0
261086|NCT02642575|627466|P1|COMPLETED|Overall Study||67
261087|NCT02642575|627466|P1|STARTED|Overall Study||67
261088|NCT02641912|627474|P2|NOT COMPLETED|Overall Study||0
261089|NCT02641912|627475|P1|NOT COMPLETED|Overall Study||0
261090|NCT02641912|627474|P2|COMPLETED|Overall Study||47
261091|NCT02641912|627475|P1|COMPLETED|Overall Study||53
261092|NCT02641912|627474|P2|STARTED|Overall Study||47
261093|NCT02641912|627475|P1|STARTED|Overall Study||53
261094|NCT02641379|627554|P11|NOT COMPLETED|Overall Study||8
261095|NCT02641379|627555|P10|NOT COMPLETED|Overall Study||9
261096|NCT02641379|627556|P9|NOT COMPLETED|Overall Study||6
261097|NCT02641379|627557|P8|NOT COMPLETED|Overall Study||19
261098|NCT02641379|627558|P7|NOT COMPLETED|Overall Study||13
261099|NCT02641379|627559|P6|NOT COMPLETED|Overall Study||16
261100|NCT02641379|627560|P5|NOT COMPLETED|Overall Study||17
261101|NCT02641379|627561|P4|NOT COMPLETED|Overall Study||17
261102|NCT02641379|627562|P3|NOT COMPLETED|Overall Study||71
261103|NCT02641379|627563|P2|NOT COMPLETED|Overall Study||51
261104|NCT02641379|627564|P1|NOT COMPLETED|Overall Study||35
261105|NCT02641379|627554|P11|COMPLETED|Overall Study||0
261106|NCT02641379|627555|P10|COMPLETED|Overall Study||36
261107|NCT02641379|627556|P9|COMPLETED|Overall Study||36
261108|NCT02641379|627557|P8|COMPLETED|Overall Study||1
261109|NCT02641379|627558|P7|COMPLETED|Overall Study||12
261110|NCT02641379|627559|P6|COMPLETED|Overall Study||20
261111|NCT02641379|627560|P5|COMPLETED|Overall Study||0
261112|NCT02641379|627561|P4|COMPLETED|Overall Study||139
261113|NCT02641379|627562|P3|COMPLETED|Overall Study||7
261114|NCT02641379|627563|P2|COMPLETED|Overall Study||101
261115|NCT02641379|627564|P1|COMPLETED|Overall Study||107
261116|NCT02641379|627554|P11|STARTED|Overall Study||8
261117|NCT02641379|627555|P10|STARTED|Overall Study||45
261118|NCT02641379|627556|P9|STARTED|Overall Study||42
261119|NCT02641379|627557|P8|STARTED|Overall Study||20
261120|NCT02641379|627558|P7|STARTED|Overall Study||25
261121|NCT02641379|627559|P6|STARTED|Overall Study||36
261122|NCT02641379|627560|P5|STARTED|Overall Study||17
261123|NCT02641379|627561|P4|STARTED|Overall Study||156
261124|NCT02641379|627562|P3|STARTED|Overall Study||78
261125|NCT02641379|627563|P2|STARTED|Overall Study||152
261126|NCT02641379|627564|P1|STARTED|Overall Study||142
261127|NCT02641249|627629|P1|NOT COMPLETED|Overall Study||4
261128|NCT02641249|627629|P1|COMPLETED|Overall Study||15
261129|NCT02641249|627629|P1|STARTED|Overall Study||19
261130|NCT02639052|627638|P1|NOT COMPLETED|Overall Study||1
261131|NCT02639052|627638|P1|COMPLETED|Overall Study||34
261132|NCT02639052|627638|P1|Visit 4 (3-month Follow-up)|Overall Study||34
261133|NCT02639052|627638|P1|Visit 3 (1-month Follow-up)|Overall Study||35
261134|NCT02639052|627638|P1|Visit 2 (1-week Follow-up)|Overall Study||35
261135|NCT02639052|627638|P1|Visit 1 (Baseline)|Overall Study||35
261136|NCT02639052|627638|P1|STARTED|Overall Study||35
261137|NCT02638129|627654|P2|NOT COMPLETED|Overall Study||30
261138|NCT02638129|627655|P1|NOT COMPLETED|Overall Study||28
261139|NCT02638129|627654|P2|COMPLETED|Overall Study||0
261140|NCT02638129|627655|P1|COMPLETED|Overall Study||0
261141|NCT02638129|627654|P2|STARTED|Overall Study||30
261142|NCT02638129|627655|P1|STARTED|Overall Study||28
261143|NCT02638051|627669|P2|NOT COMPLETED|Overall Study||0
261144|NCT02638051|627670|P1|NOT COMPLETED|Overall Study||0
261145|NCT02638051|627669|P2|COMPLETED|Overall Study||130
261146|NCT02638051|627670|P1|COMPLETED|Overall Study||130
261147|NCT02638051|627669|P2|STARTED|Overall Study||130
261148|NCT02638051|627670|P1|STARTED|Overall Study||130
261149|NCT02637063|627683|P3|NOT COMPLETED|Overall Study||6
261150|NCT02637063|627684|P2|NOT COMPLETED|Overall Study||4
261151|NCT02637063|627685|P1|NOT COMPLETED|Overall Study||5
261152|NCT02637063|627683|P3|COMPLETED|Overall Study||62
261153|NCT02637063|627684|P2|COMPLETED|Overall Study||64
261154|NCT02637063|627685|P1|COMPLETED|Overall Study||62
261155|NCT02637063|627683|P3|STARTED|Overall Study||68
261156|NCT02637063|627684|P2|STARTED|Overall Study||68
261157|NCT02637063|627685|P1|STARTED|Overall Study||67
261158|NCT02635828|627711|P1|NOT COMPLETED|Overall Study||14
261159|NCT02635828|627711|P1|COMPLETED|Overall Study||40
261160|NCT02635828|627711|P1|STARTED|Overall Study||54
261161|NCT02635425|627718|P2|NOT COMPLETED|Overall Study||0
261162|NCT02635425|627719|P1|NOT COMPLETED|Overall Study||0
261163|NCT02635425|627718|P2|COMPLETED|Overall Study||15
261164|NCT02635425|627719|P1|COMPLETED|Overall Study||15
261165|NCT02635425|627718|P2|STARTED|Overall Study||15
261166|NCT02635425|627719|P1|STARTED|Overall Study||15
261167|NCT02634073|627725|P4|NOT COMPLETED|Overall Study||0
261168|NCT02634073|627726|P3|NOT COMPLETED|Overall Study||0
261169|NCT02634073|627727|P2|NOT COMPLETED|Overall Study||0
261170|NCT02634073|627728|P1|NOT COMPLETED|Overall Study||0
261171|NCT02634073|627725|P4|COMPLETED|Overall Study||4
261172|NCT02634073|627726|P3|COMPLETED|Overall Study||4
261173|NCT02634073|627727|P2|COMPLETED|Overall Study||4
261174|NCT02634073|627728|P1|COMPLETED|Overall Study||4
261175|NCT02634073|627725|P4|STARTED|Overall Study||4
261176|NCT02634073|627726|P3|STARTED|Overall Study||4
261177|NCT02634073|627727|P2|STARTED|Overall Study||4
261178|NCT02634073|627728|P1|STARTED|Overall Study||4
261179|NCT02633787|627814|P1|NOT COMPLETED|Overall Study||1
261180|NCT02633787|627814|P1|COMPLETED|Overall Study||109
261181|NCT02633787|627814|P1|STARTED|Overall Study||110
261182|NCT02632812|627822|P2|NOT COMPLETED|Overall Study||0
261183|NCT02632812|627823|P1|NOT COMPLETED|Overall Study||0
261184|NCT02632812|627822|P2|COMPLETED|Overall Study||12
261185|NCT02632812|627823|P1|COMPLETED|Overall Study||12
261186|NCT02632812|627822|P2|STARTED|Overall Study||12
261187|NCT02632812|627823|P1|STARTED|Overall Study||12
261188|NCT02630563|627841|P1|NOT COMPLETED|Overall Study||1
261189|NCT02630563|627841|P1|COMPLETED|Overall Study||8
261190|NCT02630563|627841|P1|STARTED|Overall Study||9
261191|NCT02629354|627852|P2|NOT COMPLETED|Follow-up||0
261192|NCT02629354|627853|P1|NOT COMPLETED|Follow-up||0
261193|NCT02629354|627852|P2|COMPLETED|Follow-up||18
261194|NCT02629354|627853|P1|COMPLETED|Follow-up||18
261195|NCT02629354|627852|P2|STARTED|Follow-up||18
261196|NCT02629354|627853|P1|STARTED|Follow-up||18
261197|NCT02629354|627852|P2|NOT COMPLETED|Period 2||0
261198|NCT02629354|627853|P1|NOT COMPLETED|Period 2||0
261199|NCT02629354|627852|P2|COMPLETED|Period 2||18
261200|NCT02629354|627853|P1|COMPLETED|Period 2||18
261201|NCT02629354|627852|P2|STARTED|Period 2||18
261202|NCT02629354|627853|P1|STARTED|Period 2||18
261203|NCT02629354|627852|P2|NOT COMPLETED|Washout Period||0
261204|NCT02629354|627853|P1|NOT COMPLETED|Washout Period||0
261205|NCT02629354|627852|P2|COMPLETED|Washout Period||18
261206|NCT02629354|627853|P1|COMPLETED|Washout Period||18
261207|NCT02629354|627852|P2|STARTED|Washout Period||18
261208|NCT02629354|627853|P1|STARTED|Washout Period||18
261209|NCT02629354|627852|P2|NOT COMPLETED|Period 1||0
261210|NCT02629354|627853|P1|NOT COMPLETED|Period 1||0
261211|NCT02629354|627852|P2|COMPLETED|Period 1||18
261212|NCT02629354|627853|P1|COMPLETED|Period 1||18
261213|NCT02629354|627852|P2|STARTED|Period 1||18
261214|NCT02629354|627853|P1|STARTED|Period 1||18
261215|NCT02628938|627878|P3|NOT COMPLETED|Overall Study||4
261216|NCT02628938|627879|P2|NOT COMPLETED|Overall Study||2
261217|NCT02628938|627880|P1|NOT COMPLETED|Overall Study||5
261218|NCT02628938|627878|P3|COMPLETED|Overall Study||11
261219|NCT02628938|627879|P2|COMPLETED|Overall Study||13
261220|NCT02628938|627880|P1|COMPLETED|Overall Study||10
261221|NCT02628938|627878|P3|STARTED|Overall Study||15
261222|NCT02628938|627879|P2|STARTED|Overall Study||15
261223|NCT02628938|627880|P1|STARTED|Overall Study||15
261224|NCT02628418|627896|P2|NOT COMPLETED|Overall Study||2
261225|NCT02628418|627897|P1|NOT COMPLETED|Overall Study||1
261226|NCT02628418|627896|P2|COMPLETED|Overall Study||13
261227|NCT02628418|627897|P1|COMPLETED|Overall Study||14
261228|NCT02628418|627896|P2|STARTED|Overall Study||15
261229|NCT02628418|627897|P1|STARTED|Overall Study||15
261230|NCT02628106|627918|P1|NOT COMPLETED|Overall Study||0
261231|NCT02628106|627918|P1|COMPLETED|Overall Study||21
261232|NCT02628106|627918|P1|STARTED|Overall Study||21
261233|NCT02627144|627922|P1|NOT COMPLETED|Overall Study||365
261234|NCT02627144|627922|P1|COMPLETED|Overall Study||0
261235|NCT02627144|627922|P1|Treated|Overall Study||359
261236|NCT02627144|627922|P1|STARTED|Overall Study||365
261237|NCT02627001|627932|P2|NOT COMPLETED|Overall Study||0
261238|NCT02627001|627933|P1|NOT COMPLETED|Overall Study||0
261239|NCT02627001|627932|P2|COMPLETED|Overall Study||14
261240|NCT02627001|627933|P1|COMPLETED|Overall Study||13
261241|NCT02627001|627932|P2|STARTED|Overall Study||14
261242|NCT02627001|627933|P1|STARTED|Overall Study||13
261243|NCT02625844|627939|P1|NOT COMPLETED|Overall Study||0
261244|NCT02625844|627939|P1|COMPLETED|Overall Study||110
261245|NCT02625844|627939|P1|STARTED|Overall Study||110
261246|NCT02625220|627943|P1|NOT COMPLETED|Overall Study||7
261247|NCT02625220|627943|P1|COMPLETED|Overall Study||163
261248|NCT02625220|627943|P1|STARTED|Overall Study||170
261249|NCT02625207|627954|P4|NOT COMPLETED|Part 2 (11 Days)||0
261250|NCT02625207|627955|P3|NOT COMPLETED|Part 2 (11 Days)||0
261251|NCT02625207|627956|P2|NOT COMPLETED|Part 2 (11 Days)||0
261252|NCT02625207|627957|P1|NOT COMPLETED|Part 2 (11 Days)||0
261253|NCT02625207|627954|P4|COMPLETED|Part 2 (11 Days)||0
261254|NCT02625207|627955|P3|COMPLETED|Part 2 (11 Days)||12
261255|NCT02625207|627956|P2|COMPLETED|Part 2 (11 Days)||0
261256|NCT02625207|627957|P1|COMPLETED|Part 2 (11 Days)||11
261257|NCT02625207|627954|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
261258|NCT02625207|627955|P3|STARTED|Part 2 (11 Days)||12
261259|NCT02625207|627956|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
261260|NCT02625207|627957|P1|STARTED|Part 2 (11 Days)||11
261261|NCT02625207|627954|P4|NOT COMPLETED|Part 1 (6 Days)||0
261262|NCT02625207|627955|P3|NOT COMPLETED|Part 1 (6 Days)||0
261263|NCT02625207|627956|P2|NOT COMPLETED|Part 1 (6 Days)||0
261264|NCT02625207|627957|P1|NOT COMPLETED|Part 1 (6 Days)||0
261265|NCT02625207|627954|P4|COMPLETED|Part 1 (6 Days)||12
261266|NCT02625207|627955|P3|COMPLETED|Part 1 (6 Days)||12
261267|NCT02625207|627956|P2|COMPLETED|Part 1 (6 Days)||12
261268|NCT02625207|627957|P1|COMPLETED|Part 1 (6 Days)||11
261269|NCT02625207|627954|P4|STARTED|Part 1 (6 Days)||12
261270|NCT02625207|627955|P3|STARTED|Part 1 (6 Days)||12
261271|NCT02625207|627956|P2|STARTED|Part 1 (6 Days)||12
261272|NCT02625207|627957|P1|STARTED|Part 1 (6 Days)||11
261273|NCT02624791|628043|P6|NOT COMPLETED|Overall Study||0
261274|NCT02624791|628044|P5|NOT COMPLETED|Overall Study||0
261275|NCT02624791|628045|P4|NOT COMPLETED|Overall Study||0
261276|NCT02624791|628046|P3|NOT COMPLETED|Overall Study||0
261277|NCT02624791|628047|P2|NOT COMPLETED|Overall Study||0
261278|NCT02624791|628048|P1|NOT COMPLETED|Overall Study||2
261279|NCT02624791|628043|P6|COMPLETED|Overall Study||2
261280|NCT02624791|628044|P5|COMPLETED|Overall Study||2
261281|NCT02624791|628045|P4|COMPLETED|Overall Study||2
261282|NCT02624791|628046|P3|COMPLETED|Overall Study||2
261283|NCT02624791|628047|P2|COMPLETED|Overall Study||1
261284|NCT02624791|628048|P1|COMPLETED|Overall Study||0
261285|NCT02624791|628043|P6|STARTED|Overall Study||2
261286|NCT02624791|628044|P5|STARTED|Overall Study||2
261287|NCT02624791|628045|P4|STARTED|Overall Study||2
261288|NCT02624791|628046|P3|STARTED|Overall Study||2
261289|NCT02624791|628047|P2|STARTED|Overall Study||1
261290|NCT02624791|628048|P1|STARTED|Overall Study||2
261291|NCT02621034|628056|P3|NOT COMPLETED|Overall Study||5
261292|NCT02621034|628057|P2|NOT COMPLETED|Overall Study||2
261293|NCT02621034|628058|P1|NOT COMPLETED|Overall Study||3
261294|NCT02621034|628056|P3|COMPLETED|Overall Study||50
261295|NCT02621034|628057|P2|COMPLETED|Overall Study||50
261296|NCT02621034|628058|P1|COMPLETED|Overall Study||50
261297|NCT02621034|628056|P3|STARTED|Overall Study||55
261298|NCT02621034|628057|P2|STARTED|Overall Study||52
261299|NCT02621034|628058|P1|STARTED|Overall Study||53
261300|NCT02619812|628075|P4|NOT COMPLETED|Overall Study||2
261301|NCT02619812|628076|P3|NOT COMPLETED|Overall Study||1
261302|NCT02619812|628077|P2|NOT COMPLETED|Overall Study||0
261303|NCT02619812|628078|P1|NOT COMPLETED|Overall Study||0
261304|NCT02619812|628075|P4|COMPLETED|Overall Study||0
261305|NCT02619812|628076|P3|COMPLETED|Overall Study||0
261306|NCT02619812|628077|P2|COMPLETED|Overall Study||0
261307|NCT02619812|628078|P1|COMPLETED|Overall Study||0
261308|NCT02619812|628075|P4|STARTED|Overall Study||2
261309|NCT02619812|628076|P3|STARTED|Overall Study||1
261310|NCT02619812|628077|P2|STARTED|Overall Study||0
261311|NCT02619812|628078|P1|STARTED|Overall Study||0
261312|NCT02619799|628094|P2|NOT COMPLETED|Overall Study||0
261313|NCT02619799|628095|P1|NOT COMPLETED|Overall Study||0
261314|NCT02619799|628094|P2|COMPLETED|Overall Study||25
261315|NCT02619799|628095|P1|COMPLETED|Overall Study||25
261316|NCT02619799|628094|P2|STARTED|Overall Study||25
261317|NCT02619799|628095|P1|STARTED|Overall Study||25
261318|NCT02619591|628113|P2|NOT COMPLETED|Overall Study||121
261319|NCT02619591|628114|P1|NOT COMPLETED|Overall Study||139
261320|NCT02619591|628113|P2|COMPLETED|Overall Study||0
261321|NCT02619591|628114|P1|COMPLETED|Overall Study||0
261322|NCT02619591|628113|P2|STARTED|Overall Study||121
261323|NCT02619591|628114|P1|STARTED|Overall Study||139
261324|NCT02618772|628122|P2|NOT COMPLETED|Overall Study||0
261325|NCT02618772|628123|P1|NOT COMPLETED|Overall Study||1
261326|NCT02618772|628122|P2|COMPLETED|Overall Study||40
261327|NCT02618772|628123|P1|COMPLETED|Overall Study||38
261328|NCT02618772|628122|P2|Withdrawal by Subject|Overall Study||0
261329|NCT02618772|628123|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
261330|NCT02618772|628122|P2|STARTED|Overall Study||40
261331|NCT02618772|628123|P1|STARTED|Overall Study||39
261332|NCT02617888|628157|P2|NOT COMPLETED|Overall Study||0
261333|NCT02617888|628158|P1|NOT COMPLETED|Overall Study||0
261334|NCT02617888|628157|P2|COMPLETED|Overall Study||51
261335|NCT02617888|628158|P1|COMPLETED|Overall Study||50
261336|NCT02617888|628157|P2|STARTED|Overall Study||51
261337|NCT02617888|628158|P1|STARTED|Overall Study||50
261338|NCT02617784|628166|P2|NOT COMPLETED|Overall Study||0
261339|NCT02617784|628167|P1|NOT COMPLETED|Overall Study||0
261340|NCT02617784|628166|P2|COMPLETED|Overall Study||12
261341|NCT02617784|628167|P1|COMPLETED|Overall Study||12
261342|NCT02617784|628166|P2|Second Dose Assessment Period|Overall Study||12
261343|NCT02617784|628167|P1|Second Dose Assessment Period|Overall Study||11
261344|NCT02617784|628166|P2|First Dose Assessment Period|Overall Study||12
261345|NCT02617784|628167|P1|First Dose Assessment Period|Overall Study||12
261346|NCT02617784|628166|P2|STARTED|Overall Study||12
261347|NCT02617784|628167|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
261348|NCT02616523|628217|P3|NOT COMPLETED|Overall Study||0
261349|NCT02616523|628218|P2|NOT COMPLETED|Overall Study||0
261350|NCT02616523|628219|P1|NOT COMPLETED|Overall Study||1
261351|NCT02616523|628217|P3|COMPLETED|Overall Study|April 2015|20
261352|NCT02616523|628218|P2|COMPLETED|Overall Study|April 2015|20
261353|NCT02616523|628219|P1|COMPLETED|Overall Study|April 2015|19
261354|NCT02616523|628217|P3|STARTED|Overall Study|June 2014|20
261355|NCT02616523|628218|P2|STARTED|Overall Study|June 2014|20
261356|NCT02616523|628219|P1|STARTED|Overall Study|June 2014|20
261357|NCT02615717|628235|P2|NOT COMPLETED|Overall Study||0
261358|NCT02615717|628236|P1|NOT COMPLETED|Overall Study||0
261359|NCT02615717|628235|P2|COMPLETED|Overall Study||3
261360|NCT02615717|628236|P1|COMPLETED|Overall Study||3
261361|NCT02615717|628235|P2|STARTED|Overall Study||3
261362|NCT02615717|628236|P1|STARTED|Overall Study||3
261363|NCT02614924|628250|P2|NOT COMPLETED|Overall Study||0
261364|NCT02614924|628251|P1|NOT COMPLETED|Overall Study||0
261365|NCT02614924|628250|P2|COMPLETED|Overall Study||20
261366|NCT02614924|628251|P1|COMPLETED|Overall Study||20
261367|NCT02614924|628250|P2|STARTED|Overall Study||20
261368|NCT02614924|628251|P1|STARTED|Overall Study||20
261369|NCT02614586|628259|P1|NOT COMPLETED|Overall Study||0
261370|NCT02614586|628259|P1|COMPLETED|Overall Study||11
261371|NCT02614586|628259|P1|STARTED|Overall Study||11
261372|NCT02614469|628266|P2|NOT COMPLETED|Period 2||0
261373|NCT02614469|628267|P1|NOT COMPLETED|Period 2||0
261374|NCT02614469|628266|P2|COMPLETED|Period 2||9
261375|NCT02614469|628267|P1|COMPLETED|Period 2||9
261376|NCT02614469|628266|P2|STARTED|Period 2||9
261377|NCT02614469|628267|P1|STARTED|Period 2||9
261378|NCT02614469|628266|P2|NOT COMPLETED|Period 1||0
261379|NCT02614469|628267|P1|NOT COMPLETED|Period 1||0
261380|NCT02614469|628266|P2|COMPLETED|Period 1||9
261381|NCT02614469|628267|P1|COMPLETED|Period 1||9
261382|NCT02614469|628266|P2|STARTED|Period 1||9
261383|NCT02614469|628267|P1|STARTED|Period 1||9
261384|NCT02614222|628297|P2|NOT COMPLETED|Overall Study||0
261385|NCT02614222|628298|P1|NOT COMPLETED|Overall Study||0
261386|NCT02614222|628297|P2|COMPLETED|Overall Study||14
261387|NCT02614222|628298|P1|COMPLETED|Overall Study||13
261388|NCT02614222|628297|P2|STARTED|Overall Study||14
261389|NCT02614222|628298|P1|STARTED|Overall Study||13
261390|NCT02613910|628318|P1|NOT COMPLETED|Overall Study||1
261391|NCT02613910|628318|P1|COMPLETED|Overall Study||0
261392|NCT02613910|628318|P1|STARTED|Overall Study||1
261393|NCT02612077|628367|P1|NOT COMPLETED|Overall Study||466
261394|NCT02612077|628367|P1|COMPLETED|Overall Study||299
261395|NCT02612077|628367|P1|Efficacy Analysis Set|Overall Study||737
261396|NCT02612077|628367|P1|Safety Analysis Set|Overall Study||760
261397|NCT02612077|628367|P1|Did Not Receive Study Product|Overall Study||5
261398|NCT02612077|628367|P1|STARTED|Overall Study||765
261399|NCT02612064|628379|P2|NOT COMPLETED|Overall Study||3
261400|NCT02612064|628380|P1|NOT COMPLETED|Overall Study||1
261401|NCT02612064|628379|P2|COMPLETED|Overall Study||112
261402|NCT02612064|628380|P1|COMPLETED|Overall Study||114
261403|NCT02612064|628379|P2|STARTED|Overall Study||115
261404|NCT02612064|628380|P1|STARTED|Overall Study||115
261405|NCT02611765|628392|P2|NOT COMPLETED|Overall Study||6
261406|NCT02611765|628393|P1|NOT COMPLETED|Overall Study||2
261407|NCT02611765|628392|P2|COMPLETED|Overall Study||29
261408|NCT02611765|628393|P1|COMPLETED|Overall Study||27
261409|NCT02611765|628392|P2|STARTED|Overall Study||35
261410|NCT02611765|628393|P1|STARTED|Overall Study||29
261411|NCT02611154|628399|P1|NOT COMPLETED|Overall Study||0
261412|NCT02611154|628399|P1|COMPLETED|Overall Study||5
261413|NCT02611154|628399|P1|STARTED|Overall Study||5
261414|NCT02610634|628420|P2|NOT COMPLETED|Overall Study||0
261415|NCT02610634|628421|P1|NOT COMPLETED|Overall Study||0
261416|NCT02610634|628420|P2|COMPLETED|Overall Study||40
261417|NCT02610634|628421|P1|COMPLETED|Overall Study||60
261418|NCT02610634|628420|P2|STARTED|Overall Study||40
261419|NCT02610634|628421|P1|STARTED|Overall Study||60
261420|NCT02609672|628429|P2|NOT COMPLETED|Overall Study||1
261421|NCT02609672|628430|P1|NOT COMPLETED|Overall Study||3
261422|NCT02609672|628429|P2|COMPLETED|Overall Study||11
261423|NCT02609672|628430|P1|COMPLETED|Overall Study||9
261424|NCT02609672|628429|P2|STARTED|Overall Study||12
261425|NCT02609672|628430|P1|STARTED|Overall Study||12
261426|NCT02609178|628464|P6|NOT COMPLETED|Third Crown||0
261427|NCT02609178|628465|P5|NOT COMPLETED|Third Crown||0
261428|NCT02609178|628466|P4|NOT COMPLETED|Third Crown||0
261429|NCT02609178|628467|P3|NOT COMPLETED|Third Crown||0
261430|NCT02609178|628468|P2|NOT COMPLETED|Third Crown||0
261431|NCT02609178|628469|P1|NOT COMPLETED|Third Crown||0
261432|NCT02609178|628464|P6|COMPLETED|Third Crown||2
261433|NCT02609178|628465|P5|COMPLETED|Third Crown||0
261434|NCT02609178|628466|P4|COMPLETED|Third Crown||2
261435|NCT02609178|628467|P3|COMPLETED|Third Crown||5
261436|NCT02609178|628468|P2|COMPLETED|Third Crown||1
261437|NCT02609178|628469|P1|COMPLETED|Third Crown||0
261438|NCT02609178|628464|P6|STARTED|Third Crown||2
261439|NCT02609178|628465|P5|STARTED|Third Crown||0
261440|NCT02609178|628466|P4|STARTED|Third Crown||2
261441|NCT02609178|628467|P3|STARTED|Third Crown||5
261442|NCT02609178|628468|P2|STARTED|Third Crown||1
261443|NCT02609178|628469|P1|STARTED|Third Crown||0
261444|NCT02609178|628464|P6|NOT COMPLETED|5-minute Washout Time||0
261445|NCT02609178|628465|P5|NOT COMPLETED|5-minute Washout Time||0
261446|NCT02609178|628466|P4|NOT COMPLETED|5-minute Washout Time||0
261447|NCT02609178|628467|P3|NOT COMPLETED|5-minute Washout Time||0
261448|NCT02609178|628468|P2|NOT COMPLETED|5-minute Washout Time||0
261449|NCT02609178|628469|P1|NOT COMPLETED|5-minute Washout Time||0
261450|NCT02609178|628464|P6|COMPLETED|5-minute Washout Time||2
261451|NCT02609178|628465|P5|COMPLETED|5-minute Washout Time||0
261452|NCT02609178|628466|P4|COMPLETED|5-minute Washout Time||2
261453|NCT02609178|628467|P3|COMPLETED|5-minute Washout Time||5
261454|NCT02609178|628468|P2|COMPLETED|5-minute Washout Time||1
261455|NCT02609178|628469|P1|COMPLETED|5-minute Washout Time||0
261456|NCT02609178|628464|P6|STARTED|5-minute Washout Time||2
261457|NCT02609178|628465|P5|STARTED|5-minute Washout Time||0
261458|NCT02609178|628466|P4|STARTED|5-minute Washout Time||2
261459|NCT02609178|628467|P3|STARTED|5-minute Washout Time||5
261460|NCT02609178|628468|P2|STARTED|5-minute Washout Time||1
261461|NCT02609178|628469|P1|STARTED|5-minute Washout Time||0
261462|NCT02609178|628464|P6|NOT COMPLETED|Second Crown||0
261463|NCT02609178|628465|P5|NOT COMPLETED|Second Crown||0
261464|NCT02609178|628466|P4|NOT COMPLETED|Second Crown||0
261465|NCT02609178|628467|P3|NOT COMPLETED|Second Crown||0
261466|NCT02609178|628468|P2|NOT COMPLETED|Second Crown||0
261467|NCT02609178|628469|P1|NOT COMPLETED|Second Crown||0
261468|NCT02609178|628464|P6|COMPLETED|Second Crown||2
261469|NCT02609178|628465|P5|COMPLETED|Second Crown||0
261470|NCT02609178|628466|P4|COMPLETED|Second Crown||2
261471|NCT02609178|628467|P3|COMPLETED|Second Crown||5
261472|NCT02609178|628468|P2|COMPLETED|Second Crown||1
261473|NCT02609178|628469|P1|COMPLETED|Second Crown||0
261474|NCT02609178|628464|P6|STARTED|Second Crown||2
261475|NCT02609178|628465|P5|STARTED|Second Crown||0
261476|NCT02609178|628466|P4|STARTED|Second Crown||2
261477|NCT02609178|628467|P3|STARTED|Second Crown||5
261478|NCT02609178|628468|P2|STARTED|Second Crown||1
261479|NCT02609178|628469|P1|STARTED|Second Crown||0
261480|NCT02609178|628464|P6|NOT COMPLETED|5-minute Washout Time||0
261481|NCT02609178|628465|P5|NOT COMPLETED|5-minute Washout Time||0
261482|NCT02609178|628466|P4|NOT COMPLETED|5-minute Washout Time||0
261483|NCT02609178|628467|P3|NOT COMPLETED|5-minute Washout Time||0
261484|NCT02609178|628468|P2|NOT COMPLETED|5-minute Washout Time||0
261485|NCT02609178|628469|P1|NOT COMPLETED|5-minute Washout Time||0
261486|NCT02609178|628464|P6|COMPLETED|5-minute Washout Time||2
261487|NCT02609178|628465|P5|COMPLETED|5-minute Washout Time||0
261488|NCT02609178|628466|P4|COMPLETED|5-minute Washout Time||2
261489|NCT02609178|628467|P3|COMPLETED|5-minute Washout Time||5
261490|NCT02609178|628468|P2|COMPLETED|5-minute Washout Time||1
261491|NCT02609178|628469|P1|COMPLETED|5-minute Washout Time||0
261492|NCT02609178|628464|P6|STARTED|5-minute Washout Time||2
261493|NCT02609178|628465|P5|STARTED|5-minute Washout Time||0
261494|NCT02609178|628466|P4|STARTED|5-minute Washout Time||2
261495|NCT02609178|628467|P3|STARTED|5-minute Washout Time||5
261496|NCT02609178|628468|P2|STARTED|5-minute Washout Time||1
261497|NCT02609178|628469|P1|STARTED|5-minute Washout Time||0
261498|NCT02609178|628464|P6|NOT COMPLETED|First Crown||0
261499|NCT02609178|628465|P5|NOT COMPLETED|First Crown||0
261500|NCT02609178|628466|P4|NOT COMPLETED|First Crown||1
261501|NCT02609178|628467|P3|NOT COMPLETED|First Crown||1
261502|NCT02609178|628468|P2|NOT COMPLETED|First Crown||0
261503|NCT02609178|628469|P1|NOT COMPLETED|First Crown||0
261504|NCT02609178|628464|P6|COMPLETED|First Crown||2
261505|NCT02609178|628465|P5|COMPLETED|First Crown||0
261506|NCT02609178|628466|P4|COMPLETED|First Crown||2
261507|NCT02609178|628467|P3|COMPLETED|First Crown||5
261508|NCT02609178|628468|P2|COMPLETED|First Crown||1
261509|NCT02609178|628469|P1|COMPLETED|First Crown||0
261510|NCT02609178|628464|P6|STARTED|First Crown||2
261511|NCT02609178|628465|P5|STARTED|First Crown||0
261512|NCT02609178|628466|P4|STARTED|First Crown||3
261513|NCT02609178|628467|P3|STARTED|First Crown||6
261514|NCT02609178|628468|P2|STARTED|First Crown||1
261515|NCT02609178|628469|P1|STARTED|First Crown||0
261516|NCT02608489|628486|P2|NOT COMPLETED|Overall Study||10
261517|NCT02608489|628487|P1|NOT COMPLETED|Overall Study||13
261518|NCT02608489|628486|P2|COMPLETED|Overall Study||33
261519|NCT02608489|628487|P1|COMPLETED|Overall Study||30
261520|NCT02608489|628486|P2|STARTED|Overall Study||43
261521|NCT02608489|628487|P1|STARTED|Overall Study||43
261522|NCT02606838|628507|P1|NOT COMPLETED|Overall Study||0
261523|NCT02606838|628507|P1|COMPLETED|Overall Study||119
261524|NCT02606838|628507|P1|STARTED|Overall Study||119
261525|NCT02606734|628515|P1|NOT COMPLETED|Overall Study||0
261526|NCT02606734|628515|P1|COMPLETED|Overall Study||44
261527|NCT02606734|628515|P1|STARTED|Overall Study||44
261528|NCT02605928|628519|P1|NOT COMPLETED|Overall Study||33
261529|NCT02605928|628519|P1|COMPLETED|Overall Study||46
261530|NCT02605928|628519|P1|Pivotal Phase, Statistical Phase|Overall Study||51
261531|NCT02605928|628519|P1|STARTED|Overall Study||79
261532|NCT02604589|628526|P3|NOT COMPLETED|Overall Study||1
261533|NCT02604589|628527|P2|NOT COMPLETED|Overall Study||0
261534|NCT02604589|628528|P1|NOT COMPLETED|Overall Study||0
261535|NCT02604589|628526|P3|COMPLETED|Overall Study||1
261536|NCT02604589|628527|P2|COMPLETED|Overall Study||5
261537|NCT02604589|628528|P1|COMPLETED|Overall Study||3
261538|NCT02604589|628526|P3|STARTED|Overall Study||2
261539|NCT02604589|628527|P2|STARTED|Overall Study||5
261540|NCT02604589|628528|P1|STARTED|Overall Study||3
261541|NCT02604550|628556|P2|NOT COMPLETED|Overall Study||26
261542|NCT02604550|628557|P1|NOT COMPLETED|Overall Study||25
261543|NCT02604550|628556|P2|COMPLETED|Overall Study||33
261544|NCT02604550|628557|P1|COMPLETED|Overall Study||31
261545|NCT02604550|628556|P2|STARTED|Overall Study||59
261546|NCT02604550|628557|P1|STARTED|Overall Study||56
261547|NCT02604407|628584|P3|NOT COMPLETED|Overall Study||16
261548|NCT02604407|628585|P2|NOT COMPLETED|Overall Study||12
261549|NCT02604407|628586|P1|NOT COMPLETED|Overall Study||11
261550|NCT02604407|628584|P3|COMPLETED|Overall Study||76
261551|NCT02604407|628585|P2|COMPLETED|Overall Study||80
261552|NCT02604407|628586|P1|COMPLETED|Overall Study||80
261553|NCT02604407|628584|P3|TREATED|Overall Study||90
261554|NCT02604407|628585|P2|TREATED|Overall Study||92
261555|NCT02604407|628586|P1|TREATED|Overall Study||89
261556|NCT02604407|628584|P3|STARTED|Overall Study||92
261557|NCT02604407|628585|P2|STARTED|Overall Study||92
261558|NCT02604407|628586|P1|STARTED|Overall Study||91
261559|NCT02604264|628599|P2|NOT COMPLETED|Overall Study||242
261560|NCT02604264|628600|P1|NOT COMPLETED|Overall Study||200
261561|NCT02604264|628599|P2|COMPLETED|Overall Study||1225
261562|NCT02604264|628600|P1|COMPLETED|Overall Study||1245
261563|NCT02604264|628599|P2|STARTED|Overall Study||1467
261564|NCT02604264|628600|P1|STARTED|Overall Study||1445
261565|NCT02603666|628606|P1|NOT COMPLETED|Overall Study||0
261566|NCT02603666|628606|P1|COMPLETED|Overall Study||130
261567|NCT02603666|628606|P1|STARTED|Overall Study||130
261568|NCT02602223|628610|P1|NOT COMPLETED|Overall Study||0
261569|NCT02602223|628610|P1|COMPLETED|Overall Study||9
261570|NCT02602223|628610|P1|STARTED|Overall Study||9
261571|NCT02598934|628628|P2|NOT COMPLETED|Overall Study||22
261572|NCT02598934|628629|P1|NOT COMPLETED|Overall Study||19
261573|NCT02598934|628628|P2|COMPLETED|Overall Study||132
261574|NCT02598934|628629|P1|COMPLETED|Overall Study||135
261575|NCT02598934|628628|P2|STARTED|Overall Study||154
261576|NCT02598934|628629|P1|STARTED|Overall Study||154
261577|NCT02598622|628641|P2|NOT COMPLETED|Overall Study||0
261578|NCT02598622|628642|P1|NOT COMPLETED|Overall Study||6
261579|NCT02598622|628641|P2|COMPLETED|Overall Study||0
261580|NCT02598622|628642|P1|COMPLETED|Overall Study||2
261581|NCT02598622|628641|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
261582|NCT02598622|628642|P1|STARTED|Overall Study||8
261583|NCT02598128|628648|P4|NOT COMPLETED|Period C: Days 12 to 20||0
261584|NCT02598128|628649|P3|NOT COMPLETED|Period C: Days 12 to 20||0
261585|NCT02598128|628650|P2|NOT COMPLETED|Period C: Days 12 to 20||0
261586|NCT02598128|628651|P1|NOT COMPLETED|Period C: Days 12 to 20||0
261587|NCT02598128|628648|P4|COMPLETED|Period C: Days 12 to 20||33
261588|NCT02598128|628649|P3|COMPLETED|Period C: Days 12 to 20||0
261589|NCT02598128|628650|P2|COMPLETED|Period C: Days 12 to 20||0
261590|NCT02598128|628651|P1|COMPLETED|Period C: Days 12 to 20||0
261591|NCT02598128|628648|P4|STARTED|Period C: Days 12 to 20||33
261592|NCT02598128|628649|P3|STARTED|Period C: Days 12 to 20||0
261593|NCT02598128|628650|P2|STARTED|Period C: Days 12 to 20||0
261594|NCT02598128|628651|P1|STARTED|Period C: Days 12 to 20||0
261595|NCT02598128|628648|P4|NOT COMPLETED|Period B: Days 1 to 11||0
261596|NCT02598128|628649|P3|NOT COMPLETED|Period B: Days 1 to 11||0
261597|NCT02598128|628650|P2|NOT COMPLETED|Period B: Days 1 to 11||0
261598|NCT02598128|628651|P1|NOT COMPLETED|Period B: Days 1 to 11||0
261599|NCT02598128|628648|P4|COMPLETED|Period B: Days 1 to 11||0
261600|NCT02598128|628649|P3|COMPLETED|Period B: Days 1 to 11||16
261601|NCT02598128|628650|P2|COMPLETED|Period B: Days 1 to 11||17
261602|NCT02598128|628651|P1|COMPLETED|Period B: Days 1 to 11||0
261603|NCT02598128|628648|P4|STARTED|Period B: Days 1 to 11||0
261604|NCT02598128|628649|P3|STARTED|Period B: Days 1 to 11||16
261605|NCT02598128|628650|P2|STARTED|Period B: Days 1 to 11||17
261606|NCT02598128|628651|P1|STARTED|Period B: Days 1 to 11||0
261607|NCT02598128|628648|P4|NOT COMPLETED|Period A: Days -7 to -1||0
261608|NCT02598128|628649|P3|NOT COMPLETED|Period A: Days -7 to -1||0
261609|NCT02598128|628650|P2|NOT COMPLETED|Period A: Days -7 to -1||0
261610|NCT02598128|628651|P1|NOT COMPLETED|Period A: Days -7 to -1||1
261611|NCT02598128|628648|P4|COMPLETED|Period A: Days -7 to -1||0
261612|NCT02598128|628649|P3|COMPLETED|Period A: Days -7 to -1||0
261613|NCT02598128|628650|P2|COMPLETED|Period A: Days -7 to -1||0
261614|NCT02598128|628651|P1|COMPLETED|Period A: Days -7 to -1||33
261615|NCT02598128|628648|P4|STARTED|Period A: Days -7 to -1||0
261616|NCT02598128|628649|P3|STARTED|Period A: Days -7 to -1||0
261617|NCT02598128|628650|P2|STARTED|Period A: Days -7 to -1||0
261618|NCT02598128|628651|P1|STARTED|Period A: Days -7 to -1||34
261619|NCT02597907|628665|P2|NOT COMPLETED|Overall Study||0
261620|NCT02597907|628666|P1|NOT COMPLETED|Overall Study||0
261621|NCT02597907|628665|P2|COMPLETED|Overall Study||44
261622|NCT02597907|628666|P1|COMPLETED|Overall Study||44
261623|NCT02597907|628665|P2|STARTED|Overall Study||44
261624|NCT02597907|628666|P1|STARTED|Overall Study||44
261625|NCT02597855|628674|P2|NOT COMPLETED|Overall Study||1
261626|NCT02597855|628675|P1|NOT COMPLETED|Overall Study||2
261627|NCT02597855|628674|P2|COMPLETED|Overall Study||13
261628|NCT02597855|628675|P1|COMPLETED|Overall Study||16
261629|NCT02597855|628674|P2|STARTED|Overall Study||14
261630|NCT02597855|628675|P1|STARTED|Overall Study||18
261631|NCT02597582|628685|P2|NOT COMPLETED|Overall Study||0
261632|NCT02597582|628686|P1|NOT COMPLETED|Overall Study||0
261633|NCT02597582|628685|P2|COMPLETED|Overall Study||20
261634|NCT02597582|628686|P1|COMPLETED|Overall Study||21
261635|NCT02597582|628685|P2|STARTED|Overall Study||20
261636|NCT02597582|628686|P1|STARTED|Overall Study||21
261637|NCT02596958|628702|P1|NOT COMPLETED|Overall Study||996
261638|NCT02596958|628702|P1|COMPLETED|Overall Study||0
261639|NCT02596958|628702|P1|STARTED|Overall Study||996
261640|NCT02596945|628714|P1|NOT COMPLETED|Overall Study||56
261641|NCT02596945|628714|P1|COMPLETED|Overall Study||167
261642|NCT02596945|628714|P1|Treated|Overall Study||220
261643|NCT02596945|628714|P1|STARTED|Overall Study||223
261644|NCT02596620|628722|P2|NOT COMPLETED|Overall Study||1
261645|NCT02596620|628723|P1|NOT COMPLETED|Overall Study||1
261646|NCT02596620|628722|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
261647|NCT02596620|628723|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
261648|NCT02596620|628722|P2|STARTED|Overall Study|Started from 1st October 2013|82
261649|NCT02596620|628723|P1|STARTED|Overall Study|Started from 1st October 2013|82
261650|NCT02595502|628729|P2|NOT COMPLETED|Period 3||2
261651|NCT02595502|628730|P1|NOT COMPLETED|Period 3||1
261652|NCT02595502|628729|P2|COMPLETED|Period 3||136
261653|NCT02595502|628730|P1|COMPLETED|Period 3||140
261654|NCT02595502|628729|P2|STARTED|Period 3||138
261655|NCT02595502|628730|P1|STARTED|Period 3||141
261656|NCT02595502|628729|P2|NOT COMPLETED|Period 2||2
261657|NCT02595502|628730|P1|NOT COMPLETED|Period 2||1
261658|NCT02595502|628729|P2|COMPLETED|Period 2||138
261659|NCT02595502|628730|P1|COMPLETED|Period 2||141
261660|NCT02595502|628729|P2|STARTED|Period 2||140
261661|NCT02595502|628730|P1|STARTED|Period 2||142
261662|NCT02595502|628729|P2|NOT COMPLETED|Period 1||2
261663|NCT02595502|628730|P1|NOT COMPLETED|Period 1||1
261664|NCT02595502|628729|P2|COMPLETED|Period 1||140
261665|NCT02595502|628730|P1|COMPLETED|Period 1||142
261666|NCT02595502|628729|P2|STARTED|Period 1||142
261667|NCT02595502|628730|P1|STARTED|Period 1||143
261668|NCT02595450|628736|P1|NOT COMPLETED|Overall Study||81
261669|NCT02595450|628736|P1|COMPLETED|Overall Study||218
261670|NCT02595450|628736|P1|Treated|Overall Study||291
261671|NCT02595450|628736|P1|STARTED|Overall Study||299
261672|NCT02594826|628744|P2|NOT COMPLETED|Overall Study||60
261673|NCT02594826|628745|P1|NOT COMPLETED|Overall Study||57
261674|NCT02594826|628744|P2|COMPLETED|Overall Study||298
261675|NCT02594826|628745|P1|COMPLETED|Overall Study||290
261676|NCT02594826|628744|P2|STARTED|Overall Study||358
261677|NCT02594826|628745|P1|STARTED|Overall Study||347
261678|NCT02591238|628755|P4|NOT COMPLETED|Overall Study||3
261679|NCT02591238|628756|P3|NOT COMPLETED|Overall Study||0
261680|NCT02591238|628757|P2|NOT COMPLETED|Overall Study||1
261681|NCT02591238|628758|P1|NOT COMPLETED|Overall Study||1
261682|NCT02591238|628755|P4|COMPLETED|Overall Study||15
261683|NCT02591238|628756|P3|COMPLETED|Overall Study||17
261684|NCT02591238|628757|P2|COMPLETED|Overall Study||16
261685|NCT02591238|628758|P1|COMPLETED|Overall Study||15
261686|NCT02591238|628755|P4|STARTED|Overall Study||18
261687|NCT02591238|628756|P3|STARTED|Overall Study||17
261688|NCT02591238|628757|P2|STARTED|Overall Study||17
261689|NCT02591238|628758|P1|STARTED|Overall Study||16
261690|NCT02591056|628788|P1|NOT COMPLETED|Overall Study||0
261691|NCT02591056|628788|P1|COMPLETED|Overall Study||27
261692|NCT02591056|628788|P1|STARTED|Overall Study||27
261693|NCT02590588|628792|P1|NOT COMPLETED|Overall Study||1
261694|NCT02590588|628792|P1|COMPLETED|Overall Study||0
261695|NCT02590588|628792|P1|STARTED|Overall Study||1
261696|NCT02590562|628800|P1|NOT COMPLETED|Overall Study||6
261697|NCT02590562|628800|P1|COMPLETED|Overall Study||802
261698|NCT02590562|628800|P1|STARTED|Overall Study||808
261699|NCT02588872|628859|P2|NOT COMPLETED|Overall Study||0
261700|NCT02588872|628860|P1|NOT COMPLETED|Overall Study||0
261701|NCT02588872|628859|P2|COMPLETED|Overall Study||52
261702|NCT02588872|628860|P1|COMPLETED|Overall Study||59
261703|NCT02588872|628859|P2|STARTED|Overall Study||52
261704|NCT02588872|628860|P1|STARTED|Overall Study||59
261705|NCT02588599|628874|P1|NOT COMPLETED|Overall Study||0
261706|NCT02588599|628874|P1|COMPLETED|Overall Study||54
261707|NCT02588599|628874|P1|STARTED|Overall Study||54
261708|NCT02587819|628879|P1|NOT COMPLETED|Overall Study||2
261709|NCT02587819|628879|P1|COMPLETED|Overall Study||19
261710|NCT02587819|628879|P1|Exposed|Overall Study||21
261711|NCT02587819|628879|P1|STARTED|Overall Study||21
261712|NCT02587117|628888|P2|NOT COMPLETED|Overall Study||0
261713|NCT02587117|628889|P1|NOT COMPLETED|Overall Study||0
261714|NCT02587117|628888|P2|COMPLETED|Overall Study||15
261715|NCT02587117|628889|P1|COMPLETED|Overall Study||13
261716|NCT02587117|628888|P2|STARTED|Overall Study||15
261717|NCT02587117|628889|P1|STARTED|Overall Study||13
261718|NCT02586506|628897|P1|NOT COMPLETED|Overall Study||9
261719|NCT02586506|628897|P1|COMPLETED|Overall Study||250
261720|NCT02586506|628897|P1|STARTED|Overall Study||259
261721|NCT02586493|628903|P1|NOT COMPLETED|Overall Study||12
261722|NCT02586493|628903|P1|COMPLETED|Overall Study||266
261723|NCT02586493|628903|P1|STARTED|Overall Study||278
261724|NCT02585999|628909|P1|NOT COMPLETED|Overall Study||2
261725|NCT02585999|628909|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
261726|NCT02585999|628909|P1|STARTED|Overall Study||28
261727|NCT02584686|628916|P2|NOT COMPLETED|Overall Study||0
261728|NCT02584686|628917|P1|NOT COMPLETED|Overall Study||0
261729|NCT02584686|628916|P2|COMPLETED|Overall Study||12
261730|NCT02584686|628917|P1|COMPLETED|Overall Study||12
261731|NCT02584686|628916|P2|STARTED|Overall Study||12
261732|NCT02584686|628917|P1|STARTED|Overall Study||12
261733|NCT02584673|628945|P2|NOT COMPLETED|Overall Study||0
261734|NCT02584673|628946|P1|NOT COMPLETED|Overall Study||0
261735|NCT02584673|628945|P2|COMPLETED|Overall Study||15
261736|NCT02584673|628946|P1|COMPLETED|Overall Study||15
261737|NCT02584673|628945|P2|STARTED|Overall Study||15
261738|NCT02584673|628946|P1|STARTED|Overall Study||15
261739|NCT02582983|628958|P1|NOT COMPLETED|Overall Study||6
261740|NCT02582983|628958|P1|COMPLETED|Overall Study||17
261741|NCT02582983|628958|P1|STARTED|Overall Study||23
261742|NCT02582970|628963|P1|NOT COMPLETED|Overall Study||0
261743|NCT02582970|628963|P1|COMPLETED|Overall Study||40
261744|NCT02582970|628963|P1|STARTED|Overall Study||40
261745|NCT02581475|628975|P2|NOT COMPLETED|Overall Study||15
261746|NCT02581475|628976|P1|NOT COMPLETED|Overall Study||11
261747|NCT02581475|628975|P2|COMPLETED|Overall Study||178
261748|NCT02581475|628976|P1|COMPLETED|Overall Study||182
261749|NCT02581475|628975|P2|STARTED|Overall Study||193
261750|NCT02581475|628976|P1|STARTED|Overall Study||193
261751|NCT02580799|628988|P1|NOT COMPLETED|Overall Study||0
261752|NCT02580799|628988|P1|COMPLETED|Overall Study||30
261753|NCT02580799|628988|P1|STARTED|Overall Study||30
261754|NCT02580357|629013|P3|NOT COMPLETED|Overall Study||0
261755|NCT02580357|629014|P2|NOT COMPLETED|Overall Study||0
261756|NCT02580357|629015|P1|NOT COMPLETED|Overall Study||3
261757|NCT02580357|629013|P3|COMPLETED|Overall Study||18
261758|NCT02580357|629014|P2|COMPLETED|Overall Study||18
261759|NCT02580357|629015|P1|COMPLETED|Overall Study||15
261760|NCT02580357|629013|P3|STARTED|Overall Study||18
261761|NCT02580357|629014|P2|STARTED|Overall Study||18
261762|NCT02580357|629015|P1|STARTED|Overall Study||18
261763|NCT02578992|629028|P2|NOT COMPLETED|Overall Study||3
261764|NCT02578992|629029|P1|NOT COMPLETED|Overall Study||3
261765|NCT02578992|629028|P2|COMPLETED|Overall Study|October 2015|62
261766|NCT02578992|629029|P1|COMPLETED|Overall Study|October 2015|62
261767|NCT02578992|629028|P2|STARTED|Overall Study|November 2014|65
261768|NCT02578992|629029|P1|STARTED|Overall Study|November 2014|65
261769|NCT02578186|629041|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
261770|NCT02578186|629042|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
261771|NCT02578186|629041|P2|COMPLETED|Period 2 (Second of Crossover)||13
261772|NCT02578186|629042|P1|COMPLETED|Period 2 (Second of Crossover)||12
261773|NCT02578186|629041|P2|STARTED|Period 2 (Second of Crossover)||13
261774|NCT02578186|629042|P1|STARTED|Period 2 (Second of Crossover)||12
261775|NCT02578186|629041|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
261776|NCT02578186|629042|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
261777|NCT02578186|629041|P2|COMPLETED|Period 1 (First of Crossover)||13
261778|NCT02578186|629042|P1|COMPLETED|Period 1 (First of Crossover)||12
261779|NCT02578186|629041|P2|STARTED|Period 1 (First of Crossover)||18
261780|NCT02578186|629042|P1|STARTED|Period 1 (First of Crossover)||17
261781|NCT02577445|629050|P2|NOT COMPLETED|Overall Study||17
261782|NCT02577445|629051|P1|NOT COMPLETED|Overall Study||14
261783|NCT02577445|629050|P2|COMPLETED|Overall Study|study terminated prematurely|0
261784|NCT02577445|629051|P1|COMPLETED|Overall Study|study terminated prematurely|0
261785|NCT02577445|629050|P2|STARTED|Overall Study||17
261786|NCT02577445|629051|P1|STARTED|Overall Study||14
261787|NCT02577315|629064|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
261788|NCT02577315|629065|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
261789|NCT02577315|629064|P2|COMPLETED|Treatment Period 2 (4 Days)||12
261790|NCT02577315|629065|P1|COMPLETED|Treatment Period 2 (4 Days)||12
261791|NCT02577315|629064|P2|STARTED|Treatment Period 2 (4 Days)||12
261792|NCT02577315|629065|P1|STARTED|Treatment Period 2 (4 Days)||12
261793|NCT02577315|629064|P2|NOT COMPLETED|Washout Period (5 Days)||0
261794|NCT02577315|629065|P1|NOT COMPLETED|Washout Period (5 Days)||0
261795|NCT02577315|629064|P2|COMPLETED|Washout Period (5 Days)||12
261796|NCT02577315|629065|P1|COMPLETED|Washout Period (5 Days)||12
261797|NCT02577315|629064|P2|STARTED|Washout Period (5 Days)||12
261798|NCT02577315|629065|P1|STARTED|Washout Period (5 Days)||12
261799|NCT02577315|629064|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
261800|NCT02577315|629065|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
261801|NCT02577315|629064|P2|COMPLETED|Treatment Period 1 (4 Days)||12
261802|NCT02577315|629065|P1|COMPLETED|Treatment Period 1 (4 Days)||12
261803|NCT02577315|629064|P2|STARTED|Treatment Period 1 (4 Days)||13
261804|NCT02577315|629065|P1|STARTED|Treatment Period 1 (4 Days)||12
261805|NCT02576639|629086|P5|NOT COMPLETED|Overall Study||4
261806|NCT02576639|629087|P4|NOT COMPLETED|Overall Study||1
261807|NCT02576639|629088|P3|NOT COMPLETED|Overall Study||2
261808|NCT02576639|629089|P2|NOT COMPLETED|Overall Study||2
261809|NCT02576639|629090|P1|NOT COMPLETED|Overall Study||2
261810|NCT02576639|629086|P5|COMPLETED|Overall Study||20
261811|NCT02576639|629087|P4|COMPLETED|Overall Study||25
261812|NCT02576639|629088|P3|COMPLETED|Overall Study||23
261813|NCT02576639|629089|P2|COMPLETED|Overall Study||23
261814|NCT02576639|629090|P1|COMPLETED|Overall Study||22
261815|NCT02576639|629086|P5|Safety Analysis Set|Overall Study||24
261816|NCT02576639|629087|P4|Safety Analysis Set|Overall Study||26
261817|NCT02576639|629088|P3|Safety Analysis Set|Overall Study||25
261818|NCT02576639|629089|P2|Safety Analysis Set|Overall Study||25
261819|NCT02576639|629090|P1|Safety Analysis Set|Overall Study||24
261820|NCT02576639|629086|P5|Pharmacokinetic Analysis Set|Overall Study||24
261821|NCT02576639|629087|P4|Pharmacokinetic Analysis Set|Overall Study||26
261822|NCT02576639|629088|P3|Pharmacokinetic Analysis Set|Overall Study||25
261823|NCT02576639|629089|P2|Pharmacokinetic Analysis Set|Overall Study||25
261824|NCT02576639|629090|P1|Pharmacokinetic Analysis Set|Overall Study||0
261825|NCT02576639|629086|P5|Pharmacodynamic Analysis Set|Overall Study||25
261826|NCT02576639|629087|P4|Pharmacodynamic Analysis Set|Overall Study||25
261827|NCT02576639|629088|P3|Pharmacodynamic Analysis Set|Overall Study||25
261828|NCT02576639|629089|P2|Pharmacodynamic Analysis Set|Overall Study||24
261829|NCT02576639|629090|P1|Pharmacodynamic Analysis Set|Overall Study||24
261830|NCT02576639|629086|P5|STARTED|Overall Study||24
261831|NCT02576639|629087|P4|STARTED|Overall Study||26
261832|NCT02576639|629088|P3|STARTED|Overall Study||25
261833|NCT02576639|629089|P2|STARTED|Overall Study||25
261834|NCT02576639|629090|P1|STARTED|Overall Study||24
261835|NCT02576535|629147|P1|NOT COMPLETED|Overall Study||2
261836|NCT02576535|629147|P1|COMPLETED|Overall Study||16
261837|NCT02576535|629147|P1|STARTED|Overall Study||18
261838|NCT02576145|629158|P2|NOT COMPLETED|Overall Study||1
261839|NCT02576145|629159|P1|NOT COMPLETED|Overall Study||3
261840|NCT02576145|629158|P2|COMPLETED|Overall Study||4
261841|NCT02576145|629159|P1|COMPLETED|Overall Study||3
261842|NCT02576145|629158|P2|STARTED|Overall Study||5
261843|NCT02576145|629159|P1|STARTED|Overall Study||6
261844|NCT02576041|629195|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
261845|NCT02576041|629195|P1|COMPLETED|Bilastine (Active Treatement)||18
261846|NCT02576041|629195|P1|STARTED|Bilastine (Active Treatement)||18
261847|NCT02576041|629195|P1|NOT COMPLETED|Placebo (run-in)||0
261848|NCT02576041|629195|P1|COMPLETED|Placebo (run-in)||18
261849|NCT02576041|629195|P1|STARTED|Placebo (run-in)||18
261850|NCT02575911|629201|P1|NOT COMPLETED|Overall Study||1
261851|NCT02575911|629201|P1|COMPLETED|Overall Study||29
261852|NCT02575911|629201|P1|STARTED|Overall Study||30
261853|NCT02574845|629225|P6|NOT COMPLETED|Overall Study||1
261854|NCT02574845|629226|P5|NOT COMPLETED|Overall Study||1
261855|NCT02574845|629227|P4|NOT COMPLETED|Overall Study||0
261856|NCT02574845|629228|P3|NOT COMPLETED|Overall Study||0
261857|NCT02574845|629229|P2|NOT COMPLETED|Overall Study||1
261858|NCT02574845|629230|P1|NOT COMPLETED|Overall Study||0
261859|NCT02574845|629225|P6|COMPLETED|Overall Study||2
261860|NCT02574845|629226|P5|COMPLETED|Overall Study||2
261861|NCT02574845|629227|P4|COMPLETED|Overall Study||3
261862|NCT02574845|629228|P3|COMPLETED|Overall Study||3
261863|NCT02574845|629229|P2|COMPLETED|Overall Study||2
261864|NCT02574845|629230|P1|COMPLETED|Overall Study||3
261865|NCT02574845|629225|P6|Received R|Overall Study||3
261866|NCT02574845|629226|P5|Received R|Overall Study||2
261867|NCT02574845|629227|P4|Received R|Overall Study||3
261868|NCT02574845|629228|P3|Received R|Overall Study||3
261869|NCT02574845|629229|P2|Received R|Overall Study||2
261870|NCT02574845|629230|P1|Received R|Overall Study||3
261871|NCT02574845|629225|P6|Received T5|Overall Study||2
261872|NCT02574845|629226|P5|Received T5|Overall Study||3
261873|NCT02574845|629227|P4|Received T5|Overall Study||3
261874|NCT02574845|629228|P3|Received T5|Overall Study||3
261875|NCT02574845|629229|P2|Received T5|Overall Study||2
261876|NCT02574845|629230|P1|Received T5|Overall Study||3
261877|NCT02574845|629225|P6|Received T4|Overall Study||2
261878|NCT02574845|629226|P5|Received T4|Overall Study||2
261879|NCT02574845|629227|P4|Received T4|Overall Study||3
261880|NCT02574845|629228|P3|Received T4|Overall Study||3
261881|NCT02574845|629229|P2|Received T4|Overall Study||2
261882|NCT02574845|629230|P1|Received T4|Overall Study||3
261883|NCT02574845|629225|P6|Received T3|Overall Study||3
261884|NCT02574845|629226|P5|Received T3|Overall Study||2
261885|NCT02574845|629227|P4|Received T3|Overall Study||3
261886|NCT02574845|629228|P3|Received T3|Overall Study||3
261887|NCT02574845|629229|P2|Received T3|Overall Study||2
261888|NCT02574845|629230|P1|Received T3|Overall Study|one subject missed treatment period 2|2
261889|NCT02574845|629225|P6|Received T2|Overall Study||3
261890|NCT02574845|629226|P5|Received T2|Overall Study||2
261891|NCT02574845|629227|P4|Received T2|Overall Study||3
261892|NCT02574845|629228|P3|Received T2|Overall Study||3
261893|NCT02574845|629229|P2|Received T2|Overall Study||3
261894|NCT02574845|629230|P1|Received T2|Overall Study||3
261895|NCT02574845|629225|P6|Received T1|Overall Study|one subject missed treatment period 2|2
261896|NCT02574845|629226|P5|Received T1|Overall Study||2
261897|NCT02574845|629227|P4|Received T1|Overall Study||3
261898|NCT02574845|629228|P3|Received T1|Overall Study||3
261899|NCT02574845|629229|P2|Received T1|Overall Study||2
261900|NCT02574845|629230|P1|Received T1|Overall Study||3
261901|NCT02574845|629225|P6|STARTED|Overall Study||3
261902|NCT02574845|629226|P5|STARTED|Overall Study||3
261903|NCT02574845|629227|P4|STARTED|Overall Study||3
261904|NCT02574845|629228|P3|STARTED|Overall Study||3
261905|NCT02574845|629229|P2|STARTED|Overall Study||3
261906|NCT02574845|629230|P1|STARTED|Overall Study||3
261907|NCT02574260|629256|P1|NOT COMPLETED|Overall Study||1
261908|NCT02574260|629256|P1|COMPLETED|Overall Study||2
261909|NCT02574260|629256|P1|STARTED|Overall Study||3
261910|NCT02573870|629264|P2|NOT COMPLETED|Overall Study||7
261911|NCT02573870|629265|P1|NOT COMPLETED|Overall Study||0
261912|NCT02573870|629264|P2|COMPLETED|Overall Study||35
261913|NCT02573870|629265|P1|COMPLETED|Overall Study||20
261914|NCT02573870|629264|P2|STARTED|Overall Study||42
261915|NCT02573870|629265|P1|STARTED|Overall Study||20
261916|NCT02572752|629274|P3|NOT COMPLETED|Period 3 Including Washout||0
261917|NCT02572752|629275|P2|NOT COMPLETED|Period 3 Including Washout||0
261918|NCT02572752|629276|P1|NOT COMPLETED|Period 3 Including Washout||0
261919|NCT02572752|629274|P3|COMPLETED|Period 3 Including Washout||24
261920|NCT02572752|629275|P2|COMPLETED|Period 3 Including Washout||23
261921|NCT02572752|629276|P1|COMPLETED|Period 3 Including Washout||23
261922|NCT02572752|629274|P3|STARTED|Period 3 Including Washout||24
261923|NCT02572752|629275|P2|STARTED|Period 3 Including Washout||23
261924|NCT02572752|629276|P1|STARTED|Period 3 Including Washout||23
261925|NCT02572752|629274|P3|NOT COMPLETED|Period 2 Including Washout||0
261926|NCT02572752|629275|P2|NOT COMPLETED|Period 2 Including Washout||0
261927|NCT02572752|629276|P1|NOT COMPLETED|Period 2 Including Washout||0
261928|NCT02572752|629274|P3|COMPLETED|Period 2 Including Washout||24
261929|NCT02572752|629275|P2|COMPLETED|Period 2 Including Washout||23
261930|NCT02572752|629276|P1|COMPLETED|Period 2 Including Washout||23
261931|NCT02572752|629274|P3|STARTED|Period 2 Including Washout||24
261932|NCT02572752|629275|P2|STARTED|Period 2 Including Washout||23
261933|NCT02572752|629276|P1|STARTED|Period 2 Including Washout||23
261934|NCT02572752|629274|P3|NOT COMPLETED|Period 1 Including Washout||0
261935|NCT02572752|629275|P2|NOT COMPLETED|Period 1 Including Washout||0
261936|NCT02572752|629276|P1|NOT COMPLETED|Period 1 Including Washout||0
261937|NCT02572752|629274|P3|COMPLETED|Period 1 Including Washout||24
261938|NCT02572752|629275|P2|COMPLETED|Period 1 Including Washout||23
261939|NCT02572752|629276|P1|COMPLETED|Period 1 Including Washout||23
261940|NCT02572752|629274|P3|STARTED|Period 1 Including Washout||24
261941|NCT02572752|629275|P2|STARTED|Period 1 Including Washout||23
261942|NCT02572752|629276|P1|STARTED|Period 1 Including Washout||23
261943|NCT02572609|629291|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
261944|NCT02572609|629292|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
261945|NCT02572609|629291|P2|COMPLETED|Period 2: Treatment Period 2||18
261946|NCT02572609|629292|P1|COMPLETED|Period 2: Treatment Period 2||18
261947|NCT02572609|629291|P2|STARTED|Period 2: Treatment Period 2||18
261948|NCT02572609|629292|P1|STARTED|Period 2: Treatment Period 2||18
261949|NCT02572609|629291|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
261950|NCT02572609|629292|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
261951|NCT02572609|629291|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
261952|NCT02572609|629292|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
261953|NCT02572609|629291|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
261954|NCT02572609|629292|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
261955|NCT02572427|629302|P2|NOT COMPLETED|Overall Study||9
261956|NCT02572427|629303|P1|NOT COMPLETED|Overall Study||6
261957|NCT02572427|629302|P2|COMPLETED|Overall Study||36
261958|NCT02572427|629303|P1|COMPLETED|Overall Study||31
261959|NCT02572427|629302|P2|STARTED|Overall Study||45
261960|NCT02572427|629303|P1|STARTED|Overall Study||37
261961|NCT02571634|629311|P1|NOT COMPLETED|Overall Study||0
261962|NCT02571634|629311|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
261963|NCT02571634|629311|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
261964|NCT02571153|629322|P3|NOT COMPLETED|Overall Study||2
261965|NCT02571153|629323|P2|NOT COMPLETED|Overall Study||8
261966|NCT02571153|629324|P1|NOT COMPLETED|Overall Study||6
261967|NCT02571153|629322|P3|COMPLETED|Overall Study||43
261968|NCT02571153|629323|P2|COMPLETED|Overall Study||37
261969|NCT02571153|629324|P1|COMPLETED|Overall Study||39
261970|NCT02571153|629322|P3|STARTED|Overall Study||45
261971|NCT02571153|629323|P2|STARTED|Overall Study||45
261972|NCT02571153|629324|P1|STARTED|Overall Study||45
261973|NCT02570425|629352|P2|NOT COMPLETED|Visit 3||0
261974|NCT02570425|629353|P1|NOT COMPLETED|Visit 3||0
261975|NCT02570425|629352|P2|COMPLETED|Visit 3||231
261976|NCT02570425|629353|P1|COMPLETED|Visit 3||229
261977|NCT02570425|629352|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
261978|NCT02570425|629353|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
261979|NCT02570425|629352|P2|NOT COMPLETED|Visit 2||0
261980|NCT02570425|629353|P1|NOT COMPLETED|Visit 2||0
261981|NCT02570425|629352|P2|COMPLETED|Visit 2||247
261982|NCT02570425|629353|P1|COMPLETED|Visit 2||251
261983|NCT02570425|629352|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
261984|NCT02570425|629353|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
261985|NCT02570425|629352|P2|NOT COMPLETED|Visit 1||0
261986|NCT02570425|629353|P1|NOT COMPLETED|Visit 1||0
261987|NCT02570425|629352|P2|COMPLETED|Visit 1||242
261988|NCT02570425|629353|P1|COMPLETED|Visit 1||274
261989|NCT02570425|629352|P2|STARTED|Visit 1||242
261990|NCT02570425|629353|P1|STARTED|Visit 1||274
261991|NCT02570295|629402|P2|NOT COMPLETED|Overall Study||58
261992|NCT02570295|629403|P1|NOT COMPLETED|Overall Study||11
261993|NCT02570295|629402|P2|COMPLETED|Overall Study||289
261994|NCT02570295|629403|P1|COMPLETED|Overall Study||364
261995|NCT02570295|629402|P2|STARTED|Overall Study||347
261996|NCT02570295|629403|P1|STARTED|Overall Study||375
261997|NCT02570165|629432|P7|NOT COMPLETED|Overall Study||0
261998|NCT02570165|629433|P6|NOT COMPLETED|Overall Study||2
261999|NCT02570165|629434|P5|NOT COMPLETED|Overall Study||6
262000|NCT02570165|629435|P4|NOT COMPLETED|Overall Study||5
262001|NCT02570165|629436|P3|NOT COMPLETED|Overall Study||5
262002|NCT02570165|629437|P2|NOT COMPLETED|Overall Study||3
262003|NCT02570165|629438|P1|NOT COMPLETED|Overall Study||2
262004|NCT02570165|629432|P7|COMPLETED|Overall Study||47
262005|NCT02570165|629433|P6|COMPLETED|Overall Study||44
262006|NCT02570165|629434|P5|COMPLETED|Overall Study||41
262007|NCT02570165|629435|P4|COMPLETED|Overall Study||40
262008|NCT02570165|629436|P3|COMPLETED|Overall Study||41
262009|NCT02570165|629437|P2|COMPLETED|Overall Study||43
262010|NCT02570165|629438|P1|COMPLETED|Overall Study||44
262011|NCT02570165|629432|P7|STARTED|Overall Study||47
262012|NCT02570165|629433|P6|STARTED|Overall Study||46
262013|NCT02570165|629434|P5|STARTED|Overall Study||47
262014|NCT02570165|629435|P4|STARTED|Overall Study||45
262015|NCT02570165|629436|P3|STARTED|Overall Study||46
262016|NCT02570165|629437|P2|STARTED|Overall Study||46
262017|NCT02570165|629438|P1|STARTED|Overall Study||46
262018|NCT02570022|629463|P2|NOT COMPLETED|Overall Study||0
262019|NCT02570022|629464|P1|NOT COMPLETED|Overall Study||0
262020|NCT02570022|629463|P2|COMPLETED|Overall Study||31
262021|NCT02570022|629464|P1|COMPLETED|Overall Study||26
262022|NCT02570022|629463|P2|STARTED|Overall Study||31
262023|NCT02570022|629464|P1|STARTED|Overall Study||26
262024|NCT02569996|629472|P1|NOT COMPLETED|Overall Study||55
262025|NCT02569996|629472|P1|COMPLETED|Overall Study||69
262026|NCT02569996|629472|P1|STARTED|Overall Study||124
262027|NCT02569658|629484|P2|NOT COMPLETED|Overall Study||1
262028|NCT02569658|629485|P1|NOT COMPLETED|Overall Study||1
262029|NCT02569658|629484|P2|COMPLETED|Overall Study||56
262030|NCT02569658|629485|P1|COMPLETED|Overall Study||52
262031|NCT02569658|629484|P2|STARTED|Overall Study||57
262032|NCT02569658|629485|P1|STARTED|Overall Study||53
262033|NCT02568852|629503|P2|NOT COMPLETED|Overall Study||0
262034|NCT02568852|629504|P1|NOT COMPLETED|Overall Study||0
262035|NCT02568852|629503|P2|COMPLETED|Overall Study||25
262036|NCT02568852|629504|P1|COMPLETED|Overall Study||25
262037|NCT02568852|629503|P2|STARTED|Overall Study||25
262038|NCT02568852|629504|P1|STARTED|Overall Study||25
262039|NCT02567188|629540|P1|NOT COMPLETED|Overall Study||35
262040|NCT02567188|629540|P1|COMPLETED|Overall Study||109
262041|NCT02567188|629540|P1|STARTED|Overall Study||144
262042|NCT02568345|629569|P1|NOT COMPLETED|Overall Study||0
262043|NCT02568345|629569|P1|COMPLETED|Overall Study||31
262044|NCT02568345|629569|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
262045|NCT02568345|629569|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
262046|NCT02568345|629569|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
262047|NCT02568345|629569|P1|STARTED|Overall Study||31
262048|NCT02563834|629575|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
262049|NCT02563834|629576|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
262050|NCT02563834|629575|P2|COMPLETED|Insulin Infusion (*Day 2)||8
262051|NCT02563834|629576|P1|COMPLETED|Insulin Infusion (*Day 2)||10
262052|NCT02563834|629575|P2|STARTED|Insulin Infusion (*Day 2)||8
262053|NCT02563834|629576|P1|STARTED|Insulin Infusion (*Day 2)||10
262054|NCT02563834|629575|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
262055|NCT02563834|629576|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
262056|NCT02563834|629575|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
262057|NCT02563834|629576|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
262058|NCT02563834|629575|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
262059|NCT02563834|629576|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
262060|NCT02563093|629596|P4|NOT COMPLETED|Overall Study||0
262061|NCT02563093|629597|P3|NOT COMPLETED|Overall Study||0
262062|NCT02563093|629598|P2|NOT COMPLETED|Overall Study||0
262063|NCT02563093|629599|P1|NOT COMPLETED|Overall Study||0
262064|NCT02563093|629596|P4|COMPLETED|Overall Study||51
262065|NCT02563093|629597|P3|COMPLETED|Overall Study||53
262066|NCT02563093|629598|P2|COMPLETED|Overall Study||52
262067|NCT02563093|629599|P1|COMPLETED|Overall Study||52
262068|NCT02563093|629596|P4|STARTED|Overall Study||51
262069|NCT02563093|629597|P3|STARTED|Overall Study||53
262070|NCT02563093|629598|P2|STARTED|Overall Study||52
262071|NCT02563093|629599|P1|STARTED|Overall Study||52
262072|NCT02561572|629627|P2|NOT COMPLETED|Overall Study||2
262073|NCT02561572|629628|P1|NOT COMPLETED|Overall Study||2
262074|NCT02561572|629627|P2|COMPLETED|Overall Study||62
262075|NCT02561572|629628|P1|COMPLETED|Overall Study||62
262076|NCT02561572|629627|P2|STARTED|Overall Study||64
262077|NCT02561572|629628|P1|STARTED|Overall Study||64
262078|NCT02557698|629646|P2|NOT COMPLETED|Overall Study||0
262079|NCT02557698|629647|P1|NOT COMPLETED|Overall Study||0
262080|NCT02557698|629646|P2|COMPLETED|Overall Study||30
262081|NCT02557698|629647|P1|COMPLETED|Overall Study||30
262082|NCT02557698|629646|P2|STARTED|Overall Study||30
262083|NCT02557698|629647|P1|STARTED|Overall Study||30
262084|NCT02557646|629711|P1|NOT COMPLETED|Overall Study||276
262085|NCT02557646|629711|P1|COMPLETED|Overall Study||417
262086|NCT02557646|629711|P1|STARTED|Overall Study||693
262087|NCT02555228|629731|P2|NOT COMPLETED|Overall Study||0
262088|NCT02555228|629732|P1|NOT COMPLETED|Overall Study||0
262089|NCT02555228|629731|P2|COMPLETED|Overall Study|29th October 2015|27
262090|NCT02555228|629732|P1|COMPLETED|Overall Study|19th November 2015|27
262091|NCT02555228|629731|P2|STARTED|Overall Study|14th August 2015|27
262092|NCT02555228|629732|P1|STARTED|Overall Study|20th August 2015|27
262093|NCT02556307|629744|P1|NOT COMPLETED|Overall Study||53
262094|NCT02556307|629744|P1|COMPLETED|Overall Study||217
262095|NCT02556307|629744|P1|Treated|Overall Study||268
262096|NCT02556307|629744|P1|STARTED|Overall Study||270
262097|NCT02555722|629756|P2|NOT COMPLETED|Month 3||0
262098|NCT02555722|629757|P1|NOT COMPLETED|Month 3||0
262099|NCT02555722|629756|P2|COMPLETED|Month 3||29
262100|NCT02555722|629757|P1|COMPLETED|Month 3||53
262101|NCT02555722|629756|P2|STARTED|Month 3||29
262102|NCT02555722|629757|P1|STARTED|Month 3||53
262103|NCT02555722|629756|P2|NOT COMPLETED|Month 2||0
262104|NCT02555722|629757|P1|NOT COMPLETED|Month 2||3
262105|NCT02555722|629756|P2|COMPLETED|Month 2||29
262106|NCT02555722|629757|P1|COMPLETED|Month 2||53
262107|NCT02555722|629756|P2|STARTED|Month 2||29
262108|NCT02555722|629757|P1|STARTED|Month 2||56
262109|NCT02555722|629756|P2|NOT COMPLETED|Month 1||0
262110|NCT02555722|629757|P1|NOT COMPLETED|Month 1||2
262111|NCT02555722|629756|P2|COMPLETED|Month 1||29
262112|NCT02555722|629757|P1|COMPLETED|Month 1||56
262113|NCT02555722|629756|P2|STARTED|Month 1||29
262114|NCT02555722|629757|P1|STARTED|Month 1||58
262115|NCT02555722|629756|P2|NOT COMPLETED|Week 2||1
262116|NCT02555722|629757|P1|NOT COMPLETED|Week 2||0
262117|NCT02555722|629756|P2|COMPLETED|Week 2||29
262118|NCT02555722|629757|P1|COMPLETED|Week 2||58
262119|NCT02555722|629756|P2|STARTED|Week 2||30
262120|NCT02555722|629757|P1|STARTED|Week 2||58
262121|NCT02555722|629756|P2|NOT COMPLETED|Week 1||0
262122|NCT02555722|629757|P1|NOT COMPLETED|Week 1||1
262123|NCT02555722|629756|P2|COMPLETED|Week 1||30
262124|NCT02555722|629757|P1|COMPLETED|Week 1||58
262125|NCT02555722|629756|P2|STARTED|Week 1||30
262126|NCT02555722|629757|P1|STARTED|Week 1||59
262127|NCT02555722|629756|P2|NOT COMPLETED|Lens Dispensed||0
262128|NCT02555722|629757|P1|NOT COMPLETED|Lens Dispensed||0
262129|NCT02555722|629756|P2|COMPLETED|Lens Dispensed||30
262130|NCT02555722|629757|P1|COMPLETED|Lens Dispensed||59
262131|NCT02555722|629756|P2|STARTED|Lens Dispensed||30
262132|NCT02555722|629757|P1|STARTED|Lens Dispensed||59
262133|NCT02555618|629917|P2|NOT COMPLETED|Overall Study||0
262134|NCT02555618|629918|P1|NOT COMPLETED|Overall Study||1
262135|NCT02555618|629917|P2|COMPLETED|Overall Study||200
262136|NCT02555618|629918|P1|COMPLETED|Overall Study||199
262137|NCT02555618|629917|P2|STARTED|Overall Study||200
262138|NCT02555618|629918|P1|STARTED|Overall Study||200
262139|NCT02554981|629960|P1|NOT COMPLETED|Overall Study||5
262140|NCT02554981|629960|P1|COMPLETED|Overall Study||46
262141|NCT02554981|629960|P1|STARTED|Overall Study||51
262142|NCT02553629|629986|P2|NOT COMPLETED|Overall Study||6
262143|NCT02553629|629987|P1|NOT COMPLETED|Overall Study||3
262144|NCT02553629|629986|P2|COMPLETED|Overall Study||50
262145|NCT02553629|629987|P1|COMPLETED|Overall Study||50
262146|NCT02553629|629986|P2|STARTED|Overall Study||56
262147|NCT02553629|629987|P1|STARTED|Overall Study||53
262148|NCT02553512|630001|P1|NOT COMPLETED|Overall Study||23
262149|NCT02553512|630001|P1|COMPLETED|Overall Study||144
262150|NCT02553512|630001|P1|STARTED|Overall Study||167
262151|NCT02553421|630011|P2|NOT COMPLETED|Overall Study||1
262152|NCT02553421|630012|P1|NOT COMPLETED|Overall Study||29
262153|NCT02553421|630011|P2|COMPLETED|Overall Study||57
262154|NCT02553421|630012|P1|COMPLETED|Overall Study||156
262155|NCT02553421|630011|P2|STARTED|Overall Study||58
262156|NCT02553421|630012|P1|STARTED|Overall Study||185
262157|NCT02552810|630022|P2|NOT COMPLETED|Overall Study||0
262158|NCT02552810|630023|P1|NOT COMPLETED|Overall Study||0
262159|NCT02552810|630022|P2|COMPLETED|Overall Study||15
262160|NCT02552810|630023|P1|COMPLETED|Overall Study||15
262161|NCT02552810|630022|P2|STARTED|Overall Study||15
262162|NCT02552810|630023|P1|STARTED|Overall Study||15
262163|NCT02551887|630042|P3|NOT COMPLETED|Overall Study||0
262164|NCT02551887|630043|P2|NOT COMPLETED|Overall Study||0
262165|NCT02551887|630044|P1|NOT COMPLETED|Overall Study||0
262166|NCT02551887|630042|P3|COMPLETED|Overall Study||222
262167|NCT02551887|630043|P2|COMPLETED|Overall Study||124
262168|NCT02551887|630044|P1|COMPLETED|Overall Study||301
262169|NCT02551887|630042|P3|STARTED|Overall Study||222
262170|NCT02551887|630043|P2|STARTED|Overall Study||124
262171|NCT02551887|630044|P1|STARTED|Overall Study||301
262172|NCT02550197|630057|P2|NOT COMPLETED|Overall Study||0
262173|NCT02550197|630058|P1|NOT COMPLETED|Overall Study||0
262174|NCT02550197|630057|P2|COMPLETED|Overall Study||100
262175|NCT02550197|630058|P1|COMPLETED|Overall Study||200
262176|NCT02550197|630057|P2|STARTED|Overall Study||100
262177|NCT02550197|630058|P1|STARTED|Overall Study||200
262178|NCT02550132|630076|P1|NOT COMPLETED|Overall Study||0
262179|NCT02550132|630076|P1|COMPLETED|Overall Study||25
262180|NCT02550132|630076|P1|STARTED|Overall Study||25
262181|NCT02549027|630107|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
262182|NCT02549027|630108|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
262183|NCT02549027|630109|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
262184|NCT02549027|630110|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
262185|NCT02549027|630111|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
262186|NCT02549027|630112|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
262187|NCT02549027|630107|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
262188|NCT02549027|630108|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
262189|NCT02549027|630109|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
262190|NCT02549027|630110|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
262191|NCT02549027|630111|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
262192|NCT02549027|630112|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
262193|NCT02549027|630107|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
262194|NCT02549027|630108|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
262195|NCT02549027|630109|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
262196|NCT02549027|630110|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
262197|NCT02549027|630111|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
262198|NCT02549027|630112|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
262199|NCT02549027|630107|P6|NOT COMPLETED|Washout After Period 4||0
262200|NCT02549027|630108|P5|NOT COMPLETED|Washout After Period 4||0
262201|NCT02549027|630109|P4|NOT COMPLETED|Washout After Period 4||1
262202|NCT02549027|630110|P3|NOT COMPLETED|Washout After Period 4||1
262203|NCT02549027|630111|P2|NOT COMPLETED|Washout After Period 4||1
262204|NCT02549027|630112|P1|NOT COMPLETED|Washout After Period 4||0
262205|NCT02549027|630107|P6|COMPLETED|Washout After Period 4||0
262206|NCT02549027|630108|P5|COMPLETED|Washout After Period 4||0
262207|NCT02549027|630109|P4|COMPLETED|Washout After Period 4||4
262208|NCT02549027|630110|P3|COMPLETED|Washout After Period 4||4
262209|NCT02549027|630111|P2|COMPLETED|Washout After Period 4||4
262210|NCT02549027|630112|P1|COMPLETED|Washout After Period 4||5
262211|NCT02549027|630107|P6|STARTED|Washout After Period 4||0
262212|NCT02549027|630108|P5|STARTED|Washout After Period 4||0
262213|NCT02549027|630109|P4|STARTED|Washout After Period 4||5
262214|NCT02549027|630110|P3|STARTED|Washout After Period 4||5
262215|NCT02549027|630111|P2|STARTED|Washout After Period 4||5
262216|NCT02549027|630112|P1|STARTED|Washout After Period 4||5
262217|NCT02549027|630107|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
262218|NCT02549027|630108|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
262219|NCT02549027|630109|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
262220|NCT02549027|630110|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
262221|NCT02549027|630111|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
262222|NCT02549027|630112|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
262223|NCT02549027|630107|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
262224|NCT02549027|630108|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
262225|NCT02549027|630109|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
262226|NCT02549027|630110|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
262227|NCT02549027|630111|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
262228|NCT02549027|630112|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
262229|NCT02549027|630107|P6|STARTED|Period 4 - MK-1064 or Placebo||0
262230|NCT02549027|630108|P5|STARTED|Period 4 - MK-1064 or Placebo||0
262231|NCT02549027|630109|P4|STARTED|Period 4 - MK-1064 or Placebo||5
262232|NCT02549027|630110|P3|STARTED|Period 4 - MK-1064 or Placebo||5
262233|NCT02549027|630111|P2|STARTED|Period 4 - MK-1064 or Placebo||5
262234|NCT02549027|630112|P1|STARTED|Period 4 - MK-1064 or Placebo||5
262235|NCT02549027|630107|P6|NOT COMPLETED|Washout After Period 3||0
262236|NCT02549027|630108|P5|NOT COMPLETED|Washout After Period 3||0
262237|NCT02549027|630109|P4|NOT COMPLETED|Washout After Period 3||0
262238|NCT02549027|630110|P3|NOT COMPLETED|Washout After Period 3||0
262239|NCT02549027|630111|P2|NOT COMPLETED|Washout After Period 3||0
262240|NCT02549027|630112|P1|NOT COMPLETED|Washout After Period 3||0
262241|NCT02549027|630107|P6|COMPLETED|Washout After Period 3||0
262242|NCT02549027|630108|P5|COMPLETED|Washout After Period 3||0
262243|NCT02549027|630109|P4|COMPLETED|Washout After Period 3||5
262244|NCT02549027|630110|P3|COMPLETED|Washout After Period 3||5
262245|NCT02549027|630111|P2|COMPLETED|Washout After Period 3||5
262246|NCT02549027|630112|P1|COMPLETED|Washout After Period 3||5
262247|NCT02549027|630107|P6|STARTED|Washout After Period 3||0
262248|NCT02549027|630108|P5|STARTED|Washout After Period 3||0
262249|NCT02549027|630109|P4|STARTED|Washout After Period 3||5
262250|NCT02549027|630110|P3|STARTED|Washout After Period 3||5
262251|NCT02549027|630111|P2|STARTED|Washout After Period 3||5
262252|NCT02549027|630112|P1|STARTED|Washout After Period 3||5
262253|NCT02549027|630107|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
262254|NCT02549027|630108|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
262255|NCT02549027|630109|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
262256|NCT02549027|630110|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
262257|NCT02549027|630111|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
262258|NCT02549027|630112|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
262259|NCT02549027|630107|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
262260|NCT02549027|630108|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
262261|NCT02549027|630109|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
262262|NCT02549027|630110|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
262263|NCT02549027|630111|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
262264|NCT02549027|630112|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
262265|NCT02549027|630107|P6|STARTED|Period 3 - MK-1064 or Placebo||0
262266|NCT02549027|630108|P5|STARTED|Period 3 - MK-1064 or Placebo||0
262267|NCT02549027|630109|P4|STARTED|Period 3 - MK-1064 or Placebo||5
262268|NCT02549027|630110|P3|STARTED|Period 3 - MK-1064 or Placebo||5
262269|NCT02549027|630111|P2|STARTED|Period 3 - MK-1064 or Placebo||5
262270|NCT02549027|630112|P1|STARTED|Period 3 - MK-1064 or Placebo||5
262271|NCT02549027|630107|P6|NOT COMPLETED|Washout After Period 2||0
262272|NCT02549027|630108|P5|NOT COMPLETED|Washout After Period 2||0
262273|NCT02549027|630109|P4|NOT COMPLETED|Washout After Period 2||0
262274|NCT02549027|630110|P3|NOT COMPLETED|Washout After Period 2||0
262275|NCT02549027|630111|P2|NOT COMPLETED|Washout After Period 2||0
262276|NCT02549027|630112|P1|NOT COMPLETED|Washout After Period 2||0
262277|NCT02549027|630107|P6|COMPLETED|Washout After Period 2||0
262278|NCT02549027|630108|P5|COMPLETED|Washout After Period 2||0
262279|NCT02549027|630109|P4|COMPLETED|Washout After Period 2||5
262280|NCT02549027|630110|P3|COMPLETED|Washout After Period 2||5
262281|NCT02549027|630111|P2|COMPLETED|Washout After Period 2||5
262282|NCT02549027|630112|P1|COMPLETED|Washout After Period 2||5
262283|NCT02549027|630107|P6|STARTED|Washout After Period 2||0
262284|NCT02549027|630108|P5|STARTED|Washout After Period 2||0
262285|NCT02549027|630109|P4|STARTED|Washout After Period 2||5
262286|NCT02549027|630110|P3|STARTED|Washout After Period 2||5
262287|NCT02549027|630111|P2|STARTED|Washout After Period 2||5
262288|NCT02549027|630112|P1|STARTED|Washout After Period 2||5
262289|NCT02549027|630107|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
262290|NCT02549027|630108|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
262291|NCT02549027|630109|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
262292|NCT02549027|630110|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
262293|NCT02549027|630111|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
262294|NCT02549027|630112|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
262295|NCT02549027|630107|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
262296|NCT02549027|630108|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
262297|NCT02549027|630109|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
262298|NCT02549027|630110|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
262299|NCT02549027|630111|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
262300|NCT02549027|630112|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
262301|NCT02549027|630107|P6|STARTED|Period 2 - MK-1064 or Placebo||0
262302|NCT02549027|630108|P5|STARTED|Period 2 - MK-1064 or Placebo||0
262303|NCT02549027|630109|P4|STARTED|Period 2 - MK-1064 or Placebo||5
262304|NCT02549027|630110|P3|STARTED|Period 2 - MK-1064 or Placebo||5
262305|NCT02549027|630111|P2|STARTED|Period 2 - MK-1064 or Placebo||5
262306|NCT02549027|630112|P1|STARTED|Period 2 - MK-1064 or Placebo||5
262307|NCT02549027|630107|P6|NOT COMPLETED|Washout After Period 1||0
262308|NCT02549027|630108|P5|NOT COMPLETED|Washout After Period 1||0
262309|NCT02549027|630109|P4|NOT COMPLETED|Washout After Period 1||0
262310|NCT02549027|630110|P3|NOT COMPLETED|Washout After Period 1||0
262311|NCT02549027|630111|P2|NOT COMPLETED|Washout After Period 1||0
262312|NCT02549027|630112|P1|NOT COMPLETED|Washout After Period 1||0
262313|NCT02549027|630107|P6|COMPLETED|Washout After Period 1||0
262314|NCT02549027|630108|P5|COMPLETED|Washout After Period 1||0
262315|NCT02549027|630109|P4|COMPLETED|Washout After Period 1||5
262316|NCT02549027|630110|P3|COMPLETED|Washout After Period 1||5
262317|NCT02549027|630111|P2|COMPLETED|Washout After Period 1||5
262318|NCT02549027|630112|P1|COMPLETED|Washout After Period 1||5
262319|NCT02549027|630107|P6|STARTED|Washout After Period 1||0
262320|NCT02549027|630108|P5|STARTED|Washout After Period 1||0
262321|NCT02549027|630109|P4|STARTED|Washout After Period 1||5
262322|NCT02549027|630110|P3|STARTED|Washout After Period 1||5
262323|NCT02549027|630111|P2|STARTED|Washout After Period 1||5
262324|NCT02549027|630112|P1|STARTED|Washout After Period 1||5
262325|NCT02549027|630107|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
262326|NCT02549027|630108|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
262327|NCT02549027|630109|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
262328|NCT02549027|630110|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
262329|NCT02549027|630111|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
262330|NCT02549027|630112|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
262331|NCT02549027|630107|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
262332|NCT02549027|630108|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
262333|NCT02549027|630109|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
262334|NCT02549027|630110|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
262335|NCT02549027|630111|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
262336|NCT02549027|630112|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
262337|NCT02549027|630107|P6|STARTED|Period 1 - MK-1064 or Placebo||0
262338|NCT02549027|630108|P5|STARTED|Period 1 - MK-1064 or Placebo||0
262339|NCT02549027|630109|P4|STARTED|Period 1 - MK-1064 or Placebo||5
262340|NCT02549027|630110|P3|STARTED|Period 1 - MK-1064 or Placebo||5
262341|NCT02549027|630111|P2|STARTED|Period 1 - MK-1064 or Placebo||5
262342|NCT02549027|630112|P1|STARTED|Period 1 - MK-1064 or Placebo||5
262343|NCT02549014|630149|P2|NOT COMPLETED|Overall Study||0
262344|NCT02549014|630150|P1|NOT COMPLETED|Overall Study||0
262345|NCT02549014|630149|P2|COMPLETED|Overall Study||8
262346|NCT02549014|630150|P1|COMPLETED|Overall Study||8
262347|NCT02549014|630149|P2|STARTED|Overall Study||8
262348|NCT02549014|630150|P1|STARTED|Overall Study||8
262349|NCT02548156|630240|P6|NOT COMPLETED|Period 3||0
262350|NCT02548156|630241|P5|NOT COMPLETED|Period 3||0
262351|NCT02548156|630242|P4|NOT COMPLETED|Period 3||0
262352|NCT02548156|630243|P3|NOT COMPLETED|Period 3||0
262353|NCT02548156|630244|P2|NOT COMPLETED|Period 3||0
262354|NCT02548156|630245|P1|NOT COMPLETED|Period 3||0
262355|NCT02548156|630240|P6|COMPLETED|Period 3||5
262356|NCT02548156|630241|P5|COMPLETED|Period 3||4
262357|NCT02548156|630242|P4|COMPLETED|Period 3||5
262358|NCT02548156|630243|P3|COMPLETED|Period 3||4
262359|NCT02548156|630244|P2|COMPLETED|Period 3||5
262360|NCT02548156|630245|P1|COMPLETED|Period 3||5
262361|NCT02548156|630240|P6|STARTED|Period 3||5
262362|NCT02548156|630241|P5|STARTED|Period 3||4
262363|NCT02548156|630242|P4|STARTED|Period 3||5
262364|NCT02548156|630243|P3|STARTED|Period 3||4
262365|NCT02548156|630244|P2|STARTED|Period 3||5
262366|NCT02548156|630245|P1|STARTED|Period 3||5
262367|NCT02548156|630240|P6|NOT COMPLETED|Washout Period 2||0
262368|NCT02548156|630241|P5|NOT COMPLETED|Washout Period 2||0
262369|NCT02548156|630242|P4|NOT COMPLETED|Washout Period 2||0
262370|NCT02548156|630243|P3|NOT COMPLETED|Washout Period 2||0
262371|NCT02548156|630244|P2|NOT COMPLETED|Washout Period 2||0
262372|NCT02548156|630245|P1|NOT COMPLETED|Washout Period 2||0
262373|NCT02548156|630240|P6|COMPLETED|Washout Period 2||5
262374|NCT02548156|630241|P5|COMPLETED|Washout Period 2||4
262375|NCT02548156|630242|P4|COMPLETED|Washout Period 2||5
262376|NCT02548156|630243|P3|COMPLETED|Washout Period 2||4
262377|NCT02548156|630244|P2|COMPLETED|Washout Period 2||5
262378|NCT02548156|630245|P1|COMPLETED|Washout Period 2||5
262379|NCT02548156|630240|P6|STARTED|Washout Period 2||5
262380|NCT02548156|630241|P5|STARTED|Washout Period 2||4
262381|NCT02548156|630242|P4|STARTED|Washout Period 2||5
262382|NCT02548156|630243|P3|STARTED|Washout Period 2||4
262383|NCT02548156|630244|P2|STARTED|Washout Period 2||5
262384|NCT02548156|630245|P1|STARTED|Washout Period 2||5
262385|NCT02548156|630240|P6|NOT COMPLETED|Period 2||0
262386|NCT02548156|630241|P5|NOT COMPLETED|Period 2||0
262387|NCT02548156|630242|P4|NOT COMPLETED|Period 2||0
262388|NCT02548156|630243|P3|NOT COMPLETED|Period 2||0
262389|NCT02548156|630244|P2|NOT COMPLETED|Period 2||0
262390|NCT02548156|630245|P1|NOT COMPLETED|Period 2||0
262391|NCT02548156|630240|P6|COMPLETED|Period 2||5
262392|NCT02548156|630241|P5|COMPLETED|Period 2||4
262393|NCT02548156|630242|P4|COMPLETED|Period 2||5
262394|NCT02548156|630243|P3|COMPLETED|Period 2||4
262395|NCT02548156|630244|P2|COMPLETED|Period 2||5
262396|NCT02548156|630245|P1|COMPLETED|Period 2||5
262397|NCT02548156|630240|P6|STARTED|Period 2||5
262398|NCT02548156|630241|P5|STARTED|Period 2||4
262399|NCT02548156|630242|P4|STARTED|Period 2||5
262400|NCT02548156|630243|P3|STARTED|Period 2||4
262401|NCT02548156|630244|P2|STARTED|Period 2||5
262402|NCT02548156|630245|P1|STARTED|Period 2||5
262403|NCT02548156|630240|P6|NOT COMPLETED|Washout Period 1||0
262404|NCT02548156|630241|P5|NOT COMPLETED|Washout Period 1||1
262405|NCT02548156|630242|P4|NOT COMPLETED|Washout Period 1||0
262406|NCT02548156|630243|P3|NOT COMPLETED|Washout Period 1||0
262407|NCT02548156|630244|P2|NOT COMPLETED|Washout Period 1||0
262408|NCT02548156|630245|P1|NOT COMPLETED|Washout Period 1||0
262409|NCT02548156|630240|P6|COMPLETED|Washout Period 1||5
262410|NCT02548156|630241|P5|COMPLETED|Washout Period 1||4
262411|NCT02548156|630242|P4|COMPLETED|Washout Period 1||5
262412|NCT02548156|630243|P3|COMPLETED|Washout Period 1||4
262413|NCT02548156|630244|P2|COMPLETED|Washout Period 1||5
262414|NCT02548156|630245|P1|COMPLETED|Washout Period 1||5
262415|NCT02548156|630240|P6|STARTED|Washout Period 1||5
262416|NCT02548156|630241|P5|STARTED|Washout Period 1||5
262417|NCT02548156|630242|P4|STARTED|Washout Period 1||5
262418|NCT02548156|630243|P3|STARTED|Washout Period 1||4
262419|NCT02548156|630244|P2|STARTED|Washout Period 1||5
262420|NCT02548156|630245|P1|STARTED|Washout Period 1||5
262421|NCT02548156|630240|P6|NOT COMPLETED|Period 1||0
262422|NCT02548156|630241|P5|NOT COMPLETED|Period 1||0
262423|NCT02548156|630242|P4|NOT COMPLETED|Period 1||0
262424|NCT02548156|630243|P3|NOT COMPLETED|Period 1||0
262425|NCT02548156|630244|P2|NOT COMPLETED|Period 1||0
262426|NCT02548156|630245|P1|NOT COMPLETED|Period 1||0
262427|NCT02548156|630240|P6|COMPLETED|Period 1||5
262428|NCT02548156|630241|P5|COMPLETED|Period 1||5
262429|NCT02548156|630242|P4|COMPLETED|Period 1||5
262430|NCT02548156|630243|P3|COMPLETED|Period 1||4
262431|NCT02548156|630244|P2|COMPLETED|Period 1||5
262432|NCT02548156|630245|P1|COMPLETED|Period 1||5
262433|NCT02548156|630240|P6|STARTED|Period 1||5
262434|NCT02548156|630241|P5|STARTED|Period 1||5
262435|NCT02548156|630242|P4|STARTED|Period 1||5
262436|NCT02548156|630243|P3|STARTED|Period 1||4
262437|NCT02548156|630244|P2|STARTED|Period 1||5
262438|NCT02548156|630245|P1|STARTED|Period 1||5
262439|NCT02547454|630262|P1|NOT COMPLETED|Overall Study||172
262440|NCT02547454|630262|P1|COMPLETED|Overall Study||221
262441|NCT02547454|630262|P1|STARTED|Overall Study||393
262442|NCT02547064|630292|P2|NOT COMPLETED|Overall Study||2
262443|NCT02547064|630293|P1|NOT COMPLETED|Overall Study||3
262444|NCT02547064|630292|P2|COMPLETED|Overall Study||79
262445|NCT02547064|630293|P1|COMPLETED|Overall Study||78
262446|NCT02547064|630292|P2|STARTED|Overall Study||81
262447|NCT02547064|630293|P1|STARTED|Overall Study||81
262448|NCT02545543|630321|P2|NOT COMPLETED|Overall Study||34
262449|NCT02545543|630322|P1|NOT COMPLETED|Overall Study||81
262450|NCT02545543|630321|P2|COMPLETED|Overall Study||535
262451|NCT02545543|630322|P1|COMPLETED|Overall Study||1628
262452|NCT02545543|630321|P2|STARTED|Overall Study||569
262453|NCT02545543|630322|P1|STARTED|Overall Study||1709
262454|NCT02545322|630346|P1|NOT COMPLETED|Overall Study||3
262455|NCT02545322|630346|P1|COMPLETED|Overall Study||15
262456|NCT02545322|630346|P1|STARTED|Overall Study||18
262460|NCT02543918|630357|P2|NOT COMPLETED|Overall Study||4
262461|NCT02543918|630358|P1|NOT COMPLETED|Overall Study||3
262462|NCT02543918|630357|P2|COMPLETED|Overall Study||39
262463|NCT02543918|630358|P1|COMPLETED|Overall Study||38
262464|NCT02543918|630357|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
262465|NCT02543918|630358|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
262466|NCT02543918|630357|P2|STARTED|Overall Study||43
262467|NCT02543918|630358|P1|STARTED|Overall Study||41
262468|NCT02543437|630364|P1|NOT COMPLETED|Overall Study||0
262469|NCT02543437|630364|P1|COMPLETED|Overall Study||117
262470|NCT02543437|630364|P1|STARTED|Overall Study||117
262471|NCT02542943|630372|P3|NOT COMPLETED|Overall Study||0
262472|NCT02542943|630373|P2|NOT COMPLETED|Overall Study||1
262473|NCT02542943|630374|P1|NOT COMPLETED|Overall Study||1
262474|NCT02542943|630372|P3|COMPLETED|Overall Study||81
262475|NCT02542943|630373|P2|COMPLETED|Overall Study||79
262476|NCT02542943|630374|P1|COMPLETED|Overall Study||78
262477|NCT02542943|630372|P3|STARTED|Overall Study||81
262478|NCT02542943|630373|P2|STARTED|Overall Study||80
262479|NCT02542943|630374|P1|STARTED|Overall Study||79
262480|NCT02542280|630401|P2|NOT COMPLETED|Overall Study||8
262481|NCT02542280|630402|P1|NOT COMPLETED|Overall Study||12
262482|NCT02542280|630401|P2|COMPLETED|Overall Study||167
262483|NCT02542280|630402|P1|COMPLETED|Overall Study||162
262484|NCT02542280|630401|P2|STARTED|Overall Study||175
262485|NCT02542280|630402|P1|STARTED|Overall Study||174
262486|NCT02542072|630410|P2|NOT COMPLETED|Second Intervention (1 Month)||0
262487|NCT02542072|630411|P1|NOT COMPLETED|Second Intervention (1 Month)||2
262488|NCT02542072|630410|P2|COMPLETED|Second Intervention (1 Month)||43
262489|NCT02542072|630411|P1|COMPLETED|Second Intervention (1 Month)||37
262490|NCT02542072|630410|P2|STARTED|Second Intervention (1 Month)||43
262491|NCT02542072|630411|P1|STARTED|Second Intervention (1 Month)||39
262492|NCT02542072|630410|P2|NOT COMPLETED|First Intervention (1 Month)||3
262493|NCT02542072|630411|P1|NOT COMPLETED|First Intervention (1 Month)||5
262494|NCT02542072|630410|P2|COMPLETED|First Intervention (1 Month)||43
262495|NCT02542072|630411|P1|COMPLETED|First Intervention (1 Month)||39
262496|NCT02542072|630410|P2|STARTED|First Intervention (1 Month)||46
262497|NCT02542072|630411|P1|STARTED|First Intervention (1 Month)||44
262498|NCT02540850|630514|P3|NOT COMPLETED|Overall Study||34
262499|NCT02540850|630515|P2|NOT COMPLETED|Overall Study||66
262500|NCT02540850|630516|P1|NOT COMPLETED|Overall Study||69
262501|NCT02540850|630514|P3|COMPLETED|Overall Study||410
262502|NCT02540850|630515|P2|COMPLETED|Overall Study||330
262503|NCT02540850|630516|P1|COMPLETED|Overall Study||291
262504|NCT02540850|630514|P3|STARTED|Overall Study||444
262505|NCT02540850|630515|P2|STARTED|Overall Study||396
262506|NCT02540850|630516|P1|STARTED|Overall Study||360
262507|NCT02540772|630544|P2|NOT COMPLETED|Overall Study||0
262508|NCT02540772|630545|P1|NOT COMPLETED|Overall Study||0
262509|NCT02540772|630544|P2|COMPLETED|Overall Study||10
262510|NCT02540772|630545|P1|COMPLETED|Overall Study||10
262511|NCT02540772|630544|P2|STARTED|Overall Study||10
262512|NCT02540772|630545|P1|STARTED|Overall Study||10
262513|NCT02540447|630559|P2|NOT COMPLETED|Overall Study||0
262514|NCT02540447|630560|P1|NOT COMPLETED|Overall Study||0
262515|NCT02540447|630559|P2|COMPLETED|Overall Study||40
262516|NCT02540447|630560|P1|COMPLETED|Overall Study||40
262517|NCT02540447|630559|P2|STARTED|Overall Study||40
262518|NCT02540447|630560|P1|STARTED|Overall Study||40
262519|NCT02540434|630576|P2|NOT COMPLETED|Overall Study||0
262520|NCT02540434|630577|P1|NOT COMPLETED|Overall Study||0
262521|NCT02540434|630576|P2|COMPLETED|Overall Study||1
262522|NCT02540434|630577|P1|COMPLETED|Overall Study||0
262523|NCT02540434|630576|P2|STARTED|Overall Study||1
262524|NCT02540434|630577|P1|STARTED|Overall Study||0
262525|NCT02540356|630587|P2|NOT COMPLETED|Overall Study||0
262526|NCT02540356|630588|P1|NOT COMPLETED|Overall Study||1
262527|NCT02540356|630587|P2|COMPLETED|Overall Study||0
262528|NCT02540356|630588|P1|COMPLETED|Overall Study||0
262529|NCT02540356|630587|P2|STARTED|Overall Study||0
262530|NCT02540356|630588|P1|STARTED|Overall Study||1
262531|NCT02540265|630622|P3|NOT COMPLETED|Overall Study||1
262532|NCT02540265|630623|P2|NOT COMPLETED|Overall Study||0
262533|NCT02540265|630624|P1|NOT COMPLETED|Overall Study||0
262534|NCT02540265|630622|P3|COMPLETED|Overall Study||18
262535|NCT02540265|630623|P2|COMPLETED|Overall Study||20
262536|NCT02540265|630624|P1|COMPLETED|Overall Study||20
262537|NCT02540265|630622|P3|Treatment Completion|Overall Study||18
262538|NCT02540265|630623|P2|Treatment Completion|Overall Study||19
262539|NCT02540265|630624|P1|Treatment Completion|Overall Study||20
262540|NCT02540265|630622|P3|STARTED|Overall Study||19
262541|NCT02540265|630623|P2|STARTED|Overall Study||20
262542|NCT02540265|630624|P1|STARTED|Overall Study||20
262543|NCT02540213|630644|P1|NOT COMPLETED|Overall Study||39
262544|NCT02540213|630644|P1|COMPLETED|Overall Study||201
262545|NCT02540213|630644|P1|STARTED|Overall Study||240
262546|NCT02539992|630668|P3|NOT COMPLETED|Overall Study||4
262547|NCT02539992|630669|P2|NOT COMPLETED|Overall Study||4
262548|NCT02539992|630670|P1|NOT COMPLETED|Overall Study||0
262549|NCT02539992|630668|P3|COMPLETED|Overall Study||14
262550|NCT02539992|630669|P2|COMPLETED|Overall Study||7
262551|NCT02539992|630670|P1|COMPLETED|Overall Study||15
262552|NCT02539992|630668|P3|STARTED|Overall Study||18
262553|NCT02539992|630669|P2|STARTED|Overall Study||11
262554|NCT02539992|630670|P1|STARTED|Overall Study||15
262555|NCT02539108|630698|P2|NOT COMPLETED|Overall Study||0
262556|NCT02539108|630699|P1|NOT COMPLETED|Overall Study||0
262557|NCT02539108|630698|P2|COMPLETED|Overall Study||30
262558|NCT02539108|630699|P1|COMPLETED|Overall Study||30
262559|NCT02539108|630698|P2|STARTED|Overall Study||30
262560|NCT02539108|630699|P1|STARTED|Overall Study||30
262561|NCT02538107|630713|P1|NOT COMPLETED|Overall Study||110
262562|NCT02538107|630713|P1|COMPLETED|Overall Study||180
262563|NCT02538107|630713|P1|STARTED|Overall Study||290
262564|NCT02537730|630733|P2|NOT COMPLETED|Second Intervention (7 Days)||0
262565|NCT02537730|630734|P1|NOT COMPLETED|Second Intervention (7 Days)||0
262566|NCT02537730|630733|P2|COMPLETED|Second Intervention (7 Days)||16
262567|NCT02537730|630734|P1|COMPLETED|Second Intervention (7 Days)||17
262568|NCT02537730|630733|P2|STARTED|Second Intervention (7 Days)||16
262569|NCT02537730|630734|P1|STARTED|Second Intervention (7 Days)||17
262570|NCT02537730|630733|P2|NOT COMPLETED|First Intervention (7 Days)||0
262571|NCT02537730|630734|P1|NOT COMPLETED|First Intervention (7 Days)||0
262572|NCT02537730|630733|P2|COMPLETED|First Intervention (7 Days)||16
262573|NCT02537730|630734|P1|COMPLETED|First Intervention (7 Days)||17
262574|NCT02537730|630733|P2|STARTED|First Intervention (7 Days)||16
262575|NCT02537730|630734|P1|STARTED|First Intervention (7 Days)||17
262576|NCT02537522|630746|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262577|NCT02537522|630747|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262578|NCT02537522|630748|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262579|NCT02537522|630749|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262580|NCT02537522|630746|P4|COMPLETED|Phase II - Period 1 Bilateral||22
262581|NCT02537522|630747|P3|COMPLETED|Phase II - Period 1 Bilateral||23
262582|NCT02537522|630748|P2|COMPLETED|Phase II - Period 1 Bilateral||0
262583|NCT02537522|630749|P1|COMPLETED|Phase II - Period 1 Bilateral||0
262584|NCT02537522|630746|P4|STARTED|Phase II - Period 1 Bilateral||22
262585|NCT02537522|630747|P3|STARTED|Phase II - Period 1 Bilateral||23
262586|NCT02537522|630748|P2|STARTED|Phase II - Period 1 Bilateral||0
262587|NCT02537522|630749|P1|STARTED|Phase II - Period 1 Bilateral||0
262588|NCT02537522|630746|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
262589|NCT02537522|630747|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262590|NCT02537522|630748|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262591|NCT02537522|630749|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
262592|NCT02537522|630746|P4|COMPLETED|Phase II - Period 1 Bilateral||22
262593|NCT02537522|630747|P3|COMPLETED|Phase II - Period 1 Bilateral||23
262594|NCT02537522|630748|P2|COMPLETED|Phase II - Period 1 Bilateral||0
262595|NCT02537522|630749|P1|COMPLETED|Phase II - Period 1 Bilateral||0
262596|NCT02537522|630746|P4|STARTED|Phase II - Period 1 Bilateral||23
262597|NCT02537522|630747|P3|STARTED|Phase II - Period 1 Bilateral||23
262598|NCT02537522|630748|P2|STARTED|Phase II - Period 1 Bilateral||0
262599|NCT02537522|630749|P1|STARTED|Phase II - Period 1 Bilateral||0
262600|NCT02537522|630746|P4|NOT COMPLETED|Phase I - Contralateral||0
262601|NCT02537522|630747|P3|NOT COMPLETED|Phase I - Contralateral||0
262602|NCT02537522|630748|P2|NOT COMPLETED|Phase I - Contralateral||10
262603|NCT02537522|630749|P1|NOT COMPLETED|Phase I - Contralateral||15
262604|NCT02537522|630746|P4|COMPLETED|Phase I - Contralateral||0
262605|NCT02537522|630747|P3|COMPLETED|Phase I - Contralateral||0
262606|NCT02537522|630748|P2|COMPLETED|Phase I - Contralateral||27
262607|NCT02537522|630749|P1|COMPLETED|Phase I - Contralateral||19
262608|NCT02537522|630746|P4|STARTED|Phase I - Contralateral||0
262609|NCT02537522|630747|P3|STARTED|Phase I - Contralateral||0
262610|NCT02537522|630748|P2|STARTED|Phase I - Contralateral||37
262611|NCT02537522|630749|P1|STARTED|Phase I - Contralateral||34
262612|NCT02536664|630759|P2|NOT COMPLETED|Overall Study||80
262613|NCT02536664|630760|P1|NOT COMPLETED|Overall Study||107
262614|NCT02536664|630759|P2|COMPLETED|Overall Study||97
262615|NCT02536664|630760|P1|COMPLETED|Overall Study||205
262616|NCT02536664|630759|P2|STARTED|Overall Study||177
262617|NCT02536664|630760|P1|STARTED|Overall Study||312
262618|NCT02535741|630778|P1|NOT COMPLETED|Overall Study||32
262619|NCT02535741|630778|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
262620|NCT02535741|630778|P1|STARTED|Overall Study||168
262621|NCT02535026|630782|P1|NOT COMPLETED|Overall Study||0
262622|NCT02535026|630782|P1|COMPLETED|Overall Study||580
262623|NCT02535026|630782|P1|STARTED|Overall Study||580
262624|NCT02534324|630836|P2|NOT COMPLETED|Overall Study||8
262625|NCT02534324|630837|P1|NOT COMPLETED|Overall Study||25
262626|NCT02534324|630836|P2|COMPLETED|Overall Study||40
262627|NCT02534324|630837|P1|COMPLETED|Overall Study||73
262628|NCT02534324|630836|P2|STARTED|Overall Study||48
262629|NCT02534324|630837|P1|STARTED|Overall Study||98
262630|NCT02533466|630849|P2|NOT COMPLETED|Overall Study||0
262631|NCT02533466|630850|P1|NOT COMPLETED|Overall Study||0
262632|NCT02533466|630849|P2|COMPLETED|Overall Study||14
262633|NCT02533466|630850|P1|COMPLETED|Overall Study||16
262634|NCT02533466|630849|P2|STARTED|Overall Study||14
262635|NCT02533466|630850|P1|STARTED|Overall Study||16
262636|NCT02533401|630874|P1|NOT COMPLETED|Overall Study||11
262637|NCT02533401|630874|P1|COMPLETED|Overall Study||23
262638|NCT02533401|630874|P1|STARTED|Overall Study||34
262639|NCT02532998|630882|P1|NOT COMPLETED|Overall Study||0
262640|NCT02532998|630882|P1|COMPLETED|Overall Study||23
262641|NCT02532998|630882|P1|STARTED|Overall Study||23
262642|NCT02532374|630964|P1|NOT COMPLETED|Overall Study||2
262643|NCT02532374|630964|P1|COMPLETED|Overall Study||14
262644|NCT02532374|630964|P1|STARTED|Overall Study||16
262645|NCT02531867|630988|P1|NOT COMPLETED|Overall Study||0
262646|NCT02531867|630988|P1|COMPLETED|Overall Study||13
262647|NCT02531867|630988|P1|STARTED|Overall Study||13
262648|NCT02531646|630995|P3|NOT COMPLETED|Overall Study||0
262649|NCT02531646|630996|P2|NOT COMPLETED|Overall Study||1
262650|NCT02531646|630997|P1|NOT COMPLETED|Overall Study||5
262651|NCT02531646|630995|P3|COMPLETED|Overall Study||11
262652|NCT02531646|630996|P2|COMPLETED|Overall Study||17
262653|NCT02531646|630997|P1|COMPLETED|Overall Study||32
262654|NCT02531646|630995|P3|STARTED|Overall Study||11
262655|NCT02531646|630996|P2|STARTED|Overall Study||18
262656|NCT02531646|630997|P1|STARTED|Overall Study||37
262657|NCT02531308|631011|P1|NOT COMPLETED|Overall Study||3
262658|NCT02531308|631011|P1|COMPLETED|Overall Study||2
262659|NCT02531308|631011|P1|STARTED|Overall Study||5
262660|NCT02530671|631017|P2|NOT COMPLETED|Overall Study||0
262661|NCT02530671|631018|P1|NOT COMPLETED|Overall Study||3
262662|NCT02530671|631017|P2|COMPLETED|Overall Study||55
262663|NCT02530671|631018|P1|COMPLETED|Overall Study||52
262664|NCT02530671|631017|P2|STARTED|Overall Study||55
262665|NCT02530671|631018|P1|STARTED|Overall Study||55
262666|NCT02530450|631036|P2|NOT COMPLETED|Overall Study||5
262667|NCT02530450|631037|P1|NOT COMPLETED|Overall Study||6
262668|NCT02530450|631036|P2|COMPLETED|Overall Study||9
262669|NCT02530450|631037|P1|COMPLETED|Overall Study||10
262670|NCT02530450|631036|P2|STARTED|Overall Study||14
262671|NCT02530450|631037|P1|STARTED|Overall Study||16
262672|NCT02529995|631045|P2|NOT COMPLETED|Part B||0
262673|NCT02529995|631046|P1|NOT COMPLETED|Part B||0
262674|NCT02529995|631045|P2|COMPLETED|Part B||0
262675|NCT02529995|631046|P1|COMPLETED|Part B||0
262676|NCT02529995|631045|P2|STARTED|Part B||0
262677|NCT02529995|631046|P1|STARTED|Part B||0
262678|NCT02529995|631045|P2|NOT COMPLETED|Part A||16
262679|NCT02529995|631046|P1|NOT COMPLETED|Part A||15
262680|NCT02529995|631045|P2|COMPLETED|Part A||0
262681|NCT02529995|631046|P1|COMPLETED|Part A||0
262682|NCT02529995|631045|P2|STARTED|Part A||16
262683|NCT02529995|631046|P1|STARTED|Part A||15
262684|NCT02528721|631082|P2|NOT COMPLETED|Overall Study||3
262685|NCT02528721|631083|P1|NOT COMPLETED|Overall Study||7
262686|NCT02528721|631082|P2|COMPLETED|Overall Study||76
262687|NCT02528721|631083|P1|COMPLETED|Overall Study||196
262688|NCT02528721|631082|P2|STARTED|Overall Study||79
262689|NCT02528721|631083|P1|STARTED|Overall Study||203
262690|NCT02528331|631093|P1|NOT COMPLETED|Overall Study||2
262691|NCT02528331|631093|P1|COMPLETED|Overall Study||0
262692|NCT02528331|631093|P1|STARTED|Overall Study||2
262693|NCT02528097|631102|P2|NOT COMPLETED|Overall Study||0
262694|NCT02528097|631103|P1|NOT COMPLETED|Overall Study||0
262695|NCT02528097|631102|P2|COMPLETED|Overall Study||1
262696|NCT02528097|631103|P1|COMPLETED|Overall Study||1
262697|NCT02528097|631102|P2|STARTED|Overall Study||1
262698|NCT02528097|631103|P1|STARTED|Overall Study||1
262699|NCT02527161|631111|P1|NOT COMPLETED|Overall Study||62
262700|NCT02527161|631111|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
262701|NCT02527161|631111|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
262702|NCT02527148|631130|P2|NOT COMPLETED|Overall Study||0
262703|NCT02527148|631131|P1|NOT COMPLETED|Overall Study||1
262704|NCT02527148|631130|P2|COMPLETED|Overall Study||50
262705|NCT02527148|631131|P1|COMPLETED|Overall Study||49
262706|NCT02527148|631130|P2|STARTED|Overall Study||50
262707|NCT02527148|631131|P1|STARTED|Overall Study||50
262708|NCT02526550|631149|P1|NOT COMPLETED|Overall Study||1
262709|NCT02526550|631149|P1|COMPLETED|Overall Study||49
262710|NCT02526550|631149|P1|STARTED|Overall Study||50
262711|NCT02525536|631158|P3|NOT COMPLETED|Overall Study||0
262712|NCT02525536|631159|P2|NOT COMPLETED|Overall Study||0
262713|NCT02525536|631160|P1|NOT COMPLETED|Overall Study||0
262714|NCT02525536|631158|P3|COMPLETED|Overall Study||6
262715|NCT02525536|631159|P2|COMPLETED|Overall Study||6
262716|NCT02525536|631160|P1|COMPLETED|Overall Study||6
262717|NCT02525536|631158|P3|STARTED|Overall Study||6
262718|NCT02525536|631159|P2|STARTED|Overall Study||6
262719|NCT02525536|631160|P1|STARTED|Overall Study||6
262720|NCT02524665|631231|P1|NOT COMPLETED|Overall Study||1
262721|NCT02524665|631231|P1|COMPLETED|Overall Study||19
262722|NCT02524665|631231|P1|STARTED|Overall Study||20
262723|NCT02524561|631249|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
262724|NCT02524561|631250|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
262725|NCT02524561|631251|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
262726|NCT02524561|631249|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
262727|NCT02524561|631250|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
262728|NCT02524561|631251|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
262729|NCT02524561|631249|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
262730|NCT02524561|631250|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
262731|NCT02524561|631251|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
262732|NCT02524561|631249|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
262733|NCT02524561|631250|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
262734|NCT02524561|631251|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
262735|NCT02524561|631249|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
262736|NCT02524561|631250|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
262737|NCT02524561|631251|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
262738|NCT02524561|631249|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
262739|NCT02524561|631250|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
262740|NCT02524561|631251|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
262741|NCT02524561|631249|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
262742|NCT02524561|631250|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
262743|NCT02524561|631251|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
262744|NCT02524561|631249|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
262745|NCT02524561|631250|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
262746|NCT02524561|631251|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
262747|NCT02524561|631249|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
262748|NCT02524561|631250|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
262749|NCT02524561|631251|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
262750|NCT02524561|631249|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
262751|NCT02524561|631250|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
262752|NCT02524561|631251|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
262753|NCT02524561|631249|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
262754|NCT02524561|631250|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
262755|NCT02524561|631251|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
262756|NCT02524561|631249|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
262757|NCT02524561|631250|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
262758|NCT02524561|631251|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
262759|NCT02524418|631268|P1|NOT COMPLETED|Overall Study||13
262760|NCT02524418|631268|P1|COMPLETED|Overall Study||75
262761|NCT02524418|631268|P1|STARTED|Overall Study||88
262762|NCT02522624|631284|P2|NOT COMPLETED|Overall Study||0
262763|NCT02522624|631285|P1|NOT COMPLETED|Overall Study||1
262764|NCT02522624|631284|P2|COMPLETED|Overall Study||163
262765|NCT02522624|631285|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
262766|NCT02522624|631284|P2|STARTED|Overall Study||163
262767|NCT02522624|631285|P1|STARTED|Overall Study||165
262768|NCT02520414|631301|P1|NOT COMPLETED|Overall Study||0
262769|NCT02520414|631301|P1|COMPLETED|Overall Study||10
262770|NCT02520414|631301|P1|STARTED|Overall Study||10
262771|NCT02519855|631307|P2|NOT COMPLETED|Overall Study||4
262772|NCT02519855|631308|P1|NOT COMPLETED|Overall Study||3
262773|NCT02519855|631307|P2|COMPLETED|Overall Study||437
262774|NCT02519855|631308|P1|COMPLETED|Overall Study||438
262775|NCT02519855|631307|P2|Vaccinated at Week 4|Overall Study||424
262776|NCT02519855|631308|P1|Vaccinated at Week 4|Overall Study||432
262777|NCT02519855|631307|P2|Vaccinated on Day 1|Overall Study||441
262778|NCT02519855|631308|P1|Vaccinated on Day 1|Overall Study||440
262779|NCT02519855|631307|P2|STARTED|Overall Study|Participants are included as treated|441
262780|NCT02519855|631308|P1|STARTED|Overall Study|Participants are included as treated|441
262781|NCT02519595|631327|P3|NOT COMPLETED|Overall Study||16
262782|NCT02519595|631328|P2|NOT COMPLETED|Overall Study||22
262783|NCT02519595|631329|P1|NOT COMPLETED|Overall Study||8
262784|NCT02519595|631327|P3|COMPLETED|Overall Study||40
262785|NCT02519595|631328|P2|COMPLETED|Overall Study||35
262786|NCT02519595|631329|P1|COMPLETED|Overall Study||50
262787|NCT02519595|631327|P3|STARTED|Overall Study||56
262788|NCT02519595|631328|P2|STARTED|Overall Study||57
262789|NCT02519595|631329|P1|STARTED|Overall Study||58
262790|NCT02519387|631352|P1|NOT COMPLETED|Overall Study||22
262791|NCT02519387|631352|P1|COMPLETED|Overall Study||56
262792|NCT02519387|631352|P1|STARTED|Overall Study||78
262793|NCT02518048|631360|P1|NOT COMPLETED|Overall Study||1
262794|NCT02518048|631360|P1|COMPLETED|Overall Study||34
262795|NCT02518048|631360|P1|STARTED|Overall Study||35
262796|NCT02516306|631373|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
262797|NCT02516306|631374|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
262798|NCT02516306|631373|P2|COMPLETED|Period 2: Day 8 - 91||23
262799|NCT02516306|631374|P1|COMPLETED|Period 2: Day 8 - 91||49
262800|NCT02516306|631373|P2|STARTED|Period 2: Day 8 - 91||25
262801|NCT02516306|631374|P1|STARTED|Period 2: Day 8 - 91||50
262802|NCT02516306|631373|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
262803|NCT02516306|631374|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
262804|NCT02516306|631373|P2|COMPLETED|Period 1: Day 1 - 7||25
262805|NCT02516306|631374|P1|COMPLETED|Period 1: Day 1 - 7||50
262806|NCT02516306|631373|P2|STARTED|Period 1: Day 1 - 7||25
262807|NCT02516306|631374|P1|STARTED|Period 1: Day 1 - 7||50
262808|NCT02516163|631380|P1|NOT COMPLETED|Overall Study||28
262809|NCT02516163|631380|P1|COMPLETED|Overall Study||24
262810|NCT02516163|631380|P1|STARTED|Overall Study||52
262811|NCT02516098|631386|P2|NOT COMPLETED|Washout After Period 2||0
262812|NCT02516098|631387|P1|NOT COMPLETED|Washout After Period 2||0
262813|NCT02516098|631386|P2|COMPLETED|Washout After Period 2||26
262814|NCT02516098|631387|P1|COMPLETED|Washout After Period 2||27
262815|NCT02516098|631386|P2|STARTED|Washout After Period 2||26
262816|NCT02516098|631387|P1|STARTED|Washout After Period 2||27
262817|NCT02516098|631386|P2|NOT COMPLETED|Period 2||1
262818|NCT02516098|631387|P1|NOT COMPLETED|Period 2||0
262819|NCT02516098|631386|P2|COMPLETED|Period 2||26
262820|NCT02516098|631387|P1|COMPLETED|Period 2||27
262821|NCT02516098|631386|P2|STARTED|Period 2||27
262822|NCT02516098|631387|P1|STARTED|Period 2||27
262823|NCT02516098|631386|P2|NOT COMPLETED|Washout After Period 1||1
262824|NCT02516098|631387|P1|NOT COMPLETED|Washout After Period 1||0
262825|NCT02516098|631386|P2|COMPLETED|Washout After Period 1||27
262826|NCT02516098|631387|P1|COMPLETED|Washout After Period 1||27
262827|NCT02516098|631386|P2|STARTED|Washout After Period 1||28
262828|NCT02516098|631387|P1|STARTED|Washout After Period 1||27
262829|NCT02516098|631386|P2|NOT COMPLETED|Period 1||0
262830|NCT02516098|631387|P1|NOT COMPLETED|Period 1||1
262831|NCT02516098|631386|P2|COMPLETED|Period 1||28
262832|NCT02516098|631387|P1|COMPLETED|Period 1||27
262833|NCT02516098|631386|P2|STARTED|Period 1||28
262834|NCT02516098|631387|P1|STARTED|Period 1||28
262835|NCT02515994|631401|P2|NOT COMPLETED|Overall Study||7
262836|NCT02515994|631402|P1|NOT COMPLETED|Overall Study||10
262837|NCT02515994|631401|P2|COMPLETED|Overall Study||105
262838|NCT02515994|631402|P1|COMPLETED|Overall Study||99
262839|NCT02515994|631401|P2|STARTED|Overall Study||112
262840|NCT02515994|631402|P1|STARTED|Overall Study||109
262841|NCT02515279|631414|P1|NOT COMPLETED|Overall Study||104
262842|NCT02515279|631414|P1|COMPLETED|Overall Study||359
262843|NCT02515279|631414|P1|STARTED|Overall Study||463
262844|NCT02513095|631422|P2|NOT COMPLETED|Overall Study||16
262845|NCT02513095|631423|P1|NOT COMPLETED|Overall Study||14
262846|NCT02513095|631422|P2|COMPLETED|Overall Study||1
262847|NCT02513095|631423|P1|COMPLETED|Overall Study||3
262848|NCT02513095|631422|P2|STARTED|Overall Study||17
262849|NCT02513095|631423|P1|STARTED|Overall Study||17
262850|NCT02512900|631431|P2|NOT COMPLETED|Overall Study||0
262851|NCT02512900|631432|P1|NOT COMPLETED|Overall Study||0
262852|NCT02512900|631431|P2|COMPLETED|Overall Study||10
262853|NCT02512900|631432|P1|COMPLETED|Overall Study||11
262854|NCT02512900|631431|P2|STARTED|Overall Study||10
262855|NCT02512900|631432|P1|STARTED|Overall Study||11
262856|NCT02512783|631465|P2|NOT COMPLETED|Overall Study||0
262857|NCT02512783|631466|P1|NOT COMPLETED|Overall Study||0
262858|NCT02512783|631465|P2|COMPLETED|Overall Study||75
262859|NCT02512783|631466|P1|COMPLETED|Overall Study||96
262860|NCT02512783|631465|P2|STARTED|Overall Study||75
262861|NCT02512783|631466|P1|STARTED|Overall Study||96
262862|NCT02512679|631474|P2|NOT COMPLETED|Overall Study||0
262863|NCT02512679|631475|P1|NOT COMPLETED|Overall Study||0
262864|NCT02512679|631474|P2|COMPLETED|Overall Study||0
262865|NCT02512679|631475|P1|COMPLETED|Overall Study||20
262866|NCT02512679|631474|P2|STARTED|Overall Study||0
262867|NCT02512679|631475|P1|STARTED|Overall Study||20
262868|NCT02512224|631485|P2|NOT COMPLETED|Overall Study||0
262869|NCT02512224|631486|P1|NOT COMPLETED|Overall Study||0
262870|NCT02512224|631485|P2|COMPLETED|Overall Study||2912
262871|NCT02512224|631486|P1|COMPLETED|Overall Study||2912
262872|NCT02512224|631485|P2|STARTED|Overall Study||2912
262873|NCT02512224|631486|P1|STARTED|Overall Study||2912
262874|NCT02511782|631505|P3|NOT COMPLETED|Overall Study||0
262875|NCT02511782|631506|P2|NOT COMPLETED|Overall Study||0
262876|NCT02511782|631507|P1|NOT COMPLETED|Overall Study||1
262877|NCT02511782|631505|P3|COMPLETED|Overall Study||10
262878|NCT02511782|631506|P2|COMPLETED|Overall Study||2
262879|NCT02511782|631507|P1|COMPLETED|Overall Study||50
262880|NCT02511782|631505|P3|STARTED|Overall Study||10
262881|NCT02511782|631506|P2|STARTED|Overall Study||2
262882|NCT02511782|631507|P1|STARTED|Overall Study||51
262883|NCT02510820|631517|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
262884|NCT02510820|631518|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
262885|NCT02510820|631517|P2|COMPLETED|Second Intervention (4 Weeks)||26
262886|NCT02510820|631518|P1|COMPLETED|Second Intervention (4 Weeks)||20
262887|NCT02510820|631517|P2|STARTED|Second Intervention (4 Weeks)||26
262888|NCT02510820|631518|P1|STARTED|Second Intervention (4 Weeks)||21
262889|NCT02510820|631517|P2|NOT COMPLETED|Washout (1 Week)||0
262890|NCT02510820|631518|P1|NOT COMPLETED|Washout (1 Week)||0
262891|NCT02510820|631517|P2|COMPLETED|Washout (1 Week)||26
262892|NCT02510820|631518|P1|COMPLETED|Washout (1 Week)||21
262893|NCT02510820|631517|P2|STARTED|Washout (1 Week)||26
262894|NCT02510820|631518|P1|STARTED|Washout (1 Week)||21
262895|NCT02510820|631517|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
262896|NCT02510820|631518|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
262897|NCT02510820|631517|P2|COMPLETED|First Intervention (4 Weeks)||26
262898|NCT02510820|631518|P1|COMPLETED|First Intervention (4 Weeks)||21
262899|NCT02510820|631517|P2|STARTED|First Intervention (4 Weeks)||27
262900|NCT02510820|631518|P1|STARTED|First Intervention (4 Weeks)||21
262901|NCT02507752|631556|P1|NOT COMPLETED|Overall Study||17
262902|NCT02507752|631556|P1|COMPLETED|Overall Study||55
262903|NCT02507752|631556|P1|STARTED|Overall Study||72
262904|NCT02507375|631576|P2|NOT COMPLETED|Overall Study||8
262905|NCT02507375|631577|P1|NOT COMPLETED|Overall Study||4
262906|NCT02507375|631576|P2|COMPLETED|Overall Study||1
262907|NCT02507375|631577|P1|COMPLETED|Overall Study||2
262908|NCT02507375|631576|P2|Extension Period|Overall Study||1
262909|NCT02507375|631577|P1|Extension Period|Overall Study||2
262910|NCT02507375|631576|P2|Cycle 6|Overall Study||1
262911|NCT02507375|631577|P1|Cycle 6|Overall Study||3
262912|NCT02507375|631576|P2|Cycle 5|Overall Study||1
262913|NCT02507375|631577|P1|Cycle 5|Overall Study||3
262914|NCT02507375|631576|P2|Cycle 4|Overall Study||2
262915|NCT02507375|631577|P1|Cycle 4|Overall Study||4
262916|NCT02507375|631576|P2|Cycle 3|Overall Study||5
262917|NCT02507375|631577|P1|Cycle 3|Overall Study||4
262918|NCT02507375|631576|P2|Cycle 2|Overall Study||5
262919|NCT02507375|631577|P1|Cycle 2|Overall Study||5
262920|NCT02507375|631576|P2|Received Pertuzumab|Overall Study||6
262921|NCT02507375|631577|P1|Received Pertuzumab|Overall Study||6
262922|NCT02507375|631576|P2|Cycle 1|Overall Study||9
262923|NCT02507375|631577|P1|Cycle 1|Overall Study||6
262924|NCT02507375|631576|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
262925|NCT02507375|631577|P1|STARTED|Overall Study||6
262926|NCT02506881|631598|P4|NOT COMPLETED|Second Intervention (Day 1)||0
262927|NCT02506881|631599|P3|NOT COMPLETED|Second Intervention (Day 1)||0
262928|NCT02506881|631600|P2|NOT COMPLETED|Second Intervention (Day 1)||0
262929|NCT02506881|631601|P1|NOT COMPLETED|Second Intervention (Day 1)||0
262930|NCT02506881|631598|P4|COMPLETED|Second Intervention (Day 1)||12
262931|NCT02506881|631599|P3|COMPLETED|Second Intervention (Day 1)||12
262932|NCT02506881|631600|P2|COMPLETED|Second Intervention (Day 1)||12
262933|NCT02506881|631601|P1|COMPLETED|Second Intervention (Day 1)||12
262934|NCT02506881|631598|P4|STARTED|Second Intervention (Day 1)||12
262935|NCT02506881|631599|P3|STARTED|Second Intervention (Day 1)||12
262936|NCT02506881|631600|P2|STARTED|Second Intervention (Day 1)||12
262937|NCT02506881|631601|P1|STARTED|Second Intervention (Day 1)||12
262938|NCT02506881|631598|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
262939|NCT02506881|631599|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
262940|NCT02506881|631600|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
262941|NCT02506881|631601|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
262942|NCT02506881|631598|P4|COMPLETED|Washout (at Least 25 Days)||12
262943|NCT02506881|631599|P3|COMPLETED|Washout (at Least 25 Days)||12
262944|NCT02506881|631600|P2|COMPLETED|Washout (at Least 25 Days)||12
262945|NCT02506881|631601|P1|COMPLETED|Washout (at Least 25 Days)||12
262946|NCT02506881|631598|P4|STARTED|Washout (at Least 25 Days)||12
262947|NCT02506881|631599|P3|STARTED|Washout (at Least 25 Days)||12
262948|NCT02506881|631600|P2|STARTED|Washout (at Least 25 Days)||12
262949|NCT02506881|631601|P1|STARTED|Washout (at Least 25 Days)||12
262950|NCT02506881|631598|P4|NOT COMPLETED|First Intervention (Day 1)||12
262951|NCT02506881|631599|P3|NOT COMPLETED|First Intervention (Day 1)||13
262952|NCT02506881|631600|P2|NOT COMPLETED|First Intervention (Day 1)||0
262953|NCT02506881|631601|P1|NOT COMPLETED|First Intervention (Day 1)||1
262954|NCT02506881|631598|P4|COMPLETED|First Intervention (Day 1)||12
262955|NCT02506881|631599|P3|COMPLETED|First Intervention (Day 1)||12
262956|NCT02506881|631600|P2|COMPLETED|First Intervention (Day 1)||12
262957|NCT02506881|631601|P1|COMPLETED|First Intervention (Day 1)||12
262958|NCT02506881|631598|P4|STARTED|First Intervention (Day 1)||24
262959|NCT02506881|631599|P3|STARTED|First Intervention (Day 1)||25
262960|NCT02506881|631600|P2|STARTED|First Intervention (Day 1)||12
262961|NCT02506881|631601|P1|STARTED|First Intervention (Day 1)||13
262962|NCT02506309|631637|P2|NOT COMPLETED|Overall Study||1
262963|NCT02506309|631638|P1|NOT COMPLETED|Overall Study||2
262964|NCT02506309|631637|P2|COMPLETED|Overall Study||44
262965|NCT02506309|631638|P1|COMPLETED|Overall Study||46
262966|NCT02506309|631637|P2|STARTED|Overall Study||45
262967|NCT02506309|631638|P1|STARTED|Overall Study||48
262968|NCT02506257|631654|P4|NOT COMPLETED|Overall Study||0
262969|NCT02506257|631655|P3|NOT COMPLETED|Overall Study||4
262970|NCT02506257|631656|P2|NOT COMPLETED|Overall Study||2
262971|NCT02506257|631657|P1|NOT COMPLETED|Overall Study||0
262972|NCT02506257|631654|P4|COMPLETED|Overall Study||9
262973|NCT02506257|631655|P3|COMPLETED|Overall Study||23
262974|NCT02506257|631656|P2|COMPLETED|Overall Study||26
262975|NCT02506257|631657|P1|COMPLETED|Overall Study||26
262976|NCT02506257|631654|P4|STARTED|Overall Study||9
262977|NCT02506257|631655|P3|STARTED|Overall Study||27
262978|NCT02506257|631656|P2|STARTED|Overall Study||28
262979|NCT02506257|631657|P1|STARTED|Overall Study||26
262980|NCT02504775|631687|P2|NOT COMPLETED|Period 2||0
262981|NCT02504775|631688|P1|NOT COMPLETED|Period 2||0
262982|NCT02504775|631687|P2|COMPLETED|Period 2||14
262983|NCT02504775|631688|P1|COMPLETED|Period 2||14
262984|NCT02504775|631687|P2|STARTED|Period 2||14
262985|NCT02504775|631688|P1|STARTED|Period 2||14
262986|NCT02504775|631687|P2|NOT COMPLETED|Washout||0
262987|NCT02504775|631688|P1|NOT COMPLETED|Washout||0
262988|NCT02504775|631687|P2|COMPLETED|Washout||14
262989|NCT02504775|631688|P1|COMPLETED|Washout||14
262990|NCT02504775|631687|P2|STARTED|Washout||14
262991|NCT02504775|631688|P1|STARTED|Washout||14
262992|NCT02504775|631687|P2|NOT COMPLETED|Period 1||0
262993|NCT02504775|631688|P1|NOT COMPLETED|Period 1||0
262994|NCT02504775|631687|P2|COMPLETED|Period 1||14
262995|NCT02504775|631688|P1|COMPLETED|Period 1||14
262996|NCT02504775|631687|P2|STARTED|Period 1||14
262997|NCT02504775|631688|P1|STARTED|Period 1||14
262998|NCT02504502|631702|P2|NOT COMPLETED|Crossover to Enhanced Report||0
262999|NCT02504502|631703|P1|NOT COMPLETED|Crossover to Enhanced Report||5
263000|NCT02504502|631702|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
263001|NCT02504502|631703|P1|COMPLETED|Crossover to Enhanced Report||15
263002|NCT02504502|631702|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
263003|NCT02504502|631703|P1|STARTED|Crossover to Enhanced Report||20
263004|NCT02504502|631702|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
263005|NCT02504502|631703|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
263006|NCT02504502|631702|P2|COMPLETED|Routine Care vs. Enhanced Report||21
263007|NCT02504502|631703|P1|COMPLETED|Routine Care vs. Enhanced Report||20
263008|NCT02504502|631702|P2|STARTED|Routine Care vs. Enhanced Report||28
263009|NCT02504502|631703|P1|STARTED|Routine Care vs. Enhanced Report||24
263010|NCT02504320|631713|P4|NOT COMPLETED|Treatment Period 4||0
263011|NCT02504320|631714|P3|NOT COMPLETED|Treatment Period 4||0
263012|NCT02504320|631715|P2|NOT COMPLETED|Treatment Period 4||0
263013|NCT02504320|631716|P1|NOT COMPLETED|Treatment Period 4||0
263014|NCT02504320|631713|P4|COMPLETED|Treatment Period 4||19
263015|NCT02504320|631714|P3|COMPLETED|Treatment Period 4||18
263016|NCT02504320|631715|P2|COMPLETED|Treatment Period 4||18
263017|NCT02504320|631716|P1|COMPLETED|Treatment Period 4||19
263018|NCT02504320|631713|P4|STARTED|Treatment Period 4||19
263019|NCT02504320|631714|P3|STARTED|Treatment Period 4||18
263020|NCT02504320|631715|P2|STARTED|Treatment Period 4||18
263021|NCT02504320|631716|P1|STARTED|Treatment Period 4||19
263022|NCT02504320|631713|P4|NOT COMPLETED|Treatment Period 3||1
263023|NCT02504320|631714|P3|NOT COMPLETED|Treatment Period 3||1
263024|NCT02504320|631715|P2|NOT COMPLETED|Treatment Period 3||0
263025|NCT02504320|631716|P1|NOT COMPLETED|Treatment Period 3||0
263026|NCT02504320|631713|P4|COMPLETED|Treatment Period 3||19
263027|NCT02504320|631714|P3|COMPLETED|Treatment Period 3||18
263028|NCT02504320|631715|P2|COMPLETED|Treatment Period 3||18
263029|NCT02504320|631716|P1|COMPLETED|Treatment Period 3||19
263030|NCT02504320|631713|P4|STARTED|Treatment Period 3||20
263031|NCT02504320|631714|P3|STARTED|Treatment Period 3||19
263032|NCT02504320|631715|P2|STARTED|Treatment Period 3||18
263033|NCT02504320|631716|P1|STARTED|Treatment Period 3||19
263034|NCT02504320|631713|P4|NOT COMPLETED|Treatment Period 2||0
263035|NCT02504320|631714|P3|NOT COMPLETED|Treatment Period 2||0
263036|NCT02504320|631715|P2|NOT COMPLETED|Treatment Period 2||1
263037|NCT02504320|631716|P1|NOT COMPLETED|Treatment Period 2||0
263038|NCT02504320|631713|P4|COMPLETED|Treatment Period 2||20
263039|NCT02504320|631714|P3|COMPLETED|Treatment Period 2||19
263040|NCT02504320|631715|P2|COMPLETED|Treatment Period 2||18
263041|NCT02504320|631716|P1|COMPLETED|Treatment Period 2||19
263042|NCT02504320|631713|P4|STARTED|Treatment Period 2||20
263043|NCT02504320|631714|P3|STARTED|Treatment Period 2||19
263044|NCT02504320|631715|P2|STARTED|Treatment Period 2||19
263045|NCT02504320|631716|P1|STARTED|Treatment Period 2||19
263046|NCT02504320|631713|P4|NOT COMPLETED|Treatment Period 1||0
263047|NCT02504320|631714|P3|NOT COMPLETED|Treatment Period 1||1
263048|NCT02504320|631715|P2|NOT COMPLETED|Treatment Period 1||0
263049|NCT02504320|631716|P1|NOT COMPLETED|Treatment Period 1||0
263050|NCT02504320|631713|P4|COMPLETED|Treatment Period 1||20
263051|NCT02504320|631714|P3|COMPLETED|Treatment Period 1||19
263052|NCT02504320|631715|P2|COMPLETED|Treatment Period 1||19
263053|NCT02504320|631716|P1|COMPLETED|Treatment Period 1||19
263054|NCT02504320|631713|P4|STARTED|Treatment Period 1||20
263055|NCT02504320|631714|P3|STARTED|Treatment Period 1||20
263056|NCT02504320|631715|P2|STARTED|Treatment Period 1||19
263057|NCT02504320|631716|P1|STARTED|Treatment Period 1||19
263058|NCT02503982|631734|P1|NOT COMPLETED|Overall Study||0
263059|NCT02503982|631734|P1|COMPLETED|Overall Study||13
263060|NCT02503982|631734|P1|STARTED|Overall Study||13
263061|NCT02503865|631741|P3|NOT COMPLETED|Overall Study||2
263062|NCT02503865|631742|P2|NOT COMPLETED|Overall Study||47
263063|NCT02503865|631743|P1|NOT COMPLETED|Overall Study||5
263064|NCT02503865|631741|P3|COMPLETED|Overall Study||64
263065|NCT02503865|631742|P2|COMPLETED|Overall Study||222
263066|NCT02503865|631743|P1|COMPLETED|Overall Study||65
263067|NCT02503865|631741|P3|STARTED|Overall Study||66
263068|NCT02503865|631742|P2|STARTED|Overall Study||269
263069|NCT02503865|631743|P1|STARTED|Overall Study||70
263070|NCT02503254|631765|P2|NOT COMPLETED|Overall Study||0
263071|NCT02503254|631766|P1|NOT COMPLETED|Overall Study||0
263072|NCT02503254|631765|P2|COMPLETED|Overall Study||39
263073|NCT02503254|631766|P1|COMPLETED|Overall Study||41
263074|NCT02503254|631765|P2|STARTED|Overall Study||39
263075|NCT02503254|631766|P1|STARTED|Overall Study||41
263076|NCT02503215|631779|P1|NOT COMPLETED|Overall Study||3
263077|NCT02503215|631779|P1|COMPLETED|Overall Study||14
263078|NCT02503215|631779|P1|STARTED|Overall Study||17
263079|NCT02502487|631788|P3|NOT COMPLETED|Overall Study||0
263080|NCT02502487|631789|P2|NOT COMPLETED|Overall Study||0
263081|NCT02502487|631790|P1|NOT COMPLETED|Overall Study||0
263082|NCT02502487|631788|P3|COMPLETED|Overall Study||86
263083|NCT02502487|631789|P2|COMPLETED|Overall Study||86
263084|NCT02502487|631790|P1|COMPLETED|Overall Study||86
263085|NCT02502487|631788|P3|STARTED|Overall Study||86
263086|NCT02502487|631789|P2|STARTED|Overall Study||86
263087|NCT02502487|631790|P1|STARTED|Overall Study||86
263088|NCT02502734|631858|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
263089|NCT02502734|631859|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
263090|NCT02502734|631858|P2|COMPLETED|Double-blind Treatment Period 2||30
263091|NCT02502734|631859|P1|COMPLETED|Double-blind Treatment Period 2||28
263092|NCT02502734|631858|P2|STARTED|Double-blind Treatment Period 2||30
263093|NCT02502734|631859|P1|STARTED|Double-blind Treatment Period 2||28
263094|NCT02502734|631858|P2|NOT COMPLETED|Washout Period||0
263095|NCT02502734|631859|P1|NOT COMPLETED|Washout Period||1
263096|NCT02502734|631858|P2|COMPLETED|Washout Period||30
263097|NCT02502734|631859|P1|COMPLETED|Washout Period||28
263098|NCT02502734|631858|P2|STARTED|Washout Period||30
263099|NCT02502734|631859|P1|STARTED|Washout Period||29
263100|NCT02502734|631858|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
263101|NCT02502734|631859|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
263102|NCT02502734|631858|P2|COMPLETED|Double-blind Treatment Period 1||30
263103|NCT02502734|631859|P1|COMPLETED|Double-blind Treatment Period 1||29
263104|NCT02502734|631858|P2|STARTED|Double-blind Treatment Period 1||30
263105|NCT02502734|631859|P1|STARTED|Double-blind Treatment Period 1||30
263106|NCT02500836|631870|P3|NOT COMPLETED|Overall Study||1
263107|NCT02500836|631871|P2|NOT COMPLETED|Overall Study||5
263108|NCT02500836|631872|P1|NOT COMPLETED|Overall Study||3
263109|NCT02500836|631870|P3|COMPLETED|Overall Study||127
263110|NCT02500836|631871|P2|COMPLETED|Overall Study||254
263111|NCT02500836|631872|P1|COMPLETED|Overall Study||256
263112|NCT02500836|631870|P3|STARTED|Overall Study||128
263113|NCT02500836|631871|P2|STARTED|Overall Study||259
263114|NCT02500836|631872|P1|STARTED|Overall Study||259
263115|NCT02500758|631883|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
263116|NCT02500758|631884|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
263117|NCT02500758|631883|P2|COMPLETED|Second Intervention (2 Minutes)||10
263118|NCT02500758|631884|P1|COMPLETED|Second Intervention (2 Minutes)||10
263119|NCT02500758|631883|P2|STARTED|Second Intervention (2 Minutes)||12
263120|NCT02500758|631884|P1|STARTED|Second Intervention (2 Minutes)||13
263121|NCT02500758|631883|P2|NOT COMPLETED|Washout (1 Week)||2
263122|NCT02500758|631884|P1|NOT COMPLETED|Washout (1 Week)||2
263123|NCT02500758|631883|P2|COMPLETED|Washout (1 Week)||12
263124|NCT02500758|631884|P1|COMPLETED|Washout (1 Week)||13
263125|NCT02500758|631883|P2|STARTED|Washout (1 Week)||14
263126|NCT02500758|631884|P1|STARTED|Washout (1 Week)||15
263127|NCT02500758|631883|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
263128|NCT02500758|631884|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
263129|NCT02500758|631883|P2|COMPLETED|First Intervention (2 Minutes)||14
263130|NCT02500758|631884|P1|COMPLETED|First Intervention (2 Minutes)||15
263131|NCT02500758|631883|P2|STARTED|First Intervention (2 Minutes)||15
263132|NCT02500758|631884|P1|STARTED|First Intervention (2 Minutes)||15
263133|NCT02500537|631894|P2|NOT COMPLETED|Overall Study||1
263134|NCT02500537|631895|P1|NOT COMPLETED|Overall Study||3
263135|NCT02500537|631894|P2|COMPLETED|Overall Study||39
263136|NCT02500537|631895|P1|COMPLETED|Overall Study||57
263137|NCT02500537|631894|P2|STARTED|Overall Study||40
263138|NCT02500537|631895|P1|STARTED|Overall Study||60
263139|NCT02500368|631913|P2|NOT COMPLETED|Second Intervention (1 Week)||0
263140|NCT02500368|631914|P1|NOT COMPLETED|Second Intervention (1 Week)||0
263141|NCT02500368|631913|P2|COMPLETED|Second Intervention (1 Week)||20
263142|NCT02500368|631914|P1|COMPLETED|Second Intervention (1 Week)||20
263143|NCT02500368|631913|P2|STARTED|Second Intervention (1 Week)||20
263144|NCT02500368|631914|P1|STARTED|Second Intervention (1 Week)||20
263145|NCT02500368|631913|P2|NOT COMPLETED|First Intervention (1 Week)||0
263146|NCT02500368|631914|P1|NOT COMPLETED|First Intervention (1 Week)||0
263147|NCT02500368|631913|P2|COMPLETED|First Intervention (1 Week)||20
263148|NCT02500368|631914|P1|COMPLETED|First Intervention (1 Week)||20
263149|NCT02500368|631913|P2|STARTED|First Intervention (1 Week)||20
263150|NCT02500368|631914|P1|STARTED|First Intervention (1 Week)||20
263151|NCT02500056|631964|P2|NOT COMPLETED|Overall Study||8
263152|NCT02500056|631965|P1|NOT COMPLETED|Overall Study||7
263153|NCT02500056|631964|P2|COMPLETED|Overall Study||65
263154|NCT02500056|631965|P1|COMPLETED|Overall Study||63
263155|NCT02500056|631964|P2|STARTED|Overall Study||73
263156|NCT02500056|631965|P1|STARTED|Overall Study||70
263157|NCT02499692|631975|P1|NOT COMPLETED|Overall Study||0
263158|NCT02499692|631975|P1|COMPLETED|Overall Study||103
263159|NCT02499692|631975|P1|STARTED|Overall Study||103
263160|NCT02499575|631986|P2|NOT COMPLETED|Overall Study||1
263161|NCT02499575|631987|P1|NOT COMPLETED|Overall Study||0
263162|NCT02499575|631986|P2|COMPLETED|Overall Study||0
263163|NCT02499575|631987|P1|COMPLETED|Overall Study||1
263164|NCT02499575|631986|P2|STARTED|Overall Study||1
263165|NCT02499575|631987|P1|STARTED|Overall Study||1
263166|NCT02498821|631999|P2|NOT COMPLETED|Overall Study||5
263167|NCT02498821|632000|P1|NOT COMPLETED|Overall Study||3
263168|NCT02498821|631999|P2|COMPLETED|Overall Study||60
263169|NCT02498821|632000|P1|COMPLETED|Overall Study||60
263170|NCT02498821|631999|P2|STARTED|Overall Study||65
263171|NCT02498821|632000|P1|STARTED|Overall Study||63
263172|NCT02498678|632029|P2|NOT COMPLETED|Overall Study||2
263173|NCT02498678|632030|P1|NOT COMPLETED|Overall Study||0
263174|NCT02498678|632029|P2|COMPLETED|Overall Study||23
263175|NCT02498678|632030|P1|COMPLETED|Overall Study||25
263176|NCT02498678|632029|P2|STARTED|Overall Study||25
263177|NCT02498678|632030|P1|STARTED|Overall Study||25
263178|NCT02498522|632046|P2|NOT COMPLETED|Overall Study||2
263179|NCT02498522|632047|P1|NOT COMPLETED|Overall Study||2
263180|NCT02498522|632046|P2|COMPLETED|Overall Study||83
263181|NCT02498522|632047|P1|COMPLETED|Overall Study||83
263182|NCT02498522|632046|P2|STARTED|Overall Study||85
263183|NCT02498522|632047|P1|STARTED|Overall Study||85
263184|NCT02497235|632058|P5|NOT COMPLETED|Overall Study||0
263185|NCT02497235|632059|P4|NOT COMPLETED|Overall Study||0
263186|NCT02497235|632060|P3|NOT COMPLETED|Overall Study||0
263187|NCT02497235|632061|P2|NOT COMPLETED|Overall Study||0
263188|NCT02497235|632062|P1|NOT COMPLETED|Overall Study||0
263189|NCT02497235|632058|P5|COMPLETED|Overall Study||3
263190|NCT02497235|632059|P4|COMPLETED|Overall Study||2
263191|NCT02497235|632060|P3|COMPLETED|Overall Study||2
263192|NCT02497235|632061|P2|COMPLETED|Overall Study||2
263193|NCT02497235|632062|P1|COMPLETED|Overall Study||2
263194|NCT02497235|632058|P5|STARTED|Overall Study||3
263195|NCT02497235|632059|P4|STARTED|Overall Study||2
263196|NCT02497235|632060|P3|STARTED|Overall Study||2
263197|NCT02497235|632061|P2|STARTED|Overall Study||2
263198|NCT02497235|632062|P1|STARTED|Overall Study||2
263199|NCT02496533|632094|P2|NOT COMPLETED|Overall Study||6
263200|NCT02496533|632095|P1|NOT COMPLETED|Overall Study||3
263201|NCT02496533|632094|P2|COMPLETED|Overall Study||106
263202|NCT02496533|632095|P1|COMPLETED|Overall Study||102
263203|NCT02496533|632094|P2|STARTED|Overall Study||112
263204|NCT02496533|632095|P1|STARTED|Overall Study||105
263205|NCT02496221|632107|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
263206|NCT02496221|632108|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
263207|NCT02496221|632107|P2|COMPLETED|Treatment Period 2 - 4 Days||9
263208|NCT02496221|632108|P1|COMPLETED|Treatment Period 2 - 4 Days||8
263209|NCT02496221|632107|P2|STARTED|Treatment Period 2 - 4 Days||10
263210|NCT02496221|632108|P1|STARTED|Treatment Period 2 - 4 Days||10
263211|NCT02496221|632107|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
263212|NCT02496221|632108|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
263213|NCT02496221|632107|P2|COMPLETED|Treatment Period 1 - 4 Days||10
263214|NCT02496221|632108|P1|COMPLETED|Treatment Period 1 - 4 Days||10
263215|NCT02496221|632107|P2|STARTED|Treatment Period 1 - 4 Days||10
263216|NCT02496221|632108|P1|STARTED|Treatment Period 1 - 4 Days||10
263217|NCT02496000|632145|P3|NOT COMPLETED|Overall Study||2
263218|NCT02496000|632146|P2|NOT COMPLETED|Overall Study||5
263219|NCT02496000|632147|P1|NOT COMPLETED|Overall Study||2
263220|NCT02496000|632145|P3|COMPLETED|Overall Study||61
263221|NCT02496000|632146|P2|COMPLETED|Overall Study||56
263222|NCT02496000|632147|P1|COMPLETED|Overall Study||62
263223|NCT02496000|632145|P3|STARTED|Overall Study||63
263224|NCT02496000|632146|P2|STARTED|Overall Study||61
263225|NCT02496000|632147|P1|STARTED|Overall Study||64
263226|NCT02495948|632156|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
263227|NCT02495948|632157|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
263228|NCT02495948|632156|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
263229|NCT02495948|632157|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
263230|NCT02495948|632156|P2|STARTED|Period 2, Second 30 Days of Wear||83
263231|NCT02495948|632157|P1|STARTED|Period 2, Second 30 Days of Wear||83
263232|NCT02495948|632156|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
263233|NCT02495948|632157|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
263234|NCT02495948|632156|P2|COMPLETED|Period 1, First 30 Days of Wear||83
263235|NCT02495948|632157|P1|COMPLETED|Period 1, First 30 Days of Wear||83
263236|NCT02495948|632156|P2|STARTED|Period 1, First 30 Days of Wear||84
263237|NCT02495948|632157|P1|STARTED|Period 1, First 30 Days of Wear||83
263238|NCT02495831|632164|P2|NOT COMPLETED|Second Intervention||0
263239|NCT02495831|632165|P1|NOT COMPLETED|Second Intervention||0
263240|NCT02495831|632164|P2|COMPLETED|Second Intervention||10
263241|NCT02495831|632165|P1|COMPLETED|Second Intervention||12
263242|NCT02495831|632164|P2|STARTED|Second Intervention||10
263243|NCT02495831|632165|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
263244|NCT02495831|632164|P2|NOT COMPLETED|First Intervention||0
263245|NCT02495831|632165|P1|NOT COMPLETED|First Intervention||0
263246|NCT02495831|632164|P2|COMPLETED|First Intervention||10
263247|NCT02495831|632165|P1|COMPLETED|First Intervention||13
263248|NCT02495831|632164|P2|STARTED|First Intervention||10
263249|NCT02495831|632165|P1|STARTED|First Intervention||13
263250|NCT02495623|632182|P3|NOT COMPLETED|Overall Study||8
263251|NCT02495623|632183|P2|NOT COMPLETED|Overall Study||9
263252|NCT02495623|632184|P1|NOT COMPLETED|Overall Study||5
263253|NCT02495623|632182|P3|COMPLETED|Overall Study||20
263254|NCT02495623|632183|P2|COMPLETED|Overall Study||17
263255|NCT02495623|632184|P1|COMPLETED|Overall Study||20
263256|NCT02495623|632182|P3|STARTED|Overall Study|28 Randomized 22 Dosed|28
263257|NCT02495623|632183|P2|STARTED|Overall Study|26 Randomized 19 Dosed|26
263258|NCT02495623|632184|P1|STARTED|Overall Study|25 Randomized 22 Dosed|25
263259|NCT02493855|632195|P3|NOT COMPLETED|Overall Study||0
263260|NCT02493855|632196|P2|NOT COMPLETED|Overall Study||1
263261|NCT02493855|632197|P1|NOT COMPLETED|Overall Study||2
263262|NCT02493855|632195|P3|COMPLETED|Overall Study||6
263263|NCT02493855|632196|P2|COMPLETED|Overall Study||18
263264|NCT02493855|632197|P1|COMPLETED|Overall Study||19
263265|NCT02493855|632195|P3|STARTED|Overall Study||6
263266|NCT02493855|632196|P2|STARTED|Overall Study||19
263267|NCT02493855|632197|P1|STARTED|Overall Study||21
263268|NCT02494596|632205|P3|NOT COMPLETED|Overall Study||1
263269|NCT02494596|632206|P2|NOT COMPLETED|Overall Study||5
263270|NCT02494596|632207|P1|NOT COMPLETED|Overall Study||3
263271|NCT02494596|632205|P3|COMPLETED|Overall Study||6
263272|NCT02494596|632206|P2|COMPLETED|Overall Study||2
263273|NCT02494596|632207|P1|COMPLETED|Overall Study||2
263274|NCT02494596|632205|P3|STARTED|Overall Study||7
263275|NCT02494596|632206|P2|STARTED|Overall Study||7
263276|NCT02494596|632207|P1|STARTED|Overall Study||5
263277|NCT02494440|632232|P1|NOT COMPLETED|Overall Study||0
263278|NCT02494440|632232|P1|COMPLETED|Overall Study||90
263279|NCT02494440|632232|P1|STARTED|Overall Study||90
263280|NCT02494323|632238|P1|NOT COMPLETED|Overall Study||0
263281|NCT02494323|632238|P1|COMPLETED|Overall Study||70
263282|NCT02494323|632238|P1|STARTED|Overall Study||70
263283|NCT02493127|632245|P2|NOT COMPLETED|Overall Study||1
263284|NCT02493127|632246|P1|NOT COMPLETED|Overall Study||1
263285|NCT02493127|632245|P2|COMPLETED|Overall Study||60
263286|NCT02493127|632246|P1|COMPLETED|Overall Study||60
263287|NCT02493127|632245|P2|STARTED|Overall Study||61
263288|NCT02493127|632246|P1|STARTED|Overall Study||61
263289|NCT02493088|632258|P1|NOT COMPLETED|Overall Study||0
263290|NCT02493088|632258|P1|COMPLETED|Overall Study||11
263291|NCT02493088|632258|P1|STARTED|Overall Study||11
263292|NCT02493036|632267|P3|NOT COMPLETED|Overall Study||2
263293|NCT02493036|632268|P2|NOT COMPLETED|Overall Study||2
263294|NCT02493036|632269|P1|NOT COMPLETED|Overall Study||1
263295|NCT02493036|632267|P3|COMPLETED|Overall Study||15
263296|NCT02493036|632268|P2|COMPLETED|Overall Study||18
263297|NCT02493036|632269|P1|COMPLETED|Overall Study||16
263298|NCT02493036|632267|P3|STARTED|Overall Study||17
263299|NCT02493036|632268|P2|STARTED|Overall Study||20
263300|NCT02493036|632269|P1|STARTED|Overall Study||17
263301|NCT02492984|632279|P2|NOT COMPLETED|Overall Study||0
263302|NCT02492984|632280|P1|NOT COMPLETED|Overall Study||3
263303|NCT02492984|632279|P2|COMPLETED|Overall Study||14
263304|NCT02492984|632280|P1|COMPLETED|Overall Study||70
263305|NCT02492984|632279|P2|STARTED|Overall Study||14
263306|NCT02492984|632280|P1|STARTED|Overall Study||73
263307|NCT02492451|632303|P3|NOT COMPLETED|Overall Study||0
263308|NCT02492451|632304|P2|NOT COMPLETED|Overall Study||0
263309|NCT02492451|632305|P1|NOT COMPLETED|Overall Study||0
263310|NCT02492451|632303|P3|COMPLETED|Overall Study||39
263311|NCT02492451|632304|P2|COMPLETED|Overall Study||39
263312|NCT02492451|632305|P1|COMPLETED|Overall Study||40
263313|NCT02492451|632303|P3|STARTED|Overall Study||39
263314|NCT02492451|632304|P2|STARTED|Overall Study||39
263315|NCT02492451|632305|P1|STARTED|Overall Study||40
263316|NCT02492165|632317|P4|NOT COMPLETED|Overall Study||0
263317|NCT02492165|632318|P3|NOT COMPLETED|Overall Study||0
263318|NCT02492165|632319|P2|NOT COMPLETED|Overall Study||1
263319|NCT02492165|632320|P1|NOT COMPLETED|Overall Study||0
263320|NCT02492165|632317|P4|COMPLETED|Overall Study||30
263321|NCT02492165|632318|P3|COMPLETED|Overall Study||60
263322|NCT02492165|632319|P2|COMPLETED|Overall Study||59
263323|NCT02492165|632320|P1|COMPLETED|Overall Study||100
263324|NCT02492165|632317|P4|STARTED|Overall Study||30
263325|NCT02492165|632318|P3|STARTED|Overall Study||60
263326|NCT02492165|632319|P2|STARTED|Overall Study||60
263327|NCT02492165|632320|P1|STARTED|Overall Study||100
263328|NCT02491944|632342|P1|NOT COMPLETED|Overall Study||0
263329|NCT02491944|632342|P1|COMPLETED|Overall Study||10
263330|NCT02491944|632342|P1|STARTED|Overall Study||10
263331|NCT02491892|632364|P2|NOT COMPLETED|Overall Study||38
263332|NCT02491892|632365|P1|NOT COMPLETED|Overall Study||41
263333|NCT02491892|632364|P2|COMPLETED|Overall Study||0
263334|NCT02491892|632365|P1|COMPLETED|Overall Study||0
263335|NCT02491892|632364|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
263336|NCT02491892|632365|P1|Treated|Overall Study||41
263337|NCT02491892|632364|P2|STARTED|Overall Study||38
263338|NCT02491892|632365|P1|STARTED|Overall Study||41
263339|NCT02490670|632411|P2|NOT COMPLETED|Period 2 (19 Days)||0
263340|NCT02490670|632412|P1|NOT COMPLETED|Period 2 (19 Days)||0
263341|NCT02490670|632411|P2|COMPLETED|Period 2 (19 Days)||14
263342|NCT02490670|632412|P1|COMPLETED|Period 2 (19 Days)||14
263343|NCT02490670|632411|P2|STARTED|Period 2 (19 Days)||14
263344|NCT02490670|632412|P1|STARTED|Period 2 (19 Days)||14
263345|NCT02490670|632411|P2|NOT COMPLETED|Washout Period (7 Days)||0
263346|NCT02490670|632412|P1|NOT COMPLETED|Washout Period (7 Days)||0
263347|NCT02490670|632411|P2|COMPLETED|Washout Period (7 Days)||14
263348|NCT02490670|632412|P1|COMPLETED|Washout Period (7 Days)||14
263349|NCT02490670|632411|P2|STARTED|Washout Period (7 Days)||14
263350|NCT02490670|632412|P1|STARTED|Washout Period (7 Days)||14
263351|NCT02490670|632411|P2|NOT COMPLETED|Period 1 (19 Days)||0
263352|NCT02490670|632412|P1|NOT COMPLETED|Period 1 (19 Days)||0
263353|NCT02490670|632411|P2|COMPLETED|Period 1 (19 Days)||14
263354|NCT02490670|632412|P1|COMPLETED|Period 1 (19 Days)||14
263355|NCT02490670|632411|P2|STARTED|Period 1 (19 Days)||14
263356|NCT02490670|632412|P1|STARTED|Period 1 (19 Days)||14
263357|NCT02490475|632424|P4|NOT COMPLETED|Period 2: Extension Phase||1
263358|NCT02490475|632425|P3|NOT COMPLETED|Period 2: Extension Phase||3
263359|NCT02490475|632426|P2|NOT COMPLETED|Period 2: Extension Phase||0
263360|NCT02490475|632427|P1|NOT COMPLETED|Period 2: Extension Phase||1
263361|NCT02490475|632424|P4|COMPLETED|Period 2: Extension Phase||0
263362|NCT02490475|632425|P3|COMPLETED|Period 2: Extension Phase||0
263363|NCT02490475|632426|P2|COMPLETED|Period 2: Extension Phase||0
263364|NCT02490475|632427|P1|COMPLETED|Period 2: Extension Phase||0
263365|NCT02490475|632424|P4|STARTED|Period 2: Extension Phase||1
263366|NCT02490475|632425|P3|STARTED|Period 2: Extension Phase||3
263367|NCT02490475|632426|P2|STARTED|Period 2: Extension Phase||0
263368|NCT02490475|632427|P1|STARTED|Period 2: Extension Phase||1
263369|NCT02490475|632424|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
263370|NCT02490475|632425|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
263371|NCT02490475|632426|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
263372|NCT02490475|632427|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
263373|NCT02490475|632424|P4|COMPLETED|Period 1: First 6 Cycles||0
263374|NCT02490475|632425|P3|COMPLETED|Period 1: First 6 Cycles||0
263375|NCT02490475|632426|P2|COMPLETED|Period 1: First 6 Cycles||0
263376|NCT02490475|632427|P1|COMPLETED|Period 1: First 6 Cycles||0
263377|NCT02490475|632424|P4|STARTED|Period 1: First 6 Cycles||5
263378|NCT02490475|632425|P3|STARTED|Period 1: First 6 Cycles||6
263379|NCT02490475|632426|P2|STARTED|Period 1: First 6 Cycles||2
263380|NCT02490475|632427|P1|STARTED|Period 1: First 6 Cycles||6
263381|NCT02490293|632505|P2|NOT COMPLETED|Overall Study||3
263382|NCT02490293|632506|P1|NOT COMPLETED|Overall Study||2
263383|NCT02490293|632505|P2|COMPLETED|Overall Study||99
263384|NCT02490293|632506|P1|COMPLETED|Overall Study||94
263385|NCT02490293|632505|P2|STARTED|Overall Study||102
263386|NCT02490293|632506|P1|STARTED|Overall Study||96
263387|NCT02488980|632517|P3|NOT COMPLETED|Overall Study||2
263388|NCT02488980|632518|P2|NOT COMPLETED|Overall Study||2
263389|NCT02488980|632519|P1|NOT COMPLETED|Overall Study||2
263390|NCT02488980|632517|P3|COMPLETED|Overall Study||99
263391|NCT02488980|632518|P2|COMPLETED|Overall Study||99
263392|NCT02488980|632519|P1|COMPLETED|Overall Study||102
263393|NCT02488980|632517|P3|STARTED|Overall Study||101
263394|NCT02488980|632518|P2|STARTED|Overall Study||101
263395|NCT02488980|632519|P1|STARTED|Overall Study||104
263396|NCT02488317|632538|P2|NOT COMPLETED|Overall Study||47
263397|NCT02488317|632539|P1|NOT COMPLETED|Overall Study||54
263398|NCT02488317|632538|P2|COMPLETED|Overall Study||70
263399|NCT02488317|632539|P1|COMPLETED|Overall Study||63
263400|NCT02488317|632538|P2|STARTED|Overall Study||117
263401|NCT02488317|632539|P1|STARTED|Overall Study||117
263402|NCT02488070|632553|P1|NOT COMPLETED|Overall Study||0
263403|NCT02488070|632553|P1|COMPLETED|Overall Study||10
263404|NCT02488070|632553|P1|STARTED|Overall Study||10
263405|NCT02488018|632561|P1|NOT COMPLETED|Overall Study||0
263406|NCT02488018|632561|P1|COMPLETED|Overall Study||10
263407|NCT02488018|632561|P1|STARTED|Overall Study||10
263408|NCT02486952|632565|P1|NOT COMPLETED|Overall Study||50
263409|NCT02486952|632565|P1|COMPLETED|Overall Study||104
263410|NCT02486952|632565|P1|Started Induction Therapy|Overall Study||151
263411|NCT02486952|632565|P1|STARTED|Overall Study||154
263412|NCT02485483|632572|P2|NOT COMPLETED|Overall Study||0
263413|NCT02485483|632573|P1|NOT COMPLETED|Overall Study||54
263414|NCT02485483|632572|P2|COMPLETED|Overall Study||1015
263415|NCT02485483|632573|P1|COMPLETED|Overall Study||223
263416|NCT02485483|632572|P2|STARTED|Overall Study||1015
263417|NCT02485483|632573|P1|STARTED|Overall Study||277
263418|NCT02485158|632588|P1|NOT COMPLETED|Overall Study||4
263419|NCT02485158|632588|P1|COMPLETED|Overall Study||24
263420|NCT02485158|632588|P1|STARTED|Overall Study||28
263421|NCT02484911|632677|P2|NOT COMPLETED|Overall Study||2
263422|NCT02484911|632678|P1|NOT COMPLETED|Overall Study||4
263423|NCT02484911|632677|P2|COMPLETED|Overall Study||58
263424|NCT02484911|632678|P1|COMPLETED|Overall Study||56
263425|NCT02484911|632677|P2|STARTED|Overall Study||60
263426|NCT02484911|632678|P1|STARTED|Overall Study||60
263427|NCT02484898|632706|P1|NOT COMPLETED|Overall Study||18
263428|NCT02484898|632706|P1|COMPLETED|Overall Study||182
263429|NCT02484898|632706|P1|STARTED|Overall Study||200
263430|NCT02484729|632720|P10|NOT COMPLETED|Overall Study||1
263431|NCT02484729|632721|P9|NOT COMPLETED|Overall Study||0
263432|NCT02484729|632722|P8|NOT COMPLETED|Overall Study||0
263433|NCT02484729|632723|P7|NOT COMPLETED|Overall Study||0
263434|NCT02484729|632724|P6|NOT COMPLETED|Overall Study||0
263435|NCT02484729|632725|P5|NOT COMPLETED|Overall Study||0
263436|NCT02484729|632726|P4|NOT COMPLETED|Overall Study||0
263437|NCT02484729|632727|P3|NOT COMPLETED|Overall Study||0
263438|NCT02484729|632728|P2|NOT COMPLETED|Overall Study||0
263439|NCT02484729|632729|P1|NOT COMPLETED|Overall Study||0
263440|NCT02484729|632720|P10|COMPLETED|Overall Study||7
263441|NCT02484729|632721|P9|COMPLETED|Overall Study||6
263442|NCT02484729|632722|P8|COMPLETED|Overall Study||6
263443|NCT02484729|632723|P7|COMPLETED|Overall Study||5
263444|NCT02484729|632724|P6|COMPLETED|Overall Study||6
263445|NCT02484729|632725|P5|COMPLETED|Overall Study||5
263446|NCT02484729|632726|P4|COMPLETED|Overall Study||6
263447|NCT02484729|632727|P3|COMPLETED|Overall Study||6
263448|NCT02484729|632728|P2|COMPLETED|Overall Study||6
263449|NCT02484729|632729|P1|COMPLETED|Overall Study||16
263450|NCT02484729|632720|P10|STARTED|Overall Study||8
263451|NCT02484729|632721|P9|STARTED|Overall Study||6
263452|NCT02484729|632722|P8|STARTED|Overall Study||6
263453|NCT02484729|632723|P7|STARTED|Overall Study||5
263454|NCT02484729|632724|P6|STARTED|Overall Study||6
263455|NCT02484729|632725|P5|STARTED|Overall Study||5
263456|NCT02484729|632726|P4|STARTED|Overall Study||6
263457|NCT02484729|632727|P3|STARTED|Overall Study||6
263458|NCT02484729|632728|P2|STARTED|Overall Study||6
263459|NCT02484729|632729|P1|STARTED|Overall Study||16
263460|NCT02483975|632927|P2|NOT COMPLETED|Overall Study||2
263461|NCT02483975|632928|P1|NOT COMPLETED|Overall Study||2
263462|NCT02483975|632927|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
263463|NCT02483975|632928|P1|COMPLETED|Overall Study||54
263464|NCT02483975|632927|P2|STARTED|Overall Study||55
263465|NCT02483975|632928|P1|STARTED|Overall Study||56
263466|NCT02483611|632945|P3|NOT COMPLETED|Overall Study||1
263467|NCT02483611|632946|P2|NOT COMPLETED|Overall Study||0
263468|NCT02483611|632947|P1|NOT COMPLETED|Overall Study||0
263469|NCT02483611|632945|P3|COMPLETED|Overall Study|One patient required decurarization|15
263470|NCT02483611|632946|P2|COMPLETED|Overall Study||16
263471|NCT02483611|632947|P1|COMPLETED|Overall Study||16
263472|NCT02483611|632945|P3|STARTED|Overall Study||16
263473|NCT02483611|632946|P2|STARTED|Overall Study||16
263474|NCT02483611|632947|P1|STARTED|Overall Study||16
263475|NCT02481934|633042|P1|NOT COMPLETED|Overall Study||2
263476|NCT02481934|633042|P1|COMPLETED|Overall Study||3
263477|NCT02481934|633042|P1|STARTED|Overall Study||5
263478|NCT02481219|633049|P2|NOT COMPLETED|Overall Study||1
263479|NCT02481219|633050|P1|NOT COMPLETED|Overall Study||2
263480|NCT02481219|633049|P2|COMPLETED|Overall Study||61
263481|NCT02481219|633050|P1|COMPLETED|Overall Study||58
263482|NCT02481219|633049|P2|STARTED|Overall Study||62
263483|NCT02481219|633050|P1|STARTED|Overall Study||60
263484|NCT02480712|633066|P1|NOT COMPLETED|Overall Study||11
263485|NCT02480712|633066|P1|COMPLETED|Overall Study||96
263486|NCT02480712|633066|P1|STARTED|Overall Study||107
263487|NCT02480582|633083|P6|NOT COMPLETED|Overall Study||0
263488|NCT02480582|633084|P5|NOT COMPLETED|Overall Study||0
263489|NCT02480582|633085|P4|NOT COMPLETED|Overall Study||0
263490|NCT02480582|633086|P3|NOT COMPLETED|Overall Study||0
263491|NCT02480582|633087|P2|NOT COMPLETED|Overall Study||0
263492|NCT02480582|633088|P1|NOT COMPLETED|Overall Study||0
263493|NCT02480582|633083|P6|COMPLETED|Overall Study||7
263494|NCT02480582|633084|P5|COMPLETED|Overall Study||7
263495|NCT02480582|633085|P4|COMPLETED|Overall Study||7
263496|NCT02480582|633086|P3|COMPLETED|Overall Study||7
263497|NCT02480582|633087|P2|COMPLETED|Overall Study||7
263498|NCT02480582|633088|P1|COMPLETED|Overall Study||7
263499|NCT02480582|633083|P6|STARTED|Overall Study||7
263500|NCT02480582|633084|P5|STARTED|Overall Study||7
263501|NCT02480582|633085|P4|STARTED|Overall Study||7
263502|NCT02480582|633086|P3|STARTED|Overall Study||7
263503|NCT02480582|633087|P2|STARTED|Overall Study||7
263504|NCT02480582|633088|P1|STARTED|Overall Study||7
263505|NCT02480439|633111|P3|NOT COMPLETED|Treatment Period 3||0
263506|NCT02480439|633112|P2|NOT COMPLETED|Treatment Period 3||0
263507|NCT02480439|633113|P1|NOT COMPLETED|Treatment Period 3||0
263508|NCT02480439|633111|P3|COMPLETED|Treatment Period 3||7
263509|NCT02480439|633112|P2|COMPLETED|Treatment Period 3||7
263510|NCT02480439|633113|P1|COMPLETED|Treatment Period 3||8
263511|NCT02480439|633111|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
263512|NCT02480439|633112|P2|STARTED|Treatment Period 3||7
263513|NCT02480439|633113|P1|STARTED|Treatment Period 3||8
263514|NCT02480439|633111|P3|NOT COMPLETED|Treatment Period 2||0
263515|NCT02480439|633112|P2|NOT COMPLETED|Treatment Period 2||0
263516|NCT02480439|633113|P1|NOT COMPLETED|Treatment Period 2||0
263517|NCT02480439|633111|P3|COMPLETED|Treatment Period 2||8
263518|NCT02480439|633112|P2|COMPLETED|Treatment Period 2||7
263519|NCT02480439|633113|P1|COMPLETED|Treatment Period 2||8
263520|NCT02480439|633111|P3|STARTED|Treatment Period 2||8
263521|NCT02480439|633112|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
263522|NCT02480439|633113|P1|STARTED|Treatment Period 2||8
263523|NCT02480439|633111|P3|NOT COMPLETED|Treatment Period 1||0
263524|NCT02480439|633112|P2|NOT COMPLETED|Treatment Period 1||0
263525|NCT02480439|633113|P1|NOT COMPLETED|Treatment Period 1||0
263526|NCT02480439|633111|P3|COMPLETED|Treatment Period 1||8
263527|NCT02480439|633112|P2|COMPLETED|Treatment Period 1||8
263528|NCT02480439|633113|P1|COMPLETED|Treatment Period 1||8
263529|NCT02480439|633111|P3|STARTED|Treatment Period 1||8
263530|NCT02480439|633112|P2|STARTED|Treatment Period 1||8
263531|NCT02480439|633113|P1|STARTED|Treatment Period 1||8
263532|NCT02480010|633138|P2|NOT COMPLETED|Overall Study||33
263533|NCT02480010|633139|P1|NOT COMPLETED|Overall Study||35
263534|NCT02480010|633138|P2|COMPLETED|Overall Study||0
263535|NCT02480010|633139|P1|COMPLETED|Overall Study||0
263536|NCT02480010|633138|P2|STARTED|Overall Study||33
263537|NCT02480010|633139|P1|STARTED|Overall Study||35
263538|NCT02479763|633185|P2|NOT COMPLETED|Overall Study||3
263539|NCT02479763|633186|P1|NOT COMPLETED|Overall Study||3
263540|NCT02479763|633185|P2|COMPLETED|Overall Study||50
263541|NCT02479763|633186|P1|COMPLETED|Overall Study||50
263542|NCT02479763|633185|P2|STARTED|Overall Study||53
263543|NCT02479763|633186|P1|STARTED|Overall Study||53
263544|NCT02478671|633192|P1|NOT COMPLETED|Overall Study||0
263545|NCT02478671|633192|P1|COMPLETED|Overall Study||4
263546|NCT02478671|633192|P1|STARTED|Overall Study||4
263547|NCT02478580|633199|P2|NOT COMPLETED|Overall Study||0
263548|NCT02478580|633200|P1|NOT COMPLETED|Overall Study||0
263549|NCT02478580|633199|P2|COMPLETED|Overall Study||33
263550|NCT02478580|633200|P1|COMPLETED|Overall Study||34
263551|NCT02478580|633199|P2|STARTED|Overall Study||33
263552|NCT02478580|633200|P1|STARTED|Overall Study||34
263553|NCT02478372|633208|P2|NOT COMPLETED|Overall Study||14
263554|NCT02478372|633209|P1|NOT COMPLETED|Overall Study||13
263555|NCT02478372|633208|P2|COMPLETED|Overall Study||107
263556|NCT02478372|633209|P1|COMPLETED|Overall Study||108
263557|NCT02478372|633208|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
263558|NCT02478372|633209|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
263559|NCT02478372|633208|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
263560|NCT02478372|633209|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
263561|NCT02478372|633208|P2|Recieved Allocation Intervention|Overall Study||113
263562|NCT02478372|633209|P1|Recieved Allocation Intervention|Overall Study||109
263563|NCT02478372|633208|P2|STARTED|Overall Study||121
263564|NCT02478372|633209|P1|STARTED|Overall Study||121
263565|NCT02477709|633231|P1|NOT COMPLETED|Overall Study||0
263566|NCT02477709|633231|P1|COMPLETED|Overall Study||6
263567|NCT02477709|633231|P1|STARTED|Overall Study||6
263568|NCT02476422|633237|P2|NOT COMPLETED|Overall Study||1
263569|NCT02476422|633238|P1|NOT COMPLETED|Overall Study||0
263570|NCT02476422|633237|P2|COMPLETED|Overall Study||161
263571|NCT02476422|633238|P1|COMPLETED|Overall Study||166
263572|NCT02476422|633237|P2|STARTED|Overall Study||162
263573|NCT02476422|633238|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
263574|NCT02475980|633268|P1|NOT COMPLETED|Overall Study||5
263575|NCT02475980|633268|P1|COMPLETED|Overall Study||8
263576|NCT02475980|633268|P1|STARTED|Overall Study||13
263577|NCT02475564|633279|P2|NOT COMPLETED|Overall Study||1
263578|NCT02475564|633280|P1|NOT COMPLETED|Overall Study||4
263579|NCT02475564|633279|P2|COMPLETED|Overall Study||21
263580|NCT02475564|633280|P1|COMPLETED|Overall Study||18
263581|NCT02475564|633279|P2|STARTED|Overall Study||22
263582|NCT02475564|633280|P1|STARTED|Overall Study||22
263583|NCT02475278|633290|P1|NOT COMPLETED|Overall Study||2
263584|NCT02475278|633290|P1|COMPLETED|Overall Study||48
263585|NCT02475278|633290|P1|STARTED|Overall Study||50
263586|NCT02475031|633303|P2|NOT COMPLETED|Overall Study||0
263587|NCT02475031|633304|P1|NOT COMPLETED|Overall Study||0
263588|NCT02475031|633303|P2|COMPLETED|Overall Study||35
263589|NCT02475031|633304|P1|COMPLETED|Overall Study||35
263590|NCT02475031|633303|P2|STARTED|Overall Study||35
263591|NCT02475031|633304|P1|STARTED|Overall Study||35
263592|NCT02474498|633321|P3|NOT COMPLETED|Overall Study||0
263593|NCT02474498|633322|P2|NOT COMPLETED|Overall Study||0
263594|NCT02474498|633323|P1|NOT COMPLETED|Overall Study||0
263595|NCT02474498|633321|P3|COMPLETED|Overall Study||14
263596|NCT02474498|633322|P2|COMPLETED|Overall Study||14
263597|NCT02474498|633323|P1|COMPLETED|Overall Study||13
263598|NCT02474498|633321|P3|STARTED|Overall Study||14
263599|NCT02474498|633322|P2|STARTED|Overall Study||14
263600|NCT02474498|633323|P1|STARTED|Overall Study||13
263601|NCT02473523|633340|P1|NOT COMPLETED|Overall Study||2
263602|NCT02473523|633340|P1|COMPLETED|Overall Study||0
263603|NCT02473523|633340|P1|STARTED|Overall Study||2
263604|NCT02473510|633361|P2|NOT COMPLETED|Overall Study||2
263605|NCT02473510|633362|P1|NOT COMPLETED|Overall Study||1
263606|NCT02473510|633361|P2|COMPLETED|Overall Study||238
263607|NCT02473510|633362|P1|COMPLETED|Overall Study||59
263608|NCT02473510|633361|P2|STARTED|Overall Study||240
263609|NCT02473510|633362|P1|STARTED|Overall Study||60
263610|NCT02473367|633376|P1|NOT COMPLETED|Period 4||1
263611|NCT02473367|633376|P1|COMPLETED|Period 4||18
263612|NCT02473367|633376|P1|STARTED|Period 4||19
263613|NCT02473367|633376|P1|NOT COMPLETED|Wait 3||0
263614|NCT02473367|633376|P1|COMPLETED|Wait 3||19
263615|NCT02473367|633376|P1|STARTED|Wait 3||19
263616|NCT02473367|633376|P1|NOT COMPLETED|Period 3||0
263617|NCT02473367|633376|P1|COMPLETED|Period 3||19
263618|NCT02473367|633376|P1|STARTED|Period 3||19
263619|NCT02473367|633376|P1|NOT COMPLETED|Wait 2||0
263620|NCT02473367|633376|P1|COMPLETED|Wait 2||19
263621|NCT02473367|633376|P1|STARTED|Wait 2||19
263622|NCT02473367|633376|P1|NOT COMPLETED|Period 2||0
263623|NCT02473367|633376|P1|COMPLETED|Period 2||19
263624|NCT02473367|633376|P1|STARTED|Period 2||19
263625|NCT02473367|633376|P1|NOT COMPLETED|Wait 1||1
263626|NCT02473367|633376|P1|COMPLETED|Wait 1||19
263627|NCT02473367|633376|P1|STARTED|Wait 1||20
263628|NCT02473367|633376|P1|NOT COMPLETED|Period 1||0
263629|NCT02473367|633376|P1|COMPLETED|Period 1||20
263630|NCT02473367|633376|P1|STARTED|Period 1||20
263631|NCT02472886|633397|P3|NOT COMPLETED|Overall Study||1
263632|NCT02472886|633398|P2|NOT COMPLETED|Overall Study||2
263633|NCT02472886|633399|P1|NOT COMPLETED|Overall Study||0
263634|NCT02472886|633397|P3|COMPLETED|Overall Study||26
263635|NCT02472886|633398|P2|COMPLETED|Overall Study||57
263636|NCT02472886|633399|P1|COMPLETED|Overall Study||67
263637|NCT02472886|633397|P3|STARTED|Overall Study||27
263638|NCT02472886|633398|P2|STARTED|Overall Study||59
263639|NCT02472886|633399|P1|STARTED|Overall Study||67
263640|NCT02472847|633427|P2|NOT COMPLETED|Overall Study||5
263641|NCT02472847|633428|P1|NOT COMPLETED|Overall Study||1
263642|NCT02472847|633427|P2|COMPLETED|Overall Study||21
263643|NCT02472847|633428|P1|COMPLETED|Overall Study||23
263644|NCT02472847|633427|P2|STARTED|Overall Study||26
263645|NCT02472847|633428|P1|STARTED|Overall Study||24
263646|NCT02472756|633434|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
263647|NCT02472756|633434|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
263648|NCT02472756|633434|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
263649|NCT02472756|633434|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
263650|NCT02472756|633434|P1|COMPLETED|Induction (Approximately 6 Months)||39
263651|NCT02472756|633434|P1|Treated|Induction (Approximately 6 Months)||40
263652|NCT02472756|633434|P1|STARTED|Induction (Approximately 6 Months)||41
263653|NCT02472522|633442|P2|NOT COMPLETED|Overall Study||0
263654|NCT02472522|633443|P1|NOT COMPLETED|Overall Study||0
263655|NCT02472522|633442|P2|COMPLETED|Overall Study||50
263656|NCT02472522|633443|P1|COMPLETED|Overall Study||50
263657|NCT02472522|633442|P2|STARTED|Overall Study||50
263658|NCT02472522|633443|P1|STARTED|Overall Study||50
263659|NCT02472366|633475|P2|NOT COMPLETED|Overall Study||0
263660|NCT02472366|633476|P1|NOT COMPLETED|Overall Study||1
263661|NCT02472366|633475|P2|COMPLETED|Overall Study||10
263662|NCT02472366|633476|P1|COMPLETED|Overall Study||5
263663|NCT02472366|633475|P2|STARTED|Overall Study||10
263664|NCT02472366|633476|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
263665|NCT02471755|633492|P2|NOT COMPLETED|Overall Study||1
263666|NCT02471755|633493|P1|NOT COMPLETED|Overall Study||1
263667|NCT02471755|633492|P2|COMPLETED|Overall Study||44
263668|NCT02471755|633493|P1|COMPLETED|Overall Study||44
263669|NCT02471755|633492|P2|STARTED|Overall Study||45
263670|NCT02471755|633493|P1|STARTED|Overall Study||45
263671|NCT02471612|633509|P1|NOT COMPLETED|Overall Study||2
263672|NCT02471612|633509|P1|COMPLETED|Overall Study||157
263673|NCT02471612|633509|P1|STARTED|Overall Study||159
263674|NCT02470949|633526|P2|NOT COMPLETED|Second Intervention||0
263675|NCT02470949|633527|P1|NOT COMPLETED|Second Intervention||0
263676|NCT02470949|633526|P2|COMPLETED|Second Intervention||2
263677|NCT02470949|633527|P1|COMPLETED|Second Intervention||4
263678|NCT02470949|633526|P2|STARTED|Second Intervention||2
263679|NCT02470949|633527|P1|STARTED|Second Intervention||4
263680|NCT02470949|633526|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
263681|NCT02470949|633527|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
263682|NCT02470949|633526|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
263683|NCT02470949|633527|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
263684|NCT02470949|633526|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
263685|NCT02470949|633527|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
263686|NCT02470949|633526|P2|NOT COMPLETED|First Intervention||0
263687|NCT02470949|633527|P1|NOT COMPLETED|First Intervention||0
263688|NCT02470949|633526|P2|COMPLETED|First Intervention||5
263689|NCT02470949|633527|P1|COMPLETED|First Intervention||4
263690|NCT02470949|633526|P2|STARTED|First Intervention||5
263691|NCT02470949|633527|P1|STARTED|First Intervention||4
263692|NCT02470429|633539|P2|NOT COMPLETED|Overall Study||0
263693|NCT02470429|633540|P1|NOT COMPLETED|Overall Study||2
263694|NCT02470429|633539|P2|COMPLETED|Overall Study||49
263695|NCT02470429|633540|P1|COMPLETED|Overall Study||48
263696|NCT02470429|633539|P2|STARTED|Overall Study||49
263697|NCT02470429|633540|P1|STARTED|Overall Study||50
263698|NCT02470403|633556|P5|NOT COMPLETED|Overall Study||0
263699|NCT02470403|633557|P4|NOT COMPLETED|Overall Study||4
263700|NCT02470403|633558|P3|NOT COMPLETED|Overall Study||0
263701|NCT02470403|633559|P2|NOT COMPLETED|Overall Study||1
263702|NCT02470403|633560|P1|NOT COMPLETED|Overall Study||2
263703|NCT02470403|633556|P5|COMPLETED|Overall Study||10
263704|NCT02470403|633557|P4|COMPLETED|Overall Study||39
263705|NCT02470403|633558|P3|COMPLETED|Overall Study||40
263706|NCT02470403|633559|P2|COMPLETED|Overall Study||43
263707|NCT02470403|633560|P1|COMPLETED|Overall Study||42
263708|NCT02470403|633556|P5|Normoglycemic|Overall Study||5
263709|NCT02470403|633557|P4|Normoglycemic|Overall Study||23
263710|NCT02470403|633558|P3|Normoglycemic|Overall Study||20
263711|NCT02470403|633559|P2|Normoglycemic|Overall Study||20
263712|NCT02470403|633560|P1|Normoglycemic|Overall Study||20
263713|NCT02470403|633556|P5|Dysglycemic|Overall Study||5
263714|NCT02470403|633557|P4|Dysglycemic|Overall Study||20
263715|NCT02470403|633558|P3|Dysglycemic|Overall Study||20
263716|NCT02470403|633559|P2|Dysglycemic|Overall Study||24
263717|NCT02470403|633560|P1|Dysglycemic|Overall Study||24
263718|NCT02470403|633556|P5|STARTED|Overall Study||10
263719|NCT02470403|633557|P4|STARTED|Overall Study||43
263720|NCT02470403|633558|P3|STARTED|Overall Study||40
263721|NCT02470403|633559|P2|STARTED|Overall Study||44
263722|NCT02470403|633560|P1|STARTED|Overall Study||44
263723|NCT02469961|633600|P2|NOT COMPLETED|Overall Study||1
263724|NCT02469961|633601|P1|NOT COMPLETED|Overall Study||4
263725|NCT02469961|633600|P2|COMPLETED|Overall Study||24
263726|NCT02469961|633601|P1|COMPLETED|Overall Study||21
263727|NCT02469961|633600|P2|STARTED|Overall Study||25
263728|NCT02469961|633601|P1|STARTED|Overall Study||25
263729|NCT02469597|633615|P2|NOT COMPLETED|Overall Study||0
263730|NCT02469597|633616|P1|NOT COMPLETED|Overall Study||0
263731|NCT02469597|633615|P2|COMPLETED|Overall Study||24
263732|NCT02469597|633616|P1|COMPLETED|Overall Study||22
263733|NCT02469597|633615|P2|STARTED|Overall Study||24
263734|NCT02469597|633616|P1|STARTED|Overall Study||22
263735|NCT02469116|633632|P1|NOT COMPLETED|Overall Study||0
263736|NCT02469116|633632|P1|COMPLETED|Overall Study||18
263737|NCT02469116|633632|P1|STARTED|Overall Study||18
263738|NCT02468154|633644|P2|NOT COMPLETED|Overall Study||0
263739|NCT02468154|633645|P1|NOT COMPLETED|Overall Study||0
263740|NCT02468154|633644|P2|COMPLETED|Overall Study||28
263741|NCT02468154|633645|P1|COMPLETED|Overall Study||29
263742|NCT02468154|633644|P2|STARTED|Overall Study||28
263743|NCT02468154|633645|P1|STARTED|Overall Study||29
263744|NCT02467777|633659|P2|NOT COMPLETED|Overall Study||0
263745|NCT02467777|633660|P1|NOT COMPLETED|Overall Study||0
263746|NCT02467777|633659|P2|COMPLETED|Overall Study||27
263747|NCT02467777|633660|P1|COMPLETED|Overall Study||23
263748|NCT02467777|633659|P2|STARTED|Overall Study||27
263749|NCT02467777|633660|P1|STARTED|Overall Study||23
263750|NCT02467491|633666|P1|NOT COMPLETED|Overall Study||0
263751|NCT02467491|633666|P1|COMPLETED|Overall Study||12
263752|NCT02467491|633666|P1|STARTED|Overall Study||12
263753|NCT02466425|633677|P2|NOT COMPLETED|Overall Study||16
263754|NCT02466425|633678|P1|NOT COMPLETED|Overall Study||14
263755|NCT02466425|633677|P2|COMPLETED|Overall Study||116
263756|NCT02466425|633678|P1|COMPLETED|Overall Study||118
263757|NCT02466425|633677|P2|Treated|Overall Study||132
263758|NCT02466425|633678|P1|Treated|Overall Study||131
263759|NCT02466425|633677|P2|STARTED|Overall Study||132
263760|NCT02466425|633678|P1|STARTED|Overall Study||132
263761|NCT02466412|633688|P2|NOT COMPLETED|Second Intervention (Day 3)||0
263762|NCT02466412|633689|P1|NOT COMPLETED|Second Intervention (Day 3)||0
263763|NCT02466412|633688|P2|COMPLETED|Second Intervention (Day 3)||24
263764|NCT02466412|633689|P1|COMPLETED|Second Intervention (Day 3)||24
263765|NCT02466412|633688|P2|STARTED|Second Intervention (Day 3)||24
263766|NCT02466412|633689|P1|STARTED|Second Intervention (Day 3)||24
263767|NCT02466412|633688|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
263768|NCT02466412|633689|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
263769|NCT02466412|633688|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
263770|NCT02466412|633689|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
263771|NCT02466412|633688|P2|STARTED|Washout Period of 1 Day (Day 2)||24
263772|NCT02466412|633689|P1|STARTED|Washout Period of 1 Day (Day 2)||24
263773|NCT02466412|633688|P2|NOT COMPLETED|First Intervention (Day 1)||0
263774|NCT02466412|633689|P1|NOT COMPLETED|First Intervention (Day 1)||0
263775|NCT02466412|633688|P2|COMPLETED|First Intervention (Day 1)||24
263776|NCT02466412|633689|P1|COMPLETED|First Intervention (Day 1)||24
263777|NCT02466412|633688|P2|STARTED|First Intervention (Day 1)||24
263778|NCT02466412|633689|P1|STARTED|First Intervention (Day 1)||24
263779|NCT02466412|633688|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
263780|NCT02466412|633689|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
263781|NCT02466412|633688|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
263782|NCT02466412|633689|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
263783|NCT02466412|633688|P2|STARTED|Washout Period of 1 Day (Day -1)||24
263784|NCT02466412|633689|P1|STARTED|Washout Period of 1 Day (Day -1)||24
263785|NCT02465866|633698|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
263786|NCT02465866|633699|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
263787|NCT02465866|633700|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
263788|NCT02465866|633701|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
263789|NCT02465866|633698|P4|COMPLETED|Period 4: Washout (14 Days)||5
263790|NCT02465866|633699|P3|COMPLETED|Period 4: Washout (14 Days)||5
263791|NCT02465866|633700|P2|COMPLETED|Period 4: Washout (14 Days)||4
263792|NCT02465866|633701|P1|COMPLETED|Period 4: Washout (14 Days)||5
263793|NCT02465866|633698|P4|STARTED|Period 4: Washout (14 Days)||5
263794|NCT02465866|633699|P3|STARTED|Period 4: Washout (14 Days)||5
263795|NCT02465866|633700|P2|STARTED|Period 4: Washout (14 Days)||4
263796|NCT02465866|633701|P1|STARTED|Period 4: Washout (14 Days)||5
263797|NCT02465866|633698|P4|NOT COMPLETED|Period 4||0
263798|NCT02465866|633699|P3|NOT COMPLETED|Period 4||0
263799|NCT02465866|633700|P2|NOT COMPLETED|Period 4||0
263800|NCT02465866|633701|P1|NOT COMPLETED|Period 4||0
263801|NCT02465866|633698|P4|COMPLETED|Period 4||5
263802|NCT02465866|633699|P3|COMPLETED|Period 4||5
263803|NCT02465866|633700|P2|COMPLETED|Period 4||4
263804|NCT02465866|633701|P1|COMPLETED|Period 4||5
263805|NCT02465866|633698|P4|STARTED|Period 4||5
263806|NCT02465866|633699|P3|STARTED|Period 4||5
263807|NCT02465866|633700|P2|STARTED|Period 4||4
263808|NCT02465866|633701|P1|STARTED|Period 4||5
263809|NCT02465866|633698|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
263810|NCT02465866|633699|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
263811|NCT02465866|633700|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
263812|NCT02465866|633701|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
263813|NCT02465866|633698|P4|COMPLETED|Period 3: Washout (14 Days)||5
263814|NCT02465866|633699|P3|COMPLETED|Period 3: Washout (14 Days)||5
263815|NCT02465866|633700|P2|COMPLETED|Period 3: Washout (14 Days)||4
263816|NCT02465866|633701|P1|COMPLETED|Period 3: Washout (14 Days)||5
263817|NCT02465866|633698|P4|STARTED|Period 3: Washout (14 Days)||5
263818|NCT02465866|633699|P3|STARTED|Period 3: Washout (14 Days)||5
263819|NCT02465866|633700|P2|STARTED|Period 3: Washout (14 Days)||4
263820|NCT02465866|633701|P1|STARTED|Period 3: Washout (14 Days)||5
263821|NCT02465866|633698|P4|NOT COMPLETED|Period 3||0
263822|NCT02465866|633699|P3|NOT COMPLETED|Period 3||0
263823|NCT02465866|633700|P2|NOT COMPLETED|Period 3||1
263824|NCT02465866|633701|P1|NOT COMPLETED|Period 3||0
263825|NCT02465866|633698|P4|COMPLETED|Period 3||5
263826|NCT02465866|633699|P3|COMPLETED|Period 3||5
263827|NCT02465866|633700|P2|COMPLETED|Period 3||4
263828|NCT02465866|633701|P1|COMPLETED|Period 3||5
263829|NCT02465866|633698|P4|STARTED|Period 3||5
263830|NCT02465866|633699|P3|STARTED|Period 3||5
263831|NCT02465866|633700|P2|STARTED|Period 3||5
263832|NCT02465866|633701|P1|STARTED|Period 3||5
263833|NCT02465866|633698|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
263834|NCT02465866|633699|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
263835|NCT02465866|633700|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
263836|NCT02465866|633701|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
263837|NCT02465866|633698|P4|COMPLETED|Period 2: Washout (14 Days)||5
263838|NCT02465866|633699|P3|COMPLETED|Period 2: Washout (14 Days)||5
263839|NCT02465866|633700|P2|COMPLETED|Period 2: Washout (14 Days)||5
263840|NCT02465866|633701|P1|COMPLETED|Period 2: Washout (14 Days)||5
263841|NCT02465866|633698|P4|STARTED|Period 2: Washout (14 Days)||5
263842|NCT02465866|633699|P3|STARTED|Period 2: Washout (14 Days)||5
263843|NCT02465866|633700|P2|STARTED|Period 2: Washout (14 Days)||5
263844|NCT02465866|633701|P1|STARTED|Period 2: Washout (14 Days)||5
263845|NCT02465866|633698|P4|NOT COMPLETED|Period 2||0
263846|NCT02465866|633699|P3|NOT COMPLETED|Period 2||0
263847|NCT02465866|633700|P2|NOT COMPLETED|Period 2||0
263848|NCT02465866|633701|P1|NOT COMPLETED|Period 2||0
263849|NCT02465866|633698|P4|COMPLETED|Period 2||5
263850|NCT02465866|633699|P3|COMPLETED|Period 2||5
263851|NCT02465866|633700|P2|COMPLETED|Period 2||5
263852|NCT02465866|633701|P1|COMPLETED|Period 2||5
263853|NCT02465866|633698|P4|STARTED|Period 2||5
263854|NCT02465866|633699|P3|STARTED|Period 2||5
263855|NCT02465866|633700|P2|STARTED|Period 2||5
263856|NCT02465866|633701|P1|STARTED|Period 2||5
263857|NCT02465866|633698|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
263858|NCT02465866|633699|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
263859|NCT02465866|633700|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
263860|NCT02465866|633701|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
263861|NCT02465866|633698|P4|COMPLETED|Period 1: Washout (14 Days)||5
263862|NCT02465866|633699|P3|COMPLETED|Period 1: Washout (14 Days)||5
263863|NCT02465866|633700|P2|COMPLETED|Period 1: Washout (14 Days)||5
263864|NCT02465866|633701|P1|COMPLETED|Period 1: Washout (14 Days)||5
263865|NCT02465866|633698|P4|STARTED|Period 1: Washout (14 Days)||5
263866|NCT02465866|633699|P3|STARTED|Period 1: Washout (14 Days)||5
263867|NCT02465866|633700|P2|STARTED|Period 1: Washout (14 Days)||5
263868|NCT02465866|633701|P1|STARTED|Period 1: Washout (14 Days)||5
263869|NCT02465866|633698|P4|NOT COMPLETED|Period 1||0
263870|NCT02465866|633699|P3|NOT COMPLETED|Period 1||0
263871|NCT02465866|633700|P2|NOT COMPLETED|Period 1||0
263872|NCT02465866|633701|P1|NOT COMPLETED|Period 1||0
263873|NCT02465866|633698|P4|COMPLETED|Period 1||5
263874|NCT02465866|633699|P3|COMPLETED|Period 1||5
263875|NCT02465866|633700|P2|COMPLETED|Period 1||5
263876|NCT02465866|633701|P1|COMPLETED|Period 1||5
263877|NCT02465866|633698|P4|STARTED|Period 1||5
263878|NCT02465866|633699|P3|STARTED|Period 1||5
263879|NCT02465866|633700|P2|STARTED|Period 1||5
263880|NCT02465866|633701|P1|STARTED|Period 1||5
263881|NCT02465489|633771|P1|NOT COMPLETED|Overall Study||5
263882|NCT02465489|633771|P1|COMPLETED|Overall Study||15
263883|NCT02465489|633771|P1|STARTED|Overall Study||20
263884|NCT02465073|633801|P3|NOT COMPLETED|Overall Study||1
263885|NCT02465073|633802|P2|NOT COMPLETED|Overall Study||1
263886|NCT02465073|633803|P1|NOT COMPLETED|Overall Study||2
263887|NCT02465073|633801|P3|COMPLETED|Overall Study||15
263888|NCT02465073|633802|P2|COMPLETED|Overall Study||15
263889|NCT02465073|633803|P1|COMPLETED|Overall Study||15
263890|NCT02465073|633801|P3|STARTED|Overall Study||16
263891|NCT02465073|633802|P2|STARTED|Overall Study||16
263892|NCT02465073|633803|P1|STARTED|Overall Study||17
263893|NCT02463409|633811|P1|NOT COMPLETED|Overall Study||2
263894|NCT02463409|633811|P1|COMPLETED|Overall Study||4
263895|NCT02463409|633811|P1|STARTED|Overall Study||6
263896|NCT02463331|633818|P2|NOT COMPLETED|Overall Study||6
263897|NCT02463331|633819|P1|NOT COMPLETED|Overall Study||16
263898|NCT02463331|633818|P2|COMPLETED|Overall Study||25
263899|NCT02463331|633819|P1|COMPLETED|Overall Study||10
263900|NCT02463331|633818|P2|STARTED|Overall Study||31
263901|NCT02463331|633819|P1|STARTED|Overall Study||26
263902|NCT02463227|633827|P1|NOT COMPLETED|Overall Study||0
263903|NCT02463227|633827|P1|COMPLETED|Overall Study||14
263904|NCT02463227|633827|P1|STARTED|Overall Study||14
263905|NCT02463097|633835|P1|NOT COMPLETED|Overall Study||1
263906|NCT02463097|633835|P1|COMPLETED|Overall Study||123
263907|NCT02463097|633835|P1|STARTED|Overall Study||124
263908|NCT02462473|633841|P1|NOT COMPLETED|Overall Study||4
263909|NCT02462473|633841|P1|COMPLETED|Overall Study||5
263910|NCT02462473|633841|P1|STARTED|Overall Study||9
263911|NCT02462291|633854|P2|NOT COMPLETED|Overall Study||6
263912|NCT02462291|633855|P1|NOT COMPLETED|Overall Study||5
263913|NCT02462291|633854|P2|COMPLETED|Overall Study||75
263914|NCT02462291|633855|P1|COMPLETED|Overall Study||77
263915|NCT02462291|633854|P2|STARTED|Overall Study||81
263916|NCT02462291|633855|P1|STARTED|Overall Study||82
263917|NCT02461992|633893|P1|NOT COMPLETED|Overall Study||0
263918|NCT02461992|633893|P1|COMPLETED|Overall Study||13
263919|NCT02461992|633893|P1|STARTED|Overall Study||13
263920|NCT02461290|633910|P1|NOT COMPLETED|Overall Study||10
263921|NCT02461290|633910|P1|COMPLETED|Overall Study||89
263922|NCT02461290|633910|P1|STARTED|Overall Study||99
263923|NCT02460822|633917|P1|NOT COMPLETED|Overall Study||1
263924|NCT02460822|633917|P1|COMPLETED|Overall Study||15
263925|NCT02460822|633917|P1|STARTED|Overall Study||16
263926|NCT02460458|633926|P1|NOT COMPLETED|Prospective Phase||0
263927|NCT02460458|633926|P1|COMPLETED|Prospective Phase|Information not yet available.|0
263928|NCT02460458|633926|P1|STARTED|Prospective Phase|Information not yet available.|0
263929|NCT02460458|633926|P1|NOT COMPLETED|Confirmatory Phase||266
263930|NCT02460458|633926|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
263931|NCT02460458|633926|P1|STARTED|Confirmatory Phase||266
263932|NCT02460458|633926|P1|NOT COMPLETED|Retrospective Phase||0
263933|NCT02460458|633926|P1|COMPLETED|Retrospective Phase||266
263934|NCT02460458|633926|P1|STARTED|Retrospective Phase||266
263935|NCT02458768|633934|P2|NOT COMPLETED|Overall Study||5
263936|NCT02458768|633935|P1|NOT COMPLETED|Overall Study||7
263937|NCT02458768|633934|P2|COMPLETED|Overall Study||50
263938|NCT02458768|633935|P1|COMPLETED|Overall Study||50
263939|NCT02458768|633934|P2|STARTED|Overall Study||55
263940|NCT02458768|633935|P1|STARTED|Overall Study||57
263941|NCT02458365|633943|P2|NOT COMPLETED|Overall Study||294
263942|NCT02458365|633944|P1|NOT COMPLETED|Overall Study||277
263943|NCT02458365|633943|P2|COMPLETED|Overall Study||1607
263944|NCT02458365|633944|P1|COMPLETED|Overall Study||1723
263945|NCT02458365|633943|P2|STARTED|Overall Study||1901
263946|NCT02458365|633944|P1|STARTED|Overall Study||2000
263947|NCT02457728|633964|P1|NOT COMPLETED|Overall Study||0
263948|NCT02457728|633964|P1|COMPLETED|Overall Study||34
263949|NCT02457728|633964|P1|STARTED|Overall Study||34
263950|NCT02457611|633968|P1|NOT COMPLETED|Overall Study||3
263951|NCT02457611|633968|P1|COMPLETED|Overall Study||23
263952|NCT02457611|633968|P1|STARTED|Overall Study||26
263953|NCT02457247|633984|P4|NOT COMPLETED|Period 2||0
263954|NCT02457247|633985|P3|NOT COMPLETED|Period 2||0
263955|NCT02457247|633986|P2|NOT COMPLETED|Period 2||3
263956|NCT02457247|633987|P1|NOT COMPLETED|Period 2||2
263957|NCT02457247|633984|P4|COMPLETED|Period 2||70
263958|NCT02457247|633985|P3|COMPLETED|Period 2||68
263959|NCT02457247|633986|P2|COMPLETED|Period 2||65
263960|NCT02457247|633987|P1|COMPLETED|Period 2||64
263961|NCT02457247|633984|P4|STARTED|Period 2||70
263962|NCT02457247|633985|P3|STARTED|Period 2||68
263963|NCT02457247|633986|P2|STARTED|Period 2||68
263964|NCT02457247|633987|P1|STARTED|Period 2||66
263965|NCT02457247|633984|P4|NOT COMPLETED|Period 1||0
263966|NCT02457247|633985|P3|NOT COMPLETED|Period 1||0
263967|NCT02457247|633986|P2|NOT COMPLETED|Period 1||2
263968|NCT02457247|633987|P1|NOT COMPLETED|Period 1||2
263969|NCT02457247|633984|P4|COMPLETED|Period 1||70
263970|NCT02457247|633985|P3|COMPLETED|Period 1||68
263971|NCT02457247|633986|P2|COMPLETED|Period 1||68
263972|NCT02457247|633987|P1|COMPLETED|Period 1||66
263973|NCT02457247|633984|P4|STARTED|Period 1||70
263974|NCT02457247|633985|P3|STARTED|Period 1||68
263975|NCT02457247|633986|P2|STARTED|Period 1||70
263976|NCT02457247|633987|P1|STARTED|Period 1||68
263977|NCT02455050|634011|P4|NOT COMPLETED|Treatment Period 2||1
263978|NCT02455050|634012|P3|NOT COMPLETED|Treatment Period 2||2
263979|NCT02455050|634013|P2|NOT COMPLETED|Treatment Period 2||0
263980|NCT02455050|634014|P1|NOT COMPLETED|Treatment Period 2||1
263981|NCT02455050|634011|P4|COMPLETED|Treatment Period 2||17
263982|NCT02455050|634012|P3|COMPLETED|Treatment Period 2||17
263983|NCT02455050|634013|P2|COMPLETED|Treatment Period 2||18
263984|NCT02455050|634014|P1|COMPLETED|Treatment Period 2||18
263985|NCT02455050|634011|P4|STARTED|Treatment Period 2||18
263986|NCT02455050|634012|P3|STARTED|Treatment Period 2||19
263987|NCT02455050|634013|P2|STARTED|Treatment Period 2||18
263988|NCT02455050|634014|P1|STARTED|Treatment Period 2||19
263989|NCT02455050|634011|P4|NOT COMPLETED|Treatment Period 1||2
263990|NCT02455050|634012|P3|NOT COMPLETED|Treatment Period 1||1
263991|NCT02455050|634013|P2|NOT COMPLETED|Treatment Period 1||1
263992|NCT02455050|634014|P1|NOT COMPLETED|Treatment Period 1||1
263993|NCT02455050|634011|P4|COMPLETED|Treatment Period 1||18
263994|NCT02455050|634012|P3|COMPLETED|Treatment Period 1||19
263995|NCT02455050|634013|P2|COMPLETED|Treatment Period 1||18
263996|NCT02455050|634014|P1|COMPLETED|Treatment Period 1||19
263997|NCT02455050|634011|P4|STARTED|Treatment Period 1||20
263998|NCT02455050|634012|P3|STARTED|Treatment Period 1||20
263999|NCT02455050|634013|P2|STARTED|Treatment Period 1||19
264000|NCT02455050|634014|P1|STARTED|Treatment Period 1||20
264001|NCT02454959|634078|P1|NOT COMPLETED|Overall Study||9
264002|NCT02454959|634078|P1|COMPLETED|Overall Study||70
264003|NCT02454959|634078|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
264004|NCT02454959|634078|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
264005|NCT02454959|634078|P1|STARTED|Overall Study||79
264006|NCT02454608|634098|P2|NOT COMPLETED|Overall Study||2
264007|NCT02454608|634099|P1|NOT COMPLETED|Overall Study||0
264008|NCT02454608|634098|P2|COMPLETED|Overall Study||8
264009|NCT02454608|634099|P1|COMPLETED|Overall Study||10
264010|NCT02454608|634098|P2|STARTED|Overall Study||10
264011|NCT02454608|634099|P1|STARTED|Overall Study||10
264012|NCT02454296|634119|P2|NOT COMPLETED|Overall Study||0
264013|NCT02454296|634120|P1|NOT COMPLETED|Overall Study||0
264014|NCT02454296|634119|P2|COMPLETED|Overall Study||21
264015|NCT02454296|634120|P1|COMPLETED|Overall Study||20
264016|NCT02454296|634119|P2|STARTED|Overall Study||21
264017|NCT02454296|634120|P1|STARTED|Overall Study||20
264018|NCT02454283|634132|P2|NOT COMPLETED|Overall Study||0
264019|NCT02454283|634133|P1|NOT COMPLETED|Overall Study||0
264020|NCT02454283|634132|P2|COMPLETED|Overall Study||15
264021|NCT02454283|634133|P1|COMPLETED|Overall Study||26
264022|NCT02454283|634132|P2|STARTED|Overall Study||15
264023|NCT02454283|634133|P1|STARTED|Overall Study||26
264024|NCT02454127|634145|P4|NOT COMPLETED|Overall Study||20
264025|NCT02454127|634146|P3|NOT COMPLETED|Overall Study||14
264026|NCT02454127|634147|P2|NOT COMPLETED|Overall Study||14
264027|NCT02454127|634148|P1|NOT COMPLETED|Overall Study||19
264028|NCT02454127|634145|P4|COMPLETED|Overall Study||20
264029|NCT02454127|634146|P3|COMPLETED|Overall Study||26
264030|NCT02454127|634147|P2|COMPLETED|Overall Study||26
264031|NCT02454127|634148|P1|COMPLETED|Overall Study||21
264032|NCT02454127|634145|P4|STARTED|Overall Study||40
264033|NCT02454127|634146|P3|STARTED|Overall Study||40
264034|NCT02454127|634147|P2|STARTED|Overall Study||40
264035|NCT02454127|634148|P1|STARTED|Overall Study||40
264036|NCT02454101|634188|P2|NOT COMPLETED|Overall Study||7
264037|NCT02454101|634189|P1|NOT COMPLETED|Overall Study||5
264038|NCT02454101|634188|P2|COMPLETED|Overall Study||143
264039|NCT02454101|634189|P1|COMPLETED|Overall Study||145
264040|NCT02454101|634188|P2|STARTED|Overall Study||150
264041|NCT02454101|634189|P1|STARTED|Overall Study||150
264042|NCT02453581|634211|P3|NOT COMPLETED|Overall Study||0
264043|NCT02453581|634212|P2|NOT COMPLETED|Overall Study||0
264044|NCT02453581|634213|P1|NOT COMPLETED|Overall Study||0
264045|NCT02453581|634211|P3|COMPLETED|Overall Study||8
264046|NCT02453581|634212|P2|COMPLETED|Overall Study||8
264047|NCT02453581|634213|P1|COMPLETED|Overall Study||8
264048|NCT02453581|634211|P3|STARTED|Overall Study||8
264049|NCT02453581|634212|P2|STARTED|Overall Study||8
264050|NCT02453581|634213|P1|STARTED|Overall Study||8
264051|NCT02452944|634235|P2|NOT COMPLETED|Overall Study||0
264052|NCT02452944|634236|P1|NOT COMPLETED|Overall Study||0
264053|NCT02452944|634235|P2|COMPLETED|Overall Study||31
264054|NCT02452944|634236|P1|COMPLETED|Overall Study||31
264055|NCT02452944|634235|P2|STARTED|Overall Study||31
264056|NCT02452944|634236|P1|STARTED|Overall Study||31
264057|NCT02451150|634246|P2|NOT COMPLETED|Overall Study||0
264058|NCT02451150|634247|P1|NOT COMPLETED|Overall Study||0
264059|NCT02451150|634246|P2|COMPLETED|Overall Study||3
264060|NCT02451150|634247|P1|COMPLETED|Overall Study||3
264061|NCT02451150|634246|P2|STARTED|Overall Study||3
264062|NCT02451150|634247|P1|STARTED|Overall Study||3
264063|NCT02450799|634300|P3|NOT COMPLETED|Overall Study||0
264064|NCT02450799|634301|P2|NOT COMPLETED|Overall Study||0
264065|NCT02450799|634302|P1|NOT COMPLETED|Overall Study||0
264066|NCT02450799|634300|P3|COMPLETED|Overall Study||30
264067|NCT02450799|634301|P2|COMPLETED|Overall Study||37
264068|NCT02450799|634302|P1|COMPLETED|Overall Study||31
264069|NCT02450799|634300|P3|STARTED|Overall Study||30
264070|NCT02450799|634301|P2|STARTED|Overall Study||37
264071|NCT02450799|634302|P1|STARTED|Overall Study||31
264072|NCT02450747|634313|P1|NOT COMPLETED|Overall Study||0
264073|NCT02450747|634313|P1|COMPLETED|Overall Study||39
264074|NCT02450747|634313|P1|STARTED|Overall Study||39
264075|NCT02449902|634324|P2|NOT COMPLETED|Overall Study||2
264076|NCT02449902|634325|P1|NOT COMPLETED|Overall Study||0
264077|NCT02449902|634324|P2|COMPLETED|Overall Study||24
264078|NCT02449902|634325|P1|COMPLETED|Overall Study||24
264079|NCT02449902|634324|P2|STARTED|Overall Study||26
264080|NCT02449902|634325|P1|STARTED|Overall Study||24
264081|NCT02449798|634349|P1|NOT COMPLETED|Overall Study||0
264082|NCT02449798|634349|P1|COMPLETED|Overall Study||120
264083|NCT02449798|634349|P1|STARTED|Overall Study||120
264084|NCT02449356|634363|P2|NOT COMPLETED|Overall Study||0
264085|NCT02449356|634364|P1|NOT COMPLETED|Overall Study||0
264086|NCT02449356|634363|P2|COMPLETED|Overall Study||30
264087|NCT02449356|634364|P1|COMPLETED|Overall Study||30
264088|NCT02449356|634363|P2|STARTED|Overall Study||30
264089|NCT02449356|634364|P1|STARTED|Overall Study||30
264090|NCT02449044|634380|P1|NOT COMPLETED|Overall Study||64
264091|NCT02449044|634380|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
264092|NCT02449044|634380|P1|STARTED|Overall Study||111
264093|NCT02448914|634399|P2|NOT COMPLETED|Second Intervention (1 Day)||0
264094|NCT02448914|634400|P1|NOT COMPLETED|Second Intervention (1 Day)||0
264095|NCT02448914|634399|P2|COMPLETED|Second Intervention (1 Day)||5
264096|NCT02448914|634400|P1|COMPLETED|Second Intervention (1 Day)||6
264097|NCT02448914|634399|P2|STARTED|Second Intervention (1 Day)||5
264098|NCT02448914|634400|P1|STARTED|Second Intervention (1 Day)||6
264099|NCT02448914|634399|P2|NOT COMPLETED|First Intervention (1 Day)||0
264100|NCT02448914|634400|P1|NOT COMPLETED|First Intervention (1 Day)||0
264101|NCT02448914|634399|P2|COMPLETED|First Intervention (1 Day)||5
264102|NCT02448914|634400|P1|COMPLETED|First Intervention (1 Day)||6
264103|NCT02448914|634399|P2|STARTED|First Intervention (1 Day)||5
264104|NCT02448914|634400|P1|STARTED|First Intervention (1 Day)||6
264105|NCT02448862|634418|P2|NOT COMPLETED|Overall Study||0
264106|NCT02448862|634419|P1|NOT COMPLETED|Overall Study||0
264107|NCT02448862|634418|P2|COMPLETED|Overall Study||6050
264108|NCT02448862|634419|P1|COMPLETED|Overall Study||4525
264109|NCT02448862|634418|P2|STARTED|Overall Study||6050
264110|NCT02448862|634419|P1|STARTED|Overall Study||4525
264111|NCT02447458|634439|P6|NOT COMPLETED|Overall Study||0
264112|NCT02447458|634440|P5|NOT COMPLETED|Overall Study||0
264113|NCT02447458|634441|P4|NOT COMPLETED|Overall Study||0
264114|NCT02447458|634442|P3|NOT COMPLETED|Overall Study||1
264115|NCT02447458|634443|P2|NOT COMPLETED|Overall Study||0
264116|NCT02447458|634444|P1|NOT COMPLETED|Overall Study||0
264117|NCT02447458|634439|P6|COMPLETED|Overall Study||10
264118|NCT02447458|634440|P5|COMPLETED|Overall Study||6
264119|NCT02447458|634441|P4|COMPLETED|Overall Study||6
264120|NCT02447458|634442|P3|COMPLETED|Overall Study||5
264121|NCT02447458|634443|P2|COMPLETED|Overall Study||6
264122|NCT02447458|634444|P1|COMPLETED|Overall Study||5
264123|NCT02447458|634439|P6|STARTED|Overall Study||10
264124|NCT02447458|634440|P5|STARTED|Overall Study||6
264125|NCT02447458|634441|P4|STARTED|Overall Study||6
264126|NCT02447458|634442|P3|STARTED|Overall Study||6
264127|NCT02447458|634443|P2|STARTED|Overall Study||6
264128|NCT02447458|634444|P1|STARTED|Overall Study||5
264129|NCT02447432|634542|P2|NOT COMPLETED|Epoch 002||0
264130|NCT02447432|634543|P1|NOT COMPLETED|Epoch 002||0
264131|NCT02447432|634542|P2|COMPLETED|Epoch 002||145
264132|NCT02447432|634543|P1|COMPLETED|Epoch 002||152
264133|NCT02447432|634542|P2|STARTED|Epoch 002||145
264134|NCT02447432|634543|P1|STARTED|Epoch 002||152
264135|NCT02447432|634542|P2|NOT COMPLETED|Epoch 001||13
264136|NCT02447432|634543|P1|NOT COMPLETED|Epoch 001||5
264137|NCT02447432|634542|P2|COMPLETED|Epoch 001||147
264138|NCT02447432|634543|P1|COMPLETED|Epoch 001||155
264139|NCT02447432|634542|P2|STARTED|Epoch 001||160
264140|NCT02447432|634543|P1|STARTED|Epoch 001||160
264141|NCT02447133|634575|P1|NOT COMPLETED|Overall Study||0
264142|NCT02447133|634575|P1|COMPLETED|Overall Study||12
264143|NCT02447133|634575|P1|STARTED|Overall Study||12
264144|NCT02446990|634583|P2|NOT COMPLETED|Overall Study||658
264145|NCT02446990|634584|P1|NOT COMPLETED|Overall Study||720
264146|NCT02446990|634583|P2|COMPLETED|Overall Study||8894
264147|NCT02446990|634584|P1|COMPLETED|Overall Study||8830
264148|NCT02446990|634583|P2|STARTED|Overall Study||9552
264149|NCT02446990|634584|P1|STARTED|Overall Study||9550
264150|NCT02446613|634618|P2|NOT COMPLETED|Overall Study||0
264151|NCT02446613|634619|P1|NOT COMPLETED|Overall Study||0
264152|NCT02446613|634618|P2|COMPLETED|Overall Study||10
264153|NCT02446613|634619|P1|COMPLETED|Overall Study||6
264154|NCT02446613|634618|P2|STARTED|Overall Study||10
264155|NCT02446613|634619|P1|STARTED|Overall Study||6
264156|NCT02446496|634641|P1|NOT COMPLETED|Overall Study||0
264157|NCT02446496|634641|P1|COMPLETED|Overall Study||24
264158|NCT02446496|634641|P1|STARTED|Overall Study||24
264159|NCT02446483|634653|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
264160|NCT02446483|634654|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
264161|NCT02446483|634653|P2|COMPLETED|Period 3: Intervention Period 2||30
264162|NCT02446483|634654|P1|COMPLETED|Period 3: Intervention Period 2||30
264163|NCT02446483|634653|P2|STARTED|Period 3: Intervention Period 2||30
264164|NCT02446483|634654|P1|STARTED|Period 3: Intervention Period 2||30
264165|NCT02446483|634653|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
264166|NCT02446483|634654|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
264167|NCT02446483|634653|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
264168|NCT02446483|634654|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
264169|NCT02446483|634653|P2|STARTED|Period 2: Washout Period (7 Days)||30
264170|NCT02446483|634654|P1|STARTED|Period 2: Washout Period (7 Days)||30
264171|NCT02446483|634653|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
264172|NCT02446483|634654|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
264173|NCT02446483|634653|P2|COMPLETED|Period 1: Intervention Period 1||30
264174|NCT02446483|634654|P1|COMPLETED|Period 1: Intervention Period 1||30
264175|NCT02446483|634653|P2|STARTED|Period 1: Intervention Period 1||30
264176|NCT02446483|634654|P1|STARTED|Period 1: Intervention Period 1||30
264177|NCT02446171|634670|P4|NOT COMPLETED|Overall Study||0
264178|NCT02446171|634671|P3|NOT COMPLETED|Overall Study||2
264179|NCT02446171|634672|P2|NOT COMPLETED|Overall Study||0
264180|NCT02446171|634673|P1|NOT COMPLETED|Overall Study||0
264181|NCT02446171|634670|P4|COMPLETED|Overall Study||11
264182|NCT02446171|634671|P3|COMPLETED|Overall Study||9
264183|NCT02446171|634672|P2|COMPLETED|Overall Study||11
264184|NCT02446171|634673|P1|COMPLETED|Overall Study||11
264185|NCT02446171|634670|P4|STARTED|Overall Study||11
264186|NCT02446171|634671|P3|STARTED|Overall Study||11
264187|NCT02446171|634672|P2|STARTED|Overall Study||11
264188|NCT02446171|634673|P1|STARTED|Overall Study||11
264189|NCT02446015|634744|P2|NOT COMPLETED|Overall Study||1
264190|NCT02446015|634745|P1|NOT COMPLETED|Overall Study||1
264191|NCT02446015|634744|P2|COMPLETED|Overall Study||62
264192|NCT02446015|634745|P1|COMPLETED|Overall Study||33
264193|NCT02446015|634744|P2|STARTED|Overall Study||63
264194|NCT02446015|634745|P1|STARTED|Overall Study||34
264195|NCT02445755|634756|P1|NOT COMPLETED|Overall Study||13
264196|NCT02445755|634756|P1|COMPLETED|Overall Study||100
264197|NCT02445755|634756|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
264198|NCT02445573|634765|P2|NOT COMPLETED|Overall Study||2
264199|NCT02445573|634766|P1|NOT COMPLETED|Overall Study||1
264200|NCT02445573|634765|P2|COMPLETED|Overall Study||38
264201|NCT02445573|634766|P1|COMPLETED|Overall Study||39
264202|NCT02445573|634765|P2|STARTED|Overall Study||40
264203|NCT02445573|634766|P1|STARTED|Overall Study||40
264204|NCT02445287|634782|P2|NOT COMPLETED|Overall Study||0
264205|NCT02445287|634783|P1|NOT COMPLETED|Overall Study||0
264206|NCT02445287|634782|P2|COMPLETED|Overall Study||13
264207|NCT02445287|634783|P1|COMPLETED|Overall Study||35
264208|NCT02445287|634782|P2|STARTED|Overall Study||13
264209|NCT02445287|634783|P1|STARTED|Overall Study||35
264210|NCT02445196|634798|P2|NOT COMPLETED|Overall Study||6
264211|NCT02445196|634799|P1|NOT COMPLETED|Overall Study||11
264212|NCT02445196|634798|P2|COMPLETED|Overall Study||52
264213|NCT02445196|634799|P1|COMPLETED|Overall Study||51
264214|NCT02445196|634798|P2|STARTED|Overall Study||58
264215|NCT02445196|634799|P1|STARTED|Overall Study||62
264216|NCT02444715|634814|P2|NOT COMPLETED|Overall Study||16
264217|NCT02444715|634815|P1|NOT COMPLETED|Overall Study||10
264218|NCT02444715|634814|P2|COMPLETED|Overall Study||32
264219|NCT02444715|634815|P1|COMPLETED|Overall Study||36
264220|NCT02444715|634814|P2|STARTED|Overall Study||48
264221|NCT02444715|634815|P1|STARTED|Overall Study||46
264222|NCT02444182|634846|P2|NOT COMPLETED|Overall Study||5
264223|NCT02444182|634847|P1|NOT COMPLETED|Overall Study||2
264224|NCT02444182|634846|P2|COMPLETED|Overall Study||49
264225|NCT02444182|634847|P1|COMPLETED|Overall Study||52
264226|NCT02444182|634846|P2|STARTED|Overall Study||54
264227|NCT02444182|634847|P1|STARTED|Overall Study||54
264228|NCT02443792|634857|P2|NOT COMPLETED|Overall Study||2
264229|NCT02443792|634858|P1|NOT COMPLETED|Overall Study||7
264230|NCT02443792|634857|P2|COMPLETED|Overall Study||23
264231|NCT02443792|634858|P1|COMPLETED|Overall Study||43
264232|NCT02443792|634857|P2|STARTED|Overall Study||25
264233|NCT02443792|634858|P1|STARTED|Overall Study||50
264234|NCT02442700|634874|P2|NOT COMPLETED|Later 12 Weeks||0
264235|NCT02442700|634875|P1|NOT COMPLETED|Later 12 Weeks||0
264236|NCT02442700|634874|P2|COMPLETED|Later 12 Weeks||12
264237|NCT02442700|634875|P1|COMPLETED|Later 12 Weeks||12
264238|NCT02442700|634874|P2|STARTED|Later 12 Weeks||12
264239|NCT02442700|634875|P1|STARTED|Later 12 Weeks||12
264240|NCT02442700|634874|P2|NOT COMPLETED|First 12 Weeks||0
264241|NCT02442700|634875|P1|NOT COMPLETED|First 12 Weeks||0
264242|NCT02442700|634874|P2|COMPLETED|First 12 Weeks||12
264243|NCT02442700|634875|P1|COMPLETED|First 12 Weeks||12
264244|NCT02442700|634874|P2|STARTED|First 12 Weeks||12
264245|NCT02442700|634875|P1|STARTED|First 12 Weeks||12
264246|NCT02442349|634883|P1|NOT COMPLETED|Overall Study||171
264247|NCT02442349|634883|P1|COMPLETED|Overall Study||0
264248|NCT02442349|634883|P1|STARTED|Overall Study||171
264249|NCT02442310|634888|P1|NOT COMPLETED|Overall Study||3
264250|NCT02442310|634888|P1|COMPLETED|Overall Study||17
264251|NCT02442310|634888|P1|STARTED|Overall Study||20
264252|NCT02441218|634912|P2|NOT COMPLETED|Overall Study||612
264253|NCT02441218|634913|P1|NOT COMPLETED|Overall Study||578
264254|NCT02441218|634912|P2|COMPLETED|Overall Study||2652
264255|NCT02441218|634913|P1|COMPLETED|Overall Study||2663
264256|NCT02441218|634912|P2|STARTED|Overall Study||3264
264257|NCT02441218|634913|P1|STARTED|Overall Study||3241
264258|NCT02441179|634939|P2|NOT COMPLETED|Overall Study||1
264259|NCT02441179|634940|P1|NOT COMPLETED|Overall Study||1
264260|NCT02441179|634939|P2|COMPLETED|Overall Study||16
264261|NCT02441179|634940|P1|COMPLETED|Overall Study||17
264262|NCT02441179|634939|P2|STARTED|Overall Study||17
264263|NCT02441179|634940|P1|STARTED|Overall Study||18
264264|NCT02441114|634958|P1|NOT COMPLETED|Period3||0
264265|NCT02441114|634958|P1|COMPLETED|Period3||6
264266|NCT02441114|634958|P1|STARTED|Period3||6
264267|NCT02441114|634958|P1|NOT COMPLETED|Washout2||4
264268|NCT02441114|634958|P1|COMPLETED|Washout2||6
264269|NCT02441114|634958|P1|STARTED|Washout2||10
264270|NCT02441114|634958|P1|NOT COMPLETED|Period2||0
264271|NCT02441114|634958|P1|COMPLETED|Period2||10
264272|NCT02441114|634958|P1|STARTED|Period2||10
264273|NCT02441114|634958|P1|NOT COMPLETED|Washout1||0
264274|NCT02441114|634958|P1|COMPLETED|Washout1||10
264275|NCT02441114|634958|P1|STARTED|Washout1||10
264276|NCT02441114|634958|P1|NOT COMPLETED|Period1||0
264277|NCT02441114|634958|P1|COMPLETED|Period1||10
264278|NCT02441114|634958|P1|STARTED|Period1||10
264279|NCT02440659|634966|P2|NOT COMPLETED|Overall Study||335
264280|NCT02440659|634967|P1|NOT COMPLETED|Overall Study||651
264281|NCT02440659|634966|P2|COMPLETED|Overall Study||614
264282|NCT02440659|634967|P1|COMPLETED|Overall Study||1346
264283|NCT02440659|634966|P2|STARTED|Overall Study||949
264284|NCT02440659|634967|P1|STARTED|Overall Study||1997
264285|NCT02440633|634973|P1|NOT COMPLETED|Overall Study||0
264286|NCT02440633|634973|P1|COMPLETED|Overall Study||8
264287|NCT02440633|634973|P1|STARTED|Overall Study||8
264288|NCT02440308|634982|P1|NOT COMPLETED|Overall Study||0
264289|NCT02440308|634982|P1|COMPLETED|Overall Study||10
264290|NCT02440308|634982|P1|STARTED|Overall Study||10
264291|NCT02439879|634989|P2|NOT COMPLETED|Overall Study||0
264292|NCT02439879|634990|P1|NOT COMPLETED|Overall Study||0
264293|NCT02439879|634989|P2|COMPLETED|Overall Study||17
264294|NCT02439879|634990|P1|COMPLETED|Overall Study||16
264295|NCT02439879|634989|P2|STARTED|Overall Study||17
264296|NCT02439879|634990|P1|STARTED|Overall Study||16
264297|NCT02439138|634996|P1|NOT COMPLETED|Overall Study||3
264298|NCT02439138|634996|P1|COMPLETED|Overall Study||2
264299|NCT02439138|634996|P1|STARTED|Overall Study||5
264300|NCT02438540|635009|P2|NOT COMPLETED|Overall Study||0
264301|NCT02438540|635010|P1|NOT COMPLETED|Overall Study||0
264302|NCT02438540|635009|P2|COMPLETED|Overall Study||20
264303|NCT02438540|635010|P1|COMPLETED|Overall Study||19
264304|NCT02438540|635009|P2|STARTED|Overall Study||20
264305|NCT02438540|635010|P1|STARTED|Overall Study||19
264306|NCT02438137|635052|P2|NOT COMPLETED|Overall Study||6
264307|NCT02438137|635053|P1|NOT COMPLETED|Overall Study||8
264308|NCT02438137|635052|P2|COMPLETED|Overall Study||15
264309|NCT02438137|635053|P1|COMPLETED|Overall Study||36
264310|NCT02438137|635052|P2|STARTED|Overall Study||21
264311|NCT02438137|635053|P1|STARTED|Overall Study||44
264312|NCT02437903|635061|P1|NOT COMPLETED|Overall Study||5
264313|NCT02437903|635061|P1|COMPLETED|Overall Study||25
264314|NCT02437903|635061|P1|STARTED|Overall Study||30
264315|NCT02437409|635069|P1|NOT COMPLETED|Overall Study||15
264316|NCT02437409|635069|P1|COMPLETED|Overall Study||100
264317|NCT02437409|635069|P1|STARTED|Overall Study|100 evaluable patients, attrition rate of 15%|115
264318|NCT02437305|635082|P2|NOT COMPLETED|Overall Study||12
264319|NCT02437305|635083|P1|NOT COMPLETED|Overall Study||18
264320|NCT02437305|635082|P2|COMPLETED|Overall Study||38
264321|NCT02437305|635083|P1|COMPLETED|Overall Study||32
264322|NCT02437305|635082|P2|STARTED|Overall Study||50
264323|NCT02437305|635083|P1|STARTED|Overall Study||50
264324|NCT02436811|635094|P3|NOT COMPLETED|Overall Study||7
264325|NCT02436811|635095|P2|NOT COMPLETED|Overall Study||9
264326|NCT02436811|635096|P1|NOT COMPLETED|Overall Study||2
264327|NCT02436811|635094|P3|COMPLETED|Overall Study||53
264328|NCT02436811|635095|P2|COMPLETED|Overall Study||51
264329|NCT02436811|635096|P1|COMPLETED|Overall Study||58
264330|NCT02436811|635094|P3|STARTED|Overall Study||60
264331|NCT02436811|635095|P2|STARTED|Overall Study||60
264332|NCT02436811|635096|P1|STARTED|Overall Study||60
264333|NCT02436577|635110|P6|NOT COMPLETED|Overall Study||0
264334|NCT02436577|635111|P5|NOT COMPLETED|Overall Study||0
264335|NCT02436577|635112|P4|NOT COMPLETED|Overall Study||0
264336|NCT02436577|635113|P3|NOT COMPLETED|Overall Study||0
264337|NCT02436577|635114|P2|NOT COMPLETED|Overall Study||1
264338|NCT02436577|635115|P1|NOT COMPLETED|Overall Study||0
264339|NCT02436577|635110|P6|COMPLETED|Overall Study||7
264340|NCT02436577|635111|P5|COMPLETED|Overall Study||7
264341|NCT02436577|635112|P4|COMPLETED|Overall Study||7
264342|NCT02436577|635113|P3|COMPLETED|Overall Study||7
264343|NCT02436577|635114|P2|COMPLETED|Overall Study||6
264344|NCT02436577|635115|P1|COMPLETED|Overall Study||7
264345|NCT02436577|635110|P6|STARTED|Overall Study||7
264346|NCT02436577|635111|P5|STARTED|Overall Study||7
264347|NCT02436577|635112|P4|STARTED|Overall Study||7
264348|NCT02436577|635113|P3|STARTED|Overall Study||7
264349|NCT02436577|635114|P2|STARTED|Overall Study||7
264350|NCT02436577|635115|P1|STARTED|Overall Study||7
264351|NCT02436330|635170|P2|NOT COMPLETED|Cohort 6||1
264352|NCT02436330|635171|P1|NOT COMPLETED|Cohort 6||3
264353|NCT02436330|635170|P2|COMPLETED|Cohort 6||4
264354|NCT02436330|635171|P1|COMPLETED|Cohort 6||1
264355|NCT02436330|635170|P2|STARTED|Cohort 6||5
264356|NCT02436330|635171|P1|STARTED|Cohort 6||4
264357|NCT02436330|635170|P2|NOT COMPLETED|Cohort 5||4
264358|NCT02436330|635171|P1|NOT COMPLETED|Cohort 5||6
264359|NCT02436330|635170|P2|COMPLETED|Cohort 5||1
264360|NCT02436330|635171|P1|COMPLETED|Cohort 5||4
264361|NCT02436330|635170|P2|STARTED|Cohort 5||5
264362|NCT02436330|635171|P1|STARTED|Cohort 5||10
264363|NCT02436330|635170|P2|NOT COMPLETED|Cohort 4||0
264364|NCT02436330|635171|P1|NOT COMPLETED|Cohort 4||2
264365|NCT02436330|635170|P2|COMPLETED|Cohort 4||0
264366|NCT02436330|635171|P1|COMPLETED|Cohort 4||4
264367|NCT02436330|635170|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
264368|NCT02436330|635171|P1|STARTED|Cohort 4||6
264369|NCT02436330|635170|P2|NOT COMPLETED|Cohort 3||0
264370|NCT02436330|635171|P1|NOT COMPLETED|Cohort 3||5
264371|NCT02436330|635170|P2|COMPLETED|Cohort 3||0
264372|NCT02436330|635171|P1|COMPLETED|Cohort 3||7
264373|NCT02436330|635170|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
264374|NCT02436330|635171|P1|STARTED|Cohort 3||12
264375|NCT02436330|635170|P2|NOT COMPLETED|Cohort 2||3
264376|NCT02436330|635171|P1|NOT COMPLETED|Cohort 2||4
264377|NCT02436330|635170|P2|COMPLETED|Cohort 2||7
264378|NCT02436330|635171|P1|COMPLETED|Cohort 2||10
264379|NCT02436330|635170|P2|STARTED|Cohort 2||10
264380|NCT02436330|635171|P1|STARTED|Cohort 2||14
264381|NCT02436330|635170|P2|NOT COMPLETED|Cohort 1||3
264382|NCT02436330|635171|P1|NOT COMPLETED|Cohort 1||5
264383|NCT02436330|635170|P2|COMPLETED|Cohort 1||1
264384|NCT02436330|635171|P1|COMPLETED|Cohort 1||9
264385|NCT02436330|635170|P2|STARTED|Cohort 1||4
264386|NCT02436330|635171|P1|STARTED|Cohort 1||14
264387|NCT02436031|635213|P2|NOT COMPLETED|Second Study Night||0
264388|NCT02436031|635214|P1|NOT COMPLETED|Second Study Night||0
264389|NCT02436031|635213|P2|COMPLETED|Second Study Night||8
264390|NCT02436031|635214|P1|COMPLETED|Second Study Night||7
264391|NCT02436031|635213|P2|STARTED|Second Study Night||8
264392|NCT02436031|635214|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
264393|NCT02436031|635213|P2|NOT COMPLETED|First Study Night||0
264394|NCT02436031|635214|P1|NOT COMPLETED|First Study Night||0
264395|NCT02436031|635213|P2|COMPLETED|First Study Night||8
264396|NCT02436031|635214|P1|COMPLETED|First Study Night||8
264397|NCT02436031|635213|P2|STARTED|First Study Night||8
264398|NCT02436031|635214|P1|STARTED|First Study Night||8
264399|NCT02435966|635227|P3|NOT COMPLETED|Overall Study||0
264400|NCT02435966|635228|P2|NOT COMPLETED|Overall Study||1
264401|NCT02435966|635229|P1|NOT COMPLETED|Overall Study||0
264402|NCT02435966|635227|P3|COMPLETED|Overall Study||30
264403|NCT02435966|635228|P2|COMPLETED|Overall Study||53
264404|NCT02435966|635229|P1|COMPLETED|Overall Study||47
264405|NCT02435966|635227|P3|Follow-up|Overall Study||30
264406|NCT02435966|635228|P2|Follow-up|Overall Study||53
264407|NCT02435966|635229|P1|Follow-up|Overall Study||47
264408|NCT02435966|635227|P3|Second Intervention|Overall Study||30
264409|NCT02435966|635228|P2|Second Intervention|Overall Study||53
264410|NCT02435966|635229|P1|Second Intervention|Overall Study||47
264411|NCT02435966|635227|P3|First Intervention|Overall Study||30
264412|NCT02435966|635228|P2|First Intervention|Overall Study||54
264413|NCT02435966|635229|P1|First Intervention|Overall Study||47
264414|NCT02435966|635227|P3|STARTED|Overall Study||30
264415|NCT02435966|635228|P2|STARTED|Overall Study||54
264416|NCT02435966|635229|P1|STARTED|Overall Study||47
264417|NCT02435836|635237|P1|NOT COMPLETED|Overall Study||631
264418|NCT02435836|635237|P1|COMPLETED|Overall Study||0
264419|NCT02435836|635237|P1|STARTED|Overall Study||631
264420|NCT02434939|635255|P2|NOT COMPLETED|Overall Study||49
264421|NCT02434939|635256|P1|NOT COMPLETED|Overall Study||37
264422|NCT02434939|635255|P2|COMPLETED|Overall Study||71
264423|NCT02434939|635256|P1|COMPLETED|Overall Study||83
264424|NCT02434939|635255|P2|STARTED|Overall Study||120
264425|NCT02434939|635256|P1|STARTED|Overall Study||120
264426|NCT02434523|635270|P2|NOT COMPLETED|Overall Study||6
264427|NCT02434523|635271|P1|NOT COMPLETED|Overall Study||5
264428|NCT02434523|635270|P2|COMPLETED|Overall Study||9
264429|NCT02434523|635271|P1|COMPLETED|Overall Study||10
264430|NCT02434523|635270|P2|STARTED|Overall Study||15
264431|NCT02434523|635271|P1|STARTED|Overall Study||15
264432|NCT02434146|635283|P1|NOT COMPLETED|Overall Study||0
264433|NCT02434146|635283|P1|COMPLETED|Overall Study||3
264434|NCT02434146|635283|P1|STARTED|Overall Study||3
264435|NCT02433366|635297|P2|NOT COMPLETED|Overall Study||0
264436|NCT02433366|635298|P1|NOT COMPLETED|Overall Study||0
264437|NCT02433366|635297|P2|COMPLETED|Overall Study||802
264438|NCT02433366|635298|P1|COMPLETED|Overall Study||411
264439|NCT02433366|635297|P2|STARTED|Overall Study||802
264440|NCT02433366|635298|P1|STARTED|Overall Study||411
264441|NCT02432040|635308|P2|NOT COMPLETED|Overall Study||6
264442|NCT02432040|635309|P1|NOT COMPLETED|Overall Study||8
264443|NCT02432040|635308|P2|COMPLETED|Overall Study||8
264444|NCT02432040|635309|P1|COMPLETED|Overall Study||6
264445|NCT02432040|635308|P2|STARTED|Overall Study||14
264446|NCT02432040|635309|P1|STARTED|Overall Study||14
264447|NCT02431754|635331|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
264448|NCT02431754|635332|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
264449|NCT02431754|635331|P2|COMPLETED|Period 2 (8 Weeks)||78
264450|NCT02431754|635332|P1|COMPLETED|Period 2 (8 Weeks)||74
264451|NCT02431754|635331|P2|STARTED|Period 2 (8 Weeks)||82
264452|NCT02431754|635332|P1|STARTED|Period 2 (8 Weeks)||75
264453|NCT02431754|635331|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
264454|NCT02431754|635332|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
264455|NCT02431754|635331|P2|COMPLETED|Wash-out Period (4 Weeks)||82
264456|NCT02431754|635332|P1|COMPLETED|Wash-out Period (4 Weeks)||75
264457|NCT02431754|635331|P2|STARTED|Wash-out Period (4 Weeks)||82
264458|NCT02431754|635332|P1|STARTED|Wash-out Period (4 Weeks)||79
264459|NCT02431754|635331|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
264460|NCT02431754|635332|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
264461|NCT02431754|635331|P2|COMPLETED|Period 1 (8 Weeks)||82
264462|NCT02431754|635332|P1|COMPLETED|Period 1 (8 Weeks)||79
264463|NCT02431754|635331|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
264464|NCT02431754|635332|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
264465|NCT02431754|635331|P2|STARTED|Period 1 (8 Weeks)||86
264466|NCT02431754|635332|P1|STARTED|Period 1 (8 Weeks)||85
264467|NCT02431741|635350|P1|NOT COMPLETED|Overall Study||0
264468|NCT02431741|635350|P1|COMPLETED|Overall Study||14
264469|NCT02431741|635350|P1|STARTED|Overall Study||14
264470|NCT02431598|635354|P6|NOT COMPLETED|Overall Study||0
264471|NCT02431598|635355|P5|NOT COMPLETED|Overall Study||0
264472|NCT02431598|635356|P4|NOT COMPLETED|Overall Study||0
264473|NCT02431598|635357|P3|NOT COMPLETED|Overall Study||0
264474|NCT02431598|635358|P2|NOT COMPLETED|Overall Study||0
264475|NCT02431598|635359|P1|NOT COMPLETED|Overall Study||0
264476|NCT02431598|635354|P6|COMPLETED|Overall Study||6
264477|NCT02431598|635355|P5|COMPLETED|Overall Study||7
264478|NCT02431598|635356|P4|COMPLETED|Overall Study||7
264479|NCT02431598|635357|P3|COMPLETED|Overall Study||9
264480|NCT02431598|635358|P2|COMPLETED|Overall Study||9
264481|NCT02431598|635359|P1|COMPLETED|Overall Study||6
264482|NCT02431598|635354|P6|STARTED|Overall Study||6
264483|NCT02431598|635355|P5|STARTED|Overall Study||7
264484|NCT02431598|635356|P4|STARTED|Overall Study||7
264485|NCT02431598|635357|P3|STARTED|Overall Study||9
264486|NCT02431598|635358|P2|STARTED|Overall Study||9
264487|NCT02431598|635359|P1|STARTED|Overall Study||6
264488|NCT02431455|635385|P2|NOT COMPLETED|Overall Study||0
264489|NCT02431455|635386|P1|NOT COMPLETED|Overall Study||0
264490|NCT02431455|635385|P2|COMPLETED|Overall Study||112
264491|NCT02431455|635386|P1|COMPLETED|Overall Study||112
264492|NCT02431455|635385|P2|STARTED|Overall Study||112
264493|NCT02431455|635386|P1|STARTED|Overall Study||112
264494|NCT02431299|635400|P2|NOT COMPLETED|Overall Study||1
264495|NCT02431299|635401|P1|NOT COMPLETED|Overall Study||53
264496|NCT02431299|635400|P2|COMPLETED|Overall Study||62
264497|NCT02431299|635401|P1|COMPLETED|Overall Study||183
264498|NCT02431299|635400|P2|STARTED|Overall Study||63
264499|NCT02431299|635401|P1|STARTED|Overall Study||236
264500|NCT02430870|635422|P8|NOT COMPLETED|Part 2||1
264501|NCT02430870|635423|P7|NOT COMPLETED|Part 2||1
264502|NCT02430870|635424|P6|NOT COMPLETED|Part 2||0
264503|NCT02430870|635425|P5|NOT COMPLETED|Part 2||0
264504|NCT02430870|635426|P4|NOT COMPLETED|Part 2||0
264505|NCT02430870|635427|P3|NOT COMPLETED|Part 2||0
264506|NCT02430870|635428|P2|NOT COMPLETED|Part 2||0
264507|NCT02430870|635429|P1|NOT COMPLETED|Part 2||0
264508|NCT02430870|635422|P8|COMPLETED|Part 2||7
264509|NCT02430870|635423|P7|COMPLETED|Part 2||5
264510|NCT02430870|635424|P6|COMPLETED|Part 2||6
264511|NCT02430870|635425|P5|COMPLETED|Part 2||6
264512|NCT02430870|635426|P4|COMPLETED|Part 2||6
264513|NCT02430870|635427|P3|COMPLETED|Part 2||0
264514|NCT02430870|635428|P2|COMPLETED|Part 2||0
264515|NCT02430870|635429|P1|COMPLETED|Part 2||0
264516|NCT02430870|635422|P8|STARTED|Part 2||8
264517|NCT02430870|635423|P7|STARTED|Part 2||6
264518|NCT02430870|635424|P6|STARTED|Part 2||6
264519|NCT02430870|635425|P5|STARTED|Part 2||6
264520|NCT02430870|635426|P4|STARTED|Part 2||6
264521|NCT02430870|635427|P3|STARTED|Part 2||0
264522|NCT02430870|635428|P2|STARTED|Part 2||0
264523|NCT02430870|635429|P1|STARTED|Part 2||0
264524|NCT02430870|635422|P8|NOT COMPLETED|Part 1||0
264525|NCT02430870|635423|P7|NOT COMPLETED|Part 1||0
264526|NCT02430870|635424|P6|NOT COMPLETED|Part 1||0
264527|NCT02430870|635425|P5|NOT COMPLETED|Part 1||0
264528|NCT02430870|635426|P4|NOT COMPLETED|Part 1||0
264529|NCT02430870|635427|P3|NOT COMPLETED|Part 1||0
264530|NCT02430870|635428|P2|NOT COMPLETED|Part 1||0
264531|NCT02430870|635429|P1|NOT COMPLETED|Part 1||0
264532|NCT02430870|635422|P8|COMPLETED|Part 1||0
264533|NCT02430870|635423|P7|COMPLETED|Part 1||0
264534|NCT02430870|635424|P6|COMPLETED|Part 1||0
264535|NCT02430870|635425|P5|COMPLETED|Part 1||0
264536|NCT02430870|635426|P4|COMPLETED|Part 1||0
264537|NCT02430870|635427|P3|COMPLETED|Part 1||4
264538|NCT02430870|635428|P2|COMPLETED|Part 1||6
264539|NCT02430870|635429|P1|COMPLETED|Part 1||6
264540|NCT02430870|635422|P8|STARTED|Part 1||0
264541|NCT02430870|635423|P7|STARTED|Part 1||0
264542|NCT02430870|635424|P6|STARTED|Part 1||0
264543|NCT02430870|635425|P5|STARTED|Part 1||0
264544|NCT02430870|635426|P4|STARTED|Part 1||0
264545|NCT02430870|635427|P3|STARTED|Part 1||4
264546|NCT02430870|635428|P2|STARTED|Part 1||6
264547|NCT02430870|635429|P1|STARTED|Part 1||6
264548|NCT02430532|635503|P2|NOT COMPLETED|Overall Study||28
264549|NCT02430532|635504|P1|NOT COMPLETED|Overall Study||30
264550|NCT02430532|635503|P2|COMPLETED|Overall Study||0
264551|NCT02430532|635504|P1|COMPLETED|Overall Study||0
264552|NCT02430532|635503|P2|STARTED|Overall Study||28
264553|NCT02430532|635504|P1|STARTED|Overall Study||30
264554|NCT02430389|635520|P2|NOT COMPLETED|Overall Study||0
264555|NCT02430389|635521|P1|NOT COMPLETED|Overall Study||0
264556|NCT02430389|635520|P2|COMPLETED|Overall Study||10
264557|NCT02430389|635521|P1|COMPLETED|Overall Study||10
264558|NCT02430389|635520|P2|STARTED|Overall Study||10
264559|NCT02430389|635521|P1|STARTED|Overall Study||10
264560|NCT02430090|635532|P3|NOT COMPLETED|Overall Study||0
264561|NCT02430090|635533|P2|NOT COMPLETED|Overall Study||0
264562|NCT02430090|635534|P1|NOT COMPLETED|Overall Study||0
264563|NCT02430090|635532|P3|COMPLETED|Overall Study||15
264564|NCT02430090|635533|P2|COMPLETED|Overall Study||15
264565|NCT02430090|635534|P1|COMPLETED|Overall Study||15
264566|NCT02430090|635532|P3|STARTED|Overall Study||15
264567|NCT02430090|635533|P2|STARTED|Overall Study||15
264568|NCT02430090|635534|P1|STARTED|Overall Study||15
264569|NCT02429258|635544|P2|NOT COMPLETED|Overall Study||1
264570|NCT02429258|635545|P1|NOT COMPLETED|Overall Study||2
264571|NCT02429258|635544|P2|COMPLETED|Overall Study||49
264572|NCT02429258|635545|P1|COMPLETED|Overall Study||48
264573|NCT02429258|635544|P2|STARTED|Overall Study||50
264574|NCT02429258|635545|P1|STARTED|Overall Study||50
264575|NCT02428478|635571|P2|NOT COMPLETED|Second Study Night||0
264576|NCT02428478|635572|P1|NOT COMPLETED|Second Study Night||0
264577|NCT02428478|635571|P2|COMPLETED|Second Study Night||6
264578|NCT02428478|635572|P1|COMPLETED|Second Study Night||8
264579|NCT02428478|635571|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
264580|NCT02428478|635572|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
264581|NCT02428478|635571|P2|NOT COMPLETED|First Study Night||0
264582|NCT02428478|635572|P1|NOT COMPLETED|First Study Night||0
264583|NCT02428478|635571|P2|COMPLETED|First Study Night||8
264584|NCT02428478|635572|P1|COMPLETED|First Study Night||9
264585|NCT02428478|635571|P2|STARTED|First Study Night||8
264586|NCT02428478|635572|P1|STARTED|First Study Night||9
264587|NCT02428413|635582|P2|NOT COMPLETED|Overall Study||9
264588|NCT02428413|635583|P1|NOT COMPLETED|Overall Study||8
264589|NCT02428413|635582|P2|COMPLETED|Overall Study||52
264590|NCT02428413|635583|P1|COMPLETED|Overall Study||56
264591|NCT02428413|635582|P2|STARTED|Overall Study||61
264592|NCT02428413|635583|P1|STARTED|Overall Study||64
264593|NCT02428231|635597|P2|NOT COMPLETED|Overall Study||17
264594|NCT02428231|635598|P1|NOT COMPLETED|Overall Study||13
264595|NCT02428231|635597|P2|COMPLETED|Overall Study||15
264596|NCT02428231|635598|P1|COMPLETED|Overall Study||17
264597|NCT02428231|635597|P2|STARTED|Overall Study||32
264598|NCT02428231|635598|P1|STARTED|Overall Study||30
264599|NCT02427984|635615|P3|NOT COMPLETED|Overall Study||18
264600|NCT02427984|635616|P2|NOT COMPLETED|Overall Study||5
264601|NCT02427984|635617|P1|NOT COMPLETED|Overall Study||13
264602|NCT02427984|635615|P3|COMPLETED|Overall Study||32
264603|NCT02427984|635616|P2|COMPLETED|Overall Study||40
264604|NCT02427984|635617|P1|COMPLETED|Overall Study||40
264605|NCT02427984|635615|P3|STARTED|Overall Study||50
264606|NCT02427984|635616|P2|STARTED|Overall Study||45
264607|NCT02427984|635617|P1|STARTED|Overall Study||53
264608|NCT02427750|635633|P2|NOT COMPLETED|Overall Study||0
264609|NCT02427750|635634|P1|NOT COMPLETED|Overall Study||0
264610|NCT02427750|635633|P2|COMPLETED|Overall Study||63
264611|NCT02427750|635634|P1|COMPLETED|Overall Study||63
264612|NCT02427750|635633|P2|STARTED|Overall Study||63
264613|NCT02427750|635634|P1|STARTED|Overall Study||63
264614|NCT02427477|635659|P2|NOT COMPLETED|Period 3||0
264615|NCT02427477|635660|P1|NOT COMPLETED|Period 3||0
264616|NCT02427477|635659|P2|COMPLETED|Period 3||60
264617|NCT02427477|635660|P1|COMPLETED|Period 3||59
264618|NCT02427477|635659|P2|STARTED|Period 3||60
264619|NCT02427477|635660|P1|STARTED|Period 3||59
264620|NCT02427477|635659|P2|NOT COMPLETED|Period 2||0
264621|NCT02427477|635660|P1|NOT COMPLETED|Period 2||0
264622|NCT02427477|635659|P2|COMPLETED|Period 2||60
264623|NCT02427477|635660|P1|COMPLETED|Period 2||59
264624|NCT02427477|635659|P2|STARTED|Period 2||60
264625|NCT02427477|635660|P1|STARTED|Period 2||59
264626|NCT02427477|635659|P2|NOT COMPLETED|Period 1||0
264627|NCT02427477|635660|P1|NOT COMPLETED|Period 1||1
264628|NCT02427477|635659|P2|COMPLETED|Period 1||60
264629|NCT02427477|635660|P1|COMPLETED|Period 1||59
264630|NCT02427477|635659|P2|STARTED|Period 1||60
264631|NCT02427477|635660|P1|STARTED|Period 1||60
264632|NCT02425826|635670|P2|NOT COMPLETED|Overall Study||27
264633|NCT02425826|635671|P1|NOT COMPLETED|Overall Study||9
264634|NCT02425826|635670|P2|COMPLETED|Overall Study|Completed = participants who completed Week 16|121
264635|NCT02425826|635671|P1|COMPLETED|Overall Study||64
264636|NCT02425826|635670|P2|Received Treatment|Overall Study|Received treatment includes participants who received at least one dose of study drug.|147
264637|NCT02425826|635671|P1|Received Treatment|Overall Study|Received treatment includes participants who received at least one dose of study drug.|73
264638|NCT02425826|635670|P2|STARTED|Overall Study||148
264639|NCT02425826|635671|P1|STARTED|Overall Study||73
264640|NCT02423447|635698|P2|NOT COMPLETED|Overall Study||0
264641|NCT02423447|635699|P1|NOT COMPLETED|Overall Study||0
264642|NCT02423447|635698|P2|COMPLETED|Overall Study||12
264643|NCT02423447|635699|P1|COMPLETED|Overall Study||13
264644|NCT02423447|635698|P2|STARTED|Overall Study||12
264645|NCT02423447|635699|P1|STARTED|Overall Study||13
264646|NCT02423408|635715|P2|NOT COMPLETED|Overall Study||2
264647|NCT02423408|635716|P1|NOT COMPLETED|Overall Study||1
264648|NCT02423408|635715|P2|COMPLETED|Overall Study||80
264649|NCT02423408|635716|P1|COMPLETED|Overall Study||82
264650|NCT02423408|635715|P2|STARTED|Overall Study||82
264651|NCT02423408|635716|P1|STARTED|Overall Study||83
264652|NCT02423317|635730|P2|NOT COMPLETED|Overall Study||0
264653|NCT02423317|635731|P1|NOT COMPLETED|Overall Study||0
264654|NCT02423317|635730|P2|COMPLETED|Overall Study||30
264655|NCT02423317|635731|P1|COMPLETED|Overall Study||30
264656|NCT02423317|635730|P2|STARTED|Overall Study||30
264657|NCT02423317|635731|P1|STARTED|Overall Study||30
264658|NCT02424591|635751|P2|NOT COMPLETED|Overall Study||3
264659|NCT02424591|635752|P1|NOT COMPLETED|Overall Study||2
264660|NCT02424591|635751|P2|COMPLETED|Overall Study||20
264661|NCT02424591|635752|P1|COMPLETED|Overall Study||20
264662|NCT02424591|635751|P2|STARTED|Overall Study||23
264663|NCT02424591|635752|P1|STARTED|Overall Study||22
264664|NCT02424565|635762|P2|NOT COMPLETED|Period 2 (D3)||0
264665|NCT02424565|635763|P1|NOT COMPLETED|Period 2 (D3)||0
264666|NCT02424565|635762|P2|COMPLETED|Period 2 (D3)||6
264667|NCT02424565|635763|P1|COMPLETED|Period 2 (D3)||8
264668|NCT02424565|635762|P2|STARTED|Period 2 (D3)||6
264669|NCT02424565|635763|P1|STARTED|Period 2 (D3)||8
264670|NCT02424565|635762|P2|NOT COMPLETED|Washout Period||0
264671|NCT02424565|635763|P1|NOT COMPLETED|Washout Period||0
264672|NCT02424565|635762|P2|COMPLETED|Washout Period||6
264673|NCT02424565|635763|P1|COMPLETED|Washout Period||8
264674|NCT02424565|635762|P2|STARTED|Washout Period||6
264675|NCT02424565|635763|P1|STARTED|Washout Period||8
264676|NCT02424565|635762|P2|NOT COMPLETED|Period 1 (D0)||1
264677|NCT02424565|635763|P1|NOT COMPLETED|Period 1 (D0)||0
264678|NCT02424565|635762|P2|COMPLETED|Period 1 (D0)||6
264679|NCT02424565|635763|P1|COMPLETED|Period 1 (D0)||8
264680|NCT02424565|635762|P2|STARTED|Period 1 (D0)||7
264681|NCT02424565|635763|P1|STARTED|Period 1 (D0)||8
264682|NCT02424149|635771|P2|NOT COMPLETED|Overall Study||1
264683|NCT02424149|635772|P1|NOT COMPLETED|Overall Study||2
264684|NCT02424149|635771|P2|COMPLETED|Overall Study||52
264685|NCT02424149|635772|P1|COMPLETED|Overall Study||52
264686|NCT02424149|635771|P2|STARTED|Overall Study||53
264687|NCT02424149|635772|P1|STARTED|Overall Study||54
264688|NCT02423993|635790|P4|NOT COMPLETED|Overall Study||0
264689|NCT02423993|635791|P3|NOT COMPLETED|Overall Study||0
264690|NCT02423993|635792|P2|NOT COMPLETED|Overall Study||0
264691|NCT02423993|635793|P1|NOT COMPLETED|Overall Study||0
264692|NCT02423993|635790|P4|COMPLETED|Overall Study||19
264693|NCT02423993|635791|P3|COMPLETED|Overall Study||23
264694|NCT02423993|635792|P2|COMPLETED|Overall Study||16
264695|NCT02423993|635793|P1|COMPLETED|Overall Study||19
264696|NCT02423993|635790|P4|STARTED|Overall Study||19
264697|NCT02423993|635791|P3|STARTED|Overall Study||23
264698|NCT02423993|635792|P2|STARTED|Overall Study||16
264699|NCT02423993|635793|P1|STARTED|Overall Study||19
264700|NCT02423980|635825|P1|NOT COMPLETED|Overall Study||0
264701|NCT02423980|635825|P1|COMPLETED|Overall Study||7
264702|NCT02423980|635825|P1|STARTED|Overall Study||7
264703|NCT02421211|635837|P2|NOT COMPLETED|Overall Study||0
264704|NCT02421211|635838|P1|NOT COMPLETED|Overall Study||0
264705|NCT02421211|635837|P2|COMPLETED|Overall Study||20
264706|NCT02421211|635838|P1|COMPLETED|Overall Study||20
264707|NCT02421211|635837|P2|STARTED|Overall Study||20
264708|NCT02421211|635838|P1|STARTED|Overall Study||20
264709|NCT02421120|635882|P1|NOT COMPLETED|Overall Study||1
264710|NCT02421120|635882|P1|COMPLETED|Overall Study||20
264711|NCT02421120|635882|P1|STARTED|Overall Study||21
264712|NCT02420951|635892|P2|NOT COMPLETED|Overall Study||0
264713|NCT02420951|635893|P1|NOT COMPLETED|Overall Study||0
264714|NCT02420951|635892|P2|COMPLETED|Overall Study||25
264715|NCT02420951|635893|P1|COMPLETED|Overall Study||25
264716|NCT02420951|635892|P2|STARTED|Overall Study||25
264717|NCT02420951|635893|P1|STARTED|Overall Study||25
264718|NCT02420093|635905|P2|NOT COMPLETED|Overall Study||1
264719|NCT02420093|635906|P1|NOT COMPLETED|Overall Study||1
264720|NCT02420093|635905|P2|COMPLETED|Overall Study||7
264721|NCT02420093|635906|P1|COMPLETED|Overall Study||8
264722|NCT02420093|635905|P2|STARTED|Overall Study||8
264723|NCT02420093|635906|P1|STARTED|Overall Study||9
264724|NCT02420041|635922|P2|NOT COMPLETED|Overall Study||0
264725|NCT02420041|635923|P1|NOT COMPLETED|Overall Study||0
264726|NCT02420041|635922|P2|COMPLETED|Overall Study||14
264727|NCT02420041|635923|P1|COMPLETED|Overall Study||14
264728|NCT02420041|635922|P2|STARTED|Overall Study||14
264729|NCT02420041|635923|P1|STARTED|Overall Study||14
264730|NCT02419313|635947|P2|NOT COMPLETED|Second Intervention||0
264731|NCT02419313|635948|P1|NOT COMPLETED|Second Intervention||1
264732|NCT02419313|635947|P2|COMPLETED|Second Intervention||15
264733|NCT02419313|635948|P1|COMPLETED|Second Intervention||15
264734|NCT02419313|635947|P2|STARTED|Second Intervention||15
264735|NCT02419313|635948|P1|STARTED|Second Intervention||16
264736|NCT02419313|635947|P2|NOT COMPLETED|First Intervention||0
264737|NCT02419313|635948|P1|NOT COMPLETED|First Intervention||2
264738|NCT02419313|635947|P2|COMPLETED|First Intervention||15
264739|NCT02419313|635948|P1|COMPLETED|First Intervention||16
264740|NCT02419313|635947|P2|STARTED|First Intervention||15
264741|NCT02419313|635948|P1|STARTED|First Intervention||18
264742|NCT02419001|635960|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
264743|NCT02419001|635961|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
264744|NCT02419001|635960|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
264745|NCT02419001|635961|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
264746|NCT02419001|635960|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
264747|NCT02419001|635961|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
264748|NCT02419001|635960|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
264749|NCT02419001|635961|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
264750|NCT02419001|635960|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
264751|NCT02419001|635961|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
264752|NCT02419001|635960|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
264753|NCT02419001|635961|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
264754|NCT02418676|635974|P3|NOT COMPLETED|Overall Study||0
264755|NCT02418676|635975|P2|NOT COMPLETED|Overall Study||0
264756|NCT02418676|635976|P1|NOT COMPLETED|Overall Study||0
264757|NCT02418676|635974|P3|COMPLETED|Overall Study||5
264758|NCT02418676|635975|P2|COMPLETED|Overall Study||5
264759|NCT02418676|635976|P1|COMPLETED|Overall Study||5
264760|NCT02418676|635974|P3|STARTED|Overall Study||5
264761|NCT02418676|635975|P2|STARTED|Overall Study||5
264762|NCT02418676|635976|P1|STARTED|Overall Study||5
264763|NCT02418234|635987|P1|NOT COMPLETED|Overall Study||0
264764|NCT02418234|635987|P1|COMPLETED|Overall Study||314
264765|NCT02418234|635987|P1|STARTED|Overall Study||314
264766|NCT02418026|636000|P2|NOT COMPLETED|Overall Study||0
264767|NCT02418026|636001|P1|NOT COMPLETED|Overall Study||0
264768|NCT02418026|636000|P2|COMPLETED|Overall Study||35
264769|NCT02418026|636001|P1|COMPLETED|Overall Study||44
264770|NCT02418026|636000|P2|STARTED|Overall Study||35
264771|NCT02418026|636001|P1|STARTED|Overall Study||44
264772|NCT02417961|636031|P1|NOT COMPLETED|Overall Study||4
264773|NCT02417961|636031|P1|COMPLETED|Overall Study||112
264774|NCT02417961|636031|P1|STARTED|Overall Study||116
264775|NCT02417753|636041|P1|NOT COMPLETED|Overall Study||1
264776|NCT02417753|636041|P1|COMPLETED|Overall Study||0
264777|NCT02417753|636041|P1|STARTED|Overall Study||1
264778|NCT02417532|636051|P1|NOT COMPLETED|Overall Study||4
264779|NCT02417532|636051|P1|COMPLETED|Overall Study||52
264780|NCT02417532|636051|P1|STARTED|Overall Study||56
264781|NCT02417376|636064|P2|NOT COMPLETED|Overall Study||10
264782|NCT02417376|636065|P1|NOT COMPLETED|Overall Study||5
264783|NCT02417376|636064|P2|COMPLETED|Overall Study||25
264784|NCT02417376|636065|P1|COMPLETED|Overall Study||30
264785|NCT02417376|636064|P2|STARTED|Overall Study||35
264786|NCT02417376|636065|P1|STARTED|Overall Study||35
264787|NCT02417129|636109|P2|NOT COMPLETED|Overall Study||0
264788|NCT02417129|636110|P1|NOT COMPLETED|Overall Study||0
264789|NCT02417129|636109|P2|COMPLETED|Overall Study||0
264790|NCT02417129|636110|P1|COMPLETED|Overall Study||2
264791|NCT02417129|636109|P2|STARTED|Overall Study||0
264792|NCT02417129|636110|P1|STARTED|Overall Study||2
264793|NCT02416973|636123|P3|NOT COMPLETED|Overall Study||1
264794|NCT02416973|636124|P2|NOT COMPLETED|Overall Study||3
264795|NCT02416973|636125|P1|NOT COMPLETED|Overall Study||1
264796|NCT02416973|636123|P3|COMPLETED|Overall Study||13
264797|NCT02416973|636124|P2|COMPLETED|Overall Study||10
264798|NCT02416973|636125|P1|COMPLETED|Overall Study||13
264799|NCT02416973|636123|P3|STARTED|Overall Study||14
264800|NCT02416973|636124|P2|STARTED|Overall Study||13
264801|NCT02416973|636125|P1|STARTED|Overall Study||14
264802|NCT02416180|636133|P1|NOT COMPLETED|Overall Study||1
264803|NCT02416180|636133|P1|COMPLETED|Overall Study||110
264804|NCT02416180|636133|P1|STARTED|Overall Study||111
264805|NCT02415959|636145|P5|NOT COMPLETED|Overall Study||0
264806|NCT02415959|636146|P4|NOT COMPLETED|Overall Study||1
264807|NCT02415959|636147|P3|NOT COMPLETED|Overall Study||0
264808|NCT02415959|636148|P2|NOT COMPLETED|Overall Study||1
264809|NCT02415959|636149|P1|NOT COMPLETED|Overall Study||0
264810|NCT02415959|636145|P5|COMPLETED|Overall Study||14
264811|NCT02415959|636146|P4|COMPLETED|Overall Study||13
264812|NCT02415959|636147|P3|COMPLETED|Overall Study||14
264813|NCT02415959|636148|P2|COMPLETED|Overall Study||13
264814|NCT02415959|636149|P1|COMPLETED|Overall Study||14
264815|NCT02415959|636145|P5|STARTED|Overall Study||14
264816|NCT02415959|636146|P4|STARTED|Overall Study||14
264817|NCT02415959|636147|P3|STARTED|Overall Study||14
264818|NCT02415959|636148|P2|STARTED|Overall Study||14
264819|NCT02415959|636149|P1|STARTED|Overall Study||14
264820|NCT02415439|636194|P13|NOT COMPLETED|Overall Study||0
264821|NCT02415439|636195|P12|NOT COMPLETED|Overall Study||0
264822|NCT02415439|636196|P11|NOT COMPLETED|Overall Study||0
264823|NCT02415439|636197|P10|NOT COMPLETED|Overall Study||0
264824|NCT02415439|636198|P9|NOT COMPLETED|Overall Study||1
264825|NCT02415439|636199|P8|NOT COMPLETED|Overall Study||0
264826|NCT02415439|636200|P7|NOT COMPLETED|Overall Study||0
264827|NCT02415439|636201|P6|NOT COMPLETED|Overall Study||0
264828|NCT02415439|636202|P5|NOT COMPLETED|Overall Study||0
264829|NCT02415439|636203|P4|NOT COMPLETED|Overall Study||0
264830|NCT02415439|636204|P3|NOT COMPLETED|Overall Study||0
264831|NCT02415439|636205|P2|NOT COMPLETED|Overall Study||0
264832|NCT02415439|636206|P1|NOT COMPLETED|Overall Study||0
264833|NCT02415439|636194|P13|COMPLETED|Overall Study||8
264834|NCT02415439|636195|P12|COMPLETED|Overall Study||6
264835|NCT02415439|636196|P11|COMPLETED|Overall Study||6
264836|NCT02415439|636197|P10|COMPLETED|Overall Study||6
264837|NCT02415439|636198|P9|COMPLETED|Overall Study||5
264838|NCT02415439|636199|P8|COMPLETED|Overall Study||12
264839|NCT02415439|636200|P7|COMPLETED|Overall Study||6
264840|NCT02415439|636201|P6|COMPLETED|Overall Study||6
264841|NCT02415439|636202|P5|COMPLETED|Overall Study||6
264842|NCT02415439|636203|P4|COMPLETED|Overall Study||6
264843|NCT02415439|636204|P3|COMPLETED|Overall Study||6
264844|NCT02415439|636205|P2|COMPLETED|Overall Study||6
264845|NCT02415439|636206|P1|COMPLETED|Overall Study||6
264846|NCT02415439|636194|P13|STARTED|Overall Study||8
264847|NCT02415439|636195|P12|STARTED|Overall Study||6
264848|NCT02415439|636196|P11|STARTED|Overall Study||6
264849|NCT02415439|636197|P10|STARTED|Overall Study||6
264850|NCT02415439|636198|P9|STARTED|Overall Study||6
264851|NCT02415439|636199|P8|STARTED|Overall Study||12
264852|NCT02415439|636200|P7|STARTED|Overall Study||6
264853|NCT02415439|636201|P6|STARTED|Overall Study||6
264854|NCT02415439|636202|P5|STARTED|Overall Study||6
264855|NCT02415439|636203|P4|STARTED|Overall Study||6
264856|NCT02415439|636204|P3|STARTED|Overall Study||6
264857|NCT02415439|636205|P2|STARTED|Overall Study||6
264858|NCT02415439|636206|P1|STARTED|Overall Study||6
264859|NCT02414828|636264|P4|NOT COMPLETED|Overall Study||2
264860|NCT02414828|636265|P3|NOT COMPLETED|Overall Study||1
264861|NCT02414828|636266|P2|NOT COMPLETED|Overall Study||1
264862|NCT02414828|636267|P1|NOT COMPLETED|Overall Study||0
264863|NCT02414828|636264|P4|COMPLETED|Overall Study||29
264864|NCT02414828|636265|P3|COMPLETED|Overall Study||19
264865|NCT02414828|636266|P2|COMPLETED|Overall Study||9
264866|NCT02414828|636267|P1|COMPLETED|Overall Study||11
264867|NCT02414828|636264|P4|STARTED|Overall Study||31
264868|NCT02414828|636265|P3|STARTED|Overall Study||20
264869|NCT02414828|636266|P2|STARTED|Overall Study||10
264870|NCT02414828|636267|P1|STARTED|Overall Study||11
264871|NCT02414152|636305|P1|NOT COMPLETED|Overall Study||2
264872|NCT02414152|636305|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
264873|NCT02414152|636305|P1|STARTED|Overall Study||2
264874|NCT02413593|636309|P1|NOT COMPLETED|Overall Study||4
264875|NCT02413593|636309|P1|COMPLETED|Overall Study||107
264876|NCT02413593|636309|P1|STARTED|Overall Study||111
264877|NCT02413333|636322|P2|NOT COMPLETED|Period 2||0
264878|NCT02413333|636323|P1|NOT COMPLETED|Period 2||1
264879|NCT02413333|636322|P2|COMPLETED|Period 2||65
264880|NCT02413333|636323|P1|COMPLETED|Period 2||64
264881|NCT02413333|636322|P2|STARTED|Period 2||65
264882|NCT02413333|636323|P1|STARTED|Period 2||65
264883|NCT02413333|636322|P2|NOT COMPLETED|Period 1||1
264884|NCT02413333|636323|P1|NOT COMPLETED|Period 1||1
264885|NCT02413333|636322|P2|COMPLETED|Period 1||65
264886|NCT02413333|636323|P1|COMPLETED|Period 1||65
264887|NCT02413333|636322|P2|Randomized and Treated|Period 1||66
264888|NCT02413333|636323|P1|Randomized and Treated|Period 1||66
264889|NCT02413333|636322|P2|STARTED|Period 1||66
264890|NCT02413333|636323|P1|STARTED|Period 1||66
264891|NCT02413294|636331|P1|NOT COMPLETED|Overall Study||1
264892|NCT02413294|636331|P1|COMPLETED|Overall Study||11
264893|NCT02413294|636331|P1|STARTED|Overall Study||12
264894|NCT02413203|636351|P2|NOT COMPLETED|Overall Study||0
264895|NCT02413203|636352|P1|NOT COMPLETED|Overall Study||0
264896|NCT02413203|636351|P2|COMPLETED|Overall Study||10
264897|NCT02413203|636352|P1|COMPLETED|Overall Study||10
264898|NCT02413203|636351|P2|STARTED|Overall Study||10
264899|NCT02413203|636352|P1|STARTED|Overall Study||10
264900|NCT02413034|636374|P2|NOT COMPLETED|Overall Study||0
264901|NCT02413034|636375|P1|NOT COMPLETED|Overall Study||0
264902|NCT02413034|636374|P2|COMPLETED|Overall Study||14
264903|NCT02413034|636375|P1|COMPLETED|Overall Study||14
264904|NCT02413034|636374|P2|STARTED|Overall Study||14
264905|NCT02413034|636375|P1|STARTED|Overall Study||14
264906|NCT02412657|636386|P3|NOT COMPLETED|Overall Study||3
264907|NCT02412657|636387|P2|NOT COMPLETED|Overall Study||2
264908|NCT02412657|636388|P1|NOT COMPLETED|Overall Study||1
264909|NCT02412657|636386|P3|COMPLETED|Overall Study||22
264910|NCT02412657|636387|P2|COMPLETED|Overall Study||23
264911|NCT02412657|636388|P1|COMPLETED|Overall Study||24
264912|NCT02412657|636386|P3|STARTED|Overall Study||25
264913|NCT02412657|636387|P2|STARTED|Overall Study||25
264914|NCT02412657|636388|P1|STARTED|Overall Study||25
264915|NCT02411201|636396|P1|NOT COMPLETED|Overall Study||6
264916|NCT02411201|636396|P1|COMPLETED|Overall Study||45
264917|NCT02411201|636396|P1|STARTED|Overall Study||51
264918|NCT02411929|636407|P1|NOT COMPLETED|Period 2||0
264919|NCT02411929|636407|P1|COMPLETED|Period 2||8
264920|NCT02411929|636407|P1|STARTED|Period 2||8
264921|NCT02411929|636407|P1|NOT COMPLETED|Washout Period||0
264922|NCT02411929|636407|P1|COMPLETED|Washout Period||8
264923|NCT02411929|636407|P1|STARTED|Washout Period||8
264924|NCT02411929|636407|P1|NOT COMPLETED|Period 1||0
264925|NCT02411929|636407|P1|COMPLETED|Period 1||8
264926|NCT02411929|636407|P1|STARTED|Period 1||8
264927|NCT02411747|636439|P2|NOT COMPLETED|Overall Study||4
264928|NCT02411747|636440|P1|NOT COMPLETED|Overall Study||3
264929|NCT02411747|636439|P2|COMPLETED|Overall Study||12
264930|NCT02411747|636440|P1|COMPLETED|Overall Study||13
264931|NCT02411747|636439|P2|Simulation Training Completed|Overall Study||16
264932|NCT02411747|636440|P1|Simulation Training Completed|Overall Study||16
264933|NCT02411747|636439|P2|STARTED|Overall Study||16
264934|NCT02411747|636440|P1|STARTED|Overall Study||16
264935|NCT02410824|636446|P2|NOT COMPLETED|Second Intervention (One Week)||0
264936|NCT02410824|636447|P1|NOT COMPLETED|Second Intervention (One Week)||0
264937|NCT02410824|636446|P2|COMPLETED|Second Intervention (One Week)||22
264938|NCT02410824|636447|P1|COMPLETED|Second Intervention (One Week)||22
264939|NCT02410824|636446|P2|STARTED|Second Intervention (One Week)||22
264940|NCT02410824|636447|P1|STARTED|Second Intervention (One Week)||22
264941|NCT02410824|636446|P2|NOT COMPLETED|First Intervention (One Week)||1
264942|NCT02410824|636447|P1|NOT COMPLETED|First Intervention (One Week)||0
264943|NCT02410824|636446|P2|COMPLETED|First Intervention (One Week)||22
264944|NCT02410824|636447|P1|COMPLETED|First Intervention (One Week)||22
264945|NCT02410824|636446|P2|STARTED|First Intervention (One Week)||23
264946|NCT02410824|636447|P1|STARTED|First Intervention (One Week)||22
264947|NCT02410291|636481|P2|NOT COMPLETED|Overall Study||0
264948|NCT02410291|636482|P1|NOT COMPLETED|Overall Study||0
264949|NCT02410291|636481|P2|COMPLETED|Overall Study||29
264950|NCT02410291|636482|P1|COMPLETED|Overall Study||29
264951|NCT02410291|636481|P2|STARTED|Overall Study||29
264952|NCT02410291|636482|P1|STARTED|Overall Study||29
264953|NCT02410200|636488|P1|NOT COMPLETED|Overall Study||2
264954|NCT02410200|636488|P1|COMPLETED|Overall Study||20
264955|NCT02410200|636488|P1|STARTED|Overall Study||22
264956|NCT02408692|636502|P3|NOT COMPLETED|Overall Study||0
264957|NCT02408692|636503|P2|NOT COMPLETED|Overall Study||0
264958|NCT02408692|636504|P1|NOT COMPLETED|Overall Study||0
264959|NCT02408692|636502|P3|COMPLETED|Overall Study||5
264960|NCT02408692|636503|P2|COMPLETED|Overall Study||5
264961|NCT02408692|636504|P1|COMPLETED|Overall Study||5
264962|NCT02408692|636502|P3|STARTED|Overall Study||5
264963|NCT02408692|636503|P2|STARTED|Overall Study||5
264964|NCT02408692|636504|P1|STARTED|Overall Study||5
264965|NCT02406937|636518|P3|NOT COMPLETED|Overall Study||2
264966|NCT02406937|636519|P2|NOT COMPLETED|Overall Study||1
264967|NCT02406937|636520|P1|NOT COMPLETED|Overall Study||1
264968|NCT02406937|636518|P3|COMPLETED|Overall Study||58
264969|NCT02406937|636519|P2|COMPLETED|Overall Study||59
264970|NCT02406937|636520|P1|COMPLETED|Overall Study||59
264971|NCT02406937|636518|P3|STARTED|Overall Study||60
264972|NCT02406937|636519|P2|STARTED|Overall Study||60
264973|NCT02406937|636520|P1|STARTED|Overall Study||60
264974|NCT02406586|636579|P3|NOT COMPLETED|Overall Study||2
264975|NCT02406586|636580|P2|NOT COMPLETED|Overall Study||4
264976|NCT02406586|636581|P1|NOT COMPLETED|Overall Study||1
264977|NCT02406586|636579|P3|COMPLETED|Overall Study||10
264978|NCT02406586|636580|P2|COMPLETED|Overall Study||8
264979|NCT02406586|636581|P1|COMPLETED|Overall Study||11
264980|NCT02406586|636579|P3|STARTED|Overall Study||12
264981|NCT02406586|636580|P2|STARTED|Overall Study||12
264982|NCT02406586|636581|P1|STARTED|Overall Study||12
264983|NCT02406495|636634|P1|NOT COMPLETED|Overall Study||0
264984|NCT02406495|636634|P1|COMPLETED|Overall Study||40
264985|NCT02406495|636634|P1|STARTED|Overall Study||40
264986|NCT02405429|636673|P1|NOT COMPLETED|Overall Study||0
264987|NCT02405429|636673|P1|COMPLETED|Overall Study||49
264988|NCT02405429|636673|P1|STARTED|Overall Study||49
264989|NCT02405390|636683|P2|NOT COMPLETED|Overall Study||0
264990|NCT02405390|636684|P1|NOT COMPLETED|Overall Study||0
264991|NCT02405390|636683|P2|COMPLETED|Overall Study||46
264992|NCT02405390|636684|P1|COMPLETED|Overall Study||46
264993|NCT02405390|636683|P2|STARTED|Overall Study||46
264994|NCT02405390|636684|P1|STARTED|Overall Study||46
264995|NCT02404649|636694|P2|NOT COMPLETED|Overall Study||2
264996|NCT02404649|636695|P1|NOT COMPLETED|Overall Study||1
264997|NCT02404649|636694|P2|COMPLETED|Overall Study||14
264998|NCT02404649|636695|P1|COMPLETED|Overall Study||16
264999|NCT02404649|636694|P2|STARTED|Overall Study||16
265000|NCT02404649|636695|P1|STARTED|Overall Study||17
265001|NCT02404493|636703|P2|NOT COMPLETED|Overall Study||1
265002|NCT02404493|636704|P1|NOT COMPLETED|Overall Study||1
265003|NCT02404493|636703|P2|COMPLETED|Overall Study||5
265004|NCT02404493|636704|P1|COMPLETED|Overall Study||16
265005|NCT02404493|636703|P2|STARTED|Overall Study||6
265006|NCT02404493|636704|P1|STARTED|Overall Study||17
265007|NCT02403830|636944|P2|NOT COMPLETED|Visit 2||0
265008|NCT02403830|636945|P1|NOT COMPLETED|Visit 2||0
265009|NCT02403830|636944|P2|COMPLETED|Visit 2||15
265010|NCT02403830|636945|P1|COMPLETED|Visit 2||14
265011|NCT02403830|636944|P2|STARTED|Visit 2||15
265012|NCT02403830|636945|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
265013|NCT02403830|636944|P2|NOT COMPLETED|Visit 1||0
265014|NCT02403830|636945|P1|NOT COMPLETED|Visit 1||0
265015|NCT02403830|636944|P2|COMPLETED|Visit 1||15
265016|NCT02403830|636945|P1|COMPLETED|Visit 1||15
265017|NCT02403830|636944|P2|STARTED|Visit 1||15
265018|NCT02403830|636945|P1|STARTED|Visit 1||15
265019|NCT02403180|636957|P2|NOT COMPLETED|Period 2 (5 Days)||1
265020|NCT02403180|636958|P1|NOT COMPLETED|Period 2 (5 Days)||0
265021|NCT02403180|636957|P2|COMPLETED|Period 2 (5 Days)||32
265022|NCT02403180|636958|P1|COMPLETED|Period 2 (5 Days)||36
265023|NCT02403180|636957|P2|STARTED|Period 2 (5 Days)||33
265024|NCT02403180|636958|P1|STARTED|Period 2 (5 Days)||36
265025|NCT02403180|636957|P2|NOT COMPLETED|Period 1 (5 Days)||0
265026|NCT02403180|636958|P1|NOT COMPLETED|Period 1 (5 Days)||0
265027|NCT02403180|636957|P2|COMPLETED|Period 1 (5 Days)||33
265028|NCT02403180|636958|P1|COMPLETED|Period 1 (5 Days)||36
265029|NCT02403180|636957|P2|Randomized|Period 1 (5 Days)||33
265030|NCT02403180|636958|P1|Randomized|Period 1 (5 Days)||36
265031|NCT02403180|636957|P2|STARTED|Period 1 (5 Days)||33
265032|NCT02403180|636958|P1|STARTED|Period 1 (5 Days)||36
265033|NCT02403180|636957|P2|NOT COMPLETED|Pre-Treatment Period||1
265034|NCT02403180|636958|P1|NOT COMPLETED|Pre-Treatment Period||0
265035|NCT02403180|636957|P2|COMPLETED|Pre-Treatment Period||33
265036|NCT02403180|636958|P1|COMPLETED|Pre-Treatment Period||36
265037|NCT02403180|636957|P2|STARTED|Pre-Treatment Period||34
265038|NCT02403180|636958|P1|STARTED|Pre-Treatment Period||36
265039|NCT02402764|636966|P1|NOT COMPLETED|Overall Study||0
265040|NCT02402764|636966|P1|COMPLETED|Overall Study||10
265041|NCT02402764|636966|P1|STARTED|Overall Study||10
265042|NCT02402322|636977|P3|NOT COMPLETED|Follow-up||24
265043|NCT02402322|636978|P2|NOT COMPLETED|Follow-up||3
265044|NCT02402322|636979|P1|NOT COMPLETED|Follow-up||6
265045|NCT02402322|636977|P3|COMPLETED|Follow-up||0
265046|NCT02402322|636978|P2|COMPLETED|Follow-up||21
265047|NCT02402322|636979|P1|COMPLETED|Follow-up||18
265048|NCT02402322|636977|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
265049|NCT02402322|636978|P2|STARTED|Follow-up||24
265050|NCT02402322|636979|P1|STARTED|Follow-up||24
265051|NCT02402322|636977|P3|NOT COMPLETED|Pretreatment||1
265052|NCT02402322|636978|P2|NOT COMPLETED|Pretreatment||1
265053|NCT02402322|636979|P1|NOT COMPLETED|Pretreatment||3
265054|NCT02402322|636977|P3|COMPLETED|Pretreatment||24
265055|NCT02402322|636978|P2|COMPLETED|Pretreatment||24
265056|NCT02402322|636979|P1|COMPLETED|Pretreatment||24
265057|NCT02402322|636977|P3|Posttreatment Measures|Pretreatment||24
265058|NCT02402322|636978|P2|Posttreatment Measures|Pretreatment||24
265059|NCT02402322|636979|P1|Posttreatment Measures|Pretreatment||24
265060|NCT02402322|636977|P3|STARTED|Pretreatment||25
265061|NCT02402322|636978|P2|STARTED|Pretreatment||25
265062|NCT02402322|636979|P1|STARTED|Pretreatment||27
265063|NCT02402296|637013|P2|NOT COMPLETED|Overall Study||0
265064|NCT02402296|637014|P1|NOT COMPLETED|Overall Study||0
265065|NCT02402296|637013|P2|COMPLETED|Overall Study||15
265066|NCT02402296|637014|P1|COMPLETED|Overall Study||15
265067|NCT02402296|637013|P2|STARTED|Overall Study||15
265068|NCT02402296|637014|P1|STARTED|Overall Study||15
265069|NCT02402127|637032|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
265070|NCT02402127|637033|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
265071|NCT02402127|637034|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
265072|NCT02402127|637035|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
265073|NCT02402127|637036|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
265074|NCT02402127|637037|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
265075|NCT02402127|637032|P6|COMPLETED|Third Wear Period (1 Day)||4
265076|NCT02402127|637033|P5|COMPLETED|Third Wear Period (1 Day)||4
265077|NCT02402127|637034|P4|COMPLETED|Third Wear Period (1 Day)||4
265078|NCT02402127|637035|P3|COMPLETED|Third Wear Period (1 Day)||4
265079|NCT02402127|637036|P2|COMPLETED|Third Wear Period (1 Day)||4
265080|NCT02402127|637037|P1|COMPLETED|Third Wear Period (1 Day)||4
265081|NCT02402127|637032|P6|STARTED|Third Wear Period (1 Day)||4
265082|NCT02402127|637033|P5|STARTED|Third Wear Period (1 Day)||4
265083|NCT02402127|637034|P4|STARTED|Third Wear Period (1 Day)||4
265084|NCT02402127|637035|P3|STARTED|Third Wear Period (1 Day)||4
265085|NCT02402127|637036|P2|STARTED|Third Wear Period (1 Day)||4
265086|NCT02402127|637037|P1|STARTED|Third Wear Period (1 Day)||4
265087|NCT02402127|637032|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
265088|NCT02402127|637033|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
265089|NCT02402127|637034|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
265090|NCT02402127|637035|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
265091|NCT02402127|637036|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
265092|NCT02402127|637037|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
265093|NCT02402127|637032|P6|COMPLETED|Second Wear Period (1 Day)||4
265094|NCT02402127|637033|P5|COMPLETED|Second Wear Period (1 Day)||4
265095|NCT02402127|637034|P4|COMPLETED|Second Wear Period (1 Day)||4
265096|NCT02402127|637035|P3|COMPLETED|Second Wear Period (1 Day)||4
265097|NCT02402127|637036|P2|COMPLETED|Second Wear Period (1 Day)||4
265098|NCT02402127|637037|P1|COMPLETED|Second Wear Period (1 Day)||4
265099|NCT02402127|637032|P6|STARTED|Second Wear Period (1 Day)||4
265100|NCT02402127|637033|P5|STARTED|Second Wear Period (1 Day)||4
265101|NCT02402127|637034|P4|STARTED|Second Wear Period (1 Day)||4
265102|NCT02402127|637035|P3|STARTED|Second Wear Period (1 Day)||4
265103|NCT02402127|637036|P2|STARTED|Second Wear Period (1 Day)||4
265104|NCT02402127|637037|P1|STARTED|Second Wear Period (1 Day)||4
265105|NCT02402127|637032|P6|NOT COMPLETED|First Wear Period (1 Day)||0
265106|NCT02402127|637033|P5|NOT COMPLETED|First Wear Period (1 Day)||0
265107|NCT02402127|637034|P4|NOT COMPLETED|First Wear Period (1 Day)||0
265108|NCT02402127|637035|P3|NOT COMPLETED|First Wear Period (1 Day)||0
265109|NCT02402127|637036|P2|NOT COMPLETED|First Wear Period (1 Day)||0
265110|NCT02402127|637037|P1|NOT COMPLETED|First Wear Period (1 Day)||0
265111|NCT02402127|637032|P6|COMPLETED|First Wear Period (1 Day)||4
265112|NCT02402127|637033|P5|COMPLETED|First Wear Period (1 Day)||4
265113|NCT02402127|637034|P4|COMPLETED|First Wear Period (1 Day)||4
265114|NCT02402127|637035|P3|COMPLETED|First Wear Period (1 Day)||4
265115|NCT02402127|637036|P2|COMPLETED|First Wear Period (1 Day)||4
265116|NCT02402127|637037|P1|COMPLETED|First Wear Period (1 Day)||4
265117|NCT02402127|637032|P6|Randomized and Treated|First Wear Period (1 Day)||4
265118|NCT02402127|637033|P5|Randomized and Treated|First Wear Period (1 Day)||4
265119|NCT02402127|637034|P4|Randomized and Treated|First Wear Period (1 Day)||4
265120|NCT02402127|637035|P3|Randomized and Treated|First Wear Period (1 Day)||4
265121|NCT02402127|637036|P2|Randomized and Treated|First Wear Period (1 Day)||4
265122|NCT02402127|637037|P1|Randomized and Treated|First Wear Period (1 Day)||4
265123|NCT02402127|637032|P6|STARTED|First Wear Period (1 Day)||4
265124|NCT02402127|637033|P5|STARTED|First Wear Period (1 Day)||4
265125|NCT02402127|637034|P4|STARTED|First Wear Period (1 Day)||4
265126|NCT02402127|637035|P3|STARTED|First Wear Period (1 Day)||4
265127|NCT02402127|637036|P2|STARTED|First Wear Period (1 Day)||4
265128|NCT02402127|637037|P1|STARTED|First Wear Period (1 Day)||4
265129|NCT02401555|637051|P3|NOT COMPLETED|Overall Study||0
265130|NCT02401555|637052|P2|NOT COMPLETED|Overall Study||0
265131|NCT02401555|637053|P1|NOT COMPLETED|Overall Study||0
265132|NCT02401555|637051|P3|COMPLETED|Overall Study||120
265133|NCT02401555|637052|P2|COMPLETED|Overall Study||212
265134|NCT02401555|637053|P1|COMPLETED|Overall Study||87
265135|NCT02401555|637051|P3|STARTED|Overall Study||120
265136|NCT02401555|637052|P2|STARTED|Overall Study||212
265137|NCT02401555|637053|P1|STARTED|Overall Study||87
265138|NCT02401529|637063|P2|NOT COMPLETED|Overall Study||7
265139|NCT02401529|637064|P1|NOT COMPLETED|Overall Study||9
265140|NCT02401529|637063|P2|COMPLETED|Overall Study||50
265141|NCT02401529|637064|P1|COMPLETED|Overall Study||50
265142|NCT02401529|637063|P2|STARTED|Overall Study||57
265143|NCT02401529|637064|P1|STARTED|Overall Study||59
265144|NCT02401464|637092|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
265145|NCT02401464|637093|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
265146|NCT02401464|637094|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
265147|NCT02401464|637095|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
265148|NCT02401464|637092|P4|COMPLETED|Intervention Period 2 (6 Days)||13
265149|NCT02401464|637093|P3|COMPLETED|Intervention Period 2 (6 Days)||13
265150|NCT02401464|637094|P2|COMPLETED|Intervention Period 2 (6 Days)||13
265151|NCT02401464|637095|P1|COMPLETED|Intervention Period 2 (6 Days)||13
265152|NCT02401464|637092|P4|STARTED|Intervention Period 2 (6 Days)||13
265153|NCT02401464|637093|P3|STARTED|Intervention Period 2 (6 Days)||13
265154|NCT02401464|637094|P2|STARTED|Intervention Period 2 (6 Days)||13
265155|NCT02401464|637095|P1|STARTED|Intervention Period 2 (6 Days)||13
265156|NCT02401464|637092|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
265157|NCT02401464|637093|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
265158|NCT02401464|637094|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
265159|NCT02401464|637095|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
265160|NCT02401464|637092|P4|COMPLETED|Washout Period (At Least 6 Days)||13
265161|NCT02401464|637093|P3|COMPLETED|Washout Period (At Least 6 Days)||13
265162|NCT02401464|637094|P2|COMPLETED|Washout Period (At Least 6 Days)||13
265163|NCT02401464|637095|P1|COMPLETED|Washout Period (At Least 6 Days)||13
265164|NCT02401464|637092|P4|STARTED|Washout Period (At Least 6 Days)||13
265165|NCT02401464|637093|P3|STARTED|Washout Period (At Least 6 Days)||13
265166|NCT02401464|637094|P2|STARTED|Washout Period (At Least 6 Days)||13
265167|NCT02401464|637095|P1|STARTED|Washout Period (At Least 6 Days)||13
265168|NCT02401464|637092|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
265169|NCT02401464|637093|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
265170|NCT02401464|637094|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
265171|NCT02401464|637095|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
265172|NCT02401464|637092|P4|COMPLETED|Intervention Period 1 (6 Days)||13
265173|NCT02401464|637093|P3|COMPLETED|Intervention Period 1 (6 Days)||13
265174|NCT02401464|637094|P2|COMPLETED|Intervention Period 1 (6 Days)||13
265175|NCT02401464|637095|P1|COMPLETED|Intervention Period 1 (6 Days)||13
265176|NCT02401464|637092|P4|STARTED|Intervention Period 1 (6 Days)||13
265177|NCT02401464|637093|P3|STARTED|Intervention Period 1 (6 Days)||13
265178|NCT02401464|637094|P2|STARTED|Intervention Period 1 (6 Days)||13
265179|NCT02401464|637095|P1|STARTED|Intervention Period 1 (6 Days)||13
265180|NCT02400996|637129|P1|NOT COMPLETED|Overall Study||0
265181|NCT02400996|637129|P1|COMPLETED|Overall Study||40
265182|NCT02400996|637129|P1|STARTED|Overall Study||40
265183|NCT02400710|637135|P2|NOT COMPLETED|Overall Study||0
265184|NCT02400710|637136|P1|NOT COMPLETED|Overall Study||0
265185|NCT02400710|637135|P2|COMPLETED|Overall Study||10
265186|NCT02400710|637136|P1|COMPLETED|Overall Study||10
265187|NCT02400710|637135|P2|STARTED|Overall Study||10
265188|NCT02400710|637136|P1|STARTED|Overall Study||10
265189|NCT02400333|637148|P4|NOT COMPLETED|Overall Study||2
265190|NCT02400333|637149|P3|NOT COMPLETED|Overall Study||2
265191|NCT02400333|637150|P2|NOT COMPLETED|Overall Study||1
265192|NCT02400333|637151|P1|NOT COMPLETED|Overall Study||1
265193|NCT02400333|637148|P4|COMPLETED|Overall Study||7
265194|NCT02400333|637149|P3|COMPLETED|Overall Study||7
265195|NCT02400333|637150|P2|COMPLETED|Overall Study||8
265196|NCT02400333|637151|P1|COMPLETED|Overall Study||8
265197|NCT02400333|637148|P4|STARTED|Overall Study||9
265198|NCT02400333|637149|P3|STARTED|Overall Study||9
265199|NCT02400333|637150|P2|STARTED|Overall Study||9
265200|NCT02400333|637151|P1|STARTED|Overall Study||9
265201|NCT02399345|637209|P1|NOT COMPLETED|Overall Study||0
265202|NCT02399345|637209|P1|COMPLETED|Overall Study||10
265203|NCT02399345|637209|P1|STARTED|Overall Study||10
265204|NCT02399163|637215|P1|NOT COMPLETED|Overall Study||9
265205|NCT02399163|637215|P1|COMPLETED|Overall Study||53
265206|NCT02399163|637215|P1|STARTED|Overall Study||62
265207|NCT02399111|637243|P4|NOT COMPLETED|Overall Study||0
265208|NCT02399111|637244|P3|NOT COMPLETED|Overall Study||0
265209|NCT02399111|637245|P2|NOT COMPLETED|Overall Study||0
265210|NCT02399111|637246|P1|NOT COMPLETED|Overall Study||0
265211|NCT02399111|637243|P4|COMPLETED|Overall Study||0
265212|NCT02399111|637244|P3|COMPLETED|Overall Study||4
265213|NCT02399111|637245|P2|COMPLETED|Overall Study||1
265214|NCT02399111|637246|P1|COMPLETED|Overall Study||4
265215|NCT02399111|637243|P4|STARTED|Overall Study||0
265216|NCT02399111|637244|P3|STARTED|Overall Study||4
265217|NCT02399111|637245|P2|STARTED|Overall Study||1
265218|NCT02399111|637246|P1|STARTED|Overall Study||4
265219|NCT02397915|637260|P4|NOT COMPLETED|Period 2||0
265220|NCT02397915|637261|P3|NOT COMPLETED|Period 2||0
265221|NCT02397915|637262|P2|NOT COMPLETED|Period 2||0
265222|NCT02397915|637263|P1|NOT COMPLETED|Period 2||0
265223|NCT02397915|637260|P4|COMPLETED|Period 2||149
265224|NCT02397915|637261|P3|COMPLETED|Period 2||149
265225|NCT02397915|637262|P2|COMPLETED|Period 2||0
265226|NCT02397915|637263|P1|COMPLETED|Period 2||0
265227|NCT02397915|637260|P4|STARTED|Period 2||149
265228|NCT02397915|637261|P3|STARTED|Period 2||149
265229|NCT02397915|637262|P2|STARTED|Period 2||0
265230|NCT02397915|637263|P1|STARTED|Period 2||0
265231|NCT02397915|637260|P4|NOT COMPLETED|Period 1||0
265232|NCT02397915|637261|P3|NOT COMPLETED|Period 1||0
265233|NCT02397915|637262|P2|NOT COMPLETED|Period 1||1
265234|NCT02397915|637263|P1|NOT COMPLETED|Period 1||1
265235|NCT02397915|637260|P4|COMPLETED|Period 1||0
265236|NCT02397915|637261|P3|COMPLETED|Period 1||0
265237|NCT02397915|637262|P2|COMPLETED|Period 1||149
265238|NCT02397915|637263|P1|COMPLETED|Period 1||149
265239|NCT02397915|637260|P4|STARTED|Period 1||0
265240|NCT02397915|637261|P3|STARTED|Period 1||0
265241|NCT02397915|637262|P2|STARTED|Period 1||150
265242|NCT02397915|637263|P1|STARTED|Period 1||150
265243|NCT02397655|637313|P1|NOT COMPLETED|Overall Study||1301
265244|NCT02397655|637313|P1|COMPLETED|Overall Study||10711
265245|NCT02397655|637313|P1|STARTED|Overall Study||12012
265246|NCT02396537|637319|P2|NOT COMPLETED|Overall Study||1
265247|NCT02396537|637320|P1|NOT COMPLETED|Overall Study||0
265248|NCT02396537|637319|P2|COMPLETED|Overall Study||36
265249|NCT02396537|637320|P1|COMPLETED|Overall Study||40
265250|NCT02396537|637319|P2|STARTED|Overall Study||37
265251|NCT02396537|637320|P1|STARTED|Overall Study||40
265252|NCT02396160|637328|P2|NOT COMPLETED|Overall Study||2
265253|NCT02396160|637329|P1|NOT COMPLETED|Overall Study||6
265254|NCT02396160|637328|P2|COMPLETED|Overall Study||73
265255|NCT02396160|637329|P1|COMPLETED|Overall Study||69
265256|NCT02396160|637328|P2|STARTED|Overall Study||75
265257|NCT02396160|637329|P1|STARTED|Overall Study||75
265258|NCT02396147|637345|P2|NOT COMPLETED|Period 3||0
265259|NCT02396147|637346|P1|NOT COMPLETED|Period 3||0
265260|NCT02396147|637345|P2|COMPLETED|Period 3||27
265261|NCT02396147|637346|P1|COMPLETED|Period 3||27
265262|NCT02396147|637345|P2|STARTED|Period 3||27
265263|NCT02396147|637346|P1|STARTED|Period 3||27
265264|NCT02396147|637345|P2|NOT COMPLETED|Period 2||0
265265|NCT02396147|637346|P1|NOT COMPLETED|Period 2||0
265266|NCT02396147|637345|P2|COMPLETED|Period 2||27
265267|NCT02396147|637346|P1|COMPLETED|Period 2||27
265268|NCT02396147|637345|P2|STARTED|Period 2||27
265269|NCT02396147|637346|P1|STARTED|Period 2||27
265270|NCT02396147|637345|P2|NOT COMPLETED|Period 1||0
265271|NCT02396147|637346|P1|NOT COMPLETED|Period 1||0
265272|NCT02396147|637345|P2|COMPLETED|Period 1||27
265273|NCT02396147|637346|P1|COMPLETED|Period 1||27
265274|NCT02396147|637345|P2|STARTED|Period 1||27
265275|NCT02396147|637346|P1|STARTED|Period 1||27
265276|NCT02395302|637414|P1|NOT COMPLETED|Overall Study||14
265277|NCT02395302|637414|P1|COMPLETED|Overall Study||14
265278|NCT02395302|637414|P1|STARTED|Overall Study||28
265279|NCT02395055|637420|P2|NOT COMPLETED|Overall Study||3
265280|NCT02395055|637421|P1|NOT COMPLETED|Overall Study||7
265281|NCT02395055|637420|P2|COMPLETED|Overall Study||44
265282|NCT02395055|637421|P1|COMPLETED|Overall Study||40
265283|NCT02395055|637420|P2|STARTED|Overall Study||47
265284|NCT02395055|637421|P1|STARTED|Overall Study||47
265285|NCT02394925|637431|P1|NOT COMPLETED|Overall Study||29
265286|NCT02394925|637431|P1|COMPLETED|Overall Study||79
265287|NCT02394925|637431|P1|STARTED|Overall Study||108
265288|NCT02394756|637435|P6|NOT COMPLETED|Period 3||0
265289|NCT02394756|637436|P5|NOT COMPLETED|Period 3||0
265290|NCT02394756|637437|P4|NOT COMPLETED|Period 3||0
265291|NCT02394756|637438|P3|NOT COMPLETED|Period 3||0
265292|NCT02394756|637439|P2|NOT COMPLETED|Period 3||0
265293|NCT02394756|637440|P1|NOT COMPLETED|Period 3||0
265294|NCT02394756|637435|P6|COMPLETED|Period 3||6
265295|NCT02394756|637436|P5|COMPLETED|Period 3||6
265296|NCT02394756|637437|P4|COMPLETED|Period 3||6
265297|NCT02394756|637438|P3|COMPLETED|Period 3||6
265298|NCT02394756|637439|P2|COMPLETED|Period 3||6
265299|NCT02394756|637440|P1|COMPLETED|Period 3||7
265300|NCT02394756|637435|P6|STARTED|Period 3||6
265301|NCT02394756|637436|P5|STARTED|Period 3||6
265302|NCT02394756|637437|P4|STARTED|Period 3||6
265303|NCT02394756|637438|P3|STARTED|Period 3||6
265304|NCT02394756|637439|P2|STARTED|Period 3||6
265305|NCT02394756|637440|P1|STARTED|Period 3||7
265306|NCT02394756|637435|P6|NOT COMPLETED|Period 2||0
265307|NCT02394756|637436|P5|NOT COMPLETED|Period 2||1
265308|NCT02394756|637437|P4|NOT COMPLETED|Period 2||0
265309|NCT02394756|637438|P3|NOT COMPLETED|Period 2||0
265310|NCT02394756|637439|P2|NOT COMPLETED|Period 2||0
265311|NCT02394756|637440|P1|NOT COMPLETED|Period 2||0
265312|NCT02394756|637435|P6|COMPLETED|Period 2||6
265313|NCT02394756|637436|P5|COMPLETED|Period 2||6
265314|NCT02394756|637437|P4|COMPLETED|Period 2||6
265315|NCT02394756|637438|P3|COMPLETED|Period 2||6
265316|NCT02394756|637439|P2|COMPLETED|Period 2||6
265317|NCT02394756|637440|P1|COMPLETED|Period 2||7
265318|NCT02394756|637435|P6|STARTED|Period 2||6
265319|NCT02394756|637436|P5|STARTED|Period 2||7
265320|NCT02394756|637437|P4|STARTED|Period 2||6
265321|NCT02394756|637438|P3|STARTED|Period 2||6
265322|NCT02394756|637439|P2|STARTED|Period 2||6
265323|NCT02394756|637440|P1|STARTED|Period 2||7
265324|NCT02394756|637435|P6|NOT COMPLETED|Period 1||1
265325|NCT02394756|637436|P5|NOT COMPLETED|Period 1||0
265326|NCT02394756|637437|P4|NOT COMPLETED|Period 1||1
265327|NCT02394756|637438|P3|NOT COMPLETED|Period 1||1
265328|NCT02394756|637439|P2|NOT COMPLETED|Period 1||1
265329|NCT02394756|637440|P1|NOT COMPLETED|Period 1||0
265330|NCT02394756|637435|P6|COMPLETED|Period 1||6
265331|NCT02394756|637436|P5|COMPLETED|Period 1||7
265332|NCT02394756|637437|P4|COMPLETED|Period 1||6
265333|NCT02394756|637438|P3|COMPLETED|Period 1||6
265334|NCT02394756|637439|P2|COMPLETED|Period 1||6
265335|NCT02394756|637440|P1|COMPLETED|Period 1||7
265336|NCT02394756|637435|P6|STARTED|Period 1||7
265337|NCT02394756|637436|P5|STARTED|Period 1||7
265338|NCT02394756|637437|P4|STARTED|Period 1||7
265339|NCT02394756|637438|P3|STARTED|Period 1||7
265340|NCT02394756|637439|P2|STARTED|Period 1||7
265341|NCT02394756|637440|P1|STARTED|Period 1||7
265342|NCT02394665|637454|P3|NOT COMPLETED|Overall Study||0
265343|NCT02394665|637455|P2|NOT COMPLETED|Overall Study||0
265344|NCT02394665|637456|P1|NOT COMPLETED|Overall Study||1
265345|NCT02394665|637454|P3|COMPLETED|Overall Study||0
265346|NCT02394665|637455|P2|COMPLETED|Overall Study||0
265347|NCT02394665|637456|P1|COMPLETED|Overall Study||0
265348|NCT02394665|637454|P3|STARTED|Overall Study||0
265349|NCT02394665|637455|P2|STARTED|Overall Study||0
265350|NCT02394665|637456|P1|STARTED|Overall Study||1
265351|NCT02394457|637478|P2|NOT COMPLETED|Overall Study||0
265352|NCT02394457|637479|P1|NOT COMPLETED|Overall Study||0
265353|NCT02394457|637478|P2|COMPLETED|Overall Study||13
265354|NCT02394457|637479|P1|COMPLETED|Overall Study||15
265355|NCT02394457|637478|P2|STARTED|Overall Study||13
265356|NCT02394457|637479|P1|STARTED|Overall Study||15
265357|NCT02393950|637497|P2|NOT COMPLETED|Overall Study||1
265358|NCT02393950|637498|P1|NOT COMPLETED|Overall Study||1
265359|NCT02393950|637497|P2|COMPLETED|Overall Study||8
265360|NCT02393950|637498|P1|COMPLETED|Overall Study||8
265361|NCT02393950|637497|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
265362|NCT02393950|637498|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
265363|NCT02393950|637497|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
265364|NCT02393950|637498|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
265365|NCT02393950|637497|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
265366|NCT02393950|637498|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
265458|NCT02388815|637905|P1|NOT COMPLETED|Overall Study||4
265367|NCT02393950|637497|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
265368|NCT02393950|637498|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
265369|NCT02393950|637497|P2|STARTED|Overall Study||9
265370|NCT02393950|637498|P1|STARTED|Overall Study||9
265371|NCT02393677|637565|P2|NOT COMPLETED|Overall Study||0
265372|NCT02393677|637566|P1|NOT COMPLETED|Overall Study||0
265373|NCT02393677|637565|P2|COMPLETED|Overall Study||40
265374|NCT02393677|637566|P1|COMPLETED|Overall Study||40
265375|NCT02393677|637565|P2|STARTED|Overall Study||40
265376|NCT02393677|637566|P1|STARTED|Overall Study||40
265377|NCT02393547|637572|P1|NOT COMPLETED|Overall Study||6
265378|NCT02393547|637572|P1|COMPLETED|Overall Study||14
265379|NCT02393547|637572|P1|STARTED|Overall Study||20
265380|NCT02392767|637581|P2|NOT COMPLETED|Overall Study||0
265381|NCT02392767|637582|P1|NOT COMPLETED|Overall Study||0
265382|NCT02392767|637581|P2|COMPLETED|Overall Study||13
265383|NCT02392767|637582|P1|COMPLETED|Overall Study||12
265384|NCT02392767|637581|P2|STARTED|Overall Study||13
265385|NCT02392767|637582|P1|STARTED|Overall Study||12
265386|NCT02392247|637598|P1|NOT COMPLETED|Overall Study||2
265387|NCT02392247|637598|P1|COMPLETED|Overall Study||50
265388|NCT02392247|637598|P1|STARTED|Overall Study||52
265389|NCT02392208|637603|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
265390|NCT02392208|637603|P1|COMPLETED|Telavancin After Hemodialysis||8
265391|NCT02392208|637603|P1|STARTED|Telavancin After Hemodialysis||8
265392|NCT02392208|637603|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
265393|NCT02392208|637603|P1|COMPLETED|Telavancin Before Hemodialysis||8
265394|NCT02392208|637603|P1|STARTED|Telavancin Before Hemodialysis||8
265395|NCT02391714|637615|P2|NOT COMPLETED|Overall Study||0
265396|NCT02391714|637616|P1|NOT COMPLETED|Overall Study||0
265397|NCT02391714|637615|P2|COMPLETED|Overall Study||40
265398|NCT02391714|637616|P1|COMPLETED|Overall Study||40
265399|NCT02391714|637615|P2|STARTED|Overall Study||40
265400|NCT02391714|637616|P1|STARTED|Overall Study||40
265401|NCT02391311|637628|P2|NOT COMPLETED|Overall Study||2
265402|NCT02391311|637629|P1|NOT COMPLETED|Overall Study||3
265403|NCT02391311|637628|P2|COMPLETED|Overall Study||19
265404|NCT02391311|637629|P1|COMPLETED|Overall Study||18
265405|NCT02391311|637628|P2|STARTED|Overall Study||21
265406|NCT02391311|637629|P1|STARTED|Overall Study||21
265407|NCT02391038|637637|P3|NOT COMPLETED|Overall Study||6
265408|NCT02391038|637638|P2|NOT COMPLETED|Overall Study||3
265409|NCT02391038|637639|P1|NOT COMPLETED|Overall Study||3
265410|NCT02391038|637637|P3|COMPLETED|Overall Study||0
265411|NCT02391038|637638|P2|COMPLETED|Overall Study||0
265412|NCT02391038|637639|P1|COMPLETED|Overall Study||0
265413|NCT02391038|637637|P3|STARTED|Overall Study||6
265414|NCT02391038|637638|P2|STARTED|Overall Study||3
265415|NCT02391038|637639|P1|STARTED|Overall Study||3
265416|NCT02390167|637753|P1|NOT COMPLETED|Overall Study||1
265417|NCT02390167|637753|P1|COMPLETED|Overall Study||375
265418|NCT02390167|637753|P1|Without Diabetes|Overall Study||43
265419|NCT02390167|637753|P1|With Diabetes|Overall Study||333
265420|NCT02390167|637753|P1|STARTED|Overall Study||376
265421|NCT02389881|637779|P7|NOT COMPLETED|Overall Study||0
265422|NCT02389881|637780|P6|NOT COMPLETED|Overall Study||0
265423|NCT02389881|637781|P5|NOT COMPLETED|Overall Study||0
265424|NCT02389881|637782|P4|NOT COMPLETED|Overall Study||0
265425|NCT02389881|637783|P3|NOT COMPLETED|Overall Study||0
265426|NCT02389881|637784|P2|NOT COMPLETED|Overall Study||0
265427|NCT02389881|637785|P1|NOT COMPLETED|Overall Study||0
265428|NCT02389881|637779|P7|COMPLETED|Overall Study||2
265429|NCT02389881|637780|P6|COMPLETED|Overall Study||8
265430|NCT02389881|637781|P5|COMPLETED|Overall Study||6
265431|NCT02389881|637782|P4|COMPLETED|Overall Study||6
265432|NCT02389881|637783|P3|COMPLETED|Overall Study||6
265433|NCT02389881|637784|P2|COMPLETED|Overall Study||6
265434|NCT02389881|637785|P1|COMPLETED|Overall Study||6
265435|NCT02389881|637779|P7|STARTED|Overall Study||2
265436|NCT02389881|637780|P6|STARTED|Overall Study||8
265437|NCT02389881|637781|P5|STARTED|Overall Study||6
265438|NCT02389881|637782|P4|STARTED|Overall Study||6
265439|NCT02389881|637783|P3|STARTED|Overall Study||6
265440|NCT02389881|637784|P2|STARTED|Overall Study||6
265441|NCT02389881|637785|P1|STARTED|Overall Study||6
265442|NCT02389452|637834|P1|NOT COMPLETED|Overall Study||25
265443|NCT02389452|637834|P1|COMPLETED|Overall Study||369
265444|NCT02389452|637834|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
265445|NCT02389452|637834|P1|STARTED|Overall Study||394
265446|NCT02389361|637854|P2|NOT COMPLETED|Overall Study||0
265447|NCT02389361|637855|P1|NOT COMPLETED|Overall Study||0
265448|NCT02389361|637854|P2|COMPLETED|Overall Study||27
265449|NCT02389361|637855|P1|COMPLETED|Overall Study||24
265450|NCT02389361|637854|P2|STARTED|Overall Study||27
265451|NCT02389361|637855|P1|STARTED|Overall Study||24
265452|NCT02389088|637861|P1|NOT COMPLETED|Phase II - All Study Participants||0
265453|NCT02389088|637861|P1|COMPLETED|Phase II - All Study Participants||9
265454|NCT02389088|637861|P1|STARTED|Phase II - All Study Participants||9
265455|NCT02389088|637861|P1|NOT COMPLETED|Overall Study - Phase I||0
265456|NCT02389088|637861|P1|COMPLETED|Overall Study - Phase I||9
265457|NCT02389088|637861|P1|STARTED|Overall Study - Phase I||9
265459|NCT02388815|637905|P1|COMPLETED|Overall Study||85
265460|NCT02388815|637905|P1|STARTED|Overall Study||89
265461|NCT02388763|637909|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
265462|NCT02388763|637910|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
265463|NCT02388763|637909|P2|COMPLETED|Period 2, 10 Days of Wear||30
265464|NCT02388763|637910|P1|COMPLETED|Period 2, 10 Days of Wear||30
265465|NCT02388763|637909|P2|STARTED|Period 2, 10 Days of Wear||30
265466|NCT02388763|637910|P1|STARTED|Period 2, 10 Days of Wear||30
265467|NCT02388763|637909|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
265468|NCT02388763|637910|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
265469|NCT02388763|637909|P2|COMPLETED|Period 1, 10 Days of Wear||30
265470|NCT02388763|637910|P1|COMPLETED|Period 1, 10 Days of Wear||30
265471|NCT02388763|637909|P2|STARTED|Period 1, 10 Days of Wear||31
265472|NCT02388763|637910|P1|STARTED|Period 1, 10 Days of Wear||31
265473|NCT02388763|637909|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
265474|NCT02388763|637910|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
265475|NCT02388763|637909|P2|COMPLETED|Habitual, 10 Days of Wear||31
265476|NCT02388763|637910|P1|COMPLETED|Habitual, 10 Days of Wear||31
265477|NCT02388763|637909|P2|STARTED|Habitual, 10 Days of Wear||32
265478|NCT02388763|637910|P1|STARTED|Habitual, 10 Days of Wear||32
265479|NCT02388347|637926|P5|NOT COMPLETED|Overall Study||0
265480|NCT02388347|637927|P4|NOT COMPLETED|Overall Study||0
265481|NCT02388347|637928|P3|NOT COMPLETED|Overall Study||1
265482|NCT02388347|637929|P2|NOT COMPLETED|Overall Study||0
265483|NCT02388347|637930|P1|NOT COMPLETED|Overall Study||0
265484|NCT02388347|637926|P5|COMPLETED|Overall Study||6
265485|NCT02388347|637927|P4|COMPLETED|Overall Study||6
265486|NCT02388347|637928|P3|COMPLETED|Overall Study||5
265487|NCT02388347|637929|P2|COMPLETED|Overall Study||6
265488|NCT02388347|637930|P1|COMPLETED|Overall Study||8
265489|NCT02388347|637926|P5|STARTED|Overall Study||6
265490|NCT02388347|637927|P4|STARTED|Overall Study||6
265491|NCT02388347|637928|P3|STARTED|Overall Study||6
265492|NCT02388347|637929|P2|STARTED|Overall Study||6
265493|NCT02388347|637930|P1|STARTED|Overall Study||8
265494|NCT02388074|637995|P1|NOT COMPLETED|Overall Study||3
265495|NCT02388074|637995|P1|COMPLETED|Overall Study||22
265496|NCT02388074|637995|P1|STARTED|Overall Study||25
265497|NCT02387996|637999|P1|NOT COMPLETED|Overall Study||204
265498|NCT02387996|637999|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
265499|NCT02387996|637999|P1|STARTED|Overall Study||270
265500|NCT02387801|638012|P2|NOT COMPLETED|Post-Treatment Follow-up||0
265501|NCT02387801|638013|P1|NOT COMPLETED|Post-Treatment Follow-up||0
265502|NCT02387801|638012|P2|COMPLETED|Post-Treatment Follow-up||12
265503|NCT02387801|638013|P1|COMPLETED|Post-Treatment Follow-up||0
265504|NCT02387801|638012|P2|STARTED|Post-Treatment Follow-up||12
265505|NCT02387801|638013|P1|STARTED|Post-Treatment Follow-up||0
265506|NCT02387801|638012|P2|NOT COMPLETED|Maintenance Dosing Period||0
265507|NCT02387801|638013|P1|NOT COMPLETED|Maintenance Dosing Period||0
265508|NCT02387801|638012|P2|COMPLETED|Maintenance Dosing Period||12
265509|NCT02387801|638013|P1|COMPLETED|Maintenance Dosing Period||0
265510|NCT02387801|638012|P2|STARTED|Maintenance Dosing Period||12
265511|NCT02387801|638013|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
265512|NCT02387801|638012|P2|NOT COMPLETED|Induction Dosing Period||0
265513|NCT02387801|638013|P1|NOT COMPLETED|Induction Dosing Period||0
265514|NCT02387801|638012|P2|COMPLETED|Induction Dosing Period||6
265515|NCT02387801|638013|P1|COMPLETED|Induction Dosing Period||6
265516|NCT02387801|638012|P2|STARTED|Induction Dosing Period||6
265517|NCT02387801|638013|P1|STARTED|Induction Dosing Period||6
265518|NCT02387710|638031|P2|NOT COMPLETED|Second Study Night||0
265519|NCT02387710|638032|P1|NOT COMPLETED|Second Study Night||0
265520|NCT02387710|638031|P2|COMPLETED|Second Study Night||7
265521|NCT02387710|638032|P1|COMPLETED|Second Study Night||9
265522|NCT02387710|638031|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
265523|NCT02387710|638032|P1|STARTED|Second Study Night||9
265524|NCT02387710|638031|P2|NOT COMPLETED|First Study Night||0
265525|NCT02387710|638032|P1|NOT COMPLETED|First Study Night||0
265526|NCT02387710|638031|P2|COMPLETED|First Study Night||9
265527|NCT02387710|638032|P1|COMPLETED|First Study Night||9
265528|NCT02387710|638031|P2|STARTED|First Study Night||9
265529|NCT02387710|638032|P1|STARTED|First Study Night||9
265530|NCT02387580|638048|P6|NOT COMPLETED|Overall Study||0
265531|NCT02387580|638049|P5|NOT COMPLETED|Overall Study||0
265532|NCT02387580|638050|P4|NOT COMPLETED|Overall Study||1
265533|NCT02387580|638051|P3|NOT COMPLETED|Overall Study||0
265534|NCT02387580|638052|P2|NOT COMPLETED|Overall Study||0
265535|NCT02387580|638053|P1|NOT COMPLETED|Overall Study||0
265536|NCT02387580|638048|P6|COMPLETED|Overall Study||8
265537|NCT02387580|638049|P5|COMPLETED|Overall Study||8
265538|NCT02387580|638050|P4|COMPLETED|Overall Study||7
265539|NCT02387580|638051|P3|COMPLETED|Overall Study||8
265540|NCT02387580|638052|P2|COMPLETED|Overall Study||8
265541|NCT02387580|638053|P1|COMPLETED|Overall Study||8
265542|NCT02387580|638048|P6|STARTED|Overall Study||8
265543|NCT02387580|638049|P5|STARTED|Overall Study||8
265544|NCT02387580|638050|P4|STARTED|Overall Study||8
265545|NCT02387580|638051|P3|STARTED|Overall Study||8
265546|NCT02387580|638052|P2|STARTED|Overall Study||8
265547|NCT02387580|638053|P1|STARTED|Overall Study||8
265548|NCT02387554|638089|P4|NOT COMPLETED|Overall Study||2
265549|NCT02387554|638090|P3|NOT COMPLETED|Overall Study||2
265550|NCT02387554|638091|P2|NOT COMPLETED|Overall Study||0
265551|NCT02387554|638092|P1|NOT COMPLETED|Overall Study||3
265552|NCT02387554|638089|P4|COMPLETED|Overall Study||6
265553|NCT02387554|638090|P3|COMPLETED|Overall Study||6
265554|NCT02387554|638091|P2|COMPLETED|Overall Study||7
265555|NCT02387554|638092|P1|COMPLETED|Overall Study||7
265556|NCT02387554|638089|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
265557|NCT02387554|638090|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
265558|NCT02387554|638091|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
265559|NCT02387554|638092|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
265560|NCT02387502|638105|P3|NOT COMPLETED|Overall Study||0
265561|NCT02387502|638106|P2|NOT COMPLETED|Overall Study||0
265562|NCT02387502|638107|P1|NOT COMPLETED|Overall Study||0
265563|NCT02387502|638105|P3|COMPLETED|Overall Study||40
265564|NCT02387502|638106|P2|COMPLETED|Overall Study||40
265565|NCT02387502|638107|P1|COMPLETED|Overall Study||40
265566|NCT02387502|638105|P3|STARTED|Overall Study||40
265567|NCT02387502|638106|P2|STARTED|Overall Study||40
265568|NCT02387502|638107|P1|STARTED|Overall Study||40
265569|NCT02387268|638115|P1|NOT COMPLETED|Overall Study||1
265570|NCT02387268|638115|P1|COMPLETED|Overall Study||9
265571|NCT02387268|638115|P1|STARTED|Overall Study||10
265572|NCT02384070|638123|P3|NOT COMPLETED|Overall Study||0
265573|NCT02384070|638124|P2|NOT COMPLETED|Overall Study||0
265574|NCT02384070|638125|P1|NOT COMPLETED|Overall Study||0
265575|NCT02384070|638123|P3|COMPLETED|Overall Study||100
265576|NCT02384070|638124|P2|COMPLETED|Overall Study||100
265577|NCT02384070|638125|P1|COMPLETED|Overall Study||100
265578|NCT02384070|638123|P3|STARTED|Overall Study||100
265579|NCT02384070|638124|P2|STARTED|Overall Study||100
265580|NCT02384070|638125|P1|STARTED|Overall Study||100
265581|NCT02383862|638141|P2|NOT COMPLETED|3 Month Follow up||21
265582|NCT02383862|638142|P1|NOT COMPLETED|3 Month Follow up||23
265583|NCT02383862|638141|P2|COMPLETED|3 Month Follow up||128
265584|NCT02383862|638142|P1|COMPLETED|3 Month Follow up||128
265585|NCT02383862|638141|P2|STARTED|3 Month Follow up||149
265586|NCT02383862|638142|P1|STARTED|3 Month Follow up||151
265587|NCT02383862|638141|P2|NOT COMPLETED|Baseline||0
265588|NCT02383862|638142|P1|NOT COMPLETED|Baseline||0
265589|NCT02383862|638141|P2|COMPLETED|Baseline||149
265590|NCT02383862|638142|P1|COMPLETED|Baseline||151
265591|NCT02383862|638141|P2|STARTED|Baseline||149
265592|NCT02383862|638142|P1|STARTED|Baseline||151
265593|NCT02383719|638173|P1|NOT COMPLETED|Overall Study||0
265594|NCT02383719|638173|P1|COMPLETED|Overall Study||18
265595|NCT02383719|638173|P1|STARTED|Overall Study||18
265596|NCT02383420|638180|P3|NOT COMPLETED|Overall Study||0
265597|NCT02383420|638181|P2|NOT COMPLETED|Overall Study||0
265598|NCT02383420|638182|P1|NOT COMPLETED|Overall Study||2
265599|NCT02383420|638180|P3|COMPLETED|Overall Study||3
265600|NCT02383420|638181|P2|COMPLETED|Overall Study||10
265601|NCT02383420|638182|P1|COMPLETED|Overall Study||8
265602|NCT02383420|638180|P3|STARTED|Overall Study||3
265603|NCT02383420|638181|P2|STARTED|Overall Study||10
265604|NCT02383420|638182|P1|STARTED|Overall Study||10
265605|NCT02382913|638200|P10|NOT COMPLETED|Overall Study||0
265606|NCT02382913|638201|P9|NOT COMPLETED|Overall Study||0
265607|NCT02382913|638202|P8|NOT COMPLETED|Overall Study||0
265608|NCT02382913|638203|P7|NOT COMPLETED|Overall Study||0
265609|NCT02382913|638204|P6|NOT COMPLETED|Overall Study||0
265610|NCT02382913|638205|P5|NOT COMPLETED|Overall Study||0
265611|NCT02382913|638206|P4|NOT COMPLETED|Overall Study||0
265612|NCT02382913|638207|P3|NOT COMPLETED|Overall Study||0
265613|NCT02382913|638208|P2|NOT COMPLETED|Overall Study||0
265614|NCT02382913|638209|P1|NOT COMPLETED|Overall Study||0
265615|NCT02382913|638200|P10|COMPLETED|Overall Study||33
265616|NCT02382913|638201|P9|COMPLETED|Overall Study||30
265617|NCT02382913|638202|P8|COMPLETED|Overall Study||30
265618|NCT02382913|638203|P7|COMPLETED|Overall Study||37
265619|NCT02382913|638204|P6|COMPLETED|Overall Study||30
265620|NCT02382913|638205|P5|COMPLETED|Overall Study||33
265621|NCT02382913|638206|P4|COMPLETED|Overall Study||27
265622|NCT02382913|638207|P3|COMPLETED|Overall Study||32
265623|NCT02382913|638208|P2|COMPLETED|Overall Study||36
265624|NCT02382913|638209|P1|COMPLETED|Overall Study||27
265625|NCT02382913|638200|P10|STARTED|Overall Study||33
265626|NCT02382913|638201|P9|STARTED|Overall Study||30
265627|NCT02382913|638202|P8|STARTED|Overall Study||30
265628|NCT02382913|638203|P7|STARTED|Overall Study||37
265629|NCT02382913|638204|P6|STARTED|Overall Study||30
265630|NCT02382913|638205|P5|STARTED|Overall Study||33
265631|NCT02382913|638206|P4|STARTED|Overall Study||27
265632|NCT02382913|638207|P3|STARTED|Overall Study||32
265633|NCT02382913|638208|P2|STARTED|Overall Study||36
265634|NCT02382913|638209|P1|STARTED|Overall Study||27
265635|NCT02382640|638249|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
265636|NCT02382640|638250|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
265637|NCT02382640|638251|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
265638|NCT02382640|638252|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
265639|NCT02382640|638249|P4|COMPLETED|Intervention Period 4 (3 Days)||9
265640|NCT02382640|638250|P3|COMPLETED|Intervention Period 4 (3 Days)||9
265641|NCT02382640|638251|P2|COMPLETED|Intervention Period 4 (3 Days)||9
265642|NCT02382640|638252|P1|COMPLETED|Intervention Period 4 (3 Days)||8
265643|NCT02382640|638249|P4|STARTED|Intervention Period 4 (3 Days)||9
265644|NCT02382640|638250|P3|STARTED|Intervention Period 4 (3 Days)||9
265645|NCT02382640|638251|P2|STARTED|Intervention Period 4 (3 Days)||9
265646|NCT02382640|638252|P1|STARTED|Intervention Period 4 (3 Days)||9
265647|NCT02382640|638249|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
265648|NCT02382640|638250|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
265649|NCT02382640|638251|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
265650|NCT02382640|638252|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
265651|NCT02382640|638249|P4|COMPLETED|Washout Period 3 (7 Days)||9
265652|NCT02382640|638250|P3|COMPLETED|Washout Period 3 (7 Days)||9
265653|NCT02382640|638251|P2|COMPLETED|Washout Period 3 (7 Days)||9
265654|NCT02382640|638252|P1|COMPLETED|Washout Period 3 (7 Days)||9
265655|NCT02382640|638249|P4|STARTED|Washout Period 3 (7 Days)||9
265656|NCT02382640|638250|P3|STARTED|Washout Period 3 (7 Days)||9
265657|NCT02382640|638251|P2|STARTED|Washout Period 3 (7 Days)||9
265658|NCT02382640|638252|P1|STARTED|Washout Period 3 (7 Days)||9
265659|NCT02382640|638249|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
265660|NCT02382640|638250|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
265661|NCT02382640|638251|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
265662|NCT02382640|638252|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
265663|NCT02382640|638249|P4|COMPLETED|Intervention Period 3 (3 Days)||9
265664|NCT02382640|638250|P3|COMPLETED|Intervention Period 3 (3 Days)||9
265665|NCT02382640|638251|P2|COMPLETED|Intervention Period 3 (3 Days)||9
265666|NCT02382640|638252|P1|COMPLETED|Intervention Period 3 (3 Days)||9
265667|NCT02382640|638249|P4|STARTED|Intervention Period 3 (3 Days)||9
265668|NCT02382640|638250|P3|STARTED|Intervention Period 3 (3 Days)||9
265669|NCT02382640|638251|P2|STARTED|Intervention Period 3 (3 Days)||9
265670|NCT02382640|638252|P1|STARTED|Intervention Period 3 (3 Days)||9
265671|NCT02382640|638249|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
265672|NCT02382640|638250|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
265673|NCT02382640|638251|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
265674|NCT02382640|638252|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
265675|NCT02382640|638249|P4|COMPLETED|Washout Period 2 (7 Days)||9
265676|NCT02382640|638250|P3|COMPLETED|Washout Period 2 (7 Days)||9
265677|NCT02382640|638251|P2|COMPLETED|Washout Period 2 (7 Days)||9
265678|NCT02382640|638252|P1|COMPLETED|Washout Period 2 (7 Days)||9
265679|NCT02382640|638249|P4|STARTED|Washout Period 2 (7 Days)||9
265680|NCT02382640|638250|P3|STARTED|Washout Period 2 (7 Days)||9
265681|NCT02382640|638251|P2|STARTED|Washout Period 2 (7 Days)||9
265682|NCT02382640|638252|P1|STARTED|Washout Period 2 (7 Days)||9
265683|NCT02382640|638249|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
265684|NCT02382640|638250|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
265685|NCT02382640|638251|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
265686|NCT02382640|638252|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
265687|NCT02382640|638249|P4|COMPLETED|Intervention Period 2 (3 Days)||9
265688|NCT02382640|638250|P3|COMPLETED|Intervention Period 2 (3 Days)||9
265689|NCT02382640|638251|P2|COMPLETED|Intervention Period 2 (3 Days)||9
265690|NCT02382640|638252|P1|COMPLETED|Intervention Period 2 (3 Days)||9
265691|NCT02382640|638249|P4|STARTED|Intervention Period 2 (3 Days)||9
265692|NCT02382640|638250|P3|STARTED|Intervention Period 2 (3 Days)||9
265693|NCT02382640|638251|P2|STARTED|Intervention Period 2 (3 Days)||9
265694|NCT02382640|638252|P1|STARTED|Intervention Period 2 (3 Days)||9
265695|NCT02382640|638249|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
265696|NCT02382640|638250|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
265697|NCT02382640|638251|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
265698|NCT02382640|638252|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
265699|NCT02382640|638249|P4|COMPLETED|Washout Period 1 (7 Days)||9
265700|NCT02382640|638250|P3|COMPLETED|Washout Period 1 (7 Days)||9
265701|NCT02382640|638251|P2|COMPLETED|Washout Period 1 (7 Days)||9
265702|NCT02382640|638252|P1|COMPLETED|Washout Period 1 (7 Days)||9
265703|NCT02382640|638249|P4|STARTED|Washout Period 1 (7 Days)||9
265704|NCT02382640|638250|P3|STARTED|Washout Period 1 (7 Days)||9
265705|NCT02382640|638251|P2|STARTED|Washout Period 1 (7 Days)||9
265706|NCT02382640|638252|P1|STARTED|Washout Period 1 (7 Days)||9
265707|NCT02382640|638249|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
265708|NCT02382640|638250|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
265709|NCT02382640|638251|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
265710|NCT02382640|638252|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
265711|NCT02382640|638249|P4|COMPLETED|Intervention Period 1 (3 Days)||9
265712|NCT02382640|638250|P3|COMPLETED|Intervention Period 1 (3 Days)||9
265713|NCT02382640|638251|P2|COMPLETED|Intervention Period 1 (3 Days)||9
265714|NCT02382640|638252|P1|COMPLETED|Intervention Period 1 (3 Days)||9
265715|NCT02382640|638249|P4|STARTED|Intervention Period 1 (3 Days)||9
265716|NCT02382640|638250|P3|STARTED|Intervention Period 1 (3 Days)||9
265717|NCT02382640|638251|P2|STARTED|Intervention Period 1 (3 Days)||9
265718|NCT02382640|638252|P1|STARTED|Intervention Period 1 (3 Days)||9
265719|NCT02382133|638290|P1|NOT COMPLETED|Overall Study||33
265720|NCT02382133|638290|P1|COMPLETED|Overall Study||10
265721|NCT02382133|638290|P1|STARTED|Overall Study||43
265722|NCT02381678|638295|P3|NOT COMPLETED|Overall Study||0
265723|NCT02381678|638296|P2|NOT COMPLETED|Overall Study||0
265724|NCT02381678|638297|P1|NOT COMPLETED|Overall Study||0
265725|NCT02381678|638295|P3|COMPLETED|Overall Study||32
265726|NCT02381678|638296|P2|COMPLETED|Overall Study||139
265727|NCT02381678|638297|P1|COMPLETED|Overall Study||54
265728|NCT02381678|638295|P3|STARTED|Overall Study||32
265729|NCT02381678|638296|P2|STARTED|Overall Study||139
265730|NCT02381678|638297|P1|STARTED|Overall Study||54
265731|NCT02381418|638303|P1|NOT COMPLETED|Overall Study||0
265732|NCT02381418|638303|P1|COMPLETED|Overall Study||120
265733|NCT02381418|638303|P1|STARTED|Overall Study||120
265734|NCT02381288|638313|P4|NOT COMPLETED|Overall Study||0
265735|NCT02381288|638314|P3|NOT COMPLETED|Overall Study||0
265736|NCT02381288|638315|P2|NOT COMPLETED|Overall Study||0
265737|NCT02381288|638316|P1|NOT COMPLETED|Overall Study||0
265738|NCT02381288|638313|P4|COMPLETED|Overall Study||5
265739|NCT02381288|638314|P3|COMPLETED|Overall Study||5
265740|NCT02381288|638315|P2|COMPLETED|Overall Study||2
265741|NCT02381288|638316|P1|COMPLETED|Overall Study||5
265742|NCT02381288|638313|P4|STARTED|Overall Study||5
265743|NCT02381288|638314|P3|STARTED|Overall Study||5
265744|NCT02381288|638315|P2|STARTED|Overall Study||2
265745|NCT02381288|638316|P1|STARTED|Overall Study||5
265746|NCT02380742|638345|P2|NOT COMPLETED|Overall Study||0
265747|NCT02380742|638346|P1|NOT COMPLETED|Overall Study||1
265748|NCT02380742|638345|P2|COMPLETED|Overall Study||26
265749|NCT02380742|638346|P1|COMPLETED|Overall Study||27
265750|NCT02380742|638345|P2|STARTED|Overall Study||26
265751|NCT02380742|638346|P1|STARTED|Overall Study||28
265752|NCT02380287|638366|P8|NOT COMPLETED|Overall Study||0
265753|NCT02380287|638367|P7|NOT COMPLETED|Overall Study||0
265754|NCT02380287|638368|P6|NOT COMPLETED|Overall Study||0
265755|NCT02380287|638369|P5|NOT COMPLETED|Overall Study||0
265756|NCT02380287|638370|P4|NOT COMPLETED|Overall Study||0
265757|NCT02380287|638371|P3|NOT COMPLETED|Overall Study||1
265758|NCT02380287|638372|P2|NOT COMPLETED|Overall Study||0
265759|NCT02380287|638373|P1|NOT COMPLETED|Overall Study||0
265760|NCT02380287|638366|P8|COMPLETED|Overall Study||3
265761|NCT02380287|638367|P7|COMPLETED|Overall Study||3
265762|NCT02380287|638368|P6|COMPLETED|Overall Study||3
265763|NCT02380287|638369|P5|COMPLETED|Overall Study||3
265764|NCT02380287|638370|P4|COMPLETED|Overall Study||3
265765|NCT02380287|638371|P3|COMPLETED|Overall Study||2
265766|NCT02380287|638372|P2|COMPLETED|Overall Study||3
265767|NCT02380287|638373|P1|COMPLETED|Overall Study||1
265768|NCT02380287|638366|P8|STARTED|Overall Study||3
265769|NCT02380287|638367|P7|STARTED|Overall Study||3
265770|NCT02380287|638368|P6|STARTED|Overall Study||3
265771|NCT02380287|638369|P5|STARTED|Overall Study||3
265772|NCT02380287|638370|P4|STARTED|Overall Study||3
265773|NCT02380287|638371|P3|STARTED|Overall Study||3
265774|NCT02380287|638372|P2|STARTED|Overall Study||3
265775|NCT02380287|638373|P1|STARTED|Overall Study||1
265776|NCT02380261|638384|P1|NOT COMPLETED|Overall Study||0
265777|NCT02380261|638384|P1|COMPLETED|Overall Study||35
265778|NCT02380261|638384|P1|STARTED|Overall Study||35
265779|NCT02380248|638389|P1|NOT COMPLETED|Overall Study||14
265780|NCT02380248|638389|P1|COMPLETED|Overall Study||186
265781|NCT02380248|638389|P1|STARTED|Overall Study||200
265782|NCT02379637|638396|P2|NOT COMPLETED|Overall Study||1
265783|NCT02379637|638397|P1|NOT COMPLETED|Overall Study||2
265784|NCT02379637|638396|P2|COMPLETED|Overall Study||34
265785|NCT02379637|638397|P1|COMPLETED|Overall Study||33
265786|NCT02379637|638396|P2|STARTED|Overall Study||35
265787|NCT02379637|638397|P1|STARTED|Overall Study||35
265788|NCT02378506|638405|P1|NOT COMPLETED|Overall Study||25
265789|NCT02378506|638405|P1|COMPLETED|Overall Study||163
265790|NCT02378506|638405|P1|Treated|Overall Study||187
265791|NCT02378506|638405|P1|STARTED|Overall Study||188
265792|NCT02376998|638422|P1|NOT COMPLETED|Overall Study||9
265793|NCT02376998|638422|P1|COMPLETED|Overall Study||11
265794|NCT02376998|638422|P1|STARTED|Overall Study||20
265795|NCT02376530|638430|P4|NOT COMPLETED|Overall Study||0
265796|NCT02376530|638431|P3|NOT COMPLETED|Overall Study||0
265797|NCT02376530|638432|P2|NOT COMPLETED|Overall Study||0
265798|NCT02376530|638433|P1|NOT COMPLETED|Overall Study||0
265799|NCT02376530|638430|P4|COMPLETED|Overall Study||197
265800|NCT02376530|638431|P3|COMPLETED|Overall Study||197
265801|NCT02376530|638432|P2|COMPLETED|Overall Study||198
265802|NCT02376530|638433|P1|COMPLETED|Overall Study||196
265803|NCT02376530|638430|P4|STARTED|Overall Study||197
265804|NCT02376530|638431|P3|STARTED|Overall Study||197
265805|NCT02376530|638432|P2|STARTED|Overall Study||198
265806|NCT02376530|638433|P1|STARTED|Overall Study||196
265807|NCT02375724|638445|P2|NOT COMPLETED|Overall Study||6
265808|NCT02375724|638446|P1|NOT COMPLETED|Overall Study||6
265809|NCT02375724|638445|P2|COMPLETED|Overall Study||128
265810|NCT02375724|638446|P1|COMPLETED|Overall Study||129
265811|NCT02375724|638445|P2|STARTED|Overall Study||134
265812|NCT02375724|638446|P1|STARTED|Overall Study||135
265813|NCT02375373|638456|P1|NOT COMPLETED|Overall Study||11
265814|NCT02375373|638456|P1|COMPLETED|Overall Study||1
265815|NCT02375373|638456|P1|STARTED|Overall Study||12
265816|NCT02375347|638460|P1|NOT COMPLETED|Overall Study||1
265817|NCT02375347|638460|P1|COMPLETED|Overall Study||12
265818|NCT02375347|638460|P1|STARTED|Overall Study||13
265819|NCT02374398|638468|P4|NOT COMPLETED|Overall Study||0
265820|NCT02374398|638469|P3|NOT COMPLETED|Overall Study||3
265821|NCT02374398|638470|P2|NOT COMPLETED|Overall Study||1
265822|NCT02374398|638471|P1|NOT COMPLETED|Overall Study||2
265823|NCT02374398|638468|P4|COMPLETED|Overall Study||32
265824|NCT02374398|638469|P3|COMPLETED|Overall Study||29
265825|NCT02374398|638470|P2|COMPLETED|Overall Study||31
265826|NCT02374398|638471|P1|COMPLETED|Overall Study||29
265827|NCT02374398|638468|P4|STARTED|Overall Study||32
265828|NCT02374398|638469|P3|STARTED|Overall Study||32
265829|NCT02374398|638470|P2|STARTED|Overall Study||32
265830|NCT02374398|638471|P1|STARTED|Overall Study||31
265831|NCT02374346|638497|P1|NOT COMPLETED|Overall Study||48
265832|NCT02374346|638497|P1|COMPLETED|Overall Study||446
265833|NCT02374346|638497|P1|STARTED|Overall Study||494
265834|NCT02374164|638506|P3|NOT COMPLETED|Treatment Period 3||0
265835|NCT02374164|638507|P2|NOT COMPLETED|Treatment Period 3||0
265836|NCT02374164|638508|P1|NOT COMPLETED|Treatment Period 3||0
265837|NCT02374164|638506|P3|COMPLETED|Treatment Period 3||12
265838|NCT02374164|638507|P2|COMPLETED|Treatment Period 3||11
265839|NCT02374164|638508|P1|COMPLETED|Treatment Period 3||12
265840|NCT02374164|638506|P3|STARTED|Treatment Period 3||12
265841|NCT02374164|638507|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
265842|NCT02374164|638508|P1|STARTED|Treatment Period 3||12
265843|NCT02374164|638506|P3|NOT COMPLETED|Treatment Period 2||0
265844|NCT02374164|638507|P2|NOT COMPLETED|Treatment Period 2||0
265845|NCT02374164|638508|P1|NOT COMPLETED|Treatment Period 2||0
265846|NCT02374164|638506|P3|COMPLETED|Treatment Period 2||12
265847|NCT02374164|638507|P2|COMPLETED|Treatment Period 2||12
265848|NCT02374164|638508|P1|COMPLETED|Treatment Period 2||12
265849|NCT02374164|638506|P3|STARTED|Treatment Period 2||12
265850|NCT02374164|638507|P2|STARTED|Treatment Period 2||12
265851|NCT02374164|638508|P1|STARTED|Treatment Period 2||12
265852|NCT02374164|638506|P3|NOT COMPLETED|Treatment Period 1||0
265853|NCT02374164|638507|P2|NOT COMPLETED|Treatment Period 1||0
265854|NCT02374164|638508|P1|NOT COMPLETED|Treatment Period 1||0
265855|NCT02374164|638506|P3|COMPLETED|Treatment Period 1||12
265856|NCT02374164|638507|P2|COMPLETED|Treatment Period 1||12
265857|NCT02374164|638508|P1|COMPLETED|Treatment Period 1||12
265858|NCT02374164|638506|P3|STARTED|Treatment Period 1||12
265859|NCT02374164|638507|P2|STARTED|Treatment Period 1||12
265860|NCT02374164|638508|P1|STARTED|Treatment Period 1||12
265861|NCT02372344|638525|P3|NOT COMPLETED|Period 3 (Visit 4)||0
265862|NCT02372344|638526|P2|NOT COMPLETED|Period 3 (Visit 4)||0
265863|NCT02372344|638527|P1|NOT COMPLETED|Period 3 (Visit 4)||0
265864|NCT02372344|638525|P3|COMPLETED|Period 3 (Visit 4)||14
265865|NCT02372344|638526|P2|COMPLETED|Period 3 (Visit 4)||14
265866|NCT02372344|638527|P1|COMPLETED|Period 3 (Visit 4)||14
265867|NCT02372344|638525|P3|STARTED|Period 3 (Visit 4)||14
265868|NCT02372344|638526|P2|STARTED|Period 3 (Visit 4)||14
265869|NCT02372344|638527|P1|STARTED|Period 3 (Visit 4)||14
265870|NCT02372344|638525|P3|NOT COMPLETED|Period 2 (Visit 3)||0
265871|NCT02372344|638526|P2|NOT COMPLETED|Period 2 (Visit 3)||0
265872|NCT02372344|638527|P1|NOT COMPLETED|Period 2 (Visit 3)||0
265873|NCT02372344|638525|P3|COMPLETED|Period 2 (Visit 3)||14
265874|NCT02372344|638526|P2|COMPLETED|Period 2 (Visit 3)||14
265875|NCT02372344|638527|P1|COMPLETED|Period 2 (Visit 3)||14
265876|NCT02372344|638525|P3|STARTED|Period 2 (Visit 3)||14
265877|NCT02372344|638526|P2|STARTED|Period 2 (Visit 3)||14
265878|NCT02372344|638527|P1|STARTED|Period 2 (Visit 3)||14
265879|NCT02372344|638525|P3|NOT COMPLETED|Period 1 (Visit 2)||0
265880|NCT02372344|638526|P2|NOT COMPLETED|Period 1 (Visit 2)||0
265881|NCT02372344|638527|P1|NOT COMPLETED|Period 1 (Visit 2)||0
265882|NCT02372344|638525|P3|COMPLETED|Period 1 (Visit 2)||14
265883|NCT02372344|638526|P2|COMPLETED|Period 1 (Visit 2)||14
265884|NCT02372344|638527|P1|COMPLETED|Period 1 (Visit 2)||14
265885|NCT02372344|638525|P3|STARTED|Period 1 (Visit 2)||14
265886|NCT02372344|638526|P2|STARTED|Period 1 (Visit 2)||14
265887|NCT02372344|638527|P1|STARTED|Period 1 (Visit 2)||14
265888|NCT02372097|638543|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
265889|NCT02372097|638544|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
265890|NCT02372097|638543|P2|COMPLETED|Second Intervention Period (8 Days)||12
265891|NCT02372097|638544|P1|COMPLETED|Second Intervention Period (8 Days)||12
265892|NCT02372097|638543|P2|STARTED|Second Intervention Period (8 Days)||12
265893|NCT02372097|638544|P1|STARTED|Second Intervention Period (8 Days)||12
265894|NCT02372097|638543|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
265895|NCT02372097|638544|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
265896|NCT02372097|638543|P2|COMPLETED|Wash Out Period (13 Days)||12
265897|NCT02372097|638544|P1|COMPLETED|Wash Out Period (13 Days)||12
265898|NCT02372097|638543|P2|STARTED|Wash Out Period (13 Days)||12
265899|NCT02372097|638544|P1|STARTED|Wash Out Period (13 Days)||12
265900|NCT02372097|638543|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
265901|NCT02372097|638544|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
265902|NCT02372097|638543|P2|COMPLETED|First Intervention Period (8 Days)||12
265903|NCT02372097|638544|P1|COMPLETED|First Intervention Period (8 Days)||12
265904|NCT02372097|638543|P2|STARTED|First Intervention Period (8 Days)||12
265905|NCT02372097|638544|P1|STARTED|First Intervention Period (8 Days)||12
265906|NCT02372071|638570|P1|NOT COMPLETED|Overall Study||18
265907|NCT02372071|638570|P1|COMPLETED|Overall Study||93
265908|NCT02372071|638570|P1|STARTED|Overall Study||111
265909|NCT02372058|638575|P1|NOT COMPLETED|Overall Study||3
265910|NCT02372058|638575|P1|COMPLETED|Overall Study||100
265911|NCT02372058|638575|P1|STARTED|Overall Study||103
265912|NCT02371876|638581|P1|NOT COMPLETED|Overall Study||0
265913|NCT02371876|638581|P1|COMPLETED|Overall Study||134
265914|NCT02371876|638581|P1|STARTED|Overall Study||134
265915|NCT02371759|638599|P8|NOT COMPLETED|Overall Study||4
265916|NCT02371759|638600|P7|NOT COMPLETED|Overall Study||0
265917|NCT02371759|638601|P6|NOT COMPLETED|Overall Study||1
265918|NCT02371759|638602|P5|NOT COMPLETED|Overall Study||3
265919|NCT02371759|638603|P4|NOT COMPLETED|Overall Study||0
265920|NCT02371759|638604|P3|NOT COMPLETED|Overall Study||1
265921|NCT02371759|638605|P2|NOT COMPLETED|Overall Study||1
265922|NCT02371759|638606|P1|NOT COMPLETED|Overall Study||3
265923|NCT02371759|638599|P8|COMPLETED|Overall Study||24
265924|NCT02371759|638600|P7|COMPLETED|Overall Study||25
265925|NCT02371759|638601|P6|COMPLETED|Overall Study||25
265926|NCT02371759|638602|P5|COMPLETED|Overall Study||24
265927|NCT02371759|638603|P4|COMPLETED|Overall Study||31
265928|NCT02371759|638604|P3|COMPLETED|Overall Study||32
265929|NCT02371759|638605|P2|COMPLETED|Overall Study||30
265930|NCT02371759|638606|P1|COMPLETED|Overall Study||29
265931|NCT02371759|638599|P8|STARTED|Overall Study||28
265932|NCT02371759|638600|P7|STARTED|Overall Study||25
265933|NCT02371759|638601|P6|STARTED|Overall Study||26
265934|NCT02371759|638602|P5|STARTED|Overall Study||27
265935|NCT02371759|638603|P4|STARTED|Overall Study||31
265936|NCT02371759|638604|P3|STARTED|Overall Study||33
265937|NCT02371759|638605|P2|STARTED|Overall Study||31
265938|NCT02371759|638606|P1|STARTED|Overall Study||32
265939|NCT02370914|638816|P1|NOT COMPLETED|Overall Study||2
265940|NCT02370914|638816|P1|COMPLETED|Overall Study||82
265941|NCT02370914|638816|P1|STARTED|Overall Study||84
265942|NCT02370667|638823|P3|NOT COMPLETED|Overall Study||0
265943|NCT02370667|638824|P2|NOT COMPLETED|Overall Study||1
265944|NCT02370667|638825|P1|NOT COMPLETED|Overall Study||0
265945|NCT02370667|638823|P3|COMPLETED|Overall Study||10
265946|NCT02370667|638824|P2|COMPLETED|Overall Study||10
265947|NCT02370667|638825|P1|COMPLETED|Overall Study||10
265948|NCT02370667|638823|P3|STARTED|Overall Study||10
265949|NCT02370667|638824|P2|STARTED|Overall Study||11
265950|NCT02370667|638825|P1|STARTED|Overall Study||10
265951|NCT02370615|638889|P2|NOT COMPLETED|Overall Study||0
265952|NCT02370615|638890|P1|NOT COMPLETED|Overall Study||1
265953|NCT02370615|638889|P2|COMPLETED|Overall Study||18
265954|NCT02370615|638890|P1|COMPLETED|Overall Study||15
265955|NCT02370615|638889|P2|STARTED|Overall Study||18
265956|NCT02370615|638890|P1|STARTED|Overall Study||16
265957|NCT02370602|638933|P6|NOT COMPLETED|Overall Study||0
265958|NCT02370602|638934|P5|NOT COMPLETED|Overall Study||0
265959|NCT02370602|638935|P4|NOT COMPLETED|Overall Study||0
265960|NCT02370602|638936|P3|NOT COMPLETED|Overall Study||0
265961|NCT02370602|638937|P2|NOT COMPLETED|Overall Study||0
265962|NCT02370602|638938|P1|NOT COMPLETED|Overall Study||1
265963|NCT02370602|638933|P6|COMPLETED|Overall Study||2
265964|NCT02370602|638934|P5|COMPLETED|Overall Study||3
265965|NCT02370602|638935|P4|COMPLETED|Overall Study||3
265966|NCT02370602|638936|P3|COMPLETED|Overall Study||2
265967|NCT02370602|638937|P2|COMPLETED|Overall Study||2
265968|NCT02370602|638938|P1|COMPLETED|Overall Study||0
265969|NCT02370602|638933|P6|STARTED|Overall Study||2
265970|NCT02370602|638934|P5|STARTED|Overall Study||3
265971|NCT02370602|638935|P4|STARTED|Overall Study||3
265972|NCT02370602|638936|P3|STARTED|Overall Study||2
265973|NCT02370602|638937|P2|STARTED|Overall Study||2
265974|NCT02370602|638938|P1|STARTED|Overall Study||1
265975|NCT02370537|639032|P3|NOT COMPLETED|Part B||259
265976|NCT02370537|639033|P2|NOT COMPLETED|Part B||3
265977|NCT02370537|639034|P1|NOT COMPLETED|Part B||1
265978|NCT02370537|639032|P3|COMPLETED|Part B||23
265979|NCT02370537|639033|P2|COMPLETED|Part B||12
265980|NCT02370537|639034|P1|COMPLETED|Part B||15
265981|NCT02370537|639032|P3|Period 2 Sequence BA|Part B||12
265982|NCT02370537|639033|P2|Period 2 Sequence BA|Part B||7
265983|NCT02370537|639034|P1|Period 2 Sequence BA|Part B||7
265984|NCT02370537|639032|P3|Period 2 Sequence AB|Part B||11
265985|NCT02370537|639033|P2|Period 2 Sequence AB|Part B||5
265986|NCT02370537|639034|P1|Period 2 Sequence AB|Part B||8
265987|NCT02370537|639032|P3|Period 1 Sequence BA|Part B||12
265988|NCT02370537|639033|P2|Period 1 Sequence BA|Part B||7
265989|NCT02370537|639034|P1|Period 1 Sequence BA|Part B||7
265990|NCT02370537|639032|P3|Period 1 Sequence AB|Part B||11
265991|NCT02370537|639033|P2|Period 1 Sequence AB|Part B||6
265992|NCT02370537|639034|P1|Period 1 Sequence AB|Part B||8
265993|NCT02370537|639032|P3|Eligible for Randomisation|Part B||23
265994|NCT02370537|639033|P2|Eligible for Randomisation|Part B||13
265995|NCT02370537|639034|P1|Eligible for Randomisation|Part B||15
265996|NCT02370537|639032|P3|STARTED|Part B||282
265997|NCT02370537|639033|P2|STARTED|Part B||15
265998|NCT02370537|639034|P1|STARTED|Part B||16
265999|NCT02370537|639032|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
266000|NCT02370537|639033|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
266001|NCT02370537|639034|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
266002|NCT02370537|639032|P3|COMPLETED|Part A (Open-label Recruitment)||282
266003|NCT02370537|639033|P2|COMPLETED|Part A (Open-label Recruitment)||15
266004|NCT02370537|639034|P1|COMPLETED|Part A (Open-label Recruitment)||16
266005|NCT02370537|639032|P3|STARTED|Part A (Open-label Recruitment)||283
266006|NCT02370537|639033|P2|STARTED|Part A (Open-label Recruitment)||16
266007|NCT02370537|639034|P1|STARTED|Part A (Open-label Recruitment)||16
266008|NCT02370121|639083|P2|NOT COMPLETED|Overall Study||1
266009|NCT02370121|639084|P1|NOT COMPLETED|Overall Study||1
266010|NCT02370121|639083|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
266011|NCT02370121|639084|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
266012|NCT02370121|639083|P2|STARTED|Overall Study||12
266013|NCT02370121|639084|P1|STARTED|Overall Study||12
266014|NCT02369796|639127|P5|NOT COMPLETED|Overall Study||0
266015|NCT02369796|639128|P4|NOT COMPLETED|Overall Study||0
266016|NCT02369796|639129|P3|NOT COMPLETED|Overall Study||0
266017|NCT02369796|639130|P2|NOT COMPLETED|Overall Study||0
266018|NCT02369796|639131|P1|NOT COMPLETED|Overall Study||0
266019|NCT02369796|639127|P5|COMPLETED|Overall Study||3
266020|NCT02369796|639128|P4|COMPLETED|Overall Study||3
266021|NCT02369796|639129|P3|COMPLETED|Overall Study||3
266022|NCT02369796|639130|P2|COMPLETED|Overall Study||3
266023|NCT02369796|639131|P1|COMPLETED|Overall Study||3
266024|NCT02369796|639127|P5|STARTED|Overall Study||3
266025|NCT02369796|639128|P4|STARTED|Overall Study||3
266026|NCT02369796|639129|P3|STARTED|Overall Study||3
266027|NCT02369796|639130|P2|STARTED|Overall Study||3
266028|NCT02369796|639131|P1|STARTED|Overall Study||3
266029|NCT02369341|639172|P2|NOT COMPLETED|Overall Study||0
266030|NCT02369341|639173|P1|NOT COMPLETED|Overall Study||1
266031|NCT02369341|639172|P2|COMPLETED|Overall Study||57
266032|NCT02369341|639173|P1|COMPLETED|Overall Study||62
266033|NCT02369341|639172|P2|STARTED|Overall Study||57
266034|NCT02369341|639173|P1|STARTED|Overall Study||63
266035|NCT02368457|639229|P2|NOT COMPLETED|Overall Study||0
266036|NCT02368457|639230|P1|NOT COMPLETED|Overall Study||0
266037|NCT02368457|639229|P2|COMPLETED|Overall Study||12
266038|NCT02368457|639230|P1|COMPLETED|Overall Study||12
266039|NCT02368457|639229|P2|STARTED|Overall Study||12
266040|NCT02368457|639230|P1|STARTED|Overall Study||12
266041|NCT02368314|639240|P2|NOT COMPLETED|Overall Study||3
266042|NCT02368314|639241|P1|NOT COMPLETED|Overall Study||3
266043|NCT02368314|639240|P2|COMPLETED|Overall Study||57
266044|NCT02368314|639241|P1|COMPLETED|Overall Study||61
266045|NCT02368314|639240|P2|STARTED|Overall Study||60
266046|NCT02368314|639241|P1|STARTED|Overall Study||64
266047|NCT02368093|639253|P2|NOT COMPLETED|Overall Study||0
266048|NCT02368093|639254|P1|NOT COMPLETED|Overall Study||0
266049|NCT02368093|639253|P2|COMPLETED|Overall Study||24
266050|NCT02368093|639254|P1|COMPLETED|Overall Study||24
266051|NCT02368093|639253|P2|STARTED|Overall Study||24
266052|NCT02368093|639254|P1|STARTED|Overall Study||24
266053|NCT02367885|639263|P3|NOT COMPLETED|Overall Study||0
266054|NCT02367885|639264|P2|NOT COMPLETED|Overall Study||0
266055|NCT02367885|639265|P1|NOT COMPLETED|Overall Study||2
266056|NCT02367885|639263|P3|COMPLETED|Overall Study||33
266057|NCT02367885|639264|P2|COMPLETED|Overall Study||33
266058|NCT02367885|639265|P1|COMPLETED|Overall Study||31
266059|NCT02367885|639263|P3|STARTED|Overall Study||33
266060|NCT02367885|639264|P2|STARTED|Overall Study||33
266061|NCT02367885|639265|P1|STARTED|Overall Study||33
266062|NCT02367391|639332|P2|NOT COMPLETED|Overall Study||0
266063|NCT02367391|639333|P1|NOT COMPLETED|Overall Study||2
266064|NCT02367391|639332|P2|COMPLETED|Overall Study||76
266065|NCT02367391|639333|P1|COMPLETED|Overall Study||74
266066|NCT02367391|639332|P2|STARTED|Overall Study||76
266067|NCT02367391|639333|P1|STARTED|Overall Study||76
266068|NCT02367170|639353|P2|NOT COMPLETED|Overall Study||0
266069|NCT02367170|639354|P1|NOT COMPLETED|Overall Study||0
266070|NCT02367170|639353|P2|COMPLETED|Overall Study||0
266071|NCT02367170|639354|P1|COMPLETED|Overall Study||1
266072|NCT02367170|639353|P2|STARTED|Overall Study||0
266073|NCT02367170|639354|P1|STARTED|Overall Study||1
266074|NCT02367066|639366|P2|NOT COMPLETED|Overall Study||0
266075|NCT02367066|639367|P1|NOT COMPLETED|Overall Study||0
266076|NCT02367066|639366|P2|COMPLETED|Overall Study||10
266077|NCT02367066|639367|P1|COMPLETED|Overall Study||10
266078|NCT02367066|639366|P2|STARTED|Overall Study||10
266079|NCT02367066|639367|P1|STARTED|Overall Study||10
266080|NCT02366936|639425|P1|NOT COMPLETED|Overall Study||8
266081|NCT02366936|639425|P1|COMPLETED|Overall Study||24
266082|NCT02366936|639425|P1|STARTED|Overall Study||32
266083|NCT02366923|639430|P1|NOT COMPLETED|Overall Study||6
266084|NCT02366923|639430|P1|COMPLETED|Overall Study||22
266085|NCT02366923|639430|P1|STARTED|Overall Study||28
266086|NCT02366910|639443|P1|NOT COMPLETED|Overall Study||5
266087|NCT02366910|639443|P1|COMPLETED|Overall Study||21
266088|NCT02366910|639443|P1|STARTED|Overall Study||26
266089|NCT02366767|639457|P2|NOT COMPLETED|Overall Study||0
266090|NCT02366767|639458|P1|NOT COMPLETED|Overall Study||1
266091|NCT02366767|639457|P2|COMPLETED|Overall Study||10
266092|NCT02366767|639458|P1|COMPLETED|Overall Study||10
266093|NCT02366767|639457|P2|STARTED|Overall Study||10
266094|NCT02366767|639458|P1|STARTED|Overall Study||11
266095|NCT02366689|639471|P3|NOT COMPLETED|Overall Study||2
266096|NCT02366689|639472|P2|NOT COMPLETED|Overall Study||3
266097|NCT02366689|639473|P1|NOT COMPLETED|Overall Study||4
266098|NCT02366689|639471|P3|COMPLETED|Overall Study||59
266099|NCT02366689|639472|P2|COMPLETED|Overall Study||55
266100|NCT02366689|639473|P1|COMPLETED|Overall Study||56
266101|NCT02366689|639471|P3|STARTED|Overall Study||61
266102|NCT02366689|639472|P2|STARTED|Overall Study||58
266103|NCT02366689|639473|P1|STARTED|Overall Study||60
266104|NCT02366637|639496|P2|NOT COMPLETED|Second Intervention Period||1
266105|NCT02366637|639497|P1|NOT COMPLETED|Second Intervention Period||1
266106|NCT02366637|639496|P2|COMPLETED|Second Intervention Period||0
266107|NCT02366637|639497|P1|COMPLETED|Second Intervention Period||0
266108|NCT02366637|639496|P2|STARTED|Second Intervention Period||1
266109|NCT02366637|639497|P1|STARTED|Second Intervention Period||1
266110|NCT02366637|639496|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
266111|NCT02366637|639497|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
266112|NCT02366637|639496|P2|COMPLETED|Washout Period 28 to 49 Days||1
266113|NCT02366637|639497|P1|COMPLETED|Washout Period 28 to 49 Days||1
266114|NCT02366637|639496|P2|STARTED|Washout Period 28 to 49 Days||1
266115|NCT02366637|639497|P1|STARTED|Washout Period 28 to 49 Days||1
266116|NCT02366637|639496|P2|NOT COMPLETED|First Intervention Period||5
266117|NCT02366637|639497|P1|NOT COMPLETED|First Intervention Period||6
266118|NCT02366637|639496|P2|COMPLETED|First Intervention Period||1
266119|NCT02366637|639497|P1|COMPLETED|First Intervention Period||1
266120|NCT02366637|639496|P2|STARTED|First Intervention Period||6
266121|NCT02366637|639497|P1|STARTED|First Intervention Period||7
266122|NCT02366338|639524|P3|NOT COMPLETED|Overall Study||0
266123|NCT02366338|639525|P2|NOT COMPLETED|Overall Study||0
266124|NCT02366338|639526|P1|NOT COMPLETED|Overall Study||0
266125|NCT02366338|639524|P3|COMPLETED|Overall Study||36
266126|NCT02366338|639525|P2|COMPLETED|Overall Study||39
266127|NCT02366338|639526|P1|COMPLETED|Overall Study||73
266128|NCT02366338|639524|P3|STARTED|Overall Study||36
266129|NCT02366338|639525|P2|STARTED|Overall Study||39
266130|NCT02366338|639526|P1|STARTED|Overall Study||73
266131|NCT02365688|639534|P1|NOT COMPLETED|Overall Study||0
266132|NCT02365688|639534|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
266133|NCT02365688|639534|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
266134|NCT02364778|639540|P1|NOT COMPLETED|Overall Study||0
266135|NCT02364778|639540|P1|COMPLETED|Overall Study||30
266136|NCT02364778|639540|P1|STARTED|Overall Study||30
266137|NCT02364180|639552|P1|NOT COMPLETED|Overall Study||1
266138|NCT02364180|639552|P1|COMPLETED|Overall Study||10
266139|NCT02364180|639552|P1|STARTED|Overall Study||11
266140|NCT02363478|639556|P1|NOT COMPLETED|Overall Study||8
266141|NCT02363478|639556|P1|COMPLETED|Overall Study||22
266142|NCT02363478|639556|P1|STARTED|Overall Study||30
266143|NCT02362412|639563|P2|NOT COMPLETED|Treatment Period III||1
266144|NCT02362412|639564|P1|NOT COMPLETED|Treatment Period III||0
266145|NCT02362412|639563|P2|COMPLETED|Treatment Period III||10
266146|NCT02362412|639564|P1|COMPLETED|Treatment Period III||9
266147|NCT02362412|639563|P2|TREATED|Treatment Period III||11
266148|NCT02362412|639564|P1|TREATED|Treatment Period III||9
266149|NCT02362412|639563|P2|STARTED|Treatment Period III||11
266150|NCT02362412|639564|P1|STARTED|Treatment Period III||9
266151|NCT02362412|639563|P2|NOT COMPLETED|Treatment Period II||0
266152|NCT02362412|639564|P1|NOT COMPLETED|Treatment Period II||0
266153|NCT02362412|639563|P2|COMPLETED|Treatment Period II||11
266154|NCT02362412|639564|P1|COMPLETED|Treatment Period II||9
266155|NCT02362412|639563|P2|TREATED|Treatment Period II||11
266156|NCT02362412|639564|P1|TREATED|Treatment Period II||9
266157|NCT02362412|639563|P2|STARTED|Treatment Period II||11
266158|NCT02362412|639564|P1|STARTED|Treatment Period II||9
266159|NCT02362373|639590|P1|NOT COMPLETED|Overall Study||0
266160|NCT02362373|639590|P1|COMPLETED|Overall Study||20
266161|NCT02362373|639590|P1|STARTED|Overall Study||20
266162|NCT02362360|639598|P2|NOT COMPLETED|Period 2||0
266163|NCT02362360|639599|P1|NOT COMPLETED|Period 2||0
266164|NCT02362360|639598|P2|COMPLETED|Period 2||25
266165|NCT02362360|639599|P1|COMPLETED|Period 2||23
266166|NCT02362360|639598|P2|STARTED|Period 2||25
266167|NCT02362360|639599|P1|STARTED|Period 2||23
266168|NCT02362360|639598|P2|NOT COMPLETED|Period 1||1
266169|NCT02362360|639599|P1|NOT COMPLETED|Period 1||3
266170|NCT02362360|639598|P2|COMPLETED|Period 1||25
266171|NCT02362360|639599|P1|COMPLETED|Period 1||23
266172|NCT02362360|639598|P2|STARTED|Period 1||26
266173|NCT02362360|639599|P1|STARTED|Period 1||26
266174|NCT02362321|639607|P2|NOT COMPLETED|Overall Study||0
266175|NCT02362321|639608|P1|NOT COMPLETED|Overall Study||4
266176|NCT02362321|639607|P2|COMPLETED|Overall Study||10
266177|NCT02362321|639608|P1|COMPLETED|Overall Study||6
266178|NCT02362321|639607|P2|STARTED|Overall Study||10
266179|NCT02362321|639608|P1|STARTED|Overall Study||10
266180|NCT02361736|639616|P2|NOT COMPLETED|Overall Study||1
266181|NCT02361736|639617|P1|NOT COMPLETED|Overall Study||1
266182|NCT02361736|639616|P2|COMPLETED|Overall Study||59
266183|NCT02361736|639617|P1|COMPLETED|Overall Study||59
266184|NCT02361736|639616|P2|STARTED|Overall Study||60
266185|NCT02361736|639617|P1|STARTED|Overall Study||60
266186|NCT02361580|639637|P2|NOT COMPLETED|Overall Study||3
266187|NCT02361580|639638|P1|NOT COMPLETED|Overall Study||6
266188|NCT02361580|639637|P2|COMPLETED|Overall Study||0
266189|NCT02361580|639638|P1|COMPLETED|Overall Study||0
266190|NCT02361580|639637|P2|STARTED|Overall Study||3
266191|NCT02361580|639638|P1|STARTED|Overall Study||6
266192|NCT02360995|639651|P3|NOT COMPLETED|Overall Study||2
266193|NCT02360995|639652|P2|NOT COMPLETED|Overall Study||1
266194|NCT02360995|639653|P1|NOT COMPLETED|Overall Study||2
266195|NCT02360995|639651|P3|COMPLETED|Overall Study||41
266196|NCT02360995|639652|P2|COMPLETED|Overall Study||42
266197|NCT02360995|639653|P1|COMPLETED|Overall Study||41
266198|NCT02360995|639651|P3|STARTED|Overall Study||43
266199|NCT02360995|639652|P2|STARTED|Overall Study||43
266200|NCT02360995|639653|P1|STARTED|Overall Study||43
266201|NCT02360124|639679|P3|NOT COMPLETED|Overall Study||26
266202|NCT02360124|639680|P2|NOT COMPLETED|Overall Study||12
266203|NCT02360124|639681|P1|NOT COMPLETED|Overall Study||28
266204|NCT02360124|639679|P3|COMPLETED|Overall Study||82
266205|NCT02360124|639680|P2|COMPLETED|Overall Study||95
266206|NCT02360124|639681|P1|COMPLETED|Overall Study||80
266207|NCT02360124|639679|P3|STARTED|Overall Study||108
266208|NCT02360124|639680|P2|STARTED|Overall Study||107
266209|NCT02360124|639681|P1|STARTED|Overall Study||108
266210|NCT02359955|639694|P2|NOT COMPLETED|Overall Study||0
266211|NCT02359955|639695|P1|NOT COMPLETED|Overall Study||0
266212|NCT02359955|639694|P2|COMPLETED|Overall Study||10
266213|NCT02359955|639695|P1|COMPLETED|Overall Study||10
266214|NCT02359955|639694|P2|STARTED|Overall Study||10
266215|NCT02359955|639695|P1|STARTED|Overall Study||10
266216|NCT02359903|639713|P2|NOT COMPLETED|Overall Study||2
266217|NCT02359903|639714|P1|NOT COMPLETED|Overall Study||0
266218|NCT02359903|639713|P2|COMPLETED|Overall Study||43
266219|NCT02359903|639714|P1|COMPLETED|Overall Study||45
266220|NCT02359903|639713|P2|STARTED|Overall Study||45
266221|NCT02359903|639714|P1|STARTED|Overall Study||45
266222|NCT02359877|639726|P4|NOT COMPLETED|Overall Study||3
266223|NCT02359877|639727|P3|NOT COMPLETED|Overall Study||0
266224|NCT02359877|639728|P2|NOT COMPLETED|Overall Study||0
266225|NCT02359877|639729|P1|NOT COMPLETED|Overall Study||1
266226|NCT02359877|639726|P4|COMPLETED|Overall Study||11
266227|NCT02359877|639727|P3|COMPLETED|Overall Study||6
266228|NCT02359877|639728|P2|COMPLETED|Overall Study||6
266229|NCT02359877|639729|P1|COMPLETED|Overall Study||33
266230|NCT02359877|639726|P4|STARTED|Overall Study||14
266231|NCT02359877|639727|P3|STARTED|Overall Study||6
266232|NCT02359877|639728|P2|STARTED|Overall Study||6
266233|NCT02359877|639729|P1|STARTED|Overall Study||34
266234|NCT02359435|639781|P2|NOT COMPLETED|Overall Study||4
266235|NCT02359435|639782|P1|NOT COMPLETED|Overall Study||4
266236|NCT02359435|639781|P2|COMPLETED|Overall Study||216
266237|NCT02359435|639782|P1|COMPLETED|Overall Study||216
266238|NCT02359435|639781|P2|STARTED|Overall Study||220
266239|NCT02359435|639782|P1|STARTED|Overall Study||220
266240|NCT02359045|639790|P2|NOT COMPLETED|Overall Study||3
266241|NCT02359045|639791|P1|NOT COMPLETED|Overall Study||4
266242|NCT02359045|639790|P2|COMPLETED|Overall Study||39
266243|NCT02359045|639791|P1|COMPLETED|Overall Study||36
266244|NCT02359045|639790|P2|STARTED|Overall Study||42
266245|NCT02359045|639791|P1|STARTED|Overall Study||40
266246|NCT02358876|640024|P1|NOT COMPLETED|Overall Study||2
266247|NCT02358876|640024|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
266248|NCT02358876|640024|P1|STARTED|Overall Study||32
266249|NCT02358668|640031|P3|NOT COMPLETED|Overall Study||0
266250|NCT02358668|640032|P2|NOT COMPLETED|Overall Study||1
266251|NCT02358668|640033|P1|NOT COMPLETED|Overall Study||2
266252|NCT02358668|640031|P3|COMPLETED|Overall Study||12
266253|NCT02358668|640032|P2|COMPLETED|Overall Study||23
266254|NCT02358668|640033|P1|COMPLETED|Overall Study||22
266255|NCT02358668|640031|P3|STARTED|Overall Study||12
266256|NCT02358668|640032|P2|STARTED|Overall Study||24
266257|NCT02358668|640033|P1|STARTED|Overall Study||24
266258|NCT02358044|640175|P2|NOT COMPLETED|Overall Study||7
266259|NCT02358044|640176|P1|NOT COMPLETED|Overall Study||2
266260|NCT02358044|640175|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
266261|NCT02358044|640176|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
266262|NCT02358044|640175|P2|Treated|Overall Study||126
266263|NCT02358044|640176|P1|Treated|Overall Study||129
266264|NCT02358044|640175|P2|STARTED|Overall Study||128
266265|NCT02358044|640176|P1|STARTED|Overall Study||129
266266|NCT02357940|640194|P2|NOT COMPLETED|Overall Study||2
266267|NCT02357940|640195|P1|NOT COMPLETED|Overall Study||0
266268|NCT02357940|640194|P2|COMPLETED|Overall Study||30
266269|NCT02357940|640195|P1|COMPLETED|Overall Study||9
266270|NCT02357940|640194|P2|STARTED|Overall Study||32
266271|NCT02357940|640195|P1|STARTED|Overall Study||9
266272|NCT02357485|640319|P1|NOT COMPLETED|Overall Study||0
266273|NCT02357485|640319|P1|COMPLETED|Overall Study||6
266274|NCT02357485|640319|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
266287|NCT02357264|640342|P2|NOT COMPLETED|Overall Study||0
266288|NCT02357264|640343|P1|NOT COMPLETED|Overall Study||0
266289|NCT02357264|640342|P2|COMPLETED|Overall Study||130
266290|NCT02357264|640343|P1|COMPLETED|Overall Study||56
266291|NCT02357264|640342|P2|STARTED|Overall Study||130
266292|NCT02357264|640343|P1|STARTED|Overall Study||56
266293|NCT02356900|640351|P2|NOT COMPLETED|Overall Study||0
266294|NCT02356900|640352|P1|NOT COMPLETED|Overall Study||0
266295|NCT02356900|640351|P2|COMPLETED|Overall Study||10
266296|NCT02356900|640352|P1|COMPLETED|Overall Study||11
266297|NCT02356900|640351|P2|STARTED|Overall Study||10
266298|NCT02356900|640352|P1|STARTED|Overall Study||11
266299|NCT02356588|640372|P2|NOT COMPLETED|Overall Study||13
266300|NCT02356588|640373|P1|NOT COMPLETED|Overall Study||5
266301|NCT02356588|640372|P2|COMPLETED|Overall Study||41
266302|NCT02356588|640373|P1|COMPLETED|Overall Study||102
266303|NCT02356588|640372|P2|STARTED|Overall Study||54
266304|NCT02356588|640373|P1|STARTED|Overall Study||107
266305|NCT02355977|640408|P3|NOT COMPLETED|Overall Study||0
266306|NCT02355977|640409|P2|NOT COMPLETED|Overall Study||0
266307|NCT02355977|640410|P1|NOT COMPLETED|Overall Study||0
266308|NCT02355977|640408|P3|COMPLETED|Overall Study||23
266309|NCT02355977|640409|P2|COMPLETED|Overall Study||26
266310|NCT02355977|640410|P1|COMPLETED|Overall Study||21
266311|NCT02355977|640408|P3|STARTED|Overall Study||23
266312|NCT02355977|640409|P2|STARTED|Overall Study||26
266313|NCT02355977|640410|P1|STARTED|Overall Study||21
266314|NCT02355275|640424|P1|NOT COMPLETED|Overall Study||8
266315|NCT02355275|640424|P1|COMPLETED|Overall Study||14
266316|NCT02355275|640424|P1|STARTED|Overall Study||22
266317|NCT02354924|640431|P2|NOT COMPLETED|Overall Study||0
266318|NCT02354924|640432|P1|NOT COMPLETED|Overall Study||0
266319|NCT02354924|640431|P2|COMPLETED|Overall Study||20
266320|NCT02354924|640432|P1|COMPLETED|Overall Study||40
266321|NCT02354924|640431|P2|STARTED|Overall Study||20
266322|NCT02354924|640432|P1|STARTED|Overall Study||40
266323|NCT02354833|640444|P2|NOT COMPLETED|Overall Study||0
266324|NCT02354833|640445|P1|NOT COMPLETED|Overall Study||0
266325|NCT02354833|640444|P2|COMPLETED|Overall Study||43
266326|NCT02354833|640445|P1|COMPLETED|Overall Study||38
266327|NCT02354833|640444|P2|STARTED|Overall Study||43
266328|NCT02354833|640445|P1|STARTED|Overall Study||38
266329|NCT02354599|640463|P6|NOT COMPLETED|Overall Study||1
266330|NCT02354599|640464|P5|NOT COMPLETED|Overall Study||0
266331|NCT02354599|640465|P4|NOT COMPLETED|Overall Study||0
266332|NCT02354599|640466|P3|NOT COMPLETED|Overall Study||0
266333|NCT02354599|640467|P2|NOT COMPLETED|Overall Study||1
266334|NCT02354599|640468|P1|NOT COMPLETED|Overall Study||1
266335|NCT02354599|640463|P6|COMPLETED|Overall Study||5
266336|NCT02354599|640464|P5|COMPLETED|Overall Study||2
266337|NCT02354599|640465|P4|COMPLETED|Overall Study||6
266338|NCT02354599|640466|P3|COMPLETED|Overall Study||6
266339|NCT02354599|640467|P2|COMPLETED|Overall Study||5
266340|NCT02354599|640468|P1|COMPLETED|Overall Study||5
266341|NCT02354599|640463|P6|STARTED|Overall Study||6
266342|NCT02354599|640464|P5|STARTED|Overall Study||2
266343|NCT02354599|640465|P4|STARTED|Overall Study||6
266344|NCT02354599|640466|P3|STARTED|Overall Study||6
266345|NCT02354599|640467|P2|STARTED|Overall Study||6
266346|NCT02354599|640468|P1|STARTED|Overall Study||6
266347|NCT02353754|640540|P2|NOT COMPLETED|Overall Study||0
266348|NCT02353754|640541|P1|NOT COMPLETED|Overall Study||2
266349|NCT02353754|640540|P2|COMPLETED|Overall Study||0
266350|NCT02353754|640541|P1|COMPLETED|Overall Study||10
266351|NCT02353754|640540|P2|STARTED|Overall Study||0
266352|NCT02353754|640541|P1|STARTED|Overall Study||12
266353|NCT02353572|640551|P1|NOT COMPLETED|Overall Study||3
266354|NCT02353572|640551|P1|COMPLETED|Overall Study||0
266355|NCT02353572|640551|P1|STARTED|Overall Study||3
266356|NCT02353468|640555|P1|NOT COMPLETED|Overall Study||3
266357|NCT02353468|640555|P1|COMPLETED|Overall Study||0
266358|NCT02353468|640555|P1|STARTED|Overall Study||3
266359|NCT02353442|640561|P2|NOT COMPLETED|Overall Study||4
266360|NCT02353442|640562|P1|NOT COMPLETED|Overall Study||3
266361|NCT02353442|640561|P2|COMPLETED|Overall Study||27
266362|NCT02353442|640562|P1|COMPLETED|Overall Study||25
266363|NCT02353442|640561|P2|STARTED|Overall Study||31
266364|NCT02353442|640562|P1|STARTED|Overall Study||28
266365|NCT02352298|640576|P1|NOT COMPLETED|Overall Study||0
266366|NCT02352298|640576|P1|COMPLETED|Overall Study||52
266367|NCT02352298|640576|P1|STARTED|Overall Study||52
266368|NCT02351817|640581|P2|NOT COMPLETED|Period 2||2
266369|NCT02351817|640582|P1|NOT COMPLETED|Period 2||1
266370|NCT02351817|640581|P2|COMPLETED|Period 2||3
266371|NCT02351817|640582|P1|COMPLETED|Period 2||4
266372|NCT02351817|640581|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
266373|NCT02351817|640582|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
266374|NCT02351817|640581|P2|NOT COMPLETED|Period 1||3
266375|NCT02351817|640582|P1|NOT COMPLETED|Period 1||1
266376|NCT02351817|640581|P2|COMPLETED|Period 1||2
266377|NCT02351817|640582|P1|COMPLETED|Period 1||4
266378|NCT02351817|640581|P2|STARTED|Period 1||5
266379|NCT02351817|640582|P1|STARTED|Period 1||5
266380|NCT02351817|640581|P2|NOT COMPLETED|Baseline Period||0
266381|NCT02351817|640582|P1|NOT COMPLETED|Baseline Period||0
266382|NCT02351817|640581|P2|COMPLETED|Baseline Period||5
266383|NCT02351817|640582|P1|COMPLETED|Baseline Period||5
266384|NCT02351817|640581|P2|STARTED|Baseline Period||5
266385|NCT02351817|640582|P1|STARTED|Baseline Period||5
266386|NCT02351505|640589|P1|NOT COMPLETED|Overall Study||0
266387|NCT02351505|640589|P1|COMPLETED|Overall Study||1
266388|NCT02351505|640589|P1|STARTED|Overall Study||1
266389|NCT02350881|640600|P1|NOT COMPLETED|Overall Study||0
266390|NCT02350881|640600|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
266391|NCT02350881|640600|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
266392|NCT02350569|640628|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
266393|NCT02350569|640628|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
266394|NCT02350569|640628|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
266395|NCT02350569|640628|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
266396|NCT02350569|640628|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
266397|NCT02350569|640628|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
266398|NCT02349711|640640|P2|NOT COMPLETED|Overall Study||2
266399|NCT02349711|640641|P1|NOT COMPLETED|Overall Study||3
266400|NCT02349711|640640|P2|COMPLETED|Overall Study||84
266401|NCT02349711|640641|P1|COMPLETED|Overall Study||84
266402|NCT02349711|640640|P2|STARTED|Overall Study||86
266403|NCT02349711|640641|P1|STARTED|Overall Study||87
266404|NCT02349685|640656|P3|NOT COMPLETED|Overall Study||4
266405|NCT02349685|640657|P2|NOT COMPLETED|Overall Study||2
266406|NCT02349685|640658|P1|NOT COMPLETED|Overall Study||5
266407|NCT02349685|640656|P3|COMPLETED|Overall Study||37
266408|NCT02349685|640657|P2|COMPLETED|Overall Study||87
266409|NCT02349685|640658|P1|COMPLETED|Overall Study||84
266410|NCT02349685|640656|P3|STARTED|Overall Study||41
266411|NCT02349685|640657|P2|STARTED|Overall Study||89
266412|NCT02349685|640658|P1|STARTED|Overall Study||89
266413|NCT02349438|640669|P2|NOT COMPLETED|Period 2||0
266414|NCT02349438|640670|P1|NOT COMPLETED|Period 2||0
266415|NCT02349438|640669|P2|COMPLETED|Period 2||10
266416|NCT02349438|640670|P1|COMPLETED|Period 2||11
266417|NCT02349438|640669|P2|STARTED|Period 2||10
266418|NCT02349438|640670|P1|STARTED|Period 2||11
266419|NCT02349438|640669|P2|NOT COMPLETED|Period 1||0
266420|NCT02349438|640670|P1|NOT COMPLETED|Period 1||0
266421|NCT02349438|640669|P2|COMPLETED|Period 1||10
266422|NCT02349438|640670|P1|COMPLETED|Period 1||11
266423|NCT02349438|640669|P2|STARTED|Period 1||10
266424|NCT02349438|640670|P1|STARTED|Period 1||11
266425|NCT02349048|640682|P2|NOT COMPLETED|Overall Study||0
266426|NCT02349048|640683|P1|NOT COMPLETED|Overall Study||5
266427|NCT02349048|640682|P2|COMPLETED|Overall Study||9
266428|NCT02349048|640683|P1|COMPLETED|Overall Study||54
266429|NCT02349048|640682|P2|STARTED|Overall Study||9
266430|NCT02349048|640683|P1|STARTED|Overall Study||59
266431|NCT02348658|640703|P2|NOT COMPLETED|Period 2 (7 Days)||0
266432|NCT02348658|640704|P1|NOT COMPLETED|Period 2 (7 Days)||0
266433|NCT02348658|640703|P2|COMPLETED|Period 2 (7 Days)||6
266434|NCT02348658|640704|P1|COMPLETED|Period 2 (7 Days)||6
266435|NCT02348658|640703|P2|STARTED|Period 2 (7 Days)||6
266436|NCT02348658|640704|P1|STARTED|Period 2 (7 Days)||6
266437|NCT02348658|640703|P2|NOT COMPLETED|Washout Period (22 Days)||0
266438|NCT02348658|640704|P1|NOT COMPLETED|Washout Period (22 Days)||0
266439|NCT02348658|640703|P2|COMPLETED|Washout Period (22 Days)||6
266440|NCT02348658|640704|P1|COMPLETED|Washout Period (22 Days)||6
266441|NCT02348658|640703|P2|STARTED|Washout Period (22 Days)||6
266442|NCT02348658|640704|P1|STARTED|Washout Period (22 Days)||6
266443|NCT02348658|640703|P2|NOT COMPLETED|Period 1 (7 Days)||0
266444|NCT02348658|640704|P1|NOT COMPLETED|Period 1 (7 Days)||0
266445|NCT02348658|640703|P2|COMPLETED|Period 1 (7 Days)||6
266446|NCT02348658|640704|P1|COMPLETED|Period 1 (7 Days)||6
266447|NCT02348658|640703|P2|STARTED|Period 1 (7 Days)||6
266448|NCT02348658|640704|P1|STARTED|Period 1 (7 Days)||6
266449|NCT02347488|640738|P1|NOT COMPLETED|Overall Study||0
266450|NCT02347488|640738|P1|COMPLETED|Overall Study||30
266451|NCT02347488|640738|P1|STARTED|Overall Study||30
266452|NCT02347176|640752|P4|NOT COMPLETED|Overall Study||4
266453|NCT02347176|640753|P3|NOT COMPLETED|Overall Study||8
266454|NCT02347176|640754|P2|NOT COMPLETED|Overall Study||10
266455|NCT02347176|640755|P1|NOT COMPLETED|Overall Study||12
266456|NCT02347176|640752|P4|COMPLETED|Overall Study||48
266457|NCT02347176|640753|P3|COMPLETED|Overall Study||43
266458|NCT02347176|640754|P2|COMPLETED|Overall Study||40
266459|NCT02347176|640755|P1|COMPLETED|Overall Study||39
266460|NCT02347176|640752|P4|STARTED|Overall Study||52
266461|NCT02347176|640753|P3|STARTED|Overall Study||51
266462|NCT02347176|640754|P2|STARTED|Overall Study||50
266463|NCT02347176|640755|P1|STARTED|Overall Study||51
266464|NCT02347085|640801|P1|NOT COMPLETED|Overall Study||10
266465|NCT02347085|640801|P1|COMPLETED|Overall Study||30
266466|NCT02347085|640801|P1|Placebo MDI|Overall Study||40
266467|NCT02347085|640801|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
266468|NCT02347085|640801|P1|STARTED|Overall Study||40
266469|NCT02347072|640823|P1|NOT COMPLETED|Overall Study||18
266470|NCT02347072|640823|P1|COMPLETED|Overall Study||62
266471|NCT02347072|640823|P1|Spiriva Respimat 5 µg|Overall Study||73
266472|NCT02347072|640823|P1|Placebo MDI|Overall Study||72
266473|NCT02347072|640823|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
266474|NCT02347072|640823|P1|STARTED|Overall Study||80
266475|NCT02346877|640857|P2|NOT COMPLETED|Overall Study||0
266476|NCT02346877|640858|P1|NOT COMPLETED|Overall Study||19
266477|NCT02346877|640857|P2|COMPLETED|Overall Study||0
266478|NCT02346877|640858|P1|COMPLETED|Overall Study||0
266479|NCT02346877|640857|P2|STARTED|Overall Study||0
266480|NCT02346877|640858|P1|STARTED|Overall Study||19
266481|NCT02346721|640868|P1|NOT COMPLETED|Overall Study||4
266482|NCT02346721|640868|P1|COMPLETED|Overall Study||107
266483|NCT02346721|640868|P1|STARTED|Overall Study||111
266484|NCT02345720|640877|P1|NOT COMPLETED|Overall Study||0
266485|NCT02345720|640877|P1|COMPLETED|Overall Study||20
266486|NCT02345720|640877|P1|STARTED|Overall Study||20
266487|NCT02344745|640885|P2|NOT COMPLETED|Overall Study||0
266488|NCT02344745|640886|P1|NOT COMPLETED|Overall Study||2
266489|NCT02344745|640885|P2|COMPLETED|Overall Study||40
266490|NCT02344745|640886|P1|COMPLETED|Overall Study||38
266491|NCT02344745|640885|P2|STARTED|Overall Study||40
266492|NCT02344745|640886|P1|STARTED|Overall Study||40
266493|NCT02344342|640902|P4|NOT COMPLETED|Overall Study||10
266494|NCT02344342|640903|P3|NOT COMPLETED|Overall Study||14
266495|NCT02344342|640904|P2|NOT COMPLETED|Overall Study||9
266496|NCT02344342|640905|P1|NOT COMPLETED|Overall Study||11
266497|NCT02344342|640902|P4|COMPLETED|Overall Study||3
266498|NCT02344342|640903|P3|COMPLETED|Overall Study||0
266499|NCT02344342|640904|P2|COMPLETED|Overall Study||2
266500|NCT02344342|640905|P1|COMPLETED|Overall Study||2
266501|NCT02344342|640902|P4|STARTED|Overall Study||13
266502|NCT02344342|640903|P3|STARTED|Overall Study||14
266503|NCT02344342|640904|P2|STARTED|Overall Study||11
266504|NCT02344342|640905|P1|STARTED|Overall Study||13
266505|NCT02343380|640929|P2|NOT COMPLETED|Overall Study||0
266506|NCT02343380|640930|P1|NOT COMPLETED|Overall Study||0
266507|NCT02343380|640929|P2|COMPLETED|Overall Study|Morning test (second week)|10
266508|NCT02343380|640930|P1|COMPLETED|Overall Study|Evening test (second week)|10
266509|NCT02343380|640929|P2|STARTED|Overall Study|Evening test (first week)|10
266510|NCT02343380|640930|P1|STARTED|Overall Study|Morning test (first week)|10
266511|NCT02343159|640943|P3|NOT COMPLETED|Overall Study||30
266512|NCT02343159|640944|P2|NOT COMPLETED|Overall Study||26
266513|NCT02343159|640945|P1|NOT COMPLETED|Overall Study||26
266514|NCT02343159|640943|P3|COMPLETED|Overall Study||0
266515|NCT02343159|640944|P2|COMPLETED|Overall Study||1
266516|NCT02343159|640945|P1|COMPLETED|Overall Study||1
266517|NCT02343159|640943|P3|STARTED|Overall Study||30
266518|NCT02343159|640944|P2|STARTED|Overall Study||27
266519|NCT02343159|640945|P1|STARTED|Overall Study||27
266520|NCT02343081|640972|P2|NOT COMPLETED|Second Intervention (Day 4)||0
266521|NCT02343081|640973|P1|NOT COMPLETED|Second Intervention (Day 4)||0
266522|NCT02343081|640972|P2|COMPLETED|Second Intervention (Day 4)||8
266523|NCT02343081|640973|P1|COMPLETED|Second Intervention (Day 4)||8
266524|NCT02343081|640972|P2|Received Intervention|Second Intervention (Day 4)||8
266525|NCT02343081|640973|P1|Received Intervention|Second Intervention (Day 4)||8
266526|NCT02343081|640972|P2|STARTED|Second Intervention (Day 4)||8
266527|NCT02343081|640973|P1|STARTED|Second Intervention (Day 4)||8
266528|NCT02343081|640972|P2|NOT COMPLETED|Washout (10 Hours)||0
266529|NCT02343081|640973|P1|NOT COMPLETED|Washout (10 Hours)||0
266530|NCT02343081|640972|P2|COMPLETED|Washout (10 Hours)||8
266531|NCT02343081|640973|P1|COMPLETED|Washout (10 Hours)||8
266532|NCT02343081|640972|P2|STARTED|Washout (10 Hours)||8
266533|NCT02343081|640973|P1|STARTED|Washout (10 Hours)||8
266534|NCT02343081|640972|P2|NOT COMPLETED|First Intervention (Day 3)||0
266535|NCT02343081|640973|P1|NOT COMPLETED|First Intervention (Day 3)||0
266536|NCT02343081|640972|P2|COMPLETED|First Intervention (Day 3)||8
266537|NCT02343081|640973|P1|COMPLETED|First Intervention (Day 3)||8
266538|NCT02343081|640972|P2|Received Intervention|First Intervention (Day 3)||8
266539|NCT02343081|640973|P1|Received Intervention|First Intervention (Day 3)||8
266540|NCT02343081|640972|P2|STARTED|First Intervention (Day 3)||8
266541|NCT02343081|640973|P1|STARTED|First Intervention (Day 3)||8
266542|NCT02342704|640989|P2|NOT COMPLETED|Overall Study||51
266543|NCT02342704|640990|P1|NOT COMPLETED|Overall Study||53
266544|NCT02342704|640989|P2|COMPLETED|Overall Study||3
266545|NCT02342704|640990|P1|COMPLETED|Overall Study||1
266546|NCT02342704|640989|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
266547|NCT02342704|640990|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
266548|NCT02342561|641016|P1|NOT COMPLETED|Overall Study||0
266549|NCT02342561|641016|P1|COMPLETED|Overall Study||20
266550|NCT02342561|641016|P1|STARTED|Overall Study||20
266551|NCT02342418|641026|P2|NOT COMPLETED|Overall Study||1
266552|NCT02342418|641027|P1|NOT COMPLETED|Overall Study||0
266553|NCT02342418|641026|P2|COMPLETED|Overall Study||9
266554|NCT02342418|641027|P1|COMPLETED|Overall Study||9
266555|NCT02342418|641026|P2|STARTED|Overall Study||10
266556|NCT02342418|641027|P1|STARTED|Overall Study||9
266557|NCT02342288|641037|P2|NOT COMPLETED|Overall Study||6
266558|NCT02342288|641038|P1|NOT COMPLETED|Overall Study||5
266559|NCT02342288|641037|P2|COMPLETED|Overall Study||27
266560|NCT02342288|641038|P1|COMPLETED|Overall Study||25
266561|NCT02342288|641037|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
266562|NCT02342288|641038|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
266563|NCT02342223|641044|P1|NOT COMPLETED|Overall Study||1
266564|NCT02342223|641044|P1|COMPLETED|Overall Study||19
266565|NCT02342223|641044|P1|STARTED|Overall Study||20
266566|NCT02342197|641055|P2|NOT COMPLETED|Overall Study||2
266567|NCT02342197|641056|P1|NOT COMPLETED|Overall Study||3
266568|NCT02342197|641055|P2|COMPLETED|Overall Study||28
266569|NCT02342197|641056|P1|COMPLETED|Overall Study||27
266570|NCT02342197|641055|P2|STARTED|Overall Study||30
266571|NCT02342197|641056|P1|STARTED|Overall Study||30
266572|NCT02341859|641062|P2|NOT COMPLETED|Second Intervention (1 Day)||0
266573|NCT02341859|641063|P1|NOT COMPLETED|Second Intervention (1 Day)||0
266574|NCT02341859|641062|P2|COMPLETED|Second Intervention (1 Day)||9
266575|NCT02341859|641063|P1|COMPLETED|Second Intervention (1 Day)||10
266576|NCT02341859|641062|P2|STARTED|Second Intervention (1 Day)||9
266577|NCT02341859|641063|P1|STARTED|Second Intervention (1 Day)||10
266578|NCT02341859|641062|P2|NOT COMPLETED|First Intervention (1 Day)||0
266579|NCT02341859|641063|P1|NOT COMPLETED|First Intervention (1 Day)||0
266580|NCT02341859|641062|P2|COMPLETED|First Intervention (1 Day)||9
266581|NCT02341859|641063|P1|COMPLETED|First Intervention (1 Day)||10
266582|NCT02341859|641062|P2|STARTED|First Intervention (1 Day)||9
266583|NCT02341859|641063|P1|STARTED|First Intervention (1 Day)||10
266584|NCT02341482|641216|P1|NOT COMPLETED|Overall Study||1
266585|NCT02341482|641216|P1|COMPLETED|Overall Study||12
266586|NCT02341482|641216|P1|STARTED|Overall Study||13
266587|NCT02341144|641244|P2|NOT COMPLETED|Overall Study||1
266588|NCT02341144|641245|P1|NOT COMPLETED|Overall Study||2
266589|NCT02341144|641244|P2|COMPLETED|Overall Study||30
266590|NCT02341144|641245|P1|COMPLETED|Overall Study||28
266591|NCT02341144|641244|P2|STARTED|Overall Study||31
266592|NCT02341144|641245|P1|STARTED|Overall Study||30
266593|NCT02340338|641266|P7|NOT COMPLETED|Overall Study||0
266594|NCT02340338|641267|P6|NOT COMPLETED|Overall Study||0
266595|NCT02340338|641268|P5|NOT COMPLETED|Overall Study||0
266596|NCT02340338|641269|P4|NOT COMPLETED|Overall Study||0
266597|NCT02340338|641270|P3|NOT COMPLETED|Overall Study||0
266598|NCT02340338|641271|P2|NOT COMPLETED|Overall Study||0
266599|NCT02340338|641272|P1|NOT COMPLETED|Overall Study||0
266600|NCT02340338|641266|P7|COMPLETED|Overall Study||12
266601|NCT02340338|641267|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
266602|NCT02340338|641268|P5|COMPLETED|Overall Study||9
266603|NCT02340338|641269|P4|COMPLETED|Overall Study||9
266604|NCT02340338|641270|P3|COMPLETED|Overall Study||3
266605|NCT02340338|641271|P2|COMPLETED|Overall Study||2
266606|NCT02340338|641272|P1|COMPLETED|Overall Study||2
266607|NCT02340338|641266|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
266608|NCT02340338|641267|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
266609|NCT02340338|641268|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
266610|NCT02340338|641269|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
266611|NCT02340338|641270|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
266612|NCT02340338|641271|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
266613|NCT02340338|641272|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
266614|NCT02340104|641295|P1|NOT COMPLETED|Overall Study||0
266615|NCT02340104|641295|P1|COMPLETED|Overall Study||8
266616|NCT02340104|641295|P1|STARTED|Overall Study||8
266617|NCT02339831|641302|P2|NOT COMPLETED|Overall Study||7
266618|NCT02339831|641303|P1|NOT COMPLETED|Overall Study||20
266619|NCT02339831|641302|P2|COMPLETED|Overall Study||45
266620|NCT02339831|641303|P1|COMPLETED|Overall Study||38
266621|NCT02339831|641302|P2|Lost to Follow Up|Overall Study||7
266622|NCT02339831|641303|P1|Lost to Follow Up|Overall Study||20
266623|NCT02339831|641302|P2|STARTED|Overall Study||52
266624|NCT02339831|641303|P1|STARTED|Overall Study||58
266625|NCT02339246|641327|P3|NOT COMPLETED|Third Period (7 Days)||0
266626|NCT02339246|641328|P2|NOT COMPLETED|Third Period (7 Days)||0
266627|NCT02339246|641329|P1|NOT COMPLETED|Third Period (7 Days)||0
266628|NCT02339246|641327|P3|COMPLETED|Third Period (7 Days)||0
266629|NCT02339246|641328|P2|COMPLETED|Third Period (7 Days)||16
266630|NCT02339246|641329|P1|COMPLETED|Third Period (7 Days)||15
266631|NCT02339246|641327|P3|STARTED|Third Period (7 Days)||0
266632|NCT02339246|641328|P2|STARTED|Third Period (7 Days)||16
266633|NCT02339246|641329|P1|STARTED|Third Period (7 Days)||15
266634|NCT02339246|641327|P3|NOT COMPLETED|Second Intervention (7 Days)||0
266635|NCT02339246|641328|P2|NOT COMPLETED|Second Intervention (7 Days)||0
266636|NCT02339246|641329|P1|NOT COMPLETED|Second Intervention (7 Days)||0
266637|NCT02339246|641327|P3|COMPLETED|Second Intervention (7 Days)||0
266638|NCT02339246|641328|P2|COMPLETED|Second Intervention (7 Days)||15
266639|NCT02339246|641329|P1|COMPLETED|Second Intervention (7 Days)||16
266640|NCT02339246|641327|P3|STARTED|Second Intervention (7 Days)||0
266641|NCT02339246|641328|P2|STARTED|Second Intervention (7 Days)||15
266642|NCT02339246|641329|P1|STARTED|Second Intervention (7 Days)||16
266643|NCT02339246|641327|P3|NOT COMPLETED|First Intervention (7 Days)||0
266644|NCT02339246|641328|P2|NOT COMPLETED|First Intervention (7 Days)||0
266645|NCT02339246|641329|P1|NOT COMPLETED|First Intervention (7 Days)||0
266646|NCT02339246|641327|P3|COMPLETED|First Intervention (7 Days)||31
266647|NCT02339246|641328|P2|COMPLETED|First Intervention (7 Days)||0
266648|NCT02339246|641329|P1|COMPLETED|First Intervention (7 Days)||0
266649|NCT02339246|641327|P3|STARTED|First Intervention (7 Days)||31
266650|NCT02339246|641328|P2|STARTED|First Intervention (7 Days)||0
266651|NCT02339246|641329|P1|STARTED|First Intervention (7 Days)||0
266652|NCT02338713|641343|P1|NOT COMPLETED|Overall Study||0
266653|NCT02338713|641343|P1|COMPLETED|Overall Study||27
266654|NCT02338713|641343|P1|STARTED|Overall Study||27
266655|NCT02338336|641367|P4|NOT COMPLETED|Overall Study||0
266656|NCT02338336|641368|P3|NOT COMPLETED|Overall Study||0
266657|NCT02338336|641369|P2|NOT COMPLETED|Overall Study||0
266658|NCT02338336|641370|P1|NOT COMPLETED|Overall Study||2
266659|NCT02338336|641367|P4|COMPLETED|Overall Study||4
266660|NCT02338336|641368|P3|COMPLETED|Overall Study||7
266661|NCT02338336|641369|P2|COMPLETED|Overall Study||17
266662|NCT02338336|641370|P1|COMPLETED|Overall Study||24
266663|NCT02338336|641367|P4|STARTED|Overall Study||4
266664|NCT02338336|641368|P3|STARTED|Overall Study||7
266665|NCT02338336|641369|P2|STARTED|Overall Study||17
266666|NCT02338336|641370|P1|STARTED|Overall Study||26
266667|NCT02338076|641378|P1|NOT COMPLETED|Overall Study||0
266668|NCT02338076|641378|P1|COMPLETED|Overall Study||20
266669|NCT02338076|641378|P1|STARTED|Overall Study||20
266670|NCT02337959|641396|P3|NOT COMPLETED|Overall Study||0
266671|NCT02337959|641397|P2|NOT COMPLETED|Overall Study||3
266672|NCT02337959|641398|P1|NOT COMPLETED|Overall Study||0
266673|NCT02337959|641396|P3|COMPLETED|Overall Study||7
266674|NCT02337959|641397|P2|COMPLETED|Overall Study||7
266675|NCT02337959|641398|P1|COMPLETED|Overall Study||10
266676|NCT02337959|641396|P3|STARTED|Overall Study||7
266677|NCT02337959|641397|P2|STARTED|Overall Study||10
266678|NCT02337959|641398|P1|STARTED|Overall Study||10
266679|NCT02336958|641408|P2|NOT COMPLETED|Overall Study||0
266680|NCT02336958|641409|P1|NOT COMPLETED|Overall Study||0
266681|NCT02336958|641408|P2|COMPLETED|Overall Study||20
266682|NCT02336958|641409|P1|COMPLETED|Overall Study||20
266683|NCT02336958|641408|P2|STARTED|Overall Study||20
266684|NCT02336958|641409|P1|STARTED|Overall Study||20
266685|NCT02336763|641417|P1|NOT COMPLETED|Overall Study||0
266686|NCT02336763|641417|P1|COMPLETED|Overall Study||2
266687|NCT02336763|641417|P1|STARTED|Overall Study||2
266688|NCT02336607|641431|P4|NOT COMPLETED|Overall Study||87
266689|NCT02336607|641432|P3|NOT COMPLETED|Overall Study||6
266690|NCT02336607|641433|P2|NOT COMPLETED|Overall Study||10
266691|NCT02336607|641434|P1|NOT COMPLETED|Overall Study||4
266692|NCT02336607|641431|P4|COMPLETED|Overall Study||180
266693|NCT02336607|641432|P3|COMPLETED|Overall Study||86
266694|NCT02336607|641433|P2|COMPLETED|Overall Study||75
266695|NCT02336607|641434|P1|COMPLETED|Overall Study||81
266696|NCT02336607|641431|P4|Patients Included in Safety Population|Overall Study||260
266697|NCT02336607|641432|P3|Patients Included in Safety Population|Overall Study||92
266698|NCT02336607|641433|P2|Patients Included in Safety Population|Overall Study||85
266699|NCT02336607|641434|P1|Patients Included in Safety Population|Overall Study||85
266700|NCT02336607|641431|P4|Patients Included in PP Population|Overall Study||162
266701|NCT02336607|641432|P3|Patients Included in PP Population|Overall Study||75
266702|NCT02336607|641433|P2|Patients Included in PP Population|Overall Study||75
266703|NCT02336607|641434|P1|Patients Included in PP Population|Overall Study||78
266704|NCT02336607|641431|P4|Patients Included in ITT Population|Overall Study||222
266705|NCT02336607|641432|P3|Patients Included in ITT Population|Overall Study||91
266706|NCT02336607|641433|P2|Patients Included in ITT Population|Overall Study||84
266707|NCT02336607|641434|P1|Patients Included in ITT Population|Overall Study||84
266708|NCT02336607|641431|P4|STARTED|Overall Study||267
266709|NCT02336607|641432|P3|STARTED|Overall Study||92
266710|NCT02336607|641433|P2|STARTED|Overall Study||85
266711|NCT02336607|641434|P1|STARTED|Overall Study||85
266712|NCT02336438|641488|P1|NOT COMPLETED|Overall Study||1
266713|NCT02336438|641488|P1|COMPLETED|Overall Study||10
266714|NCT02336438|641488|P1|STARTED|Overall Study||11
266715|NCT02336425|641501|P4|NOT COMPLETED|Overall Study||3
266716|NCT02336425|641502|P3|NOT COMPLETED|Overall Study||3
266717|NCT02336425|641503|P2|NOT COMPLETED|Overall Study||2
266718|NCT02336425|641504|P1|NOT COMPLETED|Overall Study||2
266719|NCT02336425|641501|P4|COMPLETED|Overall Study||0
266720|NCT02336425|641502|P3|COMPLETED|Overall Study||0
266721|NCT02336425|641503|P2|COMPLETED|Overall Study||0
266722|NCT02336425|641504|P1|COMPLETED|Overall Study||0
266723|NCT02336425|641501|P4|STARTED|Overall Study||3
266724|NCT02336425|641502|P3|STARTED|Overall Study||3
266725|NCT02336425|641503|P2|STARTED|Overall Study||2
266726|NCT02336425|641504|P1|STARTED|Overall Study||2
266727|NCT02336178|641554|P1|NOT COMPLETED|Overall Study||4
266728|NCT02336178|641554|P1|COMPLETED|Overall Study||66
266729|NCT02336178|641554|P1|STARTED|Overall Study||70
266730|NCT02335710|641642|P2|NOT COMPLETED|Overall Study||0
266731|NCT02335710|641643|P1|NOT COMPLETED|Overall Study||0
266732|NCT02335710|641642|P2|COMPLETED|Overall Study||10
266733|NCT02335710|641643|P1|COMPLETED|Overall Study||40
266734|NCT02335710|641642|P2|STARTED|Overall Study||10
266735|NCT02335710|641643|P1|STARTED|Overall Study||40
266736|NCT02334982|641670|P7|NOT COMPLETED|Overall Study||0
266737|NCT02334982|641671|P6|NOT COMPLETED|Overall Study||0
266738|NCT02334982|641672|P5|NOT COMPLETED|Overall Study||0
266739|NCT02334982|641673|P4|NOT COMPLETED|Overall Study||0
266740|NCT02334982|641674|P3|NOT COMPLETED|Overall Study||0
266741|NCT02334982|641675|P2|NOT COMPLETED|Overall Study||0
266742|NCT02334982|641676|P1|NOT COMPLETED|Overall Study||0
266743|NCT02334982|641670|P7|COMPLETED|Overall Study||12
266744|NCT02334982|641671|P6|COMPLETED|Overall Study||6
266745|NCT02334982|641672|P5|COMPLETED|Overall Study||6
266746|NCT02334982|641673|P4|COMPLETED|Overall Study||6
266747|NCT02334982|641674|P3|COMPLETED|Overall Study||6
266748|NCT02334982|641675|P2|COMPLETED|Overall Study||5
266749|NCT02334982|641676|P1|COMPLETED|Overall Study||6
266750|NCT02334982|641670|P7|STARTED|Overall Study||12
266751|NCT02334982|641671|P6|STARTED|Overall Study||6
266752|NCT02334982|641672|P5|STARTED|Overall Study||6
266753|NCT02334982|641673|P4|STARTED|Overall Study||6
266754|NCT02334982|641674|P3|STARTED|Overall Study||6
266755|NCT02334982|641675|P2|STARTED|Overall Study||5
266756|NCT02334982|641676|P1|STARTED|Overall Study||6
266757|NCT02334813|641782|P2|NOT COMPLETED|Overall Study||1
266758|NCT02334813|641783|P1|NOT COMPLETED|Overall Study||3
266759|NCT02334813|641782|P2|COMPLETED|Overall Study||13
266760|NCT02334813|641783|P1|COMPLETED|Overall Study||9
266761|NCT02334813|641782|P2|STARTED|Overall Study||14
266762|NCT02334813|641783|P1|STARTED|Overall Study||12
266763|NCT02334787|641793|P4|NOT COMPLETED|Overall Study||0
266764|NCT02334787|641794|P3|NOT COMPLETED|Overall Study||0
266765|NCT02334787|641795|P2|NOT COMPLETED|Overall Study||0
266766|NCT02334787|641796|P1|NOT COMPLETED|Overall Study||0
266767|NCT02334787|641793|P4|COMPLETED|Overall Study||8
266768|NCT02334787|641794|P3|COMPLETED|Overall Study||8
266769|NCT02334787|641795|P2|COMPLETED|Overall Study||8
266770|NCT02334787|641796|P1|COMPLETED|Overall Study||8
266771|NCT02334787|641793|P4|STARTED|Overall Study||8
266772|NCT02334787|641794|P3|STARTED|Overall Study||8
266773|NCT02334787|641795|P2|STARTED|Overall Study||8
266774|NCT02334787|641796|P1|STARTED|Overall Study||8
266775|NCT02334267|641820|P2|NOT COMPLETED|Overall Study||0
266776|NCT02334267|641821|P1|NOT COMPLETED|Overall Study||1
266777|NCT02334267|641820|P2|COMPLETED|Overall Study||5
266778|NCT02334267|641821|P1|COMPLETED|Overall Study||5
266779|NCT02334267|641820|P2|STARTED|Overall Study||5
266780|NCT02334267|641821|P1|STARTED|Overall Study||6
266781|NCT02332902|641833|P1|NOT COMPLETED|Overall Study||7
266782|NCT02332902|641833|P1|COMPLETED|Overall Study||17
266783|NCT02332902|641833|P1|STARTED|Overall Study||24
266784|NCT02332798|641841|P3|NOT COMPLETED|Overall Study||1
266785|NCT02332798|641842|P2|NOT COMPLETED|Overall Study||2
266786|NCT02332798|641843|P1|NOT COMPLETED|Overall Study||1
266787|NCT02332798|641841|P3|COMPLETED|Overall Study||11
266788|NCT02332798|641842|P2|COMPLETED|Overall Study||12
266789|NCT02332798|641843|P1|COMPLETED|Overall Study||12
266790|NCT02332798|641841|P3|STARTED|Overall Study||12
266791|NCT02332798|641842|P2|STARTED|Overall Study||14
266792|NCT02332798|641843|P1|STARTED|Overall Study||13
266793|NCT02331940|641895|P2|NOT COMPLETED|Overall Study||5
266794|NCT02331940|641896|P1|NOT COMPLETED|Overall Study||7
266795|NCT02331940|641895|P2|COMPLETED|Overall Study||95
266796|NCT02331940|641896|P1|COMPLETED|Overall Study||93
266797|NCT02331940|641895|P2|STARTED|Overall Study||100
266798|NCT02331940|641896|P1|STARTED|Overall Study||100
266799|NCT02331589|641910|P2|NOT COMPLETED|Overall Study||5
266800|NCT02331589|641911|P1|NOT COMPLETED|Overall Study||5
266801|NCT02331589|641910|P2|COMPLETED|Overall Study||31
266802|NCT02331589|641911|P1|COMPLETED|Overall Study||34
266803|NCT02331589|641910|P2|STARTED|Overall Study||36
266804|NCT02331589|641911|P1|STARTED|Overall Study||39
266805|NCT02331446|641927|P4|NOT COMPLETED|Overall Study||3
266806|NCT02331446|641928|P3|NOT COMPLETED|Overall Study||3
266807|NCT02331446|641929|P2|NOT COMPLETED|Overall Study||5
266808|NCT02331446|641930|P1|NOT COMPLETED|Overall Study||4
266809|NCT02331446|641927|P4|COMPLETED|Overall Study||8
266810|NCT02331446|641928|P3|COMPLETED|Overall Study||8
266811|NCT02331446|641929|P2|COMPLETED|Overall Study||6
266812|NCT02331446|641930|P1|COMPLETED|Overall Study||5
266813|NCT02331446|641927|P4|STARTED|Overall Study||11
266814|NCT02331446|641928|P3|STARTED|Overall Study||11
266815|NCT02331446|641929|P2|STARTED|Overall Study||11
266816|NCT02331446|641930|P1|STARTED|Overall Study||9
266817|NCT02331108|642006|P6|NOT COMPLETED|Overall Study||2
266818|NCT02331108|642007|P5|NOT COMPLETED|Overall Study||2
266819|NCT02331108|642008|P4|NOT COMPLETED|Overall Study||1
266820|NCT02331108|642009|P3|NOT COMPLETED|Overall Study||1
266821|NCT02331108|642010|P2|NOT COMPLETED|Overall Study||2
266822|NCT02331108|642011|P1|NOT COMPLETED|Overall Study||1
266823|NCT02331108|642006|P6|COMPLETED|Overall Study||50
266824|NCT02331108|642007|P5|COMPLETED|Overall Study||50
266825|NCT02331108|642008|P4|COMPLETED|Overall Study||50
266826|NCT02331108|642009|P3|COMPLETED|Overall Study||50
266827|NCT02331108|642010|P2|COMPLETED|Overall Study||50
266828|NCT02331108|642011|P1|COMPLETED|Overall Study||50
266829|NCT02331108|642006|P6|STARTED|Overall Study||52
266830|NCT02331108|642007|P5|STARTED|Overall Study||52
266831|NCT02331108|642008|P4|STARTED|Overall Study||51
266832|NCT02331108|642009|P3|STARTED|Overall Study||51
266833|NCT02331108|642010|P2|STARTED|Overall Study||52
266834|NCT02331108|642011|P1|STARTED|Overall Study||51
266835|NCT02330588|642038|P5|NOT COMPLETED|Overall Study||19
266836|NCT02330588|642039|P4|NOT COMPLETED|Overall Study||22
266837|NCT02330588|642040|P3|NOT COMPLETED|Overall Study||15
266838|NCT02330588|642041|P2|NOT COMPLETED|Overall Study||18
266839|NCT02330588|642042|P1|NOT COMPLETED|Overall Study||16
266840|NCT02330588|642038|P5|COMPLETED|Overall Study||28
266841|NCT02330588|642039|P4|COMPLETED|Overall Study||24
266842|NCT02330588|642040|P3|COMPLETED|Overall Study||31
266843|NCT02330588|642041|P2|COMPLETED|Overall Study||25
266844|NCT02330588|642042|P1|COMPLETED|Overall Study||28
266845|NCT02330588|642038|P5|STARTED|Overall Study||47
266846|NCT02330588|642039|P4|STARTED|Overall Study||46
266847|NCT02330588|642040|P3|STARTED|Overall Study||46
266848|NCT02330588|642041|P2|STARTED|Overall Study||43
266849|NCT02330588|642042|P1|STARTED|Overall Study||44
266850|NCT02330523|642069|P2|NOT COMPLETED|Overall Study||0
266851|NCT02330523|642070|P1|NOT COMPLETED|Overall Study||0
266852|NCT02330523|642069|P2|COMPLETED|Overall Study||19
266853|NCT02330523|642070|P1|COMPLETED|Overall Study||21
266854|NCT02330523|642069|P2|STARTED|Overall Study||19
266855|NCT02330523|642070|P1|STARTED|Overall Study||21
266856|NCT02330276|642083|P3|NOT COMPLETED|Overall Study||0
266857|NCT02330276|642084|P2|NOT COMPLETED|Overall Study||0
266858|NCT02330276|642085|P1|NOT COMPLETED|Overall Study||0
266859|NCT02330276|642083|P3|COMPLETED|Overall Study||4
266860|NCT02330276|642084|P2|COMPLETED|Overall Study||4
266861|NCT02330276|642085|P1|COMPLETED|Overall Study||4
266862|NCT02330276|642083|P3|STARTED|Overall Study||4
266863|NCT02330276|642084|P2|STARTED|Overall Study||4
266864|NCT02330276|642085|P1|STARTED|Overall Study||4
266865|NCT02330172|642107|P2|NOT COMPLETED|Overall Study||1
266866|NCT02330172|642108|P1|NOT COMPLETED|Overall Study||3
266867|NCT02330172|642107|P2|COMPLETED|Overall Study||21
266868|NCT02330172|642108|P1|COMPLETED|Overall Study||19
266869|NCT02330172|642107|P2|STARTED|Overall Study||22
266870|NCT02330172|642108|P1|STARTED|Overall Study||22
266871|NCT02329964|642118|P2|NOT COMPLETED|Overall Study||0
266872|NCT02329964|642119|P1|NOT COMPLETED|Overall Study||0
266873|NCT02329964|642118|P2|COMPLETED|Overall Study||40
266874|NCT02329964|642119|P1|COMPLETED|Overall Study||40
266875|NCT02329964|642118|P2|STARTED|Overall Study||40
266876|NCT02329964|642119|P1|STARTED|Overall Study||40
266877|NCT02329730|642145|P12|NOT COMPLETED|Overall Study||0
266878|NCT02329730|642146|P11|NOT COMPLETED|Overall Study||0
266879|NCT02329730|642147|P10|NOT COMPLETED|Overall Study||1
266880|NCT02329730|642148|P9|NOT COMPLETED|Overall Study||1
266881|NCT02329730|642149|P8|NOT COMPLETED|Overall Study||1
266882|NCT02329730|642150|P7|NOT COMPLETED|Overall Study||1
266883|NCT02329730|642151|P6|NOT COMPLETED|Overall Study||2
266884|NCT02329730|642152|P5|NOT COMPLETED|Overall Study||3
266885|NCT02329730|642153|P4|NOT COMPLETED|Overall Study||0
266886|NCT02329730|642154|P3|NOT COMPLETED|Overall Study||0
266887|NCT02329730|642155|P2|NOT COMPLETED|Overall Study||0
266888|NCT02329730|642156|P1|NOT COMPLETED|Overall Study||0
266889|NCT02329730|642145|P12|COMPLETED|Overall Study||8
266890|NCT02329730|642146|P11|COMPLETED|Overall Study||8
266891|NCT02329730|642147|P10|COMPLETED|Overall Study||7
266892|NCT02329730|642148|P9|COMPLETED|Overall Study||7
266893|NCT02329730|642149|P8|COMPLETED|Overall Study||13
266894|NCT02329730|642150|P7|COMPLETED|Overall Study||13
266895|NCT02329730|642151|P6|COMPLETED|Overall Study||12
266896|NCT02329730|642152|P5|COMPLETED|Overall Study||11
266897|NCT02329730|642153|P4|COMPLETED|Overall Study||14
266898|NCT02329730|642154|P3|COMPLETED|Overall Study||14
266899|NCT02329730|642155|P2|COMPLETED|Overall Study||14
266900|NCT02329730|642156|P1|COMPLETED|Overall Study||14
266901|NCT02329730|642145|P12|STARTED|Overall Study||8
266902|NCT02329730|642146|P11|STARTED|Overall Study||8
266903|NCT02329730|642147|P10|STARTED|Overall Study||8
266904|NCT02329730|642148|P9|STARTED|Overall Study||8
266905|NCT02329730|642149|P8|STARTED|Overall Study||14
266906|NCT02329730|642150|P7|STARTED|Overall Study||14
266907|NCT02329730|642151|P6|STARTED|Overall Study||14
266908|NCT02329730|642152|P5|STARTED|Overall Study||14
266909|NCT02329730|642153|P4|STARTED|Overall Study||14
266910|NCT02329730|642154|P3|STARTED|Overall Study||14
266911|NCT02329730|642155|P2|STARTED|Overall Study||14
266912|NCT02329730|642156|P1|STARTED|Overall Study||14
266913|NCT02329600|642233|P3|NOT COMPLETED|Overall Study||0
266914|NCT02329600|642234|P2|NOT COMPLETED|Overall Study||0
266915|NCT02329600|642235|P1|NOT COMPLETED|Overall Study||0
266916|NCT02329600|642233|P3|COMPLETED|Overall Study||15
266917|NCT02329600|642234|P2|COMPLETED|Overall Study||15
266918|NCT02329600|642235|P1|COMPLETED|Overall Study||10
266919|NCT02329600|642233|P3|STARTED|Overall Study||15
266920|NCT02329600|642234|P2|STARTED|Overall Study||15
266921|NCT02329600|642235|P1|STARTED|Overall Study||10
266922|NCT02329223|642249|P3|NOT COMPLETED|Overall Study||6
266923|NCT02329223|642250|P2|NOT COMPLETED|Overall Study||3
266924|NCT02329223|642251|P1|NOT COMPLETED|Overall Study||1
266925|NCT02329223|642249|P3|COMPLETED|Overall Study||68
266926|NCT02329223|642250|P2|COMPLETED|Overall Study||68
266927|NCT02329223|642251|P1|COMPLETED|Overall Study||72
266928|NCT02329223|642249|P3|Safety Set|Overall Study||74
266929|NCT02329223|642250|P2|Safety Set|Overall Study||71
266930|NCT02329223|642251|P1|Safety Set|Overall Study||73
266931|NCT02329223|642249|P3|Full Analysis Set|Overall Study||74
266932|NCT02329223|642250|P2|Full Analysis Set|Overall Study||70
266933|NCT02329223|642251|P1|Full Analysis Set|Overall Study||73
266934|NCT02329223|642249|P3|STARTED|Overall Study||74
266935|NCT02329223|642250|P2|STARTED|Overall Study||71
266936|NCT02329223|642251|P1|STARTED|Overall Study||73
266937|NCT02329015|642284|P2|NOT COMPLETED|Overall Study||0
266938|NCT02329015|642285|P1|NOT COMPLETED|Overall Study||0
266939|NCT02329015|642284|P2|COMPLETED|Overall Study||64
266940|NCT02329015|642285|P1|COMPLETED|Overall Study||48
266941|NCT02329015|642284|P2|STARTED|Overall Study||64
266942|NCT02329015|642285|P1|STARTED|Overall Study||48
266943|NCT02328937|642301|P6|NOT COMPLETED|Period 3||0
266944|NCT02328937|642302|P5|NOT COMPLETED|Period 3||0
266945|NCT02328937|642303|P4|NOT COMPLETED|Period 3||0
266946|NCT02328937|642304|P3|NOT COMPLETED|Period 3||0
266947|NCT02328937|642305|P2|NOT COMPLETED|Period 3||0
266948|NCT02328937|642306|P1|NOT COMPLETED|Period 3||0
266949|NCT02328937|642301|P6|COMPLETED|Period 3||6
266950|NCT02328937|642302|P5|COMPLETED|Period 3||6
266951|NCT02328937|642303|P4|COMPLETED|Period 3||5
266952|NCT02328937|642304|P3|COMPLETED|Period 3||6
266953|NCT02328937|642305|P2|COMPLETED|Period 3||6
266954|NCT02328937|642306|P1|COMPLETED|Period 3||7
266955|NCT02328937|642301|P6|STARTED|Period 3||6
266956|NCT02328937|642302|P5|STARTED|Period 3||6
266957|NCT02328937|642303|P4|STARTED|Period 3||5
266958|NCT02328937|642304|P3|STARTED|Period 3||6
266959|NCT02328937|642305|P2|STARTED|Period 3||6
266960|NCT02328937|642306|P1|STARTED|Period 3||7
266961|NCT02328937|642301|P6|NOT COMPLETED|Period 2||0
266962|NCT02328937|642302|P5|NOT COMPLETED|Period 2||0
266963|NCT02328937|642303|P4|NOT COMPLETED|Period 2||0
266964|NCT02328937|642304|P3|NOT COMPLETED|Period 2||1
266965|NCT02328937|642305|P2|NOT COMPLETED|Period 2||0
266966|NCT02328937|642306|P1|NOT COMPLETED|Period 2||0
266967|NCT02328937|642301|P6|COMPLETED|Period 2||6
266968|NCT02328937|642302|P5|COMPLETED|Period 2||6
266969|NCT02328937|642303|P4|COMPLETED|Period 2||5
266970|NCT02328937|642304|P3|COMPLETED|Period 2||6
266971|NCT02328937|642305|P2|COMPLETED|Period 2||6
266972|NCT02328937|642306|P1|COMPLETED|Period 2||7
266973|NCT02328937|642301|P6|STARTED|Period 2||6
266974|NCT02328937|642302|P5|STARTED|Period 2||6
266975|NCT02328937|642303|P4|STARTED|Period 2||5
266976|NCT02328937|642304|P3|STARTED|Period 2||7
266977|NCT02328937|642305|P2|STARTED|Period 2||6
266978|NCT02328937|642306|P1|STARTED|Period 2||7
266979|NCT02328937|642301|P6|NOT COMPLETED|Period 1||0
266980|NCT02328937|642302|P5|NOT COMPLETED|Period 1||0
266981|NCT02328937|642303|P4|NOT COMPLETED|Period 1||1
266982|NCT02328937|642304|P3|NOT COMPLETED|Period 1||0
266983|NCT02328937|642305|P2|NOT COMPLETED|Period 1||0
266984|NCT02328937|642306|P1|NOT COMPLETED|Period 1||0
266985|NCT02328937|642301|P6|COMPLETED|Period 1||6
266986|NCT02328937|642302|P5|COMPLETED|Period 1||6
266987|NCT02328937|642303|P4|COMPLETED|Period 1||5
266988|NCT02328937|642304|P3|COMPLETED|Period 1||7
266989|NCT02328937|642305|P2|COMPLETED|Period 1||6
266990|NCT02328937|642306|P1|COMPLETED|Period 1||7
266991|NCT02328937|642301|P6|STARTED|Period 1||6
266992|NCT02328937|642302|P5|STARTED|Period 1||6
266993|NCT02328937|642303|P4|STARTED|Period 1||6
266994|NCT02328937|642304|P3|STARTED|Period 1||7
266995|NCT02328937|642305|P2|STARTED|Period 1||6
266996|NCT02328937|642306|P1|STARTED|Period 1||7
266997|NCT02328404|642319|P2|NOT COMPLETED|Overall Study||1
266998|NCT02328404|642320|P1|NOT COMPLETED|Overall Study||1
266999|NCT02328404|642319|P2|COMPLETED|Overall Study||29
267000|NCT02328404|642320|P1|COMPLETED|Overall Study||29
267001|NCT02328404|642319|P2|STARTED|Overall Study||30
267002|NCT02328404|642320|P1|STARTED|Overall Study||30
267003|NCT02327117|642356|P2|NOT COMPLETED|Overall Study||0
267004|NCT02327117|642357|P1|NOT COMPLETED|Overall Study||0
267005|NCT02327117|642356|P2|COMPLETED|Overall Study||45
267006|NCT02327117|642357|P1|COMPLETED|Overall Study||45
267007|NCT02327117|642356|P2|STARTED|Overall Study||45
267008|NCT02327117|642357|P1|STARTED|Overall Study||45
267009|NCT02326844|642363|P1|NOT COMPLETED|Overall Study||0
267010|NCT02326844|642363|P1|COMPLETED|Overall Study||3
267011|NCT02326844|642363|P1|STARTED|Overall Study||3
267012|NCT02326649|642370|P1|NOT COMPLETED|Overall Study||12
267013|NCT02326649|642370|P1|COMPLETED|Overall Study||21
267014|NCT02326649|642370|P1|STARTED|Overall Study||33
267015|NCT02325856|642376|P2|NOT COMPLETED|Overall Study||27
267016|NCT02325856|642377|P1|NOT COMPLETED|Overall Study||20
267017|NCT02325856|642376|P2|COMPLETED|Overall Study||123
267018|NCT02325856|642377|P1|COMPLETED|Overall Study||128
267019|NCT02325856|642376|P2|STARTED|Overall Study||150
267020|NCT02325856|642377|P1|STARTED|Overall Study||148
267021|NCT02325713|642401|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267022|NCT02325713|642402|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267023|NCT02325713|642403|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267024|NCT02325713|642404|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267025|NCT02325713|642405|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267026|NCT02325713|642406|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267027|NCT02325713|642407|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267028|NCT02325713|642408|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267108|NCT02325713|642408|P9|STARTED|Intervention Period 3 (2 Days)||2
267029|NCT02325713|642409|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267030|NCT02325713|642410|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267031|NCT02325713|642411|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267032|NCT02325713|642412|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267033|NCT02325713|642413|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267034|NCT02325713|642414|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267035|NCT02325713|642415|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267036|NCT02325713|642416|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
267037|NCT02325713|642401|P16|COMPLETED|Intervention Period 4 (2 Days)||2
267038|NCT02325713|642402|P15|COMPLETED|Intervention Period 4 (2 Days)||2
267039|NCT02325713|642403|P14|COMPLETED|Intervention Period 4 (2 Days)||2
267040|NCT02325713|642404|P13|COMPLETED|Intervention Period 4 (2 Days)||2
267041|NCT02325713|642405|P12|COMPLETED|Intervention Period 4 (2 Days)||2
267042|NCT02325713|642406|P11|COMPLETED|Intervention Period 4 (2 Days)||1
267043|NCT02325713|642407|P10|COMPLETED|Intervention Period 4 (2 Days)||1
267044|NCT02325713|642408|P9|COMPLETED|Intervention Period 4 (2 Days)||2
267045|NCT02325713|642409|P8|COMPLETED|Intervention Period 4 (2 Days)||2
267046|NCT02325713|642410|P7|COMPLETED|Intervention Period 4 (2 Days)||2
267047|NCT02325713|642411|P6|COMPLETED|Intervention Period 4 (2 Days)||2
267048|NCT02325713|642412|P5|COMPLETED|Intervention Period 4 (2 Days)||2
267049|NCT02325713|642413|P4|COMPLETED|Intervention Period 4 (2 Days)||2
267050|NCT02325713|642414|P3|COMPLETED|Intervention Period 4 (2 Days)||2
267051|NCT02325713|642415|P2|COMPLETED|Intervention Period 4 (2 Days)||2
267052|NCT02325713|642416|P1|COMPLETED|Intervention Period 4 (2 Days)||1
267053|NCT02325713|642401|P16|STARTED|Intervention Period 4 (2 Days)||2
267054|NCT02325713|642402|P15|STARTED|Intervention Period 4 (2 Days)||2
267055|NCT02325713|642403|P14|STARTED|Intervention Period 4 (2 Days)||2
267056|NCT02325713|642404|P13|STARTED|Intervention Period 4 (2 Days)||2
267057|NCT02325713|642405|P12|STARTED|Intervention Period 4 (2 Days)||2
267058|NCT02325713|642406|P11|STARTED|Intervention Period 4 (2 Days)||1
267059|NCT02325713|642407|P10|STARTED|Intervention Period 4 (2 Days)||1
267060|NCT02325713|642408|P9|STARTED|Intervention Period 4 (2 Days)||2
267061|NCT02325713|642409|P8|STARTED|Intervention Period 4 (2 Days)||2
267062|NCT02325713|642410|P7|STARTED|Intervention Period 4 (2 Days)||2
267063|NCT02325713|642411|P6|STARTED|Intervention Period 4 (2 Days)||2
267064|NCT02325713|642412|P5|STARTED|Intervention Period 4 (2 Days)||2
267065|NCT02325713|642413|P4|STARTED|Intervention Period 4 (2 Days)||2
267066|NCT02325713|642414|P3|STARTED|Intervention Period 4 (2 Days)||2
267067|NCT02325713|642415|P2|STARTED|Intervention Period 4 (2 Days)||2
267068|NCT02325713|642416|P1|STARTED|Intervention Period 4 (2 Days)||1
267069|NCT02325713|642401|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267070|NCT02325713|642402|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267071|NCT02325713|642403|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267072|NCT02325713|642404|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267073|NCT02325713|642405|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267074|NCT02325713|642406|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267075|NCT02325713|642407|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
267076|NCT02325713|642408|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267077|NCT02325713|642409|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267078|NCT02325713|642410|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267079|NCT02325713|642411|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267080|NCT02325713|642412|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267081|NCT02325713|642413|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267082|NCT02325713|642414|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267083|NCT02325713|642415|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267084|NCT02325713|642416|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
267085|NCT02325713|642401|P16|COMPLETED|Intervention Period 3 (2 Days)||2
267086|NCT02325713|642402|P15|COMPLETED|Intervention Period 3 (2 Days)||2
267087|NCT02325713|642403|P14|COMPLETED|Intervention Period 3 (2 Days)||2
267088|NCT02325713|642404|P13|COMPLETED|Intervention Period 3 (2 Days)||2
267089|NCT02325713|642405|P12|COMPLETED|Intervention Period 3 (2 Days)||2
267090|NCT02325713|642406|P11|COMPLETED|Intervention Period 3 (2 Days)||1
267091|NCT02325713|642407|P10|COMPLETED|Intervention Period 3 (2 Days)||1
267092|NCT02325713|642408|P9|COMPLETED|Intervention Period 3 (2 Days)||2
267093|NCT02325713|642409|P8|COMPLETED|Intervention Period 3 (2 Days)||2
267094|NCT02325713|642410|P7|COMPLETED|Intervention Period 3 (2 Days)||2
267095|NCT02325713|642411|P6|COMPLETED|Intervention Period 3 (2 Days)||2
267096|NCT02325713|642412|P5|COMPLETED|Intervention Period 3 (2 Days)||2
267097|NCT02325713|642413|P4|COMPLETED|Intervention Period 3 (2 Days)||2
267098|NCT02325713|642414|P3|COMPLETED|Intervention Period 3 (2 Days)||2
267099|NCT02325713|642415|P2|COMPLETED|Intervention Period 3 (2 Days)||2
267100|NCT02325713|642416|P1|COMPLETED|Intervention Period 3 (2 Days)||1
267101|NCT02325713|642401|P16|STARTED|Intervention Period 3 (2 Days)||2
267102|NCT02325713|642402|P15|STARTED|Intervention Period 3 (2 Days)||2
267103|NCT02325713|642403|P14|STARTED|Intervention Period 3 (2 Days)||2
267104|NCT02325713|642404|P13|STARTED|Intervention Period 3 (2 Days)||2
267105|NCT02325713|642405|P12|STARTED|Intervention Period 3 (2 Days)||2
267106|NCT02325713|642406|P11|STARTED|Intervention Period 3 (2 Days)||1
267107|NCT02325713|642407|P10|STARTED|Intervention Period 3 (2 Days)||2
267109|NCT02325713|642409|P8|STARTED|Intervention Period 3 (2 Days)||2
267110|NCT02325713|642410|P7|STARTED|Intervention Period 3 (2 Days)||2
267111|NCT02325713|642411|P6|STARTED|Intervention Period 3 (2 Days)||2
267112|NCT02325713|642412|P5|STARTED|Intervention Period 3 (2 Days)||2
267113|NCT02325713|642413|P4|STARTED|Intervention Period 3 (2 Days)||2
267114|NCT02325713|642414|P3|STARTED|Intervention Period 3 (2 Days)||2
267115|NCT02325713|642415|P2|STARTED|Intervention Period 3 (2 Days)||2
267116|NCT02325713|642416|P1|STARTED|Intervention Period 3 (2 Days)||1
267117|NCT02325713|642401|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267118|NCT02325713|642402|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267119|NCT02325713|642403|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267120|NCT02325713|642404|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267121|NCT02325713|642405|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267122|NCT02325713|642406|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267123|NCT02325713|642407|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267124|NCT02325713|642408|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267125|NCT02325713|642409|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267126|NCT02325713|642410|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267127|NCT02325713|642411|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267128|NCT02325713|642412|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267129|NCT02325713|642413|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267130|NCT02325713|642414|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267131|NCT02325713|642415|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
267132|NCT02325713|642416|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
267133|NCT02325713|642401|P16|COMPLETED|Intervention Period 2 (2 Days)||2
267134|NCT02325713|642402|P15|COMPLETED|Intervention Period 2 (2 Days)||2
267135|NCT02325713|642403|P14|COMPLETED|Intervention Period 2 (2 Days)||2
267136|NCT02325713|642404|P13|COMPLETED|Intervention Period 2 (2 Days)||2
267137|NCT02325713|642405|P12|COMPLETED|Intervention Period 2 (2 Days)||2
267138|NCT02325713|642406|P11|COMPLETED|Intervention Period 2 (2 Days)||1
267139|NCT02325713|642407|P10|COMPLETED|Intervention Period 2 (2 Days)||2
267140|NCT02325713|642408|P9|COMPLETED|Intervention Period 2 (2 Days)||2
267141|NCT02325713|642409|P8|COMPLETED|Intervention Period 2 (2 Days)||2
267142|NCT02325713|642410|P7|COMPLETED|Intervention Period 2 (2 Days)||2
267143|NCT02325713|642411|P6|COMPLETED|Intervention Period 2 (2 Days)||2
267144|NCT02325713|642412|P5|COMPLETED|Intervention Period 2 (2 Days)||2
267145|NCT02325713|642413|P4|COMPLETED|Intervention Period 2 (2 Days)||2
267146|NCT02325713|642414|P3|COMPLETED|Intervention Period 2 (2 Days)||2
267147|NCT02325713|642415|P2|COMPLETED|Intervention Period 2 (2 Days)||2
267148|NCT02325713|642416|P1|COMPLETED|Intervention Period 2 (2 Days)||1
267149|NCT02325713|642401|P16|STARTED|Intervention Period 2 (2 Days)||2
267150|NCT02325713|642402|P15|STARTED|Intervention Period 2 (2 Days)||2
267151|NCT02325713|642403|P14|STARTED|Intervention Period 2 (2 Days)||2
267152|NCT02325713|642404|P13|STARTED|Intervention Period 2 (2 Days)||2
267153|NCT02325713|642405|P12|STARTED|Intervention Period 2 (2 Days)||2
267154|NCT02325713|642406|P11|STARTED|Intervention Period 2 (2 Days)||1
267155|NCT02325713|642407|P10|STARTED|Intervention Period 2 (2 Days)||2
267156|NCT02325713|642408|P9|STARTED|Intervention Period 2 (2 Days)||2
267157|NCT02325713|642409|P8|STARTED|Intervention Period 2 (2 Days)||2
267158|NCT02325713|642410|P7|STARTED|Intervention Period 2 (2 Days)||2
267159|NCT02325713|642411|P6|STARTED|Intervention Period 2 (2 Days)||2
267160|NCT02325713|642412|P5|STARTED|Intervention Period 2 (2 Days)||2
267161|NCT02325713|642413|P4|STARTED|Intervention Period 2 (2 Days)||2
267162|NCT02325713|642414|P3|STARTED|Intervention Period 2 (2 Days)||2
267163|NCT02325713|642415|P2|STARTED|Intervention Period 2 (2 Days)||2
267164|NCT02325713|642416|P1|STARTED|Intervention Period 2 (2 Days)||2
267165|NCT02325713|642401|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267166|NCT02325713|642402|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267167|NCT02325713|642403|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267168|NCT02325713|642404|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267169|NCT02325713|642405|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267170|NCT02325713|642406|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
267171|NCT02325713|642407|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267172|NCT02325713|642408|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267173|NCT02325713|642409|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267174|NCT02325713|642410|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267175|NCT02325713|642411|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267176|NCT02325713|642412|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267177|NCT02325713|642413|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267178|NCT02325713|642414|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267179|NCT02325713|642415|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267180|NCT02325713|642416|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
267181|NCT02325713|642401|P16|COMPLETED|Intervention Period 1 (2 Days)||2
267182|NCT02325713|642402|P15|COMPLETED|Intervention Period 1 (2 Days)||2
267183|NCT02325713|642403|P14|COMPLETED|Intervention Period 1 (2 Days)||2
267184|NCT02325713|642404|P13|COMPLETED|Intervention Period 1 (2 Days)||2
267185|NCT02325713|642405|P12|COMPLETED|Intervention Period 1 (2 Days)||2
267186|NCT02325713|642406|P11|COMPLETED|Intervention Period 1 (2 Days)||1
267187|NCT02325713|642407|P10|COMPLETED|Intervention Period 1 (2 Days)||2
267188|NCT02325713|642408|P9|COMPLETED|Intervention Period 1 (2 Days)||2
267189|NCT02325713|642409|P8|COMPLETED|Intervention Period 1 (2 Days)||2
267190|NCT02325713|642410|P7|COMPLETED|Intervention Period 1 (2 Days)||2
267191|NCT02325713|642411|P6|COMPLETED|Intervention Period 1 (2 Days)||2
267192|NCT02325713|642412|P5|COMPLETED|Intervention Period 1 (2 Days)||2
267193|NCT02325713|642413|P4|COMPLETED|Intervention Period 1 (2 Days)||2
267194|NCT02325713|642414|P3|COMPLETED|Intervention Period 1 (2 Days)||2
267195|NCT02325713|642415|P2|COMPLETED|Intervention Period 1 (2 Days)||2
267196|NCT02325713|642416|P1|COMPLETED|Intervention Period 1 (2 Days)||2
267197|NCT02325713|642401|P16|STARTED|Intervention Period 1 (2 Days)||2
267198|NCT02325713|642402|P15|STARTED|Intervention Period 1 (2 Days)||2
267199|NCT02325713|642403|P14|STARTED|Intervention Period 1 (2 Days)||2
267200|NCT02325713|642404|P13|STARTED|Intervention Period 1 (2 Days)||2
267201|NCT02325713|642405|P12|STARTED|Intervention Period 1 (2 Days)||2
267202|NCT02325713|642406|P11|STARTED|Intervention Period 1 (2 Days)||2
267203|NCT02325713|642407|P10|STARTED|Intervention Period 1 (2 Days)||2
267204|NCT02325713|642408|P9|STARTED|Intervention Period 1 (2 Days)||2
267205|NCT02325713|642409|P8|STARTED|Intervention Period 1 (2 Days)||2
267206|NCT02325713|642410|P7|STARTED|Intervention Period 1 (2 Days)||2
267207|NCT02325713|642411|P6|STARTED|Intervention Period 1 (2 Days)||2
267208|NCT02325713|642412|P5|STARTED|Intervention Period 1 (2 Days)||2
267209|NCT02325713|642413|P4|STARTED|Intervention Period 1 (2 Days)||2
267210|NCT02325713|642414|P3|STARTED|Intervention Period 1 (2 Days)||2
267211|NCT02325713|642415|P2|STARTED|Intervention Period 1 (2 Days)||2
267212|NCT02325713|642416|P1|STARTED|Intervention Period 1 (2 Days)||2
267213|NCT02325518|642511|P2|NOT COMPLETED|Overall Study||3
267214|NCT02325518|642512|P1|NOT COMPLETED|Overall Study||4
267215|NCT02325518|642511|P2|COMPLETED|Overall Study||100
267216|NCT02325518|642512|P1|COMPLETED|Overall Study||94
267217|NCT02325518|642511|P2|Per Protocol Set (PPS)|Overall Study||97
267218|NCT02325518|642512|P1|Per Protocol Set (PPS)|Overall Study||92
267219|NCT02325518|642511|P2|Full Analysis Set (FAS)|Overall Study||101
267220|NCT02325518|642512|P1|Full Analysis Set (FAS)|Overall Study||98
267221|NCT02325518|642511|P2|Safety Set|Overall Study||103
267222|NCT02325518|642512|P1|Safety Set|Overall Study||98
267223|NCT02325518|642511|P2|STARTED|Overall Study||103
267224|NCT02325518|642512|P1|STARTED|Overall Study||98
267225|NCT02322892|642523|P2|NOT COMPLETED|Overall Study||3
267226|NCT02322892|642524|P1|NOT COMPLETED|Overall Study||2
267227|NCT02322892|642523|P2|COMPLETED|Overall Study|Received thiamine|31
267228|NCT02322892|642524|P1|COMPLETED|Overall Study|Received placebo|33
267229|NCT02322892|642523|P2|STARTED|Overall Study|Number randomized|34
267230|NCT02322892|642524|P1|STARTED|Overall Study|Number randomized|35
267231|NCT02322788|642538|P4|NOT COMPLETED|Visit 6||0
267232|NCT02322788|642539|P3|NOT COMPLETED|Visit 6||0
267233|NCT02322788|642540|P2|NOT COMPLETED|Visit 6||0
267234|NCT02322788|642541|P1|NOT COMPLETED|Visit 6||0
267235|NCT02322788|642538|P4|COMPLETED|Visit 6||15
267236|NCT02322788|642539|P3|COMPLETED|Visit 6||15
267237|NCT02322788|642540|P2|COMPLETED|Visit 6||16
267238|NCT02322788|642541|P1|COMPLETED|Visit 6||14
267239|NCT02322788|642538|P4|STARTED|Visit 6||15
267240|NCT02322788|642539|P3|STARTED|Visit 6||15
267241|NCT02322788|642540|P2|STARTED|Visit 6||16
267242|NCT02322788|642541|P1|STARTED|Visit 6||14
267243|NCT02322788|642538|P4|NOT COMPLETED|Visit 5||0
267244|NCT02322788|642539|P3|NOT COMPLETED|Visit 5||0
267245|NCT02322788|642540|P2|NOT COMPLETED|Visit 5||0
267246|NCT02322788|642541|P1|NOT COMPLETED|Visit 5||0
267247|NCT02322788|642538|P4|COMPLETED|Visit 5||14
267248|NCT02322788|642539|P3|COMPLETED|Visit 5||15
267249|NCT02322788|642540|P2|COMPLETED|Visit 5||15
267250|NCT02322788|642541|P1|COMPLETED|Visit 5||16
267251|NCT02322788|642538|P4|STARTED|Visit 5||14
267252|NCT02322788|642539|P3|STARTED|Visit 5||15
267253|NCT02322788|642540|P2|STARTED|Visit 5||15
267254|NCT02322788|642541|P1|STARTED|Visit 5||16
267255|NCT02322788|642538|P4|NOT COMPLETED|Visit 4||0
267256|NCT02322788|642539|P3|NOT COMPLETED|Visit 4||0
267257|NCT02322788|642540|P2|NOT COMPLETED|Visit 4||0
267258|NCT02322788|642541|P1|NOT COMPLETED|Visit 4||0
267259|NCT02322788|642538|P4|COMPLETED|Visit 4||15
267260|NCT02322788|642539|P3|COMPLETED|Visit 4||16
267261|NCT02322788|642540|P2|COMPLETED|Visit 4||14
267262|NCT02322788|642541|P1|COMPLETED|Visit 4||15
267263|NCT02322788|642538|P4|STARTED|Visit 4||15
267264|NCT02322788|642539|P3|STARTED|Visit 4||16
267265|NCT02322788|642540|P2|STARTED|Visit 4||14
267266|NCT02322788|642541|P1|STARTED|Visit 4||15
267267|NCT02322788|642538|P4|NOT COMPLETED|Visit 3||0
267268|NCT02322788|642539|P3|NOT COMPLETED|Visit 3||0
267269|NCT02322788|642540|P2|NOT COMPLETED|Visit 3||0
267270|NCT02322788|642541|P1|NOT COMPLETED|Visit 3||0
267271|NCT02322788|642538|P4|COMPLETED|Visit 3||16
267272|NCT02322788|642539|P3|COMPLETED|Visit 3||14
267273|NCT02322788|642540|P2|COMPLETED|Visit 3||15
267274|NCT02322788|642541|P1|COMPLETED|Visit 3||15
267275|NCT02322788|642538|P4|STARTED|Visit 3||16
267276|NCT02322788|642539|P3|STARTED|Visit 3||14
267277|NCT02322788|642540|P2|STARTED|Visit 3||15
267278|NCT02322788|642541|P1|STARTED|Visit 3||15
267279|NCT02322775|642553|P2|NOT COMPLETED|Overall Study||6
267280|NCT02322775|642554|P1|NOT COMPLETED|Overall Study||5
267281|NCT02322775|642553|P2|COMPLETED|Overall Study||99
267282|NCT02322775|642554|P1|COMPLETED|Overall Study||101
267283|NCT02322775|642553|P2|STARTED|Overall Study||105
267284|NCT02322775|642554|P1|STARTED|Overall Study||106
267285|NCT02322749|642580|P6|NOT COMPLETED|Period 3||0
267286|NCT02322749|642581|P5|NOT COMPLETED|Period 3||0
267287|NCT02322749|642582|P4|NOT COMPLETED|Period 3||0
267288|NCT02322749|642583|P3|NOT COMPLETED|Period 3||1
267289|NCT02322749|642584|P2|NOT COMPLETED|Period 3||0
267290|NCT02322749|642585|P1|NOT COMPLETED|Period 3||0
267291|NCT02322749|642580|P6|COMPLETED|Period 3||8
267292|NCT02322749|642581|P5|COMPLETED|Period 3||8
267293|NCT02322749|642582|P4|COMPLETED|Period 3||6
267294|NCT02322749|642583|P3|COMPLETED|Period 3||7
267295|NCT02322749|642584|P2|COMPLETED|Period 3||8
267296|NCT02322749|642585|P1|COMPLETED|Period 3||8
267297|NCT02322749|642580|P6|STARTED|Period 3||8
267298|NCT02322749|642581|P5|STARTED|Period 3||8
267299|NCT02322749|642582|P4|STARTED|Period 3||6
267300|NCT02322749|642583|P3|STARTED|Period 3||8
267301|NCT02322749|642584|P2|STARTED|Period 3||8
267302|NCT02322749|642585|P1|STARTED|Period 3||8
267303|NCT02322749|642580|P6|NOT COMPLETED|Period 2||0
267304|NCT02322749|642581|P5|NOT COMPLETED|Period 2||0
267305|NCT02322749|642582|P4|NOT COMPLETED|Period 2||2
267306|NCT02322749|642583|P3|NOT COMPLETED|Period 2||0
267307|NCT02322749|642584|P2|NOT COMPLETED|Period 2||0
267308|NCT02322749|642585|P1|NOT COMPLETED|Period 2||0
267309|NCT02322749|642580|P6|COMPLETED|Period 2||8
267310|NCT02322749|642581|P5|COMPLETED|Period 2||8
267311|NCT02322749|642582|P4|COMPLETED|Period 2||6
267312|NCT02322749|642583|P3|COMPLETED|Period 2||8
267313|NCT02322749|642584|P2|COMPLETED|Period 2||8
267314|NCT02322749|642585|P1|COMPLETED|Period 2||8
267315|NCT02322749|642580|P6|STARTED|Period 2||8
267316|NCT02322749|642581|P5|STARTED|Period 2||8
267317|NCT02322749|642582|P4|STARTED|Period 2||8
267318|NCT02322749|642583|P3|STARTED|Period 2||8
267319|NCT02322749|642584|P2|STARTED|Period 2||8
267320|NCT02322749|642585|P1|STARTED|Period 2||8
267321|NCT02322749|642580|P6|NOT COMPLETED|Period 1||0
267322|NCT02322749|642581|P5|NOT COMPLETED|Period 1||0
267323|NCT02322749|642582|P4|NOT COMPLETED|Period 1||0
267324|NCT02322749|642583|P3|NOT COMPLETED|Period 1||0
267325|NCT02322749|642584|P2|NOT COMPLETED|Period 1||0
267326|NCT02322749|642585|P1|NOT COMPLETED|Period 1||0
267327|NCT02322749|642580|P6|COMPLETED|Period 1||8
267328|NCT02322749|642581|P5|COMPLETED|Period 1||8
267329|NCT02322749|642582|P4|COMPLETED|Period 1||8
267330|NCT02322749|642583|P3|COMPLETED|Period 1||8
267331|NCT02322749|642584|P2|COMPLETED|Period 1||8
267332|NCT02322749|642585|P1|COMPLETED|Period 1||8
267333|NCT02322749|642580|P6|STARTED|Period 1||8
267334|NCT02322749|642581|P5|STARTED|Period 1||8
267335|NCT02322749|642582|P4|STARTED|Period 1||8
267336|NCT02322749|642583|P3|STARTED|Period 1||8
267337|NCT02322749|642584|P2|STARTED|Period 1||8
267338|NCT02322749|642585|P1|STARTED|Period 1||8
267339|NCT02322528|642608|P1|NOT COMPLETED|Overall Study||0
267340|NCT02322528|642608|P1|COMPLETED|Overall Study||10
267341|NCT02322528|642608|P1|STARTED|Overall Study||10
267342|NCT02322216|642615|P2|NOT COMPLETED|Overall Study||4
267343|NCT02322216|642616|P1|NOT COMPLETED|Overall Study||2
267344|NCT02322216|642615|P2|COMPLETED|Overall Study||123
267345|NCT02322216|642616|P1|COMPLETED|Overall Study||124
267346|NCT02322216|642615|P2|Per Protocol Set (PPS)|Overall Study||122
267347|NCT02322216|642616|P1|Per Protocol Set (PPS)|Overall Study||123
267348|NCT02322216|642615|P2|Treated (Safety Set)|Overall Study||126
267349|NCT02322216|642616|P1|Treated (Safety Set)|Overall Study||126
267350|NCT02322216|642615|P2|STARTED|Overall Study||127
267351|NCT02322216|642616|P1|STARTED|Overall Study||126
267352|NCT02320695|642623|P1|NOT COMPLETED|Overall Study||0
267353|NCT02320695|642623|P1|COMPLETED|Overall Study||60
267354|NCT02320695|642623|P1|Pain Relief Ointment|Overall Study||60
267355|NCT02320695|642623|P1|Original Ointment|Overall Study||60
267356|NCT02320695|642623|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
267357|NCT02320695|642623|P1|Pain Relieving Cream|Overall Study||59
267358|NCT02320695|642623|P1|Alcohol|Overall Study||60
267359|NCT02320695|642623|P1|Saline|Overall Study||60
267360|NCT02320695|642623|P1|STARTED|Overall Study||60
267361|NCT02320396|642652|P2|NOT COMPLETED|Overall Study||4
267362|NCT02320396|642653|P1|NOT COMPLETED|Overall Study||4
267363|NCT02320396|642652|P2|COMPLETED|Overall Study||221
267364|NCT02320396|642653|P1|COMPLETED|Overall Study||220
267365|NCT02320396|642652|P2|Treated (Full Analysis Set)|Overall Study||225
267366|NCT02320396|642653|P1|Treated (Full Analysis Set)|Overall Study||223
267367|NCT02320396|642652|P2|STARTED|Overall Study||225
267368|NCT02320396|642653|P1|STARTED|Overall Study||224
267369|NCT02320227|642683|P1|NOT COMPLETED|Overall Study||0
267370|NCT02320227|642683|P1|COMPLETED|Overall Study||30
267371|NCT02320227|642683|P1|STARTED|Overall Study||30
267372|NCT02320214|642688|P1|NOT COMPLETED|Overall Study||0
267373|NCT02320214|642688|P1|COMPLETED|Overall Study||30
267374|NCT02320214|642688|P1|STARTED|Overall Study||30
267375|NCT02319668|642695|P2|NOT COMPLETED|Overall Study||2
267376|NCT02319668|642696|P1|NOT COMPLETED|Overall Study||0
267377|NCT02319668|642695|P2|COMPLETED|Overall Study||17
267378|NCT02319668|642696|P1|COMPLETED|Overall Study||19
267379|NCT02319668|642695|P2|STARTED|Overall Study||19
267380|NCT02319668|642696|P1|STARTED|Overall Study||19
267381|NCT02319525|642710|P2|NOT COMPLETED|Overall Study||1
267382|NCT02319525|642711|P1|NOT COMPLETED|Overall Study||2
267383|NCT02319525|642710|P2|COMPLETED|Overall Study||147
267384|NCT02319525|642711|P1|COMPLETED|Overall Study||151
267385|NCT02319525|642710|P2|Primary Research Completion|Overall Study||147
267386|NCT02319525|642711|P1|Primary Research Completion|Overall Study||151
267387|NCT02319525|642710|P2|STARTED|Overall Study||148
267388|NCT02319525|642711|P1|STARTED|Overall Study||153
267389|NCT02319486|642725|P1|NOT COMPLETED|Overall Study||0
267390|NCT02319486|642725|P1|COMPLETED|Overall Study||26
267391|NCT02319486|642725|P1|STARTED|Overall Study||26
267392|NCT02319148|642734|P4|NOT COMPLETED|Second Intervention Period||2
267393|NCT02319148|642735|P3|NOT COMPLETED|Second Intervention Period||1
267394|NCT02319148|642736|P2|NOT COMPLETED|Second Intervention Period||1
267395|NCT02319148|642737|P1|NOT COMPLETED|Second Intervention Period||0
267396|NCT02319148|642734|P4|COMPLETED|Second Intervention Period||6
267397|NCT02319148|642735|P3|COMPLETED|Second Intervention Period||6
267398|NCT02319148|642736|P2|COMPLETED|Second Intervention Period||6
267399|NCT02319148|642737|P1|COMPLETED|Second Intervention Period||0
267400|NCT02319148|642734|P4|STARTED|Second Intervention Period||8
267401|NCT02319148|642735|P3|STARTED|Second Intervention Period||7
267402|NCT02319148|642736|P2|STARTED|Second Intervention Period||7
267403|NCT02319148|642737|P1|STARTED|Second Intervention Period||0
267404|NCT02319148|642734|P4|NOT COMPLETED|Washout Period 4 Days||0
267405|NCT02319148|642735|P3|NOT COMPLETED|Washout Period 4 Days||0
267406|NCT02319148|642736|P2|NOT COMPLETED|Washout Period 4 Days||0
267407|NCT02319148|642737|P1|NOT COMPLETED|Washout Period 4 Days||0
267408|NCT02319148|642734|P4|COMPLETED|Washout Period 4 Days||0
267409|NCT02319148|642735|P3|COMPLETED|Washout Period 4 Days||0
267410|NCT02319148|642736|P2|COMPLETED|Washout Period 4 Days||0
267411|NCT02319148|642737|P1|COMPLETED|Washout Period 4 Days||22
267412|NCT02319148|642734|P4|STARTED|Washout Period 4 Days||0
267413|NCT02319148|642735|P3|STARTED|Washout Period 4 Days||0
267414|NCT02319148|642736|P2|STARTED|Washout Period 4 Days||0
267415|NCT02319148|642737|P1|STARTED|Washout Period 4 Days||22
267416|NCT02319148|642734|P4|NOT COMPLETED|First Intervention Period||0
267417|NCT02319148|642735|P3|NOT COMPLETED|First Intervention Period||0
267418|NCT02319148|642736|P2|NOT COMPLETED|First Intervention Period||0
267419|NCT02319148|642737|P1|NOT COMPLETED|First Intervention Period||0
267420|NCT02319148|642734|P4|COMPLETED|First Intervention Period||0
267421|NCT02319148|642735|P3|COMPLETED|First Intervention Period||0
267422|NCT02319148|642736|P2|COMPLETED|First Intervention Period||0
267423|NCT02319148|642737|P1|COMPLETED|First Intervention Period||22
267424|NCT02319148|642734|P4|STARTED|First Intervention Period||0
267425|NCT02319148|642735|P3|STARTED|First Intervention Period||0
267426|NCT02319148|642736|P2|STARTED|First Intervention Period||0
267427|NCT02319148|642737|P1|STARTED|First Intervention Period||22
267428|NCT02319031|642799|P2|NOT COMPLETED|Follow-Up Period||0
267429|NCT02319031|642800|P1|NOT COMPLETED|Follow-Up Period||0
267430|NCT02319031|642799|P2|COMPLETED|Follow-Up Period||26
267431|NCT02319031|642800|P1|COMPLETED|Follow-Up Period||23
267432|NCT02319031|642799|P2|STARTED|Follow-Up Period||26
267433|NCT02319031|642800|P1|STARTED|Follow-Up Period||23
267434|NCT02319031|642799|P2|NOT COMPLETED|Treatment Period||0
267435|NCT02319031|642800|P1|NOT COMPLETED|Treatment Period||1
267436|NCT02319031|642799|P2|COMPLETED|Treatment Period||26
267437|NCT02319031|642800|P1|COMPLETED|Treatment Period||23
267438|NCT02319031|642799|P2|STARTED|Treatment Period||26
267439|NCT02319031|642800|P1|STARTED|Treatment Period||24
267440|NCT02318940|642812|P2|NOT COMPLETED|Overall Study||0
267441|NCT02318940|642813|P1|NOT COMPLETED|Overall Study||1
267442|NCT02318940|642812|P2|COMPLETED|Overall Study||50
267443|NCT02318940|642813|P1|COMPLETED|Overall Study||49
267444|NCT02318940|642812|P2|STARTED|Overall Study||50
267445|NCT02318940|642813|P1|STARTED|Overall Study|in the last patient we lost the record.|50
267446|NCT02318693|642827|P2|NOT COMPLETED|Overall Study||1
267447|NCT02318693|642828|P1|NOT COMPLETED|Overall Study||0
267448|NCT02318693|642827|P2|COMPLETED|Overall Study||26
267449|NCT02318693|642828|P1|COMPLETED|Overall Study||26
267450|NCT02318693|642827|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
267451|NCT02318693|642828|P1|Treated|Overall Study||26
267452|NCT02318693|642827|P2|STARTED|Overall Study||27
267453|NCT02318693|642828|P1|STARTED|Overall Study||26
267454|NCT02317809|642842|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
267455|NCT02317809|642843|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
267456|NCT02317809|642842|P2|COMPLETED|Second Intervention Period (8 Days)||17
267457|NCT02317809|642843|P1|COMPLETED|Second Intervention Period (8 Days)||14
267458|NCT02317809|642842|P2|STARTED|Second Intervention Period (8 Days)||17
267459|NCT02317809|642843|P1|STARTED|Second Intervention Period (8 Days)||14
267460|NCT02317809|642842|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
267461|NCT02317809|642843|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
267462|NCT02317809|642842|P2|COMPLETED|First Intervention Period (8 Days)||17
267463|NCT02317809|642843|P1|COMPLETED|First Intervention Period (8 Days)||14
267464|NCT02317809|642842|P2|STARTED|First Intervention Period (8 Days)||17
267465|NCT02317809|642843|P1|STARTED|First Intervention Period (8 Days)||17
267466|NCT02317510|642887|P2|NOT COMPLETED|Overall Study||1
267467|NCT02317510|642888|P1|NOT COMPLETED|Overall Study||0
267468|NCT02317510|642887|P2|COMPLETED|Overall Study||24
267469|NCT02317510|642888|P1|COMPLETED|Overall Study||25
267470|NCT02317510|642887|P2|STARTED|Overall Study||25
267471|NCT02317510|642888|P1|STARTED|Overall Study||25
267472|NCT02317016|642916|P1|NOT COMPLETED|Period 3||2
267473|NCT02317016|642916|P1|COMPLETED|Period 3||41
267474|NCT02317016|642916|P1|STARTED|Period 3||43
267475|NCT02317016|642916|P1|NOT COMPLETED|Period 2||1
267476|NCT02317016|642916|P1|COMPLETED|Period 2||43
267477|NCT02317016|642916|P1|STARTED|Period 2||44
267478|NCT02317016|642916|P1|NOT COMPLETED|Period 1||0
267479|NCT02317016|642916|P1|COMPLETED|Period 1||44
267480|NCT02317016|642916|P1|STARTED|Period 1||44
267481|NCT02316769|642942|P2|NOT COMPLETED|Overall Study||0
267482|NCT02316769|642943|P1|NOT COMPLETED|Overall Study||2
267483|NCT02316769|642942|P2|COMPLETED|Overall Study||33
267484|NCT02316769|642943|P1|COMPLETED|Overall Study||31
267485|NCT02316769|642942|P2|STARTED|Overall Study||33
267486|NCT02316769|642943|P1|STARTED|Overall Study||33
267487|NCT02316678|642953|P2|NOT COMPLETED|Overall Study||0
267488|NCT02316678|642954|P1|NOT COMPLETED|Overall Study||0
267489|NCT02316678|642953|P2|COMPLETED|Overall Study||7694
267490|NCT02316678|642954|P1|COMPLETED|Overall Study||1879
267491|NCT02316678|642953|P2|STARTED|Overall Study||7694
267492|NCT02316678|642954|P1|STARTED|Overall Study||1879
267493|NCT02316613|642960|P1|NOT COMPLETED|Overall Study||104
267494|NCT02316613|642960|P1|COMPLETED|Overall Study||156
267495|NCT02316613|642960|P1|Overall Population|Overall Study||241
267496|NCT02316613|642960|P1|Safety Population|Overall Study||255
267497|NCT02316613|642960|P1|STARTED|Overall Study||260
267498|NCT02316470|643001|P4|NOT COMPLETED|Overall Study||2
267499|NCT02316470|643002|P3|NOT COMPLETED|Overall Study||5
267500|NCT02316470|643003|P2|NOT COMPLETED|Overall Study||6
267501|NCT02316470|643004|P1|NOT COMPLETED|Overall Study||5
267502|NCT02316470|643001|P4|COMPLETED|Overall Study||46
267503|NCT02316470|643002|P3|COMPLETED|Overall Study||147
267504|NCT02316470|643003|P2|COMPLETED|Overall Study||146
267505|NCT02316470|643004|P1|COMPLETED|Overall Study||143
267506|NCT02316470|643001|P4|STARTED|Overall Study||48
267507|NCT02316470|643002|P3|STARTED|Overall Study||152
267508|NCT02316470|643003|P2|STARTED|Overall Study||152
267509|NCT02316470|643004|P1|STARTED|Overall Study||148
267510|NCT02316366|643100|P2|NOT COMPLETED|Overall Study||0
267511|NCT02316366|643101|P1|NOT COMPLETED|Overall Study||0
267512|NCT02316366|643100|P2|COMPLETED|Overall Study||40
267513|NCT02316366|643101|P1|COMPLETED|Overall Study||40
267514|NCT02316366|643100|P2|STARTED|Overall Study||40
267515|NCT02316366|643101|P1|STARTED|Overall Study||40
267516|NCT02315989|643111|P1|NOT COMPLETED|Overall Study||0
267517|NCT02315989|643111|P1|COMPLETED|Overall Study||6
267518|NCT02315989|643111|P1|STARTED|Overall Study||6
267519|NCT02315352|643121|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
267520|NCT02315352|643122|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
267521|NCT02315352|643123|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
267522|NCT02315352|643124|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
267523|NCT02315352|643125|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
267524|NCT02315352|643126|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
267525|NCT02315352|643127|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
267526|NCT02315352|643128|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
267527|NCT02315352|643121|P8|COMPLETED|Fifth Intervention (Day 2)||8
267528|NCT02315352|643122|P7|COMPLETED|Fifth Intervention (Day 2)||9
267529|NCT02315352|643123|P6|COMPLETED|Fifth Intervention (Day 2)||7
267530|NCT02315352|643124|P5|COMPLETED|Fifth Intervention (Day 2)||8
267531|NCT02315352|643125|P4|COMPLETED|Fifth Intervention (Day 2)||8
267532|NCT02315352|643126|P3|COMPLETED|Fifth Intervention (Day 2)||7
267533|NCT02315352|643127|P2|COMPLETED|Fifth Intervention (Day 2)||0
267534|NCT02315352|643128|P1|COMPLETED|Fifth Intervention (Day 2)||0
267535|NCT02315352|643121|P8|STARTED|Fifth Intervention (Day 2)||8
267536|NCT02315352|643122|P7|STARTED|Fifth Intervention (Day 2)||9
267537|NCT02315352|643123|P6|STARTED|Fifth Intervention (Day 2)||7
267538|NCT02315352|643124|P5|STARTED|Fifth Intervention (Day 2)||8
267539|NCT02315352|643125|P4|STARTED|Fifth Intervention (Day 2)||8
267540|NCT02315352|643126|P3|STARTED|Fifth Intervention (Day 2)||7
267541|NCT02315352|643127|P2|STARTED|Fifth Intervention (Day 2)||0
267542|NCT02315352|643128|P1|STARTED|Fifth Intervention (Day 2)||0
267543|NCT02315352|643121|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
267544|NCT02315352|643122|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
267545|NCT02315352|643123|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
267546|NCT02315352|643124|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
267547|NCT02315352|643125|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
267548|NCT02315352|643126|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
267549|NCT02315352|643127|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
267550|NCT02315352|643128|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
267551|NCT02315352|643121|P8|COMPLETED|Fourth Intervention (Day 2)||8
267552|NCT02315352|643122|P7|COMPLETED|Fourth Intervention (Day 2)||9
267553|NCT02315352|643123|P6|COMPLETED|Fourth Intervention (Day 2)||7
267554|NCT02315352|643124|P5|COMPLETED|Fourth Intervention (Day 2)||8
267555|NCT02315352|643125|P4|COMPLETED|Fourth Intervention (Day 2)||8
267556|NCT02315352|643126|P3|COMPLETED|Fourth Intervention (Day 2)||7
267557|NCT02315352|643127|P2|COMPLETED|Fourth Intervention (Day 2)||0
267558|NCT02315352|643128|P1|COMPLETED|Fourth Intervention (Day 2)||0
267559|NCT02315352|643121|P8|STARTED|Fourth Intervention (Day 2)||8
267560|NCT02315352|643122|P7|STARTED|Fourth Intervention (Day 2)||9
267561|NCT02315352|643123|P6|STARTED|Fourth Intervention (Day 2)||7
267562|NCT02315352|643124|P5|STARTED|Fourth Intervention (Day 2)||8
267563|NCT02315352|643125|P4|STARTED|Fourth Intervention (Day 2)||8
267564|NCT02315352|643126|P3|STARTED|Fourth Intervention (Day 2)||7
267565|NCT02315352|643127|P2|STARTED|Fourth Intervention (Day 2)||0
267566|NCT02315352|643128|P1|STARTED|Fourth Intervention (Day 2)||0
267567|NCT02315352|643121|P8|NOT COMPLETED|Third Intervention (Day 2)||0
267568|NCT02315352|643122|P7|NOT COMPLETED|Third Intervention (Day 2)||0
267569|NCT02315352|643123|P6|NOT COMPLETED|Third Intervention (Day 2)||0
267570|NCT02315352|643124|P5|NOT COMPLETED|Third Intervention (Day 2)||0
267571|NCT02315352|643125|P4|NOT COMPLETED|Third Intervention (Day 2)||0
267572|NCT02315352|643126|P3|NOT COMPLETED|Third Intervention (Day 2)||0
267573|NCT02315352|643127|P2|NOT COMPLETED|Third Intervention (Day 2)||0
267574|NCT02315352|643128|P1|NOT COMPLETED|Third Intervention (Day 2)||0
267575|NCT02315352|643121|P8|COMPLETED|Third Intervention (Day 2)||8
267576|NCT02315352|643122|P7|COMPLETED|Third Intervention (Day 2)||9
267577|NCT02315352|643123|P6|COMPLETED|Third Intervention (Day 2)||7
267578|NCT02315352|643124|P5|COMPLETED|Third Intervention (Day 2)||8
267579|NCT02315352|643125|P4|COMPLETED|Third Intervention (Day 2)||8
267580|NCT02315352|643126|P3|COMPLETED|Third Intervention (Day 2)||7
267581|NCT02315352|643127|P2|COMPLETED|Third Intervention (Day 2)||0
267582|NCT02315352|643128|P1|COMPLETED|Third Intervention (Day 2)||0
267583|NCT02315352|643121|P8|STARTED|Third Intervention (Day 2)||8
267584|NCT02315352|643122|P7|STARTED|Third Intervention (Day 2)||9
267585|NCT02315352|643123|P6|STARTED|Third Intervention (Day 2)||7
267586|NCT02315352|643124|P5|STARTED|Third Intervention (Day 2)||8
267587|NCT02315352|643125|P4|STARTED|Third Intervention (Day 2)||8
267588|NCT02315352|643126|P3|STARTED|Third Intervention (Day 2)||7
267589|NCT02315352|643127|P2|STARTED|Third Intervention (Day 2)||0
267590|NCT02315352|643128|P1|STARTED|Third Intervention (Day 2)||0
267591|NCT02315352|643121|P8|NOT COMPLETED|Second Intervention (Day 1)||0
267592|NCT02315352|643122|P7|NOT COMPLETED|Second Intervention (Day 1)||0
267593|NCT02315352|643123|P6|NOT COMPLETED|Second Intervention (Day 1)||0
267594|NCT02315352|643124|P5|NOT COMPLETED|Second Intervention (Day 1)||0
267595|NCT02315352|643125|P4|NOT COMPLETED|Second Intervention (Day 1)||0
267596|NCT02315352|643126|P3|NOT COMPLETED|Second Intervention (Day 1)||0
267597|NCT02315352|643127|P2|NOT COMPLETED|Second Intervention (Day 1)||0
267598|NCT02315352|643128|P1|NOT COMPLETED|Second Intervention (Day 1)||0
267599|NCT02315352|643121|P8|COMPLETED|Second Intervention (Day 1)||0
267600|NCT02315352|643122|P7|COMPLETED|Second Intervention (Day 1)||0
267601|NCT02315352|643123|P6|COMPLETED|Second Intervention (Day 1)||0
267602|NCT02315352|643124|P5|COMPLETED|Second Intervention (Day 1)||0
267603|NCT02315352|643125|P4|COMPLETED|Second Intervention (Day 1)||0
267604|NCT02315352|643126|P3|COMPLETED|Second Intervention (Day 1)||0
267605|NCT02315352|643127|P2|COMPLETED|Second Intervention (Day 1)||24
267606|NCT02315352|643128|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
267607|NCT02315352|643121|P8|STARTED|Second Intervention (Day 1)||0
267608|NCT02315352|643122|P7|STARTED|Second Intervention (Day 1)||0
267609|NCT02315352|643123|P6|STARTED|Second Intervention (Day 1)||0
267610|NCT02315352|643124|P5|STARTED|Second Intervention (Day 1)||0
267611|NCT02315352|643125|P4|STARTED|Second Intervention (Day 1)||0
267612|NCT02315352|643126|P3|STARTED|Second Intervention (Day 1)||0
267613|NCT02315352|643127|P2|STARTED|Second Intervention (Day 1)||24
267614|NCT02315352|643128|P1|STARTED|Second Intervention (Day 1)||24
267615|NCT02315352|643121|P8|NOT COMPLETED|First Intervention (Day 1)||0
267616|NCT02315352|643122|P7|NOT COMPLETED|First Intervention (Day 1)||0
267617|NCT02315352|643123|P6|NOT COMPLETED|First Intervention (Day 1)||0
267618|NCT02315352|643124|P5|NOT COMPLETED|First Intervention (Day 1)||0
267619|NCT02315352|643125|P4|NOT COMPLETED|First Intervention (Day 1)||0
267620|NCT02315352|643126|P3|NOT COMPLETED|First Intervention (Day 1)||0
267621|NCT02315352|643127|P2|NOT COMPLETED|First Intervention (Day 1)||0
267622|NCT02315352|643128|P1|NOT COMPLETED|First Intervention (Day 1)||0
267623|NCT02315352|643121|P8|COMPLETED|First Intervention (Day 1)||0
267624|NCT02315352|643122|P7|COMPLETED|First Intervention (Day 1)||0
267625|NCT02315352|643123|P6|COMPLETED|First Intervention (Day 1)||0
267626|NCT02315352|643124|P5|COMPLETED|First Intervention (Day 1)||0
267627|NCT02315352|643125|P4|COMPLETED|First Intervention (Day 1)||0
267628|NCT02315352|643126|P3|COMPLETED|First Intervention (Day 1)||0
267629|NCT02315352|643127|P2|COMPLETED|First Intervention (Day 1)||24
267630|NCT02315352|643128|P1|COMPLETED|First Intervention (Day 1)||24
267631|NCT02315352|643121|P8|STARTED|First Intervention (Day 1)||0
267632|NCT02315352|643122|P7|STARTED|First Intervention (Day 1)||0
267633|NCT02315352|643123|P6|STARTED|First Intervention (Day 1)||0
267634|NCT02315352|643124|P5|STARTED|First Intervention (Day 1)||0
267635|NCT02315352|643125|P4|STARTED|First Intervention (Day 1)||0
267636|NCT02315352|643126|P3|STARTED|First Intervention (Day 1)||0
267637|NCT02315352|643127|P2|STARTED|First Intervention (Day 1)||24
267638|NCT02315352|643128|P1|STARTED|First Intervention (Day 1)||24
267639|NCT02314689|643155|P1|NOT COMPLETED|Overall Study||0
267819|NCT02310750|643508|P13|COMPLETED|HP Washout 2||2
267640|NCT02314689|643155|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
267641|NCT02314689|643155|P1|STARTED|Overall Study||4
267642|NCT02314637|643161|P2|NOT COMPLETED|Overall Study||14
267643|NCT02314637|643162|P1|NOT COMPLETED|Overall Study||16
267644|NCT02314637|643161|P2|COMPLETED|Overall Study||75
267645|NCT02314637|643162|P1|COMPLETED|Overall Study||135
267646|NCT02314637|643161|P2|STARTED|Overall Study||89
267647|NCT02314637|643162|P1|STARTED|Overall Study||151
267648|NCT02314546|643175|P3|NOT COMPLETED|Overall Study||0
267649|NCT02314546|643176|P2|NOT COMPLETED|Overall Study||0
267650|NCT02314546|643177|P1|NOT COMPLETED|Overall Study||0
267651|NCT02314546|643175|P3|COMPLETED|Overall Study||5
267652|NCT02314546|643176|P2|COMPLETED|Overall Study||5
267653|NCT02314546|643177|P1|COMPLETED|Overall Study||5
267654|NCT02314546|643175|P3|STARTED|Overall Study||5
267655|NCT02314546|643176|P2|STARTED|Overall Study||5
267656|NCT02314546|643177|P1|STARTED|Overall Study||5
267657|NCT02314260|643203|P1|NOT COMPLETED|Overall Study||0
267658|NCT02314260|643203|P1|COMPLETED|Overall Study||80
267659|NCT02314260|643203|P1|STARTED|Overall Study||80
267660|NCT02314104|643213|P3|NOT COMPLETED|Overall Study||18
267661|NCT02314104|643214|P2|NOT COMPLETED|Overall Study||20
267662|NCT02314104|643215|P1|NOT COMPLETED|Overall Study||14
267663|NCT02314104|643213|P3|COMPLETED|Overall Study||53
267664|NCT02314104|643214|P2|COMPLETED|Overall Study||58
267665|NCT02314104|643215|P1|COMPLETED|Overall Study||57
267666|NCT02314104|643213|P3|STARTED|Overall Study||71
267667|NCT02314104|643214|P2|STARTED|Overall Study||78
267668|NCT02314104|643215|P1|STARTED|Overall Study||71
267669|NCT02313766|643238|P3|NOT COMPLETED|Overall Study||0
267670|NCT02313766|643239|P2|NOT COMPLETED|Overall Study||3
267671|NCT02313766|643240|P1|NOT COMPLETED|Overall Study||1
267672|NCT02313766|643238|P3|COMPLETED|Overall Study||50
267673|NCT02313766|643239|P2|COMPLETED|Overall Study||47
267674|NCT02313766|643240|P1|COMPLETED|Overall Study||49
267675|NCT02313766|643238|P3|STARTED|Overall Study||50
267676|NCT02313766|643239|P2|STARTED|Overall Study||50
267677|NCT02313766|643240|P1|STARTED|Overall Study||50
267678|NCT02313558|643256|P2|NOT COMPLETED|Overall Study||4
267679|NCT02313558|643257|P1|NOT COMPLETED|Overall Study||6
267680|NCT02313558|643256|P2|COMPLETED|Overall Study||46
267681|NCT02313558|643257|P1|COMPLETED|Overall Study||44
267682|NCT02313558|643256|P2|STARTED|Overall Study||50
267683|NCT02313558|643257|P1|STARTED|Overall Study||50
267684|NCT02313233|643271|P2|NOT COMPLETED|Overall Study||3
267685|NCT02313233|643272|P1|NOT COMPLETED|Overall Study||2
267686|NCT02313233|643271|P2|COMPLETED|Overall Study||18
267687|NCT02313233|643272|P1|COMPLETED|Overall Study||18
267688|NCT02313233|643271|P2|STARTED|Overall Study||21
267689|NCT02313233|643272|P1|STARTED|Overall Study||20
267690|NCT02313155|643294|P2|NOT COMPLETED|Overall Study||1
267691|NCT02313155|643295|P1|NOT COMPLETED|Overall Study||0
267692|NCT02313155|643294|P2|COMPLETED|Overall Study||54
267693|NCT02313155|643295|P1|COMPLETED|Overall Study||55
267694|NCT02313155|643294|P2|STARTED|Overall Study||55
267695|NCT02313155|643295|P1|STARTED|Overall Study||55
267696|NCT02312739|643345|P2|NOT COMPLETED|Overall Study||2
267697|NCT02312739|643346|P1|NOT COMPLETED|Overall Study||6
267698|NCT02312739|643345|P2|COMPLETED|Overall Study||34
267699|NCT02312739|643346|P1|COMPLETED|Overall Study||30
267700|NCT02312739|643345|P2|Withdrawn Prior to Procedure|Overall Study||2
267701|NCT02312739|643346|P1|Withdrawn Prior to Procedure|Overall Study||6
267702|NCT02312739|643345|P2|STARTED|Overall Study||36
267703|NCT02312739|643346|P1|STARTED|Overall Study||36
267704|NCT02312726|643360|P3|NOT COMPLETED|Overall Study||67
267705|NCT02312726|643361|P2|NOT COMPLETED|Overall Study||0
267706|NCT02312726|643362|P1|NOT COMPLETED|Overall Study||0
267707|NCT02312726|643360|P3|COMPLETED|Overall Study||0
267708|NCT02312726|643361|P2|COMPLETED|Overall Study||30
267709|NCT02312726|643362|P1|COMPLETED|Overall Study||38
267710|NCT02312726|643360|P3|STARTED|Overall Study||67
267711|NCT02312726|643361|P2|STARTED|Overall Study||30
267712|NCT02312726|643362|P1|STARTED|Overall Study||38
267713|NCT02312154|643374|P1|NOT COMPLETED|Overall Study||1
267714|NCT02312154|643374|P1|COMPLETED|Overall Study||24
267715|NCT02312154|643374|P1|STARTED|Overall Study||25
267716|NCT02311972|643391|P2|NOT COMPLETED|Overall Study||0
267717|NCT02311972|643392|P1|NOT COMPLETED|Overall Study||0
267718|NCT02311972|643391|P2|COMPLETED|Overall Study||8
267719|NCT02311972|643392|P1|COMPLETED|Overall Study||12
267720|NCT02311972|643391|P2|STARTED|Overall Study||8
267721|NCT02311972|643392|P1|STARTED|Overall Study||12
267722|NCT02311907|643411|P2|NOT COMPLETED|Overall Study||0
267723|NCT02311907|643412|P1|NOT COMPLETED|Overall Study||0
267724|NCT02311907|643411|P2|COMPLETED|Overall Study||91
267725|NCT02311907|643412|P1|COMPLETED|Overall Study||94
267726|NCT02311907|643411|P2|STARTED|Overall Study||91
267727|NCT02311907|643412|P1|STARTED|Overall Study||94
267728|NCT02311881|643437|P3|NOT COMPLETED|Overall Study||41
267729|NCT02311881|643438|P2|NOT COMPLETED|Overall Study||43
267730|NCT02311881|643439|P1|NOT COMPLETED|Overall Study||35
267731|NCT02311881|643437|P3|COMPLETED|Overall Study||196
267732|NCT02311881|643438|P2|COMPLETED|Overall Study||193
267733|NCT02311881|643439|P1|COMPLETED|Overall Study||200
267820|NCT02310750|643509|P12|COMPLETED|HP Washout 2||2
267734|NCT02311881|643437|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
267735|NCT02311881|643438|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
267736|NCT02311881|643439|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
267737|NCT02311881|643437|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
267738|NCT02311881|643438|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
267739|NCT02311881|643439|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
267740|NCT02311309|643477|P3|NOT COMPLETED|Overall Study||0
267741|NCT02311309|643478|P2|NOT COMPLETED|Overall Study||0
267742|NCT02311309|643479|P1|NOT COMPLETED|Overall Study||0
267743|NCT02311309|643477|P3|COMPLETED|Overall Study||863
267744|NCT02311309|643478|P2|COMPLETED|Overall Study||35
267745|NCT02311309|643479|P1|COMPLETED|Overall Study||541
267746|NCT02311309|643477|P3|STARTED|Overall Study||863
267747|NCT02311309|643478|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
267748|NCT02311309|643479|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
267749|NCT02310776|643490|P1|NOT COMPLETED|Overall Study||0
267750|NCT02310776|643490|P1|COMPLETED|Overall Study||501
267751|NCT02310776|643490|P1|STARTED|Overall Study||501
267752|NCT02310750|643505|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
267753|NCT02310750|643506|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
267754|NCT02310750|643507|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
267755|NCT02310750|643508|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
267756|NCT02310750|643509|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
267757|NCT02310750|643510|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
267758|NCT02310750|643511|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
267759|NCT02310750|643512|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
267760|NCT02310750|643513|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
267761|NCT02310750|643514|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
267762|NCT02310750|643515|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
267763|NCT02310750|643516|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
267764|NCT02310750|643517|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
267765|NCT02310750|643518|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
267766|NCT02310750|643519|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
267767|NCT02310750|643520|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
267768|NCT02310750|643505|P16|COMPLETED|HP MAD and Fasted/Fed||2
267769|NCT02310750|643506|P15|COMPLETED|HP MAD and Fasted/Fed||2
267770|NCT02310750|643507|P14|COMPLETED|HP MAD and Fasted/Fed||2
267771|NCT02310750|643508|P13|COMPLETED|HP MAD and Fasted/Fed||2
267772|NCT02310750|643509|P12|COMPLETED|HP MAD and Fasted/Fed||2
267773|NCT02310750|643510|P11|COMPLETED|HP MAD and Fasted/Fed||2
267774|NCT02310750|643511|P10|COMPLETED|HP MAD and Fasted/Fed||0
267775|NCT02310750|643512|P9|COMPLETED|HP MAD and Fasted/Fed||0
267776|NCT02310750|643513|P8|COMPLETED|HP MAD and Fasted/Fed||0
267777|NCT02310750|643514|P7|COMPLETED|HP MAD and Fasted/Fed||2
267778|NCT02310750|643515|P6|COMPLETED|HP MAD and Fasted/Fed||0
267779|NCT02310750|643516|P5|COMPLETED|HP MAD and Fasted/Fed||4
267780|NCT02310750|643517|P4|COMPLETED|HP MAD and Fasted/Fed||0
267781|NCT02310750|643518|P3|COMPLETED|HP MAD and Fasted/Fed||0
267782|NCT02310750|643519|P2|COMPLETED|HP MAD and Fasted/Fed||0
267783|NCT02310750|643520|P1|COMPLETED|HP MAD and Fasted/Fed||0
267784|NCT02310750|643505|P16|STARTED|HP MAD and Fasted/Fed||2
267785|NCT02310750|643506|P15|STARTED|HP MAD and Fasted/Fed||2
267786|NCT02310750|643507|P14|STARTED|HP MAD and Fasted/Fed||2
267787|NCT02310750|643508|P13|STARTED|HP MAD and Fasted/Fed||2
267788|NCT02310750|643509|P12|STARTED|HP MAD and Fasted/Fed||2
267789|NCT02310750|643510|P11|STARTED|HP MAD and Fasted/Fed||2
267790|NCT02310750|643511|P10|STARTED|HP MAD and Fasted/Fed||0
267791|NCT02310750|643512|P9|STARTED|HP MAD and Fasted/Fed||0
267792|NCT02310750|643513|P8|STARTED|HP MAD and Fasted/Fed||0
267793|NCT02310750|643514|P7|STARTED|HP MAD and Fasted/Fed||2
267794|NCT02310750|643515|P6|STARTED|HP MAD and Fasted/Fed||0
267795|NCT02310750|643516|P5|STARTED|HP MAD and Fasted/Fed||5
267796|NCT02310750|643517|P4|STARTED|HP MAD and Fasted/Fed||0
267797|NCT02310750|643518|P3|STARTED|HP MAD and Fasted/Fed||0
267798|NCT02310750|643519|P2|STARTED|HP MAD and Fasted/Fed||0
267799|NCT02310750|643520|P1|STARTED|HP MAD and Fasted/Fed||0
267800|NCT02310750|643505|P16|NOT COMPLETED|HP Washout 2||0
267801|NCT02310750|643506|P15|NOT COMPLETED|HP Washout 2||0
267802|NCT02310750|643507|P14|NOT COMPLETED|HP Washout 2||0
267803|NCT02310750|643508|P13|NOT COMPLETED|HP Washout 2||0
267804|NCT02310750|643509|P12|NOT COMPLETED|HP Washout 2||0
267805|NCT02310750|643510|P11|NOT COMPLETED|HP Washout 2||0
267806|NCT02310750|643511|P10|NOT COMPLETED|HP Washout 2||0
267807|NCT02310750|643512|P9|NOT COMPLETED|HP Washout 2||0
267808|NCT02310750|643513|P8|NOT COMPLETED|HP Washout 2||0
267809|NCT02310750|643514|P7|NOT COMPLETED|HP Washout 2||7
267810|NCT02310750|643515|P6|NOT COMPLETED|HP Washout 2||0
267811|NCT02310750|643516|P5|NOT COMPLETED|HP Washout 2||1
267812|NCT02310750|643517|P4|NOT COMPLETED|HP Washout 2||0
267813|NCT02310750|643518|P3|NOT COMPLETED|HP Washout 2||0
267814|NCT02310750|643519|P2|NOT COMPLETED|HP Washout 2||0
267815|NCT02310750|643520|P1|NOT COMPLETED|HP Washout 2||0
267816|NCT02310750|643505|P16|COMPLETED|HP Washout 2||2
267817|NCT02310750|643506|P15|COMPLETED|HP Washout 2||2
267818|NCT02310750|643507|P14|COMPLETED|HP Washout 2||2
267821|NCT02310750|643510|P11|COMPLETED|HP Washout 2||2
267822|NCT02310750|643511|P10|COMPLETED|HP Washout 2||0
267823|NCT02310750|643512|P9|COMPLETED|HP Washout 2||0
267824|NCT02310750|643513|P8|COMPLETED|HP Washout 2||0
267825|NCT02310750|643514|P7|COMPLETED|HP Washout 2||2
267826|NCT02310750|643515|P6|COMPLETED|HP Washout 2||0
267827|NCT02310750|643516|P5|COMPLETED|HP Washout 2||5
267828|NCT02310750|643517|P4|COMPLETED|HP Washout 2||0
267829|NCT02310750|643518|P3|COMPLETED|HP Washout 2||0
267830|NCT02310750|643519|P2|COMPLETED|HP Washout 2||0
267831|NCT02310750|643520|P1|COMPLETED|HP Washout 2||0
267832|NCT02310750|643505|P16|STARTED|HP Washout 2||2
267833|NCT02310750|643506|P15|STARTED|HP Washout 2||2
267834|NCT02310750|643507|P14|STARTED|HP Washout 2||2
267835|NCT02310750|643508|P13|STARTED|HP Washout 2||2
267836|NCT02310750|643509|P12|STARTED|HP Washout 2||2
267837|NCT02310750|643510|P11|STARTED|HP Washout 2||2
267838|NCT02310750|643511|P10|STARTED|HP Washout 2||0
267839|NCT02310750|643512|P9|STARTED|HP Washout 2||0
267840|NCT02310750|643513|P8|STARTED|HP Washout 2||0
267841|NCT02310750|643514|P7|STARTED|HP Washout 2||9
267842|NCT02310750|643515|P6|STARTED|HP Washout 2||0
267843|NCT02310750|643516|P5|STARTED|HP Washout 2||6
267844|NCT02310750|643517|P4|STARTED|HP Washout 2||0
267845|NCT02310750|643518|P3|STARTED|HP Washout 2||0
267846|NCT02310750|643519|P2|STARTED|HP Washout 2||0
267847|NCT02310750|643520|P1|STARTED|HP Washout 2||0
267848|NCT02310750|643505|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267849|NCT02310750|643506|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267850|NCT02310750|643507|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267851|NCT02310750|643508|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267852|NCT02310750|643509|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267853|NCT02310750|643510|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267854|NCT02310750|643511|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
267855|NCT02310750|643512|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
267856|NCT02310750|643513|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267857|NCT02310750|643514|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267858|NCT02310750|643515|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267859|NCT02310750|643516|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267860|NCT02310750|643517|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
267861|NCT02310750|643518|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267862|NCT02310750|643519|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267863|NCT02310750|643520|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267864|NCT02310750|643505|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267865|NCT02310750|643506|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267866|NCT02310750|643507|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267867|NCT02310750|643508|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267868|NCT02310750|643509|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267869|NCT02310750|643510|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267870|NCT02310750|643511|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
267871|NCT02310750|643512|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
267872|NCT02310750|643513|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
267873|NCT02310750|643514|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
267874|NCT02310750|643515|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
267875|NCT02310750|643516|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
267876|NCT02310750|643517|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
267877|NCT02310750|643518|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
267878|NCT02310750|643519|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267879|NCT02310750|643520|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267880|NCT02310750|643505|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267881|NCT02310750|643506|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267882|NCT02310750|643507|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267883|NCT02310750|643508|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267884|NCT02310750|643509|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267885|NCT02310750|643510|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
267886|NCT02310750|643511|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
267887|NCT02310750|643512|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
267888|NCT02310750|643513|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
267889|NCT02310750|643514|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
267890|NCT02310750|643515|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
267891|NCT02310750|643516|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
267892|NCT02310750|643517|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
267893|NCT02310750|643518|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
267894|NCT02310750|643519|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267895|NCT02310750|643520|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
267896|NCT02310750|643505|P16|NOT COMPLETED|HP Washout 1||0
267897|NCT02310750|643506|P15|NOT COMPLETED|HP Washout 1||0
267898|NCT02310750|643507|P14|NOT COMPLETED|HP Washout 1||0
267899|NCT02310750|643508|P13|NOT COMPLETED|HP Washout 1||0
267900|NCT02310750|643509|P12|NOT COMPLETED|HP Washout 1||0
267901|NCT02310750|643510|P11|NOT COMPLETED|HP Washout 1||0
267902|NCT02310750|643511|P10|NOT COMPLETED|HP Washout 1||0
267903|NCT02310750|643512|P9|NOT COMPLETED|HP Washout 1||0
267904|NCT02310750|643513|P8|NOT COMPLETED|HP Washout 1||0
267905|NCT02310750|643514|P7|NOT COMPLETED|HP Washout 1||3
267906|NCT02310750|643515|P6|NOT COMPLETED|HP Washout 1||2
267907|NCT02310750|643516|P5|NOT COMPLETED|HP Washout 1||2
267908|NCT02310750|643517|P4|NOT COMPLETED|HP Washout 1||1
267909|NCT02310750|643518|P3|NOT COMPLETED|HP Washout 1||1
267910|NCT02310750|643519|P2|NOT COMPLETED|HP Washout 1||0
267911|NCT02310750|643520|P1|NOT COMPLETED|HP Washout 1||0
267912|NCT02310750|643505|P16|COMPLETED|HP Washout 1||2
267913|NCT02310750|643506|P15|COMPLETED|HP Washout 1||2
267914|NCT02310750|643507|P14|COMPLETED|HP Washout 1||2
267915|NCT02310750|643508|P13|COMPLETED|HP Washout 1||2
267916|NCT02310750|643509|P12|COMPLETED|HP Washout 1||2
267917|NCT02310750|643510|P11|COMPLETED|HP Washout 1||2
267918|NCT02310750|643511|P10|COMPLETED|HP Washout 1||0
267919|NCT02310750|643512|P9|COMPLETED|HP Washout 1||0
267920|NCT02310750|643513|P8|COMPLETED|HP Washout 1||0
267921|NCT02310750|643514|P7|COMPLETED|HP Washout 1||9
267922|NCT02310750|643515|P6|COMPLETED|HP Washout 1||6
267923|NCT02310750|643516|P5|COMPLETED|HP Washout 1||6
267924|NCT02310750|643517|P4|COMPLETED|HP Washout 1||4
267925|NCT02310750|643518|P3|COMPLETED|HP Washout 1||5
267926|NCT02310750|643519|P2|COMPLETED|HP Washout 1||0
267927|NCT02310750|643520|P1|COMPLETED|HP Washout 1||0
267928|NCT02310750|643505|P16|STARTED|HP Washout 1||2
267929|NCT02310750|643506|P15|STARTED|HP Washout 1||2
267930|NCT02310750|643507|P14|STARTED|HP Washout 1||2
267931|NCT02310750|643508|P13|STARTED|HP Washout 1||2
267932|NCT02310750|643509|P12|STARTED|HP Washout 1||2
267933|NCT02310750|643510|P11|STARTED|HP Washout 1||2
267934|NCT02310750|643511|P10|STARTED|HP Washout 1||0
267935|NCT02310750|643512|P9|STARTED|HP Washout 1||0
267936|NCT02310750|643513|P8|STARTED|HP Washout 1||0
267937|NCT02310750|643514|P7|STARTED|HP Washout 1||12
267938|NCT02310750|643515|P6|STARTED|HP Washout 1||8
267939|NCT02310750|643516|P5|STARTED|HP Washout 1||8
267940|NCT02310750|643517|P4|STARTED|HP Washout 1||5
267941|NCT02310750|643518|P3|STARTED|HP Washout 1||6
267942|NCT02310750|643519|P2|STARTED|HP Washout 1||0
267943|NCT02310750|643520|P1|STARTED|HP Washout 1||0
267944|NCT02310750|643505|P16|NOT COMPLETED|HP Period 1||0
267945|NCT02310750|643506|P15|NOT COMPLETED|HP Period 1||0
267946|NCT02310750|643507|P14|NOT COMPLETED|HP Period 1||0
267947|NCT02310750|643508|P13|NOT COMPLETED|HP Period 1||0
267948|NCT02310750|643509|P12|NOT COMPLETED|HP Period 1||0
267949|NCT02310750|643510|P11|NOT COMPLETED|HP Period 1||0
267950|NCT02310750|643511|P10|NOT COMPLETED|HP Period 1||0
267951|NCT02310750|643512|P9|NOT COMPLETED|HP Period 1||0
267952|NCT02310750|643513|P8|NOT COMPLETED|HP Period 1||0
267953|NCT02310750|643514|P7|NOT COMPLETED|HP Period 1||1
267954|NCT02310750|643515|P6|NOT COMPLETED|HP Period 1||0
267955|NCT02310750|643516|P5|NOT COMPLETED|HP Period 1||0
267956|NCT02310750|643517|P4|NOT COMPLETED|HP Period 1||1
267957|NCT02310750|643518|P3|NOT COMPLETED|HP Period 1||0
267958|NCT02310750|643519|P2|NOT COMPLETED|HP Period 1||0
267959|NCT02310750|643520|P1|NOT COMPLETED|HP Period 1||1
267960|NCT02310750|643505|P16|COMPLETED|HP Period 1||2
267961|NCT02310750|643506|P15|COMPLETED|HP Period 1||2
267962|NCT02310750|643507|P14|COMPLETED|HP Period 1||2
267963|NCT02310750|643508|P13|COMPLETED|HP Period 1||2
267964|NCT02310750|643509|P12|COMPLETED|HP Period 1||2
267965|NCT02310750|643510|P11|COMPLETED|HP Period 1||2
267966|NCT02310750|643511|P10|COMPLETED|HP Period 1||0
267967|NCT02310750|643512|P9|COMPLETED|HP Period 1||0
267968|NCT02310750|643513|P8|COMPLETED|HP Period 1||0
267969|NCT02310750|643514|P7|COMPLETED|HP Period 1||12
267970|NCT02310750|643515|P6|COMPLETED|HP Period 1||8
267971|NCT02310750|643516|P5|COMPLETED|HP Period 1||8
267972|NCT02310750|643517|P4|COMPLETED|HP Period 1||5
267973|NCT02310750|643518|P3|COMPLETED|HP Period 1||6
267974|NCT02310750|643519|P2|COMPLETED|HP Period 1||6
267975|NCT02310750|643520|P1|COMPLETED|HP Period 1||6
267976|NCT02310750|643505|P16|STARTED|HP Period 1||2
267977|NCT02310750|643506|P15|STARTED|HP Period 1||2
267978|NCT02310750|643507|P14|STARTED|HP Period 1||2
267979|NCT02310750|643508|P13|STARTED|HP Period 1||2
267980|NCT02310750|643509|P12|STARTED|HP Period 1||2
267981|NCT02310750|643510|P11|STARTED|HP Period 1||2
267982|NCT02310750|643511|P10|STARTED|HP Period 1||0
267983|NCT02310750|643512|P9|STARTED|HP Period 1||0
267984|NCT02310750|643513|P8|STARTED|HP Period 1||0
267985|NCT02310750|643514|P7|STARTED|HP Period 1||13
267986|NCT02310750|643515|P6|STARTED|HP Period 1||8
267987|NCT02310750|643516|P5|STARTED|HP Period 1||8
267988|NCT02310750|643517|P4|STARTED|HP Period 1||6
267989|NCT02310750|643518|P3|STARTED|HP Period 1||6
267990|NCT02310750|643519|P2|STARTED|HP Period 1||6
267991|NCT02310750|643520|P1|STARTED|HP Period 1||7
267992|NCT02310646|643961|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
267993|NCT02310646|643962|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
267994|NCT02310646|643961|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
267995|NCT02310646|643962|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
267996|NCT02310646|643961|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
267997|NCT02310646|643962|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
267998|NCT02310646|643961|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
267999|NCT02310646|643962|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
268000|NCT02310646|643961|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
268001|NCT02310646|643962|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
268002|NCT02310646|643961|P2|STARTED|First Intervention (Day 1 - Day 7)||104
268003|NCT02310646|643962|P1|STARTED|First Intervention (Day 1 - Day 7)||109
268004|NCT02310568|643991|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
268005|NCT02310568|643992|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
268006|NCT02310568|643993|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
268007|NCT02310568|643994|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
268008|NCT02310568|643995|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
268009|NCT02310568|643991|P5|COMPLETED|Stage 2 (4 Weeks)||19
268010|NCT02310568|643992|P4|COMPLETED|Stage 2 (4 Weeks)||17
268011|NCT02310568|643993|P3|COMPLETED|Stage 2 (4 Weeks)||13
268012|NCT02310568|643994|P2|COMPLETED|Stage 2 (4 Weeks)||12
268013|NCT02310568|643995|P1|COMPLETED|Stage 2 (4 Weeks)||11
268014|NCT02310568|643991|P5|STARTED|Stage 2 (4 Weeks)||20
268015|NCT02310568|643992|P4|STARTED|Stage 2 (4 Weeks)||22
268016|NCT02310568|643993|P3|STARTED|Stage 2 (4 Weeks)||14
268017|NCT02310568|643994|P2|STARTED|Stage 2 (4 Weeks)||13
268018|NCT02310568|643995|P1|STARTED|Stage 2 (4 Weeks)||12
268019|NCT02310568|643991|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
268020|NCT02310568|643992|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
268021|NCT02310568|643993|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
268022|NCT02310568|643994|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
268023|NCT02310568|643995|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
268024|NCT02310568|643991|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
268025|NCT02310568|643992|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
268026|NCT02310568|643993|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
268027|NCT02310568|643994|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
268028|NCT02310568|643995|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
268029|NCT02310568|643991|P5|STARTED|Stage 1 ( 4 Weeks)||21
268030|NCT02310568|643992|P4|STARTED|Stage 1 ( 4 Weeks)||24
268031|NCT02310568|643993|P3|STARTED|Stage 1 ( 4 Weeks)||15
268032|NCT02310568|643994|P2|STARTED|Stage 1 ( 4 Weeks)||15
268033|NCT02310568|643995|P1|STARTED|Stage 1 ( 4 Weeks)||15
268034|NCT02310126|644075|P2|NOT COMPLETED|Period 2||0
268035|NCT02310126|644076|P1|NOT COMPLETED|Period 2||0
268036|NCT02310126|644075|P2|COMPLETED|Period 2||95
268037|NCT02310126|644076|P1|COMPLETED|Period 2||94
268038|NCT02310126|644075|P2|Myopes|Period 2||63
268039|NCT02310126|644076|P1|Myopes|Period 2||56
268040|NCT02310126|644075|P2|Hyperopes|Period 2||32
268041|NCT02310126|644076|P1|Hyperopes|Period 2||38
268042|NCT02310126|644075|P2|STARTED|Period 2||95
268043|NCT02310126|644076|P1|STARTED|Period 2||94
268044|NCT02310126|644075|P2|NOT COMPLETED|Period 1||2
268045|NCT02310126|644076|P1|NOT COMPLETED|Period 1||0
268046|NCT02310126|644075|P2|COMPLETED|Period 1||95
268047|NCT02310126|644076|P1|COMPLETED|Period 1||94
268048|NCT02310126|644075|P2|Myopes|Period 1||64
268049|NCT02310126|644076|P1|Myopes|Period 1||56
268050|NCT02310126|644075|P2|Hyperopes|Period 1||33
268051|NCT02310126|644076|P1|Hyperopes|Period 1||38
268052|NCT02310126|644075|P2|STARTED|Period 1||97
268053|NCT02310126|644076|P1|STARTED|Period 1||94
268054|NCT02309723|644085|P3|NOT COMPLETED|Overall Study||24
268055|NCT02309723|644086|P2|NOT COMPLETED|Overall Study||23
268056|NCT02309723|644087|P1|NOT COMPLETED|Overall Study||24
268057|NCT02309723|644085|P3|COMPLETED|Overall Study||105
268058|NCT02309723|644086|P2|COMPLETED|Overall Study||105
268059|NCT02309723|644087|P1|COMPLETED|Overall Study||105
268060|NCT02309723|644085|P3|STARTED|Overall Study||129
268061|NCT02309723|644086|P2|STARTED|Overall Study||128
268062|NCT02309723|644087|P1|STARTED|Overall Study||129
268063|NCT02309294|644101|P1|NOT COMPLETED|Overall Study||2
268064|NCT02309294|644101|P1|COMPLETED|Overall Study||41
268065|NCT02309294|644101|P1|STARTED|Overall Study||43
268066|NCT02309112|644108|P3|NOT COMPLETED|Overall Study||1
268067|NCT02309112|644109|P2|NOT COMPLETED|Overall Study||1
268068|NCT02309112|644110|P1|NOT COMPLETED|Overall Study||1
268069|NCT02309112|644108|P3|COMPLETED|Overall Study||4
268070|NCT02309112|644109|P2|COMPLETED|Overall Study||4
268071|NCT02309112|644110|P1|COMPLETED|Overall Study||4
268072|NCT02309112|644108|P3|Completed Yoga Intervention|Overall Study||4
268073|NCT02309112|644109|P2|Completed Yoga Intervention|Overall Study||5
268074|NCT02309112|644110|P1|Completed Yoga Intervention|Overall Study||4
268075|NCT02309112|644108|P3|STARTED|Overall Study||5
268076|NCT02309112|644109|P2|STARTED|Overall Study||5
268077|NCT02309112|644110|P1|STARTED|Overall Study||5
268078|NCT02308787|644131|P1|NOT COMPLETED|Overall Study||0
268079|NCT02308787|644131|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
268080|NCT02308787|644131|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
268081|NCT02308748|644146|P10|NOT COMPLETED|Period 5||0
268082|NCT02308748|644147|P9|NOT COMPLETED|Period 5||1
268083|NCT02308748|644148|P8|NOT COMPLETED|Period 5||0
268084|NCT02308748|644149|P7|NOT COMPLETED|Period 5||0
268085|NCT02308748|644150|P6|NOT COMPLETED|Period 5||0
268086|NCT02308748|644151|P5|NOT COMPLETED|Period 5||0
268087|NCT02308748|644152|P4|NOT COMPLETED|Period 5||0
268088|NCT02308748|644153|P3|NOT COMPLETED|Period 5||0
268089|NCT02308748|644154|P2|NOT COMPLETED|Period 5||0
268090|NCT02308748|644155|P1|NOT COMPLETED|Period 5||1
268091|NCT02308748|644146|P10|COMPLETED|Period 5||2
268092|NCT02308748|644147|P9|COMPLETED|Period 5||1
268093|NCT02308748|644148|P8|COMPLETED|Period 5||1
268094|NCT02308748|644149|P7|COMPLETED|Period 5||2
268095|NCT02308748|644150|P6|COMPLETED|Period 5||3
268096|NCT02308748|644151|P5|COMPLETED|Period 5||2
268097|NCT02308748|644152|P4|COMPLETED|Period 5||2
268098|NCT02308748|644153|P3|COMPLETED|Period 5||1
268099|NCT02308748|644154|P2|COMPLETED|Period 5||2
268100|NCT02308748|644155|P1|COMPLETED|Period 5||1
268101|NCT02308748|644146|P10|STARTED|Period 5||2
268102|NCT02308748|644147|P9|STARTED|Period 5||2
268103|NCT02308748|644148|P8|STARTED|Period 5||1
268104|NCT02308748|644149|P7|STARTED|Period 5||2
268105|NCT02308748|644150|P6|STARTED|Period 5||3
268106|NCT02308748|644151|P5|STARTED|Period 5||2
268107|NCT02308748|644152|P4|STARTED|Period 5||2
268108|NCT02308748|644153|P3|STARTED|Period 5||1
268109|NCT02308748|644154|P2|STARTED|Period 5||2
268110|NCT02308748|644155|P1|STARTED|Period 5||2
268111|NCT02308748|644146|P10|NOT COMPLETED|Period 4||0
268112|NCT02308748|644147|P9|NOT COMPLETED|Period 4||0
268113|NCT02308748|644148|P8|NOT COMPLETED|Period 4||0
268114|NCT02308748|644149|P7|NOT COMPLETED|Period 4||0
268115|NCT02308748|644150|P6|NOT COMPLETED|Period 4||0
268116|NCT02308748|644151|P5|NOT COMPLETED|Period 4||0
268117|NCT02308748|644152|P4|NOT COMPLETED|Period 4||0
268118|NCT02308748|644153|P3|NOT COMPLETED|Period 4||0
268119|NCT02308748|644154|P2|NOT COMPLETED|Period 4||0
268120|NCT02308748|644155|P1|NOT COMPLETED|Period 4||0
268121|NCT02308748|644146|P10|COMPLETED|Period 4||2
268122|NCT02308748|644147|P9|COMPLETED|Period 4||2
268123|NCT02308748|644148|P8|COMPLETED|Period 4||1
268124|NCT02308748|644149|P7|COMPLETED|Period 4||2
268125|NCT02308748|644150|P6|COMPLETED|Period 4||3
268126|NCT02308748|644151|P5|COMPLETED|Period 4||2
268127|NCT02308748|644152|P4|COMPLETED|Period 4||2
268128|NCT02308748|644153|P3|COMPLETED|Period 4||1
268129|NCT02308748|644154|P2|COMPLETED|Period 4||2
268130|NCT02308748|644155|P1|COMPLETED|Period 4||2
268131|NCT02308748|644146|P10|STARTED|Period 4||2
268132|NCT02308748|644147|P9|STARTED|Period 4||2
268133|NCT02308748|644148|P8|STARTED|Period 4||1
268134|NCT02308748|644149|P7|STARTED|Period 4||2
268135|NCT02308748|644150|P6|STARTED|Period 4||3
268136|NCT02308748|644151|P5|STARTED|Period 4||2
268137|NCT02308748|644152|P4|STARTED|Period 4||2
268138|NCT02308748|644153|P3|STARTED|Period 4||1
268139|NCT02308748|644154|P2|STARTED|Period 4||2
268140|NCT02308748|644155|P1|STARTED|Period 4||2
268141|NCT02308748|644146|P10|NOT COMPLETED|Period 3||1
268142|NCT02308748|644147|P9|NOT COMPLETED|Period 3||0
268143|NCT02308748|644148|P8|NOT COMPLETED|Period 3||0
268144|NCT02308748|644149|P7|NOT COMPLETED|Period 3||0
268145|NCT02308748|644150|P6|NOT COMPLETED|Period 3||0
268146|NCT02308748|644151|P5|NOT COMPLETED|Period 3||0
268147|NCT02308748|644152|P4|NOT COMPLETED|Period 3||0
268148|NCT02308748|644153|P3|NOT COMPLETED|Period 3||0
268149|NCT02308748|644154|P2|NOT COMPLETED|Period 3||0
268150|NCT02308748|644155|P1|NOT COMPLETED|Period 3||0
268151|NCT02308748|644146|P10|COMPLETED|Period 3||2
268152|NCT02308748|644147|P9|COMPLETED|Period 3||2
268153|NCT02308748|644148|P8|COMPLETED|Period 3||1
268154|NCT02308748|644149|P7|COMPLETED|Period 3||2
268155|NCT02308748|644150|P6|COMPLETED|Period 3||3
268156|NCT02308748|644151|P5|COMPLETED|Period 3||2
268157|NCT02308748|644152|P4|COMPLETED|Period 3||2
268158|NCT02308748|644153|P3|COMPLETED|Period 3||1
268159|NCT02308748|644154|P2|COMPLETED|Period 3||2
268160|NCT02308748|644155|P1|COMPLETED|Period 3||2
268161|NCT02308748|644146|P10|STARTED|Period 3||3
268162|NCT02308748|644147|P9|STARTED|Period 3||2
268163|NCT02308748|644148|P8|STARTED|Period 3||1
268164|NCT02308748|644149|P7|STARTED|Period 3||2
268165|NCT02308748|644150|P6|STARTED|Period 3||3
268166|NCT02308748|644151|P5|STARTED|Period 3||2
268167|NCT02308748|644152|P4|STARTED|Period 3||2
268168|NCT02308748|644153|P3|STARTED|Period 3||1
268169|NCT02308748|644154|P2|STARTED|Period 3||2
268170|NCT02308748|644155|P1|STARTED|Period 3||2
268171|NCT02308748|644146|P10|NOT COMPLETED|Period 2||0
268172|NCT02308748|644147|P9|NOT COMPLETED|Period 2||0
268173|NCT02308748|644148|P8|NOT COMPLETED|Period 2||1
268174|NCT02308748|644149|P7|NOT COMPLETED|Period 2||0
268175|NCT02308748|644150|P6|NOT COMPLETED|Period 2||0
268176|NCT02308748|644151|P5|NOT COMPLETED|Period 2||0
268177|NCT02308748|644152|P4|NOT COMPLETED|Period 2||0
268178|NCT02308748|644153|P3|NOT COMPLETED|Period 2||0
268179|NCT02308748|644154|P2|NOT COMPLETED|Period 2||0
268180|NCT02308748|644155|P1|NOT COMPLETED|Period 2||0
268181|NCT02308748|644146|P10|COMPLETED|Period 2||3
268182|NCT02308748|644147|P9|COMPLETED|Period 2||2
268183|NCT02308748|644148|P8|COMPLETED|Period 2||1
268184|NCT02308748|644149|P7|COMPLETED|Period 2||2
268185|NCT02308748|644150|P6|COMPLETED|Period 2||3
268186|NCT02308748|644151|P5|COMPLETED|Period 2||2
268187|NCT02308748|644152|P4|COMPLETED|Period 2||2
268188|NCT02308748|644153|P3|COMPLETED|Period 2||1
268189|NCT02308748|644154|P2|COMPLETED|Period 2||2
268190|NCT02308748|644155|P1|COMPLETED|Period 2||2
268191|NCT02308748|644146|P10|STARTED|Period 2||3
268192|NCT02308748|644147|P9|STARTED|Period 2||2
268193|NCT02308748|644148|P8|STARTED|Period 2||2
268194|NCT02308748|644149|P7|STARTED|Period 2||2
268195|NCT02308748|644150|P6|STARTED|Period 2||3
268196|NCT02308748|644151|P5|STARTED|Period 2||2
268197|NCT02308748|644152|P4|STARTED|Period 2||2
268198|NCT02308748|644153|P3|STARTED|Period 2||1
268199|NCT02308748|644154|P2|STARTED|Period 2||2
268200|NCT02308748|644155|P1|STARTED|Period 2||2
268201|NCT02308748|644146|P10|NOT COMPLETED|Period 1||0
268202|NCT02308748|644147|P9|NOT COMPLETED|Period 1||0
268203|NCT02308748|644148|P8|NOT COMPLETED|Period 1||0
268204|NCT02308748|644149|P7|NOT COMPLETED|Period 1||0
268205|NCT02308748|644150|P6|NOT COMPLETED|Period 1||0
268206|NCT02308748|644151|P5|NOT COMPLETED|Period 1||0
268207|NCT02308748|644152|P4|NOT COMPLETED|Period 1||0
268208|NCT02308748|644153|P3|NOT COMPLETED|Period 1||1
268209|NCT02308748|644154|P2|NOT COMPLETED|Period 1||0
268210|NCT02308748|644155|P1|NOT COMPLETED|Period 1||0
268211|NCT02308748|644146|P10|COMPLETED|Period 1||3
268212|NCT02308748|644147|P9|COMPLETED|Period 1||2
268213|NCT02308748|644148|P8|COMPLETED|Period 1||2
268214|NCT02308748|644149|P7|COMPLETED|Period 1||2
268215|NCT02308748|644150|P6|COMPLETED|Period 1||3
268216|NCT02308748|644151|P5|COMPLETED|Period 1||2
268217|NCT02308748|644152|P4|COMPLETED|Period 1||2
268218|NCT02308748|644153|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
268219|NCT02308748|644154|P2|COMPLETED|Period 1||2
268220|NCT02308748|644155|P1|COMPLETED|Period 1||2
268221|NCT02308748|644146|P10|STARTED|Period 1||3
268222|NCT02308748|644147|P9|STARTED|Period 1||2
268223|NCT02308748|644148|P8|STARTED|Period 1||2
268224|NCT02308748|644149|P7|STARTED|Period 1||2
268225|NCT02308748|644150|P6|STARTED|Period 1||3
268226|NCT02308748|644151|P5|STARTED|Period 1||2
268227|NCT02308748|644152|P4|STARTED|Period 1||2
268228|NCT02308748|644153|P3|STARTED|Period 1||2
268229|NCT02308748|644154|P2|STARTED|Period 1||2
268230|NCT02308748|644155|P1|STARTED|Period 1||2
268231|NCT02308371|644169|P2|NOT COMPLETED|Overall Study||0
268232|NCT02308371|644170|P1|NOT COMPLETED|Overall Study||0
268233|NCT02308371|644169|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
268234|NCT02308371|644170|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
268235|NCT02308371|644169|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
268236|NCT02308371|644170|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
268237|NCT02308124|644187|P3|NOT COMPLETED|Overall Study||8
268238|NCT02308124|644188|P2|NOT COMPLETED|Overall Study||8
268239|NCT02308124|644189|P1|NOT COMPLETED|Overall Study||6
268240|NCT02308124|644187|P3|COMPLETED|Overall Study||21
268241|NCT02308124|644188|P2|COMPLETED|Overall Study||21
268242|NCT02308124|644189|P1|COMPLETED|Overall Study||23
268243|NCT02308124|644187|P3|STARTED|Overall Study||29
268244|NCT02308124|644188|P2|STARTED|Overall Study||29
268245|NCT02308124|644189|P1|STARTED|Overall Study||29
268246|NCT02307838|644212|P3|NOT COMPLETED|Overall Study||0
268247|NCT02307838|644213|P2|NOT COMPLETED|Overall Study||0
268248|NCT02307838|644214|P1|NOT COMPLETED|Overall Study||0
268249|NCT02307838|644212|P3|COMPLETED|Overall Study||55
268250|NCT02307838|644213|P2|COMPLETED|Overall Study||64
268251|NCT02307838|644214|P1|COMPLETED|Overall Study||56
268252|NCT02307838|644212|P3|STARTED|Overall Study||55
268253|NCT02307838|644213|P2|STARTED|Overall Study||64
268254|NCT02307838|644214|P1|STARTED|Overall Study||56
268255|NCT02307318|644257|P1|NOT COMPLETED|Overall Study||0
268256|NCT02307318|644257|P1|COMPLETED|Overall Study||51
268257|NCT02307318|644257|P1|STARTED|Overall Study||51
268258|NCT02307266|644267|P3|NOT COMPLETED|Overall Study||6
268259|NCT02307266|644268|P2|NOT COMPLETED|Overall Study||1
268260|NCT02307266|644269|P1|NOT COMPLETED|Overall Study||8
268261|NCT02307266|644267|P3|COMPLETED|Overall Study||25
268262|NCT02307266|644268|P2|COMPLETED|Overall Study||32
268263|NCT02307266|644269|P1|COMPLETED|Overall Study||25
268264|NCT02307266|644267|P3|STARTED|Overall Study||31
268265|NCT02307266|644268|P2|STARTED|Overall Study||33
268266|NCT02307266|644269|P1|STARTED|Overall Study||33
268267|NCT02307188|644277|P1|NOT COMPLETED|Overall Study||4
268268|NCT02307188|644277|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
268269|NCT02307188|644277|P1|STARTED|Overall Study||5
268270|NCT02307123|644281|P1|NOT COMPLETED|Overall Study||0
268271|NCT02307123|644281|P1|COMPLETED|Overall Study||483
268272|NCT02307123|644281|P1|STARTED|Overall Study||483
268273|NCT02306928|644286|P1|NOT COMPLETED|Overall Study||0
268274|NCT02306928|644286|P1|COMPLETED|Overall Study||15
268275|NCT02306928|644286|P1|STARTED|Overall Study||15
268276|NCT02306759|644296|P2|NOT COMPLETED|Overall Study||0
268277|NCT02306759|644297|P1|NOT COMPLETED|Overall Study||0
268278|NCT02306759|644296|P2|COMPLETED|Overall Study||30
268279|NCT02306759|644297|P1|COMPLETED|Overall Study||30
268280|NCT02306759|644296|P2|STARTED|Overall Study||30
268281|NCT02306759|644297|P1|STARTED|Overall Study||30
268282|NCT02305446|644311|P1|NOT COMPLETED|Overall Study||1
268283|NCT02305446|644311|P1|COMPLETED|Overall Study||54
268284|NCT02305446|644311|P1|STARTED|Overall Study||55
268285|NCT02305329|644320|P4|NOT COMPLETED|Overall Study||0
268286|NCT02305329|644321|P3|NOT COMPLETED|Overall Study||0
268287|NCT02305329|644322|P2|NOT COMPLETED|Overall Study||1
268288|NCT02305329|644323|P1|NOT COMPLETED|Overall Study||0
268289|NCT02305329|644320|P4|COMPLETED|Overall Study||14
268290|NCT02305329|644321|P3|COMPLETED|Overall Study||14
268291|NCT02305329|644322|P2|COMPLETED|Overall Study||13
268292|NCT02305329|644323|P1|COMPLETED|Overall Study||14
268293|NCT02305329|644320|P4|Period 2|Overall Study||14
268294|NCT02305329|644321|P3|Period 2|Overall Study||14
268295|NCT02305329|644322|P2|Period 2|Overall Study||13
268296|NCT02305329|644323|P1|Period 2|Overall Study||14
268297|NCT02305329|644320|P4|Period 1|Overall Study||14
268298|NCT02305329|644321|P3|Period 1|Overall Study||14
268299|NCT02305329|644322|P2|Period 1|Overall Study||14
268300|NCT02305329|644323|P1|Period 1|Overall Study||14
268301|NCT02305329|644320|P4|STARTED|Overall Study||14
268302|NCT02305329|644321|P3|STARTED|Overall Study||14
268303|NCT02305329|644322|P2|STARTED|Overall Study||14
268304|NCT02305329|644323|P1|STARTED|Overall Study||14
268305|NCT02305316|644347|P2|NOT COMPLETED|Overall Study||0
268306|NCT02305316|644348|P1|NOT COMPLETED|Overall Study||0
268307|NCT02305316|644347|P2|COMPLETED|Overall Study||14
268308|NCT02305316|644348|P1|COMPLETED|Overall Study||14
268309|NCT02305316|644347|P2|STARTED|Overall Study||14
268310|NCT02305316|644348|P1|STARTED|Overall Study||14
268311|NCT02305277|644366|P6|NOT COMPLETED|Overall Study||0
268312|NCT02305277|644367|P5|NOT COMPLETED|Overall Study||1
268313|NCT02305277|644368|P4|NOT COMPLETED|Overall Study||0
268314|NCT02305277|644369|P3|NOT COMPLETED|Overall Study||0
268315|NCT02305277|644370|P2|NOT COMPLETED|Overall Study||0
268316|NCT02305277|644371|P1|NOT COMPLETED|Overall Study||1
268317|NCT02305277|644366|P6|COMPLETED|Overall Study||14
268318|NCT02305277|644367|P5|COMPLETED|Overall Study||13
268319|NCT02305277|644368|P4|COMPLETED|Overall Study||14
268320|NCT02305277|644369|P3|COMPLETED|Overall Study||14
268321|NCT02305277|644370|P2|COMPLETED|Overall Study||14
268322|NCT02305277|644371|P1|COMPLETED|Overall Study||14
268323|NCT02305277|644366|P6|Received TBM|Overall Study||14
268324|NCT02305277|644367|P5|Received TBM|Overall Study||14
268325|NCT02305277|644368|P4|Received TBM|Overall Study||14
268326|NCT02305277|644369|P3|Received TBM|Overall Study||14
268327|NCT02305277|644370|P2|Received TBM|Overall Study||14
268328|NCT02305277|644371|P1|Received TBM|Overall Study||15
268329|NCT02305277|644366|P6|Received CM|Overall Study||14
268330|NCT02305277|644367|P5|Received CM|Overall Study||14
268331|NCT02305277|644368|P4|Received CM|Overall Study||14
268332|NCT02305277|644369|P3|Received CM|Overall Study||14
268333|NCT02305277|644370|P2|Received CM|Overall Study||14
268334|NCT02305277|644371|P1|Received CM|Overall Study||15
268335|NCT02305277|644366|P6|STARTED|Overall Study||14
268336|NCT02305277|644367|P5|STARTED|Overall Study||14
268337|NCT02305277|644368|P4|STARTED|Overall Study||14
268338|NCT02305277|644369|P3|STARTED|Overall Study||14
268339|NCT02305277|644370|P2|STARTED|Overall Study||14
268340|NCT02305277|644371|P1|STARTED|Overall Study||15
268341|NCT02305017|644399|P2|NOT COMPLETED|Overall Study||0
268342|NCT02305017|644400|P1|NOT COMPLETED|Overall Study||0
268343|NCT02305017|644399|P2|COMPLETED|Overall Study||14
268344|NCT02305017|644400|P1|COMPLETED|Overall Study||14
268345|NCT02305017|644399|P2|STARTED|Overall Study||14
268346|NCT02305017|644400|P1|STARTED|Overall Study||14
268347|NCT02304926|644414|P2|NOT COMPLETED|Overall Study||1
268348|NCT02304926|644415|P1|NOT COMPLETED|Overall Study||2
268349|NCT02304926|644414|P2|COMPLETED|Overall Study||19
268350|NCT02304926|644415|P1|COMPLETED|Overall Study||20
268351|NCT02304926|644414|P2|STARTED|Overall Study||20
268352|NCT02304926|644415|P1|STARTED|Overall Study||22
268353|NCT02303743|644461|P2|NOT COMPLETED|Overall Study||0
268354|NCT02303743|644462|P1|NOT COMPLETED|Overall Study||0
268355|NCT02303743|644461|P2|COMPLETED|Overall Study||152
268356|NCT02303743|644462|P1|COMPLETED|Overall Study||108
268357|NCT02303743|644461|P2|STARTED|Overall Study||152
268358|NCT02303743|644462|P1|STARTED|Overall Study||108
268359|NCT02303704|644472|P2|NOT COMPLETED|Overall Study||9
268360|NCT02303704|644473|P1|NOT COMPLETED|Overall Study||5
268361|NCT02303704|644472|P2|COMPLETED|Overall Study||219
268362|NCT02303704|644473|P1|COMPLETED|Overall Study||215
268363|NCT02303704|644472|P2|STARTED|Overall Study||228
268364|NCT02303704|644473|P1|STARTED|Overall Study||220
268365|NCT02302365|644489|P1|NOT COMPLETED|Overall Study||2
268366|NCT02302365|644489|P1|COMPLETED|Overall Study|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
268367|NCT02302365|644489|P1|STARTED|Overall Study|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
268368|NCT02301975|644508|P3|NOT COMPLETED|Overall Study||22
268369|NCT02301975|644509|P2|NOT COMPLETED|Overall Study||25
268370|NCT02301975|644510|P1|NOT COMPLETED|Overall Study||31
268371|NCT02301975|644508|P3|COMPLETED|Overall Study||477
268372|NCT02301975|644509|P2|COMPLETED|Overall Study||476
268373|NCT02301975|644510|P1|COMPLETED|Overall Study||473
268374|NCT02301975|644508|P3|STARTED|Overall Study||499
268375|NCT02301975|644509|P2|STARTED|Overall Study||501
268376|NCT02301975|644510|P1|STARTED|Overall Study||504
268377|NCT02301936|644538|P2|NOT COMPLETED|Overall Study||0
268378|NCT02301936|644539|P1|NOT COMPLETED|Overall Study||1
268379|NCT02301936|644538|P2|COMPLETED|Overall Study||1
268380|NCT02301936|644539|P1|COMPLETED|Overall Study||8
268381|NCT02301936|644538|P2|STARTED|Overall Study||1
268382|NCT02301936|644539|P1|STARTED|Overall Study||9
268383|NCT02301429|644561|P1|NOT COMPLETED|Overall Study||3
268384|NCT02301429|644561|P1|COMPLETED|Overall Study||13
268385|NCT02301429|644561|P1|STARTED|Overall Study||16
268386|NCT02301377|644567|P2|NOT COMPLETED|Overall Study||0
268387|NCT02301377|644568|P1|NOT COMPLETED|Overall Study||0
268388|NCT02301377|644567|P2|COMPLETED|Overall Study||2
268389|NCT02301377|644568|P1|COMPLETED|Overall Study||3
268390|NCT02301377|644567|P2|STARTED|Overall Study||2
268391|NCT02301377|644568|P1|STARTED|Overall Study||3
268392|NCT02301169|644580|P2|NOT COMPLETED|Overall Study||0
268393|NCT02301169|644581|P1|NOT COMPLETED|Overall Study||1
268394|NCT02301169|644580|P2|COMPLETED|Overall Study||21
268395|NCT02301169|644581|P1|COMPLETED|Overall Study||20
268396|NCT02301169|644580|P2|STARTED|Overall Study||21
268397|NCT02301169|644581|P1|STARTED|Overall Study||21
268398|NCT02300311|644597|P2|NOT COMPLETED|Overall Study||0
268399|NCT02300311|644598|P1|NOT COMPLETED|Overall Study||19
268400|NCT02300311|644597|P2|COMPLETED|Overall Study||69
268401|NCT02300311|644598|P1|COMPLETED|Overall Study||50
268402|NCT02300311|644597|P2|STARTED|Overall Study||69
268403|NCT02300311|644598|P1|STARTED|Overall Study||69
268404|NCT02300129|644610|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
268405|NCT02300129|644611|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
268406|NCT02300129|644612|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
268407|NCT02300129|644613|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
268408|NCT02300129|644610|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
268409|NCT02300129|644611|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
268410|NCT02300129|644612|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
268411|NCT02300129|644613|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
268412|NCT02300129|644610|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
268413|NCT02300129|644611|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
268414|NCT02300129|644612|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
268415|NCT02300129|644613|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
268416|NCT02300129|644610|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
268417|NCT02300129|644611|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
268418|NCT02300129|644612|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
268419|NCT02300129|644613|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
268420|NCT02300129|644610|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
268421|NCT02300129|644611|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
268422|NCT02300129|644612|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
268423|NCT02300129|644613|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
268424|NCT02300129|644610|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
268425|NCT02300129|644611|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
268426|NCT02300129|644612|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
268427|NCT02300129|644613|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
268428|NCT02300129|644610|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
268429|NCT02300129|644611|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
268430|NCT02300129|644612|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
268431|NCT02300129|644613|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
268432|NCT02300129|644610|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
268433|NCT02300129|644611|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
268434|NCT02300129|644612|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
268435|NCT02300129|644613|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
268436|NCT02300129|644610|P4|STARTED|Period 1 Session 3 (Day 5)||11
268437|NCT02300129|644611|P3|STARTED|Period 1 Session 3 (Day 5)||7
268438|NCT02300129|644612|P2|STARTED|Period 1 Session 3 (Day 5)||4
268439|NCT02300129|644613|P1|STARTED|Period 1 Session 3 (Day 5)||11
268440|NCT02300129|644610|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
268441|NCT02300129|644611|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
268442|NCT02300129|644612|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
268443|NCT02300129|644613|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
268444|NCT02300129|644610|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
268445|NCT02300129|644611|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
268446|NCT02300129|644612|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
268447|NCT02300129|644613|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
268448|NCT02300129|644610|P4|STARTED|Period 1 Session 2 (Day 3)||11
268449|NCT02300129|644611|P3|STARTED|Period 1 Session 2 (Day 3)||7
268450|NCT02300129|644612|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
268451|NCT02300129|644613|P1|STARTED|Period 1 Session 2 (Day 3)||11
268452|NCT02300129|644610|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
268453|NCT02300129|644611|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
268454|NCT02300129|644612|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
268455|NCT02300129|644613|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
268456|NCT02300129|644610|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
268457|NCT02300129|644611|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
268458|NCT02300129|644612|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
268459|NCT02300129|644613|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
268460|NCT02300129|644610|P4|STARTED|Period 1 Session 1 (Day 1)||11
268461|NCT02300129|644611|P3|STARTED|Period 1 Session 1 (Day 1)||7
268462|NCT02300129|644612|P2|STARTED|Period 1 Session 1 (Day 1)||5
268463|NCT02300129|644613|P1|STARTED|Period 1 Session 1 (Day 1)||11
268464|NCT02300025|644627|P4|NOT COMPLETED|Overall Study||0
268465|NCT02300025|644628|P3|NOT COMPLETED|Overall Study||0
268466|NCT02300025|644629|P2|NOT COMPLETED|Overall Study||0
268467|NCT02300025|644630|P1|NOT COMPLETED|Overall Study||0
268468|NCT02300025|644627|P4|COMPLETED|Overall Study||6
268469|NCT02300025|644628|P3|COMPLETED|Overall Study||6
268470|NCT02300025|644629|P2|COMPLETED|Overall Study||6
268471|NCT02300025|644630|P1|COMPLETED|Overall Study||10
268472|NCT02300025|644627|P4|STARTED|Overall Study||6
268473|NCT02300025|644628|P3|STARTED|Overall Study||6
268474|NCT02300025|644629|P2|STARTED|Overall Study||6
268475|NCT02300025|644630|P1|STARTED|Overall Study||10
268476|NCT02299869|644676|P4|NOT COMPLETED|Overall Study||0
268477|NCT02299869|644677|P3|NOT COMPLETED|Overall Study||0
268478|NCT02299869|644678|P2|NOT COMPLETED|Overall Study||0
268479|NCT02299869|644679|P1|NOT COMPLETED|Overall Study||0
268480|NCT02299869|644676|P4|COMPLETED|Overall Study||10
268481|NCT02299869|644677|P3|COMPLETED|Overall Study||10
268482|NCT02299869|644678|P2|COMPLETED|Overall Study||10
268483|NCT02299869|644679|P1|COMPLETED|Overall Study||10
268484|NCT02299869|644676|P4|STARTED|Overall Study||10
268485|NCT02299869|644677|P3|STARTED|Overall Study||10
268486|NCT02299869|644678|P2|STARTED|Overall Study||10
268487|NCT02299869|644679|P1|STARTED|Overall Study||10
268488|NCT02299635|644702|P1|NOT COMPLETED|Overall Study||19
268489|NCT02299635|644702|P1|COMPLETED|Overall Study||0
268490|NCT02299635|644702|P1|STARTED|Overall Study||19
268491|NCT02299427|644723|P2|NOT COMPLETED|Overall Study||3
268492|NCT02299427|644724|P1|NOT COMPLETED|Overall Study||23
268493|NCT02299427|644723|P2|COMPLETED|Overall Study||31
268494|NCT02299427|644724|P1|COMPLETED|Overall Study||12
268495|NCT02299427|644723|P2|STARTED|Overall Study||34
268496|NCT02299427|644724|P1|STARTED|Overall Study||35
268497|NCT02299349|644734|P2|NOT COMPLETED|Overall Study||0
268498|NCT02299349|644735|P1|NOT COMPLETED|Overall Study||0
268499|NCT02299349|644734|P2|COMPLETED|Overall Study||35
268500|NCT02299349|644735|P1|COMPLETED|Overall Study||35
268501|NCT02299349|644734|P2|STARTED|Overall Study||35
268502|NCT02299349|644735|P1|STARTED|Overall Study||35
268503|NCT02299258|644745|P2|NOT COMPLETED|Overall Study||1
268504|NCT02299258|644746|P1|NOT COMPLETED|Overall Study||1
268505|NCT02299258|644745|P2|COMPLETED|Overall Study||30
268506|NCT02299258|644746|P1|COMPLETED|Overall Study||31
268507|NCT02299258|644745|P2|STARTED|Overall Study||31
268508|NCT02299258|644746|P1|STARTED|Overall Study||32
268509|NCT02298868|644754|P1|NOT COMPLETED|Overall Study||3
268510|NCT02298868|644754|P1|COMPLETED|Overall Study||7
268511|NCT02298868|644754|P1|STARTED|Overall Study||10
268512|NCT02298361|644769|P3|NOT COMPLETED|Overall Study||0
268513|NCT02298361|644770|P2|NOT COMPLETED|Overall Study||0
268514|NCT02298361|644771|P1|NOT COMPLETED|Overall Study||0
268515|NCT02298361|644769|P3|COMPLETED|Overall Study||12227
268516|NCT02298361|644770|P2|COMPLETED|Overall Study||12784
268517|NCT02298361|644771|P1|COMPLETED|Overall Study||2240
268518|NCT02298361|644769|P3|STARTED|Overall Study||12227
268519|NCT02298361|644770|P2|STARTED|Overall Study||12784
268520|NCT02298361|644771|P1|STARTED|Overall Study||2240
268521|NCT02298192|644787|P2|NOT COMPLETED|Overall Study||6
268522|NCT02298192|644788|P1|NOT COMPLETED|Overall Study||19
268523|NCT02298192|644787|P2|COMPLETED|Overall Study||204
268524|NCT02298192|644788|P1|COMPLETED|Overall Study||191
268525|NCT02298192|644787|P2|STARTED|Overall Study||210
268526|NCT02298192|644788|P1|STARTED|Overall Study||210
268527|NCT02297841|644800|P1|NOT COMPLETED|Overall Study||8
268528|NCT02297841|644800|P1|COMPLETED|Overall Study||201
268529|NCT02297841|644800|P1|Challenge Phase|Overall Study||201
268530|NCT02297841|644800|P1|Induction Phase|Overall Study||209
268531|NCT02297841|644800|P1|STARTED|Overall Study||209
268532|NCT02297308|644804|P1|NOT COMPLETED|Overall Study||0
268533|NCT02297308|644804|P1|COMPLETED|Overall Study||90
268534|NCT02297308|644804|P1|STARTED|Overall Study||90
268535|NCT02296931|644811|P2|NOT COMPLETED|Overall Study||2
268536|NCT02296931|644812|P1|NOT COMPLETED|Overall Study||0
268537|NCT02296931|644811|P2|COMPLETED|Overall Study||22
268538|NCT02296931|644812|P1|COMPLETED|Overall Study||10
268539|NCT02296931|644811|P2|STARTED|Overall Study||24
268540|NCT02296931|644812|P1|STARTED|Overall Study||10
268541|NCT02295774|644818|P1|NOT COMPLETED|Overall Study||3
268542|NCT02295774|644818|P1|COMPLETED|Overall Study||10
268543|NCT02295774|644818|P1|STARTED|Overall Study||13
268544|NCT02295644|644826|P4|NOT COMPLETED|Overall Study||0
268545|NCT02295644|644827|P3|NOT COMPLETED|Overall Study||0
268546|NCT02295644|644828|P2|NOT COMPLETED|Overall Study||0
268547|NCT02295644|644829|P1|NOT COMPLETED|Overall Study||0
268548|NCT02295644|644826|P4|COMPLETED|Overall Study||7
268549|NCT02295644|644827|P3|COMPLETED|Overall Study||7
268550|NCT02295644|644828|P2|COMPLETED|Overall Study||7
268551|NCT02295644|644829|P1|COMPLETED|Overall Study||7
268552|NCT02295644|644826|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
268553|NCT02295644|644827|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
268554|NCT02295644|644828|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
268555|NCT02295644|644829|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
268556|NCT02295020|644849|P2|NOT COMPLETED|Overall Study||3
268557|NCT02295020|644850|P1|NOT COMPLETED|Overall Study||3
268558|NCT02295020|644849|P2|COMPLETED|Overall Study||17
268559|NCT02295020|644850|P1|COMPLETED|Overall Study||17
268560|NCT02295020|644849|P2|STARTED|Overall Study||20
268561|NCT02295020|644850|P1|STARTED|Overall Study||20
268562|NCT02294773|644882|P2|NOT COMPLETED|Overall Study||2
268563|NCT02294773|644883|P1|NOT COMPLETED|Overall Study||0
268564|NCT02294773|644882|P2|COMPLETED|Overall Study||4
268565|NCT02294773|644883|P1|COMPLETED|Overall Study||7
268566|NCT02294773|644882|P2|STARTED|Overall Study||6
268567|NCT02294773|644883|P1|STARTED|Overall Study||7
268568|NCT02294734|644899|P2|NOT COMPLETED|Overall Study||8
268569|NCT02294734|644900|P1|NOT COMPLETED|Overall Study||14
268570|NCT02294734|644899|P2|COMPLETED|Overall Study||55
268571|NCT02294734|644900|P1|COMPLETED|Overall Study||49
268572|NCT02294734|644899|P2|STARTED|Overall Study||63
268573|NCT02294734|644900|P1|STARTED|Overall Study||63
268574|NCT02294682|644952|P2|NOT COMPLETED|Overall Study||0
268575|NCT02294682|644953|P1|NOT COMPLETED|Overall Study||1
268576|NCT02294682|644952|P2|COMPLETED|Overall Study||53
268577|NCT02294682|644953|P1|COMPLETED|Overall Study||52
268578|NCT02294682|644952|P2|STARTED|Overall Study||53
268579|NCT02294682|644953|P1|STARTED|Overall Study||53
268580|NCT02294604|644996|P3|NOT COMPLETED|Overall Study||0
268581|NCT02294604|644997|P2|NOT COMPLETED|Overall Study||3
268582|NCT02294604|644998|P1|NOT COMPLETED|Overall Study||1
268583|NCT02294604|644996|P3|COMPLETED|Overall Study||80
268584|NCT02294604|644997|P2|COMPLETED|Overall Study||77
268585|NCT02294604|644998|P1|COMPLETED|Overall Study||79
268586|NCT02294604|644996|P3|STARTED|Overall Study||80
268587|NCT02294604|644997|P2|STARTED|Overall Study||80
268588|NCT02294604|644998|P1|STARTED|Overall Study||80
268589|NCT02294461|645017|P2|NOT COMPLETED|Overall Study||137
268590|NCT02294461|645018|P1|NOT COMPLETED|Overall Study||65
268591|NCT02294461|645017|P2|COMPLETED|Overall Study||63
268592|NCT02294461|645018|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|144
268593|NCT02294461|645017|P2|Treated/Received Study Drug|Overall Study||200
268594|NCT02294461|645018|P1|Treated/Received Study Drug|Overall Study||209
268595|NCT02294461|645017|P2|STARTED|Overall Study||200
268596|NCT02294461|645018|P1|STARTED|Overall Study||209
268597|NCT02294019|645070|P1|NOT COMPLETED|Overall Study||103
268598|NCT02294019|645070|P1|COMPLETED|Overall Study||635
268599|NCT02294019|645070|P1|STARTED|Overall Study||738
268600|NCT02293538|645077|P2|NOT COMPLETED|Overall Study||2
268601|NCT02293538|645078|P1|NOT COMPLETED|Overall Study||1
268602|NCT02293538|645077|P2|COMPLETED|Overall Study||69
268603|NCT02293538|645078|P1|COMPLETED|Overall Study||72
268604|NCT02293538|645077|P2|STARTED|Overall Study||71
268605|NCT02293538|645078|P1|STARTED|Overall Study||73
268606|NCT02292433|645094|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
268607|NCT02292433|645095|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
268608|NCT02292433|645096|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
268609|NCT02292433|645094|P3|COMPLETED|Third Intervention Period (7 Days)||4
268610|NCT02292433|645095|P2|COMPLETED|Third Intervention Period (7 Days)||4
268611|NCT02292433|645096|P1|COMPLETED|Third Intervention Period (7 Days)||4
268612|NCT02292433|645094|P3|STARTED|Third Intervention Period (7 Days)||4
268613|NCT02292433|645095|P2|STARTED|Third Intervention Period (7 Days)||4
268614|NCT02292433|645096|P1|STARTED|Third Intervention Period (7 Days)||4
268615|NCT02292433|645094|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
268616|NCT02292433|645095|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
268617|NCT02292433|645096|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
268618|NCT02292433|645094|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
268619|NCT02292433|645095|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
268620|NCT02292433|645096|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
268621|NCT02292433|645094|P3|STARTED|Second Washout Period (7 to 14 Days)||4
268622|NCT02292433|645095|P2|STARTED|Second Washout Period (7 to 14 Days)||4
268623|NCT02292433|645096|P1|STARTED|Second Washout Period (7 to 14 Days)||4
268624|NCT02292433|645094|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
268625|NCT02292433|645095|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
268626|NCT02292433|645096|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
268627|NCT02292433|645094|P3|COMPLETED|Second Intervention Period (7 Days)||4
268628|NCT02292433|645095|P2|COMPLETED|Second Intervention Period (7 Days)||4
268629|NCT02292433|645096|P1|COMPLETED|Second Intervention Period (7 Days)||4
268630|NCT02292433|645094|P3|STARTED|Second Intervention Period (7 Days)||4
268631|NCT02292433|645095|P2|STARTED|Second Intervention Period (7 Days)||4
268632|NCT02292433|645096|P1|STARTED|Second Intervention Period (7 Days)||4
268633|NCT02292433|645094|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
268634|NCT02292433|645095|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
268635|NCT02292433|645096|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
268636|NCT02292433|645094|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
268637|NCT02292433|645095|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
268638|NCT02292433|645096|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
268639|NCT02292433|645094|P3|STARTED|First Washout Period (7 to 14 Days)||4
268640|NCT02292433|645095|P2|STARTED|First Washout Period (7 to 14 Days)||4
268641|NCT02292433|645096|P1|STARTED|First Washout Period (7 to 14 Days)||4
268642|NCT02292433|645094|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
268643|NCT02292433|645095|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
268644|NCT02292433|645096|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
268645|NCT02292433|645094|P3|COMPLETED|First Intervention Period (7 Days)||4
268646|NCT02292433|645095|P2|COMPLETED|First Intervention Period (7 Days)||4
268647|NCT02292433|645096|P1|COMPLETED|First Intervention Period (7 Days)||4
268648|NCT02292433|645094|P3|STARTED|First Intervention Period (7 Days)||4
268649|NCT02292433|645095|P2|STARTED|First Intervention Period (7 Days)||4
268650|NCT02292433|645096|P1|STARTED|First Intervention Period (7 Days)||4
268651|NCT02291718|645170|P3|NOT COMPLETED|Overall Study||0
268652|NCT02291718|645171|P2|NOT COMPLETED|Overall Study||0
268653|NCT02291718|645172|P1|NOT COMPLETED|Overall Study||0
268654|NCT02291718|645170|P3|COMPLETED|Overall Study||50
268655|NCT02291718|645171|P2|COMPLETED|Overall Study||50
268656|NCT02291718|645172|P1|COMPLETED|Overall Study||50
268657|NCT02291718|645170|P3|STARTED|Overall Study||50
268658|NCT02291718|645171|P2|STARTED|Overall Study||50
268659|NCT02291718|645172|P1|STARTED|Overall Study||50
268660|NCT02291679|645192|P3|NOT COMPLETED|Overall Study||59
268661|NCT02291679|645193|P2|NOT COMPLETED|Overall Study||42
268662|NCT02291679|645194|P1|NOT COMPLETED|Overall Study||44
268663|NCT02291679|645192|P3|COMPLETED|Overall Study||352
268664|NCT02291679|645193|P2|COMPLETED|Overall Study||369
268665|NCT02291679|645194|P1|COMPLETED|Overall Study||357
268666|NCT02291679|645192|P3|STARTED|Overall Study||411
268667|NCT02291679|645193|P2|STARTED|Overall Study||411
268668|NCT02291679|645194|P1|STARTED|Overall Study||401
268669|NCT02291510|645227|P4|NOT COMPLETED|Overall Study||1
268670|NCT02291510|645228|P3|NOT COMPLETED|Overall Study||0
268671|NCT02291510|645229|P2|NOT COMPLETED|Overall Study||0
268672|NCT02291510|645230|P1|NOT COMPLETED|Overall Study||0
268673|NCT02291510|645227|P4|COMPLETED|Overall Study||4
268674|NCT02291510|645228|P3|COMPLETED|Overall Study||5
268675|NCT02291510|645229|P2|COMPLETED|Overall Study||5
268676|NCT02291510|645230|P1|COMPLETED|Overall Study||5
268677|NCT02291510|645227|P4|Completed Treatment D|Overall Study||5
268678|NCT02291510|645228|P3|Completed Treatment D|Overall Study||5
268679|NCT02291510|645229|P2|Completed Treatment D|Overall Study||5
268680|NCT02291510|645230|P1|Completed Treatment D|Overall Study||5
268681|NCT02291510|645227|P4|Completed Treatment C|Overall Study||4
268682|NCT02291510|645228|P3|Completed Treatment C|Overall Study||5
268683|NCT02291510|645229|P2|Completed Treatment C|Overall Study||5
268684|NCT02291510|645230|P1|Completed Treatment C|Overall Study||5
268685|NCT02291510|645227|P4|Completed Treatment B|Overall Study||4
268686|NCT02291510|645228|P3|Completed Treatment B|Overall Study||5
268687|NCT02291510|645229|P2|Completed Treatment B|Overall Study||5
268688|NCT02291510|645230|P1|Completed Treatment B|Overall Study||5
268689|NCT02291510|645227|P4|Completed Treatment A|Overall Study||5
268690|NCT02291510|645228|P3|Completed Treatment A|Overall Study||5
268691|NCT02291510|645229|P2|Completed Treatment A|Overall Study||5
268692|NCT02291510|645230|P1|Completed Treatment A|Overall Study||5
268693|NCT02291510|645227|P4|STARTED|Overall Study||5
268694|NCT02291510|645228|P3|STARTED|Overall Study||5
268695|NCT02291510|645229|P2|STARTED|Overall Study||5
268696|NCT02291510|645230|P1|STARTED|Overall Study||5
268697|NCT02291419|645246|P2|NOT COMPLETED|Overall Study||5
268698|NCT02291419|645247|P1|NOT COMPLETED|Overall Study||1
268699|NCT02291419|645246|P2|COMPLETED|Overall Study||0
268700|NCT02291419|645247|P1|COMPLETED|Overall Study||0
268701|NCT02291419|645246|P2|STARTED|Overall Study||5
268702|NCT02291419|645247|P1|STARTED|Overall Study||1
268703|NCT02290821|645265|P2|NOT COMPLETED|Overall Study||3
268704|NCT02290821|645266|P1|NOT COMPLETED|Overall Study||6
268705|NCT02290821|645265|P2|COMPLETED|Overall Study||103
268706|NCT02290821|645266|P1|COMPLETED|Overall Study||103
268707|NCT02290821|645265|P2|STARTED|Overall Study||106
268708|NCT02290821|645266|P1|STARTED|Overall Study||109
268709|NCT02290509|645274|P2|NOT COMPLETED|Overall Study||14
268710|NCT02290509|645275|P1|NOT COMPLETED|Overall Study||49
268711|NCT02290509|645274|P2|COMPLETED|Overall Study||325
268712|NCT02290509|645275|P1|COMPLETED|Overall Study||962
268713|NCT02290509|645274|P2|STARTED|Overall Study||339
268714|NCT02290509|645275|P1|STARTED|Overall Study||1011
268715|NCT02289989|645289|P2|NOT COMPLETED|Overall Study||0
268716|NCT02289989|645290|P1|NOT COMPLETED|Overall Study||0
268717|NCT02289989|645289|P2|COMPLETED|Overall Study||1
268718|NCT02289989|645290|P1|COMPLETED|Overall Study||0
268719|NCT02289989|645289|P2|STARTED|Overall Study||1
268720|NCT02289989|645290|P1|STARTED|Overall Study||0
268721|NCT02289755|645306|P1|NOT COMPLETED|Follow up Period [4 Days]||0
268722|NCT02289755|645306|P1|COMPLETED|Follow up Period [4 Days]||16
268723|NCT02289755|645306|P1|STARTED|Follow up Period [4 Days]||16
268724|NCT02289755|645306|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
268725|NCT02289755|645306|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
268726|NCT02289755|645306|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
268727|NCT02289755|645306|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
268728|NCT02289755|645306|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
268729|NCT02289755|645306|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
268730|NCT02289742|645313|P4|NOT COMPLETED|Third Wear Period||1
268731|NCT02289742|645314|P3|NOT COMPLETED|Third Wear Period||0
268732|NCT02289742|645315|P2|NOT COMPLETED|Third Wear Period||1
268733|NCT02289742|645316|P1|NOT COMPLETED|Third Wear Period||0
268734|NCT02289742|645313|P4|COMPLETED|Third Wear Period||8
268735|NCT02289742|645314|P3|COMPLETED|Third Wear Period||11
268736|NCT02289742|645315|P2|COMPLETED|Third Wear Period||10
268737|NCT02289742|645316|P1|COMPLETED|Third Wear Period||11
268738|NCT02289742|645313|P4|STARTED|Third Wear Period||9
268739|NCT02289742|645314|P3|STARTED|Third Wear Period||11
268740|NCT02289742|645315|P2|STARTED|Third Wear Period||11
268741|NCT02289742|645316|P1|STARTED|Third Wear Period||11
268742|NCT02289742|645313|P4|NOT COMPLETED|Second Wear Period||0
268743|NCT02289742|645314|P3|NOT COMPLETED|Second Wear Period||0
268744|NCT02289742|645315|P2|NOT COMPLETED|Second Wear Period||0
268745|NCT02289742|645316|P1|NOT COMPLETED|Second Wear Period||0
268746|NCT02289742|645313|P4|COMPLETED|Second Wear Period||9
268747|NCT02289742|645314|P3|COMPLETED|Second Wear Period||11
268748|NCT02289742|645315|P2|COMPLETED|Second Wear Period||11
268749|NCT02289742|645316|P1|COMPLETED|Second Wear Period||11
268750|NCT02289742|645313|P4|STARTED|Second Wear Period||9
268751|NCT02289742|645314|P3|STARTED|Second Wear Period||11
268752|NCT02289742|645315|P2|STARTED|Second Wear Period||11
268753|NCT02289742|645316|P1|STARTED|Second Wear Period||11
268754|NCT02289742|645313|P4|NOT COMPLETED|First Wear Period||1
268755|NCT02289742|645314|P3|NOT COMPLETED|First Wear Period||1
268756|NCT02289742|645315|P2|NOT COMPLETED|First Wear Period||1
268757|NCT02289742|645316|P1|NOT COMPLETED|First Wear Period||0
268758|NCT02289742|645313|P4|COMPLETED|First Wear Period||9
268759|NCT02289742|645314|P3|COMPLETED|First Wear Period||11
268760|NCT02289742|645315|P2|COMPLETED|First Wear Period||11
268761|NCT02289742|645316|P1|COMPLETED|First Wear Period||11
268762|NCT02289742|645313|P4|Treated|First Wear Period||9
268763|NCT02289742|645314|P3|Treated|First Wear Period||12
268764|NCT02289742|645315|P2|Treated|First Wear Period||11
268765|NCT02289742|645316|P1|Treated|First Wear Period||11
268766|NCT02289742|645313|P4|STARTED|First Wear Period||10
268767|NCT02289742|645314|P3|STARTED|First Wear Period||12
268768|NCT02289742|645315|P2|STARTED|First Wear Period||12
268769|NCT02289742|645316|P1|STARTED|First Wear Period||11
268770|NCT02289105|645335|P2|NOT COMPLETED|Overall Study||0
268771|NCT02289105|645336|P1|NOT COMPLETED|Overall Study||0
268772|NCT02289105|645335|P2|COMPLETED|Overall Study||637
268773|NCT02289105|645336|P1|COMPLETED|Overall Study||642
268774|NCT02289105|645335|P2|STARTED|Overall Study||637
268775|NCT02289105|645336|P1|STARTED|Overall Study||642
268776|NCT02289079|645348|P2|NOT COMPLETED|Overall Study||1
268777|NCT02289079|645349|P1|NOT COMPLETED|Overall Study||2
268778|NCT02289079|645348|P2|COMPLETED|Overall Study||29
268779|NCT02289079|645349|P1|COMPLETED|Overall Study||28
268780|NCT02289079|645348|P2|STARTED|Overall Study||30
268781|NCT02289079|645349|P1|STARTED|Overall Study||30
268782|NCT02288364|645363|P2|NOT COMPLETED|Overall Study||0
268783|NCT02288364|645364|P1|NOT COMPLETED|Overall Study||0
268784|NCT02288364|645363|P2|COMPLETED|Overall Study||44
268785|NCT02288364|645364|P1|COMPLETED|Overall Study||42
268786|NCT02288364|645363|P2|STARTED|Overall Study||44
268787|NCT02288364|645364|P1|STARTED|Overall Study||42
268788|NCT02288312|645391|P3|NOT COMPLETED|Overall Study||0
268789|NCT02288312|645392|P2|NOT COMPLETED|Overall Study||0
268790|NCT02288312|645393|P1|NOT COMPLETED|Overall Study||1
268791|NCT02288312|645391|P3|COMPLETED|Overall Study||6
268792|NCT02288312|645392|P2|COMPLETED|Overall Study||6
268793|NCT02288312|645393|P1|COMPLETED|Overall Study||5
268794|NCT02288312|645391|P3|STARTED|Overall Study||6
268795|NCT02288312|645392|P2|STARTED|Overall Study||6
268796|NCT02288312|645393|P1|STARTED|Overall Study||6
268797|NCT02288273|645412|P2|NOT COMPLETED|Overall Study||8
268798|NCT02288273|645413|P1|NOT COMPLETED|Overall Study||8
268799|NCT02288273|645412|P2|COMPLETED|Overall Study||48
268800|NCT02288273|645413|P1|COMPLETED|Overall Study||53
268801|NCT02288273|645412|P2|STARTED|Overall Study||56
268802|NCT02288273|645413|P1|STARTED|Overall Study||61
268803|NCT02287779|645439|P8|NOT COMPLETED|Overall Study||0
268804|NCT02287779|645440|P7|NOT COMPLETED|Overall Study||0
268805|NCT02287779|645441|P6|NOT COMPLETED|Overall Study||0
268806|NCT02287779|645442|P5|NOT COMPLETED|Overall Study||0
268807|NCT02287779|645443|P4|NOT COMPLETED|Overall Study||0
268808|NCT02287779|645444|P3|NOT COMPLETED|Overall Study||0
268809|NCT02287779|645445|P2|NOT COMPLETED|Overall Study||0
268810|NCT02287779|645446|P1|NOT COMPLETED|Overall Study||0
268811|NCT02287779|645439|P8|COMPLETED|Overall Study||9
268812|NCT02287779|645440|P7|COMPLETED|Overall Study||9
268813|NCT02287779|645441|P6|COMPLETED|Overall Study||9
268814|NCT02287779|645442|P5|COMPLETED|Overall Study||9
268815|NCT02287779|645443|P4|COMPLETED|Overall Study||9
268816|NCT02287779|645444|P3|COMPLETED|Overall Study||9
268817|NCT02287779|645445|P2|COMPLETED|Overall Study||9
268818|NCT02287779|645446|P1|COMPLETED|Overall Study||21
268819|NCT02287779|645439|P8|STARTED|Overall Study||9
268820|NCT02287779|645440|P7|STARTED|Overall Study||9
268821|NCT02287779|645441|P6|STARTED|Overall Study||9
268822|NCT02287779|645442|P5|STARTED|Overall Study||9
268823|NCT02287779|645443|P4|STARTED|Overall Study||9
268824|NCT02287779|645444|P3|STARTED|Overall Study||9
268825|NCT02287779|645445|P2|STARTED|Overall Study||9
268826|NCT02287779|645446|P1|STARTED|Overall Study||21
268827|NCT02287623|645586|P2|NOT COMPLETED|Overall Study||1
268828|NCT02287623|645587|P1|NOT COMPLETED|Overall Study||0
268829|NCT02287623|645586|P2|COMPLETED|Overall Study||29
268830|NCT02287623|645587|P1|COMPLETED|Overall Study||30
268831|NCT02287623|645586|P2|STARTED|Overall Study||30
268832|NCT02287623|645587|P1|STARTED|Overall Study||30
268833|NCT02287610|645603|P1|NOT COMPLETED|Overall Study||16
268834|NCT02287610|645603|P1|COMPLETED|Overall Study||48
268835|NCT02287610|645603|P1|Per Protocol Follow-Up|Overall Study||56
268836|NCT02287610|645603|P1|STARTED|Overall Study||64
268837|NCT02287415|645636|P1|NOT COMPLETED|Overall Study||0
268838|NCT02287415|645636|P1|COMPLETED|Overall Study||13
268839|NCT02287415|645636|P1|STARTED|Overall Study||13
268840|NCT02287402|645642|P1|NOT COMPLETED|Follow-up||3
268841|NCT02287402|645642|P1|COMPLETED|Follow-up||103
268842|NCT02287402|645642|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
268843|NCT02287402|645642|P1|NOT COMPLETED|Treatment Period||27
268844|NCT02287402|645642|P1|COMPLETED|Treatment Period||170
268845|NCT02287402|645642|P1|STARTED|Treatment Period||197
268846|NCT02286518|645671|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268847|NCT02286518|645672|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268848|NCT02286518|645673|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268849|NCT02286518|645674|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268850|NCT02286518|645675|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268851|NCT02286518|645676|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268852|NCT02286518|645677|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268853|NCT02286518|645678|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268854|NCT02286518|645679|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268855|NCT02286518|645680|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268856|NCT02286518|645681|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268857|NCT02286518|645682|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268858|NCT02286518|645683|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268859|NCT02286518|645684|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268860|NCT02286518|645671|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268861|NCT02286518|645672|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268862|NCT02286518|645673|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268863|NCT02286518|645674|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268864|NCT02286518|645675|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268865|NCT02286518|645676|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
268866|NCT02286518|645677|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
268867|NCT02286518|645678|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268868|NCT02286518|645679|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268869|NCT02286518|645680|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268870|NCT02286518|645681|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268871|NCT02286518|645682|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268872|NCT02286518|645683|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268873|NCT02286518|645684|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
268874|NCT02286518|645671|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268875|NCT02286518|645672|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268876|NCT02286518|645673|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268877|NCT02286518|645674|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268878|NCT02286518|645675|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268879|NCT02286518|645676|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
268880|NCT02286518|645677|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
268881|NCT02286518|645678|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268882|NCT02286518|645679|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268883|NCT02286518|645680|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268884|NCT02286518|645681|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268885|NCT02286518|645682|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268886|NCT02286518|645683|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268887|NCT02286518|645684|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
268888|NCT02286518|645671|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268889|NCT02286518|645672|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268890|NCT02286518|645673|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268891|NCT02286518|645674|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268892|NCT02286518|645675|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268893|NCT02286518|645676|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268894|NCT02286518|645677|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268895|NCT02286518|645678|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268896|NCT02286518|645679|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268897|NCT02286518|645680|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268898|NCT02286518|645681|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268899|NCT02286518|645682|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268900|NCT02286518|645683|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268901|NCT02286518|645684|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268902|NCT02286518|645671|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268903|NCT02286518|645672|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268904|NCT02286518|645673|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268905|NCT02286518|645674|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268906|NCT02286518|645675|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268907|NCT02286518|645676|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
268908|NCT02286518|645677|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
268909|NCT02286518|645678|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268910|NCT02286518|645679|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268911|NCT02286518|645680|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268912|NCT02286518|645681|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268913|NCT02286518|645682|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268914|NCT02286518|645683|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268915|NCT02286518|645684|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
268916|NCT02286518|645671|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268917|NCT02286518|645672|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268918|NCT02286518|645673|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268919|NCT02286518|645674|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268920|NCT02286518|645675|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268921|NCT02286518|645676|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
268922|NCT02286518|645677|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
268923|NCT02286518|645678|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268924|NCT02286518|645679|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268925|NCT02286518|645680|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268926|NCT02286518|645681|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268927|NCT02286518|645682|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268928|NCT02286518|645683|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268929|NCT02286518|645684|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
268930|NCT02286518|645671|P14|NOT COMPLETED|All Parts (16 Days)||0
268931|NCT02286518|645672|P13|NOT COMPLETED|All Parts (16 Days)||0
268932|NCT02286518|645673|P12|NOT COMPLETED|All Parts (16 Days)||0
268933|NCT02286518|645674|P11|NOT COMPLETED|All Parts (16 Days)||0
268934|NCT02286518|645675|P10|NOT COMPLETED|All Parts (16 Days)||0
268935|NCT02286518|645676|P9|NOT COMPLETED|All Parts (16 Days)||0
268936|NCT02286518|645677|P8|NOT COMPLETED|All Parts (16 Days)||0
268937|NCT02286518|645678|P7|NOT COMPLETED|All Parts (16 Days)||0
268938|NCT02286518|645679|P6|NOT COMPLETED|All Parts (16 Days)||0
268939|NCT02286518|645680|P5|NOT COMPLETED|All Parts (16 Days)||0
268940|NCT02286518|645681|P4|NOT COMPLETED|All Parts (16 Days)||0
268941|NCT02286518|645682|P3|NOT COMPLETED|All Parts (16 Days)||0
268942|NCT02286518|645683|P2|NOT COMPLETED|All Parts (16 Days)||0
268943|NCT02286518|645684|P1|NOT COMPLETED|All Parts (16 Days)||0
268944|NCT02286518|645671|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268945|NCT02286518|645672|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268946|NCT02286518|645673|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268947|NCT02286518|645674|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268948|NCT02286518|645675|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
268949|NCT02286518|645676|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
268950|NCT02286518|645677|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
268951|NCT02286518|645678|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268952|NCT02286518|645679|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268953|NCT02286518|645680|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268954|NCT02286518|645681|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268955|NCT02286518|645682|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268956|NCT02286518|645683|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268957|NCT02286518|645684|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
268958|NCT02286518|645671|P14|STARTED|All Parts (16 Days)||6
268959|NCT02286518|645672|P13|STARTED|All Parts (16 Days)||6
268960|NCT02286518|645673|P12|STARTED|All Parts (16 Days)||6
268961|NCT02286518|645674|P11|STARTED|All Parts (16 Days)||6
268962|NCT02286518|645675|P10|STARTED|All Parts (16 Days)||4
268963|NCT02286518|645676|P9|STARTED|All Parts (16 Days)||6
268964|NCT02286518|645677|P8|STARTED|All Parts (16 Days)||6
268965|NCT02286518|645678|P7|STARTED|All Parts (16 Days)||6
268966|NCT02286518|645679|P6|STARTED|All Parts (16 Days)||6
268967|NCT02286518|645680|P5|STARTED|All Parts (16 Days)||6
268968|NCT02286518|645681|P4|STARTED|All Parts (16 Days)||6
268969|NCT02286518|645682|P3|STARTED|All Parts (16 Days)||6
268970|NCT02286518|645683|P2|STARTED|All Parts (16 Days)||6
268971|NCT02286518|645684|P1|STARTED|All Parts (16 Days)||6
268972|NCT02286193|645824|P1|NOT COMPLETED|Overall Study||204
268973|NCT02286193|645824|P1|COMPLETED|Overall Study||418
268974|NCT02286193|645824|P1|STARTED|Overall Study||622
268975|NCT02285998|645831|P2|NOT COMPLETED|Overall Study||253
268976|NCT02285998|645832|P1|NOT COMPLETED|Overall Study||246
268977|NCT02285998|645831|P2|COMPLETED|Overall Study||4236
268978|NCT02285998|645832|P1|COMPLETED|Overall Study||4228
268979|NCT02285998|645831|P2|STARTED|Overall Study||4489
268980|NCT02285998|645832|P1|STARTED|Overall Study||4474
268981|NCT02285270|645856|P1|NOT COMPLETED|Overall Study||5
268982|NCT02285270|645856|P1|COMPLETED|Overall Study||5
268983|NCT02285270|645856|P1|STARTED|Overall Study||10
268984|NCT02284880|645864|P4|NOT COMPLETED|Overall Study||0
268985|NCT02284880|645865|P3|NOT COMPLETED|Overall Study||2
268986|NCT02284880|645866|P2|NOT COMPLETED|Overall Study||0
268987|NCT02284880|645867|P1|NOT COMPLETED|Overall Study||0
268988|NCT02284880|645864|P4|COMPLETED|Overall Study||10
268989|NCT02284880|645865|P3|COMPLETED|Overall Study||8
268990|NCT02284880|645866|P2|COMPLETED|Overall Study||9
268991|NCT02284880|645867|P1|COMPLETED|Overall Study||11
268992|NCT02284880|645864|P4|Second Period (4 Days)|Overall Study||10
268993|NCT02284880|645865|P3|Second Period (4 Days)|Overall Study||8
268994|NCT02284880|645866|P2|Second Period (4 Days)|Overall Study||9
268995|NCT02284880|645867|P1|Second Period (4 Days)|Overall Study||11
268996|NCT02284880|645864|P4|Wash-out Period (7 Days)|Overall Study||10
268997|NCT02284880|645865|P3|Wash-out Period (7 Days)|Overall Study||10
268998|NCT02284880|645866|P2|Wash-out Period (7 Days)|Overall Study||9
268999|NCT02284880|645867|P1|Wash-out Period (7 Days)|Overall Study||11
269000|NCT02284880|645864|P4|First Period (4 Days)|Overall Study||10
269001|NCT02284880|645865|P3|First Period (4 Days)|Overall Study||10
269002|NCT02284880|645866|P2|First Period (4 Days)|Overall Study||9
269003|NCT02284880|645867|P1|First Period (4 Days)|Overall Study||11
269004|NCT02284880|645864|P4|STARTED|Overall Study||10
269005|NCT02284880|645865|P3|STARTED|Overall Study||10
269006|NCT02284880|645866|P2|STARTED|Overall Study||9
269007|NCT02284880|645867|P1|STARTED|Overall Study||11
269008|NCT02284867|645883|P2|NOT COMPLETED|Overall Study||0
269009|NCT02284867|645884|P1|NOT COMPLETED|Overall Study||0
269010|NCT02284867|645883|P2|COMPLETED|Overall Study||30
269011|NCT02284867|645884|P1|COMPLETED|Overall Study||30
269012|NCT02284867|645883|P2|STARTED|Overall Study||30
269013|NCT02284867|645884|P1|STARTED|Overall Study||30
269014|NCT02284854|645894|P2|NOT COMPLETED|Overall Study||0
269015|NCT02284854|645895|P1|NOT COMPLETED|Overall Study||5
269016|NCT02284854|645894|P2|COMPLETED|Overall Study||20
269017|NCT02284854|645895|P1|COMPLETED|Overall Study||18
269018|NCT02284854|645894|P2|STARTED|Overall Study||20
269019|NCT02284854|645895|P1|STARTED|Overall Study||23
269020|NCT02284828|645912|P1|NOT COMPLETED|Overall Study||4
269021|NCT02284828|645912|P1|COMPLETED|Overall Study||22
269022|NCT02284828|645912|P1|STARTED|Overall Study||26
269023|NCT02284555|645924|P1|NOT COMPLETED|Overall Study||0
269024|NCT02284555|645924|P1|COMPLETED|Overall Study||12
269025|NCT02284555|645924|P1|STARTED|Overall Study||12
269026|NCT02284516|645931|P2|NOT COMPLETED|Overall Study||36
269027|NCT02284516|645932|P1|NOT COMPLETED|Overall Study||38
269028|NCT02284516|645931|P2|COMPLETED|Overall Study||319
269029|NCT02284516|645932|P1|COMPLETED|Overall Study||318
269030|NCT02284516|645931|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
269031|NCT02284516|645932|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
269032|NCT02284516|645931|P2|STARTED|Overall Study||355
269033|NCT02284516|645932|P1|STARTED|Overall Study||356
269034|NCT02284386|645940|P1|NOT COMPLETED|Overall Study||0
269035|NCT02284386|645940|P1|COMPLETED|Overall Study||15
269036|NCT02284386|645940|P1|STARTED|Overall Study||15
269037|NCT02284347|645949|P1|NOT COMPLETED|Overall Study||3
269038|NCT02284347|645949|P1|COMPLETED|Overall Study||48
269039|NCT02284347|645949|P1|STARTED|Overall Study||51
269040|NCT02284243|645957|P2|NOT COMPLETED|Overall Study||3
269041|NCT02284243|645958|P1|NOT COMPLETED|Overall Study||4
269042|NCT02284243|645957|P2|COMPLETED|Overall Study||81
269043|NCT02284243|645958|P1|COMPLETED|Overall Study||80
269044|NCT02284243|645957|P2|STARTED|Overall Study||84
269045|NCT02284243|645958|P1|STARTED|Overall Study||84
269046|NCT02284165|645979|P3|NOT COMPLETED|Overall Study||0
269047|NCT02284165|645980|P2|NOT COMPLETED|Overall Study||0
269048|NCT02284165|645981|P1|NOT COMPLETED|Overall Study||0
269049|NCT02284165|645979|P3|COMPLETED|Overall Study||70996
269050|NCT02284165|645980|P2|COMPLETED|Overall Study||40272
269051|NCT02284165|645981|P1|COMPLETED|Overall Study||36448
269052|NCT02284165|645979|P3|STARTED|Overall Study||70996
269053|NCT02284165|645980|P2|STARTED|Overall Study||40272
269054|NCT02284165|645981|P1|STARTED|Overall Study||36448
269055|NCT02283840|646000|P3|NOT COMPLETED|Overall Study||0
269056|NCT02283840|646001|P2|NOT COMPLETED|Overall Study||1
269057|NCT02283840|646002|P1|NOT COMPLETED|Overall Study||0
269058|NCT02283840|646000|P3|COMPLETED|Overall Study||20
269059|NCT02283840|646001|P2|COMPLETED|Overall Study||19
269060|NCT02283840|646002|P1|COMPLETED|Overall Study||20
269061|NCT02283840|646000|P3|STARTED|Overall Study||20
269062|NCT02283840|646001|P2|STARTED|Overall Study||20
269063|NCT02283840|646002|P1|STARTED|Overall Study||20
269064|NCT02283827|646021|P2|NOT COMPLETED|Overall Study||3
269065|NCT02283827|646022|P1|NOT COMPLETED|Overall Study||1
269066|NCT02283827|646021|P2|COMPLETED|Overall Study||13
269067|NCT02283827|646022|P1|COMPLETED|Overall Study||15
269068|NCT02283827|646021|P2|STARTED|Overall Study||16
269069|NCT02283827|646022|P1|STARTED|Overall Study||16
269070|NCT02283814|646039|P2|NOT COMPLETED|Overall Study||2
269071|NCT02283814|646040|P1|NOT COMPLETED|Overall Study||3
269072|NCT02283814|646039|P2|COMPLETED|Overall Study||14
269073|NCT02283814|646040|P1|COMPLETED|Overall Study||13
269074|NCT02283814|646039|P2|STARTED|Overall Study||16
269075|NCT02283814|646040|P1|STARTED|Overall Study||16
269076|NCT02283788|646054|P4|NOT COMPLETED|Overall Study||2
269077|NCT02283788|646055|P3|NOT COMPLETED|Overall Study||5
269078|NCT02283788|646056|P2|NOT COMPLETED|Overall Study||4
269079|NCT02283788|646057|P1|NOT COMPLETED|Overall Study||1
269080|NCT02283788|646054|P4|COMPLETED|Overall Study||14
269081|NCT02283788|646055|P3|COMPLETED|Overall Study||12
269082|NCT02283788|646056|P2|COMPLETED|Overall Study||13
269083|NCT02283788|646057|P1|COMPLETED|Overall Study||16
269084|NCT02283788|646054|P4|STARTED|Overall Study||16
269085|NCT02283788|646055|P3|STARTED|Overall Study||17
269086|NCT02283788|646056|P2|STARTED|Overall Study||17
269087|NCT02283788|646057|P1|STARTED|Overall Study||17
269088|NCT02282982|646067|P1|NOT COMPLETED|Overall Study||206
269089|NCT02282982|646067|P1|COMPLETED|Overall Study||153
269090|NCT02282982|646067|P1|Attended Follow-up Visit|Overall Study||349
269091|NCT02282982|646067|P1|Attended Visit 5|Overall Study||83
269092|NCT02282982|646067|P1|Attended Visit 4|Overall Study||194
269093|NCT02282982|646067|P1|Attended Visit 3|Overall Study||298
269094|NCT02282982|646067|P1|Attended Visit 2|Overall Study||341
269095|NCT02282982|646067|P1|Attended Visit 1|Overall Study||359
269096|NCT02282982|646067|P1|STARTED|Overall Study||359
269097|NCT02282813|646085|P3|NOT COMPLETED|Overall Study||3
269098|NCT02282813|646086|P2|NOT COMPLETED|Overall Study||23
269099|NCT02282813|646087|P1|NOT COMPLETED|Overall Study||12
269100|NCT02282813|646085|P3|COMPLETED|Overall Study||39
269101|NCT02282813|646086|P2|COMPLETED|Overall Study||130
269102|NCT02282813|646087|P1|COMPLETED|Overall Study||91
269103|NCT02282813|646085|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
269104|NCT02282813|646086|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
269105|NCT02282813|646087|P1|STARTED|Overall Study|ITT Population|103
269106|NCT02282631|646106|P2|NOT COMPLETED|Overall Study||0
269107|NCT02282631|646107|P1|NOT COMPLETED|Overall Study||2
269108|NCT02282631|646106|P2|COMPLETED|Overall Study||15
269109|NCT02282631|646107|P1|COMPLETED|Overall Study||12
269110|NCT02282631|646106|P2|STARTED|Overall Study||15
269111|NCT02282631|646107|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
269112|NCT02282605|646148|P3|NOT COMPLETED|Overall Study||0
269113|NCT02282605|646149|P2|NOT COMPLETED|Overall Study||0
269114|NCT02282605|646150|P1|NOT COMPLETED|Overall Study||3
269115|NCT02282605|646148|P3|COMPLETED|Overall Study||24
269116|NCT02282605|646149|P2|COMPLETED|Overall Study||12
269117|NCT02282605|646150|P1|COMPLETED|Overall Study||24
269118|NCT02282605|646148|P3|STARTED|Overall Study||24
269119|NCT02282605|646149|P2|STARTED|Overall Study||12
269120|NCT02282605|646150|P1|STARTED|Overall Study||27
269121|NCT02282527|646172|P2|NOT COMPLETED|Overall Study||1
269122|NCT02282527|646173|P1|NOT COMPLETED|Overall Study||1
269123|NCT02282527|646172|P2|COMPLETED|Overall Study||15
269124|NCT02282527|646173|P1|COMPLETED|Overall Study||15
269125|NCT02282527|646172|P2|STARTED|Overall Study||16
269126|NCT02282527|646173|P1|STARTED|Overall Study||16
269127|NCT02281591|646187|P4|NOT COMPLETED|Overall Study||0
269128|NCT02281591|646188|P3|NOT COMPLETED|Overall Study||0
269129|NCT02281591|646189|P2|NOT COMPLETED|Overall Study||0
269130|NCT02281591|646190|P1|NOT COMPLETED|Overall Study||0
269131|NCT02281591|646187|P4|COMPLETED|Overall Study||8
269132|NCT02281591|646188|P3|COMPLETED|Overall Study||8
269133|NCT02281591|646189|P2|COMPLETED|Overall Study||8
269134|NCT02281591|646190|P1|COMPLETED|Overall Study||8
269135|NCT02281591|646187|P4|STARTED|Overall Study||8
269136|NCT02281591|646188|P3|STARTED|Overall Study||8
269137|NCT02281591|646189|P2|STARTED|Overall Study||8
269138|NCT02281591|646190|P1|STARTED|Overall Study||8
269139|NCT02281526|646214|P2|NOT COMPLETED|Overall Study||0
269140|NCT02281526|646215|P1|NOT COMPLETED|Overall Study||1
269141|NCT02281526|646214|P2|COMPLETED|Overall Study||8
269142|NCT02281526|646215|P1|COMPLETED|Overall Study||8
269143|NCT02281526|646214|P2|STARTED|Overall Study||8
269144|NCT02281526|646215|P1|STARTED|Overall Study||9
269145|NCT02281448|646225|P2|NOT COMPLETED|Overall Study||1
269146|NCT02281448|646226|P1|NOT COMPLETED|Overall Study||2
269147|NCT02281448|646225|P2|COMPLETED|Overall Study||9
269148|NCT02281448|646226|P1|COMPLETED|Overall Study||8
269149|NCT02281448|646225|P2|STARTED|Overall Study||10
269150|NCT02281448|646226|P1|STARTED|Overall Study||10
269151|NCT02281422|646239|P5|NOT COMPLETED|Overall Study||0
269152|NCT02281422|646240|P4|NOT COMPLETED|Overall Study||0
269153|NCT02281422|646241|P3|NOT COMPLETED|Overall Study||0
269154|NCT02281422|646242|P2|NOT COMPLETED|Overall Study||0
269155|NCT02281422|646243|P1|NOT COMPLETED|Overall Study||0
269156|NCT02281422|646239|P5|COMPLETED|Overall Study||8
269157|NCT02281422|646240|P4|COMPLETED|Overall Study||8
269158|NCT02281422|646241|P3|COMPLETED|Overall Study||8
269159|NCT02281422|646242|P2|COMPLETED|Overall Study||8
269160|NCT02281422|646243|P1|COMPLETED|Overall Study||8
269161|NCT02281422|646239|P5|STARTED|Overall Study||8
269162|NCT02281422|646240|P4|STARTED|Overall Study||8
269163|NCT02281422|646241|P3|STARTED|Overall Study||8
269164|NCT02281422|646242|P2|STARTED|Overall Study||8
269165|NCT02281422|646243|P1|STARTED|Overall Study||8
269166|NCT02281318|646267|P2|NOT COMPLETED|Overall Study||5
269167|NCT02281318|646268|P1|NOT COMPLETED|Overall Study||14
269168|NCT02281318|646267|P2|COMPLETED|Overall Study||269
269169|NCT02281318|646268|P1|COMPLETED|Overall Study||263
269170|NCT02281318|646267|P2|STARTED|Overall Study||274
269171|NCT02281318|646268|P1|STARTED|Overall Study||277
269172|NCT02281136|646280|P1|NOT COMPLETED|Overall Study||0
269173|NCT02281136|646280|P1|COMPLETED|Overall Study||29
269174|NCT02281136|646280|P1|STARTED|Overall Study||29
269175|NCT02280655|646314|P2|NOT COMPLETED|Overall Study||0
269176|NCT02280655|646315|P1|NOT COMPLETED|Overall Study||0
269177|NCT02280655|646314|P2|COMPLETED|Overall Study||18
269178|NCT02280655|646315|P1|COMPLETED|Overall Study||25
269179|NCT02280655|646314|P2|STARTED|Overall Study||18
269180|NCT02280655|646315|P1|STARTED|Overall Study||25
269181|NCT02280499|646323|P1|NOT COMPLETED|Overall Study||61
269182|NCT02280499|646323|P1|COMPLETED|Overall Study||26
269183|NCT02280499|646323|P1|STARTED|Overall Study||87
269184|NCT02280473|646331|P2|NOT COMPLETED|Overall Study||3
269185|NCT02280473|646332|P1|NOT COMPLETED|Overall Study||1
269186|NCT02280473|646331|P2|COMPLETED|Overall Study||91
269187|NCT02280473|646332|P1|COMPLETED|Overall Study||93
269188|NCT02280473|646331|P2|STARTED|Overall Study||94
269189|NCT02280473|646332|P1|STARTED|Overall Study||94
269190|NCT02280187|646346|P1|NOT COMPLETED|Overall Study||218
269191|NCT02280187|646346|P1|COMPLETED|Overall Study||182
269192|NCT02280187|646346|P1|STARTED|Overall Study||400
269193|NCT02280122|646364|P3|NOT COMPLETED|Overall Study||0
269194|NCT02280122|646365|P2|NOT COMPLETED|Overall Study||0
269195|NCT02280122|646366|P1|NOT COMPLETED|Overall Study||0
269196|NCT02280122|646364|P3|COMPLETED|Overall Study||30
269197|NCT02280122|646365|P2|COMPLETED|Overall Study||15
269198|NCT02280122|646366|P1|COMPLETED|Overall Study||15
269199|NCT02280122|646364|P3|STARTED|Overall Study||30
269200|NCT02280122|646365|P2|STARTED|Overall Study||15
269201|NCT02280122|646366|P1|STARTED|Overall Study||15
269202|NCT02279667|646375|P3|NOT COMPLETED|Overall Study||0
269203|NCT02279667|646376|P2|NOT COMPLETED|Overall Study||0
269204|NCT02279667|646377|P1|NOT COMPLETED|Overall Study||0
269205|NCT02279667|646375|P3|COMPLETED|Overall Study||6
269206|NCT02279667|646376|P2|COMPLETED|Overall Study||6
269207|NCT02279667|646377|P1|COMPLETED|Overall Study||6
269208|NCT02279667|646375|P3|STARTED|Overall Study||6
269209|NCT02279667|646376|P2|STARTED|Overall Study||6
269210|NCT02279667|646377|P1|STARTED|Overall Study||6
269211|NCT02279420|646395|P1|NOT COMPLETED|Overall Study||23
269212|NCT02279420|646395|P1|COMPLETED|Overall Study||50
269213|NCT02279420|646395|P1|STARTED|Overall Study||73
269214|NCT02279407|646403|P4|NOT COMPLETED|Overall Study||1
269215|NCT02279407|646404|P3|NOT COMPLETED|Overall Study||5
269216|NCT02279407|646405|P2|NOT COMPLETED|Overall Study||1
269217|NCT02279407|646406|P1|NOT COMPLETED|Overall Study||2
269218|NCT02279407|646403|P4|COMPLETED|Overall Study||20
269219|NCT02279407|646404|P3|COMPLETED|Overall Study||15
269220|NCT02279407|646405|P2|COMPLETED|Overall Study||20
269221|NCT02279407|646406|P1|COMPLETED|Overall Study||20
269222|NCT02279407|646403|P4|STARTED|Overall Study||21
269223|NCT02279407|646404|P3|STARTED|Overall Study||20
269224|NCT02279407|646405|P2|STARTED|Overall Study||21
269225|NCT02279407|646406|P1|STARTED|Overall Study||22
269226|NCT02278783|646417|P1|NOT COMPLETED|Overall Study||0
269227|NCT02278783|646417|P1|COMPLETED|Overall Study||1
269228|NCT02278783|646417|P1|STARTED|Overall Study||1
269229|NCT02278640|646424|P1|NOT COMPLETED|Overall Study||0
269230|NCT02278640|646424|P1|COMPLETED|Overall Study||40
269231|NCT02278640|646424|P1|STARTED|Overall Study||40
269232|NCT02278614|646433|P2|NOT COMPLETED|Overall Study||5
269233|NCT02278614|646434|P1|NOT COMPLETED|Overall Study||5
269234|NCT02278614|646433|P2|COMPLETED|Overall Study||110
269235|NCT02278614|646434|P1|COMPLETED|Overall Study||122
269236|NCT02278614|646433|P2|STARTED|Overall Study||115
269237|NCT02278614|646434|P1|STARTED|Overall Study||127
269238|NCT02278484|646440|P1|NOT COMPLETED|Overall Study||0
269239|NCT02278484|646440|P1|COMPLETED|Overall Study||50
269240|NCT02278484|646440|P1|STARTED|Overall Study||50
269241|NCT02278146|646449|P2|NOT COMPLETED|Overall Study||2
269242|NCT02278146|646450|P1|NOT COMPLETED|Overall Study||0
269243|NCT02278146|646449|P2|COMPLETED|Overall Study||8
269244|NCT02278146|646450|P1|COMPLETED|Overall Study||6
269245|NCT02278146|646449|P2|STARTED|Overall Study||10
269246|NCT02278146|646450|P1|STARTED|Overall Study||6
269247|NCT02277626|646460|P2|NOT COMPLETED|Overall Study||0
269248|NCT02277626|646461|P1|NOT COMPLETED|Overall Study||0
269249|NCT02277626|646460|P2|COMPLETED|Overall Study||9
269250|NCT02277626|646461|P1|COMPLETED|Overall Study||6
269251|NCT02277626|646460|P2|STARTED|Overall Study||9
269252|NCT02277626|646461|P1|STARTED|Overall Study||6
269253|NCT02277249|646477|P2|NOT COMPLETED|Overall Study||0
269254|NCT02277249|646478|P1|NOT COMPLETED|Overall Study||0
269255|NCT02277249|646477|P2|COMPLETED|Overall Study||30
269256|NCT02277249|646478|P1|COMPLETED|Overall Study||30
269257|NCT02277249|646477|P2|STARTED|Overall Study||30
269258|NCT02277249|646478|P1|STARTED|Overall Study||30
269259|NCT02277119|646487|P3|NOT COMPLETED|Overall Study||8
269260|NCT02277119|646488|P2|NOT COMPLETED|Overall Study||4
269261|NCT02277119|646489|P1|NOT COMPLETED|Overall Study||3
269262|NCT02277119|646487|P3|COMPLETED|Overall Study||19
269263|NCT02277119|646488|P2|COMPLETED|Overall Study||20
269264|NCT02277119|646489|P1|COMPLETED|Overall Study||55
269265|NCT02277119|646487|P3|STARTED|Overall Study||27
269266|NCT02277119|646488|P2|STARTED|Overall Study||24
269267|NCT02277119|646489|P1|STARTED|Overall Study||58
269268|NCT02277093|646506|P1|NOT COMPLETED|Overall Study||0
269269|NCT02277093|646506|P1|COMPLETED|Overall Study||11
269270|NCT02277093|646506|P1|STARTED|Overall Study||11
269271|NCT02276560|646517|P3|NOT COMPLETED|Overall Study||0
269272|NCT02276560|646518|P2|NOT COMPLETED|Overall Study||0
269273|NCT02276560|646519|P1|NOT COMPLETED|Overall Study||1
269274|NCT02276560|646517|P3|COMPLETED|Overall Study||0
269275|NCT02276560|646518|P2|COMPLETED|Overall Study||0
269276|NCT02276560|646519|P1|COMPLETED|Overall Study||0
269277|NCT02276560|646517|P3|STARTED|Overall Study||0
269278|NCT02276560|646518|P2|STARTED|Overall Study||0
269279|NCT02276560|646519|P1|STARTED|Overall Study||1
269280|NCT02276274|646529|P2|NOT COMPLETED|Second Intervention Period||0
269281|NCT02276274|646530|P1|NOT COMPLETED|Second Intervention Period||0
269282|NCT02276274|646529|P2|COMPLETED|Second Intervention Period||6
269283|NCT02276274|646530|P1|COMPLETED|Second Intervention Period||6
269284|NCT02276274|646529|P2|STARTED|Second Intervention Period||6
269285|NCT02276274|646530|P1|STARTED|Second Intervention Period||6
269286|NCT02276274|646529|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
269287|NCT02276274|646530|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
269288|NCT02276274|646529|P2|COMPLETED|Washout Period (at Least 15 Days)||6
269289|NCT02276274|646530|P1|COMPLETED|Washout Period (at Least 15 Days)||6
269290|NCT02276274|646529|P2|STARTED|Washout Period (at Least 15 Days)||6
269291|NCT02276274|646530|P1|STARTED|Washout Period (at Least 15 Days)||6
269292|NCT02276274|646529|P2|NOT COMPLETED|First Intervention Period||0
269293|NCT02276274|646530|P1|NOT COMPLETED|First Intervention Period||0
269294|NCT02276274|646529|P2|COMPLETED|First Intervention Period||6
269295|NCT02276274|646530|P1|COMPLETED|First Intervention Period||6
269296|NCT02276274|646529|P2|STARTED|First Intervention Period||6
269297|NCT02276274|646530|P1|STARTED|First Intervention Period||6
269298|NCT02275767|646641|P3|NOT COMPLETED|Overall Study||3
269299|NCT02275767|646642|P2|NOT COMPLETED|Overall Study||4
269300|NCT02275767|646643|P1|NOT COMPLETED|Overall Study||2
269301|NCT02275767|646641|P3|COMPLETED|Overall Study||19
269302|NCT02275767|646642|P2|COMPLETED|Overall Study||18
269303|NCT02275767|646643|P1|COMPLETED|Overall Study||20
269304|NCT02275767|646641|P3|STARTED|Overall Study||22
269305|NCT02275767|646642|P2|STARTED|Overall Study||22
269306|NCT02275767|646643|P1|STARTED|Overall Study||22
269307|NCT02275611|646658|P4|NOT COMPLETED|Outpatient Drinking||0
269308|NCT02275611|646659|P3|NOT COMPLETED|Outpatient Drinking||0
269309|NCT02275611|646660|P2|NOT COMPLETED|Outpatient Drinking||0
269310|NCT02275611|646661|P1|NOT COMPLETED|Outpatient Drinking||0
269311|NCT02275611|646658|P4|COMPLETED|Outpatient Drinking||3
269312|NCT02275611|646659|P3|COMPLETED|Outpatient Drinking||6
269313|NCT02275611|646660|P2|COMPLETED|Outpatient Drinking||0
269314|NCT02275611|646661|P1|COMPLETED|Outpatient Drinking||0
269315|NCT02275611|646658|P4|STARTED|Outpatient Drinking||3
269316|NCT02275611|646659|P3|STARTED|Outpatient Drinking||6
269317|NCT02275611|646660|P2|STARTED|Outpatient Drinking||0
269318|NCT02275611|646661|P1|STARTED|Outpatient Drinking||0
269319|NCT02275611|646658|P4|NOT COMPLETED|Inpatient Withdrawal||0
269320|NCT02275611|646659|P3|NOT COMPLETED|Inpatient Withdrawal||0
269321|NCT02275611|646660|P2|NOT COMPLETED|Inpatient Withdrawal||0
269322|NCT02275611|646661|P1|NOT COMPLETED|Inpatient Withdrawal||1
269323|NCT02275611|646658|P4|COMPLETED|Inpatient Withdrawal||0
269324|NCT02275611|646659|P3|COMPLETED|Inpatient Withdrawal||0
269325|NCT02275611|646660|P2|COMPLETED|Inpatient Withdrawal||4
269326|NCT02275611|646661|P1|COMPLETED|Inpatient Withdrawal||4
269327|NCT02275611|646658|P4|STARTED|Inpatient Withdrawal||0
269328|NCT02275611|646659|P3|STARTED|Inpatient Withdrawal||0
269329|NCT02275611|646660|P2|STARTED|Inpatient Withdrawal||4
269330|NCT02275611|646661|P1|STARTED|Inpatient Withdrawal||5
269331|NCT02275546|646673|P2|NOT COMPLETED|Treatment Period 2||2
269332|NCT02275546|646674|P1|NOT COMPLETED|Treatment Period 2||2
269333|NCT02275546|646673|P2|COMPLETED|Treatment Period 2||81
269334|NCT02275546|646674|P1|COMPLETED|Treatment Period 2||79
269335|NCT02275546|646673|P2|STARTED|Treatment Period 2||83
269336|NCT02275546|646674|P1|STARTED|Treatment Period 2||81
269337|NCT02275546|646673|P2|NOT COMPLETED|Treatment Period 1||0
269338|NCT02275546|646674|P1|NOT COMPLETED|Treatment Period 1||0
269339|NCT02275546|646673|P2|COMPLETED|Treatment Period 1||83
269340|NCT02275546|646674|P1|COMPLETED|Treatment Period 1||81
269341|NCT02275546|646673|P2|STARTED|Treatment Period 1||83
269342|NCT02275546|646674|P1|STARTED|Treatment Period 1||81
269343|NCT02275364|646682|P2|NOT COMPLETED|Period 4||0
269344|NCT02275364|646683|P1|NOT COMPLETED|Period 4||0
269345|NCT02275364|646682|P2|COMPLETED|Period 4||14
269346|NCT02275364|646683|P1|COMPLETED|Period 4||12
269347|NCT02275364|646682|P2|STARTED|Period 4||14
269348|NCT02275364|646683|P1|STARTED|Period 4||12
269349|NCT02275364|646682|P2|NOT COMPLETED|Period 3||0
269350|NCT02275364|646683|P1|NOT COMPLETED|Period 3||0
269351|NCT02275364|646682|P2|COMPLETED|Period 3||14
269352|NCT02275364|646683|P1|COMPLETED|Period 3||12
269353|NCT02275364|646682|P2|STARTED|Period 3||14
269354|NCT02275364|646683|P1|STARTED|Period 3||12
269355|NCT02275364|646682|P2|NOT COMPLETED|Washout Period 2||0
269356|NCT02275364|646683|P1|NOT COMPLETED|Washout Period 2||0
269357|NCT02275364|646682|P2|COMPLETED|Washout Period 2||14
269358|NCT02275364|646683|P1|COMPLETED|Washout Period 2||12
269359|NCT02275364|646682|P2|STARTED|Washout Period 2||14
269360|NCT02275364|646683|P1|STARTED|Washout Period 2||12
269361|NCT02275364|646682|P2|NOT COMPLETED|Period 2||0
269362|NCT02275364|646683|P1|NOT COMPLETED|Period 2||0
269363|NCT02275364|646682|P2|COMPLETED|Period 2||14
269364|NCT02275364|646683|P1|COMPLETED|Period 2||12
269365|NCT02275364|646682|P2|STARTED|Period 2||14
269366|NCT02275364|646683|P1|STARTED|Period 2||12
269367|NCT02275364|646682|P2|NOT COMPLETED|Washout Period 1||0
269368|NCT02275364|646683|P1|NOT COMPLETED|Washout Period 1||0
269369|NCT02275364|646682|P2|COMPLETED|Washout Period 1||14
269370|NCT02275364|646683|P1|COMPLETED|Washout Period 1||12
269371|NCT02275364|646682|P2|STARTED|Washout Period 1||14
269372|NCT02275364|646683|P1|STARTED|Washout Period 1||12
269373|NCT02275364|646682|P2|NOT COMPLETED|Period 1||0
269374|NCT02275364|646683|P1|NOT COMPLETED|Period 1||2
269375|NCT02275364|646682|P2|COMPLETED|Period 1||14
269376|NCT02275364|646683|P1|COMPLETED|Period 1||12
269377|NCT02275364|646682|P2|STARTED|Period 1||14
269378|NCT02275364|646683|P1|STARTED|Period 1||14
269379|NCT02275156|646715|P3|NOT COMPLETED|Overall Study||0
269380|NCT02275156|646716|P2|NOT COMPLETED|Overall Study||0
269381|NCT02275156|646717|P1|NOT COMPLETED|Overall Study||0
269382|NCT02275156|646715|P3|COMPLETED|Overall Study||6
269383|NCT02275156|646716|P2|COMPLETED|Overall Study||6
269384|NCT02275156|646717|P1|COMPLETED|Overall Study||6
269385|NCT02275156|646715|P3|STARTED|Overall Study||6
269386|NCT02275156|646716|P2|STARTED|Overall Study||6
269387|NCT02275156|646717|P1|STARTED|Overall Study||6
269388|NCT02275052|646744|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
269389|NCT02275052|646745|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
269390|NCT02275052|646746|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
269391|NCT02275052|646747|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
269392|NCT02275052|646744|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
269393|NCT02275052|646745|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
269394|NCT02275052|646746|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
269395|NCT02275052|646747|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
269396|NCT02275052|646744|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
269397|NCT02275052|646745|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
269398|NCT02275052|646746|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
269399|NCT02275052|646747|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
269400|NCT02275052|646744|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
269401|NCT02275052|646745|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
269402|NCT02275052|646746|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
269403|NCT02275052|646747|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
269404|NCT02275052|646744|P4|COMPLETED|Washout Period (12-17 Days)||0
269405|NCT02275052|646745|P3|COMPLETED|Washout Period (12-17 Days)||0
269406|NCT02275052|646746|P2|COMPLETED|Washout Period (12-17 Days)||93
269407|NCT02275052|646747|P1|COMPLETED|Washout Period (12-17 Days)||86
269408|NCT02275052|646744|P4|STARTED|Washout Period (12-17 Days)||0
269409|NCT02275052|646745|P3|STARTED|Washout Period (12-17 Days)||0
269410|NCT02275052|646746|P2|STARTED|Washout Period (12-17 Days)||93
269411|NCT02275052|646747|P1|STARTED|Washout Period (12-17 Days)||90
269412|NCT02275052|646744|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
269413|NCT02275052|646745|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
269414|NCT02275052|646746|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
269415|NCT02275052|646747|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
269416|NCT02275052|646744|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
269417|NCT02275052|646745|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
269418|NCT02275052|646746|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
269419|NCT02275052|646747|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
269420|NCT02275052|646744|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
269421|NCT02275052|646745|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
269422|NCT02275052|646746|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
269423|NCT02275052|646747|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
269424|NCT02274948|646761|P2|NOT COMPLETED|Overall Study||91
269425|NCT02274948|646762|P1|NOT COMPLETED|Overall Study||98
269426|NCT02274948|646761|P2|COMPLETED|Overall Study||82
269427|NCT02274948|646762|P1|COMPLETED|Overall Study||68
269428|NCT02274948|646761|P2|STARTED|Overall Study||173
269429|NCT02274948|646762|P1|STARTED|Overall Study||166
269430|NCT02274792|646776|P1|NOT COMPLETED|Overall Study||25
269431|NCT02274792|646776|P1|COMPLETED|Overall Study||107
269432|NCT02274792|646776|P1|Received Treatment|Overall Study||131
269433|NCT02274792|646776|P1|STARTED|Overall Study||132
269434|NCT02274675|646784|P1|NOT COMPLETED|Overall Study||0
269435|NCT02274675|646784|P1|COMPLETED|Overall Study||7
269436|NCT02274675|646784|P1|STARTED|Overall Study||7
269437|NCT02273908|646796|P2|NOT COMPLETED|Overall Study||5
269438|NCT02273908|646797|P1|NOT COMPLETED|Overall Study||33
269439|NCT02273908|646796|P2|COMPLETED|Overall Study||169
269440|NCT02273908|646797|P1|COMPLETED|Overall Study||124
269441|NCT02273908|646796|P2|STARTED|Overall Study||174
269442|NCT02273908|646797|P1|STARTED|Overall Study||157
269443|NCT02273752|646819|P1|NOT COMPLETED|Overall Study||2
269444|NCT02273752|646819|P1|COMPLETED|Overall Study||0
269445|NCT02273752|646819|P1|STARTED|Overall Study||2
269446|NCT02273323|646830|P2|NOT COMPLETED|Overall Study||0
269447|NCT02273323|646831|P1|NOT COMPLETED|Overall Study||0
269448|NCT02273323|646830|P2|COMPLETED|Overall Study||15
269449|NCT02273323|646831|P1|COMPLETED|Overall Study||15
269450|NCT02273323|646830|P2|STARTED|Overall Study||15
269451|NCT02273323|646831|P1|STARTED|Overall Study||15
269452|NCT02273310|646849|P2|NOT COMPLETED|Overall Study||3
269453|NCT02273310|646850|P1|NOT COMPLETED|Overall Study||18
269454|NCT02273310|646849|P2|COMPLETED|Overall Study||38
269455|NCT02273310|646850|P1|COMPLETED|Overall Study||24
269456|NCT02273310|646849|P2|STARTED|Overall Study||41
269457|NCT02273310|646850|P1|STARTED|Overall Study||42
269458|NCT02273167|646864|P3|NOT COMPLETED|Overall Study||21
269459|NCT02273167|646865|P2|NOT COMPLETED|Overall Study||23
269460|NCT02273167|646866|P1|NOT COMPLETED|Overall Study||24
269461|NCT02273167|646864|P3|COMPLETED|Overall Study||262
269462|NCT02273167|646865|P2|COMPLETED|Overall Study||260
269463|NCT02273167|646866|P1|COMPLETED|Overall Study||259
269464|NCT02273167|646864|P3|STARTED|Overall Study||283
269465|NCT02273167|646865|P2|STARTED|Overall Study||283
269466|NCT02273167|646866|P1|STARTED|Overall Study||283
269467|NCT02273141|646891|P2|NOT COMPLETED|Overall Study||25
269468|NCT02273141|646892|P1|NOT COMPLETED|Overall Study||17
269469|NCT02273141|646891|P2|COMPLETED|Overall Study||233
269470|NCT02273141|646892|P1|COMPLETED|Overall Study||240
269471|NCT02273141|646891|P2|STARTED|Overall Study||258
269472|NCT02273141|646892|P1|STARTED|Overall Study||257
269473|NCT02273115|646912|P4|NOT COMPLETED|Overall Study||1
269474|NCT02273115|646913|P3|NOT COMPLETED|Overall Study||0
269475|NCT02273115|646914|P2|NOT COMPLETED|Overall Study||0
269476|NCT02273115|646915|P1|NOT COMPLETED|Overall Study||0
269477|NCT02273115|646912|P4|COMPLETED|Overall Study||71
269478|NCT02273115|646913|P3|COMPLETED|Overall Study||67
269479|NCT02273115|646914|P2|COMPLETED|Overall Study||90
269480|NCT02273115|646915|P1|COMPLETED|Overall Study||94
269481|NCT02273115|646912|P4|STARTED|Overall Study||72
269482|NCT02273115|646913|P3|STARTED|Overall Study||67
269483|NCT02273115|646914|P2|STARTED|Overall Study||90
269484|NCT02273115|646915|P1|STARTED|Overall Study||94
269485|NCT02272725|646959|P2|NOT COMPLETED|Overall Study||0
269486|NCT02272725|646960|P1|NOT COMPLETED|Overall Study||2
269487|NCT02272725|646959|P2|COMPLETED|Overall Study||42
269488|NCT02272725|646960|P1|COMPLETED|Overall Study||47
269489|NCT02272725|646959|P2|STARTED|Overall Study||42
269490|NCT02272725|646960|P1|STARTED|Overall Study||49
269491|NCT02271854|646970|P1|NOT COMPLETED|Overall Study||4
269492|NCT02271854|646970|P1|COMPLETED|Overall Study||98
269493|NCT02271854|646970|P1|STARTED|Overall Study||102
269494|NCT02271698|646981|P4|NOT COMPLETED|Overall Study||0
269495|NCT02271698|646982|P3|NOT COMPLETED|Overall Study||0
269496|NCT02271698|646983|P2|NOT COMPLETED|Overall Study||0
269497|NCT02271698|646984|P1|NOT COMPLETED|Overall Study||0
269498|NCT02271698|646981|P4|COMPLETED|Overall Study||11
269499|NCT02271698|646982|P3|COMPLETED|Overall Study||10
269500|NCT02271698|646983|P2|COMPLETED|Overall Study||10
269501|NCT02271698|646984|P1|COMPLETED|Overall Study||11
269502|NCT02271698|646981|P4|STARTED|Overall Study||11
269503|NCT02271698|646982|P3|STARTED|Overall Study||10
269504|NCT02271698|646983|P2|STARTED|Overall Study||10
269505|NCT02271698|646984|P1|STARTED|Overall Study||11
269506|NCT02271529|646998|P1|NOT COMPLETED|Overall Study||1
269507|NCT02271529|646998|P1|COMPLETED|Overall Study||39
269508|NCT02271529|646998|P1|STARTED|Overall Study||40
269509|NCT02271477|647004|P2|NOT COMPLETED|Overall Study||0
269510|NCT02271477|647005|P1|NOT COMPLETED|Overall Study||0
269511|NCT02271477|647004|P2|COMPLETED|Overall Study||80
269512|NCT02271477|647005|P1|COMPLETED|Overall Study||80
269513|NCT02271477|647004|P2|STARTED|Overall Study||80
269514|NCT02271477|647005|P1|STARTED|Overall Study||80
269515|NCT02270684|647019|P2|NOT COMPLETED|Overall Study||3
269516|NCT02270684|647020|P1|NOT COMPLETED|Overall Study||1
269517|NCT02270684|647019|P2|COMPLETED|Overall Study||0
269518|NCT02270684|647020|P1|COMPLETED|Overall Study||0
269519|NCT02270684|647019|P2|STARTED|Overall Study||3
269520|NCT02270684|647020|P1|STARTED|Overall Study||1
269521|NCT02270515|647026|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
269522|NCT02270515|647026|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
269523|NCT02270515|647026|P1|STARTED|Intervention Period 3: 12-18 Months||127
269524|NCT02270515|647026|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
269525|NCT02270515|647026|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
269526|NCT02270515|647026|P1|STARTED|Intervention Period 2: 6-12 Months||159
269527|NCT02270515|647026|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
269528|NCT02270515|647026|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
269529|NCT02270515|647026|P1|STARTED|Intervention Period 1: 0-6 Months||175
269530|NCT02269657|647041|P1|NOT COMPLETED|Overall Study||3
269531|NCT02269657|647041|P1|COMPLETED|Overall Study||37
269532|NCT02269657|647041|P1|STARTED|Overall Study||40
269533|NCT02269488|647055|P1|NOT COMPLETED|Overall Study||0
269534|NCT02269488|647055|P1|COMPLETED|Overall Study||100
269535|NCT02269488|647055|P1|STARTED|Overall Study||100
269536|NCT02269475|647061|P2|NOT COMPLETED|Overall Study||1
269537|NCT02269475|647062|P1|NOT COMPLETED|Overall Study||3
269538|NCT02269475|647061|P2|COMPLETED|Overall Study||432
269539|NCT02269475|647062|P1|COMPLETED|Overall Study||865
269540|NCT02269475|647061|P2|Per Protocol Population|Overall Study||430
269541|NCT02269475|647062|P1|Per Protocol Population|Overall Study||849
269542|NCT02269475|647061|P2|Received IP (Safety Population)|Overall Study||433
269543|NCT02269475|647062|P1|Received IP (Safety Population)|Overall Study||868
269544|NCT02269475|647061|P2|STARTED|Overall Study||433
269545|NCT02269475|647062|P1|STARTED|Overall Study||868
269546|NCT02269098|647075|P2|NOT COMPLETED|Overall Study||9
269547|NCT02269098|647076|P1|NOT COMPLETED|Overall Study||14
269548|NCT02269098|647075|P2|COMPLETED|Overall Study||41
269549|NCT02269098|647076|P1|COMPLETED|Overall Study||37
269550|NCT02269098|647075|P2|STARTED|Overall Study||50
269551|NCT02269098|647076|P1|STARTED|Overall Study||51
269552|NCT02268877|647092|P2|NOT COMPLETED|Overall Study||5
269553|NCT02268877|647093|P1|NOT COMPLETED|Overall Study||4
269554|NCT02268877|647092|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
269555|NCT02268877|647093|P1|COMPLETED|Overall Study||118
269556|NCT02268877|647092|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
269557|NCT02268877|647093|P1|STARTED|Overall Study||122
269558|NCT02268864|647104|P3|NOT COMPLETED|Overall Study||0
269559|NCT02268864|647105|P2|NOT COMPLETED|Overall Study||1
269560|NCT02268864|647106|P1|NOT COMPLETED|Overall Study||2
269561|NCT02268864|647104|P3|COMPLETED|Overall Study||64
269562|NCT02268864|647105|P2|COMPLETED|Overall Study||24
269563|NCT02268864|647106|P1|COMPLETED|Overall Study||15
269564|NCT02268864|647104|P3|STARTED|Overall Study||64
269565|NCT02268864|647105|P2|STARTED|Overall Study||25
269566|NCT02268864|647106|P1|STARTED|Overall Study||17
269567|NCT02268396|647128|P1|NOT COMPLETED|Overall Study||12
269568|NCT02268396|647128|P1|COMPLETED|Overall Study||126
269569|NCT02268396|647128|P1|STARTED|Overall Study||138
269570|NCT02268058|647141|P4|NOT COMPLETED|Overall Study||0
269571|NCT02268058|647142|P3|NOT COMPLETED|Overall Study||0
269572|NCT02268058|647143|P2|NOT COMPLETED|Overall Study||0
269573|NCT02268058|647144|P1|NOT COMPLETED|Overall Study||1
269574|NCT02268058|647141|P4|COMPLETED|Overall Study||20
269575|NCT02268058|647142|P3|COMPLETED|Overall Study||20
269576|NCT02268058|647143|P2|COMPLETED|Overall Study||20
269577|NCT02268058|647144|P1|COMPLETED|Overall Study||19
269578|NCT02268058|647141|P4|STARTED|Overall Study||20
269579|NCT02268058|647142|P3|STARTED|Overall Study||20
269580|NCT02268058|647143|P2|STARTED|Overall Study||20
269581|NCT02268058|647144|P1|STARTED|Overall Study||20
269582|NCT02267837|647168|P2|NOT COMPLETED|Overall Study||0
269583|NCT02267837|647169|P1|NOT COMPLETED|Overall Study||0
269584|NCT02267837|647168|P2|COMPLETED|Overall Study||9
269585|NCT02267837|647169|P1|COMPLETED|Overall Study||11
269586|NCT02267837|647168|P2|STARTED|Overall Study||9
269587|NCT02267837|647169|P1|STARTED|Overall Study||11
269588|NCT02267824|647177|P2|NOT COMPLETED|Overall Study||1
269589|NCT02267824|647178|P1|NOT COMPLETED|Overall Study||10
269590|NCT02267824|647177|P2|COMPLETED|Overall Study||17
269591|NCT02267824|647178|P1|COMPLETED|Overall Study||73
269592|NCT02267824|647177|P2|STARTED|Overall Study||18
269593|NCT02267824|647178|P1|STARTED|Overall Study||83
269594|NCT02267629|647184|P1|NOT COMPLETED|Overall Study||0
269595|NCT02267629|647184|P1|COMPLETED|Overall Study||7
269596|NCT02267629|647184|P1|STARTED|Overall Study||7
269597|NCT02266797|647191|P2|NOT COMPLETED|Overall Study||1
269598|NCT02266797|647192|P1|NOT COMPLETED|Overall Study||0
269599|NCT02266797|647191|P2|COMPLETED|Overall Study||2
269600|NCT02266797|647192|P1|COMPLETED|Overall Study||1
269601|NCT02266797|647191|P2|STARTED|Overall Study||3
269602|NCT02266797|647192|P1|STARTED|Overall Study||1
269603|NCT02266472|647210|P2|NOT COMPLETED|Period 2+ Washout||0
269604|NCT02266472|647211|P1|NOT COMPLETED|Period 2+ Washout||0
269605|NCT02266472|647210|P2|COMPLETED|Period 2+ Washout||15
269606|NCT02266472|647211|P1|COMPLETED|Period 2+ Washout||15
269607|NCT02266472|647210|P2|STARTED|Period 2+ Washout||15
269608|NCT02266472|647211|P1|STARTED|Period 2+ Washout||15
269609|NCT02266472|647210|P2|NOT COMPLETED|Period 1+ Washout||0
269610|NCT02266472|647211|P1|NOT COMPLETED|Period 1+ Washout||0
269611|NCT02266472|647210|P2|COMPLETED|Period 1+ Washout||15
269612|NCT02266472|647211|P1|COMPLETED|Period 1+ Washout||15
269613|NCT02266472|647210|P2|STARTED|Period 1+ Washout||15
269614|NCT02266472|647211|P1|STARTED|Period 1+ Washout||15
269615|NCT02266381|647230|P3|NOT COMPLETED|Overall Study||4
269616|NCT02266381|647231|P2|NOT COMPLETED|Overall Study||5
269617|NCT02266381|647232|P1|NOT COMPLETED|Overall Study||3
269618|NCT02266381|647230|P3|COMPLETED|Overall Study||146
269619|NCT02266381|647231|P2|COMPLETED|Overall Study||145
269620|NCT02266381|647232|P1|COMPLETED|Overall Study||147
269621|NCT02266381|647230|P3|STARTED|Overall Study||150
269622|NCT02266381|647231|P2|STARTED|Overall Study||150
269623|NCT02266381|647232|P1|STARTED|Overall Study||150
269624|NCT02266277|647255|P6|NOT COMPLETED|Overall Study||0
269625|NCT02266277|647256|P5|NOT COMPLETED|Overall Study||0
269626|NCT02266277|647257|P4|NOT COMPLETED|Overall Study||0
269627|NCT02266277|647258|P3|NOT COMPLETED|Overall Study||0
269628|NCT02266277|647259|P2|NOT COMPLETED|Overall Study||0
269629|NCT02266277|647260|P1|NOT COMPLETED|Overall Study||0
269630|NCT02266277|647255|P6|COMPLETED|Overall Study||5000
269631|NCT02266277|647256|P5|COMPLETED|Overall Study||5000
269632|NCT02266277|647257|P4|COMPLETED|Overall Study||5000
269633|NCT02266277|647258|P3|COMPLETED|Overall Study||5000
269634|NCT02266277|647259|P2|COMPLETED|Overall Study||5000
269635|NCT02266277|647260|P1|COMPLETED|Overall Study||5000
269636|NCT02266277|647255|P6|STARTED|Overall Study||5000
269637|NCT02266277|647256|P5|STARTED|Overall Study||5000
269638|NCT02266277|647257|P4|STARTED|Overall Study||5000
269639|NCT02266277|647258|P3|STARTED|Overall Study||5000
269640|NCT02266277|647259|P2|STARTED|Overall Study||5000
269641|NCT02266277|647260|P1|STARTED|Overall Study||5000
269642|NCT02265848|647284|P2|NOT COMPLETED|Overall Study||0
269643|NCT02265848|647285|P1|NOT COMPLETED|Overall Study||0
269644|NCT02265848|647284|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
269645|NCT02265848|647285|P1|COMPLETED|Overall Study||11
269646|NCT02265848|647284|P2|STARTED|Overall Study||11
269647|NCT02265848|647285|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
269648|NCT02265783|647297|P1|NOT COMPLETED|Overall Study||0
269649|NCT02265783|647297|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
269650|NCT02265783|647297|P1|STARTED|Overall Study||20
269651|NCT02264821|647304|P3|NOT COMPLETED|Overall Study||6
269652|NCT02264821|647305|P2|NOT COMPLETED|Overall Study||3
269653|NCT02264821|647306|P1|NOT COMPLETED|Overall Study||1
269654|NCT02264821|647304|P3|COMPLETED|Overall Study||58
269655|NCT02264821|647305|P2|COMPLETED|Overall Study||61
269656|NCT02264821|647306|P1|COMPLETED|Overall Study||63
269657|NCT02264821|647304|P3|STARTED|Overall Study|Double Blind|64
269658|NCT02264821|647305|P2|STARTED|Overall Study|Double Blind|64
269659|NCT02264821|647306|P1|STARTED|Overall Study|Double Blind|64
269660|NCT02264249|647320|P3|NOT COMPLETED|Overall Study||0
269661|NCT02264249|647321|P2|NOT COMPLETED|Overall Study||0
269662|NCT02264249|647322|P1|NOT COMPLETED|Overall Study||0
269663|NCT02264249|647320|P3|COMPLETED|Overall Study||241
269664|NCT02264249|647321|P2|COMPLETED|Overall Study||187
269665|NCT02264249|647322|P1|COMPLETED|Overall Study||21
269666|NCT02264249|647320|P3|STARTED|Overall Study||241
269667|NCT02264249|647321|P2|STARTED|Overall Study||187
269668|NCT02264249|647322|P1|STARTED|Overall Study||21
269669|NCT02263911|647336|P4|NOT COMPLETED|Period 5||0
269670|NCT02263911|647337|P3|NOT COMPLETED|Period 5||0
269671|NCT02263911|647338|P2|NOT COMPLETED|Period 5||0
269672|NCT02263911|647339|P1|NOT COMPLETED|Period 5||0
269673|NCT02263911|647336|P4|COMPLETED|Period 5||4
269674|NCT02263911|647337|P3|COMPLETED|Period 5||4
269675|NCT02263911|647338|P2|COMPLETED|Period 5||4
269676|NCT02263911|647339|P1|COMPLETED|Period 5||4
269677|NCT02263911|647336|P4|STARTED|Period 5||4
269678|NCT02263911|647337|P3|STARTED|Period 5||4
269679|NCT02263911|647338|P2|STARTED|Period 5||4
269680|NCT02263911|647339|P1|STARTED|Period 5||4
269681|NCT02263911|647336|P4|NOT COMPLETED|Period 4 Washout||0
269682|NCT02263911|647337|P3|NOT COMPLETED|Period 4 Washout||0
269683|NCT02263911|647338|P2|NOT COMPLETED|Period 4 Washout||0
269684|NCT02263911|647339|P1|NOT COMPLETED|Period 4 Washout||0
269685|NCT02263911|647336|P4|COMPLETED|Period 4 Washout||4
269686|NCT02263911|647337|P3|COMPLETED|Period 4 Washout||4
269687|NCT02263911|647338|P2|COMPLETED|Period 4 Washout||4
269688|NCT02263911|647339|P1|COMPLETED|Period 4 Washout||4
269689|NCT02263911|647336|P4|STARTED|Period 4 Washout||4
269690|NCT02263911|647337|P3|STARTED|Period 4 Washout||4
269691|NCT02263911|647338|P2|STARTED|Period 4 Washout||4
269692|NCT02263911|647339|P1|STARTED|Period 4 Washout||4
269693|NCT02263911|647336|P4|NOT COMPLETED|Period 4||0
269694|NCT02263911|647337|P3|NOT COMPLETED|Period 4||0
269695|NCT02263911|647338|P2|NOT COMPLETED|Period 4||0
269696|NCT02263911|647339|P1|NOT COMPLETED|Period 4||0
269697|NCT02263911|647336|P4|COMPLETED|Period 4||4
269698|NCT02263911|647337|P3|COMPLETED|Period 4||4
269699|NCT02263911|647338|P2|COMPLETED|Period 4||4
269700|NCT02263911|647339|P1|COMPLETED|Period 4||4
269701|NCT02263911|647336|P4|STARTED|Period 4||4
269702|NCT02263911|647337|P3|STARTED|Period 4||4
269703|NCT02263911|647338|P2|STARTED|Period 4||4
269704|NCT02263911|647339|P1|STARTED|Period 4||4
269705|NCT02263911|647336|P4|NOT COMPLETED|Period 3 Washout||0
269706|NCT02263911|647337|P3|NOT COMPLETED|Period 3 Washout||0
269707|NCT02263911|647338|P2|NOT COMPLETED|Period 3 Washout||0
269708|NCT02263911|647339|P1|NOT COMPLETED|Period 3 Washout||0
269709|NCT02263911|647336|P4|COMPLETED|Period 3 Washout||4
269710|NCT02263911|647337|P3|COMPLETED|Period 3 Washout||4
269711|NCT02263911|647338|P2|COMPLETED|Period 3 Washout||4
269712|NCT02263911|647339|P1|COMPLETED|Period 3 Washout||4
269713|NCT02263911|647336|P4|STARTED|Period 3 Washout||4
269714|NCT02263911|647337|P3|STARTED|Period 3 Washout||4
269715|NCT02263911|647338|P2|STARTED|Period 3 Washout||4
269716|NCT02263911|647339|P1|STARTED|Period 3 Washout||4
269717|NCT02263911|647336|P4|NOT COMPLETED|Period 3||0
269718|NCT02263911|647337|P3|NOT COMPLETED|Period 3||0
269719|NCT02263911|647338|P2|NOT COMPLETED|Period 3||0
269720|NCT02263911|647339|P1|NOT COMPLETED|Period 3||0
269721|NCT02263911|647336|P4|COMPLETED|Period 3||4
269722|NCT02263911|647337|P3|COMPLETED|Period 3||4
269723|NCT02263911|647338|P2|COMPLETED|Period 3||4
269724|NCT02263911|647339|P1|COMPLETED|Period 3||4
269725|NCT02263911|647336|P4|STARTED|Period 3||4
269726|NCT02263911|647337|P3|STARTED|Period 3||4
269727|NCT02263911|647338|P2|STARTED|Period 3||4
269728|NCT02263911|647339|P1|STARTED|Period 3||4
269729|NCT02263911|647336|P4|NOT COMPLETED|Period 2 Washout||0
269730|NCT02263911|647337|P3|NOT COMPLETED|Period 2 Washout||0
269731|NCT02263911|647338|P2|NOT COMPLETED|Period 2 Washout||0
269732|NCT02263911|647339|P1|NOT COMPLETED|Period 2 Washout||0
269733|NCT02263911|647336|P4|COMPLETED|Period 2 Washout||4
269734|NCT02263911|647337|P3|COMPLETED|Period 2 Washout||4
269735|NCT02263911|647338|P2|COMPLETED|Period 2 Washout||4
269736|NCT02263911|647339|P1|COMPLETED|Period 2 Washout||4
269737|NCT02263911|647336|P4|STARTED|Period 2 Washout||4
269738|NCT02263911|647337|P3|STARTED|Period 2 Washout||4
269739|NCT02263911|647338|P2|STARTED|Period 2 Washout||4
269740|NCT02263911|647339|P1|STARTED|Period 2 Washout||4
269741|NCT02263911|647336|P4|NOT COMPLETED|Period 2||0
269742|NCT02263911|647337|P3|NOT COMPLETED|Period 2||0
269743|NCT02263911|647338|P2|NOT COMPLETED|Period 2||0
269744|NCT02263911|647339|P1|NOT COMPLETED|Period 2||0
269745|NCT02263911|647336|P4|COMPLETED|Period 2||4
269746|NCT02263911|647337|P3|COMPLETED|Period 2||4
269747|NCT02263911|647338|P2|COMPLETED|Period 2||4
269748|NCT02263911|647339|P1|COMPLETED|Period 2||4
269749|NCT02263911|647336|P4|STARTED|Period 2||4
269750|NCT02263911|647337|P3|STARTED|Period 2||4
269751|NCT02263911|647338|P2|STARTED|Period 2||4
269752|NCT02263911|647339|P1|STARTED|Period 2||4
269753|NCT02263911|647336|P4|NOT COMPLETED|Period 1 Washout||0
269754|NCT02263911|647337|P3|NOT COMPLETED|Period 1 Washout||0
269755|NCT02263911|647338|P2|NOT COMPLETED|Period 1 Washout||0
269756|NCT02263911|647339|P1|NOT COMPLETED|Period 1 Washout||0
269757|NCT02263911|647336|P4|COMPLETED|Period 1 Washout||4
269758|NCT02263911|647337|P3|COMPLETED|Period 1 Washout||4
269759|NCT02263911|647338|P2|COMPLETED|Period 1 Washout||4
269760|NCT02263911|647339|P1|COMPLETED|Period 1 Washout||4
269761|NCT02263911|647336|P4|STARTED|Period 1 Washout||4
269762|NCT02263911|647337|P3|STARTED|Period 1 Washout||4
269763|NCT02263911|647338|P2|STARTED|Period 1 Washout||4
269764|NCT02263911|647339|P1|STARTED|Period 1 Washout||4
269765|NCT02263911|647336|P4|NOT COMPLETED|Period 1||0
269766|NCT02263911|647337|P3|NOT COMPLETED|Period 1||0
269767|NCT02263911|647338|P2|NOT COMPLETED|Period 1||0
269768|NCT02263911|647339|P1|NOT COMPLETED|Period 1||0
269769|NCT02263911|647336|P4|COMPLETED|Period 1||4
269770|NCT02263911|647337|P3|COMPLETED|Period 1||4
269771|NCT02263911|647338|P2|COMPLETED|Period 1||4
269772|NCT02263911|647339|P1|COMPLETED|Period 1||4
269773|NCT02263911|647336|P4|STARTED|Period 1||4
269774|NCT02263911|647337|P3|STARTED|Period 1||4
269775|NCT02263911|647338|P2|STARTED|Period 1||4
269776|NCT02263911|647339|P1|STARTED|Period 1||4
269777|NCT02263833|647361|P1|NOT COMPLETED|Overall Study||0
269778|NCT02263833|647361|P1|COMPLETED|Overall Study||742
269779|NCT02263833|647361|P1|STARTED|Overall Study||742
269780|NCT02263131|647368|P2|NOT COMPLETED|Overall Study||1
269781|NCT02263131|647369|P1|NOT COMPLETED|Overall Study||10
269782|NCT02263131|647368|P2|COMPLETED|Overall Study||68
269783|NCT02263131|647369|P1|COMPLETED|Overall Study||337
269784|NCT02263131|647368|P2|STARTED|Overall Study||69
269785|NCT02263131|647369|P1|STARTED|Overall Study||347
269786|NCT02263118|647381|P4|NOT COMPLETED|Overall Study||2
269787|NCT02263118|647382|P3|NOT COMPLETED|Overall Study||8
269788|NCT02263118|647383|P2|NOT COMPLETED|Overall Study||8
269789|NCT02263118|647384|P1|NOT COMPLETED|Overall Study||4
269790|NCT02263118|647381|P4|COMPLETED|Overall Study||12
269791|NCT02263118|647382|P3|COMPLETED|Overall Study||22
269792|NCT02263118|647383|P2|COMPLETED|Overall Study||24
269793|NCT02263118|647384|P1|COMPLETED|Overall Study||20
269794|NCT02263118|647381|P4|STARTED|Overall Study||14
269795|NCT02263118|647382|P3|STARTED|Overall Study||30
269796|NCT02263118|647383|P2|STARTED|Overall Study||32
269797|NCT02263118|647384|P1|STARTED|Overall Study||24
269798|NCT02262754|647409|P3|NOT COMPLETED|Overall Study||9
269799|NCT02262754|647410|P2|NOT COMPLETED|Overall Study||9
269800|NCT02262754|647411|P1|NOT COMPLETED|Overall Study||16
269801|NCT02262754|647409|P3|COMPLETED|Overall Study||65
269802|NCT02262754|647410|P2|COMPLETED|Overall Study||65
269803|NCT02262754|647411|P1|COMPLETED|Overall Study||58
269804|NCT02262754|647409|P3|STARTED|Overall Study||74
269805|NCT02262754|647410|P2|STARTED|Overall Study||74
269806|NCT02262754|647411|P1|STARTED|Overall Study||74
269807|NCT02262728|647486|P2|NOT COMPLETED|Overall Study||0
269808|NCT02262728|647487|P1|NOT COMPLETED|Overall Study||0
269809|NCT02262728|647486|P2|COMPLETED|Overall Study||21
269810|NCT02262728|647487|P1|COMPLETED|Overall Study||19
269811|NCT02262728|647486|P2|STARTED|Overall Study||21
269812|NCT02262728|647487|P1|STARTED|Overall Study||19
269813|NCT02262078|647517|P2|NOT COMPLETED|Overall Study||0
269814|NCT02262078|647518|P1|NOT COMPLETED|Overall Study||0
269815|NCT02262078|647517|P2|COMPLETED|Overall Study||13
269816|NCT02262078|647518|P1|COMPLETED|Overall Study||13
269817|NCT02262078|647517|P2|STARTED|Overall Study||13
269818|NCT02262078|647518|P1|STARTED|Overall Study||13
269819|NCT02262039|647526|P2|NOT COMPLETED|Overall Study||0
269820|NCT02262039|647527|P1|NOT COMPLETED|Overall Study||0
269821|NCT02262039|647526|P2|COMPLETED|Overall Study||27
269822|NCT02262039|647527|P1|COMPLETED|Overall Study||14
269823|NCT02262039|647526|P2|STARTED|Overall Study||27
269824|NCT02262039|647527|P1|STARTED|Overall Study||14
269825|NCT02261948|647547|P2|NOT COMPLETED|Overall Study||0
269826|NCT02261948|647548|P1|NOT COMPLETED|Overall Study||0
269827|NCT02261948|647547|P2|COMPLETED|Overall Study||19
269828|NCT02261948|647548|P1|COMPLETED|Overall Study||23
269829|NCT02261948|647547|P2|STARTED|Overall Study||19
269830|NCT02261948|647548|P1|STARTED|Overall Study||23
269831|NCT02261428|647560|P2|NOT COMPLETED|Overall Study||0
269832|NCT02261428|647561|P1|NOT COMPLETED|Overall Study||0
269833|NCT02261428|647560|P2|COMPLETED|Overall Study||10
269834|NCT02261428|647561|P1|COMPLETED|Overall Study||10
269835|NCT02261428|647560|P2|STARTED|Overall Study|Washout (30 minutes)|10
269836|NCT02261428|647561|P1|STARTED|Overall Study|Washout (30 minutes)|10
269837|NCT02260882|647581|P2|NOT COMPLETED|Overall Study||1
269838|NCT02260882|647582|P1|NOT COMPLETED|Overall Study||0
269839|NCT02260882|647581|P2|COMPLETED|Overall Study||81
269840|NCT02260882|647582|P1|COMPLETED|Overall Study||161
269841|NCT02260882|647581|P2|STARTED|Overall Study||82
269842|NCT02260882|647582|P1|STARTED|Overall Study||161
269843|NCT02260492|647607|P3|NOT COMPLETED|Overall Study||5
269844|NCT02260492|647608|P2|NOT COMPLETED|Overall Study||13
269845|NCT02260492|647609|P1|NOT COMPLETED|Overall Study||23
269846|NCT02260492|647607|P3|COMPLETED|Overall Study||37
269847|NCT02260492|647608|P2|COMPLETED|Overall Study||406
269848|NCT02260492|647609|P1|COMPLETED|Overall Study||395
269849|NCT02260492|647607|P3|Completed Day 1|Overall Study||42
269850|NCT02260492|647608|P2|Completed Day 1|Overall Study||419
269851|NCT02260492|647609|P1|Completed Day 1|Overall Study||418
269852|NCT02260492|647607|P3|STARTED|Overall Study||42
269853|NCT02260492|647608|P2|STARTED|Overall Study||419
269854|NCT02260492|647609|P1|STARTED|Overall Study||418
269855|NCT02260440|647623|P1|NOT COMPLETED|Overall Study||0
269856|NCT02260440|647623|P1|COMPLETED|Overall Study||31
269857|NCT02260440|647623|P1|STARTED|Overall Study||31
269858|NCT02260401|647631|P2|NOT COMPLETED|Overall Study||12
269859|NCT02260401|647632|P1|NOT COMPLETED|Overall Study||5
269860|NCT02260401|647631|P2|COMPLETED|Overall Study||73
269861|NCT02260401|647632|P1|COMPLETED|Overall Study||75
269862|NCT02260401|647631|P2|STARTED|Overall Study||85
269863|NCT02260401|647632|P1|STARTED|Overall Study||80
269864|NCT02259608|647638|P1|NOT COMPLETED|Overall Study||0
269865|NCT02259608|647638|P1|COMPLETED|Overall Study||15
269866|NCT02259608|647638|P1|STARTED|Overall Study||15
269867|NCT02259400|647645|P2|NOT COMPLETED|Overall Study||2
269868|NCT02259400|647646|P1|NOT COMPLETED|Overall Study||0
269869|NCT02259400|647645|P2|COMPLETED|Overall Study||60
269870|NCT02259400|647646|P1|COMPLETED|Overall Study||62
269871|NCT02259400|647645|P2|STARTED|Overall Study||62
269872|NCT02259400|647646|P1|STARTED|Overall Study||62
269873|NCT02259348|647678|P1|NOT COMPLETED|Overall Study||10
269874|NCT02259348|647678|P1|COMPLETED|Overall Study||2
269875|NCT02259348|647678|P1|One Year Post-transplant|Overall Study||2
269876|NCT02259348|647678|P1|STARTED|Overall Study||12
269877|NCT02258529|647690|P1|NOT COMPLETED|Overall Study||10
269878|NCT02258529|647690|P1|COMPLETED|Overall Study||0
269879|NCT02258529|647690|P1|STARTED|Overall Study||10
269880|NCT02258477|647702|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
269881|NCT02258477|647703|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
269882|NCT02258477|647704|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
269883|NCT02258477|647705|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
269884|NCT02258477|647702|P4|COMPLETED|Fourth Intervention (1 Week)||8
269885|NCT02258477|647703|P3|COMPLETED|Fourth Intervention (1 Week)||8
269886|NCT02258477|647704|P2|COMPLETED|Fourth Intervention (1 Week)||8
269887|NCT02258477|647705|P1|COMPLETED|Fourth Intervention (1 Week)||9
269888|NCT02258477|647702|P4|STARTED|Fourth Intervention (1 Week)||8
269889|NCT02258477|647703|P3|STARTED|Fourth Intervention (1 Week)||8
269890|NCT02258477|647704|P2|STARTED|Fourth Intervention (1 Week)||8
269891|NCT02258477|647705|P1|STARTED|Fourth Intervention (1 Week)||9
269892|NCT02258477|647702|P4|NOT COMPLETED|Third Intervention (1 Week)||0
269893|NCT02258477|647703|P3|NOT COMPLETED|Third Intervention (1 Week)||0
269894|NCT02258477|647704|P2|NOT COMPLETED|Third Intervention (1 Week)||0
269895|NCT02258477|647705|P1|NOT COMPLETED|Third Intervention (1 Week)||0
269896|NCT02258477|647702|P4|COMPLETED|Third Intervention (1 Week)||8
269897|NCT02258477|647703|P3|COMPLETED|Third Intervention (1 Week)||8
269898|NCT02258477|647704|P2|COMPLETED|Third Intervention (1 Week)||8
269899|NCT02258477|647705|P1|COMPLETED|Third Intervention (1 Week)||9
269900|NCT02258477|647702|P4|STARTED|Third Intervention (1 Week)||8
269901|NCT02258477|647703|P3|STARTED|Third Intervention (1 Week)||8
269902|NCT02258477|647704|P2|STARTED|Third Intervention (1 Week)||8
269903|NCT02258477|647705|P1|STARTED|Third Intervention (1 Week)||9
269904|NCT02258477|647702|P4|NOT COMPLETED|Second Intervention (1 Week)||1
269905|NCT02258477|647703|P3|NOT COMPLETED|Second Intervention (1 Week)||1
269906|NCT02258477|647704|P2|NOT COMPLETED|Second Intervention (1 Week)||0
269907|NCT02258477|647705|P1|NOT COMPLETED|Second Intervention (1 Week)||0
269908|NCT02258477|647702|P4|COMPLETED|Second Intervention (1 Week)||8
269909|NCT02258477|647703|P3|COMPLETED|Second Intervention (1 Week)||8
269910|NCT02258477|647704|P2|COMPLETED|Second Intervention (1 Week)||8
269911|NCT02258477|647705|P1|COMPLETED|Second Intervention (1 Week)||9
269912|NCT02258477|647702|P4|STARTED|Second Intervention (1 Week)||9
269913|NCT02258477|647703|P3|STARTED|Second Intervention (1 Week)||9
269914|NCT02258477|647704|P2|STARTED|Second Intervention (1 Week)||8
269915|NCT02258477|647705|P1|STARTED|Second Intervention (1 Week)||9
269916|NCT02258477|647702|P4|NOT COMPLETED|First Intervention (1 Week)||0
269917|NCT02258477|647703|P3|NOT COMPLETED|First Intervention (1 Week)||0
269918|NCT02258477|647704|P2|NOT COMPLETED|First Intervention (1 Week)||1
269919|NCT02258477|647705|P1|NOT COMPLETED|First Intervention (1 Week)||1
269920|NCT02258477|647702|P4|COMPLETED|First Intervention (1 Week)||9
269921|NCT02258477|647703|P3|COMPLETED|First Intervention (1 Week)||9
269922|NCT02258477|647704|P2|COMPLETED|First Intervention (1 Week)||8
269923|NCT02258477|647705|P1|COMPLETED|First Intervention (1 Week)||9
269924|NCT02258477|647702|P4|STARTED|First Intervention (1 Week)||9
269925|NCT02258477|647703|P3|STARTED|First Intervention (1 Week)||9
269926|NCT02258477|647704|P2|STARTED|First Intervention (1 Week)||9
269927|NCT02258477|647705|P1|STARTED|First Intervention (1 Week)||10
269928|NCT02258412|647723|P3|NOT COMPLETED|Overall Study||0
269929|NCT02258412|647724|P2|NOT COMPLETED|Overall Study||0
269930|NCT02258412|647725|P1|NOT COMPLETED|Overall Study||0
269931|NCT02258412|647723|P3|COMPLETED|Overall Study||61
269932|NCT02258412|647724|P2|COMPLETED|Overall Study||25
269933|NCT02258412|647725|P1|COMPLETED|Overall Study||26
269934|NCT02258412|647723|P3|STARTED|Overall Study||61
269935|NCT02258412|647724|P2|STARTED|Overall Study||25
269936|NCT02258412|647725|P1|STARTED|Overall Study||26
269937|NCT02258334|647736|P4|NOT COMPLETED|Overall Study||0
269938|NCT02258334|647737|P3|NOT COMPLETED|Overall Study||0
269939|NCT02258334|647738|P2|NOT COMPLETED|Overall Study||0
269940|NCT02258334|647739|P1|NOT COMPLETED|Overall Study||1
269941|NCT02258334|647736|P4|COMPLETED|Overall Study||52
269942|NCT02258334|647737|P3|COMPLETED|Overall Study||52
269943|NCT02258334|647738|P2|COMPLETED|Overall Study||54
269944|NCT02258334|647739|P1|COMPLETED|Overall Study||49
269945|NCT02258334|647736|P4|STARTED|Overall Study||52
269946|NCT02258334|647737|P3|STARTED|Overall Study||52
269947|NCT02258334|647738|P2|STARTED|Overall Study||54
269948|NCT02258334|647739|P1|STARTED|Overall Study||50
269949|NCT02257918|647768|P3|NOT COMPLETED|Overall Study||2
269950|NCT02257918|647769|P2|NOT COMPLETED|Overall Study||1
269951|NCT02257918|647770|P1|NOT COMPLETED|Overall Study||4
269952|NCT02257918|647768|P3|COMPLETED|Overall Study||39
269953|NCT02257918|647769|P2|COMPLETED|Overall Study||66
269954|NCT02257918|647770|P1|COMPLETED|Overall Study||68
269955|NCT02257918|647768|P3|Test of Cure Visit|Overall Study||40
269956|NCT02257918|647769|P2|Test of Cure Visit|Overall Study||67
269957|NCT02257918|647770|P1|Test of Cure Visit|Overall Study||72
269958|NCT02257918|647768|P3|STARTED|Overall Study||41
269959|NCT02257918|647769|P2|STARTED|Overall Study||67
269960|NCT02257918|647770|P1|STARTED|Overall Study||72
269961|NCT02257684|647820|P1|NOT COMPLETED|Overall Study||4
269962|NCT02257684|647820|P1|COMPLETED|Overall Study||0
269963|NCT02257684|647820|P1|STARTED|Overall Study||4
269964|NCT02257385|647830|P2|NOT COMPLETED|Overall Study||22
269965|NCT02257385|647831|P1|NOT COMPLETED|Overall Study||22
269966|NCT02257385|647830|P2|COMPLETED|Overall Study||457
269967|NCT02257385|647831|P1|COMPLETED|Overall Study||460
269968|NCT02257385|647830|P2|STARTED|Overall Study||479
269969|NCT02257385|647831|P1|STARTED|Overall Study||482
269970|NCT02257372|647841|P2|NOT COMPLETED|Overall Study||10
269971|NCT02257372|647842|P1|NOT COMPLETED|Overall Study||7
269972|NCT02257372|647841|P2|COMPLETED|Overall Study||109
269973|NCT02257372|647842|P1|COMPLETED|Overall Study||110
269974|NCT02257372|647841|P2|STARTED|Overall Study||119
269975|NCT02257372|647842|P1|STARTED|Overall Study||117
269976|NCT02256982|647852|P2|NOT COMPLETED|Overall Study||1
269977|NCT02256982|647853|P1|NOT COMPLETED|Overall Study||0
269978|NCT02256982|647852|P2|COMPLETED|Overall Study||1
269979|NCT02256982|647853|P1|COMPLETED|Overall Study||1
269980|NCT02256982|647852|P2|STARTED|Overall Study||2
269981|NCT02256982|647853|P1|STARTED|Overall Study||1
269982|NCT02256969|647862|P3|NOT COMPLETED|Overall Study||1
269983|NCT02256969|647863|P2|NOT COMPLETED|Overall Study||1
269984|NCT02256969|647864|P1|NOT COMPLETED|Overall Study||2
269985|NCT02256969|647862|P3|COMPLETED|Overall Study||14
269986|NCT02256969|647863|P2|COMPLETED|Overall Study||14
269987|NCT02256969|647864|P1|COMPLETED|Overall Study||13
269988|NCT02256969|647862|P3|STARTED|Overall Study||15
269989|NCT02256969|647863|P2|STARTED|Overall Study||15
269990|NCT02256969|647864|P1|STARTED|Overall Study||15
269991|NCT02256553|647881|P1|NOT COMPLETED|Period III||3
269992|NCT02256553|647881|P1|COMPLETED|Period III||91
269993|NCT02256553|647881|P1|STARTED|Period III||94
269994|NCT02256553|647881|P1|NOT COMPLETED|Period II||2
269995|NCT02256553|647881|P1|COMPLETED|Period II||94
269996|NCT02256553|647881|P1|STARTED|Period II||96
269997|NCT02256553|647881|P1|NOT COMPLETED|Period I||6
269998|NCT02256553|647881|P1|COMPLETED|Period I||96
269999|NCT02256553|647881|P1|STARTED|Period I||102
270000|NCT02256488|647894|P4|NOT COMPLETED|Overall Study||6
270001|NCT02256488|647895|P3|NOT COMPLETED|Overall Study||10
270002|NCT02256488|647896|P2|NOT COMPLETED|Overall Study||6
270003|NCT02256488|647897|P1|NOT COMPLETED|Overall Study||8
270004|NCT02256488|647894|P4|COMPLETED|Overall Study||384
270005|NCT02256488|647895|P3|COMPLETED|Overall Study||382
270006|NCT02256488|647896|P2|COMPLETED|Overall Study||386
270007|NCT02256488|647897|P1|COMPLETED|Overall Study||379
270008|NCT02256488|647894|P4|STARTED|Overall Study||390
270009|NCT02256488|647895|P3|STARTED|Overall Study||392
270010|NCT02256488|647896|P2|STARTED|Overall Study||392
270011|NCT02256488|647897|P1|STARTED|Overall Study||387
270012|NCT02256358|647913|P2|NOT COMPLETED|Overall Study||1
270013|NCT02256358|647914|P1|NOT COMPLETED|Overall Study||0
270014|NCT02256358|647913|P2|COMPLETED|Overall Study||33
270015|NCT02256358|647914|P1|COMPLETED|Overall Study||34
270016|NCT02256358|647913|P2|STARTED|Overall Study||34
270017|NCT02256358|647914|P1|STARTED|Overall Study||34
270018|NCT02256072|647922|P2|NOT COMPLETED|Overall Study||29
270019|NCT02256072|647923|P1|NOT COMPLETED|Overall Study||42
270020|NCT02256072|647922|P2|COMPLETED|Overall Study||162
270021|NCT02256072|647923|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
270022|NCT02256072|647922|P2|Completed 1 Month Follow-Up|Overall Study||179
270023|NCT02256072|647923|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
270024|NCT02256072|647922|P2|STARTED|Overall Study||191
270025|NCT02256072|647923|P1|STARTED|Overall Study||194
270026|NCT02255565|647940|P3|NOT COMPLETED|Overall Study||0
270027|NCT02255565|647941|P2|NOT COMPLETED|Overall Study||1
270028|NCT02255565|647942|P1|NOT COMPLETED|Overall Study||0
270029|NCT02255565|647940|P3|COMPLETED|Overall Study||9
270030|NCT02255565|647941|P2|COMPLETED|Overall Study||8
270031|NCT02255565|647942|P1|COMPLETED|Overall Study||9
270032|NCT02255565|647940|P3|STARTED|Overall Study||9
270033|NCT02255565|647941|P2|STARTED|Overall Study||9
270034|NCT02255565|647942|P1|STARTED|Overall Study||9
270035|NCT02255279|648003|P2|NOT COMPLETED|Overall Study||9
270036|NCT02255279|648004|P1|NOT COMPLETED|Overall Study||5
270037|NCT02255279|648003|P2|COMPLETED|Overall Study||134
270038|NCT02255279|648004|P1|COMPLETED|Overall Study||139
270039|NCT02255279|648003|P2|STARTED|Overall Study||143
270040|NCT02255279|648004|P1|STARTED|Overall Study||144
270041|NCT02255149|648030|P1|NOT COMPLETED|Overall Study||5
270042|NCT02255149|648030|P1|COMPLETED|Overall Study||5
270043|NCT02255149|648030|P1|STARTED|Overall Study||10
270044|NCT02254551|648034|P1|NOT COMPLETED|Maintenance||0
270045|NCT02254551|648034|P1|COMPLETED|Maintenance||0
270046|NCT02254551|648034|P1|STARTED|Maintenance||0
270047|NCT02254551|648034|P1|NOT COMPLETED|Expansion||0
270048|NCT02254551|648034|P1|COMPLETED|Expansion||0
270049|NCT02254551|648034|P1|STARTED|Expansion||0
270050|NCT02254551|648034|P1|NOT COMPLETED|Dose Escalation||3
270051|NCT02254551|648034|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
270052|NCT02254551|648034|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
270053|NCT02254551|648034|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
270054|NCT02254551|648034|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
270055|NCT02254551|648034|P1|STARTED|Dose Escalation||7
270056|NCT02254486|648044|P2|NOT COMPLETED|Overall Study||55
270057|NCT02254486|648045|P1|NOT COMPLETED|Overall Study||50
270058|NCT02254486|648044|P2|COMPLETED|Overall Study||255
270059|NCT02254486|648045|P1|COMPLETED|Overall Study||261
270060|NCT02254486|648044|P2|STARTED|Overall Study||310
270061|NCT02254486|648045|P1|STARTED|Overall Study||311
270062|NCT02254460|648061|P2|NOT COMPLETED|Overall Study||0
270063|NCT02254460|648062|P1|NOT COMPLETED|Overall Study||1
270064|NCT02254460|648061|P2|COMPLETED|Overall Study||12
270065|NCT02254460|648062|P1|COMPLETED|Overall Study||12
270066|NCT02254460|648061|P2|STARTED|Overall Study||12
270067|NCT02254460|648062|P1|STARTED|Overall Study||13
270068|NCT02254252|648070|P2|NOT COMPLETED|Overall Study||2
270069|NCT02254252|648071|P1|NOT COMPLETED|Overall Study||3
270070|NCT02254252|648070|P2|COMPLETED|Overall Study||25
270071|NCT02254252|648071|P1|COMPLETED|Overall Study||24
270072|NCT02254252|648070|P2|STARTED|Overall Study||27
270073|NCT02254252|648071|P1|STARTED|Overall Study||27
270074|NCT02253654|648083|P2|NOT COMPLETED|Overall Study||18
270075|NCT02253654|648084|P1|NOT COMPLETED|Overall Study||23
270076|NCT02253654|648083|P2|COMPLETED|Overall Study||90
270077|NCT02253654|648084|P1|COMPLETED|Overall Study||85
270078|NCT02253654|648083|P2|Received Treatment|Overall Study||107
270079|NCT02253654|648084|P1|Received Treatment|Overall Study||104
270080|NCT02253654|648083|P2|STARTED|Overall Study||108
270081|NCT02253654|648084|P1|STARTED|Overall Study||108
270082|NCT02253173|648108|P4|NOT COMPLETED|Overall Study||14
270083|NCT02253173|648109|P3|NOT COMPLETED|Overall Study||13
270084|NCT02253173|648110|P2|NOT COMPLETED|Overall Study||17
270085|NCT02253173|648111|P1|NOT COMPLETED|Overall Study||16
270086|NCT02253173|648108|P4|COMPLETED|Overall Study||178
270087|NCT02253173|648109|P3|COMPLETED|Overall Study||177
270088|NCT02253173|648110|P2|COMPLETED|Overall Study||174
270089|NCT02253173|648111|P1|COMPLETED|Overall Study||175
270090|NCT02253173|648108|P4|STARTED|Overall Study||192
270091|NCT02253173|648109|P3|STARTED|Overall Study||190
270092|NCT02253173|648110|P2|STARTED|Overall Study||191
270093|NCT02253173|648111|P1|STARTED|Overall Study||191
270094|NCT02253160|648308|P3|NOT COMPLETED|Overall Study||0
270095|NCT02253160|648309|P2|NOT COMPLETED|Overall Study||0
270096|NCT02253160|648310|P1|NOT COMPLETED|Overall Study||0
270097|NCT02253160|648308|P3|COMPLETED|Overall Study||10
270098|NCT02253160|648309|P2|COMPLETED|Overall Study||12
270099|NCT02253160|648310|P1|COMPLETED|Overall Study||1
270100|NCT02253160|648308|P3|STARTED|Overall Study||10
270101|NCT02253160|648309|P2|STARTED|Overall Study||12
270102|NCT02253160|648310|P1|STARTED|Overall Study||1
270103|NCT02252965|648348|P2|NOT COMPLETED|Overall Study||43
270104|NCT02252965|648349|P1|NOT COMPLETED|Overall Study||40
270105|NCT02252965|648348|P2|COMPLETED|Overall Study||222
270106|NCT02252965|648349|P1|COMPLETED|Overall Study||227
270107|NCT02252965|648348|P2|Safety Population|Overall Study||264
270108|NCT02252965|648349|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
270109|NCT02252965|648348|P2|STARTED|Overall Study||265
270110|NCT02252965|648349|P1|STARTED|Overall Study||267
270111|NCT02252744|648376|P1|NOT COMPLETED|Overall Study||0
270112|NCT02252744|648376|P1|COMPLETED|Overall Study||286
270113|NCT02252744|648376|P1|STARTED|Overall Study||286
270114|NCT02252718|648380|P1|NOT COMPLETED|Overall Study||0
270115|NCT02252718|648380|P1|COMPLETED|Overall Study||100
270116|NCT02252718|648380|P1|STARTED|Overall Study||100
270117|NCT02252445|648386|P2|NOT COMPLETED|Overall Study||0
270118|NCT02252445|648387|P1|NOT COMPLETED|Overall Study||0
270119|NCT02252445|648386|P2|COMPLETED|Overall Study||41
270120|NCT02252445|648387|P1|COMPLETED|Overall Study||41
270121|NCT02252445|648386|P2|STARTED|Overall Study||41
270122|NCT02252445|648387|P1|STARTED|Overall Study||41
270123|NCT02252354|648413|P2|NOT COMPLETED|Overall Study||0
270124|NCT02252354|648414|P1|NOT COMPLETED|Overall Study||0
270125|NCT02252354|648413|P2|COMPLETED|Overall Study||6
270126|NCT02252354|648414|P1|COMPLETED|Overall Study||6
270127|NCT02252354|648413|P2|STARTED|Overall Study||6
270128|NCT02252354|648414|P1|STARTED|Overall Study||6
270129|NCT02252133|648459|P2|NOT COMPLETED|Period 2||0
270130|NCT02252133|648460|P1|NOT COMPLETED|Period 2||0
270131|NCT02252133|648459|P2|COMPLETED|Period 2||24
270132|NCT02252133|648460|P1|COMPLETED|Period 2||23
270133|NCT02252133|648459|P2|STARTED|Period 2||24
270134|NCT02252133|648460|P1|STARTED|Period 2||23
270135|NCT02252133|648459|P2|NOT COMPLETED|Period 1||0
270136|NCT02252133|648460|P1|NOT COMPLETED|Period 1||0
270137|NCT02252133|648459|P2|COMPLETED|Period 1||24
270138|NCT02252133|648460|P1|COMPLETED|Period 1||23
270139|NCT02252133|648459|P2|STARTED|Period 1||24
270140|NCT02252133|648460|P1|STARTED|Period 1||23
270141|NCT02252016|648468|P2|NOT COMPLETED|Safety Follow-Up||50
270142|NCT02252016|648469|P1|NOT COMPLETED|Safety Follow-Up||106
270143|NCT02252016|648468|P2|COMPLETED|Safety Follow-Up||0
270144|NCT02252016|648469|P1|COMPLETED|Safety Follow-Up||0
270145|NCT02252016|648468|P2|STARTED|Safety Follow-Up||50
270146|NCT02252016|648469|P1|STARTED|Safety Follow-Up||106
270147|NCT02252016|648468|P2|NOT COMPLETED|Treatment||2
270148|NCT02252016|648469|P1|NOT COMPLETED|Treatment||1
270149|NCT02252016|648468|P2|COMPLETED|Treatment||50
270150|NCT02252016|648469|P1|COMPLETED|Treatment||106
270151|NCT02252016|648468|P2|STARTED|Treatment||52
270152|NCT02252016|648469|P1|STARTED|Treatment||107
270153|NCT02251886|648485|P4|NOT COMPLETED|Overall Study||0
270154|NCT02251886|648486|P3|NOT COMPLETED|Overall Study||0
270155|NCT02251886|648487|P2|NOT COMPLETED|Overall Study||0
270156|NCT02251886|648488|P1|NOT COMPLETED|Overall Study||0
270157|NCT02251886|648485|P4|COMPLETED|Overall Study||54
270158|NCT02251886|648486|P3|COMPLETED|Overall Study||44
270159|NCT02251886|648487|P2|COMPLETED|Overall Study||54
270160|NCT02251886|648488|P1|COMPLETED|Overall Study||48
270161|NCT02251886|648485|P4|STARTED|Overall Study||54
270162|NCT02251886|648486|P3|STARTED|Overall Study||44
270163|NCT02251886|648487|P2|STARTED|Overall Study||54
270164|NCT02251886|648488|P1|STARTED|Overall Study||48
270165|NCT02251652|648498|P1|NOT COMPLETED|Overall Study||1
270166|NCT02251652|648498|P1|COMPLETED|Overall Study||16
270167|NCT02251652|648498|P1|STARTED|Overall Study||17
270168|NCT02251613|648508|P1|NOT COMPLETED|Overall Study||0
270169|NCT02251613|648508|P1|COMPLETED|Overall Study||50
270170|NCT02251613|648508|P1|STARTED|Overall Study||50
270171|NCT02251561|648516|P1|NOT COMPLETED|Overall Study||0
270172|NCT02251561|648516|P1|COMPLETED|Overall Study||28
270173|NCT02251561|648516|P1|STARTED|Overall Study||28
270174|NCT02250807|648524|P1|NOT COMPLETED|Overall Study||0
270175|NCT02250807|648524|P1|COMPLETED|Overall Study||40
270176|NCT02250807|648524|P1|STARTED|Overall Study||40
270177|NCT02250274|648536|P2|NOT COMPLETED|Overall Study||6
270178|NCT02250274|648537|P1|NOT COMPLETED|Overall Study||7
270179|NCT02250274|648536|P2|COMPLETED|Overall Study||40
270180|NCT02250274|648537|P1|COMPLETED|Overall Study||78
270181|NCT02250274|648536|P2|STARTED|Overall Study||46
270182|NCT02250274|648537|P1|STARTED|Overall Study||85
270183|NCT02249728|648547|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
270184|NCT02249728|648547|P1|COMPLETED|Part Two (up to 6 Days)||6
270185|NCT02249728|648547|P1|STARTED|Part Two (up to 6 Days)||6
270186|NCT02249728|648547|P1|NOT COMPLETED|Part One (4 Days)||0
270187|NCT02249728|648547|P1|COMPLETED|Part One (4 Days)||6
270188|NCT02249728|648547|P1|STARTED|Part One (4 Days)||6
270189|NCT02249104|648557|P1|NOT COMPLETED|Overall Study||3
270190|NCT02249104|648557|P1|COMPLETED|Overall Study||25
270191|NCT02249104|648557|P1|STARTED|Overall Study||28
270192|NCT02249052|648566|P1|NOT COMPLETED|Overall Study||0
270193|NCT02249052|648566|P1|COMPLETED|Overall Study||19
270194|NCT02249052|648566|P1|STARTED|Overall Study||19
270195|NCT02248818|648590|P9|NOT COMPLETED|Randomised Study||0
270196|NCT02248818|648591|P8|NOT COMPLETED|Randomised Study||0
270197|NCT02248818|648592|P7|NOT COMPLETED|Randomised Study||0
270198|NCT02248818|648593|P6|NOT COMPLETED|Randomised Study||8
270199|NCT02248818|648594|P5|NOT COMPLETED|Randomised Study||0
270200|NCT02248818|648595|P4|NOT COMPLETED|Randomised Study||0
270201|NCT02248818|648596|P3|NOT COMPLETED|Randomised Study||0
270202|NCT02248818|648597|P2|NOT COMPLETED|Randomised Study||0
270203|NCT02248818|648598|P1|NOT COMPLETED|Randomised Study||0
270204|NCT02248818|648590|P9|COMPLETED|Randomised Study||0
270205|NCT02248818|648591|P8|COMPLETED|Randomised Study||4
270206|NCT02248818|648592|P7|COMPLETED|Randomised Study||6
270207|NCT02248818|648593|P6|COMPLETED|Randomised Study||0
270208|NCT02248818|648594|P5|COMPLETED|Randomised Study||6
270209|NCT02248818|648595|P4|COMPLETED|Randomised Study||6
270210|NCT02248818|648596|P3|COMPLETED|Randomised Study||6
270211|NCT02248818|648597|P2|COMPLETED|Randomised Study||6
270212|NCT02248818|648598|P1|COMPLETED|Randomised Study||6
270213|NCT02248818|648590|P9|STARTED|Randomised Study||0
270214|NCT02248818|648591|P8|STARTED|Randomised Study||4
270215|NCT02248818|648592|P7|STARTED|Randomised Study||6
270216|NCT02248818|648593|P6|STARTED|Randomised Study||8
270217|NCT02248818|648594|P5|STARTED|Randomised Study||6
270218|NCT02248818|648595|P4|STARTED|Randomised Study||6
270219|NCT02248818|648596|P3|STARTED|Randomised Study||6
270220|NCT02248818|648597|P2|STARTED|Randomised Study||6
270221|NCT02248818|648598|P1|STARTED|Randomised Study||6
270222|NCT02248818|648590|P9|NOT COMPLETED|Screening||107
270223|NCT02248818|648591|P8|NOT COMPLETED|Screening||0
270224|NCT02248818|648592|P7|NOT COMPLETED|Screening||0
270225|NCT02248818|648593|P6|NOT COMPLETED|Screening||0
270226|NCT02248818|648594|P5|NOT COMPLETED|Screening||0
270227|NCT02248818|648595|P4|NOT COMPLETED|Screening||0
270228|NCT02248818|648596|P3|NOT COMPLETED|Screening||0
270229|NCT02248818|648597|P2|NOT COMPLETED|Screening||0
270230|NCT02248818|648598|P1|NOT COMPLETED|Screening||0
270231|NCT02248818|648590|P9|COMPLETED|Screening||48
270232|NCT02248818|648591|P8|COMPLETED|Screening||0
270233|NCT02248818|648592|P7|COMPLETED|Screening||0
270234|NCT02248818|648593|P6|COMPLETED|Screening||0
270235|NCT02248818|648594|P5|COMPLETED|Screening||0
270236|NCT02248818|648595|P4|COMPLETED|Screening||0
270237|NCT02248818|648596|P3|COMPLETED|Screening||0
270238|NCT02248818|648597|P2|COMPLETED|Screening||0
270239|NCT02248818|648598|P1|COMPLETED|Screening||0
270240|NCT02248818|648590|P9|STARTED|Screening||155
270241|NCT02248818|648591|P8|STARTED|Screening||0
270242|NCT02248818|648592|P7|STARTED|Screening||0
270243|NCT02248818|648593|P6|STARTED|Screening||0
270244|NCT02248818|648594|P5|STARTED|Screening||0
270245|NCT02248818|648595|P4|STARTED|Screening||0
270246|NCT02248818|648596|P3|STARTED|Screening||0
270247|NCT02248818|648597|P2|STARTED|Screening||0
270248|NCT02248818|648598|P1|STARTED|Screening||0
270249|NCT02248766|648736|P1|NOT COMPLETED|Overall Study||0
270250|NCT02248766|648736|P1|COMPLETED|Overall Study||30
270251|NCT02248766|648736|P1|STARTED|Overall Study||30
270252|NCT02248727|648748|P1|NOT COMPLETED|Overall Study||0
270253|NCT02248727|648748|P1|COMPLETED|Overall Study||30
270254|NCT02248727|648748|P1|STARTED|Overall Study||30
270255|NCT02248675|648761|P2|NOT COMPLETED|Overall Study||1
270256|NCT02248675|648762|P1|NOT COMPLETED|Overall Study||3
270257|NCT02248675|648761|P2|COMPLETED|Overall Study||27
270258|NCT02248675|648762|P1|COMPLETED|Overall Study||23
270259|NCT02248675|648761|P2|STARTED|Overall Study||28
270260|NCT02248675|648762|P1|STARTED|Overall Study||26
270261|NCT02248558|648776|P2|NOT COMPLETED|Overall Study||45
270262|NCT02248558|648777|P1|NOT COMPLETED|Overall Study||52
270263|NCT02248558|648776|P2|COMPLETED|Overall Study||307
270264|NCT02248558|648777|P1|COMPLETED|Overall Study||317
270265|NCT02248558|648776|P2|STARTED|Overall Study||352
270266|NCT02248558|648777|P1|STARTED|Overall Study||369
270267|NCT02248480|648789|P2|NOT COMPLETED|Overall Study||14
270268|NCT02248480|648790|P1|NOT COMPLETED|Overall Study||17
270269|NCT02248480|648789|P2|COMPLETED|Overall Study||162
270270|NCT02248480|648790|P1|COMPLETED|Overall Study||161
270271|NCT02248480|648789|P2|Efficacy Population|Overall Study||176
270272|NCT02248480|648790|P1|Efficacy Population|Overall Study||177
270273|NCT02248480|648789|P2|STARTED|Overall Study||176
270274|NCT02248480|648790|P1|STARTED|Overall Study||178
270275|NCT02248246|648828|P1|NOT COMPLETED|Overall Study||0
270276|NCT02248246|648828|P1|COMPLETED|Overall Study||40
270277|NCT02248246|648828|P1|STARTED|Overall Study||40
270278|NCT02248103|648835|P2|NOT COMPLETED|Overall Study||0
270279|NCT02248103|648836|P1|NOT COMPLETED|Overall Study||0
270280|NCT02248103|648835|P2|COMPLETED|Overall Study||10
270281|NCT02248103|648836|P1|COMPLETED|Overall Study||10
270282|NCT02248103|648835|P2|STARTED|Overall Study||10
270283|NCT02248103|648836|P1|STARTED|Overall Study||10
270284|NCT02247960|648848|P2|NOT COMPLETED|Catheter Removed||10
270285|NCT02247960|648849|P1|NOT COMPLETED|Catheter Removed||7
270286|NCT02247960|648848|P2|COMPLETED|Catheter Removed||74
270287|NCT02247960|648849|P1|COMPLETED|Catheter Removed||76
270288|NCT02247960|648848|P2|STARTED|Catheter Removed||84
270289|NCT02247960|648849|P1|STARTED|Catheter Removed||83
270290|NCT02247960|648848|P2|NOT COMPLETED|Patient Consent and Randomization||6
270291|NCT02247960|648849|P1|NOT COMPLETED|Patient Consent and Randomization||2
270292|NCT02247960|648848|P2|COMPLETED|Patient Consent and Randomization||84
270293|NCT02247960|648849|P1|COMPLETED|Patient Consent and Randomization||83
270294|NCT02247960|648848|P2|STARTED|Patient Consent and Randomization||90
270295|NCT02247960|648849|P1|STARTED|Patient Consent and Randomization||85
270296|NCT02247765|648859|P1|NOT COMPLETED|Overall Study||0
270297|NCT02247765|648859|P1|COMPLETED|Overall Study||18
270298|NCT02247765|648859|P1|STARTED|Overall Study||18
270299|NCT02247011|648866|P1|NOT COMPLETED|Overall Study||125
270300|NCT02247011|648866|P1|COMPLETED|Overall Study||975
270301|NCT02247011|648866|P1|STARTED|Overall Study||1100
270302|NCT02246582|648883|P2|NOT COMPLETED|Overall Study||4
270303|NCT02246582|648884|P1|NOT COMPLETED|Overall Study||3
270304|NCT02246582|648883|P2|COMPLETED|Overall Study||41
270305|NCT02246582|648884|P1|COMPLETED|Overall Study||41
270306|NCT02246582|648883|P2|STARTED|Overall Study||45
270307|NCT02246582|648884|P1|STARTED|Overall Study||44
270308|NCT02246166|648892|P2|NOT COMPLETED|Overall Study||0
270309|NCT02246166|648893|P1|NOT COMPLETED|Overall Study||1
270310|NCT02246166|648892|P2|COMPLETED|Overall Study||27
270311|NCT02246166|648893|P1|COMPLETED|Overall Study||25
270312|NCT02246166|648892|P2|STARTED|Overall Study||27
270313|NCT02246166|648893|P1|STARTED|Overall Study||26
270314|NCT02246114|648929|P2|NOT COMPLETED|Overall Study||0
270315|NCT02246114|648930|P1|NOT COMPLETED|Overall Study||1
270316|NCT02246114|648929|P2|COMPLETED|Overall Study||0
270317|NCT02246114|648930|P1|COMPLETED|Overall Study||0
270318|NCT02246114|648929|P2|STARTED|Overall Study||0
270319|NCT02246114|648930|P1|STARTED|Overall Study||1
270320|NCT02246062|648940|P4|NOT COMPLETED|Overall Study||0
270321|NCT02246062|648941|P3|NOT COMPLETED|Overall Study||0
270322|NCT02246062|648942|P2|NOT COMPLETED|Overall Study||0
270323|NCT02246062|648943|P1|NOT COMPLETED|Overall Study||0
270324|NCT02246062|648940|P4|COMPLETED|Overall Study||21
270325|NCT02246062|648941|P3|COMPLETED|Overall Study||21
270326|NCT02246062|648942|P2|COMPLETED|Overall Study||21
270327|NCT02246062|648943|P1|COMPLETED|Overall Study||21
270328|NCT02246062|648940|P4|STARTED|Overall Study||21
270329|NCT02246062|648941|P3|STARTED|Overall Study||21
270330|NCT02246062|648942|P2|STARTED|Overall Study||21
270331|NCT02246062|648943|P1|STARTED|Overall Study||21
270332|NCT02245360|648963|P2|NOT COMPLETED|Overall Study||2
270333|NCT02245360|648964|P1|NOT COMPLETED|Overall Study||5
270334|NCT02245360|648963|P2|COMPLETED|Overall Study||52
270335|NCT02245360|648964|P1|COMPLETED|Overall Study||48
270336|NCT02245360|648963|P2|STARTED|Overall Study||54
270337|NCT02245360|648964|P1|STARTED|Overall Study||53
270338|NCT02244840|648972|P1|NOT COMPLETED|Overall Study||0
270339|NCT02244840|648972|P1|COMPLETED|Overall Study||40
270340|NCT02244840|648972|P1|STARTED|Overall Study||40
270341|NCT02244580|648976|P1|NOT COMPLETED|Overall Study||241
270342|NCT02244580|648976|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
270343|NCT02244580|648976|P1|STARTED|Overall Study||1010
270344|NCT02243943|648986|P2|NOT COMPLETED|Overall Study||0
270345|NCT02243943|648987|P1|NOT COMPLETED|Overall Study||0
270346|NCT02243943|648986|P2|COMPLETED|Overall Study||50
270347|NCT02243943|648987|P1|COMPLETED|Overall Study||50
270348|NCT02243943|648986|P2|STARTED|Overall Study||50
270349|NCT02243943|648987|P1|STARTED|Overall Study||50
270350|NCT02243280|649008|P11|NOT COMPLETED|Treated||3
270351|NCT02243280|649009|P10|NOT COMPLETED|Treated||0
270352|NCT02243280|649010|P9|NOT COMPLETED|Treated||1
270353|NCT02243280|649011|P8|NOT COMPLETED|Treated||0
270354|NCT02243280|649012|P7|NOT COMPLETED|Treated||0
270355|NCT02243280|649013|P6|NOT COMPLETED|Treated||0
270356|NCT02243280|649014|P5|NOT COMPLETED|Treated||0
270357|NCT02243280|649015|P4|NOT COMPLETED|Treated||0
270358|NCT02243280|649016|P3|NOT COMPLETED|Treated||0
270359|NCT02243280|649017|P2|NOT COMPLETED|Treated||0
270360|NCT02243280|649018|P1|NOT COMPLETED|Treated||1
270361|NCT02243280|649008|P11|COMPLETED|Treated||31
270362|NCT02243280|649009|P10|COMPLETED|Treated||0
270363|NCT02243280|649010|P9|COMPLETED|Treated||31
270364|NCT02243280|649011|P8|COMPLETED|Treated||0
270365|NCT02243280|649012|P7|COMPLETED|Treated||0
270366|NCT02243280|649013|P6|COMPLETED|Treated||27
270367|NCT02243280|649014|P5|COMPLETED|Treated||0
270368|NCT02243280|649015|P4|COMPLETED|Treated||0
270369|NCT02243280|649016|P3|COMPLETED|Treated||0
270370|NCT02243280|649017|P2|COMPLETED|Treated||39
270371|NCT02243280|649018|P1|COMPLETED|Treated||41
270372|NCT02243280|649008|P11|Completed Treatment|Treated||33
270373|NCT02243280|649009|P10|Completed Treatment|Treated||0
270374|NCT02243280|649010|P9|Completed Treatment|Treated||32
270375|NCT02243280|649011|P8|Completed Treatment|Treated||0
270376|NCT02243280|649012|P7|Completed Treatment|Treated||0
270377|NCT02243280|649013|P6|Completed Treatment|Treated||27
270378|NCT02243280|649014|P5|Completed Treatment|Treated||0
270379|NCT02243280|649015|P4|Completed Treatment|Treated||0
270380|NCT02243280|649016|P3|Completed Treatment|Treated||0
270381|NCT02243280|649017|P2|Completed Treatment|Treated||38
270382|NCT02243280|649018|P1|Completed Treatment|Treated||42
270383|NCT02243280|649008|P11|STARTED|Treated||34
270384|NCT02243280|649009|P10|STARTED|Treated||0
270385|NCT02243280|649010|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
270386|NCT02243280|649011|P8|STARTED|Treated||0
270387|NCT02243280|649012|P7|STARTED|Treated||0
270388|NCT02243280|649013|P6|STARTED|Treated||27
270389|NCT02243280|649014|P5|STARTED|Treated||0
270390|NCT02243280|649015|P4|STARTED|Treated||0
270391|NCT02243280|649016|P3|STARTED|Treated||0
270392|NCT02243280|649017|P2|STARTED|Treated||39
270393|NCT02243280|649018|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
270394|NCT02243280|649008|P11|NOT COMPLETED|Enrolled||0
270395|NCT02243280|649009|P10|NOT COMPLETED|Enrolled||0
270396|NCT02243280|649010|P9|NOT COMPLETED|Enrolled||0
270397|NCT02243280|649011|P8|NOT COMPLETED|Enrolled||0
270398|NCT02243280|649012|P7|NOT COMPLETED|Enrolled||0
270399|NCT02243280|649013|P6|NOT COMPLETED|Enrolled||0
270400|NCT02243280|649014|P5|NOT COMPLETED|Enrolled||0
270401|NCT02243280|649015|P4|NOT COMPLETED|Enrolled||0
270402|NCT02243280|649016|P3|NOT COMPLETED|Enrolled||0
270403|NCT02243280|649017|P2|NOT COMPLETED|Enrolled||0
270404|NCT02243280|649018|P1|NOT COMPLETED|Enrolled||0
270405|NCT02243280|649008|P11|COMPLETED|Enrolled||34
270406|NCT02243280|649009|P10|COMPLETED|Enrolled||0
270407|NCT02243280|649010|P9|COMPLETED|Enrolled||34
270408|NCT02243280|649011|P8|COMPLETED|Enrolled||0
270409|NCT02243280|649012|P7|COMPLETED|Enrolled||0
270410|NCT02243280|649013|P6|COMPLETED|Enrolled||27
270411|NCT02243280|649014|P5|COMPLETED|Enrolled||0
270412|NCT02243280|649015|P4|COMPLETED|Enrolled||0
270413|NCT02243280|649016|P3|COMPLETED|Enrolled||0
270414|NCT02243280|649017|P2|COMPLETED|Enrolled||39
270415|NCT02243280|649018|P1|COMPLETED|Enrolled||40
270416|NCT02243280|649008|P11|STARTED|Enrolled||34
270417|NCT02243280|649009|P10|STARTED|Enrolled||0
270418|NCT02243280|649010|P9|STARTED|Enrolled||34
270419|NCT02243280|649011|P8|STARTED|Enrolled||0
270420|NCT02243280|649012|P7|STARTED|Enrolled||0
270421|NCT02243280|649013|P6|STARTED|Enrolled||27
270422|NCT02243280|649014|P5|STARTED|Enrolled||0
270423|NCT02243280|649015|P4|STARTED|Enrolled||0
270424|NCT02243280|649016|P3|STARTED|Enrolled||0
270425|NCT02243280|649017|P2|STARTED|Enrolled||39
270426|NCT02243280|649018|P1|STARTED|Enrolled||40
270427|NCT02243202|649073|P4|NOT COMPLETED|Overall Study||23
270428|NCT02243202|649074|P3|NOT COMPLETED|Overall Study||31
270429|NCT02243202|649075|P2|NOT COMPLETED|Overall Study||25
270430|NCT02243202|649076|P1|NOT COMPLETED|Overall Study||25
270431|NCT02243202|649073|P4|COMPLETED|Overall Study||61
270432|NCT02243202|649074|P3|COMPLETED|Overall Study||53
270433|NCT02243202|649075|P2|COMPLETED|Overall Study||60
270434|NCT02243202|649076|P1|COMPLETED|Overall Study||57
270435|NCT02243202|649073|P4|Treated|Overall Study||83
270436|NCT02243202|649074|P3|Treated|Overall Study||84
270437|NCT02243202|649075|P2|Treated|Overall Study||85
270438|NCT02243202|649076|P1|Treated|Overall Study||82
270439|NCT02243202|649073|P4|STARTED|Overall Study||84
270440|NCT02243202|649074|P3|STARTED|Overall Study||84
270441|NCT02243202|649075|P2|STARTED|Overall Study||85
270442|NCT02243202|649076|P1|STARTED|Overall Study||82
270443|NCT02243176|649112|P2|NOT COMPLETED|Overall Study||15
270444|NCT02243176|649113|P1|NOT COMPLETED|Overall Study||14
270445|NCT02243176|649112|P2|COMPLETED|Overall Study||229
270446|NCT02243176|649113|P1|COMPLETED|Overall Study||230
270447|NCT02243176|649112|P2|STARTED|Overall Study||244
270448|NCT02243176|649113|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
270449|NCT02243046|649138|P3|NOT COMPLETED|Overall Study||4
270450|NCT02243046|649139|P2|NOT COMPLETED|Overall Study||1
270451|NCT02243046|649140|P1|NOT COMPLETED|Overall Study||1
270452|NCT02243046|649138|P3|COMPLETED|Overall Study||49
270453|NCT02243046|649139|P2|COMPLETED|Overall Study||53
270454|NCT02243046|649140|P1|COMPLETED|Overall Study||54
270455|NCT02243046|649138|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
270456|NCT02243046|649139|P2|6 Month|Overall Study||53
270457|NCT02243046|649140|P1|6 Month|Overall Study||54
270458|NCT02243046|649138|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
270459|NCT02243046|649139|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
270460|NCT02243046|649140|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
270461|NCT02243046|649138|P3|STARTED|Overall Study||53
270462|NCT02243046|649139|P2|STARTED|Overall Study||54
270463|NCT02243046|649140|P1|STARTED|Overall Study||55
270464|NCT02243007|649165|P2|NOT COMPLETED|Overall Study||0
270465|NCT02243007|649166|P1|NOT COMPLETED|Overall Study||0
270466|NCT02243007|649165|P2|COMPLETED|Overall Study||3
270467|NCT02243007|649166|P1|COMPLETED|Overall Study||4
270468|NCT02243007|649165|P2|STARTED|Overall Study||3
270469|NCT02243007|649166|P1|STARTED|Overall Study||4
270470|NCT02242994|649188|P1|NOT COMPLETED|Overall Study||0
270471|NCT02242994|649188|P1|COMPLETED|Overall Study||5
270472|NCT02242994|649188|P1|STARTED|Overall Study||5
270473|NCT02242643|649195|P2|NOT COMPLETED|Overall Study||78
270474|NCT02242643|649196|P1|NOT COMPLETED|Overall Study||75
270475|NCT02242643|649195|P2|COMPLETED|Overall Study||1139
270476|NCT02242643|649196|P1|COMPLETED|Overall Study||1132
270477|NCT02242643|649195|P2|STARTED|Overall Study||1217
270478|NCT02242643|649196|P1|STARTED|Overall Study||1207
270479|NCT02242630|649232|P4|NOT COMPLETED|Overall Study||0
270480|NCT02242630|649233|P3|NOT COMPLETED|Overall Study||0
270481|NCT02242630|649234|P2|NOT COMPLETED|Overall Study||0
270482|NCT02242630|649235|P1|NOT COMPLETED|Overall Study||0
270483|NCT02242630|649232|P4|COMPLETED|Overall Study||16
270484|NCT02242630|649233|P3|COMPLETED|Overall Study||15
270485|NCT02242630|649234|P2|COMPLETED|Overall Study||15
270486|NCT02242630|649235|P1|COMPLETED|Overall Study||15
270487|NCT02242630|649232|P4|STARTED|Overall Study||16
270488|NCT02242630|649233|P3|STARTED|Overall Study||15
270489|NCT02242630|649234|P2|STARTED|Overall Study||15
270490|NCT02242630|649235|P1|STARTED|Overall Study||15
270491|NCT02242019|649249|P1|NOT COMPLETED|Overall Study||0
270492|NCT02242019|649249|P1|COMPLETED|Overall Study||109
270493|NCT02242019|649249|P1|STARTED|Overall Study||109
270494|NCT02241889|649255|P6|NOT COMPLETED|Overall Study||1
270495|NCT02241889|649256|P5|NOT COMPLETED|Overall Study||0
270496|NCT02241889|649257|P4|NOT COMPLETED|Overall Study||0
270497|NCT02241889|649258|P3|NOT COMPLETED|Overall Study||1
270498|NCT02241889|649259|P2|NOT COMPLETED|Overall Study||0
270499|NCT02241889|649260|P1|NOT COMPLETED|Overall Study||0
270500|NCT02241889|649255|P6|COMPLETED|Overall Study||3
270501|NCT02241889|649256|P5|COMPLETED|Overall Study||5
270502|NCT02241889|649257|P4|COMPLETED|Overall Study||3
270503|NCT02241889|649258|P3|COMPLETED|Overall Study||2
270504|NCT02241889|649259|P2|COMPLETED|Overall Study||4
270505|NCT02241889|649260|P1|COMPLETED|Overall Study||4
270506|NCT02241889|649255|P6|STARTED|Overall Study||4
270507|NCT02241889|649256|P5|STARTED|Overall Study||5
270508|NCT02241889|649257|P4|STARTED|Overall Study||3
270509|NCT02241889|649258|P3|STARTED|Overall Study||3
270510|NCT02241889|649259|P2|STARTED|Overall Study||4
270511|NCT02241889|649260|P1|STARTED|Overall Study||4
270512|NCT02241785|649295|P1|NOT COMPLETED|Overall Study||47
270513|NCT02241785|649295|P1|COMPLETED|Overall Study||0
270514|NCT02241785|649295|P1|STARTED|Overall Study||47
270515|NCT02241486|649303|P1|NOT COMPLETED|Overall Study||0
270516|NCT02241486|649303|P1|COMPLETED|Overall Study||2
270517|NCT02241486|649303|P1|STARTED|Overall Study||2
270518|NCT02240628|649309|P2|NOT COMPLETED|Overall Study||5
270519|NCT02240628|649310|P1|NOT COMPLETED|Overall Study||6
270520|NCT02240628|649309|P2|COMPLETED|Overall Study||33
270521|NCT02240628|649310|P1|COMPLETED|Overall Study||32
270522|NCT02240628|649309|P2|STARTED|Overall Study||38
270523|NCT02240628|649310|P1|STARTED|Overall Study||38
270524|NCT02240368|649321|P3|NOT COMPLETED|Overall Study||1
270525|NCT02240368|649322|P2|NOT COMPLETED|Overall Study||0
270526|NCT02240368|649323|P1|NOT COMPLETED|Overall Study||1
270527|NCT02240368|649321|P3|COMPLETED|Overall Study||18
270528|NCT02240368|649322|P2|COMPLETED|Overall Study||22
270529|NCT02240368|649323|P1|COMPLETED|Overall Study||8
270530|NCT02240368|649321|P3|STARTED|Overall Study||19
270531|NCT02240368|649322|P2|STARTED|Overall Study||22
270532|NCT02240368|649323|P1|STARTED|Overall Study||9
270533|NCT02240329|649340|P1|NOT COMPLETED|Overall Study||0
270534|NCT02240329|649340|P1|COMPLETED|Overall Study||4
270535|NCT02240329|649340|P1|Determination of Urge to Cough|Overall Study||4
270536|NCT02240329|649340|P1|STARTED|Overall Study||4
270537|NCT02239978|649347|P2|NOT COMPLETED|Overall Study||0
270538|NCT02239978|649348|P1|NOT COMPLETED|Overall Study||2
270539|NCT02239978|649347|P2|COMPLETED|Overall Study||12
270540|NCT02239978|649348|P1|COMPLETED|Overall Study||28
270541|NCT02239978|649347|P2|STARTED|Overall Study||12
270542|NCT02239978|649348|P1|STARTED|Overall Study||30
270543|NCT02239926|649365|P2|NOT COMPLETED|Overall Study||1
270544|NCT02239926|649366|P1|NOT COMPLETED|Overall Study||0
270545|NCT02239926|649365|P2|COMPLETED|Overall Study||1
270546|NCT02239926|649366|P1|COMPLETED|Overall Study||0
270547|NCT02239926|649365|P2|STARTED|Overall Study||2
270548|NCT02239926|649366|P1|STARTED|Overall Study||0
270549|NCT02239744|649376|P2|NOT COMPLETED|Period 2||0
270550|NCT02239744|649377|P1|NOT COMPLETED|Period 2||0
270551|NCT02239744|649376|P2|COMPLETED|Period 2||18
270552|NCT02239744|649377|P1|COMPLETED|Period 2||17
270553|NCT02239744|649376|P2|STARTED|Period 2||18
270554|NCT02239744|649377|P1|STARTED|Period 2||17
270555|NCT02239744|649376|P2|NOT COMPLETED|Period 1||0
270556|NCT02239744|649377|P1|NOT COMPLETED|Period 1||0
270557|NCT02239744|649376|P2|COMPLETED|Period 1||18
270558|NCT02239744|649377|P1|COMPLETED|Period 1||17
270559|NCT02239744|649376|P2|STARTED|Period 1||18
270560|NCT02239744|649377|P1|STARTED|Period 1||17
270561|NCT02239692|649391|P2|NOT COMPLETED|Overall Study||13
270562|NCT02239692|649392|P1|NOT COMPLETED|Overall Study||6
270563|NCT02239692|649391|P2|COMPLETED|Overall Study||118
270564|NCT02239692|649392|P1|COMPLETED|Overall Study||67
270565|NCT02239692|649391|P2|Safety Analysis Set|Overall Study||125
270566|NCT02239692|649392|P1|Safety Analysis Set|Overall Study||70
270567|NCT02239692|649391|P2|Per-protocol Analysis Set|Overall Study||120
270568|NCT02239692|649392|P1|Per-protocol Analysis Set|Overall Study||66
270569|NCT02239692|649391|P2|Intention-to-treat Analysis Set|Overall Study||131
270570|NCT02239692|649392|P1|Intention-to-treat Analysis Set|Overall Study||73
270571|NCT02239692|649391|P2|STARTED|Overall Study||131
270572|NCT02239692|649392|P1|STARTED|Overall Study||73
270573|NCT02239289|649408|P1|NOT COMPLETED|Overall Study||0
270574|NCT02239289|649408|P1|COMPLETED|Overall Study||21
270575|NCT02239289|649408|P1|STARTED|Overall Study||21
270576|NCT02238782|649427|P1|NOT COMPLETED|Overall Study||0
270577|NCT02238782|649427|P1|COMPLETED|Overall Study||12
270578|NCT02238782|649427|P1|Subjects Treated|Overall Study||12
270579|NCT02238782|649427|P1|STARTED|Overall Study||12
270580|NCT02238379|649433|P2|NOT COMPLETED|Overall Study||0
270581|NCT02238379|649434|P1|NOT COMPLETED|Overall Study||1
270582|NCT02238379|649433|P2|COMPLETED|Overall Study||14
270583|NCT02238379|649434|P1|COMPLETED|Overall Study||11
270584|NCT02238379|649433|P2|STARTED|Overall Study||14
270585|NCT02238379|649434|P1|STARTED|Overall Study||12
270586|NCT02238080|649460|P1|NOT COMPLETED|Overall Study||25
270587|NCT02238080|649460|P1|COMPLETED|Overall Study||172
270588|NCT02238080|649460|P1|STARTED|Overall Study||197
270589|NCT02238067|649474|P1|NOT COMPLETED|Overall Study||45
270590|NCT02238067|649474|P1|COMPLETED|Overall Study||151
270591|NCT02238067|649474|P1|STARTED|Overall Study||196
270592|NCT02238028|649497|P2|NOT COMPLETED|Overall Study||2
270593|NCT02238028|649498|P1|NOT COMPLETED|Overall Study||2
270594|NCT02238028|649497|P2|COMPLETED|Overall Study||12
270595|NCT02238028|649498|P1|COMPLETED|Overall Study||12
270596|NCT02238028|649497|P2|STARTED|Overall Study||14
270597|NCT02238028|649498|P1|STARTED|Overall Study||14
270598|NCT02237118|649519|P2|NOT COMPLETED|Overall Study||1
270599|NCT02237118|649520|P1|NOT COMPLETED|Overall Study||1
270600|NCT02237118|649519|P2|COMPLETED|Overall Study||62
270601|NCT02237118|649520|P1|COMPLETED|Overall Study||59
270602|NCT02237118|649519|P2|STARTED|Overall Study||63
270603|NCT02237118|649520|P1|STARTED|Overall Study||60
270604|NCT02237092|649534|P1|NOT COMPLETED|Overall Study||0
270605|NCT02237092|649534|P1|COMPLETED|Overall Study||196
270606|NCT02237092|649534|P1|STARTED|Overall Study||196
270607|NCT02236767|649551|P1|NOT COMPLETED|Overall Study||0
270608|NCT02236767|649551|P1|COMPLETED|Overall Study||1
270609|NCT02236767|649551|P1|STARTED|Overall Study||1
270610|NCT02236611|649557|P2|NOT COMPLETED|Overall Study||34
270611|NCT02236611|649558|P1|NOT COMPLETED|Overall Study||26
270612|NCT02236611|649557|P2|COMPLETED|Overall Study||484
270613|NCT02236611|649558|P1|COMPLETED|Overall Study||490
270614|NCT02236611|649557|P2|STARTED|Overall Study||518
270615|NCT02236611|649558|P1|STARTED|Overall Study||516
270616|NCT02236598|649566|P2|NOT COMPLETED|Overall Study||2
270617|NCT02236598|649567|P1|NOT COMPLETED|Overall Study||0
270618|NCT02236598|649566|P2|COMPLETED|Overall Study||12
270619|NCT02236598|649567|P1|COMPLETED|Overall Study||15
270620|NCT02236598|649566|P2|STARTED|Overall Study||14
270621|NCT02236598|649567|P1|STARTED|Overall Study||15
270622|NCT02236546|649579|P1|NOT COMPLETED|Overall Study||0
270623|NCT02236546|649579|P1|COMPLETED|Overall Study||3
270624|NCT02236546|649579|P1|STARTED|Overall Study||3
270625|NCT02236130|649588|P2|NOT COMPLETED|Overall Study||12
270626|NCT02236130|649589|P1|NOT COMPLETED|Overall Study||7
270627|NCT02236130|649588|P2|COMPLETED|Overall Study||15
270628|NCT02236130|649589|P1|COMPLETED|Overall Study||15
270629|NCT02236130|649588|P2|STARTED|Overall Study||27
270630|NCT02236130|649589|P1|STARTED|Overall Study||22
270631|NCT02235831|649597|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
270632|NCT02235831|649598|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
270633|NCT02235831|649599|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
270634|NCT02235831|649600|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
270635|NCT02235831|649601|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
270636|NCT02235831|649602|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
270637|NCT02235831|649597|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
270638|NCT02235831|649598|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
270639|NCT02235831|649599|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
270640|NCT02235831|649600|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
270641|NCT02235831|649601|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
270642|NCT02235831|649602|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
270643|NCT02235831|649597|P6|STARTED|Period 3, Third 5 Days of Wear||4
270644|NCT02235831|649598|P5|STARTED|Period 3, Third 5 Days of Wear||4
270645|NCT02235831|649599|P4|STARTED|Period 3, Third 5 Days of Wear||4
270646|NCT02235831|649600|P3|STARTED|Period 3, Third 5 Days of Wear||4
270647|NCT02235831|649601|P2|STARTED|Period 3, Third 5 Days of Wear||4
270648|NCT02235831|649602|P1|STARTED|Period 3, Third 5 Days of Wear||4
270649|NCT02235831|649597|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
270650|NCT02235831|649598|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
270651|NCT02235831|649599|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
270652|NCT02235831|649600|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
270653|NCT02235831|649601|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
270654|NCT02235831|649602|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
270655|NCT02235831|649597|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
270656|NCT02235831|649598|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
270657|NCT02235831|649599|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
270658|NCT02235831|649600|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
270659|NCT02235831|649601|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
270660|NCT02235831|649602|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
270661|NCT02235831|649597|P6|STARTED|Period 2, Second 5 Days of Wear||4
270662|NCT02235831|649598|P5|STARTED|Period 2, Second 5 Days of Wear||4
270663|NCT02235831|649599|P4|STARTED|Period 2, Second 5 Days of Wear||4
270664|NCT02235831|649600|P3|STARTED|Period 2, Second 5 Days of Wear||4
270665|NCT02235831|649601|P2|STARTED|Period 2, Second 5 Days of Wear||4
270666|NCT02235831|649602|P1|STARTED|Period 2, Second 5 Days of Wear||4
270667|NCT02235831|649597|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
270668|NCT02235831|649598|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
270669|NCT02235831|649599|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
270670|NCT02235831|649600|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
270671|NCT02235831|649601|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
270672|NCT02235831|649602|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
270673|NCT02235831|649597|P6|COMPLETED|Period 1, First 5 Days of Wear||4
270674|NCT02235831|649598|P5|COMPLETED|Period 1, First 5 Days of Wear||4
270675|NCT02235831|649599|P4|COMPLETED|Period 1, First 5 Days of Wear||4
270676|NCT02235831|649600|P3|COMPLETED|Period 1, First 5 Days of Wear||4
270677|NCT02235831|649601|P2|COMPLETED|Period 1, First 5 Days of Wear||4
270678|NCT02235831|649602|P1|COMPLETED|Period 1, First 5 Days of Wear||4
270679|NCT02235831|649597|P6|STARTED|Period 1, First 5 Days of Wear||4
270680|NCT02235831|649598|P5|STARTED|Period 1, First 5 Days of Wear||4
270681|NCT02235831|649599|P4|STARTED|Period 1, First 5 Days of Wear||4
270682|NCT02235831|649600|P3|STARTED|Period 1, First 5 Days of Wear||4
270683|NCT02235831|649601|P2|STARTED|Period 1, First 5 Days of Wear||4
270684|NCT02235831|649602|P1|STARTED|Period 1, First 5 Days of Wear||4
270685|NCT02235493|649609|P1|NOT COMPLETED|Overall Study||0
270686|NCT02235493|649609|P1|COMPLETED|Overall Study||6
270687|NCT02235493|649609|P1|STARTED|Overall Study||6
270688|NCT02235285|649614|P1|NOT COMPLETED|Overall Study||13
270689|NCT02235285|649614|P1|COMPLETED|Overall Study||149
270690|NCT02235285|649614|P1|STARTED|Overall Study||162
270691|NCT02235077|649620|P2|NOT COMPLETED|Overall Study||19
270692|NCT02235077|649621|P1|NOT COMPLETED|Overall Study||18
270693|NCT02235077|649620|P2|COMPLETED|Overall Study||159
270694|NCT02235077|649621|P1|COMPLETED|Overall Study||164
270695|NCT02235077|649620|P2|STARTED|Overall Study||178
270696|NCT02235077|649621|P1|STARTED|Overall Study||182
270697|NCT02235064|649649|P2|NOT COMPLETED|Overall Study||0
270698|NCT02235064|649650|P1|NOT COMPLETED|Overall Study||0
270699|NCT02235064|649649|P2|COMPLETED|Overall Study||1
270700|NCT02235064|649650|P1|COMPLETED|Overall Study||1
270701|NCT02235064|649649|P2|STARTED|Overall Study||1
270702|NCT02235064|649650|P1|STARTED|Overall Study||1
270703|NCT02234479|649658|P2|NOT COMPLETED|Overall Study||3
270704|NCT02234479|649659|P1|NOT COMPLETED|Overall Study||1
270705|NCT02234479|649658|P2|COMPLETED|Overall Study||15
270706|NCT02234479|649659|P1|COMPLETED|Overall Study||15
270707|NCT02234479|649658|P2|STARTED|Overall Study||18
270708|NCT02234479|649659|P1|STARTED|Overall Study||16
270709|NCT02234427|649665|P1|NOT COMPLETED|Overall Study||1
270710|NCT02234427|649665|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
270711|NCT02234427|649665|P1|STARTED|Overall Study||34
270716|NCT02234011|649686|P1|NOT COMPLETED|Overall Study||0
270717|NCT02234011|649686|P1|COMPLETED|Overall Study||0
270718|NCT02234011|649686|P1|STARTED|Overall Study||0
270719|NCT02233998|649693|P3|NOT COMPLETED|Overall Study||0
270720|NCT02233998|649694|P2|NOT COMPLETED|Overall Study||0
270721|NCT02233998|649695|P1|NOT COMPLETED|Overall Study||0
270722|NCT02233998|649693|P3|COMPLETED|Overall Study||53
270723|NCT02233998|649694|P2|COMPLETED|Overall Study||52
270724|NCT02233998|649695|P1|COMPLETED|Overall Study||53
270725|NCT02233998|649693|P3|STARTED|Overall Study||53
270726|NCT02233998|649694|P2|STARTED|Overall Study||52
270727|NCT02233998|649695|P1|STARTED|Overall Study||53
270728|NCT02233985|649729|P2|NOT COMPLETED|Overall Study||0
270729|NCT02233985|649730|P1|NOT COMPLETED|Overall Study||0
270730|NCT02233985|649729|P2|COMPLETED|Overall Study||31
270731|NCT02233985|649730|P1|COMPLETED|Overall Study||33
270732|NCT02233985|649729|P2|STARTED|Overall Study||31
270733|NCT02233985|649730|P1|STARTED|Overall Study||33
270734|NCT02233842|649738|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
270735|NCT02233842|649738|P1|COMPLETED|Questionnaire 3 Version 2||5
270736|NCT02233842|649738|P1|STARTED|Questionnaire 3 Version 2||5
270737|NCT02233842|649738|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
270738|NCT02233842|649738|P1|COMPLETED|Questionnaire 3 Version 1||5
270739|NCT02233842|649738|P1|STARTED|Questionnaire 3 Version 1||5
270740|NCT02233842|649738|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
270741|NCT02233842|649738|P1|COMPLETED|Questionnaire 2 Version 2||5
270742|NCT02233842|649738|P1|STARTED|Questionnaire 2 Version 2||5
270743|NCT02233842|649738|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
270744|NCT02233842|649738|P1|COMPLETED|Questionnaire 2 Version 1||5
270745|NCT02233842|649738|P1|STARTED|Questionnaire 2 Version 1||5
270746|NCT02233842|649738|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
270747|NCT02233842|649738|P1|COMPLETED|Questionnaire 1 Version 2||5
270748|NCT02233842|649738|P1|STARTED|Questionnaire 1 Version 2||5
270749|NCT02233842|649738|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
270750|NCT02233842|649738|P1|COMPLETED|Questionnaire 1 Version 1||5
270751|NCT02233842|649738|P1|STARTED|Questionnaire 1 Version 1||5
270752|NCT02233647|649745|P1|NOT COMPLETED|Overall Study||1
270753|NCT02233647|649745|P1|COMPLETED|Overall Study||10
270754|NCT02233647|649745|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
270755|NCT02233647|649745|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
270756|NCT02233647|649745|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
270757|NCT02233647|649745|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
270758|NCT02233647|649745|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
270844|NCT02231177|649917|P6|STARTED|Treatment Period 2 (21 Days)||9
270759|NCT02233647|649745|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
270760|NCT02233647|649745|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
270761|NCT02233647|649745|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
270762|NCT02233647|649745|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
270763|NCT02233647|649745|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
270764|NCT02233647|649745|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
270765|NCT02233647|649745|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
270766|NCT02233647|649745|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
270767|NCT02233647|649745|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
270768|NCT02233647|649745|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
270769|NCT02233647|649745|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
270770|NCT02233647|649745|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
270771|NCT02233647|649745|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
270772|NCT02233647|649745|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
270773|NCT02233647|649745|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
270774|NCT02233647|649745|P1|STARTED|Overall Study||11
270775|NCT02233309|649774|P1|NOT COMPLETED|Overall Study||5
270776|NCT02233309|649774|P1|COMPLETED|Overall Study||31
270777|NCT02233309|649774|P1|STARTED|Overall Study||36
270778|NCT02233296|649780|P2|NOT COMPLETED|Overall Study||0
270779|NCT02233296|649781|P1|NOT COMPLETED|Overall Study||0
270780|NCT02233296|649780|P2|COMPLETED|Overall Study||14
270781|NCT02233296|649781|P1|COMPLETED|Overall Study||16
270782|NCT02233296|649780|P2|STARTED|Overall Study||14
270783|NCT02233296|649781|P1|STARTED|Overall Study||16
270784|NCT02233101|649799|P2|NOT COMPLETED|Overall Study||1
270785|NCT02233101|649800|P1|NOT COMPLETED|Overall Study||12
270786|NCT02233101|649799|P2|COMPLETED|Overall Study||80
270787|NCT02233101|649800|P1|COMPLETED|Overall Study||74
270788|NCT02233101|649799|P2|STARTED|Overall Study||81
270789|NCT02233101|649800|P1|STARTED|Overall Study||86
270790|NCT02232880|649808|P1|NOT COMPLETED|Overall Study||1
270791|NCT02232880|649808|P1|COMPLETED|Overall Study||0
270792|NCT02232880|649808|P1|STARTED|Overall Study||1
270793|NCT02232698|649817|P2|NOT COMPLETED|Overall Study||20
270794|NCT02232698|649818|P1|NOT COMPLETED|Overall Study||10
270795|NCT02232698|649817|P2|COMPLETED|Overall Study||101
270796|NCT02232698|649818|P1|COMPLETED|Overall Study||110
270797|NCT02232698|649817|P2|STARTED|Overall Study||121
270798|NCT02232698|649818|P1|STARTED|Overall Study||120
270799|NCT02232126|649841|P2|NOT COMPLETED|Overall Study||0
270800|NCT02232126|649842|P1|NOT COMPLETED|Overall Study||0
270801|NCT02232126|649841|P2|COMPLETED|Overall Study||90
270802|NCT02232126|649842|P1|COMPLETED|Overall Study||91
270803|NCT02232126|649841|P2|STARTED|Overall Study||90
270804|NCT02232126|649842|P1|STARTED|Overall Study||91
270805|NCT02231918|649853|P3|NOT COMPLETED|Overall Study||1
270806|NCT02231918|649854|P2|NOT COMPLETED|Overall Study||1
270807|NCT02231918|649855|P1|NOT COMPLETED|Overall Study||0
270808|NCT02231918|649853|P3|COMPLETED|Overall Study||1
270809|NCT02231918|649854|P2|COMPLETED|Overall Study||14
270810|NCT02231918|649855|P1|COMPLETED|Overall Study||9
270811|NCT02231918|649853|P3|STARTED|Overall Study||2
270812|NCT02231918|649854|P2|STARTED|Overall Study||15
270813|NCT02231918|649855|P1|STARTED|Overall Study||9
270814|NCT02231177|649917|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
270815|NCT02231177|649918|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
270816|NCT02231177|649919|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
270817|NCT02231177|649920|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
270818|NCT02231177|649921|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
270819|NCT02231177|649922|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
270820|NCT02231177|649917|P6|COMPLETED|Treatment Period 3 (21 Days)||9
270821|NCT02231177|649918|P5|COMPLETED|Treatment Period 3 (21 Days)||8
270822|NCT02231177|649919|P4|COMPLETED|Treatment Period 3 (21 Days)||7
270823|NCT02231177|649920|P3|COMPLETED|Treatment Period 3 (21 Days)||8
270824|NCT02231177|649921|P2|COMPLETED|Treatment Period 3 (21 Days)||7
270825|NCT02231177|649922|P1|COMPLETED|Treatment Period 3 (21 Days)||8
270826|NCT02231177|649917|P6|STARTED|Treatment Period 3 (21 Days)||9
270827|NCT02231177|649918|P5|STARTED|Treatment Period 3 (21 Days)||8
270828|NCT02231177|649919|P4|STARTED|Treatment Period 3 (21 Days)||7
270829|NCT02231177|649920|P3|STARTED|Treatment Period 3 (21 Days)||8
270830|NCT02231177|649921|P2|STARTED|Treatment Period 3 (21 Days)||7
270831|NCT02231177|649922|P1|STARTED|Treatment Period 3 (21 Days)||8
270832|NCT02231177|649917|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
270833|NCT02231177|649918|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
270834|NCT02231177|649919|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
270835|NCT02231177|649920|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
270836|NCT02231177|649921|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
270837|NCT02231177|649922|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
270838|NCT02231177|649917|P6|COMPLETED|Treatment Period 2 (21 Days)||9
270839|NCT02231177|649918|P5|COMPLETED|Treatment Period 2 (21 Days)||8
270840|NCT02231177|649919|P4|COMPLETED|Treatment Period 2 (21 Days)||7
270841|NCT02231177|649920|P3|COMPLETED|Treatment Period 2 (21 Days)||8
270842|NCT02231177|649921|P2|COMPLETED|Treatment Period 2 (21 Days)||7
270843|NCT02231177|649922|P1|COMPLETED|Treatment Period 2 (21 Days)||8
270845|NCT02231177|649918|P5|STARTED|Treatment Period 2 (21 Days)||8
270846|NCT02231177|649919|P4|STARTED|Treatment Period 2 (21 Days)||7
270847|NCT02231177|649920|P3|STARTED|Treatment Period 2 (21 Days)||8
270848|NCT02231177|649921|P2|STARTED|Treatment Period 2 (21 Days)||7
270849|NCT02231177|649922|P1|STARTED|Treatment Period 2 (21 Days)||8
270850|NCT02231177|649917|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
270851|NCT02231177|649918|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
270852|NCT02231177|649919|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
270853|NCT02231177|649920|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
270854|NCT02231177|649921|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
270855|NCT02231177|649922|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
270856|NCT02231177|649917|P6|COMPLETED|Treatment Period 1 (21 Days)||9
270857|NCT02231177|649918|P5|COMPLETED|Treatment Period 1 (21 Days)||8
270858|NCT02231177|649919|P4|COMPLETED|Treatment Period 1 (21 Days)||7
270859|NCT02231177|649920|P3|COMPLETED|Treatment Period 1 (21 Days)||8
270860|NCT02231177|649921|P2|COMPLETED|Treatment Period 1 (21 Days)||7
270861|NCT02231177|649922|P1|COMPLETED|Treatment Period 1 (21 Days)||8
270862|NCT02231177|649917|P6|STARTED|Treatment Period 1 (21 Days)||9
270863|NCT02231177|649918|P5|STARTED|Treatment Period 1 (21 Days)||8
270864|NCT02231177|649919|P4|STARTED|Treatment Period 1 (21 Days)||7
270865|NCT02231177|649920|P3|STARTED|Treatment Period 1 (21 Days)||8
270866|NCT02231177|649921|P2|STARTED|Treatment Period 1 (21 Days)||7
270867|NCT02231177|649922|P1|STARTED|Treatment Period 1 (21 Days)||8
270868|NCT02231164|649978|P2|NOT COMPLETED|Overall Study||6
270869|NCT02231164|649979|P1|NOT COMPLETED|Overall Study||6
270870|NCT02231164|649978|P2|COMPLETED|Overall Study||0
270871|NCT02231164|649979|P1|COMPLETED|Overall Study||0
270872|NCT02231164|649978|P2|STARTED|Overall Study||6
270873|NCT02231164|649979|P1|STARTED|Overall Study||6
270874|NCT02230995|649987|P2|NOT COMPLETED|Period 2 + Washout||0
270875|NCT02230995|649988|P1|NOT COMPLETED|Period 2 + Washout||0
270876|NCT02230995|649987|P2|COMPLETED|Period 2 + Washout||15
270877|NCT02230995|649988|P1|COMPLETED|Period 2 + Washout||15
270878|NCT02230995|649987|P2|STARTED|Period 2 + Washout||15
270879|NCT02230995|649988|P1|STARTED|Period 2 + Washout||15
270880|NCT02230995|649987|P2|NOT COMPLETED|Period 1 + Washout||0
270881|NCT02230995|649988|P1|NOT COMPLETED|Period 1 + Washout||0
270882|NCT02230995|649987|P2|COMPLETED|Period 1 + Washout||15
270883|NCT02230995|649988|P1|COMPLETED|Period 1 + Washout||15
270884|NCT02230995|649987|P2|STARTED|Period 1 + Washout||15
270885|NCT02230995|649988|P1|STARTED|Period 1 + Washout||15
270886|NCT02230956|650007|P3|NOT COMPLETED|Overall Study||7
270887|NCT02230956|650008|P2|NOT COMPLETED|Overall Study||6
270888|NCT02230956|650009|P1|NOT COMPLETED|Overall Study||5
270889|NCT02230956|650007|P3|COMPLETED|Overall Study||82
270890|NCT02230956|650008|P2|COMPLETED|Overall Study||37
270891|NCT02230956|650009|P1|COMPLETED|Overall Study||39
270892|NCT02230956|650007|P3|STARTED|Overall Study||89
270893|NCT02230956|650008|P2|STARTED|Overall Study||43
270894|NCT02230956|650009|P1|STARTED|Overall Study||44
270895|NCT02230904|650031|P2|NOT COMPLETED|Overall Study||1
270896|NCT02230904|650032|P1|NOT COMPLETED|Overall Study||0
270897|NCT02230904|650031|P2|COMPLETED|Overall Study||27
270898|NCT02230904|650032|P1|COMPLETED|Overall Study||29
270899|NCT02230904|650031|P2|STARTED|Overall Study||28
270900|NCT02230904|650032|P1|STARTED|Overall Study||29
270901|NCT02230761|650054|P2|NOT COMPLETED|Overall Study||1
270902|NCT02230761|650055|P1|NOT COMPLETED|Overall Study||0
270903|NCT02230761|650054|P2|COMPLETED|Overall Study||29
270904|NCT02230761|650055|P1|COMPLETED|Overall Study||60
270905|NCT02230761|650054|P2|STARTED|Overall Study||30
270906|NCT02230761|650055|P1|STARTED|Overall Study||60
270907|NCT02230683|650065|P1|NOT COMPLETED|Overall Study||1
270908|NCT02230683|650065|P1|COMPLETED|Overall Study||22
270909|NCT02230683|650065|P1|STARTED|Overall Study||23
270910|NCT02230540|650080|P2|NOT COMPLETED|Overall Study||0
270911|NCT02230540|650081|P1|NOT COMPLETED|Overall Study||0
270912|NCT02230540|650080|P2|COMPLETED|Overall Study||0
270913|NCT02230540|650081|P1|COMPLETED|Overall Study||8
270914|NCT02230540|650080|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
270915|NCT02230540|650081|P1|STARTED|Overall Study||8
270916|NCT02230085|650085|P1|NOT COMPLETED|Overall Study||4
270917|NCT02230085|650085|P1|COMPLETED|Overall Study||106
270918|NCT02230085|650085|P1|STARTED|Overall Study||110
270919|NCT02229864|650089|P1|NOT COMPLETED|1 - Year Visit||1
270920|NCT02229864|650089|P1|COMPLETED|1 - Year Visit||11
270921|NCT02229864|650089|P1|STARTED|1 - Year Visit||12
270922|NCT02229864|650089|P1|NOT COMPLETED|6 - Month Visit||0
270923|NCT02229864|650089|P1|COMPLETED|6 - Month Visit||12
270924|NCT02229864|650089|P1|STARTED|6 - Month Visit||12
270925|NCT02229864|650089|P1|NOT COMPLETED|1 - Month Visit||0
270926|NCT02229864|650089|P1|COMPLETED|1 - Month Visit||12
270927|NCT02229864|650089|P1|STARTED|1 - Month Visit||12
270928|NCT02229539|650130|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
270929|NCT02229539|650131|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
270930|NCT02229539|650132|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
270931|NCT02229539|650130|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
270932|NCT02229539|650131|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
271371|NCT02219997|651035|P1|STARTED|First Filter||33
270933|NCT02229539|650132|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
270934|NCT02229539|650130|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
270935|NCT02229539|650131|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
270936|NCT02229539|650132|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
270937|NCT02229539|650130|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
270938|NCT02229539|650131|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
270939|NCT02229539|650132|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
270940|NCT02229539|650130|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
270941|NCT02229539|650131|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
270942|NCT02229539|650132|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
270943|NCT02229539|650130|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
270944|NCT02229539|650131|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
270945|NCT02229539|650132|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
270946|NCT02229513|650142|P2|NOT COMPLETED|Overall Study||0
270947|NCT02229513|650143|P1|NOT COMPLETED|Overall Study||0
270948|NCT02229513|650142|P2|COMPLETED|Overall Study||100
270949|NCT02229513|650143|P1|COMPLETED|Overall Study||100
270950|NCT02229513|650142|P2|STARTED|Overall Study||100
270951|NCT02229513|650143|P1|STARTED|Overall Study||100
270952|NCT02229461|650184|P6|NOT COMPLETED|Overall Study||0
270953|NCT02229461|650185|P5|NOT COMPLETED|Overall Study||0
270954|NCT02229461|650186|P4|NOT COMPLETED|Overall Study||0
270955|NCT02229461|650187|P3|NOT COMPLETED|Overall Study||0
270956|NCT02229461|650188|P2|NOT COMPLETED|Overall Study||0
270957|NCT02229461|650189|P1|NOT COMPLETED|Overall Study||0
270958|NCT02229461|650184|P6|COMPLETED|Overall Study||17
270959|NCT02229461|650185|P5|COMPLETED|Overall Study||17
270960|NCT02229461|650186|P4|COMPLETED|Overall Study||17
270961|NCT02229461|650187|P3|COMPLETED|Overall Study||17
270962|NCT02229461|650188|P2|COMPLETED|Overall Study||17
270963|NCT02229461|650189|P1|COMPLETED|Overall Study||17
270964|NCT02229461|650184|P6|STARTED|Overall Study|Randomized and received treatment|17
270965|NCT02229461|650185|P5|STARTED|Overall Study|Randomized and received treatment|17
270966|NCT02229461|650186|P4|STARTED|Overall Study|Randomized and received treatment|17
270967|NCT02229461|650187|P3|STARTED|Overall Study|Randomized and received treatment|17
270968|NCT02229461|650188|P2|STARTED|Overall Study|Randomized and received treatment|17
270969|NCT02229461|650189|P1|STARTED|Overall Study|Randomized and received treatment|17
270970|NCT02229318|650222|P1|NOT COMPLETED|Overall Study||0
270971|NCT02229318|650222|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
270972|NCT02229318|650222|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
270973|NCT02229214|650229|P2|NOT COMPLETED|Overall Study||0
270974|NCT02229214|650230|P1|NOT COMPLETED|Overall Study||6
270975|NCT02229214|650229|P2|COMPLETED|Overall Study||10
270976|NCT02229214|650230|P1|COMPLETED|Overall Study||35
270977|NCT02229214|650229|P2|STARTED|Overall Study||10
270978|NCT02229214|650230|P1|STARTED|Overall Study||41
270979|NCT02228980|650254|P4|NOT COMPLETED|Overall Study||3
270980|NCT02228980|650255|P3|NOT COMPLETED|Overall Study||2
270981|NCT02228980|650256|P2|NOT COMPLETED|Overall Study||3
270982|NCT02228980|650257|P1|NOT COMPLETED|Overall Study||24
270983|NCT02228980|650254|P4|COMPLETED|Overall Study||148
270984|NCT02228980|650255|P3|COMPLETED|Overall Study||149
270985|NCT02228980|650256|P2|COMPLETED|Overall Study||147
270986|NCT02228980|650257|P1|COMPLETED|Overall Study||126
270987|NCT02228980|650254|P4|STARTED|Overall Study||151
270988|NCT02228980|650255|P3|STARTED|Overall Study||151
270989|NCT02228980|650256|P2|STARTED|Overall Study||150
270990|NCT02228980|650257|P1|STARTED|Overall Study||150
270991|NCT02228395|650279|P3|NOT COMPLETED|Third Intervention Period||0
270992|NCT02228395|650280|P2|NOT COMPLETED|Third Intervention Period||0
270993|NCT02228395|650281|P1|NOT COMPLETED|Third Intervention Period||0
270994|NCT02228395|650279|P3|COMPLETED|Third Intervention Period||3
270995|NCT02228395|650280|P2|COMPLETED|Third Intervention Period||3
270996|NCT02228395|650281|P1|COMPLETED|Third Intervention Period||3
270997|NCT02228395|650279|P3|STARTED|Third Intervention Period||3
270998|NCT02228395|650280|P2|STARTED|Third Intervention Period||3
270999|NCT02228395|650281|P1|STARTED|Third Intervention Period||3
271000|NCT02228395|650279|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
271001|NCT02228395|650280|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
271002|NCT02228395|650281|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
271003|NCT02228395|650279|P3|COMPLETED|Washout Period (at Least 10 Days)||3
271004|NCT02228395|650280|P2|COMPLETED|Washout Period (at Least 10 Days)||3
271005|NCT02228395|650281|P1|COMPLETED|Washout Period (at Least 10 Days)||3
271006|NCT02228395|650279|P3|STARTED|Washout Period (at Least 10 Days)||3
271007|NCT02228395|650280|P2|STARTED|Washout Period (at Least 10 Days)||3
271008|NCT02228395|650281|P1|STARTED|Washout Period (at Least 10 Days)||3
271009|NCT02228395|650279|P3|NOT COMPLETED|Second Intervention Period||0
271010|NCT02228395|650280|P2|NOT COMPLETED|Second Intervention Period||0
271011|NCT02228395|650281|P1|NOT COMPLETED|Second Intervention Period||0
271012|NCT02228395|650279|P3|COMPLETED|Second Intervention Period||3
271013|NCT02228395|650280|P2|COMPLETED|Second Intervention Period||3
271014|NCT02228395|650281|P1|COMPLETED|Second Intervention Period||3
271015|NCT02228395|650279|P3|STARTED|Second Intervention Period||3
271016|NCT02228395|650280|P2|STARTED|Second Intervention Period||3
271017|NCT02228395|650281|P1|STARTED|Second Intervention Period||3
271018|NCT02228395|650279|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
271019|NCT02228395|650280|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
271020|NCT02228395|650281|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
271021|NCT02228395|650279|P3|COMPLETED|Washout Period (at Least 10 Days)||3
271022|NCT02228395|650280|P2|COMPLETED|Washout Period (at Least 10 Days)||3
271023|NCT02228395|650281|P1|COMPLETED|Washout Period (at Least 10 Days)||3
271024|NCT02228395|650279|P3|STARTED|Washout Period (at Least 10 Days)||3
271025|NCT02228395|650280|P2|STARTED|Washout Period (at Least 10 Days)||3
271026|NCT02228395|650281|P1|STARTED|Washout Period (at Least 10 Days)||3
271027|NCT02228395|650279|P3|NOT COMPLETED|First Intervention Period||1
271028|NCT02228395|650280|P2|NOT COMPLETED|First Intervention Period||1
271029|NCT02228395|650281|P1|NOT COMPLETED|First Intervention Period||1
271030|NCT02228395|650279|P3|COMPLETED|First Intervention Period||2
271031|NCT02228395|650280|P2|COMPLETED|First Intervention Period||2
271032|NCT02228395|650281|P1|COMPLETED|First Intervention Period||2
271033|NCT02228395|650279|P3|STARTED|First Intervention Period||3
271034|NCT02228395|650280|P2|STARTED|First Intervention Period||3
271035|NCT02228395|650281|P1|STARTED|First Intervention Period||3
271036|NCT02227810|650347|P2|NOT COMPLETED|Overall Study||5
271037|NCT02227810|650348|P1|NOT COMPLETED|Overall Study||2
271038|NCT02227810|650347|P2|COMPLETED|Overall Study||29
271039|NCT02227810|650348|P1|COMPLETED|Overall Study||17
271040|NCT02227810|650347|P2|STARTED|Overall Study||34
271041|NCT02227810|650348|P1|STARTED|Overall Study||19
271042|NCT02227485|650362|P2|NOT COMPLETED|Second Follow-up||2
271043|NCT02227485|650363|P1|NOT COMPLETED|Second Follow-up||2
271044|NCT02227485|650362|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
271045|NCT02227485|650363|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
271046|NCT02227485|650362|P2|STARTED|Second Follow-up||38
271047|NCT02227485|650363|P1|STARTED|Second Follow-up||36
271048|NCT02227485|650362|P2|NOT COMPLETED|First Follow-up||2
271049|NCT02227485|650363|P1|NOT COMPLETED|First Follow-up||4
271050|NCT02227485|650362|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
271051|NCT02227485|650363|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
271052|NCT02227485|650362|P2|STARTED|First Follow-up||40
271053|NCT02227485|650363|P1|STARTED|First Follow-up||40
271054|NCT02227368|650381|P2|NOT COMPLETED|Overall Study||4
271055|NCT02227368|650382|P1|NOT COMPLETED|Overall Study||2
271056|NCT02227368|650381|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
271057|NCT02227368|650382|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
271058|NCT02227368|650381|P2|Sujects Who Completed Treatment|Overall Study||17
271059|NCT02227368|650382|P1|Sujects Who Completed Treatment|Overall Study||10
271060|NCT02227368|650381|P2|Sujects Who Received Treatment|Overall Study||24
271061|NCT02227368|650382|P1|Sujects Who Received Treatment|Overall Study||16
271062|NCT02227368|650381|P2|STARTED|Overall Study||24
271063|NCT02227368|650382|P1|STARTED|Overall Study||16
271064|NCT02227121|650390|P1|NOT COMPLETED|Overall Study||0
271065|NCT02227121|650390|P1|COMPLETED|Overall Study||16
271066|NCT02227121|650390|P1|STARTED|Overall Study||16
271067|NCT02227108|650394|P1|NOT COMPLETED|Overall Study||31
271068|NCT02227108|650394|P1|COMPLETED|Overall Study||1
271069|NCT02227108|650394|P1|Treated|Overall Study||30
271070|NCT02227108|650394|P1|STARTED|Overall Study||32
271071|NCT02226562|650423|P2|NOT COMPLETED|Overall Study||1
271072|NCT02226562|650424|P1|NOT COMPLETED|Overall Study||0
271073|NCT02226562|650423|P2|COMPLETED|Overall Study|Lost to follow up|95
271074|NCT02226562|650424|P1|COMPLETED|Overall Study||95
271075|NCT02226562|650423|P2|STARTED|Overall Study||96
271076|NCT02226562|650424|P1|STARTED|Overall Study||95
271077|NCT02226549|650442|P2|NOT COMPLETED|Overall Study||1
271078|NCT02226549|650443|P1|NOT COMPLETED|Overall Study||1
271079|NCT02226549|650442|P2|COMPLETED|Overall Study||23
271080|NCT02226549|650443|P1|COMPLETED|Overall Study||22
271081|NCT02226549|650442|P2|STARTED|Overall Study||24
271082|NCT02226549|650443|P1|STARTED|Overall Study||23
271083|NCT02226198|650453|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
271084|NCT02226198|650454|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
271085|NCT02226198|650455|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
271086|NCT02226198|650453|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
271087|NCT02226198|650454|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
271088|NCT02226198|650455|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
271089|NCT02226198|650453|P3|STARTED|Maintenance Phase (12 Weeks)||0
271090|NCT02226198|650454|P2|STARTED|Maintenance Phase (12 Weeks)||0
271091|NCT02226198|650455|P1|STARTED|Maintenance Phase (12 Weeks)||13
271092|NCT02226198|650453|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
271093|NCT02226198|650454|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
271094|NCT02226198|650455|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
271095|NCT02226198|650453|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
271096|NCT02226198|650454|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
271097|NCT02226198|650455|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
271098|NCT02226198|650453|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
271099|NCT02226198|650454|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
271100|NCT02226198|650455|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
271101|NCT02226198|650453|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
271102|NCT02226198|650454|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
271103|NCT02226198|650455|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
271104|NCT02226198|650453|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
271105|NCT02226198|650454|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
271106|NCT02226198|650455|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
271107|NCT02226198|650453|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
271108|NCT02226198|650454|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
271109|NCT02226198|650455|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
271110|NCT02226198|650453|P3|NOT COMPLETED|Lead-in Phase||0
271111|NCT02226198|650454|P2|NOT COMPLETED|Lead-in Phase||0
271112|NCT02226198|650455|P1|NOT COMPLETED|Lead-in Phase||1
271113|NCT02226198|650453|P3|COMPLETED|Lead-in Phase||0
271114|NCT02226198|650454|P2|COMPLETED|Lead-in Phase||0
271115|NCT02226198|650455|P1|COMPLETED|Lead-in Phase||10
271116|NCT02226198|650453|P3|STARTED|Lead-in Phase||0
271117|NCT02226198|650454|P2|STARTED|Lead-in Phase||0
271118|NCT02226198|650455|P1|STARTED|Lead-in Phase||11
271119|NCT02226003|650531|P3|NOT COMPLETED|Overall Study||6
271120|NCT02226003|650532|P2|NOT COMPLETED|Overall Study||1
271121|NCT02226003|650533|P1|NOT COMPLETED|Overall Study||2
271122|NCT02226003|650531|P3|COMPLETED|Overall Study||91
271123|NCT02226003|650532|P2|COMPLETED|Overall Study||95
271124|NCT02226003|650533|P1|COMPLETED|Overall Study||96
271125|NCT02226003|650531|P3|STARTED|Overall Study||97
271126|NCT02226003|650532|P2|STARTED|Overall Study||96
271127|NCT02226003|650533|P1|STARTED|Overall Study||98
271128|NCT02225860|650567|P2|NOT COMPLETED|Overall Study||0
271129|NCT02225860|650568|P1|NOT COMPLETED|Overall Study||1
271130|NCT02225860|650567|P2|COMPLETED|Overall Study||17
271131|NCT02225860|650568|P1|COMPLETED|Overall Study||16
271132|NCT02225860|650567|P2|STARTED|Overall Study||17
271133|NCT02225860|650568|P1|STARTED|Overall Study||17
271134|NCT02224820|650578|P1|NOT COMPLETED|Overall Study||0
271135|NCT02224820|650578|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
271136|NCT02224820|650578|P1|STARTED|Overall Study||8
271137|NCT02224664|650586|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
271138|NCT02224664|650587|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
271139|NCT02224664|650588|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
271140|NCT02224664|650589|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
271141|NCT02224664|650590|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
271142|NCT02224664|650586|P5|COMPLETED|Dose Escalation Period (21 Days)||8
271143|NCT02224664|650587|P4|COMPLETED|Dose Escalation Period (21 Days)||3
271144|NCT02224664|650588|P3|COMPLETED|Dose Escalation Period (21 Days)||9
271145|NCT02224664|650589|P2|COMPLETED|Dose Escalation Period (21 Days)||9
271146|NCT02224664|650590|P1|COMPLETED|Dose Escalation Period (21 Days)||0
271147|NCT02224664|650586|P5|STARTED|Dose Escalation Period (21 Days)||19
271148|NCT02224664|650587|P4|STARTED|Dose Escalation Period (21 Days)||6
271149|NCT02224664|650588|P3|STARTED|Dose Escalation Period (21 Days)||11
271150|NCT02224664|650589|P2|STARTED|Dose Escalation Period (21 Days)||9
271151|NCT02224664|650590|P1|STARTED|Dose Escalation Period (21 Days)||0
271152|NCT02224664|650586|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
271153|NCT02224664|650587|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
271154|NCT02224664|650588|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
271155|NCT02224664|650589|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
271156|NCT02224664|650590|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
271157|NCT02224664|650586|P5|COMPLETED|Lead-in Period (3 Days)||0
271158|NCT02224664|650587|P4|COMPLETED|Lead-in Period (3 Days)||0
271159|NCT02224664|650588|P3|COMPLETED|Lead-in Period (3 Days)||0
271160|NCT02224664|650589|P2|COMPLETED|Lead-in Period (3 Days)||0
271161|NCT02224664|650590|P1|COMPLETED|Lead-in Period (3 Days)||45
271162|NCT02224664|650586|P5|STARTED|Lead-in Period (3 Days)||0
271163|NCT02224664|650587|P4|STARTED|Lead-in Period (3 Days)||0
271164|NCT02224664|650588|P3|STARTED|Lead-in Period (3 Days)||0
271165|NCT02224664|650589|P2|STARTED|Lead-in Period (3 Days)||0
271166|NCT02224664|650590|P1|STARTED|Lead-in Period (3 Days)||50
271167|NCT02224625|650670|P1|NOT COMPLETED|Sensitization||55
271168|NCT02224625|650670|P1|COMPLETED|Sensitization||194
271169|NCT02224625|650670|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
271170|NCT02224625|650670|P1|NOT COMPLETED|Irritation||6
271171|NCT02224625|650670|P1|COMPLETED|Irritation||33
271172|NCT02224625|650670|P1|STARTED|Irritation||39
271173|NCT02224508|650684|P2|NOT COMPLETED|Overall Study||0
271174|NCT02224508|650685|P1|NOT COMPLETED|Overall Study||0
271175|NCT02224508|650684|P2|COMPLETED|Overall Study||653
271176|NCT02224508|650685|P1|COMPLETED|Overall Study||935
271177|NCT02224508|650684|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
271178|NCT02224508|650685|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
271179|NCT02224404|650695|P1|NOT COMPLETED|Overall Study||0
271180|NCT02224404|650695|P1|COMPLETED|Overall Study||21
271181|NCT02224404|650695|P1|STARTED|Overall Study||21
271182|NCT02224053|650700|P1|NOT COMPLETED|AZD9291 Alone||0
271183|NCT02224053|650700|P1|COMPLETED|AZD9291 Alone||47
271184|NCT02224053|650700|P1|STARTED|AZD9291 Alone||47
271185|NCT02224053|650700|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
271186|NCT02224053|650700|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
271187|NCT02224053|650700|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
271188|NCT02223871|650732|P1|NOT COMPLETED|Overall Study||0
271189|NCT02223871|650732|P1|COMPLETED|Overall Study||8
271190|NCT02223871|650732|P1|STARTED|Overall Study||8
271191|NCT02223754|650746|P2|NOT COMPLETED|Period 2||3
271192|NCT02223754|650747|P1|NOT COMPLETED|Period 2||3
271193|NCT02223754|650746|P2|COMPLETED|Period 2||141
271194|NCT02223754|650747|P1|COMPLETED|Period 2||156
271195|NCT02223754|650746|P2|STARTED|Period 2||144
271196|NCT02223754|650747|P1|STARTED|Period 2||159
271197|NCT02223754|650746|P2|NOT COMPLETED|Period 1||15
271198|NCT02223754|650747|P1|NOT COMPLETED|Period 1||4
271199|NCT02223754|650746|P2|COMPLETED|Period 1||144
271200|NCT02223754|650747|P1|COMPLETED|Period 1||159
271201|NCT02223754|650746|P2|STARTED|Period 1||159
271202|NCT02223754|650747|P1|STARTED|Period 1||163
271203|NCT02223715|650767|P1|NOT COMPLETED|Overall Study||104
271204|NCT02223715|650767|P1|COMPLETED|Overall Study||496
271205|NCT02223715|650767|P1|STARTED|Overall Study||600
271206|NCT02223650|650776|P2|NOT COMPLETED|Overall Study||0
271207|NCT02223650|650777|P1|NOT COMPLETED|Overall Study||0
271208|NCT02223650|650776|P2|COMPLETED|Overall Study||31
271209|NCT02223650|650777|P1|COMPLETED|Overall Study||27
271210|NCT02223650|650776|P2|STARTED|Overall Study||31
271211|NCT02223650|650777|P1|STARTED|Overall Study||27
271212|NCT02223429|650811|P4|NOT COMPLETED|Overall Study||0
271213|NCT02223429|650812|P3|NOT COMPLETED|Overall Study||0
271214|NCT02223429|650813|P2|NOT COMPLETED|Overall Study||0
271215|NCT02223429|650814|P1|NOT COMPLETED|Overall Study||1
271216|NCT02223429|650811|P4|COMPLETED|Overall Study||8
271217|NCT02223429|650812|P3|COMPLETED|Overall Study||8
271218|NCT02223429|650813|P2|COMPLETED|Overall Study||8
271219|NCT02223429|650814|P1|COMPLETED|Overall Study||7
271220|NCT02223429|650811|P4|STARTED|Overall Study||8
271221|NCT02223429|650812|P3|STARTED|Overall Study||8
271222|NCT02223429|650813|P2|STARTED|Overall Study||8
271223|NCT02223429|650814|P1|STARTED|Overall Study||8
271224|NCT02223260|650842|P1|NOT COMPLETED|Overall Study||0
271225|NCT02223260|650842|P1|COMPLETED|Overall Study||8
271226|NCT02223260|650842|P1|STARTED|Overall Study||8
271227|NCT02223065|650860|P2|NOT COMPLETED|Overall Study||0
271228|NCT02223065|650861|P1|NOT COMPLETED|Overall Study||0
271229|NCT02223065|650860|P2|COMPLETED|Overall Study||18
271230|NCT02223065|650861|P1|COMPLETED|Overall Study||18
271231|NCT02223065|650860|P2|STARTED|Overall Study||18
271232|NCT02223065|650861|P1|STARTED|Overall Study||18
271233|NCT02222870|650879|P2|NOT COMPLETED|Overall Study||0
271234|NCT02222870|650880|P1|NOT COMPLETED|Overall Study||0
271235|NCT02222870|650879|P2|COMPLETED|Overall Study||30
271236|NCT02222870|650880|P1|COMPLETED|Overall Study||30
271237|NCT02222870|650879|P2|STARTED|Overall Study||30
271238|NCT02222870|650880|P1|STARTED|Overall Study||30
271239|NCT02222818|650896|P2|NOT COMPLETED|Period 2||0
271240|NCT02222818|650897|P1|NOT COMPLETED|Period 2||0
271241|NCT02222818|650896|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
271242|NCT02222818|650897|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
271243|NCT02222818|650896|P2|STARTED|Period 2|Start of CAFR evaluation period|30
271244|NCT02222818|650897|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
271245|NCT02222818|650896|P2|NOT COMPLETED|Period 1||3
271246|NCT02222818|650897|P1|NOT COMPLETED|Period 1||0
271247|NCT02222818|650896|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
271248|NCT02222818|650897|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
271249|NCT02222818|650896|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
271250|NCT02222818|650897|P1|STARTED|Period 1|Start of CAFR evaluation period|33
271251|NCT02222558|650904|P6|NOT COMPLETED|Period 3||1
271252|NCT02222558|650905|P5|NOT COMPLETED|Period 3||0
271253|NCT02222558|650906|P4|NOT COMPLETED|Period 3||0
271254|NCT02222558|650907|P3|NOT COMPLETED|Period 3||0
271255|NCT02222558|650908|P2|NOT COMPLETED|Period 3||0
271256|NCT02222558|650909|P1|NOT COMPLETED|Period 3||0
271257|NCT02222558|650904|P6|COMPLETED|Period 3||7
271258|NCT02222558|650905|P5|COMPLETED|Period 3||8
271259|NCT02222558|650906|P4|COMPLETED|Period 3||1
271260|NCT02222558|650907|P3|COMPLETED|Period 3||4
271261|NCT02222558|650908|P2|COMPLETED|Period 3||0
271262|NCT02222558|650909|P1|COMPLETED|Period 3||0
271263|NCT02222558|650904|P6|STARTED|Period 3||8
271264|NCT02222558|650905|P5|STARTED|Period 3||8
271265|NCT02222558|650906|P4|STARTED|Period 3||1
271266|NCT02222558|650907|P3|STARTED|Period 3||4
271267|NCT02222558|650908|P2|STARTED|Period 3||0
271268|NCT02222558|650909|P1|STARTED|Period 3||0
271269|NCT02222558|650904|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271270|NCT02222558|650905|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271271|NCT02222558|650906|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271272|NCT02222558|650907|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271273|NCT02222558|650908|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271274|NCT02222558|650909|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271275|NCT02222558|650904|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271276|NCT02222558|650905|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271277|NCT02222558|650906|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271278|NCT02222558|650907|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271279|NCT02222558|650908|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
271280|NCT02222558|650909|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
271281|NCT02222558|650904|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
271282|NCT02222558|650905|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
271283|NCT02222558|650906|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
271284|NCT02222558|650907|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
271285|NCT02222558|650908|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
271286|NCT02222558|650909|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
271287|NCT02222558|650904|P6|NOT COMPLETED|Period 1: Single Dose||0
271288|NCT02222558|650905|P5|NOT COMPLETED|Period 1: Single Dose||0
271289|NCT02222558|650906|P4|NOT COMPLETED|Period 1: Single Dose||0
271290|NCT02222558|650907|P3|NOT COMPLETED|Period 1: Single Dose||0
271291|NCT02222558|650908|P2|NOT COMPLETED|Period 1: Single Dose||0
271292|NCT02222558|650909|P1|NOT COMPLETED|Period 1: Single Dose||4
271293|NCT02222558|650904|P6|COMPLETED|Period 1: Single Dose||0
271294|NCT02222558|650905|P5|COMPLETED|Period 1: Single Dose||0
271295|NCT02222558|650906|P4|COMPLETED|Period 1: Single Dose||0
271296|NCT02222558|650907|P3|COMPLETED|Period 1: Single Dose||0
271297|NCT02222558|650908|P2|COMPLETED|Period 1: Single Dose||0
271298|NCT02222558|650909|P1|COMPLETED|Period 1: Single Dose||21
271299|NCT02222558|650904|P6|STARTED|Period 1: Single Dose||0
271300|NCT02222558|650905|P5|STARTED|Period 1: Single Dose||0
271301|NCT02222558|650906|P4|STARTED|Period 1: Single Dose||0
271302|NCT02222558|650907|P3|STARTED|Period 1: Single Dose||0
271303|NCT02222558|650908|P2|STARTED|Period 1: Single Dose||0
271304|NCT02222558|650909|P1|STARTED|Period 1: Single Dose||25
271305|NCT02222207|650923|P1|NOT COMPLETED|Overall Study||4
271306|NCT02222207|650923|P1|COMPLETED|Overall Study||48
271307|NCT02222207|650923|P1|Treated and Valid for Full Analysis Set|Overall Study||51
271308|NCT02222207|650923|P1|STARTED|Overall Study||52
271309|NCT02222181|650930|P1|NOT COMPLETED|Overall Study||108
271310|NCT02222181|650930|P1|COMPLETED|Overall Study||55
271311|NCT02222181|650930|P1|STARTED|Overall Study||163
271312|NCT02222129|650942|P2|NOT COMPLETED|Overall Study||0
271313|NCT02222129|650943|P1|NOT COMPLETED|Overall Study||0
271314|NCT02222129|650942|P2|COMPLETED|Overall Study||106
271315|NCT02222129|650943|P1|COMPLETED|Overall Study||100
271316|NCT02222129|650942|P2|STARTED|Overall Study||106
271317|NCT02222129|650943|P1|STARTED|Overall Study||100
271318|NCT02221947|650951|P2|NOT COMPLETED|Overall Study||0
271319|NCT02221947|650952|P1|NOT COMPLETED|Overall Study||0
271320|NCT02221947|650951|P2|COMPLETED|Overall Study||3
271321|NCT02221947|650952|P1|COMPLETED|Overall Study||6
271322|NCT02221947|650951|P2|STARTED|Overall Study||3
271323|NCT02221947|650952|P1|STARTED|Overall Study||6
271324|NCT02221648|650960|P2|NOT COMPLETED|Overall Study||3
271325|NCT02221648|650961|P1|NOT COMPLETED|Overall Study||3
271326|NCT02221648|650960|P2|COMPLETED|Overall Study||18
271327|NCT02221648|650961|P1|COMPLETED|Overall Study||19
271328|NCT02221648|650960|P2|STARTED|Overall Study||21
271329|NCT02221648|650961|P1|STARTED|Overall Study||22
271330|NCT02220998|650973|P2|NOT COMPLETED|Overall Study||11
271331|NCT02220998|650974|P1|NOT COMPLETED|Overall Study||7
271332|NCT02220998|650973|P2|COMPLETED|Overall Study||123
271333|NCT02220998|650974|P1|COMPLETED|Overall Study||128
271334|NCT02220998|650973|P2|STARTED|Overall Study||134
271335|NCT02220998|650974|P1|STARTED|Overall Study||135
271336|NCT02220920|650992|P2|NOT COMPLETED|Overall Study||3
271337|NCT02220920|650993|P1|NOT COMPLETED|Overall Study||3
271338|NCT02220920|650992|P2|COMPLETED|Overall Study||67
271339|NCT02220920|650993|P1|COMPLETED|Overall Study||73
271340|NCT02220920|650992|P2|STARTED|Overall Study||70
271341|NCT02220920|650993|P1|STARTED|Overall Study||76
271342|NCT02220764|651009|P2|NOT COMPLETED|Overall Study||1
271343|NCT02220764|651010|P1|NOT COMPLETED|Overall Study||4
271344|NCT02220764|651009|P2|COMPLETED|Overall Study||7
271345|NCT02220764|651010|P1|COMPLETED|Overall Study||20
271346|NCT02220764|651009|P2|STARTED|Overall Study||8
271347|NCT02220764|651010|P1|STARTED|Overall Study||24
271348|NCT02220205|651022|P2|NOT COMPLETED|Overall Study||0
271349|NCT02220205|651023|P1|NOT COMPLETED|Overall Study||1
271350|NCT02220205|651022|P2|COMPLETED|Overall Study||30
271351|NCT02220205|651023|P1|COMPLETED|Overall Study||29
271352|NCT02220205|651022|P2|STARTED|Overall Study||30
271353|NCT02220205|651023|P1|STARTED|Overall Study||30
271354|NCT02219997|651033|P3|NOT COMPLETED|Second Filter||0
271355|NCT02219997|651034|P2|NOT COMPLETED|Second Filter||0
271356|NCT02219997|651035|P1|NOT COMPLETED|Second Filter||0
271357|NCT02219997|651033|P3|COMPLETED|Second Filter||18
271358|NCT02219997|651034|P2|COMPLETED|Second Filter||17
271359|NCT02219997|651035|P1|COMPLETED|Second Filter||0
271360|NCT02219997|651033|P3|STARTED|Second Filter||18
271361|NCT02219997|651034|P2|STARTED|Second Filter||17
271362|NCT02219997|651035|P1|STARTED|Second Filter||0
271363|NCT02219997|651033|P3|NOT COMPLETED|First Filter||0
271364|NCT02219997|651034|P2|NOT COMPLETED|First Filter||0
271365|NCT02219997|651035|P1|NOT COMPLETED|First Filter||0
271366|NCT02219997|651033|P3|COMPLETED|First Filter||18
271367|NCT02219997|651034|P2|COMPLETED|First Filter||17
271368|NCT02219997|651035|P1|COMPLETED|First Filter||33
271369|NCT02219997|651033|P3|STARTED|First Filter||18
271370|NCT02219997|651034|P2|STARTED|First Filter||17
271372|NCT02219932|651048|P2|NOT COMPLETED|Overall Study||51
271373|NCT02219932|651049|P1|NOT COMPLETED|Overall Study||65
271374|NCT02219932|651048|P2|COMPLETED|Overall Study||266
271375|NCT02219932|651049|P1|COMPLETED|Overall Study||254
271376|NCT02219932|651048|P2|Randomized, Not Treated|Overall Study||1
271377|NCT02219932|651049|P1|Randomized, Not Treated|Overall Study||0
271378|NCT02219932|651048|P2|STARTED|Overall Study||317
271379|NCT02219932|651049|P1|STARTED|Overall Study||319
271380|NCT02219685|651065|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
271381|NCT02219685|651066|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
271382|NCT02219685|651065|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
271383|NCT02219685|651066|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
271384|NCT02219685|651065|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
271385|NCT02219685|651066|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
271386|NCT02219685|651065|P2|NOT COMPLETED|Blinded Treatment Phase||0
271387|NCT02219685|651066|P1|NOT COMPLETED|Blinded Treatment Phase||2
271388|NCT02219685|651065|P2|COMPLETED|Blinded Treatment Phase||14
271389|NCT02219685|651066|P1|COMPLETED|Blinded Treatment Phase||24
271390|NCT02219685|651065|P2|STARTED|Blinded Treatment Phase||14
271391|NCT02219685|651066|P1|STARTED|Blinded Treatment Phase||26
271392|NCT02219516|651114|P4|NOT COMPLETED|Overall Study||0
271393|NCT02219516|651115|P3|NOT COMPLETED|Overall Study||0
271394|NCT02219516|651116|P2|NOT COMPLETED|Overall Study||0
271395|NCT02219516|651117|P1|NOT COMPLETED|Overall Study||0
271396|NCT02219516|651114|P4|COMPLETED|Overall Study||8
271397|NCT02219516|651115|P3|COMPLETED|Overall Study||7
271398|NCT02219516|651116|P2|COMPLETED|Overall Study||8
271399|NCT02219516|651117|P1|COMPLETED|Overall Study||8
271400|NCT02219516|651114|P4|STARTED|Overall Study||8
271401|NCT02219516|651115|P3|STARTED|Overall Study||7
271402|NCT02219516|651116|P2|STARTED|Overall Study||8
271403|NCT02219516|651117|P1|STARTED|Overall Study||8
271404|NCT02219503|651163|P1|NOT COMPLETED|Overall Study||0
271405|NCT02219503|651163|P1|COMPLETED|Overall Study||60
271406|NCT02219503|651163|P1|STARTED|Overall Study||60
271407|NCT02219464|651171|P2|NOT COMPLETED|Overall Study||0
271408|NCT02219464|651172|P1|NOT COMPLETED|Overall Study||3
271409|NCT02219464|651171|P2|COMPLETED|Overall Study||30
271410|NCT02219464|651172|P1|COMPLETED|Overall Study||27
271411|NCT02219464|651171|P2|STARTED|Overall Study||30
271412|NCT02219464|651172|P1|STARTED|Overall Study||30
271413|NCT02219256|651192|P12|NOT COMPLETED|Overall Study||0
271414|NCT02219256|651193|P11|NOT COMPLETED|Overall Study||0
271415|NCT02219256|651194|P10|NOT COMPLETED|Overall Study||0
271416|NCT02219256|651195|P9|NOT COMPLETED|Overall Study||0
271417|NCT02219256|651196|P8|NOT COMPLETED|Overall Study||0
271418|NCT02219256|651197|P7|NOT COMPLETED|Overall Study||0
271419|NCT02219256|651198|P6|NOT COMPLETED|Overall Study||0
271420|NCT02219256|651199|P5|NOT COMPLETED|Overall Study||0
271421|NCT02219256|651200|P4|NOT COMPLETED|Overall Study||0
271422|NCT02219256|651201|P3|NOT COMPLETED|Overall Study||0
271423|NCT02219256|651202|P2|NOT COMPLETED|Overall Study||0
271424|NCT02219256|651203|P1|NOT COMPLETED|Overall Study||0
271425|NCT02219256|651192|P12|COMPLETED|Overall Study||6
271426|NCT02219256|651193|P11|COMPLETED|Overall Study||6
271427|NCT02219256|651194|P10|COMPLETED|Overall Study||6
271428|NCT02219256|651195|P9|COMPLETED|Overall Study||6
271429|NCT02219256|651196|P8|COMPLETED|Overall Study||8
271430|NCT02219256|651197|P7|COMPLETED|Overall Study||6
271431|NCT02219256|651198|P6|COMPLETED|Overall Study||6
271432|NCT02219256|651199|P5|COMPLETED|Overall Study||6
271433|NCT02219256|651200|P4|COMPLETED|Overall Study||4
271434|NCT02219256|651201|P3|COMPLETED|Overall Study||4
271435|NCT02219256|651202|P2|COMPLETED|Overall Study||4
271436|NCT02219256|651203|P1|COMPLETED|Overall Study||12
271437|NCT02219256|651192|P12|STARTED|Overall Study||6
271438|NCT02219256|651193|P11|STARTED|Overall Study||6
271439|NCT02219256|651194|P10|STARTED|Overall Study||6
271440|NCT02219256|651195|P9|STARTED|Overall Study||6
271441|NCT02219256|651196|P8|STARTED|Overall Study||8
271442|NCT02219256|651197|P7|STARTED|Overall Study||6
271443|NCT02219256|651198|P6|STARTED|Overall Study||6
271444|NCT02219256|651199|P5|STARTED|Overall Study||6
271445|NCT02219256|651200|P4|STARTED|Overall Study||4
271446|NCT02219256|651201|P3|STARTED|Overall Study||4
271447|NCT02219256|651202|P2|STARTED|Overall Study||4
271448|NCT02219256|651203|P1|STARTED|Overall Study||12
271449|NCT02218697|651315|P2|NOT COMPLETED|Overall Study||6
271450|NCT02218697|651316|P1|NOT COMPLETED|Overall Study||2
271451|NCT02218697|651315|P2|COMPLETED|Overall Study||171
271452|NCT02218697|651316|P1|COMPLETED|Overall Study||177
271453|NCT02218697|651315|P2|STARTED|Overall Study||177
271454|NCT02218697|651316|P1|STARTED|Overall Study||179
271455|NCT02218307|651356|P2|NOT COMPLETED|Overall Study||2
271456|NCT02218307|651357|P1|NOT COMPLETED|Overall Study||10
271457|NCT02218307|651356|P2|COMPLETED|Overall Study||32
271458|NCT02218307|651357|P1|COMPLETED|Overall Study||24
271459|NCT02218307|651356|P2|STARTED|Overall Study||34
271460|NCT02218307|651357|P1|STARTED|Overall Study||34
271461|NCT02218268|651365|P2|NOT COMPLETED|Final Phase (2 Hours)||0
271462|NCT02218268|651366|P1|NOT COMPLETED|Final Phase (2 Hours)||0
271463|NCT02218268|651365|P2|COMPLETED|Final Phase (2 Hours)||21
271464|NCT02218268|651366|P1|COMPLETED|Final Phase (2 Hours)||19
271465|NCT02218268|651365|P2|STARTED|Final Phase (2 Hours)||21
271466|NCT02218268|651366|P1|STARTED|Final Phase (2 Hours)||19
271467|NCT02218268|651365|P2|NOT COMPLETED|24 Hour Washout||9
271468|NCT02218268|651366|P1|NOT COMPLETED|24 Hour Washout||11
271469|NCT02218268|651365|P2|COMPLETED|24 Hour Washout||21
271470|NCT02218268|651366|P1|COMPLETED|24 Hour Washout||19
271471|NCT02218268|651365|P2|STARTED|24 Hour Washout||30
271472|NCT02218268|651366|P1|STARTED|24 Hour Washout||30
271473|NCT02218268|651365|P2|NOT COMPLETED|First Phase (2 Hours)||0
271474|NCT02218268|651366|P1|NOT COMPLETED|First Phase (2 Hours)||0
271475|NCT02218268|651365|P2|COMPLETED|First Phase (2 Hours)||30
271476|NCT02218268|651366|P1|COMPLETED|First Phase (2 Hours)||30
271477|NCT02218268|651365|P2|STARTED|First Phase (2 Hours)||30
271478|NCT02218268|651366|P1|STARTED|First Phase (2 Hours)||30
271479|NCT02217982|651374|P2|NOT COMPLETED|Overall Study||1
271480|NCT02217982|651375|P1|NOT COMPLETED|Overall Study||1
271481|NCT02217982|651374|P2|COMPLETED|Overall Study||3
271482|NCT02217982|651375|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
271483|NCT02217982|651374|P2|STARTED|Overall Study||4
271484|NCT02217982|651375|P1|STARTED|Overall Study||1
271485|NCT02217878|651385|P2|NOT COMPLETED|Overall Study||2
271486|NCT02217878|651386|P1|NOT COMPLETED|Overall Study||2
271487|NCT02217878|651385|P2|COMPLETED|Overall Study||35
271488|NCT02217878|651386|P1|COMPLETED|Overall Study||35
271489|NCT02217878|651385|P2|STARTED|Overall Study||37
271490|NCT02217878|651386|P1|STARTED|Overall Study||37
271491|NCT02216695|651466|P1|NOT COMPLETED|Overall Study||0
271492|NCT02216695|651466|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
271493|NCT02216695|651466|P1|STARTED|Overall Study||64882
271494|NCT02216422|651475|P1|NOT COMPLETED|Overall Study||0
271495|NCT02216422|651475|P1|COMPLETED|Overall Study||36
271496|NCT02216422|651475|P1|STARTED|Overall Study||36
271497|NCT02216357|651483|P2|NOT COMPLETED|Overall Study||1
271498|NCT02216357|651484|P1|NOT COMPLETED|Overall Study||2
271499|NCT02216357|651483|P2|COMPLETED|Overall Study||4
271500|NCT02216357|651484|P1|COMPLETED|Overall Study||12
271501|NCT02216357|651483|P2|STARTED|Overall Study||5
271502|NCT02216357|651484|P1|STARTED|Overall Study||14
271503|NCT02216097|651510|P2|NOT COMPLETED|Overall Study||0
271504|NCT02216097|651511|P1|NOT COMPLETED|Overall Study||0
271505|NCT02216097|651510|P2|COMPLETED|Overall Study||6
271506|NCT02216097|651511|P1|COMPLETED|Overall Study||8
271507|NCT02216097|651510|P2|STARTED|Overall Study||6
271508|NCT02216097|651511|P1|STARTED|Overall Study||8
271509|NCT02215252|651536|P3|NOT COMPLETED|Overall Study||4
271510|NCT02215252|651537|P2|NOT COMPLETED|Overall Study||8
271511|NCT02215252|651538|P1|NOT COMPLETED|Overall Study||2
271512|NCT02215252|651536|P3|COMPLETED|Overall Study||41
271513|NCT02215252|651537|P2|COMPLETED|Overall Study||38
271514|NCT02215252|651538|P1|COMPLETED|Overall Study||42
271515|NCT02215252|651536|P3|STARTED|Overall Study||45
271516|NCT02215252|651537|P2|STARTED|Overall Study||46
271517|NCT02215252|651538|P1|STARTED|Overall Study||44
271518|NCT02214615|651597|P2|NOT COMPLETED|Second Intervention||0
271519|NCT02214615|651598|P1|NOT COMPLETED|Second Intervention||0
271520|NCT02214615|651597|P2|COMPLETED|Second Intervention||1
271521|NCT02214615|651598|P1|COMPLETED|Second Intervention||1
271522|NCT02214615|651597|P2|STARTED|Second Intervention||1
271523|NCT02214615|651598|P1|STARTED|Second Intervention||1
271524|NCT02214615|651597|P2|NOT COMPLETED|Washout||0
271525|NCT02214615|651598|P1|NOT COMPLETED|Washout||0
271526|NCT02214615|651597|P2|COMPLETED|Washout||1
271527|NCT02214615|651598|P1|COMPLETED|Washout||1
271528|NCT02214615|651597|P2|STARTED|Washout||1
271529|NCT02214615|651598|P1|STARTED|Washout||1
271530|NCT02214615|651597|P2|NOT COMPLETED|First Intervention||0
271531|NCT02214615|651598|P1|NOT COMPLETED|First Intervention||0
271532|NCT02214615|651597|P2|COMPLETED|First Intervention||1
271533|NCT02214615|651598|P1|COMPLETED|First Intervention||1
271534|NCT02214615|651597|P2|STARTED|First Intervention||1
271535|NCT02214615|651598|P1|STARTED|First Intervention||1
271536|NCT02214238|651608|P2|NOT COMPLETED|Overall Study||6
271537|NCT02214238|651609|P1|NOT COMPLETED|Overall Study||6
271538|NCT02214238|651608|P2|COMPLETED|Overall Study||17
271539|NCT02214238|651609|P1|COMPLETED|Overall Study||20
271540|NCT02214238|651608|P2|STARTED|Overall Study||23
271541|NCT02214238|651609|P1|STARTED|Overall Study||26
271542|NCT02214225|651622|P3|NOT COMPLETED|Overall Study||22
271543|NCT02214225|651623|P2|NOT COMPLETED|Overall Study||19
271544|NCT02214225|651624|P1|NOT COMPLETED|Overall Study||55
271545|NCT02214225|651622|P3|COMPLETED|Overall Study||850
271546|NCT02214225|651623|P2|COMPLETED|Overall Study||852
271547|NCT02214225|651624|P1|COMPLETED|Overall Study||1686
271548|NCT02214225|651622|P3|STARTED|Overall Study||872
271549|NCT02214225|651623|P2|STARTED|Overall Study||871
271550|NCT02214225|651624|P1|STARTED|Overall Study||1741
271551|NCT02214186|651683|P2|NOT COMPLETED|Overall Study||2
271552|NCT02214186|651684|P1|NOT COMPLETED|Overall Study||2
271553|NCT02214186|651683|P2|COMPLETED|Overall Study||21
271554|NCT02214186|651684|P1|COMPLETED|Overall Study||21
271555|NCT02214186|651683|P2|STARTED|Overall Study||23
271556|NCT02214186|651684|P1|STARTED|Overall Study||23
271557|NCT02213900|651708|P2|NOT COMPLETED|Overall Study||0
271558|NCT02213900|651709|P1|NOT COMPLETED|Overall Study||0
271559|NCT02213900|651708|P2|COMPLETED|Overall Study||67
271560|NCT02213900|651709|P1|COMPLETED|Overall Study||68
271561|NCT02213900|651708|P2|STARTED|Overall Study||67
271562|NCT02213900|651709|P1|STARTED|Overall Study||68
271563|NCT02213666|651721|P1|NOT COMPLETED|Overall Study||1
271564|NCT02213666|651721|P1|COMPLETED|Overall Study||71
271565|NCT02213666|651721|P1|STARTED|Overall Study||72
271566|NCT02213510|651727|P2|NOT COMPLETED|Overall Study||1
271567|NCT02213510|651728|P1|NOT COMPLETED|Overall Study||1
271568|NCT02213510|651727|P2|COMPLETED|Overall Study||18
271569|NCT02213510|651728|P1|COMPLETED|Overall Study||20
271570|NCT02213510|651727|P2|STARTED|Overall Study||19
271571|NCT02213510|651728|P1|STARTED|Overall Study||21
271572|NCT02213250|651754|P2|NOT COMPLETED|Overall Study||0
271573|NCT02213250|651755|P1|NOT COMPLETED|Overall Study||0
271574|NCT02213250|651754|P2|COMPLETED|Overall Study||8
271575|NCT02213250|651755|P1|COMPLETED|Overall Study||4
271576|NCT02213250|651754|P2|STARTED|Overall Study||8
271577|NCT02213250|651755|P1|STARTED|Overall Study||4
271578|NCT02213198|651786|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
271579|NCT02213198|651787|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
271675|NCT02209506|652033|P3|COMPLETED|Overall Study||6
271580|NCT02213198|651786|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
271581|NCT02213198|651787|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
271582|NCT02213198|651786|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
271583|NCT02213198|651787|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
271584|NCT02213198|651786|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
271585|NCT02213198|651787|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
271586|NCT02213198|651786|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
271587|NCT02213198|651787|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
271588|NCT02213198|651786|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
271589|NCT02213198|651787|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
271590|NCT02213198|651786|P2|NOT COMPLETED|Baseline||51
271591|NCT02213198|651787|P1|NOT COMPLETED|Baseline||88
271592|NCT02213198|651786|P2|COMPLETED|Baseline||108
271593|NCT02213198|651787|P1|COMPLETED|Baseline||218
271594|NCT02213198|651786|P2|STARTED|Baseline||159
271595|NCT02213198|651787|P1|STARTED|Baseline||306
271596|NCT02213055|651797|P2|NOT COMPLETED|Overall Study||0
271597|NCT02213055|651798|P1|NOT COMPLETED|Overall Study||39
271598|NCT02213055|651797|P2|COMPLETED|Overall Study||0
271599|NCT02213055|651798|P1|COMPLETED|Overall Study||58
271600|NCT02213055|651797|P2|STARTED|Overall Study||0
271601|NCT02213055|651798|P1|STARTED|Overall Study||97
271602|NCT02212977|651806|P2|NOT COMPLETED|Overall Study||6
271603|NCT02212977|651807|P1|NOT COMPLETED|Overall Study||5
271604|NCT02212977|651806|P2|COMPLETED|Overall Study||48
271605|NCT02212977|651807|P1|COMPLETED|Overall Study||50
271606|NCT02212977|651806|P2|STARTED|Overall Study||54
271607|NCT02212977|651807|P1|STARTED|Overall Study||55
271608|NCT02212834|651823|P2|NOT COMPLETED|Overall Study||0
271609|NCT02212834|651824|P1|NOT COMPLETED|Overall Study||0
271610|NCT02212834|651823|P2|COMPLETED|Overall Study||2506
271611|NCT02212834|651824|P1|COMPLETED|Overall Study||33938
271612|NCT02212834|651823|P2|STARTED|Overall Study||2506
271613|NCT02212834|651824|P1|STARTED|Overall Study||33938
271614|NCT02212301|651830|P2|NOT COMPLETED|Period 2||0
271615|NCT02212301|651831|P1|NOT COMPLETED|Period 2||0
271616|NCT02212301|651830|P2|COMPLETED|Period 2||21
271617|NCT02212301|651831|P1|COMPLETED|Period 2||21
271618|NCT02212301|651830|P2|STARTED|Period 2||21
271619|NCT02212301|651831|P1|STARTED|Period 2||21
271620|NCT02212301|651830|P2|NOT COMPLETED|Period 1||1
271621|NCT02212301|651831|P1|NOT COMPLETED|Period 1||0
271622|NCT02212301|651830|P2|COMPLETED|Period 1||21
271623|NCT02212301|651831|P1|COMPLETED|Period 1||21
271624|NCT02212301|651830|P2|STARTED|Period 1||22
271625|NCT02212301|651831|P1|STARTED|Period 1||21
271626|NCT02212197|651842|P3|NOT COMPLETED|Overall Study||0
271627|NCT02212197|651843|P2|NOT COMPLETED|Overall Study||0
271628|NCT02212197|651844|P1|NOT COMPLETED|Overall Study||1
271629|NCT02212197|651842|P3|COMPLETED|Overall Study||17
271630|NCT02212197|651843|P2|COMPLETED|Overall Study||15
271631|NCT02212197|651844|P1|COMPLETED|Overall Study||18
271632|NCT02212197|651842|P3|STARTED|Overall Study||17
271633|NCT02212197|651843|P2|STARTED|Overall Study||15
271634|NCT02212197|651844|P1|STARTED|Overall Study||19
271635|NCT02212106|651869|P2|NOT COMPLETED|Overall Study||4
271636|NCT02212106|651870|P1|NOT COMPLETED|Overall Study||10
271637|NCT02212106|651869|P2|COMPLETED|Overall Study||96
271638|NCT02212106|651870|P1|COMPLETED|Overall Study||292
271639|NCT02212106|651869|P2|STARTED|Overall Study||100
271640|NCT02212106|651870|P1|STARTED|Overall Study||302
271641|NCT02212028|651888|P2|NOT COMPLETED|Overall Study||0
271642|NCT02212028|651889|P1|NOT COMPLETED|Overall Study||0
271643|NCT02212028|651888|P2|COMPLETED|Overall Study||26
271644|NCT02212028|651889|P1|COMPLETED|Overall Study||26
271645|NCT02212028|651888|P2|STARTED|Overall Study||26
271646|NCT02212028|651889|P1|STARTED|Overall Study||26
271647|NCT02210091|651899|P2|NOT COMPLETED|Overall Study||2
271648|NCT02210091|651900|P1|NOT COMPLETED|Overall Study||0
271649|NCT02210091|651899|P2|COMPLETED|Overall Study||32
271650|NCT02210091|651900|P1|COMPLETED|Overall Study||32
271651|NCT02210091|651899|P2|STARTED|Overall Study||34
271652|NCT02210091|651900|P1|STARTED|Overall Study||32
271653|NCT02209766|651976|P5|NOT COMPLETED|Overall Study||0
271654|NCT02209766|651977|P4|NOT COMPLETED|Overall Study||1
271655|NCT02209766|651978|P3|NOT COMPLETED|Overall Study||0
271656|NCT02209766|651979|P2|NOT COMPLETED|Overall Study||0
271657|NCT02209766|651980|P1|NOT COMPLETED|Overall Study||0
271658|NCT02209766|651976|P5|COMPLETED|Overall Study||6
271659|NCT02209766|651977|P4|COMPLETED|Overall Study||2
271660|NCT02209766|651978|P3|COMPLETED|Overall Study||6
271661|NCT02209766|651979|P2|COMPLETED|Overall Study||3
271662|NCT02209766|651980|P1|COMPLETED|Overall Study||6
271663|NCT02209766|651976|P5|STARTED|Overall Study||6
271664|NCT02209766|651977|P4|STARTED|Overall Study||3
271665|NCT02209766|651978|P3|STARTED|Overall Study||6
271666|NCT02209766|651979|P2|STARTED|Overall Study||3
271667|NCT02209766|651980|P1|STARTED|Overall Study||6
271668|NCT02209506|652031|P5|NOT COMPLETED|Overall Study||1
271669|NCT02209506|652032|P4|NOT COMPLETED|Overall Study||0
271670|NCT02209506|652033|P3|NOT COMPLETED|Overall Study||0
271671|NCT02209506|652034|P2|NOT COMPLETED|Overall Study||0
271672|NCT02209506|652035|P1|NOT COMPLETED|Overall Study||0
271673|NCT02209506|652031|P5|COMPLETED|Overall Study||5
271674|NCT02209506|652032|P4|COMPLETED|Overall Study||2
271676|NCT02209506|652034|P2|COMPLETED|Overall Study||6
271677|NCT02209506|652035|P1|COMPLETED|Overall Study||3
271678|NCT02209506|652031|P5|STARTED|Overall Study||6
271679|NCT02209506|652032|P4|STARTED|Overall Study||2
271680|NCT02209506|652033|P3|STARTED|Overall Study||6
271681|NCT02209506|652034|P2|STARTED|Overall Study||6
271682|NCT02209506|652035|P1|STARTED|Overall Study||3
271683|NCT02209454|652110|P2|NOT COMPLETED|Second Period||0
271684|NCT02209454|652111|P1|NOT COMPLETED|Second Period||1
271685|NCT02209454|652110|P2|COMPLETED|Second Period||13
271686|NCT02209454|652111|P1|COMPLETED|Second Period||12
271687|NCT02209454|652110|P2|STARTED|Second Period||13
271688|NCT02209454|652111|P1|STARTED|Second Period||13
271689|NCT02209454|652110|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
271690|NCT02209454|652111|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
271691|NCT02209454|652110|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
271692|NCT02209454|652111|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
271693|NCT02209454|652110|P2|STARTED|Washout Period a Minimum of a 7 Day||13
271694|NCT02209454|652111|P1|STARTED|Washout Period a Minimum of a 7 Day||13
271695|NCT02209454|652110|P2|NOT COMPLETED|First Period||0
271696|NCT02209454|652111|P1|NOT COMPLETED|First Period||0
271697|NCT02209454|652110|P2|COMPLETED|First Period||13
271698|NCT02209454|652111|P1|COMPLETED|First Period||13
271699|NCT02209454|652110|P2|STARTED|First Period||13
271700|NCT02209454|652111|P1|STARTED|First Period||13
271701|NCT02209181|652129|P4|NOT COMPLETED|Overall Study||0
271702|NCT02209181|652130|P3|NOT COMPLETED|Overall Study||1
271703|NCT02209181|652131|P2|NOT COMPLETED|Overall Study||1
271704|NCT02209181|652132|P1|NOT COMPLETED|Overall Study||1
271705|NCT02209181|652129|P4|COMPLETED|Overall Study||66
271706|NCT02209181|652130|P3|COMPLETED|Overall Study||68
271707|NCT02209181|652131|P2|COMPLETED|Overall Study||66
271708|NCT02209181|652132|P1|COMPLETED|Overall Study||66
271709|NCT02209181|652129|P4|STARTED|Overall Study||66
271710|NCT02209181|652130|P3|STARTED|Overall Study||69
271711|NCT02209181|652131|P2|STARTED|Overall Study||67
271712|NCT02209181|652132|P1|STARTED|Overall Study||67
271713|NCT02209064|652294|P1|NOT COMPLETED|Overall Study||0
271714|NCT02209064|652294|P1|COMPLETED|Overall Study||25
271715|NCT02209064|652294|P1|STARTED|Overall Study||25
271716|NCT02207907|652303|P2|NOT COMPLETED|Overall Study||8
271717|NCT02207907|652304|P1|NOT COMPLETED|Overall Study||11
271718|NCT02207907|652303|P2|COMPLETED|Overall Study||115
271719|NCT02207907|652304|P1|COMPLETED|Overall Study||113
271720|NCT02207907|652303|P2|STARTED|Overall Study||123
271721|NCT02207907|652304|P1|STARTED|Overall Study||124
271722|NCT02207829|652322|P2|NOT COMPLETED|Overall Study||34
271723|NCT02207829|652323|P1|NOT COMPLETED|Overall Study||42
271724|NCT02207829|652322|P2|COMPLETED|Overall Study||474
271725|NCT02207829|652323|P1|COMPLETED|Overall Study||467
271726|NCT02207829|652322|P2|STARTED|Overall Study||508
271727|NCT02207829|652323|P1|STARTED|Overall Study||509
271728|NCT02207608|652331|P2|NOT COMPLETED|Overall Study||0
271729|NCT02207608|652332|P1|NOT COMPLETED|Overall Study||1
271730|NCT02207608|652331|P2|COMPLETED|Overall Study||15
271731|NCT02207608|652332|P1|COMPLETED|Overall Study||14
271732|NCT02207608|652331|P2|STARTED|Overall Study||15
271733|NCT02207608|652332|P1|STARTED|Overall Study||15
271734|NCT02207478|652340|P2|NOT COMPLETED|Overall Study||0
271735|NCT02207478|652341|P1|NOT COMPLETED|Overall Study||0
271736|NCT02207478|652340|P2|COMPLETED|Overall Study||46
271737|NCT02207478|652341|P1|COMPLETED|Overall Study||40
271738|NCT02207478|652340|P2|STARTED|Overall Study||46
271739|NCT02207478|652341|P1|STARTED|Overall Study||40
271740|NCT02207413|652355|P6|NOT COMPLETED|Overall Study||13
271741|NCT02207413|652356|P5|NOT COMPLETED|Overall Study||7
271742|NCT02207413|652357|P4|NOT COMPLETED|Overall Study||1
271743|NCT02207413|652358|P3|NOT COMPLETED|Overall Study||0
271744|NCT02207413|652359|P2|NOT COMPLETED|Overall Study||0
271745|NCT02207413|652360|P1|NOT COMPLETED|Overall Study||1
271746|NCT02207413|652355|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
271747|NCT02207413|652356|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
271748|NCT02207413|652357|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
271749|NCT02207413|652358|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
271750|NCT02207413|652359|P2|COMPLETED|Overall Study||60
271751|NCT02207413|652360|P1|COMPLETED|Overall Study||59
271752|NCT02207413|652355|P6|STARTED|Overall Study||474
271753|NCT02207413|652356|P5|STARTED|Overall Study||466
271754|NCT02207413|652357|P4|STARTED|Overall Study||411
271755|NCT02207413|652358|P3|STARTED|Overall Study||410
271756|NCT02207413|652359|P2|STARTED|Overall Study||60
271757|NCT02207413|652360|P1|STARTED|Overall Study||60
271758|NCT02207400|652456|P2|NOT COMPLETED|Overall Study||14
271759|NCT02207400|652457|P1|NOT COMPLETED|Overall Study||16
271760|NCT02207400|652456|P2|COMPLETED|Overall Study||109
271761|NCT02207400|652457|P1|COMPLETED|Overall Study||107
271762|NCT02207400|652456|P2|STARTED|Overall Study||123
271763|NCT02207400|652457|P1|STARTED|Overall Study||123
271764|NCT02206776|652477|P2|NOT COMPLETED|Overall Study||0
271765|NCT02206776|652478|P1|NOT COMPLETED|Overall Study||0
271766|NCT02206776|652477|P2|COMPLETED|Overall Study||1
271767|NCT02206776|652478|P1|COMPLETED|Overall Study||1
271768|NCT02206776|652477|P2|STARTED|Overall Study||1
271769|NCT02206776|652478|P1|STARTED|Overall Study||1
271770|NCT02206607|652484|P5|NOT COMPLETED|Fourth Intervention Period||0
271771|NCT02206607|652485|P4|NOT COMPLETED|Fourth Intervention Period||0
271772|NCT02206607|652486|P3|NOT COMPLETED|Fourth Intervention Period||0
271773|NCT02206607|652487|P2|NOT COMPLETED|Fourth Intervention Period||0
271774|NCT02206607|652488|P1|NOT COMPLETED|Fourth Intervention Period||0
271775|NCT02206607|652484|P5|COMPLETED|Fourth Intervention Period||10
271776|NCT02206607|652485|P4|COMPLETED|Fourth Intervention Period||10
271777|NCT02206607|652486|P3|COMPLETED|Fourth Intervention Period||9
271778|NCT02206607|652487|P2|COMPLETED|Fourth Intervention Period||9
271779|NCT02206607|652488|P1|COMPLETED|Fourth Intervention Period||0
271780|NCT02206607|652484|P5|STARTED|Fourth Intervention Period||10
271781|NCT02206607|652485|P4|STARTED|Fourth Intervention Period||10
271782|NCT02206607|652486|P3|STARTED|Fourth Intervention Period||9
271783|NCT02206607|652487|P2|STARTED|Fourth Intervention Period||9
271784|NCT02206607|652488|P1|STARTED|Fourth Intervention Period||0
271785|NCT02206607|652484|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
271786|NCT02206607|652485|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
271787|NCT02206607|652486|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
271788|NCT02206607|652487|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
271789|NCT02206607|652488|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
271790|NCT02206607|652484|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
271791|NCT02206607|652485|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
271792|NCT02206607|652486|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
271793|NCT02206607|652487|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
271794|NCT02206607|652488|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
271795|NCT02206607|652484|P5|STARTED|Third Washout Period 5 to 10 Days||10
271796|NCT02206607|652485|P4|STARTED|Third Washout Period 5 to 10 Days||10
271797|NCT02206607|652486|P3|STARTED|Third Washout Period 5 to 10 Days||9
271798|NCT02206607|652487|P2|STARTED|Third Washout Period 5 to 10 Days||9
271799|NCT02206607|652488|P1|STARTED|Third Washout Period 5 to 10 Days||0
271800|NCT02206607|652484|P5|NOT COMPLETED|Third Intervention Period||0
271801|NCT02206607|652485|P4|NOT COMPLETED|Third Intervention Period||0
271802|NCT02206607|652486|P3|NOT COMPLETED|Third Intervention Period||0
271803|NCT02206607|652487|P2|NOT COMPLETED|Third Intervention Period||0
271804|NCT02206607|652488|P1|NOT COMPLETED|Third Intervention Period||0
271805|NCT02206607|652484|P5|COMPLETED|Third Intervention Period||10
271806|NCT02206607|652485|P4|COMPLETED|Third Intervention Period||10
271807|NCT02206607|652486|P3|COMPLETED|Third Intervention Period||9
271808|NCT02206607|652487|P2|COMPLETED|Third Intervention Period||9
271809|NCT02206607|652488|P1|COMPLETED|Third Intervention Period||0
271810|NCT02206607|652484|P5|STARTED|Third Intervention Period||10
271811|NCT02206607|652485|P4|STARTED|Third Intervention Period||10
271812|NCT02206607|652486|P3|STARTED|Third Intervention Period||9
271813|NCT02206607|652487|P2|STARTED|Third Intervention Period||9
271814|NCT02206607|652488|P1|STARTED|Third Intervention Period||0
271815|NCT02206607|652484|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
271816|NCT02206607|652485|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
271817|NCT02206607|652486|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
271818|NCT02206607|652487|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
271819|NCT02206607|652488|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
271820|NCT02206607|652484|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
271821|NCT02206607|652485|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
271822|NCT02206607|652486|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
271823|NCT02206607|652487|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
271824|NCT02206607|652488|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
271825|NCT02206607|652484|P5|STARTED|Second Washout Period 5 to 10 Days||10
271826|NCT02206607|652485|P4|STARTED|Second Washout Period 5 to 10 Days||10
271827|NCT02206607|652486|P3|STARTED|Second Washout Period 5 to 10 Days||9
271828|NCT02206607|652487|P2|STARTED|Second Washout Period 5 to 10 Days||9
271829|NCT02206607|652488|P1|STARTED|Second Washout Period 5 to 10 Days||0
271830|NCT02206607|652484|P5|NOT COMPLETED|Second Intervention Period||0
271831|NCT02206607|652485|P4|NOT COMPLETED|Second Intervention Period||1
271832|NCT02206607|652486|P3|NOT COMPLETED|Second Intervention Period||0
271833|NCT02206607|652487|P2|NOT COMPLETED|Second Intervention Period||0
271834|NCT02206607|652488|P1|NOT COMPLETED|Second Intervention Period||0
271835|NCT02206607|652484|P5|COMPLETED|Second Intervention Period||10
271836|NCT02206607|652485|P4|COMPLETED|Second Intervention Period||10
271837|NCT02206607|652486|P3|COMPLETED|Second Intervention Period||9
271838|NCT02206607|652487|P2|COMPLETED|Second Intervention Period||9
271839|NCT02206607|652488|P1|COMPLETED|Second Intervention Period||0
271840|NCT02206607|652484|P5|STARTED|Second Intervention Period||10
271841|NCT02206607|652485|P4|STARTED|Second Intervention Period||11
271842|NCT02206607|652486|P3|STARTED|Second Intervention Period||9
271843|NCT02206607|652487|P2|STARTED|Second Intervention Period||9
271844|NCT02206607|652488|P1|STARTED|Second Intervention Period||0
271845|NCT02206607|652484|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
271846|NCT02206607|652485|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
271847|NCT02206607|652486|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
271848|NCT02206607|652487|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
271849|NCT02206607|652488|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
271850|NCT02206607|652484|P5|COMPLETED|First Washout Period 5 to 10 Days||10
271851|NCT02206607|652485|P4|COMPLETED|First Washout Period 5 to 10 Days||11
271852|NCT02206607|652486|P3|COMPLETED|First Washout Period 5 to 10 Days||9
271853|NCT02206607|652487|P2|COMPLETED|First Washout Period 5 to 10 Days||9
271854|NCT02206607|652488|P1|COMPLETED|First Washout Period 5 to 10 Days||0
271855|NCT02206607|652484|P5|STARTED|First Washout Period 5 to 10 Days||10
271856|NCT02206607|652485|P4|STARTED|First Washout Period 5 to 10 Days||11
271857|NCT02206607|652486|P3|STARTED|First Washout Period 5 to 10 Days||9
271858|NCT02206607|652487|P2|STARTED|First Washout Period 5 to 10 Days||9
271859|NCT02206607|652488|P1|STARTED|First Washout Period 5 to 10 Days||0
271860|NCT02206607|652484|P5|NOT COMPLETED|First Intervention Period||0
271861|NCT02206607|652485|P4|NOT COMPLETED|First Intervention Period||0
271862|NCT02206607|652486|P3|NOT COMPLETED|First Intervention Period||0
271863|NCT02206607|652487|P2|NOT COMPLETED|First Intervention Period||0
271864|NCT02206607|652488|P1|NOT COMPLETED|First Intervention Period||0
271865|NCT02206607|652484|P5|COMPLETED|First Intervention Period||10
271866|NCT02206607|652485|P4|COMPLETED|First Intervention Period||11
271867|NCT02206607|652486|P3|COMPLETED|First Intervention Period||9
271868|NCT02206607|652487|P2|COMPLETED|First Intervention Period||9
271869|NCT02206607|652488|P1|COMPLETED|First Intervention Period||0
271870|NCT02206607|652484|P5|STARTED|First Intervention Period||10
271871|NCT02206607|652485|P4|STARTED|First Intervention Period||11
271872|NCT02206607|652486|P3|STARTED|First Intervention Period||9
271873|NCT02206607|652487|P2|STARTED|First Intervention Period||9
271874|NCT02206607|652488|P1|STARTED|First Intervention Period||0
271875|NCT02206607|652484|P5|NOT COMPLETED|Open-Label Run-In||0
271876|NCT02206607|652485|P4|NOT COMPLETED|Open-Label Run-In||0
271877|NCT02206607|652486|P3|NOT COMPLETED|Open-Label Run-In||0
271878|NCT02206607|652487|P2|NOT COMPLETED|Open-Label Run-In||0
271879|NCT02206607|652488|P1|NOT COMPLETED|Open-Label Run-In||3
271880|NCT02206607|652484|P5|COMPLETED|Open-Label Run-In||0
271881|NCT02206607|652485|P4|COMPLETED|Open-Label Run-In||0
271882|NCT02206607|652486|P3|COMPLETED|Open-Label Run-In||0
271883|NCT02206607|652487|P2|COMPLETED|Open-Label Run-In||0
271884|NCT02206607|652488|P1|COMPLETED|Open-Label Run-In||39
271885|NCT02206607|652484|P5|STARTED|Open-Label Run-In||0
271886|NCT02206607|652485|P4|STARTED|Open-Label Run-In||0
271887|NCT02206607|652486|P3|STARTED|Open-Label Run-In||0
271888|NCT02206607|652487|P2|STARTED|Open-Label Run-In||0
271889|NCT02206607|652488|P1|STARTED|Open-Label Run-In||42
271890|NCT02205814|652544|P4|NOT COMPLETED|Overall Study||4
271891|NCT02205814|652545|P3|NOT COMPLETED|Overall Study||5
271892|NCT02205814|652546|P2|NOT COMPLETED|Overall Study||1
271893|NCT02205814|652547|P1|NOT COMPLETED|Overall Study||2
271894|NCT02205814|652544|P4|COMPLETED|Overall Study||104
271895|NCT02205814|652545|P3|COMPLETED|Overall Study||103
271896|NCT02205814|652546|P2|COMPLETED|Overall Study||109
271897|NCT02205814|652547|P1|COMPLETED|Overall Study||108
271898|NCT02205814|652544|P4|STARTED|Overall Study||108
271899|NCT02205814|652545|P3|STARTED|Overall Study||108
271900|NCT02205814|652546|P2|STARTED|Overall Study||110
271901|NCT02205814|652547|P1|STARTED|Overall Study||110
271902|NCT02205476|652571|P2|NOT COMPLETED|Overall Study||3
271903|NCT02205476|652572|P1|NOT COMPLETED|Overall Study||7
271904|NCT02205476|652571|P2|COMPLETED|Overall Study||0
271905|NCT02205476|652572|P1|COMPLETED|Overall Study||0
271906|NCT02205476|652571|P2|STARTED|Overall Study||3
271907|NCT02205476|652572|P1|STARTED|Overall Study||7
271908|NCT02205333|652611|P9|NOT COMPLETED|Overall Study||0
271909|NCT02205333|652612|P8|NOT COMPLETED|Overall Study||2
271910|NCT02205333|652613|P7|NOT COMPLETED|Overall Study||5
271911|NCT02205333|652614|P6|NOT COMPLETED|Overall Study||3
271912|NCT02205333|652615|P5|NOT COMPLETED|Overall Study||5
271913|NCT02205333|652616|P4|NOT COMPLETED|Overall Study||7
271914|NCT02205333|652617|P3|NOT COMPLETED|Overall Study||2
271915|NCT02205333|652618|P2|NOT COMPLETED|Overall Study||6
271916|NCT02205333|652619|P1|NOT COMPLETED|Overall Study||6
271917|NCT02205333|652611|P9|COMPLETED|Overall Study||1
271918|NCT02205333|652612|P8|COMPLETED|Overall Study||1
271919|NCT02205333|652613|P7|COMPLETED|Overall Study||2
271920|NCT02205333|652614|P6|COMPLETED|Overall Study||4
271921|NCT02205333|652615|P5|COMPLETED|Overall Study||1
271922|NCT02205333|652616|P4|COMPLETED|Overall Study||0
271923|NCT02205333|652617|P3|COMPLETED|Overall Study||1
271924|NCT02205333|652618|P2|COMPLETED|Overall Study||0
271925|NCT02205333|652619|P1|COMPLETED|Overall Study||2
271926|NCT02205333|652611|P9|STARTED|Overall Study||1
271927|NCT02205333|652612|P8|STARTED|Overall Study||3
271928|NCT02205333|652613|P7|STARTED|Overall Study||7
271929|NCT02205333|652614|P6|STARTED|Overall Study||7
271930|NCT02205333|652615|P5|STARTED|Overall Study||6
271931|NCT02205333|652616|P4|STARTED|Overall Study||7
271932|NCT02205333|652617|P3|STARTED|Overall Study||3
271933|NCT02205333|652618|P2|STARTED|Overall Study||6
271934|NCT02205333|652619|P1|STARTED|Overall Study||8
271935|NCT02204748|652792|P1|NOT COMPLETED|Overall Study||0
271936|NCT02204748|652792|P1|COMPLETED|Overall Study||5
271937|NCT02204748|652792|P1|STARTED|Overall Study||5
271938|NCT02204657|652806|P2|NOT COMPLETED|Overall Study||0
271939|NCT02204657|652807|P1|NOT COMPLETED|Overall Study||7
271940|NCT02204657|652806|P2|COMPLETED|Overall Study||25
271941|NCT02204657|652807|P1|COMPLETED|Overall Study||25
271942|NCT02204657|652806|P2|STARTED|Overall Study||25
271943|NCT02204657|652807|P1|STARTED|Overall Study||32
271944|NCT02204579|652815|P1|NOT COMPLETED|Overall Study||2
271945|NCT02204579|652815|P1|COMPLETED|Overall Study||5
271946|NCT02204579|652815|P1|Treated|Overall Study||5
271947|NCT02204579|652815|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
271948|NCT02204579|652815|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
271949|NCT02204579|652815|P1|STARTED|Overall Study||7
271950|NCT02204449|652869|P2|NOT COMPLETED|Overall Study||11
271951|NCT02204449|652870|P1|NOT COMPLETED|Overall Study||7
271952|NCT02204449|652869|P2|COMPLETED|Overall Study||37
271953|NCT02204449|652870|P1|COMPLETED|Overall Study||39
271954|NCT02204449|652869|P2|STARTED|Overall Study||48
271955|NCT02204449|652870|P1|STARTED|Overall Study||46
271956|NCT02204007|652882|P2|NOT COMPLETED|Overall Study||1
271957|NCT02204007|652883|P1|NOT COMPLETED|Overall Study||1
271958|NCT02204007|652882|P2|COMPLETED|Overall Study||17
271959|NCT02204007|652883|P1|COMPLETED|Overall Study||17
271960|NCT02204007|652882|P2|STARTED|Overall Study||18
271961|NCT02204007|652883|P1|STARTED|Overall Study||18
271962|NCT02203916|652894|P3|NOT COMPLETED|Overall Study||11
271963|NCT02203916|652895|P2|NOT COMPLETED|Overall Study||10
271964|NCT02203916|652896|P1|NOT COMPLETED|Overall Study||8
271965|NCT02203916|652894|P3|COMPLETED|Overall Study||120
271966|NCT02203916|652895|P2|COMPLETED|Overall Study||122
271967|NCT02203916|652896|P1|COMPLETED|Overall Study||57
271968|NCT02203916|652894|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
271969|NCT02203916|652895|P2|Safety Analysis Set (SAS)|Overall Study||132
271970|NCT02203916|652896|P1|Safety Analysis Set (SAS)|Overall Study||65
271971|NCT02203916|652894|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
271972|NCT02203916|652895|P2|Full Analysis Set (FAS)|Overall Study||132
271973|NCT02203916|652896|P1|Full Analysis Set (FAS)|Overall Study||65
271974|NCT02203916|652894|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
271975|NCT02203916|652895|P2|STARTED|Overall Study||132
271976|NCT02203916|652896|P1|STARTED|Overall Study||65
271977|NCT02203786|652920|P4|NOT COMPLETED|Overall Study||0
271978|NCT02203786|652921|P3|NOT COMPLETED|Overall Study||2
271979|NCT02203786|652922|P2|NOT COMPLETED|Overall Study||0
271980|NCT02203786|652923|P1|NOT COMPLETED|Overall Study||0
271981|NCT02203786|652920|P4|COMPLETED|Overall Study||15
271982|NCT02203786|652921|P3|COMPLETED|Overall Study||15
271983|NCT02203786|652922|P2|COMPLETED|Overall Study||15
271984|NCT02203786|652923|P1|COMPLETED|Overall Study||15
271985|NCT02203786|652920|P4|STARTED|Overall Study||15
271986|NCT02203786|652921|P3|STARTED|Overall Study||17
271987|NCT02203786|652922|P2|STARTED|Overall Study||15
271988|NCT02203786|652923|P1|STARTED|Overall Study||15
271989|NCT02203747|652955|P2|NOT COMPLETED|Overall Study||0
271990|NCT02203747|652956|P1|NOT COMPLETED|Overall Study||0
271991|NCT02203747|652955|P2|COMPLETED|Overall Study||34
271992|NCT02203747|652956|P1|COMPLETED|Overall Study||45
271993|NCT02203747|652955|P2|STARTED|Overall Study||34
271994|NCT02203747|652956|P1|STARTED|Overall Study||45
271995|NCT02203721|652966|P2|NOT COMPLETED|Overall Study||3
271996|NCT02203721|652967|P1|NOT COMPLETED|Overall Study||1
271997|NCT02203721|652966|P2|COMPLETED|Overall Study||148
271998|NCT02203721|652967|P1|COMPLETED|Overall Study||147
271999|NCT02203721|652966|P2|STARTED|Overall Study||151
272000|NCT02203721|652967|P1|STARTED|Overall Study||148
272001|NCT02203578|652975|P1|NOT COMPLETED|Overall Study||0
272002|NCT02203578|652975|P1|COMPLETED|Overall Study||1
272003|NCT02203578|652975|P1|STARTED|Overall Study||1
272004|NCT02203162|652987|P1|NOT COMPLETED|Overall Study||0
272005|NCT02203162|652987|P1|COMPLETED|Overall Study||30
272006|NCT02203162|652987|P1|STARTED|Overall Study||30
272007|NCT02203149|652996|P5|NOT COMPLETED|Part 2||1
272008|NCT02203149|652997|P4|NOT COMPLETED|Part 2||3
272009|NCT02203149|652998|P3|NOT COMPLETED|Part 2||1
272010|NCT02203149|652999|P2|NOT COMPLETED|Part 2||0
272011|NCT02203149|653000|P1|NOT COMPLETED|Part 2||0
272012|NCT02203149|652996|P5|COMPLETED|Part 2||34
272013|NCT02203149|652997|P4|COMPLETED|Part 2||71
272014|NCT02203149|652998|P3|COMPLETED|Part 2||226
272015|NCT02203149|652999|P2|COMPLETED|Part 2||0
272016|NCT02203149|653000|P1|COMPLETED|Part 2||0
272017|NCT02203149|652996|P5|Started Deferred Active Treatment|Part 2||0
272018|NCT02203149|652997|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
272019|NCT02203149|652998|P3|Started Deferred Active Treatment|Part 2||0
272020|NCT02203149|652999|P2|Started Deferred Active Treatment|Part 2||0
272021|NCT02203149|653000|P1|Started Deferred Active Treatment|Part 2||0
272022|NCT02203149|652996|P5|STARTED|Part 2||35
272023|NCT02203149|652997|P4|STARTED|Part 2||74
272024|NCT02203149|652998|P3|STARTED|Part 2||227
272025|NCT02203149|652999|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
272026|NCT02203149|653000|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
272027|NCT02203149|652996|P5|NOT COMPLETED|Part 1||0
272028|NCT02203149|652997|P4|NOT COMPLETED|Part 1||0
272029|NCT02203149|652998|P3|NOT COMPLETED|Part 1||0
272030|NCT02203149|652999|P2|NOT COMPLETED|Part 1||1
272031|NCT02203149|653000|P1|NOT COMPLETED|Part 1||0
272032|NCT02203149|652996|P5|COMPLETED|Part 1||0
272033|NCT02203149|652997|P4|COMPLETED|Part 1||0
272034|NCT02203149|652998|P3|COMPLETED|Part 1||0
272035|NCT02203149|652999|P2|COMPLETED|Part 1||31
272036|NCT02203149|653000|P1|COMPLETED|Part 1||31
272037|NCT02203149|652996|P5|STARTED|Part 1||0
272038|NCT02203149|652997|P4|STARTED|Part 1||0
272039|NCT02203149|652998|P3|STARTED|Part 1||0
272040|NCT02203149|652999|P2|STARTED|Part 1||32
272041|NCT02203149|653000|P1|STARTED|Part 1||31
272042|NCT02202785|653036|P3|NOT COMPLETED|Overall Study||17
272043|NCT02202785|653037|P2|NOT COMPLETED|Overall Study||15
272044|NCT02202785|653038|P1|NOT COMPLETED|Overall Study||11
272045|NCT02202785|653036|P3|COMPLETED|Overall Study||0
272046|NCT02202785|653037|P2|COMPLETED|Overall Study||0
272047|NCT02202785|653038|P1|COMPLETED|Overall Study||0
272048|NCT02202785|653036|P3|STARTED|Overall Study||17
272049|NCT02202785|653037|P2|STARTED|Overall Study||15
272050|NCT02202785|653038|P1|STARTED|Overall Study||11
272051|NCT02202759|653075|P3|NOT COMPLETED|Overall Study||14
272052|NCT02202759|653076|P2|NOT COMPLETED|Overall Study||15
272053|NCT02202759|653077|P1|NOT COMPLETED|Overall Study||9
272054|NCT02202759|653075|P3|COMPLETED|Overall Study||0
272055|NCT02202759|653076|P2|COMPLETED|Overall Study||0
272056|NCT02202759|653077|P1|COMPLETED|Overall Study||0
272057|NCT02202759|653075|P3|STARTED|Overall Study||14
272058|NCT02202759|653076|P2|STARTED|Overall Study||15
272059|NCT02202759|653077|P1|STARTED|Overall Study||9
272060|NCT02202538|653111|P1|NOT COMPLETED|Overall Study||8
272061|NCT02202538|653111|P1|COMPLETED|Overall Study||45
272062|NCT02202538|653111|P1|Screen Failure|Overall Study||2
272063|NCT02202538|653111|P1|STARTED|Overall Study||53
272064|NCT02202252|653124|P2|NOT COMPLETED|Overall Study||0
272065|NCT02202252|653125|P1|NOT COMPLETED|Overall Study||0
272066|NCT02202252|653124|P2|COMPLETED|Overall Study||30
272067|NCT02202252|653125|P1|COMPLETED|Overall Study||30
272068|NCT02202252|653124|P2|STARTED|Overall Study||30
272069|NCT02202252|653125|P1|STARTED|Overall Study||30
272070|NCT02202135|653135|P1|NOT COMPLETED|Overall Study||0
272071|NCT02202135|653135|P1|COMPLETED|Overall Study||4
272072|NCT02202135|653135|P1|STARTED|Overall Study||4
272073|NCT02201953|653141|P2|NOT COMPLETED|Overall Study||56
272074|NCT02201953|653142|P1|NOT COMPLETED|Overall Study||20
272075|NCT02201953|653141|P2|COMPLETED|Overall Study||224
272076|NCT02201953|653142|P1|COMPLETED|Overall Study||258
272077|NCT02201953|653141|P2|STARTED|Overall Study||280
272078|NCT02201953|653142|P1|STARTED|Overall Study||278
272079|NCT02201940|653160|P2|NOT COMPLETED|Overall Study||116
272080|NCT02201940|653161|P1|NOT COMPLETED|Overall Study||12
272081|NCT02201940|653160|P2|COMPLETED|Overall Study||0
272082|NCT02201940|653161|P1|COMPLETED|Overall Study||613
272083|NCT02201940|653160|P2|STARTED|Overall Study||116
272084|NCT02201940|653161|P1|STARTED|Overall Study||625
272085|NCT02201901|653180|P3|NOT COMPLETED|Overall Study||13
272086|NCT02201901|653181|P2|NOT COMPLETED|Overall Study||9
272087|NCT02201901|653182|P1|NOT COMPLETED|Overall Study||15
272088|NCT02201901|653180|P3|COMPLETED|Overall Study||77
272089|NCT02201901|653181|P2|COMPLETED|Overall Study||79
272090|NCT02201901|653182|P1|COMPLETED|Overall Study||75
272091|NCT02201901|653180|P3|STARTED|Overall Study||90
272092|NCT02201901|653181|P2|STARTED|Overall Study||88
272093|NCT02201901|653182|P1|STARTED|Overall Study||90
272094|NCT02201784|653213|P2|NOT COMPLETED|Overall Study||0
272095|NCT02201784|653214|P1|NOT COMPLETED|Overall Study||2
272096|NCT02201784|653213|P2|COMPLETED|Overall Study||30
272097|NCT02201784|653214|P1|COMPLETED|Overall Study||28
272098|NCT02201784|653213|P2|STARTED|Overall Study||30
272099|NCT02201784|653214|P1|STARTED|Overall Study||30
272100|NCT02201524|653232|P4|NOT COMPLETED|Overall Study||4
272101|NCT02201524|653233|P3|NOT COMPLETED|Overall Study||4
272102|NCT02201524|653234|P2|NOT COMPLETED|Overall Study||3
272103|NCT02201524|653235|P1|NOT COMPLETED|Overall Study||2
272104|NCT02201524|653232|P4|COMPLETED|Overall Study||10
272105|NCT02201524|653233|P3|COMPLETED|Overall Study||12
272106|NCT02201524|653234|P2|COMPLETED|Overall Study||12
272107|NCT02201524|653235|P1|COMPLETED|Overall Study||12
272108|NCT02201524|653232|P4|STARTED|Overall Study||14
272109|NCT02201524|653233|P3|STARTED|Overall Study||16
272110|NCT02201524|653234|P2|STARTED|Overall Study||15
272111|NCT02201524|653235|P1|STARTED|Overall Study||14
272112|NCT02201446|653319|P2|NOT COMPLETED|Overall Study||0
272113|NCT02201446|653320|P1|NOT COMPLETED|Overall Study||0
272114|NCT02201446|653319|P2|COMPLETED|Overall Study||58
272115|NCT02201446|653320|P1|COMPLETED|Overall Study||81
272116|NCT02201446|653319|P2|STARTED|Overall Study||58
272117|NCT02201446|653320|P1|STARTED|Overall Study||81
272118|NCT02201420|653348|P1|NOT COMPLETED|Overall Study||0
272119|NCT02201420|653348|P1|COMPLETED|Overall Study||5
272120|NCT02201420|653348|P1|STARTED|Overall Study||5
272121|NCT02201056|653360|P7|NOT COMPLETED|Overall Study||0
272122|NCT02201056|653361|P6|NOT COMPLETED|Overall Study||0
272123|NCT02201056|653362|P5|NOT COMPLETED|Overall Study||0
272124|NCT02201056|653363|P4|NOT COMPLETED|Overall Study||0
272125|NCT02201056|653364|P3|NOT COMPLETED|Overall Study||0
272126|NCT02201056|653365|P2|NOT COMPLETED|Overall Study||0
272127|NCT02201056|653366|P1|NOT COMPLETED|Overall Study||0
272128|NCT02201056|653360|P7|COMPLETED|Overall Study||6
272129|NCT02201056|653361|P6|COMPLETED|Overall Study||6
272130|NCT02201056|653362|P5|COMPLETED|Overall Study||6
272131|NCT02201056|653363|P4|COMPLETED|Overall Study||6
272132|NCT02201056|653364|P3|COMPLETED|Overall Study||6
272133|NCT02201056|653365|P2|COMPLETED|Overall Study||6
272134|NCT02201056|653366|P1|COMPLETED|Overall Study||12
272135|NCT02201056|653360|P7|STARTED|Overall Study||6
272136|NCT02201056|653361|P6|STARTED|Overall Study||6
272137|NCT02201056|653362|P5|STARTED|Overall Study||6
272138|NCT02201056|653363|P4|STARTED|Overall Study||6
272139|NCT02201056|653364|P3|STARTED|Overall Study||6
272140|NCT02201056|653365|P2|STARTED|Overall Study||6
272141|NCT02201056|653366|P1|STARTED|Overall Study||12
272142|NCT02200536|653424|P3|NOT COMPLETED|Overall Study||0
272143|NCT02200536|653425|P2|NOT COMPLETED|Overall Study||0
272144|NCT02200536|653426|P1|NOT COMPLETED|Overall Study||0
272145|NCT02200536|653424|P3|COMPLETED|Overall Study||30
272146|NCT02200536|653425|P2|COMPLETED|Overall Study||30
272147|NCT02200536|653426|P1|COMPLETED|Overall Study||32
272148|NCT02200536|653424|P3|STARTED|Overall Study||30
272149|NCT02200536|653425|P2|STARTED|Overall Study||30
272150|NCT02200536|653426|P1|STARTED|Overall Study||32
272151|NCT02200458|653437|P1|NOT COMPLETED|Overall Study||0
272152|NCT02200458|653437|P1|COMPLETED|Overall Study||62
272153|NCT02200458|653437|P1|STARTED|Overall Study||62
272154|NCT02200328|653443|P2|NOT COMPLETED|Overall Study||33
272155|NCT02200328|653444|P1|NOT COMPLETED|Overall Study||43
272156|NCT02200328|653443|P2|COMPLETED|Overall Study||0
272157|NCT02200328|653444|P1|COMPLETED|Overall Study||0
272158|NCT02200328|653443|P2|STARTED|Overall Study||33
272159|NCT02200328|653444|P1|STARTED|Overall Study||43
272160|NCT02199717|653452|P1|NOT COMPLETED|Overall Study||0
272161|NCT02199717|653452|P1|COMPLETED|Overall Study||66
272162|NCT02199717|653452|P1|STARTED|Overall Study||66
272163|NCT02199574|653459|P1|NOT COMPLETED|Overall Study||0
272164|NCT02199574|653459|P1|COMPLETED|Overall Study||12
272165|NCT02199574|653459|P1|STARTED|Overall Study||12
272166|NCT02198963|653468|P1|NOT COMPLETED|Overall Study||7
272167|NCT02198963|653468|P1|COMPLETED|Overall Study||36
272168|NCT02198963|653468|P1|STARTED|Overall Study||43
272169|NCT02198833|653479|P2|NOT COMPLETED|Overall Study||0
272170|NCT02198833|653480|P1|NOT COMPLETED|Overall Study||0
272171|NCT02198833|653479|P2|COMPLETED|Overall Study||1
272172|NCT02198833|653480|P1|COMPLETED|Overall Study||1
272173|NCT02198833|653479|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
272174|NCT02198833|653480|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
272175|NCT02198430|653494|P2|NOT COMPLETED|Overall Study||0
272176|NCT02198430|653495|P1|NOT COMPLETED|Overall Study||0
272177|NCT02198430|653494|P2|COMPLETED|Overall Study||51
272178|NCT02198430|653495|P1|COMPLETED|Overall Study||53
272179|NCT02198430|653494|P2|STARTED|Overall Study||51
272180|NCT02198430|653495|P1|STARTED|Overall Study||53
272181|NCT02198235|653510|P3|NOT COMPLETED|Overall Study||2
272182|NCT02198235|653511|P2|NOT COMPLETED|Overall Study||2
272183|NCT02198235|653512|P1|NOT COMPLETED|Overall Study||3
272184|NCT02198235|653510|P3|COMPLETED|Overall Study||28
272185|NCT02198235|653511|P2|COMPLETED|Overall Study||28
272186|NCT02198235|653512|P1|COMPLETED|Overall Study||27
272187|NCT02198235|653510|P3|STARTED|Overall Study||30
272188|NCT02198235|653511|P2|STARTED|Overall Study||30
272189|NCT02198235|653512|P1|STARTED|Overall Study||30
272190|NCT02198040|653532|P3|NOT COMPLETED|Overall Study||1
272191|NCT02198040|653533|P2|NOT COMPLETED|Overall Study||1
272192|NCT02198040|653534|P1|NOT COMPLETED|Overall Study||0
272193|NCT02198040|653532|P3|COMPLETED|Overall Study||8
272194|NCT02198040|653533|P2|COMPLETED|Overall Study||8
272195|NCT02198040|653534|P1|COMPLETED|Overall Study||9
272196|NCT02198040|653532|P3|STARTED|Overall Study||9
272197|NCT02198040|653533|P2|STARTED|Overall Study||9
272198|NCT02198040|653534|P1|STARTED|Overall Study||9
272199|NCT02197806|653564|P4|NOT COMPLETED|Overall Study||1
272200|NCT02197806|653565|P3|NOT COMPLETED|Overall Study||0
272201|NCT02197806|653566|P2|NOT COMPLETED|Overall Study||1
272202|NCT02197806|653567|P1|NOT COMPLETED|Overall Study||0
272203|NCT02197806|653564|P4|COMPLETED|Overall Study||16
272204|NCT02197806|653565|P3|COMPLETED|Overall Study||16
272205|NCT02197806|653566|P2|COMPLETED|Overall Study||16
272206|NCT02197806|653567|P1|COMPLETED|Overall Study||15
272207|NCT02197806|653564|P4|STARTED|Overall Study||17
272208|NCT02197806|653565|P3|STARTED|Overall Study||16
272209|NCT02197806|653566|P2|STARTED|Overall Study||17
272210|NCT02197806|653567|P1|STARTED|Overall Study||15
272211|NCT02197455|653577|P1|NOT COMPLETED|Overall Study||0
272212|NCT02197455|653577|P1|COMPLETED|Overall Study||30
272213|NCT02197455|653577|P1|STARTED|Overall Study||30
272214|NCT02197273|653584|P2|NOT COMPLETED|Overall Study||0
272215|NCT02197273|653585|P1|NOT COMPLETED|Overall Study||0
272216|NCT02197273|653584|P2|COMPLETED|Overall Study||104
272217|NCT02197273|653585|P1|COMPLETED|Overall Study||107
272218|NCT02197273|653584|P2|STARTED|Overall Study||104
272219|NCT02197273|653585|P1|STARTED|Overall Study||107
272220|NCT02197247|653595|P1|NOT COMPLETED|Period 3||5
272221|NCT02197247|653595|P1|COMPLETED|Period 3||32
272222|NCT02197247|653595|P1|STARTED|Period 3||37
272223|NCT02197247|653595|P1|NOT COMPLETED|Period 2||4
272224|NCT02197247|653595|P1|COMPLETED|Period 2||37
272225|NCT02197247|653595|P1|STARTED|Period 2||41
272226|NCT02197247|653595|P1|NOT COMPLETED|Period 1||0
272227|NCT02197247|653595|P1|COMPLETED|Period 1||41
272228|NCT02197247|653595|P1|STARTED|Period 1||41
272229|NCT02197234|653638|P1|NOT COMPLETED|Overall Study||3
272230|NCT02197234|653638|P1|COMPLETED|Overall Study||49
272231|NCT02197234|653638|P1|STARTED|Overall Study||52
272232|NCT02196766|653658|P2|NOT COMPLETED|Second Intervention (7 Days)||0
272233|NCT02196766|653659|P1|NOT COMPLETED|Second Intervention (7 Days)||0
272234|NCT02196766|653658|P2|COMPLETED|Second Intervention (7 Days)||15
272235|NCT02196766|653659|P1|COMPLETED|Second Intervention (7 Days)||15
272236|NCT02196766|653658|P2|STARTED|Second Intervention (7 Days)||15
272237|NCT02196766|653659|P1|STARTED|Second Intervention (7 Days)||15
272238|NCT02196766|653658|P2|NOT COMPLETED|First Intervention (7 Days)||0
272239|NCT02196766|653659|P1|NOT COMPLETED|First Intervention (7 Days)||0
272240|NCT02196766|653658|P2|COMPLETED|First Intervention (7 Days)||15
272241|NCT02196766|653659|P1|COMPLETED|First Intervention (7 Days)||15
272242|NCT02196766|653658|P2|STARTED|First Intervention (7 Days)||15
272243|NCT02196766|653659|P1|STARTED|First Intervention (7 Days)||15
272244|NCT02196714|653675|P4|NOT COMPLETED|Overall Study||0
272245|NCT02196714|653676|P3|NOT COMPLETED|Overall Study||1
272246|NCT02196714|653677|P2|NOT COMPLETED|Overall Study||0
272247|NCT02196714|653678|P1|NOT COMPLETED|Overall Study||0
272248|NCT02196714|653675|P4|COMPLETED|Overall Study||24
272249|NCT02196714|653676|P3|COMPLETED|Overall Study||23
272250|NCT02196714|653677|P2|COMPLETED|Overall Study||23
272251|NCT02196714|653678|P1|COMPLETED|Overall Study||24
272252|NCT02196714|653675|P4|STARTED|Overall Study||24
272253|NCT02196714|653676|P3|STARTED|Overall Study||24
272254|NCT02196714|653677|P2|STARTED|Overall Study||23
272255|NCT02196714|653678|P1|STARTED|Overall Study||24
272256|NCT02196675|653801|P3|NOT COMPLETED|Overall Study||1
272257|NCT02196675|653802|P2|NOT COMPLETED|Overall Study||2
272258|NCT02196675|653803|P1|NOT COMPLETED|Overall Study||2
272259|NCT02196675|653801|P3|COMPLETED|Overall Study||7
272260|NCT02196675|653802|P2|COMPLETED|Overall Study||68
272261|NCT02196675|653803|P1|COMPLETED|Overall Study||25
272262|NCT02196675|653801|P3|STARTED|Overall Study||8
272263|NCT02196675|653802|P2|STARTED|Overall Study||70
272264|NCT02196675|653803|P1|STARTED|Overall Study||27
272265|NCT02196259|653826|P3|NOT COMPLETED|Overall Study||1
272266|NCT02196259|653827|P2|NOT COMPLETED|Overall Study||3
272267|NCT02196259|653828|P1|NOT COMPLETED|Overall Study||0
272268|NCT02196259|653826|P3|COMPLETED|Overall Study||2
272269|NCT02196259|653827|P2|COMPLETED|Overall Study||4
272270|NCT02196259|653828|P1|COMPLETED|Overall Study||3
272271|NCT02196259|653826|P3|STARTED|Overall Study||3
272272|NCT02196259|653827|P2|STARTED|Overall Study||7
272273|NCT02196259|653828|P1|STARTED|Overall Study||3
272274|NCT02196168|653837|P2|NOT COMPLETED|Overall Study||0
272275|NCT02196168|653838|P1|NOT COMPLETED|Overall Study||0
272276|NCT02196168|653837|P2|COMPLETED|Overall Study||0
272277|NCT02196168|653838|P1|COMPLETED|Overall Study||6
272278|NCT02196168|653837|P2|STARTED|Overall Study||0
272279|NCT02196168|653838|P1|STARTED|Overall Study||6
272280|NCT02196077|653856|P1|NOT COMPLETED|Overall Study||47
272281|NCT02196077|653856|P1|COMPLETED|Overall Study||133
272282|NCT02196077|653856|P1|FF MDI 9.6 μg|Overall Study||157
272283|NCT02196077|653856|P1|BD MDI 320 μg|Overall Study||108
272284|NCT02196077|653856|P1|BFF MDI 80/9.6 μg|Overall Study||103
272285|NCT02196077|653856|P1|BFF MDI 160/9.6 μg|Overall Study||106
272286|NCT02196077|653856|P1|BFF MDI 320/9.6 μg|Overall Study||155
272287|NCT02196077|653856|P1|STARTED|Overall Study||180
272288|NCT02195713|653905|P2|NOT COMPLETED|Overall Study||0
272289|NCT02195713|653906|P1|NOT COMPLETED|Overall Study||0
272290|NCT02195713|653905|P2|COMPLETED|Overall Study||10
272291|NCT02195713|653906|P1|COMPLETED|Overall Study||10
272292|NCT02195713|653905|P2|STARTED|Overall Study||10
272293|NCT02195713|653906|P1|STARTED|Overall Study||10
272294|NCT02195687|653914|P2|NOT COMPLETED|Overall Study||2
272295|NCT02195687|653915|P1|NOT COMPLETED|Overall Study||5
272296|NCT02195687|653914|P2|COMPLETED|Overall Study||99
272297|NCT02195687|653915|P1|COMPLETED|Overall Study||311
272298|NCT02195687|653914|P2|STARTED|Overall Study||101
272299|NCT02195687|653915|P1|STARTED|Overall Study||316
272300|NCT02195583|653931|P1|NOT COMPLETED|Overall Study||9
272301|NCT02195583|653931|P1|COMPLETED|Overall Study||53
272302|NCT02195583|653931|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
272303|NCT02195583|653931|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
272304|NCT02195583|653931|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
272305|NCT02195583|653931|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
272306|NCT02195583|653931|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
272307|NCT02195583|653931|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
272308|NCT02195583|653931|P1|STARTED|Overall Study||62
272309|NCT02195414|653963|P1|NOT COMPLETED|Overall Study||0
272310|NCT02195414|653963|P1|COMPLETED|Overall Study||31
272311|NCT02195414|653963|P1|Primary Endpoint|Overall Study||31
272312|NCT02195414|653963|P1|STARTED|Overall Study||31
272313|NCT02194621|653973|P3|NOT COMPLETED|Overall Study||9
272314|NCT02194621|653974|P2|NOT COMPLETED|Overall Study||6
272315|NCT02194621|653975|P1|NOT COMPLETED|Overall Study||6
272316|NCT02194621|653973|P3|COMPLETED|Overall Study||34
272317|NCT02194621|653974|P2|COMPLETED|Overall Study||36
272318|NCT02194621|653975|P1|COMPLETED|Overall Study||37
272319|NCT02194621|653973|P3|STARTED|Overall Study||43
272320|NCT02194621|653974|P2|STARTED|Overall Study||42
272321|NCT02194621|653975|P1|STARTED|Overall Study||43
272322|NCT02194088|653994|P2|NOT COMPLETED|Overall Study||0
272323|NCT02194088|653995|P1|NOT COMPLETED|Overall Study||0
272324|NCT02194088|653994|P2|COMPLETED|Overall Study||25
272325|NCT02194088|653995|P1|COMPLETED|Overall Study||75
272326|NCT02194088|653994|P2|STARTED|Overall Study||25
272327|NCT02194088|653995|P1|STARTED|Overall Study||75
272328|NCT02194062|654008|P3|NOT COMPLETED|Overall Study||5
272329|NCT02194062|654009|P2|NOT COMPLETED|Overall Study||2
272330|NCT02194062|654010|P1|NOT COMPLETED|Overall Study||2
272331|NCT02194062|654008|P3|COMPLETED|Overall Study||7
272332|NCT02194062|654009|P2|COMPLETED|Overall Study||8
272333|NCT02194062|654010|P1|COMPLETED|Overall Study||8
272334|NCT02194062|654008|P3|STARTED|Overall Study||12
272335|NCT02194062|654009|P2|STARTED|Overall Study||10
272336|NCT02194062|654010|P1|STARTED|Overall Study||10
272337|NCT02193828|654025|P4|NOT COMPLETED|Overall Study||1
272338|NCT02193828|654026|P3|NOT COMPLETED|Overall Study||1
272339|NCT02193828|654027|P2|NOT COMPLETED|Overall Study||0
272340|NCT02193828|654028|P1|NOT COMPLETED|Overall Study||0
272341|NCT02193828|654025|P4|COMPLETED|Overall Study||16
272342|NCT02193828|654026|P3|COMPLETED|Overall Study||22
272343|NCT02193828|654027|P2|COMPLETED|Overall Study||18
272344|NCT02193828|654028|P1|COMPLETED|Overall Study||18
272345|NCT02193828|654025|P4|STARTED|Overall Study||17
272346|NCT02193828|654026|P3|STARTED|Overall Study||23
272347|NCT02193828|654027|P2|STARTED|Overall Study||18
272348|NCT02193828|654028|P1|STARTED|Overall Study||18
272349|NCT02193815|654066|P1|NOT COMPLETED|Overall Study||0
272350|NCT02193815|654066|P1|COMPLETED|Overall Study||15
272351|NCT02193815|654066|P1|STARTED|Overall Study||15
272352|NCT02193178|654101|P1|NOT COMPLETED|Overall Study||2
272353|NCT02193178|654101|P1|COMPLETED|Overall Study||13
272354|NCT02193178|654101|P1|STARTED|Overall Study||15
272355|NCT02193165|654151|P3|NOT COMPLETED|6 Week Product Use||0
272356|NCT02193165|654152|P2|NOT COMPLETED|6 Week Product Use||1
272357|NCT02193165|654153|P1|NOT COMPLETED|6 Week Product Use||0
272358|NCT02193165|654151|P3|COMPLETED|6 Week Product Use||39
272359|NCT02193165|654152|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
272360|NCT02193165|654153|P1|COMPLETED|6 Week Product Use||39
272361|NCT02193165|654151|P3|STARTED|6 Week Product Use||39
272362|NCT02193165|654152|P2|STARTED|6 Week Product Use||39
272363|NCT02193165|654153|P1|STARTED|6 Week Product Use||39
272364|NCT02193165|654151|P3|NOT COMPLETED|4 Week Product Use||1
272365|NCT02193165|654152|P2|NOT COMPLETED|4 Week Product Use||1
272366|NCT02193165|654153|P1|NOT COMPLETED|4 Week Product Use||1
272367|NCT02193165|654151|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
272368|NCT02193165|654152|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
272369|NCT02193165|654153|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
272370|NCT02193165|654151|P3|STARTED|4 Week Product Use||40
272371|NCT02193165|654152|P2|STARTED|4 Week Product Use||40
272372|NCT02193165|654153|P1|STARTED|4 Week Product Use||40
272373|NCT02193087|654180|P4|NOT COMPLETED|Overall Study||79
272374|NCT02193087|654181|P3|NOT COMPLETED|Overall Study||7
272375|NCT02193087|654182|P2|NOT COMPLETED|Overall Study||14
272376|NCT02193087|654183|P1|NOT COMPLETED|Overall Study||37
272377|NCT02193087|654180|P4|COMPLETED|Overall Study||524
272378|NCT02193087|654181|P3|COMPLETED|Overall Study||93
272379|NCT02193087|654182|P2|COMPLETED|Overall Study||86
272380|NCT02193087|654183|P1|COMPLETED|Overall Study||162
272381|NCT02193087|654180|P4|Received Vaccination|Overall Study||602
272382|NCT02193087|654181|P3|Received Vaccination|Overall Study||100
272383|NCT02193087|654182|P2|Received Vaccination|Overall Study||97
272384|NCT02193087|654183|P1|Received Vaccination|Overall Study||197
272385|NCT02193087|654180|P4|STARTED|Overall Study||603
272386|NCT02193087|654181|P3|STARTED|Overall Study||100
272387|NCT02193087|654182|P2|STARTED|Overall Study||100
272388|NCT02193087|654183|P1|STARTED|Overall Study||199
272389|NCT02192879|654229|P3|NOT COMPLETED|Overall Study||0
272390|NCT02192879|654230|P2|NOT COMPLETED|Overall Study||0
272391|NCT02192879|654231|P1|NOT COMPLETED|Overall Study||0
272392|NCT02192879|654229|P3|COMPLETED|Overall Study||3
272393|NCT02192879|654230|P2|COMPLETED|Overall Study||4
272394|NCT02192879|654231|P1|COMPLETED|Overall Study||3
272395|NCT02192879|654229|P3|STARTED|Overall Study||3
272396|NCT02192879|654230|P2|STARTED|Overall Study||4
272397|NCT02192879|654231|P1|STARTED|Overall Study||3
272398|NCT02192814|654257|P1|NOT COMPLETED|Overall Study||0
272399|NCT02192814|654257|P1|COMPLETED|Overall Study||9
272400|NCT02192814|654257|P1|STARTED|Overall Study||9
272401|NCT02192684|654270|P2|NOT COMPLETED|Overall Study||0
272402|NCT02192684|654271|P1|NOT COMPLETED|Overall Study||0
272403|NCT02192684|654270|P2|COMPLETED|Overall Study||15
272404|NCT02192684|654271|P1|COMPLETED|Overall Study||30
272405|NCT02192684|654270|P2|STARTED|Overall Study||15
272406|NCT02192684|654271|P1|STARTED|Overall Study||30
272407|NCT02191865|654280|P3|NOT COMPLETED|Overall Study||0
272408|NCT02191865|654281|P2|NOT COMPLETED|Overall Study||0
272409|NCT02191865|654282|P1|NOT COMPLETED|Overall Study||0
272410|NCT02191865|654280|P3|COMPLETED|Overall Study||17
272411|NCT02191865|654281|P2|COMPLETED|Overall Study||8
272412|NCT02191865|654282|P1|COMPLETED|Overall Study||8
272413|NCT02191865|654280|P3|STARTED|Overall Study||17
272414|NCT02191865|654281|P2|STARTED|Overall Study||8
272415|NCT02191865|654282|P1|STARTED|Overall Study||8
272416|NCT02191046|654304|P2|NOT COMPLETED|Overall Study||1
272417|NCT02191046|654305|P1|NOT COMPLETED|Overall Study||5
272418|NCT02191046|654304|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
272419|NCT02191046|654305|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
272420|NCT02191046|654304|P2|STARTED|Overall Study||39
272421|NCT02191046|654305|P1|STARTED|Overall Study||41
272422|NCT02191033|654313|P2|NOT COMPLETED|Overall Study||1
272423|NCT02191033|654314|P1|NOT COMPLETED|Overall Study||2
272424|NCT02191033|654313|P2|COMPLETED|Overall Study||19
272425|NCT02191033|654314|P1|COMPLETED|Overall Study||18
272426|NCT02191033|654313|P2|STARTED|Overall Study||20
272427|NCT02191033|654314|P1|STARTED|Overall Study||20
272428|NCT02190591|654326|P2|NOT COMPLETED|Overall Study||11
272429|NCT02190591|654327|P1|NOT COMPLETED|Overall Study||2
272430|NCT02190591|654326|P2|COMPLETED|Overall Study||91
272431|NCT02190591|654327|P1|COMPLETED|Overall Study||100
272432|NCT02190591|654326|P2|STARTED|Overall Study||102
272433|NCT02190591|654327|P1|STARTED|Overall Study||102
272434|NCT02190435|654339|P2|NOT COMPLETED|Overall Study||0
272435|NCT02190435|654340|P1|NOT COMPLETED|Overall Study||15
272436|NCT02190435|654339|P2|COMPLETED|Overall Study||24
272437|NCT02190435|654340|P1|COMPLETED|Overall Study||26
272438|NCT02190435|654339|P2|STARTED|Overall Study||24
272439|NCT02190435|654340|P1|STARTED|Overall Study||41
272440|NCT02189954|654350|P2|NOT COMPLETED|Overall Study||0
272441|NCT02189954|654351|P1|NOT COMPLETED|Overall Study||0
272442|NCT02189954|654350|P2|COMPLETED|Overall Study||45
272443|NCT02189954|654351|P1|COMPLETED|Overall Study||45
272444|NCT02189954|654350|P2|STARTED|Overall Study||45
272445|NCT02189954|654351|P1|STARTED|Overall Study||45
272446|NCT02189941|654359|P3|NOT COMPLETED|Overall Study||1
272447|NCT02189941|654360|P2|NOT COMPLETED|Overall Study||0
272448|NCT02189941|654361|P1|NOT COMPLETED|Overall Study||0
272449|NCT02189941|654359|P3|COMPLETED|Overall Study||2
272450|NCT02189941|654360|P2|COMPLETED|Overall Study||4
272451|NCT02189941|654361|P1|COMPLETED|Overall Study||4
272452|NCT02189941|654359|P3|STARTED|Overall Study||3
272453|NCT02189941|654360|P2|STARTED|Overall Study||4
272454|NCT02189941|654361|P1|STARTED|Overall Study||4
272455|NCT02189915|654384|P1|NOT COMPLETED|Overall Study||3
272456|NCT02189915|654384|P1|COMPLETED|Overall Study||11
272457|NCT02189915|654384|P1|STARTED|Overall Study||14
272458|NCT02189863|654389|P2|NOT COMPLETED|Second 2 Weeks||0
272459|NCT02189863|654390|P1|NOT COMPLETED|Second 2 Weeks||0
272460|NCT02189863|654389|P2|COMPLETED|Second 2 Weeks||13
272461|NCT02189863|654390|P1|COMPLETED|Second 2 Weeks||8
272462|NCT02189863|654389|P2|STARTED|Second 2 Weeks||13
272463|NCT02189863|654390|P1|STARTED|Second 2 Weeks||8
272464|NCT02189863|654389|P2|NOT COMPLETED|First 2 Weeks||2
272465|NCT02189863|654390|P1|NOT COMPLETED|First 2 Weeks||4
272466|NCT02189863|654389|P2|COMPLETED|First 2 Weeks||13
272467|NCT02189863|654390|P1|COMPLETED|First 2 Weeks||8
272468|NCT02189863|654389|P2|STARTED|First 2 Weeks||15
272469|NCT02189863|654390|P1|STARTED|First 2 Weeks||12
272470|NCT02189837|654405|P4|NOT COMPLETED|Overall Study||2
272471|NCT02189837|654406|P3|NOT COMPLETED|Overall Study||3
272472|NCT02189837|654407|P2|NOT COMPLETED|Overall Study||1
272473|NCT02189837|654408|P1|NOT COMPLETED|Overall Study||2
272474|NCT02189837|654405|P4|COMPLETED|Overall Study||19
272475|NCT02189837|654406|P3|COMPLETED|Overall Study||20
272476|NCT02189837|654407|P2|COMPLETED|Overall Study||22
272477|NCT02189837|654408|P1|COMPLETED|Overall Study||20
272478|NCT02189837|654405|P4|Received Treatment|Overall Study||20
272479|NCT02189837|654406|P3|Received Treatment|Overall Study||22
272480|NCT02189837|654407|P2|Received Treatment|Overall Study||22
272481|NCT02189837|654408|P1|Received Treatment|Overall Study||21
272482|NCT02189837|654405|P4|STARTED|Overall Study||21
272483|NCT02189837|654406|P3|STARTED|Overall Study||23
272484|NCT02189837|654407|P2|STARTED|Overall Study||23
272485|NCT02189837|654408|P1|STARTED|Overall Study||22
272486|NCT02189317|654436|P2|NOT COMPLETED|Overall Study||0
272487|NCT02189317|654437|P1|NOT COMPLETED|Overall Study||0
272488|NCT02189317|654436|P2|COMPLETED|Overall Study||16
272489|NCT02189317|654437|P1|COMPLETED|Overall Study||16
272490|NCT02189317|654436|P2|STARTED|Overall Study||16
272491|NCT02189317|654437|P1|STARTED|Overall Study||16
272492|NCT02189252|654451|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
272493|NCT02189252|654452|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
272494|NCT02189252|654453|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
272495|NCT02189252|654454|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
272496|NCT02189252|654451|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
272497|NCT02189252|654452|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
272498|NCT02189252|654453|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
272499|NCT02189252|654454|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
272500|NCT02189252|654451|P4|STARTED|Period 2 (Visit6b, Week 12)||4
272501|NCT02189252|654452|P3|STARTED|Period 2 (Visit6b, Week 12)||3
272502|NCT02189252|654453|P2|STARTED|Period 2 (Visit6b, Week 12)||2
272503|NCT02189252|654454|P1|STARTED|Period 2 (Visit6b, Week 12)||4
272504|NCT02189252|654451|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
272505|NCT02189252|654452|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
272506|NCT02189252|654453|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
272507|NCT02189252|654454|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
272508|NCT02189252|654451|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
272509|NCT02189252|654452|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
272510|NCT02189252|654453|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
272511|NCT02189252|654454|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
272512|NCT02189252|654451|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
272513|NCT02189252|654452|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
272514|NCT02189252|654453|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
272515|NCT02189252|654454|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
272516|NCT02189161|654486|P1|NOT COMPLETED|Overall Study||0
272517|NCT02189161|654486|P1|COMPLETED|Overall Study||10
272518|NCT02189161|654486|P1|STARTED|Overall Study||10
272519|NCT02189122|654494|P2|NOT COMPLETED|Overall Study||0
272520|NCT02189122|654495|P1|NOT COMPLETED|Overall Study||0
272521|NCT02189122|654494|P2|COMPLETED|Overall Study||18
272522|NCT02189122|654495|P1|COMPLETED|Overall Study||18
272523|NCT02189122|654494|P2|STARTED|Overall Study||18
272524|NCT02189122|654495|P1|STARTED|Overall Study||18
272525|NCT02188849|654513|P2|NOT COMPLETED|Overall Study||8
272526|NCT02188849|654514|P1|NOT COMPLETED|Overall Study||3
272527|NCT02188849|654513|P2|COMPLETED|Overall Study||17
272528|NCT02188849|654514|P1|COMPLETED|Overall Study||22
272529|NCT02188849|654513|P2|STARTED|Overall Study||25
272530|NCT02188849|654514|P1|STARTED|Overall Study||25
272531|NCT02188784|654528|P2|NOT COMPLETED|Overall Study||13
272532|NCT02188784|654529|P1|NOT COMPLETED|Overall Study||9
272533|NCT02188784|654528|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
272534|NCT02188784|654529|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
272535|NCT02188784|654528|P2|STARTED|Overall Study||114
272536|NCT02188784|654529|P1|STARTED|Overall Study||111
272537|NCT02188589|654545|P1|NOT COMPLETED|Overall Study||0
272538|NCT02188589|654545|P1|COMPLETED|Overall Study||30
272539|NCT02188589|654545|P1|STARTED|Overall Study||30
272540|NCT02187809|654550|P1|NOT COMPLETED|Overall Study||3
272541|NCT02187809|654550|P1|COMPLETED|Overall Study||0
272542|NCT02187809|654550|P1|Treated|Overall Study||1
272543|NCT02187809|654550|P1|STARTED|Overall Study||3
272544|NCT02187744|654562|P2|NOT COMPLETED|Treatment||5
272545|NCT02187744|654563|P1|NOT COMPLETED|Treatment||4
272546|NCT02187744|654562|P2|COMPLETED|Treatment||107
272547|NCT02187744|654563|P1|COMPLETED|Treatment||109
272548|NCT02187744|654562|P2|STARTED|Treatment||112
272549|NCT02187744|654563|P1|STARTED|Treatment||113
272550|NCT02187744|654562|P2|NOT COMPLETED|Study||6
272551|NCT02187744|654563|P1|NOT COMPLETED|Study||4
272552|NCT02187744|654562|P2|COMPLETED|Study||106
272553|NCT02187744|654563|P1|COMPLETED|Study||109
272554|NCT02187744|654562|P2|STARTED|Study|Received treatment|112
272555|NCT02187744|654563|P1|STARTED|Study|Received treatment|113
272556|NCT02187029|654583|P4|NOT COMPLETED|Overall Study||3
272557|NCT02187029|654584|P3|NOT COMPLETED|Overall Study||11
272558|NCT02187029|654585|P2|NOT COMPLETED|Overall Study||1
272559|NCT02187029|654586|P1|NOT COMPLETED|Overall Study||1
272560|NCT02187029|654583|P4|COMPLETED|Overall Study||6
272561|NCT02187029|654584|P3|COMPLETED|Overall Study||0
272562|NCT02187029|654585|P2|COMPLETED|Overall Study||2
272563|NCT02187029|654586|P1|COMPLETED|Overall Study||6
272564|NCT02187029|654583|P4|STARTED|Overall Study||9
272565|NCT02187029|654584|P3|STARTED|Overall Study||11
272566|NCT02187029|654585|P2|STARTED|Overall Study||3
272567|NCT02187029|654586|P1|STARTED|Overall Study||7
272568|NCT02187016|654662|P4|NOT COMPLETED|Overall Study||0
272569|NCT02187016|654663|P3|NOT COMPLETED|Overall Study||1
272570|NCT02187016|654664|P2|NOT COMPLETED|Overall Study||2
272571|NCT02187016|654665|P1|NOT COMPLETED|Overall Study||1
272572|NCT02187016|654662|P4|COMPLETED|Overall Study||51
272573|NCT02187016|654663|P3|COMPLETED|Overall Study||78
272574|NCT02187016|654664|P2|COMPLETED|Overall Study||78
272575|NCT02187016|654665|P1|COMPLETED|Overall Study||79
272576|NCT02187016|654662|P4|STARTED|Overall Study||51
272577|NCT02187016|654663|P3|STARTED|Overall Study||79
272578|NCT02187016|654664|P2|STARTED|Overall Study||80
272579|NCT02187016|654665|P1|STARTED|Overall Study||80
272580|NCT02186808|654695|P1|NOT COMPLETED|Overall Study||13
272581|NCT02186808|654695|P1|COMPLETED|Overall Study||67
272582|NCT02186808|654695|P1|STARTED|Overall Study||80
272583|NCT02186665|654702|P2|NOT COMPLETED|Overall Study||1
272584|NCT02186665|654703|P1|NOT COMPLETED|Overall Study||0
272585|NCT02186665|654702|P2|COMPLETED|Overall Study||10
272586|NCT02186665|654703|P1|COMPLETED|Overall Study||8
272587|NCT02186665|654702|P2|STARTED|Overall Study||11
272588|NCT02186665|654703|P1|STARTED|Overall Study||8
272589|NCT02186587|654711|P2|NOT COMPLETED|Overall Study||0
272590|NCT02186587|654712|P1|NOT COMPLETED|Overall Study||5
272591|NCT02186587|654711|P2|COMPLETED|Overall Study||0
272592|NCT02186587|654712|P1|COMPLETED|Overall Study||23
272593|NCT02186587|654711|P2|STARTED|Overall Study||0
272594|NCT02186587|654712|P1|STARTED|Overall Study||28
272595|NCT02186223|654717|P1|NOT COMPLETED|Overall Study||21
272596|NCT02186223|654717|P1|COMPLETED|Overall Study||151
272597|NCT02186223|654717|P1|Device Placed|Overall Study||163
272598|NCT02186223|654717|P1|STARTED|Overall Study||172
272599|NCT02185729|654726|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
272600|NCT02185729|654726|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
272601|NCT02185729|654726|P1|STARTED|24 Hours Into Dextrose Infusion||12
272602|NCT02185729|654726|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
272603|NCT02185729|654726|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
272604|NCT02185729|654726|P1|STARTED|4 Hours Into Dextrose Infusion||12
272605|NCT02185729|654726|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
272606|NCT02185729|654726|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
272607|NCT02185729|654726|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
272608|NCT02185729|654726|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
272609|NCT02185729|654726|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
272610|NCT02185729|654726|P1|STARTED|24 Hours Into ClinOleic Infusion||12
272611|NCT02185729|654726|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
272612|NCT02185729|654726|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
272613|NCT02185729|654726|P1|STARTED|4 Hours Into ClinOleic Infusion||12
272614|NCT02185729|654726|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
272615|NCT02185729|654726|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
272616|NCT02185729|654726|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
272617|NCT02185729|654726|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
272618|NCT02185729|654726|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
272619|NCT02185729|654726|P1|STARTED|24 Hours Into Intralipid Infusion||12
272620|NCT02185729|654726|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
272621|NCT02185729|654726|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
272622|NCT02185729|654726|P1|STARTED|4 Hours Into Intralipid Infusion||12
272623|NCT02185729|654726|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
272624|NCT02185729|654726|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
272625|NCT02185729|654726|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
272626|NCT02185729|654726|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
272627|NCT02185729|654726|P1|COMPLETED|24 Hours Into Saline Infusion||12
272628|NCT02185729|654726|P1|STARTED|24 Hours Into Saline Infusion||12
272629|NCT02185729|654726|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
272630|NCT02185729|654726|P1|COMPLETED|4 Hours Into Saline Infusion||12
272631|NCT02185729|654726|P1|STARTED|4 Hours Into Saline Infusion||12
272632|NCT02185729|654726|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
272633|NCT02185729|654726|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
272634|NCT02185729|654726|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
272635|NCT02185534|654747|P6|NOT COMPLETED|Third Period||0
272636|NCT02185534|654748|P5|NOT COMPLETED|Third Period||0
272637|NCT02185534|654749|P4|NOT COMPLETED|Third Period||0
272638|NCT02185534|654750|P3|NOT COMPLETED|Third Period||0
272639|NCT02185534|654751|P2|NOT COMPLETED|Third Period||0
272640|NCT02185534|654752|P1|NOT COMPLETED|Third Period||0
272641|NCT02185534|654747|P6|COMPLETED|Third Period||13
272642|NCT02185534|654748|P5|COMPLETED|Third Period||13
272643|NCT02185534|654749|P4|COMPLETED|Third Period||13
272644|NCT02185534|654750|P3|COMPLETED|Third Period||14
272645|NCT02185534|654751|P2|COMPLETED|Third Period||14
272646|NCT02185534|654752|P1|COMPLETED|Third Period||13
272647|NCT02185534|654747|P6|STARTED|Third Period||13
272648|NCT02185534|654748|P5|STARTED|Third Period||13
272649|NCT02185534|654749|P4|STARTED|Third Period||13
272650|NCT02185534|654750|P3|STARTED|Third Period||14
272651|NCT02185534|654751|P2|STARTED|Third Period||14
272652|NCT02185534|654752|P1|STARTED|Third Period||13
272653|NCT02185534|654747|P6|NOT COMPLETED|Second Washout Period||0
272654|NCT02185534|654748|P5|NOT COMPLETED|Second Washout Period||0
272655|NCT02185534|654749|P4|NOT COMPLETED|Second Washout Period||0
272656|NCT02185534|654750|P3|NOT COMPLETED|Second Washout Period||0
272657|NCT02185534|654751|P2|NOT COMPLETED|Second Washout Period||0
272658|NCT02185534|654752|P1|NOT COMPLETED|Second Washout Period||0
272659|NCT02185534|654747|P6|COMPLETED|Second Washout Period||13
272660|NCT02185534|654748|P5|COMPLETED|Second Washout Period||13
272661|NCT02185534|654749|P4|COMPLETED|Second Washout Period||13
272662|NCT02185534|654750|P3|COMPLETED|Second Washout Period||14
272663|NCT02185534|654751|P2|COMPLETED|Second Washout Period||14
272664|NCT02185534|654752|P1|COMPLETED|Second Washout Period||13
272665|NCT02185534|654747|P6|STARTED|Second Washout Period||13
272666|NCT02185534|654748|P5|STARTED|Second Washout Period||13
272667|NCT02185534|654749|P4|STARTED|Second Washout Period||13
272668|NCT02185534|654750|P3|STARTED|Second Washout Period||14
272669|NCT02185534|654751|P2|STARTED|Second Washout Period||14
272670|NCT02185534|654752|P1|STARTED|Second Washout Period||13
272671|NCT02185534|654747|P6|NOT COMPLETED|Second Period||0
272672|NCT02185534|654748|P5|NOT COMPLETED|Second Period||0
272673|NCT02185534|654749|P4|NOT COMPLETED|Second Period||0
272674|NCT02185534|654750|P3|NOT COMPLETED|Second Period||0
272675|NCT02185534|654751|P2|NOT COMPLETED|Second Period||0
272676|NCT02185534|654752|P1|NOT COMPLETED|Second Period||0
272677|NCT02185534|654747|P6|COMPLETED|Second Period||13
272678|NCT02185534|654748|P5|COMPLETED|Second Period||13
272679|NCT02185534|654749|P4|COMPLETED|Second Period||13
272680|NCT02185534|654750|P3|COMPLETED|Second Period||14
272681|NCT02185534|654751|P2|COMPLETED|Second Period||14
272682|NCT02185534|654752|P1|COMPLETED|Second Period||13
272683|NCT02185534|654747|P6|STARTED|Second Period||13
272684|NCT02185534|654748|P5|STARTED|Second Period||13
272685|NCT02185534|654749|P4|STARTED|Second Period||13
272686|NCT02185534|654750|P3|STARTED|Second Period||14
272687|NCT02185534|654751|P2|STARTED|Second Period||14
272688|NCT02185534|654752|P1|STARTED|Second Period||13
272689|NCT02185534|654747|P6|NOT COMPLETED|First Washout Period||1
272690|NCT02185534|654748|P5|NOT COMPLETED|First Washout Period||1
272691|NCT02185534|654749|P4|NOT COMPLETED|First Washout Period||0
272692|NCT02185534|654750|P3|NOT COMPLETED|First Washout Period||0
272693|NCT02185534|654751|P2|NOT COMPLETED|First Washout Period||0
272694|NCT02185534|654752|P1|NOT COMPLETED|First Washout Period||1
272695|NCT02185534|654747|P6|COMPLETED|First Washout Period||13
272696|NCT02185534|654748|P5|COMPLETED|First Washout Period||13
272697|NCT02185534|654749|P4|COMPLETED|First Washout Period||13
272698|NCT02185534|654750|P3|COMPLETED|First Washout Period||14
272699|NCT02185534|654751|P2|COMPLETED|First Washout Period||14
272700|NCT02185534|654752|P1|COMPLETED|First Washout Period||13
272701|NCT02185534|654747|P6|STARTED|First Washout Period||14
272702|NCT02185534|654748|P5|STARTED|First Washout Period||14
272703|NCT02185534|654749|P4|STARTED|First Washout Period||13
272704|NCT02185534|654750|P3|STARTED|First Washout Period||14
272705|NCT02185534|654751|P2|STARTED|First Washout Period||14
272706|NCT02185534|654752|P1|STARTED|First Washout Period||14
272707|NCT02185534|654747|P6|NOT COMPLETED|First Period||0
272708|NCT02185534|654748|P5|NOT COMPLETED|First Period||0
272709|NCT02185534|654749|P4|NOT COMPLETED|First Period||1
272710|NCT02185534|654750|P3|NOT COMPLETED|First Period||0
272711|NCT02185534|654751|P2|NOT COMPLETED|First Period||0
272712|NCT02185534|654752|P1|NOT COMPLETED|First Period||0
272713|NCT02185534|654747|P6|COMPLETED|First Period||14
272714|NCT02185534|654748|P5|COMPLETED|First Period||14
272715|NCT02185534|654749|P4|COMPLETED|First Period||13
272716|NCT02185534|654750|P3|COMPLETED|First Period||14
272717|NCT02185534|654751|P2|COMPLETED|First Period||14
272718|NCT02185534|654752|P1|COMPLETED|First Period||14
272719|NCT02185534|654747|P6|STARTED|First Period||14
272720|NCT02185534|654748|P5|STARTED|First Period||14
272721|NCT02185534|654749|P4|STARTED|First Period||14
272722|NCT02185534|654750|P3|STARTED|First Period||14
272723|NCT02185534|654751|P2|STARTED|First Period||14
272724|NCT02185534|654752|P1|STARTED|First Period||14
272725|NCT02185339|654769|P2|NOT COMPLETED|Overall Study||1
272726|NCT02185339|654770|P1|NOT COMPLETED|Overall Study||0
272727|NCT02185339|654769|P2|COMPLETED|Overall Study||30
272728|NCT02185339|654770|P1|COMPLETED|Overall Study||30
272729|NCT02185339|654769|P2|STARTED|Overall Study||31
272730|NCT02185339|654770|P1|STARTED|Overall Study||30
272731|NCT02185183|654792|P1|NOT COMPLETED|Overall Study||0
272732|NCT02185183|654792|P1|COMPLETED|Overall Study||14
272733|NCT02185183|654792|P1|STARTED|Overall Study||14
272734|NCT02185131|654798|P2|NOT COMPLETED|Overall Study||1
272735|NCT02185131|654799|P1|NOT COMPLETED|Overall Study||1
272736|NCT02185131|654798|P2|COMPLETED|Overall Study||8
272737|NCT02185131|654799|P1|COMPLETED|Overall Study||6
272738|NCT02185131|654798|P2|STARTED|Overall Study||9
272739|NCT02185131|654799|P1|STARTED|Overall Study||7
272740|NCT02185105|654807|P1|NOT COMPLETED|Overall Study||0
272741|NCT02185105|654807|P1|COMPLETED|Overall Study||30
272742|NCT02185105|654807|P1|STARTED|Overall Study||30
272743|NCT02184624|654855|P5|NOT COMPLETED|Overall Study||0
272744|NCT02184624|654856|P4|NOT COMPLETED|Overall Study||0
272745|NCT02184624|654857|P3|NOT COMPLETED|Overall Study||0
272746|NCT02184624|654858|P2|NOT COMPLETED|Overall Study||0
272747|NCT02184624|654859|P1|NOT COMPLETED|Overall Study||0
272748|NCT02184624|654855|P5|COMPLETED|Overall Study||98
272749|NCT02184624|654856|P4|COMPLETED|Overall Study||118
272750|NCT02184624|654857|P3|COMPLETED|Overall Study||100
272751|NCT02184624|654858|P2|COMPLETED|Overall Study||80
272752|NCT02184624|654859|P1|COMPLETED|Overall Study||171
272753|NCT02184624|654855|P5|STARTED|Overall Study||98
272754|NCT02184624|654856|P4|STARTED|Overall Study||118
272755|NCT02184624|654857|P3|STARTED|Overall Study||100
272756|NCT02184624|654858|P2|STARTED|Overall Study||80
272757|NCT02184624|654859|P1|STARTED|Overall Study||171
272758|NCT02184494|654904|P3|NOT COMPLETED|Overall Study||0
272759|NCT02184494|654905|P2|NOT COMPLETED|Overall Study||2
272760|NCT02184494|654906|P1|NOT COMPLETED|Overall Study||1
272761|NCT02184494|654904|P3|COMPLETED|Overall Study||8
272762|NCT02184494|654905|P2|COMPLETED|Overall Study||11
272763|NCT02184494|654906|P1|COMPLETED|Overall Study||12
272764|NCT02184494|654904|P3|STARTED|Overall Study||8
272765|NCT02184494|654905|P2|STARTED|Overall Study||13
272766|NCT02184494|654906|P1|STARTED|Overall Study||13
272767|NCT02183675|654932|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
272768|NCT02183675|654933|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
272769|NCT02183675|654934|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
272770|NCT02183675|654935|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
272771|NCT02183675|654936|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
272772|NCT02183675|654937|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
272773|NCT02183675|654932|P6|COMPLETED|Treatment Period 3 (10 Days)||4
272774|NCT02183675|654933|P5|COMPLETED|Treatment Period 3 (10 Days)||6
272775|NCT02183675|654934|P4|COMPLETED|Treatment Period 3 (10 Days)||6
272776|NCT02183675|654935|P3|COMPLETED|Treatment Period 3 (10 Days)||6
272777|NCT02183675|654936|P2|COMPLETED|Treatment Period 3 (10 Days)||6
272778|NCT02183675|654937|P1|COMPLETED|Treatment Period 3 (10 Days)||6
272779|NCT02183675|654932|P6|STARTED|Treatment Period 3 (10 Days)||4
272780|NCT02183675|654933|P5|STARTED|Treatment Period 3 (10 Days)||6
272781|NCT02183675|654934|P4|STARTED|Treatment Period 3 (10 Days)||6
272782|NCT02183675|654935|P3|STARTED|Treatment Period 3 (10 Days)||6
272783|NCT02183675|654936|P2|STARTED|Treatment Period 3 (10 Days)||6
272784|NCT02183675|654937|P1|STARTED|Treatment Period 3 (10 Days)||6
272785|NCT02183675|654932|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
272786|NCT02183675|654933|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
272787|NCT02183675|654934|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
272788|NCT02183675|654935|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
272789|NCT02183675|654936|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
272790|NCT02183675|654937|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
272791|NCT02183675|654932|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
272792|NCT02183675|654933|P5|COMPLETED|Treatment Period 2 (10 Days)||6
272793|NCT02183675|654934|P4|COMPLETED|Treatment Period 2 (10 Days)||6
272794|NCT02183675|654935|P3|COMPLETED|Treatment Period 2 (10 Days)||6
272795|NCT02183675|654936|P2|COMPLETED|Treatment Period 2 (10 Days)||6
272796|NCT02183675|654937|P1|COMPLETED|Treatment Period 2 (10 Days)||6
272797|NCT02183675|654932|P6|STARTED|Treatment Period 2 (10 Days)||6
272798|NCT02183675|654933|P5|STARTED|Treatment Period 2 (10 Days)||6
272799|NCT02183675|654934|P4|STARTED|Treatment Period 2 (10 Days)||6
272800|NCT02183675|654935|P3|STARTED|Treatment Period 2 (10 Days)||6
272801|NCT02183675|654936|P2|STARTED|Treatment Period 2 (10 Days)||6
272802|NCT02183675|654937|P1|STARTED|Treatment Period 2 (10 Days)||6
272803|NCT02183675|654932|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
272804|NCT02183675|654933|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
272805|NCT02183675|654934|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
272806|NCT02183675|654935|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
272807|NCT02183675|654936|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
272808|NCT02183675|654937|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
272809|NCT02183675|654932|P6|COMPLETED|Treatment Period 1 (10 Days)||6
272810|NCT02183675|654933|P5|COMPLETED|Treatment Period 1 (10 Days)||6
272811|NCT02183675|654934|P4|COMPLETED|Treatment Period 1 (10 Days)||6
272812|NCT02183675|654935|P3|COMPLETED|Treatment Period 1 (10 Days)||6
272813|NCT02183675|654936|P2|COMPLETED|Treatment Period 1 (10 Days)||6
272814|NCT02183675|654937|P1|COMPLETED|Treatment Period 1 (10 Days)||6
272815|NCT02183675|654932|P6|STARTED|Treatment Period 1 (10 Days)||6
272816|NCT02183675|654933|P5|STARTED|Treatment Period 1 (10 Days)||6
272817|NCT02183675|654934|P4|STARTED|Treatment Period 1 (10 Days)||6
272818|NCT02183675|654935|P3|STARTED|Treatment Period 1 (10 Days)||6
272819|NCT02183675|654936|P2|STARTED|Treatment Period 1 (10 Days)||6
272820|NCT02183675|654937|P1|STARTED|Treatment Period 1 (10 Days)||6
272821|NCT02183519|654961|P2|NOT COMPLETED|Overall Study||3
272822|NCT02183519|654962|P1|NOT COMPLETED|Overall Study||3
272823|NCT02183519|654961|P2|COMPLETED|Overall Study||13
272824|NCT02183519|654962|P1|COMPLETED|Overall Study||25
272825|NCT02183519|654961|P2|STARTED|Overall Study||16
272826|NCT02183519|654962|P1|STARTED|Overall Study||28
272827|NCT02182895|654970|P2|NOT COMPLETED|Overall Study||4
272828|NCT02182895|654971|P1|NOT COMPLETED|Overall Study||2
272829|NCT02182895|654970|P2|COMPLETED|Overall Study||33
272830|NCT02182895|654971|P1|COMPLETED|Overall Study||33
272831|NCT02182895|654970|P2|STARTED|Overall Study||37
272832|NCT02182895|654971|P1|STARTED|Overall Study||35
272833|NCT02181790|654993|P2|NOT COMPLETED|Overall Study||0
272834|NCT02181790|654994|P1|NOT COMPLETED|Overall Study||2
272835|NCT02181790|654993|P2|COMPLETED|Overall Study||0
272836|NCT02181790|654994|P1|COMPLETED|Overall Study||0
272837|NCT02181790|654993|P2|STARTED|Overall Study||0
272838|NCT02181790|654994|P1|STARTED|Overall Study||2
272839|NCT02181530|655002|P1|NOT COMPLETED|Overall Study||0
272840|NCT02181530|655002|P1|COMPLETED|Overall Study||43
272841|NCT02181530|655002|P1|STARTED|Overall Study||43
272842|NCT02181517|655015|P3|NOT COMPLETED|Overall Study||0
272843|NCT02181517|655016|P2|NOT COMPLETED|Overall Study||0
272844|NCT02181517|655017|P1|NOT COMPLETED|Overall Study||0
272845|NCT02181517|655015|P3|COMPLETED|Overall Study||5
272846|NCT02181517|655016|P2|COMPLETED|Overall Study||10
272847|NCT02181517|655017|P1|COMPLETED|Overall Study||10
272848|NCT02181517|655015|P3|STARTED|Overall Study||5
272849|NCT02181517|655016|P2|STARTED|Overall Study||10
272850|NCT02181517|655017|P1|STARTED|Overall Study||10
272851|NCT02181504|655040|P3|NOT COMPLETED|Overall Study||1
272852|NCT02181504|655041|P2|NOT COMPLETED|Overall Study||1
272853|NCT02181504|655042|P1|NOT COMPLETED|Overall Study||1
272854|NCT02181504|655040|P3|COMPLETED|Overall Study||4
272855|NCT02181504|655041|P2|COMPLETED|Overall Study||9
272856|NCT02181504|655042|P1|COMPLETED|Overall Study||9
272857|NCT02181504|655040|P3|STARTED|Overall Study||5
272858|NCT02181504|655041|P2|STARTED|Overall Study||10
272859|NCT02181504|655042|P1|STARTED|Overall Study||10
272860|NCT02181140|655062|P1|NOT COMPLETED|Overall Study||0
272861|NCT02181140|655062|P1|COMPLETED|Overall Study||56
272862|NCT02181140|655062|P1|STARTED|Overall Study||56
272863|NCT02181127|655068|P1|NOT COMPLETED|Overall Study||0
272864|NCT02181127|655068|P1|COMPLETED|Overall Study||22
272865|NCT02181127|655068|P1|STARTED|Overall Study||22
272866|NCT02180893|655075|P2|NOT COMPLETED|Overall Study||7
272867|NCT02180893|655076|P1|NOT COMPLETED|Overall Study||3
272868|NCT02180893|655075|P2|COMPLETED|Overall Study||23
272869|NCT02180893|655076|P1|COMPLETED|Overall Study||27
272870|NCT02180893|655075|P2|STARTED|Overall Study||30
272871|NCT02180893|655076|P1|STARTED|Overall Study||30
272872|NCT02180828|655090|P2|NOT COMPLETED|Overall Study||7
272873|NCT02180828|655091|P1|NOT COMPLETED|Overall Study||5
272874|NCT02180828|655090|P2|COMPLETED|Overall Study||113
272875|NCT02180828|655091|P1|COMPLETED|Overall Study||115
272876|NCT02180828|655090|P2|STARTED|Overall Study||120
272877|NCT02180828|655091|P1|STARTED|Overall Study||120
272878|NCT02180646|655115|P2|NOT COMPLETED|Second Intervention (7 Days)||0
272879|NCT02180646|655116|P1|NOT COMPLETED|Second Intervention (7 Days)||0
272880|NCT02180646|655115|P2|COMPLETED|Second Intervention (7 Days)||6
272881|NCT02180646|655116|P1|COMPLETED|Second Intervention (7 Days)||6
272882|NCT02180646|655115|P2|STARTED|Second Intervention (7 Days)||6
272883|NCT02180646|655116|P1|STARTED|Second Intervention (7 Days)||6
272884|NCT02180646|655115|P2|NOT COMPLETED|Washout (7 Days)||0
272885|NCT02180646|655116|P1|NOT COMPLETED|Washout (7 Days)||0
272886|NCT02180646|655115|P2|COMPLETED|Washout (7 Days)||6
272887|NCT02180646|655116|P1|COMPLETED|Washout (7 Days)||6
272888|NCT02180646|655115|P2|STARTED|Washout (7 Days)||6
272889|NCT02180646|655116|P1|STARTED|Washout (7 Days)||6
272890|NCT02180646|655115|P2|NOT COMPLETED|First Intervention (7 Days)||0
272891|NCT02180646|655116|P1|NOT COMPLETED|First Intervention (7 Days)||0
272892|NCT02180646|655115|P2|COMPLETED|First Intervention (7 Days)||6
272893|NCT02180646|655116|P1|COMPLETED|First Intervention (7 Days)||6
272894|NCT02180646|655115|P2|STARTED|First Intervention (7 Days)||6
272895|NCT02180646|655116|P1|STARTED|First Intervention (7 Days)||6
272896|NCT02180230|655126|P1|NOT COMPLETED|Overall Study||7
272897|NCT02180230|655126|P1|COMPLETED|Overall Study||31
272898|NCT02180230|655126|P1|STARTED|Overall Study||38
272899|NCT02180061|655133|P2|NOT COMPLETED|Overall Study||8
272900|NCT02180061|655134|P1|NOT COMPLETED|Overall Study||34
272901|NCT02180061|655133|P2|COMPLETED|Overall Study||0
272902|NCT02180061|655134|P1|COMPLETED|Overall Study||0
272903|NCT02180061|655133|P2|STARTED|Overall Study||8
272904|NCT02180061|655134|P1|STARTED|Overall Study||34
272905|NCT02179424|655152|P4|NOT COMPLETED|Overall Study||0
272906|NCT02179424|655153|P3|NOT COMPLETED|Overall Study||0
272907|NCT02179424|655154|P2|NOT COMPLETED|Overall Study||0
272908|NCT02179424|655155|P1|NOT COMPLETED|Overall Study||0
272909|NCT02179424|655152|P4|COMPLETED|Overall Study||39
272910|NCT02179424|655153|P3|COMPLETED|Overall Study||516
272911|NCT02179424|655154|P2|COMPLETED|Overall Study||11
272912|NCT02179424|655155|P1|COMPLETED|Overall Study||76
272913|NCT02179424|655152|P4|STARTED|Overall Study||39
272914|NCT02179424|655153|P3|STARTED|Overall Study||516
272915|NCT02179424|655154|P2|STARTED|Overall Study||11
272916|NCT02179424|655155|P1|STARTED|Overall Study||76
272917|NCT02179398|655172|P2|NOT COMPLETED|Overall Study||4
272918|NCT02179398|655173|P1|NOT COMPLETED|Overall Study||3
272919|NCT02179398|655172|P2|COMPLETED|Overall Study||140
272920|NCT02179398|655173|P1|COMPLETED|Overall Study||131
272921|NCT02179398|655172|P2|STARTED|Overall Study||144
272922|NCT02179398|655173|P1|STARTED|Overall Study||134
272923|NCT02178995|655193|P9|NOT COMPLETED|Open Label||0
272924|NCT02178995|655194|P8|NOT COMPLETED|Open Label||0
272925|NCT02178995|655195|P7|NOT COMPLETED|Open Label||0
272926|NCT02178995|655196|P6|NOT COMPLETED|Open Label||0
272927|NCT02178995|655197|P5|NOT COMPLETED|Open Label||0
272928|NCT02178995|655198|P4|NOT COMPLETED|Open Label||0
272929|NCT02178995|655199|P3|NOT COMPLETED|Open Label||0
272930|NCT02178995|655200|P2|NOT COMPLETED|Open Label||0
272931|NCT02178995|655201|P1|NOT COMPLETED|Open Label||2
272932|NCT02178995|655193|P9|COMPLETED|Open Label||0
272933|NCT02178995|655194|P8|COMPLETED|Open Label||0
272934|NCT02178995|655195|P7|COMPLETED|Open Label||0
272935|NCT02178995|655196|P6|COMPLETED|Open Label||0
272936|NCT02178995|655197|P5|COMPLETED|Open Label||0
272937|NCT02178995|655198|P4|COMPLETED|Open Label||0
272938|NCT02178995|655199|P3|COMPLETED|Open Label||0
272939|NCT02178995|655200|P2|COMPLETED|Open Label||14
272940|NCT02178995|655201|P1|COMPLETED|Open Label||28
272941|NCT02178995|655193|P9|STARTED|Open Label||0
272942|NCT02178995|655194|P8|STARTED|Open Label||0
272943|NCT02178995|655195|P7|STARTED|Open Label||0
272944|NCT02178995|655196|P6|STARTED|Open Label||0
272945|NCT02178995|655197|P5|STARTED|Open Label||0
272946|NCT02178995|655198|P4|STARTED|Open Label||0
272947|NCT02178995|655199|P3|STARTED|Open Label||0
272948|NCT02178995|655200|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
272949|NCT02178995|655201|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
272950|NCT02178995|655193|P9|NOT COMPLETED|Double Blind||1
272951|NCT02178995|655194|P8|NOT COMPLETED|Double Blind||2
272952|NCT02178995|655195|P7|NOT COMPLETED|Double Blind||0
272953|NCT02178995|655196|P6|NOT COMPLETED|Double Blind||1
272954|NCT02178995|655197|P5|NOT COMPLETED|Double Blind||0
272955|NCT02178995|655198|P4|NOT COMPLETED|Double Blind||0
272956|NCT02178995|655199|P3|NOT COMPLETED|Double Blind||0
272957|NCT02178995|655200|P2|NOT COMPLETED|Double Blind||1
272958|NCT02178995|655201|P1|NOT COMPLETED|Double Blind||0
272959|NCT02178995|655193|P9|COMPLETED|Double Blind||0
272960|NCT02178995|655194|P8|COMPLETED|Double Blind||4
272961|NCT02178995|655195|P7|COMPLETED|Double Blind||5
272962|NCT02178995|655196|P6|COMPLETED|Double Blind||5
272963|NCT02178995|655197|P5|COMPLETED|Double Blind||6
272964|NCT02178995|655198|P4|COMPLETED|Double Blind||6
272965|NCT02178995|655199|P3|COMPLETED|Double Blind||5
272966|NCT02178995|655200|P2|COMPLETED|Double Blind||15
272967|NCT02178995|655201|P1|COMPLETED|Double Blind||0
272968|NCT02178995|655193|P9|STARTED|Double Blind||1
272969|NCT02178995|655194|P8|STARTED|Double Blind||6
272970|NCT02178995|655195|P7|STARTED|Double Blind||5
272971|NCT02178995|655196|P6|STARTED|Double Blind||6
272972|NCT02178995|655197|P5|STARTED|Double Blind||6
272973|NCT02178995|655198|P4|STARTED|Double Blind||6
272974|NCT02178995|655199|P3|STARTED|Double Blind||5
272975|NCT02178995|655200|P2|STARTED|Double Blind||16
272976|NCT02178995|655201|P1|STARTED|Double Blind||0
272977|NCT02178787|655274|P2|NOT COMPLETED|Overall Study||9
272978|NCT02178787|655275|P1|NOT COMPLETED|Overall Study||5
272979|NCT02178787|655274|P2|COMPLETED|Overall Study||30
272980|NCT02178787|655275|P1|COMPLETED|Overall Study||30
272981|NCT02178787|655274|P2|STARTED|Overall Study||39
272982|NCT02178787|655275|P1|STARTED|Overall Study||35
272983|NCT02178540|655283|P1|NOT COMPLETED|Overall Study||0
272984|NCT02178540|655283|P1|COMPLETED|Overall Study||45
272985|NCT02178540|655283|P1|STARTED|Overall Study||45
272986|NCT02178059|655290|P2|NOT COMPLETED|Second Intervention||0
272987|NCT02178059|655291|P1|NOT COMPLETED|Second Intervention||0
272988|NCT02178059|655290|P2|COMPLETED|Second Intervention||17
272989|NCT02178059|655291|P1|COMPLETED|Second Intervention||16
272990|NCT02178059|655290|P2|STARTED|Second Intervention||17
272991|NCT02178059|655291|P1|STARTED|Second Intervention||16
272992|NCT02178059|655290|P2|NOT COMPLETED|Washout||0
272993|NCT02178059|655291|P1|NOT COMPLETED|Washout||1
272994|NCT02178059|655290|P2|COMPLETED|Washout||17
272995|NCT02178059|655291|P1|COMPLETED|Washout||16
272996|NCT02178059|655290|P2|STARTED|Washout||17
272997|NCT02178059|655291|P1|STARTED|Washout||17
272998|NCT02178059|655290|P2|NOT COMPLETED|First Intervention||0
272999|NCT02178059|655291|P1|NOT COMPLETED|First Intervention||0
273000|NCT02178059|655290|P2|COMPLETED|First Intervention||17
273001|NCT02178059|655291|P1|COMPLETED|First Intervention||17
273002|NCT02178059|655290|P2|STARTED|First Intervention||17
273003|NCT02178059|655291|P1|STARTED|First Intervention||17
273004|NCT02177201|655309|P2|NOT COMPLETED|Overall Study||3
273005|NCT02177201|655310|P1|NOT COMPLETED|Overall Study||3
273006|NCT02177201|655309|P2|COMPLETED|Overall Study||77
273007|NCT02177201|655310|P1|COMPLETED|Overall Study||77
273008|NCT02177201|655309|P2|STARTED|Overall Study||80
273009|NCT02177201|655310|P1|STARTED|Overall Study||80
273010|NCT02177032|655320|P4|NOT COMPLETED|Overall Study||0
273011|NCT02177032|655321|P3|NOT COMPLETED|Overall Study||3
273012|NCT02177032|655322|P2|NOT COMPLETED|Overall Study||2
273013|NCT02177032|655323|P1|NOT COMPLETED|Overall Study||5
273014|NCT02177032|655320|P4|COMPLETED|Overall Study||88
273015|NCT02177032|655321|P3|COMPLETED|Overall Study||351
273016|NCT02177032|655322|P2|COMPLETED|Overall Study||86
273017|NCT02177032|655323|P1|COMPLETED|Overall Study||350
273018|NCT02177032|655320|P4|STARTED|Overall Study||88
273019|NCT02177032|655321|P3|STARTED|Overall Study||354
273020|NCT02177032|655322|P2|STARTED|Overall Study||88
273021|NCT02177032|655323|P1|STARTED|Overall Study||355
273022|NCT02176655|655357|P1|NOT COMPLETED|Overall Study||6
273023|NCT02176655|655357|P1|COMPLETED|Overall Study||25
273024|NCT02176655|655357|P1|STARTED|Overall Study||31
273025|NCT02176525|655386|P8|NOT COMPLETED|Overall Study||0
273026|NCT02176525|655387|P7|NOT COMPLETED|Overall Study||1
273027|NCT02176525|655388|P6|NOT COMPLETED|Overall Study||1
273028|NCT02176525|655389|P5|NOT COMPLETED|Overall Study||1
273029|NCT02176525|655390|P4|NOT COMPLETED|Overall Study||1
273030|NCT02176525|655391|P3|NOT COMPLETED|Overall Study||0
273031|NCT02176525|655392|P2|NOT COMPLETED|Overall Study||0
273032|NCT02176525|655393|P1|NOT COMPLETED|Overall Study||1
273033|NCT02176525|655386|P8|COMPLETED|Overall Study||10
273034|NCT02176525|655387|P7|COMPLETED|Overall Study||8
273035|NCT02176525|655388|P6|COMPLETED|Overall Study||5
273036|NCT02176525|655389|P5|COMPLETED|Overall Study||7
273037|NCT02176525|655390|P4|COMPLETED|Overall Study||8
273038|NCT02176525|655391|P3|COMPLETED|Overall Study||9
273039|NCT02176525|655392|P2|COMPLETED|Overall Study||9
273040|NCT02176525|655393|P1|COMPLETED|Overall Study||14
273041|NCT02176525|655386|P8|STARTED|Overall Study||10
273042|NCT02176525|655387|P7|STARTED|Overall Study||9
273043|NCT02176525|655388|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
273044|NCT02176525|655389|P5|STARTED|Overall Study||8
273045|NCT02176525|655390|P4|STARTED|Overall Study||9
273046|NCT02176525|655391|P3|STARTED|Overall Study||9
273047|NCT02176525|655392|P2|STARTED|Overall Study||9
273048|NCT02176525|655393|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
273049|NCT02176421|655570|P1|NOT COMPLETED|Overall Study||5
273050|NCT02176421|655570|P1|COMPLETED|Overall Study||75
273051|NCT02176421|655570|P1|STARTED|Overall Study||80
273052|NCT02176356|655579|P1|NOT COMPLETED|Overall Study||23
273053|NCT02176356|655579|P1|COMPLETED|Overall Study||93
273054|NCT02176356|655579|P1|Eligible and Received Treatment|Overall Study||100
273055|NCT02176356|655579|P1|STARTED|Overall Study||116
273056|NCT02175771|655604|P9|NOT COMPLETED|Treatment Period||6
273057|NCT02175771|655605|P8|NOT COMPLETED|Treatment Period||17
273058|NCT02175771|655606|P7|NOT COMPLETED|Treatment Period||5
273059|NCT02175771|655607|P6|NOT COMPLETED|Treatment Period||10
273060|NCT02175771|655608|P5|NOT COMPLETED|Treatment Period||5
273061|NCT02175771|655609|P4|NOT COMPLETED|Treatment Period||13
273062|NCT02175771|655610|P3|NOT COMPLETED|Treatment Period||7
273063|NCT02175771|655611|P2|NOT COMPLETED|Treatment Period||16
273064|NCT02175771|655612|P1|NOT COMPLETED|Treatment Period||0
273065|NCT02175771|655604|P9|COMPLETED|Treatment Period||38
273066|NCT02175771|655605|P8|COMPLETED|Treatment Period||116
273067|NCT02175771|655606|P7|COMPLETED|Treatment Period||36
273068|NCT02175771|655607|P6|COMPLETED|Treatment Period||110
273069|NCT02175771|655608|P5|COMPLETED|Treatment Period||36
273070|NCT02175771|655609|P4|COMPLETED|Treatment Period||113
273071|NCT02175771|655610|P3|COMPLETED|Treatment Period||35
273072|NCT02175771|655611|P2|COMPLETED|Treatment Period||111
273073|NCT02175771|655612|P1|COMPLETED|Treatment Period||0
273074|NCT02175771|655604|P9|STARTED|Treatment Period||44
273075|NCT02175771|655605|P8|STARTED|Treatment Period||133
273076|NCT02175771|655606|P7|STARTED|Treatment Period||41
273077|NCT02175771|655607|P6|STARTED|Treatment Period||120
273078|NCT02175771|655608|P5|STARTED|Treatment Period||41
273079|NCT02175771|655609|P4|STARTED|Treatment Period||126
273080|NCT02175771|655610|P3|STARTED|Treatment Period||42
273081|NCT02175771|655611|P2|STARTED|Treatment Period||127
273082|NCT02175771|655612|P1|STARTED|Treatment Period||0
273083|NCT02175771|655604|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273084|NCT02175771|655605|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273085|NCT02175771|655606|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273086|NCT02175771|655607|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273087|NCT02175771|655608|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273088|NCT02175771|655609|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273089|NCT02175771|655610|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273090|NCT02175771|655611|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
273091|NCT02175771|655612|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
273092|NCT02175771|655604|P9|COMPLETED|Run-In Period (Pre-assignment)||0
273093|NCT02175771|655605|P8|COMPLETED|Run-In Period (Pre-assignment)||0
273094|NCT02175771|655606|P7|COMPLETED|Run-In Period (Pre-assignment)||0
273095|NCT02175771|655607|P6|COMPLETED|Run-In Period (Pre-assignment)||0
273096|NCT02175771|655608|P5|COMPLETED|Run-In Period (Pre-assignment)||0
273097|NCT02175771|655609|P4|COMPLETED|Run-In Period (Pre-assignment)||0
273098|NCT02175771|655610|P3|COMPLETED|Run-In Period (Pre-assignment)||0
273099|NCT02175771|655611|P2|COMPLETED|Run-In Period (Pre-assignment)||0
273100|NCT02175771|655612|P1|COMPLETED|Run-In Period (Pre-assignment)||674
273101|NCT02175771|655604|P9|STARTED|Run-In Period (Pre-assignment)||0
273102|NCT02175771|655605|P8|STARTED|Run-In Period (Pre-assignment)||0
273103|NCT02175771|655606|P7|STARTED|Run-In Period (Pre-assignment)||0
273104|NCT02175771|655607|P6|STARTED|Run-In Period (Pre-assignment)||0
273105|NCT02175771|655608|P5|STARTED|Run-In Period (Pre-assignment)||0
273106|NCT02175771|655609|P4|STARTED|Run-In Period (Pre-assignment)||0
273107|NCT02175771|655610|P3|STARTED|Run-In Period (Pre-assignment)||0
273108|NCT02175771|655611|P2|STARTED|Run-In Period (Pre-assignment)||0
273109|NCT02175771|655612|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
273110|NCT02175745|655670|P1|NOT COMPLETED|Overall Study||1
273111|NCT02175745|655670|P1|COMPLETED|Overall Study||1
273112|NCT02175745|655670|P1|STARTED|Overall Study||2
273113|NCT02175212|655677|P2|NOT COMPLETED|Overall Study||147
273114|NCT02175212|655678|P1|NOT COMPLETED|Overall Study||163
273115|NCT02175212|655677|P2|COMPLETED|Overall Study||31
273116|NCT02175212|655678|P1|COMPLETED|Overall Study||14
273117|NCT02175212|655677|P2|STARTED|Overall Study||178
273118|NCT02175212|655678|P1|STARTED|Overall Study||177
273119|NCT02175199|655694|P2|NOT COMPLETED|Overall Study||5
273120|NCT02175199|655695|P1|NOT COMPLETED|Overall Study||3
273121|NCT02175199|655694|P2|COMPLETED|Overall Study||71
273122|NCT02175199|655695|P1|COMPLETED|Overall Study||71
273123|NCT02175199|655694|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
273124|NCT02175199|655695|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
273125|NCT02175199|655694|P2|STARTED|Overall Study||76
273126|NCT02175199|655695|P1|STARTED|Overall Study||74
273127|NCT02175121|655709|P5|NOT COMPLETED|Overall Study||1
273128|NCT02175121|655710|P4|NOT COMPLETED|Overall Study||1
273129|NCT02175121|655711|P3|NOT COMPLETED|Overall Study||2
273130|NCT02175121|655712|P2|NOT COMPLETED|Overall Study||1
273131|NCT02175121|655713|P1|NOT COMPLETED|Overall Study||1
273132|NCT02175121|655709|P5|COMPLETED|Overall Study||33
273133|NCT02175121|655710|P4|COMPLETED|Overall Study||34
273134|NCT02175121|655711|P3|COMPLETED|Overall Study||32
273135|NCT02175121|655712|P2|COMPLETED|Overall Study||34
273136|NCT02175121|655713|P1|COMPLETED|Overall Study||33
273137|NCT02175121|655709|P5|STARTED|Overall Study||34
273138|NCT02175121|655710|P4|STARTED|Overall Study||35
273139|NCT02175121|655711|P3|STARTED|Overall Study||34
273140|NCT02175121|655712|P2|STARTED|Overall Study||35
273141|NCT02175121|655713|P1|STARTED|Overall Study||34
273142|NCT02173769|655840|P1|NOT COMPLETED|Overall Study||4
273143|NCT02173769|655840|P1|COMPLETED|Overall Study||1854
273144|NCT02173769|655840|P1|STARTED|Overall Study||1858
273145|NCT02173535|655871|P20|NOT COMPLETED|Period 5||0
273146|NCT02173535|655872|P19|NOT COMPLETED|Period 5||0
273147|NCT02173535|655873|P18|NOT COMPLETED|Period 5||0
273148|NCT02173535|655874|P17|NOT COMPLETED|Period 5||0
273149|NCT02173535|655875|P16|NOT COMPLETED|Period 5||0
273150|NCT02173535|655876|P15|NOT COMPLETED|Period 5||0
273151|NCT02173535|655877|P14|NOT COMPLETED|Period 5||0
273152|NCT02173535|655878|P13|NOT COMPLETED|Period 5||0
273153|NCT02173535|655879|P12|NOT COMPLETED|Period 5||0
273154|NCT02173535|655880|P11|NOT COMPLETED|Period 5||0
273155|NCT02173535|655881|P10|NOT COMPLETED|Period 5||0
273156|NCT02173535|655882|P9|NOT COMPLETED|Period 5||0
273157|NCT02173535|655883|P8|NOT COMPLETED|Period 5||0
273158|NCT02173535|655884|P7|NOT COMPLETED|Period 5||0
273159|NCT02173535|655885|P6|NOT COMPLETED|Period 5||0
273160|NCT02173535|655886|P5|NOT COMPLETED|Period 5||0
273161|NCT02173535|655887|P4|NOT COMPLETED|Period 5||0
273162|NCT02173535|655888|P3|NOT COMPLETED|Period 5||0
273163|NCT02173535|655889|P2|NOT COMPLETED|Period 5||0
273164|NCT02173535|655890|P1|NOT COMPLETED|Period 5||0
273165|NCT02173535|655871|P20|COMPLETED|Period 5||12
273166|NCT02173535|655872|P19|COMPLETED|Period 5||12
273167|NCT02173535|655873|P18|COMPLETED|Period 5||12
273168|NCT02173535|655874|P17|COMPLETED|Period 5||12
273169|NCT02173535|655875|P16|COMPLETED|Period 5||12
273170|NCT02173535|655876|P15|COMPLETED|Period 5||12
273171|NCT02173535|655877|P14|COMPLETED|Period 5||12
273172|NCT02173535|655878|P13|COMPLETED|Period 5||12
273173|NCT02173535|655879|P12|COMPLETED|Period 5||12
273174|NCT02173535|655880|P11|COMPLETED|Period 5||12
273175|NCT02173535|655881|P10|COMPLETED|Period 5||12
273176|NCT02173535|655882|P9|COMPLETED|Period 5||12
273177|NCT02173535|655883|P8|COMPLETED|Period 5||12
273178|NCT02173535|655884|P7|COMPLETED|Period 5||12
273179|NCT02173535|655885|P6|COMPLETED|Period 5||12
273180|NCT02173535|655886|P5|COMPLETED|Period 5||12
273181|NCT02173535|655887|P4|COMPLETED|Period 5||12
273182|NCT02173535|655888|P3|COMPLETED|Period 5||12
273183|NCT02173535|655889|P2|COMPLETED|Period 5||12
273184|NCT02173535|655890|P1|COMPLETED|Period 5||12
273185|NCT02173535|655871|P20|STARTED|Period 5||12
273186|NCT02173535|655872|P19|STARTED|Period 5||12
273187|NCT02173535|655873|P18|STARTED|Period 5||12
273188|NCT02173535|655874|P17|STARTED|Period 5||12
273189|NCT02173535|655875|P16|STARTED|Period 5||12
273190|NCT02173535|655876|P15|STARTED|Period 5||12
273191|NCT02173535|655877|P14|STARTED|Period 5||12
273192|NCT02173535|655878|P13|STARTED|Period 5||12
273193|NCT02173535|655879|P12|STARTED|Period 5||12
273194|NCT02173535|655880|P11|STARTED|Period 5||12
273195|NCT02173535|655881|P10|STARTED|Period 5||12
273196|NCT02173535|655882|P9|STARTED|Period 5||12
273197|NCT02173535|655883|P8|STARTED|Period 5||12
273198|NCT02173535|655884|P7|STARTED|Period 5||12
273199|NCT02173535|655885|P6|STARTED|Period 5||12
273200|NCT02173535|655886|P5|STARTED|Period 5||12
273201|NCT02173535|655887|P4|STARTED|Period 5||12
273202|NCT02173535|655888|P3|STARTED|Period 5||12
273203|NCT02173535|655889|P2|STARTED|Period 5||12
273204|NCT02173535|655890|P1|STARTED|Period 5||12
273205|NCT02173535|655871|P20|NOT COMPLETED|Period 4||0
273206|NCT02173535|655872|P19|NOT COMPLETED|Period 4||0
273207|NCT02173535|655873|P18|NOT COMPLETED|Period 4||0
273208|NCT02173535|655874|P17|NOT COMPLETED|Period 4||0
273209|NCT02173535|655875|P16|NOT COMPLETED|Period 4||0
273210|NCT02173535|655876|P15|NOT COMPLETED|Period 4||0
273211|NCT02173535|655877|P14|NOT COMPLETED|Period 4||0
273212|NCT02173535|655878|P13|NOT COMPLETED|Period 4||0
273213|NCT02173535|655879|P12|NOT COMPLETED|Period 4||0
273214|NCT02173535|655880|P11|NOT COMPLETED|Period 4||0
273215|NCT02173535|655881|P10|NOT COMPLETED|Period 4||0
273216|NCT02173535|655882|P9|NOT COMPLETED|Period 4||0
273217|NCT02173535|655883|P8|NOT COMPLETED|Period 4||0
273218|NCT02173535|655884|P7|NOT COMPLETED|Period 4||0
273219|NCT02173535|655885|P6|NOT COMPLETED|Period 4||0
273220|NCT02173535|655886|P5|NOT COMPLETED|Period 4||0
273221|NCT02173535|655887|P4|NOT COMPLETED|Period 4||0
273222|NCT02173535|655888|P3|NOT COMPLETED|Period 4||0
273223|NCT02173535|655889|P2|NOT COMPLETED|Period 4||0
273224|NCT02173535|655890|P1|NOT COMPLETED|Period 4||0
273225|NCT02173535|655871|P20|COMPLETED|Period 4||12
273226|NCT02173535|655872|P19|COMPLETED|Period 4||12
273227|NCT02173535|655873|P18|COMPLETED|Period 4||12
273228|NCT02173535|655874|P17|COMPLETED|Period 4||12
273229|NCT02173535|655875|P16|COMPLETED|Period 4||12
273230|NCT02173535|655876|P15|COMPLETED|Period 4||12
273231|NCT02173535|655877|P14|COMPLETED|Period 4||12
273232|NCT02173535|655878|P13|COMPLETED|Period 4||12
273233|NCT02173535|655879|P12|COMPLETED|Period 4||12
273234|NCT02173535|655880|P11|COMPLETED|Period 4||12
273235|NCT02173535|655881|P10|COMPLETED|Period 4||12
273236|NCT02173535|655882|P9|COMPLETED|Period 4||12
273237|NCT02173535|655883|P8|COMPLETED|Period 4||12
273238|NCT02173535|655884|P7|COMPLETED|Period 4||12
273239|NCT02173535|655885|P6|COMPLETED|Period 4||12
273240|NCT02173535|655886|P5|COMPLETED|Period 4||12
273241|NCT02173535|655887|P4|COMPLETED|Period 4||12
273242|NCT02173535|655888|P3|COMPLETED|Period 4||12
273243|NCT02173535|655889|P2|COMPLETED|Period 4||12
273244|NCT02173535|655890|P1|COMPLETED|Period 4||12
273245|NCT02173535|655871|P20|STARTED|Period 4||12
273246|NCT02173535|655872|P19|STARTED|Period 4||12
273247|NCT02173535|655873|P18|STARTED|Period 4||12
273248|NCT02173535|655874|P17|STARTED|Period 4||12
273249|NCT02173535|655875|P16|STARTED|Period 4||12
273250|NCT02173535|655876|P15|STARTED|Period 4||12
273251|NCT02173535|655877|P14|STARTED|Period 4||12
273252|NCT02173535|655878|P13|STARTED|Period 4||12
273253|NCT02173535|655879|P12|STARTED|Period 4||12
273254|NCT02173535|655880|P11|STARTED|Period 4||12
273255|NCT02173535|655881|P10|STARTED|Period 4||12
273256|NCT02173535|655882|P9|STARTED|Period 4||12
273257|NCT02173535|655883|P8|STARTED|Period 4||12
273258|NCT02173535|655884|P7|STARTED|Period 4||12
273259|NCT02173535|655885|P6|STARTED|Period 4||12
273260|NCT02173535|655886|P5|STARTED|Period 4||12
273261|NCT02173535|655887|P4|STARTED|Period 4||12
273262|NCT02173535|655888|P3|STARTED|Period 4||12
273263|NCT02173535|655889|P2|STARTED|Period 4||12
273264|NCT02173535|655890|P1|STARTED|Period 4||12
273265|NCT02173535|655871|P20|NOT COMPLETED|Period 3||0
273266|NCT02173535|655872|P19|NOT COMPLETED|Period 3||0
273267|NCT02173535|655873|P18|NOT COMPLETED|Period 3||0
273268|NCT02173535|655874|P17|NOT COMPLETED|Period 3||0
273269|NCT02173535|655875|P16|NOT COMPLETED|Period 3||0
273270|NCT02173535|655876|P15|NOT COMPLETED|Period 3||0
273271|NCT02173535|655877|P14|NOT COMPLETED|Period 3||0
273272|NCT02173535|655878|P13|NOT COMPLETED|Period 3||0
273273|NCT02173535|655879|P12|NOT COMPLETED|Period 3||0
273274|NCT02173535|655880|P11|NOT COMPLETED|Period 3||0
273275|NCT02173535|655881|P10|NOT COMPLETED|Period 3||0
273276|NCT02173535|655882|P9|NOT COMPLETED|Period 3||0
273277|NCT02173535|655883|P8|NOT COMPLETED|Period 3||0
273278|NCT02173535|655884|P7|NOT COMPLETED|Period 3||0
273279|NCT02173535|655885|P6|NOT COMPLETED|Period 3||0
273280|NCT02173535|655886|P5|NOT COMPLETED|Period 3||0
273281|NCT02173535|655887|P4|NOT COMPLETED|Period 3||0
273282|NCT02173535|655888|P3|NOT COMPLETED|Period 3||0
273283|NCT02173535|655889|P2|NOT COMPLETED|Period 3||0
273284|NCT02173535|655890|P1|NOT COMPLETED|Period 3||0
273285|NCT02173535|655871|P20|COMPLETED|Period 3||12
273286|NCT02173535|655872|P19|COMPLETED|Period 3||12
273287|NCT02173535|655873|P18|COMPLETED|Period 3||12
273288|NCT02173535|655874|P17|COMPLETED|Period 3||12
273289|NCT02173535|655875|P16|COMPLETED|Period 3||12
273290|NCT02173535|655876|P15|COMPLETED|Period 3||12
273291|NCT02173535|655877|P14|COMPLETED|Period 3||12
273292|NCT02173535|655878|P13|COMPLETED|Period 3||12
273293|NCT02173535|655879|P12|COMPLETED|Period 3||12
273294|NCT02173535|655880|P11|COMPLETED|Period 3||12
273295|NCT02173535|655881|P10|COMPLETED|Period 3||12
273296|NCT02173535|655882|P9|COMPLETED|Period 3||12
273297|NCT02173535|655883|P8|COMPLETED|Period 3||12
273298|NCT02173535|655884|P7|COMPLETED|Period 3||12
273299|NCT02173535|655885|P6|COMPLETED|Period 3||12
273300|NCT02173535|655886|P5|COMPLETED|Period 3||12
273301|NCT02173535|655887|P4|COMPLETED|Period 3||12
273302|NCT02173535|655888|P3|COMPLETED|Period 3||12
273303|NCT02173535|655889|P2|COMPLETED|Period 3||12
273304|NCT02173535|655890|P1|COMPLETED|Period 3||12
273305|NCT02173535|655871|P20|STARTED|Period 3||12
273306|NCT02173535|655872|P19|STARTED|Period 3||12
273307|NCT02173535|655873|P18|STARTED|Period 3||12
273308|NCT02173535|655874|P17|STARTED|Period 3||12
273309|NCT02173535|655875|P16|STARTED|Period 3||12
273310|NCT02173535|655876|P15|STARTED|Period 3||12
273311|NCT02173535|655877|P14|STARTED|Period 3||12
273312|NCT02173535|655878|P13|STARTED|Period 3||12
273313|NCT02173535|655879|P12|STARTED|Period 3||12
273314|NCT02173535|655880|P11|STARTED|Period 3||12
273315|NCT02173535|655881|P10|STARTED|Period 3||12
273316|NCT02173535|655882|P9|STARTED|Period 3||12
273317|NCT02173535|655883|P8|STARTED|Period 3||12
273318|NCT02173535|655884|P7|STARTED|Period 3||12
273319|NCT02173535|655885|P6|STARTED|Period 3||12
273320|NCT02173535|655886|P5|STARTED|Period 3||12
273321|NCT02173535|655887|P4|STARTED|Period 3||12
273322|NCT02173535|655888|P3|STARTED|Period 3||12
273323|NCT02173535|655889|P2|STARTED|Period 3||12
273324|NCT02173535|655890|P1|STARTED|Period 3||12
273325|NCT02173535|655871|P20|NOT COMPLETED|Period 2||0
273326|NCT02173535|655872|P19|NOT COMPLETED|Period 2||0
273327|NCT02173535|655873|P18|NOT COMPLETED|Period 2||0
273328|NCT02173535|655874|P17|NOT COMPLETED|Period 2||0
273329|NCT02173535|655875|P16|NOT COMPLETED|Period 2||0
273330|NCT02173535|655876|P15|NOT COMPLETED|Period 2||0
273331|NCT02173535|655877|P14|NOT COMPLETED|Period 2||0
273332|NCT02173535|655878|P13|NOT COMPLETED|Period 2||0
273333|NCT02173535|655879|P12|NOT COMPLETED|Period 2||0
273334|NCT02173535|655880|P11|NOT COMPLETED|Period 2||0
273335|NCT02173535|655881|P10|NOT COMPLETED|Period 2||0
273336|NCT02173535|655882|P9|NOT COMPLETED|Period 2||0
273337|NCT02173535|655883|P8|NOT COMPLETED|Period 2||0
273338|NCT02173535|655884|P7|NOT COMPLETED|Period 2||0
273339|NCT02173535|655885|P6|NOT COMPLETED|Period 2||0
273340|NCT02173535|655886|P5|NOT COMPLETED|Period 2||0
273341|NCT02173535|655887|P4|NOT COMPLETED|Period 2||0
273342|NCT02173535|655888|P3|NOT COMPLETED|Period 2||0
273343|NCT02173535|655889|P2|NOT COMPLETED|Period 2||0
273344|NCT02173535|655890|P1|NOT COMPLETED|Period 2||0
273345|NCT02173535|655871|P20|COMPLETED|Period 2||12
273346|NCT02173535|655872|P19|COMPLETED|Period 2||12
273347|NCT02173535|655873|P18|COMPLETED|Period 2||12
273348|NCT02173535|655874|P17|COMPLETED|Period 2||12
273349|NCT02173535|655875|P16|COMPLETED|Period 2||12
273350|NCT02173535|655876|P15|COMPLETED|Period 2||12
273351|NCT02173535|655877|P14|COMPLETED|Period 2||12
273352|NCT02173535|655878|P13|COMPLETED|Period 2||12
273353|NCT02173535|655879|P12|COMPLETED|Period 2||12
273354|NCT02173535|655880|P11|COMPLETED|Period 2||12
273355|NCT02173535|655881|P10|COMPLETED|Period 2||12
273356|NCT02173535|655882|P9|COMPLETED|Period 2||12
273357|NCT02173535|655883|P8|COMPLETED|Period 2||12
273358|NCT02173535|655884|P7|COMPLETED|Period 2||12
273359|NCT02173535|655885|P6|COMPLETED|Period 2||12
273360|NCT02173535|655886|P5|COMPLETED|Period 2||12
273361|NCT02173535|655887|P4|COMPLETED|Period 2||12
273362|NCT02173535|655888|P3|COMPLETED|Period 2||12
273363|NCT02173535|655889|P2|COMPLETED|Period 2||12
273364|NCT02173535|655890|P1|COMPLETED|Period 2||12
273365|NCT02173535|655871|P20|STARTED|Period 2||12
273366|NCT02173535|655872|P19|STARTED|Period 2||12
273367|NCT02173535|655873|P18|STARTED|Period 2||12
273368|NCT02173535|655874|P17|STARTED|Period 2||12
273369|NCT02173535|655875|P16|STARTED|Period 2||12
273370|NCT02173535|655876|P15|STARTED|Period 2||12
273371|NCT02173535|655877|P14|STARTED|Period 2||12
273372|NCT02173535|655878|P13|STARTED|Period 2||12
273373|NCT02173535|655879|P12|STARTED|Period 2||12
273374|NCT02173535|655880|P11|STARTED|Period 2||12
273375|NCT02173535|655881|P10|STARTED|Period 2||12
273376|NCT02173535|655882|P9|STARTED|Period 2||12
273377|NCT02173535|655883|P8|STARTED|Period 2||12
273378|NCT02173535|655884|P7|STARTED|Period 2||12
273379|NCT02173535|655885|P6|STARTED|Period 2||12
273380|NCT02173535|655886|P5|STARTED|Period 2||12
273381|NCT02173535|655887|P4|STARTED|Period 2||12
273382|NCT02173535|655888|P3|STARTED|Period 2||12
273383|NCT02173535|655889|P2|STARTED|Period 2||12
273384|NCT02173535|655890|P1|STARTED|Period 2||12
273385|NCT02173535|655871|P20|NOT COMPLETED|Period 1||0
273386|NCT02173535|655872|P19|NOT COMPLETED|Period 1||0
273387|NCT02173535|655873|P18|NOT COMPLETED|Period 1||0
273388|NCT02173535|655874|P17|NOT COMPLETED|Period 1||0
273389|NCT02173535|655875|P16|NOT COMPLETED|Period 1||0
273390|NCT02173535|655876|P15|NOT COMPLETED|Period 1||0
273391|NCT02173535|655877|P14|NOT COMPLETED|Period 1||0
273392|NCT02173535|655878|P13|NOT COMPLETED|Period 1||0
273393|NCT02173535|655879|P12|NOT COMPLETED|Period 1||0
273394|NCT02173535|655880|P11|NOT COMPLETED|Period 1||0
273395|NCT02173535|655881|P10|NOT COMPLETED|Period 1||0
273396|NCT02173535|655882|P9|NOT COMPLETED|Period 1||0
273397|NCT02173535|655883|P8|NOT COMPLETED|Period 1||0
273398|NCT02173535|655884|P7|NOT COMPLETED|Period 1||0
273399|NCT02173535|655885|P6|NOT COMPLETED|Period 1||0
273400|NCT02173535|655886|P5|NOT COMPLETED|Period 1||0
273401|NCT02173535|655887|P4|NOT COMPLETED|Period 1||0
273402|NCT02173535|655888|P3|NOT COMPLETED|Period 1||0
273403|NCT02173535|655889|P2|NOT COMPLETED|Period 1||0
273404|NCT02173535|655890|P1|NOT COMPLETED|Period 1||0
273405|NCT02173535|655871|P20|COMPLETED|Period 1||12
273406|NCT02173535|655872|P19|COMPLETED|Period 1||12
273407|NCT02173535|655873|P18|COMPLETED|Period 1||12
273408|NCT02173535|655874|P17|COMPLETED|Period 1||12
273409|NCT02173535|655875|P16|COMPLETED|Period 1||12
273410|NCT02173535|655876|P15|COMPLETED|Period 1||12
273411|NCT02173535|655877|P14|COMPLETED|Period 1||12
273412|NCT02173535|655878|P13|COMPLETED|Period 1||12
273413|NCT02173535|655879|P12|COMPLETED|Period 1||12
273414|NCT02173535|655880|P11|COMPLETED|Period 1||12
273415|NCT02173535|655881|P10|COMPLETED|Period 1||12
273416|NCT02173535|655882|P9|COMPLETED|Period 1||12
273417|NCT02173535|655883|P8|COMPLETED|Period 1||12
273418|NCT02173535|655884|P7|COMPLETED|Period 1||12
273419|NCT02173535|655885|P6|COMPLETED|Period 1||12
273420|NCT02173535|655886|P5|COMPLETED|Period 1||12
273421|NCT02173535|655887|P4|COMPLETED|Period 1||12
273422|NCT02173535|655888|P3|COMPLETED|Period 1||12
273423|NCT02173535|655889|P2|COMPLETED|Period 1||12
273424|NCT02173535|655890|P1|COMPLETED|Period 1||12
273425|NCT02173535|655871|P20|STARTED|Period 1||12
273426|NCT02173535|655872|P19|STARTED|Period 1||12
273427|NCT02173535|655873|P18|STARTED|Period 1||12
273428|NCT02173535|655874|P17|STARTED|Period 1||12
273429|NCT02173535|655875|P16|STARTED|Period 1||12
273430|NCT02173535|655876|P15|STARTED|Period 1||12
273431|NCT02173535|655877|P14|STARTED|Period 1||12
273432|NCT02173535|655878|P13|STARTED|Period 1||12
273433|NCT02173535|655879|P12|STARTED|Period 1||12
273434|NCT02173535|655880|P11|STARTED|Period 1||12
273435|NCT02173535|655881|P10|STARTED|Period 1||12
273436|NCT02173535|655882|P9|STARTED|Period 1||12
273437|NCT02173535|655883|P8|STARTED|Period 1||12
273438|NCT02173535|655884|P7|STARTED|Period 1||12
273439|NCT02173535|655885|P6|STARTED|Period 1||12
273440|NCT02173535|655886|P5|STARTED|Period 1||12
273441|NCT02173535|655887|P4|STARTED|Period 1||12
273442|NCT02173535|655888|P3|STARTED|Period 1||12
273443|NCT02173535|655889|P2|STARTED|Period 1||12
273444|NCT02173535|655890|P1|STARTED|Period 1||12
273445|NCT02173054|655930|P3|NOT COMPLETED|Overall Study||1
273446|NCT02173054|655931|P2|NOT COMPLETED|Overall Study||0
273447|NCT02173054|655932|P1|NOT COMPLETED|Overall Study||1
273448|NCT02173054|655930|P3|COMPLETED|Overall Study||39
273449|NCT02173054|655931|P2|COMPLETED|Overall Study||40
273450|NCT02173054|655932|P1|COMPLETED|Overall Study||39
273451|NCT02173054|655930|P3|STARTED|Overall Study||40
273452|NCT02173054|655931|P2|STARTED|Overall Study||40
273453|NCT02173054|655932|P1|STARTED|Overall Study||40
273454|NCT02172755|655954|P2|NOT COMPLETED|Overall Study||4
273455|NCT02172755|655955|P1|NOT COMPLETED|Overall Study||2
273456|NCT02172755|655954|P2|COMPLETED|Overall Study||12
273457|NCT02172755|655955|P1|COMPLETED|Overall Study||12
273458|NCT02172755|655954|P2|STARTED|Overall Study||16
273459|NCT02172755|655955|P1|STARTED|Overall Study||14
273460|NCT02172742|655967|P2|NOT COMPLETED|Overall Study||0
273461|NCT02172742|655968|P1|NOT COMPLETED|Overall Study||1
273462|NCT02172742|655967|P2|COMPLETED|Overall Study||6
273463|NCT02172742|655968|P1|COMPLETED|Overall Study||6
273464|NCT02172742|655967|P2|STARTED|Overall Study||6
273465|NCT02172742|655968|P1|STARTED|Overall Study||7
273466|NCT02172625|655977|P2|NOT COMPLETED|Overall Study||3
273467|NCT02172625|655978|P1|NOT COMPLETED|Overall Study||0
273468|NCT02172625|655977|P2|COMPLETED|Overall Study||16
273469|NCT02172625|655978|P1|COMPLETED|Overall Study||19
273470|NCT02172625|655977|P2|STARTED|Overall Study||19
273471|NCT02172625|655978|P1|STARTED|Overall Study||19
273472|NCT02171611|655996|P6|NOT COMPLETED|Overall Study||0
273473|NCT02171611|655997|P5|NOT COMPLETED|Overall Study||0
273474|NCT02171611|655998|P4|NOT COMPLETED|Overall Study||0
273475|NCT02171611|655999|P3|NOT COMPLETED|Overall Study||0
273476|NCT02171611|656000|P2|NOT COMPLETED|Overall Study||0
273477|NCT02171611|656001|P1|NOT COMPLETED|Overall Study||0
273478|NCT02171611|655996|P6|COMPLETED|Overall Study||5
273479|NCT02171611|655997|P5|COMPLETED|Overall Study||5
273480|NCT02171611|655998|P4|COMPLETED|Overall Study||5
273481|NCT02171611|655999|P3|COMPLETED|Overall Study||5
273482|NCT02171611|656000|P2|COMPLETED|Overall Study||5
273483|NCT02171611|656001|P1|COMPLETED|Overall Study||5
273484|NCT02171611|655996|P6|STARTED|Overall Study||5
273485|NCT02171611|655997|P5|STARTED|Overall Study||5
273486|NCT02171611|655998|P4|STARTED|Overall Study||5
273487|NCT02171611|655999|P3|STARTED|Overall Study||5
273488|NCT02171611|656000|P2|STARTED|Overall Study||5
273489|NCT02171611|656001|P1|STARTED|Overall Study||5
273490|NCT02171247|656071|P2|NOT COMPLETED|Overall Study||0
273491|NCT02171247|656072|P1|NOT COMPLETED|Overall Study||0
273492|NCT02171247|656071|P2|COMPLETED|Overall Study||17
273493|NCT02171247|656072|P1|COMPLETED|Overall Study||16
273494|NCT02171247|656071|P2|STARTED|Overall Study||17
273495|NCT02171247|656072|P1|STARTED|Overall Study||16
273496|NCT02171234|656089|P5|NOT COMPLETED|Overall Study||0
273497|NCT02171234|656090|P4|NOT COMPLETED|Overall Study||0
273498|NCT02171234|656091|P3|NOT COMPLETED|Overall Study||0
273499|NCT02171234|656092|P2|NOT COMPLETED|Overall Study||0
273500|NCT02171234|656093|P1|NOT COMPLETED|Overall Study||0
273501|NCT02171234|656089|P5|COMPLETED|Overall Study||6
273502|NCT02171234|656090|P4|COMPLETED|Overall Study||6
273503|NCT02171234|656091|P3|COMPLETED|Overall Study||6
273504|NCT02171234|656092|P2|COMPLETED|Overall Study||6
273505|NCT02171234|656093|P1|COMPLETED|Overall Study||8
273506|NCT02171234|656089|P5|STARTED|Overall Study||6
273507|NCT02171234|656090|P4|STARTED|Overall Study||6
273508|NCT02171234|656091|P3|STARTED|Overall Study||6
273509|NCT02171234|656092|P2|STARTED|Overall Study||6
273510|NCT02171234|656093|P1|STARTED|Overall Study||8
273511|NCT02171195|656122|P9|NOT COMPLETED|Overall Study||0
273512|NCT02171195|656123|P8|NOT COMPLETED|Overall Study||0
273513|NCT02171195|656124|P7|NOT COMPLETED|Overall Study||0
273514|NCT02171195|656125|P6|NOT COMPLETED|Overall Study||0
273515|NCT02171195|656126|P5|NOT COMPLETED|Overall Study||0
273516|NCT02171195|656127|P4|NOT COMPLETED|Overall Study||0
273517|NCT02171195|656128|P3|NOT COMPLETED|Overall Study||0
273518|NCT02171195|656129|P2|NOT COMPLETED|Overall Study||0
273519|NCT02171195|656130|P1|NOT COMPLETED|Overall Study||0
273520|NCT02171195|656122|P9|COMPLETED|Overall Study||6
273521|NCT02171195|656123|P8|COMPLETED|Overall Study||6
273522|NCT02171195|656124|P7|COMPLETED|Overall Study||6
273523|NCT02171195|656125|P6|COMPLETED|Overall Study||6
273524|NCT02171195|656126|P5|COMPLETED|Overall Study||6
273525|NCT02171195|656127|P4|COMPLETED|Overall Study||6
273526|NCT02171195|656128|P3|COMPLETED|Overall Study||6
273527|NCT02171195|656129|P2|COMPLETED|Overall Study||6
273528|NCT02171195|656130|P1|COMPLETED|Overall Study||16
273529|NCT02171195|656122|P9|STARTED|Overall Study||6
273530|NCT02171195|656123|P8|STARTED|Overall Study||6
273531|NCT02171195|656124|P7|STARTED|Overall Study||6
273532|NCT02171195|656125|P6|STARTED|Overall Study||6
273533|NCT02171195|656126|P5|STARTED|Overall Study||6
273534|NCT02171195|656127|P4|STARTED|Overall Study||6
273535|NCT02171195|656128|P3|STARTED|Overall Study||6
273536|NCT02171195|656129|P2|STARTED|Overall Study||6
273537|NCT02171195|656130|P1|STARTED|Overall Study||16
273538|NCT02170779|656152|P2|NOT COMPLETED|Overall Study||1
273539|NCT02170779|656153|P1|NOT COMPLETED|Overall Study||1
273540|NCT02170779|656152|P2|COMPLETED|Overall Study||19
273541|NCT02170779|656153|P1|COMPLETED|Overall Study||19
273542|NCT02170779|656152|P2|STARTED|Overall Study||20
273543|NCT02170779|656153|P1|STARTED|Overall Study||20
273544|NCT02170688|656180|P5|NOT COMPLETED|Overall Study||0
273545|NCT02170688|656181|P4|NOT COMPLETED|Overall Study||2
273546|NCT02170688|656182|P3|NOT COMPLETED|Overall Study||4
273547|NCT02170688|656183|P2|NOT COMPLETED|Overall Study||3
273548|NCT02170688|656184|P1|NOT COMPLETED|Overall Study||4
273549|NCT02170688|656180|P5|COMPLETED|Overall Study||25
273550|NCT02170688|656181|P4|COMPLETED|Overall Study||25
273551|NCT02170688|656182|P3|COMPLETED|Overall Study||25
273552|NCT02170688|656183|P2|COMPLETED|Overall Study||26
273553|NCT02170688|656184|P1|COMPLETED|Overall Study||25
273554|NCT02170688|656180|P5|STARTED|Overall Study||25
273555|NCT02170688|656181|P4|STARTED|Overall Study||27
273556|NCT02170688|656182|P3|STARTED|Overall Study||29
273557|NCT02170688|656183|P2|STARTED|Overall Study||29
273558|NCT02170688|656184|P1|STARTED|Overall Study||29
273559|NCT02170662|656203|P2|NOT COMPLETED|Overall Study||0
273560|NCT02170662|656204|P1|NOT COMPLETED|Overall Study||0
273561|NCT02170662|656203|P2|COMPLETED|Overall Study||6
273562|NCT02170662|656204|P1|COMPLETED|Overall Study||3
273563|NCT02170662|656203|P2|STARTED|Overall Study||6
273564|NCT02170662|656204|P1|STARTED|Overall Study||3
273565|NCT02170649|656216|P1|NOT COMPLETED|Fed Period||0
273566|NCT02170649|656216|P1|COMPLETED|Fed Period||12
273567|NCT02170649|656216|P1|STARTED|Fed Period||12
273568|NCT02170649|656216|P1|NOT COMPLETED|Fasting Period||0
273569|NCT02170649|656216|P1|COMPLETED|Fasting Period||12
273570|NCT02170649|656216|P1|STARTED|Fasting Period||12
273571|NCT02170532|656223|P1|NOT COMPLETED|Overall Study||0
273572|NCT02170532|656223|P1|COMPLETED|Overall Study||10
273573|NCT02170532|656223|P1|STARTED|Overall Study||10
273574|NCT02170519|656253|P2|NOT COMPLETED|Overall Study||0
273575|NCT02170519|656254|P1|NOT COMPLETED|Overall Study||0
273576|NCT02170519|656253|P2|COMPLETED|Overall Study||5
273577|NCT02170519|656254|P1|COMPLETED|Overall Study||22
273578|NCT02170519|656253|P2|STARTED|Overall Study||5
273579|NCT02170519|656254|P1|STARTED|Overall Study||22
273580|NCT02170376|656275|P5|NOT COMPLETED|Overall Study||0
273581|NCT02170376|656276|P4|NOT COMPLETED|Overall Study||0
273582|NCT02170376|656277|P3|NOT COMPLETED|Overall Study||0
273583|NCT02170376|656278|P2|NOT COMPLETED|Overall Study||1
273584|NCT02170376|656279|P1|NOT COMPLETED|Overall Study||0
273585|NCT02170376|656275|P5|COMPLETED|Overall Study||16
273586|NCT02170376|656276|P4|COMPLETED|Overall Study||16
273587|NCT02170376|656277|P3|COMPLETED|Overall Study||16
273588|NCT02170376|656278|P2|COMPLETED|Overall Study||15
273589|NCT02170376|656279|P1|COMPLETED|Overall Study||16
273590|NCT02170376|656275|P5|Pharmacokinetic Population|Overall Study||16
273591|NCT02170376|656276|P4|Pharmacokinetic Population|Overall Study||16
273592|NCT02170376|656277|P3|Pharmacokinetic Population|Overall Study||16
273593|NCT02170376|656278|P2|Pharmacokinetic Population|Overall Study||15
273594|NCT02170376|656279|P1|Pharmacokinetic Population|Overall Study||16
273595|NCT02170376|656275|P5|STARTED|Overall Study||16
273596|NCT02170376|656276|P4|STARTED|Overall Study||16
273597|NCT02170376|656277|P3|STARTED|Overall Study||16
273598|NCT02170376|656278|P2|STARTED|Overall Study||16
273599|NCT02170376|656279|P1|STARTED|Overall Study||16
273600|NCT02170220|656318|P2|NOT COMPLETED|Overall Study||0
273601|NCT02170220|656319|P1|NOT COMPLETED|Overall Study||0
273602|NCT02170220|656318|P2|COMPLETED|Overall Study||6
273603|NCT02170220|656319|P1|COMPLETED|Overall Study||6
273604|NCT02170220|656318|P2|STARTED|Overall Study||6
273605|NCT02170220|656319|P1|STARTED|Overall Study||6
273606|NCT02170207|656345|P1|NOT COMPLETED|Overall Study||5
273607|NCT02170207|656345|P1|COMPLETED|Overall Study||58
273608|NCT02170207|656345|P1|STARTED|Overall Study||63
273609|NCT02170077|656356|P3|NOT COMPLETED|Overall Study||12
273610|NCT02170077|656357|P2|NOT COMPLETED|Overall Study||13
273611|NCT02170077|656358|P1|NOT COMPLETED|Overall Study||9
273612|NCT02170077|656356|P3|COMPLETED|Overall Study||35
273613|NCT02170077|656357|P2|COMPLETED|Overall Study||34
273614|NCT02170077|656358|P1|COMPLETED|Overall Study||41
273615|NCT02170077|656356|P3|Intent to Treat (ITT) Population|Overall Study||47
273616|NCT02170077|656357|P2|Intent to Treat (ITT) Population|Overall Study||46
273617|NCT02170077|656358|P1|Intent to Treat (ITT) Population|Overall Study||50
273618|NCT02170077|656356|P3|STARTED|Overall Study||47
273619|NCT02170077|656357|P2|STARTED|Overall Study||47
273620|NCT02170077|656358|P1|STARTED|Overall Study||50
273621|NCT02170064|656369|P3|NOT COMPLETED|Overall Study||1
273622|NCT02170064|656370|P2|NOT COMPLETED|Overall Study||2
273623|NCT02170064|656371|P1|NOT COMPLETED|Overall Study||6
273624|NCT02170064|656369|P3|COMPLETED|Overall Study||10
273625|NCT02170064|656370|P2|COMPLETED|Overall Study||7
273626|NCT02170064|656371|P1|COMPLETED|Overall Study||9
273627|NCT02170064|656369|P3|Efficacy Population (EP)|Overall Study||10
273628|NCT02170064|656370|P2|Efficacy Population (EP)|Overall Study||8
273629|NCT02170064|656371|P1|Efficacy Population (EP)|Overall Study||11
273630|NCT02170064|656369|P3|Pharmacokinetic Population (PKP)|Overall Study||10
273631|NCT02170064|656370|P2|Pharmacokinetic Population (PKP)|Overall Study||8
273632|NCT02170064|656371|P1|Pharmacokinetic Population (PKP)|Overall Study||11
273633|NCT02170064|656369|P3|Safety Population (SP)|Overall Study||11
273634|NCT02170064|656370|P2|Safety Population (SP)|Overall Study||8
273635|NCT02170064|656371|P1|Safety Population (SP)|Overall Study||12
273636|NCT02170064|656369|P3|STARTED|Overall Study||11
273637|NCT02170064|656370|P2|STARTED|Overall Study||9
273638|NCT02170064|656371|P1|STARTED|Overall Study||15
273639|NCT02169895|656389|P4|NOT COMPLETED|Overall Study||2
273640|NCT02169895|656390|P3|NOT COMPLETED|Overall Study||0
273641|NCT02169895|656391|P2|NOT COMPLETED|Overall Study||0
273642|NCT02169895|656392|P1|NOT COMPLETED|Overall Study||0
273643|NCT02169895|656389|P4|COMPLETED|Overall Study||2
273644|NCT02169895|656390|P3|COMPLETED|Overall Study||4
273645|NCT02169895|656391|P2|COMPLETED|Overall Study||4
273646|NCT02169895|656392|P1|COMPLETED|Overall Study||4
273647|NCT02169895|656389|P4|Placebo|Overall Study||4
273648|NCT02169895|656390|P3|Placebo|Overall Study||4
273649|NCT02169895|656391|P2|Placebo|Overall Study||4
273650|NCT02169895|656392|P1|Placebo|Overall Study||4
273651|NCT02169895|656389|P4|100 mg BIA 9-1067|Overall Study||2
273652|NCT02169895|656390|P3|100 mg BIA 9-1067|Overall Study||4
273653|NCT02169895|656391|P2|100 mg BIA 9-1067|Overall Study||4
273654|NCT02169895|656392|P1|100 mg BIA 9-1067|Overall Study||4
273655|NCT02169895|656389|P4|50 mg BIA 9-1067|Overall Study||4
273656|NCT02169895|656390|P3|50 mg BIA 9-1067|Overall Study||4
273657|NCT02169895|656391|P2|50 mg BIA 9-1067|Overall Study||4
273658|NCT02169895|656392|P1|50 mg BIA 9-1067|Overall Study||4
273659|NCT02169895|656389|P4|25 mg BIA 9-1067|Overall Study||4
273660|NCT02169895|656390|P3|25 mg BIA 9-1067|Overall Study||4
273661|NCT02169895|656391|P2|25 mg BIA 9-1067|Overall Study||4
273662|NCT02169895|656392|P1|25 mg BIA 9-1067|Overall Study||4
273663|NCT02169895|656389|P4|STARTED|Overall Study||4
273664|NCT02169895|656390|P3|STARTED|Overall Study||4
273665|NCT02169895|656391|P2|STARTED|Overall Study||4
273666|NCT02169895|656392|P1|STARTED|Overall Study||4
273667|NCT02169479|656414|P4|NOT COMPLETED|Overall Study||0
273668|NCT02169479|656415|P3|NOT COMPLETED|Overall Study||0
273669|NCT02169479|656416|P2|NOT COMPLETED|Overall Study||1
273670|NCT02169479|656417|P1|NOT COMPLETED|Overall Study||1
273671|NCT02169479|656414|P4|COMPLETED|Overall Study||4
273672|NCT02169479|656415|P3|COMPLETED|Overall Study||4
273673|NCT02169479|656416|P2|COMPLETED|Overall Study||3
273674|NCT02169479|656417|P1|COMPLETED|Overall Study||3
273675|NCT02169479|656414|P4|Placebo|Overall Study||4
273676|NCT02169479|656415|P3|Placebo|Overall Study||4
273677|NCT02169479|656416|P2|Placebo|Overall Study||3
273678|NCT02169479|656417|P1|Placebo|Overall Study||3
273679|NCT02169479|656414|P4|100 mg BIA 9-1067|Overall Study||4
273680|NCT02169479|656415|P3|100 mg BIA 9-1067|Overall Study||4
273681|NCT02169479|656416|P2|100 mg BIA 9-1067|Overall Study||4
273682|NCT02169479|656417|P1|100 mg BIA 9-1067|Overall Study||3
273683|NCT02169479|656414|P4|50 mg BIA 9-1067|Overall Study||4
273684|NCT02169479|656415|P3|50 mg BIA 9-1067|Overall Study||4
273685|NCT02169479|656416|P2|50 mg BIA 9-1067|Overall Study||4
273686|NCT02169479|656417|P1|50 mg BIA 9-1067|Overall Study||4
273687|NCT02169479|656414|P4|25 mg BIA 9-1067|Overall Study||4
273688|NCT02169479|656415|P3|25 mg BIA 9-1067|Overall Study||4
273689|NCT02169479|656416|P2|25 mg BIA 9-1067|Overall Study||3
273690|NCT02169479|656417|P1|25 mg BIA 9-1067|Overall Study||4
273691|NCT02169479|656414|P4|STARTED|Overall Study||4
273692|NCT02169479|656415|P3|STARTED|Overall Study||4
273693|NCT02169479|656416|P2|STARTED|Overall Study||4
273694|NCT02169479|656417|P1|STARTED|Overall Study||4
273695|NCT02169466|656439|P4|NOT COMPLETED|Overall Study||0
273696|NCT02169466|656440|P3|NOT COMPLETED|Overall Study||0
273697|NCT02169466|656441|P2|NOT COMPLETED|Overall Study||1
273698|NCT02169466|656442|P1|NOT COMPLETED|Overall Study||1
273699|NCT02169466|656439|P4|COMPLETED|Overall Study||5
273700|NCT02169466|656440|P3|COMPLETED|Overall Study||5
273701|NCT02169466|656441|P2|COMPLETED|Overall Study||5
273702|NCT02169466|656442|P1|COMPLETED|Overall Study||5
273703|NCT02169466|656439|P4|Placebo|Overall Study||5
273704|NCT02169466|656440|P3|Placebo|Overall Study||5
273705|NCT02169466|656441|P2|Placebo|Overall Study||6
273706|NCT02169466|656442|P1|Placebo|Overall Study||5
273707|NCT02169466|656439|P4|100 mg BIA 9-1067|Overall Study||5
273708|NCT02169466|656440|P3|100 mg BIA 9-1067|Overall Study||5
273709|NCT02169466|656441|P2|100 mg BIA 9-1067|Overall Study||6
273710|NCT02169466|656442|P1|100 mg BIA 9-1067|Overall Study||6
273711|NCT02169466|656439|P4|50 mg BIA 9-1067|Overall Study||5
273712|NCT02169466|656440|P3|50 mg BIA 9-1067|Overall Study||5
273713|NCT02169466|656441|P2|50 mg BIA 9-1067|Overall Study||6
273714|NCT02169466|656442|P1|50 mg BIA 9-1067|Overall Study||6
273715|NCT02169466|656439|P4|25 mg BIA 9-1067|Overall Study||5
273716|NCT02169466|656440|P3|25 mg BIA 9-1067|Overall Study||5
273717|NCT02169466|656441|P2|25 mg BIA 9-1067|Overall Study||5
273718|NCT02169466|656442|P1|25 mg BIA 9-1067|Overall Study||6
273719|NCT02169466|656439|P4|STARTED|Overall Study||5
273720|NCT02169466|656440|P3|STARTED|Overall Study||5
273721|NCT02169466|656441|P2|STARTED|Overall Study||6
273722|NCT02169466|656442|P1|STARTED|Overall Study||6
273723|NCT02169453|656468|P4|NOT COMPLETED|Overall Study||0
273724|NCT02169453|656469|P3|NOT COMPLETED|Overall Study||1
273725|NCT02169453|656470|P2|NOT COMPLETED|Overall Study||0
273726|NCT02169453|656471|P1|NOT COMPLETED|Overall Study||0
273727|NCT02169453|656468|P4|COMPLETED|Overall Study||3
273728|NCT02169453|656469|P3|COMPLETED|Overall Study||2
273729|NCT02169453|656470|P2|COMPLETED|Overall Study||3
273730|NCT02169453|656471|P1|COMPLETED|Overall Study||3
273731|NCT02169453|656468|P4|Placebo|Overall Study||3
273732|NCT02169453|656469|P3|Placebo|Overall Study||3
273733|NCT02169453|656470|P2|Placebo|Overall Study||3
273734|NCT02169453|656471|P1|Placebo|Overall Study||3
273735|NCT02169453|656468|P4|100 mg BIA 9-1067|Overall Study||3
273736|NCT02169453|656469|P3|100 mg BIA 9-1067|Overall Study||3
273737|NCT02169453|656470|P2|100 mg BIA 9-1067|Overall Study||3
273738|NCT02169453|656471|P1|100 mg BIA 9-1067|Overall Study||3
273739|NCT02169453|656468|P4|50 mg BIA 9-1067|Overall Study||3
273740|NCT02169453|656469|P3|50 mg BIA 9-1067|Overall Study||2
273741|NCT02169453|656470|P2|50 mg BIA 9-1067|Overall Study||3
273742|NCT02169453|656471|P1|50 mg BIA 9-1067|Overall Study||3
273743|NCT02169453|656468|P4|25 mg BIA 9-1067|Overall Study||3
273744|NCT02169453|656469|P3|25 mg BIA 9-1067|Overall Study||3
273745|NCT02169453|656470|P2|25 mg BIA 9-1067|Overall Study||3
273746|NCT02169453|656471|P1|25 mg BIA 9-1067|Overall Study||3
273747|NCT02169453|656468|P4|STARTED|Overall Study||3
273748|NCT02169453|656469|P3|STARTED|Overall Study||3
273749|NCT02169453|656470|P2|STARTED|Overall Study||3
273750|NCT02169453|656471|P1|STARTED|Overall Study||3
273751|NCT02169440|656503|P2|NOT COMPLETED|Overall Study||0
273752|NCT02169440|656504|P1|NOT COMPLETED|Overall Study||0
273753|NCT02169440|656503|P2|COMPLETED|Overall Study||10
273754|NCT02169440|656504|P1|COMPLETED|Overall Study||10
273755|NCT02169440|656503|P2|STARTED|Overall Study||10
273756|NCT02169440|656504|P1|STARTED|Overall Study||10
273757|NCT02169427|656517|P1|NOT COMPLETED|Overall Study||0
273758|NCT02169427|656517|P1|COMPLETED|Overall Study||6
273759|NCT02169427|656517|P1|STARTED|Overall Study||6
273760|NCT02169414|656527|P4|NOT COMPLETED|Overall Study||0
273761|NCT02169414|656528|P3|NOT COMPLETED|Overall Study||0
273762|NCT02169414|656529|P2|NOT COMPLETED|Overall Study||1
273763|NCT02169414|656530|P1|NOT COMPLETED|Overall Study||1
273764|NCT02169414|656527|P4|COMPLETED|Overall Study||18
273765|NCT02169414|656528|P3|COMPLETED|Overall Study||18
273766|NCT02169414|656529|P2|COMPLETED|Overall Study||18
273767|NCT02169414|656530|P1|COMPLETED|Overall Study||18
273768|NCT02169414|656527|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
273769|NCT02169414|656528|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
273770|NCT02169414|656529|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
273771|NCT02169414|656530|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
273772|NCT02169414|656527|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
273773|NCT02169414|656528|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
273774|NCT02169414|656529|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
273775|NCT02169414|656530|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
273776|NCT02169414|656527|P4|STARTED|Overall Study||18
273777|NCT02169414|656528|P3|STARTED|Overall Study||18
273778|NCT02169414|656529|P2|STARTED|Overall Study||19
273779|NCT02169414|656530|P1|STARTED|Overall Study||19
273780|NCT02169336|656571|P3|NOT COMPLETED|Overall Study||3
273781|NCT02169336|656572|P2|NOT COMPLETED|Overall Study||4
273782|NCT02169336|656573|P1|NOT COMPLETED|Overall Study||4
273783|NCT02169336|656571|P3|COMPLETED|Overall Study||29
273784|NCT02169336|656572|P2|COMPLETED|Overall Study||28
273785|NCT02169336|656573|P1|COMPLETED|Overall Study||27
273786|NCT02169336|656571|P3|STARTED|Overall Study||32
273787|NCT02169336|656572|P2|STARTED|Overall Study||32
273788|NCT02169336|656573|P1|STARTED|Overall Study||31
273789|NCT02169115|656584|P3|NOT COMPLETED|Overall Study||0
273790|NCT02169115|656585|P2|NOT COMPLETED|Overall Study||0
273791|NCT02169115|656586|P1|NOT COMPLETED|Overall Study||0
273792|NCT02169115|656584|P3|COMPLETED|Overall Study||21
273793|NCT02169115|656585|P2|COMPLETED|Overall Study||21
273794|NCT02169115|656586|P1|COMPLETED|Overall Study||19
273795|NCT02169115|656584|P3|STARTED|Overall Study||21
273796|NCT02169115|656585|P2|STARTED|Overall Study||21
273797|NCT02169115|656586|P1|STARTED|Overall Study||19
273798|NCT02168491|656594|P1|NOT COMPLETED|Overall Study||1
273799|NCT02168491|656594|P1|COMPLETED|Overall Study||8
273800|NCT02168491|656594|P1|STARTED|Overall Study||9
273801|NCT02168478|656600|P1|NOT COMPLETED|Overall Study||4
273802|NCT02168478|656600|P1|COMPLETED|Overall Study||202
273803|NCT02168478|656600|P1|STARTED|Overall Study||206
273804|NCT02168439|656606|P2|NOT COMPLETED|Overall Study||2
273805|NCT02168439|656607|P1|NOT COMPLETED|Overall Study||0
273806|NCT02168439|656606|P2|COMPLETED|Overall Study||18
273807|NCT02168439|656607|P1|COMPLETED|Overall Study||20
273808|NCT02168439|656606|P2|STARTED|Overall Study||20
273809|NCT02168439|656607|P1|STARTED|Overall Study||20
273810|NCT02168387|656625|P2|NOT COMPLETED|Overall Study||3
273811|NCT02168387|656626|P1|NOT COMPLETED|Overall Study||7
273812|NCT02168387|656625|P2|COMPLETED|Overall Study||16
273813|NCT02168387|656626|P1|COMPLETED|Overall Study||13
273814|NCT02168387|656625|P2|STARTED|Overall Study||19
273815|NCT02168387|656626|P1|STARTED|Overall Study||20
273816|NCT02168361|656638|P2|NOT COMPLETED|Overall Study||10
273817|NCT02168361|656639|P1|NOT COMPLETED|Overall Study||5
273818|NCT02168361|656638|P2|COMPLETED|Overall Study||21
273819|NCT02168361|656639|P1|COMPLETED|Overall Study||57
273820|NCT02168361|656638|P2|STARTED|Overall Study||31
273821|NCT02168361|656639|P1|STARTED|Overall Study||62
273822|NCT02167893|656647|P1|NOT COMPLETED|Overall Study||163
273823|NCT02167893|656647|P1|COMPLETED|Overall Study||11125
273824|NCT02167893|656647|P1|STARTED|Overall Study||11288
273825|NCT02166697|656656|P1|NOT COMPLETED|Overall Study||347
273826|NCT02166697|656656|P1|COMPLETED|Overall Study||13804
273827|NCT02166697|656656|P1|STARTED|Overall Study||14151
273828|NCT02167867|656667|P2|NOT COMPLETED|Overall Study||0
273829|NCT02167867|656668|P1|NOT COMPLETED|Overall Study||0
273830|NCT02167867|656667|P2|COMPLETED|Overall Study||22
273831|NCT02167867|656668|P1|COMPLETED|Overall Study||22
273832|NCT02167867|656667|P2|STARTED|Overall Study||22
273833|NCT02167867|656668|P1|STARTED|Overall Study||22
273834|NCT02167815|656676|P2|NOT COMPLETED|Overall Study||0
273835|NCT02167815|656677|P1|NOT COMPLETED|Overall Study||0
273836|NCT02167815|656676|P2|COMPLETED|Overall Study||21
273837|NCT02167815|656677|P1|COMPLETED|Overall Study||9
273838|NCT02167815|656676|P2|STARTED|Overall Study||21
273839|NCT02167815|656677|P1|STARTED|Overall Study||9
273840|NCT02167139|656690|P4|NOT COMPLETED|Transition-extension||5
273841|NCT02167139|656691|P3|NOT COMPLETED|Transition-extension||8
273842|NCT02167139|656692|P2|NOT COMPLETED|Transition-extension||0
273843|NCT02167139|656693|P1|NOT COMPLETED|Transition-extension||6
273844|NCT02167139|656690|P4|COMPLETED|Transition-extension||124
273845|NCT02167139|656691|P3|COMPLETED|Transition-extension||117
273846|NCT02167139|656692|P2|COMPLETED|Transition-extension||0
273847|NCT02167139|656693|P1|COMPLETED|Transition-extension||248
273848|NCT02167139|656690|P4|STARTED|Transition-extension||129
273849|NCT02167139|656691|P3|STARTED|Transition-extension||125
273850|NCT02167139|656692|P2|STARTED|Transition-extension||0
273851|NCT02167139|656693|P1|STARTED|Transition-extension||254
273852|NCT02167139|656690|P4|NOT COMPLETED|Randomised, Double-blind||0
273853|NCT02167139|656691|P3|NOT COMPLETED|Randomised, Double-blind||0
273854|NCT02167139|656692|P2|NOT COMPLETED|Randomised, Double-blind||19
273855|NCT02167139|656693|P1|NOT COMPLETED|Randomised, Double-blind||17
273856|NCT02167139|656690|P4|COMPLETED|Randomised, Double-blind||0
273857|NCT02167139|656691|P3|COMPLETED|Randomised, Double-blind||0
273858|NCT02167139|656692|P2|COMPLETED|Randomised, Double-blind||254
273859|NCT02167139|656693|P1|COMPLETED|Randomised, Double-blind||254
273860|NCT02167139|656690|P4|STARTED|Randomised, Double-blind||0
273861|NCT02167139|656691|P3|STARTED|Randomised, Double-blind||0
273862|NCT02167139|656692|P2|STARTED|Randomised, Double-blind||273
273863|NCT02167139|656693|P1|STARTED|Randomised, Double-blind||271
273864|NCT02165826|656710|P3|NOT COMPLETED|Down-Titration Period||7
273865|NCT02165826|656711|P2|NOT COMPLETED|Down-Titration Period||11
273866|NCT02165826|656712|P1|NOT COMPLETED|Down-Titration Period||7
273867|NCT02165826|656710|P3|COMPLETED|Down-Titration Period||31
273868|NCT02165826|656711|P2|COMPLETED|Down-Titration Period||28
273869|NCT02165826|656712|P1|COMPLETED|Down-Titration Period||20
273870|NCT02165826|656710|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
273871|NCT02165826|656711|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
273872|NCT02165826|656712|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
273873|NCT02165826|656710|P3|STARTED|Down-Titration Period||38
273874|NCT02165826|656711|P2|STARTED|Down-Titration Period||39
273875|NCT02165826|656712|P1|STARTED|Down-Titration Period||27
273876|NCT02165826|656710|P3|NOT COMPLETED|Main Treatment Period||109
273877|NCT02165826|656711|P2|NOT COMPLETED|Main Treatment Period||90
273878|NCT02165826|656712|P1|NOT COMPLETED|Main Treatment Period||81
273879|NCT02165826|656710|P3|COMPLETED|Main Treatment Period||334
273880|NCT02165826|656711|P2|COMPLETED|Main Treatment Period||349
273881|NCT02165826|656712|P1|COMPLETED|Main Treatment Period||360
273882|NCT02165826|656710|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
273883|NCT02165826|656711|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
273884|NCT02165826|656712|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
273885|NCT02165826|656710|P3|STARTED|Main Treatment Period||443
273886|NCT02165826|656711|P2|STARTED|Main Treatment Period||439
273887|NCT02165826|656712|P1|STARTED|Main Treatment Period||441
273888|NCT02165462|656769|P1|NOT COMPLETED|Overall Study||0
273889|NCT02165462|656769|P1|COMPLETED|Overall Study||17
273890|NCT02165462|656769|P1|STARTED|Overall Study||17
273891|NCT02165111|656788|P2|NOT COMPLETED|Overall Study||0
273892|NCT02165111|656789|P1|NOT COMPLETED|Overall Study||0
273893|NCT02165111|656788|P2|COMPLETED|Overall Study||40
273894|NCT02165111|656789|P1|COMPLETED|Overall Study||40
273895|NCT02165111|656788|P2|STARTED|Overall Study||40
273896|NCT02165111|656789|P1|STARTED|Overall Study||40
273897|NCT02165072|656805|P1|NOT COMPLETED|Overall Study||0
273898|NCT02165072|656805|P1|COMPLETED|Overall Study||30
273899|NCT02165072|656805|P1|STARTED|Overall Study||30
273900|NCT02164539|656816|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
273901|NCT02164539|656817|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
273902|NCT02164539|656818|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
273903|NCT02164539|656819|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
273904|NCT02164539|656820|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
273905|NCT02164539|656821|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
273906|NCT02164539|656822|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
273907|NCT02164539|656816|P7|COMPLETED|Treatment Phase C (1 Week)||78
273908|NCT02164539|656817|P6|COMPLETED|Treatment Phase C (1 Week)||82
273909|NCT02164539|656818|P5|COMPLETED|Treatment Phase C (1 Week)||84
273910|NCT02164539|656819|P4|COMPLETED|Treatment Phase C (1 Week)||0
273911|NCT02164539|656820|P3|COMPLETED|Treatment Phase C (1 Week)||0
273912|NCT02164539|656821|P2|COMPLETED|Treatment Phase C (1 Week)||0
273913|NCT02164539|656822|P1|COMPLETED|Treatment Phase C (1 Week)||78
273914|NCT02164539|656816|P7|STARTED|Treatment Phase C (1 Week)||80
273915|NCT02164539|656817|P6|STARTED|Treatment Phase C (1 Week)||82
273916|NCT02164539|656818|P5|STARTED|Treatment Phase C (1 Week)||84
273917|NCT02164539|656819|P4|STARTED|Treatment Phase C (1 Week)||0
273918|NCT02164539|656820|P3|STARTED|Treatment Phase C (1 Week)||0
273919|NCT02164539|656821|P2|STARTED|Treatment Phase C (1 Week)||0
273920|NCT02164539|656822|P1|STARTED|Treatment Phase C (1 Week)||79
273921|NCT02164539|656816|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
273922|NCT02164539|656817|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
273923|NCT02164539|656818|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
273924|NCT02164539|656819|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
273925|NCT02164539|656820|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
273926|NCT02164539|656821|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
273927|NCT02164539|656822|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
273928|NCT02164539|656816|P7|COMPLETED|Treatment Phase B (1 Week)||162
273929|NCT02164539|656817|P6|COMPLETED|Treatment Phase B (1 Week)||0
273930|NCT02164539|656818|P5|COMPLETED|Treatment Phase B (1 Week)||163
273931|NCT02164539|656819|P4|COMPLETED|Treatment Phase B (1 Week)||0
273932|NCT02164539|656820|P3|COMPLETED|Treatment Phase B (1 Week)||0
273933|NCT02164539|656821|P2|COMPLETED|Treatment Phase B (1 Week)||0
273934|NCT02164539|656822|P1|COMPLETED|Treatment Phase B (1 Week)||0
273935|NCT02164539|656816|P7|STARTED|Treatment Phase B (1 Week)||163
273936|NCT02164539|656817|P6|STARTED|Treatment Phase B (1 Week)||0
273937|NCT02164539|656818|P5|STARTED|Treatment Phase B (1 Week)||166
273938|NCT02164539|656819|P4|STARTED|Treatment Phase B (1 Week)||0
273939|NCT02164539|656820|P3|STARTED|Treatment Phase B (1 Week)||0
273940|NCT02164539|656821|P2|STARTED|Treatment Phase B (1 Week)||0
273941|NCT02164539|656822|P1|STARTED|Treatment Phase B (1 Week)||0
273942|NCT02164539|656816|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
273943|NCT02164539|656817|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
273944|NCT02164539|656818|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
273945|NCT02164539|656819|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
273946|NCT02164539|656820|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
273947|NCT02164539|656821|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
273948|NCT02164539|656822|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
273949|NCT02164539|656816|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
273950|NCT02164539|656817|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
273951|NCT02164539|656818|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
273952|NCT02164539|656819|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
273953|NCT02164539|656820|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
273954|NCT02164539|656821|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
273955|NCT02164539|656822|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
273956|NCT02164539|656816|P7|STARTED|Treatment Phase A (4 Weeks)||0
273957|NCT02164539|656817|P6|STARTED|Treatment Phase A (4 Weeks)||84
273958|NCT02164539|656818|P5|STARTED|Treatment Phase A (4 Weeks)||85
273959|NCT02164539|656819|P4|STARTED|Treatment Phase A (4 Weeks)||46
273960|NCT02164539|656820|P3|STARTED|Treatment Phase A (4 Weeks)||40
273961|NCT02164539|656821|P2|STARTED|Treatment Phase A (4 Weeks)||42
273962|NCT02164539|656822|P1|STARTED|Treatment Phase A (4 Weeks)||41
273963|NCT02164396|656870|P3|NOT COMPLETED|Overall Study||0
273964|NCT02164396|656871|P2|NOT COMPLETED|Overall Study||0
273965|NCT02164396|656872|P1|NOT COMPLETED|Overall Study||0
273966|NCT02164396|656870|P3|COMPLETED|Overall Study||10
273967|NCT02164396|656871|P2|COMPLETED|Overall Study||10
273968|NCT02164396|656872|P1|COMPLETED|Overall Study||10
273969|NCT02164396|656870|P3|STARTED|Overall Study||10
273970|NCT02164396|656871|P2|STARTED|Overall Study||10
273971|NCT02164396|656872|P1|STARTED|Overall Study||10
273972|NCT02164318|656884|P4|NOT COMPLETED|Overall Study||1
273973|NCT02164318|656885|P3|NOT COMPLETED|Overall Study||0
273974|NCT02164318|656886|P2|NOT COMPLETED|Overall Study||1
273975|NCT02164318|656887|P1|NOT COMPLETED|Overall Study||0
273976|NCT02164318|656884|P4|COMPLETED|Overall Study||2
273977|NCT02164318|656885|P3|COMPLETED|Overall Study||1
273978|NCT02164318|656886|P2|COMPLETED|Overall Study||2
273979|NCT02164318|656887|P1|COMPLETED|Overall Study||4
273980|NCT02164318|656884|P4|STARTED|Overall Study||3
273981|NCT02164318|656885|P3|STARTED|Overall Study||1
273982|NCT02164318|656886|P2|STARTED|Overall Study||3
273983|NCT02164318|656887|P1|STARTED|Overall Study||4
273984|NCT02163915|656910|P5|NOT COMPLETED|Overall Study||4
273985|NCT02163915|656911|P4|NOT COMPLETED|Overall Study||3
273986|NCT02163915|656912|P3|NOT COMPLETED|Overall Study||2
273987|NCT02163915|656913|P2|NOT COMPLETED|Overall Study||0
273988|NCT02163915|656914|P1|NOT COMPLETED|Overall Study||3
273989|NCT02163915|656910|P5|COMPLETED|Overall Study||6
273990|NCT02163915|656911|P4|COMPLETED|Overall Study||6
273991|NCT02163915|656912|P3|COMPLETED|Overall Study||8
273992|NCT02163915|656913|P2|COMPLETED|Overall Study||8
273993|NCT02163915|656914|P1|COMPLETED|Overall Study||7
273994|NCT02163915|656910|P5|STARTED|Overall Study||10
273995|NCT02163915|656911|P4|STARTED|Overall Study||9
273996|NCT02163915|656912|P3|STARTED|Overall Study||10
273997|NCT02163915|656913|P2|STARTED|Overall Study||8
273998|NCT02163915|656914|P1|STARTED|Overall Study||10
273999|NCT02163733|656969|P2|NOT COMPLETED|2: Second Intervention (Day 10)||0
274000|NCT02163733|656970|P1|NOT COMPLETED|2: Second Intervention (Day 10)||0
274001|NCT02163733|656969|P2|COMPLETED|2: Second Intervention (Day 10)||20
274002|NCT02163733|656970|P1|COMPLETED|2: Second Intervention (Day 10)||18
274003|NCT02163733|656969|P2|STARTED|2: Second Intervention (Day 10)||20
274004|NCT02163733|656970|P1|STARTED|2: Second Intervention (Day 10)||18
274005|NCT02163733|656969|P2|NOT COMPLETED|1: First Intervention (Day 1)||0
274006|NCT02163733|656970|P1|NOT COMPLETED|1: First Intervention (Day 1)||0
274007|NCT02163733|656969|P2|COMPLETED|1: First Intervention (Day 1)||20
274008|NCT02163733|656970|P1|COMPLETED|1: First Intervention (Day 1)||18
274009|NCT02163733|656969|P2|STARTED|1: First Intervention (Day 1)||20
274010|NCT02163733|656970|P1|STARTED|1: First Intervention (Day 1)||18
274011|NCT02163421|657009|P4|NOT COMPLETED|Overall Study||0
274012|NCT02163421|657010|P3|NOT COMPLETED|Overall Study||0
274013|NCT02163421|657011|P2|NOT COMPLETED|Overall Study||0
274014|NCT02163421|657012|P1|NOT COMPLETED|Overall Study||0
274015|NCT02163421|657009|P4|COMPLETED|Overall Study||12
274016|NCT02163421|657010|P3|COMPLETED|Overall Study||12
274017|NCT02163421|657011|P2|COMPLETED|Overall Study||12
274018|NCT02163421|657012|P1|COMPLETED|Overall Study||12
274019|NCT02163421|657009|P4|STARTED|Overall Study||12
274020|NCT02163421|657010|P3|STARTED|Overall Study||12
274021|NCT02163421|657011|P2|STARTED|Overall Study||12
274022|NCT02163421|657012|P1|STARTED|Overall Study||12
274023|NCT02163395|657019|P1|NOT COMPLETED|Overall Study||5
274024|NCT02163395|657019|P1|COMPLETED|Overall Study||39
274025|NCT02163395|657019|P1|STARTED|Overall Study||44
274026|NCT02162979|657028|P2|NOT COMPLETED|Overall Study||0
274027|NCT02162979|657029|P1|NOT COMPLETED|Overall Study||0
274028|NCT02162979|657028|P2|COMPLETED|Overall Study||0
274029|NCT02162979|657029|P1|COMPLETED|Overall Study||0
274030|NCT02162979|657028|P2|STARTED|Overall Study||0
274031|NCT02162979|657029|P1|STARTED|Overall Study||0
274032|NCT02162758|657037|P2|NOT COMPLETED|Overall Study||1
274033|NCT02162758|657038|P1|NOT COMPLETED|Overall Study||0
274034|NCT02162758|657037|P2|COMPLETED|Overall Study||2
274035|NCT02162758|657038|P1|COMPLETED|Overall Study||3
274036|NCT02162758|657037|P2|STARTED|Overall Study||3
274037|NCT02162758|657038|P1|STARTED|Overall Study||3
274038|NCT02162680|657053|P3|NOT COMPLETED|Overall Study||0
274039|NCT02162680|657054|P2|NOT COMPLETED|Overall Study||0
274040|NCT02162680|657055|P1|NOT COMPLETED|Overall Study||0
274041|NCT02162680|657053|P3|COMPLETED|Overall Study||32
274042|NCT02162680|657054|P2|COMPLETED|Overall Study||33
274043|NCT02162680|657055|P1|COMPLETED|Overall Study||33
274044|NCT02162680|657053|P3|STARTED|Overall Study||32
274045|NCT02162680|657054|P2|STARTED|Overall Study||33
274046|NCT02162680|657055|P1|STARTED|Overall Study||33
274047|NCT02161549|657065|P2|NOT COMPLETED|Overall Study||2
274048|NCT02161549|657066|P1|NOT COMPLETED|Overall Study||6
274049|NCT02161549|657065|P2|COMPLETED|Overall Study||29
274050|NCT02161549|657066|P1|COMPLETED|Overall Study||34
274051|NCT02161549|657065|P2|STARTED|Overall Study||31
274052|NCT02161549|657066|P1|STARTED|Overall Study||40
274053|NCT02161146|657077|P5|NOT COMPLETED|Overall Study||1
274054|NCT02161146|657078|P4|NOT COMPLETED|Overall Study||3
274055|NCT02161146|657079|P3|NOT COMPLETED|Overall Study||0
274056|NCT02161146|657080|P2|NOT COMPLETED|Overall Study||4
274057|NCT02161146|657081|P1|NOT COMPLETED|Overall Study||1
274058|NCT02161146|657077|P5|COMPLETED|Overall Study||48
274059|NCT02161146|657078|P4|COMPLETED|Overall Study||45
274060|NCT02161146|657079|P3|COMPLETED|Overall Study||49
274061|NCT02161146|657080|P2|COMPLETED|Overall Study||43
274062|NCT02161146|657081|P1|COMPLETED|Overall Study||46
274063|NCT02161146|657077|P5|STARTED|Overall Study||49
274064|NCT02161146|657078|P4|STARTED|Overall Study||48
274065|NCT02161146|657079|P3|STARTED|Overall Study||49
274066|NCT02161146|657080|P2|STARTED|Overall Study||47
274067|NCT02161146|657081|P1|STARTED|Overall Study||47
274068|NCT02161016|657094|P1|NOT COMPLETED|Overall Study||1
274069|NCT02161016|657094|P1|COMPLETED|Overall Study||0
274070|NCT02161016|657094|P1|STARTED|Overall Study||1
274071|NCT02160990|657104|P2|NOT COMPLETED|Overall Study||0
274072|NCT02160990|657105|P1|NOT COMPLETED|Overall Study||0
274073|NCT02160990|657104|P2|COMPLETED|Overall Study||10
274074|NCT02160990|657105|P1|COMPLETED|Overall Study||10
274075|NCT02160990|657104|P2|STARTED|Overall Study||10
274076|NCT02160990|657105|P1|STARTED|Overall Study||10
274077|NCT02160977|657125|P2|NOT COMPLETED|Six Months After Surgery||1
274078|NCT02160977|657126|P1|NOT COMPLETED|Six Months After Surgery||2
274079|NCT02160977|657125|P2|COMPLETED|Six Months After Surgery||42
274080|NCT02160977|657126|P1|COMPLETED|Six Months After Surgery||42
274081|NCT02160977|657125|P2|STARTED|Six Months After Surgery||43
274082|NCT02160977|657126|P1|STARTED|Six Months After Surgery||44
274083|NCT02160977|657125|P2|NOT COMPLETED|Three Months After Surgery||2
274084|NCT02160977|657126|P1|NOT COMPLETED|Three Months After Surgery||0
274085|NCT02160977|657125|P2|COMPLETED|Three Months After Surgery||43
274086|NCT02160977|657126|P1|COMPLETED|Three Months After Surgery||44
274087|NCT02160977|657125|P2|STARTED|Three Months After Surgery||45
274088|NCT02160977|657126|P1|STARTED|Three Months After Surgery||44
274089|NCT02160977|657125|P2|NOT COMPLETED|Six Weeks After Surgery||0
274090|NCT02160977|657126|P1|NOT COMPLETED|Six Weeks After Surgery||1
274091|NCT02160977|657125|P2|COMPLETED|Six Weeks After Surgery||45
274092|NCT02160977|657126|P1|COMPLETED|Six Weeks After Surgery||44
274093|NCT02160977|657125|P2|STARTED|Six Weeks After Surgery||45
274094|NCT02160977|657126|P1|STARTED|Six Weeks After Surgery||45
274095|NCT02160977|657125|P2|NOT COMPLETED|One Week After Surgery||0
274096|NCT02160977|657126|P1|NOT COMPLETED|One Week After Surgery||0
274097|NCT02160977|657125|P2|COMPLETED|One Week After Surgery||45
274098|NCT02160977|657126|P1|COMPLETED|One Week After Surgery||45
274099|NCT02160977|657125|P2|STARTED|One Week After Surgery||45
274100|NCT02160977|657126|P1|STARTED|One Week After Surgery||45
274101|NCT02160873|657138|P2|NOT COMPLETED|Overall Study||0
274102|NCT02160873|657139|P1|NOT COMPLETED|Overall Study||0
274103|NCT02160873|657138|P2|COMPLETED|Overall Study||6
274104|NCT02160873|657139|P1|COMPLETED|Overall Study||6
274105|NCT02160873|657138|P2|STARTED|Overall Study||6
274106|NCT02160873|657139|P1|STARTED|Overall Study||6
274107|NCT02160314|657153|P2|NOT COMPLETED|Overall Study||13
274108|NCT02160314|657154|P1|NOT COMPLETED|Overall Study||1
274109|NCT02160314|657153|P2|COMPLETED|Overall Study||59
274110|NCT02160314|657154|P1|COMPLETED|Overall Study||72
274111|NCT02160314|657153|P2|STARTED|Overall Study||72
274112|NCT02160314|657154|P1|STARTED|Overall Study||73
274113|NCT02159950|657162|P2|NOT COMPLETED|Overall Study||2
274114|NCT02159950|657163|P1|NOT COMPLETED|Overall Study||0
274115|NCT02159950|657162|P2|COMPLETED|Overall Study||0
274116|NCT02159950|657163|P1|COMPLETED|Overall Study||0
274117|NCT02159950|657162|P2|STARTED|Overall Study||2
274118|NCT02159950|657163|P1|STARTED|Overall Study||0
274119|NCT02159859|657195|P1|NOT COMPLETED|Overall Study||0
274120|NCT02159859|657195|P1|COMPLETED|Overall Study||7
274121|NCT02159859|657195|P1|STARTED|Overall Study||7
274122|NCT02159768|657208|P1|NOT COMPLETED|Overall Study||0
274123|NCT02159768|657208|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
274124|NCT02159768|657208|P1|STARTED|Overall Study|Started 16 July 2014|30
274125|NCT02159547|657215|P2|NOT COMPLETED|Overall Study||0
274126|NCT02159547|657216|P1|NOT COMPLETED|Overall Study||0
274127|NCT02159547|657215|P2|COMPLETED|Overall Study||112
274128|NCT02159547|657216|P1|COMPLETED|Overall Study||112
274129|NCT02159547|657215|P2|STARTED|Overall Study||112
274130|NCT02159547|657216|P1|STARTED|Overall Study||112
274131|NCT02159482|657224|P1|NOT COMPLETED|Overall Study||5
274132|NCT02159482|657224|P1|COMPLETED|Overall Study||6
274133|NCT02159482|657224|P1|STARTED|Overall Study||11
274134|NCT02159365|657229|P1|NOT COMPLETED|Overall Study||22
274135|NCT02159365|657229|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
274136|NCT02159365|657229|P1|STARTED|Overall Study||70
274137|NCT02159352|657235|P2|NOT COMPLETED|Overall Study||2
274138|NCT02159352|657236|P1|NOT COMPLETED|Overall Study||3
274139|NCT02159352|657235|P2|COMPLETED|Overall Study||12
274140|NCT02159352|657236|P1|COMPLETED|Overall Study||11
274141|NCT02159352|657235|P2|Phase 2 (Day 5-14)|Overall Study||12
274142|NCT02159352|657236|P1|Phase 2 (Day 5-14)|Overall Study||11
274143|NCT02159352|657235|P2|Phase 1 (Day 1- 4)|Overall Study||14
274144|NCT02159352|657236|P1|Phase 1 (Day 1- 4)|Overall Study||14
274145|NCT02159352|657235|P2|STARTED|Overall Study||14
274146|NCT02159352|657236|P1|STARTED|Overall Study||14
274147|NCT02159118|657288|P2|NOT COMPLETED|Overall Study||0
274148|NCT02159118|657289|P1|NOT COMPLETED|Overall Study||0
274149|NCT02159118|657288|P2|COMPLETED|Overall Study||22
274150|NCT02159118|657289|P1|COMPLETED|Overall Study||22
274151|NCT02159118|657288|P2|STARTED|Overall Study||22
274152|NCT02159118|657289|P1|STARTED|Overall Study||22
274153|NCT02159040|657311|P1|NOT COMPLETED|Overall Study||1
274154|NCT02159040|657311|P1|COMPLETED|Overall Study||0
274155|NCT02159040|657311|P1|STARTED|Overall Study||1
274156|NCT02158728|657324|P1|NOT COMPLETED|Overall Study||27
274157|NCT02158728|657324|P1|COMPLETED|Overall Study||53
274158|NCT02158728|657324|P1|STARTED|Overall Study||80
274159|NCT02158442|657330|P2|NOT COMPLETED|Overall Study||0
274160|NCT02158442|657331|P1|NOT COMPLETED|Overall Study||2
274161|NCT02158442|657330|P2|COMPLETED|Overall Study||7
274162|NCT02158442|657331|P1|COMPLETED|Overall Study||6
274163|NCT02158442|657330|P2|STARTED|Overall Study||7
274164|NCT02158442|657331|P1|STARTED|Overall Study||8
274165|NCT02158273|657339|P2|NOT COMPLETED|Overall Study||3
274166|NCT02158273|657340|P1|NOT COMPLETED|Overall Study||3
274167|NCT02158273|657339|P2|COMPLETED|Overall Study||22
274168|NCT02158273|657340|P1|COMPLETED|Overall Study||22
274169|NCT02158273|657339|P2|STARTED|Overall Study||25
274170|NCT02158273|657340|P1|STARTED|Overall Study||25
274171|NCT02158247|657350|P1|NOT COMPLETED|Overall Study||5
274172|NCT02158247|657350|P1|COMPLETED|Overall Study||176
274173|NCT02158247|657350|P1|STARTED|Overall Study||181
274174|NCT02158039|657366|P1|NOT COMPLETED|Overall Study||10
274175|NCT02158039|657366|P1|COMPLETED|Overall Study||23
274176|NCT02158039|657366|P1|STARTED|Overall Study||33
274177|NCT02157935|657373|P2|NOT COMPLETED|Overall Study||65
274178|NCT02157935|657374|P1|NOT COMPLETED|Overall Study||39
274179|NCT02157935|657373|P2|COMPLETED|Overall Study||548
274180|NCT02157935|657374|P1|COMPLETED|Overall Study||567
274181|NCT02157935|657373|P2|STARTED|Overall Study||613
274182|NCT02157935|657374|P1|STARTED|Overall Study||606
274183|NCT02157909|657392|P2|NOT COMPLETED|Overall Study||0
274184|NCT02157909|657393|P1|NOT COMPLETED|Overall Study||0
274185|NCT02157909|657392|P2|COMPLETED|Overall Study||66
274186|NCT02157909|657393|P1|COMPLETED|Overall Study||66
274187|NCT02157909|657392|P2|STARTED|Overall Study||66
274188|NCT02157909|657393|P1|STARTED|Overall Study||66
274189|NCT02157883|657400|P1|NOT COMPLETED|2: AZD9291+Itraconozole||1
274190|NCT02157883|657400|P1|COMPLETED|2: AZD9291+Itraconozole||38
274191|NCT02157883|657400|P1|STARTED|2: AZD9291+Itraconozole||39
274192|NCT02157883|657400|P1|NOT COMPLETED|1: AZD9291 Alone||0
274193|NCT02157883|657400|P1|COMPLETED|1: AZD9291 Alone||39
274194|NCT02157883|657400|P1|STARTED|1: AZD9291 Alone||39
274195|NCT02157623|657431|P2|NOT COMPLETED|Overall Study||3
274196|NCT02157623|657432|P1|NOT COMPLETED|Overall Study||4
274197|NCT02157623|657431|P2|COMPLETED|Overall Study||0
274198|NCT02157623|657432|P1|COMPLETED|Overall Study||0
274199|NCT02157623|657431|P2|STARTED|Overall Study||3
274200|NCT02157623|657432|P1|STARTED|Overall Study||4
274201|NCT02157376|657440|P2|NOT COMPLETED|Overall Study||18
274202|NCT02157376|657441|P1|NOT COMPLETED|Overall Study||22
274203|NCT02157376|657440|P2|COMPLETED|Overall Study||138
274204|NCT02157376|657441|P1|COMPLETED|Overall Study||133
274205|NCT02157376|657440|P2|STARTED|Overall Study||156
274206|NCT02157376|657441|P1|STARTED|Overall Study||155
274207|NCT02157298|657451|P2|NOT COMPLETED|Overall Study||2
274208|NCT02157298|657452|P1|NOT COMPLETED|Overall Study||4
274209|NCT02157298|657451|P2|COMPLETED|Overall Study||58
274210|NCT02157298|657452|P1|COMPLETED|Overall Study||119
274211|NCT02157298|657451|P2|STARTED|Overall Study||60
274212|NCT02157298|657452|P1|STARTED|Overall Study||123
274213|NCT02157116|657466|P1|NOT COMPLETED|Overall Study||9
274214|NCT02157116|657466|P1|COMPLETED|Overall Study||4
274215|NCT02157116|657466|P1|STARTED|Overall Study|signed consent form|13
274216|NCT02156466|657480|P5|NOT COMPLETED|Overall Study||0
274217|NCT02156466|657481|P4|NOT COMPLETED|Overall Study||2
274218|NCT02156466|657482|P3|NOT COMPLETED|Overall Study||1
274219|NCT02156466|657483|P2|NOT COMPLETED|Overall Study||0
274220|NCT02156466|657484|P1|NOT COMPLETED|Overall Study||0
274221|NCT02156466|657480|P5|COMPLETED|Overall Study||8
274222|NCT02156466|657481|P4|COMPLETED|Overall Study||7
274223|NCT02156466|657482|P3|COMPLETED|Overall Study||7
274224|NCT02156466|657483|P2|COMPLETED|Overall Study||8
274225|NCT02156466|657484|P1|COMPLETED|Overall Study||8
274226|NCT02156466|657480|P5|STARTED|Overall Study||8
274227|NCT02156466|657481|P4|STARTED|Overall Study||9
274228|NCT02156466|657482|P3|STARTED|Overall Study||8
274229|NCT02156466|657483|P2|STARTED|Overall Study||8
274230|NCT02156466|657484|P1|STARTED|Overall Study||8
274231|NCT02156271|657665|P2|NOT COMPLETED|Overall Study||3
274232|NCT02156271|657666|P1|NOT COMPLETED|Overall Study||4
274233|NCT02156271|657665|P2|COMPLETED|Overall Study||10
274234|NCT02156271|657666|P1|COMPLETED|Overall Study||22
274235|NCT02156271|657665|P2|STARTED|Overall Study||13
274236|NCT02156271|657666|P1|STARTED|Overall Study||26
274237|NCT02156167|657698|P1|NOT COMPLETED|Overall Study||0
274238|NCT02156167|657698|P1|COMPLETED|Overall Study||15
274239|NCT02156167|657698|P1|STARTED|Overall Study||15
274240|NCT02155985|657705|P3|NOT COMPLETED|Overall Study||1
274241|NCT02155985|657706|P2|NOT COMPLETED|Overall Study||0
274242|NCT02155985|657707|P1|NOT COMPLETED|Overall Study||1
274243|NCT02155985|657705|P3|COMPLETED|Overall Study||39
274244|NCT02155985|657706|P2|COMPLETED|Overall Study||41
274245|NCT02155985|657707|P1|COMPLETED|Overall Study||39
274246|NCT02155985|657705|P3|STARTED|Overall Study||40
274247|NCT02155985|657706|P2|STARTED|Overall Study||41
274248|NCT02155985|657707|P1|STARTED|Overall Study||40
274249|NCT02155881|657774|P2|NOT COMPLETED|Overall Study||4
274250|NCT02155881|657775|P1|NOT COMPLETED|Overall Study||2
274251|NCT02155881|657774|P2|COMPLETED|Overall Study||36
274252|NCT02155881|657775|P1|COMPLETED|Overall Study||38
274253|NCT02155881|657774|P2|STARTED|Overall Study||40
274254|NCT02155881|657775|P1|STARTED|Overall Study||40
274255|NCT02155543|657802|P7|NOT COMPLETED|Overall Study||0
274256|NCT02155543|657803|P6|NOT COMPLETED|Overall Study||0
274257|NCT02155543|657804|P5|NOT COMPLETED|Overall Study||0
274258|NCT02155543|657805|P4|NOT COMPLETED|Overall Study||0
274259|NCT02155543|657806|P3|NOT COMPLETED|Overall Study||0
274260|NCT02155543|657807|P2|NOT COMPLETED|Overall Study||0
274261|NCT02155543|657808|P1|NOT COMPLETED|Overall Study||0
274262|NCT02155543|657802|P7|COMPLETED|Overall Study||9
274263|NCT02155543|657803|P6|COMPLETED|Overall Study||3
274264|NCT02155543|657804|P5|COMPLETED|Overall Study||3
274265|NCT02155543|657805|P4|COMPLETED|Overall Study||9
274266|NCT02155543|657806|P3|COMPLETED|Overall Study||9
274267|NCT02155543|657807|P2|COMPLETED|Overall Study||9
274268|NCT02155543|657808|P1|COMPLETED|Overall Study||9
274269|NCT02155543|657802|P7|STARTED|Overall Study||9
274270|NCT02155543|657803|P6|STARTED|Overall Study||3
274271|NCT02155543|657804|P5|STARTED|Overall Study||3
274272|NCT02155543|657805|P4|STARTED|Overall Study||9
274273|NCT02155543|657806|P3|STARTED|Overall Study||9
274274|NCT02155543|657807|P2|STARTED|Overall Study||9
274275|NCT02155543|657808|P1|STARTED|Overall Study||9
274276|NCT02155335|657821|P2|NOT COMPLETED|Period 2||0
274277|NCT02155335|657822|P1|NOT COMPLETED|Period 2||0
274278|NCT02155335|657821|P2|COMPLETED|Period 2||49
274279|NCT02155335|657822|P1|COMPLETED|Period 2||50
274280|NCT02155335|657821|P2|STARTED|Period 2||49
274281|NCT02155335|657822|P1|STARTED|Period 2||50
274282|NCT02155335|657821|P2|NOT COMPLETED|Period 1||1
274283|NCT02155335|657822|P1|NOT COMPLETED|Period 1||0
274284|NCT02155335|657821|P2|COMPLETED|Period 1||49
274285|NCT02155335|657822|P1|COMPLETED|Period 1||50
274286|NCT02155335|657821|P2|Treated|Period 1||49
274287|NCT02155335|657822|P1|Treated|Period 1||50
274288|NCT02155335|657821|P2|STARTED|Period 1||50
274289|NCT02155335|657822|P1|STARTED|Period 1||50
274290|NCT02155322|657827|P1|NOT COMPLETED|Overall Study||14
274291|NCT02155322|657827|P1|COMPLETED|Overall Study||19
274292|NCT02155322|657827|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
274293|NCT02155322|657827|P1|STARTED|Overall Study||33
274294|NCT02155283|657832|P1|NOT COMPLETED|Overall Study||7
274295|NCT02155283|657832|P1|COMPLETED|Overall Study||9
274296|NCT02155283|657832|P1|STARTED|Overall Study||16
274297|NCT02155010|657839|P2|NOT COMPLETED|Overall Study||6
274298|NCT02155010|657840|P1|NOT COMPLETED|Overall Study||6
274299|NCT02155010|657839|P2|COMPLETED|Overall Study||31
274300|NCT02155010|657840|P1|COMPLETED|Overall Study||31
274301|NCT02155010|657839|P2|STARTED|Overall Study||37
274302|NCT02155010|657840|P1|STARTED|Overall Study||37
274303|NCT02154906|657850|P2|NOT COMPLETED|Overall Study||3
274304|NCT02154906|657851|P1|NOT COMPLETED|Overall Study||2
274305|NCT02154906|657850|P2|COMPLETED|Overall Study||17
274306|NCT02154906|657851|P1|COMPLETED|Overall Study||19
274307|NCT02154906|657850|P2|STARTED|Overall Study||20
274308|NCT02154906|657851|P1|STARTED|Overall Study||21
274309|NCT02154425|657859|P1|NOT COMPLETED|Sampling Period||0
274310|NCT02154425|657859|P1|COMPLETED|Sampling Period||17
274311|NCT02154425|657859|P1|STARTED|Sampling Period||17
274312|NCT02154425|657859|P1|NOT COMPLETED|Screening Period||1
274313|NCT02154425|657859|P1|COMPLETED|Screening Period||17
274314|NCT02154425|657859|P1|STARTED|Screening Period||18
274315|NCT02154386|657891|P2|NOT COMPLETED|Overall Study||2
274316|NCT02154386|657892|P1|NOT COMPLETED|Overall Study||1
274317|NCT02154386|657891|P2|COMPLETED|Overall Study||21
274318|NCT02154386|657892|P1|COMPLETED|Overall Study||22
274319|NCT02154386|657891|P2|STARTED|Overall Study||23
274320|NCT02154386|657892|P1|STARTED|Overall Study||23
274321|NCT02154139|657902|P1|NOT COMPLETED|Overall Study||7
274322|NCT02154139|657902|P1|COMPLETED|Overall Study||644
274323|NCT02154139|657902|P1|STARTED|Overall Study||651
274324|NCT02154087|657910|P1|NOT COMPLETED|Overall Study||1
274325|NCT02154087|657910|P1|COMPLETED|Overall Study||0
274326|NCT02154087|657910|P1|STARTED|Overall Study||1
274327|NCT02154048|657917|P3|NOT COMPLETED|Overall Study||0
274328|NCT02154048|657918|P2|NOT COMPLETED|Overall Study||0
274329|NCT02154048|657919|P1|NOT COMPLETED|Overall Study||0
274330|NCT02154048|657917|P3|COMPLETED|Overall Study||1
274331|NCT02154048|657918|P2|COMPLETED|Overall Study||2
274332|NCT02154048|657919|P1|COMPLETED|Overall Study||2
274333|NCT02154048|657917|P3|STARTED|Overall Study||1
274334|NCT02154048|657918|P2|STARTED|Overall Study||2
274335|NCT02154048|657919|P1|STARTED|Overall Study||2
274336|NCT02153827|657929|P2|NOT COMPLETED|Overall Study||9
274337|NCT02153827|657930|P1|NOT COMPLETED|Overall Study||3
274338|NCT02153827|657929|P2|COMPLETED|Overall Study||14
274339|NCT02153827|657930|P1|COMPLETED|Overall Study||22
274340|NCT02153827|657929|P2|STARTED|Overall Study||23
274341|NCT02153827|657930|P1|STARTED|Overall Study||25
274342|NCT02153788|657946|P2|NOT COMPLETED|Overall Study||1
274343|NCT02153788|657947|P1|NOT COMPLETED|Overall Study||2
274344|NCT02153788|657946|P2|COMPLETED|Overall Study||18
274345|NCT02153788|657947|P1|COMPLETED|Overall Study||23
274346|NCT02153788|657946|P2|STARTED|Overall Study||19
274347|NCT02153788|657947|P1|STARTED|Overall Study||25
274348|NCT02153489|657965|P2|NOT COMPLETED|Period 2||0
274349|NCT02153489|657966|P1|NOT COMPLETED|Period 2||0
274350|NCT02153489|657965|P2|COMPLETED|Period 2||15
274351|NCT02153489|657966|P1|COMPLETED|Period 2||15
274352|NCT02153489|657965|P2|STARTED|Period 2||15
274353|NCT02153489|657966|P1|STARTED|Period 2||15
274354|NCT02153489|657965|P2|NOT COMPLETED|Period 1||0
274355|NCT02153489|657966|P1|NOT COMPLETED|Period 1||0
274356|NCT02153489|657965|P2|COMPLETED|Period 1||15
274357|NCT02153489|657966|P1|COMPLETED|Period 1||15
274358|NCT02153489|657965|P2|STARTED|Period 1||15
274359|NCT02153489|657966|P1|STARTED|Period 1||15
274360|NCT02153398|658009|P5|NOT COMPLETED|Overall Study||0
274361|NCT02153398|658010|P4|NOT COMPLETED|Overall Study||1
274362|NCT02153398|658011|P3|NOT COMPLETED|Overall Study||1
274363|NCT02153398|658012|P2|NOT COMPLETED|Overall Study||0
274364|NCT02153398|658013|P1|NOT COMPLETED|Overall Study||1
274365|NCT02153398|658009|P5|COMPLETED|Overall Study||10
274366|NCT02153398|658010|P4|COMPLETED|Overall Study||9
274367|NCT02153398|658011|P3|COMPLETED|Overall Study||9
274368|NCT02153398|658012|P2|COMPLETED|Overall Study||10
274369|NCT02153398|658013|P1|COMPLETED|Overall Study||9
274370|NCT02153398|658009|P5|STARTED|Overall Study||10
274371|NCT02153398|658010|P4|STARTED|Overall Study||10
274372|NCT02153398|658011|P3|STARTED|Overall Study||10
274373|NCT02153398|658012|P2|STARTED|Overall Study||10
274374|NCT02153398|658013|P1|STARTED|Overall Study||10
274375|NCT02153346|658135|P1|NOT COMPLETED|Overall Study||11
274376|NCT02153346|658135|P1|COMPLETED|Overall Study||90
274377|NCT02153346|658135|P1|STARTED|Overall Study||101
274378|NCT02153099|658149|P7|NOT COMPLETED|Overall Study||0
274379|NCT02153099|658150|P6|NOT COMPLETED|Overall Study||0
274380|NCT02153099|658151|P5|NOT COMPLETED|Overall Study||0
274381|NCT02153099|658152|P4|NOT COMPLETED|Overall Study||0
274382|NCT02153099|658153|P3|NOT COMPLETED|Overall Study||0
274383|NCT02153099|658154|P2|NOT COMPLETED|Overall Study||0
274384|NCT02153099|658155|P1|NOT COMPLETED|Overall Study||0
274385|NCT02153099|658149|P7|COMPLETED|Overall Study||12
274386|NCT02153099|658150|P6|COMPLETED|Overall Study||6
274387|NCT02153099|658151|P5|COMPLETED|Overall Study||6
274388|NCT02153099|658152|P4|COMPLETED|Overall Study||6
274389|NCT02153099|658153|P3|COMPLETED|Overall Study||6
274390|NCT02153099|658154|P2|COMPLETED|Overall Study||6
274391|NCT02153099|658155|P1|COMPLETED|Overall Study||6
274392|NCT02153099|658149|P7|STARTED|Overall Study||12
274393|NCT02153099|658150|P6|STARTED|Overall Study||6
274394|NCT02153099|658151|P5|STARTED|Overall Study||6
274395|NCT02153099|658152|P4|STARTED|Overall Study||6
274396|NCT02153099|658153|P3|STARTED|Overall Study||6
274397|NCT02153099|658154|P2|STARTED|Overall Study||6
274398|NCT02153099|658155|P1|STARTED|Overall Study||6
274399|NCT02153086|658209|P1|NOT COMPLETED|Overall Study||4
274400|NCT02153086|658209|P1|COMPLETED|Overall Study||232
274401|NCT02153086|658209|P1|STARTED|Overall Study||236
274402|NCT02152605|658225|P2|NOT COMPLETED|Overall Study||18
274403|NCT02152605|658226|P1|NOT COMPLETED|Overall Study||19
274404|NCT02152605|658225|P2|COMPLETED|Overall Study||230
274405|NCT02152605|658226|P1|COMPLETED|Overall Study||229
274406|NCT02152605|658225|P2|STARTED|Overall Study||248
274407|NCT02152605|658226|P1|STARTED|Overall Study||248
274408|NCT02152566|658236|P1|NOT COMPLETED|Overall Study||3
274409|NCT02152566|658236|P1|COMPLETED|Overall Study||3
274410|NCT02152566|658236|P1|STARTED|Overall Study||6
274411|NCT02152371|658242|P2|NOT COMPLETED|Overall Study||16
274412|NCT02152371|658243|P1|NOT COMPLETED|Overall Study||12
274413|NCT02152371|658242|P2|COMPLETED|Overall Study||134
274414|NCT02152371|658243|P1|COMPLETED|Overall Study||138
274415|NCT02152371|658242|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
274416|NCT02152371|658243|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
274417|NCT02152371|658242|P2|STARTED|Overall Study||150
274418|NCT02152371|658243|P1|STARTED|Overall Study||150
274419|NCT02152007|658279|P1|NOT COMPLETED|Overall Study||1
274420|NCT02152007|658279|P1|COMPLETED|Overall Study||14
274421|NCT02152007|658279|P1|STARTED|Overall Study||15
274422|NCT02151994|658288|P13|NOT COMPLETED|Food Effect (FE): Fed||0
274423|NCT02151994|658289|P12|NOT COMPLETED|Food Effect (FE): Fed||0
274424|NCT02151994|658290|P11|NOT COMPLETED|Food Effect (FE): Fed||0
274425|NCT02151994|658291|P10|NOT COMPLETED|Food Effect (FE): Fed||0
274426|NCT02151994|658292|P9|NOT COMPLETED|Food Effect (FE): Fed||0
274427|NCT02151994|658293|P8|NOT COMPLETED|Food Effect (FE): Fed||0
274428|NCT02151994|658294|P7|NOT COMPLETED|Food Effect (FE): Fed||0
274429|NCT02151994|658295|P6|NOT COMPLETED|Food Effect (FE): Fed||0
274430|NCT02151994|658296|P5|NOT COMPLETED|Food Effect (FE): Fed||0
274431|NCT02151994|658297|P4|NOT COMPLETED|Food Effect (FE): Fed||0
274432|NCT02151994|658298|P3|NOT COMPLETED|Food Effect (FE): Fed||0
274433|NCT02151994|658299|P2|NOT COMPLETED|Food Effect (FE): Fed||0
274434|NCT02151994|658300|P1|NOT COMPLETED|Food Effect (FE): Fed||0
274435|NCT02151994|658288|P13|COMPLETED|Food Effect (FE): Fed||12
274436|NCT02151994|658289|P12|COMPLETED|Food Effect (FE): Fed||0
274437|NCT02151994|658290|P11|COMPLETED|Food Effect (FE): Fed||0
274438|NCT02151994|658291|P10|COMPLETED|Food Effect (FE): Fed||0
274439|NCT02151994|658292|P9|COMPLETED|Food Effect (FE): Fed||0
274440|NCT02151994|658293|P8|COMPLETED|Food Effect (FE): Fed||0
274441|NCT02151994|658294|P7|COMPLETED|Food Effect (FE): Fed||0
274442|NCT02151994|658295|P6|COMPLETED|Food Effect (FE): Fed||0
274443|NCT02151994|658296|P5|COMPLETED|Food Effect (FE): Fed||0
274444|NCT02151994|658297|P4|COMPLETED|Food Effect (FE): Fed||0
274445|NCT02151994|658298|P3|COMPLETED|Food Effect (FE): Fed||0
274446|NCT02151994|658299|P2|COMPLETED|Food Effect (FE): Fed||0
274447|NCT02151994|658300|P1|COMPLETED|Food Effect (FE): Fed||0
274448|NCT02151994|658288|P13|STARTED|Food Effect (FE): Fed||12
274449|NCT02151994|658289|P12|STARTED|Food Effect (FE): Fed||0
274450|NCT02151994|658290|P11|STARTED|Food Effect (FE): Fed||0
274451|NCT02151994|658291|P10|STARTED|Food Effect (FE): Fed||0
274452|NCT02151994|658292|P9|STARTED|Food Effect (FE): Fed||0
274453|NCT02151994|658293|P8|STARTED|Food Effect (FE): Fed||0
274454|NCT02151994|658294|P7|STARTED|Food Effect (FE): Fed||0
274455|NCT02151994|658295|P6|STARTED|Food Effect (FE): Fed||0
274456|NCT02151994|658296|P5|STARTED|Food Effect (FE): Fed||0
274457|NCT02151994|658297|P4|STARTED|Food Effect (FE): Fed||0
274458|NCT02151994|658298|P3|STARTED|Food Effect (FE): Fed||0
274459|NCT02151994|658299|P2|STARTED|Food Effect (FE): Fed||0
274460|NCT02151994|658300|P1|STARTED|Food Effect (FE): Fed||0
274461|NCT02151994|658288|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
274462|NCT02151994|658289|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
274463|NCT02151994|658290|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
274464|NCT02151994|658291|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
274465|NCT02151994|658292|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
274466|NCT02151994|658293|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
274467|NCT02151994|658294|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
274468|NCT02151994|658295|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
274469|NCT02151994|658296|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
274470|NCT02151994|658297|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
274471|NCT02151994|658298|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
274472|NCT02151994|658299|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
274473|NCT02151994|658300|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
274474|NCT02151994|658288|P13|COMPLETED|Food Effect (FE): Fasted||0
274475|NCT02151994|658289|P12|COMPLETED|Food Effect (FE): Fasted||12
274476|NCT02151994|658290|P11|COMPLETED|Food Effect (FE): Fasted||0
274477|NCT02151994|658291|P10|COMPLETED|Food Effect (FE): Fasted||0
274478|NCT02151994|658292|P9|COMPLETED|Food Effect (FE): Fasted||0
274479|NCT02151994|658293|P8|COMPLETED|Food Effect (FE): Fasted||0
274480|NCT02151994|658294|P7|COMPLETED|Food Effect (FE): Fasted||0
274481|NCT02151994|658295|P6|COMPLETED|Food Effect (FE): Fasted||0
274482|NCT02151994|658296|P5|COMPLETED|Food Effect (FE): Fasted||0
274483|NCT02151994|658297|P4|COMPLETED|Food Effect (FE): Fasted||0
274484|NCT02151994|658298|P3|COMPLETED|Food Effect (FE): Fasted||0
274485|NCT02151994|658299|P2|COMPLETED|Food Effect (FE): Fasted||0
274486|NCT02151994|658300|P1|COMPLETED|Food Effect (FE): Fasted||0
274487|NCT02151994|658288|P13|STARTED|Food Effect (FE): Fasted||0
274488|NCT02151994|658289|P12|STARTED|Food Effect (FE): Fasted||12
274489|NCT02151994|658290|P11|STARTED|Food Effect (FE): Fasted||0
274490|NCT02151994|658291|P10|STARTED|Food Effect (FE): Fasted||0
274491|NCT02151994|658292|P9|STARTED|Food Effect (FE): Fasted||0
274492|NCT02151994|658293|P8|STARTED|Food Effect (FE): Fasted||0
274493|NCT02151994|658294|P7|STARTED|Food Effect (FE): Fasted||0
274494|NCT02151994|658295|P6|STARTED|Food Effect (FE): Fasted||0
274495|NCT02151994|658296|P5|STARTED|Food Effect (FE): Fasted||0
274496|NCT02151994|658297|P4|STARTED|Food Effect (FE): Fasted||0
274497|NCT02151994|658298|P3|STARTED|Food Effect (FE): Fasted||0
274498|NCT02151994|658299|P2|STARTED|Food Effect (FE): Fasted||0
274499|NCT02151994|658300|P1|STARTED|Food Effect (FE): Fasted||0
274500|NCT02151994|658288|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274501|NCT02151994|658289|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274502|NCT02151994|658290|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274503|NCT02151994|658291|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274504|NCT02151994|658292|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274505|NCT02151994|658293|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274506|NCT02151994|658294|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274507|NCT02151994|658295|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274508|NCT02151994|658296|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274509|NCT02151994|658297|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274510|NCT02151994|658298|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274511|NCT02151994|658299|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274512|NCT02151994|658300|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
274513|NCT02151994|658288|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
274514|NCT02151994|658289|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
274515|NCT02151994|658290|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
274516|NCT02151994|658291|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
274517|NCT02151994|658292|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
274518|NCT02151994|658293|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
274519|NCT02151994|658294|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
274520|NCT02151994|658295|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
274521|NCT02151994|658296|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
274522|NCT02151994|658297|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
274523|NCT02151994|658298|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
274524|NCT02151994|658299|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
274525|NCT02151994|658300|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
274526|NCT02151994|658288|P13|STARTED|Multiple Ascending Dose (MAD)||0
274527|NCT02151994|658289|P12|STARTED|Multiple Ascending Dose (MAD)||0
274528|NCT02151994|658290|P11|STARTED|Multiple Ascending Dose (MAD)||0
274529|NCT02151994|658291|P10|STARTED|Multiple Ascending Dose (MAD)||0
274530|NCT02151994|658292|P9|STARTED|Multiple Ascending Dose (MAD)||6
274531|NCT02151994|658293|P8|STARTED|Multiple Ascending Dose (MAD)||0
274532|NCT02151994|658294|P7|STARTED|Multiple Ascending Dose (MAD)||6
274533|NCT02151994|658295|P6|STARTED|Multiple Ascending Dose (MAD)||6
274534|NCT02151994|658296|P5|STARTED|Multiple Ascending Dose (MAD)||6
274535|NCT02151994|658297|P4|STARTED|Multiple Ascending Dose (MAD)||6
274536|NCT02151994|658298|P3|STARTED|Multiple Ascending Dose (MAD)||0
274537|NCT02151994|658299|P2|STARTED|Multiple Ascending Dose (MAD)||0
274538|NCT02151994|658300|P1|STARTED|Multiple Ascending Dose (MAD)||10
274539|NCT02151994|658288|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
274540|NCT02151994|658289|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
274541|NCT02151994|658290|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
274542|NCT02151994|658291|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
274543|NCT02151994|658292|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
274544|NCT02151994|658293|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
274545|NCT02151994|658294|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
274546|NCT02151994|658295|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
274547|NCT02151994|658296|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
274548|NCT02151994|658297|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
274549|NCT02151994|658298|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
274550|NCT02151994|658299|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
274551|NCT02151994|658300|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
274552|NCT02151994|658288|P13|COMPLETED|Single Ascending Dose (SAD)||0
274553|NCT02151994|658289|P12|COMPLETED|Single Ascending Dose (SAD)||0
274554|NCT02151994|658290|P11|COMPLETED|Single Ascending Dose (SAD)||6
274555|NCT02151994|658291|P10|COMPLETED|Single Ascending Dose (SAD)||6
274556|NCT02151994|658292|P9|COMPLETED|Single Ascending Dose (SAD)||0
274557|NCT02151994|658293|P8|COMPLETED|Single Ascending Dose (SAD)||6
274558|NCT02151994|658294|P7|COMPLETED|Single Ascending Dose (SAD)||6
274559|NCT02151994|658295|P6|COMPLETED|Single Ascending Dose (SAD)||6
274560|NCT02151994|658296|P5|COMPLETED|Single Ascending Dose (SAD)||6
274561|NCT02151994|658297|P4|COMPLETED|Single Ascending Dose (SAD)||6
274562|NCT02151994|658298|P3|COMPLETED|Single Ascending Dose (SAD)||6
274563|NCT02151994|658299|P2|COMPLETED|Single Ascending Dose (SAD)||6
274564|NCT02151994|658300|P1|COMPLETED|Single Ascending Dose (SAD)||18
274565|NCT02151994|658288|P13|STARTED|Single Ascending Dose (SAD)||0
274566|NCT02151994|658289|P12|STARTED|Single Ascending Dose (SAD)||0
274567|NCT02151994|658290|P11|STARTED|Single Ascending Dose (SAD)||6
274568|NCT02151994|658291|P10|STARTED|Single Ascending Dose (SAD)||6
274569|NCT02151994|658292|P9|STARTED|Single Ascending Dose (SAD)||0
274570|NCT02151994|658293|P8|STARTED|Single Ascending Dose (SAD)||6
274571|NCT02151994|658294|P7|STARTED|Single Ascending Dose (SAD)||6
274572|NCT02151994|658295|P6|STARTED|Single Ascending Dose (SAD)||6
274573|NCT02151994|658296|P5|STARTED|Single Ascending Dose (SAD)||6
274574|NCT02151994|658297|P4|STARTED|Single Ascending Dose (SAD)||6
274575|NCT02151994|658298|P3|STARTED|Single Ascending Dose (SAD)||6
274576|NCT02151994|658299|P2|STARTED|Single Ascending Dose (SAD)||6
274577|NCT02151994|658300|P1|STARTED|Single Ascending Dose (SAD)||18
274578|NCT02151786|658338|P1|NOT COMPLETED|Overall Study||36
274579|NCT02151786|658338|P1|COMPLETED|Overall Study||1084
274580|NCT02151786|658338|P1|STARTED|Overall Study||1120
274581|NCT02151773|658349|P1|NOT COMPLETED|Overall Study||64
274582|NCT02151773|658349|P1|COMPLETED|Overall Study||3429
274583|NCT02151773|658349|P1|STARTED|Overall Study||3493
274584|NCT02151253|658354|P2|NOT COMPLETED|Overall Study||0
274585|NCT02151253|658355|P1|NOT COMPLETED|Overall Study||0
274586|NCT02151253|658354|P2|COMPLETED|Overall Study||15
274587|NCT02151253|658355|P1|COMPLETED|Overall Study||13
274588|NCT02151253|658354|P2|STARTED|Overall Study||15
274589|NCT02151253|658355|P1|STARTED|Overall Study||13
274590|NCT02151058|658372|P3|NOT COMPLETED|Overall Study||5
274591|NCT02151058|658373|P2|NOT COMPLETED|Overall Study||1
274592|NCT02151058|658374|P1|NOT COMPLETED|Overall Study||2
274593|NCT02151058|658372|P3|COMPLETED|Overall Study||86
274594|NCT02151058|658373|P2|COMPLETED|Overall Study||90
274595|NCT02151058|658374|P1|COMPLETED|Overall Study||43
274596|NCT02151058|658372|P3|STARTED|Overall Study||91
274597|NCT02151058|658373|P2|STARTED|Overall Study||91
274598|NCT02151058|658374|P1|STARTED|Overall Study||45
274599|NCT02150954|658408|P2|NOT COMPLETED|Overall Study||0
274600|NCT02150954|658409|P1|NOT COMPLETED|Overall Study||1
274601|NCT02150954|658408|P2|COMPLETED|Overall Study||59
274602|NCT02150954|658409|P1|COMPLETED|Overall Study||57
274603|NCT02150954|658408|P2|STARTED|Overall Study||59
274604|NCT02150954|658409|P1|STARTED|Overall Study||58
274605|NCT02150499|658433|P2|NOT COMPLETED|Overall Study||0
274606|NCT02150499|658434|P1|NOT COMPLETED|Overall Study||0
274607|NCT02150499|658433|P2|COMPLETED|Overall Study||9
274608|NCT02150499|658434|P1|COMPLETED|Overall Study||9
274609|NCT02150499|658433|P2|STARTED|Overall Study||9
274610|NCT02150499|658434|P1|STARTED|Overall Study||9
274611|NCT02150460|658456|P2|NOT COMPLETED|Overall Study||0
274612|NCT02150460|658457|P1|NOT COMPLETED|Overall Study||0
274613|NCT02150460|658456|P2|COMPLETED|Overall Study||50
274614|NCT02150460|658457|P1|COMPLETED|Overall Study||50
274615|NCT02150460|658456|P2|STARTED|Overall Study||50
274616|NCT02150460|658457|P1|STARTED|Overall Study||50
274617|NCT02150213|658481|P1|NOT COMPLETED|Overall Study||2
274618|NCT02150213|658481|P1|COMPLETED|Overall Study||57
274619|NCT02150213|658481|P1|STARTED|Overall Study||59
274620|NCT02150109|658486|P1|NOT COMPLETED|Overall Study||0
274621|NCT02150109|658486|P1|COMPLETED|Overall Study||372
274622|NCT02150109|658486|P1|STARTED|Overall Study||372
274623|NCT02150044|658498|P1|NOT COMPLETED|Overall Study||0
274624|NCT02150044|658498|P1|COMPLETED|Overall Study||29
274625|NCT02150044|658498|P1|Study Cohort|Overall Study||13
274626|NCT02150044|658498|P1|Lead-In Subjects|Overall Study||16
274627|NCT02150044|658498|P1|STARTED|Overall Study||29
274628|NCT02149875|658507|P3|NOT COMPLETED|Overall Study||9
274629|NCT02149875|658508|P2|NOT COMPLETED|Overall Study||8
274630|NCT02149875|658509|P1|NOT COMPLETED|Overall Study||7
274631|NCT02149875|658507|P3|COMPLETED|Overall Study||20
274632|NCT02149875|658508|P2|COMPLETED|Overall Study||20
274633|NCT02149875|658509|P1|COMPLETED|Overall Study||20
274634|NCT02149875|658507|P3|STARTED|Overall Study||29
274635|NCT02149875|658508|P2|STARTED|Overall Study||28
274636|NCT02149875|658509|P1|STARTED|Overall Study||27
274637|NCT02149342|658520|P1|NOT COMPLETED|Overall Study||0
274638|NCT02149342|658520|P1|COMPLETED|Overall Study|14 patients|14
274639|NCT02149342|658520|P1|STARTED|Overall Study|14 patients|14
274640|NCT02149303|658532|P1|NOT COMPLETED|Overall Study||0
274641|NCT02149303|658532|P1|COMPLETED|Overall Study||191
274642|NCT02149303|658532|P1|STARTED|Overall Study||191
274643|NCT02148809|658538|P1|NOT COMPLETED|Overall Study||0
274644|NCT02148809|658538|P1|COMPLETED|Overall Study||14
274645|NCT02148809|658538|P1|STARTED|Overall Study||14
274646|NCT02148523|658546|P3|NOT COMPLETED|Overall Study||0
274647|NCT02148523|658547|P2|NOT COMPLETED|Overall Study||0
274648|NCT02148523|658548|P1|NOT COMPLETED|Overall Study||0
274649|NCT02148523|658546|P3|COMPLETED|Overall Study||67
274650|NCT02148523|658547|P2|COMPLETED|Overall Study||67
274651|NCT02148523|658548|P1|COMPLETED|Overall Study||67
274652|NCT02148523|658546|P3|STARTED|Overall Study||67
274653|NCT02148523|658547|P2|STARTED|Overall Study||67
274654|NCT02148523|658548|P1|STARTED|Overall Study||67
274655|NCT02148107|658559|P3|NOT COMPLETED|Overall Study||0
274656|NCT02148107|658560|P2|NOT COMPLETED|Overall Study||0
274657|NCT02148107|658561|P1|NOT COMPLETED|Overall Study||0
274658|NCT02148107|658559|P3|COMPLETED|Overall Study||3
274659|NCT02148107|658560|P2|COMPLETED|Overall Study||7
274660|NCT02148107|658561|P1|COMPLETED|Overall Study||8
274661|NCT02148107|658559|P3|STARTED|Overall Study||3
274662|NCT02148107|658560|P2|STARTED|Overall Study||7
274663|NCT02148107|658561|P1|STARTED|Overall Study||8
274664|NCT02147691|658579|P2|NOT COMPLETED|Overall Study||1
274665|NCT02147691|658580|P1|NOT COMPLETED|Overall Study||4
274666|NCT02147691|658579|P2|COMPLETED|Overall Study||11
274667|NCT02147691|658580|P1|COMPLETED|Overall Study||6
274668|NCT02147691|658579|P2|STARTED|Overall Study||12
274669|NCT02147691|658580|P1|STARTED|Overall Study||10
274670|NCT02147561|658624|P1|NOT COMPLETED|Overall Study||4
274671|NCT02147561|658624|P1|COMPLETED|Overall Study||276
274672|NCT02147561|658624|P1|STARTED|Overall Study||280
274673|NCT02147288|658632|P10|NOT COMPLETED|Overall Study||0
274674|NCT02147288|658633|P9|NOT COMPLETED|Overall Study||0
274675|NCT02147288|658634|P8|NOT COMPLETED|Overall Study||0
274676|NCT02147288|658635|P7|NOT COMPLETED|Overall Study||0
274677|NCT02147288|658636|P6|NOT COMPLETED|Overall Study||0
274678|NCT02147288|658637|P5|NOT COMPLETED|Overall Study||0
274679|NCT02147288|658638|P4|NOT COMPLETED|Overall Study||0
274680|NCT02147288|658639|P3|NOT COMPLETED|Overall Study||0
274681|NCT02147288|658640|P2|NOT COMPLETED|Overall Study||2
274682|NCT02147288|658641|P1|NOT COMPLETED|Overall Study||1
274683|NCT02147288|658632|P10|COMPLETED|Overall Study||0
274684|NCT02147288|658633|P9|COMPLETED|Overall Study||0
274685|NCT02147288|658634|P8|COMPLETED|Overall Study||0
274686|NCT02147288|658635|P7|COMPLETED|Overall Study||0
274687|NCT02147288|658636|P6|COMPLETED|Overall Study||0
274688|NCT02147288|658637|P5|COMPLETED|Overall Study||0
274689|NCT02147288|658638|P4|COMPLETED|Overall Study||0
274690|NCT02147288|658639|P3|COMPLETED|Overall Study||0
274691|NCT02147288|658640|P2|COMPLETED|Overall Study||22
274692|NCT02147288|658641|P1|COMPLETED|Overall Study||21
274693|NCT02147288|658632|P10|STARTED|Overall Study||0
274694|NCT02147288|658633|P9|STARTED|Overall Study||0
274695|NCT02147288|658634|P8|STARTED|Overall Study||0
274696|NCT02147288|658635|P7|STARTED|Overall Study||0
274697|NCT02147288|658636|P6|STARTED|Overall Study||0
274698|NCT02147288|658637|P5|STARTED|Overall Study||0
274699|NCT02147288|658638|P4|STARTED|Overall Study||0
274700|NCT02147288|658639|P3|STARTED|Overall Study||0
274701|NCT02147288|658640|P2|STARTED|Overall Study||24
274702|NCT02147288|658641|P1|STARTED|Overall Study||22
274703|NCT02147093|658649|P2|NOT COMPLETED|Period 2||0
274704|NCT02147093|658650|P1|NOT COMPLETED|Period 2||2
274705|NCT02147093|658649|P2|COMPLETED|Period 2||19
274706|NCT02147093|658650|P1|COMPLETED|Period 2||18
274707|NCT02147093|658649|P2|STARTED|Period 2||19
274708|NCT02147093|658650|P1|STARTED|Period 2||20
274709|NCT02147093|658649|P2|NOT COMPLETED|Period 1||1
274710|NCT02147093|658650|P1|NOT COMPLETED|Period 1||0
274711|NCT02147093|658649|P2|COMPLETED|Period 1||19
274712|NCT02147093|658650|P1|COMPLETED|Period 1||20
274713|NCT02147093|658649|P2|STARTED|Period 1||20
274714|NCT02147093|658650|P1|STARTED|Period 1||20
274715|NCT02146599|658658|P1|NOT COMPLETED|Overall Study||5
274716|NCT02146599|658658|P1|COMPLETED|Overall Study||296
274717|NCT02146599|658658|P1|STARTED|Overall Study||301
274718|NCT02146482|658664|P2|NOT COMPLETED|Overall Study||0
274719|NCT02146482|658665|P1|NOT COMPLETED|Overall Study||0
274720|NCT02146482|658664|P2|COMPLETED|Overall Study||25
274721|NCT02146482|658665|P1|COMPLETED|Overall Study||21
274722|NCT02146482|658664|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
274723|NCT02146482|658665|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
274724|NCT02146352|658671|P1|NOT COMPLETED|Overall Study||2
274725|NCT02146352|658671|P1|COMPLETED|Overall Study||28
274726|NCT02146352|658671|P1|7 Days Post-stent Removal|Overall Study||28
274727|NCT02146352|658671|P1|30 or 60 Days Post-procedure|Overall Study||30
274728|NCT02146352|658671|P1|STARTED|Overall Study||30
274729|NCT02146326|658689|P4|NOT COMPLETED|Overall Study||48
274730|NCT02146326|658690|P3|NOT COMPLETED|Overall Study||43
274731|NCT02146326|658691|P2|NOT COMPLETED|Overall Study||37
274732|NCT02146326|658692|P1|NOT COMPLETED|Overall Study||28
274733|NCT02146326|658689|P4|COMPLETED|Overall Study||210
274734|NCT02146326|658690|P3|COMPLETED|Overall Study||168
274735|NCT02146326|658691|P2|COMPLETED|Overall Study||66
274736|NCT02146326|658692|P1|COMPLETED|Overall Study||61
274737|NCT02146326|658689|P4|12 Months|Overall Study||210
274738|NCT02146326|658690|P3|12 Months|Overall Study||168
274739|NCT02146326|658691|P2|12 Months|Overall Study||66
274740|NCT02146326|658692|P1|12 Months|Overall Study||61
274741|NCT02146326|658689|P4|6 Months|Overall Study||235
274742|NCT02146326|658690|P3|6 Months|Overall Study||186
274743|NCT02146326|658691|P2|6 Months|Overall Study||71
274744|NCT02146326|658692|P1|6 Months|Overall Study||71
274745|NCT02146326|658689|P4|3 Months|Overall Study||0
274746|NCT02146326|658690|P3|3 Months|Overall Study||0
274747|NCT02146326|658691|P2|3 Months|Overall Study||83
274748|NCT02146326|658692|P1|3 Months|Overall Study||71
274749|NCT02146326|658689|P4|Baseline|Overall Study||258
274750|NCT02146326|658690|P3|Baseline|Overall Study||211
274751|NCT02146326|658691|P2|Baseline|Overall Study||103
274752|NCT02146326|658692|P1|Baseline|Overall Study||89
274753|NCT02146326|658689|P4|STARTED|Overall Study||258
274754|NCT02146326|658690|P3|STARTED|Overall Study||211
274755|NCT02146326|658691|P2|STARTED|Overall Study||103
274756|NCT02146326|658692|P1|STARTED|Overall Study||89
274757|NCT02146248|658854|P1|NOT COMPLETED|Overall Study||2
274758|NCT02146248|658854|P1|COMPLETED|Overall Study||9
274759|NCT02146248|658854|P1|HSG 5|Overall Study||1
274760|NCT02146248|658854|P1|HSG 4|Overall Study||7
274761|NCT02146248|658854|P1|HSG 3|Overall Study||9
274762|NCT02146248|658854|P1|HSG 2|Overall Study||10
274763|NCT02146248|658854|P1|HSG 1|Overall Study||10
274764|NCT02146248|658854|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
274765|NCT02146248|658854|P1|Enrolled|Overall Study||11
274766|NCT02146248|658854|P1|STARTED|Overall Study||11
274767|NCT02146105|658862|P1|NOT COMPLETED|Overall Study||6
274768|NCT02146105|658862|P1|COMPLETED|Overall Study||39
274769|NCT02146105|658862|P1|STARTED|Overall Study||45
274770|NCT02146001|658868|P2|NOT COMPLETED|Overall Study||0
274771|NCT02146001|658869|P1|NOT COMPLETED|Overall Study||0
274772|NCT02146001|658868|P2|COMPLETED|Overall Study||19
274773|NCT02146001|658869|P1|COMPLETED|Overall Study||19
274774|NCT02146001|658868|P2|STARTED|Overall Study||19
274775|NCT02146001|658869|P1|STARTED|Overall Study||19
274776|NCT02145754|658879|P1|NOT COMPLETED|Overall Study||0
274777|NCT02145754|658879|P1|COMPLETED|Overall Study||235
274778|NCT02145754|658879|P1|STARTED|Overall Study||235
274779|NCT02145676|658886|P3|NOT COMPLETED|Overall Study||0
274780|NCT02145676|658887|P2|NOT COMPLETED|Overall Study||0
274781|NCT02145676|658888|P1|NOT COMPLETED|Overall Study||0
274782|NCT02145676|658886|P3|COMPLETED|Overall Study||18
274783|NCT02145676|658887|P2|COMPLETED|Overall Study||18
274784|NCT02145676|658888|P1|COMPLETED|Overall Study||17
274785|NCT02145676|658886|P3|STARTED|Overall Study||18
274786|NCT02145676|658887|P2|STARTED|Overall Study||18
274787|NCT02145676|658888|P1|STARTED|Overall Study||17
274788|NCT02145468|658913|P2|NOT COMPLETED|Overall Study||8
274789|NCT02145468|658914|P1|NOT COMPLETED|Overall Study||5
274790|NCT02145468|658913|P2|COMPLETED|Overall Study||1723
274791|NCT02145468|658914|P1|COMPLETED|Overall Study||1753
274792|NCT02145468|658913|P2|STARTED|Overall Study||1731
274793|NCT02145468|658914|P1|STARTED|Overall Study||1758
274794|NCT02145299|658972|P2|NOT COMPLETED|Overall Study||0
274795|NCT02145299|658973|P1|NOT COMPLETED|Overall Study||0
274796|NCT02145299|658972|P2|COMPLETED|Overall Study||2
274797|NCT02145299|658973|P1|COMPLETED|Overall Study||6
274798|NCT02145299|658972|P2|STARTED|Overall Study||2
274799|NCT02145299|658973|P1|STARTED|Overall Study||6
274800|NCT02145156|659002|P3|NOT COMPLETED|Overall Study||82
274801|NCT02145156|659003|P2|NOT COMPLETED|Overall Study||120
274802|NCT02145156|659004|P1|NOT COMPLETED|Overall Study||93
274803|NCT02145156|659002|P3|COMPLETED|Overall Study||267
274804|NCT02145156|659003|P2|COMPLETED|Overall Study||259
274805|NCT02145156|659004|P1|COMPLETED|Overall Study||280
274806|NCT02145156|659002|P3|STARTED|Overall Study||349
274807|NCT02145156|659003|P2|STARTED|Overall Study||379
274808|NCT02145156|659004|P1|STARTED|Overall Study||373
274809|NCT02144337|659047|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
274810|NCT02144337|659048|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
274811|NCT02144337|659047|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
274812|NCT02144337|659048|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
274813|NCT02144337|659047|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
274814|NCT02144337|659048|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
274815|NCT02144337|659047|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
274816|NCT02144337|659048|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
274817|NCT02144337|659047|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
274818|NCT02144337|659048|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
274819|NCT02144337|659047|P2|STARTED|T2 Follow-up (Post-intervention)||5
274820|NCT02144337|659048|P1|STARTED|T2 Follow-up (Post-intervention)||8
274821|NCT02144337|659047|P2|NOT COMPLETED|Baseline 0 Months||0
274822|NCT02144337|659048|P1|NOT COMPLETED|Baseline 0 Months||0
274823|NCT02144337|659047|P2|COMPLETED|Baseline 0 Months||5
274824|NCT02144337|659048|P1|COMPLETED|Baseline 0 Months||8
274825|NCT02144337|659047|P2|STARTED|Baseline 0 Months||5
274826|NCT02144337|659048|P1|STARTED|Baseline 0 Months||8
274827|NCT02144259|659061|P3|NOT COMPLETED|Overall Study||18
274828|NCT02144259|659062|P2|NOT COMPLETED|Overall Study||5
274829|NCT02144259|659063|P1|NOT COMPLETED|Overall Study||10
274830|NCT02144259|659061|P3|COMPLETED|Overall Study||16
274831|NCT02144259|659062|P2|COMPLETED|Overall Study||28
274832|NCT02144259|659063|P1|COMPLETED|Overall Study||23
274833|NCT02144259|659061|P3|STARTED|Overall Study||34
274834|NCT02144259|659062|P2|STARTED|Overall Study||33
274835|NCT02144259|659063|P1|STARTED|Overall Study||33
274836|NCT02144220|659077|P1|NOT COMPLETED|Overall Study||19
274837|NCT02144220|659077|P1|COMPLETED|Overall Study||258
274838|NCT02144220|659077|P1|STARTED|Overall Study||277
274839|NCT02144012|659087|P2|NOT COMPLETED|Overall Study||15
274840|NCT02144012|659088|P1|NOT COMPLETED|Overall Study||34
274841|NCT02144012|659087|P2|COMPLETED|Overall Study||0
274842|NCT02144012|659088|P1|COMPLETED|Overall Study||0
274843|NCT02144012|659087|P2|STARTED|Overall Study||15
274844|NCT02144012|659088|P1|STARTED|Overall Study||34
274845|NCT02143947|659125|P2|NOT COMPLETED|Overall Study||2
274846|NCT02143947|659126|P1|NOT COMPLETED|Overall Study||4
274847|NCT02143947|659125|P2|COMPLETED|Overall Study||42
274848|NCT02143947|659126|P1|COMPLETED|Overall Study||32
274849|NCT02143947|659125|P2|STARTED|Overall Study||44
274850|NCT02143947|659126|P1|STARTED|Overall Study||36
274851|NCT02143583|659141|P3|NOT COMPLETED|Overall Study||2
274852|NCT02143583|659142|P2|NOT COMPLETED|Overall Study||0
274853|NCT02143583|659143|P1|NOT COMPLETED|Overall Study||1
274854|NCT02143583|659141|P3|COMPLETED|Overall Study||66
274855|NCT02143583|659142|P2|COMPLETED|Overall Study||66
274856|NCT02143583|659143|P1|COMPLETED|Overall Study||61
274857|NCT02143583|659141|P3|STARTED|Overall Study||68
274858|NCT02143583|659142|P2|STARTED|Overall Study||66
274859|NCT02143583|659143|P1|STARTED|Overall Study||62
274860|NCT02142712|659157|P4|NOT COMPLETED|Overall Study||0
274861|NCT02142712|659158|P3|NOT COMPLETED|Overall Study||1
274862|NCT02142712|659159|P2|NOT COMPLETED|Overall Study||1
274863|NCT02142712|659160|P1|NOT COMPLETED|Overall Study||1
274864|NCT02142712|659157|P4|COMPLETED|Overall Study||0
274865|NCT02142712|659158|P3|COMPLETED|Overall Study||0
274866|NCT02142712|659159|P2|COMPLETED|Overall Study||0
274867|NCT02142712|659160|P1|COMPLETED|Overall Study||0
274868|NCT02142712|659157|P4|STARTED|Overall Study||0
274869|NCT02142712|659158|P3|STARTED|Overall Study||1
274870|NCT02142712|659159|P2|STARTED|Overall Study||1
274871|NCT02142712|659160|P1|STARTED|Overall Study||1
274872|NCT02142504|659183|P3|NOT COMPLETED|Overall Study||43
274873|NCT02142504|659184|P2|NOT COMPLETED|Overall Study||42
274874|NCT02142504|659185|P1|NOT COMPLETED|Overall Study||31
274875|NCT02142504|659183|P3|COMPLETED|Overall Study||111
274876|NCT02142504|659184|P2|COMPLETED|Overall Study||105
274877|NCT02142504|659185|P1|COMPLETED|Overall Study||122
274878|NCT02142504|659183|P3|Received Booster (Second Vaccination)|Overall Study||116
274879|NCT02142504|659184|P2|Received Booster (Second Vaccination)|Overall Study||109
274880|NCT02142504|659185|P1|Received Booster (Second Vaccination)|Overall Study||126
274881|NCT02142504|659183|P3|Randomized and Received Treatment|Overall Study||154
274882|NCT02142504|659184|P2|Randomized and Received Treatment|Overall Study||145
274883|NCT02142504|659185|P1|Randomized and Received Treatment|Overall Study||153
274884|NCT02142504|659183|P3|STARTED|Overall Study||154
274885|NCT02142504|659184|P2|STARTED|Overall Study||147
274886|NCT02142504|659185|P1|STARTED|Overall Study||153
274887|NCT02142361|659271|P3|NOT COMPLETED|Overall Study||0
274888|NCT02142361|659272|P2|NOT COMPLETED|Overall Study||0
274889|NCT02142361|659273|P1|NOT COMPLETED|Overall Study||0
274890|NCT02142361|659271|P3|COMPLETED|Overall Study||20
274891|NCT02142361|659272|P2|COMPLETED|Overall Study||20
274892|NCT02142361|659273|P1|COMPLETED|Overall Study||20
274893|NCT02142361|659271|P3|STARTED|Overall Study||20
274894|NCT02142361|659272|P2|STARTED|Overall Study||20
274895|NCT02142361|659273|P1|STARTED|Overall Study||20
274896|NCT02142153|659382|P10|NOT COMPLETED|Overall Study||0
274897|NCT02142153|659383|P9|NOT COMPLETED|Overall Study||0
274898|NCT02142153|659384|P8|NOT COMPLETED|Overall Study||0
274899|NCT02142153|659385|P7|NOT COMPLETED|Overall Study||0
274900|NCT02142153|659386|P6|NOT COMPLETED|Overall Study||0
274901|NCT02142153|659387|P5|NOT COMPLETED|Overall Study||0
274902|NCT02142153|659388|P4|NOT COMPLETED|Overall Study||0
274903|NCT02142153|659389|P3|NOT COMPLETED|Overall Study||0
274904|NCT02142153|659390|P2|NOT COMPLETED|Overall Study||0
274905|NCT02142153|659391|P1|NOT COMPLETED|Overall Study||0
274906|NCT02142153|659382|P10|COMPLETED|Overall Study||2
274907|NCT02142153|659383|P9|COMPLETED|Overall Study||6
274908|NCT02142153|659384|P8|COMPLETED|Overall Study||2
274909|NCT02142153|659385|P7|COMPLETED|Overall Study||6
274910|NCT02142153|659386|P6|COMPLETED|Overall Study||2
274911|NCT02142153|659387|P5|COMPLETED|Overall Study||6
274912|NCT02142153|659388|P4|COMPLETED|Overall Study||2
274913|NCT02142153|659389|P3|COMPLETED|Overall Study||6
274914|NCT02142153|659390|P2|COMPLETED|Overall Study||2
274915|NCT02142153|659391|P1|COMPLETED|Overall Study||6
274916|NCT02142153|659382|P10|STARTED|Overall Study||2
274917|NCT02142153|659383|P9|STARTED|Overall Study||6
274918|NCT02142153|659384|P8|STARTED|Overall Study||2
274919|NCT02142153|659385|P7|STARTED|Overall Study||6
274920|NCT02142153|659386|P6|STARTED|Overall Study||2
274921|NCT02142153|659387|P5|STARTED|Overall Study||6
274922|NCT02142153|659388|P4|STARTED|Overall Study||2
274923|NCT02142153|659389|P3|STARTED|Overall Study||6
274924|NCT02142153|659390|P2|STARTED|Overall Study||2
274925|NCT02142153|659391|P1|STARTED|Overall Study||6
274926|NCT02141997|659427|P4|NOT COMPLETED|Overall Study||1
274927|NCT02141997|659428|P3|NOT COMPLETED|Overall Study||3
274928|NCT02141997|659429|P2|NOT COMPLETED|Overall Study||6
274929|NCT02141997|659430|P1|NOT COMPLETED|Overall Study||3
274930|NCT02141997|659427|P4|COMPLETED|Overall Study||54
274931|NCT02141997|659428|P3|COMPLETED|Overall Study||53
274932|NCT02141997|659429|P2|COMPLETED|Overall Study||49
274933|NCT02141997|659430|P1|COMPLETED|Overall Study||53
274934|NCT02141997|659427|P4|STARTED|Overall Study||55
274935|NCT02141997|659428|P3|STARTED|Overall Study||56
274936|NCT02141997|659429|P2|STARTED|Overall Study||55
274937|NCT02141997|659430|P1|STARTED|Overall Study||56
274938|NCT02141867|659468|P1|NOT COMPLETED|Overall Study||94
274939|NCT02141867|659468|P1|COMPLETED|Overall Study||3927
274940|NCT02141867|659468|P1|STARTED|Overall Study||4021
274941|NCT02141854|659480|P6|NOT COMPLETED|Treatment Period||38
274942|NCT02141854|659481|P5|NOT COMPLETED|Treatment Period||10
274943|NCT02141854|659482|P4|NOT COMPLETED|Treatment Period||11
274944|NCT02141854|659483|P3|NOT COMPLETED|Treatment Period||9
274945|NCT02141854|659484|P2|NOT COMPLETED|Treatment Period||10
274946|NCT02141854|659485|P1|NOT COMPLETED|Treatment Period||0
274947|NCT02141854|659480|P6|COMPLETED|Treatment Period||107
274948|NCT02141854|659481|P5|COMPLETED|Treatment Period||136
274949|NCT02141854|659482|P4|COMPLETED|Treatment Period||135
274950|NCT02141854|659483|P3|COMPLETED|Treatment Period||136
274951|NCT02141854|659484|P2|COMPLETED|Treatment Period||136
274952|NCT02141854|659485|P1|COMPLETED|Treatment Period||0
274953|NCT02141854|659480|P6|Full Analysis Set|Treatment Period||143
274954|NCT02141854|659481|P5|Full Analysis Set|Treatment Period||145
274955|NCT02141854|659482|P4|Full Analysis Set|Treatment Period||146
274956|NCT02141854|659483|P3|Full Analysis Set|Treatment Period||141
274957|NCT02141854|659484|P2|Full Analysis Set|Treatment Period||145
274958|NCT02141854|659485|P1|Full Analysis Set|Treatment Period||0
274959|NCT02141854|659480|P6|Safety Population|Treatment Period||144
274960|NCT02141854|659481|P5|Safety Population|Treatment Period||145
274961|NCT02141854|659482|P4|Safety Population|Treatment Period||146
274962|NCT02141854|659483|P3|Safety Population|Treatment Period||143
274963|NCT02141854|659484|P2|Safety Population|Treatment Period||145
274964|NCT02141854|659485|P1|Safety Population|Treatment Period||0
274965|NCT02141854|659480|P6|Intent to Treat Population|Treatment Period||145
274966|NCT02141854|659481|P5|Intent to Treat Population|Treatment Period||146
274967|NCT02141854|659482|P4|Intent to Treat Population|Treatment Period||146
274968|NCT02141854|659483|P3|Intent to Treat Population|Treatment Period||145
274969|NCT02141854|659484|P2|Intent to Treat Population|Treatment Period||146
274970|NCT02141854|659485|P1|Intent to Treat Population|Treatment Period||0
274971|NCT02141854|659480|P6|STARTED|Treatment Period||145
274972|NCT02141854|659481|P5|STARTED|Treatment Period||146
274973|NCT02141854|659482|P4|STARTED|Treatment Period||146
274974|NCT02141854|659483|P3|STARTED|Treatment Period||145
274975|NCT02141854|659484|P2|STARTED|Treatment Period||146
274976|NCT02141854|659485|P1|STARTED|Treatment Period||0
274977|NCT02141854|659480|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
274978|NCT02141854|659481|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
274979|NCT02141854|659482|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
274980|NCT02141854|659483|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
274981|NCT02141854|659484|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
274982|NCT02141854|659485|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
274983|NCT02141854|659480|P6|COMPLETED|Run-In Period (Pre-assignment)||0
274984|NCT02141854|659481|P5|COMPLETED|Run-In Period (Pre-assignment)||0
274985|NCT02141854|659482|P4|COMPLETED|Run-In Period (Pre-assignment)||0
274986|NCT02141854|659483|P3|COMPLETED|Run-In Period (Pre-assignment)||0
274987|NCT02141854|659484|P2|COMPLETED|Run-In Period (Pre-assignment)||0
274988|NCT02141854|659485|P1|COMPLETED|Run-In Period (Pre-assignment)||728
274989|NCT02141854|659480|P6|STARTED|Run-In Period (Pre-assignment)||0
274990|NCT02141854|659481|P5|STARTED|Run-In Period (Pre-assignment)||0
274991|NCT02141854|659482|P4|STARTED|Run-In Period (Pre-assignment)||0
274992|NCT02141854|659483|P3|STARTED|Run-In Period (Pre-assignment)||0
274993|NCT02141854|659484|P2|STARTED|Run-In Period (Pre-assignment)||0
274994|NCT02141854|659485|P1|STARTED|Run-In Period (Pre-assignment)||882
274995|NCT02141633|659539|P2|NOT COMPLETED|Overall Study||0
274996|NCT02141633|659540|P1|NOT COMPLETED|Overall Study||1
274997|NCT02141633|659539|P2|COMPLETED|Overall Study||15
274998|NCT02141633|659540|P1|COMPLETED|Overall Study||15
274999|NCT02141633|659539|P2|STARTED|Overall Study||15
275000|NCT02141633|659540|P1|STARTED|Overall Study||16
275001|NCT02141620|659548|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
275002|NCT02141620|659549|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
275003|NCT02141620|659548|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
275004|NCT02141620|659549|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
275005|NCT02141620|659548|P2|STARTED|Treatment Condition 2 (7 Days)||7
275006|NCT02141620|659549|P1|STARTED|Treatment Condition 2 (7 Days)||7
275007|NCT02141620|659548|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
275008|NCT02141620|659549|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
275009|NCT02141620|659548|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
275010|NCT02141620|659549|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
275011|NCT02141620|659548|P2|STARTED|Treatment Condition 1 (7 Days)||7
275012|NCT02141620|659549|P1|STARTED|Treatment Condition 1 (7 Days)||8
275013|NCT02141581|659610|P3|NOT COMPLETED|Overall Study||0
275014|NCT02141581|659611|P2|NOT COMPLETED|Overall Study||0
275015|NCT02141581|659612|P1|NOT COMPLETED|Overall Study||0
275016|NCT02141581|659610|P3|COMPLETED|Overall Study||25
275017|NCT02141581|659611|P2|COMPLETED|Overall Study||19
275018|NCT02141581|659612|P1|COMPLETED|Overall Study||42
275019|NCT02141581|659610|P3|STARTED|Overall Study||25
275020|NCT02141581|659611|P2|STARTED|Overall Study||19
275021|NCT02141581|659612|P1|STARTED|Overall Study||42
275022|NCT02141516|659626|P3|NOT COMPLETED|Overall Study||0
275023|NCT02141516|659627|P2|NOT COMPLETED|Overall Study||5
275024|NCT02141516|659628|P1|NOT COMPLETED|Overall Study||0
275025|NCT02141516|659626|P3|COMPLETED|Overall Study||87
275026|NCT02141516|659627|P2|COMPLETED|Overall Study||107
275027|NCT02141516|659628|P1|COMPLETED|Overall Study||40
275028|NCT02141516|659626|P3|STARTED|Overall Study||87
275029|NCT02141516|659627|P2|STARTED|Overall Study||112
275030|NCT02141516|659628|P1|STARTED|Overall Study||40
275031|NCT02141217|659678|P2|NOT COMPLETED|Overall Study||8
275032|NCT02141217|659679|P1|NOT COMPLETED|Overall Study||11
275033|NCT02141217|659678|P2|COMPLETED|Overall Study||229
275034|NCT02141217|659679|P1|COMPLETED|Overall Study||223
275035|NCT02141217|659678|P2|ITT Population-Actual Treatment Received|Overall Study||235
275036|NCT02141217|659679|P1|ITT Population-Actual Treatment Received|Overall Study||236
275037|NCT02141217|659678|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
275038|NCT02141217|659679|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
275039|NCT02141217|659678|P2|STARTED|Overall Study||237
275040|NCT02141217|659679|P1|STARTED|Overall Study||234
275041|NCT02140957|659699|P2|NOT COMPLETED|Overall Study||23
275042|NCT02140957|659700|P1|NOT COMPLETED|Overall Study||27
275043|NCT02140957|659699|P2|COMPLETED|Overall Study||99
275044|NCT02140957|659700|P1|COMPLETED|Overall Study||102
275045|NCT02140957|659699|P2|STARTED|Overall Study||122
275046|NCT02140957|659700|P1|STARTED|Overall Study||129
275047|NCT02140788|659710|P4|NOT COMPLETED|Overall Study||0
275048|NCT02140788|659711|P3|NOT COMPLETED|Overall Study||0
275049|NCT02140788|659712|P2|NOT COMPLETED|Overall Study||0
275050|NCT02140788|659713|P1|NOT COMPLETED|Overall Study||0
275051|NCT02140788|659710|P4|COMPLETED|Overall Study||0
275052|NCT02140788|659711|P3|COMPLETED|Overall Study||0
275053|NCT02140788|659712|P2|COMPLETED|Overall Study||0
275054|NCT02140788|659713|P1|COMPLETED|Overall Study||0
275055|NCT02140788|659710|P4|STARTED|Overall Study||0
275056|NCT02140788|659711|P3|STARTED|Overall Study||0
275057|NCT02140788|659712|P2|STARTED|Overall Study||0
275058|NCT02140788|659713|P1|STARTED|Overall Study||0
275059|NCT02140645|659745|P6|NOT COMPLETED|Overall Study||70896
275060|NCT02140645|659746|P5|NOT COMPLETED|Overall Study||3286
275061|NCT02140645|659747|P4|NOT COMPLETED|Overall Study||13833
275062|NCT02140645|659748|P3|NOT COMPLETED|Overall Study||4236
275063|NCT02140645|659749|P2|NOT COMPLETED|Overall Study||61654
275064|NCT02140645|659750|P1|NOT COMPLETED|Overall Study||5489
275065|NCT02140645|659745|P6|COMPLETED|Overall Study||3050
275066|NCT02140645|659746|P5|COMPLETED|Overall Study||150
275067|NCT02140645|659747|P4|COMPLETED|Overall Study||530
275068|NCT02140645|659748|P3|COMPLETED|Overall Study||205
275069|NCT02140645|659749|P2|COMPLETED|Overall Study||3041
275070|NCT02140645|659750|P1|COMPLETED|Overall Study||243
275071|NCT02140645|659745|P6|STARTED|Overall Study||73946
275072|NCT02140645|659746|P5|STARTED|Overall Study||3436
275073|NCT02140645|659747|P4|STARTED|Overall Study||14363
275074|NCT02140645|659748|P3|STARTED|Overall Study||4441
275075|NCT02140645|659749|P2|STARTED|Overall Study||64695
275076|NCT02140645|659750|P1|STARTED|Overall Study||5732
275077|NCT02140593|659839|P2|NOT COMPLETED|Overall Study||0
275078|NCT02140593|659840|P1|NOT COMPLETED|Overall Study||0
275079|NCT02140593|659839|P2|COMPLETED|Overall Study||65
275080|NCT02140593|659840|P1|COMPLETED|Overall Study||63
275081|NCT02140593|659839|P2|STARTED|Overall Study||65
275082|NCT02140593|659840|P1|STARTED|Overall Study||63
275083|NCT02140372|659848|P1|NOT COMPLETED|Overall Study||0
275084|NCT02140372|659848|P1|COMPLETED|Overall Study||10
275085|NCT02140372|659848|P1|STARTED|Overall Study||10
275086|NCT02140164|659859|P1|NOT COMPLETED|Overall Study||2
275087|NCT02140164|659859|P1|COMPLETED|Overall Study||5
275088|NCT02140164|659859|P1|STARTED|Overall Study||7
275089|NCT02140060|659876|P6|NOT COMPLETED|Overall Study||1
275090|NCT02140060|659877|P5|NOT COMPLETED|Overall Study||1
275091|NCT02140060|659878|P4|NOT COMPLETED|Overall Study||2
275092|NCT02140060|659879|P3|NOT COMPLETED|Overall Study||0
275093|NCT02140060|659880|P2|NOT COMPLETED|Overall Study||0
275094|NCT02140060|659881|P1|NOT COMPLETED|Overall Study||0
275095|NCT02140060|659876|P6|COMPLETED|Overall Study||43
275096|NCT02140060|659877|P5|COMPLETED|Overall Study||44
275097|NCT02140060|659878|P4|COMPLETED|Overall Study||43
275098|NCT02140060|659879|P3|COMPLETED|Overall Study||44
275099|NCT02140060|659880|P2|COMPLETED|Overall Study||44
275100|NCT02140060|659881|P1|COMPLETED|Overall Study||44
275101|NCT02140060|659876|P6|STARTED|Overall Study||44
275102|NCT02140060|659877|P5|STARTED|Overall Study||45
275103|NCT02140060|659878|P4|STARTED|Overall Study||45
275104|NCT02140060|659879|P3|STARTED|Overall Study||44
275105|NCT02140060|659880|P2|STARTED|Overall Study||44
275106|NCT02140060|659881|P1|STARTED|Overall Study||44
275107|NCT02139982|659906|P10|NOT COMPLETED|Overall Study||0
275108|NCT02139982|659907|P9|NOT COMPLETED|Overall Study||0
275109|NCT02139982|659908|P8|NOT COMPLETED|Overall Study||0
275110|NCT02139982|659909|P7|NOT COMPLETED|Overall Study||0
275111|NCT02139982|659910|P6|NOT COMPLETED|Overall Study||0
275112|NCT02139982|659911|P5|NOT COMPLETED|Overall Study||0
275113|NCT02139982|659912|P4|NOT COMPLETED|Overall Study||1
275114|NCT02139982|659913|P3|NOT COMPLETED|Overall Study||0
275115|NCT02139982|659914|P2|NOT COMPLETED|Overall Study||1
275116|NCT02139982|659915|P1|NOT COMPLETED|Overall Study||0
275117|NCT02139982|659906|P10|COMPLETED|Overall Study||13
275118|NCT02139982|659907|P9|COMPLETED|Overall Study||13
275119|NCT02139982|659908|P8|COMPLETED|Overall Study||13
275120|NCT02139982|659909|P7|COMPLETED|Overall Study||13
275121|NCT02139982|659910|P6|COMPLETED|Overall Study||13
275122|NCT02139982|659911|P5|COMPLETED|Overall Study||13
275123|NCT02139982|659912|P4|COMPLETED|Overall Study||7
275124|NCT02139982|659913|P3|COMPLETED|Overall Study||8
275125|NCT02139982|659914|P2|COMPLETED|Overall Study||7
275126|NCT02139982|659915|P1|COMPLETED|Overall Study||8
275127|NCT02139982|659906|P10|STARTED|Overall Study||13
275128|NCT02139982|659907|P9|STARTED|Overall Study||13
275129|NCT02139982|659908|P8|STARTED|Overall Study||13
275130|NCT02139982|659909|P7|STARTED|Overall Study||13
275131|NCT02139982|659910|P6|STARTED|Overall Study||13
275132|NCT02139982|659911|P5|STARTED|Overall Study||13
275133|NCT02139982|659912|P4|STARTED|Overall Study||8
275134|NCT02139982|659913|P3|STARTED|Overall Study||8
275135|NCT02139982|659914|P2|STARTED|Overall Study||8
275136|NCT02139982|659915|P1|STARTED|Overall Study||8
275137|NCT02139943|659960|P3|NOT COMPLETED|Overall Study||7
275138|NCT02139943|659961|P2|NOT COMPLETED|Overall Study||6
275139|NCT02139943|659962|P1|NOT COMPLETED|Overall Study||10
275140|NCT02139943|659960|P3|COMPLETED|Overall Study||110
275141|NCT02139943|659961|P2|COMPLETED|Overall Study||111
275142|NCT02139943|659962|P1|COMPLETED|Overall Study||107
275143|NCT02139943|659960|P3|STARTED|Overall Study||117
275144|NCT02139943|659961|P2|STARTED|Overall Study||117
275145|NCT02139943|659962|P1|STARTED|Overall Study||117
275146|NCT02139878|659973|P2|NOT COMPLETED|Second Intervention (7 Days)||0
275147|NCT02139878|659974|P1|NOT COMPLETED|Second Intervention (7 Days)||0
275148|NCT02139878|659973|P2|COMPLETED|Second Intervention (7 Days)||10
275149|NCT02139878|659974|P1|COMPLETED|Second Intervention (7 Days)||9
275150|NCT02139878|659973|P2|STARTED|Second Intervention (7 Days)||10
275151|NCT02139878|659974|P1|STARTED|Second Intervention (7 Days)||9
275152|NCT02139878|659973|P2|NOT COMPLETED|Washout Period (8 Days)||0
275153|NCT02139878|659974|P1|NOT COMPLETED|Washout Period (8 Days)||0
275154|NCT02139878|659973|P2|COMPLETED|Washout Period (8 Days)||10
275155|NCT02139878|659974|P1|COMPLETED|Washout Period (8 Days)||9
275156|NCT02139878|659973|P2|STARTED|Washout Period (8 Days)||10
275157|NCT02139878|659974|P1|STARTED|Washout Period (8 Days)||9
275158|NCT02139878|659973|P2|NOT COMPLETED|First Intervention (7 Days)||0
275159|NCT02139878|659974|P1|NOT COMPLETED|First Intervention (7 Days)||1
275160|NCT02139878|659973|P2|COMPLETED|First Intervention (7 Days)||10
275161|NCT02139878|659974|P1|COMPLETED|First Intervention (7 Days)||9
275162|NCT02139878|659973|P2|STARTED|First Intervention (7 Days)||10
275163|NCT02139878|659974|P1|STARTED|First Intervention (7 Days)||10
275164|NCT02139644|659987|P6|NOT COMPLETED|Treatment Period||17
275165|NCT02139644|659988|P5|NOT COMPLETED|Treatment Period||8
275166|NCT02139644|659989|P4|NOT COMPLETED|Treatment Period||9
275167|NCT02139644|659990|P3|NOT COMPLETED|Treatment Period||8
275168|NCT02139644|659991|P2|NOT COMPLETED|Treatment Period||3
275169|NCT02139644|659992|P1|NOT COMPLETED|Treatment Period||0
275170|NCT02139644|659987|P6|COMPLETED|Treatment Period||113
275171|NCT02139644|659988|P5|COMPLETED|Treatment Period||121
275172|NCT02139644|659989|P4|COMPLETED|Treatment Period||121
275173|NCT02139644|659990|P3|COMPLETED|Treatment Period||121
275174|NCT02139644|659991|P2|COMPLETED|Treatment Period||126
275175|NCT02139644|659992|P1|COMPLETED|Treatment Period||0
275176|NCT02139644|659987|P6|STARTED|Treatment Period|Randomized|130
275177|NCT02139644|659988|P5|STARTED|Treatment Period|Randomized|129
275178|NCT02139644|659989|P4|STARTED|Treatment Period|Randomized|130
275179|NCT02139644|659990|P3|STARTED|Treatment Period|Randomized|129
275180|NCT02139644|659991|P2|STARTED|Treatment Period|Randomized|129
275181|NCT02139644|659992|P1|STARTED|Treatment Period||0
275182|NCT02139644|659987|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
275183|NCT02139644|659988|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
275184|NCT02139644|659989|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
275185|NCT02139644|659990|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
275186|NCT02139644|659991|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
275187|NCT02139644|659992|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
275188|NCT02139644|659987|P6|COMPLETED|Run-In Period (Pre-assignment)||0
275189|NCT02139644|659988|P5|COMPLETED|Run-In Period (Pre-assignment)||0
275190|NCT02139644|659989|P4|COMPLETED|Run-In Period (Pre-assignment)||0
275191|NCT02139644|659990|P3|COMPLETED|Run-In Period (Pre-assignment)||0
275192|NCT02139644|659991|P2|COMPLETED|Run-In Period (Pre-assignment)||0
275193|NCT02139644|659992|P1|COMPLETED|Run-In Period (Pre-assignment)||647
275194|NCT02139644|659987|P6|STARTED|Run-In Period (Pre-assignment)||0
275195|NCT02139644|659988|P5|STARTED|Run-In Period (Pre-assignment)||0
275196|NCT02139644|659989|P4|STARTED|Run-In Period (Pre-assignment)||0
275197|NCT02139644|659990|P3|STARTED|Run-In Period (Pre-assignment)||0
275198|NCT02139644|659991|P2|STARTED|Run-In Period (Pre-assignment)||0
275199|NCT02139644|659992|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
275200|NCT02139228|660046|P2|NOT COMPLETED|Overall Study||0
275201|NCT02139228|660047|P1|NOT COMPLETED|Overall Study||0
275202|NCT02139228|660046|P2|COMPLETED|Overall Study||211
275203|NCT02139228|660047|P1|COMPLETED|Overall Study||215
275204|NCT02139228|660046|P2|STARTED|Overall Study||211
275205|NCT02139228|660047|P1|STARTED|Overall Study||215
275206|NCT02139137|660057|P2|NOT COMPLETED|Overall Study||10
275207|NCT02139137|660058|P1|NOT COMPLETED|Overall Study||7
275208|NCT02139137|660057|P2|COMPLETED|Overall Study||10
275209|NCT02139137|660058|P1|COMPLETED|Overall Study||15
275210|NCT02139137|660057|P2|STARTED|Overall Study||20
275211|NCT02139137|660058|P1|STARTED|Overall Study||22
275212|NCT02139046|660077|P5|NOT COMPLETED|Overall Study||57
275213|NCT02139046|660078|P4|NOT COMPLETED|Overall Study||68
275214|NCT02139046|660079|P3|NOT COMPLETED|Overall Study||59
275215|NCT02139046|660080|P2|NOT COMPLETED|Overall Study||54
275216|NCT02139046|660081|P1|NOT COMPLETED|Overall Study||62
275217|NCT02139046|660077|P5|COMPLETED|Overall Study||301
275218|NCT02139046|660078|P4|COMPLETED|Overall Study||290
275219|NCT02139046|660079|P3|COMPLETED|Overall Study||298
275220|NCT02139046|660080|P2|COMPLETED|Overall Study||305
275221|NCT02139046|660081|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
275222|NCT02139046|660077|P5|Full Analysis Set|Overall Study||357
275223|NCT02139046|660078|P4|Full Analysis Set|Overall Study||357
275224|NCT02139046|660079|P3|Full Analysis Set|Overall Study||355
275225|NCT02139046|660080|P2|Full Analysis Set|Overall Study||357
275226|NCT02139046|660081|P1|Full Analysis Set|Overall Study||357
275227|NCT02139046|660077|P5|Safety Analysis Set|Overall Study||357
275228|NCT02139046|660078|P4|Safety Analysis Set|Overall Study||357
275229|NCT02139046|660079|P3|Safety Analysis Set|Overall Study||355
275230|NCT02139046|660080|P2|Safety Analysis Set|Overall Study||358
275231|NCT02139046|660081|P1|Safety Analysis Set|Overall Study||356
275232|NCT02139046|660077|P5|STARTED|Overall Study||358
275233|NCT02139046|660078|P4|STARTED|Overall Study||358
275234|NCT02139046|660079|P3|STARTED|Overall Study||357
275235|NCT02139046|660080|P2|STARTED|Overall Study||359
275236|NCT02139046|660081|P1|STARTED|Overall Study||358
275237|NCT02139007|660105|P2|NOT COMPLETED|Patient Participant Recruitment||1
275238|NCT02139007|660106|P1|NOT COMPLETED|Patient Participant Recruitment||2
275239|NCT02139007|660105|P2|COMPLETED|Patient Participant Recruitment||13
275240|NCT02139007|660106|P1|COMPLETED|Patient Participant Recruitment||11
275241|NCT02139007|660105|P2|STARTED|Patient Participant Recruitment||14
275242|NCT02139007|660106|P1|STARTED|Patient Participant Recruitment||13
275243|NCT02139007|660105|P2|NOT COMPLETED|Study Site Recruitment||4
275244|NCT02139007|660106|P1|NOT COMPLETED|Study Site Recruitment||3
275245|NCT02139007|660105|P2|COMPLETED|Study Site Recruitment||1
275246|NCT02139007|660106|P1|COMPLETED|Study Site Recruitment||1
275247|NCT02139007|660105|P2|STARTED|Study Site Recruitment||5
275248|NCT02139007|660106|P1|STARTED|Study Site Recruitment||4
275249|NCT02138825|660121|P2|NOT COMPLETED|Long-term Extension||0
275250|NCT02138825|660122|P1|NOT COMPLETED|Long-term Extension||0
275251|NCT02138825|660121|P2|COMPLETED|Long-term Extension||38
275252|NCT02138825|660122|P1|COMPLETED|Long-term Extension||32
275253|NCT02138825|660121|P2|STARTED|Long-term Extension||38
275254|NCT02138825|660122|P1|STARTED|Long-term Extension||32
275255|NCT02138825|660121|P2|NOT COMPLETED|Main Study Treatment||35
275256|NCT02138825|660122|P1|NOT COMPLETED|Main Study Treatment||40
275257|NCT02138825|660121|P2|COMPLETED|Main Study Treatment||39
275258|NCT02138825|660122|P1|COMPLETED|Main Study Treatment||33
275259|NCT02138825|660121|P2|STARTED|Main Study Treatment|safety population|74
275260|NCT02138825|660122|P1|STARTED|Main Study Treatment|safety population|73
275261|NCT02138747|660134|P4|NOT COMPLETED|Treatment Period 2||3
275262|NCT02138747|660135|P3|NOT COMPLETED|Treatment Period 2||2
275263|NCT02138747|660136|P2|NOT COMPLETED|Treatment Period 2||7
275264|NCT02138747|660137|P1|NOT COMPLETED|Treatment Period 2||17
275265|NCT02138747|660134|P4|COMPLETED|Treatment Period 2||24
275266|NCT02138747|660135|P3|COMPLETED|Treatment Period 2||24
275267|NCT02138747|660136|P2|COMPLETED|Treatment Period 2||125
275268|NCT02138747|660137|P1|COMPLETED|Treatment Period 2||121
275269|NCT02138747|660134|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
275270|NCT02138747|660135|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
275271|NCT02138747|660136|P2|STARTED|Treatment Period 2||132
275272|NCT02138747|660137|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
275273|NCT02138747|660134|P4|NOT COMPLETED|Treatment Period 1||4
275274|NCT02138747|660135|P3|NOT COMPLETED|Treatment Period 1||4
275275|NCT02138747|660136|P2|NOT COMPLETED|Treatment Period 1||25
275276|NCT02138747|660137|P1|NOT COMPLETED|Treatment Period 1||20
275277|NCT02138747|660134|P4|COMPLETED|Treatment Period 1||28
275278|NCT02138747|660135|P3|COMPLETED|Treatment Period 1||27
275279|NCT02138747|660136|P2|COMPLETED|Treatment Period 1||132
275280|NCT02138747|660137|P1|COMPLETED|Treatment Period 1||136
275281|NCT02138747|660134|P4|STARTED|Treatment Period 1||32
275282|NCT02138747|660135|P3|STARTED|Treatment Period 1||31
275283|NCT02138747|660136|P2|STARTED|Treatment Period 1||157
275284|NCT02138747|660137|P1|STARTED|Treatment Period 1||156
275285|NCT02138461|660171|P2|NOT COMPLETED|Overall Study||0
275286|NCT02138461|660172|P1|NOT COMPLETED|Overall Study||0
275287|NCT02138461|660171|P2|COMPLETED|Overall Study||110
275288|NCT02138461|660172|P1|COMPLETED|Overall Study||101
275289|NCT02138461|660171|P2|STARTED|Overall Study||110
275290|NCT02138461|660172|P1|STARTED|Overall Study||101
275291|NCT02138097|660196|P2|NOT COMPLETED|Overall Study||0
275292|NCT02138097|660197|P1|NOT COMPLETED|Overall Study||0
275293|NCT02138097|660196|P2|COMPLETED|Overall Study||459722
275294|NCT02138097|660197|P1|COMPLETED|Overall Study||155345
275295|NCT02138097|660196|P2|STARTED|Overall Study||459722
275296|NCT02138097|660197|P1|STARTED|Overall Study||155345
275297|NCT02138006|660389|P2|NOT COMPLETED|Overall Study||0
275298|NCT02138006|660390|P1|NOT COMPLETED|Overall Study||0
275299|NCT02138006|660389|P2|COMPLETED|Overall Study||54
275300|NCT02138006|660390|P1|COMPLETED|Overall Study||48
275301|NCT02138006|660389|P2|STARTED|Overall Study||54
275302|NCT02138006|660390|P1|STARTED|Overall Study||48
275303|NCT02137785|660400|P2|NOT COMPLETED|Overall Study||4
275304|NCT02137785|660401|P1|NOT COMPLETED|Overall Study||3
275305|NCT02137785|660400|P2|COMPLETED|Overall Study||130
275306|NCT02137785|660401|P1|COMPLETED|Overall Study||132
275307|NCT02137785|660400|P2|STARTED|Overall Study||134
275308|NCT02137785|660401|P1|STARTED|Overall Study||135
275309|NCT02137603|660509|P2|NOT COMPLETED|Overall Study||0
275310|NCT02137603|660510|P1|NOT COMPLETED|Overall Study||2
275311|NCT02137603|660509|P2|COMPLETED|Overall Study||18
275312|NCT02137603|660510|P1|COMPLETED|Overall Study||16
275313|NCT02137603|660509|P2|STARTED|Overall Study||18
275314|NCT02137603|660510|P1|STARTED|Overall Study||18
275315|NCT02137512|660518|P1|NOT COMPLETED|Overall Study||0
275316|NCT02137512|660518|P1|COMPLETED|Overall Study||30
275317|NCT02137512|660518|P1|STARTED|Overall Study||30
275318|NCT02137447|660534|P1|NOT COMPLETED|Overall Study||0
275319|NCT02137447|660534|P1|COMPLETED|Overall Study||10
275320|NCT02137447|660534|P1|STARTED|Overall Study||10
275321|NCT02137382|660539|P2|NOT COMPLETED|Cross-over Period 2||0
275322|NCT02137382|660540|P1|NOT COMPLETED|Cross-over Period 2||0
275323|NCT02137382|660539|P2|COMPLETED|Cross-over Period 2||21
275324|NCT02137382|660540|P1|COMPLETED|Cross-over Period 2||18
275325|NCT02137382|660539|P2|STARTED|Cross-over Period 2||21
275326|NCT02137382|660540|P1|STARTED|Cross-over Period 2||18
275327|NCT02137382|660539|P2|NOT COMPLETED|Wash Out||0
275328|NCT02137382|660540|P1|NOT COMPLETED|Wash Out||0
275329|NCT02137382|660539|P2|COMPLETED|Wash Out||21
275330|NCT02137382|660540|P1|COMPLETED|Wash Out||18
275331|NCT02137382|660539|P2|STARTED|Wash Out||21
275332|NCT02137382|660540|P1|STARTED|Wash Out||18
275333|NCT02137382|660539|P2|NOT COMPLETED|Cross-over Period 1||0
275334|NCT02137382|660540|P1|NOT COMPLETED|Cross-over Period 1||2
275335|NCT02137382|660539|P2|COMPLETED|Cross-over Period 1||21
275336|NCT02137382|660540|P1|COMPLETED|Cross-over Period 1||18
275337|NCT02137382|660539|P2|STARTED|Cross-over Period 1||21
275338|NCT02137382|660540|P1|STARTED|Cross-over Period 1||20
275339|NCT02136498|660560|P2|NOT COMPLETED|Overall Study||0
275340|NCT02136498|660561|P1|NOT COMPLETED|Overall Study||0
275341|NCT02136498|660560|P2|COMPLETED|Overall Study||33
275342|NCT02136498|660561|P1|COMPLETED|Overall Study||33
275343|NCT02136498|660560|P2|STARTED|Overall Study||33
275344|NCT02136498|660561|P1|STARTED|Overall Study||33
275345|NCT02136238|660571|P3|NOT COMPLETED|Overall Study||0
275346|NCT02136238|660572|P2|NOT COMPLETED|Overall Study||0
275347|NCT02136238|660573|P1|NOT COMPLETED|Overall Study||0
275348|NCT02136238|660571|P3|COMPLETED|Overall Study||10
275349|NCT02136238|660572|P2|COMPLETED|Overall Study||4
275350|NCT02136238|660573|P1|COMPLETED|Overall Study||4
275351|NCT02136238|660571|P3|STARTED|Overall Study||10
275352|NCT02136238|660572|P2|STARTED|Overall Study||4
275353|NCT02136238|660573|P1|STARTED|Overall Study||4
275354|NCT02136134|660586|P2|NOT COMPLETED|Overall Study||251
275355|NCT02136134|660587|P1|NOT COMPLETED|Overall Study||247
275356|NCT02136134|660586|P2|COMPLETED|Overall Study||0
275357|NCT02136134|660587|P1|COMPLETED|Overall Study||0
275358|NCT02136134|660586|P2|Treated|Overall Study||243
275359|NCT02136134|660587|P1|Treated|Overall Study||237
275360|NCT02136134|660586|P2|STARTED|Overall Study||251
275361|NCT02136134|660587|P1|STARTED|Overall Study||247
275362|NCT02136004|660605|P1|NOT COMPLETED|Overall Study||1
275363|NCT02136004|660605|P1|COMPLETED|Overall Study||219
275364|NCT02136004|660605|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
275365|NCT02135900|660616|P1|NOT COMPLETED|Overall Study||0
275366|NCT02135900|660616|P1|COMPLETED|Overall Study||32
275367|NCT02135900|660616|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
275368|NCT02135445|660625|P2|NOT COMPLETED|Overall Study||0
275369|NCT02135445|660626|P1|NOT COMPLETED|Overall Study||2
275370|NCT02135445|660625|P2|COMPLETED|Overall Study||38
275371|NCT02135445|660626|P1|COMPLETED|Overall Study||63
275372|NCT02135445|660625|P2|STARTED|Overall Study||38
275373|NCT02135445|660626|P1|STARTED|Overall Study||65
275374|NCT02135432|660677|P2|NOT COMPLETED|Overall Study||0
275375|NCT02135432|660678|P1|NOT COMPLETED|Overall Study||0
275376|NCT02135432|660677|P2|COMPLETED|Overall Study||4
275377|NCT02135432|660678|P1|COMPLETED|Overall Study||8
275378|NCT02135432|660677|P2|STARTED|Overall Study||4
275379|NCT02135432|660678|P1|STARTED|Overall Study||8
275380|NCT02135016|660693|P3|NOT COMPLETED|Overall Study||0
275381|NCT02135016|660694|P2|NOT COMPLETED|Overall Study||0
275382|NCT02135016|660695|P1|NOT COMPLETED|Overall Study||0
275383|NCT02135016|660693|P3|COMPLETED|Overall Study||15
275384|NCT02135016|660694|P2|COMPLETED|Overall Study||15
275385|NCT02135016|660695|P1|COMPLETED|Overall Study||15
275386|NCT02135016|660693|P3|STARTED|Overall Study||15
275387|NCT02135016|660694|P2|STARTED|Overall Study||15
275388|NCT02135016|660695|P1|STARTED|Overall Study||15
275389|NCT02134977|660715|P1|NOT COMPLETED|Overall Study||102
275390|NCT02134977|660715|P1|COMPLETED|Overall Study||2714
275391|NCT02134977|660715|P1|STARTED|Overall Study||2816
275392|NCT02134587|660736|P1|NOT COMPLETED|Overall Study||30
275393|NCT02134587|660736|P1|COMPLETED|Overall Study||173
275394|NCT02134587|660736|P1|STARTED|Overall Study||203
275395|NCT02134184|660748|P3|NOT COMPLETED|Overall Study||0
275396|NCT02134184|660749|P2|NOT COMPLETED|Overall Study||0
275397|NCT02134184|660750|P1|NOT COMPLETED|Overall Study||0
275398|NCT02134184|660748|P3|COMPLETED|Overall Study||8
275399|NCT02134184|660749|P2|COMPLETED|Overall Study||37
275400|NCT02134184|660750|P1|COMPLETED|Overall Study||33
275401|NCT02134184|660748|P3|STARTED|Overall Study||8
275402|NCT02134184|660749|P2|STARTED|Overall Study||37
275403|NCT02134184|660750|P1|STARTED|Overall Study||33
275404|NCT02134119|660763|P2|NOT COMPLETED|Overall Study||0
275405|NCT02134119|660764|P1|NOT COMPLETED|Overall Study||0
275406|NCT02134119|660763|P2|COMPLETED|Overall Study||15
275407|NCT02134119|660764|P1|COMPLETED|Overall Study||30
275408|NCT02134119|660763|P2|STARTED|Overall Study||15
275409|NCT02134119|660764|P1|STARTED|Overall Study||30
275410|NCT02133781|660805|P3|NOT COMPLETED|Overall Study||0
275411|NCT02133781|660806|P2|NOT COMPLETED|Overall Study||0
275412|NCT02133781|660807|P1|NOT COMPLETED|Overall Study||0
275413|NCT02133781|660805|P3|COMPLETED|Overall Study||21
275414|NCT02133781|660806|P2|COMPLETED|Overall Study||24
275415|NCT02133781|660807|P1|COMPLETED|Overall Study||6
275416|NCT02133781|660805|P3|STARTED|Overall Study||21
275417|NCT02133781|660806|P2|STARTED|Overall Study||24
275418|NCT02133781|660807|P1|STARTED|Overall Study||6
275419|NCT02133664|660820|P2|NOT COMPLETED|Overall Study||7
275420|NCT02133664|660821|P1|NOT COMPLETED|Overall Study||5
275421|NCT02133664|660820|P2|COMPLETED|Overall Study||21
275422|NCT02133664|660821|P1|COMPLETED|Overall Study||21
275423|NCT02133664|660820|P2|STARTED|Overall Study||28
275424|NCT02133664|660821|P1|STARTED|Overall Study||26
275425|NCT02133534|660833|P1|NOT COMPLETED|Overall Study||0
275426|NCT02133534|660833|P1|COMPLETED|Overall Study||1
275427|NCT02133534|660833|P1|STARTED|Overall Study||1
275428|NCT02133352|660837|P1|NOT COMPLETED|Longer Term Extension||6
275429|NCT02133352|660837|P1|COMPLETED|Longer Term Extension||4
275430|NCT02133352|660837|P1|STARTED|Longer Term Extension||10
275431|NCT02133352|660837|P1|NOT COMPLETED|Main Study (180 Day)||0
275432|NCT02133352|660837|P1|COMPLETED|Main Study (180 Day)||10
275433|NCT02133352|660837|P1|STARTED|Main Study (180 Day)||10
275434|NCT02133235|660848|P2|NOT COMPLETED|Overall Study||0
275435|NCT02133235|660849|P1|NOT COMPLETED|Overall Study||0
275436|NCT02133235|660848|P2|COMPLETED|Overall Study||57
275437|NCT02133235|660849|P1|COMPLETED|Overall Study||55
275438|NCT02133235|660848|P2|STARTED|Overall Study||57
275439|NCT02133235|660849|P1|STARTED|Overall Study||55
275440|NCT02133131|660868|P7|NOT COMPLETED|Overall Study||12
275441|NCT02133131|660869|P6|NOT COMPLETED|Overall Study||14
275442|NCT02133131|660870|P5|NOT COMPLETED|Overall Study||15
275443|NCT02133131|660871|P4|NOT COMPLETED|Overall Study||6
275444|NCT02133131|660872|P3|NOT COMPLETED|Overall Study||1
275445|NCT02133131|660873|P2|NOT COMPLETED|Overall Study||5
275446|NCT02133131|660874|P1|NOT COMPLETED|Overall Study||5
275447|NCT02133131|660868|P7|COMPLETED|Overall Study||0
275448|NCT02133131|660869|P6|COMPLETED|Overall Study||0
275449|NCT02133131|660870|P5|COMPLETED|Overall Study||0
275450|NCT02133131|660871|P4|COMPLETED|Overall Study||15
275451|NCT02133131|660872|P3|COMPLETED|Overall Study||19
275452|NCT02133131|660873|P2|COMPLETED|Overall Study||25
275453|NCT02133131|660874|P1|COMPLETED|Overall Study||26
275454|NCT02133131|660868|P7|STARTED|Overall Study||12
275455|NCT02133131|660869|P6|STARTED|Overall Study||14
275456|NCT02133131|660870|P5|STARTED|Overall Study||15
275457|NCT02133131|660871|P4|STARTED|Overall Study||21
275458|NCT02133131|660872|P3|STARTED|Overall Study||20
275459|NCT02133131|660873|P2|STARTED|Overall Study||30
275460|NCT02133131|660874|P1|STARTED|Overall Study||31
275461|NCT02132949|660913|P2|NOT COMPLETED|Adjuvant Treatment Period||167
275462|NCT02132949|660914|P1|NOT COMPLETED|Adjuvant Treatment Period||149
275463|NCT02132949|660913|P2|COMPLETED|Adjuvant Treatment Period||23
275464|NCT02132949|660914|P1|COMPLETED|Adjuvant Treatment Period||29
275465|NCT02132949|660913|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
275466|NCT02132949|660914|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
275467|NCT02132949|660913|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
275468|NCT02132949|660914|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
275469|NCT02132949|660913|P2|COMPLETED|Neoadjuvant Treatment Period||189
275470|NCT02132949|660914|P1|COMPLETED|Neoadjuvant Treatment Period||182
275471|NCT02132949|660913|P2|No Treatment|Neoadjuvant Treatment Period||3
275472|NCT02132949|660914|P1|No Treatment|Neoadjuvant Treatment Period||1
275473|NCT02132949|660913|P2|STARTED|Neoadjuvant Treatment Period||201
275474|NCT02132949|660914|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
275475|NCT02132936|660946|P4|NOT COMPLETED|Overall Study||14
275476|NCT02132936|660947|P3|NOT COMPLETED|Overall Study||14
275477|NCT02132936|660948|P2|NOT COMPLETED|Overall Study||9
275478|NCT02132936|660949|P1|NOT COMPLETED|Overall Study||10
275479|NCT02132936|660946|P4|COMPLETED|Overall Study||29
275480|NCT02132936|660947|P3|COMPLETED|Overall Study||174
275481|NCT02132936|660948|P2|COMPLETED|Overall Study||38
275482|NCT02132936|660949|P1|COMPLETED|Overall Study||175
275483|NCT02132936|660946|P4|STARTED|Overall Study||43
275484|NCT02132936|660947|P3|STARTED|Overall Study||188
275485|NCT02132936|660948|P2|STARTED|Overall Study||47
275486|NCT02132936|660949|P1|STARTED|Overall Study||185
275487|NCT02132832|660967|P2|NOT COMPLETED|Overall Study||7
275488|NCT02132832|660968|P1|NOT COMPLETED|Overall Study||3
275489|NCT02132832|660967|P2|COMPLETED|Overall Study||16
275490|NCT02132832|660968|P1|COMPLETED|Overall Study||16
275491|NCT02132832|660967|P2|STARTED|Overall Study||23
275492|NCT02132832|660968|P1|STARTED|Overall Study||19
275493|NCT02132767|660998|P2|NOT COMPLETED|Overall Study||15
275494|NCT02132767|660999|P1|NOT COMPLETED|Overall Study||17
275495|NCT02132767|660998|P2|COMPLETED|Overall Study||246
275496|NCT02132767|660999|P1|COMPLETED|Overall Study||245
275497|NCT02132767|660998|P2|STARTED|Overall Study||261
275498|NCT02132767|660999|P1|STARTED|Overall Study||262
275499|NCT02132611|661019|P1|NOT COMPLETED|Overall Study||2
275500|NCT02132611|661019|P1|COMPLETED|Overall Study||98
275501|NCT02132611|661019|P1|STARTED|Overall Study||100
275502|NCT02132572|661024|P1|NOT COMPLETED|Overall Study||0
275503|NCT02132572|661024|P1|COMPLETED|Overall Study||201
275504|NCT02132572|661024|P1|STARTED|Overall Study||201
275505|NCT02132117|661030|P2|NOT COMPLETED|Overall Study||5
275506|NCT02132117|661031|P1|NOT COMPLETED|Overall Study||11
275507|NCT02132117|661030|P2|COMPLETED|Overall Study||216
275508|NCT02132117|661031|P1|COMPLETED|Overall Study||213
275509|NCT02132117|661030|P2|STARTED|Overall Study||221
275510|NCT02132117|661031|P1|STARTED|Overall Study||224
275511|NCT02131636|661049|P2|NOT COMPLETED|Overall Study||5
275512|NCT02131636|661050|P1|NOT COMPLETED|Overall Study||12
275513|NCT02131636|661049|P2|COMPLETED|Overall Study||213
275514|NCT02131636|661050|P1|COMPLETED|Overall Study||210
275515|NCT02131636|661049|P2|STARTED|Overall Study||218
275516|NCT02131636|661050|P1|STARTED|Overall Study||222
275517|NCT02131532|661066|P1|NOT COMPLETED|Overall Study||4
275518|NCT02131532|661066|P1|COMPLETED|Overall Study||8
275519|NCT02131532|661066|P1|STARTED|Overall Study||12
275520|NCT02131402|661085|P1|NOT COMPLETED|Overall Study||0
275521|NCT02131402|661085|P1|COMPLETED|Overall Study||60
275522|NCT02131402|661085|P1|STARTED|Overall Study||60
275523|NCT02131311|661156|P1|NOT COMPLETED|Overall Study||4
275524|NCT02131311|661156|P1|COMPLETED|Overall Study||86
275525|NCT02131311|661156|P1|STARTED|Overall Study||90
275526|NCT02131233|661168|P2|NOT COMPLETED|Overall Study||27
275527|NCT02131233|661169|P1|NOT COMPLETED|Overall Study||43
275528|NCT02131233|661168|P2|COMPLETED|Overall Study|Completed to Week 48|242
275529|NCT02131233|661169|P1|COMPLETED|Overall Study|Completed to Week 48|490
275530|NCT02131233|661168|P2|Treated|Overall Study||266
275531|NCT02131233|661169|P1|Treated|Overall Study||531
275532|NCT02131233|661168|P2|STARTED|Overall Study|Enrolled participants|269
275533|NCT02131233|661169|P1|STARTED|Overall Study|Enrolled participants|533
275534|NCT02131064|661189|P2|NOT COMPLETED|Overall Study||223
275535|NCT02131064|661190|P1|NOT COMPLETED|Overall Study||221
275536|NCT02131064|661189|P2|COMPLETED|Overall Study||0
275537|NCT02131064|661190|P1|COMPLETED|Overall Study||0
275538|NCT02131064|661189|P2|STARTED|Overall Study||223
275539|NCT02131064|661190|P1|STARTED|Overall Study||221
275540|NCT02130999|661222|P2|NOT COMPLETED|Overall Study||0
275541|NCT02130999|661223|P1|NOT COMPLETED|Overall Study||0
275542|NCT02130999|661222|P2|COMPLETED|Overall Study||8
275543|NCT02130999|661223|P1|COMPLETED|Overall Study||6
275544|NCT02130999|661222|P2|STARTED|Overall Study||8
275545|NCT02130999|661223|P1|STARTED|Overall Study||6
275546|NCT02130284|661249|P1|NOT COMPLETED|Overall Study||9
275547|NCT02130284|661249|P1|COMPLETED|Overall Study||71
275548|NCT02130284|661249|P1|STARTED|Overall Study||80
275549|NCT02130193|661262|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
275550|NCT02130193|661263|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
275551|NCT02130193|661264|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
275552|NCT02130193|661262|P3|COMPLETED|Part B: 52-week Double-blind Period||37
275553|NCT02130193|661263|P2|COMPLETED|Part B: 52-week Double-blind Period||38
275554|NCT02130193|661264|P1|COMPLETED|Part B: 52-week Double-blind Period||0
275555|NCT02130193|661262|P3|STARTED|Part B: 52-week Double-blind Period||45
275556|NCT02130193|661263|P2|STARTED|Part B: 52-week Double-blind Period||48
275557|NCT02130193|661264|P1|STARTED|Part B: 52-week Double-blind Period||0
275558|NCT02130193|661262|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
275559|NCT02130193|661263|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
275560|NCT02130193|661264|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
275561|NCT02130193|661262|P3|COMPLETED|Part A: 4-week Open-label Period||0
275562|NCT02130193|661263|P2|COMPLETED|Part A: 4-week Open-label Period||0
275563|NCT02130193|661264|P1|COMPLETED|Part A: 4-week Open-label Period||9
275564|NCT02130193|661262|P3|STARTED|Part A: 4-week Open-label Period||0
275565|NCT02130193|661263|P2|STARTED|Part A: 4-week Open-label Period||0
275566|NCT02130193|661264|P1|STARTED|Part A: 4-week Open-label Period||9
275567|NCT02129777|661333|P7|NOT COMPLETED|Open-Label Period||48
275568|NCT02129777|661334|P6|NOT COMPLETED|Open-Label Period||12
275569|NCT02129777|661335|P5|NOT COMPLETED|Open-Label Period||0
275570|NCT02129777|661336|P4|NOT COMPLETED|Open-Label Period||0
275571|NCT02129777|661337|P3|NOT COMPLETED|Open-Label Period||0
275572|NCT02129777|661338|P2|NOT COMPLETED|Open-Label Period||0
275573|NCT02129777|661339|P1|NOT COMPLETED|Open-Label Period||0
275574|NCT02129777|661333|P7|COMPLETED|Open-Label Period||0
275575|NCT02129777|661334|P6|COMPLETED|Open-Label Period||0
275576|NCT02129777|661335|P5|COMPLETED|Open-Label Period||0
275577|NCT02129777|661336|P4|COMPLETED|Open-Label Period||0
275578|NCT02129777|661337|P3|COMPLETED|Open-Label Period||0
275579|NCT02129777|661338|P2|COMPLETED|Open-Label Period||0
275580|NCT02129777|661339|P1|COMPLETED|Open-Label Period||0
275581|NCT02129777|661333|P7|STARTED|Open-Label Period||48
275582|NCT02129777|661334|P6|STARTED|Open-Label Period||12
275583|NCT02129777|661335|P5|STARTED|Open-Label Period||0
275584|NCT02129777|661336|P4|STARTED|Open-Label Period||0
275585|NCT02129777|661337|P3|STARTED|Open-Label Period||0
275586|NCT02129777|661338|P2|STARTED|Open-Label Period||0
275587|NCT02129777|661339|P1|STARTED|Open-Label Period||0
275588|NCT02129777|661333|P7|NOT COMPLETED|Double-Blind Period||0
275589|NCT02129777|661334|P6|NOT COMPLETED|Double-Blind Period||0
275590|NCT02129777|661335|P5|NOT COMPLETED|Double-Blind Period||7
275591|NCT02129777|661336|P4|NOT COMPLETED|Double-Blind Period||7
275592|NCT02129777|661337|P3|NOT COMPLETED|Double-Blind Period||4
275593|NCT02129777|661338|P2|NOT COMPLETED|Double-Blind Period||8
275594|NCT02129777|661339|P1|NOT COMPLETED|Double-Blind Period||7
275595|NCT02129777|661333|P7|COMPLETED|Double-Blind Period||0
275596|NCT02129777|661334|P6|COMPLETED|Double-Blind Period||0
275597|NCT02129777|661335|P5|COMPLETED|Double-Blind Period||18
275598|NCT02129777|661336|P4|COMPLETED|Double-Blind Period||18
275599|NCT02129777|661337|P3|COMPLETED|Double-Blind Period||20
275600|NCT02129777|661338|P2|COMPLETED|Double-Blind Period||16
275601|NCT02129777|661339|P1|COMPLETED|Double-Blind Period||17
275602|NCT02129777|661333|P7|STARTED|Double-Blind Period||0
275603|NCT02129777|661334|P6|STARTED|Double-Blind Period||0
275604|NCT02129777|661335|P5|STARTED|Double-Blind Period||25
275605|NCT02129777|661336|P4|STARTED|Double-Blind Period||25
275606|NCT02129777|661337|P3|STARTED|Double-Blind Period||24
275607|NCT02129777|661338|P2|STARTED|Double-Blind Period||24
275608|NCT02129777|661339|P1|STARTED|Double-Blind Period||24
275609|NCT02129725|661445|P2|NOT COMPLETED|Overall Study||3
275610|NCT02129725|661446|P1|NOT COMPLETED|Overall Study||2
275611|NCT02129725|661445|P2|COMPLETED|Overall Study||4
275612|NCT02129725|661446|P1|COMPLETED|Overall Study||6
275613|NCT02129725|661445|P2|STARTED|Overall Study||7
275614|NCT02129725|661446|P1|STARTED|Overall Study||8
275615|NCT02129608|661455|P3|NOT COMPLETED|Overall Study||3
275616|NCT02129608|661456|P2|NOT COMPLETED|Overall Study||1
275617|NCT02129608|661457|P1|NOT COMPLETED|Overall Study||0
275618|NCT02129608|661455|P3|COMPLETED|Overall Study||12
275619|NCT02129608|661456|P2|COMPLETED|Overall Study||13
275620|NCT02129608|661457|P1|COMPLETED|Overall Study||15
275621|NCT02129608|661455|P3|End of Treatment|Overall Study||12
275622|NCT02129608|661456|P2|End of Treatment|Overall Study||13
275623|NCT02129608|661457|P1|End of Treatment|Overall Study||15
275624|NCT02129608|661455|P3|STARTED|Overall Study||15
275625|NCT02129608|661456|P2|STARTED|Overall Study||14
275626|NCT02129608|661457|P1|STARTED|Overall Study||15
275627|NCT02129192|661470|P2|NOT COMPLETED|Period 5||0
275628|NCT02129192|661471|P1|NOT COMPLETED|Period 5||0
275629|NCT02129192|661470|P2|COMPLETED|Period 5||0
275630|NCT02129192|661471|P1|COMPLETED|Period 5||36
275631|NCT02129192|661470|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
275632|NCT02129192|661471|P1|STARTED|Period 5||36
275633|NCT02129192|661470|P2|NOT COMPLETED|Period 4 Including Washout Period||0
275634|NCT02129192|661471|P1|NOT COMPLETED|Period 4 Including Washout Period||0
275635|NCT02129192|661470|P2|COMPLETED|Period 4 Including Washout Period||35
275636|NCT02129192|661471|P1|COMPLETED|Period 4 Including Washout Period||36
275637|NCT02129192|661470|P2|STARTED|Period 4 Including Washout Period||35
275638|NCT02129192|661471|P1|STARTED|Period 4 Including Washout Period||36
275639|NCT02129192|661470|P2|NOT COMPLETED|Period 3 Including Washout Period||0
275640|NCT02129192|661471|P1|NOT COMPLETED|Period 3 Including Washout Period||0
275641|NCT02129192|661470|P2|COMPLETED|Period 3 Including Washout Period||35
275642|NCT02129192|661471|P1|COMPLETED|Period 3 Including Washout Period||36
275643|NCT02129192|661470|P2|STARTED|Period 3 Including Washout Period||35
275644|NCT02129192|661471|P1|STARTED|Period 3 Including Washout Period||36
275645|NCT02129192|661470|P2|NOT COMPLETED|Period 2 Including Washout Period||0
275646|NCT02129192|661471|P1|NOT COMPLETED|Period 2 Including Washout Period||0
275647|NCT02129192|661470|P2|COMPLETED|Period 2 Including Washout Period||35
275648|NCT02129192|661471|P1|COMPLETED|Period 2 Including Washout Period||36
275649|NCT02129192|661470|P2|STARTED|Period 2 Including Washout Period||35
275650|NCT02129192|661471|P1|STARTED|Period 2 Including Washout Period||36
275651|NCT02129192|661470|P2|NOT COMPLETED|Period 1 Including Washout Period||1
275652|NCT02129192|661471|P1|NOT COMPLETED|Period 1 Including Washout Period||0
275653|NCT02129192|661470|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
275654|NCT02129192|661471|P1|COMPLETED|Period 1 Including Washout Period||36
275655|NCT02129192|661470|P2|STARTED|Period 1 Including Washout Period||36
275656|NCT02129192|661471|P1|STARTED|Period 1 Including Washout Period||36
275657|NCT02129062|661488|P1|NOT COMPLETED|Overall Study||3
275658|NCT02129062|661488|P1|COMPLETED|Overall Study||0
275659|NCT02129062|661488|P1|STARTED|Overall Study||3
275660|NCT02128867|661496|P3|NOT COMPLETED|Overall Study||4
275661|NCT02128867|661497|P2|NOT COMPLETED|Overall Study||2
275662|NCT02128867|661498|P1|NOT COMPLETED|Overall Study||3
275663|NCT02128867|661496|P3|COMPLETED|Overall Study||50
275664|NCT02128867|661497|P2|COMPLETED|Overall Study||50
275665|NCT02128867|661498|P1|COMPLETED|Overall Study||50
275666|NCT02128867|661496|P3|STARTED|Overall Study||54
275667|NCT02128867|661497|P2|STARTED|Overall Study||52
275668|NCT02128867|661498|P1|STARTED|Overall Study||53
275669|NCT02128542|661508|P2|NOT COMPLETED|Overall Study||0
275670|NCT02128542|661509|P1|NOT COMPLETED|Overall Study||4
275671|NCT02128542|661508|P2|COMPLETED|Overall Study||19
275672|NCT02128542|661509|P1|COMPLETED|Overall Study||43
275673|NCT02128542|661508|P2|STARTED|Overall Study||19
275674|NCT02128542|661509|P1|STARTED|Overall Study||47
275675|NCT02128490|661527|P5|NOT COMPLETED|Overall Study||7
275676|NCT02128490|661528|P4|NOT COMPLETED|Overall Study||6
275677|NCT02128490|661529|P3|NOT COMPLETED|Overall Study||5
275678|NCT02128490|661530|P2|NOT COMPLETED|Overall Study||6
275679|NCT02128490|661531|P1|NOT COMPLETED|Overall Study||5
275680|NCT02128490|661527|P5|COMPLETED|Overall Study||31
275681|NCT02128490|661528|P4|COMPLETED|Overall Study||31
275682|NCT02128490|661529|P3|COMPLETED|Overall Study||34
275683|NCT02128490|661530|P2|COMPLETED|Overall Study||31
275684|NCT02128490|661531|P1|COMPLETED|Overall Study||33
275685|NCT02128490|661527|P5|STARTED|Overall Study||38
275686|NCT02128490|661528|P4|STARTED|Overall Study||37
275687|NCT02128490|661529|P3|STARTED|Overall Study||39
275688|NCT02128490|661530|P2|STARTED|Overall Study||37
275689|NCT02128490|661531|P1|STARTED|Overall Study||38
275690|NCT02127567|661553|P1|NOT COMPLETED|Overall Study||0
275691|NCT02127567|661553|P1|COMPLETED|Overall Study||41
275692|NCT02127567|661553|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
275693|NCT02127372|661575|P2|NOT COMPLETED|Overall Study||0
275694|NCT02127372|661576|P1|NOT COMPLETED|Overall Study||1
275695|NCT02127372|661575|P2|COMPLETED|Overall Study||28
275696|NCT02127372|661576|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
275697|NCT02127372|661575|P2|Started Study Treatment|Overall Study||28
275698|NCT02127372|661576|P1|Started Study Treatment|Overall Study||15
275699|NCT02127372|661575|P2|STARTED|Overall Study|Signed Consent|28
275700|NCT02127372|661576|P1|STARTED|Overall Study|Signed Consent|15
275701|NCT02127307|661586|P1|NOT COMPLETED|Overall Study||308
275702|NCT02127307|661586|P1|COMPLETED|Overall Study||656
275703|NCT02127307|661586|P1|STARTED|Overall Study||964
275704|NCT02126839|661592|P2|NOT COMPLETED|Overall Study||14
275705|NCT02126839|661593|P1|NOT COMPLETED|Overall Study||10
275706|NCT02126839|661592|P2|COMPLETED|Overall Study||80
275707|NCT02126839|661593|P1|COMPLETED|Overall Study||82
275708|NCT02126839|661592|P2|Full Analysis Set|Overall Study||92
275709|NCT02126839|661593|P1|Full Analysis Set|Overall Study||92
275710|NCT02126839|661592|P2|Safety Population|Overall Study||93
275711|NCT02126839|661593|P1|Safety Population|Overall Study||92
275712|NCT02126839|661592|P2|STARTED|Overall Study||94
275713|NCT02126839|661593|P1|STARTED|Overall Study||92
275714|NCT02126748|661606|P3|NOT COMPLETED|Overall Study||5
275715|NCT02126748|661607|P2|NOT COMPLETED|Overall Study||3
275716|NCT02126748|661608|P1|NOT COMPLETED|Overall Study||2
275717|NCT02126748|661606|P3|COMPLETED|Overall Study||31
275718|NCT02126748|661607|P2|COMPLETED|Overall Study||31
275719|NCT02126748|661608|P1|COMPLETED|Overall Study||31
275720|NCT02126748|661606|P3|STARTED|Overall Study||36
275721|NCT02126748|661607|P2|STARTED|Overall Study||34
275722|NCT02126748|661608|P1|STARTED|Overall Study||33
275723|NCT02126670|661620|P4|NOT COMPLETED|Overall Study||1
275724|NCT02126670|661621|P3|NOT COMPLETED|Overall Study||0
275725|NCT02126670|661622|P2|NOT COMPLETED|Overall Study||0
275726|NCT02126670|661623|P1|NOT COMPLETED|Overall Study||1
275727|NCT02126670|661620|P4|COMPLETED|Overall Study||24
275728|NCT02126670|661621|P3|COMPLETED|Overall Study||25
275729|NCT02126670|661622|P2|COMPLETED|Overall Study||24
275730|NCT02126670|661623|P1|COMPLETED|Overall Study||25
275731|NCT02126670|661620|P4|STARTED|Overall Study||25
275732|NCT02126670|661621|P3|STARTED|Overall Study||25
275733|NCT02126670|661622|P2|STARTED|Overall Study||24
275734|NCT02126670|661623|P1|STARTED|Overall Study||26
275735|NCT02126319|661639|P2|NOT COMPLETED|Overall Study||24
275736|NCT02126319|661640|P1|NOT COMPLETED|Overall Study||21
275737|NCT02126319|661639|P2|COMPLETED|Overall Study||43
275738|NCT02126319|661640|P1|COMPLETED|Overall Study||40
275739|NCT02126319|661639|P2|STARTED|Overall Study||67
275740|NCT02126319|661640|P1|STARTED|Overall Study||61
275741|NCT02126306|661666|P2|NOT COMPLETED|Overall Study||0
275742|NCT02126306|661667|P1|NOT COMPLETED|Overall Study||0
275743|NCT02126306|661666|P2|COMPLETED|Overall Study||13
275744|NCT02126306|661667|P1|COMPLETED|Overall Study||10
275745|NCT02126306|661666|P2|STARTED|Overall Study||13
275746|NCT02126306|661667|P1|STARTED|Overall Study||10
275747|NCT02125877|661675|P2|NOT COMPLETED|Overall Study||10
275748|NCT02125877|661676|P1|NOT COMPLETED|Overall Study||13
275749|NCT02125877|661675|P2|COMPLETED|Overall Study||77
275750|NCT02125877|661676|P1|COMPLETED|Overall Study||73
275751|NCT02125877|661675|P2|Safety Set|Overall Study||87
275752|NCT02125877|661676|P1|Safety Set|Overall Study||86
275753|NCT02125877|661675|P2|Pharmacokinetic Subset A|Overall Study||15
275754|NCT02125877|661676|P1|Pharmacokinetic Subset A|Overall Study||16
275755|NCT02125877|661675|P2|Pharmacokinetic Analysis Set|Overall Study||83
275756|NCT02125877|661676|P1|Pharmacokinetic Analysis Set|Overall Study||83
275757|NCT02125877|661675|P2|STARTED|Overall Study||87
275758|NCT02125877|661676|P1|STARTED|Overall Study||86
275759|NCT02125838|661706|P2|NOT COMPLETED|Overall Study||4
275760|NCT02125838|661707|P1|NOT COMPLETED|Overall Study||4
275761|NCT02125838|661706|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
275762|NCT02125838|661707|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
275763|NCT02125838|661706|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
275764|NCT02125838|661707|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
275765|NCT02125734|661725|P2|NOT COMPLETED|Period 2||1
275766|NCT02125734|661726|P1|NOT COMPLETED|Period 2||0
275767|NCT02125734|661725|P2|COMPLETED|Period 2||47
275768|NCT02125734|661726|P1|COMPLETED|Period 2||40
275769|NCT02125734|661725|P2|STARTED|Period 2||48
275770|NCT02125734|661726|P1|STARTED|Period 2||40
275771|NCT02125734|661725|P2|NOT COMPLETED|Period 1||0
275772|NCT02125734|661726|P1|NOT COMPLETED|Period 1||0
275773|NCT02125734|661725|P2|COMPLETED|Period 1||48
275774|NCT02125734|661726|P1|COMPLETED|Period 1||40
275775|NCT02125734|661725|P2|STARTED|Period 1||48
275776|NCT02125734|661726|P1|STARTED|Period 1||40
275777|NCT02125604|661736|P1|NOT COMPLETED|Overall Study||31
275778|NCT02125604|661736|P1|COMPLETED|Overall Study||180
275779|NCT02125604|661736|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
275780|NCT02125292|661750|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
275781|NCT02125292|661751|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
275782|NCT02125292|661752|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
275783|NCT02125292|661753|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
275784|NCT02125292|661754|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
275785|NCT02125292|661755|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
275786|NCT02125292|661750|P6|COMPLETED|Third Intervention (1 Hour)||3
275787|NCT02125292|661751|P5|COMPLETED|Third Intervention (1 Hour)||3
275788|NCT02125292|661752|P4|COMPLETED|Third Intervention (1 Hour)||3
275789|NCT02125292|661753|P3|COMPLETED|Third Intervention (1 Hour)||3
275790|NCT02125292|661754|P2|COMPLETED|Third Intervention (1 Hour)||3
275791|NCT02125292|661755|P1|COMPLETED|Third Intervention (1 Hour)||3
275792|NCT02125292|661750|P6|STARTED|Third Intervention (1 Hour)||3
275793|NCT02125292|661751|P5|STARTED|Third Intervention (1 Hour)||3
275794|NCT02125292|661752|P4|STARTED|Third Intervention (1 Hour)||3
275795|NCT02125292|661753|P3|STARTED|Third Intervention (1 Hour)||3
275796|NCT02125292|661754|P2|STARTED|Third Intervention (1 Hour)||3
275797|NCT02125292|661755|P1|STARTED|Third Intervention (1 Hour)||3
275798|NCT02125292|661750|P6|NOT COMPLETED|Washout (2 Hours)||0
275799|NCT02125292|661751|P5|NOT COMPLETED|Washout (2 Hours)||0
275800|NCT02125292|661752|P4|NOT COMPLETED|Washout (2 Hours)||0
275801|NCT02125292|661753|P3|NOT COMPLETED|Washout (2 Hours)||0
275802|NCT02125292|661754|P2|NOT COMPLETED|Washout (2 Hours)||0
275803|NCT02125292|661755|P1|NOT COMPLETED|Washout (2 Hours)||0
275804|NCT02125292|661750|P6|COMPLETED|Washout (2 Hours)||3
275805|NCT02125292|661751|P5|COMPLETED|Washout (2 Hours)||3
275806|NCT02125292|661752|P4|COMPLETED|Washout (2 Hours)||3
275807|NCT02125292|661753|P3|COMPLETED|Washout (2 Hours)||3
275808|NCT02125292|661754|P2|COMPLETED|Washout (2 Hours)||3
275809|NCT02125292|661755|P1|COMPLETED|Washout (2 Hours)||3
275810|NCT02125292|661750|P6|STARTED|Washout (2 Hours)||3
275811|NCT02125292|661751|P5|STARTED|Washout (2 Hours)||3
275812|NCT02125292|661752|P4|STARTED|Washout (2 Hours)||3
275813|NCT02125292|661753|P3|STARTED|Washout (2 Hours)||3
275814|NCT02125292|661754|P2|STARTED|Washout (2 Hours)||3
275815|NCT02125292|661755|P1|STARTED|Washout (2 Hours)||3
275816|NCT02125292|661750|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
275817|NCT02125292|661751|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
275818|NCT02125292|661752|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
275819|NCT02125292|661753|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
275820|NCT02125292|661754|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
275821|NCT02125292|661755|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
275822|NCT02125292|661750|P6|COMPLETED|Second Intervention (1 Hour)||3
275823|NCT02125292|661751|P5|COMPLETED|Second Intervention (1 Hour)||3
275824|NCT02125292|661752|P4|COMPLETED|Second Intervention (1 Hour)||3
275825|NCT02125292|661753|P3|COMPLETED|Second Intervention (1 Hour)||3
275826|NCT02125292|661754|P2|COMPLETED|Second Intervention (1 Hour)||3
275827|NCT02125292|661755|P1|COMPLETED|Second Intervention (1 Hour)||3
275828|NCT02125292|661750|P6|STARTED|Second Intervention (1 Hour)||3
275829|NCT02125292|661751|P5|STARTED|Second Intervention (1 Hour)||3
275830|NCT02125292|661752|P4|STARTED|Second Intervention (1 Hour)||3
275831|NCT02125292|661753|P3|STARTED|Second Intervention (1 Hour)||3
275832|NCT02125292|661754|P2|STARTED|Second Intervention (1 Hour)||3
275833|NCT02125292|661755|P1|STARTED|Second Intervention (1 Hour)||3
275834|NCT02125292|661750|P6|NOT COMPLETED|Washout (2 Hours)||0
275835|NCT02125292|661751|P5|NOT COMPLETED|Washout (2 Hours)||0
275836|NCT02125292|661752|P4|NOT COMPLETED|Washout (2 Hours)||0
275837|NCT02125292|661753|P3|NOT COMPLETED|Washout (2 Hours)||0
275838|NCT02125292|661754|P2|NOT COMPLETED|Washout (2 Hours)||0
275839|NCT02125292|661755|P1|NOT COMPLETED|Washout (2 Hours)||0
275840|NCT02125292|661750|P6|COMPLETED|Washout (2 Hours)||3
275841|NCT02125292|661751|P5|COMPLETED|Washout (2 Hours)||3
275842|NCT02125292|661752|P4|COMPLETED|Washout (2 Hours)||3
275843|NCT02125292|661753|P3|COMPLETED|Washout (2 Hours)||3
275844|NCT02125292|661754|P2|COMPLETED|Washout (2 Hours)||3
275845|NCT02125292|661755|P1|COMPLETED|Washout (2 Hours)||3
275846|NCT02125292|661750|P6|STARTED|Washout (2 Hours)||3
275847|NCT02125292|661751|P5|STARTED|Washout (2 Hours)||3
275848|NCT02125292|661752|P4|STARTED|Washout (2 Hours)||3
275849|NCT02125292|661753|P3|STARTED|Washout (2 Hours)||3
275850|NCT02125292|661754|P2|STARTED|Washout (2 Hours)||3
275851|NCT02125292|661755|P1|STARTED|Washout (2 Hours)||3
275852|NCT02125292|661750|P6|NOT COMPLETED|First Intervention (1 Hour)||0
275853|NCT02125292|661751|P5|NOT COMPLETED|First Intervention (1 Hour)||0
275854|NCT02125292|661752|P4|NOT COMPLETED|First Intervention (1 Hour)||0
275855|NCT02125292|661753|P3|NOT COMPLETED|First Intervention (1 Hour)||0
275856|NCT02125292|661754|P2|NOT COMPLETED|First Intervention (1 Hour)||0
275857|NCT02125292|661755|P1|NOT COMPLETED|First Intervention (1 Hour)||0
275858|NCT02125292|661750|P6|COMPLETED|First Intervention (1 Hour)||3
275859|NCT02125292|661751|P5|COMPLETED|First Intervention (1 Hour)||3
275860|NCT02125292|661752|P4|COMPLETED|First Intervention (1 Hour)||3
275861|NCT02125292|661753|P3|COMPLETED|First Intervention (1 Hour)||3
275862|NCT02125292|661754|P2|COMPLETED|First Intervention (1 Hour)||3
275863|NCT02125292|661755|P1|COMPLETED|First Intervention (1 Hour)||3
275864|NCT02125292|661750|P6|STARTED|First Intervention (1 Hour)||3
275865|NCT02125292|661751|P5|STARTED|First Intervention (1 Hour)||3
275866|NCT02125292|661752|P4|STARTED|First Intervention (1 Hour)||3
275867|NCT02125292|661753|P3|STARTED|First Intervention (1 Hour)||3
275868|NCT02125292|661754|P2|STARTED|First Intervention (1 Hour)||3
275869|NCT02125292|661755|P1|STARTED|First Intervention (1 Hour)||3
275870|NCT02124863|661776|P1|NOT COMPLETED|Overall Study||17
275871|NCT02124863|661776|P1|COMPLETED|Overall Study||50
275872|NCT02124863|661776|P1|STARTED|Overall Study||67
275873|NCT02124798|661782|P1|NOT COMPLETED|Overall Study||4
275874|NCT02124798|661782|P1|COMPLETED|Overall Study||91
275875|NCT02124798|661782|P1|STARTED|Overall Study||95
275876|NCT02124603|661788|P1|NOT COMPLETED|Overall Study||0
275877|NCT02124603|661788|P1|COMPLETED|Overall Study||120
275878|NCT02124603|661788|P1|STARTED|Overall Study||120
275879|NCT02124460|661796|P2|NOT COMPLETED|Overall Study||24
275880|NCT02124460|661797|P1|NOT COMPLETED|Overall Study||33
275881|NCT02124460|661796|P2|COMPLETED|Overall Study||336
275882|NCT02124460|661797|P1|COMPLETED|Overall Study||328
275883|NCT02124460|661796|P2|STARTED|Overall Study||360
275884|NCT02124460|661797|P1|STARTED|Overall Study||361
275885|NCT02124304|661829|P2|NOT COMPLETED|Overall Study||0
275886|NCT02124304|661830|P1|NOT COMPLETED|Overall Study||0
275887|NCT02124304|661829|P2|COMPLETED|Overall Study||15
275888|NCT02124304|661830|P1|COMPLETED|Overall Study||15
275889|NCT02124304|661829|P2|STARTED|Overall Study||15
275890|NCT02124304|661830|P1|STARTED|Overall Study||15
275891|NCT02124161|661840|P2|NOT COMPLETED|Overall Study||15
275892|NCT02124161|661841|P1|NOT COMPLETED|Overall Study||16
275893|NCT02124161|661840|P2|COMPLETED|Overall Study||426
275894|NCT02124161|661841|P1|COMPLETED|Overall Study||425
275895|NCT02124161|661840|P2|Vaccination 2|Overall Study||432
275896|NCT02124161|661841|P1|Vaccination 2|Overall Study||431
275897|NCT02124161|661840|P2|Vaccination 1|Overall Study||437
275898|NCT02124161|661841|P1|Vaccination 1|Overall Study||439
275899|NCT02124161|661840|P2|STARTED|Overall Study||441
275900|NCT02124161|661841|P1|STARTED|Overall Study||441
275901|NCT02124122|661873|P2|NOT COMPLETED|Overall Study||0
275902|NCT02124122|661874|P1|NOT COMPLETED|Overall Study||0
275903|NCT02124122|661873|P2|COMPLETED|Overall Study||19
275904|NCT02124122|661874|P1|COMPLETED|Overall Study||41
275905|NCT02124122|661873|P2|STARTED|Overall Study||19
275906|NCT02124122|661874|P1|STARTED|Overall Study||41
275907|NCT02124044|661884|P2|NOT COMPLETED|Overall Study||1
275908|NCT02124044|661885|P1|NOT COMPLETED|Overall Study||0
275909|NCT02124044|661884|P2|COMPLETED|Overall Study||9
275910|NCT02124044|661885|P1|COMPLETED|Overall Study||20
275911|NCT02124044|661884|P2|STARTED|Overall Study||10
275912|NCT02124044|661885|P1|STARTED|Overall Study||20
275913|NCT02123745|661891|P1|NOT COMPLETED|Overall Study||0
275914|NCT02123745|661891|P1|COMPLETED|Overall Study||71
275915|NCT02123745|661891|P1|STARTED|Overall Study||71
275916|NCT02123472|661899|P2|NOT COMPLETED|Period 2 (7 Days)||1
275917|NCT02123472|661900|P1|NOT COMPLETED|Period 2 (7 Days)||0
275918|NCT02123472|661899|P2|COMPLETED|Period 2 (7 Days)||13
275919|NCT02123472|661900|P1|COMPLETED|Period 2 (7 Days)||14
275920|NCT02123472|661899|P2|STARTED|Period 2 (7 Days)||14
275921|NCT02123472|661900|P1|STARTED|Period 2 (7 Days)||14
275922|NCT02123472|661899|P2|NOT COMPLETED|Washout Period (1 Day)||0
275923|NCT02123472|661900|P1|NOT COMPLETED|Washout Period (1 Day)||0
275924|NCT02123472|661899|P2|COMPLETED|Washout Period (1 Day)||14
275925|NCT02123472|661900|P1|COMPLETED|Washout Period (1 Day)||14
275926|NCT02123472|661899|P2|STARTED|Washout Period (1 Day)||14
275927|NCT02123472|661900|P1|STARTED|Washout Period (1 Day)||14
275928|NCT02123472|661899|P2|NOT COMPLETED|Period 1 (7 Days)||0
275929|NCT02123472|661900|P1|NOT COMPLETED|Period 1 (7 Days)||0
275930|NCT02123472|661899|P2|COMPLETED|Period 1 (7 Days)||14
275931|NCT02123472|661900|P1|COMPLETED|Period 1 (7 Days)||14
275932|NCT02123472|661899|P2|STARTED|Period 1 (7 Days)||14
275933|NCT02123472|661900|P1|STARTED|Period 1 (7 Days)||14
275934|NCT02123459|661910|P2|NOT COMPLETED|Period 2 (7 Days)||0
275935|NCT02123459|661911|P1|NOT COMPLETED|Period 2 (7 Days)||0
275936|NCT02123459|661910|P2|COMPLETED|Period 2 (7 Days)||14
275937|NCT02123459|661911|P1|COMPLETED|Period 2 (7 Days)||13
275938|NCT02123459|661910|P2|STARTED|Period 2 (7 Days)||14
275939|NCT02123459|661911|P1|STARTED|Period 2 (7 Days)||13
275940|NCT02123459|661910|P2|NOT COMPLETED|Washout Period (1 Day)||0
275941|NCT02123459|661911|P1|NOT COMPLETED|Washout Period (1 Day)||1
275942|NCT02123459|661910|P2|COMPLETED|Washout Period (1 Day)||14
275943|NCT02123459|661911|P1|COMPLETED|Washout Period (1 Day)||13
275944|NCT02123459|661910|P2|STARTED|Washout Period (1 Day)||14
275945|NCT02123459|661911|P1|STARTED|Washout Period (1 Day)||14
275946|NCT02123459|661910|P2|NOT COMPLETED|Period 1 (7 Days)||0
275947|NCT02123459|661911|P1|NOT COMPLETED|Period 1 (7 Days)||0
275948|NCT02123459|661910|P2|COMPLETED|Period 1 (7 Days)||14
275949|NCT02123459|661911|P1|COMPLETED|Period 1 (7 Days)||14
275950|NCT02123459|661910|P2|STARTED|Period 1 (7 Days)||14
275951|NCT02123459|661911|P1|STARTED|Period 1 (7 Days)||14
275952|NCT02123446|661921|P2|NOT COMPLETED|Period 2 (7 Days)||0
275953|NCT02123446|661922|P1|NOT COMPLETED|Period 2 (7 Days)||0
275954|NCT02123446|661921|P2|COMPLETED|Period 2 (7 Days)||14
275955|NCT02123446|661922|P1|COMPLETED|Period 2 (7 Days)||13
275956|NCT02123446|661921|P2|STARTED|Period 2 (7 Days)||14
275957|NCT02123446|661922|P1|STARTED|Period 2 (7 Days)||13
275958|NCT02123446|661921|P2|NOT COMPLETED|Washout Period (1 Day)||0
275959|NCT02123446|661922|P1|NOT COMPLETED|Washout Period (1 Day)||1
275960|NCT02123446|661921|P2|COMPLETED|Washout Period (1 Day)||14
275961|NCT02123446|661922|P1|COMPLETED|Washout Period (1 Day)||13
275962|NCT02123446|661921|P2|STARTED|Washout Period (1 Day)||14
275963|NCT02123446|661922|P1|STARTED|Washout Period (1 Day)||14
275964|NCT02123446|661921|P2|NOT COMPLETED|Period 1 (7 Days)||0
275965|NCT02123446|661922|P1|NOT COMPLETED|Period 1 (7 Days)||0
275966|NCT02123446|661921|P2|COMPLETED|Period 1 (7 Days)||14
275967|NCT02123446|661922|P1|COMPLETED|Period 1 (7 Days)||14
275968|NCT02123446|661921|P2|STARTED|Period 1 (7 Days)||14
275969|NCT02123446|661922|P1|STARTED|Period 1 (7 Days)||14
275970|NCT02123017|661935|P3|NOT COMPLETED|Overall Study||0
275971|NCT02123017|661936|P2|NOT COMPLETED|Overall Study||0
275972|NCT02123017|661937|P1|NOT COMPLETED|Overall Study||0
275973|NCT02123017|661935|P3|COMPLETED|Overall Study||12
275974|NCT02123017|661936|P2|COMPLETED|Overall Study||12
275975|NCT02123017|661937|P1|COMPLETED|Overall Study||8
275976|NCT02123017|661935|P3|STARTED|Overall Study||12
275977|NCT02123017|661936|P2|STARTED|Overall Study||12
275978|NCT02123017|661937|P1|STARTED|Overall Study||8
275979|NCT02122549|661954|P1|NOT COMPLETED|Overall Study||0
275980|NCT02122549|661954|P1|COMPLETED|Overall Study||59
275981|NCT02122549|661954|P1|STARTED|Overall Study||59
275982|NCT02122445|661958|P1|NOT COMPLETED|Overall Study||0
275983|NCT02122445|661958|P1|COMPLETED|Overall Study||20
275984|NCT02122445|661958|P1|STARTED|Overall Study||20
275985|NCT02122406|661963|P1|NOT COMPLETED|Overall Study||0
275986|NCT02122406|661963|P1|COMPLETED|Overall Study||200
275987|NCT02122406|661963|P1|STARTED|Overall Study||200
275988|NCT02121860|661971|P4|NOT COMPLETED|Overall Study||0
275989|NCT02121860|661972|P3|NOT COMPLETED|Overall Study||0
275990|NCT02121860|661973|P2|NOT COMPLETED|Overall Study||0
275991|NCT02121860|661974|P1|NOT COMPLETED|Overall Study||0
275992|NCT02121860|661971|P4|COMPLETED|Overall Study||8
275993|NCT02121860|661972|P3|COMPLETED|Overall Study||8
275994|NCT02121860|661973|P2|COMPLETED|Overall Study||12
275995|NCT02121860|661974|P1|COMPLETED|Overall Study||8
275996|NCT02121860|661971|P4|STARTED|Overall Study||8
275997|NCT02121860|661972|P3|STARTED|Overall Study||8
275998|NCT02121860|661973|P2|STARTED|Overall Study||12
275999|NCT02121860|661974|P1|STARTED|Overall Study||8
276000|NCT02121847|661993|P1|NOT COMPLETED|Overall Study||3
276001|NCT02121847|661993|P1|COMPLETED|Overall Study||37
276002|NCT02121847|661993|P1|STARTED|Overall Study||40
276003|NCT02121795|662014|P2|NOT COMPLETED|Overall Study||334
276004|NCT02121795|662015|P1|NOT COMPLETED|Overall Study||334
276005|NCT02121795|662014|P2|COMPLETED|Overall Study||0
276006|NCT02121795|662015|P1|COMPLETED|Overall Study||0
276007|NCT02121795|662014|P2|STARTED|Overall Study||334
276008|NCT02121795|662015|P1|STARTED|Overall Study||334
276009|NCT02121535|662031|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
276010|NCT02121535|662032|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
276011|NCT02121535|662031|P2|COMPLETED|Period 4 (8 Trial Days)||35
276012|NCT02121535|662032|P1|COMPLETED|Period 4 (8 Trial Days)||35
276013|NCT02121535|662031|P2|STARTED|Period 4 (8 Trial Days)||35
276014|NCT02121535|662032|P1|STARTED|Period 4 (8 Trial Days)||35
276015|NCT02121535|662031|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
276016|NCT02121535|662032|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
276017|NCT02121535|662031|P2|COMPLETED|Period 3 (8 Trial Days)||35
276018|NCT02121535|662032|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
276019|NCT02121535|662031|P2|STARTED|Period 3 (8 Trial Days)||35
276020|NCT02121535|662032|P1|STARTED|Period 3 (8 Trial Days)||36
276021|NCT02121535|662031|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
276022|NCT02121535|662032|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
276023|NCT02121535|662031|P2|COMPLETED|Period 2 (8 Trial Days)||35
276024|NCT02121535|662032|P1|COMPLETED|Period 2 (8 Trial Days)||36
276025|NCT02121535|662031|P2|STARTED|Period 2 (8 Trial Days)||35
276026|NCT02121535|662032|P1|STARTED|Period 2 (8 Trial Days)||36
276027|NCT02121535|662031|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
276028|NCT02121535|662032|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
276029|NCT02121535|662031|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
276030|NCT02121535|662032|P1|COMPLETED|Period 1 (8 Trial Days)||36
276031|NCT02121535|662031|P2|STARTED|Period 1 (8 Trial Days)||36
276032|NCT02121535|662032|P1|STARTED|Period 1 (8 Trial Days)||36
276033|NCT02121522|662055|P1|NOT COMPLETED|Overall Study||1
276034|NCT02121522|662055|P1|COMPLETED|Overall Study||13
276035|NCT02121522|662055|P1|STARTED|Overall Study||14
276036|NCT02121509|662062|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
276037|NCT02121509|662063|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
276038|NCT02121509|662064|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
276039|NCT02121509|662065|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
276040|NCT02121509|662062|P4|COMPLETED|Treatment Period-2 (4 Days)||8
276041|NCT02121509|662063|P3|COMPLETED|Treatment Period-2 (4 Days)||8
276042|NCT02121509|662064|P2|COMPLETED|Treatment Period-2 (4 Days)||24
276043|NCT02121509|662065|P1|COMPLETED|Treatment Period-2 (4 Days)||28
276044|NCT02121509|662062|P4|STARTED|Treatment Period-2 (4 Days)||8
276045|NCT02121509|662063|P3|STARTED|Treatment Period-2 (4 Days)||8
276046|NCT02121509|662064|P2|STARTED|Treatment Period-2 (4 Days)||24
276047|NCT02121509|662065|P1|STARTED|Treatment Period-2 (4 Days)||28
276048|NCT02121509|662062|P4|NOT COMPLETED|Washout Period (35 Days)||0
276049|NCT02121509|662063|P3|NOT COMPLETED|Washout Period (35 Days)||0
276050|NCT02121509|662064|P2|NOT COMPLETED|Washout Period (35 Days)||4
276051|NCT02121509|662065|P1|NOT COMPLETED|Washout Period (35 Days)||2
276052|NCT02121509|662062|P4|COMPLETED|Washout Period (35 Days)||8
276053|NCT02121509|662063|P3|COMPLETED|Washout Period (35 Days)||8
276054|NCT02121509|662064|P2|COMPLETED|Washout Period (35 Days)||24
276055|NCT02121509|662065|P1|COMPLETED|Washout Period (35 Days)||28
276056|NCT02121509|662062|P4|STARTED|Washout Period (35 Days)||8
276057|NCT02121509|662063|P3|STARTED|Washout Period (35 Days)||8
276058|NCT02121509|662064|P2|STARTED|Washout Period (35 Days)||28
276059|NCT02121509|662065|P1|STARTED|Washout Period (35 Days)||30
276060|NCT02121509|662062|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
276061|NCT02121509|662063|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
276062|NCT02121509|662064|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
276063|NCT02121509|662065|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
276064|NCT02121509|662062|P4|COMPLETED|Treatment Period-1 (4 Days)||8
276065|NCT02121509|662063|P3|COMPLETED|Treatment Period-1 (4 Days)||8
276066|NCT02121509|662064|P2|COMPLETED|Treatment Period-1 (4 Days)||28
276067|NCT02121509|662065|P1|COMPLETED|Treatment Period-1 (4 Days)||30
276068|NCT02121509|662062|P4|STARTED|Treatment Period-1 (4 Days)||8
276069|NCT02121509|662063|P3|STARTED|Treatment Period-1 (4 Days)||8
276070|NCT02121509|662064|P2|STARTED|Treatment Period-1 (4 Days)||28
276071|NCT02121509|662065|P1|STARTED|Treatment Period-1 (4 Days)||30
276072|NCT02121483|662098|P3|NOT COMPLETED|Overall Study||0
276073|NCT02121483|662099|P2|NOT COMPLETED|Overall Study||0
276074|NCT02121483|662100|P1|NOT COMPLETED|Overall Study||0
276075|NCT02121483|662098|P3|COMPLETED|Overall Study||10
276076|NCT02121483|662099|P2|COMPLETED|Overall Study||8
276077|NCT02121483|662100|P1|COMPLETED|Overall Study||9
276078|NCT02121483|662098|P3|STARTED|Overall Study||10
276079|NCT02121483|662099|P2|STARTED|Overall Study||8
276080|NCT02121483|662100|P1|STARTED|Overall Study||9
276081|NCT02121067|662129|P1|NOT COMPLETED|Overall Study||0
276082|NCT02121067|662129|P1|COMPLETED|Overall Study||50
276083|NCT02121067|662129|P1|STARTED|Overall Study||50
276084|NCT02121041|662137|P2|NOT COMPLETED|Overall Study||6
276085|NCT02121041|662138|P1|NOT COMPLETED|Overall Study||1
276086|NCT02121041|662137|P2|COMPLETED|Overall Study||8
276087|NCT02121041|662138|P1|COMPLETED|Overall Study||13
276088|NCT02121041|662137|P2|STARTED|Overall Study||14
276089|NCT02121041|662138|P1|STARTED|Overall Study||14
276090|NCT02120833|662146|P2|NOT COMPLETED|Overall Study||1
276091|NCT02120833|662147|P1|NOT COMPLETED|Overall Study||4
276092|NCT02120833|662146|P2|COMPLETED|Overall Study||11
276093|NCT02120833|662147|P1|COMPLETED|Overall Study||35
276094|NCT02120833|662146|P2|STARTED|Overall Study||12
276095|NCT02120833|662147|P1|STARTED|Overall Study||39
276096|NCT02120664|662306|P5|NOT COMPLETED|Overall Study||0
276097|NCT02120664|662307|P4|NOT COMPLETED|Overall Study||1
276098|NCT02120664|662308|P3|NOT COMPLETED|Overall Study||0
276099|NCT02120664|662309|P2|NOT COMPLETED|Overall Study||0
276100|NCT02120664|662310|P1|NOT COMPLETED|Overall Study||0
276101|NCT02120664|662306|P5|COMPLETED|Overall Study||10
276102|NCT02120664|662307|P4|COMPLETED|Overall Study||3
276103|NCT02120664|662308|P3|COMPLETED|Overall Study||7
276104|NCT02120664|662309|P2|COMPLETED|Overall Study||4
276105|NCT02120664|662310|P1|COMPLETED|Overall Study||10
276106|NCT02120664|662306|P5|STARTED|Overall Study||10
276107|NCT02120664|662307|P4|STARTED|Overall Study||4
276108|NCT02120664|662308|P3|STARTED|Overall Study||7
276109|NCT02120664|662309|P2|STARTED|Overall Study||4
276110|NCT02120664|662310|P1|STARTED|Overall Study||10
276111|NCT02120625|662328|P1|NOT COMPLETED|Overall Study||2
276112|NCT02120625|662328|P1|COMPLETED|Overall Study||6
276113|NCT02120625|662328|P1|STARTED|Overall Study||8
276114|NCT02120443|662335|P1|NOT COMPLETED|Overall Study||0
276115|NCT02120443|662335|P1|COMPLETED|Overall Study||43
276116|NCT02120443|662335|P1|STARTED|Overall Study||43
276117|NCT02120300|662345|P4|NOT COMPLETED|Overall Study||1
276118|NCT02120300|662346|P3|NOT COMPLETED|Overall Study||0
276119|NCT02120300|662347|P2|NOT COMPLETED|Overall Study||0
276120|NCT02120300|662348|P1|NOT COMPLETED|Overall Study||3
276121|NCT02120300|662345|P4|COMPLETED|Overall Study||5
276122|NCT02120300|662346|P3|COMPLETED|Overall Study||10
276123|NCT02120300|662347|P2|COMPLETED|Overall Study||5
276124|NCT02120300|662348|P1|COMPLETED|Overall Study||98
276125|NCT02120300|662345|P4|STARTED|Overall Study||6
276126|NCT02120300|662346|P3|STARTED|Overall Study||10
276127|NCT02120300|662347|P2|STARTED|Overall Study||5
276128|NCT02120300|662348|P1|STARTED|Overall Study||101
276129|NCT02120027|662386|P2|NOT COMPLETED|Overall Study||119
276130|NCT02120027|662387|P1|NOT COMPLETED|Overall Study||116
276131|NCT02120027|662386|P2|COMPLETED|Overall Study||160
276132|NCT02120027|662387|P1|COMPLETED|Overall Study||161
276133|NCT02120027|662386|P2|STARTED|Overall Study||279
276134|NCT02120027|662387|P1|STARTED|Overall Study||277
276135|NCT02120001|662403|P2|NOT COMPLETED|Overall Study||0
276136|NCT02120001|662404|P1|NOT COMPLETED|Overall Study||0
276137|NCT02120001|662403|P2|COMPLETED|Overall Study||19
276138|NCT02120001|662404|P1|COMPLETED|Overall Study||17
276139|NCT02120001|662403|P2|STARTED|Overall Study||19
276140|NCT02120001|662404|P1|STARTED|Overall Study||17
276141|NCT02119676|662416|P4|NOT COMPLETED|Overall Study||101
276142|NCT02119676|662417|P3|NOT COMPLETED|Overall Study||97
276143|NCT02119676|662418|P2|NOT COMPLETED|Overall Study||86
276144|NCT02119676|662419|P1|NOT COMPLETED|Overall Study||83
276145|NCT02119676|662416|P4|COMPLETED|Overall Study||10
276146|NCT02119676|662417|P3|COMPLETED|Overall Study||13
276147|NCT02119676|662418|P2|COMPLETED|Overall Study||2
276148|NCT02119676|662419|P1|COMPLETED|Overall Study||4
276149|NCT02119676|662416|P4|Treated Patients|Overall Study||106
276150|NCT02119676|662417|P3|Treated Patients|Overall Study||106
276151|NCT02119676|662418|P2|Treated Patients|Overall Study||86
276152|NCT02119676|662419|P1|Treated Patients|Overall Study||85
276153|NCT02119676|662416|P4|STARTED|Overall Study||111
276154|NCT02119676|662417|P3|STARTED|Overall Study||110
276155|NCT02119676|662418|P2|STARTED|Overall Study||88
276156|NCT02119676|662419|P1|STARTED|Overall Study||87
276157|NCT02119663|662451|P2|NOT COMPLETED|Overall Study||41
276158|NCT02119663|662452|P1|NOT COMPLETED|Overall Study||40
276159|NCT02119663|662451|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
276160|NCT02119663|662452|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
276161|NCT02119663|662451|P2|STARTED|Overall Study||43
276162|NCT02119663|662452|P1|STARTED|Overall Study||43
276163|NCT02119650|662470|P2|NOT COMPLETED|Overall Study||26
276164|NCT02119650|662471|P1|NOT COMPLETED|Overall Study||25
276165|NCT02119650|662470|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
276166|NCT02119650|662471|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
276167|NCT02119650|662470|P2|STARTED|Overall Study||37
276168|NCT02119650|662471|P1|STARTED|Overall Study||39
276169|NCT02119325|662485|P2|NOT COMPLETED|Period 2||0
276170|NCT02119325|662486|P1|NOT COMPLETED|Period 2||0
276171|NCT02119325|662485|P2|COMPLETED|Period 2||47
276172|NCT02119325|662486|P1|COMPLETED|Period 2||48
276173|NCT02119325|662485|P2|STARTED|Period 2||47
276174|NCT02119325|662486|P1|STARTED|Period 2||48
276175|NCT02119325|662485|P2|NOT COMPLETED|Washout Period 1||1
276176|NCT02119325|662486|P1|NOT COMPLETED|Washout Period 1||0
276177|NCT02119325|662485|P2|COMPLETED|Washout Period 1||47
276178|NCT02119325|662486|P1|COMPLETED|Washout Period 1||48
276179|NCT02119325|662485|P2|STARTED|Washout Period 1||48
276180|NCT02119325|662486|P1|STARTED|Washout Period 1||48
276181|NCT02119325|662485|P2|NOT COMPLETED|Period 1||0
276182|NCT02119325|662486|P1|NOT COMPLETED|Period 1||0
276183|NCT02119325|662485|P2|COMPLETED|Period 1||48
276184|NCT02119325|662486|P1|COMPLETED|Period 1||48
276185|NCT02119325|662485|P2|STARTED|Period 1||48
276186|NCT02119325|662486|P1|STARTED|Period 1||48
276187|NCT02119286|662533|P3|NOT COMPLETED|Overall Study||7
276188|NCT02119286|662534|P2|NOT COMPLETED|Overall Study||11
276189|NCT02119286|662535|P1|NOT COMPLETED|Overall Study||26
276190|NCT02119286|662533|P3|COMPLETED|Overall Study||200
276191|NCT02119286|662534|P2|COMPLETED|Overall Study||195
276192|NCT02119286|662535|P1|COMPLETED|Overall Study||180
276193|NCT02119286|662533|P3|STARTED|Overall Study||207
276194|NCT02119286|662534|P2|STARTED|Overall Study||206
276195|NCT02119286|662535|P1|STARTED|Overall Study||206
276196|NCT02118961|662548|P2|NOT COMPLETED|Overall Study||0
276197|NCT02118961|662549|P1|NOT COMPLETED|Overall Study||1
276198|NCT02118961|662548|P2|COMPLETED|Overall Study||222
276199|NCT02118961|662549|P1|COMPLETED|Overall Study||223
276200|NCT02118961|662548|P2|STARTED|Overall Study||222
276201|NCT02118961|662549|P1|STARTED|Overall Study||224
276202|NCT02118896|662577|P10|NOT COMPLETED|Overall Study||2
276203|NCT02118896|662578|P9|NOT COMPLETED|Overall Study||4
276204|NCT02118896|662579|P8|NOT COMPLETED|Overall Study||2
276205|NCT02118896|662580|P7|NOT COMPLETED|Overall Study||2
276206|NCT02118896|662581|P6|NOT COMPLETED|Overall Study||28
276207|NCT02118896|662582|P5|NOT COMPLETED|Overall Study||17
276208|NCT02118896|662583|P4|NOT COMPLETED|Overall Study||24
276209|NCT02118896|662584|P3|NOT COMPLETED|Overall Study||14
276210|NCT02118896|662585|P2|NOT COMPLETED|Overall Study||15
276211|NCT02118896|662586|P1|NOT COMPLETED|Overall Study||17
276212|NCT02118896|662577|P10|COMPLETED|Overall Study||7
276213|NCT02118896|662578|P9|COMPLETED|Overall Study||84
276214|NCT02118896|662579|P8|COMPLETED|Overall Study||105
276215|NCT02118896|662580|P7|COMPLETED|Overall Study||83
276216|NCT02118896|662581|P6|COMPLETED|Overall Study||163
276217|NCT02118896|662582|P5|COMPLETED|Overall Study||113
276218|NCT02118896|662583|P4|COMPLETED|Overall Study||55
276219|NCT02118896|662584|P3|COMPLETED|Overall Study||53
276220|NCT02118896|662585|P2|COMPLETED|Overall Study||32
276221|NCT02118896|662586|P1|COMPLETED|Overall Study||30
276222|NCT02118896|662577|P10|STARTED|Overall Study||9
276223|NCT02118896|662578|P9|STARTED|Overall Study||88
276224|NCT02118896|662579|P8|STARTED|Overall Study||107
276225|NCT02118896|662580|P7|STARTED|Overall Study||85
276226|NCT02118896|662581|P6|STARTED|Overall Study||191
276227|NCT02118896|662582|P5|STARTED|Overall Study||130
276228|NCT02118896|662583|P4|STARTED|Overall Study||79
276229|NCT02118896|662584|P3|STARTED|Overall Study||67
276230|NCT02118896|662585|P2|STARTED|Overall Study||47
276231|NCT02118896|662586|P1|STARTED|Overall Study||47
276232|NCT02118831|662661|P3|NOT COMPLETED|Overall Study||0
276233|NCT02118831|662662|P2|NOT COMPLETED|Overall Study||0
276234|NCT02118831|662663|P1|NOT COMPLETED|Overall Study||0
276235|NCT02118831|662661|P3|COMPLETED|Overall Study||20
276236|NCT02118831|662662|P2|COMPLETED|Overall Study||15
276237|NCT02118831|662663|P1|COMPLETED|Overall Study||21
276238|NCT02118831|662661|P3|STARTED|Overall Study||20
276239|NCT02118831|662662|P2|STARTED|Overall Study||15
276240|NCT02118831|662663|P1|STARTED|Overall Study||21
276241|NCT02118792|662676|P2|NOT COMPLETED|Overall Study||37
276242|NCT02118792|662677|P1|NOT COMPLETED|Overall Study||31
276243|NCT02118792|662676|P2|COMPLETED|Overall Study||213
276244|NCT02118792|662677|P1|COMPLETED|Overall Study||483
276245|NCT02118792|662676|P2|Treated|Overall Study||250
276246|NCT02118792|662677|P1|Treated|Overall Study||513
276247|NCT02118792|662676|P2|STARTED|Overall Study||250
276248|NCT02118792|662677|P1|STARTED|Overall Study||514
276249|NCT02118766|662719|P2|NOT COMPLETED|Overall Study||31
276250|NCT02118766|662720|P1|NOT COMPLETED|Overall Study||30
276251|NCT02118766|662719|P2|COMPLETED|Overall Study||225
276252|NCT02118766|662720|P1|COMPLETED|Overall Study||477
276253|NCT02118766|662719|P2|Treated|Overall Study||256
276254|NCT02118766|662720|P1|Treated|Overall Study||503
276255|NCT02118766|662719|P2|STARTED|Overall Study||256
276256|NCT02118766|662720|P1|STARTED|Overall Study||507
276257|NCT02118597|662742|P1|NOT COMPLETED|Overall Study||16
276258|NCT02118597|662742|P1|COMPLETED|Overall Study||3
276259|NCT02118597|662742|P1|STARTED|Overall Study||19
276260|NCT02118441|662758|P2|NOT COMPLETED|Overall Study||1
276261|NCT02118441|662759|P1|NOT COMPLETED|Overall Study||3
276262|NCT02118441|662758|P2|COMPLETED|Overall Study||63
276263|NCT02118441|662759|P1|COMPLETED|Overall Study||62
276264|NCT02118441|662758|P2|STARTED|Overall Study||64
276265|NCT02118441|662759|P1|STARTED|Overall Study||65
276266|NCT02117687|662773|P2|NOT COMPLETED|Overall Study||4
276267|NCT02117687|662774|P1|NOT COMPLETED|Overall Study||1
276268|NCT02117687|662773|P2|COMPLETED|Overall Study||36
276269|NCT02117687|662774|P1|COMPLETED|Overall Study||39
276270|NCT02117687|662773|P2|STARTED|Overall Study||40
276271|NCT02117687|662774|P1|STARTED|Overall Study||40
276272|NCT02117570|662809|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
276273|NCT02117570|662810|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
276274|NCT02117570|662811|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
276275|NCT02117570|662809|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
276276|NCT02117570|662810|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
276277|NCT02117570|662811|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
276278|NCT02117570|662809|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
276279|NCT02117570|662810|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
276280|NCT02117570|662811|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
276281|NCT02117570|662809|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
276282|NCT02117570|662810|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
276283|NCT02117570|662811|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
276284|NCT02117570|662809|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
276285|NCT02117570|662810|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
276286|NCT02117570|662811|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
276287|NCT02117570|662809|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
276288|NCT02117570|662810|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
276289|NCT02117570|662811|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
276290|NCT02117570|662809|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
276291|NCT02117570|662810|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
276292|NCT02117570|662811|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
276293|NCT02117570|662809|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
276294|NCT02117570|662810|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
276295|NCT02117570|662811|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
276296|NCT02117570|662809|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
276297|NCT02117570|662810|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
276298|NCT02117570|662811|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
276299|NCT02117570|662809|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
276300|NCT02117570|662810|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
276301|NCT02117570|662811|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
276302|NCT02117570|662809|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
276303|NCT02117570|662810|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
276304|NCT02117570|662811|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
276305|NCT02117570|662809|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
276306|NCT02117570|662810|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
276307|NCT02117570|662811|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
276308|NCT02117544|662861|P2|NOT COMPLETED|Period 2||0
276309|NCT02117544|662862|P1|NOT COMPLETED|Period 2||0
276310|NCT02117544|662861|P2|COMPLETED|Period 2||55
276311|NCT02117544|662862|P1|COMPLETED|Period 2||52
276312|NCT02117544|662861|P2|STARTED|Period 2||55
276313|NCT02117544|662862|P1|STARTED|Period 2||52
276314|NCT02117544|662861|P2|NOT COMPLETED|Period 1||0
276315|NCT02117544|662862|P1|NOT COMPLETED|Period 1||2
276316|NCT02117544|662861|P2|COMPLETED|Period 1||55
276317|NCT02117544|662862|P1|COMPLETED|Period 1||52
276318|NCT02117544|662861|P2|Treated|Period 1||55
276319|NCT02117544|662862|P1|Treated|Period 1||52
276320|NCT02117544|662861|P2|STARTED|Period 1||55
276321|NCT02117544|662862|P1|STARTED|Period 1||54
276322|NCT02117414|662877|P2|NOT COMPLETED|Overall Study||6
276323|NCT02117414|662878|P1|NOT COMPLETED|Overall Study||15
276324|NCT02117414|662877|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
276325|NCT02117414|662878|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
276326|NCT02117414|662877|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
276327|NCT02117414|662878|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
276328|NCT02117310|662896|P1|NOT COMPLETED|Overall Study||0
276329|NCT02117310|662896|P1|COMPLETED|Overall Study||5
276330|NCT02117310|662896|P1|STARTED|Overall Study||5
276331|NCT02117193|662900|P1|NOT COMPLETED|Overall Study||0
276332|NCT02117193|662900|P1|COMPLETED|Overall Study||10
276333|NCT02117193|662900|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
276334|NCT02117193|662900|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
276335|NCT02117193|662900|P1|Placebo Intake + Normal Sleep|Overall Study||10
276336|NCT02117193|662900|P1|Alcohol Intake + Normal Sleep|Overall Study||10
276337|NCT02117193|662900|P1|STARTED|Overall Study||10
276338|NCT02117050|662922|P1|NOT COMPLETED|Overall Study||1
276339|NCT02117050|662922|P1|COMPLETED|Overall Study||0
276340|NCT02117050|662922|P1|STARTED|Overall Study||1
276341|NCT02116582|662934|P1|NOT COMPLETED|Overall Study||185
276342|NCT02116582|662934|P1|COMPLETED|Overall Study|Completed indicates participants were still on study drug at the time of the data cut-off.|30
276343|NCT02116582|662934|P1|Treated|Overall Study||214
276344|NCT02116582|662934|P1|STARTED|Overall Study||215
276345|NCT02116530|662944|P2|NOT COMPLETED|Overall Study||4
276346|NCT02116530|662945|P1|NOT COMPLETED|Overall Study||9
276347|NCT02116530|662944|P2|COMPLETED|Overall Study||184
276348|NCT02116530|662945|P1|COMPLETED|Overall Study||183
276349|NCT02116530|662944|P2|STARTED|Overall Study||188
276350|NCT02116530|662945|P1|STARTED|Overall Study||192
276351|NCT02115984|662961|P2|NOT COMPLETED|Overall Study||7
276352|NCT02115984|662962|P1|NOT COMPLETED|Overall Study||6
276353|NCT02115984|662961|P2|COMPLETED|Overall Study||16
276354|NCT02115984|662962|P1|COMPLETED|Overall Study||51
276355|NCT02115984|662961|P2|STARTED|Overall Study||23
276356|NCT02115984|662962|P1|STARTED|Overall Study||57
276357|NCT02115815|662975|P7|NOT COMPLETED|Overall Study||0
276358|NCT02115815|662976|P6|NOT COMPLETED|Overall Study||2
276359|NCT02115815|662977|P5|NOT COMPLETED|Overall Study||0
276360|NCT02115815|662978|P4|NOT COMPLETED|Overall Study||0
276361|NCT02115815|662979|P3|NOT COMPLETED|Overall Study||0
276362|NCT02115815|662980|P2|NOT COMPLETED|Overall Study||0
276363|NCT02115815|662981|P1|NOT COMPLETED|Overall Study||2
276364|NCT02115815|662975|P7|COMPLETED|Overall Study||20
276365|NCT02115815|662976|P6|COMPLETED|Overall Study||20
276366|NCT02115815|662977|P5|COMPLETED|Overall Study||20
276367|NCT02115815|662978|P4|COMPLETED|Overall Study||20
276368|NCT02115815|662979|P3|COMPLETED|Overall Study||20
276369|NCT02115815|662980|P2|COMPLETED|Overall Study||20
276370|NCT02115815|662981|P1|COMPLETED|Overall Study||22
276371|NCT02115815|662975|P7|STARTED|Overall Study||20
276372|NCT02115815|662976|P6|STARTED|Overall Study||22
276373|NCT02115815|662977|P5|STARTED|Overall Study||20
276374|NCT02115815|662978|P4|STARTED|Overall Study||20
276375|NCT02115815|662979|P3|STARTED|Overall Study||20
276376|NCT02115815|662980|P2|STARTED|Overall Study||20
276377|NCT02115815|662981|P1|STARTED|Overall Study||24
276378|NCT02115581|663076|P2|NOT COMPLETED|Overall Study||0
276379|NCT02115581|663077|P1|NOT COMPLETED|Overall Study||0
276380|NCT02115581|663076|P2|COMPLETED|Overall Study||21
276381|NCT02115581|663077|P1|COMPLETED|Overall Study||17
276382|NCT02115581|663076|P2|STARTED|Overall Study||21
276383|NCT02115581|663077|P1|STARTED|Overall Study||17
276384|NCT02115321|663089|P2|NOT COMPLETED|Overall Study||0
276385|NCT02115321|663090|P1|NOT COMPLETED|Overall Study||1
276386|NCT02115321|663089|P2|COMPLETED|Overall Study||10
276387|NCT02115321|663090|P1|COMPLETED|Overall Study||29
276388|NCT02115321|663089|P2|STARTED|Overall Study||10
276389|NCT02115321|663090|P1|STARTED|Overall Study||30
276390|NCT02115256|663112|P2|NOT COMPLETED|Overall Study||1
276391|NCT02115256|663113|P1|NOT COMPLETED|Overall Study||0
276392|NCT02115256|663112|P2|COMPLETED|Overall Study||2
276393|NCT02115256|663113|P1|COMPLETED|Overall Study||3
276394|NCT02115256|663112|P2|STARTED|Overall Study||3
276395|NCT02115256|663113|P1|STARTED|Overall Study||3
276396|NCT02114931|663127|P2|NOT COMPLETED|Overall Study||30
276397|NCT02114931|663128|P1|NOT COMPLETED|Overall Study||25
276398|NCT02114931|663127|P2|COMPLETED|Overall Study||207
276399|NCT02114931|663128|P1|COMPLETED|Overall Study||205
276400|NCT02114931|663127|P2|Received Treatment|Overall Study||237
276401|NCT02114931|663128|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
276402|NCT02114931|663127|P2|STARTED|Overall Study||237
276403|NCT02114931|663128|P1|STARTED|Overall Study||230
276404|NCT02114892|663144|P2|NOT COMPLETED|Overall Study||2
276405|NCT02114892|663145|P1|NOT COMPLETED|Overall Study||1
276406|NCT02114892|663144|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
276407|NCT02114892|663145|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
276408|NCT02114892|663144|P2|STARTED|Overall Study||12
276409|NCT02114892|663145|P1|STARTED|Overall Study||12
276410|NCT02114268|663185|P6|NOT COMPLETED|Overall Study||3
276411|NCT02114268|663186|P5|NOT COMPLETED|Overall Study||0
276412|NCT02114268|663187|P4|NOT COMPLETED|Overall Study||0
276413|NCT02114268|663188|P3|NOT COMPLETED|Overall Study||1
276414|NCT02114268|663189|P2|NOT COMPLETED|Overall Study||1
276415|NCT02114268|663190|P1|NOT COMPLETED|Overall Study||6
276416|NCT02114268|663185|P6|COMPLETED|Overall Study||75
276417|NCT02114268|663186|P5|COMPLETED|Overall Study||6
276418|NCT02114268|663187|P4|COMPLETED|Overall Study||6
276419|NCT02114268|663188|P3|COMPLETED|Overall Study||5
276420|NCT02114268|663189|P2|COMPLETED|Overall Study||5
276421|NCT02114268|663190|P1|COMPLETED|Overall Study||28
276422|NCT02114268|663185|P6|STARTED|Overall Study||78
276423|NCT02114268|663186|P5|STARTED|Overall Study||6
276424|NCT02114268|663187|P4|STARTED|Overall Study||6
276425|NCT02114268|663188|P3|STARTED|Overall Study||6
276426|NCT02114268|663189|P2|STARTED|Overall Study||6
276427|NCT02114268|663190|P1|STARTED|Overall Study||34
276428|NCT02114216|663243|P3|NOT COMPLETED|Overall Study||0
276429|NCT02114216|663244|P2|NOT COMPLETED|Overall Study||0
276430|NCT02114216|663245|P1|NOT COMPLETED|Overall Study||0
276431|NCT02114216|663243|P3|COMPLETED|Overall Study||14
276432|NCT02114216|663244|P2|COMPLETED|Overall Study||45
276433|NCT02114216|663245|P1|COMPLETED|Overall Study||16
276434|NCT02114216|663243|P3|STARTED|Overall Study||14
276435|NCT02114216|663244|P2|STARTED|Overall Study||45
276436|NCT02114216|663245|P1|STARTED|Overall Study||16
276437|NCT02114177|663258|P2|NOT COMPLETED|Overall Study||4
276438|NCT02114177|663259|P1|NOT COMPLETED|Overall Study||9
276439|NCT02114177|663258|P2|COMPLETED|Overall Study||151
276440|NCT02114177|663259|P1|COMPLETED|Overall Study||146
276441|NCT02114177|663258|P2|STARTED|Overall Study||155
276442|NCT02114177|663259|P1|STARTED|Overall Study||155
276443|NCT02114151|663283|P1|NOT COMPLETED|Overall Study||7
276444|NCT02114151|663283|P1|COMPLETED|Overall Study||96
276445|NCT02114151|663283|P1|STARTED|Overall Study||103
276446|NCT02113579|663300|P2|NOT COMPLETED|Overall Study||4
276447|NCT02113579|663301|P1|NOT COMPLETED|Overall Study||10
276448|NCT02113579|663300|P2|COMPLETED|Overall Study||185
276449|NCT02113579|663301|P1|COMPLETED|Overall Study||176
276450|NCT02113579|663300|P2|STARTED|Overall Study||189
276451|NCT02113579|663301|P1|STARTED|Overall Study||186
276452|NCT02113449|663325|P1|NOT COMPLETED|Overall Study||4
276453|NCT02113449|663325|P1|COMPLETED|Overall Study||143
276454|NCT02113449|663325|P1|STARTED|Overall Study||147
276455|NCT02113436|663341|P4|NOT COMPLETED|Period 2: 16 Weeks||11
276456|NCT02113436|663342|P3|NOT COMPLETED|Period 2: 16 Weeks||9
276457|NCT02113436|663343|P2|NOT COMPLETED|Period 2: 16 Weeks||0
276458|NCT02113436|663344|P1|NOT COMPLETED|Period 2: 16 Weeks||0
276459|NCT02113436|663341|P4|COMPLETED|Period 2: 16 Weeks||136
276460|NCT02113436|663342|P3|COMPLETED|Period 2: 16 Weeks||132
276461|NCT02113436|663343|P2|COMPLETED|Period 2: 16 Weeks||0
276462|NCT02113436|663344|P1|COMPLETED|Period 2: 16 Weeks||0
276463|NCT02113436|663341|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
276464|NCT02113436|663342|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
276465|NCT02113436|663343|P2|STARTED|Period 2: 16 Weeks||0
276466|NCT02113436|663344|P1|STARTED|Period 2: 16 Weeks||0
276467|NCT02113436|663341|P4|NOT COMPLETED|Period 1: 8 Weeks||0
276468|NCT02113436|663342|P3|NOT COMPLETED|Period 1: 8 Weeks||0
276469|NCT02113436|663343|P2|NOT COMPLETED|Period 1: 8 Weeks||2
276470|NCT02113436|663344|P1|NOT COMPLETED|Period 1: 8 Weeks||8
276471|NCT02113436|663341|P4|COMPLETED|Period 1: 8 Weeks||0
276472|NCT02113436|663342|P3|COMPLETED|Period 1: 8 Weeks||0
276473|NCT02113436|663343|P2|COMPLETED|Period 1: 8 Weeks||148
276474|NCT02113436|663344|P1|COMPLETED|Period 1: 8 Weeks||142
276475|NCT02113436|663341|P4|STARTED|Period 1: 8 Weeks||0
276476|NCT02113436|663342|P3|STARTED|Period 1: 8 Weeks||0
276477|NCT02113436|663343|P2|STARTED|Period 1: 8 Weeks||150
276478|NCT02113436|663344|P1|STARTED|Period 1: 8 Weeks||150
276479|NCT02113124|663367|P2|NOT COMPLETED|Overall Study||1
276480|NCT02113124|663368|P1|NOT COMPLETED|Overall Study||1
276481|NCT02113124|663367|P2|COMPLETED|Overall Study||24
276482|NCT02113124|663368|P1|COMPLETED|Overall Study||17
276483|NCT02113124|663367|P2|STARTED|Overall Study||25
276484|NCT02113124|663368|P1|STARTED|Overall Study||18
276485|NCT02113007|663374|P1|NOT COMPLETED|Overall Study||2
276486|NCT02113007|663374|P1|COMPLETED|Overall Study||0
276487|NCT02113007|663374|P1|STARTED|Overall Study||2
276488|NCT02112448|663382|P2|NOT COMPLETED|Overall Study||10
276489|NCT02112448|663383|P1|NOT COMPLETED|Overall Study||8
276490|NCT02112448|663382|P2|COMPLETED|Overall Study||30
276491|NCT02112448|663383|P1|COMPLETED|Overall Study||30
276492|NCT02112448|663382|P2|STARTED|Overall Study||40
276493|NCT02112448|663383|P1|STARTED|Overall Study||38
276494|NCT02111603|663391|P1|NOT COMPLETED|Overall Study||1
276495|NCT02111603|663391|P1|COMPLETED|Overall Study||12
276496|NCT02111603|663391|P1|STARTED|Overall Study||13
276497|NCT02111369|663400|P1|NOT COMPLETED|Overall Study||3
276498|NCT02111369|663400|P1|COMPLETED|Overall Study||15
276499|NCT02111369|663400|P1|STARTED|Overall Study||18
276500|NCT02111252|663408|P1|NOT COMPLETED|Overall Study||0
276501|NCT02111252|663408|P1|COMPLETED|Overall Study||55
276502|NCT02111252|663408|P1|STARTED|Overall Study||55
276503|NCT02111083|663424|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
276504|NCT02111083|663425|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
276505|NCT02111083|663424|P2|COMPLETED|Fourth Intervention (1 Day)||18
276506|NCT02111083|663425|P1|COMPLETED|Fourth Intervention (1 Day)||18
276507|NCT02111083|663424|P2|STARTED|Fourth Intervention (1 Day)||18
276508|NCT02111083|663425|P1|STARTED|Fourth Intervention (1 Day)||18
276509|NCT02111083|663424|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
276510|NCT02111083|663425|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
276511|NCT02111083|663424|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
276512|NCT02111083|663425|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
276513|NCT02111083|663424|P2|STARTED|Interval Between Dosing (7-8 Days)||19
276514|NCT02111083|663425|P1|STARTED|Interval Between Dosing (7-8 Days)||19
276515|NCT02111083|663424|P2|NOT COMPLETED|Third Intervention (1 Day)||0
276516|NCT02111083|663425|P1|NOT COMPLETED|Third Intervention (1 Day)||0
276517|NCT02111083|663424|P2|COMPLETED|Third Intervention (1 Day)||19
276518|NCT02111083|663425|P1|COMPLETED|Third Intervention (1 Day)||19
276519|NCT02111083|663424|P2|STARTED|Third Intervention (1 Day)||19
276520|NCT02111083|663425|P1|STARTED|Third Intervention (1 Day)||19
276521|NCT02111083|663424|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
276522|NCT02111083|663425|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
276523|NCT02111083|663424|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
276524|NCT02111083|663425|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
276525|NCT02111083|663424|P2|STARTED|Interval Between Dosing (7-8 Days)||19
276526|NCT02111083|663425|P1|STARTED|Interval Between Dosing (7-8 Days)||19
276527|NCT02111083|663424|P2|NOT COMPLETED|Second Intervention (1 Day)||0
276528|NCT02111083|663425|P1|NOT COMPLETED|Second Intervention (1 Day)||0
276529|NCT02111083|663424|P2|COMPLETED|Second Intervention (1 Day)||19
276530|NCT02111083|663425|P1|COMPLETED|Second Intervention (1 Day)||19
276531|NCT02111083|663424|P2|STARTED|Second Intervention (1 Day)||19
276532|NCT02111083|663425|P1|STARTED|Second Intervention (1 Day)||19
276533|NCT02111083|663424|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
276534|NCT02111083|663425|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
276535|NCT02111083|663424|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
276536|NCT02111083|663425|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
276537|NCT02111083|663424|P2|STARTED|Interval Between Dosing (7-8 Days)||19
276538|NCT02111083|663425|P1|STARTED|Interval Between Dosing (7-8 Days)||19
276539|NCT02111083|663424|P2|NOT COMPLETED|First Intervention (1 Day)||0
276540|NCT02111083|663425|P1|NOT COMPLETED|First Intervention (1 Day)||0
276541|NCT02111083|663424|P2|COMPLETED|First Intervention (1 Day)||19
276542|NCT02111083|663425|P1|COMPLETED|First Intervention (1 Day)||19
276543|NCT02111083|663424|P2|STARTED|First Intervention (1 Day)||19
276544|NCT02111083|663425|P1|STARTED|First Intervention (1 Day)||19
276545|NCT02110381|663445|P2|NOT COMPLETED|Dual Modality||1
276546|NCT02110381|663446|P1|NOT COMPLETED|Dual Modality||2
276547|NCT02110381|663445|P2|COMPLETED|Dual Modality||7
276548|NCT02110381|663446|P1|COMPLETED|Dual Modality||5
276549|NCT02110381|663445|P2|Began Active Treatment|Dual Modality||7
276550|NCT02110381|663446|P1|Began Active Treatment|Dual Modality||7
276551|NCT02110381|663445|P2|STARTED|Dual Modality||8
276552|NCT02110381|663446|P1|STARTED|Dual Modality||7
276553|NCT02110381|663445|P2|NOT COMPLETED|Single Modality||1
276554|NCT02110381|663446|P1|NOT COMPLETED|Single Modality||2
276555|NCT02110381|663445|P2|COMPLETED|Single Modality||8
276556|NCT02110381|663446|P1|COMPLETED|Single Modality||7
276557|NCT02110381|663445|P2|STARTED|Single Modality||9
276558|NCT02110381|663446|P1|STARTED|Single Modality||9
276559|NCT02110238|663459|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
276560|NCT02110238|663460|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
276561|NCT02110238|663459|P2|COMPLETED|14 Week Blinded Extension Phase||188
276562|NCT02110238|663460|P1|COMPLETED|14 Week Blinded Extension Phase||190
276563|NCT02110238|663459|P2|STARTED|14 Week Blinded Extension Phase||200
276564|NCT02110238|663460|P1|STARTED|14 Week Blinded Extension Phase||202
276565|NCT02110238|663459|P2|NOT COMPLETED|12 Week Pivotal Phase||9
276566|NCT02110238|663460|P1|NOT COMPLETED|12 Week Pivotal Phase||10
276567|NCT02110238|663459|P2|COMPLETED|12 Week Pivotal Phase||200
276568|NCT02110238|663460|P1|COMPLETED|12 Week Pivotal Phase||202
276569|NCT02110238|663459|P2|STARTED|12 Week Pivotal Phase||209
276570|NCT02110238|663460|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
276571|NCT02109731|663466|P1|NOT COMPLETED|Overall Study||0
276572|NCT02109731|663466|P1|COMPLETED|Overall Study||15
276573|NCT02109731|663466|P1|STARTED|Overall Study||15
276574|NCT02109640|663472|P2|NOT COMPLETED|Overall Study||0
276575|NCT02109640|663473|P1|NOT COMPLETED|Overall Study||0
276576|NCT02109640|663472|P2|COMPLETED|Overall Study||23
276577|NCT02109640|663473|P1|COMPLETED|Overall Study||27
276578|NCT02109640|663472|P2|STARTED|Overall Study||23
276579|NCT02109640|663473|P1|STARTED|Overall Study||27
276580|NCT02109497|663483|P1|NOT COMPLETED|Overall Study||1
276581|NCT02109497|663483|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
276582|NCT02109497|663483|P1|STARTED|Overall Study||18
276583|NCT02109458|663488|P1|NOT COMPLETED|Overall Study||0
276584|NCT02109458|663488|P1|COMPLETED|Overall Study||24
276585|NCT02109458|663488|P1|STARTED|Overall Study||24
276586|NCT02109445|663495|P1|NOT COMPLETED|Overall Study||3
276587|NCT02109445|663495|P1|COMPLETED|Overall Study||0
276588|NCT02109445|663495|P1|STARTED|Overall Study||3
276589|NCT02109172|663528|P6|NOT COMPLETED|Overall Study||1
276590|NCT02109172|663529|P5|NOT COMPLETED|Overall Study||1
276591|NCT02109172|663530|P4|NOT COMPLETED|Overall Study||1
276592|NCT02109172|663531|P3|NOT COMPLETED|Overall Study||1
276593|NCT02109172|663532|P2|NOT COMPLETED|Overall Study||0
276594|NCT02109172|663533|P1|NOT COMPLETED|Overall Study||1
276595|NCT02109172|663528|P6|COMPLETED|Overall Study||10
276596|NCT02109172|663529|P5|COMPLETED|Overall Study||9
276597|NCT02109172|663530|P4|COMPLETED|Overall Study||10
276598|NCT02109172|663531|P3|COMPLETED|Overall Study||9
276599|NCT02109172|663532|P2|COMPLETED|Overall Study||11
276600|NCT02109172|663533|P1|COMPLETED|Overall Study||10
276601|NCT02109172|663528|P6|STARTED|Overall Study||11
276602|NCT02109172|663529|P5|STARTED|Overall Study||10
276603|NCT02109172|663530|P4|STARTED|Overall Study||11
276604|NCT02109172|663531|P3|STARTED|Overall Study||10
276605|NCT02109172|663532|P2|STARTED|Overall Study||11
276606|NCT02109172|663533|P1|STARTED|Overall Study||11
276607|NCT02109159|663543|P2|NOT COMPLETED|Overall Study||0
276608|NCT02109159|663544|P1|NOT COMPLETED|Overall Study||0
276609|NCT02109159|663543|P2|COMPLETED|Overall Study||4175
276610|NCT02109159|663544|P1|COMPLETED|Overall Study||4178
276611|NCT02109159|663543|P2|STARTED|Overall Study||4175
276612|NCT02109159|663544|P1|STARTED|Overall Study||4178
276613|NCT02109133|663554|P2|NOT COMPLETED|Overall Study||0
276614|NCT02109133|663555|P1|NOT COMPLETED|Overall Study||1
276615|NCT02109133|663554|P2|COMPLETED|Overall Study||34
276616|NCT02109133|663555|P1|COMPLETED|Overall Study||32
276617|NCT02109133|663554|P2|STARTED|Overall Study||34
276618|NCT02109133|663555|P1|STARTED|Overall Study||33
276619|NCT02109107|663567|P1|NOT COMPLETED|Overall Study||2
276620|NCT02109107|663567|P1|COMPLETED|Overall Study||52
276621|NCT02109107|663567|P1|STARTED|Overall Study||54
276622|NCT02108977|663576|P2|NOT COMPLETED|Overall Study||1
276623|NCT02108977|663577|P1|NOT COMPLETED|Overall Study||10
276624|NCT02108977|663576|P2|COMPLETED|Overall Study||19
276625|NCT02108977|663577|P1|COMPLETED|Overall Study||8
276626|NCT02108977|663576|P2|STARTED|Overall Study||20
276627|NCT02108977|663577|P1|STARTED|Overall Study||18
276628|NCT02108691|663591|P2|NOT COMPLETED|Overall Study||9
276629|NCT02108691|663592|P1|NOT COMPLETED|Overall Study||8
276630|NCT02108691|663591|P2|COMPLETED|Overall Study||31
276631|NCT02108691|663592|P1|COMPLETED|Overall Study||32
276632|NCT02108691|663591|P2|STARTED|Overall Study||40
276633|NCT02108691|663592|P1|STARTED|Overall Study||40
276634|NCT02108652|663610|P1|NOT COMPLETED|Overall Study||310
276635|NCT02108652|663610|P1|COMPLETED|Overall Study||0
276636|NCT02108652|663610|P1|STARTED|Overall Study||310
276637|NCT02108288|663634|P3|NOT COMPLETED|Overall Study||0
276638|NCT02108288|663635|P2|NOT COMPLETED|Overall Study||0
276639|NCT02108288|663636|P1|NOT COMPLETED|Overall Study||0
276640|NCT02108288|663634|P3|COMPLETED|Overall Study||10
276641|NCT02108288|663635|P2|COMPLETED|Overall Study||10
276642|NCT02108288|663636|P1|COMPLETED|Overall Study||10
276643|NCT02108288|663634|P3|STARTED|Overall Study||10
276644|NCT02108288|663635|P2|STARTED|Overall Study||10
276645|NCT02108288|663636|P1|STARTED|Overall Study||10
276646|NCT02107196|663651|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
276647|NCT02107196|663652|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
276648|NCT02107196|663651|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
276649|NCT02107196|663652|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
276650|NCT02107196|663651|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
276651|NCT02107196|663652|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
276652|NCT02107196|663651|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
276653|NCT02107196|663652|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
276654|NCT02107196|663651|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
276655|NCT02107196|663652|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
276656|NCT02107196|663651|P2|NOT COMPLETED|12-week Treatment Period||39
276657|NCT02107196|663652|P1|NOT COMPLETED|12-week Treatment Period||44
276658|NCT02107196|663651|P2|COMPLETED|12-week Treatment Period||225
276659|NCT02107196|663652|P1|COMPLETED|12-week Treatment Period||227
276660|NCT02107196|663651|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
276661|NCT02107196|663652|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
276662|NCT02107196|663651|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
276663|NCT02107196|663652|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
276664|NCT02107196|663651|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
276665|NCT02107196|663652|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
276666|NCT02108223|663668|P3|NOT COMPLETED|Overall Study||0
276667|NCT02108223|663669|P2|NOT COMPLETED|Overall Study||0
276668|NCT02108223|663670|P1|NOT COMPLETED|Overall Study||0
276669|NCT02108223|663668|P3|COMPLETED|Overall Study||35
276670|NCT02108223|663669|P2|COMPLETED|Overall Study||50
276671|NCT02108223|663670|P1|COMPLETED|Overall Study||52
276672|NCT02108223|663668|P3|STARTED|Overall Study||35
276673|NCT02108223|663669|P2|STARTED|Overall Study||50
276674|NCT02108223|663670|P1|STARTED|Overall Study||52
276675|NCT02108171|663692|P2|NOT COMPLETED|Overall Study||0
276676|NCT02108171|663693|P1|NOT COMPLETED|Overall Study||0
276677|NCT02108171|663692|P2|COMPLETED|Overall Study||41
276678|NCT02108171|663693|P1|COMPLETED|Overall Study||40
276679|NCT02108171|663692|P2|STARTED|Overall Study||41
276680|NCT02108171|663693|P1|STARTED|Overall Study||40
276681|NCT02107898|663795|P2|NOT COMPLETED|Overall Study||12
276682|NCT02107898|663796|P1|NOT COMPLETED|Overall Study||6
276683|NCT02107898|663795|P2|COMPLETED|Overall Study||132
276684|NCT02107898|663796|P1|COMPLETED|Overall Study||66
276685|NCT02107898|663795|P2|Treated|Overall Study||143
276686|NCT02107898|663796|P1|Treated|Overall Study||72
276687|NCT02107898|663795|P2|STARTED|Overall Study|Randomized|144
276688|NCT02107898|663796|P1|STARTED|Overall Study|Randomized|72
276689|NCT02107599|663848|P1|NOT COMPLETED|Overall Study||0
276690|NCT02107599|663848|P1|COMPLETED|Overall Study||96
276691|NCT02107599|663848|P1|STARTED|Overall Study||96
276692|NCT02107482|663855|P1|NOT COMPLETED|Overall Study||4
276693|NCT02107482|663855|P1|COMPLETED|Overall Study||17
276694|NCT02107482|663855|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
276695|NCT02107339|663863|P2|NOT COMPLETED|Overall Study||4
276696|NCT02107339|663864|P1|NOT COMPLETED|Overall Study||1
276697|NCT02107339|663863|P2|COMPLETED|Overall Study||53
276698|NCT02107339|663864|P1|COMPLETED|Overall Study||62
276699|NCT02107339|663863|P2|STARTED|Overall Study||57
276700|NCT02107339|663864|P1|STARTED|Overall Study||63
276701|NCT02107313|663892|P2|NOT COMPLETED|Overall Study||1
276702|NCT02107313|663893|P1|NOT COMPLETED|Overall Study||0
276703|NCT02107313|663892|P2|COMPLETED|Overall Study||8
276704|NCT02107313|663893|P1|COMPLETED|Overall Study||9
276705|NCT02107313|663892|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
276706|NCT02107313|663893|P1|STARTED|Overall Study||9
276707|NCT02107274|663903|P2|NOT COMPLETED|Control Phase||2
276708|NCT02107274|663904|P1|NOT COMPLETED|Control Phase||3
276709|NCT02107274|663903|P2|COMPLETED|Control Phase||35
276710|NCT02107274|663904|P1|COMPLETED|Control Phase||33
276711|NCT02107274|663903|P2|STARTED|Control Phase||37
276712|NCT02107274|663904|P1|STARTED|Control Phase||36
276713|NCT02107274|663903|P2|NOT COMPLETED|Treatment vs. Placebo||2
276714|NCT02107274|663904|P1|NOT COMPLETED|Treatment vs. Placebo||3
276715|NCT02107274|663903|P2|COMPLETED|Treatment vs. Placebo||37
276716|NCT02107274|663904|P1|COMPLETED|Treatment vs. Placebo||36
276717|NCT02107274|663903|P2|STARTED|Treatment vs. Placebo||39
276718|NCT02107274|663904|P1|STARTED|Treatment vs. Placebo||39
276719|NCT02107014|663916|P1|NOT COMPLETED|Overall Study||1
276720|NCT02107014|663916|P1|COMPLETED|Overall Study||8
276721|NCT02107014|663916|P1|STARTED|Overall Study||9
276722|NCT02106923|663987|P6|NOT COMPLETED|Overall Study||1
276723|NCT02106923|663988|P5|NOT COMPLETED|Overall Study||0
276724|NCT02106923|663989|P4|NOT COMPLETED|Overall Study||0
276725|NCT02106923|663990|P3|NOT COMPLETED|Overall Study||0
276726|NCT02106923|663991|P2|NOT COMPLETED|Overall Study||0
276727|NCT02106923|663992|P1|NOT COMPLETED|Overall Study||0
276728|NCT02106923|663987|P6|COMPLETED|Overall Study||11
276729|NCT02106923|663988|P5|COMPLETED|Overall Study||12
276730|NCT02106923|663989|P4|COMPLETED|Overall Study||12
276731|NCT02106923|663990|P3|COMPLETED|Overall Study||12
276732|NCT02106923|663991|P2|COMPLETED|Overall Study||12
276733|NCT02106923|663992|P1|COMPLETED|Overall Study||12
276734|NCT02106923|663987|P6|STARTED|Overall Study||12
276735|NCT02106923|663988|P5|STARTED|Overall Study||12
276736|NCT02106923|663989|P4|STARTED|Overall Study||12
276737|NCT02106923|663990|P3|STARTED|Overall Study||12
276738|NCT02106923|663991|P2|STARTED|Overall Study||12
276739|NCT02106923|663992|P1|STARTED|Overall Study||12
276740|NCT02106728|664038|P2|NOT COMPLETED|Overall Study||0
276741|NCT02106728|664039|P1|NOT COMPLETED|Overall Study||0
276742|NCT02106728|664038|P2|COMPLETED|Overall Study||47
276743|NCT02106728|664039|P1|COMPLETED|Overall Study||70
276744|NCT02106728|664038|P2|STARTED|Overall Study||47
276745|NCT02106728|664039|P1|STARTED|Overall Study||70
276746|NCT02106494|664055|P2|NOT COMPLETED|Overall Study||25
276747|NCT02106494|664056|P1|NOT COMPLETED|Overall Study||26
276748|NCT02106494|664055|P2|COMPLETED|Overall Study||446
276749|NCT02106494|664056|P1|COMPLETED|Overall Study||445
276750|NCT02106494|664055|P2|Efficacy Population|Overall Study||452
276751|NCT02106494|664056|P1|Efficacy Population|Overall Study||450
276752|NCT02106494|664055|P2|Safety Population|Overall Study||459
276753|NCT02106494|664056|P1|Safety Population|Overall Study||456
276754|NCT02106494|664055|P2|STARTED|Overall Study||471
276755|NCT02106494|664056|P1|STARTED|Overall Study||471
276756|NCT02106403|664070|P6|NOT COMPLETED|Follow-Up Visit 3||1
276757|NCT02106403|664071|P5|NOT COMPLETED|Follow-Up Visit 3||0
276758|NCT02106403|664072|P4|NOT COMPLETED|Follow-Up Visit 3||0
276759|NCT02106403|664073|P3|NOT COMPLETED|Follow-Up Visit 3||0
276760|NCT02106403|664074|P2|NOT COMPLETED|Follow-Up Visit 3||0
276761|NCT02106403|664075|P1|NOT COMPLETED|Follow-Up Visit 3||0
276762|NCT02106403|664070|P6|COMPLETED|Follow-Up Visit 3||8
276763|NCT02106403|664071|P5|COMPLETED|Follow-Up Visit 3||8
276764|NCT02106403|664072|P4|COMPLETED|Follow-Up Visit 3||8
276765|NCT02106403|664073|P3|COMPLETED|Follow-Up Visit 3||9
276766|NCT02106403|664074|P2|COMPLETED|Follow-Up Visit 3||8
276767|NCT02106403|664075|P1|COMPLETED|Follow-Up Visit 3||8
276768|NCT02106403|664070|P6|STARTED|Follow-Up Visit 3||9
276769|NCT02106403|664071|P5|STARTED|Follow-Up Visit 3||8
276770|NCT02106403|664072|P4|STARTED|Follow-Up Visit 3||8
276771|NCT02106403|664073|P3|STARTED|Follow-Up Visit 3||9
276772|NCT02106403|664074|P2|STARTED|Follow-Up Visit 3||8
276773|NCT02106403|664075|P1|STARTED|Follow-Up Visit 3||8
276774|NCT02106403|664070|P6|NOT COMPLETED|Follow-Up Visit 2||0
276775|NCT02106403|664071|P5|NOT COMPLETED|Follow-Up Visit 2||0
276776|NCT02106403|664072|P4|NOT COMPLETED|Follow-Up Visit 2||0
276777|NCT02106403|664073|P3|NOT COMPLETED|Follow-Up Visit 2||0
276778|NCT02106403|664074|P2|NOT COMPLETED|Follow-Up Visit 2||0
276779|NCT02106403|664075|P1|NOT COMPLETED|Follow-Up Visit 2||0
276780|NCT02106403|664070|P6|COMPLETED|Follow-Up Visit 2||9
276781|NCT02106403|664071|P5|COMPLETED|Follow-Up Visit 2||8
276782|NCT02106403|664072|P4|COMPLETED|Follow-Up Visit 2||8
276783|NCT02106403|664073|P3|COMPLETED|Follow-Up Visit 2||9
276784|NCT02106403|664074|P2|COMPLETED|Follow-Up Visit 2||8
276785|NCT02106403|664075|P1|COMPLETED|Follow-Up Visit 2||8
276786|NCT02106403|664070|P6|STARTED|Follow-Up Visit 2||9
276787|NCT02106403|664071|P5|STARTED|Follow-Up Visit 2||8
276788|NCT02106403|664072|P4|STARTED|Follow-Up Visit 2||8
276789|NCT02106403|664073|P3|STARTED|Follow-Up Visit 2||9
276790|NCT02106403|664074|P2|STARTED|Follow-Up Visit 2||8
276791|NCT02106403|664075|P1|STARTED|Follow-Up Visit 2||8
276792|NCT02106403|664070|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
276793|NCT02106403|664071|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
276794|NCT02106403|664072|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
276795|NCT02106403|664073|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
276796|NCT02106403|664074|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
276797|NCT02106403|664075|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
276798|NCT02106403|664070|P6|COMPLETED|Visit 1, Treatment Period 3||9
276799|NCT02106403|664071|P5|COMPLETED|Visit 1, Treatment Period 3||8
276800|NCT02106403|664072|P4|COMPLETED|Visit 1, Treatment Period 3||8
276801|NCT02106403|664073|P3|COMPLETED|Visit 1, Treatment Period 3||9
276802|NCT02106403|664074|P2|COMPLETED|Visit 1, Treatment Period 3||8
276803|NCT02106403|664075|P1|COMPLETED|Visit 1, Treatment Period 3||8
276804|NCT02106403|664070|P6|STARTED|Visit 1, Treatment Period 3||9
276805|NCT02106403|664071|P5|STARTED|Visit 1, Treatment Period 3||8
276806|NCT02106403|664072|P4|STARTED|Visit 1, Treatment Period 3||8
276807|NCT02106403|664073|P3|STARTED|Visit 1, Treatment Period 3||9
276808|NCT02106403|664074|P2|STARTED|Visit 1, Treatment Period 3||8
276809|NCT02106403|664075|P1|STARTED|Visit 1, Treatment Period 3||8
276810|NCT02106403|664070|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
276811|NCT02106403|664071|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
276812|NCT02106403|664072|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
276813|NCT02106403|664073|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
276814|NCT02106403|664074|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
276815|NCT02106403|664075|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
276816|NCT02106403|664070|P6|COMPLETED|Visit 1, Treatment Period 2||9
276817|NCT02106403|664071|P5|COMPLETED|Visit 1, Treatment Period 2||8
276818|NCT02106403|664072|P4|COMPLETED|Visit 1, Treatment Period 2||8
276819|NCT02106403|664073|P3|COMPLETED|Visit 1, Treatment Period 2||9
276820|NCT02106403|664074|P2|COMPLETED|Visit 1, Treatment Period 2||8
276821|NCT02106403|664075|P1|COMPLETED|Visit 1, Treatment Period 2||8
276822|NCT02106403|664070|P6|STARTED|Visit 1, Treatment Period 2||9
276823|NCT02106403|664071|P5|STARTED|Visit 1, Treatment Period 2||8
276824|NCT02106403|664072|P4|STARTED|Visit 1, Treatment Period 2||8
276825|NCT02106403|664073|P3|STARTED|Visit 1, Treatment Period 2||9
276826|NCT02106403|664074|P2|STARTED|Visit 1, Treatment Period 2||8
276827|NCT02106403|664075|P1|STARTED|Visit 1, Treatment Period 2||8
276828|NCT02106403|664070|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
276829|NCT02106403|664071|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
276830|NCT02106403|664072|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
276831|NCT02106403|664073|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
276832|NCT02106403|664074|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
276833|NCT02106403|664075|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
276834|NCT02106403|664070|P6|COMPLETED|Visit 1, Treatment Period 1||9
276835|NCT02106403|664071|P5|COMPLETED|Visit 1, Treatment Period 1||8
276836|NCT02106403|664072|P4|COMPLETED|Visit 1, Treatment Period 1||8
276837|NCT02106403|664073|P3|COMPLETED|Visit 1, Treatment Period 1||9
276838|NCT02106403|664074|P2|COMPLETED|Visit 1, Treatment Period 1||8
276839|NCT02106403|664075|P1|COMPLETED|Visit 1, Treatment Period 1||8
276840|NCT02106403|664070|P6|STARTED|Visit 1, Treatment Period 1||9
276841|NCT02106403|664071|P5|STARTED|Visit 1, Treatment Period 1||8
276842|NCT02106403|664072|P4|STARTED|Visit 1, Treatment Period 1||8
276843|NCT02106403|664073|P3|STARTED|Visit 1, Treatment Period 1||9
276844|NCT02106403|664074|P2|STARTED|Visit 1, Treatment Period 1||8
276845|NCT02106403|664075|P1|STARTED|Visit 1, Treatment Period 1||8
276846|NCT02106156|664098|P3|NOT COMPLETED|Overall Study||0
276847|NCT02106156|664099|P2|NOT COMPLETED|Overall Study||40
276848|NCT02106156|664100|P1|NOT COMPLETED|Overall Study||2549
276849|NCT02106156|664098|P3|COMPLETED|Overall Study||518
276850|NCT02106156|664099|P2|COMPLETED|Overall Study||50
276851|NCT02106156|664100|P1|COMPLETED|Overall Study||7071
276852|NCT02106156|664098|P3|STARTED|Overall Study||518
276853|NCT02106156|664099|P2|STARTED|Overall Study||90
276854|NCT02106156|664100|P1|STARTED|Overall Study||9620
276855|NCT02105987|664124|P6|NOT COMPLETED|Continuation Phase||0
276856|NCT02105987|664125|P5|NOT COMPLETED|Continuation Phase||1
276857|NCT02105987|664126|P4|NOT COMPLETED|Continuation Phase||0
276858|NCT02105987|664127|P3|NOT COMPLETED|Continuation Phase||0
276859|NCT02105987|664128|P2|NOT COMPLETED|Continuation Phase||0
276860|NCT02105987|664129|P1|NOT COMPLETED|Continuation Phase||0
276861|NCT02105987|664124|P6|COMPLETED|Continuation Phase||23
276862|NCT02105987|664125|P5|COMPLETED|Continuation Phase||13
276863|NCT02105987|664126|P4|COMPLETED|Continuation Phase||0
276864|NCT02105987|664127|P3|COMPLETED|Continuation Phase||0
276865|NCT02105987|664128|P2|COMPLETED|Continuation Phase||0
276866|NCT02105987|664129|P1|COMPLETED|Continuation Phase||0
276867|NCT02105987|664124|P6|STARTED|Continuation Phase||23
276868|NCT02105987|664125|P5|STARTED|Continuation Phase||14
276869|NCT02105987|664126|P4|STARTED|Continuation Phase||0
276870|NCT02105987|664127|P3|STARTED|Continuation Phase||0
276871|NCT02105987|664128|P2|STARTED|Continuation Phase||0
276872|NCT02105987|664129|P1|STARTED|Continuation Phase||0
276873|NCT02105987|664124|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
276874|NCT02105987|664125|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
276875|NCT02105987|664126|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
276876|NCT02105987|664127|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
276877|NCT02105987|664128|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
276878|NCT02105987|664129|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
276879|NCT02105987|664124|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
276880|NCT02105987|664125|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
276881|NCT02105987|664126|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
276882|NCT02105987|664127|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
276883|NCT02105987|664128|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
276884|NCT02105987|664129|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
276885|NCT02105987|664124|P6|STARTED|Late Switch Phase (24 Weeks)||0
276886|NCT02105987|664125|P5|STARTED|Late Switch Phase (24 Weeks)||0
276887|NCT02105987|664126|P4|STARTED|Late Switch Phase (24 Weeks)||244
276888|NCT02105987|664127|P3|STARTED|Late Switch Phase (24 Weeks)||275
276889|NCT02105987|664128|P2|STARTED|Late Switch Phase (24 Weeks)||0
276890|NCT02105987|664129|P1|STARTED|Late Switch Phase (24 Weeks)||0
276891|NCT02105987|664124|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
276892|NCT02105987|664125|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
276893|NCT02105987|664126|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
276894|NCT02105987|664127|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
276895|NCT02105987|664128|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
276896|NCT02105987|664129|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
276897|NCT02105987|664124|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
276898|NCT02105987|664125|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
276899|NCT02105987|664126|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
276900|NCT02105987|664127|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
276901|NCT02105987|664128|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
276902|NCT02105987|664129|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
276903|NCT02105987|664124|P6|STARTED|Early Switch Phase (24 Weeks)||0
276904|NCT02105987|664125|P5|STARTED|Early Switch Phase (24 Weeks)||0
276905|NCT02105987|664126|P4|STARTED|Early Switch Phase (24 Weeks)||0
276906|NCT02105987|664127|P3|STARTED|Early Switch Phase (24 Weeks)||0
276907|NCT02105987|664128|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
276908|NCT02105987|664129|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
276909|NCT02105974|664183|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
276910|NCT02105974|664184|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
276911|NCT02105974|664185|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
276912|NCT02105974|664183|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
276913|NCT02105974|664184|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
276914|NCT02105974|664185|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
276915|NCT02105974|664183|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
276916|NCT02105974|664184|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
276917|NCT02105974|664185|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
276918|NCT02105974|664183|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
276919|NCT02105974|664184|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
276920|NCT02105974|664185|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
276921|NCT02105974|664183|P3|NOT COMPLETED|2 Week Run-in Period||0
276922|NCT02105974|664184|P2|NOT COMPLETED|2 Week Run-in Period||0
276923|NCT02105974|664185|P1|NOT COMPLETED|2 Week Run-in Period||801
276924|NCT02105974|664183|P3|COMPLETED|2 Week Run-in Period||0
276925|NCT02105974|664184|P2|COMPLETED|2 Week Run-in Period||0
276926|NCT02105974|664185|P1|COMPLETED|2 Week Run-in Period||1622
276927|NCT02105974|664183|P3|STARTED|2 Week Run-in Period||0
276928|NCT02105974|664184|P2|STARTED|2 Week Run-in Period||0
276929|NCT02105974|664185|P1|STARTED|2 Week Run-in Period||2423
276930|NCT02105740|664197|P2|NOT COMPLETED|Overall Study||1
276931|NCT02105740|664198|P1|NOT COMPLETED|Overall Study||0
276932|NCT02105740|664197|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
276933|NCT02105740|664198|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
276934|NCT02105740|664197|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
276935|NCT02105740|664198|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
276936|NCT02105740|664197|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
276937|NCT02105740|664198|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
276938|NCT02105701|664210|P4|NOT COMPLETED|Overall Study||2
276939|NCT02105701|664211|P3|NOT COMPLETED|Overall Study||3
276940|NCT02105701|664212|P2|NOT COMPLETED|Overall Study||1
276941|NCT02105701|664213|P1|NOT COMPLETED|Overall Study||4
276942|NCT02105701|664210|P4|COMPLETED|Overall Study||104
276943|NCT02105701|664211|P3|COMPLETED|Overall Study||102
276944|NCT02105701|664212|P2|COMPLETED|Overall Study||103
276945|NCT02105701|664213|P1|COMPLETED|Overall Study||101
276946|NCT02105701|664210|P4|STARTED|Overall Study||106
276947|NCT02105701|664211|P3|STARTED|Overall Study||105
276948|NCT02105701|664212|P2|STARTED|Overall Study||104
276949|NCT02105701|664213|P1|STARTED|Overall Study||105
276950|NCT02105688|664237|P2|NOT COMPLETED|Overall Study||99
276951|NCT02105688|664238|P1|NOT COMPLETED|Overall Study||26
276952|NCT02105688|664237|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
276953|NCT02105688|664238|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
276954|NCT02105688|664237|P2|Not Reached FU Week 12 Visit|Overall Study||15
276955|NCT02105688|664238|P1|Not Reached FU Week 12 Visit|Overall Study||2
276956|NCT02105688|664237|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
276957|NCT02105688|664238|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
276958|NCT02105688|664237|P2|STARTED|Overall Study||100
276959|NCT02105688|664238|P1|STARTED|Overall Study||201
276960|NCT02105662|664248|P1|NOT COMPLETED|Overall Study||6
276961|NCT02105662|664248|P1|COMPLETED|Overall Study||212
276962|NCT02105662|664248|P1|STARTED|Overall Study||218
276963|NCT02105636|664257|P2|NOT COMPLETED|Overall Study||108
276964|NCT02105636|664258|P1|NOT COMPLETED|Overall Study||195
276965|NCT02105636|664257|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
276966|NCT02105636|664258|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
276967|NCT02105636|664257|P2|STARTED|Overall Study||111
276968|NCT02105636|664258|P1|STARTED|Overall Study||236
276969|NCT02105467|664270|P2|NOT COMPLETED|Period 3||1
276970|NCT02105467|664271|P1|NOT COMPLETED|Period 3||0
276971|NCT02105467|664270|P2|COMPLETED|Period 3||102
276972|NCT02105467|664271|P1|COMPLETED|Period 3||0
276973|NCT02105467|664270|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
276974|NCT02105467|664271|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
276975|NCT02105467|664270|P2|NOT COMPLETED|Period 2||2
276976|NCT02105467|664271|P1|NOT COMPLETED|Period 2||2
276977|NCT02105467|664270|P2|COMPLETED|Period 2||102
276978|NCT02105467|664271|P1|COMPLETED|Period 2||312
276979|NCT02105467|664270|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
276980|NCT02105467|664271|P1|STARTED|Period 2||314
276981|NCT02105467|664270|P2|NOT COMPLETED|Period 1||0
276982|NCT02105467|664271|P1|NOT COMPLETED|Period 1||2
276983|NCT02105467|664270|P2|COMPLETED|Period 1||105
276984|NCT02105467|664271|P1|COMPLETED|Period 1||314
276985|NCT02105467|664270|P2|STARTED|Period 1||105
276986|NCT02105467|664271|P1|STARTED|Period 1||316
276987|NCT02105454|664283|P1|NOT COMPLETED|Overall Study||1
276988|NCT02105454|664283|P1|COMPLETED|Overall Study||78
276989|NCT02105454|664283|P1|STARTED|Overall Study||79
276990|NCT02105285|664293|P3|NOT COMPLETED|Overall Study||0
276991|NCT02105285|664294|P2|NOT COMPLETED|Overall Study||2
276992|NCT02105285|664295|P1|NOT COMPLETED|Overall Study||2
276993|NCT02105285|664293|P3|COMPLETED|Overall Study||37
276994|NCT02105285|664294|P2|COMPLETED|Overall Study||76
276995|NCT02105285|664295|P1|COMPLETED|Overall Study||76
276996|NCT02105285|664293|P3|STARTED|Overall Study||37
276997|NCT02105285|664294|P2|STARTED|Overall Study||78
276998|NCT02105285|664295|P1|STARTED|Overall Study||78
276999|NCT02105272|664314|P2|NOT COMPLETED|Overall Study||3
277000|NCT02105272|664315|P1|NOT COMPLETED|Overall Study||5
277001|NCT02105272|664314|P2|COMPLETED|Overall Study||116
277002|NCT02105272|664315|P1|COMPLETED|Overall Study||113
277003|NCT02105272|664314|P2|STARTED|Overall Study||119
277004|NCT02105272|664315|P1|STARTED|Overall Study||118
277005|NCT02105012|664331|P1|NOT COMPLETED|Overall Study||33
277006|NCT02105012|664331|P1|COMPLETED|Overall Study||114
277007|NCT02105012|664331|P1|Placebo MDI|Overall Study||127
277008|NCT02105012|664331|P1|BD MDI 40 µg|Overall Study||63
277009|NCT02105012|664331|P1|BD MDI 80 µg|Overall Study||64
277010|NCT02105012|664331|P1|BD MDI 160 µg|Overall Study||132
277011|NCT02105012|664331|P1|BD MDI 320 µg|Overall Study||124
277012|NCT02105012|664331|P1|STARTED|Overall Study||147
277013|NCT02104895|664365|P2|NOT COMPLETED|Overall Study||14
277014|NCT02104895|664366|P1|NOT COMPLETED|Overall Study||0
277015|NCT02104895|664365|P2|COMPLETED|Overall Study||246
277016|NCT02104895|664366|P1|COMPLETED|Overall Study||260
277017|NCT02104895|664365|P2|STARTED|Overall Study||260
277018|NCT02104895|664366|P1|STARTED|Overall Study||260
277019|NCT02104830|664379|P3|NOT COMPLETED|Overall Study||7
277020|NCT02104830|664380|P2|NOT COMPLETED|Overall Study||7
277021|NCT02104830|664381|P1|NOT COMPLETED|Overall Study||4
277022|NCT02104830|664379|P3|COMPLETED|Overall Study||36
277023|NCT02104830|664380|P2|COMPLETED|Overall Study||36
277024|NCT02104830|664381|P1|COMPLETED|Overall Study||38
277025|NCT02104830|664379|P3|STARTED|Overall Study||43
277026|NCT02104830|664380|P2|STARTED|Overall Study||43
277027|NCT02104830|664381|P1|STARTED|Overall Study||42
277028|NCT02104219|664404|P1|NOT COMPLETED|Overall Study||0
277029|NCT02104219|664404|P1|COMPLETED|Overall Study||32
277030|NCT02104219|664404|P1|STARTED|Overall Study||32
277031|NCT02103439|664413|P2|NOT COMPLETED|Overall Study||3
277032|NCT02103439|664414|P1|NOT COMPLETED|Overall Study||3
277033|NCT02103439|664413|P2|COMPLETED|Overall Study||67
277034|NCT02103439|664414|P1|COMPLETED|Overall Study||67
277035|NCT02103439|664413|P2|STARTED|Overall Study||70
277036|NCT02103439|664414|P1|STARTED|Overall Study||70
277037|NCT02103309|664434|P2|NOT COMPLETED|Overall Study||0
277038|NCT02103309|664435|P1|NOT COMPLETED|Overall Study||0
277039|NCT02103309|664434|P2|COMPLETED|Overall Study||22
277040|NCT02103309|664435|P1|COMPLETED|Overall Study||20
277041|NCT02103309|664434|P2|STARTED|Overall Study||22
277042|NCT02103309|664435|P1|STARTED|Overall Study||20
277043|NCT02103062|664449|P2|NOT COMPLETED|Overall Study||23
277044|NCT02103062|664450|P1|NOT COMPLETED|Overall Study||18
277045|NCT02103062|664449|P2|COMPLETED|Overall Study||0
277046|NCT02103062|664450|P1|COMPLETED|Overall Study||0
277047|NCT02103062|664449|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
277048|NCT02103062|664450|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
277049|NCT02103062|664449|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
277050|NCT02103062|664450|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
277051|NCT02103062|664449|P2|STARTED|Overall Study||23
277052|NCT02103062|664450|P1|STARTED|Overall Study||18
277053|NCT02102932|664476|P8|NOT COMPLETED|Overall Study||0
277054|NCT02102932|664477|P7|NOT COMPLETED|Overall Study||0
277055|NCT02102932|664478|P6|NOT COMPLETED|Overall Study||0
277056|NCT02102932|664479|P5|NOT COMPLETED|Overall Study||0
277057|NCT02102932|664480|P4|NOT COMPLETED|Overall Study||0
277058|NCT02102932|664481|P3|NOT COMPLETED|Overall Study||0
277059|NCT02102932|664482|P2|NOT COMPLETED|Overall Study||0
277060|NCT02102932|664483|P1|NOT COMPLETED|Overall Study||0
277061|NCT02102932|664476|P8|COMPLETED|Overall Study||12
277062|NCT02102932|664477|P7|COMPLETED|Overall Study||12
277063|NCT02102932|664478|P6|COMPLETED|Overall Study||12
277064|NCT02102932|664479|P5|COMPLETED|Overall Study||12
277065|NCT02102932|664480|P4|COMPLETED|Overall Study||12
277066|NCT02102932|664481|P3|COMPLETED|Overall Study||12
277067|NCT02102932|664482|P2|COMPLETED|Overall Study||12
277068|NCT02102932|664483|P1|COMPLETED|Overall Study||12
277069|NCT02102932|664476|P8|STARTED|Overall Study||12
277070|NCT02102932|664477|P7|STARTED|Overall Study||12
277071|NCT02102932|664478|P6|STARTED|Overall Study||12
277072|NCT02102932|664479|P5|STARTED|Overall Study||12
277073|NCT02102932|664480|P4|STARTED|Overall Study||12
277074|NCT02102932|664481|P3|STARTED|Overall Study||12
277075|NCT02102932|664482|P2|STARTED|Overall Study||12
277076|NCT02102932|664483|P1|STARTED|Overall Study||12
277077|NCT02102399|664543|P2|NOT COMPLETED|Overall Study||4
277078|NCT02102399|664544|P1|NOT COMPLETED|Overall Study||6
277079|NCT02102399|664543|P2|COMPLETED|Overall Study||17
277080|NCT02102399|664544|P1|COMPLETED|Overall Study||14
277081|NCT02102399|664543|P2|STARTED|Overall Study||21
277082|NCT02102399|664544|P1|STARTED|Overall Study||20
277083|NCT02101359|664594|P2|NOT COMPLETED|Overall Study||19
277084|NCT02101359|664595|P1|NOT COMPLETED|Overall Study||29
277085|NCT02101359|664594|P2|COMPLETED|Overall Study||277
277086|NCT02101359|664595|P1|COMPLETED|Overall Study||266
277087|NCT02101359|664594|P2|STARTED|Overall Study||296
277088|NCT02101359|664595|P1|STARTED|Overall Study||295
277089|NCT02101294|664601|P1|NOT COMPLETED|Overall Study||11
277090|NCT02101294|664601|P1|COMPLETED|Overall Study||20
277091|NCT02101294|664601|P1|STARTED|Overall Study||31
277092|NCT02101190|664610|P2|NOT COMPLETED|Overall Study||0
277093|NCT02101190|664611|P1|NOT COMPLETED|Overall Study||0
277094|NCT02101190|664610|P2|COMPLETED|Overall Study||8
277095|NCT02101190|664611|P1|COMPLETED|Overall Study||8
277096|NCT02101190|664610|P2|STARTED|Overall Study||8
277097|NCT02101190|664611|P1|STARTED|Overall Study||8
277098|NCT02101112|664621|P6|NOT COMPLETED|Overall Study||0
277099|NCT02101112|664622|P5|NOT COMPLETED|Overall Study||1
277100|NCT02101112|664623|P4|NOT COMPLETED|Overall Study||0
277101|NCT02101112|664624|P3|NOT COMPLETED|Overall Study||1
277102|NCT02101112|664625|P2|NOT COMPLETED|Overall Study||0
277103|NCT02101112|664626|P1|NOT COMPLETED|Overall Study||0
277104|NCT02101112|664621|P6|COMPLETED|Overall Study||5
277105|NCT02101112|664622|P5|COMPLETED|Overall Study||5
277106|NCT02101112|664623|P4|COMPLETED|Overall Study||5
277107|NCT02101112|664624|P3|COMPLETED|Overall Study||5
277108|NCT02101112|664625|P2|COMPLETED|Overall Study||5
277109|NCT02101112|664626|P1|COMPLETED|Overall Study||6
277110|NCT02101112|664621|P6|STARTED|Overall Study||5
277111|NCT02101112|664622|P5|STARTED|Overall Study||6
277112|NCT02101112|664623|P4|STARTED|Overall Study||5
277113|NCT02101112|664624|P3|STARTED|Overall Study||6
277114|NCT02101112|664625|P2|STARTED|Overall Study||5
277115|NCT02101112|664626|P1|STARTED|Overall Study||6
277116|NCT02101008|664651|P1|NOT COMPLETED|Overall Study||0
277117|NCT02101008|664651|P1|COMPLETED|Overall Study||12
277118|NCT02101008|664651|P1|STARTED|Overall Study||12
277119|NCT02100839|664658|P2|NOT COMPLETED|Multiple Ascending Dose||0
277120|NCT02100839|664659|P1|NOT COMPLETED|Multiple Ascending Dose||4
277121|NCT02100839|664658|P2|COMPLETED|Multiple Ascending Dose||3
277122|NCT02100839|664659|P1|COMPLETED|Multiple Ascending Dose||9
277123|NCT02100839|664658|P2|STARTED|Multiple Ascending Dose||3
277124|NCT02100839|664659|P1|STARTED|Multiple Ascending Dose||13
277125|NCT02100839|664658|P2|NOT COMPLETED|Single Ascending Dose||0
277126|NCT02100839|664659|P1|NOT COMPLETED|Single Ascending Dose||0
277127|NCT02100839|664658|P2|COMPLETED|Single Ascending Dose||12
277128|NCT02100839|664659|P1|COMPLETED|Single Ascending Dose||24
277129|NCT02100839|664658|P2|STARTED|Single Ascending Dose||12
277130|NCT02100839|664659|P1|STARTED|Single Ascending Dose||24
277131|NCT02100826|664671|P2|NOT COMPLETED|Period 2 (7 Days)||0
277132|NCT02100826|664672|P1|NOT COMPLETED|Period 2 (7 Days)||0
277133|NCT02100826|664671|P2|COMPLETED|Period 2 (7 Days)||14
277134|NCT02100826|664672|P1|COMPLETED|Period 2 (7 Days)||14
277135|NCT02100826|664671|P2|STARTED|Period 2 (7 Days)||14
277136|NCT02100826|664672|P1|STARTED|Period 2 (7 Days)||14
277137|NCT02100826|664671|P2|NOT COMPLETED|Washout Period (1 Day)||0
277138|NCT02100826|664672|P1|NOT COMPLETED|Washout Period (1 Day)||0
277139|NCT02100826|664671|P2|COMPLETED|Washout Period (1 Day)||14
277140|NCT02100826|664672|P1|COMPLETED|Washout Period (1 Day)||14
277141|NCT02100826|664671|P2|STARTED|Washout Period (1 Day)||14
277142|NCT02100826|664672|P1|STARTED|Washout Period (1 Day)||14
277143|NCT02100826|664671|P2|NOT COMPLETED|Period 1 (7 Days)||0
277144|NCT02100826|664672|P1|NOT COMPLETED|Period 1 (7 Days)||0
277145|NCT02100826|664671|P2|COMPLETED|Period 1 (7 Days)||14
277146|NCT02100826|664672|P1|COMPLETED|Period 1 (7 Days)||14
277147|NCT02100826|664671|P2|STARTED|Period 1 (7 Days)||14
277148|NCT02100826|664672|P1|STARTED|Period 1 (7 Days)||14
277149|NCT02100644|664682|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
277150|NCT02100644|664683|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
277151|NCT02100644|664684|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
277152|NCT02100644|664682|P3|COMPLETED|LTG and VPA Maintenance Phase||20
277153|NCT02100644|664683|P2|COMPLETED|LTG and VPA Maintenance Phase||0
277154|NCT02100644|664684|P1|COMPLETED|LTG and VPA Maintenance Phase||0
277155|NCT02100644|664682|P3|STARTED|LTG and VPA Maintenance Phase||20
277156|NCT02100644|664683|P2|STARTED|LTG and VPA Maintenance Phase||0
277157|NCT02100644|664684|P1|STARTED|LTG and VPA Maintenance Phase||0
277158|NCT02100644|664682|P3|NOT COMPLETED|VPA Reduction Phase||0
277159|NCT02100644|664683|P2|NOT COMPLETED|VPA Reduction Phase||0
277160|NCT02100644|664684|P1|NOT COMPLETED|VPA Reduction Phase||0
277161|NCT02100644|664682|P3|COMPLETED|VPA Reduction Phase||0
277162|NCT02100644|664683|P2|COMPLETED|VPA Reduction Phase||20
277163|NCT02100644|664684|P1|COMPLETED|VPA Reduction Phase||0
277164|NCT02100644|664682|P3|STARTED|VPA Reduction Phase||0
277165|NCT02100644|664683|P2|STARTED|VPA Reduction Phase||20
277166|NCT02100644|664684|P1|STARTED|VPA Reduction Phase||0
277167|NCT02100644|664682|P3|NOT COMPLETED|LTG Escalation Phase||0
277168|NCT02100644|664683|P2|NOT COMPLETED|LTG Escalation Phase||0
277169|NCT02100644|664684|P1|NOT COMPLETED|LTG Escalation Phase||13
277170|NCT02100644|664682|P3|COMPLETED|LTG Escalation Phase||0
277171|NCT02100644|664683|P2|COMPLETED|LTG Escalation Phase||0
277172|NCT02100644|664684|P1|COMPLETED|LTG Escalation Phase||20
277173|NCT02100644|664682|P3|STARTED|LTG Escalation Phase||0
277174|NCT02100644|664683|P2|STARTED|LTG Escalation Phase||0
277175|NCT02100644|664684|P1|STARTED|LTG Escalation Phase||33
277176|NCT02100579|664696|P2|NOT COMPLETED|Overall Study||0
277177|NCT02100579|664697|P1|NOT COMPLETED|Overall Study||0
277178|NCT02100579|664696|P2|COMPLETED|Overall Study||20
277179|NCT02100579|664697|P1|COMPLETED|Overall Study||20
277180|NCT02100579|664696|P2|STARTED|Overall Study||20
277181|NCT02100579|664697|P1|STARTED|Overall Study||20
277182|NCT02100475|664709|P2|NOT COMPLETED|Overall Study||2
277183|NCT02100475|664710|P1|NOT COMPLETED|Overall Study||2
277184|NCT02100475|664709|P2|COMPLETED|Overall Study||13
277185|NCT02100475|664710|P1|COMPLETED|Overall Study||14
277186|NCT02100475|664709|P2|STARTED|Overall Study||15
277187|NCT02100475|664710|P1|STARTED|Overall Study||16
277188|NCT02100410|664720|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
277189|NCT02100410|664721|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
277190|NCT02100410|664722|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
277191|NCT02100410|664723|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
277192|NCT02100410|664724|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
277193|NCT02100410|664725|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
277194|NCT02100410|664720|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
277195|NCT02100410|664721|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
277196|NCT02100410|664722|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
277197|NCT02100410|664723|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
277198|NCT02100410|664724|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
277199|NCT02100410|664725|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
277200|NCT02100410|664720|P6|STARTED|Exposure Pair 3, 30 Minutes||9
277201|NCT02100410|664721|P5|STARTED|Exposure Pair 3, 30 Minutes||8
277202|NCT02100410|664722|P4|STARTED|Exposure Pair 3, 30 Minutes||8
277203|NCT02100410|664723|P3|STARTED|Exposure Pair 3, 30 Minutes||8
277204|NCT02100410|664724|P2|STARTED|Exposure Pair 3, 30 Minutes||8
277205|NCT02100410|664725|P1|STARTED|Exposure Pair 3, 30 Minutes||8
277206|NCT02100410|664720|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
277207|NCT02100410|664721|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
277208|NCT02100410|664722|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
277209|NCT02100410|664723|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
277210|NCT02100410|664724|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
277211|NCT02100410|664725|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
277212|NCT02100410|664720|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
277213|NCT02100410|664721|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
277214|NCT02100410|664722|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
277215|NCT02100410|664723|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
277216|NCT02100410|664724|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
277217|NCT02100410|664725|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
277218|NCT02100410|664720|P6|STARTED|Exposure Pair 2, 30 Minutes||9
277219|NCT02100410|664721|P5|STARTED|Exposure Pair 2, 30 Minutes||8
277220|NCT02100410|664722|P4|STARTED|Exposure Pair 2, 30 Minutes||8
277221|NCT02100410|664723|P3|STARTED|Exposure Pair 2, 30 Minutes||8
277222|NCT02100410|664724|P2|STARTED|Exposure Pair 2, 30 Minutes||8
277223|NCT02100410|664725|P1|STARTED|Exposure Pair 2, 30 Minutes||8
277224|NCT02100410|664720|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
277225|NCT02100410|664721|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
277226|NCT02100410|664722|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
277227|NCT02100410|664723|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
277228|NCT02100410|664724|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
277229|NCT02100410|664725|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
277230|NCT02100410|664720|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
277231|NCT02100410|664721|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
277232|NCT02100410|664722|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
277233|NCT02100410|664723|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
277234|NCT02100410|664724|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
277235|NCT02100410|664725|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
277236|NCT02100410|664720|P6|STARTED|Exposure Pair 1, 30 Minutes||9
277237|NCT02100410|664721|P5|STARTED|Exposure Pair 1, 30 Minutes||8
277238|NCT02100410|664722|P4|STARTED|Exposure Pair 1, 30 Minutes||8
277239|NCT02100410|664723|P3|STARTED|Exposure Pair 1, 30 Minutes||8
277240|NCT02100410|664724|P2|STARTED|Exposure Pair 1, 30 Minutes||8
277241|NCT02100410|664725|P1|STARTED|Exposure Pair 1, 30 Minutes||8
277242|NCT02100189|664741|P1|NOT COMPLETED|Overall Study||0
277243|NCT02100189|664741|P1|COMPLETED|Overall Study||50
277244|NCT02100189|664741|P1|STARTED|Overall Study||50
277245|NCT02099838|664750|P2|NOT COMPLETED|Overall Study||2
277246|NCT02099838|664751|P1|NOT COMPLETED|Overall Study||4
277247|NCT02099838|664750|P2|COMPLETED|Overall Study||49
277248|NCT02099838|664751|P1|COMPLETED|Overall Study||43
277249|NCT02099838|664750|P2|STARTED|Overall Study||51
277250|NCT02099838|664751|P1|STARTED|Overall Study||47
277251|NCT02099708|664781|P1|NOT COMPLETED|Overall Study||200
277252|NCT02099708|664781|P1|COMPLETED|Overall Study||3302
277253|NCT02099708|664781|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
277254|NCT02099708|664781|P1|STARTED|Overall Study|Number of cases.|3502
277255|NCT02099682|664792|P1|NOT COMPLETED|Overall Study||111
277256|NCT02099682|664792|P1|COMPLETED|Overall Study||3255
277257|NCT02099682|664792|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
277258|NCT02099682|664792|P1|STARTED|Overall Study|Number of cases.|3366
277259|NCT02099461|664806|P3|NOT COMPLETED|Overall Study||0
277260|NCT02099461|664807|P2|NOT COMPLETED|Overall Study||0
277261|NCT02099461|664808|P1|NOT COMPLETED|Overall Study||0
277262|NCT02099461|664806|P3|COMPLETED|Overall Study||28
277263|NCT02099461|664807|P2|COMPLETED|Overall Study||27
277264|NCT02099461|664808|P1|COMPLETED|Overall Study||27
277265|NCT02099461|664806|P3|STARTED|Overall Study||28
277266|NCT02099461|664807|P2|STARTED|Overall Study||27
277267|NCT02099461|664808|P1|STARTED|Overall Study||27
277268|NCT02099344|664818|P2|NOT COMPLETED|Overall Study||0
277269|NCT02099344|664819|P1|NOT COMPLETED|Overall Study||1
277270|NCT02099344|664818|P2|COMPLETED|Overall Study||0
277271|NCT02099344|664819|P1|COMPLETED|Overall Study||0
277272|NCT02099344|664818|P2|STARTED|Overall Study||0
277273|NCT02099344|664819|P1|STARTED|Overall Study||1
277274|NCT02099318|664827|P2|NOT COMPLETED|Overall Study||0
277275|NCT02099318|664828|P1|NOT COMPLETED|Overall Study||0
277276|NCT02099318|664827|P2|COMPLETED|Overall Study||20
277277|NCT02099318|664828|P1|COMPLETED|Overall Study||20
277278|NCT02099318|664827|P2|STARTED|Overall Study||20
277279|NCT02099318|664828|P1|STARTED|Overall Study||20
277280|NCT02099266|664842|P1|NOT COMPLETED|Overall Study||0
277281|NCT02099266|664842|P1|COMPLETED|Overall Study||15
277282|NCT02099266|664842|P1|STARTED|Overall Study||15
277283|NCT02099084|664849|P2|NOT COMPLETED|Second Intervention||0
277284|NCT02099084|664850|P1|NOT COMPLETED|Second Intervention||0
277285|NCT02099084|664849|P2|COMPLETED|Second Intervention||4
277286|NCT02099084|664850|P1|COMPLETED|Second Intervention||4
277287|NCT02099084|664849|P2|STARTED|Second Intervention||4
277288|NCT02099084|664850|P1|STARTED|Second Intervention||4
277289|NCT02099084|664849|P2|NOT COMPLETED|Washout Period of 14 Days||0
277290|NCT02099084|664850|P1|NOT COMPLETED|Washout Period of 14 Days||0
277291|NCT02099084|664849|P2|COMPLETED|Washout Period of 14 Days||4
277292|NCT02099084|664850|P1|COMPLETED|Washout Period of 14 Days||4
277293|NCT02099084|664849|P2|STARTED|Washout Period of 14 Days||4
277294|NCT02099084|664850|P1|STARTED|Washout Period of 14 Days||4
277295|NCT02099084|664849|P2|NOT COMPLETED|First Intervention||0
277296|NCT02099084|664850|P1|NOT COMPLETED|First Intervention||0
277297|NCT02099084|664849|P2|COMPLETED|First Intervention||4
277298|NCT02099084|664850|P1|COMPLETED|First Intervention||4
277299|NCT02099084|664849|P2|STARTED|First Intervention||4
277300|NCT02099084|664850|P1|STARTED|First Intervention||4
277301|NCT02099006|664868|P1|NOT COMPLETED|Overall Study||1
277302|NCT02099006|664868|P1|COMPLETED|Overall Study||8
277303|NCT02099006|664868|P1|Received Gabapentin|Overall Study||8
277304|NCT02099006|664868|P1|Received Ketamine|Overall Study||6
277305|NCT02099006|664868|P1|Received Loperamide|Overall Study||7
277306|NCT02099006|664868|P1|Received Ketoprofen|Overall Study||3
277307|NCT02099006|664868|P1|Received Amitriptyline/ Baclofen|Overall Study||7
277308|NCT02099006|664868|P1|Received Placebo|Overall Study||9
277309|NCT02099006|664868|P1|STARTED|Overall Study||9
277310|NCT02098746|664876|P1|NOT COMPLETED|Overall Study||5
277311|NCT02098746|664876|P1|COMPLETED|Overall Study||289
277312|NCT02098746|664876|P1|STARTED|Overall Study||294
277313|NCT02098733|664884|P1|NOT COMPLETED|Overall Study||10
277314|NCT02098733|664884|P1|COMPLETED|Overall Study||1158
277315|NCT02098733|664884|P1|STARTED|Overall Study||1168
277316|NCT02098395|664898|P4|NOT COMPLETED|Overall Study||27
277317|NCT02098395|664899|P3|NOT COMPLETED|Overall Study||42
277318|NCT02098395|664900|P2|NOT COMPLETED|Overall Study||32
277319|NCT02098395|664901|P1|NOT COMPLETED|Overall Study||26
277320|NCT02098395|664898|P4|COMPLETED|Overall Study||180
277321|NCT02098395|664899|P3|COMPLETED|Overall Study||165
277322|NCT02098395|664900|P2|COMPLETED|Overall Study||177
277323|NCT02098395|664901|P1|COMPLETED|Overall Study||186
277324|NCT02098395|664898|P4|Exposed|Overall Study||206
277325|NCT02098395|664899|P3|Exposed|Overall Study||206
277326|NCT02098395|664900|P2|Exposed|Overall Study||209
277327|NCT02098395|664901|P1|Exposed|Overall Study||211
277328|NCT02098395|664898|P4|STARTED|Overall Study||207
277329|NCT02098395|664899|P3|STARTED|Overall Study||207
277330|NCT02098395|664900|P2|STARTED|Overall Study||209
277331|NCT02098395|664901|P1|STARTED|Overall Study||212
277332|NCT02098304|664919|P1|NOT COMPLETED|Overall Study||0
277333|NCT02098304|664919|P1|COMPLETED|Overall Study||42
277334|NCT02098304|664919|P1|STARTED|Overall Study||42
277335|NCT02097849|664928|P2|NOT COMPLETED|Overall Study||0
277336|NCT02097849|664929|P1|NOT COMPLETED|Overall Study||0
277337|NCT02097849|664928|P2|COMPLETED|Overall Study||38
277338|NCT02097849|664929|P1|COMPLETED|Overall Study||33
277339|NCT02097849|664928|P2|STARTED|Overall Study||38
277340|NCT02097849|664929|P1|STARTED|Overall Study||33
277341|NCT02097823|664967|P2|NOT COMPLETED|Overall Study||1
277342|NCT02097823|664968|P1|NOT COMPLETED|Overall Study||1
277343|NCT02097823|664967|P2|COMPLETED|Overall Study||3
277344|NCT02097823|664968|P1|COMPLETED|Overall Study||10
277345|NCT02097823|664967|P2|STARTED|Overall Study||4
277346|NCT02097823|664968|P1|STARTED|Overall Study||11
277347|NCT02097745|664983|P1|NOT COMPLETED|Overall Study||178
277348|NCT02097745|664983|P1|COMPLETED|Overall Study||157
277349|NCT02097745|664983|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
277350|NCT02097719|665007|P2|NOT COMPLETED|Overall Study||1
277351|NCT02097719|665008|P1|NOT COMPLETED|Overall Study||3
277352|NCT02097719|665007|P2|COMPLETED|Overall Study||50
277353|NCT02097719|665008|P1|COMPLETED|Overall Study||46
277354|NCT02097719|665007|P2|STARTED|Overall Study||51
277355|NCT02097719|665008|P1|STARTED|Overall Study||49
277356|NCT02097537|665014|P1|NOT COMPLETED|Overall Study||0
277357|NCT02097537|665014|P1|COMPLETED|Overall Study||10
277358|NCT02097537|665014|P1|Follow-Up|Overall Study||10
277359|NCT02097537|665014|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
277360|NCT02097537|665014|P1|STARTED|Overall Study||10
277361|NCT02097108|665020|P1|NOT COMPLETED|Overall Study||2
277362|NCT02097108|665020|P1|COMPLETED|Overall Study||9
277363|NCT02097108|665020|P1|STARTED|Overall Study||11
277364|NCT02097056|665027|P1|NOT COMPLETED|Overall Study||58
277365|NCT02097056|665027|P1|COMPLETED|Overall Study||113
277366|NCT02097056|665027|P1|ParticipantsTreated|Overall Study||170
277367|NCT02097056|665027|P1|STARTED|Overall Study||171
277368|NCT02097030|665035|P2|NOT COMPLETED|Second Intervention (3 Days)||0
277369|NCT02097030|665036|P1|NOT COMPLETED|Second Intervention (3 Days)||0
277370|NCT02097030|665035|P2|COMPLETED|Second Intervention (3 Days)||16
277371|NCT02097030|665036|P1|COMPLETED|Second Intervention (3 Days)||14
277372|NCT02097030|665035|P2|STARTED|Second Intervention (3 Days)||16
277373|NCT02097030|665036|P1|STARTED|Second Intervention (3 Days)||14
277374|NCT02097030|665035|P2|NOT COMPLETED|First Intervention (3 Days)||1
277375|NCT02097030|665036|P1|NOT COMPLETED|First Intervention (3 Days)||1
277376|NCT02097030|665035|P2|COMPLETED|First Intervention (3 Days)||16
277377|NCT02097030|665036|P1|COMPLETED|First Intervention (3 Days)||14
277378|NCT02097030|665035|P2|STARTED|First Intervention (3 Days)||17
277379|NCT02097030|665036|P1|STARTED|First Intervention (3 Days)||15
277380|NCT02096835|665100|P3|NOT COMPLETED|Overall Study||1
277381|NCT02096835|665101|P2|NOT COMPLETED|Overall Study||0
277382|NCT02096835|665102|P1|NOT COMPLETED|Overall Study||3
277383|NCT02096835|665100|P3|COMPLETED|Overall Study||50
277384|NCT02096835|665101|P2|COMPLETED|Overall Study||53
277385|NCT02096835|665102|P1|COMPLETED|Overall Study||50
277386|NCT02096835|665100|P3|STARTED|Overall Study||51
277387|NCT02096835|665101|P2|STARTED|Overall Study||53
277388|NCT02096835|665102|P1|STARTED|Overall Study||53
277389|NCT02096744|665119|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
277390|NCT02096744|665120|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
277391|NCT02096744|665119|P2|COMPLETED|Treatment Period 3 (7 Days)||27
277392|NCT02096744|665120|P1|COMPLETED|Treatment Period 3 (7 Days)||28
277393|NCT02096744|665119|P2|STARTED|Treatment Period 3 (7 Days)||28
277394|NCT02096744|665120|P1|STARTED|Treatment Period 3 (7 Days)||28
277395|NCT02096744|665119|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
277396|NCT02096744|665120|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
277397|NCT02096744|665119|P2|COMPLETED|Washout Period 2 (3 Days)||28
277398|NCT02096744|665120|P1|COMPLETED|Washout Period 2 (3 Days)||28
277399|NCT02096744|665119|P2|STARTED|Washout Period 2 (3 Days)||28
277400|NCT02096744|665120|P1|STARTED|Washout Period 2 (3 Days)||28
277401|NCT02096744|665119|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
277402|NCT02096744|665120|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
277403|NCT02096744|665119|P2|COMPLETED|Treatment Period 2 (7 Days)||28
277404|NCT02096744|665120|P1|COMPLETED|Treatment Period 2 (7 Days)||28
277405|NCT02096744|665119|P2|STARTED|Treatment Period 2 (7 Days)||28
277406|NCT02096744|665120|P1|STARTED|Treatment Period 2 (7 Days)||28
277407|NCT02096744|665119|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
277408|NCT02096744|665120|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
277409|NCT02096744|665119|P2|COMPLETED|Washout Period 1(7 Days)||28
277410|NCT02096744|665120|P1|COMPLETED|Washout Period 1(7 Days)||28
277411|NCT02096744|665119|P2|STARTED|Washout Period 1(7 Days)||28
277412|NCT02096744|665120|P1|STARTED|Washout Period 1(7 Days)||28
277413|NCT02096744|665119|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
277414|NCT02096744|665120|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
277415|NCT02096744|665119|P2|COMPLETED|Treatment Period 1(7 Days)||28
277416|NCT02096744|665120|P1|COMPLETED|Treatment Period 1(7 Days)||28
277417|NCT02096744|665119|P2|STARTED|Treatment Period 1(7 Days)||29
277418|NCT02096744|665120|P1|STARTED|Treatment Period 1(7 Days)||29
277419|NCT02096731|665135|P2|NOT COMPLETED|Overall Study||0
277420|NCT02096731|665136|P1|NOT COMPLETED|Overall Study||0
277421|NCT02096731|665135|P2|COMPLETED|Overall Study||88955
277422|NCT02096731|665136|P1|COMPLETED|Overall Study||26442
277423|NCT02096731|665135|P2|STARTED|Overall Study||88955
277424|NCT02096731|665136|P1|STARTED|Overall Study||26442
277425|NCT02096718|665153|P3|NOT COMPLETED|Overall Study||0
277426|NCT02096718|665154|P2|NOT COMPLETED|Overall Study||0
277427|NCT02096718|665155|P1|NOT COMPLETED|Overall Study||0
277428|NCT02096718|665153|P3|COMPLETED|Overall Study||14
277429|NCT02096718|665154|P2|COMPLETED|Overall Study||8
277430|NCT02096718|665155|P1|COMPLETED|Overall Study||8
277431|NCT02096718|665153|P3|STARTED|Overall Study||14
277432|NCT02096718|665154|P2|STARTED|Overall Study||8
277433|NCT02096718|665155|P1|STARTED|Overall Study||8
277434|NCT02096705|665174|P2|NOT COMPLETED|Follow-up||4
277435|NCT02096705|665175|P1|NOT COMPLETED|Follow-up||4
277436|NCT02096705|665174|P2|COMPLETED|Follow-up||135
277437|NCT02096705|665175|P1|COMPLETED|Follow-up||125
277438|NCT02096705|665174|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
277439|NCT02096705|665175|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
277440|NCT02096705|665174|P2|NOT COMPLETED|Treatment||5
277441|NCT02096705|665175|P1|NOT COMPLETED|Treatment||9
277442|NCT02096705|665174|P2|COMPLETED|Treatment||134
277443|NCT02096705|665175|P1|COMPLETED|Treatment||124
277444|NCT02096705|665174|P2|STARTED|Treatment||139
277445|NCT02096705|665175|P1|STARTED|Treatment||133
277446|NCT02096692|665187|P1|NOT COMPLETED|Overall Study||4
277447|NCT02096692|665187|P1|COMPLETED|Overall Study||150
277448|NCT02096692|665187|P1|STARTED|Overall Study||154
277449|NCT02096679|665193|P1|NOT COMPLETED|Overall Study||0
277450|NCT02096679|665193|P1|COMPLETED|Overall Study||8
277451|NCT02096679|665193|P1|STARTED|Overall Study||8
277452|NCT02096575|665218|P3|NOT COMPLETED|Overall Study||5
277453|NCT02096575|665219|P2|NOT COMPLETED|Overall Study||0
277454|NCT02096575|665220|P1|NOT COMPLETED|Overall Study||0
277455|NCT02096575|665218|P3|COMPLETED|Overall Study||0
277456|NCT02096575|665219|P2|COMPLETED|Overall Study||67
277457|NCT02096575|665220|P1|COMPLETED|Overall Study||68
277458|NCT02096575|665218|P3|STARTED|Overall Study||5
277459|NCT02096575|665219|P2|STARTED|Overall Study||67
277460|NCT02096575|665220|P1|STARTED|Overall Study||68
277461|NCT02096458|665234|P1|NOT COMPLETED|Overall Study||0
277462|NCT02096458|665234|P1|COMPLETED|Overall Study||8
277463|NCT02096458|665234|P1|STARTED|Overall Study||8
277464|NCT02096081|665240|P2|NOT COMPLETED|Overall Study||4
277465|NCT02096081|665241|P1|NOT COMPLETED|Overall Study||3
277466|NCT02096081|665240|P2|COMPLETED|Overall Study||124
277467|NCT02096081|665241|P1|COMPLETED|Overall Study||119
277468|NCT02096081|665240|P2|STARTED|Overall Study||128
277469|NCT02096081|665241|P1|STARTED|Overall Study||122
277470|NCT02095873|665275|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
277471|NCT02095873|665276|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
277472|NCT02095873|665275|P2|COMPLETED|Second Intervention (8 Weeks)||16
277473|NCT02095873|665276|P1|COMPLETED|Second Intervention (8 Weeks)||13
277474|NCT02095873|665275|P2|STARTED|Second Intervention (8 Weeks)||16
277475|NCT02095873|665276|P1|STARTED|Second Intervention (8 Weeks)||15
277476|NCT02095873|665275|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
277477|NCT02095873|665276|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
277478|NCT02095873|665275|P2|COMPLETED|First Intervention (8 Weeks)||16
277479|NCT02095873|665276|P1|COMPLETED|First Intervention (8 Weeks)||15
277480|NCT02095873|665275|P2|STARTED|First Intervention (8 Weeks)||16
277481|NCT02095873|665276|P1|STARTED|First Intervention (8 Weeks)||16
277482|NCT02095691|665288|P1|NOT COMPLETED|Overall Study||1
277483|NCT02095691|665288|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
277484|NCT02095691|665288|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
277485|NCT02095561|665307|P2|NOT COMPLETED|Overall Study||0
277486|NCT02095561|665308|P1|NOT COMPLETED|Overall Study||0
277487|NCT02095561|665307|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
277488|NCT02095561|665308|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
277489|NCT02095561|665307|P2|HPV Tested at Health Centers|Overall Study||599
277490|NCT02095561|665308|P1|HPV Tested at Health Centers|Overall Study||99
277491|NCT02095561|665307|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
277492|NCT02095561|665308|P1|HPV Self-tested Women|Overall Study||2519
277493|NCT02095561|665307|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
277494|NCT02095561|665308|P1|Self-testing Acceptability|Overall Study||2616
277495|NCT02095561|665307|P2|STARTED|Overall Study||2964
277496|NCT02095561|665308|P1|STARTED|Overall Study||3049
277497|NCT02095223|665322|P2|NOT COMPLETED|Overall Study||0
277498|NCT02095223|665323|P1|NOT COMPLETED|Overall Study||1
277499|NCT02095223|665322|P2|COMPLETED|Overall Study||2
277500|NCT02095223|665323|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
277501|NCT02095223|665322|P2|STARTED|Overall Study||2
277502|NCT02095223|665323|P1|STARTED|Overall Study||2
277503|NCT02095197|665333|P2|NOT COMPLETED|Overall Study||3
277504|NCT02095197|665334|P1|NOT COMPLETED|Overall Study||0
277505|NCT02095197|665333|P2|COMPLETED|Overall Study||36
277506|NCT02095197|665334|P1|COMPLETED|Overall Study||40
277507|NCT02095197|665333|P2|STARTED|Overall Study||39
277508|NCT02095197|665334|P1|STARTED|Overall Study||40
277509|NCT02095158|665346|P1|NOT COMPLETED|Overall Study||75
277510|NCT02095158|665346|P1|COMPLETED|Overall Study||365
277511|NCT02095158|665346|P1|STARTED|Overall Study||440
277512|NCT02094937|665351|P4|NOT COMPLETED|12 Weeks in Period 2||12
277513|NCT02094937|665352|P3|NOT COMPLETED|12 Weeks in Period 2||12
277514|NCT02094937|665353|P2|NOT COMPLETED|12 Weeks in Period 2||11
277515|NCT02094937|665354|P1|NOT COMPLETED|12 Weeks in Period 2||0
277516|NCT02094937|665351|P4|COMPLETED|12 Weeks in Period 2||112
277517|NCT02094937|665352|P3|COMPLETED|12 Weeks in Period 2||112
277518|NCT02094937|665353|P2|COMPLETED|12 Weeks in Period 2||112
277519|NCT02094937|665354|P1|COMPLETED|12 Weeks in Period 2||0
277520|NCT02094937|665351|P4|STARTED|12 Weeks in Period 2||124
277521|NCT02094937|665352|P3|STARTED|12 Weeks in Period 2||124
277522|NCT02094937|665353|P2|STARTED|12 Weeks in Period 2||123
277523|NCT02094937|665354|P1|STARTED|12 Weeks in Period 2||0
277524|NCT02094937|665351|P4|NOT COMPLETED|8 Weeks in Period 1||0
277525|NCT02094937|665352|P3|NOT COMPLETED|8 Weeks in Period 1||0
277526|NCT02094937|665353|P2|NOT COMPLETED|8 Weeks in Period 1||0
277527|NCT02094937|665354|P1|NOT COMPLETED|8 Weeks in Period 1||60
277528|NCT02094937|665351|P4|COMPLETED|8 Weeks in Period 1||0
277529|NCT02094937|665352|P3|COMPLETED|8 Weeks in Period 1||0
277530|NCT02094937|665353|P2|COMPLETED|8 Weeks in Period 1||0
277531|NCT02094937|665354|P1|COMPLETED|8 Weeks in Period 1||370
277532|NCT02094937|665351|P4|STARTED|8 Weeks in Period 1||0
277533|NCT02094937|665352|P3|STARTED|8 Weeks in Period 1||0
277534|NCT02094937|665353|P2|STARTED|8 Weeks in Period 1||0
277535|NCT02094937|665354|P1|STARTED|8 Weeks in Period 1||430
277536|NCT02094885|665386|P2|NOT COMPLETED|Overall Study||5
277537|NCT02094885|665387|P1|NOT COMPLETED|Overall Study||2
277538|NCT02094885|665386|P2|COMPLETED|Overall Study||122
277539|NCT02094885|665387|P1|COMPLETED|Overall Study||123
277540|NCT02094885|665386|P2|STARTED|Overall Study||127
277541|NCT02094885|665387|P1|STARTED|Overall Study||125
277542|NCT02094677|665401|P2|NOT COMPLETED|Overall Study||1
277543|NCT02094677|665402|P1|NOT COMPLETED|Overall Study||3
277544|NCT02094677|665401|P2|COMPLETED|Overall Study||30
277545|NCT02094677|665402|P1|COMPLETED|Overall Study||40
277546|NCT02094677|665401|P2|STARTED|Overall Study||31
277547|NCT02094677|665402|P1|STARTED|Overall Study||43
277548|NCT02094443|665466|P2|NOT COMPLETED|Overall Study||17
277549|NCT02094443|665467|P1|NOT COMPLETED|Overall Study||15
277550|NCT02094443|665466|P2|COMPLETED|Overall Study||9
277551|NCT02094443|665467|P1|COMPLETED|Overall Study||11
277552|NCT02094443|665466|P2|Completed at Week 24|Overall Study||8
277553|NCT02094443|665467|P1|Completed at Week 24|Overall Study||11
277554|NCT02094443|665466|P2|Completed at Week 12|Overall Study||1
277555|NCT02094443|665467|P1|Completed at Week 12|Overall Study||0
277556|NCT02094443|665466|P2|STARTED|Overall Study||26
277557|NCT02094443|665467|P1|STARTED|Overall Study||26
277558|NCT02094352|665487|P2|NOT COMPLETED|Overall Study||0
277559|NCT02094352|665488|P1|NOT COMPLETED|Overall Study||0
277560|NCT02094352|665487|P2|COMPLETED|Overall Study||1
277561|NCT02094352|665488|P1|COMPLETED|Overall Study||2
277562|NCT02094352|665487|P2|STARTED|Overall Study||1
277563|NCT02094352|665488|P1|STARTED|Overall Study||2
277564|NCT02094326|665494|P1|NOT COMPLETED|Overall Study||0
277565|NCT02094326|665494|P1|COMPLETED|Overall Study||301
277566|NCT02094326|665494|P1|STARTED|Overall Study||301
277567|NCT02094300|665503|P1|NOT COMPLETED|Overall Study||20
277568|NCT02094300|665503|P1|COMPLETED|Overall Study||6
277569|NCT02094300|665503|P1|30 Days|Overall Study||24
277570|NCT02094300|665503|P1|STARTED|Overall Study||26
277571|NCT02094261|665507|P1|NOT COMPLETED|Overall Study||210
277572|NCT02094261|665507|P1|COMPLETED|Overall Study||0
277573|NCT02094261|665507|P1|STARTED|Overall Study||210
277574|NCT02093949|665516|P2|NOT COMPLETED|Overall Study||0
277575|NCT02093949|665517|P1|NOT COMPLETED|Overall Study||0
277576|NCT02093949|665516|P2|COMPLETED|Overall Study||47
277577|NCT02093949|665517|P1|COMPLETED|Overall Study||105
277578|NCT02093949|665516|P2|STARTED|Overall Study||47
277579|NCT02093949|665517|P1|STARTED|Overall Study||105
277580|NCT02093923|665540|P5|NOT COMPLETED|Overall Study||0
277581|NCT02093923|665541|P4|NOT COMPLETED|Overall Study||2
277582|NCT02093923|665542|P3|NOT COMPLETED|Overall Study||0
277583|NCT02093923|665543|P2|NOT COMPLETED|Overall Study||0
277584|NCT02093923|665544|P1|NOT COMPLETED|Overall Study||0
277585|NCT02093923|665540|P5|COMPLETED|Overall Study||13
277586|NCT02093923|665541|P4|COMPLETED|Overall Study||10
277587|NCT02093923|665542|P3|COMPLETED|Overall Study||5
277588|NCT02093923|665543|P2|COMPLETED|Overall Study||4
277589|NCT02093923|665544|P1|COMPLETED|Overall Study||4
277590|NCT02093923|665540|P5|Treated - 2 Doses:|Overall Study||13
277591|NCT02093923|665541|P4|Treated - 2 Doses:|Overall Study||10
277592|NCT02093923|665542|P3|Treated - 2 Doses:|Overall Study||5
277593|NCT02093923|665543|P2|Treated - 2 Doses:|Overall Study||4
277594|NCT02093923|665544|P1|Treated - 2 Doses:|Overall Study||4
277595|NCT02093923|665540|P5|Treated - 1 Dose Only:|Overall Study||0
277596|NCT02093923|665541|P4|Treated - 1 Dose Only:|Overall Study||1
277597|NCT02093923|665542|P3|Treated - 1 Dose Only:|Overall Study||0
277598|NCT02093923|665543|P2|Treated - 1 Dose Only:|Overall Study||0
277599|NCT02093923|665544|P1|Treated - 1 Dose Only:|Overall Study||0
277600|NCT02093923|665540|P5|Total Treated|Overall Study||13
277601|NCT02093923|665541|P4|Total Treated|Overall Study||11
277602|NCT02093923|665542|P3|Total Treated|Overall Study||5
277603|NCT02093923|665543|P2|Total Treated|Overall Study||4
277604|NCT02093923|665544|P1|Total Treated|Overall Study||4
277605|NCT02093923|665540|P5|STARTED|Overall Study||13
277606|NCT02093923|665541|P4|STARTED|Overall Study||12
277607|NCT02093923|665542|P3|STARTED|Overall Study||5
277608|NCT02093923|665543|P2|STARTED|Overall Study||4
277609|NCT02093923|665544|P1|STARTED|Overall Study||4
277610|NCT02093897|665599|P1|NOT COMPLETED|Overall Study||19
277611|NCT02093897|665599|P1|COMPLETED|Overall Study||65
277612|NCT02093897|665599|P1|STARTED|Overall Study||84
277613|NCT02093819|665627|P8|NOT COMPLETED|Overall Study||0
277614|NCT02093819|665628|P7|NOT COMPLETED|Overall Study||0
277615|NCT02093819|665629|P6|NOT COMPLETED|Overall Study||0
277616|NCT02093819|665630|P5|NOT COMPLETED|Overall Study||0
277617|NCT02093819|665631|P4|NOT COMPLETED|Overall Study||0
277618|NCT02093819|665632|P3|NOT COMPLETED|Overall Study||0
277619|NCT02093819|665633|P2|NOT COMPLETED|Overall Study||0
277620|NCT02093819|665634|P1|NOT COMPLETED|Overall Study||0
277621|NCT02093819|665627|P8|COMPLETED|Overall Study||6
277622|NCT02093819|665628|P7|COMPLETED|Overall Study||5
277623|NCT02093819|665629|P6|COMPLETED|Overall Study||6
277624|NCT02093819|665630|P5|COMPLETED|Overall Study||6
277625|NCT02093819|665631|P4|COMPLETED|Overall Study||6
277626|NCT02093819|665632|P3|COMPLETED|Overall Study||10
277627|NCT02093819|665633|P2|COMPLETED|Overall Study||6
277628|NCT02093819|665634|P1|COMPLETED|Overall Study||15
277629|NCT02093819|665627|P8|STARTED|Overall Study||6
277630|NCT02093819|665628|P7|STARTED|Overall Study||5
277631|NCT02093819|665629|P6|STARTED|Overall Study||6
277632|NCT02093819|665630|P5|STARTED|Overall Study||6
277633|NCT02093819|665631|P4|STARTED|Overall Study||6
277634|NCT02093819|665632|P3|STARTED|Overall Study||10
277635|NCT02093819|665633|P2|STARTED|Overall Study||6
277636|NCT02093819|665634|P1|STARTED|Overall Study||15
277637|NCT02093702|665670|P2|NOT COMPLETED|Overall Study||0
277638|NCT02093702|665671|P1|NOT COMPLETED|Overall Study||0
277639|NCT02093702|665670|P2|COMPLETED|Overall Study||3
277640|NCT02093702|665671|P1|COMPLETED|Overall Study||2
277641|NCT02093702|665670|P2|STARTED|Overall Study||3
277642|NCT02093702|665671|P1|STARTED|Overall Study||2
277643|NCT02093390|665701|P2|NOT COMPLETED|Overall Study||1
277644|NCT02093390|665702|P1|NOT COMPLETED|Overall Study||0
277645|NCT02093390|665701|P2|COMPLETED|Overall Study||19
277646|NCT02093390|665702|P1|COMPLETED|Overall Study||20
277647|NCT02093390|665701|P2|STARTED|Overall Study||20
277648|NCT02093390|665702|P1|STARTED|Overall Study||20
277649|NCT02093351|665741|P3|NOT COMPLETED|Overall Study||3
277650|NCT02093351|665742|P2|NOT COMPLETED|Overall Study||2
277651|NCT02093351|665743|P1|NOT COMPLETED|Overall Study||2
277652|NCT02093351|665741|P3|COMPLETED|Overall Study||23
277653|NCT02093351|665742|P2|COMPLETED|Overall Study||21
277654|NCT02093351|665743|P1|COMPLETED|Overall Study||28
277655|NCT02093351|665741|P3|Completing Treatment Period 3|Overall Study||23
277656|NCT02093351|665742|P2|Completing Treatment Period 3|Overall Study||21
277657|NCT02093351|665743|P1|Completing Treatment Period 3|Overall Study||28
277658|NCT02093351|665741|P3|Completing Treatment Period 2|Overall Study||23
277659|NCT02093351|665742|P2|Completing Treatment Period 2|Overall Study||21
277660|NCT02093351|665743|P1|Completing Treatment Period 2|Overall Study||29
277661|NCT02093351|665741|P3|Completing Treatment Period 1|Overall Study||23
277662|NCT02093351|665742|P2|Completing Treatment Period 1|Overall Study||22
277663|NCT02093351|665743|P1|Completing Treatment Period 1|Overall Study||29
277664|NCT02093351|665741|P3|STARTED|Overall Study||26
277665|NCT02093351|665742|P2|STARTED|Overall Study||23
277666|NCT02093351|665743|P1|STARTED|Overall Study||30
277667|NCT02093234|665775|P3|NOT COMPLETED|Overall Study||4
277668|NCT02093234|665776|P2|NOT COMPLETED|Overall Study||4
277669|NCT02093234|665777|P1|NOT COMPLETED|Overall Study||3
277670|NCT02093234|665775|P3|COMPLETED|Overall Study||50
277671|NCT02093234|665776|P2|COMPLETED|Overall Study||52
277672|NCT02093234|665777|P1|COMPLETED|Overall Study||53
277673|NCT02093234|665775|P3|STARTED|Overall Study||54
277674|NCT02093234|665776|P2|STARTED|Overall Study||56
277675|NCT02093234|665777|P1|STARTED|Overall Study||56
277676|NCT02093026|665794|P1|NOT COMPLETED|Overall Study||193
277677|NCT02093026|665794|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
277678|NCT02093026|665794|P1|STARTED|Overall Study||465
277679|NCT02092961|665816|P3|NOT COMPLETED|Overall Study||16
277680|NCT02092961|665817|P2|NOT COMPLETED|Overall Study||14
277681|NCT02092961|665818|P1|NOT COMPLETED|Overall Study||21
277682|NCT02092961|665816|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
277683|NCT02092961|665817|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
277684|NCT02092961|665818|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
277866|NCT02088957|666278|P1|STARTED|Overall Study||1
277685|NCT02092961|665816|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
277686|NCT02092961|665817|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
277687|NCT02092961|665818|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
277688|NCT02092961|665816|P3|STARTED|Overall Study|Patients who received treatment|29
277689|NCT02092961|665817|P2|STARTED|Overall Study|Patients who received treatment|28
277690|NCT02092961|665818|P1|STARTED|Overall Study|Patients who received treatment|33
277691|NCT02092857|665842|P3|NOT COMPLETED|Overall Study||13
277692|NCT02092857|665843|P2|NOT COMPLETED|Overall Study||12
277693|NCT02092857|665844|P1|NOT COMPLETED|Overall Study||10
277694|NCT02092857|665842|P3|COMPLETED|Overall Study||16
277695|NCT02092857|665843|P2|COMPLETED|Overall Study||18
277696|NCT02092857|665844|P1|COMPLETED|Overall Study||20
277697|NCT02092857|665842|P3|STARTED|Overall Study||29
277698|NCT02092857|665843|P2|STARTED|Overall Study||30
277699|NCT02092857|665844|P1|STARTED|Overall Study||30
277700|NCT02092662|665854|P2|NOT COMPLETED|Overall Study||0
277701|NCT02092662|665855|P1|NOT COMPLETED|Overall Study||13
277702|NCT02092662|665854|P2|COMPLETED|Overall Study||19
277703|NCT02092662|665855|P1|COMPLETED|Overall Study||25
277704|NCT02092662|665854|P2|Recruited|Overall Study||19
277705|NCT02092662|665855|P1|Recruited|Overall Study||38
277706|NCT02092662|665854|P2|STARTED|Overall Study||19
277707|NCT02092662|665855|P1|STARTED|Overall Study||38
277708|NCT02092649|665864|P2|NOT COMPLETED|Overall Study||0
277709|NCT02092649|665865|P1|NOT COMPLETED|Overall Study||0
277710|NCT02092649|665864|P2|COMPLETED|Overall Study|13 participants finished study|13
277711|NCT02092649|665865|P1|COMPLETED|Overall Study|13 participants finished study|13
277712|NCT02092649|665864|P2|STARTED|Overall Study|13 participants recruited|13
277713|NCT02092649|665865|P1|STARTED|Overall Study|13 participants recruited|13
277714|NCT02092610|665883|P2|NOT COMPLETED|Overall Study||12
277715|NCT02092610|665884|P1|NOT COMPLETED|Overall Study||8
277716|NCT02092610|665883|P2|COMPLETED|Overall Study||40
277717|NCT02092610|665884|P1|COMPLETED|Overall Study||17
277718|NCT02092610|665883|P2|STARTED|Overall Study||52
277719|NCT02092610|665884|P1|STARTED|Overall Study||25
277720|NCT02092441|665898|P2|NOT COMPLETED|Overall Study||0
277721|NCT02092441|665899|P1|NOT COMPLETED|Overall Study||0
277722|NCT02092441|665898|P2|COMPLETED|Overall Study||43
277723|NCT02092441|665899|P1|COMPLETED|Overall Study||37
277724|NCT02092441|665898|P2|STARTED|Overall Study||43
277725|NCT02092441|665899|P1|STARTED|Overall Study||37
277726|NCT02092415|665909|P1|NOT COMPLETED|Overall Study||0
277727|NCT02092415|665909|P1|COMPLETED|Overall Study||10
277728|NCT02092415|665909|P1|STARTED|Overall Study||10
277729|NCT02092389|665914|P1|NOT COMPLETED|Overall Study||6
277730|NCT02092389|665914|P1|COMPLETED|Overall Study||4
277731|NCT02092389|665914|P1|STARTED|Overall Study||10
277732|NCT02092350|665926|P2|NOT COMPLETED|Overall Study||12
277733|NCT02092350|665927|P1|NOT COMPLETED|Overall Study||10
277734|NCT02092350|665926|P2|COMPLETED|Overall Study||102
277735|NCT02092350|665927|P1|COMPLETED|Overall Study||113
277736|NCT02092350|665926|P2|STARTED|Overall Study||114
277737|NCT02092350|665927|P1|STARTED|Overall Study||123
277738|NCT02092311|665944|P2|NOT COMPLETED|Overall Study||0
277739|NCT02092311|665945|P1|NOT COMPLETED|Overall Study||0
277740|NCT02092311|665944|P2|COMPLETED|Overall Study||285
277741|NCT02092311|665945|P1|COMPLETED|Overall Study||285
277742|NCT02092311|665944|P2|STARTED|Overall Study||285
277743|NCT02092311|665945|P1|STARTED|Overall Study||285
277744|NCT02092168|665957|P2|NOT COMPLETED|Overall Study||0
277745|NCT02092168|665958|P1|NOT COMPLETED|Overall Study||0
277746|NCT02092168|665957|P2|COMPLETED|Overall Study||12
277747|NCT02092168|665958|P1|COMPLETED|Overall Study||12
277748|NCT02092168|665957|P2|STARTED|Overall Study||12
277749|NCT02092168|665958|P1|STARTED|Overall Study||12
277750|NCT02092116|665970|P2|NOT COMPLETED|Overall Study||4
277751|NCT02092116|665971|P1|NOT COMPLETED|Overall Study||0
277752|NCT02092116|665970|P2|COMPLETED|Overall Study||16
277753|NCT02092116|665971|P1|COMPLETED|Overall Study||6
277754|NCT02092116|665970|P2|STARTED|Overall Study||20
277755|NCT02092116|665971|P1|STARTED|Overall Study||6
277756|NCT02091986|665983|P3|NOT COMPLETED|Overall Study||8
277757|NCT02091986|665984|P2|NOT COMPLETED|Overall Study||11
277758|NCT02091986|665985|P1|NOT COMPLETED|Overall Study||7
277759|NCT02091986|665983|P3|COMPLETED|Overall Study||84
277760|NCT02091986|665984|P2|COMPLETED|Overall Study||84
277761|NCT02091986|665985|P1|COMPLETED|Overall Study||85
277762|NCT02091986|665983|P3|STARTED|Overall Study||92
277763|NCT02091986|665984|P2|STARTED|Overall Study||95
277764|NCT02091986|665985|P1|STARTED|Overall Study||92
277765|NCT02091869|666034|P2|NOT COMPLETED|Overall Study||3
277766|NCT02091869|666035|P1|NOT COMPLETED|Overall Study||0
277767|NCT02091869|666034|P2|COMPLETED|Overall Study||14
277768|NCT02091869|666035|P1|COMPLETED|Overall Study||17
277769|NCT02091869|666034|P2|STARTED|Overall Study||17
277770|NCT02091869|666035|P1|STARTED|Overall Study||17
277771|NCT02091856|666050|P3|NOT COMPLETED|Follow-up Assessment||0
277772|NCT02091856|666051|P2|NOT COMPLETED|Follow-up Assessment||3
277773|NCT02091856|666052|P1|NOT COMPLETED|Follow-up Assessment||5
277774|NCT02091856|666050|P3|COMPLETED|Follow-up Assessment||0
277775|NCT02091856|666051|P2|COMPLETED|Follow-up Assessment||9
277776|NCT02091856|666052|P1|COMPLETED|Follow-up Assessment||10
277777|NCT02091856|666050|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
277778|NCT02091856|666051|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
277779|NCT02091856|666052|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
277780|NCT02091856|666050|P3|NOT COMPLETED|Active Intervention Interval||7
277781|NCT02091856|666051|P2|NOT COMPLETED|Active Intervention Interval||7
277782|NCT02091856|666052|P1|NOT COMPLETED|Active Intervention Interval||19
277783|NCT02091856|666050|P3|COMPLETED|Active Intervention Interval||19
277784|NCT02091856|666051|P2|COMPLETED|Active Intervention Interval||12
277785|NCT02091856|666052|P1|COMPLETED|Active Intervention Interval||15
277786|NCT02091856|666050|P3|STARTED|Active Intervention Interval||26
277787|NCT02091856|666051|P2|STARTED|Active Intervention Interval||19
277788|NCT02091856|666052|P1|STARTED|Active Intervention Interval||34
277789|NCT02091778|666072|P1|NOT COMPLETED|Overall Study||1
277790|NCT02091778|666072|P1|COMPLETED|Overall Study||20
277791|NCT02091778|666072|P1|STARTED|Overall Study||21
277792|NCT02091752|666076|P1|NOT COMPLETED|Overall Study||3
277793|NCT02091752|666076|P1|COMPLETED|Overall Study||0
277794|NCT02091752|666076|P1|STARTED|Overall Study||3
277795|NCT02091726|666087|P1|NOT COMPLETED|Overall Study||6
277796|NCT02091726|666087|P1|COMPLETED|Overall Study||104
277797|NCT02091726|666087|P1|4 Week Followup|Overall Study||104
277798|NCT02091726|666087|P1|1 Week Followup|Overall Study||110
277799|NCT02091726|666087|P1|STARTED|Overall Study||110
277800|NCT02091466|666097|P2|NOT COMPLETED|Overall Study||0
277801|NCT02091466|666098|P1|NOT COMPLETED|Overall Study||0
277802|NCT02091466|666097|P2|COMPLETED|Overall Study||20
277803|NCT02091466|666098|P1|COMPLETED|Overall Study||20
277804|NCT02091466|666097|P2|STARTED|Overall Study||20
277805|NCT02091466|666098|P1|STARTED|Overall Study||20
277806|NCT02091414|666104|P1|NOT COMPLETED|Overall Study||4
277807|NCT02091414|666104|P1|COMPLETED|Overall Study||32
277808|NCT02091414|666104|P1|STARTED|Overall Study||36
277809|NCT02090855|666116|P1|NOT COMPLETED|Overall Study||2
277810|NCT02090855|666116|P1|COMPLETED|Overall Study||106
277811|NCT02090855|666116|P1|STARTED|Overall Study||108
277812|NCT02090777|666123|P1|NOT COMPLETED|Overall Study||0
277813|NCT02090777|666123|P1|COMPLETED|Overall Study||4
277814|NCT02090777|666123|P1|STARTED|Overall Study||4
277815|NCT02090764|666129|P2|NOT COMPLETED|Overall Study||20
277816|NCT02090764|666130|P1|NOT COMPLETED|Overall Study||6
277817|NCT02090764|666129|P2|COMPLETED|Overall Study||186
277818|NCT02090764|666130|P1|COMPLETED|Overall Study||200
277819|NCT02090764|666129|P2|STARTED|Overall Study||206
277820|NCT02090764|666130|P1|STARTED|Overall Study||206
277821|NCT02090413|666139|P3|NOT COMPLETED|Overall Study||23
277822|NCT02090413|666140|P2|NOT COMPLETED|Overall Study||20
277823|NCT02090413|666141|P1|NOT COMPLETED|Overall Study||19
277824|NCT02090413|666139|P3|COMPLETED|Overall Study||57
277825|NCT02090413|666140|P2|COMPLETED|Overall Study||60
277826|NCT02090413|666141|P1|COMPLETED|Overall Study||62
277827|NCT02090413|666139|P3|STARTED|Overall Study||80
277828|NCT02090413|666140|P2|STARTED|Overall Study||80
277829|NCT02090413|666141|P1|STARTED|Overall Study||81
277830|NCT02090088|666215|P1|NOT COMPLETED|Overall Study||0
277831|NCT02090088|666215|P1|COMPLETED|Overall Study||4
277832|NCT02090088|666215|P1|Gave Birth|Overall Study||4
277833|NCT02090088|666215|P1|STARTED|Overall Study||4
277834|NCT02089737|666227|P1|NOT COMPLETED|Overall Study||6
277835|NCT02089737|666227|P1|COMPLETED|Overall Study||3085
277836|NCT02089737|666227|P1|STARTED|Overall Study||3091
277837|NCT02089347|666236|P2|NOT COMPLETED|Overall Study||0
277838|NCT02089347|666237|P1|NOT COMPLETED|Overall Study||1
277839|NCT02089347|666236|P2|COMPLETED|Overall Study||178
277840|NCT02089347|666237|P1|COMPLETED|Overall Study||355
277841|NCT02089347|666236|P2|STARTED|Overall Study||178
277842|NCT02089347|666237|P1|STARTED|Overall Study||356
277843|NCT02089191|666259|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
277844|NCT02089191|666260|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
277845|NCT02089191|666259|P2|COMPLETED|Period 2, Second 12 Hours||15
277846|NCT02089191|666260|P1|COMPLETED|Period 2, Second 12 Hours||15
277847|NCT02089191|666259|P2|STARTED|Period 2, Second 12 Hours||15
277848|NCT02089191|666260|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
277849|NCT02089191|666259|P2|NOT COMPLETED|Period 1, First 12 Hours||0
277850|NCT02089191|666260|P1|NOT COMPLETED|Period 1, First 12 Hours||0
277851|NCT02089191|666259|P2|COMPLETED|Period 1, First 12 Hours||15
277852|NCT02089191|666260|P1|COMPLETED|Period 1, First 12 Hours||16
277853|NCT02089191|666259|P2|STARTED|Period 1, First 12 Hours||15
277854|NCT02089191|666260|P1|STARTED|Period 1, First 12 Hours||16
277855|NCT02089113|666270|P2|NOT COMPLETED|Overall Study||0
277856|NCT02089113|666271|P1|NOT COMPLETED|Overall Study||1
277857|NCT02089113|666270|P2|COMPLETED|Overall Study||80
277858|NCT02089113|666271|P1|COMPLETED|Overall Study||160
277859|NCT02089113|666270|P2|STARTED|Overall Study||80
277860|NCT02089113|666271|P1|STARTED|Overall Study||161
277861|NCT02088957|666277|P2|NOT COMPLETED|Overall Study||0
277862|NCT02088957|666278|P1|NOT COMPLETED|Overall Study||1
277863|NCT02088957|666277|P2|COMPLETED|Overall Study||0
277864|NCT02088957|666278|P1|COMPLETED|Overall Study||0
277865|NCT02088957|666277|P2|STARTED|Overall Study||0
277867|NCT02087943|666297|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
277868|NCT02087943|666298|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
277869|NCT02087943|666299|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
277870|NCT02087943|666300|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
277871|NCT02087943|666301|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
277872|NCT02087943|666297|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
277873|NCT02087943|666298|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
277874|NCT02087943|666299|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
277875|NCT02087943|666300|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
277876|NCT02087943|666301|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
277877|NCT02087943|666297|P5|STARTED|Observational Follow-up Phase Week 24-30||23
277878|NCT02087943|666298|P4|STARTED|Observational Follow-up Phase Week 24-30||24
277879|NCT02087943|666299|P3|STARTED|Observational Follow-up Phase Week 24-30||48
277880|NCT02087943|666300|P2|STARTED|Observational Follow-up Phase Week 24-30||46
277881|NCT02087943|666301|P1|STARTED|Observational Follow-up Phase Week 24-30||0
277882|NCT02087943|666297|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
277883|NCT02087943|666298|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
277884|NCT02087943|666299|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
277885|NCT02087943|666300|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
277886|NCT02087943|666301|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
277887|NCT02087943|666297|P5|COMPLETED|Active Treatment Phase Week 12-24||21
277888|NCT02087943|666298|P4|COMPLETED|Active Treatment Phase Week 12-24||22
277889|NCT02087943|666299|P3|COMPLETED|Active Treatment Phase Week 12-24||44
277890|NCT02087943|666300|P2|COMPLETED|Active Treatment Phase Week 12-24||42
277891|NCT02087943|666301|P1|COMPLETED|Active Treatment Phase Week 12-24||0
277892|NCT02087943|666297|P5|STARTED|Active Treatment Phase Week 12-24||23
277893|NCT02087943|666298|P4|STARTED|Active Treatment Phase Week 12-24||24
277894|NCT02087943|666299|P3|STARTED|Active Treatment Phase Week 12-24||49
277895|NCT02087943|666300|P2|STARTED|Active Treatment Phase Week 12-24||46
277896|NCT02087943|666301|P1|STARTED|Active Treatment Phase Week 12-24||0
277897|NCT02087943|666297|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
277898|NCT02087943|666298|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
277899|NCT02087943|666299|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
277900|NCT02087943|666300|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
277901|NCT02087943|666301|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
277902|NCT02087943|666297|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
277903|NCT02087943|666298|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
277904|NCT02087943|666299|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
277905|NCT02087943|666300|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
277906|NCT02087943|666301|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
277907|NCT02087943|666297|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
277908|NCT02087943|666298|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
277909|NCT02087943|666299|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
277910|NCT02087943|666300|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
277911|NCT02087943|666301|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
277912|NCT02087943|666297|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
277913|NCT02087943|666298|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
277914|NCT02087943|666299|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
277915|NCT02087943|666300|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
277916|NCT02087943|666301|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
277917|NCT02087774|666327|P2|NOT COMPLETED|Overall Study||20
277918|NCT02087774|666328|P1|NOT COMPLETED|Overall Study||8
277919|NCT02087774|666327|P2|COMPLETED|Overall Study||130
277920|NCT02087774|666328|P1|COMPLETED|Overall Study||142
277921|NCT02087774|666327|P2|STARTED|Overall Study||150
277922|NCT02087774|666328|P1|STARTED|Overall Study||150
277923|NCT02087748|666336|P1|NOT COMPLETED|Overall Study||0
277924|NCT02087748|666336|P1|COMPLETED|Overall Study||24
277925|NCT02087748|666336|P1|STARTED|Overall Study||24
277926|NCT02087670|666348|P2|NOT COMPLETED|Overall Study||2
277927|NCT02087670|666349|P1|NOT COMPLETED|Overall Study||3
277928|NCT02087670|666348|P2|COMPLETED|Overall Study||20
277929|NCT02087670|666349|P1|COMPLETED|Overall Study||17
277930|NCT02087670|666348|P2|STARTED|Overall Study||22
277931|NCT02087670|666349|P1|STARTED|Overall Study||20
277932|NCT02087241|666361|P4|NOT COMPLETED|Overall Study||7
277933|NCT02087241|666362|P3|NOT COMPLETED|Overall Study||1
277934|NCT02087241|666363|P2|NOT COMPLETED|Overall Study||3
277935|NCT02087241|666364|P1|NOT COMPLETED|Overall Study||3
277936|NCT02087241|666361|P4|COMPLETED|Overall Study||0
277937|NCT02087241|666362|P3|COMPLETED|Overall Study||0
277938|NCT02087241|666363|P2|COMPLETED|Overall Study||0
277939|NCT02087241|666364|P1|COMPLETED|Overall Study||0
277940|NCT02087241|666361|P4|STARTED|Overall Study||7
277941|NCT02087241|666362|P3|STARTED|Overall Study||1
277942|NCT02087241|666363|P2|STARTED|Overall Study||3
277943|NCT02087241|666364|P1|STARTED|Overall Study||3
277944|NCT02087176|666390|P1|NOT COMPLETED|Overall Study||32
278035|NCT02084056|666577|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
277945|NCT02087176|666390|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
277946|NCT02087176|666390|P1|STARTED|Overall Study||32
277947|NCT02087059|666395|P1|NOT COMPLETED|Overall Study||7
277948|NCT02087059|666395|P1|COMPLETED|Overall Study||44
277949|NCT02087059|666395|P1|STARTED|Overall Study||51
277950|NCT02086708|666403|P1|NOT COMPLETED|Overall Study||0
277951|NCT02086708|666403|P1|COMPLETED|Overall Study||24
277952|NCT02086708|666403|P1|STARTED|Overall Study||24
277953|NCT02086591|666415|P1|NOT COMPLETED|Overall Study||5
277954|NCT02086591|666415|P1|COMPLETED|Overall Study||2
277955|NCT02086591|666415|P1|STARTED|Overall Study||7
277956|NCT02085785|666423|P2|NOT COMPLETED|Overall Study||2
277957|NCT02085785|666424|P1|NOT COMPLETED|Overall Study||2
277958|NCT02085785|666423|P2|COMPLETED|Overall Study||6
277959|NCT02085785|666424|P1|COMPLETED|Overall Study||5
277960|NCT02085785|666423|P2|STARTED|Overall Study||8
277961|NCT02085785|666424|P1|STARTED|Overall Study||7
277962|NCT02085720|666436|P1|NOT COMPLETED|Overall Study||0
277963|NCT02085720|666436|P1|COMPLETED|Overall Study||819
277964|NCT02085720|666436|P1|STARTED|Overall Study||819
277965|NCT02085161|666448|P4|NOT COMPLETED|Overall Study||10
277966|NCT02085161|666449|P3|NOT COMPLETED|Overall Study||5
277967|NCT02085161|666450|P2|NOT COMPLETED|Overall Study||10
277968|NCT02085161|666451|P1|NOT COMPLETED|Overall Study||12
277969|NCT02085161|666448|P4|COMPLETED|Overall Study||66
277970|NCT02085161|666449|P3|COMPLETED|Overall Study||71
277971|NCT02085161|666450|P2|COMPLETED|Overall Study||66
277972|NCT02085161|666451|P1|COMPLETED|Overall Study||64
277973|NCT02085161|666448|P4|STARTED|Overall Study||76
277974|NCT02085161|666449|P3|STARTED|Overall Study||76
277975|NCT02085161|666450|P2|STARTED|Overall Study||76
277976|NCT02085161|666451|P1|STARTED|Overall Study||76
277977|NCT02084797|666490|P1|NOT COMPLETED|Overall Study||0
277978|NCT02084797|666490|P1|COMPLETED|Overall Study||10
277979|NCT02084797|666490|P1|STARTED|Overall Study||10
277980|NCT02084706|666499|P2|NOT COMPLETED|Overall Study||0
277981|NCT02084706|666500|P1|NOT COMPLETED|Overall Study||0
277982|NCT02084706|666499|P2|COMPLETED|Overall Study||31
277983|NCT02084706|666500|P1|COMPLETED|Overall Study||29
277984|NCT02084706|666499|P2|STARTED|Overall Study||31
277985|NCT02084706|666500|P1|STARTED|Overall Study||29
277986|NCT02084628|666506|P1|NOT COMPLETED|Overall Study||0
277987|NCT02084628|666506|P1|COMPLETED|Overall Study||1
277988|NCT02084628|666506|P1|STARTED|Overall Study||1
277989|NCT02084238|666519|P1|NOT COMPLETED|Overall Study||2
277990|NCT02084238|666519|P1|COMPLETED|Overall Study||38
277991|NCT02084238|666519|P1|STARTED|Overall Study||40
277992|NCT02084082|666532|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
277993|NCT02084082|666533|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
277994|NCT02084082|666534|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
277995|NCT02084082|666535|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
277996|NCT02084082|666532|P4|COMPLETED|Treatment Period 2 (4 Days)||6
277997|NCT02084082|666533|P3|COMPLETED|Treatment Period 2 (4 Days)||7
277998|NCT02084082|666534|P2|COMPLETED|Treatment Period 2 (4 Days)||26
277999|NCT02084082|666535|P1|COMPLETED|Treatment Period 2 (4 Days)||26
278000|NCT02084082|666532|P4|STARTED|Treatment Period 2 (4 Days)||6
278001|NCT02084082|666533|P3|STARTED|Treatment Period 2 (4 Days)||7
278002|NCT02084082|666534|P2|STARTED|Treatment Period 2 (4 Days)||26
278003|NCT02084082|666535|P1|STARTED|Treatment Period 2 (4 Days)||26
278004|NCT02084082|666532|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
278005|NCT02084082|666533|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
278006|NCT02084082|666534|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
278007|NCT02084082|666535|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
278008|NCT02084082|666532|P4|COMPLETED|Washout Period 1 (35 Days)||6
278009|NCT02084082|666533|P3|COMPLETED|Washout Period 1 (35 Days)||7
278010|NCT02084082|666534|P2|COMPLETED|Washout Period 1 (35 Days)||26
278011|NCT02084082|666535|P1|COMPLETED|Washout Period 1 (35 Days)||26
278012|NCT02084082|666532|P4|STARTED|Washout Period 1 (35 Days)||8
278013|NCT02084082|666533|P3|STARTED|Washout Period 1 (35 Days)||8
278014|NCT02084082|666534|P2|STARTED|Washout Period 1 (35 Days)||26
278015|NCT02084082|666535|P1|STARTED|Washout Period 1 (35 Days)||26
278016|NCT02084082|666532|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278017|NCT02084082|666533|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278018|NCT02084082|666534|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278019|NCT02084082|666535|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278020|NCT02084082|666532|P4|COMPLETED|Treatment Period 1 (4 Days)||8
278021|NCT02084082|666533|P3|COMPLETED|Treatment Period 1 (4 Days)||8
278022|NCT02084082|666534|P2|COMPLETED|Treatment Period 1 (4 Days)||26
278023|NCT02084082|666535|P1|COMPLETED|Treatment Period 1 (4 Days)||26
278024|NCT02084082|666532|P4|STARTED|Treatment Period 1 (4 Days)||8
278025|NCT02084082|666533|P3|STARTED|Treatment Period 1 (4 Days)||8
278026|NCT02084082|666534|P2|STARTED|Treatment Period 1 (4 Days)||26
278027|NCT02084082|666535|P1|STARTED|Treatment Period 1 (4 Days)||26
278028|NCT02084069|666567|P2|NOT COMPLETED|Overall Study||0
278029|NCT02084069|666568|P1|NOT COMPLETED|Overall Study||0
278030|NCT02084069|666567|P2|COMPLETED|Overall Study||29
278031|NCT02084069|666568|P1|COMPLETED|Overall Study||29
278032|NCT02084069|666567|P2|STARTED|Overall Study||29
278033|NCT02084069|666568|P1|STARTED|Overall Study||29
278034|NCT02084056|666576|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
278036|NCT02084056|666578|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
278037|NCT02084056|666579|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
278038|NCT02084056|666576|P4|COMPLETED|Treatment Period 2 (4 Days)||8
278039|NCT02084056|666577|P3|COMPLETED|Treatment Period 2 (4 Days)||8
278040|NCT02084056|666578|P2|COMPLETED|Treatment Period 2 (4 Days)||30
278041|NCT02084056|666579|P1|COMPLETED|Treatment Period 2 (4 Days)||26
278042|NCT02084056|666576|P4|STARTED|Treatment Period 2 (4 Days)||8
278043|NCT02084056|666577|P3|STARTED|Treatment Period 2 (4 Days)||8
278044|NCT02084056|666578|P2|STARTED|Treatment Period 2 (4 Days)||30
278045|NCT02084056|666579|P1|STARTED|Treatment Period 2 (4 Days)||26
278046|NCT02084056|666576|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
278047|NCT02084056|666577|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
278048|NCT02084056|666578|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
278049|NCT02084056|666579|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
278050|NCT02084056|666576|P4|COMPLETED|Washout Period 1 (35 Days)||8
278051|NCT02084056|666577|P3|COMPLETED|Washout Period 1 (35 Days)||8
278052|NCT02084056|666578|P2|COMPLETED|Washout Period 1 (35 Days)||30
278053|NCT02084056|666579|P1|COMPLETED|Washout Period 1 (35 Days)||26
278054|NCT02084056|666576|P4|STARTED|Washout Period 1 (35 Days)||8
278055|NCT02084056|666577|P3|STARTED|Washout Period 1 (35 Days)||8
278056|NCT02084056|666578|P2|STARTED|Washout Period 1 (35 Days)||30
278057|NCT02084056|666579|P1|STARTED|Washout Period 1 (35 Days)||27
278058|NCT02084056|666576|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278059|NCT02084056|666577|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278060|NCT02084056|666578|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
278061|NCT02084056|666579|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
278062|NCT02084056|666576|P4|COMPLETED|Treatment Period 1 (4 Days)||8
278063|NCT02084056|666577|P3|COMPLETED|Treatment Period 1 (4 Days)||8
278064|NCT02084056|666578|P2|COMPLETED|Treatment Period 1 (4 Days)||30
278065|NCT02084056|666579|P1|COMPLETED|Treatment Period 1 (4 Days)||27
278066|NCT02084056|666576|P4|STARTED|Treatment Period 1 (4 Days)||8
278067|NCT02084056|666577|P3|STARTED|Treatment Period 1 (4 Days)||8
278068|NCT02084056|666578|P2|STARTED|Treatment Period 1 (4 Days)||30
278069|NCT02084056|666579|P1|STARTED|Treatment Period 1 (4 Days)||28
278070|NCT02083965|666611|P2|NOT COMPLETED|Overall Study||1
278071|NCT02083965|666612|P1|NOT COMPLETED|Overall Study||1
278072|NCT02083965|666611|P2|COMPLETED|Overall Study||8
278073|NCT02083965|666612|P1|COMPLETED|Overall Study||9
278074|NCT02083965|666611|P2|STARTED|Overall Study||9
278075|NCT02083965|666612|P1|STARTED|Overall Study||10
278076|NCT02083679|666672|P4|NOT COMPLETED|Overall Study||0
278077|NCT02083679|666673|P3|NOT COMPLETED|Overall Study||0
278078|NCT02083679|666674|P2|NOT COMPLETED|Overall Study||0
278079|NCT02083679|666675|P1|NOT COMPLETED|Overall Study||0
278080|NCT02083679|666672|P4|COMPLETED|Overall Study||3
278081|NCT02083679|666673|P3|COMPLETED|Overall Study||3
278082|NCT02083679|666674|P2|COMPLETED|Overall Study||6
278083|NCT02083679|666675|P1|COMPLETED|Overall Study||3
278084|NCT02083679|666672|P4|STARTED|Overall Study||3
278085|NCT02083679|666673|P3|STARTED|Overall Study||3
278086|NCT02083679|666674|P2|STARTED|Overall Study||6
278087|NCT02083679|666675|P1|STARTED|Overall Study||3
278088|NCT02083406|666692|P3|NOT COMPLETED|Overall Study||0
278089|NCT02083406|666693|P2|NOT COMPLETED|Overall Study||0
278090|NCT02083406|666694|P1|NOT COMPLETED|Overall Study||0
278091|NCT02083406|666692|P3|COMPLETED|Overall Study||7
278092|NCT02083406|666693|P2|COMPLETED|Overall Study||8
278093|NCT02083406|666694|P1|COMPLETED|Overall Study||7
278094|NCT02083406|666692|P3|STARTED|Overall Study||7
278095|NCT02083406|666693|P2|STARTED|Overall Study||8
278096|NCT02083406|666694|P1|STARTED|Overall Study||7
278097|NCT02083380|666714|P3|NOT COMPLETED|Overall Study||84
278098|NCT02083380|666715|P2|NOT COMPLETED|Overall Study||95
278099|NCT02083380|666716|P1|NOT COMPLETED|Overall Study||91
278100|NCT02083380|666714|P3|COMPLETED|Overall Study||65
278101|NCT02083380|666715|P2|COMPLETED|Overall Study||56
278102|NCT02083380|666716|P1|COMPLETED|Overall Study||57
278188|NCT02081586|666979|P4|COMPLETED|Overall Study||2
278103|NCT02083380|666714|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
278104|NCT02083380|666715|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
278105|NCT02083380|666716|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
278106|NCT02083263|666811|P2|NOT COMPLETED|Overall Study||0
278107|NCT02083263|666812|P1|NOT COMPLETED|Overall Study||0
278108|NCT02083263|666811|P2|COMPLETED|Overall Study||16
278109|NCT02083263|666812|P1|COMPLETED|Overall Study||16
278110|NCT02083263|666811|P2|STARTED|Overall Study||16
278111|NCT02083263|666812|P1|STARTED|Overall Study||16
278112|NCT02083107|666821|P3|NOT COMPLETED|Overall Study||0
278113|NCT02083107|666822|P2|NOT COMPLETED|Overall Study||0
278114|NCT02083107|666823|P1|NOT COMPLETED|Overall Study||0
278115|NCT02083107|666821|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
278116|NCT02083107|666822|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
278117|NCT02083107|666823|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
278118|NCT02083107|666821|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
278211|NCT02081183|667040|P1|NOT COMPLETED|Overall Study||4
278119|NCT02083107|666822|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
278120|NCT02083107|666823|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
278121|NCT02082912|666860|P2|NOT COMPLETED|Overall Study||1
278122|NCT02082912|666861|P1|NOT COMPLETED|Overall Study||0
278123|NCT02082912|666860|P2|COMPLETED|Overall Study||6
278124|NCT02082912|666861|P1|COMPLETED|Overall Study||7
278125|NCT02082912|666860|P2|STARTED|Overall Study||7
278126|NCT02082912|666861|P1|STARTED|Overall Study||7
278127|NCT02082769|666870|P3|NOT COMPLETED|Overall Study||36
278128|NCT02082769|666871|P2|NOT COMPLETED|Overall Study||27
278129|NCT02082769|666872|P1|NOT COMPLETED|Overall Study||24
278130|NCT02082769|666870|P3|COMPLETED|Overall Study||132
278131|NCT02082769|666871|P2|COMPLETED|Overall Study||141
278132|NCT02082769|666872|P1|COMPLETED|Overall Study||144
278133|NCT02082769|666870|P3|STARTED|Overall Study||168
278134|NCT02082769|666871|P2|STARTED|Overall Study||168
278135|NCT02082769|666872|P1|STARTED|Overall Study||168
278136|NCT02082288|666886|P1|NOT COMPLETED|Overall Study||0
278137|NCT02082288|666886|P1|COMPLETED|Overall Study||243
278138|NCT02082288|666886|P1|STARTED|Overall Study||243
278139|NCT02082262|666890|P1|NOT COMPLETED|Overall Study||51
278140|NCT02082262|666890|P1|COMPLETED|Overall Study||89
278141|NCT02082262|666890|P1|STARTED|Overall Study||140
278142|NCT02082184|666896|P2|NOT COMPLETED|Overall Study||13
278143|NCT02082184|666897|P1|NOT COMPLETED|Overall Study||10
278144|NCT02082184|666896|P2|COMPLETED|Overall Study||62
278145|NCT02082184|666897|P1|COMPLETED|Overall Study||139
278146|NCT02082184|666896|P2|STARTED|Overall Study||75
278147|NCT02082184|666897|P1|STARTED|Overall Study||149
278148|NCT02082158|666922|P6|NOT COMPLETED|Overall Study||7
278149|NCT02082158|666923|P5|NOT COMPLETED|Overall Study||4
278150|NCT02082158|666924|P4|NOT COMPLETED|Overall Study||4
278151|NCT02082158|666925|P3|NOT COMPLETED|Overall Study||14
278152|NCT02082158|666926|P2|NOT COMPLETED|Overall Study||8
278153|NCT02082158|666927|P1|NOT COMPLETED|Overall Study||8
278154|NCT02082158|666922|P6|COMPLETED|Overall Study||56
278155|NCT02082158|666923|P5|COMPLETED|Overall Study||64
278156|NCT02082158|666924|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
278157|NCT02082158|666925|P3|COMPLETED|Overall Study||38
278158|NCT02082158|666926|P2|COMPLETED|Overall Study||53
278159|NCT02082158|666927|P1|COMPLETED|Overall Study||58
278160|NCT02082158|666922|P6|STARTED|Overall Study||63
278161|NCT02082158|666923|P5|STARTED|Overall Study||68
278162|NCT02082158|666924|P4|STARTED|Overall Study||72
278163|NCT02082158|666925|P3|STARTED|Overall Study||52
278164|NCT02082158|666926|P2|STARTED|Overall Study||61
278165|NCT02082158|666927|P1|STARTED|Overall Study||66
278166|NCT02081859|666949|P2|NOT COMPLETED|Overall Study||31
278167|NCT02081859|666950|P1|NOT COMPLETED|Overall Study||34
278168|NCT02081859|666949|P2|COMPLETED|Overall Study||119
278169|NCT02081859|666950|P1|COMPLETED|Overall Study||116
278170|NCT02081859|666949|P2|STARTED|Overall Study||150
278171|NCT02081859|666950|P1|STARTED|Overall Study||150
278172|NCT02081599|666960|P2|NOT COMPLETED|Period 2：Open-label Period||4
278173|NCT02081599|666961|P1|NOT COMPLETED|Period 2：Open-label Period||6
278174|NCT02081599|666960|P2|COMPLETED|Period 2：Open-label Period||71
278175|NCT02081599|666961|P1|COMPLETED|Period 2：Open-label Period||57
278176|NCT02081599|666960|P2|STARTED|Period 2：Open-label Period||75
278177|NCT02081599|666961|P1|STARTED|Period 2：Open-label Period||63
278178|NCT02081599|666960|P2|NOT COMPLETED|Period 1：Double-blind Period||2
278179|NCT02081599|666961|P1|NOT COMPLETED|Period 1：Double-blind Period||8
278180|NCT02081599|666960|P2|COMPLETED|Period 1：Double-blind Period||75
278181|NCT02081599|666961|P1|COMPLETED|Period 1：Double-blind Period||63
278182|NCT02081599|666960|P2|STARTED|Period 1：Double-blind Period||77
278183|NCT02081599|666961|P1|STARTED|Period 1：Double-blind Period||71
278184|NCT02081586|666979|P4|NOT COMPLETED|Overall Study||1
278185|NCT02081586|666980|P3|NOT COMPLETED|Overall Study||1
278186|NCT02081586|666981|P2|NOT COMPLETED|Overall Study||1
278187|NCT02081586|666982|P1|NOT COMPLETED|Overall Study||0
278189|NCT02081586|666980|P3|COMPLETED|Overall Study||3
278190|NCT02081586|666981|P2|COMPLETED|Overall Study||2
278191|NCT02081586|666982|P1|COMPLETED|Overall Study||3
278192|NCT02081586|666979|P4|STARTED|Overall Study||3
278193|NCT02081586|666980|P3|STARTED|Overall Study||4
278194|NCT02081586|666981|P2|STARTED|Overall Study||3
278195|NCT02081586|666982|P1|STARTED|Overall Study||3
278196|NCT02081443|667011|P2|NOT COMPLETED|Overall Study||0
278197|NCT02081443|667012|P1|NOT COMPLETED|Overall Study||0
278198|NCT02081443|667011|P2|COMPLETED|Overall Study||30
278199|NCT02081443|667012|P1|COMPLETED|Overall Study||30
278200|NCT02081443|667011|P2|STARTED|Overall Study||30
278201|NCT02081443|667012|P1|STARTED|Overall Study||30
278202|NCT02081365|667024|P2|NOT COMPLETED|Overall Study||23
278203|NCT02081365|667025|P1|NOT COMPLETED|Overall Study||30
278204|NCT02081365|667024|P2|COMPLETED|Overall Study||54
278205|NCT02081365|667025|P1|COMPLETED|Overall Study||44
278206|NCT02081365|667024|P2|Received Allocated Intervention|Overall Study||59
278207|NCT02081365|667025|P1|Received Allocated Intervention|Overall Study||46
278208|NCT02081365|667024|P2|STARTED|Overall Study||77
278209|NCT02081365|667025|P1|STARTED|Overall Study||74
278210|NCT02081183|667039|P2|NOT COMPLETED|Overall Study||4
278212|NCT02081183|667039|P2|COMPLETED|Overall Study||2
278213|NCT02081183|667040|P1|COMPLETED|Overall Study||1
278214|NCT02081183|667039|P2|STARTED|Overall Study||6
278215|NCT02081183|667040|P1|STARTED|Overall Study||5
278216|NCT02081079|667056|P2|NOT COMPLETED|Overall Study||2
278217|NCT02081079|667057|P1|NOT COMPLETED|Overall Study||4
278218|NCT02081079|667056|P2|COMPLETED|Overall Study||39
278219|NCT02081079|667057|P1|COMPLETED|Overall Study||40
278220|NCT02081079|667056|P2|STARTED|Overall Study||41
278221|NCT02081079|667057|P1|STARTED|Overall Study||44
278222|NCT02081014|667079|P6|NOT COMPLETED|Overall Study||0
278223|NCT02081014|667080|P5|NOT COMPLETED|Overall Study||0
278224|NCT02081014|667081|P4|NOT COMPLETED|Overall Study||0
278225|NCT02081014|667082|P3|NOT COMPLETED|Overall Study||0
278226|NCT02081014|667083|P2|NOT COMPLETED|Overall Study||0
278227|NCT02081014|667084|P1|NOT COMPLETED|Overall Study||0
278228|NCT02081014|667079|P6|COMPLETED|Overall Study||2
278229|NCT02081014|667080|P5|COMPLETED|Overall Study||2
278230|NCT02081014|667081|P4|COMPLETED|Overall Study||2
278231|NCT02081014|667082|P3|COMPLETED|Overall Study||2
278232|NCT02081014|667083|P2|COMPLETED|Overall Study||2
278233|NCT02081014|667084|P1|COMPLETED|Overall Study||2
278234|NCT02081014|667079|P6|STARTED|Overall Study||2
278235|NCT02081014|667080|P5|STARTED|Overall Study||2
278236|NCT02081014|667081|P4|STARTED|Overall Study||2
278237|NCT02081014|667082|P3|STARTED|Overall Study||2
278238|NCT02081014|667083|P2|STARTED|Overall Study||2
278239|NCT02081014|667084|P1|STARTED|Overall Study||2
278240|NCT02081001|667130|P12|NOT COMPLETED|Overall Study||0
278241|NCT02081001|667131|P11|NOT COMPLETED|Overall Study||0
278242|NCT02081001|667132|P10|NOT COMPLETED|Overall Study||0
278243|NCT02081001|667133|P9|NOT COMPLETED|Overall Study||0
278244|NCT02081001|667134|P8|NOT COMPLETED|Overall Study||0
278245|NCT02081001|667135|P7|NOT COMPLETED|Overall Study||0
278246|NCT02081001|667136|P6|NOT COMPLETED|Overall Study||0
278247|NCT02081001|667137|P5|NOT COMPLETED|Overall Study||1
278248|NCT02081001|667138|P4|NOT COMPLETED|Overall Study||0
278249|NCT02081001|667139|P3|NOT COMPLETED|Overall Study||0
278250|NCT02081001|667140|P2|NOT COMPLETED|Overall Study||0
278251|NCT02081001|667141|P1|NOT COMPLETED|Overall Study||0
278252|NCT02081001|667130|P12|COMPLETED|Overall Study||1
278253|NCT02081001|667131|P11|COMPLETED|Overall Study||2
278254|NCT02081001|667132|P10|COMPLETED|Overall Study||1
278255|NCT02081001|667133|P9|COMPLETED|Overall Study||2
278256|NCT02081001|667134|P8|COMPLETED|Overall Study||1
278257|NCT02081001|667135|P7|COMPLETED|Overall Study||2
278258|NCT02081001|667136|P6|COMPLETED|Overall Study||1
278259|NCT02081001|667137|P5|COMPLETED|Overall Study||2
278260|NCT02081001|667138|P4|COMPLETED|Overall Study||1
278261|NCT02081001|667139|P3|COMPLETED|Overall Study||2
278262|NCT02081001|667140|P2|COMPLETED|Overall Study||1
278263|NCT02081001|667141|P1|COMPLETED|Overall Study||2
278264|NCT02081001|667130|P12|STARTED|Overall Study||1
278265|NCT02081001|667131|P11|STARTED|Overall Study||2
278266|NCT02081001|667132|P10|STARTED|Overall Study||1
278267|NCT02081001|667133|P9|STARTED|Overall Study||2
278268|NCT02081001|667134|P8|STARTED|Overall Study||1
278269|NCT02081001|667135|P7|STARTED|Overall Study||2
278270|NCT02081001|667136|P6|STARTED|Overall Study||1
278271|NCT02081001|667137|P5|STARTED|Overall Study||3
278272|NCT02081001|667138|P4|STARTED|Overall Study||1
278273|NCT02081001|667139|P3|STARTED|Overall Study||2
278274|NCT02081001|667140|P2|STARTED|Overall Study||1
278275|NCT02081001|667141|P1|STARTED|Overall Study||2
278276|NCT02080780|667205|P1|NOT COMPLETED|Overall Study||0
278277|NCT02080780|667205|P1|COMPLETED|Overall Study||24
278278|NCT02080780|667205|P1|STARTED|Overall Study||24
278279|NCT02080546|667214|P2|NOT COMPLETED|Overall Study||11
278280|NCT02080546|667215|P1|NOT COMPLETED|Overall Study||8
278281|NCT02080546|667214|P2|COMPLETED|Overall Study||52
278282|NCT02080546|667215|P1|COMPLETED|Overall Study||49
278283|NCT02080546|667214|P2|STARTED|Overall Study||63
278284|NCT02080546|667215|P1|STARTED|Overall Study||57
278285|NCT02080507|667225|P2|NOT COMPLETED|Overall Study||0
278286|NCT02080507|667226|P1|NOT COMPLETED|Overall Study||0
278287|NCT02080507|667225|P2|COMPLETED|Overall Study||7
278288|NCT02080507|667226|P1|COMPLETED|Overall Study||5
278289|NCT02080507|667225|P2|STARTED|Overall Study||7
278290|NCT02080507|667226|P1|STARTED|Overall Study||5
278291|NCT02080481|667236|P2|NOT COMPLETED|Overall Study||0
278292|NCT02080481|667237|P1|NOT COMPLETED|Overall Study||1
278293|NCT02080481|667236|P2|COMPLETED|Overall Study||67
278294|NCT02080481|667237|P1|COMPLETED|Overall Study||67
278295|NCT02080481|667236|P2|STARTED|Overall Study||67
278296|NCT02080481|667237|P1|STARTED|Overall Study||68
278297|NCT02080312|667249|P1|NOT COMPLETED|Overall Study||0
278298|NCT02080312|667249|P1|COMPLETED|Overall Study||6
278299|NCT02080312|667249|P1|STARTED|Overall Study||6
278300|NCT02080091|667255|P1|NOT COMPLETED|Overall Study||25
278301|NCT02080091|667255|P1|COMPLETED|Overall Study||0
278302|NCT02080091|667255|P1|STARTED|Overall Study||25
278303|NCT02079844|667264|P3|NOT COMPLETED|Treatment Period 3||0
278304|NCT02079844|667265|P2|NOT COMPLETED|Treatment Period 3||0
278305|NCT02079844|667266|P1|NOT COMPLETED|Treatment Period 3||0
278306|NCT02079844|667264|P3|COMPLETED|Treatment Period 3||5
278307|NCT02079844|667265|P2|COMPLETED|Treatment Period 3||5
278308|NCT02079844|667266|P1|COMPLETED|Treatment Period 3||5
278309|NCT02079844|667264|P3|STARTED|Treatment Period 3||5
278310|NCT02079844|667265|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
278311|NCT02079844|667266|P1|STARTED|Treatment Period 3||5
278312|NCT02079844|667264|P3|NOT COMPLETED|Treatment Period 2||0
278313|NCT02079844|667265|P2|NOT COMPLETED|Treatment Period 2||1
278314|NCT02079844|667266|P1|NOT COMPLETED|Treatment Period 2||0
278315|NCT02079844|667264|P3|COMPLETED|Treatment Period 2||5
278316|NCT02079844|667265|P2|COMPLETED|Treatment Period 2||6
278317|NCT02079844|667266|P1|COMPLETED|Treatment Period 2||5
278318|NCT02079844|667264|P3|STARTED|Treatment Period 2||5
278319|NCT02079844|667265|P2|STARTED|Treatment Period 2||7
278320|NCT02079844|667266|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
278321|NCT02079844|667264|P3|NOT COMPLETED|Treatment Period 1||2
278322|NCT02079844|667265|P2|NOT COMPLETED|Treatment Period 1||0
278323|NCT02079844|667266|P1|NOT COMPLETED|Treatment Period 1||0
278324|NCT02079844|667264|P3|COMPLETED|Treatment Period 1||5
278325|NCT02079844|667265|P2|COMPLETED|Treatment Period 1||7
278326|NCT02079844|667266|P1|COMPLETED|Treatment Period 1||6
278327|NCT02079844|667264|P3|STARTED|Treatment Period 1||7
278328|NCT02079844|667265|P2|STARTED|Treatment Period 1||7
278329|NCT02079844|667266|P1|STARTED|Treatment Period 1||6
278330|NCT02079649|667326|P4|NOT COMPLETED|Overall Study||2
278331|NCT02079649|667327|P3|NOT COMPLETED|Overall Study||1
278332|NCT02079649|667328|P2|NOT COMPLETED|Overall Study||0
278333|NCT02079649|667329|P1|NOT COMPLETED|Overall Study||1
278334|NCT02079649|667326|P4|COMPLETED|Overall Study||38
278335|NCT02079649|667327|P3|COMPLETED|Overall Study||40
278336|NCT02079649|667328|P2|COMPLETED|Overall Study||41
278337|NCT02079649|667329|P1|COMPLETED|Overall Study||41
278338|NCT02079649|667326|P4|Treated|Overall Study||40
278339|NCT02079649|667327|P3|Treated|Overall Study||40
278340|NCT02079649|667328|P2|Treated|Overall Study||41
278341|NCT02079649|667329|P1|Treated|Overall Study||41
278342|NCT02079649|667326|P4|STARTED|Overall Study||40
278343|NCT02079649|667327|P3|STARTED|Overall Study||41
278344|NCT02079649|667328|P2|STARTED|Overall Study||41
278345|NCT02079649|667329|P1|STARTED|Overall Study||42
278346|NCT02079532|667344|P1|NOT COMPLETED|Overall Study||29
278347|NCT02079532|667344|P1|COMPLETED|Overall Study||273
278348|NCT02079532|667344|P1|STARTED|Overall Study||302
278349|NCT02079519|667366|P1|NOT COMPLETED|Overall Study||10
278350|NCT02079519|667366|P1|COMPLETED|Overall Study||0
278351|NCT02079519|667366|P1|STARTED|Overall Study||10
278352|NCT02079311|667372|P2|NOT COMPLETED|Overall Study||1
278353|NCT02079311|667373|P1|NOT COMPLETED|Overall Study||0
278354|NCT02079311|667372|P2|COMPLETED|Overall Study||26
278355|NCT02079311|667373|P1|COMPLETED|Overall Study||28
278356|NCT02079311|667372|P2|STARTED|Overall Study||27
278357|NCT02079311|667373|P1|STARTED|Overall Study||28
278358|NCT02078492|667382|P3|NOT COMPLETED|Overall Study||0
278359|NCT02078492|667383|P2|NOT COMPLETED|Overall Study||0
278360|NCT02078492|667384|P1|NOT COMPLETED|Overall Study||0
278361|NCT02078492|667382|P3|COMPLETED|Overall Study||80
278362|NCT02078492|667383|P2|COMPLETED|Overall Study||80
278363|NCT02078492|667384|P1|COMPLETED|Overall Study||80
278364|NCT02078492|667382|P3|STARTED|Overall Study||80
278365|NCT02078492|667383|P2|STARTED|Overall Study||80
278366|NCT02078492|667384|P1|STARTED|Overall Study||80
278367|NCT02077374|667403|P2|NOT COMPLETED|Overall Study||2
278368|NCT02077374|667404|P1|NOT COMPLETED|Overall Study||0
278369|NCT02077374|667403|P2|COMPLETED|Overall Study||17
278370|NCT02077374|667404|P1|COMPLETED|Overall Study||19
278371|NCT02077374|667403|P2|STARTED|Overall Study||19
278372|NCT02077374|667404|P1|STARTED|Overall Study||19
278373|NCT02076919|667432|P4|NOT COMPLETED|Overall Study||0
278374|NCT02076919|667433|P3|NOT COMPLETED|Overall Study||0
278375|NCT02076919|667434|P2|NOT COMPLETED|Overall Study||0
278376|NCT02076919|667435|P1|NOT COMPLETED|Overall Study||0
278377|NCT02076919|667432|P4|COMPLETED|Overall Study||12
278378|NCT02076919|667433|P3|COMPLETED|Overall Study||36
278379|NCT02076919|667434|P2|COMPLETED|Overall Study||8
278380|NCT02076919|667435|P1|COMPLETED|Overall Study||24
278381|NCT02076919|667432|P4|STARTED|Overall Study||12
278382|NCT02076919|667433|P3|STARTED|Overall Study||36
278383|NCT02076919|667434|P2|STARTED|Overall Study||8
278384|NCT02076919|667435|P1|STARTED|Overall Study||24
278385|NCT02076009|667535|P2|NOT COMPLETED|Overall Study||286
278386|NCT02076009|667536|P1|NOT COMPLETED|Overall Study||283
278387|NCT02076009|667535|P2|COMPLETED|Overall Study||0
278388|NCT02076009|667536|P1|COMPLETED|Overall Study||0
278389|NCT02076009|667535|P2|Treated|Overall Study||283
278390|NCT02076009|667536|P1|Treated|Overall Study||281
278391|NCT02076009|667535|P2|STARTED|Overall Study||286
278392|NCT02076009|667536|P1|STARTED|Overall Study||283
278393|NCT02075632|667558|P2|NOT COMPLETED|Overall Study||5
278394|NCT02075632|667559|P1|NOT COMPLETED|Overall Study||1
278395|NCT02075632|667558|P2|COMPLETED|Overall Study||143
278396|NCT02075632|667559|P1|COMPLETED|Overall Study||161
278397|NCT02075632|667558|P2|STARTED|Overall Study||148
278398|NCT02075632|667559|P1|STARTED|Overall Study||162
278399|NCT02075515|667572|P3|NOT COMPLETED|Overall Study||8
278400|NCT02075515|667573|P2|NOT COMPLETED|Overall Study||5
278401|NCT02075515|667574|P1|NOT COMPLETED|Overall Study||4
278402|NCT02075515|667572|P3|COMPLETED|Overall Study||208
278403|NCT02075515|667573|P2|COMPLETED|Overall Study||212
278404|NCT02075515|667574|P1|COMPLETED|Overall Study||214
278405|NCT02075515|667572|P3|STARTED|Overall Study||216
278406|NCT02075515|667573|P2|STARTED|Overall Study||217
278407|NCT02075515|667574|P1|STARTED|Overall Study||218
278408|NCT02075411|667613|P4|NOT COMPLETED|Overall Study||0
278409|NCT02075411|667614|P3|NOT COMPLETED|Overall Study||0
278410|NCT02075411|667615|P2|NOT COMPLETED|Overall Study||0
278411|NCT02075411|667616|P1|NOT COMPLETED|Overall Study||0
278412|NCT02075411|667613|P4|COMPLETED|Overall Study||1
278413|NCT02075411|667614|P3|COMPLETED|Overall Study||0
278414|NCT02075411|667615|P2|COMPLETED|Overall Study||0
278415|NCT02075411|667616|P1|COMPLETED|Overall Study||0
278416|NCT02075411|667613|P4|STARTED|Overall Study||1
278417|NCT02075411|667614|P3|STARTED|Overall Study||0
278418|NCT02075411|667615|P2|STARTED|Overall Study||0
278419|NCT02075411|667616|P1|STARTED|Overall Study||0
278420|NCT02075125|667636|P2|NOT COMPLETED|Overall Study||1
278421|NCT02075125|667637|P1|NOT COMPLETED|Overall Study||0
278422|NCT02075125|667636|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
278423|NCT02075125|667637|P1|COMPLETED|Overall Study||19
278424|NCT02075125|667636|P2|STARTED|Overall Study||20
278425|NCT02075125|667637|P1|STARTED|Overall Study||19
278426|NCT02075073|667658|P3|NOT COMPLETED|Overall Study||0
278427|NCT02075073|667659|P2|NOT COMPLETED|Overall Study||1
278428|NCT02075073|667660|P1|NOT COMPLETED|Overall Study||0
278429|NCT02075073|667658|P3|COMPLETED|Overall Study||36
278430|NCT02075073|667659|P2|COMPLETED|Overall Study||36
278431|NCT02075073|667660|P1|COMPLETED|Overall Study||36
278432|NCT02075073|667658|P3|STARTED|Overall Study||36
278433|NCT02075073|667659|P2|STARTED|Overall Study||37
278434|NCT02075073|667660|P1|STARTED|Overall Study||36
278435|NCT02075008|667677|P1|NOT COMPLETED|Overall Study||176
278436|NCT02075008|667677|P1|COMPLETED|Overall Study||94
278437|NCT02075008|667677|P1|STARTED|Overall Study||270
278438|NCT02074995|667681|P3|NOT COMPLETED|Overall Study||0
278439|NCT02074995|667682|P2|NOT COMPLETED|Overall Study||0
278440|NCT02074995|667683|P1|NOT COMPLETED|Overall Study||0
278441|NCT02074995|667681|P3|COMPLETED|Overall Study||0
278442|NCT02074995|667682|P2|COMPLETED|Overall Study||0
278443|NCT02074995|667683|P1|COMPLETED|Overall Study||1
278444|NCT02074995|667681|P3|STARTED|Overall Study||0
278445|NCT02074995|667682|P2|STARTED|Overall Study||0
278446|NCT02074995|667683|P1|STARTED|Overall Study||1
278447|NCT02074709|667700|P2|NOT COMPLETED|Overall Study||1
278448|NCT02074709|667701|P1|NOT COMPLETED|Overall Study||1
278449|NCT02074709|667700|P2|COMPLETED|Overall Study||29
278450|NCT02074709|667701|P1|COMPLETED|Overall Study||29
278451|NCT02074709|667700|P2|STARTED|Overall Study||30
278452|NCT02074709|667701|P1|STARTED|Overall Study||30
278453|NCT02074553|667709|P8|NOT COMPLETED|Intervention Period 4||0
278454|NCT02074553|667710|P7|NOT COMPLETED|Intervention Period 4||0
278455|NCT02074553|667711|P6|NOT COMPLETED|Intervention Period 4||0
278456|NCT02074553|667712|P5|NOT COMPLETED|Intervention Period 4||0
278457|NCT02074553|667713|P4|NOT COMPLETED|Intervention Period 4||0
278458|NCT02074553|667714|P3|NOT COMPLETED|Intervention Period 4||0
278459|NCT02074553|667715|P2|NOT COMPLETED|Intervention Period 4||0
278460|NCT02074553|667716|P1|NOT COMPLETED|Intervention Period 4||0
278461|NCT02074553|667709|P8|COMPLETED|Intervention Period 4||11
278462|NCT02074553|667710|P7|COMPLETED|Intervention Period 4||11
278463|NCT02074553|667711|P6|COMPLETED|Intervention Period 4||10
278464|NCT02074553|667712|P5|COMPLETED|Intervention Period 4||12
278465|NCT02074553|667713|P4|COMPLETED|Intervention Period 4||11
278466|NCT02074553|667714|P3|COMPLETED|Intervention Period 4||11
278467|NCT02074553|667715|P2|COMPLETED|Intervention Period 4||12
278468|NCT02074553|667716|P1|COMPLETED|Intervention Period 4||11
278469|NCT02074553|667709|P8|STARTED|Intervention Period 4||11
278470|NCT02074553|667710|P7|STARTED|Intervention Period 4||11
278471|NCT02074553|667711|P6|STARTED|Intervention Period 4||10
278472|NCT02074553|667712|P5|STARTED|Intervention Period 4||12
278473|NCT02074553|667713|P4|STARTED|Intervention Period 4||11
278474|NCT02074553|667714|P3|STARTED|Intervention Period 4||11
278475|NCT02074553|667715|P2|STARTED|Intervention Period 4||12
278476|NCT02074553|667716|P1|STARTED|Intervention Period 4||11
278477|NCT02074553|667709|P8|NOT COMPLETED|Washout Period 3||1
278478|NCT02074553|667710|P7|NOT COMPLETED|Washout Period 3||0
278479|NCT02074553|667711|P6|NOT COMPLETED|Washout Period 3||0
278480|NCT02074553|667712|P5|NOT COMPLETED|Washout Period 3||0
278481|NCT02074553|667713|P4|NOT COMPLETED|Washout Period 3||0
278482|NCT02074553|667714|P3|NOT COMPLETED|Washout Period 3||0
278483|NCT02074553|667715|P2|NOT COMPLETED|Washout Period 3||0
278484|NCT02074553|667716|P1|NOT COMPLETED|Washout Period 3||0
278485|NCT02074553|667709|P8|COMPLETED|Washout Period 3||11
278486|NCT02074553|667710|P7|COMPLETED|Washout Period 3||11
278487|NCT02074553|667711|P6|COMPLETED|Washout Period 3||10
278488|NCT02074553|667712|P5|COMPLETED|Washout Period 3||12
278489|NCT02074553|667713|P4|COMPLETED|Washout Period 3||11
278490|NCT02074553|667714|P3|COMPLETED|Washout Period 3||11
278491|NCT02074553|667715|P2|COMPLETED|Washout Period 3||12
278492|NCT02074553|667716|P1|COMPLETED|Washout Period 3||11
278493|NCT02074553|667709|P8|STARTED|Washout Period 3||12
278494|NCT02074553|667710|P7|STARTED|Washout Period 3||11
278495|NCT02074553|667711|P6|STARTED|Washout Period 3||10
278496|NCT02074553|667712|P5|STARTED|Washout Period 3||12
278497|NCT02074553|667713|P4|STARTED|Washout Period 3||11
278498|NCT02074553|667714|P3|STARTED|Washout Period 3||11
278499|NCT02074553|667715|P2|STARTED|Washout Period 3||12
278500|NCT02074553|667716|P1|STARTED|Washout Period 3||11
278501|NCT02074553|667709|P8|NOT COMPLETED|Intervention Period 3||0
278502|NCT02074553|667710|P7|NOT COMPLETED|Intervention Period 3||0
278503|NCT02074553|667711|P6|NOT COMPLETED|Intervention Period 3||0
278504|NCT02074553|667712|P5|NOT COMPLETED|Intervention Period 3||0
278505|NCT02074553|667713|P4|NOT COMPLETED|Intervention Period 3||0
278506|NCT02074553|667714|P3|NOT COMPLETED|Intervention Period 3||0
278507|NCT02074553|667715|P2|NOT COMPLETED|Intervention Period 3||0
278508|NCT02074553|667716|P1|NOT COMPLETED|Intervention Period 3||0
278509|NCT02074553|667709|P8|COMPLETED|Intervention Period 3||12
278510|NCT02074553|667710|P7|COMPLETED|Intervention Period 3||11
278511|NCT02074553|667711|P6|COMPLETED|Intervention Period 3||10
278512|NCT02074553|667712|P5|COMPLETED|Intervention Period 3||12
278513|NCT02074553|667713|P4|COMPLETED|Intervention Period 3||11
278514|NCT02074553|667714|P3|COMPLETED|Intervention Period 3||11
278515|NCT02074553|667715|P2|COMPLETED|Intervention Period 3||12
278516|NCT02074553|667716|P1|COMPLETED|Intervention Period 3||11
278517|NCT02074553|667709|P8|STARTED|Intervention Period 3||12
278518|NCT02074553|667710|P7|STARTED|Intervention Period 3||11
278519|NCT02074553|667711|P6|STARTED|Intervention Period 3||10
278520|NCT02074553|667712|P5|STARTED|Intervention Period 3||12
278521|NCT02074553|667713|P4|STARTED|Intervention Period 3||11
278522|NCT02074553|667714|P3|STARTED|Intervention Period 3||11
278523|NCT02074553|667715|P2|STARTED|Intervention Period 3||12
278524|NCT02074553|667716|P1|STARTED|Intervention Period 3||11
278525|NCT02074553|667709|P8|NOT COMPLETED|Washout Period 2||0
278526|NCT02074553|667710|P7|NOT COMPLETED|Washout Period 2||1
278527|NCT02074553|667711|P6|NOT COMPLETED|Washout Period 2||1
278528|NCT02074553|667712|P5|NOT COMPLETED|Washout Period 2||0
278529|NCT02074553|667713|P4|NOT COMPLETED|Washout Period 2||0
278530|NCT02074553|667714|P3|NOT COMPLETED|Washout Period 2||1
278531|NCT02074553|667715|P2|NOT COMPLETED|Washout Period 2||0
278532|NCT02074553|667716|P1|NOT COMPLETED|Washout Period 2||0
278533|NCT02074553|667709|P8|COMPLETED|Washout Period 2||12
278534|NCT02074553|667710|P7|COMPLETED|Washout Period 2||11
278535|NCT02074553|667711|P6|COMPLETED|Washout Period 2||10
278536|NCT02074553|667712|P5|COMPLETED|Washout Period 2||12
278537|NCT02074553|667713|P4|COMPLETED|Washout Period 2||11
278538|NCT02074553|667714|P3|COMPLETED|Washout Period 2||11
278539|NCT02074553|667715|P2|COMPLETED|Washout Period 2||12
278540|NCT02074553|667716|P1|COMPLETED|Washout Period 2||11
278541|NCT02074553|667709|P8|STARTED|Washout Period 2||12
278542|NCT02074553|667710|P7|STARTED|Washout Period 2||12
278543|NCT02074553|667711|P6|STARTED|Washout Period 2||11
278544|NCT02074553|667712|P5|STARTED|Washout Period 2||12
278545|NCT02074553|667713|P4|STARTED|Washout Period 2||11
278546|NCT02074553|667714|P3|STARTED|Washout Period 2||12
278547|NCT02074553|667715|P2|STARTED|Washout Period 2||12
278548|NCT02074553|667716|P1|STARTED|Washout Period 2||11
278549|NCT02074553|667709|P8|NOT COMPLETED|Intervention Period 2||0
278550|NCT02074553|667710|P7|NOT COMPLETED|Intervention Period 2||0
278551|NCT02074553|667711|P6|NOT COMPLETED|Intervention Period 2||0
278552|NCT02074553|667712|P5|NOT COMPLETED|Intervention Period 2||0
278553|NCT02074553|667713|P4|NOT COMPLETED|Intervention Period 2||0
278554|NCT02074553|667714|P3|NOT COMPLETED|Intervention Period 2||0
278555|NCT02074553|667715|P2|NOT COMPLETED|Intervention Period 2||0
278556|NCT02074553|667716|P1|NOT COMPLETED|Intervention Period 2||0
278557|NCT02074553|667709|P8|COMPLETED|Intervention Period 2||12
278558|NCT02074553|667710|P7|COMPLETED|Intervention Period 2||12
278559|NCT02074553|667711|P6|COMPLETED|Intervention Period 2||11
278560|NCT02074553|667712|P5|COMPLETED|Intervention Period 2||12
278561|NCT02074553|667713|P4|COMPLETED|Intervention Period 2||11
278562|NCT02074553|667714|P3|COMPLETED|Intervention Period 2||12
278563|NCT02074553|667715|P2|COMPLETED|Intervention Period 2||12
278564|NCT02074553|667716|P1|COMPLETED|Intervention Period 2||11
278565|NCT02074553|667709|P8|STARTED|Intervention Period 2||12
278566|NCT02074553|667710|P7|STARTED|Intervention Period 2||12
278567|NCT02074553|667711|P6|STARTED|Intervention Period 2||11
278568|NCT02074553|667712|P5|STARTED|Intervention Period 2||12
278569|NCT02074553|667713|P4|STARTED|Intervention Period 2||11
278570|NCT02074553|667714|P3|STARTED|Intervention Period 2||12
278571|NCT02074553|667715|P2|STARTED|Intervention Period 2||12
278572|NCT02074553|667716|P1|STARTED|Intervention Period 2||11
278573|NCT02074553|667709|P8|NOT COMPLETED|Washout Period 1||0
278574|NCT02074553|667710|P7|NOT COMPLETED|Washout Period 1||0
278575|NCT02074553|667711|P6|NOT COMPLETED|Washout Period 1||1
278576|NCT02074553|667712|P5|NOT COMPLETED|Washout Period 1||0
278577|NCT02074553|667713|P4|NOT COMPLETED|Washout Period 1||1
278578|NCT02074553|667714|P3|NOT COMPLETED|Washout Period 1||0
278579|NCT02074553|667715|P2|NOT COMPLETED|Washout Period 1||0
278580|NCT02074553|667716|P1|NOT COMPLETED|Washout Period 1||1
278581|NCT02074553|667709|P8|COMPLETED|Washout Period 1||12
278582|NCT02074553|667710|P7|COMPLETED|Washout Period 1||12
278583|NCT02074553|667711|P6|COMPLETED|Washout Period 1||11
278584|NCT02074553|667712|P5|COMPLETED|Washout Period 1||12
278585|NCT02074553|667713|P4|COMPLETED|Washout Period 1||11
278586|NCT02074553|667714|P3|COMPLETED|Washout Period 1||12
278587|NCT02074553|667715|P2|COMPLETED|Washout Period 1||12
278588|NCT02074553|667716|P1|COMPLETED|Washout Period 1||11
278589|NCT02074553|667709|P8|STARTED|Washout Period 1||12
278590|NCT02074553|667710|P7|STARTED|Washout Period 1||12
278591|NCT02074553|667711|P6|STARTED|Washout Period 1||12
278592|NCT02074553|667712|P5|STARTED|Washout Period 1||12
278593|NCT02074553|667713|P4|STARTED|Washout Period 1||12
278594|NCT02074553|667714|P3|STARTED|Washout Period 1||12
278595|NCT02074553|667715|P2|STARTED|Washout Period 1||12
278596|NCT02074553|667716|P1|STARTED|Washout Period 1||12
278597|NCT02074553|667709|P8|NOT COMPLETED|Intervention Period 1||0
278598|NCT02074553|667710|P7|NOT COMPLETED|Intervention Period 1||0
278599|NCT02074553|667711|P6|NOT COMPLETED|Intervention Period 1||0
278600|NCT02074553|667712|P5|NOT COMPLETED|Intervention Period 1||0
278601|NCT02074553|667713|P4|NOT COMPLETED|Intervention Period 1||1
278602|NCT02074553|667714|P3|NOT COMPLETED|Intervention Period 1||0
278603|NCT02074553|667715|P2|NOT COMPLETED|Intervention Period 1||0
278604|NCT02074553|667716|P1|NOT COMPLETED|Intervention Period 1||0
278605|NCT02074553|667709|P8|COMPLETED|Intervention Period 1||12
278606|NCT02074553|667710|P7|COMPLETED|Intervention Period 1||12
278607|NCT02074553|667711|P6|COMPLETED|Intervention Period 1||12
278608|NCT02074553|667712|P5|COMPLETED|Intervention Period 1||12
278609|NCT02074553|667713|P4|COMPLETED|Intervention Period 1||12
278610|NCT02074553|667714|P3|COMPLETED|Intervention Period 1||12
278611|NCT02074553|667715|P2|COMPLETED|Intervention Period 1||12
278612|NCT02074553|667716|P1|COMPLETED|Intervention Period 1||12
278613|NCT02074553|667709|P8|STARTED|Intervention Period 1||12
278614|NCT02074553|667710|P7|STARTED|Intervention Period 1||12
278615|NCT02074553|667711|P6|STARTED|Intervention Period 1||12
278616|NCT02074553|667712|P5|STARTED|Intervention Period 1||12
278617|NCT02074553|667713|P4|STARTED|Intervention Period 1||13
278618|NCT02074553|667714|P3|STARTED|Intervention Period 1||12
278619|NCT02074553|667715|P2|STARTED|Intervention Period 1||12
278620|NCT02074553|667716|P1|STARTED|Intervention Period 1||12
278621|NCT02074514|667898|P2|NOT COMPLETED|Overall Study||4
278622|NCT02074514|667899|P1|NOT COMPLETED|Overall Study||3
278623|NCT02074514|667898|P2|COMPLETED|Overall Study||54
278624|NCT02074514|667899|P1|COMPLETED|Overall Study||56
278625|NCT02074514|667898|P2|STARTED|Overall Study||58
278626|NCT02074514|667899|P1|STARTED|Overall Study||59
278627|NCT02074384|667920|P3|NOT COMPLETED|Overall Study||0
278628|NCT02074384|667921|P2|NOT COMPLETED|Overall Study||0
278629|NCT02074384|667922|P1|NOT COMPLETED|Overall Study||0
278630|NCT02074384|667920|P3|COMPLETED|Overall Study||17
278631|NCT02074384|667921|P2|COMPLETED|Overall Study||70
278632|NCT02074384|667922|P1|COMPLETED|Overall Study||74
278633|NCT02074384|667920|P3|STARTED|Overall Study||17
278634|NCT02074384|667921|P2|STARTED|Overall Study||70
278635|NCT02074384|667922|P1|STARTED|Overall Study||74
278636|NCT02074358|667930|P6|NOT COMPLETED|Overall Study||0
278637|NCT02074358|667931|P5|NOT COMPLETED|Overall Study||0
278638|NCT02074358|667932|P4|NOT COMPLETED|Overall Study||0
278639|NCT02074358|667933|P3|NOT COMPLETED|Overall Study||0
278640|NCT02074358|667934|P2|NOT COMPLETED|Overall Study||0
278641|NCT02074358|667935|P1|NOT COMPLETED|Overall Study||0
278642|NCT02074358|667930|P6|COMPLETED|Overall Study||2
278643|NCT02074358|667931|P5|COMPLETED|Overall Study||3
278644|NCT02074358|667932|P4|COMPLETED|Overall Study||2
278645|NCT02074358|667933|P3|COMPLETED|Overall Study||2
278646|NCT02074358|667934|P2|COMPLETED|Overall Study||3
278647|NCT02074358|667935|P1|COMPLETED|Overall Study||3
278648|NCT02074358|667930|P6|STARTED|Overall Study||2
278649|NCT02074358|667931|P5|STARTED|Overall Study||3
278650|NCT02074358|667932|P4|STARTED|Overall Study||2
278651|NCT02074358|667933|P3|STARTED|Overall Study||2
278652|NCT02074358|667934|P2|STARTED|Overall Study||3
278653|NCT02074358|667935|P1|STARTED|Overall Study||3
278654|NCT02074345|668024|P1|NOT COMPLETED|Overall Study||0
278655|NCT02074345|668024|P1|COMPLETED|Overall Study||31
278656|NCT02074345|668024|P1|STARTED|Overall Study||31
278657|NCT02074059|668040|P6|NOT COMPLETED|Overall Study||1
278658|NCT02074059|668041|P5|NOT COMPLETED|Overall Study||1
278659|NCT02074059|668042|P4|NOT COMPLETED|Overall Study||0
278660|NCT02074059|668043|P3|NOT COMPLETED|Overall Study||0
278661|NCT02074059|668044|P2|NOT COMPLETED|Overall Study||0
278662|NCT02074059|668045|P1|NOT COMPLETED|Overall Study||0
278663|NCT02074059|668040|P6|COMPLETED|Overall Study||39
278664|NCT02074059|668041|P5|COMPLETED|Overall Study||7
278665|NCT02074059|668042|P4|COMPLETED|Overall Study||8
278666|NCT02074059|668043|P3|COMPLETED|Overall Study||8
278667|NCT02074059|668044|P2|COMPLETED|Overall Study||8
278668|NCT02074059|668045|P1|COMPLETED|Overall Study||8
278669|NCT02074059|668040|P6|STARTED|Overall Study||40
278670|NCT02074059|668041|P5|STARTED|Overall Study||8
278671|NCT02074059|668042|P4|STARTED|Overall Study||8
278672|NCT02074059|668043|P3|STARTED|Overall Study||8
278673|NCT02074059|668044|P2|STARTED|Overall Study||8
278674|NCT02074059|668045|P1|STARTED|Overall Study||8
278675|NCT02073656|668083|P1|NOT COMPLETED|Retreatment Substudy||0
278676|NCT02073656|668083|P1|COMPLETED|Retreatment Substudy||9
278677|NCT02073656|668083|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
278678|NCT02073656|668083|P1|NOT COMPLETED|Primary Study||8
278679|NCT02073656|668083|P1|COMPLETED|Primary Study||327
278680|NCT02073656|668083|P1|STARTED|Primary Study||335
278681|NCT02073461|668102|P3|NOT COMPLETED|Overall Study||1
278682|NCT02073461|668103|P2|NOT COMPLETED|Overall Study||1
278683|NCT02073461|668104|P1|NOT COMPLETED|Overall Study||4
278684|NCT02073461|668102|P3|COMPLETED|Overall Study||78
278685|NCT02073461|668103|P2|COMPLETED|Overall Study||77
278686|NCT02073461|668104|P1|COMPLETED|Overall Study||75
278687|NCT02073461|668102|P3|STARTED|Overall Study||79
278688|NCT02073461|668103|P2|STARTED|Overall Study||78
278689|NCT02073461|668104|P1|STARTED|Overall Study||79
278690|NCT02073448|668133|P3|NOT COMPLETED|Overall Study||5
278691|NCT02073448|668134|P2|NOT COMPLETED|Overall Study||12
278692|NCT02073448|668135|P1|NOT COMPLETED|Overall Study||2
278693|NCT02073448|668133|P3|COMPLETED|Overall Study||99
278694|NCT02073448|668134|P2|COMPLETED|Overall Study||200
278695|NCT02073448|668135|P1|COMPLETED|Overall Study||99
278696|NCT02073448|668133|P3|STARTED|Overall Study||104
278697|NCT02073448|668134|P2|STARTED|Overall Study||212
278698|NCT02073448|668135|P1|STARTED|Overall Study||101
278699|NCT02072980|668161|P2|NOT COMPLETED|Period 2, Second Wear||1
278700|NCT02072980|668162|P1|NOT COMPLETED|Period 2, Second Wear||0
278701|NCT02072980|668161|P2|COMPLETED|Period 2, Second Wear||7
278702|NCT02072980|668162|P1|COMPLETED|Period 2, Second Wear||7
278703|NCT02072980|668161|P2|STARTED|Period 2, Second Wear||8
278704|NCT02072980|668162|P1|STARTED|Period 2, Second Wear||7
278705|NCT02072980|668161|P2|NOT COMPLETED|Period 1, First Wear||0
278706|NCT02072980|668162|P1|NOT COMPLETED|Period 1, First Wear||0
278707|NCT02072980|668161|P2|COMPLETED|Period 1, First Wear||8
278708|NCT02072980|668162|P1|COMPLETED|Period 1, First Wear||7
278709|NCT02072980|668161|P2|STARTED|Period 1, First Wear||8
278710|NCT02072980|668162|P1|STARTED|Period 1, First Wear||7
278711|NCT02072421|668168|P1|NOT COMPLETED|Overall Study||390
278712|NCT02072421|668168|P1|COMPLETED|Overall Study||2489
278713|NCT02072421|668168|P1|STARTED|Overall Study||2879
278714|NCT02072200|668176|P1|NOT COMPLETED|Overall Study||2
278715|NCT02072200|668176|P1|COMPLETED|Overall Study||145
278716|NCT02072200|668176|P1|STARTED|Overall Study||147
278717|NCT02072096|668184|P2|NOT COMPLETED|Overall Study||78
278718|NCT02072096|668185|P1|NOT COMPLETED|Overall Study||85
278719|NCT02072096|668184|P2|COMPLETED|Overall Study||15
278720|NCT02072096|668185|P1|COMPLETED|Overall Study||14
278721|NCT02072096|668184|P2|Received at Least One Dose of Study Drug|Overall Study||93
278722|NCT02072096|668185|P1|Received at Least One Dose of Study Drug|Overall Study||98
278723|NCT02072096|668184|P2|STARTED|Overall Study||93
278724|NCT02072096|668185|P1|STARTED|Overall Study||99
278725|NCT02071849|668207|P1|NOT COMPLETED|2-year Extended Follow-up||1
278726|NCT02071849|668207|P1|COMPLETED|2-year Extended Follow-up||14
278727|NCT02071849|668207|P1|STARTED|2-year Extended Follow-up||15
278728|NCT02071849|668207|P1|NOT COMPLETED|6-month Primary Endpoint||5
278729|NCT02071849|668207|P1|COMPLETED|6-month Primary Endpoint||15
278730|NCT02071849|668207|P1|STARTED|6-month Primary Endpoint||20
278731|NCT02071823|668241|P2|NOT COMPLETED|Overall Study||0
278732|NCT02071823|668242|P1|NOT COMPLETED|Overall Study||1
278733|NCT02071823|668241|P2|COMPLETED|Overall Study||6
278734|NCT02071823|668242|P1|COMPLETED|Overall Study||5
278735|NCT02071823|668241|P2|STARTED|Overall Study||6
278736|NCT02071823|668242|P1|STARTED|Overall Study||6
278737|NCT02071810|668257|P5|NOT COMPLETED|Overall Study||1
278738|NCT02071810|668258|P4|NOT COMPLETED|Overall Study||1
278739|NCT02071810|668259|P3|NOT COMPLETED|Overall Study||0
278740|NCT02071810|668260|P2|NOT COMPLETED|Overall Study||0
278741|NCT02071810|668261|P1|NOT COMPLETED|Overall Study||0
278742|NCT02071810|668257|P5|COMPLETED|Overall Study||8
278743|NCT02071810|668258|P4|COMPLETED|Overall Study||6
278744|NCT02071810|668259|P3|COMPLETED|Overall Study||6
278745|NCT02071810|668260|P2|COMPLETED|Overall Study||6
278746|NCT02071810|668261|P1|COMPLETED|Overall Study||6
278747|NCT02071810|668257|P5|STARTED|Overall Study||9
278748|NCT02071810|668258|P4|STARTED|Overall Study||7
278749|NCT02071810|668259|P3|STARTED|Overall Study||6
278750|NCT02071810|668260|P2|STARTED|Overall Study||6
278751|NCT02071810|668261|P1|STARTED|Overall Study||6
278752|NCT02071771|668273|P2|NOT COMPLETED|Period 2: Second 10 Days||0
278753|NCT02071771|668274|P1|NOT COMPLETED|Period 2: Second 10 Days||0
278754|NCT02071771|668273|P2|COMPLETED|Period 2: Second 10 Days||38
278755|NCT02071771|668274|P1|COMPLETED|Period 2: Second 10 Days||39
278756|NCT02071771|668273|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
278757|NCT02071771|668274|P1|STARTED|Period 2: Second 10 Days||39
278758|NCT02071771|668273|P2|NOT COMPLETED|Period 1: First 10 Days||0
278759|NCT02071771|668274|P1|NOT COMPLETED|Period 1: First 10 Days||2
278760|NCT02071771|668273|P2|COMPLETED|Period 1: First 10 Days||39
278761|NCT02071771|668274|P1|COMPLETED|Period 1: First 10 Days||39
278762|NCT02071771|668273|P2|Dispensed|Period 1: First 10 Days||39
278763|NCT02071771|668274|P1|Dispensed|Period 1: First 10 Days||39
278764|NCT02071771|668273|P2|STARTED|Period 1: First 10 Days||39
278765|NCT02071771|668274|P1|STARTED|Period 1: First 10 Days||41
278766|NCT02071108|668282|P1|NOT COMPLETED|Overall Study||0
278767|NCT02071108|668282|P1|COMPLETED|Overall Study||35
278768|NCT02071108|668282|P1|STARTED|Overall Study||35
278769|NCT02071082|668303|P2|NOT COMPLETED|Overall Study||75
278770|NCT02071082|668304|P1|NOT COMPLETED|Overall Study||4
278771|NCT02071082|668303|P2|COMPLETED|Overall Study||0
278772|NCT02071082|668304|P1|COMPLETED|Overall Study||0
278773|NCT02071082|668303|P2|STARTED|Overall Study||75
278774|NCT02071082|668304|P1|STARTED|Overall Study||4
278775|NCT02070965|668335|P3|NOT COMPLETED|Overall Study||1
278776|NCT02070965|668336|P2|NOT COMPLETED|Overall Study||2
278777|NCT02070965|668337|P1|NOT COMPLETED|Overall Study||2
278778|NCT02070965|668335|P3|COMPLETED|Overall Study||24
278779|NCT02070965|668336|P2|COMPLETED|Overall Study||21
278780|NCT02070965|668337|P1|COMPLETED|Overall Study||25
278781|NCT02070965|668335|P3|STARTED|Overall Study||25
278782|NCT02070965|668336|P2|STARTED|Overall Study||23
278783|NCT02070965|668337|P1|STARTED|Overall Study||27
278784|NCT02070692|668347|P2|NOT COMPLETED|Overall Study||12
278785|NCT02070692|668348|P1|NOT COMPLETED|Overall Study||10
278786|NCT02070692|668347|P2|COMPLETED|Overall Study||16
278787|NCT02070692|668348|P1|COMPLETED|Overall Study||18
278788|NCT02070692|668347|P2|STARTED|Overall Study||28
278789|NCT02070692|668348|P1|STARTED|Overall Study||28
278790|NCT02070640|668364|P2|NOT COMPLETED|Overall Study||0
278791|NCT02070640|668365|P1|NOT COMPLETED|Overall Study||11
278792|NCT02070640|668364|P2|COMPLETED|Overall Study||6
278793|NCT02070640|668365|P1|COMPLETED|Overall Study||82
278794|NCT02070640|668364|P2|STARTED|Overall Study||6
278795|NCT02070640|668365|P1|STARTED|Overall Study||93
278796|NCT02070380|668379|P4|NOT COMPLETED|Second Injection||5
278797|NCT02070380|668380|P3|NOT COMPLETED|Second Injection||1
278798|NCT02070380|668381|P2|NOT COMPLETED|Second Injection||2
278799|NCT02070380|668382|P1|NOT COMPLETED|Second Injection||0
278800|NCT02070380|668379|P4|COMPLETED|Second Injection||46
278801|NCT02070380|668380|P3|COMPLETED|Second Injection||50
278802|NCT02070380|668381|P2|COMPLETED|Second Injection||32
278803|NCT02070380|668382|P1|COMPLETED|Second Injection||31
278804|NCT02070380|668379|P4|STARTED|Second Injection||51
278805|NCT02070380|668380|P3|STARTED|Second Injection||51
278806|NCT02070380|668381|P2|STARTED|Second Injection||34
278807|NCT02070380|668382|P1|STARTED|Second Injection||31
278808|NCT02070380|668379|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
278809|NCT02070380|668380|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
278810|NCT02070380|668381|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
278811|NCT02070380|668382|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
278812|NCT02070380|668379|P4|COMPLETED|Washout (no Second Injection/MRI)||51
278813|NCT02070380|668380|P3|COMPLETED|Washout (no Second Injection/MRI)||51
278814|NCT02070380|668381|P2|COMPLETED|Washout (no Second Injection/MRI)||34
278815|NCT02070380|668382|P1|COMPLETED|Washout (no Second Injection/MRI)||31
278816|NCT02070380|668379|P4|STARTED|Washout (no Second Injection/MRI)||54
278817|NCT02070380|668380|P3|STARTED|Washout (no Second Injection/MRI)||53
278818|NCT02070380|668381|P2|STARTED|Washout (no Second Injection/MRI)||39
278819|NCT02070380|668382|P1|STARTED|Washout (no Second Injection/MRI)||31
278820|NCT02070380|668379|P4|NOT COMPLETED|First Injection||0
278821|NCT02070380|668380|P3|NOT COMPLETED|First Injection||0
278822|NCT02070380|668381|P2|NOT COMPLETED|First Injection||0
278823|NCT02070380|668382|P1|NOT COMPLETED|First Injection||0
278824|NCT02070380|668379|P4|COMPLETED|First Injection||54
278825|NCT02070380|668380|P3|COMPLETED|First Injection||53
278826|NCT02070380|668381|P2|COMPLETED|First Injection||39
278827|NCT02070380|668382|P1|COMPLETED|First Injection||31
278828|NCT02070380|668379|P4|STARTED|First Injection||54
278829|NCT02070380|668380|P3|STARTED|First Injection||53
278830|NCT02070380|668381|P2|STARTED|First Injection||39
278831|NCT02070380|668382|P1|STARTED|First Injection||31
278832|NCT02070237|668432|P2|NOT COMPLETED|Overall Study||3
278833|NCT02070237|668433|P1|NOT COMPLETED|Overall Study||3
278834|NCT02070237|668432|P2|COMPLETED|Overall Study||42
278835|NCT02070237|668433|P1|COMPLETED|Overall Study||42
278836|NCT02070237|668432|P2|STARTED|Overall Study||45
278837|NCT02070237|668433|P1|STARTED|Overall Study||45
278838|NCT02069093|668441|P1|NOT COMPLETED|Overall Study||30
278839|NCT02069093|668441|P1|COMPLETED|Overall Study||56
278840|NCT02069093|668441|P1|Pharmacokinetic Analysis Set|Overall Study||50
278841|NCT02069093|668441|P1|STARTED|Overall Study||86
278842|NCT02068443|668453|P3|NOT COMPLETED|Overall Study||3
278843|NCT02068443|668454|P2|NOT COMPLETED|Overall Study||6
278844|NCT02068443|668455|P1|NOT COMPLETED|Overall Study||7
278845|NCT02068443|668453|P3|COMPLETED|Overall Study||148
278846|NCT02068443|668454|P2|COMPLETED|Overall Study||146
278847|NCT02068443|668455|P1|COMPLETED|Overall Study||64
278848|NCT02068443|668453|P3|STARTED|Overall Study||151
278849|NCT02068443|668454|P2|STARTED|Overall Study||152
278850|NCT02068443|668455|P1|STARTED|Overall Study||71
278851|NCT02068222|668490|P1|NOT COMPLETED|Overall Study||1
278852|NCT02068222|668490|P1|COMPLETED|Overall Study||9
278853|NCT02068222|668490|P1|STARTED|Overall Study||10
278854|NCT02067728|668499|P2|NOT COMPLETED|6 Month Measurements||97
278855|NCT02067728|668500|P1|NOT COMPLETED|6 Month Measurements||114
278856|NCT02067728|668499|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
278857|NCT02067728|668500|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
278858|NCT02067728|668499|P2|STARTED|6 Month Measurements||210
278859|NCT02067728|668500|P1|STARTED|6 Month Measurements||220
278860|NCT02067728|668499|P2|NOT COMPLETED|6 Month Follow up Survey||60
278861|NCT02067728|668500|P1|NOT COMPLETED|6 Month Follow up Survey||48
278862|NCT02067728|668499|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
278863|NCT02067728|668500|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
278864|NCT02067728|668499|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
278865|NCT02067728|668500|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
278866|NCT02067728|668499|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
278867|NCT02067728|668500|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
278868|NCT02067728|668499|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
278869|NCT02067728|668500|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
278870|NCT02067728|668499|P2|STARTED|Baseline - 1 Month Follow up Survey||210
278871|NCT02067728|668500|P1|STARTED|Baseline - 1 Month Follow up Survey||220
278872|NCT02067585|668531|P3|NOT COMPLETED|Overall Study||0
278873|NCT02067585|668532|P2|NOT COMPLETED|Overall Study||0
278874|NCT02067585|668533|P1|NOT COMPLETED|Overall Study||0
278875|NCT02067585|668531|P3|COMPLETED|Overall Study||16
278876|NCT02067585|668532|P2|COMPLETED|Overall Study||16
278877|NCT02067585|668533|P1|COMPLETED|Overall Study||16
278878|NCT02067585|668531|P3|STARTED|Overall Study||16
278879|NCT02067585|668532|P2|STARTED|Overall Study||16
278880|NCT02067585|668533|P1|STARTED|Overall Study||16
278881|NCT02067533|668570|P2|NOT COMPLETED|Overall Study||2
278882|NCT02067533|668571|P1|NOT COMPLETED|Overall Study||4
278883|NCT02067533|668570|P2|COMPLETED|Overall Study||44
278884|NCT02067533|668571|P1|COMPLETED|Overall Study||41
278885|NCT02067533|668570|P2|STARTED|Overall Study||46
278886|NCT02067533|668571|P1|STARTED|Overall Study||45
278887|NCT02067273|668579|P2|NOT COMPLETED|Overall Study||3
278888|NCT02067273|668580|P1|NOT COMPLETED|Overall Study||0
278889|NCT02067273|668579|P2|COMPLETED|Overall Study||12
278890|NCT02067273|668580|P1|COMPLETED|Overall Study||5
278891|NCT02067273|668579|P2|STARTED|Overall Study||15
278892|NCT02067273|668580|P1|STARTED|Overall Study||5
278893|NCT02066922|668586|P1|NOT COMPLETED|Overall Study||1
278894|NCT02066922|668586|P1|COMPLETED|Overall Study||14
278895|NCT02066922|668586|P1|STARTED|Overall Study||15
278896|NCT02066857|668596|P2|NOT COMPLETED|Overall Study||1
278897|NCT02066857|668597|P1|NOT COMPLETED|Overall Study||1
278898|NCT02066857|668596|P2|COMPLETED|Overall Study||3
278899|NCT02066857|668597|P1|COMPLETED|Overall Study||0
278900|NCT02066857|668596|P2|STARTED|Overall Study||4
278901|NCT02066857|668597|P1|STARTED|Overall Study||1
278902|NCT02066740|668611|P1|NOT COMPLETED|Overall Study||2
278903|NCT02066740|668611|P1|COMPLETED|Overall Study||32
278904|NCT02066740|668611|P1|STARTED|Overall Study||34
278905|NCT02066727|668618|P2|NOT COMPLETED|Overall Study||0
278906|NCT02066727|668619|P1|NOT COMPLETED|Overall Study||0
278907|NCT02066727|668618|P2|COMPLETED|Overall Study||30
278908|NCT02066727|668619|P1|COMPLETED|Overall Study||30
278909|NCT02066727|668618|P2|STARTED|Overall Study||30
278910|NCT02066727|668619|P1|STARTED|Overall Study||30
278911|NCT02066402|668627|P2|NOT COMPLETED|Overall Study||23
278912|NCT02066402|668628|P1|NOT COMPLETED|Overall Study||26
278913|NCT02066402|668627|P2|COMPLETED|Overall Study||275
278914|NCT02066402|668628|P1|COMPLETED|Overall Study||274
278915|NCT02066402|668627|P2|Completed Study Treatment Period|Overall Study||256
278916|NCT02066402|668628|P1|Completed Study Treatment Period|Overall Study||261
278917|NCT02066402|668627|P2|Participants Received Treatment|Overall Study||297
278918|NCT02066402|668628|P1|Participants Received Treatment|Overall Study||292
278919|NCT02066402|668627|P2|STARTED|Overall Study||298
278920|NCT02066402|668628|P1|STARTED|Overall Study||300
278921|NCT02066051|668654|P1|NOT COMPLETED|Overall Study||1
278922|NCT02066051|668654|P1|COMPLETED|Overall Study||7
278923|NCT02066051|668654|P1|STARTED|Overall Study||8
278924|NCT02065453|668661|P2|NOT COMPLETED|Overall Study||4
278925|NCT02065453|668662|P1|NOT COMPLETED|Overall Study||3
278926|NCT02065453|668661|P2|COMPLETED|Overall Study||21
278927|NCT02065453|668662|P1|COMPLETED|Overall Study||24
278928|NCT02065453|668661|P2|STARTED|Overall Study||25
278929|NCT02065453|668662|P1|STARTED|Overall Study||27
278930|NCT02064985|668670|P3|NOT COMPLETED|Overall Study||0
278931|NCT02064985|668671|P2|NOT COMPLETED|Overall Study||0
278932|NCT02064985|668672|P1|NOT COMPLETED|Overall Study||0
278933|NCT02064985|668670|P3|COMPLETED|Overall Study||12
278934|NCT02064985|668671|P2|COMPLETED|Overall Study||12
278935|NCT02064985|668672|P1|COMPLETED|Overall Study||12
278936|NCT02064985|668670|P3|STARTED|Overall Study||12
278937|NCT02064985|668671|P2|STARTED|Overall Study||12
278938|NCT02064985|668672|P1|STARTED|Overall Study||12
278939|NCT02064907|668835|P2|NOT COMPLETED|Period 2||0
278940|NCT02064907|668836|P1|NOT COMPLETED|Period 2||0
278941|NCT02064907|668835|P2|COMPLETED|Period 2||26
278942|NCT02064907|668836|P1|COMPLETED|Period 2||26
278943|NCT02064907|668835|P2|STARTED|Period 2||26
278944|NCT02064907|668836|P1|STARTED|Period 2||26
278945|NCT02064907|668835|P2|NOT COMPLETED|Period 1||0
278946|NCT02064907|668836|P1|NOT COMPLETED|Period 1||0
278947|NCT02064907|668835|P2|COMPLETED|Period 1||26
278948|NCT02064907|668836|P1|COMPLETED|Period 1||26
278949|NCT02064907|668835|P2|STARTED|Period 1||26
278950|NCT02064907|668836|P1|STARTED|Period 1||26
278951|NCT02064231|668852|P4|NOT COMPLETED|Third Test Period (Own Product)||0
278952|NCT02064231|668853|P3|NOT COMPLETED|Third Test Period (Own Product)||0
278953|NCT02064231|668854|P2|NOT COMPLETED|Third Test Period (Own Product)||0
278954|NCT02064231|668855|P1|NOT COMPLETED|Third Test Period (Own Product)||0
278955|NCT02064231|668852|P4|COMPLETED|Third Test Period (Own Product)||1
278956|NCT02064231|668853|P3|COMPLETED|Third Test Period (Own Product)||0
278957|NCT02064231|668854|P2|COMPLETED|Third Test Period (Own Product)||8
278958|NCT02064231|668855|P1|COMPLETED|Third Test Period (Own Product)||8
278959|NCT02064231|668852|P4|STARTED|Third Test Period (Own Product)||1
278960|NCT02064231|668853|P3|STARTED|Third Test Period (Own Product)||0
278961|NCT02064231|668854|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
278962|NCT02064231|668855|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
278963|NCT02064231|668852|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
278964|NCT02064231|668853|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
278965|NCT02064231|668854|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
278966|NCT02064231|668855|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
278967|NCT02064231|668852|P4|COMPLETED|Second Test Period (Test B or Test D)||1
278968|NCT02064231|668853|P3|COMPLETED|Second Test Period (Test B or Test D)||0
278969|NCT02064231|668854|P2|COMPLETED|Second Test Period (Test B or Test D)||7
278970|NCT02064231|668855|P1|COMPLETED|Second Test Period (Test B or Test D)||6
278971|NCT02064231|668852|P4|STARTED|Second Test Period (Test B or Test D)||1
278972|NCT02064231|668853|P3|STARTED|Second Test Period (Test B or Test D)||0
278973|NCT02064231|668854|P2|STARTED|Second Test Period (Test B or Test D)||8
278974|NCT02064231|668855|P1|STARTED|Second Test Period (Test B or Test D)||7
278975|NCT02064231|668852|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
278976|NCT02064231|668853|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
278977|NCT02064231|668854|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
278978|NCT02064231|668855|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
278979|NCT02064231|668852|P4|COMPLETED|First Test Period (Test A or Test C)||1
278980|NCT02064231|668853|P3|COMPLETED|First Test Period (Test A or Test C)||0
278981|NCT02064231|668854|P2|COMPLETED|First Test Period (Test A or Test C)||8
278982|NCT02064231|668855|P1|COMPLETED|First Test Period (Test A or Test C)||7
278983|NCT02064231|668852|P4|STARTED|First Test Period (Test A or Test C)||1
278984|NCT02064231|668853|P3|STARTED|First Test Period (Test A or Test C)||1
278985|NCT02064231|668854|P2|STARTED|First Test Period (Test A or Test C)||12
278986|NCT02064231|668855|P1|STARTED|First Test Period (Test A or Test C)||14
278987|NCT02064205|668867|P1|NOT COMPLETED|Overall Study||1
278988|NCT02064205|668867|P1|COMPLETED|Overall Study||31
278989|NCT02064205|668867|P1|Condition D|Overall Study||32
278990|NCT02064205|668867|P1|Condition C|Overall Study||31
278991|NCT02064205|668867|P1|Condition B|Overall Study||32
278992|NCT02064205|668867|P1|Condition A|Overall Study||32
278993|NCT02064205|668867|P1|STARTED|Overall Study||32
278994|NCT02063854|668890|P7|NOT COMPLETED|Overall Study||6
278995|NCT02063854|668891|P6|NOT COMPLETED|Overall Study||31
278996|NCT02063854|668892|P5|NOT COMPLETED|Overall Study||11
278997|NCT02063854|668893|P4|NOT COMPLETED|Overall Study||10
278998|NCT02063854|668894|P3|NOT COMPLETED|Overall Study||30
278999|NCT02063854|668895|P2|NOT COMPLETED|Overall Study||12
279000|NCT02063854|668896|P1|NOT COMPLETED|Overall Study||21
279001|NCT02063854|668890|P7|COMPLETED|Overall Study||60
279002|NCT02063854|668891|P6|COMPLETED|Overall Study||170
279003|NCT02063854|668892|P5|COMPLETED|Overall Study||54
279004|NCT02063854|668893|P4|COMPLETED|Overall Study||58
279005|NCT02063854|668894|P3|COMPLETED|Overall Study||176
279006|NCT02063854|668895|P2|COMPLETED|Overall Study||54
279007|NCT02063854|668896|P1|COMPLETED|Overall Study||178
279008|NCT02063854|668890|P7|Full Analysis Set: Received Study Drug|Overall Study||66
279009|NCT02063854|668891|P6|Full Analysis Set: Received Study Drug|Overall Study||200
279010|NCT02063854|668892|P5|Full Analysis Set: Received Study Drug|Overall Study||65
279011|NCT02063854|668893|P4|Full Analysis Set: Received Study Drug|Overall Study||68
279012|NCT02063854|668894|P3|Full Analysis Set: Received Study Drug|Overall Study||206
279013|NCT02063854|668895|P2|Full Analysis Set: Received Study Drug|Overall Study||66
279014|NCT02063854|668896|P1|Full Analysis Set: Received Study Drug|Overall Study||199
279015|NCT02063854|668890|P7|STARTED|Overall Study||66
279016|NCT02063854|668891|P6|STARTED|Overall Study||201
279017|NCT02063854|668892|P5|STARTED|Overall Study||65
279018|NCT02063854|668893|P4|STARTED|Overall Study||68
279019|NCT02063854|668894|P3|STARTED|Overall Study||206
279020|NCT02063854|668895|P2|STARTED|Overall Study||66
279021|NCT02063854|668896|P1|STARTED|Overall Study||199
279022|NCT02063737|668980|P2|NOT COMPLETED|Overall Study||4
279023|NCT02063737|668981|P1|NOT COMPLETED|Overall Study||11
279024|NCT02063737|668980|P2|COMPLETED|Overall Study||44
279025|NCT02063737|668981|P1|COMPLETED|Overall Study||41
279026|NCT02063737|668980|P2|STARTED|Overall Study||48
279027|NCT02063737|668981|P1|STARTED|Overall Study||52
279028|NCT02063516|669015|P2|NOT COMPLETED|Overall Study||0
279029|NCT02063516|669016|P1|NOT COMPLETED|Overall Study||0
279030|NCT02063516|669015|P2|COMPLETED|Overall Study||40
279031|NCT02063516|669016|P1|COMPLETED|Overall Study||40
279032|NCT02063516|669015|P2|STARTED|Overall Study||40
279033|NCT02063516|669016|P1|STARTED|Overall Study||40
279034|NCT02063230|669030|P4|NOT COMPLETED|Overall Study||0
279035|NCT02063230|669031|P3|NOT COMPLETED|Overall Study||0
279036|NCT02063230|669032|P2|NOT COMPLETED|Overall Study||0
279037|NCT02063230|669033|P1|NOT COMPLETED|Overall Study||0
279038|NCT02063230|669030|P4|COMPLETED|Overall Study||8
279039|NCT02063230|669031|P3|COMPLETED|Overall Study||8
279040|NCT02063230|669032|P2|COMPLETED|Overall Study||8
279041|NCT02063230|669033|P1|COMPLETED|Overall Study||8
279042|NCT02063230|669030|P4|Received Treatment|Overall Study||8
279043|NCT02063230|669031|P3|Received Treatment|Overall Study||8
279044|NCT02063230|669032|P2|Received Treatment|Overall Study||8
279045|NCT02063230|669033|P1|Received Treatment|Overall Study||8
279046|NCT02063230|669030|P4|STARTED|Overall Study||8
279047|NCT02063230|669031|P3|STARTED|Overall Study||8
279048|NCT02063230|669032|P2|STARTED|Overall Study||8
279049|NCT02063230|669033|P1|STARTED|Overall Study||8
279050|NCT02063035|669065|P2|NOT COMPLETED|Overall Study||0
279051|NCT02063035|669066|P1|NOT COMPLETED|Overall Study||0
279052|NCT02063035|669065|P2|COMPLETED|Overall Study||17
279053|NCT02063035|669066|P1|COMPLETED|Overall Study||12
279054|NCT02063035|669065|P2|STARTED|Overall Study||17
279055|NCT02063035|669066|P1|STARTED|Overall Study||12
279056|NCT02062905|669080|P2|NOT COMPLETED|Overall Study||2
279057|NCT02062905|669081|P1|NOT COMPLETED|Overall Study||7
279058|NCT02062905|669080|P2|COMPLETED|Overall Study||31
279059|NCT02062905|669081|P1|COMPLETED|Overall Study||28
279060|NCT02062905|669080|P2|STARTED|Overall Study||33
279061|NCT02062905|669081|P1|STARTED|Overall Study||35
279062|NCT02062801|669091|P2|NOT COMPLETED|Overall Study||4
279063|NCT02062801|669092|P1|NOT COMPLETED|Overall Study||2
279064|NCT02062801|669091|P2|COMPLETED|Overall Study||297
279065|NCT02062801|669092|P1|COMPLETED|Overall Study||299
279066|NCT02062801|669091|P2|STARTED|Overall Study||301
279067|NCT02062801|669092|P1|STARTED|Overall Study||301
279068|NCT02062710|669102|P6|NOT COMPLETED|Overall Study||0
279069|NCT02062710|669103|P5|NOT COMPLETED|Overall Study||0
279070|NCT02062710|669104|P4|NOT COMPLETED|Overall Study||0
279071|NCT02062710|669105|P3|NOT COMPLETED|Overall Study||0
279072|NCT02062710|669106|P2|NOT COMPLETED|Overall Study||0
279073|NCT02062710|669107|P1|NOT COMPLETED|Overall Study||0
279074|NCT02062710|669102|P6|COMPLETED|Overall Study||4
279075|NCT02062710|669103|P5|COMPLETED|Overall Study||3
279076|NCT02062710|669104|P4|COMPLETED|Overall Study||3
279077|NCT02062710|669105|P3|COMPLETED|Overall Study||5
279078|NCT02062710|669106|P2|COMPLETED|Overall Study||4
279079|NCT02062710|669107|P1|COMPLETED|Overall Study||3
279080|NCT02062710|669102|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
279081|NCT02062710|669103|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
279082|NCT02062710|669104|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
279083|NCT02062710|669105|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
279084|NCT02062710|669106|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
279085|NCT02062710|669107|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
279086|NCT02062658|669115|P1|NOT COMPLETED|Overall Study||2
279087|NCT02062658|669115|P1|COMPLETED|Overall Study||8
279088|NCT02062658|669115|P1|STARTED|Overall Study||10
279089|NCT02062645|669119|P1|NOT COMPLETED|Overall Study||15
279090|NCT02062645|669119|P1|COMPLETED|Overall Study||100
279091|NCT02062645|669119|P1|STARTED|Overall Study||115
279092|NCT02062580|669129|P2|NOT COMPLETED|Overall Study||13
279093|NCT02062580|669130|P1|NOT COMPLETED|Overall Study||12
279094|NCT02062580|669129|P2|COMPLETED|Overall Study||65
279095|NCT02062580|669130|P1|COMPLETED|Overall Study||59
279096|NCT02062580|669129|P2|STARTED|Overall Study||78
279097|NCT02062580|669130|P1|STARTED|Overall Study||71
279098|NCT02062502|669140|P2|NOT COMPLETED|Overall Study||35
279099|NCT02062502|669141|P1|NOT COMPLETED|Overall Study||43
279100|NCT02062502|669140|P2|COMPLETED|Overall Study||270
279101|NCT02062502|669141|P1|COMPLETED|Overall Study||263
279102|NCT02062502|669140|P2|Vaccinated Dose 1|Overall Study||305
279103|NCT02062502|669141|P1|Vaccinated Dose 1|Overall Study||306
279104|NCT02062502|669140|P2|STARTED|Overall Study||305
279105|NCT02062502|669141|P1|STARTED|Overall Study||306
279106|NCT02062450|669161|P1|NOT COMPLETED|Overall Study||124
279107|NCT02062450|669161|P1|COMPLETED|Overall Study||255
279108|NCT02062450|669161|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
279109|NCT02062450|669161|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
279110|NCT02062437|669175|P1|NOT COMPLETED|Overall Study||52
279111|NCT02062437|669175|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
279112|NCT02062437|669175|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
279113|NCT02062385|669188|P4|NOT COMPLETED|Overall Study||9
279114|NCT02062385|669189|P3|NOT COMPLETED|Overall Study||12
279115|NCT02062385|669190|P2|NOT COMPLETED|Overall Study||65
279116|NCT02062385|669191|P1|NOT COMPLETED|Overall Study||78
279117|NCT02062385|669188|P4|COMPLETED|Overall Study||391
279118|NCT02062385|669189|P3|COMPLETED|Overall Study||388
279119|NCT02062385|669190|P2|COMPLETED|Overall Study||1555
279120|NCT02062385|669191|P1|COMPLETED|Overall Study||1542
279121|NCT02062385|669188|P4|Received Vaccination 3|Overall Study||392
279122|NCT02062385|669189|P3|Received Vaccination 3|Overall Study||389
279123|NCT02062385|669190|P2|Received Vaccination 3|Overall Study||1554
279124|NCT02062385|669191|P1|Received Vaccination 3|Overall Study||1543
279125|NCT02062385|669188|P4|Received Vaccination 2|Overall Study||393
279126|NCT02062385|669189|P3|Received Vaccination 2|Overall Study||392
279127|NCT02062385|669190|P2|Received Vaccination 2|Overall Study||1566
279128|NCT02062385|669191|P1|Received Vaccination 2|Overall Study||1554
279129|NCT02062385|669188|P4|Received Vaccination 1|Overall Study||400
279130|NCT02062385|669189|P3|Received Vaccination 1|Overall Study||400
279131|NCT02062385|669190|P2|Received Vaccination 1|Overall Study||1619
279132|NCT02062385|669191|P1|Received Vaccination 1|Overall Study||1618
279133|NCT02062385|669188|P4|STARTED|Overall Study||400
279134|NCT02062385|669189|P3|STARTED|Overall Study||400
279135|NCT02062385|669190|P2|STARTED|Overall Study||1620
279136|NCT02062385|669191|P1|STARTED|Overall Study||1620
279137|NCT02062359|669211|P1|NOT COMPLETED|Overall Study||0
279138|NCT02062359|669211|P1|COMPLETED|Overall Study||2
279139|NCT02062359|669211|P1|STARTED|Overall Study||2
279140|NCT02062294|669217|P1|NOT COMPLETED|Overall Study||0
279141|NCT02062294|669217|P1|COMPLETED|Overall Study||14
279142|NCT02062294|669217|P1|STARTED|Overall Study||14
279143|NCT02062177|669224|P2|NOT COMPLETED|Overall Study||0
279144|NCT02062177|669225|P1|NOT COMPLETED|Overall Study||0
279145|NCT02062177|669224|P2|COMPLETED|Overall Study||70
279146|NCT02062177|669225|P1|COMPLETED|Overall Study||70
279147|NCT02062177|669224|P2|STARTED|Overall Study||70
279148|NCT02062177|669225|P1|STARTED|Overall Study||70
279149|NCT02061748|669237|P2|NOT COMPLETED|Overall Study||0
279150|NCT02061748|669238|P1|NOT COMPLETED|Overall Study||0
279151|NCT02061748|669237|P2|COMPLETED|Overall Study||30853
279152|NCT02061748|669238|P1|COMPLETED|Overall Study||7646
279153|NCT02061748|669237|P2|STARTED|Overall Study||30853
279154|NCT02061748|669238|P1|STARTED|Overall Study||7646
279155|NCT02061683|669310|P1|NOT COMPLETED|Overall Study||60
279156|NCT02061683|669310|P1|COMPLETED|Overall Study||203
279157|NCT02061683|669310|P1|STARTED|Overall Study||263
279158|NCT02061592|669317|P2|NOT COMPLETED|Period 2||1
279159|NCT02061592|669318|P1|NOT COMPLETED|Period 2||0
279160|NCT02061592|669317|P2|COMPLETED|Period 2||61
279161|NCT02061592|669318|P1|COMPLETED|Period 2||64
279162|NCT02061592|669317|P2|STARTED|Period 2||62
279163|NCT02061592|669318|P1|STARTED|Period 2||64
279164|NCT02061592|669317|P2|NOT COMPLETED|Period 1||0
279165|NCT02061592|669318|P1|NOT COMPLETED|Period 1||2
279166|NCT02061592|669317|P2|COMPLETED|Period 1||62
279167|NCT02061592|669318|P1|COMPLETED|Period 1||64
279168|NCT02061592|669317|P2|STARTED|Period 1||62
279169|NCT02061592|669318|P1|STARTED|Period 1||66
279170|NCT02061540|669330|P1|NOT COMPLETED|Overall Study||4
279171|NCT02061540|669330|P1|COMPLETED|Overall Study||23
279172|NCT02061540|669330|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
279173|NCT02061540|669330|P1|STARTED|Overall Study||27
279174|NCT02061358|669352|P9|NOT COMPLETED|Overall Study||0
279175|NCT02061358|669353|P8|NOT COMPLETED|Overall Study||0
279176|NCT02061358|669354|P7|NOT COMPLETED|Overall Study||0
279177|NCT02061358|669355|P6|NOT COMPLETED|Overall Study||0
279178|NCT02061358|669356|P5|NOT COMPLETED|Overall Study||0
279179|NCT02061358|669357|P4|NOT COMPLETED|Overall Study||0
279180|NCT02061358|669358|P3|NOT COMPLETED|Overall Study||0
279181|NCT02061358|669359|P2|NOT COMPLETED|Overall Study||0
279182|NCT02061358|669360|P1|NOT COMPLETED|Overall Study||0
279183|NCT02061358|669352|P9|COMPLETED|Overall Study||16
279184|NCT02061358|669353|P8|COMPLETED|Overall Study||6
279185|NCT02061358|669354|P7|COMPLETED|Overall Study||6
279186|NCT02061358|669355|P6|COMPLETED|Overall Study||6
279187|NCT02061358|669356|P5|COMPLETED|Overall Study||6
279188|NCT02061358|669357|P4|COMPLETED|Overall Study||6
279189|NCT02061358|669358|P3|COMPLETED|Overall Study||6
279190|NCT02061358|669359|P2|COMPLETED|Overall Study||6
279191|NCT02061358|669360|P1|COMPLETED|Overall Study||6
279192|NCT02061358|669352|P9|STARTED|Overall Study||16
279193|NCT02061358|669353|P8|STARTED|Overall Study||6
279194|NCT02061358|669354|P7|STARTED|Overall Study||6
279195|NCT02061358|669355|P6|STARTED|Overall Study||6
279196|NCT02061358|669356|P5|STARTED|Overall Study||6
279197|NCT02061358|669357|P4|STARTED|Overall Study||6
279198|NCT02061358|669358|P3|STARTED|Overall Study||6
279199|NCT02061358|669359|P2|STARTED|Overall Study||6
279200|NCT02061358|669360|P1|STARTED|Overall Study||6
279201|NCT02060838|669498|P2|NOT COMPLETED|Overall Study||0
279202|NCT02060838|669499|P1|NOT COMPLETED|Overall Study||0
279203|NCT02060838|669498|P2|COMPLETED|Overall Study||22
279204|NCT02060838|669499|P1|COMPLETED|Overall Study||28
279205|NCT02060838|669498|P2|STARTED|Overall Study||22
279206|NCT02060838|669499|P1|STARTED|Overall Study||28
279207|NCT02060539|669507|P1|NOT COMPLETED|Overall Study||0
279208|NCT02060539|669507|P1|COMPLETED|Overall Study||19
279209|NCT02060539|669507|P1|STARTED|Overall Study||19
279210|NCT02060526|669555|P3|NOT COMPLETED|Overall Study||0
279211|NCT02060526|669556|P2|NOT COMPLETED|Overall Study||0
279212|NCT02060526|669557|P1|NOT COMPLETED|Overall Study||0
279213|NCT02060526|669555|P3|COMPLETED|Overall Study||7
279214|NCT02060526|669556|P2|COMPLETED|Overall Study||7
279215|NCT02060526|669557|P1|COMPLETED|Overall Study||7
279216|NCT02060526|669555|P3|STARTED|Overall Study||7
279217|NCT02060526|669556|P2|STARTED|Overall Study||7
279218|NCT02060526|669557|P1|STARTED|Overall Study||7
279219|NCT02059993|669595|P2|NOT COMPLETED|Overall Study||4
279220|NCT02059993|669596|P1|NOT COMPLETED|Overall Study||2
279221|NCT02059993|669595|P2|COMPLETED|Overall Study||37
279222|NCT02059993|669596|P1|COMPLETED|Overall Study||40
279223|NCT02059993|669595|P2|STARTED|Overall Study||41
279224|NCT02059993|669596|P1|STARTED|Overall Study||42
279225|NCT02059928|669602|P1|NOT COMPLETED|Overall Study||0
279226|NCT02059928|669602|P1|COMPLETED|Overall Study||20
279227|NCT02059928|669602|P1|STARTED|Overall Study||20
279228|NCT02059902|669608|P2|NOT COMPLETED|Overall Study||4
279229|NCT02059902|669609|P1|NOT COMPLETED|Overall Study||4
279230|NCT02059902|669608|P2|COMPLETED|Overall Study||14
279231|NCT02059902|669609|P1|COMPLETED|Overall Study||14
279232|NCT02059902|669608|P2|STARTED|Overall Study||18
279233|NCT02059902|669609|P1|STARTED|Overall Study||18
279234|NCT02059642|669617|P2|NOT COMPLETED|Overall Study||24
279235|NCT02059642|669618|P1|NOT COMPLETED|Overall Study||27
279236|NCT02059642|669617|P2|COMPLETED|Overall Study||128
279237|NCT02059642|669618|P1|COMPLETED|Overall Study||121
279238|NCT02059642|669617|P2|STARTED|Overall Study||152
279239|NCT02059642|669618|P1|STARTED|Overall Study||148
279240|NCT02059291|669632|P6|NOT COMPLETED|Overall Study||2
279241|NCT02059291|669633|P5|NOT COMPLETED|Overall Study||0
279242|NCT02059291|669634|P4|NOT COMPLETED|Overall Study||2
279243|NCT02059291|669635|P3|NOT COMPLETED|Overall Study||1
279244|NCT02059291|669636|P2|NOT COMPLETED|Overall Study||1
279245|NCT02059291|669637|P1|NOT COMPLETED|Overall Study||0
279246|NCT02059291|669632|P6|COMPLETED|Overall Study||22
279247|NCT02059291|669633|P5|COMPLETED|Overall Study||22
279248|NCT02059291|669634|P4|COMPLETED|Overall Study||33
279249|NCT02059291|669635|P3|COMPLETED|Overall Study||36
279250|NCT02059291|669636|P2|COMPLETED|Overall Study||31
279251|NCT02059291|669637|P1|COMPLETED|Overall Study||31
279252|NCT02059291|669632|P6|STARTED|Overall Study||24
279253|NCT02059291|669633|P5|STARTED|Overall Study||22
279254|NCT02059291|669634|P4|STARTED|Overall Study||35
279255|NCT02059291|669635|P3|STARTED|Overall Study||37
279256|NCT02059291|669636|P2|STARTED|Overall Study||32
279257|NCT02059291|669637|P1|STARTED|Overall Study||31
279258|NCT02059187|669653|P2|NOT COMPLETED|Overall Study||22
279259|NCT02059187|669654|P1|NOT COMPLETED|Overall Study||25
279260|NCT02059187|669653|P2|COMPLETED|Overall Study||244
279261|NCT02059187|669654|P1|COMPLETED|Overall Study||240
279262|NCT02059187|669653|P2|STARTED|Overall Study||266
279263|NCT02059187|669654|P1|STARTED|Overall Study||265
279264|NCT02059174|669680|P2|NOT COMPLETED|Period 4||0
279265|NCT02059174|669681|P1|NOT COMPLETED|Period 4||0
279266|NCT02059174|669680|P2|COMPLETED|Period 4||35
279267|NCT02059174|669681|P1|COMPLETED|Period 4||35
279268|NCT02059174|669680|P2|STARTED|Period 4||35
279269|NCT02059174|669681|P1|STARTED|Period 4||35
279270|NCT02059174|669680|P2|NOT COMPLETED|Period 3||0
279271|NCT02059174|669681|P1|NOT COMPLETED|Period 3||1
279272|NCT02059174|669680|P2|COMPLETED|Period 3||35
279273|NCT02059174|669681|P1|COMPLETED|Period 3||35
279274|NCT02059174|669680|P2|STARTED|Period 3||35
279275|NCT02059174|669681|P1|STARTED|Period 3||36
279276|NCT02059174|669680|P2|NOT COMPLETED|Period 2||2
279277|NCT02059174|669681|P1|NOT COMPLETED|Period 2||1
279278|NCT02059174|669680|P2|COMPLETED|Period 2||35
279279|NCT02059174|669681|P1|COMPLETED|Period 2||36
279280|NCT02059174|669680|P2|STARTED|Period 2||37
279281|NCT02059174|669681|P1|STARTED|Period 2||37
279282|NCT02059174|669680|P2|NOT COMPLETED|Period 1||2
279283|NCT02059174|669681|P1|NOT COMPLETED|Period 1||0
279284|NCT02059174|669680|P2|COMPLETED|Period 1||37
279285|NCT02059174|669681|P1|COMPLETED|Period 1||37
279286|NCT02059174|669680|P2|STARTED|Period 1||39
279287|NCT02059174|669681|P1|STARTED|Period 1||37
279288|NCT02059161|669705|P2|NOT COMPLETED|Overall Study||41
279289|NCT02059161|669706|P1|NOT COMPLETED|Overall Study||49
279290|NCT02059161|669705|P2|COMPLETED|Overall Study||222
279291|NCT02059161|669706|P1|COMPLETED|Overall Study||196
279292|NCT02059161|669705|P2|Treated|Overall Study||258
279293|NCT02059161|669706|P1|Treated|Overall Study||241
279294|NCT02059161|669705|P2|STARTED|Overall Study||263
279295|NCT02059161|669706|P1|STARTED|Overall Study||245
279296|NCT02059070|669768|P2|NOT COMPLETED|Overall Study||4
279297|NCT02059070|669769|P1|NOT COMPLETED|Overall Study||5
279298|NCT02059070|669768|P2|COMPLETED|Overall Study||16
279299|NCT02059070|669769|P1|COMPLETED|Overall Study||14
279300|NCT02059070|669768|P2|STARTED|Overall Study||20
279301|NCT02059070|669769|P1|STARTED|Overall Study||19
279302|NCT02058992|669781|P1|NOT COMPLETED|Overall Study||116
279303|NCT02058992|669781|P1|COMPLETED|Overall Study||3223
279304|NCT02058992|669781|P1|STARTED|Overall Study||3339
279305|NCT02058563|669792|P2|NOT COMPLETED|Overall Study||24
279306|NCT02058563|669793|P1|NOT COMPLETED|Overall Study||28
279307|NCT02058563|669792|P2|COMPLETED|Overall Study||433
279308|NCT02058563|669793|P1|COMPLETED|Overall Study||426
279309|NCT02058563|669792|P2|STARTED|Overall Study||457
279310|NCT02058563|669793|P1|STARTED|Overall Study||454
279311|NCT02058537|669829|P1|NOT COMPLETED|Overall Study||1
279312|NCT02058537|669829|P1|COMPLETED|Overall Study||2
279313|NCT02058537|669829|P1|STARTED|Overall Study||3
279314|NCT02058498|669835|P1|NOT COMPLETED|Overall Study||4
279315|NCT02058498|669835|P1|COMPLETED|Overall Study||8
279316|NCT02058498|669835|P1|6 Weeks|Overall Study||8
279317|NCT02058498|669835|P1|STARTED|Overall Study||12
279318|NCT02058290|669843|P2|NOT COMPLETED|Overall Study||9
279319|NCT02058290|669844|P1|NOT COMPLETED|Overall Study||11
279320|NCT02058290|669843|P2|COMPLETED|Overall Study||36
279321|NCT02058290|669844|P1|COMPLETED|Overall Study||66
279322|NCT02058290|669843|P2|STARTED|Overall Study||45
279323|NCT02058290|669844|P1|STARTED|Overall Study||77
279324|NCT02058160|669860|P2|NOT COMPLETED|Overall Study||14
279325|NCT02058160|669861|P1|NOT COMPLETED|Overall Study||31
279326|NCT02058160|669860|P2|COMPLETED|Overall Study||355
279327|NCT02058160|669861|P1|COMPLETED|Overall Study||336
279328|NCT02058160|669860|P2|Treated|Overall Study||365
279329|NCT02058160|669861|P1|Treated|Overall Study||365
279330|NCT02058160|669860|P2|STARTED|Overall Study||369
279331|NCT02058160|669861|P1|STARTED|Overall Study||367
279332|NCT02058147|669898|P3|NOT COMPLETED|Overall Study||29
279333|NCT02058147|669899|P2|NOT COMPLETED|Overall Study||27
279334|NCT02058147|669900|P1|NOT COMPLETED|Overall Study||29
279335|NCT02058147|669898|P3|COMPLETED|Overall Study||205
279336|NCT02058147|669899|P2|COMPLETED|Overall Study||440
279337|NCT02058147|669900|P1|COMPLETED|Overall Study||440
279338|NCT02058147|669898|P3|Treated|Overall Study||233
279339|NCT02058147|669899|P2|Treated|Overall Study||467
279340|NCT02058147|669900|P1|Treated|Overall Study||469
279341|NCT02058147|669898|P3|STARTED|Overall Study||234
279342|NCT02058147|669899|P2|STARTED|Overall Study||467
279343|NCT02058147|669900|P1|STARTED|Overall Study||469
279344|NCT02058069|669949|P1|NOT COMPLETED|Overall Study||11
279345|NCT02058069|669949|P1|COMPLETED|Overall Study||89
279346|NCT02058069|669949|P1|STARTED|Overall Study||100
279347|NCT02057835|669968|P10|NOT COMPLETED|Overall Study||0
279348|NCT02057835|669969|P9|NOT COMPLETED|Overall Study||0
279349|NCT02057835|669970|P8|NOT COMPLETED|Overall Study||0
279350|NCT02057835|669971|P7|NOT COMPLETED|Overall Study||0
279351|NCT02057835|669972|P6|NOT COMPLETED|Overall Study||0
279352|NCT02057835|669973|P5|NOT COMPLETED|Overall Study||0
279353|NCT02057835|669974|P4|NOT COMPLETED|Overall Study||0
279354|NCT02057835|669975|P3|NOT COMPLETED|Overall Study||0
279355|NCT02057835|669976|P2|NOT COMPLETED|Overall Study||2
279356|NCT02057835|669977|P1|NOT COMPLETED|Overall Study||0
279357|NCT02057835|669968|P10|COMPLETED|Overall Study||6
279358|NCT02057835|669969|P9|COMPLETED|Overall Study||6
279359|NCT02057835|669970|P8|COMPLETED|Overall Study||6
279360|NCT02057835|669971|P7|COMPLETED|Overall Study||6
279361|NCT02057835|669972|P6|COMPLETED|Overall Study||8
279362|NCT02057835|669973|P5|COMPLETED|Overall Study||6
279363|NCT02057835|669974|P4|COMPLETED|Overall Study||6
279364|NCT02057835|669975|P3|COMPLETED|Overall Study||6
279365|NCT02057835|669976|P2|COMPLETED|Overall Study||4
279366|NCT02057835|669977|P1|COMPLETED|Overall Study||8
279367|NCT02057835|669968|P10|STARTED|Overall Study||6
279368|NCT02057835|669969|P9|STARTED|Overall Study||6
279369|NCT02057835|669970|P8|STARTED|Overall Study||6
279370|NCT02057835|669971|P7|STARTED|Overall Study||6
279371|NCT02057835|669972|P6|STARTED|Overall Study||8
279372|NCT02057835|669973|P5|STARTED|Overall Study||6
279373|NCT02057835|669974|P4|STARTED|Overall Study||6
279374|NCT02057835|669975|P3|STARTED|Overall Study||6
279375|NCT02057835|669976|P2|STARTED|Overall Study||6
279376|NCT02057835|669977|P1|STARTED|Overall Study||8
279377|NCT02057406|670057|P3|NOT COMPLETED|Overall Study||4
279378|NCT02057406|670058|P2|NOT COMPLETED|Overall Study||3
279379|NCT02057406|670059|P1|NOT COMPLETED|Overall Study||1
279380|NCT02057406|670057|P3|COMPLETED|Overall Study||32
279381|NCT02057406|670058|P2|COMPLETED|Overall Study||33
279382|NCT02057406|670059|P1|COMPLETED|Overall Study||35
279383|NCT02057406|670057|P3|STARTED|Overall Study||36
279384|NCT02057406|670058|P2|STARTED|Overall Study||36
279385|NCT02057406|670059|P1|STARTED|Overall Study||36
279386|NCT02057393|670070|P1|NOT COMPLETED|Overall Study||0
279387|NCT02057393|670070|P1|COMPLETED|Overall Study||89
279388|NCT02057393|670070|P1|STARTED|Overall Study||89
279389|NCT02057276|670076|P2|NOT COMPLETED|Overall Study||0
279390|NCT02057276|670077|P1|NOT COMPLETED|Overall Study||0
279391|NCT02057276|670076|P2|COMPLETED|Overall Study||0
279392|NCT02057276|670077|P1|COMPLETED|Overall Study||0
279393|NCT02057276|670076|P2|STARTED|Overall Study||0
279394|NCT02057276|670077|P1|STARTED|Overall Study||0
279395|NCT02057237|670087|P1|NOT COMPLETED|Overall Study||0
279396|NCT02057237|670087|P1|COMPLETED|Overall Study||1
279397|NCT02057237|670087|P1|STARTED|Overall Study||1
279398|NCT02056834|670092|P1|NOT COMPLETED|Overall Study||7
279399|NCT02056834|670092|P1|COMPLETED|Overall Study||29
279400|NCT02056834|670092|P1|6 Months|Overall Study||31
279401|NCT02056834|670092|P1|6 Weeks|Overall Study||34
279402|NCT02056834|670092|P1|STARTED|Overall Study||36
279403|NCT02056392|670117|P6|NOT COMPLETED|Overall Study||0
279404|NCT02056392|670118|P5|NOT COMPLETED|Overall Study||1
279405|NCT02056392|670119|P4|NOT COMPLETED|Overall Study||0
279406|NCT02056392|670120|P3|NOT COMPLETED|Overall Study||3
279407|NCT02056392|670121|P2|NOT COMPLETED|Overall Study||1
279408|NCT02056392|670122|P1|NOT COMPLETED|Overall Study||2
279409|NCT02056392|670117|P6|COMPLETED|Overall Study||9
279410|NCT02056392|670118|P5|COMPLETED|Overall Study||7
279411|NCT02056392|670119|P4|COMPLETED|Overall Study||9
279412|NCT02056392|670120|P3|COMPLETED|Overall Study||6
279413|NCT02056392|670121|P2|COMPLETED|Overall Study||8
279414|NCT02056392|670122|P1|COMPLETED|Overall Study||8
279415|NCT02056392|670117|P6|STARTED|Overall Study||9
279416|NCT02056392|670118|P5|STARTED|Overall Study||8
279417|NCT02056392|670119|P4|STARTED|Overall Study||9
279418|NCT02056392|670120|P3|STARTED|Overall Study||9
279419|NCT02056392|670121|P2|STARTED|Overall Study||9
279420|NCT02056392|670122|P1|STARTED|Overall Study||10
279421|NCT02055430|670159|P2|NOT COMPLETED|Overall Study||0
279422|NCT02055430|670160|P1|NOT COMPLETED|Overall Study||0
279423|NCT02055430|670159|P2|COMPLETED|Overall Study||45
279424|NCT02055430|670160|P1|COMPLETED|Overall Study||45
279425|NCT02055430|670159|P2|STARTED|Overall Study||45
279426|NCT02055430|670160|P1|STARTED|Overall Study||45
279427|NCT02055404|670166|P1|NOT COMPLETED|Overall Study||0
279428|NCT02055404|670166|P1|COMPLETED|Overall Study||3
279429|NCT02055404|670166|P1|STARTED|Overall Study||3
279430|NCT02055352|670181|P2|NOT COMPLETED|Overall Study||17
279431|NCT02055352|670182|P1|NOT COMPLETED|Overall Study||6
279432|NCT02055352|670181|P2|COMPLETED|Overall Study||96
279433|NCT02055352|670182|P1|COMPLETED|Overall Study||103
279434|NCT02055352|670181|P2|Per-Protocol Set (PPS)|Overall Study||111
279435|NCT02055352|670182|P1|Per-Protocol Set (PPS)|Overall Study||108
279436|NCT02055352|670181|P2|STARTED|Overall Study||113
279437|NCT02055352|670182|P1|STARTED|Overall Study||109
279438|NCT02054910|670198|P2|NOT COMPLETED|Overall Study||1
279439|NCT02054910|670199|P1|NOT COMPLETED|Overall Study||4
279440|NCT02054910|670198|P2|COMPLETED|Overall Study||0
279441|NCT02054910|670199|P1|COMPLETED|Overall Study||0
279442|NCT02054910|670198|P2|STARTED|Overall Study||1
279443|NCT02054910|670199|P1|STARTED|Overall Study||4
279444|NCT02054754|670217|P6|NOT COMPLETED|Overall Study||0
279445|NCT02054754|670218|P5|NOT COMPLETED|Overall Study||0
279446|NCT02054754|670219|P4|NOT COMPLETED|Overall Study||0
279447|NCT02054754|670220|P3|NOT COMPLETED|Overall Study||0
279448|NCT02054754|670221|P2|NOT COMPLETED|Overall Study||0
279449|NCT02054754|670222|P1|NOT COMPLETED|Overall Study||0
279450|NCT02054754|670217|P6|COMPLETED|Overall Study||10
279451|NCT02054754|670218|P5|COMPLETED|Overall Study||6
279452|NCT02054754|670219|P4|COMPLETED|Overall Study||6
279453|NCT02054754|670220|P3|COMPLETED|Overall Study||6
279454|NCT02054754|670221|P2|COMPLETED|Overall Study||6
279455|NCT02054754|670222|P1|COMPLETED|Overall Study||6
279456|NCT02054754|670217|P6|STARTED|Overall Study||10
279457|NCT02054754|670218|P5|STARTED|Overall Study||6
279458|NCT02054754|670219|P4|STARTED|Overall Study||6
279459|NCT02054754|670220|P3|STARTED|Overall Study||6
279460|NCT02054754|670221|P2|STARTED|Overall Study||6
279461|NCT02054754|670222|P1|STARTED|Overall Study||6
279462|NCT02054702|670239|P2|NOT COMPLETED|Overall Study||12
279463|NCT02054702|670240|P1|NOT COMPLETED|Overall Study||24
279464|NCT02054702|670239|P2|COMPLETED|Overall Study||21
279465|NCT02054702|670240|P1|COMPLETED|Overall Study||40
279466|NCT02054702|670239|P2|STARTED|Overall Study||33
279467|NCT02054702|670240|P1|STARTED|Overall Study||64
279468|NCT02054572|670268|P1|NOT COMPLETED|Overall Study||0
279469|NCT02054572|670268|P1|COMPLETED|Overall Study||6
279470|NCT02054572|670268|P1|STARTED|Overall Study||6
279471|NCT02054481|670295|P4|NOT COMPLETED|Overall Study||1
279472|NCT02054481|670296|P3|NOT COMPLETED|Overall Study||2
279473|NCT02054481|670297|P2|NOT COMPLETED|Overall Study||2
279474|NCT02054481|670298|P1|NOT COMPLETED|Overall Study||4
279475|NCT02054481|670295|P4|COMPLETED|Overall Study||39
279476|NCT02054481|670296|P3|COMPLETED|Overall Study||40
279477|NCT02054481|670297|P2|COMPLETED|Overall Study||39
279478|NCT02054481|670298|P1|COMPLETED|Overall Study||39
279479|NCT02054481|670295|P4|STARTED|Overall Study||40
279480|NCT02054481|670296|P3|STARTED|Overall Study||42
279481|NCT02054481|670297|P2|STARTED|Overall Study||41
279482|NCT02054481|670298|P1|STARTED|Overall Study||43
279483|NCT02054325|670346|P2|NOT COMPLETED|Overall Study||5
279484|NCT02054325|670347|P1|NOT COMPLETED|Overall Study||8
279485|NCT02054325|670346|P2|COMPLETED|Overall Study||50
279486|NCT02054325|670347|P1|COMPLETED|Overall Study||43
279487|NCT02054325|670346|P2|STARTED|Overall Study||55
279488|NCT02054325|670347|P1|STARTED|Overall Study||51
279489|NCT02053610|670357|P2|NOT COMPLETED|Overall Study||174
279490|NCT02053610|670358|P1|NOT COMPLETED|Overall Study||235
279491|NCT02053610|670357|P2|COMPLETED|Overall Study|Completed=Completed Treatment|159
279492|NCT02053610|670358|P1|COMPLETED|Overall Study|Completed=Completed Treatment|95
279493|NCT02053610|670357|P2|Received Study Drug|Overall Study||331
279494|NCT02053610|670358|P1|Received Study Drug|Overall Study||326
279495|NCT02053610|670357|P2|STARTED|Overall Study||333
279496|NCT02053610|670358|P1|STARTED|Overall Study||330
279497|NCT02053493|670390|P2|NOT COMPLETED|Overall Study||1
279498|NCT02053493|670391|P1|NOT COMPLETED|Overall Study||1
279499|NCT02053493|670390|P2|COMPLETED|Overall Study||58
279500|NCT02053493|670391|P1|COMPLETED|Overall Study||50
279501|NCT02053493|670390|P2|STARTED|Overall Study||59
279502|NCT02053493|670391|P1|STARTED|Overall Study||51
279503|NCT02052895|670432|P3|NOT COMPLETED|Overall Study||0
279504|NCT02052895|670433|P2|NOT COMPLETED|Overall Study||0
279505|NCT02052895|670434|P1|NOT COMPLETED|Overall Study||0
279506|NCT02052895|670432|P3|COMPLETED|Overall Study||15
279507|NCT02052895|670433|P2|COMPLETED|Overall Study||15
279508|NCT02052895|670434|P1|COMPLETED|Overall Study||196
279509|NCT02052895|670432|P3|STARTED|Overall Study||15
279510|NCT02052895|670433|P2|STARTED|Overall Study||15
279511|NCT02052895|670434|P1|STARTED|Overall Study||196
279512|NCT02052752|670444|P3|NOT COMPLETED|Overall Study||0
279513|NCT02052752|670445|P2|NOT COMPLETED|Overall Study||0
279514|NCT02052752|670446|P1|NOT COMPLETED|Overall Study||0
279515|NCT02052752|670444|P3|COMPLETED|Overall Study||30
279516|NCT02052752|670445|P2|COMPLETED|Overall Study||30
279517|NCT02052752|670446|P1|COMPLETED|Overall Study||30
279518|NCT02052752|670444|P3|STARTED|Overall Study||30
279519|NCT02052752|670445|P2|STARTED|Overall Study||30
279520|NCT02052752|670446|P1|STARTED|Overall Study||30
279521|NCT02052661|670469|P1|NOT COMPLETED|Overall Study||0
279522|NCT02052661|670469|P1|COMPLETED|Overall Study||300
279523|NCT02052661|670469|P1|STARTED|Overall Study||300
279524|NCT02052635|670483|P2|NOT COMPLETED|Overall Study||0
279525|NCT02052635|670484|P1|NOT COMPLETED|Overall Study||0
279526|NCT02052635|670483|P2|COMPLETED|Overall Study||6
279527|NCT02052635|670484|P1|COMPLETED|Overall Study||7
279528|NCT02052635|670483|P2|STARTED|Overall Study||6
279529|NCT02052635|670484|P1|STARTED|Overall Study||7
279530|NCT02052544|670492|P1|NOT COMPLETED|Overall Study||0
279531|NCT02052544|670492|P1|COMPLETED|Overall Study|Last Subject Out|123
279532|NCT02052544|670492|P1|STARTED|Overall Study|First Subject In|123
279533|NCT02052466|670497|P1|NOT COMPLETED|Overall Study||2
279534|NCT02052466|670497|P1|COMPLETED|Overall Study||30
279535|NCT02052466|670497|P1|STARTED|Overall Study||32
279536|NCT02052414|670512|P1|NOT COMPLETED|Overall Study||17
279537|NCT02052414|670512|P1|COMPLETED|Overall Study||17
279538|NCT02052414|670512|P1|STARTED|Overall Study||34
279539|NCT02052011|670522|P2|NOT COMPLETED|Overall Study||2
279540|NCT02052011|670523|P1|NOT COMPLETED|Overall Study||4
279541|NCT02052011|670522|P2|COMPLETED|Overall Study||8
279542|NCT02052011|670523|P1|COMPLETED|Overall Study||17
279543|NCT02052011|670522|P2|STARTED|Overall Study||10
279544|NCT02052011|670523|P1|STARTED|Overall Study||21
279545|NCT02051816|670533|P4|NOT COMPLETED|Overall Study||0
279546|NCT02051816|670534|P3|NOT COMPLETED|Overall Study||0
279547|NCT02051816|670535|P2|NOT COMPLETED|Overall Study||0
279548|NCT02051816|670536|P1|NOT COMPLETED|Overall Study||0
279549|NCT02051816|670533|P4|COMPLETED|Overall Study||36
279550|NCT02051816|670534|P3|COMPLETED|Overall Study||37
279551|NCT02051816|670535|P2|COMPLETED|Overall Study||40
279552|NCT02051816|670536|P1|COMPLETED|Overall Study||37
279553|NCT02051816|670533|P4|STARTED|Overall Study||36
279554|NCT02051816|670534|P3|STARTED|Overall Study||37
279555|NCT02051816|670535|P2|STARTED|Overall Study||40
279556|NCT02051816|670536|P1|STARTED|Overall Study||37
279557|NCT02051790|670574|P1|NOT COMPLETED|Overall Study||0
279558|NCT02051790|670574|P1|COMPLETED|Overall Study||241
279559|NCT02051790|670574|P1|STARTED|Overall Study||241
279560|NCT02051595|670578|P1|NOT COMPLETED|Overall Study||0
279561|NCT02051595|670578|P1|COMPLETED|Overall Study||25
279562|NCT02051595|670578|P1|STARTED|Overall Study||25
279563|NCT02051426|670584|P2|NOT COMPLETED|Second Intervention||0
279564|NCT02051426|670585|P1|NOT COMPLETED|Second Intervention||0
279565|NCT02051426|670584|P2|COMPLETED|Second Intervention||19
279566|NCT02051426|670585|P1|COMPLETED|Second Intervention||16
279567|NCT02051426|670584|P2|STARTED|Second Intervention||19
279568|NCT02051426|670585|P1|STARTED|Second Intervention||16
279569|NCT02051426|670584|P2|NOT COMPLETED|Washout Period of 1 Month||0
279570|NCT02051426|670585|P1|NOT COMPLETED|Washout Period of 1 Month||0
279571|NCT02051426|670584|P2|COMPLETED|Washout Period of 1 Month||19
279572|NCT02051426|670585|P1|COMPLETED|Washout Period of 1 Month||16
279573|NCT02051426|670584|P2|STARTED|Washout Period of 1 Month||19
279574|NCT02051426|670585|P1|STARTED|Washout Period of 1 Month||16
279575|NCT02051426|670584|P2|NOT COMPLETED|First Intervention||0
279576|NCT02051426|670585|P1|NOT COMPLETED|First Intervention||0
279577|NCT02051426|670584|P2|COMPLETED|First Intervention||19
279578|NCT02051426|670585|P1|COMPLETED|First Intervention||16
279579|NCT02051426|670584|P2|STARTED|First Intervention||19
279580|NCT02051426|670585|P1|STARTED|First Intervention||16
279581|NCT02051335|670599|P4|NOT COMPLETED|Period 4||0
279582|NCT02051335|670600|P3|NOT COMPLETED|Period 4||0
279583|NCT02051335|670601|P2|NOT COMPLETED|Period 4||0
279584|NCT02051335|670602|P1|NOT COMPLETED|Period 4||0
279585|NCT02051335|670599|P4|COMPLETED|Period 4||4
279586|NCT02051335|670600|P3|COMPLETED|Period 4||5
279587|NCT02051335|670601|P2|COMPLETED|Period 4||7
279588|NCT02051335|670602|P1|COMPLETED|Period 4||7
279589|NCT02051335|670599|P4|STARTED|Period 4||4
279590|NCT02051335|670600|P3|STARTED|Period 4||5
279591|NCT02051335|670601|P2|STARTED|Period 4||7
279592|NCT02051335|670602|P1|STARTED|Period 4||7
279593|NCT02051335|670599|P4|NOT COMPLETED|Period 3||0
279594|NCT02051335|670600|P3|NOT COMPLETED|Period 3||0
279595|NCT02051335|670601|P2|NOT COMPLETED|Period 3||0
279596|NCT02051335|670602|P1|NOT COMPLETED|Period 3||0
279597|NCT02051335|670599|P4|COMPLETED|Period 3||4
279598|NCT02051335|670600|P3|COMPLETED|Period 3||5
279599|NCT02051335|670601|P2|COMPLETED|Period 3||7
279600|NCT02051335|670602|P1|COMPLETED|Period 3||7
279601|NCT02051335|670599|P4|STARTED|Period 3||4
279602|NCT02051335|670600|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
279603|NCT02051335|670601|P2|STARTED|Period 3||7
279604|NCT02051335|670602|P1|STARTED|Period 3||7
279605|NCT02051335|670599|P4|NOT COMPLETED|Period 2||0
279606|NCT02051335|670600|P3|NOT COMPLETED|Period 2||0
279607|NCT02051335|670601|P2|NOT COMPLETED|Period 2||0
279608|NCT02051335|670602|P1|NOT COMPLETED|Period 2||0
279609|NCT02051335|670599|P4|COMPLETED|Period 2||4
279610|NCT02051335|670600|P3|COMPLETED|Period 2||7
279611|NCT02051335|670601|P2|COMPLETED|Period 2||7
279612|NCT02051335|670602|P1|COMPLETED|Period 2||7
279613|NCT02051335|670599|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
279614|NCT02051335|670600|P3|STARTED|Period 2||7
279615|NCT02051335|670601|P2|STARTED|Period 2||7
279616|NCT02051335|670602|P1|STARTED|Period 2||7
279617|NCT02051335|670599|P4|NOT COMPLETED|Period 1||0
279618|NCT02051335|670600|P3|NOT COMPLETED|Period 1||0
279619|NCT02051335|670601|P2|NOT COMPLETED|Period 1||0
279620|NCT02051335|670602|P1|NOT COMPLETED|Period 1||0
279621|NCT02051335|670599|P4|COMPLETED|Period 1||6
279622|NCT02051335|670600|P3|COMPLETED|Period 1||7
279623|NCT02051335|670601|P2|COMPLETED|Period 1||7
279624|NCT02051335|670602|P1|COMPLETED|Period 1||7
279625|NCT02051335|670599|P4|STARTED|Period 1||6
279626|NCT02051335|670600|P3|STARTED|Period 1||7
279627|NCT02051335|670601|P2|STARTED|Period 1||7
279628|NCT02051335|670602|P1|STARTED|Period 1||7
279629|NCT02050334|670654|P2|NOT COMPLETED|Overall Study||0
279630|NCT02050334|670655|P1|NOT COMPLETED|Overall Study||0
279631|NCT02050334|670654|P2|COMPLETED|Overall Study||9
279632|NCT02050334|670655|P1|COMPLETED|Overall Study||9
279633|NCT02050334|670654|P2|STARTED|Overall Study||9
279634|NCT02050334|670655|P1|STARTED|Overall Study||9
279635|NCT02050321|670663|P1|NOT COMPLETED|Overall Study||2
279636|NCT02050321|670663|P1|COMPLETED|Overall Study||0
279637|NCT02050321|670663|P1|STARTED|Overall Study||2
279638|NCT02050048|670669|P2|NOT COMPLETED|Overall Study||2
279639|NCT02050048|670670|P1|NOT COMPLETED|Overall Study||5
279640|NCT02050048|670669|P2|COMPLETED|Overall Study||10
279641|NCT02050048|670670|P1|COMPLETED|Overall Study||9
279642|NCT02050048|670669|P2|STARTED|Overall Study||12
279643|NCT02050048|670670|P1|STARTED|Overall Study||14
279644|NCT02049931|670679|P3|NOT COMPLETED|Overall Study||3
279645|NCT02049931|670680|P2|NOT COMPLETED|Overall Study||5
279646|NCT02049931|670681|P1|NOT COMPLETED|Overall Study||3
279647|NCT02049931|670679|P3|COMPLETED|Overall Study||17
279648|NCT02049931|670680|P2|COMPLETED|Overall Study||15
279649|NCT02049931|670681|P1|COMPLETED|Overall Study||17
279650|NCT02049931|670679|P3|STARTED|Overall Study||20
279651|NCT02049931|670680|P2|STARTED|Overall Study||20
279652|NCT02049931|670681|P1|STARTED|Overall Study||20
279653|NCT02049450|670689|P1|NOT COMPLETED|Overall Study||4
279654|NCT02049450|670689|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
279655|NCT02049450|670689|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
279656|NCT02049450|670689|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
279657|NCT02049450|670689|P1|STARTED|Overall Study||30
279658|NCT02049151|670705|P2|NOT COMPLETED|Overall Study||0
279659|NCT02049151|670706|P1|NOT COMPLETED|Overall Study||0
279660|NCT02049151|670705|P2|COMPLETED|Overall Study||17
279661|NCT02049151|670706|P1|COMPLETED|Overall Study||15
279662|NCT02049151|670705|P2|STARTED|Overall Study|1 subject did not receive treatment|17
279663|NCT02049151|670706|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
279664|NCT02048891|670722|P2|NOT COMPLETED|Overall Study||0
279665|NCT02048891|670723|P1|NOT COMPLETED|Overall Study||0
279666|NCT02048891|670722|P2|COMPLETED|Overall Study||1
279667|NCT02048891|670723|P1|COMPLETED|Overall Study||2
279668|NCT02048891|670722|P2|STARTED|Overall Study||1
279669|NCT02048891|670723|P1|STARTED|Overall Study||2
279670|NCT02048072|670729|P1|NOT COMPLETED|Overall Study||4
279671|NCT02048072|670729|P1|COMPLETED|Overall Study||29
279672|NCT02048072|670729|P1|STARTED|Overall Study||33
279673|NCT02047747|670733|P1|NOT COMPLETED|Overall Study||3
279674|NCT02047747|670733|P1|COMPLETED|Overall Study||1
279675|NCT02047747|670733|P1|STARTED|Overall Study||4
279676|NCT02047227|670740|P2|NOT COMPLETED|Overall Study||130
279677|NCT02047227|670741|P1|NOT COMPLETED|Overall Study||144
279678|NCT02047227|670740|P2|COMPLETED|Overall Study||347
279679|NCT02047227|670741|P1|COMPLETED|Overall Study||318
279680|NCT02047227|670740|P2|Completed Ovarian Stimulation Phase|Overall Study||440
279681|NCT02047227|670741|P1|Completed Ovarian Stimulation Phase|Overall Study||424
279682|NCT02047227|670740|P2|STARTED|Overall Study||477
279683|NCT02047227|670741|P1|STARTED|Overall Study||462
279684|NCT02046993|670759|P2|NOT COMPLETED|Overall Study||11
279685|NCT02046993|670760|P1|NOT COMPLETED|Overall Study||3
279686|NCT02046993|670759|P2|COMPLETED|Overall Study||94
279687|NCT02046993|670760|P1|COMPLETED|Overall Study||102
279688|NCT02046993|670759|P2|6th Month|Overall Study||94
279689|NCT02046993|670760|P1|6th Month|Overall Study||102
279690|NCT02046993|670759|P2|3rd Month|Overall Study||97
279691|NCT02046993|670760|P1|3rd Month|Overall Study||104
279692|NCT02046993|670759|P2|STARTED|Overall Study||105
279693|NCT02046993|670760|P1|STARTED|Overall Study||105
279694|NCT02046980|670779|P3|NOT COMPLETED|Overall Study||1
279695|NCT02046980|670780|P2|NOT COMPLETED|Overall Study||5
279696|NCT02046980|670781|P1|NOT COMPLETED|Overall Study||2
279697|NCT02046980|670779|P3|COMPLETED|Overall Study||72
279698|NCT02046980|670780|P2|COMPLETED|Overall Study||67
279699|NCT02046980|670781|P1|COMPLETED|Overall Study||70
279700|NCT02046980|670779|P3|STARTED|Overall Study||73
279701|NCT02046980|670780|P2|STARTED|Overall Study||72
279702|NCT02046980|670781|P1|STARTED|Overall Study||72
279703|NCT02046863|670789|P1|NOT COMPLETED|Overall Study||0
279704|NCT02046863|670789|P1|COMPLETED|Overall Study||7
279705|NCT02046863|670789|P1|STARTED|Overall Study||7
279706|NCT02046772|670795|P2|NOT COMPLETED|Overall Study||0
279707|NCT02046772|670796|P1|NOT COMPLETED|Overall Study||0
279708|NCT02046772|670795|P2|COMPLETED|Overall Study||33
279709|NCT02046772|670796|P1|COMPLETED|Overall Study||30
279710|NCT02046772|670795|P2|STARTED|Overall Study||33
279711|NCT02046772|670796|P1|STARTED|Overall Study||30
279712|NCT02046265|670814|P4|NOT COMPLETED|Overall Study||2
279713|NCT02046265|670815|P3|NOT COMPLETED|Overall Study||2
279714|NCT02046265|670816|P2|NOT COMPLETED|Overall Study||2
279715|NCT02046265|670817|P1|NOT COMPLETED|Overall Study||1
279716|NCT02046265|670814|P4|COMPLETED|Overall Study||12
279717|NCT02046265|670815|P3|COMPLETED|Overall Study||10
279718|NCT02046265|670816|P2|COMPLETED|Overall Study||15
279719|NCT02046265|670817|P1|COMPLETED|Overall Study||16
279720|NCT02046265|670814|P4|STARTED|Overall Study||14
279721|NCT02046265|670815|P3|STARTED|Overall Study||12
279722|NCT02046265|670816|P2|STARTED|Overall Study||17
279723|NCT02046265|670817|P1|STARTED|Overall Study||17
279724|NCT02046226|670827|P1|NOT COMPLETED|Overall Study||7
279725|NCT02046226|670827|P1|COMPLETED|Overall Study||0
279726|NCT02046226|670827|P1|STARTED|Overall Study||7
279727|NCT02046200|670834|P2|NOT COMPLETED|Second Intervention (1 Day)||0
279728|NCT02046200|670835|P1|NOT COMPLETED|Second Intervention (1 Day)||0
279729|NCT02046200|670834|P2|COMPLETED|Second Intervention (1 Day)||6
279730|NCT02046200|670835|P1|COMPLETED|Second Intervention (1 Day)||5
279731|NCT02046200|670834|P2|STARTED|Second Intervention (1 Day)||6
279732|NCT02046200|670835|P1|STARTED|Second Intervention (1 Day)||5
279733|NCT02046200|670834|P2|NOT COMPLETED|First Intervention (1 Day)||0
279734|NCT02046200|670835|P1|NOT COMPLETED|First Intervention (1 Day)||0
279735|NCT02046200|670834|P2|COMPLETED|First Intervention (1 Day)||6
279736|NCT02046200|670835|P1|COMPLETED|First Intervention (1 Day)||5
279737|NCT02046200|670834|P2|STARTED|First Intervention (1 Day)||6
279738|NCT02046200|670835|P1|STARTED|First Intervention (1 Day)||5
279739|NCT02046148|670875|P2|NOT COMPLETED|Overall Study||3
279740|NCT02046148|670876|P1|NOT COMPLETED|Overall Study||1
279741|NCT02046148|670875|P2|COMPLETED|Overall Study||23
279742|NCT02046148|670876|P1|COMPLETED|Overall Study||48
279743|NCT02046148|670875|P2|STARTED|Overall Study||26
279744|NCT02046148|670876|P1|STARTED|Overall Study||49
279745|NCT02045732|670922|P2|NOT COMPLETED|Overall Study||1
279746|NCT02045732|670923|P1|NOT COMPLETED|Overall Study||1
279747|NCT02045732|670922|P2|COMPLETED|Overall Study||2
279748|NCT02045732|670923|P1|COMPLETED|Overall Study||0
279749|NCT02045732|670922|P2|STARTED|Overall Study||3
279750|NCT02045732|670923|P1|STARTED|Overall Study||1
279751|NCT02045264|670941|P1|NOT COMPLETED|Overall Study||0
279752|NCT02045264|670941|P1|COMPLETED|Overall Study||12
279753|NCT02045264|670941|P1|STARTED|Overall Study||12
279754|NCT02045238|670958|P2|NOT COMPLETED|Overall Study||1
279755|NCT02045238|670959|P1|NOT COMPLETED|Overall Study||7
279756|NCT02045238|670958|P2|COMPLETED|Overall Study||14
279757|NCT02045238|670959|P1|COMPLETED|Overall Study||9
279758|NCT02045238|670958|P2|STARTED|Overall Study||15
279759|NCT02045238|670959|P1|STARTED|Overall Study||16
279760|NCT02044991|670969|P2|NOT COMPLETED|Overall Study||0
279761|NCT02044991|670970|P1|NOT COMPLETED|Overall Study||0
279762|NCT02044991|670969|P2|COMPLETED|Overall Study||0
279763|NCT02044991|670970|P1|COMPLETED|Overall Study||2
279764|NCT02044991|670969|P2|STARTED|Overall Study||0
279765|NCT02044991|670970|P1|STARTED|Overall Study||2
279766|NCT02044848|670982|P2|NOT COMPLETED|Overall Study||3
279767|NCT02044848|670983|P1|NOT COMPLETED|Overall Study||2
279768|NCT02044848|670982|P2|COMPLETED|Overall Study||0
279769|NCT02044848|670983|P1|COMPLETED|Overall Study||0
279770|NCT02044848|670982|P2|STARTED|Overall Study||3
279771|NCT02044848|670983|P1|STARTED|Overall Study||2
279772|NCT02044822|670989|P1|NOT COMPLETED|Overall Study||93
279773|NCT02044822|670989|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
279774|NCT02044822|670989|P1|STARTED|Overall Study||102
279775|NCT02044458|671001|P2|NOT COMPLETED|Overall Study||8
279776|NCT02044458|671002|P1|NOT COMPLETED|Overall Study||3
279777|NCT02044458|671001|P2|COMPLETED|Overall Study||61
279778|NCT02044458|671002|P1|COMPLETED|Overall Study||62
279779|NCT02044458|671001|P2|STARTED|Overall Study||69
279780|NCT02044458|671002|P1|STARTED|Overall Study||65
279781|NCT02044393|671014|P2|NOT COMPLETED|Period 2||0
279782|NCT02044393|671015|P1|NOT COMPLETED|Period 2||0
279783|NCT02044393|671014|P2|COMPLETED|Period 2||10
279784|NCT02044393|671015|P1|COMPLETED|Period 2||10
279785|NCT02044393|671014|P2|STARTED|Period 2||10
279786|NCT02044393|671015|P1|STARTED|Period 2||10
279787|NCT02044393|671014|P2|NOT COMPLETED|Period 1||0
279788|NCT02044393|671015|P1|NOT COMPLETED|Period 1||0
279789|NCT02044393|671014|P2|COMPLETED|Period 1||10
279790|NCT02044393|671015|P1|COMPLETED|Period 1||10
279791|NCT02044393|671014|P2|STARTED|Period 1||10
279792|NCT02044393|671015|P1|STARTED|Period 1||10
279793|NCT02044380|671028|P1|NOT COMPLETED|Overall Study||0
279794|NCT02044380|671028|P1|COMPLETED|Overall Study||14
279795|NCT02044380|671028|P1|STARTED|Overall Study|Started are the treated patients|14
279796|NCT02044367|671032|P6|NOT COMPLETED|Overall Study||0
279797|NCT02044367|671033|P5|NOT COMPLETED|Overall Study||0
279798|NCT02044367|671034|P4|NOT COMPLETED|Overall Study||0
279799|NCT02044367|671035|P3|NOT COMPLETED|Overall Study||0
279800|NCT02044367|671036|P2|NOT COMPLETED|Overall Study||0
279801|NCT02044367|671037|P1|NOT COMPLETED|Overall Study||0
279802|NCT02044367|671032|P6|COMPLETED|Overall Study||9
279803|NCT02044367|671033|P5|COMPLETED|Overall Study||9
279804|NCT02044367|671034|P4|COMPLETED|Overall Study||9
279805|NCT02044367|671035|P3|COMPLETED|Overall Study||9
279806|NCT02044367|671036|P2|COMPLETED|Overall Study||9
279807|NCT02044367|671037|P1|COMPLETED|Overall Study||9
279808|NCT02044367|671032|P6|STARTED|Overall Study||9
279809|NCT02044367|671033|P5|STARTED|Overall Study||9
279810|NCT02044367|671034|P4|STARTED|Overall Study||9
279811|NCT02044367|671035|P3|STARTED|Overall Study||9
279812|NCT02044367|671036|P2|STARTED|Overall Study||9
279813|NCT02044367|671037|P1|STARTED|Overall Study||9
279814|NCT02044302|671060|P2|NOT COMPLETED|Overall Study||0
279815|NCT02044302|671061|P1|NOT COMPLETED|Overall Study||2
279816|NCT02044302|671060|P2|COMPLETED|Overall Study||0
279817|NCT02044302|671061|P1|COMPLETED|Overall Study||0
279818|NCT02044302|671060|P2|STARTED|Overall Study||0
279819|NCT02044302|671061|P1|STARTED|Overall Study||2
279820|NCT02043808|671069|P2|NOT COMPLETED|Overall Study||0
279821|NCT02043808|671070|P1|NOT COMPLETED|Overall Study||0
279822|NCT02043808|671069|P2|COMPLETED|Overall Study||12793
279823|NCT02043808|671070|P1|COMPLETED|Overall Study||12793
279824|NCT02043808|671069|P2|STARTED|Overall Study||12793
279825|NCT02043808|671070|P1|STARTED|Overall Study||12793
279826|NCT02043782|671108|P6|NOT COMPLETED|Period 3||0
279827|NCT02043782|671109|P5|NOT COMPLETED|Period 3||0
279828|NCT02043782|671110|P4|NOT COMPLETED|Period 3||0
279829|NCT02043782|671111|P3|NOT COMPLETED|Period 3||0
279830|NCT02043782|671112|P2|NOT COMPLETED|Period 3||0
279831|NCT02043782|671113|P1|NOT COMPLETED|Period 3||0
279832|NCT02043782|671108|P6|COMPLETED|Period 3||6
279833|NCT02043782|671109|P5|COMPLETED|Period 3||6
279834|NCT02043782|671110|P4|COMPLETED|Period 3||6
279835|NCT02043782|671111|P3|COMPLETED|Period 3||6
279836|NCT02043782|671112|P2|COMPLETED|Period 3||6
279837|NCT02043782|671113|P1|COMPLETED|Period 3||7
279838|NCT02043782|671108|P6|STARTED|Period 3||6
279839|NCT02043782|671109|P5|STARTED|Period 3||6
279840|NCT02043782|671110|P4|STARTED|Period 3||6
279841|NCT02043782|671111|P3|STARTED|Period 3||6
279842|NCT02043782|671112|P2|STARTED|Period 3||6
279843|NCT02043782|671113|P1|STARTED|Period 3||7
279844|NCT02043782|671108|P6|NOT COMPLETED|Period 2||0
279845|NCT02043782|671109|P5|NOT COMPLETED|Period 2||0
279846|NCT02043782|671110|P4|NOT COMPLETED|Period 2||0
279847|NCT02043782|671111|P3|NOT COMPLETED|Period 2||0
279848|NCT02043782|671112|P2|NOT COMPLETED|Period 2||0
279849|NCT02043782|671113|P1|NOT COMPLETED|Period 2||0
279850|NCT02043782|671108|P6|COMPLETED|Period 2||6
279851|NCT02043782|671109|P5|COMPLETED|Period 2||6
279852|NCT02043782|671110|P4|COMPLETED|Period 2||6
279853|NCT02043782|671111|P3|COMPLETED|Period 2||6
279854|NCT02043782|671112|P2|COMPLETED|Period 2||6
279855|NCT02043782|671113|P1|COMPLETED|Period 2||7
279856|NCT02043782|671108|P6|STARTED|Period 2||6
279857|NCT02043782|671109|P5|STARTED|Period 2||6
279858|NCT02043782|671110|P4|STARTED|Period 2||6
279859|NCT02043782|671111|P3|STARTED|Period 2||6
279860|NCT02043782|671112|P2|STARTED|Period 2||6
279861|NCT02043782|671113|P1|STARTED|Period 2||7
279862|NCT02043782|671108|P6|NOT COMPLETED|Period 1||0
279863|NCT02043782|671109|P5|NOT COMPLETED|Period 1||0
279864|NCT02043782|671110|P4|NOT COMPLETED|Period 1||0
279865|NCT02043782|671111|P3|NOT COMPLETED|Period 1||1
279866|NCT02043782|671112|P2|NOT COMPLETED|Period 1||0
279867|NCT02043782|671113|P1|NOT COMPLETED|Period 1||0
279868|NCT02043782|671108|P6|COMPLETED|Period 1||6
279869|NCT02043782|671109|P5|COMPLETED|Period 1||6
279870|NCT02043782|671110|P4|COMPLETED|Period 1||6
279871|NCT02043782|671111|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
279872|NCT02043782|671112|P2|COMPLETED|Period 1||6
279873|NCT02043782|671113|P1|COMPLETED|Period 1||7
279874|NCT02043782|671108|P6|STARTED|Period 1||6
279875|NCT02043782|671109|P5|STARTED|Period 1||6
279876|NCT02043782|671110|P4|STARTED|Period 1||6
279877|NCT02043782|671111|P3|STARTED|Period 1||7
279878|NCT02043782|671112|P2|STARTED|Period 1||6
279879|NCT02043782|671113|P1|STARTED|Period 1||7
279880|NCT02043379|671123|P2|NOT COMPLETED|Overall Study||0
279881|NCT02043379|671124|P1|NOT COMPLETED|Overall Study||0
279882|NCT02043379|671123|P2|COMPLETED|Overall Study||20
279883|NCT02043379|671124|P1|COMPLETED|Overall Study||30
279884|NCT02043379|671123|P2|STARTED|Overall Study||20
279885|NCT02043379|671124|P1|STARTED|Overall Study||30
279886|NCT02043366|671186|P6|NOT COMPLETED|Overall Study||2
279887|NCT02043366|671187|P5|NOT COMPLETED|Overall Study||2
279888|NCT02043366|671188|P4|NOT COMPLETED|Overall Study||2
279889|NCT02043366|671189|P3|NOT COMPLETED|Overall Study||2
279890|NCT02043366|671190|P2|NOT COMPLETED|Overall Study||2
279891|NCT02043366|671191|P1|NOT COMPLETED|Overall Study||2
279892|NCT02043366|671186|P6|COMPLETED|Overall Study||28
279893|NCT02043366|671187|P5|COMPLETED|Overall Study||28
279894|NCT02043366|671188|P4|COMPLETED|Overall Study||28
279895|NCT02043366|671189|P3|COMPLETED|Overall Study||28
279896|NCT02043366|671190|P2|COMPLETED|Overall Study||28
279897|NCT02043366|671191|P1|COMPLETED|Overall Study||28
279898|NCT02043366|671186|P6|STARTED|Overall Study||30
279899|NCT02043366|671187|P5|STARTED|Overall Study||30
279900|NCT02043366|671188|P4|STARTED|Overall Study||30
279901|NCT02043366|671189|P3|STARTED|Overall Study||30
279902|NCT02043366|671190|P2|STARTED|Overall Study||30
279903|NCT02043366|671191|P1|STARTED|Overall Study||30
279904|NCT02043145|671214|P3|NOT COMPLETED|Overall Study||0
279905|NCT02043145|671215|P2|NOT COMPLETED|Overall Study||0
279906|NCT02043145|671216|P1|NOT COMPLETED|Overall Study||0
279907|NCT02043145|671214|P3|COMPLETED|Overall Study||425
279908|NCT02043145|671215|P2|COMPLETED|Overall Study||247
279909|NCT02043145|671216|P1|COMPLETED|Overall Study||55
279910|NCT02043145|671214|P3|STARTED|Overall Study||425
279911|NCT02043145|671215|P2|STARTED|Overall Study||247
279912|NCT02043145|671216|P1|STARTED|Overall Study||55
279913|NCT02042924|671227|P1|NOT COMPLETED|Overall Study||1
279914|NCT02042924|671227|P1|COMPLETED|Overall Study||1
279915|NCT02042924|671227|P1|STARTED|Overall Study||2
279916|NCT02042911|671233|P1|NOT COMPLETED|Overall Study||1
279917|NCT02042911|671233|P1|COMPLETED|Overall Study||9
279918|NCT02042911|671233|P1|STARTED|Overall Study||10
279919|NCT02042872|671247|P2|NOT COMPLETED|Overall Study||5
279920|NCT02042872|671248|P1|NOT COMPLETED|Overall Study||0
279921|NCT02042872|671247|P2|COMPLETED|Overall Study||8
279922|NCT02042872|671248|P1|COMPLETED|Overall Study||8
279923|NCT02042872|671247|P2|STARTED|Overall Study||13
279924|NCT02042872|671248|P1|STARTED|Overall Study||8
279925|NCT02042534|671258|P2|NOT COMPLETED|Overall Study||0
279926|NCT02042534|671259|P1|NOT COMPLETED|Overall Study||0
279927|NCT02042534|671258|P2|COMPLETED|Overall Study||94
279928|NCT02042534|671259|P1|COMPLETED|Overall Study||101
279929|NCT02042534|671258|P2|STARTED|Overall Study||94
279930|NCT02042534|671259|P1|STARTED|Overall Study||101
279931|NCT02042404|671273|P2|NOT COMPLETED|Overall Study||0
279932|NCT02042404|671274|P1|NOT COMPLETED|Overall Study||5
279933|NCT02042404|671273|P2|COMPLETED|Overall Study||5
279934|NCT02042404|671274|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
279935|NCT02042404|671273|P2|STARTED|Overall Study||5
279936|NCT02042404|671274|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
279937|NCT02042274|671285|P1|NOT COMPLETED|Overall Study||0
279938|NCT02042274|671285|P1|COMPLETED|Overall Study||12
279939|NCT02042274|671285|P1|STARTED|Overall Study||12
279940|NCT02041520|671292|P2|NOT COMPLETED|Overall Study||7
279941|NCT02041520|671293|P1|NOT COMPLETED|Overall Study||6
279942|NCT02041520|671292|P2|COMPLETED|Overall Study||28
279943|NCT02041520|671293|P1|COMPLETED|Overall Study||29
279944|NCT02041520|671292|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
279945|NCT02041520|671293|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
279946|NCT02041377|671313|P1|NOT COMPLETED|Overall Study||0
279947|NCT02041377|671313|P1|COMPLETED|Overall Study||134
279948|NCT02041377|671313|P1|STARTED|Overall Study||134
279949|NCT02041325|671323|P2|NOT COMPLETED|Overall Study||3
279950|NCT02041325|671324|P1|NOT COMPLETED|Overall Study||3
279951|NCT02041325|671323|P2|COMPLETED|Overall Study||13
279952|NCT02041325|671324|P1|COMPLETED|Overall Study||19
279953|NCT02041325|671323|P2|STARTED|Overall Study||16
279954|NCT02041325|671324|P1|STARTED|Overall Study||22
279955|NCT02041286|671336|P1|NOT COMPLETED|Overall Study||1
279956|NCT02041286|671336|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
279957|NCT02041286|671336|P1|STARTED|Overall Study||136
279958|NCT02041221|671350|P6|NOT COMPLETED|Part 2||0
279959|NCT02041221|671351|P5|NOT COMPLETED|Part 2||0
279960|NCT02041221|671352|P4|NOT COMPLETED|Part 2||0
279961|NCT02041221|671353|P3|NOT COMPLETED|Part 2||1
279962|NCT02041221|671354|P2|NOT COMPLETED|Part 2||0
279963|NCT02041221|671355|P1|NOT COMPLETED|Part 2||0
279964|NCT02041221|671350|P6|COMPLETED|Part 2||6
279965|NCT02041221|671351|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
279966|NCT02041221|671352|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
279967|NCT02041221|671353|P3|COMPLETED|Part 2||5
279968|NCT02041221|671354|P2|COMPLETED|Part 2||6
279969|NCT02041221|671355|P1|COMPLETED|Part 2||6
279970|NCT02041221|671350|P6|STARTED|Part 2||6
279971|NCT02041221|671351|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
279972|NCT02041221|671352|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
279973|NCT02041221|671353|P3|STARTED|Part 2||6
279974|NCT02041221|671354|P2|STARTED|Part 2||6
279975|NCT02041221|671355|P1|STARTED|Part 2||6
279976|NCT02041221|671350|P6|NOT COMPLETED|Part 1||0
279977|NCT02041221|671351|P5|NOT COMPLETED|Part 1||0
279978|NCT02041221|671352|P4|NOT COMPLETED|Part 1||0
279979|NCT02041221|671353|P3|NOT COMPLETED|Part 1||0
279980|NCT02041221|671354|P2|NOT COMPLETED|Part 1||0
279981|NCT02041221|671355|P1|NOT COMPLETED|Part 1||0
279982|NCT02041221|671350|P6|COMPLETED|Part 1||10
279983|NCT02041221|671351|P5|COMPLETED|Part 1||6
279984|NCT02041221|671352|P4|COMPLETED|Part 1||6
279985|NCT02041221|671353|P3|COMPLETED|Part 1||6
279986|NCT02041221|671354|P2|COMPLETED|Part 1||6
279987|NCT02041221|671355|P1|COMPLETED|Part 1||6
279988|NCT02041221|671350|P6|STARTED|Part 1||10
279989|NCT02041221|671351|P5|STARTED|Part 1||6
279990|NCT02041221|671352|P4|STARTED|Part 1||6
279991|NCT02041221|671353|P3|STARTED|Part 1||6
279992|NCT02041221|671354|P2|STARTED|Part 1||6
279993|NCT02041221|671355|P1|STARTED|Part 1||6
279994|NCT02040792|671374|P5|NOT COMPLETED|Overall Study||7
279995|NCT02040792|671375|P4|NOT COMPLETED|Overall Study||7
279996|NCT02040792|671376|P3|NOT COMPLETED|Overall Study||3
279997|NCT02040792|671377|P2|NOT COMPLETED|Overall Study||3
279998|NCT02040792|671378|P1|NOT COMPLETED|Overall Study||6
279999|NCT02040792|671374|P5|COMPLETED|Overall Study||67
280000|NCT02040792|671375|P4|COMPLETED|Overall Study||64
280001|NCT02040792|671376|P3|COMPLETED|Overall Study||68
280002|NCT02040792|671377|P2|COMPLETED|Overall Study||65
280003|NCT02040792|671378|P1|COMPLETED|Overall Study||64
280004|NCT02040792|671374|P5|STARTED|Overall Study||74
280005|NCT02040792|671375|P4|STARTED|Overall Study||71
280006|NCT02040792|671376|P3|STARTED|Overall Study||71
280007|NCT02040792|671377|P2|STARTED|Overall Study||68
280008|NCT02040792|671378|P1|STARTED|Overall Study||70
280009|NCT02040623|671393|P3|NOT COMPLETED|Overall Study||2
280010|NCT02040623|671394|P2|NOT COMPLETED|Overall Study||6
280011|NCT02040623|671395|P1|NOT COMPLETED|Overall Study||4
280012|NCT02040623|671393|P3|COMPLETED|Overall Study||10
280013|NCT02040623|671394|P2|COMPLETED|Overall Study||6
280014|NCT02040623|671395|P1|COMPLETED|Overall Study||7
280015|NCT02040623|671393|P3|STARTED|Overall Study||12
280016|NCT02040623|671394|P2|STARTED|Overall Study||12
280017|NCT02040623|671395|P1|STARTED|Overall Study||11
280018|NCT02040532|671403|P1|NOT COMPLETED|Overall Study||12
280019|NCT02040532|671403|P1|COMPLETED|Overall Study||20
280020|NCT02040532|671403|P1|Received at Least One Dose of Medication|Overall Study||26
280021|NCT02040532|671403|P1|STARTED|Overall Study||32
280022|NCT02039817|671416|P2|NOT COMPLETED|Overall Study||0
280023|NCT02039817|671417|P1|NOT COMPLETED|Overall Study||0
280024|NCT02039817|671416|P2|COMPLETED|Overall Study||8
280025|NCT02039817|671417|P1|COMPLETED|Overall Study||8
280026|NCT02039817|671416|P2|STARTED|Overall Study||8
280027|NCT02039817|671417|P1|STARTED|Overall Study||8
280028|NCT02039778|671426|P1|NOT COMPLETED|Overall Study||4
280029|NCT02039778|671426|P1|COMPLETED|Overall Study||0
280030|NCT02039778|671426|P1|STARTED|Overall Study||4
280031|NCT02039687|671438|P4|NOT COMPLETED|Overall Study||0
280032|NCT02039687|671439|P3|NOT COMPLETED|Overall Study||3
280033|NCT02039687|671440|P2|NOT COMPLETED|Overall Study||1
280034|NCT02039687|671441|P1|NOT COMPLETED|Overall Study||0
280035|NCT02039687|671438|P4|COMPLETED|Overall Study||16
280036|NCT02039687|671439|P3|COMPLETED|Overall Study||13
280037|NCT02039687|671440|P2|COMPLETED|Overall Study||15
280038|NCT02039687|671441|P1|COMPLETED|Overall Study||16
280039|NCT02039687|671438|P4|STARTED|Overall Study||16
280040|NCT02039687|671439|P3|STARTED|Overall Study||16
280041|NCT02039687|671440|P2|STARTED|Overall Study||16
280042|NCT02039687|671441|P1|STARTED|Overall Study||16
280043|NCT02039414|671469|P2|NOT COMPLETED|Overall Study||2
280044|NCT02039414|671470|P1|NOT COMPLETED|Overall Study||6
280045|NCT02039414|671469|P2|COMPLETED|Overall Study||16
280046|NCT02039414|671470|P1|COMPLETED|Overall Study||16
280047|NCT02039414|671469|P2|STARTED|Overall Study||18
280048|NCT02039414|671470|P1|STARTED|Overall Study||22
280049|NCT02038959|671484|P2|NOT COMPLETED|Overall Study||8
280050|NCT02038959|671485|P1|NOT COMPLETED|Overall Study||6
280051|NCT02038959|671484|P2|COMPLETED|Overall Study||89
280052|NCT02038959|671485|P1|COMPLETED|Overall Study||92
280053|NCT02038959|671484|P2|STARTED|Overall Study||97
280054|NCT02038959|671485|P1|STARTED|Overall Study||98
280055|NCT02038933|671513|P1|NOT COMPLETED|Follow-up||19
280056|NCT02038933|671513|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
280057|NCT02038933|671513|P1|STARTED|Follow-up||121
280058|NCT02038933|671513|P1|NOT COMPLETED|Treatment||114
280059|NCT02038933|671513|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
280060|NCT02038933|671513|P1|STARTED|Treatment||121
280061|NCT02038907|671546|P14|NOT COMPLETED|Overall Study||0
280062|NCT02038907|671547|P13|NOT COMPLETED|Overall Study||0
280063|NCT02038907|671548|P12|NOT COMPLETED|Overall Study||0
280064|NCT02038907|671549|P11|NOT COMPLETED|Overall Study||2
280065|NCT02038907|671550|P10|NOT COMPLETED|Overall Study||0
280066|NCT02038907|671551|P9|NOT COMPLETED|Overall Study||0
280067|NCT02038907|671552|P8|NOT COMPLETED|Overall Study||0
280068|NCT02038907|671553|P7|NOT COMPLETED|Overall Study||0
280069|NCT02038907|671554|P6|NOT COMPLETED|Overall Study||0
280070|NCT02038907|671555|P5|NOT COMPLETED|Overall Study||0
280071|NCT02038907|671556|P4|NOT COMPLETED|Overall Study||0
280072|NCT02038907|671557|P3|NOT COMPLETED|Overall Study||0
280073|NCT02038907|671558|P2|NOT COMPLETED|Overall Study||0
280074|NCT02038907|671559|P1|NOT COMPLETED|Overall Study||0
280075|NCT02038907|671546|P14|COMPLETED|Overall Study||31
280076|NCT02038907|671547|P13|COMPLETED|Overall Study||29
280077|NCT02038907|671548|P12|COMPLETED|Overall Study||28
280078|NCT02038907|671549|P11|COMPLETED|Overall Study||27
280079|NCT02038907|671550|P10|COMPLETED|Overall Study||30
280080|NCT02038907|671551|P9|COMPLETED|Overall Study||29
280081|NCT02038907|671552|P8|COMPLETED|Overall Study||32
280082|NCT02038907|671553|P7|COMPLETED|Overall Study||30
280083|NCT02038907|671554|P6|COMPLETED|Overall Study||31
280084|NCT02038907|671555|P5|COMPLETED|Overall Study||30
280085|NCT02038907|671556|P4|COMPLETED|Overall Study||31
280086|NCT02038907|671557|P3|COMPLETED|Overall Study||30
280087|NCT02038907|671558|P2|COMPLETED|Overall Study||30
280088|NCT02038907|671559|P1|COMPLETED|Overall Study||30
280089|NCT02038907|671546|P14|STARTED|Overall Study||31
280090|NCT02038907|671547|P13|STARTED|Overall Study||29
280091|NCT02038907|671548|P12|STARTED|Overall Study||28
280092|NCT02038907|671549|P11|STARTED|Overall Study||29
280093|NCT02038907|671550|P10|STARTED|Overall Study||30
280094|NCT02038907|671551|P9|STARTED|Overall Study||29
280095|NCT02038907|671552|P8|STARTED|Overall Study||32
280096|NCT02038907|671553|P7|STARTED|Overall Study||30
280097|NCT02038907|671554|P6|STARTED|Overall Study||31
280098|NCT02038907|671555|P5|STARTED|Overall Study||30
280099|NCT02038907|671556|P4|STARTED|Overall Study||31
280100|NCT02038907|671557|P3|STARTED|Overall Study||30
280101|NCT02038907|671558|P2|STARTED|Overall Study||30
280102|NCT02038907|671559|P1|STARTED|Overall Study||30
280103|NCT02038790|672087|P2|NOT COMPLETED|Day 1 - Second Treatment||0
280104|NCT02038790|672088|P1|NOT COMPLETED|Day 1 - Second Treatment||0
280105|NCT02038790|672087|P2|COMPLETED|Day 1 - Second Treatment||16
280106|NCT02038790|672088|P1|COMPLETED|Day 1 - Second Treatment||15
280107|NCT02038790|672087|P2|STARTED|Day 1 - Second Treatment||16
280108|NCT02038790|672088|P1|STARTED|Day 1 - Second Treatment||15
280109|NCT02038790|672087|P2|NOT COMPLETED|Day 0 - First Treatment||1
280110|NCT02038790|672088|P1|NOT COMPLETED|Day 0 - First Treatment||1
280111|NCT02038790|672087|P2|COMPLETED|Day 0 - First Treatment||16
280112|NCT02038790|672088|P1|COMPLETED|Day 0 - First Treatment||15
280113|NCT02038790|672087|P2|STARTED|Day 0 - First Treatment||17
280114|NCT02038790|672088|P1|STARTED|Day 0 - First Treatment||16
280115|NCT02038075|672121|P2|NOT COMPLETED|Overall Study||0
280116|NCT02038075|672122|P1|NOT COMPLETED|Overall Study||3
280117|NCT02038075|672121|P2|COMPLETED|Overall Study||76
280118|NCT02038075|672122|P1|COMPLETED|Overall Study||73
280119|NCT02038075|672121|P2|STARTED|Overall Study||76
280120|NCT02038075|672122|P1|STARTED|Overall Study||76
280121|NCT02037607|672128|P1|NOT COMPLETED|Overall Study||9
280122|NCT02037607|672128|P1|COMPLETED|Overall Study||91
280123|NCT02037607|672128|P1|STARTED|Overall Study||100
280124|NCT02037477|672136|P4|NOT COMPLETED|Treatment Period 2||0
280125|NCT02037477|672137|P3|NOT COMPLETED|Treatment Period 2||0
280126|NCT02037477|672138|P2|NOT COMPLETED|Treatment Period 2||0
280127|NCT02037477|672139|P1|NOT COMPLETED|Treatment Period 2||0
280128|NCT02037477|672136|P4|COMPLETED|Treatment Period 2||5
280129|NCT02037477|672137|P3|COMPLETED|Treatment Period 2||4
280130|NCT02037477|672138|P2|COMPLETED|Treatment Period 2||5
280131|NCT02037477|672139|P1|COMPLETED|Treatment Period 2||5
280132|NCT02037477|672136|P4|STARTED|Treatment Period 2||5
280133|NCT02037477|672137|P3|STARTED|Treatment Period 2||4
280134|NCT02037477|672138|P2|STARTED|Treatment Period 2||5
280135|NCT02037477|672139|P1|STARTED|Treatment Period 2||5
280136|NCT02037477|672136|P4|NOT COMPLETED|Treatment Period 1||0
280137|NCT02037477|672137|P3|NOT COMPLETED|Treatment Period 1||1
280138|NCT02037477|672138|P2|NOT COMPLETED|Treatment Period 1||0
280139|NCT02037477|672139|P1|NOT COMPLETED|Treatment Period 1||0
280140|NCT02037477|672136|P4|COMPLETED|Treatment Period 1||5
280141|NCT02037477|672137|P3|COMPLETED|Treatment Period 1||4
280142|NCT02037477|672138|P2|COMPLETED|Treatment Period 1||5
280143|NCT02037477|672139|P1|COMPLETED|Treatment Period 1||5
280144|NCT02037477|672136|P4|STARTED|Treatment Period 1||5
280145|NCT02037477|672137|P3|STARTED|Treatment Period 1||5
280146|NCT02037477|672138|P2|STARTED|Treatment Period 1||5
280147|NCT02037477|672139|P1|STARTED|Treatment Period 1||5
280148|NCT02037425|672165|P1|NOT COMPLETED|Overall Study||26
280149|NCT02037425|672165|P1|COMPLETED|Overall Study||18
280150|NCT02037425|672165|P1|Randomized to Treatment|Overall Study||32
280151|NCT02037425|672165|P1|STARTED|Overall Study||44
280152|NCT02037347|672207|P1|NOT COMPLETED|Overall Study||0
280153|NCT02037347|672207|P1|COMPLETED|Overall Study||1
280154|NCT02037347|672207|P1|STARTED|Overall Study||1
280155|NCT02036840|672213|P1|NOT COMPLETED|Overall Study||0
280156|NCT02036840|672213|P1|COMPLETED|Overall Study||513
280157|NCT02036840|672213|P1|STARTED|Overall Study||513
280158|NCT02036775|672217|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
280159|NCT02036775|672218|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
280160|NCT02036775|672219|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
280161|NCT02036775|672220|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
280162|NCT02036775|672221|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
280163|NCT02036775|672222|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
280164|NCT02036775|672217|P6|COMPLETED|Treatment Period 3 (6 Days)||3
280165|NCT02036775|672218|P5|COMPLETED|Treatment Period 3 (6 Days)||4
280166|NCT02036775|672219|P4|COMPLETED|Treatment Period 3 (6 Days)||4
280167|NCT02036775|672220|P3|COMPLETED|Treatment Period 3 (6 Days)||4
280168|NCT02036775|672221|P2|COMPLETED|Treatment Period 3 (6 Days)||4
280169|NCT02036775|672222|P1|COMPLETED|Treatment Period 3 (6 Days)||4
280170|NCT02036775|672217|P6|STARTED|Treatment Period 3 (6 Days)||3
280171|NCT02036775|672218|P5|STARTED|Treatment Period 3 (6 Days)||4
280172|NCT02036775|672219|P4|STARTED|Treatment Period 3 (6 Days)||4
280173|NCT02036775|672220|P3|STARTED|Treatment Period 3 (6 Days)||4
280174|NCT02036775|672221|P2|STARTED|Treatment Period 3 (6 Days)||4
280175|NCT02036775|672222|P1|STARTED|Treatment Period 3 (6 Days)||4
280176|NCT02036775|672217|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
280177|NCT02036775|672218|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
280178|NCT02036775|672219|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
280179|NCT02036775|672220|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
280180|NCT02036775|672221|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
280181|NCT02036775|672222|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
280182|NCT02036775|672217|P6|COMPLETED|Treatment Period 2 (6 Days)||3
280183|NCT02036775|672218|P5|COMPLETED|Treatment Period 2 (6 Days)||4
280184|NCT02036775|672219|P4|COMPLETED|Treatment Period 2 (6 Days)||4
280185|NCT02036775|672220|P3|COMPLETED|Treatment Period 2 (6 Days)||4
280186|NCT02036775|672221|P2|COMPLETED|Treatment Period 2 (6 Days)||4
280187|NCT02036775|672222|P1|COMPLETED|Treatment Period 2 (6 Days)||4
280188|NCT02036775|672217|P6|STARTED|Treatment Period 2 (6 Days)||4
280189|NCT02036775|672218|P5|STARTED|Treatment Period 2 (6 Days)||4
280190|NCT02036775|672219|P4|STARTED|Treatment Period 2 (6 Days)||4
280191|NCT02036775|672220|P3|STARTED|Treatment Period 2 (6 Days)||4
280192|NCT02036775|672221|P2|STARTED|Treatment Period 2 (6 Days)||4
280193|NCT02036775|672222|P1|STARTED|Treatment Period 2 (6 Days)||4
280194|NCT02036775|672217|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
280195|NCT02036775|672218|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
280196|NCT02036775|672219|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
280197|NCT02036775|672220|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
280198|NCT02036775|672221|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
280199|NCT02036775|672222|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
280200|NCT02036775|672217|P6|COMPLETED|Treatment Period 1 (6 Days)||4
280201|NCT02036775|672218|P5|COMPLETED|Treatment Period 1 (6 Days)||4
280202|NCT02036775|672219|P4|COMPLETED|Treatment Period 1 (6 Days)||4
280203|NCT02036775|672220|P3|COMPLETED|Treatment Period 1 (6 Days)||4
280204|NCT02036775|672221|P2|COMPLETED|Treatment Period 1 (6 Days)||4
280205|NCT02036775|672222|P1|COMPLETED|Treatment Period 1 (6 Days)||4
280206|NCT02036775|672217|P6|STARTED|Treatment Period 1 (6 Days)||4
280207|NCT02036775|672218|P5|STARTED|Treatment Period 1 (6 Days)||4
280208|NCT02036775|672219|P4|STARTED|Treatment Period 1 (6 Days)||4
280209|NCT02036775|672220|P3|STARTED|Treatment Period 1 (6 Days)||4
280210|NCT02036775|672221|P2|STARTED|Treatment Period 1 (6 Days)||4
280211|NCT02036775|672222|P1|STARTED|Treatment Period 1 (6 Days)||4
280212|NCT02036580|672263|P3|NOT COMPLETED|Overall Study||0
280213|NCT02036580|672264|P2|NOT COMPLETED|Overall Study||1
280214|NCT02036580|672265|P1|NOT COMPLETED|Overall Study||1
280215|NCT02036580|672263|P3|COMPLETED|Overall Study||4
280216|NCT02036580|672264|P2|COMPLETED|Overall Study||7
280217|NCT02036580|672265|P1|COMPLETED|Overall Study||7
280218|NCT02036580|672263|P3|STARTED|Overall Study||4
280219|NCT02036580|672264|P2|STARTED|Overall Study||8
280220|NCT02036580|672265|P1|STARTED|Overall Study||8
280221|NCT02036541|672278|P1|NOT COMPLETED|Overall Study||16
280222|NCT02036541|672278|P1|COMPLETED|Overall Study||49
280223|NCT02036541|672278|P1|Completed Endpoint Visit|Overall Study||54
280224|NCT02036541|672278|P1|STARTED|Overall Study||65
280225|NCT02036424|672285|P2|NOT COMPLETED|Overall Study||0
280226|NCT02036424|672286|P1|NOT COMPLETED|Overall Study||0
280227|NCT02036424|672285|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
280228|NCT02036424|672286|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
280229|NCT02036424|672285|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
280230|NCT02036424|672286|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
280231|NCT02036320|672294|P2|NOT COMPLETED|Period 2||0
280232|NCT02036320|672295|P1|NOT COMPLETED|Period 2||0
280233|NCT02036320|672294|P2|COMPLETED|Period 2||95
280234|NCT02036320|672295|P1|COMPLETED|Period 2||95
280235|NCT02036320|672294|P2|STARTED|Period 2||95
280236|NCT02036320|672295|P1|STARTED|Period 2||95
280237|NCT02036320|672294|P2|NOT COMPLETED|Period 1||0
280238|NCT02036320|672295|P1|NOT COMPLETED|Period 1||0
280239|NCT02036320|672294|P2|COMPLETED|Period 1||95
280240|NCT02036320|672295|P1|COMPLETED|Period 1||95
280241|NCT02036320|672294|P2|STARTED|Period 1||95
280242|NCT02036320|672295|P1|STARTED|Period 1||95
280243|NCT02035748|672305|P1|NOT COMPLETED|Overall Study||20
280244|NCT02035748|672305|P1|COMPLETED|Overall Study||448
280245|NCT02035748|672305|P1|STARTED|Overall Study||468
280246|NCT02035475|672315|P1|NOT COMPLETED|Overall Study||6
280247|NCT02035475|672315|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
280248|NCT02035475|672315|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
280249|NCT02035345|672321|P1|NOT COMPLETED|Overall Study||0
280250|NCT02035345|672321|P1|COMPLETED|Overall Study||15
280251|NCT02035345|672321|P1|STARTED|Overall Study||15
280252|NCT02035332|672326|P1|NOT COMPLETED|Overall Study||1
280253|NCT02035332|672326|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
280254|NCT02035332|672326|P1|Treated|Overall Study|Treatment Completed|20
280255|NCT02035332|672326|P1|STARTED|Overall Study|Treatment Attempted|21
280256|NCT02034877|672334|P2|NOT COMPLETED|Overall Study||6
280257|NCT02034877|672335|P1|NOT COMPLETED|Overall Study||0
280258|NCT02034877|672334|P2|COMPLETED|Overall Study||993
280259|NCT02034877|672335|P1|COMPLETED|Overall Study||200
280260|NCT02034877|672334|P2|STARTED|Overall Study||999
280261|NCT02034877|672335|P1|STARTED|Overall Study||200
280262|NCT02034708|672353|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
280263|NCT02034708|672354|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
280264|NCT02034708|672353|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
280265|NCT02034708|672354|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
280266|NCT02034708|672353|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
280267|NCT02034708|672354|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
280268|NCT02034708|672353|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
280269|NCT02034708|672354|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
280270|NCT02034708|672353|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
280271|NCT02034708|672354|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
280272|NCT02034708|672353|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
280273|NCT02034708|672354|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
280274|NCT02034708|672353|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
280275|NCT02034708|672354|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
280276|NCT02034708|672353|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
280277|NCT02034708|672354|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
280278|NCT02034708|672353|P2|STARTED|First Contrast Agent Injection (1 Day)||130
280279|NCT02034708|672354|P1|STARTED|First Contrast Agent Injection (1 Day)||138
280280|NCT02034591|672365|P6|NOT COMPLETED|Overall Study||0
280281|NCT02034591|672366|P5|NOT COMPLETED|Overall Study||1
280282|NCT02034591|672367|P4|NOT COMPLETED|Overall Study||0
280283|NCT02034591|672368|P3|NOT COMPLETED|Overall Study||0
280284|NCT02034591|672369|P2|NOT COMPLETED|Overall Study||0
280285|NCT02034591|672370|P1|NOT COMPLETED|Overall Study||0
280286|NCT02034591|672365|P6|COMPLETED|Overall Study||3
280287|NCT02034591|672366|P5|COMPLETED|Overall Study||3
280288|NCT02034591|672367|P4|COMPLETED|Overall Study||3
280289|NCT02034591|672368|P3|COMPLETED|Overall Study||4
280290|NCT02034591|672369|P2|COMPLETED|Overall Study||3
280291|NCT02034591|672370|P1|COMPLETED|Overall Study||4
280292|NCT02034591|672365|P6|STARTED|Overall Study||3
280293|NCT02034591|672366|P5|STARTED|Overall Study||4
280294|NCT02034591|672367|P4|STARTED|Overall Study||3
280295|NCT02034591|672368|P3|STARTED|Overall Study||4
280296|NCT02034591|672369|P2|STARTED|Overall Study||3
280297|NCT02034591|672370|P1|STARTED|Overall Study||4
280298|NCT02034578|672393|P6|NOT COMPLETED|Overall Study||0
280299|NCT02034578|672394|P5|NOT COMPLETED|Overall Study||0
280300|NCT02034578|672395|P4|NOT COMPLETED|Overall Study||0
280301|NCT02034578|672396|P3|NOT COMPLETED|Overall Study||0
280302|NCT02034578|672397|P2|NOT COMPLETED|Overall Study||0
280303|NCT02034578|672398|P1|NOT COMPLETED|Overall Study||0
280304|NCT02034578|672393|P6|COMPLETED|Overall Study||3
280305|NCT02034578|672394|P5|COMPLETED|Overall Study||4
280306|NCT02034578|672395|P4|COMPLETED|Overall Study||3
280307|NCT02034578|672396|P3|COMPLETED|Overall Study||4
280308|NCT02034578|672397|P2|COMPLETED|Overall Study||3
280309|NCT02034578|672398|P1|COMPLETED|Overall Study||4
280310|NCT02034578|672393|P6|STARTED|Overall Study||3
280311|NCT02034578|672394|P5|STARTED|Overall Study||4
280312|NCT02034578|672395|P4|STARTED|Overall Study||3
280313|NCT02034578|672396|P3|STARTED|Overall Study||4
280314|NCT02034578|672397|P2|STARTED|Overall Study||3
280315|NCT02034578|672398|P1|STARTED|Overall Study||4
280316|NCT02034565|672425|P2|NOT COMPLETED|Overall Study||0
280317|NCT02034565|672426|P1|NOT COMPLETED|Overall Study||1
280318|NCT02034565|672425|P2|COMPLETED|Overall Study||7
280319|NCT02034565|672426|P1|COMPLETED|Overall Study||6
280320|NCT02034565|672425|P2|STARTED|Overall Study||7
280321|NCT02034565|672426|P1|STARTED|Overall Study||7
280322|NCT02034513|672442|P2|NOT COMPLETED|Overall Study||57
280323|NCT02034513|672443|P1|NOT COMPLETED|Overall Study||49
280324|NCT02034513|672442|P2|COMPLETED|Overall Study||195
280325|NCT02034513|672443|P1|COMPLETED|Overall Study||200
280326|NCT02034513|672442|P2|Exposed|Overall Study||251
280327|NCT02034513|672443|P1|Exposed|Overall Study||249
280328|NCT02034513|672442|P2|STARTED|Overall Study||252
280329|NCT02034513|672443|P1|STARTED|Overall Study||249
280330|NCT02034162|672461|P3|NOT COMPLETED|Open-label||0
280331|NCT02034162|672462|P2|NOT COMPLETED|Open-label||0
280332|NCT02034162|672463|P1|NOT COMPLETED|Open-label||0
280333|NCT02034162|672461|P3|COMPLETED|Open-label||278
280334|NCT02034162|672462|P2|COMPLETED|Open-label||0
280335|NCT02034162|672463|P1|COMPLETED|Open-label||0
280336|NCT02034162|672461|P3|STARTED|Open-label||278
280337|NCT02034162|672462|P2|STARTED|Open-label||0
280338|NCT02034162|672463|P1|STARTED|Open-label||0
280339|NCT02034162|672461|P3|NOT COMPLETED|Double-blind||0
280340|NCT02034162|672462|P2|NOT COMPLETED|Double-blind||8
280341|NCT02034162|672463|P1|NOT COMPLETED|Double-blind||9
280342|NCT02034162|672461|P3|COMPLETED|Double-blind||0
280343|NCT02034162|672462|P2|COMPLETED|Double-blind||141
280344|NCT02034162|672463|P1|COMPLETED|Double-blind||137
280345|NCT02034162|672461|P3|STARTED|Double-blind||0
280346|NCT02034162|672462|P2|STARTED|Double-blind||149
280347|NCT02034162|672463|P1|STARTED|Double-blind||146
280348|NCT02033317|672491|P1|NOT COMPLETED|Overall Study||0
280349|NCT02033317|672491|P1|COMPLETED|Overall Study||6
280350|NCT02033317|672491|P1|STARTED|Overall Study||6
280351|NCT02033213|672498|P2|NOT COMPLETED|Overall Study||0
280352|NCT02033213|672499|P1|NOT COMPLETED|Overall Study||0
280353|NCT02033213|672498|P2|COMPLETED|Overall Study||8
280354|NCT02033213|672499|P1|COMPLETED|Overall Study||8
280355|NCT02033213|672498|P2|STARTED|Overall Study||8
280356|NCT02033213|672499|P1|STARTED|Overall Study||8
280357|NCT02033200|672517|P2|NOT COMPLETED|Overall Study||0
280358|NCT02033200|672518|P1|NOT COMPLETED|Overall Study||0
280359|NCT02033200|672517|P2|COMPLETED|Overall Study||40
280360|NCT02033200|672518|P1|COMPLETED|Overall Study||40
280361|NCT02033200|672517|P2|STARTED|Overall Study||40
280362|NCT02033200|672518|P1|STARTED|Overall Study||40
280363|NCT02033174|672538|P2|NOT COMPLETED|Second Intervention||0
280364|NCT02033174|672539|P1|NOT COMPLETED|Second Intervention||0
280365|NCT02033174|672538|P2|COMPLETED|Second Intervention||8
280366|NCT02033174|672539|P1|COMPLETED|Second Intervention||8
280367|NCT02033174|672538|P2|STARTED|Second Intervention||8
280368|NCT02033174|672539|P1|STARTED|Second Intervention||8
280369|NCT02033174|672538|P2|NOT COMPLETED|Washout (1 Week)||0
280370|NCT02033174|672539|P1|NOT COMPLETED|Washout (1 Week)||0
280371|NCT02033174|672538|P2|COMPLETED|Washout (1 Week)||8
280372|NCT02033174|672539|P1|COMPLETED|Washout (1 Week)||8
280373|NCT02033174|672538|P2|STARTED|Washout (1 Week)||8
280374|NCT02033174|672539|P1|STARTED|Washout (1 Week)||8
280375|NCT02033174|672538|P2|NOT COMPLETED|First Intervention||0
280376|NCT02033174|672539|P1|NOT COMPLETED|First Intervention||0
280377|NCT02033174|672538|P2|COMPLETED|First Intervention||8
280378|NCT02033174|672539|P1|COMPLETED|First Intervention||8
280379|NCT02033174|672538|P2|STARTED|First Intervention||8
280380|NCT02033174|672539|P1|STARTED|First Intervention||8
280381|NCT02032901|672547|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
280382|NCT02032901|672548|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
280383|NCT02032901|672547|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
280384|NCT02032901|672548|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
280385|NCT02032901|672547|P2|STARTED|Follow-Up Period (24 Weeks)||51
280386|NCT02032901|672548|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
280387|NCT02032901|672547|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
280388|NCT02032901|672548|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
280389|NCT02032901|672547|P2|COMPLETED|Treatment Period (12 Weeks)||51
280390|NCT02032901|672548|P1|COMPLETED|Treatment Period (12 Weeks)||100
280391|NCT02032901|672547|P2|STARTED|Treatment Period (12 Weeks)||51
280392|NCT02032901|672548|P1|STARTED|Treatment Period (12 Weeks)||101
280393|NCT02032888|672572|P3|NOT COMPLETED|Follow-up Period||0
280394|NCT02032888|672573|P2|NOT COMPLETED|Follow-up Period||2
280395|NCT02032888|672574|P1|NOT COMPLETED|Follow-up Period||3
280396|NCT02032888|672572|P3|COMPLETED|Follow-up Period||52
280397|NCT02032888|672573|P2|COMPLETED|Follow-up Period||47
280398|NCT02032888|672574|P1|COMPLETED|Follow-up Period||97
280399|NCT02032888|672572|P3|STARTED|Follow-up Period||52
280400|NCT02032888|672573|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
280401|NCT02032888|672574|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
280402|NCT02032888|672572|P3|NOT COMPLETED|Treatment Period||0
280403|NCT02032888|672573|P2|NOT COMPLETED|Treatment Period||2
280404|NCT02032888|672574|P1|NOT COMPLETED|Treatment Period||2
280405|NCT02032888|672572|P3|COMPLETED|Treatment Period||52
280406|NCT02032888|672573|P2|COMPLETED|Treatment Period||48
280407|NCT02032888|672574|P1|COMPLETED|Treatment Period||99
280408|NCT02032888|672572|P3|STARTED|Treatment Period||52
280409|NCT02032888|672573|P2|STARTED|Treatment Period||50
280410|NCT02032888|672574|P1|STARTED|Treatment Period||101
280411|NCT02032875|672605|P2|NOT COMPLETED|Follow-up Period||11
280412|NCT02032875|672606|P1|NOT COMPLETED|Follow-up Period||3
280413|NCT02032875|672605|P2|COMPLETED|Follow-up Period||46
280414|NCT02032875|672606|P1|COMPLETED|Follow-up Period||50
280415|NCT02032875|672605|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
280416|NCT02032875|672606|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
280417|NCT02032875|672605|P2|NOT COMPLETED|Treatment Period||4
280418|NCT02032875|672606|P1|NOT COMPLETED|Treatment Period||1
280419|NCT02032875|672605|P2|COMPLETED|Treatment Period||56
280420|NCT02032875|672606|P1|COMPLETED|Treatment Period||52
280421|NCT02032875|672605|P2|STARTED|Treatment Period||60
280422|NCT02032875|672606|P1|STARTED|Treatment Period||53
280423|NCT02032758|672626|P2|NOT COMPLETED|Overall Study||0
280424|NCT02032758|672627|P1|NOT COMPLETED|Overall Study||0
280425|NCT02032758|672626|P2|COMPLETED|Overall Study||11
280426|NCT02032758|672627|P1|COMPLETED|Overall Study||27
280427|NCT02032758|672626|P2|STARTED|Overall Study||11
280428|NCT02032758|672627|P1|STARTED|Overall Study||27
280429|NCT02032706|672635|P1|NOT COMPLETED|Overall Study||6
280430|NCT02032706|672635|P1|COMPLETED|Overall Study||30
280431|NCT02032706|672635|P1|STARTED|Overall Study||36
280432|NCT02032641|672648|P1|NOT COMPLETED|Overall Study||1
280433|NCT02032641|672648|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
280434|NCT02032641|672648|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
280435|NCT02031471|672658|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
280436|NCT02031471|672658|P1|COMPLETED|Long Term Extension (LTE) Period||37
280437|NCT02031471|672658|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
280438|NCT02031471|672658|P1|NOT COMPLETED|24 Week Treatment Period||11
280439|NCT02031471|672658|P1|COMPLETED|24 Week Treatment Period||46
280440|NCT02031471|672658|P1|STARTED|24 Week Treatment Period||57
280441|NCT02031458|672691|P3|NOT COMPLETED|Overall Study||253
280442|NCT02031458|672692|P2|NOT COMPLETED|Overall Study||267
280443|NCT02031458|672693|P1|NOT COMPLETED|Overall Study||139
280444|NCT02031458|672691|P3|COMPLETED|Overall Study||0
280445|NCT02031458|672692|P2|COMPLETED|Overall Study||0
280446|NCT02031458|672693|P1|COMPLETED|Overall Study||0
280447|NCT02031458|672691|P3|STARTED|Overall Study||253
280448|NCT02031458|672692|P2|STARTED|Overall Study||267
280449|NCT02031458|672693|P1|STARTED|Overall Study||139
280450|NCT02032420|672789|P2|NOT COMPLETED|Overall Study||0
280451|NCT02032420|672790|P1|NOT COMPLETED|Overall Study||0
280452|NCT02032420|672789|P2|COMPLETED|Overall Study||17
280453|NCT02032420|672790|P1|COMPLETED|Overall Study||18
280454|NCT02032420|672789|P2|STARTED|Overall Study||17
280455|NCT02032420|672790|P1|STARTED|Overall Study||18
280456|NCT02032407|672802|P1|NOT COMPLETED|Overall Study||5
280457|NCT02032407|672802|P1|COMPLETED|Overall Study||63
280458|NCT02032407|672802|P1|STARTED|Overall Study||68
280459|NCT02032212|672817|P4|NOT COMPLETED|Overall Study||0
280460|NCT02032212|672818|P3|NOT COMPLETED|Overall Study||0
280461|NCT02032212|672819|P2|NOT COMPLETED|Overall Study||0
280462|NCT02032212|672820|P1|NOT COMPLETED|Overall Study||0
280463|NCT02032212|672817|P4|COMPLETED|Overall Study||3
280464|NCT02032212|672818|P3|COMPLETED|Overall Study||3
280465|NCT02032212|672819|P2|COMPLETED|Overall Study||3
280466|NCT02032212|672820|P1|COMPLETED|Overall Study||3
280467|NCT02032212|672817|P4|STARTED|Overall Study||3
280468|NCT02032212|672818|P3|STARTED|Overall Study||3
280469|NCT02032212|672819|P2|STARTED|Overall Study||3
280470|NCT02032212|672820|P1|STARTED|Overall Study||3
280471|NCT02030600|672848|P2|NOT COMPLETED|Treatment Period 2||18
280472|NCT02030600|672849|P1|NOT COMPLETED|Treatment Period 2||25
280473|NCT02030600|672848|P2|COMPLETED|Treatment Period 2||297
280474|NCT02030600|672849|P1|COMPLETED|Treatment Period 2||283
280475|NCT02030600|672848|P2|STARTED|Treatment Period 2||315
280476|NCT02030600|672849|P1|STARTED|Treatment Period 2||308
280477|NCT02030600|672848|P2|NOT COMPLETED|Treatment Period 1||45
280478|NCT02030600|672849|P1|NOT COMPLETED|Treatment Period 1||53
280479|NCT02030600|672848|P2|COMPLETED|Treatment Period 1||315
280480|NCT02030600|672849|P1|COMPLETED|Treatment Period 1||308
280481|NCT02030600|672848|P2|Exposed|Treatment Period 1||357
280482|NCT02030600|672849|P1|Exposed|Treatment Period 1||356
280483|NCT02030600|672848|P2|STARTED|Treatment Period 1||360
280484|NCT02030600|672849|P1|STARTED|Treatment Period 1||361
280485|NCT02030574|672865|P1|NOT COMPLETED|Overall Study||0
280486|NCT02030574|672865|P1|COMPLETED|Overall Study||2
280487|NCT02030574|672865|P1|STARTED|Overall Study||2
280488|NCT02030535|672870|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
280489|NCT02030535|672870|P1|COMPLETED|Treatment Period 3 (1 Day)||52
280490|NCT02030535|672870|P1|STARTED|Treatment Period 3 (1 Day)||52
280491|NCT02030535|672870|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
280492|NCT02030535|672870|P1|COMPLETED|Washout Period 2 (21 Days)||52
280493|NCT02030535|672870|P1|STARTED|Washout Period 2 (21 Days)||52
280494|NCT02030535|672870|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
280495|NCT02030535|672870|P1|COMPLETED|Treatment Period 2 (1 Day)||52
280496|NCT02030535|672870|P1|STARTED|Treatment Period 2 (1 Day)||52
280497|NCT02030535|672870|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
280498|NCT02030535|672870|P1|COMPLETED|Washout Period 1 (21 Days)||52
280499|NCT02030535|672870|P1|STARTED|Washout Period 1 (21 Days)||53
280500|NCT02030535|672870|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
280501|NCT02030535|672870|P1|COMPLETED|Treatment Period 1 (1 Day)||53
280502|NCT02030535|672870|P1|STARTED|Treatment Period 1 (1 Day)||53
280503|NCT02030405|672938|P1|NOT COMPLETED|Overall Study||2
280504|NCT02030405|672938|P1|COMPLETED|Overall Study||2
280505|NCT02030405|672938|P1|STARTED|Overall Study||4
280506|NCT02030041|672946|P3|NOT COMPLETED|Overall Study||1
280507|NCT02030041|672947|P2|NOT COMPLETED|Overall Study||2
280508|NCT02030041|672948|P1|NOT COMPLETED|Overall Study||2
280509|NCT02030041|672946|P3|COMPLETED|Overall Study||10
280510|NCT02030041|672947|P2|COMPLETED|Overall Study||9
280511|NCT02030041|672948|P1|COMPLETED|Overall Study||9
280512|NCT02030041|672946|P3|STARTED|Overall Study||11
280513|NCT02030041|672947|P2|STARTED|Overall Study||11
280514|NCT02030041|672948|P1|STARTED|Overall Study||11
280515|NCT02029989|672961|P2|NOT COMPLETED|Overall Study||11
280516|NCT02029989|672962|P1|NOT COMPLETED|Overall Study||16
280517|NCT02029989|672961|P2|COMPLETED|Overall Study||49
280518|NCT02029989|672962|P1|COMPLETED|Overall Study||45
280519|NCT02029989|672961|P2|STARTED|Overall Study||60
280520|NCT02029989|672962|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
280521|NCT02029911|672968|P1|NOT COMPLETED|Overall Study||0
280522|NCT02029911|672968|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
280523|NCT02029911|672968|P1|Treated|Overall Study|Treatment Completed|60
280524|NCT02029911|672968|P1|STARTED|Overall Study|Treatment Attempted|60
280525|NCT02029846|672976|P2|NOT COMPLETED|Overall Study||0
280526|NCT02029846|672977|P1|NOT COMPLETED|Overall Study||0
280527|NCT02029846|672976|P2|COMPLETED|Overall Study||0
280528|NCT02029846|672977|P1|COMPLETED|Overall Study||0
280529|NCT02029846|672976|P2|STARTED|Overall Study||0
280530|NCT02029846|672977|P1|STARTED|Overall Study||0
280531|NCT02029755|672990|P3|NOT COMPLETED|Overall Study||0
280532|NCT02029755|672991|P2|NOT COMPLETED|Overall Study||0
280533|NCT02029755|672992|P1|NOT COMPLETED|Overall Study||0
280534|NCT02029755|672990|P3|COMPLETED|Overall Study||36
280535|NCT02029755|672991|P2|COMPLETED|Overall Study||36
280536|NCT02029755|672992|P1|COMPLETED|Overall Study||36
280537|NCT02029755|672990|P3|STARTED|Overall Study||36
280538|NCT02029755|672991|P2|STARTED|Overall Study||36
280539|NCT02029755|672992|P1|STARTED|Overall Study||36
280540|NCT02029703|673005|P2|NOT COMPLETED|Overall Study||0
280541|NCT02029703|673006|P1|NOT COMPLETED|Overall Study||0
280542|NCT02029703|673005|P2|COMPLETED|Overall Study||22
280543|NCT02029703|673006|P1|COMPLETED|Overall Study||20
280544|NCT02029703|673005|P2|STARTED|Overall Study||22
280545|NCT02029703|673006|P1|STARTED|Overall Study||20
280546|NCT02029521|673014|P2|NOT COMPLETED|Overall Study||1
280547|NCT02029521|673015|P1|NOT COMPLETED|Overall Study||2
280548|NCT02029521|673014|P2|COMPLETED|Overall Study||22
280549|NCT02029521|673015|P1|COMPLETED|Overall Study||22
280550|NCT02029521|673014|P2|STARTED|Overall Study||23
280551|NCT02029521|673015|P1|STARTED|Overall Study||24
280552|NCT02029495|673100|P3|NOT COMPLETED|Overall Study||2
280553|NCT02029495|673101|P2|NOT COMPLETED|Overall Study||0
280554|NCT02029495|673102|P1|NOT COMPLETED|Overall Study||1
280555|NCT02029495|673100|P3|COMPLETED|Overall Study||159
280556|NCT02029495|673101|P2|COMPLETED|Overall Study||158
280557|NCT02029495|673102|P1|COMPLETED|Overall Study||158
280558|NCT02029495|673100|P3|STARTED|Overall Study||161
280559|NCT02029495|673101|P2|STARTED|Overall Study||158
280560|NCT02029495|673102|P1|STARTED|Overall Study||159
280561|NCT02029417|673113|P1|NOT COMPLETED|Overall Study||2
280562|NCT02029417|673113|P1|COMPLETED|Overall Study||0
280563|NCT02029417|673113|P1|STARTED|Overall Study||2
280564|NCT02029196|673120|P2|NOT COMPLETED|Overall Study||1
280565|NCT02029196|673121|P1|NOT COMPLETED|Overall Study||20
280566|NCT02029196|673120|P2|COMPLETED|Overall Study||101
280567|NCT02029196|673121|P1|COMPLETED|Overall Study||286
280568|NCT02029196|673120|P2|STARTED|Overall Study||102
280569|NCT02029196|673121|P1|STARTED|Overall Study||306
280570|NCT02028780|673141|P12|NOT COMPLETED|Follow up Phase||0
280571|NCT02028780|673142|P11|NOT COMPLETED|Follow up Phase||0
280572|NCT02028780|673143|P10|NOT COMPLETED|Follow up Phase||0
280573|NCT02028780|673144|P9|NOT COMPLETED|Follow up Phase||0
280574|NCT02028780|673145|P8|NOT COMPLETED|Follow up Phase||0
280575|NCT02028780|673146|P7|NOT COMPLETED|Follow up Phase||0
280576|NCT02028780|673147|P6|NOT COMPLETED|Follow up Phase||0
280577|NCT02028780|673148|P5|NOT COMPLETED|Follow up Phase||0
280578|NCT02028780|673149|P4|NOT COMPLETED|Follow up Phase||0
280579|NCT02028780|673150|P3|NOT COMPLETED|Follow up Phase||0
280580|NCT02028780|673151|P2|NOT COMPLETED|Follow up Phase||0
280581|NCT02028780|673152|P1|NOT COMPLETED|Follow up Phase||0
280582|NCT02028780|673141|P12|COMPLETED|Follow up Phase||9
280583|NCT02028780|673142|P11|COMPLETED|Follow up Phase||9
280584|NCT02028780|673143|P10|COMPLETED|Follow up Phase||9
280585|NCT02028780|673144|P9|COMPLETED|Follow up Phase||9
280586|NCT02028780|673145|P8|COMPLETED|Follow up Phase||3
280587|NCT02028780|673146|P7|COMPLETED|Follow up Phase||9
280588|NCT02028780|673147|P6|COMPLETED|Follow up Phase||6
280589|NCT02028780|673148|P5|COMPLETED|Follow up Phase||6
280590|NCT02028780|673149|P4|COMPLETED|Follow up Phase||6
280591|NCT02028780|673150|P3|COMPLETED|Follow up Phase||6
280592|NCT02028780|673151|P2|COMPLETED|Follow up Phase||2
280593|NCT02028780|673152|P1|COMPLETED|Follow up Phase||6
280594|NCT02028780|673141|P12|STARTED|Follow up Phase||9
280595|NCT02028780|673142|P11|STARTED|Follow up Phase||9
280596|NCT02028780|673143|P10|STARTED|Follow up Phase||9
280597|NCT02028780|673144|P9|STARTED|Follow up Phase||9
280598|NCT02028780|673145|P8|STARTED|Follow up Phase||3
280599|NCT02028780|673146|P7|STARTED|Follow up Phase||9
280600|NCT02028780|673147|P6|STARTED|Follow up Phase||6
280601|NCT02028780|673148|P5|STARTED|Follow up Phase||6
280602|NCT02028780|673149|P4|STARTED|Follow up Phase||6
280603|NCT02028780|673150|P3|STARTED|Follow up Phase||6
280604|NCT02028780|673151|P2|STARTED|Follow up Phase||2
280605|NCT02028780|673152|P1|STARTED|Follow up Phase||6
280606|NCT02028780|673141|P12|NOT COMPLETED|Observation Phase||0
280607|NCT02028780|673142|P11|NOT COMPLETED|Observation Phase||0
280608|NCT02028780|673143|P10|NOT COMPLETED|Observation Phase||0
280609|NCT02028780|673144|P9|NOT COMPLETED|Observation Phase||0
280610|NCT02028780|673145|P8|NOT COMPLETED|Observation Phase||0
280611|NCT02028780|673146|P7|NOT COMPLETED|Observation Phase||0
280612|NCT02028780|673147|P6|NOT COMPLETED|Observation Phase||0
280613|NCT02028780|673148|P5|NOT COMPLETED|Observation Phase||0
280614|NCT02028780|673149|P4|NOT COMPLETED|Observation Phase||0
280615|NCT02028780|673150|P3|NOT COMPLETED|Observation Phase||0
280616|NCT02028780|673151|P2|NOT COMPLETED|Observation Phase||0
280617|NCT02028780|673152|P1|NOT COMPLETED|Observation Phase||0
280618|NCT02028780|673141|P12|COMPLETED|Observation Phase||9
280619|NCT02028780|673142|P11|COMPLETED|Observation Phase||9
280620|NCT02028780|673143|P10|COMPLETED|Observation Phase||9
280621|NCT02028780|673144|P9|COMPLETED|Observation Phase||9
280622|NCT02028780|673145|P8|COMPLETED|Observation Phase||3
280623|NCT02028780|673146|P7|COMPLETED|Observation Phase||9
280624|NCT02028780|673147|P6|COMPLETED|Observation Phase||6
280625|NCT02028780|673148|P5|COMPLETED|Observation Phase||6
280626|NCT02028780|673149|P4|COMPLETED|Observation Phase||6
280627|NCT02028780|673150|P3|COMPLETED|Observation Phase||6
280628|NCT02028780|673151|P2|COMPLETED|Observation Phase||2
280629|NCT02028780|673152|P1|COMPLETED|Observation Phase||6
280630|NCT02028780|673141|P12|STARTED|Observation Phase||9
280631|NCT02028780|673142|P11|STARTED|Observation Phase||9
280632|NCT02028780|673143|P10|STARTED|Observation Phase||9
280633|NCT02028780|673144|P9|STARTED|Observation Phase||9
280634|NCT02028780|673145|P8|STARTED|Observation Phase||3
280635|NCT02028780|673146|P7|STARTED|Observation Phase||9
280636|NCT02028780|673147|P6|STARTED|Observation Phase||6
280637|NCT02028780|673148|P5|STARTED|Observation Phase||6
280638|NCT02028780|673149|P4|STARTED|Observation Phase||6
280639|NCT02028780|673150|P3|STARTED|Observation Phase||6
280640|NCT02028780|673151|P2|STARTED|Observation Phase||2
280641|NCT02028780|673152|P1|STARTED|Observation Phase||6
280642|NCT02028767|673217|P2|NOT COMPLETED|Treatment Period 2||0
280643|NCT02028767|673218|P1|NOT COMPLETED|Treatment Period 2||2
280644|NCT02028767|673217|P2|COMPLETED|Treatment Period 2||16
280645|NCT02028767|673218|P1|COMPLETED|Treatment Period 2||14
280646|NCT02028767|673217|P2|STARTED|Treatment Period 2||16
280647|NCT02028767|673218|P1|STARTED|Treatment Period 2||16
280648|NCT02028767|673217|P2|NOT COMPLETED|Treatment Period 1||0
280649|NCT02028767|673218|P1|NOT COMPLETED|Treatment Period 1||0
280650|NCT02028767|673217|P2|COMPLETED|Treatment Period 1||16
280651|NCT02028767|673218|P1|COMPLETED|Treatment Period 1||16
280652|NCT02028767|673217|P2|STARTED|Treatment Period 1||16
280653|NCT02028767|673218|P1|STARTED|Treatment Period 1||16
280654|NCT02028754|673230|P2|NOT COMPLETED|Overall Study||8
280655|NCT02028754|673231|P1|NOT COMPLETED|Overall Study||7
280656|NCT02028754|673230|P2|COMPLETED|Overall Study||82
280657|NCT02028754|673231|P1|COMPLETED|Overall Study||83
280658|NCT02028754|673230|P2|STARTED|Overall Study||90
280659|NCT02028754|673231|P1|STARTED|Overall Study||90
280660|NCT02028676|673258|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280661|NCT02028676|673259|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280662|NCT02028676|673260|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280663|NCT02028676|673261|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280664|NCT02028676|673262|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280665|NCT02028676|673263|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280666|NCT02028676|673264|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280667|NCT02028676|673265|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280668|NCT02028676|673266|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
280669|NCT02028676|673258|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
280670|NCT02028676|673259|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
280671|NCT02028676|673260|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280672|NCT02028676|673261|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280673|NCT02028676|673262|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280751|NCT02028676|673259|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
280674|NCT02028676|673263|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280675|NCT02028676|673264|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280676|NCT02028676|673265|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280677|NCT02028676|673266|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
280678|NCT02028676|673258|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
280679|NCT02028676|673259|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
280680|NCT02028676|673260|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
280681|NCT02028676|673261|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
280682|NCT02028676|673262|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
280683|NCT02028676|673263|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
280684|NCT02028676|673264|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
280685|NCT02028676|673265|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
280686|NCT02028676|673266|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
280687|NCT02028676|673258|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280688|NCT02028676|673259|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280689|NCT02028676|673260|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280690|NCT02028676|673261|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280691|NCT02028676|673262|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280692|NCT02028676|673263|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280693|NCT02028676|673264|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280694|NCT02028676|673265|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280695|NCT02028676|673266|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280696|NCT02028676|673258|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280697|NCT02028676|673259|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280698|NCT02028676|673260|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
280699|NCT02028676|673261|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
280700|NCT02028676|673262|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280701|NCT02028676|673263|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280702|NCT02028676|673264|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280703|NCT02028676|673265|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280704|NCT02028676|673266|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
280705|NCT02028676|673258|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280706|NCT02028676|673259|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280707|NCT02028676|673260|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
280708|NCT02028676|673261|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
280709|NCT02028676|673262|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280710|NCT02028676|673263|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280711|NCT02028676|673264|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280712|NCT02028676|673265|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280713|NCT02028676|673266|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
280714|NCT02028676|673258|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
280715|NCT02028676|673259|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
280716|NCT02028676|673260|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
280717|NCT02028676|673261|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
280718|NCT02028676|673262|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
280719|NCT02028676|673263|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
280720|NCT02028676|673264|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
280721|NCT02028676|673265|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
280722|NCT02028676|673266|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
280723|NCT02028676|673258|P9|COMPLETED|Initial Enrolment: Induction ART||0
280724|NCT02028676|673259|P8|COMPLETED|Initial Enrolment: Induction ART||0
280725|NCT02028676|673260|P7|COMPLETED|Initial Enrolment: Induction ART||0
280726|NCT02028676|673261|P6|COMPLETED|Initial Enrolment: Induction ART||0
280727|NCT02028676|673262|P5|COMPLETED|Initial Enrolment: Induction ART||405
280728|NCT02028676|673263|P4|COMPLETED|Initial Enrolment: Induction ART||404
280729|NCT02028676|673264|P3|COMPLETED|Initial Enrolment: Induction ART||397
280730|NCT02028676|673265|P2|COMPLETED|Initial Enrolment: Induction ART||0
280731|NCT02028676|673266|P1|COMPLETED|Initial Enrolment: Induction ART||0
280732|NCT02028676|673258|P9|STARTED|Initial Enrolment: Induction ART||0
280733|NCT02028676|673259|P8|STARTED|Initial Enrolment: Induction ART||0
280734|NCT02028676|673260|P7|STARTED|Initial Enrolment: Induction ART||0
280735|NCT02028676|673261|P6|STARTED|Initial Enrolment: Induction ART||0
280736|NCT02028676|673262|P5|STARTED|Initial Enrolment: Induction ART||405
280737|NCT02028676|673263|P4|STARTED|Initial Enrolment: Induction ART||404
280738|NCT02028676|673264|P3|STARTED|Initial Enrolment: Induction ART||397
280739|NCT02028676|673265|P2|STARTED|Initial Enrolment: Induction ART||0
280740|NCT02028676|673266|P1|STARTED|Initial Enrolment: Induction ART||0
280741|NCT02028676|673258|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280742|NCT02028676|673259|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280743|NCT02028676|673260|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280744|NCT02028676|673261|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280745|NCT02028676|673262|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280746|NCT02028676|673263|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280747|NCT02028676|673264|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280748|NCT02028676|673265|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280749|NCT02028676|673266|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
280750|NCT02028676|673258|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
280752|NCT02028676|673260|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
280753|NCT02028676|673261|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
280754|NCT02028676|673262|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
280755|NCT02028676|673263|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
280756|NCT02028676|673264|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
280757|NCT02028676|673265|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
280758|NCT02028676|673266|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
280759|NCT02028676|673258|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
280760|NCT02028676|673259|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
280761|NCT02028676|673260|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
280762|NCT02028676|673261|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
280763|NCT02028676|673262|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
280764|NCT02028676|673263|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
280765|NCT02028676|673264|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
280847|NCT02026141|673575|P1|NOT COMPLETED|Overall Study||0
280848|NCT02026141|673574|P2|COMPLETED|Overall Study||19
280766|NCT02028676|673265|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
280767|NCT02028676|673266|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
280768|NCT02028325|673439|P1|NOT COMPLETED|Overall Study||10
280769|NCT02028325|673439|P1|COMPLETED|Overall Study||126
280770|NCT02028325|673439|P1|STARTED|Overall Study||136
280771|NCT02028169|673443|P1|NOT COMPLETED|Overall Study||28
280772|NCT02028169|673443|P1|COMPLETED|Overall Study||92
280773|NCT02028169|673443|P1|STARTED|Overall Study||120
280774|NCT02028065|673469|P3|NOT COMPLETED|Treatment Through Study Completion||14
280775|NCT02028065|673470|P2|NOT COMPLETED|Treatment Through Study Completion||15
280776|NCT02028065|673471|P1|NOT COMPLETED|Treatment Through Study Completion||12
280777|NCT02028065|673469|P3|COMPLETED|Treatment Through Study Completion||134
280778|NCT02028065|673470|P2|COMPLETED|Treatment Through Study Completion||136
280779|NCT02028065|673471|P1|COMPLETED|Treatment Through Study Completion||64
280780|NCT02028065|673469|P3|Received Third Dose|Treatment Through Study Completion||134
280781|NCT02028065|673470|P2|Received Third Dose|Treatment Through Study Completion||136
280782|NCT02028065|673471|P1|Received Third Dose|Treatment Through Study Completion||64
280783|NCT02028065|673469|P3|Received Second Dose|Treatment Through Study Completion||138
280784|NCT02028065|673470|P2|Received Second Dose|Treatment Through Study Completion||140
280785|NCT02028065|673471|P1|Received Second Dose|Treatment Through Study Completion||69
280786|NCT02028065|673469|P3|Received First Dose|Treatment Through Study Completion||148
280787|NCT02028065|673470|P2|Received First Dose|Treatment Through Study Completion||151
280788|NCT02028065|673471|P1|Received First Dose|Treatment Through Study Completion||76
280789|NCT02028065|673469|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
280790|NCT02028065|673470|P2|STARTED|Treatment Through Study Completion||151
280791|NCT02028065|673471|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
280792|NCT02028065|673469|P3|NOT COMPLETED|Randomization Through Start Treatment||3
280793|NCT02028065|673470|P2|NOT COMPLETED|Randomization Through Start Treatment||3
280794|NCT02028065|673471|P1|NOT COMPLETED|Randomization Through Start Treatment||1
280795|NCT02028065|673469|P3|COMPLETED|Randomization Through Start Treatment||149
280796|NCT02028065|673470|P2|COMPLETED|Randomization Through Start Treatment||151
280797|NCT02028065|673471|P1|COMPLETED|Randomization Through Start Treatment||75
280798|NCT02028065|673469|P3|STARTED|Randomization Through Start Treatment|Randomized|152
280799|NCT02028065|673470|P2|STARTED|Randomization Through Start Treatment|Randomized|154
280800|NCT02028065|673471|P1|STARTED|Randomization Through Start Treatment|Randomized|76
280801|NCT02027883|673484|P2|NOT COMPLETED|Overall Study||0
280802|NCT02027883|673485|P1|NOT COMPLETED|Overall Study||0
280803|NCT02027883|673484|P2|COMPLETED|Overall Study||50
280804|NCT02027883|673485|P1|COMPLETED|Overall Study||50
280805|NCT02027883|673484|P2|STARTED|Overall Study||50
280806|NCT02027883|673485|P1|STARTED|Overall Study||50
280807|NCT02027844|673498|P3|NOT COMPLETED|Overall Study||2
280808|NCT02027844|673499|P2|NOT COMPLETED|Overall Study||6
280809|NCT02027844|673500|P1|NOT COMPLETED|Overall Study||5
280810|NCT02027844|673498|P3|COMPLETED|Overall Study||37
280811|NCT02027844|673499|P2|COMPLETED|Overall Study||33
280812|NCT02027844|673500|P1|COMPLETED|Overall Study||34
280813|NCT02027844|673498|P3|STARTED|Overall Study||39
280814|NCT02027844|673499|P2|STARTED|Overall Study||39
280815|NCT02027844|673500|P1|STARTED|Overall Study||39
280816|NCT02027402|673519|P2|NOT COMPLETED|Overall Study||1
280817|NCT02027402|673520|P1|NOT COMPLETED|Overall Study||4
280818|NCT02027402|673519|P2|COMPLETED|Overall Study||99
280819|NCT02027402|673520|P1|COMPLETED|Overall Study||94
280820|NCT02027402|673519|P2|STARTED|Overall Study||100
280821|NCT02027402|673520|P1|STARTED|Overall Study||98
280822|NCT02027311|673534|P2|NOT COMPLETED|Overall Study||2
280823|NCT02027311|673535|P1|NOT COMPLETED|Overall Study||3
280910|NCT02024386|673731|P3|COMPLETED|Overall Study||5
280824|NCT02027311|673534|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
280825|NCT02027311|673535|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
280826|NCT02027311|673534|P2|STARTED|Overall Study||35
280827|NCT02027311|673535|P1|STARTED|Overall Study||33
280828|NCT02027272|673545|P2|NOT COMPLETED|Overall Study||1
280829|NCT02027272|673546|P1|NOT COMPLETED|Overall Study||0
280830|NCT02027272|673545|P2|COMPLETED|Overall Study||0
280831|NCT02027272|673546|P1|COMPLETED|Overall Study||0
280832|NCT02027272|673545|P2|STARTED|Overall Study||1
280833|NCT02027272|673546|P1|STARTED|Overall Study||0
280834|NCT02026206|673554|P2|NOT COMPLETED|Overall Study||8
280835|NCT02026206|673555|P1|NOT COMPLETED|Overall Study||4
280836|NCT02026206|673554|P2|COMPLETED|Overall Study||36
280837|NCT02026206|673555|P1|COMPLETED|Overall Study||40
280838|NCT02026206|673554|P2|STARTED|Overall Study||44
280839|NCT02026206|673555|P1|STARTED|Overall Study||44
280840|NCT02026193|673565|P2|NOT COMPLETED|Overall Study||0
280841|NCT02026193|673566|P1|NOT COMPLETED|Overall Study||0
280842|NCT02026193|673565|P2|COMPLETED|Overall Study||8
280843|NCT02026193|673566|P1|COMPLETED|Overall Study||3
280844|NCT02026193|673565|P2|STARTED|Overall Study||8
280845|NCT02026193|673566|P1|STARTED|Overall Study||3
280846|NCT02026141|673574|P2|NOT COMPLETED|Overall Study||1
280849|NCT02026141|673575|P1|COMPLETED|Overall Study||20
280850|NCT02026141|673574|P2|STARTED|Overall Study||20
280851|NCT02026141|673575|P1|STARTED|Overall Study||20
280852|NCT02025907|673583|P2|NOT COMPLETED|Overall Study||12
280853|NCT02025907|673584|P1|NOT COMPLETED|Overall Study||27
280854|NCT02025907|673583|P2|COMPLETED|Overall Study||96
280855|NCT02025907|673584|P1|COMPLETED|Overall Study||81
280856|NCT02025907|673583|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
280857|NCT02025907|673584|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
280858|NCT02025829|673600|P2|NOT COMPLETED|Overall Study||0
280859|NCT02025829|673601|P1|NOT COMPLETED|Overall Study||0
280860|NCT02025829|673600|P2|COMPLETED|Overall Study||11
280861|NCT02025829|673601|P1|COMPLETED|Overall Study||3
280862|NCT02025829|673600|P2|STARTED|Overall Study||11
280863|NCT02025829|673601|P1|STARTED|Overall Study||3
280864|NCT02025647|673610|P1|NOT COMPLETED|Overall Study||0
280865|NCT02025647|673610|P1|COMPLETED|Overall Study||139
280866|NCT02025647|673610|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
280867|NCT02025647|673610|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
280868|NCT02025647|673610|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
280869|NCT02025647|673610|P1|Session 1 (Narrative Module)|Overall Study||139
280870|NCT02025647|673610|P1|STARTED|Overall Study||139
280871|NCT02025075|673641|P2|NOT COMPLETED|Overall Study||2
280872|NCT02025075|673642|P1|NOT COMPLETED|Overall Study||0
280873|NCT02025075|673641|P2|COMPLETED|Overall Study||19
280874|NCT02025075|673642|P1|COMPLETED|Overall Study||16
280875|NCT02025075|673641|P2|STARTED|Overall Study||21
280876|NCT02025075|673642|P1|STARTED|Overall Study||16
280877|NCT02024971|673666|P1|NOT COMPLETED|Overall Study||36
280878|NCT02024971|673666|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
280879|NCT02024971|673666|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
280880|NCT02024971|673666|P1|STARTED|Overall Study||1103
280881|NCT02024867|673675|P2|NOT COMPLETED|Overall Study||7
280882|NCT02024867|673676|P1|NOT COMPLETED|Overall Study||9
280883|NCT02024867|673675|P2|COMPLETED|Overall Study||124
280884|NCT02024867|673676|P1|COMPLETED|Overall Study||125
280885|NCT02024867|673675|P2|STARTED|Overall Study||131
280886|NCT02024867|673676|P1|STARTED|Overall Study||134
280887|NCT02024724|673694|P2|NOT COMPLETED|Overall Study||1
280888|NCT02024724|673695|P1|NOT COMPLETED|Overall Study||1
280889|NCT02024724|673694|P2|COMPLETED|Overall Study||29
280890|NCT02024724|673695|P1|COMPLETED|Overall Study||29
280891|NCT02024724|673694|P2|STARTED|Overall Study||30
280892|NCT02024724|673695|P1|STARTED|Overall Study||30
280893|NCT02024698|673701|P2|NOT COMPLETED|Second Intervention (7 Days)||0
280894|NCT02024698|673702|P1|NOT COMPLETED|Second Intervention (7 Days)||0
280895|NCT02024698|673701|P2|COMPLETED|Second Intervention (7 Days)||26
280896|NCT02024698|673702|P1|COMPLETED|Second Intervention (7 Days)||16
280897|NCT02024698|673701|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
280898|NCT02024698|673702|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
280899|NCT02024698|673701|P2|STARTED|Second Intervention (7 Days)||26
280900|NCT02024698|673702|P1|STARTED|Second Intervention (7 Days)||16
280901|NCT02024698|673701|P2|NOT COMPLETED|First Intervention (7 Days)||1
280902|NCT02024698|673702|P1|NOT COMPLETED|First Intervention (7 Days)||0
280903|NCT02024698|673701|P2|COMPLETED|First Intervention (7 Days)||26
280904|NCT02024698|673702|P1|COMPLETED|First Intervention (7 Days)||16
280905|NCT02024698|673701|P2|STARTED|First Intervention (7 Days)||27
280906|NCT02024698|673702|P1|STARTED|First Intervention (7 Days)||16
280907|NCT02024386|673731|P3|NOT COMPLETED|Overall Study||0
280908|NCT02024386|673732|P2|NOT COMPLETED|Overall Study||0
280909|NCT02024386|673733|P1|NOT COMPLETED|Overall Study||0
280911|NCT02024386|673732|P2|COMPLETED|Overall Study||11
280912|NCT02024386|673733|P1|COMPLETED|Overall Study||6
280913|NCT02024386|673731|P3|STARTED|Overall Study||5
280914|NCT02024386|673732|P2|STARTED|Overall Study||11
280915|NCT02024386|673733|P1|STARTED|Overall Study||6
280916|NCT02024165|673756|P1|NOT COMPLETED|Overall Study||0
280917|NCT02024165|673756|P1|COMPLETED|Overall Study||71
280918|NCT02024165|673756|P1|STARTED|Overall Study||71
280919|NCT02023918|673761|P1|NOT COMPLETED|Overall Study||0
280920|NCT02023918|673761|P1|COMPLETED|Overall Study||6
280921|NCT02023918|673761|P1|STARTED|Overall Study||6
280922|NCT02023879|673769|P3|NOT COMPLETED|Overall Study||9
280923|NCT02023879|673770|P2|NOT COMPLETED|Overall Study||9
280924|NCT02023879|673771|P1|NOT COMPLETED|Overall Study||4
280925|NCT02023879|673769|P3|COMPLETED|Overall Study|48 participants entered open-label extension treatment period.|50
280926|NCT02023879|673770|P2|COMPLETED|Overall Study|106 participants entered open-label extension treatment period.|107
280927|NCT02023879|673771|P1|COMPLETED|Overall Study|51 participants entered open-label extension treatment period.|54
280928|NCT02023879|673769|P3|Treated|Overall Study||58
280929|NCT02023879|673770|P2|Treated|Overall Study||115
280930|NCT02023879|673771|P1|Treated|Overall Study||58
280931|NCT02023879|673769|P3|STARTED|Overall Study||59
280932|NCT02023879|673770|P2|STARTED|Overall Study||116
280933|NCT02023879|673771|P1|STARTED|Overall Study||58
280934|NCT02023801|673854|P1|NOT COMPLETED|Overall Study||0
280935|NCT02023801|673854|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
280936|NCT02023801|673854|P1|Treated|Overall Study|Treatment Completed|24
280937|NCT02023801|673854|P1|STARTED|Overall Study|Treatment Attempted|24
280938|NCT02023268|673862|P2|NOT COMPLETED|Overall Study||4
280939|NCT02023268|673863|P1|NOT COMPLETED|Overall Study||0
280940|NCT02023268|673862|P2|COMPLETED|Overall Study||49
280941|NCT02023268|673863|P1|COMPLETED|Overall Study||52
280942|NCT02023268|673862|P2|STARTED|Overall Study||53
280943|NCT02023268|673863|P1|STARTED|Overall Study||52
280944|NCT02023125|673871|P3|NOT COMPLETED|Period 2||0
280945|NCT02023125|673872|P2|NOT COMPLETED|Period 2||0
280946|NCT02023125|673873|P1|NOT COMPLETED|Period 2||0
280947|NCT02023125|673871|P3|COMPLETED|Period 2||24
280948|NCT02023125|673872|P2|COMPLETED|Period 2||9
280949|NCT02023125|673873|P1|COMPLETED|Period 2||9
280950|NCT02023125|673871|P3|STARTED|Period 2||24
280951|NCT02023125|673872|P2|STARTED|Period 2||9
280952|NCT02023125|673873|P1|STARTED|Period 2||9
280953|NCT02023125|673871|P3|NOT COMPLETED|Washout Period||0
280954|NCT02023125|673872|P2|NOT COMPLETED|Washout Period||0
280955|NCT02023125|673873|P1|NOT COMPLETED|Washout Period||0
280956|NCT02023125|673871|P3|COMPLETED|Washout Period||24
280957|NCT02023125|673872|P2|COMPLETED|Washout Period||9
280958|NCT02023125|673873|P1|COMPLETED|Washout Period||9
280959|NCT02023125|673871|P3|STARTED|Washout Period||24
280960|NCT02023125|673872|P2|STARTED|Washout Period||9
280961|NCT02023125|673873|P1|STARTED|Washout Period||9
280962|NCT02023125|673871|P3|NOT COMPLETED|Period 1||0
280963|NCT02023125|673872|P2|NOT COMPLETED|Period 1||0
280964|NCT02023125|673873|P1|NOT COMPLETED|Period 1||0
280965|NCT02023125|673871|P3|COMPLETED|Period 1||24
280966|NCT02023125|673872|P2|COMPLETED|Period 1||9
280967|NCT02023125|673873|P1|COMPLETED|Period 1||9
280968|NCT02023125|673871|P3|STARTED|Period 1||24
280969|NCT02023125|673872|P2|STARTED|Period 1||9
280970|NCT02023125|673873|P1|STARTED|Period 1||9
280971|NCT02023112|673934|P2|NOT COMPLETED|Overall Study||1
280972|NCT02023112|673935|P1|NOT COMPLETED|Overall Study||2
280973|NCT02023112|673934|P2|COMPLETED|Overall Study||85
280974|NCT02023112|673935|P1|COMPLETED|Overall Study||83
280975|NCT02023112|673934|P2|STARTED|Overall Study||86
280976|NCT02023112|673935|P1|STARTED|Overall Study||85
280977|NCT02023099|673956|P3|NOT COMPLETED|Overall Study||3
280978|NCT02023099|673957|P2|NOT COMPLETED|Overall Study||0
280979|NCT02023099|673958|P1|NOT COMPLETED|Overall Study||3
280980|NCT02023099|673956|P3|COMPLETED|Overall Study||39
280981|NCT02023099|673957|P2|COMPLETED|Overall Study||106
280982|NCT02023099|673958|P1|COMPLETED|Overall Study||212
280983|NCT02023099|673956|P3|STARTED|Overall Study||42
280984|NCT02023099|673957|P2|STARTED|Overall Study||106
280985|NCT02023099|673958|P1|STARTED|Overall Study||215
280986|NCT02022670|673977|P3|NOT COMPLETED|Overall Study||1
280987|NCT02022670|673978|P2|NOT COMPLETED|Overall Study||0
280988|NCT02022670|673979|P1|NOT COMPLETED|Overall Study||1
280989|NCT02022670|673977|P3|COMPLETED|Overall Study||11
280990|NCT02022670|673978|P2|COMPLETED|Overall Study||10
280991|NCT02022670|673979|P1|COMPLETED|Overall Study||10
280992|NCT02022670|673977|P3|STARTED|Overall Study||12
280993|NCT02022670|673978|P2|STARTED|Overall Study||10
280994|NCT02022670|673979|P1|STARTED|Overall Study||11
280995|NCT02022085|673993|P1|NOT COMPLETED|Overall Study||1
280996|NCT02022085|673993|P1|COMPLETED|Overall Study||53
280997|NCT02022085|673993|P1|STARTED|Overall Study||54
280998|NCT02022020|674014|P1|NOT COMPLETED|Overall Study||0
280999|NCT02022020|674014|P1|COMPLETED|Overall Study||220
281000|NCT02022020|674014|P1|STARTED|Overall Study||220
281001|NCT02021461|674020|P1|NOT COMPLETED|Overall Study||0
281002|NCT02021461|674020|P1|COMPLETED|Overall Study||38
281003|NCT02021461|674020|P1|STARTED|Overall Study||38
281004|NCT02021331|674028|P2|NOT COMPLETED|Overall Study||2
281005|NCT02021331|674029|P1|NOT COMPLETED|Overall Study||0
281006|NCT02021331|674028|P2|COMPLETED|Overall Study||1
281007|NCT02021331|674029|P1|COMPLETED|Overall Study||2
281008|NCT02021331|674028|P2|STARTED|Overall Study||3
281009|NCT02021331|674029|P1|STARTED|Overall Study||2
281010|NCT02021071|674041|P2|NOT COMPLETED|Overall Study||0
281011|NCT02021071|674042|P1|NOT COMPLETED|Overall Study||0
281012|NCT02021071|674041|P2|COMPLETED|Overall Study||12
281013|NCT02021071|674042|P1|COMPLETED|Overall Study||12
281014|NCT02021071|674041|P2|STARTED|Overall Study||12
281015|NCT02021071|674042|P1|STARTED|Overall Study||12
281016|NCT02020941|674049|P1|NOT COMPLETED|Overall Study||8
281017|NCT02020941|674049|P1|COMPLETED|Overall Study||2
281018|NCT02020941|674049|P1|STARTED|Overall Study||10
281019|NCT02020863|674058|P1|NOT COMPLETED|Overall Study||5
281020|NCT02020863|674058|P1|COMPLETED|Overall Study||35
281021|NCT02020863|674058|P1|STARTED|Overall Study||40
281022|NCT02020577|674064|P2|NOT COMPLETED|Overall Study||52
281023|NCT02020577|674065|P1|NOT COMPLETED|Overall Study||3
281024|NCT02020577|674064|P2|COMPLETED|Overall Study|3 patients on treatment at cut-off date of 18Nov2015|3
281025|NCT02020577|674065|P1|COMPLETED|Overall Study||0
281026|NCT02020577|674064|P2|STARTED|Overall Study||55
281027|NCT02020577|674065|P1|STARTED|Overall Study||3
281028|NCT02020512|674075|P1|NOT COMPLETED|Overall Study||8
281029|NCT02020512|674075|P1|COMPLETED|Overall Study||79
281030|NCT02020512|674075|P1|STARTED|Overall Study||87
281031|NCT02020369|674081|P2|NOT COMPLETED|Overall Study||2
281032|NCT02020369|674082|P1|NOT COMPLETED|Overall Study||3
281033|NCT02020369|674081|P2|COMPLETED|Overall Study||11
281034|NCT02020369|674082|P1|COMPLETED|Overall Study||11
281035|NCT02020369|674081|P2|STARTED|Overall Study||13
281036|NCT02020369|674082|P1|STARTED|Overall Study||14
281037|NCT02020135|674098|P1|NOT COMPLETED|Overall Study||9
281038|NCT02020135|674098|P1|COMPLETED|Overall Study||0
281039|NCT02020135|674098|P1|STARTED|Overall Study||9
281040|NCT02020031|674110|P2|NOT COMPLETED|Overall Study||1
281041|NCT02020031|674111|P1|NOT COMPLETED|Overall Study||1
281042|NCT02020031|674110|P2|COMPLETED|Overall Study||10
281043|NCT02020031|674111|P1|COMPLETED|Overall Study||10
281044|NCT02020031|674110|P2|STARTED|Overall Study||11
281045|NCT02020031|674111|P1|STARTED|Overall Study||11
281046|NCT02019563|674121|P2|NOT COMPLETED|Overall Study||0
281047|NCT02019563|674122|P1|NOT COMPLETED|Overall Study||0
281048|NCT02019563|674121|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
281049|NCT02019563|674122|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
281050|NCT02019563|674121|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
281051|NCT02019563|674122|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
281052|NCT02019550|674138|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
281053|NCT02019550|674139|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
281054|NCT02019550|674138|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
281055|NCT02019550|674139|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
281056|NCT02019550|674138|P2|STARTED|Treatment Period 2 (4 Weeks)||50
281057|NCT02019550|674139|P1|STARTED|Treatment Period 2 (4 Weeks)||46
281058|NCT02019550|674138|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
281059|NCT02019550|674139|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
281060|NCT02019550|674138|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
281061|NCT02019550|674139|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
281062|NCT02019550|674138|P2|STARTED|Treatment Period 1 (4 Weeks)||51
281063|NCT02019550|674139|P1|STARTED|Treatment Period 1 (4 Weeks)||46
281064|NCT02018809|674181|P4|NOT COMPLETED|Overall Study||0
281065|NCT02018809|674182|P3|NOT COMPLETED|Overall Study||0
281066|NCT02018809|674183|P2|NOT COMPLETED|Overall Study||0
281067|NCT02018809|674184|P1|NOT COMPLETED|Overall Study||0
281068|NCT02018809|674181|P4|COMPLETED|Overall Study||50
281069|NCT02018809|674182|P3|COMPLETED|Overall Study||50
281070|NCT02018809|674183|P2|COMPLETED|Overall Study||50
281071|NCT02018809|674184|P1|COMPLETED|Overall Study||50
281072|NCT02018809|674181|P4|STARTED|Overall Study||50
281073|NCT02018809|674182|P3|STARTED|Overall Study||50
281074|NCT02018809|674183|P2|STARTED|Overall Study||50
281075|NCT02018809|674184|P1|STARTED|Overall Study||50
281076|NCT02017574|674196|P2|NOT COMPLETED|Overall Study||0
281077|NCT02017574|674197|P1|NOT COMPLETED|Overall Study||0
281078|NCT02017574|674196|P2|COMPLETED|Overall Study||12
281079|NCT02017574|674197|P1|COMPLETED|Overall Study||12
281080|NCT02017574|674196|P2|STARTED|Overall Study||12
281081|NCT02017574|674197|P1|STARTED|Overall Study||12
281082|NCT02017093|674207|P2|NOT COMPLETED|Overall Study||0
281083|NCT02017093|674208|P1|NOT COMPLETED|Overall Study||0
281084|NCT02017093|674207|P2|COMPLETED|Overall Study||3
281085|NCT02017093|674208|P1|COMPLETED|Overall Study||4
281086|NCT02017093|674207|P2|STARTED|Overall Study||3
281087|NCT02017093|674208|P1|STARTED|Overall Study||4
281088|NCT02017015|674216|P1|NOT COMPLETED|Overall Study||69
281089|NCT02017015|674216|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
281090|NCT02017015|674216|P1|Safety Population|Overall Study||83
281091|NCT02017015|674216|P1|STARTED|Overall Study||83
281092|NCT02016963|674223|P1|NOT COMPLETED|Overall Study||0
281093|NCT02016963|674223|P1|COMPLETED|Overall Study||20
281094|NCT02016963|674223|P1|STARTED|Overall Study||20
281095|NCT02016690|674239|P1|NOT COMPLETED|Overall Study||24
281096|NCT02016690|674239|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
281097|NCT02016690|674239|P1|Safety Analysis Set (SAS)|Overall Study||304
281098|NCT02016690|674239|P1|Treated|Overall Study||312
281099|NCT02016690|674239|P1|STARTED|Overall Study||312
281100|NCT02016625|674252|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
281101|NCT02016625|674253|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
281102|NCT02016625|674252|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
281103|NCT02016625|674253|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
281104|NCT02016625|674252|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
281105|NCT02016625|674253|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
281106|NCT02016625|674252|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
281107|NCT02016625|674253|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
281108|NCT02016625|674252|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
281109|NCT02016625|674253|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
281110|NCT02016625|674252|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
281111|NCT02016625|674253|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
281112|NCT02016482|674287|P2|NOT COMPLETED|Period B||7
281113|NCT02016482|674288|P1|NOT COMPLETED|Period B||13
281114|NCT02016482|674287|P2|COMPLETED|Period B||87
281115|NCT02016482|674288|P1|COMPLETED|Period B||81
281116|NCT02016482|674287|P2|STARTED|Period B||94
281117|NCT02016482|674288|P1|STARTED|Period B||94
281118|NCT02016482|674287|P2|NOT COMPLETED|Period A||15
281119|NCT02016482|674288|P1|NOT COMPLETED|Period A||14
281120|NCT02016482|674287|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
281121|NCT02016482|674288|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
281122|NCT02016482|674287|P2|STARTED|Period A||109
281123|NCT02016482|674288|P1|STARTED|Period A||108
281124|NCT02016170|674379|P3|NOT COMPLETED|Overall Study||0
281125|NCT02016170|674380|P2|NOT COMPLETED|Overall Study||1
281126|NCT02016170|674381|P1|NOT COMPLETED|Overall Study||2
281127|NCT02016170|674379|P3|COMPLETED|Overall Study||27
281128|NCT02016170|674380|P2|COMPLETED|Overall Study||27
281129|NCT02016170|674381|P1|COMPLETED|Overall Study||25
281130|NCT02016170|674379|P3|STARTED|Overall Study||27
281131|NCT02016170|674380|P2|STARTED|Overall Study||28
281132|NCT02016170|674381|P1|STARTED|Overall Study||27
281133|NCT02016105|674392|P6|NOT COMPLETED|EXTENSION PERIOD||6
281134|NCT02016105|674393|P5|NOT COMPLETED|EXTENSION PERIOD||6
281135|NCT02016105|674394|P4|NOT COMPLETED|EXTENSION PERIOD||5
281136|NCT02016105|674395|P3|NOT COMPLETED|EXTENSION PERIOD||5
281137|NCT02016105|674396|P2|NOT COMPLETED|EXTENSION PERIOD||0
281138|NCT02016105|674397|P1|NOT COMPLETED|EXTENSION PERIOD||0
281139|NCT02016105|674392|P6|COMPLETED|EXTENSION PERIOD||100
281140|NCT02016105|674393|P5|COMPLETED|EXTENSION PERIOD||50
281141|NCT02016105|674394|P4|COMPLETED|EXTENSION PERIOD||104
281142|NCT02016105|674395|P3|COMPLETED|EXTENSION PERIOD||47
281143|NCT02016105|674396|P2|COMPLETED|EXTENSION PERIOD||0
281144|NCT02016105|674397|P1|COMPLETED|EXTENSION PERIOD||0
281145|NCT02016105|674392|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
281146|NCT02016105|674393|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
281147|NCT02016105|674394|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
281148|NCT02016105|674395|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
281149|NCT02016105|674396|P2|STARTED|EXTENSION PERIOD||0
281150|NCT02016105|674397|P1|STARTED|EXTENSION PERIOD||0
281151|NCT02016105|674392|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
281152|NCT02016105|674393|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
281153|NCT02016105|674394|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
281154|NCT02016105|674395|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
281155|NCT02016105|674396|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
281156|NCT02016105|674397|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
281157|NCT02016105|674392|P6|COMPLETED|TREATMENT PERIOD 2||112
281158|NCT02016105|674393|P5|COMPLETED|TREATMENT PERIOD 2||59
281159|NCT02016105|674394|P4|COMPLETED|TREATMENT PERIOD 2||116
281160|NCT02016105|674395|P3|COMPLETED|TREATMENT PERIOD 2||57
281161|NCT02016105|674396|P2|COMPLETED|TREATMENT PERIOD 2||0
281162|NCT02016105|674397|P1|COMPLETED|TREATMENT PERIOD 2||0
281163|NCT02016105|674392|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
281164|NCT02016105|674393|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
281165|NCT02016105|674394|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
281166|NCT02016105|674395|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
281167|NCT02016105|674396|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
281168|NCT02016105|674397|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
281169|NCT02016105|674392|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
281170|NCT02016105|674393|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
281171|NCT02016105|674394|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
281172|NCT02016105|674395|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
281173|NCT02016105|674396|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
281174|NCT02016105|674397|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
281175|NCT02016105|674392|P6|COMPLETED|TREATMENT PERIOD 1||0
281176|NCT02016105|674393|P5|COMPLETED|TREATMENT PERIOD 1||0
281177|NCT02016105|674394|P4|COMPLETED|TREATMENT PERIOD 1||0
281178|NCT02016105|674395|P3|COMPLETED|TREATMENT PERIOD 1||0
281179|NCT02016105|674396|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
281180|NCT02016105|674397|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
281181|NCT02016105|674392|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
281182|NCT02016105|674393|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
281183|NCT02016105|674394|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
281184|NCT02016105|674395|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
281185|NCT02016105|674396|P2|STARTED|TREATMENT PERIOD 1||234
281186|NCT02016105|674397|P1|STARTED|TREATMENT PERIOD 1||231
281187|NCT02015910|674447|P2|NOT COMPLETED|Overall Study||0
281188|NCT02015910|674448|P1|NOT COMPLETED|Overall Study||0
281189|NCT02015910|674447|P2|COMPLETED|Overall Study||1
281190|NCT02015910|674448|P1|COMPLETED|Overall Study||0
281191|NCT02015910|674447|P2|STARTED|Overall Study||1
281192|NCT02015910|674448|P1|STARTED|Overall Study||0
281193|NCT02015793|674456|P2|NOT COMPLETED|Overall Study||4
281194|NCT02015793|674457|P1|NOT COMPLETED|Overall Study||4
281195|NCT02015793|674456|P2|COMPLETED|Overall Study||11
281196|NCT02015793|674457|P1|COMPLETED|Overall Study||11
281197|NCT02015793|674456|P2|Entered Open-label Extension Period|Overall Study||14
281198|NCT02015793|674457|P1|Entered Open-label Extension Period|Overall Study||13
281199|NCT02015793|674456|P2|Completed Double-Blind Period|Overall Study||14
281200|NCT02015793|674457|P1|Completed Double-Blind Period|Overall Study||14
281201|NCT02015793|674456|P2|STARTED|Overall Study||15
281202|NCT02015793|674457|P1|STARTED|Overall Study||15
281203|NCT02015676|674490|P3|NOT COMPLETED|Overall Study||3
281204|NCT02015676|674491|P2|NOT COMPLETED|Overall Study||34
281205|NCT02015676|674492|P1|NOT COMPLETED|Overall Study||9
281206|NCT02015676|674490|P3|COMPLETED|Overall Study||3
281207|NCT02015676|674491|P2|COMPLETED|Overall Study||14
281208|NCT02015676|674492|P1|COMPLETED|Overall Study||6
281209|NCT02015676|674490|P3|STARTED|Overall Study||6
281210|NCT02015676|674491|P2|STARTED|Overall Study||48
281211|NCT02015676|674492|P1|STARTED|Overall Study||15
281212|NCT02015663|674508|P2|NOT COMPLETED|Overall Study||12
281213|NCT02015663|674509|P1|NOT COMPLETED|Overall Study||15
281214|NCT02015663|674508|P2|COMPLETED|Overall Study||4
281215|NCT02015663|674509|P1|COMPLETED|Overall Study||1
281216|NCT02015663|674508|P2|STARTED|Overall Study||16
281217|NCT02015663|674509|P1|STARTED|Overall Study||16
281218|NCT02015546|674541|P3|NOT COMPLETED|Overall Study||4
281219|NCT02015546|674542|P2|NOT COMPLETED|Overall Study||2
281220|NCT02015546|674543|P1|NOT COMPLETED|Overall Study||3
281221|NCT02015546|674541|P3|COMPLETED|Overall Study||22
281222|NCT02015546|674542|P2|COMPLETED|Overall Study||19
281223|NCT02015546|674543|P1|COMPLETED|Overall Study||20
281224|NCT02015546|674541|P3|STARTED|Overall Study||26
281225|NCT02015546|674542|P2|STARTED|Overall Study||21
281226|NCT02015546|674543|P1|STARTED|Overall Study||23
281227|NCT02015221|674577|P2|NOT COMPLETED|Overall Study||6
281228|NCT02015221|674578|P1|NOT COMPLETED|Overall Study||9
281229|NCT02015221|674577|P2|COMPLETED|Overall Study||34
281230|NCT02015221|674578|P1|COMPLETED|Overall Study||32
281231|NCT02015221|674577|P2|STARTED|Overall Study||40
281232|NCT02015221|674578|P1|STARTED|Overall Study||41
281233|NCT02015195|674591|P7|NOT COMPLETED|Overall Study||0
281234|NCT02015195|674592|P6|NOT COMPLETED|Overall Study||0
281235|NCT02015195|674593|P5|NOT COMPLETED|Overall Study||0
281236|NCT02015195|674594|P4|NOT COMPLETED|Overall Study||1
281237|NCT02015195|674595|P3|NOT COMPLETED|Overall Study||0
281238|NCT02015195|674596|P2|NOT COMPLETED|Overall Study||0
281239|NCT02015195|674597|P1|NOT COMPLETED|Overall Study||0
281240|NCT02015195|674591|P7|COMPLETED|Overall Study||16
281241|NCT02015195|674592|P6|COMPLETED|Overall Study||16
281242|NCT02015195|674593|P5|COMPLETED|Overall Study||16
281243|NCT02015195|674594|P4|COMPLETED|Overall Study||0
281244|NCT02015195|674595|P3|COMPLETED|Overall Study||16
281245|NCT02015195|674596|P2|COMPLETED|Overall Study||16
281246|NCT02015195|674597|P1|COMPLETED|Overall Study||16
281247|NCT02015195|674591|P7|STARTED|Overall Study||16
281248|NCT02015195|674592|P6|STARTED|Overall Study||16
281249|NCT02015195|674593|P5|STARTED|Overall Study||16
281250|NCT02015195|674594|P4|STARTED|Overall Study||1
281251|NCT02015195|674595|P3|STARTED|Overall Study||16
281252|NCT02015195|674596|P2|STARTED|Overall Study||16
281253|NCT02015195|674597|P1|STARTED|Overall Study||16
281254|NCT02014584|674620|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281255|NCT02014584|674621|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
281256|NCT02014584|674622|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281257|NCT02014584|674623|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281258|NCT02014584|674624|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281259|NCT02014584|674625|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281260|NCT02014584|674620|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
281261|NCT02014584|674621|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
281262|NCT02014584|674622|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281263|NCT02014584|674623|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281264|NCT02014584|674624|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281265|NCT02014584|674625|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
281266|NCT02014584|674620|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
281267|NCT02014584|674621|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
281268|NCT02014584|674622|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
281269|NCT02014584|674623|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
281270|NCT02014584|674624|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
281271|NCT02014584|674625|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
281272|NCT02014584|674620|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
281273|NCT02014584|674621|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
281274|NCT02014584|674622|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
281275|NCT02014584|674623|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
281276|NCT02014584|674624|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
281277|NCT02014584|674625|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
281278|NCT02014584|674620|P6|COMPLETED|Open-Label Period (24 Weeks)||0
281279|NCT02014584|674621|P5|COMPLETED|Open-Label Period (24 Weeks)||0
281280|NCT02014584|674622|P4|COMPLETED|Open-Label Period (24 Weeks)||47
281281|NCT02014584|674623|P3|COMPLETED|Open-Label Period (24 Weeks)||44
281282|NCT02014584|674624|P2|COMPLETED|Open-Label Period (24 Weeks)||0
281283|NCT02014584|674625|P1|COMPLETED|Open-Label Period (24 Weeks)||0
281284|NCT02014584|674620|P6|STARTED|Open-Label Period (24 Weeks)||0
281285|NCT02014584|674621|P5|STARTED|Open-Label Period (24 Weeks)||0
281286|NCT02014584|674622|P4|STARTED|Open-Label Period (24 Weeks)||48
281287|NCT02014584|674623|P3|STARTED|Open-Label Period (24 Weeks)||49
281288|NCT02014584|674624|P2|STARTED|Open-Label Period (24 Weeks)||0
281289|NCT02014584|674625|P1|STARTED|Open-Label Period (24 Weeks)||0
281290|NCT02014584|674620|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
281291|NCT02014584|674621|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
281292|NCT02014584|674622|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
281293|NCT02014584|674623|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
281294|NCT02014584|674624|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
281295|NCT02014584|674625|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
281296|NCT02014584|674620|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
281297|NCT02014584|674621|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
281298|NCT02014584|674622|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
281299|NCT02014584|674623|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
281300|NCT02014584|674624|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
281301|NCT02014584|674625|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
281302|NCT02014584|674620|P6|STARTED|Double-Blind Period (24 Weeks)||0
281303|NCT02014584|674621|P5|STARTED|Double-Blind Period (24 Weeks)||0
281304|NCT02014584|674622|P4|STARTED|Double-Blind Period (24 Weeks)||0
281305|NCT02014584|674623|P3|STARTED|Double-Blind Period (24 Weeks)||0
281306|NCT02014584|674624|P2|STARTED|Double-Blind Period (24 Weeks)||58
281307|NCT02014584|674625|P1|STARTED|Double-Blind Period (24 Weeks)||59
281308|NCT02014480|674742|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
281309|NCT02014480|674743|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
281310|NCT02014480|674744|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
281311|NCT02014480|674745|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
281312|NCT02014480|674746|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
281313|NCT02014480|674747|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
281314|NCT02014480|674742|P6|COMPLETED|Treatment Period 3 (14 Days)||32
281315|NCT02014480|674743|P5|COMPLETED|Treatment Period 3 (14 Days)||34
281316|NCT02014480|674744|P4|COMPLETED|Treatment Period 3 (14 Days)||31
281317|NCT02014480|674745|P3|COMPLETED|Treatment Period 3 (14 Days)||29
281318|NCT02014480|674746|P2|COMPLETED|Treatment Period 3 (14 Days)||32
281319|NCT02014480|674747|P1|COMPLETED|Treatment Period 3 (14 Days)||34
281320|NCT02014480|674742|P6|STARTED|Treatment Period 3 (14 Days)||34
281321|NCT02014480|674743|P5|STARTED|Treatment Period 3 (14 Days)||34
281322|NCT02014480|674744|P4|STARTED|Treatment Period 3 (14 Days)||31
281323|NCT02014480|674745|P3|STARTED|Treatment Period 3 (14 Days)||30
281324|NCT02014480|674746|P2|STARTED|Treatment Period 3 (14 Days)||33
281325|NCT02014480|674747|P1|STARTED|Treatment Period 3 (14 Days)||34
281326|NCT02014480|674742|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
281327|NCT02014480|674743|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
281328|NCT02014480|674744|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
281329|NCT02014480|674745|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
281330|NCT02014480|674746|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
281331|NCT02014480|674747|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
281332|NCT02014480|674742|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
281333|NCT02014480|674743|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
281334|NCT02014480|674744|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
281335|NCT02014480|674745|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
281336|NCT02014480|674746|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
281337|NCT02014480|674747|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
281338|NCT02014480|674742|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
281339|NCT02014480|674743|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
281340|NCT02014480|674744|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
281341|NCT02014480|674745|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
281342|NCT02014480|674746|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
281343|NCT02014480|674747|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
281344|NCT02014480|674742|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
281345|NCT02014480|674743|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
281346|NCT02014480|674744|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
281347|NCT02014480|674745|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
281348|NCT02014480|674746|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
281349|NCT02014480|674747|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
281350|NCT02014480|674742|P6|COMPLETED|Treatment Period 2 (14 Days)||34
281351|NCT02014480|674743|P5|COMPLETED|Treatment Period 2 (14 Days)||34
281352|NCT02014480|674744|P4|COMPLETED|Treatment Period 2 (14 Days)||31
281353|NCT02014480|674745|P3|COMPLETED|Treatment Period 2 (14 Days)||30
281354|NCT02014480|674746|P2|COMPLETED|Treatment Period 2 (14 Days)||33
281355|NCT02014480|674747|P1|COMPLETED|Treatment Period 2 (14 Days)||34
281356|NCT02014480|674742|P6|STARTED|Treatment Period 2 (14 Days)||34
281357|NCT02014480|674743|P5|STARTED|Treatment Period 2 (14 Days)||34
281358|NCT02014480|674744|P4|STARTED|Treatment Period 2 (14 Days)||32
281359|NCT02014480|674745|P3|STARTED|Treatment Period 2 (14 Days)||32
281360|NCT02014480|674746|P2|STARTED|Treatment Period 2 (14 Days)||34
281361|NCT02014480|674747|P1|STARTED|Treatment Period 2 (14 Days)||35
281362|NCT02014480|674742|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
281363|NCT02014480|674743|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
281364|NCT02014480|674744|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
281365|NCT02014480|674745|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
281366|NCT02014480|674746|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
281367|NCT02014480|674747|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
281368|NCT02014480|674742|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
281369|NCT02014480|674743|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
281370|NCT02014480|674744|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
281371|NCT02014480|674745|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
281372|NCT02014480|674746|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
281373|NCT02014480|674747|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
281374|NCT02014480|674742|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
281375|NCT02014480|674743|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
281376|NCT02014480|674744|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
281377|NCT02014480|674745|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
281378|NCT02014480|674746|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
281379|NCT02014480|674747|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
281380|NCT02014480|674742|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
281381|NCT02014480|674743|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
281382|NCT02014480|674744|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
281383|NCT02014480|674745|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
281384|NCT02014480|674746|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
281385|NCT02014480|674747|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
281386|NCT02014480|674742|P6|COMPLETED|Treatment Period 1 (14 Days)||34
281387|NCT02014480|674743|P5|COMPLETED|Treatment Period 1 (14 Days)||34
281388|NCT02014480|674744|P4|COMPLETED|Treatment Period 1 (14 Days)||32
281389|NCT02014480|674745|P3|COMPLETED|Treatment Period 1 (14 Days)||33
281390|NCT02014480|674746|P2|COMPLETED|Treatment Period 1 (14 Days)||34
281391|NCT02014480|674747|P1|COMPLETED|Treatment Period 1 (14 Days)||35
281392|NCT02014480|674742|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
281393|NCT02014480|674743|P5|STARTED|Treatment Period 1 (14 Days)||35
281394|NCT02014480|674744|P4|STARTED|Treatment Period 1 (14 Days)||34
281395|NCT02014480|674745|P3|STARTED|Treatment Period 1 (14 Days)||34
281396|NCT02014480|674746|P2|STARTED|Treatment Period 1 (14 Days)||35
281397|NCT02014480|674747|P1|STARTED|Treatment Period 1 (14 Days)||35
281398|NCT02014467|674766|P2|NOT COMPLETED|Overall Study||7
281399|NCT02014467|674767|P1|NOT COMPLETED|Overall Study||25
281400|NCT02014467|674766|P2|COMPLETED|Overall Study||112
281401|NCT02014467|674767|P1|COMPLETED|Overall Study||340
281402|NCT02014467|674766|P2|STARTED|Overall Study||119
281403|NCT02014467|674767|P1|STARTED|Overall Study||365
281404|NCT02014441|674827|P1|NOT COMPLETED|Overall Study||30
281405|NCT02014441|674827|P1|COMPLETED|Overall Study||31
281406|NCT02014441|674827|P1|Received Treatment|Overall Study||60
281407|NCT02014441|674827|P1|STARTED|Overall Study||61
281408|NCT02014402|674923|P4|NOT COMPLETED|Overall Study||3
281409|NCT02014402|674924|P3|NOT COMPLETED|Overall Study||3
281410|NCT02014402|674925|P2|NOT COMPLETED|Overall Study||3
281411|NCT02014402|674926|P1|NOT COMPLETED|Overall Study||2
281412|NCT02014402|674923|P4|COMPLETED|Overall Study||82
281413|NCT02014402|674924|P3|COMPLETED|Overall Study||32
281414|NCT02014402|674925|P2|COMPLETED|Overall Study||27
281415|NCT02014402|674926|P1|COMPLETED|Overall Study||29
281416|NCT02014402|674923|P4|Bovine Thrombin|Overall Study||28
281417|NCT02014402|674924|P3|Bovine Thrombin|Overall Study||12
281418|NCT02014402|674925|P2|Bovine Thrombin|Overall Study||10
281419|NCT02014402|674926|P1|Bovine Thrombin|Overall Study||11
281420|NCT02014402|674923|P4|Human Thrombin|Overall Study||57
281421|NCT02014402|674924|P3|Human Thrombin|Overall Study||23
281422|NCT02014402|674925|P2|Human Thrombin|Overall Study||20
281423|NCT02014402|674926|P1|Human Thrombin|Overall Study||20
281424|NCT02014402|674923|P4|STARTED|Overall Study||85
281425|NCT02014402|674924|P3|STARTED|Overall Study||35
281426|NCT02014402|674925|P2|STARTED|Overall Study||30
281427|NCT02014402|674926|P1|STARTED|Overall Study||31
281428|NCT02014363|674956|P3|NOT COMPLETED|Overall Study||24
281429|NCT02014363|674957|P2|NOT COMPLETED|Overall Study||19
281430|NCT02014363|674958|P1|NOT COMPLETED|Overall Study||17
281431|NCT02014363|674956|P3|COMPLETED|Overall Study||31
281432|NCT02014363|674957|P2|COMPLETED|Overall Study||35
281433|NCT02014363|674958|P1|COMPLETED|Overall Study||38
281434|NCT02014363|674956|P3|STARTED|Overall Study||55
281435|NCT02014363|674957|P2|STARTED|Overall Study||54
281436|NCT02014363|674958|P1|STARTED|Overall Study||55
281437|NCT02014272|674966|P2|NOT COMPLETED|Intervention Period 2||0
281438|NCT02014272|674967|P1|NOT COMPLETED|Intervention Period 2||0
281439|NCT02014272|674966|P2|COMPLETED|Intervention Period 2||13
281440|NCT02014272|674967|P1|COMPLETED|Intervention Period 2||13
281441|NCT02014272|674966|P2|STARTED|Intervention Period 2||13
281442|NCT02014272|674967|P1|STARTED|Intervention Period 2||13
281443|NCT02014272|674966|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
281444|NCT02014272|674967|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
281445|NCT02014272|674966|P2|COMPLETED|Washout Period 1 (7 Days)||13
281446|NCT02014272|674967|P1|COMPLETED|Washout Period 1 (7 Days)||13
281447|NCT02014272|674966|P2|STARTED|Washout Period 1 (7 Days)||13
281448|NCT02014272|674967|P1|STARTED|Washout Period 1 (7 Days)||13
281449|NCT02014272|674966|P2|NOT COMPLETED|Intervention Period 1||1
281450|NCT02014272|674967|P1|NOT COMPLETED|Intervention Period 1||1
281451|NCT02014272|674966|P2|COMPLETED|Intervention Period 1||13
281452|NCT02014272|674967|P1|COMPLETED|Intervention Period 1||13
281453|NCT02014272|674966|P2|STARTED|Intervention Period 1||14
281454|NCT02014272|674967|P1|STARTED|Intervention Period 1||14
281455|NCT02014051|674985|P2|NOT COMPLETED|Overall Study||1
281456|NCT02014051|674986|P1|NOT COMPLETED|Overall Study||1
281457|NCT02014051|674985|P2|COMPLETED|Overall Study||5
281458|NCT02014051|674986|P1|COMPLETED|Overall Study||2
281459|NCT02014051|674985|P2|STARTED|Overall Study||6
281460|NCT02014051|674986|P1|STARTED|Overall Study||3
281461|NCT02013830|674999|P1|NOT COMPLETED|Overall Study||30
281462|NCT02013830|674999|P1|COMPLETED|Overall Study||15
281463|NCT02013830|674999|P1|STARTED|Overall Study||45
281464|NCT02013817|675010|P1|NOT COMPLETED|Overall Study||27
281465|NCT02013817|675010|P1|COMPLETED|Overall Study||16
281466|NCT02013817|675010|P1|STARTED|Overall Study||43
281467|NCT02013765|675019|P1|NOT COMPLETED|Overall Study||1
281468|NCT02013765|675019|P1|COMPLETED|Overall Study||4
281469|NCT02013765|675019|P1|STARTED|Overall Study||5
281470|NCT02013687|675033|P4|NOT COMPLETED|Overall Study||2
281471|NCT02013687|675034|P3|NOT COMPLETED|Overall Study||2
281472|NCT02013687|675035|P2|NOT COMPLETED|Overall Study||0
281473|NCT02013687|675036|P1|NOT COMPLETED|Overall Study||0
281474|NCT02013687|675033|P4|COMPLETED|Overall Study||14
281475|NCT02013687|675034|P3|COMPLETED|Overall Study||14
281476|NCT02013687|675035|P2|COMPLETED|Overall Study||6
281477|NCT02013687|675036|P1|COMPLETED|Overall Study||6
281478|NCT02013687|675033|P4|STARTED|Overall Study||16
281479|NCT02013687|675034|P3|STARTED|Overall Study||16
281480|NCT02013687|675035|P2|STARTED|Overall Study||6
281481|NCT02013687|675036|P1|STARTED|Overall Study||6
281482|NCT02013622|675066|P1|NOT COMPLETED|Overall Study||24
281483|NCT02013622|675066|P1|COMPLETED|Overall Study||25
281484|NCT02013622|675066|P1|STARTED|Overall Study||49
281485|NCT02013609|675086|P1|NOT COMPLETED|Overall Study||18
281486|NCT02013609|675086|P1|COMPLETED|Overall Study||29
281487|NCT02013609|675086|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
281488|NCT02013544|675111|P2|NOT COMPLETED|Overall Study||20
281489|NCT02013544|675112|P1|NOT COMPLETED|Overall Study||11
281490|NCT02013544|675111|P2|COMPLETED|Overall Study||356
281491|NCT02013544|675112|P1|COMPLETED|Overall Study||171
281492|NCT02013544|675111|P2|ITT Population|Overall Study||325
281493|NCT02013544|675112|P1|ITT Population|Overall Study||157
281494|NCT02013544|675111|P2|Safety Population|Overall Study||374
281495|NCT02013544|675112|P1|Safety Population|Overall Study||180
281496|NCT02013544|675111|P2|STARTED|Overall Study||376
281497|NCT02013544|675112|P1|STARTED|Overall Study||182
281498|NCT02013531|675134|P1|NOT COMPLETED|Overall Study||5
281499|NCT02013531|675134|P1|COMPLETED|Overall Study||32
281500|NCT02013531|675134|P1|STARTED|Overall Study||37
281501|NCT02013388|675164|P8|NOT COMPLETED|Overall Study||0
281502|NCT02013388|675165|P7|NOT COMPLETED|Overall Study||0
281503|NCT02013388|675166|P6|NOT COMPLETED|Overall Study||0
281504|NCT02013388|675167|P5|NOT COMPLETED|Overall Study||1
281505|NCT02013388|675168|P4|NOT COMPLETED|Overall Study||0
281506|NCT02013388|675169|P3|NOT COMPLETED|Overall Study||0
281507|NCT02013388|675170|P2|NOT COMPLETED|Overall Study||0
281508|NCT02013388|675171|P1|NOT COMPLETED|Overall Study||1
281509|NCT02013388|675164|P8|COMPLETED|Overall Study||4
281510|NCT02013388|675165|P7|COMPLETED|Overall Study||6
281511|NCT02013388|675166|P6|COMPLETED|Overall Study||6
281512|NCT02013388|675167|P5|COMPLETED|Overall Study||5
281513|NCT02013388|675168|P4|COMPLETED|Overall Study||6
281514|NCT02013388|675169|P3|COMPLETED|Overall Study||6
281515|NCT02013388|675170|P2|COMPLETED|Overall Study||6
281516|NCT02013388|675171|P1|COMPLETED|Overall Study||8
281517|NCT02013388|675164|P8|STARTED|Overall Study||4
281518|NCT02013388|675165|P7|STARTED|Overall Study||6
281519|NCT02013388|675166|P6|STARTED|Overall Study||6
281520|NCT02013388|675167|P5|STARTED|Overall Study||6
281521|NCT02013388|675168|P4|STARTED|Overall Study||6
281522|NCT02013388|675169|P3|STARTED|Overall Study||6
281523|NCT02013388|675170|P2|STARTED|Overall Study||6
281524|NCT02013388|675171|P1|STARTED|Overall Study||9
281525|NCT02013245|675209|P4|NOT COMPLETED|Overall Study||0
281526|NCT02013245|675210|P3|NOT COMPLETED|Overall Study||0
281527|NCT02013245|675211|P2|NOT COMPLETED|Overall Study||1
281528|NCT02013245|675212|P1|NOT COMPLETED|Overall Study||0
281529|NCT02013245|675209|P4|COMPLETED|Overall Study||9
281530|NCT02013245|675210|P3|COMPLETED|Overall Study||9
281531|NCT02013245|675211|P2|COMPLETED|Overall Study||8
281532|NCT02013245|675212|P1|COMPLETED|Overall Study||9
281533|NCT02013245|675209|P4|STARTED|Overall Study||9
281534|NCT02013245|675210|P3|STARTED|Overall Study||9
281535|NCT02013245|675211|P2|STARTED|Overall Study||9
281536|NCT02013245|675212|P1|STARTED|Overall Study||9
281537|NCT02013206|675228|P2|NOT COMPLETED|Overall Study||22
281538|NCT02013206|675229|P1|NOT COMPLETED|Overall Study||27
281539|NCT02013206|675228|P2|COMPLETED|Overall Study||1
281540|NCT02013206|675229|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
281541|NCT02013206|675228|P2|Received Study Drug|Overall Study||23
281542|NCT02013206|675229|P1|Received Study Drug|Overall Study||26
281543|NCT02013206|675228|P2|STARTED|Overall Study||23
281544|NCT02013206|675229|P1|STARTED|Overall Study||29
281545|NCT02012686|675251|P2|NOT COMPLETED|Overall Study||2
281546|NCT02012686|675252|P1|NOT COMPLETED|Overall Study||0
281547|NCT02012686|675251|P2|COMPLETED|Overall Study||48
281548|NCT02012686|675252|P1|COMPLETED|Overall Study||50
281549|NCT02012686|675251|P2|STARTED|Overall Study||50
281550|NCT02012686|675252|P1|STARTED|Overall Study||50
281551|NCT02012582|675268|P4|NOT COMPLETED|Overall Study||1
281552|NCT02012582|675269|P3|NOT COMPLETED|Overall Study||0
281553|NCT02012582|675270|P2|NOT COMPLETED|Overall Study||0
281554|NCT02012582|675271|P1|NOT COMPLETED|Overall Study||0
281555|NCT02012582|675268|P4|COMPLETED|Overall Study||7
281556|NCT02012582|675269|P3|COMPLETED|Overall Study||8
281557|NCT02012582|675270|P2|COMPLETED|Overall Study||8
281558|NCT02012582|675271|P1|COMPLETED|Overall Study||8
281559|NCT02012582|675268|P4|STARTED|Overall Study||8
281560|NCT02012582|675269|P3|STARTED|Overall Study||8
281561|NCT02012582|675270|P2|STARTED|Overall Study||8
281562|NCT02012582|675271|P1|STARTED|Overall Study||8
281563|NCT02012452|675299|P2|NOT COMPLETED|Overall Study||1
281564|NCT02012452|675300|P1|NOT COMPLETED|Overall Study||6
281565|NCT02012452|675299|P2|COMPLETED|Overall Study||1
281566|NCT02012452|675300|P1|COMPLETED|Overall Study||1
281567|NCT02012452|675299|P2|STARTED|Overall Study||2
281568|NCT02012452|675300|P1|STARTED|Overall Study||7
281569|NCT02012218|675313|P5|NOT COMPLETED|Overall Study||1
281570|NCT02012218|675314|P4|NOT COMPLETED|Overall Study||2
281571|NCT02012218|675315|P3|NOT COMPLETED|Overall Study||2
281572|NCT02012218|675316|P2|NOT COMPLETED|Overall Study||1
281573|NCT02012218|675317|P1|NOT COMPLETED|Overall Study||4
281574|NCT02012218|675313|P5|COMPLETED|Overall Study||5
281575|NCT02012218|675314|P4|COMPLETED|Overall Study||17
281576|NCT02012218|675315|P3|COMPLETED|Overall Study||11
281577|NCT02012218|675316|P2|COMPLETED|Overall Study||10
281578|NCT02012218|675317|P1|COMPLETED|Overall Study||8
281579|NCT02012218|675313|P5|STARTED|Overall Study||6
281580|NCT02012218|675314|P4|STARTED|Overall Study||19
281581|NCT02012218|675315|P3|STARTED|Overall Study||13
281582|NCT02012218|675316|P2|STARTED|Overall Study||11
281583|NCT02012218|675317|P1|STARTED|Overall Study||12
281584|NCT02011893|675329|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
281585|NCT02011893|675330|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
281586|NCT02011893|675331|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
281587|NCT02011893|675329|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
281588|NCT02011893|675330|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
281589|NCT02011893|675331|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
281590|NCT02011893|675329|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
281591|NCT02011893|675330|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
281592|NCT02011893|675331|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
281593|NCT02011893|675329|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
281594|NCT02011893|675330|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
281595|NCT02011893|675331|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
281596|NCT02011893|675329|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
281597|NCT02011893|675330|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
281598|NCT02011893|675331|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
281599|NCT02011893|675329|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
281600|NCT02011893|675330|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
281601|NCT02011893|675331|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
281602|NCT02011893|675329|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
281603|NCT02011893|675330|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
281604|NCT02011893|675331|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
281605|NCT02011893|675329|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
281606|NCT02011893|675330|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
281607|NCT02011893|675331|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
281696|NCT02010632|675493|P2|STARTED|Second Intervention (7 Days)||16
281608|NCT02011893|675329|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
281609|NCT02011893|675330|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
281610|NCT02011893|675331|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
281611|NCT02011893|675329|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
281612|NCT02011893|675330|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
281613|NCT02011893|675331|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
281614|NCT02011893|675329|P3|NOT COMPLETED|Enrollment to Randomization||0
281615|NCT02011893|675330|P2|NOT COMPLETED|Enrollment to Randomization||0
281616|NCT02011893|675331|P1|NOT COMPLETED|Enrollment to Randomization||73
281617|NCT02011893|675329|P3|COMPLETED|Enrollment to Randomization||0
281618|NCT02011893|675330|P2|COMPLETED|Enrollment to Randomization||0
281619|NCT02011893|675331|P1|COMPLETED|Enrollment to Randomization||100
281620|NCT02011893|675329|P3|Randomization|Enrollment to Randomization||0
281621|NCT02011893|675330|P2|Randomization|Enrollment to Randomization||0
281622|NCT02011893|675331|P1|Randomization|Enrollment to Randomization||100
281623|NCT02011893|675329|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
281624|NCT02011893|675330|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
281625|NCT02011893|675331|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
281626|NCT02011893|675329|P3|Trial Stimulation Implant|Enrollment to Randomization||0
281627|NCT02011893|675330|P2|Trial Stimulation Implant|Enrollment to Randomization||0
281628|NCT02011893|675331|P1|Trial Stimulation Implant|Enrollment to Randomization||121
281629|NCT02011893|675329|P3|Baseline|Enrollment to Randomization||0
281630|NCT02011893|675330|P2|Baseline|Enrollment to Randomization||0
281631|NCT02011893|675331|P1|Baseline|Enrollment to Randomization||141
281632|NCT02011893|675329|P3|STARTED|Enrollment to Randomization||0
281633|NCT02011893|675330|P2|STARTED|Enrollment to Randomization||0
281634|NCT02011893|675331|P1|STARTED|Enrollment to Randomization||173
281635|NCT02011516|675344|P2|NOT COMPLETED|Overall Study||2
281636|NCT02011516|675345|P1|NOT COMPLETED|Overall Study||4
281637|NCT02011516|675344|P2|COMPLETED|Overall Study||6
281638|NCT02011516|675345|P1|COMPLETED|Overall Study||4
281639|NCT02011516|675344|P2|STARTED|Overall Study||8
281640|NCT02011516|675345|P1|STARTED|Overall Study||8
281641|NCT02011490|675354|P6|NOT COMPLETED|Part 2||0
281642|NCT02011490|675355|P5|NOT COMPLETED|Part 2||0
281643|NCT02011490|675356|P4|NOT COMPLETED|Part 2||0
281644|NCT02011490|675357|P3|NOT COMPLETED|Part 2||0
281645|NCT02011490|675358|P2|NOT COMPLETED|Part 2||0
281646|NCT02011490|675359|P1|NOT COMPLETED|Part 2||0
281647|NCT02011490|675354|P6|COMPLETED|Part 2||6
281648|NCT02011490|675355|P5|COMPLETED|Part 2||6
281649|NCT02011490|675356|P4|COMPLETED|Part 2||6
281650|NCT02011490|675357|P3|COMPLETED|Part 2||0
281651|NCT02011490|675358|P2|COMPLETED|Part 2||0
281652|NCT02011490|675359|P1|COMPLETED|Part 2||0
281653|NCT02011490|675354|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
281654|NCT02011490|675355|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
281655|NCT02011490|675356|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
281656|NCT02011490|675357|P3|STARTED|Part 2||0
281657|NCT02011490|675358|P2|STARTED|Part 2||0
281658|NCT02011490|675359|P1|STARTED|Part 2||0
281659|NCT02011490|675354|P6|NOT COMPLETED|Part 1||0
281660|NCT02011490|675355|P5|NOT COMPLETED|Part 1||0
281661|NCT02011490|675356|P4|NOT COMPLETED|Part 1||0
281662|NCT02011490|675357|P3|NOT COMPLETED|Part 1||0
281663|NCT02011490|675358|P2|NOT COMPLETED|Part 1||0
281664|NCT02011490|675359|P1|NOT COMPLETED|Part 1||0
281665|NCT02011490|675354|P6|COMPLETED|Part 1||0
281666|NCT02011490|675355|P5|COMPLETED|Part 1||0
281667|NCT02011490|675356|P4|COMPLETED|Part 1||0
281668|NCT02011490|675357|P3|COMPLETED|Part 1||8
281669|NCT02011490|675358|P2|COMPLETED|Part 1||8
281670|NCT02011490|675359|P1|COMPLETED|Part 1||8
281671|NCT02011490|675354|P6|STARTED|Part 1||0
281672|NCT02011490|675355|P5|STARTED|Part 1||0
281673|NCT02011490|675356|P4|STARTED|Part 1||0
281674|NCT02011490|675357|P3|STARTED|Part 1||8
281675|NCT02011490|675358|P2|STARTED|Part 1||8
281676|NCT02011490|675359|P1|STARTED|Part 1||8
281677|NCT02011113|675445|P1|NOT COMPLETED|Overall Study||36
281678|NCT02011113|675445|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
281679|NCT02011113|675445|P1|STARTED|Overall Study||36
281680|NCT02010996|675461|P2|NOT COMPLETED|Overall Study||0
281681|NCT02010996|675462|P1|NOT COMPLETED|Overall Study||0
281682|NCT02010996|675461|P2|COMPLETED|Overall Study||36
281683|NCT02010996|675462|P1|COMPLETED|Overall Study||36
281684|NCT02010996|675461|P2|STARTED|Overall Study||36
281685|NCT02010996|675462|P1|STARTED|Overall Study||36
281686|NCT02010684|675474|P2|NOT COMPLETED|Overall Study||23
281687|NCT02010684|675475|P1|NOT COMPLETED|Overall Study||12
281688|NCT02010684|675474|P2|COMPLETED|Overall Study||59
281689|NCT02010684|675475|P1|COMPLETED|Overall Study||27
281690|NCT02010684|675474|P2|STARTED|Overall Study||82
281691|NCT02010684|675475|P1|STARTED|Overall Study||39
281692|NCT02010632|675493|P2|NOT COMPLETED|Second Intervention (7 Days)||0
281693|NCT02010632|675494|P1|NOT COMPLETED|Second Intervention (7 Days)||1
281694|NCT02010632|675493|P2|COMPLETED|Second Intervention (7 Days)||16
281695|NCT02010632|675494|P1|COMPLETED|Second Intervention (7 Days)||15
281697|NCT02010632|675494|P1|STARTED|Second Intervention (7 Days)||16
281698|NCT02010632|675493|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
281699|NCT02010632|675494|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
281700|NCT02010632|675493|P2|COMPLETED|Wash Out Period (14 Days)||16
281701|NCT02010632|675494|P1|COMPLETED|Wash Out Period (14 Days)||16
281702|NCT02010632|675493|P2|STARTED|Wash Out Period (14 Days)||16
281703|NCT02010632|675494|P1|STARTED|Wash Out Period (14 Days)||16
281704|NCT02010632|675493|P2|NOT COMPLETED|First Intervention (7 Days)||0
281705|NCT02010632|675494|P1|NOT COMPLETED|First Intervention (7 Days)||0
281706|NCT02010632|675493|P2|COMPLETED|First Intervention (7 Days)||16
281707|NCT02010632|675494|P1|COMPLETED|First Intervention (7 Days)||16
281708|NCT02010632|675493|P2|STARTED|First Intervention (7 Days)||16
281709|NCT02010632|675494|P1|STARTED|First Intervention (7 Days)||16
281710|NCT02010255|675514|P14|NOT COMPLETED|Overall Study||1
281711|NCT02010255|675515|P13|NOT COMPLETED|Overall Study||0
281712|NCT02010255|675516|P12|NOT COMPLETED|Overall Study||1
281713|NCT02010255|675517|P11|NOT COMPLETED|Overall Study||2
281714|NCT02010255|675518|P10|NOT COMPLETED|Overall Study||0
281715|NCT02010255|675519|P9|NOT COMPLETED|Overall Study||1
281716|NCT02010255|675520|P8|NOT COMPLETED|Overall Study||1
281717|NCT02010255|675521|P7|NOT COMPLETED|Overall Study||1
281718|NCT02010255|675522|P6|NOT COMPLETED|Overall Study||0
281719|NCT02010255|675523|P5|NOT COMPLETED|Overall Study||4
281720|NCT02010255|675524|P4|NOT COMPLETED|Overall Study||6
281721|NCT02010255|675525|P3|NOT COMPLETED|Overall Study||7
281722|NCT02010255|675526|P2|NOT COMPLETED|Overall Study||2
281723|NCT02010255|675527|P1|NOT COMPLETED|Overall Study||6
281724|NCT02010255|675514|P14|COMPLETED|Overall Study||2
281725|NCT02010255|675515|P13|COMPLETED|Overall Study||3
281726|NCT02010255|675516|P12|COMPLETED|Overall Study||4
281727|NCT02010255|675517|P11|COMPLETED|Overall Study||1
281728|NCT02010255|675518|P10|COMPLETED|Overall Study||23
281729|NCT02010255|675519|P9|COMPLETED|Overall Study||21
281730|NCT02010255|675520|P8|COMPLETED|Overall Study||32
281731|NCT02010255|675521|P7|COMPLETED|Overall Study||33
281732|NCT02010255|675522|P6|COMPLETED|Overall Study||49
281733|NCT02010255|675523|P5|COMPLETED|Overall Study||48
281734|NCT02010255|675524|P4|COMPLETED|Overall Study||20
281735|NCT02010255|675525|P3|COMPLETED|Overall Study||18
281736|NCT02010255|675526|P2|COMPLETED|Overall Study||26
281737|NCT02010255|675527|P1|COMPLETED|Overall Study||22
281738|NCT02010255|675514|P14|STARTED|Overall Study||3
281739|NCT02010255|675515|P13|STARTED|Overall Study||3
281740|NCT02010255|675516|P12|STARTED|Overall Study||5
281741|NCT02010255|675517|P11|STARTED|Overall Study||3
281742|NCT02010255|675518|P10|STARTED|Overall Study||23
281743|NCT02010255|675519|P9|STARTED|Overall Study||22
281744|NCT02010255|675520|P8|STARTED|Overall Study||33
281745|NCT02010255|675521|P7|STARTED|Overall Study||34
281746|NCT02010255|675522|P6|STARTED|Overall Study||49
281747|NCT02010255|675523|P5|STARTED|Overall Study||52
281748|NCT02010255|675524|P4|STARTED|Overall Study||26
281749|NCT02010255|675525|P3|STARTED|Overall Study||25
281750|NCT02010255|675526|P2|STARTED|Overall Study||28
281751|NCT02010255|675527|P1|STARTED|Overall Study||28
281752|NCT02010216|675851|P1|NOT COMPLETED|Overall Study||0
281753|NCT02010216|675851|P1|COMPLETED|Overall Study||23
281754|NCT02010216|675851|P1|STARTED|Overall Study||23
281755|NCT02009982|675859|P2|NOT COMPLETED|Overall Study||0
281756|NCT02009982|675860|P1|NOT COMPLETED|Overall Study||0
281757|NCT02009982|675859|P2|COMPLETED|Overall Study||2
281758|NCT02009982|675860|P1|COMPLETED|Overall Study||1
281759|NCT02009982|675859|P2|STARTED|Overall Study||2
281760|NCT02009982|675860|P1|STARTED|Overall Study||1
281761|NCT02009878|675871|P3|NOT COMPLETED|Overall Study||0
281762|NCT02009878|675872|P2|NOT COMPLETED|Overall Study||1
281763|NCT02009878|675873|P1|NOT COMPLETED|Overall Study||0
281764|NCT02009878|675871|P3|COMPLETED|Overall Study||9
281765|NCT02009878|675872|P2|COMPLETED|Overall Study||10
281766|NCT02009878|675873|P1|COMPLETED|Overall Study||10
281767|NCT02009878|675871|P3|STARTED|Overall Study||9
281768|NCT02009878|675872|P2|STARTED|Overall Study||11
281769|NCT02009878|675873|P1|STARTED|Overall Study||10
281770|NCT02009865|675907|P2|NOT COMPLETED|Overall Study||5
281771|NCT02009865|675908|P1|NOT COMPLETED|Overall Study||1
281772|NCT02009865|675907|P2|COMPLETED|Overall Study||76
281773|NCT02009865|675908|P1|COMPLETED|Overall Study||80
281774|NCT02009865|675907|P2|STARTED|Overall Study||81
281775|NCT02009865|675908|P1|STARTED|Overall Study||81
281776|NCT02009722|675924|P2|NOT COMPLETED|Overall Study||3
281777|NCT02009722|675925|P1|NOT COMPLETED|Overall Study||1
281778|NCT02009722|675924|P2|COMPLETED|Overall Study||40
281779|NCT02009722|675925|P1|COMPLETED|Overall Study||40
281780|NCT02009722|675924|P2|Received Intervention|Overall Study||42
281781|NCT02009722|675925|P1|Received Intervention|Overall Study||41
281782|NCT02009722|675924|P2|STARTED|Overall Study||43
281783|NCT02009722|675925|P1|STARTED|Overall Study||41
281784|NCT02009696|675949|P1|NOT COMPLETED|Overall Study||2
281785|NCT02009696|675949|P1|COMPLETED|Overall Study||219
281786|NCT02009696|675949|P1|STARTED|Overall Study||221
281787|NCT02009163|675957|P3|NOT COMPLETED|Randomized-withdrawal Period||35
281788|NCT02009163|675958|P2|NOT COMPLETED|Randomized-withdrawal Period||88
281789|NCT02009163|675959|P1|NOT COMPLETED|Randomized-withdrawal Period||0
281790|NCT02009163|675957|P3|COMPLETED|Randomized-withdrawal Period||102
281791|NCT02009163|675958|P2|COMPLETED|Randomized-withdrawal Period||50
281792|NCT02009163|675959|P1|COMPLETED|Randomized-withdrawal Period||0
281793|NCT02009163|675957|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
281794|NCT02009163|675958|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
281795|NCT02009163|675959|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
281796|NCT02009163|675957|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
281797|NCT02009163|675958|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
281798|NCT02009163|675959|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
281799|NCT02009163|675957|P3|COMPLETED|Open-label Period (Non-randomized)||0
281800|NCT02009163|675958|P2|COMPLETED|Open-label Period (Non-randomized)||0
281801|NCT02009163|675959|P1|COMPLETED|Open-label Period (Non-randomized)||275
281802|NCT02009163|675957|P3|STARTED|Open-label Period (Non-randomized)||0
281803|NCT02009163|675958|P2|STARTED|Open-label Period (Non-randomized)||0
281804|NCT02009163|675959|P1|STARTED|Open-label Period (Non-randomized)||418
281805|NCT02008942|675992|P2|NOT COMPLETED|Second Intervention||0
281806|NCT02008942|675993|P1|NOT COMPLETED|Second Intervention||1
281807|NCT02008942|675992|P2|COMPLETED|Second Intervention||30
281808|NCT02008942|675993|P1|COMPLETED|Second Intervention||25
281809|NCT02008942|675992|P2|STARTED|Second Intervention||30
281810|NCT02008942|675993|P1|STARTED|Second Intervention||26
281811|NCT02008942|675992|P2|NOT COMPLETED|First Intervention||0
281812|NCT02008942|675993|P1|NOT COMPLETED|First Intervention||0
281813|NCT02008942|675992|P2|COMPLETED|First Intervention||30
281814|NCT02008942|675993|P1|COMPLETED|First Intervention||27
281815|NCT02008942|675992|P2|STARTED|First Intervention||30
281816|NCT02008942|675993|P1|STARTED|First Intervention||27
281817|NCT02008682|676001|P2|NOT COMPLETED|Overall Study||14
281818|NCT02008682|676002|P1|NOT COMPLETED|Overall Study||27
281819|NCT02008682|676001|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
281820|NCT02008682|676002|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
281821|NCT02008682|676001|P2|Exposed|Overall Study||184
281822|NCT02008682|676002|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
281823|NCT02008682|676001|P2|STARTED|Overall Study||184
281824|NCT02008682|676002|P1|STARTED|Overall Study||184
281825|NCT02008617|676020|P2|NOT COMPLETED|Overall Study||0
281826|NCT02008617|676021|P1|NOT COMPLETED|Overall Study||0
281827|NCT02008617|676020|P2|COMPLETED|Overall Study||10
281828|NCT02008617|676021|P1|COMPLETED|Overall Study||8
281829|NCT02008617|676020|P2|STARTED|Overall Study||10
281830|NCT02008617|676021|P1|STARTED|Overall Study||8
281831|NCT02007863|676033|P1|NOT COMPLETED|Overall Study||0
281832|NCT02007863|676033|P1|COMPLETED|Overall Study||2
281833|NCT02007863|676033|P1|STARTED|Overall Study||2
281834|NCT02007577|676039|P2|NOT COMPLETED|Overall Study||1
281835|NCT02007577|676040|P1|NOT COMPLETED|Overall Study||1
281836|NCT02007577|676039|P2|COMPLETED|Overall Study||13
281837|NCT02007577|676040|P1|COMPLETED|Overall Study||26
281838|NCT02007577|676039|P2|STARTED|Overall Study||14
281839|NCT02007577|676040|P1|STARTED|Overall Study||27
281840|NCT02007434|676056|P8|NOT COMPLETED|Overall Study||0
281841|NCT02007434|676057|P7|NOT COMPLETED|Overall Study||0
281842|NCT02007434|676058|P6|NOT COMPLETED|Overall Study||0
281843|NCT02007434|676059|P5|NOT COMPLETED|Overall Study||0
281844|NCT02007434|676060|P4|NOT COMPLETED|Overall Study||0
281845|NCT02007434|676061|P3|NOT COMPLETED|Overall Study||1
281846|NCT02007434|676062|P2|NOT COMPLETED|Overall Study||1
281847|NCT02007434|676063|P1|NOT COMPLETED|Overall Study||1
281848|NCT02007434|676056|P8|COMPLETED|Overall Study||4
281849|NCT02007434|676057|P7|COMPLETED|Overall Study||18
281850|NCT02007434|676058|P6|COMPLETED|Overall Study||4
281851|NCT02007434|676059|P5|COMPLETED|Overall Study||16
281852|NCT02007434|676060|P4|COMPLETED|Overall Study||4
281853|NCT02007434|676061|P3|COMPLETED|Overall Study||16
281854|NCT02007434|676062|P2|COMPLETED|Overall Study||3
281855|NCT02007434|676063|P1|COMPLETED|Overall Study||16
281856|NCT02007434|676056|P8|Received Treatment|Overall Study||4
281857|NCT02007434|676057|P7|Received Treatment|Overall Study||18
281858|NCT02007434|676058|P6|Received Treatment|Overall Study||4
281859|NCT02007434|676059|P5|Received Treatment|Overall Study||16
281860|NCT02007434|676060|P4|Received Treatment|Overall Study||4
281861|NCT02007434|676061|P3|Received Treatment|Overall Study||17
281862|NCT02007434|676062|P2|Received Treatment|Overall Study||3
281863|NCT02007434|676063|P1|Received Treatment|Overall Study||17
281864|NCT02007434|676056|P8|STARTED|Overall Study||4
281865|NCT02007434|676057|P7|STARTED|Overall Study||18
281866|NCT02007434|676058|P6|STARTED|Overall Study||4
281867|NCT02007434|676059|P5|STARTED|Overall Study||16
281868|NCT02007434|676060|P4|STARTED|Overall Study||4
281869|NCT02007434|676061|P3|STARTED|Overall Study||17
281870|NCT02007434|676062|P2|STARTED|Overall Study||4
281871|NCT02007434|676063|P1|STARTED|Overall Study||17
281872|NCT02007369|676164|P3|NOT COMPLETED|Overall Study||0
281873|NCT02007369|676165|P2|NOT COMPLETED|Overall Study||0
281874|NCT02007369|676166|P1|NOT COMPLETED|Overall Study||0
281875|NCT02007369|676164|P3|COMPLETED|Overall Study||54
281876|NCT02007369|676165|P2|COMPLETED|Overall Study||40
281877|NCT02007369|676166|P1|COMPLETED|Overall Study||42
281878|NCT02007369|676164|P3|STARTED|Overall Study||54
281879|NCT02007369|676165|P2|STARTED|Overall Study||40
281880|NCT02007369|676166|P1|STARTED|Overall Study||42
281881|NCT02007252|676185|P2|NOT COMPLETED|Overall Study||11
281882|NCT02007252|676186|P1|NOT COMPLETED|Overall Study||11
281883|NCT02007252|676185|P2|COMPLETED|Overall Study||22
281884|NCT02007252|676186|P1|COMPLETED|Overall Study||20
281885|NCT02007252|676185|P2|Pharmacodynamic Analysis Set|Overall Study||33
281886|NCT02007252|676186|P1|Pharmacodynamic Analysis Set|Overall Study||31
281887|NCT02007252|676185|P2|Safety Analysis Set|Overall Study||33
281888|NCT02007252|676186|P1|Safety Analysis Set|Overall Study||31
281889|NCT02007252|676185|P2|STARTED|Overall Study||33
281890|NCT02007252|676186|P1|STARTED|Overall Study||31
281891|NCT02007200|676192|P1|NOT COMPLETED|Overall Study||0
281892|NCT02007200|676192|P1|COMPLETED|Overall Study||55
281893|NCT02007200|676192|P1|STARTED|Overall Study||55
281894|NCT02007070|676199|P1|NOT COMPLETED|Overall Study||38
281895|NCT02007070|676199|P1|COMPLETED|Overall Study||0
281896|NCT02007070|676199|P1|STARTED|Overall Study||38
281897|NCT02006836|676211|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
281898|NCT02006836|676212|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
281899|NCT02006836|676213|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
281900|NCT02006836|676211|P3|COMPLETED|Self-control Period: Month 7-month 12||19
281901|NCT02006836|676212|P2|COMPLETED|Self-control Period: Month 7-month 12||0
281902|NCT02006836|676213|P1|COMPLETED|Self-control Period: Month 7-month 12||0
281903|NCT02006836|676211|P3|STARTED|Self-control Period: Month 7-month 12||19
281904|NCT02006836|676212|P2|STARTED|Self-control Period: Month 7-month 12||0
281905|NCT02006836|676213|P1|STARTED|Self-control Period: Month 7-month 12||0
281906|NCT02006836|676211|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
281907|NCT02006836|676212|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
281908|NCT02006836|676213|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
281909|NCT02006836|676211|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
281910|NCT02006836|676212|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
281911|NCT02006836|676213|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
281912|NCT02006836|676211|P3|STARTED|Case-control Period: Month 1- Month 6||0
281913|NCT02006836|676212|P2|STARTED|Case-control Period: Month 1- Month 6||20
281914|NCT02006836|676213|P1|STARTED|Case-control Period: Month 1- Month 6||20
281915|NCT02006732|676233|P4|NOT COMPLETED|Overall Study||4
281916|NCT02006732|676234|P3|NOT COMPLETED|Overall Study||9
281917|NCT02006732|676235|P2|NOT COMPLETED|Overall Study||12
281918|NCT02006732|676236|P1|NOT COMPLETED|Overall Study||20
281919|NCT02006732|676233|P4|COMPLETED|Overall Study||198
281920|NCT02006732|676234|P3|COMPLETED|Overall Study||193
281921|NCT02006732|676235|P2|COMPLETED|Overall Study||191
281922|NCT02006732|676236|P1|COMPLETED|Overall Study||182
281923|NCT02006732|676233|P4|STARTED|Overall Study||202
281924|NCT02006732|676234|P3|STARTED|Overall Study||202
281925|NCT02006732|676235|P2|STARTED|Overall Study||203
281926|NCT02006732|676236|P1|STARTED|Overall Study||202
281927|NCT02006719|676276|P2|NOT COMPLETED|Overall Study||5
281928|NCT02006719|676277|P1|NOT COMPLETED|Overall Study||18
281929|NCT02006719|676276|P2|COMPLETED|Overall Study||80
281930|NCT02006719|676277|P1|COMPLETED|Overall Study||219
281931|NCT02006719|676276|P2|STARTED|Overall Study||85
281932|NCT02006719|676277|P1|STARTED|Overall Study||237
281933|NCT02006706|676307|P1|NOT COMPLETED|Overall Study||1
281934|NCT02006706|676307|P1|COMPLETED|Overall Study||14
281935|NCT02006706|676307|P1|STARTED|Overall Study||15
281936|NCT02006667|676312|P1|NOT COMPLETED|Overall Study||6
281937|NCT02006667|676312|P1|COMPLETED|Overall Study||7
281938|NCT02006667|676312|P1|STARTED|Overall Study||13
281939|NCT02006407|676322|P1|NOT COMPLETED|Overall Study||0
281940|NCT02006407|676322|P1|COMPLETED|Overall Study||5
281941|NCT02006407|676322|P1|STARTED|Overall Study||5
281942|NCT02006342|676330|P2|NOT COMPLETED|Overall Study||0
281943|NCT02006342|676331|P1|NOT COMPLETED|Overall Study||1
281944|NCT02006342|676330|P2|COMPLETED|Overall Study||20
281945|NCT02006342|676331|P1|COMPLETED|Overall Study||19
281946|NCT02006342|676330|P2|STARTED|Overall Study||20
281947|NCT02006342|676331|P1|STARTED|Overall Study||20
281948|NCT02005692|676345|P1|NOT COMPLETED|Overall Study||7
281949|NCT02005692|676345|P1|COMPLETED|Overall Study||63
281950|NCT02005692|676345|P1|STARTED|Overall Study||70
281951|NCT02005562|676352|P2|NOT COMPLETED|Overall Study||15
281952|NCT02005562|676353|P1|NOT COMPLETED|Overall Study||12
281953|NCT02005562|676352|P2|COMPLETED|Overall Study||110
281954|NCT02005562|676353|P1|COMPLETED|Overall Study||115
281955|NCT02005562|676352|P2|Transplanted|Overall Study||121
281956|NCT02005562|676353|P1|Transplanted|Overall Study||126
281957|NCT02005562|676352|P2|STARTED|Overall Study||125
281958|NCT02005562|676353|P1|STARTED|Overall Study||127
281959|NCT02005549|676381|P1|NOT COMPLETED|Overall Study||0
281960|NCT02005549|676381|P1|COMPLETED|Overall Study||18
281961|NCT02005549|676381|P1|STARTED|Overall Study||18
281962|NCT02005536|676387|P1|NOT COMPLETED|Overall Study||0
281963|NCT02005536|676387|P1|COMPLETED|Overall Study||60
281964|NCT02005536|676387|P1|STARTED|Overall Study||60
281965|NCT02005484|676395|P1|NOT COMPLETED|Overall Study||4
281966|NCT02005484|676395|P1|COMPLETED|Overall Study||2
281967|NCT02005484|676395|P1|STARTED|Overall Study||6
281968|NCT02005393|676405|P1|NOT COMPLETED|Overall Study||0
281969|NCT02005393|676405|P1|COMPLETED|Overall Study||20
281970|NCT02005393|676405|P1|STARTED|Overall Study||20
281971|NCT02005211|676416|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281972|NCT02005211|676417|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281973|NCT02005211|676418|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
281974|NCT02005211|676419|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281975|NCT02005211|676420|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281976|NCT02005211|676421|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281977|NCT02005211|676422|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281978|NCT02005211|676416|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
281979|NCT02005211|676417|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
281980|NCT02005211|676418|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
281981|NCT02005211|676419|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281982|NCT02005211|676420|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281983|NCT02005211|676421|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281984|NCT02005211|676422|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281985|NCT02005211|676416|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
281986|NCT02005211|676417|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
281987|NCT02005211|676418|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
281988|NCT02005211|676419|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281989|NCT02005211|676420|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281990|NCT02005211|676421|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281991|NCT02005211|676422|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
281992|NCT02005211|676416|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281993|NCT02005211|676417|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281994|NCT02005211|676418|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281995|NCT02005211|676419|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281996|NCT02005211|676420|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281997|NCT02005211|676421|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281998|NCT02005211|676422|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
281999|NCT02005211|676416|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
282000|NCT02005211|676417|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
282001|NCT02005211|676418|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
282002|NCT02005211|676419|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
282003|NCT02005211|676420|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
282004|NCT02005211|676421|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
282005|NCT02005211|676422|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
282006|NCT02005211|676416|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
282007|NCT02005211|676417|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
282008|NCT02005211|676418|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
282009|NCT02005211|676419|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
282010|NCT02005211|676420|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
282011|NCT02005211|676421|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
282012|NCT02005211|676422|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
282013|NCT02005029|676457|P2|NOT COMPLETED|Second Intervention (1 Day)||0
282014|NCT02005029|676458|P1|NOT COMPLETED|Second Intervention (1 Day)||0
282015|NCT02005029|676457|P2|COMPLETED|Second Intervention (1 Day)||5
282016|NCT02005029|676458|P1|COMPLETED|Second Intervention (1 Day)||4
282017|NCT02005029|676457|P2|STARTED|Second Intervention (1 Day)||5
282018|NCT02005029|676458|P1|STARTED|Second Intervention (1 Day)||4
282019|NCT02005029|676457|P2|NOT COMPLETED|Washout (2 Weeks)||0
282020|NCT02005029|676458|P1|NOT COMPLETED|Washout (2 Weeks)||0
282021|NCT02005029|676457|P2|COMPLETED|Washout (2 Weeks)||5
282022|NCT02005029|676458|P1|COMPLETED|Washout (2 Weeks)||4
282023|NCT02005029|676457|P2|STARTED|Washout (2 Weeks)||5
282024|NCT02005029|676458|P1|STARTED|Washout (2 Weeks)||4
282025|NCT02005029|676457|P2|NOT COMPLETED|First Intervention (1 Day)||0
282026|NCT02005029|676458|P1|NOT COMPLETED|First Intervention (1 Day)||1
282027|NCT02005029|676457|P2|COMPLETED|First Intervention (1 Day)||5
282028|NCT02005029|676458|P1|COMPLETED|First Intervention (1 Day)||4
282029|NCT02005029|676457|P2|STARTED|First Intervention (1 Day)||5
282030|NCT02005029|676458|P1|STARTED|First Intervention (1 Day)||5
282031|NCT02004990|676484|P1|NOT COMPLETED|Overall Study||0
282032|NCT02004990|676484|P1|COMPLETED|Overall Study||12
282033|NCT02004990|676484|P1|STARTED|Overall Study||12
282034|NCT02004886|676493|P4|NOT COMPLETED|Overall Study||0
282035|NCT02004886|676494|P3|NOT COMPLETED|Overall Study||0
282036|NCT02004886|676495|P2|NOT COMPLETED|Overall Study||1
282037|NCT02004886|676496|P1|NOT COMPLETED|Overall Study||1
282038|NCT02004886|676493|P4|COMPLETED|Overall Study||19
282039|NCT02004886|676494|P3|COMPLETED|Overall Study||18
282040|NCT02004886|676495|P2|COMPLETED|Overall Study||17
282041|NCT02004886|676496|P1|COMPLETED|Overall Study||18
282042|NCT02004886|676493|P4|STARTED|Overall Study||19
282043|NCT02004886|676494|P3|STARTED|Overall Study||18
282044|NCT02004886|676495|P2|STARTED|Overall Study||18
282045|NCT02004886|676496|P1|STARTED|Overall Study||19
282046|NCT02004873|676546|P1|NOT COMPLETED|Overall Study||424
282047|NCT02004873|676546|P1|COMPLETED|Overall Study|6-Month Follow-up|301
282048|NCT02004873|676546|P1|Micra Implant Success|Overall Study||719
282049|NCT02004873|676546|P1|STARTED|Overall Study|Micra Implant Attempt|725
282050|NCT02004847|676555|P2|NOT COMPLETED|Overall Study||1
282051|NCT02004847|676556|P1|NOT COMPLETED|Overall Study||1
282052|NCT02004847|676555|P2|COMPLETED|Overall Study||22
282053|NCT02004847|676556|P1|COMPLETED|Overall Study||23
282054|NCT02004847|676555|P2|STARTED|Overall Study||23
282055|NCT02004847|676556|P1|STARTED|Overall Study||24
282056|NCT02004236|676603|P3|NOT COMPLETED|Overall Study||16
282057|NCT02004236|676604|P2|NOT COMPLETED|Overall Study||0
282058|NCT02004236|676605|P1|NOT COMPLETED|Overall Study||0
282059|NCT02004236|676603|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
282060|NCT02004236|676604|P2|COMPLETED|Overall Study||75
282061|NCT02004236|676605|P1|COMPLETED|Overall Study||75
282062|NCT02004236|676603|P3|STARTED|Overall Study||75
282063|NCT02004236|676604|P2|STARTED|Overall Study||75
282064|NCT02004236|676605|P1|STARTED|Overall Study||75
282065|NCT02004132|676649|P1|NOT COMPLETED|Overall Study||0
282066|NCT02004132|676649|P1|COMPLETED|Overall Study||12
282067|NCT02004132|676649|P1|Received Study Drug|Overall Study||12
282068|NCT02004132|676649|P1|STARTED|Overall Study||12
282069|NCT02004093|676657|P2|NOT COMPLETED|Overall Study||73
282070|NCT02004093|676658|P1|NOT COMPLETED|Overall Study||74
282071|NCT02004093|676657|P2|COMPLETED|Overall Study||1
282072|NCT02004093|676658|P1|COMPLETED|Overall Study||1
282073|NCT02004093|676657|P2|STARTED|Overall Study||74
282074|NCT02004093|676658|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
282075|NCT02003963|676690|P2|NOT COMPLETED|Overall Study||1
282076|NCT02003963|676691|P1|NOT COMPLETED|Overall Study||2
282077|NCT02003963|676690|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
282078|NCT02003963|676691|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
282079|NCT02003963|676690|P2|STARTED|Overall Study||19
282080|NCT02003963|676691|P1|STARTED|Overall Study||22
282081|NCT02003638|676709|P2|NOT COMPLETED|Overall Study||0
282082|NCT02003638|676710|P1|NOT COMPLETED|Overall Study||1
282083|NCT02003638|676709|P2|COMPLETED|Overall Study||3
282084|NCT02003638|676710|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
282085|NCT02003638|676709|P2|STARTED|Overall Study||3
282086|NCT02003638|676710|P1|STARTED|Overall Study||6
282087|NCT02003534|676716|P1|NOT COMPLETED|Overall Study||47
282088|NCT02003534|676716|P1|COMPLETED|Overall Study||329
282089|NCT02003534|676716|P1|STARTED|Overall Study||376
282090|NCT02003404|676720|P1|NOT COMPLETED|Overall Study||0
282091|NCT02003404|676720|P1|COMPLETED|Overall Study||17
282092|NCT02003404|676720|P1|STARTED|Overall Study||17
282093|NCT02003391|676728|P2|NOT COMPLETED|Overall Study||2
282094|NCT02003391|676729|P1|NOT COMPLETED|Overall Study||3
282095|NCT02003391|676728|P2|COMPLETED|Overall Study||73
282096|NCT02003391|676729|P1|COMPLETED|Overall Study||78
282097|NCT02003391|676728|P2|Intent to Treat Population|Overall Study||73
282098|NCT02003391|676729|P1|Intent to Treat Population|Overall Study||78
282099|NCT02003391|676728|P2|Safety Population|Overall Study||75
282100|NCT02003391|676729|P1|Safety Population|Overall Study||81
282101|NCT02003391|676728|P2|STARTED|Overall Study||75
282102|NCT02003391|676729|P1|STARTED|Overall Study||81
282103|NCT02003352|676739|P1|NOT COMPLETED|Overall Study||0
282104|NCT02003352|676739|P1|COMPLETED|Overall Study||98
282105|NCT02003352|676739|P1|STARTED|Overall Study||98
282106|NCT02003014|676743|P1|NOT COMPLETED|Overall Study||19
282107|NCT02003014|676743|P1|COMPLETED|Overall Study||880
282108|NCT02003014|676743|P1|STARTED|Overall Study||899
282109|NCT02002936|676753|P1|NOT COMPLETED|Overall Study||0
282110|NCT02002936|676753|P1|COMPLETED|Overall Study||1
282111|NCT02002936|676753|P1|STARTED|Overall Study||1
282112|NCT02002871|676762|P1|NOT COMPLETED|Overall Study||1
282113|NCT02002871|676762|P1|COMPLETED|Overall Study||20
282114|NCT02002871|676762|P1|STARTED|Overall Study||21
282115|NCT02002702|676791|P3|NOT COMPLETED|Overall Study||0
282116|NCT02002702|676792|P2|NOT COMPLETED|Overall Study||0
282117|NCT02002702|676793|P1|NOT COMPLETED|Overall Study||0
282118|NCT02002702|676791|P3|COMPLETED|Overall Study||15
282119|NCT02002702|676792|P2|COMPLETED|Overall Study||15
282120|NCT02002702|676793|P1|COMPLETED|Overall Study||16
282121|NCT02002702|676791|P3|STARTED|Overall Study||15
282122|NCT02002702|676792|P2|STARTED|Overall Study||15
282123|NCT02002702|676793|P1|STARTED|Overall Study||16
282124|NCT02002689|676825|P1|NOT COMPLETED|Overall Study||10
282125|NCT02002689|676825|P1|COMPLETED|Overall Study||0
282126|NCT02002689|676825|P1|STARTED|Overall Study||10
282127|NCT02002650|676833|P2|NOT COMPLETED|Overall Study||0
282128|NCT02002650|676834|P1|NOT COMPLETED|Overall Study||0
282129|NCT02002650|676833|P2|COMPLETED|Overall Study||1303
282130|NCT02002650|676834|P1|COMPLETED|Overall Study||1297
282131|NCT02002650|676833|P2|STARTED|Overall Study||1303
282132|NCT02002650|676834|P1|STARTED|Overall Study||1297
282133|NCT02002221|676844|P2|NOT COMPLETED|Overall Study||3
282134|NCT02002221|676845|P1|NOT COMPLETED|Overall Study||2
282135|NCT02002221|676844|P2|COMPLETED|Overall Study||75
282136|NCT02002221|676845|P1|COMPLETED|Overall Study||76
282137|NCT02002221|676844|P2|STARTED|Overall Study||78
282138|NCT02002221|676845|P1|STARTED|Overall Study||78
282139|NCT02002208|676861|P2|NOT COMPLETED|Overall Study||40
282140|NCT02002208|676862|P1|NOT COMPLETED|Overall Study||37
282141|NCT02002208|676861|P2|COMPLETED|Overall Study||30
282142|NCT02002208|676862|P1|COMPLETED|Overall Study||32
282143|NCT02002208|676861|P2|STARTED|Overall Study||70
282144|NCT02002208|676862|P1|STARTED|Overall Study||69
282145|NCT02001181|676872|P2|NOT COMPLETED|Overall Study||3
282146|NCT02001181|676873|P1|NOT COMPLETED|Overall Study||1
282147|NCT02001181|676872|P2|COMPLETED|Overall Study||31
282148|NCT02001181|676873|P1|COMPLETED|Overall Study||34
282149|NCT02001181|676872|P2|STARTED|Overall Study||34
282150|NCT02001181|676873|P1|STARTED|Overall Study||35
282151|NCT02000973|676891|P4|NOT COMPLETED|Overall Study||0
282152|NCT02000973|676892|P3|NOT COMPLETED|Overall Study||0
282153|NCT02000973|676893|P2|NOT COMPLETED|Overall Study||0
282154|NCT02000973|676894|P1|NOT COMPLETED|Overall Study||0
282155|NCT02000973|676891|P4|COMPLETED|Overall Study||20
282156|NCT02000973|676892|P3|COMPLETED|Overall Study||20
282157|NCT02000973|676893|P2|COMPLETED|Overall Study||20
282158|NCT02000973|676894|P1|COMPLETED|Overall Study||20
282159|NCT02000973|676891|P4|STARTED|Overall Study||20
282160|NCT02000973|676892|P3|STARTED|Overall Study||20
282161|NCT02000973|676893|P2|STARTED|Overall Study||20
282162|NCT02000973|676894|P1|STARTED|Overall Study||20
282163|NCT02000921|676919|P3|NOT COMPLETED|Overall Study||10
282164|NCT02000921|676920|P2|NOT COMPLETED|Overall Study||16
282165|NCT02000921|676921|P1|NOT COMPLETED|Overall Study||5
282166|NCT02000921|676919|P3|COMPLETED|Overall Study||46
282167|NCT02000921|676920|P2|COMPLETED|Overall Study||37
282168|NCT02000921|676921|P1|COMPLETED|Overall Study||22
282169|NCT02000921|676919|P3|STARTED|Overall Study||56
282170|NCT02000921|676920|P2|STARTED|Overall Study||53
282171|NCT02000921|676921|P1|STARTED|Overall Study||27
282172|NCT02000752|676940|P2|NOT COMPLETED|Overall Study||13
282173|NCT02000752|676941|P1|NOT COMPLETED|Overall Study||31
282174|NCT02000752|676940|P2|COMPLETED|Overall Study||47
282175|NCT02000752|676941|P1|COMPLETED|Overall Study||29
282176|NCT02000752|676940|P2|STARTED|Overall Study||60
282177|NCT02000752|676941|P1|STARTED|Overall Study||60
282178|NCT02000531|676955|P2|NOT COMPLETED|Overall Study||8
282179|NCT02000531|676956|P1|NOT COMPLETED|Overall Study||4
282180|NCT02000531|676955|P2|COMPLETED|Overall Study||16
282181|NCT02000531|676956|P1|COMPLETED|Overall Study||17
282182|NCT02000531|676955|P2|Safety Population|Overall Study||24
282183|NCT02000531|676956|P1|Safety Population|Overall Study||21
282184|NCT02000531|676955|P2|STARTED|Overall Study||24
282185|NCT02000531|676956|P1|STARTED|Overall Study||21
282186|NCT02000440|676964|P1|NOT COMPLETED|Overall Study||4
282187|NCT02000440|676964|P1|COMPLETED|Overall Study||13
282188|NCT02000440|676964|P1|STARTED|Overall Study||17
282189|NCT02000154|676984|P1|NOT COMPLETED|Overall Study||0
282190|NCT02000154|676984|P1|COMPLETED|Overall Study||1
282191|NCT02000154|676984|P1|STARTED|Overall Study||1
282192|NCT01999894|676992|P1|NOT COMPLETED|Overall Study||36
282193|NCT01999894|676992|P1|COMPLETED|Overall Study||66
282194|NCT01999894|676992|P1|STARTED|Overall Study||102
282195|NCT01999400|676997|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
282196|NCT01999400|676998|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
282197|NCT01999400|676999|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
282198|NCT01999400|677000|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
282199|NCT01999400|677001|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
282200|NCT01999400|677002|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
282201|NCT01999400|676997|P6|COMPLETED|Fourth Intervention (1 Day)||0
282202|NCT01999400|676998|P5|COMPLETED|Fourth Intervention (1 Day)||0
282203|NCT01999400|676999|P4|COMPLETED|Fourth Intervention (1 Day)||0
282204|NCT01999400|677000|P3|COMPLETED|Fourth Intervention (1 Day)||1
282205|NCT01999400|677001|P2|COMPLETED|Fourth Intervention (1 Day)||0
282206|NCT01999400|677002|P1|COMPLETED|Fourth Intervention (1 Day)||1
282207|NCT01999400|676997|P6|STARTED|Fourth Intervention (1 Day)||0
282208|NCT01999400|676998|P5|STARTED|Fourth Intervention (1 Day)||0
282209|NCT01999400|676999|P4|STARTED|Fourth Intervention (1 Day)||0
282210|NCT01999400|677000|P3|STARTED|Fourth Intervention (1 Day)||1
282211|NCT01999400|677001|P2|STARTED|Fourth Intervention (1 Day)||0
282212|NCT01999400|677002|P1|STARTED|Fourth Intervention (1 Day)||1
282213|NCT01999400|676997|P6|NOT COMPLETED|Washout (10 Days)||0
282214|NCT01999400|676998|P5|NOT COMPLETED|Washout (10 Days)||0
282215|NCT01999400|676999|P4|NOT COMPLETED|Washout (10 Days)||0
282216|NCT01999400|677000|P3|NOT COMPLETED|Washout (10 Days)||0
282217|NCT01999400|677001|P2|NOT COMPLETED|Washout (10 Days)||0
282218|NCT01999400|677002|P1|NOT COMPLETED|Washout (10 Days)||0
282219|NCT01999400|676997|P6|COMPLETED|Washout (10 Days)||0
282220|NCT01999400|676998|P5|COMPLETED|Washout (10 Days)||0
282221|NCT01999400|676999|P4|COMPLETED|Washout (10 Days)||0
282222|NCT01999400|677000|P3|COMPLETED|Washout (10 Days)||1
282223|NCT01999400|677001|P2|COMPLETED|Washout (10 Days)||0
282224|NCT01999400|677002|P1|COMPLETED|Washout (10 Days)||1
282225|NCT01999400|676997|P6|STARTED|Washout (10 Days)||0
282226|NCT01999400|676998|P5|STARTED|Washout (10 Days)||0
282227|NCT01999400|676999|P4|STARTED|Washout (10 Days)||0
282228|NCT01999400|677000|P3|STARTED|Washout (10 Days)||1
282229|NCT01999400|677001|P2|STARTED|Washout (10 Days)||0
282230|NCT01999400|677002|P1|STARTED|Washout (10 Days)||1
282231|NCT01999400|676997|P6|NOT COMPLETED|Third Intervention (1 Day)||1
282232|NCT01999400|676998|P5|NOT COMPLETED|Third Intervention (1 Day)||0
282233|NCT01999400|676999|P4|NOT COMPLETED|Third Intervention (1 Day)||0
282234|NCT01999400|677000|P3|NOT COMPLETED|Third Intervention (1 Day)||0
282235|NCT01999400|677001|P2|NOT COMPLETED|Third Intervention (1 Day)||0
282236|NCT01999400|677002|P1|NOT COMPLETED|Third Intervention (1 Day)||0
282237|NCT01999400|676997|P6|COMPLETED|Third Intervention (1 Day)||0
282238|NCT01999400|676998|P5|COMPLETED|Third Intervention (1 Day)||1
282239|NCT01999400|676999|P4|COMPLETED|Third Intervention (1 Day)||1
282240|NCT01999400|677000|P3|COMPLETED|Third Intervention (1 Day)||1
282241|NCT01999400|677001|P2|COMPLETED|Third Intervention (1 Day)||0
282242|NCT01999400|677002|P1|COMPLETED|Third Intervention (1 Day)||2
282243|NCT01999400|676997|P6|STARTED|Third Intervention (1 Day)||1
282244|NCT01999400|676998|P5|STARTED|Third Intervention (1 Day)||1
282245|NCT01999400|676999|P4|STARTED|Third Intervention (1 Day)||1
282246|NCT01999400|677000|P3|STARTED|Third Intervention (1 Day)||1
282247|NCT01999400|677001|P2|STARTED|Third Intervention (1 Day)||0
282248|NCT01999400|677002|P1|STARTED|Third Intervention (1 Day)||2
282249|NCT01999400|676997|P6|NOT COMPLETED|Washout (10 Days)||0
282250|NCT01999400|676998|P5|NOT COMPLETED|Washout (10 Days)||0
282251|NCT01999400|676999|P4|NOT COMPLETED|Washout (10 Days)||0
282252|NCT01999400|677000|P3|NOT COMPLETED|Washout (10 Days)||0
282253|NCT01999400|677001|P2|NOT COMPLETED|Washout (10 Days)||0
282254|NCT01999400|677002|P1|NOT COMPLETED|Washout (10 Days)||0
282255|NCT01999400|676997|P6|COMPLETED|Washout (10 Days)||1
282256|NCT01999400|676998|P5|COMPLETED|Washout (10 Days)||1
282257|NCT01999400|676999|P4|COMPLETED|Washout (10 Days)||1
282258|NCT01999400|677000|P3|COMPLETED|Washout (10 Days)||1
282259|NCT01999400|677001|P2|COMPLETED|Washout (10 Days)||0
282260|NCT01999400|677002|P1|COMPLETED|Washout (10 Days)||2
282261|NCT01999400|676997|P6|STARTED|Washout (10 Days)||1
282262|NCT01999400|676998|P5|STARTED|Washout (10 Days)||1
282263|NCT01999400|676999|P4|STARTED|Washout (10 Days)||1
282264|NCT01999400|677000|P3|STARTED|Washout (10 Days)||1
282265|NCT01999400|677001|P2|STARTED|Washout (10 Days)||0
282266|NCT01999400|677002|P1|STARTED|Washout (10 Days)||2
282267|NCT01999400|676997|P6|NOT COMPLETED|Second Intervention (1 Day)||0
282268|NCT01999400|676998|P5|NOT COMPLETED|Second Intervention (1 Day)||0
282269|NCT01999400|676999|P4|NOT COMPLETED|Second Intervention (1 Day)||0
282270|NCT01999400|677000|P3|NOT COMPLETED|Second Intervention (1 Day)||0
282271|NCT01999400|677001|P2|NOT COMPLETED|Second Intervention (1 Day)||0
282272|NCT01999400|677002|P1|NOT COMPLETED|Second Intervention (1 Day)||0
282273|NCT01999400|676997|P6|COMPLETED|Second Intervention (1 Day)||3
282274|NCT01999400|676998|P5|COMPLETED|Second Intervention (1 Day)||3
282275|NCT01999400|676999|P4|COMPLETED|Second Intervention (1 Day)||2
282276|NCT01999400|677000|P3|COMPLETED|Second Intervention (1 Day)||3
282277|NCT01999400|677001|P2|COMPLETED|Second Intervention (1 Day)||4
282278|NCT01999400|677002|P1|COMPLETED|Second Intervention (1 Day)||5
282279|NCT01999400|676997|P6|STARTED|Second Intervention (1 Day)||3
282280|NCT01999400|676998|P5|STARTED|Second Intervention (1 Day)||3
282281|NCT01999400|676999|P4|STARTED|Second Intervention (1 Day)||2
282282|NCT01999400|677000|P3|STARTED|Second Intervention (1 Day)||3
282283|NCT01999400|677001|P2|STARTED|Second Intervention (1 Day)||4
282284|NCT01999400|677002|P1|STARTED|Second Intervention (1 Day)||5
282285|NCT01999400|676997|P6|NOT COMPLETED|Washout (10 Days)||0
282286|NCT01999400|676998|P5|NOT COMPLETED|Washout (10 Days)||0
282287|NCT01999400|676999|P4|NOT COMPLETED|Washout (10 Days)||0
282288|NCT01999400|677000|P3|NOT COMPLETED|Washout (10 Days)||0
282289|NCT01999400|677001|P2|NOT COMPLETED|Washout (10 Days)||0
282290|NCT01999400|677002|P1|NOT COMPLETED|Washout (10 Days)||0
282291|NCT01999400|676997|P6|COMPLETED|Washout (10 Days)||3
282292|NCT01999400|676998|P5|COMPLETED|Washout (10 Days)||3
282293|NCT01999400|676999|P4|COMPLETED|Washout (10 Days)||2
282294|NCT01999400|677000|P3|COMPLETED|Washout (10 Days)||3
282295|NCT01999400|677001|P2|COMPLETED|Washout (10 Days)||4
282296|NCT01999400|677002|P1|COMPLETED|Washout (10 Days)||5
282297|NCT01999400|676997|P6|STARTED|Washout (10 Days)||3
282298|NCT01999400|676998|P5|STARTED|Washout (10 Days)||3
282299|NCT01999400|676999|P4|STARTED|Washout (10 Days)||2
282300|NCT01999400|677000|P3|STARTED|Washout (10 Days)||3
282301|NCT01999400|677001|P2|STARTED|Washout (10 Days)||4
282302|NCT01999400|677002|P1|STARTED|Washout (10 Days)||5
282303|NCT01999400|676997|P6|NOT COMPLETED|First Intervention (1 Day)||1
282304|NCT01999400|676998|P5|NOT COMPLETED|First Intervention (1 Day)||0
282305|NCT01999400|676999|P4|NOT COMPLETED|First Intervention (1 Day)||3
282306|NCT01999400|677000|P3|NOT COMPLETED|First Intervention (1 Day)||2
282307|NCT01999400|677001|P2|NOT COMPLETED|First Intervention (1 Day)||2
282308|NCT01999400|677002|P1|NOT COMPLETED|First Intervention (1 Day)||2
282309|NCT01999400|676997|P6|COMPLETED|First Intervention (1 Day)||3
282310|NCT01999400|676998|P5|COMPLETED|First Intervention (1 Day)||4
282311|NCT01999400|676999|P4|COMPLETED|First Intervention (1 Day)||2
282312|NCT01999400|677000|P3|COMPLETED|First Intervention (1 Day)||3
282313|NCT01999400|677001|P2|COMPLETED|First Intervention (1 Day)||4
282314|NCT01999400|677002|P1|COMPLETED|First Intervention (1 Day)||4
282315|NCT01999400|676997|P6|STARTED|First Intervention (1 Day)||4
282316|NCT01999400|676998|P5|STARTED|First Intervention (1 Day)||4
282317|NCT01999400|676999|P4|STARTED|First Intervention (1 Day)||5
282318|NCT01999400|677000|P3|STARTED|First Intervention (1 Day)||5
282319|NCT01999400|677001|P2|STARTED|First Intervention (1 Day)||6
282320|NCT01999400|677002|P1|STARTED|First Intervention (1 Day)||6
282321|NCT01999348|677022|P1|NOT COMPLETED|Overall Study||120
282322|NCT01999348|677022|P1|COMPLETED|Overall Study||1433
282323|NCT01999348|677022|P1|STARTED|Overall Study||1553
282324|NCT01999231|677036|P4|NOT COMPLETED|Overall Study||0
282325|NCT01999231|677037|P3|NOT COMPLETED|Overall Study||0
282326|NCT01999231|677038|P2|NOT COMPLETED|Overall Study||0
282327|NCT01999231|677039|P1|NOT COMPLETED|Overall Study||0
282328|NCT01999231|677036|P4|COMPLETED|Overall Study||6
282329|NCT01999231|677037|P3|COMPLETED|Overall Study||6
282330|NCT01999231|677038|P2|COMPLETED|Overall Study||6
282331|NCT01999231|677039|P1|COMPLETED|Overall Study||6
282332|NCT01999231|677036|P4|STARTED|Overall Study||6
282333|NCT01999231|677037|P3|STARTED|Overall Study||6
282334|NCT01999231|677038|P2|STARTED|Overall Study||6
282335|NCT01999231|677039|P1|STARTED|Overall Study||6
282336|NCT01998919|677071|P2|NOT COMPLETED|Overall Study||35
282337|NCT01998919|677072|P1|NOT COMPLETED|Overall Study||42
282338|NCT01998919|677071|P2|COMPLETED|Overall Study||39
282339|NCT01998919|677072|P1|COMPLETED|Overall Study||37
282340|NCT01998919|677071|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
282341|NCT01998919|677072|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
282342|NCT01998919|677071|P2|STARTED|Overall Study||74
282343|NCT01998919|677072|P1|STARTED|Overall Study||79
282344|NCT01998906|677093|P3|NOT COMPLETED|Overall Study||98
282345|NCT01998906|677094|P2|NOT COMPLETED|Overall Study||114
282346|NCT01998906|677095|P1|NOT COMPLETED|Overall Study||114
282347|NCT01998906|677093|P3|COMPLETED|Overall Study||1
282348|NCT01998906|677094|P2|COMPLETED|Overall Study||2
282349|NCT01998906|677095|P1|COMPLETED|Overall Study||1
282350|NCT01998906|677093|P3|STARTED|Overall Study||99
282351|NCT01998906|677094|P2|STARTED|Overall Study||116
282352|NCT01998906|677095|P1|STARTED|Overall Study||115
282353|NCT01998893|677139|P1|NOT COMPLETED|Overall Study||17
282354|NCT01998893|677139|P1|COMPLETED|Overall Study||21
282355|NCT01998893|677139|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
282356|NCT01998893|677139|P1|2nd Treatment Cycle Started|Overall Study||5
282357|NCT01998893|677139|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
282358|NCT01998893|677139|P1|STARTED|Overall Study||38
282359|NCT01998880|677151|P2|NOT COMPLETED|Overall Study||40
282360|NCT01998880|677152|P1|NOT COMPLETED|Overall Study||29
282361|NCT01998880|677151|P2|COMPLETED|Overall Study||78
282362|NCT01998880|677152|P1|COMPLETED|Overall Study|Completed=Completed treatment.|204
282363|NCT01998880|677151|P2|Received Study Drug|Overall Study||116
282364|NCT01998880|677152|P1|Received Study Drug|Overall Study||230
282365|NCT01998880|677151|P2|STARTED|Overall Study||118
282366|NCT01998880|677152|P1|STARTED|Overall Study||233
282367|NCT01998581|677170|P2|NOT COMPLETED|Overall Study||12
282368|NCT01998581|677171|P1|NOT COMPLETED|Overall Study||46
282369|NCT01998581|677170|P2|COMPLETED|Overall Study||44
282370|NCT01998581|677171|P1|COMPLETED|Overall Study||123
282371|NCT01998581|677170|P2|STARTED|Overall Study||56
282372|NCT01998581|677171|P1|STARTED|Overall Study||169
282373|NCT01998477|677183|P2|NOT COMPLETED|Overall Study||5
282374|NCT01998477|677184|P1|NOT COMPLETED|Overall Study||10
282375|NCT01998477|677183|P2|COMPLETED|Overall Study||143
282376|NCT01998477|677184|P1|COMPLETED|Overall Study||272
282377|NCT01998477|677183|P2|STARTED|Overall Study||148
282378|NCT01998477|677184|P1|STARTED|Overall Study||282
282379|NCT01998438|677218|P3|NOT COMPLETED|Overall Study||0
282380|NCT01998438|677219|P2|NOT COMPLETED|Overall Study||0
282381|NCT01998438|677220|P1|NOT COMPLETED|Overall Study||0
282382|NCT01998438|677218|P3|COMPLETED|Overall Study||318
282383|NCT01998438|677219|P2|COMPLETED|Overall Study||318
282384|NCT01998438|677220|P1|COMPLETED|Overall Study||319
282385|NCT01998438|677218|P3|STARTED|Overall Study||318
282386|NCT01998438|677219|P2|STARTED|Overall Study||318
282387|NCT01998438|677220|P1|STARTED|Overall Study||319
282388|NCT01998399|677230|P2|NOT COMPLETED|Overall Study||9
282389|NCT01998399|677231|P1|NOT COMPLETED|Overall Study||8
282390|NCT01998399|677230|P2|COMPLETED|Overall Study||4
282391|NCT01998399|677231|P1|COMPLETED|Overall Study||4
282392|NCT01998399|677230|P2|STARTED|Overall Study||13
282393|NCT01998399|677231|P1|STARTED|Overall Study||12
282394|NCT01998360|677239|P2|NOT COMPLETED|Overall Study||0
282395|NCT01998360|677240|P1|NOT COMPLETED|Overall Study||0
282396|NCT01998360|677239|P2|COMPLETED|Overall Study||50
282397|NCT01998360|677240|P1|COMPLETED|Overall Study||50
282398|NCT01998360|677239|P2|STARTED|Overall Study||50
282399|NCT01998360|677240|P1|STARTED|Overall Study||50
282400|NCT01998269|677254|P1|NOT COMPLETED|Overall Study||0
282401|NCT01998269|677254|P1|COMPLETED|Overall Study||193
282402|NCT01998269|677254|P1|STARTED|Overall Study||193
282403|NCT01997905|677258|P1|NOT COMPLETED|Overall Study||3
282404|NCT01997905|677258|P1|COMPLETED|Overall Study||10
282405|NCT01997905|677258|P1|Baseline Completed|Overall Study||11
282406|NCT01997905|677258|P1|STARTED|Overall Study||13
282407|NCT01997892|677267|P1|NOT COMPLETED|Overall Study||68
282408|NCT01997892|677267|P1|COMPLETED|Overall Study||959
282409|NCT01997892|677267|P1|Received Darbepoetin Alfa|Overall Study||987
282410|NCT01997892|677267|P1|STARTED|Overall Study||1027
282411|NCT01997723|677279|P1|NOT COMPLETED|Overall Study||0
282412|NCT01997723|677279|P1|COMPLETED|Overall Study||75
282413|NCT01997723|677279|P1|STARTED|Overall Study||75
282414|NCT01997567|677287|P2|NOT COMPLETED|Overall Study||0
282415|NCT01997567|677288|P1|NOT COMPLETED|Overall Study||0
282416|NCT01997567|677287|P2|COMPLETED|Overall Study||0
282417|NCT01997567|677288|P1|COMPLETED|Overall Study||0
282418|NCT01997567|677287|P2|STARTED|Overall Study||0
282419|NCT01997567|677288|P1|STARTED|Overall Study||0
282420|NCT01997437|677294|P1|NOT COMPLETED|Overall Study||0
282421|NCT01997437|677294|P1|COMPLETED|Overall Study||6
282422|NCT01997437|677294|P1|STARTED|Overall Study||6
282423|NCT01997411|677306|P8|NOT COMPLETED|Overall Study||0
282424|NCT01997411|677307|P7|NOT COMPLETED|Overall Study||0
282425|NCT01997411|677308|P6|NOT COMPLETED|Overall Study||1
282426|NCT01997411|677309|P5|NOT COMPLETED|Overall Study||0
282427|NCT01997411|677310|P4|NOT COMPLETED|Overall Study||0
282428|NCT01997411|677311|P3|NOT COMPLETED|Overall Study||0
282429|NCT01997411|677312|P2|NOT COMPLETED|Overall Study||0
282430|NCT01997411|677313|P1|NOT COMPLETED|Overall Study||0
282431|NCT01997411|677306|P8|COMPLETED|Overall Study||6
282432|NCT01997411|677307|P7|COMPLETED|Overall Study||6
282433|NCT01997411|677308|P6|COMPLETED|Overall Study||5
282434|NCT01997411|677309|P5|COMPLETED|Overall Study||6
282435|NCT01997411|677310|P4|COMPLETED|Overall Study||6
282436|NCT01997411|677311|P3|COMPLETED|Overall Study||6
282437|NCT01997411|677312|P2|COMPLETED|Overall Study||6
282438|NCT01997411|677313|P1|COMPLETED|Overall Study||6
282439|NCT01997411|677306|P8|STARTED|Overall Study||6
282440|NCT01997411|677307|P7|STARTED|Overall Study||6
282441|NCT01997411|677308|P6|STARTED|Overall Study||6
282442|NCT01997411|677309|P5|STARTED|Overall Study||6
282443|NCT01997411|677310|P4|STARTED|Overall Study||6
282444|NCT01997411|677311|P3|STARTED|Overall Study||6
282445|NCT01997411|677312|P2|STARTED|Overall Study||6
282446|NCT01997411|677313|P1|STARTED|Overall Study||6
282447|NCT01997398|677403|P1|NOT COMPLETED|Overall Study||1
282448|NCT01997398|677403|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
282449|NCT01997398|677403|P1|STARTED|Overall Study||35
282450|NCT01997216|677412|P2|NOT COMPLETED|Second 9 Hours||0
282451|NCT01997216|677413|P1|NOT COMPLETED|Second 9 Hours||0
282452|NCT01997216|677412|P2|COMPLETED|Second 9 Hours||21
282453|NCT01997216|677413|P1|COMPLETED|Second 9 Hours||19
282454|NCT01997216|677412|P2|STARTED|Second 9 Hours||21
282455|NCT01997216|677413|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
282456|NCT01997216|677412|P2|NOT COMPLETED|First 9 Hours||0
282457|NCT01997216|677413|P1|NOT COMPLETED|First 9 Hours||0
282458|NCT01997216|677412|P2|COMPLETED|First 9 Hours||21
282459|NCT01997216|677413|P1|COMPLETED|First 9 Hours||18
282460|NCT01997216|677412|P2|STARTED|First 9 Hours||21
282461|NCT01997216|677413|P1|STARTED|First 9 Hours||18
282462|NCT01996904|677425|P2|NOT COMPLETED|Overall Study||27
282463|NCT01996904|677426|P1|NOT COMPLETED|Overall Study||38
282464|NCT01996904|677425|P2|COMPLETED|Overall Study||90
282465|NCT01996904|677426|P1|COMPLETED|Overall Study||101
282466|NCT01996904|677425|P2|STARTED|Overall Study||117
282467|NCT01996904|677426|P1|STARTED|Overall Study||139
282468|NCT01996813|677432|P1|NOT COMPLETED|Overall Study||0
282469|NCT01996813|677432|P1|COMPLETED|Overall Study||23
282470|NCT01996813|677432|P1|STARTED|Overall Study||23
282471|NCT01996748|677439|P2|NOT COMPLETED|Overall Study||6
282472|NCT01996748|677440|P1|NOT COMPLETED|Overall Study||8
282473|NCT01996748|677439|P2|COMPLETED|Overall Study||63
282474|NCT01996748|677440|P1|COMPLETED|Overall Study||58
282475|NCT01996748|677439|P2|STARTED|Overall Study||69
282476|NCT01996748|677440|P1|STARTED|Overall Study||66
282477|NCT01996709|677454|P2|NOT COMPLETED|Overall Study||1
282478|NCT01996709|677455|P1|NOT COMPLETED|Overall Study||5
282479|NCT01996709|677454|P2|COMPLETED|Overall Study||67
282480|NCT01996709|677455|P1|COMPLETED|Overall Study||61
282481|NCT01996709|677454|P2|STARTED|Overall Study||68
282482|NCT01996709|677455|P1|STARTED|Overall Study||66
282483|NCT01996410|677477|P8|NOT COMPLETED|Overall Study||0
282484|NCT01996410|677478|P7|NOT COMPLETED|Overall Study||0
282485|NCT01996410|677479|P6|NOT COMPLETED|Overall Study||0
282486|NCT01996410|677480|P5|NOT COMPLETED|Overall Study||0
282487|NCT01996410|677481|P4|NOT COMPLETED|Overall Study||0
282488|NCT01996410|677482|P3|NOT COMPLETED|Overall Study||0
282489|NCT01996410|677483|P2|NOT COMPLETED|Overall Study||0
282490|NCT01996410|677484|P1|NOT COMPLETED|Overall Study||0
282491|NCT01996410|677477|P8|COMPLETED|Overall Study||0
282492|NCT01996410|677478|P7|COMPLETED|Overall Study||0
282493|NCT01996410|677479|P6|COMPLETED|Overall Study||2
282494|NCT01996410|677480|P5|COMPLETED|Overall Study||2
282495|NCT01996410|677481|P4|COMPLETED|Overall Study||0
282496|NCT01996410|677482|P3|COMPLETED|Overall Study||0
282497|NCT01996410|677483|P2|COMPLETED|Overall Study||3
282498|NCT01996410|677484|P1|COMPLETED|Overall Study||3
282499|NCT01996410|677477|P8|STARTED|Overall Study||0
282500|NCT01996410|677478|P7|STARTED|Overall Study||0
282501|NCT01996410|677479|P6|STARTED|Overall Study||2
282502|NCT01996410|677480|P5|STARTED|Overall Study||2
282503|NCT01996410|677481|P4|STARTED|Overall Study||0
282504|NCT01996410|677482|P3|STARTED|Overall Study||0
282505|NCT01996410|677483|P2|STARTED|Overall Study||3
282506|NCT01996410|677484|P1|STARTED|Overall Study||3
282507|NCT01996332|677496|P1|NOT COMPLETED|Overall Study||1805
282508|NCT01996332|677496|P1|COMPLETED|Overall Study||0
282509|NCT01996332|677496|P1|STARTED|Overall Study||1805
282510|NCT01996319|677504|P2|NOT COMPLETED|Overall Study||3
282511|NCT01996319|677505|P1|NOT COMPLETED|Overall Study||8
282512|NCT01996319|677504|P2|COMPLETED|Overall Study||95
282513|NCT01996319|677505|P1|COMPLETED|Overall Study||88
282514|NCT01996319|677504|P2|STARTED|Overall Study||98
282515|NCT01996319|677505|P1|STARTED|Overall Study||96
282516|NCT01995461|677525|P1|NOT COMPLETED|Overall Study||5
282517|NCT01995461|677525|P1|COMPLETED|Overall Study||21
282518|NCT01995461|677525|P1|STARTED|Overall Study||26
282519|NCT01995357|677531|P6|NOT COMPLETED|Period 5||0
282520|NCT01995357|677532|P5|NOT COMPLETED|Period 5||0
282521|NCT01995357|677533|P4|NOT COMPLETED|Period 5||0
282522|NCT01995357|677534|P3|NOT COMPLETED|Period 5||1
282523|NCT01995357|677535|P2|NOT COMPLETED|Period 5||0
282524|NCT01995357|677536|P1|NOT COMPLETED|Period 5||2
282525|NCT01995357|677531|P6|COMPLETED|Period 5||4
282526|NCT01995357|677532|P5|COMPLETED|Period 5||4
282527|NCT01995357|677533|P4|COMPLETED|Period 5||3
282528|NCT01995357|677534|P3|COMPLETED|Period 5||3
282529|NCT01995357|677535|P2|COMPLETED|Period 5||3
282530|NCT01995357|677536|P1|COMPLETED|Period 5||2
282531|NCT01995357|677531|P6|STARTED|Period 5||4
282717|NCT01993823|677777|P2|NOT COMPLETED|Overall Study||16
282532|NCT01995357|677532|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
282533|NCT01995357|677533|P4|STARTED|Period 5||3
282534|NCT01995357|677534|P3|STARTED|Period 5||4
282535|NCT01995357|677535|P2|STARTED|Period 5||3
282536|NCT01995357|677536|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
282537|NCT01995357|677531|P6|NOT COMPLETED|Period 4||0
282538|NCT01995357|677532|P5|NOT COMPLETED|Period 4||0
282539|NCT01995357|677533|P4|NOT COMPLETED|Period 4||0
282540|NCT01995357|677534|P3|NOT COMPLETED|Period 4||0
282541|NCT01995357|677535|P2|NOT COMPLETED|Period 4||0
282542|NCT01995357|677536|P1|NOT COMPLETED|Period 4||0
282543|NCT01995357|677531|P6|COMPLETED|Period 4||4
282544|NCT01995357|677532|P5|COMPLETED|Period 4||4
282545|NCT01995357|677533|P4|COMPLETED|Period 4||3
282546|NCT01995357|677534|P3|COMPLETED|Period 4||4
282547|NCT01995357|677535|P2|COMPLETED|Period 4||3
282548|NCT01995357|677536|P1|COMPLETED|Period 4||4
282549|NCT01995357|677531|P6|STARTED|Period 4||4
282550|NCT01995357|677532|P5|STARTED|Period 4||4
282551|NCT01995357|677533|P4|STARTED|Period 4||3
282552|NCT01995357|677534|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
282553|NCT01995357|677535|P2|STARTED|Period 4||3
282554|NCT01995357|677536|P1|STARTED|Period 4||4
282555|NCT01995357|677531|P6|NOT COMPLETED|Period 3||0
282556|NCT01995357|677532|P5|NOT COMPLETED|Period 3||0
282557|NCT01995357|677533|P4|NOT COMPLETED|Period 3||0
282558|NCT01995357|677534|P3|NOT COMPLETED|Period 3||0
282559|NCT01995357|677535|P2|NOT COMPLETED|Period 3||0
282560|NCT01995357|677536|P1|NOT COMPLETED|Period 3||0
282561|NCT01995357|677531|P6|COMPLETED|Period 3||4
282562|NCT01995357|677532|P5|COMPLETED|Period 3||4
282563|NCT01995357|677533|P4|COMPLETED|Period 3||3
282564|NCT01995357|677534|P3|COMPLETED|Period 3||4
282565|NCT01995357|677535|P2|COMPLETED|Period 3||3
282566|NCT01995357|677536|P1|COMPLETED|Period 3||4
282567|NCT01995357|677531|P6|STARTED|Period 3||4
282568|NCT01995357|677532|P5|STARTED|Period 3||4
282569|NCT01995357|677533|P4|STARTED|Period 3||3
282570|NCT01995357|677534|P3|STARTED|Period 3||4
282571|NCT01995357|677535|P2|STARTED|Period 3||3
282572|NCT01995357|677536|P1|STARTED|Period 3||4
282573|NCT01995357|677531|P6|NOT COMPLETED|Period 2||0
282574|NCT01995357|677532|P5|NOT COMPLETED|Period 2||0
282575|NCT01995357|677533|P4|NOT COMPLETED|Period 2||0
282576|NCT01995357|677534|P3|NOT COMPLETED|Period 2||0
282577|NCT01995357|677535|P2|NOT COMPLETED|Period 2||0
282578|NCT01995357|677536|P1|NOT COMPLETED|Period 2||0
282579|NCT01995357|677531|P6|COMPLETED|Period 2||4
282580|NCT01995357|677532|P5|COMPLETED|Period 2||4
282581|NCT01995357|677533|P4|COMPLETED|Period 2||3
282582|NCT01995357|677534|P3|COMPLETED|Period 2||4
282583|NCT01995357|677535|P2|COMPLETED|Period 2||3
282584|NCT01995357|677536|P1|COMPLETED|Period 2||4
282585|NCT01995357|677531|P6|STARTED|Period 2||4
282586|NCT01995357|677532|P5|STARTED|Period 2||4
282587|NCT01995357|677533|P4|STARTED|Period 2||3
282588|NCT01995357|677534|P3|STARTED|Period 2||4
282589|NCT01995357|677535|P2|STARTED|Period 2||3
282590|NCT01995357|677536|P1|STARTED|Period 2||4
282591|NCT01995357|677531|P6|NOT COMPLETED|Period 1||0
282592|NCT01995357|677532|P5|NOT COMPLETED|Period 1||0
282593|NCT01995357|677533|P4|NOT COMPLETED|Period 1||0
282594|NCT01995357|677534|P3|NOT COMPLETED|Period 1||0
282595|NCT01995357|677535|P2|NOT COMPLETED|Period 1||0
282596|NCT01995357|677536|P1|NOT COMPLETED|Period 1||0
282597|NCT01995357|677531|P6|COMPLETED|Period 1||4
282598|NCT01995357|677532|P5|COMPLETED|Period 1||4
282599|NCT01995357|677533|P4|COMPLETED|Period 1||3
282600|NCT01995357|677534|P3|COMPLETED|Period 1||4
282601|NCT01995357|677535|P2|COMPLETED|Period 1||3
282602|NCT01995357|677536|P1|COMPLETED|Period 1||4
282603|NCT01995357|677531|P6|STARTED|Period 1||4
282604|NCT01995357|677532|P5|STARTED|Period 1||4
282605|NCT01995357|677533|P4|STARTED|Period 1||3
282606|NCT01995357|677534|P3|STARTED|Period 1||4
282607|NCT01995357|677535|P2|STARTED|Period 1||3
282608|NCT01995357|677536|P1|STARTED|Period 1||4
282609|NCT01995136|677552|P1|NOT COMPLETED|Overall Study||1
282610|NCT01995136|677552|P1|COMPLETED|Overall Study||31
282611|NCT01995136|677552|P1|STARTED|Overall Study||32
282612|NCT01995045|677558|P2|NOT COMPLETED|Overall Study||0
282613|NCT01995045|677559|P1|NOT COMPLETED|Overall Study||0
282614|NCT01995045|677558|P2|COMPLETED|Overall Study||28
282615|NCT01995045|677559|P1|COMPLETED|Overall Study||29
282616|NCT01995045|677558|P2|STARTED|Overall Study||28
282617|NCT01995045|677559|P1|STARTED|Overall Study||29
282618|NCT01994902|677571|P2|NOT COMPLETED|Test Period 2||6
282619|NCT01994902|677572|P1|NOT COMPLETED|Test Period 2||0
282620|NCT01994902|677571|P2|COMPLETED|Test Period 2||55
282621|NCT01994902|677572|P1|COMPLETED|Test Period 2||57
282622|NCT01994902|677571|P2|STARTED|Test Period 2||61
282623|NCT01994902|677572|P1|STARTED|Test Period 2||57
282624|NCT01994902|677571|P2|NOT COMPLETED|Test Period 1||3
282625|NCT01994902|677572|P1|NOT COMPLETED|Test Period 1||6
282626|NCT01994902|677571|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
282627|NCT01994902|677572|P1|COMPLETED|Test Period 1||57
282718|NCT01993823|677778|P1|NOT COMPLETED|Overall Study||7
282628|NCT01994902|677571|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
282629|NCT01994902|677572|P1|STARTED|Test Period 1||63
282630|NCT01994876|677578|P2|NOT COMPLETED|Test Period 2||1
282631|NCT01994876|677579|P1|NOT COMPLETED|Test Period 2||1
282632|NCT01994876|677578|P2|COMPLETED|Test Period 2||6
282633|NCT01994876|677579|P1|COMPLETED|Test Period 2||8
282634|NCT01994876|677578|P2|STARTED|Test Period 2||7
282635|NCT01994876|677579|P1|STARTED|Test Period 2||9
282636|NCT01994876|677578|P2|NOT COMPLETED|Test Period 1||2
282637|NCT01994876|677579|P1|NOT COMPLETED|Test Period 1||0
282638|NCT01994876|677578|P2|COMPLETED|Test Period 1||7
282639|NCT01994876|677579|P1|COMPLETED|Test Period 1||9
282640|NCT01994876|677578|P2|STARTED|Test Period 1||9
282641|NCT01994876|677579|P1|STARTED|Test Period 1||9
282642|NCT01994876|677578|P2|NOT COMPLETED|Baseline - Own Product||0
282643|NCT01994876|677579|P1|NOT COMPLETED|Baseline - Own Product||0
282644|NCT01994876|677578|P2|COMPLETED|Baseline - Own Product||9
282645|NCT01994876|677579|P1|COMPLETED|Baseline - Own Product||9
282646|NCT01994876|677578|P2|STARTED|Baseline - Own Product||9
282647|NCT01994876|677579|P1|STARTED|Baseline - Own Product||9
282648|NCT01994863|677587|P2|NOT COMPLETED|Period 2||4
282649|NCT01994863|677588|P1|NOT COMPLETED|Period 2||1
282650|NCT01994863|677587|P2|COMPLETED|Period 2||5
282651|NCT01994863|677588|P1|COMPLETED|Period 2||7
282652|NCT01994863|677587|P2|STARTED|Period 2||9
282653|NCT01994863|677588|P1|STARTED|Period 2||8
282654|NCT01994863|677587|P2|NOT COMPLETED|Period 1||3
282655|NCT01994863|677588|P1|NOT COMPLETED|Period 1||7
282656|NCT01994863|677587|P2|COMPLETED|Period 1||9
282657|NCT01994863|677588|P1|COMPLETED|Period 1||4
282658|NCT01994863|677587|P2|STARTED|Period 1||12
282659|NCT01994863|677588|P1|STARTED|Period 1||11
282660|NCT01994746|677594|P2|NOT COMPLETED|Second Visit||0
282661|NCT01994746|677595|P1|NOT COMPLETED|Second Visit||0
282662|NCT01994746|677594|P2|COMPLETED|Second Visit||38
282663|NCT01994746|677595|P1|COMPLETED|Second Visit|Safety population|38
282664|NCT01994746|677594|P2|Efficacy|Second Visit||38
282665|NCT01994746|677595|P1|Efficacy|Second Visit|Those who completed both visits were included in the efficacy population.|37
282666|NCT01994746|677594|P2|STARTED|Second Visit||38
282667|NCT01994746|677595|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
282668|NCT01994746|677594|P2|NOT COMPLETED|First Visit||0
282669|NCT01994746|677595|P1|NOT COMPLETED|First Visit||0
282670|NCT01994746|677594|P2|COMPLETED|First Visit||38
282671|NCT01994746|677595|P1|COMPLETED|First Visit|Safety population|39
282672|NCT01994746|677594|P2|Efficacy|First Visit||38
282673|NCT01994746|677595|P1|Efficacy|First Visit|Those who completed both visits were included in the efficacy population.|37
282674|NCT01994746|677594|P2|STARTED|First Visit||38
282675|NCT01994746|677595|P1|STARTED|First Visit||39
282676|NCT01994720|677603|P2|NOT COMPLETED|Overall Study||56
282677|NCT01994720|677604|P1|NOT COMPLETED|Overall Study||46
282678|NCT01994720|677603|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
282679|NCT01994720|677604|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
282680|NCT01994720|677603|P2|STARTED|Overall Study||6610
282681|NCT01994720|677604|P1|STARTED|Overall Study||6589
282682|NCT01994629|677646|P2|NOT COMPLETED|Overall Study||3
282683|NCT01994629|677647|P1|NOT COMPLETED|Overall Study||1
282684|NCT01994629|677646|P2|COMPLETED|Overall Study||99
282685|NCT01994629|677647|P1|COMPLETED|Overall Study||99
282686|NCT01994629|677646|P2|STARTED|Overall Study||102
282687|NCT01994629|677647|P1|STARTED|Overall Study||100
282688|NCT01994486|677671|P1|NOT COMPLETED|Overall Study||0
282689|NCT01994486|677671|P1|COMPLETED|Overall Study||20
282690|NCT01994486|677671|P1|STARTED|Overall Study||20
282691|NCT01994291|677683|P3|NOT COMPLETED|Overall Study||9
282692|NCT01994291|677684|P2|NOT COMPLETED|Overall Study||7
282693|NCT01994291|677685|P1|NOT COMPLETED|Overall Study||15
282694|NCT01994291|677683|P3|COMPLETED|Overall Study||47
282695|NCT01994291|677684|P2|COMPLETED|Overall Study||36
282696|NCT01994291|677685|P1|COMPLETED|Overall Study||84
282697|NCT01994291|677683|P3|Received Treatment|Overall Study||56
282698|NCT01994291|677684|P2|Received Treatment|Overall Study||43
282699|NCT01994291|677685|P1|Received Treatment|Overall Study||99
282700|NCT01994291|677683|P3|STARTED|Overall Study||56
282701|NCT01994291|677684|P2|STARTED|Overall Study||43
282702|NCT01994291|677685|P1|STARTED|Overall Study||99
282703|NCT01993940|677741|P2|NOT COMPLETED|Overall Study||44
282704|NCT01993940|677742|P1|NOT COMPLETED|Overall Study||40
282705|NCT01993940|677741|P2|COMPLETED|Overall Study||232
282706|NCT01993940|677742|P1|COMPLETED|Overall Study||237
282707|NCT01993940|677741|P2|Received Treatment|Overall Study||276
282708|NCT01993940|677742|P1|Received Treatment|Overall Study||272
282709|NCT01993940|677741|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
282710|NCT01993940|677742|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
282711|NCT01993888|677758|P2|NOT COMPLETED|Overall Study||3
282712|NCT01993888|677759|P1|NOT COMPLETED|Overall Study||2
282713|NCT01993888|677758|P2|COMPLETED|Overall Study||49
282714|NCT01993888|677759|P1|COMPLETED|Overall Study||48
282715|NCT01993888|677758|P2|STARTED|Overall Study||52
282716|NCT01993888|677759|P1|STARTED|Overall Study||50
282719|NCT01993823|677777|P2|COMPLETED|Overall Study||79
282720|NCT01993823|677778|P1|COMPLETED|Overall Study||88
282721|NCT01993823|677777|P2|STARTED|Overall Study||95
282722|NCT01993823|677778|P1|STARTED|Overall Study||95
282723|NCT01993238|677786|P1|NOT COMPLETED|Overall Study||0
282724|NCT01993238|677786|P1|COMPLETED|Overall Study||11
282725|NCT01993238|677786|P1|STARTED|Overall Study||11
282726|NCT01993030|677793|P2|NOT COMPLETED|Overall Study||4
282727|NCT01993030|677794|P1|NOT COMPLETED|Overall Study||0
282728|NCT01993030|677793|P2|COMPLETED|Overall Study||31
282729|NCT01993030|677794|P1|COMPLETED|Overall Study||36
282730|NCT01993030|677793|P2|STARTED|Overall Study||35
282731|NCT01993030|677794|P1|STARTED|Overall Study||36
282732|NCT01992874|677808|P3|NOT COMPLETED|Part B||0
282733|NCT01992874|677809|P2|NOT COMPLETED|Part B||0
282734|NCT01992874|677810|P1|NOT COMPLETED|Part B||0
282735|NCT01992874|677808|P3|COMPLETED|Part B||38
282736|NCT01992874|677809|P2|COMPLETED|Part B||0
282737|NCT01992874|677810|P1|COMPLETED|Part B||0
282738|NCT01992874|677808|P3|STARTED|Part B||38
282739|NCT01992874|677809|P2|STARTED|Part B||0
282740|NCT01992874|677810|P1|STARTED|Part B||0
282741|NCT01992874|677808|P3|NOT COMPLETED|Part A||0
282742|NCT01992874|677809|P2|NOT COMPLETED|Part A||0
282743|NCT01992874|677810|P1|NOT COMPLETED|Part A||0
282744|NCT01992874|677808|P3|COMPLETED|Part A||0
282745|NCT01992874|677809|P2|COMPLETED|Part A||17
282746|NCT01992874|677810|P1|COMPLETED|Part A||21
282747|NCT01992874|677808|P3|STARTED|Part A||0
282748|NCT01992874|677809|P2|STARTED|Part A||17
282749|NCT01992874|677810|P1|STARTED|Part A||21
282750|NCT01992536|677848|P10|NOT COMPLETED|Overall Study||1
282751|NCT01992536|677849|P9|NOT COMPLETED|Overall Study||1
282752|NCT01992536|677850|P8|NOT COMPLETED|Overall Study||0
282753|NCT01992536|677851|P7|NOT COMPLETED|Overall Study||7
282754|NCT01992536|677852|P6|NOT COMPLETED|Overall Study||1
282755|NCT01992536|677853|P5|NOT COMPLETED|Overall Study||0
282756|NCT01992536|677854|P4|NOT COMPLETED|Overall Study||2
282757|NCT01992536|677855|P3|NOT COMPLETED|Overall Study||1
282758|NCT01992536|677856|P2|NOT COMPLETED|Overall Study||3
282759|NCT01992536|677857|P1|NOT COMPLETED|Overall Study||4
282760|NCT01992536|677848|P10|COMPLETED|Overall Study||18
282761|NCT01992536|677849|P9|COMPLETED|Overall Study||18
282762|NCT01992536|677850|P8|COMPLETED|Overall Study||21
282763|NCT01992536|677851|P7|COMPLETED|Overall Study||0
282764|NCT01992536|677852|P6|COMPLETED|Overall Study||20
282765|NCT01992536|677853|P5|COMPLETED|Overall Study||11
282766|NCT01992536|677854|P4|COMPLETED|Overall Study||22
282767|NCT01992536|677855|P3|COMPLETED|Overall Study||16
282768|NCT01992536|677856|P2|COMPLETED|Overall Study||22
282769|NCT01992536|677857|P1|COMPLETED|Overall Study||22
282770|NCT01992536|677848|P10|STARTED|Overall Study||19
282771|NCT01992536|677849|P9|STARTED|Overall Study||19
282772|NCT01992536|677850|P8|STARTED|Overall Study||21
282773|NCT01992536|677851|P7|STARTED|Overall Study||7
282774|NCT01992536|677852|P6|STARTED|Overall Study||21
282775|NCT01992536|677853|P5|STARTED|Overall Study||11
282776|NCT01992536|677854|P4|STARTED|Overall Study||24
282777|NCT01992536|677855|P3|STARTED|Overall Study||17
282778|NCT01992536|677856|P2|STARTED|Overall Study||25
282779|NCT01992536|677857|P1|STARTED|Overall Study||26
282780|NCT01992523|678074|P2|NOT COMPLETED|Overall Study||0
282781|NCT01992523|678075|P1|NOT COMPLETED|Overall Study||0
282782|NCT01992523|678074|P2|COMPLETED|Overall Study||41
282783|NCT01992523|678075|P1|COMPLETED|Overall Study||41
282784|NCT01992523|678074|P2|STARTED|Overall Study||41
282785|NCT01992523|678075|P1|STARTED|Overall Study||41
282786|NCT01992185|678089|P2|NOT COMPLETED|Overall Study||0
282787|NCT01992185|678090|P1|NOT COMPLETED|Overall Study||0
282788|NCT01992185|678089|P2|COMPLETED|Overall Study||8
282789|NCT01992185|678090|P1|COMPLETED|Overall Study||7
282790|NCT01992185|678089|P2|STARTED|Overall Study||8
282791|NCT01992185|678090|P1|STARTED|Overall Study||7
282792|NCT01992172|678098|P2|NOT COMPLETED|Overall Study||0
282793|NCT01992172|678099|P1|NOT COMPLETED|Overall Study||0
282794|NCT01992172|678098|P2|COMPLETED|Overall Study||0
282795|NCT01992172|678099|P1|COMPLETED|Overall Study||7
282796|NCT01992172|678098|P2|STARTED|Overall Study||0
282797|NCT01992172|678099|P1|STARTED|Overall Study||7
282798|NCT01992107|678108|P3|NOT COMPLETED|Overall Study||36
282799|NCT01992107|678109|P2|NOT COMPLETED|Overall Study||33
282800|NCT01992107|678110|P1|NOT COMPLETED|Overall Study||68
282801|NCT01992107|678108|P3|COMPLETED|Overall Study||545
282802|NCT01992107|678109|P2|COMPLETED|Overall Study||560
282803|NCT01992107|678110|P1|COMPLETED|Overall Study||1091
282804|NCT01992107|678108|P3|STARTED|Overall Study||581
282805|NCT01992107|678109|P2|STARTED|Overall Study||593
282806|NCT01992107|678110|P1|STARTED|Overall Study||1159
282807|NCT01992094|678166|P3|NOT COMPLETED|Overall Study||21
282808|NCT01992094|678167|P2|NOT COMPLETED|Overall Study||24
282809|NCT01992094|678168|P1|NOT COMPLETED|Overall Study||50
282810|NCT01992094|678166|P3|COMPLETED|Overall Study||648
282811|NCT01992094|678167|P2|COMPLETED|Overall Study||652
282812|NCT01992094|678168|P1|COMPLETED|Overall Study||1285
282813|NCT01992094|678166|P3|STARTED|Overall Study||669
282814|NCT01992094|678167|P2|STARTED|Overall Study||676
282815|NCT01992094|678168|P1|STARTED|Overall Study||1335
282816|NCT01991990|678226|P2|NOT COMPLETED|Overall Study||0
282817|NCT01991990|678227|P1|NOT COMPLETED|Overall Study||0
282818|NCT01991990|678226|P2|COMPLETED|Overall Study||12
282819|NCT01991990|678227|P1|COMPLETED|Overall Study||6
282820|NCT01991990|678226|P2|STARTED|Overall Study||12
282821|NCT01991990|678227|P1|STARTED|Overall Study||6
282822|NCT01991548|678267|P1|NOT COMPLETED|Overall Study||1
282823|NCT01991548|678267|P1|COMPLETED|Overall Study||39
282824|NCT01991548|678267|P1|STARTED|Overall Study||40
282825|NCT01991314|678273|P2|NOT COMPLETED|Overall Study||11
282826|NCT01991314|678274|P1|NOT COMPLETED|Overall Study||11
282827|NCT01991314|678273|P2|COMPLETED|Overall Study||32
282828|NCT01991314|678274|P1|COMPLETED|Overall Study||34
282829|NCT01991314|678273|P2|STARTED|Overall Study||43
282830|NCT01991314|678274|P1|STARTED|Overall Study||45
282831|NCT01990898|678292|P1|NOT COMPLETED|Overall Study||4
282832|NCT01990898|678292|P1|COMPLETED|Overall Study||22
282833|NCT01990898|678292|P1|3 Months|Overall Study||22
282834|NCT01990898|678292|P1|STARTED|Overall Study||26
282835|NCT01990859|678296|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
282836|NCT01990859|678296|P1|COMPLETED|90 Day Follow Up for All Participants||20
282837|NCT01990859|678296|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
282838|NCT01990859|678296|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
282839|NCT01990859|678296|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
282840|NCT01990859|678296|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
282841|NCT01990859|678296|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
282842|NCT01990859|678296|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
282843|NCT01990859|678296|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
282844|NCT01990794|678307|P1|NOT COMPLETED|Overall Study||3
282845|NCT01990794|678307|P1|COMPLETED|Overall Study||10
282846|NCT01990794|678307|P1|One Month Into Study|Overall Study||10
282847|NCT01990794|678307|P1|STARTED|Overall Study||13
282848|NCT01990703|678421|P2|NOT COMPLETED|Overall Study||45
282849|NCT01990703|678422|P1|NOT COMPLETED|Overall Study||39
282850|NCT01990703|678421|P2|COMPLETED|Overall Study||93
282851|NCT01990703|678422|P1|COMPLETED|Overall Study||108
282852|NCT01990703|678421|P2|STARTED|Overall Study||138
282853|NCT01990703|678422|P1|STARTED|Overall Study||147
282854|NCT01990664|678432|P2|NOT COMPLETED|Overall Study||11
282855|NCT01990664|678433|P1|NOT COMPLETED|Overall Study||7
282856|NCT01990664|678432|P2|COMPLETED|Overall Study||79
282857|NCT01990664|678433|P1|COMPLETED|Overall Study||95
282858|NCT01990664|678432|P2|STARTED|Overall Study||90
282859|NCT01990664|678433|P1|STARTED|Overall Study||102
282860|NCT01990534|678439|P1|NOT COMPLETED|Overall Study||60
282861|NCT01990534|678439|P1|COMPLETED|Overall Study||0
282862|NCT01990534|678439|P1|Ongoing|Overall Study||36
282863|NCT01990534|678439|P1|STARTED|Overall Study||60
282864|NCT01990339|678455|P1|NOT COMPLETED|Overall Study||2312
282865|NCT01990339|678455|P1|COMPLETED|Overall Study||12653
282866|NCT01990339|678455|P1|STARTED|Overall Study||14965
282867|NCT01990261|678460|P1|NOT COMPLETED|Overall Study||25
282868|NCT01990261|678460|P1|COMPLETED|Overall Study||8
282869|NCT01990261|678460|P1|Treated|Overall Study||29
282870|NCT01990261|678460|P1|STARTED|Overall Study||33
282871|NCT01989689|678472|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
282872|NCT01989689|678473|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
282873|NCT01989689|678472|P2|COMPLETED|Treatment Period ( 3 Months)||10
282874|NCT01989689|678473|P1|COMPLETED|Treatment Period ( 3 Months)||11
282875|NCT01989689|678472|P2|STARTED|Treatment Period ( 3 Months)||10
282876|NCT01989689|678473|P1|STARTED|Treatment Period ( 3 Months)||11
282877|NCT01989689|678472|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
282878|NCT01989689|678473|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
282879|NCT01989689|678472|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
282880|NCT01989689|678473|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
282881|NCT01989689|678472|P2|STARTED|Treatment Period 1 ( 3 Months)||13
282882|NCT01989689|678473|P1|STARTED|Treatment Period 1 ( 3 Months)||11
282883|NCT01989689|678472|P2|NOT COMPLETED|Baseline||0
282884|NCT01989689|678473|P1|NOT COMPLETED|Baseline||0
282885|NCT01989689|678472|P2|COMPLETED|Baseline||13
282886|NCT01989689|678473|P1|COMPLETED|Baseline||11
282887|NCT01989689|678472|P2|STARTED|Baseline||13
282888|NCT01989689|678473|P1|STARTED|Baseline||11
282889|NCT01989572|678489|P6|NOT COMPLETED|Overall Study||110
282890|NCT01989572|678490|P5|NOT COMPLETED|Overall Study||98
282891|NCT01989572|678491|P4|NOT COMPLETED|Overall Study||51
282892|NCT01989572|678492|P3|NOT COMPLETED|Overall Study||62
282893|NCT01989572|678493|P2|NOT COMPLETED|Overall Study||58
282894|NCT01989572|678494|P1|NOT COMPLETED|Overall Study||55
282895|NCT01989572|678489|P6|COMPLETED|Overall Study||79
282896|NCT01989572|678490|P5|COMPLETED|Overall Study||92
282897|NCT01989572|678491|P4|COMPLETED|Overall Study||56
282898|NCT01989572|678492|P3|COMPLETED|Overall Study||47
282899|NCT01989572|678493|P2|COMPLETED|Overall Study||53
282900|NCT01989572|678494|P1|COMPLETED|Overall Study||54
282901|NCT01989572|678489|P6|Treated|Overall Study||171
282902|NCT01989572|678490|P5|Treated|Overall Study||186
282903|NCT01989572|678491|P4|Treated|Overall Study||104
282904|NCT01989572|678492|P3|Treated|Overall Study||107
282905|NCT01989572|678493|P2|Treated|Overall Study||110
282906|NCT01989572|678494|P1|Treated|Overall Study||104
282907|NCT01989572|678489|P6|STARTED|Overall Study||189
282908|NCT01989572|678490|P5|STARTED|Overall Study||190
282909|NCT01989572|678491|P4|STARTED|Overall Study||107
282910|NCT01989572|678492|P3|STARTED|Overall Study||109
282911|NCT01989572|678493|P2|STARTED|Overall Study||111
282912|NCT01989572|678494|P1|STARTED|Overall Study||109
282913|NCT01989455|678527|P5|NOT COMPLETED|Overall Study||1
282914|NCT01989455|678528|P4|NOT COMPLETED|Overall Study||0
282915|NCT01989455|678529|P3|NOT COMPLETED|Overall Study||1
282916|NCT01989455|678530|P2|NOT COMPLETED|Overall Study||2
282917|NCT01989455|678531|P1|NOT COMPLETED|Overall Study||0
282918|NCT01989455|678527|P5|COMPLETED|Overall Study||7
282919|NCT01989455|678528|P4|COMPLETED|Overall Study||14
282920|NCT01989455|678529|P3|COMPLETED|Overall Study||13
282921|NCT01989455|678530|P2|COMPLETED|Overall Study||12
282922|NCT01989455|678531|P1|COMPLETED|Overall Study||14
282923|NCT01989455|678527|P5|STARTED|Overall Study||8
282924|NCT01989455|678528|P4|STARTED|Overall Study||14
282925|NCT01989455|678529|P3|STARTED|Overall Study||14
282926|NCT01989455|678530|P2|STARTED|Overall Study||14
282927|NCT01989455|678531|P1|STARTED|Overall Study||14
282928|NCT01988415|678565|P1|NOT COMPLETED|Overall Study||0
282929|NCT01988415|678565|P1|COMPLETED|Overall Study||26
282930|NCT01988415|678565|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
282931|NCT01988402|678575|P2|NOT COMPLETED|Overall Study||2
282932|NCT01988402|678576|P1|NOT COMPLETED|Overall Study||2
282933|NCT01988402|678575|P2|COMPLETED|Overall Study||17
282934|NCT01988402|678576|P1|COMPLETED|Overall Study||14
282935|NCT01988402|678575|P2|STARTED|Overall Study||19
282936|NCT01988402|678576|P1|STARTED|Overall Study||16
282937|NCT01989195|678584|P1|NOT COMPLETED|Overall Study||0
282938|NCT01989195|678584|P1|COMPLETED|Overall Study||6
282939|NCT01989195|678584|P1|STARTED|Overall Study||6
282940|NCT01989169|678594|P2|NOT COMPLETED|Period 2||1
282941|NCT01989169|678595|P1|NOT COMPLETED|Period 2||0
282942|NCT01989169|678594|P2|COMPLETED|Period 2||14
282943|NCT01989169|678595|P1|COMPLETED|Period 2||15
282944|NCT01989169|678594|P2|STARTED|Period 2||15
282945|NCT01989169|678595|P1|STARTED|Period 2||15
282946|NCT01989169|678594|P2|NOT COMPLETED|Period 1||0
282947|NCT01989169|678595|P1|NOT COMPLETED|Period 1||0
282948|NCT01989169|678594|P2|COMPLETED|Period 1||15
282949|NCT01989169|678595|P1|COMPLETED|Period 1||15
282950|NCT01989169|678594|P2|STARTED|Period 1||15
282951|NCT01989169|678595|P1|STARTED|Period 1||15
282952|NCT01989156|678608|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
282953|NCT01989156|678609|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
282954|NCT01989156|678610|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
282955|NCT01989156|678608|P3|COMPLETED|End of Study (Population at Day 90)||31
282956|NCT01989156|678609|P2|COMPLETED|End of Study (Population at Day 90)||35
282957|NCT01989156|678610|P1|COMPLETED|End of Study (Population at Day 90)||73
282958|NCT01989156|678608|P3|STARTED|End of Study (Population at Day 90)||34
282959|NCT01989156|678609|P2|STARTED|End of Study (Population at Day 90)||40
282960|NCT01989156|678610|P1|STARTED|End of Study (Population at Day 90)||80
282961|NCT01989156|678608|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
282962|NCT01989156|678609|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
282963|NCT01989156|678610|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
282964|NCT01989156|678608|P3|COMPLETED|Confinement Period (Population at Day 5)||34
282965|NCT01989156|678609|P2|COMPLETED|Confinement Period (Population at Day 5)||40
282966|NCT01989156|678610|P1|COMPLETED|Confinement Period (Population at Day 5)||80
282967|NCT01989156|678608|P3|STARTED|Confinement Period (Population at Day 5)||39
282968|NCT01989156|678609|P2|STARTED|Confinement Period (Population at Day 5)||41
282969|NCT01989156|678610|P1|STARTED|Confinement Period (Population at Day 5)||80
282970|NCT01989130|678632|P2|NOT COMPLETED|Overall Study||0
282971|NCT01989130|678633|P1|NOT COMPLETED|Overall Study||0
282972|NCT01989130|678632|P2|COMPLETED|Overall Study||27
282973|NCT01989130|678633|P1|COMPLETED|Overall Study||43
282974|NCT01989130|678632|P2|STARTED|Overall Study||27
282975|NCT01989130|678633|P1|STARTED|Overall Study||43
282976|NCT01988857|678645|P1|NOT COMPLETED|Overall Study||0
282977|NCT01988857|678645|P1|COMPLETED|Overall Study||300
282978|NCT01988857|678645|P1|STARTED|Overall Study||300
282979|NCT01988662|678654|P2|NOT COMPLETED|Overall Study||2
282980|NCT01988662|678655|P1|NOT COMPLETED|Overall Study||4
282981|NCT01988662|678654|P2|COMPLETED|Overall Study||99
282982|NCT01988662|678655|P1|COMPLETED|Overall Study||100
282983|NCT01988662|678654|P2|STARTED|Overall Study||101
282984|NCT01988662|678655|P1|STARTED|Overall Study||104
282985|NCT01988129|678674|P2|NOT COMPLETED|Overall Study||0
282986|NCT01988129|678675|P1|NOT COMPLETED|Overall Study||0
282987|NCT01988129|678674|P2|COMPLETED|Overall Study||588
282988|NCT01988129|678675|P1|COMPLETED|Overall Study||601
282989|NCT01988129|678674|P2|Completed 1-year Follow-up Survey|Overall Study||4
282990|NCT01988129|678675|P1|Completed 1-year Follow-up Survey|Overall Study||100
282991|NCT01988129|678674|P2|Screened for Sleep Disorders|Overall Study||15
282992|NCT01988129|678675|P1|Screened for Sleep Disorders|Overall Study||416
282993|NCT01988129|678674|P2|Attended Education Session|Overall Study||18
282994|NCT01988129|678675|P1|Attended Education Session|Overall Study||542
282995|NCT01988129|678674|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
282996|NCT01988129|678675|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
282997|NCT01988012|678702|P1|NOT COMPLETED|Overall Study||15
282998|NCT01988012|678702|P1|COMPLETED|Overall Study||85
282999|NCT01988012|678702|P1|STARTED|Overall Study||100
283000|NCT01987960|678726|P4|NOT COMPLETED|Period 3||71
283001|NCT01987960|678727|P3|NOT COMPLETED|Period 3||0
283002|NCT01987960|678728|P2|NOT COMPLETED|Period 3||0
283003|NCT01987960|678729|P1|NOT COMPLETED|Period 3||0
283004|NCT01987960|678726|P4|COMPLETED|Period 3||119
283005|NCT01987960|678727|P3|COMPLETED|Period 3||0
283006|NCT01987960|678728|P2|COMPLETED|Period 3||0
283007|NCT01987960|678729|P1|COMPLETED|Period 3||0
283008|NCT01987960|678726|P4|STARTED|Period 3||190
283009|NCT01987960|678727|P3|STARTED|Period 3||0
283010|NCT01987960|678728|P2|STARTED|Period 3||0
283011|NCT01987960|678729|P1|STARTED|Period 3||0
283012|NCT01987960|678726|P4|NOT COMPLETED|Period 2||0
283013|NCT01987960|678727|P3|NOT COMPLETED|Period 2||9
283014|NCT01987960|678728|P2|NOT COMPLETED|Period 2||5
283015|NCT01987960|678729|P1|NOT COMPLETED|Period 2||0
283016|NCT01987960|678726|P4|COMPLETED|Period 2||0
283017|NCT01987960|678727|P3|COMPLETED|Period 2||14
283018|NCT01987960|678728|P2|COMPLETED|Period 2||12
283019|NCT01987960|678729|P1|COMPLETED|Period 2||0
283020|NCT01987960|678726|P4|STARTED|Period 2||0
283021|NCT01987960|678727|P3|STARTED|Period 2||23
283022|NCT01987960|678728|P2|STARTED|Period 2||17
283023|NCT01987960|678729|P1|STARTED|Period 2||0
283024|NCT01987960|678726|P4|NOT COMPLETED|Period 1||0
283025|NCT01987960|678727|P3|NOT COMPLETED|Period 1||0
283026|NCT01987960|678728|P2|NOT COMPLETED|Period 1||0
283027|NCT01987960|678729|P1|NOT COMPLETED|Period 1||186
283028|NCT01987960|678726|P4|COMPLETED|Period 1||0
283029|NCT01987960|678727|P3|COMPLETED|Period 1||0
283030|NCT01987960|678728|P2|COMPLETED|Period 1||0
283031|NCT01987960|678729|P1|COMPLETED|Period 1||231
283032|NCT01987960|678726|P4|STARTED|Period 1||0
283033|NCT01987960|678727|P3|STARTED|Period 1||0
283034|NCT01987960|678728|P2|STARTED|Period 1||0
283035|NCT01987960|678729|P1|STARTED|Period 1||417
283036|NCT01987908|678741|P3|NOT COMPLETED|Post-Treatment Observation Period||0
283037|NCT01987908|678742|P2|NOT COMPLETED|Post-Treatment Observation Period||3
283038|NCT01987908|678743|P1|NOT COMPLETED|Post-Treatment Observation Period||0
283039|NCT01987908|678741|P3|COMPLETED|Post-Treatment Observation Period||2
283040|NCT01987908|678742|P2|COMPLETED|Post-Treatment Observation Period||7
283041|NCT01987908|678743|P1|COMPLETED|Post-Treatment Observation Period||0
283042|NCT01987908|678741|P3|STARTED|Post-Treatment Observation Period||2
283043|NCT01987908|678742|P2|STARTED|Post-Treatment Observation Period||10
283044|NCT01987908|678743|P1|STARTED|Post-Treatment Observation Period||0
283045|NCT01987908|678741|P3|NOT COMPLETED|Treatment Period||1
283046|NCT01987908|678742|P2|NOT COMPLETED|Treatment Period||1
283047|NCT01987908|678743|P1|NOT COMPLETED|Treatment Period||0
283048|NCT01987908|678741|P3|COMPLETED|Treatment Period||2
283049|NCT01987908|678742|P2|COMPLETED|Treatment Period||10
283050|NCT01987908|678743|P1|COMPLETED|Treatment Period||0
283051|NCT01987908|678741|P3|STARTED|Treatment Period||3
283052|NCT01987908|678742|P2|STARTED|Treatment Period||11
283053|NCT01987908|678743|P1|STARTED|Treatment Period||0
283054|NCT01987908|678741|P3|NOT COMPLETED|Placebo Lead-in Period||0
283055|NCT01987908|678742|P2|NOT COMPLETED|Placebo Lead-in Period||0
283056|NCT01987908|678743|P1|NOT COMPLETED|Placebo Lead-in Period||9
283057|NCT01987908|678741|P3|COMPLETED|Placebo Lead-in Period||0
283058|NCT01987908|678742|P2|COMPLETED|Placebo Lead-in Period||0
283059|NCT01987908|678743|P1|COMPLETED|Placebo Lead-in Period||14
283060|NCT01987908|678741|P3|STARTED|Placebo Lead-in Period||0
283061|NCT01987908|678742|P2|STARTED|Placebo Lead-in Period||0
283062|NCT01987908|678743|P1|STARTED|Placebo Lead-in Period||23
283063|NCT01987765|678824|P1|NOT COMPLETED|Overall Study||102
283064|NCT01987765|678824|P1|COMPLETED|Overall Study||745
283065|NCT01987765|678824|P1|STARTED|Overall Study||847
283066|NCT01987752|678829|P1|NOT COMPLETED|Overall Study||0
283067|NCT01987752|678829|P1|COMPLETED|Overall Study||732
283068|NCT01987752|678829|P1|STARTED|Overall Study||732
283069|NCT01987583|678836|P2|NOT COMPLETED|Overall Study||2
283070|NCT01987583|678837|P1|NOT COMPLETED|Overall Study||3
283071|NCT01987583|678836|P2|COMPLETED|Overall Study||38
283072|NCT01987583|678837|P1|COMPLETED|Overall Study||37
283073|NCT01987583|678836|P2|STARTED|Overall Study||40
283074|NCT01987583|678837|P1|STARTED|Overall Study||40
283075|NCT01987557|678848|P3|NOT COMPLETED|Overall Study||3
283076|NCT01987557|678849|P2|NOT COMPLETED|Overall Study||3
283077|NCT01987557|678850|P1|NOT COMPLETED|Overall Study||3
283078|NCT01987557|678848|P3|COMPLETED|Overall Study||13
283079|NCT01987557|678849|P2|COMPLETED|Overall Study||13
283080|NCT01987557|678850|P1|COMPLETED|Overall Study||13
283081|NCT01987557|678848|P3|STARTED|Overall Study||16
283082|NCT01987557|678849|P2|STARTED|Overall Study||16
283083|NCT01987557|678850|P1|STARTED|Overall Study||16
283084|NCT01987453|678861|P3|NOT COMPLETED|Overall Study||1
283085|NCT01987453|678862|P2|NOT COMPLETED|Overall Study||12
283086|NCT01987453|678863|P1|NOT COMPLETED|Overall Study||1
283087|NCT01987453|678861|P3|COMPLETED|Overall Study||7
283088|NCT01987453|678862|P2|COMPLETED|Overall Study||29
283089|NCT01987453|678863|P1|COMPLETED|Overall Study||50
283090|NCT01987453|678861|P3|STARTED|Overall Study||8
283091|NCT01987453|678862|P2|STARTED|Overall Study||41
283092|NCT01987453|678863|P1|STARTED|Overall Study||51
283093|NCT01987349|678894|P8|NOT COMPLETED|Overall Study||1
283094|NCT01987349|678895|P7|NOT COMPLETED|Overall Study||0
283095|NCT01987349|678896|P6|NOT COMPLETED|Overall Study||0
283096|NCT01987349|678897|P5|NOT COMPLETED|Overall Study||0
283097|NCT01987349|678898|P4|NOT COMPLETED|Overall Study||0
283098|NCT01987349|678899|P3|NOT COMPLETED|Overall Study||0
283099|NCT01987349|678900|P2|NOT COMPLETED|Overall Study||0
283100|NCT01987349|678901|P1|NOT COMPLETED|Overall Study||0
283101|NCT01987349|678894|P8|COMPLETED|Overall Study||24
283102|NCT01987349|678895|P7|COMPLETED|Overall Study||10
283103|NCT01987349|678896|P6|COMPLETED|Overall Study||6
283104|NCT01987349|678897|P5|COMPLETED|Overall Study||6
283105|NCT01987349|678898|P4|COMPLETED|Overall Study||6
283106|NCT01987349|678899|P3|COMPLETED|Overall Study||8
283107|NCT01987349|678900|P2|COMPLETED|Overall Study||6
283108|NCT01987349|678901|P1|COMPLETED|Overall Study||6
283109|NCT01987349|678894|P8|STARTED|Overall Study||25
283110|NCT01987349|678895|P7|STARTED|Overall Study||10
283111|NCT01987349|678896|P6|STARTED|Overall Study||6
283112|NCT01987349|678897|P5|STARTED|Overall Study||6
283113|NCT01987349|678898|P4|STARTED|Overall Study||6
283114|NCT01987349|678899|P3|STARTED|Overall Study||8
283115|NCT01987349|678900|P2|STARTED|Overall Study||6
283116|NCT01987349|678901|P1|STARTED|Overall Study||6
283117|NCT01987219|678933|P6|NOT COMPLETED|Overall Study||0
283118|NCT01987219|678934|P5|NOT COMPLETED|Overall Study||0
283119|NCT01987219|678935|P4|NOT COMPLETED|Overall Study||0
283120|NCT01987219|678936|P3|NOT COMPLETED|Overall Study||1
283121|NCT01987219|678937|P2|NOT COMPLETED|Overall Study||0
283122|NCT01987219|678938|P1|NOT COMPLETED|Overall Study||0
283123|NCT01987219|678933|P6|COMPLETED|Overall Study||1
283124|NCT01987219|678934|P5|COMPLETED|Overall Study||1
283125|NCT01987219|678935|P4|COMPLETED|Overall Study||2
283126|NCT01987219|678936|P3|COMPLETED|Overall Study||6
283127|NCT01987219|678937|P2|COMPLETED|Overall Study||2
283128|NCT01987219|678938|P1|COMPLETED|Overall Study||2
283129|NCT01987219|678933|P6|STARTED|Overall Study||1
283130|NCT01987219|678934|P5|STARTED|Overall Study||1
283131|NCT01987219|678935|P4|STARTED|Overall Study||2
283132|NCT01987219|678936|P3|STARTED|Overall Study||7
283133|NCT01987219|678937|P2|STARTED|Overall Study||2
283134|NCT01987219|678938|P1|STARTED|Overall Study||2
283135|NCT01986985|678955|P1|NOT COMPLETED|Overall Study||7
283136|NCT01986985|678955|P1|COMPLETED|Overall Study||51
283137|NCT01986985|678955|P1|STARTED|Overall Study||58
283138|NCT01986946|678961|P2|NOT COMPLETED|Overall Study||0
283139|NCT01986946|678962|P1|NOT COMPLETED|Overall Study||0
283140|NCT01986946|678961|P2|COMPLETED|Overall Study||9
283141|NCT01986946|678962|P1|COMPLETED|Overall Study||5
283142|NCT01986946|678961|P2|STARTED|Overall Study||9
283143|NCT01986946|678962|P1|STARTED|Overall Study||5
283144|NCT01986790|678995|P3|NOT COMPLETED|Overall Study||0
283145|NCT01986790|678996|P2|NOT COMPLETED|Overall Study||0
283146|NCT01986790|678997|P1|NOT COMPLETED|Overall Study||0
283147|NCT01986790|678995|P3|COMPLETED|Overall Study||98
283148|NCT01986790|678996|P2|COMPLETED|Overall Study||154
283149|NCT01986790|678997|P1|COMPLETED|Overall Study||91
283150|NCT01986790|678995|P3|STARTED|Overall Study||98
283151|NCT01986790|678996|P2|STARTED|Overall Study||154
283152|NCT01986790|678997|P1|STARTED|Overall Study||91
283153|NCT01986751|679013|P2|NOT COMPLETED|Overall Study||2
283154|NCT01986751|679014|P1|NOT COMPLETED|Overall Study||10
283155|NCT01986751|679013|P2|COMPLETED|Overall Study||2
283156|NCT01986751|679014|P1|COMPLETED|Overall Study||0
283157|NCT01986751|679013|P2|STARTED|Overall Study||4
283158|NCT01986751|679014|P1|STARTED|Overall Study||10
283159|NCT01986231|679034|P1|NOT COMPLETED|Overall Study||1
283160|NCT01986231|679034|P1|COMPLETED|Overall Study||11
283161|NCT01986231|679034|P1|STARTED|Overall Study||12
283162|NCT01986062|679041|P2|NOT COMPLETED|Overall Study||1
283163|NCT01986062|679042|P1|NOT COMPLETED|Overall Study||1
283164|NCT01986062|679041|P2|COMPLETED|Overall Study||49
283165|NCT01986062|679042|P1|COMPLETED|Overall Study||46
283166|NCT01986062|679041|P2|STARTED|Overall Study||50
283167|NCT01986062|679042|P1|STARTED|Overall Study||47
283168|NCT01985581|679060|P2|NOT COMPLETED|Second Intervention||4
283169|NCT01985581|679061|P1|NOT COMPLETED|Second Intervention||2
283170|NCT01985581|679060|P2|COMPLETED|Second Intervention||19
283171|NCT01985581|679061|P1|COMPLETED|Second Intervention||20
283172|NCT01985581|679060|P2|STARTED|Second Intervention||23
283173|NCT01985581|679061|P1|STARTED|Second Intervention||22
283174|NCT01985581|679060|P2|NOT COMPLETED|First Intervention||2
283175|NCT01985581|679061|P1|NOT COMPLETED|First Intervention||3
283176|NCT01985581|679060|P2|COMPLETED|First Intervention||23
283177|NCT01985581|679061|P1|COMPLETED|First Intervention||22
283178|NCT01985581|679060|P2|STARTED|First Intervention||25
283179|NCT01985581|679061|P1|STARTED|First Intervention||25
283180|NCT01985425|679081|P2|NOT COMPLETED|Overall Study||0
283181|NCT01985425|679082|P1|NOT COMPLETED|Overall Study||0
283182|NCT01985425|679081|P2|COMPLETED|Overall Study||51
283183|NCT01985425|679082|P1|COMPLETED|Overall Study||49
283184|NCT01985425|679081|P2|STARTED|Overall Study||51
283185|NCT01985425|679082|P1|STARTED|Overall Study||49
283186|NCT01985321|679102|P2|NOT COMPLETED|Overall Study||5
283187|NCT01985321|679103|P1|NOT COMPLETED|Overall Study||11
283188|NCT01985321|679102|P2|COMPLETED|Overall Study||78
283189|NCT01985321|679103|P1|COMPLETED|Overall Study||79
283190|NCT01985321|679102|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
283191|NCT01985321|679103|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
283192|NCT01985126|679113|P2|NOT COMPLETED|Overall Study||106
283193|NCT01985126|679114|P1|NOT COMPLETED|Overall Study||18
283194|NCT01985126|679113|P2|COMPLETED|Overall Study||0
283195|NCT01985126|679114|P1|COMPLETED|Overall Study||0
283196|NCT01985126|679113|P2|STARTED|Overall Study||106
283197|NCT01985126|679114|P1|STARTED|Overall Study||18
283198|NCT01984697|679137|P5|NOT COMPLETED|Overall Study||314
283199|NCT01984697|679138|P4|NOT COMPLETED|Overall Study||301
283200|NCT01984697|679139|P3|NOT COMPLETED|Overall Study||301
283201|NCT01984697|679140|P2|NOT COMPLETED|Overall Study||301
283202|NCT01984697|679141|P1|NOT COMPLETED|Overall Study||301
283203|NCT01984697|679137|P5|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
283204|NCT01984697|679138|P4|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
283205|NCT01984697|679139|P3|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
283206|NCT01984697|679140|P2|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
283207|NCT01984697|679141|P1|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
283208|NCT01984697|679137|P5|Vaccination 3|Overall Study||311
283209|NCT01984697|679138|P4|Vaccination 3|Overall Study||293
283210|NCT01984697|679139|P3|Vaccination 3|Overall Study||0
283211|NCT01984697|679140|P2|Vaccination 3|Overall Study||0
283212|NCT01984697|679141|P1|Vaccination 3|Overall Study||0
283213|NCT01984697|679137|P5|Vaccination 2|Overall Study||313
283214|NCT01984697|679138|P4|Vaccination 2|Overall Study||298
283215|NCT01984697|679139|P3|Vaccination 2|Overall Study||291
283216|NCT01984697|679140|P2|Vaccination 2|Overall Study||296
283217|NCT01984697|679141|P1|Vaccination 2|Overall Study||293
283218|NCT01984697|679137|P5|Vaccination 1|Overall Study||314
283219|NCT01984697|679138|P4|Vaccination 1|Overall Study||300
283220|NCT01984697|679139|P3|Vaccination 1|Overall Study||300
283221|NCT01984697|679140|P2|Vaccination 1|Overall Study||301
283222|NCT01984697|679141|P1|Vaccination 1|Overall Study||301
283223|NCT01984697|679137|P5|STARTED|Overall Study||314
283224|NCT01984697|679138|P4|STARTED|Overall Study||301
283225|NCT01984697|679139|P3|STARTED|Overall Study||301
283226|NCT01984697|679140|P2|STARTED|Overall Study||301
283227|NCT01984697|679141|P1|STARTED|Overall Study||301
283228|NCT01984515|679238|P1|NOT COMPLETED|Overall Study||19
283229|NCT01984515|679238|P1|COMPLETED|Overall Study||40
283230|NCT01984515|679238|P1|Received CBT Session|Overall Study||40
283231|NCT01984515|679238|P1|STARTED|Overall Study||59
283232|NCT01984294|679247|P3|NOT COMPLETED|Overall Study||7
283233|NCT01984294|679248|P2|NOT COMPLETED|Overall Study||3
283234|NCT01984294|679249|P1|NOT COMPLETED|Overall Study||4
283235|NCT01984294|679247|P3|COMPLETED|Overall Study||27
283236|NCT01984294|679248|P2|COMPLETED|Overall Study||29
283237|NCT01984294|679249|P1|COMPLETED|Overall Study||31
283238|NCT01984294|679247|P3|STARTED|Overall Study||34
283239|NCT01984294|679248|P2|STARTED|Overall Study||32
283240|NCT01984294|679249|P1|STARTED|Overall Study||35
283241|NCT01984229|679271|P2|NOT COMPLETED|Safety Follow-up Period||1
283242|NCT01984229|679272|P1|NOT COMPLETED|Safety Follow-up Period||2
283243|NCT01984229|679271|P2|COMPLETED|Safety Follow-up Period||16
283244|NCT01984229|679272|P1|COMPLETED|Safety Follow-up Period||4
283245|NCT01984229|679271|P2|STARTED|Safety Follow-up Period||17
283246|NCT01984229|679272|P1|STARTED|Safety Follow-up Period||6
283247|NCT01984229|679271|P2|NOT COMPLETED|Period 3||0
283248|NCT01984229|679272|P1|NOT COMPLETED|Period 3||0
283249|NCT01984229|679271|P2|COMPLETED|Period 3||17
283250|NCT01984229|679272|P1|COMPLETED|Period 3||6
283251|NCT01984229|679271|P2|STARTED|Period 3||17
283252|NCT01984229|679272|P1|STARTED|Period 3||6
283253|NCT01984229|679271|P2|NOT COMPLETED|Period 2||0
283254|NCT01984229|679272|P1|NOT COMPLETED|Period 2||0
283255|NCT01984229|679271|P2|COMPLETED|Period 2||17
283256|NCT01984229|679272|P1|COMPLETED|Period 2||6
283257|NCT01984229|679271|P2|STARTED|Period 2||17
283258|NCT01984229|679272|P1|STARTED|Period 2||6
283259|NCT01984229|679271|P2|NOT COMPLETED|Period 1||0
283260|NCT01984229|679272|P1|NOT COMPLETED|Period 1||0
283261|NCT01984229|679271|P2|COMPLETED|Period 1||17
283262|NCT01984229|679272|P1|COMPLETED|Period 1||6
283263|NCT01984229|679271|P2|STARTED|Period 1||17
283264|NCT01984229|679272|P1|STARTED|Period 1||6
283265|NCT01983878|679322|P1|NOT COMPLETED|Overall Study||0
283266|NCT01983878|679322|P1|COMPLETED|Overall Study||36
283267|NCT01983878|679322|P1|Received At Least One Dose of Study Drug|Overall Study||36
283268|NCT01983878|679322|P1|STARTED|Overall Study||36
283269|NCT01983839|679333|P1|NOT COMPLETED|Overall Study||0
283270|NCT01983839|679333|P1|COMPLETED|Overall Study||18
283271|NCT01983839|679333|P1|STARTED|Overall Study||18
283272|NCT01983787|679338|P1|NOT COMPLETED|Overall Study||0
283273|NCT01983787|679338|P1|COMPLETED|Overall Study||10
283274|NCT01983787|679338|P1|STARTED|Overall Study||10
283275|NCT01983566|679365|P4|NOT COMPLETED|Test Period 4||0
283276|NCT01983566|679366|P3|NOT COMPLETED|Test Period 4||0
283277|NCT01983566|679367|P2|NOT COMPLETED|Test Period 4||0
283278|NCT01983566|679368|P1|NOT COMPLETED|Test Period 4||0
283279|NCT01983566|679365|P4|COMPLETED|Test Period 4||0
283280|NCT01983566|679366|P3|COMPLETED|Test Period 4||0
283281|NCT01983566|679367|P2|COMPLETED|Test Period 4||0
283282|NCT01983566|679368|P1|COMPLETED|Test Period 4||0
283283|NCT01983566|679365|P4|STARTED|Test Period 4||0
283284|NCT01983566|679366|P3|STARTED|Test Period 4||0
283285|NCT01983566|679367|P2|STARTED|Test Period 4||0
283286|NCT01983566|679368|P1|STARTED|Test Period 4||0
283287|NCT01983566|679365|P4|NOT COMPLETED|Wash-Out 3||0
283288|NCT01983566|679366|P3|NOT COMPLETED|Wash-Out 3||0
283289|NCT01983566|679367|P2|NOT COMPLETED|Wash-Out 3||0
283290|NCT01983566|679368|P1|NOT COMPLETED|Wash-Out 3||0
283291|NCT01983566|679365|P4|COMPLETED|Wash-Out 3||0
283292|NCT01983566|679366|P3|COMPLETED|Wash-Out 3||0
283293|NCT01983566|679367|P2|COMPLETED|Wash-Out 3||0
283294|NCT01983566|679368|P1|COMPLETED|Wash-Out 3||0
283295|NCT01983566|679365|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
283296|NCT01983566|679366|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
283297|NCT01983566|679367|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
283298|NCT01983566|679368|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
283299|NCT01983566|679365|P4|NOT COMPLETED|Test Period 3||0
283300|NCT01983566|679366|P3|NOT COMPLETED|Test Period 3||0
283301|NCT01983566|679367|P2|NOT COMPLETED|Test Period 3||0
283302|NCT01983566|679368|P1|NOT COMPLETED|Test Period 3||0
283303|NCT01983566|679365|P4|COMPLETED|Test Period 3||4
283304|NCT01983566|679366|P3|COMPLETED|Test Period 3||2
283305|NCT01983566|679367|P2|COMPLETED|Test Period 3||3
283306|NCT01983566|679368|P1|COMPLETED|Test Period 3||2
283307|NCT01983566|679365|P4|STARTED|Test Period 3||4
283308|NCT01983566|679366|P3|STARTED|Test Period 3||2
283309|NCT01983566|679367|P2|STARTED|Test Period 3||3
283310|NCT01983566|679368|P1|STARTED|Test Period 3||2
283311|NCT01983566|679365|P4|NOT COMPLETED|Wash-Out 2||0
283312|NCT01983566|679366|P3|NOT COMPLETED|Wash-Out 2||0
283313|NCT01983566|679367|P2|NOT COMPLETED|Wash-Out 2||0
283314|NCT01983566|679368|P1|NOT COMPLETED|Wash-Out 2||0
283315|NCT01983566|679365|P4|COMPLETED|Wash-Out 2||4
283316|NCT01983566|679366|P3|COMPLETED|Wash-Out 2||2
283317|NCT01983566|679367|P2|COMPLETED|Wash-Out 2||3
283318|NCT01983566|679368|P1|COMPLETED|Wash-Out 2||2
283319|NCT01983566|679365|P4|STARTED|Wash-Out 2||4
283320|NCT01983566|679366|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
283321|NCT01983566|679367|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
283322|NCT01983566|679368|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
283323|NCT01983566|679365|P4|NOT COMPLETED|Test Period 2||0
283324|NCT01983566|679366|P3|NOT COMPLETED|Test Period 2||0
283325|NCT01983566|679367|P2|NOT COMPLETED|Test Period 2||0
283326|NCT01983566|679368|P1|NOT COMPLETED|Test Period 2||0
283327|NCT01983566|679365|P4|COMPLETED|Test Period 2||4
283328|NCT01983566|679366|P3|COMPLETED|Test Period 2||4
283329|NCT01983566|679367|P2|COMPLETED|Test Period 2||4
283330|NCT01983566|679368|P1|COMPLETED|Test Period 2||4
283331|NCT01983566|679365|P4|STARTED|Test Period 2||4
283332|NCT01983566|679366|P3|STARTED|Test Period 2||4
283333|NCT01983566|679367|P2|STARTED|Test Period 2||4
283334|NCT01983566|679368|P1|STARTED|Test Period 2||4
283335|NCT01983566|679365|P4|NOT COMPLETED|Wash-Out 1||0
283336|NCT01983566|679366|P3|NOT COMPLETED|Wash-Out 1||0
283337|NCT01983566|679367|P2|NOT COMPLETED|Wash-Out 1||0
283338|NCT01983566|679368|P1|NOT COMPLETED|Wash-Out 1||0
283339|NCT01983566|679365|P4|COMPLETED|Wash-Out 1||4
283340|NCT01983566|679366|P3|COMPLETED|Wash-Out 1||4
283341|NCT01983566|679367|P2|COMPLETED|Wash-Out 1||4
283342|NCT01983566|679368|P1|COMPLETED|Wash-Out 1||4
283343|NCT01983566|679365|P4|STARTED|Wash-Out 1||4
283344|NCT01983566|679366|P3|STARTED|Wash-Out 1||4
283345|NCT01983566|679367|P2|STARTED|Wash-Out 1||4
283346|NCT01983566|679368|P1|STARTED|Wash-Out 1||4
283347|NCT01983566|679365|P4|NOT COMPLETED|Test Period 1||0
283348|NCT01983566|679366|P3|NOT COMPLETED|Test Period 1||0
283349|NCT01983566|679367|P2|NOT COMPLETED|Test Period 1||0
283350|NCT01983566|679368|P1|NOT COMPLETED|Test Period 1||0
283351|NCT01983566|679365|P4|COMPLETED|Test Period 1||4
283352|NCT01983566|679366|P3|COMPLETED|Test Period 1||4
283353|NCT01983566|679367|P2|COMPLETED|Test Period 1||4
283354|NCT01983566|679368|P1|COMPLETED|Test Period 1||4
283355|NCT01983566|679365|P4|STARTED|Test Period 1||4
283356|NCT01983566|679366|P3|STARTED|Test Period 1||4
283357|NCT01983566|679367|P2|STARTED|Test Period 1||4
283358|NCT01983566|679368|P1|STARTED|Test Period 1||4
283359|NCT01983254|679389|P2|NOT COMPLETED|Overall Study||30
283360|NCT01983254|679390|P1|NOT COMPLETED|Overall Study||34
283361|NCT01983254|679389|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
283362|NCT01983254|679390|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
283363|NCT01983254|679389|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
283364|NCT01983254|679390|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
283365|NCT01983254|679389|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
283366|NCT01983254|679390|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
283367|NCT01983254|679389|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
283368|NCT01983254|679390|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
283369|NCT01983254|679389|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
283370|NCT01983254|679390|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
283371|NCT01983111|679402|P2|NOT COMPLETED|Overall Study||7
283372|NCT01983111|679403|P1|NOT COMPLETED|Overall Study||12
283373|NCT01983111|679402|P2|COMPLETED|Overall Study||59
283374|NCT01983111|679403|P1|COMPLETED|Overall Study||58
283375|NCT01983111|679402|P2|STARTED|Overall Study||66
283376|NCT01983111|679403|P1|STARTED|Overall Study||70
283377|NCT01983020|679423|P4|NOT COMPLETED|Overall Study||0
283378|NCT01983020|679424|P3|NOT COMPLETED|Overall Study||0
283379|NCT01983020|679425|P2|NOT COMPLETED|Overall Study||0
283380|NCT01983020|679426|P1|NOT COMPLETED|Overall Study||0
283381|NCT01983020|679423|P4|COMPLETED|Overall Study||11
283382|NCT01983020|679424|P3|COMPLETED|Overall Study||12
283383|NCT01983020|679425|P2|COMPLETED|Overall Study||11
283384|NCT01983020|679426|P1|COMPLETED|Overall Study||12
283385|NCT01983020|679423|P4|STARTED|Overall Study||11
283386|NCT01983020|679424|P3|STARTED|Overall Study||12
283387|NCT01983020|679425|P2|STARTED|Overall Study||11
283388|NCT01983020|679426|P1|STARTED|Overall Study||12
283389|NCT01982812|679438|P2|NOT COMPLETED|Overall Study||10
283390|NCT01982812|679439|P1|NOT COMPLETED|Overall Study||1
283391|NCT01982812|679438|P2|COMPLETED|Overall Study||11
283392|NCT01982812|679439|P1|COMPLETED|Overall Study||22
283393|NCT01982812|679438|P2|STARTED|Overall Study||21
283394|NCT01982812|679439|P1|STARTED|Overall Study||23
283395|NCT01982695|679453|P2|NOT COMPLETED|Overall Study||1
283396|NCT01982695|679454|P1|NOT COMPLETED|Overall Study||0
283397|NCT01982695|679453|P2|COMPLETED|Overall Study||10
283398|NCT01982695|679454|P1|COMPLETED|Overall Study||12
283399|NCT01982695|679453|P2|STARTED|Overall Study||11
283400|NCT01982695|679454|P1|STARTED|Overall Study||12
283401|NCT01982539|679460|P1|NOT COMPLETED|Overall Study||0
283402|NCT01982539|679460|P1|COMPLETED|Overall Study||25
283403|NCT01982539|679460|P1|STARTED|Overall Study||25
283404|NCT01982292|679466|P2|NOT COMPLETED|Overall Study||1
283405|NCT01982292|679467|P1|NOT COMPLETED|Overall Study||12
283406|NCT01982292|679466|P2|COMPLETED|Overall Study||107
283407|NCT01982292|679467|P1|COMPLETED|Overall Study||203
283408|NCT01982292|679466|P2|Safety Set|Overall Study||108
283409|NCT01982292|679467|P1|Safety Set|Overall Study||212
283410|NCT01982292|679466|P2|Full Analaysis Set (FAS)|Overall Study||108
283411|NCT01982292|679467|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
283412|NCT01982292|679466|P2|STARTED|Overall Study||108
283413|NCT01982292|679467|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
283414|NCT01982253|679488|P3|NOT COMPLETED|Overall Study||4
283415|NCT01982253|679489|P2|NOT COMPLETED|Overall Study||4
283416|NCT01982253|679490|P1|NOT COMPLETED|Overall Study||2
283417|NCT01982253|679488|P3|COMPLETED|Overall Study||0
283418|NCT01982253|679489|P2|COMPLETED|Overall Study||0
283419|NCT01982253|679490|P1|COMPLETED|Overall Study||0
283420|NCT01982253|679488|P3|STARTED|Overall Study||4
283421|NCT01982253|679489|P2|STARTED|Overall Study||4
283422|NCT01982253|679490|P1|STARTED|Overall Study||2
283423|NCT01981967|679503|P2|NOT COMPLETED|Overall Study||0
283424|NCT01981967|679504|P1|NOT COMPLETED|Overall Study||0
283425|NCT01981967|679503|P2|COMPLETED|Overall Study||3149
283426|NCT01981967|679504|P1|COMPLETED|Overall Study||6851
283427|NCT01981967|679503|P2|STARTED|Overall Study||3149
283428|NCT01981967|679504|P1|STARTED|Overall Study||6851
283429|NCT01981863|679516|P2|NOT COMPLETED|Overall Study||0
283430|NCT01981863|679517|P1|NOT COMPLETED|Overall Study||0
283431|NCT01981863|679516|P2|COMPLETED|Overall Study||20
283432|NCT01981863|679517|P1|COMPLETED|Overall Study||20
283433|NCT01981863|679516|P2|STARTED|Overall Study||20
283434|NCT01981863|679517|P1|STARTED|Overall Study||20
283435|NCT01981616|679529|P2|NOT COMPLETED|Overall Study||1
283436|NCT01981616|679530|P1|NOT COMPLETED|Overall Study||1
283437|NCT01981616|679529|P2|COMPLETED|Overall Study||62
283438|NCT01981616|679530|P1|COMPLETED|Overall Study||63
283439|NCT01981616|679529|P2|STARTED|Overall Study||63
283440|NCT01981616|679530|P1|STARTED|Overall Study||64
283441|NCT01981473|679545|P3|NOT COMPLETED|Overall Study||8
283442|NCT01981473|679546|P2|NOT COMPLETED|Overall Study||0
283443|NCT01981473|679547|P1|NOT COMPLETED|Overall Study||2
283444|NCT01981473|679545|P3|COMPLETED|Overall Study||196
283445|NCT01981473|679546|P2|COMPLETED|Overall Study||199
283446|NCT01981473|679547|P1|COMPLETED|Overall Study||200
283447|NCT01981473|679545|P3|STARTED|Overall Study||204
283448|NCT01981473|679546|P2|STARTED|Overall Study||199
283449|NCT01981473|679547|P1|STARTED|Overall Study||202
283450|NCT01981356|679588|P2|NOT COMPLETED|Overall Study||2
283451|NCT01981356|679589|P1|NOT COMPLETED|Overall Study||7
283452|NCT01981356|679588|P2|COMPLETED|Overall Study||4
283453|NCT01981356|679589|P1|COMPLETED|Overall Study||5
283454|NCT01981356|679588|P2|STARTED|Overall Study||6
283455|NCT01981356|679589|P1|STARTED|Overall Study||12
283456|NCT01981057|679616|P2|NOT COMPLETED|Overall Study||0
283457|NCT01981057|679617|P1|NOT COMPLETED|Overall Study||0
283458|NCT01981057|679616|P2|COMPLETED|Overall Study||50
283459|NCT01981057|679617|P1|COMPLETED|Overall Study||50
283460|NCT01981057|679616|P2|STARTED|Overall Study||50
283461|NCT01981057|679617|P1|STARTED|Overall Study||50
283462|NCT01980992|679625|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
283463|NCT01980992|679626|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
283464|NCT01980992|679625|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
283465|NCT01980992|679626|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
283466|NCT01980992|679625|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
283467|NCT01980992|679626|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
283468|NCT01980992|679625|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
283469|NCT01980992|679626|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
283470|NCT01980992|679625|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
283471|NCT01980992|679626|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
283472|NCT01980992|679625|P2|STARTED|52 Weeks Blinded Study Treatment||23
283473|NCT01980992|679626|P1|STARTED|52 Weeks Blinded Study Treatment||23
283474|NCT01980940|679640|P8|NOT COMPLETED|Overall Study||0
283475|NCT01980940|679641|P7|NOT COMPLETED|Overall Study||0
283476|NCT01980940|679642|P6|NOT COMPLETED|Overall Study||2
283477|NCT01980940|679643|P5|NOT COMPLETED|Overall Study||0
283478|NCT01980940|679644|P4|NOT COMPLETED|Overall Study||0
283479|NCT01980940|679645|P3|NOT COMPLETED|Overall Study||0
283480|NCT01980940|679646|P2|NOT COMPLETED|Overall Study||0
283481|NCT01980940|679647|P1|NOT COMPLETED|Overall Study||0
283482|NCT01980940|679640|P8|COMPLETED|Overall Study||24
283483|NCT01980940|679641|P7|COMPLETED|Overall Study||24
283484|NCT01980940|679642|P6|COMPLETED|Overall Study||0
283485|NCT01980940|679643|P5|COMPLETED|Overall Study||2
283486|NCT01980940|679644|P4|COMPLETED|Overall Study||3
283487|NCT01980940|679645|P3|COMPLETED|Overall Study||5
283488|NCT01980940|679646|P2|COMPLETED|Overall Study||5
283489|NCT01980940|679647|P1|COMPLETED|Overall Study||5
283490|NCT01980940|679640|P8|Treated|Overall Study||24
283491|NCT01980940|679641|P7|Treated|Overall Study||24
283492|NCT01980940|679642|P6|Treated|Overall Study||2
283493|NCT01980940|679643|P5|Treated|Overall Study||2
283494|NCT01980940|679644|P4|Treated|Overall Study||3
283495|NCT01980940|679645|P3|Treated|Overall Study||5
283496|NCT01980940|679646|P2|Treated|Overall Study||5
283497|NCT01980940|679647|P1|Treated|Overall Study||5
283498|NCT01980940|679640|P8|STARTED|Overall Study||24
283499|NCT01980940|679641|P7|STARTED|Overall Study||24
283500|NCT01980940|679642|P6|STARTED|Overall Study||2
283501|NCT01980940|679643|P5|STARTED|Overall Study||2
283502|NCT01980940|679644|P4|STARTED|Overall Study||3
283503|NCT01980940|679645|P3|STARTED|Overall Study||5
283504|NCT01980940|679646|P2|STARTED|Overall Study||5
283505|NCT01980940|679647|P1|STARTED|Overall Study||5
283506|NCT01980628|679699|P1|NOT COMPLETED|Overall Study||39
283507|NCT01980628|679699|P1|COMPLETED|Overall Study|Participants who remain on treatment at Primary Completion.|24
283508|NCT01980628|679699|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
283509|NCT01980589|679707|P3|NOT COMPLETED|Overall Study||0
283510|NCT01980589|679708|P2|NOT COMPLETED|Overall Study||0
283511|NCT01980589|679709|P1|NOT COMPLETED|Overall Study||0
283512|NCT01980589|679707|P3|COMPLETED|Overall Study||16
283513|NCT01980589|679708|P2|COMPLETED|Overall Study||3
283514|NCT01980589|679709|P1|COMPLETED|Overall Study||3
283515|NCT01980589|679707|P3|STARTED|Overall Study||16
283516|NCT01980589|679708|P2|STARTED|Overall Study||3
283517|NCT01980589|679709|P1|STARTED|Overall Study||3
283518|NCT01980524|679726|P2|NOT COMPLETED|Study Day 2||0
283519|NCT01980524|679727|P1|NOT COMPLETED|Study Day 2||0
283520|NCT01980524|679726|P2|COMPLETED|Study Day 2||4
283521|NCT01980524|679727|P1|COMPLETED|Study Day 2||4
283522|NCT01980524|679726|P2|STARTED|Study Day 2||4
283523|NCT01980524|679727|P1|STARTED|Study Day 2||4
283524|NCT01980524|679726|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
283525|NCT01980524|679727|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
283526|NCT01980524|679726|P2|COMPLETED|Washout (at Least 2 Weeks)||4
283527|NCT01980524|679727|P1|COMPLETED|Washout (at Least 2 Weeks)||4
283528|NCT01980524|679726|P2|STARTED|Washout (at Least 2 Weeks)||4
283529|NCT01980524|679727|P1|STARTED|Washout (at Least 2 Weeks)||4
283530|NCT01980524|679726|P2|NOT COMPLETED|Study Day 1||0
283531|NCT01980524|679727|P1|NOT COMPLETED|Study Day 1||0
283532|NCT01980524|679726|P2|COMPLETED|Study Day 1||4
283533|NCT01980524|679727|P1|COMPLETED|Study Day 1||4
283534|NCT01980524|679726|P2|STARTED|Study Day 1||4
283535|NCT01980524|679727|P1|STARTED|Study Day 1||4
283536|NCT01980095|679739|P2|NOT COMPLETED|Overall Study||11
283537|NCT01980095|679740|P1|NOT COMPLETED|Overall Study||14
283538|NCT01980095|679739|P2|COMPLETED|Overall Study||30
283539|NCT01980095|679740|P1|COMPLETED|Overall Study||63
283540|NCT01980095|679739|P2|Treated|Overall Study||41
283541|NCT01980095|679740|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
283542|NCT01980095|679739|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
283543|NCT01980095|679740|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
283544|NCT01979185|679750|P2|NOT COMPLETED|Period 2||1
283545|NCT01979185|679751|P1|NOT COMPLETED|Period 2||0
283546|NCT01979185|679750|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
283547|NCT01979185|679751|P1|COMPLETED|Period 2||15
283548|NCT01979185|679750|P2|STARTED|Period 2||15
283549|NCT01979185|679751|P1|STARTED|Period 2||15
283550|NCT01979185|679750|P2|NOT COMPLETED|Period 1||0
283551|NCT01979185|679751|P1|NOT COMPLETED|Period 1||0
283552|NCT01979185|679750|P2|COMPLETED|Period 1||15
283553|NCT01979185|679751|P1|COMPLETED|Period 1||15
283554|NCT01979185|679750|P2|STARTED|Period 1||15
283555|NCT01979185|679751|P1|STARTED|Period 1||15
283556|NCT01979133|679761|P1|NOT COMPLETED|Overall Study||3
283557|NCT01979133|679761|P1|COMPLETED|Overall Study||7
283558|NCT01979133|679761|P1|STARTED|Overall Study||10
283559|NCT01979029|679780|P2|NOT COMPLETED|Overall Study||0
283560|NCT01979029|679781|P1|NOT COMPLETED|Overall Study||0
283561|NCT01979029|679780|P2|COMPLETED|Overall Study||28
283562|NCT01979029|679781|P1|COMPLETED|Overall Study||29
283563|NCT01979029|679780|P2|STARTED|Overall Study||28
283564|NCT01979029|679781|P1|STARTED|Overall Study||29
283565|NCT01978600|679793|P2|NOT COMPLETED|Overall Study||0
283566|NCT01978600|679794|P1|NOT COMPLETED|Overall Study||0
283567|NCT01978600|679793|P2|COMPLETED|Overall Study||42
283568|NCT01978600|679794|P1|COMPLETED|Overall Study||44
283569|NCT01978600|679793|P2|STARTED|Overall Study||42
283570|NCT01978600|679794|P1|STARTED|Overall Study||44
283571|NCT01978145|679804|P2|NOT COMPLETED|Treatment Period 2||14
283572|NCT01978145|679805|P1|NOT COMPLETED|Treatment Period 2||19
283573|NCT01978145|679804|P2|COMPLETED|Treatment Period 2||179
283574|NCT01978145|679805|P1|COMPLETED|Treatment Period 2||185
283575|NCT01978145|679804|P2|STARTED|Treatment Period 2||193
283576|NCT01978145|679805|P1|STARTED|Treatment Period 2||204
283577|NCT01978145|679804|P2|NOT COMPLETED|Washout Period 1||3
283578|NCT01978145|679805|P1|NOT COMPLETED|Washout Period 1||1
283579|NCT01978145|679804|P2|COMPLETED|Washout Period 1||193
283580|NCT01978145|679805|P1|COMPLETED|Washout Period 1||204
283581|NCT01978145|679804|P2|STARTED|Washout Period 1||196
283582|NCT01978145|679805|P1|STARTED|Washout Period 1||205
283583|NCT01978145|679804|P2|NOT COMPLETED|Treatment Period 1||16
283584|NCT01978145|679805|P1|NOT COMPLETED|Treatment Period 1||9
283585|NCT01978145|679804|P2|COMPLETED|Treatment Period 1||196
283586|NCT01978145|679805|P1|COMPLETED|Treatment Period 1||205
283587|NCT01978145|679804|P2|STARTED|Treatment Period 1||212
283588|NCT01978145|679805|P1|STARTED|Treatment Period 1||214
283589|NCT01978119|679821|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
283590|NCT01978119|679822|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
283591|NCT01978119|679821|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
283592|NCT01978119|679822|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
283593|NCT01978119|679821|P2|STARTED|Treatment Period 2 (12 Weeks)||42
283594|NCT01978119|679822|P1|STARTED|Treatment Period 2 (12 Weeks)||38
283595|NCT01978119|679821|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
283596|NCT01978119|679822|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
283597|NCT01978119|679821|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
283598|NCT01978119|679822|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
283599|NCT01978119|679821|P2|STARTED|Washout Period 1 (3 Weeks)||42
283600|NCT01978119|679822|P1|STARTED|Washout Period 1 (3 Weeks)||38
283601|NCT01978119|679821|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
283602|NCT01978119|679822|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
283603|NCT01978119|679821|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
283604|NCT01978119|679822|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
283605|NCT01978119|679821|P2|STARTED|Treatment Period 1 (12 Weeks)||42
283606|NCT01978119|679822|P1|STARTED|Treatment Period 1 (12 Weeks)||40
283607|NCT01977820|679848|P2|NOT COMPLETED|Overall Study||1
283608|NCT01977820|679849|P1|NOT COMPLETED|Overall Study||1
283609|NCT01977820|679848|P2|COMPLETED|Overall Study||0
283610|NCT01977820|679849|P1|COMPLETED|Overall Study||0
283611|NCT01977820|679848|P2|STARTED|Overall Study||1
283612|NCT01977820|679849|P1|STARTED|Overall Study||1
283613|NCT01977794|679857|P2|NOT COMPLETED|Overall Study||6
283614|NCT01977794|679858|P1|NOT COMPLETED|Overall Study||8
283615|NCT01977794|679857|P2|COMPLETED|Overall Study||94
283616|NCT01977794|679858|P1|COMPLETED|Overall Study||92
283617|NCT01977794|679857|P2|STARTED|Overall Study||100
283618|NCT01977794|679858|P1|STARTED|Overall Study||100
283619|NCT01977781|679874|P2|NOT COMPLETED|Overall Study||1
283620|NCT01977781|679875|P1|NOT COMPLETED|Overall Study||6
283621|NCT01977781|679874|P2|COMPLETED|Overall Study||15
283622|NCT01977781|679875|P1|COMPLETED|Overall Study||18
283623|NCT01977781|679874|P2|STARTED|Overall Study||16
283624|NCT01977781|679875|P1|STARTED|Overall Study||24
283625|NCT01977729|679893|P1|NOT COMPLETED|Overall Study||1
283626|NCT01977729|679893|P1|COMPLETED|Overall Study||0
283627|NCT01977729|679893|P1|STARTED|Overall Study||1
283628|NCT01977573|679907|P4|NOT COMPLETED|Overall Study||3
283629|NCT01977573|679908|P3|NOT COMPLETED|Overall Study||4
283630|NCT01977573|679909|P2|NOT COMPLETED|Overall Study||3
283631|NCT01977573|679910|P1|NOT COMPLETED|Overall Study||20
283632|NCT01977573|679907|P4|COMPLETED|Overall Study||33
283633|NCT01977573|679908|P3|COMPLETED|Overall Study||32
283634|NCT01977573|679909|P2|COMPLETED|Overall Study||41
283635|NCT01977573|679910|P1|COMPLETED|Overall Study||116
283636|NCT01977573|679907|P4|STARTED|Overall Study||36
283637|NCT01977573|679908|P3|STARTED|Overall Study||36
283638|NCT01977573|679909|P2|STARTED|Overall Study||44
283639|NCT01977573|679910|P1|STARTED|Overall Study||136
283640|NCT01977482|680024|P6|NOT COMPLETED|Overall Study||5
283641|NCT01977482|680025|P5|NOT COMPLETED|Overall Study||3
283642|NCT01977482|680026|P4|NOT COMPLETED|Overall Study||4
283643|NCT01977482|680027|P3|NOT COMPLETED|Overall Study||5
283644|NCT01977482|680028|P2|NOT COMPLETED|Overall Study||9
283645|NCT01977482|680029|P1|NOT COMPLETED|Overall Study||3
283646|NCT01977482|680024|P6|COMPLETED|Overall Study||14
283647|NCT01977482|680025|P5|COMPLETED|Overall Study||37
283648|NCT01977482|680026|P4|COMPLETED|Overall Study||35
283649|NCT01977482|680027|P3|COMPLETED|Overall Study||35
283650|NCT01977482|680028|P2|COMPLETED|Overall Study||30
283651|NCT01977482|680029|P1|COMPLETED|Overall Study||36
283652|NCT01977482|680024|P6|STARTED|Overall Study||19
283653|NCT01977482|680025|P5|STARTED|Overall Study||40
283654|NCT01977482|680026|P4|STARTED|Overall Study||39
283655|NCT01977482|680027|P3|STARTED|Overall Study||40
283656|NCT01977482|680028|P2|STARTED|Overall Study||39
283657|NCT01977482|680029|P1|STARTED|Overall Study||39
283658|NCT01977456|680144|P1|NOT COMPLETED|Overall Study||5
283659|NCT01977456|680144|P1|COMPLETED|Overall Study||22
283660|NCT01977456|680144|P1|STARTED|Overall Study||27
283661|NCT01976988|680153|P2|NOT COMPLETED|Overall Study||18
283662|NCT01976988|680154|P1|NOT COMPLETED|Overall Study||16
283663|NCT01976988|680153|P2|COMPLETED|Overall Study||184
283664|NCT01976988|680154|P1|COMPLETED|Overall Study||192
283665|NCT01976988|680153|P2|STARTED|Overall Study||202
283666|NCT01976988|680154|P1|STARTED|Overall Study||208
283667|NCT01976871|680170|P1|NOT COMPLETED|Overall Study||1
283668|NCT01976871|680170|P1|COMPLETED|Overall Study||20
283669|NCT01976871|680170|P1|STARTED|Overall Study||21
283670|NCT01976845|680182|P3|NOT COMPLETED|Overall Study||3
283671|NCT01976845|680183|P2|NOT COMPLETED|Overall Study||8
283672|NCT01976845|680184|P1|NOT COMPLETED|Overall Study||8
283673|NCT01976845|680182|P3|COMPLETED|Overall Study||40
283674|NCT01976845|680183|P2|COMPLETED|Overall Study||40
283675|NCT01976845|680184|P1|COMPLETED|Overall Study||40
283676|NCT01976845|680182|P3|STARTED|Overall Study||43
283677|NCT01976845|680183|P2|STARTED|Overall Study||48
283678|NCT01976845|680184|P1|STARTED|Overall Study||48
283679|NCT01976806|680200|P2|NOT COMPLETED|Overall Study||6
283680|NCT01976806|680201|P1|NOT COMPLETED|Overall Study||3
283681|NCT01976806|680200|P2|COMPLETED|Overall Study||22
283682|NCT01976806|680201|P1|COMPLETED|Overall Study||24
283683|NCT01976806|680200|P2|STARTED|Overall Study||28
283684|NCT01976806|680201|P1|STARTED|Overall Study||27
283685|NCT01976663|680207|P1|NOT COMPLETED|Overall Study||42
283686|NCT01976663|680207|P1|COMPLETED|Overall Study||84
283687|NCT01976663|680207|P1|STARTED|Overall Study||126
283688|NCT01976650|680221|P1|NOT COMPLETED|Overall Study||6
283689|NCT01976650|680221|P1|COMPLETED|Overall Study||718
283690|NCT01976650|680221|P1|STARTED|Overall Study||724
283691|NCT01976624|680226|P1|NOT COMPLETED|Overall Study||14
283692|NCT01976624|680226|P1|COMPLETED|Overall Study||742
283693|NCT01976624|680226|P1|STARTED|Overall Study||756
283694|NCT01976572|680231|P3|NOT COMPLETED|Overall Study||0
283695|NCT01976572|680232|P2|NOT COMPLETED|Overall Study||0
283696|NCT01976572|680233|P1|NOT COMPLETED|Overall Study||0
283697|NCT01976572|680231|P3|COMPLETED|Overall Study||6
283698|NCT01976572|680232|P2|COMPLETED|Overall Study||6
283699|NCT01976572|680233|P1|COMPLETED|Overall Study||6
283700|NCT01976572|680231|P3|STARTED|Overall Study||6
283701|NCT01976572|680232|P2|STARTED|Overall Study||6
283702|NCT01976572|680233|P1|STARTED|Overall Study||6
283703|NCT01976442|680256|P2|NOT COMPLETED|Overall Study||0
283704|NCT01976442|680257|P1|NOT COMPLETED|Overall Study||0
283705|NCT01976442|680256|P2|COMPLETED|Overall Study||31
283706|NCT01976442|680257|P1|COMPLETED|Overall Study||69
283707|NCT01976442|680256|P2|STARTED|Overall Study||31
283708|NCT01976442|680257|P1|STARTED|Overall Study||69
283709|NCT01976338|680271|P2|NOT COMPLETED|Overall Study||4
283710|NCT01976338|680272|P1|NOT COMPLETED|Overall Study||13
283711|NCT01976338|680271|P2|COMPLETED|Overall Study|12 months|89
283712|NCT01976338|680272|P1|COMPLETED|Overall Study|12 months|177
283713|NCT01976338|680271|P2|Discontinued Study Prior to 6 Months|Overall Study||2
283714|NCT01976338|680272|P1|Discontinued Study Prior to 6 Months|Overall Study||5
283715|NCT01976338|680271|P2|Completed 6 Months|Overall Study||91
283716|NCT01976338|680272|P1|Completed 6 Months|Overall Study||185
283717|NCT01976338|680271|P2|STARTED|Overall Study||93
283718|NCT01976338|680272|P1|STARTED|Overall Study||190
283719|NCT01976312|680299|P2|NOT COMPLETED|Overall Study||9
283720|NCT01976312|680300|P1|NOT COMPLETED|Overall Study||17
283721|NCT01976312|680299|P2|COMPLETED|Overall Study|Completed study at 12 months|53
283722|NCT01976312|680300|P1|COMPLETED|Overall Study|Completed study at 12 months|173
283723|NCT01976312|680299|P2|Discontinued Study Prior to 3 Months|Overall Study||2
283724|NCT01976312|680300|P1|Discontinued Study Prior to 3 Months|Overall Study||4
283725|NCT01976312|680299|P2|Completed 3 Months|Overall Study||60
283726|NCT01976312|680300|P1|Completed 3 Months|Overall Study||186
283727|NCT01976312|680299|P2|STARTED|Overall Study||62
283728|NCT01976312|680300|P1|STARTED|Overall Study||190
283729|NCT01976299|680321|P2|NOT COMPLETED|Overall Study||6
283730|NCT01976299|680322|P1|NOT COMPLETED|Overall Study||23
283731|NCT01976299|680321|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
283732|NCT01976299|680322|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
283733|NCT01976299|680321|P2|Completed Procedure|Overall Study||284
283734|NCT01976299|680322|P1|Completed Procedure|Overall Study||283
283735|NCT01976299|680321|P2|STARTED|Overall Study||286
283736|NCT01976299|680322|P1|STARTED|Overall Study||292
283737|NCT01976273|680336|P1|NOT COMPLETED|Overall Study||2
283738|NCT01976273|680336|P1|COMPLETED|Overall Study||18
283739|NCT01976273|680336|P1|STARTED|Overall Study||20
283740|NCT01975974|680342|P1|NOT COMPLETED|Overall Study||0
283741|NCT01975974|680342|P1|COMPLETED|Overall Study||100
283742|NCT01975974|680342|P1|STARTED|Overall Study||100
283743|NCT01975935|680348|P2|NOT COMPLETED|Overall Study||1
283744|NCT01975935|680349|P1|NOT COMPLETED|Overall Study||3
283745|NCT01975935|680348|P2|COMPLETED|Overall Study||20
283746|NCT01975935|680349|P1|COMPLETED|Overall Study||18
283747|NCT01975935|680348|P2|STARTED|Overall Study||21
283748|NCT01975935|680349|P1|STARTED|Overall Study||21
283749|NCT01975909|680361|P2|NOT COMPLETED|Overall Study||0
283750|NCT01975909|680362|P1|NOT COMPLETED|Overall Study||0
283751|NCT01975909|680361|P2|COMPLETED|Overall Study||10
283752|NCT01975909|680362|P1|COMPLETED|Overall Study||10
283753|NCT01975909|680361|P2|STARTED|Overall Study||10
283754|NCT01975909|680362|P1|STARTED|Overall Study||10
283755|NCT01975675|680382|P4|NOT COMPLETED|Overall Study||0
283756|NCT01975675|680383|P3|NOT COMPLETED|Overall Study||0
283757|NCT01975675|680384|P2|NOT COMPLETED|Overall Study||1
283758|NCT01975675|680385|P1|NOT COMPLETED|Overall Study||0
283759|NCT01975675|680382|P4|COMPLETED|Overall Study||87
283760|NCT01975675|680383|P3|COMPLETED|Overall Study||88
283761|NCT01975675|680384|P2|COMPLETED|Overall Study||82
283762|NCT01975675|680385|P1|COMPLETED|Overall Study||83
283763|NCT01975675|680382|P4|STARTED|Overall Study||87
283764|NCT01975675|680383|P3|STARTED|Overall Study||88
283765|NCT01975675|680384|P2|STARTED|Overall Study||83
283766|NCT01975675|680385|P1|STARTED|Overall Study||83
283767|NCT01975467|680407|P2|NOT COMPLETED|Overall Study||0
283768|NCT01975467|680408|P1|NOT COMPLETED|Overall Study||0
283769|NCT01975467|680407|P2|COMPLETED|Overall Study||0
283770|NCT01975467|680408|P1|COMPLETED|Overall Study||0
283771|NCT01975467|680407|P2|STARTED|Overall Study|Study terminated before enrollment|0
283772|NCT01975467|680408|P1|STARTED|Overall Study|Study terminated before enrollment|0
283773|NCT01975285|680418|P2|NOT COMPLETED|Overall Study||2
283774|NCT01975285|680419|P1|NOT COMPLETED|Overall Study||2
283775|NCT01975285|680418|P2|COMPLETED|Overall Study||28
283776|NCT01975285|680419|P1|COMPLETED|Overall Study||28
283777|NCT01975285|680418|P2|STARTED|Overall Study||30
283778|NCT01975285|680419|P1|STARTED|Overall Study||30
283779|NCT01975246|680435|P2|NOT COMPLETED|Overall Study||2
283780|NCT01975246|680436|P1|NOT COMPLETED|Overall Study||4
283781|NCT01975246|680435|P2|COMPLETED|Overall Study||158
283782|NCT01975246|680436|P1|COMPLETED|Overall Study||145
283783|NCT01975246|680435|P2|STARTED|Overall Study||160
283784|NCT01975246|680436|P1|STARTED|Overall Study||149
283785|NCT01975220|680449|P6|NOT COMPLETED|Test Period 2||0
283786|NCT01975220|680450|P5|NOT COMPLETED|Test Period 2||0
283787|NCT01975220|680451|P4|NOT COMPLETED|Test Period 2||0
283788|NCT01975220|680452|P3|NOT COMPLETED|Test Period 2||0
283789|NCT01975220|680453|P2|NOT COMPLETED|Test Period 2||0
283790|NCT01975220|680454|P1|NOT COMPLETED|Test Period 2||0
283791|NCT01975220|680449|P6|COMPLETED|Test Period 2||12
283792|NCT01975220|680450|P5|COMPLETED|Test Period 2||12
283793|NCT01975220|680451|P4|COMPLETED|Test Period 2||12
283794|NCT01975220|680452|P3|COMPLETED|Test Period 2||12
283795|NCT01975220|680453|P2|COMPLETED|Test Period 2||11
283796|NCT01975220|680454|P1|COMPLETED|Test Period 2||12
283797|NCT01975220|680449|P6|STARTED|Test Period 2||12
283798|NCT01975220|680450|P5|STARTED|Test Period 2||12
283799|NCT01975220|680451|P4|STARTED|Test Period 2||12
283800|NCT01975220|680452|P3|STARTED|Test Period 2||12
283801|NCT01975220|680453|P2|STARTED|Test Period 2||11
283802|NCT01975220|680454|P1|STARTED|Test Period 2||12
283803|NCT01975220|680449|P6|NOT COMPLETED|Test Period 1||0
283804|NCT01975220|680450|P5|NOT COMPLETED|Test Period 1||0
283805|NCT01975220|680451|P4|NOT COMPLETED|Test Period 1||0
283806|NCT01975220|680452|P3|NOT COMPLETED|Test Period 1||0
283807|NCT01975220|680453|P2|NOT COMPLETED|Test Period 1||1
283808|NCT01975220|680454|P1|NOT COMPLETED|Test Period 1||0
283809|NCT01975220|680449|P6|COMPLETED|Test Period 1||12
283810|NCT01975220|680450|P5|COMPLETED|Test Period 1||12
283811|NCT01975220|680451|P4|COMPLETED|Test Period 1||12
283812|NCT01975220|680452|P3|COMPLETED|Test Period 1||12
283813|NCT01975220|680453|P2|COMPLETED|Test Period 1||11
283814|NCT01975220|680454|P1|COMPLETED|Test Period 1||12
283815|NCT01975220|680449|P6|STARTED|Test Period 1||12
283816|NCT01975220|680450|P5|STARTED|Test Period 1||12
283817|NCT01975220|680451|P4|STARTED|Test Period 1||12
283818|NCT01975220|680452|P3|STARTED|Test Period 1||12
283819|NCT01975220|680453|P2|STARTED|Test Period 1||12
283820|NCT01975220|680454|P1|STARTED|Test Period 1||12
283821|NCT01974895|680500|P2|NOT COMPLETED|Overall Study||15
283822|NCT01974895|680501|P1|NOT COMPLETED|Overall Study||15
283823|NCT01974895|680500|P2|COMPLETED|Overall Study||141
283824|NCT01974895|680501|P1|COMPLETED|Overall Study||143
283825|NCT01974895|680500|P2|STARTED|Overall Study||156
283826|NCT01974895|680501|P1|STARTED|Overall Study||158
283827|NCT01974817|680531|P1|NOT COMPLETED|Overall Study||8
283828|NCT01974817|680531|P1|COMPLETED|Overall Study||17
283829|NCT01974817|680531|P1|STARTED|Overall Study||25
283830|NCT01974752|680537|P2|NOT COMPLETED|Overall Study||15
283831|NCT01974752|680538|P1|NOT COMPLETED|Overall Study||37
283832|NCT01974752|680537|P2|COMPLETED|Overall Study||17
283833|NCT01974752|680538|P1|COMPLETED|Overall Study||60
283834|NCT01974752|680537|P2|STARTED|Overall Study||32
283835|NCT01974752|680538|P1|STARTED|Overall Study||97
283836|NCT01974700|680552|P2|NOT COMPLETED|Overall Study||0
283837|NCT01974700|680553|P1|NOT COMPLETED|Overall Study||0
283838|NCT01974700|680552|P2|COMPLETED|Overall Study||3
283839|NCT01974700|680553|P1|COMPLETED|Overall Study||5
283840|NCT01974700|680552|P2|STARTED|Overall Study||3
283841|NCT01974700|680553|P1|STARTED|Overall Study||5
283842|NCT01974323|680565|P2|NOT COMPLETED|Overall Study||93
283843|NCT01974323|680566|P1|NOT COMPLETED|Overall Study||92
283844|NCT01974323|680565|P2|COMPLETED|Overall Study||1027
283845|NCT01974323|680566|P1|COMPLETED|Overall Study||1026
283846|NCT01974323|680565|P2|STARTED|Overall Study||1120
283847|NCT01974323|680566|P1|STARTED|Overall Study||1118
283848|NCT01974245|680590|P2|NOT COMPLETED|Overall Study||8
283849|NCT01974245|680591|P1|NOT COMPLETED|Overall Study||9
283850|NCT01974245|680590|P2|COMPLETED|Overall Study||20
283851|NCT01974245|680591|P1|COMPLETED|Overall Study||18
283852|NCT01974245|680590|P2|STARTED|Overall Study||28
283853|NCT01974245|680591|P1|STARTED|Overall Study||27
283854|NCT01974141|680599|P2|NOT COMPLETED|Overall Study||82
283855|NCT01974141|680600|P1|NOT COMPLETED|Overall Study||96
283856|NCT01974141|680599|P2|COMPLETED|Overall Study||976
283857|NCT01974141|680600|P1|COMPLETED|Overall Study||948
283858|NCT01974141|680599|P2|STARTED|Overall Study||1058
283859|NCT01974141|680600|P1|STARTED|Overall Study||1044
283860|NCT01973777|680622|P1|NOT COMPLETED|Overall Study||7
283861|NCT01973777|680622|P1|COMPLETED|Overall Study||44
283862|NCT01973777|680622|P1|One Year Follow-up|Overall Study||44
283863|NCT01973777|680622|P1|STARTED|Overall Study|January 2014|51
283864|NCT01973608|680632|P4|NOT COMPLETED|Overall Study||0
283865|NCT01973608|680633|P3|NOT COMPLETED|Overall Study||0
283866|NCT01973608|680634|P2|NOT COMPLETED|Overall Study||0
283867|NCT01973608|680635|P1|NOT COMPLETED|Overall Study||0
283868|NCT01973608|680632|P4|COMPLETED|Overall Study||2
283869|NCT01973608|680633|P3|COMPLETED|Overall Study||6
283870|NCT01973608|680634|P2|COMPLETED|Overall Study||2
283871|NCT01973608|680635|P1|COMPLETED|Overall Study||2
283872|NCT01973608|680632|P4|STARTED|Overall Study||2
283873|NCT01973608|680633|P3|STARTED|Overall Study||6
283874|NCT01973608|680634|P2|STARTED|Overall Study||2
283875|NCT01973608|680635|P1|STARTED|Overall Study||2
283876|NCT01973595|680657|P4|NOT COMPLETED|Intervention Phase 2||0
283877|NCT01973595|680658|P3|NOT COMPLETED|Intervention Phase 2||0
283878|NCT01973595|680659|P2|NOT COMPLETED|Intervention Phase 2||0
283879|NCT01973595|680660|P1|NOT COMPLETED|Intervention Phase 2||0
283880|NCT01973595|680657|P4|COMPLETED|Intervention Phase 2||14
283881|NCT01973595|680658|P3|COMPLETED|Intervention Phase 2||14
283882|NCT01973595|680659|P2|COMPLETED|Intervention Phase 2||14
283883|NCT01973595|680660|P1|COMPLETED|Intervention Phase 2||14
283884|NCT01973595|680657|P4|STARTED|Intervention Phase 2||14
283885|NCT01973595|680658|P3|STARTED|Intervention Phase 2||14
283886|NCT01973595|680659|P2|STARTED|Intervention Phase 2||14
283887|NCT01973595|680660|P1|STARTED|Intervention Phase 2||14
283888|NCT01973595|680657|P4|NOT COMPLETED|Washout||0
283889|NCT01973595|680658|P3|NOT COMPLETED|Washout||1
283890|NCT01973595|680659|P2|NOT COMPLETED|Washout||0
283891|NCT01973595|680660|P1|NOT COMPLETED|Washout||1
283892|NCT01973595|680657|P4|COMPLETED|Washout||14
283893|NCT01973595|680658|P3|COMPLETED|Washout||14
283894|NCT01973595|680659|P2|COMPLETED|Washout||14
283895|NCT01973595|680660|P1|COMPLETED|Washout||14
283896|NCT01973595|680657|P4|STARTED|Washout||14
283897|NCT01973595|680658|P3|STARTED|Washout||15
283898|NCT01973595|680659|P2|STARTED|Washout||14
283899|NCT01973595|680660|P1|STARTED|Washout||15
283900|NCT01973595|680657|P4|NOT COMPLETED|Intervention Phase 1||0
283901|NCT01973595|680658|P3|NOT COMPLETED|Intervention Phase 1||0
283902|NCT01973595|680659|P2|NOT COMPLETED|Intervention Phase 1||0
283903|NCT01973595|680660|P1|NOT COMPLETED|Intervention Phase 1||0
283904|NCT01973595|680657|P4|COMPLETED|Intervention Phase 1||14
283905|NCT01973595|680658|P3|COMPLETED|Intervention Phase 1||15
283906|NCT01973595|680659|P2|COMPLETED|Intervention Phase 1||14
283907|NCT01973595|680660|P1|COMPLETED|Intervention Phase 1||15
283908|NCT01973595|680657|P4|STARTED|Intervention Phase 1||14
283909|NCT01973595|680658|P3|STARTED|Intervention Phase 1||15
283910|NCT01973595|680659|P2|STARTED|Intervention Phase 1||14
283911|NCT01973595|680660|P1|STARTED|Intervention Phase 1||15
283912|NCT01973491|680674|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
283913|NCT01973491|680674|P1|COMPLETED|Treatment Period (16 Weeks)||18
283914|NCT01973491|680674|P1|STARTED|Treatment Period (16 Weeks)||19
283915|NCT01973491|680674|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
283916|NCT01973491|680674|P1|COMPLETED|Titration Period(4 Weeks)||19
283917|NCT01973491|680674|P1|STARTED|Titration Period(4 Weeks)||19
283918|NCT01973491|680674|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
283919|NCT01973491|680674|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
283920|NCT01973491|680674|P1|STARTED|Baseline Control Period (8 Weeks)||37
283921|NCT01973439|680690|P1|NOT COMPLETED|Overall Study||5
283922|NCT01973439|680690|P1|COMPLETED|Overall Study||18
283923|NCT01973439|680690|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
283924|NCT01973439|680690|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
283925|NCT01973439|680690|P1|STARTED|Overall Study||23
283926|NCT01973413|680699|P2|NOT COMPLETED|Overall Study||0
283927|NCT01973413|680700|P1|NOT COMPLETED|Overall Study||1
283928|NCT01973413|680699|P2|COMPLETED|Overall Study||20
283929|NCT01973413|680700|P1|COMPLETED|Overall Study||11
283930|NCT01973413|680699|P2|STARTED|Overall Study||20
283931|NCT01973413|680700|P1|STARTED|Overall Study||12
283932|NCT01973387|680712|P2|NOT COMPLETED|Overall Study||18
283933|NCT01973387|680713|P1|NOT COMPLETED|Overall Study||106
283934|NCT01973387|680712|P2|COMPLETED|Overall Study||36
283935|NCT01973387|680713|P1|COMPLETED|Overall Study||0
283936|NCT01973387|680712|P2|Treated|Overall Study||52
283937|NCT01973387|680713|P1|Treated|Overall Study||104
283938|NCT01973387|680712|P2|STARTED|Overall Study||54
283939|NCT01973387|680713|P1|STARTED|Overall Study||106
283940|NCT01973231|680725|P2|NOT COMPLETED|Overall Study||12
283941|NCT01973231|680726|P1|NOT COMPLETED|Overall Study||11
283942|NCT01973231|680725|P2|COMPLETED|Overall Study||190
283943|NCT01973231|680726|P1|COMPLETED|Overall Study||191
283944|NCT01973231|680725|P2|STARTED|Overall Study||202
283945|NCT01973231|680726|P1|STARTED|Overall Study||202
283946|NCT01973218|680746|P2|NOT COMPLETED|Overall Study||0
283947|NCT01973218|680747|P1|NOT COMPLETED|Overall Study||2
283948|NCT01973218|680746|P2|COMPLETED|Overall Study||88
283949|NCT01973218|680747|P1|COMPLETED|Overall Study||174
283950|NCT01973218|680746|P2|STARTED|Overall Study||88
283951|NCT01973218|680747|P1|STARTED|Overall Study||176
283952|NCT01973205|680770|P2|NOT COMPLETED|Overall Study||22
283953|NCT01973205|680771|P1|NOT COMPLETED|Overall Study||30
283954|NCT01973205|680770|P2|COMPLETED|Overall Study||425
283955|NCT01973205|680771|P1|COMPLETED|Overall Study||423
283956|NCT01973205|680770|P2|STARTED|Overall Study||447
283957|NCT01973205|680771|P1|STARTED|Overall Study||453
283958|NCT01972776|680789|P6|NOT COMPLETED|Part 2||7
283959|NCT01972776|680790|P5|NOT COMPLETED|Part 2||13
283960|NCT01972776|680791|P4|NOT COMPLETED|Part 2||0
283961|NCT01972776|680792|P3|NOT COMPLETED|Part 2||0
283962|NCT01972776|680793|P2|NOT COMPLETED|Part 2||0
283963|NCT01972776|680794|P1|NOT COMPLETED|Part 2||0
283964|NCT01972776|680789|P6|COMPLETED|Part 2||0
283965|NCT01972776|680790|P5|COMPLETED|Part 2||1
283966|NCT01972776|680791|P4|COMPLETED|Part 2||0
283967|NCT01972776|680792|P3|COMPLETED|Part 2||0
283968|NCT01972776|680793|P2|COMPLETED|Part 2||0
283969|NCT01972776|680794|P1|COMPLETED|Part 2||0
283970|NCT01972776|680789|P6|STARTED|Part 2||7
283971|NCT01972776|680790|P5|STARTED|Part 2||14
283972|NCT01972776|680791|P4|STARTED|Part 2||0
283973|NCT01972776|680792|P3|STARTED|Part 2||0
283974|NCT01972776|680793|P2|STARTED|Part 2||0
283975|NCT01972776|680794|P1|STARTED|Part 2||0
283976|NCT01972776|680789|P6|NOT COMPLETED|Part 1||0
283977|NCT01972776|680790|P5|NOT COMPLETED|Part 1||0
283978|NCT01972776|680791|P4|NOT COMPLETED|Part 1||1
283979|NCT01972776|680792|P3|NOT COMPLETED|Part 1||2
283980|NCT01972776|680793|P2|NOT COMPLETED|Part 1||0
283981|NCT01972776|680794|P1|NOT COMPLETED|Part 1||0
283982|NCT01972776|680789|P6|COMPLETED|Part 1||0
283983|NCT01972776|680790|P5|COMPLETED|Part 1||0
283984|NCT01972776|680791|P4|COMPLETED|Part 1||6
283985|NCT01972776|680792|P3|COMPLETED|Part 1||6
283986|NCT01972776|680793|P2|COMPLETED|Part 1||6
283987|NCT01972776|680794|P1|COMPLETED|Part 1||6
283988|NCT01972776|680789|P6|STARTED|Part 1||0
283989|NCT01972776|680790|P5|STARTED|Part 1||0
283990|NCT01972776|680791|P4|STARTED|Part 1||7
283991|NCT01972776|680792|P3|STARTED|Part 1||8
283992|NCT01972776|680793|P2|STARTED|Part 1||6
283993|NCT01972776|680794|P1|STARTED|Part 1||6
283994|NCT01972659|680864|P2|NOT COMPLETED|Overall Study||3
283995|NCT01972659|680865|P1|NOT COMPLETED|Overall Study||4
283996|NCT01972659|680864|P2|COMPLETED|Overall Study||37
283997|NCT01972659|680865|P1|COMPLETED|Overall Study||36
283998|NCT01972659|680864|P2|STARTED|Overall Study||40
283999|NCT01972659|680865|P1|STARTED|Overall Study||40
284000|NCT01972516|680873|P2|NOT COMPLETED|Overall Study||0
284001|NCT01972516|680874|P1|NOT COMPLETED|Overall Study||0
284002|NCT01972516|680873|P2|COMPLETED|Overall Study||1
284003|NCT01972516|680874|P1|COMPLETED|Overall Study||3
284004|NCT01972516|680873|P2|STARTED|Overall Study||1
284005|NCT01972516|680874|P1|STARTED|Overall Study||3
284006|NCT01972438|680890|P2|NOT COMPLETED|Post Month 12 Study Period||4
284007|NCT01972438|680891|P1|NOT COMPLETED|Post Month 12 Study Period||3
284008|NCT01972438|680890|P2|COMPLETED|Post Month 12 Study Period||0
284009|NCT01972438|680891|P1|COMPLETED|Post Month 12 Study Period||0
284010|NCT01972438|680890|P2|STARTED|Post Month 12 Study Period||4
284011|NCT01972438|680891|P1|STARTED|Post Month 12 Study Period||3
284012|NCT01972438|680890|P2|NOT COMPLETED|Months 6-12 Study Period||2
284013|NCT01972438|680891|P1|NOT COMPLETED|Months 6-12 Study Period||3
284014|NCT01972438|680890|P2|COMPLETED|Months 6-12 Study Period||4
284015|NCT01972438|680891|P1|COMPLETED|Months 6-12 Study Period||3
284016|NCT01972438|680890|P2|STARTED|Months 6-12 Study Period||6
284017|NCT01972438|680891|P1|STARTED|Months 6-12 Study Period||6
284018|NCT01972438|680890|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
284019|NCT01972438|680891|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
284020|NCT01972438|680890|P2|COMPLETED|Months 3-6 Crossover Period||6
284021|NCT01972438|680891|P1|COMPLETED|Months 3-6 Crossover Period||6
284022|NCT01972438|680890|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
284023|NCT01972438|680891|P1|STARTED|Months 3-6 Crossover Period||6
284024|NCT01972438|680890|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
284025|NCT01972438|680891|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
284026|NCT01972438|680890|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
284027|NCT01972438|680891|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
284028|NCT01972438|680890|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
284029|NCT01972438|680891|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
284030|NCT01972152|680943|P6|NOT COMPLETED|Third Treatment Visit||0
284031|NCT01972152|680944|P5|NOT COMPLETED|Third Treatment Visit||0
284032|NCT01972152|680945|P4|NOT COMPLETED|Third Treatment Visit||0
284033|NCT01972152|680946|P3|NOT COMPLETED|Third Treatment Visit||0
284034|NCT01972152|680947|P2|NOT COMPLETED|Third Treatment Visit||0
284035|NCT01972152|680948|P1|NOT COMPLETED|Third Treatment Visit||0
284036|NCT01972152|680943|P6|COMPLETED|Third Treatment Visit||5
284037|NCT01972152|680944|P5|COMPLETED|Third Treatment Visit||5
284038|NCT01972152|680945|P4|COMPLETED|Third Treatment Visit||5
284039|NCT01972152|680946|P3|COMPLETED|Third Treatment Visit||5
284040|NCT01972152|680947|P2|COMPLETED|Third Treatment Visit||3
284041|NCT01972152|680948|P1|COMPLETED|Third Treatment Visit||5
284042|NCT01972152|680943|P6|STARTED|Third Treatment Visit||5
284043|NCT01972152|680944|P5|STARTED|Third Treatment Visit||5
284044|NCT01972152|680945|P4|STARTED|Third Treatment Visit||5
284045|NCT01972152|680946|P3|STARTED|Third Treatment Visit||5
284046|NCT01972152|680947|P2|STARTED|Third Treatment Visit||3
284047|NCT01972152|680948|P1|STARTED|Third Treatment Visit||5
284048|NCT01972152|680943|P6|NOT COMPLETED|Second Treatment Visit||0
284049|NCT01972152|680944|P5|NOT COMPLETED|Second Treatment Visit||0
284050|NCT01972152|680945|P4|NOT COMPLETED|Second Treatment Visit||0
284051|NCT01972152|680946|P3|NOT COMPLETED|Second Treatment Visit||0
284052|NCT01972152|680947|P2|NOT COMPLETED|Second Treatment Visit||1
284053|NCT01972152|680948|P1|NOT COMPLETED|Second Treatment Visit||0
284054|NCT01972152|680943|P6|COMPLETED|Second Treatment Visit||5
284055|NCT01972152|680944|P5|COMPLETED|Second Treatment Visit||5
284056|NCT01972152|680945|P4|COMPLETED|Second Treatment Visit||5
284057|NCT01972152|680946|P3|COMPLETED|Second Treatment Visit||5
284058|NCT01972152|680947|P2|COMPLETED|Second Treatment Visit||3
284059|NCT01972152|680948|P1|COMPLETED|Second Treatment Visit||5
284060|NCT01972152|680943|P6|STARTED|Second Treatment Visit||5
284061|NCT01972152|680944|P5|STARTED|Second Treatment Visit||5
284062|NCT01972152|680945|P4|STARTED|Second Treatment Visit||5
284063|NCT01972152|680946|P3|STARTED|Second Treatment Visit||5
284064|NCT01972152|680947|P2|STARTED|Second Treatment Visit||4
284065|NCT01972152|680948|P1|STARTED|Second Treatment Visit||5
284066|NCT01972152|680943|P6|NOT COMPLETED|First Treatment Visit||0
284067|NCT01972152|680944|P5|NOT COMPLETED|First Treatment Visit||0
284068|NCT01972152|680945|P4|NOT COMPLETED|First Treatment Visit||0
284069|NCT01972152|680946|P3|NOT COMPLETED|First Treatment Visit||0
284070|NCT01972152|680947|P2|NOT COMPLETED|First Treatment Visit||1
284071|NCT01972152|680948|P1|NOT COMPLETED|First Treatment Visit||0
284072|NCT01972152|680943|P6|COMPLETED|First Treatment Visit||5
284073|NCT01972152|680944|P5|COMPLETED|First Treatment Visit||5
284074|NCT01972152|680945|P4|COMPLETED|First Treatment Visit||5
284075|NCT01972152|680946|P3|COMPLETED|First Treatment Visit||5
284076|NCT01972152|680947|P2|COMPLETED|First Treatment Visit||4
284077|NCT01972152|680948|P1|COMPLETED|First Treatment Visit||5
284078|NCT01972152|680943|P6|STARTED|First Treatment Visit||5
284079|NCT01972152|680944|P5|STARTED|First Treatment Visit||5
284080|NCT01972152|680945|P4|STARTED|First Treatment Visit||5
284081|NCT01972152|680946|P3|STARTED|First Treatment Visit||5
284082|NCT01972152|680947|P2|STARTED|First Treatment Visit||5
284083|NCT01972152|680948|P1|STARTED|First Treatment Visit||5
284084|NCT01971723|680985|P2|NOT COMPLETED|Overall Study||3
284085|NCT01971723|680986|P1|NOT COMPLETED|Overall Study||2
284086|NCT01971723|680985|P2|COMPLETED|Overall Study||13
284087|NCT01971723|680986|P1|COMPLETED|Overall Study||14
284088|NCT01971723|680985|P2|STARTED|Overall Study||16
284089|NCT01971723|680986|P1|STARTED|Overall Study||16
284090|NCT01971554|681020|P4|NOT COMPLETED|Overall Study||0
284091|NCT01971554|681021|P3|NOT COMPLETED|Overall Study||0
284092|NCT01971554|681022|P2|NOT COMPLETED|Overall Study||0
284093|NCT01971554|681023|P1|NOT COMPLETED|Overall Study||1
284094|NCT01971554|681020|P4|COMPLETED|Overall Study||18
284095|NCT01971554|681021|P3|COMPLETED|Overall Study||18
284096|NCT01971554|681022|P2|COMPLETED|Overall Study||18
284097|NCT01971554|681023|P1|COMPLETED|Overall Study||8
284098|NCT01971554|681020|P4|STARTED|Overall Study||18
284099|NCT01971554|681021|P3|STARTED|Overall Study||18
284100|NCT01971554|681022|P2|STARTED|Overall Study||18
284101|NCT01971554|681023|P1|STARTED|Overall Study||9
284102|NCT01971255|681059|P2|NOT COMPLETED|Overall Study||2
284103|NCT01971255|681060|P1|NOT COMPLETED|Overall Study||1
284104|NCT01971255|681059|P2|COMPLETED|Overall Study||40
284105|NCT01971255|681060|P1|COMPLETED|Overall Study||31
284106|NCT01971255|681059|P2|STARTED|Overall Study||42
284107|NCT01971255|681060|P1|STARTED|Overall Study||32
284108|NCT01971086|681076|P1|NOT COMPLETED|Overall Study||0
284109|NCT01971086|681076|P1|COMPLETED|Overall Study||300
284110|NCT01971086|681076|P1|STARTED|Overall Study||300
284111|NCT01970995|681091|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
284112|NCT01970995|681092|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
284113|NCT01970995|681093|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
284114|NCT01970995|681091|P3|COMPLETED|End of Study (Population at Day 90)||38
284115|NCT01970995|681092|P2|COMPLETED|End of Study (Population at Day 90)||41
284116|NCT01970995|681093|P1|COMPLETED|End of Study (Population at Day 90)||76
284117|NCT01970995|681091|P3|STARTED|End of Study (Population at Day 90)||39
284118|NCT01970995|681092|P2|STARTED|End of Study (Population at Day 90)||41
284119|NCT01970995|681093|P1|STARTED|End of Study (Population at Day 90)||77
284120|NCT01970995|681091|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
284121|NCT01970995|681092|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
284122|NCT01970995|681093|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
284123|NCT01970995|681091|P3|COMPLETED|Confinement Period (Population at Day 5)||39
284124|NCT01970995|681092|P2|COMPLETED|Confinement Period (Population at Day 5)||41
284125|NCT01970995|681093|P1|COMPLETED|Confinement Period (Population at Day 5)||77
284126|NCT01970995|681091|P3|STARTED|Confinement Period (Population at Day 5)||40
284127|NCT01970995|681092|P2|STARTED|Confinement Period (Population at Day 5)||42
284128|NCT01970995|681093|P1|STARTED|Confinement Period (Population at Day 5)||78
284129|NCT01970982|681116|P3|NOT COMPLETED|Overall Study||2
284130|NCT01970982|681117|P2|NOT COMPLETED|Overall Study||0
284131|NCT01970982|681118|P1|NOT COMPLETED|Overall Study||0
284132|NCT01970982|681116|P3|COMPLETED|Overall Study||38
284133|NCT01970982|681117|P2|COMPLETED|Overall Study||40
284134|NCT01970982|681118|P1|COMPLETED|Overall Study||80
284135|NCT01970982|681116|P3|STARTED|Overall Study||40
284136|NCT01970982|681117|P2|STARTED|Overall Study||40
284137|NCT01970982|681118|P1|STARTED|Overall Study||80
284138|NCT01970878|681140|P4|NOT COMPLETED|Overall Study||24
284139|NCT01970878|681141|P3|NOT COMPLETED|Overall Study||26
284140|NCT01970878|681142|P2|NOT COMPLETED|Overall Study||27
284141|NCT01970878|681143|P1|NOT COMPLETED|Overall Study||37
284142|NCT01970878|681140|P4|COMPLETED|Overall Study||147
284143|NCT01970878|681141|P3|COMPLETED|Overall Study||187
284144|NCT01970878|681142|P2|COMPLETED|Overall Study||191
284145|NCT01970878|681143|P1|COMPLETED|Overall Study||253
284146|NCT01970878|681140|P4|STARTED|Overall Study||171
284147|NCT01970878|681141|P3|STARTED|Overall Study||213
284148|NCT01970878|681142|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
284149|NCT01970878|681143|P1|STARTED|Overall Study||290
284150|NCT01970787|681169|P1|NOT COMPLETED|Overall Study||1
284151|NCT01970787|681169|P1|COMPLETED|Overall Study||21
284152|NCT01970787|681169|P1|STARTED|Overall Study||22
284153|NCT01970488|681179|P5|NOT COMPLETED|Part 2: Post Week 16||8
284154|NCT01970488|681180|P4|NOT COMPLETED|Part 2: Post Week 16||8
284155|NCT01970488|681181|P3|NOT COMPLETED|Part 2: Post Week 16||17
284156|NCT01970488|681182|P2|NOT COMPLETED|Part 2: Post Week 16||0
284157|NCT01970488|681183|P1|NOT COMPLETED|Part 2: Post Week 16||0
284158|NCT01970488|681179|P5|COMPLETED|Part 2: Post Week 16||69
284159|NCT01970488|681180|P4|COMPLETED|Part 2: Post Week 16||71
284160|NCT01970488|681181|P3|COMPLETED|Part 2: Post Week 16||135
284161|NCT01970488|681182|P2|COMPLETED|Part 2: Post Week 16||0
284162|NCT01970488|681183|P1|COMPLETED|Part 2: Post Week 16||0
284163|NCT01970488|681179|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
284164|NCT01970488|681180|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
284165|NCT01970488|681181|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
284166|NCT01970488|681182|P2|STARTED|Part 2: Post Week 16||0
284167|NCT01970488|681183|P1|STARTED|Part 2: Post Week 16||0
284168|NCT01970488|681179|P5|NOT COMPLETED|Part 1: Through Week 16||0
284169|NCT01970488|681180|P4|NOT COMPLETED|Part 1: Through Week 16||0
284170|NCT01970488|681181|P3|NOT COMPLETED|Part 1: Through Week 16||0
284171|NCT01970488|681182|P2|NOT COMPLETED|Part 1: Through Week 16||13
284172|NCT01970488|681183|P1|NOT COMPLETED|Part 1: Through Week 16||11
284173|NCT01970488|681179|P5|COMPLETED|Part 1: Through Week 16||0
284174|NCT01970488|681180|P4|COMPLETED|Part 1: Through Week 16||0
284175|NCT01970488|681181|P3|COMPLETED|Part 1: Through Week 16||0
284176|NCT01970488|681182|P2|COMPLETED|Part 1: Through Week 16||162
284177|NCT01970488|681183|P1|COMPLETED|Part 1: Through Week 16||164
284178|NCT01970488|681179|P5|Received Treatment|Part 1: Through Week 16||0
284179|NCT01970488|681180|P4|Received Treatment|Part 1: Through Week 16||0
284180|NCT01970488|681181|P3|Received Treatment|Part 1: Through Week 16||0
284181|NCT01970488|681182|P2|Received Treatment|Part 1: Through Week 16||173
284182|NCT01970488|681183|P1|Received Treatment|Part 1: Through Week 16||174
284183|NCT01970488|681179|P5|STARTED|Part 1: Through Week 16||0
284184|NCT01970488|681180|P4|STARTED|Part 1: Through Week 16||0
284185|NCT01970488|681181|P3|STARTED|Part 1: Through Week 16||0
284186|NCT01970488|681182|P2|STARTED|Part 1: Through Week 16||175
284187|NCT01970488|681183|P1|STARTED|Part 1: Through Week 16||175
284188|NCT01970475|681250|P2|NOT COMPLETED|Overall Study||11
284189|NCT01970475|681251|P1|NOT COMPLETED|Overall Study||21
284190|NCT01970475|681250|P2|COMPLETED|Overall Study||251
284191|NCT01970475|681251|P1|COMPLETED|Overall Study||243
284192|NCT01970475|681250|P2|STARTED|Overall Study||262
284193|NCT01970475|681251|P1|STARTED|Overall Study||264
284194|NCT01970397|681271|P2|NOT COMPLETED|Overall Study||5
284195|NCT01970397|681272|P1|NOT COMPLETED|Overall Study||2
284196|NCT01970397|681271|P2|COMPLETED|Overall Study||64
284197|NCT01970397|681272|P1|COMPLETED|Overall Study||67
284198|NCT01970397|681271|P2|STARTED|Overall Study||69
284199|NCT01970397|681272|P1|STARTED|Overall Study||69
284200|NCT01969084|681284|P2|NOT COMPLETED|Overall Study||1
284201|NCT01969084|681285|P1|NOT COMPLETED|Overall Study||0
284202|NCT01969084|681284|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
284203|NCT01969084|681285|P1|COMPLETED|Overall Study||19
284204|NCT01969084|681284|P2|STARTED|Overall Study||22
284205|NCT01969084|681285|P1|STARTED|Overall Study||19
284206|NCT01968980|681301|P2|NOT COMPLETED|Overall Study||14
284207|NCT01968980|681302|P1|NOT COMPLETED|Overall Study||16
284208|NCT01968980|681301|P2|COMPLETED|Overall Study||171
284209|NCT01968980|681302|P1|COMPLETED|Overall Study||169
284210|NCT01968980|681301|P2|STARTED|Overall Study||185
284211|NCT01968980|681302|P1|STARTED|Overall Study||185
284212|NCT01968954|681364|P2|NOT COMPLETED|Overall Study||43
284213|NCT01968954|681365|P1|NOT COMPLETED|Overall Study||40
284214|NCT01968954|681364|P2|COMPLETED|Overall Study||314
284215|NCT01968954|681365|P1|COMPLETED|Overall Study||314
284216|NCT01968954|681364|P2|Treated|Overall Study||356
284217|NCT01968954|681365|P1|Treated|Overall Study||353
284218|NCT01968954|681364|P2|STARTED|Overall Study||357
284219|NCT01968954|681365|P1|STARTED|Overall Study||354
284220|NCT01969747|681433|P4|NOT COMPLETED|Overall Study||0
284221|NCT01969747|681434|P3|NOT COMPLETED|Overall Study||0
284222|NCT01969747|681435|P2|NOT COMPLETED|Overall Study||0
284223|NCT01969747|681436|P1|NOT COMPLETED|Overall Study||0
284224|NCT01969747|681433|P4|COMPLETED|Overall Study||18
284225|NCT01969747|681434|P3|COMPLETED|Overall Study||19
284226|NCT01969747|681435|P2|COMPLETED|Overall Study||19
284227|NCT01969747|681436|P1|COMPLETED|Overall Study||19
284228|NCT01969747|681433|P4|STARTED|Overall Study||18
284229|NCT01969747|681434|P3|STARTED|Overall Study||19
284230|NCT01969747|681435|P2|STARTED|Overall Study||19
284231|NCT01969747|681436|P1|STARTED|Overall Study||19
284232|NCT01969721|681446|P4|NOT COMPLETED|Overall Study||6
284233|NCT01969721|681447|P3|NOT COMPLETED|Overall Study||5
284234|NCT01969721|681448|P2|NOT COMPLETED|Overall Study||12
284235|NCT01969721|681449|P1|NOT COMPLETED|Overall Study||4
284236|NCT01969721|681446|P4|COMPLETED|Overall Study||46
284237|NCT01969721|681447|P3|COMPLETED|Overall Study||45
284238|NCT01969721|681448|P2|COMPLETED|Overall Study||57
284239|NCT01969721|681449|P1|COMPLETED|Overall Study||54
284240|NCT01969721|681446|P4|STARTED|Overall Study||52
284241|NCT01969721|681447|P3|STARTED|Overall Study||50
284242|NCT01969721|681448|P2|STARTED|Overall Study||69
284243|NCT01969721|681449|P1|STARTED|Overall Study||58
284244|NCT01969565|681475|P1|NOT COMPLETED|Overall Study||1
284245|NCT01969565|681475|P1|COMPLETED|Overall Study||0
284246|NCT01969565|681475|P1|STARTED|Overall Study||1
284247|NCT01969539|681479|P1|NOT COMPLETED|Overall Study||0
284248|NCT01969539|681479|P1|COMPLETED|Overall Study||11
284249|NCT01969539|681479|P1|STARTED|Overall Study||11
284250|NCT01969435|681485|P1|NOT COMPLETED|Overall Study||0
284251|NCT01969435|681485|P1|COMPLETED|Overall Study||50
284252|NCT01969435|681485|P1|STARTED|Overall Study||50
284253|NCT01969162|681498|P1|NOT COMPLETED|Overall Study||0
284254|NCT01969162|681498|P1|COMPLETED|Overall Study||35
284255|NCT01969162|681498|P1|STARTED|Overall Study||35
284256|NCT01968811|681502|P1|NOT COMPLETED|Overall Study||5
284257|NCT01968811|681502|P1|COMPLETED|Overall Study||5
284258|NCT01968811|681502|P1|STARTED|Overall Study||10
284259|NCT01968694|681509|P2|NOT COMPLETED|Visit 2 (1 Day)||0
284260|NCT01968694|681510|P1|NOT COMPLETED|Visit 2 (1 Day)||0
284261|NCT01968694|681509|P2|COMPLETED|Visit 2 (1 Day)||8
284262|NCT01968694|681510|P1|COMPLETED|Visit 2 (1 Day)||10
284263|NCT01968694|681509|P2|STARTED|Visit 2 (1 Day)||8
284264|NCT01968694|681510|P1|STARTED|Visit 2 (1 Day)||10
284265|NCT01968694|681509|P2|NOT COMPLETED|Washout (1 Month)||1
284266|NCT01968694|681510|P1|NOT COMPLETED|Washout (1 Month)||0
284267|NCT01968694|681509|P2|COMPLETED|Washout (1 Month)||8
284268|NCT01968694|681510|P1|COMPLETED|Washout (1 Month)||10
284269|NCT01968694|681509|P2|STARTED|Washout (1 Month)||9
284270|NCT01968694|681510|P1|STARTED|Washout (1 Month)||10
284271|NCT01968694|681509|P2|NOT COMPLETED|Visit 1 (1 Day)||0
284272|NCT01968694|681510|P1|NOT COMPLETED|Visit 1 (1 Day)||0
284273|NCT01968694|681509|P2|COMPLETED|Visit 1 (1 Day)||9
284274|NCT01968694|681510|P1|COMPLETED|Visit 1 (1 Day)||10
284275|NCT01968694|681509|P2|STARTED|Visit 1 (1 Day)||9
284276|NCT01968694|681510|P1|STARTED|Visit 1 (1 Day)||10
284277|NCT01968551|681527|P3|NOT COMPLETED|Extension Phase||34
284278|NCT01968551|681528|P2|NOT COMPLETED|Extension Phase||87
284279|NCT01968551|681529|P1|NOT COMPLETED|Extension Phase||20
284280|NCT01968551|681527|P3|COMPLETED|Extension Phase||0
284281|NCT01968551|681528|P2|COMPLETED|Extension Phase||0
284282|NCT01968551|681529|P1|COMPLETED|Extension Phase||0
284368|NCT01967732|681614|P3|COMPLETED|First Intervention (Day 1)||9
284283|NCT01968551|681527|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
284284|NCT01968551|681528|P2|STARTED|Extension Phase||87
284285|NCT01968551|681529|P1|STARTED|Extension Phase||20
284286|NCT01968551|681527|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
284287|NCT01968551|681528|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
284288|NCT01968551|681529|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
284289|NCT01968551|681527|P3|COMPLETED|Open Label Phase (48 Weeks)||41
284290|NCT01968551|681528|P2|COMPLETED|Open Label Phase (48 Weeks)||87
284291|NCT01968551|681529|P1|COMPLETED|Open Label Phase (48 Weeks)||20
284292|NCT01968551|681527|P3|STARTED|Open Label Phase (48 Weeks)||46
284293|NCT01968551|681528|P2|STARTED|Open Label Phase (48 Weeks)||90
284294|NCT01968551|681529|P1|STARTED|Open Label Phase (48 Weeks)||22
284295|NCT01968434|681545|P2|NOT COMPLETED|Overall Study||6
284296|NCT01968434|681546|P1|NOT COMPLETED|Overall Study||3
284297|NCT01968434|681545|P2|COMPLETED|Overall Study||66
284298|NCT01968434|681546|P1|COMPLETED|Overall Study||75
284299|NCT01968434|681545|P2|STARTED|Overall Study||72
284300|NCT01968434|681546|P1|STARTED|Overall Study||78
284301|NCT01968135|681558|P2|NOT COMPLETED|Overall Study||0
284302|NCT01968135|681559|P1|NOT COMPLETED|Overall Study||0
284303|NCT01968135|681558|P2|COMPLETED|Overall Study||16
284304|NCT01968135|681559|P1|COMPLETED|Overall Study||16
284305|NCT01968135|681558|P2|STARTED|Overall Study||16
284306|NCT01968135|681559|P1|STARTED|Overall Study||16
284307|NCT01968057|681571|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
284308|NCT01968057|681571|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
284309|NCT01968057|681571|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
284310|NCT01968057|681571|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
284311|NCT01968057|681571|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
284312|NCT01968057|681571|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
284313|NCT01968057|681571|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
284314|NCT01968057|681571|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
284315|NCT01967940|681584|P3|NOT COMPLETED|Part 2||14
284316|NCT01967940|681585|P2|NOT COMPLETED|Part 2||16
284317|NCT01967940|681586|P1|NOT COMPLETED|Part 2||8
284318|NCT01967940|681584|P3|COMPLETED|Part 2||0
284319|NCT01967940|681585|P2|COMPLETED|Part 2||0
284320|NCT01967940|681586|P1|COMPLETED|Part 2||0
284321|NCT01967940|681584|P3|STARTED|Part 2|1 participant completed Part 1, but did not enter Part 2 of the study|14
284322|NCT01967940|681585|P2|STARTED|Part 2|12 participants completed Part 1, but did not enter Part 2 of the study|16
284323|NCT01967940|681586|P1|STARTED|Part 2|4 participants completed Part 1, but did not enter Part 2 of the study|8
284324|NCT01967940|681584|P3|NOT COMPLETED|Part 1||0
284325|NCT01967940|681585|P2|NOT COMPLETED|Part 1||0
284326|NCT01967940|681586|P1|NOT COMPLETED|Part 1||0
284327|NCT01967940|681584|P3|COMPLETED|Part 1||15
284328|NCT01967940|681585|P2|COMPLETED|Part 1||28
284329|NCT01967940|681586|P1|COMPLETED|Part 1||12
284330|NCT01967940|681584|P3|STARTED|Part 1||15
284331|NCT01967940|681585|P2|STARTED|Part 1||28
284332|NCT01967940|681586|P1|STARTED|Part 1||12
284333|NCT01967836|681597|P1|NOT COMPLETED|Overall Study||9
284334|NCT01967836|681597|P1|COMPLETED|Overall Study||11
284335|NCT01967836|681597|P1|STARTED|Overall Study||20
284336|NCT01967784|681603|P1|NOT COMPLETED|Overall Study||0
284337|NCT01967784|681603|P1|COMPLETED|Overall Study||100
284338|NCT01967784|681603|P1|STARTED|Overall Study||100
284339|NCT01967732|681613|P4|NOT COMPLETED|Second Intervention (Day 3)||0
284340|NCT01967732|681614|P3|NOT COMPLETED|Second Intervention (Day 3)||0
284341|NCT01967732|681615|P2|NOT COMPLETED|Second Intervention (Day 3)||0
284342|NCT01967732|681616|P1|NOT COMPLETED|Second Intervention (Day 3)||0
284343|NCT01967732|681613|P4|COMPLETED|Second Intervention (Day 3)||9
284344|NCT01967732|681614|P3|COMPLETED|Second Intervention (Day 3)||9
284345|NCT01967732|681615|P2|COMPLETED|Second Intervention (Day 3)||20
284346|NCT01967732|681616|P1|COMPLETED|Second Intervention (Day 3)||22
284347|NCT01967732|681613|P4|STARTED|Second Intervention (Day 3)||9
284348|NCT01967732|681614|P3|STARTED|Second Intervention (Day 3)||9
284349|NCT01967732|681615|P2|STARTED|Second Intervention (Day 3)||20
284350|NCT01967732|681616|P1|STARTED|Second Intervention (Day 3)||22
284351|NCT01967732|681613|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284352|NCT01967732|681614|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284353|NCT01967732|681615|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284354|NCT01967732|681616|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284355|NCT01967732|681613|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
284356|NCT01967732|681614|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
284357|NCT01967732|681615|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
284358|NCT01967732|681616|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
284359|NCT01967732|681613|P4|STARTED|Washout Period of 1 Day (Day 2)||9
284360|NCT01967732|681614|P3|STARTED|Washout Period of 1 Day (Day 2)||9
284361|NCT01967732|681615|P2|STARTED|Washout Period of 1 Day (Day 2)||20
284362|NCT01967732|681616|P1|STARTED|Washout Period of 1 Day (Day 2)||22
284363|NCT01967732|681613|P4|NOT COMPLETED|First Intervention (Day 1)||0
284364|NCT01967732|681614|P3|NOT COMPLETED|First Intervention (Day 1)||0
284365|NCT01967732|681615|P2|NOT COMPLETED|First Intervention (Day 1)||1
284366|NCT01967732|681616|P1|NOT COMPLETED|First Intervention (Day 1)||0
284367|NCT01967732|681613|P4|COMPLETED|First Intervention (Day 1)||9
284369|NCT01967732|681615|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
284370|NCT01967732|681616|P1|COMPLETED|First Intervention (Day 1)||22
284371|NCT01967732|681613|P4|STARTED|First Intervention (Day 1)||9
284372|NCT01967732|681614|P3|STARTED|First Intervention (Day 1)||9
284373|NCT01967732|681615|P2|STARTED|First Intervention (Day 1)||21
284374|NCT01967732|681616|P1|STARTED|First Intervention (Day 1)||22
284375|NCT01967732|681613|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284376|NCT01967732|681614|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284377|NCT01967732|681615|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
284378|NCT01967732|681616|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284379|NCT01967732|681613|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
284380|NCT01967732|681614|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
284381|NCT01967732|681615|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
284382|NCT01967732|681616|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
284383|NCT01967732|681613|P4|STARTED|Washout Period of 1 Day (Day 0)||9
284384|NCT01967732|681614|P3|STARTED|Washout Period of 1 Day (Day 0)||9
284385|NCT01967732|681615|P2|STARTED|Washout Period of 1 Day (Day 0)||22
284386|NCT01967732|681616|P1|STARTED|Washout Period of 1 Day (Day 0)||22
284387|NCT01967719|681630|P4|NOT COMPLETED|Second Intervention (Day 3)||0
284388|NCT01967719|681631|P3|NOT COMPLETED|Second Intervention (Day 3)||0
284389|NCT01967719|681632|P2|NOT COMPLETED|Second Intervention (Day 3)||1
284390|NCT01967719|681633|P1|NOT COMPLETED|Second Intervention (Day 3)||0
284391|NCT01967719|681630|P4|COMPLETED|Second Intervention (Day 3)||8
284392|NCT01967719|681631|P3|COMPLETED|Second Intervention (Day 3)||9
284393|NCT01967719|681632|P2|COMPLETED|Second Intervention (Day 3)||20
284394|NCT01967719|681633|P1|COMPLETED|Second Intervention (Day 3)||22
284395|NCT01967719|681630|P4|STARTED|Second Intervention (Day 3)||8
284396|NCT01967719|681631|P3|STARTED|Second Intervention (Day 3)||9
284397|NCT01967719|681632|P2|STARTED|Second Intervention (Day 3)||21
284398|NCT01967719|681633|P1|STARTED|Second Intervention (Day 3)||22
284399|NCT01967719|681630|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284400|NCT01967719|681631|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284401|NCT01967719|681632|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284402|NCT01967719|681633|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284403|NCT01967719|681630|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
284404|NCT01967719|681631|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
284405|NCT01967719|681632|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
284406|NCT01967719|681633|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
284407|NCT01967719|681630|P4|STARTED|Washout Period of 1 Day (Day 2)||8
284408|NCT01967719|681631|P3|STARTED|Washout Period of 1 Day (Day 2)||9
284409|NCT01967719|681632|P2|STARTED|Washout Period of 1 Day (Day 2)||21
284410|NCT01967719|681633|P1|STARTED|Washout Period of 1 Day (Day 2)||22
284411|NCT01967719|681630|P4|NOT COMPLETED|First Intervention (Day 1)||1
284412|NCT01967719|681631|P3|NOT COMPLETED|First Intervention (Day 1)||0
284413|NCT01967719|681632|P2|NOT COMPLETED|First Intervention (Day 1)||1
284414|NCT01967719|681633|P1|NOT COMPLETED|First Intervention (Day 1)||0
284415|NCT01967719|681630|P4|COMPLETED|First Intervention (Day 1)||8
284416|NCT01967719|681631|P3|COMPLETED|First Intervention (Day 1)||9
284417|NCT01967719|681632|P2|COMPLETED|First Intervention (Day 1)||21
284418|NCT01967719|681633|P1|COMPLETED|First Intervention (Day 1)||22
284419|NCT01967719|681630|P4|STARTED|First Intervention (Day 1)||9
284420|NCT01967719|681631|P3|STARTED|First Intervention (Day 1)||9
284421|NCT01967719|681632|P2|STARTED|First Intervention (Day 1)||22
284422|NCT01967719|681633|P1|STARTED|First Intervention (Day 1)||22
284423|NCT01967719|681630|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284424|NCT01967719|681631|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284425|NCT01967719|681632|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284426|NCT01967719|681633|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284427|NCT01967719|681630|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
284428|NCT01967719|681631|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
284429|NCT01967719|681632|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
284430|NCT01967719|681633|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
284431|NCT01967719|681630|P4|STARTED|Washout Period of 1 Day (Day 0)||9
284432|NCT01967719|681631|P3|STARTED|Washout Period of 1 Day (Day 0)||9
284433|NCT01967719|681632|P2|STARTED|Washout Period of 1 Day (Day 0)||22
284434|NCT01967719|681633|P1|STARTED|Washout Period of 1 Day (Day 0)||22
284435|NCT01967706|681648|P4|NOT COMPLETED|Second Intervention (Day 3)||0
284436|NCT01967706|681649|P3|NOT COMPLETED|Second Intervention (Day 3)||0
284437|NCT01967706|681650|P2|NOT COMPLETED|Second Intervention (Day 3)||0
284438|NCT01967706|681651|P1|NOT COMPLETED|Second Intervention (Day 3)||0
284439|NCT01967706|681648|P4|COMPLETED|Second Intervention (Day 3)||9
284440|NCT01967706|681649|P3|COMPLETED|Second Intervention (Day 3)||9
284441|NCT01967706|681650|P2|COMPLETED|Second Intervention (Day 3)||22
284442|NCT01967706|681651|P1|COMPLETED|Second Intervention (Day 3)||21
284443|NCT01967706|681648|P4|STARTED|Second Intervention (Day 3)||9
284444|NCT01967706|681649|P3|STARTED|Second Intervention (Day 3)||9
284445|NCT01967706|681650|P2|STARTED|Second Intervention (Day 3)||22
284446|NCT01967706|681651|P1|STARTED|Second Intervention (Day 3)||21
284447|NCT01967706|681648|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284448|NCT01967706|681649|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284449|NCT01967706|681650|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284450|NCT01967706|681651|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
284451|NCT01967706|681648|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
284452|NCT01967706|681649|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
284453|NCT01967706|681650|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
284454|NCT01967706|681651|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
284455|NCT01967706|681648|P4|STARTED|Washout Period of 1 Day (Day 2)||9
284456|NCT01967706|681649|P3|STARTED|Washout Period of 1 Day (Day 2)||9
284457|NCT01967706|681650|P2|STARTED|Washout Period of 1 Day (Day 2)||22
284458|NCT01967706|681651|P1|STARTED|Washout Period of 1 Day (Day 2)||21
284459|NCT01967706|681648|P4|NOT COMPLETED|First Intervention (Day 1)||0
284460|NCT01967706|681649|P3|NOT COMPLETED|First Intervention (Day 1)||0
284461|NCT01967706|681650|P2|NOT COMPLETED|First Intervention (Day 1)||0
284462|NCT01967706|681651|P1|NOT COMPLETED|First Intervention (Day 1)||1
284463|NCT01967706|681648|P4|COMPLETED|First Intervention (Day 1)||9
284464|NCT01967706|681649|P3|COMPLETED|First Intervention (Day 1)||9
284465|NCT01967706|681650|P2|COMPLETED|First Intervention (Day 1)||22
284466|NCT01967706|681651|P1|COMPLETED|First Intervention (Day 1)||21
284467|NCT01967706|681648|P4|STARTED|First Intervention (Day 1)||9
284468|NCT01967706|681649|P3|STARTED|First Intervention (Day 1)||9
284469|NCT01967706|681650|P2|STARTED|First Intervention (Day 1)||22
284470|NCT01967706|681651|P1|STARTED|First Intervention (Day 1)||22
284471|NCT01967706|681648|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284472|NCT01967706|681649|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284473|NCT01967706|681650|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284474|NCT01967706|681651|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
284475|NCT01967706|681648|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
284476|NCT01967706|681649|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
284477|NCT01967706|681650|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
284478|NCT01967706|681651|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
284479|NCT01967706|681648|P4|STARTED|Washout Period of 1 Day (Day 0)||9
284480|NCT01967706|681649|P3|STARTED|Washout Period of 1 Day (Day 0)||9
284481|NCT01967706|681650|P2|STARTED|Washout Period of 1 Day (Day 0)||22
284482|NCT01967706|681651|P1|STARTED|Washout Period of 1 Day (Day 0)||22
284483|NCT01967550|681662|P2|NOT COMPLETED|Overall Study||2
284484|NCT01967550|681663|P1|NOT COMPLETED|Overall Study||5
284485|NCT01967550|681662|P2|COMPLETED|Overall Study||149
284486|NCT01967550|681663|P1|COMPLETED|Overall Study||148
284487|NCT01967550|681662|P2|STARTED|Overall Study||151
284488|NCT01967550|681663|P1|STARTED|Overall Study||153
284489|NCT01967342|681672|P3|NOT COMPLETED|Overall Study||29
284490|NCT01967342|681673|P2|NOT COMPLETED|Overall Study||25
284491|NCT01967342|681674|P1|NOT COMPLETED|Overall Study||27
284492|NCT01967342|681672|P3|COMPLETED|Overall Study||68
284493|NCT01967342|681673|P2|COMPLETED|Overall Study||70
284494|NCT01967342|681674|P1|COMPLETED|Overall Study||71
284495|NCT01967342|681672|P3|10-week Follow-up|Overall Study||80
284496|NCT01967342|681673|P2|10-week Follow-up|Overall Study||83
284497|NCT01967342|681674|P1|10-week Follow-up|Overall Study||78
284498|NCT01967342|681672|P3|5-week Follow-up|Overall Study||76
284499|NCT01967342|681673|P2|5-week Follow-up|Overall Study||78
284500|NCT01967342|681674|P1|5-week Follow-up|Overall Study||83
284501|NCT01967342|681672|P3|STARTED|Overall Study||97
284502|NCT01967342|681673|P2|STARTED|Overall Study||95
284503|NCT01967342|681674|P1|STARTED|Overall Study||98
284504|NCT01967277|681693|P2|NOT COMPLETED|Overall Study||3
284505|NCT01967277|681694|P1|NOT COMPLETED|Overall Study||1
284506|NCT01967277|681693|P2|COMPLETED|Overall Study||19
284507|NCT01967277|681694|P1|COMPLETED|Overall Study||21
284508|NCT01967277|681693|P2|STARTED|Overall Study||22
284509|NCT01967277|681694|P1|STARTED|Overall Study||22
284510|NCT01967147|681704|P2|NOT COMPLETED|Overall Study||20
284511|NCT01967147|681705|P1|NOT COMPLETED|Overall Study||13
284512|NCT01967147|681704|P2|COMPLETED|Overall Study||82
284513|NCT01967147|681705|P1|COMPLETED|Overall Study||99
284514|NCT01967147|681704|P2|STARTED|Overall Study||102
284515|NCT01967147|681705|P1|STARTED|Overall Study||112
284516|NCT01967121|681723|P3|NOT COMPLETED|Overall Study||0
284517|NCT01967121|681724|P2|NOT COMPLETED|Overall Study||0
284518|NCT01967121|681725|P1|NOT COMPLETED|Overall Study||0
284519|NCT01967121|681723|P3|COMPLETED|Overall Study||25
284520|NCT01967121|681724|P2|COMPLETED|Overall Study||25
284521|NCT01967121|681725|P1|COMPLETED|Overall Study||25
284522|NCT01967121|681723|P3|STARTED|Overall Study||25
284523|NCT01967121|681724|P2|STARTED|Overall Study||25
284524|NCT01967121|681725|P1|STARTED|Overall Study||25
284525|NCT01967069|681735|P2|NOT COMPLETED|Overall Study||8
284526|NCT01967069|681736|P1|NOT COMPLETED|Overall Study||8
284527|NCT01967069|681735|P2|COMPLETED|Overall Study||87
284528|NCT01967069|681736|P1|COMPLETED|Overall Study||174
284529|NCT01967069|681735|P2|STARTED|Overall Study||95
284530|NCT01967069|681736|P1|STARTED|Overall Study||182
284531|NCT01966926|681744|P2|NOT COMPLETED|Overall Study||0
284532|NCT01966926|681745|P1|NOT COMPLETED|Overall Study||0
284533|NCT01966926|681744|P2|COMPLETED|Overall Study||15
284534|NCT01966926|681745|P1|COMPLETED|Overall Study||15
284535|NCT01966926|681744|P2|STARTED|Overall Study||15
284536|NCT01966926|681745|P1|STARTED|Overall Study||15
284537|NCT01966770|681761|P1|NOT COMPLETED|Overall Study||0
284538|NCT01966770|681761|P1|COMPLETED|Overall Study||20
284539|NCT01966770|681761|P1|STARTED|Overall Study||20
284540|NCT01966718|681870|P1|NOT COMPLETED|Overall Study||0
284541|NCT01966718|681870|P1|COMPLETED|Overall Study||8
284542|NCT01966718|681870|P1|STARTED|Overall Study||8
284543|NCT01966380|681878|P2|NOT COMPLETED|Overall Study||1
284544|NCT01966380|681879|P1|NOT COMPLETED|Overall Study||0
284545|NCT01966380|681878|P2|COMPLETED|Overall Study||2
284546|NCT01966380|681879|P1|COMPLETED|Overall Study||3
284547|NCT01966380|681878|P2|STARTED|Overall Study||3
284548|NCT01966380|681879|P1|STARTED|Overall Study||3
284549|NCT01966354|681888|P3|NOT COMPLETED|Overall Study||0
284550|NCT01966354|681889|P2|NOT COMPLETED|Overall Study||0
284551|NCT01966354|681890|P1|NOT COMPLETED|Overall Study||0
284552|NCT01966354|681888|P3|COMPLETED|Overall Study||72
284553|NCT01966354|681889|P2|COMPLETED|Overall Study||73
284554|NCT01966354|681890|P1|COMPLETED|Overall Study||75
284555|NCT01966354|681888|P3|STARTED|Overall Study||72
284556|NCT01966354|681889|P2|STARTED|Overall Study||73
284557|NCT01966354|681890|P1|STARTED|Overall Study||75
284558|NCT01966159|681915|P2|NOT COMPLETED|Overall Study||0
284559|NCT01966159|681916|P1|NOT COMPLETED|Overall Study||0
284560|NCT01966159|681915|P2|COMPLETED|Overall Study||207
284561|NCT01966159|681916|P1|COMPLETED|Overall Study||205
284562|NCT01966159|681915|P2|STARTED|Overall Study||207
284563|NCT01966159|681916|P1|STARTED|Overall Study||205
284564|NCT01966120|681928|P2|NOT COMPLETED|Overall Study||6
284565|NCT01966120|681929|P1|NOT COMPLETED|Overall Study||1
284566|NCT01966120|681928|P2|COMPLETED|Overall Study||26
284567|NCT01966120|681929|P1|COMPLETED|Overall Study||54
284568|NCT01966120|681928|P2|STARTED|Overall Study||32
284569|NCT01966120|681929|P1|STARTED|Overall Study||55
284570|NCT01966068|681953|P1|NOT COMPLETED|Overall Study||138
284571|NCT01966068|681953|P1|COMPLETED|Overall Study||156
284572|NCT01966068|681953|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
284573|NCT01966068|681953|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
284574|NCT01966068|681953|P1|STARTED|Overall Study||294
284575|NCT01966042|681958|P1|NOT COMPLETED|Overall Study||2
284576|NCT01966042|681958|P1|COMPLETED|Overall Study||11
284577|NCT01966042|681958|P1|STARTED|Overall Study||13
284578|NCT01965938|681967|P2|NOT COMPLETED|Overall Study||0
284579|NCT01965938|681968|P1|NOT COMPLETED|Overall Study||1
284580|NCT01965938|681967|P2|COMPLETED|Overall Study||20
284581|NCT01965938|681968|P1|COMPLETED|Overall Study||20
284582|NCT01965938|681967|P2|STARTED|Overall Study||20
284583|NCT01965938|681968|P1|STARTED|Overall Study||21
284584|NCT01965899|681988|P1|NOT COMPLETED|Overall Study||6
284585|NCT01965899|681988|P1|COMPLETED|Overall Study||145
284586|NCT01965899|681988|P1|STARTED|Overall Study||151
284587|NCT01965834|681999|P1|NOT COMPLETED|Overall Study||4
284588|NCT01965834|681999|P1|COMPLETED|Overall Study||2
284589|NCT01965834|681999|P1|STARTED|Overall Study||6
284590|NCT01965665|682005|P1|NOT COMPLETED|Overall Study||1
284591|NCT01965665|682005|P1|COMPLETED|Overall Study||19
284592|NCT01965665|682005|P1|STARTED|Overall Study||20
284593|NCT01965652|682013|P2|NOT COMPLETED|Overall Study||210
284594|NCT01965652|682014|P1|NOT COMPLETED|Overall Study||210
284595|NCT01965652|682013|P2|COMPLETED|Overall Study||413
284596|NCT01965652|682014|P1|COMPLETED|Overall Study||413
284597|NCT01965652|682013|P2|Received Treatment|Overall Study||623
284598|NCT01965652|682014|P1|Received Treatment|Overall Study||622
284599|NCT01965652|682013|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
284600|NCT01965652|682014|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
284601|NCT01965600|682044|P4|NOT COMPLETED|Second Intervention||2
284602|NCT01965600|682045|P3|NOT COMPLETED|Second Intervention||2
284603|NCT01965600|682046|P2|NOT COMPLETED|Second Intervention||0
284604|NCT01965600|682047|P1|NOT COMPLETED|Second Intervention||0
284605|NCT01965600|682044|P4|COMPLETED|Second Intervention||0
284606|NCT01965600|682045|P3|COMPLETED|Second Intervention||1
284607|NCT01965600|682046|P2|COMPLETED|Second Intervention||4
284608|NCT01965600|682047|P1|COMPLETED|Second Intervention||4
284609|NCT01965600|682044|P4|STARTED|Second Intervention||2
284610|NCT01965600|682045|P3|STARTED|Second Intervention||3
284611|NCT01965600|682046|P2|STARTED|Second Intervention||4
284612|NCT01965600|682047|P1|STARTED|Second Intervention||4
284613|NCT01965600|682044|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
284614|NCT01965600|682045|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
284615|NCT01965600|682046|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
284616|NCT01965600|682047|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
284617|NCT01965600|682044|P4|COMPLETED|Washout Period of Approximately 15 Days||2
284618|NCT01965600|682045|P3|COMPLETED|Washout Period of Approximately 15 Days||3
284619|NCT01965600|682046|P2|COMPLETED|Washout Period of Approximately 15 Days||4
284620|NCT01965600|682047|P1|COMPLETED|Washout Period of Approximately 15 Days||4
284621|NCT01965600|682044|P4|STARTED|Washout Period of Approximately 15 Days||4
284622|NCT01965600|682045|P3|STARTED|Washout Period of Approximately 15 Days||5
284623|NCT01965600|682046|P2|STARTED|Washout Period of Approximately 15 Days||8
284624|NCT01965600|682047|P1|STARTED|Washout Period of Approximately 15 Days||6
284625|NCT01965600|682044|P4|NOT COMPLETED|First Intervention||0
284626|NCT01965600|682045|P3|NOT COMPLETED|First Intervention||0
284627|NCT01965600|682046|P2|NOT COMPLETED|First Intervention||0
284628|NCT01965600|682047|P1|NOT COMPLETED|First Intervention||0
284629|NCT01965600|682044|P4|COMPLETED|First Intervention||4
284630|NCT01965600|682045|P3|COMPLETED|First Intervention||5
284631|NCT01965600|682046|P2|COMPLETED|First Intervention||8
284632|NCT01965600|682047|P1|COMPLETED|First Intervention||6
284633|NCT01965600|682044|P4|Received at Least One Dose of Drug|First Intervention||4
284634|NCT01965600|682045|P3|Received at Least One Dose of Drug|First Intervention||5
284635|NCT01965600|682046|P2|Received at Least One Dose of Drug|First Intervention||8
284636|NCT01965600|682047|P1|Received at Least One Dose of Drug|First Intervention||6
284637|NCT01965600|682044|P4|STARTED|First Intervention||4
284638|NCT01965600|682045|P3|STARTED|First Intervention||5
284639|NCT01965600|682046|P2|STARTED|First Intervention||8
284640|NCT01965600|682047|P1|STARTED|First Intervention||6
284641|NCT01965561|682091|P1|NOT COMPLETED|Overall Study||0
284642|NCT01965561|682091|P1|COMPLETED|Overall Study||10
284643|NCT01965561|682091|P1|STARTED|Overall Study||10
284644|NCT01965535|682104|P2|NOT COMPLETED|Overall Study||1
284645|NCT01965535|682105|P1|NOT COMPLETED|Overall Study||2
284646|NCT01965535|682104|P2|COMPLETED|Overall Study||76
284647|NCT01965535|682105|P1|COMPLETED|Overall Study||76
284648|NCT01965535|682104|P2|STARTED|Overall Study||77
284649|NCT01965535|682105|P1|STARTED|Overall Study||78
284650|NCT01965431|682119|P6|NOT COMPLETED|Overall Study||6
284651|NCT01965431|682120|P5|NOT COMPLETED|Overall Study||6
284652|NCT01965431|682121|P4|NOT COMPLETED|Overall Study||6
284653|NCT01965431|682122|P3|NOT COMPLETED|Overall Study||6
284654|NCT01965431|682123|P2|NOT COMPLETED|Overall Study||6
284655|NCT01965431|682124|P1|NOT COMPLETED|Overall Study||6
284656|NCT01965431|682119|P6|COMPLETED|Overall Study||2
284657|NCT01965431|682120|P5|COMPLETED|Overall Study||2
284658|NCT01965431|682121|P4|COMPLETED|Overall Study||2
284659|NCT01965431|682122|P3|COMPLETED|Overall Study||2
284660|NCT01965431|682123|P2|COMPLETED|Overall Study||2
284661|NCT01965431|682124|P1|COMPLETED|Overall Study||2
284662|NCT01965431|682119|P6|STARTED|Overall Study||8
284663|NCT01965431|682120|P5|STARTED|Overall Study||8
284664|NCT01965431|682121|P4|STARTED|Overall Study||8
284665|NCT01965431|682122|P3|STARTED|Overall Study||8
284666|NCT01965431|682123|P2|STARTED|Overall Study||8
284667|NCT01965431|682124|P1|STARTED|Overall Study|Started are actually Treated subjects|8
284668|NCT01965327|682137|P1|NOT COMPLETED|Overall Study||2
284669|NCT01965327|682137|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
284670|NCT01965327|682137|P1|STARTED|Overall Study||12
284671|NCT01965288|682144|P2|NOT COMPLETED|Overall Study||0
284672|NCT01965288|682145|P1|NOT COMPLETED|Overall Study||0
284673|NCT01965288|682144|P2|COMPLETED|Overall Study||30
284674|NCT01965288|682145|P1|COMPLETED|Overall Study||30
284675|NCT01965288|682144|P2|STARTED|Overall Study||30
284676|NCT01965288|682145|P1|STARTED|Overall Study||30
284677|NCT01965262|682351|P2|NOT COMPLETED|Second Intervention (7 Days)||10
284678|NCT01965262|682352|P1|NOT COMPLETED|Second Intervention (7 Days)||1
284679|NCT01965262|682351|P2|COMPLETED|Second Intervention (7 Days)||5
284680|NCT01965262|682352|P1|COMPLETED|Second Intervention (7 Days)||14
284681|NCT01965262|682351|P2|STARTED|Second Intervention (7 Days)||15
284682|NCT01965262|682352|P1|STARTED|Second Intervention (7 Days)||15
284683|NCT01965262|682351|P2|NOT COMPLETED|First Intervention (7 Days)||0
284684|NCT01965262|682352|P1|NOT COMPLETED|First Intervention (7 Days)||0
284685|NCT01965262|682351|P2|COMPLETED|First Intervention (7 Days)||15
284686|NCT01965262|682352|P1|COMPLETED|First Intervention (7 Days)||15
284687|NCT01965262|682351|P2|STARTED|First Intervention (7 Days)||15
284688|NCT01965262|682352|P1|STARTED|First Intervention (7 Days)||15
284689|NCT01965158|682416|P2|NOT COMPLETED|Overall Study||35
284690|NCT01965158|682417|P1|NOT COMPLETED|Overall Study||41
284691|NCT01965158|682416|P2|COMPLETED|Overall Study||238
284692|NCT01965158|682417|P1|COMPLETED|Overall Study||233
284693|NCT01965158|682416|P2|Received Treatment|Overall Study||273
284694|NCT01965158|682417|P1|Received Treatment|Overall Study||272
284787|NCT01963611|682675|P2|Safety Analysis Set|Overall Study||49
284695|NCT01965158|682416|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
284696|NCT01965158|682417|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
284697|NCT01965067|682433|P2|NOT COMPLETED|Overall Study||0
284698|NCT01965067|682434|P1|NOT COMPLETED|Overall Study||0
284699|NCT01965067|682433|P2|COMPLETED|Overall Study||30
284700|NCT01965067|682434|P1|COMPLETED|Overall Study||30
284701|NCT01965067|682433|P2|STARTED|Overall Study||30
284702|NCT01965067|682434|P1|STARTED|Overall Study||30
284703|NCT01964976|682452|P1|NOT COMPLETED|Overall Study||31
284704|NCT01964976|682452|P1|COMPLETED|Overall Study||1065
284705|NCT01964976|682452|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
284706|NCT01964950|682466|P1|NOT COMPLETED|Overall Study||25
284707|NCT01964950|682466|P1|COMPLETED|Overall Study||1076
284708|NCT01964950|682466|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
284709|NCT01964898|682480|P2|NOT COMPLETED|Overall Study||7
284710|NCT01964898|682481|P1|NOT COMPLETED|Overall Study||7
284711|NCT01964898|682480|P2|COMPLETED|Overall Study||26
284712|NCT01964898|682481|P1|COMPLETED|Overall Study||24
284713|NCT01964898|682480|P2|12 Week Assessment|Overall Study||30
284714|NCT01964898|682481|P1|12 Week Assessment|Overall Study||25
284715|NCT01964898|682480|P2|STARTED|Overall Study||33
284716|NCT01964898|682481|P1|STARTED|Overall Study||31
284717|NCT01964716|682503|P2|NOT COMPLETED|Overall Study||6
284718|NCT01964716|682504|P1|NOT COMPLETED|Overall Study||5
284719|NCT01964716|682503|P2|COMPLETED|Overall Study||244
284720|NCT01964716|682504|P1|COMPLETED|Overall Study||245
284721|NCT01964716|682503|P2|Vaccinated Dose 3|Overall Study||244
284722|NCT01964716|682504|P1|Vaccinated Dose 3|Overall Study||247
284723|NCT01964716|682503|P2|Vaccinated Dose 2|Overall Study||248
284724|NCT01964716|682504|P1|Vaccinated Dose 2|Overall Study||249
284725|NCT01964716|682503|P2|Vaccinated Dose 1|Overall Study||250
284726|NCT01964716|682504|P1|Vaccinated Dose 1|Overall Study||250
284727|NCT01964716|682503|P2|STARTED|Overall Study||250
284728|NCT01964716|682504|P1|STARTED|Overall Study||250
284729|NCT01964547|682542|P2|NOT COMPLETED|Overall Study||11
284730|NCT01964547|682543|P1|NOT COMPLETED|Overall Study||12
284731|NCT01964547|682542|P2|COMPLETED|Overall Study||48
284732|NCT01964547|682543|P1|COMPLETED|Overall Study||50
284733|NCT01964547|682542|P2|STARTED|Overall Study||59
284734|NCT01964547|682543|P1|STARTED|Overall Study||62
284735|NCT01964352|682571|P4|NOT COMPLETED|Overall Study||8
284736|NCT01964352|682572|P3|NOT COMPLETED|Overall Study||6
284737|NCT01964352|682573|P2|NOT COMPLETED|Overall Study||11
284738|NCT01964352|682574|P1|NOT COMPLETED|Overall Study||26
284739|NCT01964352|682571|P4|COMPLETED|Overall Study||195
284740|NCT01964352|682572|P3|COMPLETED|Overall Study||196
284741|NCT01964352|682573|P2|COMPLETED|Overall Study||192
284742|NCT01964352|682574|P1|COMPLETED|Overall Study||178
284743|NCT01964352|682571|P4|STARTED|Overall Study||203
284744|NCT01964352|682572|P3|STARTED|Overall Study||202
284745|NCT01964352|682573|P2|STARTED|Overall Study||203
284746|NCT01964352|682574|P1|STARTED|Overall Study||204
284747|NCT01964326|682604|P1|NOT COMPLETED|Overall Study||297
284748|NCT01964326|682604|P1|COMPLETED|Overall Study||1014
284749|NCT01964326|682604|P1|STARTED|Overall Study||1311
284750|NCT01964222|682613|P2|NOT COMPLETED|Overall Study||11
284751|NCT01964222|682614|P1|NOT COMPLETED|Overall Study||15
284752|NCT01964222|682613|P2|COMPLETED|Overall Study||89
284753|NCT01964222|682614|P1|COMPLETED|Overall Study||86
284754|NCT01964222|682613|P2|STARTED|Overall Study||100
284755|NCT01964222|682614|P1|STARTED|Overall Study||101
284756|NCT01963845|682630|P2|NOT COMPLETED|Overall Study||0
284757|NCT01963845|682631|P1|NOT COMPLETED|Overall Study||0
284758|NCT01963845|682630|P2|COMPLETED|Overall Study||25
284759|NCT01963845|682631|P1|COMPLETED|Overall Study||25
284760|NCT01963845|682630|P2|STARTED|Overall Study||25
284761|NCT01963845|682631|P1|STARTED|Overall Study||25
284762|NCT01963767|682647|P2|NOT COMPLETED|Overall Study||2
284763|NCT01963767|682648|P1|NOT COMPLETED|Overall Study||6
284764|NCT01963767|682647|P2|COMPLETED|Overall Study||53
284765|NCT01963767|682648|P1|COMPLETED|Overall Study||52
284766|NCT01963767|682647|P2|STARTED|Overall Study||55
284767|NCT01963767|682648|P1|STARTED|Overall Study||58
284768|NCT01963676|682658|P2|NOT COMPLETED|Overall Study||0
284769|NCT01963676|682659|P1|NOT COMPLETED|Overall Study||1
284770|NCT01963676|682658|P2|COMPLETED|Overall Study||13
284771|NCT01963676|682659|P1|COMPLETED|Overall Study||13
284772|NCT01963676|682658|P2|STARTED|Overall Study||13
284773|NCT01963676|682659|P1|STARTED|Overall Study||14
284774|NCT01963611|682672|P5|NOT COMPLETED|Overall Study||51
284775|NCT01963611|682673|P4|NOT COMPLETED|Overall Study||52
284776|NCT01963611|682674|P3|NOT COMPLETED|Overall Study||52
284777|NCT01963611|682675|P2|NOT COMPLETED|Overall Study||49
284778|NCT01963611|682676|P1|NOT COMPLETED|Overall Study||51
284779|NCT01963611|682672|P5|COMPLETED|Overall Study||0
284780|NCT01963611|682673|P4|COMPLETED|Overall Study||0
284781|NCT01963611|682674|P3|COMPLETED|Overall Study||0
284782|NCT01963611|682675|P2|COMPLETED|Overall Study||0
284783|NCT01963611|682676|P1|COMPLETED|Overall Study||0
284784|NCT01963611|682672|P5|Safety Analysis Set|Overall Study||50
284785|NCT01963611|682673|P4|Safety Analysis Set|Overall Study||52
284786|NCT01963611|682674|P3|Safety Analysis Set|Overall Study||52
284788|NCT01963611|682676|P1|Safety Analysis Set|Overall Study||51
284789|NCT01963611|682672|P5|STARTED|Overall Study||51
284790|NCT01963611|682673|P4|STARTED|Overall Study||52
284791|NCT01963611|682674|P3|STARTED|Overall Study||52
284792|NCT01963611|682675|P2|STARTED|Overall Study||49
284793|NCT01963611|682676|P1|STARTED|Overall Study||51
284794|NCT01963403|682735|P2|NOT COMPLETED|Overall Study||4
284795|NCT01963403|682736|P1|NOT COMPLETED|Overall Study||2
284796|NCT01963403|682735|P2|COMPLETED|Overall Study|Follow-up over three months|9
284797|NCT01963403|682736|P1|COMPLETED|Overall Study|Follow-up over three months|11
284798|NCT01963403|682735|P2|STARTED|Overall Study||13
284799|NCT01963403|682736|P1|STARTED|Overall Study||13
284800|NCT01963260|682758|P10|NOT COMPLETED|Overall Study||0
284801|NCT01963260|682759|P9|NOT COMPLETED|Overall Study||0
284802|NCT01963260|682760|P8|NOT COMPLETED|Overall Study||0
284803|NCT01963260|682761|P7|NOT COMPLETED|Overall Study||0
284804|NCT01963260|682762|P6|NOT COMPLETED|Overall Study||0
284805|NCT01963260|682763|P5|NOT COMPLETED|Overall Study||2
284806|NCT01963260|682764|P4|NOT COMPLETED|Overall Study||1
284807|NCT01963260|682765|P3|NOT COMPLETED|Overall Study||0
284808|NCT01963260|682766|P2|NOT COMPLETED|Overall Study||0
284809|NCT01963260|682767|P1|NOT COMPLETED|Overall Study||2
284810|NCT01963260|682758|P10|COMPLETED|Overall Study||4
284811|NCT01963260|682759|P9|COMPLETED|Overall Study||1
284812|NCT01963260|682760|P8|COMPLETED|Overall Study||2
284813|NCT01963260|682761|P7|COMPLETED|Overall Study||3
284814|NCT01963260|682762|P6|COMPLETED|Overall Study||10
284815|NCT01963260|682763|P5|COMPLETED|Overall Study||4
284816|NCT01963260|682764|P4|COMPLETED|Overall Study||5
284817|NCT01963260|682765|P3|COMPLETED|Overall Study||6
284818|NCT01963260|682766|P2|COMPLETED|Overall Study||6
284819|NCT01963260|682767|P1|COMPLETED|Overall Study||4
284820|NCT01963260|682758|P10|Treated|Overall Study||4
284821|NCT01963260|682759|P9|Treated|Overall Study||1
284822|NCT01963260|682760|P8|Treated|Overall Study||2
284823|NCT01963260|682761|P7|Treated|Overall Study||3
284824|NCT01963260|682762|P6|Treated|Overall Study||10
284825|NCT01963260|682763|P5|Treated|Overall Study||6
284826|NCT01963260|682764|P4|Treated|Overall Study||6
284827|NCT01963260|682765|P3|Treated|Overall Study||6
284828|NCT01963260|682766|P2|Treated|Overall Study||6
284829|NCT01963260|682767|P1|Treated|Overall Study||6
284830|NCT01963260|682758|P10|STARTED|Overall Study||4
284831|NCT01963260|682759|P9|STARTED|Overall Study||1
284832|NCT01963260|682760|P8|STARTED|Overall Study||2
284833|NCT01963260|682761|P7|STARTED|Overall Study||3
284834|NCT01963260|682762|P6|STARTED|Overall Study||10
284835|NCT01963260|682763|P5|STARTED|Overall Study||6
284836|NCT01963260|682764|P4|STARTED|Overall Study||6
284837|NCT01963260|682765|P3|STARTED|Overall Study||6
284838|NCT01963260|682766|P2|STARTED|Overall Study||6
284839|NCT01963260|682767|P1|STARTED|Overall Study||6
284840|NCT01963143|682822|P3|NOT COMPLETED|Overall Study||1
284841|NCT01963143|682823|P2|NOT COMPLETED|Overall Study||1
284842|NCT01963143|682824|P1|NOT COMPLETED|Overall Study||0
284843|NCT01963143|682822|P3|COMPLETED|Overall Study||14
284844|NCT01963143|682823|P2|COMPLETED|Overall Study||18
284845|NCT01963143|682824|P1|COMPLETED|Overall Study||14
284846|NCT01963143|682822|P3|STARTED|Overall Study||15
284847|NCT01963143|682823|P2|STARTED|Overall Study||19
284848|NCT01963143|682824|P1|STARTED|Overall Study||14
284849|NCT01963091|682836|P2|NOT COMPLETED|Overall Study||0
284850|NCT01963091|682837|P1|NOT COMPLETED|Overall Study||0
284851|NCT01963091|682836|P2|COMPLETED|Overall Study||16
284852|NCT01963091|682837|P1|COMPLETED|Overall Study||17
284853|NCT01963091|682836|P2|STARTED|Overall Study||16
284854|NCT01963091|682837|P1|STARTED|Overall Study||17
284855|NCT01962974|682847|P1|NOT COMPLETED|Overall Study||7
284856|NCT01962974|682847|P1|COMPLETED|Overall Study||0
284857|NCT01962974|682847|P1|STARTED|Overall Study||7
284858|NCT01962961|682856|P3|NOT COMPLETED|Overall Study||1
284859|NCT01962961|682857|P2|NOT COMPLETED|Overall Study||1
284860|NCT01962961|682858|P1|NOT COMPLETED|Overall Study||0
284861|NCT01962961|682856|P3|COMPLETED|Overall Study||6
284862|NCT01962961|682857|P2|COMPLETED|Overall Study||7
284863|NCT01962961|682858|P1|COMPLETED|Overall Study||9
284864|NCT01962961|682856|P3|STARTED|Overall Study||7
284865|NCT01962961|682857|P2|STARTED|Overall Study||8
284866|NCT01962961|682858|P1|STARTED|Overall Study||9
284867|NCT01962922|682874|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
284868|NCT01962922|682875|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
284869|NCT01962922|682874|P2|COMPLETED|Extendion Portion (up to Month 6)||20
284870|NCT01962922|682875|P1|COMPLETED|Extendion Portion (up to Month 6)||18
284871|NCT01962922|682874|P2|STARTED|Extendion Portion (up to Month 6)||23
284872|NCT01962922|682875|P1|STARTED|Extendion Portion (up to Month 6)||23
284873|NCT01962922|682874|P2|NOT COMPLETED|PK Portion Day 21||0
284874|NCT01962922|682875|P1|NOT COMPLETED|PK Portion Day 21||0
284875|NCT01962922|682874|P2|COMPLETED|PK Portion Day 21||23
284876|NCT01962922|682875|P1|COMPLETED|PK Portion Day 21||23
284877|NCT01962922|682874|P2|STARTED|PK Portion Day 21||23
284878|NCT01962922|682875|P1|STARTED|PK Portion Day 21||23
284879|NCT01962922|682874|P2|NOT COMPLETED|PK Portion Day 14||0
284880|NCT01962922|682875|P1|NOT COMPLETED|PK Portion Day 14||0
284881|NCT01962922|682874|P2|COMPLETED|PK Portion Day 14||23
284882|NCT01962922|682875|P1|COMPLETED|PK Portion Day 14||23
284883|NCT01962922|682874|P2|STARTED|PK Portion Day 14||23
284884|NCT01962922|682875|P1|STARTED|PK Portion Day 14||23
284885|NCT01962922|682874|P2|NOT COMPLETED|PK Portion Day 7||0
284886|NCT01962922|682875|P1|NOT COMPLETED|PK Portion Day 7||4
284887|NCT01962922|682874|P2|COMPLETED|PK Portion Day 7||23
284888|NCT01962922|682875|P1|COMPLETED|PK Portion Day 7||23
284889|NCT01962922|682874|P2|STARTED|PK Portion Day 7||23
284890|NCT01962922|682875|P1|STARTED|PK Portion Day 7||27
284891|NCT01962675|682899|P2|NOT COMPLETED|Overall Study||0
284892|NCT01962675|682900|P1|NOT COMPLETED|Overall Study||0
284893|NCT01962675|682899|P2|COMPLETED|Overall Study||7
284894|NCT01962675|682900|P1|COMPLETED|Overall Study||7
284895|NCT01962675|682899|P2|STARTED|Overall Study||7
284896|NCT01962675|682900|P1|STARTED|Overall Study||7
284897|NCT01962493|682914|P2|NOT COMPLETED|Overall Study||5
284898|NCT01962493|682915|P1|NOT COMPLETED|Overall Study||5
284899|NCT01962493|682914|P2|COMPLETED|Overall Study||77
284900|NCT01962493|682915|P1|COMPLETED|Overall Study||73
284901|NCT01962493|682914|P2|STARTED|Overall Study||82
284902|NCT01962493|682915|P1|STARTED|Overall Study||78
284903|NCT01962441|682938|P3|NOT COMPLETED|Retreatment Substudy||0
284904|NCT01962441|682939|P2|NOT COMPLETED|Retreatment Substudy||10
284905|NCT01962441|682940|P1|NOT COMPLETED|Retreatment Substudy||20
284906|NCT01962441|682938|P3|COMPLETED|Retreatment Substudy||0
284907|NCT01962441|682939|P2|COMPLETED|Retreatment Substudy||0
284908|NCT01962441|682940|P1|COMPLETED|Retreatment Substudy||0
284909|NCT01962441|682938|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
284910|NCT01962441|682939|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
284911|NCT01962441|682940|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
284912|NCT01962441|682938|P3|NOT COMPLETED|Randomized Period||11
284913|NCT01962441|682939|P2|NOT COMPLETED|Randomized Period||11
284914|NCT01962441|682940|P1|NOT COMPLETED|Randomized Period||10
284915|NCT01962441|682938|P3|COMPLETED|Randomized Period||189
284916|NCT01962441|682939|P2|COMPLETED|Randomized Period||190
284917|NCT01962441|682940|P1|COMPLETED|Randomized Period||190
284918|NCT01962441|682938|P3|STARTED|Randomized Period||200
284919|NCT01962441|682939|P2|STARTED|Randomized Period||201
284920|NCT01962441|682940|P1|STARTED|Randomized Period||200
284921|NCT01962428|682971|P2|NOT COMPLETED|Overall Study||6
284922|NCT01962428|682972|P1|NOT COMPLETED|Overall Study||10
284923|NCT01962428|682971|P2|COMPLETED|Overall Study||133
284924|NCT01962428|682972|P1|COMPLETED|Overall Study||129
284925|NCT01962428|682971|P2|STARTED|Overall Study||139
284926|NCT01962428|682972|P1|STARTED|Overall Study||139
284927|NCT01961544|682978|P1|NOT COMPLETED|Overall Study||13
284928|NCT01961544|682978|P1|COMPLETED|Overall Study||88
284929|NCT01961544|682978|P1|STARTED|Overall Study||101
284930|NCT01961349|682986|P3|NOT COMPLETED|Overall Study||2
284931|NCT01961349|682987|P2|NOT COMPLETED|Overall Study||6
284932|NCT01961349|682988|P1|NOT COMPLETED|Overall Study||3
284933|NCT01961349|682986|P3|COMPLETED|Overall Study||109
284934|NCT01961349|682987|P2|COMPLETED|Overall Study||101
284935|NCT01961349|682988|P1|COMPLETED|Overall Study||51
284936|NCT01961349|682986|P3|STARTED|Overall Study||111
284937|NCT01961349|682987|P2|STARTED|Overall Study||107
284938|NCT01961349|682988|P1|STARTED|Overall Study||54
284939|NCT01961271|682999|P1|NOT COMPLETED|Overall Study||50
284940|NCT01961271|682999|P1|COMPLETED|Overall Study||64
284941|NCT01961271|682999|P1|STARTED|Overall Study||114
284942|NCT01960907|683010|P2|NOT COMPLETED|Overall Study||45
284943|NCT01960907|683011|P1|NOT COMPLETED|Overall Study||36
284944|NCT01960907|683010|P2|COMPLETED|Overall Study||109
284945|NCT01960907|683011|P1|COMPLETED|Overall Study||122
284946|NCT01960907|683010|P2|STARTED|Overall Study||154
284947|NCT01960907|683011|P1|STARTED|Overall Study||158
284948|NCT01960842|683021|P1|NOT COMPLETED|Overall Study||3
284949|NCT01960842|683021|P1|COMPLETED|Overall Study||28
284950|NCT01960842|683021|P1|STARTED|Overall Study||31
284951|NCT01960816|683044|P1|NOT COMPLETED|Overall Study||1
284952|NCT01960816|683044|P1|COMPLETED|Overall Study||32
284953|NCT01960816|683044|P1|STARTED|Overall Study||33
284954|NCT01960725|683052|P2|NOT COMPLETED|Overall Study||5
284955|NCT01960725|683053|P1|NOT COMPLETED|Overall Study||6
284956|NCT01960725|683052|P2|COMPLETED|Overall Study||28
284957|NCT01960725|683053|P1|COMPLETED|Overall Study||27
284958|NCT01960725|683052|P2|Received Third Vaccine|Overall Study||32
284959|NCT01960725|683053|P1|Received Third Vaccine|Overall Study||32
284960|NCT01960725|683052|P2|Recieved Second Vaccine|Overall Study||33
284961|NCT01960725|683053|P1|Recieved Second Vaccine|Overall Study||33
284962|NCT01960725|683052|P2|Received First Vaccine|Overall Study||33
284963|NCT01960725|683053|P1|Received First Vaccine|Overall Study||33
284964|NCT01960725|683052|P2|STARTED|Overall Study||33
284965|NCT01960725|683053|P1|STARTED|Overall Study||33
284966|NCT01960530|683075|P1|NOT COMPLETED|Overall Study||0
284967|NCT01960530|683075|P1|COMPLETED|Overall Study||14
284968|NCT01960530|683075|P1|STARTED|Overall Study||14
284969|NCT01960400|683110|P2|NOT COMPLETED|Overall Study||0
284970|NCT01960400|683111|P1|NOT COMPLETED|Overall Study||0
284971|NCT01960400|683110|P2|COMPLETED|Overall Study||11
284972|NCT01960400|683111|P1|COMPLETED|Overall Study||11
284973|NCT01960400|683110|P2|STARTED|Overall Study||11
284974|NCT01960400|683111|P1|STARTED|Overall Study||11
284975|NCT01960387|683123|P1|NOT COMPLETED|Overall Study||0
284976|NCT01960387|683123|P1|COMPLETED|Overall Study||2
284977|NCT01960387|683123|P1|STARTED|Overall Study||2
284978|NCT01960296|683132|P2|NOT COMPLETED|Overall Study||3
284979|NCT01960296|683133|P1|NOT COMPLETED|Overall Study||2
284980|NCT01960296|683132|P2|COMPLETED|Overall Study||22
284981|NCT01960296|683133|P1|COMPLETED|Overall Study||21
284982|NCT01960296|683132|P2|STARTED|Overall Study||25
284983|NCT01960296|683133|P1|STARTED|Overall Study||23
284984|NCT01960140|683153|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
284985|NCT01960140|683153|P1|COMPLETED|Period 2 (Days 3-18)||38
284986|NCT01960140|683153|P1|Received Simvastatin|Period 2 (Days 3-18)||38
284987|NCT01960140|683153|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
284988|NCT01960140|683153|P1|STARTED|Period 2 (Days 3-18)||40
284989|NCT01960140|683153|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
284990|NCT01960140|683153|P1|COMPLETED|Period 1 (Days 1-2)||40
284991|NCT01960140|683153|P1|Received Simvastatin|Period 1 (Days 1-2)||40
284992|NCT01960140|683153|P1|STARTED|Period 1 (Days 1-2)||40
284993|NCT01960114|683164|P2|NOT COMPLETED|Overall Study||1
284994|NCT01960114|683165|P1|NOT COMPLETED|Overall Study||1
284995|NCT01960114|683164|P2|COMPLETED|Overall Study||268
284996|NCT01960114|683165|P1|COMPLETED|Overall Study||133
284997|NCT01960114|683164|P2|STARTED|Overall Study||269
284998|NCT01960114|683165|P1|STARTED|Overall Study||134
284999|NCT01959945|683183|P4|NOT COMPLETED|Overall Study||16
285000|NCT01959945|683184|P3|NOT COMPLETED|Overall Study||19
285001|NCT01959945|683185|P2|NOT COMPLETED|Overall Study||3
285002|NCT01959945|683186|P1|NOT COMPLETED|Overall Study||4
285003|NCT01959945|683183|P4|COMPLETED|Overall Study||15
285004|NCT01959945|683184|P3|COMPLETED|Overall Study||9
285005|NCT01959945|683185|P2|COMPLETED|Overall Study||75
285006|NCT01959945|683186|P1|COMPLETED|Overall Study||76
285007|NCT01959945|683183|P4|STARTED|Overall Study||31
285008|NCT01959945|683184|P3|STARTED|Overall Study||28
285009|NCT01959945|683185|P2|STARTED|Overall Study||78
285010|NCT01959945|683186|P1|STARTED|Overall Study||80
285011|NCT01959932|683211|P3|NOT COMPLETED|Overall Study||0
285012|NCT01959932|683212|P2|NOT COMPLETED|Overall Study||0
285013|NCT01959932|683213|P1|NOT COMPLETED|Overall Study||1
285014|NCT01959932|683211|P3|COMPLETED|Overall Study||39
285015|NCT01959932|683212|P2|COMPLETED|Overall Study||41
285016|NCT01959932|683213|P1|COMPLETED|Overall Study||79
285017|NCT01959932|683211|P3|STARTED|Overall Study||39
285018|NCT01959932|683212|P2|STARTED|Overall Study||41
285019|NCT01959932|683213|P1|STARTED|Overall Study||80
285020|NCT01959880|683235|P4|NOT COMPLETED|Overall Study||181
285021|NCT01959880|683236|P3|NOT COMPLETED|Overall Study||208
285022|NCT01959880|683237|P2|NOT COMPLETED|Overall Study||369
285023|NCT01959880|683238|P1|NOT COMPLETED|Overall Study||1132
285024|NCT01959880|683235|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
285025|NCT01959880|683236|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
285026|NCT01959880|683237|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
285027|NCT01959880|683238|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
285028|NCT01959880|683235|P4|STARTED|Overall Study||181
285029|NCT01959880|683236|P3|STARTED|Overall Study||209
285030|NCT01959880|683237|P2|STARTED|Overall Study||369
285031|NCT01959880|683238|P1|STARTED|Overall Study||1132
285032|NCT01959685|683260|P1|NOT COMPLETED|Overall Study||0
285033|NCT01959685|683260|P1|COMPLETED|Overall Study||9
285034|NCT01959685|683260|P1|STARTED|Overall Study||9
285035|NCT01959607|683267|P4|NOT COMPLETED|Second Intervention (Day 3)||0
285036|NCT01959607|683268|P3|NOT COMPLETED|Second Intervention (Day 3)||0
285037|NCT01959607|683269|P2|NOT COMPLETED|Second Intervention (Day 3)||0
285038|NCT01959607|683270|P1|NOT COMPLETED|Second Intervention (Day 3)||0
285039|NCT01959607|683267|P4|COMPLETED|Second Intervention (Day 3)||9
285040|NCT01959607|683268|P3|COMPLETED|Second Intervention (Day 3)||9
285041|NCT01959607|683269|P2|COMPLETED|Second Intervention (Day 3)||21
285042|NCT01959607|683270|P1|COMPLETED|Second Intervention (Day 3)||21
285043|NCT01959607|683267|P4|STARTED|Second Intervention (Day 3)||9
285044|NCT01959607|683268|P3|STARTED|Second Intervention (Day 3)||9
285045|NCT01959607|683269|P2|STARTED|Second Intervention (Day 3)||21
285046|NCT01959607|683270|P1|STARTED|Second Intervention (Day 3)||21
285047|NCT01959607|683267|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
285048|NCT01959607|683268|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
285049|NCT01959607|683269|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
285050|NCT01959607|683270|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
285051|NCT01959607|683267|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
285052|NCT01959607|683268|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
285053|NCT01959607|683269|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
285054|NCT01959607|683270|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
285055|NCT01959607|683267|P4|STARTED|Washout Period of 1 Day (Day 2)||9
285056|NCT01959607|683268|P3|STARTED|Washout Period of 1 Day (Day 2)||9
285057|NCT01959607|683269|P2|STARTED|Washout Period of 1 Day (Day 2)||21
285058|NCT01959607|683270|P1|STARTED|Washout Period of 1 Day (Day 2)||21
285059|NCT01959607|683267|P4|NOT COMPLETED|First Intervention (Day 1)||0
285060|NCT01959607|683268|P3|NOT COMPLETED|First Intervention (Day 1)||0
285061|NCT01959607|683269|P2|NOT COMPLETED|First Intervention (Day 1)||1
285062|NCT01959607|683270|P1|NOT COMPLETED|First Intervention (Day 1)||1
285063|NCT01959607|683267|P4|COMPLETED|First Intervention (Day 1)||9
285064|NCT01959607|683268|P3|COMPLETED|First Intervention (Day 1)||9
285065|NCT01959607|683269|P2|COMPLETED|First Intervention (Day 1)||21
285066|NCT01959607|683270|P1|COMPLETED|First Intervention (Day 1)||21
285067|NCT01959607|683267|P4|STARTED|First Intervention (Day 1)||9
285068|NCT01959607|683268|P3|STARTED|First Intervention (Day 1)||9
285069|NCT01959607|683269|P2|STARTED|First Intervention (Day 1)||22
285070|NCT01959607|683270|P1|STARTED|First Intervention (Day 1)||22
285071|NCT01959607|683267|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
285072|NCT01959607|683268|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
285073|NCT01959607|683269|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
285074|NCT01959607|683270|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
285075|NCT01959607|683267|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
285076|NCT01959607|683268|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
285077|NCT01959607|683269|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
285078|NCT01959607|683270|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
285079|NCT01959607|683267|P4|STARTED|Washout Period of 1 Day (Day 0)||9
285080|NCT01959607|683268|P3|STARTED|Washout Period of 1 Day (Day 0)||9
285081|NCT01959607|683269|P2|STARTED|Washout Period of 1 Day (Day 0)||22
285082|NCT01959607|683270|P1|STARTED|Washout Period of 1 Day (Day 0)||22
285083|NCT01959516|683277|P2|NOT COMPLETED|Epoch 2||1
285084|NCT01959516|683278|P1|NOT COMPLETED|Epoch 2||2
285085|NCT01959516|683277|P2|COMPLETED|Epoch 2||62
285086|NCT01959516|683278|P1|COMPLETED|Epoch 2||61
285087|NCT01959516|683277|P2|STARTED|Epoch 2||63
285088|NCT01959516|683278|P1|STARTED|Epoch 2||63
285089|NCT01959516|683277|P2|NOT COMPLETED|Epoch 1||5
285090|NCT01959516|683278|P1|NOT COMPLETED|Epoch 1||10
285091|NCT01959516|683277|P2|COMPLETED|Epoch 1||58
285092|NCT01959516|683278|P1|COMPLETED|Epoch 1||53
285093|NCT01959516|683277|P2|ITT Population|Epoch 1||62
285094|NCT01959516|683278|P1|ITT Population|Epoch 1||62
285095|NCT01959516|683277|P2|Safety Population|Epoch 1||62
285096|NCT01959516|683278|P1|Safety Population|Epoch 1||62
285097|NCT01959516|683277|P2|STARTED|Epoch 1||63
285098|NCT01959516|683278|P1|STARTED|Epoch 1||63
285099|NCT01959503|683288|P2|NOT COMPLETED|Overall Study||2
285100|NCT01959503|683289|P1|NOT COMPLETED|Overall Study||3
285101|NCT01959503|683288|P2|COMPLETED|Overall Study||49
285102|NCT01959503|683289|P1|COMPLETED|Overall Study||104
285103|NCT01959503|683288|P2|STARTED|Overall Study||51
285104|NCT01959503|683289|P1|STARTED|Overall Study||107
285105|NCT01959412|683309|P6|NOT COMPLETED|Overall Study||0
285106|NCT01959412|683310|P5|NOT COMPLETED|Overall Study||3
285107|NCT01959412|683311|P4|NOT COMPLETED|Overall Study||2
285108|NCT01959412|683312|P3|NOT COMPLETED|Overall Study||0
285109|NCT01959412|683313|P2|NOT COMPLETED|Overall Study||1
285110|NCT01959412|683314|P1|NOT COMPLETED|Overall Study||1
285111|NCT01959412|683309|P6|COMPLETED|Overall Study||15
285112|NCT01959412|683310|P5|COMPLETED|Overall Study||13
285113|NCT01959412|683311|P4|COMPLETED|Overall Study||13
285114|NCT01959412|683312|P3|COMPLETED|Overall Study||15
285115|NCT01959412|683313|P2|COMPLETED|Overall Study||14
285116|NCT01959412|683314|P1|COMPLETED|Overall Study||14
285117|NCT01959412|683309|P6|STARTED|Overall Study||15
285118|NCT01959412|683310|P5|STARTED|Overall Study||16
285119|NCT01959412|683311|P4|STARTED|Overall Study||15
285120|NCT01959412|683312|P3|STARTED|Overall Study||15
285121|NCT01959412|683313|P2|STARTED|Overall Study||15
285122|NCT01959412|683314|P1|STARTED|Overall Study||15
285123|NCT01959035|683352|P1|NOT COMPLETED|Overall Study||11
285124|NCT01959035|683352|P1|COMPLETED|Overall Study||77
285125|NCT01959035|683352|P1|STARTED|Overall Study||88
285126|NCT01958827|683378|P1|NOT COMPLETED|Overall Study||10
285127|NCT01958827|683378|P1|COMPLETED|Overall Study||18
285128|NCT01958827|683378|P1|STARTED|Overall Study||28
285129|NCT01958788|683396|P1|NOT COMPLETED|Overall Study||0
285130|NCT01958788|683396|P1|COMPLETED|Overall Study||7
285131|NCT01958788|683396|P1|STARTED|Overall Study||7
285132|NCT01958645|683409|P3|NOT COMPLETED|Overall Study||0
285133|NCT01958645|683410|P2|NOT COMPLETED|Overall Study||0
285134|NCT01958645|683411|P1|NOT COMPLETED|Overall Study||0
285135|NCT01958645|683409|P3|COMPLETED|Overall Study||4
285136|NCT01958645|683410|P2|COMPLETED|Overall Study||4
285137|NCT01958645|683411|P1|COMPLETED|Overall Study||4
285138|NCT01958645|683409|P3|STARTED|Overall Study||4
285139|NCT01958645|683410|P2|STARTED|Overall Study||4
285140|NCT01958645|683411|P1|STARTED|Overall Study||4
285141|NCT01958619|683439|P4|NOT COMPLETED|Overall Study||0
285142|NCT01958619|683440|P3|NOT COMPLETED|Overall Study||1
285143|NCT01958619|683441|P2|NOT COMPLETED|Overall Study||0
285144|NCT01958619|683442|P1|NOT COMPLETED|Overall Study||2
285145|NCT01958619|683439|P4|COMPLETED|Overall Study||12
285146|NCT01958619|683440|P3|COMPLETED|Overall Study||13
285147|NCT01958619|683441|P2|COMPLETED|Overall Study||14
285148|NCT01958619|683442|P1|COMPLETED|Overall Study||13
285149|NCT01958619|683439|P4|STARTED|Overall Study||12
285150|NCT01958619|683440|P3|STARTED|Overall Study||14
285151|NCT01958619|683441|P2|STARTED|Overall Study||14
285152|NCT01958619|683442|P1|STARTED|Overall Study||15
285153|NCT01958606|683464|P2|NOT COMPLETED|Overall Study||0
285154|NCT01958606|683465|P1|NOT COMPLETED|Overall Study||2
285155|NCT01958606|683464|P2|COMPLETED|Overall Study||5
285156|NCT01958606|683465|P1|COMPLETED|Overall Study||11
285157|NCT01958606|683464|P2|STARTED|Overall Study||5
285158|NCT01958606|683465|P1|STARTED|Overall Study||13
285159|NCT01958346|683505|P2|NOT COMPLETED|Overall Study||0
285160|NCT01958346|683506|P1|NOT COMPLETED|Overall Study||0
285161|NCT01958346|683505|P2|COMPLETED|Overall Study||39
285162|NCT01958346|683506|P1|COMPLETED|Overall Study||39
285163|NCT01958346|683505|P2|STARTED|Overall Study||39
285164|NCT01958346|683506|P1|STARTED|Overall Study||39
285165|NCT01958164|683516|P2|NOT COMPLETED|Overall Study||5
285166|NCT01958164|683517|P1|NOT COMPLETED|Overall Study||2
285167|NCT01958164|683516|P2|COMPLETED|Overall Study||5
285168|NCT01958164|683517|P1|COMPLETED|Overall Study||4
285169|NCT01958164|683516|P2|STARTED|Overall Study|Randomised and treated|10
285170|NCT01958164|683517|P1|STARTED|Overall Study|Randomised and treated|6
285171|NCT01958060|683536|P6|NOT COMPLETED|Overall Study||0
285172|NCT01958060|683537|P5|NOT COMPLETED|Overall Study||1
285173|NCT01958060|683538|P4|NOT COMPLETED|Overall Study||0
285174|NCT01958060|683539|P3|NOT COMPLETED|Overall Study||0
285175|NCT01958060|683540|P2|NOT COMPLETED|Overall Study||0
285176|NCT01958060|683541|P1|NOT COMPLETED|Overall Study||2
285177|NCT01958060|683536|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
285178|NCT01958060|683537|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
285179|NCT01958060|683538|P4|COMPLETED|Overall Study||5
285180|NCT01958060|683539|P3|COMPLETED|Overall Study||6
285181|NCT01958060|683540|P2|COMPLETED|Overall Study||6
285182|NCT01958060|683541|P1|COMPLETED|Overall Study||8
285183|NCT01958060|683536|P6|STARTED|Overall Study||1
285184|NCT01958060|683537|P5|STARTED|Overall Study||7
285185|NCT01958060|683538|P4|STARTED|Overall Study||5
285186|NCT01958060|683539|P3|STARTED|Overall Study||6
285187|NCT01958060|683540|P2|STARTED|Overall Study||6
285188|NCT01958060|683541|P1|STARTED|Overall Study||10
285189|NCT01958021|683566|P2|NOT COMPLETED|Overall Study||180
285190|NCT01958021|683567|P1|NOT COMPLETED|Overall Study||139
285191|NCT01958021|683566|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
285192|NCT01958021|683567|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
285193|NCT01958021|683566|P2|Patients Treated|Overall Study||330
285194|NCT01958021|683567|P1|Patients Treated|Overall Study||334
285195|NCT01958021|683566|P2|Patients Untreated|Overall Study||4
285196|NCT01958021|683567|P1|Patients Untreated|Overall Study||0
285197|NCT01958021|683566|P2|STARTED|Overall Study||334
285198|NCT01958021|683567|P1|STARTED|Overall Study||334
285199|NCT01958008|683579|P4|NOT COMPLETED|Overall Study||0
285200|NCT01958008|683580|P3|NOT COMPLETED|Overall Study||1
285201|NCT01958008|683581|P2|NOT COMPLETED|Overall Study||0
285202|NCT01958008|683582|P1|NOT COMPLETED|Overall Study||1
285203|NCT01958008|683579|P4|COMPLETED|Overall Study||21
285204|NCT01958008|683580|P3|COMPLETED|Overall Study||20
285205|NCT01958008|683581|P2|COMPLETED|Overall Study||21
285206|NCT01958008|683582|P1|COMPLETED|Overall Study||20
285207|NCT01958008|683579|P4|STARTED|Overall Study||21
285208|NCT01958008|683580|P3|STARTED|Overall Study||21
285209|NCT01958008|683581|P2|STARTED|Overall Study||21
285210|NCT01958008|683582|P1|STARTED|Overall Study||21
285211|NCT01957930|683612|P2|NOT COMPLETED|Overall Study||0
285212|NCT01957930|683613|P1|NOT COMPLETED|Overall Study||0
285213|NCT01957930|683612|P2|COMPLETED|Overall Study||37
285214|NCT01957930|683613|P1|COMPLETED|Overall Study||35
285215|NCT01957930|683612|P2|STARTED|Overall Study||37
285216|NCT01957930|683613|P1|STARTED|Overall Study||35
285217|NCT01957865|683622|P3|NOT COMPLETED|Overall Study||3
285218|NCT01957865|683623|P2|NOT COMPLETED|Overall Study||2
285219|NCT01957865|683624|P1|NOT COMPLETED|Overall Study||0
285220|NCT01957865|683622|P3|COMPLETED|Overall Study||19
285221|NCT01957865|683623|P2|COMPLETED|Overall Study||18
285222|NCT01957865|683624|P1|COMPLETED|Overall Study||21
285223|NCT01957865|683622|P3|STARTED|Overall Study||22
285224|NCT01957865|683623|P2|STARTED|Overall Study||20
285225|NCT01957865|683624|P1|STARTED|Overall Study||21
285226|NCT01957761|683635|P1|NOT COMPLETED|Overall Study||0
285227|NCT01957761|683635|P1|COMPLETED|Overall Study||189
285228|NCT01957761|683635|P1|STARTED|Overall Study||189
285229|NCT01957657|683639|P1|NOT COMPLETED|Overall Study||0
285230|NCT01957657|683639|P1|COMPLETED|Overall Study||4
285231|NCT01957657|683639|P1|STARTED|Overall Study||4
285232|NCT01957579|683657|P4|NOT COMPLETED|Overall Study||0
285233|NCT01957579|683658|P3|NOT COMPLETED|Overall Study||2
285234|NCT01957579|683659|P2|NOT COMPLETED|Overall Study||1
285235|NCT01957579|683660|P1|NOT COMPLETED|Overall Study||0
285236|NCT01957579|683657|P4|COMPLETED|Overall Study||6
285237|NCT01957579|683658|P3|COMPLETED|Overall Study||2
285238|NCT01957579|683659|P2|COMPLETED|Overall Study||6
285239|NCT01957579|683660|P1|COMPLETED|Overall Study||3
285240|NCT01957579|683657|P4|STARTED|Overall Study||6
285241|NCT01957579|683658|P3|STARTED|Overall Study||4
285242|NCT01957579|683659|P2|STARTED|Overall Study||7
285243|NCT01957579|683660|P1|STARTED|Overall Study||3
285244|NCT01957553|683727|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
285245|NCT01957553|683728|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
285246|NCT01957553|683727|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
285247|NCT01957553|683728|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
285248|NCT01957553|683727|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
285249|NCT01957553|683728|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
285250|NCT01957553|683727|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
285251|NCT01957553|683728|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
285252|NCT01957553|683727|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
285253|NCT01957553|683728|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
285254|NCT01957553|683727|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
285255|NCT01957553|683728|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
285256|NCT01957488|683734|P6|NOT COMPLETED|Test Period 3||0
285257|NCT01957488|683735|P5|NOT COMPLETED|Test Period 3||0
285258|NCT01957488|683736|P4|NOT COMPLETED|Test Period 3||0
285259|NCT01957488|683737|P3|NOT COMPLETED|Test Period 3||0
285260|NCT01957488|683738|P2|NOT COMPLETED|Test Period 3||1
285261|NCT01957488|683739|P1|NOT COMPLETED|Test Period 3||1
285262|NCT01957488|683734|P6|COMPLETED|Test Period 3||23
285263|NCT01957488|683735|P5|COMPLETED|Test Period 3||25
285264|NCT01957488|683736|P4|COMPLETED|Test Period 3||28
285265|NCT01957488|683737|P3|COMPLETED|Test Period 3||25
285266|NCT01957488|683738|P2|COMPLETED|Test Period 3||26
285267|NCT01957488|683739|P1|COMPLETED|Test Period 3||23
285268|NCT01957488|683734|P6|STARTED|Test Period 3||23
285269|NCT01957488|683735|P5|STARTED|Test Period 3||25
285270|NCT01957488|683736|P4|STARTED|Test Period 3||28
285271|NCT01957488|683737|P3|STARTED|Test Period 3||25
285272|NCT01957488|683738|P2|STARTED|Test Period 3||27
285273|NCT01957488|683739|P1|STARTED|Test Period 3||24
285274|NCT01957488|683734|P6|NOT COMPLETED|Test Period 2||1
285275|NCT01957488|683735|P5|NOT COMPLETED|Test Period 2||2
285276|NCT01957488|683736|P4|NOT COMPLETED|Test Period 2||1
285277|NCT01957488|683737|P3|NOT COMPLETED|Test Period 2||1
285278|NCT01957488|683738|P2|NOT COMPLETED|Test Period 2||1
285279|NCT01957488|683739|P1|NOT COMPLETED|Test Period 2||3
285280|NCT01957488|683734|P6|COMPLETED|Test Period 2||23
285281|NCT01957488|683735|P5|COMPLETED|Test Period 2||25
285282|NCT01957488|683736|P4|COMPLETED|Test Period 2||28
285283|NCT01957488|683737|P3|COMPLETED|Test Period 2||25
285284|NCT01957488|683738|P2|COMPLETED|Test Period 2||27
285285|NCT01957488|683739|P1|COMPLETED|Test Period 2||24
285286|NCT01957488|683734|P6|STARTED|Test Period 2||24
285287|NCT01957488|683735|P5|STARTED|Test Period 2||27
285288|NCT01957488|683736|P4|STARTED|Test Period 2||29
285289|NCT01957488|683737|P3|STARTED|Test Period 2||26
285290|NCT01957488|683738|P2|STARTED|Test Period 2||28
285291|NCT01957488|683739|P1|STARTED|Test Period 2||27
285292|NCT01957488|683734|P6|NOT COMPLETED|Test Period 1||6
285293|NCT01957488|683735|P5|NOT COMPLETED|Test Period 1||3
285294|NCT01957488|683736|P4|NOT COMPLETED|Test Period 1||3
285295|NCT01957488|683737|P3|NOT COMPLETED|Test Period 1||4
285296|NCT01957488|683738|P2|NOT COMPLETED|Test Period 1||3
285297|NCT01957488|683739|P1|NOT COMPLETED|Test Period 1||3
285298|NCT01957488|683734|P6|COMPLETED|Test Period 1||24
285299|NCT01957488|683735|P5|COMPLETED|Test Period 1||27
285300|NCT01957488|683736|P4|COMPLETED|Test Period 1||29
285301|NCT01957488|683737|P3|COMPLETED|Test Period 1||26
285302|NCT01957488|683738|P2|COMPLETED|Test Period 1||28
285303|NCT01957488|683739|P1|COMPLETED|Test Period 1||27
285304|NCT01957488|683734|P6|STARTED|Test Period 1||30
285305|NCT01957488|683735|P5|STARTED|Test Period 1||30
285306|NCT01957488|683736|P4|STARTED|Test Period 1||32
285307|NCT01957488|683737|P3|STARTED|Test Period 1||30
285308|NCT01957488|683738|P2|STARTED|Test Period 1||31
285309|NCT01957488|683739|P1|STARTED|Test Period 1||30
285310|NCT01957475|683747|P2|NOT COMPLETED|Test Period 2||0
285311|NCT01957475|683748|P1|NOT COMPLETED|Test Period 2||1
285312|NCT01957475|683747|P2|COMPLETED|Test Period 2||8
285313|NCT01957475|683748|P1|COMPLETED|Test Period 2||8
285314|NCT01957475|683747|P2|STARTED|Test Period 2||8
285315|NCT01957475|683748|P1|STARTED|Test Period 2||9
285316|NCT01957475|683747|P2|NOT COMPLETED|Test Period 1||1
285317|NCT01957475|683748|P1|NOT COMPLETED|Test Period 1||2
285318|NCT01957475|683747|P2|COMPLETED|Test Period 1||9
285319|NCT01957475|683748|P1|COMPLETED|Test Period 1||8
285320|NCT01957475|683747|P2|STARTED|Test Period 1||10
285321|NCT01957475|683748|P1|STARTED|Test Period 1||10
285322|NCT01957462|683754|P2|NOT COMPLETED|Test Period 2||0
285323|NCT01957462|683755|P1|NOT COMPLETED|Test Period 2||0
285324|NCT01957462|683754|P2|COMPLETED|Test Period 2||15
285325|NCT01957462|683755|P1|COMPLETED|Test Period 2||14
285326|NCT01957462|683754|P2|STARTED|Test Period 2||15
285327|NCT01957462|683755|P1|STARTED|Test Period 2||14
285328|NCT01957462|683754|P2|NOT COMPLETED|Test Period 1||0
285329|NCT01957462|683755|P1|NOT COMPLETED|Test Period 1||2
285330|NCT01957462|683754|P2|COMPLETED|Test Period 1||15
285331|NCT01957462|683755|P1|COMPLETED|Test Period 1||14
285332|NCT01957462|683754|P2|STARTED|Test Period 1||15
285333|NCT01957462|683755|P1|STARTED|Test Period 1||16
285334|NCT01957410|683761|P1|NOT COMPLETED|Optional Open Label||0
285335|NCT01957410|683761|P1|COMPLETED|Optional Open Label||13
285336|NCT01957410|683761|P1|STARTED|Optional Open Label||13
285337|NCT01957410|683761|P1|NOT COMPLETED|Open Label||0
285338|NCT01957410|683761|P1|COMPLETED|Open Label||13
285339|NCT01957410|683761|P1|STARTED|Open Label||13
285340|NCT01957397|683766|P2|NOT COMPLETED|Test Period 3||2
285341|NCT01957397|683767|P1|NOT COMPLETED|Test Period 3||2
285342|NCT01957397|683766|P2|COMPLETED|Test Period 3||9
285343|NCT01957397|683767|P1|COMPLETED|Test Period 3||9
285344|NCT01957397|683766|P2|STARTED|Test Period 3||11
285345|NCT01957397|683767|P1|STARTED|Test Period 3||11
285346|NCT01957397|683766|P2|NOT COMPLETED|Test Period 2||1
285347|NCT01957397|683767|P1|NOT COMPLETED|Test Period 2||0
285348|NCT01957397|683766|P2|COMPLETED|Test Period 2||11
285349|NCT01957397|683767|P1|COMPLETED|Test Period 2||11
285350|NCT01957397|683766|P2|STARTED|Test Period 2||12
285351|NCT01957397|683767|P1|STARTED|Test Period 2||11
285352|NCT01957397|683766|P2|NOT COMPLETED|Test Period 1||1
285353|NCT01957397|683767|P1|NOT COMPLETED|Test Period 1||2
285354|NCT01957397|683766|P2|COMPLETED|Test Period 1||12
285355|NCT01957397|683767|P1|COMPLETED|Test Period 1||11
285356|NCT01957397|683766|P2|STARTED|Test Period 1||13
285357|NCT01957397|683767|P1|STARTED|Test Period 1||13
285358|NCT01957397|683766|P2|NOT COMPLETED|Baseline Own Product||0
285359|NCT01957397|683767|P1|NOT COMPLETED|Baseline Own Product||0
285360|NCT01957397|683766|P2|COMPLETED|Baseline Own Product||13
285361|NCT01957397|683767|P1|COMPLETED|Baseline Own Product||13
285362|NCT01957397|683766|P2|STARTED|Baseline Own Product||13
285363|NCT01957397|683767|P1|STARTED|Baseline Own Product||13
285364|NCT01957384|683777|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
285365|NCT01957384|683778|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
285366|NCT01957384|683779|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
285367|NCT01957384|683780|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
285368|NCT01957384|683781|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
285369|NCT01957384|683782|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
285370|NCT01957384|683777|P6|COMPLETED|Test Period 3 (14 Days)||3
285371|NCT01957384|683778|P5|COMPLETED|Test Period 3 (14 Days)||3
285372|NCT01957384|683779|P4|COMPLETED|Test Period 3 (14 Days)||4
285373|NCT01957384|683780|P3|COMPLETED|Test Period 3 (14 Days)||4
285374|NCT01957384|683781|P2|COMPLETED|Test Period 3 (14 Days)||4
285375|NCT01957384|683782|P1|COMPLETED|Test Period 3 (14 Days)||4
285376|NCT01957384|683777|P6|STARTED|Test Period 3 (14 Days)||3
285377|NCT01957384|683778|P5|STARTED|Test Period 3 (14 Days)||3
285378|NCT01957384|683779|P4|STARTED|Test Period 3 (14 Days)||4
285379|NCT01957384|683780|P3|STARTED|Test Period 3 (14 Days)||4
285380|NCT01957384|683781|P2|STARTED|Test Period 3 (14 Days)||4
285381|NCT01957384|683782|P1|STARTED|Test Period 3 (14 Days)||4
285382|NCT01957384|683777|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
285383|NCT01957384|683778|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
285384|NCT01957384|683779|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
285385|NCT01957384|683780|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
285386|NCT01957384|683781|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
285387|NCT01957384|683782|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
285388|NCT01957384|683777|P6|COMPLETED|Test Period 2 (14 Days)||3
285389|NCT01957384|683778|P5|COMPLETED|Test Period 2 (14 Days)||3
285390|NCT01957384|683779|P4|COMPLETED|Test Period 2 (14 Days)||4
285391|NCT01957384|683780|P3|COMPLETED|Test Period 2 (14 Days)||4
285392|NCT01957384|683781|P2|COMPLETED|Test Period 2 (14 Days)||4
285393|NCT01957384|683782|P1|COMPLETED|Test Period 2 (14 Days)||4
285394|NCT01957384|683777|P6|STARTED|Test Period 2 (14 Days)||3
285395|NCT01957384|683778|P5|STARTED|Test Period 2 (14 Days)||3
285396|NCT01957384|683779|P4|STARTED|Test Period 2 (14 Days)||4
285397|NCT01957384|683780|P3|STARTED|Test Period 2 (14 Days)||4
285398|NCT01957384|683781|P2|STARTED|Test Period 2 (14 Days)||4
285399|NCT01957384|683782|P1|STARTED|Test Period 2 (14 Days)||4
285400|NCT01957384|683777|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
285401|NCT01957384|683778|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
285402|NCT01957384|683779|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
285403|NCT01957384|683780|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
285404|NCT01957384|683781|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
285405|NCT01957384|683782|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
285406|NCT01957384|683777|P6|COMPLETED|Test Period 1 (14 Days)||3
285407|NCT01957384|683778|P5|COMPLETED|Test Period 1 (14 Days)||3
285408|NCT01957384|683779|P4|COMPLETED|Test Period 1 (14 Days)||4
285409|NCT01957384|683780|P3|COMPLETED|Test Period 1 (14 Days)||4
285410|NCT01957384|683781|P2|COMPLETED|Test Period 1 (14 Days)||4
285411|NCT01957384|683782|P1|COMPLETED|Test Period 1 (14 Days)||4
285412|NCT01957384|683777|P6|STARTED|Test Period 1 (14 Days)||3
285413|NCT01957384|683778|P5|STARTED|Test Period 1 (14 Days)||3
285414|NCT01957384|683779|P4|STARTED|Test Period 1 (14 Days)||4
285415|NCT01957384|683780|P3|STARTED|Test Period 1 (14 Days)||4
285416|NCT01957384|683781|P2|STARTED|Test Period 1 (14 Days)||4
285417|NCT01957384|683782|P1|STARTED|Test Period 1 (14 Days)||4
285418|NCT01957215|683792|P2|NOT COMPLETED|Overall Study||12
285419|NCT01957215|683793|P1|NOT COMPLETED|Overall Study||13
285420|NCT01957215|683792|P2|COMPLETED|Overall Study||123
285421|NCT01957215|683793|P1|COMPLETED|Overall Study||122
285422|NCT01957215|683792|P2|STARTED|Overall Study||135
285423|NCT01957215|683793|P1|STARTED|Overall Study||135
285424|NCT01957202|683821|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285425|NCT01957202|683822|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
285426|NCT01957202|683823|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285427|NCT01957202|683824|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285428|NCT01957202|683825|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285429|NCT01957202|683826|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285430|NCT01957202|683827|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285431|NCT01957202|683828|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285432|NCT01957202|683829|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285433|NCT01957202|683830|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285434|NCT01957202|683831|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285435|NCT01957202|683832|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285436|NCT01957202|683833|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285437|NCT01957202|683834|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285438|NCT01957202|683835|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285439|NCT01957202|683836|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285440|NCT01957202|683837|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285441|NCT01957202|683838|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
285442|NCT01957202|683821|P18|COMPLETED|Treatment Period 3 (8 Days)||3
285443|NCT01957202|683822|P17|COMPLETED|Treatment Period 3 (8 Days)||4
285444|NCT01957202|683823|P16|COMPLETED|Treatment Period 3 (8 Days)||3
285445|NCT01957202|683824|P15|COMPLETED|Treatment Period 3 (8 Days)||6
285446|NCT01957202|683825|P14|COMPLETED|Treatment Period 3 (8 Days)||3
285447|NCT01957202|683826|P13|COMPLETED|Treatment Period 3 (8 Days)||3
285448|NCT01957202|683827|P12|COMPLETED|Treatment Period 3 (8 Days)||6
285449|NCT01957202|683828|P11|COMPLETED|Treatment Period 3 (8 Days)||3
285450|NCT01957202|683829|P10|COMPLETED|Treatment Period 3 (8 Days)||6
285451|NCT01957202|683830|P9|COMPLETED|Treatment Period 3 (8 Days)||3
285452|NCT01957202|683831|P8|COMPLETED|Treatment Period 3 (8 Days)||3
285453|NCT01957202|683832|P7|COMPLETED|Treatment Period 3 (8 Days)||3
285454|NCT01957202|683833|P6|COMPLETED|Treatment Period 3 (8 Days)||2
285455|NCT01957202|683834|P5|COMPLETED|Treatment Period 3 (8 Days)||3
285456|NCT01957202|683835|P4|COMPLETED|Treatment Period 3 (8 Days)||3
285457|NCT01957202|683836|P3|COMPLETED|Treatment Period 3 (8 Days)||6
285458|NCT01957202|683837|P2|COMPLETED|Treatment Period 3 (8 Days)||5
285459|NCT01957202|683838|P1|COMPLETED|Treatment Period 3 (8 Days)||3
285460|NCT01957202|683821|P18|STARTED|Treatment Period 3 (8 Days)||3
285461|NCT01957202|683822|P17|STARTED|Treatment Period 3 (8 Days)||5
285462|NCT01957202|683823|P16|STARTED|Treatment Period 3 (8 Days)||3
285463|NCT01957202|683824|P15|STARTED|Treatment Period 3 (8 Days)||6
285464|NCT01957202|683825|P14|STARTED|Treatment Period 3 (8 Days)||3
285465|NCT01957202|683826|P13|STARTED|Treatment Period 3 (8 Days)||3
285466|NCT01957202|683827|P12|STARTED|Treatment Period 3 (8 Days)||6
285467|NCT01957202|683828|P11|STARTED|Treatment Period 3 (8 Days)||3
285468|NCT01957202|683829|P10|STARTED|Treatment Period 3 (8 Days)||6
285469|NCT01957202|683830|P9|STARTED|Treatment Period 3 (8 Days)||3
285470|NCT01957202|683831|P8|STARTED|Treatment Period 3 (8 Days)||3
285471|NCT01957202|683832|P7|STARTED|Treatment Period 3 (8 Days)||3
285472|NCT01957202|683833|P6|STARTED|Treatment Period 3 (8 Days)||2
285473|NCT01957202|683834|P5|STARTED|Treatment Period 3 (8 Days)||3
285474|NCT01957202|683835|P4|STARTED|Treatment Period 3 (8 Days)||3
285475|NCT01957202|683836|P3|STARTED|Treatment Period 3 (8 Days)||6
285476|NCT01957202|683837|P2|STARTED|Treatment Period 3 (8 Days)||5
285477|NCT01957202|683838|P1|STARTED|Treatment Period 3 (8 Days)||3
285478|NCT01957202|683821|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285479|NCT01957202|683822|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285480|NCT01957202|683823|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285481|NCT01957202|683824|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285482|NCT01957202|683825|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285483|NCT01957202|683826|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285484|NCT01957202|683827|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285485|NCT01957202|683828|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285486|NCT01957202|683829|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285487|NCT01957202|683830|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285488|NCT01957202|683831|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285489|NCT01957202|683832|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285490|NCT01957202|683833|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285491|NCT01957202|683834|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285492|NCT01957202|683835|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285493|NCT01957202|683836|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285494|NCT01957202|683837|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285495|NCT01957202|683838|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
285496|NCT01957202|683821|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285497|NCT01957202|683822|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
285498|NCT01957202|683823|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285499|NCT01957202|683824|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
285500|NCT01957202|683825|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285501|NCT01957202|683826|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285502|NCT01957202|683827|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
285503|NCT01957202|683828|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285504|NCT01957202|683829|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
285505|NCT01957202|683830|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285506|NCT01957202|683831|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285507|NCT01957202|683832|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285508|NCT01957202|683833|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
285509|NCT01957202|683834|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285510|NCT01957202|683835|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285511|NCT01957202|683836|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
285512|NCT01957202|683837|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
285513|NCT01957202|683838|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
285514|NCT01957202|683821|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
285515|NCT01957202|683822|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
285516|NCT01957202|683823|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
285517|NCT01957202|683824|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
285518|NCT01957202|683825|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
285519|NCT01957202|683826|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
285520|NCT01957202|683827|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
285521|NCT01957202|683828|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
285522|NCT01957202|683829|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
285523|NCT01957202|683830|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
285524|NCT01957202|683831|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
285525|NCT01957202|683832|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
285526|NCT01957202|683833|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
285527|NCT01957202|683834|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
285528|NCT01957202|683835|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
285529|NCT01957202|683836|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
285530|NCT01957202|683837|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
285531|NCT01957202|683838|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
285532|NCT01957202|683821|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285533|NCT01957202|683822|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
285534|NCT01957202|683823|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285535|NCT01957202|683824|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285536|NCT01957202|683825|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285537|NCT01957202|683826|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285538|NCT01957202|683827|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285539|NCT01957202|683828|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285540|NCT01957202|683829|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285541|NCT01957202|683830|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285542|NCT01957202|683831|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285543|NCT01957202|683832|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285544|NCT01957202|683833|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285545|NCT01957202|683834|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285546|NCT01957202|683835|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285547|NCT01957202|683836|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285548|NCT01957202|683837|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
285549|NCT01957202|683838|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
285550|NCT01957202|683821|P18|COMPLETED|Treatment Period 2 (8 Days)||3
285551|NCT01957202|683822|P17|COMPLETED|Treatment Period 2 (8 Days)||5
285552|NCT01957202|683823|P16|COMPLETED|Treatment Period 2 (8 Days)||3
285553|NCT01957202|683824|P15|COMPLETED|Treatment Period 2 (8 Days)||6
285554|NCT01957202|683825|P14|COMPLETED|Treatment Period 2 (8 Days)||3
285555|NCT01957202|683826|P13|COMPLETED|Treatment Period 2 (8 Days)||3
285556|NCT01957202|683827|P12|COMPLETED|Treatment Period 2 (8 Days)||6
285557|NCT01957202|683828|P11|COMPLETED|Treatment Period 2 (8 Days)||3
285558|NCT01957202|683829|P10|COMPLETED|Treatment Period 2 (8 Days)||6
285559|NCT01957202|683830|P9|COMPLETED|Treatment Period 2 (8 Days)||3
285560|NCT01957202|683831|P8|COMPLETED|Treatment Period 2 (8 Days)||3
285561|NCT01957202|683832|P7|COMPLETED|Treatment Period 2 (8 Days)||3
285562|NCT01957202|683833|P6|COMPLETED|Treatment Period 2 (8 Days)||2
285563|NCT01957202|683834|P5|COMPLETED|Treatment Period 2 (8 Days)||3
285564|NCT01957202|683835|P4|COMPLETED|Treatment Period 2 (8 Days)||3
285565|NCT01957202|683836|P3|COMPLETED|Treatment Period 2 (8 Days)||6
285566|NCT01957202|683837|P2|COMPLETED|Treatment Period 2 (8 Days)||5
285567|NCT01957202|683838|P1|COMPLETED|Treatment Period 2 (8 Days)||3
285568|NCT01957202|683821|P18|STARTED|Treatment Period 2 (8 Days)||3
285569|NCT01957202|683822|P17|STARTED|Treatment Period 2 (8 Days)||6
285570|NCT01957202|683823|P16|STARTED|Treatment Period 2 (8 Days)||3
285571|NCT01957202|683824|P15|STARTED|Treatment Period 2 (8 Days)||6
285572|NCT01957202|683825|P14|STARTED|Treatment Period 2 (8 Days)||3
285573|NCT01957202|683826|P13|STARTED|Treatment Period 2 (8 Days)||3
285574|NCT01957202|683827|P12|STARTED|Treatment Period 2 (8 Days)||6
285575|NCT01957202|683828|P11|STARTED|Treatment Period 2 (8 Days)||3
285576|NCT01957202|683829|P10|STARTED|Treatment Period 2 (8 Days)||6
285577|NCT01957202|683830|P9|STARTED|Treatment Period 2 (8 Days)||3
285578|NCT01957202|683831|P8|STARTED|Treatment Period 2 (8 Days)||3
285579|NCT01957202|683832|P7|STARTED|Treatment Period 2 (8 Days)||3
285580|NCT01957202|683833|P6|STARTED|Treatment Period 2 (8 Days)||2
285581|NCT01957202|683834|P5|STARTED|Treatment Period 2 (8 Days)||3
285582|NCT01957202|683835|P4|STARTED|Treatment Period 2 (8 Days)||3
285583|NCT01957202|683836|P3|STARTED|Treatment Period 2 (8 Days)||6
285584|NCT01957202|683837|P2|STARTED|Treatment Period 2 (8 Days)||6
285585|NCT01957202|683838|P1|STARTED|Treatment Period 2 (8 Days)||3
285586|NCT01957202|683821|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285587|NCT01957202|683822|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285588|NCT01957202|683823|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285589|NCT01957202|683824|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285590|NCT01957202|683825|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285591|NCT01957202|683826|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285592|NCT01957202|683827|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285593|NCT01957202|683828|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285594|NCT01957202|683829|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285595|NCT01957202|683830|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285596|NCT01957202|683831|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285597|NCT01957202|683832|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285598|NCT01957202|683833|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285599|NCT01957202|683834|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285600|NCT01957202|683835|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285601|NCT01957202|683836|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285602|NCT01957202|683837|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285603|NCT01957202|683838|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
285604|NCT01957202|683821|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285605|NCT01957202|683822|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
285606|NCT01957202|683823|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285607|NCT01957202|683824|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
285608|NCT01957202|683825|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285609|NCT01957202|683826|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285610|NCT01957202|683827|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
285611|NCT01957202|683828|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285612|NCT01957202|683829|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
285613|NCT01957202|683830|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285614|NCT01957202|683831|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285615|NCT01957202|683832|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285616|NCT01957202|683833|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
285617|NCT01957202|683834|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285618|NCT01957202|683835|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285619|NCT01957202|683836|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
285620|NCT01957202|683837|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
285621|NCT01957202|683838|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
285622|NCT01957202|683821|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
285623|NCT01957202|683822|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
285624|NCT01957202|683823|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
285625|NCT01957202|683824|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
285626|NCT01957202|683825|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
285627|NCT01957202|683826|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
285628|NCT01957202|683827|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
285629|NCT01957202|683828|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
285630|NCT01957202|683829|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
285631|NCT01957202|683830|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
285632|NCT01957202|683831|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
285633|NCT01957202|683832|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
285634|NCT01957202|683833|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
285635|NCT01957202|683834|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
285636|NCT01957202|683835|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
285637|NCT01957202|683836|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
285638|NCT01957202|683837|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
285639|NCT01957202|683838|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
285640|NCT01957202|683821|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285641|NCT01957202|683822|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285642|NCT01957202|683823|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285643|NCT01957202|683824|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285644|NCT01957202|683825|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285645|NCT01957202|683826|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285646|NCT01957202|683827|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285647|NCT01957202|683828|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285648|NCT01957202|683829|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285649|NCT01957202|683830|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285650|NCT01957202|683831|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285651|NCT01957202|683832|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285652|NCT01957202|683833|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285653|NCT01957202|683834|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285654|NCT01957202|683835|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285655|NCT01957202|683836|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285656|NCT01957202|683837|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285657|NCT01957202|683838|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
285658|NCT01957202|683821|P18|COMPLETED|Treatment Period 1 (8 Days)||3
285659|NCT01957202|683822|P17|COMPLETED|Treatment Period 1 (8 Days)||6
285660|NCT01957202|683823|P16|COMPLETED|Treatment Period 1 (8 Days)||3
285661|NCT01957202|683824|P15|COMPLETED|Treatment Period 1 (8 Days)||6
285662|NCT01957202|683825|P14|COMPLETED|Treatment Period 1 (8 Days)||3
285663|NCT01957202|683826|P13|COMPLETED|Treatment Period 1 (8 Days)||3
285664|NCT01957202|683827|P12|COMPLETED|Treatment Period 1 (8 Days)||6
285665|NCT01957202|683828|P11|COMPLETED|Treatment Period 1 (8 Days)||3
285666|NCT01957202|683829|P10|COMPLETED|Treatment Period 1 (8 Days)||6
285667|NCT01957202|683830|P9|COMPLETED|Treatment Period 1 (8 Days)||3
285668|NCT01957202|683831|P8|COMPLETED|Treatment Period 1 (8 Days)||3
285669|NCT01957202|683832|P7|COMPLETED|Treatment Period 1 (8 Days)||3
285670|NCT01957202|683833|P6|COMPLETED|Treatment Period 1 (8 Days)||2
285671|NCT01957202|683834|P5|COMPLETED|Treatment Period 1 (8 Days)||3
285672|NCT01957202|683835|P4|COMPLETED|Treatment Period 1 (8 Days)||3
285673|NCT01957202|683836|P3|COMPLETED|Treatment Period 1 (8 Days)||6
285674|NCT01957202|683837|P2|COMPLETED|Treatment Period 1 (8 Days)||6
285675|NCT01957202|683838|P1|COMPLETED|Treatment Period 1 (8 Days)||3
285676|NCT01957202|683821|P18|STARTED|Treatment Period 1 (8 Days)||3
285677|NCT01957202|683822|P17|STARTED|Treatment Period 1 (8 Days)||6
285678|NCT01957202|683823|P16|STARTED|Treatment Period 1 (8 Days)||3
285679|NCT01957202|683824|P15|STARTED|Treatment Period 1 (8 Days)||6
285680|NCT01957202|683825|P14|STARTED|Treatment Period 1 (8 Days)||3
285681|NCT01957202|683826|P13|STARTED|Treatment Period 1 (8 Days)||3
285682|NCT01957202|683827|P12|STARTED|Treatment Period 1 (8 Days)||6
285683|NCT01957202|683828|P11|STARTED|Treatment Period 1 (8 Days)||3
285684|NCT01957202|683829|P10|STARTED|Treatment Period 1 (8 Days)||6
285685|NCT01957202|683830|P9|STARTED|Treatment Period 1 (8 Days)||3
285686|NCT01957202|683831|P8|STARTED|Treatment Period 1 (8 Days)||3
285687|NCT01957202|683832|P7|STARTED|Treatment Period 1 (8 Days)||3
285688|NCT01957202|683833|P6|STARTED|Treatment Period 1 (8 Days)||2
285689|NCT01957202|683834|P5|STARTED|Treatment Period 1 (8 Days)||3
285690|NCT01957202|683835|P4|STARTED|Treatment Period 1 (8 Days)||3
285691|NCT01957202|683836|P3|STARTED|Treatment Period 1 (8 Days)||6
285692|NCT01957202|683837|P2|STARTED|Treatment Period 1 (8 Days)||6
285693|NCT01957202|683838|P1|STARTED|Treatment Period 1 (8 Days)||3
285694|NCT01957163|683863|P3|NOT COMPLETED|Overall Study||18
285695|NCT01957163|683864|P2|NOT COMPLETED|Overall Study||11
285696|NCT01957163|683865|P1|NOT COMPLETED|Overall Study||15
285697|NCT01957163|683863|P3|COMPLETED|Overall Study||189
285698|NCT01957163|683864|P2|COMPLETED|Overall Study||195
285699|NCT01957163|683865|P1|COMPLETED|Overall Study||191
285700|NCT01957163|683863|P3|STARTED|Overall Study||207
285701|NCT01957163|683864|P2|STARTED|Overall Study||206
285702|NCT01957163|683865|P1|STARTED|Overall Study||206
285703|NCT01957137|683876|P1|NOT COMPLETED|No Stimulation||0
285704|NCT01957137|683876|P1|COMPLETED|No Stimulation||28
285705|NCT01957137|683876|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
285706|NCT01957137|683876|P1|NOT COMPLETED|Randomized Portion||2
285707|NCT01957137|683876|P1|COMPLETED|Randomized Portion||28
285708|NCT01957137|683876|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
285709|NCT01957137|683876|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
285710|NCT01957137|683876|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
285711|NCT01957137|683876|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
285712|NCT01957137|683876|P1|STARTED|Randomized Portion||30
285713|NCT01957111|683906|P2|NOT COMPLETED|Overall Study||1
285714|NCT01957111|683907|P1|NOT COMPLETED|Overall Study||1
285715|NCT01957111|683906|P2|COMPLETED|Overall Study||15
285716|NCT01957111|683907|P1|COMPLETED|Overall Study||15
285717|NCT01957111|683906|P2|STARTED|Overall Study||16
285718|NCT01957111|683907|P1|STARTED|Overall Study||16
285719|NCT01956240|683917|P2|NOT COMPLETED|Overall Study||24
285720|NCT01956240|683918|P1|NOT COMPLETED|Overall Study||23
285721|NCT01956240|683917|P2|COMPLETED|Overall Study||25
285722|NCT01956240|683918|P1|COMPLETED|Overall Study||25
285723|NCT01956240|683917|P2|STARTED|Overall Study||49
285724|NCT01956240|683918|P1|STARTED|Overall Study||48
285725|NCT01956097|683929|P3|NOT COMPLETED|Overall Study||0
285726|NCT01956097|683930|P2|NOT COMPLETED|Overall Study||2
285727|NCT01956097|683931|P1|NOT COMPLETED|Overall Study||6
285728|NCT01956097|683929|P3|COMPLETED|Overall Study||15
285729|NCT01956097|683930|P2|COMPLETED|Overall Study||28
285730|NCT01956097|683931|P1|COMPLETED|Overall Study||24
285731|NCT01956097|683929|P3|STARTED|Overall Study||15
285732|NCT01956097|683930|P2|STARTED|Overall Study||30
285733|NCT01956097|683931|P1|STARTED|Overall Study||30
285734|NCT01956032|683948|P1|NOT COMPLETED|Overall Study||0
285735|NCT01956032|683948|P1|COMPLETED|Overall Study||15
285736|NCT01956032|683948|P1|STARTED|Overall Study||15
285737|NCT01955720|683995|P6|NOT COMPLETED|Overall Study||0
285738|NCT01955720|683996|P5|NOT COMPLETED|Overall Study||0
285739|NCT01955720|683997|P4|NOT COMPLETED|Overall Study||0
285740|NCT01955720|683998|P3|NOT COMPLETED|Overall Study||0
285741|NCT01955720|683999|P2|NOT COMPLETED|Overall Study||0
285742|NCT01955720|684000|P1|NOT COMPLETED|Overall Study||0
285743|NCT01955720|683995|P6|COMPLETED|Overall Study||7
285744|NCT01955720|683996|P5|COMPLETED|Overall Study||7
285745|NCT01955720|683997|P4|COMPLETED|Overall Study||3
285746|NCT01955720|683998|P3|COMPLETED|Overall Study||3
285747|NCT01955720|683999|P2|COMPLETED|Overall Study||13
285748|NCT01955720|684000|P1|COMPLETED|Overall Study||13
285749|NCT01955720|683995|P6|Subjects With Moderate Renal Impairment|Overall Study||0
285750|NCT01955720|683996|P5|Subjects With Moderate Renal Impairment|Overall Study||0
285751|NCT01955720|683997|P4|Subjects With Moderate Renal Impairment|Overall Study||0
285752|NCT01955720|683998|P3|Subjects With Moderate Renal Impairment|Overall Study||0
285753|NCT01955720|683999|P2|Subjects With Moderate Renal Impairment|Overall Study||3
285754|NCT01955720|684000|P1|Subjects With Moderate Renal Impairment|Overall Study||3
285755|NCT01955720|683995|P6|Subjects With Mild Renal Impairment|Overall Study||3
285756|NCT01955720|683996|P5|Subjects With Mild Renal Impairment|Overall Study||3
285757|NCT01955720|683997|P4|Subjects With Mild Renal Impairment|Overall Study||0
285758|NCT01955720|683998|P3|Subjects With Mild Renal Impairment|Overall Study||0
285759|NCT01955720|683999|P2|Subjects With Mild Renal Impairment|Overall Study||3
285760|NCT01955720|684000|P1|Subjects With Mild Renal Impairment|Overall Study||3
285761|NCT01955720|683995|P6|Healthy Subjects Aged 65-80|Overall Study||4
285762|NCT01955720|683996|P5|Healthy Subjects Aged 65-80|Overall Study||4
285763|NCT01955720|683997|P4|Healthy Subjects Aged 65-80|Overall Study||0
285764|NCT01955720|683998|P3|Healthy Subjects Aged 65-80|Overall Study||0
285765|NCT01955720|683999|P2|Healthy Subjects Aged 65-80|Overall Study||4
285766|NCT01955720|684000|P1|Healthy Subjects Aged 65-80|Overall Study||4
285767|NCT01955720|683995|P6|Healthy Subjects Aged 45-64|Overall Study||0
285768|NCT01955720|683996|P5|Healthy Subjects Aged 45-64|Overall Study||0
285769|NCT01955720|683997|P4|Healthy Subjects Aged 45-64|Overall Study||3
285770|NCT01955720|683998|P3|Healthy Subjects Aged 45-64|Overall Study||3
285771|NCT01955720|683999|P2|Healthy Subjects Aged 45-64|Overall Study||3
285772|NCT01955720|684000|P1|Healthy Subjects Aged 45-64|Overall Study||3
285773|NCT01955720|683995|P6|STARTED|Overall Study||7
285774|NCT01955720|683996|P5|STARTED|Overall Study||7
285775|NCT01955720|683997|P4|STARTED|Overall Study||3
285776|NCT01955720|683998|P3|STARTED|Overall Study||3
285777|NCT01955720|683999|P2|STARTED|Overall Study||13
285778|NCT01955720|684000|P1|STARTED|Overall Study||13
285779|NCT01955707|684068|P2|NOT COMPLETED|Overall Study||22
285780|NCT01955707|684069|P1|NOT COMPLETED|Overall Study||20
285781|NCT01955707|684068|P2|COMPLETED|Overall Study||57
285782|NCT01955707|684069|P1|COMPLETED|Overall Study||62
285783|NCT01955707|684068|P2|Received Total Volume of Study Drug|Overall Study||77
285784|NCT01955707|684069|P1|Received Total Volume of Study Drug|Overall Study||82
285785|NCT01955707|684068|P2|Dosed|Overall Study||78
285786|NCT01955707|684069|P1|Dosed|Overall Study||82
285787|NCT01955707|684068|P2|Withdrew Prior to Dosing|Overall Study||1
285788|NCT01955707|684069|P1|Withdrew Prior to Dosing|Overall Study||0
285789|NCT01955707|684068|P2|STARTED|Overall Study||79
285790|NCT01955707|684069|P1|STARTED|Overall Study||82
285791|NCT01955629|684093|P1|NOT COMPLETED|Overall Study||0
285792|NCT01955629|684093|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
285793|NCT01955629|684093|P1|STARTED|Overall Study||4
285794|NCT01955473|684110|P5|NOT COMPLETED|Overall Study||0
285795|NCT01955473|684111|P4|NOT COMPLETED|Overall Study||0
285796|NCT01955473|684112|P3|NOT COMPLETED|Overall Study||0
285797|NCT01955473|684113|P2|NOT COMPLETED|Overall Study||0
285798|NCT01955473|684114|P1|NOT COMPLETED|Overall Study||0
285799|NCT01955473|684110|P5|COMPLETED|Overall Study||30
285800|NCT01955473|684111|P4|COMPLETED|Overall Study||6
285801|NCT01955473|684112|P3|COMPLETED|Overall Study||6
285802|NCT01955473|684113|P2|COMPLETED|Overall Study||6
285803|NCT01955473|684114|P1|COMPLETED|Overall Study||3
285804|NCT01955473|684110|P5|STARTED|Overall Study||30
285805|NCT01955473|684111|P4|STARTED|Overall Study||6
285806|NCT01955473|684112|P3|STARTED|Overall Study||6
285807|NCT01955473|684113|P2|STARTED|Overall Study||6
285808|NCT01955473|684114|P1|STARTED|Overall Study||3
285809|NCT01955369|684268|P1|NOT COMPLETED|Overall Study||0
285810|NCT01955369|684268|P1|COMPLETED|Overall Study||200
285811|NCT01955369|684268|P1|STARTED|Overall Study||200
285812|NCT01955122|684276|P2|NOT COMPLETED|Overall Study||5
285813|NCT01955122|684277|P1|NOT COMPLETED|Overall Study||5
285814|NCT01955122|684276|P2|COMPLETED|Overall Study||57
285815|NCT01955122|684277|P1|COMPLETED|Overall Study||59
285816|NCT01955122|684276|P2|No. Patients Completed Double Procedure|Overall Study||57
285817|NCT01955122|684277|P1|No. Patients Completed Double Procedure|Overall Study||59
285818|NCT01955122|684276|P2|No.Patients Enrolled|Overall Study||62
285819|NCT01955122|684277|P1|No.Patients Enrolled|Overall Study||64
285820|NCT01955122|684276|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
285821|NCT01955122|684277|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
285822|NCT01955083|684297|P2|NOT COMPLETED|Overall Study||1
285823|NCT01955083|684298|P1|NOT COMPLETED|Overall Study||1
285824|NCT01955083|684297|P2|COMPLETED|Overall Study||14
285825|NCT01955083|684298|P1|COMPLETED|Overall Study||14
285826|NCT01955083|684297|P2|STARTED|Overall Study||15
285827|NCT01955083|684298|P1|STARTED|Overall Study||15
285828|NCT01955044|684331|P3|NOT COMPLETED|Overall Study||0
285829|NCT01955044|684332|P2|NOT COMPLETED|Overall Study||1
285830|NCT01955044|684333|P1|NOT COMPLETED|Overall Study||1
285831|NCT01955044|684331|P3|COMPLETED|Overall Study||10
285832|NCT01955044|684332|P2|COMPLETED|Overall Study||9
285833|NCT01955044|684333|P1|COMPLETED|Overall Study||9
285834|NCT01955044|684331|P3|STARTED|Overall Study||10
285835|NCT01955044|684332|P2|STARTED|Overall Study||10
285836|NCT01955044|684333|P1|STARTED|Overall Study||10
285837|NCT01955005|684346|P2|NOT COMPLETED|Overall Study||5
285838|NCT01955005|684347|P1|NOT COMPLETED|Overall Study||3
285839|NCT01955005|684346|P2|COMPLETED|Overall Study||25
285840|NCT01955005|684347|P1|COMPLETED|Overall Study||27
285841|NCT01955005|684346|P2|STARTED|Overall Study||30
285842|NCT01955005|684347|P1|STARTED|Overall Study||30
285843|NCT01954745|684357|P1|NOT COMPLETED|Overall Study||19
285844|NCT01954745|684357|P1|COMPLETED|Overall Study||0
285845|NCT01954745|684357|P1|STARTED|Overall Study||19
285846|NCT01954628|684366|P2|NOT COMPLETED|Overall Study||27
285847|NCT01954628|684367|P1|NOT COMPLETED|Overall Study||31
285848|NCT01954628|684366|P2|COMPLETED|Overall Study||173
285849|NCT01954628|684367|P1|COMPLETED|Overall Study||169
285850|NCT01954628|684366|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
285851|NCT01954628|684367|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
285852|NCT01954628|684366|P2|Pharmacokinetic Population|Overall Study||0
285853|NCT01954628|684367|P1|Pharmacokinetic Population|Overall Study||181
285854|NCT01954628|684366|P2|Safety Set|Overall Study||200
285855|NCT01954628|684367|P1|Safety Set|Overall Study||200
285856|NCT01954628|684366|P2|Full Analysis Set (FAS)|Overall Study||198
285857|NCT01954628|684367|P1|Full Analysis Set (FAS)|Overall Study||200
285858|NCT01954628|684366|P2|STARTED|Overall Study||200
285859|NCT01954628|684367|P1|STARTED|Overall Study||200
285860|NCT01954251|684388|P2|NOT COMPLETED|Overall Study||19
285861|NCT01954251|684389|P1|NOT COMPLETED|Overall Study||13
285862|NCT01954251|684388|P2|COMPLETED|Overall Study||396
285863|NCT01954251|684389|P1|COMPLETED|Overall Study||400
285864|NCT01954251|684388|P2|STARTED|Overall Study||415
285865|NCT01954251|684389|P1|STARTED|Overall Study||413
285866|NCT01954160|684425|P2|NOT COMPLETED|Overall Study||0
285867|NCT01954160|684426|P1|NOT COMPLETED|Overall Study||5
285868|NCT01954160|684425|P2|COMPLETED|Overall Study||0
285869|NCT01954160|684426|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
285870|NCT01954160|684425|P2|STARTED|Overall Study|Not started|0
285871|NCT01954160|684426|P1|STARTED|Overall Study||5
285872|NCT01954121|684486|P2|NOT COMPLETED|Overall Study||91
285873|NCT01954121|684487|P1|NOT COMPLETED|Overall Study||127
285874|NCT01954121|684486|P2|COMPLETED|Overall Study||125
285875|NCT01954121|684487|P1|COMPLETED|Overall Study||93
285876|NCT01954121|684486|P2|STARTED|Overall Study||216
285877|NCT01954121|684487|P1|STARTED|Overall Study||220
285878|NCT01953354|684503|P2|NOT COMPLETED|Overall Study||2
285879|NCT01953354|684504|P1|NOT COMPLETED|Overall Study||1
285880|NCT01953354|684503|P2|COMPLETED|Overall Study||5
285881|NCT01953354|684504|P1|COMPLETED|Overall Study||8
285882|NCT01953354|684503|P2|STARTED|Overall Study||7
285883|NCT01953354|684504|P1|STARTED|Overall Study||9
285884|NCT01953328|684532|P8|NOT COMPLETED|Overall Study||0
285885|NCT01953328|684533|P7|NOT COMPLETED|Overall Study||0
285886|NCT01953328|684534|P6|NOT COMPLETED|Overall Study||0
285887|NCT01953328|684535|P5|NOT COMPLETED|Overall Study||2
285888|NCT01953328|684536|P4|NOT COMPLETED|Overall Study||0
285889|NCT01953328|684537|P3|NOT COMPLETED|Overall Study||0
285890|NCT01953328|684538|P2|NOT COMPLETED|Overall Study||0
285891|NCT01953328|684539|P1|NOT COMPLETED|Overall Study||0
285892|NCT01953328|684532|P8|COMPLETED|Overall Study||51
285893|NCT01953328|684533|P7|COMPLETED|Overall Study||51
285894|NCT01953328|684534|P6|COMPLETED|Overall Study||51
285895|NCT01953328|684535|P5|COMPLETED|Overall Study||50
285896|NCT01953328|684536|P4|COMPLETED|Overall Study||50
285897|NCT01953328|684537|P3|COMPLETED|Overall Study||50
285898|NCT01953328|684538|P2|COMPLETED|Overall Study||50
285899|NCT01953328|684539|P1|COMPLETED|Overall Study||49
285900|NCT01953328|684532|P8|Received Treatment|Overall Study||51
285901|NCT01953328|684533|P7|Received Treatment|Overall Study||51
285902|NCT01953328|684534|P6|Received Treatment|Overall Study||51
285903|NCT01953328|684535|P5|Received Treatment|Overall Study||52
285904|NCT01953328|684536|P4|Received Treatment|Overall Study||50
285905|NCT01953328|684537|P3|Received Treatment|Overall Study||50
285906|NCT01953328|684538|P2|Received Treatment|Overall Study||50
285907|NCT01953328|684539|P1|Received Treatment|Overall Study||49
285908|NCT01953328|684532|P8|STARTED|Overall Study||51
285909|NCT01953328|684533|P7|STARTED|Overall Study||51
285910|NCT01953328|684534|P6|STARTED|Overall Study||51
285911|NCT01953328|684535|P5|STARTED|Overall Study||52
285912|NCT01953328|684536|P4|STARTED|Overall Study||50
285913|NCT01953328|684537|P3|STARTED|Overall Study||50
285914|NCT01953328|684538|P2|STARTED|Overall Study||50
285915|NCT01953328|684539|P1|STARTED|Overall Study||49
285916|NCT01953237|684743|P2|NOT COMPLETED|Overall Study||0
285917|NCT01953237|684744|P1|NOT COMPLETED|Overall Study||0
285918|NCT01953237|684743|P2|COMPLETED|Overall Study||21
285919|NCT01953237|684744|P1|COMPLETED|Overall Study||10
285920|NCT01953237|684743|P2|STARTED|Overall Study||21
285921|NCT01953237|684744|P1|STARTED|Overall Study||10
285922|NCT01953081|684752|P2|NOT COMPLETED|Overall Study||3
285923|NCT01953081|684753|P1|NOT COMPLETED|Overall Study||2
285924|NCT01953081|684752|P2|COMPLETED|Overall Study||3
285925|NCT01953081|684753|P1|COMPLETED|Overall Study||5
285926|NCT01953081|684752|P2|STARTED|Overall Study||6
285927|NCT01953081|684753|P1|STARTED|Overall Study||7
285928|NCT01952834|684769|P1|NOT COMPLETED|Overall Study||1
285929|NCT01952834|684769|P1|COMPLETED|Overall Study||20
285930|NCT01952834|684769|P1|STARTED|Overall Study||21
285931|NCT01952691|684776|P1|NOT COMPLETED|Overall Study||2
285932|NCT01952691|684776|P1|COMPLETED|Overall Study||20
285933|NCT01952691|684776|P1|STARTED|Overall Study||22
285934|NCT01952665|684784|P2|NOT COMPLETED|Overall Study||6
285935|NCT01952665|684785|P1|NOT COMPLETED|Overall Study||6
285936|NCT01952665|684784|P2|COMPLETED|Overall Study||20
285937|NCT01952665|684785|P1|COMPLETED|Overall Study||31
285938|NCT01952665|684784|P2|STARTED|Overall Study||26
285939|NCT01952665|684785|P1|STARTED|Overall Study||37
285940|NCT01952600|684926|P3|NOT COMPLETED|Overall Study||7
285941|NCT01952600|684927|P2|NOT COMPLETED|Overall Study||13
285942|NCT01952600|684928|P1|NOT COMPLETED|Overall Study||15
285943|NCT01952600|684926|P3|COMPLETED|Overall Study||38
285944|NCT01952600|684927|P2|COMPLETED|Overall Study||77
285945|NCT01952600|684928|P1|COMPLETED|Overall Study||65
285946|NCT01952600|684926|P3|STARTED|Overall Study||45
285947|NCT01952600|684927|P2|STARTED|Overall Study||90
285948|NCT01952600|684928|P1|STARTED|Overall Study||80
285949|NCT01952418|684938|P2|NOT COMPLETED|Overall Study||0
285950|NCT01952418|684939|P1|NOT COMPLETED|Overall Study||0
285951|NCT01952418|684938|P2|COMPLETED|Overall Study||895
285952|NCT01952418|684939|P1|COMPLETED|Overall Study||910
285953|NCT01952418|684938|P2|STARTED|Overall Study||895
285954|NCT01952418|684939|P1|STARTED|Overall Study||910
285955|NCT01952366|684951|P1|NOT COMPLETED|Overall Study||31
285956|NCT01952366|684951|P1|COMPLETED|Overall Study||138
285957|NCT01952366|684951|P1|STARTED|Overall Study||169
285958|NCT01952301|684957|P1|NOT COMPLETED|Overall Study||0
285959|NCT01952301|684957|P1|COMPLETED|Overall Study||30
285960|NCT01952301|684957|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
285961|NCT01952145|684965|P2|NOT COMPLETED|Overall Study||14
285962|NCT01952145|684966|P1|NOT COMPLETED|Overall Study||28
285963|NCT01952145|684965|P2|COMPLETED|Overall Study||265
285964|NCT01952145|684966|P1|COMPLETED|Overall Study||250
285965|NCT01952145|684965|P2|STARTED|Overall Study||279
285966|NCT01952145|684966|P1|STARTED|Overall Study||278
285967|NCT01952080|684980|P4|NOT COMPLETED|Overall Study||1
285968|NCT01952080|684981|P3|NOT COMPLETED|Overall Study||0
285969|NCT01952080|684982|P2|NOT COMPLETED|Overall Study||1
285970|NCT01952080|684983|P1|NOT COMPLETED|Overall Study||0
285971|NCT01952080|684980|P4|COMPLETED|Overall Study||14
285972|NCT01952080|684981|P3|COMPLETED|Overall Study||14
285973|NCT01952080|684982|P2|COMPLETED|Overall Study||7
285974|NCT01952080|684983|P1|COMPLETED|Overall Study||5
285975|NCT01952080|684980|P4|Treated|Overall Study||15
285976|NCT01952080|684981|P3|Treated|Overall Study||14
285977|NCT01952080|684982|P2|Treated|Overall Study||8
285978|NCT01952080|684983|P1|Treated|Overall Study||5
285979|NCT01952080|684980|P4|STARTED|Overall Study||15
285980|NCT01952080|684981|P3|STARTED|Overall Study||14
285981|NCT01952080|684982|P2|STARTED|Overall Study||8
285982|NCT01952080|684983|P1|STARTED|Overall Study||5
285983|NCT01951950|685031|P2|NOT COMPLETED|Overall Study||6
285984|NCT01951950|685032|P1|NOT COMPLETED|Overall Study||6
285985|NCT01951950|685031|P2|COMPLETED|Overall Study||20
285986|NCT01951950|685032|P1|COMPLETED|Overall Study||20
285987|NCT01951950|685031|P2|STARTED|Overall Study||26
285988|NCT01951950|685032|P1|STARTED|Overall Study||26
285989|NCT01951820|685040|P2|NOT COMPLETED|Overall Study||0
285990|NCT01951820|685041|P1|NOT COMPLETED|Overall Study||0
285991|NCT01951820|685040|P2|COMPLETED|Overall Study||30
285992|NCT01951820|685041|P1|COMPLETED|Overall Study||34
285993|NCT01951820|685040|P2|STARTED|Overall Study||30
285994|NCT01951820|685041|P1|STARTED|Overall Study||34
285995|NCT01951703|685049|P2|NOT COMPLETED|Second Intervention||2
285996|NCT01951703|685050|P1|NOT COMPLETED|Second Intervention||0
285997|NCT01951703|685049|P2|COMPLETED|Second Intervention||60
285998|NCT01951703|685050|P1|COMPLETED|Second Intervention||61
285999|NCT01951703|685049|P2|STARTED|Second Intervention||62
286000|NCT01951703|685050|P1|STARTED|Second Intervention||61
286001|NCT01951703|685049|P2|NOT COMPLETED|First Intervention||1
286002|NCT01951703|685050|P1|NOT COMPLETED|First Intervention||3
286003|NCT01951703|685049|P2|COMPLETED|First Intervention||62
286004|NCT01951703|685050|P1|COMPLETED|First Intervention||61
286005|NCT01951703|685049|P2|STARTED|First Intervention||63
286006|NCT01951703|685050|P1|STARTED|First Intervention||64
286007|NCT01951651|685060|P2|NOT COMPLETED|Overall Study||2
286008|NCT01951651|685061|P1|NOT COMPLETED|Overall Study||4
286009|NCT01951651|685060|P2|COMPLETED|Overall Study||10
286010|NCT01951651|685061|P1|COMPLETED|Overall Study||8
286011|NCT01951651|685060|P2|STARTED|Overall Study||12
286012|NCT01951651|685061|P1|STARTED|Overall Study||12
286013|NCT01951573|685073|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
286014|NCT01951573|685074|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
286015|NCT01951573|685073|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
286016|NCT01951573|685074|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
286017|NCT01951573|685073|P2|STARTED|Period 2, Second 9 Hours of Wear||16
286018|NCT01951573|685074|P1|STARTED|Period 2, Second 9 Hours of Wear||17
286019|NCT01951573|685073|P2|NOT COMPLETED|Washout Period||1
286020|NCT01951573|685074|P1|NOT COMPLETED|Washout Period||0
286021|NCT01951573|685073|P2|COMPLETED|Washout Period||16
286022|NCT01951573|685074|P1|COMPLETED|Washout Period||17
286023|NCT01951573|685073|P2|STARTED|Washout Period||17
286024|NCT01951573|685074|P1|STARTED|Washout Period||17
286025|NCT01951573|685073|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
286026|NCT01951573|685074|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
286027|NCT01951573|685073|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
286028|NCT01951573|685074|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
286029|NCT01951573|685073|P2|STARTED|Period 1, First 9 Hours of Wear||17
286030|NCT01951573|685074|P1|STARTED|Period 1, First 9 Hours of Wear||17
286031|NCT01951417|685084|P1|NOT COMPLETED|Overall Study||9
286032|NCT01951417|685084|P1|COMPLETED|Overall Study||72
286033|NCT01951417|685084|P1|STARTED|Overall Study||81
286034|NCT01951170|685107|P1|NOT COMPLETED|Overall Study||1
286035|NCT01951170|685107|P1|COMPLETED|Overall Study||51
286036|NCT01951170|685107|P1|STARTED|Overall Study||52
286037|NCT01951092|685130|P1|NOT COMPLETED|Overall Study||12
286038|NCT01951092|685130|P1|COMPLETED|Overall Study||20
286039|NCT01951092|685130|P1|STARTED|Overall Study||32
286040|NCT01951066|685135|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
286041|NCT01951066|685136|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
286042|NCT01951066|685135|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
286043|NCT01951066|685136|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
286044|NCT01951066|685135|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
286045|NCT01951066|685136|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
286046|NCT01951066|685135|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
286047|NCT01951066|685136|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
286048|NCT01951066|685135|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
286049|NCT01951066|685136|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
286050|NCT01951066|685135|P2|STARTED|First Intervention (Baseline to Week 16)||10
286051|NCT01951066|685136|P1|STARTED|First Intervention (Baseline to Week 16)||10
286052|NCT01950741|685141|P1|NOT COMPLETED|Overall Study||3
286053|NCT01950741|685141|P1|COMPLETED|Overall Study||45
286054|NCT01950741|685141|P1|STARTED|Overall Study||48
286055|NCT01950663|685150|P1|NOT COMPLETED|Overall Study||1
286056|NCT01950663|685150|P1|COMPLETED|Overall Study||467
286057|NCT01950663|685150|P1|STARTED|Overall Study||468
286058|NCT01950364|685156|P2|NOT COMPLETED|Overall Study||10
286059|NCT01950364|685157|P1|NOT COMPLETED|Overall Study||10
286060|NCT01950364|685156|P2|COMPLETED|Overall Study||0
286061|NCT01950364|685157|P1|COMPLETED|Overall Study||0
286062|NCT01950364|685156|P2|STARTED|Overall Study||10
286063|NCT01950364|685157|P1|STARTED|Overall Study||10
286064|NCT01950078|685257|P2|NOT COMPLETED|Overall Study||12
286065|NCT01950078|685258|P1|NOT COMPLETED|Overall Study||20
286066|NCT01950078|685257|P2|COMPLETED|Overall Study||496
286067|NCT01950078|685258|P1|COMPLETED|Overall Study||1005
286068|NCT01950078|685257|P2|STARTED|Overall Study||508
286069|NCT01950078|685258|P1|STARTED|Overall Study||1025
286070|NCT01949870|685266|P1|NOT COMPLETED|Overall Study||6
286071|NCT01949870|685266|P1|COMPLETED|Overall Study||0
286072|NCT01949870|685266|P1|Received Treatment|Overall Study||4
286073|NCT01949870|685266|P1|STARTED|Overall Study||6
286074|NCT01949545|685274|P4|NOT COMPLETED|Overall Study||0
286075|NCT01949545|685275|P3|NOT COMPLETED|Overall Study||0
286076|NCT01949545|685276|P2|NOT COMPLETED|Overall Study||0
286077|NCT01949545|685277|P1|NOT COMPLETED|Overall Study||0
286078|NCT01949545|685274|P4|COMPLETED|Overall Study||4
286079|NCT01949545|685275|P3|COMPLETED|Overall Study||14
286080|NCT01949545|685276|P2|COMPLETED|Overall Study||17
286081|NCT01949545|685277|P1|COMPLETED|Overall Study||11
286082|NCT01949545|685274|P4|STARTED|Overall Study||4
286083|NCT01949545|685275|P3|STARTED|Overall Study||14
286084|NCT01949545|685276|P2|STARTED|Overall Study||17
286085|NCT01949545|685277|P1|STARTED|Overall Study||11
286086|NCT01949532|685425|P2|NOT COMPLETED|Overall Study||3
286087|NCT01949532|685426|P1|NOT COMPLETED|Overall Study||3
286088|NCT01949532|685425|P2|COMPLETED|Overall Study||8
286089|NCT01949532|685426|P1|COMPLETED|Overall Study||12
286090|NCT01949532|685425|P2|STARTED|Overall Study||11
286091|NCT01949532|685426|P1|STARTED|Overall Study||15
286092|NCT01949389|685494|P1|NOT COMPLETED|Overall Study||0
286093|NCT01949389|685494|P1|COMPLETED|Overall Study||51
286094|NCT01949389|685494|P1|STARTED|Overall Study||51
286095|NCT01949155|685501|P2|NOT COMPLETED|Overall Study||0
286096|NCT01949155|685502|P1|NOT COMPLETED|Overall Study||2
286097|NCT01949155|685501|P2|COMPLETED|Overall Study||88
286098|NCT01949155|685502|P1|COMPLETED|Overall Study||176
286099|NCT01949155|685501|P2|STARTED|Overall Study||88
286100|NCT01949155|685502|P1|STARTED|Overall Study||178
286101|NCT01949142|685514|P2|NOT COMPLETED|Overall Study||1
286102|NCT01949142|685515|P1|NOT COMPLETED|Overall Study||3
286103|NCT01949142|685514|P2|COMPLETED|Overall Study||86
286104|NCT01949142|685515|P1|COMPLETED|Overall Study||176
286105|NCT01949142|685514|P2|STARTED|Overall Study||87
286106|NCT01949142|685515|P1|STARTED|Overall Study||179
286107|NCT01949051|685525|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
286108|NCT01949051|685526|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
286109|NCT01949051|685527|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
286110|NCT01949051|685528|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
286111|NCT01949051|685529|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
286112|NCT01949051|685530|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
286113|NCT01949051|685525|P6|COMPLETED|Treatment Period 3 (7 Days)||12
286114|NCT01949051|685526|P5|COMPLETED|Treatment Period 3 (7 Days)||13
286115|NCT01949051|685527|P4|COMPLETED|Treatment Period 3 (7 Days)||12
286116|NCT01949051|685528|P3|COMPLETED|Treatment Period 3 (7 Days)||12
286117|NCT01949051|685529|P2|COMPLETED|Treatment Period 3 (7 Days)||12
286118|NCT01949051|685530|P1|COMPLETED|Treatment Period 3 (7 Days)||11
286119|NCT01949051|685525|P6|STARTED|Treatment Period 3 (7 Days)||12
286120|NCT01949051|685526|P5|STARTED|Treatment Period 3 (7 Days)||13
286121|NCT01949051|685527|P4|STARTED|Treatment Period 3 (7 Days)||12
286122|NCT01949051|685528|P3|STARTED|Treatment Period 3 (7 Days)||12
286123|NCT01949051|685529|P2|STARTED|Treatment Period 3 (7 Days)||12
286124|NCT01949051|685530|P1|STARTED|Treatment Period 3 (7 Days)||11
286125|NCT01949051|685525|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
286126|NCT01949051|685526|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
286127|NCT01949051|685527|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
286128|NCT01949051|685528|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
286129|NCT01949051|685529|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
286130|NCT01949051|685530|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
286131|NCT01949051|685525|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
286132|NCT01949051|685526|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
286133|NCT01949051|685527|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
286134|NCT01949051|685528|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
286135|NCT01949051|685529|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
286136|NCT01949051|685530|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
286137|NCT01949051|685525|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
286138|NCT01949051|685526|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
286139|NCT01949051|685527|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
286140|NCT01949051|685528|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
286141|NCT01949051|685529|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
286142|NCT01949051|685530|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
286143|NCT01949051|685525|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
286144|NCT01949051|685526|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
286145|NCT01949051|685527|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
286146|NCT01949051|685528|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
286147|NCT01949051|685529|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
286148|NCT01949051|685530|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
286149|NCT01949051|685525|P6|COMPLETED|Treatment Period 2 (7 Days)||12
286150|NCT01949051|685526|P5|COMPLETED|Treatment Period 2 (7 Days)||13
286151|NCT01949051|685527|P4|COMPLETED|Treatment Period 2 (7 Days)||12
286152|NCT01949051|685528|P3|COMPLETED|Treatment Period 2 (7 Days)||12
286153|NCT01949051|685529|P2|COMPLETED|Treatment Period 2 (7 Days)||12
286154|NCT01949051|685530|P1|COMPLETED|Treatment Period 2 (7 Days)||11
286155|NCT01949051|685525|P6|STARTED|Treatment Period 2 (7 Days)||13
286156|NCT01949051|685526|P5|STARTED|Treatment Period 2 (7 Days)||13
286157|NCT01949051|685527|P4|STARTED|Treatment Period 2 (7 Days)||12
286158|NCT01949051|685528|P3|STARTED|Treatment Period 2 (7 Days)||13
286159|NCT01949051|685529|P2|STARTED|Treatment Period 2 (7 Days)||13
286160|NCT01949051|685530|P1|STARTED|Treatment Period 2 (7 Days)||11
286161|NCT01949051|685525|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
286162|NCT01949051|685526|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
286163|NCT01949051|685527|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
286164|NCT01949051|685528|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
286165|NCT01949051|685529|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
286166|NCT01949051|685530|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
286167|NCT01949051|685525|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
286168|NCT01949051|685526|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
286169|NCT01949051|685527|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
286170|NCT01949051|685528|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
286171|NCT01949051|685529|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
286172|NCT01949051|685530|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
286173|NCT01949051|685525|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
286174|NCT01949051|685526|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
286175|NCT01949051|685527|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
286176|NCT01949051|685528|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
286177|NCT01949051|685529|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
286178|NCT01949051|685530|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
286179|NCT01949051|685525|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
286180|NCT01949051|685526|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
286181|NCT01949051|685527|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
286182|NCT01949051|685528|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
286183|NCT01949051|685529|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
286184|NCT01949051|685530|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
286185|NCT01949051|685525|P6|COMPLETED|Treatment Period 1 (7 Days)||13
286186|NCT01949051|685526|P5|COMPLETED|Treatment Period 1 (7 Days)||13
286187|NCT01949051|685527|P4|COMPLETED|Treatment Period 1 (7 Days)||12
286188|NCT01949051|685528|P3|COMPLETED|Treatment Period 1 (7 Days)||13
286189|NCT01949051|685529|P2|COMPLETED|Treatment Period 1 (7 Days)||13
286190|NCT01949051|685530|P1|COMPLETED|Treatment Period 1 (7 Days)||11
286191|NCT01949051|685525|P6|STARTED|Treatment Period 1 (7 Days)||13
286192|NCT01949051|685526|P5|STARTED|Treatment Period 1 (7 Days)||13
286193|NCT01949051|685527|P4|STARTED|Treatment Period 1 (7 Days)||13
286194|NCT01949051|685528|P3|STARTED|Treatment Period 1 (7 Days)||13
286195|NCT01949051|685529|P2|STARTED|Treatment Period 1 (7 Days)||13
286196|NCT01949051|685530|P1|STARTED|Treatment Period 1 (7 Days)||13
286197|NCT01948908|685544|P3|NOT COMPLETED|Overall Study||2
286198|NCT01948908|685545|P2|NOT COMPLETED|Overall Study||0
286199|NCT01948908|685546|P1|NOT COMPLETED|Overall Study||1
286200|NCT01948908|685544|P3|COMPLETED|Overall Study||31
286201|NCT01948908|685545|P2|COMPLETED|Overall Study||33
286202|NCT01948908|685546|P1|COMPLETED|Overall Study||32
286203|NCT01948908|685544|P3|STARTED|Overall Study||33
286204|NCT01948908|685545|P2|STARTED|Overall Study||33
286205|NCT01948908|685546|P1|STARTED|Overall Study||33
286206|NCT01948830|685562|P2|NOT COMPLETED|Overall Study||32
286207|NCT01948830|685563|P1|NOT COMPLETED|Overall Study||33
286208|NCT01948830|685562|P2|COMPLETED|Overall Study||295
286209|NCT01948830|685563|P1|COMPLETED|Overall Study||290
286210|NCT01948830|685562|P2|Safety Set|Overall Study||326
286211|NCT01948830|685563|P1|Safety Set|Overall Study||323
286212|NCT01948830|685562|P2|STARTED|Overall Study||327
286213|NCT01948830|685563|P1|STARTED|Overall Study||323
286214|NCT01948791|685595|P1|NOT COMPLETED|Overall Study||71
286215|NCT01948791|685595|P1|COMPLETED|Overall Study||151
286216|NCT01948791|685595|P1|STARTED|Overall Study||222
286217|NCT01948518|685603|P1|NOT COMPLETED|Overall Study||0
286218|NCT01948518|685603|P1|COMPLETED|Overall Study||15
286219|NCT01948518|685603|P1|STARTED|Overall Study||15
286220|NCT01948375|685610|P2|NOT COMPLETED|Overall Study||0
286221|NCT01948375|685611|P1|NOT COMPLETED|Overall Study||0
286222|NCT01948375|685610|P2|COMPLETED|Overall Study||30
286223|NCT01948375|685611|P1|COMPLETED|Overall Study||30
286224|NCT01948375|685610|P2|STARTED|Overall Study||30
286225|NCT01948375|685611|P1|STARTED|Overall Study||30
286226|NCT01948193|685625|P1|NOT COMPLETED|Overall Study||9
286227|NCT01948193|685625|P1|COMPLETED|Overall Study||168
286228|NCT01948193|685625|P1|STARTED|Overall Study||177
286229|NCT01948141|685634|P1|NOT COMPLETED|Overall Study||0
286230|NCT01948141|685634|P1|COMPLETED|Overall Study||6
286231|NCT01948141|685634|P1|STARTED|Overall Study||6
286232|NCT01948076|685647|P2|NOT COMPLETED|Overall Study||1
286233|NCT01948076|685648|P1|NOT COMPLETED|Overall Study||0
286234|NCT01948076|685647|P2|COMPLETED|Overall Study||19
286235|NCT01948076|685648|P1|COMPLETED|Overall Study||20
286236|NCT01948076|685647|P2|STARTED|Overall Study||20
286237|NCT01948076|685648|P1|STARTED|Overall Study||20
286238|NCT01948063|685658|P2|NOT COMPLETED|Overall Study||2
286239|NCT01948063|685659|P1|NOT COMPLETED|Overall Study||1
286240|NCT01948063|685658|P2|COMPLETED|Overall Study||19
286241|NCT01948063|685659|P1|COMPLETED|Overall Study||19
286242|NCT01948063|685658|P2|STARTED|Overall Study||21
286243|NCT01948063|685659|P1|STARTED|Overall Study||20
286244|NCT01948050|685667|P2|NOT COMPLETED|Overall Study||1
286245|NCT01948050|685668|P1|NOT COMPLETED|Overall Study||0
286246|NCT01948050|685667|P2|COMPLETED|Overall Study||7
286247|NCT01948050|685668|P1|COMPLETED|Overall Study||16
286248|NCT01948050|685667|P2|STARTED|Overall Study||8
286249|NCT01948050|685668|P1|STARTED|Overall Study||16
286250|NCT01947946|685677|P3|NOT COMPLETED|Overall Study||5
286251|NCT01947946|685678|P2|NOT COMPLETED|Overall Study||5
286252|NCT01947946|685679|P1|NOT COMPLETED|Overall Study||3
286253|NCT01947946|685677|P3|COMPLETED|Overall Study||0
286254|NCT01947946|685678|P2|COMPLETED|Overall Study||0
286255|NCT01947946|685679|P1|COMPLETED|Overall Study|Study Stopped|0
286256|NCT01947946|685677|P3|STARTED|Overall Study||5
286257|NCT01947946|685678|P2|STARTED|Overall Study||5
286258|NCT01947946|685679|P1|STARTED|Overall Study||3
286259|NCT01947907|685691|P4|NOT COMPLETED|Overall Study||0
286260|NCT01947907|685692|P3|NOT COMPLETED|Overall Study||0
286261|NCT01947907|685693|P2|NOT COMPLETED|Overall Study||0
286262|NCT01947907|685694|P1|NOT COMPLETED|Overall Study||0
286263|NCT01947907|685691|P4|COMPLETED|Overall Study||13
286264|NCT01947907|685692|P3|COMPLETED|Overall Study||14
286265|NCT01947907|685693|P2|COMPLETED|Overall Study||14
286266|NCT01947907|685694|P1|COMPLETED|Overall Study||12
286267|NCT01947907|685691|P4|STARTED|Overall Study||13
286268|NCT01947907|685692|P3|STARTED|Overall Study||14
286269|NCT01947907|685693|P2|STARTED|Overall Study||14
286270|NCT01947907|685694|P1|STARTED|Overall Study||12
286271|NCT01947855|685736|P3|NOT COMPLETED|Overall Study||0
286272|NCT01947855|685737|P2|NOT COMPLETED|Overall Study||0
286273|NCT01947855|685738|P1|NOT COMPLETED|Overall Study||1
286274|NCT01947855|685736|P3|COMPLETED|Overall Study||19
286275|NCT01947855|685737|P2|COMPLETED|Overall Study||20
286276|NCT01947855|685738|P1|COMPLETED|Overall Study||20
286277|NCT01947855|685736|P3|STARTED|Overall Study||19
286278|NCT01947855|685737|P2|STARTED|Overall Study||20
286279|NCT01947855|685738|P1|STARTED|Overall Study||21
286280|NCT01947582|685746|P1|NOT COMPLETED|Overall Study||1
286281|NCT01947582|685746|P1|COMPLETED|Overall Study||1
286282|NCT01947582|685746|P1|STARTED|Overall Study||2
286283|NCT01947517|685755|P2|NOT COMPLETED|Overall Study||1
286284|NCT01947517|685756|P1|NOT COMPLETED|Overall Study||1
286285|NCT01947517|685755|P2|COMPLETED|Overall Study||25
286286|NCT01947517|685756|P1|COMPLETED|Overall Study||25
286287|NCT01947517|685755|P2|STARTED|Overall Study||26
286288|NCT01947517|685756|P1|STARTED|Overall Study||26
286289|NCT01947491|685774|P4|NOT COMPLETED|Overall Study||5
286290|NCT01947491|685775|P3|NOT COMPLETED|Overall Study||2
286291|NCT01947491|685776|P2|NOT COMPLETED|Overall Study||6
286292|NCT01947491|685777|P1|NOT COMPLETED|Overall Study||8
286293|NCT01947491|685774|P4|COMPLETED|Overall Study||38
286294|NCT01947491|685775|P3|COMPLETED|Overall Study||88
286295|NCT01947491|685776|P2|COMPLETED|Overall Study||81
286296|NCT01947491|685777|P1|COMPLETED|Overall Study||166
286297|NCT01947491|685774|P4|STARTED|Overall Study||43
286298|NCT01947491|685775|P3|STARTED|Overall Study||90
286299|NCT01947491|685776|P2|STARTED|Overall Study||87
286300|NCT01947491|685777|P1|STARTED|Overall Study||174
286301|NCT01947335|685789|P2|NOT COMPLETED|Overall Study||0
286302|NCT01947335|685790|P1|NOT COMPLETED|Overall Study||0
286303|NCT01947335|685789|P2|COMPLETED|Overall Study||41
286304|NCT01947335|685790|P1|COMPLETED|Overall Study||42
286305|NCT01947335|685789|P2|STARTED|Overall Study||41
286306|NCT01947335|685790|P1|STARTED|Overall Study||42
286307|NCT01947153|685800|P2|NOT COMPLETED|Test Period 2||0
286308|NCT01947153|685801|P1|NOT COMPLETED|Test Period 2||0
286309|NCT01947153|685800|P2|COMPLETED|Test Period 2||18
286310|NCT01947153|685801|P1|COMPLETED|Test Period 2||18
286311|NCT01947153|685800|P2|STARTED|Test Period 2||18
286312|NCT01947153|685801|P1|STARTED|Test Period 2||18
286313|NCT01947153|685800|P2|NOT COMPLETED|Test Period 1||0
286314|NCT01947153|685801|P1|NOT COMPLETED|Test Period 1||0
286315|NCT01947153|685800|P2|COMPLETED|Test Period 1||18
286316|NCT01947153|685801|P1|COMPLETED|Test Period 1||18
286317|NCT01947153|685800|P2|STARTED|Test Period 1||18
286318|NCT01947153|685801|P1|STARTED|Test Period 1||18
286319|NCT01947127|685821|P2|NOT COMPLETED|Overall Study||43
286320|NCT01947127|685822|P1|NOT COMPLETED|Overall Study||23
286321|NCT01947127|685821|P2|COMPLETED|Overall Study||249
286322|NCT01947127|685822|P1|COMPLETED|Overall Study||143
286323|NCT01947127|685821|P2|STARTED|Overall Study||292
286324|NCT01947127|685822|P1|STARTED|Overall Study||166
286325|NCT01946542|685834|P2|NOT COMPLETED|Testing Visit 2||0
286326|NCT01946542|685835|P1|NOT COMPLETED|Testing Visit 2||0
286327|NCT01946542|685834|P2|COMPLETED|Testing Visit 2||1
286328|NCT01946542|685835|P1|COMPLETED|Testing Visit 2||1
286329|NCT01946542|685834|P2|STARTED|Testing Visit 2||1
286330|NCT01946542|685835|P1|STARTED|Testing Visit 2||1
286331|NCT01946542|685834|P2|NOT COMPLETED|Testing Visit 1||0
286332|NCT01946542|685835|P1|NOT COMPLETED|Testing Visit 1||0
286333|NCT01946542|685834|P2|COMPLETED|Testing Visit 1||1
286334|NCT01946542|685835|P1|COMPLETED|Testing Visit 1||1
286335|NCT01946542|685834|P2|STARTED|Testing Visit 1||1
286336|NCT01946542|685835|P1|STARTED|Testing Visit 1||1
286337|NCT01946529|685846|P3|NOT COMPLETED|Completion of All Therapy||6
286338|NCT01946529|685847|P2|NOT COMPLETED|Completion of All Therapy||16
286339|NCT01946529|685848|P1|NOT COMPLETED|Completion of All Therapy||1
286340|NCT01946529|685846|P3|COMPLETED|Completion of All Therapy||0
286341|NCT01946529|685847|P2|COMPLETED|Completion of All Therapy||0
286342|NCT01946529|685848|P1|COMPLETED|Completion of All Therapy||0
286343|NCT01946529|685846|P3|STARTED|Completion of All Therapy||6
286344|NCT01946529|685847|P2|STARTED|Completion of All Therapy||16
286345|NCT01946529|685848|P1|STARTED|Completion of All Therapy||1
286346|NCT01946529|685846|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
286347|NCT01946529|685847|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
286348|NCT01946529|685848|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
286349|NCT01946529|685846|P3|COMPLETED|End of Window Therapy (2 Courses)||6
286350|NCT01946529|685847|P2|COMPLETED|End of Window Therapy (2 Courses)||16
286351|NCT01946529|685848|P1|COMPLETED|End of Window Therapy (2 Courses)||1
286352|NCT01946529|685846|P3|STARTED|End of Window Therapy (2 Courses)||6
286353|NCT01946529|685847|P2|STARTED|End of Window Therapy (2 Courses)||17
286354|NCT01946529|685848|P1|STARTED|End of Window Therapy (2 Courses)||1
286355|NCT01946438|685859|P4|NOT COMPLETED|Overall Study||1
286356|NCT01946438|685860|P3|NOT COMPLETED|Overall Study||1
286357|NCT01946438|685861|P2|NOT COMPLETED|Overall Study||0
286358|NCT01946438|685862|P1|NOT COMPLETED|Overall Study||2
286359|NCT01946438|685859|P4|COMPLETED|Overall Study||51
286360|NCT01946438|685860|P3|COMPLETED|Overall Study||51
286361|NCT01946438|685861|P2|COMPLETED|Overall Study||52
286362|NCT01946438|685862|P1|COMPLETED|Overall Study||50
286363|NCT01946438|685859|P4|STARTED|Overall Study||52
286364|NCT01946438|685860|P3|STARTED|Overall Study||52
286365|NCT01946438|685861|P2|STARTED|Overall Study||52
286366|NCT01946438|685862|P1|STARTED|Overall Study||52
286367|NCT01946425|685890|P2|NOT COMPLETED|Overall Study||0
286368|NCT01946425|685891|P1|NOT COMPLETED|Overall Study||2
286369|NCT01946425|685890|P2|COMPLETED|Overall Study||30
286370|NCT01946425|685891|P1|COMPLETED|Overall Study||28
286371|NCT01946425|685890|P2|STARTED|Overall Study||30
286372|NCT01946425|685891|P1|STARTED|Overall Study||30
286373|NCT01946412|685905|P1|NOT COMPLETED|Overall Study||5
286374|NCT01946412|685905|P1|COMPLETED|Overall Study||28
286375|NCT01946412|685905|P1|STARTED|Overall Study||33
286376|NCT01946243|685927|P1|NOT COMPLETED|Overall Study||0
286377|NCT01946243|685927|P1|COMPLETED|Overall Study||96
286378|NCT01946243|685927|P1|STARTED|Overall Study||96
286379|NCT01946178|685948|P1|NOT COMPLETED|Overall Study||2
286380|NCT01946178|685948|P1|COMPLETED|Overall Study||71
286381|NCT01946178|685948|P1|STARTED|Overall Study||73
286382|NCT01946126|685958|P2|NOT COMPLETED|Overall Study||0
286383|NCT01946126|685959|P1|NOT COMPLETED|Overall Study||0
286384|NCT01946126|685958|P2|COMPLETED|Overall Study||275
286385|NCT01946126|685959|P1|COMPLETED|Overall Study||184
286386|NCT01946126|685958|P2|STARTED|Overall Study||275
286387|NCT01946126|685959|P1|STARTED|Overall Study||184
286388|NCT01945970|685973|P6|NOT COMPLETED|Overall Study||0
286389|NCT01945970|685974|P5|NOT COMPLETED|Overall Study||0
286390|NCT01945970|685975|P4|NOT COMPLETED|Overall Study||0
286391|NCT01945970|685976|P3|NOT COMPLETED|Overall Study||0
286392|NCT01945970|685977|P2|NOT COMPLETED|Overall Study||0
286393|NCT01945970|685978|P1|NOT COMPLETED|Overall Study||0
286394|NCT01945970|685973|P6|COMPLETED|Overall Study||5
286395|NCT01945970|685974|P5|COMPLETED|Overall Study||5
286396|NCT01945970|685975|P4|COMPLETED|Overall Study||5
286397|NCT01945970|685976|P3|COMPLETED|Overall Study||5
286398|NCT01945970|685977|P2|COMPLETED|Overall Study||5
286399|NCT01945970|685978|P1|COMPLETED|Overall Study||5
286400|NCT01945970|685973|P6|STARTED|Overall Study||5
286401|NCT01945970|685974|P5|STARTED|Overall Study||5
286402|NCT01945970|685975|P4|STARTED|Overall Study||5
286403|NCT01945970|685976|P3|STARTED|Overall Study||5
286404|NCT01945970|685977|P2|STARTED|Overall Study||5
286405|NCT01945970|685978|P1|STARTED|Overall Study||5
286406|NCT01945944|686017|P2|NOT COMPLETED|Overall Study||3
286407|NCT01945944|686018|P1|NOT COMPLETED|Overall Study||1
286408|NCT01945944|686017|P2|COMPLETED|Overall Study||6
286409|NCT01945944|686018|P1|COMPLETED|Overall Study||8
286410|NCT01945944|686017|P2|STARTED|Overall Study||9
286411|NCT01945944|686018|P1|STARTED|Overall Study||9
286412|NCT01945294|686043|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
286413|NCT01945294|686044|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
286414|NCT01945294|686045|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
286415|NCT01945294|686046|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
286498|NCT01944774|686275|P1|STARTED|Overall Study||69
286416|NCT01945294|686043|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
286417|NCT01945294|686044|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
286418|NCT01945294|686045|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
286419|NCT01945294|686046|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
286420|NCT01945294|686043|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
286421|NCT01945294|686044|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
286422|NCT01945294|686045|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
286423|NCT01945294|686046|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
286424|NCT01945294|686043|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
286425|NCT01945294|686044|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
286426|NCT01945294|686045|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
286427|NCT01945294|686046|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
286428|NCT01945294|686043|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
286429|NCT01945294|686044|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
286430|NCT01945294|686045|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
286431|NCT01945294|686046|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
286432|NCT01945294|686043|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
286433|NCT01945294|686044|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
286434|NCT01945294|686045|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
286435|NCT01945294|686046|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
286436|NCT01945242|686077|P2|NOT COMPLETED|Overall Study||3
286437|NCT01945242|686078|P1|NOT COMPLETED|Overall Study||3
286438|NCT01945242|686077|P2|COMPLETED|Overall Study||120
286439|NCT01945242|686078|P1|COMPLETED|Overall Study||1248
286440|NCT01945242|686077|P2|STARTED|Overall Study||123
286441|NCT01945242|686078|P1|STARTED|Overall Study||1251
286442|NCT01945138|686092|P2|NOT COMPLETED|Overall Study||0
286443|NCT01945138|686093|P1|NOT COMPLETED|Overall Study||0
286444|NCT01945138|686092|P2|COMPLETED|Overall Study||7
286445|NCT01945138|686093|P1|COMPLETED|Overall Study||7
286446|NCT01945138|686092|P2|STARTED|Overall Study||7
286447|NCT01945138|686093|P1|STARTED|Overall Study||7
286448|NCT01945112|686127|P2|NOT COMPLETED|Overall Study||0
286449|NCT01945112|686128|P1|NOT COMPLETED|Overall Study||0
286450|NCT01945112|686127|P2|COMPLETED|Overall Study||51
286451|NCT01945112|686128|P1|COMPLETED|Overall Study||77
286452|NCT01945112|686127|P2|STARTED|Overall Study|total number of sites where tape was applied|51
286453|NCT01945112|686128|P1|STARTED|Overall Study|total number of sites where tape was applied|77
286454|NCT01945086|686136|P3|NOT COMPLETED|Overall Study||2
286455|NCT01945086|686137|P2|NOT COMPLETED|Overall Study||0
286456|NCT01945086|686138|P1|NOT COMPLETED|Overall Study||1
286457|NCT01945086|686136|P3|COMPLETED|Overall Study||26
286458|NCT01945086|686137|P2|COMPLETED|Overall Study||24
286459|NCT01945086|686138|P1|COMPLETED|Overall Study||26
286460|NCT01945086|686136|P3|STARTED|Overall Study||28
286461|NCT01945086|686137|P2|STARTED|Overall Study||24
286462|NCT01945086|686138|P1|STARTED|Overall Study||27
286463|NCT01945034|686182|P3|NOT COMPLETED|Overall Study||7
286464|NCT01945034|686183|P2|NOT COMPLETED|Overall Study||5
286465|NCT01945034|686184|P1|NOT COMPLETED|Overall Study||1
286466|NCT01945034|686182|P3|COMPLETED|Overall Study||145
286467|NCT01945034|686183|P2|COMPLETED|Overall Study||80
286468|NCT01945034|686184|P1|COMPLETED|Overall Study||66
286469|NCT01945034|686182|P3|STARTED|Overall Study||152
286470|NCT01945034|686183|P2|STARTED|Overall Study||85
286471|NCT01945034|686184|P1|STARTED|Overall Study||67
286472|NCT01945021|686234|P1|NOT COMPLETED|Overall Study||47
286473|NCT01945021|686234|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
286474|NCT01945021|686234|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
286565|NCT01943292|686465|P3|NOT COMPLETED|Overall Study||0
286475|NCT01945021|686234|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
286476|NCT01945021|686234|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
286477|NCT01945021|686234|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
286478|NCT01944969|686248|P1|NOT COMPLETED|Overall Study||26
286479|NCT01944969|686248|P1|COMPLETED|Overall Study||0
286480|NCT01944969|686248|P1|STARTED|Overall Study||26
286481|NCT01944878|686261|P2|NOT COMPLETED|Overall Study||0
286482|NCT01944878|686262|P1|NOT COMPLETED|Overall Study||0
286483|NCT01944878|686261|P2|COMPLETED|Overall Study||328
286484|NCT01944878|686262|P1|COMPLETED|Overall Study||127
286485|NCT01944878|686261|P2|STARTED|Overall Study||328
286486|NCT01944878|686262|P1|STARTED|Overall Study||127
286487|NCT01944774|686273|P3|NOT COMPLETED|Overall Study||8
286488|NCT01944774|686274|P2|NOT COMPLETED|Overall Study||8
286489|NCT01944774|686275|P1|NOT COMPLETED|Overall Study||6
286490|NCT01944774|686273|P3|COMPLETED|Overall Study||62
286491|NCT01944774|686274|P2|COMPLETED|Overall Study||60
286492|NCT01944774|686275|P1|COMPLETED|Overall Study||63
286493|NCT01944774|686273|P3|Received Treatment|Overall Study||70
286494|NCT01944774|686274|P2|Received Treatment|Overall Study||67
286495|NCT01944774|686275|P1|Received Treatment|Overall Study||68
286496|NCT01944774|686273|P3|STARTED|Overall Study||70
286497|NCT01944774|686274|P2|STARTED|Overall Study||68
286499|NCT01944670|686316|P1|NOT COMPLETED|Overall Study||2
286500|NCT01944670|686316|P1|COMPLETED|Overall Study||24
286501|NCT01944670|686316|P1|STARTED|Overall Study||26
286502|NCT01944631|686323|P2|NOT COMPLETED|Overall Study||2
286503|NCT01944631|686324|P1|NOT COMPLETED|Overall Study||4
286504|NCT01944631|686323|P2|COMPLETED|Overall Study||98
286505|NCT01944631|686324|P1|COMPLETED|Overall Study||96
286506|NCT01944631|686323|P2|STARTED|Overall Study||100
286507|NCT01944631|686324|P1|STARTED|Overall Study||100
286508|NCT01944345|686340|P1|NOT COMPLETED|Overall Study||0
286509|NCT01944345|686340|P1|COMPLETED|Overall Study||69
286510|NCT01944345|686340|P1|STARTED|Overall Study||69
286511|NCT01944319|686348|P2|NOT COMPLETED|Overall Study||0
286512|NCT01944319|686349|P1|NOT COMPLETED|Overall Study||0
286513|NCT01944319|686348|P2|COMPLETED|Overall Study||39
286514|NCT01944319|686349|P1|COMPLETED|Overall Study||40
286515|NCT01944319|686348|P2|STARTED|Overall Study||39
286516|NCT01944319|686349|P1|STARTED|Overall Study||40
286517|NCT01944059|686359|P1|NOT COMPLETED|Overall Study||7
286518|NCT01944059|686359|P1|COMPLETED|Overall Study||24
286519|NCT01944059|686359|P1|STARTED|Overall Study||31
286520|NCT01943864|686368|P1|NOT COMPLETED|Overall Study||0
286521|NCT01943864|686368|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
286522|NCT01943864|686368|P1|STARTED|Overall Study||20
286523|NCT01943552|686398|P2|NOT COMPLETED|Overall Study||25
286524|NCT01943552|686399|P1|NOT COMPLETED|Overall Study||25
286525|NCT01943552|686398|P2|COMPLETED|Overall Study||69
286526|NCT01943552|686399|P1|COMPLETED|Overall Study||71
286527|NCT01943552|686398|P2|STARTED|Overall Study||94
286528|NCT01943552|686399|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
286529|NCT01943474|686417|P2|NOT COMPLETED|Overall Study||0
286530|NCT01943474|686418|P1|NOT COMPLETED|Overall Study||0
286531|NCT01943474|686417|P2|COMPLETED|Overall Study||125
286532|NCT01943474|686418|P1|COMPLETED|Overall Study||123
286533|NCT01943474|686417|P2|STARTED|Overall Study||125
286534|NCT01943474|686418|P1|STARTED|Overall Study||123
286535|NCT01943435|686442|P3|NOT COMPLETED|6 Month Follow up||15
286536|NCT01943435|686443|P2|NOT COMPLETED|6 Month Follow up||7
286537|NCT01943435|686444|P1|NOT COMPLETED|6 Month Follow up||12
286538|NCT01943435|686442|P3|COMPLETED|6 Month Follow up||65
286539|NCT01943435|686443|P2|COMPLETED|6 Month Follow up||59
286540|NCT01943435|686444|P1|COMPLETED|6 Month Follow up||67
286541|NCT01943435|686442|P3|STARTED|6 Month Follow up||80
286542|NCT01943435|686443|P2|STARTED|6 Month Follow up||66
286543|NCT01943435|686444|P1|STARTED|6 Month Follow up||79
286544|NCT01943435|686442|P3|NOT COMPLETED|2 Month Follow up||0
286545|NCT01943435|686443|P2|NOT COMPLETED|2 Month Follow up||3
286546|NCT01943435|686444|P1|NOT COMPLETED|2 Month Follow up||2
286547|NCT01943435|686442|P3|COMPLETED|2 Month Follow up||80
286548|NCT01943435|686443|P2|COMPLETED|2 Month Follow up||66
286549|NCT01943435|686444|P1|COMPLETED|2 Month Follow up||79
286550|NCT01943435|686442|P3|STARTED|2 Month Follow up||80
286551|NCT01943435|686443|P2|STARTED|2 Month Follow up||69
286552|NCT01943435|686444|P1|STARTED|2 Month Follow up||81
286553|NCT01943435|686442|P3|NOT COMPLETED|Intervention Period||4
286554|NCT01943435|686443|P2|NOT COMPLETED|Intervention Period||3
286555|NCT01943435|686444|P1|NOT COMPLETED|Intervention Period||3
286556|NCT01943435|686442|P3|COMPLETED|Intervention Period||80
286557|NCT01943435|686443|P2|COMPLETED|Intervention Period||69
286558|NCT01943435|686444|P1|COMPLETED|Intervention Period||81
286559|NCT01943435|686442|P3|STARTED|Intervention Period||84
286560|NCT01943435|686443|P2|STARTED|Intervention Period||72
286561|NCT01943435|686444|P1|STARTED|Intervention Period||84
286562|NCT01943344|686458|P1|NOT COMPLETED|Overall Study||3
286563|NCT01943344|686458|P1|COMPLETED|Overall Study||9
286564|NCT01943344|686458|P1|STARTED|Overall Study||12
286566|NCT01943292|686466|P2|NOT COMPLETED|Overall Study||0
286567|NCT01943292|686467|P1|NOT COMPLETED|Overall Study||1
286568|NCT01943292|686465|P3|COMPLETED|Overall Study||3
286569|NCT01943292|686466|P2|COMPLETED|Overall Study||3
286570|NCT01943292|686467|P1|COMPLETED|Overall Study||2
286571|NCT01943292|686465|P3|Completed Follow-Up|Overall Study||3
286572|NCT01943292|686466|P2|Completed Follow-Up|Overall Study||3
286573|NCT01943292|686467|P1|Completed Follow-Up|Overall Study||2
286574|NCT01943292|686465|P3|Completed Treatment|Overall Study||3
286575|NCT01943292|686466|P2|Completed Treatment|Overall Study||3
286576|NCT01943292|686467|P1|Completed Treatment|Overall Study||3
286577|NCT01943292|686465|P3|Completed Cycle 1|Overall Study||3
286578|NCT01943292|686466|P2|Completed Cycle 1|Overall Study||3
286579|NCT01943292|686467|P1|Completed Cycle 1|Overall Study||3
286580|NCT01943292|686465|P3|STARTED|Overall Study||3
286581|NCT01943292|686466|P2|STARTED|Overall Study||3
286582|NCT01943292|686467|P1|STARTED|Overall Study||3
286583|NCT01943110|686478|P1|NOT COMPLETED|Overall Study||0
286584|NCT01943110|686478|P1|COMPLETED|Overall Study||30
286585|NCT01943110|686478|P1|STARTED|Overall Study||30
286586|NCT01942785|686494|P1|NOT COMPLETED|Overall Study||4
286587|NCT01942785|686494|P1|COMPLETED|Overall Study||50
286588|NCT01942785|686494|P1|STARTED|Overall Study||54
286589|NCT01942733|686523|P1|NOT COMPLETED|Overall Study||3
286590|NCT01942733|686523|P1|COMPLETED|Overall Study||41
286591|NCT01942733|686523|P1|STARTED|Overall Study||44
286592|NCT01942720|686552|P1|NOT COMPLETED|Overall Study||21
286593|NCT01942720|686552|P1|COMPLETED|Overall Study||53
286594|NCT01942720|686552|P1|STARTED|Overall Study||74
286595|NCT01942135|686562|P2|NOT COMPLETED|Overall Study||174
286596|NCT01942135|686563|P1|NOT COMPLETED|Overall Study||347
286597|NCT01942135|686562|P2|COMPLETED|Overall Study||0
286598|NCT01942135|686563|P1|COMPLETED|Overall Study||0
286599|NCT01942135|686562|P2|STARTED|Overall Study||174
286600|NCT01942135|686563|P1|STARTED|Overall Study||347
286601|NCT01941940|686600|P1|NOT COMPLETED|Overall Study||50
286602|NCT01941940|686600|P1|COMPLETED|Overall Study||177
286603|NCT01941940|686600|P1|STARTED|Overall Study||227
286604|NCT01941615|686610|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
286605|NCT01941615|686610|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
286606|NCT01941615|686610|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
286607|NCT01941615|686610|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
286608|NCT01941615|686610|P1|COMPLETED|Reference Treatment: Microgynon®||0
286609|NCT01941615|686610|P1|STARTED|Reference Treatment: Microgynon®||0
286610|NCT01941615|686610|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
286611|NCT01941615|686610|P1|COMPLETED|Run in Treatment: Microgynon®||16
286612|NCT01941615|686610|P1|STARTED|Run in Treatment: Microgynon®||16
286613|NCT01941498|686619|P1|NOT COMPLETED|Overall Study||1
286614|NCT01941498|686619|P1|COMPLETED|Overall Study||96
286615|NCT01941498|686619|P1|STARTED|Overall Study||97
286616|NCT01941485|686665|P1|NOT COMPLETED|Overall Study||0
286617|NCT01941485|686665|P1|COMPLETED|Overall Study||59
286618|NCT01941485|686665|P1|STARTED|Overall Study||59
286619|NCT01941472|686731|P1|NOT COMPLETED|Overall Study||0
286620|NCT01941472|686731|P1|COMPLETED|Overall Study||40
286621|NCT01941472|686731|P1|STARTED|Overall Study||40
286622|NCT01941186|686737|P2|NOT COMPLETED|Follow-up||0
286623|NCT01941186|686738|P1|NOT COMPLETED|Follow-up||1
286624|NCT01941186|686737|P2|COMPLETED|Follow-up||33
286625|NCT01941186|686738|P1|COMPLETED|Follow-up||30
286626|NCT01941186|686737|P2|STARTED|Follow-up||33
286627|NCT01941186|686738|P1|STARTED|Follow-up||31
286628|NCT01941186|686737|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
286629|NCT01941186|686738|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
286630|NCT01941186|686737|P2|COMPLETED|Randomization/Allocation to Study Group||33
286631|NCT01941186|686738|P1|COMPLETED|Randomization/Allocation to Study Group||31
286632|NCT01941186|686737|P2|STARTED|Randomization/Allocation to Study Group||33
286633|NCT01941186|686738|P1|STARTED|Randomization/Allocation to Study Group||31
286634|NCT01940523|686766|P2|NOT COMPLETED|Overall Study||0
286635|NCT01940523|686767|P1|NOT COMPLETED|Overall Study||0
286636|NCT01940523|686766|P2|COMPLETED|Overall Study||320
286637|NCT01940523|686767|P1|COMPLETED|Overall Study||320
286638|NCT01940523|686766|P2|STARTED|Overall Study||320
286639|NCT01940523|686767|P1|STARTED|Overall Study||320
286640|NCT01940510|686775|P1|NOT COMPLETED|Overall Study||0
286641|NCT01940510|686775|P1|COMPLETED|Overall Study||24
286642|NCT01940510|686775|P1|STARTED|Overall Study||24
286643|NCT01940484|686806|P1|NOT COMPLETED|Overall Study||10
286644|NCT01940484|686806|P1|COMPLETED|Overall Study||88
286645|NCT01940484|686806|P1|STARTED|Overall Study||98
286646|NCT01940471|686826|P2|NOT COMPLETED|Open-Label Extension||8
286647|NCT01940471|686827|P1|NOT COMPLETED|Open-Label Extension||14
286648|NCT01940471|686826|P2|COMPLETED|Open-Label Extension||0
286649|NCT01940471|686827|P1|COMPLETED|Open-Label Extension||0
286650|NCT01940471|686826|P2|STARTED|Open-Label Extension||8
286651|NCT01940471|686827|P1|STARTED|Open-Label Extension||14
286652|NCT01940471|686826|P2|NOT COMPLETED|Double-Blind Phase||285
286653|NCT01940471|686827|P1|NOT COMPLETED|Double-Blind Phase||568
286654|NCT01940471|686826|P2|COMPLETED|Double-Blind Phase||8
286655|NCT01940471|686827|P1|COMPLETED|Double-Blind Phase||14
286656|NCT01940471|686826|P2|STARTED|Double-Blind Phase||293
286657|NCT01940471|686827|P1|STARTED|Double-Blind Phase||582
286658|NCT01940341|686845|P2|NOT COMPLETED|Open-label Extension Phase||1
286659|NCT01940341|686846|P1|NOT COMPLETED|Open-label Extension Phase||4
286660|NCT01940341|686845|P2|COMPLETED|Open-label Extension Phase||0
286661|NCT01940341|686846|P1|COMPLETED|Open-label Extension Phase||0
286662|NCT01940341|686845|P2|STARTED|Open-label Extension Phase||1
286663|NCT01940341|686846|P1|STARTED|Open-label Extension Phase||4
286664|NCT01940341|686845|P2|NOT COMPLETED|Double-Blind Phase||140
286665|NCT01940341|686846|P1|NOT COMPLETED|Double-Blind Phase||281
286666|NCT01940341|686845|P2|COMPLETED|Double-Blind Phase||1
286667|NCT01940341|686846|P1|COMPLETED|Double-Blind Phase||4
286668|NCT01940341|686845|P2|STARTED|Double-Blind Phase||141
286669|NCT01940341|686846|P1|STARTED|Double-Blind Phase||285
286670|NCT01940146|686864|P4|NOT COMPLETED|Overall Study||2
286671|NCT01940146|686865|P3|NOT COMPLETED|Overall Study||1
286672|NCT01940146|686866|P2|NOT COMPLETED|Overall Study||0
286673|NCT01940146|686867|P1|NOT COMPLETED|Overall Study||1
286674|NCT01940146|686864|P4|COMPLETED|Overall Study||53
286675|NCT01940146|686865|P3|COMPLETED|Overall Study||55
286676|NCT01940146|686866|P2|COMPLETED|Overall Study||55
286677|NCT01940146|686867|P1|COMPLETED|Overall Study||55
286678|NCT01940146|686864|P4|STARTED|Overall Study||55
286679|NCT01940146|686865|P3|STARTED|Overall Study||56
286680|NCT01940146|686866|P2|STARTED|Overall Study||55
286681|NCT01940146|686867|P1|STARTED|Overall Study||56
286682|NCT01940120|686877|P1|NOT COMPLETED|Overall Study||44
286683|NCT01940120|686877|P1|COMPLETED|Overall Study||34
286684|NCT01940120|686877|P1|STARTED|Overall Study||78
286685|NCT01939938|686999|P1|NOT COMPLETED|Overall Study||0
286686|NCT01939938|686999|P1|COMPLETED|Overall Study||10
286687|NCT01939938|686999|P1|STARTED|Overall Study||10
286688|NCT01939548|687007|P3|NOT COMPLETED|Overall Study||30
286689|NCT01939548|687008|P2|NOT COMPLETED|Overall Study||49
286690|NCT01939548|687009|P1|NOT COMPLETED|Overall Study||37
286691|NCT01939548|687007|P3|COMPLETED|Overall Study||50
286692|NCT01939548|687008|P2|COMPLETED|Overall Study||33
286693|NCT01939548|687009|P1|COMPLETED|Overall Study||41
286694|NCT01939548|687007|P3|STARTED|Overall Study||80
286695|NCT01939548|687008|P2|STARTED|Overall Study||82
286696|NCT01939548|687009|P1|STARTED|Overall Study||78
286697|NCT01939496|687083|P3|NOT COMPLETED|Overall Study||2
286698|NCT01939496|687084|P2|NOT COMPLETED|Overall Study||3
286699|NCT01939496|687085|P1|NOT COMPLETED|Overall Study||9
286700|NCT01939496|687083|P3|COMPLETED|Overall Study||54
286701|NCT01939496|687084|P2|COMPLETED|Overall Study||54
286702|NCT01939496|687085|P1|COMPLETED|Overall Study||47
286703|NCT01939496|687083|P3|STARTED|Overall Study||56
286704|NCT01939496|687084|P2|STARTED|Overall Study||57
286705|NCT01939496|687085|P1|STARTED|Overall Study||56
286706|NCT01939314|687137|P2|NOT COMPLETED|Overall Study||8
286707|NCT01939314|687138|P1|NOT COMPLETED|Overall Study||9
286708|NCT01939314|687137|P2|COMPLETED|Overall Study||40
286709|NCT01939314|687138|P1|COMPLETED|Overall Study||36
286710|NCT01939314|687137|P2|24 Hour Endpoint|Overall Study||40
286711|NCT01939314|687138|P1|24 Hour Endpoint|Overall Study||36
286712|NCT01939314|687137|P2|15 Minute Endpoint|Overall Study||46
286713|NCT01939314|687138|P1|15 Minute Endpoint|Overall Study||41
286714|NCT01939314|687137|P2|STARTED|Overall Study||48
286715|NCT01939314|687138|P1|STARTED|Overall Study||45
286716|NCT01939145|687150|P2|NOT COMPLETED|Overall Study||7
286717|NCT01939145|687151|P1|NOT COMPLETED|Overall Study||2
286718|NCT01939145|687150|P2|COMPLETED|Overall Study||44
286719|NCT01939145|687151|P1|COMPLETED|Overall Study||47
286720|NCT01939145|687150|P2|STARTED|Overall Study||51
286721|NCT01939145|687151|P1|STARTED|Overall Study||49
286722|NCT01939002|687161|P2|NOT COMPLETED|Overall Study||18
286723|NCT01939002|687162|P1|NOT COMPLETED|Overall Study||19
286724|NCT01939002|687161|P2|COMPLETED|Overall Study||80
286725|NCT01939002|687162|P1|COMPLETED|Overall Study||84
286726|NCT01939002|687161|P2|STARTED|Overall Study||98
286727|NCT01939002|687162|P1|STARTED|Overall Study||103
286728|NCT01938989|687228|P2|NOT COMPLETED|Overall Study||0
286729|NCT01938989|687229|P1|NOT COMPLETED|Overall Study||0
286730|NCT01938989|687228|P2|COMPLETED|Overall Study||77
286731|NCT01938989|687229|P1|COMPLETED|Overall Study||77
286732|NCT01938989|687228|P2|STARTED|Overall Study||77
286733|NCT01938989|687229|P1|STARTED|Overall Study||77
286734|NCT01938430|687249|P14|NOT COMPLETED|Overall Study||1
286735|NCT01938430|687250|P13|NOT COMPLETED|Overall Study||0
286736|NCT01938430|687251|P12|NOT COMPLETED|Overall Study||1
286737|NCT01938430|687252|P11|NOT COMPLETED|Overall Study||3
286738|NCT01938430|687253|P10|NOT COMPLETED|Overall Study||3
286739|NCT01938430|687254|P9|NOT COMPLETED|Overall Study||4
286740|NCT01938430|687255|P8|NOT COMPLETED|Overall Study||1
286741|NCT01938430|687256|P7|NOT COMPLETED|Overall Study||2
286742|NCT01938430|687257|P6|NOT COMPLETED|Overall Study||1
286743|NCT01938430|687258|P5|NOT COMPLETED|Overall Study||0
286744|NCT01938430|687259|P4|NOT COMPLETED|Overall Study||2
286745|NCT01938430|687260|P3|NOT COMPLETED|Overall Study||5
286746|NCT01938430|687261|P2|NOT COMPLETED|Overall Study||3
286747|NCT01938430|687262|P1|NOT COMPLETED|Overall Study||4
286748|NCT01938430|687249|P14|COMPLETED|Overall Study||2
286749|NCT01938430|687250|P13|COMPLETED|Overall Study||4
286750|NCT01938430|687251|P12|COMPLETED|Overall Study||3
286751|NCT01938430|687252|P11|COMPLETED|Overall Study||3
286752|NCT01938430|687253|P10|COMPLETED|Overall Study||23
286753|NCT01938430|687254|P9|COMPLETED|Overall Study||22
286754|NCT01938430|687255|P8|COMPLETED|Overall Study||24
286755|NCT01938430|687256|P7|COMPLETED|Overall Study||24
286756|NCT01938430|687257|P6|COMPLETED|Overall Study||55
286757|NCT01938430|687258|P5|COMPLETED|Overall Study||55
286758|NCT01938430|687259|P4|COMPLETED|Overall Study||24
286759|NCT01938430|687260|P3|COMPLETED|Overall Study||18
286760|NCT01938430|687261|P2|COMPLETED|Overall Study||26
286761|NCT01938430|687262|P1|COMPLETED|Overall Study||26
286762|NCT01938430|687249|P14|STARTED|Overall Study||3
286763|NCT01938430|687250|P13|STARTED|Overall Study||4
286764|NCT01938430|687251|P12|STARTED|Overall Study||4
286765|NCT01938430|687252|P11|STARTED|Overall Study||6
286766|NCT01938430|687253|P10|STARTED|Overall Study||26
286767|NCT01938430|687254|P9|STARTED|Overall Study||26
286768|NCT01938430|687255|P8|STARTED|Overall Study||25
286769|NCT01938430|687256|P7|STARTED|Overall Study||26
286770|NCT01938430|687257|P6|STARTED|Overall Study||56
286771|NCT01938430|687258|P5|STARTED|Overall Study||55
286772|NCT01938430|687259|P4|STARTED|Overall Study||26
286773|NCT01938430|687260|P3|STARTED|Overall Study||23
286774|NCT01938430|687261|P2|STARTED|Overall Study||29
286775|NCT01938430|687262|P1|STARTED|Overall Study||30
286776|NCT01938170|687587|P1|NOT COMPLETED|Overall Study||0
286777|NCT01938170|687587|P1|COMPLETED|Overall Study||41
286778|NCT01938170|687587|P1|STARTED|Overall Study||41
286779|NCT01938079|687594|P2|NOT COMPLETED|Overall Study||0
286780|NCT01938079|687595|P1|NOT COMPLETED|Overall Study||0
286781|NCT01938079|687594|P2|COMPLETED|Overall Study||10
286782|NCT01938079|687595|P1|COMPLETED|Overall Study||10
286783|NCT01938079|687594|P2|STARTED|Overall Study||10
286784|NCT01938079|687595|P1|STARTED|Overall Study||10
286785|NCT01938066|687603|P2|NOT COMPLETED|Overall Study||2
286786|NCT01938066|687604|P1|NOT COMPLETED|Overall Study||1
286787|NCT01938066|687603|P2|COMPLETED|Overall Study||13
286788|NCT01938066|687604|P1|COMPLETED|Overall Study||14
286789|NCT01938066|687603|P2|STARTED|Overall Study||15
286790|NCT01938066|687604|P1|STARTED|Overall Study||15
286791|NCT01938040|687614|P2|NOT COMPLETED|Overall Study||0
286792|NCT01938040|687615|P1|NOT COMPLETED|Overall Study||0
286793|NCT01938040|687614|P2|COMPLETED|Overall Study||27
286794|NCT01938040|687615|P1|COMPLETED|Overall Study||28
286795|NCT01938040|687614|P2|Behavior Metrics|Overall Study||27
286796|NCT01938040|687615|P1|Behavior Metrics|Overall Study||28
286797|NCT01938040|687614|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
286798|NCT01938040|687615|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
286799|NCT01938040|687614|P2|STARTED|Overall Study||27
286800|NCT01938040|687615|P1|STARTED|Overall Study||28
286801|NCT01937975|687644|P3|NOT COMPLETED|Overall Study||0
286802|NCT01937975|687645|P2|NOT COMPLETED|Overall Study||0
286803|NCT01937975|687646|P1|NOT COMPLETED|Overall Study||0
286804|NCT01937975|687644|P3|COMPLETED|Overall Study||8
286805|NCT01937975|687645|P2|COMPLETED|Overall Study||8
286806|NCT01937975|687646|P1|COMPLETED|Overall Study||8
286807|NCT01937975|687644|P3|STARTED|Overall Study||8
286808|NCT01937975|687645|P2|STARTED|Overall Study||8
286809|NCT01937975|687646|P1|STARTED|Overall Study||8
286810|NCT01937871|687696|P3|NOT COMPLETED|Overall Study||11
286811|NCT01937871|687697|P2|NOT COMPLETED|Overall Study||17
286812|NCT01937871|687698|P1|NOT COMPLETED|Overall Study||24
286813|NCT01937871|687696|P3|COMPLETED|Overall Study||174
286814|NCT01937871|687697|P2|COMPLETED|Overall Study||346
286815|NCT01937871|687698|P1|COMPLETED|Overall Study||337
286816|NCT01937871|687696|P3|Received at Least One Dose of Study Drug|Overall Study||185
286817|NCT01937871|687697|P2|Received at Least One Dose of Study Drug|Overall Study||362
286818|NCT01937871|687698|P1|Received at Least One Dose of Study Drug|Overall Study||361
286819|NCT01937871|687696|P3|STARTED|Overall Study||185
286820|NCT01937871|687697|P2|STARTED|Overall Study||363
286821|NCT01937871|687698|P1|STARTED|Overall Study||361
286822|NCT01937715|687774|P5|NOT COMPLETED|Overall Study||2
286823|NCT01937715|687775|P4|NOT COMPLETED|Overall Study||4
286824|NCT01937715|687776|P3|NOT COMPLETED|Overall Study||0
286825|NCT01937715|687777|P2|NOT COMPLETED|Overall Study||1
286826|NCT01937715|687778|P1|NOT COMPLETED|Overall Study||0
286827|NCT01937715|687774|P5|COMPLETED|Overall Study||1
286828|NCT01937715|687775|P4|COMPLETED|Overall Study||1
286829|NCT01937715|687776|P3|COMPLETED|Overall Study||3
286830|NCT01937715|687777|P2|COMPLETED|Overall Study||3
286831|NCT01937715|687778|P1|COMPLETED|Overall Study||3
286832|NCT01937715|687774|P5|STARTED|Overall Study||3
286833|NCT01937715|687775|P4|STARTED|Overall Study||5
286834|NCT01937715|687776|P3|STARTED|Overall Study||3
286835|NCT01937715|687777|P2|STARTED|Overall Study||4
286836|NCT01937715|687778|P1|STARTED|Overall Study||3
286837|NCT01937598|687900|P2|NOT COMPLETED|Overall Study||0
286838|NCT01937598|687901|P1|NOT COMPLETED|Overall Study||0
286839|NCT01937598|687900|P2|COMPLETED|Overall Study||8
286840|NCT01937598|687901|P1|COMPLETED|Overall Study||8
286841|NCT01937598|687900|P2|STARTED|Overall Study||8
286842|NCT01937598|687901|P1|STARTED|Overall Study||8
286843|NCT01937520|687925|P2|NOT COMPLETED|Overall Study||0
286844|NCT01937520|687926|P1|NOT COMPLETED|Overall Study||0
286845|NCT01937520|687925|P2|COMPLETED|Overall Study||9
286846|NCT01937520|687926|P1|COMPLETED|Overall Study||11
286847|NCT01937520|687925|P2|STARTED|Overall Study||9
286848|NCT01937520|687926|P1|STARTED|Overall Study||11
286849|NCT01937364|687964|P2|NOT COMPLETED|Overall Study||1
286850|NCT01937364|687965|P1|NOT COMPLETED|Overall Study||2
286851|NCT01937364|687964|P2|COMPLETED|Overall Study||7
286852|NCT01937364|687965|P1|COMPLETED|Overall Study||7
286853|NCT01937364|687964|P2|STARTED|Overall Study||8
286854|NCT01937364|687965|P1|STARTED|Overall Study||9
286855|NCT01937351|687977|P2|NOT COMPLETED|Overall Study||2
286856|NCT01937351|687978|P1|NOT COMPLETED|Overall Study||9
286857|NCT01937351|687977|P2|COMPLETED|Overall Study||26
286858|NCT01937351|687978|P1|COMPLETED|Overall Study||125
286859|NCT01937351|687977|P2|6-Month Follow-up|Overall Study||26
286860|NCT01937351|687978|P1|6-Month Follow-up|Overall Study||125
286861|NCT01937351|687977|P2|30-Day Follow-up|Overall Study||27
286862|NCT01937351|687978|P1|30-Day Follow-up|Overall Study||128
286863|NCT01937351|687977|P2|Treated w Study Device|Overall Study||28
286864|NCT01937351|687978|P1|Treated w Study Device|Overall Study||130
286865|NCT01937351|687977|P2|STARTED|Overall Study||28
286866|NCT01937351|687978|P1|STARTED|Overall Study||134
286867|NCT01937312|687986|P2|NOT COMPLETED|Overall Study||3
286868|NCT01937312|687987|P1|NOT COMPLETED|Overall Study||11
286869|NCT01937312|687986|P2|COMPLETED|Overall Study||92
286870|NCT01937312|687987|P1|COMPLETED|Overall Study||83
286871|NCT01937312|687986|P2|Treated|Overall Study||95
286872|NCT01937312|687987|P1|Treated|Overall Study||93
286873|NCT01937312|687986|P2|STARTED|Overall Study||95
286874|NCT01937312|687987|P1|STARTED|Overall Study||94
286875|NCT01937299|688002|P2|NOT COMPLETED|Overall Study||4
286876|NCT01937299|688003|P1|NOT COMPLETED|Overall Study||14
286877|NCT01937299|688002|P2|COMPLETED|Overall Study||112
286878|NCT01937299|688003|P1|COMPLETED|Overall Study||103
286879|NCT01937299|688002|P2|STARTED|Overall Study||116
286880|NCT01937299|688003|P1|STARTED|Overall Study||117
286881|NCT01937260|688016|P2|NOT COMPLETED|Overall Study||0
286882|NCT01937260|688017|P1|NOT COMPLETED|Overall Study||1
286883|NCT01937260|688016|P2|COMPLETED|Overall Study||10
286884|NCT01937260|688017|P1|COMPLETED|Overall Study||20
286885|NCT01937260|688016|P2|STARTED|Overall Study||10
286886|NCT01937260|688017|P1|STARTED|Overall Study||21
286887|NCT01937195|688024|P1|NOT COMPLETED|Overall Study||0
286888|NCT01937195|688024|P1|COMPLETED|Overall Study||95
286889|NCT01937195|688024|P1|STARTED|Overall Study||95
286890|NCT01937130|688038|P4|NOT COMPLETED|Overall Study||2
286891|NCT01937130|688039|P3|NOT COMPLETED|Overall Study||3
286892|NCT01937130|688040|P2|NOT COMPLETED|Overall Study||4
286893|NCT01937130|688041|P1|NOT COMPLETED|Overall Study||5
286894|NCT01937130|688038|P4|COMPLETED|Overall Study||2
286895|NCT01937130|688039|P3|COMPLETED|Overall Study||2
286896|NCT01937130|688040|P2|COMPLETED|Overall Study||3
286897|NCT01937130|688041|P1|COMPLETED|Overall Study||0
286898|NCT01937130|688038|P4|STARTED|Overall Study||4
286899|NCT01937130|688039|P3|STARTED|Overall Study||5
286900|NCT01937130|688040|P2|STARTED|Overall Study||7
286901|NCT01937130|688041|P1|STARTED|Overall Study||5
286902|NCT01937026|688068|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
286903|NCT01937026|688068|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
286904|NCT01937026|688068|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
286905|NCT01937026|688068|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
286906|NCT01937026|688068|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
286907|NCT01937026|688068|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
286908|NCT01937026|688068|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
286909|NCT01937026|688068|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
286910|NCT01937026|688068|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
286911|NCT01936896|688077|P1|NOT COMPLETED|Overall Study||0
286912|NCT01936896|688077|P1|COMPLETED|Overall Study||10
286913|NCT01936896|688077|P1|STARTED|Overall Study||10
286914|NCT01936870|688082|P1|NOT COMPLETED|Overall Study||189
286915|NCT01936870|688082|P1|COMPLETED|Overall Study||2303
286916|NCT01936870|688082|P1|STARTED|Overall Study||2492
286917|NCT01936844|688097|P2|NOT COMPLETED|Overall Study||7
286918|NCT01936844|688098|P1|NOT COMPLETED|Overall Study||6
286919|NCT01936844|688097|P2|COMPLETED|Overall Study||8
286920|NCT01936844|688098|P1|COMPLETED|Overall Study||9
286921|NCT01936844|688097|P2|STARTED|Overall Study||15
286922|NCT01936844|688098|P1|STARTED|Overall Study||15
286923|NCT01936662|688110|P2|NOT COMPLETED|Overall Study||0
286924|NCT01936662|688111|P1|NOT COMPLETED|Overall Study||0
286925|NCT01936662|688110|P2|COMPLETED|Overall Study||42
286926|NCT01936662|688111|P1|COMPLETED|Overall Study||42
286927|NCT01936662|688110|P2|STARTED|Overall Study||42
286928|NCT01936662|688111|P1|STARTED|Overall Study||42
286929|NCT01936649|688119|P1|NOT COMPLETED|Overall Study||13
286930|NCT01936649|688119|P1|COMPLETED|Overall Study||50
286931|NCT01936649|688119|P1|Treated|Overall Study||51
286932|NCT01936649|688119|P1|STARTED|Overall Study||63
286933|NCT01936467|688126|P2|NOT COMPLETED|Overall Study||0
286934|NCT01936467|688127|P1|NOT COMPLETED|Overall Study||0
286935|NCT01936467|688126|P2|COMPLETED|Overall Study||61
286936|NCT01936467|688127|P1|COMPLETED|Overall Study||60
286937|NCT01936467|688126|P2|STARTED|Overall Study||61
286938|NCT01936467|688127|P1|STARTED|Overall Study||60
286939|NCT01936389|688147|P2|NOT COMPLETED|Overall Study||0
286940|NCT01936389|688148|P1|NOT COMPLETED|Overall Study||1
286941|NCT01936389|688147|P2|COMPLETED|Overall Study||5
286942|NCT01936389|688148|P1|COMPLETED|Overall Study||4
286943|NCT01936389|688147|P2|STARTED|Overall Study||5
286944|NCT01936389|688148|P1|STARTED|Overall Study||5
286945|NCT01936363|688156|P2|NOT COMPLETED|Overall Study||5
286946|NCT01936363|688157|P1|NOT COMPLETED|Overall Study||7
286947|NCT01936363|688156|P2|COMPLETED|Overall Study||28
286948|NCT01936363|688157|P1|COMPLETED|Overall Study||25
286949|NCT01936363|688156|P2|STARTED|Overall Study||33
286950|NCT01936363|688157|P1|STARTED|Overall Study||32
286951|NCT01936181|688183|P4|NOT COMPLETED|Transition-extension||5
286952|NCT01936181|688184|P3|NOT COMPLETED|Transition-extension||6
286953|NCT01936181|688185|P2|NOT COMPLETED|Transition-extension||0
286954|NCT01936181|688186|P1|NOT COMPLETED|Transition-extension||15
286955|NCT01936181|688183|P4|COMPLETED|Transition-extension||96
286956|NCT01936181|688184|P3|COMPLETED|Transition-extension||88
286957|NCT01936181|688185|P2|COMPLETED|Transition-extension||0
286958|NCT01936181|688186|P1|COMPLETED|Transition-extension||186
286959|NCT01936181|688183|P4|STARTED|Transition-extension||101
286960|NCT01936181|688184|P3|STARTED|Transition-extension||94
286961|NCT01936181|688185|P2|STARTED|Transition-extension||0
286962|NCT01936181|688186|P1|STARTED|Transition-extension||201
286963|NCT01936181|688183|P4|NOT COMPLETED|Randomised, Double-blind||0
286964|NCT01936181|688184|P3|NOT COMPLETED|Randomised, Double-blind||0
286965|NCT01936181|688185|P2|NOT COMPLETED|Randomised, Double-blind||68
286966|NCT01936181|688186|P1|NOT COMPLETED|Randomised, Double-blind||64
286967|NCT01936181|688183|P4|COMPLETED|Randomised, Double-blind||0
286968|NCT01936181|688184|P3|COMPLETED|Randomised, Double-blind||0
286969|NCT01936181|688185|P2|COMPLETED|Randomised, Double-blind||225
286970|NCT01936181|688186|P1|COMPLETED|Randomised, Double-blind||227
286971|NCT01936181|688183|P4|STARTED|Randomised, Double-blind||0
286972|NCT01936181|688184|P3|STARTED|Randomised, Double-blind||0
286973|NCT01936181|688185|P2|STARTED|Randomised, Double-blind||293
286974|NCT01936181|688186|P1|STARTED|Randomised, Double-blind||291
286975|NCT01935622|688200|P3|NOT COMPLETED|Overall Study||0
286976|NCT01935622|688201|P2|NOT COMPLETED|Overall Study||2
286977|NCT01935622|688202|P1|NOT COMPLETED|Overall Study||2
286978|NCT01935622|688200|P3|COMPLETED|Overall Study||4
286979|NCT01935622|688201|P2|COMPLETED|Overall Study||1
286980|NCT01935622|688202|P1|COMPLETED|Overall Study||1
286981|NCT01935622|688200|P3|STARTED|Overall Study||4
286982|NCT01935622|688201|P2|STARTED|Overall Study||3
286983|NCT01935622|688202|P1|STARTED|Overall Study||3
286984|NCT01935180|688212|P2|NOT COMPLETED|Overall Study||14
286985|NCT01935180|688213|P1|NOT COMPLETED|Overall Study||21
286986|NCT01935180|688212|P2|COMPLETED|Overall Study||561
286987|NCT01935180|688213|P1|COMPLETED|Overall Study||552
286988|NCT01935180|688212|P2|STARTED|Overall Study||575
286989|NCT01935180|688213|P1|STARTED|Overall Study||573
286990|NCT01934894|688233|P2|NOT COMPLETED|Overall Study||5
286991|NCT01934894|688234|P1|NOT COMPLETED|Overall Study||6
286992|NCT01934894|688233|P2|COMPLETED|Overall Study||0
286993|NCT01934894|688234|P1|COMPLETED|Overall Study||0
286994|NCT01934894|688233|P2|STARTED|Overall Study||5
286995|NCT01934894|688234|P1|STARTED|Overall Study||6
286996|NCT01934790|688249|P1|NOT COMPLETED|Overall Study||16
286997|NCT01934790|688249|P1|COMPLETED|Overall Study||29
286998|NCT01934790|688249|P1|Participants Received Study Treatment|Overall Study||44
286999|NCT01934790|688249|P1|STARTED|Overall Study|Eligible for treatment|45
287000|NCT01934582|688269|P1|NOT COMPLETED|Overall Study||0
287001|NCT01934582|688269|P1|COMPLETED|Overall Study||13
287002|NCT01934582|688269|P1|STARTED|Overall Study||13
287003|NCT01934517|688283|P1|NOT COMPLETED|Overall Study||0
287004|NCT01934517|688283|P1|COMPLETED|Overall Study||25
287005|NCT01934517|688283|P1|STARTED|Overall Study||25
287006|NCT01934504|688295|P4|NOT COMPLETED|Overall Study||7
287007|NCT01934504|688296|P3|NOT COMPLETED|Overall Study||5
287008|NCT01934504|688297|P2|NOT COMPLETED|Overall Study||0
287009|NCT01934504|688298|P1|NOT COMPLETED|Overall Study||1
287010|NCT01934504|688295|P4|COMPLETED|Overall Study||1
287011|NCT01934504|688296|P3|COMPLETED|Overall Study||11
287012|NCT01934504|688297|P2|COMPLETED|Overall Study||3
287013|NCT01934504|688298|P1|COMPLETED|Overall Study||5
287014|NCT01934504|688295|P4|STARTED|Overall Study||8
287015|NCT01934504|688296|P3|STARTED|Overall Study||16
287016|NCT01934504|688297|P2|STARTED|Overall Study||3
287017|NCT01934504|688298|P1|STARTED|Overall Study||6
287018|NCT01934231|688320|P1|NOT COMPLETED|Overall Study||0
287019|NCT01934231|688320|P1|COMPLETED|Overall Study||27
287020|NCT01934231|688320|P1|STARTED|Overall Study||27
287021|NCT01933880|688331|P2|NOT COMPLETED|Overall Study||1
287022|NCT01933880|688332|P1|NOT COMPLETED|Overall Study||30
287023|NCT01933880|688331|P2|COMPLETED|Overall Study||40
287024|NCT01933880|688332|P1|COMPLETED|Overall Study||123
287025|NCT01933880|688331|P2|STARTED|Overall Study||41
287026|NCT01933880|688332|P1|STARTED|Overall Study||153
287027|NCT01933776|688399|P2|NOT COMPLETED|Overall Study||0
287028|NCT01933776|688400|P1|NOT COMPLETED|Overall Study||0
287029|NCT01933776|688399|P2|COMPLETED|Overall Study||20
287030|NCT01933776|688400|P1|COMPLETED|Overall Study||20
287031|NCT01933776|688399|P2|STARTED|Overall Study||20
287032|NCT01933776|688400|P1|STARTED|Overall Study||20
287033|NCT01933672|688408|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
287034|NCT01933672|688409|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
287035|NCT01933672|688410|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
287036|NCT01933672|688411|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
287037|NCT01933672|688412|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
287038|NCT01933672|688413|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
287039|NCT01933672|688414|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
287040|NCT01933672|688408|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
287041|NCT01933672|688409|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
287042|NCT01933672|688410|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
287043|NCT01933672|688411|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
287044|NCT01933672|688412|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
287045|NCT01933672|688413|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
287046|NCT01933672|688414|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
287047|NCT01933672|688408|P7|STARTED|Third Intervention Period (12-16 Days)||6
287048|NCT01933672|688409|P6|STARTED|Third Intervention Period (12-16 Days)||4
287049|NCT01933672|688410|P5|STARTED|Third Intervention Period (12-16 Days)||6
287050|NCT01933672|688411|P4|STARTED|Third Intervention Period (12-16 Days)||5
287051|NCT01933672|688412|P3|STARTED|Third Intervention Period (12-16 Days)||1
287052|NCT01933672|688413|P2|STARTED|Third Intervention Period (12-16 Days)||6
287387|NCT01930045|688953|P1|COMPLETED|Part 2 - Period 4||3
287053|NCT01933672|688414|P1|STARTED|Third Intervention Period (12-16 Days)||0
287054|NCT01933672|688408|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287055|NCT01933672|688409|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287056|NCT01933672|688410|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287057|NCT01933672|688411|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287058|NCT01933672|688412|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287059|NCT01933672|688413|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287060|NCT01933672|688414|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
287061|NCT01933672|688408|P7|COMPLETED|Second Washout Period (7-14 Days)||6
287062|NCT01933672|688409|P6|COMPLETED|Second Washout Period (7-14 Days)||4
287063|NCT01933672|688410|P5|COMPLETED|Second Washout Period (7-14 Days)||6
287064|NCT01933672|688411|P4|COMPLETED|Second Washout Period (7-14 Days)||5
287065|NCT01933672|688412|P3|COMPLETED|Second Washout Period (7-14 Days)||1
287066|NCT01933672|688413|P2|COMPLETED|Second Washout Period (7-14 Days)||6
287067|NCT01933672|688414|P1|COMPLETED|Second Washout Period (7-14 Days)||0
287068|NCT01933672|688408|P7|STARTED|Second Washout Period (7-14 Days)||6
287069|NCT01933672|688409|P6|STARTED|Second Washout Period (7-14 Days)||4
287070|NCT01933672|688410|P5|STARTED|Second Washout Period (7-14 Days)||6
287071|NCT01933672|688411|P4|STARTED|Second Washout Period (7-14 Days)||5
287072|NCT01933672|688412|P3|STARTED|Second Washout Period (7-14 Days)||1
287073|NCT01933672|688413|P2|STARTED|Second Washout Period (7-14 Days)||6
287074|NCT01933672|688414|P1|STARTED|Second Washout Period (7-14 Days)||0
287075|NCT01933672|688408|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
287076|NCT01933672|688409|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
287077|NCT01933672|688410|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
287078|NCT01933672|688411|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
287079|NCT01933672|688412|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
287080|NCT01933672|688413|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
287081|NCT01933672|688414|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
287082|NCT01933672|688408|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
287083|NCT01933672|688409|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
287084|NCT01933672|688410|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
287085|NCT01933672|688411|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
287086|NCT01933672|688412|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
287087|NCT01933672|688413|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
287088|NCT01933672|688414|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
287089|NCT01933672|688408|P7|STARTED|Second Intervention Period (12-16 Days)||6
287090|NCT01933672|688409|P6|STARTED|Second Intervention Period (12-16 Days)||4
287091|NCT01933672|688410|P5|STARTED|Second Intervention Period (12-16 Days)||6
287092|NCT01933672|688411|P4|STARTED|Second Intervention Period (12-16 Days)||5
287093|NCT01933672|688412|P3|STARTED|Second Intervention Period (12-16 Days)||2
287094|NCT01933672|688413|P2|STARTED|Second Intervention Period (12-16 Days)||7
287095|NCT01933672|688414|P1|STARTED|Second Intervention Period (12-16 Days)||0
287096|NCT01933672|688408|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
287097|NCT01933672|688409|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
287098|NCT01933672|688410|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
287099|NCT01933672|688411|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
287100|NCT01933672|688412|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
287101|NCT01933672|688413|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
287102|NCT01933672|688414|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
287103|NCT01933672|688408|P7|COMPLETED|First Washout Period (7-14 Days)||6
287104|NCT01933672|688409|P6|COMPLETED|First Washout Period (7-14 Days)||4
287105|NCT01933672|688410|P5|COMPLETED|First Washout Period (7-14 Days)||6
287106|NCT01933672|688411|P4|COMPLETED|First Washout Period (7-14 Days)||5
287107|NCT01933672|688412|P3|COMPLETED|First Washout Period (7-14 Days)||2
287108|NCT01933672|688413|P2|COMPLETED|First Washout Period (7-14 Days)||7
287109|NCT01933672|688414|P1|COMPLETED|First Washout Period (7-14 Days)||0
287110|NCT01933672|688408|P7|STARTED|First Washout Period (7-14 Days)||6
287111|NCT01933672|688409|P6|STARTED|First Washout Period (7-14 Days)||4
287112|NCT01933672|688410|P5|STARTED|First Washout Period (7-14 Days)||6
287113|NCT01933672|688411|P4|STARTED|First Washout Period (7-14 Days)||5
287114|NCT01933672|688412|P3|STARTED|First Washout Period (7-14 Days)||2
287115|NCT01933672|688413|P2|STARTED|First Washout Period (7-14 Days)||7
287116|NCT01933672|688414|P1|STARTED|First Washout Period (7-14 Days)||0
287117|NCT01933672|688408|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
287118|NCT01933672|688409|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
287119|NCT01933672|688410|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
287120|NCT01933672|688411|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
287121|NCT01933672|688412|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
287122|NCT01933672|688413|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
287123|NCT01933672|688414|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
287124|NCT01933672|688408|P7|COMPLETED|First Intervention Period (12-16 Days)||6
287125|NCT01933672|688409|P6|COMPLETED|First Intervention Period (12-16 Days)||4
287126|NCT01933672|688410|P5|COMPLETED|First Intervention Period (12-16 Days)||6
287127|NCT01933672|688411|P4|COMPLETED|First Intervention Period (12-16 Days)||5
287128|NCT01933672|688412|P3|COMPLETED|First Intervention Period (12-16 Days)||2
287129|NCT01933672|688413|P2|COMPLETED|First Intervention Period (12-16 Days)||7
287130|NCT01933672|688414|P1|COMPLETED|First Intervention Period (12-16 Days)||0
287131|NCT01933672|688408|P7|STARTED|First Intervention Period (12-16 Days)||6
287132|NCT01933672|688409|P6|STARTED|First Intervention Period (12-16 Days)||5
287133|NCT01933672|688410|P5|STARTED|First Intervention Period (12-16 Days)||7
287134|NCT01933672|688411|P4|STARTED|First Intervention Period (12-16 Days)||5
287135|NCT01933672|688412|P3|STARTED|First Intervention Period (12-16 Days)||3
287136|NCT01933672|688413|P2|STARTED|First Intervention Period (12-16 Days)||7
287137|NCT01933672|688414|P1|STARTED|First Intervention Period (12-16 Days)||0
287138|NCT01933672|688408|P7|NOT COMPLETED|Metformin Run-in Period||0
287139|NCT01933672|688409|P6|NOT COMPLETED|Metformin Run-in Period||0
287140|NCT01933672|688410|P5|NOT COMPLETED|Metformin Run-in Period||0
287141|NCT01933672|688411|P4|NOT COMPLETED|Metformin Run-in Period||0
287142|NCT01933672|688412|P3|NOT COMPLETED|Metformin Run-in Period||0
287143|NCT01933672|688413|P2|NOT COMPLETED|Metformin Run-in Period||0
287144|NCT01933672|688414|P1|NOT COMPLETED|Metformin Run-in Period||10
287145|NCT01933672|688408|P7|COMPLETED|Metformin Run-in Period||0
287146|NCT01933672|688409|P6|COMPLETED|Metformin Run-in Period||0
287147|NCT01933672|688410|P5|COMPLETED|Metformin Run-in Period||0
287148|NCT01933672|688411|P4|COMPLETED|Metformin Run-in Period||0
287149|NCT01933672|688412|P3|COMPLETED|Metformin Run-in Period||0
287150|NCT01933672|688413|P2|COMPLETED|Metformin Run-in Period||0
287151|NCT01933672|688414|P1|COMPLETED|Metformin Run-in Period||33
287152|NCT01933672|688408|P7|Received Treatment|Metformin Run-in Period||0
287153|NCT01933672|688409|P6|Received Treatment|Metformin Run-in Period||0
287154|NCT01933672|688410|P5|Received Treatment|Metformin Run-in Period||0
287155|NCT01933672|688411|P4|Received Treatment|Metformin Run-in Period||0
287156|NCT01933672|688412|P3|Received Treatment|Metformin Run-in Period||0
287157|NCT01933672|688413|P2|Received Treatment|Metformin Run-in Period||0
287158|NCT01933672|688414|P1|Received Treatment|Metformin Run-in Period||43
287159|NCT01933672|688408|P7|STARTED|Metformin Run-in Period||0
287160|NCT01933672|688409|P6|STARTED|Metformin Run-in Period||0
287161|NCT01933672|688410|P5|STARTED|Metformin Run-in Period||0
287162|NCT01933672|688411|P4|STARTED|Metformin Run-in Period||0
287163|NCT01933672|688412|P3|STARTED|Metformin Run-in Period||0
287164|NCT01933672|688413|P2|STARTED|Metformin Run-in Period||0
287165|NCT01933672|688414|P1|STARTED|Metformin Run-in Period||43
287166|NCT01933425|688460|P2|NOT COMPLETED|Overall Study||0
287167|NCT01933425|688461|P1|NOT COMPLETED|Overall Study||0
287168|NCT01933425|688460|P2|COMPLETED|Overall Study||7
287169|NCT01933425|688461|P1|COMPLETED|Overall Study||7
287170|NCT01933425|688460|P2|STARTED|Overall Study||7
287171|NCT01933425|688461|P1|STARTED|Overall Study||7
287172|NCT01933399|688474|P3|NOT COMPLETED|Overall Study||0
287173|NCT01933399|688475|P2|NOT COMPLETED|Overall Study||0
287174|NCT01933399|688476|P1|NOT COMPLETED|Overall Study||0
287175|NCT01933399|688474|P3|COMPLETED|Overall Study||37
287176|NCT01933399|688475|P2|COMPLETED|Overall Study||32
287177|NCT01933399|688476|P1|COMPLETED|Overall Study||29
287178|NCT01933399|688474|P3|STARTED|Overall Study||37
287179|NCT01933399|688475|P2|STARTED|Overall Study||32
287180|NCT01933399|688476|P1|STARTED|Overall Study||29
287181|NCT01933334|688489|P2|NOT COMPLETED|Overall Study||2
287182|NCT01933334|688490|P1|NOT COMPLETED|Overall Study||5
287183|NCT01933334|688489|P2|COMPLETED|Overall Study||29
287184|NCT01933334|688490|P1|COMPLETED|Overall Study||27
287185|NCT01933334|688489|P2|STARTED|Overall Study||31
287186|NCT01933334|688490|P1|STARTED|Overall Study||32
287187|NCT01933230|688500|P1|NOT COMPLETED|Overall Study||0
287188|NCT01933230|688500|P1|COMPLETED|Overall Study||2
287189|NCT01933230|688500|P1|STARTED|Overall Study||2
287190|NCT01932970|688504|P1|NOT COMPLETED|Overall Study||18
287191|NCT01932970|688504|P1|COMPLETED|Overall Study||140
287192|NCT01932970|688504|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
287193|NCT01932970|688504|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
287194|NCT01932762|688516|P4|NOT COMPLETED|Overall Study||1
287195|NCT01932762|688517|P3|NOT COMPLETED|Overall Study||0
287196|NCT01932762|688518|P2|NOT COMPLETED|Overall Study||2
287197|NCT01932762|688519|P1|NOT COMPLETED|Overall Study||6
287198|NCT01932762|688516|P4|COMPLETED|Overall Study||18
287199|NCT01932762|688517|P3|COMPLETED|Overall Study||19
287200|NCT01932762|688518|P2|COMPLETED|Overall Study||28
287201|NCT01932762|688519|P1|COMPLETED|Overall Study||24
287202|NCT01932762|688516|P4|STARTED|Overall Study||19
287203|NCT01932762|688517|P3|STARTED|Overall Study||19
287204|NCT01932762|688518|P2|STARTED|Overall Study||30
287205|NCT01932762|688519|P1|STARTED|Overall Study||30
287206|NCT01932606|688555|P2|NOT COMPLETED|Overall Study||0
287207|NCT01932606|688556|P1|NOT COMPLETED|Overall Study||0
287208|NCT01932606|688555|P2|COMPLETED|Overall Study||14
287209|NCT01932606|688556|P1|COMPLETED|Overall Study||14
287210|NCT01932606|688555|P2|STARTED|Overall Study||14
287211|NCT01932606|688556|P1|STARTED|Overall Study||14
287212|NCT01932164|688606|P1|NOT COMPLETED|Overall Study||0
287213|NCT01932164|688606|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
287214|NCT01932164|688606|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
287215|NCT01932164|688606|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
287216|NCT01932164|688606|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
287217|NCT01932164|688606|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
287218|NCT01932164|688606|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
287219|NCT01932164|688606|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
287220|NCT01932112|688610|P1|NOT COMPLETED|Overall Study||0
287221|NCT01932112|688610|P1|COMPLETED|Overall Study||378
287222|NCT01932112|688610|P1|STARTED|Overall Study||378
287223|NCT01932060|688616|P2|NOT COMPLETED|Overall Study||0
287224|NCT01932060|688617|P1|NOT COMPLETED|Overall Study||0
287225|NCT01932060|688616|P2|COMPLETED|Overall Study||24
287226|NCT01932060|688617|P1|COMPLETED|Overall Study||27
287227|NCT01932060|688616|P2|STARTED|Overall Study||24
287228|NCT01932060|688617|P1|STARTED|Overall Study||27
287229|NCT01931878|688625|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
287230|NCT01931878|688626|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
287231|NCT01931878|688625|P2|COMPLETED|Second Intervention (After 3 Months)||12
287232|NCT01931878|688626|P1|COMPLETED|Second Intervention (After 3 Months)||9
287233|NCT01931878|688625|P2|STARTED|Second Intervention (After 3 Months)||14
287234|NCT01931878|688626|P1|STARTED|Second Intervention (After 3 Months)||9
287235|NCT01931878|688625|P2|NOT COMPLETED|First Intervention||0
287236|NCT01931878|688626|P1|NOT COMPLETED|First Intervention||1
287237|NCT01931878|688625|P2|COMPLETED|First Intervention||14
287238|NCT01931878|688626|P1|COMPLETED|First Intervention||9
287239|NCT01931878|688625|P2|STARTED|First Intervention||14
287240|NCT01931878|688626|P1|STARTED|First Intervention||10
287241|NCT01931865|688636|P1|NOT COMPLETED|Overall Study||4
287242|NCT01931865|688636|P1|COMPLETED|Overall Study||8
287243|NCT01931865|688636|P1|STARTED|Overall Study||12
287244|NCT01931839|688649|P7|NOT COMPLETED|Overall Study||4
287245|NCT01931839|688650|P6|NOT COMPLETED|Overall Study||5
287246|NCT01931839|688651|P5|NOT COMPLETED|Overall Study||1
287247|NCT01931839|688652|P4|NOT COMPLETED|Overall Study||14
287248|NCT01931839|688653|P3|NOT COMPLETED|Overall Study||39
287249|NCT01931839|688654|P2|NOT COMPLETED|Overall Study||26
287250|NCT01931839|688655|P1|NOT COMPLETED|Overall Study||41
287251|NCT01931839|688649|P7|COMPLETED|Overall Study||56
287252|NCT01931839|688650|P6|COMPLETED|Overall Study||50
287253|NCT01931839|688651|P5|COMPLETED|Overall Study||18
287254|NCT01931839|688652|P4|COMPLETED|Overall Study||162
287255|NCT01931839|688653|P3|COMPLETED|Overall Study||301
287256|NCT01931839|688654|P2|COMPLETED|Overall Study||152
287257|NCT01931839|688655|P1|COMPLETED|Overall Study||294
287258|NCT01931839|688649|P7|Safety Analysis Set (As Dosed)|Overall Study||60
287259|NCT01931839|688650|P6|Safety Analysis Set (As Dosed)|Overall Study||55
287260|NCT01931839|688651|P5|Safety Analysis Set (As Dosed)|Overall Study||19
287261|NCT01931839|688652|P4|Safety Analysis Set (As Dosed)|Overall Study||176
287262|NCT01931839|688653|P3|Safety Analysis Set (As Dosed)|Overall Study||340
287263|NCT01931839|688654|P2|Safety Analysis Set (As Dosed)|Overall Study||178
287264|NCT01931839|688655|P1|Safety Analysis Set (As Dosed)|Overall Study||335
287265|NCT01931839|688649|P7|Full Analysis Set (As Randomized)|Overall Study||60
287266|NCT01931839|688650|P6|Full Analysis Set (As Randomized)|Overall Study||55
287267|NCT01931839|688651|P5|Full Analysis Set (As Randomized)|Overall Study||19
287268|NCT01931839|688652|P4|Full Analysis Set (As Randomized)|Overall Study||176
287269|NCT01931839|688653|P3|Full Analysis Set (As Randomized)|Overall Study||340
287270|NCT01931839|688654|P2|Full Analysis Set (As Randomized)|Overall Study||179
287271|NCT01931839|688655|P1|Full Analysis Set (As Randomized)|Overall Study||334
287272|NCT01931839|688649|P7|STARTED|Overall Study||60
287273|NCT01931839|688650|P6|STARTED|Overall Study||55
287274|NCT01931839|688651|P5|STARTED|Overall Study||19
287275|NCT01931839|688652|P4|STARTED|Overall Study||176
287276|NCT01931839|688653|P3|STARTED|Overall Study||340
287277|NCT01931839|688654|P2|STARTED|Overall Study||178
287278|NCT01931839|688655|P1|STARTED|Overall Study||335
287279|NCT01931709|688723|P1|NOT COMPLETED|Overall Study||0
287280|NCT01931709|688723|P1|COMPLETED|Overall Study||35
287281|NCT01931709|688723|P1|STARTED|Overall Study||35
287282|NCT01931527|688735|P2|NOT COMPLETED|Overall Study||0
287283|NCT01931527|688736|P1|NOT COMPLETED|Overall Study||0
287284|NCT01931527|688735|P2|COMPLETED|Overall Study||15
287285|NCT01931527|688736|P1|COMPLETED|Overall Study||16
287286|NCT01931527|688735|P2|STARTED|Overall Study||15
287287|NCT01931527|688736|P1|STARTED|Overall Study||16
287288|NCT01931475|688746|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
287289|NCT01931475|688747|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
287290|NCT01931475|688746|P2|COMPLETED|Period 2: Extension Treatment Phase||157
287291|NCT01931475|688747|P1|COMPLETED|Period 2: Extension Treatment Phase||162
287292|NCT01931475|688746|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
287293|NCT01931475|688747|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
287294|NCT01931475|688746|P2|STARTED|Period 2: Extension Treatment Phase||176
287295|NCT01931475|688747|P1|STARTED|Period 2: Extension Treatment Phase||166
287296|NCT01931475|688746|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
287297|NCT01931475|688747|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
287298|NCT01931475|688746|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
287299|NCT01931475|688747|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
287300|NCT01931475|688746|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
287301|NCT01931475|688747|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
287302|NCT01931475|688746|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
287303|NCT01931475|688747|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
287304|NCT01931397|688774|P1|NOT COMPLETED|Overall Study||11
287305|NCT01931397|688774|P1|COMPLETED|Overall Study||19
287306|NCT01931397|688774|P1|STARTED|Overall Study||30
287307|NCT01931150|688785|P2|NOT COMPLETED|Overall Study||2
287308|NCT01931150|688786|P1|NOT COMPLETED|Overall Study||1
287309|NCT01931150|688785|P2|COMPLETED|Overall Study||4
287310|NCT01931150|688786|P1|COMPLETED|Overall Study||4
287311|NCT01931150|688785|P2|STARTED|Overall Study||6
287312|NCT01931150|688786|P1|STARTED|Overall Study||5
287313|NCT01930890|688796|P4|NOT COMPLETED|Overall Study||27
287314|NCT01930890|688797|P3|NOT COMPLETED|Overall Study||13
287315|NCT01930890|688798|P2|NOT COMPLETED|Overall Study||33
287316|NCT01930890|688799|P1|NOT COMPLETED|Overall Study||14
287317|NCT01930890|688796|P4|COMPLETED|Overall Study||0
287318|NCT01930890|688797|P3|COMPLETED|Overall Study||0
287319|NCT01930890|688798|P2|COMPLETED|Overall Study||0
287320|NCT01930890|688799|P1|COMPLETED|Overall Study||0
287321|NCT01930890|688796|P4|STARTED|Overall Study||27
287322|NCT01930890|688797|P3|STARTED|Overall Study||13
287323|NCT01930890|688798|P2|STARTED|Overall Study||33
287324|NCT01930890|688799|P1|STARTED|Overall Study||14
287325|NCT01930799|688813|P1|NOT COMPLETED|Overall Study||8
287326|NCT01930799|688813|P1|COMPLETED|Overall Study||112
287327|NCT01930799|688813|P1|STARTED|Overall Study||120
287328|NCT01930487|688818|P2|NOT COMPLETED|Second Intervention (30 Days)||0
287329|NCT01930487|688819|P1|NOT COMPLETED|Second Intervention (30 Days)||0
287330|NCT01930487|688818|P2|COMPLETED|Second Intervention (30 Days)||23
287331|NCT01930487|688819|P1|COMPLETED|Second Intervention (30 Days)||19
287332|NCT01930487|688818|P2|STARTED|Second Intervention (30 Days)||23
287333|NCT01930487|688819|P1|STARTED|Second Intervention (30 Days)||19
287334|NCT01930487|688818|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
287335|NCT01930487|688819|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
287336|NCT01930487|688818|P2|COMPLETED|Washout Period (3 Weeks)||23
287337|NCT01930487|688819|P1|COMPLETED|Washout Period (3 Weeks)||19
287338|NCT01930487|688818|P2|STARTED|Washout Period (3 Weeks)||23
287339|NCT01930487|688819|P1|STARTED|Washout Period (3 Weeks)||19
287340|NCT01930487|688818|P2|NOT COMPLETED|First Intervention (30 Days)||2
287341|NCT01930487|688819|P1|NOT COMPLETED|First Intervention (30 Days)||2
287342|NCT01930487|688818|P2|COMPLETED|First Intervention (30 Days)||23
287343|NCT01930487|688819|P1|COMPLETED|First Intervention (30 Days)||19
287344|NCT01930487|688818|P2|STARTED|First Intervention (30 Days)||25
287345|NCT01930487|688819|P1|STARTED|First Intervention (30 Days)||21
287346|NCT01930435|688913|P1|NOT COMPLETED|Overall Study||0
287347|NCT01930435|688913|P1|COMPLETED|Overall Study||20
287348|NCT01930435|688913|P1|STARTED|Overall Study||20
287349|NCT01930058|688924|P3|NOT COMPLETED|Overall Study||0
287350|NCT01930058|688925|P2|NOT COMPLETED|Overall Study||0
287351|NCT01930058|688926|P1|NOT COMPLETED|Overall Study||0
287352|NCT01930058|688924|P3|COMPLETED|Overall Study||3
287353|NCT01930058|688925|P2|COMPLETED|Overall Study||3
287354|NCT01930058|688926|P1|COMPLETED|Overall Study||3
287355|NCT01930058|688924|P3|STARTED|Overall Study||3
287356|NCT01930058|688925|P2|STARTED|Overall Study||3
287357|NCT01930058|688926|P1|STARTED|Overall Study||3
287358|NCT01930045|688948|P6|NOT COMPLETED|Part 2 - Period 5||0
287359|NCT01930045|688949|P5|NOT COMPLETED|Part 2 - Period 5||0
287360|NCT01930045|688950|P4|NOT COMPLETED|Part 2 - Period 5||0
287361|NCT01930045|688951|P3|NOT COMPLETED|Part 2 - Period 5||0
287362|NCT01930045|688952|P2|NOT COMPLETED|Part 2 - Period 5||0
287363|NCT01930045|688953|P1|NOT COMPLETED|Part 2 - Period 5||0
287364|NCT01930045|688948|P6|COMPLETED|Part 2 - Period 5||1
287365|NCT01930045|688949|P5|COMPLETED|Part 2 - Period 5||3
287366|NCT01930045|688950|P4|COMPLETED|Part 2 - Period 5||3
287367|NCT01930045|688951|P3|COMPLETED|Part 2 - Period 5||3
287368|NCT01930045|688952|P2|COMPLETED|Part 2 - Period 5||3
287369|NCT01930045|688953|P1|COMPLETED|Part 2 - Period 5||3
287370|NCT01930045|688948|P6|STARTED|Part 2 - Period 5||1
287371|NCT01930045|688949|P5|STARTED|Part 2 - Period 5||3
287372|NCT01930045|688950|P4|STARTED|Part 2 - Period 5||3
287373|NCT01930045|688951|P3|STARTED|Part 2 - Period 5||3
287374|NCT01930045|688952|P2|STARTED|Part 2 - Period 5||3
287375|NCT01930045|688953|P1|STARTED|Part 2 - Period 5||3
287376|NCT01930045|688948|P6|NOT COMPLETED|Part 2 - Period 4||0
287377|NCT01930045|688949|P5|NOT COMPLETED|Part 2 - Period 4||0
287378|NCT01930045|688950|P4|NOT COMPLETED|Part 2 - Period 4||0
287379|NCT01930045|688951|P3|NOT COMPLETED|Part 2 - Period 4||0
287380|NCT01930045|688952|P2|NOT COMPLETED|Part 2 - Period 4||0
287381|NCT01930045|688953|P1|NOT COMPLETED|Part 2 - Period 4||0
287382|NCT01930045|688948|P6|COMPLETED|Part 2 - Period 4||1
287383|NCT01930045|688949|P5|COMPLETED|Part 2 - Period 4||3
287384|NCT01930045|688950|P4|COMPLETED|Part 2 - Period 4||3
287385|NCT01930045|688951|P3|COMPLETED|Part 2 - Period 4||3
287386|NCT01930045|688952|P2|COMPLETED|Part 2 - Period 4||3
287388|NCT01930045|688948|P6|STARTED|Part 2 - Period 4||1
287389|NCT01930045|688949|P5|STARTED|Part 2 - Period 4||3
287390|NCT01930045|688950|P4|STARTED|Part 2 - Period 4||3
287391|NCT01930045|688951|P3|STARTED|Part 2 - Period 4||3
287392|NCT01930045|688952|P2|STARTED|Part 2 - Period 4||3
287393|NCT01930045|688953|P1|STARTED|Part 2 - Period 4||3
287394|NCT01930045|688948|P6|NOT COMPLETED|Pause (up to 37 Days)||2
287395|NCT01930045|688949|P5|NOT COMPLETED|Pause (up to 37 Days)||0
287396|NCT01930045|688950|P4|NOT COMPLETED|Pause (up to 37 Days)||0
287397|NCT01930045|688951|P3|NOT COMPLETED|Pause (up to 37 Days)||0
287398|NCT01930045|688952|P2|NOT COMPLETED|Pause (up to 37 Days)||0
287399|NCT01930045|688953|P1|NOT COMPLETED|Pause (up to 37 Days)||0
287400|NCT01930045|688948|P6|COMPLETED|Pause (up to 37 Days)||1
287401|NCT01930045|688949|P5|COMPLETED|Pause (up to 37 Days)||3
287402|NCT01930045|688950|P4|COMPLETED|Pause (up to 37 Days)||3
287403|NCT01930045|688951|P3|COMPLETED|Pause (up to 37 Days)||3
287404|NCT01930045|688952|P2|COMPLETED|Pause (up to 37 Days)||3
287405|NCT01930045|688953|P1|COMPLETED|Pause (up to 37 Days)||3
287406|NCT01930045|688948|P6|STARTED|Pause (up to 37 Days)||3
287407|NCT01930045|688949|P5|STARTED|Pause (up to 37 Days)||3
287408|NCT01930045|688950|P4|STARTED|Pause (up to 37 Days)||3
287409|NCT01930045|688951|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
287410|NCT01930045|688952|P2|STARTED|Pause (up to 37 Days)||3
287411|NCT01930045|688953|P1|STARTED|Pause (up to 37 Days)||3
287412|NCT01930045|688948|P6|NOT COMPLETED|Part 1 - Period 3||0
287413|NCT01930045|688949|P5|NOT COMPLETED|Part 1 - Period 3||0
287414|NCT01930045|688950|P4|NOT COMPLETED|Part 1 - Period 3||0
287415|NCT01930045|688951|P3|NOT COMPLETED|Part 1 - Period 3||0
287416|NCT01930045|688952|P2|NOT COMPLETED|Part 1 - Period 3||0
287417|NCT01930045|688953|P1|NOT COMPLETED|Part 1 - Period 3||0
287418|NCT01930045|688948|P6|COMPLETED|Part 1 - Period 3||3
287419|NCT01930045|688949|P5|COMPLETED|Part 1 - Period 3||3
287420|NCT01930045|688950|P4|COMPLETED|Part 1 - Period 3||3
287421|NCT01930045|688951|P3|COMPLETED|Part 1 - Period 3||2
287422|NCT01930045|688952|P2|COMPLETED|Part 1 - Period 3||3
287423|NCT01930045|688953|P1|COMPLETED|Part 1 - Period 3||3
287424|NCT01930045|688948|P6|STARTED|Part 1 - Period 3||3
287425|NCT01930045|688949|P5|STARTED|Part 1 - Period 3||3
287426|NCT01930045|688950|P4|STARTED|Part 1 - Period 3||3
287427|NCT01930045|688951|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
287428|NCT01930045|688952|P2|STARTED|Part 1 - Period 3||3
287429|NCT01930045|688953|P1|STARTED|Part 1 - Period 3||3
287430|NCT01930045|688948|P6|NOT COMPLETED|Part 1 - Period 2||0
287431|NCT01930045|688949|P5|NOT COMPLETED|Part 1 - Period 2||0
287432|NCT01930045|688950|P4|NOT COMPLETED|Part 1 - Period 2||0
287433|NCT01930045|688951|P3|NOT COMPLETED|Part 1 - Period 2||0
287434|NCT01930045|688952|P2|NOT COMPLETED|Part 1 - Period 2||0
287435|NCT01930045|688953|P1|NOT COMPLETED|Part 1 - Period 2||0
287436|NCT01930045|688948|P6|COMPLETED|Part 1 - Period 2||3
287437|NCT01930045|688949|P5|COMPLETED|Part 1 - Period 2||3
287438|NCT01930045|688950|P4|COMPLETED|Part 1 - Period 2||3
287439|NCT01930045|688951|P3|COMPLETED|Part 1 - Period 2||3
287440|NCT01930045|688952|P2|COMPLETED|Part 1 - Period 2||3
287441|NCT01930045|688953|P1|COMPLETED|Part 1 - Period 2||3
287442|NCT01930045|688948|P6|STARTED|Part 1 - Period 2||3
287443|NCT01930045|688949|P5|STARTED|Part 1 - Period 2||3
287444|NCT01930045|688950|P4|STARTED|Part 1 - Period 2||3
287445|NCT01930045|688951|P3|STARTED|Part 1 - Period 2||3
287446|NCT01930045|688952|P2|STARTED|Part 1 - Period 2||3
287447|NCT01930045|688953|P1|STARTED|Part 1 - Period 2||3
287448|NCT01930045|688948|P6|NOT COMPLETED|Part 1 - Period 1||0
287449|NCT01930045|688949|P5|NOT COMPLETED|Part 1 - Period 1||0
287450|NCT01930045|688950|P4|NOT COMPLETED|Part 1 - Period 1||0
287451|NCT01930045|688951|P3|NOT COMPLETED|Part 1 - Period 1||0
287452|NCT01930045|688952|P2|NOT COMPLETED|Part 1 - Period 1||0
287453|NCT01930045|688953|P1|NOT COMPLETED|Part 1 - Period 1||0
287454|NCT01930045|688948|P6|COMPLETED|Part 1 - Period 1||3
287455|NCT01930045|688949|P5|COMPLETED|Part 1 - Period 1||3
287456|NCT01930045|688950|P4|COMPLETED|Part 1 - Period 1||3
287457|NCT01930045|688951|P3|COMPLETED|Part 1 - Period 1||3
287458|NCT01930045|688952|P2|COMPLETED|Part 1 - Period 1||3
287459|NCT01930045|688953|P1|COMPLETED|Part 1 - Period 1||3
287460|NCT01930045|688948|P6|STARTED|Part 1 - Period 1||3
287461|NCT01930045|688949|P5|STARTED|Part 1 - Period 1||3
287462|NCT01930045|688950|P4|STARTED|Part 1 - Period 1||3
287463|NCT01930045|688951|P3|STARTED|Part 1 - Period 1||3
287464|NCT01930045|688952|P2|STARTED|Part 1 - Period 1||3
287465|NCT01930045|688953|P1|STARTED|Part 1 - Period 1||3
287466|NCT01929993|688980|P2|NOT COMPLETED|Overall Study||28
287467|NCT01929993|688981|P1|NOT COMPLETED|Overall Study||30
287468|NCT01929993|688980|P2|COMPLETED|Overall Study||54
287469|NCT01929993|688981|P1|COMPLETED|Overall Study||52
287470|NCT01929993|688980|P2|STARTED|Overall Study||82
287471|NCT01929993|688981|P1|STARTED|Overall Study||82
287472|NCT01929980|688987|P1|NOT COMPLETED|Overall Study||1
287473|NCT01929980|688987|P1|COMPLETED|Overall Study||3
287474|NCT01929980|688987|P1|STARTED|Overall Study||4
287475|NCT01929889|688991|P1|NOT COMPLETED|Overall Study||5
287476|NCT01929889|688991|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
287477|NCT01929889|688991|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
287478|NCT01929876|688995|P1|NOT COMPLETED|Period 2||1
287479|NCT01929876|688995|P1|COMPLETED|Period 2||15
287480|NCT01929876|688995|P1|STARTED|Period 2||16
287481|NCT01929876|688995|P1|NOT COMPLETED|Period 1||0
287482|NCT01929876|688995|P1|COMPLETED|Period 1||16
287483|NCT01929876|688995|P1|STARTED|Period 1||16
287484|NCT01929473|689008|P1|NOT COMPLETED|Overall Study||587
287485|NCT01929473|689008|P1|COMPLETED|Overall Study||3243
287486|NCT01929473|689008|P1|365 Day|Overall Study||3589
287487|NCT01929473|689008|P1|STARTED|Overall Study|0 day|3830
287488|NCT01929460|689014|P2|NOT COMPLETED|Overall Study||0
287489|NCT01929460|689015|P1|NOT COMPLETED|Overall Study||0
287490|NCT01929460|689014|P2|COMPLETED|Overall Study||13
287491|NCT01929460|689015|P1|COMPLETED|Overall Study||13
287492|NCT01929460|689014|P2|STARTED|Overall Study||13
287493|NCT01929460|689015|P1|STARTED|Overall Study||13
287494|NCT01929317|689039|P2|NOT COMPLETED|Long-term Phase||4
287495|NCT01929317|689040|P1|NOT COMPLETED|Long-term Phase||19
287496|NCT01929317|689039|P2|COMPLETED|Long-term Phase||14
287497|NCT01929317|689040|P1|COMPLETED|Long-term Phase||25
287498|NCT01929317|689039|P2|STARTED|Long-term Phase||18
287499|NCT01929317|689040|P1|STARTED|Long-term Phase||44
287500|NCT01929317|689039|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
287501|NCT01929317|689040|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
287502|NCT01929317|689039|P2|COMPLETED|Dose Increase Effect Verification Phase||19
287503|NCT01929317|689040|P1|COMPLETED|Dose Increase Effect Verification Phase||52
287504|NCT01929317|689039|P2|STARTED|Dose Increase Effect Verification Phase||20
287505|NCT01929317|689040|P1|STARTED|Dose Increase Effect Verification Phase||61
287506|NCT01929135|689109|P2|NOT COMPLETED|Overall Study||1
287507|NCT01929135|689110|P1|NOT COMPLETED|Overall Study||1
287508|NCT01929135|689109|P2|COMPLETED|Overall Study||18
287509|NCT01929135|689110|P1|COMPLETED|Overall Study||18
287510|NCT01929135|689109|P2|STARTED|Overall Study||19
287511|NCT01929135|689110|P1|STARTED|Overall Study||19
287512|NCT01929083|689124|P2|NOT COMPLETED|Intervention 2||1
287513|NCT01929083|689125|P1|NOT COMPLETED|Intervention 2||0
287514|NCT01929083|689124|P2|COMPLETED|Intervention 2||8
287515|NCT01929083|689125|P1|COMPLETED|Intervention 2||7
287516|NCT01929083|689124|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
287517|NCT01929083|689125|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
287518|NCT01929083|689124|P2|STARTED|Intervention 2||9
287519|NCT01929083|689125|P1|STARTED|Intervention 2||7
287520|NCT01929083|689124|P2|NOT COMPLETED|Intervention 1||0
287521|NCT01929083|689125|P1|NOT COMPLETED|Intervention 1||3
287522|NCT01929083|689124|P2|COMPLETED|Intervention 1||9
287523|NCT01929083|689125|P1|COMPLETED|Intervention 1||7
287524|NCT01929083|689124|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
287525|NCT01929083|689125|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
287526|NCT01929083|689124|P2|STARTED|Intervention 1||9
287527|NCT01929083|689125|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
287528|NCT01929044|689151|P2|NOT COMPLETED|Overall Study||17
287529|NCT01929044|689152|P1|NOT COMPLETED|Overall Study||11
287530|NCT01929044|689151|P2|COMPLETED|Overall Study||129
287531|NCT01929044|689152|P1|COMPLETED|Overall Study||142
287532|NCT01929044|689151|P2|STARTED|Overall Study||146
287533|NCT01929044|689152|P1|STARTED|Overall Study||153
287534|NCT01929031|689174|P6|NOT COMPLETED|Overall Study||1
287535|NCT01929031|689175|P5|NOT COMPLETED|Overall Study||1
287536|NCT01929031|689176|P4|NOT COMPLETED|Overall Study||0
287537|NCT01929031|689177|P3|NOT COMPLETED|Overall Study||1
287538|NCT01929031|689178|P2|NOT COMPLETED|Overall Study||2
287539|NCT01929031|689179|P1|NOT COMPLETED|Overall Study||4
287540|NCT01929031|689174|P6|COMPLETED|Overall Study||35
287541|NCT01929031|689175|P5|COMPLETED|Overall Study||33
287542|NCT01929031|689176|P4|COMPLETED|Overall Study||35
287543|NCT01929031|689177|P3|COMPLETED|Overall Study||34
287544|NCT01929031|689178|P2|COMPLETED|Overall Study||207
287545|NCT01929031|689179|P1|COMPLETED|Overall Study||209
287546|NCT01929031|689174|P6|STARTED|Overall Study||36
287547|NCT01929031|689175|P5|STARTED|Overall Study||34
287548|NCT01929031|689176|P4|STARTED|Overall Study||35
287549|NCT01929031|689177|P3|STARTED|Overall Study||35
287550|NCT01929031|689178|P2|STARTED|Overall Study||209
287551|NCT01929031|689179|P1|STARTED|Overall Study||213
287552|NCT01928940|689203|P2|NOT COMPLETED|Overall Study||1
287553|NCT01928940|689204|P1|NOT COMPLETED|Overall Study||0
287554|NCT01928940|689203|P2|COMPLETED|Overall Study||5
287555|NCT01928940|689204|P1|COMPLETED|Overall Study||6
287556|NCT01928940|689203|P2|STARTED|Overall Study||6
287557|NCT01928940|689204|P1|STARTED|Overall Study||6
287558|NCT01928927|689247|P2|NOT COMPLETED|Overall Study||1
287559|NCT01928927|689248|P1|NOT COMPLETED|Overall Study||2
287560|NCT01928927|689247|P2|COMPLETED|Overall Study||14
287561|NCT01928927|689248|P1|COMPLETED|Overall Study||27
287562|NCT01928927|689247|P2|STARTED|Overall Study||15
287563|NCT01928927|689248|P1|STARTED|Overall Study||29
287564|NCT01928771|689259|P3|NOT COMPLETED|Overall Study||40
287565|NCT01928771|689260|P2|NOT COMPLETED|Overall Study||40
287566|NCT01928771|689261|P1|NOT COMPLETED|Overall Study||46
287567|NCT01928771|689259|P3|COMPLETED|Overall Study||367
287568|NCT01928771|689260|P2|COMPLETED|Overall Study||358
287569|NCT01928771|689261|P1|COMPLETED|Overall Study||354
287570|NCT01928771|689259|P3|Received Treatment|Overall Study||407
287571|NCT01928771|689260|P2|Received Treatment|Overall Study||398
287572|NCT01928771|689261|P1|Received Treatment|Overall Study||399
287573|NCT01928771|689259|P3|STARTED|Overall Study||407
287574|NCT01928771|689260|P2|STARTED|Overall Study||398
287575|NCT01928771|689261|P1|STARTED|Overall Study||400
287576|NCT01928693|689341|P3|NOT COMPLETED|Overall Study||0
287577|NCT01928693|689342|P2|NOT COMPLETED|Overall Study||0
287578|NCT01928693|689343|P1|NOT COMPLETED|Overall Study||0
287579|NCT01928693|689341|P3|COMPLETED|Overall Study||1
287580|NCT01928693|689342|P2|COMPLETED|Overall Study||1
287581|NCT01928693|689343|P1|COMPLETED|Overall Study||0
287582|NCT01928693|689341|P3|STARTED|Overall Study||1
287583|NCT01928693|689342|P2|STARTED|Overall Study||1
287584|NCT01928693|689343|P1|STARTED|Overall Study||0
287585|NCT01928680|689369|P1|NOT COMPLETED|Overall Study||0
287586|NCT01928680|689369|P1|COMPLETED|Overall Study||33
287587|NCT01928680|689369|P1|STARTED|Overall Study||33
287588|NCT01928615|689373|P1|NOT COMPLETED|Overall Study||2
287589|NCT01928615|689373|P1|COMPLETED|Overall Study||0
287590|NCT01928615|689373|P1|STARTED|Overall Study||2
287591|NCT01928472|689392|P4|NOT COMPLETED|Overall Study||2
287592|NCT01928472|689393|P3|NOT COMPLETED|Overall Study||7
287593|NCT01928472|689394|P2|NOT COMPLETED|Overall Study||8
287594|NCT01928472|689395|P1|NOT COMPLETED|Overall Study||8
287595|NCT01928472|689392|P4|COMPLETED|Overall Study||100
287596|NCT01928472|689393|P3|COMPLETED|Overall Study||91
287597|NCT01928472|689394|P2|COMPLETED|Overall Study||96
287598|NCT01928472|689395|P1|COMPLETED|Overall Study||90
287599|NCT01928472|689392|P4|STARTED|Overall Study||102
287600|NCT01928472|689393|P3|STARTED|Overall Study||98
287601|NCT01928472|689394|P2|STARTED|Overall Study||104
287602|NCT01928472|689395|P1|STARTED|Overall Study||98
287603|NCT01928381|689462|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
287604|NCT01928381|689463|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
287605|NCT01928381|689464|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
287606|NCT01928381|689465|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
287607|NCT01928381|689466|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
287608|NCT01928381|689467|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
287609|NCT01928381|689468|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
287610|NCT01928381|689462|P7|COMPLETED|Part 2 - Post Third Intervention||5
287611|NCT01928381|689463|P6|COMPLETED|Part 2 - Post Third Intervention||5
287612|NCT01928381|689464|P5|COMPLETED|Part 2 - Post Third Intervention||3
287613|NCT01928381|689465|P4|COMPLETED|Part 2 - Post Third Intervention||4
287614|NCT01928381|689466|P3|COMPLETED|Part 2 - Post Third Intervention||3
287615|NCT01928381|689467|P2|COMPLETED|Part 2 - Post Third Intervention||5
287616|NCT01928381|689468|P1|COMPLETED|Part 2 - Post Third Intervention||0
287617|NCT01928381|689462|P7|STARTED|Part 2 - Post Third Intervention||5
287618|NCT01928381|689463|P6|STARTED|Part 2 - Post Third Intervention||5
287619|NCT01928381|689464|P5|STARTED|Part 2 - Post Third Intervention||3
287620|NCT01928381|689465|P4|STARTED|Part 2 - Post Third Intervention||4
287621|NCT01928381|689466|P3|STARTED|Part 2 - Post Third Intervention||4
287622|NCT01928381|689467|P2|STARTED|Part 2 - Post Third Intervention||5
287623|NCT01928381|689468|P1|STARTED|Part 2 - Post Third Intervention||0
287624|NCT01928381|689462|P7|NOT COMPLETED|Part 2 - Third Intervention||0
287625|NCT01928381|689463|P6|NOT COMPLETED|Part 2 - Third Intervention||0
287626|NCT01928381|689464|P5|NOT COMPLETED|Part 2 - Third Intervention||0
287627|NCT01928381|689465|P4|NOT COMPLETED|Part 2 - Third Intervention||0
287628|NCT01928381|689466|P3|NOT COMPLETED|Part 2 - Third Intervention||0
287629|NCT01928381|689467|P2|NOT COMPLETED|Part 2 - Third Intervention||0
287630|NCT01928381|689468|P1|NOT COMPLETED|Part 2 - Third Intervention||0
287631|NCT01928381|689462|P7|COMPLETED|Part 2 - Third Intervention||5
287632|NCT01928381|689463|P6|COMPLETED|Part 2 - Third Intervention||5
287633|NCT01928381|689464|P5|COMPLETED|Part 2 - Third Intervention||3
287634|NCT01928381|689465|P4|COMPLETED|Part 2 - Third Intervention||4
287635|NCT01928381|689466|P3|COMPLETED|Part 2 - Third Intervention||4
287636|NCT01928381|689467|P2|COMPLETED|Part 2 - Third Intervention||5
287637|NCT01928381|689468|P1|COMPLETED|Part 2 - Third Intervention||0
287638|NCT01928381|689462|P7|STARTED|Part 2 - Third Intervention||5
287639|NCT01928381|689463|P6|STARTED|Part 2 - Third Intervention||5
287640|NCT01928381|689464|P5|STARTED|Part 2 - Third Intervention||3
287641|NCT01928381|689465|P4|STARTED|Part 2 - Third Intervention||4
287642|NCT01928381|689466|P3|STARTED|Part 2 - Third Intervention||4
287643|NCT01928381|689467|P2|STARTED|Part 2 - Third Intervention||5
287644|NCT01928381|689468|P1|STARTED|Part 2 - Third Intervention||0
287645|NCT01928381|689462|P7|NOT COMPLETED|Washout Second Intervention||0
287646|NCT01928381|689463|P6|NOT COMPLETED|Washout Second Intervention||0
287647|NCT01928381|689464|P5|NOT COMPLETED|Washout Second Intervention||0
287648|NCT01928381|689465|P4|NOT COMPLETED|Washout Second Intervention||0
287649|NCT01928381|689466|P3|NOT COMPLETED|Washout Second Intervention||0
287650|NCT01928381|689467|P2|NOT COMPLETED|Washout Second Intervention||0
287651|NCT01928381|689468|P1|NOT COMPLETED|Washout Second Intervention||0
287652|NCT01928381|689462|P7|COMPLETED|Washout Second Intervention||5
287653|NCT01928381|689463|P6|COMPLETED|Washout Second Intervention||5
287654|NCT01928381|689464|P5|COMPLETED|Washout Second Intervention||3
287655|NCT01928381|689465|P4|COMPLETED|Washout Second Intervention||4
287656|NCT01928381|689466|P3|COMPLETED|Washout Second Intervention||4
287657|NCT01928381|689467|P2|COMPLETED|Washout Second Intervention||5
287658|NCT01928381|689468|P1|COMPLETED|Washout Second Intervention||0
287659|NCT01928381|689462|P7|STARTED|Washout Second Intervention||5
287660|NCT01928381|689463|P6|STARTED|Washout Second Intervention||5
287661|NCT01928381|689464|P5|STARTED|Washout Second Intervention||3
287662|NCT01928381|689465|P4|STARTED|Washout Second Intervention||4
287663|NCT01928381|689466|P3|STARTED|Washout Second Intervention||4
287664|NCT01928381|689467|P2|STARTED|Washout Second Intervention||5
287665|NCT01928381|689468|P1|STARTED|Washout Second Intervention||0
287666|NCT01928381|689462|P7|NOT COMPLETED|Part 2 - Second Intervention||0
287667|NCT01928381|689463|P6|NOT COMPLETED|Part 2 - Second Intervention||0
287668|NCT01928381|689464|P5|NOT COMPLETED|Part 2 - Second Intervention||0
287669|NCT01928381|689465|P4|NOT COMPLETED|Part 2 - Second Intervention||1
287670|NCT01928381|689466|P3|NOT COMPLETED|Part 2 - Second Intervention||0
287671|NCT01928381|689467|P2|NOT COMPLETED|Part 2 - Second Intervention||1
287672|NCT01928381|689468|P1|NOT COMPLETED|Part 2 - Second Intervention||0
287673|NCT01928381|689462|P7|COMPLETED|Part 2 - Second Intervention||5
287674|NCT01928381|689463|P6|COMPLETED|Part 2 - Second Intervention||5
287675|NCT01928381|689464|P5|COMPLETED|Part 2 - Second Intervention||3
287676|NCT01928381|689465|P4|COMPLETED|Part 2 - Second Intervention||4
287677|NCT01928381|689466|P3|COMPLETED|Part 2 - Second Intervention||4
287678|NCT01928381|689467|P2|COMPLETED|Part 2 - Second Intervention||5
287679|NCT01928381|689468|P1|COMPLETED|Part 2 - Second Intervention||0
287680|NCT01928381|689462|P7|STARTED|Part 2 - Second Intervention||5
287681|NCT01928381|689463|P6|STARTED|Part 2 - Second Intervention||5
287682|NCT01928381|689464|P5|STARTED|Part 2 - Second Intervention||3
287683|NCT01928381|689465|P4|STARTED|Part 2 - Second Intervention||5
287684|NCT01928381|689466|P3|STARTED|Part 2 - Second Intervention||4
287685|NCT01928381|689467|P2|STARTED|Part 2 - Second Intervention||6
287686|NCT01928381|689468|P1|STARTED|Part 2 - Second Intervention||0
287687|NCT01928381|689462|P7|NOT COMPLETED|Washout First Intervention||0
287688|NCT01928381|689463|P6|NOT COMPLETED|Washout First Intervention||0
287689|NCT01928381|689464|P5|NOT COMPLETED|Washout First Intervention||1
287690|NCT01928381|689465|P4|NOT COMPLETED|Washout First Intervention||0
287691|NCT01928381|689466|P3|NOT COMPLETED|Washout First Intervention||0
287692|NCT01928381|689467|P2|NOT COMPLETED|Washout First Intervention||0
287693|NCT01928381|689468|P1|NOT COMPLETED|Washout First Intervention||0
287694|NCT01928381|689462|P7|COMPLETED|Washout First Intervention||5
287695|NCT01928381|689463|P6|COMPLETED|Washout First Intervention||5
287696|NCT01928381|689464|P5|COMPLETED|Washout First Intervention||3
287697|NCT01928381|689465|P4|COMPLETED|Washout First Intervention||5
287698|NCT01928381|689466|P3|COMPLETED|Washout First Intervention||4
287699|NCT01928381|689467|P2|COMPLETED|Washout First Intervention||6
287700|NCT01928381|689468|P1|COMPLETED|Washout First Intervention||0
287701|NCT01928381|689462|P7|STARTED|Washout First Intervention||5
287702|NCT01928381|689463|P6|STARTED|Washout First Intervention||5
287703|NCT01928381|689464|P5|STARTED|Washout First Intervention||4
287704|NCT01928381|689465|P4|STARTED|Washout First Intervention||5
287705|NCT01928381|689466|P3|STARTED|Washout First Intervention||4
287706|NCT01928381|689467|P2|STARTED|Washout First Intervention||6
287707|NCT01928381|689468|P1|STARTED|Washout First Intervention||0
287708|NCT01928381|689462|P7|NOT COMPLETED|Part 2 - First Intervention||1
287709|NCT01928381|689463|P6|NOT COMPLETED|Part 2 - First Intervention||1
287710|NCT01928381|689464|P5|NOT COMPLETED|Part 2 - First Intervention||0
287711|NCT01928381|689465|P4|NOT COMPLETED|Part 2 - First Intervention||1
287712|NCT01928381|689466|P3|NOT COMPLETED|Part 2 - First Intervention||2
287713|NCT01928381|689467|P2|NOT COMPLETED|Part 2 - First Intervention||0
287714|NCT01928381|689468|P1|NOT COMPLETED|Part 2 - First Intervention||0
287715|NCT01928381|689462|P7|COMPLETED|Part 2 - First Intervention||5
287716|NCT01928381|689463|P6|COMPLETED|Part 2 - First Intervention||5
287717|NCT01928381|689464|P5|COMPLETED|Part 2 - First Intervention||4
287718|NCT01928381|689465|P4|COMPLETED|Part 2 - First Intervention||5
287719|NCT01928381|689466|P3|COMPLETED|Part 2 - First Intervention||4
287720|NCT01928381|689467|P2|COMPLETED|Part 2 - First Intervention||6
287721|NCT01928381|689468|P1|COMPLETED|Part 2 - First Intervention||0
287722|NCT01928381|689462|P7|STARTED|Part 2 - First Intervention||6
287723|NCT01928381|689463|P6|STARTED|Part 2 - First Intervention||6
287724|NCT01928381|689464|P5|STARTED|Part 2 - First Intervention||4
287725|NCT01928381|689465|P4|STARTED|Part 2 - First Intervention||6
287726|NCT01928381|689466|P3|STARTED|Part 2 - First Intervention||6
287727|NCT01928381|689467|P2|STARTED|Part 2 - First Intervention||6
287728|NCT01928381|689468|P1|STARTED|Part 2 - First Intervention||0
287729|NCT01928381|689462|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
287730|NCT01928381|689463|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
287731|NCT01928381|689464|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
287732|NCT01928381|689465|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
287733|NCT01928381|689466|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
287734|NCT01928381|689467|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
287735|NCT01928381|689468|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
287736|NCT01928381|689462|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
287737|NCT01928381|689463|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
287738|NCT01928381|689464|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
287739|NCT01928381|689465|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
287740|NCT01928381|689466|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
287741|NCT01928381|689467|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
287742|NCT01928381|689468|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
287743|NCT01928381|689462|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
287744|NCT01928381|689463|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
287745|NCT01928381|689464|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
287746|NCT01928381|689465|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
287747|NCT01928381|689466|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
287748|NCT01928381|689467|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
287749|NCT01928381|689468|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
287750|NCT01928381|689462|P7|NOT COMPLETED|Part 1 - Pain Training||0
287751|NCT01928381|689463|P6|NOT COMPLETED|Part 1 - Pain Training||0
287752|NCT01928381|689464|P5|NOT COMPLETED|Part 1 - Pain Training||0
287753|NCT01928381|689465|P4|NOT COMPLETED|Part 1 - Pain Training||0
287754|NCT01928381|689466|P3|NOT COMPLETED|Part 1 - Pain Training||0
287755|NCT01928381|689467|P2|NOT COMPLETED|Part 1 - Pain Training||0
287756|NCT01928381|689468|P1|NOT COMPLETED|Part 1 - Pain Training||35
287757|NCT01928381|689462|P7|COMPLETED|Part 1 - Pain Training||0
287758|NCT01928381|689463|P6|COMPLETED|Part 1 - Pain Training||0
287759|NCT01928381|689464|P5|COMPLETED|Part 1 - Pain Training||0
287760|NCT01928381|689465|P4|COMPLETED|Part 1 - Pain Training||0
287761|NCT01928381|689466|P3|COMPLETED|Part 1 - Pain Training||0
287762|NCT01928381|689467|P2|COMPLETED|Part 1 - Pain Training||0
287763|NCT01928381|689468|P1|COMPLETED|Part 1 - Pain Training||48
287764|NCT01928381|689462|P7|STARTED|Part 1 - Pain Training||0
287765|NCT01928381|689463|P6|STARTED|Part 1 - Pain Training||0
287766|NCT01928381|689464|P5|STARTED|Part 1 - Pain Training||0
287767|NCT01928381|689465|P4|STARTED|Part 1 - Pain Training||0
287768|NCT01928381|689466|P3|STARTED|Part 1 - Pain Training||0
287769|NCT01928381|689467|P2|STARTED|Part 1 - Pain Training||0
287770|NCT01928381|689468|P1|STARTED|Part 1 - Pain Training||83
287771|NCT01928381|689462|P7|NOT COMPLETED|Screening for Pain Training||0
287772|NCT01928381|689463|P6|NOT COMPLETED|Screening for Pain Training||0
287773|NCT01928381|689464|P5|NOT COMPLETED|Screening for Pain Training||0
287774|NCT01928381|689465|P4|NOT COMPLETED|Screening for Pain Training||0
287775|NCT01928381|689466|P3|NOT COMPLETED|Screening for Pain Training||0
287776|NCT01928381|689467|P2|NOT COMPLETED|Screening for Pain Training||0
287777|NCT01928381|689468|P1|NOT COMPLETED|Screening for Pain Training||60
287778|NCT01928381|689462|P7|COMPLETED|Screening for Pain Training||0
287779|NCT01928381|689463|P6|COMPLETED|Screening for Pain Training||0
287780|NCT01928381|689464|P5|COMPLETED|Screening for Pain Training||0
287781|NCT01928381|689465|P4|COMPLETED|Screening for Pain Training||0
287782|NCT01928381|689466|P3|COMPLETED|Screening for Pain Training||0
287783|NCT01928381|689467|P2|COMPLETED|Screening for Pain Training||0
287784|NCT01928381|689468|P1|COMPLETED|Screening for Pain Training||83
287785|NCT01928381|689462|P7|STARTED|Screening for Pain Training||0
287786|NCT01928381|689463|P6|STARTED|Screening for Pain Training||0
287787|NCT01928381|689464|P5|STARTED|Screening for Pain Training||0
287788|NCT01928381|689465|P4|STARTED|Screening for Pain Training||0
287789|NCT01928381|689466|P3|STARTED|Screening for Pain Training||0
287790|NCT01928381|689467|P2|STARTED|Screening for Pain Training||0
287791|NCT01928381|689468|P1|STARTED|Screening for Pain Training||143
287792|NCT01928030|689481|P3|NOT COMPLETED|Overall Study||0
287793|NCT01928030|689482|P2|NOT COMPLETED|Overall Study||0
287794|NCT01928030|689483|P1|NOT COMPLETED|Overall Study||0
287795|NCT01928030|689481|P3|COMPLETED|Overall Study||0
287796|NCT01928030|689482|P2|COMPLETED|Overall Study||0
287797|NCT01928030|689483|P1|COMPLETED|Overall Study||3
287798|NCT01928030|689481|P3|STARTED|Overall Study||0
287799|NCT01928030|689482|P2|STARTED|Overall Study||0
287800|NCT01928030|689483|P1|STARTED|Overall Study||3
287801|NCT01927887|689490|P1|NOT COMPLETED|Overall Study||0
287802|NCT01927887|689490|P1|COMPLETED|Overall Study||12
287803|NCT01927887|689490|P1|STARTED|Overall Study||12
287804|NCT01927757|689495|P1|NOT COMPLETED|Overall Study||23
287805|NCT01927757|689495|P1|COMPLETED|Overall Study||67
287806|NCT01927757|689495|P1|Received Etanercept|Overall Study||88
287807|NCT01927757|689495|P1|STARTED|Overall Study||90
287808|NCT01927575|689513|P1|NOT COMPLETED|Overall Study||0
287809|NCT01927575|689513|P1|COMPLETED|Overall Study||1
287810|NCT01927575|689513|P1|STARTED|Overall Study||1
287811|NCT01927419|689523|P2|NOT COMPLETED|Overall Study||28
287812|NCT01927419|689524|P1|NOT COMPLETED|Overall Study||70
287813|NCT01927419|689523|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
287814|NCT01927419|689524|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
287815|NCT01927419|689523|P2|Received Treatment|Overall Study||46
287816|NCT01927419|689524|P1|Received Treatment|Overall Study||94
287817|NCT01927419|689523|P2|STARTED|Overall Study||47
287818|NCT01927419|689524|P1|STARTED|Overall Study||95
287819|NCT01927055|689543|P3|NOT COMPLETED|Double-Blind||13
287820|NCT01927055|689544|P2|NOT COMPLETED|Double-Blind||11
287821|NCT01927055|689545|P1|NOT COMPLETED|Double-Blind||0
287822|NCT01927055|689543|P3|COMPLETED|Double-Blind||10
287823|NCT01927055|689544|P2|COMPLETED|Double-Blind||11
287824|NCT01927055|689545|P1|COMPLETED|Double-Blind||0
287825|NCT01927055|689543|P3|STARTED|Double-Blind||23
287826|NCT01927055|689544|P2|STARTED|Double-Blind||22
287827|NCT01927055|689545|P1|STARTED|Double-Blind||0
287828|NCT01927055|689543|P3|NOT COMPLETED|Open-label||0
287829|NCT01927055|689544|P2|NOT COMPLETED|Open-label||0
287830|NCT01927055|689545|P1|NOT COMPLETED|Open-label||16
287831|NCT01927055|689543|P3|COMPLETED|Open-label||0
287832|NCT01927055|689544|P2|COMPLETED|Open-label||0
287833|NCT01927055|689545|P1|COMPLETED|Open-label||45
287834|NCT01927055|689543|P3|STARTED|Open-label||0
287835|NCT01927055|689544|P2|STARTED|Open-label||0
287836|NCT01927055|689545|P1|STARTED|Open-label||61
287837|NCT01926977|689554|P2|NOT COMPLETED|Overall Study||0
287838|NCT01926977|689555|P1|NOT COMPLETED|Overall Study||0
287839|NCT01926977|689554|P2|COMPLETED|Overall Study||53
287840|NCT01926977|689555|P1|COMPLETED|Overall Study||47
287841|NCT01926977|689554|P2|STARTED|Overall Study||53
287842|NCT01926977|689555|P1|STARTED|Overall Study||47
287843|NCT01926782|689569|P6|NOT COMPLETED|Overall Study||41
287844|NCT01926782|689570|P5|NOT COMPLETED|Overall Study||8
287845|NCT01926782|689571|P4|NOT COMPLETED|Overall Study||20
287846|NCT01926782|689572|P3|NOT COMPLETED|Overall Study||40
287847|NCT01926782|689573|P2|NOT COMPLETED|Overall Study||13
287848|NCT01926782|689574|P1|NOT COMPLETED|Overall Study||28
287849|NCT01926782|689569|P6|COMPLETED|Overall Study||105
287850|NCT01926782|689570|P5|COMPLETED|Overall Study||29
287851|NCT01926782|689571|P4|COMPLETED|Overall Study||53
287852|NCT01926782|689572|P3|COMPLETED|Overall Study||272
287853|NCT01926782|689573|P2|COMPLETED|Overall Study||65
287854|NCT01926782|689574|P1|COMPLETED|Overall Study||129
287855|NCT01926782|689569|P6|Completed 24 Weeks Treatment Period|Overall Study||120
287856|NCT01926782|689570|P5|Completed 24 Weeks Treatment Period|Overall Study||31
287857|NCT01926782|689571|P4|Completed 24 Weeks Treatment Period|Overall Study||58
287858|NCT01926782|689572|P3|Completed 24 Weeks Treatment Period|Overall Study||285
287859|NCT01926782|689573|P2|Completed 24 Weeks Treatment Period|Overall Study||68
287860|NCT01926782|689574|P1|Completed 24 Weeks Treatment Period|Overall Study||137
287861|NCT01926782|689569|P6|Treated|Overall Study||146
287862|NCT01926782|689570|P5|Treated|Overall Study||37
287863|NCT01926782|689571|P4|Treated|Overall Study||72
287864|NCT01926782|689572|P3|Treated|Overall Study||312
287865|NCT01926782|689573|P2|Treated|Overall Study||78
287866|NCT01926782|689574|P1|Treated|Overall Study||157
287867|NCT01926782|689569|P6|STARTED|Overall Study||146
287868|NCT01926782|689570|P5|STARTED|Overall Study||37
287869|NCT01926782|689571|P4|STARTED|Overall Study||73
287870|NCT01926782|689572|P3|STARTED|Overall Study||312
287871|NCT01926782|689573|P2|STARTED|Overall Study||78
287872|NCT01926782|689574|P1|STARTED|Overall Study||157
287873|NCT01926626|689723|P1|NOT COMPLETED|Overall Study||22
287874|NCT01926626|689723|P1|COMPLETED|Overall Study||16
287875|NCT01926626|689723|P1|Received Moclobemide|Overall Study||37
287876|NCT01926626|689723|P1|STARTED|Overall Study||38
287877|NCT01926119|689733|P1|NOT COMPLETED|Overall Study||1
287878|NCT01926119|689733|P1|COMPLETED|Overall Study||3
287879|NCT01926119|689733|P1|STARTED|Overall Study||4
287880|NCT01926015|689745|P2|NOT COMPLETED|Overall Study||1
287881|NCT01926015|689746|P1|NOT COMPLETED|Overall Study||2
287882|NCT01926015|689745|P2|COMPLETED|Overall Study||95
287883|NCT01926015|689746|P1|COMPLETED|Overall Study||94
287884|NCT01926015|689745|P2|Received >=1 Vaccination|Overall Study||96
287885|NCT01926015|689746|P1|Received >=1 Vaccination|Overall Study||94
287886|NCT01926015|689745|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
287887|NCT01926015|689746|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
287888|NCT01925781|689778|P2|NOT COMPLETED|Overall Study||4
287889|NCT01925781|689779|P1|NOT COMPLETED|Overall Study||2
287890|NCT01925781|689778|P2|COMPLETED|Overall Study||1
287891|NCT01925781|689779|P1|COMPLETED|Overall Study||3
287892|NCT01925781|689778|P2|STARTED|Overall Study||5
287893|NCT01925781|689779|P1|STARTED|Overall Study||5
287894|NCT01925768|689789|P2|NOT COMPLETED|Overall Study||23
287895|NCT01925768|689790|P1|NOT COMPLETED|Overall Study||11
287896|NCT01925768|689789|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
287897|NCT01925768|689790|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
287898|NCT01925768|689789|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
287899|NCT01925768|689790|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
287900|NCT01925768|689789|P2|Completed Week 16|Overall Study||91
287901|NCT01925768|689790|P1|Completed Week 16|Overall Study||101
287902|NCT01925768|689789|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
287903|NCT01925768|689790|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
287904|NCT01925768|689789|P2|Received Treatment|Overall Study||109
287905|NCT01925768|689790|P1|Received Treatment|Overall Study||109
287906|NCT01925768|689789|P2|STARTED|Overall Study||110
287907|NCT01925768|689790|P1|STARTED|Overall Study||109
287908|NCT01925703|689798|P1|NOT COMPLETED|Overall Study||4
287909|NCT01925703|689798|P1|COMPLETED|Overall Study||9
287910|NCT01925703|689798|P1|Follow-up Completed|Overall Study||9
287911|NCT01925703|689798|P1|Full Iron Repletion Achieved|Overall Study||11
287912|NCT01925703|689798|P1|Dosing Regimen Completed|Overall Study||12
287913|NCT01925703|689798|P1|STARTED|Overall Study||13
287914|NCT01925469|689806|P2|NOT COMPLETED|Overall Study||0
287915|NCT01925469|689807|P1|NOT COMPLETED|Overall Study||1
287916|NCT01925469|689806|P2|COMPLETED|Overall Study||15
287917|NCT01925469|689807|P1|COMPLETED|Overall Study||14
287918|NCT01925469|689806|P2|STARTED|Overall Study||15
287919|NCT01925469|689807|P1|STARTED|Overall Study||15
287920|NCT01925417|689817|P1|NOT COMPLETED|Overall Study||3
287921|NCT01925417|689817|P1|COMPLETED|Overall Study||31
287922|NCT01925417|689817|P1|STARTED|Overall Study||34
287923|NCT01925274|689827|P3|NOT COMPLETED|Overall Study||6
287924|NCT01925274|689828|P2|NOT COMPLETED|Overall Study||6
287925|NCT01925274|689829|P1|NOT COMPLETED|Overall Study||7
287926|NCT01925274|689827|P3|COMPLETED|Overall Study||0
287927|NCT01925274|689828|P2|COMPLETED|Overall Study||0
287928|NCT01925274|689829|P1|COMPLETED|Overall Study||0
287929|NCT01925274|689827|P3|STARTED|Overall Study||6
287930|NCT01925274|689828|P2|STARTED|Overall Study||6
287931|NCT01925274|689829|P1|STARTED|Overall Study||7
287932|NCT01925209|689910|P4|NOT COMPLETED|Follow-up||4
287933|NCT01925209|689911|P3|NOT COMPLETED|Follow-up||1
287934|NCT01925209|689912|P2|NOT COMPLETED|Follow-up||6
287935|NCT01925209|689913|P1|NOT COMPLETED|Follow-up||1
287936|NCT01925209|689910|P4|COMPLETED|Follow-up||54
287937|NCT01925209|689911|P3|COMPLETED|Follow-up||55
287938|NCT01925209|689912|P2|COMPLETED|Follow-up||55
287939|NCT01925209|689913|P1|COMPLETED|Follow-up||56
287940|NCT01925209|689910|P4|STARTED|Follow-up||58
287941|NCT01925209|689911|P3|STARTED|Follow-up||56
287942|NCT01925209|689912|P2|STARTED|Follow-up||61
287943|NCT01925209|689913|P1|STARTED|Follow-up||57
287944|NCT01925209|689910|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
287945|NCT01925209|689911|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
287946|NCT01925209|689912|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
287947|NCT01925209|689913|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
287948|NCT01925209|689910|P4|COMPLETED|Maintenance Treatment Epoch||48
287949|NCT01925209|689911|P3|COMPLETED|Maintenance Treatment Epoch||50
287950|NCT01925209|689912|P2|COMPLETED|Maintenance Treatment Epoch||45
287951|NCT01925209|689913|P1|COMPLETED|Maintenance Treatment Epoch||49
287952|NCT01925209|689910|P4|STARTED|Maintenance Treatment Epoch||50
287953|NCT01925209|689911|P3|STARTED|Maintenance Treatment Epoch||52
287954|NCT01925209|689912|P2|STARTED|Maintenance Treatment Epoch||46
287955|NCT01925209|689913|P1|STARTED|Maintenance Treatment Epoch||49
287956|NCT01925209|689910|P4|NOT COMPLETED|Treatment Epoch||5
287957|NCT01925209|689911|P3|NOT COMPLETED|Treatment Epoch||7
287958|NCT01925209|689912|P2|NOT COMPLETED|Treatment Epoch||8
287959|NCT01925209|689913|P1|NOT COMPLETED|Treatment Epoch||9
287960|NCT01925209|689910|P4|COMPLETED|Treatment Epoch||57
287961|NCT01925209|689911|P3|COMPLETED|Treatment Epoch||56
287962|NCT01925209|689912|P2|COMPLETED|Treatment Epoch||55
287963|NCT01925209|689913|P1|COMPLETED|Treatment Epoch||54
287964|NCT01925209|689910|P4|Full Analysis Set|Treatment Epoch||62
287965|NCT01925209|689911|P3|Full Analysis Set|Treatment Epoch||63
287966|NCT01925209|689912|P2|Full Analysis Set|Treatment Epoch||63
287967|NCT01925209|689913|P1|Full Analysis Set|Treatment Epoch||63
287968|NCT01925209|689910|P4|STARTED|Treatment Epoch||62
287969|NCT01925209|689911|P3|STARTED|Treatment Epoch||63
287970|NCT01925209|689912|P2|STARTED|Treatment Epoch||63
287971|NCT01925209|689913|P1|STARTED|Treatment Epoch||63
287972|NCT01925183|689945|P2|NOT COMPLETED|Overall Study||0
287973|NCT01925183|689946|P1|NOT COMPLETED|Overall Study||1
287974|NCT01925183|689945|P2|COMPLETED|Overall Study||3
287975|NCT01925183|689946|P1|COMPLETED|Overall Study||2
287976|NCT01925183|689945|P2|STARTED|Overall Study||3
287977|NCT01925183|689946|P1|STARTED|Overall Study||3
287978|NCT01925170|689954|P1|NOT COMPLETED|Overall Study||53
287979|NCT01925170|689954|P1|COMPLETED|Overall Study||1585
287980|NCT01925170|689954|P1|STARTED|Overall Study||1638
287981|NCT01925144|689972|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
287982|NCT01925144|689972|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
287983|NCT01925144|689972|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
287984|NCT01925144|689972|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
287985|NCT01925144|689972|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
287986|NCT01925144|689972|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
287987|NCT01925144|689972|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
287988|NCT01925144|689972|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
287989|NCT01925144|689972|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
287990|NCT01924975|689985|P2|NOT COMPLETED|Overall Study||0
287991|NCT01924975|689986|P1|NOT COMPLETED|Overall Study||0
287992|NCT01924975|689985|P2|COMPLETED|Overall Study||51
287993|NCT01924975|689986|P1|COMPLETED|Overall Study||51
287994|NCT01924975|689985|P2|STARTED|Overall Study||51
287995|NCT01924975|689986|P1|STARTED|Overall Study||51
287996|NCT01924949|689992|P1|NOT COMPLETED|Overall Study||0
287997|NCT01924949|689992|P1|COMPLETED|Overall Study||5
287998|NCT01924949|689992|P1|STARTED|Overall Study||5
287999|NCT01924871|690003|P2|NOT COMPLETED|Overall Study||2
288000|NCT01924871|690004|P1|NOT COMPLETED|Overall Study||6
288001|NCT01924871|690003|P2|COMPLETED|Overall Study||29
288002|NCT01924871|690004|P1|COMPLETED|Overall Study||25
288003|NCT01924871|690003|P2|STARTED|Overall Study||31
288004|NCT01924871|690004|P1|STARTED|Overall Study||31
288005|NCT01924767|690015|P5|NOT COMPLETED|Overall Study||0
288006|NCT01924767|690016|P4|NOT COMPLETED|Overall Study||0
288007|NCT01924767|690017|P3|NOT COMPLETED|Overall Study||1
288008|NCT01924767|690018|P2|NOT COMPLETED|Overall Study||0
288009|NCT01924767|690019|P1|NOT COMPLETED|Overall Study||1
288010|NCT01924767|690015|P5|COMPLETED|Overall Study||9
288011|NCT01924767|690016|P4|COMPLETED|Overall Study||9
288012|NCT01924767|690017|P3|COMPLETED|Overall Study||8
288013|NCT01924767|690018|P2|COMPLETED|Overall Study||9
288014|NCT01924767|690019|P1|COMPLETED|Overall Study||11
288015|NCT01924767|690015|P5|STARTED|Overall Study||9
288016|NCT01924767|690016|P4|STARTED|Overall Study||9
288017|NCT01924767|690017|P3|STARTED|Overall Study||9
288018|NCT01924767|690018|P2|STARTED|Overall Study||9
288019|NCT01924767|690019|P1|STARTED|Overall Study||12
288020|NCT01924559|690119|P1|NOT COMPLETED|Overall Study||0
288021|NCT01924559|690119|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
288022|NCT01924559|690119|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
288023|NCT01924390|690135|P2|NOT COMPLETED|Overall Study||1
288024|NCT01924390|690136|P1|NOT COMPLETED|Overall Study||1
288025|NCT01924390|690135|P2|COMPLETED|Overall Study||21
288026|NCT01924390|690136|P1|COMPLETED|Overall Study||21
288027|NCT01924390|690135|P2|STARTED|Overall Study||22
288028|NCT01924390|690136|P1|STARTED|Overall Study||22
288029|NCT01924299|690148|P2|NOT COMPLETED|Period 2||1
288030|NCT01924299|690149|P1|NOT COMPLETED|Period 2||1
288031|NCT01924299|690148|P2|COMPLETED|Period 2||17
288032|NCT01924299|690149|P1|COMPLETED|Period 2||17
288033|NCT01924299|690148|P2|Received Baricitinib|Period 2||17
288034|NCT01924299|690149|P1|Received Baricitinib|Period 2||17
288035|NCT01924299|690148|P2|Received at Least 1 Dose of Study Drug|Period 2||18
288036|NCT01924299|690149|P1|Received at Least 1 Dose of Study Drug|Period 2||18
288037|NCT01924299|690148|P2|STARTED|Period 2||18
288038|NCT01924299|690149|P1|STARTED|Period 2||18
288039|NCT01924299|690148|P2|NOT COMPLETED|Period 1||0
288040|NCT01924299|690149|P1|NOT COMPLETED|Period 1||0
288041|NCT01924299|690148|P2|COMPLETED|Period 1||18
288042|NCT01924299|690149|P1|COMPLETED|Period 1||18
288043|NCT01924299|690148|P2|Received Baricitinib|Period 1||18
288044|NCT01924299|690149|P1|Received Baricitinib|Period 1||18
288045|NCT01924299|690148|P2|STARTED|Period 1||18
288046|NCT01924299|690149|P1|STARTED|Period 1||18
288047|NCT01924182|690171|P2|NOT COMPLETED|Overall Study||0
288048|NCT01924182|690172|P1|NOT COMPLETED|Overall Study||1
288049|NCT01924182|690171|P2|COMPLETED|Overall Study||0
288050|NCT01924182|690172|P1|COMPLETED|Overall Study||2
288051|NCT01924182|690171|P2|STARTED|Overall Study||0
288052|NCT01924182|690172|P1|STARTED|Overall Study||3
288053|NCT01923896|690180|P2|NOT COMPLETED|Overall Study||0
288054|NCT01923896|690181|P1|NOT COMPLETED|Overall Study||1
288055|NCT01923896|690180|P2|COMPLETED|Overall Study||8
288056|NCT01923896|690181|P1|COMPLETED|Overall Study||7
288057|NCT01923896|690180|P2|STARTED|Overall Study||8
288058|NCT01923896|690181|P1|STARTED|Overall Study||8
288059|NCT01923805|690195|P2|NOT COMPLETED|Overall Study||5
288060|NCT01923805|690196|P1|NOT COMPLETED|Overall Study||3
288061|NCT01923805|690195|P2|COMPLETED|Overall Study||0
288062|NCT01923805|690196|P1|COMPLETED|Overall Study||0
288063|NCT01923805|690195|P2|STARTED|Overall Study|early termination|5
288064|NCT01923805|690196|P1|STARTED|Overall Study|early termination|3
288065|NCT01923480|690205|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
288066|NCT01923480|690206|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
288067|NCT01923480|690207|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
288068|NCT01923480|690208|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
288069|NCT01923480|690209|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
288070|NCT01923480|690210|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
288071|NCT01923480|690205|P6|COMPLETED|Period 2 (Hours 1-7)||2
288072|NCT01923480|690206|P5|COMPLETED|Period 2 (Hours 1-7)||2
288073|NCT01923480|690207|P4|COMPLETED|Period 2 (Hours 1-7)||2
288074|NCT01923480|690208|P3|COMPLETED|Period 2 (Hours 1-7)||2
288075|NCT01923480|690209|P2|COMPLETED|Period 2 (Hours 1-7)||1
288076|NCT01923480|690210|P1|COMPLETED|Period 2 (Hours 1-7)||1
288077|NCT01923480|690205|P6|STARTED|Period 2 (Hours 1-7)||2
288078|NCT01923480|690206|P5|STARTED|Period 2 (Hours 1-7)||2
288079|NCT01923480|690207|P4|STARTED|Period 2 (Hours 1-7)||2
288080|NCT01923480|690208|P3|STARTED|Period 2 (Hours 1-7)||2
288081|NCT01923480|690209|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
288082|NCT01923480|690210|P1|STARTED|Period 2 (Hours 1-7)||1
288083|NCT01923480|690205|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
288084|NCT01923480|690206|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
288085|NCT01923480|690207|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
288086|NCT01923480|690208|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
288087|NCT01923480|690209|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
288088|NCT01923480|690210|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
288089|NCT01923480|690205|P6|COMPLETED|Period 1 (Hours 1-7)||2
288090|NCT01923480|690206|P5|COMPLETED|Period 1 (Hours 1-7)||2
288091|NCT01923480|690207|P4|COMPLETED|Period 1 (Hours 1-7)||2
288092|NCT01923480|690208|P3|COMPLETED|Period 1 (Hours 1-7)||2
288093|NCT01923480|690209|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
288094|NCT01923480|690210|P1|COMPLETED|Period 1 (Hours 1-7)||1
288095|NCT01923480|690205|P6|STARTED|Period 1 (Hours 1-7)||2
288096|NCT01923480|690206|P5|STARTED|Period 1 (Hours 1-7)||2
288097|NCT01923480|690207|P4|STARTED|Period 1 (Hours 1-7)||2
288098|NCT01923480|690208|P3|STARTED|Period 1 (Hours 1-7)||2
288099|NCT01923480|690209|P2|STARTED|Period 1 (Hours 1-7)||2
288100|NCT01923480|690210|P1|STARTED|Period 1 (Hours 1-7)||1
288101|NCT01923467|690365|P1|NOT COMPLETED|Overall Study||541
288102|NCT01923467|690365|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
288103|NCT01923467|690365|P1|Baseline Completed, Enrolled|Overall Study||288
288104|NCT01923467|690365|P1|STARTED|Overall Study|Offered stop smoking program|767
288105|NCT01923389|690371|P2|NOT COMPLETED|Overall Study||0
288106|NCT01923389|690372|P1|NOT COMPLETED|Overall Study||1
288107|NCT01923389|690371|P2|COMPLETED|Overall Study||2
288108|NCT01923389|690372|P1|COMPLETED|Overall Study||1
288109|NCT01923389|690371|P2|STARTED|Overall Study||2
288110|NCT01923389|690372|P1|STARTED|Overall Study||2
288111|NCT01922986|690396|P2|NOT COMPLETED|Overall Study||0
288112|NCT01922986|690397|P1|NOT COMPLETED|Overall Study||0
288113|NCT01922986|690396|P2|COMPLETED|Overall Study||2
288114|NCT01922986|690397|P1|COMPLETED|Overall Study||2
288115|NCT01922986|690396|P2|STARTED|Overall Study||2
288116|NCT01922986|690397|P1|STARTED|Overall Study||2
288117|NCT01922739|690409|P1|NOT COMPLETED|Open-label Treatment Period||34
288118|NCT01922739|690409|P1|COMPLETED|Open-label Treatment Period||136
288119|NCT01922739|690409|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
288120|NCT01922739|690409|P1|STARTED|Open-label Treatment Period||170
288121|NCT01922739|690409|P1|NOT COMPLETED|Titration/Adjustment Period||12
288122|NCT01922739|690409|P1|COMPLETED|Titration/Adjustment Period||170
288123|NCT01922739|690409|P1|Safety Analysis Set|Titration/Adjustment Period||182
288124|NCT01922739|690409|P1|STARTED|Titration/Adjustment Period||182
288125|NCT01921296|690434|P1|NOT COMPLETED|Overall Study||0
288126|NCT01921296|690434|P1|COMPLETED|Overall Study||2
288127|NCT01921296|690434|P1|STARTED|Overall Study||2
288128|NCT01922349|690446|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
288129|NCT01922349|690447|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
288130|NCT01922349|690448|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
288131|NCT01922349|690449|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
288132|NCT01922349|690446|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
288133|NCT01922349|690447|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
288134|NCT01922349|690448|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
288135|NCT01922349|690449|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
288136|NCT01922349|690446|P4|STARTED|Multiple Rising Dose (MRD) Period||27
288137|NCT01922349|690447|P3|STARTED|Multiple Rising Dose (MRD) Period||18
288138|NCT01922349|690448|P2|STARTED|Multiple Rising Dose (MRD) Period||27
288139|NCT01922349|690449|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
288140|NCT01922349|690446|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
288141|NCT01922349|690447|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
288142|NCT01922349|690448|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
288143|NCT01922349|690449|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
288144|NCT01922349|690446|P4|COMPLETED|Single Rising Dose (SRD) Period||27
288145|NCT01922349|690447|P3|COMPLETED|Single Rising Dose (SRD) Period||18
288146|NCT01922349|690448|P2|COMPLETED|Single Rising Dose (SRD) Period||27
288147|NCT01922349|690449|P1|COMPLETED|Single Rising Dose (SRD) Period||25
288148|NCT01922349|690446|P4|STARTED|Single Rising Dose (SRD) Period||27
288149|NCT01922349|690447|P3|STARTED|Single Rising Dose (SRD) Period||18
288150|NCT01922349|690448|P2|STARTED|Single Rising Dose (SRD) Period||27
288151|NCT01922349|690449|P1|STARTED|Single Rising Dose (SRD) Period||25
288152|NCT01922271|690556|P2|NOT COMPLETED|PERIOD 2||0
288153|NCT01922271|690557|P1|NOT COMPLETED|PERIOD 2||0
288154|NCT01922271|690556|P2|COMPLETED|PERIOD 2||76
288155|NCT01922271|690557|P1|COMPLETED|PERIOD 2||75
288156|NCT01922271|690556|P2|STARTED|PERIOD 2||76
288157|NCT01922271|690557|P1|STARTED|PERIOD 2||75
288158|NCT01922271|690556|P2|NOT COMPLETED|WASHOUT Period||0
288159|NCT01922271|690557|P1|NOT COMPLETED|WASHOUT Period||1
288160|NCT01922271|690556|P2|COMPLETED|WASHOUT Period||76
288161|NCT01922271|690557|P1|COMPLETED|WASHOUT Period||75
288162|NCT01922271|690556|P2|STARTED|WASHOUT Period||76
288163|NCT01922271|690557|P1|STARTED|WASHOUT Period||76
288164|NCT01922271|690556|P2|NOT COMPLETED|PERIOD 1||0
288165|NCT01922271|690557|P1|NOT COMPLETED|PERIOD 1||0
288166|NCT01922271|690556|P2|COMPLETED|PERIOD 1||76
288167|NCT01922271|690557|P1|COMPLETED|PERIOD 1||76
288168|NCT01922271|690556|P2|STARTED|PERIOD 1||76
288169|NCT01922271|690557|P1|STARTED|PERIOD 1||76
288170|NCT01922219|690575|P1|NOT COMPLETED|Overall Study||6
288171|NCT01922219|690575|P1|COMPLETED|Overall Study||32
288172|NCT01922219|690575|P1|STARTED|Overall Study||38
288173|NCT01922115|690581|P2|NOT COMPLETED|Overall Study||7
288174|NCT01922115|690582|P1|NOT COMPLETED|Overall Study||7
288175|NCT01922115|690581|P2|COMPLETED|Overall Study||24
288176|NCT01922115|690582|P1|COMPLETED|Overall Study||21
288177|NCT01922115|690581|P2|STARTED|Overall Study||31
288178|NCT01922115|690582|P1|STARTED|Overall Study||28
288179|NCT01922089|690596|P2|NOT COMPLETED|Overall Study||30
288180|NCT01922089|690597|P1|NOT COMPLETED|Overall Study||39
288181|NCT01922089|690596|P2|COMPLETED|Overall Study||221
288182|NCT01922089|690597|P1|COMPLETED|Overall Study||208
288183|NCT01922089|690596|P2|Safety Set|Overall Study||251
288184|NCT01922089|690597|P1|Safety Set|Overall Study||246
288185|NCT01922089|690596|P2|STARTED|Overall Study||251
288186|NCT01922089|690597|P1|STARTED|Overall Study||247
288187|NCT01921894|690610|P3|NOT COMPLETED|Overall Study||0
288188|NCT01921894|690611|P2|NOT COMPLETED|Overall Study||0
288189|NCT01921894|690612|P1|NOT COMPLETED|Overall Study||0
288190|NCT01921894|690610|P3|COMPLETED|Overall Study||8
288191|NCT01921894|690611|P2|COMPLETED|Overall Study||8
288192|NCT01921894|690612|P1|COMPLETED|Overall Study||8
288193|NCT01921894|690610|P3|STARTED|Overall Study||8
288194|NCT01921894|690611|P2|STARTED|Overall Study||8
288195|NCT01921894|690612|P1|STARTED|Overall Study||8
288196|NCT01921452|690632|P1|NOT COMPLETED|Overall Study||0
288197|NCT01921452|690632|P1|COMPLETED|Overall Study||283
288198|NCT01921452|690632|P1|STARTED|Overall Study||283
288199|NCT01921101|690639|P2|NOT COMPLETED|Overall Study||6
288200|NCT01921101|690640|P1|NOT COMPLETED|Overall Study||16
288201|NCT01921101|690639|P2|COMPLETED|Overall Study||32
288202|NCT01921101|690640|P1|COMPLETED|Overall Study||24
288203|NCT01921101|690639|P2|STARTED|Overall Study||38
288204|NCT01921101|690640|P1|STARTED|Overall Study||40
288205|NCT01920958|690648|P1|NOT COMPLETED|Overall Study||5
288206|NCT01920958|690648|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
288207|NCT01920958|690648|P1|STARTED|Overall Study||233
288208|NCT01920893|690666|P2|NOT COMPLETED|Overall Study||2
288209|NCT01920893|690667|P1|NOT COMPLETED|Overall Study||7
288210|NCT01920893|690666|P2|COMPLETED|Overall Study||28
288211|NCT01920893|690667|P1|COMPLETED|Overall Study||23
288212|NCT01920893|690666|P2|Treated (Safety Population)|Overall Study||30
288213|NCT01920893|690667|P1|Treated (Safety Population)|Overall Study||30
288214|NCT01920893|690666|P2|STARTED|Overall Study||30
288215|NCT01920893|690667|P1|STARTED|Overall Study||30
288216|NCT01920854|690700|P7|NOT COMPLETED|Overall Study||1
288217|NCT01920854|690701|P6|NOT COMPLETED|Overall Study||0
288218|NCT01920854|690702|P5|NOT COMPLETED|Overall Study||1
288219|NCT01920854|690703|P4|NOT COMPLETED|Overall Study||0
288220|NCT01920854|690704|P3|NOT COMPLETED|Overall Study||0
288221|NCT01920854|690705|P2|NOT COMPLETED|Overall Study||0
288222|NCT01920854|690706|P1|NOT COMPLETED|Overall Study||1
288223|NCT01920854|690700|P7|COMPLETED|Overall Study||5
288224|NCT01920854|690701|P6|COMPLETED|Overall Study||6
288225|NCT01920854|690702|P5|COMPLETED|Overall Study||5
288226|NCT01920854|690703|P4|COMPLETED|Overall Study||6
288227|NCT01920854|690704|P3|COMPLETED|Overall Study||6
288228|NCT01920854|690705|P2|COMPLETED|Overall Study||6
288229|NCT01920854|690706|P1|COMPLETED|Overall Study||11
288230|NCT01920854|690700|P7|STARTED|Overall Study||6
288231|NCT01920854|690701|P6|STARTED|Overall Study||6
288232|NCT01920854|690702|P5|STARTED|Overall Study||6
288233|NCT01920854|690703|P4|STARTED|Overall Study||6
288234|NCT01920854|690704|P3|STARTED|Overall Study||6
288235|NCT01920854|690705|P2|STARTED|Overall Study||6
288236|NCT01920854|690706|P1|STARTED|Overall Study||12
288237|NCT01920802|690833|P3|NOT COMPLETED|Overall Study||1
288238|NCT01920802|690834|P2|NOT COMPLETED|Overall Study||2
288239|NCT01920802|690835|P1|NOT COMPLETED|Overall Study||4
288240|NCT01920802|690833|P3|COMPLETED|Overall Study||10
288241|NCT01920802|690834|P2|COMPLETED|Overall Study||7
288242|NCT01920802|690835|P1|COMPLETED|Overall Study||7
288243|NCT01920802|690833|P3|STARTED|Overall Study||11
288244|NCT01920802|690834|P2|STARTED|Overall Study||9
288245|NCT01920802|690835|P1|STARTED|Overall Study||11
288246|NCT01920568|690866|P2|NOT COMPLETED|Overall Study||84
288247|NCT01920568|690867|P1|NOT COMPLETED|Overall Study||151
288248|NCT01920568|690866|P2|COMPLETED|Overall Study||75
288249|NCT01920568|690867|P1|COMPLETED|Overall Study||175
288250|NCT01920568|690866|P2|STARTED|Overall Study||159
288251|NCT01920568|690867|P1|STARTED|Overall Study||326
288252|NCT01920282|690891|P3|NOT COMPLETED|Overall Study||0
288253|NCT01920282|690892|P2|NOT COMPLETED|Overall Study||0
288254|NCT01920282|690893|P1|NOT COMPLETED|Overall Study||0
288255|NCT01920282|690891|P3|COMPLETED|Overall Study||15
288256|NCT01920282|690892|P2|COMPLETED|Overall Study||15
288257|NCT01920282|690893|P1|COMPLETED|Overall Study||15
288258|NCT01920282|690891|P3|STARTED|Overall Study||15
288259|NCT01920282|690892|P2|STARTED|Overall Study||15
288260|NCT01920282|690893|P1|STARTED|Overall Study||15
288261|NCT01920178|690906|P2|NOT COMPLETED|Overall Study||1
288262|NCT01920178|690907|P1|NOT COMPLETED|Overall Study||2
288263|NCT01920178|690906|P2|COMPLETED|Overall Study||1
288264|NCT01920178|690907|P1|COMPLETED|Overall Study||3
288265|NCT01920178|690906|P2|STARTED|Overall Study||2
288266|NCT01920178|690907|P1|STARTED|Overall Study||5
288267|NCT01919996|690917|P1|NOT COMPLETED|Overall Study||0
288268|NCT01919996|690917|P1|COMPLETED|Overall Study||8
288269|NCT01919996|690917|P1|STARTED|Overall Study||8
288270|NCT01919801|690925|P2|NOT COMPLETED|Overall Study||3
288271|NCT01919801|690926|P1|NOT COMPLETED|Overall Study||1
288272|NCT01919801|690925|P2|COMPLETED|Overall Study||57
288273|NCT01919801|690926|P1|COMPLETED|Overall Study||60
288274|NCT01919801|690925|P2|STARTED|Overall Study||60
288275|NCT01919801|690926|P1|STARTED|Overall Study||61
288276|NCT01919723|690952|P2|NOT COMPLETED|Overall Study||2
288277|NCT01919723|690953|P1|NOT COMPLETED|Overall Study||2
288278|NCT01919723|690952|P2|COMPLETED|Overall Study||33
288279|NCT01919723|690953|P1|COMPLETED|Overall Study||33
288280|NCT01919723|690952|P2|STARTED|Overall Study||35
288281|NCT01919723|690953|P1|STARTED|Overall Study||35
288282|NCT01919606|690967|P2|NOT COMPLETED|Overall Study||0
288283|NCT01919606|690968|P1|NOT COMPLETED|Overall Study||0
288284|NCT01919606|690967|P2|COMPLETED|Overall Study||0
288285|NCT01919606|690968|P1|COMPLETED|Overall Study||1
288286|NCT01919606|690967|P2|STARTED|Overall Study||0
288287|NCT01919606|690968|P1|STARTED|Overall Study||1
288288|NCT01919450|690980|P4|NOT COMPLETED|Overall Study||1
288289|NCT01919450|690981|P3|NOT COMPLETED|Overall Study||0
288290|NCT01919450|690982|P2|NOT COMPLETED|Overall Study||0
288291|NCT01919450|690983|P1|NOT COMPLETED|Overall Study||0
288292|NCT01919450|690980|P4|COMPLETED|Overall Study||19
288293|NCT01919450|690981|P3|COMPLETED|Overall Study||20
288294|NCT01919450|690982|P2|COMPLETED|Overall Study||20
288295|NCT01919450|690983|P1|COMPLETED|Overall Study||20
288296|NCT01919450|690980|P4|STARTED|Overall Study||20
288297|NCT01919450|690981|P3|STARTED|Overall Study||20
288298|NCT01919450|690982|P2|STARTED|Overall Study||20
288299|NCT01919450|690983|P1|STARTED|Overall Study||20
288300|NCT01919229|690996|P3|NOT COMPLETED|Overall Study||1
288301|NCT01919229|690997|P2|NOT COMPLETED|Overall Study||0
288302|NCT01919229|690998|P1|NOT COMPLETED|Overall Study||0
288303|NCT01919229|690996|P3|COMPLETED|Overall Study||3
288304|NCT01919229|690997|P2|COMPLETED|Overall Study||6
288305|NCT01919229|690998|P1|COMPLETED|Overall Study||4
288306|NCT01919229|690996|P3|STARTED|Overall Study||4
288307|NCT01919229|690997|P2|STARTED|Overall Study||6
288308|NCT01919229|690998|P1|STARTED|Overall Study||4
288309|NCT01918800|691029|P2|NOT COMPLETED|Overall Study||5
288310|NCT01918800|691030|P1|NOT COMPLETED|Overall Study||9
288311|NCT01918800|691029|P2|COMPLETED|Overall Study||104
288312|NCT01918800|691030|P1|COMPLETED|Overall Study||100
288313|NCT01918800|691029|P2|STARTED|Overall Study||109
288314|NCT01918800|691030|P1|STARTED|Overall Study||109
288315|NCT01918371|691050|P2|NOT COMPLETED|Overall Study||1
288316|NCT01918371|691051|P1|NOT COMPLETED|Overall Study||1
288317|NCT01918371|691050|P2|COMPLETED|Overall Study||156
288318|NCT01918371|691051|P1|COMPLETED|Overall Study||165
288319|NCT01918371|691050|P2|Participants With Complete Data|Overall Study||156
288320|NCT01918371|691051|P1|Participants With Complete Data|Overall Study||165
288321|NCT01918371|691050|P2|STARTED|Overall Study||157
288322|NCT01918371|691051|P1|STARTED|Overall Study||166
288323|NCT01918332|691129|P4|NOT COMPLETED|Overall Study||7
288324|NCT01918332|691130|P3|NOT COMPLETED|Overall Study||9
288325|NCT01918332|691131|P2|NOT COMPLETED|Overall Study||5
288326|NCT01918332|691132|P1|NOT COMPLETED|Overall Study||8
288327|NCT01918332|691129|P4|COMPLETED|Overall Study||38
288328|NCT01918332|691130|P3|COMPLETED|Overall Study||30
288329|NCT01918332|691131|P2|COMPLETED|Overall Study||36
288330|NCT01918332|691132|P1|COMPLETED|Overall Study||35
288331|NCT01918332|691129|P4|STARTED|Overall Study||45
288332|NCT01918332|691130|P3|STARTED|Overall Study||39
288333|NCT01918332|691131|P2|STARTED|Overall Study||41
288334|NCT01918332|691132|P1|STARTED|Overall Study||43
288335|NCT01918085|691144|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
288336|NCT01918085|691145|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
288337|NCT01918085|691144|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
288338|NCT01918085|691145|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
288339|NCT01918085|691144|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
288340|NCT01918085|691145|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
288341|NCT01918085|691144|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
288342|NCT01918085|691145|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
288343|NCT01918085|691144|P2|COMPLETED|Test Period 2: Strata Strip||11
288344|NCT01918085|691145|P1|COMPLETED|Test Period 2: Strata Strip||10
288345|NCT01918085|691144|P2|STARTED|Test Period 2: Strata Strip||11
288346|NCT01918085|691145|P1|STARTED|Test Period 2: Strata Strip||10
288347|NCT01918085|691144|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
288348|NCT01918085|691145|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
288349|NCT01918085|691144|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
288350|NCT01918085|691145|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
288351|NCT01918085|691144|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
288352|NCT01918085|691145|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
288353|NCT01918085|691144|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
288354|NCT01918085|691145|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
288355|NCT01918085|691144|P2|COMPLETED|Test Period 1: Strata Strip||11
288356|NCT01918085|691145|P1|COMPLETED|Test Period 1: Strata Strip||10
288357|NCT01918085|691144|P2|STARTED|Test Period 1: Strata Strip||12
288358|NCT01918085|691145|P1|STARTED|Test Period 1: Strata Strip||10
288359|NCT01918033|691156|P3|NOT COMPLETED|Overall Study||3
288360|NCT01918033|691157|P2|NOT COMPLETED|Overall Study||2
288361|NCT01918033|691158|P1|NOT COMPLETED|Overall Study||5
288362|NCT01918033|691156|P3|COMPLETED|Overall Study||199
288363|NCT01918033|691157|P2|COMPLETED|Overall Study||201
288364|NCT01918033|691158|P1|COMPLETED|Overall Study||198
288365|NCT01918033|691156|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
288366|NCT01918033|691157|P2|Treated|Overall Study||203
288367|NCT01918033|691158|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
288368|NCT01918033|691156|P3|STARTED|Overall Study||202
288369|NCT01918033|691157|P2|STARTED|Overall Study||203
288370|NCT01918033|691158|P1|STARTED|Overall Study||203
288371|NCT01917812|691199|P3|NOT COMPLETED|Overall Study||0
288372|NCT01917812|691200|P2|NOT COMPLETED|Overall Study||0
288373|NCT01917812|691201|P1|NOT COMPLETED|Overall Study||1
288374|NCT01917812|691199|P3|COMPLETED|Overall Study||16
288375|NCT01917812|691200|P2|COMPLETED|Overall Study||16
288376|NCT01917812|691201|P1|COMPLETED|Overall Study||15
288377|NCT01917812|691199|P3|STARTED|Overall Study||16
288378|NCT01917812|691200|P2|STARTED|Overall Study||16
288379|NCT01917812|691201|P1|STARTED|Overall Study||16
288380|NCT01917773|691221|P1|NOT COMPLETED|Overall Study||0
288381|NCT01917773|691221|P1|COMPLETED|Overall Study||13
288382|NCT01917773|691221|P1|STARTED|Overall Study||13
288383|NCT01917656|691229|P2|NOT COMPLETED|Overall Study||24
288384|NCT01917656|691230|P1|NOT COMPLETED|Overall Study||26
288385|NCT01917656|691229|P2|COMPLETED|Overall Study||147
288386|NCT01917656|691230|P1|COMPLETED|Overall Study||146
288387|NCT01917656|691229|P2|Exposed During Ramadan (Fasting)|Overall Study||163
288388|NCT01917656|691230|P1|Exposed During Ramadan (Fasting)|Overall Study||152
288389|NCT01917656|691229|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
288390|NCT01917656|691230|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
288391|NCT01917656|691229|P2|STARTED|Overall Study||171
288392|NCT01917656|691230|P1|STARTED|Overall Study||172
288393|NCT01917526|691256|P2|NOT COMPLETED|Overall Study||1
288394|NCT01917526|691257|P1|NOT COMPLETED|Overall Study||1
288395|NCT01917526|691256|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
288396|NCT01917526|691257|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
288397|NCT01917526|691256|P2|STARTED|Overall Study||250
288398|NCT01917526|691257|P1|STARTED|Overall Study||250
288399|NCT01917344|691265|P1|NOT COMPLETED|Overall Study||1
288400|NCT01917344|691265|P1|COMPLETED|Overall Study||9
288401|NCT01917344|691265|P1|STARTED|Overall Study||10
288402|NCT01917214|691269|P1|NOT COMPLETED|Overall Study||0
288403|NCT01917214|691269|P1|COMPLETED|Overall Study||212
288404|NCT01917214|691269|P1|STARTED|Overall Study||212
288405|NCT01916980|691280|P2|NOT COMPLETED|Overall Study||4
288406|NCT01916980|691281|P1|NOT COMPLETED|Overall Study||7
288407|NCT01916980|691280|P2|COMPLETED|Overall Study||25
288408|NCT01916980|691281|P1|COMPLETED|Overall Study||58
288409|NCT01916980|691280|P2|STARTED|Overall Study||29
288410|NCT01916980|691281|P1|STARTED|Overall Study||65
288411|NCT01916967|691300|P3|NOT COMPLETED|Overall Study||9
288412|NCT01916967|691301|P2|NOT COMPLETED|Overall Study||1
288413|NCT01916967|691302|P1|NOT COMPLETED|Overall Study||0
288414|NCT01916967|691300|P3|COMPLETED|Overall Study||71
288415|NCT01916967|691301|P2|COMPLETED|Overall Study||78
288416|NCT01916967|691302|P1|COMPLETED|Overall Study||80
288417|NCT01916967|691300|P3|STARTED|Overall Study||80
288418|NCT01916967|691301|P2|STARTED|Overall Study||79
288419|NCT01916967|691302|P1|STARTED|Overall Study||80
288420|NCT01916928|691343|P1|NOT COMPLETED|Overall Study||0
288421|NCT01916928|691343|P1|COMPLETED|Overall Study||50
288422|NCT01916928|691343|P1|STARTED|Overall Study||50
288423|NCT01916681|691351|P4|NOT COMPLETED|Overall Study||0
288424|NCT01916681|691352|P3|NOT COMPLETED|Overall Study||0
288425|NCT01916681|691353|P2|NOT COMPLETED|Overall Study||0
288426|NCT01916681|691354|P1|NOT COMPLETED|Overall Study||0
288427|NCT01916681|691351|P4|COMPLETED|Overall Study||125
288428|NCT01916681|691352|P3|COMPLETED|Overall Study||123
288429|NCT01916681|691353|P2|COMPLETED|Overall Study||120
288430|NCT01916681|691354|P1|COMPLETED|Overall Study||123
288431|NCT01916681|691351|P4|STARTED|Overall Study||125
288432|NCT01916681|691352|P3|STARTED|Overall Study||123
288433|NCT01916681|691353|P2|STARTED|Overall Study||120
288434|NCT01916681|691354|P1|STARTED|Overall Study||123
288435|NCT01916629|691394|P2|NOT COMPLETED|Overall Study||0
288436|NCT01916629|691395|P1|NOT COMPLETED|Overall Study||0
288437|NCT01916629|691394|P2|COMPLETED|Overall Study||5
288438|NCT01916629|691395|P1|COMPLETED|Overall Study||7
288439|NCT01916629|691394|P2|STARTED|Overall Study||5
288440|NCT01916629|691395|P1|STARTED|Overall Study||7
288441|NCT01916590|691403|P2|NOT COMPLETED|Overall Study||0
288442|NCT01916590|691404|P1|NOT COMPLETED|Overall Study||0
288443|NCT01916590|691403|P2|COMPLETED|Overall Study||3
288444|NCT01916590|691404|P1|COMPLETED|Overall Study||4
288445|NCT01916590|691403|P2|STARTED|Overall Study||3
288446|NCT01916590|691404|P1|STARTED|Overall Study||4
288447|NCT01916304|691410|P1|NOT COMPLETED|Overall Study||17
288448|NCT01916304|691410|P1|COMPLETED|Overall Study||84
288449|NCT01916304|691410|P1|Intent-to-Treat Set|Overall Study||84
288450|NCT01916304|691410|P1|Safety Set|Overall Study||101
288451|NCT01916304|691410|P1|STARTED|Overall Study||101
288452|NCT01916226|691422|P4|NOT COMPLETED|Overall Study||4
288453|NCT01916226|691423|P3|NOT COMPLETED|Overall Study||3
288454|NCT01916226|691424|P2|NOT COMPLETED|Overall Study||1
288455|NCT01916226|691425|P1|NOT COMPLETED|Overall Study||1
288456|NCT01916226|691422|P4|COMPLETED|Overall Study||167
288457|NCT01916226|691423|P3|COMPLETED|Overall Study||168
288458|NCT01916226|691424|P2|COMPLETED|Overall Study||169
288459|NCT01916226|691425|P1|COMPLETED|Overall Study||169
288460|NCT01916226|691422|P4|STARTED|Overall Study||171
288461|NCT01916226|691423|P3|STARTED|Overall Study||171
288462|NCT01916226|691424|P2|STARTED|Overall Study||170
288463|NCT01916226|691425|P1|STARTED|Overall Study||170
288464|NCT01916109|691459|P1|NOT COMPLETED|Overall Study||1
288465|NCT01916109|691459|P1|COMPLETED|Overall Study||3
288466|NCT01916109|691459|P1|STARTED|Overall Study||4
288467|NCT01915914|691463|P4|NOT COMPLETED|Follow-up Phase||2
288468|NCT01915914|691464|P3|NOT COMPLETED|Follow-up Phase||0
288469|NCT01915914|691465|P2|NOT COMPLETED|Follow-up Phase||0
288470|NCT01915914|691466|P1|NOT COMPLETED|Follow-up Phase||0
288471|NCT01915914|691463|P4|COMPLETED|Follow-up Phase||64
288472|NCT01915914|691464|P3|COMPLETED|Follow-up Phase||0
288473|NCT01915914|691465|P2|COMPLETED|Follow-up Phase||0
288474|NCT01915914|691466|P1|COMPLETED|Follow-up Phase||0
288475|NCT01915914|691463|P4|STARTED|Follow-up Phase||66
288476|NCT01915914|691464|P3|STARTED|Follow-up Phase||0
288477|NCT01915914|691465|P2|STARTED|Follow-up Phase||0
288478|NCT01915914|691466|P1|STARTED|Follow-up Phase||0
288479|NCT01915914|691463|P4|NOT COMPLETED|Maintenance Phase||0
288480|NCT01915914|691464|P3|NOT COMPLETED|Maintenance Phase||2
288481|NCT01915914|691465|P2|NOT COMPLETED|Maintenance Phase||6
288482|NCT01915914|691466|P1|NOT COMPLETED|Maintenance Phase||0
288483|NCT01915914|691463|P4|COMPLETED|Maintenance Phase||0
288484|NCT01915914|691464|P3|COMPLETED|Maintenance Phase||51
288485|NCT01915914|691465|P2|COMPLETED|Maintenance Phase||48
288486|NCT01915914|691466|P1|COMPLETED|Maintenance Phase||0
288487|NCT01915914|691463|P4|STARTED|Maintenance Phase||0
288488|NCT01915914|691464|P3|STARTED|Maintenance Phase||53
288489|NCT01915914|691465|P2|STARTED|Maintenance Phase||54
288490|NCT01915914|691466|P1|STARTED|Maintenance Phase||0
288491|NCT01915914|691463|P4|NOT COMPLETED|Acute Phase||0
288492|NCT01915914|691464|P3|NOT COMPLETED|Acute Phase||0
288493|NCT01915914|691465|P2|NOT COMPLETED|Acute Phase||0
288494|NCT01915914|691466|P1|NOT COMPLETED|Acute Phase||12
288495|NCT01915914|691463|P4|COMPLETED|Acute Phase||0
288496|NCT01915914|691464|P3|COMPLETED|Acute Phase||0
288497|NCT01915914|691465|P2|COMPLETED|Acute Phase||0
288498|NCT01915914|691466|P1|COMPLETED|Acute Phase||111
288499|NCT01915914|691463|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
288500|NCT01915914|691464|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
288501|NCT01915914|691465|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
288502|NCT01915914|691466|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
288503|NCT01915914|691463|P4|STARTED|Acute Phase||0
288504|NCT01915914|691464|P3|STARTED|Acute Phase||0
288505|NCT01915914|691465|P2|STARTED|Acute Phase||0
288506|NCT01915914|691466|P1|STARTED|Acute Phase||123
288507|NCT01915849|691498|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
288508|NCT01915849|691499|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
288509|NCT01915849|691500|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
288510|NCT01915849|691501|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
288511|NCT01915849|691498|P4|COMPLETED|Treatment Period 4 (4 Days)||3
288512|NCT01915849|691499|P3|COMPLETED|Treatment Period 4 (4 Days)||3
288513|NCT01915849|691500|P2|COMPLETED|Treatment Period 4 (4 Days)||3
288514|NCT01915849|691501|P1|COMPLETED|Treatment Period 4 (4 Days)||3
288515|NCT01915849|691498|P4|STARTED|Treatment Period 4 (4 Days)||3
288516|NCT01915849|691499|P3|STARTED|Treatment Period 4 (4 Days)||3
288517|NCT01915849|691500|P2|STARTED|Treatment Period 4 (4 Days)||3
288518|NCT01915849|691501|P1|STARTED|Treatment Period 4 (4 Days)||3
288519|NCT01915849|691498|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
288520|NCT01915849|691499|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
288521|NCT01915849|691500|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
288522|NCT01915849|691501|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
288523|NCT01915849|691498|P4|COMPLETED|Treatment Period 3 (4 Days)||3
288524|NCT01915849|691499|P3|COMPLETED|Treatment Period 3 (4 Days)||3
288525|NCT01915849|691500|P2|COMPLETED|Treatment Period 3 (4 Days)||3
288526|NCT01915849|691501|P1|COMPLETED|Treatment Period 3 (4 Days)||3
288527|NCT01915849|691498|P4|STARTED|Treatment Period 3 (4 Days)||3
288528|NCT01915849|691499|P3|STARTED|Treatment Period 3 (4 Days)||3
288529|NCT01915849|691500|P2|STARTED|Treatment Period 3 (4 Days)||3
288530|NCT01915849|691501|P1|STARTED|Treatment Period 3 (4 Days)||3
288531|NCT01915849|691498|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
288532|NCT01915849|691499|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
288533|NCT01915849|691500|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
288534|NCT01915849|691501|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
288535|NCT01915849|691498|P4|COMPLETED|Treatment Period 2 (4 Days)||3
288536|NCT01915849|691499|P3|COMPLETED|Treatment Period 2 (4 Days)||3
288537|NCT01915849|691500|P2|COMPLETED|Treatment Period 2 (4 Days)||3
288538|NCT01915849|691501|P1|COMPLETED|Treatment Period 2 (4 Days)||3
288539|NCT01915849|691498|P4|STARTED|Treatment Period 2 (4 Days)||3
288540|NCT01915849|691499|P3|STARTED|Treatment Period 2 (4 Days)||3
288541|NCT01915849|691500|P2|STARTED|Treatment Period 2 (4 Days)||3
288542|NCT01915849|691501|P1|STARTED|Treatment Period 2 (4 Days)||3
288543|NCT01915849|691498|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
288544|NCT01915849|691499|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
288545|NCT01915849|691500|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
288546|NCT01915849|691501|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
288547|NCT01915849|691498|P4|COMPLETED|Treatment Period 1 (4 Days)||3
288548|NCT01915849|691499|P3|COMPLETED|Treatment Period 1 (4 Days)||3
288549|NCT01915849|691500|P2|COMPLETED|Treatment Period 1 (4 Days)||3
288550|NCT01915849|691501|P1|COMPLETED|Treatment Period 1 (4 Days)||3
288551|NCT01915849|691498|P4|STARTED|Treatment Period 1 (4 Days)||3
288552|NCT01915849|691499|P3|STARTED|Treatment Period 1 (4 Days)||3
288553|NCT01915849|691500|P2|STARTED|Treatment Period 1 (4 Days)||3
288554|NCT01915849|691501|P1|STARTED|Treatment Period 1 (4 Days)||5
288555|NCT01915823|691513|P2|NOT COMPLETED|Overall Study||2
288556|NCT01915823|691514|P1|NOT COMPLETED|Overall Study||2
288557|NCT01915823|691513|P2|COMPLETED|Overall Study||173
288558|NCT01915823|691514|P1|COMPLETED|Overall Study||171
288559|NCT01915823|691513|P2|STARTED|Overall Study||175
288560|NCT01915823|691514|P1|STARTED|Overall Study||173
288561|NCT01915732|691526|P2|NOT COMPLETED|Overall Study||71
288562|NCT01915732|691527|P1|NOT COMPLETED|Overall Study||70
288563|NCT01915732|691526|P2|COMPLETED|Overall Study||445
288564|NCT01915732|691527|P1|COMPLETED|Overall Study||430
288565|NCT01915732|691526|P2|STARTED|Overall Study||516
288566|NCT01915732|691527|P1|STARTED|Overall Study||500
288567|NCT01915173|691555|P4|NOT COMPLETED|Overall Study||0
288568|NCT01915173|691556|P3|NOT COMPLETED|Overall Study||0
288569|NCT01915173|691557|P2|NOT COMPLETED|Overall Study||0
288570|NCT01915173|691558|P1|NOT COMPLETED|Overall Study||0
288571|NCT01915173|691555|P4|COMPLETED|Overall Study||6
288572|NCT01915173|691556|P3|COMPLETED|Overall Study||6
288573|NCT01915173|691557|P2|COMPLETED|Overall Study||6
288574|NCT01915173|691558|P1|COMPLETED|Overall Study||6
288575|NCT01915173|691555|P4|STARTED|Overall Study||6
288576|NCT01915173|691556|P3|STARTED|Overall Study||6
288577|NCT01915173|691557|P2|STARTED|Overall Study||6
288578|NCT01915173|691558|P1|STARTED|Overall Study||6
288579|NCT01915108|691580|P4|NOT COMPLETED|Overall Study||2
288580|NCT01915108|691581|P3|NOT COMPLETED|Overall Study||1
288581|NCT01915108|691582|P2|NOT COMPLETED|Overall Study||3
288582|NCT01915108|691583|P1|NOT COMPLETED|Overall Study||2
288583|NCT01915108|691580|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
288584|NCT01915108|691581|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
288585|NCT01915108|691582|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
288586|NCT01915108|691583|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
288587|NCT01915108|691580|P4|STARTED|Overall Study||32
288588|NCT01915108|691581|P3|STARTED|Overall Study||32
288589|NCT01915108|691582|P2|STARTED|Overall Study||32
288590|NCT01915108|691583|P1|STARTED|Overall Study||32
288591|NCT01914926|691595|P2|NOT COMPLETED|Overall Study||1
288592|NCT01914926|691596|P1|NOT COMPLETED|Overall Study||1
288593|NCT01914926|691595|P2|COMPLETED|Overall Study||24
288594|NCT01914926|691596|P1|COMPLETED|Overall Study||28
288595|NCT01914926|691595|P2|STARTED|Overall Study||25
288596|NCT01914926|691596|P1|STARTED|Overall Study||29
288597|NCT01914757|691605|P3|NOT COMPLETED|Overall Study||38
288598|NCT01914757|691606|P2|NOT COMPLETED|Overall Study||51
288599|NCT01914757|691607|P1|NOT COMPLETED|Overall Study||36
288600|NCT01914757|691605|P3|COMPLETED|Overall Study||402
288601|NCT01914757|691606|P2|COMPLETED|Overall Study||390
288602|NCT01914757|691607|P1|COMPLETED|Overall Study||389
288603|NCT01914757|691605|P3|STARTED|Overall Study||440
288604|NCT01914757|691606|P2|STARTED|Overall Study||441
288605|NCT01914757|691607|P1|STARTED|Overall Study||425
288606|NCT01914679|691681|P1|NOT COMPLETED|Overall Study||5
288607|NCT01914679|691681|P1|COMPLETED|Overall Study||12
288608|NCT01914679|691681|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
288609|NCT01914679|691681|P1|STARTED|Overall Study||17
288610|NCT01914666|691688|P3|NOT COMPLETED|Tapering Period||0
288611|NCT01914666|691689|P2|NOT COMPLETED|Tapering Period||0
288612|NCT01914666|691690|P1|NOT COMPLETED|Tapering Period||0
288613|NCT01914666|691688|P3|COMPLETED|Tapering Period||40
288614|NCT01914666|691689|P2|COMPLETED|Tapering Period||39
288615|NCT01914666|691690|P1|COMPLETED|Tapering Period||59
288616|NCT01914666|691688|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
288617|NCT01914666|691689|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
288618|NCT01914666|691690|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
288619|NCT01914666|691688|P3|NOT COMPLETED|Treatment Period||8
288620|NCT01914666|691689|P2|NOT COMPLETED|Treatment Period||6
288621|NCT01914666|691690|P1|NOT COMPLETED|Treatment Period||13
288622|NCT01914666|691688|P3|COMPLETED|Treatment Period||33
288623|NCT01914666|691689|P2|COMPLETED|Treatment Period||36
288624|NCT01914666|691690|P1|COMPLETED|Treatment Period||55
288625|NCT01914666|691688|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
288626|NCT01914666|691689|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
288627|NCT01914666|691690|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
288628|NCT01914666|691688|P3|STARTED|Treatment Period||41
288629|NCT01914666|691689|P2|STARTED|Treatment Period||42
288630|NCT01914666|691690|P1|STARTED|Treatment Period||68
288631|NCT01914003|691725|P2|NOT COMPLETED|Overall Study||12
288632|NCT01914003|691726|P1|NOT COMPLETED|Overall Study||8
288633|NCT01914003|691725|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
288634|NCT01914003|691726|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
288635|NCT01914003|691725|P2|STARTED|Overall Study||26
288636|NCT01914003|691726|P1|STARTED|Overall Study||27
288637|NCT01913795|691736|P4|NOT COMPLETED|Overall Study||1
288638|NCT01913795|691737|P3|NOT COMPLETED|Overall Study||0
288639|NCT01913795|691738|P2|NOT COMPLETED|Overall Study||3
288640|NCT01913795|691739|P1|NOT COMPLETED|Overall Study||0
288641|NCT01913795|691736|P4|COMPLETED|Overall Study||5
288642|NCT01913795|691737|P3|COMPLETED|Overall Study||9
288643|NCT01913795|691738|P2|COMPLETED|Overall Study||7
288644|NCT01913795|691739|P1|COMPLETED|Overall Study||4
288645|NCT01913795|691736|P4|STARTED|Overall Study||6
288646|NCT01913795|691737|P3|STARTED|Overall Study||9
288647|NCT01913795|691738|P2|STARTED|Overall Study||10
288648|NCT01913795|691739|P1|STARTED|Overall Study||4
288649|NCT01913483|691755|P2|NOT COMPLETED|Overall Study||22
288650|NCT01913483|691756|P1|NOT COMPLETED|Overall Study||21
288651|NCT01913483|691755|P2|COMPLETED|Overall Study||343
288652|NCT01913483|691756|P1|COMPLETED|Overall Study||346
288653|NCT01913483|691755|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
288654|NCT01913483|691756|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
288655|NCT01913483|691755|P2|STARTED|Overall Study||365
288656|NCT01913483|691756|P1|STARTED|Overall Study||367
288657|NCT01913470|691768|P2|NOT COMPLETED|Overall Study||3
288658|NCT01913470|691769|P1|NOT COMPLETED|Overall Study||0
288659|NCT01913470|691768|P2|COMPLETED|Overall Study||4
288660|NCT01913470|691769|P1|COMPLETED|Overall Study||5
288661|NCT01913470|691768|P2|STARTED|Overall Study||7
288662|NCT01913470|691769|P1|STARTED|Overall Study||5
288663|NCT01913041|691787|P1|NOT COMPLETED|Overall Study||39
288664|NCT01913041|691787|P1|COMPLETED|Overall Study||830
288665|NCT01913041|691787|P1|STARTED|Overall Study||869
288666|NCT01912781|691793|P2|NOT COMPLETED|Overall Study||0
288667|NCT01912781|691794|P1|NOT COMPLETED|Overall Study||2
288668|NCT01912781|691793|P2|COMPLETED|Overall Study||35
288669|NCT01912781|691794|P1|COMPLETED|Overall Study||69
288670|NCT01912781|691793|P2|STARTED|Overall Study||35
288671|NCT01912781|691794|P1|STARTED|Overall Study||71
288672|NCT01912768|691825|P2|NOT COMPLETED|Overall Study||4
288673|NCT01912768|691826|P1|NOT COMPLETED|Overall Study||10
288674|NCT01912768|691825|P2|COMPLETED|Overall Study||109
288675|NCT01912768|691826|P1|COMPLETED|Overall Study||229
288676|NCT01912768|691825|P2|STARTED|Overall Study||113
288677|NCT01912768|691826|P1|STARTED|Overall Study||239
288678|NCT01912599|691857|P2|NOT COMPLETED|Overall Study||1
288679|NCT01912599|691858|P1|NOT COMPLETED|Overall Study||0
288680|NCT01912599|691857|P2|COMPLETED|Overall Study||15
288681|NCT01912599|691858|P1|COMPLETED|Overall Study||20
288682|NCT01912599|691857|P2|STARTED|Overall Study||16
288683|NCT01912599|691858|P1|STARTED|Overall Study||20
288684|NCT01912495|691872|P1|NOT COMPLETED|Overall Study||0
288685|NCT01912495|691872|P1|COMPLETED|Overall Study||57
288686|NCT01912495|691872|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
288687|NCT01912404|691883|P2|NOT COMPLETED|Overall Study||0
288688|NCT01912404|691884|P1|NOT COMPLETED|Overall Study||1
288689|NCT01912404|691883|P2|COMPLETED|Overall Study||2
288690|NCT01912404|691884|P1|COMPLETED|Overall Study||2
288691|NCT01912404|691883|P2|STARTED|Overall Study||2
288692|NCT01912404|691884|P1|STARTED|Overall Study||3
288693|NCT01912352|691890|P1|NOT COMPLETED|Overall Study||5
288694|NCT01912352|691890|P1|COMPLETED|Overall Study||78
288695|NCT01912352|691890|P1|STARTED|Overall Study||83
288696|NCT01912339|691897|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
288697|NCT01912339|691898|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
288698|NCT01912339|691899|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
288699|NCT01912339|691897|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
288700|NCT01912339|691898|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
288701|NCT01912339|691899|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
288702|NCT01912339|691897|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
288703|NCT01912339|691898|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
288704|NCT01912339|691899|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
288705|NCT01912339|691897|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
288706|NCT01912339|691898|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
288707|NCT01912339|691899|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
288708|NCT01912339|691897|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
288709|NCT01912339|691898|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
288710|NCT01912339|691899|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
288711|NCT01912339|691897|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
288712|NCT01912339|691898|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
288713|NCT01912339|691899|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
288714|NCT01912339|691897|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
288715|NCT01912339|691898|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
288716|NCT01912339|691899|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
288717|NCT01912339|691897|P3|COMPLETED|Blinded (0 to 3 Months)||0
288718|NCT01912339|691898|P2|COMPLETED|Blinded (0 to 3 Months)||61
288719|NCT01912339|691899|P1|COMPLETED|Blinded (0 to 3 Months)||134
288720|NCT01912339|691897|P3|STARTED|Blinded (0 to 3 Months)||0
288721|NCT01912339|691898|P2|STARTED|Blinded (0 to 3 Months)||61
288722|NCT01912339|691899|P1|STARTED|Blinded (0 to 3 Months)||136
288723|NCT01912222|691916|P3|NOT COMPLETED|Part B: Treatment Period||20
288724|NCT01912222|691917|P2|NOT COMPLETED|Part B: Treatment Period||15
288725|NCT01912222|691918|P1|NOT COMPLETED|Part B: Treatment Period||13
288726|NCT01912222|691916|P3|COMPLETED|Part B: Treatment Period||0
288727|NCT01912222|691917|P2|COMPLETED|Part B: Treatment Period||0
288728|NCT01912222|691918|P1|COMPLETED|Part B: Treatment Period||0
288729|NCT01912222|691916|P3|STARTED|Part B: Treatment Period||20
288730|NCT01912222|691917|P2|STARTED|Part B: Treatment Period||15
288731|NCT01912222|691918|P1|STARTED|Part B: Treatment Period||13
288732|NCT01912222|691916|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
288733|NCT01912222|691917|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
288734|NCT01912222|691918|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
288735|NCT01912222|691916|P3|COMPLETED|Part A: Pharmacokinetic Period||18
288736|NCT01912222|691917|P2|COMPLETED|Part A: Pharmacokinetic Period||13
288737|NCT01912222|691918|P1|COMPLETED|Part A: Pharmacokinetic Period||12
288738|NCT01912222|691916|P3|STARTED|Part A: Pharmacokinetic Period||20
288739|NCT01912222|691917|P2|STARTED|Part A: Pharmacokinetic Period||15
288740|NCT01912222|691918|P1|STARTED|Part A: Pharmacokinetic Period||13
288741|NCT01911845|691941|P1|NOT COMPLETED|Overall Study||6
288742|NCT01911845|691941|P1|COMPLETED|Overall Study||32
288743|NCT01911845|691941|P1|Completed Study Drug|Overall Study||37
288744|NCT01911845|691941|P1|STARTED|Overall Study||38
288745|NCT01911780|691957|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
288746|NCT01911780|691958|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
288747|NCT01911780|691957|P2|COMPLETED|Extension Period (52 Weeks)||58
288748|NCT01911780|691958|P1|COMPLETED|Extension Period (52 Weeks)||61
288749|NCT01911780|691957|P2|STARTED|Extension Period (52 Weeks)||61
288750|NCT01911780|691958|P1|STARTED|Extension Period (52 Weeks)||65
288751|NCT01911780|691957|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
288752|NCT01911780|691958|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
288753|NCT01911780|691957|P2|COMPLETED|Double-blind Period (8 Weeks)||61
288754|NCT01911780|691958|P1|COMPLETED|Double-blind Period (8 Weeks)||65
288755|NCT01911780|691957|P2|STARTED|Double-blind Period (8 Weeks)||64
288756|NCT01911780|691958|P1|STARTED|Double-blind Period (8 Weeks)||68
288757|NCT01911689|691978|P2|NOT COMPLETED|Overall Study||0
288758|NCT01911689|691979|P1|NOT COMPLETED|Overall Study||0
288759|NCT01911689|691978|P2|COMPLETED|Overall Study||51
288760|NCT01911689|691979|P1|COMPLETED|Overall Study||117
288761|NCT01911689|691978|P2|STARTED|Overall Study||51
288762|NCT01911689|691979|P1|STARTED|Overall Study||117
288763|NCT01911442|691995|P3|NOT COMPLETED|Overall Study||12
288764|NCT01911442|691996|P2|NOT COMPLETED|Overall Study||4
288765|NCT01911442|691997|P1|NOT COMPLETED|Overall Study||6
288766|NCT01911442|691995|P3|COMPLETED|Overall Study||38
288767|NCT01911442|691996|P2|COMPLETED|Overall Study||47
288768|NCT01911442|691997|P1|COMPLETED|Overall Study||43
288769|NCT01911442|691995|P3|STARTED|Overall Study||50
288770|NCT01911442|691996|P2|STARTED|Overall Study||51
288771|NCT01911442|691997|P1|STARTED|Overall Study||49
288772|NCT01911429|692026|P3|NOT COMPLETED|Overall Study||20
288773|NCT01911429|692027|P2|NOT COMPLETED|Overall Study||10
288774|NCT01911429|692028|P1|NOT COMPLETED|Overall Study||12
288775|NCT01911429|692026|P3|COMPLETED|Overall Study||93
288776|NCT01911429|692027|P2|COMPLETED|Overall Study||96
288777|NCT01911429|692028|P1|COMPLETED|Overall Study||96
288778|NCT01911429|692026|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
288779|NCT01911429|692027|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
288780|NCT01911429|692028|P1|STARTED|Overall Study||108
288781|NCT01911403|692062|P2|NOT COMPLETED|Overall Study||3
288782|NCT01911403|692063|P1|NOT COMPLETED|Overall Study||9
288783|NCT01911403|692062|P2|COMPLETED|Overall Study||59
288784|NCT01911403|692063|P1|COMPLETED|Overall Study||52
288785|NCT01911403|692062|P2|STARTED|Overall Study||62
288786|NCT01911403|692063|P1|STARTED|Overall Study||61
288787|NCT01911390|692084|P4|NOT COMPLETED|Overall Study||1
288788|NCT01911390|692085|P3|NOT COMPLETED|Overall Study||1
288789|NCT01911390|692086|P2|NOT COMPLETED|Overall Study||0
288790|NCT01911390|692087|P1|NOT COMPLETED|Overall Study||1
288791|NCT01911390|692084|P4|COMPLETED|Overall Study||10
288792|NCT01911390|692085|P3|COMPLETED|Overall Study||9
288793|NCT01911390|692086|P2|COMPLETED|Overall Study||10
288794|NCT01911390|692087|P1|COMPLETED|Overall Study||9
288795|NCT01911390|692084|P4|STARTED|Overall Study||11
288796|NCT01911390|692085|P3|STARTED|Overall Study||10
288797|NCT01911390|692086|P2|STARTED|Overall Study||10
288798|NCT01911390|692087|P1|STARTED|Overall Study||10
288799|NCT01911351|692103|P2|NOT COMPLETED|Overall Study||0
288800|NCT01911351|692104|P1|NOT COMPLETED|Overall Study||0
288801|NCT01911351|692103|P2|COMPLETED|Overall Study||43
288802|NCT01911351|692104|P1|COMPLETED|Overall Study||39
288803|NCT01911351|692103|P2|STARTED|Overall Study||43
288804|NCT01911351|692104|P1|STARTED|Overall Study||39
288805|NCT01911273|692120|P2|NOT COMPLETED|Overall Study||2
288806|NCT01911273|692121|P1|NOT COMPLETED|Overall Study||1
288807|NCT01911273|692120|P2|COMPLETED|Overall Study||0
288808|NCT01911273|692121|P1|COMPLETED|Overall Study||0
288809|NCT01911273|692120|P2|STARTED|Overall Study||2
288810|NCT01911273|692121|P1|STARTED|Overall Study||1
288811|NCT01911260|692155|P4|NOT COMPLETED|Follow-up Period||12
288812|NCT01911260|692156|P3|NOT COMPLETED|Follow-up Period||15
288813|NCT01911260|692157|P2|NOT COMPLETED|Follow-up Period||20
288814|NCT01911260|692158|P1|NOT COMPLETED|Follow-up Period||13
288815|NCT01911260|692155|P4|COMPLETED|Follow-up Period||30
288816|NCT01911260|692156|P3|COMPLETED|Follow-up Period||24
288817|NCT01911260|692157|P2|COMPLETED|Follow-up Period||18
288818|NCT01911260|692158|P1|COMPLETED|Follow-up Period||27
288819|NCT01911260|692155|P4|STARTED|Follow-up Period||42
288820|NCT01911260|692156|P3|STARTED|Follow-up Period||39
288821|NCT01911260|692157|P2|STARTED|Follow-up Period||38
288822|NCT01911260|692158|P1|STARTED|Follow-up Period||40
288823|NCT01911260|692155|P4|NOT COMPLETED|Supplementation Period||8
288824|NCT01911260|692156|P3|NOT COMPLETED|Supplementation Period||10
288825|NCT01911260|692157|P2|NOT COMPLETED|Supplementation Period||12
288826|NCT01911260|692158|P1|NOT COMPLETED|Supplementation Period||10
288827|NCT01911260|692155|P4|COMPLETED|Supplementation Period||42
288828|NCT01911260|692156|P3|COMPLETED|Supplementation Period||39
288829|NCT01911260|692157|P2|COMPLETED|Supplementation Period||38
288830|NCT01911260|692158|P1|COMPLETED|Supplementation Period||40
288831|NCT01911260|692155|P4|STARTED|Supplementation Period||50
288832|NCT01911260|692156|P3|STARTED|Supplementation Period||49
288833|NCT01911260|692157|P2|STARTED|Supplementation Period||50
288834|NCT01911260|692158|P1|STARTED|Supplementation Period||50
288835|NCT01911221|692168|P1|NOT COMPLETED|Overall Study||0
288836|NCT01911221|692168|P1|COMPLETED|Overall Study||13
288837|NCT01911221|692168|P1|STARTED|Overall Study||13
288838|NCT01911065|692184|P2|NOT COMPLETED|Overall Study||0
288839|NCT01911065|692185|P1|NOT COMPLETED|Overall Study||0
288840|NCT01911065|692184|P2|COMPLETED|Overall Study||9
288841|NCT01911065|692185|P1|COMPLETED|Overall Study||45
288842|NCT01911065|692184|P2|STARTED|Overall Study||9
288843|NCT01911065|692185|P1|STARTED|Overall Study||45
288844|NCT01910831|692193|P1|NOT COMPLETED|Overall Study||1
288845|NCT01910831|692193|P1|COMPLETED|Overall Study||19
288846|NCT01910831|692193|P1|STARTED|Overall Study||20
288847|NCT01910792|692202|P2|NOT COMPLETED|Overall Study||0
288848|NCT01910792|692203|P1|NOT COMPLETED|Overall Study||0
288849|NCT01910792|692202|P2|COMPLETED|Overall Study||10
288850|NCT01910792|692203|P1|COMPLETED|Overall Study||9
288851|NCT01910792|692202|P2|STARTED|Overall Study||10
288852|NCT01910792|692203|P1|STARTED|Overall Study||9
288853|NCT01910688|692209|P1|NOT COMPLETED|Overall Study||5
288854|NCT01910688|692209|P1|COMPLETED|Overall Study||20
288855|NCT01910688|692209|P1|12months|Overall Study||22
288856|NCT01910688|692209|P1|3rd RFA Treatment|Overall Study||18
288857|NCT01910688|692209|P1|7.5months|Overall Study||24
288858|NCT01910688|692209|P1|2nd RFA Treatment|Overall Study||22
288859|NCT01910688|692209|P1|3.5month|Overall Study||25
288860|NCT01910688|692209|P1|STARTED|Overall Study||25
288861|NCT01910636|692218|P2|NOT COMPLETED|Overall Study||0
288862|NCT01910636|692219|P1|NOT COMPLETED|Overall Study||0
288863|NCT01910636|692218|P2|COMPLETED|Overall Study||63
288864|NCT01910636|692219|P1|COMPLETED|Overall Study||90
288865|NCT01910636|692218|P2|STARTED|Overall Study||63
288866|NCT01910636|692219|P1|STARTED|Overall Study||90
288867|NCT01910441|692233|P2|NOT COMPLETED|Overall Study||10
288868|NCT01910441|692234|P1|NOT COMPLETED|Overall Study||7
288869|NCT01910441|692233|P2|COMPLETED|Overall Study||37
288870|NCT01910441|692234|P1|COMPLETED|Overall Study||41
288871|NCT01910441|692233|P2|STARTED|Overall Study||47
288872|NCT01910441|692234|P1|STARTED|Overall Study||48
288873|NCT01910402|692242|P2|NOT COMPLETED|Continuation Phase||0
288874|NCT01910402|692243|P1|NOT COMPLETED|Continuation Phase||90
288875|NCT01910402|692242|P2|COMPLETED|Continuation Phase||0
288876|NCT01910402|692243|P1|COMPLETED|Continuation Phase||30
288877|NCT01910402|692242|P2|STARTED|Continuation Phase||0
288878|NCT01910402|692243|P1|STARTED|Continuation Phase||120
288879|NCT01910402|692242|P2|NOT COMPLETED|Randomized Phase||55
288880|NCT01910402|692243|P1|NOT COMPLETED|Randomized Phase||42
288881|NCT01910402|692242|P2|COMPLETED|Randomized Phase||192
288882|NCT01910402|692243|P1|COMPLETED|Randomized Phase||206
288883|NCT01910402|692242|P2|STARTED|Randomized Phase||247
288884|NCT01910402|692243|P1|STARTED|Randomized Phase||248
288885|NCT01910389|692313|P2|NOT COMPLETED|Overall Study||8
288886|NCT01910389|692314|P1|NOT COMPLETED|Overall Study||15
288887|NCT01910389|692313|P2|COMPLETED|Overall Study||0
288888|NCT01910389|692314|P1|COMPLETED|Overall Study||0
288889|NCT01910389|692313|P2|STARTED|Overall Study||8
288890|NCT01910389|692314|P1|STARTED|Overall Study||15
288891|NCT01910311|692344|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
288892|NCT01910311|692344|P1|COMPLETED|Period 2 (Days 3-32)||18
288893|NCT01910311|692344|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
288894|NCT01910311|692344|P1|Received Baricitinib|Period 2 (Days 3-32)||18
288895|NCT01910311|692344|P1|STARTED|Period 2 (Days 3-32)||18
288896|NCT01910311|692344|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
288897|NCT01910311|692344|P1|COMPLETED|Period 1 (Days 1-2)||18
288898|NCT01910311|692344|P1|Received Baricitinib|Period 1 (Days 1-2)||18
288899|NCT01910311|692344|P1|STARTED|Period 1 (Days 1-2)||18
288900|NCT01910181|692355|P1|NOT COMPLETED|Overall Study||46
288901|NCT01910181|692355|P1|COMPLETED|Overall Study||0
288902|NCT01910181|692355|P1|Expansion Cohort|Overall Study||26
288903|NCT01910181|692355|P1|PK Cohort|Overall Study||20
288904|NCT01910181|692355|P1|STARTED|Overall Study||46
288905|NCT01910116|692382|P2|NOT COMPLETED|Overall Study||16
288906|NCT01910116|692383|P1|NOT COMPLETED|Overall Study||14
288907|NCT01910116|692382|P2|COMPLETED|Overall Study||94
288908|NCT01910116|692383|P1|COMPLETED|Overall Study||96
288909|NCT01910116|692382|P2|Week 16|Overall Study||94
288910|NCT01910116|692383|P1|Week 16|Overall Study||96
288911|NCT01910116|692382|P2|Week 12|Overall Study||96
288912|NCT01910116|692383|P1|Week 12|Overall Study||97
288913|NCT01910116|692382|P2|Week 8|Overall Study||99
288914|NCT01910116|692383|P1|Week 8|Overall Study||98
288915|NCT01910116|692382|P2|Week 4|Overall Study||102
288916|NCT01910116|692383|P1|Week 4|Overall Study||106
288917|NCT01910116|692382|P2|STARTED|Overall Study||110
288918|NCT01910116|692383|P1|STARTED|Overall Study||110
288919|NCT01910064|692459|P1|NOT COMPLETED|Overall Study||45
288920|NCT01910064|692459|P1|COMPLETED|Overall Study||391
288921|NCT01910064|692459|P1|STARTED|Overall Study||436
288922|NCT01909804|692480|P12|NOT COMPLETED|Overall Study||3
288923|NCT01909804|692481|P11|NOT COMPLETED|Overall Study||1
288924|NCT01909804|692482|P10|NOT COMPLETED|Overall Study||1
288925|NCT01909804|692483|P9|NOT COMPLETED|Overall Study||0
288926|NCT01909804|692484|P8|NOT COMPLETED|Overall Study||1
288927|NCT01909804|692485|P7|NOT COMPLETED|Overall Study||2
288928|NCT01909804|692486|P6|NOT COMPLETED|Overall Study||4
288929|NCT01909804|692487|P5|NOT COMPLETED|Overall Study||8
288930|NCT01909804|692488|P4|NOT COMPLETED|Overall Study||0
288931|NCT01909804|692489|P3|NOT COMPLETED|Overall Study||0
288932|NCT01909804|692490|P2|NOT COMPLETED|Overall Study||1
288933|NCT01909804|692491|P1|NOT COMPLETED|Overall Study||4
288934|NCT01909804|692480|P12|COMPLETED|Overall Study||26
288935|NCT01909804|692481|P11|COMPLETED|Overall Study||26
288936|NCT01909804|692482|P10|COMPLETED|Overall Study||28
288937|NCT01909804|692483|P9|COMPLETED|Overall Study||27
288938|NCT01909804|692484|P8|COMPLETED|Overall Study||25
288939|NCT01909804|692485|P7|COMPLETED|Overall Study||25
288940|NCT01909804|692486|P6|COMPLETED|Overall Study||21
288941|NCT01909804|692487|P5|COMPLETED|Overall Study||18
288942|NCT01909804|692488|P4|COMPLETED|Overall Study||26
288943|NCT01909804|692489|P3|COMPLETED|Overall Study||27
288944|NCT01909804|692490|P2|COMPLETED|Overall Study||27
288945|NCT01909804|692491|P1|COMPLETED|Overall Study||22
288946|NCT01909804|692480|P12|STARTED|Overall Study||29
288947|NCT01909804|692481|P11|STARTED|Overall Study||27
288948|NCT01909804|692482|P10|STARTED|Overall Study||29
288949|NCT01909804|692483|P9|STARTED|Overall Study||27
288950|NCT01909804|692484|P8|STARTED|Overall Study||26
288951|NCT01909804|692485|P7|STARTED|Overall Study||27
288952|NCT01909804|692486|P6|STARTED|Overall Study||25
288953|NCT01909804|692487|P5|STARTED|Overall Study||26
288954|NCT01909804|692488|P4|STARTED|Overall Study||26
288955|NCT01909804|692489|P3|STARTED|Overall Study||27
288956|NCT01909804|692490|P2|STARTED|Overall Study||28
288957|NCT01909804|692491|P1|STARTED|Overall Study||26
288958|NCT01909778|692537|P1|NOT COMPLETED|Overall Study||1
288959|NCT01909778|692537|P1|COMPLETED|Overall Study||1
288960|NCT01909778|692537|P1|STARTED|Overall Study||2
288961|NCT01909713|692561|P1|NOT COMPLETED|Overall Study||0
288962|NCT01909713|692561|P1|COMPLETED|Overall Study||35
288963|NCT01909713|692561|P1|STARTED|Overall Study||35
288964|NCT01909674|692616|P2|NOT COMPLETED|Overall Study||2
288965|NCT01909674|692617|P1|NOT COMPLETED|Overall Study||5
288966|NCT01909674|692616|P2|COMPLETED|Overall Study||7
288967|NCT01909674|692617|P1|COMPLETED|Overall Study||7
288968|NCT01909674|692616|P2|STARTED|Overall Study||9
288969|NCT01909674|692617|P1|STARTED|Overall Study||12
288970|NCT01909570|692625|P2|NOT COMPLETED|Overall Study||27
288971|NCT01909570|692626|P1|NOT COMPLETED|Overall Study||27
288972|NCT01909570|692625|P2|COMPLETED|Overall Study||64
288973|NCT01909570|692626|P1|COMPLETED|Overall Study||57
288974|NCT01909570|692625|P2|STARTED|Overall Study||91
288975|NCT01909570|692626|P1|STARTED|Overall Study||84
288976|NCT01909466|692636|P2|NOT COMPLETED|Overall Study||23
288977|NCT01909466|692637|P1|NOT COMPLETED|Overall Study||22
288978|NCT01909466|692636|P2|COMPLETED|Overall Study||50
288979|NCT01909466|692637|P1|COMPLETED|Overall Study||46
288980|NCT01909466|692636|P2|STARTED|Overall Study||73
288981|NCT01909466|692637|P1|STARTED|Overall Study||68
288982|NCT01909336|692660|P3|NOT COMPLETED|Overall Study||3
288983|NCT01909336|692661|P2|NOT COMPLETED|Overall Study||3
288984|NCT01909336|692662|P1|NOT COMPLETED|Overall Study||4
288985|NCT01909336|692660|P3|COMPLETED|Overall Study||52
288986|NCT01909336|692661|P2|COMPLETED|Overall Study||50
288987|NCT01909336|692662|P1|COMPLETED|Overall Study||49
288988|NCT01909336|692660|P3|STARTED|Overall Study||55
288989|NCT01909336|692661|P2|STARTED|Overall Study||53
288990|NCT01909336|692662|P1|STARTED|Overall Study||53
288991|NCT01909180|692676|P1|NOT COMPLETED|Overall Study||0
288992|NCT01909180|692676|P1|COMPLETED|Overall Study||49
288993|NCT01909180|692676|P1|STARTED|Overall Study||49
288994|NCT01909141|692684|P2|NOT COMPLETED|Overall Study||0
288995|NCT01909141|692685|P1|NOT COMPLETED|Overall Study||0
288996|NCT01909141|692684|P2|COMPLETED|Overall Study||50
288997|NCT01909141|692685|P1|COMPLETED|Overall Study||50
288998|NCT01909141|692684|P2|STARTED|Overall Study||50
288999|NCT01909141|692685|P1|STARTED|Overall Study||50
289000|NCT01909011|692701|P2|NOT COMPLETED|Overall Study||0
289001|NCT01909011|692702|P1|NOT COMPLETED|Overall Study||0
289002|NCT01909011|692701|P2|COMPLETED|Overall Study||9
289003|NCT01909011|692702|P1|COMPLETED|Overall Study||7
289004|NCT01909011|692701|P2|STARTED|Overall Study||9
289005|NCT01909011|692702|P1|STARTED|Overall Study||7
289006|NCT01908842|692714|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
289007|NCT01908842|692715|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
289008|NCT01908842|692714|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
289009|NCT01908842|692715|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
289010|NCT01908842|692714|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
289011|NCT01908842|692715|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
289012|NCT01908842|692714|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
289013|NCT01908842|692715|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
289014|NCT01908842|692714|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
289015|NCT01908842|692715|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
289016|NCT01908842|692714|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
289017|NCT01908842|692715|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
289018|NCT01908842|692714|P2|NOT COMPLETED|Induction||31
289019|NCT01908842|692715|P1|NOT COMPLETED|Induction||26
289020|NCT01908842|692714|P2|COMPLETED|Induction||344
289021|NCT01908842|692715|P1|COMPLETED|Induction||357
289022|NCT01908842|692714|P2|STARTED|Induction||375
289023|NCT01908842|692715|P1|STARTED|Induction||383
289024|NCT01908803|692735|P2|NOT COMPLETED|Overall Study||1
289025|NCT01908803|692736|P1|NOT COMPLETED|Overall Study||4
289026|NCT01908803|692735|P2|COMPLETED|Overall Study||23
289027|NCT01908803|692736|P1|COMPLETED|Overall Study||42
289028|NCT01908803|692735|P2|Treated|Overall Study||24
289029|NCT01908803|692736|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
289030|NCT01908803|692735|P2|STARTED|Overall Study||24
289031|NCT01908803|692736|P1|STARTED|Overall Study||46
289032|NCT01908140|692749|P2|NOT COMPLETED|Overall Study||79
289033|NCT01908140|692750|P1|NOT COMPLETED|Overall Study||66
289034|NCT01908140|692749|P2|COMPLETED|Overall Study||386
289035|NCT01908140|692750|P1|COMPLETED|Overall Study||402
289036|NCT01908140|692749|P2|STARTED|Overall Study||465
289037|NCT01908140|692750|P1|STARTED|Overall Study||468
289038|NCT01908127|692760|P2|NOT COMPLETED|Overall Study||0
289039|NCT01908127|692761|P1|NOT COMPLETED|Overall Study||1
289040|NCT01908127|692760|P2|COMPLETED|Overall Study||23
289041|NCT01908127|692761|P1|COMPLETED|Overall Study||22
289042|NCT01908127|692760|P2|STARTED|Overall Study||23
289043|NCT01908127|692761|P1|STARTED|Overall Study||23
289044|NCT01907906|692771|P2|NOT COMPLETED|Overall Study||1
289045|NCT01907906|692772|P1|NOT COMPLETED|Overall Study||4
289046|NCT01907906|692771|P2|COMPLETED|Overall Study||12
289047|NCT01907906|692772|P1|COMPLETED|Overall Study||12
289048|NCT01907906|692771|P2|STARTED|Overall Study||13
289049|NCT01907906|692772|P1|STARTED|Overall Study||16
289050|NCT01907854|692852|P2|NOT COMPLETED|Overall Study||13
289051|NCT01907854|692853|P1|NOT COMPLETED|Overall Study||16
289052|NCT01907854|692852|P2|COMPLETED|Overall Study||191
289053|NCT01907854|692853|P1|COMPLETED|Overall Study||187
289054|NCT01907854|692852|P2|Exposed|Overall Study||204
289055|NCT01907854|692853|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
289056|NCT01907854|692852|P2|STARTED|Overall Study||204
289057|NCT01907854|692853|P1|STARTED|Overall Study||203
289058|NCT01907516|692873|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
289059|NCT01907516|692874|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
289060|NCT01907516|692873|P2|COMPLETED|Second Intervention (3 Weeks)||34
289061|NCT01907516|692874|P1|COMPLETED|Second Intervention (3 Weeks)||40
289062|NCT01907516|692873|P2|STARTED|Second Intervention (3 Weeks)||34
289063|NCT01907516|692874|P1|STARTED|Second Intervention (3 Weeks)||40
289064|NCT01907516|692873|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
289065|NCT01907516|692874|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
289066|NCT01907516|692873|P2|COMPLETED|First Intervention (3 Weeks)||34
289067|NCT01907516|692874|P1|COMPLETED|First Intervention (3 Weeks)||40
289068|NCT01907516|692873|P2|STARTED|First Intervention (3 Weeks)||50
289069|NCT01907516|692874|P1|STARTED|First Intervention (3 Weeks)||50
289070|NCT01907490|692881|P1|NOT COMPLETED|Overall Study||0
289071|NCT01907490|692881|P1|COMPLETED|Overall Study||38
289072|NCT01907490|692881|P1|STARTED|Overall Study||38
289073|NCT01907334|692885|P2|NOT COMPLETED|Overall Study||0
289074|NCT01907334|692886|P1|NOT COMPLETED|Overall Study||0
289075|NCT01907334|692885|P2|COMPLETED|Overall Study||4
289076|NCT01907334|692886|P1|COMPLETED|Overall Study||6
289077|NCT01907334|692885|P2|STARTED|Overall Study||4
289078|NCT01907334|692886|P1|STARTED|Overall Study||6
289079|NCT01907321|692891|P1|NOT COMPLETED|Overall Study||2
289080|NCT01907321|692891|P1|COMPLETED|Overall Study||12
289081|NCT01907321|692891|P1|STARTED|Overall Study||14
289082|NCT01907113|692901|P5|NOT COMPLETED|Overall Study||0
289083|NCT01907113|692902|P4|NOT COMPLETED|Overall Study||0
289084|NCT01907113|692903|P3|NOT COMPLETED|Overall Study||0
289085|NCT01907113|692904|P2|NOT COMPLETED|Overall Study||0
289086|NCT01907113|692905|P1|NOT COMPLETED|Overall Study||0
289087|NCT01907113|692901|P5|COMPLETED|Overall Study||8
289088|NCT01907113|692902|P4|COMPLETED|Overall Study||8
289089|NCT01907113|692903|P3|COMPLETED|Overall Study||7
289090|NCT01907113|692904|P2|COMPLETED|Overall Study||9
289091|NCT01907113|692905|P1|COMPLETED|Overall Study||8
289092|NCT01907113|692901|P5|STARTED|Overall Study||8
289093|NCT01907113|692902|P4|STARTED|Overall Study||8
289094|NCT01907113|692903|P3|STARTED|Overall Study||7
289095|NCT01907113|692904|P2|STARTED|Overall Study||9
289096|NCT01907113|692905|P1|STARTED|Overall Study||8
289097|NCT01906658|692996|P4|NOT COMPLETED|Overall Study||0
289098|NCT01906658|692997|P3|NOT COMPLETED|Overall Study||3
289099|NCT01906658|692998|P2|NOT COMPLETED|Overall Study||1
289100|NCT01906658|692999|P1|NOT COMPLETED|Overall Study||2
289101|NCT01906658|692996|P4|COMPLETED|Overall Study||11
289102|NCT01906658|692997|P3|COMPLETED|Overall Study||7
289103|NCT01906658|692998|P2|COMPLETED|Overall Study||10
289104|NCT01906658|692999|P1|COMPLETED|Overall Study||9
289105|NCT01906658|692996|P4|STARTED|Overall Study||11
289106|NCT01906658|692997|P3|STARTED|Overall Study||10
289107|NCT01906658|692998|P2|STARTED|Overall Study||11
289108|NCT01906658|692999|P1|STARTED|Overall Study||11
289109|NCT01906515|693023|P2|NOT COMPLETED|Overall Study||0
289110|NCT01906515|693024|P1|NOT COMPLETED|Overall Study||0
289111|NCT01906515|693023|P2|COMPLETED|Overall Study||61
289112|NCT01906515|693024|P1|COMPLETED|Overall Study||45
289113|NCT01906515|693023|P2|STARTED|Overall Study||61
289114|NCT01906515|693024|P1|STARTED|Overall Study||45
289115|NCT01905956|693034|P2|NOT COMPLETED|Overall Study||11
289116|NCT01905956|693035|P1|NOT COMPLETED|Overall Study||6
289117|NCT01905956|693034|P2|COMPLETED|Overall Study|Per-protocol population|48
289118|NCT01905956|693035|P1|COMPLETED|Overall Study|Per-protocol population|54
289119|NCT01905956|693034|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
289120|NCT01905956|693035|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
289121|NCT01905956|693034|P2|STARTED|Overall Study|Randomized|59
289122|NCT01905956|693035|P1|STARTED|Overall Study|Randomized|60
289123|NCT01905657|693060|P3|NOT COMPLETED|Overall Study||328
289124|NCT01905657|693061|P2|NOT COMPLETED|Overall Study||346
289125|NCT01905657|693062|P1|NOT COMPLETED|Overall Study||345
289126|NCT01905657|693060|P3|COMPLETED|Overall Study||15
289127|NCT01905657|693061|P2|COMPLETED|Overall Study||0
289128|NCT01905657|693062|P1|COMPLETED|Overall Study||0
289129|NCT01905657|693060|P3|Treated|Overall Study||309
289130|NCT01905657|693061|P2|Treated|Overall Study||343
289131|NCT01905657|693062|P1|Treated|Overall Study||339
289132|NCT01905657|693060|P3|STARTED|Overall Study||343
289133|NCT01905657|693061|P2|STARTED|Overall Study||346
289134|NCT01905657|693062|P1|STARTED|Overall Study||345
289135|NCT01904773|693085|P9|NOT COMPLETED|Sixth Intervention||0
289136|NCT01904773|693086|P8|NOT COMPLETED|Sixth Intervention||0
289137|NCT01904773|693087|P7|NOT COMPLETED|Sixth Intervention||0
289138|NCT01904773|693088|P6|NOT COMPLETED|Sixth Intervention||0
289139|NCT01904773|693089|P5|NOT COMPLETED|Sixth Intervention||0
289140|NCT01904773|693090|P4|NOT COMPLETED|Sixth Intervention||0
289141|NCT01904773|693091|P3|NOT COMPLETED|Sixth Intervention||0
289142|NCT01904773|693092|P2|NOT COMPLETED|Sixth Intervention||0
289143|NCT01904773|693093|P1|NOT COMPLETED|Sixth Intervention||0
289144|NCT01904773|693085|P9|COMPLETED|Sixth Intervention||4
289145|NCT01904773|693086|P8|COMPLETED|Sixth Intervention||2
289146|NCT01904773|693087|P7|COMPLETED|Sixth Intervention||3
289147|NCT01904773|693088|P6|COMPLETED|Sixth Intervention||4
289148|NCT01904773|693089|P5|COMPLETED|Sixth Intervention||3
289149|NCT01904773|693090|P4|COMPLETED|Sixth Intervention||2
289150|NCT01904773|693091|P3|COMPLETED|Sixth Intervention||1
289151|NCT01904773|693092|P2|COMPLETED|Sixth Intervention||0
289152|NCT01904773|693093|P1|COMPLETED|Sixth Intervention||0
289153|NCT01904773|693085|P9|STARTED|Sixth Intervention||4
289154|NCT01904773|693086|P8|STARTED|Sixth Intervention||2
289155|NCT01904773|693087|P7|STARTED|Sixth Intervention||3
289156|NCT01904773|693088|P6|STARTED|Sixth Intervention||4
289157|NCT01904773|693089|P5|STARTED|Sixth Intervention||3
289158|NCT01904773|693090|P4|STARTED|Sixth Intervention||2
289159|NCT01904773|693091|P3|STARTED|Sixth Intervention||1
289160|NCT01904773|693092|P2|STARTED|Sixth Intervention||0
289161|NCT01904773|693093|P1|STARTED|Sixth Intervention||0
289162|NCT01904773|693085|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289163|NCT01904773|693086|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289164|NCT01904773|693087|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289165|NCT01904773|693088|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289166|NCT01904773|693089|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289167|NCT01904773|693090|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289168|NCT01904773|693091|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289169|NCT01904773|693092|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
289170|NCT01904773|693093|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
289171|NCT01904773|693085|P9|COMPLETED|Placebo Washout Fifth Intervention||4
289172|NCT01904773|693086|P8|COMPLETED|Placebo Washout Fifth Intervention||2
289173|NCT01904773|693087|P7|COMPLETED|Placebo Washout Fifth Intervention||3
289174|NCT01904773|693088|P6|COMPLETED|Placebo Washout Fifth Intervention||4
289175|NCT01904773|693089|P5|COMPLETED|Placebo Washout Fifth Intervention||3
289176|NCT01904773|693090|P4|COMPLETED|Placebo Washout Fifth Intervention||2
289177|NCT01904773|693091|P3|COMPLETED|Placebo Washout Fifth Intervention||1
289178|NCT01904773|693092|P2|COMPLETED|Placebo Washout Fifth Intervention||0
289179|NCT01904773|693093|P1|COMPLETED|Placebo Washout Fifth Intervention||0
289180|NCT01904773|693085|P9|STARTED|Placebo Washout Fifth Intervention||4
289181|NCT01904773|693086|P8|STARTED|Placebo Washout Fifth Intervention||2
289182|NCT01904773|693087|P7|STARTED|Placebo Washout Fifth Intervention||3
289183|NCT01904773|693088|P6|STARTED|Placebo Washout Fifth Intervention||4
289184|NCT01904773|693089|P5|STARTED|Placebo Washout Fifth Intervention||3
289185|NCT01904773|693090|P4|STARTED|Placebo Washout Fifth Intervention||2
289186|NCT01904773|693091|P3|STARTED|Placebo Washout Fifth Intervention||1
289187|NCT01904773|693092|P2|STARTED|Placebo Washout Fifth Intervention||1
289188|NCT01904773|693093|P1|STARTED|Placebo Washout Fifth Intervention||0
289189|NCT01904773|693085|P9|NOT COMPLETED|Fifth Intervention||0
289190|NCT01904773|693086|P8|NOT COMPLETED|Fifth Intervention||1
289191|NCT01904773|693087|P7|NOT COMPLETED|Fifth Intervention||0
289192|NCT01904773|693088|P6|NOT COMPLETED|Fifth Intervention||0
289193|NCT01904773|693089|P5|NOT COMPLETED|Fifth Intervention||0
289194|NCT01904773|693090|P4|NOT COMPLETED|Fifth Intervention||0
289195|NCT01904773|693091|P3|NOT COMPLETED|Fifth Intervention||0
289196|NCT01904773|693092|P2|NOT COMPLETED|Fifth Intervention||0
289197|NCT01904773|693093|P1|NOT COMPLETED|Fifth Intervention||0
289198|NCT01904773|693085|P9|COMPLETED|Fifth Intervention||4
289199|NCT01904773|693086|P8|COMPLETED|Fifth Intervention||2
289200|NCT01904773|693087|P7|COMPLETED|Fifth Intervention||3
289201|NCT01904773|693088|P6|COMPLETED|Fifth Intervention||4
289202|NCT01904773|693089|P5|COMPLETED|Fifth Intervention||3
289203|NCT01904773|693090|P4|COMPLETED|Fifth Intervention||2
289204|NCT01904773|693091|P3|COMPLETED|Fifth Intervention||1
289205|NCT01904773|693092|P2|COMPLETED|Fifth Intervention||1
289206|NCT01904773|693093|P1|COMPLETED|Fifth Intervention||0
289207|NCT01904773|693085|P9|STARTED|Fifth Intervention||4
289208|NCT01904773|693086|P8|STARTED|Fifth Intervention||3
289209|NCT01904773|693087|P7|STARTED|Fifth Intervention||3
289210|NCT01904773|693088|P6|STARTED|Fifth Intervention||4
289211|NCT01904773|693089|P5|STARTED|Fifth Intervention||3
289212|NCT01904773|693090|P4|STARTED|Fifth Intervention||2
289213|NCT01904773|693091|P3|STARTED|Fifth Intervention||1
289214|NCT01904773|693092|P2|STARTED|Fifth Intervention||1
289215|NCT01904773|693093|P1|STARTED|Fifth Intervention||0
289216|NCT01904773|693085|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289217|NCT01904773|693086|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289218|NCT01904773|693087|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289219|NCT01904773|693088|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289220|NCT01904773|693089|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289221|NCT01904773|693090|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289222|NCT01904773|693091|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289223|NCT01904773|693092|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289224|NCT01904773|693093|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
289225|NCT01904773|693085|P9|COMPLETED|Placebo Washout Fourth Intervention||4
289226|NCT01904773|693086|P8|COMPLETED|Placebo Washout Fourth Intervention||3
289227|NCT01904773|693087|P7|COMPLETED|Placebo Washout Fourth Intervention||3
289228|NCT01904773|693088|P6|COMPLETED|Placebo Washout Fourth Intervention||4
289229|NCT01904773|693089|P5|COMPLETED|Placebo Washout Fourth Intervention||3
289230|NCT01904773|693090|P4|COMPLETED|Placebo Washout Fourth Intervention||2
289231|NCT01904773|693091|P3|COMPLETED|Placebo Washout Fourth Intervention||1
289232|NCT01904773|693092|P2|COMPLETED|Placebo Washout Fourth Intervention||1
289233|NCT01904773|693093|P1|COMPLETED|Placebo Washout Fourth Intervention||0
289234|NCT01904773|693085|P9|STARTED|Placebo Washout Fourth Intervention||4
289235|NCT01904773|693086|P8|STARTED|Placebo Washout Fourth Intervention||3
289236|NCT01904773|693087|P7|STARTED|Placebo Washout Fourth Intervention||3
289237|NCT01904773|693088|P6|STARTED|Placebo Washout Fourth Intervention||4
289238|NCT01904773|693089|P5|STARTED|Placebo Washout Fourth Intervention||3
289239|NCT01904773|693090|P4|STARTED|Placebo Washout Fourth Intervention||2
289240|NCT01904773|693091|P3|STARTED|Placebo Washout Fourth Intervention||1
289241|NCT01904773|693092|P2|STARTED|Placebo Washout Fourth Intervention||1
289242|NCT01904773|693093|P1|STARTED|Placebo Washout Fourth Intervention||0
289243|NCT01904773|693085|P9|NOT COMPLETED|Fourth Intervention||0
289244|NCT01904773|693086|P8|NOT COMPLETED|Fourth Intervention||0
289245|NCT01904773|693087|P7|NOT COMPLETED|Fourth Intervention||0
289246|NCT01904773|693088|P6|NOT COMPLETED|Fourth Intervention||0
289247|NCT01904773|693089|P5|NOT COMPLETED|Fourth Intervention||0
289248|NCT01904773|693090|P4|NOT COMPLETED|Fourth Intervention||0
289249|NCT01904773|693091|P3|NOT COMPLETED|Fourth Intervention||0
289250|NCT01904773|693092|P2|NOT COMPLETED|Fourth Intervention||0
289251|NCT01904773|693093|P1|NOT COMPLETED|Fourth Intervention||0
289252|NCT01904773|693085|P9|COMPLETED|Fourth Intervention||4
289253|NCT01904773|693086|P8|COMPLETED|Fourth Intervention||3
289254|NCT01904773|693087|P7|COMPLETED|Fourth Intervention||3
289255|NCT01904773|693088|P6|COMPLETED|Fourth Intervention||4
289256|NCT01904773|693089|P5|COMPLETED|Fourth Intervention||3
289257|NCT01904773|693090|P4|COMPLETED|Fourth Intervention||2
289258|NCT01904773|693091|P3|COMPLETED|Fourth Intervention||1
289259|NCT01904773|693092|P2|COMPLETED|Fourth Intervention||1
289260|NCT01904773|693093|P1|COMPLETED|Fourth Intervention||0
289261|NCT01904773|693085|P9|STARTED|Fourth Intervention||4
289262|NCT01904773|693086|P8|STARTED|Fourth Intervention||3
289263|NCT01904773|693087|P7|STARTED|Fourth Intervention||3
289264|NCT01904773|693088|P6|STARTED|Fourth Intervention||4
289265|NCT01904773|693089|P5|STARTED|Fourth Intervention||3
289266|NCT01904773|693090|P4|STARTED|Fourth Intervention||2
289267|NCT01904773|693091|P3|STARTED|Fourth Intervention||1
289268|NCT01904773|693092|P2|STARTED|Fourth Intervention||1
289269|NCT01904773|693093|P1|STARTED|Fourth Intervention||0
289270|NCT01904773|693085|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
289271|NCT01904773|693086|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
289272|NCT01904773|693087|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
289273|NCT01904773|693088|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
289274|NCT01904773|693089|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
289275|NCT01904773|693090|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
289276|NCT01904773|693091|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
289277|NCT01904773|693092|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
289278|NCT01904773|693093|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
289279|NCT01904773|693085|P9|COMPLETED|Placebo Washout Third Intervention||4
289280|NCT01904773|693086|P8|COMPLETED|Placebo Washout Third Intervention||3
289281|NCT01904773|693087|P7|COMPLETED|Placebo Washout Third Intervention||3
289282|NCT01904773|693088|P6|COMPLETED|Placebo Washout Third Intervention||4
289283|NCT01904773|693089|P5|COMPLETED|Placebo Washout Third Intervention||3
289284|NCT01904773|693090|P4|COMPLETED|Placebo Washout Third Intervention||2
289285|NCT01904773|693091|P3|COMPLETED|Placebo Washout Third Intervention||1
289286|NCT01904773|693092|P2|COMPLETED|Placebo Washout Third Intervention||1
289287|NCT01904773|693093|P1|COMPLETED|Placebo Washout Third Intervention||0
289288|NCT01904773|693085|P9|STARTED|Placebo Washout Third Intervention||4
289289|NCT01904773|693086|P8|STARTED|Placebo Washout Third Intervention||3
289290|NCT01904773|693087|P7|STARTED|Placebo Washout Third Intervention||3
289291|NCT01904773|693088|P6|STARTED|Placebo Washout Third Intervention||4
289292|NCT01904773|693089|P5|STARTED|Placebo Washout Third Intervention||3
289293|NCT01904773|693090|P4|STARTED|Placebo Washout Third Intervention||2
289294|NCT01904773|693091|P3|STARTED|Placebo Washout Third Intervention||1
289295|NCT01904773|693092|P2|STARTED|Placebo Washout Third Intervention||1
289296|NCT01904773|693093|P1|STARTED|Placebo Washout Third Intervention||0
289297|NCT01904773|693085|P9|NOT COMPLETED|Third Intervention||0
289298|NCT01904773|693086|P8|NOT COMPLETED|Third Intervention||0
289299|NCT01904773|693087|P7|NOT COMPLETED|Third Intervention||0
289300|NCT01904773|693088|P6|NOT COMPLETED|Third Intervention||0
289301|NCT01904773|693089|P5|NOT COMPLETED|Third Intervention||0
289302|NCT01904773|693090|P4|NOT COMPLETED|Third Intervention||0
289303|NCT01904773|693091|P3|NOT COMPLETED|Third Intervention||0
289304|NCT01904773|693092|P2|NOT COMPLETED|Third Intervention||0
289305|NCT01904773|693093|P1|NOT COMPLETED|Third Intervention||0
289306|NCT01904773|693085|P9|COMPLETED|Third Intervention||4
289307|NCT01904773|693086|P8|COMPLETED|Third Intervention||3
289308|NCT01904773|693087|P7|COMPLETED|Third Intervention||3
289309|NCT01904773|693088|P6|COMPLETED|Third Intervention||4
289310|NCT01904773|693089|P5|COMPLETED|Third Intervention||3
289311|NCT01904773|693090|P4|COMPLETED|Third Intervention||2
289312|NCT01904773|693091|P3|COMPLETED|Third Intervention||1
289313|NCT01904773|693092|P2|COMPLETED|Third Intervention||1
289314|NCT01904773|693093|P1|COMPLETED|Third Intervention||0
289315|NCT01904773|693085|P9|STARTED|Third Intervention||4
289316|NCT01904773|693086|P8|STARTED|Third Intervention||3
289317|NCT01904773|693087|P7|STARTED|Third Intervention||3
289318|NCT01904773|693088|P6|STARTED|Third Intervention||4
289319|NCT01904773|693089|P5|STARTED|Third Intervention||3
289320|NCT01904773|693090|P4|STARTED|Third Intervention||2
289321|NCT01904773|693091|P3|STARTED|Third Intervention||1
289322|NCT01904773|693092|P2|STARTED|Third Intervention||1
289323|NCT01904773|693093|P1|STARTED|Third Intervention||0
289324|NCT01904773|693085|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
289325|NCT01904773|693086|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
289326|NCT01904773|693087|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
289327|NCT01904773|693088|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
289328|NCT01904773|693089|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
289329|NCT01904773|693090|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
289330|NCT01904773|693091|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
289331|NCT01904773|693092|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
289332|NCT01904773|693093|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
289333|NCT01904773|693085|P9|COMPLETED|Placebo Washout Second Intervention||4
289334|NCT01904773|693086|P8|COMPLETED|Placebo Washout Second Intervention||3
289335|NCT01904773|693087|P7|COMPLETED|Placebo Washout Second Intervention||3
289336|NCT01904773|693088|P6|COMPLETED|Placebo Washout Second Intervention||4
289337|NCT01904773|693089|P5|COMPLETED|Placebo Washout Second Intervention||3
289338|NCT01904773|693090|P4|COMPLETED|Placebo Washout Second Intervention||2
289339|NCT01904773|693091|P3|COMPLETED|Placebo Washout Second Intervention||1
289340|NCT01904773|693092|P2|COMPLETED|Placebo Washout Second Intervention||1
289341|NCT01904773|693093|P1|COMPLETED|Placebo Washout Second Intervention||0
289342|NCT01904773|693085|P9|STARTED|Placebo Washout Second Intervention||4
289343|NCT01904773|693086|P8|STARTED|Placebo Washout Second Intervention||3
289344|NCT01904773|693087|P7|STARTED|Placebo Washout Second Intervention||3
289345|NCT01904773|693088|P6|STARTED|Placebo Washout Second Intervention||4
289346|NCT01904773|693089|P5|STARTED|Placebo Washout Second Intervention||3
289347|NCT01904773|693090|P4|STARTED|Placebo Washout Second Intervention||2
289348|NCT01904773|693091|P3|STARTED|Placebo Washout Second Intervention||1
289349|NCT01904773|693092|P2|STARTED|Placebo Washout Second Intervention||1
289350|NCT01904773|693093|P1|STARTED|Placebo Washout Second Intervention||0
289351|NCT01904773|693085|P9|NOT COMPLETED|Second Intervention||0
289352|NCT01904773|693086|P8|NOT COMPLETED|Second Intervention||0
289353|NCT01904773|693087|P7|NOT COMPLETED|Second Intervention||0
289354|NCT01904773|693088|P6|NOT COMPLETED|Second Intervention||0
289355|NCT01904773|693089|P5|NOT COMPLETED|Second Intervention||0
289356|NCT01904773|693090|P4|NOT COMPLETED|Second Intervention||0
289357|NCT01904773|693091|P3|NOT COMPLETED|Second Intervention||0
289358|NCT01904773|693092|P2|NOT COMPLETED|Second Intervention||0
289359|NCT01904773|693093|P1|NOT COMPLETED|Second Intervention||0
289360|NCT01904773|693085|P9|COMPLETED|Second Intervention||4
289361|NCT01904773|693086|P8|COMPLETED|Second Intervention||3
289362|NCT01904773|693087|P7|COMPLETED|Second Intervention||3
289363|NCT01904773|693088|P6|COMPLETED|Second Intervention||4
289364|NCT01904773|693089|P5|COMPLETED|Second Intervention||3
289365|NCT01904773|693090|P4|COMPLETED|Second Intervention||2
289366|NCT01904773|693091|P3|COMPLETED|Second Intervention||1
289367|NCT01904773|693092|P2|COMPLETED|Second Intervention||1
289368|NCT01904773|693093|P1|COMPLETED|Second Intervention||0
289369|NCT01904773|693085|P9|STARTED|Second Intervention||4
289370|NCT01904773|693086|P8|STARTED|Second Intervention||3
289371|NCT01904773|693087|P7|STARTED|Second Intervention||3
289372|NCT01904773|693088|P6|STARTED|Second Intervention||4
289373|NCT01904773|693089|P5|STARTED|Second Intervention||3
289374|NCT01904773|693090|P4|STARTED|Second Intervention||2
289375|NCT01904773|693091|P3|STARTED|Second Intervention||1
289376|NCT01904773|693092|P2|STARTED|Second Intervention||1
289377|NCT01904773|693093|P1|STARTED|Second Intervention||0
289378|NCT01904773|693085|P9|NOT COMPLETED|Placebo Washout First Intervention||0
289379|NCT01904773|693086|P8|NOT COMPLETED|Placebo Washout First Intervention||0
289380|NCT01904773|693087|P7|NOT COMPLETED|Placebo Washout First Intervention||0
289381|NCT01904773|693088|P6|NOT COMPLETED|Placebo Washout First Intervention||0
289382|NCT01904773|693089|P5|NOT COMPLETED|Placebo Washout First Intervention||0
289383|NCT01904773|693090|P4|NOT COMPLETED|Placebo Washout First Intervention||0
289384|NCT01904773|693091|P3|NOT COMPLETED|Placebo Washout First Intervention||0
289385|NCT01904773|693092|P2|NOT COMPLETED|Placebo Washout First Intervention||1
289386|NCT01904773|693093|P1|NOT COMPLETED|Placebo Washout First Intervention||0
289387|NCT01904773|693085|P9|COMPLETED|Placebo Washout First Intervention||4
289388|NCT01904773|693086|P8|COMPLETED|Placebo Washout First Intervention||3
289389|NCT01904773|693087|P7|COMPLETED|Placebo Washout First Intervention||3
289390|NCT01904773|693088|P6|COMPLETED|Placebo Washout First Intervention||4
289391|NCT01904773|693089|P5|COMPLETED|Placebo Washout First Intervention||3
289392|NCT01904773|693090|P4|COMPLETED|Placebo Washout First Intervention||2
289393|NCT01904773|693091|P3|COMPLETED|Placebo Washout First Intervention||1
289394|NCT01904773|693092|P2|COMPLETED|Placebo Washout First Intervention||1
289395|NCT01904773|693093|P1|COMPLETED|Placebo Washout First Intervention||0
289396|NCT01904773|693085|P9|STARTED|Placebo Washout First Intervention||4
289397|NCT01904773|693086|P8|STARTED|Placebo Washout First Intervention||3
289398|NCT01904773|693087|P7|STARTED|Placebo Washout First Intervention||3
289399|NCT01904773|693088|P6|STARTED|Placebo Washout First Intervention||4
289400|NCT01904773|693089|P5|STARTED|Placebo Washout First Intervention||3
289401|NCT01904773|693090|P4|STARTED|Placebo Washout First Intervention||2
289402|NCT01904773|693091|P3|STARTED|Placebo Washout First Intervention||1
289403|NCT01904773|693092|P2|STARTED|Placebo Washout First Intervention||2
289404|NCT01904773|693093|P1|STARTED|Placebo Washout First Intervention||0
289405|NCT01904773|693085|P9|NOT COMPLETED|First Intervention||0
289406|NCT01904773|693086|P8|NOT COMPLETED|First Intervention||0
289407|NCT01904773|693087|P7|NOT COMPLETED|First Intervention||1
289408|NCT01904773|693088|P6|NOT COMPLETED|First Intervention||0
289409|NCT01904773|693089|P5|NOT COMPLETED|First Intervention||0
289410|NCT01904773|693090|P4|NOT COMPLETED|First Intervention||0
289411|NCT01904773|693091|P3|NOT COMPLETED|First Intervention||0
289412|NCT01904773|693092|P2|NOT COMPLETED|First Intervention||0
289413|NCT01904773|693093|P1|NOT COMPLETED|First Intervention||0
289414|NCT01904773|693085|P9|COMPLETED|First Intervention||4
289415|NCT01904773|693086|P8|COMPLETED|First Intervention||3
289416|NCT01904773|693087|P7|COMPLETED|First Intervention||3
289417|NCT01904773|693088|P6|COMPLETED|First Intervention||4
289418|NCT01904773|693089|P5|COMPLETED|First Intervention||3
289419|NCT01904773|693090|P4|COMPLETED|First Intervention||2
289420|NCT01904773|693091|P3|COMPLETED|First Intervention||1
289421|NCT01904773|693092|P2|COMPLETED|First Intervention||2
289422|NCT01904773|693093|P1|COMPLETED|First Intervention||0
289423|NCT01904773|693085|P9|STARTED|First Intervention||4
289424|NCT01904773|693086|P8|STARTED|First Intervention||3
289425|NCT01904773|693087|P7|STARTED|First Intervention||4
289426|NCT01904773|693088|P6|STARTED|First Intervention||4
289427|NCT01904773|693089|P5|STARTED|First Intervention||3
289428|NCT01904773|693090|P4|STARTED|First Intervention||2
289429|NCT01904773|693091|P3|STARTED|First Intervention||1
289430|NCT01904773|693092|P2|STARTED|First Intervention||2
289431|NCT01904773|693093|P1|STARTED|First Intervention||0
289432|NCT01904773|693085|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289433|NCT01904773|693086|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289434|NCT01904773|693087|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289435|NCT01904773|693088|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289436|NCT01904773|693089|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289437|NCT01904773|693090|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289438|NCT01904773|693091|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289439|NCT01904773|693092|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289440|NCT01904773|693093|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
289441|NCT01904773|693085|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289442|NCT01904773|693086|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289443|NCT01904773|693087|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289444|NCT01904773|693088|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289445|NCT01904773|693089|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289446|NCT01904773|693090|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289447|NCT01904773|693091|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289448|NCT01904773|693092|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289449|NCT01904773|693093|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
289450|NCT01904773|693085|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289451|NCT01904773|693086|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289452|NCT01904773|693087|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289453|NCT01904773|693088|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289454|NCT01904773|693089|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289455|NCT01904773|693090|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289456|NCT01904773|693091|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289457|NCT01904773|693092|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289458|NCT01904773|693093|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
289459|NCT01904773|693085|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289460|NCT01904773|693086|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289461|NCT01904773|693087|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289462|NCT01904773|693088|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289463|NCT01904773|693089|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289464|NCT01904773|693090|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289465|NCT01904773|693091|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289466|NCT01904773|693092|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289467|NCT01904773|693093|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
289468|NCT01904773|693085|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289469|NCT01904773|693086|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289470|NCT01904773|693087|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289471|NCT01904773|693088|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289472|NCT01904773|693089|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289473|NCT01904773|693090|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289474|NCT01904773|693091|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289475|NCT01904773|693092|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
289476|NCT01904773|693093|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
289477|NCT01904773|693085|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289478|NCT01904773|693086|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289479|NCT01904773|693087|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289480|NCT01904773|693088|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289481|NCT01904773|693089|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289482|NCT01904773|693090|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289483|NCT01904773|693091|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289484|NCT01904773|693092|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289485|NCT01904773|693093|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289486|NCT01904773|693085|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289487|NCT01904773|693086|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289488|NCT01904773|693087|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289489|NCT01904773|693088|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289490|NCT01904773|693089|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289491|NCT01904773|693090|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289492|NCT01904773|693091|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289493|NCT01904773|693092|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289494|NCT01904773|693093|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
289495|NCT01904773|693085|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289496|NCT01904773|693086|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289497|NCT01904773|693087|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289498|NCT01904773|693088|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289499|NCT01904773|693089|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289500|NCT01904773|693090|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289501|NCT01904773|693091|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289502|NCT01904773|693092|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
289503|NCT01904773|693093|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
289504|NCT01904773|693085|P9|NOT COMPLETED|Screen||0
289505|NCT01904773|693086|P8|NOT COMPLETED|Screen||0
289506|NCT01904773|693087|P7|NOT COMPLETED|Screen||0
289507|NCT01904773|693088|P6|NOT COMPLETED|Screen||0
289508|NCT01904773|693089|P5|NOT COMPLETED|Screen||0
289509|NCT01904773|693090|P4|NOT COMPLETED|Screen||0
289510|NCT01904773|693091|P3|NOT COMPLETED|Screen||0
289511|NCT01904773|693092|P2|NOT COMPLETED|Screen||0
289512|NCT01904773|693093|P1|NOT COMPLETED|Screen||4
289513|NCT01904773|693085|P9|COMPLETED|Screen||0
289514|NCT01904773|693086|P8|COMPLETED|Screen||0
289515|NCT01904773|693087|P7|COMPLETED|Screen||0
289516|NCT01904773|693088|P6|COMPLETED|Screen||0
289517|NCT01904773|693089|P5|COMPLETED|Screen||0
289518|NCT01904773|693090|P4|COMPLETED|Screen||0
289519|NCT01904773|693091|P3|COMPLETED|Screen||0
289520|NCT01904773|693092|P2|COMPLETED|Screen||0
289521|NCT01904773|693093|P1|COMPLETED|Screen||24
289522|NCT01904773|693085|P9|STARTED|Screen||0
289523|NCT01904773|693086|P8|STARTED|Screen||0
289524|NCT01904773|693087|P7|STARTED|Screen||0
289525|NCT01904773|693088|P6|STARTED|Screen||0
289526|NCT01904773|693089|P5|STARTED|Screen||0
289527|NCT01904773|693090|P4|STARTED|Screen||0
289528|NCT01904773|693091|P3|STARTED|Screen||0
289529|NCT01904773|693092|P2|STARTED|Screen||0
289530|NCT01904773|693093|P1|STARTED|Screen||28
289531|NCT01904760|693110|P2|NOT COMPLETED|Overall Study||0
289532|NCT01904760|693111|P1|NOT COMPLETED|Overall Study||1
289533|NCT01904760|693110|P2|COMPLETED|Overall Study||40
289534|NCT01904760|693111|P1|COMPLETED|Overall Study||39
289535|NCT01904760|693110|P2|STARTED|Overall Study||40
289536|NCT01904760|693111|P1|STARTED|Overall Study||40
289537|NCT01904721|693126|P7|NOT COMPLETED|Overall Study||7
289538|NCT01904721|693127|P6|NOT COMPLETED|Overall Study||9
289539|NCT01904721|693128|P5|NOT COMPLETED|Overall Study||8
289540|NCT01904721|693129|P4|NOT COMPLETED|Overall Study||1
289541|NCT01904721|693130|P3|NOT COMPLETED|Overall Study||1
289542|NCT01904721|693131|P2|NOT COMPLETED|Overall Study||0
289543|NCT01904721|693132|P1|NOT COMPLETED|Overall Study||0
289544|NCT01904721|693126|P7|COMPLETED|Overall Study||57
289545|NCT01904721|693127|P6|COMPLETED|Overall Study||56
289546|NCT01904721|693128|P5|COMPLETED|Overall Study||57
289547|NCT01904721|693129|P4|COMPLETED|Overall Study||11
289548|NCT01904721|693130|P3|COMPLETED|Overall Study||11
289549|NCT01904721|693131|P2|COMPLETED|Overall Study||13
289550|NCT01904721|693132|P1|COMPLETED|Overall Study||13
289551|NCT01904721|693126|P7|STARTED|Overall Study||64
289552|NCT01904721|693127|P6|STARTED|Overall Study||65
289553|NCT01904721|693128|P5|STARTED|Overall Study||65
289554|NCT01904721|693129|P4|STARTED|Overall Study||12
289555|NCT01904721|693130|P3|STARTED|Overall Study||12
289556|NCT01904721|693131|P2|STARTED|Overall Study||13
289557|NCT01904721|693132|P1|STARTED|Overall Study||13
289558|NCT01905553|693161|P2|NOT COMPLETED|Period 2||0
289559|NCT01905553|693162|P1|NOT COMPLETED|Period 2||1
289560|NCT01905553|693161|P2|COMPLETED|Period 2||4
289561|NCT01905553|693162|P1|COMPLETED|Period 2||4
289562|NCT01905553|693161|P2|STARTED|Period 2||4
289563|NCT01905553|693162|P1|STARTED|Period 2||5
289564|NCT01905553|693161|P2|NOT COMPLETED|Period 1||0
289565|NCT01905553|693162|P1|NOT COMPLETED|Period 1||0
289566|NCT01905553|693161|P2|COMPLETED|Period 1||4
289567|NCT01905553|693162|P1|COMPLETED|Period 1||5
289568|NCT01905553|693161|P2|STARTED|Period 1||4
289569|NCT01905553|693162|P1|STARTED|Period 1||5
289570|NCT01905540|693176|P4|NOT COMPLETED|Period 3||1
289571|NCT01905540|693177|P3|NOT COMPLETED|Period 3||1
289572|NCT01905540|693178|P2|NOT COMPLETED|Period 3||0
289573|NCT01905540|693179|P1|NOT COMPLETED|Period 3||1
289574|NCT01905540|693176|P4|COMPLETED|Period 3||6
289575|NCT01905540|693177|P3|COMPLETED|Period 3||6
289576|NCT01905540|693178|P2|COMPLETED|Period 3||7
289577|NCT01905540|693179|P1|COMPLETED|Period 3||6
289578|NCT01905540|693176|P4|STARTED|Period 3||7
289579|NCT01905540|693177|P3|STARTED|Period 3||7
289580|NCT01905540|693178|P2|STARTED|Period 3||7
289581|NCT01905540|693179|P1|STARTED|Period 3||7
289582|NCT01905540|693176|P4|NOT COMPLETED|Period 2||0
289583|NCT01905540|693177|P3|NOT COMPLETED|Period 2||0
289584|NCT01905540|693178|P2|NOT COMPLETED|Period 2||0
289585|NCT01905540|693179|P1|NOT COMPLETED|Period 2||0
289586|NCT01905540|693176|P4|COMPLETED|Period 2||7
289587|NCT01905540|693177|P3|COMPLETED|Period 2||7
289588|NCT01905540|693178|P2|COMPLETED|Period 2||7
289589|NCT01905540|693179|P1|COMPLETED|Period 2||7
289590|NCT01905540|693176|P4|STARTED|Period 2||7
289591|NCT01905540|693177|P3|STARTED|Period 2||7
289592|NCT01905540|693178|P2|STARTED|Period 2||7
289593|NCT01905540|693179|P1|STARTED|Period 2||7
289594|NCT01905540|693176|P4|NOT COMPLETED|Period 1||0
289595|NCT01905540|693177|P3|NOT COMPLETED|Period 1||0
289596|NCT01905540|693178|P2|NOT COMPLETED|Period 1||0
289597|NCT01905540|693179|P1|NOT COMPLETED|Period 1||0
289598|NCT01905540|693176|P4|COMPLETED|Period 1||7
289599|NCT01905540|693177|P3|COMPLETED|Period 1||7
289600|NCT01905540|693178|P2|COMPLETED|Period 1||7
289601|NCT01905540|693179|P1|COMPLETED|Period 1||7
289602|NCT01905540|693176|P4|STARTED|Period 1||7
289603|NCT01905540|693177|P3|STARTED|Period 1||7
289604|NCT01905540|693178|P2|STARTED|Period 1||7
289605|NCT01905540|693179|P1|STARTED|Period 1||7
289606|NCT01905254|693197|P1|NOT COMPLETED|Overall Study||0
289607|NCT01905254|693197|P1|COMPLETED|Overall Study||34
289608|NCT01905254|693197|P1|STARTED|Overall Study||34
289609|NCT01904604|693204|P3|NOT COMPLETED|Overall Study||0
289610|NCT01904604|693205|P2|NOT COMPLETED|Overall Study||4
289611|NCT01904604|693206|P1|NOT COMPLETED|Overall Study||3
289612|NCT01904604|693204|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
289613|NCT01904604|693205|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
289614|NCT01904604|693206|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
289615|NCT01904604|693204|P3|STARTED|Overall Study||25
289616|NCT01904604|693205|P2|STARTED|Overall Study||25
289617|NCT01904604|693206|P1|STARTED|Overall Study||25
289618|NCT01904279|693224|P2|NOT COMPLETED|Overall Study||3
289619|NCT01904279|693225|P1|NOT COMPLETED|Overall Study||3
289620|NCT01904279|693224|P2|COMPLETED|Overall Study||22
289621|NCT01904279|693225|P1|COMPLETED|Overall Study||24
289622|NCT01904279|693224|P2|STARTED|Overall Study||25
289623|NCT01904279|693225|P1|STARTED|Overall Study||27
289624|NCT01904149|693251|P6|NOT COMPLETED|Overall Study||3
289625|NCT01904149|693252|P5|NOT COMPLETED|Overall Study||5
289626|NCT01904149|693253|P4|NOT COMPLETED|Overall Study||4
289627|NCT01904149|693254|P3|NOT COMPLETED|Overall Study||2
289628|NCT01904149|693255|P2|NOT COMPLETED|Overall Study||11
289629|NCT01904149|693256|P1|NOT COMPLETED|Overall Study||5
289630|NCT01904149|693251|P6|COMPLETED|Overall Study||48
289631|NCT01904149|693252|P5|COMPLETED|Overall Study||46
289632|NCT01904149|693253|P4|COMPLETED|Overall Study||47
289633|NCT01904149|693254|P3|COMPLETED|Overall Study||148
289634|NCT01904149|693255|P2|COMPLETED|Overall Study||140
289635|NCT01904149|693256|P1|COMPLETED|Overall Study||147
289636|NCT01904149|693251|P6|Multiple-dose Phase|Overall Study||49
289637|NCT01904149|693252|P5|Multiple-dose Phase|Overall Study||48
289638|NCT01904149|693253|P4|Multiple-dose Phase|Overall Study||48
289639|NCT01904149|693254|P3|Multiple-dose Phase|Overall Study||149
289640|NCT01904149|693255|P2|Multiple-dose Phase|Overall Study||146
289641|NCT01904149|693256|P1|Multiple-dose Phase|Overall Study||150
289642|NCT01904149|693251|P6|Single-dose Phase|Overall Study||51
289643|NCT01904149|693252|P5|Single-dose Phase|Overall Study||51
289644|NCT01904149|693253|P4|Single-dose Phase|Overall Study||51
289645|NCT01904149|693254|P3|Single-dose Phase|Overall Study||150
289646|NCT01904149|693255|P2|Single-dose Phase|Overall Study||151
289647|NCT01904149|693256|P1|Single-dose Phase|Overall Study||152
289648|NCT01904149|693251|P6|STARTED|Overall Study||51
289649|NCT01904149|693252|P5|STARTED|Overall Study||51
289650|NCT01904149|693253|P4|STARTED|Overall Study||51
289651|NCT01904149|693254|P3|STARTED|Overall Study||150
289652|NCT01904149|693255|P2|STARTED|Overall Study||151
289653|NCT01904149|693256|P1|STARTED|Overall Study||152
289654|NCT01904071|693281|P3|NOT COMPLETED|Overall Study||0
289655|NCT01904071|693282|P2|NOT COMPLETED|Overall Study||0
289656|NCT01904071|693283|P1|NOT COMPLETED|Overall Study||0
289657|NCT01904071|693281|P3|COMPLETED|Overall Study||20
289658|NCT01904071|693282|P2|COMPLETED|Overall Study||20
289659|NCT01904071|693283|P1|COMPLETED|Overall Study||24
289660|NCT01904071|693281|P3|STARTED|Overall Study||20
289661|NCT01904071|693282|P2|STARTED|Overall Study||20
289662|NCT01904071|693283|P1|STARTED|Overall Study||24
289663|NCT01904058|693307|P4|NOT COMPLETED|Overall Study||1
289664|NCT01904058|693308|P3|NOT COMPLETED|Overall Study||1
289665|NCT01904058|693309|P2|NOT COMPLETED|Overall Study||0
289666|NCT01904058|693310|P1|NOT COMPLETED|Overall Study||3
289667|NCT01904058|693307|P4|COMPLETED|Overall Study||12
289668|NCT01904058|693308|P3|COMPLETED|Overall Study||10
289669|NCT01904058|693309|P2|COMPLETED|Overall Study||21
289670|NCT01904058|693310|P1|COMPLETED|Overall Study||18
289671|NCT01904058|693307|P4|STARTED|Overall Study||13
289672|NCT01904058|693308|P3|STARTED|Overall Study||11
289673|NCT01904058|693309|P2|STARTED|Overall Study||21
289674|NCT01904058|693310|P1|STARTED|Overall Study||21
289675|NCT01903993|693350|P2|NOT COMPLETED|Overall Study||144
289676|NCT01903993|693351|P1|NOT COMPLETED|Overall Study||143
289677|NCT01903993|693350|P2|COMPLETED|Overall Study||0
289678|NCT01903993|693351|P1|COMPLETED|Overall Study||0
289679|NCT01903993|693350|P2|Received Treatment|Overall Study||142
289680|NCT01903993|693351|P1|Received Treatment|Overall Study||135
289681|NCT01903993|693350|P2|STARTED|Overall Study||144
289682|NCT01903993|693351|P1|STARTED|Overall Study||143
289683|NCT01903876|693368|P2|NOT COMPLETED|Six-Month Follow-up Period||145
289684|NCT01903876|693369|P1|NOT COMPLETED|Six-Month Follow-up Period||91
289685|NCT01903876|693368|P2|COMPLETED|Six-Month Follow-up Period||123
289686|NCT01903876|693369|P1|COMPLETED|Six-Month Follow-up Period||92
289687|NCT01903876|693368|P2|STARTED|Six-Month Follow-up Period||268
289688|NCT01903876|693369|P1|STARTED|Six-Month Follow-up Period||183
289689|NCT01903876|693368|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
289690|NCT01903876|693369|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
289691|NCT01903876|693368|P2|COMPLETED|Baseline to Post-Intervention Period||268
289692|NCT01903876|693369|P1|COMPLETED|Baseline to Post-Intervention Period||183
289693|NCT01903876|693368|P2|STARTED|Baseline to Post-Intervention Period||376
289694|NCT01903876|693369|P1|STARTED|Baseline to Post-Intervention Period||367
289695|NCT01903720|693377|P1|NOT COMPLETED|Overall Study||12
289696|NCT01903720|693377|P1|COMPLETED|Overall Study||59
289697|NCT01903720|693377|P1|STARTED|Overall Study||71
289698|NCT01903460|693396|P4|NOT COMPLETED|Overall Study||1
289699|NCT01903460|693397|P3|NOT COMPLETED|Overall Study||0
289700|NCT01903460|693398|P2|NOT COMPLETED|Overall Study||0
289701|NCT01903460|693399|P1|NOT COMPLETED|Overall Study||0
289702|NCT01903460|693396|P4|COMPLETED|Overall Study||2
289703|NCT01903460|693397|P3|COMPLETED|Overall Study||3
289704|NCT01903460|693398|P2|COMPLETED|Overall Study||8
289705|NCT01903460|693399|P1|COMPLETED|Overall Study||6
289706|NCT01903460|693396|P4|STARTED|Overall Study||3
289707|NCT01903460|693397|P3|STARTED|Overall Study||3
289708|NCT01903460|693398|P2|STARTED|Overall Study||8
289709|NCT01903460|693399|P1|STARTED|Overall Study||6
289710|NCT01903265|693418|P2|NOT COMPLETED|Overall Study||17
289711|NCT01903265|693419|P1|NOT COMPLETED|Overall Study||14
289712|NCT01903265|693418|P2|COMPLETED|Overall Study||85
289713|NCT01903265|693419|P1|COMPLETED|Overall Study||89
289714|NCT01903265|693418|P2|STARTED|Overall Study||102
289715|NCT01903265|693419|P1|STARTED|Overall Study||103
289716|NCT01903187|693435|P2|NOT COMPLETED|12 Month||0
289717|NCT01903187|693436|P1|NOT COMPLETED|12 Month||0
289718|NCT01903187|693435|P2|COMPLETED|12 Month||0
289719|NCT01903187|693436|P1|COMPLETED|12 Month||2
289720|NCT01903187|693435|P2|STARTED|12 Month||0
289721|NCT01903187|693436|P1|STARTED|12 Month||2
289722|NCT01903187|693435|P2|NOT COMPLETED|6 Month||0
289723|NCT01903187|693436|P1|NOT COMPLETED|6 Month||0
289724|NCT01903187|693435|P2|COMPLETED|6 Month||0
289725|NCT01903187|693436|P1|COMPLETED|6 Month||2
289726|NCT01903187|693435|P2|STARTED|6 Month||0
289727|NCT01903187|693436|P1|STARTED|6 Month||2
289728|NCT01903187|693435|P2|NOT COMPLETED|3 Month||0
289729|NCT01903187|693436|P1|NOT COMPLETED|3 Month||0
289730|NCT01903187|693435|P2|COMPLETED|3 Month||0
289731|NCT01903187|693436|P1|COMPLETED|3 Month||2
289732|NCT01903187|693435|P2|STARTED|3 Month||0
289733|NCT01903187|693436|P1|STARTED|3 Month||2
289734|NCT01903187|693435|P2|NOT COMPLETED|1 Month||0
289735|NCT01903187|693436|P1|NOT COMPLETED|1 Month||0
289736|NCT01903187|693435|P2|COMPLETED|1 Month||2
289737|NCT01903187|693436|P1|COMPLETED|1 Month||2
289738|NCT01903187|693435|P2|STARTED|1 Month||2
289739|NCT01903187|693436|P1|STARTED|1 Month||2
289740|NCT01903187|693435|P2|NOT COMPLETED|Procedure||0
289741|NCT01903187|693436|P1|NOT COMPLETED|Procedure||0
289742|NCT01903187|693435|P2|COMPLETED|Procedure||2
289743|NCT01903187|693436|P1|COMPLETED|Procedure||2
289744|NCT01903187|693435|P2|STARTED|Procedure||2
289745|NCT01903187|693436|P1|STARTED|Procedure||2
289746|NCT01903148|693449|P1|NOT COMPLETED|Overall Study||0
289747|NCT01903148|693449|P1|COMPLETED|Overall Study||441
289748|NCT01903148|693449|P1|STARTED|Overall Study||441
289749|NCT01903005|693467|P1|NOT COMPLETED|Overall Study||373
289750|NCT01903005|693467|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
289751|NCT01903005|693467|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
289752|NCT01902888|693481|P1|NOT COMPLETED|Overall Study||3
289753|NCT01902888|693481|P1|COMPLETED|Overall Study||0
289754|NCT01902888|693481|P1|STARTED|Overall Study||3
289755|NCT01902758|693488|P2|NOT COMPLETED|Overall Study||0
289756|NCT01902758|693489|P1|NOT COMPLETED|Overall Study||0
289757|NCT01902758|693488|P2|COMPLETED|Overall Study||14
289758|NCT01902758|693489|P1|COMPLETED|Overall Study||14
289759|NCT01902758|693488|P2|STARTED|Overall Study||14
289760|NCT01902758|693489|P1|STARTED|Overall Study||14
289761|NCT01902303|693497|P2|NOT COMPLETED|Overall Study||24
289762|NCT01902303|693498|P1|NOT COMPLETED|Overall Study||23
289850|NCT01901211|693637|P2|NOT COMPLETED|Second Ten-week Period||0
289763|NCT01902303|693497|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
289764|NCT01902303|693498|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
289765|NCT01902303|693497|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
289766|NCT01902303|693498|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
289767|NCT01902303|693497|P2|STARTED|Overall Study|Allocated to active treatment|81
289768|NCT01902303|693498|P1|STARTED|Overall Study|Allocated to placebo|77
289769|NCT01902134|693512|P6|NOT COMPLETED|Overall Study||9
289770|NCT01902134|693513|P5|NOT COMPLETED|Overall Study||7
289771|NCT01902134|693514|P4|NOT COMPLETED|Overall Study||2
289772|NCT01902134|693515|P3|NOT COMPLETED|Overall Study||15
289773|NCT01902134|693516|P2|NOT COMPLETED|Overall Study||11
289774|NCT01902134|693517|P1|NOT COMPLETED|Overall Study||8
289775|NCT01902134|693512|P6|COMPLETED|Overall Study||45
289776|NCT01902134|693513|P5|COMPLETED|Overall Study||46
289777|NCT01902134|693514|P4|COMPLETED|Overall Study||52
289778|NCT01902134|693515|P3|COMPLETED|Overall Study||145
289779|NCT01902134|693516|P2|COMPLETED|Overall Study||150
289780|NCT01902134|693517|P1|COMPLETED|Overall Study||151
289781|NCT01902134|693512|P6|Multiple-dose Phase|Overall Study||52
289782|NCT01902134|693513|P5|Multiple-dose Phase|Overall Study||53
289783|NCT01902134|693514|P4|Multiple-dose Phase|Overall Study||54
289784|NCT01902134|693515|P3|Multiple-dose Phase|Overall Study||160
289785|NCT01902134|693516|P2|Multiple-dose Phase|Overall Study||160
289786|NCT01902134|693517|P1|Multiple-dose Phase|Overall Study||159
289787|NCT01902134|693512|P6|Single-dose Phase|Overall Study||54
289788|NCT01902134|693513|P5|Single-dose Phase|Overall Study||53
289789|NCT01902134|693514|P4|Single-dose Phase|Overall Study||54
289790|NCT01902134|693515|P3|Single-dose Phase|Overall Study||160
289791|NCT01902134|693516|P2|Single-dose Phase|Overall Study||161
289792|NCT01902134|693517|P1|Single-dose Phase|Overall Study||159
289793|NCT01902134|693512|P6|STARTED|Overall Study||54
289794|NCT01902134|693513|P5|STARTED|Overall Study||53
289795|NCT01902134|693514|P4|STARTED|Overall Study||54
289796|NCT01902134|693515|P3|STARTED|Overall Study||160
289797|NCT01902134|693516|P2|STARTED|Overall Study||161
289798|NCT01902134|693517|P1|STARTED|Overall Study||159
289799|NCT01901588|693541|P2|NOT COMPLETED|Overall Study||0
289800|NCT01901588|693542|P1|NOT COMPLETED|Overall Study||0
289801|NCT01901588|693541|P2|COMPLETED|Overall Study||31
289802|NCT01901588|693542|P1|COMPLETED|Overall Study||32
289803|NCT01901588|693541|P2|STARTED|Overall Study||31
289804|NCT01901588|693542|P1|STARTED|Overall Study||32
289805|NCT01901575|693558|P1|NOT COMPLETED|Overall Study||0
289806|NCT01901575|693558|P1|COMPLETED|Overall Study||16
289807|NCT01901575|693558|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
289808|NCT01901393|693564|P2|NOT COMPLETED|Overall Study||0
289809|NCT01901393|693565|P1|NOT COMPLETED|Overall Study||1
289810|NCT01901393|693564|P2|COMPLETED|Overall Study||49
289811|NCT01901393|693565|P1|COMPLETED|Overall Study||50
289812|NCT01901393|693564|P2|STARTED|Overall Study||49
289813|NCT01901393|693565|P1|STARTED|Overall Study||51
289814|NCT01901341|693583|P2|NOT COMPLETED|Overall Study||21
289815|NCT01901341|693584|P1|NOT COMPLETED|Overall Study||20
289816|NCT01901341|693583|P2|COMPLETED|Overall Study||1
289817|NCT01901341|693584|P1|COMPLETED|Overall Study||2
289818|NCT01901341|693583|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
289819|NCT01901341|693584|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
289820|NCT01901341|693583|P2|STARTED|Overall Study||22
289821|NCT01901341|693584|P1|STARTED|Overall Study||22
289822|NCT01901328|693598|P2|NOT COMPLETED|Overall Study||21
289823|NCT01901328|693599|P1|NOT COMPLETED|Overall Study||22
289824|NCT01901328|693598|P2|COMPLETED|Overall Study||2
289825|NCT01901328|693599|P1|COMPLETED|Overall Study||4
289826|NCT01901328|693598|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
289827|NCT01901328|693599|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
289828|NCT01901328|693598|P2|STARTED|Overall Study||23
289829|NCT01901328|693599|P1|STARTED|Overall Study||26
289830|NCT01901302|693613|P2|NOT COMPLETED|Overall Study||23
289831|NCT01901302|693614|P1|NOT COMPLETED|Overall Study||27
289832|NCT01901302|693613|P2|COMPLETED|Overall Study||7
289833|NCT01901302|693614|P1|COMPLETED|Overall Study||4
289834|NCT01901302|693613|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
289835|NCT01901302|693614|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
289836|NCT01901302|693613|P2|STARTED|Overall Study||30
289837|NCT01901302|693614|P1|STARTED|Overall Study||31
289838|NCT01901250|693628|P2|NOT COMPLETED|Overall Study||126
289839|NCT01901250|693629|P1|NOT COMPLETED|Overall Study||138
289840|NCT01901250|693628|P2|COMPLETED|Overall Study||139
289841|NCT01901250|693629|P1|COMPLETED|Overall Study||122
289842|NCT01901250|693628|P2|End of 1st Grade|Overall Study||151
289843|NCT01901250|693629|P1|End of 1st Grade|Overall Study||143
289844|NCT01901250|693628|P2|Start of 1st Grade|Overall Study||176
289845|NCT01901250|693629|P1|Start of 1st Grade|Overall Study||173
289846|NCT01901250|693628|P2|End of Kidergarten|Overall Study||212
289847|NCT01901250|693629|P1|End of Kidergarten|Overall Study||215
289848|NCT01901250|693628|P2|STARTED|Overall Study||265
289849|NCT01901250|693629|P1|STARTED|Overall Study||260
289851|NCT01901211|693638|P1|NOT COMPLETED|Second Ten-week Period||0
289852|NCT01901211|693637|P2|COMPLETED|Second Ten-week Period||5
289853|NCT01901211|693638|P1|COMPLETED|Second Ten-week Period||6
289854|NCT01901211|693637|P2|STARTED|Second Ten-week Period||5
289855|NCT01901211|693638|P1|STARTED|Second Ten-week Period||6
289856|NCT01901211|693637|P2|NOT COMPLETED|Washout (6 Weeks)||0
289857|NCT01901211|693638|P1|NOT COMPLETED|Washout (6 Weeks)||0
289858|NCT01901211|693637|P2|COMPLETED|Washout (6 Weeks)||5
289859|NCT01901211|693638|P1|COMPLETED|Washout (6 Weeks)||6
289860|NCT01901211|693637|P2|STARTED|Washout (6 Weeks)||5
289861|NCT01901211|693638|P1|STARTED|Washout (6 Weeks)||6
289862|NCT01901211|693637|P2|NOT COMPLETED|First Ten-week Period||0
289863|NCT01901211|693638|P1|NOT COMPLETED|First Ten-week Period||0
289864|NCT01901211|693637|P2|COMPLETED|First Ten-week Period||5
289865|NCT01901211|693638|P1|COMPLETED|First Ten-week Period||6
289866|NCT01901211|693637|P2|STARTED|First Ten-week Period||5
289867|NCT01901211|693638|P1|STARTED|First Ten-week Period||6
289868|NCT01901185|693644|P1|NOT COMPLETED|Overall Study||2
289869|NCT01901185|693644|P1|COMPLETED|Overall Study||75
289870|NCT01901185|693644|P1|Received Etanercept With Autoinjector A|Overall Study||75
289871|NCT01901185|693644|P1|STARTED|Overall Study||77
289872|NCT01900314|693653|P2|NOT COMPLETED|Overall Study||4
289873|NCT01900314|693654|P1|NOT COMPLETED|Overall Study||4
289874|NCT01900314|693653|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
289875|NCT01900314|693654|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
289876|NCT01900314|693653|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
289877|NCT01900314|693654|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
289878|NCT01900314|693653|P2|STARTED|Overall Study||20
289879|NCT01900314|693654|P1|STARTED|Overall Study||20
289880|NCT01900249|693665|P3|NOT COMPLETED|Overall Study||4
289881|NCT01900249|693666|P2|NOT COMPLETED|Overall Study||5
289882|NCT01900249|693667|P1|NOT COMPLETED|Overall Study||3
289883|NCT01900249|693665|P3|COMPLETED|Overall Study||65
289884|NCT01900249|693666|P2|COMPLETED|Overall Study||63
289885|NCT01900249|693667|P1|COMPLETED|Overall Study||64
289886|NCT01900249|693665|P3|STARTED|Overall Study||69
289887|NCT01900249|693666|P2|STARTED|Overall Study||68
289888|NCT01900249|693667|P1|STARTED|Overall Study||67
289889|NCT01900067|693677|P2|NOT COMPLETED|Overall Study||13
289890|NCT01900067|693678|P1|NOT COMPLETED|Overall Study||12
289891|NCT01900067|693677|P2|COMPLETED|Overall Study||124
289892|NCT01900067|693678|P1|COMPLETED|Overall Study||122
289893|NCT01900067|693677|P2|STARTED|Overall Study||137
289894|NCT01900067|693678|P1|STARTED|Overall Study||134
289895|NCT01900054|693684|P1|NOT COMPLETED|Overall Study||2
289896|NCT01900054|693684|P1|COMPLETED|Overall Study||56
289897|NCT01900054|693684|P1|STARTED|Overall Study||58
289898|NCT01899911|693689|P1|NOT COMPLETED|Overall Study||0
289899|NCT01899911|693689|P1|COMPLETED|Overall Study||12
289900|NCT01899911|693689|P1|STARTED|Overall Study||12
289901|NCT01899768|693693|P1|NOT COMPLETED|Part C||0
289902|NCT01899768|693693|P1|COMPLETED|Part C||11
289903|NCT01899768|693693|P1|STARTED|Part C||11
289904|NCT01899768|693693|P1|NOT COMPLETED|Part B||2
289905|NCT01899768|693693|P1|COMPLETED|Part B||11
289906|NCT01899768|693693|P1|STARTED|Part B||13
289907|NCT01899768|693693|P1|NOT COMPLETED|Part A||3
289908|NCT01899768|693693|P1|COMPLETED|Part A||13
289909|NCT01899768|693693|P1|STARTED|Part A||16
289910|NCT01899742|693767|P2|NOT COMPLETED|Overall Study||16
289911|NCT01899742|693768|P1|NOT COMPLETED|Overall Study||17
289912|NCT01899742|693767|P2|COMPLETED|Overall Study||231
289913|NCT01899742|693768|P1|COMPLETED|Overall Study||230
289914|NCT01899742|693767|P2|STARTED|Overall Study||247
289915|NCT01899742|693768|P1|STARTED|Overall Study||247
289916|NCT01899677|693778|P2|NOT COMPLETED|Overall Study||7
289917|NCT01899677|693779|P1|NOT COMPLETED|Overall Study||10
289918|NCT01899677|693778|P2|COMPLETED|Overall Study||28
289919|NCT01899677|693779|P1|COMPLETED|Overall Study||25
289920|NCT01899677|693778|P2|STARTED|Overall Study||35
289921|NCT01899677|693779|P1|STARTED|Overall Study||35
289922|NCT01899144|693807|P1|NOT COMPLETED|Treatment Period 5||1
289923|NCT01899144|693807|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
289924|NCT01899144|693807|P1|STARTED|Treatment Period 5||58
289925|NCT01899144|693807|P1|NOT COMPLETED|Treatment Period 4||0
289926|NCT01899144|693807|P1|COMPLETED|Treatment Period 4||58
289927|NCT01899144|693807|P1|STARTED|Treatment Period 4||58
289928|NCT01899144|693807|P1|NOT COMPLETED|Treatment Period 3||2
289929|NCT01899144|693807|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
289930|NCT01899144|693807|P1|STARTED|Treatment Period 3||60
289931|NCT01899144|693807|P1|NOT COMPLETED|Treatment Period 2||1
289932|NCT01899144|693807|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
289933|NCT01899144|693807|P1|STARTED|Treatment Period 2||61
289934|NCT01899144|693807|P1|NOT COMPLETED|Treatment Period 1||0
289935|NCT01899144|693807|P1|COMPLETED|Treatment Period 1||61
289936|NCT01899144|693807|P1|STARTED|Treatment Period 1||61
289937|NCT01898884|693834|P9|NOT COMPLETED|Multiple Dose Period||1
289938|NCT01898884|693835|P8|NOT COMPLETED|Multiple Dose Period||0
289939|NCT01898884|693836|P7|NOT COMPLETED|Multiple Dose Period||1
289940|NCT01898884|693837|P6|NOT COMPLETED|Multiple Dose Period||0
289941|NCT01898884|693838|P5|NOT COMPLETED|Multiple Dose Period||0
289942|NCT01898884|693839|P4|NOT COMPLETED|Multiple Dose Period||0
289943|NCT01898884|693840|P3|NOT COMPLETED|Multiple Dose Period||0
289944|NCT01898884|693841|P2|NOT COMPLETED|Multiple Dose Period||0
289945|NCT01898884|693842|P1|NOT COMPLETED|Multiple Dose Period||0
289946|NCT01898884|693834|P9|COMPLETED|Multiple Dose Period||5
289947|NCT01898884|693835|P8|COMPLETED|Multiple Dose Period||6
289948|NCT01898884|693836|P7|COMPLETED|Multiple Dose Period||5
289949|NCT01898884|693837|P6|COMPLETED|Multiple Dose Period||6
289950|NCT01898884|693838|P5|COMPLETED|Multiple Dose Period||0
289951|NCT01898884|693839|P4|COMPLETED|Multiple Dose Period||0
289952|NCT01898884|693840|P3|COMPLETED|Multiple Dose Period||0
289953|NCT01898884|693841|P2|COMPLETED|Multiple Dose Period||0
289954|NCT01898884|693842|P1|COMPLETED|Multiple Dose Period||0
289955|NCT01898884|693834|P9|Treated|Multiple Dose Period||5
289956|NCT01898884|693835|P8|Treated|Multiple Dose Period||6
289957|NCT01898884|693836|P7|Treated|Multiple Dose Period||6
289958|NCT01898884|693837|P6|Treated|Multiple Dose Period||6
289959|NCT01898884|693838|P5|Treated|Multiple Dose Period||0
289960|NCT01898884|693839|P4|Treated|Multiple Dose Period||0
289961|NCT01898884|693840|P3|Treated|Multiple Dose Period||0
289962|NCT01898884|693841|P2|Treated|Multiple Dose Period||0
289963|NCT01898884|693842|P1|Treated|Multiple Dose Period||0
289964|NCT01898884|693834|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
289965|NCT01898884|693835|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
289966|NCT01898884|693836|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
289967|NCT01898884|693837|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
289968|NCT01898884|693838|P5|STARTED|Multiple Dose Period||0
289969|NCT01898884|693839|P4|STARTED|Multiple Dose Period||0
289970|NCT01898884|693840|P3|STARTED|Multiple Dose Period||0
289971|NCT01898884|693841|P2|STARTED|Multiple Dose Period||0
289972|NCT01898884|693842|P1|STARTED|Multiple Dose Period||0
289973|NCT01898884|693834|P9|NOT COMPLETED|Single Dose Period||0
289974|NCT01898884|693835|P8|NOT COMPLETED|Single Dose Period||0
289975|NCT01898884|693836|P7|NOT COMPLETED|Single Dose Period||0
289976|NCT01898884|693837|P6|NOT COMPLETED|Single Dose Period||0
289977|NCT01898884|693838|P5|NOT COMPLETED|Single Dose Period||0
289978|NCT01898884|693839|P4|NOT COMPLETED|Single Dose Period||0
289979|NCT01898884|693840|P3|NOT COMPLETED|Single Dose Period||0
289980|NCT01898884|693841|P2|NOT COMPLETED|Single Dose Period||0
289981|NCT01898884|693842|P1|NOT COMPLETED|Single Dose Period||0
289982|NCT01898884|693834|P9|COMPLETED|Single Dose Period||0
289983|NCT01898884|693835|P8|COMPLETED|Single Dose Period||0
289984|NCT01898884|693836|P7|COMPLETED|Single Dose Period||0
289985|NCT01898884|693837|P6|COMPLETED|Single Dose Period||0
289986|NCT01898884|693838|P5|COMPLETED|Single Dose Period||6
289987|NCT01898884|693839|P4|COMPLETED|Single Dose Period||6
289988|NCT01898884|693840|P3|COMPLETED|Single Dose Period||6
289989|NCT01898884|693841|P2|COMPLETED|Single Dose Period||6
289990|NCT01898884|693842|P1|COMPLETED|Single Dose Period||8
289991|NCT01898884|693834|P9|STARTED|Single Dose Period||0
289992|NCT01898884|693835|P8|STARTED|Single Dose Period||0
289993|NCT01898884|693836|P7|STARTED|Single Dose Period||0
289994|NCT01898884|693837|P6|STARTED|Single Dose Period||0
289995|NCT01898884|693838|P5|STARTED|Single Dose Period||6
289996|NCT01898884|693839|P4|STARTED|Single Dose Period||6
289997|NCT01898884|693840|P3|STARTED|Single Dose Period||6
289998|NCT01898884|693841|P2|STARTED|Single Dose Period||6
289999|NCT01898884|693842|P1|STARTED|Single Dose Period||8
290000|NCT01898598|693994|P2|NOT COMPLETED|Overall Study||2
290001|NCT01898598|693995|P1|NOT COMPLETED|Overall Study||4
290002|NCT01898598|693994|P2|COMPLETED|Overall Study||4
290003|NCT01898598|693995|P1|COMPLETED|Overall Study||8
290004|NCT01898598|693994|P2|Treated|Overall Study||5
290005|NCT01898598|693995|P1|Treated|Overall Study||11
290006|NCT01898598|693994|P2|STARTED|Overall Study||6
290007|NCT01898598|693995|P1|STARTED|Overall Study||12
290008|NCT01898442|694014|P3|NOT COMPLETED|Overall Study||3
290009|NCT01898442|694015|P2|NOT COMPLETED|Overall Study||2
290010|NCT01898442|694016|P1|NOT COMPLETED|Overall Study||1
290011|NCT01898442|694014|P3|COMPLETED|Overall Study||15
290012|NCT01898442|694015|P2|COMPLETED|Overall Study||15
290013|NCT01898442|694016|P1|COMPLETED|Overall Study||16
290014|NCT01898442|694014|P3|STARTED|Overall Study||18
290015|NCT01898442|694015|P2|STARTED|Overall Study||17
290016|NCT01898442|694016|P1|STARTED|Overall Study||17
290017|NCT01898403|694039|P1|NOT COMPLETED|Overall Study||0
290018|NCT01898403|694039|P1|COMPLETED|Overall Study||50
290019|NCT01898403|694039|P1|STARTED|Overall Study||50
290020|NCT01898286|694045|P1|NOT COMPLETED|Overall Study||3
290021|NCT01898286|694045|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
290022|NCT01898286|694045|P1|STARTED|Overall Study||38
290023|NCT01898208|694055|P3|NOT COMPLETED|Overall Study||37
290024|NCT01898208|694056|P2|NOT COMPLETED|Overall Study||49
290025|NCT01898208|694057|P1|NOT COMPLETED|Overall Study||40
290026|NCT01898208|694055|P3|COMPLETED|Overall Study||212
290027|NCT01898208|694056|P2|COMPLETED|Overall Study||198
290028|NCT01898208|694057|P1|COMPLETED|Overall Study||207
290029|NCT01898208|694055|P3|STARTED|Overall Study||249
290030|NCT01898208|694056|P2|STARTED|Overall Study||247
290031|NCT01898208|694057|P1|STARTED|Overall Study||247
290032|NCT01898091|694103|P2|NOT COMPLETED|Overall Study||6
290033|NCT01898091|694104|P1|NOT COMPLETED|Overall Study||2
290034|NCT01898091|694103|P2|COMPLETED|Overall Study||19
290035|NCT01898091|694104|P1|COMPLETED|Overall Study||23
290036|NCT01898091|694103|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
290037|NCT01898091|694104|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
290038|NCT01897792|694112|P2|NOT COMPLETED|Overall Study||0
290039|NCT01897792|694113|P1|NOT COMPLETED|Overall Study||0
290040|NCT01897792|694112|P2|COMPLETED|Overall Study||5
290041|NCT01897792|694113|P1|COMPLETED|Overall Study||6
290042|NCT01897792|694112|P2|STARTED|Overall Study||5
290043|NCT01897792|694113|P1|STARTED|Overall Study||6
290044|NCT01897727|694139|P2|NOT COMPLETED|Overall Study||1
290045|NCT01897727|694140|P1|NOT COMPLETED|Overall Study||0
290046|NCT01897727|694139|P2|COMPLETED|Overall Study||8
290047|NCT01897727|694140|P1|COMPLETED|Overall Study||8
290048|NCT01897727|694139|P2|STARTED|Overall Study||9
290049|NCT01897727|694140|P1|STARTED|Overall Study||8
290050|NCT01897402|694148|P2|NOT COMPLETED|Overall Study||16
290051|NCT01897402|694149|P1|NOT COMPLETED|Overall Study||19
290052|NCT01897402|694148|P2|COMPLETED|Overall Study||244
290053|NCT01897402|694149|P1|COMPLETED|Overall Study||246
290054|NCT01897402|694148|P2|STARTED|Overall Study||260
290055|NCT01897402|694149|P1|STARTED|Overall Study||265
290056|NCT01897285|694161|P1|NOT COMPLETED|Overall Study||0
290057|NCT01897285|694161|P1|COMPLETED|Overall Study||20
290058|NCT01897285|694161|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
290059|NCT01897233|694169|P1|NOT COMPLETED|Part B (24 Weeks)||4
290060|NCT01897233|694169|P1|COMPLETED|Part B (24 Weeks)||54
290061|NCT01897233|694169|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
290062|NCT01897233|694169|P1|NOT COMPLETED|Part A (14 Days)||0
290063|NCT01897233|694169|P1|COMPLETED|Part A (14 Days)||10
290064|NCT01897233|694169|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
290065|NCT01897233|694169|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
290066|NCT01897233|694169|P1|STARTED|Part A (14 Days)||10
290067|NCT01897025|694193|P2|NOT COMPLETED|Overall Study||0
290068|NCT01897025|694194|P1|NOT COMPLETED|Overall Study||0
290069|NCT01897025|694193|P2|COMPLETED|Overall Study||9
290070|NCT01897025|694194|P1|COMPLETED|Overall Study||10
290071|NCT01897025|694193|P2|STARTED|Overall Study||9
290072|NCT01897025|694194|P1|STARTED|Overall Study||10
290073|NCT01896986|694202|P2|NOT COMPLETED|Overall Study||23
290074|NCT01896986|694203|P1|NOT COMPLETED|Overall Study||14
290075|NCT01896986|694202|P2|COMPLETED|Overall Study||0
290076|NCT01896986|694203|P1|COMPLETED|Overall Study||0
290077|NCT01896986|694202|P2|STARTED|Overall Study||23
290078|NCT01896986|694203|P1|STARTED|Overall Study||14
290079|NCT01896726|694209|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
290080|NCT01896726|694209|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
290081|NCT01896726|694209|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
290082|NCT01896726|694209|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
290083|NCT01896726|694209|P1|STARTED|Treatment Period 2 (Days 23-31)||20
290084|NCT01896726|694209|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
290085|NCT01896726|694209|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
290086|NCT01896726|694209|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
290087|NCT01896726|694209|P1|STARTED|Treatment Period 1 (Days 1-22)||20
290088|NCT01896687|694224|P2|NOT COMPLETED|Overall Study||0
290089|NCT01896687|694225|P1|NOT COMPLETED|Overall Study||0
290090|NCT01896687|694224|P2|COMPLETED|Overall Study||15
290091|NCT01896687|694225|P1|COMPLETED|Overall Study||15
290092|NCT01896687|694224|P2|STARTED|Overall Study||15
290093|NCT01896687|694225|P1|STARTED|Overall Study||15
290094|NCT01896557|694233|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
290095|NCT01896557|694234|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
290096|NCT01896557|694233|P2|COMPLETED|Clopidogrel + GI Protector||44
290097|NCT01896557|694234|P1|COMPLETED|Clopidogrel + GI Protector||41
290098|NCT01896557|694233|P2|STARTED|Clopidogrel + GI Protector||48
290099|NCT01896557|694234|P1|STARTED|Clopidogrel + GI Protector||43
290100|NCT01896557|694233|P2|NOT COMPLETED|Clopidogrel Alone||0
290101|NCT01896557|694234|P1|NOT COMPLETED|Clopidogrel Alone||1
290102|NCT01896557|694233|P2|COMPLETED|Clopidogrel Alone||48
290103|NCT01896557|694234|P1|COMPLETED|Clopidogrel Alone||43
290104|NCT01896557|694233|P2|STARTED|Clopidogrel Alone||48
290105|NCT01896557|694234|P1|STARTED|Clopidogrel Alone||44
290106|NCT01896544|694245|P3|NOT COMPLETED|Overall Study||0
290107|NCT01896544|694246|P2|NOT COMPLETED|Overall Study||0
290108|NCT01896544|694247|P1|NOT COMPLETED|Overall Study||0
290109|NCT01896544|694245|P3|COMPLETED|Overall Study||10
290110|NCT01896544|694246|P2|COMPLETED|Overall Study||10
290111|NCT01896544|694247|P1|COMPLETED|Overall Study||10
290112|NCT01896544|694245|P3|STARTED|Overall Study||10
290113|NCT01896544|694246|P2|STARTED|Overall Study||10
290114|NCT01896544|694247|P1|STARTED|Overall Study||10
290115|NCT01896297|694267|P1|NOT COMPLETED|Overall Study||1
290116|NCT01896297|694267|P1|COMPLETED|Overall Study||59
290117|NCT01896297|694267|P1|STARTED|Overall Study||60
290118|NCT01896232|694274|P2|NOT COMPLETED|Overall Study||53
290119|NCT01896232|694275|P1|NOT COMPLETED|Overall Study||49
290120|NCT01896232|694274|P2|COMPLETED|Overall Study||287
290121|NCT01896232|694275|P1|COMPLETED|Overall Study||294
290122|NCT01896232|694274|P2|Received Treatment|Overall Study||338
290123|NCT01896232|694275|P1|Received Treatment|Overall Study||341
290124|NCT01896232|694274|P2|STARTED|Overall Study||340
290125|NCT01896232|694275|P1|STARTED|Overall Study||343
290126|NCT01896206|694295|P1|NOT COMPLETED|Overall Study||0
290127|NCT01896206|694295|P1|COMPLETED|Overall Study||21
290128|NCT01896206|694295|P1|STARTED|Overall Study||21
290129|NCT01896193|694303|P2|NOT COMPLETED|Overall Study||12
290130|NCT01896193|694304|P1|NOT COMPLETED|Overall Study||21
290131|NCT01896193|694303|P2|COMPLETED|Overall Study||53
290132|NCT01896193|694304|P1|COMPLETED|Overall Study||41
290133|NCT01896193|694303|P2|STARTED|Overall Study||65
290134|NCT01896193|694304|P1|STARTED|Overall Study||62
290135|NCT01896115|694328|P1|NOT COMPLETED|Overall Study||1
290136|NCT01896115|694328|P1|COMPLETED|Overall Study||15
290137|NCT01896115|694328|P1|Ventral Steering|Overall Study||15
290138|NCT01896115|694328|P1|Dorsal Steering|Overall Study||15
290139|NCT01896115|694328|P1|Conventional PW|Overall Study||15
290140|NCT01896115|694328|P1|Short PW|Overall Study||15
290141|NCT01896115|694328|P1|STARTED|Overall Study||16
290142|NCT01896050|694353|P2|NOT COMPLETED|Overall Study||2
290143|NCT01896050|694354|P1|NOT COMPLETED|Overall Study||38
290144|NCT01896050|694353|P2|COMPLETED|Overall Study||20
290145|NCT01896050|694354|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
290146|NCT01896050|694353|P2|STARTED|Overall Study||22
290147|NCT01896050|694354|P1|STARTED|Overall Study||93
290148|NCT01895946|694366|P2|NOT COMPLETED|Overall Study||0
290149|NCT01895946|694367|P1|NOT COMPLETED|Overall Study||0
290150|NCT01895946|694366|P2|COMPLETED|Overall Study||12
290151|NCT01895946|694367|P1|COMPLETED|Overall Study||18
290152|NCT01895946|694366|P2|STARTED|Overall Study||12
290153|NCT01895946|694367|P1|STARTED|Overall Study||18
290154|NCT01895634|694385|P1|NOT COMPLETED|Overall Study||3
290155|NCT01895634|694385|P1|COMPLETED|Overall Study||46
290156|NCT01895634|694385|P1|STARTED|Overall Study||49
290157|NCT01895543|694393|P1|NOT COMPLETED|Overall Study||129
290158|NCT01895543|694393|P1|COMPLETED|Overall Study||282
290159|NCT01895543|694393|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
290160|NCT01895543|694393|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
290161|NCT01895543|694393|P1|STARTED|Overall Study||411
290162|NCT01895335|694407|P1|NOT COMPLETED|Overall Study||215
290163|NCT01895335|694407|P1|COMPLETED|Overall Study||786
290164|NCT01895335|694407|P1|Treated|Overall Study||1000
290165|NCT01895335|694407|P1|STARTED|Overall Study||1001
290166|NCT01895322|694424|P1|NOT COMPLETED|Overall Study||13
290167|NCT01895322|694424|P1|COMPLETED|Overall Study||7
290168|NCT01895322|694424|P1|STARTED|Overall Study||20
290169|NCT01895309|694433|P2|NOT COMPLETED|Overall Study||51
290170|NCT01895309|694434|P1|NOT COMPLETED|Overall Study||40
290171|NCT01895309|694433|P2|COMPLETED|Overall Study||246
290172|NCT01895309|694434|P1|COMPLETED|Overall Study||259
290173|NCT01895309|694433|P2|STARTED|Overall Study||297
290174|NCT01895309|694434|P1|STARTED|Overall Study||299
290175|NCT01895270|694448|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
290176|NCT01895270|694449|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
290177|NCT01895270|694448|P2|COMPLETED|Isradipine Taper (W7-8)||0
290178|NCT01895270|694449|P1|COMPLETED|Isradipine Taper (W7-8)||2
290179|NCT01895270|694448|P2|STARTED|Isradipine Taper (W7-8)||2
290180|NCT01895270|694449|P1|STARTED|Isradipine Taper (W7-8)||2
290181|NCT01895270|694448|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
290182|NCT01895270|694449|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
290183|NCT01895270|694448|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
290184|NCT01895270|694449|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
290185|NCT01895270|694448|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
290186|NCT01895270|694449|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
290187|NCT01895270|694448|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
290188|NCT01895270|694449|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
290189|NCT01895270|694448|P2|COMPLETED|Study Medications Induction (W1-4)||8
290190|NCT01895270|694449|P1|COMPLETED|Study Medications Induction (W1-4)||5
290191|NCT01895270|694448|P2|STARTED|Study Medications Induction (W1-4)||14
290192|NCT01895270|694449|P1|STARTED|Study Medications Induction (W1-4)||11
290193|NCT01895101|694458|P3|NOT COMPLETED|Overall Study||5
290194|NCT01895101|694459|P2|NOT COMPLETED|Overall Study||5
290195|NCT01895101|694460|P1|NOT COMPLETED|Overall Study||1
290196|NCT01895101|694458|P3|COMPLETED|Overall Study||245
290197|NCT01895101|694459|P2|COMPLETED|Overall Study||245
290198|NCT01895101|694460|P1|COMPLETED|Overall Study||249
290199|NCT01895101|694458|P3|STARTED|Overall Study||250
290200|NCT01895101|694459|P2|STARTED|Overall Study||250
290201|NCT01895101|694460|P1|STARTED|Overall Study||250
290202|NCT01895062|694476|P2|NOT COMPLETED|Overall Study||0
290203|NCT01895062|694477|P1|NOT COMPLETED|Overall Study||0
290204|NCT01895062|694476|P2|COMPLETED|Overall Study||24
290205|NCT01895062|694477|P1|COMPLETED|Overall Study||30
290206|NCT01895062|694476|P2|STARTED|Overall Study||24
290207|NCT01895062|694477|P1|STARTED|Overall Study||30
290208|NCT01894984|694487|P2|NOT COMPLETED|Overall Study||175
290209|NCT01894984|694488|P1|NOT COMPLETED|Overall Study||314
290210|NCT01894984|694487|P2|COMPLETED|Overall Study||69
290211|NCT01894984|694488|P1|COMPLETED|Overall Study||82
290212|NCT01894984|694487|P2|STARTED|Overall Study||244
290213|NCT01894984|694488|P1|STARTED|Overall Study||396
290214|NCT01894906|694506|P2|NOT COMPLETED|Overall Study||0
290215|NCT01894906|694507|P1|NOT COMPLETED|Overall Study||0
290216|NCT01894906|694506|P2|COMPLETED|Overall Study||6
290217|NCT01894906|694507|P1|COMPLETED|Overall Study||6
290218|NCT01894906|694506|P2|Treatment F|Overall Study||6
290219|NCT01894906|694507|P1|Treatment F|Overall Study||6
290220|NCT01894906|694506|P2|Treatment E|Overall Study||6
290221|NCT01894906|694507|P1|Treatment E|Overall Study||6
290222|NCT01894906|694506|P2|Treatment D|Overall Study||6
290223|NCT01894906|694507|P1|Treatment D|Overall Study||6
290224|NCT01894906|694506|P2|Treatment C|Overall Study||6
290225|NCT01894906|694507|P1|Treatment C|Overall Study||6
290226|NCT01894906|694506|P2|Treatment B|Overall Study||6
290227|NCT01894906|694507|P1|Treatment B|Overall Study||6
290228|NCT01894906|694506|P2|Treatment A|Overall Study||6
290229|NCT01894906|694507|P1|Treatment A|Overall Study||6
290230|NCT01894906|694506|P2|STARTED|Overall Study||6
290231|NCT01894906|694507|P1|STARTED|Overall Study||6
290232|NCT01894607|694537|P1|NOT COMPLETED|Overall Study||1
290233|NCT01894607|694537|P1|COMPLETED|Overall Study||10
290234|NCT01894607|694537|P1|STARTED|Overall Study||11
290235|NCT01894581|694544|P2|NOT COMPLETED|Overall Study||7
290236|NCT01894581|694545|P1|NOT COMPLETED|Overall Study||5
290237|NCT01894581|694544|P2|COMPLETED|Overall Study||12
290238|NCT01894581|694545|P1|COMPLETED|Overall Study||15
290239|NCT01894581|694544|P2|STARTED|Overall Study||19
290240|NCT01894581|694545|P1|STARTED|Overall Study||20
290241|NCT01894555|694551|P1|NOT COMPLETED|Overall Study||0
290242|NCT01894555|694551|P1|COMPLETED|Overall Study||33
290243|NCT01894555|694551|P1|STARTED|Overall Study||33
290244|NCT01894256|694558|P3|NOT COMPLETED|Part B||14
290245|NCT01894256|694559|P2|NOT COMPLETED|Part B||14
290246|NCT01894256|694560|P1|NOT COMPLETED|Part B||15
290247|NCT01894256|694558|P3|COMPLETED|Part B||0
290248|NCT01894256|694559|P2|COMPLETED|Part B||0
290249|NCT01894256|694560|P1|COMPLETED|Part B||0
290250|NCT01894256|694558|P3|STARTED|Part B||14
290251|NCT01894256|694559|P2|STARTED|Part B||14
290252|NCT01894256|694560|P1|STARTED|Part B||15
290253|NCT01894256|694558|P3|NOT COMPLETED|Part A||0
290254|NCT01894256|694559|P2|NOT COMPLETED|Part A||1
290255|NCT01894256|694560|P1|NOT COMPLETED|Part A||0
290256|NCT01894256|694558|P3|COMPLETED|Part A||14
290257|NCT01894256|694559|P2|COMPLETED|Part A||14
290258|NCT01894256|694560|P1|COMPLETED|Part A||15
290259|NCT01894256|694558|P3|STARTED|Part A||14
290260|NCT01894256|694559|P2|STARTED|Part A||15
290261|NCT01894256|694560|P1|STARTED|Part A||15
290262|NCT01894100|694606|P2|NOT COMPLETED|Overall Study||1
290263|NCT01894100|694607|P1|NOT COMPLETED|Overall Study||3
290264|NCT01894100|694606|P2|COMPLETED|Overall Study||14
290265|NCT01894100|694607|P1|COMPLETED|Overall Study||12
290266|NCT01894100|694606|P2|STARTED|Overall Study||15
290267|NCT01894100|694607|P1|STARTED|Overall Study||15
290268|NCT01894022|694617|P2|NOT COMPLETED|Overall Study||10
290269|NCT01894022|694618|P1|NOT COMPLETED|Overall Study||9
290270|NCT01894022|694617|P2|COMPLETED|Overall Study||0
290271|NCT01894022|694618|P1|COMPLETED|Overall Study||0
290272|NCT01894022|694617|P2|STARTED|Overall Study||10
290273|NCT01894022|694618|P1|STARTED|Overall Study||9
290274|NCT01893879|694672|P2|NOT COMPLETED|Overall Study||3
290275|NCT01893879|694673|P1|NOT COMPLETED|Overall Study||2
290276|NCT01893879|694672|P2|COMPLETED|Overall Study||4
290277|NCT01893879|694673|P1|COMPLETED|Overall Study||5
290278|NCT01893879|694672|P2|STARTED|Overall Study||7
290279|NCT01893879|694673|P1|STARTED|Overall Study||7
290280|NCT01893567|694679|P1|NOT COMPLETED|Overall Study||0
290281|NCT01893567|694679|P1|COMPLETED|Overall Study||28
290282|NCT01893567|694679|P1|STARTED|Overall Study||28
290283|NCT01893411|694686|P3|NOT COMPLETED|Overall Study||9
290284|NCT01893411|694687|P2|NOT COMPLETED|Overall Study||7
290285|NCT01893411|694688|P1|NOT COMPLETED|Overall Study||17
290286|NCT01893411|694686|P3|COMPLETED|Overall Study||69
290287|NCT01893411|694687|P2|COMPLETED|Overall Study||70
290288|NCT01893411|694688|P1|COMPLETED|Overall Study||139
290289|NCT01893411|694686|P3|STARTED|Overall Study||78
290290|NCT01893411|694687|P2|STARTED|Overall Study||77
290291|NCT01893411|694688|P1|STARTED|Overall Study||156
290301|NCT01893346|694770|P4|NOT COMPLETED|Overall Study||0
290302|NCT01893346|694771|P3|NOT COMPLETED|Overall Study||0
290303|NCT01893346|694772|P2|NOT COMPLETED|Overall Study||1
290304|NCT01893346|694773|P1|NOT COMPLETED|Overall Study||3
290305|NCT01893346|694770|P4|COMPLETED|Overall Study||8
290306|NCT01893346|694771|P3|COMPLETED|Overall Study||8
290307|NCT01893346|694772|P2|COMPLETED|Overall Study||7
290308|NCT01893346|694773|P1|COMPLETED|Overall Study||8
290309|NCT01893346|694770|P4|Patients Who Received Full Infusion|Overall Study||8
290310|NCT01893346|694771|P3|Patients Who Received Full Infusion|Overall Study||8
290311|NCT01893346|694772|P2|Patients Who Received Full Infusion|Overall Study||8
290312|NCT01893346|694773|P1|Patients Who Received Full Infusion|Overall Study||8
290313|NCT01893346|694770|P4|STARTED|Overall Study||8
290314|NCT01893346|694771|P3|STARTED|Overall Study||8
290315|NCT01893346|694772|P2|STARTED|Overall Study||8
290316|NCT01893346|694773|P1|STARTED|Overall Study||11
290317|NCT01893281|694787|P1|NOT COMPLETED|Overall Study||3
290318|NCT01893281|694787|P1|COMPLETED|Overall Study||75
290319|NCT01893281|694787|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
290320|NCT01893281|694787|P1|STARTED|Overall Study||78
290321|NCT01893203|694794|P1|NOT COMPLETED|Overall Study||1
290322|NCT01893203|694794|P1|COMPLETED|Overall Study||13
290323|NCT01893203|694794|P1|STARTED|Overall Study||14
290324|NCT01892657|694801|P1|NOT COMPLETED|Overall Study||18
290325|NCT01892657|694801|P1|COMPLETED|Overall Study||110
290326|NCT01892657|694801|P1|STARTED|Overall Study||128
290327|NCT01892306|694819|P2|NOT COMPLETED|Overall Study||6
290328|NCT01892306|694820|P1|NOT COMPLETED|Overall Study||5
290329|NCT01892306|694819|P2|COMPLETED|Overall Study||10
290330|NCT01892306|694820|P1|COMPLETED|Overall Study||8
290331|NCT01892306|694819|P2|STARTED|Overall Study||16
290332|NCT01892306|694820|P1|STARTED|Overall Study||13
290333|NCT01892267|694842|P2|NOT COMPLETED|Overall Study||0
290334|NCT01892267|694843|P1|NOT COMPLETED|Overall Study||0
290335|NCT01892267|694842|P2|COMPLETED|Overall Study||10
290336|NCT01892267|694843|P1|COMPLETED|Overall Study||9
290337|NCT01892267|694842|P2|STARTED|Overall Study||10
290338|NCT01892267|694843|P1|STARTED|Overall Study||9
290339|NCT01892189|694878|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
290340|NCT01892189|694879|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
290341|NCT01892189|694880|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
290342|NCT01892189|694881|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
290343|NCT01892189|694882|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
290344|NCT01892189|694883|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
290345|NCT01892189|694884|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
290346|NCT01892189|694885|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
290347|NCT01892189|694886|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
290348|NCT01892189|694878|P9|COMPLETED|Third Intervention Period (1 Day)||1
290349|NCT01892189|694879|P8|COMPLETED|Third Intervention Period (1 Day)||3
290350|NCT01892189|694880|P7|COMPLETED|Third Intervention Period (1 Day)||2
290351|NCT01892189|694881|P6|COMPLETED|Third Intervention Period (1 Day)||2
290352|NCT01892189|694882|P5|COMPLETED|Third Intervention Period (1 Day)||3
290353|NCT01892189|694883|P4|COMPLETED|Third Intervention Period (1 Day)||2
290354|NCT01892189|694884|P3|COMPLETED|Third Intervention Period (1 Day)||1
290355|NCT01892189|694885|P2|COMPLETED|Third Intervention Period (1 Day)||3
290356|NCT01892189|694886|P1|COMPLETED|Third Intervention Period (1 Day)||3
290357|NCT01892189|694878|P9|STARTED|Third Intervention Period (1 Day)||1
290358|NCT01892189|694879|P8|STARTED|Third Intervention Period (1 Day)||3
290359|NCT01892189|694880|P7|STARTED|Third Intervention Period (1 Day)||2
290360|NCT01892189|694881|P6|STARTED|Third Intervention Period (1 Day)||2
290361|NCT01892189|694882|P5|STARTED|Third Intervention Period (1 Day)||3
290362|NCT01892189|694883|P4|STARTED|Third Intervention Period (1 Day)||2
290363|NCT01892189|694884|P3|STARTED|Third Intervention Period (1 Day)||1
290364|NCT01892189|694885|P2|STARTED|Third Intervention Period (1 Day)||3
290365|NCT01892189|694886|P1|STARTED|Third Intervention Period (1 Day)||3
290366|NCT01892189|694878|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
290367|NCT01892189|694879|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
290368|NCT01892189|694880|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
290369|NCT01892189|694881|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
290370|NCT01892189|694882|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
290371|NCT01892189|694883|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
290372|NCT01892189|694884|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
290373|NCT01892189|694885|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
290374|NCT01892189|694886|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
290375|NCT01892189|694878|P9|COMPLETED|Washout Period 2 (7 Days)||1
290376|NCT01892189|694879|P8|COMPLETED|Washout Period 2 (7 Days)||3
290377|NCT01892189|694880|P7|COMPLETED|Washout Period 2 (7 Days)||2
290378|NCT01892189|694881|P6|COMPLETED|Washout Period 2 (7 Days)||2
290379|NCT01892189|694882|P5|COMPLETED|Washout Period 2 (7 Days)||3
290380|NCT01892189|694883|P4|COMPLETED|Washout Period 2 (7 Days)||2
290381|NCT01892189|694884|P3|COMPLETED|Washout Period 2 (7 Days)||1
290382|NCT01892189|694885|P2|COMPLETED|Washout Period 2 (7 Days)||3
290383|NCT01892189|694886|P1|COMPLETED|Washout Period 2 (7 Days)||3
290384|NCT01892189|694878|P9|STARTED|Washout Period 2 (7 Days)||1
290385|NCT01892189|694879|P8|STARTED|Washout Period 2 (7 Days)||3
290386|NCT01892189|694880|P7|STARTED|Washout Period 2 (7 Days)||2
290387|NCT01892189|694881|P6|STARTED|Washout Period 2 (7 Days)||2
290388|NCT01892189|694882|P5|STARTED|Washout Period 2 (7 Days)||3
290389|NCT01892189|694883|P4|STARTED|Washout Period 2 (7 Days)||2
290390|NCT01892189|694884|P3|STARTED|Washout Period 2 (7 Days)||1
290391|NCT01892189|694885|P2|STARTED|Washout Period 2 (7 Days)||3
290392|NCT01892189|694886|P1|STARTED|Washout Period 2 (7 Days)||3
290393|NCT01892189|694878|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
290394|NCT01892189|694879|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
290395|NCT01892189|694880|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
290396|NCT01892189|694881|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
290397|NCT01892189|694882|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
290398|NCT01892189|694883|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
290399|NCT01892189|694884|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
290400|NCT01892189|694885|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
290401|NCT01892189|694886|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
290402|NCT01892189|694878|P9|COMPLETED|Second Intervention Period (1 Day)||1
290403|NCT01892189|694879|P8|COMPLETED|Second Intervention Period (1 Day)||3
290404|NCT01892189|694880|P7|COMPLETED|Second Intervention Period (1 Day)||2
290405|NCT01892189|694881|P6|COMPLETED|Second Intervention Period (1 Day)||2
290406|NCT01892189|694882|P5|COMPLETED|Second Intervention Period (1 Day)||3
290407|NCT01892189|694883|P4|COMPLETED|Second Intervention Period (1 Day)||2
290408|NCT01892189|694884|P3|COMPLETED|Second Intervention Period (1 Day)||1
290409|NCT01892189|694885|P2|COMPLETED|Second Intervention Period (1 Day)||3
290410|NCT01892189|694886|P1|COMPLETED|Second Intervention Period (1 Day)||3
290411|NCT01892189|694878|P9|STARTED|Second Intervention Period (1 Day)||1
290412|NCT01892189|694879|P8|STARTED|Second Intervention Period (1 Day)||3
290413|NCT01892189|694880|P7|STARTED|Second Intervention Period (1 Day)||2
290414|NCT01892189|694881|P6|STARTED|Second Intervention Period (1 Day)||2
290415|NCT01892189|694882|P5|STARTED|Second Intervention Period (1 Day)||3
290416|NCT01892189|694883|P4|STARTED|Second Intervention Period (1 Day)||2
290417|NCT01892189|694884|P3|STARTED|Second Intervention Period (1 Day)||1
290418|NCT01892189|694885|P2|STARTED|Second Intervention Period (1 Day)||3
290419|NCT01892189|694886|P1|STARTED|Second Intervention Period (1 Day)||3
290420|NCT01892189|694878|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
290421|NCT01892189|694879|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
290422|NCT01892189|694880|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
290423|NCT01892189|694881|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
290424|NCT01892189|694882|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
290425|NCT01892189|694883|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
290426|NCT01892189|694884|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
290427|NCT01892189|694885|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
290428|NCT01892189|694886|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
290429|NCT01892189|694878|P9|COMPLETED|Washout Period 1 (7 Days)||1
290430|NCT01892189|694879|P8|COMPLETED|Washout Period 1 (7 Days)||3
290431|NCT01892189|694880|P7|COMPLETED|Washout Period 1 (7 Days)||2
290432|NCT01892189|694881|P6|COMPLETED|Washout Period 1 (7 Days)||2
290433|NCT01892189|694882|P5|COMPLETED|Washout Period 1 (7 Days)||3
290434|NCT01892189|694883|P4|COMPLETED|Washout Period 1 (7 Days)||2
290435|NCT01892189|694884|P3|COMPLETED|Washout Period 1 (7 Days)||1
290436|NCT01892189|694885|P2|COMPLETED|Washout Period 1 (7 Days)||3
290437|NCT01892189|694886|P1|COMPLETED|Washout Period 1 (7 Days)||3
290438|NCT01892189|694878|P9|STARTED|Washout Period 1 (7 Days)||3
290439|NCT01892189|694879|P8|STARTED|Washout Period 1 (7 Days)||3
290440|NCT01892189|694880|P7|STARTED|Washout Period 1 (7 Days)||3
290441|NCT01892189|694881|P6|STARTED|Washout Period 1 (7 Days)||3
290442|NCT01892189|694882|P5|STARTED|Washout Period 1 (7 Days)||3
290443|NCT01892189|694883|P4|STARTED|Washout Period 1 (7 Days)||3
290444|NCT01892189|694884|P3|STARTED|Washout Period 1 (7 Days)||3
290445|NCT01892189|694885|P2|STARTED|Washout Period 1 (7 Days)||3
290446|NCT01892189|694886|P1|STARTED|Washout Period 1 (7 Days)||3
290447|NCT01892189|694878|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
290448|NCT01892189|694879|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
290449|NCT01892189|694880|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
290450|NCT01892189|694881|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
290451|NCT01892189|694882|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
290452|NCT01892189|694883|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
290453|NCT01892189|694884|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
290454|NCT01892189|694885|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
290455|NCT01892189|694886|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
290456|NCT01892189|694878|P9|COMPLETED|First Intervention Period (1 Day)||3
290457|NCT01892189|694879|P8|COMPLETED|First Intervention Period (1 Day)||3
290458|NCT01892189|694880|P7|COMPLETED|First Intervention Period (1 Day)||3
290459|NCT01892189|694881|P6|COMPLETED|First Intervention Period (1 Day)||3
290460|NCT01892189|694882|P5|COMPLETED|First Intervention Period (1 Day)||3
290461|NCT01892189|694883|P4|COMPLETED|First Intervention Period (1 Day)||3
290462|NCT01892189|694884|P3|COMPLETED|First Intervention Period (1 Day)||3
290463|NCT01892189|694885|P2|COMPLETED|First Intervention Period (1 Day)||3
290464|NCT01892189|694886|P1|COMPLETED|First Intervention Period (1 Day)||3
290465|NCT01892189|694878|P9|STARTED|First Intervention Period (1 Day)||3
290466|NCT01892189|694879|P8|STARTED|First Intervention Period (1 Day)||3
290467|NCT01892189|694880|P7|STARTED|First Intervention Period (1 Day)||3
290468|NCT01892189|694881|P6|STARTED|First Intervention Period (1 Day)||3
290469|NCT01892189|694882|P5|STARTED|First Intervention Period (1 Day)||3
290470|NCT01892189|694883|P4|STARTED|First Intervention Period (1 Day)||3
290471|NCT01892189|694884|P3|STARTED|First Intervention Period (1 Day)||3
290472|NCT01892189|694885|P2|STARTED|First Intervention Period (1 Day)||3
290473|NCT01892189|694886|P1|STARTED|First Intervention Period (1 Day)||3
290474|NCT01892163|694928|P2|NOT COMPLETED|Overall Study||1
290475|NCT01892163|694929|P1|NOT COMPLETED|Overall Study||2
290476|NCT01892163|694928|P2|COMPLETED|Overall Study||49
290477|NCT01892163|694929|P1|COMPLETED|Overall Study||48
290478|NCT01892163|694928|P2|STARTED|Overall Study||50
290479|NCT01892163|694929|P1|STARTED|Overall Study||50
290480|NCT01892020|694941|P2|NOT COMPLETED|Period 2||0
290481|NCT01892020|694942|P1|NOT COMPLETED|Period 2||1
290482|NCT01892020|694941|P2|COMPLETED|Period 2||74
290483|NCT01892020|694942|P1|COMPLETED|Period 2||77
290484|NCT01892020|694941|P2|STARTED|Period 2||74
290485|NCT01892020|694942|P1|STARTED|Period 2||78
290486|NCT01892020|694941|P2|NOT COMPLETED|Period 1||6
290487|NCT01892020|694942|P1|NOT COMPLETED|Period 1||3
290488|NCT01892020|694941|P2|COMPLETED|Period 1||74
290489|NCT01892020|694942|P1|COMPLETED|Period 1||78
290490|NCT01892020|694941|P2|STARTED|Period 1||80
290491|NCT01892020|694942|P1|STARTED|Period 1||81
290492|NCT01891864|694962|P6|NOT COMPLETED|Extension Period||0
290493|NCT01891864|694963|P5|NOT COMPLETED|Extension Period||7
290494|NCT01891864|694964|P4|NOT COMPLETED|Extension Period||5
290495|NCT01891864|694965|P3|NOT COMPLETED|Extension Period||8
290496|NCT01891864|694966|P2|NOT COMPLETED|Extension Period||0
290497|NCT01891864|694967|P1|NOT COMPLETED|Extension Period||0
290498|NCT01891864|694962|P6|COMPLETED|Extension Period||90
290499|NCT01891864|694963|P5|COMPLETED|Extension Period||88
290500|NCT01891864|694964|P4|COMPLETED|Extension Period||137
290501|NCT01891864|694965|P3|COMPLETED|Extension Period||132
290502|NCT01891864|694966|P2|COMPLETED|Extension Period||0
290503|NCT01891864|694967|P1|COMPLETED|Extension Period||0
290504|NCT01891864|694962|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
290505|NCT01891864|694963|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
290506|NCT01891864|694964|P4|STARTED|Extension Period||142
290507|NCT01891864|694965|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
290508|NCT01891864|694966|P2|STARTED|Extension Period||0
290509|NCT01891864|694967|P1|STARTED|Extension Period||0
290510|NCT01891864|694962|P6|NOT COMPLETED|Treatment Period 2||5
290511|NCT01891864|694963|P5|NOT COMPLETED|Treatment Period 2||4
290512|NCT01891864|694964|P4|NOT COMPLETED|Treatment Period 2||9
290513|NCT01891864|694965|P3|NOT COMPLETED|Treatment Period 2||7
290514|NCT01891864|694966|P2|NOT COMPLETED|Treatment Period 2||0
290515|NCT01891864|694967|P1|NOT COMPLETED|Treatment Period 2||0
290516|NCT01891864|694962|P6|COMPLETED|Treatment Period 2||91
290517|NCT01891864|694963|P5|COMPLETED|Treatment Period 2||96
290518|NCT01891864|694964|P4|COMPLETED|Treatment Period 2||142
290519|NCT01891864|694965|P3|COMPLETED|Treatment Period 2||143
290520|NCT01891864|694966|P2|COMPLETED|Treatment Period 2||0
290521|NCT01891864|694967|P1|COMPLETED|Treatment Period 2||0
290522|NCT01891864|694962|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
290523|NCT01891864|694963|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
290524|NCT01891864|694964|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
290525|NCT01891864|694965|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
290526|NCT01891864|694966|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
290527|NCT01891864|694967|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
290528|NCT01891864|694962|P6|NOT COMPLETED|Treatment Period 1||0
290529|NCT01891864|694963|P5|NOT COMPLETED|Treatment Period 1||0
290530|NCT01891864|694964|P4|NOT COMPLETED|Treatment Period 1||0
290531|NCT01891864|694965|P3|NOT COMPLETED|Treatment Period 1||0
290532|NCT01891864|694966|P2|NOT COMPLETED|Treatment Period 1||12
290533|NCT01891864|694967|P1|NOT COMPLETED|Treatment Period 1||8
290534|NCT01891864|694962|P6|COMPLETED|Treatment Period 1||0
290535|NCT01891864|694963|P5|COMPLETED|Treatment Period 1||0
290536|NCT01891864|694964|P4|COMPLETED|Treatment Period 1||0
290537|NCT01891864|694965|P3|COMPLETED|Treatment Period 1||0
290538|NCT01891864|694966|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
290539|NCT01891864|694967|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
290540|NCT01891864|694962|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
290541|NCT01891864|694963|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
290542|NCT01891864|694964|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
290543|NCT01891864|694965|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
290544|NCT01891864|694966|P2|STARTED|Treatment Period 1||267
290545|NCT01891864|694967|P1|STARTED|Treatment Period 1||264
290546|NCT01891734|694989|P2|NOT COMPLETED|Overall Study||3
290547|NCT01891734|694990|P1|NOT COMPLETED|Overall Study||3
290548|NCT01891734|694989|P2|COMPLETED|Overall Study||13
290549|NCT01891734|694990|P1|COMPLETED|Overall Study||14
290550|NCT01891734|694989|P2|STARTED|Overall Study||16
290551|NCT01891734|694990|P1|STARTED|Overall Study||17
290552|NCT01891669|695010|P10|NOT COMPLETED|Overall Study||2
290553|NCT01891669|695011|P9|NOT COMPLETED|Overall Study||1
290554|NCT01891669|695012|P8|NOT COMPLETED|Overall Study||4
290555|NCT01891669|695013|P7|NOT COMPLETED|Overall Study||1
290556|NCT01891669|695014|P6|NOT COMPLETED|Overall Study||0
290557|NCT01891669|695015|P5|NOT COMPLETED|Overall Study||0
290558|NCT01891669|695016|P4|NOT COMPLETED|Overall Study||0
290559|NCT01891669|695017|P3|NOT COMPLETED|Overall Study||0
290560|NCT01891669|695018|P2|NOT COMPLETED|Overall Study||1
290561|NCT01891669|695019|P1|NOT COMPLETED|Overall Study||2
290562|NCT01891669|695010|P10|COMPLETED|Overall Study||1
290563|NCT01891669|695011|P9|COMPLETED|Overall Study||2
290564|NCT01891669|695012|P8|COMPLETED|Overall Study||2
290565|NCT01891669|695013|P7|COMPLETED|Overall Study||1
290566|NCT01891669|695014|P6|COMPLETED|Overall Study||2
290567|NCT01891669|695015|P5|COMPLETED|Overall Study||2
290568|NCT01891669|695016|P4|COMPLETED|Overall Study||2
290569|NCT01891669|695017|P3|COMPLETED|Overall Study||2
290570|NCT01891669|695018|P2|COMPLETED|Overall Study||1
290571|NCT01891669|695019|P1|COMPLETED|Overall Study||0
290572|NCT01891669|695010|P10|STARTED|Overall Study||3
290573|NCT01891669|695011|P9|STARTED|Overall Study||3
290574|NCT01891669|695012|P8|STARTED|Overall Study||6
290575|NCT01891669|695013|P7|STARTED|Overall Study||2
290576|NCT01891669|695014|P6|STARTED|Overall Study||2
290577|NCT01891669|695015|P5|STARTED|Overall Study||2
290578|NCT01891669|695016|P4|STARTED|Overall Study||2
290579|NCT01891669|695017|P3|STARTED|Overall Study||2
290580|NCT01891669|695018|P2|STARTED|Overall Study||2
290581|NCT01891669|695019|P1|STARTED|Overall Study||2
290582|NCT01890954|695172|P2|NOT COMPLETED|Overall Study||0
290583|NCT01890954|695173|P1|NOT COMPLETED|Overall Study||1
290584|NCT01890954|695172|P2|COMPLETED|Overall Study||8
290585|NCT01890954|695173|P1|COMPLETED|Overall Study||8
290586|NCT01890954|695172|P2|STARTED|Overall Study||8
290587|NCT01890954|695173|P1|STARTED|Overall Study||9
290588|NCT01890915|695181|P2|NOT COMPLETED|Overall Study||1
290589|NCT01890915|695182|P1|NOT COMPLETED|Overall Study||3
290590|NCT01890915|695181|P2|COMPLETED|Overall Study||9
290591|NCT01890915|695182|P1|COMPLETED|Overall Study||8
290592|NCT01890915|695181|P2|STARTED|Overall Study||10
290593|NCT01890915|695182|P1|STARTED|Overall Study||11
290594|NCT01890785|695198|P6|NOT COMPLETED|Third Intervention||0
290595|NCT01890785|695199|P5|NOT COMPLETED|Third Intervention||0
290596|NCT01890785|695200|P4|NOT COMPLETED|Third Intervention||0
290597|NCT01890785|695201|P3|NOT COMPLETED|Third Intervention||0
290598|NCT01890785|695202|P2|NOT COMPLETED|Third Intervention||1
290599|NCT01890785|695203|P1|NOT COMPLETED|Third Intervention||0
290600|NCT01890785|695198|P6|COMPLETED|Third Intervention||5
290601|NCT01890785|695199|P5|COMPLETED|Third Intervention||5
290602|NCT01890785|695200|P4|COMPLETED|Third Intervention||5
290603|NCT01890785|695201|P3|COMPLETED|Third Intervention||5
290604|NCT01890785|695202|P2|COMPLETED|Third Intervention||4
290605|NCT01890785|695203|P1|COMPLETED|Third Intervention||5
290606|NCT01890785|695198|P6|STARTED|Third Intervention||5
290607|NCT01890785|695199|P5|STARTED|Third Intervention||5
290608|NCT01890785|695200|P4|STARTED|Third Intervention||5
290609|NCT01890785|695201|P3|STARTED|Third Intervention||5
290610|NCT01890785|695202|P2|STARTED|Third Intervention||5
290611|NCT01890785|695203|P1|STARTED|Third Intervention||5
290612|NCT01890785|695198|P6|NOT COMPLETED|Second Intervention||0
290613|NCT01890785|695199|P5|NOT COMPLETED|Second Intervention||0
290614|NCT01890785|695200|P4|NOT COMPLETED|Second Intervention||0
290615|NCT01890785|695201|P3|NOT COMPLETED|Second Intervention||0
290616|NCT01890785|695202|P2|NOT COMPLETED|Second Intervention||0
290617|NCT01890785|695203|P1|NOT COMPLETED|Second Intervention||0
290618|NCT01890785|695198|P6|COMPLETED|Second Intervention||5
290619|NCT01890785|695199|P5|COMPLETED|Second Intervention||5
290620|NCT01890785|695200|P4|COMPLETED|Second Intervention||5
290621|NCT01890785|695201|P3|COMPLETED|Second Intervention||5
290622|NCT01890785|695202|P2|COMPLETED|Second Intervention||5
290623|NCT01890785|695203|P1|COMPLETED|Second Intervention||5
290624|NCT01890785|695198|P6|STARTED|Second Intervention||5
290625|NCT01890785|695199|P5|STARTED|Second Intervention||5
290626|NCT01890785|695200|P4|STARTED|Second Intervention||5
290627|NCT01890785|695201|P3|STARTED|Second Intervention||5
290628|NCT01890785|695202|P2|STARTED|Second Intervention||5
290629|NCT01890785|695203|P1|STARTED|Second Intervention||5
290630|NCT01890785|695198|P6|NOT COMPLETED|First Intervention||0
290631|NCT01890785|695199|P5|NOT COMPLETED|First Intervention||0
290632|NCT01890785|695200|P4|NOT COMPLETED|First Intervention||0
290633|NCT01890785|695201|P3|NOT COMPLETED|First Intervention||0
290634|NCT01890785|695202|P2|NOT COMPLETED|First Intervention||0
290635|NCT01890785|695203|P1|NOT COMPLETED|First Intervention||0
290636|NCT01890785|695198|P6|COMPLETED|First Intervention||5
290637|NCT01890785|695199|P5|COMPLETED|First Intervention||5
290638|NCT01890785|695200|P4|COMPLETED|First Intervention||5
290639|NCT01890785|695201|P3|COMPLETED|First Intervention||5
290640|NCT01890785|695202|P2|COMPLETED|First Intervention||5
290641|NCT01890785|695203|P1|COMPLETED|First Intervention||5
290642|NCT01890785|695198|P6|STARTED|First Intervention||5
290643|NCT01890785|695199|P5|STARTED|First Intervention||5
290644|NCT01890785|695200|P4|STARTED|First Intervention||5
290645|NCT01890785|695201|P3|STARTED|First Intervention||5
290646|NCT01890785|695202|P2|STARTED|First Intervention||5
290647|NCT01890785|695203|P1|STARTED|First Intervention||5
290648|NCT01890746|695222|P2|NOT COMPLETED|Overall Study||74
290649|NCT01890746|695223|P1|NOT COMPLETED|Overall Study||74
290650|NCT01890746|695222|P2|COMPLETED|Overall Study||0
290651|NCT01890746|695223|P1|COMPLETED|Overall Study||0
290652|NCT01890746|695222|P2|STARTED|Overall Study||74
290653|NCT01890746|695223|P1|STARTED|Overall Study||74
290654|NCT01890694|695249|P2|NOT COMPLETED|Overall Study||1
290655|NCT01890694|695250|P1|NOT COMPLETED|Overall Study||1
290656|NCT01890694|695249|P2|COMPLETED|Overall Study||0
290657|NCT01890694|695250|P1|COMPLETED|Overall Study||0
290658|NCT01890694|695249|P2|STARTED|Overall Study||1
290659|NCT01890694|695250|P1|STARTED|Overall Study||1
290660|NCT01890642|695260|P3|NOT COMPLETED|Overall Study||0
290661|NCT01890642|695261|P2|NOT COMPLETED|Overall Study||0
290662|NCT01890642|695262|P1|NOT COMPLETED|Overall Study||0
290663|NCT01890642|695260|P3|COMPLETED|Overall Study||96
290664|NCT01890642|695261|P2|COMPLETED|Overall Study||53
290665|NCT01890642|695262|P1|COMPLETED|Overall Study||56
290666|NCT01890642|695260|P3|STARTED|Overall Study||96
290667|NCT01890642|695261|P2|STARTED|Overall Study||53
290668|NCT01890642|695262|P1|STARTED|Overall Study||56
290669|NCT01890577|695282|P1|NOT COMPLETED|Overall Study||28
290670|NCT01890577|695282|P1|COMPLETED|Overall Study||0
290671|NCT01890577|695282|P1|STARTED|Overall Study||28
290672|NCT01890512|695295|P1|NOT COMPLETED|Overall Study||3
290673|NCT01890512|695295|P1|COMPLETED|Overall Study||17
290674|NCT01890512|695295|P1|STARTED|Overall Study||20
290675|NCT01890473|695301|P2|NOT COMPLETED|Overall Study||0
290676|NCT01890473|695302|P1|NOT COMPLETED|Overall Study||2
290677|NCT01890473|695301|P2|COMPLETED|Overall Study||113
290678|NCT01890473|695302|P1|COMPLETED|Overall Study||109
290679|NCT01890473|695301|P2|STARTED|Overall Study||113
290680|NCT01890473|695302|P1|STARTED|Overall Study||111
290681|NCT01890343|695331|P3|NOT COMPLETED|Overall Study||0
290682|NCT01890343|695332|P2|NOT COMPLETED|Overall Study||0
290683|NCT01890343|695333|P1|NOT COMPLETED|Overall Study||0
290684|NCT01890343|695331|P3|COMPLETED|Overall Study||10
290685|NCT01890343|695332|P2|COMPLETED|Overall Study||10
290686|NCT01890343|695333|P1|COMPLETED|Overall Study||8
290687|NCT01890343|695331|P3|STARTED|Overall Study||10
290688|NCT01890343|695332|P2|STARTED|Overall Study||10
290689|NCT01890343|695333|P1|STARTED|Overall Study||8
290690|NCT01890148|695344|P1|NOT COMPLETED|Overall Study||1
290691|NCT01890148|695344|P1|COMPLETED|Overall Study||4
290692|NCT01890148|695344|P1|STARTED|Overall Study||5
290693|NCT01890122|695364|P4|NOT COMPLETED|Overall Study||59
290694|NCT01890122|695365|P3|NOT COMPLETED|Overall Study||13
290695|NCT01890122|695366|P2|NOT COMPLETED|Overall Study||37
290696|NCT01890122|695367|P1|NOT COMPLETED|Overall Study||27
290697|NCT01890122|695364|P4|COMPLETED|Overall Study||104
290698|NCT01890122|695365|P3|COMPLETED|Overall Study||146
290699|NCT01890122|695366|P2|COMPLETED|Overall Study||126
290700|NCT01890122|695367|P1|COMPLETED|Overall Study||135
290701|NCT01890122|695364|P4|Treated|Overall Study||163
290702|NCT01890122|695365|P3|Treated|Overall Study||159
290703|NCT01890122|695366|P2|Treated|Overall Study||162
290704|NCT01890122|695367|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
290705|NCT01890122|695364|P4|STARTED|Overall Study||163
290706|NCT01890122|695365|P3|STARTED|Overall Study||159
290707|NCT01890122|695366|P2|STARTED|Overall Study||163
290708|NCT01890122|695367|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
290709|NCT01890031|695434|P5|NOT COMPLETED|Overall Study||0
290710|NCT01890031|695435|P4|NOT COMPLETED|Overall Study||0
290711|NCT01890031|695436|P3|NOT COMPLETED|Overall Study||0
290712|NCT01890031|695437|P2|NOT COMPLETED|Overall Study||0
290713|NCT01890031|695438|P1|NOT COMPLETED|Overall Study||0
290714|NCT01890031|695434|P5|COMPLETED|Overall Study||8
290715|NCT01890031|695435|P4|COMPLETED|Overall Study||11
290716|NCT01890031|695436|P3|COMPLETED|Overall Study||12
290717|NCT01890031|695437|P2|COMPLETED|Overall Study||50
290718|NCT01890031|695438|P1|COMPLETED|Overall Study||50
290719|NCT01890031|695434|P5|STARTED|Overall Study||8
290720|NCT01890031|695435|P4|STARTED|Overall Study||11
290721|NCT01890031|695436|P3|STARTED|Overall Study||12
290722|NCT01890031|695437|P2|STARTED|Overall Study||50
290723|NCT01890031|695438|P1|STARTED|Overall Study||50
290724|NCT01889797|695457|P2|NOT COMPLETED|Overall Study||0
290725|NCT01889797|695458|P1|NOT COMPLETED|Overall Study||0
290726|NCT01889797|695457|P2|COMPLETED|Overall Study||16
290727|NCT01889797|695458|P1|COMPLETED|Overall Study||16
290728|NCT01889797|695457|P2|STARTED|Overall Study||16
290729|NCT01889797|695458|P1|STARTED|Overall Study||16
290730|NCT01889667|695473|P3|NOT COMPLETED|Overall Study||0
290731|NCT01889667|695474|P2|NOT COMPLETED|Overall Study||0
290732|NCT01889667|695475|P1|NOT COMPLETED|Overall Study||0
290733|NCT01889667|695473|P3|COMPLETED|Overall Study||10
290734|NCT01889667|695474|P2|COMPLETED|Overall Study||10
290735|NCT01889667|695475|P1|COMPLETED|Overall Study||10
290736|NCT01889667|695473|P3|STARTED|Overall Study||10
290737|NCT01889667|695474|P2|STARTED|Overall Study||10
290738|NCT01889667|695475|P1|STARTED|Overall Study||10
290739|NCT01889563|695497|P2|NOT COMPLETED|Overall Study||5
290740|NCT01889563|695498|P1|NOT COMPLETED|Overall Study||7
290741|NCT01889563|695497|P2|COMPLETED|Overall Study||10
290742|NCT01889563|695498|P1|COMPLETED|Overall Study||10
290743|NCT01889563|695497|P2|STARTED|Overall Study||15
290744|NCT01889563|695498|P1|STARTED|Overall Study||17
290745|NCT01889420|695506|P1|NOT COMPLETED|Overall Study||0
290746|NCT01889420|695506|P1|COMPLETED|Overall Study||1
290747|NCT01889420|695506|P1|STARTED|Overall Study||1
290748|NCT01889251|695514|P2|NOT COMPLETED|Overall Study||0
290749|NCT01889251|695515|P1|NOT COMPLETED|Overall Study||1
290750|NCT01889251|695514|P2|COMPLETED|Overall Study||57
290751|NCT01889251|695515|P1|COMPLETED|Overall Study||114
290752|NCT01889251|695514|P2|STARTED|Overall Study||57
290753|NCT01889251|695515|P1|STARTED|Overall Study||115
290754|NCT01888965|695521|P1|NOT COMPLETED|Overall Study||9
290755|NCT01888965|695521|P1|COMPLETED|Overall Study||0
290756|NCT01888965|695521|P1|STARTED|Overall Study||9
290757|NCT01888952|695527|P1|NOT COMPLETED|Overall Study||0
290758|NCT01888952|695527|P1|COMPLETED|Overall Study||10
290759|NCT01888952|695527|P1|STARTED|Overall Study||10
290760|NCT01888900|695533|P2|NOT COMPLETED|Overall Study||2
290761|NCT01888900|695534|P1|NOT COMPLETED|Overall Study||0
290762|NCT01888900|695533|P2|COMPLETED|Overall Study||11
290763|NCT01888900|695534|P1|COMPLETED|Overall Study||22
290764|NCT01888900|695533|P2|STARTED|Overall Study||13
290765|NCT01888900|695534|P1|STARTED|Overall Study||22
290766|NCT01888367|695557|P3|NOT COMPLETED|Overall Study||5
290767|NCT01888367|695558|P2|NOT COMPLETED|Overall Study||5
290768|NCT01888367|695559|P1|NOT COMPLETED|Overall Study||8
290769|NCT01888367|695557|P3|COMPLETED|Overall Study||73
290770|NCT01888367|695558|P2|COMPLETED|Overall Study||66
290771|NCT01888367|695559|P1|COMPLETED|Overall Study||288
290772|NCT01888367|695557|P3|STARTED|Overall Study||78
290773|NCT01888367|695558|P2|STARTED|Overall Study||71
290774|NCT01888367|695559|P1|STARTED|Overall Study||296
290775|NCT01888003|695579|P3|NOT COMPLETED|Overall Study||40
290776|NCT01888003|695580|P2|NOT COMPLETED|Overall Study||6
290777|NCT01888003|695581|P1|NOT COMPLETED|Overall Study||5
290778|NCT01888003|695579|P3|COMPLETED|Overall Study||0
290779|NCT01888003|695580|P2|COMPLETED|Overall Study||0
290780|NCT01888003|695581|P1|COMPLETED|Overall Study||0
290781|NCT01888003|695579|P3|STARTED|Overall Study||40
290782|NCT01888003|695580|P2|STARTED|Overall Study||6
290783|NCT01888003|695581|P1|STARTED|Overall Study||5
290784|NCT01887990|695602|P4|NOT COMPLETED|Overall Study||0
290785|NCT01887990|695603|P3|NOT COMPLETED|Overall Study||0
290786|NCT01887990|695604|P2|NOT COMPLETED|Overall Study||0
290787|NCT01887990|695605|P1|NOT COMPLETED|Overall Study||0
290788|NCT01887990|695602|P4|COMPLETED|Overall Study||2
290789|NCT01887990|695603|P3|COMPLETED|Overall Study||2
290790|NCT01887990|695604|P2|COMPLETED|Overall Study||7
290791|NCT01887990|695605|P1|COMPLETED|Overall Study||7
290792|NCT01887990|695602|P4|STARTED|Overall Study||2
290793|NCT01887990|695603|P3|STARTED|Overall Study||2
290794|NCT01887990|695604|P2|STARTED|Overall Study||7
290795|NCT01887990|695605|P1|STARTED|Overall Study||7
290796|NCT01887678|695621|P2|NOT COMPLETED|Overall Study||28
290797|NCT01887678|695622|P1|NOT COMPLETED|Overall Study||17
290798|NCT01887678|695621|P2|COMPLETED|Overall Study||85
290799|NCT01887678|695622|P1|COMPLETED|Overall Study||102
290800|NCT01887678|695621|P2|STARTED|Overall Study||113
290801|NCT01887678|695622|P1|STARTED|Overall Study||119
290802|NCT01887470|695668|P4|NOT COMPLETED|Overall Study||0
290803|NCT01887470|695669|P3|NOT COMPLETED|Overall Study||0
290804|NCT01887470|695670|P2|NOT COMPLETED|Overall Study||0
290805|NCT01887470|695671|P1|NOT COMPLETED|Overall Study||0
290806|NCT01887470|695668|P4|COMPLETED|Overall Study||10
290807|NCT01887470|695669|P3|COMPLETED|Overall Study||10
290808|NCT01887470|695670|P2|COMPLETED|Overall Study||10
290809|NCT01887470|695671|P1|COMPLETED|Overall Study||10
290810|NCT01887470|695668|P4|STARTED|Overall Study||10
290811|NCT01887470|695669|P3|STARTED|Overall Study||10
290812|NCT01887470|695670|P2|STARTED|Overall Study||10
290813|NCT01887470|695671|P1|STARTED|Overall Study||10
290814|NCT01887418|695690|P3|NOT COMPLETED|Overall Study||1
290815|NCT01887418|695691|P2|NOT COMPLETED|Overall Study||0
290816|NCT01887418|695692|P1|NOT COMPLETED|Overall Study||0
290817|NCT01887418|695690|P3|COMPLETED|Overall Study||9
290818|NCT01887418|695691|P2|COMPLETED|Overall Study||14
290819|NCT01887418|695692|P1|COMPLETED|Overall Study||15
290820|NCT01887418|695690|P3|STARTED|Overall Study||10
290821|NCT01887418|695691|P2|STARTED|Overall Study||14
290822|NCT01887418|695692|P1|STARTED|Overall Study||15
290823|NCT01887353|695711|P2|NOT COMPLETED|Overall Study||3
290824|NCT01887353|695712|P1|NOT COMPLETED|Overall Study||4
290825|NCT01887353|695711|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
290826|NCT01887353|695712|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
290827|NCT01887353|695711|P2|STARTED|Overall Study||4
290828|NCT01887353|695712|P1|STARTED|Overall Study||4
290829|NCT01887171|695720|P2|NOT COMPLETED|Overall Study||0
290830|NCT01887171|695721|P1|NOT COMPLETED|Overall Study||0
290831|NCT01887171|695720|P2|COMPLETED|Overall Study||43
290832|NCT01887171|695721|P1|COMPLETED|Overall Study||43
290833|NCT01887171|695720|P2|STARTED|Overall Study||43
290834|NCT01887171|695721|P1|STARTED|Overall Study||43
290835|NCT01886963|695729|P2|NOT COMPLETED|Overall Study||4
290836|NCT01886963|695730|P1|NOT COMPLETED|Overall Study||5
290837|NCT01886963|695729|P2|COMPLETED|Overall Study||49
290838|NCT01886963|695730|P1|COMPLETED|Overall Study||46
290839|NCT01886963|695729|P2|12 Week Follow Up|Overall Study||22
290840|NCT01886963|695730|P1|12 Week Follow Up|Overall Study||24
290841|NCT01886963|695729|P2|4 Week Follow Up|Overall Study||26
290842|NCT01886963|695730|P1|4 Week Follow Up|Overall Study||24
290843|NCT01886963|695729|P2|2 Week Follow Up|Overall Study||35
290844|NCT01886963|695730|P1|2 Week Follow Up|Overall Study||38
290845|NCT01886963|695729|P2|STARTED|Overall Study||53
290846|NCT01886963|695730|P1|STARTED|Overall Study||51
290847|NCT01886807|695739|P3|NOT COMPLETED|Overall Study||10
290848|NCT01886807|695740|P2|NOT COMPLETED|Overall Study||10
290849|NCT01886807|695741|P1|NOT COMPLETED|Overall Study||5
290850|NCT01886807|695739|P3|COMPLETED|Overall Study||153
290851|NCT01886807|695740|P2|COMPLETED|Overall Study||145
290852|NCT01886807|695741|P1|COMPLETED|Overall Study||159
290853|NCT01886807|695739|P3|STARTED|Overall Study||163
290854|NCT01886807|695740|P2|STARTED|Overall Study||155
290855|NCT01886807|695741|P1|STARTED|Overall Study||164
290856|NCT01886781|695751|P2|NOT COMPLETED|Overall Study||2
290857|NCT01886781|695752|P1|NOT COMPLETED|Overall Study||14
290858|NCT01886781|695751|P2|COMPLETED|Overall Study||25
290859|NCT01886781|695752|P1|COMPLETED|Overall Study||40
290860|NCT01886781|695751|P2|STARTED|Overall Study||27
290861|NCT01886781|695752|P1|STARTED|Overall Study||54
290862|NCT01886716|695762|P4|NOT COMPLETED|1-Month Post Follow-Up||0
290863|NCT01886716|695763|P3|NOT COMPLETED|1-Month Post Follow-Up||0
290864|NCT01886716|695764|P2|NOT COMPLETED|1-Month Post Follow-Up||0
290865|NCT01886716|695765|P1|NOT COMPLETED|1-Month Post Follow-Up||0
290866|NCT01886716|695762|P4|COMPLETED|1-Month Post Follow-Up||14
290867|NCT01886716|695763|P3|COMPLETED|1-Month Post Follow-Up||19
290868|NCT01886716|695764|P2|COMPLETED|1-Month Post Follow-Up||17
290869|NCT01886716|695765|P1|COMPLETED|1-Month Post Follow-Up||20
290870|NCT01886716|695762|P4|STARTED|1-Month Post Follow-Up||14
290871|NCT01886716|695763|P3|STARTED|1-Month Post Follow-Up||19
290872|NCT01886716|695764|P2|STARTED|1-Month Post Follow-Up||17
290873|NCT01886716|695765|P1|STARTED|1-Month Post Follow-Up||20
290874|NCT01886716|695762|P4|NOT COMPLETED|1-Week Post Follow-Up||0
290875|NCT01886716|695763|P3|NOT COMPLETED|1-Week Post Follow-Up||0
290876|NCT01886716|695764|P2|NOT COMPLETED|1-Week Post Follow-Up||0
290877|NCT01886716|695765|P1|NOT COMPLETED|1-Week Post Follow-Up||0
290878|NCT01886716|695762|P4|COMPLETED|1-Week Post Follow-Up||14
290879|NCT01886716|695763|P3|COMPLETED|1-Week Post Follow-Up||19
290880|NCT01886716|695764|P2|COMPLETED|1-Week Post Follow-Up||17
290881|NCT01886716|695765|P1|COMPLETED|1-Week Post Follow-Up||20
290882|NCT01886716|695762|P4|STARTED|1-Week Post Follow-Up||14
290883|NCT01886716|695763|P3|STARTED|1-Week Post Follow-Up||19
290884|NCT01886716|695764|P2|STARTED|1-Week Post Follow-Up||17
290885|NCT01886716|695765|P1|STARTED|1-Week Post Follow-Up||20
290886|NCT01886716|695762|P4|NOT COMPLETED|Week 4||0
290887|NCT01886716|695763|P3|NOT COMPLETED|Week 4||0
290888|NCT01886716|695764|P2|NOT COMPLETED|Week 4||0
290889|NCT01886716|695765|P1|NOT COMPLETED|Week 4||0
290890|NCT01886716|695762|P4|COMPLETED|Week 4||14
290891|NCT01886716|695763|P3|COMPLETED|Week 4||19
290892|NCT01886716|695764|P2|COMPLETED|Week 4||17
290893|NCT01886716|695765|P1|COMPLETED|Week 4||20
290894|NCT01886716|695762|P4|STARTED|Week 4||14
290895|NCT01886716|695763|P3|STARTED|Week 4||19
290896|NCT01886716|695764|P2|STARTED|Week 4||17
290897|NCT01886716|695765|P1|STARTED|Week 4||20
290898|NCT01886716|695762|P4|NOT COMPLETED|Week 3||1
290899|NCT01886716|695763|P3|NOT COMPLETED|Week 3||0
290900|NCT01886716|695764|P2|NOT COMPLETED|Week 3||1
290901|NCT01886716|695765|P1|NOT COMPLETED|Week 3||1
290902|NCT01886716|695762|P4|COMPLETED|Week 3||14
290903|NCT01886716|695763|P3|COMPLETED|Week 3||19
290904|NCT01886716|695764|P2|COMPLETED|Week 3||17
290905|NCT01886716|695765|P1|COMPLETED|Week 3||20
290906|NCT01886716|695762|P4|STARTED|Week 3||15
290907|NCT01886716|695763|P3|STARTED|Week 3||19
290908|NCT01886716|695764|P2|STARTED|Week 3||18
290909|NCT01886716|695765|P1|STARTED|Week 3||21
290910|NCT01886716|695762|P4|NOT COMPLETED|Week 2||3
290911|NCT01886716|695763|P3|NOT COMPLETED|Week 2||1
290912|NCT01886716|695764|P2|NOT COMPLETED|Week 2||2
290913|NCT01886716|695765|P1|NOT COMPLETED|Week 2||3
290914|NCT01886716|695762|P4|COMPLETED|Week 2||15
290915|NCT01886716|695763|P3|COMPLETED|Week 2||19
290916|NCT01886716|695764|P2|COMPLETED|Week 2||18
290917|NCT01886716|695765|P1|COMPLETED|Week 2||21
290918|NCT01886716|695762|P4|STARTED|Week 2||18
290919|NCT01886716|695763|P3|STARTED|Week 2||20
290920|NCT01886716|695764|P2|STARTED|Week 2||20
290921|NCT01886716|695765|P1|STARTED|Week 2||24
290922|NCT01886716|695762|P4|NOT COMPLETED|Week 1||2
290923|NCT01886716|695763|P3|NOT COMPLETED|Week 1||2
290924|NCT01886716|695764|P2|NOT COMPLETED|Week 1||0
290925|NCT01886716|695765|P1|NOT COMPLETED|Week 1||0
290926|NCT01886716|695762|P4|COMPLETED|Week 1||18
290927|NCT01886716|695763|P3|COMPLETED|Week 1||20
290928|NCT01886716|695764|P2|COMPLETED|Week 1||20
290929|NCT01886716|695765|P1|COMPLETED|Week 1||24
290930|NCT01886716|695762|P4|STARTED|Week 1||20
290931|NCT01886716|695763|P3|STARTED|Week 1||22
290932|NCT01886716|695764|P2|STARTED|Week 1||20
290933|NCT01886716|695765|P1|STARTED|Week 1||24
290934|NCT01886690|695781|P2|NOT COMPLETED|Overall Study||2
290935|NCT01886690|695782|P1|NOT COMPLETED|Overall Study||0
290936|NCT01886690|695781|P2|COMPLETED|Overall Study||71
290937|NCT01886690|695782|P1|COMPLETED|Overall Study||75
290938|NCT01886690|695781|P2|STARTED|Overall Study||73
290939|NCT01886690|695782|P1|STARTED|Overall Study||75
290940|NCT01886313|695798|P2|NOT COMPLETED|Overall Study||1
290941|NCT01886313|695799|P1|NOT COMPLETED|Overall Study||1
290942|NCT01886313|695798|P2|COMPLETED|Overall Study||4
290943|NCT01886313|695799|P1|COMPLETED|Overall Study||5
290944|NCT01886313|695798|P2|STARTED|Overall Study||5
290945|NCT01886313|695799|P1|STARTED|Overall Study||6
290946|NCT01886300|695805|P1|NOT COMPLETED|Overall Study||16
290947|NCT01886300|695805|P1|COMPLETED|Overall Study||0
290948|NCT01886300|695805|P1|STARTED|Overall Study||16
290949|NCT01886287|695816|P1|NOT COMPLETED|Overall Study||2
290950|NCT01886287|695816|P1|COMPLETED|Overall Study||0
290951|NCT01886287|695816|P1|STARTED|Overall Study||2
290952|NCT01886235|695821|P1|NOT COMPLETED|Overall Study||0
290953|NCT01886235|695821|P1|COMPLETED|Overall Study||10
290954|NCT01886235|695821|P1|STARTED|Overall Study||10
290955|NCT01885910|695832|P1|NOT COMPLETED|Overall Study||8
290956|NCT01885910|695832|P1|COMPLETED|Overall Study||24
290957|NCT01885910|695832|P1|STARTED|Overall Study||32
290958|NCT01885871|695846|P1|NOT COMPLETED|Overall Study||0
290959|NCT01885871|695846|P1|COMPLETED|Overall Study||20
290960|NCT01885871|695846|P1|STARTED|Overall Study||20
290961|NCT01885559|695856|P2|NOT COMPLETED|Overall Study||36
290962|NCT01885559|695857|P1|NOT COMPLETED|Overall Study||24
290963|NCT01885559|695856|P2|COMPLETED|Overall Study||208
290964|NCT01885559|695857|P1|COMPLETED|Overall Study||218
290965|NCT01885559|695856|P2|STARTED|Overall Study||244
290966|NCT01885559|695857|P1|STARTED|Overall Study||242
290967|NCT01885117|695879|P2|NOT COMPLETED|Overall Study||0
290968|NCT01885117|695880|P1|NOT COMPLETED|Overall Study||0
290969|NCT01885117|695879|P2|COMPLETED|Overall Study||64
290970|NCT01885117|695880|P1|COMPLETED|Overall Study||61
290971|NCT01885117|695879|P2|STARTED|Overall Study||64
290972|NCT01885117|695880|P1|STARTED|Overall Study||61
290973|NCT01885104|695902|P2|NOT COMPLETED|Overall Study||1
290974|NCT01885104|695903|P1|NOT COMPLETED|Overall Study||2
290975|NCT01885104|695902|P2|COMPLETED|Overall Study||33
290976|NCT01885104|695903|P1|COMPLETED|Overall Study||29
290977|NCT01885104|695902|P2|STARTED|Overall Study||34
290978|NCT01885104|695903|P1|STARTED|Overall Study||31
290979|NCT01885000|695913|P2|NOT COMPLETED|Overall Study||2
290980|NCT01885000|695914|P1|NOT COMPLETED|Overall Study||2
290981|NCT01885000|695913|P2|COMPLETED|Overall Study||42
290982|NCT01885000|695914|P1|COMPLETED|Overall Study||46
290983|NCT01885000|695913|P2|STARTED|Overall Study||44
290984|NCT01885000|695914|P1|STARTED|Overall Study||48
290985|NCT01884688|695926|P1|NOT COMPLETED|Overall Study||2
290986|NCT01884688|695926|P1|COMPLETED|Overall Study||1
290987|NCT01884688|695926|P1|STARTED|Overall Study||3
290988|NCT01884675|695932|P2|NOT COMPLETED|Overall Study||2
290989|NCT01884675|695933|P1|NOT COMPLETED|Overall Study||3
290990|NCT01884675|695932|P2|COMPLETED|Overall Study||15
290991|NCT01884675|695933|P1|COMPLETED|Overall Study||13
290992|NCT01884675|695932|P2|STARTED|Overall Study||17
290993|NCT01884675|695933|P1|STARTED|Overall Study||16
290994|NCT01884519|695975|P2|NOT COMPLETED|Overall Study||0
290995|NCT01884519|695976|P1|NOT COMPLETED|Overall Study||0
290996|NCT01884519|695975|P2|COMPLETED|Overall Study||60
290997|NCT01884519|695976|P1|COMPLETED|Overall Study||60
290998|NCT01884519|695975|P2|STARTED|Overall Study||60
290999|NCT01884519|695976|P1|STARTED|Overall Study||60
291000|NCT01884064|696020|P2|NOT COMPLETED|Overall Study||0
291001|NCT01884064|696021|P1|NOT COMPLETED|Overall Study||0
291002|NCT01884064|696020|P2|COMPLETED|Overall Study||5
291003|NCT01884064|696021|P1|COMPLETED|Overall Study||12
291004|NCT01884064|696020|P2|STARTED|Overall Study||5
291005|NCT01884064|696021|P1|STARTED|Overall Study||12
291006|NCT01883999|696027|P1|NOT COMPLETED|Overall Study||3
291007|NCT01883999|696027|P1|COMPLETED|Overall Study||61
291008|NCT01883999|696027|P1|STARTED|Overall Study||64
291009|NCT01883986|696035|P2|NOT COMPLETED|Overall Study||1
291010|NCT01883986|696036|P1|NOT COMPLETED|Overall Study||3
291011|NCT01883986|696035|P2|COMPLETED|Overall Study|Completed study|19
291012|NCT01883986|696036|P1|COMPLETED|Overall Study|Received allocated intervention|17
291013|NCT01883986|696035|P2|Did Not Complete Study|Overall Study|Did not completed study|1
291014|NCT01883986|696036|P1|Did Not Complete Study|Overall Study||3
291015|NCT01883986|696035|P2|STARTED|Overall Study|Allocated to usual care arm|20
291016|NCT01883986|696036|P1|STARTED|Overall Study|Allocated to intervention arm|20
291017|NCT01883908|696050|P2|NOT COMPLETED|Overall Study||0
291018|NCT01883908|696051|P1|NOT COMPLETED|Overall Study||0
291019|NCT01883908|696050|P2|COMPLETED|Overall Study||1
291020|NCT01883908|696051|P1|COMPLETED|Overall Study||3
291021|NCT01883908|696050|P2|STARTED|Overall Study||1
291022|NCT01883908|696051|P1|STARTED|Overall Study||3
291023|NCT01883635|696061|P2|NOT COMPLETED|Overall Study||0
291024|NCT01883635|696062|P1|NOT COMPLETED|Overall Study||4
291025|NCT01883635|696061|P2|COMPLETED|Overall Study||20
291026|NCT01883635|696062|P1|COMPLETED|Overall Study||20
291027|NCT01883635|696061|P2|STARTED|Overall Study||20
291028|NCT01883635|696062|P1|STARTED|Overall Study||24
291029|NCT01883453|696076|P2|NOT COMPLETED|Overall Study||23
291030|NCT01883453|696077|P1|NOT COMPLETED|Overall Study||25
291031|NCT01883453|696076|P2|COMPLETED|Overall Study||50
291032|NCT01883453|696077|P1|COMPLETED|Overall Study||48
291033|NCT01883453|696076|P2|STARTED|Overall Study||73
291034|NCT01883453|696077|P1|STARTED|Overall Study||73
291035|NCT01883440|696085|P2|NOT COMPLETED|Overall Study||0
291036|NCT01883440|696086|P1|NOT COMPLETED|Overall Study||3
291037|NCT01883440|696085|P2|COMPLETED|Overall Study||45
291038|NCT01883440|696086|P1|COMPLETED|Overall Study||42
291039|NCT01883440|696085|P2|STARTED|Overall Study||45
291040|NCT01883440|696086|P1|STARTED|Overall Study||45
291041|NCT01883427|696096|P2|NOT COMPLETED|Overall Study||0
291042|NCT01883427|696097|P1|NOT COMPLETED|Overall Study||0
291043|NCT01883427|696096|P2|COMPLETED|Overall Study||20
291044|NCT01883427|696097|P1|COMPLETED|Overall Study||20
291045|NCT01883427|696096|P2|STARTED|Overall Study||20
291046|NCT01883427|696097|P1|STARTED|Overall Study||20
291047|NCT01882907|696105|P2|NOT COMPLETED|Overall Study||28
291048|NCT01882907|696106|P1|NOT COMPLETED|Overall Study||14
291049|NCT01882907|696105|P2|COMPLETED|Overall Study||83
291050|NCT01882907|696106|P1|COMPLETED|Overall Study||103
291051|NCT01882907|696105|P2|STARTED|Overall Study||111
291052|NCT01882907|696106|P1|STARTED|Overall Study||117
291053|NCT01882868|696112|P1|NOT COMPLETED|Overall Study||0
291054|NCT01882868|696112|P1|COMPLETED|Overall Study||62
291055|NCT01882868|696112|P1|STARTED|Overall Study||62
291056|NCT01882725|696142|P1|NOT COMPLETED|Overall Study||0
291057|NCT01882725|696142|P1|COMPLETED|Overall Study||14
291058|NCT01882725|696142|P1|STARTED|Overall Study||14
291059|NCT01882647|696149|P2|NOT COMPLETED|Overall Study||6
291060|NCT01882647|696150|P1|NOT COMPLETED|Overall Study||2
291061|NCT01882647|696149|P2|COMPLETED|Overall Study||106
291062|NCT01882647|696150|P1|COMPLETED|Overall Study||108
291063|NCT01882647|696149|P2|STARTED|Overall Study||112
291064|NCT01882647|696150|P1|STARTED|Overall Study||110
291065|NCT01882465|696166|P7|NOT COMPLETED|Period 3||0
291066|NCT01882465|696167|P6|NOT COMPLETED|Period 3||0
291067|NCT01882465|696168|P5|NOT COMPLETED|Period 3||0
291068|NCT01882465|696169|P4|NOT COMPLETED|Period 3||0
291069|NCT01882465|696170|P3|NOT COMPLETED|Period 3||0
291070|NCT01882465|696171|P2|NOT COMPLETED|Period 3||0
291071|NCT01882465|696172|P1|NOT COMPLETED|Period 3||0
291072|NCT01882465|696166|P7|COMPLETED|Period 3||0
291073|NCT01882465|696167|P6|COMPLETED|Period 3||5
291074|NCT01882465|696168|P5|COMPLETED|Period 3||4
291075|NCT01882465|696169|P4|COMPLETED|Period 3||5
291076|NCT01882465|696170|P3|COMPLETED|Period 3||5
291077|NCT01882465|696171|P2|COMPLETED|Period 3||6
291078|NCT01882465|696172|P1|COMPLETED|Period 3||6
291079|NCT01882465|696166|P7|STARTED|Period 3||0
291080|NCT01882465|696167|P6|STARTED|Period 3||5
291081|NCT01882465|696168|P5|STARTED|Period 3||4
291082|NCT01882465|696169|P4|STARTED|Period 3||5
291083|NCT01882465|696170|P3|STARTED|Period 3||5
291084|NCT01882465|696171|P2|STARTED|Period 3||6
291085|NCT01882465|696172|P1|STARTED|Period 3||6
291086|NCT01882465|696166|P7|NOT COMPLETED|Period 2||0
291087|NCT01882465|696167|P6|NOT COMPLETED|Period 2||0
291088|NCT01882465|696168|P5|NOT COMPLETED|Period 2||1
291089|NCT01882465|696169|P4|NOT COMPLETED|Period 2||0
291090|NCT01882465|696170|P3|NOT COMPLETED|Period 2||0
291091|NCT01882465|696171|P2|NOT COMPLETED|Period 2||0
291092|NCT01882465|696172|P1|NOT COMPLETED|Period 2||0
291093|NCT01882465|696166|P7|COMPLETED|Period 2||0
291094|NCT01882465|696167|P6|COMPLETED|Period 2||5
291095|NCT01882465|696168|P5|COMPLETED|Period 2||4
291096|NCT01882465|696169|P4|COMPLETED|Period 2||5
291097|NCT01882465|696170|P3|COMPLETED|Period 2||5
291098|NCT01882465|696171|P2|COMPLETED|Period 2||6
291099|NCT01882465|696172|P1|COMPLETED|Period 2||6
291100|NCT01882465|696166|P7|STARTED|Period 2||0
291101|NCT01882465|696167|P6|STARTED|Period 2||5
291102|NCT01882465|696168|P5|STARTED|Period 2||5
291103|NCT01882465|696169|P4|STARTED|Period 2||5
291104|NCT01882465|696170|P3|STARTED|Period 2||5
291105|NCT01882465|696171|P2|STARTED|Period 2||6
291106|NCT01882465|696172|P1|STARTED|Period 2||6
291107|NCT01882465|696166|P7|NOT COMPLETED|Period 1||1
291108|NCT01882465|696167|P6|NOT COMPLETED|Period 1||0
291109|NCT01882465|696168|P5|NOT COMPLETED|Period 1||0
291110|NCT01882465|696169|P4|NOT COMPLETED|Period 1||1
291111|NCT01882465|696170|P3|NOT COMPLETED|Period 1||0
291112|NCT01882465|696171|P2|NOT COMPLETED|Period 1||0
291113|NCT01882465|696172|P1|NOT COMPLETED|Period 1||0
291114|NCT01882465|696166|P7|COMPLETED|Period 1||0
291115|NCT01882465|696167|P6|COMPLETED|Period 1||5
291116|NCT01882465|696168|P5|COMPLETED|Period 1||5
291117|NCT01882465|696169|P4|COMPLETED|Period 1||5
291118|NCT01882465|696170|P3|COMPLETED|Period 1||5
291119|NCT01882465|696171|P2|COMPLETED|Period 1||6
291120|NCT01882465|696172|P1|COMPLETED|Period 1||6
291121|NCT01882465|696166|P7|STARTED|Period 1||1
291122|NCT01882465|696167|P6|STARTED|Period 1||5
291123|NCT01882465|696168|P5|STARTED|Period 1||5
291124|NCT01882465|696169|P4|STARTED|Period 1||6
291125|NCT01882465|696170|P3|STARTED|Period 1||5
291126|NCT01882465|696171|P2|STARTED|Period 1||6
291127|NCT01882465|696172|P1|STARTED|Period 1||6
291128|NCT01882413|696180|P1|NOT COMPLETED|Overall Study||0
291129|NCT01882413|696180|P1|COMPLETED|Overall Study||204
291130|NCT01882413|696180|P1|STARTED|Overall Study||204
291131|NCT01882257|696197|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
291132|NCT01882257|696198|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
291133|NCT01882257|696199|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
291134|NCT01882257|696197|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
291135|NCT01882257|696198|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
291136|NCT01882257|696199|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
291137|NCT01882257|696197|P3|STARTED|Therapy Portion of Study (12 Months)||22
291138|NCT01882257|696198|P2|STARTED|Therapy Portion of Study (12 Months)||38
291139|NCT01882257|696199|P1|STARTED|Therapy Portion of Study (12 Months)||11
291140|NCT01882257|696197|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
291141|NCT01882257|696198|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
291142|NCT01882257|696199|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
291143|NCT01882257|696197|P3|COMPLETED|Study Origination to Beginning Therapy||22
291144|NCT01882257|696198|P2|COMPLETED|Study Origination to Beginning Therapy||38
291145|NCT01882257|696199|P1|COMPLETED|Study Origination to Beginning Therapy||11
291146|NCT01882257|696197|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
291240|NCT01880320|696438|P3|STARTED|Overall Study||69
291147|NCT01882257|696198|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
291148|NCT01882257|696199|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
291149|NCT01882257|696197|P3|STARTED|Study Origination to Beginning Therapy||23
291150|NCT01882257|696198|P2|STARTED|Study Origination to Beginning Therapy||40
291151|NCT01882257|696199|P1|STARTED|Study Origination to Beginning Therapy||11
291152|NCT01882062|696206|P1|NOT COMPLETED|Overall Study||0
291153|NCT01882062|696206|P1|COMPLETED|Overall Study|18th of july 2013|10
291154|NCT01882062|696206|P1|STARTED|Overall Study|16th of may 2013|10
291155|NCT01881932|696213|P3|NOT COMPLETED|Overall Study||0
291156|NCT01881932|696214|P2|NOT COMPLETED|Overall Study||0
291157|NCT01881932|696215|P1|NOT COMPLETED|Overall Study||0
291158|NCT01881932|696213|P3|COMPLETED|Overall Study||13
291159|NCT01881932|696214|P2|COMPLETED|Overall Study||4
291160|NCT01881932|696215|P1|COMPLETED|Overall Study||2
291161|NCT01881932|696213|P3|STARTED|Overall Study||13
291162|NCT01881932|696214|P2|STARTED|Overall Study||4
291163|NCT01881932|696215|P1|STARTED|Overall Study||2
291164|NCT01881776|696226|P3|NOT COMPLETED|Overall Study||2
291165|NCT01881776|696227|P2|NOT COMPLETED|Overall Study||4
291166|NCT01881776|696228|P1|NOT COMPLETED|Overall Study||1
291167|NCT01881776|696226|P3|COMPLETED|Overall Study||20
291168|NCT01881776|696227|P2|COMPLETED|Overall Study||20
291169|NCT01881776|696228|P1|COMPLETED|Overall Study||23
291170|NCT01881776|696226|P3|STARTED|Overall Study||22
291171|NCT01881776|696227|P2|STARTED|Overall Study||24
291172|NCT01881776|696228|P1|STARTED|Overall Study||24
291173|NCT01881737|696254|P1|NOT COMPLETED|Overall Study||5
291174|NCT01881737|696254|P1|COMPLETED|Overall Study||10
291175|NCT01881737|696254|P1|Number Screened|Overall Study||15
291176|NCT01881737|696254|P1|STARTED|Overall Study|This is a pilot study|15
291177|NCT01881126|696265|P2|NOT COMPLETED|Overall Study||2
291178|NCT01881126|696266|P1|NOT COMPLETED|Overall Study||1
291179|NCT01881126|696265|P2|COMPLETED|Overall Study||44
291180|NCT01881126|696266|P1|COMPLETED|Overall Study||46
291181|NCT01881126|696265|P2|STARTED|Overall Study||46
291182|NCT01881126|696266|P1|STARTED|Overall Study||47
291183|NCT01880840|696274|P2|NOT COMPLETED|Overall Study||5
291184|NCT01880840|696275|P1|NOT COMPLETED|Overall Study||8
291185|NCT01880840|696274|P2|COMPLETED|Overall Study||91
291186|NCT01880840|696275|P1|COMPLETED|Overall Study||87
291187|NCT01880840|696274|P2|STARTED|Overall Study||96
291188|NCT01880840|696275|P1|STARTED|Overall Study||95
291189|NCT01880736|696285|P4|NOT COMPLETED|Overall Study||6
291190|NCT01880736|696286|P3|NOT COMPLETED|Overall Study||1
291191|NCT01880736|696287|P2|NOT COMPLETED|Overall Study||2
291192|NCT01880736|696288|P1|NOT COMPLETED|Overall Study||1
291193|NCT01880736|696285|P4|COMPLETED|Overall Study||108
291194|NCT01880736|696286|P3|COMPLETED|Overall Study||114
291195|NCT01880736|696287|P2|COMPLETED|Overall Study||113
291196|NCT01880736|696288|P1|COMPLETED|Overall Study||113
291197|NCT01880736|696285|P4|STARTED|Overall Study||114
291198|NCT01880736|696286|P3|STARTED|Overall Study||115
291199|NCT01880736|696287|P2|STARTED|Overall Study||115
291200|NCT01880736|696288|P1|STARTED|Overall Study||114
291201|NCT01880723|696332|P2|NOT COMPLETED|Overall Study||0
291202|NCT01880723|696333|P1|NOT COMPLETED|Overall Study||0
291203|NCT01880723|696332|P2|COMPLETED|Overall Study||16
291204|NCT01880723|696333|P1|COMPLETED|Overall Study||16
291205|NCT01880723|696332|P2|STARTED|Overall Study||16
291206|NCT01880723|696333|P1|STARTED|Overall Study||16
291207|NCT01880697|696349|P2|NOT COMPLETED|Overall Study||1
291208|NCT01880697|696350|P1|NOT COMPLETED|Overall Study||0
291209|NCT01880697|696349|P2|COMPLETED|Overall Study||62
291210|NCT01880697|696350|P1|COMPLETED|Overall Study||63
291211|NCT01880697|696349|P2|STARTED|Overall Study||63
291212|NCT01880697|696350|P1|STARTED|Overall Study||63
291213|NCT01880515|696372|P2|NOT COMPLETED|Overall Study||9
291214|NCT01880515|696373|P1|NOT COMPLETED|Overall Study||8
291215|NCT01880515|696372|P2|COMPLETED|Overall Study||45
291216|NCT01880515|696373|P1|COMPLETED|Overall Study||45
291217|NCT01880515|696372|P2|STARTED|Overall Study||54
291218|NCT01880515|696373|P1|STARTED|Overall Study||53
291219|NCT01880437|696384|P3|NOT COMPLETED|Overall Study||19
291220|NCT01880437|696385|P2|NOT COMPLETED|Overall Study||4
291221|NCT01880437|696386|P1|NOT COMPLETED|Overall Study||15
291222|NCT01880437|696384|P3|COMPLETED|Overall Study||0
291223|NCT01880437|696385|P2|COMPLETED|Overall Study||0
291224|NCT01880437|696386|P1|COMPLETED|Overall Study||0
291225|NCT01880437|696384|P3|STARTED|Overall Study||19
291226|NCT01880437|696385|P2|STARTED|Overall Study||4
291227|NCT01880437|696386|P1|STARTED|Overall Study||15
291228|NCT01880424|696412|P2|NOT COMPLETED|Overall Study||55
291229|NCT01880424|696413|P1|NOT COMPLETED|Overall Study||33
291230|NCT01880424|696412|P2|COMPLETED|Overall Study||367
291231|NCT01880424|696413|P1|COMPLETED|Overall Study||384
291232|NCT01880424|696412|P2|STARTED|Overall Study||422
291233|NCT01880424|696413|P1|STARTED|Overall Study||417
291234|NCT01880320|696438|P3|NOT COMPLETED|Overall Study||8
291235|NCT01880320|696439|P2|NOT COMPLETED|Overall Study||25
291236|NCT01880320|696440|P1|NOT COMPLETED|Overall Study||20
291237|NCT01880320|696438|P3|COMPLETED|Overall Study||61
291238|NCT01880320|696439|P2|COMPLETED|Overall Study||192
291239|NCT01880320|696440|P1|COMPLETED|Overall Study||197
291241|NCT01880320|696439|P2|STARTED|Overall Study||217
291242|NCT01880320|696440|P1|STARTED|Overall Study||217
291243|NCT01880086|696456|P2|NOT COMPLETED|Overall Study||1
291244|NCT01880086|696457|P1|NOT COMPLETED|Overall Study||1
291245|NCT01880086|696456|P2|COMPLETED|Overall Study||6
291246|NCT01880086|696457|P1|COMPLETED|Overall Study||5
291247|NCT01880086|696456|P2|STARTED|Overall Study||7
291248|NCT01880086|696457|P1|STARTED|Overall Study||6
291249|NCT01879852|696477|P2|NOT COMPLETED|Overall Study||0
291250|NCT01879852|696478|P1|NOT COMPLETED|Overall Study||2
291251|NCT01879852|696477|P2|COMPLETED|Overall Study||13
291252|NCT01879852|696478|P1|COMPLETED|Overall Study||12
291253|NCT01879852|696477|P2|STARTED|Overall Study||13
291254|NCT01879852|696478|P1|STARTED|Overall Study||14
291255|NCT01879800|696492|P2|NOT COMPLETED|Overall Study||4
291256|NCT01879800|696493|P1|NOT COMPLETED|Overall Study||0
291257|NCT01879800|696492|P2|COMPLETED|Overall Study||26
291258|NCT01879800|696493|P1|COMPLETED|Overall Study||14
291259|NCT01879800|696492|P2|STARTED|Overall Study||30
291260|NCT01879800|696493|P1|STARTED|Overall Study||14
291261|NCT01879735|696505|P2|NOT COMPLETED|Overall Study||0
291262|NCT01879735|696506|P1|NOT COMPLETED|Overall Study||0
291263|NCT01879735|696505|P2|COMPLETED|Overall Study||16
291264|NCT01879735|696506|P1|COMPLETED|Overall Study||6
291265|NCT01879735|696505|P2|STARTED|Overall Study||16
291266|NCT01879735|696506|P1|STARTED|Overall Study||6
291267|NCT01879722|696522|P10|NOT COMPLETED|Overall Study||0
291268|NCT01879722|696523|P9|NOT COMPLETED|Overall Study||2
291269|NCT01879722|696524|P8|NOT COMPLETED|Overall Study||1
291270|NCT01879722|696525|P7|NOT COMPLETED|Overall Study||0
291271|NCT01879722|696526|P6|NOT COMPLETED|Overall Study||0
291272|NCT01879722|696527|P5|NOT COMPLETED|Overall Study||1
291273|NCT01879722|696528|P4|NOT COMPLETED|Overall Study||1
291274|NCT01879722|696529|P3|NOT COMPLETED|Overall Study||0
291275|NCT01879722|696530|P2|NOT COMPLETED|Overall Study||1
291276|NCT01879722|696531|P1|NOT COMPLETED|Overall Study||0
291277|NCT01879722|696522|P10|COMPLETED|Overall Study||6
291278|NCT01879722|696523|P9|COMPLETED|Overall Study||6
291279|NCT01879722|696524|P8|COMPLETED|Overall Study||7
291280|NCT01879722|696525|P7|COMPLETED|Overall Study||8
291281|NCT01879722|696526|P6|COMPLETED|Overall Study||9
291282|NCT01879722|696527|P5|COMPLETED|Overall Study||7
291283|NCT01879722|696528|P4|COMPLETED|Overall Study||7
291284|NCT01879722|696529|P3|COMPLETED|Overall Study||7
291285|NCT01879722|696530|P2|COMPLETED|Overall Study||7
291286|NCT01879722|696531|P1|COMPLETED|Overall Study||7
291287|NCT01879722|696522|P10|STARTED|Overall Study||6
291288|NCT01879722|696523|P9|STARTED|Overall Study||8
291289|NCT01879722|696524|P8|STARTED|Overall Study||8
291290|NCT01879722|696525|P7|STARTED|Overall Study||8
291291|NCT01879722|696526|P6|STARTED|Overall Study||9
291292|NCT01879722|696527|P5|STARTED|Overall Study||8
291293|NCT01879722|696528|P4|STARTED|Overall Study||8
291294|NCT01879722|696529|P3|STARTED|Overall Study||7
291295|NCT01879722|696530|P2|STARTED|Overall Study||8
291296|NCT01879722|696531|P1|STARTED|Overall Study||7
291297|NCT01879683|696679|P1|NOT COMPLETED|Overall Study||1
291298|NCT01879683|696679|P1|COMPLETED|Overall Study||9
291299|NCT01879683|696679|P1|STARTED|Overall Study||10
291300|NCT01879618|696686|P1|NOT COMPLETED|Overall Study||21
291301|NCT01879618|696686|P1|COMPLETED|Overall Study||131
291302|NCT01879618|696686|P1|STARTED|Overall Study||152
291303|NCT01879579|696693|P2|NOT COMPLETED|Overall Study||2
291304|NCT01879579|696694|P1|NOT COMPLETED|Overall Study||5
291305|NCT01879579|696693|P2|COMPLETED|Overall Study||26
291306|NCT01879579|696694|P1|COMPLETED|Overall Study||28
291307|NCT01879579|696693|P2|STARTED|Overall Study||28
291308|NCT01879579|696694|P1|STARTED|Overall Study||33
291309|NCT01879553|696724|P2|NOT COMPLETED|Overall Study||0
291310|NCT01879553|696725|P1|NOT COMPLETED|Overall Study||1
291311|NCT01879553|696724|P2|COMPLETED|Overall Study||63
291312|NCT01879553|696725|P1|COMPLETED|Overall Study||62
291313|NCT01879553|696724|P2|STARTED|Overall Study||63
291314|NCT01879553|696725|P1|STARTED|Overall Study||63
291315|NCT01879540|696746|P1|NOT COMPLETED|Overall Study||0
291316|NCT01879540|696746|P1|COMPLETED|Overall Study||63
291317|NCT01879540|696746|P1|STARTED|Overall Study||63
291318|NCT01879410|696759|P2|NOT COMPLETED|Overall Study||38
291319|NCT01879410|696760|P1|NOT COMPLETED|Overall Study||24
291320|NCT01879410|696759|P2|COMPLETED|Overall Study||312
291321|NCT01879410|696760|P1|COMPLETED|Overall Study||326
291322|NCT01879410|696759|P2|Intent-to-Treat Population|Overall Study||348
291323|NCT01879410|696760|P1|Intent-to-Treat Population|Overall Study||349
291324|NCT01879410|696759|P2|STARTED|Overall Study||350
291325|NCT01879410|696760|P1|STARTED|Overall Study||350
291326|NCT01879371|696774|P6|NOT COMPLETED|Overall Study||0
291327|NCT01879371|696775|P5|NOT COMPLETED|Overall Study||0
291328|NCT01879371|696776|P4|NOT COMPLETED|Overall Study||0
291329|NCT01879371|696777|P3|NOT COMPLETED|Overall Study||0
291330|NCT01879371|696778|P2|NOT COMPLETED|Overall Study||0
291331|NCT01879371|696779|P1|NOT COMPLETED|Overall Study||0
291332|NCT01879371|696774|P6|COMPLETED|Overall Study||6
291333|NCT01879371|696775|P5|COMPLETED|Overall Study||6
291334|NCT01879371|696776|P4|COMPLETED|Overall Study||6
291335|NCT01879371|696777|P3|COMPLETED|Overall Study||6
291336|NCT01879371|696778|P2|COMPLETED|Overall Study||6
291337|NCT01879371|696779|P1|COMPLETED|Overall Study||6
291338|NCT01879371|696774|P6|STARTED|Overall Study||6
291339|NCT01879371|696775|P5|STARTED|Overall Study||6
291340|NCT01879371|696776|P4|STARTED|Overall Study||6
291341|NCT01879371|696777|P3|STARTED|Overall Study||6
291342|NCT01879371|696778|P2|STARTED|Overall Study||6
291343|NCT01879371|696779|P1|STARTED|Overall Study||6
291344|NCT01879345|696796|P3|NOT COMPLETED|7-day Multiple-dose Period||0
291345|NCT01879345|696797|P2|NOT COMPLETED|7-day Multiple-dose Period||0
291346|NCT01879345|696798|P1|NOT COMPLETED|7-day Multiple-dose Period||0
291347|NCT01879345|696796|P3|COMPLETED|7-day Multiple-dose Period||6
291348|NCT01879345|696797|P2|COMPLETED|7-day Multiple-dose Period||6
291349|NCT01879345|696798|P1|COMPLETED|7-day Multiple-dose Period||6
291350|NCT01879345|696796|P3|STARTED|7-day Multiple-dose Period||6
291351|NCT01879345|696797|P2|STARTED|7-day Multiple-dose Period||6
291352|NCT01879345|696798|P1|STARTED|7-day Multiple-dose Period||6
291353|NCT01879345|696796|P3|NOT COMPLETED|Single-dose Period||0
291354|NCT01879345|696797|P2|NOT COMPLETED|Single-dose Period||0
291355|NCT01879345|696798|P1|NOT COMPLETED|Single-dose Period||0
291356|NCT01879345|696796|P3|COMPLETED|Single-dose Period||6
291357|NCT01879345|696797|P2|COMPLETED|Single-dose Period||6
291358|NCT01879345|696798|P1|COMPLETED|Single-dose Period||6
291359|NCT01879345|696796|P3|STARTED|Single-dose Period||6
291360|NCT01879345|696797|P2|STARTED|Single-dose Period||6
291361|NCT01879345|696798|P1|STARTED|Single-dose Period||6
291362|NCT01879332|696815|P3|NOT COMPLETED|Overall Study||4
291363|NCT01879332|696816|P2|NOT COMPLETED|Overall Study||6
291364|NCT01879332|696817|P1|NOT COMPLETED|Overall Study||6
291365|NCT01879332|696815|P3|COMPLETED|Overall Study||0
291366|NCT01879332|696816|P2|COMPLETED|Overall Study||0
291367|NCT01879332|696817|P1|COMPLETED|Overall Study||0
291368|NCT01879332|696815|P3|STARTED|Overall Study||4
291369|NCT01879332|696816|P2|STARTED|Overall Study||6
291370|NCT01879332|696817|P1|STARTED|Overall Study||6
291371|NCT01879319|696827|P2|NOT COMPLETED|Overall Study||5
291372|NCT01879319|696828|P1|NOT COMPLETED|Overall Study||2
291373|NCT01879319|696827|P2|COMPLETED|Overall Study||77
291374|NCT01879319|696828|P1|COMPLETED|Overall Study||80
291375|NCT01879319|696827|P2|Received Treatment|Overall Study||82
291376|NCT01879319|696828|P1|Received Treatment|Overall Study||82
291377|NCT01879319|696827|P2|STARTED|Overall Study||82
291378|NCT01879319|696828|P1|STARTED|Overall Study||82
291379|NCT01879176|696838|P2|NOT COMPLETED|Overall Study||6
291380|NCT01879176|696839|P1|NOT COMPLETED|Overall Study||8
291381|NCT01879176|696838|P2|COMPLETED|Overall Study||16
291382|NCT01879176|696839|P1|COMPLETED|Overall Study||16
291383|NCT01879176|696838|P2|STARTED|Overall Study||22
291384|NCT01879176|696839|P1|STARTED|Overall Study||24
291385|NCT01879059|696845|P1|NOT COMPLETED|Overall Study||0
291386|NCT01879059|696845|P1|COMPLETED|Overall Study||13
291387|NCT01879059|696845|P1|STARTED|Overall Study||13
291388|NCT01878825|696851|P2|NOT COMPLETED|Overall Study||0
291389|NCT01878825|696852|P1|NOT COMPLETED|Overall Study||0
291390|NCT01878825|696851|P2|COMPLETED|Overall Study||60
291391|NCT01878825|696852|P1|COMPLETED|Overall Study||60
291392|NCT01878825|696851|P2|STARTED|Overall Study||60
291393|NCT01878825|696852|P1|STARTED|Overall Study||60
291394|NCT01878812|696890|P2|NOT COMPLETED|Overall Study||0
291395|NCT01878812|696891|P1|NOT COMPLETED|Overall Study||0
291396|NCT01878812|696890|P2|COMPLETED|Overall Study||57
291397|NCT01878812|696891|P1|COMPLETED|Overall Study||60
291398|NCT01878812|696890|P2|STARTED|Overall Study||57
291399|NCT01878812|696891|P1|STARTED|Overall Study||60
291400|NCT01878799|696927|P2|NOT COMPLETED|Overall Study||0
291401|NCT01878799|696928|P1|NOT COMPLETED|Overall Study||1
291402|NCT01878799|696927|P2|COMPLETED|Overall Study||13
291403|NCT01878799|696928|P1|COMPLETED|Overall Study||36
291404|NCT01878799|696927|P2|STARTED|Overall Study||13
291405|NCT01878799|696928|P1|STARTED|Overall Study||37
291406|NCT01878656|696936|P2|NOT COMPLETED|Overall Study||0
291407|NCT01878656|696937|P1|NOT COMPLETED|Overall Study||0
291408|NCT01878656|696936|P2|COMPLETED|Overall Study||72
291409|NCT01878656|696937|P1|COMPLETED|Overall Study||72
291410|NCT01878656|696936|P2|STARTED|Overall Study||72
291411|NCT01878656|696937|P1|STARTED|Overall Study||72
291412|NCT01878604|696943|P1|NOT COMPLETED|Overall Study||0
291413|NCT01878604|696943|P1|COMPLETED|Overall Study||5
291414|NCT01878604|696943|P1|STARTED|Overall Study||5
291415|NCT01878526|696950|P2|NOT COMPLETED|Overall Study||2
291416|NCT01878526|696951|P1|NOT COMPLETED|Overall Study||3
291417|NCT01878526|696950|P2|COMPLETED|Overall Study||38
291418|NCT01878526|696951|P1|COMPLETED|Overall Study||37
291419|NCT01878526|696950|P2|STARTED|Overall Study||40
291420|NCT01878526|696951|P1|STARTED|Overall Study||40
291421|NCT01878214|696966|P2|NOT COMPLETED|Overall Study||44
291422|NCT01878214|696967|P1|NOT COMPLETED|Overall Study||53
291423|NCT01878214|696966|P2|COMPLETED|Overall Study||175
291424|NCT01878214|696967|P1|COMPLETED|Overall Study||170
291425|NCT01878214|696966|P2|STARTED|Overall Study||219
291426|NCT01878214|696967|P1|STARTED|Overall Study||223
291427|NCT01878175|696981|P1|NOT COMPLETED|Overall Study||2
291428|NCT01878175|696981|P1|COMPLETED|Overall Study||13
291429|NCT01878175|696981|P1|STARTED|Overall Study||15
291430|NCT01878149|697000|P2|NOT COMPLETED|Overall Study||2
291431|NCT01878149|697001|P1|NOT COMPLETED|Overall Study||2
291432|NCT01878149|697000|P2|COMPLETED|Overall Study||15
291433|NCT01878149|697001|P1|COMPLETED|Overall Study||19
291434|NCT01878149|697000|P2|STARTED|Overall Study||17
291435|NCT01878149|697001|P1|STARTED|Overall Study||21
291436|NCT01877941|697007|P1|NOT COMPLETED|Overall Study||0
291437|NCT01877941|697007|P1|COMPLETED|Overall Study||39
291438|NCT01877941|697007|P1|STARTED|Overall Study||39
291439|NCT01877720|697013|P2|NOT COMPLETED|Overall Study||0
291440|NCT01877720|697014|P1|NOT COMPLETED|Overall Study||1
291441|NCT01877720|697013|P2|COMPLETED|Overall Study||8
291442|NCT01877720|697014|P1|COMPLETED|Overall Study||7
291443|NCT01877720|697013|P2|2nd Intervention|Overall Study||8
291444|NCT01877720|697014|P1|2nd Intervention|Overall Study||7
291445|NCT01877720|697013|P2|1st Intervention|Overall Study||8
291446|NCT01877720|697014|P1|1st Intervention|Overall Study||7
291447|NCT01877720|697013|P2|STARTED|Overall Study||8
291448|NCT01877720|697014|P1|STARTED|Overall Study||8
291449|NCT01877538|697038|P1|NOT COMPLETED|Overall Study||0
291450|NCT01877538|697038|P1|COMPLETED|Overall Study||7
291451|NCT01877538|697038|P1|STARTED|Overall Study||7
291452|NCT01877408|697045|P2|NOT COMPLETED|Overall Study||2
291453|NCT01877408|697046|P1|NOT COMPLETED|Overall Study||0
291454|NCT01877408|697045|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
291455|NCT01877408|697046|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
291456|NCT01877408|697045|P2|STARTED|Overall Study||100
291457|NCT01877408|697046|P1|STARTED|Overall Study||50
291458|NCT01877343|697066|P7|NOT COMPLETED|Overall Study||0
291459|NCT01877343|697067|P6|NOT COMPLETED|Overall Study||0
291460|NCT01877343|697068|P5|NOT COMPLETED|Overall Study||0
291461|NCT01877343|697069|P4|NOT COMPLETED|Overall Study||0
291462|NCT01877343|697070|P3|NOT COMPLETED|Overall Study||0
291463|NCT01877343|697071|P2|NOT COMPLETED|Overall Study||0
291464|NCT01877343|697072|P1|NOT COMPLETED|Overall Study||0
291465|NCT01877343|697066|P7|COMPLETED|Overall Study||0
291466|NCT01877343|697067|P6|COMPLETED|Overall Study||5
291467|NCT01877343|697068|P5|COMPLETED|Overall Study||0
291468|NCT01877343|697069|P4|COMPLETED|Overall Study||0
291469|NCT01877343|697070|P3|COMPLETED|Overall Study||0
291470|NCT01877343|697071|P2|COMPLETED|Overall Study||3
291471|NCT01877343|697072|P1|COMPLETED|Overall Study||2
291472|NCT01877343|697066|P7|STARTED|Overall Study||0
291473|NCT01877343|697067|P6|STARTED|Overall Study||5
291474|NCT01877343|697068|P5|STARTED|Overall Study||0
291475|NCT01877343|697069|P4|STARTED|Overall Study||0
291476|NCT01877343|697070|P3|STARTED|Overall Study||0
291477|NCT01877343|697071|P2|STARTED|Overall Study||3
291478|NCT01877343|697072|P1|STARTED|Overall Study||2
291479|NCT01877278|697079|P2|NOT COMPLETED|Overall Study||3
291480|NCT01877278|697080|P1|NOT COMPLETED|Overall Study||3
291481|NCT01877278|697079|P2|COMPLETED|Overall Study||30
291482|NCT01877278|697080|P1|COMPLETED|Overall Study||30
291483|NCT01877278|697079|P2|STARTED|Overall Study||33
291484|NCT01877278|697080|P1|STARTED|Overall Study||33
291485|NCT01877161|697088|P1|NOT COMPLETED|Third Session of Stimulation||0
291486|NCT01877161|697088|P1|COMPLETED|Third Session of Stimulation||12
291487|NCT01877161|697088|P1|STARTED|Third Session of Stimulation||12
291488|NCT01877161|697088|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
291489|NCT01877161|697088|P1|COMPLETED|Washout (at Least 3 Days)||12
291490|NCT01877161|697088|P1|STARTED|Washout (at Least 3 Days)||12
291491|NCT01877161|697088|P1|NOT COMPLETED|Second Session of Stimulation||0
291492|NCT01877161|697088|P1|COMPLETED|Second Session of Stimulation||12
291493|NCT01877161|697088|P1|STARTED|Second Session of Stimulation||12
291494|NCT01877161|697088|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
291495|NCT01877161|697088|P1|COMPLETED|Washout (at Least 3 Days)||12
291496|NCT01877161|697088|P1|STARTED|Washout (at Least 3 Days)||12
291497|NCT01877161|697088|P1|NOT COMPLETED|First Session of Stimulation||0
291498|NCT01877161|697088|P1|COMPLETED|First Session of Stimulation||12
291499|NCT01877161|697088|P1|STARTED|First Session of Stimulation||12
291500|NCT01877148|697098|P2|NOT COMPLETED|Overall Study||1
291501|NCT01877148|697099|P1|NOT COMPLETED|Overall Study||1
291502|NCT01877148|697098|P2|COMPLETED|Overall Study||5
291503|NCT01877148|697099|P1|COMPLETED|Overall Study||5
291504|NCT01877148|697098|P2|STARTED|Overall Study||6
291505|NCT01877148|697099|P1|STARTED|Overall Study||6
291506|NCT01876823|697111|P1|NOT COMPLETED|Overall Study||9
291507|NCT01876823|697111|P1|COMPLETED|Overall Study||26
291508|NCT01876823|697111|P1|STARTED|Overall Study||35
291509|NCT01876810|697124|P2|NOT COMPLETED|Overall Study||1
291510|NCT01876810|697125|P1|NOT COMPLETED|Overall Study||0
291511|NCT01876810|697124|P2|COMPLETED|Overall Study||13
291512|NCT01876810|697125|P1|COMPLETED|Overall Study||14
291513|NCT01876810|697124|P2|STARTED|Overall Study||14
291514|NCT01876810|697125|P1|STARTED|Overall Study||14
291515|NCT01876784|697137|P2|NOT COMPLETED|Overall Study||119
291516|NCT01876784|697138|P1|NOT COMPLETED|Overall Study||119
291517|NCT01876784|697137|P2|COMPLETED|Overall Study||0
291518|NCT01876784|697138|P1|COMPLETED|Overall Study||0
291519|NCT01876784|697137|P2|Treated|Overall Study||118
291520|NCT01876784|697138|P1|Treated|Overall Study||117
291521|NCT01876784|697137|P2|STARTED|Overall Study||119
291522|NCT01876784|697138|P1|STARTED|Overall Study||119
291523|NCT01876732|697144|P1|NOT COMPLETED|Overall Study||75
291524|NCT01876732|697144|P1|COMPLETED|Overall Study||57
291525|NCT01876732|697144|P1|STARTED|Overall Study||132
291526|NCT01876706|697149|P1|NOT COMPLETED|Overall Study||4
291527|NCT01876706|697149|P1|COMPLETED|Overall Study||47
291528|NCT01876706|697149|P1|12 Months|Overall Study||41
291529|NCT01876706|697149|P1|1 Month|Overall Study||51
291530|NCT01876706|697149|P1|STARTED|Overall Study||51
291531|NCT01876368|697168|P2|NOT COMPLETED|Overall Study||13
291532|NCT01876368|697169|P1|NOT COMPLETED|Overall Study||9
291533|NCT01876368|697168|P2|COMPLETED|Overall Study||175
291534|NCT01876368|697169|P1|COMPLETED|Overall Study||179
291535|NCT01876368|697168|P2|Safety Set (SAF)|Overall Study||187
291536|NCT01876368|697169|P1|Safety Set (SAF)|Overall Study||188
291537|NCT01876368|697168|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
291538|NCT01876368|697169|P1|Full Analysis Set (FAS)|Overall Study||188
291539|NCT01876368|697168|P2|STARTED|Overall Study||188
291540|NCT01876368|697169|P1|STARTED|Overall Study||188
291541|NCT01876329|697198|P3|NOT COMPLETED|Overall Study||0
291542|NCT01876329|697199|P2|NOT COMPLETED|Overall Study||0
291543|NCT01876329|697200|P1|NOT COMPLETED|Overall Study||0
291544|NCT01876329|697198|P3|COMPLETED|Overall Study||44
291545|NCT01876329|697199|P2|COMPLETED|Overall Study||36
291546|NCT01876329|697200|P1|COMPLETED|Overall Study||45
291547|NCT01876329|697198|P3|STARTED|Overall Study||44
291548|NCT01876329|697199|P2|STARTED|Overall Study||36
291549|NCT01876329|697200|P1|STARTED|Overall Study||45
291550|NCT01875991|697213|P2|NOT COMPLETED|Overall Study||6
291551|NCT01875991|697214|P1|NOT COMPLETED|Overall Study||7
291552|NCT01875991|697213|P2|COMPLETED|Overall Study||103
291553|NCT01875991|697214|P1|COMPLETED|Overall Study||101
291554|NCT01875991|697213|P2|Received Etanercept in Period 2|Overall Study||103
291555|NCT01875991|697214|P1|Received Etanercept in Period 2|Overall Study||102
291556|NCT01875991|697213|P2|Received Etanercept in Period 1|Overall Study||108
291557|NCT01875991|697214|P1|Received Etanercept in Period 1|Overall Study||108
291558|NCT01875991|697213|P2|STARTED|Overall Study||109
291559|NCT01875991|697214|P1|STARTED|Overall Study||108
291560|NCT01875978|697237|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
291561|NCT01875978|697238|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
291562|NCT01875978|697237|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
291563|NCT01875978|697238|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
291564|NCT01875978|697237|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
291565|NCT01875978|697238|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
291566|NCT01875978|697237|P2|NOT COMPLETED|Study 4weeks||0
291567|NCT01875978|697238|P1|NOT COMPLETED|Study 4weeks||0
291568|NCT01875978|697237|P2|COMPLETED|Study 4weeks||20
291569|NCT01875978|697238|P1|COMPLETED|Study 4weeks||20
291570|NCT01875978|697237|P2|STARTED|Study 4weeks||20
291571|NCT01875978|697238|P1|STARTED|Study 4weeks||20
291572|NCT01875848|697252|P2|NOT COMPLETED|Overall Study||0
291573|NCT01875848|697253|P1|NOT COMPLETED|Overall Study||2
291574|NCT01875848|697252|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
291575|NCT01875848|697253|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
291576|NCT01875848|697252|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
291577|NCT01875848|697253|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
291578|NCT01875731|697263|P2|NOT COMPLETED|Overall Study||0
291579|NCT01875731|697264|P1|NOT COMPLETED|Overall Study||1
291580|NCT01875731|697263|P2|COMPLETED|Overall Study||32
291581|NCT01875731|697264|P1|COMPLETED|Overall Study||33
291582|NCT01875731|697263|P2|STARTED|Overall Study||32
291583|NCT01875731|697264|P1|STARTED|Overall Study||34
291584|NCT01875510|697274|P2|NOT COMPLETED|Overall Study||0
291585|NCT01875510|697275|P1|NOT COMPLETED|Overall Study||0
291586|NCT01875510|697274|P2|COMPLETED|Overall Study||40
291587|NCT01875510|697275|P1|COMPLETED|Overall Study||40
291588|NCT01875510|697274|P2|STARTED|Overall Study||40
291589|NCT01875510|697275|P1|STARTED|Overall Study||40
291590|NCT01875471|697283|P2|NOT COMPLETED|Overall Study||1
291591|NCT01875471|697284|P1|NOT COMPLETED|Overall Study||1
291592|NCT01875471|697283|P2|COMPLETED|Overall Study||137
291593|NCT01875471|697284|P1|COMPLETED|Overall Study||136
291594|NCT01875471|697283|P2|Completed Per Protocol|Overall Study||123
291595|NCT01875471|697284|P1|Completed Per Protocol|Overall Study||127
291596|NCT01875471|697283|P2|STARTED|Overall Study||138
291597|NCT01875471|697284|P1|STARTED|Overall Study||137
291598|NCT01875445|697292|P2|NOT COMPLETED|Overall Study||0
291599|NCT01875445|697293|P1|NOT COMPLETED|Overall Study||7
291600|NCT01875445|697292|P2|COMPLETED|Overall Study||19
291601|NCT01875445|697293|P1|COMPLETED|Overall Study||12
291602|NCT01875445|697292|P2|STARTED|Overall Study||19
291603|NCT01875445|697293|P1|STARTED|Overall Study||19
291604|NCT01875159|697303|P2|NOT COMPLETED|Overall Study||0
291605|NCT01875159|697304|P1|NOT COMPLETED|Overall Study||3
291606|NCT01875159|697303|P2|COMPLETED|Overall Study||53
291607|NCT01875159|697304|P1|COMPLETED|Overall Study||42
291608|NCT01875159|697303|P2|STARTED|Overall Study||53
291609|NCT01875159|697304|P1|STARTED|Overall Study||45
291610|NCT01874951|697314|P2|NOT COMPLETED|Overall Study||0
291611|NCT01874951|697315|P1|NOT COMPLETED|Overall Study||0
291612|NCT01874951|697314|P2|COMPLETED|Overall Study||6
291613|NCT01874951|697315|P1|COMPLETED|Overall Study||6
291614|NCT01874951|697314|P2|STARTED|Overall Study||6
291615|NCT01874951|697315|P1|STARTED|Overall Study||6
291616|NCT01874665|697337|P2|NOT COMPLETED|Overall Study||2
291617|NCT01874665|697338|P1|NOT COMPLETED|Overall Study||4
291618|NCT01874665|697337|P2|COMPLETED|Overall Study|Completed = off treatment|13
291619|NCT01874665|697338|P1|COMPLETED|Overall Study|Completed = off treatment|26
291620|NCT01874665|697337|P2|STARTED|Overall Study||15
291621|NCT01874665|697338|P1|STARTED|Overall Study||30
291622|NCT01874340|697347|P4|NOT COMPLETED|Overall Study||5
291623|NCT01874340|697348|P3|NOT COMPLETED|Overall Study||8
291624|NCT01874340|697349|P2|NOT COMPLETED|Overall Study||8
291625|NCT01874340|697350|P1|NOT COMPLETED|Overall Study||6
291626|NCT01874340|697347|P4|COMPLETED|Overall Study||1
291627|NCT01874340|697348|P3|COMPLETED|Overall Study||0
291628|NCT01874340|697349|P2|COMPLETED|Overall Study||0
291629|NCT01874340|697350|P1|COMPLETED|Overall Study||0
291630|NCT01874340|697347|P4|STARTED|Overall Study||6
291631|NCT01874340|697348|P3|STARTED|Overall Study||8
291632|NCT01874340|697349|P2|STARTED|Overall Study||8
291633|NCT01874340|697350|P1|STARTED|Overall Study||6
291634|NCT01874275|697378|P2|NOT COMPLETED|Overall Study||0
291635|NCT01874275|697379|P1|NOT COMPLETED|Overall Study||1
291636|NCT01874275|697378|P2|COMPLETED|Overall Study||2
291637|NCT01874275|697379|P1|COMPLETED|Overall Study||3
291638|NCT01874275|697378|P2|STARTED|Overall Study||2
291639|NCT01874275|697379|P1|STARTED|Overall Study||4
291640|NCT01874262|697393|P2|NOT COMPLETED|Overall Study||3
291641|NCT01874262|697394|P1|NOT COMPLETED|Overall Study||5
291642|NCT01874262|697393|P2|COMPLETED|Overall Study||80
291643|NCT01874262|697394|P1|COMPLETED|Overall Study||86
291644|NCT01874262|697393|P2|Not Included Due to Tehnical Issues|Overall Study||3
291645|NCT01874262|697394|P1|Not Included Due to Tehnical Issues|Overall Study||3
291646|NCT01874262|697393|P2|Not Correctly Randomised|Overall Study||0
291647|NCT01874262|697394|P1|Not Correctly Randomised|Overall Study||2
291648|NCT01874262|697393|P2|STARTED|Overall Study||83
291649|NCT01874262|697394|P1|STARTED|Overall Study||91
291650|NCT01874145|697402|P2|NOT COMPLETED|Extension Period||4
291651|NCT01874145|697403|P1|NOT COMPLETED|Extension Period||6
291652|NCT01874145|697402|P2|COMPLETED|Extension Period||97
291653|NCT01874145|697403|P1|COMPLETED|Extension Period||91
291654|NCT01874145|697402|P2|Full Analysis Set|Extension Period||101
291655|NCT01874145|697403|P1|Full Analysis Set|Extension Period||95
291656|NCT01874145|697402|P2|STARTED|Extension Period|Non-Switchers|101
291657|NCT01874145|697403|P1|STARTED|Extension Period|Switchers|97
291658|NCT01874145|697402|P2|NOT COMPLETED|Core Period||7
291659|NCT01874145|697403|P1|NOT COMPLETED|Core Period||3
291660|NCT01874145|697402|P2|COMPLETED|Core Period||101
291661|NCT01874145|697403|P1|COMPLETED|Core Period||98
291662|NCT01874145|697402|P2|Full Analysis Set|Core Period||108
291663|NCT01874145|697403|P1|Full Analysis Set|Core Period||100
291664|NCT01874145|697402|P2|STARTED|Core Period||108
291665|NCT01874145|697403|P1|STARTED|Core Period||101
291666|NCT01874132|697442|P3|NOT COMPLETED|Overall Study||3
291667|NCT01874132|697443|P2|NOT COMPLETED|Overall Study||4
291668|NCT01874132|697444|P1|NOT COMPLETED|Overall Study||4
291669|NCT01874132|697442|P3|COMPLETED|Overall Study||19
291670|NCT01874132|697443|P2|COMPLETED|Overall Study||18
291671|NCT01874132|697444|P1|COMPLETED|Overall Study||18
291672|NCT01874132|697442|P3|STARTED|Overall Study||22
291673|NCT01874132|697443|P2|STARTED|Overall Study||22
291674|NCT01874132|697444|P1|STARTED|Overall Study||22
291675|NCT01874054|697455|P1|NOT COMPLETED|Follow-up Period||49
291676|NCT01874054|697455|P1|COMPLETED|Follow-up Period||2
291677|NCT01874054|697455|P1|STARTED|Follow-up Period|4 patients withdrew consent and did not enter the follow-up period.|51
291678|NCT01874054|697455|P1|NOT COMPLETED|Treatment Period||38
291679|NCT01874054|697455|P1|COMPLETED|Treatment Period||17
291680|NCT01874054|697455|P1|STARTED|Treatment Period||55
291681|NCT01873989|697466|P2|NOT COMPLETED|Overall Study||1
291682|NCT01873989|697467|P1|NOT COMPLETED|Overall Study||1
291683|NCT01873989|697466|P2|COMPLETED|Overall Study||6
291684|NCT01873989|697467|P1|COMPLETED|Overall Study||7
291685|NCT01873989|697466|P2|STARTED|Overall Study||7
291686|NCT01873989|697467|P1|STARTED|Overall Study||8
291687|NCT01873950|697477|P5|NOT COMPLETED|Period 5||0
291688|NCT01873950|697478|P4|NOT COMPLETED|Period 5||1
291689|NCT01873950|697479|P3|NOT COMPLETED|Period 5||0
291690|NCT01873950|697480|P2|NOT COMPLETED|Period 5||0
291691|NCT01873950|697481|P1|NOT COMPLETED|Period 5||0
291692|NCT01873950|697477|P5|COMPLETED|Period 5||4
291693|NCT01873950|697478|P4|COMPLETED|Period 5||3
291694|NCT01873950|697479|P3|COMPLETED|Period 5||4
291695|NCT01873950|697480|P2|COMPLETED|Period 5||5
291696|NCT01873950|697481|P1|COMPLETED|Period 5||4
291697|NCT01873950|697477|P5|STARTED|Period 5||4
291698|NCT01873950|697478|P4|STARTED|Period 5||4
291699|NCT01873950|697479|P3|STARTED|Period 5||4
291700|NCT01873950|697480|P2|STARTED|Period 5||5
291701|NCT01873950|697481|P1|STARTED|Period 5||4
291702|NCT01873950|697477|P5|NOT COMPLETED|Period 4||0
291703|NCT01873950|697478|P4|NOT COMPLETED|Period 4||0
291704|NCT01873950|697479|P3|NOT COMPLETED|Period 4||0
291705|NCT01873950|697480|P2|NOT COMPLETED|Period 4||0
291706|NCT01873950|697481|P1|NOT COMPLETED|Period 4||0
291707|NCT01873950|697477|P5|COMPLETED|Period 4||5
291708|NCT01873950|697478|P4|COMPLETED|Period 4||4
291709|NCT01873950|697479|P3|COMPLETED|Period 4||4
291710|NCT01873950|697480|P2|COMPLETED|Period 4||5
291711|NCT01873950|697481|P1|COMPLETED|Period 4||4
291712|NCT01873950|697477|P5|STARTED|Period 4||5
291713|NCT01873950|697478|P4|STARTED|Period 4||4
291714|NCT01873950|697479|P3|STARTED|Period 4||4
291715|NCT01873950|697480|P2|STARTED|Period 4||5
291716|NCT01873950|697481|P1|STARTED|Period 4||4
291717|NCT01873950|697477|P5|NOT COMPLETED|Period 3||0
291718|NCT01873950|697478|P4|NOT COMPLETED|Period 3||0
291719|NCT01873950|697479|P3|NOT COMPLETED|Period 3||0
291720|NCT01873950|697480|P2|NOT COMPLETED|Period 3||0
291721|NCT01873950|697481|P1|NOT COMPLETED|Period 3||0
291722|NCT01873950|697477|P5|COMPLETED|Period 3||4
291723|NCT01873950|697478|P4|COMPLETED|Period 3||5
291724|NCT01873950|697479|P3|COMPLETED|Period 3||5
291725|NCT01873950|697480|P2|COMPLETED|Period 3||4
291726|NCT01873950|697481|P1|COMPLETED|Period 3||4
291727|NCT01873950|697477|P5|STARTED|Period 3||4
291728|NCT01873950|697478|P4|STARTED|Period 3||5
291729|NCT01873950|697479|P3|STARTED|Period 3||5
291730|NCT01873950|697480|P2|STARTED|Period 3||4
291731|NCT01873950|697481|P1|STARTED|Period 3||4
291732|NCT01873950|697477|P5|NOT COMPLETED|Period 2||0
291733|NCT01873950|697478|P4|NOT COMPLETED|Period 2||0
291734|NCT01873950|697479|P3|NOT COMPLETED|Period 2||0
291735|NCT01873950|697480|P2|NOT COMPLETED|Period 2||0
291736|NCT01873950|697481|P1|NOT COMPLETED|Period 2||0
291737|NCT01873950|697477|P5|COMPLETED|Period 2||5
291738|NCT01873950|697478|P4|COMPLETED|Period 2||4
291739|NCT01873950|697479|P3|COMPLETED|Period 2||4
291740|NCT01873950|697480|P2|COMPLETED|Period 2||4
291741|NCT01873950|697481|P1|COMPLETED|Period 2||5
291742|NCT01873950|697477|P5|STARTED|Period 2||5
291743|NCT01873950|697478|P4|STARTED|Period 2||4
291744|NCT01873950|697479|P3|STARTED|Period 2||4
291745|NCT01873950|697480|P2|STARTED|Period 2||4
291746|NCT01873950|697481|P1|STARTED|Period 2||5
291747|NCT01873950|697477|P5|NOT COMPLETED|Period 1||0
291748|NCT01873950|697478|P4|NOT COMPLETED|Period 1||0
291749|NCT01873950|697479|P3|NOT COMPLETED|Period 1||0
291750|NCT01873950|697480|P2|NOT COMPLETED|Period 1||0
291751|NCT01873950|697481|P1|NOT COMPLETED|Period 1||0
291752|NCT01873950|697477|P5|COMPLETED|Period 1||4
291753|NCT01873950|697478|P4|COMPLETED|Period 1||4
291754|NCT01873950|697479|P3|COMPLETED|Period 1||5
291755|NCT01873950|697480|P2|COMPLETED|Period 1||4
291756|NCT01873950|697481|P1|COMPLETED|Period 1||5
291757|NCT01873950|697477|P5|STARTED|Period 1||4
291758|NCT01873950|697478|P4|STARTED|Period 1||4
291759|NCT01873950|697479|P3|STARTED|Period 1||5
291760|NCT01873950|697480|P2|STARTED|Period 1||4
291761|NCT01873950|697481|P1|STARTED|Period 1||5
291762|NCT01873859|697502|P2|NOT COMPLETED|Overall Study||4
291763|NCT01873859|697503|P1|NOT COMPLETED|Overall Study||0
291764|NCT01873859|697502|P2|COMPLETED|Overall Study||79
291765|NCT01873859|697503|P1|COMPLETED|Overall Study||83
291766|NCT01873859|697502|P2|STARTED|Overall Study||83
291767|NCT01873859|697503|P1|STARTED|Overall Study||83
291768|NCT01873729|697511|P1|NOT COMPLETED|Overall Study||1
291769|NCT01873729|697511|P1|COMPLETED|Overall Study||2
291770|NCT01873729|697511|P1|STARTED|Overall Study||3
291771|NCT01873417|697516|P1|NOT COMPLETED|Overall Study||35
291772|NCT01873417|697516|P1|COMPLETED|Overall Study||202
291773|NCT01873417|697516|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
291774|NCT01873417|697516|P1|STARTED|Overall Study||237
291775|NCT01872819|697527|P1|NOT COMPLETED|Overall Study||2
291776|NCT01872819|697527|P1|COMPLETED|Overall Study||14
291777|NCT01872819|697527|P1|STARTED|Overall Study||16
291778|NCT01872715|697531|P1|NOT COMPLETED|Overall Study||4
291779|NCT01872715|697531|P1|COMPLETED|Overall Study||20
291780|NCT01872715|697531|P1|STARTED|Overall Study||24
291781|NCT01872611|697548|P2|NOT COMPLETED|Overall Study||12
291782|NCT01872611|697549|P1|NOT COMPLETED|Overall Study||24
291783|NCT01872611|697548|P2|COMPLETED|Overall Study||292
291784|NCT01872611|697549|P1|COMPLETED|Overall Study||277
291785|NCT01872611|697548|P2|Full Analysis Set|Overall Study||293
291786|NCT01872611|697549|P1|Full Analysis Set|Overall Study||289
291787|NCT01872611|697548|P2|Treated (Safety Analysis Set)|Overall Study||295
291788|NCT01872611|697549|P1|Treated (Safety Analysis Set)|Overall Study||293
291789|NCT01872611|697548|P2|Randomized|Overall Study||304
291790|NCT01872611|697549|P1|Randomized|Overall Study||301
291791|NCT01872611|697548|P2|STARTED|Overall Study||304
291792|NCT01872611|697549|P1|STARTED|Overall Study||301
291793|NCT01872078|697571|P4|NOT COMPLETED|Overall Study||2
291794|NCT01872078|697572|P3|NOT COMPLETED|Overall Study||3
291795|NCT01872078|697573|P2|NOT COMPLETED|Overall Study||0
291796|NCT01872078|697574|P1|NOT COMPLETED|Overall Study||0
291797|NCT01872078|697571|P4|COMPLETED|Overall Study||15
291798|NCT01872078|697572|P3|COMPLETED|Overall Study||14
291799|NCT01872078|697573|P2|COMPLETED|Overall Study||15
291800|NCT01872078|697574|P1|COMPLETED|Overall Study||16
291801|NCT01872078|697571|P4|STARTED|Overall Study||17
291802|NCT01872078|697572|P3|STARTED|Overall Study||17
291803|NCT01872078|697573|P2|STARTED|Overall Study||15
291804|NCT01872078|697574|P1|STARTED|Overall Study||16
291805|NCT01871870|697584|P1|NOT COMPLETED|Overall Study||9
291806|NCT01871870|697584|P1|COMPLETED|Overall Study||11
291807|NCT01871870|697584|P1|STARTED|Overall Study||20
291808|NCT01871805|697595|P6|NOT COMPLETED|Phase II||87
291809|NCT01871805|697596|P5|NOT COMPLETED|Phase II||0
291810|NCT01871805|697597|P4|NOT COMPLETED|Phase II||0
291811|NCT01871805|697598|P3|NOT COMPLETED|Phase II||0
291812|NCT01871805|697599|P2|NOT COMPLETED|Phase II||0
291813|NCT01871805|697600|P1|NOT COMPLETED|Phase II||0
291814|NCT01871805|697595|P6|COMPLETED|Phase II||0
291815|NCT01871805|697596|P5|COMPLETED|Phase II||0
291816|NCT01871805|697597|P4|COMPLETED|Phase II||0
291817|NCT01871805|697598|P3|COMPLETED|Phase II||0
291818|NCT01871805|697599|P2|COMPLETED|Phase II||0
291819|NCT01871805|697600|P1|COMPLETED|Phase II||0
291820|NCT01871805|697595|P6|STARTED|Phase II||87
291821|NCT01871805|697596|P5|STARTED|Phase II||0
291822|NCT01871805|697597|P4|STARTED|Phase II||0
291823|NCT01871805|697598|P3|STARTED|Phase II||0
291824|NCT01871805|697599|P2|STARTED|Phase II||0
291825|NCT01871805|697600|P1|STARTED|Phase II||0
291826|NCT01871805|697595|P6|NOT COMPLETED|Phase I||0
291827|NCT01871805|697596|P5|NOT COMPLETED|Phase I||13
291828|NCT01871805|697597|P4|NOT COMPLETED|Phase I||7
291829|NCT01871805|697598|P3|NOT COMPLETED|Phase I||13
291830|NCT01871805|697599|P2|NOT COMPLETED|Phase I||7
291831|NCT01871805|697600|P1|NOT COMPLETED|Phase I||7
291832|NCT01871805|697595|P6|COMPLETED|Phase I||0
291833|NCT01871805|697596|P5|COMPLETED|Phase I||0
291834|NCT01871805|697597|P4|COMPLETED|Phase I||0
291835|NCT01871805|697598|P3|COMPLETED|Phase I||0
291836|NCT01871805|697599|P2|COMPLETED|Phase I||0
291837|NCT01871805|697600|P1|COMPLETED|Phase I||0
291838|NCT01871805|697595|P6|STARTED|Phase I||0
291839|NCT01871805|697596|P5|STARTED|Phase I||13
291840|NCT01871805|697597|P4|STARTED|Phase I||7
291841|NCT01871805|697598|P3|STARTED|Phase I||13
291842|NCT01871805|697599|P2|STARTED|Phase I||7
291843|NCT01871805|697600|P1|STARTED|Phase I||7
291844|NCT01871558|697668|P2|NOT COMPLETED|Overall Study||2
291845|NCT01871558|697669|P1|NOT COMPLETED|Overall Study||3
291846|NCT01871558|697668|P2|COMPLETED|Overall Study||19
291847|NCT01871558|697669|P1|COMPLETED|Overall Study||18
291848|NCT01871558|697668|P2|STARTED|Overall Study||21
291849|NCT01871558|697669|P1|STARTED|Overall Study||21
291850|NCT01871532|697689|P2|NOT COMPLETED|Overall Study||2
291851|NCT01871532|697690|P1|NOT COMPLETED|Overall Study||1
291852|NCT01871532|697689|P2|COMPLETED|Overall Study||10
291853|NCT01871532|697690|P1|COMPLETED|Overall Study||11
291854|NCT01871532|697689|P2|Subjects Received hCG Treatment|Overall Study||9
291855|NCT01871532|697690|P1|Subjects Received hCG Treatment|Overall Study||11
291856|NCT01871532|697689|P2|STARTED|Overall Study||12
291857|NCT01871532|697690|P1|STARTED|Overall Study||12
291858|NCT01871519|697724|P1|NOT COMPLETED|Overall Study||90
291859|NCT01871519|697724|P1|COMPLETED|Overall Study||260
291860|NCT01871519|697724|P1|STARTED|Overall Study||350
291861|NCT01871402|697747|P2|NOT COMPLETED|Overall Study||3
291862|NCT01871402|697748|P1|NOT COMPLETED|Overall Study||1
291863|NCT01871402|697747|P2|COMPLETED|Overall Study||108
291864|NCT01871402|697748|P1|COMPLETED|Overall Study||109
291865|NCT01871402|697747|P2|STARTED|Overall Study||111
291866|NCT01871402|697748|P1|STARTED|Overall Study||110
291867|NCT01871285|697766|P4|NOT COMPLETED|Second Intervention (1 Day)||0
291868|NCT01871285|697767|P3|NOT COMPLETED|Second Intervention (1 Day)||0
291869|NCT01871285|697768|P2|NOT COMPLETED|Second Intervention (1 Day)||0
291870|NCT01871285|697769|P1|NOT COMPLETED|Second Intervention (1 Day)||0
291871|NCT01871285|697766|P4|COMPLETED|Second Intervention (1 Day)||2
291872|NCT01871285|697767|P3|COMPLETED|Second Intervention (1 Day)||3
291873|NCT01871285|697768|P2|COMPLETED|Second Intervention (1 Day)||14
291874|NCT01871285|697769|P1|COMPLETED|Second Intervention (1 Day)||17
291875|NCT01871285|697766|P4|STARTED|Second Intervention (1 Day)||2
291876|NCT01871285|697767|P3|STARTED|Second Intervention (1 Day)||3
291877|NCT01871285|697768|P2|STARTED|Second Intervention (1 Day)||14
291878|NCT01871285|697769|P1|STARTED|Second Intervention (1 Day)||17
291879|NCT01871285|697766|P4|NOT COMPLETED|First Intervention (1 Day)||0
291880|NCT01871285|697767|P3|NOT COMPLETED|First Intervention (1 Day)||1
291881|NCT01871285|697768|P2|NOT COMPLETED|First Intervention (1 Day)||1
291882|NCT01871285|697769|P1|NOT COMPLETED|First Intervention (1 Day)||1
291883|NCT01871285|697766|P4|COMPLETED|First Intervention (1 Day)||2
291884|NCT01871285|697767|P3|COMPLETED|First Intervention (1 Day)||3
291885|NCT01871285|697768|P2|COMPLETED|First Intervention (1 Day)||14
291886|NCT01871285|697769|P1|COMPLETED|First Intervention (1 Day)||17
291887|NCT01871285|697766|P4|STARTED|First Intervention (1 Day)||2
291888|NCT01871285|697767|P3|STARTED|First Intervention (1 Day)||4
291889|NCT01871285|697768|P2|STARTED|First Intervention (1 Day)||15
291890|NCT01871285|697769|P1|STARTED|First Intervention (1 Day)||18
291891|NCT01871142|697795|P1|NOT COMPLETED|Overall Study||1
291892|NCT01871142|697795|P1|COMPLETED|Overall Study||11
291893|NCT01871142|697795|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
291894|NCT01871142|697795|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
291895|NCT01871142|697795|P1|Received Placebo + Hypoxia|Overall Study||12
291896|NCT01871142|697795|P1|Received Placebo + Normoixa|Overall Study||11
291897|NCT01871142|697795|P1|STARTED|Overall Study||12
291898|NCT01871090|697811|P2|NOT COMPLETED|Overall Study||23
291899|NCT01871090|697812|P1|NOT COMPLETED|Overall Study||2
291900|NCT01871090|697811|P2|COMPLETED|Overall Study||25
291901|NCT01871090|697812|P1|COMPLETED|Overall Study||33
291902|NCT01871090|697811|P2|STARTED|Overall Study||48
291903|NCT01871090|697812|P1|STARTED|Overall Study||35
291904|NCT01870999|697825|P3|NOT COMPLETED|Overall Study||7
291905|NCT01870999|697826|P2|NOT COMPLETED|Overall Study||8
291906|NCT01870999|697827|P1|NOT COMPLETED|Overall Study||4
291907|NCT01870999|697825|P3|COMPLETED|Overall Study||4
291908|NCT01870999|697826|P2|COMPLETED|Overall Study||8
291909|NCT01870999|697827|P1|COMPLETED|Overall Study||10
291910|NCT01870999|697825|P3|Safety Population; Received Study Drug|Overall Study||10
291911|NCT01870999|697826|P2|Safety Population; Received Study Drug|Overall Study||15
291912|NCT01870999|697827|P1|Safety Population; Received Study Drug|Overall Study||14
291913|NCT01870999|697825|P3|STARTED|Overall Study||11
291914|NCT01870999|697826|P2|STARTED|Overall Study||16
291915|NCT01870999|697827|P1|STARTED|Overall Study||14
291916|NCT01870973|697885|P2|NOT COMPLETED|Overall Study||3
291917|NCT01870973|697886|P1|NOT COMPLETED|Overall Study||10
291918|NCT01870973|697885|P2|COMPLETED|Overall Study||49
291919|NCT01870973|697886|P1|COMPLETED|Overall Study||46
291920|NCT01870973|697885|P2|STARTED|Overall Study||52
291921|NCT01870973|697886|P1|STARTED|Overall Study||56
291922|NCT01870921|697892|P1|NOT COMPLETED|Overall Study||90
291923|NCT01870921|697892|P1|COMPLETED|Overall Study||1914
291924|NCT01870921|697892|P1|STARTED|Overall Study||2004
291925|NCT01870856|697900|P2|NOT COMPLETED|Overall Study||0
291926|NCT01870856|697901|P1|NOT COMPLETED|Overall Study||0
291927|NCT01870856|697900|P2|COMPLETED|Overall Study||27
291928|NCT01870856|697901|P1|COMPLETED|Overall Study||25
291929|NCT01870856|697900|P2|STARTED|Overall Study||27
291930|NCT01870856|697901|P1|STARTED|Overall Study||25
291931|NCT01870843|697911|P1|NOT COMPLETED|Overall Study||53
291932|NCT01870843|697911|P1|COMPLETED|Overall Study||208
291933|NCT01870843|697911|P1|STARTED|Overall Study||261
291934|NCT01870739|697926|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
291935|NCT01870739|697927|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
291936|NCT01870739|697926|P2|COMPLETED|Add-on Period (40 Weeks)||51
291937|NCT01870739|697927|P1|COMPLETED|Add-on Period (40 Weeks)||51
291938|NCT01870739|697926|P2|STARTED|Add-on Period (40 Weeks)||53
291939|NCT01870739|697927|P1|STARTED|Add-on Period (40 Weeks)||54
291940|NCT01870739|697926|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
291941|NCT01870739|697927|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
291942|NCT01870739|697926|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
291943|NCT01870739|697927|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
291944|NCT01870739|697926|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
291945|NCT01870739|697927|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
291946|NCT01870739|697926|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
291947|NCT01870739|697927|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
291948|NCT01870739|697926|P2|STARTED|Single Drug Treatment (12 Weeks)||57
291949|NCT01870739|697927|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
291950|NCT01870596|697961|P2|NOT COMPLETED|Overall Study||0
291951|NCT01870596|697962|P1|NOT COMPLETED|Overall Study||0
291952|NCT01870596|697961|P2|COMPLETED|Overall Study||18
291953|NCT01870596|697962|P1|COMPLETED|Overall Study||14
291954|NCT01870596|697961|P2|STARTED|Overall Study||18
291955|NCT01870596|697962|P1|STARTED|Overall Study||14
291956|NCT01870388|697970|P2|NOT COMPLETED|Overall Study||0
291957|NCT01870388|697971|P1|NOT COMPLETED|Overall Study||0
291958|NCT01870388|697970|P2|COMPLETED|Overall Study||8
291959|NCT01870388|697971|P1|COMPLETED|Overall Study||8
291960|NCT01870388|697970|P2|Received 1 Dose of Study Drug|Overall Study||8
291961|NCT01870388|697971|P1|Received 1 Dose of Study Drug|Overall Study||8
291962|NCT01870388|697970|P2|STARTED|Overall Study||8
291963|NCT01870388|697971|P1|STARTED|Overall Study||8
291964|NCT01869959|697983|P5|NOT COMPLETED|Treatment Period||0
291965|NCT01869959|697984|P4|NOT COMPLETED|Treatment Period||2
291966|NCT01869959|697985|P3|NOT COMPLETED|Treatment Period||3
291967|NCT01869959|697986|P2|NOT COMPLETED|Treatment Period||2
291968|NCT01869959|697987|P1|NOT COMPLETED|Treatment Period||1
291969|NCT01869959|697983|P5|COMPLETED|Treatment Period||0
291970|NCT01869959|697984|P4|COMPLETED|Treatment Period||8
291971|NCT01869959|697985|P3|COMPLETED|Treatment Period||12
291972|NCT01869959|697986|P2|COMPLETED|Treatment Period||8
291973|NCT01869959|697987|P1|COMPLETED|Treatment Period||10
291974|NCT01869959|697983|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
291975|NCT01869959|697984|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
291976|NCT01869959|697985|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
291977|NCT01869959|697986|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
291978|NCT01869959|697987|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
291979|NCT01869959|697983|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
291980|NCT01869959|697984|P4|STARTED|Treatment Period||10
291981|NCT01869959|697985|P3|STARTED|Treatment Period||15
291982|NCT01869959|697986|P2|STARTED|Treatment Period||10
291983|NCT01869959|697987|P1|STARTED|Treatment Period||11
291984|NCT01869959|697983|P5|NOT COMPLETED|Randomization Period||1
291985|NCT01869959|697984|P4|NOT COMPLETED|Randomization Period||0
291986|NCT01869959|697985|P3|NOT COMPLETED|Randomization Period||0
291987|NCT01869959|697986|P2|NOT COMPLETED|Randomization Period||0
291988|NCT01869959|697987|P1|NOT COMPLETED|Randomization Period||0
291989|NCT01869959|697983|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
291990|NCT01869959|697984|P4|COMPLETED|Randomization Period||0
291991|NCT01869959|697985|P3|COMPLETED|Randomization Period||0
291992|NCT01869959|697986|P2|COMPLETED|Randomization Period||0
291993|NCT01869959|697987|P1|COMPLETED|Randomization Period||0
291994|NCT01869959|697983|P5|STARTED|Randomization Period||47
291995|NCT01869959|697984|P4|STARTED|Randomization Period||0
291996|NCT01869959|697985|P3|STARTED|Randomization Period||0
291997|NCT01869959|697986|P2|STARTED|Randomization Period||0
291998|NCT01869959|697987|P1|STARTED|Randomization Period||0
291999|NCT01869686|698055|P1|NOT COMPLETED|Overall Study||0
292000|NCT01869686|698055|P1|COMPLETED|Overall Study||12
292001|NCT01869686|698055|P1|STARTED|Overall Study||12
292002|NCT01869647|698070|P3|NOT COMPLETED|Overall Study||0
292003|NCT01869647|698071|P2|NOT COMPLETED|Overall Study||6
292004|NCT01869647|698072|P1|NOT COMPLETED|Overall Study||1
292005|NCT01869647|698070|P3|COMPLETED|Overall Study||62
292006|NCT01869647|698071|P2|COMPLETED|Overall Study||130
292007|NCT01869647|698072|P1|COMPLETED|Overall Study||65
292008|NCT01869647|698070|P3|STARTED|Overall Study||62
292009|NCT01869647|698071|P2|STARTED|Overall Study||136
292010|NCT01869647|698072|P1|STARTED|Overall Study||66
292011|NCT01869478|698085|P2|NOT COMPLETED|Overall Study||0
292012|NCT01869478|698086|P1|NOT COMPLETED|Overall Study||0
292013|NCT01869478|698085|P2|COMPLETED|Overall Study||1
292014|NCT01869478|698086|P1|COMPLETED|Overall Study||0
292015|NCT01869478|698085|P2|STARTED|Overall Study||1
292016|NCT01869478|698086|P1|STARTED|Overall Study||0
292017|NCT01869075|698100|P6|NOT COMPLETED|Phase 2||0
292018|NCT01869075|698101|P5|NOT COMPLETED|Phase 2||0
292019|NCT01869075|698102|P4|NOT COMPLETED|Phase 2||0
292020|NCT01869075|698103|P3|NOT COMPLETED|Phase 2||0
292021|NCT01869075|698104|P2|NOT COMPLETED|Phase 2||0
292022|NCT01869075|698105|P1|NOT COMPLETED|Phase 2||0
292023|NCT01869075|698100|P6|COMPLETED|Phase 2||45
292024|NCT01869075|698101|P5|COMPLETED|Phase 2||75
292025|NCT01869075|698102|P4|COMPLETED|Phase 2||45
292026|NCT01869075|698103|P3|COMPLETED|Phase 2||75
292027|NCT01869075|698104|P2|COMPLETED|Phase 2||30
292028|NCT01869075|698105|P1|COMPLETED|Phase 2||90
292029|NCT01869075|698100|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
292030|NCT01869075|698101|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
292031|NCT01869075|698102|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
292032|NCT01869075|698103|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
292033|NCT01869075|698104|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
292034|NCT01869075|698105|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
292035|NCT01869075|698100|P6|NOT COMPLETED|Phase 1||0
292036|NCT01869075|698101|P5|NOT COMPLETED|Phase 1||0
292037|NCT01869075|698102|P4|NOT COMPLETED|Phase 1||0
292038|NCT01869075|698103|P3|NOT COMPLETED|Phase 1||0
292039|NCT01869075|698104|P2|NOT COMPLETED|Phase 1||0
292040|NCT01869075|698105|P1|NOT COMPLETED|Phase 1||0
292041|NCT01869075|698100|P6|COMPLETED|Phase 1||90
292042|NCT01869075|698101|P5|COMPLETED|Phase 1||30
292043|NCT01869075|698102|P4|COMPLETED|Phase 1||75
292044|NCT01869075|698103|P3|COMPLETED|Phase 1||45
292045|NCT01869075|698104|P2|COMPLETED|Phase 1||75
292046|NCT01869075|698105|P1|COMPLETED|Phase 1||45
292047|NCT01869075|698100|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
292048|NCT01869075|698101|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
292049|NCT01869075|698102|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
292050|NCT01869075|698103|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
292051|NCT01869075|698104|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
292052|NCT01869075|698105|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
292053|NCT01869075|698100|P6|NOT COMPLETED|Phase 0 (Baseline)||0
292054|NCT01869075|698101|P5|NOT COMPLETED|Phase 0 (Baseline)||0
292055|NCT01869075|698102|P4|NOT COMPLETED|Phase 0 (Baseline)||0
292056|NCT01869075|698103|P3|NOT COMPLETED|Phase 0 (Baseline)||0
292057|NCT01869075|698104|P2|NOT COMPLETED|Phase 0 (Baseline)||0
292058|NCT01869075|698105|P1|NOT COMPLETED|Phase 0 (Baseline)||0
292059|NCT01869075|698100|P6|COMPLETED|Phase 0 (Baseline)||341
292060|NCT01869075|698101|P5|COMPLETED|Phase 0 (Baseline)||0
292061|NCT01869075|698102|P4|COMPLETED|Phase 0 (Baseline)||416
292062|NCT01869075|698103|P3|COMPLETED|Phase 0 (Baseline)||0
292063|NCT01869075|698104|P2|COMPLETED|Phase 0 (Baseline)||418
292064|NCT01869075|698105|P1|COMPLETED|Phase 0 (Baseline)||0
292065|NCT01869075|698100|P6|STARTED|Phase 0 (Baseline)||341
292066|NCT01869075|698101|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
292067|NCT01869075|698102|P4|STARTED|Phase 0 (Baseline)||416
292068|NCT01869075|698103|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
292069|NCT01869075|698104|P2|STARTED|Phase 0 (Baseline)||418
292070|NCT01869075|698105|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
292071|NCT01868893|698119|P1|NOT COMPLETED|Overall Study||20
292072|NCT01868893|698119|P1|COMPLETED|Overall Study||0
292073|NCT01868893|698119|P1|STARTED|Overall Study||20
292074|NCT01868776|698128|P2|NOT COMPLETED|Overall Study||0
292075|NCT01868776|698129|P1|NOT COMPLETED|Overall Study||0
292076|NCT01868776|698128|P2|COMPLETED|Overall Study||50
292077|NCT01868776|698129|P1|COMPLETED|Overall Study||50
292078|NCT01868776|698128|P2|STARTED|Overall Study||50
292079|NCT01868776|698129|P1|STARTED|Overall Study||50
292080|NCT01868633|698137|P2|NOT COMPLETED|Overall Study||0
292081|NCT01868633|698138|P1|NOT COMPLETED|Overall Study||0
292082|NCT01868633|698137|P2|COMPLETED|Overall Study||26
292083|NCT01868633|698138|P1|COMPLETED|Overall Study||26
292084|NCT01868633|698137|P2|STARTED|Overall Study||26
292085|NCT01868633|698138|P1|STARTED|Overall Study||26
292086|NCT01868542|698150|P2|NOT COMPLETED|Overall Study||2
292087|NCT01868542|698151|P1|NOT COMPLETED|Overall Study||0
292088|NCT01868542|698150|P2|COMPLETED|Overall Study||21
292089|NCT01868542|698151|P1|COMPLETED|Overall Study||23
292090|NCT01868542|698150|P2|STARTED|Overall Study||23
292091|NCT01868542|698151|P1|STARTED|Overall Study||23
292092|NCT01868503|698169|P1|NOT COMPLETED|Overall Study||2
292093|NCT01868503|698169|P1|COMPLETED|Overall Study||5
292094|NCT01868503|698169|P1|STARTED|Overall Study||7
292095|NCT01868243|698175|P2|NOT COMPLETED|Overall Study||1
292096|NCT01868243|698176|P1|NOT COMPLETED|Overall Study||0
292097|NCT01868243|698175|P2|COMPLETED|Overall Study||11
292098|NCT01868243|698176|P1|COMPLETED|Overall Study||15
292099|NCT01868243|698175|P2|STARTED|Overall Study||12
292100|NCT01868243|698176|P1|STARTED|Overall Study||15
292101|NCT01868074|698186|P2|NOT COMPLETED|Overall Study||4
292102|NCT01868074|698187|P1|NOT COMPLETED|Overall Study||7
292103|NCT01868074|698186|P2|COMPLETED|Overall Study||32
292104|NCT01868074|698187|P1|COMPLETED|Overall Study||29
292105|NCT01868074|698186|P2|STARTED|Overall Study||36
292106|NCT01868074|698187|P1|STARTED|Overall Study||36
292107|NCT01868035|698197|P1|NOT COMPLETED|Overall Study||7
292108|NCT01868035|698197|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
292109|NCT01868035|698197|P1|STARTED|Overall Study||15
292110|NCT01868009|698213|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
292111|NCT01868009|698214|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
292112|NCT01868009|698213|P2|COMPLETED|Period 2 (5-9 Days)||142
292113|NCT01868009|698214|P1|COMPLETED|Period 2 (5-9 Days)||141
292114|NCT01868009|698213|P2|STARTED|Period 2 (5-9 Days)||142
292115|NCT01868009|698214|P1|STARTED|Period 2 (5-9 Days)||143
292116|NCT01868009|698213|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
292117|NCT01868009|698214|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
292118|NCT01868009|698213|P2|COMPLETED|Period 1 (5-9 Days)||142
292119|NCT01868009|698214|P1|COMPLETED|Period 1 (5-9 Days)||143
292120|NCT01868009|698213|P2|STARTED|Period 1 (5-9 Days)||144
292121|NCT01868009|698214|P1|STARTED|Period 1 (5-9 Days)||143
292122|NCT01867710|698228|P4|NOT COMPLETED|Overall Study||7
292123|NCT01867710|698229|P3|NOT COMPLETED|Overall Study||9
292124|NCT01867710|698230|P2|NOT COMPLETED|Overall Study||7
292125|NCT01867710|698231|P1|NOT COMPLETED|Overall Study||8
292126|NCT01867710|698228|P4|COMPLETED|Overall Study||35
292127|NCT01867710|698229|P3|COMPLETED|Overall Study||31
292128|NCT01867710|698230|P2|COMPLETED|Overall Study||34
292129|NCT01867710|698231|P1|COMPLETED|Overall Study||33
292130|NCT01867710|698228|P4|Treated|Overall Study||42
292131|NCT01867710|698229|P3|Treated|Overall Study||39
292132|NCT01867710|698230|P2|Treated|Overall Study||41
292133|NCT01867710|698231|P1|Treated|Overall Study||41
292134|NCT01867710|698228|P4|STARTED|Overall Study||42
292135|NCT01867710|698229|P3|STARTED|Overall Study||40
292136|NCT01867710|698230|P2|STARTED|Overall Study||41
292137|NCT01867710|698231|P1|STARTED|Overall Study||41
292138|NCT01867658|698245|P1|NOT COMPLETED|Overall Study||9
292139|NCT01867658|698245|P1|COMPLETED|Overall Study||103
292140|NCT01867658|698245|P1|STARTED|Overall Study||112
292141|NCT01867632|698256|P1|NOT COMPLETED|Overall Study||0
292142|NCT01867632|698256|P1|COMPLETED|Overall Study||65
292143|NCT01867632|698256|P1|STARTED|Overall Study||65
292144|NCT01867307|698263|P2|NOT COMPLETED|Overall Study||3
292145|NCT01867307|698264|P1|NOT COMPLETED|Overall Study||3
292146|NCT01867307|698263|P2|COMPLETED|Overall Study||16
292147|NCT01867307|698264|P1|COMPLETED|Overall Study||15
292148|NCT01867307|698263|P2|STARTED|Overall Study|Started are the treated patients|19
292149|NCT01867307|698264|P1|STARTED|Overall Study|Started are the treated patients|18
292150|NCT01867164|698272|P2|NOT COMPLETED|Overall Study||0
292151|NCT01867164|698273|P1|NOT COMPLETED|Overall Study||0
292152|NCT01867164|698272|P2|COMPLETED|Overall Study||79
292153|NCT01867164|698273|P1|COMPLETED|Overall Study||81
292154|NCT01867164|698272|P2|STARTED|Overall Study||79
292155|NCT01867164|698273|P1|STARTED|Overall Study||81
292156|NCT01867021|698289|P2|NOT COMPLETED|Overall Study||10
292157|NCT01867021|698290|P1|NOT COMPLETED|Overall Study||2
292158|NCT01867021|698289|P2|COMPLETED|Overall Study||1440
292159|NCT01867021|698290|P1|COMPLETED|Overall Study||1450
292160|NCT01867021|698289|P2|STARTED|Overall Study||1450
292161|NCT01867021|698290|P1|STARTED|Overall Study||1452
292162|NCT01866709|698311|P2|NOT COMPLETED|Overall Study||0
292163|NCT01866709|698312|P1|NOT COMPLETED|Overall Study||1
292164|NCT01866709|698311|P2|COMPLETED|Overall Study||17
292165|NCT01866709|698312|P1|COMPLETED|Overall Study||14
292166|NCT01866709|698311|P2|STARTED|Overall Study||17
292167|NCT01866709|698312|P1|STARTED|Overall Study||15
292168|NCT01866319|698323|P3|NOT COMPLETED|Overall Study||277
292169|NCT01866319|698324|P2|NOT COMPLETED|Overall Study||279
292170|NCT01866319|698325|P1|NOT COMPLETED|Overall Study||277
292171|NCT01866319|698323|P3|COMPLETED|Overall Study||0
292172|NCT01866319|698324|P2|COMPLETED|Overall Study||0
292173|NCT01866319|698325|P1|COMPLETED|Overall Study||1
292174|NCT01866319|698323|P3|Treated|Overall Study||277
292175|NCT01866319|698324|P2|Treated|Overall Study||278
292176|NCT01866319|698325|P1|Treated|Overall Study||256
292177|NCT01866319|698323|P3|STARTED|Overall Study||277
292178|NCT01866319|698324|P2|STARTED|Overall Study||279
292179|NCT01866319|698325|P1|STARTED|Overall Study||278
292180|NCT01866306|698346|P7|NOT COMPLETED|Overall Study||0
292181|NCT01866306|698347|P6|NOT COMPLETED|Overall Study||0
292182|NCT01866306|698348|P5|NOT COMPLETED|Overall Study||0
292183|NCT01866306|698349|P4|NOT COMPLETED|Overall Study||0
292184|NCT01866306|698350|P3|NOT COMPLETED|Overall Study||0
292185|NCT01866306|698351|P2|NOT COMPLETED|Overall Study||0
292186|NCT01866306|698352|P1|NOT COMPLETED|Overall Study||0
292187|NCT01866306|698346|P7|COMPLETED|Overall Study||23
292188|NCT01866306|698347|P6|COMPLETED|Overall Study||6
292189|NCT01866306|698348|P5|COMPLETED|Overall Study||6
292190|NCT01866306|698349|P4|COMPLETED|Overall Study||6
292191|NCT01866306|698350|P3|COMPLETED|Overall Study||6
292192|NCT01866306|698351|P2|COMPLETED|Overall Study||6
292193|NCT01866306|698352|P1|COMPLETED|Overall Study||6
292194|NCT01866306|698346|P7|STARTED|Overall Study||23
292195|NCT01866306|698347|P6|STARTED|Overall Study||6
292196|NCT01866306|698348|P5|STARTED|Overall Study||6
292197|NCT01866306|698349|P4|STARTED|Overall Study||6
292198|NCT01866306|698350|P3|STARTED|Overall Study||6
292199|NCT01866306|698351|P2|STARTED|Overall Study||6
292200|NCT01866306|698352|P1|STARTED|Overall Study||6
292201|NCT01866163|698426|P2|NOT COMPLETED|Overall Study||4
292202|NCT01866163|698427|P1|NOT COMPLETED|Overall Study||10
292203|NCT01866163|698426|P2|COMPLETED|Overall Study||99
292204|NCT01866163|698427|P1|COMPLETED|Overall Study||313
292205|NCT01866163|698426|P2|STARTED|Overall Study||103
292206|NCT01866163|698427|P1|STARTED|Overall Study||323
292207|NCT01866150|698437|P1|NOT COMPLETED|Overall Study||0
292208|NCT01866150|698437|P1|COMPLETED|Overall Study||450
292209|NCT01866150|698437|P1|STARTED|Overall Study||450
292210|NCT01865812|698458|P1|NOT COMPLETED|Overall Study||2
292211|NCT01865812|698458|P1|COMPLETED|Overall Study||24
292212|NCT01865812|698458|P1|STARTED|Overall Study||26
292213|NCT01865084|698467|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
292214|NCT01865084|698468|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
292215|NCT01865084|698469|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
292216|NCT01865084|698467|P3|COMPLETED|Open Label Extension (OLE) Period||158
292217|NCT01865084|698468|P2|COMPLETED|Open Label Extension (OLE) Period||139
292218|NCT01865084|698469|P1|COMPLETED|Open Label Extension (OLE) Period||0
292219|NCT01865084|698467|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
292220|NCT01865084|698468|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
292221|NCT01865084|698469|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
292222|NCT01865084|698467|P3|NOT COMPLETED|Double Blind Period (DB)||6
292223|NCT01865084|698468|P2|NOT COMPLETED|Double Blind Period (DB)||4
292224|NCT01865084|698469|P1|NOT COMPLETED|Double Blind Period (DB)||5
292225|NCT01865084|698467|P3|COMPLETED|Double Blind Period (DB)||107
292226|NCT01865084|698468|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
292227|NCT01865084|698469|P1|COMPLETED|Double Blind Period (DB)||111
292228|NCT01865084|698467|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
292229|NCT01865084|698468|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
292230|NCT01865084|698469|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
292231|NCT01865084|698467|P3|STARTED|Double Blind Period (DB)||113
292232|NCT01865084|698468|P2|STARTED|Double Blind Period (DB)||102
292233|NCT01865084|698469|P1|STARTED|Double Blind Period (DB)||116
292234|NCT01864434|698497|P2|NOT COMPLETED|Overall Study||0
292235|NCT01864434|698498|P1|NOT COMPLETED|Overall Study||0
292236|NCT01864434|698497|P2|COMPLETED|Overall Study||25
292237|NCT01864434|698498|P1|COMPLETED|Overall Study||25
292238|NCT01864434|698497|P2|STARTED|Overall Study||25
292239|NCT01864434|698498|P1|STARTED|Overall Study||25
292240|NCT01864148|698513|P5|NOT COMPLETED|Overall Study||23
292241|NCT01864148|698514|P4|NOT COMPLETED|Overall Study||26
292242|NCT01864148|698515|P3|NOT COMPLETED|Overall Study||11
292243|NCT01864148|698516|P2|NOT COMPLETED|Overall Study||5
292244|NCT01864148|698517|P1|NOT COMPLETED|Overall Study||20
292245|NCT01864148|698513|P5|COMPLETED|Overall Study||69
292246|NCT01864148|698514|P4|COMPLETED|Overall Study||68
292247|NCT01864148|698515|P3|COMPLETED|Overall Study||84
292248|NCT01864148|698516|P2|COMPLETED|Overall Study||40
292249|NCT01864148|698517|P1|COMPLETED|Overall Study||73
292250|NCT01864148|698513|P5|Randomized and Dosed|Overall Study||92
292251|NCT01864148|698514|P4|Randomized and Dosed|Overall Study||93
292252|NCT01864148|698515|P3|Randomized and Dosed|Overall Study||95
292253|NCT01864148|698516|P2|Randomized and Dosed|Overall Study||45
292254|NCT01864148|698517|P1|Randomized and Dosed|Overall Study||93
292255|NCT01864148|698513|P5|STARTED|Overall Study||92
292256|NCT01864148|698514|P4|STARTED|Overall Study||94
292257|NCT01864148|698515|P3|STARTED|Overall Study||95
292258|NCT01864148|698516|P2|STARTED|Overall Study||45
292259|NCT01864148|698517|P1|STARTED|Overall Study||93
292260|NCT01864005|698546|P2|NOT COMPLETED|Overall Study||6
292261|NCT01864005|698547|P1|NOT COMPLETED|Overall Study||3
292262|NCT01864005|698546|P2|COMPLETED|Overall Study||25
292263|NCT01864005|698547|P1|COMPLETED|Overall Study||26
292264|NCT01864005|698546|P2|STARTED|Overall Study||31
292265|NCT01864005|698547|P1|STARTED|Overall Study||29
292266|NCT01863953|698564|P3|NOT COMPLETED|Overall Study||1
292267|NCT01863953|698565|P2|NOT COMPLETED|Overall Study||0
292268|NCT01863953|698566|P1|NOT COMPLETED|Overall Study||0
292269|NCT01863953|698564|P3|COMPLETED|Overall Study||37
292270|NCT01863953|698565|P2|COMPLETED|Overall Study||36
292271|NCT01863953|698566|P1|COMPLETED|Overall Study||38
292272|NCT01863953|698564|P3|STARTED|Overall Study||38
292273|NCT01863953|698565|P2|STARTED|Overall Study||36
292274|NCT01863953|698566|P1|STARTED|Overall Study||38
292275|NCT01863771|698580|P4|NOT COMPLETED|Maintenance Phase||43
292276|NCT01863771|698581|P3|NOT COMPLETED|Maintenance Phase||12
292277|NCT01863771|698582|P2|NOT COMPLETED|Maintenance Phase||5
292278|NCT01863771|698583|P1|NOT COMPLETED|Maintenance Phase||0
292279|NCT01863771|698580|P4|COMPLETED|Maintenance Phase||17
292280|NCT01863771|698581|P3|COMPLETED|Maintenance Phase||19
292281|NCT01863771|698582|P2|COMPLETED|Maintenance Phase||27
292282|NCT01863771|698583|P1|COMPLETED|Maintenance Phase||0
292283|NCT01863771|698580|P4|STARTED|Maintenance Phase||60
292284|NCT01863771|698581|P3|STARTED|Maintenance Phase||31
292285|NCT01863771|698582|P2|STARTED|Maintenance Phase||32
292286|NCT01863771|698583|P1|STARTED|Maintenance Phase||0
292287|NCT01863771|698580|P4|NOT COMPLETED|Induction Phase||0
292288|NCT01863771|698581|P3|NOT COMPLETED|Induction Phase||0
292289|NCT01863771|698582|P2|NOT COMPLETED|Induction Phase||0
292290|NCT01863771|698583|P1|NOT COMPLETED|Induction Phase||21
292291|NCT01863771|698580|P4|COMPLETED|Induction Phase||0
292292|NCT01863771|698581|P3|COMPLETED|Induction Phase||0
292293|NCT01863771|698582|P2|COMPLETED|Induction Phase||0
292294|NCT01863771|698583|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
292295|NCT01863771|698580|P4|STARTED|Induction Phase||0
292296|NCT01863771|698581|P3|STARTED|Induction Phase||0
292297|NCT01863771|698582|P2|STARTED|Induction Phase||0
292298|NCT01863771|698583|P1|STARTED|Induction Phase||144
292299|NCT01863680|698595|P1|NOT COMPLETED|Overall Study||57
292300|NCT01863680|698595|P1|COMPLETED|Overall Study||121
292301|NCT01863680|698595|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
292302|NCT01863680|698595|P1|Subjects Received Study Drug|Overall Study||149
292303|NCT01863680|698595|P1|Subjects Received hCG Injection|Overall Study||162
292304|NCT01863680|698595|P1|Subjects Started COS Treatment|Overall Study||169
292305|NCT01863680|698595|P1|STARTED|Overall Study||178
292306|NCT01863667|698603|P2|NOT COMPLETED|Overall Study||32
292307|NCT01863667|698604|P1|NOT COMPLETED|Overall Study||33
292308|NCT01863667|698603|P2|COMPLETED|Overall Study||0
292309|NCT01863667|698604|P1|COMPLETED|Overall Study||0
292310|NCT01863667|698603|P2|STARTED|Overall Study||32
292311|NCT01863667|698604|P1|STARTED|Overall Study||33
292312|NCT01863433|698624|P1|NOT COMPLETED|Overall Study||1
292313|NCT01863433|698624|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
292314|NCT01863433|698624|P1|STARTED|Overall Study||120
292315|NCT01863368|698634|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
292316|NCT01863368|698635|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
292317|NCT01863368|698634|P2|COMPLETED|Phase II, Day 35 to Day 90||41
292318|NCT01863368|698635|P1|COMPLETED|Phase II, Day 35 to Day 90||41
292319|NCT01863368|698634|P2|STARTED|Phase II, Day 35 to Day 90||41
292320|NCT01863368|698635|P1|STARTED|Phase II, Day 35 to Day 90||43
292321|NCT01863368|698634|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
292322|NCT01863368|698635|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
292323|NCT01863368|698634|P2|COMPLETED|Phase I, Day 0 to Day 35||41
292324|NCT01863368|698635|P1|COMPLETED|Phase I, Day 0 to Day 35||43
292325|NCT01863368|698634|P2|Treated|Phase I, Day 0 to Day 35||47
292326|NCT01863368|698635|P1|Treated|Phase I, Day 0 to Day 35||46
292327|NCT01863368|698634|P2|STARTED|Phase I, Day 0 to Day 35||48
292328|NCT01863368|698635|P1|STARTED|Phase I, Day 0 to Day 35||46
292329|NCT01863134|698650|P2|NOT COMPLETED|Overall Study||0
292330|NCT01863134|698651|P1|NOT COMPLETED|Overall Study||0
292331|NCT01863134|698650|P2|COMPLETED|Overall Study||68
292332|NCT01863134|698651|P1|COMPLETED|Overall Study||72
292333|NCT01863134|698650|P2|STARTED|Overall Study||68
292334|NCT01863134|698651|P1|STARTED|Overall Study||72
292335|NCT01862991|698660|P3|NOT COMPLETED|Overall Study||1
292336|NCT01862991|698661|P2|NOT COMPLETED|Overall Study||1
292337|NCT01862991|698662|P1|NOT COMPLETED|Overall Study||3
292338|NCT01862991|698660|P3|COMPLETED|Overall Study||27
292339|NCT01862991|698661|P2|COMPLETED|Overall Study||27
292340|NCT01862991|698662|P1|COMPLETED|Overall Study||21
292341|NCT01862991|698660|P3|STARTED|Overall Study||28
292342|NCT01862991|698661|P2|STARTED|Overall Study||28
292343|NCT01862991|698662|P1|STARTED|Overall Study||24
292344|NCT01862484|698675|P2|NOT COMPLETED|Overall Study||8
292345|NCT01862484|698676|P1|NOT COMPLETED|Overall Study||2
292346|NCT01862484|698675|P2|COMPLETED|Overall Study||6
292347|NCT01862484|698676|P1|COMPLETED|Overall Study||13
292348|NCT01862484|698675|P2|STARTED|Overall Study||14
292349|NCT01862484|698676|P1|STARTED|Overall Study||15
292350|NCT01862419|698684|P2|NOT COMPLETED|Overall Study||0
292351|NCT01862419|698685|P1|NOT COMPLETED|Overall Study||0
292352|NCT01862419|698684|P2|COMPLETED|Overall Study||1192
292353|NCT01862419|698685|P1|COMPLETED|Overall Study||1201
292354|NCT01862419|698684|P2|STARTED|Overall Study||1192
292355|NCT01862419|698685|P1|STARTED|Overall Study||1201
292356|NCT01862133|698695|P2|NOT COMPLETED|Overall Study||0
292357|NCT01862133|698696|P1|NOT COMPLETED|Overall Study||0
292358|NCT01862133|698695|P2|COMPLETED|Overall Study||31
292359|NCT01862133|698696|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
292360|NCT01862133|698695|P2|Returned During 6 mo Study|Overall Study||31
292361|NCT01862133|698696|P1|Returned During 6 mo Study|Overall Study||92
292362|NCT01862133|698695|P2|STARTED|Overall Study||31
292363|NCT01862133|698696|P1|STARTED|Overall Study||105
292364|NCT01861925|698705|P3|NOT COMPLETED|Overall Study||0
292365|NCT01861925|698706|P2|NOT COMPLETED|Overall Study||0
292366|NCT01861925|698707|P1|NOT COMPLETED|Overall Study||0
292367|NCT01861925|698705|P3|COMPLETED|Overall Study||8
292368|NCT01861925|698706|P2|COMPLETED|Overall Study||8
292369|NCT01861925|698707|P1|COMPLETED|Overall Study||34
292370|NCT01861925|698705|P3|STARTED|Overall Study||8
292371|NCT01861925|698706|P2|STARTED|Overall Study||8
292372|NCT01861925|698707|P1|STARTED|Overall Study||34
292373|NCT01861756|698730|P2|NOT COMPLETED|Overall Study||18
292374|NCT01861756|698731|P1|NOT COMPLETED|Overall Study||13
292375|NCT01861756|698730|P2|COMPLETED|Overall Study||85
292376|NCT01861756|698731|P1|COMPLETED|Overall Study||88
292377|NCT01861756|698730|P2|STARTED|Overall Study||103
292378|NCT01861756|698731|P1|STARTED|Overall Study||101
292379|NCT01861704|698739|P2|NOT COMPLETED|Overall Study||3
292380|NCT01861704|698740|P1|NOT COMPLETED|Overall Study||3
292381|NCT01861704|698739|P2|COMPLETED|Overall Study||104
292382|NCT01861704|698740|P1|COMPLETED|Overall Study||67
292383|NCT01861704|698739|P2|STARTED|Overall Study||107
292384|NCT01861704|698740|P1|STARTED|Overall Study||70
292385|NCT01861522|698748|P2|NOT COMPLETED|Overall Study||0
292386|NCT01861522|698749|P1|NOT COMPLETED|Overall Study||3
292387|NCT01861522|698748|P2|COMPLETED|Overall Study||232
292388|NCT01861522|698749|P1|COMPLETED|Overall Study||237
292389|NCT01861522|698748|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
292390|NCT01861522|698749|P1|STARTED|Overall Study||240
292391|NCT01861457|698757|P2|NOT COMPLETED|Overall Study||0
292392|NCT01861457|698758|P1|NOT COMPLETED|Overall Study||0
292393|NCT01861457|698757|P2|COMPLETED|Overall Study||19
292394|NCT01861457|698758|P1|COMPLETED|Overall Study||20
292395|NCT01861457|698757|P2|STARTED|Overall Study||19
292396|NCT01861457|698758|P1|STARTED|Overall Study||20
292397|NCT01861301|698766|P1|NOT COMPLETED|Overall Study||0
292398|NCT01861301|698766|P1|COMPLETED|Overall Study||18
292399|NCT01861301|698766|P1|STARTED|Overall Study||18
292400|NCT01860989|698773|P1|NOT COMPLETED|Overall Study||5
292401|NCT01860989|698773|P1|COMPLETED|Overall Study||6
292402|NCT01860989|698773|P1|STARTED|Overall Study||11
292403|NCT01860846|698777|P1|NOT COMPLETED|Overall Study||33
292404|NCT01860846|698777|P1|COMPLETED|Overall Study||73
292405|NCT01860846|698777|P1|Month 12|Overall Study||73
292406|NCT01860846|698777|P1|Month 6|Overall Study||85
292407|NCT01860846|698777|P1|Month 4|Overall Study||82
292408|NCT01860846|698777|P1|Month 2|Overall Study||83
292409|NCT01860846|698777|P1|Month 1|Overall Study||97
292410|NCT01860846|698777|P1|STARTED|Overall Study||106
292411|NCT01860703|698788|P4|NOT COMPLETED|Overall Study||2
292412|NCT01860703|698789|P3|NOT COMPLETED|Overall Study||1
292413|NCT01860703|698790|P2|NOT COMPLETED|Overall Study||5
292414|NCT01860703|698791|P1|NOT COMPLETED|Overall Study||2
292415|NCT01860703|698788|P4|COMPLETED|Overall Study||10
292416|NCT01860703|698789|P3|COMPLETED|Overall Study||11
292417|NCT01860703|698790|P2|COMPLETED|Overall Study||8
292418|NCT01860703|698791|P1|COMPLETED|Overall Study||11
292419|NCT01860703|698788|P4|STARTED|Overall Study||12
292420|NCT01860703|698789|P3|STARTED|Overall Study||12
292421|NCT01860703|698790|P2|STARTED|Overall Study||13
292422|NCT01860703|698791|P1|STARTED|Overall Study||13
292423|NCT01860677|698823|P2|NOT COMPLETED|Second Intervention (1 Day)||0
292424|NCT01860677|698824|P1|NOT COMPLETED|Second Intervention (1 Day)||7
292425|NCT01860677|698823|P2|COMPLETED|Second Intervention (1 Day)||0
292426|NCT01860677|698824|P1|COMPLETED|Second Intervention (1 Day)||1
292427|NCT01860677|698823|P2|STARTED|Second Intervention (1 Day)||0
292428|NCT01860677|698824|P1|STARTED|Second Intervention (1 Day)||8
292429|NCT01860677|698823|P2|NOT COMPLETED|First Intervention (1 Day)||0
292430|NCT01860677|698824|P1|NOT COMPLETED|First Intervention (1 Day)||0
292431|NCT01860677|698823|P2|COMPLETED|First Intervention (1 Day)||0
292432|NCT01860677|698824|P1|COMPLETED|First Intervention (1 Day)||8
292433|NCT01860677|698823|P2|STARTED|First Intervention (1 Day)||0
292434|NCT01860677|698824|P1|STARTED|First Intervention (1 Day)||8
292435|NCT01860586|698833|P1|NOT COMPLETED|Overall Study||0
292436|NCT01860586|698833|P1|COMPLETED|Overall Study||20
292437|NCT01860586|698833|P1|STARTED|Overall Study||20
292438|NCT01860573|698841|P2|NOT COMPLETED|Overall Study||0
292439|NCT01860573|698842|P1|NOT COMPLETED|Overall Study||0
292440|NCT01860573|698841|P2|COMPLETED|Overall Study||85
292441|NCT01860573|698842|P1|COMPLETED|Overall Study||83
292442|NCT01860573|698841|P2|STARTED|Overall Study||85
292443|NCT01860573|698842|P1|STARTED|Overall Study||83
292444|NCT01860534|698862|P2|NOT COMPLETED|ROP #2||0
292445|NCT01860534|698863|P1|NOT COMPLETED|ROP #2||1
292446|NCT01860534|698862|P2|COMPLETED|ROP #2||13
292447|NCT01860534|698863|P1|COMPLETED|ROP #2||13
292448|NCT01860534|698862|P2|STARTED|ROP #2||13
292449|NCT01860534|698863|P1|STARTED|ROP #2||14
292450|NCT01860534|698862|P2|NOT COMPLETED|ROP #1||1
292451|NCT01860534|698863|P1|NOT COMPLETED|ROP #1||0
292452|NCT01860534|698862|P2|COMPLETED|ROP #1||13
292453|NCT01860534|698863|P1|COMPLETED|ROP #1||14
292454|NCT01860534|698862|P2|STARTED|ROP #1||14
292455|NCT01860534|698863|P1|STARTED|ROP #1||14
292456|NCT01860521|698877|P2|NOT COMPLETED|Overall Study||0
292457|NCT01860521|698878|P1|NOT COMPLETED|Overall Study||0
292458|NCT01860521|698877|P2|COMPLETED|Overall Study|June 2013|52
292459|NCT01860521|698878|P1|COMPLETED|Overall Study|June 2013|52
292460|NCT01860521|698877|P2|STARTED|Overall Study|September 2011|52
292461|NCT01860521|698878|P1|STARTED|Overall Study|September 2011|52
292462|NCT01860170|698893|P3|NOT COMPLETED|Overall Study||0
292463|NCT01860170|698894|P2|NOT COMPLETED|Overall Study||0
292464|NCT01860170|698895|P1|NOT COMPLETED|Overall Study||0
292465|NCT01860170|698893|P3|COMPLETED|Overall Study||22
292466|NCT01860170|698894|P2|COMPLETED|Overall Study||3
292467|NCT01860170|698895|P1|COMPLETED|Overall Study||3
292468|NCT01860170|698893|P3|STARTED|Overall Study||22
292469|NCT01860170|698894|P2|STARTED|Overall Study||3
292470|NCT01860170|698895|P1|STARTED|Overall Study||3
292471|NCT01860079|698911|P2|NOT COMPLETED|Overall Study||22
292472|NCT01860079|698912|P1|NOT COMPLETED|Overall Study||14
292473|NCT01860079|698911|P2|COMPLETED|Overall Study||363
292474|NCT01860079|698912|P1|COMPLETED|Overall Study||370
292475|NCT01860079|698911|P2|STARTED|Overall Study||385
292476|NCT01860079|698912|P1|STARTED|Overall Study||384
292477|NCT01859949|698920|P2|NOT COMPLETED|Overall Study||17
292478|NCT01859949|698921|P1|NOT COMPLETED|Overall Study||14
292479|NCT01859949|698920|P2|COMPLETED|Overall Study||15
292480|NCT01859949|698921|P1|COMPLETED|Overall Study||15
292481|NCT01859949|698920|P2|STARTED|Overall Study|Treated participants|32
292482|NCT01859949|698921|P1|STARTED|Overall Study|Treated participants|29
292483|NCT01859793|698939|P2|NOT COMPLETED|2nd Intervention Period||0
292484|NCT01859793|698940|P1|NOT COMPLETED|2nd Intervention Period||0
292485|NCT01859793|698939|P2|COMPLETED|2nd Intervention Period||16
292486|NCT01859793|698940|P1|COMPLETED|2nd Intervention Period||14
292487|NCT01859793|698939|P2|STARTED|2nd Intervention Period||16
292488|NCT01859793|698940|P1|STARTED|2nd Intervention Period||14
292489|NCT01859793|698939|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
292490|NCT01859793|698940|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
292491|NCT01859793|698939|P2|COMPLETED|Washout Period (4 Weeks)||16
292492|NCT01859793|698940|P1|COMPLETED|Washout Period (4 Weeks)||14
292493|NCT01859793|698939|P2|STARTED|Washout Period (4 Weeks)||17
292494|NCT01859793|698940|P1|STARTED|Washout Period (4 Weeks)||15
292495|NCT01859793|698939|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
292496|NCT01859793|698940|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
292497|NCT01859793|698939|P2|COMPLETED|First Intervention (8 Weeks)||17
292498|NCT01859793|698940|P1|COMPLETED|First Intervention (8 Weeks)||15
292499|NCT01859793|698939|P2|STARTED|First Intervention (8 Weeks)||18
292500|NCT01859793|698940|P1|STARTED|First Intervention (8 Weeks)||20
292501|NCT01859715|698953|P3|NOT COMPLETED|Overall Study||23
292502|NCT01859715|698954|P2|NOT COMPLETED|Overall Study||8
292503|NCT01859715|698955|P1|NOT COMPLETED|Overall Study||16
292504|NCT01859715|698953|P3|COMPLETED|Overall Study||93
292505|NCT01859715|698954|P2|COMPLETED|Overall Study||83
292506|NCT01859715|698955|P1|COMPLETED|Overall Study||125
292507|NCT01859715|698953|P3|STARTED|Overall Study||116
292508|NCT01859715|698954|P2|STARTED|Overall Study||91
292509|NCT01859715|698955|P1|STARTED|Overall Study||141
292510|NCT01859702|698966|P1|NOT COMPLETED|Overall Study||5
292511|NCT01859702|698966|P1|COMPLETED|Overall Study||31
292512|NCT01859702|698966|P1|STARTED|Overall Study||36
292513|NCT01859637|698970|P1|NOT COMPLETED|Overall Study||0
292514|NCT01859637|698970|P1|COMPLETED|Overall Study||6
292515|NCT01859637|698970|P1|STARTED|Overall Study||6
292516|NCT01859611|698976|P1|NOT COMPLETED|Overall Study||8
292517|NCT01859611|698976|P1|COMPLETED|Overall Study||43
292518|NCT01859611|698976|P1|STARTED|Overall Study||51
292519|NCT01859598|698980|P1|NOT COMPLETED|Visit 3 at 6 Months||912
292520|NCT01859598|698980|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
292521|NCT01859598|698980|P1|STARTED|Visit 3 at 6 Months||17253
292522|NCT01859598|698980|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
292523|NCT01859598|698980|P1|COMPLETED|Visit 2 at 3 Months||17253
292524|NCT01859598|698980|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
292525|NCT01859507|698988|P1|NOT COMPLETED|Overall Study||4
292526|NCT01859507|698988|P1|COMPLETED|Overall Study||28
292527|NCT01859507|698988|P1|STARTED|Overall Study||32
292528|NCT01859494|698993|P1|NOT COMPLETED|Overall Study||1
292529|NCT01859494|698993|P1|COMPLETED|Overall Study||218
292530|NCT01859494|698993|P1|STARTED|Overall Study||219
292531|NCT01859390|699004|P2|NOT COMPLETED|Overall Study||7
292532|NCT01859390|699005|P1|NOT COMPLETED|Overall Study||1
292533|NCT01859390|699004|P2|COMPLETED|Overall Study||30
292534|NCT01859390|699005|P1|COMPLETED|Overall Study||35
292535|NCT01859390|699004|P2|Withdrawals|Overall Study||2
292536|NCT01859390|699005|P1|Withdrawals|Overall Study||2
292537|NCT01859390|699004|P2|STARTED|Overall Study||37
292538|NCT01859390|699005|P1|STARTED|Overall Study||36
292539|NCT01859247|699035|P8|NOT COMPLETED|Overall Study||0
292540|NCT01859247|699036|P7|NOT COMPLETED|Overall Study||0
292541|NCT01859247|699037|P6|NOT COMPLETED|Overall Study||0
292542|NCT01859247|699038|P5|NOT COMPLETED|Overall Study||0
292543|NCT01859247|699039|P4|NOT COMPLETED|Overall Study||0
292544|NCT01859247|699040|P3|NOT COMPLETED|Overall Study||0
292545|NCT01859247|699041|P2|NOT COMPLETED|Overall Study||0
292546|NCT01859247|699042|P1|NOT COMPLETED|Overall Study||0
292547|NCT01859247|699035|P8|COMPLETED|Overall Study||1
292548|NCT01859247|699036|P7|COMPLETED|Overall Study||1
292549|NCT01859247|699037|P6|COMPLETED|Overall Study||1
292550|NCT01859247|699038|P5|COMPLETED|Overall Study||1
292551|NCT01859247|699039|P4|COMPLETED|Overall Study||1
292552|NCT01859247|699040|P3|COMPLETED|Overall Study||1
292553|NCT01859247|699041|P2|COMPLETED|Overall Study||1
292554|NCT01859247|699042|P1|COMPLETED|Overall Study||1
292555|NCT01859247|699035|P8|STARTED|Overall Study||1
292556|NCT01859247|699036|P7|STARTED|Overall Study||1
292557|NCT01859247|699037|P6|STARTED|Overall Study||1
292558|NCT01859247|699038|P5|STARTED|Overall Study||1
292559|NCT01859247|699039|P4|STARTED|Overall Study||1
292560|NCT01859247|699040|P3|STARTED|Overall Study||1
292561|NCT01859247|699041|P2|STARTED|Overall Study||1
292562|NCT01859247|699042|P1|STARTED|Overall Study||1
292563|NCT01859143|699069|P2|NOT COMPLETED|Overall Study||0
292564|NCT01859143|699070|P1|NOT COMPLETED|Overall Study||2
292565|NCT01859143|699069|P2|COMPLETED|Overall Study||60
292566|NCT01859143|699070|P1|COMPLETED|Overall Study||238
292567|NCT01859143|699069|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
292568|NCT01859143|699070|P1|STARTED|Overall Study||240
292569|NCT01859078|699084|P1|NOT COMPLETED|Overall Study||0
292570|NCT01859078|699084|P1|COMPLETED|Overall Study||28
292571|NCT01859078|699084|P1|STARTED|Overall Study||28
292572|NCT01858766|699117|P19|NOT COMPLETED|Overall Study||4
292573|NCT01858766|699118|P18|NOT COMPLETED|Overall Study||4
292574|NCT01858766|699119|P17|NOT COMPLETED|Overall Study||3
292575|NCT01858766|699120|P16|NOT COMPLETED|Overall Study||6
292576|NCT01858766|699121|P15|NOT COMPLETED|Overall Study||8
292577|NCT01858766|699122|P14|NOT COMPLETED|Overall Study||3
292578|NCT01858766|699123|P13|NOT COMPLETED|Overall Study||5
292579|NCT01858766|699124|P12|NOT COMPLETED|Overall Study||5
292580|NCT01858766|699125|P11|NOT COMPLETED|Overall Study||0
292581|NCT01858766|699126|P10|NOT COMPLETED|Overall Study||0
292582|NCT01858766|699127|P9|NOT COMPLETED|Overall Study||0
292583|NCT01858766|699128|P8|NOT COMPLETED|Overall Study||2
292584|NCT01858766|699129|P7|NOT COMPLETED|Overall Study||0
292585|NCT01858766|699130|P6|NOT COMPLETED|Overall Study||4
292586|NCT01858766|699131|P5|NOT COMPLETED|Overall Study||1
292587|NCT01858766|699132|P4|NOT COMPLETED|Overall Study||0
292588|NCT01858766|699133|P3|NOT COMPLETED|Overall Study||1
292589|NCT01858766|699134|P2|NOT COMPLETED|Overall Study||0
292590|NCT01858766|699135|P1|NOT COMPLETED|Overall Study||1
292591|NCT01858766|699117|P19|COMPLETED|Overall Study||22
292592|NCT01858766|699118|P18|COMPLETED|Overall Study||23
292593|NCT01858766|699119|P17|COMPLETED|Overall Study||22
292594|NCT01858766|699120|P16|COMPLETED|Overall Study||20
292595|NCT01858766|699121|P15|COMPLETED|Overall Study||23
292596|NCT01858766|699122|P14|COMPLETED|Overall Study||26
292597|NCT01858766|699123|P13|COMPLETED|Overall Study||25
292598|NCT01858766|699124|P12|COMPLETED|Overall Study||25
292599|NCT01858766|699125|P11|COMPLETED|Overall Study||5
292600|NCT01858766|699126|P10|COMPLETED|Overall Study||4
292601|NCT01858766|699127|P9|COMPLETED|Overall Study||1
292602|NCT01858766|699128|P8|COMPLETED|Overall Study||5
292603|NCT01858766|699129|P7|COMPLETED|Overall Study||7
292604|NCT01858766|699130|P6|COMPLETED|Overall Study||24
292605|NCT01858766|699131|P5|COMPLETED|Overall Study||26
292606|NCT01858766|699132|P4|COMPLETED|Overall Study||10
292607|NCT01858766|699133|P3|COMPLETED|Overall Study||10
292608|NCT01858766|699134|P2|COMPLETED|Overall Study||28
292609|NCT01858766|699135|P1|COMPLETED|Overall Study||26
292610|NCT01858766|699117|P19|STARTED|Overall Study||26
292611|NCT01858766|699118|P18|STARTED|Overall Study||27
292612|NCT01858766|699119|P17|STARTED|Overall Study||25
292613|NCT01858766|699120|P16|STARTED|Overall Study||26
292614|NCT01858766|699121|P15|STARTED|Overall Study||31
292615|NCT01858766|699122|P14|STARTED|Overall Study||29
292616|NCT01858766|699123|P13|STARTED|Overall Study||30
292617|NCT01858766|699124|P12|STARTED|Overall Study||30
292618|NCT01858766|699125|P11|STARTED|Overall Study||5
292619|NCT01858766|699126|P10|STARTED|Overall Study||4
292620|NCT01858766|699127|P9|STARTED|Overall Study||1
292621|NCT01858766|699128|P8|STARTED|Overall Study||7
292622|NCT01858766|699129|P7|STARTED|Overall Study||7
292623|NCT01858766|699130|P6|STARTED|Overall Study||28
292624|NCT01858766|699131|P5|STARTED|Overall Study||27
292625|NCT01858766|699132|P4|STARTED|Overall Study||10
292626|NCT01858766|699133|P3|STARTED|Overall Study||11
292627|NCT01858766|699134|P2|STARTED|Overall Study||28
292628|NCT01858766|699135|P1|STARTED|Overall Study||27
292629|NCT01858701|699206|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
292630|NCT01858701|699207|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
292631|NCT01858701|699206|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
292632|NCT01858701|699207|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
292633|NCT01858701|699206|P2|STARTED|Period 2, Second 30 Days of Wear||17
292634|NCT01858701|699207|P1|STARTED|Period 2, Second 30 Days of Wear||18
292635|NCT01858701|699206|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
292636|NCT01858701|699207|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
292637|NCT01858701|699206|P2|COMPLETED|Washout Period, 1-13 Days||17
292638|NCT01858701|699207|P1|COMPLETED|Washout Period, 1-13 Days||18
292639|NCT01858701|699206|P2|STARTED|Washout Period, 1-13 Days||19
292640|NCT01858701|699207|P1|STARTED|Washout Period, 1-13 Days||20
292641|NCT01858701|699206|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
292642|NCT01858701|699207|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
292643|NCT01858701|699206|P2|COMPLETED|Period 1, First 30 Days of Wear||19
292644|NCT01858701|699207|P1|COMPLETED|Period 1, First 30 Days of Wear||20
292645|NCT01858701|699206|P2|STARTED|Period 1, First 30 Days of Wear||20
292646|NCT01858701|699207|P1|STARTED|Period 1, First 30 Days of Wear||20
292647|NCT01858636|699213|P1|NOT COMPLETED|Overall Study||28
292648|NCT01858636|699213|P1|COMPLETED|Overall Study||207
292649|NCT01858636|699213|P1|Device Deployment|Overall Study||211
292650|NCT01858636|699213|P1|STARTED|Overall Study|Subjects consented|235
292651|NCT01858376|699218|P1|NOT COMPLETED|Overall Study||4
292652|NCT01858376|699218|P1|COMPLETED|Overall Study||20
292653|NCT01858376|699218|P1|STARTED|Overall Study||24
292654|NCT01857882|699226|P2|NOT COMPLETED|Overall Study||0
292655|NCT01857882|699227|P1|NOT COMPLETED|Overall Study||0
292656|NCT01857882|699226|P2|COMPLETED|Overall Study||20
292657|NCT01857882|699227|P1|COMPLETED|Overall Study||21
292658|NCT01857882|699226|P2|STARTED|Overall Study||20
292659|NCT01857882|699227|P1|STARTED|Overall Study||21
292660|NCT01857713|699233|P1|NOT COMPLETED|Overall Study||6
292661|NCT01857713|699233|P1|COMPLETED|Overall Study||89
292662|NCT01857713|699233|P1|STARTED|Overall Study||95
292663|NCT01857622|699243|P3|NOT COMPLETED|Overall Study||2
292664|NCT01857622|699244|P2|NOT COMPLETED|Overall Study||1
292665|NCT01857622|699245|P1|NOT COMPLETED|Overall Study||11
292666|NCT01857622|699243|P3|COMPLETED|Overall Study||19
292667|NCT01857622|699244|P2|COMPLETED|Overall Study||21
292668|NCT01857622|699245|P1|COMPLETED|Overall Study||39
292669|NCT01857622|699243|P3|STARTED|Overall Study||21
292670|NCT01857622|699244|P2|STARTED|Overall Study||22
292671|NCT01857622|699245|P1|STARTED|Overall Study||50
292672|NCT01857583|699257|P4|NOT COMPLETED|Overall Study||4
292673|NCT01857583|699258|P3|NOT COMPLETED|Overall Study||3
292674|NCT01857583|699259|P2|NOT COMPLETED|Overall Study||1
292675|NCT01857583|699260|P1|NOT COMPLETED|Overall Study||1
292676|NCT01857583|699257|P4|COMPLETED|Overall Study||17
292677|NCT01857583|699258|P3|COMPLETED|Overall Study||19
292678|NCT01857583|699259|P2|COMPLETED|Overall Study||6
292679|NCT01857583|699260|P1|COMPLETED|Overall Study||29
292680|NCT01857583|699257|P4|Safety Analysis Population|Overall Study||20
292681|NCT01857583|699258|P3|Safety Analysis Population|Overall Study||22
292682|NCT01857583|699259|P2|Safety Analysis Population|Overall Study||7
292683|NCT01857583|699260|P1|Safety Analysis Population|Overall Study||30
292684|NCT01857583|699257|P4|STARTED|Overall Study||21
292685|NCT01857583|699258|P3|STARTED|Overall Study||22
292686|NCT01857583|699259|P2|STARTED|Overall Study||7
292687|NCT01857583|699260|P1|STARTED|Overall Study||30
292688|NCT01857531|699270|P1|NOT COMPLETED|Overall Study||4
292689|NCT01857531|699270|P1|COMPLETED|Overall Study||12
292690|NCT01857531|699270|P1|STARTED|Overall Study||16
292691|NCT01857362|699279|P2|NOT COMPLETED|Overall Study||0
292692|NCT01857362|699280|P1|NOT COMPLETED|Overall Study||0
292693|NCT01857362|699279|P2|COMPLETED|Overall Study||6
292694|NCT01857362|699280|P1|COMPLETED|Overall Study||6
292695|NCT01857362|699279|P2|STARTED|Overall Study||6
292696|NCT01857362|699280|P1|STARTED|Overall Study||6
292697|NCT01857323|699288|P1|NOT COMPLETED|Overall Study||64
292698|NCT01857323|699288|P1|COMPLETED|Overall Study||253
292699|NCT01857323|699288|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
292700|NCT01857323|699288|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
292701|NCT01857297|699299|P2|NOT COMPLETED|Overall Study||0
292702|NCT01857297|699300|P1|NOT COMPLETED|Overall Study||0
292703|NCT01857297|699299|P2|COMPLETED|Overall Study||60
292704|NCT01857297|699300|P1|COMPLETED|Overall Study||60
292705|NCT01857297|699299|P2|STARTED|Overall Study||60
292706|NCT01857297|699300|P1|STARTED|Overall Study||60
292707|NCT01857258|699314|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
292708|NCT01857258|699315|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
292709|NCT01857258|699314|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
292710|NCT01857258|699315|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
292711|NCT01857258|699314|P2|STARTED|Second Intervention (3 h Postprandially)||7
292712|NCT01857258|699315|P1|STARTED|Second Intervention (3 h Postprandially)||8
292713|NCT01857258|699314|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
292714|NCT01857258|699315|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
292715|NCT01857258|699314|P2|COMPLETED|Wash-out Period (7 Days)||7
292716|NCT01857258|699315|P1|COMPLETED|Wash-out Period (7 Days)||8
292717|NCT01857258|699314|P2|STARTED|Wash-out Period (7 Days)||7
292718|NCT01857258|699315|P1|STARTED|Wash-out Period (7 Days)||8
292719|NCT01857258|699314|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
292720|NCT01857258|699315|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
292721|NCT01857258|699314|P2|COMPLETED|First Intervention (3 h Postprandially)||7
292722|NCT01857258|699315|P1|COMPLETED|First Intervention (3 h Postprandially)||8
292723|NCT01857258|699314|P2|STARTED|First Intervention (3 h Postprandially)||7
292724|NCT01857258|699315|P1|STARTED|First Intervention (3 h Postprandially)||8
292725|NCT01857206|699337|P2|NOT COMPLETED|Overall Study||10
292726|NCT01857206|699338|P1|NOT COMPLETED|Overall Study||13
292727|NCT01857206|699337|P2|COMPLETED|Overall Study||673
292728|NCT01857206|699338|P1|COMPLETED|Overall Study||1359
292729|NCT01857206|699337|P2|STARTED|Overall Study||683
292730|NCT01857206|699338|P1|STARTED|Overall Study||1372
292731|NCT01857102|699356|P2|NOT COMPLETED|Period 2||0
292732|NCT01857102|699357|P1|NOT COMPLETED|Period 2||2
292733|NCT01857102|699356|P2|COMPLETED|Period 2||51
292734|NCT01857102|699357|P1|COMPLETED|Period 2||53
292735|NCT01857102|699356|P2|Neophytes|Period 2||4
292736|NCT01857102|699357|P1|Neophytes|Period 2||7
292737|NCT01857102|699356|P2|Habitual Users|Period 2||47
292738|NCT01857102|699357|P1|Habitual Users|Period 2||48
292739|NCT01857102|699356|P2|STARTED|Period 2||51
292740|NCT01857102|699357|P1|STARTED|Period 2||55
292741|NCT01857102|699356|P2|NOT COMPLETED|Period 1||5
292742|NCT01857102|699357|P1|NOT COMPLETED|Period 1||3
292743|NCT01857102|699356|P2|COMPLETED|Period 1||51
292744|NCT01857102|699357|P1|COMPLETED|Period 1||55
292745|NCT01857102|699356|P2|Neophtyes|Period 1||4
292746|NCT01857102|699357|P1|Neophtyes|Period 1||7
292747|NCT01857102|699356|P2|Habitual Users|Period 1||52
292748|NCT01857102|699357|P1|Habitual Users|Period 1||51
292749|NCT01857102|699356|P2|STARTED|Period 1||56
292750|NCT01857102|699357|P1|STARTED|Period 1||58
292751|NCT01857063|699367|P2|NOT COMPLETED|Period 2 (7 Days)||2
292752|NCT01857063|699368|P1|NOT COMPLETED|Period 2 (7 Days)||4
292753|NCT01857063|699367|P2|COMPLETED|Period 2 (7 Days)||104
292754|NCT01857063|699368|P1|COMPLETED|Period 2 (7 Days)||104
292755|NCT01857063|699367|P2|STARTED|Period 2 (7 Days)||106
292756|NCT01857063|699368|P1|STARTED|Period 2 (7 Days)||108
292757|NCT01857063|699367|P2|NOT COMPLETED|Period 1 (7 Days)||4
292758|NCT01857063|699368|P1|NOT COMPLETED|Period 1 (7 Days)||2
292759|NCT01857063|699367|P2|COMPLETED|Period 1 (7 Days)||106
292760|NCT01857063|699368|P1|COMPLETED|Period 1 (7 Days)||108
292761|NCT01857063|699367|P2|STARTED|Period 1 (7 Days)||110
292762|NCT01857063|699368|P1|STARTED|Period 1 (7 Days)||110
292763|NCT01856933|699394|P1|NOT COMPLETED|Overall Study||0
292764|NCT01856933|699394|P1|COMPLETED|Overall Study||6
292765|NCT01856933|699394|P1|STARTED|Overall Study||6
292766|NCT01856764|699400|P2|NOT COMPLETED|Overall Study||0
292767|NCT01856764|699401|P1|NOT COMPLETED|Overall Study||0
292768|NCT01856764|699400|P2|COMPLETED|Overall Study||20
292769|NCT01856764|699401|P1|COMPLETED|Overall Study||20
292770|NCT01856764|699400|P2|STARTED|Overall Study||20
292771|NCT01856764|699401|P1|STARTED|Overall Study||20
292772|NCT01856686|699413|P2|NOT COMPLETED|Overall Study||11
292773|NCT01856686|699414|P1|NOT COMPLETED|Overall Study||5
292774|NCT01856686|699413|P2|COMPLETED|Overall Study||22
292775|NCT01856686|699414|P1|COMPLETED|Overall Study||26
292776|NCT01856686|699413|P2|STARTED|Overall Study||33
292777|NCT01856686|699414|P1|STARTED|Overall Study||31
292778|NCT01856673|699457|P3|NOT COMPLETED|Overall Study||34
292779|NCT01856673|699458|P2|NOT COMPLETED|Overall Study||85
292780|NCT01856673|699459|P1|NOT COMPLETED|Overall Study||98
292781|NCT01856673|699457|P3|COMPLETED|Overall Study||137
292782|NCT01856673|699458|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
292783|NCT01856673|699459|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
292784|NCT01856673|699457|P3|Quibdó Participants|Overall Study||83
292785|NCT01856673|699458|P2|Quibdó Participants|Overall Study||86
292786|NCT01856673|699459|P1|Quibdó Participants|Overall Study||83
292787|NCT01856673|699457|P3|Buenaventura Participants|Overall Study||88
292788|NCT01856673|699458|P2|Buenaventura Participants|Overall Study||89
292789|NCT01856673|699459|P1|Buenaventura Participants|Overall Study||92
292790|NCT01856673|699457|P3|STARTED|Overall Study||171
292791|NCT01856673|699458|P2|STARTED|Overall Study||175
292792|NCT01856673|699459|P1|STARTED|Overall Study||175
292793|NCT01856569|699470|P1|NOT COMPLETED|Overall Study||13
292794|NCT01856569|699470|P1|COMPLETED|Overall Study||139
292795|NCT01856569|699470|P1|Full Analysis Set|Overall Study||144
292796|NCT01856569|699470|P1|STARTED|Overall Study||152
292797|NCT01856530|699481|P2|NOT COMPLETED|Overall Study||0
292798|NCT01856530|699482|P1|NOT COMPLETED|Overall Study||0
292799|NCT01856530|699481|P2|COMPLETED|Overall Study||27
292800|NCT01856530|699482|P1|COMPLETED|Overall Study||27
292801|NCT01856530|699481|P2|STARTED|Overall Study||27
292802|NCT01856530|699482|P1|STARTED|Overall Study||27
292803|NCT01856361|699500|P2|NOT COMPLETED|Overall Study||0
292804|NCT01856361|699501|P1|NOT COMPLETED|Overall Study||0
292805|NCT01856361|699500|P2|COMPLETED|Overall Study||1
292806|NCT01856361|699501|P1|COMPLETED|Overall Study||1
292807|NCT01856361|699500|P2|STARTED|Overall Study||1
292808|NCT01856361|699501|P1|STARTED|Overall Study||1
292809|NCT01856322|699518|P3|NOT COMPLETED|Overall Study||3
292810|NCT01856322|699519|P2|NOT COMPLETED|Overall Study||0
292811|NCT01856322|699520|P1|NOT COMPLETED|Overall Study||0
292812|NCT01856322|699518|P3|COMPLETED|Overall Study||0
292813|NCT01856322|699519|P2|COMPLETED|Overall Study||0
292814|NCT01856322|699520|P1|COMPLETED|Overall Study||0
292815|NCT01856322|699518|P3|STARTED|Overall Study||3
292816|NCT01856322|699519|P2|STARTED|Overall Study||0
292817|NCT01856322|699520|P1|STARTED|Overall Study||0
292818|NCT01855997|699527|P1|NOT COMPLETED|Overall Study||0
292819|NCT01855997|699527|P1|COMPLETED|Overall Study||1669
292820|NCT01855997|699527|P1|STARTED|Overall Study||1669
292821|NCT01855958|699582|P2|NOT COMPLETED|Overall Study||0
292822|NCT01855958|699583|P1|NOT COMPLETED|Overall Study||1
292823|NCT01855958|699582|P2|COMPLETED|Overall Study||13
292824|NCT01855958|699583|P1|COMPLETED|Overall Study||12
292825|NCT01855958|699582|P2|STARTED|Overall Study||13
292826|NCT01855958|699583|P1|STARTED|Overall Study||13
292827|NCT01855945|699613|P12|NOT COMPLETED|Overall Study||3
292828|NCT01855945|699614|P11|NOT COMPLETED|Overall Study||5
292829|NCT01855945|699615|P10|NOT COMPLETED|Overall Study||2
292830|NCT01855945|699616|P9|NOT COMPLETED|Overall Study||2
292831|NCT01855945|699617|P8|NOT COMPLETED|Overall Study||8
292832|NCT01855945|699618|P7|NOT COMPLETED|Overall Study||10
292833|NCT01855945|699619|P6|NOT COMPLETED|Overall Study||3
292834|NCT01855945|699620|P5|NOT COMPLETED|Overall Study||1
292835|NCT01855945|699621|P4|NOT COMPLETED|Overall Study||4
292836|NCT01855945|699622|P3|NOT COMPLETED|Overall Study||12
292837|NCT01855945|699623|P2|NOT COMPLETED|Overall Study||11
292838|NCT01855945|699624|P1|NOT COMPLETED|Overall Study||16
292839|NCT01855945|699613|P12|COMPLETED|Overall Study||49
292840|NCT01855945|699614|P11|COMPLETED|Overall Study||46
292841|NCT01855945|699615|P10|COMPLETED|Overall Study||49
292842|NCT01855945|699616|P9|COMPLETED|Overall Study||46
292843|NCT01855945|699617|P8|COMPLETED|Overall Study||47
292844|NCT01855945|699618|P7|COMPLETED|Overall Study||43
292845|NCT01855945|699619|P6|COMPLETED|Overall Study||50
292846|NCT01855945|699620|P5|COMPLETED|Overall Study||50
292847|NCT01855945|699621|P4|COMPLETED|Overall Study||49
292848|NCT01855945|699622|P3|COMPLETED|Overall Study||39
292849|NCT01855945|699623|P2|COMPLETED|Overall Study||44
292850|NCT01855945|699624|P1|COMPLETED|Overall Study||38
292851|NCT01855945|699613|P12|STARTED|Overall Study||52
292852|NCT01855945|699614|P11|STARTED|Overall Study||51
292853|NCT01855945|699615|P10|STARTED|Overall Study||51
292854|NCT01855945|699616|P9|STARTED|Overall Study||48
292855|NCT01855945|699617|P8|STARTED|Overall Study||55
292856|NCT01855945|699618|P7|STARTED|Overall Study||53
292857|NCT01855945|699619|P6|STARTED|Overall Study||53
292858|NCT01855945|699620|P5|STARTED|Overall Study||51
292859|NCT01855945|699621|P4|STARTED|Overall Study||53
292860|NCT01855945|699622|P3|STARTED|Overall Study||51
292861|NCT01855945|699623|P2|STARTED|Overall Study||55
292862|NCT01855945|699624|P1|STARTED|Overall Study||54
292863|NCT01855919|699760|P2|NOT COMPLETED|Overall Study||26
292864|NCT01855919|699761|P1|NOT COMPLETED|Overall Study||23
292865|NCT01855919|699760|P2|COMPLETED|Overall Study||200
292866|NCT01855919|699761|P1|COMPLETED|Overall Study||209
292867|NCT01855919|699760|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
292868|NCT01855919|699761|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
292869|NCT01855919|699760|P2|STARTED|Overall Study||226
292870|NCT01855919|699761|P1|STARTED|Overall Study||232
292871|NCT01855074|699793|P1|NOT COMPLETED|Overall Study||14
292872|NCT01855074|699793|P1|COMPLETED|Overall Study||66
292873|NCT01855074|699793|P1|Treated|Overall Study||79
292874|NCT01855074|699793|P1|STARTED|Overall Study||80
292875|NCT01854944|699805|P3|NOT COMPLETED|Overall Study||1
292876|NCT01854944|699806|P2|NOT COMPLETED|Overall Study||0
292877|NCT01854944|699807|P1|NOT COMPLETED|Overall Study||0
292878|NCT01854944|699805|P3|COMPLETED|Overall Study||3
292879|NCT01854944|699806|P2|COMPLETED|Overall Study||4
292880|NCT01854944|699807|P1|COMPLETED|Overall Study||4
292881|NCT01854944|699805|P3|STARTED|Overall Study||4
292882|NCT01854944|699806|P2|STARTED|Overall Study||4
292883|NCT01854944|699807|P1|STARTED|Overall Study||4
292884|NCT01854905|699857|P1|NOT COMPLETED|Overall Study||0
292885|NCT01854905|699857|P1|COMPLETED|Overall Study||400
292886|NCT01854905|699857|P1|STARTED|Overall Study||400
292887|NCT01854697|699866|P5|NOT COMPLETED|Overall Study||2
292888|NCT01854697|699867|P4|NOT COMPLETED|Overall Study||3
292889|NCT01854697|699868|P3|NOT COMPLETED|Overall Study||2
292890|NCT01854697|699869|P2|NOT COMPLETED|Overall Study||3
292891|NCT01854697|699870|P1|NOT COMPLETED|Overall Study||6
292892|NCT01854697|699866|P5|COMPLETED|Overall Study||39
292893|NCT01854697|699867|P4|COMPLETED|Overall Study||80
292894|NCT01854697|699868|P3|COMPLETED|Overall Study||82
292895|NCT01854697|699869|P2|COMPLETED|Overall Study||31
292896|NCT01854697|699870|P1|COMPLETED|Overall Study||63
292897|NCT01854697|699866|P5|STARTED|Overall Study||41
292898|NCT01854697|699867|P4|STARTED|Overall Study||83
292899|NCT01854697|699868|P3|STARTED|Overall Study||84
292900|NCT01854697|699869|P2|STARTED|Overall Study||34
292901|NCT01854697|699870|P1|STARTED|Overall Study||69
292902|NCT01854658|699914|P4|NOT COMPLETED|Overall Study||59
292903|NCT01854658|699915|P3|NOT COMPLETED|Overall Study||80
292904|NCT01854658|699916|P2|NOT COMPLETED|Overall Study||75
292905|NCT01854658|699917|P1|NOT COMPLETED|Overall Study||93
292906|NCT01854658|699914|P4|COMPLETED|Overall Study||165
292907|NCT01854658|699915|P3|COMPLETED|Overall Study||432
292908|NCT01854658|699916|P2|COMPLETED|Overall Study||365
292909|NCT01854658|699917|P1|COMPLETED|Overall Study||346
292910|NCT01854658|699914|P4|STARTED|Overall Study||224
292911|NCT01854658|699915|P3|STARTED|Overall Study||512
292912|NCT01854658|699916|P2|STARTED|Overall Study||440
292913|NCT01854658|699917|P1|STARTED|Overall Study||439
292914|NCT01854645|699952|P5|NOT COMPLETED|Overall Study||60
292915|NCT01854645|699953|P4|NOT COMPLETED|Overall Study||62
292916|NCT01854645|699954|P3|NOT COMPLETED|Overall Study||82
292917|NCT01854645|699955|P2|NOT COMPLETED|Overall Study||106
292918|NCT01854645|699956|P1|NOT COMPLETED|Overall Study||98
292919|NCT01854645|699952|P5|COMPLETED|Overall Study||160
292920|NCT01854645|699953|P4|COMPLETED|Overall Study||391
292921|NCT01854645|699954|P3|COMPLETED|Overall Study||370
292922|NCT01854645|699955|P2|COMPLETED|Overall Study||345
292923|NCT01854645|699956|P1|COMPLETED|Overall Study||429
292924|NCT01854645|699952|P5|STARTED|Overall Study||220
292925|NCT01854645|699953|P4|STARTED|Overall Study||453
292926|NCT01854645|699954|P3|STARTED|Overall Study||452
292927|NCT01854645|699955|P2|STARTED|Overall Study||451
292928|NCT01854645|699956|P1|STARTED|Overall Study||527
292929|NCT01854632|699995|P2|NOT COMPLETED|Overall Study||13
292930|NCT01854632|699996|P1|NOT COMPLETED|Overall Study||26
292931|NCT01854632|699995|P2|COMPLETED|Overall Study||574
292932|NCT01854632|699996|P1|COMPLETED|Overall Study||1148
292933|NCT01854632|699995|P2|STARTED|Overall Study||587
292934|NCT01854632|699996|P1|STARTED|Overall Study||1174
292935|NCT01854593|700004|P2|NOT COMPLETED|Overall Study||1
292936|NCT01854593|700005|P1|NOT COMPLETED|Overall Study||2
292937|NCT01854593|700004|P2|COMPLETED|Overall Study||34
292938|NCT01854593|700005|P1|COMPLETED|Overall Study||32
292939|NCT01854593|700004|P2|STARTED|Overall Study||35
292940|NCT01854593|700005|P1|STARTED|Overall Study||34
292941|NCT01854528|700037|P2|NOT COMPLETED|Overall Study||15
292942|NCT01854528|700038|P1|NOT COMPLETED|Overall Study||0
292943|NCT01854528|700037|P2|COMPLETED|Overall Study||32
292944|NCT01854528|700038|P1|COMPLETED|Overall Study||101
292945|NCT01854528|700037|P2|STARTED|Overall Study||47
292946|NCT01854528|700038|P1|STARTED|Overall Study||101
292947|NCT01854281|700058|P4|NOT COMPLETED|Overall Study||0
292948|NCT01854281|700059|P3|NOT COMPLETED|Overall Study||0
292949|NCT01854281|700060|P2|NOT COMPLETED|Overall Study||0
292950|NCT01854281|700061|P1|NOT COMPLETED|Overall Study||0
292951|NCT01854281|700058|P4|COMPLETED|Overall Study||8
292952|NCT01854281|700059|P3|COMPLETED|Overall Study||5
292953|NCT01854281|700060|P2|COMPLETED|Overall Study||19
292954|NCT01854281|700061|P1|COMPLETED|Overall Study||15
292955|NCT01854281|700058|P4|STARTED|Overall Study||8
292956|NCT01854281|700059|P3|STARTED|Overall Study||5
292957|NCT01854281|700060|P2|STARTED|Overall Study||19
292958|NCT01854281|700061|P1|STARTED|Overall Study||15
292959|NCT01854268|700071|P1|NOT COMPLETED|Overall Study||0
292960|NCT01854268|700071|P1|COMPLETED|Overall Study||25
292961|NCT01854268|700071|P1|STARTED|Overall Study||25
292962|NCT01854242|700077|P1|NOT COMPLETED|Overall Study||0
292963|NCT01854242|700077|P1|COMPLETED|Overall Study||50
292964|NCT01854242|700077|P1|STARTED|Overall Study||50
292965|NCT01854047|700086|P5|NOT COMPLETED|Overall Study||19
292966|NCT01854047|700087|P4|NOT COMPLETED|Overall Study||15
292967|NCT01854047|700088|P3|NOT COMPLETED|Overall Study||13
292968|NCT01854047|700089|P2|NOT COMPLETED|Overall Study||8
292969|NCT01854047|700090|P1|NOT COMPLETED|Overall Study||12
292970|NCT01854047|700086|P5|COMPLETED|Overall Study||135
292971|NCT01854047|700087|P4|COMPLETED|Overall Study||142
292972|NCT01854047|700088|P3|COMPLETED|Overall Study||137
292973|NCT01854047|700089|P2|COMPLETED|Overall Study||149
292974|NCT01854047|700090|P1|COMPLETED|Overall Study||146
292975|NCT01854047|700086|P5|Completed 12-week Study Treatment|Overall Study||143
292976|NCT01854047|700087|P4|Completed 12-week Study Treatment|Overall Study||146
292977|NCT01854047|700088|P3|Completed 12-week Study Treatment|Overall Study||141
292978|NCT01854047|700089|P2|Completed 12-week Study Treatment|Overall Study||149
292979|NCT01854047|700090|P1|Completed 12-week Study Treatment|Overall Study||153
292980|NCT01854047|700086|P5|Treated|Overall Study||150
292981|NCT01854047|700087|P4|Treated|Overall Study||157
292982|NCT01854047|700088|P3|Treated|Overall Study||148
292983|NCT01854047|700089|P2|Treated|Overall Study||156
292984|NCT01854047|700090|P1|Treated|Overall Study||158
292985|NCT01854047|700086|P5|STARTED|Overall Study||154
292986|NCT01854047|700087|P4|STARTED|Overall Study||157
292987|NCT01854047|700088|P3|STARTED|Overall Study||150
292988|NCT01854047|700089|P2|STARTED|Overall Study||157
292989|NCT01854047|700090|P1|STARTED|Overall Study||158
292990|NCT01853982|700214|P2|NOT COMPLETED|Overall Study||1
292991|NCT01853982|700215|P1|NOT COMPLETED|Overall Study||2
292992|NCT01853982|700214|P2|COMPLETED|Overall Study||1
292993|NCT01853982|700215|P1|COMPLETED|Overall Study||0
292994|NCT01853982|700214|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
292995|NCT01853982|700215|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
292996|NCT01853982|700214|P2|STARTED|Overall Study||2
292997|NCT01853982|700215|P1|STARTED|Overall Study||2
292998|NCT01853839|700221|P1|NOT COMPLETED|Overall Study||429
292999|NCT01853839|700221|P1|COMPLETED|Overall Study||1663
293000|NCT01853839|700221|P1|STARTED|Overall Study||2092
293001|NCT01853696|700243|P2|NOT COMPLETED|Overall Study||5
293002|NCT01853696|700244|P1|NOT COMPLETED|Overall Study||6
293003|NCT01853696|700243|P2|COMPLETED|Overall Study||78
293004|NCT01853696|700244|P1|COMPLETED|Overall Study||78
293005|NCT01853696|700243|P2|STARTED|Overall Study||83
293006|NCT01853696|700244|P1|STARTED|Overall Study||84
293007|NCT01853605|700256|P4|NOT COMPLETED|Overall Study||0
293008|NCT01853605|700257|P3|NOT COMPLETED|Overall Study||0
293009|NCT01853605|700258|P2|NOT COMPLETED|Overall Study||0
293010|NCT01853605|700259|P1|NOT COMPLETED|Overall Study||0
293011|NCT01853605|700256|P4|COMPLETED|Overall Study||428
293012|NCT01853605|700257|P3|COMPLETED|Overall Study||751
293013|NCT01853605|700258|P2|COMPLETED|Overall Study||693
293014|NCT01853605|700259|P1|COMPLETED|Overall Study||1939
293015|NCT01853605|700256|P4|STARTED|Overall Study||428
293016|NCT01853605|700257|P3|STARTED|Overall Study||751
293017|NCT01853605|700258|P2|STARTED|Overall Study||693
293018|NCT01853605|700259|P1|STARTED|Overall Study||1939
293019|NCT01853475|700280|P3|NOT COMPLETED|Overall Study||0
293020|NCT01853475|700281|P2|NOT COMPLETED|Overall Study||1
293021|NCT01853475|700282|P1|NOT COMPLETED|Overall Study||0
293022|NCT01853475|700280|P3|COMPLETED|Overall Study||8
293023|NCT01853475|700281|P2|COMPLETED|Overall Study||7
293024|NCT01853475|700282|P1|COMPLETED|Overall Study||8
293025|NCT01853475|700280|P3|STARTED|Overall Study||8
293026|NCT01853475|700281|P2|STARTED|Overall Study||8
293027|NCT01853475|700282|P1|STARTED|Overall Study||8
293028|NCT01853397|700303|P4|NOT COMPLETED|Overall Study||2
293029|NCT01853397|700304|P3|NOT COMPLETED|Overall Study||0
293030|NCT01853397|700305|P2|NOT COMPLETED|Overall Study||0
293031|NCT01853397|700306|P1|NOT COMPLETED|Overall Study||0
293032|NCT01853397|700303|P4|COMPLETED|Overall Study||15
293033|NCT01853397|700304|P3|COMPLETED|Overall Study||17
293034|NCT01853397|700305|P2|COMPLETED|Overall Study||20
293035|NCT01853397|700306|P1|COMPLETED|Overall Study||18
293036|NCT01853397|700303|P4|STARTED|Overall Study||17
293037|NCT01853397|700304|P3|STARTED|Overall Study||17
293038|NCT01853397|700305|P2|STARTED|Overall Study||20
293039|NCT01853397|700306|P1|STARTED|Overall Study||18
293040|NCT01853384|700334|P2|NOT COMPLETED|Completed Follow up Visit 2||3
293041|NCT01853384|700335|P1|NOT COMPLETED|Completed Follow up Visit 2||3
293042|NCT01853384|700334|P2|COMPLETED|Completed Follow up Visit 2||91
293043|NCT01853384|700335|P1|COMPLETED|Completed Follow up Visit 2||93
293044|NCT01853384|700334|P2|STARTED|Completed Follow up Visit 2||94
293045|NCT01853384|700335|P1|STARTED|Completed Follow up Visit 2||96
293046|NCT01853384|700334|P2|NOT COMPLETED|Completed Follow up Visit 1||9
293047|NCT01853384|700335|P1|NOT COMPLETED|Completed Follow up Visit 1||14
293048|NCT01853384|700334|P2|COMPLETED|Completed Follow up Visit 1||85
293049|NCT01853384|700335|P1|COMPLETED|Completed Follow up Visit 1||82
293050|NCT01853384|700334|P2|STARTED|Completed Follow up Visit 1||94
293051|NCT01853384|700335|P1|STARTED|Completed Follow up Visit 1||96
293052|NCT01853384|700334|P2|NOT COMPLETED|Enrolled in Follow up Period||0
293053|NCT01853384|700335|P1|NOT COMPLETED|Enrolled in Follow up Period||0
293054|NCT01853384|700334|P2|COMPLETED|Enrolled in Follow up Period||94
293055|NCT01853384|700335|P1|COMPLETED|Enrolled in Follow up Period||96
293056|NCT01853384|700334|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
293057|NCT01853384|700335|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
293058|NCT01853384|700334|P2|STARTED|Enrolled in Follow up Period||94
293059|NCT01853384|700335|P1|STARTED|Enrolled in Follow up Period||96
293060|NCT01853384|700334|P2|NOT COMPLETED|Randomized||46
293061|NCT01853384|700335|P1|NOT COMPLETED|Randomized||62
293062|NCT01853384|700334|P2|COMPLETED|Randomized||75
293063|NCT01853384|700335|P1|COMPLETED|Randomized||69
293064|NCT01853384|700334|P2|STARTED|Randomized||121
293065|NCT01853384|700335|P1|STARTED|Randomized||131
293066|NCT01853371|700355|P2|NOT COMPLETED|Overall Study||2
293067|NCT01853371|700356|P1|NOT COMPLETED|Overall Study||0
293068|NCT01853371|700355|P2|COMPLETED|Overall Study||8
293069|NCT01853371|700356|P1|COMPLETED|Overall Study||10
293070|NCT01853371|700355|P2|STARTED|Overall Study||10
293071|NCT01853371|700356|P1|STARTED|Overall Study||10
293072|NCT01853254|700364|P1|NOT COMPLETED|Overall Study||104
293073|NCT01853254|700364|P1|COMPLETED|Overall Study||168
293074|NCT01853254|700364|P1|STARTED|Overall Study||272
293075|NCT01853215|700368|P1|NOT COMPLETED|Overall Study||0
293076|NCT01853215|700368|P1|COMPLETED|Overall Study||24
293077|NCT01853215|700368|P1|STARTED|Overall Study||24
293078|NCT01853176|700381|P2|NOT COMPLETED|Overall Study||0
293079|NCT01853176|700382|P1|NOT COMPLETED|Overall Study||4
293080|NCT01853176|700381|P2|COMPLETED|Overall Study||0
293081|NCT01853176|700382|P1|COMPLETED|Overall Study||0
293082|NCT01853176|700381|P2|STARTED|Overall Study||0
293083|NCT01853176|700382|P1|STARTED|Overall Study||4
293084|NCT01853085|700388|P1|NOT COMPLETED|Overall Study||235
293085|NCT01853085|700388|P1|COMPLETED|Overall Study||1595
293086|NCT01853085|700388|P1|STARTED|Overall Study||1830
293087|NCT01853072|700401|P2|NOT COMPLETED|Overall Study||21
293088|NCT01853072|700402|P1|NOT COMPLETED|Overall Study||12
293089|NCT01853072|700401|P2|COMPLETED|Overall Study||286
293090|NCT01853072|700402|P1|COMPLETED|Overall Study||296
293091|NCT01853072|700401|P2|Full Analysis Set|Overall Study||300
293092|NCT01853072|700402|P1|Full Analysis Set|Overall Study||298
293093|NCT01853072|700401|P2|Treated (Safety Analysis Set)|Overall Study||302
293094|NCT01853072|700402|P1|Treated (Safety Analysis Set)|Overall Study||301
293095|NCT01853072|700401|P2|Randomized|Overall Study||307
293096|NCT01853072|700402|P1|Randomized|Overall Study||308
293097|NCT01853072|700401|P2|STARTED|Overall Study||307
293098|NCT01853072|700402|P1|STARTED|Overall Study||308
293099|NCT01853046|700422|P2|NOT COMPLETED|Overall Study||6
293100|NCT01853046|700423|P1|NOT COMPLETED|Overall Study||18
293101|NCT01853046|700422|P2|COMPLETED|Overall Study||0
293102|NCT01853046|700423|P1|COMPLETED|Overall Study||0
293103|NCT01853046|700422|P2|Received Treatment|Overall Study||6
293104|NCT01853046|700423|P1|Received Treatment|Overall Study||18
293105|NCT01853046|700422|P2|STARTED|Overall Study||6
293106|NCT01853046|700423|P1|STARTED|Overall Study||18
293107|NCT01852955|700477|P2|NOT COMPLETED|Overall Study||3
293108|NCT01852955|700478|P1|NOT COMPLETED|Overall Study||2
293109|NCT01852955|700477|P2|COMPLETED|Overall Study||32
293110|NCT01852955|700478|P1|COMPLETED|Overall Study||33
293111|NCT01852955|700477|P2|STARTED|Overall Study||35
293112|NCT01852955|700478|P1|STARTED|Overall Study||35
293113|NCT01852825|700491|P3|NOT COMPLETED|Overall Study||0
293114|NCT01852825|700492|P2|NOT COMPLETED|Overall Study||0
293115|NCT01852825|700493|P1|NOT COMPLETED|Overall Study||2
293116|NCT01852825|700491|P3|COMPLETED|Overall Study||3
293117|NCT01852825|700492|P2|COMPLETED|Overall Study||7
293118|NCT01852825|700493|P1|COMPLETED|Overall Study||14
293119|NCT01852825|700491|P3|STARTED|Overall Study||3
293120|NCT01852825|700492|P2|STARTED|Overall Study||7
293121|NCT01852825|700493|P1|STARTED|Overall Study||16
293122|NCT01852812|700519|P3|NOT COMPLETED|Overall Study||1
293123|NCT01852812|700520|P2|NOT COMPLETED|Overall Study||1
293124|NCT01852812|700521|P1|NOT COMPLETED|Overall Study||0
293125|NCT01852812|700519|P3|COMPLETED|Overall Study||17
293126|NCT01852812|700520|P2|COMPLETED|Overall Study||17
293127|NCT01852812|700521|P1|COMPLETED|Overall Study||51
293128|NCT01852812|700519|P3|STARTED|Overall Study||18
293129|NCT01852812|700520|P2|STARTED|Overall Study||18
293130|NCT01852812|700521|P1|STARTED|Overall Study||51
293131|NCT01852669|700543|P2|NOT COMPLETED|Overall Study||1
293132|NCT01852669|700544|P1|NOT COMPLETED|Overall Study||0
293133|NCT01852669|700543|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
293134|NCT01852669|700544|P1|COMPLETED|Overall Study||71
293135|NCT01852669|700543|P2|STARTED|Overall Study||69
293136|NCT01852669|700544|P1|STARTED|Overall Study||71
293137|NCT01852591|700550|P1|NOT COMPLETED|Overall Study||3
293138|NCT01852591|700550|P1|COMPLETED|Overall Study||5
293139|NCT01852591|700550|P1|STARTED|Overall Study||8
293140|NCT01852383|700557|P1|NOT COMPLETED|Overall Study||11
293141|NCT01852383|700557|P1|COMPLETED|Overall Study||19
293142|NCT01852383|700557|P1|STARTED|Overall Study||30
293143|NCT01852214|700564|P2|NOT COMPLETED|Period 2||0
293144|NCT01852214|700565|P1|NOT COMPLETED|Period 2||0
293145|NCT01852214|700564|P2|COMPLETED|Period 2||20
293146|NCT01852214|700565|P1|COMPLETED|Period 2||25
293147|NCT01852214|700564|P2|STARTED|Period 2||20
293148|NCT01852214|700565|P1|STARTED|Period 2||25
293149|NCT01852214|700564|P2|NOT COMPLETED|Washout Period||1
293150|NCT01852214|700565|P1|NOT COMPLETED|Washout Period||0
293151|NCT01852214|700564|P2|COMPLETED|Washout Period||20
293152|NCT01852214|700565|P1|COMPLETED|Washout Period||25
293153|NCT01852214|700564|P2|STARTED|Washout Period||21
293154|NCT01852214|700565|P1|STARTED|Washout Period||25
293155|NCT01852214|700564|P2|NOT COMPLETED|Period 1||3
293156|NCT01852214|700565|P1|NOT COMPLETED|Period 1||1
293157|NCT01852214|700564|P2|COMPLETED|Period 1||21
293158|NCT01852214|700565|P1|COMPLETED|Period 1||25
293159|NCT01852214|700564|P2|STARTED|Period 1||24
293160|NCT01852214|700565|P1|STARTED|Period 1||26
293161|NCT01852175|700579|P2|NOT COMPLETED|Overall Study||0
293162|NCT01852175|700580|P1|NOT COMPLETED|Overall Study||0
293163|NCT01852175|700579|P2|COMPLETED|Overall Study||55
293164|NCT01852175|700580|P1|COMPLETED|Overall Study||55
293165|NCT01852175|700579|P2|STARTED|Overall Study||55
293166|NCT01852175|700580|P1|STARTED|Overall Study||55
293167|NCT01852162|700592|P2|NOT COMPLETED|Overall Study||1
293168|NCT01852162|700593|P1|NOT COMPLETED|Overall Study||4
293169|NCT01852162|700592|P2|COMPLETED|Overall Study||16
293170|NCT01852162|700593|P1|COMPLETED|Overall Study||14
293171|NCT01852162|700592|P2|STARTED|Overall Study||17
293172|NCT01852162|700593|P1|STARTED|Overall Study||18
293173|NCT01852019|700609|P5|NOT COMPLETED|Day 8||0
293174|NCT01852019|700610|P4|NOT COMPLETED|Day 8||0
293175|NCT01852019|700611|P3|NOT COMPLETED|Day 8||0
293176|NCT01852019|700612|P2|NOT COMPLETED|Day 8||0
293177|NCT01852019|700613|P1|NOT COMPLETED|Day 8||0
293178|NCT01852019|700609|P5|COMPLETED|Day 8||6
293179|NCT01852019|700610|P4|COMPLETED|Day 8||6
293180|NCT01852019|700611|P3|COMPLETED|Day 8||0
293181|NCT01852019|700612|P2|COMPLETED|Day 8||0
293182|NCT01852019|700613|P1|COMPLETED|Day 8||0
293183|NCT01852019|700609|P5|STARTED|Day 8||6
293184|NCT01852019|700610|P4|STARTED|Day 8||6
293185|NCT01852019|700611|P3|STARTED|Day 8||0
293186|NCT01852019|700612|P2|STARTED|Day 8||0
293187|NCT01852019|700613|P1|STARTED|Day 8||0
293188|NCT01852019|700609|P5|NOT COMPLETED|Day 1||0
293189|NCT01852019|700610|P4|NOT COMPLETED|Day 1||0
293190|NCT01852019|700611|P3|NOT COMPLETED|Day 1||0
293191|NCT01852019|700612|P2|NOT COMPLETED|Day 1||0
293192|NCT01852019|700613|P1|NOT COMPLETED|Day 1||0
293193|NCT01852019|700609|P5|COMPLETED|Day 1||0
293194|NCT01852019|700610|P4|COMPLETED|Day 1||0
293195|NCT01852019|700611|P3|COMPLETED|Day 1||6
293196|NCT01852019|700612|P2|COMPLETED|Day 1||3
293197|NCT01852019|700613|P1|COMPLETED|Day 1||3
293198|NCT01852019|700609|P5|STARTED|Day 1||0
293199|NCT01852019|700610|P4|STARTED|Day 1||0
293200|NCT01852019|700611|P3|STARTED|Day 1||6
293201|NCT01852019|700612|P2|STARTED|Day 1||3
293202|NCT01852019|700613|P1|STARTED|Day 1||3
293203|NCT01851876|700634|P2|NOT COMPLETED|Overall Study||0
293204|NCT01851876|700635|P1|NOT COMPLETED|Overall Study||0
293205|NCT01851876|700634|P2|COMPLETED|Overall Study||62
293206|NCT01851876|700635|P1|COMPLETED|Overall Study||56
293207|NCT01851876|700634|P2|STARTED|Overall Study||62
293208|NCT01851876|700635|P1|STARTED|Overall Study||56
293209|NCT01851863|700645|P4|NOT COMPLETED|Overall Study||3
293210|NCT01851863|700646|P3|NOT COMPLETED|Overall Study||5
293211|NCT01851863|700647|P2|NOT COMPLETED|Overall Study||9
293212|NCT01851863|700648|P1|NOT COMPLETED|Overall Study||5
293213|NCT01851863|700645|P4|COMPLETED|Overall Study||63
293214|NCT01851863|700646|P3|COMPLETED|Overall Study||60
293215|NCT01851863|700647|P2|COMPLETED|Overall Study||57
293216|NCT01851863|700648|P1|COMPLETED|Overall Study||60
293217|NCT01851863|700645|P4|STARTED|Overall Study||66
293218|NCT01851863|700646|P3|STARTED|Overall Study||65
293219|NCT01851863|700647|P2|STARTED|Overall Study||66
293220|NCT01851863|700648|P1|STARTED|Overall Study||65
293221|NCT01851772|700669|P1|NOT COMPLETED|Overall Study||0
293222|NCT01851772|700669|P1|COMPLETED|Overall Study||3
293223|NCT01851772|700669|P1|STARTED|Overall Study||3
293224|NCT01851655|700677|P2|NOT COMPLETED|Overall Study||0
293225|NCT01851655|700678|P1|NOT COMPLETED|Overall Study||0
293226|NCT01851655|700677|P2|COMPLETED|Overall Study||12
293227|NCT01851655|700678|P1|COMPLETED|Overall Study||12
293228|NCT01851655|700677|P2|STARTED|Overall Study||12
293229|NCT01851655|700678|P1|STARTED|Overall Study||12
293230|NCT01851590|700699|P3|NOT COMPLETED|Overall Study||3
293231|NCT01851590|700700|P2|NOT COMPLETED|Overall Study||1
293232|NCT01851590|700701|P1|NOT COMPLETED|Overall Study||0
293233|NCT01851590|700699|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
293234|NCT01851590|700700|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
293235|NCT01851590|700701|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
293236|NCT01851590|700699|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
293237|NCT01851590|700700|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
293238|NCT01851590|700701|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
293321|NCT01849770|700907|P1|STARTED|Overall Study||20
293239|NCT01851590|700699|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
293240|NCT01851590|700700|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
293241|NCT01851590|700701|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
293242|NCT01851590|700699|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
293243|NCT01851590|700700|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
293244|NCT01851590|700701|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
293245|NCT01851590|700699|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
293246|NCT01851590|700700|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
293247|NCT01851590|700701|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
293248|NCT01851590|700699|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
293249|NCT01851590|700700|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
293250|NCT01851590|700701|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
293251|NCT01851330|700724|P3|NOT COMPLETED|Overall Study||12
293252|NCT01851330|700725|P2|NOT COMPLETED|Overall Study||16
293253|NCT01851330|700726|P1|NOT COMPLETED|Overall Study||13
293254|NCT01851330|700724|P3|COMPLETED|Overall Study||204
293255|NCT01851330|700725|P2|COMPLETED|Overall Study||200
293256|NCT01851330|700726|P1|COMPLETED|Overall Study||202
293257|NCT01851330|700724|P3|STARTED|Overall Study||216
293258|NCT01851330|700725|P2|STARTED|Overall Study||216
293259|NCT01851330|700726|P1|STARTED|Overall Study||215
293260|NCT01849588|700761|P1|NOT COMPLETED|Overall Study||3
293261|NCT01849588|700761|P1|COMPLETED|Overall Study||0
293262|NCT01849588|700761|P1|STARTED|Overall Study||3
293263|NCT01849562|700771|P3|NOT COMPLETED|Overall Study||0
293264|NCT01849562|700772|P2|NOT COMPLETED|Overall Study||0
293265|NCT01849562|700773|P1|NOT COMPLETED|Overall Study||2
293266|NCT01849562|700771|P3|COMPLETED|Overall Study||10
293267|NCT01849562|700772|P2|COMPLETED|Overall Study||10
293268|NCT01849562|700773|P1|COMPLETED|Overall Study||8
293269|NCT01849562|700771|P3|STARTED|Overall Study||10
293270|NCT01849562|700772|P2|STARTED|Overall Study||10
293271|NCT01849562|700773|P1|STARTED|Overall Study||10
293272|NCT01849497|700786|P2|NOT COMPLETED|Overall Study||4
293273|NCT01849497|700787|P1|NOT COMPLETED|Overall Study||1
293274|NCT01849497|700786|P2|COMPLETED|Overall Study||70
293275|NCT01849497|700787|P1|COMPLETED|Overall Study||74
293276|NCT01849497|700786|P2|Received Treatment|Overall Study||74
293277|NCT01849497|700787|P1|Received Treatment|Overall Study||75
293278|NCT01849497|700786|P2|STARTED|Overall Study||74
293279|NCT01849497|700787|P1|STARTED|Overall Study||75
293280|NCT01849419|700795|P1|NOT COMPLETED|Overall Study||0
293281|NCT01849419|700795|P1|COMPLETED|Overall Study||65
293282|NCT01849419|700795|P1|STARTED|Overall Study||65
293283|NCT01850589|700824|P2|NOT COMPLETED|Overall Study||0
293284|NCT01850589|700825|P1|NOT COMPLETED|Overall Study||8
293285|NCT01850589|700824|P2|COMPLETED|Overall Study||22
293286|NCT01850589|700825|P1|COMPLETED|Overall Study||14
293287|NCT01850589|700824|P2|STARTED|Overall Study||22
293288|NCT01850589|700825|P1|STARTED|Overall Study||22
293289|NCT01850550|700833|P2|NOT COMPLETED|Overall Study||3
293290|NCT01850550|700834|P1|NOT COMPLETED|Overall Study||0
293291|NCT01850550|700833|P2|COMPLETED|Overall Study||37
293292|NCT01850550|700834|P1|COMPLETED|Overall Study||40
293293|NCT01850550|700833|P2|STARTED|Overall Study||40
293294|NCT01850550|700834|P1|STARTED|Overall Study||40
293295|NCT01850485|700844|P2|NOT COMPLETED|Overall Study||0
293296|NCT01850485|700845|P1|NOT COMPLETED|Overall Study||0
293297|NCT01850485|700844|P2|COMPLETED|Overall Study||13
293298|NCT01850485|700845|P1|COMPLETED|Overall Study||9
293299|NCT01850485|700844|P2|STARTED|Overall Study||13
293300|NCT01850485|700845|P1|STARTED|Overall Study||9
293301|NCT01850394|700866|P3|NOT COMPLETED|Overall Study||0
293302|NCT01850394|700867|P2|NOT COMPLETED|Overall Study||0
293303|NCT01850394|700868|P1|NOT COMPLETED|Overall Study||0
293304|NCT01850394|700866|P3|COMPLETED|Overall Study||45
293305|NCT01850394|700867|P2|COMPLETED|Overall Study||45
293306|NCT01850394|700868|P1|COMPLETED|Overall Study||45
293307|NCT01850394|700866|P3|STARTED|Overall Study||45
293308|NCT01850394|700867|P2|STARTED|Overall Study||45
293309|NCT01850394|700868|P1|STARTED|Overall Study||45
293310|NCT01849848|700888|P1|NOT COMPLETED|Overall Study||4
293311|NCT01849848|700888|P1|COMPLETED|Overall Study||13
293312|NCT01849848|700888|P1|STARTED|Overall Study||17
293313|NCT01849770|700905|P3|NOT COMPLETED|Overall Study||1
293314|NCT01849770|700906|P2|NOT COMPLETED|Overall Study||4
293315|NCT01849770|700907|P1|NOT COMPLETED|Overall Study||0
293316|NCT01849770|700905|P3|COMPLETED|Overall Study||19
293317|NCT01849770|700906|P2|COMPLETED|Overall Study||15
293318|NCT01849770|700907|P1|COMPLETED|Overall Study||20
293319|NCT01849770|700905|P3|STARTED|Overall Study||20
293320|NCT01849770|700906|P2|STARTED|Overall Study||19
293322|NCT01849692|700950|P8|NOT COMPLETED|Overall Study||0
293323|NCT01849692|700951|P7|NOT COMPLETED|Overall Study||0
293324|NCT01849692|700952|P6|NOT COMPLETED|Overall Study||0
293325|NCT01849692|700953|P5|NOT COMPLETED|Overall Study||0
293326|NCT01849692|700954|P4|NOT COMPLETED|Overall Study||0
293327|NCT01849692|700955|P3|NOT COMPLETED|Overall Study||0
293328|NCT01849692|700956|P2|NOT COMPLETED|Overall Study||0
293329|NCT01849692|700957|P1|NOT COMPLETED|Overall Study||0
293330|NCT01849692|700950|P8|COMPLETED|Overall Study||3
293331|NCT01849692|700951|P7|COMPLETED|Overall Study||10
293332|NCT01849692|700952|P6|COMPLETED|Overall Study||3
293333|NCT01849692|700953|P5|COMPLETED|Overall Study||10
293334|NCT01849692|700954|P4|COMPLETED|Overall Study||3
293335|NCT01849692|700955|P3|COMPLETED|Overall Study||10
293336|NCT01849692|700956|P2|COMPLETED|Overall Study||3
293337|NCT01849692|700957|P1|COMPLETED|Overall Study||10
293338|NCT01849692|700950|P8|STARTED|Overall Study||3
293339|NCT01849692|700951|P7|STARTED|Overall Study||10
293340|NCT01849692|700952|P6|STARTED|Overall Study||3
293341|NCT01849692|700953|P5|STARTED|Overall Study||10
293342|NCT01849692|700954|P4|STARTED|Overall Study||3
293343|NCT01849692|700955|P3|STARTED|Overall Study||10
293344|NCT01849692|700956|P2|STARTED|Overall Study||3
293345|NCT01849692|700957|P1|STARTED|Overall Study||10
293346|NCT01849289|700988|P2|NOT COMPLETED|Overall Study||24
293347|NCT01849289|700989|P1|NOT COMPLETED|Overall Study||32
293348|NCT01849289|700988|P2|COMPLETED|Overall Study||254
293349|NCT01849289|700989|P1|COMPLETED|Overall Study||523
293350|NCT01849289|700988|P2|Exposed|Overall Study||278
293351|NCT01849289|700989|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
293352|NCT01849289|700988|P2|STARTED|Overall Study||278
293353|NCT01849289|700989|P1|STARTED|Overall Study||555
293354|NCT01849068|701007|P2|NOT COMPLETED|Overall Study||0
293355|NCT01849068|701008|P1|NOT COMPLETED|Overall Study||0
293356|NCT01849068|701007|P2|COMPLETED|Overall Study||10
293357|NCT01849068|701008|P1|COMPLETED|Overall Study||10
293358|NCT01849068|701007|P2|STARTED|Overall Study||10
293359|NCT01849068|701008|P1|STARTED|Overall Study||10
293360|NCT01848990|701023|P3|NOT COMPLETED|Overall Study||11
293361|NCT01848990|701024|P2|NOT COMPLETED|Overall Study||9
293362|NCT01848990|701025|P1|NOT COMPLETED|Overall Study||33
293363|NCT01848990|701023|P3|COMPLETED|Overall Study||103
293364|NCT01848990|701024|P2|COMPLETED|Overall Study||106
293365|NCT01848990|701025|P1|COMPLETED|Overall Study||194
293366|NCT01848990|701023|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
293367|NCT01848990|701024|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
293368|NCT01848990|701025|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
293369|NCT01848990|701023|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
293370|NCT01848990|701024|P2|STARTED|Overall Study||115
293371|NCT01848990|701025|P1|STARTED|Overall Study||227
293372|NCT01848977|701040|P1|NOT COMPLETED|Overall Study||0
293373|NCT01848977|701040|P1|COMPLETED|Overall Study||20
293374|NCT01848977|701040|P1|STARTED|Overall Study||20
293375|NCT01848938|701051|P2|NOT COMPLETED|Overall Study||1
293376|NCT01848938|701052|P1|NOT COMPLETED|Overall Study||1
293377|NCT01848938|701051|P2|COMPLETED|Overall Study||60
293378|NCT01848938|701052|P1|COMPLETED|Overall Study||61
293379|NCT01848938|701051|P2|STARTED|Overall Study||61
293380|NCT01848938|701052|P1|STARTED|Overall Study||62
293381|NCT01848899|701070|P2|NOT COMPLETED|Overall Study||0
293382|NCT01848899|701071|P1|NOT COMPLETED|Overall Study||0
293383|NCT01848899|701070|P2|COMPLETED|Overall Study||50
293384|NCT01848899|701071|P1|COMPLETED|Overall Study||50
293385|NCT01848899|701070|P2|STARTED|Overall Study||50
293386|NCT01848899|701071|P1|STARTED|Overall Study||50
293387|NCT01848847|701087|P2|NOT COMPLETED|Overall Study||3
293388|NCT01848847|701088|P1|NOT COMPLETED|Overall Study||2
293389|NCT01848847|701087|P2|COMPLETED|Overall Study||48
293390|NCT01848847|701088|P1|COMPLETED|Overall Study||49
293391|NCT01848847|701087|P2|STARTED|Overall Study||51
293392|NCT01848847|701088|P1|STARTED|Overall Study||51
293393|NCT01848756|701096|P1|NOT COMPLETED|Overall Study||3
293394|NCT01848756|701096|P1|COMPLETED|Overall Study|Cycle 1|12
293395|NCT01848756|701096|P1|STARTED|Overall Study||15
293396|NCT01848366|701106|P1|NOT COMPLETED|Overall Study||0
293397|NCT01848366|701106|P1|COMPLETED|Overall Study||8
293398|NCT01848366|701106|P1|STARTED|Overall Study||8
293399|NCT01848288|701110|P1|NOT COMPLETED|Overall Study||3
293400|NCT01848288|701110|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
293401|NCT01848288|701110|P1|STARTED|Overall Study||100
293402|NCT01848210|701121|P2|NOT COMPLETED|Overall Study||78
293403|NCT01848210|701122|P1|NOT COMPLETED|Overall Study||88
293404|NCT01848210|701121|P2|COMPLETED|Overall Study||340
293405|NCT01848210|701122|P1|COMPLETED|Overall Study||323
293406|NCT01848210|701121|P2|Per Protocol Population|Overall Study||245
293407|NCT01848210|701122|P1|Per Protocol Population|Overall Study||222
293408|NCT01848210|701121|P2|Intent-to-Treat (ITT) Population|Overall Study||388
293409|NCT01848210|701122|P1|Intent-to-Treat (ITT) Population|Overall Study||383
293410|NCT01848210|701121|P2|Safety Population-Received Study Drug|Overall Study||398
293411|NCT01848210|701122|P1|Safety Population-Received Study Drug|Overall Study||394
293412|NCT01848210|701121|P2|STARTED|Overall Study||418
293413|NCT01848210|701122|P1|STARTED|Overall Study||411
293414|NCT01848145|701134|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
293415|NCT01848145|701134|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
293416|NCT01848145|701134|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
293417|NCT01848145|701134|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
293418|NCT01848145|701134|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
293419|NCT01848145|701134|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
293420|NCT01848145|701134|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
293421|NCT01848145|701134|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
293422|NCT01848145|701134|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
293423|NCT01848145|701134|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
293424|NCT01848145|701134|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
293425|NCT01848145|701134|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
293426|NCT01848145|701134|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
293427|NCT01848145|701134|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
293428|NCT01848145|701134|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
293429|NCT01848054|701145|P2|NOT COMPLETED|Stabilization/Maintenance||40
293430|NCT01848054|701146|P1|NOT COMPLETED|Stabilization/Maintenance||40
293431|NCT01848054|701145|P2|COMPLETED|Stabilization/Maintenance||107
293432|NCT01848054|701146|P1|COMPLETED|Stabilization/Maintenance||92
293433|NCT01848054|701145|P2|STARTED|Stabilization/Maintenance||147
293434|NCT01848054|701146|P1|STARTED|Stabilization/Maintenance||132
293435|NCT01848054|701145|P2|NOT COMPLETED|Induction Phase||8
293436|NCT01848054|701146|P1|NOT COMPLETED|Induction Phase||23
293437|NCT01848054|701145|P2|COMPLETED|Induction Phase||147
293438|NCT01848054|701146|P1|COMPLETED|Induction Phase||132
293439|NCT01848054|701145|P2|STARTED|Induction Phase||155
293440|NCT01848054|701146|P1|STARTED|Induction Phase||155
293441|NCT01847547|701168|P2|NOT COMPLETED|Overall Study||0
293442|NCT01847547|701169|P1|NOT COMPLETED|Overall Study||0
293443|NCT01847547|701168|P2|COMPLETED|Overall Study||2991
293444|NCT01847547|701169|P1|COMPLETED|Overall Study||2991
293445|NCT01847547|701168|P2|STARTED|Overall Study||2991
293446|NCT01847547|701169|P1|STARTED|Overall Study||2991
293447|NCT01847443|701211|P4|NOT COMPLETED|Study Period 4||0
293448|NCT01847443|701212|P3|NOT COMPLETED|Study Period 4||0
293449|NCT01847443|701213|P2|NOT COMPLETED|Study Period 4||0
293450|NCT01847443|701214|P1|NOT COMPLETED|Study Period 4||0
293451|NCT01847443|701211|P4|COMPLETED|Study Period 4||21
293452|NCT01847443|701212|P3|COMPLETED|Study Period 4||21
293453|NCT01847443|701213|P2|COMPLETED|Study Period 4||19
293454|NCT01847443|701214|P1|COMPLETED|Study Period 4||16
293455|NCT01847443|701211|P4|STARTED|Study Period 4||21
293456|NCT01847443|701212|P3|STARTED|Study Period 4||21
293457|NCT01847443|701213|P2|STARTED|Study Period 4||19
293458|NCT01847443|701214|P1|STARTED|Study Period 4||16
293459|NCT01847443|701211|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
293460|NCT01847443|701212|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
293461|NCT01847443|701213|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
293462|NCT01847443|701214|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
293463|NCT01847443|701211|P4|COMPLETED|Washout Period Before Study Period 4||21
293464|NCT01847443|701212|P3|COMPLETED|Washout Period Before Study Period 4||21
293465|NCT01847443|701213|P2|COMPLETED|Washout Period Before Study Period 4||19
293466|NCT01847443|701214|P1|COMPLETED|Washout Period Before Study Period 4||16
293467|NCT01847443|701211|P4|STARTED|Washout Period Before Study Period 4||21
293468|NCT01847443|701212|P3|STARTED|Washout Period Before Study Period 4||21
293469|NCT01847443|701213|P2|STARTED|Washout Period Before Study Period 4||19
293470|NCT01847443|701214|P1|STARTED|Washout Period Before Study Period 4||18
293471|NCT01847443|701211|P4|NOT COMPLETED|Study Period 3||0
293472|NCT01847443|701212|P3|NOT COMPLETED|Study Period 3||0
293473|NCT01847443|701213|P2|NOT COMPLETED|Study Period 3||0
293474|NCT01847443|701214|P1|NOT COMPLETED|Study Period 3||0
293475|NCT01847443|701211|P4|COMPLETED|Study Period 3||21
293476|NCT01847443|701212|P3|COMPLETED|Study Period 3||21
293477|NCT01847443|701213|P2|COMPLETED|Study Period 3||19
293478|NCT01847443|701214|P1|COMPLETED|Study Period 3||18
293479|NCT01847443|701211|P4|STARTED|Study Period 3||21
293480|NCT01847443|701212|P3|STARTED|Study Period 3||21
293481|NCT01847443|701213|P2|STARTED|Study Period 3||19
293482|NCT01847443|701214|P1|STARTED|Study Period 3||18
293483|NCT01847443|701211|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
293484|NCT01847443|701212|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
293485|NCT01847443|701213|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
293486|NCT01847443|701214|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
293487|NCT01847443|701211|P4|COMPLETED|Washout Period Before Study Period 3||21
293488|NCT01847443|701212|P3|COMPLETED|Washout Period Before Study Period 3||21
293489|NCT01847443|701213|P2|COMPLETED|Washout Period Before Study Period 3||19
293490|NCT01847443|701214|P1|COMPLETED|Washout Period Before Study Period 3||18
293491|NCT01847443|701211|P4|STARTED|Washout Period Before Study Period 3||21
293492|NCT01847443|701212|P3|STARTED|Washout Period Before Study Period 3||21
293493|NCT01847443|701213|P2|STARTED|Washout Period Before Study Period 3||19
293494|NCT01847443|701214|P1|STARTED|Washout Period Before Study Period 3||19
293495|NCT01847443|701211|P4|NOT COMPLETED|Study Period 2||0
293496|NCT01847443|701212|P3|NOT COMPLETED|Study Period 2||0
293497|NCT01847443|701213|P2|NOT COMPLETED|Study Period 2||0
293498|NCT01847443|701214|P1|NOT COMPLETED|Study Period 2||0
293499|NCT01847443|701211|P4|COMPLETED|Study Period 2||21
293500|NCT01847443|701212|P3|COMPLETED|Study Period 2||21
293501|NCT01847443|701213|P2|COMPLETED|Study Period 2||19
293502|NCT01847443|701214|P1|COMPLETED|Study Period 2||19
293503|NCT01847443|701211|P4|STARTED|Study Period 2||21
293504|NCT01847443|701212|P3|STARTED|Study Period 2||21
293505|NCT01847443|701213|P2|STARTED|Study Period 2||19
293506|NCT01847443|701214|P1|STARTED|Study Period 2||19
293507|NCT01847443|701211|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
293508|NCT01847443|701212|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
293509|NCT01847443|701213|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
293510|NCT01847443|701214|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
293511|NCT01847443|701211|P4|COMPLETED|Washout Period Before Study Period 2||21
293512|NCT01847443|701212|P3|COMPLETED|Washout Period Before Study Period 2||21
293513|NCT01847443|701213|P2|COMPLETED|Washout Period Before Study Period 2||19
293514|NCT01847443|701214|P1|COMPLETED|Washout Period Before Study Period 2||19
293515|NCT01847443|701211|P4|STARTED|Washout Period Before Study Period 2||21
293516|NCT01847443|701212|P3|STARTED|Washout Period Before Study Period 2||21
293517|NCT01847443|701213|P2|STARTED|Washout Period Before Study Period 2||20
293518|NCT01847443|701214|P1|STARTED|Washout Period Before Study Period 2||21
293519|NCT01847443|701211|P4|NOT COMPLETED|Study Period 1||0
293520|NCT01847443|701212|P3|NOT COMPLETED|Study Period 1||0
293521|NCT01847443|701213|P2|NOT COMPLETED|Study Period 1||1
293522|NCT01847443|701214|P1|NOT COMPLETED|Study Period 1||0
293523|NCT01847443|701211|P4|COMPLETED|Study Period 1||21
293524|NCT01847443|701212|P3|COMPLETED|Study Period 1||21
293525|NCT01847443|701213|P2|COMPLETED|Study Period 1||20
293526|NCT01847443|701214|P1|COMPLETED|Study Period 1||21
293527|NCT01847443|701211|P4|STARTED|Study Period 1||21
293528|NCT01847443|701212|P3|STARTED|Study Period 1||21
293529|NCT01847443|701213|P2|STARTED|Study Period 1||21
293530|NCT01847443|701214|P1|STARTED|Study Period 1||21
293531|NCT01847430|701244|P1|NOT COMPLETED|Overall Study||0
293532|NCT01847430|701244|P1|COMPLETED|Overall Study||302
293533|NCT01847430|701244|P1|STARTED|Overall Study||302
293534|NCT01847196|701255|P1|NOT COMPLETED|Overall Study||0
293535|NCT01847196|701255|P1|COMPLETED|Overall Study||5
293536|NCT01847196|701255|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
293537|NCT01847131|701262|P2|NOT COMPLETED|Overall Study||0
293538|NCT01847131|701263|P1|NOT COMPLETED|Overall Study||0
293539|NCT01847131|701262|P2|COMPLETED|Overall Study||25
293540|NCT01847131|701263|P1|COMPLETED|Overall Study||25
293541|NCT01847131|701262|P2|STARTED|Overall Study||25
293542|NCT01847131|701263|P1|STARTED|Overall Study||25
293543|NCT01846741|701271|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
293544|NCT01846741|701271|P1|COMPLETED|Implantation to 18-Month/End of Study||20
293545|NCT01846741|701271|P1|STARTED|Implantation to 18-Month/End of Study||20
293546|NCT01846741|701271|P1|NOT COMPLETED|Baseline Visit||2
293547|NCT01846741|701271|P1|COMPLETED|Baseline Visit||20
293548|NCT01846741|701271|P1|STARTED|Baseline Visit||22
293549|NCT01846455|701332|P5|NOT COMPLETED|Overall Study||0
293550|NCT01846455|701333|P4|NOT COMPLETED|Overall Study||0
293551|NCT01846455|701334|P3|NOT COMPLETED|Overall Study||0
293552|NCT01846455|701335|P2|NOT COMPLETED|Overall Study||0
293553|NCT01846455|701336|P1|NOT COMPLETED|Overall Study||0
293554|NCT01846455|701332|P5|COMPLETED|Overall Study||8
293555|NCT01846455|701333|P4|COMPLETED|Overall Study||10
293556|NCT01846455|701334|P3|COMPLETED|Overall Study||8
293557|NCT01846455|701335|P2|COMPLETED|Overall Study||8
293558|NCT01846455|701336|P1|COMPLETED|Overall Study||9
293559|NCT01846455|701332|P5|PK Population|Overall Study||8
293560|NCT01846455|701333|P4|PK Population|Overall Study||6
293561|NCT01846455|701334|P3|PK Population|Overall Study||6
293562|NCT01846455|701335|P2|PK Population|Overall Study||7
293563|NCT01846455|701336|P1|PK Population|Overall Study||6
293564|NCT01846455|701332|P5|STARTED|Overall Study||8
293565|NCT01846455|701333|P4|STARTED|Overall Study||10
293566|NCT01846455|701334|P3|STARTED|Overall Study||8
293567|NCT01846455|701335|P2|STARTED|Overall Study||8
293568|NCT01846455|701336|P1|STARTED|Overall Study||9
293569|NCT01846442|701397|P4|NOT COMPLETED|Overall Study||3
293570|NCT01846442|701398|P3|NOT COMPLETED|Overall Study||4
293571|NCT01846442|701399|P2|NOT COMPLETED|Overall Study||6
293572|NCT01846442|701400|P1|NOT COMPLETED|Overall Study||6
293573|NCT01846442|701397|P4|COMPLETED|Overall Study||51
293574|NCT01846442|701398|P3|COMPLETED|Overall Study||52
293575|NCT01846442|701399|P2|COMPLETED|Overall Study||48
293576|NCT01846442|701400|P1|COMPLETED|Overall Study||48
293577|NCT01846442|701397|P4|ITT Population|Overall Study||54
293578|NCT01846442|701398|P3|ITT Population|Overall Study||56
293579|NCT01846442|701399|P2|ITT Population|Overall Study||53
293580|NCT01846442|701400|P1|ITT Population|Overall Study||53
293581|NCT01846442|701397|P4|Safety Population|Overall Study||54
293582|NCT01846442|701398|P3|Safety Population|Overall Study||56
293583|NCT01846442|701399|P2|Safety Population|Overall Study||53
293584|NCT01846442|701400|P1|Safety Population|Overall Study||54
293585|NCT01846442|701397|P4|STARTED|Overall Study||54
293586|NCT01846442|701398|P3|STARTED|Overall Study||56
293587|NCT01846442|701399|P2|STARTED|Overall Study||54
293588|NCT01846442|701400|P1|STARTED|Overall Study||54
293589|NCT01846416|701441|P3|NOT COMPLETED|Overall Study||13
293590|NCT01846416|701442|P2|NOT COMPLETED|Overall Study||93
293591|NCT01846416|701443|P1|NOT COMPLETED|Overall Study||31
293592|NCT01846416|701441|P3|COMPLETED|Overall Study||0
293593|NCT01846416|701442|P2|COMPLETED|Overall Study||0
293594|NCT01846416|701443|P1|COMPLETED|Overall Study||0
293595|NCT01846416|701441|P3|STARTED|Overall Study||13
293596|NCT01846416|701442|P2|STARTED|Overall Study||93
293597|NCT01846416|701443|P1|STARTED|Overall Study||31
293598|NCT01846299|701488|P2|NOT COMPLETED|Overall Study||10
293599|NCT01846299|701489|P1|NOT COMPLETED|Overall Study||12
293600|NCT01846299|701488|P2|COMPLETED|Overall Study||50
293601|NCT01846299|701489|P1|COMPLETED|Overall Study||106
293602|NCT01846299|701488|P2|Safety Set|Overall Study||58
293603|NCT01846299|701489|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
293604|NCT01846299|701488|P2|Full Analysis Set|Overall Study||60
293605|NCT01846299|701489|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
293606|NCT01846299|701488|P2|STARTED|Overall Study||60
293607|NCT01846299|701489|P1|STARTED|Overall Study||118
293608|NCT01846104|701525|P1|NOT COMPLETED|Overall Study||1
293609|NCT01846104|701525|P1|COMPLETED|Overall Study||3
293610|NCT01846104|701525|P1|STARTED|Overall Study||4
293611|NCT01846039|701531|P1|NOT COMPLETED|Overall Study||2
293612|NCT01846039|701531|P1|COMPLETED|Overall Study||27
293613|NCT01846039|701531|P1|STARTED|Overall Study||29
293614|NCT01845831|701543|P5|NOT COMPLETED|Outpatient Phase||0
293615|NCT01845831|701544|P4|NOT COMPLETED|Outpatient Phase||0
293616|NCT01845831|701545|P3|NOT COMPLETED|Outpatient Phase||0
293617|NCT01845831|701546|P2|NOT COMPLETED|Outpatient Phase||0
293618|NCT01845831|701547|P1|NOT COMPLETED|Outpatient Phase||0
293619|NCT01845831|701543|P5|COMPLETED|Outpatient Phase||87
293620|NCT01845831|701544|P4|COMPLETED|Outpatient Phase||98
293621|NCT01845831|701545|P3|COMPLETED|Outpatient Phase||68
293622|NCT01845831|701546|P2|COMPLETED|Outpatient Phase||0
293623|NCT01845831|701547|P1|COMPLETED|Outpatient Phase||0
293624|NCT01845831|701543|P5|STARTED|Outpatient Phase||87
293625|NCT01845831|701544|P4|STARTED|Outpatient Phase||98
293626|NCT01845831|701545|P3|STARTED|Outpatient Phase||68
293627|NCT01845831|701546|P2|STARTED|Outpatient Phase||0
293628|NCT01845831|701547|P1|STARTED|Outpatient Phase||0
293629|NCT01845831|701543|P5|NOT COMPLETED|Inpatient Phase||0
293630|NCT01845831|701544|P4|NOT COMPLETED|Inpatient Phase||0
293631|NCT01845831|701545|P3|NOT COMPLETED|Inpatient Phase||0
293632|NCT01845831|701546|P2|NOT COMPLETED|Inpatient Phase||1
293633|NCT01845831|701547|P1|NOT COMPLETED|Inpatient Phase||1
293634|NCT01845831|701543|P5|COMPLETED|Inpatient Phase||0
293635|NCT01845831|701544|P4|COMPLETED|Inpatient Phase||0
293636|NCT01845831|701545|P3|COMPLETED|Inpatient Phase||0
293637|NCT01845831|701546|P2|COMPLETED|Inpatient Phase||138
293638|NCT01845831|701547|P1|COMPLETED|Inpatient Phase||139
293639|NCT01845831|701543|P5|STARTED|Inpatient Phase||0
293640|NCT01845831|701544|P4|STARTED|Inpatient Phase||0
293641|NCT01845831|701545|P3|STARTED|Inpatient Phase||0
293642|NCT01845831|701546|P2|STARTED|Inpatient Phase||139
293643|NCT01845831|701547|P1|STARTED|Inpatient Phase||140
293644|NCT01845155|701576|P2|NOT COMPLETED|Overall Study||0
293645|NCT01845155|701577|P1|NOT COMPLETED|Overall Study||1
293646|NCT01845155|701576|P2|COMPLETED|Overall Study||144
293647|NCT01845155|701577|P1|COMPLETED|Overall Study||145
293648|NCT01845155|701576|P2|STARTED|Overall Study||144
293649|NCT01845155|701577|P1|STARTED|Overall Study||146
293650|NCT01845103|701585|P1|NOT COMPLETED|Overall Study||0
293651|NCT01845103|701585|P1|COMPLETED|Overall Study||1
293652|NCT01845103|701585|P1|STARTED|Overall Study||1
293653|NCT01845077|701593|P6|NOT COMPLETED|Treatment Period 2||0
293654|NCT01845077|701594|P5|NOT COMPLETED|Treatment Period 2||0
293655|NCT01845077|701595|P4|NOT COMPLETED|Treatment Period 2||0
293656|NCT01845077|701596|P3|NOT COMPLETED|Treatment Period 2||0
293657|NCT01845077|701597|P2|NOT COMPLETED|Treatment Period 2||0
293658|NCT01845077|701598|P1|NOT COMPLETED|Treatment Period 2||0
293659|NCT01845077|701593|P6|COMPLETED|Treatment Period 2||11
293660|NCT01845077|701594|P5|COMPLETED|Treatment Period 2||11
293661|NCT01845077|701595|P4|COMPLETED|Treatment Period 2||10
293662|NCT01845077|701596|P3|COMPLETED|Treatment Period 2||11
293663|NCT01845077|701597|P2|COMPLETED|Treatment Period 2||11
293664|NCT01845077|701598|P1|COMPLETED|Treatment Period 2||11
293665|NCT01845077|701593|P6|STARTED|Treatment Period 2||11
293666|NCT01845077|701594|P5|STARTED|Treatment Period 2||11
293667|NCT01845077|701595|P4|STARTED|Treatment Period 2||10
293668|NCT01845077|701596|P3|STARTED|Treatment Period 2||11
293669|NCT01845077|701597|P2|STARTED|Treatment Period 2||11
293670|NCT01845077|701598|P1|STARTED|Treatment Period 2||11
293671|NCT01845077|701593|P6|NOT COMPLETED|Washout Period||1
293672|NCT01845077|701594|P5|NOT COMPLETED|Washout Period||1
293673|NCT01845077|701595|P4|NOT COMPLETED|Washout Period||2
293674|NCT01845077|701596|P3|NOT COMPLETED|Washout Period||1
293675|NCT01845077|701597|P2|NOT COMPLETED|Washout Period||1
293676|NCT01845077|701598|P1|NOT COMPLETED|Washout Period||1
293677|NCT01845077|701593|P6|COMPLETED|Washout Period||11
293678|NCT01845077|701594|P5|COMPLETED|Washout Period||11
293679|NCT01845077|701595|P4|COMPLETED|Washout Period||10
293680|NCT01845077|701596|P3|COMPLETED|Washout Period||11
293681|NCT01845077|701597|P2|COMPLETED|Washout Period||11
293682|NCT01845077|701598|P1|COMPLETED|Washout Period||11
293683|NCT01845077|701593|P6|STARTED|Washout Period||12
293684|NCT01845077|701594|P5|STARTED|Washout Period||12
293685|NCT01845077|701595|P4|STARTED|Washout Period||12
293686|NCT01845077|701596|P3|STARTED|Washout Period||12
293687|NCT01845077|701597|P2|STARTED|Washout Period||12
293688|NCT01845077|701598|P1|STARTED|Washout Period||12
293689|NCT01845077|701593|P6|NOT COMPLETED|Treatment Period 1||0
293690|NCT01845077|701594|P5|NOT COMPLETED|Treatment Period 1||0
293691|NCT01845077|701595|P4|NOT COMPLETED|Treatment Period 1||0
293692|NCT01845077|701596|P3|NOT COMPLETED|Treatment Period 1||0
293693|NCT01845077|701597|P2|NOT COMPLETED|Treatment Period 1||0
293694|NCT01845077|701598|P1|NOT COMPLETED|Treatment Period 1||0
293695|NCT01845077|701593|P6|COMPLETED|Treatment Period 1||12
293696|NCT01845077|701594|P5|COMPLETED|Treatment Period 1||12
293697|NCT01845077|701595|P4|COMPLETED|Treatment Period 1||12
293698|NCT01845077|701596|P3|COMPLETED|Treatment Period 1||12
293699|NCT01845077|701597|P2|COMPLETED|Treatment Period 1||12
293700|NCT01845077|701598|P1|COMPLETED|Treatment Period 1||12
293701|NCT01845077|701593|P6|STARTED|Treatment Period 1||12
293702|NCT01845077|701594|P5|STARTED|Treatment Period 1||12
293703|NCT01845077|701595|P4|STARTED|Treatment Period 1||12
293704|NCT01845077|701596|P3|STARTED|Treatment Period 1||12
293705|NCT01845077|701597|P2|STARTED|Treatment Period 1||12
293706|NCT01845077|701598|P1|STARTED|Treatment Period 1||12
293707|NCT01845025|701644|P2|NOT COMPLETED|Overall Study||77
293708|NCT01845025|701645|P1|NOT COMPLETED|Overall Study||85
293709|NCT01845025|701644|P2|COMPLETED|Overall Study||332
293710|NCT01845025|701645|P1|COMPLETED|Overall Study||326
293711|NCT01845025|701644|P2|STARTED|Overall Study||409
293712|NCT01845025|701645|P1|STARTED|Overall Study||411
293713|NCT01844895|701667|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
293714|NCT01844895|701667|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
293715|NCT01844895|701667|P1|STARTED|Day 29 - Day113 - Autoinjector||117
293716|NCT01844895|701667|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
293717|NCT01844895|701667|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
293718|NCT01844895|701667|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
293719|NCT01844856|701685|P2|NOT COMPLETED|Overall Study||16
293720|NCT01844856|701686|P1|NOT COMPLETED|Overall Study||24
293721|NCT01844856|701685|P2|COMPLETED|Overall Study||255
293722|NCT01844856|701686|P1|COMPLETED|Overall Study||246
293723|NCT01844856|701685|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
293724|NCT01844856|701686|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
293725|NCT01844856|701685|P2|STARTED|Overall Study||271
293726|NCT01844856|701686|P1|STARTED|Overall Study||270
293727|NCT01844817|701698|P2|NOT COMPLETED|Treatment||63
293728|NCT01844817|701699|P1|NOT COMPLETED|Treatment||64
293729|NCT01844817|701698|P2|COMPLETED|Treatment||0
293730|NCT01844817|701699|P1|COMPLETED|Treatment||0
293731|NCT01844817|701698|P2|STARTED|Treatment||63
293732|NCT01844817|701699|P1|STARTED|Treatment||64
293733|NCT01844817|701698|P2|NOT COMPLETED|Enrolled and Randomized||3
293734|NCT01844817|701699|P1|NOT COMPLETED|Enrolled and Randomized||2
293735|NCT01844817|701698|P2|COMPLETED|Enrolled and Randomized||63
293736|NCT01844817|701699|P1|COMPLETED|Enrolled and Randomized||64
293737|NCT01844817|701698|P2|STARTED|Enrolled and Randomized||66
293738|NCT01844817|701699|P1|STARTED|Enrolled and Randomized||66
293739|NCT01844778|701712|P3|NOT COMPLETED|Overall Study||4
293740|NCT01844778|701713|P2|NOT COMPLETED|Overall Study||3
293741|NCT01844778|701714|P1|NOT COMPLETED|Overall Study||2
293742|NCT01844778|701712|P3|COMPLETED|Overall Study||14
293743|NCT01844778|701713|P2|COMPLETED|Overall Study||25
293744|NCT01844778|701714|P1|COMPLETED|Overall Study||12
293745|NCT01844778|701712|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
293746|NCT01844778|701713|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
293747|NCT01844778|701714|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
293748|NCT01844778|701712|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
293749|NCT01844778|701713|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
293750|NCT01844778|701714|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
293751|NCT01844778|701712|P3|STARTED|Overall Study||18
293752|NCT01844778|701713|P2|STARTED|Overall Study||28
293753|NCT01844778|701714|P1|STARTED|Overall Study||14
293754|NCT01844700|701740|P2|NOT COMPLETED|Overall Study||1
293755|NCT01844700|701741|P1|NOT COMPLETED|Overall Study||3
293756|NCT01844700|701740|P2|COMPLETED|Overall Study||2
293757|NCT01844700|701741|P1|COMPLETED|Overall Study||1
293758|NCT01844700|701740|P2|STARTED|Overall Study||3
293759|NCT01844700|701741|P1|STARTED|Overall Study||4
293760|NCT01844687|701753|P1|NOT COMPLETED|Visit 8||0
293761|NCT01844687|701753|P1|COMPLETED|Visit 8||31
293762|NCT01844687|701753|P1|STARTED|Visit 8||31
293763|NCT01844687|701753|P1|NOT COMPLETED|Visit 7||0
293764|NCT01844687|701753|P1|COMPLETED|Visit 7||31
293765|NCT01844687|701753|P1|STARTED|Visit 7||31
293766|NCT01844687|701753|P1|NOT COMPLETED|Visit 6||0
293767|NCT01844687|701753|P1|COMPLETED|Visit 6||31
293768|NCT01844687|701753|P1|STARTED|Visit 6||31
293769|NCT01844687|701753|P1|NOT COMPLETED|Visit 5||0
293770|NCT01844687|701753|P1|COMPLETED|Visit 5||31
293771|NCT01844687|701753|P1|STARTED|Visit 5||31
293772|NCT01844687|701753|P1|NOT COMPLETED|Visit 4||4
293773|NCT01844687|701753|P1|COMPLETED|Visit 4||31
293774|NCT01844687|701753|P1|STARTED|Visit 4||35
293775|NCT01844687|701753|P1|NOT COMPLETED|Visit 3||5
293776|NCT01844687|701753|P1|COMPLETED|Visit 3||35
293777|NCT01844687|701753|P1|STARTED|Visit 3||40
293778|NCT01844687|701753|P1|NOT COMPLETED|Visit 2||2
293779|NCT01844687|701753|P1|COMPLETED|Visit 2||40
293780|NCT01844687|701753|P1|STARTED|Visit 2||42
293781|NCT01844687|701753|P1|NOT COMPLETED|Visit 1||8
293782|NCT01844687|701753|P1|COMPLETED|Visit 1||42
293783|NCT01844687|701753|P1|STARTED|Visit 1||50
293784|NCT01844531|701816|P4|NOT COMPLETED|Overall Study||0
293785|NCT01844531|701817|P3|NOT COMPLETED|Overall Study||0
293786|NCT01844531|701818|P2|NOT COMPLETED|Overall Study||1
293787|NCT01844531|701819|P1|NOT COMPLETED|Overall Study||0
293788|NCT01844531|701816|P4|COMPLETED|Overall Study||6
293789|NCT01844531|701817|P3|COMPLETED|Overall Study||6
293790|NCT01844531|701818|P2|COMPLETED|Overall Study||5
293791|NCT01844531|701819|P1|COMPLETED|Overall Study||6
293792|NCT01844531|701816|P4|STARTED|Overall Study||6
293793|NCT01844531|701817|P3|STARTED|Overall Study||6
293794|NCT01844531|701818|P2|STARTED|Overall Study||6
293795|NCT01844531|701819|P1|STARTED|Overall Study||6
293796|NCT01844518|701849|P1|NOT COMPLETED|Long-Term Extension||157
293797|NCT01844518|701849|P1|COMPLETED|Long-Term Extension|Study is on-going|0
293798|NCT01844518|701849|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
293799|NCT01844518|701849|P1|NOT COMPLETED|Short-Term (ST) Period||9
293800|NCT01844518|701849|P1|COMPLETED|Short-Term (ST) Period||164
293801|NCT01844518|701849|P1|STARTED|Short-Term (ST) Period||173
293802|NCT01844479|701863|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
293803|NCT01844479|701864|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
293804|NCT01844479|701863|P2|COMPLETED|Second Intervention up to 30 Minutes||13
293805|NCT01844479|701864|P1|COMPLETED|Second Intervention up to 30 Minutes||14
293806|NCT01844479|701863|P2|STARTED|Second Intervention up to 30 Minutes||13
293807|NCT01844479|701864|P1|STARTED|Second Intervention up to 30 Minutes||14
293808|NCT01844479|701863|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
293809|NCT01844479|701864|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
293810|NCT01844479|701863|P2|COMPLETED|First Intervention up to 30 Minutes||13
293811|NCT01844479|701864|P1|COMPLETED|First Intervention up to 30 Minutes||14
293812|NCT01844479|701863|P2|STARTED|First Intervention up to 30 Minutes||13
293813|NCT01844479|701864|P1|STARTED|First Intervention up to 30 Minutes||14
293814|NCT01844388|701894|P2|NOT COMPLETED|Overall Study||7
293815|NCT01844388|701895|P1|NOT COMPLETED|Overall Study||8
293816|NCT01844388|701894|P2|COMPLETED|Overall Study||114
293817|NCT01844388|701895|P1|COMPLETED|Overall Study||236
293818|NCT01844388|701894|P2|STARTED|Overall Study||121
293819|NCT01844388|701895|P1|STARTED|Overall Study||244
293820|NCT01844206|701907|P2|NOT COMPLETED|Overall Study||1
293821|NCT01844206|701908|P1|NOT COMPLETED|Overall Study||0
293822|NCT01844206|701907|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
293823|NCT01844206|701908|P1|COMPLETED|Overall Study||2
293824|NCT01844206|701907|P2|STARTED|Overall Study||3
293825|NCT01844206|701908|P1|STARTED|Overall Study||2
293826|NCT01843972|701924|P10|NOT COMPLETED|Overall Study||0
293827|NCT01843972|701925|P9|NOT COMPLETED|Overall Study||0
293828|NCT01843972|701926|P8|NOT COMPLETED|Overall Study||0
293829|NCT01843972|701927|P7|NOT COMPLETED|Overall Study||0
293830|NCT01843972|701928|P6|NOT COMPLETED|Overall Study||0
293831|NCT01843972|701929|P5|NOT COMPLETED|Overall Study||1
293832|NCT01843972|701930|P4|NOT COMPLETED|Overall Study||0
293833|NCT01843972|701931|P3|NOT COMPLETED|Overall Study||0
293834|NCT01843972|701932|P2|NOT COMPLETED|Overall Study||0
293835|NCT01843972|701933|P1|NOT COMPLETED|Overall Study||0
293836|NCT01843972|701924|P10|COMPLETED|Overall Study||12
293837|NCT01843972|701925|P9|COMPLETED|Overall Study||17
293838|NCT01843972|701926|P8|COMPLETED|Overall Study||5
293839|NCT01843972|701927|P7|COMPLETED|Overall Study||5
293840|NCT01843972|701928|P6|COMPLETED|Overall Study||6
293841|NCT01843972|701929|P5|COMPLETED|Overall Study||5
293842|NCT01843972|701930|P4|COMPLETED|Overall Study||6
293843|NCT01843972|701931|P3|COMPLETED|Overall Study||5
293844|NCT01843972|701932|P2|COMPLETED|Overall Study||6
293845|NCT01843972|701933|P1|COMPLETED|Overall Study||13
293846|NCT01843972|701924|P10|STARTED|Overall Study||12
293847|NCT01843972|701925|P9|STARTED|Overall Study||17
293848|NCT01843972|701926|P8|STARTED|Overall Study||5
293849|NCT01843972|701927|P7|STARTED|Overall Study||5
293850|NCT01843972|701928|P6|STARTED|Overall Study||6
293851|NCT01843972|701929|P5|STARTED|Overall Study||6
293852|NCT01843972|701930|P4|STARTED|Overall Study||6
293853|NCT01843972|701931|P3|STARTED|Overall Study||5
293854|NCT01843972|701932|P2|STARTED|Overall Study||6
293855|NCT01843972|701933|P1|STARTED|Overall Study||13
293856|NCT01843933|702003|P2|NOT COMPLETED|Overall Study||4
293857|NCT01843933|702004|P1|NOT COMPLETED|Overall Study||6
293858|NCT01843933|702003|P2|COMPLETED|Overall Study||103
293859|NCT01843933|702004|P1|COMPLETED|Overall Study||98
293860|NCT01843933|702003|P2|STARTED|Overall Study||107
293861|NCT01843933|702004|P1|STARTED|Overall Study||104
293862|NCT01843920|702012|P2|NOT COMPLETED|Overall Study||0
293863|NCT01843920|702013|P1|NOT COMPLETED|Overall Study||0
293864|NCT01843920|702012|P2|COMPLETED|Overall Study||9
293865|NCT01843920|702013|P1|COMPLETED|Overall Study||12
293866|NCT01843920|702012|P2|STARTED|Overall Study||9
293867|NCT01843920|702013|P1|STARTED|Overall Study||12
293868|NCT01843777|702021|P2|NOT COMPLETED|Overall Study||0
293869|NCT01843777|702022|P1|NOT COMPLETED|Overall Study||1
293870|NCT01843777|702021|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
293871|NCT01843777|702022|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
293872|NCT01843777|702021|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
293873|NCT01843777|702022|P1|Per Protocol Population|Overall Study||11
293874|NCT01843777|702021|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
293875|NCT01843777|702022|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
293876|NCT01843673|702030|P1|NOT COMPLETED|Overall Study||6
293877|NCT01843673|702030|P1|COMPLETED|Overall Study||10
293878|NCT01843673|702030|P1|STARTED|Overall Study||16
293879|NCT01843660|702042|P1|NOT COMPLETED|Overall Study||30
293880|NCT01843660|702042|P1|COMPLETED|Overall Study||1029
293881|NCT01843660|702042|P1|STARTED|Overall Study||1059
293882|NCT01843465|702060|P1|NOT COMPLETED|Overall Study||0
293883|NCT01843465|702060|P1|COMPLETED|Overall Study||34
293884|NCT01843465|702060|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
293885|NCT01843348|702067|P3|NOT COMPLETED|Overall Study||41
293886|NCT01843348|702068|P2|NOT COMPLETED|Overall Study||40
293887|NCT01843348|702069|P1|NOT COMPLETED|Overall Study||23
293888|NCT01843348|702067|P3|COMPLETED|Overall Study||158
293889|NCT01843348|702068|P2|COMPLETED|Overall Study||168
293890|NCT01843348|702069|P1|COMPLETED|Overall Study||182
293891|NCT01843348|702067|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
293892|NCT01843348|702068|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
293893|NCT01843348|702069|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
293894|NCT01843348|702067|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
293895|NCT01843348|702068|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
293896|NCT01843348|702069|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
293897|NCT01843348|702067|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
293898|NCT01843348|702068|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
293899|NCT01843348|702069|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
293900|NCT01843348|702067|P3|STARTED|Overall Study||199
293901|NCT01843348|702068|P2|STARTED|Overall Study||208
293902|NCT01843348|702069|P1|STARTED|Overall Study||205
293903|NCT01843192|702112|P3|NOT COMPLETED|Overall Study||2
293904|NCT01843192|702113|P2|NOT COMPLETED|Overall Study||6
293905|NCT01843192|702114|P1|NOT COMPLETED|Overall Study||2
293906|NCT01843192|702112|P3|COMPLETED|Overall Study||9
293907|NCT01843192|702113|P2|COMPLETED|Overall Study||28
293908|NCT01843192|702114|P1|COMPLETED|Overall Study||24
293909|NCT01843192|702112|P3|STARTED|Overall Study||11
293910|NCT01843192|702113|P2|STARTED|Overall Study||34
293911|NCT01843192|702114|P1|STARTED|Overall Study||26
293912|NCT01842906|702145|P2|NOT COMPLETED|Overall Study||0
293913|NCT01842906|702146|P1|NOT COMPLETED|Overall Study||0
293914|NCT01842906|702145|P2|COMPLETED|Overall Study||104
293915|NCT01842906|702146|P1|COMPLETED|Overall Study||115
293916|NCT01842906|702145|P2|STARTED|Overall Study||104
293917|NCT01842906|702146|P1|STARTED|Overall Study||115
293918|NCT01842841|702158|P1|NOT COMPLETED|Overall Study||0
293919|NCT01842841|702158|P1|COMPLETED|Overall Study||5
293920|NCT01842841|702158|P1|STARTED|Overall Study||5
293921|NCT01842646|702177|P1|NOT COMPLETED|Overall Study||0
293922|NCT01842646|702177|P1|COMPLETED|Overall Study||35
293923|NCT01842646|702177|P1|STARTED|Overall Study||35
293924|NCT01842607|702183|P1|NOT COMPLETED|Overall Study||66
293925|NCT01842607|702183|P1|COMPLETED|Overall Study||585
293926|NCT01842607|702183|P1|STARTED|Overall Study||651
293927|NCT01842594|702202|P1|NOT COMPLETED|Overall Study||3
293928|NCT01842594|702202|P1|COMPLETED|Overall Study||10
293929|NCT01842594|702202|P1|STARTED|Overall Study||13
293930|NCT01842464|702207|P1|NOT COMPLETED|Overall Study||0
293931|NCT01842464|702207|P1|COMPLETED|Overall Study||44
293932|NCT01842464|702207|P1|STARTED|Overall Study||44
293933|NCT01842438|702215|P2|NOT COMPLETED|T2: 6month Follow-up||4
293934|NCT01842438|702216|P1|NOT COMPLETED|T2: 6month Follow-up||4
293935|NCT01842438|702215|P2|COMPLETED|T2: 6month Follow-up||32
293936|NCT01842438|702216|P1|COMPLETED|T2: 6month Follow-up||32
293937|NCT01842438|702215|P2|STARTED|T2: 6month Follow-up||36
293938|NCT01842438|702216|P1|STARTED|T2: 6month Follow-up||36
293939|NCT01842438|702215|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
293940|NCT01842438|702216|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
293941|NCT01842438|702215|P2|COMPLETED|T1: Immediately After the Intervention||36
293942|NCT01842438|702216|P1|COMPLETED|T1: Immediately After the Intervention||36
293943|NCT01842438|702215|P2|STARTED|T1: Immediately After the Intervention||44
293944|NCT01842438|702216|P1|STARTED|T1: Immediately After the Intervention||42
293945|NCT01841970|702228|P1|NOT COMPLETED|Overall Study||11
293946|NCT01841970|702228|P1|COMPLETED|Overall Study||9
293947|NCT01841970|702228|P1|STARTED|Overall Study||20
293948|NCT01841697|702246|P2|NOT COMPLETED|Overall Study||18
293949|NCT01841697|702247|P1|NOT COMPLETED|Overall Study||20
293950|NCT01841697|702246|P2|COMPLETED|Overall Study||302
293951|NCT01841697|702247|P1|COMPLETED|Overall Study||302
293952|NCT01841697|702246|P2|STARTED|Overall Study||320
293953|NCT01841697|702247|P1|STARTED|Overall Study||322
293954|NCT01841619|702263|P1|NOT COMPLETED|Overall Study||0
293955|NCT01841619|702263|P1|COMPLETED|Overall Study||16
293956|NCT01841619|702263|P1|STARTED|Overall Study||16
293957|NCT01841593|702273|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
293958|NCT01841593|702274|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
293959|NCT01841593|702273|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
293960|NCT01841593|702274|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
293961|NCT01841593|702273|P2|STARTED|Third Intervention (Days 15 to 21)||6
293962|NCT01841593|702274|P1|STARTED|Third Intervention (Days 15 to 21)||11
293963|NCT01841593|702273|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
293964|NCT01841593|702274|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
293965|NCT01841593|702273|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
293966|NCT01841593|702274|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
293967|NCT01841593|702273|P2|STARTED|Second Intervention (Days 8 to 14)||6
293968|NCT01841593|702274|P1|STARTED|Second Intervention (Days 8 to 14)||12
293969|NCT01841593|702273|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
293970|NCT01841593|702274|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
293971|NCT01841593|702273|P2|COMPLETED|First Intervention (Days 1 to 7)||6
293972|NCT01841593|702274|P1|COMPLETED|First Intervention (Days 1 to 7)||12
293973|NCT01841593|702273|P2|STARTED|First Intervention (Days 1 to 7)||7
293974|NCT01841593|702274|P1|STARTED|First Intervention (Days 1 to 7)||12
293975|NCT01841567|702290|P1|NOT COMPLETED|Overall Study||3
293976|NCT01841567|702290|P1|COMPLETED|Overall Study||57
293977|NCT01841567|702290|P1|STARTED|Overall Study||60
293978|NCT01841216|702297|P2|NOT COMPLETED|Overall Study||0
293979|NCT01841216|702298|P1|NOT COMPLETED|Overall Study||0
293980|NCT01841216|702297|P2|COMPLETED|Overall Study||15
293981|NCT01841216|702298|P1|COMPLETED|Overall Study||15
293982|NCT01841216|702297|P2|STARTED|Overall Study||15
293983|NCT01841216|702298|P1|STARTED|Overall Study||15
293984|NCT01841021|702306|P1|NOT COMPLETED|Overall Study||0
293985|NCT01841021|702306|P1|COMPLETED|Overall Study||1
293986|NCT01841021|702306|P1|STARTED|Overall Study||1
293987|NCT01840943|702318|P2|NOT COMPLETED|Overall Study||12
293988|NCT01840943|702319|P1|NOT COMPLETED|Overall Study||13
293989|NCT01840943|702318|P2|COMPLETED|Overall Study||0
293990|NCT01840943|702319|P1|COMPLETED|Overall Study||1
293991|NCT01840943|702318|P2|STARTED|Overall Study||12
293992|NCT01840943|702319|P1|STARTED|Overall Study||14
293993|NCT01840605|702355|P2|NOT COMPLETED|Overall Study||2
293994|NCT01840605|702356|P1|NOT COMPLETED|Overall Study||2
293995|NCT01840605|702355|P2|COMPLETED|Overall Study||150
293996|NCT01840605|702356|P1|COMPLETED|Overall Study||149
293997|NCT01840605|702355|P2|STARTED|Overall Study||152
293998|NCT01840605|702356|P1|STARTED|Overall Study||151
293999|NCT01840410|702364|P2|NOT COMPLETED|Overall Study||4
294000|NCT01840410|702365|P1|NOT COMPLETED|Overall Study||7
294001|NCT01840410|702364|P2|COMPLETED|Overall Study||55
294002|NCT01840410|702365|P1|COMPLETED|Overall Study||112
294003|NCT01840410|702364|P2|Full Analysis Set|Overall Study||59
294004|NCT01840410|702365|P1|Full Analysis Set|Overall Study||119
294005|NCT01840410|702364|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
294006|NCT01840410|702365|P1|Safety Set|Overall Study||119
294007|NCT01840410|702364|P2|STARTED|Overall Study||59
294008|NCT01840410|702365|P1|STARTED|Overall Study||119
294009|NCT01840319|702401|P1|NOT COMPLETED|Overall Study||0
294010|NCT01840319|702401|P1|COMPLETED|Overall Study||156
294011|NCT01840319|702401|P1|STARTED|Overall Study||156
294012|NCT01840072|702407|P2|NOT COMPLETED|Overall Study||47
294013|NCT01840072|702408|P1|NOT COMPLETED|Overall Study||7
294014|NCT01840072|702407|P2|COMPLETED|Overall Study||1986
294015|NCT01840072|702408|P1|COMPLETED|Overall Study||2031
294016|NCT01840072|702407|P2|STARTED|Overall Study||2033
294017|NCT01840072|702408|P1|STARTED|Overall Study||2038
294018|NCT01839695|702430|P1|NOT COMPLETED|Overall Study||0
294019|NCT01839695|702430|P1|COMPLETED|Overall Study||9
294020|NCT01839695|702430|P1|STARTED|Overall Study||9
294021|NCT01839604|702440|P5|NOT COMPLETED|Overall Study||0
294022|NCT01839604|702441|P4|NOT COMPLETED|Overall Study||0
294023|NCT01839604|702442|P3|NOT COMPLETED|Overall Study||0
294024|NCT01839604|702443|P2|NOT COMPLETED|Overall Study||0
294025|NCT01839604|702444|P1|NOT COMPLETED|Overall Study||0
294026|NCT01839604|702440|P5|COMPLETED|Overall Study||15
294027|NCT01839604|702441|P4|COMPLETED|Overall Study||5
294028|NCT01839604|702442|P3|COMPLETED|Overall Study||7
294029|NCT01839604|702443|P2|COMPLETED|Overall Study||6
294030|NCT01839604|702444|P1|COMPLETED|Overall Study||6
294031|NCT01839604|702440|P5|STARTED|Overall Study||15
294032|NCT01839604|702441|P4|STARTED|Overall Study||5
294033|NCT01839604|702442|P3|STARTED|Overall Study||7
294034|NCT01839604|702443|P2|STARTED|Overall Study||6
294035|NCT01839604|702444|P1|STARTED|Overall Study||6
294036|NCT01839318|702471|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
294037|NCT01839318|702472|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
294038|NCT01839318|702473|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
294039|NCT01839318|702474|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
294040|NCT01839318|702475|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
294041|NCT01839318|702476|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
294042|NCT01839318|702471|P6|COMPLETED|Period 3, Third Day of Wear||2
294043|NCT01839318|702472|P5|COMPLETED|Period 3, Third Day of Wear||7
294044|NCT01839318|702473|P4|COMPLETED|Period 3, Third Day of Wear||6
294045|NCT01839318|702474|P3|COMPLETED|Period 3, Third Day of Wear||5
294046|NCT01839318|702475|P2|COMPLETED|Period 3, Third Day of Wear||4
294047|NCT01839318|702476|P1|COMPLETED|Period 3, Third Day of Wear||4
294048|NCT01839318|702471|P6|STARTED|Period 3, Third Day of Wear||2
294049|NCT01839318|702472|P5|STARTED|Period 3, Third Day of Wear||7
294050|NCT01839318|702473|P4|STARTED|Period 3, Third Day of Wear||6
294051|NCT01839318|702474|P3|STARTED|Period 3, Third Day of Wear||5
294052|NCT01839318|702475|P2|STARTED|Period 3, Third Day of Wear||4
294053|NCT01839318|702476|P1|STARTED|Period 3, Third Day of Wear||4
294054|NCT01839318|702471|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
294055|NCT01839318|702472|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
294056|NCT01839318|702473|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
294057|NCT01839318|702474|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
294058|NCT01839318|702475|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
294059|NCT01839318|702476|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
294060|NCT01839318|702471|P6|COMPLETED|Period 2, Second Day of Wear||2
294061|NCT01839318|702472|P5|COMPLETED|Period 2, Second Day of Wear||7
294062|NCT01839318|702473|P4|COMPLETED|Period 2, Second Day of Wear||6
294063|NCT01839318|702474|P3|COMPLETED|Period 2, Second Day of Wear||5
294064|NCT01839318|702475|P2|COMPLETED|Period 2, Second Day of Wear||4
294065|NCT01839318|702476|P1|COMPLETED|Period 2, Second Day of Wear||4
294066|NCT01839318|702471|P6|STARTED|Period 2, Second Day of Wear||2
294067|NCT01839318|702472|P5|STARTED|Period 2, Second Day of Wear||7
294068|NCT01839318|702473|P4|STARTED|Period 2, Second Day of Wear||6
294069|NCT01839318|702474|P3|STARTED|Period 2, Second Day of Wear||5
294070|NCT01839318|702475|P2|STARTED|Period 2, Second Day of Wear||4
294071|NCT01839318|702476|P1|STARTED|Period 2, Second Day of Wear||4
294072|NCT01839318|702471|P6|NOT COMPLETED|Period 1, First Day of Wear||0
294073|NCT01839318|702472|P5|NOT COMPLETED|Period 1, First Day of Wear||0
294074|NCT01839318|702473|P4|NOT COMPLETED|Period 1, First Day of Wear||0
294075|NCT01839318|702474|P3|NOT COMPLETED|Period 1, First Day of Wear||0
294076|NCT01839318|702475|P2|NOT COMPLETED|Period 1, First Day of Wear||0
294077|NCT01839318|702476|P1|NOT COMPLETED|Period 1, First Day of Wear||0
294078|NCT01839318|702471|P6|COMPLETED|Period 1, First Day of Wear||2
294079|NCT01839318|702472|P5|COMPLETED|Period 1, First Day of Wear||7
294080|NCT01839318|702473|P4|COMPLETED|Period 1, First Day of Wear||6
294081|NCT01839318|702474|P3|COMPLETED|Period 1, First Day of Wear||5
294082|NCT01839318|702475|P2|COMPLETED|Period 1, First Day of Wear||4
294083|NCT01839318|702476|P1|COMPLETED|Period 1, First Day of Wear||4
294084|NCT01839318|702471|P6|STARTED|Period 1, First Day of Wear||2
294085|NCT01839318|702472|P5|STARTED|Period 1, First Day of Wear||7
294086|NCT01839318|702473|P4|STARTED|Period 1, First Day of Wear||6
294087|NCT01839318|702474|P3|STARTED|Period 1, First Day of Wear||5
294088|NCT01839318|702475|P2|STARTED|Period 1, First Day of Wear||4
294089|NCT01839318|702476|P1|STARTED|Period 1, First Day of Wear||4
294090|NCT01839279|702490|P3|NOT COMPLETED|Overall Study||2
294091|NCT01839279|702491|P2|NOT COMPLETED|Overall Study||2
294092|NCT01839279|702492|P1|NOT COMPLETED|Overall Study||13
294093|NCT01839279|702490|P3|COMPLETED|Overall Study||30
294094|NCT01839279|702491|P2|COMPLETED|Overall Study||30
294095|NCT01839279|702492|P1|COMPLETED|Overall Study||59
294096|NCT01839279|702490|P3|PK/QTc Analysis Set|Overall Study||0
294097|NCT01839279|702491|P2|PK/QTc Analysis Set|Overall Study||0
294098|NCT01839279|702492|P1|PK/QTc Analysis Set|Overall Study||70
294099|NCT01839279|702490|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
294100|NCT01839279|702491|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
294101|NCT01839279|702492|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
294102|NCT01839279|702490|P3|PK Analysis Set|Overall Study||0
294103|NCT01839279|702491|P2|PK Analysis Set|Overall Study||0
294104|NCT01839279|702492|P1|PK Analysis Set|Overall Study||70
294105|NCT01839279|702490|P3|QT/QTc Analysis Set|Overall Study||32
294106|NCT01839279|702491|P2|QT/QTc Analysis Set|Overall Study||32
294107|NCT01839279|702492|P1|QT/QTc Analysis Set|Overall Study||72
294108|NCT01839279|702490|P3|STARTED|Overall Study||32
294109|NCT01839279|702491|P2|STARTED|Overall Study||32
294110|NCT01839279|702492|P1|STARTED|Overall Study||72
294111|NCT01838980|702511|P1|NOT COMPLETED|Overall Study||0
294112|NCT01838980|702511|P1|COMPLETED|Overall Study||15
294113|NCT01838980|702511|P1|STARTED|Overall Study||15
294114|NCT01838941|702515|P1|NOT COMPLETED|Overall Study||2
294115|NCT01838941|702515|P1|COMPLETED|Overall Study||10
294116|NCT01838941|702515|P1|STARTED|Overall Study||12
294117|NCT01838694|702522|P2|NOT COMPLETED|Overall Study||1
294118|NCT01838694|702523|P1|NOT COMPLETED|Overall Study||0
294119|NCT01838694|702522|P2|COMPLETED|Overall Study||21
294120|NCT01838694|702523|P1|COMPLETED|Overall Study||8
294121|NCT01838694|702522|P2|STARTED|Overall Study||22
294122|NCT01838694|702523|P1|STARTED|Overall Study||8
294123|NCT01838642|702532|P1|NOT COMPLETED|Overall Study||1
294124|NCT01838642|702532|P1|COMPLETED|Overall Study||2
294125|NCT01838642|702532|P1|STARTED|Overall Study||3
294126|NCT01838616|702545|P2|NOT COMPLETED|Pick-up Arm||0
294127|NCT01838616|702546|P1|NOT COMPLETED|Pick-up Arm||15
294128|NCT01838616|702545|P2|COMPLETED|Pick-up Arm||0
294129|NCT01838616|702546|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
294130|NCT01838616|702545|P2|Full Analysis Set|Pick-up Arm||0
294131|NCT01838616|702546|P1|Full Analysis Set|Pick-up Arm||49
294132|NCT01838616|702545|P2|STARTED|Pick-up Arm||0
294133|NCT01838616|702546|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
294134|NCT01838616|702545|P2|NOT COMPLETED|Continuation Period||14
294135|NCT01838616|702546|P1|NOT COMPLETED|Continuation Period||14
294136|NCT01838616|702545|P2|COMPLETED|Continuation Period||48
294137|NCT01838616|702546|P1|COMPLETED|Continuation Period||86
294138|NCT01838616|702545|P2|Switched to Pick-up Arm|Continuation Period||7
294139|NCT01838616|702546|P1|Switched to Pick-up Arm|Continuation Period||0
294140|NCT01838616|702545|P2|STARTED|Continuation Period||62
294141|NCT01838616|702546|P1|STARTED|Continuation Period||100
294142|NCT01838616|702545|P2|NOT COMPLETED|Titration Period||66
294143|NCT01838616|702546|P1|NOT COMPLETED|Titration Period||30
294144|NCT01838616|702545|P2|COMPLETED|Titration Period||62
294145|NCT01838616|702546|P1|COMPLETED|Titration Period||100
294146|NCT01838616|702545|P2|Per Protocol Set|Titration Period||112
294147|NCT01838616|702546|P1|Per Protocol Set|Titration Period||117
294148|NCT01838616|702545|P2|Full Analysis Set|Titration Period||128
294149|NCT01838616|702546|P1|Full Analysis Set|Titration Period||130
294150|NCT01838616|702545|P2|Switched to Pick-up Arm|Titration Period||43
294151|NCT01838616|702546|P1|Switched to Pick-up Arm|Titration Period||0
294152|NCT01838616|702545|P2|Major Protocol Deviations|Titration Period||16
294153|NCT01838616|702546|P1|Major Protocol Deviations|Titration Period||13
294154|NCT01838616|702545|P2|No Post Baseline Pain Intensity Values|Titration Period||2
294155|NCT01838616|702546|P1|No Post Baseline Pain Intensity Values|Titration Period||0
294156|NCT01838616|702545|P2|STARTED|Titration Period||128
294157|NCT01838616|702546|P1|STARTED|Titration Period||130
294158|NCT01838590|702617|P2|NOT COMPLETED|Overall Study||5
294159|NCT01838590|702618|P1|NOT COMPLETED|Overall Study||12
294160|NCT01838590|702617|P2|COMPLETED|Overall Study||46
294161|NCT01838590|702618|P1|COMPLETED|Overall Study||40
294162|NCT01838590|702617|P2|STARTED|Overall Study||51
294163|NCT01838590|702618|P1|STARTED|Overall Study||52
294164|NCT01838499|702642|P2|NOT COMPLETED|Overall Study||17
294165|NCT01838499|702643|P1|NOT COMPLETED|Overall Study||24
294166|NCT01838499|702642|P2|COMPLETED|Overall Study||37
294167|NCT01838499|702643|P1|COMPLETED|Overall Study||31
294168|NCT01838499|702642|P2|STARTED|Overall Study||54
294169|NCT01838499|702643|P1|STARTED|Overall Study||55
294170|NCT01838213|702655|P2|NOT COMPLETED|Overall Study||191
294171|NCT01838213|702656|P1|NOT COMPLETED|Overall Study||166
294172|NCT01838213|702655|P2|COMPLETED|Overall Study||262
294173|NCT01838213|702656|P1|COMPLETED|Overall Study||81
294174|NCT01838213|702655|P2|STARTED|Overall Study||453
294175|NCT01838213|702656|P1|STARTED|Overall Study||247
294176|NCT01838044|702664|P2|NOT COMPLETED|Overall Study||16
294177|NCT01838044|702665|P1|NOT COMPLETED|Overall Study||8
294178|NCT01838044|702664|P2|COMPLETED|Overall Study||75
294179|NCT01838044|702665|P1|COMPLETED|Overall Study||81
294180|NCT01838044|702664|P2|STARTED|Overall Study||91
294181|NCT01838044|702665|P1|STARTED|Overall Study||89
294182|NCT01837966|702698|P2|NOT COMPLETED|Overall Study||1
294183|NCT01837966|702699|P1|NOT COMPLETED|Overall Study||2
294184|NCT01837966|702698|P2|COMPLETED|Overall Study||45
294185|NCT01837966|702699|P1|COMPLETED|Overall Study||45
294186|NCT01837966|702698|P2|STARTED|Overall Study||46
294187|NCT01837966|702699|P1|STARTED|Overall Study||47
294188|NCT01837797|702708|P5|NOT COMPLETED|Period 3||23
294189|NCT01837797|702709|P4|NOT COMPLETED|Period 3||0
294190|NCT01837797|702710|P3|NOT COMPLETED|Period 3||0
294191|NCT01837797|702711|P2|NOT COMPLETED|Period 3||0
294192|NCT01837797|702712|P1|NOT COMPLETED|Period 3||0
294193|NCT01837797|702708|P5|COMPLETED|Period 3||24
294194|NCT01837797|702709|P4|COMPLETED|Period 3||0
294195|NCT01837797|702710|P3|COMPLETED|Period 3||0
294196|NCT01837797|702711|P2|COMPLETED|Period 3||0
294197|NCT01837797|702712|P1|COMPLETED|Period 3||0
294198|NCT01837797|702708|P5|STARTED|Period 3||47
294199|NCT01837797|702709|P4|STARTED|Period 3||0
294200|NCT01837797|702710|P3|STARTED|Period 3||0
294201|NCT01837797|702711|P2|STARTED|Period 3||0
294202|NCT01837797|702712|P1|STARTED|Period 3||0
294203|NCT01837797|702708|P5|NOT COMPLETED|Period 2||0
294204|NCT01837797|702709|P4|NOT COMPLETED|Period 2||5
294205|NCT01837797|702710|P3|NOT COMPLETED|Period 2||2
294206|NCT01837797|702711|P2|NOT COMPLETED|Period 2||5
294207|NCT01837797|702712|P1|NOT COMPLETED|Period 2||0
294208|NCT01837797|702708|P5|COMPLETED|Period 2||0
294209|NCT01837797|702709|P4|COMPLETED|Period 2||1
294210|NCT01837797|702710|P3|COMPLETED|Period 2||1
294211|NCT01837797|702711|P2|COMPLETED|Period 2||1
294212|NCT01837797|702712|P1|COMPLETED|Period 2||0
294213|NCT01837797|702708|P5|STARTED|Period 2||0
294214|NCT01837797|702709|P4|STARTED|Period 2||6
294215|NCT01837797|702710|P3|STARTED|Period 2||3
294216|NCT01837797|702711|P2|STARTED|Period 2||6
294217|NCT01837797|702712|P1|STARTED|Period 2||0
294218|NCT01837797|702708|P5|NOT COMPLETED|Period 1||0
294219|NCT01837797|702709|P4|NOT COMPLETED|Period 1||0
294220|NCT01837797|702710|P3|NOT COMPLETED|Period 1||0
294221|NCT01837797|702711|P2|NOT COMPLETED|Period 1||0
294222|NCT01837797|702712|P1|NOT COMPLETED|Period 1||102
294223|NCT01837797|702708|P5|COMPLETED|Period 1||0
294224|NCT01837797|702709|P4|COMPLETED|Period 1||0
294225|NCT01837797|702710|P3|COMPLETED|Period 1||0
294226|NCT01837797|702711|P2|COMPLETED|Period 1||0
294227|NCT01837797|702712|P1|COMPLETED|Period 1||27
294228|NCT01837797|702708|P5|STARTED|Period 1||0
294229|NCT01837797|702709|P4|STARTED|Period 1||0
294230|NCT01837797|702710|P3|STARTED|Period 1||0
294231|NCT01837797|702711|P2|STARTED|Period 1||0
294232|NCT01837797|702712|P1|STARTED|Period 1||129
294233|NCT01837719|702747|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
294234|NCT01837719|702747|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
294235|NCT01837719|702747|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
294236|NCT01837719|702747|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
294237|NCT01837719|702747|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
294238|NCT01837719|702747|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
294239|NCT01837719|702747|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
294240|NCT01837719|702747|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
294241|NCT01837719|702747|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
294242|NCT01837719|702747|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
294243|NCT01837719|702747|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
294244|NCT01837719|702747|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
294245|NCT01837719|702747|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
294246|NCT01837719|702747|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
294247|NCT01837719|702747|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
294248|NCT01837680|702816|P2|NOT COMPLETED|Overall Study||8
294249|NCT01837680|702817|P1|NOT COMPLETED|Overall Study||10
294250|NCT01837680|702816|P2|COMPLETED|Overall Study||45
294251|NCT01837680|702817|P1|COMPLETED|Overall Study||42
294252|NCT01837680|702816|P2|STARTED|Overall Study||53
294253|NCT01837680|702817|P1|STARTED|Overall Study||52
294254|NCT01837550|702855|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
294255|NCT01837550|702856|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
294256|NCT01837550|702855|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
294257|NCT01837550|702856|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
294258|NCT01837550|702855|P2|STARTED|T0-T2, 6 Months Follow-up||37
294259|NCT01837550|702856|P1|STARTED|T0-T2, 6 Months Follow-up||37
294260|NCT01837550|702855|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
294261|NCT01837550|702856|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
294262|NCT01837550|702855|P2|COMPLETED|T0-T1, 5 Weeks||37
294263|NCT01837550|702856|P1|COMPLETED|T0-T1, 5 Weeks||37
294264|NCT01837550|702855|P2|STARTED|T0-T1, 5 Weeks||37
294265|NCT01837550|702856|P1|STARTED|T0-T1, 5 Weeks||37
294266|NCT01837537|702868|P1|NOT COMPLETED|Overall Study||0
294267|NCT01837537|702868|P1|COMPLETED|Overall Study||90
294268|NCT01837537|702868|P1|STARTED|Overall Study||90
294269|NCT01837524|702875|P2|NOT COMPLETED|Overall Study||2
294270|NCT01837524|702876|P1|NOT COMPLETED|Overall Study||3
294271|NCT01837524|702875|P2|COMPLETED|Overall Study||25
294272|NCT01837524|702876|P1|COMPLETED|Overall Study||25
294273|NCT01837524|702875|P2|STARTED|Overall Study||27
294274|NCT01837524|702876|P1|STARTED|Overall Study||28
294275|NCT01836809|702886|P4|NOT COMPLETED|Overall Study||2
294276|NCT01836809|702887|P3|NOT COMPLETED|Overall Study||0
294277|NCT01836809|702888|P2|NOT COMPLETED|Overall Study||0
294278|NCT01836809|702889|P1|NOT COMPLETED|Overall Study||0
294279|NCT01836809|702886|P4|COMPLETED|Overall Study||0
294280|NCT01836809|702887|P3|COMPLETED|Overall Study||0
294281|NCT01836809|702888|P2|COMPLETED|Overall Study||0
294282|NCT01836809|702889|P1|COMPLETED|Overall Study||0
294283|NCT01836809|702886|P4|STARTED|Overall Study||2
294284|NCT01836809|702887|P3|STARTED|Overall Study||0
294285|NCT01836809|702888|P2|STARTED|Overall Study||0
294286|NCT01836809|702889|P1|STARTED|Overall Study||0
294287|NCT01836523|702923|P4|NOT COMPLETED|Overall Study||74
294288|NCT01836523|702924|P3|NOT COMPLETED|Overall Study||91
294289|NCT01836523|702925|P2|NOT COMPLETED|Overall Study||85
294290|NCT01836523|702926|P1|NOT COMPLETED|Overall Study||51
294291|NCT01836523|702923|P4|COMPLETED|Overall Study||274
294292|NCT01836523|702924|P3|COMPLETED|Overall Study||258
294293|NCT01836523|702925|P2|COMPLETED|Overall Study||265
294294|NCT01836523|702926|P1|COMPLETED|Overall Study||300
294295|NCT01836523|702923|P4|Exposed|Overall Study||348
294296|NCT01836523|702924|P3|Exposed|Overall Study||347
294297|NCT01836523|702925|P2|Exposed|Overall Study||348
294298|NCT01836523|702926|P1|Exposed|Overall Study||350
294299|NCT01836523|702923|P4|STARTED|Overall Study||348
294300|NCT01836523|702924|P3|STARTED|Overall Study||349
294301|NCT01836523|702925|P2|STARTED|Overall Study||350
294302|NCT01836523|702926|P1|STARTED|Overall Study||351
294303|NCT01836471|702953|P5|NOT COMPLETED|Overall Study||5
294304|NCT01836471|702954|P4|NOT COMPLETED|Overall Study||2
294305|NCT01836471|702955|P3|NOT COMPLETED|Overall Study||2
294306|NCT01836471|702956|P2|NOT COMPLETED|Overall Study||9
294307|NCT01836471|702957|P1|NOT COMPLETED|Overall Study||11
294308|NCT01836471|702953|P5|COMPLETED|Overall Study||49
294309|NCT01836471|702954|P4|COMPLETED|Overall Study||40
294310|NCT01836471|702955|P3|COMPLETED|Overall Study||49
294311|NCT01836471|702956|P2|COMPLETED|Overall Study||85
294312|NCT01836471|702957|P1|COMPLETED|Overall Study||82
294313|NCT01836471|702953|P5|STARTED|Overall Study||54
294314|NCT01836471|702954|P4|STARTED|Overall Study||42
294315|NCT01836471|702955|P3|STARTED|Overall Study||51
294316|NCT01836471|702956|P2|STARTED|Overall Study||94
294317|NCT01836471|702957|P1|STARTED|Overall Study||93
294318|NCT01836458|702986|P4|NOT COMPLETED|Overall Study||6
294319|NCT01836458|702987|P3|NOT COMPLETED|Overall Study||5
294320|NCT01836458|702988|P2|NOT COMPLETED|Overall Study||2
294321|NCT01836458|702989|P1|NOT COMPLETED|Overall Study||3
294322|NCT01836458|702986|P4|COMPLETED|Overall Study||1
294323|NCT01836458|702987|P3|COMPLETED|Overall Study||2
294324|NCT01836458|702988|P2|COMPLETED|Overall Study||2
294325|NCT01836458|702989|P1|COMPLETED|Overall Study||4
294326|NCT01836458|702986|P4|STARTED|Overall Study||7
294327|NCT01836458|702987|P3|STARTED|Overall Study||7
294328|NCT01836458|702988|P2|STARTED|Overall Study||4
294329|NCT01836458|702989|P1|STARTED|Overall Study||7
294330|NCT01836133|703011|P1|NOT COMPLETED|Overall Study||0
294331|NCT01836133|703011|P1|COMPLETED|Overall Study||70
294332|NCT01836133|703011|P1|STARTED|Overall Study||70
294333|NCT01836042|703020|P3|NOT COMPLETED|Overall Study||0
294334|NCT01836042|703021|P2|NOT COMPLETED|Overall Study||0
294335|NCT01836042|703022|P1|NOT COMPLETED|Overall Study||0
294336|NCT01836042|703020|P3|COMPLETED|Overall Study||22
294337|NCT01836042|703021|P2|COMPLETED|Overall Study||35
294338|NCT01836042|703022|P1|COMPLETED|Overall Study||51
294339|NCT01836042|703020|P3|STARTED|Overall Study||22
294340|NCT01836042|703021|P2|STARTED|Overall Study||35
294341|NCT01836042|703022|P1|STARTED|Overall Study||51
294342|NCT01835912|703030|P1|NOT COMPLETED|Overall Study||0
294343|NCT01835912|703030|P1|COMPLETED|Overall Study||10
294344|NCT01835912|703030|P1|Chronic Placebo|Overall Study||10
294345|NCT01835912|703030|P1|Chronic|Overall Study||10
294346|NCT01835912|703030|P1|Acute Placebo|Overall Study||10
294347|NCT01835912|703030|P1|Acute|Overall Study||10
294348|NCT01835912|703030|P1|STARTED|Overall Study||10
294349|NCT01835899|703051|P3|NOT COMPLETED|Overall Study||1
294350|NCT01835899|703052|P2|NOT COMPLETED|Overall Study||1
294351|NCT01835899|703053|P1|NOT COMPLETED|Overall Study||0
294352|NCT01835899|703051|P3|COMPLETED|Overall Study||8
294353|NCT01835899|703052|P2|COMPLETED|Overall Study||8
294354|NCT01835899|703053|P1|COMPLETED|Overall Study||6
294355|NCT01835899|703051|P3|STARTED|Overall Study||9
294356|NCT01835899|703052|P2|STARTED|Overall Study||9
294357|NCT01835899|703053|P1|STARTED|Overall Study||6
294358|NCT01835756|703073|P2|NOT COMPLETED|Overall Study||0
294359|NCT01835756|703074|P1|NOT COMPLETED|Overall Study||0
294360|NCT01835756|703073|P2|COMPLETED|Overall Study||31
294361|NCT01835756|703074|P1|COMPLETED|Overall Study||31
294362|NCT01835756|703073|P2|STARTED|Overall Study||31
294363|NCT01835756|703074|P1|STARTED|Overall Study||31
294364|NCT01835743|703086|P2|NOT COMPLETED|Overall Study||0
294365|NCT01835743|703087|P1|NOT COMPLETED|Overall Study||0
294366|NCT01835743|703086|P2|COMPLETED|Overall Study||32
294367|NCT01835743|703087|P1|COMPLETED|Overall Study||37
294368|NCT01835743|703086|P2|STARTED|Overall Study||32
294369|NCT01835743|703087|P1|STARTED|Overall Study||37
294370|NCT01835496|703095|P1|NOT COMPLETED|Overall Study||0
294371|NCT01835496|703095|P1|COMPLETED|Overall Study||8
294372|NCT01835496|703095|P1|STARTED|Overall Study||8
294373|NCT01835470|703104|P1|NOT COMPLETED|Long Term Treatment Period||2
294374|NCT01835470|703104|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
294375|NCT01835470|703104|P1|STARTED|Long Term Treatment Period||20
294376|NCT01835470|703104|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
294377|NCT01835470|703104|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
294378|NCT01835470|703104|P1|STARTED|Short Term Treatment Period (to Week 16)||20
294379|NCT01835431|703116|P2|NOT COMPLETED|Overall Study||12
294380|NCT01835431|703117|P1|NOT COMPLETED|Overall Study||8
294381|NCT01835431|703116|P2|COMPLETED|Overall Study||168
294382|NCT01835431|703117|P1|COMPLETED|Overall Study||174
294383|NCT01835431|703116|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
294384|NCT01835431|703117|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
294385|NCT01835431|703116|P2|STARTED|Overall Study||180
294386|NCT01835431|703117|P1|STARTED|Overall Study||182
294387|NCT01835379|703137|P2|NOT COMPLETED|Overall Study||0
294388|NCT01835379|703138|P1|NOT COMPLETED|Overall Study||0
294389|NCT01835379|703137|P2|COMPLETED|Overall Study||41
294390|NCT01835379|703138|P1|COMPLETED|Overall Study||41
294391|NCT01835379|703137|P2|STARTED|Overall Study||41
294392|NCT01835379|703138|P1|STARTED|Overall Study||41
294393|NCT01835262|703148|P2|NOT COMPLETED|Overall Study||0
294394|NCT01835262|703149|P1|NOT COMPLETED|Overall Study||0
294395|NCT01835262|703148|P2|COMPLETED|Overall Study||45
294396|NCT01835262|703149|P1|COMPLETED|Overall Study||45
294397|NCT01835262|703148|P2|STARTED|Overall Study||45
294398|NCT01835262|703149|P1|STARTED|Overall Study||45
294399|NCT01835132|703155|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
294400|NCT01835132|703155|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
294401|NCT01835132|703155|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
294402|NCT01835132|703155|P1|NOT COMPLETED|1st Extension Phase||0
294403|NCT01835132|703155|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
294404|NCT01835132|703155|P1|STARTED|1st Extension Phase||6
294405|NCT01835132|703155|P1|NOT COMPLETED|Initial Phase||2
294406|NCT01835132|703155|P1|COMPLETED|Initial Phase||6
294407|NCT01835132|703155|P1|STARTED|Initial Phase||8
294408|NCT01835015|703199|P5|NOT COMPLETED|Overall Study||0
294409|NCT01835015|703200|P4|NOT COMPLETED|Overall Study||0
294410|NCT01835015|703201|P3|NOT COMPLETED|Overall Study||1
294411|NCT01835015|703202|P2|NOT COMPLETED|Overall Study||0
294412|NCT01835015|703203|P1|NOT COMPLETED|Overall Study||0
294413|NCT01835015|703199|P5|COMPLETED|Overall Study||6
294414|NCT01835015|703200|P4|COMPLETED|Overall Study||6
294415|NCT01835015|703201|P3|COMPLETED|Overall Study||6
294416|NCT01835015|703202|P2|COMPLETED|Overall Study||6
294417|NCT01835015|703203|P1|COMPLETED|Overall Study||6
294418|NCT01835015|703199|P5|STARTED|Overall Study||6
294419|NCT01835015|703200|P4|STARTED|Overall Study||6
294420|NCT01835015|703201|P3|STARTED|Overall Study||7
294421|NCT01835015|703202|P2|STARTED|Overall Study||6
294422|NCT01835015|703203|P1|STARTED|Overall Study||6
294423|NCT01834404|703278|P2|NOT COMPLETED|Overall Study||0
294424|NCT01834404|703279|P1|NOT COMPLETED|Overall Study||0
294425|NCT01834404|703278|P2|COMPLETED|Overall Study||12
294426|NCT01834404|703279|P1|COMPLETED|Overall Study||12
294427|NCT01834404|703278|P2|STARTED|Overall Study||12
294428|NCT01834404|703279|P1|STARTED|Overall Study||12
294429|NCT01834274|703311|P2|NOT COMPLETED|Overall Study||41
294430|NCT01834274|703312|P1|NOT COMPLETED|Overall Study||47
294431|NCT01834274|703311|P2|COMPLETED|Overall Study||5
294432|NCT01834274|703312|P1|COMPLETED|Overall Study||3
294433|NCT01834274|703311|P2|STARTED|Overall Study||46
294434|NCT01834274|703312|P1|STARTED|Overall Study||50
294435|NCT01834261|703324|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
294436|NCT01834261|703325|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
294437|NCT01834261|703324|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
294438|NCT01834261|703325|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
294439|NCT01834261|703324|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
294440|NCT01834261|703325|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
294441|NCT01834261|703324|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
294442|NCT01834261|703325|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
294443|NCT01834261|703324|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
294444|NCT01834261|703325|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
294445|NCT01834261|703324|P2|STARTED|MIT fMRI and MEG Resting State Study||10
294446|NCT01834261|703325|P1|STARTED|MIT fMRI and MEG Resting State Study||11
294447|NCT01834222|703335|P1|NOT COMPLETED|Overall Study||1
294448|NCT01834222|703335|P1|COMPLETED|Overall Study||658
294449|NCT01834222|703335|P1|Treated|Overall Study||658
294450|NCT01834222|703335|P1|STARTED|Overall Study||659
294451|NCT01834027|703346|P2|NOT COMPLETED|Overall Study||0
294452|NCT01834027|703347|P1|NOT COMPLETED|Overall Study||0
294453|NCT01834027|703346|P2|COMPLETED|Overall Study||28
294454|NCT01834027|703347|P1|COMPLETED|Overall Study||28
294455|NCT01834027|703346|P2|STARTED|Overall Study||28
294456|NCT01834027|703347|P1|STARTED|Overall Study||28
294457|NCT01833897|703357|P1|NOT COMPLETED|Overall Study||1
294458|NCT01833897|703357|P1|COMPLETED|Overall Study||7
294459|NCT01833897|703357|P1|STARTED|Overall Study||8
294460|NCT01833845|703365|P1|NOT COMPLETED|Overall Study||0
294461|NCT01833845|703365|P1|COMPLETED|Overall Study||4
294462|NCT01833845|703365|P1|STARTED|Overall Study||4
294463|NCT01833741|703369|P1|NOT COMPLETED|Overall Study||140
294464|NCT01833741|703369|P1|COMPLETED|Overall Study||997
294465|NCT01833741|703369|P1|STARTED|Overall Study||1137
294466|NCT01833533|703384|P2|NOT COMPLETED|Overall Study||21
294467|NCT01833533|703385|P1|NOT COMPLETED|Overall Study||6
294468|NCT01833533|703384|P2|COMPLETED|Overall Study||184
294469|NCT01833533|703385|P1|COMPLETED|Overall Study||94
294470|NCT01833533|703384|P2|STARTED|Overall Study||205
294471|NCT01833533|703385|P1|STARTED|Overall Study||100
294472|NCT01833481|703402|P3|NOT COMPLETED|Overall Study||0
294473|NCT01833481|703403|P2|NOT COMPLETED|Overall Study||0
294474|NCT01833481|703404|P1|NOT COMPLETED|Overall Study||0
294475|NCT01833481|703402|P3|COMPLETED|Overall Study||10
294476|NCT01833481|703403|P2|COMPLETED|Overall Study||10
294477|NCT01833481|703404|P1|COMPLETED|Overall Study||10
294478|NCT01833481|703402|P3|STARTED|Overall Study||10
294479|NCT01833481|703403|P2|STARTED|Overall Study||10
294480|NCT01833481|703404|P1|STARTED|Overall Study||10
294481|NCT01833403|703418|P1|NOT COMPLETED|Overall Study||0
294482|NCT01833403|703418|P1|COMPLETED|Overall Study||4
294483|NCT01833403|703418|P1|STARTED|Overall Study||4
294484|NCT01833247|703423|P1|NOT COMPLETED|Overall Study||0
294485|NCT01833247|703423|P1|COMPLETED|Overall Study||12
294486|NCT01833247|703423|P1|STARTED|Overall Study||12
294487|NCT01833130|703431|P2|NOT COMPLETED|Overall Study||19
294488|NCT01833130|703432|P1|NOT COMPLETED|Overall Study||10
294489|NCT01833130|703431|P2|COMPLETED|Overall Study||8
294490|NCT01833130|703432|P1|COMPLETED|Overall Study||15
294491|NCT01833130|703431|P2|STARTED|Overall Study||27
294492|NCT01833130|703432|P1|STARTED|Overall Study||25
294493|NCT01833117|703470|P2|NOT COMPLETED|Overall Study||0
294494|NCT01833117|703471|P1|NOT COMPLETED|Overall Study||0
294495|NCT01833117|703470|P2|COMPLETED|Overall Study||19
294496|NCT01833117|703471|P1|COMPLETED|Overall Study||43
294497|NCT01833117|703470|P2|STARTED|Overall Study||19
294498|NCT01833117|703471|P1|STARTED|Overall Study||43
294499|NCT01833078|703479|P1|NOT COMPLETED|Overall Study||0
294500|NCT01833078|703479|P1|COMPLETED|Overall Study||5
294501|NCT01833078|703479|P1|STARTED|Overall Study||5
294502|NCT01833065|703487|P5|NOT COMPLETED|Overall Study||36
294503|NCT01833065|703488|P4|NOT COMPLETED|Overall Study||9
294504|NCT01833065|703489|P3|NOT COMPLETED|Overall Study||12
294505|NCT01833065|703490|P2|NOT COMPLETED|Overall Study||13
294506|NCT01833065|703491|P1|NOT COMPLETED|Overall Study||24
294507|NCT01833065|703487|P5|COMPLETED|Overall Study||74
294508|NCT01833065|703488|P4|COMPLETED|Overall Study||41
294509|NCT01833065|703489|P3|COMPLETED|Overall Study||23
294510|NCT01833065|703490|P2|COMPLETED|Overall Study||40
294511|NCT01833065|703491|P1|COMPLETED|Overall Study||41
294512|NCT01833065|703487|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
294513|NCT01833065|703488|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
294514|NCT01833065|703489|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
294515|NCT01833065|703490|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
294516|NCT01833065|703491|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
294517|NCT01833065|703487|P5|STARTED|Overall Study|Randomized patients - As treated|110
294518|NCT01833065|703488|P4|STARTED|Overall Study|Randomized patients - As treated|50
294519|NCT01833065|703489|P3|STARTED|Overall Study|Randomized patients - As treated|35
294520|NCT01833065|703490|P2|STARTED|Overall Study|Randomized patients - As treated|53
294521|NCT01833065|703491|P1|STARTED|Overall Study|Randomized patients - As treated|65
294522|NCT01832766|703522|P2|NOT COMPLETED|Second Intervention||0
294523|NCT01832766|703523|P1|NOT COMPLETED|Second Intervention||0
294524|NCT01832766|703522|P2|COMPLETED|Second Intervention||5
294525|NCT01832766|703523|P1|COMPLETED|Second Intervention||7
294526|NCT01832766|703522|P2|STARTED|Second Intervention||5
294527|NCT01832766|703523|P1|STARTED|Second Intervention||7
294528|NCT01832766|703522|P2|NOT COMPLETED|Washout||1
294529|NCT01832766|703523|P1|NOT COMPLETED|Washout||0
294530|NCT01832766|703522|P2|COMPLETED|Washout||5
294531|NCT01832766|703523|P1|COMPLETED|Washout||7
294532|NCT01832766|703522|P2|STARTED|Washout||6
294533|NCT01832766|703523|P1|STARTED|Washout||7
294534|NCT01832766|703522|P2|NOT COMPLETED|First Intervention||0
294535|NCT01832766|703523|P1|NOT COMPLETED|First Intervention||0
294536|NCT01832766|703522|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
294537|NCT01832766|703523|P1|COMPLETED|First Intervention||7
294538|NCT01832766|703522|P2|STARTED|First Intervention||6
294539|NCT01832766|703523|P1|STARTED|First Intervention||7
294540|NCT01832506|703536|P3|NOT COMPLETED|Overall Study||0
294541|NCT01832506|703537|P2|NOT COMPLETED|Overall Study||0
294542|NCT01832506|703538|P1|NOT COMPLETED|Overall Study||0
294543|NCT01832506|703536|P3|COMPLETED|Overall Study||6
294544|NCT01832506|703537|P2|COMPLETED|Overall Study||3
294545|NCT01832506|703538|P1|COMPLETED|Overall Study||3
294546|NCT01832506|703536|P3|STARTED|Overall Study||6
294547|NCT01832506|703537|P2|STARTED|Overall Study||3
294548|NCT01832506|703538|P1|STARTED|Overall Study||3
294549|NCT01832493|703589|P1|NOT COMPLETED|Overall Study||8
294550|NCT01832493|703589|P1|COMPLETED|Overall Study||42
294551|NCT01832493|703589|P1|STARTED|Overall Study||50
294552|NCT01832155|703598|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
294553|NCT01832155|703599|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
294554|NCT01832155|703598|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
294555|NCT01832155|703599|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
294556|NCT01832155|703598|P2|STARTED|End of Study: 4 - 8 Weeks||18
294557|NCT01832155|703599|P1|STARTED|End of Study: 4 - 8 Weeks||16
294558|NCT01832155|703598|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
294559|NCT01832155|703599|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
294560|NCT01832155|703598|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
294561|NCT01832155|703599|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
294562|NCT01832155|703598|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
294563|NCT01832155|703599|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
294564|NCT01832155|703598|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
294565|NCT01832155|703599|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
294566|NCT01832155|703598|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
294567|NCT01832155|703599|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
294568|NCT01832155|703598|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
294569|NCT01832155|703599|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
294570|NCT01831934|703622|P2|NOT COMPLETED|Overall Study||0
294571|NCT01831934|703623|P1|NOT COMPLETED|Overall Study||1
294572|NCT01831934|703622|P2|COMPLETED|Overall Study||10
294573|NCT01831934|703623|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
294574|NCT01831934|703622|P2|STARTED|Overall Study||10
294575|NCT01831934|703623|P1|STARTED|Overall Study||12
294576|NCT01831817|703633|P4|NOT COMPLETED|Overall Study||0
294577|NCT01831817|703634|P3|NOT COMPLETED|Overall Study||0
294578|NCT01831817|703635|P2|NOT COMPLETED|Overall Study||0
294579|NCT01831817|703636|P1|NOT COMPLETED|Overall Study||4
294580|NCT01831817|703633|P4|COMPLETED|Overall Study||36
294581|NCT01831817|703634|P3|COMPLETED|Overall Study||35
294582|NCT01831817|703635|P2|COMPLETED|Overall Study||34
294583|NCT01831817|703636|P1|COMPLETED|Overall Study||31
294584|NCT01831817|703633|P4|STARTED|Overall Study||36
294585|NCT01831817|703634|P3|STARTED|Overall Study||35
294586|NCT01831817|703635|P2|STARTED|Overall Study||34
294587|NCT01831817|703636|P1|STARTED|Overall Study||35
294588|NCT01831791|703674|P1|NOT COMPLETED|Overall Study||10
294589|NCT01831791|703674|P1|COMPLETED|Overall Study||110
294590|NCT01831791|703674|P1|STARTED|Overall Study||120
294591|NCT01831726|703700|P1|NOT COMPLETED|Overall Study||80
294592|NCT01831726|703700|P1|COMPLETED|Overall Study||0
294593|NCT01831726|703700|P1|STARTED|Overall Study||80
294594|NCT01831466|703719|P12|NOT COMPLETED|Overall Study||4
294595|NCT01831466|703720|P11|NOT COMPLETED|Overall Study||2
294596|NCT01831466|703721|P10|NOT COMPLETED|Overall Study||5
294597|NCT01831466|703722|P9|NOT COMPLETED|Overall Study||3
294598|NCT01831466|703723|P8|NOT COMPLETED|Overall Study||2
294599|NCT01831466|703724|P7|NOT COMPLETED|Overall Study||1
294600|NCT01831466|703725|P6|NOT COMPLETED|Overall Study||26
294601|NCT01831466|703726|P5|NOT COMPLETED|Overall Study||17
294602|NCT01831466|703727|P4|NOT COMPLETED|Overall Study||19
294603|NCT01831466|703728|P3|NOT COMPLETED|Overall Study||23
294604|NCT01831466|703729|P2|NOT COMPLETED|Overall Study||18
294605|NCT01831466|703730|P1|NOT COMPLETED|Overall Study||16
294606|NCT01831466|703719|P12|COMPLETED|Overall Study||3
294607|NCT01831466|703720|P11|COMPLETED|Overall Study||4
294608|NCT01831466|703721|P10|COMPLETED|Overall Study||2
294609|NCT01831466|703722|P9|COMPLETED|Overall Study||4
294610|NCT01831466|703723|P8|COMPLETED|Overall Study||5
294611|NCT01831466|703724|P7|COMPLETED|Overall Study||6
294612|NCT01831466|703725|P6|COMPLETED|Overall Study||48
294613|NCT01831466|703726|P5|COMPLETED|Overall Study||57
294614|NCT01831466|703727|P4|COMPLETED|Overall Study||51
294615|NCT01831466|703728|P3|COMPLETED|Overall Study||48
294616|NCT01831466|703729|P2|COMPLETED|Overall Study||52
294617|NCT01831466|703730|P1|COMPLETED|Overall Study||55
294618|NCT01831466|703719|P12|STARTED|Overall Study|Treated|7
294619|NCT01831466|703720|P11|STARTED|Overall Study|Treated|6
294620|NCT01831466|703721|P10|STARTED|Overall Study|Treated|7
294621|NCT01831466|703722|P9|STARTED|Overall Study|Treated|7
294622|NCT01831466|703723|P8|STARTED|Overall Study|Treated|7
294623|NCT01831466|703724|P7|STARTED|Overall Study|Treated|7
294624|NCT01831466|703725|P6|STARTED|Overall Study|Treated|74
294625|NCT01831466|703726|P5|STARTED|Overall Study|Treated|74
294626|NCT01831466|703727|P4|STARTED|Overall Study|Treated|70
294627|NCT01831466|703728|P3|STARTED|Overall Study|Treated|71
294628|NCT01831466|703729|P2|STARTED|Overall Study|Treated|70
294629|NCT01831466|703730|P1|STARTED|Overall Study|Treated|71
294630|NCT01831219|703854|P2|NOT COMPLETED|Overall Study||24
294631|NCT01831219|703855|P1|NOT COMPLETED|Overall Study||33
294632|NCT01831219|703854|P2|COMPLETED|Overall Study||21
294633|NCT01831219|703855|P1|COMPLETED|Overall Study||40
294634|NCT01831219|703854|P2|STARTED|Overall Study||45
294635|NCT01831219|703855|P1|STARTED|Overall Study||73
294636|NCT01831154|703876|P3|NOT COMPLETED|Overall Study||0
294637|NCT01831154|703877|P2|NOT COMPLETED|Overall Study||0
294638|NCT01831154|703878|P1|NOT COMPLETED|Overall Study||0
294639|NCT01831154|703876|P3|COMPLETED|Overall Study||11
294640|NCT01831154|703877|P2|COMPLETED|Overall Study||11
294641|NCT01831154|703878|P1|COMPLETED|Overall Study||15
294642|NCT01831154|703876|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
294643|NCT01831154|703877|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
294644|NCT01831154|703878|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
294645|NCT01830933|703903|P2|NOT COMPLETED|Overall Study||232
294646|NCT01830933|703904|P1|NOT COMPLETED|Overall Study||168
294647|NCT01830933|703903|P2|COMPLETED|Overall Study||580
294648|NCT01830933|703904|P1|COMPLETED|Overall Study||655
294649|NCT01830933|703903|P2|Completed Meet-up|Overall Study||603
294650|NCT01830933|703904|P1|Completed Meet-up|Overall Study||675
294651|NCT01830933|703903|P2|STARTED|Overall Study||812
294652|NCT01830933|703904|P1|STARTED|Overall Study||823
294653|NCT01830920|703921|P5|NOT COMPLETED|Overall Study||8
294654|NCT01830920|703922|P4|NOT COMPLETED|Overall Study||16
294655|NCT01830920|703923|P3|NOT COMPLETED|Overall Study||8
294656|NCT01830920|703924|P2|NOT COMPLETED|Overall Study||6
294657|NCT01830920|703925|P1|NOT COMPLETED|Overall Study||21
294658|NCT01830920|703921|P5|COMPLETED|Overall Study||99
294659|NCT01830920|703922|P4|COMPLETED|Overall Study||109
294660|NCT01830920|703923|P3|COMPLETED|Overall Study||40
294661|NCT01830920|703924|P2|COMPLETED|Overall Study||40
294662|NCT01830920|703925|P1|COMPLETED|Overall Study||105
294663|NCT01830920|703921|P5|Received Allocated Drug|Overall Study||105
294664|NCT01830920|703922|P4|Received Allocated Drug|Overall Study||119
294665|NCT01830920|703923|P3|Received Allocated Drug|Overall Study||47
294666|NCT01830920|703924|P2|Received Allocated Drug|Overall Study||45
294667|NCT01830920|703925|P1|Received Allocated Drug|Overall Study||115
294668|NCT01830920|703921|P5|STARTED|Overall Study||107
294669|NCT01830920|703922|P4|STARTED|Overall Study||125
294670|NCT01830920|703923|P3|STARTED|Overall Study||48
294671|NCT01830920|703924|P2|STARTED|Overall Study||46
294672|NCT01830920|703925|P1|STARTED|Overall Study||126
294673|NCT01830881|703964|P2|NOT COMPLETED|Overall Study||1
294674|NCT01830881|703965|P1|NOT COMPLETED|Overall Study||0
294675|NCT01830881|703964|P2|COMPLETED|Overall Study||61
294676|NCT01830881|703965|P1|COMPLETED|Overall Study||62
294677|NCT01830881|703964|P2|STARTED|Overall Study||62
294678|NCT01830881|703965|P1|STARTED|Overall Study||62
294679|NCT01830855|704009|P4|NOT COMPLETED|Overall Study||82
294680|NCT01830855|704010|P3|NOT COMPLETED|Overall Study||66
294681|NCT01830855|704011|P2|NOT COMPLETED|Overall Study||61
294682|NCT01830855|704012|P1|NOT COMPLETED|Overall Study||155
294683|NCT01830855|704009|P4|COMPLETED|Overall Study||815
294684|NCT01830855|704010|P3|COMPLETED|Overall Study||521
294685|NCT01830855|704011|P2|COMPLETED|Overall Study||537
294686|NCT01830855|704012|P1|COMPLETED|Overall Study||1353
294687|NCT01830855|704009|P4|STARTED|Overall Study||897
294688|NCT01830855|704010|P3|STARTED|Overall Study||587
294689|NCT01830855|704011|P2|STARTED|Overall Study||598
294690|NCT01830855|704012|P1|STARTED|Overall Study||1508
294691|NCT01830790|704118|P2|NOT COMPLETED|Overall Study||0
294692|NCT01830790|704119|P1|NOT COMPLETED|Overall Study||0
294693|NCT01830790|704118|P2|COMPLETED|Overall Study||10
294694|NCT01830790|704119|P1|COMPLETED|Overall Study||0
294695|NCT01830790|704118|P2|STARTED|Overall Study||10
294696|NCT01830790|704119|P1|STARTED|Overall Study||0
294697|NCT01830699|704129|P2|NOT COMPLETED|Overall Study||0
294698|NCT01830699|704130|P1|NOT COMPLETED|Overall Study||0
294699|NCT01830699|704129|P2|COMPLETED|Overall Study||20
294700|NCT01830699|704130|P1|COMPLETED|Overall Study||13
294701|NCT01830699|704129|P2|STARTED|Overall Study||20
294702|NCT01830699|704130|P1|STARTED|Overall Study||13
294703|NCT01830205|704144|P4|NOT COMPLETED|Overall Study||0
294704|NCT01830205|704145|P3|NOT COMPLETED|Overall Study||0
294705|NCT01830205|704146|P2|NOT COMPLETED|Overall Study||0
294706|NCT01830205|704147|P1|NOT COMPLETED|Overall Study||0
294707|NCT01830205|704144|P4|COMPLETED|Overall Study||12
294708|NCT01830205|704145|P3|COMPLETED|Overall Study||6
294709|NCT01830205|704146|P2|COMPLETED|Overall Study||6
294710|NCT01830205|704147|P1|COMPLETED|Overall Study||12
294711|NCT01830205|704144|P4|STARTED|Overall Study||12
294712|NCT01830205|704145|P3|STARTED|Overall Study||6
294713|NCT01830205|704146|P2|STARTED|Overall Study||6
294714|NCT01830205|704147|P1|STARTED|Overall Study||12
294715|NCT01830140|704231|P2|NOT COMPLETED|Overall Study||4
294716|NCT01830140|704232|P1|NOT COMPLETED|Overall Study||7
294717|NCT01830140|704231|P2|COMPLETED|Overall Study||229
294718|NCT01830140|704232|P1|COMPLETED|Overall Study||226
294719|NCT01830140|704231|P2|STARTED|Overall Study||233
294720|NCT01830140|704232|P1|STARTED|Overall Study||233
294721|NCT01830127|704240|P2|NOT COMPLETED|Overall Study||9
294722|NCT01830127|704241|P1|NOT COMPLETED|Overall Study||5
294723|NCT01830127|704240|P2|COMPLETED|Overall Study||8
294724|NCT01830127|704241|P1|COMPLETED|Overall Study||13
294725|NCT01830127|704240|P2|STARTED|Overall Study||17
294726|NCT01830127|704241|P1|STARTED|Overall Study||18
294727|NCT01829919|704249|P1|NOT COMPLETED|Overall Study||0
294728|NCT01829919|704249|P1|COMPLETED|Overall Study||24
294729|NCT01829919|704249|P1|STARTED|Overall Study||24
294730|NCT01829516|704265|P2|NOT COMPLETED|2nd Intervention||0
294731|NCT01829516|704266|P1|NOT COMPLETED|2nd Intervention||0
294732|NCT01829516|704265|P2|COMPLETED|2nd Intervention||14
294733|NCT01829516|704266|P1|COMPLETED|2nd Intervention||18
294734|NCT01829516|704265|P2|STARTED|2nd Intervention||14
294735|NCT01829516|704266|P1|STARTED|2nd Intervention||18
294736|NCT01829516|704265|P2|NOT COMPLETED|Washout Period - 1 Week||0
294737|NCT01829516|704266|P1|NOT COMPLETED|Washout Period - 1 Week||0
294738|NCT01829516|704265|P2|COMPLETED|Washout Period - 1 Week||14
294739|NCT01829516|704266|P1|COMPLETED|Washout Period - 1 Week||18
294740|NCT01829516|704265|P2|STARTED|Washout Period - 1 Week||14
294741|NCT01829516|704266|P1|STARTED|Washout Period - 1 Week||18
294742|NCT01829516|704265|P2|NOT COMPLETED|First Intervention||0
294743|NCT01829516|704266|P1|NOT COMPLETED|First Intervention||0
294744|NCT01829516|704265|P2|COMPLETED|First Intervention||14
294745|NCT01829516|704266|P1|COMPLETED|First Intervention||18
294746|NCT01829516|704265|P2|STARTED|First Intervention||14
294747|NCT01829516|704266|P1|STARTED|First Intervention||18
294748|NCT01829477|704276|P2|NOT COMPLETED|Overall Study||15
294749|NCT01829477|704277|P1|NOT COMPLETED|Overall Study||16
294750|NCT01829477|704276|P2|COMPLETED|Overall Study||1
294751|NCT01829477|704277|P1|COMPLETED|Overall Study||1
294752|NCT01829477|704276|P2|STARTED|Overall Study||16
294753|NCT01829477|704277|P1|STARTED|Overall Study||17
294754|NCT01829464|704290|P3|NOT COMPLETED|Overall Study||26
294755|NCT01829464|704291|P2|NOT COMPLETED|Overall Study||29
294756|NCT01829464|704292|P1|NOT COMPLETED|Overall Study||28
294757|NCT01829464|704290|P3|COMPLETED|Overall Study||3
294758|NCT01829464|704291|P2|COMPLETED|Overall Study||2
294759|NCT01829464|704292|P1|COMPLETED|Overall Study||2
294760|NCT01829464|704290|P3|STARTED|Overall Study||29
294761|NCT01829464|704291|P2|STARTED|Overall Study||31
294762|NCT01829464|704292|P1|STARTED|Overall Study||30
294763|NCT01829399|704308|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
294764|NCT01829399|704309|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
294765|NCT01829399|704308|P2|COMPLETED|Visit 2 (One Month Later)||12
294766|NCT01829399|704309|P1|COMPLETED|Visit 2 (One Month Later)||12
294767|NCT01829399|704308|P2|STARTED|Visit 2 (One Month Later)||12
294768|NCT01829399|704309|P1|STARTED|Visit 2 (One Month Later)||12
294769|NCT01829399|704308|P2|NOT COMPLETED|Visit 1||0
294770|NCT01829399|704309|P1|NOT COMPLETED|Visit 1||0
294771|NCT01829399|704308|P2|COMPLETED|Visit 1||12
294772|NCT01829399|704309|P1|COMPLETED|Visit 1||12
294773|NCT01829399|704308|P2|STARTED|Visit 1||12
294774|NCT01829399|704309|P1|STARTED|Visit 1||12
294775|NCT01829243|704317|P2|NOT COMPLETED|Second Intervention||0
294776|NCT01829243|704318|P1|NOT COMPLETED|Second Intervention||0
294777|NCT01829243|704317|P2|COMPLETED|Second Intervention||13
294778|NCT01829243|704318|P1|COMPLETED|Second Intervention||7
294779|NCT01829243|704317|P2|STARTED|Second Intervention||13
294780|NCT01829243|704318|P1|STARTED|Second Intervention||7
294781|NCT01829243|704317|P2|NOT COMPLETED|Washout Period of 1 Week||0
294782|NCT01829243|704318|P1|NOT COMPLETED|Washout Period of 1 Week||0
294783|NCT01829243|704317|P2|COMPLETED|Washout Period of 1 Week||13
294784|NCT01829243|704318|P1|COMPLETED|Washout Period of 1 Week||7
294785|NCT01829243|704317|P2|STARTED|Washout Period of 1 Week||13
294786|NCT01829243|704318|P1|STARTED|Washout Period of 1 Week||7
294787|NCT01829243|704317|P2|NOT COMPLETED|First Intervention||2
294788|NCT01829243|704318|P1|NOT COMPLETED|First Intervention||4
294789|NCT01829243|704317|P2|COMPLETED|First Intervention||13
294790|NCT01829243|704318|P1|COMPLETED|First Intervention||7
294791|NCT01829243|704317|P2|STARTED|First Intervention||15
294792|NCT01829243|704318|P1|STARTED|First Intervention||11
294793|NCT01829230|704332|P2|NOT COMPLETED|Overall Study||4
294794|NCT01829230|704333|P1|NOT COMPLETED|Overall Study||1
294795|NCT01829230|704332|P2|COMPLETED|Overall Study||38
294796|NCT01829230|704333|P1|COMPLETED|Overall Study||39
294797|NCT01829230|704332|P2|STARTED|Overall Study||42
294798|NCT01829230|704333|P1|STARTED|Overall Study||40
294799|NCT01829191|704343|P2|NOT COMPLETED|Overall Study||14
294800|NCT01829191|704344|P1|NOT COMPLETED|Overall Study||7
294801|NCT01829191|704343|P2|COMPLETED|Overall Study||50
294802|NCT01829191|704344|P1|COMPLETED|Overall Study||56
294803|NCT01829191|704343|P2|STARTED|Overall Study||64
294804|NCT01829191|704344|P1|STARTED|Overall Study||63
294805|NCT01828593|704354|P3|NOT COMPLETED|Placebo-Free Phase||6
294806|NCT01828593|704355|P2|NOT COMPLETED|Placebo-Free Phase||6
294807|NCT01828593|704356|P1|NOT COMPLETED|Placebo-Free Phase||0
294808|NCT01828593|704354|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
294809|NCT01828593|704355|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
294810|NCT01828593|704356|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
294811|NCT01828593|704354|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
294812|NCT01828593|704355|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
294813|NCT01828593|704356|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
294814|NCT01828593|704354|P3|NOT COMPLETED|Placebo-Controlled Phase||1
294815|NCT01828593|704355|P2|NOT COMPLETED|Placebo-Controlled Phase||0
294816|NCT01828593|704356|P1|NOT COMPLETED|Placebo-Controlled Phase||0
294817|NCT01828593|704354|P3|COMPLETED|Placebo-Controlled Phase||32
294818|NCT01828593|704355|P2|COMPLETED|Placebo-Controlled Phase||34
294819|NCT01828593|704356|P1|COMPLETED|Placebo-Controlled Phase||36
294820|NCT01828593|704354|P3|STARTED|Placebo-Controlled Phase||33
294821|NCT01828593|704355|P2|STARTED|Placebo-Controlled Phase||34
294822|NCT01828593|704356|P1|STARTED|Placebo-Controlled Phase||36
294823|NCT01828476|704368|P2|NOT COMPLETED|Overall Study||0
294824|NCT01828476|704369|P1|NOT COMPLETED|Overall Study||0
294825|NCT01828476|704368|P2|COMPLETED|Overall Study||0
294826|NCT01828476|704369|P1|COMPLETED|Overall Study||13
294827|NCT01828476|704368|P2|STARTED|Overall Study||0
294828|NCT01828476|704369|P1|STARTED|Overall Study||13
294829|NCT01828281|704391|P2|NOT COMPLETED|Overall Study||0
294830|NCT01828281|704392|P1|NOT COMPLETED|Overall Study||1
294831|NCT01828281|704391|P2|COMPLETED|Overall Study||45
294832|NCT01828281|704392|P1|COMPLETED|Overall Study||44
294833|NCT01828281|704391|P2|STARTED|Overall Study||45
294834|NCT01828281|704392|P1|STARTED|Overall Study||45
294835|NCT01828216|704404|P2|NOT COMPLETED|Overall Study||0
294836|NCT01828216|704405|P1|NOT COMPLETED|Overall Study||0
294837|NCT01828216|704404|P2|COMPLETED|Overall Study||157
294838|NCT01828216|704405|P1|COMPLETED|Overall Study||159
294839|NCT01828216|704404|P2|STARTED|Overall Study||157
294840|NCT01828216|704405|P1|STARTED|Overall Study||159
294841|NCT01828164|704413|P1|NOT COMPLETED|Overall Study||17
294842|NCT01828164|704413|P1|COMPLETED|Overall Study||32
294937|NCT01826981|704624|P7|COMPLETED|Overall Study||24
294843|NCT01828164|704413|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
294844|NCT01827839|704423|P1|NOT COMPLETED|Overall Study||3
294845|NCT01827839|704423|P1|COMPLETED|Overall Study||93
294846|NCT01827839|704423|P1|STARTED|Overall Study||96
294847|NCT01827670|704447|P2|NOT COMPLETED|Overall Study||3
294848|NCT01827670|704448|P1|NOT COMPLETED|Overall Study||3
294849|NCT01827670|704447|P2|COMPLETED|Overall Study||56
294850|NCT01827670|704448|P1|COMPLETED|Overall Study||57
294851|NCT01827670|704447|P2|STARTED|Overall Study||59
294852|NCT01827670|704448|P1|STARTED|Overall Study||60
294853|NCT01827592|704467|P3|NOT COMPLETED|Overall Study||76
294854|NCT01827592|704468|P2|NOT COMPLETED|Overall Study||80
294855|NCT01827592|704469|P1|NOT COMPLETED|Overall Study||74
294856|NCT01827592|704467|P3|COMPLETED|Overall Study||48
294857|NCT01827592|704468|P2|COMPLETED|Overall Study||46
294858|NCT01827592|704469|P1|COMPLETED|Overall Study||52
294859|NCT01827592|704467|P3|Safety Analysis Set|Overall Study||124
294860|NCT01827592|704468|P2|Safety Analysis Set|Overall Study||126
294861|NCT01827592|704469|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
294862|NCT01827592|704467|P3|STARTED|Overall Study|Randomized patients.|124
294863|NCT01827592|704468|P2|STARTED|Overall Study|Randomized patients.|126
294864|NCT01827592|704469|P1|STARTED|Overall Study|Randomized patients.|126
294865|NCT01827475|704501|P3|NOT COMPLETED|Overall Study||0
294866|NCT01827475|704502|P2|NOT COMPLETED|Overall Study||0
294867|NCT01827475|704503|P1|NOT COMPLETED|Overall Study||0
294868|NCT01827475|704501|P3|COMPLETED|Overall Study||30
294869|NCT01827475|704502|P2|COMPLETED|Overall Study||30
294870|NCT01827475|704503|P1|COMPLETED|Overall Study||30
294871|NCT01827475|704501|P3|STARTED|Overall Study||30
294872|NCT01827475|704502|P2|STARTED|Overall Study||30
294873|NCT01827475|704503|P1|STARTED|Overall Study||30
294874|NCT01827462|704517|P3|NOT COMPLETED|Overall Study||28
294875|NCT01827462|704518|P2|NOT COMPLETED|Overall Study||18
294876|NCT01827462|704519|P1|NOT COMPLETED|Overall Study||41
294877|NCT01827462|704517|P3|COMPLETED|Overall Study||12
294878|NCT01827462|704518|P2|COMPLETED|Overall Study||19
294879|NCT01827462|704519|P1|COMPLETED|Overall Study||18
294880|NCT01827462|704517|P3|STARTED|Overall Study||40
294881|NCT01827462|704518|P2|STARTED|Overall Study||37
294882|NCT01827462|704519|P1|STARTED|Overall Study||59
294883|NCT01827371|704534|P4|NOT COMPLETED|Overall Study||23
294884|NCT01827371|704535|P3|NOT COMPLETED|Overall Study||11
294885|NCT01827371|704536|P2|NOT COMPLETED|Overall Study||7
294886|NCT01827371|704537|P1|NOT COMPLETED|Overall Study||13
294887|NCT01827371|704534|P4|COMPLETED|Overall Study||97
294888|NCT01827371|704535|P3|COMPLETED|Overall Study||93
294889|NCT01827371|704536|P2|COMPLETED|Overall Study||89
294890|NCT01827371|704537|P1|COMPLETED|Overall Study||102
294891|NCT01827371|704534|P4|STARTED|Overall Study||120
294892|NCT01827371|704535|P3|STARTED|Overall Study||104
294893|NCT01827371|704536|P2|STARTED|Overall Study||96
294894|NCT01827371|704537|P1|STARTED|Overall Study||115
294895|NCT01827332|704561|P2|NOT COMPLETED|Overall Study||1
294896|NCT01827332|704562|P1|NOT COMPLETED|Overall Study||2
294897|NCT01827332|704561|P2|COMPLETED|Overall Study||7
294898|NCT01827332|704562|P1|COMPLETED|Overall Study||6
294899|NCT01827332|704561|P2|STARTED|Overall Study||8
294900|NCT01827332|704562|P1|STARTED|Overall Study||8
294901|NCT01827319|704570|P1|NOT COMPLETED|Overall Study||3
294902|NCT01827319|704570|P1|COMPLETED|Overall Study||200
294903|NCT01827319|704570|P1|STARTED|Overall Study||203
294904|NCT01827306|704578|P2|NOT COMPLETED|Overall Study||5
294905|NCT01827306|704579|P1|NOT COMPLETED|Overall Study||11
294906|NCT01827306|704578|P2|COMPLETED|Overall Study||8
294907|NCT01827306|704579|P1|COMPLETED|Overall Study||10
294908|NCT01827306|704578|P2|STARTED|Overall Study||13
294909|NCT01827306|704579|P1|STARTED|Overall Study||21
294910|NCT01827254|704591|P1|NOT COMPLETED|Overall Study||59
294911|NCT01827254|704591|P1|COMPLETED|Overall Study||2
294912|NCT01827254|704591|P1|Evaluable Population|Overall Study||52
294913|NCT01827254|704591|P1|STARTED|Overall Study||61
294914|NCT01826981|704616|P15|NOT COMPLETED|Overall Study||0
294915|NCT01826981|704617|P14|NOT COMPLETED|Overall Study||5
294916|NCT01826981|704618|P13|NOT COMPLETED|Overall Study||1
294917|NCT01826981|704619|P12|NOT COMPLETED|Overall Study||2
294918|NCT01826981|704620|P11|NOT COMPLETED|Overall Study||2
294919|NCT01826981|704621|P10|NOT COMPLETED|Overall Study||1
294920|NCT01826981|704622|P9|NOT COMPLETED|Overall Study||7
294921|NCT01826981|704623|P8|NOT COMPLETED|Overall Study||11
294922|NCT01826981|704624|P7|NOT COMPLETED|Overall Study||1
294923|NCT01826981|704625|P6|NOT COMPLETED|Overall Study||1
294924|NCT01826981|704626|P5|NOT COMPLETED|Overall Study||7
294925|NCT01826981|704627|P4|NOT COMPLETED|Overall Study||0
294926|NCT01826981|704628|P3|NOT COMPLETED|Overall Study||0
294927|NCT01826981|704629|P2|NOT COMPLETED|Overall Study||1
294928|NCT01826981|704630|P1|NOT COMPLETED|Overall Study||0
294929|NCT01826981|704616|P15|COMPLETED|Overall Study||8
294930|NCT01826981|704617|P14|COMPLETED|Overall Study||15
294931|NCT01826981|704618|P13|COMPLETED|Overall Study||25
294932|NCT01826981|704619|P12|COMPLETED|Overall Study||25
294933|NCT01826981|704620|P11|COMPLETED|Overall Study||22
294934|NCT01826981|704621|P10|COMPLETED|Overall Study||26
294935|NCT01826981|704622|P9|COMPLETED|Overall Study||13
294936|NCT01826981|704623|P8|COMPLETED|Overall Study||40
294938|NCT01826981|704625|P6|COMPLETED|Overall Study||25
294939|NCT01826981|704626|P5|COMPLETED|Overall Study||18
294940|NCT01826981|704627|P4|COMPLETED|Overall Study||26
294941|NCT01826981|704628|P3|COMPLETED|Overall Study||25
294942|NCT01826981|704629|P2|COMPLETED|Overall Study||9
294943|NCT01826981|704630|P1|COMPLETED|Overall Study||19
294944|NCT01826981|704616|P15|STARTED|Overall Study||8
294945|NCT01826981|704617|P14|STARTED|Overall Study||20
294946|NCT01826981|704618|P13|STARTED|Overall Study||26
294947|NCT01826981|704619|P12|STARTED|Overall Study||27
294948|NCT01826981|704620|P11|STARTED|Overall Study||24
294949|NCT01826981|704621|P10|STARTED|Overall Study||27
294950|NCT01826981|704622|P9|STARTED|Overall Study||20
294951|NCT01826981|704623|P8|STARTED|Overall Study||51
294952|NCT01826981|704624|P7|STARTED|Overall Study||25
294953|NCT01826981|704625|P6|STARTED|Overall Study||26
294954|NCT01826981|704626|P5|STARTED|Overall Study||25
294955|NCT01826981|704627|P4|STARTED|Overall Study||26
294956|NCT01826981|704628|P3|STARTED|Overall Study||25
294957|NCT01826981|704629|P2|STARTED|Overall Study||10
294958|NCT01826981|704630|P1|STARTED|Overall Study||19
294959|NCT01826812|704778|P2|NOT COMPLETED|Overall Study||1
294960|NCT01826812|704779|P1|NOT COMPLETED|Overall Study||0
294961|NCT01826812|704778|P2|COMPLETED|Overall Study||32
294962|NCT01826812|704779|P1|COMPLETED|Overall Study||167
294963|NCT01826812|704778|P2|STARTED|Overall Study||33
294964|NCT01826812|704779|P1|STARTED|Overall Study||167
294965|NCT01826604|704793|P2|NOT COMPLETED|Overall Study||9
294966|NCT01826604|704794|P1|NOT COMPLETED|Overall Study||8
294967|NCT01826604|704793|P2|COMPLETED|Overall Study||148
294968|NCT01826604|704794|P1|COMPLETED|Overall Study||136
294969|NCT01826604|704793|P2|STARTED|Overall Study||157
294970|NCT01826604|704794|P1|STARTED|Overall Study||144
294971|NCT01826513|704805|P3|NOT COMPLETED|Overall Study||0
294972|NCT01826513|704806|P2|NOT COMPLETED|Overall Study||0
294973|NCT01826513|704807|P1|NOT COMPLETED|Overall Study||0
294974|NCT01826513|704805|P3|COMPLETED|Overall Study||10
294975|NCT01826513|704806|P2|COMPLETED|Overall Study||10
294976|NCT01826513|704807|P1|COMPLETED|Overall Study||5
294977|NCT01826513|704805|P3|STARTED|Overall Study||10
294978|NCT01826513|704806|P2|STARTED|Overall Study||10
294979|NCT01826513|704807|P1|STARTED|Overall Study||5
294980|NCT01826370|704836|P1|NOT COMPLETED|Overall Study||20
294981|NCT01826370|704836|P1|COMPLETED|Overall Study||658
294982|NCT01826370|704836|P1|STARTED|Overall Study||678
294983|NCT01826214|704844|P2|NOT COMPLETED|Overall Study||34
294984|NCT01826214|704845|P1|NOT COMPLETED|Overall Study||35
294985|NCT01826214|704844|P2|COMPLETED|Overall Study||0
294986|NCT01826214|704845|P1|COMPLETED|Overall Study||0
294987|NCT01826214|704844|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
294988|NCT01826214|704845|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
294989|NCT01826214|704844|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
294990|NCT01826214|704845|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
294991|NCT01826214|704844|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
294992|NCT01826214|704845|P1|STARTED|Overall Study||35
294993|NCT01826201|704863|P1|NOT COMPLETED|Overall Study||4
294994|NCT01826201|704863|P1|COMPLETED|Overall Study||17
294995|NCT01826201|704863|P1|STARTED|Overall Study|Subjects in each arm are same|21
294996|NCT01825837|704873|P4|NOT COMPLETED|PART II||0
294997|NCT01825837|704874|P3|NOT COMPLETED|PART II||19
294998|NCT01825837|704875|P2|NOT COMPLETED|PART II||14
294999|NCT01825837|704876|P1|NOT COMPLETED|PART II||19
295000|NCT01825837|704873|P4|COMPLETED|PART II||0
295001|NCT01825837|704874|P3|COMPLETED|PART II||7
295002|NCT01825837|704875|P2|COMPLETED|PART II||12
295003|NCT01825837|704876|P1|COMPLETED|PART II||16
295004|NCT01825837|704873|P4|Per-Protocol Population|PART II||0
295005|NCT01825837|704874|P3|Per-Protocol Population|PART II||24
295006|NCT01825837|704875|P2|Per-Protocol Population|PART II||23
295007|NCT01825837|704876|P1|Per-Protocol Population|PART II||32
295008|NCT01825837|704873|P4|Intent-to-Treat Population|PART II||0
295009|NCT01825837|704874|P3|Intent-to-Treat Population|PART II||26
295010|NCT01825837|704875|P2|Intent-to-Treat Population|PART II||25
295011|NCT01825837|704876|P1|Intent-to-Treat Population|PART II||34
295012|NCT01825837|704873|P4|Safety Population (Double-Blind)|PART II||0
295013|NCT01825837|704874|P3|Safety Population (Double-Blind)|PART II||26
295014|NCT01825837|704875|P2|Safety Population (Double-Blind)|PART II||26
295015|NCT01825837|704876|P1|Safety Population (Double-Blind)|PART II||35
295016|NCT01825837|704873|P4|Randomized Patients|PART II||0
295017|NCT01825837|704874|P3|Randomized Patients|PART II||26
295018|NCT01825837|704875|P2|Randomized Patients|PART II||26
295019|NCT01825837|704876|P1|Randomized Patients|PART II||35
295020|NCT01825837|704873|P4|STARTED|PART II||0
295021|NCT01825837|704874|P3|STARTED|PART II||26
295022|NCT01825837|704875|P2|STARTED|PART II||26
295023|NCT01825837|704876|P1|STARTED|PART II||35
295024|NCT01825837|704873|P4|NOT COMPLETED|PART I||17
295025|NCT01825837|704874|P3|NOT COMPLETED|PART I||0
295026|NCT01825837|704875|P2|NOT COMPLETED|PART I||0
295027|NCT01825837|704876|P1|NOT COMPLETED|PART I||0
295028|NCT01825837|704873|P4|COMPLETED|PART I||87
295029|NCT01825837|704874|P3|COMPLETED|PART I||0
295030|NCT01825837|704875|P2|COMPLETED|PART I||0
295031|NCT01825837|704876|P1|COMPLETED|PART I||0
295032|NCT01825837|704873|P4|Safety Population (Open-Label)|PART I||104
295033|NCT01825837|704874|P3|Safety Population (Open-Label)|PART I||0
295034|NCT01825837|704875|P2|Safety Population (Open-Label)|PART I||0
295035|NCT01825837|704876|P1|Safety Population (Open-Label)|PART I||0
295036|NCT01825837|704873|P4|Enrolled|PART I||104
295037|NCT01825837|704874|P3|Enrolled|PART I||0
295038|NCT01825837|704875|P2|Enrolled|PART I||0
295039|NCT01825837|704876|P1|Enrolled|PART I||0
295040|NCT01825837|704873|P4|STARTED|PART I||104
295041|NCT01825837|704874|P3|STARTED|PART I||0
295042|NCT01825837|704875|P2|STARTED|PART I||0
295043|NCT01825837|704876|P1|STARTED|PART I||0
295044|NCT01825577|704884|P1|NOT COMPLETED|Overall Study||8
295045|NCT01825577|704884|P1|COMPLETED|Overall Study||6
295046|NCT01825577|704884|P1|STARTED|Overall Study||14
295047|NCT01825408|704893|P4|NOT COMPLETED|Overall Study||0
295048|NCT01825408|704894|P3|NOT COMPLETED|Overall Study||0
295049|NCT01825408|704895|P2|NOT COMPLETED|Overall Study||0
295050|NCT01825408|704896|P1|NOT COMPLETED|Overall Study||0
295051|NCT01825408|704893|P4|COMPLETED|Overall Study||12
295052|NCT01825408|704894|P3|COMPLETED|Overall Study||14
295053|NCT01825408|704895|P2|COMPLETED|Overall Study||7
295054|NCT01825408|704896|P1|COMPLETED|Overall Study||7
295055|NCT01825408|704893|P4|STARTED|Overall Study||12
295056|NCT01825408|704894|P3|STARTED|Overall Study||14
295057|NCT01825408|704895|P2|STARTED|Overall Study||7
295058|NCT01825408|704896|P1|STARTED|Overall Study||7
295059|NCT01825200|704908|P2|NOT COMPLETED|Overall Study||7
295060|NCT01825200|704909|P1|NOT COMPLETED|Overall Study||5
295061|NCT01825200|704908|P2|COMPLETED|Overall Study||1314
295062|NCT01825200|704909|P1|COMPLETED|Overall Study||1314
295063|NCT01825200|704908|P2|STARTED|Overall Study||1321
295064|NCT01825200|704909|P1|STARTED|Overall Study||1319
295065|NCT01825122|704923|P2|NOT COMPLETED|Overall Study||19
295066|NCT01825122|704924|P1|NOT COMPLETED|Overall Study||10
295067|NCT01825122|704923|P2|COMPLETED|Overall Study||59
295068|NCT01825122|704924|P1|COMPLETED|Overall Study||67
295069|NCT01825122|704923|P2|STARTED|Overall Study||78
295070|NCT01825122|704924|P1|STARTED|Overall Study||77
295071|NCT01824901|704930|P4|NOT COMPLETED|Overall Study||0
295072|NCT01824901|704931|P3|NOT COMPLETED|Overall Study||0
295073|NCT01824901|704932|P2|NOT COMPLETED|Overall Study||0
295074|NCT01824901|704933|P1|NOT COMPLETED|Overall Study||0
295075|NCT01824901|704930|P4|COMPLETED|Overall Study||0
295076|NCT01824901|704931|P3|COMPLETED|Overall Study||0
295077|NCT01824901|704932|P2|COMPLETED|Overall Study||0
295078|NCT01824901|704933|P1|COMPLETED|Overall Study||2
295079|NCT01824901|704930|P4|STARTED|Overall Study||0
295080|NCT01824901|704931|P3|STARTED|Overall Study||0
295081|NCT01824901|704932|P2|STARTED|Overall Study||0
295082|NCT01824901|704933|P1|STARTED|Overall Study||2
295083|NCT01824823|704939|P2|NOT COMPLETED|Overall Study||1
295084|NCT01824823|704940|P1|NOT COMPLETED|Overall Study||2
295085|NCT01824823|704939|P2|COMPLETED|Overall Study||0
295086|NCT01824823|704940|P1|COMPLETED|Overall Study||0
295087|NCT01824823|704939|P2|STARTED|Overall Study||1
295088|NCT01824823|704940|P1|STARTED|Overall Study||2
295089|NCT01824602|704950|P4|NOT COMPLETED|Overall Study||5
295090|NCT01824602|704951|P3|NOT COMPLETED|Overall Study||4
295091|NCT01824602|704952|P2|NOT COMPLETED|Overall Study||0
295092|NCT01824602|704953|P1|NOT COMPLETED|Overall Study||1
295093|NCT01824602|704950|P4|COMPLETED|Overall Study||5
295094|NCT01824602|704951|P3|COMPLETED|Overall Study||5
295095|NCT01824602|704952|P2|COMPLETED|Overall Study||8
295096|NCT01824602|704953|P1|COMPLETED|Overall Study||10
295097|NCT01824602|704950|P4|Intent-to-treat Population|Overall Study||9
295098|NCT01824602|704951|P3|Intent-to-treat Population|Overall Study||9
295099|NCT01824602|704952|P2|Intent-to-treat Population|Overall Study||8
295100|NCT01824602|704953|P1|Intent-to-treat Population|Overall Study||11
295101|NCT01824602|704950|P4|Safety Population|Overall Study||10
295102|NCT01824602|704951|P3|Safety Population|Overall Study||9
295103|NCT01824602|704952|P2|Safety Population|Overall Study||8
295104|NCT01824602|704953|P1|Safety Population|Overall Study||11
295105|NCT01824602|704950|P4|STARTED|Overall Study||10
295106|NCT01824602|704951|P3|STARTED|Overall Study||9
295107|NCT01824602|704952|P2|STARTED|Overall Study||8
295108|NCT01824602|704953|P1|STARTED|Overall Study||11
295109|NCT01824589|704967|P4|NOT COMPLETED|Overall Study||0
295110|NCT01824589|704968|P3|NOT COMPLETED|Overall Study||0
295111|NCT01824589|704969|P2|NOT COMPLETED|Overall Study||0
295112|NCT01824589|704970|P1|NOT COMPLETED|Overall Study||0
295113|NCT01824589|704967|P4|COMPLETED|Overall Study||0
295114|NCT01824589|704968|P3|COMPLETED|Overall Study||0
295115|NCT01824589|704969|P2|COMPLETED|Overall Study||0
295116|NCT01824589|704970|P1|COMPLETED|Overall Study||1
295117|NCT01824589|704967|P4|STARTED|Overall Study||0
295118|NCT01824589|704968|P3|STARTED|Overall Study||0
295119|NCT01824589|704969|P2|STARTED|Overall Study||0
295120|NCT01824589|704970|P1|STARTED|Overall Study||1
295121|NCT01824498|704998|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
295122|NCT01824498|704999|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
295123|NCT01824498|705000|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
295124|NCT01824498|705001|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
295125|NCT01824498|705002|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
295126|NCT01824498|705003|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
295127|NCT01824498|704998|P6|COMPLETED|3rd Intervention (8 Weeks)||4
295128|NCT01824498|704999|P5|COMPLETED|3rd Intervention (8 Weeks)||3
295129|NCT01824498|705000|P4|COMPLETED|3rd Intervention (8 Weeks)||2
295130|NCT01824498|705001|P3|COMPLETED|3rd Intervention (8 Weeks)||4
295131|NCT01824498|705002|P2|COMPLETED|3rd Intervention (8 Weeks)||2
295132|NCT01824498|705003|P1|COMPLETED|3rd Intervention (8 Weeks)||3
295133|NCT01824498|704998|P6|STARTED|3rd Intervention (8 Weeks)||4
295134|NCT01824498|704999|P5|STARTED|3rd Intervention (8 Weeks)||3
295135|NCT01824498|705000|P4|STARTED|3rd Intervention (8 Weeks)||2
295136|NCT01824498|705001|P3|STARTED|3rd Intervention (8 Weeks)||4
295137|NCT01824498|705002|P2|STARTED|3rd Intervention (8 Weeks)||2
295138|NCT01824498|705003|P1|STARTED|3rd Intervention (8 Weeks)||3
295139|NCT01824498|704998|P6|NOT COMPLETED|Washout (8 Weeks)||0
295140|NCT01824498|704999|P5|NOT COMPLETED|Washout (8 Weeks)||0
295141|NCT01824498|705000|P4|NOT COMPLETED|Washout (8 Weeks)||0
295142|NCT01824498|705001|P3|NOT COMPLETED|Washout (8 Weeks)||0
295143|NCT01824498|705002|P2|NOT COMPLETED|Washout (8 Weeks)||0
295144|NCT01824498|705003|P1|NOT COMPLETED|Washout (8 Weeks)||0
295145|NCT01824498|704998|P6|COMPLETED|Washout (8 Weeks)||4
295146|NCT01824498|704999|P5|COMPLETED|Washout (8 Weeks)||3
295147|NCT01824498|705000|P4|COMPLETED|Washout (8 Weeks)||2
295148|NCT01824498|705001|P3|COMPLETED|Washout (8 Weeks)||4
295149|NCT01824498|705002|P2|COMPLETED|Washout (8 Weeks)||2
295150|NCT01824498|705003|P1|COMPLETED|Washout (8 Weeks)||3
295151|NCT01824498|704998|P6|STARTED|Washout (8 Weeks)||4
295152|NCT01824498|704999|P5|STARTED|Washout (8 Weeks)||3
295153|NCT01824498|705000|P4|STARTED|Washout (8 Weeks)||2
295154|NCT01824498|705001|P3|STARTED|Washout (8 Weeks)||4
295155|NCT01824498|705002|P2|STARTED|Washout (8 Weeks)||2
295156|NCT01824498|705003|P1|STARTED|Washout (8 Weeks)||3
295157|NCT01824498|704998|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
295158|NCT01824498|704999|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
295159|NCT01824498|705000|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
295160|NCT01824498|705001|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
295161|NCT01824498|705002|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
295162|NCT01824498|705003|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
295163|NCT01824498|704998|P6|COMPLETED|2nd Intervention (8 Weeks)||4
295164|NCT01824498|704999|P5|COMPLETED|2nd Intervention (8 Weeks)||3
295165|NCT01824498|705000|P4|COMPLETED|2nd Intervention (8 Weeks)||2
295166|NCT01824498|705001|P3|COMPLETED|2nd Intervention (8 Weeks)||4
295167|NCT01824498|705002|P2|COMPLETED|2nd Intervention (8 Weeks)||2
295168|NCT01824498|705003|P1|COMPLETED|2nd Intervention (8 Weeks)||3
295169|NCT01824498|704998|P6|STARTED|2nd Intervention (8 Weeks)||4
295170|NCT01824498|704999|P5|STARTED|2nd Intervention (8 Weeks)||3
295171|NCT01824498|705000|P4|STARTED|2nd Intervention (8 Weeks)||2
295172|NCT01824498|705001|P3|STARTED|2nd Intervention (8 Weeks)||4
295173|NCT01824498|705002|P2|STARTED|2nd Intervention (8 Weeks)||2
295174|NCT01824498|705003|P1|STARTED|2nd Intervention (8 Weeks)||3
295175|NCT01824498|704998|P6|NOT COMPLETED|Washout (8 Weeks)||0
295176|NCT01824498|704999|P5|NOT COMPLETED|Washout (8 Weeks)||1
295177|NCT01824498|705000|P4|NOT COMPLETED|Washout (8 Weeks)||1
295178|NCT01824498|705001|P3|NOT COMPLETED|Washout (8 Weeks)||2
295179|NCT01824498|705002|P2|NOT COMPLETED|Washout (8 Weeks)||0
295180|NCT01824498|705003|P1|NOT COMPLETED|Washout (8 Weeks)||2
295181|NCT01824498|704998|P6|COMPLETED|Washout (8 Weeks)||4
295182|NCT01824498|704999|P5|COMPLETED|Washout (8 Weeks)||3
295183|NCT01824498|705000|P4|COMPLETED|Washout (8 Weeks)||2
295184|NCT01824498|705001|P3|COMPLETED|Washout (8 Weeks)||4
295185|NCT01824498|705002|P2|COMPLETED|Washout (8 Weeks)||2
295186|NCT01824498|705003|P1|COMPLETED|Washout (8 Weeks)||3
295187|NCT01824498|704998|P6|STARTED|Washout (8 Weeks)||4
295188|NCT01824498|704999|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
295189|NCT01824498|705000|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
295190|NCT01824498|705001|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
295191|NCT01824498|705002|P2|STARTED|Washout (8 Weeks)||2
295192|NCT01824498|705003|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
295193|NCT01824498|704998|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
295194|NCT01824498|704999|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
295195|NCT01824498|705000|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
295196|NCT01824498|705001|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
295197|NCT01824498|705002|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
295198|NCT01824498|705003|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
295199|NCT01824498|704998|P6|COMPLETED|1st Intervention (8 Weeks)||4
295200|NCT01824498|704999|P5|COMPLETED|1st Intervention (8 Weeks)||4
295201|NCT01824498|705000|P4|COMPLETED|1st Intervention (8 Weeks)||3
295202|NCT01824498|705001|P3|COMPLETED|1st Intervention (8 Weeks)||6
295203|NCT01824498|705002|P2|COMPLETED|1st Intervention (8 Weeks)||2
295204|NCT01824498|705003|P1|COMPLETED|1st Intervention (8 Weeks)||5
295205|NCT01824498|704998|P6|STARTED|1st Intervention (8 Weeks)||4
295206|NCT01824498|704999|P5|STARTED|1st Intervention (8 Weeks)||4
295207|NCT01824498|705000|P4|STARTED|1st Intervention (8 Weeks)||3
295208|NCT01824498|705001|P3|STARTED|1st Intervention (8 Weeks)||6
295209|NCT01824498|705002|P2|STARTED|1st Intervention (8 Weeks)||2
295210|NCT01824498|705003|P1|STARTED|1st Intervention (8 Weeks)||5
295211|NCT01824446|705011|P1|NOT COMPLETED|Overall Study||0
295212|NCT01824446|705011|P1|COMPLETED|Overall Study||6
295213|NCT01824446|705011|P1|STARTED|Overall Study||6
295214|NCT01824355|705034|P1|NOT COMPLETED|Overall Study||3
295215|NCT01824355|705034|P1|COMPLETED|Overall Study||110
295216|NCT01824355|705034|P1|STARTED|Overall Study||113
295217|NCT01824342|705045|P2|NOT COMPLETED|Overall Study||5
295218|NCT01824342|705046|P1|NOT COMPLETED|Overall Study||9
295219|NCT01824342|705045|P2|COMPLETED|Overall Study||2
295220|NCT01824342|705046|P1|COMPLETED|Overall Study||2
295221|NCT01824342|705045|P2|STARTED|Overall Study||7
295222|NCT01824342|705046|P1|STARTED|Overall Study||11
295223|NCT01824303|705060|P2|NOT COMPLETED|Open Label Extension||0
295224|NCT01824303|705061|P1|NOT COMPLETED|Open Label Extension||0
295225|NCT01824303|705060|P2|COMPLETED|Open Label Extension||11
295226|NCT01824303|705061|P1|COMPLETED|Open Label Extension||12
295227|NCT01824303|705060|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
295228|NCT01824303|705061|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
295229|NCT01824303|705060|P2|NOT COMPLETED|Randomized Study||1
295230|NCT01824303|705061|P1|NOT COMPLETED|Randomized Study||2
295231|NCT01824303|705060|P2|COMPLETED|Randomized Study||13
295232|NCT01824303|705061|P1|COMPLETED|Randomized Study||14
295233|NCT01824303|705060|P2|STARTED|Randomized Study||14
295234|NCT01824303|705061|P1|STARTED|Randomized Study||16
295235|NCT01824160|705085|P1|NOT COMPLETED|Overall Study||0
295236|NCT01824160|705085|P1|COMPLETED|Overall Study||50
295237|NCT01824160|705085|P1|STARTED|Overall Study||50
295238|NCT01823679|705089|P1|NOT COMPLETED|Overall Study||1
295239|NCT01823679|705089|P1|COMPLETED|Overall Study||1
295240|NCT01823679|705089|P1|STARTED|Overall Study||2
295241|NCT01823653|705097|P1|NOT COMPLETED|Overall Study||0
295242|NCT01823653|705097|P1|COMPLETED|Overall Study||60
295243|NCT01823653|705097|P1|STARTED|Overall Study||60
295244|NCT01823614|705111|P6|NOT COMPLETED|Overall Study||0
295245|NCT01823614|705112|P5|NOT COMPLETED|Overall Study||0
295246|NCT01823614|705113|P4|NOT COMPLETED|Overall Study||0
295247|NCT01823614|705114|P3|NOT COMPLETED|Overall Study||0
295248|NCT01823614|705115|P2|NOT COMPLETED|Overall Study||0
295249|NCT01823614|705116|P1|NOT COMPLETED|Overall Study||0
295250|NCT01823614|705111|P6|COMPLETED|Overall Study||154
295251|NCT01823614|705112|P5|COMPLETED|Overall Study||172
295252|NCT01823614|705113|P4|COMPLETED|Overall Study||122
295253|NCT01823614|705114|P3|COMPLETED|Overall Study||176
295254|NCT01823614|705115|P2|COMPLETED|Overall Study||140
295255|NCT01823614|705116|P1|COMPLETED|Overall Study||179
295256|NCT01823614|705111|P6|STARTED|Overall Study||154
295257|NCT01823614|705112|P5|STARTED|Overall Study||172
295258|NCT01823614|705113|P4|STARTED|Overall Study||122
295259|NCT01823614|705114|P3|STARTED|Overall Study||176
295260|NCT01823614|705115|P2|STARTED|Overall Study||140
295261|NCT01823614|705116|P1|STARTED|Overall Study||179
295262|NCT01823536|705142|P6|NOT COMPLETED|Overall Study||0
295263|NCT01823536|705143|P5|NOT COMPLETED|Overall Study||2
295264|NCT01823536|705144|P4|NOT COMPLETED|Overall Study||2
295265|NCT01823536|705145|P3|NOT COMPLETED|Overall Study||1
295266|NCT01823536|705146|P2|NOT COMPLETED|Overall Study||2
295267|NCT01823536|705147|P1|NOT COMPLETED|Overall Study||2
295268|NCT01823536|705142|P6|COMPLETED|Overall Study||2
295269|NCT01823536|705143|P5|COMPLETED|Overall Study||99
295270|NCT01823536|705144|P4|COMPLETED|Overall Study||64
295271|NCT01823536|705145|P3|COMPLETED|Overall Study||119
295272|NCT01823536|705146|P2|COMPLETED|Overall Study||101
295273|NCT01823536|705147|P1|COMPLETED|Overall Study||71
295274|NCT01823536|705142|P6|STARTED|Overall Study||2
295275|NCT01823536|705143|P5|STARTED|Overall Study||101
295276|NCT01823536|705144|P4|STARTED|Overall Study||66
295277|NCT01823536|705145|P3|STARTED|Overall Study||120
295278|NCT01823536|705146|P2|STARTED|Overall Study||103
295279|NCT01823536|705147|P1|STARTED|Overall Study||73
295280|NCT01823341|705185|P1|NOT COMPLETED|Overall Study||15
295281|NCT01823341|705185|P1|COMPLETED|Overall Study||82
295282|NCT01823341|705185|P1|STARTED|Overall Study||97
295283|NCT01823289|705228|P1|NOT COMPLETED|Overall Study||24
295284|NCT01823289|705228|P1|COMPLETED|Overall Study||47
295285|NCT01823289|705228|P1|STARTED|Overall Study||71
295286|NCT01823224|705236|P2|NOT COMPLETED|Overall Study||11
295287|NCT01823224|705237|P1|NOT COMPLETED|Overall Study||6
295288|NCT01823224|705236|P2|COMPLETED|Overall Study||22
295289|NCT01823224|705237|P1|COMPLETED|Overall Study||28
295290|NCT01823224|705236|P2|STARTED|Overall Study||33
295291|NCT01823224|705237|P1|STARTED|Overall Study||34
295292|NCT01823146|705247|P2|NOT COMPLETED|Overall Study||2
295293|NCT01823146|705248|P1|NOT COMPLETED|Overall Study||2
295294|NCT01823146|705247|P2|COMPLETED|Overall Study||49
295295|NCT01823146|705248|P1|COMPLETED|Overall Study||53
295296|NCT01823146|705247|P2|STARTED|Overall Study||51
295297|NCT01823146|705248|P1|STARTED|Overall Study||55
295298|NCT01822899|705260|P2|NOT COMPLETED|Overall Study||18
295299|NCT01822899|705261|P1|NOT COMPLETED|Overall Study||24
295300|NCT01822899|705260|P2|COMPLETED|Overall Study||340
295301|NCT01822899|705261|P1|COMPLETED|Overall Study||334
295302|NCT01822899|705260|P2|STARTED|Overall Study||358
295303|NCT01822899|705261|P1|STARTED|Overall Study||358
295304|NCT01822821|705271|P2|NOT COMPLETED|Overall Study||1
295305|NCT01822821|705272|P1|NOT COMPLETED|Overall Study||2
295306|NCT01822821|705271|P2|COMPLETED|Overall Study||74
295307|NCT01822821|705272|P1|COMPLETED|Overall Study||73
295308|NCT01822821|705271|P2|STARTED|Overall Study||75
295309|NCT01822821|705272|P1|STARTED|Overall Study||75
295310|NCT01822756|705301|P5|NOT COMPLETED|Overall Study||7
295311|NCT01822756|705302|P4|NOT COMPLETED|Overall Study||4
295312|NCT01822756|705303|P3|NOT COMPLETED|Overall Study||10
295313|NCT01822756|705304|P2|NOT COMPLETED|Overall Study||4
295314|NCT01822756|705305|P1|NOT COMPLETED|Overall Study||16
295315|NCT01822756|705301|P5|COMPLETED|Overall Study||1
295316|NCT01822756|705302|P4|COMPLETED|Overall Study||0
295317|NCT01822756|705303|P3|COMPLETED|Overall Study||0
295318|NCT01822756|705304|P2|COMPLETED|Overall Study||0
295319|NCT01822756|705305|P1|COMPLETED|Overall Study||0
295320|NCT01822756|705301|P5|Discontinued From the Study|Overall Study||7
295321|NCT01822756|705302|P4|Discontinued From the Study|Overall Study||4
295322|NCT01822756|705303|P3|Discontinued From the Study|Overall Study||10
295323|NCT01822756|705304|P2|Discontinued From the Study|Overall Study||4
295324|NCT01822756|705305|P1|Discontinued From the Study|Overall Study||16
295325|NCT01822756|705301|P5|STARTED|Overall Study||8
295326|NCT01822756|705302|P4|STARTED|Overall Study||4
295327|NCT01822756|705303|P3|STARTED|Overall Study||10
295328|NCT01822756|705304|P2|STARTED|Overall Study||4
295329|NCT01822756|705305|P1|STARTED|Overall Study||16
295330|NCT01822691|705347|P1|NOT COMPLETED|Overall Study||2
295331|NCT01822691|705347|P1|COMPLETED|Overall Study||13
295332|NCT01822691|705347|P1|STARTED|Overall Study||15
295333|NCT01822678|705358|P3|NOT COMPLETED|Overall Study||11
295334|NCT01822678|705359|P2|NOT COMPLETED|Overall Study||15
295335|NCT01822678|705360|P1|NOT COMPLETED|Overall Study||12
295336|NCT01822678|705358|P3|COMPLETED|Overall Study||29
295337|NCT01822678|705359|P2|COMPLETED|Overall Study||49
295338|NCT01822678|705360|P1|COMPLETED|Overall Study||45
295339|NCT01822678|705358|P3|Per Protocol Population|Overall Study||34
295340|NCT01822678|705359|P2|Per Protocol Population|Overall Study||52
295341|NCT01822678|705360|P1|Per Protocol Population|Overall Study||45
295342|NCT01822678|705358|P3|Intention-to-Treat Population (ITT)|Overall Study||40
295343|NCT01822678|705359|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
295344|NCT01822678|705360|P1|Intention-to-Treat Population (ITT)|Overall Study||57
295345|NCT01822678|705358|P3|Safety Population|Overall Study||40
295346|NCT01822678|705359|P2|Safety Population|Overall Study||64
295347|NCT01822678|705360|P1|Safety Population|Overall Study||57
295348|NCT01822678|705358|P3|Treated|Overall Study||40
295349|NCT01822678|705359|P2|Treated|Overall Study||64
295350|NCT01822678|705360|P1|Treated|Overall Study||57
295351|NCT01822678|705358|P3|STARTED|Overall Study||40
295352|NCT01822678|705359|P2|STARTED|Overall Study||64
295353|NCT01822678|705360|P1|STARTED|Overall Study||57
295354|NCT01822665|705368|P1|NOT COMPLETED|Overall Study||8
295355|NCT01822665|705368|P1|COMPLETED|Overall Study||20
295356|NCT01822665|705368|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
295357|NCT01822665|705368|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
295358|NCT01822665|705368|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
295359|NCT01822665|705368|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
295360|NCT01822665|705368|P1|STARTED|Overall Study||28
295361|NCT01822574|705395|P3|NOT COMPLETED|Overall Study||0
295362|NCT01822574|705396|P2|NOT COMPLETED|Overall Study||0
295363|NCT01822574|705397|P1|NOT COMPLETED|Overall Study||0
295364|NCT01822574|705395|P3|COMPLETED|Overall Study||30
295365|NCT01822574|705396|P2|COMPLETED|Overall Study||30
295366|NCT01822574|705397|P1|COMPLETED|Overall Study||30
295367|NCT01822574|705395|P3|STARTED|Overall Study||30
295368|NCT01822574|705396|P2|STARTED|Overall Study||30
295369|NCT01822574|705397|P1|STARTED|Overall Study||30
295370|NCT01822535|705413|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
295371|NCT01822535|705414|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
295372|NCT01822535|705413|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
295373|NCT01822535|705414|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
295374|NCT01822535|705413|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
295375|NCT01822535|705414|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
295376|NCT01822535|705413|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
295377|NCT01822535|705414|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
295378|NCT01822535|705413|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
295379|NCT01822535|705414|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
295380|NCT01822535|705413|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
295381|NCT01822535|705414|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
295382|NCT01822301|705426|P1|NOT COMPLETED|Overall Study||0
295383|NCT01822301|705426|P1|COMPLETED|Overall Study||5
295384|NCT01822301|705426|P1|STARTED|Overall Study||5
295385|NCT01822223|705438|P2|NOT COMPLETED|Overall Study||1
295386|NCT01822223|705439|P1|NOT COMPLETED|Overall Study||0
295387|NCT01822223|705438|P2|COMPLETED|Overall Study||9
295388|NCT01822223|705439|P1|COMPLETED|Overall Study||10
295389|NCT01822223|705438|P2|STARTED|Overall Study||10
295390|NCT01822223|705439|P1|STARTED|Overall Study||10
295391|NCT01822197|705455|P1|NOT COMPLETED|Overall Study||0
295392|NCT01822197|705455|P1|COMPLETED|Overall Study||30
295393|NCT01822197|705455|P1|STARTED|Overall Study||30
295394|NCT01822119|705461|P1|NOT COMPLETED|Overall Study||0
295395|NCT01822119|705461|P1|COMPLETED|Overall Study||27
295396|NCT01822119|705461|P1|STARTED|Overall Study||27
295397|NCT01821963|705484|P1|NOT COMPLETED|Overall Study||1
295398|NCT01821963|705484|P1|COMPLETED|Overall Study||0
295399|NCT01821963|705484|P1|STARTED|Overall Study||1
295400|NCT01821937|705490|P2|NOT COMPLETED|Overall Study||3
295401|NCT01821937|705491|P1|NOT COMPLETED|Overall Study||0
295402|NCT01821937|705490|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
295403|NCT01821937|705491|P1|COMPLETED|Overall Study||10
295404|NCT01821937|705490|P2|STARTED|Overall Study||15
295405|NCT01821937|705491|P1|STARTED|Overall Study||10
295406|NCT01821859|705509|P1|NOT COMPLETED|Overall Study||5
295407|NCT01821859|705509|P1|COMPLETED|Overall Study||0
295408|NCT01821859|705509|P1|STARTED|Overall Study||5
295409|NCT01821807|705515|P2|NOT COMPLETED|Overall Study||1
295410|NCT01821807|705516|P1|NOT COMPLETED|Overall Study||3
295411|NCT01821807|705515|P2|COMPLETED|Overall Study||109
295412|NCT01821807|705516|P1|COMPLETED|Overall Study||147
295413|NCT01821807|705515|P2|STARTED|Overall Study||110
295414|NCT01821807|705516|P1|STARTED|Overall Study||150
295415|NCT01821534|705524|P1|NOT COMPLETED|Overall Study||0
295416|NCT01821534|705524|P1|COMPLETED|Overall Study||201
295417|NCT01821534|705524|P1|STARTED|Overall Study||201
295418|NCT01821417|705533|P2|NOT COMPLETED|Overall Study||0
295419|NCT01821417|705534|P1|NOT COMPLETED|Overall Study||0
295420|NCT01821417|705533|P2|COMPLETED|Overall Study||31
295421|NCT01821417|705534|P1|COMPLETED|Overall Study||37
295422|NCT01821417|705533|P2|STARTED|Overall Study||31
295423|NCT01821417|705534|P1|STARTED|Overall Study||37
295424|NCT01821378|705547|P3|NOT COMPLETED|Overall Study||42
295425|NCT01821378|705548|P2|NOT COMPLETED|Overall Study||54
295426|NCT01821378|705549|P1|NOT COMPLETED|Overall Study||27
295427|NCT01821378|705547|P3|COMPLETED|Overall Study||70
295428|NCT01821378|705548|P2|COMPLETED|Overall Study||145
295429|NCT01821378|705549|P1|COMPLETED|Overall Study||74
295430|NCT01821378|705547|P3|STARTED|Overall Study||112
295431|NCT01821378|705548|P2|STARTED|Overall Study||199
295432|NCT01821378|705549|P1|STARTED|Overall Study||101
295433|NCT01821352|705587|P2|NOT COMPLETED|Overall Study||0
295434|NCT01821352|705588|P1|NOT COMPLETED|Overall Study||0
295435|NCT01821352|705587|P2|COMPLETED|Overall Study||25
295436|NCT01821352|705588|P1|COMPLETED|Overall Study||28
295437|NCT01821352|705587|P2|STARTED|Overall Study||25
295438|NCT01821352|705588|P1|STARTED|Overall Study||28
295439|NCT01821326|705598|P1|NOT COMPLETED|Overall Study||0
295440|NCT01821326|705598|P1|COMPLETED|Overall Study||339
295441|NCT01821326|705598|P1|STARTED|Overall Study||339
295442|NCT01821118|705604|P2|NOT COMPLETED|Overall Study||1
295443|NCT01821118|705605|P1|NOT COMPLETED|Overall Study||0
295444|NCT01821118|705604|P2|COMPLETED|Overall Study||11
295445|NCT01821118|705605|P1|COMPLETED|Overall Study||24
295446|NCT01821118|705604|P2|STARTED|Overall Study||12
295447|NCT01821118|705605|P1|STARTED|Overall Study||24
295448|NCT01821105|705638|P1|NOT COMPLETED|Overall Study||0
295449|NCT01821105|705638|P1|COMPLETED|Overall Study||21
295450|NCT01821105|705638|P1|STARTED|Overall Study||21
295451|NCT01820585|705648|P4|NOT COMPLETED|Overall Study||49
295452|NCT01820585|705649|P3|NOT COMPLETED|Overall Study||34
295453|NCT01820585|705650|P2|NOT COMPLETED|Overall Study||32
295454|NCT01820585|705651|P1|NOT COMPLETED|Overall Study||27
295455|NCT01820585|705648|P4|COMPLETED|Overall Study||83
295456|NCT01820585|705649|P3|COMPLETED|Overall Study||101
295457|NCT01820585|705650|P2|COMPLETED|Overall Study||98
295458|NCT01820585|705651|P1|COMPLETED|Overall Study||104
295459|NCT01820585|705648|P4|Completed Maintenance Period|Overall Study||84
295460|NCT01820585|705649|P3|Completed Maintenance Period|Overall Study||101
295461|NCT01820585|705650|P2|Completed Maintenance Period|Overall Study||98
295462|NCT01820585|705651|P1|Completed Maintenance Period|Overall Study||105
295463|NCT01820585|705648|P4|Entered Maintenance Period|Overall Study||123
295464|NCT01820585|705649|P3|Entered Maintenance Period|Overall Study||131
295465|NCT01820585|705650|P2|Entered Maintenance Period|Overall Study||124
295466|NCT01820585|705651|P1|Entered Maintenance Period|Overall Study||128
295467|NCT01820585|705648|P4|Completed Titration Period|Overall Study||126
295468|NCT01820585|705649|P3|Completed Titration Period|Overall Study||131
295469|NCT01820585|705650|P2|Completed Titration Period|Overall Study||125
295470|NCT01820585|705651|P1|Completed Titration Period|Overall Study||128
295471|NCT01820585|705648|P4|Full Analysis Set|Overall Study||129
295472|NCT01820585|705649|P3|Full Analysis Set|Overall Study||135
295473|NCT01820585|705650|P2|Full Analysis Set|Overall Study||130
295474|NCT01820585|705651|P1|Full Analysis Set|Overall Study||131
295475|NCT01820585|705648|P4|Randomized and Treated|Overall Study||132
295476|NCT01820585|705649|P3|Randomized and Treated|Overall Study||135
295477|NCT01820585|705650|P2|Randomized and Treated|Overall Study||130
295478|NCT01820585|705651|P1|Randomized and Treated|Overall Study||131
295479|NCT01820585|705648|P4|STARTED|Overall Study||132
295480|NCT01820585|705649|P3|STARTED|Overall Study||135
295481|NCT01820585|705650|P2|STARTED|Overall Study||130
295482|NCT01820585|705651|P1|STARTED|Overall Study||131
295483|NCT01820559|705664|P3|NOT COMPLETED|Overall Study||29
295484|NCT01820559|705665|P2|NOT COMPLETED|Overall Study||13
295485|NCT01820559|705666|P1|NOT COMPLETED|Overall Study||14
295486|NCT01820559|705664|P3|COMPLETED|Overall Study||110
295487|NCT01820559|705665|P2|COMPLETED|Overall Study||122
295488|NCT01820559|705666|P1|COMPLETED|Overall Study||122
295489|NCT01820559|705664|P3|Completed Maintenance Period|Overall Study||110
295490|NCT01820559|705665|P2|Completed Maintenance Period|Overall Study||123
295491|NCT01820559|705666|P1|Completed Maintenance Period|Overall Study||122
295492|NCT01820559|705664|P3|Entered Maintenance Period|Overall Study||129
295493|NCT01820559|705665|P2|Entered Maintenance Period|Overall Study||133
295494|NCT01820559|705666|P1|Entered Maintenance Period|Overall Study||129
295495|NCT01820559|705664|P3|Completed Tutration Period|Overall Study||131
295496|NCT01820559|705665|P2|Completed Tutration Period|Overall Study||134
295497|NCT01820559|705666|P1|Completed Tutration Period|Overall Study||130
295498|NCT01820559|705664|P3|Randomized and Treated|Overall Study||139
295499|NCT01820559|705665|P2|Randomized and Treated|Overall Study||135
295500|NCT01820559|705666|P1|Randomized and Treated|Overall Study||136
295501|NCT01820559|705664|P3|STARTED|Overall Study||139
295502|NCT01820559|705665|P2|STARTED|Overall Study||135
295503|NCT01820559|705666|P1|STARTED|Overall Study||136
295504|NCT01820416|705677|P3|NOT COMPLETED|Overall Study||0
295505|NCT01820416|705678|P2|NOT COMPLETED|Overall Study||2
295506|NCT01820416|705679|P1|NOT COMPLETED|Overall Study||3
295507|NCT01820416|705677|P3|COMPLETED|Overall Study||11
295508|NCT01820416|705678|P2|COMPLETED|Overall Study||10
295509|NCT01820416|705679|P1|COMPLETED|Overall Study||9
295510|NCT01820416|705677|P3|STARTED|Overall Study||11
295511|NCT01820416|705678|P2|STARTED|Overall Study||12
295512|NCT01820416|705679|P1|STARTED|Overall Study||12
295513|NCT01820364|705687|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
295514|NCT01820364|705688|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
295515|NCT01820364|705687|P2|COMPLETED|Part II: LGX818 + MEK162||0
295516|NCT01820364|705688|P1|COMPLETED|Part II: LGX818 + MEK162||0
295517|NCT01820364|705687|P2|STARTED|Part II: LGX818 + MEK162||1
295518|NCT01820364|705688|P1|STARTED|Part II: LGX818 + MEK162||0
295519|NCT01820364|705687|P2|NOT COMPLETED|Part I: LGX818||0
295520|NCT01820364|705688|P1|NOT COMPLETED|Part I: LGX818||14
295521|NCT01820364|705687|P2|COMPLETED|Part I: LGX818||0
295522|NCT01820364|705688|P1|COMPLETED|Part I: LGX818||1
295523|NCT01820364|705687|P2|STARTED|Part I: LGX818||0
295524|NCT01820364|705688|P1|STARTED|Part I: LGX818||15
295525|NCT01819935|705702|P2|NOT COMPLETED|Overall Study||0
295526|NCT01819935|705703|P1|NOT COMPLETED|Overall Study||0
295527|NCT01819935|705702|P2|COMPLETED|Overall Study||4943
295528|NCT01819935|705703|P1|COMPLETED|Overall Study||328
295529|NCT01819935|705702|P2|STARTED|Overall Study||4943
295530|NCT01819935|705703|P1|STARTED|Overall Study||328
295531|NCT01819922|705723|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
295532|NCT01819922|705724|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
295533|NCT01819922|705723|P2|COMPLETED|Second Intervention Period (1 Day)||6
295534|NCT01819922|705724|P1|COMPLETED|Second Intervention Period (1 Day)||6
295535|NCT01819922|705723|P2|STARTED|Second Intervention Period (1 Day)||6
295536|NCT01819922|705724|P1|STARTED|Second Intervention Period (1 Day)||6
295537|NCT01819922|705723|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
295538|NCT01819922|705724|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
295539|NCT01819922|705723|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
295540|NCT01819922|705724|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
295541|NCT01819922|705723|P2|STARTED|Washout Period (at Least 7-10 Days)||6
295542|NCT01819922|705724|P1|STARTED|Washout Period (at Least 7-10 Days)||6
295543|NCT01819922|705723|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
295544|NCT01819922|705724|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
295545|NCT01819922|705723|P2|COMPLETED|First Intervention Period (1 Day)||6
295546|NCT01819922|705724|P1|COMPLETED|First Intervention Period (1 Day)||6
295547|NCT01819922|705723|P2|STARTED|First Intervention Period (1 Day)||6
295548|NCT01819922|705724|P1|STARTED|First Intervention Period (1 Day)||6
295549|NCT01819415|705812|P4|NOT COMPLETED|Overall Study||2
295550|NCT01819415|705813|P3|NOT COMPLETED|Overall Study||1
295551|NCT01819415|705814|P2|NOT COMPLETED|Overall Study||4
295552|NCT01819415|705815|P1|NOT COMPLETED|Overall Study||3
295553|NCT01819415|705812|P4|COMPLETED|Overall Study||8
295554|NCT01819415|705813|P3|COMPLETED|Overall Study||9
295555|NCT01819415|705814|P2|COMPLETED|Overall Study||6
295556|NCT01819415|705815|P1|COMPLETED|Overall Study||7
295557|NCT01819415|705812|P4|STARTED|Overall Study||10
295558|NCT01819415|705813|P3|STARTED|Overall Study||10
295559|NCT01819415|705814|P2|STARTED|Overall Study||10
295560|NCT01819415|705815|P1|STARTED|Overall Study||10
295561|NCT01819272|705831|P6|NOT COMPLETED|Overall Study||7
295562|NCT01819272|705832|P5|NOT COMPLETED|Overall Study||4
295563|NCT01819272|705833|P4|NOT COMPLETED|Overall Study||5
295564|NCT01819272|705834|P3|NOT COMPLETED|Overall Study||3
295565|NCT01819272|705835|P2|NOT COMPLETED|Overall Study||3
295566|NCT01819272|705836|P1|NOT COMPLETED|Overall Study||6
295567|NCT01819272|705831|P6|COMPLETED|Overall Study||33
295568|NCT01819272|705832|P5|COMPLETED|Overall Study||36
295569|NCT01819272|705833|P4|COMPLETED|Overall Study||35
295570|NCT01819272|705834|P3|COMPLETED|Overall Study||37
295571|NCT01819272|705835|P2|COMPLETED|Overall Study||36
295572|NCT01819272|705836|P1|COMPLETED|Overall Study||35
295573|NCT01819272|705831|P6|STARTED|Overall Study||40
295574|NCT01819272|705832|P5|STARTED|Overall Study||40
295575|NCT01819272|705833|P4|STARTED|Overall Study||40
295576|NCT01819272|705834|P3|STARTED|Overall Study||40
295577|NCT01819272|705835|P2|STARTED|Overall Study||39
295578|NCT01819272|705836|P1|STARTED|Overall Study||41
295579|NCT01819194|705862|P1|NOT COMPLETED|Overall Study||2
295580|NCT01819194|705862|P1|COMPLETED|Overall Study||60
295581|NCT01819194|705862|P1|STARTED|Overall Study||62
295582|NCT01818700|705867|P1|NOT COMPLETED|Overall Study||104
295583|NCT01818700|705867|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
295584|NCT01818700|705867|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
295585|NCT01818700|705867|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
295586|NCT01818700|705867|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
295587|NCT01818700|705867|P1|STARTED|Overall Study|The No. of enrolled patients|245
295588|NCT01818596|705878|P2|NOT COMPLETED|Overall Study||6
295589|NCT01818596|705879|P1|NOT COMPLETED|Overall Study||246
295590|NCT01818596|705878|P2|COMPLETED|Overall Study||0
295591|NCT01818596|705879|P1|COMPLETED|Overall Study||0
295592|NCT01818596|705878|P2|STARTED|Overall Study||6
295593|NCT01818596|705879|P1|STARTED|Overall Study||246
295594|NCT01818414|705912|P2|NOT COMPLETED|Overall Study||0
295595|NCT01818414|705913|P1|NOT COMPLETED|Overall Study||0
295596|NCT01818414|705912|P2|COMPLETED|Overall Study||15
295597|NCT01818414|705913|P1|COMPLETED|Overall Study||14
295598|NCT01818414|705912|P2|STARTED|Overall Study||15
295599|NCT01818414|705913|P1|STARTED|Overall Study||14
295600|NCT01818336|705927|P2|NOT COMPLETED|Overall Study||12
295601|NCT01818336|705928|P1|NOT COMPLETED|Overall Study||0
295602|NCT01818336|705927|P2|COMPLETED|Overall Study||47
295603|NCT01818336|705928|P1|COMPLETED|Overall Study||391
295604|NCT01818336|705927|P2|STARTED|Overall Study||59
295605|NCT01818336|705928|P1|STARTED|Overall Study||391
295606|NCT01817907|705936|P2|NOT COMPLETED|Second Intervention||0
295607|NCT01817907|705937|P1|NOT COMPLETED|Second Intervention||0
295608|NCT01817907|705936|P2|COMPLETED|Second Intervention||7
295609|NCT01817907|705937|P1|COMPLETED|Second Intervention||8
295610|NCT01817907|705936|P2|STARTED|Second Intervention||7
295611|NCT01817907|705937|P1|STARTED|Second Intervention||8
295612|NCT01817907|705936|P2|NOT COMPLETED|Washout Period||0
295613|NCT01817907|705937|P1|NOT COMPLETED|Washout Period||0
295614|NCT01817907|705936|P2|COMPLETED|Washout Period||7
295615|NCT01817907|705937|P1|COMPLETED|Washout Period||8
295616|NCT01817907|705936|P2|STARTED|Washout Period||7
295617|NCT01817907|705937|P1|STARTED|Washout Period||8
295618|NCT01817907|705936|P2|NOT COMPLETED|First Intervention||0
295619|NCT01817907|705937|P1|NOT COMPLETED|First Intervention||0
295620|NCT01817907|705936|P2|COMPLETED|First Intervention||7
295621|NCT01817907|705937|P1|COMPLETED|First Intervention||8
295622|NCT01817907|705936|P2|STARTED|First Intervention||7
295623|NCT01817907|705937|P1|STARTED|First Intervention||8
295624|NCT01817855|705949|P4|NOT COMPLETED|Overall Study||0
295625|NCT01817855|705950|P3|NOT COMPLETED|Overall Study||2
295626|NCT01817855|705951|P2|NOT COMPLETED|Overall Study||2
295627|NCT01817855|705952|P1|NOT COMPLETED|Overall Study||0
295628|NCT01817855|705949|P4|COMPLETED|Overall Study||5
295629|NCT01817855|705950|P3|COMPLETED|Overall Study||9
295630|NCT01817855|705951|P2|COMPLETED|Overall Study||6
295631|NCT01817855|705952|P1|COMPLETED|Overall Study||23
295632|NCT01817855|705949|P4|STARTED|Overall Study||5
295633|NCT01817855|705950|P3|STARTED|Overall Study||11
295634|NCT01817855|705951|P2|STARTED|Overall Study||8
295635|NCT01817855|705952|P1|STARTED|Overall Study||23
295636|NCT01817790|705982|P2|NOT COMPLETED|Overall Study||8
295637|NCT01817790|705983|P1|NOT COMPLETED|Overall Study||4
295638|NCT01817790|705982|P2|COMPLETED|Overall Study||304
295639|NCT01817790|705983|P1|COMPLETED|Overall Study||310
295640|NCT01817790|705982|P2|STARTED|Overall Study||312
295641|NCT01817790|705983|P1|STARTED|Overall Study||314
295642|NCT01817777|706027|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
295643|NCT01817777|706028|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
295644|NCT01817777|706029|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
295645|NCT01817777|706027|P3|COMPLETED|Interventional Phase (20 Weeks)||10
295646|NCT01817777|706028|P2|COMPLETED|Interventional Phase (20 Weeks)||11
295647|NCT01817777|706029|P1|COMPLETED|Interventional Phase (20 Weeks)||0
295648|NCT01817777|706027|P3|STARTED|Interventional Phase (20 Weeks)||15
295649|NCT01817777|706028|P2|STARTED|Interventional Phase (20 Weeks)||16
295650|NCT01817777|706029|P1|STARTED|Interventional Phase (20 Weeks)||0
295651|NCT01817777|706027|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
295652|NCT01817777|706028|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
295653|NCT01817777|706029|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
295654|NCT01817777|706027|P3|COMPLETED|Observational Phase (8 Weeks)||0
295655|NCT01817777|706028|P2|COMPLETED|Observational Phase (8 Weeks)||0
295656|NCT01817777|706029|P1|COMPLETED|Observational Phase (8 Weeks)||31
295657|NCT01817777|706027|P3|STARTED|Observational Phase (8 Weeks)||0
295658|NCT01817777|706028|P2|STARTED|Observational Phase (8 Weeks)||0
295659|NCT01817777|706029|P1|STARTED|Observational Phase (8 Weeks)||36
295660|NCT01817764|706053|P2|NOT COMPLETED|Overall Study||38
295661|NCT01817764|706054|P1|NOT COMPLETED|Overall Study||34
295662|NCT01817764|706053|P2|COMPLETED|Overall Study||315
295663|NCT01817764|706054|P1|COMPLETED|Overall Study||319
295664|NCT01817764|706053|P2|STARTED|Overall Study||353
295665|NCT01817764|706054|P1|STARTED|Overall Study||353
295666|NCT01817725|706062|P1|NOT COMPLETED|Overall Study||1
295667|NCT01817725|706062|P1|COMPLETED|Overall Study||19
295668|NCT01817725|706062|P1|STARTED|Overall Study||20
295669|NCT01816685|706069|P2|NOT COMPLETED|Overall Study||11
295670|NCT01816685|706070|P1|NOT COMPLETED|Overall Study||10
295671|NCT01816685|706069|P2|COMPLETED|Overall Study||56
295672|NCT01816685|706070|P1|COMPLETED|Overall Study||58
295673|NCT01816685|706069|P2|STARTED|Overall Study||67
295674|NCT01816685|706070|P1|STARTED|Overall Study||68
295675|NCT01816477|706080|P2|NOT COMPLETED|Overall Study||1
295676|NCT01816477|706081|P1|NOT COMPLETED|Overall Study||16
295677|NCT01816477|706080|P2|COMPLETED|Overall Study||41
295678|NCT01816477|706081|P1|COMPLETED|Overall Study||27
295679|NCT01816477|706080|P2|STARTED|Overall Study||42
295680|NCT01816477|706081|P1|STARTED|Overall Study||43
295681|NCT01816451|706094|P3|NOT COMPLETED|Overall Study||0
295682|NCT01816451|706095|P2|NOT COMPLETED|Overall Study||0
295683|NCT01816451|706096|P1|NOT COMPLETED|Overall Study||0
295684|NCT01816451|706094|P3|COMPLETED|Overall Study||8
295685|NCT01816451|706095|P2|COMPLETED|Overall Study||11
295686|NCT01816451|706096|P1|COMPLETED|Overall Study||13
295687|NCT01816451|706094|P3|STARTED|Overall Study||8
295688|NCT01816451|706095|P2|STARTED|Overall Study||11
295689|NCT01816451|706096|P1|STARTED|Overall Study||13
295690|NCT01816295|706135|P2|NOT COMPLETED|OLE Phase||56
295691|NCT01816295|706136|P1|NOT COMPLETED|OLE Phase||53
295692|NCT01816295|706135|P2|COMPLETED|OLE Phase||227
295693|NCT01816295|706136|P1|COMPLETED|OLE Phase||222
295694|NCT01816295|706135|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
295695|NCT01816295|706136|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
295696|NCT01816295|706135|P2|NOT COMPLETED|Double Blind Phase||56
295697|NCT01816295|706136|P1|NOT COMPLETED|Double Blind Phase||63
295698|NCT01816295|706135|P2|COMPLETED|Double Blind Phase||302
295699|NCT01816295|706136|P1|COMPLETED|Double Blind Phase||294
295700|NCT01816295|706135|P2|Received Study Drug|Double Blind Phase||354
295701|NCT01816295|706136|P1|Received Study Drug|Double Blind Phase||356
295702|NCT01816295|706135|P2|STARTED|Double Blind Phase||358
295703|NCT01816295|706136|P1|STARTED|Double Blind Phase||357
295704|NCT01816243|706151|P1|NOT COMPLETED|Overall Study||12
295705|NCT01816243|706151|P1|COMPLETED|Overall Study||27
295706|NCT01816243|706151|P1|STARTED|Overall Study||39
295707|NCT01815918|706160|P2|NOT COMPLETED|Overall Study||19
295708|NCT01815918|706161|P1|NOT COMPLETED|Overall Study||18
295709|NCT01815918|706160|P2|COMPLETED|Overall Study||11
295710|NCT01815918|706161|P1|COMPLETED|Overall Study||12
295711|NCT01815918|706160|P2|STARTED|Overall Study||30
295712|NCT01815918|706161|P1|STARTED|Overall Study||30
295713|NCT01815840|706177|P2|NOT COMPLETED|Overall Study||113
295714|NCT01815840|706178|P1|NOT COMPLETED|Overall Study||116
295715|NCT01815840|706177|P2|COMPLETED|Overall Study||0
295716|NCT01815840|706178|P1|COMPLETED|Overall Study||0
295717|NCT01815840|706177|P2|STARTED|Overall Study||113
295718|NCT01815840|706178|P1|STARTED|Overall Study||116
295719|NCT01815736|706208|P2|NOT COMPLETED|Overall Study||478
295720|NCT01815736|706209|P1|NOT COMPLETED|Overall Study||961
295721|NCT01815736|706208|P2|COMPLETED|Overall Study||2
295722|NCT01815736|706209|P1|COMPLETED|Overall Study||2
295723|NCT01815736|706208|P2|STARTED|Overall Study||480
295724|NCT01815736|706209|P1|STARTED|Overall Study||963
295725|NCT01815671|706225|P2|NOT COMPLETED|Overall Study||0
295726|NCT01815671|706226|P1|NOT COMPLETED|Overall Study||0
295727|NCT01815671|706225|P2|COMPLETED|Overall Study||85
295728|NCT01815671|706226|P1|COMPLETED|Overall Study||88
295729|NCT01815671|706225|P2|STARTED|Overall Study||85
295730|NCT01815671|706226|P1|STARTED|Overall Study||88
295731|NCT01815099|706236|P1|NOT COMPLETED|Overall Study||2
295732|NCT01815099|706236|P1|COMPLETED|Overall Study||2
295733|NCT01815099|706236|P1|Began rTMS Treatment|Overall Study||3
295734|NCT01815099|706236|P1|STARTED|Overall Study||4
295735|NCT01815008|706241|P1|NOT COMPLETED|Overall Study||4
295736|NCT01815008|706241|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
295737|NCT01815008|706241|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
295738|NCT01814878|706250|P2|NOT COMPLETED|Overall Study||30
295739|NCT01814878|706251|P1|NOT COMPLETED|Overall Study||46
295740|NCT01814878|706250|P2|COMPLETED|Overall Study||128
295741|NCT01814878|706251|P1|COMPLETED|Overall Study||116
295742|NCT01814878|706250|P2|STARTED|Overall Study||158
295743|NCT01814878|706251|P1|STARTED|Overall Study||162
295744|NCT01814800|706271|P1|NOT COMPLETED|Overall Study||5
295745|NCT01814800|706271|P1|COMPLETED|Overall Study||54
295746|NCT01814800|706271|P1|STARTED|Overall Study||59
295747|NCT01814787|706310|P2|NOT COMPLETED|Overall Study||0
295748|NCT01814787|706311|P1|NOT COMPLETED|Overall Study||0
295749|NCT01814787|706310|P2|COMPLETED|Overall Study||684
295750|NCT01814787|706311|P1|COMPLETED|Overall Study||685
295751|NCT01814787|706310|P2|STARTED|Overall Study||684
295752|NCT01814787|706311|P1|STARTED|Overall Study||685
295753|NCT01814774|706317|P1|NOT COMPLETED|Overall Study||0
295754|NCT01814774|706317|P1|COMPLETED|Overall Study||48
295755|NCT01814774|706317|P1|STARTED|Overall Study||48
295756|NCT01814761|706331|P2|NOT COMPLETED|Overall Study||30
295757|NCT01814761|706332|P1|NOT COMPLETED|Overall Study||8
295758|NCT01814761|706331|P2|COMPLETED|Overall Study||240
295759|NCT01814761|706332|P1|COMPLETED|Overall Study||34
295760|NCT01814761|706331|P2|STARTED|Overall Study||270
295761|NCT01814761|706332|P1|STARTED|Overall Study||42
295762|NCT01814748|706346|P2|NOT COMPLETED|Overall Study||7
295763|NCT01814748|706347|P1|NOT COMPLETED|Overall Study||8
295764|NCT01814748|706346|P2|COMPLETED|Overall Study||94
295765|NCT01814748|706347|P1|COMPLETED|Overall Study||94
295766|NCT01814748|706346|P2|STARTED|Overall Study||101
295767|NCT01814748|706347|P1|STARTED|Overall Study||102
295768|NCT01814722|706370|P3|NOT COMPLETED|Overall Study||0
295769|NCT01814722|706371|P2|NOT COMPLETED|Overall Study||0
295770|NCT01814722|706372|P1|NOT COMPLETED|Overall Study||0
295771|NCT01814722|706370|P3|COMPLETED|Overall Study||6
295772|NCT01814722|706371|P2|COMPLETED|Overall Study||21
295773|NCT01814722|706372|P1|COMPLETED|Overall Study||36
295774|NCT01814722|706370|P3|STARTED|Overall Study||6
295775|NCT01814722|706371|P2|STARTED|Overall Study||21
295776|NCT01814722|706372|P1|STARTED|Overall Study||36
295777|NCT01814696|706391|P2|NOT COMPLETED|Overall Study||0
295778|NCT01814696|706392|P1|NOT COMPLETED|Overall Study||2
295779|NCT01814696|706391|P2|COMPLETED|Overall Study||11
295780|NCT01814696|706392|P1|COMPLETED|Overall Study||13
295781|NCT01814696|706391|P2|STARTED|Overall Study||11
295782|NCT01814696|706392|P1|STARTED|Overall Study||15
295783|NCT01814670|706410|P1|NOT COMPLETED|Overall Study||12
295784|NCT01814670|706410|P1|COMPLETED|Overall Study||173
295785|NCT01814670|706410|P1|STARTED|Overall Study||185
295786|NCT01814553|706420|P2|NOT COMPLETED|Overall Study||22
295787|NCT01814553|706421|P1|NOT COMPLETED|Overall Study||18
295788|NCT01814553|706420|P2|COMPLETED|Overall Study||0
295789|NCT01814553|706421|P1|COMPLETED|Overall Study||0
295790|NCT01814553|706420|P2|STARTED|Overall Study||22
295791|NCT01814553|706421|P1|STARTED|Overall Study||18
295792|NCT01814397|706435|P1|NOT COMPLETED|Overall Study||14
295793|NCT01814397|706435|P1|COMPLETED|Overall Study||36
295794|NCT01814397|706435|P1|3 Month Evaluation|Overall Study||43
295795|NCT01814397|706435|P1|STARTED|Overall Study||50
295796|NCT01814332|706444|P2|NOT COMPLETED|Overall Study||16
295797|NCT01814332|706445|P1|NOT COMPLETED|Overall Study||16
295798|NCT01814332|706444|P2|COMPLETED|Overall Study||49
295799|NCT01814332|706445|P1|COMPLETED|Overall Study||47
295800|NCT01814332|706444|P2|STARTED|Overall Study||65
295801|NCT01814332|706445|P1|STARTED|Overall Study||63
295802|NCT01814241|706457|P1|NOT COMPLETED|Overall Study||4
295803|NCT01814241|706457|P1|COMPLETED|Overall Study||16
295804|NCT01814241|706457|P1|STARTED|Overall Study||20
295805|NCT01814137|706465|P2|NOT COMPLETED|Overall Study||5
295806|NCT01814137|706466|P1|NOT COMPLETED|Overall Study||5
295807|NCT01814137|706465|P2|COMPLETED|Overall Study||15
295808|NCT01814137|706466|P1|COMPLETED|Overall Study||15
295809|NCT01814137|706465|P2|STARTED|Overall Study||20
295810|NCT01814137|706466|P1|STARTED|Overall Study||20
295811|NCT01813890|706483|P3|NOT COMPLETED|Overall Study||6
295812|NCT01813890|706484|P2|NOT COMPLETED|Overall Study||4
295813|NCT01813890|706485|P1|NOT COMPLETED|Overall Study||9
295814|NCT01813890|706483|P3|COMPLETED|Overall Study||13
295815|NCT01813890|706484|P2|COMPLETED|Overall Study||17
295816|NCT01813890|706485|P1|COMPLETED|Overall Study||11
295817|NCT01813890|706483|P3|STARTED|Overall Study||19
295818|NCT01813890|706484|P2|STARTED|Overall Study||21
295819|NCT01813890|706485|P1|STARTED|Overall Study||20
295820|NCT01813721|706514|P1|NOT COMPLETED|Overall Study||64
295821|NCT01813721|706514|P1|COMPLETED|Overall Study||943
295822|NCT01813721|706514|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
295823|NCT01813019|706568|P2|NOT COMPLETED|Overall Study||6
295824|NCT01813019|706569|P1|NOT COMPLETED|Overall Study||7
295825|NCT01813019|706568|P2|COMPLETED|Overall Study||20
295826|NCT01813019|706569|P1|COMPLETED|Overall Study||17
295827|NCT01813019|706568|P2|STARTED|Overall Study||26
295828|NCT01813019|706569|P1|STARTED|Overall Study||24
295829|NCT01812837|706580|P3|NOT COMPLETED|Overall Study||0
295830|NCT01812837|706581|P2|NOT COMPLETED|Overall Study||1
295831|NCT01812837|706582|P1|NOT COMPLETED|Overall Study||2
295832|NCT01812837|706580|P3|COMPLETED|Overall Study||17
295833|NCT01812837|706581|P2|COMPLETED|Overall Study||16
295834|NCT01812837|706582|P1|COMPLETED|Overall Study||15
295835|NCT01812837|706580|P3|STARTED|Overall Study||17
295836|NCT01812837|706581|P2|STARTED|Overall Study||17
295837|NCT01812837|706582|P1|STARTED|Overall Study||17
295838|NCT01812707|706594|P4|NOT COMPLETED|Overall Study||2
295839|NCT01812707|706595|P3|NOT COMPLETED|Overall Study||0
295840|NCT01812707|706596|P2|NOT COMPLETED|Overall Study||0
295841|NCT01812707|706597|P1|NOT COMPLETED|Overall Study||2
295842|NCT01812707|706594|P4|COMPLETED|Overall Study||23
295843|NCT01812707|706595|P3|COMPLETED|Overall Study||25
295844|NCT01812707|706596|P2|COMPLETED|Overall Study||25
295845|NCT01812707|706597|P1|COMPLETED|Overall Study||23
295846|NCT01812707|706594|P4|Treated|Overall Study||25
295847|NCT01812707|706595|P3|Treated|Overall Study||25
295848|NCT01812707|706596|P2|Treated|Overall Study||25
295849|NCT01812707|706597|P1|Treated|Overall Study||25
295850|NCT01812707|706594|P4|STARTED|Overall Study||25
295851|NCT01812707|706595|P3|STARTED|Overall Study||25
295852|NCT01812707|706596|P2|STARTED|Overall Study||25
295853|NCT01812707|706597|P1|STARTED|Overall Study||25
295854|NCT01812681|706633|P2|NOT COMPLETED|Overall Study||0
295855|NCT01812681|706634|P1|NOT COMPLETED|Overall Study||3
295856|NCT01812681|706633|P2|COMPLETED|Overall Study||24
295857|NCT01812681|706634|P1|COMPLETED|Overall Study||57
295858|NCT01812681|706633|P2|STARTED|Overall Study||24
295859|NCT01812681|706634|P1|STARTED|Overall Study||60
295860|NCT01812655|706645|P3|NOT COMPLETED|Overall Study||0
295861|NCT01812655|706646|P2|NOT COMPLETED|Overall Study||1
295862|NCT01812655|706647|P1|NOT COMPLETED|Overall Study||1
295863|NCT01812655|706645|P3|COMPLETED|Overall Study||10
295864|NCT01812655|706646|P2|COMPLETED|Overall Study||10
295865|NCT01812655|706647|P1|COMPLETED|Overall Study||8
295866|NCT01812655|706645|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
295867|NCT01812655|706646|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
295868|NCT01812655|706647|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
295869|NCT01812473|706663|P2|NOT COMPLETED|Overall Study||0
295870|NCT01812473|706664|P1|NOT COMPLETED|Overall Study||0
295871|NCT01812473|706663|P2|COMPLETED|Overall Study||13
295872|NCT01812473|706664|P1|COMPLETED|Overall Study||22
295873|NCT01812473|706663|P2|STARTED|Overall Study||13
295874|NCT01812473|706664|P1|STARTED|Overall Study||22
295875|NCT01812044|706673|P3|NOT COMPLETED|Overall Study||0
295876|NCT01812044|706674|P2|NOT COMPLETED|Overall Study||0
295877|NCT01812044|706675|P1|NOT COMPLETED|Overall Study||0
295878|NCT01812044|706673|P3|COMPLETED|Overall Study||16
295879|NCT01812044|706674|P2|COMPLETED|Overall Study||17
295880|NCT01812044|706675|P1|COMPLETED|Overall Study||17
295881|NCT01812044|706673|P3|STARTED|Overall Study||16
295882|NCT01812044|706674|P2|STARTED|Overall Study||17
295883|NCT01812044|706675|P1|STARTED|Overall Study||17
295884|NCT01811953|706710|P6|NOT COMPLETED|Overall Study||1
295885|NCT01811953|706711|P5|NOT COMPLETED|Overall Study||1
295886|NCT01811953|706712|P4|NOT COMPLETED|Overall Study||1
295887|NCT01811953|706713|P3|NOT COMPLETED|Overall Study||0
295888|NCT01811953|706714|P2|NOT COMPLETED|Overall Study||0
295889|NCT01811953|706715|P1|NOT COMPLETED|Overall Study||0
295890|NCT01811953|706710|P6|COMPLETED|Overall Study||11
295891|NCT01811953|706711|P5|COMPLETED|Overall Study||11
295892|NCT01811953|706712|P4|COMPLETED|Overall Study||5
295893|NCT01811953|706713|P3|COMPLETED|Overall Study||6
295894|NCT01811953|706714|P2|COMPLETED|Overall Study||6
295895|NCT01811953|706715|P1|COMPLETED|Overall Study||6
295896|NCT01811953|706710|P6|STARTED|Overall Study||12
295897|NCT01811953|706711|P5|STARTED|Overall Study||12
295898|NCT01811953|706712|P4|STARTED|Overall Study||6
295899|NCT01811953|706713|P3|STARTED|Overall Study||6
295900|NCT01811953|706714|P2|STARTED|Overall Study||6
295901|NCT01811953|706715|P1|STARTED|Overall Study||6
295902|NCT01811706|706759|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
295903|NCT01811706|706760|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
295904|NCT01811706|706759|P2|COMPLETED|Second Intervention (4 Weeks)||10
295905|NCT01811706|706760|P1|COMPLETED|Second Intervention (4 Weeks)||9
295906|NCT01811706|706759|P2|STARTED|Second Intervention (4 Weeks)||10
295907|NCT01811706|706760|P1|STARTED|Second Intervention (4 Weeks)||9
295908|NCT01811706|706759|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
295909|NCT01811706|706760|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
295910|NCT01811706|706759|P2|COMPLETED|Washout ( 2 Weeks)||10
295911|NCT01811706|706760|P1|COMPLETED|Washout ( 2 Weeks)||9
295912|NCT01811706|706759|P2|STARTED|Washout ( 2 Weeks)||10
295913|NCT01811706|706760|P1|STARTED|Washout ( 2 Weeks)||9
295914|NCT01811706|706759|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
295915|NCT01811706|706760|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
295916|NCT01811706|706759|P2|COMPLETED|First Intervention ( 4 Weeks)||10
295917|NCT01811706|706760|P1|COMPLETED|First Intervention ( 4 Weeks)||9
295918|NCT01811706|706759|P2|STARTED|First Intervention ( 4 Weeks)||10
295919|NCT01811706|706760|P1|STARTED|First Intervention ( 4 Weeks)||10
295920|NCT01811680|706770|P1|NOT COMPLETED|Overall Study||0
295921|NCT01811680|706770|P1|COMPLETED|Overall Study||10
295922|NCT01811680|706770|P1|STARTED|Overall Study||10
295923|NCT01811563|706777|P2|NOT COMPLETED|Overall Study||3
295924|NCT01811563|706778|P1|NOT COMPLETED|Overall Study||5
295925|NCT01811563|706777|P2|COMPLETED|Overall Study||20
295926|NCT01811563|706778|P1|COMPLETED|Overall Study||20
295927|NCT01811563|706777|P2|STARTED|Overall Study||23
295928|NCT01811563|706778|P1|STARTED|Overall Study||25
295929|NCT01811485|706807|P3|NOT COMPLETED|Overall Study||5
295930|NCT01811485|706808|P2|NOT COMPLETED|Overall Study||4
295931|NCT01811485|706809|P1|NOT COMPLETED|Overall Study||2
295932|NCT01811485|706807|P3|COMPLETED|Overall Study||51
295933|NCT01811485|706808|P2|COMPLETED|Overall Study||55
295934|NCT01811485|706809|P1|COMPLETED|Overall Study||54
295935|NCT01811485|706807|P3|STARTED|Overall Study||56
295936|NCT01811485|706808|P2|STARTED|Overall Study||59
295937|NCT01811485|706809|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
295938|NCT01811472|706829|P3|NOT COMPLETED|Overall Study||5
295939|NCT01811472|706830|P2|NOT COMPLETED|Overall Study||0
295940|NCT01811472|706831|P1|NOT COMPLETED|Overall Study||2
295941|NCT01811472|706829|P3|COMPLETED|Overall Study||16
295942|NCT01811472|706830|P2|COMPLETED|Overall Study||11
295943|NCT01811472|706831|P1|COMPLETED|Overall Study||18
295944|NCT01811472|706829|P3|STARTED|Overall Study||21
295945|NCT01811472|706830|P2|STARTED|Overall Study||11
295946|NCT01811472|706831|P1|STARTED|Overall Study||20
295947|NCT01811303|706876|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
295948|NCT01811303|706877|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
295949|NCT01811303|706878|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
295950|NCT01811303|706879|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
295951|NCT01811303|706876|P4|COMPLETED|Fourth Intervention (1 Day)||2
295952|NCT01811303|706877|P3|COMPLETED|Fourth Intervention (1 Day)||4
295953|NCT01811303|706878|P2|COMPLETED|Fourth Intervention (1 Day)||4
295954|NCT01811303|706879|P1|COMPLETED|Fourth Intervention (1 Day)||4
295955|NCT01811303|706876|P4|STARTED|Fourth Intervention (1 Day)||2
295956|NCT01811303|706877|P3|STARTED|Fourth Intervention (1 Day)||4
295957|NCT01811303|706878|P2|STARTED|Fourth Intervention (1 Day)||4
295958|NCT01811303|706879|P1|STARTED|Fourth Intervention (1 Day)||4
295959|NCT01811303|706876|P4|NOT COMPLETED|Washout (2 Days or More)||0
295960|NCT01811303|706877|P3|NOT COMPLETED|Washout (2 Days or More)||0
295961|NCT01811303|706878|P2|NOT COMPLETED|Washout (2 Days or More)||0
295962|NCT01811303|706879|P1|NOT COMPLETED|Washout (2 Days or More)||0
295963|NCT01811303|706876|P4|COMPLETED|Washout (2 Days or More)||2
295964|NCT01811303|706877|P3|COMPLETED|Washout (2 Days or More)||4
295965|NCT01811303|706878|P2|COMPLETED|Washout (2 Days or More)||4
295966|NCT01811303|706879|P1|COMPLETED|Washout (2 Days or More)||4
295967|NCT01811303|706876|P4|STARTED|Washout (2 Days or More)||2
295968|NCT01811303|706877|P3|STARTED|Washout (2 Days or More)||4
295969|NCT01811303|706878|P2|STARTED|Washout (2 Days or More)||4
295970|NCT01811303|706879|P1|STARTED|Washout (2 Days or More)||4
295971|NCT01811303|706876|P4|NOT COMPLETED|Third Intervention (1 Day)||0
295972|NCT01811303|706877|P3|NOT COMPLETED|Third Intervention (1 Day)||0
295973|NCT01811303|706878|P2|NOT COMPLETED|Third Intervention (1 Day)||0
295974|NCT01811303|706879|P1|NOT COMPLETED|Third Intervention (1 Day)||0
295975|NCT01811303|706876|P4|COMPLETED|Third Intervention (1 Day)||2
295976|NCT01811303|706877|P3|COMPLETED|Third Intervention (1 Day)||4
295977|NCT01811303|706878|P2|COMPLETED|Third Intervention (1 Day)||4
295978|NCT01811303|706879|P1|COMPLETED|Third Intervention (1 Day)||4
295979|NCT01811303|706876|P4|STARTED|Third Intervention (1 Day)||2
295980|NCT01811303|706877|P3|STARTED|Third Intervention (1 Day)||4
295981|NCT01811303|706878|P2|STARTED|Third Intervention (1 Day)||4
295982|NCT01811303|706879|P1|STARTED|Third Intervention (1 Day)||4
295983|NCT01811303|706876|P4|NOT COMPLETED|Washout (2 Days or More)||0
295984|NCT01811303|706877|P3|NOT COMPLETED|Washout (2 Days or More)||0
295985|NCT01811303|706878|P2|NOT COMPLETED|Washout (2 Days or More)||0
295986|NCT01811303|706879|P1|NOT COMPLETED|Washout (2 Days or More)||0
295987|NCT01811303|706876|P4|COMPLETED|Washout (2 Days or More)||2
295988|NCT01811303|706877|P3|COMPLETED|Washout (2 Days or More)||4
295989|NCT01811303|706878|P2|COMPLETED|Washout (2 Days or More)||4
295990|NCT01811303|706879|P1|COMPLETED|Washout (2 Days or More)||4
295991|NCT01811303|706876|P4|STARTED|Washout (2 Days or More)||2
295992|NCT01811303|706877|P3|STARTED|Washout (2 Days or More)||4
295993|NCT01811303|706878|P2|STARTED|Washout (2 Days or More)||4
295994|NCT01811303|706879|P1|STARTED|Washout (2 Days or More)||4
295995|NCT01811303|706876|P4|NOT COMPLETED|Second Intervention (1 Day)||0
295996|NCT01811303|706877|P3|NOT COMPLETED|Second Intervention (1 Day)||0
295997|NCT01811303|706878|P2|NOT COMPLETED|Second Intervention (1 Day)||0
295998|NCT01811303|706879|P1|NOT COMPLETED|Second Intervention (1 Day)||0
295999|NCT01811303|706876|P4|COMPLETED|Second Intervention (1 Day)||2
296000|NCT01811303|706877|P3|COMPLETED|Second Intervention (1 Day)||4
296001|NCT01811303|706878|P2|COMPLETED|Second Intervention (1 Day)||4
296002|NCT01811303|706879|P1|COMPLETED|Second Intervention (1 Day)||4
296003|NCT01811303|706876|P4|STARTED|Second Intervention (1 Day)||2
296004|NCT01811303|706877|P3|STARTED|Second Intervention (1 Day)||4
296005|NCT01811303|706878|P2|STARTED|Second Intervention (1 Day)||4
296006|NCT01811303|706879|P1|STARTED|Second Intervention (1 Day)||4
296007|NCT01811303|706876|P4|NOT COMPLETED|Washout (2 Days or More)||0
296008|NCT01811303|706877|P3|NOT COMPLETED|Washout (2 Days or More)||0
296009|NCT01811303|706878|P2|NOT COMPLETED|Washout (2 Days or More)||0
296010|NCT01811303|706879|P1|NOT COMPLETED|Washout (2 Days or More)||0
296011|NCT01811303|706876|P4|COMPLETED|Washout (2 Days or More)||2
296012|NCT01811303|706877|P3|COMPLETED|Washout (2 Days or More)||4
296013|NCT01811303|706878|P2|COMPLETED|Washout (2 Days or More)||4
296014|NCT01811303|706879|P1|COMPLETED|Washout (2 Days or More)||4
296015|NCT01811303|706876|P4|STARTED|Washout (2 Days or More)||2
296016|NCT01811303|706877|P3|STARTED|Washout (2 Days or More)||4
296017|NCT01811303|706878|P2|STARTED|Washout (2 Days or More)||4
296018|NCT01811303|706879|P1|STARTED|Washout (2 Days or More)||4
296019|NCT01811303|706876|P4|NOT COMPLETED|First Intervention (1 Day)||0
296020|NCT01811303|706877|P3|NOT COMPLETED|First Intervention (1 Day)||0
296021|NCT01811303|706878|P2|NOT COMPLETED|First Intervention (1 Day)||0
296022|NCT01811303|706879|P1|NOT COMPLETED|First Intervention (1 Day)||0
296023|NCT01811303|706876|P4|COMPLETED|First Intervention (1 Day)||2
296024|NCT01811303|706877|P3|COMPLETED|First Intervention (1 Day)||4
296025|NCT01811303|706878|P2|COMPLETED|First Intervention (1 Day)||4
296026|NCT01811303|706879|P1|COMPLETED|First Intervention (1 Day)||4
296027|NCT01811303|706876|P4|STARTED|First Intervention (1 Day)||2
296028|NCT01811303|706877|P3|STARTED|First Intervention (1 Day)||4
296029|NCT01811303|706878|P2|STARTED|First Intervention (1 Day)||4
296030|NCT01811303|706879|P1|STARTED|First Intervention (1 Day)||4
296031|NCT01811238|706887|P1|NOT COMPLETED|Overall Study||81
296032|NCT01811238|706887|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
296033|NCT01811238|706887|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
296034|NCT01811238|706887|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
296035|NCT01811238|706887|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
296036|NCT01811238|706887|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
296037|NCT01811186|706898|P2|NOT COMPLETED|Overall Study||62
296038|NCT01811186|706899|P1|NOT COMPLETED|Overall Study||71
296039|NCT01811186|706898|P2|COMPLETED|Overall Study||64
296040|NCT01811186|706899|P1|COMPLETED|Overall Study||61
296041|NCT01811186|706898|P2|STARTED|Overall Study||126
296042|NCT01811186|706899|P1|STARTED|Overall Study||132
296043|NCT01810952|706917|P2|NOT COMPLETED|Overall Study||0
296044|NCT01810952|706918|P1|NOT COMPLETED|Overall Study||0
296045|NCT01810952|706917|P2|COMPLETED|Overall Study||17
296046|NCT01810952|706918|P1|COMPLETED|Overall Study||20
296047|NCT01810952|706917|P2|STARTED|Overall Study||17
296048|NCT01810952|706918|P1|STARTED|Overall Study||20
296049|NCT01810939|706932|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
296050|NCT01810939|706933|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
296051|NCT01810939|706934|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
296052|NCT01810939|706932|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
296053|NCT01810939|706933|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
296054|NCT01810939|706934|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
296055|NCT01810939|706932|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
296056|NCT01810939|706933|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
296057|NCT01810939|706934|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
296058|NCT01810939|706932|P3|NOT COMPLETED|Part A Treatment Period||0
296059|NCT01810939|706933|P2|NOT COMPLETED|Part A Treatment Period||0
296060|NCT01810939|706934|P1|NOT COMPLETED|Part A Treatment Period||24
296061|NCT01810939|706932|P3|COMPLETED|Part A Treatment Period||0
296062|NCT01810939|706933|P2|COMPLETED|Part A Treatment Period||0
296063|NCT01810939|706934|P1|COMPLETED|Part A Treatment Period||219
296064|NCT01810939|706932|P3|STARTED|Part A Treatment Period||0
296065|NCT01810939|706933|P2|STARTED|Part A Treatment Period||0
296066|NCT01810939|706934|P1|STARTED|Part A Treatment Period||243
296067|NCT01810783|706947|P1|NOT COMPLETED|Overall Study||109
296068|NCT01810783|706947|P1|COMPLETED|Overall Study||101
296069|NCT01810783|706947|P1|STARTED|Overall Study||210
296070|NCT01810692|706953|P2|NOT COMPLETED|Overall Study||0
296071|NCT01810692|706954|P1|NOT COMPLETED|Overall Study||0
296072|NCT01810692|706953|P2|COMPLETED|Overall Study||77
296073|NCT01810692|706954|P1|COMPLETED|Overall Study||77
296074|NCT01810692|706953|P2|STARTED|Overall Study||77
296075|NCT01810692|706954|P1|STARTED|Overall Study||77
296076|NCT01810666|706966|P1|NOT COMPLETED|Overall Study||0
296077|NCT01810666|706966|P1|COMPLETED|Overall Study||30
296078|NCT01810666|706966|P1|STARTED|Overall Study||30
296079|NCT01810380|706975|P3|NOT COMPLETED|Overall Study||32
296080|NCT01810380|706976|P2|NOT COMPLETED|Overall Study||38
296081|NCT01810380|706977|P1|NOT COMPLETED|Overall Study||55
296082|NCT01810380|706975|P3|COMPLETED|Overall Study||122
296083|NCT01810380|706976|P2|COMPLETED|Overall Study||113
296084|NCT01810380|706977|P1|COMPLETED|Overall Study||108
296085|NCT01810380|706975|P3|Treated|Overall Study||153
296086|NCT01810380|706976|P2|Treated|Overall Study||150
296087|NCT01810380|706977|P1|Treated|Overall Study||161
296088|NCT01810380|706975|P3|STARTED|Overall Study||154
296089|NCT01810380|706976|P2|STARTED|Overall Study||151
296090|NCT01810380|706977|P1|STARTED|Overall Study||163
296091|NCT01810302|707038|P2|NOT COMPLETED|Overall Study||1
296092|NCT01810302|707039|P1|NOT COMPLETED|Overall Study||1
296093|NCT01810302|707038|P2|COMPLETED|Overall Study||0
296094|NCT01810302|707039|P1|COMPLETED|Overall Study||0
296095|NCT01810302|707038|P2|STARTED|Overall Study||1
296096|NCT01810302|707039|P1|STARTED|Overall Study||1
296097|NCT01810289|707049|P2|NOT COMPLETED|Overall Study||0
296098|NCT01810289|707050|P1|NOT COMPLETED|Overall Study||0
296099|NCT01810289|707049|P2|COMPLETED|Overall Study||4747
296100|NCT01810289|707050|P1|COMPLETED|Overall Study||7277
296101|NCT01810289|707049|P2|STARTED|Overall Study||4747
296102|NCT01810289|707050|P1|STARTED|Overall Study||7277
296103|NCT01810263|707058|P2|NOT COMPLETED|Overall Study||7
296104|NCT01810263|707059|P1|NOT COMPLETED|Overall Study||8
296105|NCT01810263|707058|P2|COMPLETED|Overall Study||11
296106|NCT01810263|707059|P1|COMPLETED|Overall Study|2014 July|8
296107|NCT01810263|707058|P2|STARTED|Overall Study||18
296108|NCT01810263|707059|P1|STARTED|Overall Study||16
296109|NCT01810042|707065|P1|NOT COMPLETED|Overall Study||10
296110|NCT01810042|707065|P1|COMPLETED|Overall Study||39
296111|NCT01810042|707065|P1|STARTED|Overall Study||49
296112|NCT01809938|707072|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
296113|NCT01809938|707073|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
296114|NCT01809938|707072|P2|COMPLETED|Second Intervention (170 Minutes)||5
296115|NCT01809938|707073|P1|COMPLETED|Second Intervention (170 Minutes)||5
296116|NCT01809938|707072|P2|STARTED|Second Intervention (170 Minutes)||5
296117|NCT01809938|707073|P1|STARTED|Second Intervention (170 Minutes)||5
296118|NCT01809938|707072|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
296119|NCT01809938|707073|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
296120|NCT01809938|707072|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
296121|NCT01809938|707073|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
296122|NCT01809938|707072|P2|STARTED|Washout (Not Less Than 24 Hours)||5
296123|NCT01809938|707073|P1|STARTED|Washout (Not Less Than 24 Hours)||5
296124|NCT01809938|707072|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
296125|NCT01809938|707073|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
296126|NCT01809938|707072|P2|COMPLETED|First Intervention (170 Minutes)||5
296127|NCT01809938|707073|P1|COMPLETED|First Intervention (170 Minutes)||5
296128|NCT01809938|707072|P2|STARTED|First Intervention (170 Minutes)||5
296129|NCT01809938|707073|P1|STARTED|First Intervention (170 Minutes)||5
296130|NCT01809834|707080|P1|NOT COMPLETED|Overall Study||0
296131|NCT01809834|707080|P1|COMPLETED|Overall Study||44
296132|NCT01809834|707080|P1|STARTED|Overall Study||44
296133|NCT01809639|707108|P2|NOT COMPLETED|Overall Study||0
296134|NCT01809639|707109|P1|NOT COMPLETED|Overall Study||0
296135|NCT01809639|707108|P2|COMPLETED|Overall Study||7
296136|NCT01809639|707109|P1|COMPLETED|Overall Study||18
296137|NCT01809639|707108|P2|STARTED|Overall Study||7
296138|NCT01809639|707109|P1|STARTED|Overall Study||18
296139|NCT01809327|707120|P5|NOT COMPLETED|Overall Study||25
296140|NCT01809327|707121|P4|NOT COMPLETED|Overall Study||12
296141|NCT01809327|707122|P3|NOT COMPLETED|Overall Study||22
296142|NCT01809327|707123|P2|NOT COMPLETED|Overall Study||26
296143|NCT01809327|707124|P1|NOT COMPLETED|Overall Study||32
296144|NCT01809327|707120|P5|COMPLETED|Overall Study||212
296145|NCT01809327|707121|P4|COMPLETED|Overall Study||225
296146|NCT01809327|707122|P3|COMPLETED|Overall Study||216
296147|NCT01809327|707123|P2|COMPLETED|Overall Study||211
296148|NCT01809327|707124|P1|COMPLETED|Overall Study||205
296149|NCT01809327|707120|P5|STARTED|Overall Study||237
296150|NCT01809327|707121|P4|STARTED|Overall Study||237
296151|NCT01809327|707122|P3|STARTED|Overall Study||238
296152|NCT01809327|707123|P2|STARTED|Overall Study||237
296153|NCT01809327|707124|P1|STARTED|Overall Study||237
296154|NCT01809314|707166|P1|NOT COMPLETED|Overall Study||745
296155|NCT01809314|707166|P1|COMPLETED|Overall Study||422
296156|NCT01809314|707166|P1|STARTED|Overall Study||1167
296157|NCT01809262|707172|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296158|NCT01809262|707173|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296159|NCT01809262|707174|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296160|NCT01809262|707175|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296161|NCT01809262|707176|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296162|NCT01809262|707177|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296163|NCT01809262|707178|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296164|NCT01809262|707179|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296165|NCT01809262|707180|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296166|NCT01809262|707181|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
296167|NCT01809262|707172|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
296168|NCT01809262|707173|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
296169|NCT01809262|707174|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
296170|NCT01809262|707175|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
296171|NCT01809262|707176|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
296172|NCT01809262|707177|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
296173|NCT01809262|707178|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
296174|NCT01809262|707179|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
296175|NCT01809262|707180|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
296176|NCT01809262|707181|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
296177|NCT01809262|707172|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
296178|NCT01809262|707173|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
296179|NCT01809262|707174|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
296180|NCT01809262|707175|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
296181|NCT01809262|707176|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
296182|NCT01809262|707177|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
296183|NCT01809262|707178|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
296184|NCT01809262|707179|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
296185|NCT01809262|707180|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
296186|NCT01809262|707181|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
296187|NCT01809262|707172|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296188|NCT01809262|707173|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296189|NCT01809262|707174|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296190|NCT01809262|707175|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296191|NCT01809262|707176|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296192|NCT01809262|707177|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296193|NCT01809262|707178|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296194|NCT01809262|707179|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296195|NCT01809262|707180|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296196|NCT01809262|707181|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
296197|NCT01809262|707172|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
296198|NCT01809262|707173|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
296199|NCT01809262|707174|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
296200|NCT01809262|707175|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
296201|NCT01809262|707176|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
296202|NCT01809262|707177|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
296203|NCT01809262|707178|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
296204|NCT01809262|707179|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
296205|NCT01809262|707180|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
296206|NCT01809262|707181|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
296207|NCT01809262|707172|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
296208|NCT01809262|707173|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
296209|NCT01809262|707174|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
296210|NCT01809262|707175|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
296211|NCT01809262|707176|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
296212|NCT01809262|707177|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
296213|NCT01809262|707178|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
296214|NCT01809262|707179|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
296215|NCT01809262|707180|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
296216|NCT01809262|707181|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
296217|NCT01809262|707172|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296218|NCT01809262|707173|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296219|NCT01809262|707174|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296220|NCT01809262|707175|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296221|NCT01809262|707176|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296222|NCT01809262|707177|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296223|NCT01809262|707178|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296224|NCT01809262|707179|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296225|NCT01809262|707180|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
296226|NCT01809262|707181|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
296227|NCT01809262|707172|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
296228|NCT01809262|707173|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
296229|NCT01809262|707174|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
296230|NCT01809262|707175|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
296231|NCT01809262|707176|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
296232|NCT01809262|707177|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
296233|NCT01809262|707178|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
296234|NCT01809262|707179|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
296235|NCT01809262|707180|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
296236|NCT01809262|707181|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
296237|NCT01809262|707172|P10|STARTED|Period 3 (Third Dose + Washout)||4
296238|NCT01809262|707173|P9|STARTED|Period 3 (Third Dose + Washout)||3
296239|NCT01809262|707174|P8|STARTED|Period 3 (Third Dose + Washout)||4
296240|NCT01809262|707175|P7|STARTED|Period 3 (Third Dose + Washout)||3
296241|NCT01809262|707176|P6|STARTED|Period 3 (Third Dose + Washout)||3
296242|NCT01809262|707177|P5|STARTED|Period 3 (Third Dose + Washout)||3
296243|NCT01809262|707178|P4|STARTED|Period 3 (Third Dose + Washout)||3
296244|NCT01809262|707179|P3|STARTED|Period 3 (Third Dose + Washout)||4
296245|NCT01809262|707180|P2|STARTED|Period 3 (Third Dose + Washout)||4
296246|NCT01809262|707181|P1|STARTED|Period 3 (Third Dose + Washout)||4
296247|NCT01809262|707172|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296248|NCT01809262|707173|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296249|NCT01809262|707174|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296250|NCT01809262|707175|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296251|NCT01809262|707176|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296252|NCT01809262|707177|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296253|NCT01809262|707178|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296254|NCT01809262|707179|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296255|NCT01809262|707180|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296256|NCT01809262|707181|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
296257|NCT01809262|707172|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
296258|NCT01809262|707173|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
296259|NCT01809262|707174|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
296260|NCT01809262|707175|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
296261|NCT01809262|707176|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
296262|NCT01809262|707177|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
296263|NCT01809262|707178|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
296264|NCT01809262|707179|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
296265|NCT01809262|707180|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
296266|NCT01809262|707181|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
296267|NCT01809262|707172|P10|STARTED|Period 2 (Second Dose + Washout)||4
296268|NCT01809262|707173|P9|STARTED|Period 2 (Second Dose + Washout)||3
296269|NCT01809262|707174|P8|STARTED|Period 2 (Second Dose + Washout)||4
296270|NCT01809262|707175|P7|STARTED|Period 2 (Second Dose + Washout)||3
296271|NCT01809262|707176|P6|STARTED|Period 2 (Second Dose + Washout)||3
296272|NCT01809262|707177|P5|STARTED|Period 2 (Second Dose + Washout)||3
296273|NCT01809262|707178|P4|STARTED|Period 2 (Second Dose + Washout)||3
296274|NCT01809262|707179|P3|STARTED|Period 2 (Second Dose + Washout)||4
296275|NCT01809262|707180|P2|STARTED|Period 2 (Second Dose + Washout)||4
296276|NCT01809262|707181|P1|STARTED|Period 2 (Second Dose + Washout)||4
296277|NCT01809262|707172|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296278|NCT01809262|707173|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296279|NCT01809262|707174|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296280|NCT01809262|707175|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296281|NCT01809262|707176|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296282|NCT01809262|707177|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
296283|NCT01809262|707178|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296284|NCT01809262|707179|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296285|NCT01809262|707180|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296286|NCT01809262|707181|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
296287|NCT01809262|707172|P10|COMPLETED|Period 1 (First Dose + Washout)||4
296288|NCT01809262|707173|P9|COMPLETED|Period 1 (First Dose + Washout)||3
296289|NCT01809262|707174|P8|COMPLETED|Period 1 (First Dose + Washout)||4
296290|NCT01809262|707175|P7|COMPLETED|Period 1 (First Dose + Washout)||3
296291|NCT01809262|707176|P6|COMPLETED|Period 1 (First Dose + Washout)||3
296292|NCT01809262|707177|P5|COMPLETED|Period 1 (First Dose + Washout)||3
296293|NCT01809262|707178|P4|COMPLETED|Period 1 (First Dose + Washout)||3
296294|NCT01809262|707179|P3|COMPLETED|Period 1 (First Dose + Washout)||4
296295|NCT01809262|707180|P2|COMPLETED|Period 1 (First Dose + Washout)||4
296296|NCT01809262|707181|P1|COMPLETED|Period 1 (First Dose + Washout)||4
296297|NCT01809262|707172|P10|STARTED|Period 1 (First Dose + Washout)||4
296298|NCT01809262|707173|P9|STARTED|Period 1 (First Dose + Washout)||3
296299|NCT01809262|707174|P8|STARTED|Period 1 (First Dose + Washout)||4
296300|NCT01809262|707175|P7|STARTED|Period 1 (First Dose + Washout)||3
296301|NCT01809262|707176|P6|STARTED|Period 1 (First Dose + Washout)||3
296302|NCT01809262|707177|P5|STARTED|Period 1 (First Dose + Washout)||4
296303|NCT01809262|707178|P4|STARTED|Period 1 (First Dose + Washout)||3
296304|NCT01809262|707179|P3|STARTED|Period 1 (First Dose + Washout)||4
296305|NCT01809262|707180|P2|STARTED|Period 1 (First Dose + Washout)||4
296306|NCT01809262|707181|P1|STARTED|Period 1 (First Dose + Washout)||4
296307|NCT01809197|707250|P2|NOT COMPLETED|Overall Study||8
296308|NCT01809197|707251|P1|NOT COMPLETED|Overall Study||10
296309|NCT01809197|707250|P2|COMPLETED|Overall Study||177
296310|NCT01809197|707251|P1|COMPLETED|Overall Study||177
296311|NCT01809197|707250|P2|STARTED|Overall Study||185
296312|NCT01809197|707251|P1|STARTED|Overall Study||187
296313|NCT01809106|707261|P4|NOT COMPLETED|Overall Study||4
296314|NCT01809106|707262|P3|NOT COMPLETED|Overall Study||3
296315|NCT01809106|707263|P2|NOT COMPLETED|Overall Study||5
296316|NCT01809106|707264|P1|NOT COMPLETED|Overall Study||8
296317|NCT01809106|707261|P4|COMPLETED|Overall Study||124
296318|NCT01809106|707262|P3|COMPLETED|Overall Study||127
296319|NCT01809106|707263|P2|COMPLETED|Overall Study||125
296320|NCT01809106|707264|P1|COMPLETED|Overall Study||122
296321|NCT01809106|707261|P4|STARTED|Overall Study||128
296322|NCT01809106|707262|P3|STARTED|Overall Study||130
296323|NCT01809106|707263|P2|STARTED|Overall Study||130
296324|NCT01809106|707264|P1|STARTED|Overall Study||130
296325|NCT01809054|707284|P2|NOT COMPLETED|Overall Study||0
296326|NCT01809054|707285|P1|NOT COMPLETED|Overall Study||0
296327|NCT01809054|707284|P2|COMPLETED|Overall Study||22
296328|NCT01809054|707285|P1|COMPLETED|Overall Study||27
296329|NCT01809054|707284|P2|STARTED|Overall Study||22
296330|NCT01809054|707285|P1|STARTED|Overall Study||27
296331|NCT01808963|707293|P1|NOT COMPLETED|Overall Study||0
296332|NCT01808963|707293|P1|COMPLETED|Overall Study||13
296333|NCT01808963|707293|P1|STARTED|Overall Study||13
296334|NCT01808950|707300|P3|NOT COMPLETED|Overall Study||0
296335|NCT01808950|707301|P2|NOT COMPLETED|Overall Study||0
296336|NCT01808950|707302|P1|NOT COMPLETED|Overall Study||0
296337|NCT01808950|707300|P3|COMPLETED|Overall Study||0
296338|NCT01808950|707301|P2|COMPLETED|Overall Study||3
296339|NCT01808950|707302|P1|COMPLETED|Overall Study||1
296340|NCT01808950|707300|P3|STARTED|Overall Study||0
296341|NCT01808950|707301|P2|STARTED|Overall Study||3
296342|NCT01808950|707302|P1|STARTED|Overall Study||1
296343|NCT01808755|707313|P2|NOT COMPLETED|Overall Study||0
296344|NCT01808755|707314|P1|NOT COMPLETED|Overall Study||0
296345|NCT01808755|707313|P2|COMPLETED|Overall Study||30
296346|NCT01808755|707314|P1|COMPLETED|Overall Study||30
296347|NCT01808755|707313|P2|STARTED|Overall Study||30
296348|NCT01808755|707314|P1|STARTED|Overall Study||30
296349|NCT01808651|707322|P3|NOT COMPLETED|Study Period 2||0
296350|NCT01808651|707323|P2|NOT COMPLETED|Study Period 2||0
296351|NCT01808651|707324|P1|NOT COMPLETED|Study Period 2||0
296352|NCT01808651|707322|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
296353|NCT01808651|707323|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
296354|NCT01808651|707324|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
296355|NCT01808651|707322|P3|STARTED|Study Period 2||33
296356|NCT01808651|707323|P2|STARTED|Study Period 2||52
296357|NCT01808651|707324|P1|STARTED|Study Period 2||77
296358|NCT01808651|707322|P3|NOT COMPLETED|Study Period 1||5
296359|NCT01808651|707323|P2|NOT COMPLETED|Study Period 1||17
296360|NCT01808651|707324|P1|NOT COMPLETED|Study Period 1||26
296361|NCT01808651|707322|P3|COMPLETED|Study Period 1||31
296362|NCT01808651|707323|P2|COMPLETED|Study Period 1||48
296363|NCT01808651|707324|P1|COMPLETED|Study Period 1||73
296364|NCT01808651|707322|P3|Received at Least One Dose of Study Drug|Study Period 1||36
296365|NCT01808651|707323|P2|Received at Least One Dose of Study Drug|Study Period 1||65
296366|NCT01808651|707324|P1|Received at Least One Dose of Study Drug|Study Period 1||98
296367|NCT01808651|707322|P3|STARTED|Study Period 1||36
296368|NCT01808651|707323|P2|STARTED|Study Period 1||65
296369|NCT01808651|707324|P1|STARTED|Study Period 1||99
296370|NCT01808612|707359|P3|NOT COMPLETED|Discontinuation Period||0
296371|NCT01808612|707360|P2|NOT COMPLETED|Discontinuation Period||1
296372|NCT01808612|707361|P1|NOT COMPLETED|Discontinuation Period||2
296373|NCT01808612|707359|P3|COMPLETED|Discontinuation Period||145
296374|NCT01808612|707360|P2|COMPLETED|Discontinuation Period||37
296375|NCT01808612|707361|P1|COMPLETED|Discontinuation Period||85
296376|NCT01808612|707359|P3|STARTED|Discontinuation Period||145
296377|NCT01808612|707360|P2|STARTED|Discontinuation Period||38
296378|NCT01808612|707361|P1|STARTED|Discontinuation Period||87
296379|NCT01808612|707359|P3|NOT COMPLETED|Treatment Period||14
296380|NCT01808612|707360|P2|NOT COMPLETED|Treatment Period||7
296381|NCT01808612|707361|P1|NOT COMPLETED|Treatment Period||15
296382|NCT01808612|707359|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
296383|NCT01808612|707360|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
296384|NCT01808612|707361|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
296385|NCT01808612|707359|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
296469|NCT01808339|707431|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
296386|NCT01808612|707360|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
296387|NCT01808612|707361|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
296388|NCT01808612|707359|P3|STARTED|Treatment Period||260
296389|NCT01808612|707360|P2|STARTED|Treatment Period||84
296390|NCT01808612|707361|P1|STARTED|Treatment Period||169
296391|NCT01808547|707392|P2|NOT COMPLETED|Overall Study||46
296392|NCT01808547|707393|P1|NOT COMPLETED|Overall Study||37
296393|NCT01808547|707392|P2|COMPLETED|Overall Study||48
296394|NCT01808547|707393|P1|COMPLETED|Overall Study||137
296395|NCT01808547|707392|P2|mITT Population|Overall Study||85
296396|NCT01808547|707393|P1|mITT Population|Overall Study||168
296397|NCT01808547|707392|P2|Safety Population|Overall Study||85
296398|NCT01808547|707393|P1|Safety Population|Overall Study||170
296399|NCT01808547|707392|P2|STARTED|Overall Study||94
296400|NCT01808547|707393|P1|STARTED|Overall Study||174
296401|NCT01808534|707399|P1|NOT COMPLETED|Overall Study||4
296402|NCT01808534|707399|P1|COMPLETED|Overall Study||1
296403|NCT01808534|707399|P1|STARTED|Overall Study||5
296404|NCT01808508|707410|P3|NOT COMPLETED|Overall Study||0
296405|NCT01808508|707411|P2|NOT COMPLETED|Overall Study||0
296406|NCT01808508|707412|P1|NOT COMPLETED|Overall Study||1
296407|NCT01808508|707410|P3|COMPLETED|Overall Study||3
296408|NCT01808508|707411|P2|COMPLETED|Overall Study||9
296409|NCT01808508|707412|P1|COMPLETED|Overall Study||10
296410|NCT01808508|707410|P3|STARTED|Overall Study||3
296411|NCT01808508|707411|P2|STARTED|Overall Study||9
296412|NCT01808508|707412|P1|STARTED|Overall Study||11
296413|NCT01808339|707429|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
296414|NCT01808339|707430|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
296415|NCT01808339|707431|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
296416|NCT01808339|707432|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
296417|NCT01808339|707433|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
296418|NCT01808339|707434|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
296419|NCT01808339|707429|P6|COMPLETED|Treatment Period 3 (14 Days)||5
296420|NCT01808339|707430|P5|COMPLETED|Treatment Period 3 (14 Days)||4
296421|NCT01808339|707431|P4|COMPLETED|Treatment Period 3 (14 Days)||2
296422|NCT01808339|707432|P3|COMPLETED|Treatment Period 3 (14 Days)||3
296423|NCT01808339|707433|P2|COMPLETED|Treatment Period 3 (14 Days)||3
296424|NCT01808339|707434|P1|COMPLETED|Treatment Period 3 (14 Days)||4
296425|NCT01808339|707429|P6|STARTED|Treatment Period 3 (14 Days)||5
296426|NCT01808339|707430|P5|STARTED|Treatment Period 3 (14 Days)||4
296427|NCT01808339|707431|P4|STARTED|Treatment Period 3 (14 Days)||2
296428|NCT01808339|707432|P3|STARTED|Treatment Period 3 (14 Days)||4
296429|NCT01808339|707433|P2|STARTED|Treatment Period 3 (14 Days)||3
296430|NCT01808339|707434|P1|STARTED|Treatment Period 3 (14 Days)||4
296431|NCT01808339|707429|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
296432|NCT01808339|707430|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
296433|NCT01808339|707431|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
296434|NCT01808339|707432|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
296435|NCT01808339|707433|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
296436|NCT01808339|707434|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
296437|NCT01808339|707429|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
296438|NCT01808339|707430|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
296439|NCT01808339|707431|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
296440|NCT01808339|707432|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
296441|NCT01808339|707433|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
296442|NCT01808339|707434|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
296443|NCT01808339|707429|P6|STARTED|Washout Period 2 (14-21 Days)||5
296444|NCT01808339|707430|P5|STARTED|Washout Period 2 (14-21 Days)||4
296445|NCT01808339|707431|P4|STARTED|Washout Period 2 (14-21 Days)||2
296446|NCT01808339|707432|P3|STARTED|Washout Period 2 (14-21 Days)||4
296447|NCT01808339|707433|P2|STARTED|Washout Period 2 (14-21 Days)||3
296448|NCT01808339|707434|P1|STARTED|Washout Period 2 (14-21 Days)||4
296449|NCT01808339|707429|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
296450|NCT01808339|707430|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
296451|NCT01808339|707431|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
296452|NCT01808339|707432|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
296453|NCT01808339|707433|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
296454|NCT01808339|707434|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
296455|NCT01808339|707429|P6|COMPLETED|Treatment Period 2 (14 Days)||5
296456|NCT01808339|707430|P5|COMPLETED|Treatment Period 2 (14 Days)||4
296457|NCT01808339|707431|P4|COMPLETED|Treatment Period 2 (14 Days)||2
296458|NCT01808339|707432|P3|COMPLETED|Treatment Period 2 (14 Days)||4
296459|NCT01808339|707433|P2|COMPLETED|Treatment Period 2 (14 Days)||3
296460|NCT01808339|707434|P1|COMPLETED|Treatment Period 2 (14 Days)||4
296461|NCT01808339|707429|P6|STARTED|Treatment Period 2 (14 Days)||5
296462|NCT01808339|707430|P5|STARTED|Treatment Period 2 (14 Days)||4
296463|NCT01808339|707431|P4|STARTED|Treatment Period 2 (14 Days)||2
296464|NCT01808339|707432|P3|STARTED|Treatment Period 2 (14 Days)||4
296465|NCT01808339|707433|P2|STARTED|Treatment Period 2 (14 Days)||3
296466|NCT01808339|707434|P1|STARTED|Treatment Period 2 (14 Days)||4
296467|NCT01808339|707429|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
296468|NCT01808339|707430|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
296470|NCT01808339|707432|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
296471|NCT01808339|707433|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
296472|NCT01808339|707434|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
296473|NCT01808339|707429|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
296474|NCT01808339|707430|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
296475|NCT01808339|707431|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
296476|NCT01808339|707432|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
296477|NCT01808339|707433|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
296478|NCT01808339|707434|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
296479|NCT01808339|707429|P6|STARTED|Washout Period 1 (14-21 Days)||5
296480|NCT01808339|707430|P5|STARTED|Washout Period 1 (14-21 Days)||4
296481|NCT01808339|707431|P4|STARTED|Washout Period 1 (14-21 Days)||2
296482|NCT01808339|707432|P3|STARTED|Washout Period 1 (14-21 Days)||4
296483|NCT01808339|707433|P2|STARTED|Washout Period 1 (14-21 Days)||3
296484|NCT01808339|707434|P1|STARTED|Washout Period 1 (14-21 Days)||4
296485|NCT01808339|707429|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
296486|NCT01808339|707430|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
296487|NCT01808339|707431|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
296488|NCT01808339|707432|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
296489|NCT01808339|707433|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
296490|NCT01808339|707434|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
296491|NCT01808339|707429|P6|COMPLETED|Treatment Period 1 (14 Days)||5
296492|NCT01808339|707430|P5|COMPLETED|Treatment Period 1 (14 Days)||4
296493|NCT01808339|707431|P4|COMPLETED|Treatment Period 1 (14 Days)||2
296494|NCT01808339|707432|P3|COMPLETED|Treatment Period 1 (14 Days)||4
296495|NCT01808339|707433|P2|COMPLETED|Treatment Period 1 (14 Days)||3
296496|NCT01808339|707434|P1|COMPLETED|Treatment Period 1 (14 Days)||4
296497|NCT01808339|707429|P6|STARTED|Treatment Period 1 (14 Days)||6
296498|NCT01808339|707430|P5|STARTED|Treatment Period 1 (14 Days)||6
296499|NCT01808339|707431|P4|STARTED|Treatment Period 1 (14 Days)||4
296500|NCT01808339|707432|P3|STARTED|Treatment Period 1 (14 Days)||4
296501|NCT01808339|707433|P2|STARTED|Treatment Period 1 (14 Days)||4
296502|NCT01808339|707434|P1|STARTED|Treatment Period 1 (14 Days)||4
296503|NCT01808326|707451|P1|NOT COMPLETED|Overall Study||0
296504|NCT01808326|707451|P1|COMPLETED|Overall Study||5
296505|NCT01808326|707451|P1|STARTED|Overall Study||5
296506|NCT01808313|707478|P1|NOT COMPLETED|Overall Study||10
296507|NCT01808313|707478|P1|COMPLETED|Overall Study||123
296508|NCT01808313|707478|P1|STARTED|Overall Study||133
296509|NCT01808248|707508|P1|NOT COMPLETED|Overall Study||5
296510|NCT01808248|707508|P1|COMPLETED|Overall Study||42
296511|NCT01808248|707508|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
296512|NCT01808248|707508|P1|STARTED|Overall Study||47
296513|NCT01808209|707522|P2|NOT COMPLETED|Overall Study||1
296514|NCT01808209|707523|P1|NOT COMPLETED|Overall Study||0
296515|NCT01808209|707522|P2|COMPLETED|Overall Study||26
296516|NCT01808209|707523|P1|COMPLETED|Overall Study||33
296517|NCT01808209|707522|P2|STARTED|Overall Study||27
296518|NCT01808209|707523|P1|STARTED|Overall Study||33
296519|NCT01808092|707567|P2|NOT COMPLETED|Overall Study||45
296520|NCT01808092|707568|P1|NOT COMPLETED|Overall Study||54
296521|NCT01808092|707567|P2|COMPLETED|Overall Study||363
296522|NCT01808092|707568|P1|COMPLETED|Overall Study||355
296523|NCT01808092|707567|P2|STARTED|Overall Study||408
296524|NCT01808092|707568|P1|STARTED|Overall Study||409
296525|NCT01808066|707670|P1|NOT COMPLETED|Overall Study||15
296526|NCT01808066|707670|P1|COMPLETED|Overall Study||6
296527|NCT01808066|707670|P1|STARTED|Overall Study||21
296528|NCT01807949|707677|P3|NOT COMPLETED|Overall Study||9
296529|NCT01807949|707678|P2|NOT COMPLETED|Overall Study||7
296530|NCT01807949|707679|P1|NOT COMPLETED|Overall Study||2
296531|NCT01807949|707677|P3|COMPLETED|Overall Study||180
296532|NCT01807949|707678|P2|COMPLETED|Overall Study||180
296533|NCT01807949|707679|P1|COMPLETED|Overall Study||185
296534|NCT01807949|707677|P3|STARTED|Overall Study||189
296535|NCT01807949|707678|P2|STARTED|Overall Study||187
296536|NCT01807949|707679|P1|STARTED|Overall Study||187
296537|NCT01807923|707731|P3|NOT COMPLETED|Overall Study||11
296538|NCT01807923|707732|P2|NOT COMPLETED|Overall Study||6
296539|NCT01807923|707733|P1|NOT COMPLETED|Overall Study||5
296540|NCT01807923|707731|P3|COMPLETED|Overall Study||176
296541|NCT01807923|707732|P2|COMPLETED|Overall Study||179
296542|NCT01807923|707733|P1|COMPLETED|Overall Study||182
296543|NCT01807923|707731|P3|STARTED|Overall Study||187
296544|NCT01807923|707732|P2|STARTED|Overall Study||185
296545|NCT01807923|707733|P1|STARTED|Overall Study||187
296546|NCT01807871|707784|P2|NOT COMPLETED|Overall Study||218
296547|NCT01807871|707785|P1|NOT COMPLETED|Overall Study||178
296548|NCT01807871|707784|P2|COMPLETED|Overall Study||127
296549|NCT01807871|707785|P1|COMPLETED|Overall Study||178
296550|NCT01807871|707784|P2|STARTED|Overall Study||345
296551|NCT01807871|707785|P1|STARTED|Overall Study||356
296552|NCT01807624|707795|P1|NOT COMPLETED|Overall Study||16
296553|NCT01807624|707795|P1|COMPLETED|Overall Study||24
296554|NCT01807624|707795|P1|STARTED|Overall Study||40
296555|NCT01807455|707811|P1|NOT COMPLETED|Overall Study||0
296556|NCT01807455|707811|P1|COMPLETED|Overall Study||12
296557|NCT01807455|707811|P1|STARTED|Overall Study||12
296558|NCT01807234|707825|P6|NOT COMPLETED|Overall Study||4
296559|NCT01807234|707826|P5|NOT COMPLETED|Overall Study||4
296560|NCT01807234|707827|P4|NOT COMPLETED|Overall Study||2
296561|NCT01807234|707828|P3|NOT COMPLETED|Overall Study||2
296562|NCT01807234|707829|P2|NOT COMPLETED|Overall Study||6
296563|NCT01807234|707830|P1|NOT COMPLETED|Overall Study||5
296564|NCT01807234|707825|P6|COMPLETED|Overall Study||8
296565|NCT01807234|707826|P5|COMPLETED|Overall Study||8
296566|NCT01807234|707827|P4|COMPLETED|Overall Study||10
296567|NCT01807234|707828|P3|COMPLETED|Overall Study||10
296568|NCT01807234|707829|P2|COMPLETED|Overall Study||6
296569|NCT01807234|707830|P1|COMPLETED|Overall Study||7
296570|NCT01807234|707825|P6|Completed Only 1 Attack|Overall Study||1
296571|NCT01807234|707826|P5|Completed Only 1 Attack|Overall Study||0
296572|NCT01807234|707827|P4|Completed Only 1 Attack|Overall Study||1
296573|NCT01807234|707828|P3|Completed Only 1 Attack|Overall Study||0
296574|NCT01807234|707829|P2|Completed Only 1 Attack|Overall Study||1
296575|NCT01807234|707830|P1|Completed Only 1 Attack|Overall Study||2
296576|NCT01807234|707825|P6|Randomized, But Did Not Take Drug|Overall Study||3
296577|NCT01807234|707826|P5|Randomized, But Did Not Take Drug|Overall Study||4
296578|NCT01807234|707827|P4|Randomized, But Did Not Take Drug|Overall Study||1
296579|NCT01807234|707828|P3|Randomized, But Did Not Take Drug|Overall Study||2
296580|NCT01807234|707829|P2|Randomized, But Did Not Take Drug|Overall Study||5
296581|NCT01807234|707830|P1|Randomized, But Did Not Take Drug|Overall Study||3
296582|NCT01807234|707825|P6|STARTED|Overall Study||12
296583|NCT01807234|707826|P5|STARTED|Overall Study||12
296584|NCT01807234|707827|P4|STARTED|Overall Study||12
296585|NCT01807234|707828|P3|STARTED|Overall Study||12
296586|NCT01807234|707829|P2|STARTED|Overall Study||12
296587|NCT01807234|707830|P1|STARTED|Overall Study||12
296588|NCT01807156|707865|P1|NOT COMPLETED|Overall Study||1
296589|NCT01807156|707865|P1|COMPLETED|Overall Study||6
296590|NCT01807156|707865|P1|STARTED|Overall Study||7
296591|NCT01807000|707870|P1|NOT COMPLETED|Overall Study||0
296592|NCT01807000|707870|P1|COMPLETED|Overall Study||6
296593|NCT01807000|707870|P1|STARTED|Overall Study||6
296594|NCT01806961|707889|P1|NOT COMPLETED|Overall Study||16
296595|NCT01806961|707889|P1|COMPLETED|Overall Study||0
296596|NCT01806961|707889|P1|STARTED|Overall Study||16
296597|NCT01806857|707893|P2|NOT COMPLETED|Overall Study||0
296598|NCT01806857|707894|P1|NOT COMPLETED|Overall Study||1
296599|NCT01806857|707893|P2|COMPLETED|Overall Study||29
296600|NCT01806857|707894|P1|COMPLETED|Overall Study||30
296601|NCT01806857|707893|P2|STARTED|Overall Study||29
296602|NCT01806857|707894|P1|STARTED|Overall Study||31
296603|NCT01806779|707932|P3|NOT COMPLETED|Overall Study||23
296604|NCT01806779|707933|P2|NOT COMPLETED|Overall Study||44
296605|NCT01806779|707934|P1|NOT COMPLETED|Overall Study||42
296606|NCT01806779|707932|P3|COMPLETED|Overall Study||0
296607|NCT01806779|707933|P2|COMPLETED|Overall Study||40
296608|NCT01806779|707934|P1|COMPLETED|Overall Study||48
296609|NCT01806779|707932|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
296610|NCT01806779|707933|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
296611|NCT01806779|707934|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
296612|NCT01806779|707932|P3|Randomized at Visit 2|Overall Study||0
296613|NCT01806779|707933|P2|Randomized at Visit 2|Overall Study||84
296614|NCT01806779|707934|P1|Randomized at Visit 2|Overall Study||90
296615|NCT01806779|707932|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
296616|NCT01806779|707933|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
296706|NCT01804946|708122|P2|STARTED|Overall Study||80
296617|NCT01806779|707934|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
296618|NCT01806779|707932|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
296619|NCT01806779|707933|P2|STARTED|Overall Study||84
296620|NCT01806779|707934|P1|STARTED|Overall Study||90
296621|NCT01806623|707947|P1|NOT COMPLETED|Overall Study||58
296622|NCT01806623|707947|P1|COMPLETED|Overall Study||99
296623|NCT01806623|707947|P1|STARTED|Overall Study||157
296624|NCT01806584|707966|P2|NOT COMPLETED|Overall Study||18
296625|NCT01806584|707967|P1|NOT COMPLETED|Overall Study||14
296626|NCT01806584|707966|P2|COMPLETED|Overall Study||0
296627|NCT01806584|707967|P1|COMPLETED|Overall Study||0
296628|NCT01806584|707966|P2|STARTED|Overall Study||18
296629|NCT01806584|707967|P1|STARTED|Overall Study||14
296630|NCT01806545|707981|P2|NOT COMPLETED|Overall Study||5
296631|NCT01806545|707982|P1|NOT COMPLETED|Overall Study||6
296632|NCT01806545|707981|P2|COMPLETED|Overall Study||30
296633|NCT01806545|707982|P1|COMPLETED|Overall Study||23
296634|NCT01806545|707981|P2|STARTED|Overall Study||35
296635|NCT01806545|707982|P1|STARTED|Overall Study||29
296636|NCT01806389|708004|P1|NOT COMPLETED|Overall Study||4
296637|NCT01806389|708004|P1|COMPLETED|Overall Study||10
296638|NCT01806389|708004|P1|STARTED|Overall Study||14
296639|NCT01806298|708018|P1|NOT COMPLETED|Overall Study||10
296640|NCT01806298|708018|P1|COMPLETED|Overall Study||68
296641|NCT01806298|708018|P1|STARTED|Overall Study||78
296642|NCT01806051|708028|P1|NOT COMPLETED|Overall Study||6
296643|NCT01806051|708028|P1|COMPLETED|Overall Study||0
296644|NCT01806051|708028|P1|STARTED|Overall Study||6
296645|NCT01805882|708043|P9|NOT COMPLETED|Overall Study||1
296646|NCT01805882|708044|P8|NOT COMPLETED|Overall Study||0
296647|NCT01805882|708045|P7|NOT COMPLETED|Overall Study||2
296648|NCT01805882|708046|P6|NOT COMPLETED|Overall Study||1
296649|NCT01805882|708047|P5|NOT COMPLETED|Overall Study||0
296650|NCT01805882|708048|P4|NOT COMPLETED|Overall Study||2
296651|NCT01805882|708049|P3|NOT COMPLETED|Overall Study||1
296652|NCT01805882|708050|P2|NOT COMPLETED|Overall Study||0
296653|NCT01805882|708051|P1|NOT COMPLETED|Overall Study||0
296654|NCT01805882|708043|P9|COMPLETED|Overall Study||24
296655|NCT01805882|708044|P8|COMPLETED|Overall Study||25
296656|NCT01805882|708045|P7|COMPLETED|Overall Study||48
296657|NCT01805882|708046|P6|COMPLETED|Overall Study||20
296658|NCT01805882|708047|P5|COMPLETED|Overall Study||14
296659|NCT01805882|708048|P4|COMPLETED|Overall Study||32
296660|NCT01805882|708049|P3|COMPLETED|Overall Study||19
296661|NCT01805882|708050|P2|COMPLETED|Overall Study||20
296662|NCT01805882|708051|P1|COMPLETED|Overall Study||20
296663|NCT01805882|708043|P9|STARTED|Overall Study||25
296664|NCT01805882|708044|P8|STARTED|Overall Study||25
296665|NCT01805882|708045|P7|STARTED|Overall Study||50
296666|NCT01805882|708046|P6|STARTED|Overall Study||21
296667|NCT01805882|708047|P5|STARTED|Overall Study||14
296668|NCT01805882|708048|P4|STARTED|Overall Study||34
296669|NCT01805882|708049|P3|STARTED|Overall Study||20
296670|NCT01805882|708050|P2|STARTED|Overall Study||20
296671|NCT01805882|708051|P1|STARTED|Overall Study||20
296672|NCT01805687|708071|P1|NOT COMPLETED|Overall Study||0
296673|NCT01805687|708071|P1|COMPLETED|Overall Study||25
296674|NCT01805687|708071|P1|STARTED|Overall Study||25
296675|NCT01805323|708075|P1|NOT COMPLETED|Overall Study||0
296676|NCT01805323|708075|P1|COMPLETED|Overall Study||101
296677|NCT01805323|708075|P1|STARTED|Overall Study||101
296678|NCT01805180|708082|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
296679|NCT01805180|708083|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
296680|NCT01805180|708084|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
296681|NCT01805180|708082|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
296682|NCT01805180|708083|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
296683|NCT01805180|708084|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
296684|NCT01805180|708082|P3|STARTED|Pivotal Randomization Through Study Exit||20
296685|NCT01805180|708083|P2|STARTED|Pivotal Randomization Through Study Exit||22
296686|NCT01805180|708084|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
296687|NCT01805180|708082|P3|NOT COMPLETED|Lead-in Donor Phase||0
296688|NCT01805180|708083|P2|NOT COMPLETED|Lead-in Donor Phase||0
296689|NCT01805180|708084|P1|NOT COMPLETED|Lead-in Donor Phase||1
296690|NCT01805180|708082|P3|COMPLETED|Lead-in Donor Phase||0
296691|NCT01805180|708083|P2|COMPLETED|Lead-in Donor Phase||0
296692|NCT01805180|708084|P1|COMPLETED|Lead-in Donor Phase||6
296693|NCT01805180|708082|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
296694|NCT01805180|708083|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
296695|NCT01805180|708084|P1|STARTED|Lead-in Donor Phase||7
296696|NCT01805089|708109|P2|NOT COMPLETED|Overall Study||4
296697|NCT01805089|708110|P1|NOT COMPLETED|Overall Study||5
296698|NCT01805089|708109|P2|COMPLETED|Overall Study||43
296699|NCT01805089|708110|P1|COMPLETED|Overall Study||43
296700|NCT01805089|708109|P2|STARTED|Overall Study||47
296701|NCT01805089|708110|P1|STARTED|Overall Study||48
296702|NCT01804946|708122|P2|NOT COMPLETED|Overall Study||4
296703|NCT01804946|708123|P1|NOT COMPLETED|Overall Study||2
296704|NCT01804946|708122|P2|COMPLETED|Overall Study||76
296705|NCT01804946|708123|P1|COMPLETED|Overall Study||79
296707|NCT01804946|708123|P1|STARTED|Overall Study||81
296708|NCT01804881|708147|P2|NOT COMPLETED|Overall Study||4
296709|NCT01804881|708148|P1|NOT COMPLETED|Overall Study||5
296710|NCT01804881|708147|P2|COMPLETED|Overall Study||10
296711|NCT01804881|708148|P1|COMPLETED|Overall Study||11
296712|NCT01804881|708147|P2|STARTED|Overall Study||14
296713|NCT01804881|708148|P1|STARTED|Overall Study||16
296714|NCT01804842|708161|P3|NOT COMPLETED|Overall Study||1
296715|NCT01804842|708162|P2|NOT COMPLETED|Overall Study||2
296716|NCT01804842|708163|P1|NOT COMPLETED|Overall Study||3
296717|NCT01804842|708161|P3|COMPLETED|Overall Study||8
296718|NCT01804842|708162|P2|COMPLETED|Overall Study||6
296719|NCT01804842|708163|P1|COMPLETED|Overall Study||6
296720|NCT01804842|708161|P3|Completed Treatment C|Overall Study||9
296721|NCT01804842|708162|P2|Completed Treatment C|Overall Study||7
296722|NCT01804842|708163|P1|Completed Treatment C|Overall Study||7
296723|NCT01804842|708161|P3|Completed Treatment B|Overall Study||8
296724|NCT01804842|708162|P2|Completed Treatment B|Overall Study||8
296725|NCT01804842|708163|P1|Completed Treatment B|Overall Study||8
296726|NCT01804842|708161|P3|Completed Treatment A|Overall Study||8
296727|NCT01804842|708162|P2|Completed Treatment A|Overall Study||6
296728|NCT01804842|708163|P1|Completed Treatment A|Overall Study||9
296729|NCT01804842|708161|P3|STARTED|Overall Study||9
296730|NCT01804842|708162|P2|STARTED|Overall Study||8
296731|NCT01804842|708163|P1|STARTED|Overall Study||9
296732|NCT01804673|708180|P1|NOT COMPLETED|Overall Study||140
296733|NCT01804673|708180|P1|COMPLETED|Overall Study||34
296734|NCT01804673|708180|P1|Completed Hour 72|Overall Study||36
296735|NCT01804673|708180|P1|Completed Hour 48|Overall Study||79
296736|NCT01804673|708180|P1|Completed Hour 24|Overall Study||170
296737|NCT01804673|708180|P1|STARTED|Overall Study||174
296738|NCT01804257|708196|P1|NOT COMPLETED|Overall Study||1
296739|NCT01804257|708196|P1|COMPLETED|Overall Study||27
296740|NCT01804257|708196|P1|STARTED|Overall Study||28
296741|NCT01804140|708200|P1|NOT COMPLETED|Overall Study||114
296742|NCT01804140|708200|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
296743|NCT01804140|708200|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
296744|NCT01804062|708205|P1|NOT COMPLETED|Overall Study||0
296745|NCT01804062|708205|P1|COMPLETED|Overall Study||30
296746|NCT01804062|708205|P1|STARTED|Overall Study||30
296747|NCT01804036|708212|P2|NOT COMPLETED|Overall Study||20
296748|NCT01804036|708213|P1|NOT COMPLETED|Overall Study||13
296749|NCT01804036|708212|P2|COMPLETED|Overall Study||21
296750|NCT01804036|708213|P1|COMPLETED|Overall Study||18
296751|NCT01804036|708212|P2|STARTED|Overall Study||41
296752|NCT01804036|708213|P1|STARTED|Overall Study||31
296753|NCT01803737|708247|P2|NOT COMPLETED|Overall Study||3
296754|NCT01803737|708248|P1|NOT COMPLETED|Overall Study||1
296755|NCT01803737|708247|P2|COMPLETED|Overall Study||10
296756|NCT01803737|708248|P1|COMPLETED|Overall Study||12
296757|NCT01803737|708247|P2|STARTED|Overall Study||13
296758|NCT01803737|708248|P1|STARTED|Overall Study||13
296759|NCT01803607|708272|P2|NOT COMPLETED|Overall Study||67
296760|NCT01803607|708273|P1|NOT COMPLETED|Overall Study||68
296761|NCT01803607|708272|P2|COMPLETED|Overall Study||0
296762|NCT01803607|708273|P1|COMPLETED|Overall Study||0
296763|NCT01803607|708272|P2|STARTED|Overall Study||67
296764|NCT01803607|708273|P1|STARTED|Overall Study||68
296765|NCT01802632|708299|P6|NOT COMPLETED|Overall Study||28
296766|NCT01802632|708300|P5|NOT COMPLETED|Overall Study||12
296767|NCT01802632|708301|P4|NOT COMPLETED|Overall Study||60
296768|NCT01802632|708302|P3|NOT COMPLETED|Overall Study||271
296769|NCT01802632|708303|P2|NOT COMPLETED|Overall Study||31
296770|NCT01802632|708304|P1|NOT COMPLETED|Overall Study||201
296771|NCT01802632|708299|P6|COMPLETED|Overall Study||0
296772|NCT01802632|708300|P5|COMPLETED|Overall Study||0
296773|NCT01802632|708301|P4|COMPLETED|Overall Study||0
296774|NCT01802632|708302|P3|COMPLETED|Overall Study||0
296775|NCT01802632|708303|P2|COMPLETED|Overall Study||0
296776|NCT01802632|708304|P1|COMPLETED|Overall Study||0
296777|NCT01802632|708299|P6|STARTED|Overall Study||28
296778|NCT01802632|708300|P5|STARTED|Overall Study||12
296779|NCT01802632|708301|P4|STARTED|Overall Study||60
296780|NCT01802632|708302|P3|STARTED|Overall Study||271
296781|NCT01802632|708303|P2|STARTED|Overall Study||31
296782|NCT01802632|708304|P1|STARTED|Overall Study||201
296783|NCT01802554|708320|P2|NOT COMPLETED|Overall Study||6
296784|NCT01802554|708321|P1|NOT COMPLETED|Overall Study||8
296785|NCT01802554|708320|P2|COMPLETED|Overall Study||43
296786|NCT01802554|708321|P1|COMPLETED|Overall Study||43
296787|NCT01802554|708320|P2|STARTED|Overall Study||49
296788|NCT01802554|708321|P1|STARTED|Overall Study||51
296789|NCT01802515|708338|P3|NOT COMPLETED|Overall Study||0
296790|NCT01802515|708339|P2|NOT COMPLETED|Overall Study||0
296791|NCT01802515|708340|P1|NOT COMPLETED|Overall Study||3
296792|NCT01802515|708338|P3|COMPLETED|Overall Study||4
296793|NCT01802515|708339|P2|COMPLETED|Overall Study||5
296794|NCT01802515|708340|P1|COMPLETED|Overall Study||2
296795|NCT01802515|708338|P3|STARTED|Overall Study||4
296796|NCT01802515|708339|P2|STARTED|Overall Study||5
296797|NCT01802515|708340|P1|STARTED|Overall Study||5
296798|NCT01802320|708351|P1|NOT COMPLETED|Overall Study||2
296799|NCT01802320|708351|P1|COMPLETED|Overall Study||16
296800|NCT01802320|708351|P1|STARTED|Overall Study||18
296801|NCT01802151|708359|P4|NOT COMPLETED|Overall Study||0
296802|NCT01802151|708360|P3|NOT COMPLETED|Overall Study||2
296803|NCT01802151|708361|P2|NOT COMPLETED|Overall Study||0
296804|NCT01802151|708362|P1|NOT COMPLETED|Overall Study||0
296805|NCT01802151|708359|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
296806|NCT01802151|708360|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
296807|NCT01802151|708361|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
296808|NCT01802151|708362|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
296809|NCT01802151|708359|P4|STARTED|Overall Study||20
296810|NCT01802151|708360|P3|STARTED|Overall Study||22
296811|NCT01802151|708361|P2|STARTED|Overall Study||21
296812|NCT01802151|708362|P1|STARTED|Overall Study||20
296813|NCT01801982|708424|P1|NOT COMPLETED|Overall Study||1
296814|NCT01801982|708424|P1|COMPLETED|Overall Study||0
296815|NCT01801982|708424|P1|STARTED|Overall Study||1
296816|NCT01801735|708434|P1|NOT COMPLETED|Overall Study||210
296817|NCT01801735|708434|P1|COMPLETED|Overall Study||390
296818|NCT01801735|708434|P1|STARTED|Overall Study||600
296819|NCT01801475|708441|P5|NOT COMPLETED|Overall Study||1
296820|NCT01801475|708442|P4|NOT COMPLETED|Overall Study||0
296821|NCT01801475|708443|P3|NOT COMPLETED|Overall Study||0
296822|NCT01801475|708444|P2|NOT COMPLETED|Overall Study||0
296823|NCT01801475|708445|P1|NOT COMPLETED|Overall Study||0
296824|NCT01801475|708441|P5|COMPLETED|Overall Study||39
296825|NCT01801475|708442|P4|COMPLETED|Overall Study||10
296826|NCT01801475|708443|P3|COMPLETED|Overall Study||10
296827|NCT01801475|708444|P2|COMPLETED|Overall Study||30
296828|NCT01801475|708445|P1|COMPLETED|Overall Study||10
296829|NCT01801475|708441|P5|STARTED|Overall Study||40
296830|NCT01801475|708442|P4|STARTED|Overall Study||10
296831|NCT01801475|708443|P3|STARTED|Overall Study||10
296832|NCT01801475|708444|P2|STARTED|Overall Study||30
296833|NCT01801475|708445|P1|STARTED|Overall Study||10
296834|NCT01801436|708456|P1|NOT COMPLETED|Overall Study||9
296835|NCT01801436|708456|P1|COMPLETED|Overall Study||5
296836|NCT01801436|708456|P1|STARTED|Overall Study||14
296837|NCT01801358|708494|P6|NOT COMPLETED|Overall Study||8
296838|NCT01801358|708495|P5|NOT COMPLETED|Overall Study||6
296839|NCT01801358|708496|P4|NOT COMPLETED|Overall Study||6
296840|NCT01801358|708497|P3|NOT COMPLETED|Overall Study||6
296841|NCT01801358|708498|P2|NOT COMPLETED|Overall Study||6
296842|NCT01801358|708499|P1|NOT COMPLETED|Overall Study||6
296843|NCT01801358|708494|P6|COMPLETED|Overall Study||0
296844|NCT01801358|708495|P5|COMPLETED|Overall Study||0
296845|NCT01801358|708496|P4|COMPLETED|Overall Study||0
296846|NCT01801358|708497|P3|COMPLETED|Overall Study||0
296847|NCT01801358|708498|P2|COMPLETED|Overall Study||0
296848|NCT01801358|708499|P1|COMPLETED|Overall Study||0
296849|NCT01801358|708494|P6|STARTED|Overall Study||8
296850|NCT01801358|708495|P5|STARTED|Overall Study||6
296851|NCT01801358|708496|P4|STARTED|Overall Study||6
296852|NCT01801358|708497|P3|STARTED|Overall Study||6
296853|NCT01801358|708498|P2|STARTED|Overall Study||6
296854|NCT01801358|708499|P1|STARTED|Overall Study||6
296855|NCT01801280|708621|P4|NOT COMPLETED|Period 4||0
296856|NCT01801280|708622|P3|NOT COMPLETED|Period 4||1
296857|NCT01801280|708623|P2|NOT COMPLETED|Period 4||0
296858|NCT01801280|708624|P1|NOT COMPLETED|Period 4||0
296859|NCT01801280|708621|P4|COMPLETED|Period 4||5
296860|NCT01801280|708622|P3|COMPLETED|Period 4||4
296861|NCT01801280|708623|P2|COMPLETED|Period 4||4
296862|NCT01801280|708624|P1|COMPLETED|Period 4||4
296863|NCT01801280|708621|P4|STARTED|Period 4||5
296864|NCT01801280|708622|P3|STARTED|Period 4||5
296865|NCT01801280|708623|P2|STARTED|Period 4||4
296866|NCT01801280|708624|P1|STARTED|Period 4||4
296867|NCT01801280|708621|P4|NOT COMPLETED|Period 3||0
296868|NCT01801280|708622|P3|NOT COMPLETED|Period 3||0
296869|NCT01801280|708623|P2|NOT COMPLETED|Period 3||0
296870|NCT01801280|708624|P1|NOT COMPLETED|Period 3||0
296871|NCT01801280|708621|P4|COMPLETED|Period 3||5
296872|NCT01801280|708622|P3|COMPLETED|Period 3||5
296873|NCT01801280|708623|P2|COMPLETED|Period 3||4
296874|NCT01801280|708624|P1|COMPLETED|Period 3||4
296875|NCT01801280|708621|P4|STARTED|Period 3||5
296876|NCT01801280|708622|P3|STARTED|Period 3||5
296877|NCT01801280|708623|P2|STARTED|Period 3||4
296878|NCT01801280|708624|P1|STARTED|Period 3||4
296879|NCT01801280|708621|P4|NOT COMPLETED|Period 2||0
296880|NCT01801280|708622|P3|NOT COMPLETED|Period 2||0
296881|NCT01801280|708623|P2|NOT COMPLETED|Period 2||0
296882|NCT01801280|708624|P1|NOT COMPLETED|Period 2||1
296883|NCT01801280|708621|P4|COMPLETED|Period 2||5
296884|NCT01801280|708622|P3|COMPLETED|Period 2||5
296885|NCT01801280|708623|P2|COMPLETED|Period 2||4
296886|NCT01801280|708624|P1|COMPLETED|Period 2||4
296887|NCT01801280|708621|P4|STARTED|Period 2||5
296888|NCT01801280|708622|P3|STARTED|Period 2||5
296889|NCT01801280|708623|P2|STARTED|Period 2||4
296890|NCT01801280|708624|P1|STARTED|Period 2||5
296891|NCT01801280|708621|P4|NOT COMPLETED|Period 1||0
296892|NCT01801280|708622|P3|NOT COMPLETED|Period 1||0
296893|NCT01801280|708623|P2|NOT COMPLETED|Period 1||1
296894|NCT01801280|708624|P1|NOT COMPLETED|Period 1||0
296895|NCT01801280|708621|P4|COMPLETED|Period 1||5
296896|NCT01801280|708622|P3|COMPLETED|Period 1||5
296897|NCT01801280|708623|P2|COMPLETED|Period 1||4
296898|NCT01801280|708624|P1|COMPLETED|Period 1||5
296899|NCT01801280|708621|P4|STARTED|Period 1||5
296900|NCT01801280|708622|P3|STARTED|Period 1||5
296901|NCT01801280|708623|P2|STARTED|Period 1||5
296902|NCT01801280|708624|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
296903|NCT01801124|708634|P1|NOT COMPLETED|Overall Study||0
296904|NCT01801124|708634|P1|COMPLETED|Overall Study||13
296905|NCT01801124|708634|P1|STARTED|Overall Study||13
296906|NCT01801111|708639|P1|NOT COMPLETED|Overall Study||138
296907|NCT01801111|708639|P1|COMPLETED|Overall Study||0
296908|NCT01801111|708639|P1|STARTED|Overall Study||138
296909|NCT01800968|708664|P2|NOT COMPLETED|Overall Study||32
296910|NCT01800968|708665|P1|NOT COMPLETED|Overall Study||36
296911|NCT01800968|708664|P2|COMPLETED|Overall Study||114
296912|NCT01800968|708665|P1|COMPLETED|Overall Study||118
296913|NCT01800968|708664|P2|STARTED|Overall Study||146
296914|NCT01800968|708665|P1|STARTED|Overall Study||154
296915|NCT01800916|708707|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
296916|NCT01800916|708708|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
296917|NCT01800916|708709|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
296918|NCT01800916|708710|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
296919|NCT01800916|708711|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
296920|NCT01800916|708712|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
296921|NCT01800916|708713|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
296922|NCT01800916|708714|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
296923|NCT01800916|708715|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
296924|NCT01800916|708707|P9|COMPLETED|Test Period 3 (1 Week)||7
296925|NCT01800916|708708|P8|COMPLETED|Test Period 3 (1 Week)||7
296926|NCT01800916|708709|P7|COMPLETED|Test Period 3 (1 Week)||7
296927|NCT01800916|708710|P6|COMPLETED|Test Period 3 (1 Week)||7
296928|NCT01800916|708711|P5|COMPLETED|Test Period 3 (1 Week)||7
296929|NCT01800916|708712|P4|COMPLETED|Test Period 3 (1 Week)||6
296930|NCT01800916|708713|P3|COMPLETED|Test Period 3 (1 Week)||7
296931|NCT01800916|708714|P2|COMPLETED|Test Period 3 (1 Week)||7
296932|NCT01800916|708715|P1|COMPLETED|Test Period 3 (1 Week)||7
296933|NCT01800916|708707|P9|STARTED|Test Period 3 (1 Week)||7
296934|NCT01800916|708708|P8|STARTED|Test Period 3 (1 Week)||7
296935|NCT01800916|708709|P7|STARTED|Test Period 3 (1 Week)||7
296936|NCT01800916|708710|P6|STARTED|Test Period 3 (1 Week)||7
296937|NCT01800916|708711|P5|STARTED|Test Period 3 (1 Week)||7
296938|NCT01800916|708712|P4|STARTED|Test Period 3 (1 Week)||6
296939|NCT01800916|708713|P3|STARTED|Test Period 3 (1 Week)||7
296940|NCT01800916|708714|P2|STARTED|Test Period 3 (1 Week)||7
296941|NCT01800916|708715|P1|STARTED|Test Period 3 (1 Week)||7
296942|NCT01800916|708707|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
296943|NCT01800916|708708|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
296944|NCT01800916|708709|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
296945|NCT01800916|708710|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
296946|NCT01800916|708711|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
296947|NCT01800916|708712|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
296948|NCT01800916|708713|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
296949|NCT01800916|708714|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
296950|NCT01800916|708715|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
296951|NCT01800916|708707|P9|COMPLETED|Test Period 2 (1 Week)||7
296952|NCT01800916|708708|P8|COMPLETED|Test Period 2 (1 Week)||7
296953|NCT01800916|708709|P7|COMPLETED|Test Period 2 (1 Week)||7
296954|NCT01800916|708710|P6|COMPLETED|Test Period 2 (1 Week)||7
296955|NCT01800916|708711|P5|COMPLETED|Test Period 2 (1 Week)||7
296956|NCT01800916|708712|P4|COMPLETED|Test Period 2 (1 Week)||6
296957|NCT01800916|708713|P3|COMPLETED|Test Period 2 (1 Week)||7
296958|NCT01800916|708714|P2|COMPLETED|Test Period 2 (1 Week)||7
296959|NCT01800916|708715|P1|COMPLETED|Test Period 2 (1 Week)||7
296960|NCT01800916|708707|P9|STARTED|Test Period 2 (1 Week)||7
296961|NCT01800916|708708|P8|STARTED|Test Period 2 (1 Week)||7
296962|NCT01800916|708709|P7|STARTED|Test Period 2 (1 Week)||7
296963|NCT01800916|708710|P6|STARTED|Test Period 2 (1 Week)||7
296964|NCT01800916|708711|P5|STARTED|Test Period 2 (1 Week)||7
296965|NCT01800916|708712|P4|STARTED|Test Period 2 (1 Week)||6
296966|NCT01800916|708713|P3|STARTED|Test Period 2 (1 Week)||7
296967|NCT01800916|708714|P2|STARTED|Test Period 2 (1 Week)||7
296968|NCT01800916|708715|P1|STARTED|Test Period 2 (1 Week)||7
296969|NCT01800916|708707|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
296970|NCT01800916|708708|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
296971|NCT01800916|708709|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
296972|NCT01800916|708710|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
296973|NCT01800916|708711|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
296974|NCT01800916|708712|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
296975|NCT01800916|708713|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
296976|NCT01800916|708714|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
296977|NCT01800916|708715|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
296978|NCT01800916|708707|P9|COMPLETED|Test Period 1 (1 Week)||7
296979|NCT01800916|708708|P8|COMPLETED|Test Period 1 (1 Week)||7
296980|NCT01800916|708709|P7|COMPLETED|Test Period 1 (1 Week)||7
296981|NCT01800916|708710|P6|COMPLETED|Test Period 1 (1 Week)||7
296982|NCT01800916|708711|P5|COMPLETED|Test Period 1 (1 Week)||7
296983|NCT01800916|708712|P4|COMPLETED|Test Period 1 (1 Week)||6
296984|NCT01800916|708713|P3|COMPLETED|Test Period 1 (1 Week)||7
296985|NCT01800916|708714|P2|COMPLETED|Test Period 1 (1 Week)||7
296986|NCT01800916|708715|P1|COMPLETED|Test Period 1 (1 Week)||7
296987|NCT01800916|708707|P9|STARTED|Test Period 1 (1 Week)||7
296988|NCT01800916|708708|P8|STARTED|Test Period 1 (1 Week)||7
296989|NCT01800916|708709|P7|STARTED|Test Period 1 (1 Week)||7
296990|NCT01800916|708710|P6|STARTED|Test Period 1 (1 Week)||7
296991|NCT01800916|708711|P5|STARTED|Test Period 1 (1 Week)||8
296992|NCT01800916|708712|P4|STARTED|Test Period 1 (1 Week)||7
296993|NCT01800916|708713|P3|STARTED|Test Period 1 (1 Week)||7
296994|NCT01800916|708714|P2|STARTED|Test Period 1 (1 Week)||7
296995|NCT01800916|708715|P1|STARTED|Test Period 1 (1 Week)||7
296996|NCT01800903|708725|P6|NOT COMPLETED|Third Test Period||0
296997|NCT01800903|708726|P5|NOT COMPLETED|Third Test Period||0
296998|NCT01800903|708727|P4|NOT COMPLETED|Third Test Period||0
296999|NCT01800903|708728|P3|NOT COMPLETED|Third Test Period||0
297000|NCT01800903|708729|P2|NOT COMPLETED|Third Test Period||0
297001|NCT01800903|708730|P1|NOT COMPLETED|Third Test Period||0
297002|NCT01800903|708725|P6|COMPLETED|Third Test Period||6
297003|NCT01800903|708726|P5|COMPLETED|Third Test Period||6
297004|NCT01800903|708727|P4|COMPLETED|Third Test Period||7
297005|NCT01800903|708728|P3|COMPLETED|Third Test Period||4
297006|NCT01800903|708729|P2|COMPLETED|Third Test Period||6
297007|NCT01800903|708730|P1|COMPLETED|Third Test Period||6
297008|NCT01800903|708725|P6|STARTED|Third Test Period||6
297009|NCT01800903|708726|P5|STARTED|Third Test Period||6
297010|NCT01800903|708727|P4|STARTED|Third Test Period||7
297011|NCT01800903|708728|P3|STARTED|Third Test Period||4
297012|NCT01800903|708729|P2|STARTED|Third Test Period||6
297013|NCT01800903|708730|P1|STARTED|Third Test Period||6
297014|NCT01800903|708725|P6|NOT COMPLETED|Second Test Period||0
297015|NCT01800903|708726|P5|NOT COMPLETED|Second Test Period||0
297016|NCT01800903|708727|P4|NOT COMPLETED|Second Test Period||0
297017|NCT01800903|708728|P3|NOT COMPLETED|Second Test Period||0
297018|NCT01800903|708729|P2|NOT COMPLETED|Second Test Period||0
297019|NCT01800903|708730|P1|NOT COMPLETED|Second Test Period||1
297020|NCT01800903|708725|P6|COMPLETED|Second Test Period||6
297021|NCT01800903|708726|P5|COMPLETED|Second Test Period||6
297022|NCT01800903|708727|P4|COMPLETED|Second Test Period||7
297023|NCT01800903|708728|P3|COMPLETED|Second Test Period||4
297024|NCT01800903|708729|P2|COMPLETED|Second Test Period||6
297025|NCT01800903|708730|P1|COMPLETED|Second Test Period||6
297026|NCT01800903|708725|P6|STARTED|Second Test Period||6
297027|NCT01800903|708726|P5|STARTED|Second Test Period||6
297028|NCT01800903|708727|P4|STARTED|Second Test Period||7
297029|NCT01800903|708728|P3|STARTED|Second Test Period||4
297030|NCT01800903|708729|P2|STARTED|Second Test Period||6
297031|NCT01800903|708730|P1|STARTED|Second Test Period||7
297032|NCT01800903|708725|P6|NOT COMPLETED|First Test Period||0
297033|NCT01800903|708726|P5|NOT COMPLETED|First Test Period||0
297034|NCT01800903|708727|P4|NOT COMPLETED|First Test Period||0
297035|NCT01800903|708728|P3|NOT COMPLETED|First Test Period||0
297036|NCT01800903|708729|P2|NOT COMPLETED|First Test Period||0
297037|NCT01800903|708730|P1|NOT COMPLETED|First Test Period||0
297038|NCT01800903|708725|P6|COMPLETED|First Test Period||6
297039|NCT01800903|708726|P5|COMPLETED|First Test Period||6
297040|NCT01800903|708727|P4|COMPLETED|First Test Period||7
297041|NCT01800903|708728|P3|COMPLETED|First Test Period||4
297042|NCT01800903|708729|P2|COMPLETED|First Test Period||6
297043|NCT01800903|708730|P1|COMPLETED|First Test Period||7
297044|NCT01800903|708725|P6|STARTED|First Test Period||6
297045|NCT01800903|708726|P5|STARTED|First Test Period||6
297046|NCT01800903|708727|P4|STARTED|First Test Period||7
297047|NCT01800903|708728|P3|STARTED|First Test Period||4
297048|NCT01800903|708729|P2|STARTED|First Test Period||6
297049|NCT01800903|708730|P1|STARTED|First Test Period||7
297050|NCT01800890|708736|P9|NOT COMPLETED|Test Period 3||0
297051|NCT01800890|708737|P8|NOT COMPLETED|Test Period 3||0
297052|NCT01800890|708738|P7|NOT COMPLETED|Test Period 3||0
297053|NCT01800890|708739|P6|NOT COMPLETED|Test Period 3||0
297054|NCT01800890|708740|P5|NOT COMPLETED|Test Period 3||0
297055|NCT01800890|708741|P4|NOT COMPLETED|Test Period 3||0
297056|NCT01800890|708742|P3|NOT COMPLETED|Test Period 3||0
297057|NCT01800890|708743|P2|NOT COMPLETED|Test Period 3||0
297058|NCT01800890|708744|P1|NOT COMPLETED|Test Period 3||0
297059|NCT01800890|708736|P9|COMPLETED|Test Period 3||3
297060|NCT01800890|708737|P8|COMPLETED|Test Period 3||3
297061|NCT01800890|708738|P7|COMPLETED|Test Period 3||3
297062|NCT01800890|708739|P6|COMPLETED|Test Period 3||4
297063|NCT01800890|708740|P5|COMPLETED|Test Period 3||4
297064|NCT01800890|708741|P4|COMPLETED|Test Period 3||2
297065|NCT01800890|708742|P3|COMPLETED|Test Period 3||3
297066|NCT01800890|708743|P2|COMPLETED|Test Period 3||3
297067|NCT01800890|708744|P1|COMPLETED|Test Period 3||3
297068|NCT01800890|708736|P9|STARTED|Test Period 3||3
297069|NCT01800890|708737|P8|STARTED|Test Period 3||3
297070|NCT01800890|708738|P7|STARTED|Test Period 3||3
297071|NCT01800890|708739|P6|STARTED|Test Period 3||4
297072|NCT01800890|708740|P5|STARTED|Test Period 3||4
297073|NCT01800890|708741|P4|STARTED|Test Period 3||2
297074|NCT01800890|708742|P3|STARTED|Test Period 3||3
297075|NCT01800890|708743|P2|STARTED|Test Period 3||3
297076|NCT01800890|708744|P1|STARTED|Test Period 3||3
297077|NCT01800890|708736|P9|NOT COMPLETED|Test Period 2||0
297078|NCT01800890|708737|P8|NOT COMPLETED|Test Period 2||0
297079|NCT01800890|708738|P7|NOT COMPLETED|Test Period 2||0
297080|NCT01800890|708739|P6|NOT COMPLETED|Test Period 2||0
297081|NCT01800890|708740|P5|NOT COMPLETED|Test Period 2||0
297082|NCT01800890|708741|P4|NOT COMPLETED|Test Period 2||0
297083|NCT01800890|708742|P3|NOT COMPLETED|Test Period 2||0
297084|NCT01800890|708743|P2|NOT COMPLETED|Test Period 2||0
297085|NCT01800890|708744|P1|NOT COMPLETED|Test Period 2||0
297086|NCT01800890|708736|P9|COMPLETED|Test Period 2||3
297087|NCT01800890|708737|P8|COMPLETED|Test Period 2||3
297088|NCT01800890|708738|P7|COMPLETED|Test Period 2||3
297089|NCT01800890|708739|P6|COMPLETED|Test Period 2||4
297090|NCT01800890|708740|P5|COMPLETED|Test Period 2||4
297091|NCT01800890|708741|P4|COMPLETED|Test Period 2||2
297092|NCT01800890|708742|P3|COMPLETED|Test Period 2||3
297093|NCT01800890|708743|P2|COMPLETED|Test Period 2||3
297094|NCT01800890|708744|P1|COMPLETED|Test Period 2||3
297095|NCT01800890|708736|P9|STARTED|Test Period 2||3
297096|NCT01800890|708737|P8|STARTED|Test Period 2||3
297097|NCT01800890|708738|P7|STARTED|Test Period 2||3
297098|NCT01800890|708739|P6|STARTED|Test Period 2||4
297099|NCT01800890|708740|P5|STARTED|Test Period 2||4
297100|NCT01800890|708741|P4|STARTED|Test Period 2||2
297101|NCT01800890|708742|P3|STARTED|Test Period 2||3
297102|NCT01800890|708743|P2|STARTED|Test Period 2||3
297103|NCT01800890|708744|P1|STARTED|Test Period 2||3
297104|NCT01800890|708736|P9|NOT COMPLETED|Test Period 1||0
297105|NCT01800890|708737|P8|NOT COMPLETED|Test Period 1||0
297106|NCT01800890|708738|P7|NOT COMPLETED|Test Period 1||0
297107|NCT01800890|708739|P6|NOT COMPLETED|Test Period 1||0
297108|NCT01800890|708740|P5|NOT COMPLETED|Test Period 1||0
297109|NCT01800890|708741|P4|NOT COMPLETED|Test Period 1||1
297110|NCT01800890|708742|P3|NOT COMPLETED|Test Period 1||0
297111|NCT01800890|708743|P2|NOT COMPLETED|Test Period 1||0
297112|NCT01800890|708744|P1|NOT COMPLETED|Test Period 1||0
297113|NCT01800890|708736|P9|COMPLETED|Test Period 1||3
297114|NCT01800890|708737|P8|COMPLETED|Test Period 1||3
297115|NCT01800890|708738|P7|COMPLETED|Test Period 1||3
297116|NCT01800890|708739|P6|COMPLETED|Test Period 1||4
297117|NCT01800890|708740|P5|COMPLETED|Test Period 1||4
297118|NCT01800890|708741|P4|COMPLETED|Test Period 1||2
297119|NCT01800890|708742|P3|COMPLETED|Test Period 1||3
297120|NCT01800890|708743|P2|COMPLETED|Test Period 1||3
297121|NCT01800890|708744|P1|COMPLETED|Test Period 1||3
297122|NCT01800890|708736|P9|STARTED|Test Period 1||3
297123|NCT01800890|708737|P8|STARTED|Test Period 1||3
297124|NCT01800890|708738|P7|STARTED|Test Period 1||3
297125|NCT01800890|708739|P6|STARTED|Test Period 1||4
297126|NCT01800890|708740|P5|STARTED|Test Period 1||4
297127|NCT01800890|708741|P4|STARTED|Test Period 1||3
297128|NCT01800890|708742|P3|STARTED|Test Period 1||3
297129|NCT01800890|708743|P2|STARTED|Test Period 1||3
297130|NCT01800890|708744|P1|STARTED|Test Period 1||3
297131|NCT01800786|708756|P2|NOT COMPLETED|Overall Study||1
297132|NCT01800786|708757|P1|NOT COMPLETED|Overall Study||2
297133|NCT01800786|708756|P2|COMPLETED|Overall Study||15
297134|NCT01800786|708757|P1|COMPLETED|Overall Study||15
297135|NCT01800786|708756|P2|STARTED|Overall Study||16
297136|NCT01800786|708757|P1|STARTED|Overall Study||17
297137|NCT01800318|708767|P4|NOT COMPLETED|Overall Study||1
297138|NCT01800318|708768|P3|NOT COMPLETED|Overall Study||1
297139|NCT01800318|708769|P2|NOT COMPLETED|Overall Study||5
297140|NCT01800318|708770|P1|NOT COMPLETED|Overall Study||2
297141|NCT01800318|708767|P4|COMPLETED|Overall Study||39
297142|NCT01800318|708768|P3|COMPLETED|Overall Study||40
297143|NCT01800318|708769|P2|COMPLETED|Overall Study||37
297144|NCT01800318|708770|P1|COMPLETED|Overall Study||37
297145|NCT01800318|708767|P4|STARTED|Overall Study||40
297146|NCT01800318|708768|P3|STARTED|Overall Study||41
297147|NCT01800318|708769|P2|STARTED|Overall Study||42
297148|NCT01800318|708770|P1|STARTED|Overall Study||39
297149|NCT01800162|708799|P3|NOT COMPLETED|Overall Study||0
297150|NCT01800162|708800|P2|NOT COMPLETED|Overall Study||0
297151|NCT01800162|708801|P1|NOT COMPLETED|Overall Study||0
297152|NCT01800162|708799|P3|COMPLETED|Overall Study||1
297153|NCT01800162|708800|P2|COMPLETED|Overall Study||0
297154|NCT01800162|708801|P1|COMPLETED|Overall Study||1
297155|NCT01800162|708799|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
297156|NCT01800162|708800|P2|STARTED|Overall Study||0
297157|NCT01800162|708801|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
297158|NCT01799941|708807|P1|NOT COMPLETED|Overall Study||96
297159|NCT01799941|708807|P1|COMPLETED|Overall Study||271
297160|NCT01799941|708807|P1|STARTED|Overall Study||367
297161|NCT01799720|708864|P3|NOT COMPLETED|Overall Study||1
297162|NCT01799720|708865|P2|NOT COMPLETED|Overall Study||1
297163|NCT01799720|708866|P1|NOT COMPLETED|Overall Study||3
297164|NCT01799720|708864|P3|COMPLETED|Overall Study||18
297165|NCT01799720|708865|P2|COMPLETED|Overall Study||17
297166|NCT01799720|708866|P1|COMPLETED|Overall Study||17
297167|NCT01799720|708864|P3|Began the Treatment and Finished it|Overall Study||18
297168|NCT01799720|708865|P2|Began the Treatment and Finished it|Overall Study||17
297169|NCT01799720|708866|P1|Began the Treatment and Finished it|Overall Study||17
297170|NCT01799720|708864|P3|Began the Treatment|Overall Study||19
297171|NCT01799720|708865|P2|Began the Treatment|Overall Study||18
297172|NCT01799720|708866|P1|Began the Treatment|Overall Study||20
297173|NCT01799720|708864|P3|STARTED|Overall Study||19
297174|NCT01799720|708865|P2|STARTED|Overall Study||18
297175|NCT01799720|708866|P1|STARTED|Overall Study||20
297176|NCT01799590|708904|P3|NOT COMPLETED|Overall Study||14
297177|NCT01799590|708905|P2|NOT COMPLETED|Overall Study||16
297178|NCT01799590|708906|P1|NOT COMPLETED|Overall Study||26
297179|NCT01799590|708904|P3|COMPLETED|Overall Study||77
297180|NCT01799590|708905|P2|COMPLETED|Overall Study||78
297181|NCT01799590|708906|P1|COMPLETED|Overall Study||85
297182|NCT01799590|708904|P3|STARTED|Overall Study||91
297183|NCT01799590|708905|P2|STARTED|Overall Study||94
297184|NCT01799590|708906|P1|STARTED|Overall Study||111
297185|NCT01799239|708941|P2|NOT COMPLETED|Period 2 (7 Days)||1
297186|NCT01799239|708942|P1|NOT COMPLETED|Period 2 (7 Days)||2
297187|NCT01799239|708941|P2|COMPLETED|Period 2 (7 Days)||14
297188|NCT01799239|708942|P1|COMPLETED|Period 2 (7 Days)||11
297189|NCT01799239|708941|P2|STARTED|Period 2 (7 Days)||15
297190|NCT01799239|708942|P1|STARTED|Period 2 (7 Days)||13
297191|NCT01799239|708941|P2|NOT COMPLETED|Period 1 (7 Days)||1
297192|NCT01799239|708942|P1|NOT COMPLETED|Period 1 (7 Days)||3
297193|NCT01799239|708941|P2|COMPLETED|Period 1 (7 Days)||15
297194|NCT01799239|708942|P1|COMPLETED|Period 1 (7 Days)||12
297195|NCT01799239|708941|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
297196|NCT01799239|708942|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
297197|NCT01799226|708950|P2|NOT COMPLETED|Overall Study||0
297198|NCT01799226|708951|P1|NOT COMPLETED|Overall Study||2
297199|NCT01799226|708950|P2|COMPLETED|Overall Study||16
297200|NCT01799226|708951|P1|COMPLETED|Overall Study||14
297201|NCT01799226|708950|P2|Left Stent Side|Overall Study||8
297202|NCT01799226|708951|P1|Left Stent Side|Overall Study||8
297203|NCT01799226|708950|P2|Right Stent Side|Overall Study||8
297204|NCT01799226|708951|P1|Right Stent Side|Overall Study||8
297205|NCT01799226|708950|P2|STARTED|Overall Study||16
297206|NCT01799226|708951|P1|STARTED|Overall Study||16
297207|NCT01798992|708963|P4|NOT COMPLETED|Overall Study||1
297208|NCT01798992|708964|P3|NOT COMPLETED|Overall Study||2
297209|NCT01798992|708965|P2|NOT COMPLETED|Overall Study||2
297210|NCT01798992|708966|P1|NOT COMPLETED|Overall Study||0
297211|NCT01798992|708963|P4|COMPLETED|Overall Study||16
297212|NCT01798992|708964|P3|COMPLETED|Overall Study||14
297213|NCT01798992|708965|P2|COMPLETED|Overall Study||17
297214|NCT01798992|708966|P1|COMPLETED|Overall Study||4
297215|NCT01798992|708963|P4|STARTED|Overall Study||17
297216|NCT01798992|708964|P3|STARTED|Overall Study||16
297217|NCT01798992|708965|P2|STARTED|Overall Study||19
297218|NCT01798992|708966|P1|STARTED|Overall Study||4
297219|NCT01798966|708980|P1|NOT COMPLETED|Overall Study||0
297220|NCT01798966|708980|P1|COMPLETED|Overall Study||10
297221|NCT01798966|708980|P1|STARTED|Overall Study||10
297222|NCT01798927|708986|P1|NOT COMPLETED|Overall Study||1
297223|NCT01798927|708986|P1|COMPLETED|Overall Study||3
297224|NCT01798927|708986|P1|STARTED|Overall Study||4
297225|NCT01798706|708994|P2|NOT COMPLETED|Overall Study||21
297226|NCT01798706|708995|P1|NOT COMPLETED|Overall Study||21
297227|NCT01798706|708994|P2|COMPLETED|Overall Study||153
297228|NCT01798706|708995|P1|COMPLETED|Overall Study||155
297229|NCT01798706|708994|P2|STARTED|Overall Study||174
297230|NCT01798706|708995|P1|STARTED|Overall Study||176
297231|NCT01798485|709023|P2|NOT COMPLETED|Overall Study||290
297232|NCT01798485|709024|P1|NOT COMPLETED|Overall Study||346
297233|NCT01798485|709023|P2|COMPLETED|Overall Study||59
297234|NCT01798485|709024|P1|COMPLETED|Overall Study||1
297235|NCT01798485|709023|P2|Randomized as of 19 October 2015|Overall Study||337
297236|NCT01798485|709024|P1|Randomized as of 19 October 2015|Overall Study||335
297237|NCT01798485|709023|P2|Safety Population as of 23 Dec 2015|Overall Study||342
297238|NCT01798485|709024|P1|Safety Population as of 23 Dec 2015|Overall Study||338
297239|NCT01798485|709023|P2|STARTED|Overall Study||349
297240|NCT01798485|709024|P1|STARTED|Overall Study||347
297241|NCT01798394|709060|P2|NOT COMPLETED|Overall Study||3
297242|NCT01798394|709061|P1|NOT COMPLETED|Overall Study||3
297243|NCT01798394|709060|P2|COMPLETED|Overall Study||19
297244|NCT01798394|709061|P1|COMPLETED|Overall Study||21
297245|NCT01798394|709060|P2|STARTED|Overall Study||22
297246|NCT01798394|709061|P1|STARTED|Overall Study||24
297247|NCT01798316|709081|P2|NOT COMPLETED|Overall Study||0
297248|NCT01798316|709082|P1|NOT COMPLETED|Overall Study||0
297249|NCT01798316|709081|P2|COMPLETED|Overall Study||53
297250|NCT01798316|709082|P1|COMPLETED|Overall Study||52
297251|NCT01798316|709081|P2|STARTED|Overall Study||53
297252|NCT01798316|709082|P1|STARTED|Overall Study||52
297253|NCT01798264|709104|P4|NOT COMPLETED|Overall Study||4
297254|NCT01798264|709105|P3|NOT COMPLETED|Overall Study||0
297255|NCT01798264|709106|P2|NOT COMPLETED|Overall Study||0
297256|NCT01798264|709107|P1|NOT COMPLETED|Overall Study||1
297257|NCT01798264|709104|P4|COMPLETED|Overall Study||7
297258|NCT01798264|709105|P3|COMPLETED|Overall Study||10
297259|NCT01798264|709106|P2|COMPLETED|Overall Study||11
297260|NCT01798264|709107|P1|COMPLETED|Overall Study||11
297261|NCT01798264|709104|P4|STARTED|Overall Study||11
297262|NCT01798264|709105|P3|STARTED|Overall Study||10
297263|NCT01798264|709106|P2|STARTED|Overall Study||11
297264|NCT01798264|709107|P1|STARTED|Overall Study||12
297265|NCT01798134|709129|P1|NOT COMPLETED|Overall Study||16
297266|NCT01798134|709129|P1|COMPLETED|Overall Study||9
297267|NCT01798134|709129|P1|STARTED|Overall Study||25
297268|NCT01798004|709136|P1|NOT COMPLETED|Overall Study||87
297269|NCT01798004|709136|P1|COMPLETED|Overall Study||63
297270|NCT01798004|709136|P1|STARTED|Overall Study||150
297271|NCT01797783|709142|P2|NOT COMPLETED|Overall Study||1
297272|NCT01797783|709143|P1|NOT COMPLETED|Overall Study||2
297273|NCT01797783|709142|P2|COMPLETED|Overall Study||26
297274|NCT01797783|709143|P1|COMPLETED|Overall Study||50
297275|NCT01797783|709142|P2|STARTED|Overall Study||27
297276|NCT01797783|709143|P1|STARTED|Overall Study||52
297277|NCT01797705|709165|P1|NOT COMPLETED|Overall Study||5
297278|NCT01797705|709165|P1|COMPLETED|Overall Study||28
297279|NCT01797705|709165|P1|STARTED|Overall Study||33
297280|NCT01797536|709173|P4|NOT COMPLETED|Overall Study||0
297281|NCT01797536|709174|P3|NOT COMPLETED|Overall Study||0
297282|NCT01797536|709175|P2|NOT COMPLETED|Overall Study||1
297283|NCT01797536|709176|P1|NOT COMPLETED|Overall Study||0
297284|NCT01797536|709173|P4|COMPLETED|Overall Study||8
297285|NCT01797536|709174|P3|COMPLETED|Overall Study||7
297286|NCT01797536|709175|P2|COMPLETED|Overall Study||10
297287|NCT01797536|709176|P1|COMPLETED|Overall Study||8
297288|NCT01797536|709173|P4|STARTED|Overall Study||8
297289|NCT01797536|709174|P3|STARTED|Overall Study||7
297290|NCT01797536|709175|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
297291|NCT01797536|709176|P1|STARTED|Overall Study||8
297292|NCT01797445|709208|P2|NOT COMPLETED|Overall Study||437
297293|NCT01797445|709209|P1|NOT COMPLETED|Overall Study||435
297294|NCT01797445|709208|P2|COMPLETED|Overall Study||0
297295|NCT01797445|709209|P1|COMPLETED|Overall Study||0
297296|NCT01797445|709208|P2|STARTED|Overall Study||437
297297|NCT01797445|709209|P1|STARTED|Overall Study||435
297298|NCT01797380|709249|P2|NOT COMPLETED|Overall Study||2
297299|NCT01797380|709250|P1|NOT COMPLETED|Overall Study||3
297300|NCT01797380|709249|P2|COMPLETED|Overall Study||0
297301|NCT01797380|709250|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
297302|NCT01797380|709249|P2|STARTED|Overall Study||2
297303|NCT01797380|709250|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
297304|NCT01797328|709258|P2|NOT COMPLETED|Overall Study||0
297305|NCT01797328|709259|P1|NOT COMPLETED|Overall Study||2
297306|NCT01797328|709258|P2|COMPLETED|Overall Study||12
297307|NCT01797328|709259|P1|COMPLETED|Overall Study||14
297308|NCT01797328|709258|P2|STARTED|Overall Study||12
297309|NCT01797328|709259|P1|STARTED|Overall Study||16
297310|NCT01797094|709267|P2|NOT COMPLETED|Overall Study||2
297311|NCT01797094|709268|P1|NOT COMPLETED|Overall Study||6
297312|NCT01797094|709267|P2|COMPLETED|Overall Study||51
297313|NCT01797094|709268|P1|COMPLETED|Overall Study||42
297314|NCT01797094|709267|P2|STARTED|Overall Study||53
297315|NCT01797094|709268|P1|STARTED|Overall Study||48
297316|NCT01797081|709290|P4|NOT COMPLETED|Overall Study||9
297317|NCT01797081|709291|P3|NOT COMPLETED|Overall Study||5
297318|NCT01797081|709292|P2|NOT COMPLETED|Overall Study||4
297319|NCT01797081|709293|P1|NOT COMPLETED|Overall Study||14
297320|NCT01797081|709290|P4|COMPLETED|Overall Study||40
297321|NCT01797081|709291|P3|COMPLETED|Overall Study||43
297322|NCT01797081|709292|P2|COMPLETED|Overall Study||95
297323|NCT01797081|709293|P1|COMPLETED|Overall Study||90
297324|NCT01797081|709290|P4|STARTED|Overall Study||49
297325|NCT01797081|709291|P3|STARTED|Overall Study||48
297326|NCT01797081|709292|P2|STARTED|Overall Study||99
297327|NCT01797081|709293|P1|STARTED|Overall Study||104
297328|NCT01797029|709312|P2|NOT COMPLETED|Overall Study||61
297329|NCT01797029|709313|P1|NOT COMPLETED|Overall Study||159
297330|NCT01797029|709312|P2|COMPLETED|Overall Study||526
297331|NCT01797029|709313|P1|COMPLETED|Overall Study||1015
297332|NCT01797029|709312|P2|STARTED|Overall Study||587
297333|NCT01797029|709313|P1|STARTED|Overall Study||1174
297334|NCT01796977|709321|P1|NOT COMPLETED|Overall Study||0
297335|NCT01796977|709321|P1|COMPLETED|Overall Study||27
297336|NCT01796977|709321|P1|STARTED|Overall Study||27
297337|NCT01796964|709334|P2|NOT COMPLETED|Overall Study||3
297338|NCT01796964|709335|P1|NOT COMPLETED|Overall Study||3
297339|NCT01796964|709334|P2|COMPLETED|Overall Study||42
297340|NCT01796964|709335|P1|COMPLETED|Overall Study||41
297341|NCT01796964|709334|P2|STARTED|Overall Study||45
297342|NCT01796964|709335|P1|STARTED|Overall Study||44
297343|NCT01796860|709357|P1|NOT COMPLETED|Overall Study||3
297344|NCT01796860|709357|P1|COMPLETED|Overall Study||7
297345|NCT01796860|709357|P1|STARTED|Overall Study||10
297346|NCT01796548|709363|P1|NOT COMPLETED|Overall Study||3
297347|NCT01796548|709363|P1|COMPLETED|Overall Study||14
297348|NCT01796548|709363|P1|Treated|Overall Study||15
297349|NCT01796548|709363|P1|STARTED|Overall Study||17
297350|NCT01796236|709377|P2|NOT COMPLETED|Overall Study||2
297351|NCT01796236|709378|P1|NOT COMPLETED|Overall Study||2
297352|NCT01796236|709377|P2|COMPLETED|Overall Study||50
297353|NCT01796236|709378|P1|COMPLETED|Overall Study||49
297354|NCT01796236|709377|P2|STARTED|Overall Study||52
297355|NCT01796236|709378|P1|STARTED|Overall Study||51
297356|NCT01795937|709397|P3|NOT COMPLETED|Overall Study||0
297357|NCT01795937|709398|P2|NOT COMPLETED|Overall Study||1
297358|NCT01795937|709399|P1|NOT COMPLETED|Overall Study||1
297359|NCT01795937|709397|P3|COMPLETED|Overall Study||17
297360|NCT01795937|709398|P2|COMPLETED|Overall Study||15
297361|NCT01795937|709399|P1|COMPLETED|Overall Study||17
297362|NCT01795937|709397|P3|STARTED|Overall Study||17
297363|NCT01795937|709398|P2|STARTED|Overall Study||16
297364|NCT01795937|709399|P1|STARTED|Overall Study||18
297365|NCT01795898|709428|P1|NOT COMPLETED|Overall Study||60
297366|NCT01795898|709428|P1|COMPLETED|Overall Study||177
297367|NCT01795898|709428|P1|STARTED|Overall Study||237
297368|NCT01795716|709438|P2|NOT COMPLETED|Second Intervention (13 Days)||0
297369|NCT01795716|709439|P1|NOT COMPLETED|Second Intervention (13 Days)||0
297370|NCT01795716|709438|P2|COMPLETED|Second Intervention (13 Days)||11
297371|NCT01795716|709439|P1|COMPLETED|Second Intervention (13 Days)||10
297372|NCT01795716|709438|P2|STARTED|Second Intervention (13 Days)||11
297373|NCT01795716|709439|P1|STARTED|Second Intervention (13 Days)||10
297374|NCT01795716|709438|P2|NOT COMPLETED|Washout (10 Days)||0
297375|NCT01795716|709439|P1|NOT COMPLETED|Washout (10 Days)||0
297376|NCT01795716|709438|P2|COMPLETED|Washout (10 Days)||11
297377|NCT01795716|709439|P1|COMPLETED|Washout (10 Days)||10
297378|NCT01795716|709438|P2|STARTED|Washout (10 Days)||11
297379|NCT01795716|709439|P1|STARTED|Washout (10 Days)||10
297380|NCT01795716|709438|P2|NOT COMPLETED|First Intervention (13 Days)||0
297381|NCT01795716|709439|P1|NOT COMPLETED|First Intervention (13 Days)||0
297382|NCT01795716|709438|P2|COMPLETED|First Intervention (13 Days)||11
297383|NCT01795716|709439|P1|COMPLETED|First Intervention (13 Days)||10
297384|NCT01795716|709438|P2|STARTED|First Intervention (13 Days)||11
297385|NCT01795716|709439|P1|STARTED|First Intervention (13 Days)||10
297386|NCT01795547|709447|P2|NOT COMPLETED|Overall Study||64
297387|NCT01795547|709448|P1|NOT COMPLETED|Overall Study||48
297388|NCT01795547|709447|P2|COMPLETED|Overall Study||83
297389|NCT01795547|709448|P1|COMPLETED|Overall Study||100
297390|NCT01795547|709447|P2|STARTED|Overall Study||147
297391|NCT01795547|709448|P1|STARTED|Overall Study||148
297392|NCT01795534|709470|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
297393|NCT01795534|709471|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
297394|NCT01795534|709470|P2|COMPLETED|Second Intervention (Second Shot)||5
297395|NCT01795534|709471|P1|COMPLETED|Second Intervention (Second Shot)||5
297396|NCT01795534|709470|P2|STARTED|Second Intervention (Second Shot)||5
297397|NCT01795534|709471|P1|STARTED|Second Intervention (Second Shot)||5
297398|NCT01795534|709470|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
297399|NCT01795534|709471|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
297400|NCT01795534|709470|P2|COMPLETED|Wash Out Period (4 Days)||5
297401|NCT01795534|709471|P1|COMPLETED|Wash Out Period (4 Days)||5
297402|NCT01795534|709470|P2|STARTED|Wash Out Period (4 Days)||5
297403|NCT01795534|709471|P1|STARTED|Wash Out Period (4 Days)||5
297404|NCT01795534|709470|P2|NOT COMPLETED|First Intervention (First Shot)||0
297405|NCT01795534|709471|P1|NOT COMPLETED|First Intervention (First Shot)||0
297406|NCT01795534|709470|P2|COMPLETED|First Intervention (First Shot)||5
297407|NCT01795534|709471|P1|COMPLETED|First Intervention (First Shot)||5
297408|NCT01795534|709470|P2|STARTED|First Intervention (First Shot)||5
297409|NCT01795534|709471|P1|STARTED|First Intervention (First Shot)||5
297410|NCT01794949|709479|P2|NOT COMPLETED|Overall Study||0
297411|NCT01794949|709480|P1|NOT COMPLETED|Overall Study||1
297412|NCT01794949|709479|P2|COMPLETED|Overall Study||1
297413|NCT01794949|709480|P1|COMPLETED|Overall Study||6
297414|NCT01794949|709479|P2|6 Month Follow-up|Overall Study||1
297415|NCT01794949|709480|P1|6 Month Follow-up|Overall Study||6
297416|NCT01794949|709479|P2|STARTED|Overall Study||1
297417|NCT01794949|709480|P1|STARTED|Overall Study||7
297418|NCT01794936|709486|P1|NOT COMPLETED|Overall Study||0
297419|NCT01794936|709486|P1|COMPLETED|Overall Study||9
297420|NCT01794936|709486|P1|STARTED|Overall Study||9
297421|NCT01794845|709491|P1|NOT COMPLETED|Overall Study||1
297422|NCT01794845|709491|P1|COMPLETED|Overall Study||4
297423|NCT01794845|709491|P1|STARTED|Overall Study||5
297424|NCT01794741|709500|P2|NOT COMPLETED|Overall Study||9
297425|NCT01794741|709501|P1|NOT COMPLETED|Overall Study||19
297426|NCT01794741|709500|P2|COMPLETED|Overall Study||92
297427|NCT01794741|709501|P1|COMPLETED|Overall Study||285
297428|NCT01794741|709500|P2|STARTED|Overall Study||101
297429|NCT01794741|709501|P1|STARTED|Overall Study||304
297430|NCT01794455|709509|P2|NOT COMPLETED|Overall Study||0
297431|NCT01794455|709510|P1|NOT COMPLETED|Overall Study||0
297432|NCT01794455|709509|P2|COMPLETED|Overall Study||1
297433|NCT01794455|709510|P1|COMPLETED|Overall Study||0
297434|NCT01794455|709509|P2|STARTED|Overall Study||1
297435|NCT01794455|709510|P1|STARTED|Overall Study||0
297436|NCT01794000|709528|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
297437|NCT01794000|709529|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
297438|NCT01794000|709528|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
297439|NCT01794000|709529|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
297440|NCT01794000|709528|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
297441|NCT01794000|709529|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
297442|NCT01794000|709528|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
297443|NCT01794000|709529|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
297444|NCT01794000|709528|P2|COMPLETED|Double-Blind Phase (DBP)||4
297445|NCT01794000|709529|P1|COMPLETED|Double-Blind Phase (DBP)||2
297446|NCT01794000|709528|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
297447|NCT01794000|709529|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
297448|NCT01794000|709528|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
297449|NCT01794000|709529|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
297450|NCT01794000|709528|P2|STARTED|Double-Blind Phase (DBP)||170
297451|NCT01794000|709529|P1|STARTED|Double-Blind Phase (DBP)||171
297452|NCT01793688|709560|P1|NOT COMPLETED|Overall Study||2
297453|NCT01793688|709560|P1|COMPLETED|Overall Study||980
297454|NCT01793688|709560|P1|STARTED|Overall Study||982
297455|NCT01793285|709567|P1|NOT COMPLETED|Overall Study||0
297456|NCT01793285|709567|P1|COMPLETED|Overall Study||85
297457|NCT01793285|709567|P1|STARTED|Overall Study||85
297458|NCT01792986|709587|P1|NOT COMPLETED|Overall Study||0
297459|NCT01792986|709587|P1|COMPLETED|Overall Study||12
297460|NCT01792986|709587|P1|STARTED|Overall Study||12
297461|NCT01792830|709602|P7|NOT COMPLETED|Overall Study||3
297462|NCT01792830|709603|P6|NOT COMPLETED|Overall Study||0
297463|NCT01792830|709604|P5|NOT COMPLETED|Overall Study||12
297464|NCT01792830|709605|P4|NOT COMPLETED|Overall Study||5
297465|NCT01792830|709606|P3|NOT COMPLETED|Overall Study||0
297466|NCT01792830|709607|P2|NOT COMPLETED|Overall Study||0
297467|NCT01792830|709608|P1|NOT COMPLETED|Overall Study||25
297468|NCT01792830|709602|P7|COMPLETED|Overall Study||9
297469|NCT01792830|709603|P6|COMPLETED|Overall Study||4
297470|NCT01792830|709604|P5|COMPLETED|Overall Study||29
297471|NCT01792830|709605|P4|COMPLETED|Overall Study||22
297472|NCT01792830|709606|P3|COMPLETED|Overall Study||4
297473|NCT01792830|709607|P2|COMPLETED|Overall Study||3
297474|NCT01792830|709608|P1|COMPLETED|Overall Study||59
297475|NCT01792830|709602|P7|STARTED|Overall Study||12
297476|NCT01792830|709603|P6|STARTED|Overall Study||4
297477|NCT01792830|709604|P5|STARTED|Overall Study||41
297478|NCT01792830|709605|P4|STARTED|Overall Study||27
297479|NCT01792830|709606|P3|STARTED|Overall Study||4
297480|NCT01792830|709607|P2|STARTED|Overall Study||3
297481|NCT01792830|709608|P1|STARTED|Overall Study||84
297482|NCT01792635|709639|P3|NOT COMPLETED|Part B||4
297483|NCT01792635|709640|P2|NOT COMPLETED|Part B||4
297484|NCT01792635|709641|P1|NOT COMPLETED|Part B||0
297485|NCT01792635|709639|P3|COMPLETED|Part B||3
297486|NCT01792635|709640|P2|COMPLETED|Part B||2
297487|NCT01792635|709641|P1|COMPLETED|Part B||0
297488|NCT01792635|709639|P3|STARTED|Part B||7
297489|NCT01792635|709640|P2|STARTED|Part B||6
297490|NCT01792635|709641|P1|STARTED|Part B||0
297491|NCT01792635|709639|P3|NOT COMPLETED|Part A||0
297492|NCT01792635|709640|P2|NOT COMPLETED|Part A||0
297493|NCT01792635|709641|P1|NOT COMPLETED|Part A||0
297494|NCT01792635|709639|P3|COMPLETED|Part A||0
297495|NCT01792635|709640|P2|COMPLETED|Part A||0
297496|NCT01792635|709641|P1|COMPLETED|Part A||6
297497|NCT01792635|709639|P3|STARTED|Part A||0
297498|NCT01792635|709640|P2|STARTED|Part A||0
297499|NCT01792635|709641|P1|STARTED|Part A||6
297500|NCT01792518|709669|P2|NOT COMPLETED|Overall Study||7
297501|NCT01792518|709670|P1|NOT COMPLETED|Overall Study||8
297502|NCT01792518|709669|P2|COMPLETED|Overall Study||175
297503|NCT01792518|709670|P1|COMPLETED|Overall Study||170
297504|NCT01792518|709669|P2|STARTED|Overall Study||182
297505|NCT01792518|709670|P1|STARTED|Overall Study||178
297506|NCT01791972|709682|P2|NOT COMPLETED|Overall Study||0
297507|NCT01791972|709683|P1|NOT COMPLETED|Overall Study||0
297508|NCT01791972|709682|P2|COMPLETED|Overall Study||19
297509|NCT01791972|709683|P1|COMPLETED|Overall Study||19
297510|NCT01791972|709682|P2|STARTED|Overall Study||19
297511|NCT01791972|709683|P1|STARTED|Overall Study||19
297512|NCT01791894|709693|P1|NOT COMPLETED|Overall Study||1
297513|NCT01791894|709693|P1|COMPLETED|Overall Study||4
297514|NCT01791894|709693|P1|STARTED|Overall Study||5
297515|NCT01791803|709704|P4|NOT COMPLETED|Overall Study||5
297516|NCT01791803|709705|P3|NOT COMPLETED|Overall Study||2
297517|NCT01791803|709706|P2|NOT COMPLETED|Overall Study||2
297518|NCT01791803|709707|P1|NOT COMPLETED|Overall Study||0
297519|NCT01791803|709704|P4|COMPLETED|Overall Study||37
297520|NCT01791803|709705|P3|COMPLETED|Overall Study||38
297521|NCT01791803|709706|P2|COMPLETED|Overall Study||39
297522|NCT01791803|709707|P1|COMPLETED|Overall Study||41
297523|NCT01791803|709704|P4|STARTED|Overall Study||42
297524|NCT01791803|709705|P3|STARTED|Overall Study||40
297525|NCT01791803|709706|P2|STARTED|Overall Study||41
297526|NCT01791803|709707|P1|STARTED|Overall Study||41
297527|NCT01791725|709725|P3|NOT COMPLETED|Overall Study||0
297528|NCT01791725|709726|P2|NOT COMPLETED|Overall Study||1
297529|NCT01791725|709727|P1|NOT COMPLETED|Overall Study||0
297530|NCT01791725|709725|P3|COMPLETED|Overall Study||6
297531|NCT01791725|709726|P2|COMPLETED|Overall Study||4
297532|NCT01791725|709727|P1|COMPLETED|Overall Study||12
297533|NCT01791725|709725|P3|STARTED|Overall Study||6
297534|NCT01791725|709726|P2|STARTED|Overall Study||5
297535|NCT01791725|709727|P1|STARTED|Overall Study||12
297536|NCT01791465|709747|P1|NOT COMPLETED|Overall Study||0
297537|NCT01791465|709747|P1|COMPLETED|Overall Study||6
297538|NCT01791465|709747|P1|STARTED|Overall Study||6
297539|NCT01791413|709773|P2|NOT COMPLETED|Overall Study||1
297540|NCT01791413|709774|P1|NOT COMPLETED|Overall Study||5
297541|NCT01791413|709773|P2|COMPLETED|Overall Study||19
297542|NCT01791413|709774|P1|COMPLETED|Overall Study||15
297543|NCT01791413|709773|P2|STARTED|Overall Study||20
297544|NCT01791413|709774|P1|STARTED|Overall Study||20
297545|NCT01791205|709783|P2|NOT COMPLETED|Phase II||0
297546|NCT01791205|709784|P1|NOT COMPLETED|Phase II||12
297547|NCT01791205|709783|P2|COMPLETED|Phase II||0
297548|NCT01791205|709784|P1|COMPLETED|Phase II||92
297549|NCT01791205|709783|P2|STARTED|Phase II||0
297550|NCT01791205|709784|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
297551|NCT01791205|709783|P2|NOT COMPLETED|Phase I||0
297552|NCT01791205|709784|P1|NOT COMPLETED|Phase I||0
297553|NCT01791205|709783|P2|COMPLETED|Phase I||152
297554|NCT01791205|709784|P1|COMPLETED|Phase I||152
297555|NCT01791205|709783|P2|STARTED|Phase I||152
297556|NCT01791205|709784|P1|STARTED|Phase I||152
297557|NCT01791153|709868|P4|NOT COMPLETED|Overall Study||5
297558|NCT01791153|709869|P3|NOT COMPLETED|Overall Study||6
297559|NCT01791153|709870|P2|NOT COMPLETED|Overall Study||8
297560|NCT01791153|709871|P1|NOT COMPLETED|Overall Study||15
297561|NCT01791153|709868|P4|COMPLETED|Overall Study|Completed Study to Week 52|46
297562|NCT01791153|709869|P3|COMPLETED|Overall Study|Completed Study to Week 52|44
297563|NCT01791153|709870|P2|COMPLETED|Overall Study|Completed Study to Week 52|41
297564|NCT01791153|709871|P1|COMPLETED|Overall Study|Completed Study to Week 52|85
297565|NCT01791153|709868|P4|STARTED|Overall Study||51
297566|NCT01791153|709869|P3|STARTED|Overall Study||50
297567|NCT01791153|709870|P2|STARTED|Overall Study||49
297568|NCT01791153|709871|P1|STARTED|Overall Study||100
297569|NCT01791127|709927|P1|NOT COMPLETED|Overall Study||1758
297570|NCT01791127|709927|P1|COMPLETED|Overall Study||0
297571|NCT01791127|709927|P1|Pre-Market Analysis|Overall Study||820
297572|NCT01791127|709927|P1|STARTED|Overall Study||1758
297573|NCT01790828|709933|P1|NOT COMPLETED|Overall Study||34
297574|NCT01790828|709933|P1|COMPLETED|Overall Study||8
297575|NCT01790828|709933|P1|STARTED|Overall Study||42
297576|NCT01790750|709956|P1|NOT COMPLETED|Overall Study||0
297577|NCT01790750|709956|P1|COMPLETED|Overall Study||50
297578|NCT01790750|709956|P1|STARTED|Overall Study||50
297579|NCT01790685|709963|P2|NOT COMPLETED|Overall Study||0
297580|NCT01790685|709964|P1|NOT COMPLETED|Overall Study||0
297581|NCT01790685|709963|P2|COMPLETED|Overall Study||17
297582|NCT01790685|709964|P1|COMPLETED|Overall Study||23
297583|NCT01790685|709963|P2|STARTED|Overall Study||17
297584|NCT01790685|709964|P1|STARTED|Overall Study||23
297585|NCT01790633|709972|P2|NOT COMPLETED|Overall Study||5
297586|NCT01790633|709973|P1|NOT COMPLETED|Overall Study||48
297587|NCT01790633|709972|P2|COMPLETED|Overall Study||159
297588|NCT01790633|709973|P1|COMPLETED|Overall Study||115
297589|NCT01790633|709972|P2|STARTED|Overall Study||164
297590|NCT01790633|709973|P1|STARTED|Overall Study||163
297591|NCT01790581|709986|P2|NOT COMPLETED|Overall Study||0
297592|NCT01790581|709987|P1|NOT COMPLETED|Overall Study||0
297593|NCT01790581|709986|P2|COMPLETED|Overall Study||12
297594|NCT01790581|709987|P1|COMPLETED|Overall Study||12
297595|NCT01790581|709986|P2|STARTED|Overall Study||12
297596|NCT01790581|709987|P1|STARTED|Overall Study||12
297597|NCT01790516|709997|P2|NOT COMPLETED|Overall Study||0
297598|NCT01790516|709998|P1|NOT COMPLETED|Overall Study||1
297599|NCT01790516|709997|P2|COMPLETED|Overall Study||1
297600|NCT01790516|709998|P1|COMPLETED|Overall Study||0
297601|NCT01790516|709997|P2|STARTED|Overall Study||1
297602|NCT01790516|709998|P1|STARTED|Overall Study||1
297603|NCT01790490|710007|P3|NOT COMPLETED|Overall Study||0
297604|NCT01790490|710008|P2|NOT COMPLETED|Overall Study||0
297605|NCT01790490|710009|P1|NOT COMPLETED|Overall Study||0
297606|NCT01790490|710007|P3|COMPLETED|Overall Study||2
297607|NCT01790490|710008|P2|COMPLETED|Overall Study||3
297608|NCT01790490|710009|P1|COMPLETED|Overall Study||3
297609|NCT01790490|710007|P3|STARTED|Overall Study||2
297610|NCT01790490|710008|P2|STARTED|Overall Study||3
297611|NCT01790490|710009|P1|STARTED|Overall Study||3
297612|NCT01790178|710022|P2|NOT COMPLETED|Overall Study||0
297613|NCT01790178|710023|P1|NOT COMPLETED|Overall Study||0
297614|NCT01790178|710022|P2|COMPLETED|Overall Study||24
297615|NCT01790178|710023|P1|COMPLETED|Overall Study||16
297616|NCT01790178|710022|P2|STARTED|Overall Study||24
297617|NCT01790178|710023|P1|STARTED|Overall Study||16
297618|NCT01789970|710039|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
297619|NCT01789970|710040|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
297620|NCT01789970|710041|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
297621|NCT01789970|710039|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
297622|NCT01789970|710040|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
297623|NCT01789970|710041|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
297624|NCT01789970|710039|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
297625|NCT01789970|710040|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
297626|NCT01789970|710041|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
297627|NCT01789970|710039|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
297628|NCT01789970|710040|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
297629|NCT01789970|710041|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
297630|NCT01789970|710039|P3|NOT COMPLETED|Open-label Titration Period||0
297631|NCT01789970|710040|P2|NOT COMPLETED|Open-label Titration Period||0
297632|NCT01789970|710041|P1|NOT COMPLETED|Open-label Titration Period||254
297633|NCT01789970|710039|P3|COMPLETED|Open-label Titration Period||0
297634|NCT01789970|710040|P2|COMPLETED|Open-label Titration Period||0
297635|NCT01789970|710041|P1|COMPLETED|Open-label Titration Period||371
297636|NCT01789970|710039|P3|Safety Analysis Set|Open-label Titration Period||0
297637|NCT01789970|710040|P2|Safety Analysis Set|Open-label Titration Period||0
297638|NCT01789970|710041|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
297639|NCT01789970|710039|P3|STARTED|Open-label Titration Period||0
297640|NCT01789970|710040|P2|STARTED|Open-label Titration Period||0
297641|NCT01789970|710041|P1|STARTED|Open-label Titration Period||625
297642|NCT01789814|710075|P2|NOT COMPLETED|Overall Study||0
297643|NCT01789814|710076|P1|NOT COMPLETED|Overall Study||0
297644|NCT01789814|710075|P2|COMPLETED|Overall Study||12
297645|NCT01789814|710076|P1|COMPLETED|Overall Study||12
297646|NCT01789814|710075|P2|STARTED|Overall Study||12
297647|NCT01789814|710076|P1|STARTED|Overall Study||12
297648|NCT01789775|710084|P2|NOT COMPLETED|Overall Study||7
297649|NCT01789775|710085|P1|NOT COMPLETED|Overall Study||2
297650|NCT01789775|710084|P2|COMPLETED|Overall Study||50
297651|NCT01789775|710085|P1|COMPLETED|Overall Study||53
297652|NCT01789775|710084|P2|STARTED|Overall Study||57
297653|NCT01789775|710085|P1|STARTED|Overall Study||55
297654|NCT01789476|710093|P2|NOT COMPLETED|Overall Study||2
297655|NCT01789476|710094|P1|NOT COMPLETED|Overall Study||8
297656|NCT01789476|710093|P2|COMPLETED|Overall Study||15
297657|NCT01789476|710094|P1|COMPLETED|Overall Study||26
297658|NCT01789476|710093|P2|STARTED|Overall Study||17
297659|NCT01789476|710094|P1|STARTED|Overall Study||34
297660|NCT01789255|710104|P1|NOT COMPLETED|Overall Study||0
297661|NCT01789255|710104|P1|COMPLETED|Overall Study||12
297662|NCT01789255|710104|P1|STARTED|Overall Study||12
297663|NCT01789138|710111|P2|NOT COMPLETED|Overall Study||52
297664|NCT01789138|710112|P1|NOT COMPLETED|Overall Study||41
297665|NCT01789138|710111|P2|COMPLETED|Overall Study||206
297666|NCT01789138|710112|P1|COMPLETED|Overall Study||213
297667|NCT01789138|710111|P2|STARTED|Overall Study||258
297668|NCT01789138|710112|P1|STARTED|Overall Study||254
297669|NCT01788566|710120|P1|NOT COMPLETED|Overall Study||8
297670|NCT01788566|710120|P1|COMPLETED|Overall Study||53
297671|NCT01788566|710120|P1|STARTED|Overall Study||61
297672|NCT01788358|710130|P1|NOT COMPLETED|Overall Study||98
297673|NCT01788358|710130|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
297674|NCT01788358|710130|P1|Completed Week 52|Overall Study||193
297675|NCT01788358|710130|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
297676|NCT01788358|710130|P1|Completed Week 28|Overall Study||417
297677|NCT01788358|710130|P1|Treated|Overall Study||508
297678|NCT01788358|710130|P1|STARTED|Overall Study||508
297679|NCT01788228|710144|P2|NOT COMPLETED|Overall Study||0
297680|NCT01788228|710145|P1|NOT COMPLETED|Overall Study||1
297681|NCT01788228|710144|P2|COMPLETED|Overall Study||1
297682|NCT01788228|710145|P1|COMPLETED|Overall Study||48
297683|NCT01788228|710144|P2|STARTED|Overall Study||1
297684|NCT01788228|710145|P1|STARTED|Overall Study||49
297685|NCT01788215|710164|P2|NOT COMPLETED|Overall Study||1
297686|NCT01788215|710165|P1|NOT COMPLETED|Overall Study||2
297687|NCT01788215|710164|P2|COMPLETED|Overall Study||4
297688|NCT01788215|710165|P1|COMPLETED|Overall Study||3
297689|NCT01788215|710164|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
297690|NCT01788215|710165|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
297691|NCT01788215|710164|P2|STARTED|Overall Study||5
297692|NCT01788215|710165|P1|STARTED|Overall Study||5
297693|NCT01788163|710194|P9|NOT COMPLETED|Overall Study||16
297694|NCT01788163|710195|P8|NOT COMPLETED|Overall Study||48
297695|NCT01788163|710196|P7|NOT COMPLETED|Overall Study||1
297696|NCT01788163|710197|P6|NOT COMPLETED|Overall Study||7
297697|NCT01788163|710198|P5|NOT COMPLETED|Overall Study||0
297698|NCT01788163|710199|P4|NOT COMPLETED|Overall Study||0
297699|NCT01788163|710200|P3|NOT COMPLETED|Overall Study||0
297700|NCT01788163|710201|P2|NOT COMPLETED|Overall Study||0
297701|NCT01788163|710202|P1|NOT COMPLETED|Overall Study||55
297702|NCT01788163|710194|P9|COMPLETED|Overall Study||956
297703|NCT01788163|710195|P8|COMPLETED|Overall Study||254
297704|NCT01788163|710196|P7|COMPLETED|Overall Study||49
297705|NCT01788163|710197|P6|COMPLETED|Overall Study||95
297706|NCT01788163|710198|P5|COMPLETED|Overall Study||94
297707|NCT01788163|710199|P4|COMPLETED|Overall Study||71
297708|NCT01788163|710200|P3|COMPLETED|Overall Study||62
297709|NCT01788163|710201|P2|COMPLETED|Overall Study||271
297710|NCT01788163|710202|P1|COMPLETED|Overall Study||1403
297711|NCT01788163|710194|P9|STARTED|Overall Study||972
297712|NCT01788163|710195|P8|STARTED|Overall Study||302
297713|NCT01788163|710196|P7|STARTED|Overall Study||50
297714|NCT01788163|710197|P6|STARTED|Overall Study||102
297715|NCT01788163|710198|P5|STARTED|Overall Study||94
297716|NCT01788163|710199|P4|STARTED|Overall Study||71
297717|NCT01788163|710200|P3|STARTED|Overall Study||62
297718|NCT01788163|710201|P2|STARTED|Overall Study||271
297719|NCT01788163|710202|P1|STARTED|Overall Study||1458
297720|NCT01788046|710365|P2|NOT COMPLETED|Overall Study||37
297721|NCT01788046|710366|P1|NOT COMPLETED|Overall Study||56
297722|NCT01788046|710365|P2|COMPLETED|Overall Study||218
297723|NCT01788046|710366|P1|COMPLETED|Overall Study||204
297724|NCT01788046|710365|P2|Received Treatment|Overall Study||252
297725|NCT01788046|710366|P1|Received Treatment|Overall Study||259
297726|NCT01788046|710365|P2|STARTED|Overall Study||255
297727|NCT01788046|710366|P1|STARTED|Overall Study||260
297728|NCT01787838|710382|P1|NOT COMPLETED|Overall Study||1413
297729|NCT01787838|710382|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
297730|NCT01787838|710382|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
297731|NCT01787825|710386|P2|NOT COMPLETED|Overall Study||1
297732|NCT01787825|710387|P1|NOT COMPLETED|Overall Study||6
297733|NCT01787825|710386|P2|COMPLETED|Overall Study||60
297734|NCT01787825|710387|P1|COMPLETED|Overall Study||54
297735|NCT01787825|710386|P2|STARTED|Overall Study||61
297736|NCT01787825|710387|P1|STARTED|Overall Study||60
297737|NCT01787799|710398|P1|NOT COMPLETED|Overall Study||0
297738|NCT01787799|710398|P1|COMPLETED|Overall Study||100
297739|NCT01787799|710398|P1|STARTED|Overall Study||100
297740|NCT01787760|710405|P3|NOT COMPLETED|Overall Study||5
297741|NCT01787760|710406|P2|NOT COMPLETED|Overall Study||16
297742|NCT01787760|710407|P1|NOT COMPLETED|Overall Study||26
297743|NCT01787760|710405|P3|COMPLETED|Overall Study||46
297744|NCT01787760|710406|P2|COMPLETED|Overall Study||34
297745|NCT01787760|710407|P1|COMPLETED|Overall Study||25
297746|NCT01787760|710405|P3|STARTED|Overall Study||51
297747|NCT01787760|710406|P2|STARTED|Overall Study||50
297748|NCT01787760|710407|P1|STARTED|Overall Study||51
297749|NCT01787591|710421|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
297750|NCT01787591|710422|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
297751|NCT01787591|710423|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
297752|NCT01787591|710424|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
297753|NCT01787591|710421|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
297754|NCT01787591|710422|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
297755|NCT01787591|710423|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
297756|NCT01787591|710424|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
297757|NCT01787591|710421|P4|STARTED|Period 4 (Cross-over Arm 4)||5
297758|NCT01787591|710422|P3|STARTED|Period 4 (Cross-over Arm 4)||5
297759|NCT01787591|710423|P2|STARTED|Period 4 (Cross-over Arm 4)||5
297760|NCT01787591|710424|P1|STARTED|Period 4 (Cross-over Arm 4)||5
297761|NCT01787591|710421|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
297762|NCT01787591|710422|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
297763|NCT01787591|710423|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
297764|NCT01787591|710424|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
297765|NCT01787591|710421|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
297766|NCT01787591|710422|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
297767|NCT01787591|710423|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
297768|NCT01787591|710424|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
297769|NCT01787591|710421|P4|STARTED|Period 3 (Cross-over Arm 3)||5
297770|NCT01787591|710422|P3|STARTED|Period 3 (Cross-over Arm 3)||5
297771|NCT01787591|710423|P2|STARTED|Period 3 (Cross-over Arm 3)||5
297772|NCT01787591|710424|P1|STARTED|Period 3 (Cross-over Arm 3)||5
297773|NCT01787591|710421|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
297774|NCT01787591|710422|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
297775|NCT01787591|710423|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
297776|NCT01787591|710424|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
297777|NCT01787591|710421|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
297778|NCT01787591|710422|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
297779|NCT01787591|710423|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
297780|NCT01787591|710424|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
297781|NCT01787591|710421|P4|STARTED|Period 2 (Cross-over Arm 2)||5
297782|NCT01787591|710422|P3|STARTED|Period 2 (Cross-over Arm 2)||5
297783|NCT01787591|710423|P2|STARTED|Period 2 (Cross-over Arm 2)||5
297784|NCT01787591|710424|P1|STARTED|Period 2 (Cross-over Arm 2)||5
297785|NCT01787591|710421|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
297786|NCT01787591|710422|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
297787|NCT01787591|710423|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
297788|NCT01787591|710424|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
297789|NCT01787591|710421|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
297790|NCT01787591|710422|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
297791|NCT01787591|710423|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
297792|NCT01787591|710424|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
297793|NCT01787591|710421|P4|STARTED|Period 1 (Cross-over Arm 1)||6
297794|NCT01787591|710422|P3|STARTED|Period 1 (Cross-over Arm 1)||5
297795|NCT01787591|710423|P2|STARTED|Period 1 (Cross-over Arm 1)||5
297796|NCT01787591|710424|P1|STARTED|Period 1 (Cross-over Arm 1)||5
297797|NCT01787461|710452|P2|NOT COMPLETED|Overall Study||9
297798|NCT01787461|710453|P1|NOT COMPLETED|Overall Study||14
297799|NCT01787461|710452|P2|COMPLETED|Overall Study||89
297800|NCT01787461|710453|P1|COMPLETED|Overall Study||82
297801|NCT01787461|710452|P2|STARTED|Overall Study||98
297802|NCT01787461|710453|P1|STARTED|Overall Study||96
297803|NCT01787383|710481|P2|NOT COMPLETED|Overall Study||22
297804|NCT01787383|710482|P1|NOT COMPLETED|Overall Study||9
297805|NCT01787383|710481|P2|COMPLETED|Overall Study||76
297806|NCT01787383|710482|P1|COMPLETED|Overall Study||92
297807|NCT01787383|710481|P2|STARTED|Overall Study||98
297808|NCT01787383|710482|P1|STARTED|Overall Study||101
297809|NCT01787279|710502|P1|NOT COMPLETED|Overall Study||3
297810|NCT01787279|710502|P1|COMPLETED|Overall Study||56
297811|NCT01787279|710502|P1|STARTED|Overall Study||59
297812|NCT01787240|710513|P2|NOT COMPLETED|Overall Study||1
297813|NCT01787240|710514|P1|NOT COMPLETED|Overall Study||5
297814|NCT01787240|710513|P2|COMPLETED|Overall Study||4
297815|NCT01787240|710514|P1|COMPLETED|Overall Study||10
297816|NCT01787240|710513|P2|STARTED|Overall Study||5
297817|NCT01787240|710514|P1|STARTED|Overall Study||15
297818|NCT01787188|710528|P3|NOT COMPLETED|Overall Study||18
297819|NCT01787188|710529|P2|NOT COMPLETED|Overall Study||18
297820|NCT01787188|710530|P1|NOT COMPLETED|Overall Study||17
297821|NCT01787188|710528|P3|COMPLETED|Overall Study||116
297822|NCT01787188|710529|P2|COMPLETED|Overall Study||112
297823|NCT01787188|710530|P1|COMPLETED|Overall Study||122
297824|NCT01787188|710528|P3|STARTED|Overall Study||134
297825|NCT01787188|710529|P2|STARTED|Overall Study||130
297826|NCT01787188|710530|P1|STARTED|Overall Study||139
297827|NCT01787175|710585|P2|NOT COMPLETED|Overall Study||0
297828|NCT01787175|710586|P1|NOT COMPLETED|Overall Study||0
297829|NCT01787175|710585|P2|COMPLETED|Overall Study||28
297830|NCT01787175|710586|P1|COMPLETED|Overall Study||30
297831|NCT01787175|710585|P2|STARTED|Overall Study||28
297832|NCT01787175|710586|P1|STARTED|Overall Study||30
297833|NCT01787032|710602|P6|NOT COMPLETED|Overall Study||1
297834|NCT01787032|710603|P5|NOT COMPLETED|Overall Study||1
297835|NCT01787032|710604|P4|NOT COMPLETED|Overall Study||0
297836|NCT01787032|710605|P3|NOT COMPLETED|Overall Study||0
297837|NCT01787032|710606|P2|NOT COMPLETED|Overall Study||0
297838|NCT01787032|710607|P1|NOT COMPLETED|Overall Study||0
297839|NCT01787032|710602|P6|COMPLETED|Overall Study||3
297840|NCT01787032|710603|P5|COMPLETED|Overall Study||3
297841|NCT01787032|710604|P4|COMPLETED|Overall Study||3
297842|NCT01787032|710605|P3|COMPLETED|Overall Study||3
297843|NCT01787032|710606|P2|COMPLETED|Overall Study||3
297844|NCT01787032|710607|P1|COMPLETED|Overall Study||3
297845|NCT01787032|710602|P6|Received T2|Overall Study||4
297846|NCT01787032|710603|P5|Received T2|Overall Study||4
297847|NCT01787032|710604|P4|Received T2|Overall Study||3
297848|NCT01787032|710605|P3|Received T2|Overall Study||3
297849|NCT01787032|710606|P2|Received T2|Overall Study||3
297850|NCT01787032|710607|P1|Received T2|Overall Study||3
297851|NCT01787032|710602|P6|Received T1|Overall Study||4
297852|NCT01787032|710603|P5|Received T1|Overall Study||3
297853|NCT01787032|710604|P4|Received T1|Overall Study||3
297854|NCT01787032|710605|P3|Received T1|Overall Study||3
297855|NCT01787032|710606|P2|Received T1|Overall Study||3
297856|NCT01787032|710607|P1|Received T1|Overall Study||3
297857|NCT01787032|710602|P6|Received R|Overall Study||3
297858|NCT01787032|710603|P5|Received R|Overall Study||4
297859|NCT01787032|710604|P4|Received R|Overall Study||3
297860|NCT01787032|710605|P3|Received R|Overall Study||3
297861|NCT01787032|710606|P2|Received R|Overall Study||3
297862|NCT01787032|710607|P1|Received R|Overall Study||3
297863|NCT01787032|710602|P6|STARTED|Overall Study||4
297864|NCT01787032|710603|P5|STARTED|Overall Study||4
297865|NCT01787032|710604|P4|STARTED|Overall Study||3
297866|NCT01787032|710605|P3|STARTED|Overall Study||3
297867|NCT01787032|710606|P2|STARTED|Overall Study||3
297868|NCT01787032|710607|P1|STARTED|Overall Study||3
297869|NCT01786993|710631|P2|NOT COMPLETED|Overall Study||10
297870|NCT01786993|710632|P1|NOT COMPLETED|Overall Study||12
297871|NCT01786993|710631|P2|COMPLETED|Overall Study||170
297872|NCT01786993|710632|P1|COMPLETED|Overall Study||189
297873|NCT01786993|710631|P2|Per Protocol Population at 9 Months|Overall Study||170
297874|NCT01786993|710632|P1|Per Protocol Population at 9 Months|Overall Study||189
297875|NCT01786993|710631|P2|STARTED|Overall Study||180
297876|NCT01786993|710632|P1|STARTED|Overall Study||201
297877|NCT01786954|710639|P2|NOT COMPLETED|Overall Study||0
297878|NCT01786954|710640|P1|NOT COMPLETED|Overall Study||0
297879|NCT01786954|710639|P2|COMPLETED|Overall Study||34
297880|NCT01786954|710640|P1|COMPLETED|Overall Study||34
297881|NCT01786954|710639|P2|STARTED|Overall Study||34
297882|NCT01786954|710640|P1|STARTED|Overall Study||34
297883|NCT01786902|710652|P2|NOT COMPLETED|Overall Study||3
297884|NCT01786902|710653|P1|NOT COMPLETED|Overall Study||4
297885|NCT01786902|710652|P2|COMPLETED|Overall Study||31
297886|NCT01786902|710653|P1|COMPLETED|Overall Study||32
297887|NCT01786902|710652|P2|STARTED|Overall Study||34
297888|NCT01786902|710653|P1|STARTED|Overall Study||36
297889|NCT01786876|710663|P1|NOT COMPLETED|Overall Study||0
297890|NCT01786876|710663|P1|COMPLETED|Overall Study||6
297891|NCT01786876|710663|P1|STARTED|Overall Study||6
297892|NCT01786707|710682|P2|NOT COMPLETED|Overall Study||1
297893|NCT01786707|710683|P1|NOT COMPLETED|Overall Study||1
297894|NCT01786707|710682|P2|COMPLETED|Overall Study||0
297895|NCT01786707|710683|P1|COMPLETED|Overall Study||0
297896|NCT01786707|710682|P2|STARTED|Overall Study||1
297897|NCT01786707|710683|P1|STARTED|Overall Study||1
297898|NCT01786668|710693|P4|NOT COMPLETED|Overall Study||4
297899|NCT01786668|710694|P3|NOT COMPLETED|Overall Study||5
297900|NCT01786668|710695|P2|NOT COMPLETED|Overall Study||1
297901|NCT01786668|710696|P1|NOT COMPLETED|Overall Study||1
297902|NCT01786668|710693|P4|COMPLETED|Overall Study||47
297903|NCT01786668|710694|P3|COMPLETED|Overall Study||47
297904|NCT01786668|710695|P2|COMPLETED|Overall Study||51
297905|NCT01786668|710696|P1|COMPLETED|Overall Study||51
297906|NCT01786668|710693|P4|STARTED|Overall Study||51
297907|NCT01786668|710694|P3|STARTED|Overall Study||52
297908|NCT01786668|710695|P2|STARTED|Overall Study||52
297909|NCT01786668|710696|P1|STARTED|Overall Study||52
297910|NCT01786629|710796|P2|NOT COMPLETED|Overall Study||5
297911|NCT01786629|710797|P1|NOT COMPLETED|Overall Study||0
297912|NCT01786629|710796|P2|COMPLETED|Overall Study||164
297913|NCT01786629|710797|P1|COMPLETED|Overall Study||169
297914|NCT01786629|710796|P2|STARTED|Overall Study||169
297915|NCT01786629|710797|P1|STARTED|Overall Study||169
297916|NCT01786551|710803|P1|NOT COMPLETED|Overall Study||2
297917|NCT01786551|710803|P1|COMPLETED|Overall Study||14
297918|NCT01786551|710803|P1|STARTED|Overall Study||16
297919|NCT01786330|710811|P2|NOT COMPLETED|Overall Study||3
297920|NCT01786330|710812|P1|NOT COMPLETED|Overall Study||1
297921|NCT01786330|710811|P2|COMPLETED|Overall Study||27
297922|NCT01786330|710812|P1|COMPLETED|Overall Study||29
297923|NCT01786330|710811|P2|STARTED|Overall Study||30
297924|NCT01786330|710812|P1|STARTED|Overall Study||30
297925|NCT01786252|710826|P2|NOT COMPLETED|Overall Study||0
297926|NCT01786252|710827|P1|NOT COMPLETED|Overall Study||0
297927|NCT01786252|710826|P2|COMPLETED|Overall Study||8
297928|NCT01786252|710827|P1|COMPLETED|Overall Study||7
297929|NCT01786252|710826|P2|STARTED|Overall Study||8
297930|NCT01786252|710827|P1|STARTED|Overall Study||7
297931|NCT01786239|710841|P2|NOT COMPLETED|Overall Study||11
297932|NCT01786239|710842|P1|NOT COMPLETED|Overall Study||11
297933|NCT01786239|710841|P2|COMPLETED|Overall Study||14
297934|NCT01786239|710842|P1|COMPLETED|Overall Study||14
297935|NCT01786239|710841|P2|STARTED|Overall Study||25
297936|NCT01786239|710842|P1|STARTED|Overall Study||25
297937|NCT01786174|710850|P2|NOT COMPLETED|Overall Study||0
297938|NCT01786174|710851|P1|NOT COMPLETED|Overall Study||2
297939|NCT01786174|710850|P2|COMPLETED|Overall Study||10
297940|NCT01786174|710851|P1|COMPLETED|Overall Study||16
297941|NCT01786174|710850|P2|Randomized|Overall Study||11
297942|NCT01786174|710851|P1|Randomized|Overall Study||19
297943|NCT01786174|710850|P2|STARTED|Overall Study||10
297944|NCT01786174|710851|P1|STARTED|Overall Study||18
297945|NCT01786161|710867|P2|NOT COMPLETED|Overall Study||0
297946|NCT01786161|710868|P1|NOT COMPLETED|Overall Study||0
297947|NCT01786161|710867|P2|COMPLETED|Overall Study||22
297948|NCT01786161|710868|P1|COMPLETED|Overall Study||22
297949|NCT01786161|710867|P2|STARTED|Overall Study||22
297950|NCT01786161|710868|P1|STARTED|Overall Study||22
297951|NCT01786109|710881|P3|NOT COMPLETED|Overall Study||2
297952|NCT01786109|710882|P2|NOT COMPLETED|Overall Study||0
297953|NCT01786109|710883|P1|NOT COMPLETED|Overall Study||1
297954|NCT01786109|710881|P3|COMPLETED|Overall Study||25
297955|NCT01786109|710882|P2|COMPLETED|Overall Study||24
297956|NCT01786109|710883|P1|COMPLETED|Overall Study||23
297957|NCT01786109|710881|P3|STARTED|Overall Study||27
297958|NCT01786109|710882|P2|STARTED|Overall Study||24
297959|NCT01786109|710883|P1|STARTED|Overall Study||24
297960|NCT01785875|710912|P3|NOT COMPLETED|Overall Study||107
297961|NCT01785875|710913|P2|NOT COMPLETED|Overall Study||289
297962|NCT01785875|710914|P1|NOT COMPLETED|Overall Study||294
297963|NCT01785875|710912|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
297964|NCT01785875|710913|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
297965|NCT01785875|710914|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
297966|NCT01785875|710912|P3|Received Etelcalcetide|Overall Study||123
297967|NCT01785875|710913|P2|Received Etelcalcetide|Overall Study||384
297968|NCT01785875|710914|P1|Received Etelcalcetide|Overall Study||383
297969|NCT01785875|710912|P3|STARTED|Overall Study||123
297970|NCT01785875|710913|P2|STARTED|Overall Study||384
297971|NCT01785875|710914|P1|STARTED|Overall Study||384
297972|NCT01785849|710983|P2|NOT COMPLETED|Overall Study||34
297973|NCT01785849|710984|P1|NOT COMPLETED|Overall Study||61
297974|NCT01785849|710983|P2|COMPLETED|Overall Study||220
297975|NCT01785849|710984|P1|COMPLETED|Overall Study||193
297976|NCT01785849|710983|P2|Received Treatment|Overall Study||251
297977|NCT01785849|710984|P1|Received Treatment|Overall Study||254
297978|NCT01785849|710983|P2|STARTED|Overall Study||254
297979|NCT01785849|710984|P1|STARTED|Overall Study||254
297980|NCT01785628|711002|P2|NOT COMPLETED|Overall Study||3
297981|NCT01785628|711003|P1|NOT COMPLETED|Overall Study||2
297982|NCT01785628|711002|P2|COMPLETED|Overall Study||12
297983|NCT01785628|711003|P1|COMPLETED|Overall Study||13
297984|NCT01785628|711002|P2|STARTED|Overall Study||15
297985|NCT01785628|711003|P1|STARTED|Overall Study||15
297986|NCT01785615|711026|P4|NOT COMPLETED|Atorvastatin Phase||0
297987|NCT01785615|711027|P3|NOT COMPLETED|Atorvastatin Phase||0
297988|NCT01785615|711028|P2|NOT COMPLETED|Atorvastatin Phase||0
297989|NCT01785615|711029|P1|NOT COMPLETED|Atorvastatin Phase||0
297990|NCT01785615|711026|P4|COMPLETED|Atorvastatin Phase||0
297991|NCT01785615|711027|P3|COMPLETED|Atorvastatin Phase||0
297992|NCT01785615|711028|P2|COMPLETED|Atorvastatin Phase||44
297993|NCT01785615|711029|P1|COMPLETED|Atorvastatin Phase||44
297994|NCT01785615|711026|P4|STARTED|Atorvastatin Phase||0
297995|NCT01785615|711027|P3|STARTED|Atorvastatin Phase||0
297996|NCT01785615|711028|P2|STARTED|Atorvastatin Phase||44
297997|NCT01785615|711029|P1|STARTED|Atorvastatin Phase||44
297998|NCT01785615|711026|P4|NOT COMPLETED|Dietary Phase||24
297999|NCT01785615|711027|P3|NOT COMPLETED|Dietary Phase||0
298000|NCT01785615|711028|P2|NOT COMPLETED|Dietary Phase||0
298001|NCT01785615|711029|P1|NOT COMPLETED|Dietary Phase||0
298002|NCT01785615|711026|P4|COMPLETED|Dietary Phase||116
298003|NCT01785615|711027|P3|COMPLETED|Dietary Phase||35
298004|NCT01785615|711028|P2|COMPLETED|Dietary Phase||0
298005|NCT01785615|711029|P1|COMPLETED|Dietary Phase||0
298006|NCT01785615|711026|P4|STARTED|Dietary Phase||140
298007|NCT01785615|711027|P3|STARTED|Dietary Phase||35
298008|NCT01785615|711028|P2|STARTED|Dietary Phase||0
298009|NCT01785615|711029|P1|STARTED|Dietary Phase||0
298010|NCT01785602|711101|P2|NOT COMPLETED|Overall Study||9
298011|NCT01785602|711102|P1|NOT COMPLETED|Overall Study||13
298012|NCT01785602|711101|P2|COMPLETED|Overall Study||18
298013|NCT01785602|711102|P1|COMPLETED|Overall Study||63
298014|NCT01785602|711101|P2|STARTED|Overall Study||27
298015|NCT01785602|711102|P1|STARTED|Overall Study||76
298016|NCT01785524|711112|P2|NOT COMPLETED|Overall Study||2
298017|NCT01785524|711113|P1|NOT COMPLETED|Overall Study||2
298018|NCT01785524|711112|P2|COMPLETED|Overall Study||2
298019|NCT01785524|711113|P1|COMPLETED|Overall Study||5
298020|NCT01785524|711112|P2|STARTED|Overall Study||4
298021|NCT01785524|711113|P1|STARTED|Overall Study||7
298022|NCT01785472|711128|P3|NOT COMPLETED|Overall Study||22
298023|NCT01785472|711129|P2|NOT COMPLETED|Overall Study||19
298024|NCT01785472|711130|P1|NOT COMPLETED|Overall Study||24
298025|NCT01785472|711128|P3|COMPLETED|Overall Study||464
298026|NCT01785472|711129|P2|COMPLETED|Overall Study||454
298027|NCT01785472|711130|P1|COMPLETED|Overall Study||455
298028|NCT01785472|711128|P3|Safety Set (SAF)|Overall Study||484
298029|NCT01785472|711129|P2|Safety Set (SAF)|Overall Study||472
298030|NCT01785472|711130|P1|Safety Set (SAF)|Overall Study||478
298031|NCT01785472|711128|P3|Full Analysis Set (FAS)|Overall Study||484
298032|NCT01785472|711129|P2|Full Analysis Set (FAS)|Overall Study||472
298033|NCT01785472|711130|P1|Full Analysis Set (FAS)|Overall Study||479
298034|NCT01785472|711128|P3|STARTED|Overall Study||486
298035|NCT01785472|711129|P2|STARTED|Overall Study||473
298036|NCT01785472|711130|P1|STARTED|Overall Study||479
298037|NCT01785160|711172|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
298038|NCT01785160|711172|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
298039|NCT01785160|711172|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
298040|NCT01785160|711172|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
298041|NCT01785160|711172|P1|COMPLETED|Washout Period of at Least 7 Days||23
298042|NCT01785160|711172|P1|STARTED|Washout Period of at Least 7 Days||24
298043|NCT01785160|711172|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
298044|NCT01785160|711172|P1|COMPLETED|Treatment Period 1: Raltegravir||24
298045|NCT01785160|711172|P1|STARTED|Treatment Period 1: Raltegravir||25
298046|NCT01785134|711182|P2|NOT COMPLETED|Overall Study||7
298047|NCT01785134|711183|P1|NOT COMPLETED|Overall Study||12
298048|NCT01785134|711182|P2|COMPLETED|Overall Study||33
298049|NCT01785134|711183|P1|COMPLETED|Overall Study||29
298050|NCT01785134|711182|P2|STARTED|Overall Study||40
298051|NCT01785134|711183|P1|STARTED|Overall Study||41
298052|NCT01785095|711197|P1|NOT COMPLETED|Overall Study||3
298053|NCT01785095|711197|P1|COMPLETED|Overall Study||24
298054|NCT01785095|711197|P1|STARTED|Overall Study||27
298055|NCT01784965|711207|P2|NOT COMPLETED|Overall Study||11
298056|NCT01784965|711208|P1|NOT COMPLETED|Overall Study||6
298057|NCT01784965|711207|P2|COMPLETED|Overall Study||24
298058|NCT01784965|711208|P1|COMPLETED|Overall Study||27
298059|NCT01784965|711207|P2|STARTED|Overall Study||35
298060|NCT01784965|711208|P1|STARTED|Overall Study||33
298061|NCT01784666|711221|P3|NOT COMPLETED|Overall Study||0
298062|NCT01784666|711222|P2|NOT COMPLETED|Overall Study||0
298063|NCT01784666|711223|P1|NOT COMPLETED|Overall Study||0
298064|NCT01784666|711221|P3|COMPLETED|Overall Study||1
298065|NCT01784666|711222|P2|COMPLETED|Overall Study||0
298066|NCT01784666|711223|P1|COMPLETED|Overall Study||1
298067|NCT01784666|711221|P3|STARTED|Overall Study||1
298068|NCT01784666|711222|P2|STARTED|Overall Study||0
298069|NCT01784666|711223|P1|STARTED|Overall Study||1
298070|NCT01784614|711231|P8|NOT COMPLETED|Period 4||0
298071|NCT01784614|711232|P7|NOT COMPLETED|Period 4||0
298072|NCT01784614|711233|P6|NOT COMPLETED|Period 4||0
298073|NCT01784614|711234|P5|NOT COMPLETED|Period 4||0
298074|NCT01784614|711235|P4|NOT COMPLETED|Period 4||0
298075|NCT01784614|711236|P3|NOT COMPLETED|Period 4||0
298076|NCT01784614|711237|P2|NOT COMPLETED|Period 4||0
298077|NCT01784614|711238|P1|NOT COMPLETED|Period 4||0
298078|NCT01784614|711231|P8|COMPLETED|Period 4||2
298079|NCT01784614|711232|P7|COMPLETED|Period 4||3
298080|NCT01784614|711233|P6|COMPLETED|Period 4||3
298081|NCT01784614|711234|P5|COMPLETED|Period 4||3
298082|NCT01784614|711235|P4|COMPLETED|Period 4||3
298083|NCT01784614|711236|P3|COMPLETED|Period 4||3
298084|NCT01784614|711237|P2|COMPLETED|Period 4||2
298085|NCT01784614|711238|P1|COMPLETED|Period 4||3
298086|NCT01784614|711231|P8|STARTED|Period 4||2
298087|NCT01784614|711232|P7|STARTED|Period 4||3
298088|NCT01784614|711233|P6|STARTED|Period 4||3
298089|NCT01784614|711234|P5|STARTED|Period 4||3
298090|NCT01784614|711235|P4|STARTED|Period 4||3
298091|NCT01784614|711236|P3|STARTED|Period 4||3
298092|NCT01784614|711237|P2|STARTED|Period 4||2
298093|NCT01784614|711238|P1|STARTED|Period 4||3
298094|NCT01784614|711231|P8|NOT COMPLETED|Period 3||0
298095|NCT01784614|711232|P7|NOT COMPLETED|Period 3||0
298096|NCT01784614|711233|P6|NOT COMPLETED|Period 3||0
298097|NCT01784614|711234|P5|NOT COMPLETED|Period 3||0
298098|NCT01784614|711235|P4|NOT COMPLETED|Period 3||0
298099|NCT01784614|711236|P3|NOT COMPLETED|Period 3||0
298100|NCT01784614|711237|P2|NOT COMPLETED|Period 3||0
298101|NCT01784614|711238|P1|NOT COMPLETED|Period 3||0
298102|NCT01784614|711231|P8|COMPLETED|Period 3||2
298103|NCT01784614|711232|P7|COMPLETED|Period 3||3
298104|NCT01784614|711233|P6|COMPLETED|Period 3||3
298105|NCT01784614|711234|P5|COMPLETED|Period 3||3
298106|NCT01784614|711235|P4|COMPLETED|Period 3||3
298107|NCT01784614|711236|P3|COMPLETED|Period 3||3
298108|NCT01784614|711237|P2|COMPLETED|Period 3||2
298109|NCT01784614|711238|P1|COMPLETED|Period 3||3
298110|NCT01784614|711231|P8|STARTED|Period 3||2
298111|NCT01784614|711232|P7|STARTED|Period 3||3
298112|NCT01784614|711233|P6|STARTED|Period 3||3
298113|NCT01784614|711234|P5|STARTED|Period 3||3
298114|NCT01784614|711235|P4|STARTED|Period 3||3
298115|NCT01784614|711236|P3|STARTED|Period 3||3
298116|NCT01784614|711237|P2|STARTED|Period 3||2
298117|NCT01784614|711238|P1|STARTED|Period 3||3
298118|NCT01784614|711231|P8|NOT COMPLETED|Period 2||0
298119|NCT01784614|711232|P7|NOT COMPLETED|Period 2||0
298120|NCT01784614|711233|P6|NOT COMPLETED|Period 2||0
298121|NCT01784614|711234|P5|NOT COMPLETED|Period 2||0
298122|NCT01784614|711235|P4|NOT COMPLETED|Period 2||0
298123|NCT01784614|711236|P3|NOT COMPLETED|Period 2||0
298124|NCT01784614|711237|P2|NOT COMPLETED|Period 2||0
298125|NCT01784614|711238|P1|NOT COMPLETED|Period 2||0
298126|NCT01784614|711231|P8|COMPLETED|Period 2||2
298127|NCT01784614|711232|P7|COMPLETED|Period 2||3
298128|NCT01784614|711233|P6|COMPLETED|Period 2||3
298129|NCT01784614|711234|P5|COMPLETED|Period 2||3
298130|NCT01784614|711235|P4|COMPLETED|Period 2||3
298131|NCT01784614|711236|P3|COMPLETED|Period 2||3
298132|NCT01784614|711237|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
298133|NCT01784614|711238|P1|COMPLETED|Period 2||3
298134|NCT01784614|711231|P8|STARTED|Period 2||2
298135|NCT01784614|711232|P7|STARTED|Period 2||3
298136|NCT01784614|711233|P6|STARTED|Period 2||3
298137|NCT01784614|711234|P5|STARTED|Period 2||3
298138|NCT01784614|711235|P4|STARTED|Period 2||3
298139|NCT01784614|711236|P3|STARTED|Period 2||3
298140|NCT01784614|711237|P2|STARTED|Period 2||3
298141|NCT01784614|711238|P1|STARTED|Period 2||3
298142|NCT01784614|711231|P8|NOT COMPLETED|Period 1||0
298143|NCT01784614|711232|P7|NOT COMPLETED|Period 1||0
298144|NCT01784614|711233|P6|NOT COMPLETED|Period 1||0
298145|NCT01784614|711234|P5|NOT COMPLETED|Period 1||0
298146|NCT01784614|711235|P4|NOT COMPLETED|Period 1||0
298147|NCT01784614|711236|P3|NOT COMPLETED|Period 1||0
298148|NCT01784614|711237|P2|NOT COMPLETED|Period 1||0
298149|NCT01784614|711238|P1|NOT COMPLETED|Period 1||0
298150|NCT01784614|711231|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
298151|NCT01784614|711232|P7|COMPLETED|Period 1||3
298152|NCT01784614|711233|P6|COMPLETED|Period 1||3
298153|NCT01784614|711234|P5|COMPLETED|Period 1||3
298154|NCT01784614|711235|P4|COMPLETED|Period 1||3
298155|NCT01784614|711236|P3|COMPLETED|Period 1||3
298156|NCT01784614|711237|P2|COMPLETED|Period 1||3
298157|NCT01784614|711238|P1|COMPLETED|Period 1||3
298158|NCT01784614|711231|P8|Received at Least 1 Dose of Study Drug|Period 1||3
298159|NCT01784614|711232|P7|Received at Least 1 Dose of Study Drug|Period 1||3
298160|NCT01784614|711233|P6|Received at Least 1 Dose of Study Drug|Period 1||3
298161|NCT01784614|711234|P5|Received at Least 1 Dose of Study Drug|Period 1||3
298162|NCT01784614|711235|P4|Received at Least 1 Dose of Study Drug|Period 1||3
298163|NCT01784614|711236|P3|Received at Least 1 Dose of Study Drug|Period 1||3
298164|NCT01784614|711237|P2|Received at Least 1 Dose of Study Drug|Period 1||3
298165|NCT01784614|711238|P1|Received at Least 1 Dose of Study Drug|Period 1||3
298166|NCT01784614|711231|P8|STARTED|Period 1||3
298167|NCT01784614|711232|P7|STARTED|Period 1||3
298168|NCT01784614|711233|P6|STARTED|Period 1||3
298169|NCT01784614|711234|P5|STARTED|Period 1||3
298170|NCT01784614|711235|P4|STARTED|Period 1||3
298171|NCT01784614|711236|P3|STARTED|Period 1||3
298172|NCT01784614|711237|P2|STARTED|Period 1||3
298173|NCT01784614|711238|P1|STARTED|Period 1||3
298174|NCT01783938|711274|P2|NOT COMPLETED|Overall Study||53
298175|NCT01783938|711275|P1|NOT COMPLETED|Overall Study||47
298176|NCT01783938|711274|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
298177|NCT01783938|711275|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
298178|NCT01783938|711274|P2|STARTED|Overall Study||70
298179|NCT01783938|711275|P1|STARTED|Overall Study||68
298180|NCT01783912|711290|P3|NOT COMPLETED|Overall Study||23
298181|NCT01783912|711291|P2|NOT COMPLETED|Overall Study||46
298182|NCT01783912|711292|P1|NOT COMPLETED|Overall Study||30
298183|NCT01783912|711290|P3|COMPLETED|Overall Study||25
298184|NCT01783912|711291|P2|COMPLETED|Overall Study||58
298185|NCT01783912|711292|P1|COMPLETED|Overall Study||88
298186|NCT01783912|711290|P3|STARTED|Overall Study||48
298187|NCT01783912|711291|P2|STARTED|Overall Study||104
298188|NCT01783912|711292|P1|STARTED|Overall Study||118
298189|NCT01783886|711303|P3|NOT COMPLETED|Overall Study||10
298190|NCT01783886|711304|P2|NOT COMPLETED|Overall Study||11
298191|NCT01783886|711305|P1|NOT COMPLETED|Overall Study||5
298192|NCT01783886|711303|P3|COMPLETED|Overall Study||117
298193|NCT01783886|711304|P2|COMPLETED|Overall Study||116
298194|NCT01783886|711305|P1|COMPLETED|Overall Study||122
298195|NCT01783886|711303|P3|Participants Received Treatment|Overall Study||124
298196|NCT01783886|711304|P2|Participants Received Treatment|Overall Study||127
298197|NCT01783886|711305|P1|Participants Received Treatment|Overall Study||127
298198|NCT01783886|711303|P3|STARTED|Overall Study||127
298199|NCT01783886|711304|P2|STARTED|Overall Study||127
298200|NCT01783886|711305|P1|STARTED|Overall Study||127
298201|NCT01783860|711333|P2|NOT COMPLETED|Overall Study||0
298202|NCT01783860|711334|P1|NOT COMPLETED|Overall Study||0
298203|NCT01783860|711333|P2|COMPLETED|Overall Study||50
298204|NCT01783860|711334|P1|COMPLETED|Overall Study||50
298205|NCT01783860|711333|P2|STARTED|Overall Study||50
298206|NCT01783860|711334|P1|STARTED|Overall Study||50
298207|NCT01783821|711352|P2|NOT COMPLETED|Overall Study||1
298208|NCT01783821|711353|P1|NOT COMPLETED|Overall Study||1
298209|NCT01783821|711352|P2|COMPLETED|Overall Study||30
298210|NCT01783821|711353|P1|COMPLETED|Overall Study||29
298211|NCT01783821|711352|P2|STARTED|Overall Study||31
298212|NCT01783821|711353|P1|STARTED|Overall Study||30
298213|NCT01783730|711369|P1|NOT COMPLETED|Overall Study||6
298214|NCT01783730|711369|P1|COMPLETED|Overall Study||157
298215|NCT01783730|711369|P1|STARTED|Overall Study||163
298216|NCT01783678|711394|P6|NOT COMPLETED|Overall Study||5
298217|NCT01783678|711395|P5|NOT COMPLETED|Overall Study||7
298218|NCT01783678|711396|P4|NOT COMPLETED|Overall Study||8
298219|NCT01783678|711397|P3|NOT COMPLETED|Overall Study||1
298220|NCT01783678|711398|P2|NOT COMPLETED|Overall Study||18
298221|NCT01783678|711399|P1|NOT COMPLETED|Overall Study||2
298222|NCT01783678|711394|P6|COMPLETED|Overall Study||26
298223|NCT01783678|711395|P5|COMPLETED|Overall Study||42
298224|NCT01783678|711396|P4|COMPLETED|Overall Study||50
298225|NCT01783678|711397|P3|COMPLETED|Overall Study||5
298226|NCT01783678|711398|P2|COMPLETED|Overall Study||94
298227|NCT01783678|711399|P1|COMPLETED|Overall Study||17
298228|NCT01783678|711394|P6|STARTED|Overall Study||31
298229|NCT01783678|711395|P5|STARTED|Overall Study||49
298230|NCT01783678|711396|P4|STARTED|Overall Study||58
298231|NCT01783678|711397|P3|STARTED|Overall Study||6
298232|NCT01783678|711398|P2|STARTED|Overall Study||112
298233|NCT01783678|711399|P1|STARTED|Overall Study||19
298234|NCT01783639|711471|P1|NOT COMPLETED|Overall Study||22
298235|NCT01783639|711471|P1|COMPLETED|Overall Study||120
298236|NCT01783639|711471|P1|STARTED|Overall Study||142
298237|NCT01783548|711477|P2|NOT COMPLETED|Overall Study||18
298238|NCT01783548|711478|P1|NOT COMPLETED|Overall Study||34
298239|NCT01783548|711477|P2|COMPLETED|Overall Study||167
298240|NCT01783548|711478|P1|COMPLETED|Overall Study||328
298241|NCT01783548|711477|P2|Full Analysis Set (FAS)|Overall Study||184
298242|NCT01783548|711478|P1|Full Analysis Set (FAS)|Overall Study||358
298243|NCT01783548|711477|P2|STARTED|Overall Study|Randomized|185
298244|NCT01783548|711478|P1|STARTED|Overall Study|Randomized|362
298245|NCT01783496|711496|P6|NOT COMPLETED|Overall Study||1
298246|NCT01783496|711497|P5|NOT COMPLETED|Overall Study||0
298247|NCT01783496|711498|P4|NOT COMPLETED|Overall Study||2
298248|NCT01783496|711499|P3|NOT COMPLETED|Overall Study||0
298249|NCT01783496|711500|P2|NOT COMPLETED|Overall Study||0
298250|NCT01783496|711501|P1|NOT COMPLETED|Overall Study||1
298251|NCT01783496|711496|P6|COMPLETED|Overall Study||4
298252|NCT01783496|711497|P5|COMPLETED|Overall Study||5
298253|NCT01783496|711498|P4|COMPLETED|Overall Study||8
298254|NCT01783496|711499|P3|COMPLETED|Overall Study||10
298255|NCT01783496|711500|P2|COMPLETED|Overall Study||10
298256|NCT01783496|711501|P1|COMPLETED|Overall Study||9
298257|NCT01783496|711496|P6|STARTED|Overall Study||5
298258|NCT01783496|711497|P5|STARTED|Overall Study||5
298259|NCT01783496|711498|P4|STARTED|Overall Study||10
298260|NCT01783496|711499|P3|STARTED|Overall Study||10
298261|NCT01783496|711500|P2|STARTED|Overall Study||10
298262|NCT01783496|711501|P1|STARTED|Overall Study||10
298263|NCT01783470|711527|P2|NOT COMPLETED|Overall Study||0
298264|NCT01783470|711528|P1|NOT COMPLETED|Overall Study||0
298265|NCT01783470|711527|P2|COMPLETED|Overall Study||6
298266|NCT01783470|711528|P1|COMPLETED|Overall Study||6
298267|NCT01783470|711527|P2|STARTED|Overall Study|Single-dose|6
298268|NCT01783470|711528|P1|STARTED|Overall Study||6
298269|NCT01783418|711537|P2|NOT COMPLETED|Overall Study||0
298270|NCT01783418|711538|P1|NOT COMPLETED|Overall Study||1
298271|NCT01783418|711537|P2|COMPLETED|Overall Study||6
298272|NCT01783418|711538|P1|COMPLETED|Overall Study||7
298273|NCT01783418|711537|P2|STARTED|Overall Study||6
298274|NCT01783418|711538|P1|STARTED|Overall Study||8
298275|NCT01783236|711558|P2|NOT COMPLETED|Overall Study||0
298276|NCT01783236|711559|P1|NOT COMPLETED|Overall Study||2
298277|NCT01783236|711558|P2|COMPLETED|Overall Study||8
298278|NCT01783236|711559|P1|COMPLETED|Overall Study||6
298279|NCT01783236|711558|P2|STARTED|Overall Study||8
298280|NCT01783236|711559|P1|STARTED|Overall Study||8
298281|NCT01783054|711573|P1|NOT COMPLETED|Overall Study||0
298282|NCT01783054|711573|P1|COMPLETED|Overall Study||2
298283|NCT01783054|711573|P1|STARTED|Overall Study||2
298284|NCT01783015|711584|P3|NOT COMPLETED|Open Label Treatment||6
298285|NCT01783015|711585|P2|NOT COMPLETED|Open Label Treatment||0
298286|NCT01783015|711586|P1|NOT COMPLETED|Open Label Treatment||0
298287|NCT01783015|711584|P3|COMPLETED|Open Label Treatment||5
298288|NCT01783015|711585|P2|COMPLETED|Open Label Treatment||0
298289|NCT01783015|711586|P1|COMPLETED|Open Label Treatment||0
298290|NCT01783015|711584|P3|STARTED|Open Label Treatment||11
298291|NCT01783015|711585|P2|STARTED|Open Label Treatment||0
298292|NCT01783015|711586|P1|STARTED|Open Label Treatment||0
298293|NCT01783015|711584|P3|NOT COMPLETED|Blinded Treatment||0
298294|NCT01783015|711585|P2|NOT COMPLETED|Blinded Treatment||3
298295|NCT01783015|711586|P1|NOT COMPLETED|Blinded Treatment||2
298296|NCT01783015|711584|P3|COMPLETED|Blinded Treatment||0
298297|NCT01783015|711585|P2|COMPLETED|Blinded Treatment||2
298298|NCT01783015|711586|P1|COMPLETED|Blinded Treatment||9
298299|NCT01783015|711584|P3|Treated|Blinded Treatment||0
298300|NCT01783015|711585|P2|Treated|Blinded Treatment||5
298301|NCT01783015|711586|P1|Treated|Blinded Treatment||11
298302|NCT01783015|711584|P3|STARTED|Blinded Treatment||0
298303|NCT01783015|711585|P2|STARTED|Blinded Treatment||5
298304|NCT01783015|711586|P1|STARTED|Blinded Treatment||11
298305|NCT01782898|711673|P2|NOT COMPLETED|Overall Study||6
298306|NCT01782898|711674|P1|NOT COMPLETED|Overall Study||6
298307|NCT01782898|711673|P2|COMPLETED|Overall Study||29
298308|NCT01782898|711674|P1|COMPLETED|Overall Study||29
298309|NCT01782898|711673|P2|STARTED|Overall Study||35
298310|NCT01782898|711674|P1|STARTED|Overall Study||35
298311|NCT01782885|711686|P2|NOT COMPLETED|Overall Study||6
298312|NCT01782885|711687|P1|NOT COMPLETED|Overall Study||4
298313|NCT01782885|711686|P2|COMPLETED|Overall Study||33
298314|NCT01782885|711687|P1|COMPLETED|Overall Study||32
298315|NCT01782885|711686|P2|STARTED|Overall Study||39
298316|NCT01782885|711687|P1|STARTED|Overall Study||36
298317|NCT01782872|711713|P4|NOT COMPLETED|Overall Study||1
298318|NCT01782872|711714|P3|NOT COMPLETED|Overall Study||0
298319|NCT01782872|711715|P2|NOT COMPLETED|Overall Study||1
298320|NCT01782872|711716|P1|NOT COMPLETED|Overall Study||0
298321|NCT01782872|711713|P4|COMPLETED|Overall Study||19
298322|NCT01782872|711714|P3|COMPLETED|Overall Study||20
298323|NCT01782872|711715|P2|COMPLETED|Overall Study||19
298324|NCT01782872|711716|P1|COMPLETED|Overall Study||20
298325|NCT01782872|711713|P4|STARTED|Overall Study||20
298326|NCT01782872|711714|P3|STARTED|Overall Study||20
298327|NCT01782872|711715|P2|STARTED|Overall Study||20
298328|NCT01782872|711716|P1|STARTED|Overall Study||20
298329|NCT01782859|711740|P2|NOT COMPLETED|Overall Study||7
298330|NCT01782859|711741|P1|NOT COMPLETED|Overall Study||6
298331|NCT01782859|711740|P2|COMPLETED|Overall Study||13
298332|NCT01782859|711741|P1|COMPLETED|Overall Study||14
298333|NCT01782859|711740|P2|STARTED|Overall Study||20
298334|NCT01782859|711741|P1|STARTED|Overall Study||20
298335|NCT01782742|711757|P2|NOT COMPLETED|Open Label Phase||0
298336|NCT01782742|711758|P1|NOT COMPLETED|Open Label Phase||0
298337|NCT01782742|711757|P2|COMPLETED|Open Label Phase||0
298338|NCT01782742|711758|P1|COMPLETED|Open Label Phase||19
298339|NCT01782742|711757|P2|STARTED|Open Label Phase||0
298340|NCT01782742|711758|P1|STARTED|Open Label Phase||19
298341|NCT01782742|711757|P2|NOT COMPLETED|Double-blind Treatment Phase||0
298342|NCT01782742|711758|P1|NOT COMPLETED|Double-blind Treatment Phase||1
298343|NCT01782742|711757|P2|COMPLETED|Double-blind Treatment Phase||4
298344|NCT01782742|711758|P1|COMPLETED|Double-blind Treatment Phase||15
298345|NCT01782742|711757|P2|STARTED|Double-blind Treatment Phase||4
298346|NCT01782742|711758|P1|STARTED|Double-blind Treatment Phase||16
298347|NCT01782482|711793|P2|NOT COMPLETED|Overall Study||10
298348|NCT01782482|711794|P1|NOT COMPLETED|Overall Study||10
298349|NCT01782482|711793|P2|COMPLETED|Overall Study||270
298350|NCT01782482|711794|P1|COMPLETED|Overall Study||271
298351|NCT01782482|711793|P2|STARTED|Overall Study||280
298352|NCT01782482|711794|P1|STARTED|Overall Study||281
298353|NCT01782469|711802|P1|NOT COMPLETED|Overall Study||1
298354|NCT01782469|711802|P1|COMPLETED|Overall Study||15
298355|NCT01782469|711802|P1|STARTED|Overall Study||16
298356|NCT01782326|711812|P2|NOT COMPLETED|Double-blind Treatment||320
298357|NCT01782326|711813|P1|NOT COMPLETED|Double-blind Treatment||278
298358|NCT01782326|711812|P2|COMPLETED|Double-blind Treatment||1360
298359|NCT01782326|711813|P1|COMPLETED|Double-blind Treatment||1400
298360|NCT01782326|711812|P2|STARTED|Double-blind Treatment||1680
298361|NCT01782326|711813|P1|STARTED|Double-blind Treatment||1678
298362|NCT01782326|711812|P2|NOT COMPLETED|Planned Treatment Epoch||208
298363|NCT01782326|711813|P1|NOT COMPLETED|Planned Treatment Epoch||202
298364|NCT01782326|711812|P2|COMPLETED|Planned Treatment Epoch||1474
298365|NCT01782326|711813|P1|COMPLETED|Planned Treatment Epoch||1478
298366|NCT01782326|711812|P2|Urine Cortisol Set|Planned Treatment Epoch||269
298367|NCT01782326|711813|P1|Urine Cortisol Set|Planned Treatment Epoch||266
298368|NCT01782326|711812|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
298369|NCT01782326|711813|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
298370|NCT01782326|711812|P2|Serial Spirometry Set|Planned Treatment Epoch||279
298371|NCT01782326|711813|P1|Serial Spirometry Set|Planned Treatment Epoch||280
298372|NCT01782326|711812|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
298373|NCT01782326|711813|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
298374|NCT01782326|711812|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
298375|NCT01782326|711813|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
298376|NCT01782326|711812|P2|STARTED|Planned Treatment Epoch||1682
298377|NCT01782326|711813|P1|STARTED|Planned Treatment Epoch||1680
298378|NCT01782222|711876|P3|NOT COMPLETED|Overall Study||4
298379|NCT01782222|711877|P2|NOT COMPLETED|Overall Study||11
298380|NCT01782222|711878|P1|NOT COMPLETED|Overall Study||8
298381|NCT01782222|711876|P3|COMPLETED|Overall Study||37
298382|NCT01782222|711877|P2|COMPLETED|Overall Study||30
298383|NCT01782222|711878|P1|COMPLETED|Overall Study||32
298384|NCT01782222|711876|P3|STARTED|Overall Study||41
298385|NCT01782222|711877|P2|STARTED|Overall Study||41
298386|NCT01782222|711878|P1|STARTED|Overall Study||40
298387|NCT01781962|711910|P1|NOT COMPLETED|Overall Study||5
298388|NCT01781962|711910|P1|COMPLETED|Overall Study||201
298389|NCT01781962|711910|P1|STARTED|Overall Study||206
298390|NCT01781637|711918|P2|NOT COMPLETED|Overall Study||6
298391|NCT01781637|711919|P1|NOT COMPLETED|Overall Study||4
298392|NCT01781637|711918|P2|COMPLETED|Overall Study||2
298393|NCT01781637|711919|P1|COMPLETED|Overall Study||24
298394|NCT01781637|711918|P2|STARTED|Overall Study||8
298395|NCT01781637|711919|P1|STARTED|Overall Study||28
298396|NCT01781481|711927|P1|NOT COMPLETED|Overall Study||0
298397|NCT01781481|711927|P1|COMPLETED|Overall Study||148
298398|NCT01781481|711927|P1|STARTED|Overall Study||148
298399|NCT01781403|711986|P3|NOT COMPLETED|Overall Study||0
298400|NCT01781403|711987|P2|NOT COMPLETED|Overall Study||0
298401|NCT01781403|711988|P1|NOT COMPLETED|Overall Study||0
298402|NCT01781403|711986|P3|COMPLETED|Overall Study||18
298403|NCT01781403|711987|P2|COMPLETED|Overall Study||2
298404|NCT01781403|711988|P1|COMPLETED|Overall Study||2
298405|NCT01781403|711986|P3|STARTED|Overall Study||18
298406|NCT01781403|711987|P2|STARTED|Overall Study||2
298407|NCT01781403|711988|P1|STARTED|Overall Study||2
298408|NCT01781299|712006|P2|NOT COMPLETED|Overall Study||1
298409|NCT01781299|712007|P1|NOT COMPLETED|Overall Study||0
298410|NCT01781299|712006|P2|COMPLETED|Overall Study||4
298411|NCT01781299|712007|P1|COMPLETED|Overall Study||4
298412|NCT01781299|712006|P2|STARTED|Overall Study||5
298413|NCT01781299|712007|P1|STARTED|Overall Study||4
298414|NCT01781208|712015|P1|NOT COMPLETED|Overall Study||0
298415|NCT01781208|712015|P1|COMPLETED|Overall Study||62
298416|NCT01781208|712015|P1|Overall Study|Overall Study||62
298417|NCT01781208|712015|P1|STARTED|Overall Study||62
298418|NCT01781169|712022|P2|NOT COMPLETED|Overall Study||0
298419|NCT01781169|712023|P1|NOT COMPLETED|Overall Study||1
298420|NCT01781169|712022|P2|COMPLETED|Overall Study||21
298421|NCT01781169|712023|P1|COMPLETED|Overall Study||21
298422|NCT01781169|712022|P2|STARTED|Overall Study||21
298423|NCT01781169|712023|P1|STARTED|Overall Study||22
298424|NCT01781078|712031|P3|NOT COMPLETED|Overall Study||16
298425|NCT01781078|712032|P2|NOT COMPLETED|Overall Study||5
298426|NCT01781078|712033|P1|NOT COMPLETED|Overall Study||12
298427|NCT01781078|712031|P3|COMPLETED|Overall Study||0
298428|NCT01781078|712032|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
298429|NCT01781078|712033|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
298430|NCT01781078|712031|P3|STARTED|Overall Study||16
298431|NCT01781078|712032|P2|STARTED|Overall Study|Randomized post implantation|118
298432|NCT01781078|712033|P1|STARTED|Overall Study|Randomized post implantation|229
298433|NCT01781026|712043|P1|NOT COMPLETED|Overall Study||2
298434|NCT01781026|712043|P1|COMPLETED|Overall Study||0
298435|NCT01781026|712043|P1|STARTED|Overall Study||2
298436|NCT01780987|712049|P2|NOT COMPLETED|Overall Study||6
298437|NCT01780987|712050|P1|NOT COMPLETED|Overall Study||3
298438|NCT01780987|712049|P2|COMPLETED|Overall Study||34
298439|NCT01780987|712050|P1|COMPLETED|Overall Study||37
298440|NCT01780987|712049|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
298441|NCT01780987|712050|P1|STARTED|Overall Study||40
298442|NCT01780974|712068|P2|NOT COMPLETED|Overall Study||3
298443|NCT01780974|712069|P1|NOT COMPLETED|Overall Study||2
298444|NCT01780974|712068|P2|COMPLETED|Overall Study||18
298445|NCT01780974|712069|P1|COMPLETED|Overall Study||19
298446|NCT01780974|712068|P2|STARTED|Overall Study||21
298447|NCT01780974|712069|P1|STARTED|Overall Study||21
298448|NCT01780935|712079|P2|NOT COMPLETED|Overall Study||336
298449|NCT01780935|712080|P1|NOT COMPLETED|Overall Study||335
298450|NCT01780935|712079|P2|COMPLETED|Overall Study||0
298451|NCT01780935|712080|P1|COMPLETED|Overall Study||0
298452|NCT01780935|712079|P2|Safety Set|Overall Study||336
298453|NCT01780935|712080|P1|Safety Set|Overall Study||334
298454|NCT01780935|712079|P2|STARTED|Overall Study||336
298455|NCT01780935|712080|P1|STARTED|Overall Study||335
298456|NCT01780922|712110|P6|NOT COMPLETED|Third Intervention (1 Day)||0
298457|NCT01780922|712111|P5|NOT COMPLETED|Third Intervention (1 Day)||0
298458|NCT01780922|712112|P4|NOT COMPLETED|Third Intervention (1 Day)||0
298459|NCT01780922|712113|P3|NOT COMPLETED|Third Intervention (1 Day)||0
298460|NCT01780922|712114|P2|NOT COMPLETED|Third Intervention (1 Day)||0
298461|NCT01780922|712115|P1|NOT COMPLETED|Third Intervention (1 Day)||0
298462|NCT01780922|712110|P6|COMPLETED|Third Intervention (1 Day)||2
298463|NCT01780922|712111|P5|COMPLETED|Third Intervention (1 Day)||2
298464|NCT01780922|712112|P4|COMPLETED|Third Intervention (1 Day)||2
298465|NCT01780922|712113|P3|COMPLETED|Third Intervention (1 Day)||2
298466|NCT01780922|712114|P2|COMPLETED|Third Intervention (1 Day)||2
298467|NCT01780922|712115|P1|COMPLETED|Third Intervention (1 Day)||2
298468|NCT01780922|712110|P6|STARTED|Third Intervention (1 Day)||2
298469|NCT01780922|712111|P5|STARTED|Third Intervention (1 Day)||2
298470|NCT01780922|712112|P4|STARTED|Third Intervention (1 Day)||2
298471|NCT01780922|712113|P3|STARTED|Third Intervention (1 Day)||2
298472|NCT01780922|712114|P2|STARTED|Third Intervention (1 Day)||2
298473|NCT01780922|712115|P1|STARTED|Third Intervention (1 Day)||2
298474|NCT01780922|712110|P6|NOT COMPLETED|Washout (7 Days)||0
298475|NCT01780922|712111|P5|NOT COMPLETED|Washout (7 Days)||0
298476|NCT01780922|712112|P4|NOT COMPLETED|Washout (7 Days)||0
298477|NCT01780922|712113|P3|NOT COMPLETED|Washout (7 Days)||0
298478|NCT01780922|712114|P2|NOT COMPLETED|Washout (7 Days)||0
298479|NCT01780922|712115|P1|NOT COMPLETED|Washout (7 Days)||0
298480|NCT01780922|712110|P6|COMPLETED|Washout (7 Days)||2
298481|NCT01780922|712111|P5|COMPLETED|Washout (7 Days)||2
298482|NCT01780922|712112|P4|COMPLETED|Washout (7 Days)||2
298483|NCT01780922|712113|P3|COMPLETED|Washout (7 Days)||2
298484|NCT01780922|712114|P2|COMPLETED|Washout (7 Days)||2
298485|NCT01780922|712115|P1|COMPLETED|Washout (7 Days)||2
298486|NCT01780922|712110|P6|STARTED|Washout (7 Days)||2
298487|NCT01780922|712111|P5|STARTED|Washout (7 Days)||2
298488|NCT01780922|712112|P4|STARTED|Washout (7 Days)||2
298489|NCT01780922|712113|P3|STARTED|Washout (7 Days)||2
298490|NCT01780922|712114|P2|STARTED|Washout (7 Days)||2
298491|NCT01780922|712115|P1|STARTED|Washout (7 Days)||2
298492|NCT01780922|712110|P6|NOT COMPLETED|Second Intervention (1 Day)||0
298493|NCT01780922|712111|P5|NOT COMPLETED|Second Intervention (1 Day)||0
298494|NCT01780922|712112|P4|NOT COMPLETED|Second Intervention (1 Day)||0
298495|NCT01780922|712113|P3|NOT COMPLETED|Second Intervention (1 Day)||0
298496|NCT01780922|712114|P2|NOT COMPLETED|Second Intervention (1 Day)||0
298497|NCT01780922|712115|P1|NOT COMPLETED|Second Intervention (1 Day)||0
298498|NCT01780922|712110|P6|COMPLETED|Second Intervention (1 Day)||2
298499|NCT01780922|712111|P5|COMPLETED|Second Intervention (1 Day)||2
298500|NCT01780922|712112|P4|COMPLETED|Second Intervention (1 Day)||2
298501|NCT01780922|712113|P3|COMPLETED|Second Intervention (1 Day)||2
298502|NCT01780922|712114|P2|COMPLETED|Second Intervention (1 Day)||2
298503|NCT01780922|712115|P1|COMPLETED|Second Intervention (1 Day)||2
298504|NCT01780922|712110|P6|STARTED|Second Intervention (1 Day)||2
298505|NCT01780922|712111|P5|STARTED|Second Intervention (1 Day)||2
298506|NCT01780922|712112|P4|STARTED|Second Intervention (1 Day)||2
298507|NCT01780922|712113|P3|STARTED|Second Intervention (1 Day)||2
298508|NCT01780922|712114|P2|STARTED|Second Intervention (1 Day)||2
298509|NCT01780922|712115|P1|STARTED|Second Intervention (1 Day)||2
298510|NCT01780922|712110|P6|NOT COMPLETED|Washout (7 Days)||0
298511|NCT01780922|712111|P5|NOT COMPLETED|Washout (7 Days)||0
298512|NCT01780922|712112|P4|NOT COMPLETED|Washout (7 Days)||0
298513|NCT01780922|712113|P3|NOT COMPLETED|Washout (7 Days)||0
298514|NCT01780922|712114|P2|NOT COMPLETED|Washout (7 Days)||0
298515|NCT01780922|712115|P1|NOT COMPLETED|Washout (7 Days)||0
298516|NCT01780922|712110|P6|COMPLETED|Washout (7 Days)||2
298517|NCT01780922|712111|P5|COMPLETED|Washout (7 Days)||2
298518|NCT01780922|712112|P4|COMPLETED|Washout (7 Days)||2
298519|NCT01780922|712113|P3|COMPLETED|Washout (7 Days)||2
298520|NCT01780922|712114|P2|COMPLETED|Washout (7 Days)||2
298521|NCT01780922|712115|P1|COMPLETED|Washout (7 Days)||2
298522|NCT01780922|712110|P6|STARTED|Washout (7 Days)||2
298523|NCT01780922|712111|P5|STARTED|Washout (7 Days)||2
298524|NCT01780922|712112|P4|STARTED|Washout (7 Days)||2
298525|NCT01780922|712113|P3|STARTED|Washout (7 Days)||2
298526|NCT01780922|712114|P2|STARTED|Washout (7 Days)||2
298527|NCT01780922|712115|P1|STARTED|Washout (7 Days)||2
298528|NCT01780922|712110|P6|NOT COMPLETED|First Intervention (1 Day)||0
298529|NCT01780922|712111|P5|NOT COMPLETED|First Intervention (1 Day)||0
298530|NCT01780922|712112|P4|NOT COMPLETED|First Intervention (1 Day)||0
298531|NCT01780922|712113|P3|NOT COMPLETED|First Intervention (1 Day)||0
298532|NCT01780922|712114|P2|NOT COMPLETED|First Intervention (1 Day)||0
298533|NCT01780922|712115|P1|NOT COMPLETED|First Intervention (1 Day)||0
298534|NCT01780922|712110|P6|COMPLETED|First Intervention (1 Day)||2
298535|NCT01780922|712111|P5|COMPLETED|First Intervention (1 Day)||2
298536|NCT01780922|712112|P4|COMPLETED|First Intervention (1 Day)||2
298537|NCT01780922|712113|P3|COMPLETED|First Intervention (1 Day)||2
298538|NCT01780922|712114|P2|COMPLETED|First Intervention (1 Day)||2
298539|NCT01780922|712115|P1|COMPLETED|First Intervention (1 Day)||2
298540|NCT01780922|712110|P6|STARTED|First Intervention (1 Day)||2
298541|NCT01780922|712111|P5|STARTED|First Intervention (1 Day)||2
298542|NCT01780922|712112|P4|STARTED|First Intervention (1 Day)||2
298543|NCT01780922|712113|P3|STARTED|First Intervention (1 Day)||2
298544|NCT01780922|712114|P2|STARTED|First Intervention (1 Day)||2
298545|NCT01780922|712115|P1|STARTED|First Intervention (1 Day)||2
298546|NCT01780584|712171|P3|NOT COMPLETED|Overall Study||2
298547|NCT01780584|712172|P2|NOT COMPLETED|Overall Study||1
298548|NCT01780584|712173|P1|NOT COMPLETED|Overall Study||1
298549|NCT01780584|712171|P3|COMPLETED|Overall Study||13
298550|NCT01780584|712172|P2|COMPLETED|Overall Study||14
298551|NCT01780584|712173|P1|COMPLETED|Overall Study||14
298552|NCT01780584|712171|P3|STARTED|Overall Study||15
298553|NCT01780584|712172|P2|STARTED|Overall Study||15
298554|NCT01780584|712173|P1|STARTED|Overall Study||15
298555|NCT01780506|712195|P2|NOT COMPLETED|Overall Study||434
298556|NCT01780506|712196|P1|NOT COMPLETED|Overall Study||438
298557|NCT01780506|712195|P2|COMPLETED|Overall Study||0
298558|NCT01780506|712196|P1|COMPLETED|Overall Study||0
298559|NCT01780506|712195|P2|STARTED|Overall Study||434
298560|NCT01780506|712196|P1|STARTED|Overall Study||438
298561|NCT01780389|712234|P1|NOT COMPLETED|Overall Study||1
298562|NCT01780389|712234|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
298563|NCT01780389|712234|P1|STARTED|Overall Study||5
298564|NCT01780350|712245|P1|NOT COMPLETED|Overall Study||0
298565|NCT01780350|712245|P1|COMPLETED|Overall Study||200
298566|NCT01780350|712245|P1|STARTED|Overall Study||200
298567|NCT01780337|712252|P2|NOT COMPLETED|Overall Study||0
298568|NCT01780337|712253|P1|NOT COMPLETED|Overall Study||0
298569|NCT01780337|712252|P2|COMPLETED|Overall Study||6
298570|NCT01780337|712253|P1|COMPLETED|Overall Study||6
298571|NCT01780337|712252|P2|STARTED|Overall Study||6
298572|NCT01780337|712253|P1|STARTED|Overall Study||6
298573|NCT01780324|712265|P2|NOT COMPLETED|Overall Study||6
298574|NCT01780324|712266|P1|NOT COMPLETED|Overall Study||1
298575|NCT01780324|712265|P2|COMPLETED|Overall Study||33
298576|NCT01780324|712266|P1|COMPLETED|Overall Study||40
298577|NCT01780324|712265|P2|STARTED|Overall Study||39
298578|NCT01780324|712266|P1|STARTED|Overall Study||41
298579|NCT01779648|712274|P2|NOT COMPLETED|Overall Study||0
298580|NCT01779648|712275|P1|NOT COMPLETED|Overall Study||1
298581|NCT01779648|712274|P2|COMPLETED|Overall Study||27
298582|NCT01779648|712275|P1|COMPLETED|Overall Study||27
298583|NCT01779648|712274|P2|STARTED|Overall Study||27
298584|NCT01779648|712275|P1|STARTED|Overall Study||28
298585|NCT01779219|712305|P2|NOT COMPLETED|Overall Study||0
298586|NCT01779219|712306|P1|NOT COMPLETED|Overall Study||0
298587|NCT01779219|712305|P2|COMPLETED|Overall Study|First interim analysis|21
298588|NCT01779219|712306|P1|COMPLETED|Overall Study|First interim analysis|21
298589|NCT01779219|712305|P2|STARTED|Overall Study|First interim analysis|21
298590|NCT01779219|712306|P1|STARTED|Overall Study|First interim analysis|21
298591|NCT01779167|712318|P1|NOT COMPLETED|Overall Study||1
298592|NCT01779167|712318|P1|COMPLETED|Overall Study||3
298593|NCT01779167|712318|P1|STARTED|Overall Study||4
298594|NCT01778985|712325|P2|NOT COMPLETED|Overall Study||3
298595|NCT01778985|712326|P1|NOT COMPLETED|Overall Study||7
298596|NCT01778985|712325|P2|COMPLETED|Overall Study||12
298597|NCT01778985|712326|P1|COMPLETED|Overall Study||8
298598|NCT01778985|712325|P2|STARTED|Overall Study||15
298599|NCT01778985|712326|P1|STARTED|Overall Study||15
298600|NCT01778855|712372|P2|NOT COMPLETED|Overall Study||1
298601|NCT01778855|712373|P1|NOT COMPLETED|Overall Study||0
298602|NCT01778855|712372|P2|COMPLETED|Overall Study||3
298603|NCT01778855|712373|P1|COMPLETED|Overall Study||2
298604|NCT01778855|712372|P2|STARTED|Overall Study||4
298605|NCT01778855|712373|P1|STARTED|Overall Study||2
298606|NCT01778751|712381|P2|NOT COMPLETED|Overall Study||2
298607|NCT01778751|712382|P1|NOT COMPLETED|Overall Study||2
298608|NCT01778751|712381|P2|COMPLETED|Overall Study||23
298609|NCT01778751|712382|P1|COMPLETED|Overall Study||23
298610|NCT01778751|712381|P2|STARTED|Overall Study||25
298611|NCT01778751|712382|P1|STARTED|Overall Study||25
298612|NCT01778530|712394|P1|NOT COMPLETED|Overall Study||2
298613|NCT01778530|712394|P1|COMPLETED|Overall Study||0
298614|NCT01778530|712394|P1|STARTED|Overall Study||2
298615|NCT01778296|712399|P1|NOT COMPLETED|Overall Study||0
298616|NCT01778296|712399|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
298617|NCT01778296|712399|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
298618|NCT01778127|712406|P3|NOT COMPLETED|Overall Study||6
298619|NCT01778127|712407|P2|NOT COMPLETED|Overall Study||2
298620|NCT01778127|712408|P1|NOT COMPLETED|Overall Study||8
298621|NCT01778127|712406|P3|COMPLETED|Overall Study||26
298622|NCT01778127|712407|P2|COMPLETED|Overall Study||31
298623|NCT01778127|712408|P1|COMPLETED|Overall Study||25
298624|NCT01778127|712406|P3|STARTED|Overall Study||32
298625|NCT01778127|712407|P2|STARTED|Overall Study||33
298626|NCT01778127|712408|P1|STARTED|Overall Study||33
298627|NCT01778062|712451|P2|NOT COMPLETED|Overall Study||11
298628|NCT01778062|712452|P1|NOT COMPLETED|Overall Study||6
298629|NCT01778062|712451|P2|COMPLETED|Overall Study||57
298630|NCT01778062|712452|P1|COMPLETED|Overall Study||62
298631|NCT01778062|712451|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
298632|NCT01778062|712452|P1|Intent to Treat (ITT)|Overall Study||68
298633|NCT01778062|712451|P2|Safety Set|Overall Study||68
298634|NCT01778062|712452|P1|Safety Set|Overall Study||68
298635|NCT01778062|712451|P2|STARTED|Overall Study||68
298636|NCT01778062|712452|P1|STARTED|Overall Study||68
298637|NCT01778049|712466|P6|NOT COMPLETED|Double Blind Treatment Period||7
298638|NCT01778049|712467|P5|NOT COMPLETED|Double Blind Treatment Period||12
298639|NCT01778049|712468|P4|NOT COMPLETED|Double Blind Treatment Period||12
298640|NCT01778049|712469|P3|NOT COMPLETED|Double Blind Treatment Period||15
298641|NCT01778049|712470|P2|NOT COMPLETED|Double Blind Treatment Period||0
298642|NCT01778049|712471|P1|NOT COMPLETED|Double Blind Treatment Period||0
298643|NCT01778049|712466|P6|COMPLETED|Double Blind Treatment Period||105
298644|NCT01778049|712467|P5|COMPLETED|Double Blind Treatment Period||102
298645|NCT01778049|712468|P4|COMPLETED|Double Blind Treatment Period||118
298646|NCT01778049|712469|P3|COMPLETED|Double Blind Treatment Period||111
298647|NCT01778049|712470|P2|COMPLETED|Double Blind Treatment Period||0
298648|NCT01778049|712471|P1|COMPLETED|Double Blind Treatment Period||0
298649|NCT01778049|712466|P6|STARTED|Double Blind Treatment Period||112
298650|NCT01778049|712467|P5|STARTED|Double Blind Treatment Period||114
298651|NCT01778049|712468|P4|STARTED|Double Blind Treatment Period||130
298652|NCT01778049|712469|P3|STARTED|Double Blind Treatment Period||126
298653|NCT01778049|712470|P2|STARTED|Double Blind Treatment Period||0
298654|NCT01778049|712471|P1|STARTED|Double Blind Treatment Period||0
298655|NCT01778049|712466|P6|NOT COMPLETED|Open Label Treatment Period||0
298656|NCT01778049|712467|P5|NOT COMPLETED|Open Label Treatment Period||0
298657|NCT01778049|712468|P4|NOT COMPLETED|Open Label Treatment Period||0
298658|NCT01778049|712469|P3|NOT COMPLETED|Open Label Treatment Period||0
298659|NCT01778049|712470|P2|NOT COMPLETED|Open Label Treatment Period||129
298660|NCT01778049|712471|P1|NOT COMPLETED|Open Label Treatment Period||98
298661|NCT01778049|712466|P6|COMPLETED|Open Label Treatment Period||0
298662|NCT01778049|712467|P5|COMPLETED|Open Label Treatment Period||0
298663|NCT01778049|712468|P4|COMPLETED|Open Label Treatment Period||0
298664|NCT01778049|712469|P3|COMPLETED|Open Label Treatment Period||0
298665|NCT01778049|712470|P2|COMPLETED|Open Label Treatment Period||226
298666|NCT01778049|712471|P1|COMPLETED|Open Label Treatment Period||256
298667|NCT01778049|712466|P6|STARTED|Open Label Treatment Period||0
298668|NCT01778049|712467|P5|STARTED|Open Label Treatment Period||0
298669|NCT01778049|712468|P4|STARTED|Open Label Treatment Period||0
298670|NCT01778049|712469|P3|STARTED|Open Label Treatment Period||0
298671|NCT01778049|712470|P2|STARTED|Open Label Treatment Period||355
298672|NCT01778049|712471|P1|STARTED|Open Label Treatment Period||354
298673|NCT01778023|712489|P2|NOT COMPLETED|Overall Study||3
298674|NCT01778023|712490|P1|NOT COMPLETED|Overall Study||0
298675|NCT01778023|712489|P2|COMPLETED|Overall Study||15
298676|NCT01778023|712490|P1|COMPLETED|Overall Study||36
298677|NCT01778023|712489|P2|Exposed|Overall Study||15
298678|NCT01778023|712490|P1|Exposed|Overall Study||36
298679|NCT01778023|712489|P2|STARTED|Overall Study||18
298680|NCT01778023|712490|P1|STARTED|Overall Study||36
298681|NCT01777945|712507|P1|NOT COMPLETED|Overall Study||0
298682|NCT01777945|712507|P1|COMPLETED|Overall Study||46
298683|NCT01777945|712507|P1|Evaluable Participants|Overall Study||45
298684|NCT01777945|712507|P1|STARTED|Overall Study||46
298685|NCT01777932|712517|P1|NOT COMPLETED|Overall Study||205
298686|NCT01777932|712517|P1|COMPLETED|Overall Study||15
298687|NCT01777932|712517|P1|STARTED|Overall Study||220
298688|NCT01777776|712535|P4|NOT COMPLETED|Overall Study||4
298689|NCT01777776|712536|P3|NOT COMPLETED|Overall Study||6
298690|NCT01777776|712537|P2|NOT COMPLETED|Overall Study||12
298691|NCT01777776|712538|P1|NOT COMPLETED|Overall Study||6
298692|NCT01777776|712535|P4|COMPLETED|Overall Study||0
298693|NCT01777776|712536|P3|COMPLETED|Overall Study||0
298694|NCT01777776|712537|P2|COMPLETED|Overall Study||0
298695|NCT01777776|712538|P1|COMPLETED|Overall Study||0
298696|NCT01777776|712535|P4|STARTED|Overall Study||4
298697|NCT01777776|712536|P3|STARTED|Overall Study||6
298698|NCT01777776|712537|P2|STARTED|Overall Study||12
298699|NCT01777776|712538|P1|STARTED|Overall Study||6
298700|NCT01777763|712597|P2|NOT COMPLETED|Overall Study||47
298701|NCT01777763|712598|P1|NOT COMPLETED|Overall Study||4
298702|NCT01777763|712597|P2|COMPLETED|Overall Study||163
298703|NCT01777763|712598|P1|COMPLETED|Overall Study||16
298704|NCT01777763|712597|P2|STARTED|Overall Study||210
298705|NCT01777763|712598|P1|STARTED|Overall Study||20
298706|NCT01777620|712622|P2|NOT COMPLETED|Overall Study||0
298707|NCT01777620|712623|P1|NOT COMPLETED|Overall Study||1
298708|NCT01777620|712622|P2|COMPLETED|Overall Study||62
298709|NCT01777620|712623|P1|COMPLETED|Overall Study||62
298710|NCT01777620|712622|P2|STARTED|Overall Study||62
298711|NCT01777620|712623|P1|STARTED|Overall Study||63
298712|NCT01777581|712649|P2|NOT COMPLETED|Overall Study||2
298713|NCT01777581|712650|P1|NOT COMPLETED|Overall Study||3
298714|NCT01777581|712649|P2|COMPLETED|Overall Study||3
298715|NCT01777581|712650|P1|COMPLETED|Overall Study||5
298716|NCT01777581|712649|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
298717|NCT01777581|712650|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
298718|NCT01777438|712670|P2|NOT COMPLETED|Overall Study||0
298719|NCT01777438|712671|P1|NOT COMPLETED|Overall Study||0
298720|NCT01777438|712670|P2|COMPLETED|Overall Study||82
298721|NCT01777438|712671|P1|COMPLETED|Overall Study||352
298722|NCT01777438|712670|P2|STARTED|Overall Study||82
298723|NCT01777438|712671|P1|STARTED|Overall Study||352
298724|NCT01777425|712683|P1|NOT COMPLETED|Overall Study||0
298725|NCT01777425|712683|P1|COMPLETED|Overall Study||389
298726|NCT01777425|712683|P1|STARTED|Overall Study||389
298727|NCT01777412|712689|P1|NOT COMPLETED|Overall Study||0
298728|NCT01777412|712689|P1|COMPLETED|Overall Study||10
298729|NCT01777412|712689|P1|STARTED|Overall Study||10
298730|NCT01777334|712697|P2|NOT COMPLETED|Overall Study||63
298731|NCT01777334|712698|P1|NOT COMPLETED|Overall Study||53
298732|NCT01777334|712697|P2|COMPLETED|Overall Study||388
298733|NCT01777334|712698|P1|COMPLETED|Overall Study||401
298734|NCT01777334|712697|P2|STARTED|Overall Study||451
298735|NCT01777334|712698|P1|STARTED|Overall Study||454
298736|NCT01777321|712708|P2|NOT COMPLETED|Overall Study||1
298737|NCT01777321|712709|P1|NOT COMPLETED|Overall Study||0
298738|NCT01777321|712708|P2|COMPLETED|Overall Study||29
298739|NCT01777321|712709|P1|COMPLETED|Overall Study||30
298740|NCT01777321|712708|P2|STARTED|Overall Study||30
298741|NCT01777321|712709|P1|STARTED|Overall Study||30
298742|NCT01777282|712750|P5|NOT COMPLETED|Overall Study||7
298743|NCT01777282|712751|P4|NOT COMPLETED|Overall Study||2
298744|NCT01777282|712752|P3|NOT COMPLETED|Overall Study||6
298745|NCT01777282|712753|P2|NOT COMPLETED|Overall Study||4
298746|NCT01777282|712754|P1|NOT COMPLETED|Overall Study||11
298747|NCT01777282|712750|P5|COMPLETED|Overall Study||54
298748|NCT01777282|712751|P4|COMPLETED|Overall Study||59
298749|NCT01777282|712752|P3|COMPLETED|Overall Study||59
298750|NCT01777282|712753|P2|COMPLETED|Overall Study||63
298751|NCT01777282|712754|P1|COMPLETED|Overall Study||109
298752|NCT01777282|712750|P5|Completing Follow-up Period|Overall Study||54
298753|NCT01777282|712751|P4|Completing Follow-up Period|Overall Study||59
298754|NCT01777282|712752|P3|Completing Follow-up Period|Overall Study||59
298755|NCT01777282|712753|P2|Completing Follow-up Period|Overall Study||63
298756|NCT01777282|712754|P1|Completing Follow-up Period|Overall Study||109
298757|NCT01777282|712750|P5|Completing Treatment Period|Overall Study||54
298758|NCT01777282|712751|P4|Completing Treatment Period|Overall Study||59
298759|NCT01777282|712752|P3|Completing Treatment Period|Overall Study||59
298760|NCT01777282|712753|P2|Completing Treatment Period|Overall Study||63
298761|NCT01777282|712754|P1|Completing Treatment Period|Overall Study||109
298762|NCT01777282|712750|P5|STARTED|Overall Study||61
298763|NCT01777282|712751|P4|STARTED|Overall Study||61
298764|NCT01777282|712752|P3|STARTED|Overall Study||65
298765|NCT01777282|712753|P2|STARTED|Overall Study||67
298766|NCT01777282|712754|P1|STARTED|Overall Study||120
298767|NCT01777217|712798|P2|NOT COMPLETED|Overall Study||0
298768|NCT01777217|712799|P1|NOT COMPLETED|Overall Study||0
298769|NCT01777217|712798|P2|COMPLETED|Overall Study||4
298770|NCT01777217|712799|P1|COMPLETED|Overall Study||4
298771|NCT01777217|712798|P2|STARTED|Overall Study||4
298772|NCT01777217|712799|P1|STARTED|Overall Study||4
298773|NCT01777191|712807|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
298774|NCT01777191|712808|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
298775|NCT01777191|712807|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
298776|NCT01777191|712808|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
298777|NCT01777191|712807|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
298778|NCT01777191|712808|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
298779|NCT01777191|712807|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
298780|NCT01777191|712808|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
298781|NCT01777191|712807|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
298782|NCT01777191|712808|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
298783|NCT01777191|712807|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
298784|NCT01777191|712808|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
298785|NCT01777126|712838|P2|NOT COMPLETED|Overall Study||0
298786|NCT01777126|712839|P1|NOT COMPLETED|Overall Study||0
298787|NCT01777126|712838|P2|COMPLETED|Overall Study||46
298788|NCT01777126|712839|P1|COMPLETED|Overall Study||48
298789|NCT01777126|712838|P2|STARTED|Overall Study||46
298790|NCT01777126|712839|P1|STARTED|Overall Study||48
298791|NCT01776645|712862|P2|NOT COMPLETED|Overall Study||14
298792|NCT01776645|712863|P1|NOT COMPLETED|Overall Study||14
298793|NCT01776645|712862|P2|COMPLETED|Overall Study||14
298794|NCT01776645|712863|P1|COMPLETED|Overall Study||14
298795|NCT01776645|712862|P2|STARTED|Overall Study||28
298796|NCT01776645|712863|P1|STARTED|Overall Study||28
298797|NCT01776554|712871|P2|NOT COMPLETED|Overall Study||23
298798|NCT01776554|712872|P1|NOT COMPLETED|Overall Study||17
298799|NCT01776554|712871|P2|COMPLETED|Overall Study||307
298800|NCT01776554|712872|P1|COMPLETED|Overall Study||315
298801|NCT01776554|712871|P2|STARTED|Overall Study||330
298802|NCT01776554|712872|P1|STARTED|Overall Study||332
298803|NCT01776541|712915|P2|NOT COMPLETED|Overall Study||75
298804|NCT01776541|712916|P1|NOT COMPLETED|Overall Study||56
298805|NCT01776541|712915|P2|COMPLETED|Overall Study||416
298806|NCT01776541|712916|P1|COMPLETED|Overall Study||432
298807|NCT01776541|712915|P2|STARTED|Overall Study||491
298808|NCT01776541|712916|P1|STARTED|Overall Study||488
298809|NCT01775995|712937|P2|NOT COMPLETED|Overall Study||1
298810|NCT01775995|712938|P1|NOT COMPLETED|Overall Study||1
298811|NCT01775995|712937|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
298812|NCT01775995|712938|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
298813|NCT01775995|712937|P2|STARTED|Overall Study||14
298814|NCT01775995|712938|P1|STARTED|Overall Study||21
298815|NCT01775852|713000|P2|NOT COMPLETED|Overall Study||1
298816|NCT01775852|713001|P1|NOT COMPLETED|Overall Study||0
298817|NCT01775852|713000|P2|COMPLETED|Overall Study||13
298818|NCT01775852|713001|P1|COMPLETED|Overall Study||31
298819|NCT01775852|713000|P2|STARTED|Overall Study||14
298820|NCT01775852|713001|P1|STARTED|Overall Study||31
298821|NCT01775670|713015|P2|NOT COMPLETED|Overall Study||1
298822|NCT01775670|713016|P1|NOT COMPLETED|Overall Study||1
298823|NCT01775670|713015|P2|COMPLETED|Overall Study||2
298824|NCT01775670|713016|P1|COMPLETED|Overall Study||0
298825|NCT01775670|713015|P2|STARTED|Overall Study||3
298826|NCT01775670|713016|P1|STARTED|Overall Study||1
298827|NCT01775137|713042|P1|NOT COMPLETED|Overall Study||11
298828|NCT01775137|713042|P1|COMPLETED|Overall Study||34
298829|NCT01775137|713042|P1|STARTED|Overall Study||45
298830|NCT01774968|713069|P2|NOT COMPLETED|Overall Study||35
298831|NCT01774968|713070|P1|NOT COMPLETED|Overall Study||30
298832|NCT01774968|713069|P2|COMPLETED|Overall Study||128
298833|NCT01774968|713070|P1|COMPLETED|Overall Study||132
298834|NCT01774968|713069|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
298835|NCT01774968|713070|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
298836|NCT01774968|713069|P2|STARTED|Overall Study||163
298837|NCT01774968|713070|P1|STARTED|Overall Study||162
298838|NCT01774929|713104|P1|NOT COMPLETED|Overall Study||3
298839|NCT01774929|713104|P1|COMPLETED|Overall Study||32
298840|NCT01774929|713104|P1|STARTED|Overall Study||35
298841|NCT01774903|713110|P1|NOT COMPLETED|Overall Study||11
298842|NCT01774903|713110|P1|COMPLETED|Overall Study||34
298843|NCT01774903|713110|P1|STARTED|Overall Study||45
298844|NCT01774604|713119|P2|NOT COMPLETED|Overall Study||0
298845|NCT01774604|713120|P1|NOT COMPLETED|Overall Study||0
298846|NCT01774604|713119|P2|COMPLETED|Overall Study||226
298847|NCT01774604|713120|P1|COMPLETED|Overall Study||223
298848|NCT01774604|713119|P2|STARTED|Overall Study||226
298849|NCT01774604|713120|P1|STARTED|Overall Study||223
298850|NCT01774344|713140|P2|NOT COMPLETED|Overall Study||148
298851|NCT01774344|713141|P1|NOT COMPLETED|Overall Study||32
298852|NCT01774344|713140|P2|COMPLETED|Overall Study||231
298853|NCT01774344|713141|P1|COMPLETED|Overall Study||162
298854|NCT01774344|713140|P2|Treated|Overall Study||374
298855|NCT01774344|713141|P1|Treated|Overall Study||193
298856|NCT01774344|713140|P2|STARTED|Overall Study||379
298857|NCT01774344|713141|P1|STARTED|Overall Study||194
298858|NCT01774305|713157|P2|NOT COMPLETED|Overall Study||0
298859|NCT01774305|713158|P1|NOT COMPLETED|Overall Study||1
298860|NCT01774305|713157|P2|COMPLETED|Overall Study||71
298861|NCT01774305|713158|P1|COMPLETED|Overall Study||70
298862|NCT01774305|713157|P2|STARTED|Overall Study||71
298863|NCT01774305|713158|P1|STARTED|Overall Study||71
298864|NCT01774253|713166|P1|NOT COMPLETED|Overall Study||9
298865|NCT01774253|713166|P1|COMPLETED|Overall Study||0
298866|NCT01774253|713166|P1|STARTED|Overall Study||9
298867|NCT01774149|713176|P2|NOT COMPLETED|Overall Study||3
298868|NCT01774149|713177|P1|NOT COMPLETED|Overall Study||1
298869|NCT01774149|713176|P2|COMPLETED|Overall Study||12
298870|NCT01774149|713177|P1|COMPLETED|Overall Study||14
298871|NCT01774149|713176|P2|STARTED|Overall Study||15
298872|NCT01774149|713177|P1|STARTED|Overall Study||15
298873|NCT01774110|713185|P1|NOT COMPLETED|Overall Study||7
298874|NCT01774110|713185|P1|COMPLETED|Overall Study||5
298875|NCT01774110|713185|P1|STARTED|Overall Study||12
298876|NCT01774097|713193|P2|NOT COMPLETED|Overall Study||2
298877|NCT01774097|713194|P1|NOT COMPLETED|Overall Study||2
298878|NCT01774097|713193|P2|COMPLETED|Overall Study||40
298879|NCT01774097|713194|P1|COMPLETED|Overall Study||38
298880|NCT01774097|713193|P2|STARTED|Overall Study||42
298881|NCT01774097|713194|P1|STARTED|Overall Study||40
298882|NCT01774084|713224|P2|NOT COMPLETED|Overall Study||0
298883|NCT01774084|713225|P1|NOT COMPLETED|Overall Study||1
298884|NCT01774084|713224|P2|COMPLETED|Overall Study||12
298885|NCT01774084|713225|P1|COMPLETED|Overall Study||10
298886|NCT01774084|713224|P2|STARTED|Overall Study||12
298887|NCT01774084|713225|P1|STARTED|Overall Study||11
298888|NCT01774045|713235|P2|NOT COMPLETED|Overall Study||0
298889|NCT01774045|713236|P1|NOT COMPLETED|Overall Study||0
298890|NCT01774045|713235|P2|COMPLETED|Overall Study||7
298891|NCT01774045|713236|P1|COMPLETED|Overall Study||23
298892|NCT01774045|713235|P2|STARTED|Overall Study||7
298893|NCT01774045|713236|P1|STARTED|Overall Study||23
298894|NCT01773122|713254|P4|NOT COMPLETED|Overall Study||1
298895|NCT01773122|713255|P3|NOT COMPLETED|Overall Study||0
298896|NCT01773122|713256|P2|NOT COMPLETED|Overall Study||1
298897|NCT01773122|713257|P1|NOT COMPLETED|Overall Study||3
298898|NCT01773122|713254|P4|COMPLETED|Overall Study||18
298899|NCT01773122|713255|P3|COMPLETED|Overall Study||19
298900|NCT01773122|713256|P2|COMPLETED|Overall Study||18
298901|NCT01773122|713257|P1|COMPLETED|Overall Study||17
298902|NCT01773122|713254|P4|STARTED|Overall Study||19
298903|NCT01773122|713255|P3|STARTED|Overall Study||19
298904|NCT01773122|713256|P2|STARTED|Overall Study||19
298905|NCT01773122|713257|P1|STARTED|Overall Study||20
298906|NCT01773889|713271|P1|NOT COMPLETED|Overall Study||2
298907|NCT01773889|713271|P1|COMPLETED|Overall Study||0
298908|NCT01773889|713271|P1|STARTED|Overall Study||2
298909|NCT01773473|713277|P2|NOT COMPLETED|Overall Study||19
298910|NCT01773473|713278|P1|NOT COMPLETED|Overall Study||16
298911|NCT01773473|713277|P2|COMPLETED|Overall Study||177
298912|NCT01773473|713278|P1|COMPLETED|Overall Study||191
298913|NCT01773473|713277|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
298914|NCT01773473|713278|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
298915|NCT01773473|713277|P2|STARTED|Overall Study||196
298916|NCT01773473|713278|P1|STARTED|Overall Study||207
298917|NCT01773291|713299|P3|NOT COMPLETED|Overall Study||1
298918|NCT01773291|713300|P2|NOT COMPLETED|Overall Study||0
298919|NCT01773291|713301|P1|NOT COMPLETED|Overall Study||1
298920|NCT01773291|713299|P3|COMPLETED|Overall Study||6
298921|NCT01773291|713300|P2|COMPLETED|Overall Study||9
298922|NCT01773291|713301|P1|COMPLETED|Overall Study||7
298923|NCT01773291|713299|P3|STARTED|Overall Study||7
298924|NCT01773291|713300|P2|STARTED|Overall Study||9
298925|NCT01773291|713301|P1|STARTED|Overall Study||8
298926|NCT01773226|713312|P1|NOT COMPLETED|Overall Study||1
298927|NCT01773226|713312|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
298928|NCT01773226|713312|P1|STARTED|Overall Study||11
298929|NCT01773135|713322|P1|NOT COMPLETED|Overall Study||0
298930|NCT01773135|713322|P1|COMPLETED|Overall Study||262
298931|NCT01773135|713322|P1|STARTED|Overall Study||262
298932|NCT01772654|713329|P2|NOT COMPLETED|Overall Study||0
298933|NCT01772654|713330|P1|NOT COMPLETED|Overall Study||0
298934|NCT01772654|713329|P2|COMPLETED|Overall Study||15
298935|NCT01772654|713330|P1|COMPLETED|Overall Study||2
298936|NCT01772654|713329|P2|STARTED|Overall Study||15
298937|NCT01772654|713330|P1|STARTED|Overall Study||2
298938|NCT01772576|713336|P1|NOT COMPLETED|Overall Study||34
298939|NCT01772576|713336|P1|COMPLETED|Overall Study||133
298940|NCT01772576|713336|P1|STARTED|Overall Study||167
298941|NCT01772550|713348|P3|NOT COMPLETED|Overall Study||6
298942|NCT01772550|713349|P2|NOT COMPLETED|Overall Study||1
298943|NCT01772550|713350|P1|NOT COMPLETED|Overall Study||1
298944|NCT01772550|713348|P3|COMPLETED|Overall Study||27
298945|NCT01772550|713349|P2|COMPLETED|Overall Study||102
298946|NCT01772550|713350|P1|COMPLETED|Overall Study||101
298947|NCT01772550|713348|P3|CT Cardiac|Overall Study||1
298948|NCT01772550|713349|P2|CT Cardiac|Overall Study||7
298949|NCT01772550|713350|P1|CT Cardiac|Overall Study||7
298950|NCT01772550|713348|P3|CT Kidney|Overall Study||6
298951|NCT01772550|713349|P2|CT Kidney|Overall Study||19
298952|NCT01772550|713350|P1|CT Kidney|Overall Study||12
298953|NCT01772550|713348|P3|CT Liver|Overall Study||8
298954|NCT01772550|713349|P2|CT Liver|Overall Study||14
298955|NCT01772550|713350|P1|CT Liver|Overall Study||18
298956|NCT01772550|713348|P3|CT Angiogram|Overall Study||4
298957|NCT01772550|713349|P2|CT Angiogram|Overall Study||25
298958|NCT01772550|713350|P1|CT Angiogram|Overall Study||24
298959|NCT01772550|713348|P3|CT Pancreas|Overall Study||8
298960|NCT01772550|713349|P2|CT Pancreas|Overall Study||36
298961|NCT01772550|713350|P1|CT Pancreas|Overall Study||40
298962|NCT01772550|713348|P3|STARTED|Overall Study||33
298963|NCT01772550|713349|P2|STARTED|Overall Study||103
298964|NCT01772550|713350|P1|STARTED|Overall Study||102
298965|NCT01772537|713391|P3|NOT COMPLETED|Overall Study||0
298966|NCT01772537|713392|P2|NOT COMPLETED|Overall Study||0
298967|NCT01772537|713393|P1|NOT COMPLETED|Overall Study||1
298968|NCT01772537|713391|P3|COMPLETED|Overall Study||6
298969|NCT01772537|713392|P2|COMPLETED|Overall Study||3
298970|NCT01772537|713393|P1|COMPLETED|Overall Study||4
298971|NCT01772537|713391|P3|STARTED|Overall Study||6
298972|NCT01772537|713392|P2|STARTED|Overall Study||3
298973|NCT01772537|713393|P1|STARTED|Overall Study||5
298974|NCT01772368|713407|P1|NOT COMPLETED|Overall Study||7
298975|NCT01772368|713407|P1|COMPLETED|Overall Study||65
298976|NCT01772368|713407|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
298977|NCT01772368|713407|P1|Received FS MDPI 100/50 mcg|Overall Study||68
298978|NCT01772368|713407|P1|Received FS MDPI 100/25 mcg|Overall Study||67
298979|NCT01772368|713407|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
298980|NCT01772368|713407|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
298981|NCT01772368|713407|P1|Received Fp MDPI 100 mcg|Overall Study||67
298982|NCT01772368|713407|P1|STARTED|Overall Study||72
298983|NCT01772316|713453|P1|NOT COMPLETED|Overall Study||7
298984|NCT01772316|713453|P1|COMPLETED|Overall Study||40
298985|NCT01772316|713453|P1|STARTED|Overall Study||47
298986|NCT01772147|713474|P3|NOT COMPLETED|Overall Study||18
298987|NCT01772147|713475|P2|NOT COMPLETED|Overall Study||25
298988|NCT01772147|713476|P1|NOT COMPLETED|Overall Study||31
298989|NCT01772147|713474|P3|COMPLETED|Overall Study||184
298990|NCT01772147|713475|P2|COMPLETED|Overall Study||178
298991|NCT01772147|713476|P1|COMPLETED|Overall Study||170
298992|NCT01772147|713474|P3|STARTED|Overall Study||202
298993|NCT01772147|713475|P2|STARTED|Overall Study||203
298994|NCT01772147|713476|P1|STARTED|Overall Study||201
298995|NCT01772134|713496|P3|NOT COMPLETED|Overall Study||22
298996|NCT01772134|713497|P2|NOT COMPLETED|Overall Study||14
298997|NCT01772134|713498|P1|NOT COMPLETED|Overall Study||29
298998|NCT01772134|713496|P3|COMPLETED|Overall Study||184
298999|NCT01772134|713497|P2|COMPLETED|Overall Study||190
299000|NCT01772134|713498|P1|COMPLETED|Overall Study||178
299001|NCT01772134|713496|P3|Received Randomized Study Medication|Overall Study||205
299002|NCT01772134|713497|P2|Received Randomized Study Medication|Overall Study||204
299003|NCT01772134|713498|P1|Received Randomized Study Medication|Overall Study||205
299004|NCT01772134|713496|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
299005|NCT01772134|713497|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
299006|NCT01772134|713498|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
299007|NCT01771991|713517|P2|NOT COMPLETED|Overall Study||6
299008|NCT01771991|713518|P1|NOT COMPLETED|Overall Study||8
299009|NCT01771991|713517|P2|COMPLETED|Overall Study||30
299010|NCT01771991|713518|P1|COMPLETED|Overall Study||30
299011|NCT01771991|713517|P2|Started Treatment|Overall Study||34
299012|NCT01771991|713518|P1|Started Treatment|Overall Study||37
299013|NCT01771991|713517|P2|STARTED|Overall Study||36
299014|NCT01771991|713518|P1|STARTED|Overall Study||38
299015|NCT01771913|713526|P2|NOT COMPLETED|Overall Study||0
299016|NCT01771913|713527|P1|NOT COMPLETED|Overall Study||1
299017|NCT01771913|713526|P2|COMPLETED|Overall Study||11
299018|NCT01771913|713527|P1|COMPLETED|Overall Study||8
299019|NCT01771913|713526|P2|STARTED|Overall Study||11
299020|NCT01771913|713527|P1|STARTED|Overall Study||9
299021|NCT01771172|713537|P1|NOT COMPLETED|Overall Study||2
299022|NCT01771172|713537|P1|COMPLETED|Overall Study||46
299023|NCT01771172|713537|P1|STARTED|Overall Study||48
299024|NCT01770860|713541|P1|NOT COMPLETED|Overall Study||6
299025|NCT01770860|713541|P1|COMPLETED|Overall Study||40
299026|NCT01770860|713541|P1|Randomization|Overall Study|One participant withdrew before randomization|45
299027|NCT01770860|713541|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
299028|NCT01770743|713589|P5|NOT COMPLETED|Overall Study||2
299029|NCT01770743|713590|P4|NOT COMPLETED|Overall Study||2
299030|NCT01770743|713591|P3|NOT COMPLETED|Overall Study||1
299031|NCT01770743|713592|P2|NOT COMPLETED|Overall Study||3
299032|NCT01770743|713593|P1|NOT COMPLETED|Overall Study||2
299033|NCT01770743|713589|P5|COMPLETED|Overall Study||21
299034|NCT01770743|713590|P4|COMPLETED|Overall Study||42
299035|NCT01770743|713591|P3|COMPLETED|Overall Study||22
299036|NCT01770743|713592|P2|COMPLETED|Overall Study||31
299037|NCT01770743|713593|P1|COMPLETED|Overall Study||42
299038|NCT01770743|713589|P5|Treated|Overall Study||23
299039|NCT01770743|713590|P4|Treated|Overall Study||44
299040|NCT01770743|713591|P3|Treated|Overall Study||23
299041|NCT01770743|713592|P2|Treated|Overall Study||34
299042|NCT01770743|713593|P1|Treated|Overall Study||44
299043|NCT01770743|713589|P5|STARTED|Overall Study||23
299044|NCT01770743|713590|P4|STARTED|Overall Study||44
299045|NCT01770743|713591|P3|STARTED|Overall Study||23
299046|NCT01770743|713592|P2|STARTED|Overall Study||34
299047|NCT01770743|713593|P1|STARTED|Overall Study||44
299048|NCT01770691|713645|P1|NOT COMPLETED|Overall Study||0
299049|NCT01770691|713645|P1|COMPLETED|Overall Study||7
299050|NCT01770691|713645|P1|STARTED|Overall Study||7
299051|NCT01770652|713656|P4|NOT COMPLETED|Overall Study||0
299052|NCT01770652|713657|P3|NOT COMPLETED|Overall Study||0
299053|NCT01770652|713658|P2|NOT COMPLETED|Overall Study||0
299054|NCT01770652|713659|P1|NOT COMPLETED|Overall Study||0
299055|NCT01770652|713656|P4|COMPLETED|Overall Study||8
299056|NCT01770652|713657|P3|COMPLETED|Overall Study||8
299057|NCT01770652|713658|P2|COMPLETED|Overall Study||8
299058|NCT01770652|713659|P1|COMPLETED|Overall Study||8
299059|NCT01770652|713656|P4|STARTED|Overall Study||8
299060|NCT01770652|713657|P3|STARTED|Overall Study||8
299061|NCT01770652|713658|P2|STARTED|Overall Study||8
299062|NCT01770652|713659|P1|STARTED|Overall Study||8
299063|NCT01770509|713695|P2|NOT COMPLETED|Overall Study||3
299064|NCT01770509|713696|P1|NOT COMPLETED|Overall Study||1
299065|NCT01770509|713695|P2|COMPLETED|Overall Study||14
299066|NCT01770509|713696|P1|COMPLETED|Overall Study||11
299067|NCT01770509|713695|P2|STARTED|Overall Study||17
299068|NCT01770509|713696|P1|STARTED|Overall Study||12
299069|NCT01770483|713712|P2|NOT COMPLETED|Overall Study||0
299070|NCT01770483|713713|P1|NOT COMPLETED|Overall Study||0
299071|NCT01770483|713712|P2|COMPLETED|Overall Study||33
299072|NCT01770483|713713|P1|COMPLETED|Overall Study||33
299073|NCT01770483|713712|P2|STARTED|Overall Study||33
299074|NCT01770483|713713|P1|STARTED|Overall Study||33
299075|NCT01770392|713721|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
299076|NCT01770392|713721|P1|COMPLETED|Nintedanib+ Rifampicin||25
299077|NCT01770392|713721|P1|STARTED|Nintedanib+ Rifampicin||25
299078|NCT01770392|713721|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
299079|NCT01770392|713721|P1|COMPLETED|Washout Period of at Least 14 Days||25
299080|NCT01770392|713721|P1|STARTED|Washout Period of at Least 14 Days||26
299081|NCT01770392|713721|P1|NOT COMPLETED|Nintedanib||0
299082|NCT01770392|713721|P1|COMPLETED|Nintedanib||26
299083|NCT01770392|713721|P1|STARTED|Nintedanib||26
299084|NCT01770379|713736|P3|NOT COMPLETED|Overall Study||42
299085|NCT01770379|713737|P2|NOT COMPLETED|Overall Study||44
299086|NCT01770379|713738|P1|NOT COMPLETED|Overall Study||39
299087|NCT01770379|713736|P3|COMPLETED|Overall Study||39
299088|NCT01770379|713737|P2|COMPLETED|Overall Study||37
299089|NCT01770379|713738|P1|COMPLETED|Overall Study||41
299090|NCT01770379|713736|P3|STARTED|Overall Study||81
299091|NCT01770379|713737|P2|STARTED|Overall Study||81
299092|NCT01770379|713738|P1|STARTED|Overall Study||80
299093|NCT01770366|713757|P2|NOT COMPLETED|Overall Study||2
299094|NCT01770366|713758|P1|NOT COMPLETED|Overall Study||2
299095|NCT01770366|713757|P2|COMPLETED|Overall Study||4
299096|NCT01770366|713758|P1|COMPLETED|Overall Study||2
299097|NCT01770366|713757|P2|STARTED|Overall Study||6
299098|NCT01770366|713758|P1|STARTED|Overall Study||4
299099|NCT01770314|713766|P2|NOT COMPLETED|Overall Study||0
299100|NCT01770314|713767|P1|NOT COMPLETED|Overall Study||0
299101|NCT01770314|713766|P2|COMPLETED|Overall Study||90
299102|NCT01770314|713767|P1|COMPLETED|Overall Study||86
299103|NCT01770314|713766|P2|Contributed Data to One-month Follow-up|Overall Study||66
299104|NCT01770314|713767|P1|Contributed Data to One-month Follow-up|Overall Study||61
299105|NCT01770314|713766|P2|Contributed Data to Post-test|Overall Study||67
299106|NCT01770314|713767|P1|Contributed Data to Post-test|Overall Study||65
299107|NCT01770314|713766|P2|Contributed Data to Baseline|Overall Study||72
299108|NCT01770314|713767|P1|Contributed Data to Baseline|Overall Study||68
299109|NCT01770314|713766|P2|STARTED|Overall Study||90
299110|NCT01770314|713767|P1|STARTED|Overall Study||86
299111|NCT01770145|713775|P1|NOT COMPLETED|Treatment||4
299112|NCT01770145|713775|P1|COMPLETED|Treatment||97
299113|NCT01770145|713775|P1|STARTED|Treatment||101
299114|NCT01770145|713775|P1|NOT COMPLETED|Baseline||26
299115|NCT01770145|713775|P1|COMPLETED|Baseline||101
299116|NCT01770145|713775|P1|STARTED|Baseline||127
299117|NCT01769586|713782|P2|NOT COMPLETED|Overall Study||0
299118|NCT01769586|713783|P1|NOT COMPLETED|Overall Study||0
299119|NCT01769586|713782|P2|COMPLETED|Overall Study||100
299120|NCT01769586|713783|P1|COMPLETED|Overall Study||100
299121|NCT01769586|713782|P2|STARTED|Overall Study||100
299122|NCT01769586|713783|P1|STARTED|Overall Study||100
299123|NCT01769508|713789|P1|NOT COMPLETED|Overall Study||6
299124|NCT01769508|713789|P1|COMPLETED|Overall Study||6
299125|NCT01769508|713789|P1|STARTED|Overall Study||12
299126|NCT01769443|713800|P2|NOT COMPLETED|Overall Study||0
299127|NCT01769443|713801|P1|NOT COMPLETED|Overall Study||1
299128|NCT01769443|713800|P2|COMPLETED|Overall Study||1
299129|NCT01769443|713801|P1|COMPLETED|Overall Study||0
299130|NCT01769443|713800|P2|STARTED|Overall Study||1
299131|NCT01769443|713801|P1|STARTED|Overall Study||1
299132|NCT01769391|713845|P2|NOT COMPLETED|Overall Study||9
299133|NCT01769391|713846|P1|NOT COMPLETED|Overall Study||20
299134|NCT01769391|713845|P2|COMPLETED|Overall Study||48
299135|NCT01769391|713846|P1|COMPLETED|Overall Study||90
299136|NCT01769391|713845|P2|Received at Least One Dose of Study Drug|Overall Study||55
299137|NCT01769391|713846|P1|Received at Least One Dose of Study Drug|Overall Study||106
299138|NCT01769391|713845|P2|STARTED|Overall Study||57
299139|NCT01769391|713846|P1|STARTED|Overall Study||110
299140|NCT01769378|713865|P2|NOT COMPLETED|Overall Study||4
299141|NCT01769378|713866|P1|NOT COMPLETED|Overall Study||25
299142|NCT01769378|713865|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
299143|NCT01769378|713866|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
299144|NCT01769378|713865|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
299145|NCT01769378|713866|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
299146|NCT01769378|713865|P2|STARTED|Overall Study||60
299147|NCT01769378|713866|P1|STARTED|Overall Study||240
299148|NCT01769365|713904|P3|NOT COMPLETED|Overall Study||2
299149|NCT01769365|713905|P2|NOT COMPLETED|Overall Study||2
299150|NCT01769365|713906|P1|NOT COMPLETED|Overall Study||0
299151|NCT01769365|713904|P3|COMPLETED|Overall Study||101
299152|NCT01769365|713905|P2|COMPLETED|Overall Study||100
299153|NCT01769365|713906|P1|COMPLETED|Overall Study||102
299154|NCT01769365|713904|P3|STARTED|Overall Study||103
299155|NCT01769365|713905|P2|STARTED|Overall Study||102
299156|NCT01769365|713906|P1|STARTED|Overall Study||102
299157|NCT01769339|713914|P1|NOT COMPLETED|Overall Study||43
299158|NCT01769339|713914|P1|COMPLETED|Overall Study||72
299159|NCT01769339|713914|P1|STARTED|Overall Study||115
299160|NCT01769326|713925|P4|NOT COMPLETED|Overall Study||0
299161|NCT01769326|713926|P3|NOT COMPLETED|Overall Study||1
299162|NCT01769326|713927|P2|NOT COMPLETED|Overall Study||4
299163|NCT01769326|713928|P1|NOT COMPLETED|Overall Study||2
299164|NCT01769326|713925|P4|COMPLETED|Overall Study||8
299165|NCT01769326|713926|P3|COMPLETED|Overall Study||8
299166|NCT01769326|713927|P2|COMPLETED|Overall Study||8
299167|NCT01769326|713928|P1|COMPLETED|Overall Study||9
299168|NCT01769326|713925|P4|STARTED|Overall Study||8
299169|NCT01769326|713926|P3|STARTED|Overall Study||9
299170|NCT01769326|713927|P2|STARTED|Overall Study||12
299171|NCT01769326|713928|P1|STARTED|Overall Study||11
299172|NCT01769248|713940|P2|NOT COMPLETED|Overall Study||0
299173|NCT01769248|713941|P1|NOT COMPLETED|Overall Study||0
299174|NCT01769248|713940|P2|COMPLETED|Overall Study||70
299175|NCT01769248|713941|P1|COMPLETED|Overall Study||70
299176|NCT01769248|713940|P2|STARTED|Overall Study||70
299177|NCT01769248|713941|P1|STARTED|Overall Study||70
299178|NCT01769222|713949|P2|NOT COMPLETED|Overall Study||0
299179|NCT01769222|713950|P1|NOT COMPLETED|Overall Study||0
299180|NCT01769222|713949|P2|COMPLETED|Overall Study||0
299181|NCT01769222|713950|P1|COMPLETED|Overall Study||3
299182|NCT01769222|713949|P2|STARTED|Overall Study||0
299183|NCT01769222|713950|P1|STARTED|Overall Study||3
299184|NCT01769196|713966|P2|NOT COMPLETED|Overall Study||272
299185|NCT01769196|713967|P1|NOT COMPLETED|Overall Study||272
299186|NCT01769196|713966|P2|COMPLETED|Overall Study||0
299187|NCT01769196|713967|P1|COMPLETED|Overall Study||0
299188|NCT01769196|713966|P2|STARTED|Overall Study||272
299189|NCT01769196|713967|P1|STARTED|Overall Study||272
299190|NCT01769105|713997|P2|NOT COMPLETED|Cross-over||0
299191|NCT01769105|713998|P1|NOT COMPLETED|Cross-over||5
299192|NCT01769105|713997|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
299193|NCT01769105|713998|P1|COMPLETED|Cross-over||9
299194|NCT01769105|713997|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
299195|NCT01769105|713998|P1|STARTED|Cross-over||14
299196|NCT01769105|713997|P2|NOT COMPLETED|First Intervention||2
299197|NCT01769105|713998|P1|NOT COMPLETED|First Intervention||2
299198|NCT01769105|713997|P2|COMPLETED|First Intervention||17
299199|NCT01769105|713998|P1|COMPLETED|First Intervention||14
299200|NCT01769105|713997|P2|STARTED|First Intervention||19
299201|NCT01769105|713998|P1|STARTED|First Intervention||16
299202|NCT01768676|714019|P2|NOT COMPLETED|Overall Study||31
299203|NCT01768676|714020|P1|NOT COMPLETED|Overall Study||24
299204|NCT01768676|714019|P2|COMPLETED|Overall Study||60
299205|NCT01768676|714020|P1|COMPLETED|Overall Study||66
299206|NCT01768676|714019|P2|STARTED|Overall Study||91
299207|NCT01768676|714020|P1|STARTED|Overall Study||90
299208|NCT01768559|714037|P3|NOT COMPLETED|Overall Study||13
299209|NCT01768559|714038|P2|NOT COMPLETED|Overall Study||17
299210|NCT01768559|714039|P1|NOT COMPLETED|Overall Study||30
299211|NCT01768559|714037|P3|COMPLETED|Overall Study||285
299212|NCT01768559|714038|P2|COMPLETED|Overall Study||281
299213|NCT01768559|714039|P1|COMPLETED|Overall Study||268
299214|NCT01768559|714037|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
299215|NCT01768559|714038|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
299216|NCT01768559|714039|P1|Treated|Overall Study||298
299217|NCT01768559|714037|P3|STARTED|Overall Study||298
299218|NCT01768559|714038|P2|STARTED|Overall Study||298
299219|NCT01768559|714039|P1|STARTED|Overall Study||298
299220|NCT01768325|714089|P2|NOT COMPLETED|Overall Study||0
299221|NCT01768325|714090|P1|NOT COMPLETED|Overall Study||0
299222|NCT01768325|714089|P2|COMPLETED|Overall Study||41
299223|NCT01768325|714090|P1|COMPLETED|Overall Study||37
299224|NCT01768325|714089|P2|STARTED|Overall Study||41
299225|NCT01768325|714090|P1|STARTED|Overall Study||37
299226|NCT01768286|714104|P4|NOT COMPLETED|Overall Study||1
299227|NCT01768286|714105|P3|NOT COMPLETED|Overall Study||2
299228|NCT01768286|714106|P2|NOT COMPLETED|Overall Study||4
299229|NCT01768286|714107|P1|NOT COMPLETED|Overall Study||7
299230|NCT01768286|714104|P4|COMPLETED|Overall Study||110
299231|NCT01768286|714105|P3|COMPLETED|Overall Study||108
299232|NCT01768286|714106|P2|COMPLETED|Overall Study||107
299233|NCT01768286|714107|P1|COMPLETED|Overall Study||102
299234|NCT01768286|714104|P4|STARTED|Overall Study||111
299235|NCT01768286|714105|P3|STARTED|Overall Study||110
299236|NCT01768286|714106|P2|STARTED|Overall Study||111
299237|NCT01768286|714107|P1|STARTED|Overall Study||109
299238|NCT01768117|714169|P1|NOT COMPLETED|Overall Study||6
299239|NCT01768117|714169|P1|COMPLETED|Overall Study||7
299240|NCT01768117|714169|P1|STARTED|Overall Study||13
299241|NCT01768013|714177|P1|NOT COMPLETED|Overall Study||0
299242|NCT01768013|714177|P1|COMPLETED|Overall Study||13
299243|NCT01768013|714177|P1|STARTED|Overall Study||13
299244|NCT01768000|714210|P4|NOT COMPLETED|Overall Study||2
299245|NCT01768000|714211|P3|NOT COMPLETED|Overall Study||1
299246|NCT01768000|714212|P2|NOT COMPLETED|Overall Study||2
299247|NCT01768000|714213|P1|NOT COMPLETED|Overall Study||1
299248|NCT01768000|714210|P4|COMPLETED|Overall Study||8
299249|NCT01768000|714211|P3|COMPLETED|Overall Study||9
299250|NCT01768000|714212|P2|COMPLETED|Overall Study||8
299251|NCT01768000|714213|P1|COMPLETED|Overall Study||9
299252|NCT01768000|714210|P4|STARTED|Overall Study||10
299253|NCT01768000|714211|P3|STARTED|Overall Study||10
299254|NCT01768000|714212|P2|STARTED|Overall Study||10
299255|NCT01768000|714213|P1|STARTED|Overall Study||10
299256|NCT01767987|714233|P2|NOT COMPLETED|Overall Study||1
299257|NCT01767987|714234|P1|NOT COMPLETED|Overall Study||4
299258|NCT01767987|714233|P2|COMPLETED|Overall Study||1
299259|NCT01767987|714234|P1|COMPLETED|Overall Study||0
299260|NCT01767987|714233|P2|STARTED|Overall Study||2
299261|NCT01767987|714234|P1|STARTED|Overall Study||4
299262|NCT01767701|714256|P1|NOT COMPLETED|Overall Study||0
299263|NCT01767701|714256|P1|COMPLETED|Overall Study||20
299264|NCT01767701|714256|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
299265|NCT01767688|714269|P2|NOT COMPLETED|Overall Study||0
299266|NCT01767688|714270|P1|NOT COMPLETED|Overall Study||0
299267|NCT01767688|714269|P2|COMPLETED|Overall Study||8
299268|NCT01767688|714270|P1|COMPLETED|Overall Study||8
299269|NCT01767688|714269|P2|STARTED|Overall Study||8
299270|NCT01767688|714270|P1|STARTED|Overall Study||8
299271|NCT01767597|714292|P2|NOT COMPLETED|Overall Study||1
299272|NCT01767597|714293|P1|NOT COMPLETED|Overall Study||4
299273|NCT01767597|714292|P2|COMPLETED|Overall Study||499
299274|NCT01767597|714293|P1|COMPLETED|Overall Study||496
299275|NCT01767597|714292|P2|STARTED|Overall Study||500
299276|NCT01767597|714293|P1|STARTED|Overall Study||500
299277|NCT01767519|714302|P3|NOT COMPLETED|Overall Study||5
299278|NCT01767519|714303|P2|NOT COMPLETED|Overall Study||13
299279|NCT01767519|714304|P1|NOT COMPLETED|Overall Study||14
299280|NCT01767519|714302|P3|COMPLETED|Overall Study||55
299281|NCT01767519|714303|P2|COMPLETED|Overall Study||138
299282|NCT01767519|714304|P1|COMPLETED|Overall Study||131
299283|NCT01767519|714302|P3|STARTED|Overall Study||60
299284|NCT01767519|714303|P2|STARTED|Overall Study||151
299285|NCT01767519|714304|P1|STARTED|Overall Study||145
299286|NCT01767467|714332|P2|NOT COMPLETED|Overall Study||20
299287|NCT01767467|714333|P1|NOT COMPLETED|Overall Study||17
299288|NCT01767467|714332|P2|COMPLETED|Overall Study||259
299289|NCT01767467|714333|P1|COMPLETED|Overall Study||266
299290|NCT01767467|714332|P2|STARTED|Overall Study||279
299291|NCT01767467|714333|P1|STARTED|Overall Study||283
299292|NCT01767285|714363|P2|NOT COMPLETED|Overall Study||6
299293|NCT01767285|714364|P1|NOT COMPLETED|Overall Study||7
299294|NCT01767285|714363|P2|COMPLETED|Overall Study||24
299295|NCT01767285|714364|P1|COMPLETED|Overall Study||22
299296|NCT01767285|714363|P2|STARTED|Overall Study||30
299297|NCT01767285|714364|P1|STARTED|Overall Study||29
299298|NCT01767116|714382|P2|NOT COMPLETED|Overall Study||2
299299|NCT01767116|714383|P1|NOT COMPLETED|Overall Study||2
299300|NCT01767116|714382|P2|COMPLETED|Overall Study||207
299301|NCT01767116|714383|P1|COMPLETED|Overall Study||208
299302|NCT01767116|714382|P2|STARTED|Overall Study||209
299303|NCT01767116|714383|P1|STARTED|Overall Study||210
299304|NCT01767103|714402|P3|NOT COMPLETED|Overall Study||0
299305|NCT01767103|714403|P2|NOT COMPLETED|Overall Study||0
299306|NCT01767103|714404|P1|NOT COMPLETED|Overall Study||0
299307|NCT01767103|714402|P3|COMPLETED|Overall Study||7
299308|NCT01767103|714403|P2|COMPLETED|Overall Study||7
299309|NCT01767103|714404|P1|COMPLETED|Overall Study||7
299310|NCT01767103|714402|P3|STARTED|Overall Study||7
299311|NCT01767103|714403|P2|STARTED|Overall Study||7
299312|NCT01767103|714404|P1|STARTED|Overall Study||7
299313|NCT01766921|714432|P2|NOT COMPLETED|Overall Study||17
299314|NCT01766921|714433|P1|NOT COMPLETED|Overall Study||24
299315|NCT01766921|714432|P2|COMPLETED|Overall Study||676
299316|NCT01766921|714433|P1|COMPLETED|Overall Study||676
299317|NCT01766921|714432|P2|STARTED|Overall Study||693
299318|NCT01766921|714433|P1|STARTED|Overall Study||700
299319|NCT01766778|714454|P2|NOT COMPLETED|Overall Study||4
299320|NCT01766778|714455|P1|NOT COMPLETED|Overall Study||5
299321|NCT01766778|714454|P2|COMPLETED|Overall Study||57
299322|NCT01766778|714455|P1|COMPLETED|Overall Study||51
299323|NCT01766778|714454|P2|STARTED|Overall Study||61
299324|NCT01766778|714455|P1|STARTED|Overall Study|Intent to treat population|56
299325|NCT01766713|714473|P2|NOT COMPLETED|Overall Study||2
299326|NCT01766713|714474|P1|NOT COMPLETED|Overall Study||2
299327|NCT01766713|714473|P2|COMPLETED|Overall Study||23
299328|NCT01766713|714474|P1|COMPLETED|Overall Study||23
299329|NCT01766713|714473|P2|STARTED|Overall Study||25
299330|NCT01766713|714474|P1|STARTED|Overall Study||25
299331|NCT01766466|714482|P4|NOT COMPLETED|Day 5||0
299332|NCT01766466|714483|P3|NOT COMPLETED|Day 5||0
299333|NCT01766466|714484|P2|NOT COMPLETED|Day 5||0
299334|NCT01766466|714485|P1|NOT COMPLETED|Day 5||0
299335|NCT01766466|714482|P4|COMPLETED|Day 5||6
299336|NCT01766466|714483|P3|COMPLETED|Day 5||0
299337|NCT01766466|714484|P2|COMPLETED|Day 5||6
299338|NCT01766466|714485|P1|COMPLETED|Day 5||0
299339|NCT01766466|714482|P4|STARTED|Day 5||6
299340|NCT01766466|714483|P3|STARTED|Day 5||0
299341|NCT01766466|714484|P2|STARTED|Day 5||6
299342|NCT01766466|714485|P1|STARTED|Day 5||0
299343|NCT01766466|714482|P4|NOT COMPLETED|Day 1||0
299344|NCT01766466|714483|P3|NOT COMPLETED|Day 1||0
299345|NCT01766466|714484|P2|NOT COMPLETED|Day 1||0
299346|NCT01766466|714485|P1|NOT COMPLETED|Day 1||0
299347|NCT01766466|714482|P4|COMPLETED|Day 1||0
299348|NCT01766466|714483|P3|COMPLETED|Day 1||6
299349|NCT01766466|714484|P2|COMPLETED|Day 1||0
299350|NCT01766466|714485|P1|COMPLETED|Day 1||6
299351|NCT01766466|714482|P4|STARTED|Day 1||0
299352|NCT01766466|714483|P3|STARTED|Day 1||6
299353|NCT01766466|714484|P2|STARTED|Day 1||0
299354|NCT01766466|714485|P1|STARTED|Day 1||6
299355|NCT01766440|714498|P1|NOT COMPLETED|Overall Study||1
299356|NCT01766440|714498|P1|COMPLETED|Overall Study||17
299357|NCT01766440|714498|P1|STARTED|Overall Study||18
299358|NCT01766336|714509|P2|NOT COMPLETED|Overall Study||75
299359|NCT01766336|714510|P1|NOT COMPLETED|Overall Study||90
299360|NCT01766336|714509|P2|COMPLETED|Overall Study||71
299361|NCT01766336|714510|P1|COMPLETED|Overall Study||60
299362|NCT01766336|714509|P2|STARTED|Overall Study||146
299363|NCT01766336|714510|P1|STARTED|Overall Study||150
299364|NCT01766310|714518|P2|NOT COMPLETED|Overall Study||3
299365|NCT01766310|714519|P1|NOT COMPLETED|Overall Study||1
299366|NCT01766310|714518|P2|COMPLETED|Overall Study||23
299367|NCT01766310|714519|P1|COMPLETED|Overall Study||23
299368|NCT01766310|714518|P2|STARTED|Overall Study||26
299369|NCT01766310|714519|P1|STARTED|Overall Study||24
299370|NCT01766076|714529|P2|NOT COMPLETED|Overall Study||0
299371|NCT01766076|714530|P1|NOT COMPLETED|Overall Study||0
299372|NCT01766076|714529|P2|COMPLETED|Overall Study||15
299373|NCT01766076|714530|P1|COMPLETED|Overall Study||15
299374|NCT01766076|714529|P2|STARTED|Overall Study||15
299375|NCT01766076|714530|P1|STARTED|Overall Study||15
299376|NCT01766050|714536|P1|NOT COMPLETED|Overall Study||4
299377|NCT01766050|714536|P1|COMPLETED|Overall Study||18
299378|NCT01766050|714536|P1|STARTED|Overall Study||22
299379|NCT01766037|714671|P2|NOT COMPLETED|Overall Study||29
299380|NCT01766037|714672|P1|NOT COMPLETED|Overall Study||29
299381|NCT01766037|714671|P2|COMPLETED|Overall Study||31
299382|NCT01766037|714672|P1|COMPLETED|Overall Study||82
299383|NCT01766037|714671|P2|STARTED|Overall Study||60
299384|NCT01766037|714672|P1|STARTED|Overall Study||111
299385|NCT01766024|714709|P2|NOT COMPLETED|Overall Study||0
299386|NCT01766024|714710|P1|NOT COMPLETED|Overall Study||0
299387|NCT01766024|714709|P2|COMPLETED|Overall Study||16
299388|NCT01766024|714710|P1|COMPLETED|Overall Study||16
299389|NCT01766024|714709|P2|STARTED|Overall Study||16
299390|NCT01766024|714710|P1|STARTED|Overall Study||16
299391|NCT01765972|714720|P4|NOT COMPLETED|Overall Study||0
299392|NCT01765972|714721|P3|NOT COMPLETED|Overall Study||0
299393|NCT01765972|714722|P2|NOT COMPLETED|Overall Study||0
299394|NCT01765972|714723|P1|NOT COMPLETED|Overall Study||0
299395|NCT01765972|714720|P4|COMPLETED|Overall Study||6
299396|NCT01765972|714721|P3|COMPLETED|Overall Study||6
299397|NCT01765972|714722|P2|COMPLETED|Overall Study||6
299398|NCT01765972|714723|P1|COMPLETED|Overall Study||6
299399|NCT01765972|714720|P4|STARTED|Overall Study||6
299400|NCT01765972|714721|P3|STARTED|Overall Study||6
299401|NCT01765972|714722|P2|STARTED|Overall Study||6
299402|NCT01765972|714723|P1|STARTED|Overall Study||6
299403|NCT01765803|714733|P1|NOT COMPLETED|Overall Study||0
299404|NCT01765803|714733|P1|COMPLETED|Overall Study||6
299405|NCT01765803|714733|P1|STARTED|Overall Study||6
299406|NCT01765764|714741|P3|NOT COMPLETED|Post-treatment Period||0
299407|NCT01765764|714742|P2|NOT COMPLETED|Post-treatment Period||0
299408|NCT01765764|714743|P1|NOT COMPLETED|Post-treatment Period||0
299409|NCT01765764|714741|P3|COMPLETED|Post-treatment Period||112
299410|NCT01765764|714742|P2|COMPLETED|Post-treatment Period||107
299411|NCT01765764|714743|P1|COMPLETED|Post-treatment Period||114
299412|NCT01765764|714741|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
299413|NCT01765764|714742|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
299414|NCT01765764|714743|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
299415|NCT01765764|714741|P3|NOT COMPLETED|Treatment Period||6
299416|NCT01765764|714742|P2|NOT COMPLETED|Treatment Period||9
299417|NCT01765764|714743|P1|NOT COMPLETED|Treatment Period||3
299418|NCT01765764|714741|P3|COMPLETED|Treatment Period||115
299419|NCT01765764|714742|P2|COMPLETED|Treatment Period||109
299420|NCT01765764|714743|P1|COMPLETED|Treatment Period||115
299421|NCT01765764|714741|P3|STARTED|Treatment Period||121
299422|NCT01765764|714742|P2|STARTED|Treatment Period||118
299423|NCT01765764|714743|P1|STARTED|Treatment Period||118
299424|NCT01765569|714760|P1|NOT COMPLETED|Period C||1
299425|NCT01765569|714760|P1|COMPLETED|Period C||27
299426|NCT01765569|714760|P1|STARTED|Period C||28
299427|NCT01765569|714760|P1|NOT COMPLETED|Period B||1
299428|NCT01765569|714760|P1|COMPLETED|Period B||28
299429|NCT01765569|714760|P1|STARTED|Period B||29
299430|NCT01765569|714760|P1|NOT COMPLETED|Period A||0
299431|NCT01765569|714760|P1|COMPLETED|Period A||29
299432|NCT01765569|714760|P1|STARTED|Period A||29
299433|NCT01765543|714781|P1|NOT COMPLETED|Overall Study||3
299434|NCT01765543|714781|P1|COMPLETED|Overall Study||24
299435|NCT01765543|714781|P1|STARTED|Overall Study||27
299436|NCT01765530|714805|P2|NOT COMPLETED|Overall Study||1
299437|NCT01765530|714806|P1|NOT COMPLETED|Overall Study||1
299438|NCT01765530|714805|P2|COMPLETED|Overall Study||36
299439|NCT01765530|714806|P1|COMPLETED|Overall Study||36
299440|NCT01765530|714805|P2|STARTED|Overall Study||37
299441|NCT01765530|714806|P1|STARTED|Overall Study||37
299442|NCT01765465|714816|P2|NOT COMPLETED|Overall Study||4
299443|NCT01765465|714817|P1|NOT COMPLETED|Overall Study||7
299444|NCT01765465|714816|P2|COMPLETED|Overall Study||63
299445|NCT01765465|714817|P1|COMPLETED|Overall Study||64
299446|NCT01765465|714816|P2|STARTED|Overall Study||67
299447|NCT01765465|714817|P1|STARTED|Overall Study||71
299448|NCT01765426|714833|P4|NOT COMPLETED|Overall Study||0
299449|NCT01765426|714834|P3|NOT COMPLETED|Overall Study||0
299450|NCT01765426|714835|P2|NOT COMPLETED|Overall Study||1
299451|NCT01765426|714836|P1|NOT COMPLETED|Overall Study||0
299452|NCT01765426|714833|P4|COMPLETED|Overall Study||15
299453|NCT01765426|714834|P3|COMPLETED|Overall Study||17
299454|NCT01765426|714835|P2|COMPLETED|Overall Study||16
299455|NCT01765426|714836|P1|COMPLETED|Overall Study||18
299456|NCT01765426|714833|P4|Completed All Vaccinations|Overall Study||15
299457|NCT01765426|714834|P3|Completed All Vaccinations|Overall Study||17
299458|NCT01765426|714835|P2|Completed All Vaccinations|Overall Study||16
299459|NCT01765426|714836|P1|Completed All Vaccinations|Overall Study||17
299460|NCT01765426|714833|P4|STARTED|Overall Study||15
299461|NCT01765426|714834|P3|STARTED|Overall Study||17
299462|NCT01765426|714835|P2|STARTED|Overall Study||17
299463|NCT01765426|714836|P1|STARTED|Overall Study||18
299464|NCT01765270|714892|P2|NOT COMPLETED|Overall Study||1
299465|NCT01765270|714893|P1|NOT COMPLETED|Overall Study||1
299466|NCT01765270|714892|P2|COMPLETED|Overall Study||6
299467|NCT01765270|714893|P1|COMPLETED|Overall Study||4
299468|NCT01765270|714892|P2|STARTED|Overall Study||7
299469|NCT01765270|714893|P1|STARTED|Overall Study||5
299470|NCT01765192|714915|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
299471|NCT01765192|714916|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
299472|NCT01765192|714915|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
299473|NCT01765192|714916|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
299474|NCT01765192|714915|P2|STARTED|End of Treatment Period 2 to Final Visit||28
299475|NCT01765192|714916|P1|STARTED|End of Treatment Period 2 to Final Visit||30
299476|NCT01765192|714915|P2|NOT COMPLETED|Treatment Period 2||2
299477|NCT01765192|714916|P1|NOT COMPLETED|Treatment Period 2||0
299478|NCT01765192|714915|P2|COMPLETED|Treatment Period 2||28
299479|NCT01765192|714916|P1|COMPLETED|Treatment Period 2||30
299480|NCT01765192|714915|P2|STARTED|Treatment Period 2||30
299481|NCT01765192|714916|P1|STARTED|Treatment Period 2||30
299482|NCT01765192|714915|P2|NOT COMPLETED|Washout Period||1
299483|NCT01765192|714916|P1|NOT COMPLETED|Washout Period||2
299484|NCT01765192|714915|P2|COMPLETED|Washout Period||30
299485|NCT01765192|714916|P1|COMPLETED|Washout Period||30
299486|NCT01765192|714915|P2|STARTED|Washout Period||31
299487|NCT01765192|714916|P1|STARTED|Washout Period||32
299488|NCT01765192|714915|P2|NOT COMPLETED|Treatment Period 1||1
299489|NCT01765192|714916|P1|NOT COMPLETED|Treatment Period 1||0
299490|NCT01765192|714915|P2|COMPLETED|Treatment Period 1||31
299491|NCT01765192|714916|P1|COMPLETED|Treatment Period 1||32
299492|NCT01765192|714915|P2|STARTED|Treatment Period 1||32
299493|NCT01765192|714916|P1|STARTED|Treatment Period 1||32
299494|NCT01765153|714936|P2|NOT COMPLETED|Rest Phase 2||1
299495|NCT01765153|714937|P1|NOT COMPLETED|Rest Phase 2||2
299496|NCT01765153|714936|P2|COMPLETED|Rest Phase 2||7
299497|NCT01765153|714937|P1|COMPLETED|Rest Phase 2||8
299498|NCT01765153|714936|P2|STARTED|Rest Phase 2||8
299499|NCT01765153|714937|P1|STARTED|Rest Phase 2||10
299500|NCT01765153|714936|P2|NOT COMPLETED|Training Phase 2||1
299501|NCT01765153|714937|P1|NOT COMPLETED|Training Phase 2||0
299502|NCT01765153|714936|P2|COMPLETED|Training Phase 2||8
299503|NCT01765153|714937|P1|COMPLETED|Training Phase 2||10
299504|NCT01765153|714936|P2|STARTED|Training Phase 2||9
299505|NCT01765153|714937|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
299506|NCT01765153|714936|P2|NOT COMPLETED|Rest Phase 1||1
299507|NCT01765153|714937|P1|NOT COMPLETED|Rest Phase 1||0
299508|NCT01765153|714936|P2|COMPLETED|Rest Phase 1||9
299509|NCT01765153|714937|P1|COMPLETED|Rest Phase 1||9
299510|NCT01765153|714936|P2|STARTED|Rest Phase 1||10
299511|NCT01765153|714937|P1|STARTED|Rest Phase 1||9
299512|NCT01765153|714936|P2|NOT COMPLETED|Training Phase 1||1
299513|NCT01765153|714937|P1|NOT COMPLETED|Training Phase 1||1
299514|NCT01765153|714936|P2|COMPLETED|Training Phase 1||10
299515|NCT01765153|714937|P1|COMPLETED|Training Phase 1||9
299516|NCT01765153|714936|P2|STARTED|Training Phase 1||11
299517|NCT01765153|714937|P1|STARTED|Training Phase 1||10
299518|NCT01764945|715047|P8|NOT COMPLETED|Overall Study||0
299519|NCT01764945|715048|P7|NOT COMPLETED|Overall Study||1
299520|NCT01764945|715049|P6|NOT COMPLETED|Overall Study||0
299521|NCT01764945|715050|P5|NOT COMPLETED|Overall Study||0
299522|NCT01764945|715051|P4|NOT COMPLETED|Overall Study||0
299523|NCT01764945|715052|P3|NOT COMPLETED|Overall Study||0
299524|NCT01764945|715053|P2|NOT COMPLETED|Overall Study||1
299525|NCT01764945|715054|P1|NOT COMPLETED|Overall Study||0
299526|NCT01764945|715047|P8|COMPLETED|Overall Study||9
299527|NCT01764945|715048|P7|COMPLETED|Overall Study||8
299528|NCT01764945|715049|P6|COMPLETED|Overall Study||8
299529|NCT01764945|715050|P5|COMPLETED|Overall Study||10
299530|NCT01764945|715051|P4|COMPLETED|Overall Study||5
299531|NCT01764945|715052|P3|COMPLETED|Overall Study||5
299532|NCT01764945|715053|P2|COMPLETED|Overall Study||4
299533|NCT01764945|715054|P1|COMPLETED|Overall Study||5
299534|NCT01764945|715047|P8|STARTED|Overall Study||9
299535|NCT01764945|715048|P7|STARTED|Overall Study||9
299536|NCT01764945|715049|P6|STARTED|Overall Study||8
299537|NCT01764945|715050|P5|STARTED|Overall Study||10
299538|NCT01764945|715051|P4|STARTED|Overall Study||5
299539|NCT01764945|715052|P3|STARTED|Overall Study||5
299540|NCT01764945|715053|P2|STARTED|Overall Study||5
299541|NCT01764945|715054|P1|STARTED|Overall Study||5
299542|NCT01764919|715088|P1|NOT COMPLETED|Overall Study||0
299543|NCT01764919|715088|P1|COMPLETED|Overall Study||4
299544|NCT01764919|715088|P1|STARTED|Overall Study||4
299545|NCT01764841|715100|P4|NOT COMPLETED|Overall Study||19
299546|NCT01764841|715101|P3|NOT COMPLETED|Overall Study||14
299547|NCT01764841|715102|P2|NOT COMPLETED|Overall Study||26
299548|NCT01764841|715103|P1|NOT COMPLETED|Overall Study||23
299549|NCT01764841|715100|P4|COMPLETED|Overall Study||49
299550|NCT01764841|715101|P3|COMPLETED|Overall Study||56
299551|NCT01764841|715102|P2|COMPLETED|Overall Study||111
299552|NCT01764841|715103|P1|COMPLETED|Overall Study||118
299553|NCT01764841|715100|P4|Participants Received Treatment|Overall Study|safety population|68
299554|NCT01764841|715101|P3|Participants Received Treatment|Overall Study|safety population|69
299555|NCT01764841|715102|P2|Participants Received Treatment|Overall Study|safety population|136
299556|NCT01764841|715103|P1|Participants Received Treatment|Overall Study|safety population|141
299557|NCT01764841|715100|P4|STARTED|Overall Study||68
299558|NCT01764841|715101|P3|STARTED|Overall Study||70
299559|NCT01764841|715102|P2|STARTED|Overall Study||137
299560|NCT01764841|715103|P1|STARTED|Overall Study||141
299561|NCT01764685|715137|P2|NOT COMPLETED|Overall Study||1
299562|NCT01764685|715138|P1|NOT COMPLETED|Overall Study||0
299563|NCT01764685|715137|P2|COMPLETED|Overall Study||3
299564|NCT01764685|715138|P1|COMPLETED|Overall Study||0
299565|NCT01764685|715137|P2|STARTED|Overall Study||4
299566|NCT01764685|715138|P1|STARTED|Overall Study||0
299567|NCT01764607|715144|P1|NOT COMPLETED|Overall Study||0
299568|NCT01764607|715144|P1|COMPLETED|Overall Study||1
299569|NCT01764607|715144|P1|STARTED|Overall Study||1
299570|NCT01764386|715151|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
299571|NCT01764386|715152|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
299572|NCT01764386|715151|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
299573|NCT01764386|715152|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
299574|NCT01764386|715151|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
299575|NCT01764386|715152|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
299576|NCT01764386|715151|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
299577|NCT01764386|715152|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
299578|NCT01764386|715151|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
299579|NCT01764386|715152|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
299580|NCT01764386|715151|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
299581|NCT01764386|715152|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
299582|NCT01764386|715151|P2|STARTED|Controlled Treatment Period (CTP)||89
299583|NCT01764386|715152|P1|STARTED|Controlled Treatment Period (CTP)||153
299584|NCT01764022|715195|P2|NOT COMPLETED|Overall Study||12
299585|NCT01764022|715196|P1|NOT COMPLETED|Overall Study||21
299586|NCT01764022|715195|P2|COMPLETED|Overall Study||49
299587|NCT01764022|715196|P1|COMPLETED|Overall Study||44
299588|NCT01764022|715195|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
299589|NCT01764022|715196|P1|Received at Least 1 Dose of Study Drug|Overall Study||63
299590|NCT01764022|715195|P2|STARTED|Overall Study||61
299591|NCT01764022|715196|P1|STARTED|Overall Study||65
299592|NCT01763996|715224|P2|NOT COMPLETED|Treatment Period 2||1
299593|NCT01763996|715225|P1|NOT COMPLETED|Treatment Period 2||0
299594|NCT01763996|715224|P2|COMPLETED|Treatment Period 2||14
299595|NCT01763996|715225|P1|COMPLETED|Treatment Period 2||15
299596|NCT01763996|715224|P2|STARTED|Treatment Period 2||15
299597|NCT01763996|715225|P1|STARTED|Treatment Period 2||15
299598|NCT01763996|715224|P2|NOT COMPLETED|Treatment Period 1||0
299599|NCT01763996|715225|P1|NOT COMPLETED|Treatment Period 1||0
299600|NCT01763996|715224|P2|COMPLETED|Treatment Period 1||15
299601|NCT01763996|715225|P1|COMPLETED|Treatment Period 1||15
299602|NCT01763996|715224|P2|STARTED|Treatment Period 1||15
299603|NCT01763996|715225|P1|STARTED|Treatment Period 1||15
299604|NCT01763918|715255|P4|NOT COMPLETED|Overall Study||2
299605|NCT01763918|715256|P3|NOT COMPLETED|Overall Study||10
299606|NCT01763918|715257|P2|NOT COMPLETED|Overall Study||1
299607|NCT01763918|715258|P1|NOT COMPLETED|Overall Study||6
299608|NCT01763918|715255|P4|COMPLETED|Overall Study||108
299609|NCT01763918|715256|P3|COMPLETED|Overall Study||101
299610|NCT01763918|715257|P2|COMPLETED|Overall Study||54
299611|NCT01763918|715258|P1|COMPLETED|Overall Study||49
299612|NCT01763918|715255|P4|Received Treatment|Overall Study||110
299613|NCT01763918|715256|P3|Received Treatment|Overall Study||110
299614|NCT01763918|715257|P2|Received Treatment|Overall Study||55
299615|NCT01763918|715258|P1|Received Treatment|Overall Study||54
299616|NCT01763918|715255|P4|STARTED|Overall Study||110
299617|NCT01763918|715256|P3|STARTED|Overall Study||111
299618|NCT01763918|715257|P2|STARTED|Overall Study||55
299619|NCT01763918|715258|P1|STARTED|Overall Study||55
299620|NCT01763905|715356|P4|NOT COMPLETED|Overall Study||1
299621|NCT01763905|715357|P3|NOT COMPLETED|Overall Study||9
299622|NCT01763905|715358|P2|NOT COMPLETED|Overall Study||1
299623|NCT01763905|715359|P1|NOT COMPLETED|Overall Study||6
299624|NCT01763905|715356|P4|COMPLETED|Overall Study||101
299625|NCT01763905|715357|P3|COMPLETED|Overall Study||94
299626|NCT01763905|715358|P2|COMPLETED|Overall Study||50
299627|NCT01763905|715359|P1|COMPLETED|Overall Study||45
299628|NCT01763905|715356|P4|STARTED|Overall Study||102
299629|NCT01763905|715357|P3|STARTED|Overall Study||103
299630|NCT01763905|715358|P2|STARTED|Overall Study||51
299631|NCT01763905|715359|P1|STARTED|Overall Study||51
299632|NCT01763866|715477|P24|NOT COMPLETED|Overall Study||2
299633|NCT01763866|715478|P23|NOT COMPLETED|Overall Study||3
299634|NCT01763866|715479|P22|NOT COMPLETED|Overall Study||1
299635|NCT01763866|715480|P21|NOT COMPLETED|Overall Study||4
299636|NCT01763866|715481|P20|NOT COMPLETED|Overall Study||2
299637|NCT01763866|715482|P19|NOT COMPLETED|Overall Study||6
299638|NCT01763866|715483|P18|NOT COMPLETED|Overall Study||1
299639|NCT01763866|715484|P17|NOT COMPLETED|Overall Study||1
299640|NCT01763866|715485|P16|NOT COMPLETED|Overall Study||3
299641|NCT01763866|715486|P15|NOT COMPLETED|Overall Study||12
299642|NCT01763866|715487|P14|NOT COMPLETED|Overall Study||0
299643|NCT01763866|715488|P13|NOT COMPLETED|Overall Study||4
299644|NCT01763866|715489|P12|NOT COMPLETED|Overall Study||2
299645|NCT01763866|715490|P11|NOT COMPLETED|Overall Study||8
299646|NCT01763866|715491|P10|NOT COMPLETED|Overall Study||1
299647|NCT01763866|715492|P9|NOT COMPLETED|Overall Study||3
299648|NCT01763866|715493|P8|NOT COMPLETED|Overall Study||0
299649|NCT01763866|715494|P7|NOT COMPLETED|Overall Study||7
299650|NCT01763866|715495|P6|NOT COMPLETED|Overall Study||3
299651|NCT01763866|715496|P5|NOT COMPLETED|Overall Study||2
299652|NCT01763866|715497|P4|NOT COMPLETED|Overall Study||0
299653|NCT01763866|715498|P3|NOT COMPLETED|Overall Study||5
299654|NCT01763866|715499|P2|NOT COMPLETED|Overall Study||1
299655|NCT01763866|715500|P1|NOT COMPLETED|Overall Study||2
299656|NCT01763866|715477|P24|COMPLETED|Overall Study||113
299657|NCT01763866|715478|P23|COMPLETED|Overall Study||109
299658|NCT01763866|715479|P22|COMPLETED|Overall Study||54
299659|NCT01763866|715480|P21|COMPLETED|Overall Study||52
299660|NCT01763866|715481|P20|COMPLETED|Overall Study||110
299661|NCT01763866|715482|P19|COMPLETED|Overall Study||105
299662|NCT01763866|715483|P18|COMPLETED|Overall Study||55
299663|NCT01763866|715484|P17|COMPLETED|Overall Study||55
299664|NCT01763866|715485|P16|COMPLETED|Overall Study||112
299665|NCT01763866|715486|P15|COMPLETED|Overall Study||102
299666|NCT01763866|715487|P14|COMPLETED|Overall Study||57
299667|NCT01763866|715488|P13|COMPLETED|Overall Study||54
299668|NCT01763866|715489|P12|COMPLETED|Overall Study||108
299669|NCT01763866|715490|P11|COMPLETED|Overall Study||102
299670|NCT01763866|715491|P10|COMPLETED|Overall Study||53
299671|NCT01763866|715492|P9|COMPLETED|Overall Study||53
299672|NCT01763866|715493|P8|COMPLETED|Overall Study||55
299673|NCT01763866|715494|P7|COMPLETED|Overall Study||48
299674|NCT01763866|715495|P6|COMPLETED|Overall Study||107
299675|NCT01763866|715496|P5|COMPLETED|Overall Study||108
299676|NCT01763866|715497|P4|COMPLETED|Overall Study||55
299677|NCT01763866|715498|P3|COMPLETED|Overall Study||51
299678|NCT01763866|715499|P2|COMPLETED|Overall Study||54
299679|NCT01763866|715500|P1|COMPLETED|Overall Study||54
299680|NCT01763866|715477|P24|Received Treatment|Overall Study||115
299681|NCT01763866|715478|P23|Received Treatment|Overall Study||112
299682|NCT01763866|715479|P22|Received Treatment|Overall Study||55
299683|NCT01763866|715480|P21|Received Treatment|Overall Study||56
299684|NCT01763866|715481|P20|Received Treatment|Overall Study||112
299685|NCT01763866|715482|P19|Received Treatment|Overall Study||111
299686|NCT01763866|715483|P18|Received Treatment|Overall Study||55
299687|NCT01763866|715484|P17|Received Treatment|Overall Study||56
299688|NCT01763866|715485|P16|Received Treatment|Overall Study||115
299689|NCT01763866|715486|P15|Received Treatment|Overall Study||113
299690|NCT01763866|715487|P14|Received Treatment|Overall Study||57
299691|NCT01763866|715488|P13|Received Treatment|Overall Study||58
299692|NCT01763866|715489|P12|Received Treatment|Overall Study||110
299693|NCT01763866|715490|P11|Received Treatment|Overall Study||109
299694|NCT01763866|715491|P10|Received Treatment|Overall Study||54
299695|NCT01763866|715492|P9|Received Treatment|Overall Study||56
299696|NCT01763866|715493|P8|Received Treatment|Overall Study||55
299697|NCT01763866|715494|P7|Received Treatment|Overall Study||55
299698|NCT01763866|715495|P6|Received Treatment|Overall Study||110
299699|NCT01763866|715496|P5|Received Treatment|Overall Study||110
299700|NCT01763866|715497|P4|Received Treatment|Overall Study||55
299701|NCT01763866|715498|P3|Received Treatment|Overall Study||56
299702|NCT01763866|715499|P2|Received Treatment|Overall Study||55
299703|NCT01763866|715500|P1|Received Treatment|Overall Study||56
299704|NCT01763866|715477|P24|STARTED|Overall Study||115
299705|NCT01763866|715478|P23|STARTED|Overall Study||112
299706|NCT01763866|715479|P22|STARTED|Overall Study||55
299707|NCT01763866|715480|P21|STARTED|Overall Study||56
299708|NCT01763866|715481|P20|STARTED|Overall Study||112
299709|NCT01763866|715482|P19|STARTED|Overall Study||111
299710|NCT01763866|715483|P18|STARTED|Overall Study||56
299711|NCT01763866|715484|P17|STARTED|Overall Study||56
299712|NCT01763866|715485|P16|STARTED|Overall Study||115
299713|NCT01763866|715486|P15|STARTED|Overall Study||114
299714|NCT01763866|715487|P14|STARTED|Overall Study||57
299715|NCT01763866|715488|P13|STARTED|Overall Study||58
299716|NCT01763866|715489|P12|STARTED|Overall Study||110
299717|NCT01763866|715490|P11|STARTED|Overall Study||110
299718|NCT01763866|715491|P10|STARTED|Overall Study||54
299719|NCT01763866|715492|P9|STARTED|Overall Study||56
299720|NCT01763866|715493|P8|STARTED|Overall Study||55
299721|NCT01763866|715494|P7|STARTED|Overall Study||55
299722|NCT01763866|715495|P6|STARTED|Overall Study||110
299723|NCT01763866|715496|P5|STARTED|Overall Study||110
299724|NCT01763866|715497|P4|STARTED|Overall Study||55
299725|NCT01763866|715498|P3|STARTED|Overall Study||56
299726|NCT01763866|715499|P2|STARTED|Overall Study||55
299727|NCT01763866|715500|P1|STARTED|Overall Study||56
299728|NCT01763827|716060|P6|NOT COMPLETED|Overall Study||2
299729|NCT01763827|716061|P5|NOT COMPLETED|Overall Study||6
299730|NCT01763827|716062|P4|NOT COMPLETED|Overall Study||1
299731|NCT01763827|716063|P3|NOT COMPLETED|Overall Study||4
299732|NCT01763827|716064|P2|NOT COMPLETED|Overall Study||1
299733|NCT01763827|716065|P1|NOT COMPLETED|Overall Study||3
299734|NCT01763827|716060|P6|COMPLETED|Overall Study||151
299735|NCT01763827|716061|P5|COMPLETED|Overall Study||147
299736|NCT01763827|716062|P4|COMPLETED|Overall Study||76
299737|NCT01763827|716063|P3|COMPLETED|Overall Study||73
299738|NCT01763827|716064|P2|COMPLETED|Overall Study||77
299739|NCT01763827|716065|P1|COMPLETED|Overall Study||74
299740|NCT01763827|716060|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
299741|NCT01763827|716061|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
299742|NCT01763827|716062|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
299743|NCT01763827|716063|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
299744|NCT01763827|716064|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
299745|NCT01763827|716065|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
299746|NCT01763827|716060|P6|STARTED|Overall Study||153
299747|NCT01763827|716061|P5|STARTED|Overall Study||153
299748|NCT01763827|716062|P4|STARTED|Overall Study||77
299749|NCT01763827|716063|P3|STARTED|Overall Study||77
299750|NCT01763827|716064|P2|STARTED|Overall Study||78
299751|NCT01763827|716065|P1|STARTED|Overall Study||77
299752|NCT01763645|716207|P2|NOT COMPLETED|Overall Study||24
299753|NCT01763645|716208|P1|NOT COMPLETED|Overall Study||26
299754|NCT01763645|716207|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
299755|NCT01763645|716208|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
299756|NCT01763645|716207|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
299757|NCT01763645|716208|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
299758|NCT01763645|716207|P2|STARTED|Overall Study||69
299759|NCT01763645|716208|P1|STARTED|Overall Study||69
299760|NCT01763567|716226|P1|NOT COMPLETED|Overall Study||0
299761|NCT01763567|716226|P1|COMPLETED|Overall Study||19
299762|NCT01763567|716226|P1|STARTED|Overall Study||19
299763|NCT01763047|716236|P2|NOT COMPLETED|Period 2||5
299764|NCT01763047|716237|P1|NOT COMPLETED|Period 2||4
299765|NCT01763047|716236|P2|COMPLETED|Period 2||121
299766|NCT01763047|716237|P1|COMPLETED|Period 2||126
299767|NCT01763047|716236|P2|Hyperopes|Period 2||54
299768|NCT01763047|716237|P1|Hyperopes|Period 2||56
299769|NCT01763047|716236|P2|Myopes|Period 2||72
299770|NCT01763047|716237|P1|Myopes|Period 2||74
299771|NCT01763047|716236|P2|STARTED|Period 2||126
299772|NCT01763047|716237|P1|STARTED|Period 2||130
299773|NCT01763047|716236|P2|NOT COMPLETED|Period 1||11
299774|NCT01763047|716237|P1|NOT COMPLETED|Period 1||9
299775|NCT01763047|716236|P2|COMPLETED|Period 1||126
299776|NCT01763047|716237|P1|COMPLETED|Period 1||130
299777|NCT01763047|716236|P2|Hyperopes|Period 1||61
299778|NCT01763047|716237|P1|Hyperopes|Period 1||62
299779|NCT01763047|716236|P2|Myopes|Period 1||76
299780|NCT01763047|716237|P1|Myopes|Period 1||77
299781|NCT01763047|716236|P2|STARTED|Period 1||137
299782|NCT01763047|716237|P1|STARTED|Period 1||139
299783|NCT01762982|716253|P1|NOT COMPLETED|Overall Study||0
299784|NCT01762982|716253|P1|COMPLETED|Overall Study||36
299785|NCT01762982|716253|P1|Received Empty Finn Chamber|Overall Study||36
299786|NCT01762982|716253|P1|Received SLS|Overall Study||36
299787|NCT01762982|716253|P1|Received Benzalkonium Chloride|Overall Study||36
299788|NCT01762982|716253|P1|Received Saline Water|Overall Study||36
299789|NCT01762982|716253|P1|STARTED|Overall Study||36
299790|NCT01762904|716274|P1|NOT COMPLETED|Overall Study||0
299791|NCT01762904|716274|P1|COMPLETED|Overall Study|October, 2013|135
299792|NCT01762904|716274|P1|STARTED|Overall Study|January, 2013|135
299793|NCT01762800|716283|P2|NOT COMPLETED|Overall Study||21
299794|NCT01762800|716284|P1|NOT COMPLETED|Overall Study||19
299795|NCT01762800|716283|P2|COMPLETED|Overall Study||183
299796|NCT01762800|716284|P1|COMPLETED|Overall Study||183
299797|NCT01762800|716283|P2|STARTED|Overall Study||204
299798|NCT01762800|716284|P1|STARTED|Overall Study||202
299805|NCT01762722|716413|P2|NOT COMPLETED|Overall Study||0
299806|NCT01762722|716414|P1|NOT COMPLETED|Overall Study||0
299807|NCT01762722|716413|P2|COMPLETED|Overall Study||11
299808|NCT01762722|716414|P1|COMPLETED|Overall Study||12
299809|NCT01762722|716413|P2|STARTED|Overall Study||11
299810|NCT01762722|716414|P1|STARTED|Overall Study||12
299811|NCT01762501|716422|P2|NOT COMPLETED|Overall Study||23
299812|NCT01762501|716423|P1|NOT COMPLETED|Overall Study||27
299813|NCT01762501|716422|P2|COMPLETED|Overall Study||336
299814|NCT01762501|716423|P1|COMPLETED|Overall Study||332
299815|NCT01762501|716422|P2|STARTED|Overall Study||359
299816|NCT01762501|716423|P1|STARTED|Overall Study||359
299817|NCT01762345|716437|P1|NOT COMPLETED|Overall Study||7
299818|NCT01762345|716437|P1|COMPLETED|Overall Study||76
299819|NCT01762345|716437|P1|STARTED|Overall Study||83
299820|NCT01761747|716447|P1|NOT COMPLETED|Overall Study||1
299821|NCT01761747|716447|P1|COMPLETED|Overall Study||2
299822|NCT01761747|716447|P1|STARTED|Overall Study||3
299823|NCT01761565|716458|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
299824|NCT01761565|716458|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
299825|NCT01761565|716458|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
299826|NCT01761565|716458|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
299827|NCT01761565|716458|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
299828|NCT01761565|716458|P1|STARTED|Single Dose of SUF NT 15 mcg||40
299829|NCT01761279|716467|P1|NOT COMPLETED|Overall Study||0
299830|NCT01761279|716467|P1|COMPLETED|Overall Study||84
299831|NCT01761279|716467|P1|STARTED|Overall Study||84
299832|NCT01761162|716480|P1|NOT COMPLETED|Overall Study||3
299833|NCT01761162|716480|P1|COMPLETED|Overall Study||226
299834|NCT01761162|716480|P1|STARTED|Overall Study||229
299835|NCT01761019|716488|P1|NOT COMPLETED|Overall Study||0
299836|NCT01761019|716488|P1|COMPLETED|Overall Study||8
299837|NCT01761019|716488|P1|STARTED|Overall Study||8
299838|NCT01760993|716496|P1|NOT COMPLETED|Overall Study||0
299839|NCT01760993|716496|P1|COMPLETED|Overall Study||0
299840|NCT01760993|716496|P1|STARTED|Overall Study||0
299841|NCT01760941|716513|P1|NOT COMPLETED|Overall Study||0
299842|NCT01760941|716513|P1|COMPLETED|Overall Study||1
299843|NCT01760941|716513|P1|STARTED|Overall Study||1
299844|NCT01760889|716523|P3|NOT COMPLETED|Overall Study||0
299845|NCT01760889|716524|P2|NOT COMPLETED|Overall Study||0
299846|NCT01760889|716525|P1|NOT COMPLETED|Overall Study||0
299847|NCT01760889|716523|P3|COMPLETED|Overall Study||0
299848|NCT01760889|716524|P2|COMPLETED|Overall Study||0
299849|NCT01760889|716525|P1|COMPLETED|Overall Study||0
299850|NCT01760889|716523|P3|STARTED|Overall Study||0
299851|NCT01760889|716524|P2|STARTED|Overall Study||0
299852|NCT01760889|716525|P1|STARTED|Overall Study||0
299853|NCT01760876|716572|P1|NOT COMPLETED|Overall Study||6
299854|NCT01760876|716572|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
299855|NCT01760876|716572|P1|STARTED|Overall Study||106
299856|NCT01760785|716578|P2|NOT COMPLETED|Overall Study||0
299857|NCT01760785|716579|P1|NOT COMPLETED|Overall Study||0
299858|NCT01760785|716578|P2|COMPLETED|Overall Study||27
299859|NCT01760785|716579|P1|COMPLETED|Overall Study||23
299860|NCT01760785|716578|P2|STARTED|Overall Study||27
299861|NCT01760785|716579|P1|STARTED|Overall Study||23
299862|NCT01760304|716587|P2|NOT COMPLETED|Overall Study||0
299863|NCT01760304|716588|P1|NOT COMPLETED|Overall Study||0
299864|NCT01760304|716587|P2|COMPLETED|Overall Study||3
299865|NCT01760304|716588|P1|COMPLETED|Overall Study||2
299866|NCT01760304|716587|P2|STARTED|Overall Study||3
299867|NCT01760304|716588|P1|STARTED|Overall Study||2
299868|NCT01759602|716598|P1|NOT COMPLETED|Overall Study||0
299869|NCT01759602|716598|P1|COMPLETED|Overall Study||10
299870|NCT01759602|716598|P1|STARTED|Overall Study||10
299871|NCT01759511|716606|P1|NOT COMPLETED|Overall Study||34
299872|NCT01759511|716606|P1|COMPLETED|Overall Study||0
299873|NCT01759511|716606|P1|STARTED|Overall Study||34
299874|NCT01759420|716614|P1|NOT COMPLETED|Overall Study||6
299875|NCT01759420|716614|P1|COMPLETED|Overall Study||22
299876|NCT01759420|716614|P1|STARTED|Overall Study||28
299877|NCT01759381|716621|P2|NOT COMPLETED|Overall Study||0
299878|NCT01759381|716622|P1|NOT COMPLETED|Overall Study||1
299879|NCT01759381|716621|P2|COMPLETED|Overall Study||11
299880|NCT01759381|716622|P1|COMPLETED|Overall Study||7
299881|NCT01759381|716621|P2|STARTED|Overall Study||11
299882|NCT01759381|716622|P1|STARTED|Overall Study||8
299883|NCT01759368|716630|P2|NOT COMPLETED|Overall Study||0
299884|NCT01759368|716631|P1|NOT COMPLETED|Overall Study||1
299885|NCT01759368|716630|P2|COMPLETED|Overall Study||47
299886|NCT01759368|716631|P1|COMPLETED|Overall Study||46
299887|NCT01759368|716630|P2|STARTED|Overall Study||47
299888|NCT01759368|716631|P1|STARTED|Overall Study||47
299889|NCT01759290|716649|P1|NOT COMPLETED|Overall Study||81
299890|NCT01759290|716649|P1|COMPLETED|Overall Study||1719
299891|NCT01759290|716649|P1|STARTED|Overall Study||1800
299892|NCT01759264|716709|P1|NOT COMPLETED|Overall Study||10
299893|NCT01759264|716709|P1|COMPLETED|Overall Study||91
299894|NCT01759264|716709|P1|STARTED|Overall Study||101
299895|NCT01759251|716722|P1|NOT COMPLETED|Follow-up Period||0
299896|NCT01759251|716722|P1|COMPLETED|Follow-up Period||305
299897|NCT01759251|716722|P1|STARTED|Follow-up Period||305
299898|NCT01759251|716722|P1|NOT COMPLETED|60 Days Treatment Period||0
299899|NCT01759251|716722|P1|COMPLETED|60 Days Treatment Period||305
299900|NCT01759251|716722|P1|STARTED|60 Days Treatment Period||305
299901|NCT01759251|716722|P1|NOT COMPLETED|30 Days Treatment Period||4
299902|NCT01759251|716722|P1|COMPLETED|30 Days Treatment Period||305
299903|NCT01759251|716722|P1|STARTED|30 Days Treatment Period||309
299904|NCT01759160|716728|P2|NOT COMPLETED|Overall Study||0
299905|NCT01759160|716729|P1|NOT COMPLETED|Overall Study||0
299906|NCT01759160|716728|P2|COMPLETED|Overall Study||30
299907|NCT01759160|716729|P1|COMPLETED|Overall Study||30
299908|NCT01759160|716728|P2|STARTED|Overall Study||30
299909|NCT01759160|716729|P1|STARTED|Overall Study||30
299910|NCT01758900|716737|P2|NOT COMPLETED|Overall Study||8
299911|NCT01758900|716738|P1|NOT COMPLETED|Overall Study||7
299912|NCT01758900|716737|P2|COMPLETED|Overall Study||100
299913|NCT01758900|716738|P1|COMPLETED|Overall Study||99
299914|NCT01758900|716737|P2|STARTED|Overall Study||108
299915|NCT01758900|716738|P1|STARTED|Overall Study||106
299916|NCT01758289|716756|P1|NOT COMPLETED|Overall Study||53
299917|NCT01758289|716756|P1|COMPLETED|Overall Study||52
299918|NCT01758289|716756|P1|STARTED|Overall Study||105
299919|NCT01757964|716775|P2|NOT COMPLETED|Overall Study||0
299920|NCT01757964|716776|P1|NOT COMPLETED|Overall Study||0
299921|NCT01757964|716775|P2|COMPLETED|Overall Study||4
299922|NCT01757964|716776|P1|COMPLETED|Overall Study||9
299923|NCT01757964|716775|P2|STARTED|Overall Study||4
299924|NCT01757964|716776|P1|STARTED|Overall Study||9
299925|NCT01757847|716782|P2|NOT COMPLETED|Overall Study||4
299926|NCT01757847|716783|P1|NOT COMPLETED|Overall Study||3
299927|NCT01757847|716782|P2|COMPLETED|Overall Study||42
299928|NCT01757847|716783|P1|COMPLETED|Overall Study||41
299929|NCT01757847|716782|P2|STARTED|Overall Study||46
299930|NCT01757847|716783|P1|STARTED|Overall Study||44
299931|NCT01757704|716793|P2|NOT COMPLETED|Overall Study||3
299932|NCT01757704|716794|P1|NOT COMPLETED|Overall Study||1
299933|NCT01757704|716793|P2|COMPLETED|Overall Study||10
299934|NCT01757704|716794|P1|COMPLETED|Overall Study||10
299935|NCT01757704|716793|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
299936|NCT01757704|716794|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
299937|NCT01757691|716812|P2|NOT COMPLETED|Overall Study||0
299938|NCT01757691|716813|P1|NOT COMPLETED|Overall Study||2
299939|NCT01757691|716812|P2|COMPLETED|Overall Study||0
299940|NCT01757691|716813|P1|COMPLETED|Overall Study||0
299941|NCT01757691|716812|P2|STARTED|Overall Study||0
299942|NCT01757691|716813|P1|STARTED|Overall Study||2
299943|NCT01757561|716830|P4|NOT COMPLETED|Overall Study||9
299944|NCT01757561|716831|P3|NOT COMPLETED|Overall Study||7
299945|NCT01757561|716832|P2|NOT COMPLETED|Overall Study||6
299946|NCT01757561|716833|P1|NOT COMPLETED|Overall Study||6
299947|NCT01757561|716830|P4|COMPLETED|Overall Study||25
299948|NCT01757561|716831|P3|COMPLETED|Overall Study||31
299949|NCT01757561|716832|P2|COMPLETED|Overall Study||28
299950|NCT01757561|716833|P1|COMPLETED|Overall Study||32
299951|NCT01757561|716830|P4|STARTED|Overall Study||34
299952|NCT01757561|716831|P3|STARTED|Overall Study||38
299953|NCT01757561|716832|P2|STARTED|Overall Study||34
299954|NCT01757561|716833|P1|STARTED|Overall Study||38
299955|NCT01757405|716849|P2|NOT COMPLETED|Overall Study||2
299956|NCT01757405|716850|P1|NOT COMPLETED|Overall Study||1
299957|NCT01757405|716849|P2|COMPLETED|Overall Study||18
299958|NCT01757405|716850|P1|COMPLETED|Overall Study||17
299959|NCT01757405|716849|P2|STARTED|Overall Study||20
299960|NCT01757405|716850|P1|STARTED|Overall Study||18
299961|NCT01757275|716868|P2|NOT COMPLETED|Overall Study||13
299962|NCT01757275|716869|P1|NOT COMPLETED|Overall Study||9
299963|NCT01757275|716868|P2|COMPLETED|Overall Study||98
299964|NCT01757275|716869|P1|COMPLETED|Overall Study||102
299965|NCT01757275|716868|P2|STARTED|Overall Study||111
299966|NCT01757275|716869|P1|STARTED|Overall Study||111
299967|NCT01757184|716893|P2|NOT COMPLETED|Open-Label Period||0
299968|NCT01757184|716894|P1|NOT COMPLETED|Open-Label Period||0
299969|NCT01757184|716893|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
299970|NCT01757184|716894|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
299971|NCT01757184|716893|P2|STARTED|Open-Label Period||30
299972|NCT01757184|716894|P1|STARTED|Open-Label Period||35
299973|NCT01757184|716893|P2|NOT COMPLETED|Double-Blind Period||0
299974|NCT01757184|716894|P1|NOT COMPLETED|Double-Blind Period||1
299975|NCT01757184|716893|P2|COMPLETED|Double-Blind Period||30
299976|NCT01757184|716894|P1|COMPLETED|Double-Blind Period||35
299977|NCT01757184|716893|P2|STARTED|Double-Blind Period||30
299978|NCT01757184|716894|P1|STARTED|Double-Blind Period||36
299979|NCT01756976|716918|P2|NOT COMPLETED|Overall Study||0
299980|NCT01756976|716919|P1|NOT COMPLETED|Overall Study||3
299981|NCT01756976|716918|P2|COMPLETED|Overall Study||8
299982|NCT01756976|716919|P1|COMPLETED|Overall Study||73
299983|NCT01756976|716918|P2|STARTED|Overall Study||8
299984|NCT01756976|716919|P1|STARTED|Overall Study||76
299985|NCT01756391|716925|P1|NOT COMPLETED|Overall Study||32
299986|NCT01756391|716925|P1|COMPLETED|Overall Study||319
299987|NCT01756391|716925|P1|STARTED|Overall Study||351
299988|NCT01756300|716929|P1|NOT COMPLETED|Overall Study||2
299989|NCT01756300|716929|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
299990|NCT01756300|716929|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
299991|NCT01756274|716951|P1|NOT COMPLETED|Overall Study||3
299992|NCT01756274|716951|P1|COMPLETED|Overall Study||159
299993|NCT01756274|716951|P1|STARTED|Overall Study||162
299994|NCT01756235|716958|P1|NOT COMPLETED|Overall Study||2
299995|NCT01756235|716958|P1|COMPLETED|Overall Study||460
299996|NCT01756235|716958|P1|STARTED|Overall Study||462
299997|NCT01756157|716979|P2|NOT COMPLETED|Second Intervention Period||0
299998|NCT01756157|716980|P1|NOT COMPLETED|Second Intervention Period||0
299999|NCT01756157|716979|P2|COMPLETED|Second Intervention Period||22
300000|NCT01756157|716980|P1|COMPLETED|Second Intervention Period||22
300001|NCT01756157|716979|P2|STARTED|Second Intervention Period||22
300002|NCT01756157|716980|P1|STARTED|Second Intervention Period||22
300003|NCT01756157|716979|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
300004|NCT01756157|716980|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
300005|NCT01756157|716979|P2|COMPLETED|Washout Period (at Least 7 Days)||22
300006|NCT01756157|716980|P1|COMPLETED|Washout Period (at Least 7 Days)||22
300007|NCT01756157|716979|P2|STARTED|Washout Period (at Least 7 Days)||22
300008|NCT01756157|716980|P1|STARTED|Washout Period (at Least 7 Days)||22
300009|NCT01756157|716979|P2|NOT COMPLETED|First Intervention Period||2
300010|NCT01756157|716980|P1|NOT COMPLETED|First Intervention Period||1
300011|NCT01756157|716979|P2|COMPLETED|First Intervention Period||22
300012|NCT01756157|716980|P1|COMPLETED|First Intervention Period||22
300013|NCT01756157|716979|P2|STARTED|First Intervention Period||24
300014|NCT01756157|716980|P1|STARTED|First Intervention Period||23
300015|NCT01756079|716994|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
300016|NCT01756079|716994|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
300017|NCT01756079|716994|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
300018|NCT01756079|716994|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
300019|NCT01756079|716994|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
300020|NCT01756079|716994|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
300021|NCT01756079|716994|P1|STARTED|Lead-in: Day 0 to Week 4||58
300022|NCT01756053|717000|P2|NOT COMPLETED|Period 2 (10 Days)||2
300023|NCT01756053|717001|P1|NOT COMPLETED|Period 2 (10 Days)||0
300024|NCT01756053|717000|P2|COMPLETED|Period 2 (10 Days)||6
300025|NCT01756053|717001|P1|COMPLETED|Period 2 (10 Days)||7
300026|NCT01756053|717000|P2|STARTED|Period 2 (10 Days)||8
300027|NCT01756053|717001|P1|STARTED|Period 2 (10 Days)||7
300028|NCT01756053|717000|P2|NOT COMPLETED|Washout Period (~21 Days)||0
300029|NCT01756053|717001|P1|NOT COMPLETED|Washout Period (~21 Days)||0
300030|NCT01756053|717000|P2|COMPLETED|Washout Period (~21 Days)||8
300031|NCT01756053|717001|P1|COMPLETED|Washout Period (~21 Days)||7
300032|NCT01756053|717000|P2|STARTED|Washout Period (~21 Days)||8
300033|NCT01756053|717001|P1|STARTED|Washout Period (~21 Days)||7
300034|NCT01756053|717000|P2|NOT COMPLETED|Period 1 (10 Days)||1
300035|NCT01756053|717001|P1|NOT COMPLETED|Period 1 (10 Days)||1
300036|NCT01756053|717000|P2|COMPLETED|Period 1 (10 Days)||8
300037|NCT01756053|717001|P1|COMPLETED|Period 1 (10 Days)||7
300038|NCT01756053|717000|P2|STARTED|Period 1 (10 Days)||9
300039|NCT01756053|717001|P1|STARTED|Period 1 (10 Days)||8
300040|NCT01755702|717021|P1|NOT COMPLETED|Period III||0
300041|NCT01755702|717021|P1|COMPLETED|Period III||58
300042|NCT01755702|717021|P1|Received Ibuprofen|Period III||18
300043|NCT01755702|717021|P1|Received Paracetamol/Caffeine|Period III||10
300044|NCT01755702|717021|P1|Received Placebo|Period III||13
300045|NCT01755702|717021|P1|Received Paracetamol|Period III||17
300046|NCT01755702|717021|P1|STARTED|Period III||58
300047|NCT01755702|717021|P1|NOT COMPLETED|Washout Period II||5
300048|NCT01755702|717021|P1|COMPLETED|Washout Period II||58
300049|NCT01755702|717021|P1|STARTED|Washout Period II||63
300050|NCT01755702|717021|P1|NOT COMPLETED|Period II||0
300051|NCT01755702|717021|P1|COMPLETED|Period II||63
300052|NCT01755702|717021|P1|Received Paracetamol|Period II||17
300053|NCT01755702|717021|P1|Received Paracetamol/Caffeine|Period II||20
300054|NCT01755702|717021|P1|Received Placebo|Period II||15
300055|NCT01755702|717021|P1|Received Ibuprofen|Period II||11
300056|NCT01755702|717021|P1|STARTED|Period II||63
300057|NCT01755702|717021|P1|NOT COMPLETED|Wash Out Period I||3
300058|NCT01755702|717021|P1|COMPLETED|Wash Out Period I||63
300059|NCT01755702|717021|P1|STARTED|Wash Out Period I||66
300060|NCT01755702|717021|P1|NOT COMPLETED|Period I||0
300061|NCT01755702|717021|P1|COMPLETED|Period I||66
300062|NCT01755702|717021|P1|Received Paracetamol/Caffeine|Period I||17
300063|NCT01755702|717021|P1|Received Ibuprofen|Period I||16
300064|NCT01755702|717021|P1|Received Placebo|Period I||17
300065|NCT01755702|717021|P1|Received Paracetamol|Period I||16
300066|NCT01755702|717021|P1|STARTED|Period I||66
300067|NCT01755637|717063|P2|NOT COMPLETED|Period 2||0
300068|NCT01755637|717064|P1|NOT COMPLETED|Period 2||0
300069|NCT01755637|717063|P2|COMPLETED|Period 2||27
300070|NCT01755637|717064|P1|COMPLETED|Period 2||28
300071|NCT01755637|717063|P2|STARTED|Period 2||27
300072|NCT01755637|717064|P1|STARTED|Period 2||28
300073|NCT01755637|717063|P2|NOT COMPLETED|Period 1||1
300074|NCT01755637|717064|P1|NOT COMPLETED|Period 1||0
300075|NCT01755637|717063|P2|COMPLETED|Period 1||27
300076|NCT01755637|717064|P1|COMPLETED|Period 1||28
300077|NCT01755637|717063|P2|STARTED|Period 1||28
300078|NCT01755637|717064|P1|STARTED|Period 1||28
300079|NCT01755455|717082|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
300080|NCT01755455|717083|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
300081|NCT01755455|717082|P2|COMPLETED|Second Intervention (6 Weeks)||11
300082|NCT01755455|717083|P1|COMPLETED|Second Intervention (6 Weeks)||11
300083|NCT01755455|717082|P2|STARTED|Second Intervention (6 Weeks)||11
300084|NCT01755455|717083|P1|STARTED|Second Intervention (6 Weeks)||11
300085|NCT01755455|717082|P2|NOT COMPLETED|Washout (4 Weeks)||0
300086|NCT01755455|717083|P1|NOT COMPLETED|Washout (4 Weeks)||0
300087|NCT01755455|717082|P2|COMPLETED|Washout (4 Weeks)||11
300088|NCT01755455|717083|P1|COMPLETED|Washout (4 Weeks)||11
300089|NCT01755455|717082|P2|STARTED|Washout (4 Weeks)||11
300090|NCT01755455|717083|P1|STARTED|Washout (4 Weeks)||11
300091|NCT01755455|717082|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
300092|NCT01755455|717083|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
300093|NCT01755455|717082|P2|COMPLETED|First Intervention (6 Weeks)||11
300094|NCT01755455|717083|P1|COMPLETED|First Intervention (6 Weeks)||11
300095|NCT01755455|717082|P2|STARTED|First Intervention (6 Weeks)||11
300096|NCT01755455|717083|P1|STARTED|First Intervention (6 Weeks)||11
300097|NCT01755234|717097|P2|NOT COMPLETED|Overall Study||8
300098|NCT01755234|717098|P1|NOT COMPLETED|Overall Study||15
300099|NCT01755234|717097|P2|COMPLETED|Overall Study||37
300100|NCT01755234|717098|P1|COMPLETED|Overall Study||30
300101|NCT01755234|717097|P2|STARTED|Overall Study||45
300102|NCT01755234|717098|P1|STARTED|Overall Study||45
300103|NCT01755169|717114|P4|NOT COMPLETED|Overall Study||0
300104|NCT01755169|717115|P3|NOT COMPLETED|Overall Study||0
300105|NCT01755169|717116|P2|NOT COMPLETED|Overall Study||0
300106|NCT01755169|717117|P1|NOT COMPLETED|Overall Study||0
300107|NCT01755169|717114|P4|COMPLETED|Overall Study||1
300108|NCT01755169|717115|P3|COMPLETED|Overall Study||0
300109|NCT01755169|717116|P2|COMPLETED|Overall Study||1
300110|NCT01755169|717117|P1|COMPLETED|Overall Study||2
300111|NCT01755169|717114|P4|STARTED|Overall Study||1
300112|NCT01755169|717115|P3|STARTED|Overall Study||0
300113|NCT01755169|717116|P2|STARTED|Overall Study||1
300114|NCT01755169|717117|P1|STARTED|Overall Study||2
300115|NCT01755156|717129|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
300116|NCT01755156|717130|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
300117|NCT01755156|717129|P2|COMPLETED|Phase B (Weeks 24-104)||141
300118|NCT01755156|717130|P1|COMPLETED|Phase B (Weeks 24-104)||144
300119|NCT01755156|717129|P2|STARTED|Phase B (Weeks 24-104)||177
300120|NCT01755156|717130|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
300121|NCT01755156|717129|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
300122|NCT01755156|717130|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
300123|NCT01755156|717129|P2|COMPLETED|Phase A (Weeks 0-24)||177
300124|NCT01755156|717130|P1|COMPLETED|Phase A (Weeks 0-24)||184
300125|NCT01755156|717129|P2|STARTED|Phase A (Weeks 0-24)||201
300126|NCT01755156|717130|P1|STARTED|Phase A (Weeks 0-24)||201
300127|NCT01755143|717176|P2|NOT COMPLETED|Overall Study||3
300128|NCT01755143|717177|P1|NOT COMPLETED|Overall Study||11
300129|NCT01755143|717176|P2|COMPLETED|Overall Study||86
300130|NCT01755143|717177|P1|COMPLETED|Overall Study||166
300131|NCT01755143|717176|P2|STARTED|Overall Study||89
300132|NCT01755143|717177|P1|STARTED|Overall Study||177
300133|NCT01755026|717193|P2|NOT COMPLETED|Overall Study||1
300134|NCT01755026|717194|P1|NOT COMPLETED|Overall Study||2
300135|NCT01755026|717193|P2|COMPLETED|Overall Study||11
300136|NCT01755026|717194|P1|COMPLETED|Overall Study||9
300137|NCT01755026|717193|P2|STARTED|Overall Study||12
300138|NCT01755026|717194|P1|STARTED|Overall Study||11
300139|NCT01754922|717202|P2|NOT COMPLETED|Overall Study||1
300140|NCT01754922|717203|P1|NOT COMPLETED|Overall Study||0
300141|NCT01754922|717202|P2|COMPLETED|Overall Study||17
300142|NCT01754922|717203|P1|COMPLETED|Overall Study||32
300143|NCT01754922|717202|P2|STARTED|Overall Study||18
300144|NCT01754922|717203|P1|STARTED|Overall Study||32
300145|NCT01754766|717216|P3|NOT COMPLETED|Overall Study||0
300146|NCT01754766|717217|P2|NOT COMPLETED|Overall Study||1
300147|NCT01754766|717218|P1|NOT COMPLETED|Overall Study||1
300148|NCT01754766|717216|P3|COMPLETED|Overall Study||30
300149|NCT01754766|717217|P2|COMPLETED|Overall Study||28
300150|NCT01754766|717218|P1|COMPLETED|Overall Study||30
300151|NCT01754766|717216|P3|STARTED|Overall Study||30
300152|NCT01754766|717217|P2|STARTED|Overall Study||29
300153|NCT01754766|717218|P1|STARTED|Overall Study||31
300154|NCT01754727|717232|P1|NOT COMPLETED|Overall Study||2
300155|NCT01754727|717232|P1|COMPLETED|Overall Study||450
300156|NCT01754727|717232|P1|STARTED|Overall Study||452
300157|NCT01754714|717250|P4|NOT COMPLETED|Overall Study||1
300158|NCT01754714|717251|P3|NOT COMPLETED|Overall Study||2
300159|NCT01754714|717252|P2|NOT COMPLETED|Overall Study||1
300160|NCT01754714|717253|P1|NOT COMPLETED|Overall Study||0
300161|NCT01754714|717250|P4|COMPLETED|Overall Study||27
300162|NCT01754714|717251|P3|COMPLETED|Overall Study||24
300163|NCT01754714|717252|P2|COMPLETED|Overall Study||26
300164|NCT01754714|717253|P1|COMPLETED|Overall Study||27
300165|NCT01754714|717250|P4|STARTED|Overall Study||28
300166|NCT01754714|717251|P3|STARTED|Overall Study||26
300167|NCT01754714|717252|P2|STARTED|Overall Study||27
300168|NCT01754714|717253|P1|STARTED|Overall Study||27
300169|NCT01754623|717343|P1|NOT COMPLETED|Overall Study||0
300170|NCT01754623|717343|P1|COMPLETED|Overall Study||9
300171|NCT01754623|717343|P1|STARTED|Overall Study||9
300172|NCT01754519|717350|P1|NOT COMPLETED|Overall Study||0
300173|NCT01754519|717350|P1|COMPLETED|Overall Study||1
300174|NCT01754519|717350|P1|STARTED|Overall Study||1
300175|NCT01754493|717359|P1|NOT COMPLETED|Overall Study||7
300176|NCT01754493|717359|P1|COMPLETED|Overall Study||10
300177|NCT01754493|717359|P1|STARTED|Overall Study||17
300178|NCT01754480|717369|P2|NOT COMPLETED|Primary Part II||11
300179|NCT01754480|717370|P1|NOT COMPLETED|Primary Part II||15
300180|NCT01754480|717369|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
300181|NCT01754480|717370|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
300182|NCT01754480|717369|P2|Completed Study up to Week 6|Primary Part II||108
300183|NCT01754480|717370|P1|Completed Study up to Week 6|Primary Part II||100
300184|NCT01754480|717369|P2|STARTED|Primary Part II||113
300185|NCT01754480|717370|P1|STARTED|Primary Part II||111
300186|NCT01754480|717369|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
300187|NCT01754480|717370|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
300188|NCT01754480|717369|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
300189|NCT01754480|717370|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
300190|NCT01754480|717369|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
300191|NCT01754480|717370|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
300192|NCT01754480|717369|P2|STARTED|Part I + Part II (Overall Study)||162
300193|NCT01754480|717370|P1|STARTED|Part I + Part II (Overall Study)||163
300194|NCT01754467|717384|P1|NOT COMPLETED|Overall Study||1
300195|NCT01754467|717384|P1|COMPLETED|Overall Study||8
300196|NCT01754467|717384|P1|STARTED|Overall Study||9
300197|NCT01754402|717394|P3|NOT COMPLETED|Overall Study||4
300198|NCT01754402|717395|P2|NOT COMPLETED|Overall Study||2
300199|NCT01754402|717396|P1|NOT COMPLETED|Overall Study||2
300200|NCT01754402|717394|P3|COMPLETED|Overall Study||26
300201|NCT01754402|717395|P2|COMPLETED|Overall Study||0
300202|NCT01754402|717396|P1|COMPLETED|Overall Study||4
300203|NCT01754402|717394|P3|STARTED|Overall Study||30
300204|NCT01754402|717395|P2|STARTED|Overall Study||2
300205|NCT01754402|717396|P1|STARTED|Overall Study||6
300206|NCT01754376|717403|P1|NOT COMPLETED|Overall Study||3
300207|NCT01754376|717403|P1|COMPLETED|Overall Study||3
300208|NCT01754376|717403|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
300209|NCT01754376|717403|P1|STARTED|Overall Study||6
300210|NCT01753856|717414|P2|NOT COMPLETED|Overall Study||2
300211|NCT01753856|717415|P1|NOT COMPLETED|Overall Study||3
300212|NCT01753856|717414|P2|COMPLETED|Overall Study||34
300213|NCT01753856|717415|P1|COMPLETED|Overall Study||30
300214|NCT01753856|717414|P2|Completed 3-Month Bone Biopsy|Overall Study||35
300215|NCT01753856|717415|P1|Completed 3-Month Bone Biopsy|Overall Study||31
300216|NCT01753856|717414|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
300217|NCT01753856|717415|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
300218|NCT01753856|717414|P2|STARTED|Overall Study||36
300219|NCT01753856|717415|P1|STARTED|Overall Study||33
300220|NCT01753557|717467|P2|NOT COMPLETED|Overall Study||0
300221|NCT01753557|717468|P1|NOT COMPLETED|Overall Study||0
300222|NCT01753557|717467|P2|COMPLETED|Overall Study||19
300223|NCT01753557|717468|P1|COMPLETED|Overall Study||35
300224|NCT01753557|717467|P2|STARTED|Overall Study||19
300225|NCT01753557|717468|P1|STARTED|Overall Study||35
300226|NCT01753518|717486|P2|NOT COMPLETED|Postpartum Follow-up||15
300227|NCT01753518|717487|P1|NOT COMPLETED|Postpartum Follow-up||22
300228|NCT01753518|717486|P2|COMPLETED|Postpartum Follow-up||88
300229|NCT01753518|717487|P1|COMPLETED|Postpartum Follow-up||81
300230|NCT01753518|717486|P2|STARTED|Postpartum Follow-up||103
300231|NCT01753518|717487|P1|STARTED|Postpartum Follow-up||103
300232|NCT01753518|717486|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
300233|NCT01753518|717487|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
300234|NCT01753518|717486|P2|COMPLETED|Intention-to-Treat Analysis||103
300235|NCT01753518|717487|P1|COMPLETED|Intention-to-Treat Analysis||103
300236|NCT01753518|717486|P2|STARTED|Intention-to-Treat Analysis||110
300237|NCT01753518|717487|P1|STARTED|Intention-to-Treat Analysis||110
300238|NCT01753336|717509|P1|NOT COMPLETED|Overall Study||20
300239|NCT01753336|717509|P1|COMPLETED|Overall Study||92
300240|NCT01753336|717509|P1|Cycle 3|Overall Study||93
300241|NCT01753336|717509|P1|Cycle 2|Overall Study||98
300242|NCT01753336|717509|P1|Cycle 1|Overall Study||112
300243|NCT01753336|717509|P1|STARTED|Overall Study||112
300244|NCT01753323|717521|P3|NOT COMPLETED|Overall Study||9
300245|NCT01753323|717522|P2|NOT COMPLETED|Overall Study||0
300246|NCT01753323|717523|P1|NOT COMPLETED|Overall Study||1
300247|NCT01753323|717521|P3|COMPLETED|Overall Study||13
300248|NCT01753323|717522|P2|COMPLETED|Overall Study||10
300249|NCT01753323|717523|P1|COMPLETED|Overall Study||10
300250|NCT01753323|717521|P3|Intent-to-treat Analysis Set|Overall Study||22
300251|NCT01753323|717522|P2|Intent-to-treat Analysis Set|Overall Study||10
300252|NCT01753323|717523|P1|Intent-to-treat Analysis Set|Overall Study||11
300253|NCT01753323|717521|P3|Safety Set|Overall Study||22
300254|NCT01753323|717522|P2|Safety Set|Overall Study||10
300255|NCT01753323|717523|P1|Safety Set|Overall Study||11
300256|NCT01753323|717521|P3|Pharmacokinetic(PK) Set|Overall Study||21
300257|NCT01753323|717522|P2|Pharmacokinetic(PK) Set|Overall Study||10
300258|NCT01753323|717523|P1|Pharmacokinetic(PK) Set|Overall Study||10
300259|NCT01753323|717521|P3|Pharmacodynamic (PD) Set|Overall Study||21
300260|NCT01753323|717522|P2|Pharmacodynamic (PD) Set|Overall Study||10
300261|NCT01753323|717523|P1|Pharmacodynamic (PD) Set|Overall Study||10
300262|NCT01753323|717521|P3|STARTED|Overall Study||22
300263|NCT01753323|717522|P2|STARTED|Overall Study||10
300264|NCT01753323|717523|P1|STARTED|Overall Study||11
300265|NCT01753310|717561|P2|NOT COMPLETED|Overall Study||24
300266|NCT01753310|717562|P1|NOT COMPLETED|Overall Study||32
300267|NCT01753310|717561|P2|COMPLETED|Overall Study||21
300268|NCT01753310|717562|P1|COMPLETED|Overall Study||57
300269|NCT01753310|717561|P2|STARTED|Overall Study||45
300270|NCT01753310|717562|P1|STARTED|Overall Study||89
300271|NCT01753115|717585|P3|NOT COMPLETED|Overall Study||14
300272|NCT01753115|717586|P2|NOT COMPLETED|Overall Study||15
300273|NCT01753115|717587|P1|NOT COMPLETED|Overall Study||12
300274|NCT01753115|717585|P3|COMPLETED|Overall Study||56
300275|NCT01753115|717586|P2|COMPLETED|Overall Study||25
300276|NCT01753115|717587|P1|COMPLETED|Overall Study||32
300277|NCT01753115|717585|P3|Treated|Overall Study||67
300278|NCT01753115|717586|P2|Treated|Overall Study||39
300279|NCT01753115|717587|P1|Treated|Overall Study||38
300280|NCT01753115|717585|P3|STARTED|Overall Study||70
300281|NCT01753115|717586|P2|STARTED|Overall Study||40
300282|NCT01753115|717587|P1|STARTED|Overall Study||44
300283|NCT01753076|717597|P2|NOT COMPLETED|Overall Study||46
300284|NCT01753076|717598|P1|NOT COMPLETED|Overall Study||41
300285|NCT01753076|717597|P2|COMPLETED|Overall Study||106
300286|NCT01753076|717598|P1|COMPLETED|Overall Study||110
300287|NCT01753076|717597|P2|STARTED|Overall Study||152
300288|NCT01753076|717598|P1|STARTED|Overall Study||151
300289|NCT01752907|717624|P2|NOT COMPLETED|Overall Study||20
300290|NCT01752907|717625|P1|NOT COMPLETED|Overall Study||12
300291|NCT01752907|717624|P2|COMPLETED|Overall Study||133
300292|NCT01752907|717625|P1|COMPLETED|Overall Study||139
300293|NCT01752907|717624|P2|Received Pegfilgrastim|Overall Study||151
300294|NCT01752907|717625|P1|Received Pegfilgrastim|Overall Study||149
300295|NCT01752907|717624|P2|STARTED|Overall Study||153
300296|NCT01752907|717625|P1|STARTED|Overall Study||151
300297|NCT01752855|717645|P2|NOT COMPLETED|Overall Study||4
300298|NCT01752855|717646|P1|NOT COMPLETED|Overall Study||1
300299|NCT01752855|717645|P2|COMPLETED|Overall Study||40
300300|NCT01752855|717646|P1|COMPLETED|Overall Study||43
300301|NCT01752855|717645|P2|STARTED|Overall Study||44
300302|NCT01752855|717646|P1|STARTED|Overall Study||44
300303|NCT01752023|717662|P2|NOT COMPLETED|Overall Study||1
300304|NCT01752023|717663|P1|NOT COMPLETED|Overall Study||2
300305|NCT01752023|717662|P2|COMPLETED|Overall Study||0
300306|NCT01752023|717663|P1|COMPLETED|Overall Study||0
300307|NCT01752023|717662|P2|STARTED|Overall Study||1
300308|NCT01752023|717663|P1|STARTED|Overall Study||2
300309|NCT01751867|717673|P2|NOT COMPLETED|Overall Study||99
300310|NCT01751867|717674|P1|NOT COMPLETED|Overall Study||36
300311|NCT01751867|717673|P2|COMPLETED|Overall Study||0
300312|NCT01751867|717674|P1|COMPLETED|Overall Study||0
300313|NCT01751867|717673|P2|Treated|Overall Study||98
300314|NCT01751867|717674|P1|Treated|Overall Study||34
300315|NCT01751867|717673|P2|STARTED|Overall Study||99
300316|NCT01751867|717674|P1|STARTED|Overall Study||36
300317|NCT01751802|717694|P2|NOT COMPLETED|Overall Study||2
300318|NCT01751802|717695|P1|NOT COMPLETED|Overall Study||4
300319|NCT01751802|717694|P2|COMPLETED|Overall Study||2
300320|NCT01751802|717695|P1|COMPLETED|Overall Study||1
300321|NCT01751802|717694|P2|Completed Period 3|Overall Study||1
300322|NCT01751802|717695|P1|Completed Period 3|Overall Study||2
300323|NCT01751802|717694|P2|Completed Period 2|Overall Study||1
300324|NCT01751802|717695|P1|Completed Period 2|Overall Study||2
300325|NCT01751802|717694|P2|Completed Period 1|Overall Study||4
300326|NCT01751802|717695|P1|Completed Period 1|Overall Study||2
300327|NCT01751802|717694|P2|STARTED|Overall Study||4
300328|NCT01751802|717695|P1|STARTED|Overall Study||5
300329|NCT01751308|717712|P5|NOT COMPLETED|Phase 2||0
300330|NCT01751308|717713|P4|NOT COMPLETED|Phase 2||0
300331|NCT01751308|717714|P3|NOT COMPLETED|Phase 2||0
300332|NCT01751308|717715|P2|NOT COMPLETED|Phase 2||0
300333|NCT01751308|717716|P1|NOT COMPLETED|Phase 2||0
300334|NCT01751308|717712|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
300335|NCT01751308|717713|P4|COMPLETED|Phase 2||0
300336|NCT01751308|717714|P3|COMPLETED|Phase 2||0
300337|NCT01751308|717715|P2|COMPLETED|Phase 2||0
300338|NCT01751308|717716|P1|COMPLETED|Phase 2||0
300339|NCT01751308|717712|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
300340|NCT01751308|717713|P4|STARTED|Phase 2||0
300341|NCT01751308|717714|P3|STARTED|Phase 2||0
300342|NCT01751308|717715|P2|STARTED|Phase 2||0
300343|NCT01751308|717716|P1|STARTED|Phase 2||0
300344|NCT01751308|717712|P5|NOT COMPLETED|Phase 1||0
300345|NCT01751308|717713|P4|NOT COMPLETED|Phase 1||0
300346|NCT01751308|717714|P3|NOT COMPLETED|Phase 1||0
300347|NCT01751308|717715|P2|NOT COMPLETED|Phase 1||0
300348|NCT01751308|717716|P1|NOT COMPLETED|Phase 1||0
300349|NCT01751308|717712|P5|COMPLETED|Phase 1||0
300350|NCT01751308|717713|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
300351|NCT01751308|717714|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
300352|NCT01751308|717715|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
300353|NCT01751308|717716|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
300354|NCT01751308|717712|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
300355|NCT01751308|717713|P4|STARTED|Phase 1||7
300356|NCT01751308|717714|P3|STARTED|Phase 1||7
300357|NCT01751308|717715|P2|STARTED|Phase 1||3
300358|NCT01751308|717716|P1|STARTED|Phase 1||6
300359|NCT01751178|717756|P3|NOT COMPLETED|Overall Study||2
300360|NCT01751178|717757|P2|NOT COMPLETED|Overall Study||0
300361|NCT01751178|717758|P1|NOT COMPLETED|Overall Study||3
300362|NCT01751178|717756|P3|COMPLETED|Overall Study||105
300363|NCT01751178|717757|P2|COMPLETED|Overall Study||109
300364|NCT01751178|717758|P1|COMPLETED|Overall Study||105
300365|NCT01751178|717756|P3|STARTED|Overall Study||107
300366|NCT01751178|717757|P2|STARTED|Overall Study||109
300367|NCT01751178|717758|P1|STARTED|Overall Study||108
300368|NCT01751165|717778|P3|NOT COMPLETED|Overall Study||3
300369|NCT01751165|717779|P2|NOT COMPLETED|Overall Study||3
300370|NCT01751165|717780|P1|NOT COMPLETED|Overall Study||2
300371|NCT01751165|717778|P3|COMPLETED|Overall Study||113
300372|NCT01751165|717779|P2|COMPLETED|Overall Study||116
300373|NCT01751165|717780|P1|COMPLETED|Overall Study||117
300374|NCT01751165|717778|P3|STARTED|Overall Study||116
300375|NCT01751165|717779|P2|STARTED|Overall Study||119
300376|NCT01751165|717780|P1|STARTED|Overall Study||119
300377|NCT01751113|717820|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
300378|NCT01751113|717821|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
300379|NCT01751113|717822|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
300380|NCT01751113|717823|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
300381|NCT01751113|717824|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
300382|NCT01751113|717825|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
300383|NCT01751113|717820|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
300384|NCT01751113|717821|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
300385|NCT01751113|717822|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
300386|NCT01751113|717823|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
300387|NCT01751113|717824|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
300388|NCT01751113|717825|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
300389|NCT01751113|717820|P6|STARTED|Treatment Period 3 (4 Weeks)||10
300390|NCT01751113|717821|P5|STARTED|Treatment Period 3 (4 Weeks)||8
300391|NCT01751113|717822|P4|STARTED|Treatment Period 3 (4 Weeks)||8
300392|NCT01751113|717823|P3|STARTED|Treatment Period 3 (4 Weeks)||9
300393|NCT01751113|717824|P2|STARTED|Treatment Period 3 (4 Weeks)||8
300394|NCT01751113|717825|P1|STARTED|Treatment Period 3 (4 Weeks)||8
300395|NCT01751113|717820|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
300396|NCT01751113|717821|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
300397|NCT01751113|717822|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
300398|NCT01751113|717823|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
300399|NCT01751113|717824|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
300400|NCT01751113|717825|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
300401|NCT01751113|717820|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
300402|NCT01751113|717821|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
300403|NCT01751113|717822|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
300404|NCT01751113|717823|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
300405|NCT01751113|717824|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
300406|NCT01751113|717825|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
300407|NCT01751113|717820|P6|STARTED|Washout Period 2 (2 Weeks)||10
300408|NCT01751113|717821|P5|STARTED|Washout Period 2 (2 Weeks)||8
300409|NCT01751113|717822|P4|STARTED|Washout Period 2 (2 Weeks)||8
300410|NCT01751113|717823|P3|STARTED|Washout Period 2 (2 Weeks)||9
300411|NCT01751113|717824|P2|STARTED|Washout Period 2 (2 Weeks)||8
300412|NCT01751113|717825|P1|STARTED|Washout Period 2 (2 Weeks)||8
300413|NCT01751113|717820|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
300414|NCT01751113|717821|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
300415|NCT01751113|717822|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
300416|NCT01751113|717823|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
300417|NCT01751113|717824|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
300418|NCT01751113|717825|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
300419|NCT01751113|717820|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
300420|NCT01751113|717821|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
300421|NCT01751113|717822|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
300422|NCT01751113|717823|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
300423|NCT01751113|717824|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
300424|NCT01751113|717825|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
300425|NCT01751113|717820|P6|STARTED|Treatment Period 2 (4 Weeks)||10
300426|NCT01751113|717821|P5|STARTED|Treatment Period 2 (4 Weeks)||8
300427|NCT01751113|717822|P4|STARTED|Treatment Period 2 (4 Weeks)||8
300428|NCT01751113|717823|P3|STARTED|Treatment Period 2 (4 Weeks)||9
300429|NCT01751113|717824|P2|STARTED|Treatment Period 2 (4 Weeks)||8
300430|NCT01751113|717825|P1|STARTED|Treatment Period 2 (4 Weeks)||8
300431|NCT01751113|717820|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
300432|NCT01751113|717821|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
300433|NCT01751113|717822|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
300434|NCT01751113|717823|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
300435|NCT01751113|717824|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
300436|NCT01751113|717825|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
300437|NCT01751113|717820|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
300438|NCT01751113|717821|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
300439|NCT01751113|717822|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
300440|NCT01751113|717823|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
300441|NCT01751113|717824|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
300442|NCT01751113|717825|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
300443|NCT01751113|717820|P6|STARTED|Washout Period 1 (2 Weeks)||10
300444|NCT01751113|717821|P5|STARTED|Washout Period 1 (2 Weeks)||8
300445|NCT01751113|717822|P4|STARTED|Washout Period 1 (2 Weeks)||8
300446|NCT01751113|717823|P3|STARTED|Washout Period 1 (2 Weeks)||9
300447|NCT01751113|717824|P2|STARTED|Washout Period 1 (2 Weeks)||8
300448|NCT01751113|717825|P1|STARTED|Washout Period 1 (2 Weeks)||8
300449|NCT01751113|717820|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
300450|NCT01751113|717821|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
300451|NCT01751113|717822|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
300452|NCT01751113|717823|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
300453|NCT01751113|717824|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
300454|NCT01751113|717825|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
300455|NCT01751113|717820|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
300456|NCT01751113|717821|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
300457|NCT01751113|717822|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
300458|NCT01751113|717823|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
300459|NCT01751113|717824|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
300460|NCT01751113|717825|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
300461|NCT01751113|717820|P6|STARTED|Treatment Period 1 (4 Weeks)||10
300462|NCT01751113|717821|P5|STARTED|Treatment Period 1 (4 Weeks)||9
300463|NCT01751113|717822|P4|STARTED|Treatment Period 1 (4 Weeks)||9
300464|NCT01751113|717823|P3|STARTED|Treatment Period 1 (4 Weeks)||9
300465|NCT01751113|717824|P2|STARTED|Treatment Period 1 (4 Weeks)||8
300466|NCT01751113|717825|P1|STARTED|Treatment Period 1 (4 Weeks)||8
300467|NCT01751087|717866|P3|NOT COMPLETED|Overall Study||1
300468|NCT01751087|717867|P2|NOT COMPLETED|Overall Study||0
300469|NCT01751087|717868|P1|NOT COMPLETED|Overall Study||1
300470|NCT01751087|717866|P3|COMPLETED|Overall Study||99
300471|NCT01751087|717867|P2|COMPLETED|Overall Study||100
300472|NCT01751087|717868|P1|COMPLETED|Overall Study||99
300473|NCT01751087|717866|P3|STARTED|Overall Study||100
300474|NCT01751087|717867|P2|STARTED|Overall Study||100
300475|NCT01751087|717868|P1|STARTED|Overall Study||100
300476|NCT01751022|717903|P3|NOT COMPLETED|Overall Study||27
300477|NCT01751022|717904|P2|NOT COMPLETED|Overall Study||44
300478|NCT01751022|717905|P1|NOT COMPLETED|Overall Study||56
300479|NCT01751022|717903|P3|COMPLETED|Overall Study|6 month visit|273
300480|NCT01751022|717904|P2|COMPLETED|Overall Study|6 month visit|282
300481|NCT01751022|717905|P1|COMPLETED|Overall Study|6 month visit|443
300482|NCT01751022|717903|P3|STARTED|Overall Study||300
300483|NCT01751022|717904|P2|STARTED|Overall Study||326
300484|NCT01751022|717905|P1|STARTED|Overall Study||499
300485|NCT01750840|717937|P1|NOT COMPLETED|Overall Study||4
300486|NCT01750840|717937|P1|COMPLETED|Overall Study||4
300487|NCT01750840|717937|P1|STARTED|Overall Study||8
300488|NCT01750684|717944|P2|NOT COMPLETED|Overall Study||2
300489|NCT01750684|717945|P1|NOT COMPLETED|Overall Study||2
300490|NCT01750684|717944|P2|COMPLETED|Overall Study||5
300491|NCT01750684|717945|P1|COMPLETED|Overall Study||4
300492|NCT01750684|717944|P2|STARTED|Overall Study||7
300493|NCT01750684|717945|P1|STARTED|Overall Study||6
300494|NCT01750502|717953|P2|NOT COMPLETED|Overall Study||0
300495|NCT01750502|717954|P1|NOT COMPLETED|Overall Study||0
300496|NCT01750502|717953|P2|COMPLETED|Overall Study||186
300497|NCT01750502|717954|P1|COMPLETED|Overall Study||70
300498|NCT01750502|717953|P2|STARTED|Overall Study||186
300499|NCT01750502|717954|P1|STARTED|Overall Study||70
300500|NCT01750398|717967|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
300501|NCT01750398|717967|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
300502|NCT01750398|717967|P1|STARTED|Bipolar Androgen Thearpy Phase||29
300503|NCT01750398|717967|P1|NOT COMPLETED|ADT Lead In Phase||4
300504|NCT01750398|717967|P1|COMPLETED|ADT Lead In Phase||29
300505|NCT01750398|717967|P1|STARTED|ADT Lead In Phase||33
300506|NCT01750346|717980|P3|NOT COMPLETED|Overall Study||0
300507|NCT01750346|717981|P2|NOT COMPLETED|Overall Study||0
300508|NCT01750346|717982|P1|NOT COMPLETED|Overall Study||1
300509|NCT01750346|717980|P3|COMPLETED|Overall Study||3
300510|NCT01750346|717981|P2|COMPLETED|Overall Study||2
300511|NCT01750346|717982|P1|COMPLETED|Overall Study||2
300512|NCT01750346|717980|P3|STARTED|Overall Study||3
300513|NCT01750346|717981|P2|STARTED|Overall Study||2
300514|NCT01750346|717982|P1|STARTED|Overall Study||3
300515|NCT01750294|718008|P1|NOT COMPLETED|Overall Study||2
300516|NCT01750294|718008|P1|COMPLETED|Overall Study||12
300517|NCT01750294|718008|P1|STARTED|Overall Study||14
300518|NCT01750255|718014|P2|NOT COMPLETED|Overall Study||5
300519|NCT01750255|718015|P1|NOT COMPLETED|Overall Study||6
300520|NCT01750255|718014|P2|COMPLETED|Overall Study||38
300521|NCT01750255|718015|P1|COMPLETED|Overall Study||43
300522|NCT01750255|718014|P2|STARTED|Overall Study||43
300523|NCT01750255|718015|P1|STARTED|Overall Study||49
300524|NCT01750242|718031|P1|NOT COMPLETED|Overall Study||3
300525|NCT01750242|718031|P1|COMPLETED|Overall Study||20
300526|NCT01750242|718031|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
300527|NCT01750242|718031|P1|STARTED|Overall Study||23
300528|NCT01750086|718038|P2|NOT COMPLETED|Overall Study||1
300529|NCT01750086|718039|P1|NOT COMPLETED|Overall Study||1
300530|NCT01750086|718038|P2|COMPLETED|Overall Study||13
300531|NCT01750086|718039|P1|COMPLETED|Overall Study||12
300532|NCT01750086|718038|P2|STARTED|Overall Study||14
300533|NCT01750086|718039|P1|STARTED|Overall Study||13
300534|NCT01749982|718049|P4|NOT COMPLETED|Overall Study||3
300535|NCT01749982|718050|P3|NOT COMPLETED|Overall Study||0
300536|NCT01749982|718051|P2|NOT COMPLETED|Overall Study||0
300537|NCT01749982|718052|P1|NOT COMPLETED|Overall Study||0
300538|NCT01749982|718049|P4|COMPLETED|Overall Study||12
300539|NCT01749982|718050|P3|COMPLETED|Overall Study||15
300540|NCT01749982|718051|P2|COMPLETED|Overall Study||15
300541|NCT01749982|718052|P1|COMPLETED|Overall Study||15
300542|NCT01749982|718049|P4|STARTED|Overall Study||15
300543|NCT01749982|718050|P3|STARTED|Overall Study||15
300544|NCT01749982|718051|P2|STARTED|Overall Study||15
300545|NCT01749982|718052|P1|STARTED|Overall Study||15
300546|NCT01749956|718070|P1|NOT COMPLETED|Overall Study||15
300547|NCT01749956|718070|P1|COMPLETED|Overall Study||24
300548|NCT01749956|718070|P1|STARTED|Overall Study||39
300549|NCT01748799|718088|P8|NOT COMPLETED|Overall Study||0
300550|NCT01748799|718089|P7|NOT COMPLETED|Overall Study||1
300551|NCT01748799|718090|P6|NOT COMPLETED|Overall Study||1
300552|NCT01748799|718091|P5|NOT COMPLETED|Overall Study||0
300553|NCT01748799|718092|P4|NOT COMPLETED|Overall Study||0
300554|NCT01748799|718093|P3|NOT COMPLETED|Overall Study||0
300555|NCT01748799|718094|P2|NOT COMPLETED|Overall Study||0
300556|NCT01748799|718095|P1|NOT COMPLETED|Overall Study||5
300557|NCT01748799|718088|P8|COMPLETED|Overall Study||1
300558|NCT01748799|718089|P7|COMPLETED|Overall Study||1
300559|NCT01748799|718090|P6|COMPLETED|Overall Study||1
300560|NCT01748799|718091|P5|COMPLETED|Overall Study||1
300561|NCT01748799|718092|P4|COMPLETED|Overall Study||2
300562|NCT01748799|718093|P3|COMPLETED|Overall Study||1
300563|NCT01748799|718094|P2|COMPLETED|Overall Study||1
300564|NCT01748799|718095|P1|COMPLETED|Overall Study||1
300565|NCT01748799|718088|P8|Completed Self-titrated Sativex|Overall Study||1
300566|NCT01748799|718089|P7|Completed Self-titrated Sativex|Overall Study||1
300567|NCT01748799|718090|P6|Completed Self-titrated Sativex|Overall Study||1
300568|NCT01748799|718091|P5|Completed Self-titrated Sativex|Overall Study||1
300569|NCT01748799|718092|P4|Completed Self-titrated Sativex|Overall Study||2
300570|NCT01748799|718093|P3|Completed Self-titrated Sativex|Overall Study||1
300571|NCT01748799|718094|P2|Completed Self-titrated Sativex|Overall Study||1
300572|NCT01748799|718095|P1|Completed Self-titrated Sativex|Overall Study||1
300573|NCT01748799|718088|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
300574|NCT01748799|718089|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
300575|NCT01748799|718090|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
300576|NCT01748799|718091|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
300577|NCT01748799|718092|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
300578|NCT01748799|718093|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
300579|NCT01748799|718094|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
300580|NCT01748799|718095|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
300581|NCT01748799|718088|P8|Completed Self-titrated Placebo|Overall Study||1
300582|NCT01748799|718089|P7|Completed Self-titrated Placebo|Overall Study||1
300583|NCT01748799|718090|P6|Completed Self-titrated Placebo|Overall Study||2
300584|NCT01748799|718091|P5|Completed Self-titrated Placebo|Overall Study||1
300585|NCT01748799|718092|P4|Completed Self-titrated Placebo|Overall Study||2
300586|NCT01748799|718093|P3|Completed Self-titrated Placebo|Overall Study||1
300587|NCT01748799|718094|P2|Completed Self-titrated Placebo|Overall Study||1
300588|NCT01748799|718095|P1|Completed Self-titrated Placebo|Overall Study||4
300589|NCT01748799|718088|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
300590|NCT01748799|718089|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
300591|NCT01748799|718090|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
300592|NCT01748799|718091|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
300593|NCT01748799|718092|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
300594|NCT01748799|718093|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
300595|NCT01748799|718094|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
300596|NCT01748799|718095|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
300597|NCT01748799|718088|P8|Completed Fixed Dose Sativex|Overall Study||1
300598|NCT01748799|718089|P7|Completed Fixed Dose Sativex|Overall Study||1
300599|NCT01748799|718090|P6|Completed Fixed Dose Sativex|Overall Study||1
300600|NCT01748799|718091|P5|Completed Fixed Dose Sativex|Overall Study||1
300601|NCT01748799|718092|P4|Completed Fixed Dose Sativex|Overall Study||2
300602|NCT01748799|718093|P3|Completed Fixed Dose Sativex|Overall Study||1
300603|NCT01748799|718094|P2|Completed Fixed Dose Sativex|Overall Study||1
300604|NCT01748799|718095|P1|Completed Fixed Dose Sativex|Overall Study||1
300605|NCT01748799|718088|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
300606|NCT01748799|718089|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
300607|NCT01748799|718090|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
300608|NCT01748799|718091|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
300609|NCT01748799|718092|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
300610|NCT01748799|718093|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
300611|NCT01748799|718094|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
300612|NCT01748799|718095|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
300613|NCT01748799|718088|P8|Completed Fixed Dose Placebo|Overall Study||1
300614|NCT01748799|718089|P7|Completed Fixed Dose Placebo|Overall Study||1
300615|NCT01748799|718090|P6|Completed Fixed Dose Placebo|Overall Study||1
300616|NCT01748799|718091|P5|Completed Fixed Dose Placebo|Overall Study||1
300617|NCT01748799|718092|P4|Completed Fixed Dose Placebo|Overall Study||2
300618|NCT01748799|718093|P3|Completed Fixed Dose Placebo|Overall Study||1
300619|NCT01748799|718094|P2|Completed Fixed Dose Placebo|Overall Study||1
300620|NCT01748799|718095|P1|Completed Fixed Dose Placebo|Overall Study||2
300621|NCT01748799|718088|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
300622|NCT01748799|718089|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
300623|NCT01748799|718090|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
300624|NCT01748799|718091|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
300625|NCT01748799|718092|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
300626|NCT01748799|718093|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
300627|NCT01748799|718094|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
300628|NCT01748799|718095|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
300629|NCT01748799|718088|P8|STARTED|Overall Study||1
300630|NCT01748799|718089|P7|STARTED|Overall Study||2
300631|NCT01748799|718090|P6|STARTED|Overall Study||2
300632|NCT01748799|718091|P5|STARTED|Overall Study||1
300633|NCT01748799|718092|P4|STARTED|Overall Study||2
300634|NCT01748799|718093|P3|STARTED|Overall Study||1
300635|NCT01748799|718094|P2|STARTED|Overall Study||1
300636|NCT01748799|718095|P1|STARTED|Overall Study||6
300637|NCT01748760|718131|P2|NOT COMPLETED|Overall Study||2
300638|NCT01748760|718132|P1|NOT COMPLETED|Overall Study||6
300639|NCT01748760|718131|P2|COMPLETED|Overall Study||23
300640|NCT01748760|718132|P1|COMPLETED|Overall Study||19
300641|NCT01748760|718131|P2|STARTED|Overall Study||25
300642|NCT01748760|718132|P1|STARTED|Overall Study||25
300643|NCT01748695|718138|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
300644|NCT01748695|718139|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
300645|NCT01748695|718138|P2|COMPLETED|Second Intervention (4 Weeks)||11
300646|NCT01748695|718139|P1|COMPLETED|Second Intervention (4 Weeks)||14
300647|NCT01748695|718138|P2|STARTED|Second Intervention (4 Weeks)||11
300648|NCT01748695|718139|P1|STARTED|Second Intervention (4 Weeks)||14
300649|NCT01748695|718138|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
300650|NCT01748695|718139|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
300651|NCT01748695|718138|P2|COMPLETED|First Intervention (4 Weeks)||11
300652|NCT01748695|718139|P1|COMPLETED|First Intervention (4 Weeks)||14
300653|NCT01748695|718138|P2|STARTED|First Intervention (4 Weeks)||11
300654|NCT01748695|718139|P1|STARTED|First Intervention (4 Weeks)||14
300655|NCT01749800|718150|P3|NOT COMPLETED|Overall Study||0
300656|NCT01749800|718151|P2|NOT COMPLETED|Overall Study||1
300657|NCT01749800|718152|P1|NOT COMPLETED|Overall Study||3
300658|NCT01749800|718150|P3|COMPLETED|Overall Study||0
300659|NCT01749800|718151|P2|COMPLETED|Overall Study||0
300660|NCT01749800|718152|P1|COMPLETED|Overall Study||3
300661|NCT01749800|718150|P3|STARTED|Overall Study||0
300662|NCT01749800|718151|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
300663|NCT01749800|718152|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
300664|NCT01749735|718162|P2|NOT COMPLETED|Overall Study||0
300665|NCT01749735|718163|P1|NOT COMPLETED|Overall Study||1
300666|NCT01749735|718162|P2|COMPLETED|Overall Study||0
300667|NCT01749735|718163|P1|COMPLETED|Overall Study||1
300668|NCT01749735|718162|P2|STARTED|Overall Study||0
300669|NCT01749735|718163|P1|STARTED|Overall Study||2
300670|NCT01749631|718171|P1|NOT COMPLETED|Overall Study||0
300671|NCT01749631|718171|P1|COMPLETED|Overall Study||97
300672|NCT01749631|718171|P1|STARTED|Overall Study||97
300673|NCT01749605|718183|P2|NOT COMPLETED|Overall Study||3
300674|NCT01749605|718184|P1|NOT COMPLETED|Overall Study||4
300675|NCT01749605|718183|P2|COMPLETED|Overall Study||14
300676|NCT01749605|718184|P1|COMPLETED|Overall Study||14
300677|NCT01749605|718183|P2|STARTED|Overall Study||17
300678|NCT01749605|718184|P1|STARTED|Overall Study||18
300679|NCT01749501|718192|P2|NOT COMPLETED|Overall Study||0
300680|NCT01749501|718193|P1|NOT COMPLETED|Overall Study||0
300681|NCT01749501|718192|P2|COMPLETED|Overall Study||23
300682|NCT01749501|718193|P1|COMPLETED|Overall Study||22
300683|NCT01749501|718192|P2|STARTED|Overall Study||23
300684|NCT01749501|718193|P1|STARTED|Overall Study||22
300685|NCT01749410|718201|P1|NOT COMPLETED|Overall Study||0
300686|NCT01749410|718201|P1|COMPLETED|Overall Study||33
300687|NCT01749410|718201|P1|STARTED|Overall Study||33
300688|NCT01748955|718207|P2|NOT COMPLETED|Overall Study||5
300689|NCT01748955|718208|P1|NOT COMPLETED|Overall Study||3
300690|NCT01748955|718207|P2|COMPLETED|Overall Study||4
300691|NCT01748955|718208|P1|COMPLETED|Overall Study||3
300692|NCT01748955|718207|P2|STARTED|Overall Study||9
300693|NCT01748955|718208|P1|STARTED|Overall Study||6
300694|NCT01748916|718216|P6|NOT COMPLETED|Overall Study||0
300695|NCT01748916|718217|P5|NOT COMPLETED|Overall Study||0
300696|NCT01748916|718218|P4|NOT COMPLETED|Overall Study||0
300697|NCT01748916|718219|P3|NOT COMPLETED|Overall Study||0
300698|NCT01748916|718220|P2|NOT COMPLETED|Overall Study||0
300699|NCT01748916|718221|P1|NOT COMPLETED|Overall Study||0
300700|NCT01748916|718216|P6|COMPLETED|Overall Study||3
300701|NCT01748916|718217|P5|COMPLETED|Overall Study||3
300702|NCT01748916|718218|P4|COMPLETED|Overall Study||3
300703|NCT01748916|718219|P3|COMPLETED|Overall Study||2
300704|NCT01748916|718220|P2|COMPLETED|Overall Study||3
300705|NCT01748916|718221|P1|COMPLETED|Overall Study||2
300706|NCT01748916|718216|P6|STARTED|Overall Study||3
300707|NCT01748916|718217|P5|STARTED|Overall Study||3
300708|NCT01748916|718218|P4|STARTED|Overall Study||3
300709|NCT01748916|718219|P3|STARTED|Overall Study||2
300710|NCT01748916|718220|P2|STARTED|Overall Study||3
300711|NCT01748916|718221|P1|STARTED|Overall Study||2
300712|NCT01748890|718229|P1|NOT COMPLETED|Overall Study||4
300713|NCT01748890|718229|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
300714|NCT01748890|718229|P1|STARTED|Overall Study||4
300715|NCT01748227|718233|P1|NOT COMPLETED|Overall Study||3
300716|NCT01748227|718233|P1|COMPLETED|Overall Study||17
300717|NCT01748227|718233|P1|STARTED|Overall Study||20
300718|NCT01748071|718244|P3|NOT COMPLETED|Overall Study||0
300719|NCT01748071|718245|P2|NOT COMPLETED|Overall Study||2
300720|NCT01748071|718246|P1|NOT COMPLETED|Overall Study||2
300721|NCT01748071|718244|P3|COMPLETED|Overall Study||40
300722|NCT01748071|718245|P2|COMPLETED|Overall Study||38
300723|NCT01748071|718246|P1|COMPLETED|Overall Study||38
300724|NCT01748071|718244|P3|STARTED|Overall Study||40
300725|NCT01748071|718245|P2|STARTED|Overall Study||40
300726|NCT01748071|718246|P1|STARTED|Overall Study||40
300727|NCT01747928|718274|P8|NOT COMPLETED|Overall Study||0
300728|NCT01747928|718275|P7|NOT COMPLETED|Overall Study||0
300729|NCT01747928|718276|P6|NOT COMPLETED|Overall Study||0
300730|NCT01747928|718277|P5|NOT COMPLETED|Overall Study||0
300731|NCT01747928|718278|P4|NOT COMPLETED|Overall Study||0
300732|NCT01747928|718279|P3|NOT COMPLETED|Overall Study||0
300733|NCT01747928|718280|P2|NOT COMPLETED|Overall Study||0
300734|NCT01747928|718281|P1|NOT COMPLETED|Overall Study||0
300735|NCT01747928|718274|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300736|NCT01747928|718275|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300737|NCT01747928|718276|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300738|NCT01747928|718277|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300739|NCT01747928|718278|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300740|NCT01747928|718279|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300741|NCT01747928|718280|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300742|NCT01747928|718281|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
300743|NCT01747928|718274|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300744|NCT01747928|718275|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300745|NCT01747928|718276|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300746|NCT01747928|718277|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300747|NCT01747928|718278|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300748|NCT01747928|718279|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300749|NCT01747928|718280|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300750|NCT01747928|718281|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
300751|NCT01747811|718487|P2|NOT COMPLETED|Overall Study||4
300752|NCT01747811|718488|P1|NOT COMPLETED|Overall Study||2
300753|NCT01747811|718487|P2|COMPLETED|Overall Study||12
300754|NCT01747811|718488|P1|COMPLETED|Overall Study||14
300755|NCT01747811|718487|P2|STARTED|Overall Study||16
300756|NCT01747811|718488|P1|STARTED|Overall Study||16
300757|NCT01747772|718504|P1|NOT COMPLETED|Overall Study||9
300758|NCT01747772|718504|P1|COMPLETED|Overall Study||171
300759|NCT01747772|718504|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
300760|NCT01747772|718504|P1|STARTED|Overall Study||180
300761|NCT01747655|718512|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
300762|NCT01747655|718513|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
300763|NCT01747655|718512|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
300764|NCT01747655|718513|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
300765|NCT01747655|718512|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
300766|NCT01747655|718513|P1|STARTED|PEG-J Period (Continued Treatment)||41
300767|NCT01747655|718512|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
300768|NCT01747655|718513|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
300769|NCT01747655|718512|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
300770|NCT01747655|718513|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
300771|NCT01747655|718512|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
300772|NCT01747655|718513|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
300773|NCT01747655|718512|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
300774|NCT01747655|718513|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
300775|NCT01747655|718512|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
300776|NCT01747655|718513|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
300777|NCT01747655|718512|P2|STARTED|Temporary Naso-jejunal Tube Period||0
300778|NCT01747655|718513|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
300779|NCT01747629|718543|P2|NOT COMPLETED|Overall Study||6
300780|NCT01747629|718544|P1|NOT COMPLETED|Overall Study||8
300781|NCT01747629|718543|P2|COMPLETED|Overall Study||69
300782|NCT01747629|718544|P1|COMPLETED|Overall Study||77
300783|NCT01747629|718543|P2|Treated|Overall Study|Safety set and full analysis set|75
300784|NCT01747629|718544|P1|Treated|Overall Study|Safety set and full analysis set|84
300785|NCT01747629|718543|P2|STARTED|Overall Study||75
300786|NCT01747629|718544|P1|STARTED|Overall Study||85
300787|NCT01747343|718576|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
300788|NCT01747343|718576|P1|COMPLETED|Underwear/Differential Reinforcement||4
300789|NCT01747343|718576|P1|STARTED|Underwear/Differential Reinforcement||4
300790|NCT01747343|718576|P1|NOT COMPLETED|Underwear||0
300791|NCT01747343|718576|P1|COMPLETED|Underwear||4
300792|NCT01747343|718576|P1|STARTED|Underwear||4
300793|NCT01747343|718576|P1|NOT COMPLETED|Baseline||0
300794|NCT01747343|718576|P1|COMPLETED|Baseline||4
300795|NCT01747343|718576|P1|STARTED|Baseline||4
300796|NCT01747330|718582|P1|NOT COMPLETED|Overall Study||0
300797|NCT01747330|718582|P1|COMPLETED|Overall Study||40
300798|NCT01747330|718582|P1|STARTED|Overall Study||40
300799|NCT01746940|718598|P4|NOT COMPLETED|Safety Second Phase||0
300800|NCT01746940|718599|P3|NOT COMPLETED|Safety Second Phase||0
300801|NCT01746940|718600|P2|NOT COMPLETED|Safety Second Phase||0
300802|NCT01746940|718601|P1|NOT COMPLETED|Safety Second Phase||0
300803|NCT01746940|718598|P4|COMPLETED|Safety Second Phase||0
300804|NCT01746940|718599|P3|COMPLETED|Safety Second Phase||0
300805|NCT01746940|718600|P2|COMPLETED|Safety Second Phase||18
300806|NCT01746940|718601|P1|COMPLETED|Safety Second Phase||18
300807|NCT01746940|718598|P4|STARTED|Safety Second Phase||0
300808|NCT01746940|718599|P3|STARTED|Safety Second Phase||0
300809|NCT01746940|718600|P2|STARTED|Safety Second Phase||18
300810|NCT01746940|718601|P1|STARTED|Safety Second Phase||18
300811|NCT01746940|718598|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
300812|NCT01746940|718599|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
300813|NCT01746940|718600|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
300814|NCT01746940|718601|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
300815|NCT01746940|718598|P4|COMPLETED|Safety and Efficacy First Phase||0
300816|NCT01746940|718599|P3|COMPLETED|Safety and Efficacy First Phase||40
300817|NCT01746940|718600|P2|COMPLETED|Safety and Efficacy First Phase||41
300818|NCT01746940|718601|P1|COMPLETED|Safety and Efficacy First Phase||39
300819|NCT01746940|718598|P4|STARTED|Safety and Efficacy First Phase||3
300820|NCT01746940|718599|P3|STARTED|Safety and Efficacy First Phase||40
300821|NCT01746940|718600|P2|STARTED|Safety and Efficacy First Phase||41
300822|NCT01746940|718601|P1|STARTED|Safety and Efficacy First Phase||39
300823|NCT01746862|718611|P2|NOT COMPLETED|Overall Study||3
300824|NCT01746862|718612|P1|NOT COMPLETED|Overall Study||8
300825|NCT01746862|718611|P2|COMPLETED|Overall Study||27
300826|NCT01746862|718612|P1|COMPLETED|Overall Study||52
300827|NCT01746862|718611|P2|Treated|Overall Study||30
300828|NCT01746862|718612|P1|Treated|Overall Study||59
300829|NCT01746862|718611|P2|STARTED|Overall Study||30
300830|NCT01746862|718612|P1|STARTED|Overall Study||60
300831|NCT01746784|718637|P5|NOT COMPLETED|Overall Study||0
300832|NCT01746784|718638|P4|NOT COMPLETED|Overall Study||0
300833|NCT01746784|718639|P3|NOT COMPLETED|Overall Study||0
300834|NCT01746784|718640|P2|NOT COMPLETED|Overall Study||0
300835|NCT01746784|718641|P1|NOT COMPLETED|Overall Study||0
300836|NCT01746784|718637|P5|COMPLETED|Overall Study||19
300837|NCT01746784|718638|P4|COMPLETED|Overall Study||9
300838|NCT01746784|718639|P3|COMPLETED|Overall Study||9
300839|NCT01746784|718640|P2|COMPLETED|Overall Study||10
300840|NCT01746784|718641|P1|COMPLETED|Overall Study||19
300841|NCT01746784|718637|P5|Enrolled|Overall Study||19
300842|NCT01746784|718638|P4|Enrolled|Overall Study||9
300843|NCT01746784|718639|P3|Enrolled|Overall Study||9
300844|NCT01746784|718640|P2|Enrolled|Overall Study||10
300845|NCT01746784|718641|P1|Enrolled|Overall Study||19
300846|NCT01746784|718637|P5|STARTED|Overall Study||19
300847|NCT01746784|718638|P4|STARTED|Overall Study||9
300848|NCT01746784|718639|P3|STARTED|Overall Study||9
300849|NCT01746784|718640|P2|STARTED|Overall Study||10
300850|NCT01746784|718641|P1|STARTED|Overall Study||19
300851|NCT01746511|718665|P2|NOT COMPLETED|Overall Study||0
300852|NCT01746511|718666|P1|NOT COMPLETED|Overall Study||0
300853|NCT01746511|718665|P2|COMPLETED|Overall Study||39
300854|NCT01746511|718666|P1|COMPLETED|Overall Study||40
300855|NCT01746511|718665|P2|STARTED|Overall Study||39
300856|NCT01746511|718666|P1|STARTED|Overall Study||40
300857|NCT01746368|718682|P2|NOT COMPLETED|Overall Study||1
300858|NCT01746368|718683|P1|NOT COMPLETED|Overall Study||2
300859|NCT01746368|718682|P2|COMPLETED|Overall Study||16
300860|NCT01746368|718683|P1|COMPLETED|Overall Study||31
300861|NCT01746368|718682|P2|Analyzed for Satisfaction|Overall Study||16
300862|NCT01746368|718683|P1|Analyzed for Satisfaction|Overall Study||30
300863|NCT01746368|718682|P2|Analyzed for AD Completion Rate|Overall Study||17
300864|NCT01746368|718683|P1|Analyzed for AD Completion Rate|Overall Study||32
300865|NCT01746368|718682|P2|Assessment Completed|Overall Study||16
300866|NCT01746368|718683|P1|Assessment Completed|Overall Study||31
300867|NCT01746368|718682|P2|Recieved Allocated Intervention|Overall Study||8
300868|NCT01746368|718683|P1|Recieved Allocated Intervention|Overall Study||31
300869|NCT01746368|718682|P2|STARTED|Overall Study||17
300870|NCT01746368|718683|P1|STARTED|Overall Study||33
300871|NCT01746264|718691|P1|NOT COMPLETED|Overall Study||0
300872|NCT01746264|718691|P1|COMPLETED|Overall Study||19
300873|NCT01746264|718691|P1|STARTED|Overall Study||19
300874|NCT01746173|718710|P1|NOT COMPLETED|Overall Study||2
300875|NCT01746173|718710|P1|COMPLETED|Overall Study||3
300876|NCT01746173|718710|P1|STARTED|Overall Study||5
300877|NCT01746108|718718|P3|NOT COMPLETED|Overall Study||0
300878|NCT01746108|718719|P2|NOT COMPLETED|Overall Study||4
300879|NCT01746108|718720|P1|NOT COMPLETED|Overall Study||0
300880|NCT01746108|718718|P3|COMPLETED|Overall Study||6
300881|NCT01746108|718719|P2|COMPLETED|Overall Study||24
300882|NCT01746108|718720|P1|COMPLETED|Overall Study||18
300883|NCT01746108|718718|P3|STARTED|Overall Study||6
300884|NCT01746108|718719|P2|STARTED|Overall Study||28
300885|NCT01746108|718720|P1|STARTED|Overall Study||18
300886|NCT01745952|718756|P3|NOT COMPLETED|Overall Study||0
300887|NCT01745952|718757|P2|NOT COMPLETED|Overall Study||1
300888|NCT01745952|718758|P1|NOT COMPLETED|Overall Study||1
300889|NCT01745952|718756|P3|COMPLETED|Overall Study||3
300890|NCT01745952|718757|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
300891|NCT01745952|718758|P1|COMPLETED|Overall Study||3
300892|NCT01745952|718756|P3|STARTED|Overall Study||3
300893|NCT01745952|718757|P2|STARTED|Overall Study||4
300894|NCT01745952|718758|P1|STARTED|Overall Study||4
300895|NCT01745380|718784|P2|NOT COMPLETED|Overall Study||1
300896|NCT01745380|718785|P1|NOT COMPLETED|Overall Study||1
300897|NCT01745380|718784|P2|COMPLETED|Overall Study||49
300898|NCT01745380|718785|P1|COMPLETED|Overall Study||99
300899|NCT01745380|718784|P2|STARTED|Overall Study||50
300900|NCT01745380|718785|P1|STARTED|Overall Study||100
300901|NCT01745133|718824|P3|NOT COMPLETED|Overall Study||4
300902|NCT01745133|718825|P2|NOT COMPLETED|Overall Study||4
300903|NCT01745133|718826|P1|NOT COMPLETED|Overall Study||6
300904|NCT01745133|718824|P3|COMPLETED|Overall Study||15
300905|NCT01745133|718825|P2|COMPLETED|Overall Study||16
300906|NCT01745133|718826|P1|COMPLETED|Overall Study||13
300907|NCT01745133|718824|P3|STARTED|Overall Study||19
300908|NCT01745133|718825|P2|STARTED|Overall Study||20
300909|NCT01745133|718826|P1|STARTED|Overall Study||19
300910|NCT01745055|718834|P1|NOT COMPLETED|Overall Study||0
300911|NCT01745055|718834|P1|COMPLETED|Overall Study||12
300912|NCT01745055|718834|P1|STARTED|Overall Study||12
300913|NCT01744977|718869|P2|NOT COMPLETED|Overall Study||5
300914|NCT01744977|718870|P1|NOT COMPLETED|Overall Study||11
300915|NCT01744977|718869|P2|COMPLETED|Overall Study||115
300916|NCT01744977|718870|P1|COMPLETED|Overall Study||109
300917|NCT01744977|718869|P2|6 Month Completed|Overall Study||115
300918|NCT01744977|718870|P1|6 Month Completed|Overall Study||113
300919|NCT01744977|718869|P2|STARTED|Overall Study||120
300920|NCT01744977|718870|P1|STARTED|Overall Study||120
300921|NCT01744860|718878|P1|NOT COMPLETED|Overall Study||0
300922|NCT01744860|718878|P1|COMPLETED|Overall Study||420
300923|NCT01744860|718878|P1|STARTED|Overall Study||420
300924|NCT01744821|718916|P4|NOT COMPLETED|Overall Study||0
300925|NCT01744821|718917|P3|NOT COMPLETED|Overall Study||0
300926|NCT01744821|718918|P2|NOT COMPLETED|Overall Study||0
300927|NCT01744821|718919|P1|NOT COMPLETED|Overall Study||0
300928|NCT01744821|718916|P4|COMPLETED|Overall Study||1
300929|NCT01744821|718917|P3|COMPLETED|Overall Study||2
300930|NCT01744821|718918|P2|COMPLETED|Overall Study||3
300931|NCT01744821|718919|P1|COMPLETED|Overall Study||1
300932|NCT01744821|718916|P4|STARTED|Overall Study||1
300933|NCT01744821|718917|P3|STARTED|Overall Study||2
300934|NCT01744821|718918|P2|STARTED|Overall Study||3
300935|NCT01744821|718919|P1|STARTED|Overall Study||1
300936|NCT01744730|718946|P5|NOT COMPLETED|Overall Study||0
300937|NCT01744730|718947|P4|NOT COMPLETED|Overall Study||0
300938|NCT01744730|718948|P3|NOT COMPLETED|Overall Study||0
300939|NCT01744730|718949|P2|NOT COMPLETED|Overall Study||0
300940|NCT01744730|718950|P1|NOT COMPLETED|Overall Study||0
300941|NCT01744730|718946|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
300942|NCT01744730|718947|P4|COMPLETED|Overall Study||11
300943|NCT01744730|718948|P3|COMPLETED|Overall Study||4
300944|NCT01744730|718949|P2|COMPLETED|Overall Study||3
300945|NCT01744730|718950|P1|COMPLETED|Overall Study||4
300946|NCT01744730|718946|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
300947|NCT01744730|718947|P4|STARTED|Overall Study||11
300948|NCT01744730|718948|P3|STARTED|Overall Study||4
300949|NCT01744730|718949|P2|STARTED|Overall Study||3
300950|NCT01744730|718950|P1|STARTED|Overall Study||4
300951|NCT01744691|718993|P1|NOT COMPLETED|Overall Study||43
300952|NCT01744691|718993|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
300953|NCT01744691|718993|P1|STARTED|Overall Study|Participants who received study treatment|144
300954|NCT01744496|719000|P2|NOT COMPLETED|Maintenance Period||4
300955|NCT01744496|719001|P1|NOT COMPLETED|Maintenance Period||4
300956|NCT01744496|719000|P2|COMPLETED|Maintenance Period||29
300957|NCT01744496|719001|P1|COMPLETED|Maintenance Period||27
300958|NCT01744496|719000|P2|STARTED|Maintenance Period||33
300959|NCT01744496|719001|P1|STARTED|Maintenance Period||31
300960|NCT01744496|719000|P2|NOT COMPLETED|Titration Period||2
300961|NCT01744496|719001|P1|NOT COMPLETED|Titration Period||2
300962|NCT01744496|719000|P2|COMPLETED|Titration Period||33
300963|NCT01744496|719001|P1|COMPLETED|Titration Period||31
300964|NCT01744496|719000|P2|STARTED|Titration Period||35
300965|NCT01744496|719001|P1|STARTED|Titration Period||33
300966|NCT01744483|719022|P3|NOT COMPLETED|Overall Study||28
300967|NCT01744483|719023|P2|NOT COMPLETED|Overall Study||22
300968|NCT01744483|719024|P1|NOT COMPLETED|Overall Study||29
300969|NCT01744483|719022|P3|COMPLETED|Overall Study||10
300970|NCT01744483|719023|P2|COMPLETED|Overall Study||13
300971|NCT01744483|719024|P1|COMPLETED|Overall Study||15
300972|NCT01744483|719022|P3|STARTED|Overall Study||38
300973|NCT01744483|719023|P2|STARTED|Overall Study||35
300974|NCT01744483|719024|P1|STARTED|Overall Study||44
300975|NCT01744392|719032|P1|NOT COMPLETED|Overall Study||1
300976|NCT01744392|719032|P1|COMPLETED|Overall Study||22
300977|NCT01744392|719032|P1|STARTED|Overall Study||23
300978|NCT01744353|719048|P3|NOT COMPLETED|Overall Study||0
300979|NCT01744353|719049|P2|NOT COMPLETED|Overall Study||0
300980|NCT01744353|719050|P1|NOT COMPLETED|Overall Study||0
300981|NCT01744353|719048|P3|COMPLETED|Overall Study||3
300982|NCT01744353|719049|P2|COMPLETED|Overall Study||26
300983|NCT01744353|719050|P1|COMPLETED|Overall Study||6
300984|NCT01744353|719048|P3|STARTED|Overall Study||3
300985|NCT01744353|719049|P2|STARTED|Overall Study||26
300986|NCT01744353|719050|P1|STARTED|Overall Study||6
300987|NCT01744340|719061|P2|NOT COMPLETED|Overall Study||0
300988|NCT01744340|719062|P1|NOT COMPLETED|Overall Study||0
300989|NCT01744340|719061|P2|COMPLETED|Overall Study||15
300990|NCT01744340|719062|P1|COMPLETED|Overall Study||8
300991|NCT01744340|719061|P2|STARTED|Overall Study||15
300992|NCT01744340|719062|P1|STARTED|Overall Study||8
300993|NCT01744197|719072|P2|NOT COMPLETED|Overall Study||3
300994|NCT01744197|719073|P1|NOT COMPLETED|Overall Study||4
300995|NCT01744197|719072|P2|COMPLETED|Overall Study||26
300996|NCT01744197|719073|P1|COMPLETED|Overall Study||28
300997|NCT01744197|719072|P2|STARTED|Overall Study||29
300998|NCT01744197|719073|P1|STARTED|Overall Study||32
300999|NCT01743963|719085|P2|NOT COMPLETED|Overall Study||0
301000|NCT01743963|719086|P1|NOT COMPLETED|Overall Study||0
301001|NCT01743963|719085|P2|COMPLETED|Overall Study||17
301002|NCT01743963|719086|P1|COMPLETED|Overall Study||21
301003|NCT01743963|719085|P2|STARTED|Overall Study||17
301004|NCT01743963|719086|P1|STARTED|Overall Study||21
301005|NCT01743729|719094|P2|NOT COMPLETED|Overall Study||12
301006|NCT01743729|719095|P1|NOT COMPLETED|Overall Study||37
301007|NCT01743729|719094|P2|COMPLETED|Overall Study||348
301008|NCT01743729|719095|P1|COMPLETED|Overall Study||321
301009|NCT01743729|719094|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
301010|NCT01743729|719095|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
301011|NCT01743521|719107|P4|NOT COMPLETED|Overall Study||0
301012|NCT01743521|719108|P3|NOT COMPLETED|Overall Study||0
301013|NCT01743521|719109|P2|NOT COMPLETED|Overall Study||0
301014|NCT01743521|719110|P1|NOT COMPLETED|Overall Study||0
301015|NCT01743521|719107|P4|COMPLETED|Overall Study||2
301016|NCT01743521|719108|P3|COMPLETED|Overall Study||2
301017|NCT01743521|719109|P2|COMPLETED|Overall Study||3
301018|NCT01743521|719110|P1|COMPLETED|Overall Study||7
301019|NCT01743521|719107|P4|STARTED|Overall Study||2
301020|NCT01743521|719108|P3|STARTED|Overall Study||2
301021|NCT01743521|719109|P2|STARTED|Overall Study||3
301022|NCT01743521|719110|P1|STARTED|Overall Study||7
301023|NCT01743092|719162|P2|NOT COMPLETED|Overall Study||15
301024|NCT01743092|719163|P1|NOT COMPLETED|Overall Study||14
301025|NCT01743092|719162|P2|COMPLETED|Overall Study||11
301026|NCT01743092|719163|P1|COMPLETED|Overall Study||19
301027|NCT01743092|719162|P2|STARTED|Overall Study||26
301028|NCT01743092|719163|P1|STARTED|Overall Study||33
301029|NCT01743027|719175|P4|NOT COMPLETED|Overall Study||1
301030|NCT01743027|719176|P3|NOT COMPLETED|Overall Study||9
301031|NCT01743027|719177|P2|NOT COMPLETED|Overall Study||5
301032|NCT01743027|719178|P1|NOT COMPLETED|Overall Study||5
301033|NCT01743027|719175|P4|COMPLETED|Overall Study||48
301034|NCT01743027|719176|P3|COMPLETED|Overall Study||90
301035|NCT01743027|719177|P2|COMPLETED|Overall Study||94
301036|NCT01743027|719178|P1|COMPLETED|Overall Study||93
301037|NCT01743027|719175|P4|STARTED|Overall Study||49
301038|NCT01743027|719176|P3|STARTED|Overall Study||99
301039|NCT01743027|719177|P2|STARTED|Overall Study||99
301040|NCT01743027|719178|P1|STARTED|Overall Study||98
301041|NCT01742936|719218|P2|NOT COMPLETED|Overall Study||0
301042|NCT01742936|719219|P1|NOT COMPLETED|Overall Study||0
301043|NCT01742936|719218|P2|COMPLETED|Overall Study||50
301044|NCT01742936|719219|P1|COMPLETED|Overall Study||50
301045|NCT01742936|719218|P2|STARTED|Overall Study||50
301046|NCT01742936|719219|P1|STARTED|Overall Study||50
301047|NCT01742897|719227|P1|NOT COMPLETED|Overall Study||5
301048|NCT01742897|719227|P1|COMPLETED|Overall Study||30
301049|NCT01742897|719227|P1|Treated|Overall Study||33
301050|NCT01742897|719227|P1|STARTED|Overall Study||35
301051|NCT01742832|719233|P2|NOT COMPLETED|Overall Study||5
301052|NCT01742832|719234|P1|NOT COMPLETED|Overall Study||1
301053|NCT01742832|719233|P2|COMPLETED|Overall Study||23
301054|NCT01742832|719234|P1|COMPLETED|Overall Study||19
301055|NCT01742832|719233|P2|STARTED|Overall Study||28
301056|NCT01742832|719234|P1|STARTED|Overall Study||20
301057|NCT01742364|719244|P4|NOT COMPLETED|Overall Study||0
301058|NCT01742364|719245|P3|NOT COMPLETED|Overall Study||0
301059|NCT01742364|719246|P2|NOT COMPLETED|Overall Study||0
301060|NCT01742364|719247|P1|NOT COMPLETED|Overall Study||0
301061|NCT01742364|719244|P4|COMPLETED|Overall Study||15
301062|NCT01742364|719245|P3|COMPLETED|Overall Study||15
301063|NCT01742364|719246|P2|COMPLETED|Overall Study||33
301064|NCT01742364|719247|P1|COMPLETED|Overall Study||33
301065|NCT01742364|719244|P4|STARTED|Overall Study||15
301066|NCT01742364|719245|P3|STARTED|Overall Study||15
301067|NCT01742364|719246|P2|STARTED|Overall Study||33
301068|NCT01742364|719247|P1|STARTED|Overall Study||33
301069|NCT01741792|719276|P3|NOT COMPLETED|Overall Study||12
301070|NCT01741792|719277|P2|NOT COMPLETED|Overall Study||1
301071|NCT01741792|719278|P1|NOT COMPLETED|Overall Study||6
301072|NCT01741792|719276|P3|COMPLETED|Overall Study||2
301073|NCT01741792|719277|P2|COMPLETED|Overall Study||1
301074|NCT01741792|719278|P1|COMPLETED|Overall Study||3
301075|NCT01741792|719276|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
301076|NCT01741792|719277|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
301077|NCT01741792|719278|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
301078|NCT01741792|719276|P3|STARTED|Overall Study||14
301079|NCT01741792|719277|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
301080|NCT01741792|719278|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
301081|NCT01741701|719345|P2|NOT COMPLETED|Overall Study||2
301082|NCT01741701|719346|P1|NOT COMPLETED|Overall Study||5
301083|NCT01741701|719345|P2|COMPLETED|Overall Study||13
301084|NCT01741701|719346|P1|COMPLETED|Overall Study||13
301085|NCT01741701|719345|P2|STARTED|Overall Study||15
301086|NCT01741701|719346|P1|STARTED|Overall Study||18
301087|NCT01741688|719362|P1|NOT COMPLETED|Overall Study||3
301088|NCT01741688|719362|P1|COMPLETED|Overall Study||13
301089|NCT01741688|719362|P1|STARTED|Overall Study||16
301090|NCT01741350|719381|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
301091|NCT01741350|719382|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
301092|NCT01741350|719381|P2|COMPLETED|12-Month Follow-up Assessment||109
301093|NCT01741350|719382|P1|COMPLETED|12-Month Follow-up Assessment||111
301094|NCT01741350|719381|P2|STARTED|12-Month Follow-up Assessment||111
301095|NCT01741350|719382|P1|STARTED|12-Month Follow-up Assessment||114
301096|NCT01741350|719381|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
301097|NCT01741350|719382|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
301098|NCT01741350|719381|P2|COMPLETED|6-Month Follow-up Assessment||111
301099|NCT01741350|719382|P1|COMPLETED|6-Month Follow-up Assessment||114
301100|NCT01741350|719381|P2|STARTED|6-Month Follow-up Assessment||119
301101|NCT01741350|719382|P1|STARTED|6-Month Follow-up Assessment||129
301102|NCT01741350|719381|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
301103|NCT01741350|719382|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
301104|NCT01741350|719381|P2|COMPLETED|3-Month Follow-up Assessment||119
301105|NCT01741350|719382|P1|COMPLETED|3-Month Follow-up Assessment||129
301106|NCT01741350|719381|P2|STARTED|3-Month Follow-up Assessment||141
301107|NCT01741350|719382|P1|STARTED|3-Month Follow-up Assessment||135
301108|NCT01741350|719381|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
301109|NCT01741350|719382|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
301110|NCT01741350|719381|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
301111|NCT01741350|719382|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
301112|NCT01741350|719381|P2|STARTED|Post Intervention Assessment (at Week 4)||155
301113|NCT01741350|719382|P1|STARTED|Post Intervention Assessment (at Week 4)||149
301114|NCT01741350|719381|P2|NOT COMPLETED|Study Intervention||0
301115|NCT01741350|719382|P1|NOT COMPLETED|Study Intervention||0
301116|NCT01741350|719381|P2|COMPLETED|Study Intervention||155
301117|NCT01741350|719382|P1|COMPLETED|Study Intervention||149
301118|NCT01741350|719381|P2|STARTED|Study Intervention||155
301119|NCT01741350|719382|P1|STARTED|Study Intervention||149
301120|NCT01741272|719518|P2|NOT COMPLETED|Overall Study||0
301121|NCT01741272|719519|P1|NOT COMPLETED|Overall Study||0
301122|NCT01741272|719518|P2|COMPLETED|Overall Study||97
301123|NCT01741272|719519|P1|COMPLETED|Overall Study||92
301124|NCT01741272|719518|P2|STARTED|Overall Study||97
301125|NCT01741272|719519|P1|STARTED|Overall Study||92
301126|NCT01740817|719533|P2|NOT COMPLETED|Second Intervention (48 h)||0
301127|NCT01740817|719534|P1|NOT COMPLETED|Second Intervention (48 h)||0
301128|NCT01740817|719533|P2|COMPLETED|Second Intervention (48 h)||4
301129|NCT01740817|719534|P1|COMPLETED|Second Intervention (48 h)||8
301130|NCT01740817|719533|P2|STARTED|Second Intervention (48 h)||4
301131|NCT01740817|719534|P1|STARTED|Second Intervention (48 h)||8
301132|NCT01740817|719533|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
301133|NCT01740817|719534|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
301134|NCT01740817|719533|P2|COMPLETED|Washout (4-6 Weeks)||4
301135|NCT01740817|719534|P1|COMPLETED|Washout (4-6 Weeks)||8
301136|NCT01740817|719533|P2|STARTED|Washout (4-6 Weeks)||4
301137|NCT01740817|719534|P1|STARTED|Washout (4-6 Weeks)||8
301138|NCT01740817|719533|P2|NOT COMPLETED|First Intervention (48 h)||0
301139|NCT01740817|719534|P1|NOT COMPLETED|First Intervention (48 h)||0
301140|NCT01740817|719533|P2|COMPLETED|First Intervention (48 h)||4
301141|NCT01740817|719534|P1|COMPLETED|First Intervention (48 h)||8
301142|NCT01740817|719533|P2|STARTED|First Intervention (48 h)||4
301143|NCT01740817|719534|P1|STARTED|First Intervention (48 h)||8
301144|NCT01740726|719546|P2|NOT COMPLETED|Overall Study||0
301145|NCT01740726|719547|P1|NOT COMPLETED|Overall Study||0
301146|NCT01740726|719546|P2|COMPLETED|Overall Study||1
301147|NCT01740726|719547|P1|COMPLETED|Overall Study||0
301148|NCT01740726|719546|P2|STARTED|Overall Study||1
301149|NCT01740726|719547|P1|STARTED|Overall Study||0
301150|NCT01740713|719556|P3|NOT COMPLETED|Overall Study||1
301151|NCT01740713|719557|P2|NOT COMPLETED|Overall Study||2
301152|NCT01740713|719558|P1|NOT COMPLETED|Overall Study||0
301153|NCT01740713|719556|P3|COMPLETED|Overall Study||6
301154|NCT01740713|719557|P2|COMPLETED|Overall Study||6
301155|NCT01740713|719558|P1|COMPLETED|Overall Study||6
301156|NCT01740713|719556|P3|STARTED|Overall Study||7
301157|NCT01740713|719557|P2|STARTED|Overall Study||8
301158|NCT01740713|719558|P1|STARTED|Overall Study||6
301159|NCT01740440|719582|P1|NOT COMPLETED|Overall Study||3
301160|NCT01740440|719582|P1|COMPLETED|Overall Study||27
301161|NCT01740440|719582|P1|STARTED|Overall Study||30
301162|NCT01740427|719590|P2|NOT COMPLETED|Overall Study||222
301163|NCT01740427|719591|P1|NOT COMPLETED|Overall Study||444
301164|NCT01740427|719590|P2|COMPLETED|Overall Study||0
301165|NCT01740427|719591|P1|COMPLETED|Overall Study||0
301166|NCT01740427|719590|P2|STARTED|Overall Study||222
301167|NCT01740427|719591|P1|STARTED|Overall Study||444
301168|NCT01740401|719618|P1|NOT COMPLETED|Overall Study||10
301169|NCT01740401|719618|P1|COMPLETED|Overall Study||0
301170|NCT01740401|719618|P1|STARTED|Overall Study||10
301171|NCT01740388|719627|P2|NOT COMPLETED|Overall Study||44
301172|NCT01740388|719628|P1|NOT COMPLETED|Overall Study||46
301173|NCT01740388|719627|P2|COMPLETED|Overall Study||28
301174|NCT01740388|719628|P1|COMPLETED|Overall Study||18
301175|NCT01740388|719627|P2|STARTED|Overall Study||72
301176|NCT01740388|719628|P1|STARTED|Overall Study||64
301177|NCT01740362|719648|P4|NOT COMPLETED|Overall Study||0
301178|NCT01740362|719649|P3|NOT COMPLETED|Overall Study||0
301179|NCT01740362|719650|P2|NOT COMPLETED|Overall Study||0
301180|NCT01740362|719651|P1|NOT COMPLETED|Overall Study||0
301181|NCT01740362|719648|P4|COMPLETED|Overall Study||6
301182|NCT01740362|719649|P3|COMPLETED|Overall Study||6
301183|NCT01740362|719650|P2|COMPLETED|Overall Study||6
301184|NCT01740362|719651|P1|COMPLETED|Overall Study||6
301185|NCT01740362|719648|P4|STARTED|Overall Study||6
301186|NCT01740362|719649|P3|STARTED|Overall Study||6
301187|NCT01740362|719650|P2|STARTED|Overall Study||6
301188|NCT01740362|719651|P1|STARTED|Overall Study||6
301189|NCT01740089|719680|P3|NOT COMPLETED|After 12 Weeks||11
301190|NCT01740089|719681|P2|NOT COMPLETED|After 12 Weeks||3
301191|NCT01740089|719682|P1|NOT COMPLETED|After 12 Weeks||7
301192|NCT01740089|719680|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
301193|NCT01740089|719681|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
301194|NCT01740089|719682|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
301195|NCT01740089|719680|P3|STARTED|After 12 Weeks||48
301196|NCT01740089|719681|P2|STARTED|After 12 Weeks||48
301197|NCT01740089|719682|P1|STARTED|After 12 Weeks||50
301198|NCT01740089|719680|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
301199|NCT01740089|719681|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
301200|NCT01740089|719682|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
301201|NCT01740089|719680|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
301202|NCT01740089|719681|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
301203|NCT01740089|719682|P1|COMPLETED|First 12 Weeks of Treatment||50
301204|NCT01740089|719680|P3|STARTED|First 12 Weeks of Treatment||50
301205|NCT01740089|719681|P2|STARTED|First 12 Weeks of Treatment||50
301206|NCT01740089|719682|P1|STARTED|First 12 Weeks of Treatment||50
301207|NCT01739803|719700|P2|NOT COMPLETED|Overall Study||6
301208|NCT01739803|719701|P1|NOT COMPLETED|Overall Study||9
301209|NCT01739803|719700|P2|COMPLETED|Overall Study||68
301210|NCT01739803|719701|P1|COMPLETED|Overall Study||67
301211|NCT01739803|719700|P2|STARTED|Overall Study||74
301212|NCT01739803|719701|P1|STARTED|Overall Study||76
301213|NCT01739595|719714|P3|NOT COMPLETED|Overall Study||2
301214|NCT01739595|719715|P2|NOT COMPLETED|Overall Study||1
301215|NCT01739595|719716|P1|NOT COMPLETED|Overall Study||13
301216|NCT01739595|719714|P3|COMPLETED|Overall Study||45
301217|NCT01739595|719715|P2|COMPLETED|Overall Study||21
301218|NCT01739595|719716|P1|COMPLETED|Overall Study||99
301219|NCT01739595|719714|P3|STARTED|Overall Study||47
301220|NCT01739595|719715|P2|STARTED|Overall Study||22
301221|NCT01739595|719716|P1|STARTED|Overall Study||112
301222|NCT01739361|719726|P2|NOT COMPLETED|Overall Study||1
301223|NCT01739361|719727|P1|NOT COMPLETED|Overall Study||3
301224|NCT01739361|719726|P2|COMPLETED|Overall Study||22
301225|NCT01739361|719727|P1|COMPLETED|Overall Study||18
301226|NCT01739361|719726|P2|STARTED|Overall Study||23
301227|NCT01739361|719727|P1|STARTED|Overall Study||21
301228|NCT01738984|719735|P2|NOT COMPLETED|Overall Study||39
301229|NCT01738984|719736|P1|NOT COMPLETED|Overall Study||64
301230|NCT01738984|719735|P2|COMPLETED|Overall Study||210
301231|NCT01738984|719736|P1|COMPLETED|Overall Study||186
301232|NCT01738984|719735|P2|STARTED|Overall Study||249
301233|NCT01738984|719736|P1|STARTED|Overall Study||250
301234|NCT01738971|719749|P3|NOT COMPLETED|Overall Study||17
301235|NCT01738971|719750|P2|NOT COMPLETED|Overall Study||30
301236|NCT01738971|719751|P1|NOT COMPLETED|Overall Study||19
301237|NCT01738971|719749|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
301238|NCT01738971|719750|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
301239|NCT01738971|719751|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
301240|NCT01738971|719749|P3|STARTED|Overall Study|56 participants recruited to this arm|56
301241|NCT01738971|719750|P2|STARTED|Overall Study|58 participants recruited to this arm|58
301242|NCT01738971|719751|P1|STARTED|Overall Study|54 participants recruited to this arm|54
301243|NCT01738919|719767|P2|NOT COMPLETED|Overall Study||3
301244|NCT01738919|719768|P1|NOT COMPLETED|Overall Study||1
301245|NCT01738919|719767|P2|COMPLETED|Overall Study||14
301246|NCT01738919|719768|P1|COMPLETED|Overall Study||14
301247|NCT01738919|719767|P2|STARTED|Overall Study||17
301248|NCT01738919|719768|P1|STARTED|Overall Study||15
301249|NCT01738750|719786|P2|NOT COMPLETED|Overall Study||0
301250|NCT01738750|719787|P1|NOT COMPLETED|Overall Study||0
301251|NCT01738750|719786|P2|COMPLETED|Overall Study||51
301252|NCT01738750|719787|P1|COMPLETED|Overall Study||49
301253|NCT01738750|719786|P2|STARTED|Overall Study||51
301254|NCT01738750|719787|P1|STARTED|Overall Study||49
301255|NCT01738737|719800|P5|NOT COMPLETED|Overall Study||4
301256|NCT01738737|719801|P4|NOT COMPLETED|Overall Study||4
301257|NCT01738737|719802|P3|NOT COMPLETED|Overall Study||4
301258|NCT01738737|719803|P2|NOT COMPLETED|Overall Study||4
301259|NCT01738737|719804|P1|NOT COMPLETED|Overall Study||4
301260|NCT01738737|719800|P5|COMPLETED|Overall Study||25
301261|NCT01738737|719801|P4|COMPLETED|Overall Study||25
301262|NCT01738737|719802|P3|COMPLETED|Overall Study||25
301263|NCT01738737|719803|P2|COMPLETED|Overall Study||25
301264|NCT01738737|719804|P1|COMPLETED|Overall Study||25
301265|NCT01738737|719800|P5|STARTED|Overall Study||29
301266|NCT01738737|719801|P4|STARTED|Overall Study||29
301267|NCT01738737|719802|P3|STARTED|Overall Study||29
301268|NCT01738737|719803|P2|STARTED|Overall Study||29
301269|NCT01738737|719804|P1|STARTED|Overall Study||29
301270|NCT01738698|719840|P4|NOT COMPLETED|Overall Study||0
301271|NCT01738698|719841|P3|NOT COMPLETED|Overall Study||0
301272|NCT01738698|719842|P2|NOT COMPLETED|Overall Study||0
301273|NCT01738698|719843|P1|NOT COMPLETED|Overall Study||0
301274|NCT01738698|719840|P4|COMPLETED|Overall Study||0
301275|NCT01738698|719841|P3|COMPLETED|Overall Study||0
301276|NCT01738698|719842|P2|COMPLETED|Overall Study||0
301277|NCT01738698|719843|P1|COMPLETED|Overall Study||0
301278|NCT01738698|719840|P4|STARTED|Overall Study||0
301279|NCT01738698|719841|P3|STARTED|Overall Study||0
301280|NCT01738698|719842|P2|STARTED|Overall Study||0
301281|NCT01738698|719843|P1|STARTED|Overall Study||0
301282|NCT01738646|719909|P1|NOT COMPLETED|Overall Study||2
301283|NCT01738646|719909|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
301284|NCT01738646|719909|P1|STARTED|Overall Study||40
301285|NCT01738581|719919|P2|NOT COMPLETED|Overall Study||0
301286|NCT01738581|719920|P1|NOT COMPLETED|Overall Study||1
301287|NCT01738581|719919|P2|COMPLETED|Overall Study||4
301288|NCT01738581|719920|P1|COMPLETED|Overall Study||4
301289|NCT01738581|719919|P2|STARTED|Overall Study||4
301290|NCT01738581|719920|P1|STARTED|Overall Study||5
301291|NCT01738438|719938|P1|NOT COMPLETED|Overall Study||35
301292|NCT01738438|719938|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
301293|NCT01738438|719938|P1|STARTED|Overall Study||35
301294|NCT01738321|719946|P2|NOT COMPLETED|Overall Study||0
301295|NCT01738321|719947|P1|NOT COMPLETED|Overall Study||0
301296|NCT01738321|719946|P2|COMPLETED|Overall Study||30
301297|NCT01738321|719947|P1|COMPLETED|Overall Study||33
301298|NCT01738321|719946|P2|STARTED|Overall Study||30
301299|NCT01738321|719947|P1|STARTED|Overall Study||33
301300|NCT01737996|719956|P3|NOT COMPLETED|Overall Study||2
301301|NCT01737996|719957|P2|NOT COMPLETED|Overall Study||1
301302|NCT01737996|719958|P1|NOT COMPLETED|Overall Study||0
301303|NCT01737996|719956|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
301304|NCT01737996|719957|P2|COMPLETED|Overall Study||7
301305|NCT01737996|719958|P1|COMPLETED|Overall Study||8
301306|NCT01737996|719956|P3|STARTED|Overall Study||16
301307|NCT01737996|719957|P2|STARTED|Overall Study||8
301308|NCT01737996|719958|P1|STARTED|Overall Study||8
301309|NCT01737944|719999|P4|NOT COMPLETED|Overall Study||0
301310|NCT01737944|720000|P3|NOT COMPLETED|Overall Study||0
301311|NCT01737944|720001|P2|NOT COMPLETED|Overall Study||0
301312|NCT01737944|720002|P1|NOT COMPLETED|Overall Study||0
301313|NCT01737944|719999|P4|COMPLETED|Overall Study||9
301314|NCT01737944|720000|P3|COMPLETED|Overall Study||9
301315|NCT01737944|720001|P2|COMPLETED|Overall Study||9
301316|NCT01737944|720002|P1|COMPLETED|Overall Study||9
301317|NCT01737944|719999|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
301318|NCT01737944|720000|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
301319|NCT01737944|720001|P2|STARTED|Overall Study||9
301320|NCT01737944|720002|P1|STARTED|Overall Study||9
301321|NCT01737931|720020|P3|NOT COMPLETED|Overall Study||1
301322|NCT01737931|720021|P2|NOT COMPLETED|Overall Study||2
301323|NCT01737931|720022|P1|NOT COMPLETED|Overall Study||0
301324|NCT01737931|720020|P3|COMPLETED|Overall Study||38
301325|NCT01737931|720021|P2|COMPLETED|Overall Study||38
301326|NCT01737931|720022|P1|COMPLETED|Overall Study||38
301327|NCT01737931|720020|P3|STARTED|Overall Study||39
301328|NCT01737931|720021|P2|STARTED|Overall Study||40
301329|NCT01737931|720022|P1|STARTED|Overall Study||38
301330|NCT01737879|720037|P1|NOT COMPLETED|Overall Study||41
301331|NCT01737879|720037|P1|COMPLETED|Overall Study||0
301332|NCT01737879|720037|P1|Transitioned to Epoetin Alfa|Overall Study||0
301333|NCT01737879|720037|P1|Received Peginesatide|Overall Study||34
301334|NCT01737879|720037|P1|STARTED|Overall Study||41
301335|NCT01737840|720046|P2|NOT COMPLETED|Overall Study||2
301336|NCT01737840|720047|P1|NOT COMPLETED|Overall Study||2
301337|NCT01737840|720046|P2|COMPLETED|Overall Study||33
301338|NCT01737840|720047|P1|COMPLETED|Overall Study||33
301339|NCT01737840|720046|P2|STARTED|Overall Study||35
301340|NCT01737840|720047|P1|STARTED|Overall Study||35
301341|NCT01737710|720060|P5|NOT COMPLETED|Overall Study||0
301342|NCT01737710|720061|P4|NOT COMPLETED|Overall Study||0
301343|NCT01737710|720062|P3|NOT COMPLETED|Overall Study||3
301344|NCT01737710|720063|P2|NOT COMPLETED|Overall Study||4
301345|NCT01737710|720064|P1|NOT COMPLETED|Overall Study||2
301346|NCT01737710|720060|P5|COMPLETED|Overall Study||21
301347|NCT01737710|720061|P4|COMPLETED|Overall Study||23
301348|NCT01737710|720062|P3|COMPLETED|Overall Study||102
301349|NCT01737710|720063|P2|COMPLETED|Overall Study||101
301350|NCT01737710|720064|P1|COMPLETED|Overall Study||112
301351|NCT01737710|720060|P5|STARTED|Overall Study||21
301352|NCT01737710|720061|P4|STARTED|Overall Study||23
301353|NCT01737710|720062|P3|STARTED|Overall Study||105
301354|NCT01737710|720063|P2|STARTED|Overall Study||105
301355|NCT01737710|720064|P1|STARTED|Overall Study||114
301356|NCT01737684|720103|P3|NOT COMPLETED|Overall Study||0
301357|NCT01737684|720104|P2|NOT COMPLETED|Overall Study||0
301358|NCT01737684|720105|P1|NOT COMPLETED|Overall Study||0
301359|NCT01737684|720103|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
301360|NCT01737684|720104|P2|COMPLETED|Overall Study||8
301361|NCT01737684|720105|P1|COMPLETED|Overall Study||8
301362|NCT01737684|720103|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
301363|NCT01737684|720104|P2|STARTED|Overall Study||8
301364|NCT01737684|720105|P1|STARTED|Overall Study||8
301365|NCT01737593|720124|P3|NOT COMPLETED|Overall Study||0
301366|NCT01737593|720125|P2|NOT COMPLETED|Overall Study||0
301367|NCT01737593|720126|P1|NOT COMPLETED|Overall Study||0
301368|NCT01737593|720124|P3|COMPLETED|Overall Study||39
301369|NCT01737593|720125|P2|COMPLETED|Overall Study||32
301370|NCT01737593|720126|P1|COMPLETED|Overall Study||37
301371|NCT01737593|720124|P3|STARTED|Overall Study||39
301372|NCT01737593|720125|P2|STARTED|Overall Study||32
301373|NCT01737593|720126|P1|STARTED|Overall Study||37
301374|NCT01737021|720157|P2|NOT COMPLETED|Overall Study||3
301375|NCT01737021|720158|P1|NOT COMPLETED|Overall Study||5
301376|NCT01737021|720157|P2|COMPLETED|Overall Study||6
301377|NCT01737021|720158|P1|COMPLETED|Overall Study||17
301378|NCT01737021|720157|P2|STARTED|Overall Study||9
301379|NCT01737021|720158|P1|STARTED|Overall Study||22
301380|NCT01736930|720164|P1|NOT COMPLETED|Overall Study||1
301381|NCT01736930|720164|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
301382|NCT01736930|720164|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
301383|NCT01736917|720204|P1|NOT COMPLETED|Overall Study||11
301384|NCT01736917|720204|P1|COMPLETED|Overall Study||54
301385|NCT01736917|720204|P1|STARTED|Overall Study||65
301386|NCT01736696|720218|P7|NOT COMPLETED|Overall Study||0
301387|NCT01736696|720219|P6|NOT COMPLETED|Overall Study||0
301388|NCT01736696|720220|P5|NOT COMPLETED|Overall Study||0
301389|NCT01736696|720221|P4|NOT COMPLETED|Overall Study||0
301390|NCT01736696|720222|P3|NOT COMPLETED|Overall Study||1
301391|NCT01736696|720223|P2|NOT COMPLETED|Overall Study||0
301392|NCT01736696|720224|P1|NOT COMPLETED|Overall Study||0
301393|NCT01736696|720218|P7|COMPLETED|Overall Study||13
301394|NCT01736696|720219|P6|COMPLETED|Overall Study||8
301395|NCT01736696|720220|P5|COMPLETED|Overall Study||9
301396|NCT01736696|720221|P4|COMPLETED|Overall Study||9
301397|NCT01736696|720222|P3|COMPLETED|Overall Study||9
301398|NCT01736696|720223|P2|COMPLETED|Overall Study||5
301399|NCT01736696|720224|P1|COMPLETED|Overall Study||5
301400|NCT01736696|720218|P7|STARTED|Overall Study||13
301401|NCT01736696|720219|P6|STARTED|Overall Study||8
301402|NCT01736696|720220|P5|STARTED|Overall Study||9
301403|NCT01736696|720221|P4|STARTED|Overall Study||9
301404|NCT01736696|720222|P3|STARTED|Overall Study||10
301405|NCT01736696|720223|P2|STARTED|Overall Study||5
301406|NCT01736696|720224|P1|STARTED|Overall Study||5
301407|NCT01736657|720541|P1|NOT COMPLETED|Overall Study||1
301408|NCT01736657|720541|P1|COMPLETED|Overall Study||72
301409|NCT01736657|720541|P1|STARTED|Overall Study||73
301410|NCT01736579|720550|P2|NOT COMPLETED|Overall Study||2
301411|NCT01736579|720551|P1|NOT COMPLETED|Overall Study||2
301412|NCT01736579|720550|P2|COMPLETED|Overall Study||0
301413|NCT01736579|720551|P1|COMPLETED|Overall Study||0
301414|NCT01736579|720550|P2|STARTED|Overall Study||2
301415|NCT01736579|720551|P1|STARTED|Overall Study||2
301416|NCT01736540|720585|P1|NOT COMPLETED|Overall Study||15
301417|NCT01736540|720585|P1|COMPLETED|Overall Study||228
301418|NCT01736540|720585|P1|STARTED|Overall Study||243
301419|NCT01736527|720642|P1|NOT COMPLETED|Overall Study||0
301420|NCT01736527|720642|P1|COMPLETED|Overall Study||12
301421|NCT01736527|720642|P1|STARTED|Overall Study||12
301422|NCT01736475|720651|P2|NOT COMPLETED|Overall Study||0
301423|NCT01736475|720652|P1|NOT COMPLETED|Overall Study||12
301424|NCT01736475|720651|P2|COMPLETED|Overall Study||17
301425|NCT01736475|720652|P1|COMPLETED|Overall Study||109
301426|NCT01736475|720651|P2|STARTED|Overall Study||17
301427|NCT01736475|720652|P1|STARTED|Overall Study||121
301428|NCT01736215|720705|P1|NOT COMPLETED|Overall Study||14
301429|NCT01736215|720705|P1|COMPLETED|Overall Study||19
301430|NCT01736215|720705|P1|Treated|Overall Study||25
301431|NCT01736215|720705|P1|STARTED|Overall Study||33
301432|NCT01736176|720717|P1|NOT COMPLETED|Overall Study||11
301433|NCT01736176|720717|P1|COMPLETED|Overall Study||28
301434|NCT01736176|720717|P1|Received LCIG|Overall Study||38
301435|NCT01736176|720717|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
301436|NCT01735916|720764|P3|NOT COMPLETED|Overall Study||7
301437|NCT01735916|720765|P2|NOT COMPLETED|Overall Study||19
301438|NCT01735916|720766|P1|NOT COMPLETED|Overall Study||18
301439|NCT01735916|720764|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
301440|NCT01735916|720765|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
301441|NCT01735916|720766|P1|COMPLETED|Overall Study||0
301442|NCT01735916|720764|P3|STARTED|Overall Study||7
301443|NCT01735916|720765|P2|STARTED|Overall Study||19
301444|NCT01735916|720766|P1|STARTED|Overall Study||18
301445|NCT01735877|720787|P2|NOT COMPLETED|Overall Study||0
301446|NCT01735877|720788|P1|NOT COMPLETED|Overall Study||1
301447|NCT01735877|720787|P2|COMPLETED|Overall Study||21
301448|NCT01735877|720788|P1|COMPLETED|Overall Study||26
301449|NCT01735877|720787|P2|STARTED|Overall Study||21
301450|NCT01735877|720788|P1|STARTED|Overall Study||27
301451|NCT01735630|720804|P2|NOT COMPLETED|Overall Study||18
301452|NCT01735630|720805|P1|NOT COMPLETED|Overall Study||18
301453|NCT01735630|720804|P2|COMPLETED|Overall Study||157
301454|NCT01735630|720805|P1|COMPLETED|Overall Study||157
301455|NCT01735630|720804|P2|STARTED|Overall Study||175
301456|NCT01735630|720805|P1|STARTED|Overall Study||175
301457|NCT01735617|720819|P1|NOT COMPLETED|Overall Study||0
301458|NCT01735617|720819|P1|COMPLETED|Overall Study||16
301459|NCT01735617|720819|P1|STARTED|Overall Study||16
301460|NCT01735396|720832|P1|NOT COMPLETED|Overall Study||1
301461|NCT01735396|720832|P1|COMPLETED|Overall Study||10
301462|NCT01735396|720832|P1|STARTED|Overall Study||11
301463|NCT01735214|720841|P1|NOT COMPLETED|Overall Study||0
301464|NCT01735214|720841|P1|COMPLETED|Overall Study||358
301465|NCT01735214|720841|P1|STARTED|Overall Study||358
301466|NCT01735201|720861|P8|NOT COMPLETED|Overall Study||2
301467|NCT01735201|720862|P7|NOT COMPLETED|Overall Study||3
301468|NCT01735201|720863|P6|NOT COMPLETED|Overall Study||5
301469|NCT01735201|720864|P5|NOT COMPLETED|Overall Study||1
301470|NCT01735201|720865|P4|NOT COMPLETED|Overall Study||2
301471|NCT01735201|720866|P3|NOT COMPLETED|Overall Study||0
301472|NCT01735201|720867|P2|NOT COMPLETED|Overall Study||1
301473|NCT01735201|720868|P1|NOT COMPLETED|Overall Study||3
301474|NCT01735201|720861|P8|COMPLETED|Overall Study||42
301475|NCT01735201|720862|P7|COMPLETED|Overall Study||42
301476|NCT01735201|720863|P6|COMPLETED|Overall Study||40
301477|NCT01735201|720864|P5|COMPLETED|Overall Study||44
301478|NCT01735201|720865|P4|COMPLETED|Overall Study||42
301479|NCT01735201|720866|P3|COMPLETED|Overall Study||44
301480|NCT01735201|720867|P2|COMPLETED|Overall Study||43
301481|NCT01735201|720868|P1|COMPLETED|Overall Study||42
301482|NCT01735201|720861|P8|STARTED|Overall Study||44
301483|NCT01735201|720862|P7|STARTED|Overall Study||45
301484|NCT01735201|720863|P6|STARTED|Overall Study||45
301485|NCT01735201|720864|P5|STARTED|Overall Study||45
301486|NCT01735201|720865|P4|STARTED|Overall Study||44
301487|NCT01735201|720866|P3|STARTED|Overall Study||44
301488|NCT01735201|720867|P2|STARTED|Overall Study||44
301489|NCT01735201|720868|P1|STARTED|Overall Study||45
301490|NCT01735175|720904|P2|NOT COMPLETED|Overall Study||13
301491|NCT01735175|720905|P1|NOT COMPLETED|Overall Study||29
301492|NCT01735175|720904|P2|COMPLETED|Overall Study||144
301493|NCT01735175|720905|P1|COMPLETED|Overall Study||130
301494|NCT01735175|720904|P2|Completed the 6-month SFU Visit|Overall Study||138
301495|NCT01735175|720905|P1|Completed the 6-month SFU Visit|Overall Study||120
301496|NCT01735175|720904|P2|Completed All Treatments as Planned|Overall Study||150
301497|NCT01735175|720905|P1|Completed All Treatments as Planned|Overall Study||140
301498|NCT01735175|720904|P2|Completed All Cycles|Overall Study||150
301499|NCT01735175|720905|P1|Completed All Cycles|Overall Study||141
301500|NCT01735175|720904|P2|STARTED|Overall Study||157
301501|NCT01735175|720905|P1|STARTED|Overall Study||159
301502|NCT01734993|720925|P1|NOT COMPLETED|Overall Study||2
301503|NCT01734993|720925|P1|COMPLETED|Overall Study||9
301504|NCT01734993|720925|P1|STARTED|Overall Study||11
301505|NCT01734889|720951|P1|NOT COMPLETED|Overall Study||0
301506|NCT01734889|720951|P1|COMPLETED|Overall Study||18
301507|NCT01734889|720951|P1|STARTED|Overall Study||18
301508|NCT01734785|720962|P4|NOT COMPLETED|Double−Blind Period||0
301509|NCT01734785|720963|P3|NOT COMPLETED|Double−Blind Period||5
301510|NCT01734785|720964|P2|NOT COMPLETED|Double−Blind Period||9
301511|NCT01734785|720965|P1|NOT COMPLETED|Double−Blind Period||5
301512|NCT01734785|720962|P4|COMPLETED|Double−Blind Period||0
301513|NCT01734785|720963|P3|COMPLETED|Double−Blind Period||105
301514|NCT01734785|720964|P2|COMPLETED|Double−Blind Period||103
301515|NCT01734785|720965|P1|COMPLETED|Double−Blind Period||106
301516|NCT01734785|720962|P4|STARTED|Double−Blind Period||0
301517|NCT01734785|720963|P3|STARTED|Double−Blind Period||110
301518|NCT01734785|720964|P2|STARTED|Double−Blind Period||112
301519|NCT01734785|720965|P1|STARTED|Double−Blind Period||111
301520|NCT01734785|720962|P4|NOT COMPLETED|Open−Label Period||273
301521|NCT01734785|720963|P3|NOT COMPLETED|Open−Label Period||0
301522|NCT01734785|720964|P2|NOT COMPLETED|Open−Label Period||0
301523|NCT01734785|720965|P1|NOT COMPLETED|Open−Label Period||0
301524|NCT01734785|720962|P4|COMPLETED|Open−Label Period||333
301525|NCT01734785|720963|P3|COMPLETED|Open−Label Period||0
301526|NCT01734785|720964|P2|COMPLETED|Open−Label Period||0
301527|NCT01734785|720965|P1|COMPLETED|Open−Label Period||0
301528|NCT01734785|720962|P4|STARTED|Open−Label Period||606
301529|NCT01734785|720963|P3|STARTED|Open−Label Period||0
301530|NCT01734785|720964|P2|STARTED|Open−Label Period||0
301531|NCT01734785|720965|P1|STARTED|Open−Label Period||0
301532|NCT01734772|720982|P2|NOT COMPLETED|Overall Study||3
301533|NCT01734772|720983|P1|NOT COMPLETED|Overall Study||1
301534|NCT01734772|720982|P2|COMPLETED|Overall Study||21
301535|NCT01734772|720983|P1|COMPLETED|Overall Study||23
301536|NCT01734772|720982|P2|STARTED|Overall Study||24
301537|NCT01734772|720983|P1|STARTED|Overall Study||24
301538|NCT01734655|721000|P1|NOT COMPLETED|Overall Study||0
301539|NCT01734655|721000|P1|COMPLETED|Overall Study||40
301540|NCT01734655|721000|P1|STARTED|Overall Study||40
301541|NCT01734395|721009|P1|NOT COMPLETED|Overall Study||410
301542|NCT01734395|721009|P1|COMPLETED|Overall Study||1472
301543|NCT01734395|721009|P1|STARTED|Overall Study||1882
301544|NCT01734317|721015|P1|NOT COMPLETED|Overall Study||0
301545|NCT01734317|721015|P1|COMPLETED|Overall Study||10
301546|NCT01734317|721015|P1|STARTED|Overall Study||10
301547|NCT01734239|721021|P2|NOT COMPLETED|Overall Study||0
301548|NCT01734239|721022|P1|NOT COMPLETED|Overall Study||0
301549|NCT01734239|721021|P2|COMPLETED|Overall Study||50
301550|NCT01734239|721022|P1|COMPLETED|Overall Study||52
301551|NCT01734239|721021|P2|STARTED|Overall Study||50
301552|NCT01734239|721022|P1|STARTED|Overall Study||52
301553|NCT01734161|721037|P2|NOT COMPLETED|Overall Study||8
301554|NCT01734161|721038|P1|NOT COMPLETED|Overall Study||6
301555|NCT01734161|721037|P2|COMPLETED|Overall Study||53
301556|NCT01734161|721038|P1|COMPLETED|Overall Study||55
301557|NCT01734161|721037|P2|STARTED|Overall Study||61
301558|NCT01734161|721038|P1|STARTED|Overall Study||61
301559|NCT01733953|721046|P2|NOT COMPLETED|Overall Study||7
301560|NCT01733953|721047|P1|NOT COMPLETED|Overall Study||5
301561|NCT01733953|721046|P2|COMPLETED|Overall Study||6
301562|NCT01733953|721047|P1|COMPLETED|Overall Study||9
301563|NCT01733953|721046|P2|STARTED|Overall Study||13
301564|NCT01733953|721047|P1|STARTED|Overall Study||14
301565|NCT01733758|721067|P4|NOT COMPLETED|Overall Study||8
301566|NCT01733758|721068|P3|NOT COMPLETED|Overall Study||15
301567|NCT01733758|721069|P2|NOT COMPLETED|Overall Study||12
301568|NCT01733758|721070|P1|NOT COMPLETED|Overall Study||15
301569|NCT01733758|721067|P4|COMPLETED|Overall Study||95
301570|NCT01733758|721068|P3|COMPLETED|Overall Study||135
301571|NCT01733758|721069|P2|COMPLETED|Overall Study||148
301572|NCT01733758|721070|P1|COMPLETED|Overall Study||62
301573|NCT01733758|721067|P4|STARTED|Overall Study||103
301574|NCT01733758|721068|P3|STARTED|Overall Study||150
301575|NCT01733758|721069|P2|STARTED|Overall Study||160
301576|NCT01733758|721070|P1|STARTED|Overall Study||77
301577|NCT01733745|721123|P2|NOT COMPLETED|Overall Study||0
301578|NCT01733745|721124|P1|NOT COMPLETED|Overall Study||0
301579|NCT01733745|721123|P2|COMPLETED|Overall Study||13
301580|NCT01733745|721124|P1|COMPLETED|Overall Study||13
301581|NCT01733745|721123|P2|STARTED|Overall Study||13
301582|NCT01733745|721124|P1|STARTED|Overall Study||13
301583|NCT01733732|721136|P2|NOT COMPLETED|Overall Study||0
301584|NCT01733732|721137|P1|NOT COMPLETED|Overall Study||2
301585|NCT01733732|721136|P2|COMPLETED|Overall Study||27
301586|NCT01733732|721137|P1|COMPLETED|Overall Study||25
301587|NCT01733732|721136|P2|STARTED|Overall Study||27
301588|NCT01733732|721137|P1|STARTED|Overall Study||27
301589|NCT01733329|721173|P2|NOT COMPLETED|Overall Study||1
301590|NCT01733329|721174|P1|NOT COMPLETED|Overall Study||2
301591|NCT01733329|721173|P2|COMPLETED|Overall Study||60
301592|NCT01733329|721174|P1|COMPLETED|Overall Study||60
301593|NCT01733329|721173|P2|STARTED|Overall Study||61
301594|NCT01733329|721174|P1|STARTED|Overall Study||62
301595|NCT01733316|721186|P1|NOT COMPLETED|Overall Study||2
301596|NCT01733316|721186|P1|COMPLETED|Overall Study||39
301597|NCT01733316|721186|P1|STARTED|Overall Study||41
301598|NCT01733277|721210|P2|NOT COMPLETED|Overall Study||0
301599|NCT01733277|721211|P1|NOT COMPLETED|Overall Study||0
301600|NCT01733277|721210|P2|COMPLETED|Overall Study||25
301601|NCT01733277|721211|P1|COMPLETED|Overall Study||25
301602|NCT01733277|721210|P2|STARTED|Overall Study||25
301603|NCT01733277|721211|P1|STARTED|Overall Study||25
301604|NCT01733069|721223|P2|NOT COMPLETED|Overall Study||0
301605|NCT01733069|721224|P1|NOT COMPLETED|Overall Study||0
301606|NCT01733069|721223|P2|COMPLETED|Overall Study||1598
301607|NCT01733069|721224|P1|COMPLETED|Overall Study||264
301608|NCT01733069|721223|P2|STARTED|Overall Study||1598
301609|NCT01733069|721224|P1|STARTED|Overall Study||264
301610|NCT01733056|721233|P3|NOT COMPLETED|Overall Study||0
301611|NCT01733056|721234|P2|NOT COMPLETED|Overall Study||0
301612|NCT01733056|721235|P1|NOT COMPLETED|Overall Study||0
301613|NCT01733056|721233|P3|COMPLETED|Overall Study||12
301614|NCT01733056|721234|P2|COMPLETED|Overall Study||10
301615|NCT01733056|721235|P1|COMPLETED|Overall Study||21
301616|NCT01733056|721233|P3|STARTED|Overall Study||12
301617|NCT01733056|721234|P2|STARTED|Overall Study||10
301618|NCT01733056|721235|P1|STARTED|Overall Study||21
301619|NCT01732926|721251|P2|NOT COMPLETED|Overall Study||110
301620|NCT01732926|721252|P1|NOT COMPLETED|Overall Study||267
301621|NCT01732926|721251|P2|COMPLETED|Overall Study||45
301622|NCT01732926|721252|P1|COMPLETED|Overall Study||53
301623|NCT01732926|721251|P2|STARTED|Overall Study||155
301624|NCT01732926|721252|P1|STARTED|Overall Study||320
301625|NCT01732913|721268|P2|NOT COMPLETED|Overall Study||69
301626|NCT01732913|721269|P1|NOT COMPLETED|Overall Study||156
301627|NCT01732913|721268|P2|COMPLETED|Overall Study||28
301628|NCT01732913|721269|P1|COMPLETED|Overall Study||42
301629|NCT01732913|721268|P2|STARTED|Overall Study||97
301630|NCT01732913|721269|P1|STARTED|Overall Study||198
301631|NCT01732835|721283|P1|NOT COMPLETED|2-year Extended Follow-up||5
301632|NCT01732835|721283|P1|COMPLETED|2-year Extended Follow-up||39
301633|NCT01732835|721283|P1|STARTED|2-year Extended Follow-up||44
301634|NCT01732835|721283|P1|NOT COMPLETED|6-month Primary Endpoint||24
301635|NCT01732835|721283|P1|COMPLETED|6-month Primary Endpoint||44
301636|NCT01732835|721283|P1|STARTED|6-month Primary Endpoint||68
301637|NCT01732796|721317|P3|NOT COMPLETED|Overall Study||13
301638|NCT01732796|721318|P2|NOT COMPLETED|Overall Study||42
301639|NCT01732796|721319|P1|NOT COMPLETED|Overall Study||46
301640|NCT01732796|721317|P3|COMPLETED|Overall Study||38
301641|NCT01732796|721318|P2|COMPLETED|Overall Study||169
301642|NCT01732796|721319|P1|COMPLETED|Overall Study||162
301643|NCT01732796|721317|P3|STARTED|Overall Study||51
301644|NCT01732796|721318|P2|STARTED|Overall Study||211
301645|NCT01732796|721319|P1|STARTED|Overall Study||208
301646|NCT01732770|721337|P2|NOT COMPLETED|Overall Study||8
301647|NCT01732770|721338|P1|NOT COMPLETED|Overall Study||10
301648|NCT01732770|721337|P2|COMPLETED|Overall Study||313
301649|NCT01732770|721338|P1|COMPLETED|Overall Study||312
301650|NCT01732770|721337|P2|Received Study Treatment|Overall Study||320
301651|NCT01732770|721338|P1|Received Study Treatment|Overall Study||320
301652|NCT01732770|721337|P2|STARTED|Overall Study||321
301653|NCT01732770|721338|P1|STARTED|Overall Study||322
301654|NCT01732757|721353|P3|NOT COMPLETED|Overall Study||0
301655|NCT01732757|721354|P2|NOT COMPLETED|Overall Study||0
301656|NCT01732757|721355|P1|NOT COMPLETED|Overall Study||1
301657|NCT01732757|721353|P3|COMPLETED|Overall Study||52
301658|NCT01732757|721354|P2|COMPLETED|Overall Study||52
301659|NCT01732757|721355|P1|COMPLETED|Overall Study||52
301660|NCT01732757|721353|P3|STARTED|Overall Study||52
301661|NCT01732757|721354|P2|STARTED|Overall Study||52
301662|NCT01732757|721355|P1|STARTED|Overall Study||53
301663|NCT01732692|721395|P2|NOT COMPLETED|Overall Study||1
301664|NCT01732692|721396|P1|NOT COMPLETED|Overall Study||0
301665|NCT01732692|721395|P2|COMPLETED|Overall Study||69
301666|NCT01732692|721396|P1|COMPLETED|Overall Study||70
301667|NCT01732692|721395|P2|STARTED|Overall Study||70
301668|NCT01732692|721396|P1|STARTED|Overall Study||70
301669|NCT01732588|721413|P3|NOT COMPLETED|Third Intervention (7 Days)||0
301670|NCT01732588|721414|P2|NOT COMPLETED|Third Intervention (7 Days)||0
301671|NCT01732588|721415|P1|NOT COMPLETED|Third Intervention (7 Days)||0
301672|NCT01732588|721413|P3|COMPLETED|Third Intervention (7 Days)||4
301673|NCT01732588|721414|P2|COMPLETED|Third Intervention (7 Days)||2
301674|NCT01732588|721415|P1|COMPLETED|Third Intervention (7 Days)||4
301675|NCT01732588|721413|P3|STARTED|Third Intervention (7 Days)||4
301676|NCT01732588|721414|P2|STARTED|Third Intervention (7 Days)||2
301677|NCT01732588|721415|P1|STARTED|Third Intervention (7 Days)||4
301678|NCT01732588|721413|P3|NOT COMPLETED|Second Intervention (7 Days)||0
301679|NCT01732588|721414|P2|NOT COMPLETED|Second Intervention (7 Days)||0
301680|NCT01732588|721415|P1|NOT COMPLETED|Second Intervention (7 Days)||0
301681|NCT01732588|721413|P3|COMPLETED|Second Intervention (7 Days)||4
301682|NCT01732588|721414|P2|COMPLETED|Second Intervention (7 Days)||2
301683|NCT01732588|721415|P1|COMPLETED|Second Intervention (7 Days)||4
301684|NCT01732588|721413|P3|STARTED|Second Intervention (7 Days)||4
301685|NCT01732588|721414|P2|STARTED|Second Intervention (7 Days)||2
301686|NCT01732588|721415|P1|STARTED|Second Intervention (7 Days)||4
301687|NCT01732588|721413|P3|NOT COMPLETED|First Intervention (7 Days)||0
301688|NCT01732588|721414|P2|NOT COMPLETED|First Intervention (7 Days)||1
301689|NCT01732588|721415|P1|NOT COMPLETED|First Intervention (7 Days)||0
301690|NCT01732588|721413|P3|COMPLETED|First Intervention (7 Days)||4
301691|NCT01732588|721414|P2|COMPLETED|First Intervention (7 Days)||2
301692|NCT01732588|721415|P1|COMPLETED|First Intervention (7 Days)||4
301693|NCT01732588|721413|P3|STARTED|First Intervention (7 Days)||4
301694|NCT01732588|721414|P2|STARTED|First Intervention (7 Days)||3
301695|NCT01732588|721415|P1|STARTED|First Intervention (7 Days)||4
301696|NCT01732549|721431|P2|NOT COMPLETED|Overall Study||73
301697|NCT01732549|721432|P1|NOT COMPLETED|Overall Study||71
301698|NCT01732549|721431|P2|COMPLETED|Overall Study||0
301699|NCT01732549|721432|P1|COMPLETED|Overall Study||0
301700|NCT01732549|721431|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
301701|NCT01732549|721432|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
301702|NCT01732549|721431|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
301703|NCT01732549|721432|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
301704|NCT01732549|721431|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
301705|NCT01732549|721432|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
301706|NCT01732549|721431|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
301707|NCT01732549|721432|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
301708|NCT01732549|721431|P2|STARTED|Overall Study||73
301709|NCT01732549|721432|P1|STARTED|Overall Study||71
301710|NCT01732510|721459|P7|NOT COMPLETED|Overall Study||8
301711|NCT01732510|721460|P6|NOT COMPLETED|Overall Study||13
301712|NCT01732510|721461|P5|NOT COMPLETED|Overall Study||5
301713|NCT01732510|721462|P4|NOT COMPLETED|Overall Study||5
301714|NCT01732510|721463|P3|NOT COMPLETED|Overall Study||4
301715|NCT01732510|721464|P2|NOT COMPLETED|Overall Study||5
301716|NCT01732510|721465|P1|NOT COMPLETED|Overall Study||1
301717|NCT01732510|721459|P7|COMPLETED|Overall Study||0
301718|NCT01732510|721460|P6|COMPLETED|Overall Study||0
301719|NCT01732510|721461|P5|COMPLETED|Overall Study||3
301720|NCT01732510|721462|P4|COMPLETED|Overall Study||5
301721|NCT01732510|721463|P3|COMPLETED|Overall Study||4
301722|NCT01732510|721464|P2|COMPLETED|Overall Study||4
301723|NCT01732510|721465|P1|COMPLETED|Overall Study||8
301724|NCT01732510|721459|P7|STARTED|Overall Study||8
301725|NCT01732510|721460|P6|STARTED|Overall Study||13
301726|NCT01732510|721461|P5|STARTED|Overall Study||8
301727|NCT01732510|721462|P4|STARTED|Overall Study||10
301728|NCT01732510|721463|P3|STARTED|Overall Study||8
301729|NCT01732510|721464|P2|STARTED|Overall Study||9
301730|NCT01732510|721465|P1|STARTED|Overall Study||9
301731|NCT01732484|721544|P1|NOT COMPLETED|Overall Study||26
301732|NCT01732484|721544|P1|COMPLETED|Overall Study||74
301733|NCT01732484|721544|P1|Allocation|Overall Study||100
301734|NCT01732484|721544|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
301735|NCT01732484|721544|P1|STARTED|Overall Study||100
301736|NCT01732471|721552|P1|NOT COMPLETED|Overall Study||1
301737|NCT01732471|721552|P1|COMPLETED|Overall Study||89
301738|NCT01732471|721552|P1|STARTED|Overall Study||90
301739|NCT01732263|721561|P2|NOT COMPLETED|Overall Study||0
301740|NCT01732263|721562|P1|NOT COMPLETED|Overall Study||0
301741|NCT01732263|721561|P2|COMPLETED|Overall Study||20
301742|NCT01732263|721562|P1|COMPLETED|Overall Study||23
301743|NCT01732263|721561|P2|STARTED|Overall Study||20
301744|NCT01732263|721562|P1|STARTED|Overall Study||23
301745|NCT01731938|721606|P2|NOT COMPLETED|Primary Part II||13
301746|NCT01731938|721607|P1|NOT COMPLETED|Primary Part II||13
301747|NCT01731938|721606|P2|COMPLETED|Primary Part II||95
301748|NCT01731938|721607|P1|COMPLETED|Primary Part II||103
301749|NCT01731938|721606|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
301750|NCT01731938|721607|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
301751|NCT01731938|721606|P2|NOT COMPLETED|Preliminary Part I||8
301752|NCT01731938|721607|P1|NOT COMPLETED|Preliminary Part I||3
301753|NCT01731938|721606|P2|COMPLETED|Preliminary Part I||44
301754|NCT01731938|721607|P1|COMPLETED|Preliminary Part I||48
301755|NCT01731938|721606|P2|STARTED|Preliminary Part I||52
301756|NCT01731938|721607|P1|STARTED|Preliminary Part I||51
301757|NCT01731470|721619|P1|NOT COMPLETED|Overall Study||2
301758|NCT01731470|721619|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
301759|NCT01731470|721619|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
301760|NCT01731119|721624|P1|NOT COMPLETED|Overall Study||2
301761|NCT01731119|721624|P1|COMPLETED|Overall Study||7
301762|NCT01731119|721624|P1|STARTED|Overall Study||9
301763|NCT01731041|721634|P2|NOT COMPLETED|Overall Study||0
301764|NCT01731041|721635|P1|NOT COMPLETED|Overall Study||0
301765|NCT01731041|721634|P2|COMPLETED|Overall Study||30
301766|NCT01731041|721635|P1|COMPLETED|Overall Study||30
301767|NCT01731041|721634|P2|STARTED|Overall Study||30
301768|NCT01731041|721635|P1|STARTED|Overall Study||30
301769|NCT01730378|721645|P2|NOT COMPLETED|Overall Study||0
301770|NCT01730378|721646|P1|NOT COMPLETED|Overall Study||1
301771|NCT01730378|721645|P2|COMPLETED|Overall Study||47
301772|NCT01730378|721646|P1|COMPLETED|Overall Study||83
301773|NCT01730378|721645|P2|STARTED|Overall Study||47
301774|NCT01730378|721646|P1|STARTED|Overall Study||84
301775|NCT01730339|721677|P2|NOT COMPLETED|Overall Study||3
301776|NCT01730339|721678|P1|NOT COMPLETED|Overall Study||5
301777|NCT01730339|721677|P2|COMPLETED|Overall Study||52
301778|NCT01730339|721678|P1|COMPLETED|Overall Study||40
301779|NCT01730339|721677|P2|STARTED|Overall Study||55
301780|NCT01730339|721678|P1|STARTED|Overall Study||45
301781|NCT01730053|721718|P6|NOT COMPLETED|Overall Study||13
301782|NCT01730053|721719|P5|NOT COMPLETED|Overall Study||9
301783|NCT01730053|721720|P4|NOT COMPLETED|Overall Study||8
301784|NCT01730053|721721|P3|NOT COMPLETED|Overall Study||11
301785|NCT01730053|721722|P2|NOT COMPLETED|Overall Study||14
301786|NCT01730053|721723|P1|NOT COMPLETED|Overall Study||5
301787|NCT01730053|721718|P6|COMPLETED|Overall Study||41
301788|NCT01730053|721719|P5|COMPLETED|Overall Study||44
301789|NCT01730053|721720|P4|COMPLETED|Overall Study||45
301790|NCT01730053|721721|P3|COMPLETED|Overall Study||38
301791|NCT01730053|721722|P2|COMPLETED|Overall Study||34
301792|NCT01730053|721723|P1|COMPLETED|Overall Study||43
301793|NCT01730053|721718|P6|Treated|Overall Study||54
301794|NCT01730053|721719|P5|Treated|Overall Study||53
301795|NCT01730053|721720|P4|Treated|Overall Study||53
301796|NCT01730053|721721|P3|Treated|Overall Study||49
301797|NCT01730053|721722|P2|Treated|Overall Study||48
301798|NCT01730053|721723|P1|Treated|Overall Study||48
301799|NCT01730053|721718|P6|STARTED|Overall Study||54
301800|NCT01730053|721719|P5|STARTED|Overall Study||53
301801|NCT01730053|721720|P4|STARTED|Overall Study||53
301802|NCT01730053|721721|P3|STARTED|Overall Study||49
301803|NCT01730053|721722|P2|STARTED|Overall Study||48
301804|NCT01730053|721723|P1|STARTED|Overall Study||48
301805|NCT01730040|721882|P7|NOT COMPLETED|Overall Study||9
301806|NCT01730040|721883|P6|NOT COMPLETED|Overall Study||7
301807|NCT01730040|721884|P5|NOT COMPLETED|Overall Study||6
301808|NCT01730040|721885|P4|NOT COMPLETED|Overall Study||8
301809|NCT01730040|721886|P3|NOT COMPLETED|Overall Study||11
301810|NCT01730040|721887|P2|NOT COMPLETED|Overall Study||15
301811|NCT01730040|721888|P1|NOT COMPLETED|Overall Study||13
301812|NCT01730040|721882|P7|COMPLETED|Overall Study||38
301813|NCT01730040|721883|P6|COMPLETED|Overall Study||40
301814|NCT01730040|721884|P5|COMPLETED|Overall Study||39
301815|NCT01730040|721885|P4|COMPLETED|Overall Study||39
301816|NCT01730040|721886|P3|COMPLETED|Overall Study||46
301817|NCT01730040|721887|P2|COMPLETED|Overall Study||40
301818|NCT01730040|721888|P1|COMPLETED|Overall Study||44
301819|NCT01730040|721882|P7|Treated|Overall Study||47
301820|NCT01730040|721883|P6|Treated|Overall Study||46
301821|NCT01730040|721884|P5|Treated|Overall Study||45
301822|NCT01730040|721885|P4|Treated|Overall Study||47
301823|NCT01730040|721886|P3|Treated|Overall Study||57
301824|NCT01730040|721887|P2|Treated|Overall Study||55
301825|NCT01730040|721888|P1|Treated|Overall Study||57
301826|NCT01730040|721882|P7|STARTED|Overall Study||47
301827|NCT01730040|721883|P6|STARTED|Overall Study||47
301828|NCT01730040|721884|P5|STARTED|Overall Study||45
301829|NCT01730040|721885|P4|STARTED|Overall Study||47
301830|NCT01730040|721886|P3|STARTED|Overall Study||57
301831|NCT01730040|721887|P2|STARTED|Overall Study||55
301832|NCT01730040|721888|P1|STARTED|Overall Study||57
301833|NCT01729871|722067|P2|NOT COMPLETED|Overall Study||23
301834|NCT01729871|722068|P1|NOT COMPLETED|Overall Study||12
301835|NCT01729871|722067|P2|COMPLETED|Overall Study||101
301836|NCT01729871|722068|P1|COMPLETED|Overall Study||112
301837|NCT01729871|722067|P2|STARTED|Overall Study||124
301838|NCT01729871|722068|P1|STARTED|Overall Study||124
301839|NCT01729728|722087|P3|NOT COMPLETED|Overall Study||1
301840|NCT01729728|722088|P2|NOT COMPLETED|Overall Study||6
301841|NCT01729728|722089|P1|NOT COMPLETED|Overall Study||1
301842|NCT01729728|722087|P3|COMPLETED|Overall Study||16
301843|NCT01729728|722088|P2|COMPLETED|Overall Study||22
301844|NCT01729728|722089|P1|COMPLETED|Overall Study||20
301845|NCT01729728|722087|P3|STARTED|Overall Study||17
301846|NCT01729728|722088|P2|STARTED|Overall Study||28
301847|NCT01729728|722089|P1|STARTED|Overall Study||21
301848|NCT01729559|722222|P2|NOT COMPLETED|Overall Study||28
301849|NCT01729559|722223|P1|NOT COMPLETED|Overall Study||31
301850|NCT01729559|722222|P2|COMPLETED|Overall Study||216
301851|NCT01729559|722223|P1|COMPLETED|Overall Study||220
301852|NCT01729559|722222|P2|STARTED|Overall Study||244
301853|NCT01729559|722223|P1|STARTED|Overall Study||251
301854|NCT01729338|722235|P1|NOT COMPLETED|Overall Study||2
301855|NCT01729338|722235|P1|COMPLETED|Overall Study||14
301856|NCT01729338|722235|P1|STARTED|Overall Study||16
301857|NCT01729247|722250|P1|NOT COMPLETED|Overall Study||0
301858|NCT01729247|722250|P1|COMPLETED|Overall Study||50
301859|NCT01729247|722250|P1|STARTED|Overall Study||50
301860|NCT01729026|722266|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
301861|NCT01729026|722267|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
301862|NCT01729026|722266|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
301863|NCT01729026|722267|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
301864|NCT01729026|722266|P2|STARTED|3-month to 6-month (Final) Follow-up||8
301865|NCT01729026|722267|P1|STARTED|3-month to 6-month (Final) Follow-up||7
301866|NCT01729026|722266|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
301867|NCT01729026|722267|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
301868|NCT01729026|722266|P2|COMPLETED|Randomization to 3-month Follow-up||8
301869|NCT01729026|722267|P1|COMPLETED|Randomization to 3-month Follow-up||7
301870|NCT01729026|722266|P2|STARTED|Randomization to 3-month Follow-up||10
301871|NCT01729026|722267|P1|STARTED|Randomization to 3-month Follow-up||9
301872|NCT01728792|722278|P5|NOT COMPLETED|Overall Study||0
301873|NCT01728792|722279|P4|NOT COMPLETED|Overall Study||3
301874|NCT01728792|722280|P3|NOT COMPLETED|Overall Study||4
301875|NCT01728792|722281|P2|NOT COMPLETED|Overall Study||2
301876|NCT01728792|722282|P1|NOT COMPLETED|Overall Study||3
301877|NCT01728792|722278|P5|COMPLETED|Overall Study||16
301878|NCT01728792|722279|P4|COMPLETED|Overall Study||14
301879|NCT01728792|722280|P3|COMPLETED|Overall Study||13
301880|NCT01728792|722281|P2|COMPLETED|Overall Study||14
301881|NCT01728792|722282|P1|COMPLETED|Overall Study||11
301882|NCT01728792|722278|P5|STARTED|Overall Study||16
301883|NCT01728792|722279|P4|STARTED|Overall Study||17
301884|NCT01728792|722280|P3|STARTED|Overall Study||17
301885|NCT01728792|722281|P2|STARTED|Overall Study||16
301886|NCT01728792|722282|P1|STARTED|Overall Study||14
301887|NCT01728584|722333|P4|NOT COMPLETED|Overall Study||1
301888|NCT01728584|722334|P3|NOT COMPLETED|Overall Study||1
301889|NCT01728584|722335|P2|NOT COMPLETED|Overall Study||0
301890|NCT01728584|722336|P1|NOT COMPLETED|Overall Study||8
301891|NCT01728584|722333|P4|COMPLETED|Overall Study||29
301892|NCT01728584|722334|P3|COMPLETED|Overall Study||30
301893|NCT01728584|722335|P2|COMPLETED|Overall Study||30
301894|NCT01728584|722336|P1|COMPLETED|Overall Study||28
301895|NCT01728584|722333|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
301896|NCT01728584|722334|P3|STARTED|Overall Study|Randomized|31
301897|NCT01728584|722335|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
301898|NCT01728584|722336|P1|STARTED|Overall Study|Randomized|36
301899|NCT01728376|722394|P6|NOT COMPLETED|Overall Study||2
301900|NCT01728376|722395|P5|NOT COMPLETED|Overall Study||2
301901|NCT01728376|722396|P4|NOT COMPLETED|Overall Study||2
301902|NCT01728376|722397|P3|NOT COMPLETED|Overall Study||2
301903|NCT01728376|722398|P2|NOT COMPLETED|Overall Study||2
301904|NCT01728376|722399|P1|NOT COMPLETED|Overall Study||4
301905|NCT01728376|722394|P6|COMPLETED|Overall Study||5
301906|NCT01728376|722395|P5|COMPLETED|Overall Study||12
301907|NCT01728376|722396|P4|COMPLETED|Overall Study||7
301908|NCT01728376|722397|P3|COMPLETED|Overall Study||17
301909|NCT01728376|722398|P2|COMPLETED|Overall Study||9
301910|NCT01728376|722399|P1|COMPLETED|Overall Study||18
301911|NCT01728376|722394|P6|Treated|Overall Study||7
301912|NCT01728376|722395|P5|Treated|Overall Study||14
301913|NCT01728376|722396|P4|Treated|Overall Study||9
301914|NCT01728376|722397|P3|Treated|Overall Study||19
301915|NCT01728376|722398|P2|Treated|Overall Study||10
301916|NCT01728376|722399|P1|Treated|Overall Study||22
301917|NCT01728376|722394|P6|STARTED|Overall Study||7
301918|NCT01728376|722395|P5|STARTED|Overall Study||14
301919|NCT01728376|722396|P4|STARTED|Overall Study||9
301920|NCT01728376|722397|P3|STARTED|Overall Study||19
301921|NCT01728376|722398|P2|STARTED|Overall Study||11
301922|NCT01728376|722399|P1|STARTED|Overall Study||22
301923|NCT01728337|722461|P1|NOT COMPLETED|Overall Study||0
301924|NCT01728337|722461|P1|COMPLETED|Overall Study||80
301925|NCT01728337|722461|P1|STARTED|Overall Study||80
301926|NCT01728324|722472|P3|NOT COMPLETED|Termination of RBV||15
301927|NCT01728324|722473|P2|NOT COMPLETED|Termination of RBV||37
301928|NCT01728324|722474|P1|NOT COMPLETED|Termination of RBV||39
301929|NCT01728324|722472|P3|COMPLETED|Termination of RBV||57
301930|NCT01728324|722473|P2|COMPLETED|Termination of RBV||176
301931|NCT01728324|722474|P1|COMPLETED|Termination of RBV||172
301932|NCT01728324|722472|P3|STARTED|Termination of RBV||72
301933|NCT01728324|722473|P2|STARTED|Termination of RBV||213
301934|NCT01728324|722474|P1|STARTED|Termination of RBV||211
301935|NCT01728324|722472|P3|NOT COMPLETED|Termination of FDV||14
301936|NCT01728324|722473|P2|NOT COMPLETED|Termination of FDV||36
301937|NCT01728324|722474|P1|NOT COMPLETED|Termination of FDV||38
301938|NCT01728324|722472|P3|COMPLETED|Termination of FDV||58
301939|NCT01728324|722473|P2|COMPLETED|Termination of FDV||177
301940|NCT01728324|722474|P1|COMPLETED|Termination of FDV||173
301941|NCT01728324|722472|P3|STARTED|Termination of FDV||72
301942|NCT01728324|722473|P2|STARTED|Termination of FDV||213
301943|NCT01728324|722474|P1|STARTED|Termination of FDV||211
301944|NCT01728324|722472|P3|NOT COMPLETED|Termination of DBV||14
301945|NCT01728324|722473|P2|NOT COMPLETED|Termination of DBV||36
301946|NCT01728324|722474|P1|NOT COMPLETED|Termination of DBV||38
301947|NCT01728324|722472|P3|COMPLETED|Termination of DBV||58
301948|NCT01728324|722473|P2|COMPLETED|Termination of DBV||177
301949|NCT01728324|722474|P1|COMPLETED|Termination of DBV||173
301950|NCT01728324|722472|P3|STARTED|Termination of DBV||72
301951|NCT01728324|722473|P2|STARTED|Termination of DBV||213
301952|NCT01728324|722474|P1|STARTED|Termination of DBV||211
301953|NCT01728246|722495|P2|NOT COMPLETED|Overall Study||36
301954|NCT01728246|722496|P1|NOT COMPLETED|Overall Study||36
301955|NCT01728246|722495|P2|COMPLETED|Overall Study||195
301956|NCT01728246|722496|P1|COMPLETED|Overall Study||206
301957|NCT01728246|722495|P2|STARTED|Overall Study||231
301958|NCT01728246|722496|P1|STARTED|Overall Study||242
301959|NCT01728116|722514|P2|NOT COMPLETED|Overall Study||47
301960|NCT01728116|722515|P1|NOT COMPLETED|Overall Study||161
301961|NCT01728116|722514|P2|COMPLETED|Overall Study|Completed to Week 52|60
301962|NCT01728116|722515|P1|COMPLETED|Overall Study|Completed to Week 78|52
301963|NCT01728116|722514|P2|STARTED|Overall Study|Sham mITT subjects|107
301964|NCT01728116|722515|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
301965|NCT01727895|722540|P2|NOT COMPLETED|Overall Study||0
301966|NCT01727895|722541|P1|NOT COMPLETED|Overall Study||0
301967|NCT01727895|722540|P2|COMPLETED|Overall Study||5
301968|NCT01727895|722541|P1|COMPLETED|Overall Study||10
301969|NCT01727895|722540|P2|STARTED|Overall Study||5
301970|NCT01727895|722541|P1|STARTED|Overall Study||10
301971|NCT01727791|722547|P1|NOT COMPLETED|Overall Study||0
301972|NCT01727791|722547|P1|COMPLETED|Overall Study||10
301973|NCT01727791|722547|P1|STARTED|Overall Study||10
301974|NCT01727713|722577|P1|NOT COMPLETED|Overall Study||35
301975|NCT01727713|722577|P1|COMPLETED|Overall Study||75
301976|NCT01727713|722577|P1|STARTED|Overall Study||110
301977|NCT01727700|722604|P3|NOT COMPLETED|Overall Study||2
301978|NCT01727700|722605|P2|NOT COMPLETED|Overall Study||10
301979|NCT01727700|722606|P1|NOT COMPLETED|Overall Study||2
301980|NCT01727700|722604|P3|COMPLETED|Overall Study||42
301981|NCT01727700|722605|P2|COMPLETED|Overall Study||35
301982|NCT01727700|722606|P1|COMPLETED|Overall Study||42
301983|NCT01727700|722604|P3|STARTED|Overall Study||44
301984|NCT01727700|722605|P2|STARTED|Overall Study||45
301985|NCT01727700|722606|P1|STARTED|Overall Study||44
301986|NCT01727505|722629|P2|NOT COMPLETED|Second 24 Hours||1
301987|NCT01727505|722630|P1|NOT COMPLETED|Second 24 Hours||0
301988|NCT01727505|722629|P2|COMPLETED|Second 24 Hours||10
301989|NCT01727505|722630|P1|COMPLETED|Second 24 Hours||14
301990|NCT01727505|722629|P2|STARTED|Second 24 Hours||11
301991|NCT01727505|722630|P1|STARTED|Second 24 Hours||14
301992|NCT01727505|722629|P2|NOT COMPLETED|First 24 Hours||1
301993|NCT01727505|722630|P1|NOT COMPLETED|First 24 Hours||0
301994|NCT01727505|722629|P2|COMPLETED|First 24 Hours||11
301995|NCT01727505|722630|P1|COMPLETED|First 24 Hours||14
301996|NCT01727505|722629|P2|STARTED|First 24 Hours||12
301997|NCT01727505|722630|P1|STARTED|First 24 Hours||14
301998|NCT01727258|722649|P3|NOT COMPLETED|Overall Study||1
301999|NCT01727258|722650|P2|NOT COMPLETED|Overall Study||3
302000|NCT01727258|722651|P1|NOT COMPLETED|Overall Study||2
302001|NCT01727258|722649|P3|COMPLETED|Overall Study||50
302002|NCT01727258|722650|P2|COMPLETED|Overall Study||48
302003|NCT01727258|722651|P1|COMPLETED|Overall Study||49
302004|NCT01727258|722649|P3|STARTED|Overall Study||51
302005|NCT01727258|722650|P2|STARTED|Overall Study||51
302006|NCT01727258|722651|P1|STARTED|Overall Study||51
302007|NCT01727180|722674|P1|NOT COMPLETED|Overall Study||0
302008|NCT01727180|722674|P1|COMPLETED|Overall Study||108
302009|NCT01727180|722674|P1|STARTED|Overall Study||108
302010|NCT01727167|722680|P2|NOT COMPLETED|Overall Study||0
302011|NCT01727167|722681|P1|NOT COMPLETED|Overall Study||0
302012|NCT01727167|722680|P2|COMPLETED|Overall Study||0
302013|NCT01727167|722681|P1|COMPLETED|Overall Study||1
302014|NCT01727167|722680|P2|STARTED|Overall Study||0
302015|NCT01727167|722681|P1|STARTED|Overall Study||1
302016|NCT01727141|722693|P4|NOT COMPLETED|Overall Study||15
302017|NCT01727141|722694|P3|NOT COMPLETED|Overall Study||3
302018|NCT01727141|722695|P2|NOT COMPLETED|Overall Study||9
302019|NCT01727141|722696|P1|NOT COMPLETED|Overall Study||5
302020|NCT01727141|722693|P4|COMPLETED|Overall Study||246
302021|NCT01727141|722694|P3|COMPLETED|Overall Study||258
302022|NCT01727141|722695|P2|COMPLETED|Overall Study||251
302023|NCT01727141|722696|P1|COMPLETED|Overall Study||255
302024|NCT01727141|722693|P4|Full Analysis Set|Overall Study||261
302025|NCT01727141|722694|P3|Full Analysis Set|Overall Study||261
302026|NCT01727141|722695|P2|Full Analysis Set|Overall Study||260
302027|NCT01727141|722696|P1|Full Analysis Set|Overall Study||258
302028|NCT01727141|722693|P4|Safety Set|Overall Study||260
302029|NCT01727141|722694|P3|Safety Set|Overall Study||262
302030|NCT01727141|722695|P2|Safety Set|Overall Study||260
302031|NCT01727141|722696|P1|Safety Set|Overall Study||258
302032|NCT01727141|722693|P4|STARTED|Overall Study||261
302033|NCT01727141|722694|P3|STARTED|Overall Study||261
302034|NCT01727141|722695|P2|STARTED|Overall Study||260
302035|NCT01727141|722696|P1|STARTED|Overall Study||260
302036|NCT01727024|722746|P2|NOT COMPLETED|Period 2||0
302037|NCT01727024|722747|P1|NOT COMPLETED|Period 2||0
302038|NCT01727024|722746|P2|COMPLETED|Period 2||64
302039|NCT01727024|722747|P1|COMPLETED|Period 2||68
302040|NCT01727024|722746|P2|STARTED|Period 2||64
302041|NCT01727024|722747|P1|STARTED|Period 2||68
302042|NCT01727024|722746|P2|NOT COMPLETED|Period 1||4
302043|NCT01727024|722747|P1|NOT COMPLETED|Period 1||3
302044|NCT01727024|722746|P2|COMPLETED|Period 1||64
302045|NCT01727024|722747|P1|COMPLETED|Period 1||68
302046|NCT01727024|722746|P2|STARTED|Period 1||68
302047|NCT01727024|722747|P1|STARTED|Period 1||71
302048|NCT01726621|722760|P1|NOT COMPLETED|Overall Study||4
302049|NCT01726621|722760|P1|COMPLETED|Overall Study||51
302050|NCT01726621|722760|P1|STARTED|Overall Study||55
302051|NCT01726517|722769|P5|NOT COMPLETED|Overall Study||0
302052|NCT01726517|722770|P4|NOT COMPLETED|Overall Study||0
302053|NCT01726517|722771|P3|NOT COMPLETED|Overall Study||1
302054|NCT01726517|722772|P2|NOT COMPLETED|Overall Study||0
302055|NCT01726517|722773|P1|NOT COMPLETED|Overall Study||0
302056|NCT01726517|722769|P5|COMPLETED|Overall Study||21
302057|NCT01726517|722770|P4|COMPLETED|Overall Study||19
302058|NCT01726517|722771|P3|COMPLETED|Overall Study||18
302059|NCT01726517|722772|P2|COMPLETED|Overall Study||21
302060|NCT01726517|722773|P1|COMPLETED|Overall Study||20
302061|NCT01726517|722769|P5|STARTED|Overall Study||21
302062|NCT01726517|722770|P4|STARTED|Overall Study||19
302063|NCT01726517|722771|P3|STARTED|Overall Study||19
302064|NCT01726517|722772|P2|STARTED|Overall Study||21
302065|NCT01726517|722773|P1|STARTED|Overall Study||20
302066|NCT01726504|722802|P2|NOT COMPLETED|Overall Study||28
302067|NCT01726504|722803|P1|NOT COMPLETED|Overall Study||12
302068|NCT01726504|722802|P2|COMPLETED|Overall Study||511
302069|NCT01726504|722803|P1|COMPLETED|Overall Study||524
302070|NCT01726504|722802|P2|STARTED|Overall Study||539
302071|NCT01726504|722803|P1|STARTED|Overall Study||536
302072|NCT01726335|722829|P1|NOT COMPLETED|Overall Study||24
302073|NCT01726335|722829|P1|COMPLETED|Overall Study||29
302074|NCT01726335|722829|P1|STARTED|Overall Study||53
302075|NCT01726049|722847|P2|NOT COMPLETED|Overall Study||4
302076|NCT01726049|722848|P1|NOT COMPLETED|Overall Study||5
302077|NCT01726049|722847|P2|COMPLETED|Overall Study||22
302078|NCT01726049|722848|P1|COMPLETED|Overall Study||21
302079|NCT01726049|722847|P2|STARTED|Overall Study||26
302080|NCT01726049|722848|P1|STARTED|Overall Study||26
302081|NCT01726023|722862|P2|NOT COMPLETED|Overall Study||26
302082|NCT01726023|722863|P1|NOT COMPLETED|Overall Study||29
302083|NCT01726023|722862|P2|COMPLETED|Overall Study||196
302084|NCT01726023|722863|P1|COMPLETED|Overall Study||190
302085|NCT01726023|722862|P2|STARTED|Overall Study||222
302086|NCT01726023|722863|P1|STARTED|Overall Study||219
302087|NCT01725984|722955|P2|NOT COMPLETED|Overall Study||0
302088|NCT01725984|722956|P1|NOT COMPLETED|Overall Study||0
302089|NCT01725984|722955|P2|COMPLETED|Overall Study||41
302090|NCT01725984|722956|P1|COMPLETED|Overall Study||39
302091|NCT01725984|722955|P2|STARTED|Overall Study||41
302092|NCT01725984|722956|P1|STARTED|Overall Study||39
302093|NCT01725529|722983|P3|NOT COMPLETED|Overall Study||10
302094|NCT01725529|722984|P2|NOT COMPLETED|Overall Study||16
302095|NCT01725529|722985|P1|NOT COMPLETED|Overall Study||15
302096|NCT01725529|722983|P3|COMPLETED|Overall Study||142
302097|NCT01725529|722984|P2|COMPLETED|Overall Study||137
302098|NCT01725529|722985|P1|COMPLETED|Overall Study||137
302099|NCT01725529|722983|P3|STARTED|Overall Study||152
302100|NCT01725529|722984|P2|STARTED|Overall Study||153
302101|NCT01725529|722985|P1|STARTED|Overall Study||152
302102|NCT01725451|723011|P4|NOT COMPLETED|Period 6||0
302103|NCT01725451|723012|P3|NOT COMPLETED|Period 6||0
302104|NCT01725451|723013|P2|NOT COMPLETED|Period 6||0
302105|NCT01725451|723014|P1|NOT COMPLETED|Period 6||0
302106|NCT01725451|723011|P4|COMPLETED|Period 6||7
302107|NCT01725451|723012|P3|COMPLETED|Period 6||6
302108|NCT01725451|723013|P2|COMPLETED|Period 6||6
302109|NCT01725451|723014|P1|COMPLETED|Period 6||7
302110|NCT01725451|723011|P4|STARTED|Period 6||7
302111|NCT01725451|723012|P3|STARTED|Period 6||6
302112|NCT01725451|723013|P2|STARTED|Period 6||6
302113|NCT01725451|723014|P1|STARTED|Period 6||7
302114|NCT01725451|723011|P4|NOT COMPLETED|Washout From Period 5||0
302115|NCT01725451|723012|P3|NOT COMPLETED|Washout From Period 5||0
302116|NCT01725451|723013|P2|NOT COMPLETED|Washout From Period 5||0
302117|NCT01725451|723014|P1|NOT COMPLETED|Washout From Period 5||0
302118|NCT01725451|723011|P4|COMPLETED|Washout From Period 5||7
302119|NCT01725451|723012|P3|COMPLETED|Washout From Period 5||6
302120|NCT01725451|723013|P2|COMPLETED|Washout From Period 5||6
302121|NCT01725451|723014|P1|COMPLETED|Washout From Period 5||7
302122|NCT01725451|723011|P4|STARTED|Washout From Period 5||7
302123|NCT01725451|723012|P3|STARTED|Washout From Period 5||6
302124|NCT01725451|723013|P2|STARTED|Washout From Period 5||6
302125|NCT01725451|723014|P1|STARTED|Washout From Period 5||7
302126|NCT01725451|723011|P4|NOT COMPLETED|Period 5||0
302127|NCT01725451|723012|P3|NOT COMPLETED|Period 5||0
302128|NCT01725451|723013|P2|NOT COMPLETED|Period 5||0
302129|NCT01725451|723014|P1|NOT COMPLETED|Period 5||0
302130|NCT01725451|723011|P4|COMPLETED|Period 5||7
302131|NCT01725451|723012|P3|COMPLETED|Period 5||6
302132|NCT01725451|723013|P2|COMPLETED|Period 5||6
302133|NCT01725451|723014|P1|COMPLETED|Period 5||7
302134|NCT01725451|723011|P4|STARTED|Period 5||7
302135|NCT01725451|723012|P3|STARTED|Period 5||6
302136|NCT01725451|723013|P2|STARTED|Period 5||6
302137|NCT01725451|723014|P1|STARTED|Period 5||7
302138|NCT01725451|723011|P4|NOT COMPLETED|Washout From Period 4||0
302139|NCT01725451|723012|P3|NOT COMPLETED|Washout From Period 4||0
302140|NCT01725451|723013|P2|NOT COMPLETED|Washout From Period 4||0
302141|NCT01725451|723014|P1|NOT COMPLETED|Washout From Period 4||0
302142|NCT01725451|723011|P4|COMPLETED|Washout From Period 4||7
302143|NCT01725451|723012|P3|COMPLETED|Washout From Period 4||6
302144|NCT01725451|723013|P2|COMPLETED|Washout From Period 4||6
302145|NCT01725451|723014|P1|COMPLETED|Washout From Period 4||7
302146|NCT01725451|723011|P4|STARTED|Washout From Period 4||7
302147|NCT01725451|723012|P3|STARTED|Washout From Period 4||6
302148|NCT01725451|723013|P2|STARTED|Washout From Period 4||6
302149|NCT01725451|723014|P1|STARTED|Washout From Period 4||7
302150|NCT01725451|723011|P4|NOT COMPLETED|Period 4||0
302151|NCT01725451|723012|P3|NOT COMPLETED|Period 4||1
302152|NCT01725451|723013|P2|NOT COMPLETED|Period 4||0
302153|NCT01725451|723014|P1|NOT COMPLETED|Period 4||0
302154|NCT01725451|723011|P4|COMPLETED|Period 4||7
302155|NCT01725451|723012|P3|COMPLETED|Period 4||6
302156|NCT01725451|723013|P2|COMPLETED|Period 4||6
302157|NCT01725451|723014|P1|COMPLETED|Period 4||7
302158|NCT01725451|723011|P4|STARTED|Period 4||7
302159|NCT01725451|723012|P3|STARTED|Period 4||7
302160|NCT01725451|723013|P2|STARTED|Period 4||6
302161|NCT01725451|723014|P1|STARTED|Period 4||7
302162|NCT01725451|723011|P4|NOT COMPLETED|Washout From Period 3||0
302163|NCT01725451|723012|P3|NOT COMPLETED|Washout From Period 3||1
302164|NCT01725451|723013|P2|NOT COMPLETED|Washout From Period 3||1
302165|NCT01725451|723014|P1|NOT COMPLETED|Washout From Period 3||0
302166|NCT01725451|723011|P4|COMPLETED|Washout From Period 3||7
302167|NCT01725451|723012|P3|COMPLETED|Washout From Period 3||7
302168|NCT01725451|723013|P2|COMPLETED|Washout From Period 3||6
302169|NCT01725451|723014|P1|COMPLETED|Washout From Period 3||7
302170|NCT01725451|723011|P4|STARTED|Washout From Period 3||7
302171|NCT01725451|723012|P3|STARTED|Washout From Period 3||8
302172|NCT01725451|723013|P2|STARTED|Washout From Period 3||7
302173|NCT01725451|723014|P1|STARTED|Washout From Period 3||7
302174|NCT01725451|723011|P4|NOT COMPLETED|Period 3||0
302175|NCT01725451|723012|P3|NOT COMPLETED|Period 3||0
302176|NCT01725451|723013|P2|NOT COMPLETED|Period 3||0
302177|NCT01725451|723014|P1|NOT COMPLETED|Period 3||0
302178|NCT01725451|723011|P4|COMPLETED|Period 3||7
302179|NCT01725451|723012|P3|COMPLETED|Period 3||8
302180|NCT01725451|723013|P2|COMPLETED|Period 3||7
302181|NCT01725451|723014|P1|COMPLETED|Period 3||7
302182|NCT01725451|723011|P4|STARTED|Period 3||7
302183|NCT01725451|723012|P3|STARTED|Period 3||8
302184|NCT01725451|723013|P2|STARTED|Period 3||7
302185|NCT01725451|723014|P1|STARTED|Period 3||7
302186|NCT01725451|723011|P4|NOT COMPLETED|Washout From Period 2||0
302187|NCT01725451|723012|P3|NOT COMPLETED|Washout From Period 2||0
302188|NCT01725451|723013|P2|NOT COMPLETED|Washout From Period 2||0
302189|NCT01725451|723014|P1|NOT COMPLETED|Washout From Period 2||0
302190|NCT01725451|723011|P4|COMPLETED|Washout From Period 2||7
302191|NCT01725451|723012|P3|COMPLETED|Washout From Period 2||8
302192|NCT01725451|723013|P2|COMPLETED|Washout From Period 2||7
302193|NCT01725451|723014|P1|COMPLETED|Washout From Period 2||7
302194|NCT01725451|723011|P4|STARTED|Washout From Period 2||7
302195|NCT01725451|723012|P3|STARTED|Washout From Period 2||8
302196|NCT01725451|723013|P2|STARTED|Washout From Period 2||7
302197|NCT01725451|723014|P1|STARTED|Washout From Period 2||7
302198|NCT01725451|723011|P4|NOT COMPLETED|Period 2||0
302199|NCT01725451|723012|P3|NOT COMPLETED|Period 2||0
302200|NCT01725451|723013|P2|NOT COMPLETED|Period 2||0
302201|NCT01725451|723014|P1|NOT COMPLETED|Period 2||0
302202|NCT01725451|723011|P4|COMPLETED|Period 2||7
302203|NCT01725451|723012|P3|COMPLETED|Period 2||8
302204|NCT01725451|723013|P2|COMPLETED|Period 2||7
302205|NCT01725451|723014|P1|COMPLETED|Period 2||7
302206|NCT01725451|723011|P4|STARTED|Period 2||7
302207|NCT01725451|723012|P3|STARTED|Period 2||8
302208|NCT01725451|723013|P2|STARTED|Period 2||7
302209|NCT01725451|723014|P1|STARTED|Period 2||7
302210|NCT01725451|723011|P4|NOT COMPLETED|Washout From Period 1||0
302211|NCT01725451|723012|P3|NOT COMPLETED|Washout From Period 1||0
302212|NCT01725451|723013|P2|NOT COMPLETED|Washout From Period 1||0
302213|NCT01725451|723014|P1|NOT COMPLETED|Washout From Period 1||0
302214|NCT01725451|723011|P4|COMPLETED|Washout From Period 1||7
302215|NCT01725451|723012|P3|COMPLETED|Washout From Period 1||8
302216|NCT01725451|723013|P2|COMPLETED|Washout From Period 1||7
302217|NCT01725451|723014|P1|COMPLETED|Washout From Period 1||7
302218|NCT01725451|723011|P4|STARTED|Washout From Period 1||7
302219|NCT01725451|723012|P3|STARTED|Washout From Period 1||8
302220|NCT01725451|723013|P2|STARTED|Washout From Period 1||7
302221|NCT01725451|723014|P1|STARTED|Washout From Period 1||7
302222|NCT01725451|723011|P4|NOT COMPLETED|Period 1||0
302223|NCT01725451|723012|P3|NOT COMPLETED|Period 1||0
302224|NCT01725451|723013|P2|NOT COMPLETED|Period 1||0
302225|NCT01725451|723014|P1|NOT COMPLETED|Period 1||1
302226|NCT01725451|723011|P4|COMPLETED|Period 1||7
302227|NCT01725451|723012|P3|COMPLETED|Period 1||8
302228|NCT01725451|723013|P2|COMPLETED|Period 1||7
302229|NCT01725451|723014|P1|COMPLETED|Period 1||7
302230|NCT01725451|723011|P4|STARTED|Period 1||7
302231|NCT01725451|723012|P3|STARTED|Period 1||8
302232|NCT01725451|723013|P2|STARTED|Period 1||7
302233|NCT01725451|723014|P1|STARTED|Period 1||8
302234|NCT01725386|723036|P2|NOT COMPLETED|Overall Study||46
302235|NCT01725386|723037|P1|NOT COMPLETED|Overall Study||175
302236|NCT01725386|723036|P2|COMPLETED|Overall Study||17
302237|NCT01725386|723037|P1|COMPLETED|Overall Study||13
302238|NCT01725386|723036|P2|STARTED|Overall Study||63
302239|NCT01725386|723037|P1|STARTED|Overall Study||188
302240|NCT01725308|723056|P3|NOT COMPLETED|Overall Study||41
302241|NCT01725308|723057|P2|NOT COMPLETED|Overall Study||14
302242|NCT01725308|723058|P1|NOT COMPLETED|Overall Study||44
302243|NCT01725308|723056|P3|COMPLETED|Overall Study||138
302244|NCT01725308|723057|P2|COMPLETED|Overall Study||60
302245|NCT01725308|723058|P1|COMPLETED|Overall Study||134
302246|NCT01725308|723056|P3|Treated|Overall Study||179
302247|NCT01725308|723057|P2|Treated|Overall Study||74
302248|NCT01725308|723058|P1|Treated|Overall Study||177
302249|NCT01725308|723056|P3|STARTED|Overall Study||179
302250|NCT01725308|723057|P2|STARTED|Overall Study||74
302251|NCT01725308|723058|P1|STARTED|Overall Study||178
302252|NCT01725282|723112|P4|NOT COMPLETED|Overall Study||7
302253|NCT01725282|723113|P3|NOT COMPLETED|Overall Study||8
302254|NCT01725282|723114|P2|NOT COMPLETED|Overall Study||5
302255|NCT01725282|723115|P1|NOT COMPLETED|Overall Study||2
302256|NCT01725282|723112|P4|COMPLETED|Overall Study||36
302257|NCT01725282|723113|P3|COMPLETED|Overall Study||33
302258|NCT01725282|723114|P2|COMPLETED|Overall Study||39
302259|NCT01725282|723115|P1|COMPLETED|Overall Study||42
302260|NCT01725282|723112|P4|STARTED|Overall Study||43
302261|NCT01725282|723113|P3|STARTED|Overall Study||41
302262|NCT01725282|723114|P2|STARTED|Overall Study||44
302263|NCT01725282|723115|P1|STARTED|Overall Study||44
302264|NCT01725217|723148|P3|NOT COMPLETED|Overall Study||0
302265|NCT01725217|723149|P2|NOT COMPLETED|Overall Study||0
302266|NCT01725217|723150|P1|NOT COMPLETED|Overall Study||1
302267|NCT01725217|723148|P3|COMPLETED|Overall Study||66
302268|NCT01725217|723149|P2|COMPLETED|Overall Study||66
302269|NCT01725217|723150|P1|COMPLETED|Overall Study||65
302270|NCT01725217|723148|P3|STARTED|Overall Study||66
302271|NCT01725217|723149|P2|STARTED|Overall Study||66
302272|NCT01725217|723150|P1|STARTED|Overall Study||66
302273|NCT01724528|723180|P2|NOT COMPLETED|Overall Study||3
302274|NCT01724528|723181|P1|NOT COMPLETED|Overall Study||4
302275|NCT01724528|723180|P2|COMPLETED|Overall Study||170
302276|NCT01724528|723181|P1|COMPLETED|Overall Study||169
302277|NCT01724528|723180|P2|STARTED|Overall Study||173
302278|NCT01724528|723181|P1|STARTED|Overall Study||173
302279|NCT01724359|723195|P1|NOT COMPLETED|Overall Study||31
302280|NCT01724359|723195|P1|COMPLETED|Overall Study||64
302281|NCT01724359|723195|P1|STARTED|Overall Study||95
302282|NCT01724216|723208|P1|NOT COMPLETED|Overall Study||1
302283|NCT01724216|723208|P1|COMPLETED|Overall Study||10
302284|NCT01724216|723208|P1|STARTED|Overall Study||11
302285|NCT01724177|723212|P1|NOT COMPLETED|Overall Study||21
302286|NCT01724177|723212|P1|COMPLETED|Overall Study|Completed includes participants who continue receiving oral lenalidomide|5
302287|NCT01724177|723212|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
302288|NCT01724177|723212|P1|STARTED|Overall Study||26
302289|NCT01724021|723224|P2|NOT COMPLETED|Overall Study||60
302290|NCT01724021|723225|P1|NOT COMPLETED|Overall Study||48
302291|NCT01724021|723224|P2|COMPLETED|Overall Study||309
302292|NCT01724021|723225|P1|COMPLETED|Overall Study||323
302293|NCT01724021|723224|P2|STARTED|Overall Study||369
302294|NCT01724021|723225|P1|STARTED|Overall Study||371
302295|NCT01723904|723257|P1|NOT COMPLETED|Overall Study||11
302296|NCT01723904|723257|P1|COMPLETED|Overall Study||79
302297|NCT01723904|723257|P1|STARTED|Overall Study||90
302298|NCT01723722|723269|P2|NOT COMPLETED|Overall Study||0
302299|NCT01723722|723270|P1|NOT COMPLETED|Overall Study||0
302300|NCT01723722|723269|P2|COMPLETED|Overall Study||20
302301|NCT01723722|723270|P1|COMPLETED|Overall Study||20
302302|NCT01723722|723269|P2|STARTED|Overall Study||20
302303|NCT01723722|723270|P1|STARTED|Overall Study||20
302304|NCT01723397|723278|P2|NOT COMPLETED|Study Period 2||1
302305|NCT01723397|723279|P1|NOT COMPLETED|Study Period 2||0
302306|NCT01723397|723278|P2|COMPLETED|Study Period 2||5
302307|NCT01723397|723279|P1|COMPLETED|Study Period 2||7
302308|NCT01723397|723278|P2|STARTED|Study Period 2||6
302309|NCT01723397|723279|P1|STARTED|Study Period 2||7
302310|NCT01723397|723278|P2|NOT COMPLETED|Washout||0
302311|NCT01723397|723279|P1|NOT COMPLETED|Washout||0
302312|NCT01723397|723278|P2|COMPLETED|Washout||6
302313|NCT01723397|723279|P1|COMPLETED|Washout||7
302314|NCT01723397|723278|P2|STARTED|Washout||6
302315|NCT01723397|723279|P1|STARTED|Washout||7
302316|NCT01723397|723278|P2|NOT COMPLETED|Study Period 1||1
302317|NCT01723397|723279|P1|NOT COMPLETED|Study Period 1||0
302318|NCT01723397|723278|P2|COMPLETED|Study Period 1||6
302319|NCT01723397|723279|P1|COMPLETED|Study Period 1||7
302320|NCT01723397|723278|P2|STARTED|Study Period 1||7
302321|NCT01723397|723279|P1|STARTED|Study Period 1||7
302322|NCT01723254|723293|P8|NOT COMPLETED|Overall Study||3
302323|NCT01723254|723294|P7|NOT COMPLETED|Overall Study||1
302324|NCT01723254|723295|P6|NOT COMPLETED|Overall Study||2
302325|NCT01723254|723296|P5|NOT COMPLETED|Overall Study||2
302326|NCT01723254|723297|P4|NOT COMPLETED|Overall Study||2
302327|NCT01723254|723298|P3|NOT COMPLETED|Overall Study||3
302328|NCT01723254|723299|P2|NOT COMPLETED|Overall Study||3
302329|NCT01723254|723300|P1|NOT COMPLETED|Overall Study||1
302330|NCT01723254|723293|P8|COMPLETED|Overall Study||60
302331|NCT01723254|723294|P7|COMPLETED|Overall Study||19
302332|NCT01723254|723295|P6|COMPLETED|Overall Study||18
302333|NCT01723254|723296|P5|COMPLETED|Overall Study||18
302334|NCT01723254|723297|P4|COMPLETED|Overall Study||18
302335|NCT01723254|723298|P3|COMPLETED|Overall Study||17
302336|NCT01723254|723299|P2|COMPLETED|Overall Study||18
302337|NCT01723254|723300|P1|COMPLETED|Overall Study||5
302338|NCT01723254|723293|P8|STARTED|Overall Study||63
302339|NCT01723254|723294|P7|STARTED|Overall Study||20
302340|NCT01723254|723295|P6|STARTED|Overall Study||20
302341|NCT01723254|723296|P5|STARTED|Overall Study||20
302342|NCT01723254|723297|P4|STARTED|Overall Study||20
302343|NCT01723254|723298|P3|STARTED|Overall Study||20
302344|NCT01723254|723299|P2|STARTED|Overall Study||21
302345|NCT01723254|723300|P1|STARTED|Overall Study||6
302346|NCT01723228|723352|P2|NOT COMPLETED|Overall Study||11
302347|NCT01723228|723353|P1|NOT COMPLETED|Overall Study||8
302348|NCT01723228|723352|P2|COMPLETED|Overall Study||73
302349|NCT01723228|723353|P1|COMPLETED|Overall Study||78
302350|NCT01723228|723352|P2|STARTED|Overall Study||84
302351|NCT01723228|723353|P1|STARTED|Overall Study||86
302352|NCT01722994|723371|P2|NOT COMPLETED|Overall Study||17
302353|NCT01722994|723372|P1|NOT COMPLETED|Overall Study||25
302354|NCT01722994|723371|P2|COMPLETED|Overall Study||31
302355|NCT01722994|723372|P1|COMPLETED|Overall Study||24
302356|NCT01722994|723371|P2|STARTED|Overall Study||48
302357|NCT01722994|723372|P1|STARTED|Overall Study||49
302358|NCT01722877|723386|P1|NOT COMPLETED|Overall Study||2
302359|NCT01722877|723386|P1|COMPLETED|Overall Study||27
302360|NCT01722877|723386|P1|STARTED|Overall Study||29
302361|NCT01722734|723396|P3|NOT COMPLETED|Overall Study||2
302362|NCT01722734|723397|P2|NOT COMPLETED|Overall Study||1
302363|NCT01722734|723398|P1|NOT COMPLETED|Overall Study||2
302364|NCT01722734|723396|P3|COMPLETED|Overall Study||307
302365|NCT01722734|723397|P2|COMPLETED|Overall Study||276
302366|NCT01722734|723398|P1|COMPLETED|Overall Study||552
302367|NCT01722734|723396|P3|STARTED|Overall Study||309
302368|NCT01722734|723397|P2|STARTED|Overall Study||277
302369|NCT01722734|723398|P1|STARTED|Overall Study||554
302370|NCT01722552|723406|P1|NOT COMPLETED|Overall Study||4
302456|NCT01721330|723589|P2|COMPLETED|Overall Study||1
302371|NCT01722552|723406|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
302372|NCT01722552|723406|P1|STARTED|Overall Study|Number of subjects enrolled|120
302373|NCT01722487|723416|P2|NOT COMPLETED|Overall Study||7
302374|NCT01722487|723417|P1|NOT COMPLETED|Overall Study||2
302375|NCT01722487|723416|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
302376|NCT01722487|723417|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
302377|NCT01722487|723416|P2|STARTED|Overall Study||133
302378|NCT01722487|723417|P1|STARTED|Overall Study||136
302379|NCT01722435|723435|P1|NOT COMPLETED|Overall Study||0
302380|NCT01722435|723435|P1|COMPLETED|Overall Study||78
302381|NCT01722435|723435|P1|STARTED|Overall Study||78
302382|NCT01722266|723447|P4|NOT COMPLETED|Overall Study||0
302383|NCT01722266|723448|P3|NOT COMPLETED|Overall Study||5
302384|NCT01722266|723449|P2|NOT COMPLETED|Overall Study||3
302385|NCT01722266|723450|P1|NOT COMPLETED|Overall Study||1
302386|NCT01722266|723447|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
302387|NCT01722266|723448|P3|COMPLETED|Overall Study||13
302388|NCT01722266|723449|P2|COMPLETED|Overall Study||15
302389|NCT01722266|723450|P1|COMPLETED|Overall Study||17
302390|NCT01722266|723447|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
302391|NCT01722266|723448|P3|STARTED|Overall Study||18
302392|NCT01722266|723449|P2|STARTED|Overall Study||18
302393|NCT01722266|723450|P1|STARTED|Overall Study||18
302394|NCT01722162|723478|P2|NOT COMPLETED|Overall Study||6
302395|NCT01722162|723479|P1|NOT COMPLETED|Overall Study||5
302396|NCT01722162|723478|P2|COMPLETED|Overall Study||18
302397|NCT01722162|723479|P1|COMPLETED|Overall Study||18
302398|NCT01722162|723478|P2|STARTED|Overall Study||24
302399|NCT01722162|723479|P1|STARTED|Overall Study||23
302400|NCT01722097|723489|P2|NOT COMPLETED|Overall Study||5
302401|NCT01722097|723490|P1|NOT COMPLETED|Overall Study||6
302402|NCT01722097|723489|P2|COMPLETED|Overall Study||50
302403|NCT01722097|723490|P1|COMPLETED|Overall Study||49
302404|NCT01722097|723489|P2|STARTED|Overall Study||55
302405|NCT01722097|723490|P1|STARTED|Overall Study||55
302406|NCT01722071|723498|P2|NOT COMPLETED|Overall Study||0
302407|NCT01722071|723499|P1|NOT COMPLETED|Overall Study||1
302408|NCT01722071|723498|P2|COMPLETED|Overall Study||10
302409|NCT01722071|723499|P1|COMPLETED|Overall Study||9
302410|NCT01722071|723498|P2|STARTED|Overall Study||10
302411|NCT01722071|723499|P1|STARTED|Overall Study||10
302412|NCT01721967|723505|P1|NOT COMPLETED|Overall Study||3
302413|NCT01721967|723505|P1|COMPLETED|Overall Study||11
302414|NCT01721967|723505|P1|STARTED|Overall Study||14
302415|NCT01721837|723514|P1|NOT COMPLETED|Overall Study||0
302416|NCT01721837|723514|P1|COMPLETED|Overall Study||2120
302417|NCT01721837|723514|P1|STARTED|Overall Study||2120
302418|NCT01721772|723520|P2|NOT COMPLETED|Overall Study||192
302419|NCT01721772|723521|P1|NOT COMPLETED|Overall Study||111
302420|NCT01721772|723520|P2|COMPLETED|Overall Study|Continuing in treatment period|13
302421|NCT01721772|723521|P1|COMPLETED|Overall Study|Continuing in treatment period|95
302422|NCT01721772|723520|P2|STARTED|Overall Study||205
302423|NCT01721772|723521|P1|STARTED|Overall Study||206
302424|NCT01721759|723541|P1|NOT COMPLETED|Overall Study||102
302425|NCT01721759|723541|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
302426|NCT01721759|723541|P1|STARTED|Overall Study||117
302427|NCT01721746|723549|P3|NOT COMPLETED|Follow-Up Period||0
302428|NCT01721746|723550|P2|NOT COMPLETED|Follow-Up Period||0
302429|NCT01721746|723551|P1|NOT COMPLETED|Follow-Up Period||0
302430|NCT01721746|723549|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
302431|NCT01721746|723550|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
302432|NCT01721746|723551|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
302433|NCT01721746|723549|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
302434|NCT01721746|723550|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
302435|NCT01721746|723551|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
302436|NCT01721746|723549|P3|NOT COMPLETED|Treatment Period||57
302437|NCT01721746|723550|P2|NOT COMPLETED|Treatment Period||45
302438|NCT01721746|723551|P1|NOT COMPLETED|Treatment Period||233
302439|NCT01721746|723549|P3|COMPLETED|Treatment Period||0
302440|NCT01721746|723550|P2|COMPLETED|Treatment Period||0
302441|NCT01721746|723551|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
302442|NCT01721746|723549|P3|STARTED|Treatment Period||57
302443|NCT01721746|723550|P2|STARTED|Treatment Period||45
302444|NCT01721746|723551|P1|STARTED|Treatment Period||268
302445|NCT01721564|723567|P1|NOT COMPLETED|Overall Study||0
302446|NCT01721564|723567|P1|COMPLETED|Overall Study||8
302447|NCT01721564|723567|P1|STARTED|Overall Study||8
302448|NCT01721486|723574|P2|NOT COMPLETED|Overall Study||1
302449|NCT01721486|723575|P1|NOT COMPLETED|Overall Study||1
302450|NCT01721486|723574|P2|COMPLETED|Overall Study||19
302451|NCT01721486|723575|P1|COMPLETED|Overall Study||20
302452|NCT01721486|723574|P2|STARTED|Overall Study||20
302453|NCT01721486|723575|P1|STARTED|Overall Study||21
302454|NCT01721330|723589|P2|NOT COMPLETED|Overall Study||1
302455|NCT01721330|723590|P1|NOT COMPLETED|Overall Study||0
302457|NCT01721330|723590|P1|COMPLETED|Overall Study||1
302458|NCT01721330|723589|P2|STARTED|Overall Study||2
302459|NCT01721330|723590|P1|STARTED|Overall Study||1
302460|NCT01721317|723598|P2|NOT COMPLETED|Overall Study||4
302461|NCT01721317|723599|P1|NOT COMPLETED|Overall Study||2
302462|NCT01721317|723598|P2|COMPLETED|Overall Study||0
302463|NCT01721317|723599|P1|COMPLETED|Overall Study||0
302464|NCT01721317|723598|P2|STARTED|Overall Study||4
302465|NCT01721317|723599|P1|STARTED|Overall Study||2
302466|NCT01721226|723667|P2|NOT COMPLETED|Overall Study||7
302467|NCT01721226|723668|P1|NOT COMPLETED|Overall Study||5
302468|NCT01721226|723667|P2|COMPLETED|Overall Study||50
302469|NCT01721226|723668|P1|COMPLETED|Overall Study||50
302470|NCT01721226|723667|P2|Week 24|Overall Study||50
302471|NCT01721226|723668|P1|Week 24|Overall Study||50
302472|NCT01721226|723667|P2|Week 12|Overall Study||53
302473|NCT01721226|723668|P1|Week 12|Overall Study||48
302474|NCT01721226|723667|P2|Baseline|Overall Study||57
302475|NCT01721226|723668|P1|Baseline|Overall Study||53
302476|NCT01721226|723667|P2|STARTED|Overall Study||57
302477|NCT01721226|723668|P1|STARTED|Overall Study||55
302478|NCT01721161|723678|P2|NOT COMPLETED|Overall Study||7
302479|NCT01721161|723679|P1|NOT COMPLETED|Overall Study||4
302480|NCT01721161|723678|P2|COMPLETED|Overall Study||34
302481|NCT01721161|723679|P1|COMPLETED|Overall Study||37
302482|NCT01721161|723678|P2|STARTED|Overall Study||41
302483|NCT01721161|723679|P1|STARTED|Overall Study||41
302484|NCT01721109|723702|P1|NOT COMPLETED|Extension Phase||37
302485|NCT01721109|723702|P1|COMPLETED|Extension Phase|Participants turned 18 years old or the study drug became commercially available in their country.|3
302486|NCT01721109|723702|P1|STARTED|Extension Phase|Only 40 participants entered the optional extension phase.|40
302487|NCT01721109|723702|P1|NOT COMPLETED|Main Phase||1
302488|NCT01721109|723702|P1|COMPLETED|Main Phase||49
302489|NCT01721109|723702|P1|STARTED|Main Phase||50
302490|NCT01721096|723717|P2|NOT COMPLETED|Follow-up Completed at 3 Year||204
302491|NCT01721096|723718|P1|NOT COMPLETED|Follow-up Completed at 3 Year||302
302492|NCT01721096|723717|P2|COMPLETED|Follow-up Completed at 3 Year||2
302493|NCT01721096|723718|P1|COMPLETED|Follow-up Completed at 3 Year||5
302494|NCT01721096|723717|P2|STARTED|Follow-up Completed at 3 Year||206
302495|NCT01721096|723718|P1|STARTED|Follow-up Completed at 3 Year||307
302496|NCT01721096|723717|P2|NOT COMPLETED|Follow-up Completed at 2 Year||1
302497|NCT01721096|723718|P1|NOT COMPLETED|Follow-up Completed at 2 Year||8
302498|NCT01721096|723717|P2|COMPLETED|Follow-up Completed at 2 Year||206
302499|NCT01721096|723718|P1|COMPLETED|Follow-up Completed at 2 Year||307
302500|NCT01721096|723717|P2|STARTED|Follow-up Completed at 2 Year||207
302501|NCT01721096|723718|P1|STARTED|Follow-up Completed at 2 Year||315
302502|NCT01721096|723717|P2|NOT COMPLETED|Follow-up Completed at 1 Year||1
302503|NCT01721096|723718|P1|NOT COMPLETED|Follow-up Completed at 1 Year||4
302504|NCT01721096|723717|P2|COMPLETED|Follow-up Completed at 1 Year||207
302505|NCT01721096|723718|P1|COMPLETED|Follow-up Completed at 1 Year||315
302506|NCT01721096|723717|P2|STARTED|Follow-up Completed at 1 Year||208
302507|NCT01721096|723718|P1|STARTED|Follow-up Completed at 1 Year||319
302508|NCT01721096|723717|P2|NOT COMPLETED|Follow-up Completed at 8 Months||5
302509|NCT01721096|723718|P1|NOT COMPLETED|Follow-up Completed at 8 Months||4
302510|NCT01721096|723717|P2|COMPLETED|Follow-up Completed at 8 Months||208
302511|NCT01721096|723718|P1|COMPLETED|Follow-up Completed at 8 Months||319
302512|NCT01721096|723717|P2|STARTED|Follow-up Completed at 8 Months||213
302513|NCT01721096|723718|P1|STARTED|Follow-up Completed at 8 Months||323
302514|NCT01721070|723808|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
302515|NCT01721070|723808|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
302516|NCT01721070|723808|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
302517|NCT01721070|723808|P1|NOT COMPLETED|SUF NT 15 mcg||0
302518|NCT01721070|723808|P1|COMPLETED|SUF NT 15 mcg||19
302519|NCT01721070|723808|P1|STARTED|SUF NT 15 mcg||19
302520|NCT01721057|723819|P7|NOT COMPLETED|Follow Up||0
302521|NCT01721057|723820|P6|NOT COMPLETED|Follow Up||0
302522|NCT01721057|723821|P5|NOT COMPLETED|Follow Up||0
302523|NCT01721057|723822|P4|NOT COMPLETED|Follow Up||0
302524|NCT01721057|723823|P3|NOT COMPLETED|Follow Up||0
302525|NCT01721057|723824|P2|NOT COMPLETED|Follow Up||0
302526|NCT01721057|723825|P1|NOT COMPLETED|Follow Up||0
302527|NCT01721057|723819|P7|COMPLETED|Follow Up||22
302528|NCT01721057|723820|P6|COMPLETED|Follow Up||19
302529|NCT01721057|723821|P5|COMPLETED|Follow Up||17
302530|NCT01721057|723822|P4|COMPLETED|Follow Up||0
302531|NCT01721057|723823|P3|COMPLETED|Follow Up||0
302532|NCT01721057|723824|P2|COMPLETED|Follow Up||0
302533|NCT01721057|723825|P1|COMPLETED|Follow Up||0
302534|NCT01721057|723819|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
302535|NCT01721057|723820|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
302536|NCT01721057|723821|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
302537|NCT01721057|723822|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
302538|NCT01721057|723823|P3|STARTED|Follow Up||0
302539|NCT01721057|723824|P2|STARTED|Follow Up||0
302540|NCT01721057|723825|P1|STARTED|Follow Up||0
302541|NCT01721057|723819|P7|NOT COMPLETED|Rescue Period||0
302542|NCT01721057|723820|P6|NOT COMPLETED|Rescue Period||0
302543|NCT01721057|723821|P5|NOT COMPLETED|Rescue Period||0
302544|NCT01721057|723822|P4|NOT COMPLETED|Rescue Period||3
302545|NCT01721057|723823|P3|NOT COMPLETED|Rescue Period||0
302546|NCT01721057|723824|P2|NOT COMPLETED|Rescue Period||0
302547|NCT01721057|723825|P1|NOT COMPLETED|Rescue Period||0
302548|NCT01721057|723819|P7|COMPLETED|Rescue Period||0
302549|NCT01721057|723820|P6|COMPLETED|Rescue Period||0
302550|NCT01721057|723821|P5|COMPLETED|Rescue Period||0
302551|NCT01721057|723822|P4|COMPLETED|Rescue Period||88
302552|NCT01721057|723823|P3|COMPLETED|Rescue Period||0
302553|NCT01721057|723824|P2|COMPLETED|Rescue Period||0
302554|NCT01721057|723825|P1|COMPLETED|Rescue Period||0
302555|NCT01721057|723819|P7|STARTED|Rescue Period||0
302556|NCT01721057|723820|P6|STARTED|Rescue Period||0
302557|NCT01721057|723821|P5|STARTED|Rescue Period||0
302558|NCT01721057|723822|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
302559|NCT01721057|723823|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
302560|NCT01721057|723824|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
302561|NCT01721057|723825|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
302562|NCT01721057|723819|P7|NOT COMPLETED|Treatment Period||0
302563|NCT01721057|723820|P6|NOT COMPLETED|Treatment Period||0
302564|NCT01721057|723821|P5|NOT COMPLETED|Treatment Period||0
302565|NCT01721057|723822|P4|NOT COMPLETED|Treatment Period||0
302566|NCT01721057|723823|P3|NOT COMPLETED|Treatment Period||23
302567|NCT01721057|723824|P2|NOT COMPLETED|Treatment Period||19
302568|NCT01721057|723825|P1|NOT COMPLETED|Treatment Period||28
302569|NCT01721057|723819|P7|COMPLETED|Treatment Period||0
302570|NCT01721057|723820|P6|COMPLETED|Treatment Period||0
302571|NCT01721057|723821|P5|COMPLETED|Treatment Period||0
302572|NCT01721057|723822|P4|COMPLETED|Treatment Period||0
302573|NCT01721057|723823|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
302574|NCT01721057|723824|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
302575|NCT01721057|723825|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
302576|NCT01721057|723819|P7|Rescued|Treatment Period||0
302577|NCT01721057|723820|P6|Rescued|Treatment Period||0
302578|NCT01721057|723821|P5|Rescued|Treatment Period||0
302579|NCT01721057|723822|P4|Rescued|Treatment Period||0
302580|NCT01721057|723823|P3|Rescued|Treatment Period||15
302581|NCT01721057|723824|P2|Rescued|Treatment Period||21
302582|NCT01721057|723825|P1|Rescued|Treatment Period||55
302583|NCT01721057|723819|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
302584|NCT01721057|723820|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
302585|NCT01721057|723821|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
302586|NCT01721057|723822|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
302587|NCT01721057|723823|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
302588|NCT01721057|723824|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
302589|NCT01721057|723825|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
302590|NCT01721057|723819|P7|STARTED|Treatment Period||0
302591|NCT01721057|723820|P6|STARTED|Treatment Period||0
302592|NCT01721057|723821|P5|STARTED|Treatment Period||0
302593|NCT01721057|723822|P4|STARTED|Treatment Period||0
302594|NCT01721057|723823|P3|STARTED|Treatment Period||227
302595|NCT01721057|723824|P2|STARTED|Treatment Period||229
302596|NCT01721057|723825|P1|STARTED|Treatment Period||228
302597|NCT01720797|723897|P2|NOT COMPLETED|Overall Study||0
302598|NCT01720797|723898|P1|NOT COMPLETED|Overall Study||3
302599|NCT01720797|723897|P2|COMPLETED|Overall Study||9
302600|NCT01720797|723898|P1|COMPLETED|Overall Study||9
302601|NCT01720797|723897|P2|STARTED|Overall Study||9
302602|NCT01720797|723898|P1|STARTED|Overall Study||12
302603|NCT01720602|723904|P1|NOT COMPLETED|Overall Study||5
302604|NCT01720602|723904|P1|COMPLETED|Overall Study||10
302605|NCT01720602|723904|P1|STARTED|Overall Study||15
302606|NCT01720316|723912|P2|NOT COMPLETED|Open-label Glycine||0
302607|NCT01720316|723913|P1|NOT COMPLETED|Open-label Glycine||0
302608|NCT01720316|723912|P2|COMPLETED|Open-label Glycine||1
302609|NCT01720316|723913|P1|COMPLETED|Open-label Glycine||1
302610|NCT01720316|723912|P2|STARTED|Open-label Glycine||1
302611|NCT01720316|723913|P1|STARTED|Open-label Glycine||1
302612|NCT01720316|723912|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
302613|NCT01720316|723913|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
302614|NCT01720316|723912|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
302615|NCT01720316|723913|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
302616|NCT01720316|723912|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
302617|NCT01720316|723913|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
302618|NCT01720251|723962|P3|NOT COMPLETED|Overall Study||0
302619|NCT01720251|723963|P2|NOT COMPLETED|Overall Study||2
302620|NCT01720251|723964|P1|NOT COMPLETED|Overall Study||1
302621|NCT01720251|723962|P3|COMPLETED|Overall Study||82
302622|NCT01720251|723963|P2|COMPLETED|Overall Study||77
302623|NCT01720251|723964|P1|COMPLETED|Overall Study||78
302624|NCT01720251|723962|P3|STARTED|Overall Study||82
302625|NCT01720251|723963|P2|STARTED|Overall Study||79
302626|NCT01720251|723964|P1|STARTED|Overall Study||79
302627|NCT01719861|723972|P1|NOT COMPLETED|Cycle 2||1
302628|NCT01719861|723972|P1|COMPLETED|Cycle 2||1
302629|NCT01719861|723972|P1|STARTED|Cycle 2||2
302630|NCT01719861|723972|P1|NOT COMPLETED|Cycle 1||4
302631|NCT01719861|723972|P1|COMPLETED|Cycle 1||2
302632|NCT01719861|723972|P1|STARTED|Cycle 1||6
302633|NCT01719757|723980|P1|NOT COMPLETED|Overall Study||101
302634|NCT01719757|723980|P1|COMPLETED|Overall Study||258
302635|NCT01719757|723980|P1|STARTED|Overall Study||359
302636|NCT01719653|723993|P5|NOT COMPLETED|Overall Study||21
302637|NCT01719653|723994|P4|NOT COMPLETED|Overall Study||18
302638|NCT01719653|723995|P3|NOT COMPLETED|Overall Study||18
302639|NCT01719653|723996|P2|NOT COMPLETED|Overall Study||13
302640|NCT01719653|723997|P1|NOT COMPLETED|Overall Study||9
302641|NCT01719653|723993|P5|COMPLETED|Overall Study||200
302642|NCT01719653|723994|P4|COMPLETED|Overall Study||200
302643|NCT01719653|723995|P3|COMPLETED|Overall Study||200
302644|NCT01719653|723996|P2|COMPLETED|Overall Study||200
302645|NCT01719653|723997|P1|COMPLETED|Overall Study||200
302646|NCT01719653|723993|P5|STARTED|Overall Study||221
302647|NCT01719653|723994|P4|STARTED|Overall Study||218
302648|NCT01719653|723995|P3|STARTED|Overall Study||218
302649|NCT01719653|723996|P2|STARTED|Overall Study||213
302650|NCT01719653|723997|P1|STARTED|Overall Study||209
302651|NCT01719172|724019|P1|NOT COMPLETED|Overall Study||2
302652|NCT01719172|724019|P1|COMPLETED|Overall Study||28
302653|NCT01719172|724019|P1|STARTED|Overall Study||30
302654|NCT01719003|724033|P9|NOT COMPLETED|Overall Study||4
302655|NCT01719003|724034|P8|NOT COMPLETED|Overall Study||20
302656|NCT01719003|724035|P7|NOT COMPLETED|Overall Study||20
302657|NCT01719003|724036|P6|NOT COMPLETED|Overall Study||12
302658|NCT01719003|724037|P5|NOT COMPLETED|Overall Study||17
302659|NCT01719003|724038|P4|NOT COMPLETED|Overall Study||13
302660|NCT01719003|724039|P3|NOT COMPLETED|Overall Study||17
302661|NCT01719003|724040|P2|NOT COMPLETED|Overall Study||17
302662|NCT01719003|724041|P1|NOT COMPLETED|Overall Study||9
302663|NCT01719003|724033|P9|COMPLETED|Overall Study||49
302664|NCT01719003|724034|P8|COMPLETED|Overall Study||151
302665|NCT01719003|724035|P7|COMPLETED|Overall Study||150
302666|NCT01719003|724036|P6|COMPLETED|Overall Study||160
302667|NCT01719003|724037|P5|COMPLETED|Overall Study||150
302668|NCT01719003|724038|P4|COMPLETED|Overall Study||156
302669|NCT01719003|724039|P3|COMPLETED|Overall Study||154
302670|NCT01719003|724040|P2|COMPLETED|Overall Study||153
302671|NCT01719003|724041|P1|COMPLETED|Overall Study||161
302672|NCT01719003|724033|P9|STARTED|Overall Study||53
302673|NCT01719003|724034|P8|STARTED|Overall Study||171
302674|NCT01719003|724035|P7|STARTED|Overall Study||170
302675|NCT01719003|724036|P6|STARTED|Overall Study||172
302676|NCT01719003|724037|P5|STARTED|Overall Study||167
302677|NCT01719003|724038|P4|STARTED|Overall Study||169
302678|NCT01719003|724039|P3|STARTED|Overall Study||171
302679|NCT01719003|724040|P2|STARTED|Overall Study||170
302680|NCT01719003|724041|P1|STARTED|Overall Study||170
302681|NCT01718691|724078|P2|NOT COMPLETED|Overall Study||1
302682|NCT01718691|724079|P1|NOT COMPLETED|Overall Study||18
302683|NCT01718691|724078|P2|COMPLETED|Overall Study||9
302684|NCT01718691|724079|P1|COMPLETED|Overall Study||42
302685|NCT01718691|724078|P2|STARTED|Overall Study||10
302686|NCT01718691|724079|P1|STARTED|Overall Study||60
302687|NCT01718535|724122|P10|NOT COMPLETED|Overall Study||0
302688|NCT01718535|724123|P9|NOT COMPLETED|Overall Study||0
302689|NCT01718535|724124|P8|NOT COMPLETED|Overall Study||0
302690|NCT01718535|724125|P7|NOT COMPLETED|Overall Study||0
302691|NCT01718535|724126|P6|NOT COMPLETED|Overall Study||0
302692|NCT01718535|724127|P5|NOT COMPLETED|Overall Study||0
302693|NCT01718535|724128|P4|NOT COMPLETED|Overall Study||1
302694|NCT01718535|724129|P3|NOT COMPLETED|Overall Study||0
302695|NCT01718535|724130|P2|NOT COMPLETED|Overall Study||0
302696|NCT01718535|724131|P1|NOT COMPLETED|Overall Study||1
302697|NCT01718535|724122|P10|COMPLETED|Overall Study||1
302698|NCT01718535|724123|P9|COMPLETED|Overall Study||15
302699|NCT01718535|724124|P8|COMPLETED|Overall Study||6
302700|NCT01718535|724125|P7|COMPLETED|Overall Study||11
302701|NCT01718535|724126|P6|COMPLETED|Overall Study||40
302702|NCT01718535|724127|P5|COMPLETED|Overall Study||1
302703|NCT01718535|724128|P4|COMPLETED|Overall Study||7
302704|NCT01718535|724129|P3|COMPLETED|Overall Study||19
302705|NCT01718535|724130|P2|COMPLETED|Overall Study||95
302706|NCT01718535|724131|P1|COMPLETED|Overall Study||130
302707|NCT01718535|724122|P10|First Pass|Overall Study||1
302708|NCT01718535|724123|P9|First Pass|Overall Study||15
302709|NCT01718535|724124|P8|First Pass|Overall Study||6
302710|NCT01718535|724125|P7|First Pass|Overall Study||11
302711|NCT01718535|724126|P6|First Pass|Overall Study||39
302712|NCT01718535|724127|P5|First Pass|Overall Study||1
302713|NCT01718535|724128|P4|First Pass|Overall Study||7
302714|NCT01718535|724129|P3|First Pass|Overall Study||19
302715|NCT01718535|724130|P2|First Pass|Overall Study||94
302716|NCT01718535|724131|P1|First Pass|Overall Study||128
302717|NCT01718535|724122|P10|STARTED|Overall Study||1
302718|NCT01718535|724123|P9|STARTED|Overall Study||15
302719|NCT01718535|724124|P8|STARTED|Overall Study||6
302720|NCT01718535|724125|P7|STARTED|Overall Study||11
302721|NCT01718535|724126|P6|STARTED|Overall Study||40
302722|NCT01718535|724127|P5|STARTED|Overall Study||1
302723|NCT01718535|724128|P4|STARTED|Overall Study||8
302724|NCT01718535|724129|P3|STARTED|Overall Study||19
302725|NCT01718535|724130|P2|STARTED|Overall Study||95
302726|NCT01718535|724131|P1|STARTED|Overall Study||131
302727|NCT01718509|724155|P2|NOT COMPLETED|Overall Study||48
302728|NCT01718509|724156|P1|NOT COMPLETED|Overall Study||48
302729|NCT01718509|724155|P2|COMPLETED|Overall Study||147
302730|NCT01718509|724156|P1|COMPLETED|Overall Study||147
302731|NCT01718509|724155|P2|STARTED|Overall Study||195
302732|NCT01718509|724156|P1|STARTED|Overall Study||195
302733|NCT01718483|724202|P2|NOT COMPLETED|Overall Study||34
302734|NCT01718483|724203|P1|NOT COMPLETED|Overall Study||34
302735|NCT01718483|724202|P2|COMPLETED|Overall Study||158
302736|NCT01718483|724203|P1|COMPLETED|Overall Study||157
302737|NCT01718483|724202|P2|Treated|Overall Study||192
302738|NCT01718483|724203|P1|Treated|Overall Study||187
302739|NCT01718483|724202|P2|STARTED|Overall Study||192
302740|NCT01718483|724203|P1|STARTED|Overall Study||191
302741|NCT01718028|724249|P2|NOT COMPLETED|Overall Study||0
302742|NCT01718028|724250|P1|NOT COMPLETED|Overall Study||0
302743|NCT01718028|724249|P2|COMPLETED|Overall Study||24
302744|NCT01718028|724250|P1|COMPLETED|Overall Study||25
302745|NCT01718028|724249|P2|STARTED|Overall Study||24
302746|NCT01718028|724250|P1|STARTED|Overall Study||25
302747|NCT01717989|724262|P1|NOT COMPLETED|Overall Study||1066
302748|NCT01717989|724262|P1|COMPLETED|Overall Study||1182
302749|NCT01717989|724262|P1|STARTED|Overall Study||2248
302750|NCT01717976|724330|P2|NOT COMPLETED|Overall Study||2
302751|NCT01717976|724331|P1|NOT COMPLETED|Overall Study||0
302752|NCT01717976|724330|P2|COMPLETED|Overall Study||255
302753|NCT01717976|724331|P1|COMPLETED|Overall Study||257
302754|NCT01717976|724330|P2|STARTED|Overall Study||257
302755|NCT01717976|724331|P1|STARTED|Overall Study||257
302756|NCT01717872|724347|P2|NOT COMPLETED|Overall Study||0
302757|NCT01717872|724348|P1|NOT COMPLETED|Overall Study||0
302758|NCT01717872|724347|P2|COMPLETED|Overall Study||25
302759|NCT01717872|724348|P1|COMPLETED|Overall Study||25
302760|NCT01717872|724347|P2|STARTED|Overall Study||25
302761|NCT01717872|724348|P1|STARTED|Overall Study||25
302762|NCT01717768|724368|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302763|NCT01717768|724369|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302764|NCT01717768|724370|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
302765|NCT01717768|724371|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302766|NCT01717768|724372|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
302767|NCT01717768|724373|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302768|NCT01717768|724374|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302769|NCT01717768|724375|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302770|NCT01717768|724376|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302771|NCT01717768|724377|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302772|NCT01717768|724378|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302773|NCT01717768|724379|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302774|NCT01717768|724368|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302775|NCT01717768|724369|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302776|NCT01717768|724370|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
302777|NCT01717768|724371|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302778|NCT01717768|724372|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
302779|NCT01717768|724373|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302780|NCT01717768|724374|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302781|NCT01717768|724375|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302782|NCT01717768|724376|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302783|NCT01717768|724377|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302784|NCT01717768|724378|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302785|NCT01717768|724379|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
302786|NCT01717768|724368|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302787|NCT01717768|724369|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302788|NCT01717768|724370|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
302789|NCT01717768|724371|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302790|NCT01717768|724372|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
302791|NCT01717768|724373|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302792|NCT01717768|724374|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302793|NCT01717768|724375|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302794|NCT01717768|724376|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302795|NCT01717768|724377|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302796|NCT01717768|724378|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302797|NCT01717768|724379|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
302798|NCT01717768|724368|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
302799|NCT01717768|724369|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302800|NCT01717768|724370|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302801|NCT01717768|724371|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302802|NCT01717768|724372|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302803|NCT01717768|724373|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302804|NCT01717768|724374|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302805|NCT01717768|724375|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302806|NCT01717768|724376|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302807|NCT01717768|724377|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302808|NCT01717768|724378|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302809|NCT01717768|724379|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302810|NCT01717768|724368|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
302811|NCT01717768|724369|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
302812|NCT01717768|724370|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302813|NCT01717768|724371|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
302814|NCT01717768|724372|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302815|NCT01717768|724373|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
302816|NCT01717768|724374|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302817|NCT01717768|724375|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302818|NCT01717768|724376|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302819|NCT01717768|724377|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302820|NCT01717768|724378|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302821|NCT01717768|724379|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
302822|NCT01717768|724368|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
302823|NCT01717768|724369|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
302824|NCT01717768|724370|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302825|NCT01717768|724371|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
302826|NCT01717768|724372|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302827|NCT01717768|724373|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
302828|NCT01717768|724374|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302829|NCT01717768|724375|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302830|NCT01717768|724376|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302831|NCT01717768|724377|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302832|NCT01717768|724378|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302833|NCT01717768|724379|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
302834|NCT01717768|724368|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302835|NCT01717768|724369|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302836|NCT01717768|724370|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302837|NCT01717768|724371|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302838|NCT01717768|724372|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302839|NCT01717768|724373|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302840|NCT01717768|724374|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302841|NCT01717768|724375|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302842|NCT01717768|724376|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302843|NCT01717768|724377|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302844|NCT01717768|724378|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302845|NCT01717768|724379|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302846|NCT01717768|724368|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302847|NCT01717768|724369|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302848|NCT01717768|724370|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302849|NCT01717768|724371|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302850|NCT01717768|724372|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302851|NCT01717768|724373|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302852|NCT01717768|724374|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
302853|NCT01717768|724375|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
302854|NCT01717768|724376|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
302855|NCT01717768|724377|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302856|NCT01717768|724378|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302857|NCT01717768|724379|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302858|NCT01717768|724368|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302859|NCT01717768|724369|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302860|NCT01717768|724370|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302861|NCT01717768|724371|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302862|NCT01717768|724372|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302863|NCT01717768|724373|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302864|NCT01717768|724374|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
302865|NCT01717768|724375|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
302866|NCT01717768|724376|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
302867|NCT01717768|724377|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302868|NCT01717768|724378|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302869|NCT01717768|724379|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
302870|NCT01717768|724368|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302871|NCT01717768|724369|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302872|NCT01717768|724370|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302873|NCT01717768|724371|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302874|NCT01717768|724372|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302875|NCT01717768|724373|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302876|NCT01717768|724374|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302877|NCT01717768|724375|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302878|NCT01717768|724376|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302879|NCT01717768|724377|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302880|NCT01717768|724378|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302881|NCT01717768|724379|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302882|NCT01717768|724368|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302883|NCT01717768|724369|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302884|NCT01717768|724370|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302885|NCT01717768|724371|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302886|NCT01717768|724372|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302887|NCT01717768|724373|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302888|NCT01717768|724374|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
302889|NCT01717768|724375|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
302890|NCT01717768|724376|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
302891|NCT01717768|724377|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302892|NCT01717768|724378|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302893|NCT01717768|724379|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302894|NCT01717768|724368|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302895|NCT01717768|724369|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302896|NCT01717768|724370|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302897|NCT01717768|724371|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302898|NCT01717768|724372|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302899|NCT01717768|724373|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302900|NCT01717768|724374|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
302901|NCT01717768|724375|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
302902|NCT01717768|724376|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
302903|NCT01717768|724377|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302904|NCT01717768|724378|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302905|NCT01717768|724379|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
302906|NCT01717768|724368|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302907|NCT01717768|724369|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302908|NCT01717768|724370|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302909|NCT01717768|724371|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302910|NCT01717768|724372|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302911|NCT01717768|724373|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302912|NCT01717768|724374|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302913|NCT01717768|724375|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302914|NCT01717768|724376|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302915|NCT01717768|724377|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302916|NCT01717768|724378|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302917|NCT01717768|724379|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302918|NCT01717768|724368|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302919|NCT01717768|724369|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302920|NCT01717768|724370|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302921|NCT01717768|724371|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302922|NCT01717768|724372|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302923|NCT01717768|724373|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302924|NCT01717768|724374|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
302925|NCT01717768|724375|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
302926|NCT01717768|724376|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
302927|NCT01717768|724377|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302928|NCT01717768|724378|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302929|NCT01717768|724379|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302930|NCT01717768|724368|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302931|NCT01717768|724369|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302932|NCT01717768|724370|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302933|NCT01717768|724371|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302934|NCT01717768|724372|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302935|NCT01717768|724373|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302936|NCT01717768|724374|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
302937|NCT01717768|724375|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
302938|NCT01717768|724376|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
302939|NCT01717768|724377|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302940|NCT01717768|724378|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302941|NCT01717768|724379|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
302942|NCT01717768|724368|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302943|NCT01717768|724369|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302944|NCT01717768|724370|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302945|NCT01717768|724371|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302946|NCT01717768|724372|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302947|NCT01717768|724373|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302948|NCT01717768|724374|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302949|NCT01717768|724375|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302950|NCT01717768|724376|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302951|NCT01717768|724377|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302952|NCT01717768|724378|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302953|NCT01717768|724379|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
302954|NCT01717768|724368|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
302955|NCT01717768|724369|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
302956|NCT01717768|724370|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
302957|NCT01717768|724371|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
302958|NCT01717768|724372|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
302959|NCT01717768|724373|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
302960|NCT01717768|724374|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
302961|NCT01717768|724375|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
302962|NCT01717768|724376|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
302963|NCT01717768|724377|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
302964|NCT01717768|724378|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
302965|NCT01717768|724379|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
302966|NCT01717768|724368|P12|STARTED|Part 2 (Duration of 15 Days)||0
302967|NCT01717768|724369|P11|STARTED|Part 2 (Duration of 15 Days)||0
302968|NCT01717768|724370|P10|STARTED|Part 2 (Duration of 15 Days)||0
302969|NCT01717768|724371|P9|STARTED|Part 2 (Duration of 15 Days)||0
302970|NCT01717768|724372|P8|STARTED|Part 2 (Duration of 15 Days)||0
302971|NCT01717768|724373|P7|STARTED|Part 2 (Duration of 15 Days)||0
302972|NCT01717768|724374|P6|STARTED|Part 2 (Duration of 15 Days)||0
302973|NCT01717768|724375|P5|STARTED|Part 2 (Duration of 15 Days)||0
302974|NCT01717768|724376|P4|STARTED|Part 2 (Duration of 15 Days)||0
302975|NCT01717768|724377|P3|STARTED|Part 2 (Duration of 15 Days)||17
302976|NCT01717768|724378|P2|STARTED|Part 2 (Duration of 15 Days)||0
302977|NCT01717768|724379|P1|STARTED|Part 2 (Duration of 15 Days)||0
302978|NCT01717768|724368|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302979|NCT01717768|724369|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302980|NCT01717768|724370|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302981|NCT01717768|724371|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302982|NCT01717768|724372|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302983|NCT01717768|724373|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302984|NCT01717768|724374|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302985|NCT01717768|724375|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302986|NCT01717768|724376|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302987|NCT01717768|724377|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302988|NCT01717768|724378|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
302989|NCT01717768|724379|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
302990|NCT01717768|724368|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
302991|NCT01717768|724369|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
302992|NCT01717768|724370|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
302993|NCT01717768|724371|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
302994|NCT01717768|724372|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
302995|NCT01717768|724373|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
302996|NCT01717768|724374|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
302997|NCT01717768|724375|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
302998|NCT01717768|724376|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
302999|NCT01717768|724377|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
303000|NCT01717768|724378|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
303001|NCT01717768|724379|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
303002|NCT01717768|724368|P12|STARTED|Part 1 (Duration of 15 Days)||0
303003|NCT01717768|724369|P11|STARTED|Part 1 (Duration of 15 Days)||0
303004|NCT01717768|724370|P10|STARTED|Part 1 (Duration of 15 Days)||0
303005|NCT01717768|724371|P9|STARTED|Part 1 (Duration of 15 Days)||0
303006|NCT01717768|724372|P8|STARTED|Part 1 (Duration of 15 Days)||0
303007|NCT01717768|724373|P7|STARTED|Part 1 (Duration of 15 Days)||0
303008|NCT01717768|724374|P6|STARTED|Part 1 (Duration of 15 Days)||0
303009|NCT01717768|724375|P5|STARTED|Part 1 (Duration of 15 Days)||0
303010|NCT01717768|724376|P4|STARTED|Part 1 (Duration of 15 Days)||0
303011|NCT01717768|724377|P3|STARTED|Part 1 (Duration of 15 Days)||0
303012|NCT01717768|724378|P2|STARTED|Part 1 (Duration of 15 Days)||17
303013|NCT01717768|724379|P1|STARTED|Part 1 (Duration of 15 Days)||17
303014|NCT01717638|724430|P13|NOT COMPLETED|Overall Study||19
303015|NCT01717638|724431|P12|NOT COMPLETED|Overall Study||0
303016|NCT01717638|724432|P11|NOT COMPLETED|Overall Study||0
303017|NCT01717638|724433|P10|NOT COMPLETED|Overall Study||1
303018|NCT01717638|724434|P9|NOT COMPLETED|Overall Study||2
303019|NCT01717638|724435|P8|NOT COMPLETED|Overall Study||1
303020|NCT01717638|724436|P7|NOT COMPLETED|Overall Study||2
303021|NCT01717638|724437|P6|NOT COMPLETED|Overall Study||1
303022|NCT01717638|724438|P5|NOT COMPLETED|Overall Study||1
303023|NCT01717638|724439|P4|NOT COMPLETED|Overall Study||0
303024|NCT01717638|724440|P3|NOT COMPLETED|Overall Study||1
303025|NCT01717638|724441|P2|NOT COMPLETED|Overall Study||1
303026|NCT01717638|724442|P1|NOT COMPLETED|Overall Study||0
303027|NCT01717638|724430|P13|COMPLETED|Overall Study||190
303028|NCT01717638|724431|P12|COMPLETED|Overall Study||12
303029|NCT01717638|724432|P11|COMPLETED|Overall Study||11
303030|NCT01717638|724433|P10|COMPLETED|Overall Study||99
303031|NCT01717638|724434|P9|COMPLETED|Overall Study||26
303032|NCT01717638|724435|P8|COMPLETED|Overall Study||28
303033|NCT01717638|724436|P7|COMPLETED|Overall Study||41
303034|NCT01717638|724437|P6|COMPLETED|Overall Study||54
303035|NCT01717638|724438|P5|COMPLETED|Overall Study||63
303036|NCT01717638|724439|P4|COMPLETED|Overall Study||66
303037|NCT01717638|724440|P3|COMPLETED|Overall Study||59
303038|NCT01717638|724441|P2|COMPLETED|Overall Study||60
303039|NCT01717638|724442|P1|COMPLETED|Overall Study||67
303040|NCT01717638|724430|P13|STARTED|Overall Study||209
303041|NCT01717638|724431|P12|STARTED|Overall Study||12
303042|NCT01717638|724432|P11|STARTED|Overall Study||11
303043|NCT01717638|724433|P10|STARTED|Overall Study||100
303044|NCT01717638|724434|P9|STARTED|Overall Study||28
303045|NCT01717638|724435|P8|STARTED|Overall Study||29
303046|NCT01717638|724436|P7|STARTED|Overall Study||43
303047|NCT01717638|724437|P6|STARTED|Overall Study||55
303048|NCT01717638|724438|P5|STARTED|Overall Study||64
303049|NCT01717638|724439|P4|STARTED|Overall Study||66
303050|NCT01717638|724440|P3|STARTED|Overall Study||60
303051|NCT01717638|724441|P2|STARTED|Overall Study||61
303052|NCT01717638|724442|P1|STARTED|Overall Study||67
303053|NCT01717456|724586|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
303054|NCT01717456|724587|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
303055|NCT01717456|724586|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
303056|NCT01717456|724587|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
303057|NCT01717456|724586|P2|STARTED|Follow-Up 6 Months After End of Tx||6
303058|NCT01717456|724587|P1|STARTED|Follow-Up 6 Months After End of Tx||11
303059|NCT01717456|724586|P2|NOT COMPLETED|End of Treatment||2
303060|NCT01717456|724587|P1|NOT COMPLETED|End of Treatment||0
303061|NCT01717456|724586|P2|COMPLETED|End of Treatment||6
303062|NCT01717456|724587|P1|COMPLETED|End of Treatment||11
303063|NCT01717456|724586|P2|STARTED|End of Treatment||8
303064|NCT01717456|724587|P1|STARTED|End of Treatment||11
303065|NCT01717326|724675|P20|NOT COMPLETED|Overall Study||6
303066|NCT01717326|724676|P19|NOT COMPLETED|Overall Study||4
303067|NCT01717326|724677|P18|NOT COMPLETED|Overall Study||0
303068|NCT01717326|724678|P17|NOT COMPLETED|Overall Study||1
303069|NCT01717326|724679|P16|NOT COMPLETED|Overall Study||3
303070|NCT01717326|724680|P15|NOT COMPLETED|Overall Study||0
303071|NCT01717326|724681|P14|NOT COMPLETED|Overall Study||0
303072|NCT01717326|724682|P13|NOT COMPLETED|Overall Study||1
303073|NCT01717326|724683|P12|NOT COMPLETED|Overall Study||0
303074|NCT01717326|724684|P11|NOT COMPLETED|Overall Study||2
303075|NCT01717326|724685|P10|NOT COMPLETED|Overall Study||2
303076|NCT01717326|724686|P9|NOT COMPLETED|Overall Study||0
303077|NCT01717326|724687|P8|NOT COMPLETED|Overall Study||0
303078|NCT01717326|724688|P7|NOT COMPLETED|Overall Study||1
303079|NCT01717326|724689|P6|NOT COMPLETED|Overall Study||0
303080|NCT01717326|724690|P5|NOT COMPLETED|Overall Study||2
303081|NCT01717326|724691|P4|NOT COMPLETED|Overall Study||2
303082|NCT01717326|724692|P3|NOT COMPLETED|Overall Study||0
303083|NCT01717326|724693|P2|NOT COMPLETED|Overall Study||1
303084|NCT01717326|724694|P1|NOT COMPLETED|Overall Study||3
303085|NCT01717326|724675|P20|COMPLETED|Overall Study||15
303086|NCT01717326|724676|P19|COMPLETED|Overall Study||16
303087|NCT01717326|724677|P18|COMPLETED|Overall Study||31
303088|NCT01717326|724678|P17|COMPLETED|Overall Study||29
303089|NCT01717326|724679|P16|COMPLETED|Overall Study||27
303090|NCT01717326|724680|P15|COMPLETED|Overall Study||29
303091|NCT01717326|724681|P14|COMPLETED|Overall Study||32
303092|NCT01717326|724682|P13|COMPLETED|Overall Study||32
303093|NCT01717326|724683|P12|COMPLETED|Overall Study||33
303094|NCT01717326|724684|P11|COMPLETED|Overall Study||30
303095|NCT01717326|724685|P10|COMPLETED|Overall Study||29
303096|NCT01717326|724686|P9|COMPLETED|Overall Study||32
303097|NCT01717326|724687|P8|COMPLETED|Overall Study||29
303098|NCT01717326|724688|P7|COMPLETED|Overall Study||30
303099|NCT01717326|724689|P6|COMPLETED|Overall Study||31
303100|NCT01717326|724690|P5|COMPLETED|Overall Study||31
303101|NCT01717326|724691|P4|COMPLETED|Overall Study||28
303102|NCT01717326|724692|P3|COMPLETED|Overall Study||13
303103|NCT01717326|724693|P2|COMPLETED|Overall Study||26
303104|NCT01717326|724694|P1|COMPLETED|Overall Study||22
303105|NCT01717326|724675|P20|Treated|Overall Study||21
303106|NCT01717326|724676|P19|Treated|Overall Study||20
303107|NCT01717326|724677|P18|Treated|Overall Study||31
303108|NCT01717326|724678|P17|Treated|Overall Study||30
303109|NCT01717326|724679|P16|Treated|Overall Study||30
303110|NCT01717326|724680|P15|Treated|Overall Study||29
303111|NCT01717326|724681|P14|Treated|Overall Study||32
303112|NCT01717326|724682|P13|Treated|Overall Study||33
303113|NCT01717326|724683|P12|Treated|Overall Study||33
303114|NCT01717326|724684|P11|Treated|Overall Study||32
303115|NCT01717326|724685|P10|Treated|Overall Study||31
303116|NCT01717326|724686|P9|Treated|Overall Study||32
303117|NCT01717326|724687|P8|Treated|Overall Study||29
303118|NCT01717326|724688|P7|Treated|Overall Study||31
303119|NCT01717326|724689|P6|Treated|Overall Study||31
303120|NCT01717326|724690|P5|Treated|Overall Study||33
303121|NCT01717326|724691|P4|Treated|Overall Study||30
303122|NCT01717326|724692|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
303123|NCT01717326|724693|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
303124|NCT01717326|724694|P1|Treated|Overall Study||25
303125|NCT01717326|724675|P20|STARTED|Overall Study||21
303126|NCT01717326|724676|P19|STARTED|Overall Study||20
303127|NCT01717326|724677|P18|STARTED|Overall Study||31
303128|NCT01717326|724678|P17|STARTED|Overall Study||30
303129|NCT01717326|724679|P16|STARTED|Overall Study||30
303130|NCT01717326|724680|P15|STARTED|Overall Study||29
303131|NCT01717326|724681|P14|STARTED|Overall Study||32
303132|NCT01717326|724682|P13|STARTED|Overall Study||33
303133|NCT01717326|724683|P12|STARTED|Overall Study||33
303134|NCT01717326|724684|P11|STARTED|Overall Study||32
303135|NCT01717326|724685|P10|STARTED|Overall Study||31
303136|NCT01717326|724686|P9|STARTED|Overall Study||32
303137|NCT01717326|724687|P8|STARTED|Overall Study||29
303138|NCT01717326|724688|P7|STARTED|Overall Study||31
303139|NCT01717326|724689|P6|STARTED|Overall Study||31
303140|NCT01717326|724690|P5|STARTED|Overall Study||33
303141|NCT01717326|724691|P4|STARTED|Overall Study||30
303142|NCT01717326|724692|P3|STARTED|Overall Study||13
303143|NCT01717326|724693|P2|STARTED|Overall Study||27
303144|NCT01717326|724694|P1|STARTED|Overall Study||25
303145|NCT01717313|724958|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
303146|NCT01717313|724959|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
303147|NCT01717313|724958|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
303148|NCT01717313|724959|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
303149|NCT01717313|724958|P2|STARTED|Phase B (Weeks 24 to 54)||151
303150|NCT01717313|724959|P1|STARTED|Phase B (Weeks 24 to 54)||146
303151|NCT01717313|724958|P2|NOT COMPLETED|Interphase||0
303152|NCT01717313|724959|P1|NOT COMPLETED|Interphase||1
303153|NCT01717313|724958|P2|COMPLETED|Interphase||151
303154|NCT01717313|724959|P1|COMPLETED|Interphase||146
303155|NCT01717313|724958|P2|STARTED|Interphase||151
303156|NCT01717313|724959|P1|STARTED|Interphase||147
303157|NCT01717313|724958|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
303158|NCT01717313|724959|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
303159|NCT01717313|724958|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
303160|NCT01717313|724959|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
303161|NCT01717313|724958|P2|STARTED|Phase A (Weeks 0 to 24)||164
303162|NCT01717313|724959|P1|STARTED|Phase A (Weeks 0 to 24)||165
303163|NCT01717287|724997|P2|NOT COMPLETED|Overall Study||3
303164|NCT01717287|724998|P1|NOT COMPLETED|Overall Study||0
303165|NCT01717287|724997|P2|COMPLETED|Overall Study||25
303166|NCT01717287|724998|P1|COMPLETED|Overall Study||4
303167|NCT01717287|724997|P2|STARTED|Overall Study||28
303168|NCT01717287|724998|P1|STARTED|Overall Study||4
303169|NCT01717040|725022|P2|NOT COMPLETED|Overall Study||5
303170|NCT01717040|725023|P1|NOT COMPLETED|Overall Study||5
303171|NCT01717040|725022|P2|COMPLETED|Overall Study||15
303172|NCT01717040|725023|P1|COMPLETED|Overall Study||12
303173|NCT01717040|725022|P2|STARTED|Overall Study||20
303174|NCT01717040|725023|P1|STARTED|Overall Study||17
303175|NCT01717014|725029|P1|NOT COMPLETED|Overall Study||0
303176|NCT01717014|725029|P1|COMPLETED|Overall Study||8
303177|NCT01717014|725029|P1|STARTED|Overall Study||8
303178|NCT01716754|725041|P4|NOT COMPLETED|Overall Study||8
303179|NCT01716754|725042|P3|NOT COMPLETED|Overall Study||14
303180|NCT01716754|725043|P2|NOT COMPLETED|Overall Study||4
303181|NCT01716754|725044|P1|NOT COMPLETED|Overall Study||11
303182|NCT01716754|725041|P4|COMPLETED|Overall Study||89
303183|NCT01716754|725042|P3|COMPLETED|Overall Study||121
303184|NCT01716754|725043|P2|COMPLETED|Overall Study||36
303185|NCT01716754|725044|P1|COMPLETED|Overall Study||188
303186|NCT01716754|725041|P4|Safety Set|Overall Study||96
303187|NCT01716754|725042|P3|Safety Set|Overall Study||131
303188|NCT01716754|725043|P2|Safety Set|Overall Study||40
303189|NCT01716754|725044|P1|Safety Set|Overall Study||199
303190|NCT01716754|725041|P4|FAS|Overall Study||96
303191|NCT01716754|725042|P3|FAS|Overall Study||131
303192|NCT01716754|725043|P2|FAS|Overall Study||40
303193|NCT01716754|725044|P1|FAS|Overall Study||199
303194|NCT01716754|725041|P4|STARTED|Overall Study||97
303195|NCT01716754|725042|P3|STARTED|Overall Study||135
303196|NCT01716754|725043|P2|STARTED|Overall Study||40
303197|NCT01716754|725044|P1|STARTED|Overall Study||199
303198|NCT01716663|725065|P1|NOT COMPLETED|Overall Study||6
303199|NCT01716663|725065|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
303200|NCT01716663|725065|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
303201|NCT01716663|725065|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
303202|NCT01716585|725075|P2|NOT COMPLETED|Open-label Treatment||7
303203|NCT01716585|725076|P1|NOT COMPLETED|Open-label Treatment||0
303204|NCT01716585|725075|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
303205|NCT01716585|725076|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
303206|NCT01716585|725075|P2|STARTED|Open-label Treatment||157
303207|NCT01716585|725076|P1|STARTED|Open-label Treatment|not applicable to this arm|0
303208|NCT01716585|725075|P2|NOT COMPLETED|Double-blind Treatment||2
303209|NCT01716585|725076|P1|NOT COMPLETED|Double-blind Treatment||13
303210|NCT01716585|725075|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
303211|NCT01716585|725076|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
303212|NCT01716585|725075|P2|Randomized But Not Treated|Double-blind Treatment||1
303213|NCT01716585|725076|P1|Randomized But Not Treated|Double-blind Treatment||4
303214|NCT01716585|725075|P2|STARTED|Double-blind Treatment||159
303215|NCT01716585|725076|P1|STARTED|Double-blind Treatment||477
303216|NCT01716559|725088|P1|NOT COMPLETED|Overall Study||111
303217|NCT01716559|725088|P1|COMPLETED|Overall Study||49
303218|NCT01716559|725088|P1|STARTED|Overall Study||160
303219|NCT01716520|725096|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
303220|NCT01716520|725097|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
303221|NCT01716520|725098|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
303222|NCT01716520|725099|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
303223|NCT01716520|725100|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
303224|NCT01716520|725101|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
303225|NCT01716520|725096|P6|COMPLETED|Treatment Period 3 (14 Days)||23
303226|NCT01716520|725097|P5|COMPLETED|Treatment Period 3 (14 Days)||29
303227|NCT01716520|725098|P4|COMPLETED|Treatment Period 3 (14 Days)||28
303228|NCT01716520|725099|P3|COMPLETED|Treatment Period 3 (14 Days)||25
303229|NCT01716520|725100|P2|COMPLETED|Treatment Period 3 (14 Days)||27
303230|NCT01716520|725101|P1|COMPLETED|Treatment Period 3 (14 Days)||27
303231|NCT01716520|725096|P6|STARTED|Treatment Period 3 (14 Days)||25
303232|NCT01716520|725097|P5|STARTED|Treatment Period 3 (14 Days)||29
303233|NCT01716520|725098|P4|STARTED|Treatment Period 3 (14 Days)||28
303234|NCT01716520|725099|P3|STARTED|Treatment Period 3 (14 Days)||26
303235|NCT01716520|725100|P2|STARTED|Treatment Period 3 (14 Days)||27
303236|NCT01716520|725101|P1|STARTED|Treatment Period 3 (14 Days)||27
303237|NCT01716520|725096|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
303238|NCT01716520|725097|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
303239|NCT01716520|725098|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
303240|NCT01716520|725099|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
303241|NCT01716520|725100|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
303242|NCT01716520|725101|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
303243|NCT01716520|725096|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
303244|NCT01716520|725097|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
303245|NCT01716520|725098|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
303246|NCT01716520|725099|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
303247|NCT01716520|725100|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
303248|NCT01716520|725101|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
303249|NCT01716520|725096|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
303250|NCT01716520|725097|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
303251|NCT01716520|725098|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
303252|NCT01716520|725099|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
303253|NCT01716520|725100|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
303254|NCT01716520|725101|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
303255|NCT01716520|725096|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
303256|NCT01716520|725097|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
303257|NCT01716520|725098|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
303258|NCT01716520|725099|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
303259|NCT01716520|725100|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
303260|NCT01716520|725101|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
303261|NCT01716520|725096|P6|COMPLETED|Treatment Period 2 (14 Days)||27
303262|NCT01716520|725097|P5|COMPLETED|Treatment Period 2 (14 Days)||29
303263|NCT01716520|725098|P4|COMPLETED|Treatment Period 2 (14 Days)||28
303264|NCT01716520|725099|P3|COMPLETED|Treatment Period 2 (14 Days)||27
303265|NCT01716520|725100|P2|COMPLETED|Treatment Period 2 (14 Days)||28
303266|NCT01716520|725101|P1|COMPLETED|Treatment Period 2 (14 Days)||29
303267|NCT01716520|725096|P6|STARTED|Treatment Period 2 (14 Days)||27
303268|NCT01716520|725097|P5|STARTED|Treatment Period 2 (14 Days)||31
303269|NCT01716520|725098|P4|STARTED|Treatment Period 2 (14 Days)||29
303270|NCT01716520|725099|P3|STARTED|Treatment Period 2 (14 Days)||27
303271|NCT01716520|725100|P2|STARTED|Treatment Period 2 (14 Days)||28
303272|NCT01716520|725101|P1|STARTED|Treatment Period 2 (14 Days)||29
303273|NCT01716520|725096|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
303274|NCT01716520|725097|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
303275|NCT01716520|725098|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
303276|NCT01716520|725099|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
303277|NCT01716520|725100|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
303278|NCT01716520|725101|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
303279|NCT01716520|725096|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
303280|NCT01716520|725097|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
303281|NCT01716520|725098|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
303282|NCT01716520|725099|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
303283|NCT01716520|725100|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
303284|NCT01716520|725101|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
303285|NCT01716520|725096|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
303286|NCT01716520|725097|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
303287|NCT01716520|725098|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
303288|NCT01716520|725099|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
303289|NCT01716520|725100|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
303290|NCT01716520|725101|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
303291|NCT01716520|725096|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
303292|NCT01716520|725097|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
303293|NCT01716520|725098|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
303294|NCT01716520|725099|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
303295|NCT01716520|725100|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
303296|NCT01716520|725101|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
303297|NCT01716520|725096|P6|COMPLETED|Treatment Period 1 (14 Days)||29
303298|NCT01716520|725097|P5|COMPLETED|Treatment Period 1 (14 Days)||31
303299|NCT01716520|725098|P4|COMPLETED|Treatment Period 1 (14 Days)||29
303300|NCT01716520|725099|P3|COMPLETED|Treatment Period 1 (14 Days)||28
303301|NCT01716520|725100|P2|COMPLETED|Treatment Period 1 (14 Days)||29
303302|NCT01716520|725101|P1|COMPLETED|Treatment Period 1 (14 Days)||29
303303|NCT01716520|725096|P6|STARTED|Treatment Period 1 (14 Days)||30
303304|NCT01716520|725097|P5|STARTED|Treatment Period 1 (14 Days)||31
303305|NCT01716520|725098|P4|STARTED|Treatment Period 1 (14 Days)||30
303306|NCT01716520|725099|P3|STARTED|Treatment Period 1 (14 Days)||30
303307|NCT01716520|725100|P2|STARTED|Treatment Period 1 (14 Days)||30
303308|NCT01716520|725101|P1|STARTED|Treatment Period 1 (14 Days)||31
303309|NCT01716468|725117|P1|NOT COMPLETED|Overall Study||6
303310|NCT01716468|725117|P1|COMPLETED|Overall Study||11
303311|NCT01716468|725117|P1|STARTED|Overall Study||17
303312|NCT01716455|725127|P6|NOT COMPLETED|Overall Study||0
303313|NCT01716455|725128|P5|NOT COMPLETED|Overall Study||0
303314|NCT01716455|725129|P4|NOT COMPLETED|Overall Study||0
303315|NCT01716455|725130|P3|NOT COMPLETED|Overall Study||0
303316|NCT01716455|725131|P2|NOT COMPLETED|Overall Study||0
303317|NCT01716455|725132|P1|NOT COMPLETED|Overall Study||0
303318|NCT01716455|725127|P6|COMPLETED|Overall Study||8
303319|NCT01716455|725128|P5|COMPLETED|Overall Study||26
303320|NCT01716455|725129|P4|COMPLETED|Overall Study||8
303321|NCT01716455|725130|P3|COMPLETED|Overall Study||8
303322|NCT01716455|725131|P2|COMPLETED|Overall Study||8
303323|NCT01716455|725132|P1|COMPLETED|Overall Study||8
303324|NCT01716455|725127|P6|STARTED|Overall Study||8
303325|NCT01716455|725128|P5|STARTED|Overall Study||26
303326|NCT01716455|725129|P4|STARTED|Overall Study||8
303327|NCT01716455|725130|P3|STARTED|Overall Study||8
303328|NCT01716455|725131|P2|STARTED|Overall Study||8
303329|NCT01716455|725132|P1|STARTED|Overall Study||8
303330|NCT01716234|725156|P7|NOT COMPLETED|Overall Study||0
303331|NCT01716234|725157|P6|NOT COMPLETED|Overall Study||14
303332|NCT01716234|725158|P5|NOT COMPLETED|Overall Study||5
303333|NCT01716234|725159|P4|NOT COMPLETED|Overall Study||12
303334|NCT01716234|725160|P3|NOT COMPLETED|Overall Study||5
303335|NCT01716234|725161|P2|NOT COMPLETED|Overall Study||10
303336|NCT01716234|725162|P1|NOT COMPLETED|Overall Study||10
303337|NCT01716234|725156|P7|COMPLETED|Overall Study||1
303338|NCT01716234|725157|P6|COMPLETED|Overall Study||18
303339|NCT01716234|725158|P5|COMPLETED|Overall Study||10
303340|NCT01716234|725159|P4|COMPLETED|Overall Study||16
303341|NCT01716234|725160|P3|COMPLETED|Overall Study||15
303342|NCT01716234|725161|P2|COMPLETED|Overall Study||12
303343|NCT01716234|725162|P1|COMPLETED|Overall Study||14
303344|NCT01716234|725156|P7|Treated|Overall Study||1
303345|NCT01716234|725157|P6|Treated|Overall Study||30
303346|NCT01716234|725158|P5|Treated|Overall Study||15
303347|NCT01716234|725159|P4|Treated|Overall Study||28
303348|NCT01716234|725160|P3|Treated|Overall Study||19
303349|NCT01716234|725161|P2|Treated|Overall Study||21
303350|NCT01716234|725162|P1|Treated|Overall Study||22
303351|NCT01716234|725156|P7|STARTED|Overall Study||1
303352|NCT01716234|725157|P6|STARTED|Overall Study||32
303353|NCT01716234|725158|P5|STARTED|Overall Study||15
303354|NCT01716234|725159|P4|STARTED|Overall Study||28
303355|NCT01716234|725160|P3|STARTED|Overall Study||20
303356|NCT01716234|725161|P2|STARTED|Overall Study||22
303357|NCT01716234|725162|P1|STARTED|Overall Study||24
303358|NCT01716221|725199|P1|NOT COMPLETED|Overall Study||0
303359|NCT01716221|725199|P1|COMPLETED|Overall Study||1
303360|NCT01716221|725199|P1|STARTED|Overall Study||1
303361|NCT01716169|725225|P1|NOT COMPLETED|Overall Study||4
303362|NCT01716169|725225|P1|COMPLETED|Overall Study||6
303363|NCT01716169|725225|P1|Standard of Care Dressings Used|Overall Study||7
303364|NCT01716169|725225|P1|STARTED|Overall Study||10
303365|NCT01716156|725234|P3|NOT COMPLETED|Overall Study||2
303366|NCT01716156|725235|P2|NOT COMPLETED|Overall Study||1
303367|NCT01716156|725236|P1|NOT COMPLETED|Overall Study||2
303368|NCT01716156|725234|P3|COMPLETED|Overall Study||11
303369|NCT01716156|725235|P2|COMPLETED|Overall Study||3
303370|NCT01716156|725236|P1|COMPLETED|Overall Study||7
303371|NCT01716156|725234|P3|STARTED|Overall Study||13
303372|NCT01716156|725235|P2|STARTED|Overall Study||4
303373|NCT01716156|725236|P1|STARTED|Overall Study||9
303374|NCT01716052|725262|P2|NOT COMPLETED|Overall Study||1
303375|NCT01716052|725263|P1|NOT COMPLETED|Overall Study||1
303376|NCT01716052|725262|P2|COMPLETED|Overall Study||0
303377|NCT01716052|725263|P1|COMPLETED|Overall Study||0
303378|NCT01716052|725262|P2|STARTED|Overall Study||1
303379|NCT01716052|725263|P1|STARTED|Overall Study||1
303380|NCT01716013|725271|P2|NOT COMPLETED|Overall Study||0
303381|NCT01716013|725272|P1|NOT COMPLETED|Overall Study||3
303382|NCT01716013|725271|P2|COMPLETED|Overall Study||54
303383|NCT01716013|725272|P1|COMPLETED|Overall Study||105
303384|NCT01716013|725271|P2|STARTED|Overall Study||54
303385|NCT01716013|725272|P1|STARTED|Overall Study||108
303386|NCT01715948|725284|P1|NOT COMPLETED|Overall Study||1
303387|NCT01715948|725284|P1|COMPLETED|Overall Study||8
303388|NCT01715948|725284|P1|STARTED|Overall Study||9
303389|NCT01715896|725305|P2|NOT COMPLETED|Overall Study||11
303390|NCT01715896|725306|P1|NOT COMPLETED|Overall Study||3
303391|NCT01715896|725305|P2|COMPLETED|Overall Study||59
303392|NCT01715896|725306|P1|COMPLETED|Overall Study||65
303393|NCT01715896|725305|P2|STARTED|Overall Study||70
303394|NCT01715896|725306|P1|STARTED|Overall Study||68
303395|NCT01715857|725369|P1|NOT COMPLETED|Overall Study||96
303396|NCT01715857|725369|P1|COMPLETED|Overall Study||4004
303397|NCT01715857|725369|P1|STARTED|Overall Study||4100
303398|NCT01715831|725379|P1|NOT COMPLETED|Overall Study||1
303399|NCT01715831|725379|P1|COMPLETED|Overall Study||25
303400|NCT01715831|725379|P1|STARTED|Overall Study||26
303401|NCT01714336|725397|P2|NOT COMPLETED|Overall Study||0
303402|NCT01714336|725398|P1|NOT COMPLETED|Overall Study||0
303403|NCT01714336|725397|P2|COMPLETED|Overall Study||69
303404|NCT01714336|725398|P1|COMPLETED|Overall Study||69
303405|NCT01714336|725397|P2|STARTED|Overall Study||69
303406|NCT01714336|725398|P1|STARTED|Overall Study||69
303407|NCT01714232|725418|P1|NOT COMPLETED|Overall Study||0
303408|NCT01714232|725418|P1|COMPLETED|Overall Study||106
303409|NCT01714232|725418|P1|STARTED|Overall Study||106
303410|NCT01715415|725426|P2|NOT COMPLETED|Open-label Treatment||2
303411|NCT01715415|725427|P1|NOT COMPLETED|Open-label Treatment||0
303412|NCT01715415|725426|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
303413|NCT01715415|725427|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
303414|NCT01715415|725426|P2|STARTED|Open-label Treatment||96
303415|NCT01715415|725427|P1|STARTED|Open-label Treatment|not applicable to this arm|0
303416|NCT01715415|725426|P2|NOT COMPLETED|Double-blind Treatment||2
303417|NCT01715415|725427|P1|NOT COMPLETED|Double-blind Treatment||5
303418|NCT01715415|725426|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
303419|NCT01715415|725427|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
303420|NCT01715415|725426|P2|Randomized But Not Treated|Double-blind Treatment||1
303421|NCT01715415|725427|P1|Randomized But Not Treated|Double-blind Treatment||0
303422|NCT01715415|725426|P2|STARTED|Double-blind Treatment||98
303423|NCT01715415|725427|P1|STARTED|Double-blind Treatment||297
303424|NCT01715298|725441|P2|NOT COMPLETED|Overall Study||11
303425|NCT01715298|725442|P1|NOT COMPLETED|Overall Study||7
303426|NCT01715298|725441|P2|COMPLETED|Overall Study||205
303427|NCT01715298|725442|P1|COMPLETED|Overall Study||209
303428|NCT01715298|725441|P2|Full Analysis Set (FAS)|Overall Study||214
303429|NCT01715298|725442|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
303430|NCT01715298|725441|P2|STARTED|Overall Study||216
303431|NCT01715298|725442|P1|STARTED|Overall Study||216
303432|NCT01715207|725480|P2|NOT COMPLETED|Overall Study||1
303433|NCT01715207|725481|P1|NOT COMPLETED|Overall Study||1
303434|NCT01715207|725480|P2|COMPLETED|Overall Study||14
303435|NCT01715207|725481|P1|COMPLETED|Overall Study||14
303436|NCT01715207|725480|P2|STARTED|Overall Study||15
303437|NCT01715207|725481|P1|STARTED|Overall Study||15
303438|NCT01715129|725489|P1|NOT COMPLETED|Overall Study||9
303439|NCT01715129|725489|P1|COMPLETED|Overall Study||117
303440|NCT01715129|725489|P1|STARTED|Overall Study||126
303441|NCT01715064|725508|P2|NOT COMPLETED|Overall Study||0
303442|NCT01715064|725509|P1|NOT COMPLETED|Overall Study||0
303443|NCT01715064|725508|P2|COMPLETED|Overall Study||18
303444|NCT01715064|725509|P1|COMPLETED|Overall Study||18
303445|NCT01715064|725508|P2|STARTED|Overall Study||18
303446|NCT01715064|725509|P1|STARTED|Overall Study||18
303447|NCT01714635|725518|P3|NOT COMPLETED|Overall Study||2
303448|NCT01714635|725519|P2|NOT COMPLETED|Overall Study||0
303449|NCT01714635|725520|P1|NOT COMPLETED|Overall Study||2
303450|NCT01714635|725518|P3|COMPLETED|Overall Study||146
303451|NCT01714635|725519|P2|COMPLETED|Overall Study||150
303452|NCT01714635|725520|P1|COMPLETED|Overall Study||145
303453|NCT01714635|725518|P3|STARTED|Overall Study||148
303454|NCT01714635|725519|P2|STARTED|Overall Study||150
303455|NCT01714635|725520|P1|STARTED|Overall Study||147
303456|NCT01714609|725536|P2|NOT COMPLETED|Overall Study||0
303457|NCT01714609|725537|P1|NOT COMPLETED|Overall Study||1
303458|NCT01714609|725536|P2|COMPLETED|Overall Study||5
303459|NCT01714609|725537|P1|COMPLETED|Overall Study||4
303460|NCT01714609|725536|P2|STARTED|Overall Study||5
303461|NCT01714609|725537|P1|STARTED|Overall Study||5
303462|NCT01714544|725543|P1|NOT COMPLETED|Overall Study||3
303463|NCT01714544|725543|P1|COMPLETED|Overall Study||57
303464|NCT01714544|725543|P1|STARTED|Overall Study||60
303465|NCT01714505|725547|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
303466|NCT01714505|725548|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
303467|NCT01714505|725547|P2|COMPLETED|Admission 2 (40 Hours)||9
303468|NCT01714505|725548|P1|COMPLETED|Admission 2 (40 Hours)||9
303469|NCT01714505|725547|P2|STARTED|Admission 2 (40 Hours)||9
303470|NCT01714505|725548|P1|STARTED|Admission 2 (40 Hours)||9
303471|NCT01714505|725547|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
303472|NCT01714505|725548|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
303473|NCT01714505|725547|P2|COMPLETED|Admission 1 (40 Hours)||9
303474|NCT01714505|725548|P1|COMPLETED|Admission 1 (40 Hours)||9
303475|NCT01714505|725547|P2|STARTED|Admission 1 (40 Hours)||10
303476|NCT01714505|725548|P1|STARTED|Admission 1 (40 Hours)||10
303477|NCT01714492|725558|P1|NOT COMPLETED|Overall Study||0
303478|NCT01714492|725558|P1|COMPLETED|Overall Study||8
303479|NCT01714492|725558|P1|STARTED|Overall Study||8
303480|NCT01713998|725570|P3|NOT COMPLETED|Overall Study||2
303481|NCT01713998|725571|P2|NOT COMPLETED|Overall Study||0
303482|NCT01713998|725572|P1|NOT COMPLETED|Overall Study||3
303483|NCT01713998|725570|P3|COMPLETED|Overall Study||14
303484|NCT01713998|725571|P2|COMPLETED|Overall Study||15
303485|NCT01713998|725572|P1|COMPLETED|Overall Study||13
303486|NCT01713998|725570|P3|STARTED|Overall Study||16
303487|NCT01713998|725571|P2|STARTED|Overall Study||15
303488|NCT01713998|725572|P1|STARTED|Overall Study||16
303489|NCT01713933|725590|P1|NOT COMPLETED|Overall Study||6
303490|NCT01713933|725590|P1|COMPLETED|Overall Study||31
303491|NCT01713933|725590|P1|STARTED|Overall Study||37
303492|NCT01713686|725602|P1|NOT COMPLETED|Overall Study||15
303493|NCT01713686|725602|P1|COMPLETED|Overall Study||110
303494|NCT01713686|725602|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
303495|NCT01713660|725611|P1|NOT COMPLETED|Overall Study||0
303496|NCT01713660|725611|P1|COMPLETED|Overall Study||37
303497|NCT01713660|725611|P1|STARTED|Overall Study||37
303498|NCT01713621|725619|P2|NOT COMPLETED|Overall Study||16
303499|NCT01713621|725620|P1|NOT COMPLETED|Overall Study||7
303500|NCT01713621|725619|P2|COMPLETED|Overall Study||1
303501|NCT01713621|725620|P1|COMPLETED|Overall Study||1
303502|NCT01713621|725619|P2|STARTED|Overall Study||17
303503|NCT01713621|725620|P1|STARTED|Overall Study||8
303504|NCT01713608|725630|P4|NOT COMPLETED|Overall Study||0
303505|NCT01713608|725631|P3|NOT COMPLETED|Overall Study||0
303506|NCT01713608|725632|P2|NOT COMPLETED|Overall Study||0
303507|NCT01713608|725633|P1|NOT COMPLETED|Overall Study||0
303508|NCT01713608|725630|P4|COMPLETED|Overall Study||12
303509|NCT01713608|725631|P3|COMPLETED|Overall Study||8
303510|NCT01713608|725632|P2|COMPLETED|Overall Study||6
303511|NCT01713608|725633|P1|COMPLETED|Overall Study||8
303512|NCT01713608|725630|P4|STARTED|Overall Study||12
303513|NCT01713608|725631|P3|STARTED|Overall Study||8
303514|NCT01713608|725632|P2|STARTED|Overall Study||6
303515|NCT01713608|725633|P1|STARTED|Overall Study||8
303516|NCT01713530|725653|P2|NOT COMPLETED|Overall Study||19
303517|NCT01713530|725654|P1|NOT COMPLETED|Overall Study||25
303518|NCT01713530|725653|P2|COMPLETED|Overall Study||117
303519|NCT01713530|725654|P1|COMPLETED|Overall Study||113
303520|NCT01713530|725653|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
303521|NCT01713530|725654|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
303522|NCT01713530|725653|P2|STARTED|Overall Study||136
303523|NCT01713530|725654|P1|STARTED|Overall Study||138
303524|NCT01713400|725672|P2|NOT COMPLETED|Overall Study||0
303525|NCT01713400|725673|P1|NOT COMPLETED|Overall Study||0
303526|NCT01713400|725672|P2|COMPLETED|Overall Study||15
303527|NCT01713400|725673|P1|COMPLETED|Overall Study||15
303528|NCT01713400|725672|P2|STARTED|Overall Study||15
303529|NCT01713400|725673|P1|STARTED|Overall Study||15
303530|NCT01713348|725685|P4|NOT COMPLETED|Overall Study||0
303531|NCT01713348|725686|P3|NOT COMPLETED|Overall Study||2
303532|NCT01713348|725687|P2|NOT COMPLETED|Overall Study||2
303533|NCT01713348|725688|P1|NOT COMPLETED|Overall Study||4
303534|NCT01713348|725685|P4|COMPLETED|Overall Study||15
303535|NCT01713348|725686|P3|COMPLETED|Overall Study||28
303536|NCT01713348|725687|P2|COMPLETED|Overall Study||11
303537|NCT01713348|725688|P1|COMPLETED|Overall Study||25
303538|NCT01713348|725685|P4|STARTED|Overall Study||15
303539|NCT01713348|725686|P3|STARTED|Overall Study||30
303540|NCT01713348|725687|P2|STARTED|Overall Study||13
303541|NCT01713348|725688|P1|STARTED|Overall Study||29
303542|NCT01713283|725718|P2|NOT COMPLETED|Overall Study||3
303543|NCT01713283|725719|P1|NOT COMPLETED|Overall Study||11
303544|NCT01713283|725718|P2|COMPLETED|Overall Study||26
303545|NCT01713283|725719|P1|COMPLETED|Overall Study||20
303546|NCT01713283|725718|P2|STARTED|Overall Study||29
303547|NCT01713283|725719|P1|STARTED|Overall Study||31
303548|NCT01713036|725741|P1|NOT COMPLETED|Overall Study||1
303549|NCT01713036|725741|P1|COMPLETED|Overall Study||5
303550|NCT01713036|725741|P1|STARTED|Overall Study||6
303551|NCT01712984|725781|P3|NOT COMPLETED|Overall Study||10
303552|NCT01712984|725782|P2|NOT COMPLETED|Overall Study||16
303553|NCT01712984|725783|P1|NOT COMPLETED|Overall Study||16
303554|NCT01712984|725781|P3|COMPLETED|Overall Study||836
303555|NCT01712984|725782|P2|COMPLETED|Overall Study||821
303556|NCT01712984|725783|P1|COMPLETED|Overall Study||1656
303557|NCT01712984|725781|P3|STARTED|Overall Study||846
303558|NCT01712984|725782|P2|STARTED|Overall Study||837
303559|NCT01712984|725783|P1|STARTED|Overall Study||1672
303560|NCT01712854|725803|P1|NOT COMPLETED|Overall Study||1
303561|NCT01712854|725803|P1|COMPLETED|Overall Study||8
303562|NCT01712854|725803|P1|STARTED|Overall Study||9
303563|NCT01712776|725810|P2|NOT COMPLETED|Overall Study||0
303564|NCT01712776|725811|P1|NOT COMPLETED|Overall Study||0
303565|NCT01712776|725810|P2|COMPLETED|Overall Study||50
303566|NCT01712776|725811|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
303567|NCT01712776|725810|P2|STARTED|Overall Study||50
303568|NCT01712776|725811|P1|STARTED|Overall Study||50
303569|NCT01712711|725819|P2|NOT COMPLETED|Overall Study||0
303570|NCT01712711|725820|P1|NOT COMPLETED|Overall Study||0
303571|NCT01712711|725819|P2|COMPLETED|Overall Study||20
303572|NCT01712711|725820|P1|COMPLETED|Overall Study||20
303573|NCT01712711|725819|P2|STARTED|Overall Study||20
303574|NCT01712711|725820|P1|STARTED|Overall Study||20
303575|NCT01712685|725826|P1|NOT COMPLETED|Overall Study||1
303576|NCT01712685|725826|P1|COMPLETED|Overall Study||11
303577|NCT01712685|725826|P1|STARTED|Overall Study||12
303578|NCT01712516|725842|P4|NOT COMPLETED|Overall Study||13
303579|NCT01712516|725843|P3|NOT COMPLETED|Overall Study||6
303580|NCT01712516|725844|P2|NOT COMPLETED|Overall Study||10
303581|NCT01712516|725845|P1|NOT COMPLETED|Overall Study||6
303582|NCT01712516|725842|P4|COMPLETED|Overall Study||236
303583|NCT01712516|725843|P3|COMPLETED|Overall Study||245
303584|NCT01712516|725844|P2|COMPLETED|Overall Study||241
303585|NCT01712516|725845|P1|COMPLETED|Overall Study||244
303586|NCT01712516|725842|P4|Full Analysis Set|Overall Study||247
303587|NCT01712516|725843|P3|Full Analysis Set|Overall Study||250
303588|NCT01712516|725844|P2|Full Analysis Set|Overall Study||251
303589|NCT01712516|725845|P1|Full Analysis Set|Overall Study||250
303590|NCT01712516|725842|P4|Safety Set|Overall Study||248
303591|NCT01712516|725843|P3|Safety Set|Overall Study||251
303592|NCT01712516|725844|P2|Safety Set|Overall Study||251
303593|NCT01712516|725845|P1|Safety Set|Overall Study||250
303594|NCT01712516|725842|P4|STARTED|Overall Study||249
303595|NCT01712516|725843|P3|STARTED|Overall Study||251
303596|NCT01712516|725844|P2|STARTED|Overall Study||251
303597|NCT01712516|725845|P1|STARTED|Overall Study||250
303598|NCT01712399|725895|P1|NOT COMPLETED|Overall Study||397
303599|NCT01712399|725895|P1|COMPLETED|Overall Study||0
303600|NCT01712399|725895|P1|STARTED|Overall Study||397
303601|NCT01712360|725912|P4|NOT COMPLETED|Overall Study||2
303602|NCT01712360|725913|P3|NOT COMPLETED|Overall Study||0
303603|NCT01712360|725914|P2|NOT COMPLETED|Overall Study||1
303604|NCT01712360|725915|P1|NOT COMPLETED|Overall Study||0
303605|NCT01712360|725912|P4|COMPLETED|Overall Study||4
303606|NCT01712360|725913|P3|COMPLETED|Overall Study||6
303607|NCT01712360|725914|P2|COMPLETED|Overall Study||21
303608|NCT01712360|725915|P1|COMPLETED|Overall Study||22
303609|NCT01712360|725912|P4|STARTED|Overall Study||6
303610|NCT01712360|725913|P3|STARTED|Overall Study||6
303611|NCT01712360|725914|P2|STARTED|Overall Study||22
303612|NCT01712360|725915|P1|STARTED|Overall Study||22
303613|NCT01712334|725941|P2|NOT COMPLETED|Treatment Period 2||0
303614|NCT01712334|725942|P1|NOT COMPLETED|Treatment Period 2||0
303615|NCT01712334|725941|P2|COMPLETED|Treatment Period 2||41
303616|NCT01712334|725942|P1|COMPLETED|Treatment Period 2||44
303617|NCT01712334|725941|P2|STARTED|Treatment Period 2||41
303618|NCT01712334|725942|P1|STARTED|Treatment Period 2||44
303619|NCT01712334|725941|P2|NOT COMPLETED|Treatment Period 1||2
303620|NCT01712334|725942|P1|NOT COMPLETED|Treatment Period 1||0
303621|NCT01712334|725941|P2|COMPLETED|Treatment Period 1||41
303622|NCT01712334|725942|P1|COMPLETED|Treatment Period 1||44
303623|NCT01712334|725941|P2|Received Treatment|Treatment Period 1||41
303624|NCT01712334|725942|P1|Received Treatment|Treatment Period 1||44
303625|NCT01712334|725941|P2|STARTED|Treatment Period 1||43
303626|NCT01712334|725942|P1|STARTED|Treatment Period 1||44
303627|NCT01712256|725950|P1|NOT COMPLETED|Overall Study||1
303628|NCT01712256|725950|P1|COMPLETED|Overall Study||32
303629|NCT01712256|725950|P1|STARTED|Overall Study||33
303630|NCT01712204|725961|P2|NOT COMPLETED|Overall Study||5
303631|NCT01712204|725962|P1|NOT COMPLETED|Overall Study||8
303632|NCT01712204|725961|P2|COMPLETED|Overall Study||36
303633|NCT01712204|725962|P1|COMPLETED|Overall Study||33
303634|NCT01712204|725961|P2|STARTED|Overall Study||41
303635|NCT01712204|725962|P1|STARTED|Overall Study||41
303636|NCT01712178|725970|P2|NOT COMPLETED|Overall Study||3
303637|NCT01712178|725971|P1|NOT COMPLETED|Overall Study||1
303638|NCT01712178|725970|P2|COMPLETED|Overall Study||47
303639|NCT01712178|725971|P1|COMPLETED|Overall Study||49
303640|NCT01712178|725970|P2|STARTED|Overall Study||50
303641|NCT01712178|725971|P1|STARTED|Overall Study||50
303642|NCT01712074|725996|P3|NOT COMPLETED|Double Blind Period||8
303643|NCT01712074|725997|P2|NOT COMPLETED|Double Blind Period||14
303644|NCT01712074|725998|P1|NOT COMPLETED|Double Blind Period||0
303645|NCT01712074|725996|P3|COMPLETED|Double Blind Period||86
303646|NCT01712074|725997|P2|COMPLETED|Double Blind Period||77
303647|NCT01712074|725998|P1|COMPLETED|Double Blind Period||0
303648|NCT01712074|725996|P3|STARTED|Double Blind Period||94
303649|NCT01712074|725997|P2|STARTED|Double Blind Period||91
303650|NCT01712074|725998|P1|STARTED|Double Blind Period||0
303651|NCT01712074|725996|P3|NOT COMPLETED|Placebo Run-in Period||0
303652|NCT01712074|725997|P2|NOT COMPLETED|Placebo Run-in Period||0
303653|NCT01712074|725998|P1|NOT COMPLETED|Placebo Run-in Period||10
303654|NCT01712074|725996|P3|COMPLETED|Placebo Run-in Period||0
303655|NCT01712074|725997|P2|COMPLETED|Placebo Run-in Period||0
303656|NCT01712074|725998|P1|COMPLETED|Placebo Run-in Period||185
303657|NCT01712074|725996|P3|STARTED|Placebo Run-in Period||0
303658|NCT01712074|725997|P2|STARTED|Placebo Run-in Period||0
303659|NCT01712074|725998|P1|STARTED|Placebo Run-in Period||195
303660|NCT01712061|726054|P3|NOT COMPLETED|Overall Study||11
303661|NCT01712061|726055|P2|NOT COMPLETED|Overall Study||26
303662|NCT01712061|726056|P1|NOT COMPLETED|Overall Study||10
303663|NCT01712061|726054|P3|COMPLETED|Overall Study||45
303664|NCT01712061|726055|P2|COMPLETED|Overall Study||114
303665|NCT01712061|726056|P1|COMPLETED|Overall Study||20
303666|NCT01712061|726054|P3|STARTED|Overall Study||56
303667|NCT01712061|726055|P2|STARTED|Overall Study||140
303668|NCT01712061|726056|P1|STARTED|Overall Study||30
303669|NCT01712009|726096|P3|NOT COMPLETED|Overall Study||21
303670|NCT01712009|726097|P2|NOT COMPLETED|Overall Study||29
303671|NCT01712009|726098|P1|NOT COMPLETED|Overall Study||38
303672|NCT01712009|726096|P3|COMPLETED|Overall Study||181
303673|NCT01712009|726097|P2|COMPLETED|Overall Study||171
303674|NCT01712009|726098|P1|COMPLETED|Overall Study||160
303675|NCT01712009|726096|P3|Received Naproxen / Loratadine|Overall Study||198
303676|NCT01712009|726097|P2|Received Naproxen / Loratadine|Overall Study||193
303677|NCT01712009|726098|P1|Received Naproxen / Loratadine|Overall Study||0
303678|NCT01712009|726096|P3|Received Pegfilgrastim|Overall Study||200
303679|NCT01712009|726097|P2|Received Pegfilgrastim|Overall Study||196
303680|NCT01712009|726098|P1|Received Pegfilgrastim|Overall Study||191
303681|NCT01712009|726096|P3|STARTED|Overall Study||202
303682|NCT01712009|726097|P2|STARTED|Overall Study||200
303683|NCT01712009|726098|P1|STARTED|Overall Study||198
303684|NCT01711918|726124|P1|NOT COMPLETED|Overall Study||2
303685|NCT01711918|726124|P1|COMPLETED|Overall Study||7
303686|NCT01711918|726124|P1|STARTED|Overall Study||9
303687|NCT01711866|726132|P1|NOT COMPLETED|Overall Study||8
303688|NCT01711866|726132|P1|COMPLETED|Overall Study||79
303689|NCT01711866|726132|P1|STARTED|Overall Study||87
303690|NCT01711853|726137|P1|NOT COMPLETED|Overall Study||3
303691|NCT01711853|726137|P1|COMPLETED|Overall Study||16
303692|NCT01711853|726137|P1|STARTED|Overall Study||19
303693|NCT01711736|726144|P2|NOT COMPLETED|Overall Study||8
303694|NCT01711736|726145|P1|NOT COMPLETED|Overall Study||12
303695|NCT01711736|726144|P2|COMPLETED|Overall Study|Up to Day 180|294
303696|NCT01711736|726145|P1|COMPLETED|Overall Study|Up to Day 180|287
303697|NCT01711736|726144|P2|STARTED|Overall Study||302
303698|NCT01711736|726145|P1|STARTED|Overall Study||299
303699|NCT01711645|726173|P1|NOT COMPLETED|Overall Study||19
303700|NCT01711645|726173|P1|COMPLETED|Overall Study||36
303701|NCT01711645|726173|P1|STARTED|Overall Study||55
303702|NCT01711424|726208|P1|NOT COMPLETED|Overall Study||0
303703|NCT01711424|726208|P1|COMPLETED|Overall Study||1209
303704|NCT01711424|726208|P1|STARTED|Overall Study||1209
303705|NCT01711216|726215|P1|NOT COMPLETED|Overall Study||217
303706|NCT01711216|726215|P1|COMPLETED|Overall Study||782
303707|NCT01711216|726215|P1|STARTED|Overall Study||999
303708|NCT01711177|726239|P3|NOT COMPLETED|Overall Study||0
303709|NCT01711177|726240|P2|NOT COMPLETED|Overall Study||0
303710|NCT01711177|726241|P1|NOT COMPLETED|Overall Study||0
303711|NCT01711177|726239|P3|COMPLETED|Overall Study||3
303712|NCT01711177|726240|P2|COMPLETED|Overall Study||3
303713|NCT01711177|726241|P1|COMPLETED|Overall Study||10
303714|NCT01711177|726239|P3|STARTED|Overall Study||3
303715|NCT01711177|726240|P2|STARTED|Overall Study||3
303716|NCT01711177|726241|P1|STARTED|Overall Study||10
303717|NCT01710839|726251|P2|NOT COMPLETED|Overall Study||6
303718|NCT01710839|726252|P1|NOT COMPLETED|Overall Study||1
303719|NCT01710839|726251|P2|COMPLETED|Overall Study||0
303720|NCT01710839|726252|P1|COMPLETED|Overall Study||23
303721|NCT01710839|726251|P2|STARTED|Overall Study||6
303722|NCT01710839|726252|P1|STARTED|Overall Study||24
303723|NCT01710800|726268|P1|NOT COMPLETED|Overall Study||22
303724|NCT01710800|726268|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
303725|NCT01710800|726268|P1|Received Placebo Intervention|Overall Study||45
303726|NCT01710800|726268|P1|Received PPI Intervention|Overall Study||44
303727|NCT01710800|726268|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
303728|NCT01710657|726277|P3|NOT COMPLETED|Overall Study||32
303729|NCT01710657|726278|P2|NOT COMPLETED|Overall Study||12
303730|NCT01710657|726279|P1|NOT COMPLETED|Overall Study||18
303731|NCT01710657|726277|P3|COMPLETED|Overall Study||148
303732|NCT01710657|726278|P2|COMPLETED|Overall Study||171
303733|NCT01710657|726279|P1|COMPLETED|Overall Study||166
303734|NCT01710657|726277|P3|Maintenance Period (12 Weeks)|Overall Study||168
303735|NCT01710657|726278|P2|Maintenance Period (12 Weeks)|Overall Study||175
303736|NCT01710657|726279|P1|Maintenance Period (12 Weeks)|Overall Study||176
303737|NCT01710657|726277|P3|Titration Period (4 Weeks)|Overall Study||180
303738|NCT01710657|726278|P2|Titration Period (4 Weeks)|Overall Study||183
303739|NCT01710657|726279|P1|Titration Period (4 Weeks)|Overall Study||184
303740|NCT01710657|726277|P3|STARTED|Overall Study||180
303741|NCT01710657|726278|P2|STARTED|Overall Study||183
303742|NCT01710657|726279|P1|STARTED|Overall Study||184
303743|NCT01710527|726296|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
303744|NCT01710527|726297|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
303745|NCT01710527|726296|P2|COMPLETED|Period 3: Intervention Period 2||15
303746|NCT01710527|726297|P1|COMPLETED|Period 3: Intervention Period 2||16
303747|NCT01710527|726296|P2|STARTED|Period 3: Intervention Period 2||15
303748|NCT01710527|726297|P1|STARTED|Period 3: Intervention Period 2||16
303749|NCT01710527|726296|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
303750|NCT01710527|726297|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
303751|NCT01710527|726296|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
303752|NCT01710527|726297|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
303753|NCT01710527|726296|P2|STARTED|Period 2: Washout Period (7 Days)||16
303754|NCT01710527|726297|P1|STARTED|Period 2: Washout Period (7 Days)||16
303755|NCT01710527|726296|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
303756|NCT01710527|726297|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
303757|NCT01710527|726296|P2|COMPLETED|Period 1: Intervention Period 1||16
303758|NCT01710527|726297|P1|COMPLETED|Period 1: Intervention Period 1||16
303759|NCT01710527|726296|P2|STARTED|Period 1: Intervention Period 1||16
303760|NCT01710527|726297|P1|STARTED|Period 1: Intervention Period 1||16
303761|NCT01710514|726323|P2|NOT COMPLETED|Overall Study||7
303762|NCT01710514|726324|P1|NOT COMPLETED|Overall Study||7
303763|NCT01710514|726323|P2|COMPLETED|Overall Study||47
303764|NCT01710514|726324|P1|COMPLETED|Overall Study||47
303765|NCT01710514|726323|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
303766|NCT01710514|726324|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
303767|NCT01710514|726323|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
303768|NCT01710514|726324|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
303769|NCT01710514|726323|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
303770|NCT01710514|726324|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
303771|NCT01710514|726323|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
303772|NCT01710514|726324|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
303773|NCT01710514|726323|P2|STARTED|Overall Study||54
303774|NCT01710514|726324|P1|STARTED|Overall Study||54
303775|NCT01710501|726345|P3|NOT COMPLETED|Overall Study||0
303776|NCT01710501|726346|P2|NOT COMPLETED|Overall Study||0
303777|NCT01710501|726347|P1|NOT COMPLETED|Overall Study||2
303778|NCT01710501|726345|P3|COMPLETED|Overall Study||30
303779|NCT01710501|726346|P2|COMPLETED|Overall Study||28
303780|NCT01710501|726347|P1|COMPLETED|Overall Study||27
303781|NCT01710501|726345|P3|STARTED|Overall Study||30
303782|NCT01710501|726346|P2|STARTED|Overall Study||28
303783|NCT01710501|726347|P1|STARTED|Overall Study||29
303784|NCT01710345|726379|P3|NOT COMPLETED|Overall Study||1
303785|NCT01710345|726380|P2|NOT COMPLETED|Overall Study||5
303786|NCT01710345|726381|P1|NOT COMPLETED|Overall Study||3
303787|NCT01710345|726379|P3|COMPLETED|Overall Study||19
303788|NCT01710345|726380|P2|COMPLETED|Overall Study||35
303789|NCT01710345|726381|P1|COMPLETED|Overall Study||37
303790|NCT01710345|726379|P3|STARTED|Overall Study||20
303791|NCT01710345|726380|P2|STARTED|Overall Study||40
303792|NCT01710345|726381|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
303793|NCT01710332|726391|P2|NOT COMPLETED|Overall Study||0
303794|NCT01710332|726392|P1|NOT COMPLETED|Overall Study||0
303795|NCT01710332|726391|P2|COMPLETED|Overall Study||6
303796|NCT01710332|726392|P1|COMPLETED|Overall Study||6
303797|NCT01710332|726391|P2|STARTED|Overall Study||6
303798|NCT01710332|726392|P1|STARTED|Overall Study||6
303799|NCT01710046|726402|P2|NOT COMPLETED|Overall Study||0
303800|NCT01710046|726403|P1|NOT COMPLETED|Overall Study||1
303801|NCT01710046|726402|P2|COMPLETED|Overall Study||3
303802|NCT01710046|726403|P1|COMPLETED|Overall Study||8
303803|NCT01710046|726402|P2|STARTED|Overall Study||3
303804|NCT01710046|726403|P1|STARTED|Overall Study||9
303805|NCT01710033|726443|P5|NOT COMPLETED|Stage 2||1
303806|NCT01710033|726444|P4|NOT COMPLETED|Stage 2||0
303807|NCT01710033|726445|P3|NOT COMPLETED|Stage 2||0
303808|NCT01710033|726446|P2|NOT COMPLETED|Stage 2||0
303809|NCT01710033|726447|P1|NOT COMPLETED|Stage 2||0
303810|NCT01710033|726443|P5|COMPLETED|Stage 2||3
303811|NCT01710033|726444|P4|COMPLETED|Stage 2||0
303812|NCT01710033|726445|P3|COMPLETED|Stage 2||0
303813|NCT01710033|726446|P2|COMPLETED|Stage 2||0
303814|NCT01710033|726447|P1|COMPLETED|Stage 2||0
303815|NCT01710033|726443|P5|STARTED|Stage 2||4
303816|NCT01710033|726444|P4|STARTED|Stage 2||0
303817|NCT01710033|726445|P3|STARTED|Stage 2||0
303818|NCT01710033|726446|P2|STARTED|Stage 2||0
303819|NCT01710033|726447|P1|STARTED|Stage 2||0
303820|NCT01710033|726443|P5|NOT COMPLETED|Stage 1||0
303821|NCT01710033|726444|P4|NOT COMPLETED|Stage 1||0
303822|NCT01710033|726445|P3|NOT COMPLETED|Stage 1||0
303823|NCT01710033|726446|P2|NOT COMPLETED|Stage 1||0
303824|NCT01710033|726447|P1|NOT COMPLETED|Stage 1||0
303825|NCT01710033|726443|P5|COMPLETED|Stage 1||0
303826|NCT01710033|726444|P4|COMPLETED|Stage 1||6
303827|NCT01710033|726445|P3|COMPLETED|Stage 1||6
303828|NCT01710033|726446|P2|COMPLETED|Stage 1||6
303829|NCT01710033|726447|P1|COMPLETED|Stage 1||6
303830|NCT01710033|726443|P5|STARTED|Stage 1||0
303831|NCT01710033|726444|P4|STARTED|Stage 1||6
303832|NCT01710033|726445|P3|STARTED|Stage 1||6
303833|NCT01710033|726446|P2|STARTED|Stage 1||6
303834|NCT01710033|726447|P1|STARTED|Stage 1||6
303835|NCT01710020|726528|P1|NOT COMPLETED|Period 2||0
303836|NCT01710020|726528|P1|COMPLETED|Period 2||11
303837|NCT01710020|726528|P1|STARTED|Period 2||11
303838|NCT01710020|726528|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
303839|NCT01710020|726528|P1|COMPLETED|Washout Period (at Least 14 Days)||11
303840|NCT01710020|726528|P1|STARTED|Washout Period (at Least 14 Days)||11
303841|NCT01710020|726528|P1|NOT COMPLETED|Period 1||1
303842|NCT01710020|726528|P1|COMPLETED|Period 1||11
303843|NCT01710020|726528|P1|STARTED|Period 1||12
303844|NCT01709903|726547|P2|NOT COMPLETED|Overall Study||39
303845|NCT01709903|726548|P1|NOT COMPLETED|Overall Study||29
303846|NCT01709903|726547|P2|COMPLETED|Overall Study||333
303847|NCT01709903|726548|P1|COMPLETED|Overall Study||343
303848|NCT01709903|726547|P2|STARTED|Overall Study|Randomized set|372
303849|NCT01709903|726548|P1|STARTED|Overall Study|Randomized set|372
303850|NCT01709864|726572|P2|NOT COMPLETED|Overall Study||11
303851|NCT01709864|726573|P1|NOT COMPLETED|Overall Study||7
303852|NCT01709864|726572|P2|COMPLETED|Overall Study||208
303853|NCT01709864|726573|P1|COMPLETED|Overall Study||215
303854|NCT01709864|726572|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
303855|NCT01709864|726573|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
303856|NCT01709864|726572|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
303857|NCT01709864|726573|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
303858|NCT01709864|726572|P2|STARTED|Overall Study||219
303859|NCT01709864|726573|P1|STARTED|Overall Study||222
303860|NCT01709799|726610|P3|NOT COMPLETED|Overall Study||3
303861|NCT01709799|726611|P2|NOT COMPLETED|Overall Study||3
303862|NCT01709799|726612|P1|NOT COMPLETED|Overall Study||3
303863|NCT01709799|726610|P3|COMPLETED|Overall Study||15
303864|NCT01709799|726611|P2|COMPLETED|Overall Study||18
303865|NCT01709799|726612|P1|COMPLETED|Overall Study||22
303866|NCT01709799|726610|P3|STARTED|Overall Study||18
303867|NCT01709799|726611|P2|STARTED|Overall Study||21
303868|NCT01709799|726612|P1|STARTED|Overall Study||25
303869|NCT01709786|726635|P1|NOT COMPLETED|Overall Study||0
303870|NCT01709786|726635|P1|COMPLETED|Overall Study||88
303871|NCT01709786|726635|P1|STARTED|Overall Study||88
303872|NCT01709708|726644|P2|NOT COMPLETED|Overall Study||2
303873|NCT01709708|726645|P1|NOT COMPLETED|Overall Study||1
303874|NCT01709708|726644|P2|COMPLETED|Overall Study||12
303875|NCT01709708|726645|P1|COMPLETED|Overall Study||26
303876|NCT01709708|726644|P2|STARTED|Overall Study||14
303877|NCT01709708|726645|P1|STARTED|Overall Study||27
303878|NCT01709513|726654|P3|NOT COMPLETED|Overall Study||30
303879|NCT01709513|726655|P2|NOT COMPLETED|Overall Study||43
303880|NCT01709513|726656|P1|NOT COMPLETED|Overall Study||21
303881|NCT01709513|726654|P3|COMPLETED|Overall Study||96
303882|NCT01709513|726655|P2|COMPLETED|Overall Study||82
303883|NCT01709513|726656|P1|COMPLETED|Overall Study||42
303884|NCT01709513|726654|P3|Treated|Overall Study||126
303885|NCT01709513|726655|P2|Treated|Overall Study||124
303886|NCT01709513|726656|P1|Treated|Overall Study||63
303887|NCT01709513|726654|P3|STARTED|Overall Study||126
303888|NCT01709513|726655|P2|STARTED|Overall Study||125
303889|NCT01709513|726656|P1|STARTED|Overall Study||63
303890|NCT01709500|726717|P2|NOT COMPLETED|Overall Study||82
303891|NCT01709500|726718|P1|NOT COMPLETED|Overall Study||167
303892|NCT01709500|726717|P2|COMPLETED|Overall Study||0
303893|NCT01709500|726718|P1|COMPLETED|Overall Study||0
303894|NCT01709500|726717|P2|Treated|Overall Study||81
303895|NCT01709500|726718|P1|Treated|Overall Study||167
303896|NCT01709500|726717|P2|STARTED|Overall Study||82
303897|NCT01709500|726718|P1|STARTED|Overall Study||167
303898|NCT01709474|726774|P2|NOT COMPLETED|Overall Study||0
303899|NCT01709474|726775|P1|NOT COMPLETED|Overall Study||0
303900|NCT01709474|726774|P2|COMPLETED|Overall Study||4
303901|NCT01709474|726775|P1|COMPLETED|Overall Study||3
303902|NCT01709474|726774|P2|STARTED|Overall Study||4
303903|NCT01709474|726775|P1|STARTED|Overall Study||3
303904|NCT01709422|726785|P2|NOT COMPLETED|Overall Study||0
303905|NCT01709422|726786|P1|NOT COMPLETED|Overall Study||0
303906|NCT01709422|726785|P2|COMPLETED|Overall Study||70
303907|NCT01709422|726786|P1|COMPLETED|Overall Study||70
303908|NCT01709422|726785|P2|STARTED|Overall Study||70
303909|NCT01709422|726786|P1|STARTED|Overall Study||70
303910|NCT01709331|726794|P1|NOT COMPLETED|Overall Study||1
303911|NCT01709331|726794|P1|COMPLETED|Overall Study||17
303912|NCT01709331|726794|P1|STARTED|Overall Study||18
303913|NCT01709305|726800|P5|NOT COMPLETED|Phase 2||47
303914|NCT01709305|726801|P4|NOT COMPLETED|Phase 2||48
303915|NCT01709305|726802|P3|NOT COMPLETED|Phase 2||45
303916|NCT01709305|726803|P2|NOT COMPLETED|Phase 2||52
303917|NCT01709305|726804|P1|NOT COMPLETED|Phase 2||0
303918|NCT01709305|726800|P5|COMPLETED|Phase 2||507
303919|NCT01709305|726801|P4|COMPLETED|Phase 2||508
303920|NCT01709305|726802|P3|COMPLETED|Phase 2||505
303921|NCT01709305|726803|P2|COMPLETED|Phase 2||500
303922|NCT01709305|726804|P1|COMPLETED|Phase 2||0
303923|NCT01709305|726800|P5|STARTED|Phase 2||554
303924|NCT01709305|726801|P4|STARTED|Phase 2||556
303925|NCT01709305|726802|P3|STARTED|Phase 2||550
303926|NCT01709305|726803|P2|STARTED|Phase 2||552
303927|NCT01709305|726804|P1|STARTED|Phase 2||0
303928|NCT01709305|726800|P5|NOT COMPLETED|Phase 1||0
303929|NCT01709305|726801|P4|NOT COMPLETED|Phase 1||0
303930|NCT01709305|726802|P3|NOT COMPLETED|Phase 1||0
303931|NCT01709305|726803|P2|NOT COMPLETED|Phase 1||0
303932|NCT01709305|726804|P1|NOT COMPLETED|Phase 1||637
303933|NCT01709305|726800|P5|COMPLETED|Phase 1||0
303934|NCT01709305|726801|P4|COMPLETED|Phase 1||0
303935|NCT01709305|726802|P3|COMPLETED|Phase 1||0
303936|NCT01709305|726803|P2|COMPLETED|Phase 1||0
303937|NCT01709305|726804|P1|COMPLETED|Phase 1||4933
303938|NCT01709305|726800|P5|STARTED|Phase 1||0
303939|NCT01709305|726801|P4|STARTED|Phase 1||0
303940|NCT01709305|726802|P3|STARTED|Phase 1||0
303941|NCT01709305|726803|P2|STARTED|Phase 1||0
303942|NCT01709305|726804|P1|STARTED|Phase 1||5570
303943|NCT01709227|726841|P2|NOT COMPLETED|Overall Study||9
303944|NCT01709227|726842|P1|NOT COMPLETED|Overall Study||1
303945|NCT01709227|726841|P2|COMPLETED|Overall Study||32
303946|NCT01709227|726842|P1|COMPLETED|Overall Study||31
303947|NCT01709227|726841|P2|STARTED|Overall Study||41
303948|NCT01709227|726842|P1|STARTED|Overall Study||32
303949|NCT01709162|726868|P2|NOT COMPLETED|Overall Study||5
303950|NCT01709162|726869|P1|NOT COMPLETED|Overall Study||6
303951|NCT01709162|726868|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
303952|NCT01709162|726869|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
303953|NCT01709162|726868|P2|Still Receiving Treatment|Overall Study||0
303954|NCT01709162|726869|P1|Still Receiving Treatment|Overall Study||0
303955|NCT01709162|726868|P2|Received Treatment|Overall Study||4
303956|NCT01709162|726869|P1|Received Treatment|Overall Study||18
303957|NCT01709162|726868|P2|STARTED|Overall Study|Randomized|5
303958|NCT01709162|726869|P1|STARTED|Overall Study|Randomized|18
303959|NCT01709136|726881|P1|NOT COMPLETED|Overall Study||0
303960|NCT01709136|726881|P1|COMPLETED|Overall Study||3
303961|NCT01709136|726881|P1|STARTED|Overall Study||3
303962|NCT01709084|726890|P2|NOT COMPLETED|Overall Study||15
303963|NCT01709084|726891|P1|NOT COMPLETED|Overall Study||16
303964|NCT01709084|726890|P2|COMPLETED|Overall Study||198
303965|NCT01709084|726891|P1|COMPLETED|Overall Study||197
303966|NCT01709084|726890|P2|Treated|Overall Study||211
303967|NCT01709084|726891|P1|Treated|Overall Study||213
303968|NCT01709084|726890|P2|STARTED|Overall Study||213
303969|NCT01709084|726891|P1|STARTED|Overall Study||213
303970|NCT01708967|726909|P2|NOT COMPLETED|Overall Study||7
303971|NCT01708967|726910|P1|NOT COMPLETED|Overall Study||0
303972|NCT01708967|726909|P2|COMPLETED|Overall Study||43
303973|NCT01708967|726910|P1|COMPLETED|Overall Study||50
303974|NCT01708967|726909|P2|STARTED|Overall Study||50
303975|NCT01708967|726910|P1|STARTED|Overall Study||50
303976|NCT01708954|726919|P3|NOT COMPLETED|Step 2||0
303977|NCT01708954|726920|P2|NOT COMPLETED|Step 2||7
303978|NCT01708954|726921|P1|NOT COMPLETED|Step 2||13
303979|NCT01708954|726919|P3|COMPLETED|Step 2||0
304064|NCT01708278|727071|P5|COMPLETED|Overall Study||1
303980|NCT01708954|726920|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
303981|NCT01708954|726921|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
303982|NCT01708954|726919|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
303983|NCT01708954|726920|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
303984|NCT01708954|726921|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
303985|NCT01708954|726919|P3|NOT COMPLETED|Step 1||43
303986|NCT01708954|726920|P2|NOT COMPLETED|Step 1||40
303987|NCT01708954|726921|P1|NOT COMPLETED|Step 1||42
303988|NCT01708954|726919|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
303989|NCT01708954|726920|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
303990|NCT01708954|726921|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
303991|NCT01708954|726919|P3|Patients With MET Status Data Available|Step 1||24
303992|NCT01708954|726920|P2|Patients With MET Status Data Available|Step 1||32
303993|NCT01708954|726921|P1|Patients With MET Status Data Available|Step 1||30
303994|NCT01708954|726919|P3|Eligible and Treated|Step 1||35
303995|NCT01708954|726920|P2|Eligible and Treated|Step 1||38
303996|NCT01708954|726921|P1|Eligible and Treated|Step 1||38
303997|NCT01708954|726919|P3|Started Protocol Therapy|Step 1||39
303998|NCT01708954|726920|P2|Started Protocol Therapy|Step 1||40
303999|NCT01708954|726921|P1|Started Protocol Therapy|Step 1||40
304000|NCT01708954|726919|P3|STARTED|Step 1||43
304001|NCT01708954|726920|P2|STARTED|Step 1||40
304002|NCT01708954|726921|P1|STARTED|Step 1||42
304003|NCT01708915|726946|P4|NOT COMPLETED|Overall Study||33
304004|NCT01708915|726947|P3|NOT COMPLETED|Overall Study||46
304005|NCT01708915|726948|P2|NOT COMPLETED|Overall Study||62
304006|NCT01708915|726949|P1|NOT COMPLETED|Overall Study||86
304007|NCT01708915|726946|P4|COMPLETED|Overall Study||169
304008|NCT01708915|726947|P3|COMPLETED|Overall Study||152
304009|NCT01708915|726948|P2|COMPLETED|Overall Study||139
304010|NCT01708915|726949|P1|COMPLETED|Overall Study||118
304011|NCT01708915|726946|P4|STARTED|Overall Study||202
304012|NCT01708915|726947|P3|STARTED|Overall Study||198
304013|NCT01708915|726948|P2|STARTED|Overall Study||201
304014|NCT01708915|726949|P1|STARTED|Overall Study||204
304015|NCT01708902|726978|P7|NOT COMPLETED|Overall Study||7
304016|NCT01708902|726979|P6|NOT COMPLETED|Overall Study||7
304017|NCT01708902|726980|P5|NOT COMPLETED|Overall Study||16
304018|NCT01708902|726981|P4|NOT COMPLETED|Overall Study||10
304019|NCT01708902|726982|P3|NOT COMPLETED|Overall Study||17
304020|NCT01708902|726983|P2|NOT COMPLETED|Overall Study||8
304021|NCT01708902|726984|P1|NOT COMPLETED|Overall Study||17
304022|NCT01708902|726978|P7|COMPLETED|Overall Study||65
304023|NCT01708902|726979|P6|COMPLETED|Overall Study||64
304024|NCT01708902|726980|P5|COMPLETED|Overall Study||131
304025|NCT01708902|726981|P4|COMPLETED|Overall Study||137
304026|NCT01708902|726982|P3|COMPLETED|Overall Study||127
304027|NCT01708902|726983|P2|COMPLETED|Overall Study||137
304028|NCT01708902|726984|P1|COMPLETED|Overall Study||130
304029|NCT01708902|726978|P7|STARTED|Overall Study||72
304030|NCT01708902|726979|P6|STARTED|Overall Study||71
304031|NCT01708902|726980|P5|STARTED|Overall Study||147
304032|NCT01708902|726981|P4|STARTED|Overall Study||147
304033|NCT01708902|726982|P3|STARTED|Overall Study||144
304034|NCT01708902|726983|P2|STARTED|Overall Study||145
304035|NCT01708902|726984|P1|STARTED|Overall Study||147
304036|NCT01708525|727043|P1|NOT COMPLETED|Overall Study||0
304037|NCT01708525|727043|P1|COMPLETED|Overall Study||2
304038|NCT01708525|727043|P1|STARTED|Overall Study||2
304039|NCT01708317|727048|P1|NOT COMPLETED|Final Education Period||0
304040|NCT01708317|727048|P1|COMPLETED|Final Education Period||909
304041|NCT01708317|727048|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
304042|NCT01708317|727048|P1|NOT COMPLETED|ACASI + Education Period||0
304043|NCT01708317|727048|P1|COMPLETED|ACASI + Education Period||2601
304044|NCT01708317|727048|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
304045|NCT01708317|727048|P1|NOT COMPLETED|Initial Education Period||0
304046|NCT01708317|727048|P1|COMPLETED|Initial Education Period||982
304047|NCT01708317|727048|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
304048|NCT01708317|727048|P1|NOT COMPLETED|2010 Control Period||0
304049|NCT01708317|727048|P1|COMPLETED|2010 Control Period||3929
304050|NCT01708317|727048|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
304051|NCT01708291|727057|P2|NOT COMPLETED|Overall Study||1
304052|NCT01708291|727058|P1|NOT COMPLETED|Overall Study||2
304053|NCT01708291|727057|P2|COMPLETED|Overall Study||20
304054|NCT01708291|727058|P1|COMPLETED|Overall Study||19
304055|NCT01708291|727057|P2|STARTED|Overall Study||21
304056|NCT01708291|727058|P1|STARTED|Overall Study||21
304057|NCT01708278|727070|P6|NOT COMPLETED|Overall Study||0
304058|NCT01708278|727071|P5|NOT COMPLETED|Overall Study||0
304059|NCT01708278|727072|P4|NOT COMPLETED|Overall Study||0
304060|NCT01708278|727073|P3|NOT COMPLETED|Overall Study||0
304061|NCT01708278|727074|P2|NOT COMPLETED|Overall Study||0
304062|NCT01708278|727075|P1|NOT COMPLETED|Overall Study||0
304063|NCT01708278|727070|P6|COMPLETED|Overall Study||1
304065|NCT01708278|727072|P4|COMPLETED|Overall Study||2
304066|NCT01708278|727073|P3|COMPLETED|Overall Study||2
304067|NCT01708278|727074|P2|COMPLETED|Overall Study||2
304068|NCT01708278|727075|P1|COMPLETED|Overall Study||1
304069|NCT01708278|727070|P6|STARTED|Overall Study||1
304070|NCT01708278|727071|P5|STARTED|Overall Study||1
304071|NCT01708278|727072|P4|STARTED|Overall Study||2
304072|NCT01708278|727073|P3|STARTED|Overall Study||2
304073|NCT01708278|727074|P2|STARTED|Overall Study||2
304074|NCT01708278|727075|P1|STARTED|Overall Study||1
304075|NCT01708213|727089|P1|NOT COMPLETED|Overall Study||1
304076|NCT01708213|727089|P1|COMPLETED|Overall Study||71
304077|NCT01708213|727089|P1|STARTED|Overall Study||72
304078|NCT01708187|727097|P2|NOT COMPLETED|Overall Study||1
304079|NCT01708187|727098|P1|NOT COMPLETED|Overall Study||0
304080|NCT01708187|727097|P2|COMPLETED|Overall Study||0
304081|NCT01708187|727098|P1|COMPLETED|Overall Study||1
304082|NCT01708187|727097|P2|STARTED|Overall Study||1
304083|NCT01708187|727098|P1|STARTED|Overall Study||1
304084|NCT01708174|727107|P3|NOT COMPLETED|Survival Follow-up||0
304085|NCT01708174|727108|P2|NOT COMPLETED|Survival Follow-up||0
304086|NCT01708174|727109|P1|NOT COMPLETED|Survival Follow-up||0
304087|NCT01708174|727107|P3|COMPLETED|Survival Follow-up||0
304088|NCT01708174|727108|P2|COMPLETED|Survival Follow-up||10
304089|NCT01708174|727109|P1|COMPLETED|Survival Follow-up||1
304090|NCT01708174|727107|P3|STARTED|Survival Follow-up||0
304091|NCT01708174|727108|P2|STARTED|Survival Follow-up||10
304092|NCT01708174|727109|P1|STARTED|Survival Follow-up||1
304093|NCT01708174|727107|P3|NOT COMPLETED|Treatment Period||1
304094|NCT01708174|727108|P2|NOT COMPLETED|Treatment Period||2
304095|NCT01708174|727109|P1|NOT COMPLETED|Treatment Period||1
304096|NCT01708174|727107|P3|COMPLETED|Treatment Period||3
304097|NCT01708174|727108|P2|COMPLETED|Treatment Period||14
304098|NCT01708174|727109|P1|COMPLETED|Treatment Period||1
304099|NCT01708174|727107|P3|Pharmacokinetic Analysis Set|Treatment Period||0
304100|NCT01708174|727108|P2|Pharmacokinetic Analysis Set|Treatment Period||13
304101|NCT01708174|727109|P1|Pharmacokinetic Analysis Set|Treatment Period||2
304102|NCT01708174|727107|P3|STARTED|Treatment Period||4
304103|NCT01708174|727108|P2|STARTED|Treatment Period||16
304104|NCT01708174|727109|P1|STARTED|Treatment Period||2
304105|NCT01708122|727137|P2|NOT COMPLETED|Overall Study||0
304106|NCT01708122|727138|P1|NOT COMPLETED|Overall Study||0
304107|NCT01708122|727137|P2|COMPLETED|Overall Study||26
304108|NCT01708122|727138|P1|COMPLETED|Overall Study||27
304109|NCT01708122|727137|P2|STARTED|Overall Study||26
304110|NCT01708122|727138|P1|STARTED|Overall Study||27
304111|NCT01708057|727146|P3|NOT COMPLETED|Overall Study||1
304112|NCT01708057|727147|P2|NOT COMPLETED|Overall Study||1
304113|NCT01708057|727148|P1|NOT COMPLETED|Overall Study||1
304114|NCT01708057|727146|P3|COMPLETED|Overall Study||0
304115|NCT01708057|727147|P2|COMPLETED|Overall Study||0
304116|NCT01708057|727148|P1|COMPLETED|Overall Study||0
304117|NCT01708057|727146|P3|STARTED|Overall Study||1
304118|NCT01708057|727147|P2|STARTED|Overall Study||1
304119|NCT01708057|727148|P1|STARTED|Overall Study||1
304120|NCT01707667|727206|P2|NOT COMPLETED|Period 2||0
304121|NCT01707667|727207|P1|NOT COMPLETED|Period 2||0
304122|NCT01707667|727206|P2|COMPLETED|Period 2||6
304123|NCT01707667|727207|P1|COMPLETED|Period 2||6
304124|NCT01707667|727206|P2|STARTED|Period 2||6
304125|NCT01707667|727207|P1|STARTED|Period 2||6
304126|NCT01707667|727206|P2|NOT COMPLETED|Period 1||0
304127|NCT01707667|727207|P1|NOT COMPLETED|Period 1||1
304128|NCT01707667|727206|P2|COMPLETED|Period 1||6
304129|NCT01707667|727207|P1|COMPLETED|Period 1||6
304130|NCT01707667|727206|P2|STARTED|Period 1||6
304131|NCT01707667|727207|P1|STARTED|Period 1||7
304132|NCT01707654|727225|P1|NOT COMPLETED|Overall Study||0
304133|NCT01707654|727225|P1|COMPLETED|Overall Study||9
304134|NCT01707654|727225|P1|STARTED|Overall Study||9
304135|NCT01707290|727231|P2|NOT COMPLETED|Overall Study||1
304136|NCT01707290|727232|P1|NOT COMPLETED|Overall Study||86
304137|NCT01707290|727231|P2|COMPLETED|Overall Study||3
304138|NCT01707290|727232|P1|COMPLETED|Overall Study||35
304139|NCT01707290|727231|P2|STARTED|Overall Study||4
304140|NCT01707290|727232|P1|STARTED|Overall Study||121
304141|NCT01707238|727255|P2|NOT COMPLETED|Overall Study||0
304142|NCT01707238|727256|P1|NOT COMPLETED|Overall Study||0
304143|NCT01707238|727255|P2|COMPLETED|Overall Study||52
304144|NCT01707238|727256|P1|COMPLETED|Overall Study||48
304145|NCT01707238|727255|P2|STARTED|Overall Study||52
304146|NCT01707238|727256|P1|STARTED|Overall Study||48
304147|NCT01707225|727272|P1|NOT COMPLETED|Overall Study||0
304148|NCT01707225|727272|P1|COMPLETED|Overall Study||10
304149|NCT01707225|727272|P1|STARTED|Overall Study||10
304150|NCT01707095|727279|P2|NOT COMPLETED|Overall Study||0
304151|NCT01707095|727280|P1|NOT COMPLETED|Overall Study||0
304152|NCT01707095|727279|P2|COMPLETED|Overall Study||42
304153|NCT01707095|727280|P1|COMPLETED|Overall Study||42
304154|NCT01707095|727279|P2|STARTED|Overall Study||42
304155|NCT01707095|727280|P1|STARTED|Overall Study||42
304156|NCT01706952|727288|P1|NOT COMPLETED|Overall Study||8
304157|NCT01706952|727288|P1|COMPLETED|Overall Study||37
304158|NCT01706952|727288|P1|STARTED|Overall Study||45
304159|NCT01706926|727304|P4|NOT COMPLETED|Overall Study||5
304160|NCT01706926|727305|P3|NOT COMPLETED|Overall Study||6
304161|NCT01706926|727306|P2|NOT COMPLETED|Overall Study||4
304162|NCT01706926|727307|P1|NOT COMPLETED|Overall Study||6
304163|NCT01706926|727304|P4|COMPLETED|Overall Study||74
304164|NCT01706926|727305|P3|COMPLETED|Overall Study||79
304165|NCT01706926|727306|P2|COMPLETED|Overall Study||77
304166|NCT01706926|727307|P1|COMPLETED|Overall Study||75
304167|NCT01706926|727304|P4|STARTED|Overall Study||79
304168|NCT01706926|727305|P3|STARTED|Overall Study||85
304169|NCT01706926|727306|P2|STARTED|Overall Study||81
304170|NCT01706926|727307|P1|STARTED|Overall Study||81
304171|NCT01706822|727416|P1|NOT COMPLETED|Overall Study||0
304172|NCT01706822|727416|P1|COMPLETED|Overall Study||8
304173|NCT01706822|727416|P1|STARTED|Overall Study||8
304174|NCT01706770|727426|P2|NOT COMPLETED|Overall Study||0
304175|NCT01706770|727427|P1|NOT COMPLETED|Overall Study||2
304176|NCT01706770|727426|P2|COMPLETED|Overall Study||17
304177|NCT01706770|727427|P1|COMPLETED|Overall Study||31
304178|NCT01706770|727426|P2|STARTED|Overall Study||17
304179|NCT01706770|727427|P1|STARTED|Overall Study||33
304180|NCT01706666|727438|P3|NOT COMPLETED|Overall Study||0
304181|NCT01706666|727439|P2|NOT COMPLETED|Overall Study||0
304182|NCT01706666|727440|P1|NOT COMPLETED|Overall Study||0
304183|NCT01706666|727438|P3|COMPLETED|Overall Study||1
304184|NCT01706666|727439|P2|COMPLETED|Overall Study||1
304185|NCT01706666|727440|P1|COMPLETED|Overall Study||1
304186|NCT01706666|727438|P3|STARTED|Overall Study||1
304187|NCT01706666|727439|P2|STARTED|Overall Study||1
304188|NCT01706666|727440|P1|STARTED|Overall Study||1
304189|NCT01706588|727459|P5|NOT COMPLETED|Overall Study||0
304190|NCT01706588|727460|P4|NOT COMPLETED|Overall Study||0
304191|NCT01706588|727461|P3|NOT COMPLETED|Overall Study||0
304192|NCT01706588|727462|P2|NOT COMPLETED|Overall Study||0
304193|NCT01706588|727463|P1|NOT COMPLETED|Overall Study||0
304194|NCT01706588|727459|P5|COMPLETED|Overall Study||16
304195|NCT01706588|727460|P4|COMPLETED|Overall Study||14
304196|NCT01706588|727461|P3|COMPLETED|Overall Study||15
304197|NCT01706588|727462|P2|COMPLETED|Overall Study||15
304198|NCT01706588|727463|P1|COMPLETED|Overall Study||15
304199|NCT01706588|727459|P5|STARTED|Overall Study||16
304200|NCT01706588|727460|P4|STARTED|Overall Study||14
304201|NCT01706588|727461|P3|STARTED|Overall Study||15
304202|NCT01706588|727462|P2|STARTED|Overall Study||15
304203|NCT01706588|727463|P1|STARTED|Overall Study||15
304204|NCT01706575|727475|P1|NOT COMPLETED|Overall Study||12
304205|NCT01706575|727475|P1|COMPLETED|Overall Study||64
304206|NCT01706575|727475|P1|Treated|Overall Study||70
304207|NCT01706575|727475|P1|STARTED|Overall Study||76
304208|NCT01706549|727486|P1|NOT COMPLETED|Overall Study||0
304209|NCT01706549|727486|P1|COMPLETED|Overall Study||16
304210|NCT01706549|727486|P1|STARTED|Overall Study||16
304211|NCT01706328|727493|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
304212|NCT01706328|727494|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
304213|NCT01706328|727495|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
304214|NCT01706328|727493|P3|COMPLETED|12-week Double-blind Treatment Period||371
304215|NCT01706328|727494|P2|COMPLETED|12-week Double-blind Treatment Period||366
304216|NCT01706328|727495|P1|COMPLETED|12-week Double-blind Treatment Period||0
304217|NCT01706328|727493|P3|STARTED|12-week Double-blind Treatment Period||416
304218|NCT01706328|727494|P2|STARTED|12-week Double-blind Treatment Period||412
304219|NCT01706328|727495|P1|STARTED|12-week Double-blind Treatment Period||0
304220|NCT01706328|727493|P3|NOT COMPLETED|2-week Run-in Period||0
304221|NCT01706328|727494|P2|NOT COMPLETED|2-week Run-in Period||0
304222|NCT01706328|727495|P1|NOT COMPLETED|2-week Run-in Period||165
304223|NCT01706328|727493|P3|COMPLETED|2-week Run-in Period||0
304224|NCT01706328|727494|P2|COMPLETED|2-week Run-in Period||0
304225|NCT01706328|727495|P1|COMPLETED|2-week Run-in Period||828
304226|NCT01706328|727493|P3|STARTED|2-week Run-in Period||0
304227|NCT01706328|727494|P2|STARTED|2-week Run-in Period||0
304228|NCT01706328|727495|P1|STARTED|2-week Run-in Period||993
304229|NCT01706159|727507|P2|NOT COMPLETED|Overall Study||2
304230|NCT01706159|727508|P1|NOT COMPLETED|Overall Study||8
304231|NCT01706159|727507|P2|COMPLETED|Overall Study||4
304232|NCT01706159|727508|P1|COMPLETED|Overall Study||6
304233|NCT01706159|727507|P2|Completers (With Baron Score at Week 8)|Overall Study||3
304234|NCT01706159|727508|P1|Completers (With Baron Score at Week 8)|Overall Study||6
304235|NCT01706159|727507|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
304236|NCT01706159|727508|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
304237|NCT01706159|727507|P2|STARTED|Overall Study||6
304238|NCT01706159|727508|P1|STARTED|Overall Study||14
304239|NCT01706146|727522|P1|NOT COMPLETED|Overall Study||6
304240|NCT01706146|727522|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
304241|NCT01706146|727522|P1|STARTED|Overall Study||59
304242|NCT01705717|727529|P2|NOT COMPLETED|Overall Study||5
304243|NCT01705717|727530|P1|NOT COMPLETED|Overall Study||2
304244|NCT01705717|727529|P2|COMPLETED|Overall Study||7
304245|NCT01705717|727530|P1|COMPLETED|Overall Study||35
304246|NCT01705717|727529|P2|STARTED|Overall Study||12
304247|NCT01705717|727530|P1|STARTED|Overall Study||37
304248|NCT01705652|727547|P2|NOT COMPLETED|Overall Study||3
304249|NCT01705652|727548|P1|NOT COMPLETED|Overall Study||3
304250|NCT01705652|727547|P2|COMPLETED|Overall Study||9
304251|NCT01705652|727548|P1|COMPLETED|Overall Study||6
304252|NCT01705652|727547|P2|STARTED|Overall Study||12
304253|NCT01705652|727548|P1|STARTED|Overall Study||9
304254|NCT01705574|727556|P2|NOT COMPLETED|Overall Study||163
304255|NCT01705574|727557|P1|NOT COMPLETED|Overall Study||167
304256|NCT01705574|727556|P2|COMPLETED|Overall Study||127
304257|NCT01705574|727557|P1|COMPLETED|Overall Study||126
304258|NCT01705574|727556|P2|STARTED|Overall Study||290
304259|NCT01705574|727557|P1|STARTED|Overall Study||293
304260|NCT01705496|727565|P1|NOT COMPLETED|Overall Study||4
304261|NCT01705496|727565|P1|COMPLETED|Overall Study||19
304262|NCT01705496|727565|P1|STARTED|Overall Study||23
304263|NCT01705145|727575|P1|NOT COMPLETED|Part B||1
304264|NCT01705145|727575|P1|COMPLETED|Part B||33
304265|NCT01705145|727575|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
304266|NCT01705145|727575|P1|NOT COMPLETED|Part A||0
304267|NCT01705145|727575|P1|COMPLETED|Part A||9
304268|NCT01705145|727575|P1|STARTED|Part A||9
304269|NCT01704976|727605|P2|NOT COMPLETED|Overall Study||2
304270|NCT01704976|727606|P1|NOT COMPLETED|Overall Study||1
304271|NCT01704976|727605|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
304272|NCT01704976|727606|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
304273|NCT01704976|727605|P2|STARTED|Overall Study||13
304274|NCT01704976|727606|P1|STARTED|Overall Study||14
304275|NCT01704846|727622|P2|NOT COMPLETED|Treatment Period 4||0
304276|NCT01704846|727623|P1|NOT COMPLETED|Treatment Period 4||0
304277|NCT01704846|727622|P2|COMPLETED|Treatment Period 4||29
304278|NCT01704846|727623|P1|COMPLETED|Treatment Period 4||30
304279|NCT01704846|727622|P2|STARTED|Treatment Period 4||29
304280|NCT01704846|727623|P1|STARTED|Treatment Period 4||30
304281|NCT01704846|727622|P2|NOT COMPLETED|Treatment Period 3||0
304282|NCT01704846|727623|P1|NOT COMPLETED|Treatment Period 3||0
304283|NCT01704846|727622|P2|COMPLETED|Treatment Period 3||29
304284|NCT01704846|727623|P1|COMPLETED|Treatment Period 3||30
304285|NCT01704846|727622|P2|STARTED|Treatment Period 3||29
304286|NCT01704846|727623|P1|STARTED|Treatment Period 3||30
304287|NCT01704846|727622|P2|NOT COMPLETED|Treatment Period 2||1
304288|NCT01704846|727623|P1|NOT COMPLETED|Treatment Period 2||0
304289|NCT01704846|727622|P2|COMPLETED|Treatment Period 2||29
304290|NCT01704846|727623|P1|COMPLETED|Treatment Period 2||30
304291|NCT01704846|727622|P2|STARTED|Treatment Period 2||30
304292|NCT01704846|727623|P1|STARTED|Treatment Period 2||30
304293|NCT01704846|727622|P2|NOT COMPLETED|Treatment Period 1||0
304294|NCT01704846|727623|P1|NOT COMPLETED|Treatment Period 1||0
304295|NCT01704846|727622|P2|COMPLETED|Treatment Period 1||30
304296|NCT01704846|727623|P1|COMPLETED|Treatment Period 1||30
304297|NCT01704846|727622|P2|STARTED|Treatment Period 1||30
304298|NCT01704846|727623|P1|STARTED|Treatment Period 1||30
304299|NCT01704781|727646|P5|NOT COMPLETED|Overall Study||0
304300|NCT01704781|727647|P4|NOT COMPLETED|Overall Study||0
304301|NCT01704781|727648|P3|NOT COMPLETED|Overall Study||0
304302|NCT01704781|727649|P2|NOT COMPLETED|Overall Study||0
304303|NCT01704781|727650|P1|NOT COMPLETED|Overall Study||0
304304|NCT01704781|727646|P5|COMPLETED|Overall Study||12
304305|NCT01704781|727647|P4|COMPLETED|Overall Study||12
304306|NCT01704781|727648|P3|COMPLETED|Overall Study||6
304307|NCT01704781|727649|P2|COMPLETED|Overall Study||3
304308|NCT01704781|727650|P1|COMPLETED|Overall Study||3
304309|NCT01704781|727646|P5|STARTED|Overall Study||12
304310|NCT01704781|727647|P4|STARTED|Overall Study||12
304311|NCT01704781|727648|P3|STARTED|Overall Study||6
304312|NCT01704781|727649|P2|STARTED|Overall Study||3
304313|NCT01704781|727650|P1|STARTED|Overall Study||3
304314|NCT01704755|727678|P2|NOT COMPLETED|Overall Study||7
304315|NCT01704755|727679|P1|NOT COMPLETED|Overall Study||12
304316|NCT01704755|727678|P2|COMPLETED|Overall Study||165
304317|NCT01704755|727679|P1|COMPLETED|Overall Study||196
304318|NCT01704755|727678|P2|Completed Study Drug|Overall Study||163
304319|NCT01704755|727679|P1|Completed Study Drug|Overall Study||204
304320|NCT01704755|727678|P2|STARTED|Overall Study||172
304321|NCT01704755|727679|P1|STARTED|Overall Study||208
304322|NCT01704651|727693|P2|NOT COMPLETED|Overall Study||7
304323|NCT01704651|727694|P1|NOT COMPLETED|Overall Study||5
304324|NCT01704651|727693|P2|COMPLETED|Overall Study||68
304325|NCT01704651|727694|P1|COMPLETED|Overall Study||66
304326|NCT01704651|727693|P2|STARTED|Overall Study||75
304327|NCT01704651|727694|P1|STARTED|Overall Study||71
304328|NCT01704599|727702|P1|NOT COMPLETED|Overall Study||1
304329|NCT01704599|727702|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
304330|NCT01704599|727702|P1|STARTED|Overall Study|Study was started January 22, 2010|8
304331|NCT01704521|727731|P2|NOT COMPLETED|Overall Study||0
304332|NCT01704521|727732|P1|NOT COMPLETED|Overall Study||0
304333|NCT01704521|727731|P2|COMPLETED|Overall Study||2
304334|NCT01704521|727732|P1|COMPLETED|Overall Study||3
304335|NCT01704521|727731|P2|STARTED|Overall Study||2
304336|NCT01704521|727732|P1|STARTED|Overall Study||3
304337|NCT01704495|727742|P4|NOT COMPLETED|Optional Safety Extension||31
304338|NCT01704495|727743|P3|NOT COMPLETED|Optional Safety Extension||31
304339|NCT01704495|727744|P2|NOT COMPLETED|Optional Safety Extension||33
304340|NCT01704495|727745|P1|NOT COMPLETED|Optional Safety Extension||29
304341|NCT01704495|727742|P4|COMPLETED|Optional Safety Extension||85
304342|NCT01704495|727743|P3|COMPLETED|Optional Safety Extension||83
304343|NCT01704495|727744|P2|COMPLETED|Optional Safety Extension||88
304344|NCT01704495|727745|P1|COMPLETED|Optional Safety Extension||87
304345|NCT01704495|727742|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
304346|NCT01704495|727743|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
304347|NCT01704495|727744|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
304348|NCT01704495|727745|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
304349|NCT01704495|727742|P4|NOT COMPLETED|Subjects Randomized||17
304350|NCT01704495|727743|P3|NOT COMPLETED|Subjects Randomized||16
304351|NCT01704495|727744|P2|NOT COMPLETED|Subjects Randomized||15
304352|NCT01704495|727745|P1|NOT COMPLETED|Subjects Randomized||22
304353|NCT01704495|727742|P4|COMPLETED|Subjects Randomized||145
304354|NCT01704495|727743|P3|COMPLETED|Subjects Randomized||144
304355|NCT01704495|727744|P2|COMPLETED|Subjects Randomized||141
304356|NCT01704495|727745|P1|COMPLETED|Subjects Randomized||140
304357|NCT01704495|727742|P4|STARTED|Subjects Randomized||162
304358|NCT01704495|727743|P3|STARTED|Subjects Randomized||160
304359|NCT01704495|727744|P2|STARTED|Subjects Randomized||156
304360|NCT01704495|727745|P1|STARTED|Subjects Randomized||162
304361|NCT01704404|727919|P6|NOT COMPLETED|Overall Study||0
304362|NCT01704404|727920|P5|NOT COMPLETED|Overall Study||1
304363|NCT01704404|727921|P4|NOT COMPLETED|Overall Study||3
304364|NCT01704404|727922|P3|NOT COMPLETED|Overall Study||1
304365|NCT01704404|727923|P2|NOT COMPLETED|Overall Study||1
304366|NCT01704404|727924|P1|NOT COMPLETED|Overall Study||1
304367|NCT01704404|727919|P6|COMPLETED|Overall Study||9
304368|NCT01704404|727920|P5|COMPLETED|Overall Study||10
304369|NCT01704404|727921|P4|COMPLETED|Overall Study||8
304370|NCT01704404|727922|P3|COMPLETED|Overall Study||9
304371|NCT01704404|727923|P2|COMPLETED|Overall Study||9
304372|NCT01704404|727924|P1|COMPLETED|Overall Study||10
304373|NCT01704404|727919|P6|STARTED|Overall Study||9
304374|NCT01704404|727920|P5|STARTED|Overall Study||11
304375|NCT01704404|727921|P4|STARTED|Overall Study||11
304376|NCT01704404|727922|P3|STARTED|Overall Study||10
304377|NCT01704404|727923|P2|STARTED|Overall Study||10
304378|NCT01704404|727924|P1|STARTED|Overall Study||11
304379|NCT01704287|727961|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||45
304380|NCT01704287|727962|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||53
304381|NCT01704287|727963|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
304382|NCT01704287|727964|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
304383|NCT01704287|727965|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
304384|NCT01704287|727961|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||0
304385|NCT01704287|727962|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||0
304386|NCT01704287|727963|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
304387|NCT01704287|727964|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
304388|NCT01704287|727965|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
304389|NCT01704287|727961|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
304390|NCT01704287|727962|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
304391|NCT01704287|727963|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
304392|NCT01704287|727964|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
304393|NCT01704287|727965|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
304394|NCT01704287|727961|P5|NOT COMPLETED|Initial Treatment Period||0
304395|NCT01704287|727962|P4|NOT COMPLETED|Initial Treatment Period||0
304396|NCT01704287|727963|P3|NOT COMPLETED|Initial Treatment Period||179
304397|NCT01704287|727964|P2|NOT COMPLETED|Initial Treatment Period||181
304398|NCT01704287|727965|P1|NOT COMPLETED|Initial Treatment Period||180
304399|NCT01704287|727961|P5|COMPLETED|Initial Treatment Period||0
304400|NCT01704287|727962|P4|COMPLETED|Initial Treatment Period||0
304401|NCT01704287|727963|P3|COMPLETED|Initial Treatment Period||0
304402|NCT01704287|727964|P2|COMPLETED|Initial Treatment Period||0
304403|NCT01704287|727965|P1|COMPLETED|Initial Treatment Period||0
304404|NCT01704287|727961|P5|Treated|Initial Treatment Period||0
304405|NCT01704287|727962|P4|Treated|Initial Treatment Period||0
304406|NCT01704287|727963|P3|Treated|Initial Treatment Period||171
304407|NCT01704287|727964|P2|Treated|Initial Treatment Period||179
304408|NCT01704287|727965|P1|Treated|Initial Treatment Period||178
304409|NCT01704287|727961|P5|STARTED|Initial Treatment Period||0
304410|NCT01704287|727962|P4|STARTED|Initial Treatment Period||0
304411|NCT01704287|727963|P3|STARTED|Initial Treatment Period||179
304412|NCT01704287|727964|P2|STARTED|Initial Treatment Period||181
304413|NCT01704287|727965|P1|STARTED|Initial Treatment Period||180
304414|NCT01704261|728000|P2|NOT COMPLETED|Overall Study||15
304415|NCT01704261|728001|P1|NOT COMPLETED|Overall Study||13
304416|NCT01704261|728000|P2|COMPLETED|Overall Study||138
304417|NCT01704261|728001|P1|COMPLETED|Overall Study||141
304418|NCT01704261|728000|P2|STARTED|Overall Study||153
304419|NCT01704261|728001|P1|STARTED|Overall Study||154
304420|NCT01704196|728017|P2|NOT COMPLETED|Overall Study||24
304421|NCT01704196|728018|P1|NOT COMPLETED|Overall Study||19
304422|NCT01704196|728017|P2|COMPLETED|Overall Study||65
304423|NCT01704196|728018|P1|COMPLETED|Overall Study||71
304424|NCT01704196|728017|P2|STARTED|Overall Study||89
304425|NCT01704196|728018|P1|STARTED|Overall Study||90
304426|NCT01704079|728028|P2|NOT COMPLETED|Overall Study||23
304427|NCT01704079|728029|P1|NOT COMPLETED|Overall Study||14
304428|NCT01704079|728028|P2|COMPLETED|Overall Study||121
304429|NCT01704079|728029|P1|COMPLETED|Overall Study||58
304430|NCT01704079|728028|P2|Entered Extension Study|Overall Study||102
304431|NCT01704079|728029|P1|Entered Extension Study|Overall Study||53
304432|NCT01704079|728028|P2|STARTED|Overall Study||144
304433|NCT01704079|728029|P1|STARTED|Overall Study||72
304434|NCT01703988|728045|P4|NOT COMPLETED|Overall Study||1
304435|NCT01703988|728046|P3|NOT COMPLETED|Overall Study||0
304436|NCT01703988|728047|P2|NOT COMPLETED|Overall Study||0
304437|NCT01703988|728048|P1|NOT COMPLETED|Overall Study||0
304438|NCT01703988|728045|P4|COMPLETED|Overall Study||8
304439|NCT01703988|728046|P3|COMPLETED|Overall Study||9
304440|NCT01703988|728047|P2|COMPLETED|Overall Study||8
304441|NCT01703988|728048|P1|COMPLETED|Overall Study||8
304442|NCT01703988|728045|P4|STARTED|Overall Study||9
304443|NCT01703988|728046|P3|STARTED|Overall Study||9
304444|NCT01703988|728047|P2|STARTED|Overall Study||8
304445|NCT01703988|728048|P1|STARTED|Overall Study||8
304446|NCT01703858|728078|P3|NOT COMPLETED|Overall Study||0
304447|NCT01703858|728079|P2|NOT COMPLETED|Overall Study||1
304448|NCT01703858|728080|P1|NOT COMPLETED|Overall Study||0
304449|NCT01703858|728078|P3|COMPLETED|Overall Study||5
304450|NCT01703858|728079|P2|COMPLETED|Overall Study||4
304451|NCT01703858|728080|P1|COMPLETED|Overall Study||5
304452|NCT01703858|728078|P3|STARTED|Overall Study||5
304453|NCT01703858|728079|P2|STARTED|Overall Study||5
304454|NCT01703858|728080|P1|STARTED|Overall Study||5
304455|NCT01703845|728105|P2|NOT COMPLETED|Overall Study||0
304456|NCT01703845|728106|P1|NOT COMPLETED|Overall Study||3
304457|NCT01703845|728105|P2|COMPLETED|Overall Study||16
304458|NCT01703845|728106|P1|COMPLETED|Overall Study||13
304459|NCT01703845|728105|P2|STARTED|Overall Study|started are actually the randomized|16
304460|NCT01703845|728106|P1|STARTED|Overall Study|started are actually the randomized|16
304461|NCT01703832|728143|P2|NOT COMPLETED|Overall Study||0
304462|NCT01703832|728144|P1|NOT COMPLETED|Overall Study||1
304463|NCT01703832|728143|P2|COMPLETED|Overall Study||32
304464|NCT01703832|728144|P1|COMPLETED|Overall Study||32
304465|NCT01703832|728143|P2|STARTED|Overall Study||32
304466|NCT01703832|728144|P1|STARTED|Overall Study||33
304467|NCT01703819|728176|P2|NOT COMPLETED|Overall Study||2
304468|NCT01703819|728177|P1|NOT COMPLETED|Overall Study||0
304469|NCT01703819|728176|P2|COMPLETED|Overall Study||30
304470|NCT01703819|728177|P1|COMPLETED|Overall Study||34
304471|NCT01703819|728176|P2|STARTED|Overall Study||32
304472|NCT01703819|728177|P1|STARTED|Overall Study||34
304473|NCT01703702|728209|P2|NOT COMPLETED|Overall Study||22
304474|NCT01703702|728210|P1|NOT COMPLETED|Overall Study||36
304475|NCT01703702|728209|P2|COMPLETED|Overall Study||288
304476|NCT01703702|728210|P1|COMPLETED|Overall Study||272
304477|NCT01703702|728209|P2|STARTED|Overall Study||310
304478|NCT01703702|728210|P1|STARTED|Overall Study||308
304479|NCT01703663|728227|P2|NOT COMPLETED|Second Treatment Period||0
304480|NCT01703663|728228|P1|NOT COMPLETED|Second Treatment Period||0
304481|NCT01703663|728227|P2|COMPLETED|Second Treatment Period||8
304482|NCT01703663|728228|P1|COMPLETED|Second Treatment Period||11
304483|NCT01703663|728227|P2|STARTED|Second Treatment Period||8
304484|NCT01703663|728228|P1|STARTED|Second Treatment Period||11
304485|NCT01703663|728227|P2|NOT COMPLETED|First Treatment Period||0
304486|NCT01703663|728228|P1|NOT COMPLETED|First Treatment Period||0
304487|NCT01703663|728227|P2|COMPLETED|First Treatment Period||20
304488|NCT01703663|728228|P1|COMPLETED|First Treatment Period||20
304489|NCT01703663|728227|P2|STARTED|First Treatment Period||20
304490|NCT01703663|728228|P1|STARTED|First Treatment Period||20
304491|NCT01703286|728234|P6|NOT COMPLETED|Period 3 Including Washout||0
304492|NCT01703286|728235|P5|NOT COMPLETED|Period 3 Including Washout||0
304493|NCT01703286|728236|P4|NOT COMPLETED|Period 3 Including Washout||0
304494|NCT01703286|728237|P3|NOT COMPLETED|Period 3 Including Washout||0
304495|NCT01703286|728238|P2|NOT COMPLETED|Period 3 Including Washout||0
304496|NCT01703286|728239|P1|NOT COMPLETED|Period 3 Including Washout||0
304497|NCT01703286|728234|P6|COMPLETED|Period 3 Including Washout||6
304498|NCT01703286|728235|P5|COMPLETED|Period 3 Including Washout||7
304499|NCT01703286|728236|P4|COMPLETED|Period 3 Including Washout||5
304500|NCT01703286|728237|P3|COMPLETED|Period 3 Including Washout||7
304501|NCT01703286|728238|P2|COMPLETED|Period 3 Including Washout||7
304502|NCT01703286|728239|P1|COMPLETED|Period 3 Including Washout||7
304503|NCT01703286|728234|P6|STARTED|Period 3 Including Washout||6
304504|NCT01703286|728235|P5|STARTED|Period 3 Including Washout||7
304505|NCT01703286|728236|P4|STARTED|Period 3 Including Washout||5
304506|NCT01703286|728237|P3|STARTED|Period 3 Including Washout||7
304507|NCT01703286|728238|P2|STARTED|Period 3 Including Washout||7
304508|NCT01703286|728239|P1|STARTED|Period 3 Including Washout||7
304509|NCT01703286|728234|P6|NOT COMPLETED|Period 2 Including Washout||0
304510|NCT01703286|728235|P5|NOT COMPLETED|Period 2 Including Washout||0
304511|NCT01703286|728236|P4|NOT COMPLETED|Period 2 Including Washout||1
304512|NCT01703286|728237|P3|NOT COMPLETED|Period 2 Including Washout||0
304513|NCT01703286|728238|P2|NOT COMPLETED|Period 2 Including Washout||0
304514|NCT01703286|728239|P1|NOT COMPLETED|Period 2 Including Washout||0
304515|NCT01703286|728234|P6|COMPLETED|Period 2 Including Washout||6
304516|NCT01703286|728235|P5|COMPLETED|Period 2 Including Washout||7
304517|NCT01703286|728236|P4|COMPLETED|Period 2 Including Washout||5
304518|NCT01703286|728237|P3|COMPLETED|Period 2 Including Washout||7
304519|NCT01703286|728238|P2|COMPLETED|Period 2 Including Washout||7
304520|NCT01703286|728239|P1|COMPLETED|Period 2 Including Washout||7
304521|NCT01703286|728234|P6|STARTED|Period 2 Including Washout||6
304522|NCT01703286|728235|P5|STARTED|Period 2 Including Washout||7
304523|NCT01703286|728236|P4|STARTED|Period 2 Including Washout||6
304524|NCT01703286|728237|P3|STARTED|Period 2 Including Washout||7
304525|NCT01703286|728238|P2|STARTED|Period 2 Including Washout||7
304526|NCT01703286|728239|P1|STARTED|Period 2 Including Washout||7
304527|NCT01703286|728234|P6|NOT COMPLETED|Period 1 Including Washout||1
304528|NCT01703286|728235|P5|NOT COMPLETED|Period 1 Including Washout||0
304529|NCT01703286|728236|P4|NOT COMPLETED|Period 1 Including Washout||1
304530|NCT01703286|728237|P3|NOT COMPLETED|Period 1 Including Washout||0
304531|NCT01703286|728238|P2|NOT COMPLETED|Period 1 Including Washout||0
304532|NCT01703286|728239|P1|NOT COMPLETED|Period 1 Including Washout||0
304533|NCT01703286|728234|P6|COMPLETED|Period 1 Including Washout||6
304534|NCT01703286|728235|P5|COMPLETED|Period 1 Including Washout||7
304535|NCT01703286|728236|P4|COMPLETED|Period 1 Including Washout||6
304536|NCT01703286|728237|P3|COMPLETED|Period 1 Including Washout||7
304537|NCT01703286|728238|P2|COMPLETED|Period 1 Including Washout||7
304538|NCT01703286|728239|P1|COMPLETED|Period 1 Including Washout||7
304539|NCT01703286|728234|P6|STARTED|Period 1 Including Washout||7
304540|NCT01703286|728235|P5|STARTED|Period 1 Including Washout||7
304541|NCT01703286|728236|P4|STARTED|Period 1 Including Washout||7
304542|NCT01703286|728237|P3|STARTED|Period 1 Including Washout||7
304543|NCT01703286|728238|P2|STARTED|Period 1 Including Washout||7
304544|NCT01703286|728239|P1|STARTED|Period 1 Including Washout||7
304545|NCT01703260|728262|P3|NOT COMPLETED|Overall Study||3
304546|NCT01703260|728263|P2|NOT COMPLETED|Overall Study||4
304547|NCT01703260|728264|P1|NOT COMPLETED|Overall Study||3
304548|NCT01703260|728262|P3|COMPLETED|Overall Study||3
304549|NCT01703260|728263|P2|COMPLETED|Overall Study||3
304550|NCT01703260|728264|P1|COMPLETED|Overall Study||4
304551|NCT01703260|728262|P3|STARTED|Overall Study||6
304552|NCT01703260|728263|P2|STARTED|Overall Study||7
304553|NCT01703260|728264|P1|STARTED|Overall Study||7
304554|NCT01703221|728290|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
304555|NCT01703221|728291|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
304556|NCT01703221|728292|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
304557|NCT01703221|728290|P3|COMPLETED|Phase B - (Week 25 to 52)||75
304558|NCT01703221|728291|P2|COMPLETED|Phase B - (Week 25 to 52)||147
304559|NCT01703221|728292|P1|COMPLETED|Phase B - (Week 25 to 52)||143
304560|NCT01703221|728290|P3|STARTED|Phase B - (Week 25 to 52)||80
304561|NCT01703221|728291|P2|STARTED|Phase B - (Week 25 to 52)||161
304562|NCT01703221|728292|P1|STARTED|Phase B - (Week 25 to 52)||159
304563|NCT01703221|728290|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
304564|NCT01703221|728291|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
304565|NCT01703221|728292|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
304566|NCT01703221|728290|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
304567|NCT01703221|728291|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
304568|NCT01703221|728292|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
304569|NCT01703221|728290|P3|STARTED|Phase A (Up to 24 Weeks)||83
304570|NCT01703221|728291|P2|STARTED|Phase A (Up to 24 Weeks)||165
304571|NCT01703221|728292|P1|STARTED|Phase A (Up to 24 Weeks)||166
304572|NCT01703091|728323|P2|NOT COMPLETED|Overall Study||4
304573|NCT01703091|728324|P1|NOT COMPLETED|Overall Study||9
304574|NCT01703091|728323|P2|COMPLETED|Overall Study||95
304575|NCT01703091|728324|P1|COMPLETED|Overall Study||89
304576|NCT01703091|728323|P2|Received at Least One Dose of Study Drug|Overall Study||98
304577|NCT01703091|728324|P1|Received at Least One Dose of Study Drug|Overall Study||94
304578|NCT01703091|728323|P2|STARTED|Overall Study||99
304579|NCT01703091|728324|P1|STARTED|Overall Study||98
304580|NCT01703000|728340|P1|NOT COMPLETED|Overall Study||1
304581|NCT01703000|728340|P1|COMPLETED|Overall Study||99
304582|NCT01703000|728340|P1|STARTED|Overall Study||100
304583|NCT01702987|728373|P2|NOT COMPLETED|Overall Study||0
304584|NCT01702987|728374|P1|NOT COMPLETED|Overall Study||1
304585|NCT01702987|728373|P2|COMPLETED|Overall Study||12
304586|NCT01702987|728374|P1|COMPLETED|Overall Study||9
304587|NCT01702987|728373|P2|STARTED|Overall Study||12
304588|NCT01702987|728374|P1|STARTED|Overall Study||10
304589|NCT01702961|728380|P1|NOT COMPLETED|Overall Study||47
304590|NCT01702961|728380|P1|COMPLETED|Overall Study||28
304591|NCT01702961|728380|P1|STARTED|Overall Study||75
304592|NCT01702532|728388|P2|NOT COMPLETED|Overall Study||1
304593|NCT01702532|728389|P1|NOT COMPLETED|Overall Study||0
304594|NCT01702532|728388|P2|COMPLETED|Overall Study||160
304595|NCT01702532|728389|P1|COMPLETED|Overall Study||161
304596|NCT01702532|728388|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
304597|NCT01702532|728389|P1|Safety Population|Overall Study||161
304598|NCT01702532|728388|P2|STARTED|Overall Study||161
304599|NCT01702532|728389|P1|STARTED|Overall Study||161
304600|NCT01702519|728399|P2|NOT COMPLETED|Period 2||0
304601|NCT01702519|728400|P1|NOT COMPLETED|Period 2||0
304602|NCT01702519|728399|P2|COMPLETED|Period 2||18
304603|NCT01702519|728400|P1|COMPLETED|Period 2||19
304604|NCT01702519|728399|P2|STARTED|Period 2||18
304605|NCT01702519|728400|P1|STARTED|Period 2||19
304606|NCT01702519|728399|P2|NOT COMPLETED|Washout Period||2
304607|NCT01702519|728400|P1|NOT COMPLETED|Washout Period||1
304608|NCT01702519|728399|P2|COMPLETED|Washout Period||18
304609|NCT01702519|728400|P1|COMPLETED|Washout Period||19
304610|NCT01702519|728399|P2|STARTED|Washout Period||20
304611|NCT01702519|728400|P1|STARTED|Washout Period||20
304612|NCT01702519|728399|P2|NOT COMPLETED|Period 1||0
304613|NCT01702519|728400|P1|NOT COMPLETED|Period 1||0
304614|NCT01702519|728399|P2|COMPLETED|Period 1||20
304615|NCT01702519|728400|P1|COMPLETED|Period 1||20
304616|NCT01702519|728399|P2|STARTED|Period 1||20
304617|NCT01702519|728400|P1|STARTED|Period 1||20
304618|NCT01702454|728418|P2|NOT COMPLETED|Overall Study||8
304619|NCT01702454|728419|P1|NOT COMPLETED|Overall Study||3
304620|NCT01702454|728418|P2|COMPLETED|Overall Study||221
304621|NCT01702454|728419|P1|COMPLETED|Overall Study||238
304622|NCT01702454|728418|P2|STARTED|Overall Study||229
304623|NCT01702454|728419|P1|STARTED|Overall Study||241
304624|NCT01702363|728497|P1|NOT COMPLETED|Overall Study||20
304625|NCT01702363|728497|P1|COMPLETED|Overall Study||111
304626|NCT01702363|728497|P1|STARTED|Overall Study||131
304627|NCT01702311|728514|P2|NOT COMPLETED|Overall Study||13
304628|NCT01702311|728515|P1|NOT COMPLETED|Overall Study||16
304629|NCT01702311|728514|P2|COMPLETED|Overall Study||100
304630|NCT01702311|728515|P1|COMPLETED|Overall Study||106
304631|NCT01702311|728514|P2|STARTED|Overall Study||113
304632|NCT01702311|728515|P1|STARTED|Overall Study||122
304633|NCT01702298|728521|P1|NOT COMPLETED|Overall Study||1
304634|NCT01702298|728521|P1|COMPLETED|Overall Study||41
304635|NCT01702298|728521|P1|STARTED|Overall Study||42
304636|NCT01702259|728534|P2|NOT COMPLETED|Overall Study||0
304637|NCT01702259|728535|P1|NOT COMPLETED|Overall Study||0
304638|NCT01702259|728534|P2|COMPLETED|Overall Study||34
304639|NCT01702259|728535|P1|COMPLETED|Overall Study||34
304640|NCT01702259|728534|P2|STARTED|Overall Study||34
304641|NCT01702259|728535|P1|STARTED|Overall Study||34
304642|NCT01702246|728549|P1|NOT COMPLETED|Overall Study||5
304643|NCT01702246|728549|P1|COMPLETED|Overall Study||19
304644|NCT01702246|728549|P1|STARTED|Overall Study||24
304645|NCT01702233|728561|P3|NOT COMPLETED|Overall Study||5
304646|NCT01702233|728562|P2|NOT COMPLETED|Overall Study||3
304647|NCT01702233|728563|P1|NOT COMPLETED|Overall Study||6
304648|NCT01702233|728561|P3|COMPLETED|Overall Study||31
304649|NCT01702233|728562|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
304650|NCT01702233|728563|P1|COMPLETED|Overall Study||66
304651|NCT01702233|728561|P3|Per Protocol Set|Overall Study||27
304652|NCT01702233|728562|P2|Per Protocol Set|Overall Study||58
304653|NCT01702233|728563|P1|Per Protocol Set|Overall Study||58
304654|NCT01702233|728561|P3|Full Analysis Set (ITT)|Overall Study||31
304655|NCT01702233|728562|P2|Full Analysis Set (ITT)|Overall Study||63
304656|NCT01702233|728563|P1|Full Analysis Set (ITT)|Overall Study||66
304657|NCT01702233|728561|P3|STARTED|Overall Study||36
304658|NCT01702233|728562|P2|STARTED|Overall Study||67
304659|NCT01702233|728563|P1|STARTED|Overall Study||72
304660|NCT01702025|728603|P4|NOT COMPLETED|Overall Study||0
304661|NCT01702025|728604|P3|NOT COMPLETED|Overall Study||1
304662|NCT01702025|728605|P2|NOT COMPLETED|Overall Study||1
304663|NCT01702025|728606|P1|NOT COMPLETED|Overall Study||2
304664|NCT01702025|728603|P4|COMPLETED|Overall Study||10
304665|NCT01702025|728604|P3|COMPLETED|Overall Study||9
304666|NCT01702025|728605|P2|COMPLETED|Overall Study||9
304667|NCT01702025|728606|P1|COMPLETED|Overall Study||9
304668|NCT01702025|728603|P4|STARTED|Overall Study||10
304669|NCT01702025|728604|P3|STARTED|Overall Study||10
304670|NCT01702025|728605|P2|STARTED|Overall Study||10
304671|NCT01702025|728606|P1|STARTED|Overall Study||11
304672|NCT01701999|728622|P2|NOT COMPLETED|Overall Study||0
304673|NCT01701999|728623|P1|NOT COMPLETED|Overall Study||0
304674|NCT01701999|728622|P2|COMPLETED|Overall Study||37
304675|NCT01701999|728623|P1|COMPLETED|Overall Study||8
304676|NCT01701999|728622|P2|STARTED|Overall Study||37
304677|NCT01701999|728623|P1|STARTED|Overall Study||8
304678|NCT01701674|728635|P1|NOT COMPLETED|Overall Study||1
304679|NCT01701674|728635|P1|COMPLETED|Overall Study||12
304680|NCT01701674|728635|P1|STARTED|Overall Study||13
304681|NCT01701622|728640|P1|NOT COMPLETED|Overall Study||0
304682|NCT01701622|728640|P1|COMPLETED|Overall Study||1
304683|NCT01701622|728640|P1|STARTED|Overall Study||1
304684|NCT01701414|728647|P2|NOT COMPLETED|Overall Study||1
304685|NCT01701414|728648|P1|NOT COMPLETED|Overall Study||1
304686|NCT01701414|728647|P2|COMPLETED|Overall Study||18
304687|NCT01701414|728648|P1|COMPLETED|Overall Study||18
304688|NCT01701414|728647|P2|STARTED|Overall Study||19
304689|NCT01701414|728648|P1|STARTED|Overall Study||19
304690|NCT01701401|728658|P4|NOT COMPLETED|Overall Study||6
304691|NCT01701401|728659|P3|NOT COMPLETED|Overall Study||5
304692|NCT01701401|728660|P2|NOT COMPLETED|Overall Study||9
304693|NCT01701401|728661|P1|NOT COMPLETED|Overall Study||10
304694|NCT01701401|728658|P4|COMPLETED|Overall Study||212
304695|NCT01701401|728659|P3|COMPLETED|Overall Study||212
304696|NCT01701401|728660|P2|COMPLETED|Overall Study||209
304697|NCT01701401|728661|P1|COMPLETED|Overall Study||207
304698|NCT01701401|728658|P4|STARTED|Overall Study||218
304699|NCT01701401|728659|P3|STARTED|Overall Study||217
304700|NCT01701401|728660|P2|STARTED|Overall Study||218
304701|NCT01701401|728661|P1|STARTED|Overall Study||217
304702|NCT01701375|728707|P1|NOT COMPLETED|Overall Study||0
304703|NCT01701375|728707|P1|COMPLETED|Overall Study||2
304704|NCT01701375|728707|P1|STARTED|Overall Study||2
304705|NCT01701362|728713|P2|NOT COMPLETED|Overall Study||56
304706|NCT01701362|728714|P1|NOT COMPLETED|Overall Study||42
304707|NCT01701362|728713|P2|COMPLETED|Overall Study||211
304708|NCT01701362|728714|P1|COMPLETED|Overall Study||233
304709|NCT01701362|728713|P2|TREATED|Overall Study||265
304710|NCT01701362|728714|P1|TREATED|Overall Study||274
304711|NCT01701362|728713|P2|STARTED|Overall Study||267
304712|NCT01701362|728714|P1|STARTED|Overall Study||275
304713|NCT01701271|728742|P1|NOT COMPLETED|Overall Study||0
304714|NCT01701271|728742|P1|COMPLETED|Overall Study||20
304715|NCT01701271|728742|P1|STARTED|Overall Study||20
304716|NCT01701245|728750|P2|NOT COMPLETED|Overall Study||15
304717|NCT01701245|728751|P1|NOT COMPLETED|Overall Study||12
304718|NCT01701245|728750|P2|COMPLETED|Overall Study||33
304719|NCT01701245|728751|P1|COMPLETED|Overall Study||37
304720|NCT01701245|728750|P2|FAS Matched Data|Overall Study||32
304721|NCT01701245|728751|P1|FAS Matched Data|Overall Study||42
304722|NCT01701245|728750|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
304723|NCT01701245|728751|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
304724|NCT01701245|728750|P2|STARTED|Overall Study||48
304725|NCT01701245|728751|P1|STARTED|Overall Study||49
304726|NCT01701102|728767|P4|NOT COMPLETED|Overall Study||0
304727|NCT01701102|728768|P3|NOT COMPLETED|Overall Study||0
304728|NCT01701102|728769|P2|NOT COMPLETED|Overall Study||0
304729|NCT01701102|728770|P1|NOT COMPLETED|Overall Study||0
304730|NCT01701102|728767|P4|COMPLETED|Overall Study||18
304731|NCT01701102|728768|P3|COMPLETED|Overall Study||10
304732|NCT01701102|728769|P2|COMPLETED|Overall Study||6
304733|NCT01701102|728770|P1|COMPLETED|Overall Study||22
304734|NCT01701102|728767|P4|STARTED|Overall Study||18
304735|NCT01701102|728768|P3|STARTED|Overall Study||10
304736|NCT01701102|728769|P2|STARTED|Overall Study||6
304737|NCT01701102|728770|P1|STARTED|Overall Study||22
304738|NCT01701063|728783|P3|NOT COMPLETED|Overall Study||2
304739|NCT01701063|728784|P2|NOT COMPLETED|Overall Study||1
304740|NCT01701063|728785|P1|NOT COMPLETED|Overall Study||0
304741|NCT01701063|728783|P3|COMPLETED|Overall Study||8
304742|NCT01701063|728784|P2|COMPLETED|Overall Study||18
304743|NCT01701063|728785|P1|COMPLETED|Overall Study||13
304744|NCT01701063|728783|P3|STARTED|Overall Study||10
304745|NCT01701063|728784|P2|STARTED|Overall Study||19
304746|NCT01701063|728785|P1|STARTED|Overall Study||13
304747|NCT01701024|728829|P2|NOT COMPLETED|Overall Study||9
304748|NCT01701024|728830|P1|NOT COMPLETED|Overall Study||10
304749|NCT01701024|728829|P2|COMPLETED|Overall Study||236
304750|NCT01701024|728830|P1|COMPLETED|Overall Study||243
304751|NCT01701024|728829|P2|STARTED|Overall Study||245
304752|NCT01701024|728830|P1|STARTED|Overall Study||253
304753|NCT01701011|728845|P3|NOT COMPLETED|Overall Study||34
304754|NCT01701011|728846|P2|NOT COMPLETED|Overall Study||24
304755|NCT01701011|728847|P1|NOT COMPLETED|Overall Study||35
304756|NCT01701011|728845|P3|COMPLETED|Overall Study||90
304757|NCT01701011|728846|P2|COMPLETED|Overall Study||102
304758|NCT01701011|728847|P1|COMPLETED|Overall Study||92
304759|NCT01701011|728845|P3|STARTED|Overall Study||124
304760|NCT01701011|728846|P2|STARTED|Overall Study||126
304761|NCT01701011|728847|P1|STARTED|Overall Study||127
304762|NCT01700907|728860|P2|NOT COMPLETED|Overall Study||0
304763|NCT01700907|728861|P1|NOT COMPLETED|Overall Study||0
304764|NCT01700907|728860|P2|COMPLETED|Overall Study||10
304765|NCT01700907|728861|P1|COMPLETED|Overall Study||10
304766|NCT01700907|728860|P2|STARTED|Overall Study||10
304767|NCT01700907|728861|P1|STARTED|Overall Study||10
304768|NCT01699698|728877|P2|NOT COMPLETED|Overall Study||5
304769|NCT01699698|728878|P1|NOT COMPLETED|Overall Study||2
304770|NCT01699698|728877|P2|COMPLETED|Overall Study||56
304771|NCT01699698|728878|P1|COMPLETED|Overall Study||42
304772|NCT01699698|728877|P2|STARTED|Overall Study||61
304773|NCT01699698|728878|P1|STARTED|Overall Study||44
304774|NCT01699685|728888|P2|NOT COMPLETED|Period 2||0
304775|NCT01699685|728889|P1|NOT COMPLETED|Period 2||1
304776|NCT01699685|728888|P2|COMPLETED|Period 2||36
304777|NCT01699685|728889|P1|COMPLETED|Period 2||35
304778|NCT01699685|728888|P2|STARTED|Period 2||36
304779|NCT01699685|728889|P1|STARTED|Period 2||36
304780|NCT01699685|728888|P2|NOT COMPLETED|Period 1||3
304781|NCT01699685|728889|P1|NOT COMPLETED|Period 1||3
304782|NCT01699685|728888|P2|COMPLETED|Period 1||36
304783|NCT01699685|728889|P1|COMPLETED|Period 1||36
304784|NCT01699685|728888|P2|Full Analysis Population (FAS)|Period 1||38
304785|NCT01699685|728889|P1|Full Analysis Population (FAS)|Period 1||38
304786|NCT01699685|728888|P2|Safety Population|Period 1||38
304787|NCT01699685|728889|P1|Safety Population|Period 1||39
304788|NCT01699685|728888|P2|STARTED|Period 1||39
304789|NCT01699685|728889|P1|STARTED|Period 1||39
304790|NCT01699607|728907|P2|NOT COMPLETED|Overall Study||0
304791|NCT01699607|728908|P1|NOT COMPLETED|Overall Study||0
304792|NCT01699607|728907|P2|COMPLETED|Overall Study||4
304793|NCT01699607|728908|P1|COMPLETED|Overall Study||6
304794|NCT01699607|728907|P2|STARTED|Overall Study||4
304795|NCT01699607|728908|P1|STARTED|Overall Study||6
304796|NCT01700530|728916|P3|NOT COMPLETED|Overall Study||1
304797|NCT01700530|728917|P2|NOT COMPLETED|Overall Study||3
304798|NCT01700530|728918|P1|NOT COMPLETED|Overall Study||0
304799|NCT01700530|728916|P3|COMPLETED|Overall Study||19
304800|NCT01700530|728917|P2|COMPLETED|Overall Study||18
304801|NCT01700530|728918|P1|COMPLETED|Overall Study||9
304802|NCT01700530|728916|P3|STARTED|Overall Study||20
304803|NCT01700530|728917|P2|STARTED|Overall Study||21
304804|NCT01700530|728918|P1|STARTED|Overall Study||9
304805|NCT01700517|728932|P3|NOT COMPLETED|Overall Study||0
304806|NCT01700517|728933|P2|NOT COMPLETED|Overall Study||0
304807|NCT01700517|728934|P1|NOT COMPLETED|Overall Study||0
304808|NCT01700517|728932|P3|COMPLETED|Overall Study||40
304809|NCT01700517|728933|P2|COMPLETED|Overall Study||40
304810|NCT01700517|728934|P1|COMPLETED|Overall Study||40
304811|NCT01700517|728932|P3|STARTED|Overall Study||40
304812|NCT01700517|728933|P2|STARTED|Overall Study||40
304813|NCT01700517|728934|P1|STARTED|Overall Study||40
304814|NCT01700387|728944|P2|NOT COMPLETED|Overall Study||4
304815|NCT01700387|728945|P1|NOT COMPLETED|Overall Study||4
304816|NCT01700387|728944|P2|COMPLETED|Overall Study||6
304817|NCT01700387|728945|P1|COMPLETED|Overall Study||6
304818|NCT01700387|728944|P2|STARTED|Overall Study||10
304819|NCT01700387|728945|P1|STARTED|Overall Study||10
304820|NCT01700348|728955|P1|NOT COMPLETED|Overall Study||23
304821|NCT01700348|728955|P1|COMPLETED|Overall Study||93
304822|NCT01700348|728955|P1|STARTED|Overall Study||116
304823|NCT01700335|728959|P2|NOT COMPLETED|Overall Study||4
304824|NCT01700335|728960|P1|NOT COMPLETED|Overall Study||1
304825|NCT01700335|728959|P2|COMPLETED|Overall Study||2
304826|NCT01700335|728960|P1|COMPLETED|Overall Study||2
304827|NCT01700335|728959|P2|STARTED|Overall Study||6
304828|NCT01700335|728960|P1|STARTED|Overall Study||3
304829|NCT01700192|728973|P2|NOT COMPLETED|Overall Study||128
304830|NCT01700192|728974|P1|NOT COMPLETED|Overall Study||180
304831|NCT01700192|728973|P2|COMPLETED|Overall Study||613
304832|NCT01700192|728974|P1|COMPLETED|Overall Study||561
304833|NCT01700192|728973|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
304834|NCT01700192|728974|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
304835|NCT01700192|728973|P2|Treated|Overall Study||741
304836|NCT01700192|728974|P1|Treated|Overall Study||740
304837|NCT01700192|728973|P2|STARTED|Overall Study||741
304838|NCT01700192|728974|P1|STARTED|Overall Study||741
304839|NCT01700179|728992|P1|NOT COMPLETED|Overall Study||2
304840|NCT01700179|728992|P1|COMPLETED|Overall Study||6
304841|NCT01700179|728992|P1|STARTED|Overall Study||8
304842|NCT01700140|728999|P3|NOT COMPLETED|Overall Study||1
304843|NCT01700140|729000|P2|NOT COMPLETED|Overall Study||9
304844|NCT01700140|729001|P1|NOT COMPLETED|Overall Study||6
304845|NCT01700140|728999|P3|COMPLETED|Overall Study||61
304846|NCT01700140|729000|P2|COMPLETED|Overall Study||57
304847|NCT01700140|729001|P1|COMPLETED|Overall Study||55
304848|NCT01700140|728999|P3|STARTED|Overall Study||62
304849|NCT01700140|729000|P2|STARTED|Overall Study||66
304850|NCT01700140|729001|P1|STARTED|Overall Study||61
304851|NCT01699867|729033|P1|NOT COMPLETED|Overall Study||3
304852|NCT01699867|729033|P1|COMPLETED|Overall Study||47
304853|NCT01699867|729033|P1|STARTED|Overall Study||50
304854|NCT01699815|729040|P2|NOT COMPLETED|Overall Study||8
304855|NCT01699815|729041|P1|NOT COMPLETED|Overall Study||5
304856|NCT01699815|729040|P2|COMPLETED|Overall Study||56
304857|NCT01699815|729041|P1|COMPLETED|Overall Study||57
304858|NCT01699815|729040|P2|STARTED|Overall Study||64
304859|NCT01699815|729041|P1|STARTED|Overall Study||62
304860|NCT01699789|729053|P2|NOT COMPLETED|Overall Study||126
304861|NCT01699789|729054|P1|NOT COMPLETED|Overall Study||102
304862|NCT01699789|729053|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
304863|NCT01699789|729054|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
304864|NCT01699789|729053|P2|12-Month Follow-Up|Overall Study||369
304865|NCT01699789|729054|P1|12-Month Follow-Up|Overall Study||364
304866|NCT01699789|729053|P2|6-Month Follow-Up|Overall Study||379
304867|NCT01699789|729054|P1|6-Month Follow-Up|Overall Study||380
304868|NCT01699789|729053|P2|Baseline|Overall Study||488
304869|NCT01699789|729054|P1|Baseline|Overall Study||492
304870|NCT01699789|729053|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
304871|NCT01699789|729054|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
304872|NCT01699763|729116|P1|NOT COMPLETED|Overall Study||0
304873|NCT01699763|729116|P1|COMPLETED|Overall Study||112
304874|NCT01699763|729116|P1|STARTED|Overall Study||112
304875|NCT01699750|729124|P2|NOT COMPLETED|Overall Study||3
304876|NCT01699750|729125|P1|NOT COMPLETED|Overall Study||0
304877|NCT01699750|729124|P2|COMPLETED|Overall Study||33
304878|NCT01699750|729125|P1|COMPLETED|Overall Study||34
304879|NCT01699750|729124|P2|STARTED|Overall Study||36
304880|NCT01699750|729125|P1|STARTED|Overall Study||34
304881|NCT01699373|729149|P2|NOT COMPLETED|Overall Study||0
304882|NCT01699373|729150|P1|NOT COMPLETED|Overall Study||0
304883|NCT01699373|729149|P2|COMPLETED|Overall Study||85
304884|NCT01699373|729150|P1|COMPLETED|Overall Study||85
304885|NCT01699373|729149|P2|STARTED|Overall Study||85
304886|NCT01699373|729150|P1|STARTED|Overall Study||85
304887|NCT01699087|729156|P1|NOT COMPLETED|Overall Study||24
304888|NCT01699087|729156|P1|COMPLETED|Overall Study||152
304889|NCT01699087|729156|P1|Treated|Overall Study||161
304890|NCT01699087|729156|P1|STARTED|Overall Study||176
304891|NCT01699022|729170|P1|NOT COMPLETED|Overall Study||3
304892|NCT01699022|729170|P1|COMPLETED|Overall Study||14
304893|NCT01699022|729170|P1|STARTED|Overall Study||17
304894|NCT01698814|729185|P2|NOT COMPLETED|Overall Study||3
304895|NCT01698814|729186|P1|NOT COMPLETED|Overall Study||2
304896|NCT01698814|729185|P2|COMPLETED|Overall Study||166
304897|NCT01698814|729186|P1|COMPLETED|Overall Study||329
304898|NCT01698814|729185|P2|STARTED|Overall Study||169
304899|NCT01698814|729186|P1|STARTED|Overall Study||331
304900|NCT01698801|729192|P1|NOT COMPLETED|Follow Up Phase||5
304901|NCT01698801|729192|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
304902|NCT01698801|729192|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
304903|NCT01698801|729192|P1|NOT COMPLETED|Treatment Phase||11
304904|NCT01698801|729192|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
304905|NCT01698801|729192|P1|STARTED|Treatment Phase||26
304906|NCT01698775|729203|P2|NOT COMPLETED|Phase B||11
304907|NCT01698775|729204|P1|NOT COMPLETED|Phase B||14
304908|NCT01698775|729203|P2|COMPLETED|Phase B||86
304909|NCT01698775|729204|P1|COMPLETED|Phase B||84
304910|NCT01698775|729203|P2|STARTED|Phase B||97
304911|NCT01698775|729204|P1|STARTED|Phase B||98
304912|NCT01698775|729203|P2|NOT COMPLETED|Phase A||9
304913|NCT01698775|729204|P1|NOT COMPLETED|Phase A||9
304914|NCT01698775|729203|P2|COMPLETED|Phase A||97
304915|NCT01698775|729204|P1|COMPLETED|Phase A||98
304916|NCT01698775|729203|P2|STARTED|Phase A||106
304917|NCT01698775|729204|P1|STARTED|Phase A||107
304918|NCT01698684|729233|P3|NOT COMPLETED|Overall Study||21
304919|NCT01698684|729234|P2|NOT COMPLETED|Overall Study||23
304920|NCT01698684|729235|P1|NOT COMPLETED|Overall Study||29
304921|NCT01698684|729233|P3|COMPLETED|Overall Study||127
304922|NCT01698684|729234|P2|COMPLETED|Overall Study||124
304923|NCT01698684|729235|P1|COMPLETED|Overall Study||116
304924|NCT01698684|729233|P3|Safety Population|Overall Study||146
304925|NCT01698684|729234|P2|Safety Population|Overall Study||146
304926|NCT01698684|729235|P1|Safety Population|Overall Study||143
304927|NCT01698684|729233|P3|ITT Population|Overall Study||139
304928|NCT01698684|729234|P2|ITT Population|Overall Study||139
304929|NCT01698684|729235|P1|ITT Population|Overall Study||136
304930|NCT01698684|729233|P3|STARTED|Overall Study||148
304931|NCT01698684|729234|P2|STARTED|Overall Study||147
304932|NCT01698684|729235|P1|STARTED|Overall Study||145
304933|NCT01698554|729247|P4|NOT COMPLETED|Overall Study||2
304934|NCT01698554|729248|P3|NOT COMPLETED|Overall Study||2
304935|NCT01698554|729249|P2|NOT COMPLETED|Overall Study||10
304936|NCT01698554|729250|P1|NOT COMPLETED|Overall Study||6
304937|NCT01698554|729247|P4|COMPLETED|Overall Study||77
304938|NCT01698554|729248|P3|COMPLETED|Overall Study||73
304939|NCT01698554|729249|P2|COMPLETED|Overall Study||147
304940|NCT01698554|729250|P1|COMPLETED|Overall Study||147
304941|NCT01698554|729247|P4|STARTED|Overall Study||79
304942|NCT01698554|729248|P3|STARTED|Overall Study||75
304943|NCT01698554|729249|P2|STARTED|Overall Study||157
304944|NCT01698554|729250|P1|STARTED|Overall Study||153
304945|NCT01698502|729278|P2|NOT COMPLETED|Overall Study||0
304946|NCT01698502|729279|P1|NOT COMPLETED|Overall Study||0
304947|NCT01698502|729278|P2|COMPLETED|Overall Study||10
304948|NCT01698502|729279|P1|COMPLETED|Overall Study||11
304949|NCT01698502|729278|P2|STARTED|Overall Study||10
304950|NCT01698502|729279|P1|STARTED|Overall Study||11
304951|NCT01698320|729289|P3|NOT COMPLETED|40-Week Open-Label Period||10
304952|NCT01698320|729290|P2|NOT COMPLETED|40-Week Open-Label Period||19
304953|NCT01698320|729291|P1|NOT COMPLETED|40-Week Open-Label Period||0
304954|NCT01698320|729289|P3|COMPLETED|40-Week Open-Label Period||146
304955|NCT01698320|729290|P2|COMPLETED|40-Week Open-Label Period||146
304956|NCT01698320|729291|P1|COMPLETED|40-Week Open-Label Period||0
304957|NCT01698320|729289|P3|STARTED|40-Week Open-Label Period||156
304958|NCT01698320|729290|P2|STARTED|40-Week Open-Label Period||165
304959|NCT01698320|729291|P1|STARTED|40-Week Open-Label Period||0
304960|NCT01698320|729289|P3|NOT COMPLETED|12-Week Double-Blind Period||12
304961|NCT01698320|729290|P2|NOT COMPLETED|12-Week Double-Blind Period||4
304962|NCT01698320|729291|P1|NOT COMPLETED|12-Week Double-Blind Period||0
304963|NCT01698320|729289|P3|COMPLETED|12-Week Double-Blind Period||156
304964|NCT01698320|729290|P2|COMPLETED|12-Week Double-Blind Period||165
304965|NCT01698320|729291|P1|COMPLETED|12-Week Double-Blind Period||0
304966|NCT01698320|729289|P3|Safety Population|12-Week Double-Blind Period||168
304967|NCT01698320|729290|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
304968|NCT01698320|729291|P1|Safety Population|12-Week Double-Blind Period||0
304969|NCT01698320|729289|P3|STARTED|12-Week Double-Blind Period||168
304970|NCT01698320|729290|P2|STARTED|12-Week Double-Blind Period||169
304971|NCT01698320|729291|P1|STARTED|12-Week Double-Blind Period||0
304972|NCT01698320|729289|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
304973|NCT01698320|729290|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
304974|NCT01698320|729291|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
304975|NCT01698320|729289|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
304976|NCT01698320|729290|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
304977|NCT01698320|729291|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
304978|NCT01698320|729289|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
304979|NCT01698320|729290|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
304980|NCT01698320|729291|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
304981|NCT01697969|729309|P1|NOT COMPLETED|Overall Study||3
304982|NCT01697969|729309|P1|COMPLETED|Overall Study||10
304983|NCT01697969|729309|P1|STARTED|Overall Study||13
304984|NCT01697956|729316|P2|NOT COMPLETED|Overall Study||1
304985|NCT01697956|729317|P1|NOT COMPLETED|Overall Study||1
304986|NCT01697956|729316|P2|COMPLETED|Overall Study||31
304987|NCT01697956|729317|P1|COMPLETED|Overall Study||66
304988|NCT01697956|729316|P2|Per Protocol Population|Overall Study||31
304989|NCT01697956|729317|P1|Per Protocol Population|Overall Study||66
304990|NCT01697956|729316|P2|STARTED|Overall Study|enrolled and randomized|32
304991|NCT01697956|729317|P1|STARTED|Overall Study|enrolled and randomized|67
304992|NCT01697696|729347|P2|NOT COMPLETED|Overall Study||47
304993|NCT01697696|729348|P1|NOT COMPLETED|Overall Study||47
304994|NCT01697696|729347|P2|COMPLETED|Overall Study||210
304995|NCT01697696|729348|P1|COMPLETED|Overall Study||207
304996|NCT01697696|729347|P2|Full Analysis Set (FAS)|Overall Study||255
304997|NCT01697696|729348|P1|Full Analysis Set (FAS)|Overall Study||251
304998|NCT01697696|729347|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
304999|NCT01697696|729348|P1|Safety Set|Overall Study||251
305000|NCT01697696|729347|P2|STARTED|Overall Study||257
305001|NCT01697696|729348|P1|STARTED|Overall Study||254
305002|NCT01697592|729380|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
305003|NCT01697592|729381|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
305004|NCT01697592|729382|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
305005|NCT01697592|729383|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
305006|NCT01697592|729384|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
305007|NCT01697592|729385|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
305008|NCT01697592|729386|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
305009|NCT01697592|729387|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
305010|NCT01697592|729388|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
305011|NCT01697592|729389|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
305012|NCT01697592|729380|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
305013|NCT01697592|729381|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
305014|NCT01697592|729382|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
305015|NCT01697592|729383|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
305016|NCT01697592|729384|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
305017|NCT01697592|729385|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
305018|NCT01697592|729386|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
305019|NCT01697592|729387|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
305020|NCT01697592|729388|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
305021|NCT01697592|729389|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
305022|NCT01697592|729380|P10|STARTED|Phase B (Week 25 to Week 52)||30
305023|NCT01697592|729381|P9|STARTED|Phase B (Week 25 to Week 52)||34
305024|NCT01697592|729382|P8|STARTED|Phase B (Week 25 to Week 52)||33
305025|NCT01697592|729383|P7|STARTED|Phase B (Week 25 to Week 52)||32
305026|NCT01697592|729384|P6|STARTED|Phase B (Week 25 to Week 52)||62
305027|NCT01697592|729385|P5|STARTED|Phase B (Week 25 to Week 52)||67
305028|NCT01697592|729386|P4|STARTED|Phase B (Week 25 to Week 52)||63
305029|NCT01697592|729387|P3|STARTED|Phase B (Week 25 to Week 52)||65
305030|NCT01697592|729388|P2|STARTED|Phase B (Week 25 to Week 52)||62
305031|NCT01697592|729389|P1|STARTED|Phase B (Week 25 to Week 52)||123
305032|NCT01697592|729380|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
305033|NCT01697592|729381|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
305034|NCT01697592|729382|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
305035|NCT01697592|729383|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
305036|NCT01697592|729384|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
305037|NCT01697592|729385|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
305038|NCT01697592|729386|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
305039|NCT01697592|729387|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
305040|NCT01697592|729388|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
305041|NCT01697592|729389|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
305042|NCT01697592|729380|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
305043|NCT01697592|729381|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
305044|NCT01697592|729382|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
305045|NCT01697592|729383|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
305046|NCT01697592|729384|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
305047|NCT01697592|729385|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
305048|NCT01697592|729386|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
305049|NCT01697592|729387|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
305050|NCT01697592|729388|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
305051|NCT01697592|729389|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
305052|NCT01697592|729380|P10|STARTED|Phase A (Up to 24 Weeks)||32
305053|NCT01697592|729381|P9|STARTED|Phase A (Up to 24 Weeks)||34
305054|NCT01697592|729382|P8|STARTED|Phase A (Up to 24 Weeks)||33
305055|NCT01697592|729383|P7|STARTED|Phase A (Up to 24 Weeks)||34
305056|NCT01697592|729384|P6|STARTED|Phase A (Up to 24 Weeks)||63
305057|NCT01697592|729385|P5|STARTED|Phase A (Up to 24 Weeks)||67
305058|NCT01697592|729386|P4|STARTED|Phase A (Up to 24 Weeks)||65
305059|NCT01697592|729387|P3|STARTED|Phase A (Up to 24 Weeks)||66
305060|NCT01697592|729388|P2|STARTED|Phase A (Up to 24 Weeks)||65
305061|NCT01697592|729389|P1|STARTED|Phase A (Up to 24 Weeks)||126
305062|NCT01697501|729453|P1|NOT COMPLETED|Overall Study||2
305063|NCT01697501|729453|P1|COMPLETED|Overall Study||86
305064|NCT01697501|729453|P1|STARTED|Overall Study||88
305065|NCT01697462|729496|P1|NOT COMPLETED|Overall Study||77
305066|NCT01697462|729496|P1|COMPLETED|Overall Study||181
305067|NCT01697462|729496|P1|STARTED|Overall Study||258
305068|NCT01697449|729503|P1|NOT COMPLETED|Overall Study||90
305069|NCT01697449|729503|P1|COMPLETED|Overall Study||101
305070|NCT01697449|729503|P1|STARTED|Overall Study||191
305071|NCT01697358|729514|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
305072|NCT01697358|729515|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
305073|NCT01697358|729514|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
305074|NCT01697358|729515|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
305075|NCT01697358|729514|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
305076|NCT01697358|729515|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
305077|NCT01697358|729514|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
305078|NCT01697358|729515|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
305079|NCT01697358|729514|P2|COMPLETED|Period I: Randomization to 6 Months||107
305080|NCT01697358|729515|P1|COMPLETED|Period I: Randomization to 6 Months||97
305081|NCT01697358|729514|P2|STARTED|Period I: Randomization to 6 Months||108
305082|NCT01697358|729515|P1|STARTED|Period I: Randomization to 6 Months||110
305083|NCT01697345|729531|P1|NOT COMPLETED|Overall Study||1
305084|NCT01697345|729531|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
305085|NCT01697345|729531|P1|STARTED|Overall Study||13
305086|NCT01697319|729550|P1|NOT COMPLETED|Extension Phase||15
305087|NCT01697319|729550|P1|COMPLETED|Extension Phase||0
305088|NCT01697319|729550|P1|STARTED|Extension Phase||15
305089|NCT01697319|729550|P1|NOT COMPLETED|Primary Phase||1
305090|NCT01697319|729550|P1|COMPLETED|Primary Phase||15
305091|NCT01697319|729550|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
305092|NCT01696994|729559|P2|NOT COMPLETED|Overall Study||8437
305093|NCT01696994|729560|P1|NOT COMPLETED|Overall Study||5192
305094|NCT01696994|729559|P2|COMPLETED|Overall Study||30668
305095|NCT01696994|729560|P1|COMPLETED|Overall Study||33919
305096|NCT01696994|729559|P2|STARTED|Overall Study||39105
305097|NCT01696994|729560|P1|STARTED|Overall Study||39111
305098|NCT01696981|729588|P2|NOT COMPLETED|Overall Study||10374
305099|NCT01696981|729589|P1|NOT COMPLETED|Overall Study||1201
305100|NCT01696981|729588|P2|COMPLETED|Overall Study||67071
305101|NCT01696981|729589|P1|COMPLETED|Overall Study||76254
305102|NCT01696981|729588|P2|STARTED|Overall Study||77445
305103|NCT01696981|729589|P1|STARTED|Overall Study||77455
305104|NCT01696968|729609|P2|NOT COMPLETED|Overall Study||6812
305105|NCT01696968|729610|P1|NOT COMPLETED|Overall Study||1201
305106|NCT01696968|729609|P2|COMPLETED|Overall Study||70633
305107|NCT01696968|729610|P1|COMPLETED|Overall Study||76255
305108|NCT01696968|729609|P2|STARTED|Overall Study||77445
305109|NCT01696968|729610|P1|STARTED|Overall Study||77456
305110|NCT01696929|729630|P1|NOT COMPLETED|Overall Study||1
305111|NCT01696929|729630|P1|COMPLETED|Overall Study||5
305112|NCT01696929|729630|P1|STARTED|Overall Study||6
305113|NCT01696773|729637|P2|NOT COMPLETED|Day 28, Second Intervention||0
305114|NCT01696773|729638|P1|NOT COMPLETED|Day 28, Second Intervention||0
305115|NCT01696773|729637|P2|COMPLETED|Day 28, Second Intervention||6
305116|NCT01696773|729638|P1|COMPLETED|Day 28, Second Intervention||5
305117|NCT01696773|729637|P2|STARTED|Day 28, Second Intervention||6
305118|NCT01696773|729638|P1|STARTED|Day 28, Second Intervention||5
305119|NCT01696773|729637|P2|NOT COMPLETED|Days 15-27, Washout||0
305120|NCT01696773|729638|P1|NOT COMPLETED|Days 15-27, Washout||1
305121|NCT01696773|729637|P2|COMPLETED|Days 15-27, Washout||6
305122|NCT01696773|729638|P1|COMPLETED|Days 15-27, Washout||5
305123|NCT01696773|729637|P2|STARTED|Days 15-27, Washout||6
305124|NCT01696773|729638|P1|STARTED|Days 15-27, Washout||6
305125|NCT01696773|729637|P2|NOT COMPLETED|Day 14, First Intervention||0
305126|NCT01696773|729638|P1|NOT COMPLETED|Day 14, First Intervention||0
305127|NCT01696773|729637|P2|COMPLETED|Day 14, First Intervention||6
305128|NCT01696773|729638|P1|COMPLETED|Day 14, First Intervention||6
305129|NCT01696773|729637|P2|STARTED|Day 14, First Intervention||6
305130|NCT01696773|729638|P1|STARTED|Day 14, First Intervention||6
305131|NCT01696773|729637|P2|NOT COMPLETED|Days 1-13, Washout||0
305132|NCT01696773|729638|P1|NOT COMPLETED|Days 1-13, Washout||0
305133|NCT01696773|729637|P2|COMPLETED|Days 1-13, Washout||6
305134|NCT01696773|729638|P1|COMPLETED|Days 1-13, Washout||6
305135|NCT01696773|729637|P2|STARTED|Days 1-13, Washout||6
305136|NCT01696773|729638|P1|STARTED|Days 1-13, Washout||6
305137|NCT01696760|729646|P2|NOT COMPLETED|Overall Study||0
305138|NCT01696760|729647|P1|NOT COMPLETED|Overall Study||0
305139|NCT01696760|729646|P2|COMPLETED|Overall Study||3
305140|NCT01696760|729647|P1|COMPLETED|Overall Study||9
305141|NCT01696760|729646|P2|STARTED|Overall Study||3
305142|NCT01696760|729647|P1|STARTED|Overall Study||9
305143|NCT01696695|729665|P1|NOT COMPLETED|Overall Study||882
305144|NCT01696695|729665|P1|COMPLETED|Overall Study||0
305145|NCT01696695|729665|P1|STARTED|Overall Study||882
305146|NCT01696643|729677|P2|NOT COMPLETED|Overall Study||535
305147|NCT01696643|729678|P1|NOT COMPLETED|Overall Study||529
305148|NCT01696643|729677|P2|COMPLETED|Overall Study||169
305149|NCT01696643|729678|P1|COMPLETED|Overall Study||174
305150|NCT01696643|729677|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
305151|NCT01696643|729678|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
305152|NCT01696643|729677|P2|STARTED|Overall Study||704
305153|NCT01696643|729678|P1|STARTED|Overall Study||703
305154|NCT01696357|729695|P2|NOT COMPLETED|Overall Study||1
305155|NCT01696357|729696|P1|NOT COMPLETED|Overall Study||2
305156|NCT01696357|729695|P2|COMPLETED|Overall Study||41
305157|NCT01696357|729696|P1|COMPLETED|Overall Study||40
305158|NCT01696357|729695|P2|STARTED|Overall Study||42
305159|NCT01696357|729696|P1|STARTED|Overall Study||42
305160|NCT01696214|729706|P4|NOT COMPLETED|Overall Study||0
305161|NCT01696214|729707|P3|NOT COMPLETED|Overall Study||0
305162|NCT01696214|729708|P2|NOT COMPLETED|Overall Study||1
305163|NCT01696214|729709|P1|NOT COMPLETED|Overall Study||0
305164|NCT01696214|729706|P4|COMPLETED|Overall Study||5
305165|NCT01696214|729707|P3|COMPLETED|Overall Study||5
305166|NCT01696214|729708|P2|COMPLETED|Overall Study||4
305167|NCT01696214|729709|P1|COMPLETED|Overall Study||5
305168|NCT01696214|729706|P4|STARTED|Overall Study||5
305169|NCT01696214|729707|P3|STARTED|Overall Study||5
305170|NCT01696214|729708|P2|STARTED|Overall Study||5
305171|NCT01696214|729709|P1|STARTED|Overall Study||5
305172|NCT01696188|729721|P2|NOT COMPLETED|Overall Study||1
305173|NCT01696188|729722|P1|NOT COMPLETED|Overall Study||1
305174|NCT01696188|729721|P2|COMPLETED|Overall Study||42
305175|NCT01696188|729722|P1|COMPLETED|Overall Study||40
305176|NCT01696188|729721|P2|STARTED|Overall Study||43
305177|NCT01696188|729722|P1|STARTED|Overall Study||41
305178|NCT01696071|729734|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
305179|NCT01696071|729735|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
305180|NCT01696071|729734|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
305181|NCT01696071|729735|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
305182|NCT01696071|729734|P2|STARTED|Treatment Period 2: 4 Weeks||47
305183|NCT01696071|729735|P1|STARTED|Treatment Period 2: 4 Weeks||51
305184|NCT01696071|729734|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
305185|NCT01696071|729735|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
305186|NCT01696071|729734|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
305187|NCT01696071|729735|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
305188|NCT01696071|729734|P2|STARTED|Treatment Period 1: 4 Weeks||47
305189|NCT01696071|729735|P1|STARTED|Treatment Period 1: 4 Weeks||51
305190|NCT01696058|729763|P2|NOT COMPLETED|Overall Study||31
305191|NCT01696058|729764|P1|NOT COMPLETED|Overall Study||43
305192|NCT01696058|729763|P2|COMPLETED|Overall Study||538
305193|NCT01696058|729764|P1|COMPLETED|Overall Study||523
305194|NCT01696058|729763|P2|STARTED|Overall Study||569
305195|NCT01696058|729764|P1|STARTED|Overall Study||566
305196|NCT01695772|729790|P1|NOT COMPLETED|Overall Study||38
305197|NCT01695772|729790|P1|COMPLETED|Overall Study||12
305198|NCT01695772|729790|P1|STARTED|Overall Study||50
305199|NCT01695746|729802|P1|NOT COMPLETED|Overall Study||12
305200|NCT01695746|729802|P1|COMPLETED|Overall Study||96
305201|NCT01695746|729802|P1|STARTED|Overall Study||108
305202|NCT01695668|729818|P2|NOT COMPLETED|Overall Study||17
305203|NCT01695668|729819|P1|NOT COMPLETED|Overall Study||15
305204|NCT01695668|729818|P2|COMPLETED|Overall Study||20
305205|NCT01695668|729819|P1|COMPLETED|Overall Study||23
305206|NCT01695668|729818|P2|STARTED|Overall Study||37
305207|NCT01695668|729819|P1|STARTED|Overall Study||38
305208|NCT01695369|729825|P1|NOT COMPLETED|Overall Study||0
305209|NCT01695369|729825|P1|COMPLETED|Overall Study||61
305210|NCT01695369|729825|P1|STARTED|Overall Study||61
305211|NCT01695330|729831|P2|NOT COMPLETED|Overall Study||0
305212|NCT01695330|729832|P1|NOT COMPLETED|Overall Study||47
305213|NCT01695330|729831|P2|COMPLETED|Overall Study||0
305214|NCT01695330|729832|P1|COMPLETED|Overall Study||5
305215|NCT01695330|729831|P2|STARTED|Overall Study||0
305216|NCT01695330|729832|P1|STARTED|Overall Study||52
305217|NCT01695304|729838|P2|NOT COMPLETED|Overall Study||0
305218|NCT01695304|729839|P1|NOT COMPLETED|Overall Study||0
305219|NCT01695304|729838|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
305220|NCT01695304|729839|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
305221|NCT01695304|729838|P2|STARTED|Overall Study||120
305222|NCT01695304|729839|P1|STARTED|Overall Study||120
305223|NCT01695239|729851|P4|NOT COMPLETED|Overall Study||6
305224|NCT01695239|729852|P3|NOT COMPLETED|Overall Study||10
305225|NCT01695239|729853|P2|NOT COMPLETED|Overall Study||4
305226|NCT01695239|729854|P1|NOT COMPLETED|Overall Study||15
305227|NCT01695239|729851|P4|COMPLETED|Overall Study||97
305228|NCT01695239|729852|P3|COMPLETED|Overall Study||97
305229|NCT01695239|729853|P2|COMPLETED|Overall Study||97
305230|NCT01695239|729854|P1|COMPLETED|Overall Study||91
305231|NCT01695239|729851|P4|Classified as Inadequate Responder (IR)|Overall Study||10
305232|NCT01695239|729852|P3|Classified as Inadequate Responder (IR)|Overall Study||11
305233|NCT01695239|729853|P2|Classified as Inadequate Responder (IR)|Overall Study||9
305234|NCT01695239|729854|P1|Classified as Inadequate Responder (IR)|Overall Study||27
305235|NCT01695239|729851|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
305236|NCT01695239|729852|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
305237|NCT01695239|729853|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
305238|NCT01695239|729854|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
305239|NCT01695239|729851|P4|STARTED|Overall Study||103
305240|NCT01695239|729852|P3|STARTED|Overall Study||107
305241|NCT01695239|729853|P2|STARTED|Overall Study||101
305242|NCT01695239|729854|P1|STARTED|Overall Study||106
305243|NCT01695044|729945|P1|NOT COMPLETED|Overall Study||102
305244|NCT01695044|729945|P1|COMPLETED|Overall Study||17
305245|NCT01695044|729945|P1|STARTED|Overall Study||119
305246|NCT01694771|729957|P2|NOT COMPLETED|Overall Study||40
305247|NCT01694771|729958|P1|NOT COMPLETED|Overall Study||40
305248|NCT01694771|729957|P2|COMPLETED|Overall Study||525
305249|NCT01694771|729958|P1|COMPLETED|Overall Study||527
305250|NCT01694771|729957|P2|STARTED|Overall Study||565
305251|NCT01694771|729958|P1|STARTED|Overall Study||567
305252|NCT01694706|729982|P3|NOT COMPLETED|Overall Study||0
305253|NCT01694706|729983|P2|NOT COMPLETED|Overall Study||1
305254|NCT01694706|729984|P1|NOT COMPLETED|Overall Study||1
305255|NCT01694706|729982|P3|COMPLETED|Overall Study||5
305256|NCT01694706|729983|P2|COMPLETED|Overall Study||4
305257|NCT01694706|729984|P1|COMPLETED|Overall Study||4
305258|NCT01694706|729982|P3|Received Faldaprevir Fed|Overall Study||5
305259|NCT01694706|729983|P2|Received Faldaprevir Fed|Overall Study||5
305260|NCT01694706|729984|P1|Received Faldaprevir Fed|Overall Study||4
305261|NCT01694706|729982|P3|Received Faldaprevir +OMP|Overall Study||5
305262|NCT01694706|729983|P2|Received Faldaprevir +OMP|Overall Study||5
305263|NCT01694706|729984|P1|Received Faldaprevir +OMP|Overall Study||5
305264|NCT01694706|729982|P3|Received Faldaprevir|Overall Study||5
305265|NCT01694706|729983|P2|Received Faldaprevir|Overall Study||5
305266|NCT01694706|729984|P1|Received Faldaprevir|Overall Study||5
305267|NCT01694706|729982|P3|STARTED|Overall Study||5
305268|NCT01694706|729983|P2|STARTED|Overall Study||5
305269|NCT01694706|729984|P1|STARTED|Overall Study||5
305270|NCT01694667|730001|P2|NOT COMPLETED|Overall Study||0
305271|NCT01694667|730002|P1|NOT COMPLETED|Overall Study||0
305272|NCT01694667|730001|P2|COMPLETED|Overall Study||28
305273|NCT01694667|730002|P1|COMPLETED|Overall Study||29
305274|NCT01694667|730001|P2|STARTED|Overall Study||28
305275|NCT01694667|730002|P1|STARTED|Overall Study||29
305276|NCT01694641|730020|P2|NOT COMPLETED|Overall Study||10
305277|NCT01694641|730021|P1|NOT COMPLETED|Overall Study||12
305278|NCT01694641|730020|P2|COMPLETED|Overall Study||71
305279|NCT01694641|730021|P1|COMPLETED|Overall Study||68
305280|NCT01694641|730020|P2|STARTED|Overall Study||81
305281|NCT01694641|730021|P1|STARTED|Overall Study||80
305282|NCT01694420|730027|P1|NOT COMPLETED|Overall Study||3
305283|NCT01694420|730027|P1|COMPLETED|Overall Study||30
305284|NCT01694420|730027|P1|STARTED|Overall Study||33
305285|NCT01694199|730038|P2|NOT COMPLETED|Overall Study||0
305286|NCT01694199|730039|P1|NOT COMPLETED|Overall Study||0
305287|NCT01694199|730038|P2|COMPLETED|Overall Study||68
305288|NCT01694199|730039|P1|COMPLETED|Overall Study||71
305289|NCT01694199|730038|P2|STARTED|Overall Study||68
305290|NCT01694199|730039|P1|STARTED|Overall Study||71
305291|NCT01694108|730055|P2|NOT COMPLETED|Overall Study||0
305292|NCT01694108|730056|P1|NOT COMPLETED|Overall Study||0
305293|NCT01694108|730055|P2|COMPLETED|Overall Study|100% follow-up|2133
305294|NCT01694108|730056|P1|COMPLETED|Overall Study|100% follow-up|2129
305295|NCT01694108|730055|P2|STARTED|Overall Study||2133
305296|NCT01694108|730056|P1|STARTED|Overall Study||2129
305297|NCT01693900|730112|P2|NOT COMPLETED|Overall Study||0
305298|NCT01693900|730113|P1|NOT COMPLETED|Overall Study||0
305299|NCT01693900|730112|P2|COMPLETED|Overall Study||25
305300|NCT01693900|730113|P1|COMPLETED|Overall Study||25
305301|NCT01693900|730112|P2|STARTED|Overall Study||25
305302|NCT01693900|730113|P1|STARTED|Overall Study||25
305303|NCT01693653|730127|P2|NOT COMPLETED|Overall Study||0
305304|NCT01693653|730128|P1|NOT COMPLETED|Overall Study||0
305305|NCT01693653|730127|P2|COMPLETED|Overall Study||0
305306|NCT01693653|730128|P1|COMPLETED|Overall Study||1
305307|NCT01693653|730127|P2|STARTED|Overall Study||0
305308|NCT01693653|730128|P1|STARTED|Overall Study||1
305309|NCT01693484|730134|P1|NOT COMPLETED|Overall Study||13
305310|NCT01693484|730134|P1|COMPLETED|Overall Study|Study closed by PI|0
305311|NCT01693484|730134|P1|STARTED|Overall Study||13
305312|NCT01693367|730140|P2|NOT COMPLETED|Overall Study||2
305313|NCT01693367|730141|P1|NOT COMPLETED|Overall Study||1
305314|NCT01693367|730140|P2|COMPLETED|Overall Study||1
305315|NCT01693367|730141|P1|COMPLETED|Overall Study||1
305316|NCT01693367|730140|P2|STARTED|Overall Study||3
305317|NCT01693367|730141|P1|STARTED|Overall Study||2
305318|NCT01693185|730159|P2|NOT COMPLETED|Overall Study||6
305319|NCT01693185|730160|P1|NOT COMPLETED|Overall Study||0
305320|NCT01693185|730159|P2|COMPLETED|Overall Study||27
305321|NCT01693185|730160|P1|COMPLETED|Overall Study||27
305322|NCT01693185|730159|P2|STARTED|Overall Study||33
305323|NCT01693185|730160|P1|STARTED|Overall Study||27
305324|NCT01693029|730178|P2|NOT COMPLETED|Overall Study||57
305325|NCT01693029|730179|P1|NOT COMPLETED|Overall Study||44
305326|NCT01693029|730178|P2|COMPLETED|Overall Study||161
305327|NCT01693029|730179|P1|COMPLETED|Overall Study||173
305328|NCT01693029|730178|P2|STARTED|Overall Study||218
305329|NCT01693029|730179|P1|STARTED|Overall Study||217
305330|NCT01692938|730193|P2|NOT COMPLETED|Overall Study||4
305331|NCT01692938|730194|P1|NOT COMPLETED|Overall Study||4
305332|NCT01692938|730193|P2|COMPLETED|Overall Study||12
305333|NCT01692938|730194|P1|COMPLETED|Overall Study||12
305334|NCT01692938|730193|P2|STARTED|Overall Study||16
305335|NCT01692938|730194|P1|STARTED|Overall Study||16
305336|NCT01692782|730205|P3|NOT COMPLETED|Overall Study||10
305337|NCT01692782|730206|P2|NOT COMPLETED|Overall Study||56
305338|NCT01692782|730207|P1|NOT COMPLETED|Overall Study||20
305339|NCT01692782|730205|P3|COMPLETED|Overall Study||100
305340|NCT01692782|730206|P2|COMPLETED|Overall Study||59
305341|NCT01692782|730207|P1|COMPLETED|Overall Study||96
305342|NCT01692782|730205|P3|STARTED|Overall Study||110
305343|NCT01692782|730206|P2|STARTED|Overall Study||115
305344|NCT01692782|730207|P1|STARTED|Overall Study||116
305345|NCT01692691|730230|P1|NOT COMPLETED|Overall Study||0
305346|NCT01692691|730230|P1|COMPLETED|Overall Study||1
305347|NCT01692691|730230|P1|STARTED|Overall Study||1
305348|NCT01692626|730235|P2|NOT COMPLETED|Overall Study||6
305349|NCT01692626|730236|P1|NOT COMPLETED|Overall Study||4
305350|NCT01692626|730235|P2|COMPLETED|Overall Study||1
305351|NCT01692626|730236|P1|COMPLETED|Overall Study||2
305352|NCT01692626|730235|P2|STARTED|Overall Study||7
305353|NCT01692626|730236|P1|STARTED|Overall Study||6
305354|NCT01692340|730244|P3|NOT COMPLETED|Overall Study||0
305355|NCT01692340|730245|P2|NOT COMPLETED|Overall Study||0
305356|NCT01692340|730246|P1|NOT COMPLETED|Overall Study||0
305357|NCT01692340|730244|P3|COMPLETED|Overall Study||0
305358|NCT01692340|730245|P2|COMPLETED|Overall Study||4
305359|NCT01692340|730246|P1|COMPLETED|Overall Study||8
305360|NCT01692340|730244|P3|STARTED|Overall Study||0
305361|NCT01692340|730245|P2|STARTED|Overall Study||4
305362|NCT01692340|730246|P1|STARTED|Overall Study||8
305363|NCT01692301|730265|P2|NOT COMPLETED|Overall Study||42
305364|NCT01692301|730266|P1|NOT COMPLETED|Overall Study||45
305365|NCT01692301|730265|P2|COMPLETED|Overall Study||183
305366|NCT01692301|730266|P1|COMPLETED|Overall Study||184
305367|NCT01692301|730265|P2|STARTED|Overall Study||225
305368|NCT01692301|730266|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
305369|NCT01691885|730292|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
305370|NCT01691885|730293|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
305371|NCT01691885|730292|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
305372|NCT01691885|730293|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
305373|NCT01691885|730292|P2|STARTED|Treatment Period 2 (7-14 Days)||21
305374|NCT01691885|730293|P1|STARTED|Treatment Period 2 (7-14 Days)||21
305375|NCT01691885|730292|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
305376|NCT01691885|730293|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
305377|NCT01691885|730292|P2|COMPLETED|Washout Period (7-9 Days)||21
305378|NCT01691885|730293|P1|COMPLETED|Washout Period (7-9 Days)||21
305379|NCT01691885|730292|P2|STARTED|Washout Period (7-9 Days)||22
305380|NCT01691885|730293|P1|STARTED|Washout Period (7-9 Days)||21
305381|NCT01691885|730292|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
305382|NCT01691885|730293|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
305383|NCT01691885|730292|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
305384|NCT01691885|730293|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
305385|NCT01691885|730292|P2|STARTED|Treatment Period 1(7-14 Days)||23
305386|NCT01691885|730293|P1|STARTED|Treatment Period 1(7-14 Days)||22
305387|NCT01691794|730302|P3|NOT COMPLETED|Overall Study||3
305388|NCT01691794|730303|P2|NOT COMPLETED|Overall Study||3
305389|NCT01691794|730304|P1|NOT COMPLETED|Overall Study||0
305390|NCT01691794|730302|P3|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|20
305391|NCT01691794|730303|P2|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|30
305392|NCT01691794|730304|P1|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|3
305393|NCT01691794|730302|P3|STARTED|Overall Study||23
305394|NCT01691794|730303|P2|STARTED|Overall Study||33
305395|NCT01691794|730304|P1|STARTED|Overall Study||3
305396|NCT01691690|730320|P2|NOT COMPLETED|Overall Study||4
305397|NCT01691690|730321|P1|NOT COMPLETED|Overall Study||7
305398|NCT01691690|730320|P2|COMPLETED|Overall Study||121
305399|NCT01691690|730321|P1|COMPLETED|Overall Study||118
305400|NCT01691690|730320|P2|STARTED|Overall Study||125
305401|NCT01691690|730321|P1|STARTED|Overall Study||125
305402|NCT01691560|730335|P4|NOT COMPLETED|Overall Study||0
305403|NCT01691560|730336|P3|NOT COMPLETED|Overall Study||0
305404|NCT01691560|730337|P2|NOT COMPLETED|Overall Study||0
305405|NCT01691560|730338|P1|NOT COMPLETED|Overall Study||0
305406|NCT01691560|730335|P4|COMPLETED|Overall Study||33
305407|NCT01691560|730336|P3|COMPLETED|Overall Study||34
305408|NCT01691560|730337|P2|COMPLETED|Overall Study||33
305409|NCT01691560|730338|P1|COMPLETED|Overall Study||34
305410|NCT01691560|730335|P4|STARTED|Overall Study||33
305411|NCT01691560|730336|P3|STARTED|Overall Study||34
305412|NCT01691560|730337|P2|STARTED|Overall Study||33
305413|NCT01691560|730338|P1|STARTED|Overall Study||34
305414|NCT01691534|730375|P7|NOT COMPLETED|Overall Study||1
305415|NCT01691534|730376|P6|NOT COMPLETED|Overall Study||1
305416|NCT01691534|730377|P5|NOT COMPLETED|Overall Study||0
305417|NCT01691534|730378|P4|NOT COMPLETED|Overall Study||1
305418|NCT01691534|730379|P3|NOT COMPLETED|Overall Study||1
305419|NCT01691534|730380|P2|NOT COMPLETED|Overall Study||1
305420|NCT01691534|730381|P1|NOT COMPLETED|Overall Study||0
305421|NCT01691534|730375|P7|COMPLETED|Overall Study||14
305422|NCT01691534|730376|P6|COMPLETED|Overall Study||14
305423|NCT01691534|730377|P5|COMPLETED|Overall Study||15
305424|NCT01691534|730378|P4|COMPLETED|Overall Study||14
305425|NCT01691534|730379|P3|COMPLETED|Overall Study||14
305426|NCT01691534|730380|P2|COMPLETED|Overall Study||14
305427|NCT01691534|730381|P1|COMPLETED|Overall Study||15
305428|NCT01691534|730375|P7|STARTED|Overall Study||15
305429|NCT01691534|730376|P6|STARTED|Overall Study||15
305430|NCT01691534|730377|P5|STARTED|Overall Study||15
305431|NCT01691534|730378|P4|STARTED|Overall Study||15
305432|NCT01691534|730379|P3|STARTED|Overall Study||15
305433|NCT01691534|730380|P2|STARTED|Overall Study||15
305434|NCT01691534|730381|P1|STARTED|Overall Study||15
305435|NCT01691521|730435|P3|NOT COMPLETED|Overall Study||9
305436|NCT01691521|730436|P2|NOT COMPLETED|Overall Study||16
305437|NCT01691521|730437|P1|NOT COMPLETED|Overall Study||12
305438|NCT01691521|730435|P3|COMPLETED|Overall Study||185
305439|NCT01691521|730436|P2|COMPLETED|Overall Study||175
305440|NCT01691521|730437|P1|COMPLETED|Overall Study||179
305441|NCT01691521|730435|P3|STARTED|Overall Study||194
305442|NCT01691521|730436|P2|STARTED|Overall Study||191
305443|NCT01691521|730437|P1|STARTED|Overall Study||191
305444|NCT01691508|730459|P2|NOT COMPLETED|Overall Study||3
305445|NCT01691508|730460|P1|NOT COMPLETED|Overall Study||4
305446|NCT01691508|730459|P2|COMPLETED|Overall Study||66
305447|NCT01691508|730460|P1|COMPLETED|Overall Study||62
305448|NCT01691508|730459|P2|STARTED|Overall Study||69
305449|NCT01691508|730460|P1|STARTED|Overall Study||66
305450|NCT01691482|730474|P2|NOT COMPLETED|Treatment Period 2||2
305451|NCT01691482|730475|P1|NOT COMPLETED|Treatment Period 2||1
305452|NCT01691482|730474|P2|COMPLETED|Treatment Period 2||26
305453|NCT01691482|730475|P1|COMPLETED|Treatment Period 2||27
305454|NCT01691482|730474|P2|STARTED|Treatment Period 2||28
305455|NCT01691482|730475|P1|STARTED|Treatment Period 2||28
305456|NCT01691482|730474|P2|NOT COMPLETED|Treatment Period 1||0
305457|NCT01691482|730475|P1|NOT COMPLETED|Treatment Period 1||0
305458|NCT01691482|730474|P2|COMPLETED|Treatment Period 1||28
305459|NCT01691482|730475|P1|COMPLETED|Treatment Period 1||28
305460|NCT01691482|730474|P2|STARTED|Treatment Period 1||28
305461|NCT01691482|730475|P1|STARTED|Treatment Period 1||28
305462|NCT01691339|730495|P4|NOT COMPLETED|Overall Study||0
305463|NCT01691339|730496|P3|NOT COMPLETED|Overall Study||0
305464|NCT01691339|730497|P2|NOT COMPLETED|Overall Study||0
305465|NCT01691339|730498|P1|NOT COMPLETED|Overall Study||0
305466|NCT01691339|730495|P4|COMPLETED|Overall Study||49
305467|NCT01691339|730496|P3|COMPLETED|Overall Study||51
305468|NCT01691339|730497|P2|COMPLETED|Overall Study||50
305469|NCT01691339|730498|P1|COMPLETED|Overall Study||50
305470|NCT01691339|730495|P4|STARTED|Overall Study||49
305471|NCT01691339|730496|P3|STARTED|Overall Study||51
305472|NCT01691339|730497|P2|STARTED|Overall Study||50
305473|NCT01691339|730498|P1|STARTED|Overall Study||50
305474|NCT01691326|730526|P2|NOT COMPLETED|Overall Study||0
305475|NCT01691326|730527|P1|NOT COMPLETED|Overall Study||0
305476|NCT01691326|730526|P2|COMPLETED|Overall Study||30
305477|NCT01691326|730527|P1|COMPLETED|Overall Study||30
305478|NCT01691326|730526|P2|STARTED|Overall Study||30
305479|NCT01691326|730527|P1|STARTED|Overall Study||30
305480|NCT01691313|730545|P4|NOT COMPLETED|Overall Study||0
305481|NCT01691313|730546|P3|NOT COMPLETED|Overall Study||0
305482|NCT01691313|730547|P2|NOT COMPLETED|Overall Study||0
305483|NCT01691313|730548|P1|NOT COMPLETED|Overall Study||0
305484|NCT01691313|730545|P4|COMPLETED|Overall Study||25
305485|NCT01691313|730546|P3|COMPLETED|Overall Study||25
305486|NCT01691313|730547|P2|COMPLETED|Overall Study||32
305487|NCT01691313|730548|P1|COMPLETED|Overall Study||22
305488|NCT01691313|730545|P4|STARTED|Overall Study||25
305489|NCT01691313|730546|P3|STARTED|Overall Study||25
305490|NCT01691313|730547|P2|STARTED|Overall Study||32
305491|NCT01691313|730548|P1|STARTED|Overall Study||22
305492|NCT01691248|730564|P2|NOT COMPLETED|Overall Study||114
305493|NCT01691248|730565|P1|NOT COMPLETED|Overall Study||111
305494|NCT01691248|730564|P2|COMPLETED|Overall Study||192
305495|NCT01691248|730565|P1|COMPLETED|Overall Study||194
305496|NCT01691248|730564|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
305497|NCT01691248|730565|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
305498|NCT01691248|730564|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
305499|NCT01691248|730565|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
305500|NCT01691248|730564|P2|STARTED|Overall Study|Randomized|306
305501|NCT01691248|730565|P1|STARTED|Overall Study|Randomized|305
305502|NCT01691092|730575|P1|NOT COMPLETED|Overall Study||41
305503|NCT01691092|730575|P1|COMPLETED|Overall Study||38
305504|NCT01691092|730575|P1|STARTED|Overall Study||79
305505|NCT01691014|730583|P4|NOT COMPLETED|Overall Study||5
305506|NCT01691014|730584|P3|NOT COMPLETED|Overall Study||11
305507|NCT01691014|730585|P2|NOT COMPLETED|Overall Study||15
305508|NCT01691014|730586|P1|NOT COMPLETED|Overall Study||3
305509|NCT01691014|730583|P4|COMPLETED|Overall Study||4
305510|NCT01691014|730584|P3|COMPLETED|Overall Study||25
305511|NCT01691014|730585|P2|COMPLETED|Overall Study||11
305512|NCT01691014|730586|P1|COMPLETED|Overall Study||5
305513|NCT01691014|730583|P4|STARTED|Overall Study||9
305514|NCT01691014|730584|P3|STARTED|Overall Study||36
305515|NCT01691014|730585|P2|STARTED|Overall Study||26
305516|NCT01691014|730586|P1|STARTED|Overall Study||8
305517|NCT01690923|730628|P2|NOT COMPLETED|Overall Study||1
305518|NCT01690923|730629|P1|NOT COMPLETED|Overall Study||0
305519|NCT01690923|730628|P2|COMPLETED|Overall Study||10
305520|NCT01690923|730629|P1|COMPLETED|Overall Study||10
305521|NCT01690923|730628|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
305522|NCT01690923|730629|P1|STARTED|Overall Study||10
305523|NCT01690663|730638|P4|NOT COMPLETED|Overall Study||4
305524|NCT01690663|730639|P3|NOT COMPLETED|Overall Study||3
305525|NCT01690663|730640|P2|NOT COMPLETED|Overall Study||3
305526|NCT01690663|730641|P1|NOT COMPLETED|Overall Study||3
305527|NCT01690663|730638|P4|COMPLETED|Overall Study||20
305528|NCT01690663|730639|P3|COMPLETED|Overall Study||19
305529|NCT01690663|730640|P2|COMPLETED|Overall Study||17
305530|NCT01690663|730641|P1|COMPLETED|Overall Study||20
305531|NCT01690663|730638|P4|STARTED|Overall Study||24
305532|NCT01690663|730639|P3|STARTED|Overall Study||22
305533|NCT01690663|730640|P2|STARTED|Overall Study||20
305534|NCT01690663|730641|P1|STARTED|Overall Study||23
305535|NCT01690546|730655|P1|NOT COMPLETED|Overall Study||9
305536|NCT01690546|730655|P1|COMPLETED|Overall Study||26
305537|NCT01690546|730655|P1|Extended Release Injectable NTX|Overall Study||27
305538|NCT01690546|730655|P1|STARTED|Overall Study||35
305539|NCT01690299|730671|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
305540|NCT01690299|730672|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
305541|NCT01690299|730673|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
305542|NCT01690299|730674|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
305543|NCT01690299|730675|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
305544|NCT01690299|730676|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
305545|NCT01690299|730671|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
305546|NCT01690299|730672|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
305547|NCT01690299|730673|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
305548|NCT01690299|730674|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
305549|NCT01690299|730675|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
305550|NCT01690299|730676|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
305551|NCT01690299|730671|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
305552|NCT01690299|730672|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
305553|NCT01690299|730673|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
305554|NCT01690299|730674|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
305555|NCT01690299|730675|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
305556|NCT01690299|730676|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
305557|NCT01690299|730671|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
305637|NCT01689532|730849|P2|NOT COMPLETED|Overall Study||9
305558|NCT01690299|730672|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
305559|NCT01690299|730673|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
305560|NCT01690299|730674|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
305561|NCT01690299|730675|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
305562|NCT01690299|730676|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
305563|NCT01690299|730671|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
305564|NCT01690299|730672|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
305565|NCT01690299|730673|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
305566|NCT01690299|730674|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
305567|NCT01690299|730675|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
305568|NCT01690299|730676|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
305569|NCT01690299|730671|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
305570|NCT01690299|730672|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
305571|NCT01690299|730673|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
305572|NCT01690299|730674|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
305573|NCT01690299|730675|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
305574|NCT01690299|730676|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
305575|NCT01690299|730671|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
305576|NCT01690299|730672|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
305577|NCT01690299|730673|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
305578|NCT01690299|730674|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
305579|NCT01690299|730675|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
305580|NCT01690299|730676|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
305581|NCT01690299|730671|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
305582|NCT01690299|730672|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
305583|NCT01690299|730673|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
305584|NCT01690299|730674|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
305585|NCT01690299|730675|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
305586|NCT01690299|730676|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
305587|NCT01690273|730721|P3|NOT COMPLETED|Overall Study||0
305588|NCT01690273|730722|P2|NOT COMPLETED|Overall Study||0
305589|NCT01690273|730723|P1|NOT COMPLETED|Overall Study||0
305590|NCT01690273|730721|P3|COMPLETED|Overall Study||20
305591|NCT01690273|730722|P2|COMPLETED|Overall Study||17
305592|NCT01690273|730723|P1|COMPLETED|Overall Study||18
305593|NCT01690273|730721|P3|STARTED|Overall Study||20
305594|NCT01690273|730722|P2|STARTED|Overall Study||17
305595|NCT01690273|730723|P1|STARTED|Overall Study||18
305596|NCT01690117|730775|P2|NOT COMPLETED|Overall Study||14
305597|NCT01690117|730776|P1|NOT COMPLETED|Overall Study||16
305598|NCT01690117|730775|P2|COMPLETED|Overall Study||31
305599|NCT01690117|730776|P1|COMPLETED|Overall Study||31
305600|NCT01690117|730775|P2|Post-Measurement|Overall Study||40
305601|NCT01690117|730776|P1|Post-Measurement|Overall Study||41
305602|NCT01690117|730775|P2|STARTED|Overall Study||45
305603|NCT01690117|730776|P1|STARTED|Overall Study||47
305604|NCT01690052|730812|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
305605|NCT01690052|730813|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
305606|NCT01690052|730812|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
305607|NCT01690052|730813|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
305608|NCT01690052|730812|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
305609|NCT01690052|730813|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
305610|NCT01690052|730812|P2|NOT COMPLETED|Washout Period of 1 Week||0
305611|NCT01690052|730813|P1|NOT COMPLETED|Washout Period of 1 Week||0
305612|NCT01690052|730812|P2|COMPLETED|Washout Period of 1 Week||6
305613|NCT01690052|730813|P1|COMPLETED|Washout Period of 1 Week||6
305614|NCT01690052|730812|P2|STARTED|Washout Period of 1 Week||6
305615|NCT01690052|730813|P1|STARTED|Washout Period of 1 Week||6
305616|NCT01690052|730812|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
305617|NCT01690052|730813|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
305618|NCT01690052|730812|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
305619|NCT01690052|730813|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
305620|NCT01690052|730812|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
305621|NCT01690052|730813|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
305622|NCT01690000|730821|P2|NOT COMPLETED|Overall Study||6
305623|NCT01690000|730822|P1|NOT COMPLETED|Overall Study||3
305624|NCT01690000|730821|P2|COMPLETED|Overall Study||35
305625|NCT01690000|730822|P1|COMPLETED|Overall Study||37
305626|NCT01690000|730821|P2|STARTED|Overall Study||41
305627|NCT01690000|730822|P1|STARTED|Overall Study||40
305628|NCT01689857|730830|P2|NOT COMPLETED|Overall Study||2
305629|NCT01689857|730831|P1|NOT COMPLETED|Overall Study||5
305630|NCT01689857|730830|P2|COMPLETED|Overall Study||18
305631|NCT01689857|730831|P1|COMPLETED|Overall Study||15
305632|NCT01689857|730830|P2|STARTED|Overall Study||20
305633|NCT01689857|730831|P1|STARTED|Overall Study||20
305634|NCT01689649|730837|P1|NOT COMPLETED|Overall Study||22
305635|NCT01689649|730837|P1|COMPLETED|Overall Study||117
305636|NCT01689649|730837|P1|STARTED|Overall Study||139
305638|NCT01689532|730850|P1|NOT COMPLETED|Overall Study||14
305639|NCT01689532|730849|P2|COMPLETED|Overall Study||52
305640|NCT01689532|730850|P1|COMPLETED|Overall Study||47
305641|NCT01689532|730849|P2|STARTED|Overall Study||61
305642|NCT01689532|730850|P1|STARTED|Overall Study||61
305643|NCT01689519|730914|P2|NOT COMPLETED|Overall Study||138
305644|NCT01689519|730915|P1|NOT COMPLETED|Overall Study||166
305645|NCT01689519|730914|P2|COMPLETED|Overall Study||109
305646|NCT01689519|730915|P1|COMPLETED|Overall Study||82
305647|NCT01689519|730914|P2|Received Treatment|Overall Study||246
305648|NCT01689519|730915|P1|Received Treatment|Overall Study||247
305649|NCT01689519|730914|P2|STARTED|Overall Study||247
305650|NCT01689519|730915|P1|STARTED|Overall Study||248
305651|NCT01689441|730931|P2|NOT COMPLETED|Overall Study||0
305652|NCT01689441|730932|P1|NOT COMPLETED|Overall Study||0
305653|NCT01689441|730931|P2|COMPLETED|Overall Study||31
305654|NCT01689441|730932|P1|COMPLETED|Overall Study||36
305655|NCT01689441|730931|P2|STARTED|Overall Study||31
305656|NCT01689441|730932|P1|STARTED|Overall Study||36
305657|NCT01689363|730942|P8|NOT COMPLETED|Overall Study||0
305658|NCT01689363|730943|P7|NOT COMPLETED|Overall Study||0
305659|NCT01689363|730944|P6|NOT COMPLETED|Overall Study||0
305660|NCT01689363|730945|P5|NOT COMPLETED|Overall Study||0
305661|NCT01689363|730946|P4|NOT COMPLETED|Overall Study||0
305662|NCT01689363|730947|P3|NOT COMPLETED|Overall Study||0
305663|NCT01689363|730948|P2|NOT COMPLETED|Overall Study||1
305664|NCT01689363|730949|P1|NOT COMPLETED|Overall Study||0
305665|NCT01689363|730942|P8|COMPLETED|Overall Study||32
305666|NCT01689363|730943|P7|COMPLETED|Overall Study||32
305667|NCT01689363|730944|P6|COMPLETED|Overall Study||31
305668|NCT01689363|730945|P5|COMPLETED|Overall Study||31
305669|NCT01689363|730946|P4|COMPLETED|Overall Study||31
305670|NCT01689363|730947|P3|COMPLETED|Overall Study||32
305671|NCT01689363|730948|P2|COMPLETED|Overall Study||31
305672|NCT01689363|730949|P1|COMPLETED|Overall Study||32
305673|NCT01689363|730942|P8|STARTED|Overall Study||32
305674|NCT01689363|730943|P7|STARTED|Overall Study||32
305675|NCT01689363|730944|P6|STARTED|Overall Study||31
305676|NCT01689363|730945|P5|STARTED|Overall Study||31
305677|NCT01689363|730946|P4|STARTED|Overall Study||31
305678|NCT01689363|730947|P3|STARTED|Overall Study||32
305679|NCT01689363|730948|P2|STARTED|Overall Study||32
305680|NCT01689363|730949|P1|STARTED|Overall Study||32
305681|NCT01689350|730995|P2|NOT COMPLETED|Overall Study||0
305682|NCT01689350|730996|P1|NOT COMPLETED|Overall Study||0
305683|NCT01689350|730995|P2|COMPLETED|Overall Study||45
305684|NCT01689350|730996|P1|COMPLETED|Overall Study||47
305685|NCT01689350|730995|P2|STARTED|Overall Study||45
305686|NCT01689350|730996|P1|STARTED|Overall Study||47
305687|NCT01689337|731004|P1|NOT COMPLETED|Overall Study||1
305688|NCT01689337|731004|P1|COMPLETED|Overall Study||0
305689|NCT01689337|731004|P1|STARTED|Overall Study||1
305690|NCT01689324|731019|P1|NOT COMPLETED|Overall Study||0
305691|NCT01689324|731019|P1|COMPLETED|Overall Study||43
305692|NCT01689324|731019|P1|STARTED|Overall Study||43
305693|NCT01689207|731043|P11|NOT COMPLETED|Overall Study||0
305694|NCT01689207|731044|P10|NOT COMPLETED|Overall Study||0
305695|NCT01689207|731045|P9|NOT COMPLETED|Overall Study||1
305696|NCT01689207|731046|P8|NOT COMPLETED|Overall Study||0
305697|NCT01689207|731047|P7|NOT COMPLETED|Overall Study||0
305698|NCT01689207|731048|P6|NOT COMPLETED|Overall Study||1
305699|NCT01689207|731049|P5|NOT COMPLETED|Overall Study||2
305700|NCT01689207|731050|P4|NOT COMPLETED|Overall Study||0
305701|NCT01689207|731051|P3|NOT COMPLETED|Overall Study||0
305702|NCT01689207|731052|P2|NOT COMPLETED|Overall Study||1
305703|NCT01689207|731053|P1|NOT COMPLETED|Overall Study||0
305704|NCT01689207|731043|P11|COMPLETED|Overall Study|Subjects completed study|8
305705|NCT01689207|731044|P10|COMPLETED|Overall Study|Subjects completed study|10
305706|NCT01689207|731045|P9|COMPLETED|Overall Study|Subjects completed study|5
305707|NCT01689207|731046|P8|COMPLETED|Overall Study|Subjects completed study|10
305708|NCT01689207|731047|P7|COMPLETED|Overall Study|Subjects completed study|10
305709|NCT01689207|731048|P6|COMPLETED|Overall Study|Subjects completed study|7
305710|NCT01689207|731049|P5|COMPLETED|Overall Study|Subjects completed study|2
305711|NCT01689207|731050|P4|COMPLETED|Overall Study|Subjects completed study|8
305712|NCT01689207|731051|P3|COMPLETED|Overall Study|Subjects completed study|16
305713|NCT01689207|731052|P2|COMPLETED|Overall Study|Subjects completed study|7
305714|NCT01689207|731053|P1|COMPLETED|Overall Study|Subjects completed study|4
305715|NCT01689207|731043|P11|STARTED|Overall Study|Subjects randomised|8
305716|NCT01689207|731044|P10|STARTED|Overall Study|Subjects randomised|10
305717|NCT01689207|731045|P9|STARTED|Overall Study|Subjects randomised|6
305718|NCT01689207|731046|P8|STARTED|Overall Study|Subjects randomised|10
305719|NCT01689207|731047|P7|STARTED|Overall Study|Subjects randomised|10
305720|NCT01689207|731048|P6|STARTED|Overall Study|Subjects randomised|8
305721|NCT01689207|731049|P5|STARTED|Overall Study|Subjects randomised|4
305722|NCT01689207|731050|P4|STARTED|Overall Study|Subjects randomised|8
305723|NCT01689207|731051|P3|STARTED|Overall Study|Subjects randomised|16
305724|NCT01689207|731052|P2|STARTED|Overall Study|Subjects randomised|8
305725|NCT01689207|731053|P1|STARTED|Overall Study|Subjects randomised|4
305726|NCT01689155|731149|P1|NOT COMPLETED|Overall Study||0
305727|NCT01689155|731149|P1|COMPLETED|Overall Study||116
305728|NCT01689155|731149|P1|STARTED|Overall Study||116
305729|NCT01688921|731160|P2|NOT COMPLETED|Overall Study||15
305730|NCT01688921|731161|P1|NOT COMPLETED|Overall Study||16
305731|NCT01688921|731160|P2|COMPLETED|Overall Study||608
305732|NCT01688921|731161|P1|COMPLETED|Overall Study||611
305733|NCT01688921|731160|P2|STARTED|Overall Study||623
305734|NCT01688921|731161|P1|STARTED|Overall Study||627
305735|NCT01688882|731186|P2|NOT COMPLETED|Overall Study||1
305736|NCT01688882|731187|P1|NOT COMPLETED|Overall Study||3
305737|NCT01688882|731186|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
305738|NCT01688882|731187|P1|COMPLETED|Overall Study||10
305739|NCT01688882|731186|P2|Safety Follow-up|Overall Study||5
305740|NCT01688882|731187|P1|Safety Follow-up|Overall Study||11
305741|NCT01688882|731186|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
305742|NCT01688882|731187|P1|STARTED|Overall Study||13
305743|NCT01688830|731222|P21|NOT COMPLETED|Overall Study||0
305744|NCT01688830|731223|P20|NOT COMPLETED|Overall Study||0
305745|NCT01688830|731224|P19|NOT COMPLETED|Overall Study||0
305746|NCT01688830|731225|P18|NOT COMPLETED|Overall Study||0
305747|NCT01688830|731226|P17|NOT COMPLETED|Overall Study||0
305748|NCT01688830|731227|P16|NOT COMPLETED|Overall Study||0
305749|NCT01688830|731228|P15|NOT COMPLETED|Overall Study||0
305750|NCT01688830|731229|P14|NOT COMPLETED|Overall Study||0
305751|NCT01688830|731230|P13|NOT COMPLETED|Overall Study||0
305752|NCT01688830|731231|P12|NOT COMPLETED|Overall Study||0
305753|NCT01688830|731232|P11|NOT COMPLETED|Overall Study||1
305754|NCT01688830|731233|P10|NOT COMPLETED|Overall Study||0
305755|NCT01688830|731234|P9|NOT COMPLETED|Overall Study||0
305756|NCT01688830|731235|P8|NOT COMPLETED|Overall Study||0
305757|NCT01688830|731236|P7|NOT COMPLETED|Overall Study||0
305758|NCT01688830|731237|P6|NOT COMPLETED|Overall Study||0
305759|NCT01688830|731238|P5|NOT COMPLETED|Overall Study||0
305760|NCT01688830|731239|P4|NOT COMPLETED|Overall Study||0
305761|NCT01688830|731240|P3|NOT COMPLETED|Overall Study||0
305762|NCT01688830|731241|P2|NOT COMPLETED|Overall Study||0
305763|NCT01688830|731242|P1|NOT COMPLETED|Overall Study||0
305764|NCT01688830|731222|P21|COMPLETED|Overall Study||9
305765|NCT01688830|731223|P20|COMPLETED|Overall Study||3
305766|NCT01688830|731224|P19|COMPLETED|Overall Study||8
305767|NCT01688830|731225|P18|COMPLETED|Overall Study||9
305768|NCT01688830|731226|P17|COMPLETED|Overall Study||9
305769|NCT01688830|731227|P16|COMPLETED|Overall Study||9
305770|NCT01688830|731228|P15|COMPLETED|Overall Study||6
305771|NCT01688830|731229|P14|COMPLETED|Overall Study||6
305772|NCT01688830|731230|P13|COMPLETED|Overall Study||6
305773|NCT01688830|731231|P12|COMPLETED|Overall Study||6
305774|NCT01688830|731232|P11|COMPLETED|Overall Study||5
305775|NCT01688830|731233|P10|COMPLETED|Overall Study||6
305776|NCT01688830|731234|P9|COMPLETED|Overall Study||6
305777|NCT01688830|731235|P8|COMPLETED|Overall Study||6
305778|NCT01688830|731236|P7|COMPLETED|Overall Study||12
305779|NCT01688830|731237|P6|COMPLETED|Overall Study||6
305780|NCT01688830|731238|P5|COMPLETED|Overall Study||5
305781|NCT01688830|731239|P4|COMPLETED|Overall Study||6
305782|NCT01688830|731240|P3|COMPLETED|Overall Study||6
305783|NCT01688830|731241|P2|COMPLETED|Overall Study||6
305784|NCT01688830|731242|P1|COMPLETED|Overall Study||21
305785|NCT01688830|731222|P21|STARTED|Overall Study||9
305786|NCT01688830|731223|P20|STARTED|Overall Study||3
305787|NCT01688830|731224|P19|STARTED|Overall Study||8
305788|NCT01688830|731225|P18|STARTED|Overall Study||9
305789|NCT01688830|731226|P17|STARTED|Overall Study||9
305790|NCT01688830|731227|P16|STARTED|Overall Study||9
305791|NCT01688830|731228|P15|STARTED|Overall Study||6
305792|NCT01688830|731229|P14|STARTED|Overall Study||6
305793|NCT01688830|731230|P13|STARTED|Overall Study||6
305794|NCT01688830|731231|P12|STARTED|Overall Study||6
305795|NCT01688830|731232|P11|STARTED|Overall Study||6
305796|NCT01688830|731233|P10|STARTED|Overall Study||6
305797|NCT01688830|731234|P9|STARTED|Overall Study||6
305798|NCT01688830|731235|P8|STARTED|Overall Study||6
305799|NCT01688830|731236|P7|STARTED|Overall Study||12
305800|NCT01688830|731237|P6|STARTED|Overall Study||6
305801|NCT01688830|731238|P5|STARTED|Overall Study||5
305802|NCT01688830|731239|P4|STARTED|Overall Study||6
305803|NCT01688830|731240|P3|STARTED|Overall Study||6
305804|NCT01688830|731241|P2|STARTED|Overall Study||6
305805|NCT01688830|731242|P1|STARTED|Overall Study||21
305806|NCT01688726|731388|P2|NOT COMPLETED|Overall Study||1
305807|NCT01688726|731389|P1|NOT COMPLETED|Overall Study||1
305808|NCT01688726|731388|P2|COMPLETED|Overall Study||44
305809|NCT01688726|731389|P1|COMPLETED|Overall Study||45
305810|NCT01688726|731388|P2|STARTED|Overall Study||45
305811|NCT01688726|731389|P1|STARTED|Overall Study||46
305812|NCT01688635|731401|P2|NOT COMPLETED|Period 4||0
305813|NCT01688635|731402|P1|NOT COMPLETED|Period 4||0
305814|NCT01688635|731401|P2|COMPLETED|Period 4||42
305815|NCT01688635|731402|P1|COMPLETED|Period 4||40
305816|NCT01688635|731401|P2|STARTED|Period 4||42
305817|NCT01688635|731402|P1|STARTED|Period 4||40
305818|NCT01688635|731401|P2|NOT COMPLETED|Washout 3||0
305819|NCT01688635|731402|P1|NOT COMPLETED|Washout 3||1
305820|NCT01688635|731401|P2|COMPLETED|Washout 3||42
305821|NCT01688635|731402|P1|COMPLETED|Washout 3||40
305822|NCT01688635|731401|P2|STARTED|Washout 3||42
305823|NCT01688635|731402|P1|STARTED|Washout 3||41
305824|NCT01688635|731401|P2|NOT COMPLETED|Period 3||0
305825|NCT01688635|731402|P1|NOT COMPLETED|Period 3||0
305826|NCT01688635|731401|P2|COMPLETED|Period 3||42
305827|NCT01688635|731402|P1|COMPLETED|Period 3||41
305828|NCT01688635|731401|P2|STARTED|Period 3||42
305829|NCT01688635|731402|P1|STARTED|Period 3||41
305830|NCT01688635|731401|P2|NOT COMPLETED|Washout 2||2
305831|NCT01688635|731402|P1|NOT COMPLETED|Washout 2||3
305832|NCT01688635|731401|P2|COMPLETED|Washout 2||42
305833|NCT01688635|731402|P1|COMPLETED|Washout 2||41
305834|NCT01688635|731401|P2|STARTED|Washout 2||44
305835|NCT01688635|731402|P1|STARTED|Washout 2||44
305836|NCT01688635|731401|P2|NOT COMPLETED|Period 2||0
305837|NCT01688635|731402|P1|NOT COMPLETED|Period 2||0
305838|NCT01688635|731401|P2|COMPLETED|Period 2||44
305839|NCT01688635|731402|P1|COMPLETED|Period 2||44
305840|NCT01688635|731401|P2|STARTED|Period 2||44
305841|NCT01688635|731402|P1|STARTED|Period 2||44
305842|NCT01688635|731401|P2|NOT COMPLETED|Washout 1||2
305843|NCT01688635|731402|P1|NOT COMPLETED|Washout 1||1
305844|NCT01688635|731401|P2|COMPLETED|Washout 1||44
305845|NCT01688635|731402|P1|COMPLETED|Washout 1||44
305846|NCT01688635|731401|P2|STARTED|Washout 1||46
305847|NCT01688635|731402|P1|STARTED|Washout 1||45
305848|NCT01688635|731401|P2|NOT COMPLETED|Period 1||0
305849|NCT01688635|731402|P1|NOT COMPLETED|Period 1||0
305850|NCT01688635|731401|P2|COMPLETED|Period 1||46
305851|NCT01688635|731402|P1|COMPLETED|Period 1||45
305852|NCT01688635|731401|P2|Received at Least 1 Dose of Study Drug|Period 1||46
305853|NCT01688635|731402|P1|Received at Least 1 Dose of Study Drug|Period 1||45
305854|NCT01688635|731401|P2|STARTED|Period 1||46
305855|NCT01688635|731402|P1|STARTED|Period 1||45
305856|NCT01688310|731416|P2|NOT COMPLETED|Overall Study||0
305857|NCT01688310|731417|P1|NOT COMPLETED|Overall Study||0
305858|NCT01688310|731416|P2|COMPLETED|Overall Study||100
305859|NCT01688310|731417|P1|COMPLETED|Overall Study||100
305860|NCT01688310|731416|P2|STARTED|Overall Study||100
305861|NCT01688310|731417|P1|STARTED|Overall Study||100
305862|NCT01688102|731437|P2|NOT COMPLETED|Overall Study||18
305863|NCT01688102|731438|P1|NOT COMPLETED|Overall Study||16
305864|NCT01688102|731437|P2|COMPLETED|Overall Study||40
305865|NCT01688102|731438|P1|COMPLETED|Overall Study||44
305866|NCT01688102|731437|P2|STARTED|Overall Study||58
305867|NCT01688102|731438|P1|STARTED|Overall Study||60
305868|NCT01688050|731444|P1|NOT COMPLETED|Overall Study||50
305869|NCT01688050|731444|P1|COMPLETED|Overall Study||0
305870|NCT01688050|731444|P1|30 Days|Overall Study||50
305871|NCT01688050|731444|P1|STARTED|Overall Study||50
305872|NCT01687790|731450|P1|NOT COMPLETED|Overall Study||0
305873|NCT01687790|731450|P1|COMPLETED|Overall Study||60
305874|NCT01687790|731450|P1|STARTED|Overall Study||60
305875|NCT01687270|731455|P1|NOT COMPLETED|Overall Study||12
305876|NCT01687270|731455|P1|COMPLETED|Overall Study||28
305877|NCT01687270|731455|P1|STARTED|Overall Study||40
305878|NCT01687257|731466|P3|NOT COMPLETED|Overall Study||6
305879|NCT01687257|731467|P2|NOT COMPLETED|Overall Study||4
305880|NCT01687257|731468|P1|NOT COMPLETED|Overall Study||8
305881|NCT01687257|731466|P3|COMPLETED|Overall Study||15
305882|NCT01687257|731467|P2|COMPLETED|Overall Study||0
305883|NCT01687257|731468|P1|COMPLETED|Overall Study||17
305884|NCT01687257|731466|P3|STARTED|Overall Study||21
305885|NCT01687257|731467|P2|STARTED|Overall Study||4
305886|NCT01687257|731468|P1|STARTED|Overall Study||25
305887|NCT01687244|731496|P2|NOT COMPLETED|Overall Study||0
305888|NCT01687244|731497|P1|NOT COMPLETED|Overall Study||0
305889|NCT01687244|731496|P2|COMPLETED|Overall Study||19
305890|NCT01687244|731497|P1|COMPLETED|Overall Study||21
305891|NCT01687244|731496|P2|STARTED|Overall Study||19
305892|NCT01687244|731497|P1|STARTED|Overall Study||21
305893|NCT01687218|731533|P6|NOT COMPLETED|Overall Study||0
305894|NCT01687218|731534|P5|NOT COMPLETED|Overall Study||1
305895|NCT01687218|731535|P4|NOT COMPLETED|Overall Study||2
305896|NCT01687218|731536|P3|NOT COMPLETED|Overall Study||1
305897|NCT01687218|731537|P2|NOT COMPLETED|Overall Study||3
305898|NCT01687218|731538|P1|NOT COMPLETED|Overall Study||3
305899|NCT01687218|731533|P6|COMPLETED|Overall Study||32
305900|NCT01687218|731534|P5|COMPLETED|Overall Study||32
305901|NCT01687218|731535|P4|COMPLETED|Overall Study||32
305902|NCT01687218|731536|P3|COMPLETED|Overall Study||30
305903|NCT01687218|731537|P2|COMPLETED|Overall Study||29
305904|NCT01687218|731538|P1|COMPLETED|Overall Study||30
305905|NCT01687218|731533|P6|STARTED|Overall Study||32
305906|NCT01687218|731534|P5|STARTED|Overall Study||33
305907|NCT01687218|731535|P4|STARTED|Overall Study||34
305908|NCT01687218|731536|P3|STARTED|Overall Study||31
305909|NCT01687218|731537|P2|STARTED|Overall Study||32
305910|NCT01687218|731538|P1|STARTED|Overall Study||33
305911|NCT01687114|731558|P1|NOT COMPLETED|Overall Study||0
305912|NCT01687114|731558|P1|COMPLETED|Overall Study||5
305913|NCT01687114|731558|P1|STARTED|Overall Study||5
305914|NCT01687101|731562|P1|NOT COMPLETED|Overall Study||7
305915|NCT01687101|731562|P1|COMPLETED|Overall Study||25
305916|NCT01687101|731562|P1|STARTED|Overall Study||32
305917|NCT01687088|731568|P2|NOT COMPLETED|Overall Study||0
305918|NCT01687088|731569|P1|NOT COMPLETED|Overall Study||0
305919|NCT01687088|731568|P2|COMPLETED|Overall Study||50
305920|NCT01687088|731569|P1|COMPLETED|Overall Study||50
305921|NCT01687088|731568|P2|STARTED|Overall Study||50
305922|NCT01687088|731569|P1|STARTED|Overall Study||50
305923|NCT01687036|731575|P1|NOT COMPLETED|Overall Study||0
305924|NCT01687036|731575|P1|COMPLETED|Overall Study||10
305925|NCT01687036|731575|P1|STARTED|Overall Study||10
305926|NCT01686932|731589|P2|NOT COMPLETED|Period 2||0
305927|NCT01686932|731590|P1|NOT COMPLETED|Period 2||0
305928|NCT01686932|731589|P2|COMPLETED|Period 2||25
305929|NCT01686932|731590|P1|COMPLETED|Period 2||24
305930|NCT01686932|731589|P2|STARTED|Period 2||25
305931|NCT01686932|731590|P1|STARTED|Period 2||24
305932|NCT01686932|731589|P2|NOT COMPLETED|Period 1||1
305933|NCT01686932|731590|P1|NOT COMPLETED|Period 1||1
305934|NCT01686932|731589|P2|COMPLETED|Period 1||25
305935|NCT01686932|731590|P1|COMPLETED|Period 1||24
305936|NCT01686932|731589|P2|STARTED|Period 1||26
305937|NCT01686932|731590|P1|STARTED|Period 1||25
305938|NCT01686828|731620|P4|NOT COMPLETED|Overall Study||0
305939|NCT01686828|731621|P3|NOT COMPLETED|Overall Study||1
305940|NCT01686828|731622|P2|NOT COMPLETED|Overall Study||1
305941|NCT01686828|731623|P1|NOT COMPLETED|Overall Study||1
305942|NCT01686828|731620|P4|COMPLETED|Overall Study||13
305943|NCT01686828|731621|P3|COMPLETED|Overall Study||12
305944|NCT01686828|731622|P2|COMPLETED|Overall Study||13
305945|NCT01686828|731623|P1|COMPLETED|Overall Study||12
305946|NCT01686828|731620|P4|STARTED|Overall Study||13
305947|NCT01686828|731621|P3|STARTED|Overall Study||13
305948|NCT01686828|731622|P2|STARTED|Overall Study||14
305949|NCT01686828|731623|P1|STARTED|Overall Study||13
305950|NCT01686646|731645|P4|NOT COMPLETED|Overall Study||0
305951|NCT01686646|731646|P3|NOT COMPLETED|Overall Study||0
305952|NCT01686646|731647|P2|NOT COMPLETED|Overall Study||0
305953|NCT01686646|731648|P1|NOT COMPLETED|Overall Study||0
305954|NCT01686646|731645|P4|COMPLETED|Overall Study||75
305955|NCT01686646|731646|P3|COMPLETED|Overall Study||75
305956|NCT01686646|731647|P2|COMPLETED|Overall Study||45
305957|NCT01686646|731648|P1|COMPLETED|Overall Study||45
305958|NCT01686646|731645|P4|Safety Population|Overall Study||75
305959|NCT01686646|731646|P3|Safety Population|Overall Study||74
305960|NCT01686646|731647|P2|Safety Population|Overall Study||45
305961|NCT01686646|731648|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
305962|NCT01686646|731645|P4|Intent to Treat Population|Overall Study||75
305963|NCT01686646|731646|P3|Intent to Treat Population|Overall Study||75
305964|NCT01686646|731647|P2|Intent to Treat Population|Overall Study||45
305965|NCT01686646|731648|P1|Intent to Treat Population|Overall Study||45
305966|NCT01686646|731645|P4|STARTED|Overall Study||75
305967|NCT01686646|731646|P3|STARTED|Overall Study||75
305968|NCT01686646|731647|P2|STARTED|Overall Study||45
305969|NCT01686646|731648|P1|STARTED|Overall Study||45
305970|NCT01686633|731697|P3|NOT COMPLETED|Overall Study||25
305971|NCT01686633|731698|P2|NOT COMPLETED|Overall Study||32
305972|NCT01686633|731699|P1|NOT COMPLETED|Overall Study||51
305973|NCT01686633|731697|P3|COMPLETED|Overall Study||321
305974|NCT01686633|731698|P2|COMPLETED|Overall Study||314
305975|NCT01686633|731699|P1|COMPLETED|Overall Study||296
305976|NCT01686633|731697|P3|STARTED|Overall Study||346
305977|NCT01686633|731698|P2|STARTED|Overall Study||346
305978|NCT01686633|731699|P1|STARTED|Overall Study||347
305979|NCT01686568|731724|P2|NOT COMPLETED|Sub-Study||2
305980|NCT01686568|731725|P1|NOT COMPLETED|Sub-Study||2
305981|NCT01686568|731724|P2|COMPLETED|Sub-Study||9
305982|NCT01686568|731725|P1|COMPLETED|Sub-Study||12
305983|NCT01686568|731724|P2|STARTED|Sub-Study||11
305984|NCT01686568|731725|P1|STARTED|Sub-Study||14
305985|NCT01686568|731724|P2|NOT COMPLETED|Main Study||4
305986|NCT01686568|731725|P1|NOT COMPLETED|Main Study||2
305987|NCT01686568|731724|P2|COMPLETED|Main Study||11
305988|NCT01686568|731725|P1|COMPLETED|Main Study||14
305989|NCT01686568|731724|P2|STARTED|Main Study||15
305990|NCT01686568|731725|P1|STARTED|Main Study||16
305991|NCT01686503|731751|P4|NOT COMPLETED|Overall Study||1
305992|NCT01686503|731752|P3|NOT COMPLETED|Overall Study||2
305993|NCT01686503|731753|P2|NOT COMPLETED|Overall Study||3
305994|NCT01686503|731754|P1|NOT COMPLETED|Overall Study||1
305995|NCT01686503|731751|P4|COMPLETED|Overall Study||32
305996|NCT01686503|731752|P3|COMPLETED|Overall Study||64
305997|NCT01686503|731753|P2|COMPLETED|Overall Study||63
305998|NCT01686503|731754|P1|COMPLETED|Overall Study||65
305999|NCT01686503|731751|P4|STARTED|Overall Study||33
306000|NCT01686503|731752|P3|STARTED|Overall Study||66
306001|NCT01686503|731753|P2|STARTED|Overall Study||66
306002|NCT01686503|731754|P1|STARTED|Overall Study||66
306003|NCT01686451|731770|P2|NOT COMPLETED|Overall Study||0
306004|NCT01686451|731771|P1|NOT COMPLETED|Overall Study||0
306005|NCT01686451|731770|P2|COMPLETED|Overall Study||27
306006|NCT01686451|731771|P1|COMPLETED|Overall Study||33
306007|NCT01686451|731770|P2|STARTED|Overall Study||27
306008|NCT01686451|731771|P1|STARTED|Overall Study||33
306009|NCT01685996|731801|P2|NOT COMPLETED|Overall Study||13
306010|NCT01685996|731802|P1|NOT COMPLETED|Overall Study||16
306011|NCT01685996|731801|P2|COMPLETED|Overall Study||27
306012|NCT01685996|731802|P1|COMPLETED|Overall Study||18
306013|NCT01685996|731801|P2|STARTED|Overall Study||40
306014|NCT01685996|731802|P1|STARTED|Overall Study||34
306015|NCT01685983|731810|P1|NOT COMPLETED|Overall Study||82
306016|NCT01685983|731810|P1|COMPLETED|Overall Study||0
306017|NCT01685983|731810|P1|STARTED|Overall Study||82
306018|NCT01685801|731824|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
306019|NCT01685801|731825|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
306020|NCT01685801|731826|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
306021|NCT01685801|731827|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
306022|NCT01685801|731824|P4|COMPLETED|Open-label Period (8 Weeks)||4
306023|NCT01685801|731825|P3|COMPLETED|Open-label Period (8 Weeks)||7
306024|NCT01685801|731826|P2|COMPLETED|Open-label Period (8 Weeks)||5
306025|NCT01685801|731827|P1|COMPLETED|Open-label Period (8 Weeks)||5
306026|NCT01685801|731824|P4|STARTED|Open-label Period (8 Weeks)||4
306027|NCT01685801|731825|P3|STARTED|Open-label Period (8 Weeks)||7
306028|NCT01685801|731826|P2|STARTED|Open-label Period (8 Weeks)||5
306029|NCT01685801|731827|P1|STARTED|Open-label Period (8 Weeks)||5
306030|NCT01685801|731824|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
306031|NCT01685801|731825|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
306032|NCT01685801|731826|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
306033|NCT01685801|731827|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
306034|NCT01685801|731824|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
306035|NCT01685801|731825|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
306036|NCT01685801|731826|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
306037|NCT01685801|731827|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
306038|NCT01685801|731824|P4|STARTED|Washout Period 2 (4 Weeks)||4
306039|NCT01685801|731825|P3|STARTED|Washout Period 2 (4 Weeks)||7
306040|NCT01685801|731826|P2|STARTED|Washout Period 2 (4 Weeks)||5
306041|NCT01685801|731827|P1|STARTED|Washout Period 2 (4 Weeks)||5
306042|NCT01685801|731824|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
306043|NCT01685801|731825|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
306044|NCT01685801|731826|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
306045|NCT01685801|731827|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
306046|NCT01685801|731824|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
306047|NCT01685801|731825|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
306048|NCT01685801|731826|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
306049|NCT01685801|731827|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
306050|NCT01685801|731824|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
306051|NCT01685801|731825|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
306052|NCT01685801|731826|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
306053|NCT01685801|731827|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
306054|NCT01685801|731824|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
306055|NCT01685801|731825|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
306056|NCT01685801|731826|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
306057|NCT01685801|731827|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
306058|NCT01685801|731824|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
306059|NCT01685801|731825|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
306060|NCT01685801|731826|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
306061|NCT01685801|731827|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
306062|NCT01685801|731824|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
306063|NCT01685801|731825|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
306064|NCT01685801|731826|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
306065|NCT01685801|731827|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
306066|NCT01685801|731824|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
306067|NCT01685801|731825|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
306068|NCT01685801|731826|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
306069|NCT01685801|731827|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
306070|NCT01685801|731824|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
306071|NCT01685801|731825|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
306072|NCT01685801|731826|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
306073|NCT01685801|731827|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
306074|NCT01685801|731824|P4|STARTED|Washout Period 1 (4 Weeks)||5
306075|NCT01685801|731825|P3|STARTED|Washout Period 1 (4 Weeks)||7
306076|NCT01685801|731826|P2|STARTED|Washout Period 1 (4 Weeks)||6
306077|NCT01685801|731827|P1|STARTED|Washout Period 1 (4 Weeks)||5
306078|NCT01685801|731824|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
306079|NCT01685801|731825|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
306080|NCT01685801|731826|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
306081|NCT01685801|731827|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
306082|NCT01685801|731824|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
306083|NCT01685801|731825|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
306084|NCT01685801|731826|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
306085|NCT01685801|731827|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
306086|NCT01685801|731824|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
306087|NCT01685801|731825|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
306088|NCT01685801|731826|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
306089|NCT01685801|731827|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
306090|NCT01685801|731824|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
306091|NCT01685801|731825|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
306092|NCT01685801|731826|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
306093|NCT01685801|731827|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
306094|NCT01685801|731824|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
306095|NCT01685801|731825|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
306096|NCT01685801|731826|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
306097|NCT01685801|731827|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
306098|NCT01685801|731824|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
306099|NCT01685801|731825|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
306100|NCT01685801|731826|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
306101|NCT01685801|731827|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
306102|NCT01685684|731849|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
306103|NCT01685684|731850|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
306104|NCT01685684|731851|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
306105|NCT01685684|731849|P3|COMPLETED|Double-blind Maintenance Phase||100
306106|NCT01685684|731850|P2|COMPLETED|Double-blind Maintenance Phase||122
306107|NCT01685684|731851|P1|COMPLETED|Double-blind Maintenance Phase||0
306108|NCT01685684|731849|P3|STARTED|Double-blind Maintenance Phase||196
306109|NCT01685684|731850|P2|STARTED|Double-blind Maintenance Phase||193
306110|NCT01685684|731851|P1|STARTED|Double-blind Maintenance Phase||0
306111|NCT01685684|731849|P3|NOT COMPLETED|Titration Phase||0
306112|NCT01685684|731850|P2|NOT COMPLETED|Titration Phase||0
306113|NCT01685684|731851|P1|NOT COMPLETED|Titration Phase||351
306114|NCT01685684|731849|P3|COMPLETED|Titration Phase||0
306115|NCT01685684|731850|P2|COMPLETED|Titration Phase||0
306116|NCT01685684|731851|P1|COMPLETED|Titration Phase||389
306117|NCT01685684|731849|P3|STARTED|Titration Phase||0
306118|NCT01685684|731850|P2|STARTED|Titration Phase||0
306119|NCT01685684|731851|P1|STARTED|Titration Phase||740
306120|NCT01685606|731875|P1|NOT COMPLETED|Overall Study||1
306121|NCT01685606|731875|P1|COMPLETED|Overall Study||5
306122|NCT01685606|731875|P1|STARTED|Overall Study||6
306123|NCT01685567|731880|P1|NOT COMPLETED|Overall Study||0
306124|NCT01685567|731880|P1|COMPLETED|Overall Study||219
306125|NCT01685567|731880|P1|STARTED|Overall Study||219
306126|NCT01685437|731888|P1|NOT COMPLETED|Overall Study||31
306127|NCT01685437|731888|P1|COMPLETED|Overall Study||158
306128|NCT01685437|731888|P1|STARTED|Overall Study||189
306129|NCT01685320|731902|P2|NOT COMPLETED|Overall Study||0
306130|NCT01685320|731903|P1|NOT COMPLETED|Overall Study||0
306131|NCT01685320|731902|P2|COMPLETED|Overall Study||15
306132|NCT01685320|731903|P1|COMPLETED|Overall Study||15
306133|NCT01685320|731902|P2|STARTED|Overall Study||15
306134|NCT01685320|731903|P1|STARTED|Overall Study||15
306135|NCT01685216|731911|P1|NOT COMPLETED|Overall Study||1
306136|NCT01685216|731911|P1|COMPLETED|Overall Study||6
306137|NCT01685216|731911|P1|STARTED|Overall Study||7
306138|NCT01685203|731928|P7|NOT COMPLETED|Overall Study||0
306139|NCT01685203|731929|P6|NOT COMPLETED|Overall Study||3
306140|NCT01685203|731930|P5|NOT COMPLETED|Overall Study||0
306141|NCT01685203|731931|P4|NOT COMPLETED|Overall Study||1
306142|NCT01685203|731932|P3|NOT COMPLETED|Overall Study||0
306143|NCT01685203|731933|P2|NOT COMPLETED|Overall Study||3
306144|NCT01685203|731934|P1|NOT COMPLETED|Overall Study||4
306145|NCT01685203|731928|P7|COMPLETED|Overall Study||52
306146|NCT01685203|731929|P6|COMPLETED|Overall Study||44
306147|NCT01685203|731930|P5|COMPLETED|Overall Study||49
306148|NCT01685203|731931|P4|COMPLETED|Overall Study||41
306149|NCT01685203|731932|P3|COMPLETED|Overall Study||40
306150|NCT01685203|731933|P2|COMPLETED|Overall Study||39
306151|NCT01685203|731934|P1|COMPLETED|Overall Study||40
306152|NCT01685203|731928|P7|Completed Study Drug|Overall Study||52
306153|NCT01685203|731929|P6|Completed Study Drug|Overall Study||43
306154|NCT01685203|731930|P5|Completed Study Drug|Overall Study||49
306155|NCT01685203|731931|P4|Completed Study Drug|Overall Study||42
306156|NCT01685203|731932|P3|Completed Study Drug|Overall Study||39
306157|NCT01685203|731933|P2|Completed Study Drug|Overall Study||40
306158|NCT01685203|731934|P1|Completed Study Drug|Overall Study||42
306159|NCT01685203|731928|P7|STARTED|Overall Study||52
306160|NCT01685203|731929|P6|STARTED|Overall Study||47
306161|NCT01685203|731930|P5|STARTED|Overall Study||49
306162|NCT01685203|731931|P4|STARTED|Overall Study||42
306163|NCT01685203|731932|P3|STARTED|Overall Study||40
306164|NCT01685203|731933|P2|STARTED|Overall Study||42
306165|NCT01685203|731934|P1|STARTED|Overall Study||44
306166|NCT01685060|731978|P1|NOT COMPLETED|Overall Study||140
306167|NCT01685060|731978|P1|COMPLETED|Overall Study||0
306168|NCT01685060|731978|P1|Discontinued From Study|Overall Study||35
306169|NCT01685060|731978|P1|Entered Survival Follow up|Overall Study||98
306170|NCT01685060|731978|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
306171|NCT01685060|731978|P1|STARTED|Overall Study||140
306172|NCT01684930|731995|P2|NOT COMPLETED|Overall Study||1
306173|NCT01684930|731996|P1|NOT COMPLETED|Overall Study||3
306174|NCT01684930|731995|P2|COMPLETED|Overall Study||13
306175|NCT01684930|731996|P1|COMPLETED|Overall Study||9
306176|NCT01684930|731995|P2|STARTED|Overall Study||14
306177|NCT01684930|731996|P1|STARTED|Overall Study||12
306178|NCT01684878|732012|P4|NOT COMPLETED|Part 2: Randomized Phase||78
306179|NCT01684878|732013|P3|NOT COMPLETED|Part 2: Randomized Phase||78
306180|NCT01684878|732014|P2|NOT COMPLETED|Part 2: Randomized Phase||0
306181|NCT01684878|732015|P1|NOT COMPLETED|Part 2: Randomized Phase||0
306182|NCT01684878|732012|P4|COMPLETED|Part 2: Randomized Phase||0
306183|NCT01684878|732013|P3|COMPLETED|Part 2: Randomized Phase||0
306184|NCT01684878|732014|P2|COMPLETED|Part 2: Randomized Phase||0
306185|NCT01684878|732015|P1|COMPLETED|Part 2: Randomized Phase||0
306186|NCT01684878|732012|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
306187|NCT01684878|732013|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
306188|NCT01684878|732014|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
306189|NCT01684878|732015|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
306190|NCT01684878|732012|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
306191|NCT01684878|732013|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
306192|NCT01684878|732014|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
306193|NCT01684878|732015|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
306194|NCT01684878|732012|P4|STARTED|Part 2: Randomized Phase||78
306195|NCT01684878|732013|P3|STARTED|Part 2: Randomized Phase||78
306196|NCT01684878|732014|P2|STARTED|Part 2: Randomized Phase||0
306197|NCT01684878|732015|P1|STARTED|Part 2: Randomized Phase||0
306198|NCT01684878|732012|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
306199|NCT01684878|732013|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
306200|NCT01684878|732014|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
306201|NCT01684878|732015|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
306202|NCT01684878|732012|P4|COMPLETED|Part 1: Safety Run in Phase||0
306203|NCT01684878|732013|P3|COMPLETED|Part 1: Safety Run in Phase||0
306204|NCT01684878|732014|P2|COMPLETED|Part 1: Safety Run in Phase||5
306205|NCT01684878|732015|P1|COMPLETED|Part 1: Safety Run in Phase||6
306206|NCT01684878|732012|P4|STARTED|Part 1: Safety Run in Phase||0
306207|NCT01684878|732013|P3|STARTED|Part 1: Safety Run in Phase||0
306208|NCT01684878|732014|P2|STARTED|Part 1: Safety Run in Phase||28
306209|NCT01684878|732015|P1|STARTED|Part 1: Safety Run in Phase||22
306210|NCT01684839|732039|P1|NOT COMPLETED|Overall Study||0
306211|NCT01684839|732039|P1|COMPLETED|Overall Study||9
306212|NCT01684839|732039|P1|STARTED|Overall Study||9
306213|NCT01684826|732043|P1|NOT COMPLETED|Overall Study||10
306214|NCT01684826|732043|P1|COMPLETED|Overall Study||39
306215|NCT01684826|732043|P1|Collected Dose and Image Information|Overall Study||39
306216|NCT01684826|732043|P1|STARTED|Overall Study||49
306217|NCT01684748|732051|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
306218|NCT01684748|732052|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
306219|NCT01684748|732051|P2|COMPLETED|Second Intervention - 8 Weeks||8
306220|NCT01684748|732052|P1|COMPLETED|Second Intervention - 8 Weeks||8
306221|NCT01684748|732051|P2|STARTED|Second Intervention - 8 Weeks||8
306222|NCT01684748|732052|P1|STARTED|Second Intervention - 8 Weeks||8
306223|NCT01684748|732051|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
306224|NCT01684748|732052|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
306225|NCT01684748|732051|P2|COMPLETED|First Intervention - 8 Weeks||8
306226|NCT01684748|732052|P1|COMPLETED|First Intervention - 8 Weeks||8
306227|NCT01684748|732051|P2|STARTED|First Intervention - 8 Weeks||10
306228|NCT01684748|732052|P1|STARTED|First Intervention - 8 Weeks||10
306229|NCT01684566|732060|P2|NOT COMPLETED|Overall Study||7
306230|NCT01684566|732061|P1|NOT COMPLETED|Overall Study||16
306231|NCT01684566|732060|P2|COMPLETED|Overall Study||49
306232|NCT01684566|732061|P1|COMPLETED|Overall Study||44
306233|NCT01684566|732060|P2|Treated (ITT)|Overall Study||52
306234|NCT01684566|732061|P1|Treated (ITT)|Overall Study||57
306235|NCT01684566|732060|P2|STARTED|Overall Study||56
306236|NCT01684566|732061|P1|STARTED|Overall Study||60
306237|NCT01684436|732083|P1|NOT COMPLETED|Overall Study||1
306238|NCT01684436|732083|P1|COMPLETED|Overall Study||29
306239|NCT01684436|732083|P1|STARTED|Overall Study||30
306240|NCT01684410|732095|P3|NOT COMPLETED|Overall Study||0
306241|NCT01684410|732096|P2|NOT COMPLETED|Overall Study||0
306242|NCT01684410|732097|P1|NOT COMPLETED|Overall Study||0
306243|NCT01684410|732095|P3|COMPLETED|Overall Study||10
306244|NCT01684410|732096|P2|COMPLETED|Overall Study||10
306245|NCT01684410|732097|P1|COMPLETED|Overall Study||10
306246|NCT01684410|732095|P3|STARTED|Overall Study||10
306247|NCT01684410|732096|P2|STARTED|Overall Study||10
306248|NCT01684410|732097|P1|STARTED|Overall Study||10
306249|NCT01684215|732115|P4|NOT COMPLETED|Overall Study||43
306250|NCT01684215|732116|P3|NOT COMPLETED|Overall Study||6
306251|NCT01684215|732117|P2|NOT COMPLETED|Overall Study||6
306252|NCT01684215|732118|P1|NOT COMPLETED|Overall Study||6
306253|NCT01684215|732115|P4|COMPLETED|Overall Study||0
306254|NCT01684215|732116|P3|COMPLETED|Overall Study||0
306255|NCT01684215|732117|P2|COMPLETED|Overall Study||0
306256|NCT01684215|732118|P1|COMPLETED|Overall Study||0
306257|NCT01684215|732115|P4|Treated|Overall Study||42
306258|NCT01684215|732116|P3|Treated|Overall Study||6
306259|NCT01684215|732117|P2|Treated|Overall Study||6
306260|NCT01684215|732118|P1|Treated|Overall Study||6
306261|NCT01684215|732115|P4|STARTED|Overall Study||43
306262|NCT01684215|732116|P3|STARTED|Overall Study||6
306263|NCT01684215|732117|P2|STARTED|Overall Study||6
306264|NCT01684215|732118|P1|STARTED|Overall Study||6
306265|NCT01684046|732192|P2|NOT COMPLETED|Period 2, Second 30 Days||0
306266|NCT01684046|732193|P1|NOT COMPLETED|Period 2, Second 30 Days||0
306267|NCT01684046|732192|P2|COMPLETED|Period 2, Second 30 Days||93
306268|NCT01684046|732193|P1|COMPLETED|Period 2, Second 30 Days||97
306269|NCT01684046|732192|P2|STARTED|Period 2, Second 30 Days||93
306270|NCT01684046|732193|P1|STARTED|Period 2, Second 30 Days||97
306271|NCT01684046|732192|P2|NOT COMPLETED|Period 1, First 30 Days||2
306272|NCT01684046|732193|P1|NOT COMPLETED|Period 1, First 30 Days||0
306273|NCT01684046|732192|P2|COMPLETED|Period 1, First 30 Days||93
306274|NCT01684046|732193|P1|COMPLETED|Period 1, First 30 Days||97
306275|NCT01684046|732192|P2|STARTED|Period 1, First 30 Days||95
306276|NCT01684046|732193|P1|STARTED|Period 1, First 30 Days||97
306277|NCT01684033|732199|P2|NOT COMPLETED|Period 2, Second 30 Days||0
306278|NCT01684033|732200|P1|NOT COMPLETED|Period 2, Second 30 Days||1
306279|NCT01684033|732199|P2|COMPLETED|Period 2, Second 30 Days||98
306280|NCT01684033|732200|P1|COMPLETED|Period 2, Second 30 Days||94
306281|NCT01684033|732199|P2|STARTED|Period 2, Second 30 Days||98
306282|NCT01684033|732200|P1|STARTED|Period 2, Second 30 Days||95
306283|NCT01684033|732199|P2|NOT COMPLETED|Period 1, First 30 Days||1
306284|NCT01684033|732200|P1|NOT COMPLETED|Period 1, First 30 Days||4
306285|NCT01684033|732199|P2|COMPLETED|Period 1, First 30 Days||98
306286|NCT01684033|732200|P1|COMPLETED|Period 1, First 30 Days||95
306287|NCT01684033|732199|P2|STARTED|Period 1, First 30 Days||99
306288|NCT01684033|732200|P1|STARTED|Period 1, First 30 Days||99
306289|NCT01684007|732210|P2|NOT COMPLETED|Overall Study||0
306290|NCT01684007|732211|P1|NOT COMPLETED|Overall Study||0
306291|NCT01684007|732210|P2|COMPLETED|Overall Study||50
306292|NCT01684007|732211|P1|COMPLETED|Overall Study||53
306293|NCT01684007|732210|P2|STARTED|Overall Study||50
306294|NCT01684007|732211|P1|STARTED|Overall Study||53
306295|NCT01682954|732221|P2|NOT COMPLETED|Overall Study||5
306296|NCT01682954|732222|P1|NOT COMPLETED|Overall Study||5
306297|NCT01682954|732221|P2|COMPLETED|Overall Study||33
306298|NCT01682954|732222|P1|COMPLETED|Overall Study||35
306299|NCT01682954|732221|P2|STARTED|Overall Study||38
306300|NCT01682954|732222|P1|STARTED|Overall Study||40
306301|NCT01682876|732234|P4|NOT COMPLETED|Overall Study||19
306302|NCT01682876|732235|P3|NOT COMPLETED|Overall Study||11
306303|NCT01682876|732236|P2|NOT COMPLETED|Overall Study||20
306304|NCT01682876|732237|P1|NOT COMPLETED|Overall Study||21
306305|NCT01682876|732234|P4|COMPLETED|Overall Study||157
306306|NCT01682876|732235|P3|COMPLETED|Overall Study||169
306307|NCT01682876|732236|P2|COMPLETED|Overall Study||163
306308|NCT01682876|732237|P1|COMPLETED|Overall Study||155
306309|NCT01682876|732234|P4|STARTED|Overall Study||176
306310|NCT01682876|732235|P3|STARTED|Overall Study||180
306311|NCT01682876|732236|P2|STARTED|Overall Study||183
306312|NCT01682876|732237|P1|STARTED|Overall Study||176
306313|NCT01682863|732283|P3|NOT COMPLETED|Overall Study||24
306314|NCT01682863|732284|P2|NOT COMPLETED|Overall Study||17
306315|NCT01682863|732285|P1|NOT COMPLETED|Overall Study||27
306316|NCT01682863|732283|P3|COMPLETED|Overall Study||183
306317|NCT01682863|732284|P2|COMPLETED|Overall Study||187
306318|NCT01682863|732285|P1|COMPLETED|Overall Study||177
306406|NCT01683266|732621|P2|NOT COMPLETED|Overall Study||50
306319|NCT01682863|732283|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
306320|NCT01682863|732284|P2|Randomized Set|Overall Study||204
306321|NCT01682863|732285|P1|Randomized Set|Overall Study||204
306322|NCT01682863|732283|P3|Full Analysis Set (FAS)|Overall Study||206
306323|NCT01682863|732284|P2|Full Analysis Set (FAS)|Overall Study||204
306324|NCT01682863|732285|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
306325|NCT01682863|732283|P3|Safety Set|Overall Study||206
306326|NCT01682863|732284|P2|Safety Set|Overall Study||204
306327|NCT01682863|732285|P1|Safety Set|Overall Study||204
306328|NCT01682863|732283|P3|STARTED|Overall Study||207
306329|NCT01682863|732284|P2|STARTED|Overall Study||204
306330|NCT01682863|732285|P1|STARTED|Overall Study||204
306331|NCT01682837|732314|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
306332|NCT01682837|732314|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
306333|NCT01682837|732314|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
306334|NCT01682837|732314|P1|Received KCl|Fourth Intervention (4 Weeks)||8
306335|NCT01682837|732314|P1|Received KCit|Fourth Intervention (4 Weeks)||9
306336|NCT01682837|732314|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
306337|NCT01682837|732314|P1|STARTED|Fourth Intervention (4 Weeks)||30
306338|NCT01682837|732314|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
306339|NCT01682837|732314|P1|COMPLETED|Third Intervention (4 Weeks)||30
306340|NCT01682837|732314|P1|Received Placebo|Third Intervention (4 Weeks)||7
306341|NCT01682837|732314|P1|Received KCl|Third Intervention (4 Weeks)||7
306342|NCT01682837|732314|P1|Received KCit|Third Intervention (4 Weeks)||7
306343|NCT01682837|732314|P1|Received KMgCit|Third Intervention (4 Weeks)||9
306344|NCT01682837|732314|P1|STARTED|Third Intervention (4 Weeks)||30
306345|NCT01682837|732314|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
306346|NCT01682837|732314|P1|COMPLETED|Second Intervention (4 Weeks)||30
306347|NCT01682837|732314|P1|Received Placebo|Second Intervention (4 Weeks)||9
306348|NCT01682837|732314|P1|Received KCl|Second Intervention (4 Weeks)||8
306349|NCT01682837|732314|P1|Received KCit|Second Intervention (4 Weeks)||6
306350|NCT01682837|732314|P1|Received KMgCit|Second Intervention (4 Weeks)||7
306351|NCT01682837|732314|P1|STARTED|Second Intervention (4 Weeks)||30
306352|NCT01682837|732314|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
306353|NCT01682837|732314|P1|COMPLETED|First Intervention (4 Weeks)||30
306354|NCT01682837|732314|P1|Received Placebo|First Intervention (4 Weeks)||7
306355|NCT01682837|732314|P1|Received KCl|First Intervention (4 Weeks)||7
306356|NCT01682837|732314|P1|Received KCit|First Intervention (4 Weeks)||8
306357|NCT01682837|732314|P1|Received KMgCit|First Intervention (4 Weeks)||8
306358|NCT01682837|732314|P1|STARTED|First Intervention (4 Weeks)||30
306359|NCT01682837|732314|P1|NOT COMPLETED|Baseline||5
306360|NCT01682837|732314|P1|COMPLETED|Baseline||30
306361|NCT01682837|732314|P1|STARTED|Baseline||35
306362|NCT01682031|732358|P2|NOT COMPLETED|Overall Study||5
306363|NCT01682031|732359|P1|NOT COMPLETED|Overall Study||1
306364|NCT01682031|732358|P2|COMPLETED|Overall Study||5
306365|NCT01682031|732359|P1|COMPLETED|Overall Study||7
306366|NCT01682031|732358|P2|STARTED|Overall Study||10
306367|NCT01682031|732359|P1|STARTED|Overall Study||8
306368|NCT01683838|732381|P2|NOT COMPLETED|Overall Study||12
306369|NCT01683838|732382|P1|NOT COMPLETED|Overall Study||26
306370|NCT01683838|732381|P2|COMPLETED|Overall Study||88
306371|NCT01683838|732382|P1|COMPLETED|Overall Study||78
306372|NCT01683838|732381|P2|Efficacy Population|Overall Study||93
306373|NCT01683838|732382|P1|Efficacy Population|Overall Study||89
306374|NCT01683838|732381|P2|Safety Population|Overall Study||100
306375|NCT01683838|732382|P1|Safety Population|Overall Study||103
306376|NCT01683838|732381|P2|Intent to Treat (ITT) Population|Overall Study||100
306377|NCT01683838|732382|P1|Intent to Treat (ITT) Population|Overall Study||103
306378|NCT01683838|732381|P2|STARTED|Overall Study||100
306379|NCT01683838|732382|P1|STARTED|Overall Study||104
306380|NCT01683812|732404|P1|NOT COMPLETED|Overall Study||0
306381|NCT01683812|732404|P1|COMPLETED|Overall Study||23
306382|NCT01683812|732404|P1|STARTED|Overall Study||23
306383|NCT01683630|732411|P2|NOT COMPLETED|Overall Study||0
306384|NCT01683630|732412|P1|NOT COMPLETED|Overall Study||0
306385|NCT01683630|732411|P2|COMPLETED|Overall Study||445
306386|NCT01683630|732412|P1|COMPLETED|Overall Study||1404
306387|NCT01683630|732411|P2|STARTED|Overall Study||445
306388|NCT01683630|732412|P1|STARTED|Overall Study||1404
306389|NCT01683604|732422|P1|NOT COMPLETED|Overall Study||5
306390|NCT01683604|732422|P1|COMPLETED|Overall Study||32
306391|NCT01683604|732422|P1|STARTED|Overall Study||37
306392|NCT01683526|732587|P2|NOT COMPLETED|Overall Study||0
306393|NCT01683526|732588|P1|NOT COMPLETED|Overall Study||0
306394|NCT01683526|732587|P2|COMPLETED|Overall Study||57
306395|NCT01683526|732588|P1|COMPLETED|Overall Study||60
306396|NCT01683526|732587|P2|STARTED|Overall Study||57
306397|NCT01683526|732588|P1|STARTED|Overall Study||60
306398|NCT01683383|732604|P2|NOT COMPLETED|Overall Study||0
306399|NCT01683383|732605|P1|NOT COMPLETED|Overall Study||1
306400|NCT01683383|732604|P2|COMPLETED|Overall Study||51
306401|NCT01683383|732605|P1|COMPLETED|Overall Study||49
306402|NCT01683383|732604|P2|Transported and Treated|Overall Study||51
306403|NCT01683383|732605|P1|Transported and Treated|Overall Study||49
306404|NCT01683383|732604|P2|STARTED|Overall Study||51
306405|NCT01683383|732605|P1|STARTED|Overall Study||50
306407|NCT01683266|732622|P1|NOT COMPLETED|Overall Study||55
306408|NCT01683266|732621|P2|COMPLETED|Overall Study||225
306409|NCT01683266|732622|P1|COMPLETED|Overall Study||219
306410|NCT01683266|732621|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
306411|NCT01683266|732622|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
306412|NCT01683266|732621|P2|STARTED|Overall Study||275
306413|NCT01683266|732622|P1|STARTED|Overall Study||274
306414|NCT01683058|732650|P1|NOT COMPLETED|Overall Study||29
306415|NCT01683058|732650|P1|COMPLETED|Overall Study||45
306416|NCT01683058|732650|P1|STARTED|Overall Study||74
306417|NCT01683019|732681|P3|NOT COMPLETED|Overall Study||4
306418|NCT01683019|732682|P2|NOT COMPLETED|Overall Study||1
306419|NCT01683019|732683|P1|NOT COMPLETED|Overall Study||2
306420|NCT01683019|732681|P3|COMPLETED|Overall Study||15
306421|NCT01683019|732682|P2|COMPLETED|Overall Study||14
306422|NCT01683019|732683|P1|COMPLETED|Overall Study||16
306423|NCT01683019|732681|P3|STARTED|Overall Study||19
306424|NCT01683019|732682|P2|STARTED|Overall Study||15
306425|NCT01683019|732683|P1|STARTED|Overall Study||18
306426|NCT01682759|732693|P2|NOT COMPLETED|Overall Study||70
306427|NCT01682759|732694|P1|NOT COMPLETED|Overall Study||69
306428|NCT01682759|732693|P2|COMPLETED|Overall Study||305
306429|NCT01682759|732694|P1|COMPLETED|Overall Study||307
306430|NCT01682759|732693|P2|Treated|Overall Study||375
306431|NCT01682759|732694|P1|Treated|Overall Study||375
306432|NCT01682759|732693|P2|STARTED|Overall Study||375
306433|NCT01682759|732694|P1|STARTED|Overall Study||376
306434|NCT01682720|732718|P4|NOT COMPLETED|Overall Study||39
306435|NCT01682720|732719|P3|NOT COMPLETED|Overall Study||7
306436|NCT01682720|732720|P2|NOT COMPLETED|Overall Study||5
306437|NCT01682720|732721|P1|NOT COMPLETED|Overall Study||85
306438|NCT01682720|732718|P4|COMPLETED|Overall Study||211
306439|NCT01682720|732719|P3|COMPLETED|Overall Study||5
306440|NCT01682720|732720|P2|COMPLETED|Overall Study||69
306441|NCT01682720|732721|P1|COMPLETED|Overall Study||0
306442|NCT01682720|732718|P4|Included in Full Analysis Set|Overall Study||250
306443|NCT01682720|732719|P3|Included in Full Analysis Set|Overall Study||11
306444|NCT01682720|732720|P2|Included in Full Analysis Set|Overall Study||73
306445|NCT01682720|732721|P1|Included in Full Analysis Set|Overall Study||0
306446|NCT01682720|732718|P4|STARTED|Overall Study||250
306447|NCT01682720|732719|P3|STARTED|Overall Study||12
306448|NCT01682720|732720|P2|STARTED|Overall Study||74
306449|NCT01682720|732721|P1|STARTED|Overall Study||85
306450|NCT01682681|732738|P1|NOT COMPLETED|Overall Study||332
306451|NCT01682681|732738|P1|COMPLETED|Overall Study||902
306452|NCT01682681|732738|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
306453|NCT01682681|732738|P1|STARTED|Overall Study||1234
306454|NCT01682642|732748|P2|NOT COMPLETED|Overall Study||1
306455|NCT01682642|732749|P1|NOT COMPLETED|Overall Study||0
306456|NCT01682642|732748|P2|COMPLETED|Overall Study||58
306457|NCT01682642|732749|P1|COMPLETED|Overall Study||61
306458|NCT01682642|732748|P2|STARTED|Overall Study||59
306459|NCT01682642|732749|P1|STARTED|Overall Study||61
306460|NCT01682603|732767|P1|NOT COMPLETED|Overall Study||3
306461|NCT01682603|732767|P1|COMPLETED|Overall Study||34
306462|NCT01682603|732767|P1|STARTED|Overall Study||37
306463|NCT01682538|732781|P1|NOT COMPLETED|Overall Study||0
306464|NCT01682538|732781|P1|COMPLETED|Overall Study||12
306465|NCT01682538|732781|P1|STARTED|Overall Study||12
306466|NCT01682460|732809|P1|NOT COMPLETED|Overall Study||4
306467|NCT01682460|732809|P1|COMPLETED|Overall Study||11
306468|NCT01682460|732809|P1|STARTED|Overall Study||15
306469|NCT01682135|732827|P3|NOT COMPLETED|Overall Study||0
306470|NCT01682135|732828|P2|NOT COMPLETED|Overall Study||0
306471|NCT01682135|732829|P1|NOT COMPLETED|Overall Study||0
306472|NCT01682135|732827|P3|COMPLETED|Overall Study||12
306473|NCT01682135|732828|P2|COMPLETED|Overall Study||10
306474|NCT01682135|732829|P1|COMPLETED|Overall Study||6
306475|NCT01682135|732827|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
306476|NCT01682135|732828|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
306477|NCT01682135|732829|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
306478|NCT01682135|732827|P3|STARTED|Overall Study||12
306479|NCT01682135|732828|P2|STARTED|Overall Study||10
306480|NCT01682135|732829|P1|STARTED|Overall Study||6
306481|NCT01681628|732863|P2|NOT COMPLETED|19 Months Follow-up||43
306482|NCT01681628|732864|P1|NOT COMPLETED|19 Months Follow-up||62
306483|NCT01681628|732863|P2|COMPLETED|19 Months Follow-up||64
306484|NCT01681628|732864|P1|COMPLETED|19 Months Follow-up||52
306485|NCT01681628|732863|P2|STARTED|19 Months Follow-up||107
306486|NCT01681628|732864|P1|STARTED|19 Months Follow-up||114
306487|NCT01681628|732863|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
306488|NCT01681628|732864|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
306489|NCT01681628|732863|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
306490|NCT01681628|732864|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
306491|NCT01681628|732863|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
306492|NCT01681628|732864|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
306493|NCT01681628|732863|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
306581|NCT01680991|733060|P3|STARTED|Overall Study||13
306494|NCT01681628|732864|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
306495|NCT01681628|732863|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
306496|NCT01681628|732864|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
306497|NCT01681628|732863|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
306498|NCT01681628|732864|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
306499|NCT01681576|732877|P2|NOT COMPLETED|Period 2||1
306500|NCT01681576|732878|P1|NOT COMPLETED|Period 2||4
306501|NCT01681576|732877|P2|COMPLETED|Period 2||35
306502|NCT01681576|732878|P1|COMPLETED|Period 2||30
306503|NCT01681576|732877|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
306504|NCT01681576|732878|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
306505|NCT01681576|732877|P2|NOT COMPLETED|Period 1||0
306506|NCT01681576|732878|P1|NOT COMPLETED|Period 1||2
306507|NCT01681576|732877|P2|COMPLETED|Period 1||36
306508|NCT01681576|732878|P1|COMPLETED|Period 1||34
306509|NCT01681576|732877|P2|STARTED|Period 1||36
306510|NCT01681576|732878|P1|STARTED|Period 1||36
306511|NCT01681511|732894|P2|NOT COMPLETED|Overall Study||14
306512|NCT01681511|732895|P1|NOT COMPLETED|Overall Study||18
306513|NCT01681511|732894|P2|COMPLETED|Overall Study||35
306514|NCT01681511|732895|P1|COMPLETED|Overall Study||28
306515|NCT01681511|732894|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
306516|NCT01681511|732895|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
306517|NCT01681511|732894|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
306518|NCT01681511|732895|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
306519|NCT01681511|732894|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
306520|NCT01681511|732895|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
306521|NCT01681472|732913|P4|NOT COMPLETED|Overall Study||0
306522|NCT01681472|732914|P3|NOT COMPLETED|Overall Study||0
306523|NCT01681472|732915|P2|NOT COMPLETED|Overall Study||1
306524|NCT01681472|732916|P1|NOT COMPLETED|Overall Study||0
306525|NCT01681472|732913|P4|COMPLETED|Overall Study||8
306526|NCT01681472|732914|P3|COMPLETED|Overall Study||8
306527|NCT01681472|732915|P2|COMPLETED|Overall Study||7
306528|NCT01681472|732916|P1|COMPLETED|Overall Study||8
306529|NCT01681472|732913|P4|STARTED|Overall Study||8
306530|NCT01681472|732914|P3|STARTED|Overall Study||8
306531|NCT01681472|732915|P2|STARTED|Overall Study||8
306532|NCT01681472|732916|P1|STARTED|Overall Study||8
306533|NCT01681368|732926|P1|NOT COMPLETED|Overall Study||2
306534|NCT01681368|732926|P1|COMPLETED|Overall Study||9
306535|NCT01681368|732926|P1|STARTED|Overall Study||11
306536|NCT01681277|732943|P5|NOT COMPLETED|Overall Study||0
306537|NCT01681277|732944|P4|NOT COMPLETED|Overall Study||0
306538|NCT01681277|732945|P3|NOT COMPLETED|Overall Study||0
306539|NCT01681277|732946|P2|NOT COMPLETED|Overall Study||0
306540|NCT01681277|732947|P1|NOT COMPLETED|Overall Study||1
306541|NCT01681277|732943|P5|COMPLETED|Overall Study||9
306542|NCT01681277|732944|P4|COMPLETED|Overall Study||9
306543|NCT01681277|732945|P3|COMPLETED|Overall Study||9
306544|NCT01681277|732946|P2|COMPLETED|Overall Study||9
306545|NCT01681277|732947|P1|COMPLETED|Overall Study||11
306546|NCT01681277|732943|P5|STARTED|Overall Study||9
306547|NCT01681277|732944|P4|STARTED|Overall Study||9
306548|NCT01681277|732945|P3|STARTED|Overall Study||9
306549|NCT01681277|732946|P2|STARTED|Overall Study||9
306550|NCT01681277|732947|P1|STARTED|Overall Study||12
306551|NCT01681212|732988|P1|NOT COMPLETED|Overall Study||6
306552|NCT01681212|732988|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
306553|NCT01681212|732988|P1|Received Treatment|Overall Study||15
306554|NCT01681212|732988|P1|STARTED|Overall Study|Enrolled|21
306555|NCT01681121|732996|P2|NOT COMPLETED|Overall Study||11
306556|NCT01681121|732997|P1|NOT COMPLETED|Overall Study||8
306557|NCT01681121|732996|P2|COMPLETED|Overall Study||38
306558|NCT01681121|732997|P1|COMPLETED|Overall Study||36
306559|NCT01681121|732996|P2|STARTED|Overall Study||49
306560|NCT01681121|732997|P1|STARTED|Overall Study||44
306561|NCT01681095|733005|P2|NOT COMPLETED|Overall Study||0
306562|NCT01681095|733006|P1|NOT COMPLETED|Overall Study||0
306563|NCT01681095|733005|P2|COMPLETED|Overall Study||55
306564|NCT01681095|733006|P1|COMPLETED|Overall Study||55
306565|NCT01681095|733005|P2|STARTED|Overall Study||55
306566|NCT01681095|733006|P1|STARTED|Overall Study||55
306567|NCT01681069|733046|P2|NOT COMPLETED|Overall Study||7
306568|NCT01681069|733047|P1|NOT COMPLETED|Overall Study||5
306569|NCT01681069|733046|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
306570|NCT01681069|733047|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
306571|NCT01681069|733046|P2|Full Analysis Set (FAS)|Overall Study||60
306572|NCT01681069|733047|P1|Full Analysis Set (FAS)|Overall Study||57
306573|NCT01681069|733046|P2|STARTED|Overall Study||60
306574|NCT01681069|733047|P1|STARTED|Overall Study||60
306575|NCT01680991|733060|P3|NOT COMPLETED|Overall Study||4
306576|NCT01680991|733061|P2|NOT COMPLETED|Overall Study||19
306577|NCT01680991|733062|P1|NOT COMPLETED|Overall Study||8
306578|NCT01680991|733060|P3|COMPLETED|Overall Study||9
306579|NCT01680991|733061|P2|COMPLETED|Overall Study||4
306580|NCT01680991|733062|P1|COMPLETED|Overall Study||4
306582|NCT01680991|733061|P2|STARTED|Overall Study||23
306583|NCT01680991|733062|P1|STARTED|Overall Study||12
306584|NCT01680900|733123|P2|NOT COMPLETED|Overall Study||1
306585|NCT01680900|733124|P1|NOT COMPLETED|Overall Study||4
306586|NCT01680900|733123|P2|COMPLETED|Overall Study||11
306587|NCT01680900|733124|P1|COMPLETED|Overall Study||20
306588|NCT01680900|733123|P2|STARTED|Overall Study||12
306589|NCT01680900|733124|P1|STARTED|Overall Study||24
306590|NCT01680861|733142|P2|NOT COMPLETED|First 12 Months Post-transplant||0
306591|NCT01680861|733143|P1|NOT COMPLETED|First 12 Months Post-transplant||0
306592|NCT01680861|733142|P2|COMPLETED|First 12 Months Post-transplant||15
306593|NCT01680861|733143|P1|COMPLETED|First 12 Months Post-transplant||15
306594|NCT01680861|733142|P2|STARTED|First 12 Months Post-transplant||15
306595|NCT01680861|733143|P1|STARTED|First 12 Months Post-transplant||15
306596|NCT01680861|733142|P2|NOT COMPLETED|Early Post-transplant Period||1
306597|NCT01680861|733143|P1|NOT COMPLETED|Early Post-transplant Period||1
306598|NCT01680861|733142|P2|COMPLETED|Early Post-transplant Period||15
306599|NCT01680861|733143|P1|COMPLETED|Early Post-transplant Period||15
306600|NCT01680861|733142|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
306601|NCT01680861|733143|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
306602|NCT01680848|733161|P1|NOT COMPLETED|Overall Study||93
306603|NCT01680848|733161|P1|COMPLETED|Overall Study||189
306604|NCT01680848|733161|P1|STARTED|Overall Study||282
306605|NCT01680666|733167|P2|NOT COMPLETED|Overall Study||0
306606|NCT01680666|733168|P1|NOT COMPLETED|Overall Study||0
306607|NCT01680666|733167|P2|COMPLETED|Overall Study||66
306608|NCT01680666|733168|P1|COMPLETED|Overall Study||84
306609|NCT01680666|733167|P2|STARTED|Overall Study||66
306610|NCT01680666|733168|P1|STARTED|Overall Study||84
306611|NCT01680549|733176|P2|NOT COMPLETED|Overall Study||8
306612|NCT01680549|733177|P1|NOT COMPLETED|Overall Study||5
306613|NCT01680549|733176|P2|COMPLETED|Overall Study||17
306614|NCT01680549|733177|P1|COMPLETED|Overall Study||20
306615|NCT01680549|733176|P2|STARTED|Overall Study||25
306616|NCT01680549|733177|P1|STARTED|Overall Study||25
306617|NCT01680497|733189|P1|NOT COMPLETED|Overall Study||2
306618|NCT01680497|733189|P1|COMPLETED|Overall Study||68
306619|NCT01680497|733189|P1|STARTED|Overall Study||70
306620|NCT01680458|733199|P1|NOT COMPLETED|Overall Study||3
306621|NCT01680458|733199|P1|COMPLETED|Overall Study||27
306622|NCT01680458|733199|P1|STARTED|Overall Study||30
306623|NCT01680341|733210|P2|NOT COMPLETED|Overall Study||17
306624|NCT01680341|733211|P1|NOT COMPLETED|Overall Study||21
306625|NCT01680341|733210|P2|COMPLETED|Overall Study||119
306626|NCT01680341|733211|P1|COMPLETED|Overall Study||115
306627|NCT01680341|733210|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
306628|NCT01680341|733211|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
306629|NCT01680341|733210|P2|STARTED|Overall Study||136
306630|NCT01680341|733211|P1|STARTED|Overall Study||136
306631|NCT01680328|733231|P1|NOT COMPLETED|Overall Study||2
306632|NCT01680328|733231|P1|COMPLETED|Overall Study||80
306633|NCT01680328|733231|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
306634|NCT01680328|733231|P1|STARTED|Overall Study||82
306635|NCT01680172|733269|P2|NOT COMPLETED|Overall Study||0
306636|NCT01680172|733270|P1|NOT COMPLETED|Overall Study||0
306637|NCT01680172|733269|P2|COMPLETED|Overall Study||2
306638|NCT01680172|733270|P1|COMPLETED|Overall Study||3
306639|NCT01680172|733269|P2|STARTED|Overall Study||2
306640|NCT01680172|733270|P1|STARTED|Overall Study||3
306641|NCT01680159|733282|P1|NOT COMPLETED|Increased Dose Period||8
306642|NCT01680159|733282|P1|COMPLETED|Increased Dose Period||43
306643|NCT01680159|733282|P1|STARTED|Increased Dose Period||51
306644|NCT01680159|733282|P1|NOT COMPLETED|Screening Period||7
306645|NCT01680159|733282|P1|COMPLETED|Screening Period||39
306646|NCT01680159|733282|P1|STARTED|Screening Period||46
306647|NCT01680016|733309|P4|NOT COMPLETED|Overall Study||5
306648|NCT01680016|733310|P3|NOT COMPLETED|Overall Study||5
306649|NCT01680016|733311|P2|NOT COMPLETED|Overall Study||8
306650|NCT01680016|733312|P1|NOT COMPLETED|Overall Study||6
306651|NCT01680016|733309|P4|COMPLETED|Overall Study||195
306652|NCT01680016|733310|P3|COMPLETED|Overall Study||196
306653|NCT01680016|733311|P2|COMPLETED|Overall Study||114
306654|NCT01680016|733312|P1|COMPLETED|Overall Study||115
306655|NCT01680016|733309|P4|STARTED|Overall Study||200
306656|NCT01680016|733310|P3|STARTED|Overall Study||201
306657|NCT01680016|733311|P2|STARTED|Overall Study||122
306658|NCT01680016|733312|P1|STARTED|Overall Study||121
306659|NCT01679613|733374|P4|NOT COMPLETED|Overall Study||2
306660|NCT01679613|733375|P3|NOT COMPLETED|Overall Study||2
306661|NCT01679613|733376|P2|NOT COMPLETED|Overall Study||1
306662|NCT01679613|733377|P1|NOT COMPLETED|Overall Study||0
306663|NCT01679613|733374|P4|COMPLETED|Overall Study||11
306664|NCT01679613|733375|P3|COMPLETED|Overall Study||11
306665|NCT01679613|733376|P2|COMPLETED|Overall Study||3
306666|NCT01679613|733377|P1|COMPLETED|Overall Study||4
306667|NCT01679613|733374|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
306668|NCT01679613|733375|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
306669|NCT01679613|733376|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
306670|NCT01679613|733377|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
306671|NCT01679613|733374|P4|Received Nintedanib (Main)|Overall Study||11
306672|NCT01679613|733375|P3|Received Nintedanib (Main)|Overall Study||13
306673|NCT01679613|733376|P2|Received Nintedanib (Main)|Overall Study||0
306674|NCT01679613|733377|P1|Received Nintedanib (Main)|Overall Study||0
306675|NCT01679613|733374|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
306676|NCT01679613|733375|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
306677|NCT01679613|733376|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
306678|NCT01679613|733377|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
306679|NCT01679613|733374|P4|Received Nintedanib (Pilot)|Overall Study||0
306680|NCT01679613|733375|P3|Received Nintedanib (Pilot)|Overall Study||0
306681|NCT01679613|733376|P2|Received Nintedanib (Pilot)|Overall Study||3
306682|NCT01679613|733377|P1|Received Nintedanib (Pilot)|Overall Study||4
306683|NCT01679613|733374|P4|STARTED|Overall Study||13
306684|NCT01679613|733375|P3|STARTED|Overall Study||13
306685|NCT01679613|733376|P2|STARTED|Overall Study||4
306686|NCT01679613|733377|P1|STARTED|Overall Study||4
306687|NCT01679600|733390|P2|NOT COMPLETED|Overall Study||0
306688|NCT01679600|733391|P1|NOT COMPLETED|Overall Study||0
306689|NCT01679600|733390|P2|COMPLETED|Overall Study||7
306690|NCT01679600|733391|P1|COMPLETED|Overall Study||7
306691|NCT01679600|733390|P2|STARTED|Overall Study||7
306692|NCT01679600|733391|P1|STARTED|Overall Study||7
306693|NCT01679314|733399|P2|NOT COMPLETED|Overall Study||0
306694|NCT01679314|733400|P1|NOT COMPLETED|Overall Study||2
306695|NCT01679314|733399|P2|COMPLETED|Overall Study||28
306696|NCT01679314|733400|P1|COMPLETED|Overall Study||24
306697|NCT01679314|733399|P2|STARTED|Overall Study||28
306698|NCT01679314|733400|P1|STARTED|Overall Study||26
306699|NCT01679236|733420|P2|NOT COMPLETED|Overall Study||15
306700|NCT01679236|733421|P1|NOT COMPLETED|Overall Study||15
306701|NCT01679236|733420|P2|COMPLETED|Overall Study||10
306702|NCT01679236|733421|P1|COMPLETED|Overall Study||15
306703|NCT01679236|733420|P2|STARTED|Overall Study||25
306704|NCT01679236|733421|P1|STARTED|Overall Study||30
306705|NCT01679197|733427|P1|NOT COMPLETED|Overall Study||4
306706|NCT01679197|733427|P1|COMPLETED|Overall Study||19
306707|NCT01679197|733427|P1|STARTED|Overall Study||23
306708|NCT01679028|733446|P6|NOT COMPLETED|Overall Study||0
306709|NCT01679028|733447|P5|NOT COMPLETED|Overall Study||0
306710|NCT01679028|733448|P4|NOT COMPLETED|Overall Study||0
306711|NCT01679028|733449|P3|NOT COMPLETED|Overall Study||0
306712|NCT01679028|733450|P2|NOT COMPLETED|Overall Study||0
306713|NCT01679028|733451|P1|NOT COMPLETED|Overall Study||0
306714|NCT01679028|733446|P6|COMPLETED|Overall Study||6
306715|NCT01679028|733447|P5|COMPLETED|Overall Study||2
306716|NCT01679028|733448|P4|COMPLETED|Overall Study||4
306717|NCT01679028|733449|P3|COMPLETED|Overall Study||2
306718|NCT01679028|733450|P2|COMPLETED|Overall Study||4
306719|NCT01679028|733451|P1|COMPLETED|Overall Study||2
306720|NCT01679028|733446|P6|STARTED|Overall Study||6
306721|NCT01679028|733447|P5|STARTED|Overall Study||2
306722|NCT01679028|733448|P4|STARTED|Overall Study||4
306723|NCT01679028|733449|P3|STARTED|Overall Study||2
306724|NCT01679028|733450|P2|STARTED|Overall Study||4
306725|NCT01679028|733451|P1|STARTED|Overall Study||2
306726|NCT01679002|733468|P3|NOT COMPLETED|Overall Study||0
306727|NCT01679002|733469|P2|NOT COMPLETED|Overall Study||1
306728|NCT01679002|733470|P1|NOT COMPLETED|Overall Study||1
306729|NCT01679002|733468|P3|COMPLETED|Overall Study||4
306730|NCT01679002|733469|P2|COMPLETED|Overall Study||3
306731|NCT01679002|733470|P1|COMPLETED|Overall Study||3
306732|NCT01679002|733468|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
306733|NCT01679002|733469|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
306734|NCT01679002|733470|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
306735|NCT01679002|733468|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
306736|NCT01679002|733469|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
306737|NCT01679002|733470|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
306738|NCT01679002|733468|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
306739|NCT01679002|733469|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
306740|NCT01679002|733470|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
306741|NCT01679002|733468|P3|STARTED|Overall Study||4
306742|NCT01679002|733469|P2|STARTED|Overall Study||4
306743|NCT01679002|733470|P1|STARTED|Overall Study||4
306744|NCT01678976|733486|P2|NOT COMPLETED|Second Period||0
306745|NCT01678976|733487|P1|NOT COMPLETED|Second Period||0
306746|NCT01678976|733486|P2|COMPLETED|Second Period||6
306747|NCT01678976|733487|P1|COMPLETED|Second Period||6
306748|NCT01678976|733486|P2|STARTED|Second Period||6
306749|NCT01678976|733487|P1|STARTED|Second Period||6
306750|NCT01678976|733486|P2|NOT COMPLETED|First Period||1
306751|NCT01678976|733487|P1|NOT COMPLETED|First Period||0
306752|NCT01678976|733486|P2|COMPLETED|First Period||6
306753|NCT01678976|733487|P1|COMPLETED|First Period||6
306754|NCT01678976|733486|P2|STARTED|First Period||7
306755|NCT01678976|733487|P1|STARTED|First Period||6
306756|NCT01678911|733497|P2|NOT COMPLETED|Second Intervention||0
306757|NCT01678911|733498|P1|NOT COMPLETED|Second Intervention||2
306758|NCT01678911|733497|P2|COMPLETED|Second Intervention||1
306759|NCT01678911|733498|P1|COMPLETED|Second Intervention||2
306760|NCT01678911|733497|P2|STARTED|Second Intervention||1
306761|NCT01678911|733498|P1|STARTED|Second Intervention||4
306762|NCT01678911|733497|P2|NOT COMPLETED|First Intervention||0
306763|NCT01678911|733498|P1|NOT COMPLETED|First Intervention||0
306764|NCT01678911|733497|P2|COMPLETED|First Intervention||1
306765|NCT01678911|733498|P1|COMPLETED|First Intervention||4
306766|NCT01678911|733497|P2|Cross Over|First Intervention||1
306767|NCT01678911|733498|P1|Cross Over|First Intervention||4
306768|NCT01678911|733497|P2|STARTED|First Intervention||1
306769|NCT01678911|733498|P1|STARTED|First Intervention||4
306770|NCT01678885|733514|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
306771|NCT01678885|733515|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306772|NCT01678885|733516|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306773|NCT01678885|733517|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306774|NCT01678885|733518|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306775|NCT01678885|733514|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
306776|NCT01678885|733515|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306777|NCT01678885|733516|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306778|NCT01678885|733517|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306779|NCT01678885|733518|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
306780|NCT01678885|733514|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
306781|NCT01678885|733515|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
306782|NCT01678885|733516|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
306783|NCT01678885|733517|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
306784|NCT01678885|733518|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
306785|NCT01678885|733514|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
306786|NCT01678885|733515|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
306787|NCT01678885|733516|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
306788|NCT01678885|733517|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
306789|NCT01678885|733518|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
306790|NCT01678885|733514|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
306791|NCT01678885|733515|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
306792|NCT01678885|733516|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
306793|NCT01678885|733517|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
306794|NCT01678885|733518|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
306795|NCT01678885|733514|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
306796|NCT01678885|733515|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
306797|NCT01678885|733516|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
306798|NCT01678885|733517|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
306799|NCT01678885|733518|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
306800|NCT01678846|733528|P2|NOT COMPLETED|Overall Study||0
306801|NCT01678846|733529|P1|NOT COMPLETED|Overall Study||0
306802|NCT01678846|733528|P2|COMPLETED|Overall Study||1899
306803|NCT01678846|733529|P1|COMPLETED|Overall Study||1921
306804|NCT01678846|733528|P2|STARTED|Overall Study||1899
306805|NCT01678846|733529|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
306806|NCT01678820|733544|P3|NOT COMPLETED|Overall Study||57
306807|NCT01678820|733545|P2|NOT COMPLETED|Overall Study||63
306808|NCT01678820|733546|P1|NOT COMPLETED|Overall Study||62
306809|NCT01678820|733544|P3|COMPLETED|Overall Study||43
306810|NCT01678820|733545|P2|COMPLETED|Overall Study||36
306811|NCT01678820|733546|P1|COMPLETED|Overall Study||38
306812|NCT01678820|733544|P3|Treated With Double-blind Study Drug|Overall Study||98
306813|NCT01678820|733545|P2|Treated With Double-blind Study Drug|Overall Study||97
306814|NCT01678820|733546|P1|Treated With Double-blind Study Drug|Overall Study||100
306815|NCT01678820|733544|P3|STARTED|Overall Study||100
306816|NCT01678820|733545|P2|STARTED|Overall Study||99
306817|NCT01678820|733546|P1|STARTED|Overall Study||100
306818|NCT01678807|733591|P3|NOT COMPLETED|Overall Study||0
306819|NCT01678807|733592|P2|NOT COMPLETED|Overall Study||5
306820|NCT01678807|733593|P1|NOT COMPLETED|Overall Study||4
306821|NCT01678807|733591|P3|COMPLETED|Overall Study||65
306822|NCT01678807|733592|P2|COMPLETED|Overall Study||60
306823|NCT01678807|733593|P1|COMPLETED|Overall Study||61
306824|NCT01678807|733591|P3|STARTED|Overall Study||65
306825|NCT01678807|733592|P2|STARTED|Overall Study||65
306826|NCT01678807|733593|P1|STARTED|Overall Study||65
306827|NCT01678313|733606|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
306828|NCT01678313|733607|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
306829|NCT01678313|733606|P2|COMPLETED|Prostate Biopsy at 3 Months||37
306830|NCT01678313|733607|P1|COMPLETED|Prostate Biopsy at 3 Months||45
306831|NCT01678313|733606|P2|STARTED|Prostate Biopsy at 3 Months||49
306832|NCT01678313|733607|P1|STARTED|Prostate Biopsy at 3 Months||56
306833|NCT01678313|733606|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
306834|NCT01678313|733607|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
306835|NCT01678313|733606|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
306836|NCT01678313|733607|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
306837|NCT01678313|733606|P2|STARTED|PSA >4 ng/dL at 3 Months||58
306838|NCT01678313|733607|P1|STARTED|PSA >4 ng/dL at 3 Months||64
306839|NCT01678313|733606|P2|NOT COMPLETED|Completed the 3-month Therapy||12
306840|NCT01678313|733607|P1|NOT COMPLETED|Completed the 3-month Therapy||6
306841|NCT01678313|733606|P2|COMPLETED|Completed the 3-month Therapy||58
306842|NCT01678313|733607|P1|COMPLETED|Completed the 3-month Therapy||64
306843|NCT01678313|733606|P2|STARTED|Completed the 3-month Therapy||70
306844|NCT01678313|733607|P1|STARTED|Completed the 3-month Therapy||70
306845|NCT01678196|733625|P2|NOT COMPLETED|Overall Study||0
306846|NCT01678196|733626|P1|NOT COMPLETED|Overall Study||0
306847|NCT01678196|733625|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
306848|NCT01678196|733626|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
306849|NCT01678196|733625|P2|STARTED|Overall Study||32
306850|NCT01678196|733626|P1|STARTED|Overall Study||34
306851|NCT01678131|733641|P3|NOT COMPLETED|Overall Study||2
306852|NCT01678131|733642|P2|NOT COMPLETED|Overall Study||1
306853|NCT01678131|733643|P1|NOT COMPLETED|Overall Study||0
306854|NCT01678131|733641|P3|COMPLETED|Overall Study||9
306855|NCT01678131|733642|P2|COMPLETED|Overall Study||9
306856|NCT01678131|733643|P1|COMPLETED|Overall Study||10
306857|NCT01678131|733641|P3|STARTED|Overall Study||11
306858|NCT01678131|733642|P2|STARTED|Overall Study||10
306859|NCT01678131|733643|P1|STARTED|Overall Study||10
306860|NCT01677988|733651|P1|NOT COMPLETED|Overall Study||2
306861|NCT01677988|733651|P1|COMPLETED|Overall Study||1
306862|NCT01677988|733651|P1|STARTED|Overall Study||3
306863|NCT01677936|733664|P2|NOT COMPLETED|Overall Study||5
306864|NCT01677936|733665|P1|NOT COMPLETED|Overall Study||9
306865|NCT01677936|733664|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
306866|NCT01677936|733665|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
306867|NCT01677936|733664|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
306868|NCT01677936|733665|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
306869|NCT01677767|733673|P1|NOT COMPLETED|Overall Study||22
306870|NCT01677767|733673|P1|COMPLETED|Overall Study||102
306871|NCT01677767|733673|P1|STARTED|Overall Study||124
306872|NCT01677624|733687|P1|NOT COMPLETED|Overall Study||1
306873|NCT01677624|733687|P1|COMPLETED|Overall Study||27
306874|NCT01677624|733687|P1|STARTED|Overall Study||28
306875|NCT01677299|733696|P4|NOT COMPLETED|Overall Study||1
306876|NCT01677299|733697|P3|NOT COMPLETED|Overall Study||1
306877|NCT01677299|733698|P2|NOT COMPLETED|Overall Study||3
306878|NCT01677299|733699|P1|NOT COMPLETED|Overall Study||0
306879|NCT01677299|733696|P4|COMPLETED|Overall Study||5
306880|NCT01677299|733697|P3|COMPLETED|Overall Study||5
306881|NCT01677299|733698|P2|COMPLETED|Overall Study||3
306882|NCT01677299|733699|P1|COMPLETED|Overall Study||6
306883|NCT01677299|733696|P4|STARTED|Overall Study||6
306884|NCT01677299|733697|P3|STARTED|Overall Study||6
306885|NCT01677299|733698|P2|STARTED|Overall Study||6
306886|NCT01677299|733699|P1|STARTED|Overall Study||6
306887|NCT01677286|733721|P1|NOT COMPLETED|Overall Study||11
306888|NCT01677286|733721|P1|COMPLETED|Overall Study||14
306889|NCT01677286|733721|P1|STARTED|Overall Study||25
306890|NCT01677195|733731|P3|NOT COMPLETED|Overall Study||30
306891|NCT01677195|733732|P2|NOT COMPLETED|Overall Study||32
306892|NCT01677195|733733|P1|NOT COMPLETED|Overall Study||29
306893|NCT01677195|733731|P3|COMPLETED|Overall Study||50
306894|NCT01677195|733732|P2|COMPLETED|Overall Study||51
306895|NCT01677195|733733|P1|COMPLETED|Overall Study||42
306896|NCT01677195|733731|P3|STARTED|Overall Study||80
306897|NCT01677195|733732|P2|STARTED|Overall Study||83
306898|NCT01677195|733733|P1|STARTED|Overall Study||71
306899|NCT01677182|733744|P3|NOT COMPLETED|Overall Study||39
306900|NCT01677182|733745|P2|NOT COMPLETED|Overall Study||28
306901|NCT01677182|733746|P1|NOT COMPLETED|Overall Study||34
306902|NCT01677182|733744|P3|COMPLETED|Overall Study||143
306903|NCT01677182|733745|P2|COMPLETED|Overall Study||141
306904|NCT01677182|733746|P1|COMPLETED|Overall Study||150
306905|NCT01677182|733744|P3|STARTED|Overall Study||182
306906|NCT01677182|733745|P2|STARTED|Overall Study||169
306907|NCT01677182|733746|P1|STARTED|Overall Study||184
306908|NCT01676896|733781|P3|NOT COMPLETED|Overall Study||19
306909|NCT01676896|733782|P2|NOT COMPLETED|Overall Study||7
306910|NCT01676896|733783|P1|NOT COMPLETED|Overall Study||12
306911|NCT01676896|733781|P3|COMPLETED|Overall Study||81
306912|NCT01676896|733782|P2|COMPLETED|Overall Study||89
306913|NCT01676896|733783|P1|COMPLETED|Overall Study||84
306914|NCT01676896|733781|P3|STARTED|Overall Study||100
306915|NCT01676896|733782|P2|STARTED|Overall Study||96
306916|NCT01676896|733783|P1|STARTED|Overall Study||96
306917|NCT01676714|733878|P1|NOT COMPLETED|Overall Study||0
306918|NCT01676714|733878|P1|COMPLETED|Overall Study||10
306919|NCT01676714|733878|P1|STARTED|Overall Study||10
306920|NCT01676532|733885|P1|NOT COMPLETED|Overall Study||0
306921|NCT01676532|733885|P1|COMPLETED|Overall Study||127
306922|NCT01676532|733885|P1|STARTED|Overall Study||127
306923|NCT01676415|733896|P2|NOT COMPLETED|Overall Study||0
306924|NCT01676415|733897|P1|NOT COMPLETED|Overall Study||0
306925|NCT01676415|733896|P2|COMPLETED|Overall Study||5
306926|NCT01676415|733897|P1|COMPLETED|Overall Study||4
306927|NCT01676415|733896|P2|STARTED|Overall Study||5
306928|NCT01676415|733897|P1|STARTED|Overall Study||4
306929|NCT01676298|733917|P8|NOT COMPLETED|Overall Study||0
306930|NCT01676298|733918|P7|NOT COMPLETED|Overall Study||0
306931|NCT01676298|733919|P6|NOT COMPLETED|Overall Study||0
306932|NCT01676298|733920|P5|NOT COMPLETED|Overall Study||0
306933|NCT01676298|733921|P4|NOT COMPLETED|Overall Study||0
306934|NCT01676298|733922|P3|NOT COMPLETED|Overall Study||0
306935|NCT01676298|733923|P2|NOT COMPLETED|Overall Study||0
306936|NCT01676298|733924|P1|NOT COMPLETED|Overall Study||0
306937|NCT01676298|733917|P8|COMPLETED|Overall Study||1
306938|NCT01676298|733918|P7|COMPLETED|Overall Study||1
306939|NCT01676298|733919|P6|COMPLETED|Overall Study||1
306940|NCT01676298|733920|P5|COMPLETED|Overall Study||1
306941|NCT01676298|733921|P4|COMPLETED|Overall Study||1
306942|NCT01676298|733922|P3|COMPLETED|Overall Study||1
306943|NCT01676298|733923|P2|COMPLETED|Overall Study||1
306944|NCT01676298|733924|P1|COMPLETED|Overall Study||1
306945|NCT01676298|733917|P8|Participated in All Tests|Overall Study||1
306946|NCT01676298|733918|P7|Participated in All Tests|Overall Study||1
306947|NCT01676298|733919|P6|Participated in All Tests|Overall Study||1
306948|NCT01676298|733920|P5|Participated in All Tests|Overall Study||1
306949|NCT01676298|733921|P4|Participated in All Tests|Overall Study||1
306950|NCT01676298|733922|P3|Participated in All Tests|Overall Study||1
306951|NCT01676298|733923|P2|Participated in All Tests|Overall Study||1
306952|NCT01676298|733924|P1|Participated in All Tests|Overall Study||1
306953|NCT01676298|733917|P8|All Genotypes Confirmed With Reference|Overall Study||1
306954|NCT01676298|733918|P7|All Genotypes Confirmed With Reference|Overall Study||1
306955|NCT01676298|733919|P6|All Genotypes Confirmed With Reference|Overall Study||1
306956|NCT01676298|733920|P5|All Genotypes Confirmed With Reference|Overall Study||1
306957|NCT01676298|733921|P4|All Genotypes Confirmed With Reference|Overall Study||1
306958|NCT01676298|733922|P3|All Genotypes Confirmed With Reference|Overall Study||1
306959|NCT01676298|733923|P2|All Genotypes Confirmed With Reference|Overall Study||1
306960|NCT01676298|733924|P1|All Genotypes Confirmed With Reference|Overall Study||1
306961|NCT01676298|733917|P8|STARTED|Overall Study||1
306962|NCT01676298|733918|P7|STARTED|Overall Study||1
306963|NCT01676298|733919|P6|STARTED|Overall Study||1
306964|NCT01676298|733920|P5|STARTED|Overall Study||1
306965|NCT01676298|733921|P4|STARTED|Overall Study||1
306966|NCT01676298|733922|P3|STARTED|Overall Study||1
306967|NCT01676298|733923|P2|STARTED|Overall Study||1
306968|NCT01676298|733924|P1|STARTED|Overall Study||1
306969|NCT01676220|733944|P2|NOT COMPLETED|Overall Study||125
306970|NCT01676220|733945|P1|NOT COMPLETED|Overall Study||102
306971|NCT01676220|733944|P2|COMPLETED|Overall Study||314
306972|NCT01676220|733945|P1|COMPLETED|Overall Study||337
306973|NCT01676220|733944|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
306974|NCT01676220|733945|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
306975|NCT01676220|733944|P2|Treated|Overall Study||438
306976|NCT01676220|733945|P1|Treated|Overall Study||435
306977|NCT01676220|733944|P2|STARTED|Overall Study||439
306978|NCT01676220|733945|P1|STARTED|Overall Study||439
306979|NCT01676012|733975|P1|NOT COMPLETED|Overall Study||3
306980|NCT01676012|733975|P1|COMPLETED|Overall Study||29
306981|NCT01676012|733975|P1|STARTED|Overall Study||32
306982|NCT01675830|733979|P1|NOT COMPLETED|Overall Study||0
306983|NCT01675830|733979|P1|COMPLETED|Overall Study||10
306984|NCT01675830|733979|P1|STARTED|Overall Study||10
306985|NCT01675661|733986|P2|NOT COMPLETED|Overall Study||46
306986|NCT01675661|733987|P1|NOT COMPLETED|Overall Study||40
306987|NCT01675661|733986|P2|COMPLETED|Overall Study||103
306988|NCT01675661|733987|P1|COMPLETED|Overall Study||113
306989|NCT01675661|733986|P2|STARTED|Overall Study||149
306990|NCT01675661|733987|P1|STARTED|Overall Study||153
306991|NCT01675544|733999|P1|NOT COMPLETED|Overall Study||2
306992|NCT01675544|733999|P1|COMPLETED|Overall Study||44
306993|NCT01675544|733999|P1|STARTED|Overall Study||46
306994|NCT01675531|734004|P1|NOT COMPLETED|Overall Study||25
306995|NCT01675531|734004|P1|COMPLETED|Overall Study||41
306996|NCT01675531|734004|P1|STARTED|Overall Study||66
306997|NCT01675492|734011|P1|NOT COMPLETED|Overall Study||42
306998|NCT01675492|734011|P1|COMPLETED|Overall Study||42
306999|NCT01675492|734011|P1|STARTED|Overall Study||84
307000|NCT01675453|734018|P2|NOT COMPLETED|Overall Study||0
307001|NCT01675453|734019|P1|NOT COMPLETED|Overall Study||0
307002|NCT01675453|734018|P2|COMPLETED|Overall Study||20
307003|NCT01675453|734019|P1|COMPLETED|Overall Study||20
307004|NCT01675453|734018|P2|STARTED|Overall Study||20
307005|NCT01675453|734019|P1|STARTED|Overall Study||20
307006|NCT01675427|734025|P1|NOT COMPLETED|Overall Study||34
307007|NCT01675427|734025|P1|COMPLETED|Overall Study||4732
307008|NCT01675427|734025|P1|STARTED|Overall Study||4766
307009|NCT01675167|734312|P3|NOT COMPLETED|Double-blind Treatment Phase||110
307010|NCT01675167|734313|P2|NOT COMPLETED|Double-blind Treatment Phase||48
307011|NCT01675167|734314|P1|NOT COMPLETED|Double-blind Treatment Phase||0
307012|NCT01675167|734312|P3|COMPLETED|Double-blind Treatment Phase||147
307013|NCT01675167|734313|P2|COMPLETED|Double-blind Treatment Phase||206
307014|NCT01675167|734314|P1|COMPLETED|Double-blind Treatment Phase||0
307015|NCT01675167|734312|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
307016|NCT01675167|734313|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
307108|NCT01674621|734485|P3|STARTED|Overall Study||51
307109|NCT01674621|734486|P2|STARTED|Overall Study||50
307017|NCT01675167|734314|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
307018|NCT01675167|734312|P3|NOT COMPLETED|Open-label Titration Phase||0
307019|NCT01675167|734313|P2|NOT COMPLETED|Open-label Titration Phase||0
307020|NCT01675167|734314|P1|NOT COMPLETED|Open-label Titration Phase||304
307021|NCT01675167|734312|P3|COMPLETED|Open-label Titration Phase||0
307022|NCT01675167|734313|P2|COMPLETED|Open-label Titration Phase||0
307023|NCT01675167|734314|P1|COMPLETED|Open-label Titration Phase||511
307024|NCT01675167|734312|P3|STARTED|Open-label Titration Phase||0
307025|NCT01675167|734313|P2|STARTED|Open-label Titration Phase||0
307026|NCT01675167|734314|P1|STARTED|Open-label Titration Phase||815
307027|NCT01675141|734336|P1|NOT COMPLETED|Overall Study||11
307028|NCT01675141|734336|P1|COMPLETED|Overall Study||0
307029|NCT01675141|734336|P1|STARTED|Overall Study||11
307030|NCT01675128|734349|P3|NOT COMPLETED|Overall Study||1
307031|NCT01675128|734350|P2|NOT COMPLETED|Overall Study||2
307032|NCT01675128|734351|P1|NOT COMPLETED|Overall Study||2
307033|NCT01675128|734349|P3|COMPLETED|Overall Study||9
307034|NCT01675128|734350|P2|COMPLETED|Overall Study||8
307035|NCT01675128|734351|P1|COMPLETED|Overall Study||2
307036|NCT01675128|734349|P3|STARTED|Overall Study||10
307037|NCT01675128|734350|P2|STARTED|Overall Study||10
307038|NCT01675128|734351|P1|STARTED|Overall Study||4
307039|NCT01675063|734373|P1|NOT COMPLETED|Overall Study||0
307040|NCT01675063|734373|P1|COMPLETED|Overall Study||77
307041|NCT01675063|734373|P1|STARTED|Overall Study||77
307042|NCT01675011|734379|P2|NOT COMPLETED|Overall Study||1
307043|NCT01675011|734380|P1|NOT COMPLETED|Overall Study||3
307044|NCT01675011|734379|P2|COMPLETED|Overall Study||0
307045|NCT01675011|734380|P1|COMPLETED|Overall Study||0
307046|NCT01675011|734379|P2|STARTED|Overall Study||1
307047|NCT01675011|734380|P1|STARTED|Overall Study||3
307048|NCT01674725|734388|P2|NOT COMPLETED|Overall Study||1
307049|NCT01674725|734389|P1|NOT COMPLETED|Overall Study||3
307050|NCT01674725|734388|P2|COMPLETED|Overall Study||94
307051|NCT01674725|734389|P1|COMPLETED|Overall Study||89
307052|NCT01674725|734388|P2|STARTED|Overall Study||95
307053|NCT01674725|734389|P1|STARTED|Overall Study||92
307054|NCT01674712|734408|P5|NOT COMPLETED|Overall Study||11
307055|NCT01674712|734409|P4|NOT COMPLETED|Overall Study||8
307056|NCT01674712|734410|P3|NOT COMPLETED|Overall Study||9
307057|NCT01674712|734411|P2|NOT COMPLETED|Overall Study||9
307058|NCT01674712|734412|P1|NOT COMPLETED|Overall Study||10
307059|NCT01674712|734408|P5|COMPLETED|Overall Study||102
307060|NCT01674712|734409|P4|COMPLETED|Overall Study||108
307061|NCT01674712|734410|P3|COMPLETED|Overall Study||106
307062|NCT01674712|734411|P2|COMPLETED|Overall Study||108
307063|NCT01674712|734412|P1|COMPLETED|Overall Study||104
307064|NCT01674712|734408|P5|Safety Subject Sample|Overall Study||112
307065|NCT01674712|734409|P4|Safety Subject Sample|Overall Study||115
307066|NCT01674712|734410|P3|Safety Subject Sample|Overall Study||113
307067|NCT01674712|734411|P2|Safety Subject Sample|Overall Study||117
307068|NCT01674712|734412|P1|Safety Subject Sample|Overall Study||111
307069|NCT01674712|734408|P5|Full Analysis Subject Sample|Overall Study||111
307070|NCT01674712|734409|P4|Full Analysis Subject Sample|Overall Study||112
307071|NCT01674712|734410|P3|Full Analysis Subject Sample|Overall Study||110
307072|NCT01674712|734411|P2|Full Analysis Subject Sample|Overall Study||114
307073|NCT01674712|734412|P1|Full Analysis Subject Sample|Overall Study||109
307074|NCT01674712|734408|P5|STARTED|Overall Study||113
307075|NCT01674712|734409|P4|STARTED|Overall Study||116
307076|NCT01674712|734410|P3|STARTED|Overall Study||115
307077|NCT01674712|734411|P2|STARTED|Overall Study||117
307078|NCT01674712|734412|P1|STARTED|Overall Study||114
307079|NCT01674647|734436|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
307080|NCT01674647|734437|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
307081|NCT01674647|734436|P2|COMPLETED|30-day Safety Follow-up Period||446
307082|NCT01674647|734437|P1|COMPLETED|30-day Safety Follow-up Period||924
307083|NCT01674647|734436|P2|STARTED|30-day Safety Follow-up Period||487
307084|NCT01674647|734437|P1|STARTED|30-day Safety Follow-up Period||982
307085|NCT01674647|734436|P2|NOT COMPLETED|Treatment Period||102
307086|NCT01674647|734437|P1|NOT COMPLETED|Treatment Period||156
307087|NCT01674647|734436|P2|COMPLETED|Treatment Period||400
307088|NCT01674647|734437|P1|COMPLETED|Treatment Period||846
307089|NCT01674647|734436|P2|Subjects Received Treatment|Treatment Period||499
307090|NCT01674647|734437|P1|Subjects Received Treatment|Treatment Period||988
307091|NCT01674647|734436|P2|STARTED|Treatment Period||502
307092|NCT01674647|734437|P1|STARTED|Treatment Period||1002
307093|NCT01674634|734463|P1|NOT COMPLETED|Overall Study||6
307094|NCT01674634|734463|P1|COMPLETED|Overall Study||709
307095|NCT01674634|734463|P1|STARTED|Overall Study||715
307096|NCT01674621|734483|P5|NOT COMPLETED|Overall Study||6
307097|NCT01674621|734484|P4|NOT COMPLETED|Overall Study||7
307098|NCT01674621|734485|P3|NOT COMPLETED|Overall Study||8
307099|NCT01674621|734486|P2|NOT COMPLETED|Overall Study||5
307100|NCT01674621|734487|P1|NOT COMPLETED|Overall Study||6
307101|NCT01674621|734483|P5|COMPLETED|Overall Study||45
307102|NCT01674621|734484|P4|COMPLETED|Overall Study||41
307103|NCT01674621|734485|P3|COMPLETED|Overall Study||43
307104|NCT01674621|734486|P2|COMPLETED|Overall Study||45
307105|NCT01674621|734487|P1|COMPLETED|Overall Study||44
307106|NCT01674621|734483|P5|STARTED|Overall Study||51
307107|NCT01674621|734484|P4|STARTED|Overall Study||48
307110|NCT01674621|734487|P1|STARTED|Overall Study||50
307111|NCT01674062|734511|P2|NOT COMPLETED|Overall Study||29
307112|NCT01674062|734512|P1|NOT COMPLETED|Overall Study||66
307113|NCT01674062|734511|P2|COMPLETED|Overall Study||0
307114|NCT01674062|734512|P1|COMPLETED|Overall Study||0
307115|NCT01674062|734511|P2|STARTED|Overall Study||29
307116|NCT01674062|734512|P1|STARTED|Overall Study||66
307117|NCT01674010|734527|P3|NOT COMPLETED|Randomization Phase 2||61
307118|NCT01674010|734528|P2|NOT COMPLETED|Randomization Phase 2||62
307119|NCT01674010|734529|P1|NOT COMPLETED|Randomization Phase 2||0
307120|NCT01674010|734527|P3|COMPLETED|Randomization Phase 2||3
307121|NCT01674010|734528|P2|COMPLETED|Randomization Phase 2||3
307122|NCT01674010|734529|P1|COMPLETED|Randomization Phase 2||0
307123|NCT01674010|734527|P3|STARTED|Randomization Phase 2||64
307124|NCT01674010|734528|P2|STARTED|Randomization Phase 2||65
307125|NCT01674010|734529|P1|STARTED|Randomization Phase 2||0
307126|NCT01674010|734527|P3|NOT COMPLETED|Open Treatment Phase 1||0
307127|NCT01674010|734528|P2|NOT COMPLETED|Open Treatment Phase 1||0
307128|NCT01674010|734529|P1|NOT COMPLETED|Open Treatment Phase 1||180
307129|NCT01674010|734527|P3|COMPLETED|Open Treatment Phase 1||0
307130|NCT01674010|734528|P2|COMPLETED|Open Treatment Phase 1||0
307131|NCT01674010|734529|P1|COMPLETED|Open Treatment Phase 1||129
307132|NCT01674010|734527|P3|STARTED|Open Treatment Phase 1||0
307133|NCT01674010|734528|P2|STARTED|Open Treatment Phase 1||0
307134|NCT01674010|734529|P1|STARTED|Open Treatment Phase 1||309
307135|NCT01673984|734548|P2|NOT COMPLETED|Overall Study||6
307136|NCT01673984|734549|P1|NOT COMPLETED|Overall Study||10
307137|NCT01673984|734548|P2|COMPLETED|Overall Study||1
307138|NCT01673984|734549|P1|COMPLETED|Overall Study||4
307139|NCT01673984|734548|P2|STARTED|Overall Study||7
307140|NCT01673984|734549|P1|STARTED|Overall Study||14
307141|NCT01673919|734567|P1|NOT COMPLETED|Overall Study||0
307142|NCT01673919|734567|P1|COMPLETED|Overall Study||7
307143|NCT01673919|734567|P1|STARTED|Overall Study||7
307144|NCT01673867|734591|P2|NOT COMPLETED|Treatment||268
307145|NCT01673867|734592|P1|NOT COMPLETED|Treatment||244
307146|NCT01673867|734591|P2|COMPLETED|Treatment||0
307147|NCT01673867|734592|P1|COMPLETED|Treatment||43
307148|NCT01673867|734591|P2|STARTED|Treatment||268
307149|NCT01673867|734592|P1|STARTED|Treatment||287
307150|NCT01673867|734591|P2|NOT COMPLETED|Randomization||22
307151|NCT01673867|734592|P1|NOT COMPLETED|Randomization||5
307152|NCT01673867|734591|P2|COMPLETED|Randomization||268
307153|NCT01673867|734592|P1|COMPLETED|Randomization||287
307154|NCT01673867|734591|P2|STARTED|Randomization||290
307155|NCT01673867|734592|P1|STARTED|Randomization||292
307156|NCT01673854|734618|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
307157|NCT01673854|734618|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
307158|NCT01673854|734618|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
307159|NCT01673854|734618|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
307160|NCT01673854|734618|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
307161|NCT01673854|734618|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
307162|NCT01673854|734618|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
307163|NCT01673854|734618|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
307164|NCT01673854|734618|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
307165|NCT01673802|734626|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
307166|NCT01673802|734626|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
307167|NCT01673802|734626|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
307168|NCT01673802|734626|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
307169|NCT01673802|734626|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
307170|NCT01673802|734626|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
307171|NCT01673698|734632|P2|NOT COMPLETED|Overall Study||13
307172|NCT01673698|734633|P1|NOT COMPLETED|Overall Study||51
307173|NCT01673698|734632|P2|COMPLETED|Overall Study||126
307174|NCT01673698|734633|P1|COMPLETED|Overall Study||136
307175|NCT01673698|734632|P2|STARTED|Overall Study||139
307176|NCT01673698|734633|P1|STARTED|Overall Study||187
307177|NCT01673620|734643|P2|NOT COMPLETED|Overall Study||0
307178|NCT01673620|734644|P1|NOT COMPLETED|Overall Study||1
307179|NCT01673620|734643|P2|COMPLETED|Overall Study||22
307180|NCT01673620|734644|P1|COMPLETED|Overall Study||46
307181|NCT01673620|734643|P2|STARTED|Overall Study||22
307182|NCT01673620|734644|P1|STARTED|Overall Study||47
307183|NCT01673594|734654|P2|NOT COMPLETED|Overall Study||6
307184|NCT01673594|734655|P1|NOT COMPLETED|Overall Study||6
307185|NCT01673594|734654|P2|COMPLETED|Overall Study||13
307186|NCT01673594|734655|P1|COMPLETED|Overall Study||12
307187|NCT01673594|734654|P2|STARTED|Overall Study||19
307188|NCT01673594|734655|P1|STARTED|Overall Study||18
307189|NCT01673568|734665|P2|NOT COMPLETED|Overall Study||0
307190|NCT01673568|734666|P1|NOT COMPLETED|Overall Study||0
307191|NCT01673568|734665|P2|COMPLETED|Overall Study||28
307192|NCT01673568|734666|P1|COMPLETED|Overall Study||28
307193|NCT01673568|734665|P2|STARTED|Overall Study||28
307194|NCT01673568|734666|P1|STARTED|Overall Study||28
307195|NCT01673490|734674|P1|NOT COMPLETED|Overall Study||7
307196|NCT01673490|734674|P1|COMPLETED|Overall Study||52
307197|NCT01673490|734674|P1|STARTED|Overall Study||59
307198|NCT01673425|734687|P1|NOT COMPLETED|Overall Study||1
307199|NCT01673425|734687|P1|COMPLETED|Overall Study||4
307200|NCT01673425|734687|P1|STARTED|Overall Study||5
307201|NCT01673347|734691|P1|NOT COMPLETED|Overall Study||7
307202|NCT01673347|734691|P1|COMPLETED|Overall Study||17
307203|NCT01673347|734691|P1|STARTED|Overall Study||24
307204|NCT01673282|734700|P2|NOT COMPLETED|Overall Study||26
307205|NCT01673282|734701|P1|NOT COMPLETED|Overall Study||33
307206|NCT01673282|734700|P2|COMPLETED|Overall Study||132
307207|NCT01673282|734701|P1|COMPLETED|Overall Study||120
307208|NCT01673282|734700|P2|STARTED|Overall Study||158
307209|NCT01673282|734701|P1|STARTED|Overall Study||153
307210|NCT01673256|734707|P1|NOT COMPLETED|Overall Study||0
307211|NCT01673256|734707|P1|COMPLETED|Overall Study||90
307212|NCT01673256|734707|P1|STARTED|Overall Study||90
307213|NCT01673191|734713|P2|NOT COMPLETED|Overall Study||0
307214|NCT01673191|734714|P1|NOT COMPLETED|Overall Study||0
307215|NCT01673191|734713|P2|COMPLETED|Overall Study||11
307216|NCT01673191|734714|P1|COMPLETED|Overall Study||26
307217|NCT01673191|734713|P2|STARTED|Overall Study||11
307218|NCT01673191|734714|P1|STARTED|Overall Study||26
307219|NCT01673178|734737|P5|NOT COMPLETED|Overall Study||2
307220|NCT01673178|734738|P4|NOT COMPLETED|Overall Study||8
307221|NCT01673178|734739|P3|NOT COMPLETED|Overall Study||3
307222|NCT01673178|734740|P2|NOT COMPLETED|Overall Study||2
307223|NCT01673178|734741|P1|NOT COMPLETED|Overall Study||3
307224|NCT01673178|734737|P5|COMPLETED|Overall Study||19
307225|NCT01673178|734738|P4|COMPLETED|Overall Study||14
307226|NCT01673178|734739|P3|COMPLETED|Overall Study||18
307227|NCT01673178|734740|P2|COMPLETED|Overall Study||19
307228|NCT01673178|734741|P1|COMPLETED|Overall Study||19
307229|NCT01673178|734737|P5|STARTED|Overall Study||21
307230|NCT01673178|734738|P4|STARTED|Overall Study||22
307231|NCT01673178|734739|P3|STARTED|Overall Study||21
307232|NCT01673178|734740|P2|STARTED|Overall Study||21
307233|NCT01673178|734741|P1|STARTED|Overall Study||22
307234|NCT01673126|734980|P2|NOT COMPLETED|Overall Study||3
307235|NCT01673126|734981|P1|NOT COMPLETED|Overall Study||4
307236|NCT01673126|734980|P2|COMPLETED|Overall Study||23
307237|NCT01673126|734981|P1|COMPLETED|Overall Study||32
307238|NCT01673126|734980|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
307239|NCT01673126|734981|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
307240|NCT01673113|734989|P2|NOT COMPLETED|Overall Study||0
307241|NCT01673113|734990|P1|NOT COMPLETED|Overall Study||0
307242|NCT01673113|734989|P2|COMPLETED|Overall Study||11
307243|NCT01673113|734990|P1|COMPLETED|Overall Study||11
307244|NCT01673113|734989|P2|STARTED|Overall Study||11
307245|NCT01673113|734990|P1|STARTED|Overall Study||11
307246|NCT01673009|734997|P1|NOT COMPLETED|Overall Study||13
307247|NCT01673009|734997|P1|COMPLETED|Overall Study||23
307248|NCT01673009|734997|P1|STARTED|Overall Study||36
307249|NCT01672996|735009|P3|NOT COMPLETED|Overall Study||0
307250|NCT01672996|735010|P2|NOT COMPLETED|Overall Study||0
307251|NCT01672996|735011|P1|NOT COMPLETED|Overall Study||0
307252|NCT01672996|735009|P3|COMPLETED|Overall Study||6
307253|NCT01672996|735010|P2|COMPLETED|Overall Study||30
307254|NCT01672996|735011|P1|COMPLETED|Overall Study||30
307255|NCT01672996|735009|P3|STARTED|Overall Study||6
307256|NCT01672996|735010|P2|STARTED|Overall Study||30
307257|NCT01672996|735011|P1|STARTED|Overall Study||30
307258|NCT01672983|735047|P6|NOT COMPLETED|Overall Study||0
307259|NCT01672983|735048|P5|NOT COMPLETED|Overall Study||0
307260|NCT01672983|735049|P4|NOT COMPLETED|Overall Study||0
307261|NCT01672983|735050|P3|NOT COMPLETED|Overall Study||0
307262|NCT01672983|735051|P2|NOT COMPLETED|Overall Study||0
307263|NCT01672983|735052|P1|NOT COMPLETED|Overall Study||0
307264|NCT01672983|735047|P6|COMPLETED|Overall Study||18
307265|NCT01672983|735048|P5|COMPLETED|Overall Study||19
307266|NCT01672983|735049|P4|COMPLETED|Overall Study||18
307267|NCT01672983|735050|P3|COMPLETED|Overall Study||19
307268|NCT01672983|735051|P2|COMPLETED|Overall Study||18
307269|NCT01672983|735052|P1|COMPLETED|Overall Study||18
307270|NCT01672983|735047|P6|Completed Study Drug|Overall Study||17
307271|NCT01672983|735048|P5|Completed Study Drug|Overall Study||12
307272|NCT01672983|735049|P4|Completed Study Drug|Overall Study||18
307273|NCT01672983|735050|P3|Completed Study Drug|Overall Study||18
307274|NCT01672983|735051|P2|Completed Study Drug|Overall Study||17
307275|NCT01672983|735052|P1|Completed Study Drug|Overall Study||18
307276|NCT01672983|735047|P6|STARTED|Overall Study||18
307277|NCT01672983|735048|P5|STARTED|Overall Study||19
307278|NCT01672983|735049|P4|STARTED|Overall Study||18
307279|NCT01672983|735050|P3|STARTED|Overall Study||19
307280|NCT01672983|735051|P2|STARTED|Overall Study||18
307281|NCT01672983|735052|P1|STARTED|Overall Study||18
307282|NCT01672970|735082|P1|NOT COMPLETED|Overall Study||47
307283|NCT01672970|735082|P1|COMPLETED|Overall Study||244
307284|NCT01672970|735082|P1|Treated|Overall Study||290
307285|NCT01672970|735082|P1|STARTED|Overall Study||291
307286|NCT01672957|735118|P1|NOT COMPLETED|Overall Study||55
307287|NCT01672957|735118|P1|COMPLETED|Overall Study||73
307288|NCT01672957|735118|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
307289|NCT01672957|735118|P1|STARTED|Overall Study||128
307290|NCT01672827|735131|P1|NOT COMPLETED|Overall Study||0
307291|NCT01672827|735131|P1|COMPLETED|Overall Study||276
307292|NCT01672827|735131|P1|STARTED|Overall Study||276
307293|NCT01672788|735137|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
307294|NCT01672788|735138|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
307295|NCT01672788|735139|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
307296|NCT01672788|735140|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
307297|NCT01672788|735137|P4|COMPLETED|Treatment Period 4 (3 Days)||8
307298|NCT01672788|735138|P3|COMPLETED|Treatment Period 4 (3 Days)||9
307299|NCT01672788|735139|P2|COMPLETED|Treatment Period 4 (3 Days)||9
307300|NCT01672788|735140|P1|COMPLETED|Treatment Period 4 (3 Days)||9
307301|NCT01672788|735137|P4|STARTED|Treatment Period 4 (3 Days)||8
307302|NCT01672788|735138|P3|STARTED|Treatment Period 4 (3 Days)||9
307303|NCT01672788|735139|P2|STARTED|Treatment Period 4 (3 Days)||9
307304|NCT01672788|735140|P1|STARTED|Treatment Period 4 (3 Days)||9
307305|NCT01672788|735137|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
307306|NCT01672788|735138|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
307307|NCT01672788|735139|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
307308|NCT01672788|735140|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
307309|NCT01672788|735137|P4|COMPLETED|Washout Period 3 (7 Days)||8
307310|NCT01672788|735138|P3|COMPLETED|Washout Period 3 (7 Days)||9
307311|NCT01672788|735139|P2|COMPLETED|Washout Period 3 (7 Days)||9
307312|NCT01672788|735140|P1|COMPLETED|Washout Period 3 (7 Days)||9
307313|NCT01672788|735137|P4|STARTED|Washout Period 3 (7 Days)||8
307314|NCT01672788|735138|P3|STARTED|Washout Period 3 (7 Days)||9
307315|NCT01672788|735139|P2|STARTED|Washout Period 3 (7 Days)||9
307316|NCT01672788|735140|P1|STARTED|Washout Period 3 (7 Days)||9
307317|NCT01672788|735137|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
307318|NCT01672788|735138|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
307319|NCT01672788|735139|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
307320|NCT01672788|735140|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
307321|NCT01672788|735137|P4|COMPLETED|Treatment Period 3 (3 Days)||8
307322|NCT01672788|735138|P3|COMPLETED|Treatment Period 3 (3 Days)||9
307323|NCT01672788|735139|P2|COMPLETED|Treatment Period 3 (3 Days)||9
307324|NCT01672788|735140|P1|COMPLETED|Treatment Period 3 (3 Days)||9
307325|NCT01672788|735137|P4|STARTED|Treatment Period 3 (3 Days)||8
307326|NCT01672788|735138|P3|STARTED|Treatment Period 3 (3 Days)||9
307327|NCT01672788|735139|P2|STARTED|Treatment Period 3 (3 Days)||9
307328|NCT01672788|735140|P1|STARTED|Treatment Period 3 (3 Days)||9
307329|NCT01672788|735137|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
307330|NCT01672788|735138|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
307331|NCT01672788|735139|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
307332|NCT01672788|735140|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
307333|NCT01672788|735137|P4|COMPLETED|Washout Period 2 (7 Days)||8
307334|NCT01672788|735138|P3|COMPLETED|Washout Period 2 (7 Days)||9
307335|NCT01672788|735139|P2|COMPLETED|Washout Period 2 (7 Days)||9
307336|NCT01672788|735140|P1|COMPLETED|Washout Period 2 (7 Days)||9
307337|NCT01672788|735137|P4|STARTED|Washout Period 2 (7 Days)||9
307338|NCT01672788|735138|P3|STARTED|Washout Period 2 (7 Days)||9
307339|NCT01672788|735139|P2|STARTED|Washout Period 2 (7 Days)||9
307340|NCT01672788|735140|P1|STARTED|Washout Period 2 (7 Days)||9
307341|NCT01672788|735137|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
307342|NCT01672788|735138|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
307343|NCT01672788|735139|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
307344|NCT01672788|735140|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
307345|NCT01672788|735137|P4|COMPLETED|Treatment Period 2 (3 Days)||9
307346|NCT01672788|735138|P3|COMPLETED|Treatment Period 2 (3 Days)||9
307347|NCT01672788|735139|P2|COMPLETED|Treatment Period 2 (3 Days)||9
307348|NCT01672788|735140|P1|COMPLETED|Treatment Period 2 (3 Days)||9
307349|NCT01672788|735137|P4|STARTED|Treatment Period 2 (3 Days)||9
307350|NCT01672788|735138|P3|STARTED|Treatment Period 2 (3 Days)||9
307351|NCT01672788|735139|P2|STARTED|Treatment Period 2 (3 Days)||9
307352|NCT01672788|735140|P1|STARTED|Treatment Period 2 (3 Days)||9
307353|NCT01672788|735137|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
307354|NCT01672788|735138|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
307355|NCT01672788|735139|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
307356|NCT01672788|735140|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
307357|NCT01672788|735137|P4|COMPLETED|Washout Period 1 (7 Days)||9
307358|NCT01672788|735138|P3|COMPLETED|Washout Period 1 (7 Days)||9
307359|NCT01672788|735139|P2|COMPLETED|Washout Period 1 (7 Days)||9
307360|NCT01672788|735140|P1|COMPLETED|Washout Period 1 (7 Days)||9
307361|NCT01672788|735137|P4|STARTED|Washout Period 1 (7 Days)||9
307362|NCT01672788|735138|P3|STARTED|Washout Period 1 (7 Days)||9
307363|NCT01672788|735139|P2|STARTED|Washout Period 1 (7 Days)||9
307364|NCT01672788|735140|P1|STARTED|Washout Period 1 (7 Days)||9
307365|NCT01672788|735137|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
307366|NCT01672788|735138|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
307367|NCT01672788|735139|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
307368|NCT01672788|735140|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
307369|NCT01672788|735137|P4|COMPLETED|Treatment Period 1 (3 Days)||9
307370|NCT01672788|735138|P3|COMPLETED|Treatment Period 1 (3 Days)||9
307371|NCT01672788|735139|P2|COMPLETED|Treatment Period 1 (3 Days)||9
307372|NCT01672788|735140|P1|COMPLETED|Treatment Period 1 (3 Days)||9
307373|NCT01672788|735137|P4|STARTED|Treatment Period 1 (3 Days)||9
307374|NCT01672788|735138|P3|STARTED|Treatment Period 1 (3 Days)||9
307375|NCT01672788|735139|P2|STARTED|Treatment Period 1 (3 Days)||9
307376|NCT01672788|735140|P1|STARTED|Treatment Period 1 (3 Days)||9
307377|NCT01672723|735170|P2|NOT COMPLETED|Second Intervention||0
307378|NCT01672723|735171|P1|NOT COMPLETED|Second Intervention||0
307379|NCT01672723|735170|P2|COMPLETED|Second Intervention||15
307380|NCT01672723|735171|P1|COMPLETED|Second Intervention||16
307381|NCT01672723|735170|P2|STARTED|Second Intervention||15
307382|NCT01672723|735171|P1|STARTED|Second Intervention||16
307383|NCT01672723|735170|P2|NOT COMPLETED|Washout Period of 10 Days||0
307384|NCT01672723|735171|P1|NOT COMPLETED|Washout Period of 10 Days||0
307385|NCT01672723|735170|P2|COMPLETED|Washout Period of 10 Days||15
307386|NCT01672723|735171|P1|COMPLETED|Washout Period of 10 Days||16
307387|NCT01672723|735170|P2|STARTED|Washout Period of 10 Days||15
307388|NCT01672723|735171|P1|STARTED|Washout Period of 10 Days||16
307389|NCT01672723|735170|P2|NOT COMPLETED|First Intervention||0
307390|NCT01672723|735171|P1|NOT COMPLETED|First Intervention||3
307391|NCT01672723|735170|P2|COMPLETED|First Intervention||15
307392|NCT01672723|735171|P1|COMPLETED|First Intervention||16
307393|NCT01672723|735170|P2|STARTED|First Intervention||15
307394|NCT01672723|735171|P1|STARTED|First Intervention||19
307395|NCT01672658|735183|P2|NOT COMPLETED|Overall Study||1
307396|NCT01672658|735184|P1|NOT COMPLETED|Overall Study||0
307397|NCT01672658|735183|P2|COMPLETED|Overall Study||14
307398|NCT01672658|735184|P1|COMPLETED|Overall Study||16
307399|NCT01672658|735183|P2|STARTED|Overall Study||15
307400|NCT01672658|735184|P1|STARTED|Overall Study||16
307401|NCT01672294|735208|P4|NOT COMPLETED|Overall Study||13
307402|NCT01672294|735209|P3|NOT COMPLETED|Overall Study||11
307403|NCT01672294|735210|P2|NOT COMPLETED|Overall Study||21
307404|NCT01672294|735211|P1|NOT COMPLETED|Overall Study||6
307405|NCT01672294|735208|P4|COMPLETED|Overall Study||59
307406|NCT01672294|735209|P3|COMPLETED|Overall Study||61
307407|NCT01672294|735210|P2|COMPLETED|Overall Study||50
307408|NCT01672294|735211|P1|COMPLETED|Overall Study||65
307409|NCT01672294|735208|P4|STARTED|Overall Study||72
307410|NCT01672294|735209|P3|STARTED|Overall Study||72
307411|NCT01672294|735210|P2|STARTED|Overall Study||71
307412|NCT01672294|735211|P1|STARTED|Overall Study||71
307413|NCT01671839|735233|P1|NOT COMPLETED|Overall Study||5
307414|NCT01671839|735233|P1|COMPLETED|Overall Study||50
307415|NCT01671839|735233|P1|STARTED|Overall Study||55
307416|NCT01671748|735244|P2|NOT COMPLETED|12 Week Treatment Phase||0
307417|NCT01671748|735245|P1|NOT COMPLETED|12 Week Treatment Phase||0
307418|NCT01671748|735244|P2|COMPLETED|12 Week Treatment Phase||17
307419|NCT01671748|735245|P1|COMPLETED|12 Week Treatment Phase||19
307420|NCT01671748|735244|P2|STARTED|12 Week Treatment Phase||17
307421|NCT01671748|735245|P1|STARTED|12 Week Treatment Phase||19
307422|NCT01671748|735244|P2|NOT COMPLETED|4 Week run-in Phase||0
307423|NCT01671748|735245|P1|NOT COMPLETED|4 Week run-in Phase||11
307424|NCT01671748|735244|P2|COMPLETED|4 Week run-in Phase||0
307425|NCT01671748|735245|P1|COMPLETED|4 Week run-in Phase||36
307426|NCT01671748|735244|P2|STARTED|4 Week run-in Phase||0
307427|NCT01671748|735245|P1|STARTED|4 Week run-in Phase||47
307428|NCT01671605|735265|P2|NOT COMPLETED|Overall Study||0
307429|NCT01671605|735266|P1|NOT COMPLETED|Overall Study||0
307430|NCT01671605|735265|P2|COMPLETED|Overall Study||31
307431|NCT01671605|735266|P1|COMPLETED|Overall Study||72
307432|NCT01671605|735265|P2|STARTED|Overall Study||31
307433|NCT01671605|735266|P1|STARTED|Overall Study||72
307434|NCT01671488|735272|P1|NOT COMPLETED|Overall Study||1
307435|NCT01671488|735272|P1|COMPLETED|Overall Study||10
307436|NCT01671488|735272|P1|STARTED|Overall Study||11
307437|NCT01671293|735280|P2|NOT COMPLETED|Overall Study||2
307438|NCT01671293|735281|P1|NOT COMPLETED|Overall Study||3
307439|NCT01671293|735280|P2|COMPLETED|Overall Study||32
307440|NCT01671293|735281|P1|COMPLETED|Overall Study||33
307441|NCT01671293|735280|P2|STARTED|Overall Study||34
307442|NCT01671293|735281|P1|STARTED|Overall Study||36
307443|NCT01671280|735287|P1|NOT COMPLETED|Overall Study||2
307444|NCT01671280|735287|P1|COMPLETED|Overall Study||401
307445|NCT01671280|735287|P1|STARTED|Overall Study|The number is enrollment.|403
307446|NCT01671111|735293|P1|NOT COMPLETED|Overall Study||30
307447|NCT01671111|735293|P1|COMPLETED|Overall Study||0
307448|NCT01671111|735293|P1|STARTED|Overall Study||30
307449|NCT01671059|735303|P1|NOT COMPLETED|Overall Study||5
307450|NCT01671059|735303|P1|COMPLETED|Overall Study||75
307451|NCT01671059|735303|P1|STARTED|Overall Study||80
307452|NCT01670825|735328|P2|NOT COMPLETED|Overall Study||0
307453|NCT01670825|735329|P1|NOT COMPLETED|Overall Study||0
307454|NCT01670825|735328|P2|COMPLETED|Overall Study||39
307455|NCT01670825|735329|P1|COMPLETED|Overall Study||42
307456|NCT01670825|735328|P2|STARTED|Overall Study||39
307457|NCT01670825|735329|P1|STARTED|Overall Study||42
307458|NCT01670721|735395|P1|NOT COMPLETED|Overall Study||53
307459|NCT01670721|735395|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
307460|NCT01670721|735395|P1|STARTED|Overall Study||175
307461|NCT01670487|735404|P2|NOT COMPLETED|Overall Study||0
307462|NCT01670487|735405|P1|NOT COMPLETED|Overall Study||0
307463|NCT01670487|735404|P2|COMPLETED|Overall Study||150
307464|NCT01670487|735405|P1|COMPLETED|Overall Study||150
307465|NCT01670487|735404|P2|STARTED|Overall Study||150
307466|NCT01670487|735405|P1|STARTED|Overall Study||150
307467|NCT01670279|735414|P4|NOT COMPLETED|Overall Study||1
307468|NCT01670279|735415|P3|NOT COMPLETED|Overall Study||0
307469|NCT01670279|735416|P2|NOT COMPLETED|Overall Study||2
307470|NCT01670279|735417|P1|NOT COMPLETED|Overall Study||0
307471|NCT01670279|735414|P4|COMPLETED|Overall Study||4
307472|NCT01670279|735415|P3|COMPLETED|Overall Study||0
307473|NCT01670279|735416|P2|COMPLETED|Overall Study||5
307474|NCT01670279|735417|P1|COMPLETED|Overall Study||6
307475|NCT01670279|735414|P4|STARTED|Overall Study||5
307476|NCT01670279|735415|P3|STARTED|Overall Study||0
307477|NCT01670279|735416|P2|STARTED|Overall Study||7
307478|NCT01670279|735417|P1|STARTED|Overall Study||6
307479|NCT01670201|735452|P1|NOT COMPLETED|Overall Study||0
307480|NCT01670201|735452|P1|COMPLETED|Overall Study||8
307481|NCT01670201|735452|P1|STARTED|Overall Study||8
307482|NCT01670045|735457|P1|NOT COMPLETED|Overall Study||16
307483|NCT01670045|735457|P1|COMPLETED|Overall Study||27
307484|NCT01670045|735457|P1|STARTED|Overall Study||43
307485|NCT01670019|735475|P2|NOT COMPLETED|Overall Study||0
307486|NCT01670019|735476|P1|NOT COMPLETED|Overall Study||9
307487|NCT01670019|735475|P2|COMPLETED|Overall Study||23
307488|NCT01670019|735476|P1|COMPLETED|Overall Study||14
307489|NCT01670019|735475|P2|STARTED|Overall Study||23
307490|NCT01670019|735476|P1|STARTED|Overall Study||23
307491|NCT01668836|735494|P4|NOT COMPLETED|Overall Study||0
307492|NCT01668836|735495|P3|NOT COMPLETED|Overall Study||0
307493|NCT01668836|735496|P2|NOT COMPLETED|Overall Study||0
307494|NCT01668836|735497|P1|NOT COMPLETED|Overall Study||0
307495|NCT01668836|735494|P4|COMPLETED|Overall Study||12
307496|NCT01668836|735495|P3|COMPLETED|Overall Study||12
307497|NCT01668836|735496|P2|COMPLETED|Overall Study||12
307498|NCT01668836|735497|P1|COMPLETED|Overall Study||12
307499|NCT01668836|735494|P4|STARTED|Overall Study||12
307500|NCT01668836|735495|P3|STARTED|Overall Study||12
307501|NCT01668836|735496|P2|STARTED|Overall Study||12
307502|NCT01668836|735497|P1|STARTED|Overall Study||12
307503|NCT01668797|735553|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
307504|NCT01668797|735554|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
307505|NCT01668797|735555|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
307506|NCT01668797|735556|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
307507|NCT01668797|735553|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
307508|NCT01668797|735554|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
307509|NCT01668797|735555|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
307510|NCT01668797|735556|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
307511|NCT01668797|735553|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
307512|NCT01668797|735554|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
307513|NCT01668797|735555|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
307514|NCT01668797|735556|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
307515|NCT01668797|735553|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
307516|NCT01668797|735554|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
307517|NCT01668797|735555|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
307518|NCT01668797|735556|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
307519|NCT01668797|735553|P4|COMPLETED|Phase B (Stabilization Phase)||0
307520|NCT01668797|735554|P3|COMPLETED|Phase B (Stabilization Phase)||0
307521|NCT01668797|735555|P2|COMPLETED|Phase B (Stabilization Phase)||202
307522|NCT01668797|735556|P1|COMPLETED|Phase B (Stabilization Phase)||0
307523|NCT01668797|735553|P4|STARTED|Phase B (Stabilization Phase)||0
307524|NCT01668797|735554|P3|STARTED|Phase B (Stabilization Phase)||0
307525|NCT01668797|735555|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
307526|NCT01668797|735556|P1|STARTED|Phase B (Stabilization Phase)||0
307527|NCT01668797|735553|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
307528|NCT01668797|735554|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
307529|NCT01668797|735555|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
307530|NCT01668797|735556|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
307531|NCT01668797|735553|P4|COMPLETED|Phase A (Conversion Phase)||0
307532|NCT01668797|735554|P3|COMPLETED|Phase A (Conversion Phase)||0
307533|NCT01668797|735555|P2|COMPLETED|Phase A (Conversion Phase)||0
307534|NCT01668797|735556|P1|COMPLETED|Phase A (Conversion Phase)||346
307535|NCT01668797|735553|P4|STARTED|Phase A (Conversion Phase)||0
307536|NCT01668797|735554|P3|STARTED|Phase A (Conversion Phase)||0
307537|NCT01668797|735555|P2|STARTED|Phase A (Conversion Phase)||0
307538|NCT01668797|735556|P1|STARTED|Phase A (Conversion Phase)||406
307539|NCT01668784|735621|P2|NOT COMPLETED|Treated (Overall)||369
307540|NCT01668784|735622|P1|NOT COMPLETED|Treated (Overall)||339
307541|NCT01668784|735621|P2|COMPLETED|Treated (Overall)||28
307542|NCT01668784|735622|P1|COMPLETED|Treated (Overall)||67
307543|NCT01668784|735621|P2|STARTED|Treated (Overall)||397
307544|NCT01668784|735622|P1|STARTED|Treated (Overall)||406
307545|NCT01668784|735621|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
307546|NCT01668784|735622|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
307547|NCT01668784|735621|P2|COMPLETED|Randomized (Pre-treatment)||397
307548|NCT01668784|735622|P1|COMPLETED|Randomized (Pre-treatment)||406
307549|NCT01668784|735621|P2|STARTED|Randomized (Pre-treatment)||411
307550|NCT01668784|735622|P1|STARTED|Randomized (Pre-treatment)||410
307551|NCT01669902|735646|P1|NOT COMPLETED|Overall Study||29
307552|NCT01669902|735646|P1|COMPLETED|Overall Study||78
307553|NCT01669902|735646|P1|STARTED|Overall Study||107
307554|NCT01669863|735673|P1|NOT COMPLETED|Overall Study||0
307555|NCT01669863|735673|P1|COMPLETED|Overall Study||6
307556|NCT01669863|735673|P1|STARTED|Overall Study||6
307557|NCT01669811|735681|P2|NOT COMPLETED|Overall Study||11
307558|NCT01669811|735682|P1|NOT COMPLETED|Overall Study||3
307559|NCT01669811|735681|P2|COMPLETED|Overall Study||131
307560|NCT01669811|735682|P1|COMPLETED|Overall Study||142
307561|NCT01669811|735681|P2|STARTED|Overall Study||142
307562|NCT01669811|735682|P1|STARTED|Overall Study||145
307563|NCT01669785|735703|P3|NOT COMPLETED|Overall Study||0
307564|NCT01669785|735704|P2|NOT COMPLETED|Overall Study||0
307565|NCT01669785|735705|P1|NOT COMPLETED|Overall Study||0
307566|NCT01669785|735703|P3|COMPLETED|Overall Study||46
307567|NCT01669785|735704|P2|COMPLETED|Overall Study||48
307568|NCT01669785|735705|P1|COMPLETED|Overall Study||45
307569|NCT01669785|735703|P3|STARTED|Overall Study||46
307570|NCT01669785|735704|P2|STARTED|Overall Study||48
307571|NCT01669785|735705|P1|STARTED|Overall Study||45
307572|NCT01669720|735742|P2|NOT COMPLETED|Overall Study||0
307573|NCT01669720|735743|P1|NOT COMPLETED|Overall Study||0
307574|NCT01669720|735742|P2|COMPLETED|Overall Study||3
307575|NCT01669720|735743|P1|COMPLETED|Overall Study||7
307576|NCT01669720|735742|P2|STARTED|Overall Study||3
307577|NCT01669720|735743|P1|STARTED|Overall Study||7
307578|NCT01669629|735749|P2|NOT COMPLETED|Period 2||0
307579|NCT01669629|735750|P1|NOT COMPLETED|Period 2||0
307580|NCT01669629|735749|P2|COMPLETED|Period 2||89
307581|NCT01669629|735750|P1|COMPLETED|Period 2||91
307582|NCT01669629|735749|P2|STARTED|Period 2||89
307583|NCT01669629|735750|P1|STARTED|Period 2||91
307584|NCT01669629|735749|P2|NOT COMPLETED|Period 1||2
307585|NCT01669629|735750|P1|NOT COMPLETED|Period 1||1
307586|NCT01669629|735749|P2|COMPLETED|Period 1||89
307587|NCT01669629|735750|P1|COMPLETED|Period 1||91
307588|NCT01669629|735749|P2|STARTED|Period 1||91
307589|NCT01669629|735750|P1|STARTED|Period 1||92
307590|NCT01669603|735766|P2|NOT COMPLETED|Overall Study||38
307591|NCT01669603|735767|P1|NOT COMPLETED|Overall Study||37
307592|NCT01669603|735766|P2|COMPLETED|Overall Study||57
307593|NCT01669603|735767|P1|COMPLETED|Overall Study||58
307594|NCT01669603|735766|P2|STARTED|Overall Study||95
307595|NCT01669603|735767|P1|STARTED|Overall Study||95
307596|NCT01669577|735773|P1|NOT COMPLETED|Overall Study||134
307597|NCT01669577|735773|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
307598|NCT01669577|735773|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
307599|NCT01669174|735779|P2|NOT COMPLETED|Overall Study||6
307600|NCT01669174|735780|P1|NOT COMPLETED|Overall Study||6
307601|NCT01669174|735779|P2|COMPLETED|Overall Study||28
307602|NCT01669174|735780|P1|COMPLETED|Overall Study||27
307603|NCT01669174|735779|P2|STARTED|Overall Study||34
307604|NCT01669174|735780|P1|STARTED|Overall Study||33
307605|NCT01669148|735791|P1|NOT COMPLETED|Overall Study||70
307606|NCT01669148|735791|P1|COMPLETED|Overall Study||426
307607|NCT01669148|735791|P1|STARTED|Overall Study||496
307608|NCT01669122|735796|P1|NOT COMPLETED|Period IV||0
307609|NCT01669122|735796|P1|COMPLETED|Period IV||37
307610|NCT01669122|735796|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
307611|NCT01669122|735796|P1|NOT COMPLETED|Period III||0
307612|NCT01669122|735796|P1|COMPLETED|Period III||37
307613|NCT01669122|735796|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
307614|NCT01669122|735796|P1|NOT COMPLETED|Washout Period III||0
307615|NCT01669122|735796|P1|COMPLETED|Washout Period III||37
307616|NCT01669122|735796|P1|STARTED|Washout Period III||37
307617|NCT01669122|735796|P1|NOT COMPLETED|Washout Period II||2
307618|NCT01669122|735796|P1|COMPLETED|Washout Period II||37
307619|NCT01669122|735796|P1|STARTED|Washout Period II||39
307620|NCT01669122|735796|P1|NOT COMPLETED|Period II||0
307621|NCT01669122|735796|P1|COMPLETED|Period II||39
307622|NCT01669122|735796|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
307623|NCT01669122|735796|P1|NOT COMPLETED|Washout Period I||0
307624|NCT01669122|735796|P1|COMPLETED|Washout Period I||39
307625|NCT01669122|735796|P1|STARTED|Washout Period I||39
307626|NCT01669122|735796|P1|NOT COMPLETED|Period I||1
307627|NCT01669122|735796|P1|COMPLETED|Period I||39
307628|NCT01669122|735796|P1|Safety Population|Period I||39
307629|NCT01669122|735796|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
307630|NCT01668667|735830|P4|NOT COMPLETED|Overall Study||23
307631|NCT01668667|735831|P3|NOT COMPLETED|Overall Study||31
307632|NCT01668667|735832|P2|NOT COMPLETED|Overall Study||26
307633|NCT01668667|735833|P1|NOT COMPLETED|Overall Study||31
307634|NCT01668667|735830|P4|COMPLETED|Overall Study||102
307635|NCT01668667|735831|P3|COMPLETED|Overall Study||94
307636|NCT01668667|735832|P2|COMPLETED|Overall Study||99
307637|NCT01668667|735833|P1|COMPLETED|Overall Study||95
307638|NCT01668667|735830|P4|STARTED|Overall Study||125
307639|NCT01668667|735831|P3|STARTED|Overall Study||125
307640|NCT01668667|735832|P2|STARTED|Overall Study||125
307641|NCT01668667|735833|P1|STARTED|Overall Study||126
307642|NCT01668654|735855|P1|NOT COMPLETED|Overall Study||4
307643|NCT01668654|735855|P1|COMPLETED|Overall Study||0
307644|NCT01668654|735855|P1|STARTED|Overall Study||4
307645|NCT01668628|735898|P3|NOT COMPLETED|Overall Study||0
307646|NCT01668628|735899|P2|NOT COMPLETED|Overall Study||0
307647|NCT01668628|735900|P1|NOT COMPLETED|Overall Study||2
307648|NCT01668628|735898|P3|COMPLETED|Overall Study||367
307649|NCT01668628|735899|P2|COMPLETED|Overall Study||359
307650|NCT01668628|735900|P1|COMPLETED|Overall Study||347
307651|NCT01668628|735898|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
307652|NCT01668628|735899|P2|STARTED|Overall Study||359
307653|NCT01668628|735900|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
307654|NCT01668589|735916|P4|NOT COMPLETED|Overall Study||35
307655|NCT01668589|735917|P3|NOT COMPLETED|Overall Study||35
307656|NCT01668589|735918|P2|NOT COMPLETED|Overall Study||58
307657|NCT01668589|735919|P1|NOT COMPLETED|Overall Study||139
307658|NCT01668589|735916|P4|COMPLETED|Overall Study||266
307659|NCT01668589|735917|P3|COMPLETED|Overall Study||265
307660|NCT01668589|735918|P2|COMPLETED|Overall Study||242
307661|NCT01668589|735919|P1|COMPLETED|Overall Study||461
307662|NCT01668589|735916|P4|Received Denosumab|Overall Study||301
307663|NCT01668589|735917|P3|Received Denosumab|Overall Study||300
307664|NCT01668589|735918|P2|Received Denosumab|Overall Study||300
307665|NCT01668589|735919|P1|Received Denosumab|Overall Study||599
307666|NCT01668589|735916|P4|STARTED|Overall Study||301
307667|NCT01668589|735917|P3|STARTED|Overall Study||300
307668|NCT01668589|735918|P2|STARTED|Overall Study||300
307669|NCT01668589|735919|P1|STARTED|Overall Study||600
307670|NCT01668173|735957|P1|NOT COMPLETED|Overall Study||7
307671|NCT01668173|735957|P1|COMPLETED|Overall Study||0
307672|NCT01668173|735957|P1|STARTED|Overall Study||7
307673|NCT01668017|735966|P5|NOT COMPLETED|Overall Study||0
307674|NCT01668017|735967|P4|NOT COMPLETED|Overall Study||0
307675|NCT01668017|735968|P3|NOT COMPLETED|Overall Study||0
307676|NCT01668017|735969|P2|NOT COMPLETED|Overall Study||0
307677|NCT01668017|735970|P1|NOT COMPLETED|Overall Study||0
307678|NCT01668017|735966|P5|COMPLETED|Overall Study||2
307679|NCT01668017|735967|P4|COMPLETED|Overall Study||5
307680|NCT01668017|735968|P3|COMPLETED|Overall Study||6
307681|NCT01668017|735969|P2|COMPLETED|Overall Study||9
307682|NCT01668017|735970|P1|COMPLETED|Overall Study||4
307683|NCT01668017|735966|P5|STARTED|Overall Study||2
307684|NCT01668017|735967|P4|STARTED|Overall Study||5
307685|NCT01668017|735968|P3|STARTED|Overall Study||6
307686|NCT01668017|735969|P2|STARTED|Overall Study||9
307687|NCT01668017|735970|P1|STARTED|Overall Study||4
307688|NCT01668004|736077|P1|NOT COMPLETED|Overall Study||25
307689|NCT01668004|736077|P1|COMPLETED|Overall Study||76
307690|NCT01668004|736077|P1|Treated|Overall Study||101
307691|NCT01668004|736077|P1|STARTED|Overall Study||101
307692|NCT01667978|736090|P2|NOT COMPLETED|Overall Study||0
307693|NCT01667978|736091|P1|NOT COMPLETED|Overall Study||2
307694|NCT01667978|736090|P2|COMPLETED|Overall Study||17
307695|NCT01667978|736091|P1|COMPLETED|Overall Study||16
307696|NCT01667978|736090|P2|STARTED|Overall Study||17
307697|NCT01667978|736091|P1|STARTED|Overall Study||18
307698|NCT01667926|736099|P3|NOT COMPLETED|Overall Study||11
307699|NCT01667926|736100|P2|NOT COMPLETED|Overall Study||4
307700|NCT01667926|736101|P1|NOT COMPLETED|Overall Study||5
307701|NCT01667926|736099|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
307702|NCT01667926|736100|P2|COMPLETED|Overall Study||9
307703|NCT01667926|736101|P1|COMPLETED|Overall Study||8
307704|NCT01667926|736099|P3|STARTED|Overall Study||11
307705|NCT01667926|736100|P2|STARTED|Overall Study||13
307706|NCT01667926|736101|P1|STARTED|Overall Study||13
307707|NCT01667900|736114|P20|NOT COMPLETED|Part B||0
307708|NCT01667900|736115|P19|NOT COMPLETED|Part B||0
307709|NCT01667900|736116|P18|NOT COMPLETED|Part B||0
307710|NCT01667900|736117|P17|NOT COMPLETED|Part B||1
307711|NCT01667900|736118|P16|NOT COMPLETED|Part B||0
307712|NCT01667900|736119|P15|NOT COMPLETED|Part B||0
307713|NCT01667900|736120|P14|NOT COMPLETED|Part B||0
307714|NCT01667900|736121|P13|NOT COMPLETED|Part B||0
307715|NCT01667900|736122|P12|NOT COMPLETED|Part B||0
307716|NCT01667900|736123|P11|NOT COMPLETED|Part B||0
307717|NCT01667900|736124|P10|NOT COMPLETED|Part B||0
307718|NCT01667900|736125|P9|NOT COMPLETED|Part B||0
307719|NCT01667900|736126|P8|NOT COMPLETED|Part B||0
307720|NCT01667900|736127|P7|NOT COMPLETED|Part B||0
307721|NCT01667900|736128|P6|NOT COMPLETED|Part B||0
307722|NCT01667900|736129|P5|NOT COMPLETED|Part B||0
307723|NCT01667900|736130|P4|NOT COMPLETED|Part B||0
307724|NCT01667900|736131|P3|NOT COMPLETED|Part B||0
307725|NCT01667900|736132|P2|NOT COMPLETED|Part B||0
307726|NCT01667900|736133|P1|NOT COMPLETED|Part B||0
307727|NCT01667900|736114|P20|COMPLETED|Part B||10
307728|NCT01667900|736115|P19|COMPLETED|Part B||10
307729|NCT01667900|736116|P18|COMPLETED|Part B||11
307730|NCT01667900|736117|P17|COMPLETED|Part B||10
307731|NCT01667900|736118|P16|COMPLETED|Part B||0
307732|NCT01667900|736119|P15|COMPLETED|Part B||0
307733|NCT01667900|736120|P14|COMPLETED|Part B||0
307734|NCT01667900|736121|P13|COMPLETED|Part B||0
307735|NCT01667900|736122|P12|COMPLETED|Part B||0
307736|NCT01667900|736123|P11|COMPLETED|Part B||0
307737|NCT01667900|736124|P10|COMPLETED|Part B||0
307738|NCT01667900|736125|P9|COMPLETED|Part B||0
307739|NCT01667900|736126|P8|COMPLETED|Part B||0
307740|NCT01667900|736127|P7|COMPLETED|Part B||0
307741|NCT01667900|736128|P6|COMPLETED|Part B||0
307742|NCT01667900|736129|P5|COMPLETED|Part B||0
307743|NCT01667900|736130|P4|COMPLETED|Part B||0
307744|NCT01667900|736131|P3|COMPLETED|Part B||0
307745|NCT01667900|736132|P2|COMPLETED|Part B||0
307746|NCT01667900|736133|P1|COMPLETED|Part B||0
307747|NCT01667900|736114|P20|STARTED|Part B||10
307748|NCT01667900|736115|P19|STARTED|Part B||10
307749|NCT01667900|736116|P18|STARTED|Part B||11
307750|NCT01667900|736117|P17|STARTED|Part B||11
307751|NCT01667900|736118|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
307752|NCT01667900|736119|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
307753|NCT01667900|736120|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
307754|NCT01667900|736121|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
307755|NCT01667900|736122|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
307756|NCT01667900|736123|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
307757|NCT01667900|736124|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
307758|NCT01667900|736125|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
307759|NCT01667900|736126|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
307760|NCT01667900|736127|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
307761|NCT01667900|736128|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
307762|NCT01667900|736129|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
307763|NCT01667900|736130|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
307764|NCT01667900|736131|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
307765|NCT01667900|736132|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
307766|NCT01667900|736133|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
307767|NCT01667900|736114|P20|NOT COMPLETED|Part A, Period 3||0
307768|NCT01667900|736115|P19|NOT COMPLETED|Part A, Period 3||0
307769|NCT01667900|736116|P18|NOT COMPLETED|Part A, Period 3||0
307770|NCT01667900|736117|P17|NOT COMPLETED|Part A, Period 3||0
307771|NCT01667900|736118|P16|NOT COMPLETED|Part A, Period 3||0
307772|NCT01667900|736119|P15|NOT COMPLETED|Part A, Period 3||0
307773|NCT01667900|736120|P14|NOT COMPLETED|Part A, Period 3||0
307774|NCT01667900|736121|P13|NOT COMPLETED|Part A, Period 3||0
307775|NCT01667900|736122|P12|NOT COMPLETED|Part A, Period 3||0
307776|NCT01667900|736123|P11|NOT COMPLETED|Part A, Period 3||0
307777|NCT01667900|736124|P10|NOT COMPLETED|Part A, Period 3||0
307778|NCT01667900|736125|P9|NOT COMPLETED|Part A, Period 3||0
307779|NCT01667900|736126|P8|NOT COMPLETED|Part A, Period 3||0
307780|NCT01667900|736127|P7|NOT COMPLETED|Part A, Period 3||0
307781|NCT01667900|736128|P6|NOT COMPLETED|Part A, Period 3||0
307782|NCT01667900|736129|P5|NOT COMPLETED|Part A, Period 3||0
307783|NCT01667900|736130|P4|NOT COMPLETED|Part A, Period 3||0
307784|NCT01667900|736131|P3|NOT COMPLETED|Part A, Period 3||0
307785|NCT01667900|736132|P2|NOT COMPLETED|Part A, Period 3||0
307786|NCT01667900|736133|P1|NOT COMPLETED|Part A, Period 3||0
307787|NCT01667900|736114|P20|COMPLETED|Part A, Period 3||0
307788|NCT01667900|736115|P19|COMPLETED|Part A, Period 3||0
307789|NCT01667900|736116|P18|COMPLETED|Part A, Period 3||0
307790|NCT01667900|736117|P17|COMPLETED|Part A, Period 3||0
307791|NCT01667900|736118|P16|COMPLETED|Part A, Period 3||1
307792|NCT01667900|736119|P15|COMPLETED|Part A, Period 3||1
307793|NCT01667900|736120|P14|COMPLETED|Part A, Period 3||1
307794|NCT01667900|736121|P13|COMPLETED|Part A, Period 3||1
307795|NCT01667900|736122|P12|COMPLETED|Part A, Period 3||1
307796|NCT01667900|736123|P11|COMPLETED|Part A, Period 3||1
307797|NCT01667900|736124|P10|COMPLETED|Part A, Period 3||1
307798|NCT01667900|736125|P9|COMPLETED|Part A, Period 3||1
307799|NCT01667900|736126|P8|COMPLETED|Part A, Period 3||1
307800|NCT01667900|736127|P7|COMPLETED|Part A, Period 3||1
307801|NCT01667900|736128|P6|COMPLETED|Part A, Period 3||1
307802|NCT01667900|736129|P5|COMPLETED|Part A, Period 3||1
307803|NCT01667900|736130|P4|COMPLETED|Part A, Period 3||1
307804|NCT01667900|736131|P3|COMPLETED|Part A, Period 3||1
307805|NCT01667900|736132|P2|COMPLETED|Part A, Period 3||1
307806|NCT01667900|736133|P1|COMPLETED|Part A, Period 3||1
307807|NCT01667900|736114|P20|STARTED|Part A, Period 3||0
307808|NCT01667900|736115|P19|STARTED|Part A, Period 3||0
307809|NCT01667900|736116|P18|STARTED|Part A, Period 3||0
307810|NCT01667900|736117|P17|STARTED|Part A, Period 3||0
307811|NCT01667900|736118|P16|STARTED|Part A, Period 3||1
307812|NCT01667900|736119|P15|STARTED|Part A, Period 3||1
307813|NCT01667900|736120|P14|STARTED|Part A, Period 3||1
307814|NCT01667900|736121|P13|STARTED|Part A, Period 3||1
307815|NCT01667900|736122|P12|STARTED|Part A, Period 3||1
307816|NCT01667900|736123|P11|STARTED|Part A, Period 3||1
307817|NCT01667900|736124|P10|STARTED|Part A, Period 3||1
307818|NCT01667900|736125|P9|STARTED|Part A, Period 3||1
307819|NCT01667900|736126|P8|STARTED|Part A, Period 3||1
307820|NCT01667900|736127|P7|STARTED|Part A, Period 3||1
307821|NCT01667900|736128|P6|STARTED|Part A, Period 3||1
307822|NCT01667900|736129|P5|STARTED|Part A, Period 3||1
307823|NCT01667900|736130|P4|STARTED|Part A, Period 3||1
307824|NCT01667900|736131|P3|STARTED|Part A, Period 3||1
307825|NCT01667900|736132|P2|STARTED|Part A, Period 3||1
307826|NCT01667900|736133|P1|STARTED|Part A, Period 3||1
307827|NCT01667900|736114|P20|NOT COMPLETED|Part A, Washout 2||0
307828|NCT01667900|736115|P19|NOT COMPLETED|Part A, Washout 2||0
307829|NCT01667900|736116|P18|NOT COMPLETED|Part A, Washout 2||0
307830|NCT01667900|736117|P17|NOT COMPLETED|Part A, Washout 2||0
307831|NCT01667900|736118|P16|NOT COMPLETED|Part A, Washout 2||0
307832|NCT01667900|736119|P15|NOT COMPLETED|Part A, Washout 2||0
307833|NCT01667900|736120|P14|NOT COMPLETED|Part A, Washout 2||0
307834|NCT01667900|736121|P13|NOT COMPLETED|Part A, Washout 2||0
307835|NCT01667900|736122|P12|NOT COMPLETED|Part A, Washout 2||0
307836|NCT01667900|736123|P11|NOT COMPLETED|Part A, Washout 2||0
307837|NCT01667900|736124|P10|NOT COMPLETED|Part A, Washout 2||0
307838|NCT01667900|736125|P9|NOT COMPLETED|Part A, Washout 2||0
307839|NCT01667900|736126|P8|NOT COMPLETED|Part A, Washout 2||0
307840|NCT01667900|736127|P7|NOT COMPLETED|Part A, Washout 2||0
307841|NCT01667900|736128|P6|NOT COMPLETED|Part A, Washout 2||0
307842|NCT01667900|736129|P5|NOT COMPLETED|Part A, Washout 2||0
307843|NCT01667900|736130|P4|NOT COMPLETED|Part A, Washout 2||0
307844|NCT01667900|736131|P3|NOT COMPLETED|Part A, Washout 2||0
307845|NCT01667900|736132|P2|NOT COMPLETED|Part A, Washout 2||0
307846|NCT01667900|736133|P1|NOT COMPLETED|Part A, Washout 2||0
307847|NCT01667900|736114|P20|COMPLETED|Part A, Washout 2||0
307848|NCT01667900|736115|P19|COMPLETED|Part A, Washout 2||0
307849|NCT01667900|736116|P18|COMPLETED|Part A, Washout 2||0
307850|NCT01667900|736117|P17|COMPLETED|Part A, Washout 2||0
307851|NCT01667900|736118|P16|COMPLETED|Part A, Washout 2||1
307852|NCT01667900|736119|P15|COMPLETED|Part A, Washout 2||1
307853|NCT01667900|736120|P14|COMPLETED|Part A, Washout 2||1
307854|NCT01667900|736121|P13|COMPLETED|Part A, Washout 2||1
307855|NCT01667900|736122|P12|COMPLETED|Part A, Washout 2||1
307856|NCT01667900|736123|P11|COMPLETED|Part A, Washout 2||1
307857|NCT01667900|736124|P10|COMPLETED|Part A, Washout 2||1
307858|NCT01667900|736125|P9|COMPLETED|Part A, Washout 2||1
307859|NCT01667900|736126|P8|COMPLETED|Part A, Washout 2||1
307860|NCT01667900|736127|P7|COMPLETED|Part A, Washout 2||1
307861|NCT01667900|736128|P6|COMPLETED|Part A, Washout 2||1
307862|NCT01667900|736129|P5|COMPLETED|Part A, Washout 2||1
307863|NCT01667900|736130|P4|COMPLETED|Part A, Washout 2||1
307864|NCT01667900|736131|P3|COMPLETED|Part A, Washout 2||1
307865|NCT01667900|736132|P2|COMPLETED|Part A, Washout 2||1
307866|NCT01667900|736133|P1|COMPLETED|Part A, Washout 2||1
307867|NCT01667900|736114|P20|STARTED|Part A, Washout 2||0
307868|NCT01667900|736115|P19|STARTED|Part A, Washout 2||0
307869|NCT01667900|736116|P18|STARTED|Part A, Washout 2||0
307870|NCT01667900|736117|P17|STARTED|Part A, Washout 2||0
307871|NCT01667900|736118|P16|STARTED|Part A, Washout 2||1
307872|NCT01667900|736119|P15|STARTED|Part A, Washout 2||1
307873|NCT01667900|736120|P14|STARTED|Part A, Washout 2||1
307874|NCT01667900|736121|P13|STARTED|Part A, Washout 2||1
307875|NCT01667900|736122|P12|STARTED|Part A, Washout 2||1
307876|NCT01667900|736123|P11|STARTED|Part A, Washout 2||1
307877|NCT01667900|736124|P10|STARTED|Part A, Washout 2||1
307878|NCT01667900|736125|P9|STARTED|Part A, Washout 2||1
307879|NCT01667900|736126|P8|STARTED|Part A, Washout 2||1
307880|NCT01667900|736127|P7|STARTED|Part A, Washout 2||1
307881|NCT01667900|736128|P6|STARTED|Part A, Washout 2||1
307882|NCT01667900|736129|P5|STARTED|Part A, Washout 2||1
307883|NCT01667900|736130|P4|STARTED|Part A, Washout 2||1
307884|NCT01667900|736131|P3|STARTED|Part A, Washout 2||1
307885|NCT01667900|736132|P2|STARTED|Part A, Washout 2||1
307886|NCT01667900|736133|P1|STARTED|Part A, Washout 2||1
307887|NCT01667900|736114|P20|NOT COMPLETED|Part A, Period 2||0
307888|NCT01667900|736115|P19|NOT COMPLETED|Part A, Period 2||0
307889|NCT01667900|736116|P18|NOT COMPLETED|Part A, Period 2||0
307890|NCT01667900|736117|P17|NOT COMPLETED|Part A, Period 2||0
307891|NCT01667900|736118|P16|NOT COMPLETED|Part A, Period 2||0
307892|NCT01667900|736119|P15|NOT COMPLETED|Part A, Period 2||0
307893|NCT01667900|736120|P14|NOT COMPLETED|Part A, Period 2||0
307894|NCT01667900|736121|P13|NOT COMPLETED|Part A, Period 2||0
307895|NCT01667900|736122|P12|NOT COMPLETED|Part A, Period 2||0
307896|NCT01667900|736123|P11|NOT COMPLETED|Part A, Period 2||0
307897|NCT01667900|736124|P10|NOT COMPLETED|Part A, Period 2||0
307898|NCT01667900|736125|P9|NOT COMPLETED|Part A, Period 2||0
307899|NCT01667900|736126|P8|NOT COMPLETED|Part A, Period 2||0
307900|NCT01667900|736127|P7|NOT COMPLETED|Part A, Period 2||0
307901|NCT01667900|736128|P6|NOT COMPLETED|Part A, Period 2||0
307902|NCT01667900|736129|P5|NOT COMPLETED|Part A, Period 2||0
307903|NCT01667900|736130|P4|NOT COMPLETED|Part A, Period 2||0
307904|NCT01667900|736131|P3|NOT COMPLETED|Part A, Period 2||0
307905|NCT01667900|736132|P2|NOT COMPLETED|Part A, Period 2||0
307906|NCT01667900|736133|P1|NOT COMPLETED|Part A, Period 2||0
307907|NCT01667900|736114|P20|COMPLETED|Part A, Period 2||0
307908|NCT01667900|736115|P19|COMPLETED|Part A, Period 2||0
307909|NCT01667900|736116|P18|COMPLETED|Part A, Period 2||0
307910|NCT01667900|736117|P17|COMPLETED|Part A, Period 2||0
307911|NCT01667900|736118|P16|COMPLETED|Part A, Period 2||1
307912|NCT01667900|736119|P15|COMPLETED|Part A, Period 2||1
307913|NCT01667900|736120|P14|COMPLETED|Part A, Period 2||1
307914|NCT01667900|736121|P13|COMPLETED|Part A, Period 2||1
307915|NCT01667900|736122|P12|COMPLETED|Part A, Period 2||1
307916|NCT01667900|736123|P11|COMPLETED|Part A, Period 2||1
307917|NCT01667900|736124|P10|COMPLETED|Part A, Period 2||1
307918|NCT01667900|736125|P9|COMPLETED|Part A, Period 2||1
307919|NCT01667900|736126|P8|COMPLETED|Part A, Period 2||1
307920|NCT01667900|736127|P7|COMPLETED|Part A, Period 2||1
307921|NCT01667900|736128|P6|COMPLETED|Part A, Period 2||1
307922|NCT01667900|736129|P5|COMPLETED|Part A, Period 2||1
307923|NCT01667900|736130|P4|COMPLETED|Part A, Period 2||1
307924|NCT01667900|736131|P3|COMPLETED|Part A, Period 2||1
307925|NCT01667900|736132|P2|COMPLETED|Part A, Period 2||1
307926|NCT01667900|736133|P1|COMPLETED|Part A, Period 2||1
307927|NCT01667900|736114|P20|STARTED|Part A, Period 2||0
307928|NCT01667900|736115|P19|STARTED|Part A, Period 2||0
307929|NCT01667900|736116|P18|STARTED|Part A, Period 2||0
307930|NCT01667900|736117|P17|STARTED|Part A, Period 2||0
307931|NCT01667900|736118|P16|STARTED|Part A, Period 2||1
307932|NCT01667900|736119|P15|STARTED|Part A, Period 2||1
307933|NCT01667900|736120|P14|STARTED|Part A, Period 2||1
307934|NCT01667900|736121|P13|STARTED|Part A, Period 2||1
307935|NCT01667900|736122|P12|STARTED|Part A, Period 2||1
307936|NCT01667900|736123|P11|STARTED|Part A, Period 2||1
307937|NCT01667900|736124|P10|STARTED|Part A, Period 2||1
307938|NCT01667900|736125|P9|STARTED|Part A, Period 2||1
307939|NCT01667900|736126|P8|STARTED|Part A, Period 2||1
307940|NCT01667900|736127|P7|STARTED|Part A, Period 2||1
307941|NCT01667900|736128|P6|STARTED|Part A, Period 2||1
307942|NCT01667900|736129|P5|STARTED|Part A, Period 2||1
307943|NCT01667900|736130|P4|STARTED|Part A, Period 2||1
307944|NCT01667900|736131|P3|STARTED|Part A, Period 2||1
307945|NCT01667900|736132|P2|STARTED|Part A, Period 2||1
307946|NCT01667900|736133|P1|STARTED|Part A, Period 2||1
307947|NCT01667900|736114|P20|NOT COMPLETED|Part A, Washout 1||0
307948|NCT01667900|736115|P19|NOT COMPLETED|Part A, Washout 1||0
307949|NCT01667900|736116|P18|NOT COMPLETED|Part A, Washout 1||0
307950|NCT01667900|736117|P17|NOT COMPLETED|Part A, Washout 1||0
307951|NCT01667900|736118|P16|NOT COMPLETED|Part A, Washout 1||0
307952|NCT01667900|736119|P15|NOT COMPLETED|Part A, Washout 1||0
307953|NCT01667900|736120|P14|NOT COMPLETED|Part A, Washout 1||0
307954|NCT01667900|736121|P13|NOT COMPLETED|Part A, Washout 1||0
307955|NCT01667900|736122|P12|NOT COMPLETED|Part A, Washout 1||0
307956|NCT01667900|736123|P11|NOT COMPLETED|Part A, Washout 1||0
307957|NCT01667900|736124|P10|NOT COMPLETED|Part A, Washout 1||0
307958|NCT01667900|736125|P9|NOT COMPLETED|Part A, Washout 1||0
307959|NCT01667900|736126|P8|NOT COMPLETED|Part A, Washout 1||0
307960|NCT01667900|736127|P7|NOT COMPLETED|Part A, Washout 1||0
307961|NCT01667900|736128|P6|NOT COMPLETED|Part A, Washout 1||0
307962|NCT01667900|736129|P5|NOT COMPLETED|Part A, Washout 1||0
307963|NCT01667900|736130|P4|NOT COMPLETED|Part A, Washout 1||0
307964|NCT01667900|736131|P3|NOT COMPLETED|Part A, Washout 1||0
307965|NCT01667900|736132|P2|NOT COMPLETED|Part A, Washout 1||0
307966|NCT01667900|736133|P1|NOT COMPLETED|Part A, Washout 1||0
307967|NCT01667900|736114|P20|COMPLETED|Part A, Washout 1||0
307968|NCT01667900|736115|P19|COMPLETED|Part A, Washout 1||0
307969|NCT01667900|736116|P18|COMPLETED|Part A, Washout 1||0
307970|NCT01667900|736117|P17|COMPLETED|Part A, Washout 1||0
307971|NCT01667900|736118|P16|COMPLETED|Part A, Washout 1||1
307972|NCT01667900|736119|P15|COMPLETED|Part A, Washout 1||1
307973|NCT01667900|736120|P14|COMPLETED|Part A, Washout 1||1
307974|NCT01667900|736121|P13|COMPLETED|Part A, Washout 1||1
307975|NCT01667900|736122|P12|COMPLETED|Part A, Washout 1||1
307976|NCT01667900|736123|P11|COMPLETED|Part A, Washout 1||1
307977|NCT01667900|736124|P10|COMPLETED|Part A, Washout 1||1
307978|NCT01667900|736125|P9|COMPLETED|Part A, Washout 1||1
307979|NCT01667900|736126|P8|COMPLETED|Part A, Washout 1||1
307980|NCT01667900|736127|P7|COMPLETED|Part A, Washout 1||1
307981|NCT01667900|736128|P6|COMPLETED|Part A, Washout 1||1
307982|NCT01667900|736129|P5|COMPLETED|Part A, Washout 1||1
307983|NCT01667900|736130|P4|COMPLETED|Part A, Washout 1||1
307984|NCT01667900|736131|P3|COMPLETED|Part A, Washout 1||1
307985|NCT01667900|736132|P2|COMPLETED|Part A, Washout 1||1
307986|NCT01667900|736133|P1|COMPLETED|Part A, Washout 1||1
307987|NCT01667900|736114|P20|STARTED|Part A, Washout 1||0
307988|NCT01667900|736115|P19|STARTED|Part A, Washout 1||0
307989|NCT01667900|736116|P18|STARTED|Part A, Washout 1||0
307990|NCT01667900|736117|P17|STARTED|Part A, Washout 1||0
307991|NCT01667900|736118|P16|STARTED|Part A, Washout 1||1
307992|NCT01667900|736119|P15|STARTED|Part A, Washout 1||1
307993|NCT01667900|736120|P14|STARTED|Part A, Washout 1||1
307994|NCT01667900|736121|P13|STARTED|Part A, Washout 1||1
307995|NCT01667900|736122|P12|STARTED|Part A, Washout 1||1
307996|NCT01667900|736123|P11|STARTED|Part A, Washout 1||1
307997|NCT01667900|736124|P10|STARTED|Part A, Washout 1||1
307998|NCT01667900|736125|P9|STARTED|Part A, Washout 1||1
307999|NCT01667900|736126|P8|STARTED|Part A, Washout 1||1
308000|NCT01667900|736127|P7|STARTED|Part A, Washout 1||1
308001|NCT01667900|736128|P6|STARTED|Part A, Washout 1||1
308002|NCT01667900|736129|P5|STARTED|Part A, Washout 1||1
308003|NCT01667900|736130|P4|STARTED|Part A, Washout 1||1
308004|NCT01667900|736131|P3|STARTED|Part A, Washout 1||1
308005|NCT01667900|736132|P2|STARTED|Part A, Washout 1||1
308006|NCT01667900|736133|P1|STARTED|Part A, Washout 1||1
308007|NCT01667900|736114|P20|NOT COMPLETED|Part A, Period 1||0
308008|NCT01667900|736115|P19|NOT COMPLETED|Part A, Period 1||0
308009|NCT01667900|736116|P18|NOT COMPLETED|Part A, Period 1||0
308010|NCT01667900|736117|P17|NOT COMPLETED|Part A, Period 1||0
308011|NCT01667900|736118|P16|NOT COMPLETED|Part A, Period 1||0
308012|NCT01667900|736119|P15|NOT COMPLETED|Part A, Period 1||0
308013|NCT01667900|736120|P14|NOT COMPLETED|Part A, Period 1||0
308014|NCT01667900|736121|P13|NOT COMPLETED|Part A, Period 1||0
308015|NCT01667900|736122|P12|NOT COMPLETED|Part A, Period 1||0
308016|NCT01667900|736123|P11|NOT COMPLETED|Part A, Period 1||0
308017|NCT01667900|736124|P10|NOT COMPLETED|Part A, Period 1||0
308018|NCT01667900|736125|P9|NOT COMPLETED|Part A, Period 1||0
308019|NCT01667900|736126|P8|NOT COMPLETED|Part A, Period 1||0
308020|NCT01667900|736127|P7|NOT COMPLETED|Part A, Period 1||0
308021|NCT01667900|736128|P6|NOT COMPLETED|Part A, Period 1||0
308022|NCT01667900|736129|P5|NOT COMPLETED|Part A, Period 1||0
308023|NCT01667900|736130|P4|NOT COMPLETED|Part A, Period 1||0
308024|NCT01667900|736131|P3|NOT COMPLETED|Part A, Period 1||0
308025|NCT01667900|736132|P2|NOT COMPLETED|Part A, Period 1||0
308026|NCT01667900|736133|P1|NOT COMPLETED|Part A, Period 1||0
308027|NCT01667900|736114|P20|COMPLETED|Part A, Period 1||0
308028|NCT01667900|736115|P19|COMPLETED|Part A, Period 1||0
308029|NCT01667900|736116|P18|COMPLETED|Part A, Period 1||0
308030|NCT01667900|736117|P17|COMPLETED|Part A, Period 1||0
308031|NCT01667900|736118|P16|COMPLETED|Part A, Period 1||1
308032|NCT01667900|736119|P15|COMPLETED|Part A, Period 1||1
308033|NCT01667900|736120|P14|COMPLETED|Part A, Period 1||1
308034|NCT01667900|736121|P13|COMPLETED|Part A, Period 1||1
308035|NCT01667900|736122|P12|COMPLETED|Part A, Period 1||1
308036|NCT01667900|736123|P11|COMPLETED|Part A, Period 1||1
308037|NCT01667900|736124|P10|COMPLETED|Part A, Period 1||1
308038|NCT01667900|736125|P9|COMPLETED|Part A, Period 1||1
308039|NCT01667900|736126|P8|COMPLETED|Part A, Period 1||1
308040|NCT01667900|736127|P7|COMPLETED|Part A, Period 1||1
308041|NCT01667900|736128|P6|COMPLETED|Part A, Period 1||1
308042|NCT01667900|736129|P5|COMPLETED|Part A, Period 1||1
308043|NCT01667900|736130|P4|COMPLETED|Part A, Period 1||1
308044|NCT01667900|736131|P3|COMPLETED|Part A, Period 1||1
308045|NCT01667900|736132|P2|COMPLETED|Part A, Period 1||1
308046|NCT01667900|736133|P1|COMPLETED|Part A, Period 1||1
308047|NCT01667900|736114|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
308048|NCT01667900|736115|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
308049|NCT01667900|736116|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
308050|NCT01667900|736117|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
308051|NCT01667900|736118|P16|STARTED|Part A, Period 1||1
308052|NCT01667900|736119|P15|STARTED|Part A, Period 1||1
308053|NCT01667900|736120|P14|STARTED|Part A, Period 1||1
308054|NCT01667900|736121|P13|STARTED|Part A, Period 1||1
308055|NCT01667900|736122|P12|STARTED|Part A, Period 1||1
308056|NCT01667900|736123|P11|STARTED|Part A, Period 1||1
308057|NCT01667900|736124|P10|STARTED|Part A, Period 1||1
308058|NCT01667900|736125|P9|STARTED|Part A, Period 1||1
308059|NCT01667900|736126|P8|STARTED|Part A, Period 1||1
308060|NCT01667900|736127|P7|STARTED|Part A, Period 1||1
308061|NCT01667900|736128|P6|STARTED|Part A, Period 1||1
308062|NCT01667900|736129|P5|STARTED|Part A, Period 1||1
308063|NCT01667900|736130|P4|STARTED|Part A, Period 1||1
308064|NCT01667900|736131|P3|STARTED|Part A, Period 1||1
308065|NCT01667900|736132|P2|STARTED|Part A, Period 1||1
308066|NCT01667900|736133|P1|STARTED|Part A, Period 1||1
308067|NCT01667848|736173|P2|NOT COMPLETED|Overall Study||0
308068|NCT01667848|736174|P1|NOT COMPLETED|Overall Study||0
308069|NCT01667848|736173|P2|COMPLETED|Overall Study||81
308070|NCT01667848|736174|P1|COMPLETED|Overall Study||67
308071|NCT01667848|736173|P2|STARTED|Overall Study||81
308072|NCT01667848|736174|P1|STARTED|Overall Study||67
308073|NCT01667796|736184|P2|NOT COMPLETED|Overall Study||1
308074|NCT01667796|736185|P1|NOT COMPLETED|Overall Study||3
308075|NCT01667796|736184|P2|COMPLETED|Overall Study||29
308076|NCT01667796|736185|P1|COMPLETED|Overall Study||24
308077|NCT01667796|736184|P2|STARTED|Overall Study||30
308078|NCT01667796|736185|P1|STARTED|Overall Study||27
308079|NCT01667731|736196|P5|NOT COMPLETED|Overall Study||28
308080|NCT01667731|736197|P4|NOT COMPLETED|Overall Study||2
308081|NCT01667731|736198|P3|NOT COMPLETED|Overall Study||2
308082|NCT01667731|736199|P2|NOT COMPLETED|Overall Study||16
308083|NCT01667731|736200|P1|NOT COMPLETED|Overall Study||5
308084|NCT01667731|736196|P5|COMPLETED|Overall Study||87
308085|NCT01667731|736197|P4|COMPLETED|Overall Study||15
308086|NCT01667731|736198|P3|COMPLETED|Overall Study||22
308087|NCT01667731|736199|P2|COMPLETED|Overall Study||26
308088|NCT01667731|736200|P1|COMPLETED|Overall Study||21
308089|NCT01667731|736196|P5|STARTED|Overall Study||115
308090|NCT01667731|736197|P4|STARTED|Overall Study||17
308091|NCT01667731|736198|P3|STARTED|Overall Study||24
308092|NCT01667731|736199|P2|STARTED|Overall Study||42
308093|NCT01667731|736200|P1|STARTED|Overall Study||26
308094|NCT01667679|736255|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
308095|NCT01667679|736256|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
308096|NCT01667679|736255|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
308097|NCT01667679|736256|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
308098|NCT01667679|736255|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
308099|NCT01667679|736256|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
308100|NCT01667679|736255|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
308101|NCT01667679|736256|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
308102|NCT01667679|736255|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
308103|NCT01667679|736256|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
308104|NCT01667679|736255|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
308105|NCT01667679|736256|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
308106|NCT01667536|736314|P1|NOT COMPLETED|Overall Study||0
308201|NCT01665170|736542|P2|During TSST|Overall Study||30
308107|NCT01667536|736314|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
308108|NCT01667536|736314|P1|STARTED|Overall Study||105
308109|NCT01667471|736325|P1|NOT COMPLETED|Overall Study||0
308110|NCT01667471|736325|P1|COMPLETED|Overall Study||7
308111|NCT01667471|736325|P1|STARTED|Overall Study||7
308112|NCT01667432|736341|P1|NOT COMPLETED|Overall Study||57
308113|NCT01667432|736341|P1|COMPLETED|Overall Study||84
308114|NCT01667432|736341|P1|STARTED|Overall Study||141
308115|NCT01667224|736348|P2|NOT COMPLETED|Overall Study||2
308116|NCT01667224|736349|P1|NOT COMPLETED|Overall Study||4
308117|NCT01667224|736348|P2|COMPLETED|Overall Study||38
308118|NCT01667224|736349|P1|COMPLETED|Overall Study||36
308119|NCT01667224|736348|P2|STARTED|Overall Study||40
308120|NCT01667224|736349|P1|STARTED|Overall Study||40
308121|NCT01667107|736363|P2|NOT COMPLETED|Overall Study||7
308122|NCT01667107|736364|P1|NOT COMPLETED|Overall Study||4
308123|NCT01667107|736363|P2|COMPLETED|Overall Study||11
308124|NCT01667107|736364|P1|COMPLETED|Overall Study||4
308125|NCT01667107|736363|P2|STARTED|Overall Study||18
308126|NCT01667107|736364|P1|STARTED|Overall Study||8
308127|NCT01666951|736382|P2|NOT COMPLETED|Overall Study||1
308128|NCT01666951|736383|P1|NOT COMPLETED|Overall Study||1
308129|NCT01666951|736382|P2|COMPLETED|Overall Study||17
308130|NCT01666951|736383|P1|COMPLETED|Overall Study||17
308131|NCT01666951|736382|P2|STARTED|Overall Study||18
308132|NCT01666951|736383|P1|STARTED|Overall Study||18
308133|NCT01666912|736421|P2|NOT COMPLETED|Overall Study||11
308134|NCT01666912|736422|P1|NOT COMPLETED|Overall Study||21
308135|NCT01666912|736421|P2|COMPLETED|Overall Study||37
308136|NCT01666912|736422|P1|COMPLETED|Overall Study||27
308137|NCT01666912|736421|P2|STARTED|Overall Study||48
308138|NCT01666912|736422|P1|STARTED|Overall Study||48
308139|NCT01666782|736434|P2|NOT COMPLETED|Overall Study||1
308140|NCT01666782|736435|P1|NOT COMPLETED|Overall Study||4
308141|NCT01666782|736434|P2|COMPLETED|Overall Study||50
308142|NCT01666782|736435|P1|COMPLETED|Overall Study||50
308143|NCT01666782|736434|P2|STARTED|Overall Study||51
308144|NCT01666782|736435|P1|STARTED|Overall Study||54
308145|NCT01666210|736453|P2|NOT COMPLETED|Overall Study||1
308146|NCT01666210|736454|P1|NOT COMPLETED|Overall Study||2
308147|NCT01666210|736453|P2|COMPLETED|Overall Study||29
308148|NCT01666210|736454|P1|COMPLETED|Overall Study||28
308149|NCT01666210|736453|P2|STARTED|Overall Study||30
308150|NCT01666210|736454|P1|STARTED|Overall Study||30
308151|NCT01666197|736466|P2|NOT COMPLETED|Overall Study||0
308152|NCT01666197|736467|P1|NOT COMPLETED|Overall Study||0
308153|NCT01666197|736466|P2|COMPLETED|Overall Study||50
308154|NCT01666197|736467|P1|COMPLETED|Overall Study||50
308155|NCT01666197|736466|P2|STARTED|Overall Study||50
308156|NCT01666197|736467|P1|STARTED|Overall Study||50
308157|NCT01666119|736473|P1|NOT COMPLETED|Overall Study||52
308158|NCT01666119|736473|P1|COMPLETED|Overall Study||197
308159|NCT01666119|736473|P1|STARTED|Overall Study||249
308160|NCT01666002|736480|P2|NOT COMPLETED|Overall Study||0
308161|NCT01666002|736481|P1|NOT COMPLETED|Overall Study||5
308162|NCT01666002|736480|P2|COMPLETED|Overall Study||10
308163|NCT01666002|736481|P1|COMPLETED|Overall Study||12
308164|NCT01666002|736480|P2|STARTED|Overall Study||10
308165|NCT01666002|736481|P1|STARTED|Overall Study||17
308166|NCT01665950|736492|P3|NOT COMPLETED|Overall Study||1
308167|NCT01665950|736493|P2|NOT COMPLETED|Overall Study||0
308168|NCT01665950|736494|P1|NOT COMPLETED|Overall Study||1
308169|NCT01665950|736492|P3|COMPLETED|Overall Study||1
308170|NCT01665950|736493|P2|COMPLETED|Overall Study||0
308171|NCT01665950|736494|P1|COMPLETED|Overall Study||1
308172|NCT01665950|736492|P3|STARTED|Overall Study||2
308173|NCT01665950|736493|P2|STARTED|Overall Study||0
308174|NCT01665950|736494|P1|STARTED|Overall Study||2
308175|NCT01665911|736502|P1|NOT COMPLETED|Overall Study||6
308176|NCT01665911|736502|P1|COMPLETED|Overall Study||22
308177|NCT01665911|736502|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
308178|NCT01665911|736502|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
308179|NCT01665911|736502|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
308180|NCT01665911|736502|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
308181|NCT01665911|736502|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
308182|NCT01665911|736502|P1|STARTED|Overall Study||28
308183|NCT01665807|736511|P3|NOT COMPLETED|Overall Study||1
308184|NCT01665807|736512|P2|NOT COMPLETED|Overall Study||0
308185|NCT01665807|736513|P1|NOT COMPLETED|Overall Study||2
308186|NCT01665807|736511|P3|COMPLETED|Overall Study||401
308187|NCT01665807|736512|P2|COMPLETED|Overall Study||58
308188|NCT01665807|736513|P1|COMPLETED|Overall Study||409
308189|NCT01665807|736511|P3|STARTED|Overall Study||402
308190|NCT01665807|736512|P2|STARTED|Overall Study||58
308191|NCT01665807|736513|P1|STARTED|Overall Study||411
308192|NCT01665508|736524|P1|NOT COMPLETED|Overall Study||5
308193|NCT01665508|736524|P1|COMPLETED|Overall Study||7
308194|NCT01665508|736524|P1|STARTED|Overall Study||12
308195|NCT01665170|736542|P2|NOT COMPLETED|Overall Study||0
308196|NCT01665170|736543|P1|NOT COMPLETED|Overall Study||0
308197|NCT01665170|736542|P2|COMPLETED|Overall Study||30
308198|NCT01665170|736543|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
308199|NCT01665170|736542|P2|After TSST|Overall Study||30
308200|NCT01665170|736543|P1|After TSST|Overall Study||30
308202|NCT01665170|736543|P1|During TSST|Overall Study||30
308203|NCT01665170|736542|P2|Bevore TSST|Overall Study||30
308204|NCT01665170|736543|P1|Bevore TSST|Overall Study||30
308205|NCT01665170|736542|P2|STARTED|Overall Study||30
308206|NCT01665170|736543|P1|STARTED|Overall Study|First patient in|30
308207|NCT01665157|736594|P3|NOT COMPLETED|Overall Study||0
308208|NCT01665157|736595|P2|NOT COMPLETED|Overall Study||0
308209|NCT01665157|736596|P1|NOT COMPLETED|Overall Study||0
308210|NCT01665157|736594|P3|COMPLETED|Overall Study||60
308211|NCT01665157|736595|P2|COMPLETED|Overall Study||60
308212|NCT01665157|736596|P1|COMPLETED|Overall Study||60
308213|NCT01665157|736594|P3|STARTED|Overall Study||60
308214|NCT01665157|736595|P2|STARTED|Overall Study||60
308215|NCT01665157|736596|P1|STARTED|Overall Study||60
308216|NCT01665053|736624|P2|NOT COMPLETED|Overall Study||15
308217|NCT01665053|736625|P1|NOT COMPLETED|Overall Study||32
308218|NCT01665053|736624|P2|COMPLETED|Overall Study||831
308219|NCT01665053|736625|P1|COMPLETED|Overall Study||806
308220|NCT01665053|736624|P2|Death With No 12-month Clinical FU|Overall Study||9
308221|NCT01665053|736625|P1|Death With No 12-month Clinical FU|Overall Study||9
308222|NCT01665053|736624|P2|No 12-Month F/U|Overall Study||15
308223|NCT01665053|736625|P1|No 12-Month F/U|Overall Study||32
308224|NCT01665053|736624|P2|Completed 12-Month Clinical F/U|Overall Study||822
308225|NCT01665053|736625|P1|Completed 12-Month Clinical F/U|Overall Study||797
308226|NCT01665053|736624|P2|STARTED|Overall Study||846
308227|NCT01665053|736625|P1|STARTED|Overall Study||838
308228|NCT01664975|736665|P2|NOT COMPLETED|Overall Study||3
308229|NCT01664975|736666|P1|NOT COMPLETED|Overall Study||5
308230|NCT01664975|736665|P2|COMPLETED|Overall Study||51
308231|NCT01664975|736666|P1|COMPLETED|Overall Study||52
308232|NCT01664975|736665|P2|STARTED|Overall Study||54
308233|NCT01664975|736666|P1|STARTED|Overall Study||57
308234|NCT01664949|736674|P2|NOT COMPLETED|Overall Study||25
308235|NCT01664949|736675|P1|NOT COMPLETED|Overall Study||24
308236|NCT01664949|736674|P2|COMPLETED|Overall Study||211
308237|NCT01664949|736675|P1|COMPLETED|Overall Study||200
308238|NCT01664949|736674|P2|STARTED|Overall Study||236
308239|NCT01664949|736675|P1|STARTED|Overall Study||224
308240|NCT01664923|736691|P2|NOT COMPLETED|Overall Study||158
308241|NCT01664923|736692|P1|NOT COMPLETED|Overall Study||93
308242|NCT01664923|736691|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
308243|NCT01664923|736692|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
308244|NCT01664923|736691|P2|Received Study Treatment|Overall Study||198
308245|NCT01664923|736692|P1|Received Study Treatment|Overall Study||197
308246|NCT01664923|736691|P2|STARTED|Overall Study||198
308247|NCT01664923|736692|P1|STARTED|Overall Study||198
308248|NCT01664806|736712|P2|NOT COMPLETED|Overall Study||0
308249|NCT01664806|736713|P1|NOT COMPLETED|Overall Study||0
308250|NCT01664806|736712|P2|COMPLETED|Overall Study||20
308251|NCT01664806|736713|P1|COMPLETED|Overall Study||20
308252|NCT01664806|736712|P2|STARTED|Overall Study||20
308253|NCT01664806|736713|P1|STARTED|Overall Study||20
308254|NCT01664793|736723|P2|NOT COMPLETED|Overall Study||0
308255|NCT01664793|736724|P1|NOT COMPLETED|Overall Study||0
308256|NCT01664793|736723|P2|COMPLETED|Overall Study||38626
308257|NCT01664793|736724|P1|COMPLETED|Overall Study||49039
308258|NCT01664793|736723|P2|STARTED|Overall Study||38626
308259|NCT01664793|736724|P1|STARTED|Overall Study||49039
308260|NCT01664624|736736|P4|NOT COMPLETED|Overall Study||0
308261|NCT01664624|736737|P3|NOT COMPLETED|Overall Study||0
308262|NCT01664624|736738|P2|NOT COMPLETED|Overall Study||1
308263|NCT01664624|736739|P1|NOT COMPLETED|Overall Study||0
308264|NCT01664624|736736|P4|COMPLETED|Overall Study||9
308265|NCT01664624|736737|P3|COMPLETED|Overall Study||10
308266|NCT01664624|736738|P2|COMPLETED|Overall Study||10
308267|NCT01664624|736739|P1|COMPLETED|Overall Study||10
308268|NCT01664624|736736|P4|STARTED|Overall Study||9
308269|NCT01664624|736737|P3|STARTED|Overall Study||10
308270|NCT01664624|736738|P2|STARTED|Overall Study||11
308271|NCT01664624|736739|P1|STARTED|Overall Study||10
308272|NCT01664559|736771|P2|NOT COMPLETED|Overall Study||0
308273|NCT01664559|736772|P1|NOT COMPLETED|Overall Study||0
308274|NCT01664559|736771|P2|COMPLETED|Overall Study||33
308275|NCT01664559|736772|P1|COMPLETED|Overall Study||34
308276|NCT01664559|736771|P2|STARTED|Overall Study||33
308277|NCT01664559|736772|P1|STARTED|Overall Study||34
308278|NCT01664533|736786|P1|NOT COMPLETED|Overall Study||57
308279|NCT01664533|736786|P1|COMPLETED|Overall Study||0
308280|NCT01664533|736786|P1|STARTED|Overall Study||57
308281|NCT01664494|736794|P1|NOT COMPLETED|Overall Study||193
308282|NCT01664494|736794|P1|COMPLETED|Overall Study||370
308283|NCT01664494|736794|P1|STARTED|Overall Study||563
308284|NCT01664247|736801|P2|NOT COMPLETED|Overall Study||41
308285|NCT01664247|736802|P1|NOT COMPLETED|Overall Study||14
308286|NCT01664247|736801|P2|COMPLETED|Overall Study||131
308287|NCT01664247|736802|P1|COMPLETED|Overall Study||160
308288|NCT01664247|736801|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
308289|NCT01664247|736802|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
308290|NCT01664247|736801|P2|STARTED|Overall Study||172
308291|NCT01664247|736802|P1|STARTED|Overall Study||174
308292|NCT01664117|736824|P1|NOT COMPLETED|Overall Study||0
308293|NCT01664117|736824|P1|COMPLETED|Overall Study||209
308294|NCT01664117|736824|P1|STARTED|Overall Study||209
308295|NCT01664052|736881|P2|NOT COMPLETED|Phase 2||4
308296|NCT01664052|736882|P1|NOT COMPLETED|Phase 2||0
308297|NCT01664052|736881|P2|COMPLETED|Phase 2||31
308298|NCT01664052|736882|P1|COMPLETED|Phase 2||0
308299|NCT01664052|736881|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
308300|NCT01664052|736882|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
308301|NCT01664052|736881|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
308302|NCT01664052|736882|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
308303|NCT01664052|736881|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
308304|NCT01664052|736882|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
308305|NCT01664052|736881|P2|HSG 1 Hour Post Placement|Phase 2||31
308306|NCT01664052|736882|P1|HSG 1 Hour Post Placement|Phase 2||0
308307|NCT01664052|736881|P2|Insert Placed|Phase 2||31
308308|NCT01664052|736882|P1|Insert Placed|Phase 2||0
308309|NCT01664052|736881|P2|STARTED|Phase 2||35
308310|NCT01664052|736882|P1|STARTED|Phase 2|Screened and enrolled|0
308311|NCT01664052|736881|P2|NOT COMPLETED|Phase 1||0
308312|NCT01664052|736882|P1|NOT COMPLETED|Phase 1||7
308313|NCT01664052|736881|P2|COMPLETED|Phase 1||0
308314|NCT01664052|736882|P1|COMPLETED|Phase 1||24
308315|NCT01664052|736881|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
308316|NCT01664052|736882|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
308317|NCT01664052|736881|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
308318|NCT01664052|736882|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
308319|NCT01664052|736881|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
308320|NCT01664052|736882|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
308321|NCT01664052|736881|P2|HSG 1 Hour Post Placement|Phase 1||0
308322|NCT01664052|736882|P1|HSG 1 Hour Post Placement|Phase 1||24
308323|NCT01664052|736881|P2|Insert Placed in at Least One Tube|Phase 1||0
308324|NCT01664052|736882|P1|Insert Placed in at Least One Tube|Phase 1||25
308325|NCT01664052|736881|P2|STARTED|Phase 1||0
308326|NCT01664052|736882|P1|STARTED|Phase 1|Screening and enrollment|31
308327|NCT01664039|736900|P2|NOT COMPLETED|Overall Study||9
308328|NCT01664039|736901|P1|NOT COMPLETED|Overall Study||6
308329|NCT01664039|736900|P2|COMPLETED|Overall Study||43
308330|NCT01664039|736901|P1|COMPLETED|Overall Study||46
308331|NCT01664039|736900|P2|STARTED|Overall Study||52
308332|NCT01664039|736901|P1|STARTED|Overall Study||52
308333|NCT01663987|736923|P2|NOT COMPLETED|Overall Study||6
308334|NCT01663987|736924|P1|NOT COMPLETED|Overall Study||13
308335|NCT01663987|736923|P2|COMPLETED|Overall Study||34
308336|NCT01663987|736924|P1|COMPLETED|Overall Study||26
308337|NCT01663987|736923|P2|STARTED|Overall Study||40
308338|NCT01663987|736924|P1|STARTED|Overall Study||39
308339|NCT01663922|736950|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
308340|NCT01663922|736951|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
308341|NCT01663922|736950|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
308342|NCT01663922|736951|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
308343|NCT01663922|736950|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
308344|NCT01663922|736951|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
308345|NCT01663922|736950|P2|NOT COMPLETED|Washout (7 Days)||0
308346|NCT01663922|736951|P1|NOT COMPLETED|Washout (7 Days)||0
308347|NCT01663922|736950|P2|COMPLETED|Washout (7 Days)||9
308348|NCT01663922|736951|P1|COMPLETED|Washout (7 Days)||8
308349|NCT01663922|736950|P2|STARTED|Washout (7 Days)||9
308350|NCT01663922|736951|P1|STARTED|Washout (7 Days)||8
308351|NCT01663922|736950|P2|NOT COMPLETED|Second Intervention (14 Days)||0
308352|NCT01663922|736951|P1|NOT COMPLETED|Second Intervention (14 Days)||0
308353|NCT01663922|736950|P2|COMPLETED|Second Intervention (14 Days)||9
308354|NCT01663922|736951|P1|COMPLETED|Second Intervention (14 Days)||8
308355|NCT01663922|736950|P2|STARTED|Second Intervention (14 Days)||9
308356|NCT01663922|736951|P1|STARTED|Second Intervention (14 Days)||8
308357|NCT01663922|736950|P2|NOT COMPLETED|Washout (7 Days)||0
308358|NCT01663922|736951|P1|NOT COMPLETED|Washout (7 Days)||0
308359|NCT01663922|736950|P2|COMPLETED|Washout (7 Days)||9
308360|NCT01663922|736951|P1|COMPLETED|Washout (7 Days)||8
308361|NCT01663922|736950|P2|STARTED|Washout (7 Days)||9
308362|NCT01663922|736951|P1|STARTED|Washout (7 Days)||8
308363|NCT01663922|736950|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
308364|NCT01663922|736951|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
308365|NCT01663922|736950|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
308366|NCT01663922|736951|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
308367|NCT01663922|736950|P2|STARTED|First Intervention (14 Days or 5 Days)||9
308368|NCT01663922|736951|P1|STARTED|First Intervention (14 Days or 5 Days)||8
308369|NCT01663779|736958|P2|NOT COMPLETED|Overall Study||0
308370|NCT01663779|736959|P1|NOT COMPLETED|Overall Study||0
308371|NCT01663779|736958|P2|COMPLETED|Overall Study||23
308372|NCT01663779|736959|P1|COMPLETED|Overall Study||27
308373|NCT01663779|736958|P2|STARTED|Overall Study||23
308374|NCT01663779|736959|P1|STARTED|Overall Study||27
308375|NCT01663727|736967|P2|NOT COMPLETED|Overall Study||239
308376|NCT01663727|736968|P1|NOT COMPLETED|Overall Study||242
308377|NCT01663727|736967|P2|COMPLETED|Overall Study||0
308378|NCT01663727|736968|P1|COMPLETED|Overall Study||0
308379|NCT01663727|736967|P2|STARTED|Overall Study||239
308380|NCT01663727|736968|P1|STARTED|Overall Study||242
308381|NCT01663714|736996|P1|NOT COMPLETED|Long-Term Follow-Up||6
308382|NCT01663714|736996|P1|COMPLETED|Long-Term Follow-Up||16
308383|NCT01663714|736996|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
308384|NCT01663714|736996|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
308385|NCT01663714|736996|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
308386|NCT01663714|736996|P1|STARTED|Dosimetric and Therapeutic Treatment||30
308387|NCT01663532|737025|P2|NOT COMPLETED|Overall Study||107
308388|NCT01663532|737026|P1|NOT COMPLETED|Overall Study||74
308389|NCT01663532|737025|P2|COMPLETED|Overall Study||65
308390|NCT01663532|737026|P1|COMPLETED|Overall Study||94
308391|NCT01663532|737025|P2|STARTED|Overall Study||172
308392|NCT01663532|737026|P1|STARTED|Overall Study||168
308393|NCT01663506|737044|P1|NOT COMPLETED|Overall Study||8
308394|NCT01663506|737044|P1|COMPLETED|Overall Study||15
308395|NCT01663506|737044|P1|STARTED|Overall Study||23
308396|NCT01663363|737073|P1|NOT COMPLETED|Overall Study||0
308397|NCT01663363|737073|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
308398|NCT01663363|737073|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
308399|NCT01663285|737078|P1|NOT COMPLETED|Overall Study||0
308400|NCT01663285|737078|P1|COMPLETED|Overall Study||1
308401|NCT01663285|737078|P1|STARTED|Overall Study||1
308402|NCT01663233|737086|P2|NOT COMPLETED|Overall Study||7
308403|NCT01663233|737087|P1|NOT COMPLETED|Overall Study||4
308404|NCT01663233|737086|P2|COMPLETED|Overall Study||129
308405|NCT01663233|737087|P1|COMPLETED|Overall Study||126
308406|NCT01663233|737086|P2|STARTED|Overall Study||136
308407|NCT01663233|737087|P1|STARTED|Overall Study||130
308408|NCT01663103|737111|P2|NOT COMPLETED|Overall Study||2
308409|NCT01663103|737112|P1|NOT COMPLETED|Overall Study||3
308410|NCT01663103|737111|P2|COMPLETED|Overall Study||19
308411|NCT01663103|737112|P1|COMPLETED|Overall Study||18
308412|NCT01663103|737111|P2|STARTED|Overall Study||21
308413|NCT01663103|737112|P1|STARTED|Overall Study||21
308414|NCT01663012|737128|P1|NOT COMPLETED|Overall Study||0
308415|NCT01663012|737128|P1|COMPLETED|Overall Study||20
308416|NCT01663012|737128|P1|STARTED|Overall Study||20
308417|NCT01662999|737140|P6|NOT COMPLETED|Period 3||0
308418|NCT01662999|737141|P5|NOT COMPLETED|Period 3||0
308419|NCT01662999|737142|P4|NOT COMPLETED|Period 3||0
308420|NCT01662999|737143|P3|NOT COMPLETED|Period 3||0
308421|NCT01662999|737144|P2|NOT COMPLETED|Period 3||1
308422|NCT01662999|737145|P1|NOT COMPLETED|Period 3||0
308423|NCT01662999|737140|P6|COMPLETED|Period 3||7
308424|NCT01662999|737141|P5|COMPLETED|Period 3||7
308425|NCT01662999|737142|P4|COMPLETED|Period 3||7
308426|NCT01662999|737143|P3|COMPLETED|Period 3||7
308427|NCT01662999|737144|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
308428|NCT01662999|737145|P1|COMPLETED|Period 3||7
308429|NCT01662999|737140|P6|STARTED|Period 3||7
308430|NCT01662999|737141|P5|STARTED|Period 3||7
308431|NCT01662999|737142|P4|STARTED|Period 3||7
308432|NCT01662999|737143|P3|STARTED|Period 3||7
308433|NCT01662999|737144|P2|STARTED|Period 3||7
308434|NCT01662999|737145|P1|STARTED|Period 3||7
308435|NCT01662999|737140|P6|NOT COMPLETED|Period 2||0
308436|NCT01662999|737141|P5|NOT COMPLETED|Period 2||0
308437|NCT01662999|737142|P4|NOT COMPLETED|Period 2||0
308438|NCT01662999|737143|P3|NOT COMPLETED|Period 2||0
308439|NCT01662999|737144|P2|NOT COMPLETED|Period 2||0
308440|NCT01662999|737145|P1|NOT COMPLETED|Period 2||0
308441|NCT01662999|737140|P6|COMPLETED|Period 2||7
308442|NCT01662999|737141|P5|COMPLETED|Period 2||7
308443|NCT01662999|737142|P4|COMPLETED|Period 2||7
308444|NCT01662999|737143|P3|COMPLETED|Period 2||7
308445|NCT01662999|737144|P2|COMPLETED|Period 2||7
308446|NCT01662999|737145|P1|COMPLETED|Period 2||7
308447|NCT01662999|737140|P6|STARTED|Period 2||7
308448|NCT01662999|737141|P5|STARTED|Period 2||7
308449|NCT01662999|737142|P4|STARTED|Period 2||7
308450|NCT01662999|737143|P3|STARTED|Period 2||7
308451|NCT01662999|737144|P2|STARTED|Period 2||7
308452|NCT01662999|737145|P1|STARTED|Period 2||7
308453|NCT01662999|737140|P6|NOT COMPLETED|Period 1||0
308454|NCT01662999|737141|P5|NOT COMPLETED|Period 1||0
308455|NCT01662999|737142|P4|NOT COMPLETED|Period 1||0
308456|NCT01662999|737143|P3|NOT COMPLETED|Period 1||0
308457|NCT01662999|737144|P2|NOT COMPLETED|Period 1||0
308458|NCT01662999|737145|P1|NOT COMPLETED|Period 1||0
308459|NCT01662999|737140|P6|COMPLETED|Period 1||7
308460|NCT01662999|737141|P5|COMPLETED|Period 1||7
308461|NCT01662999|737142|P4|COMPLETED|Period 1||7
308462|NCT01662999|737143|P3|COMPLETED|Period 1||7
308463|NCT01662999|737144|P2|COMPLETED|Period 1||7
308464|NCT01662999|737145|P1|COMPLETED|Period 1||7
308465|NCT01662999|737140|P6|STARTED|Period 1||7
308466|NCT01662999|737141|P5|STARTED|Period 1||7
308467|NCT01662999|737142|P4|STARTED|Period 1||7
308468|NCT01662999|737143|P3|STARTED|Period 1||7
308469|NCT01662999|737144|P2|STARTED|Period 1||7
308470|NCT01662999|737145|P1|STARTED|Period 1||7
308471|NCT01662986|737216|P2|NOT COMPLETED|Overall Study||13
308472|NCT01662986|737217|P1|NOT COMPLETED|Overall Study||18
308473|NCT01662986|737216|P2|COMPLETED|Overall Study||26
308474|NCT01662986|737217|P1|COMPLETED|Overall Study||22
308475|NCT01662986|737216|P2|STARTED|Overall Study||39
308476|NCT01662986|737217|P1|STARTED|Overall Study||40
308477|NCT01662908|737249|P2|NOT COMPLETED|Overall Study||5
308478|NCT01662908|737250|P1|NOT COMPLETED|Overall Study||6
308479|NCT01662908|737249|P2|COMPLETED|Overall Study||23
308480|NCT01662908|737250|P1|COMPLETED|Overall Study||50
308481|NCT01662908|737249|P2|STARTED|Overall Study||28
308482|NCT01662908|737250|P1|STARTED|Overall Study||56
308483|NCT01662882|737267|P3|NOT COMPLETED|Overall Study||0
308484|NCT01662882|737268|P2|NOT COMPLETED|Overall Study||0
308485|NCT01662882|737269|P1|NOT COMPLETED|Overall Study||0
308486|NCT01662882|737267|P3|COMPLETED|Overall Study||15
308487|NCT01662882|737268|P2|COMPLETED|Overall Study||18
308488|NCT01662882|737269|P1|COMPLETED|Overall Study||15
308489|NCT01662882|737267|P3|STARTED|Overall Study||15
308490|NCT01662882|737268|P2|STARTED|Overall Study||18
308491|NCT01662882|737269|P1|STARTED|Overall Study||15
308492|NCT01662856|737282|P2|NOT COMPLETED|Primary Part II||2
308493|NCT01662856|737283|P1|NOT COMPLETED|Primary Part II||10
308494|NCT01662856|737282|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
308495|NCT01662856|737283|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
308496|NCT01662856|737282|P2|Completed Study up to Week 6|Primary Part II||56
308497|NCT01662856|737283|P1|Completed Study up to Week 6|Primary Part II||106
308498|NCT01662856|737282|P2|STARTED|Primary Part II||57
308499|NCT01662856|737283|P1|STARTED|Primary Part II||109
308500|NCT01662856|737282|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
308501|NCT01662856|737283|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
308502|NCT01662856|737282|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
308503|NCT01662856|737283|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
308504|NCT01662856|737282|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
308505|NCT01662856|737283|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
308506|NCT01662856|737282|P2|STARTED|Part I + Part II (Overall Study)||57
308507|NCT01662856|737283|P1|STARTED|Part I + Part II (Overall Study)||168
308508|NCT01662791|737297|P2|NOT COMPLETED|Part 2 - Interventional||0
308509|NCT01662791|737298|P1|NOT COMPLETED|Part 2 - Interventional||0
308510|NCT01662791|737297|P2|COMPLETED|Part 2 - Interventional||0
308511|NCT01662791|737298|P1|COMPLETED|Part 2 - Interventional||8
308512|NCT01662791|737297|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
308513|NCT01662791|737298|P1|STARTED|Part 2 - Interventional||8
308514|NCT01662791|737297|P2|NOT COMPLETED|Part 1 - Observational||0
308515|NCT01662791|737298|P1|NOT COMPLETED|Part 1 - Observational||0
308516|NCT01662791|737297|P2|COMPLETED|Part 1 - Observational||41
308517|NCT01662791|737298|P1|COMPLETED|Part 1 - Observational||8
308518|NCT01662791|737297|P2|STARTED|Part 1 - Observational||41
308519|NCT01662791|737298|P1|STARTED|Part 1 - Observational||8
308520|NCT01662765|737322|P2|NOT COMPLETED|Overall Study||2
308521|NCT01662765|737323|P1|NOT COMPLETED|Overall Study||1
308522|NCT01662765|737322|P2|COMPLETED|Overall Study||40
308523|NCT01662765|737323|P1|COMPLETED|Overall Study||41
308524|NCT01662765|737322|P2|STARTED|Overall Study||42
308525|NCT01662765|737323|P1|STARTED|Overall Study||42
308526|NCT01662648|737337|P2|NOT COMPLETED|Overall Study||178
308527|NCT01662648|737338|P1|NOT COMPLETED|Overall Study||147
308528|NCT01662648|737337|P2|COMPLETED|Overall Study||419
308529|NCT01662648|737338|P1|COMPLETED|Overall Study||373
308530|NCT01662648|737337|P2|STARTED|Overall Study||597
308531|NCT01662648|737338|P1|STARTED|Overall Study||520
308532|NCT01662635|737360|P1|NOT COMPLETED|Overall Study||30
308533|NCT01662635|737360|P1|COMPLETED|Overall Study||200
308534|NCT01662635|737360|P1|STARTED|Overall Study||230
308535|NCT01662583|737369|P3|NOT COMPLETED|Overall Study||0
308536|NCT01662583|737370|P2|NOT COMPLETED|Overall Study||0
308537|NCT01662583|737371|P1|NOT COMPLETED|Overall Study||0
308538|NCT01662583|737369|P3|COMPLETED|Overall Study||219
308539|NCT01662583|737370|P2|COMPLETED|Overall Study||225
308540|NCT01662583|737371|P1|COMPLETED|Overall Study||216
308541|NCT01662583|737369|P3|STARTED|Overall Study||219
308542|NCT01662583|737370|P2|STARTED|Overall Study||225
308543|NCT01662583|737371|P1|STARTED|Overall Study||216
308544|NCT01662531|737384|P1|NOT COMPLETED|Overall Study||0
308545|NCT01662531|737384|P1|COMPLETED|Overall Study||27
308546|NCT01662531|737384|P1|STARTED|Overall Study||27
308547|NCT01662440|737412|P4|NOT COMPLETED|Overall Study||4
308548|NCT01662440|737413|P3|NOT COMPLETED|Overall Study||6
308549|NCT01662440|737414|P2|NOT COMPLETED|Overall Study||6
308550|NCT01662440|737415|P1|NOT COMPLETED|Overall Study||9
308551|NCT01662440|737412|P4|COMPLETED|Overall Study||52
308552|NCT01662440|737413|P3|COMPLETED|Overall Study||215
308553|NCT01662440|737414|P2|COMPLETED|Overall Study||211
308554|NCT01662440|737415|P1|COMPLETED|Overall Study||158
308555|NCT01662440|737412|P4|STARTED|Overall Study||56
308556|NCT01662440|737413|P3|STARTED|Overall Study||221
308557|NCT01662440|737414|P2|STARTED|Overall Study||217
308558|NCT01662440|737415|P1|STARTED|Overall Study||167
308559|NCT01662362|737463|P1|NOT COMPLETED|Overall Study||38
308560|NCT01662362|737463|P1|COMPLETED|Overall Study||25
308561|NCT01662362|737463|P1|STARTED|Overall Study||63
308562|NCT01662310|737468|P5|NOT COMPLETED|Open-Label Extension Phase||10
308563|NCT01662310|737469|P4|NOT COMPLETED|Open-Label Extension Phase||11
308564|NCT01662310|737470|P3|NOT COMPLETED|Open-Label Extension Phase||0
308565|NCT01662310|737471|P2|NOT COMPLETED|Open-Label Extension Phase||0
308566|NCT01662310|737472|P1|NOT COMPLETED|Open-Label Extension Phase||0
308567|NCT01662310|737468|P5|COMPLETED|Open-Label Extension Phase||49
308568|NCT01662310|737469|P4|COMPLETED|Open-Label Extension Phase||36
308569|NCT01662310|737470|P3|COMPLETED|Open-Label Extension Phase||0
308570|NCT01662310|737471|P2|COMPLETED|Open-Label Extension Phase||0
308571|NCT01662310|737472|P1|COMPLETED|Open-Label Extension Phase||0
308572|NCT01662310|737468|P5|STARTED|Open-Label Extension Phase||59
308573|NCT01662310|737469|P4|STARTED|Open-Label Extension Phase||47
308574|NCT01662310|737470|P3|STARTED|Open-Label Extension Phase||0
308575|NCT01662310|737471|P2|STARTED|Open-Label Extension Phase||0
308576|NCT01662310|737472|P1|STARTED|Open-Label Extension Phase||0
308577|NCT01662310|737468|P5|NOT COMPLETED|Double-Blind Phase||0
308578|NCT01662310|737469|P4|NOT COMPLETED|Double-Blind Phase||0
308579|NCT01662310|737470|P3|NOT COMPLETED|Double-Blind Phase||5
308580|NCT01662310|737471|P2|NOT COMPLETED|Double-Blind Phase||15
308581|NCT01662310|737472|P1|NOT COMPLETED|Double-Blind Phase||0
308582|NCT01662310|737468|P5|COMPLETED|Double-Blind Phase||0
308583|NCT01662310|737469|P4|COMPLETED|Double-Blind Phase||0
308584|NCT01662310|737470|P3|COMPLETED|Double-Blind Phase||66
308585|NCT01662310|737471|P2|COMPLETED|Double-Blind Phase||50
308586|NCT01662310|737472|P1|COMPLETED|Double-Blind Phase||0
308587|NCT01662310|737468|P5|Treated|Double-Blind Phase||0
308588|NCT01662310|737469|P4|Treated|Double-Blind Phase||0
308589|NCT01662310|737470|P3|Treated|Double-Blind Phase||71
308590|NCT01662310|737471|P2|Treated|Double-Blind Phase||64
308591|NCT01662310|737472|P1|Treated|Double-Blind Phase||0
308592|NCT01662310|737468|P5|STARTED|Double-Blind Phase||0
308593|NCT01662310|737469|P4|STARTED|Double-Blind Phase||0
308594|NCT01662310|737470|P3|STARTED|Double-Blind Phase||71
308595|NCT01662310|737471|P2|STARTED|Double-Blind Phase||65
308596|NCT01662310|737472|P1|STARTED|Double-Blind Phase||0
308597|NCT01662310|737468|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
308598|NCT01662310|737469|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
308599|NCT01662310|737470|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
308600|NCT01662310|737471|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
308601|NCT01662310|737472|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
308602|NCT01662310|737468|P5|COMPLETED|Run-In or Stabilization Phase||0
308603|NCT01662310|737469|P4|COMPLETED|Run-In or Stabilization Phase||0
308604|NCT01662310|737470|P3|COMPLETED|Run-In or Stabilization Phase||0
308605|NCT01662310|737471|P2|COMPLETED|Run-In or Stabilization Phase||0
308606|NCT01662310|737472|P1|COMPLETED|Run-In or Stabilization Phase||136
308607|NCT01662310|737468|P5|STARTED|Run-In or Stabilization Phase||0
308608|NCT01662310|737469|P4|STARTED|Run-In or Stabilization Phase||0
308609|NCT01662310|737470|P3|STARTED|Run-In or Stabilization Phase||0
308610|NCT01662310|737471|P2|STARTED|Run-In or Stabilization Phase||0
308611|NCT01662310|737472|P1|STARTED|Run-In or Stabilization Phase||201
308612|NCT01662102|737506|P2|NOT COMPLETED|Overall Study||0
308613|NCT01662102|737507|P1|NOT COMPLETED|Overall Study||1
308614|NCT01662102|737506|P2|COMPLETED|Overall Study||0
308615|NCT01662102|737507|P1|COMPLETED|Overall Study||0
308616|NCT01662102|737506|P2|STARTED|Overall Study||0
308617|NCT01662102|737507|P1|STARTED|Overall Study||1
308618|NCT01662063|737515|P3|NOT COMPLETED|Overall Study||1
308619|NCT01662063|737516|P2|NOT COMPLETED|Overall Study||29
308620|NCT01662063|737517|P1|NOT COMPLETED|Overall Study||5
308621|NCT01662063|737515|P3|COMPLETED|Overall Study||0
308622|NCT01662063|737516|P2|COMPLETED|Overall Study||144
308623|NCT01662063|737517|P1|COMPLETED|Overall Study||39
308624|NCT01662063|737515|P3|STARTED|Overall Study||1
308625|NCT01662063|737516|P2|STARTED|Overall Study||173
308626|NCT01662063|737517|P1|STARTED|Overall Study||44
308627|NCT01662024|737596|P1|NOT COMPLETED|Overall Study||5
308628|NCT01662024|737596|P1|COMPLETED|Overall Study||15
308629|NCT01662024|737596|P1|STARTED|Overall Study||20
308630|NCT01661933|737606|P1|NOT COMPLETED|High-dose Gluten Challenge||2
308631|NCT01661933|737606|P1|COMPLETED|High-dose Gluten Challenge||8
308632|NCT01661933|737606|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
308633|NCT01661933|737606|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
308634|NCT01661933|737606|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
308635|NCT01661933|737606|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
308636|NCT01661933|737606|P1|NOT COMPLETED|Gluten Micro-challenge||0
308637|NCT01661933|737606|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
308638|NCT01661933|737606|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
308639|NCT01661881|737613|P1|NOT COMPLETED|Overall Study||0
308640|NCT01661881|737613|P1|COMPLETED|Overall Study||23
308641|NCT01661881|737613|P1|STARTED|Overall Study||23
308642|NCT01661790|737621|P2|NOT COMPLETED|Overall Study||2
308643|NCT01661790|737622|P1|NOT COMPLETED|Overall Study||0
308644|NCT01661790|737621|P2|COMPLETED|Overall Study||34
308645|NCT01661790|737622|P1|COMPLETED|Overall Study||36
308646|NCT01661790|737621|P2|STARTED|Overall Study||36
308647|NCT01661790|737622|P1|STARTED|Overall Study||36
308648|NCT01661621|737630|P2|NOT COMPLETED|Overall Study||0
308649|NCT01661621|737631|P1|NOT COMPLETED|Overall Study||0
308650|NCT01661621|737630|P2|COMPLETED|Overall Study||279
308651|NCT01661621|737631|P1|COMPLETED|Overall Study||116
308652|NCT01661621|737630|P2|STARTED|Overall Study||279
308653|NCT01661621|737631|P1|STARTED|Overall Study||116
308654|NCT01661270|737653|P2|NOT COMPLETED|Overall Study||0
308655|NCT01661270|737654|P1|NOT COMPLETED|Overall Study||0
308656|NCT01661270|737653|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
308657|NCT01661270|737654|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
308658|NCT01661270|737653|P2|Other Reasons|Overall Study||2
308659|NCT01661270|737654|P1|Other Reasons|Overall Study||0
308660|NCT01661270|737653|P2|Participant’s Request|Overall Study|Met EOT criteria|48
308661|NCT01661270|737654|P1|Participant’s Request|Overall Study|Met EOT criteria|15
308662|NCT01661270|737653|P2|Physician Decision|Overall Study|Met EOT criteria|8
308663|NCT01661270|737654|P1|Physician Decision|Overall Study|Met EOT criteria|1
308664|NCT01661270|737653|P2|Disease Progression|Overall Study|Met EOT criteria|118
308665|NCT01661270|737654|P1|Disease Progression|Overall Study|Met EOT criteria|67
308666|NCT01661270|737653|P2|Adverse Event|Overall Study|Met EOT criteria|47
308667|NCT01661270|737654|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
308668|NCT01661270|737653|P2|STARTED|Overall Study||223
308669|NCT01661270|737654|P1|STARTED|Overall Study||109
308670|NCT01661205|737665|P1|NOT COMPLETED|Overall Study||2
308671|NCT01661205|737665|P1|COMPLETED|Overall Study||24
308672|NCT01661205|737665|P1|STARTED|Overall Study||26
308673|NCT01661179|737676|P1|NOT COMPLETED|Overall Study||6
308674|NCT01661179|737676|P1|COMPLETED|Overall Study||8
308675|NCT01661179|737676|P1|STARTED|Overall Study||14
308676|NCT01661140|737680|P3|NOT COMPLETED|Double-Blind Period||50
308677|NCT01661140|737681|P2|NOT COMPLETED|Double-Blind Period||41
308678|NCT01661140|737682|P1|NOT COMPLETED|Double-Blind Period||0
308679|NCT01661140|737680|P3|COMPLETED|Double-Blind Period||86
308680|NCT01661140|737681|P2|COMPLETED|Double-Blind Period||95
308681|NCT01661140|737682|P1|COMPLETED|Double-Blind Period||0
308682|NCT01661140|737680|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
308683|NCT01661140|737681|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
308684|NCT01661140|737682|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
308685|NCT01661140|737680|P3|NOT COMPLETED|Open-Label Period||0
308686|NCT01661140|737681|P2|NOT COMPLETED|Open-Label Period||0
308687|NCT01661140|737682|P1|NOT COMPLETED|Open-Label Period||76
308688|NCT01661140|737680|P3|COMPLETED|Open-Label Period||0
308689|NCT01661140|737681|P2|COMPLETED|Open-Label Period||0
308690|NCT01661140|737682|P1|COMPLETED|Open-Label Period||351
308691|NCT01661140|737680|P3|STARTED|Open-Label Period||0
308692|NCT01661140|737681|P2|STARTED|Open-Label Period||0
308788|NCT01660191|738008|P2|NOT COMPLETED|Enrollment and Washout||0
308693|NCT01661140|737682|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
308694|NCT01661114|737723|P1|NOT COMPLETED|Overall Study||0
308695|NCT01661114|737723|P1|COMPLETED|Overall Study||39
308696|NCT01661114|737723|P1|STARTED|Overall Study||39
308697|NCT01661062|737728|P1|NOT COMPLETED|Overall Study||5
308698|NCT01661062|737728|P1|COMPLETED|Overall Study||18
308699|NCT01661062|737728|P1|STARTED|Overall Study||23
308700|NCT01660906|737733|P1|NOT COMPLETED|Overall Study||3
308701|NCT01660906|737733|P1|COMPLETED|Overall Study||36
308702|NCT01660906|737733|P1|STARTED|Overall Study||39
308703|NCT01660815|737742|P1|NOT COMPLETED|Overall Study||0
308704|NCT01660815|737742|P1|COMPLETED|Overall Study||7
308705|NCT01660815|737742|P1|STARTED|Overall Study||7
308706|NCT01660802|737749|P2|NOT COMPLETED|Overall Study||11
308707|NCT01660802|737750|P1|NOT COMPLETED|Overall Study||4
308708|NCT01660802|737749|P2|COMPLETED|Overall Study||121
308709|NCT01660802|737750|P1|COMPLETED|Overall Study||126
308710|NCT01660802|737749|P2|STARTED|Overall Study||132
308711|NCT01660802|737750|P1|STARTED|Overall Study||130
308712|NCT01660763|737764|P2|NOT COMPLETED|Overall Study||61
308713|NCT01660763|737765|P1|NOT COMPLETED|Overall Study||100
308714|NCT01660763|737764|P2|COMPLETED|Overall Study||43
308715|NCT01660763|737765|P1|COMPLETED|Overall Study||215
308716|NCT01660763|737764|P2|STARTED|Overall Study||104
308717|NCT01660763|737765|P1|STARTED|Overall Study||315
308718|NCT01660698|737773|P2|NOT COMPLETED|Overall Study||0
308719|NCT01660698|737774|P1|NOT COMPLETED|Overall Study||0
308720|NCT01660698|737773|P2|COMPLETED|Overall Study||10
308721|NCT01660698|737774|P1|COMPLETED|Overall Study||10
308722|NCT01660698|737773|P2|STARTED|Overall Study||10
308723|NCT01660698|737774|P1|STARTED|Overall Study||10
308724|NCT01660672|737784|P1|NOT COMPLETED|Overall Study||0
308725|NCT01660672|737784|P1|COMPLETED|Overall Study||7
308726|NCT01660672|737784|P1|STARTED|Overall Study||7
308727|NCT01660334|737795|P1|NOT COMPLETED|Overall Study||1
308728|NCT01660334|737795|P1|COMPLETED|Overall Study||12
308729|NCT01660334|737795|P1|STARTED|Overall Study||13
308730|NCT01660321|737800|P1|NOT COMPLETED|Overall Study||0
308731|NCT01660321|737800|P1|COMPLETED|Overall Study||26
308732|NCT01660321|737800|P1|STARTED|Overall Study||26
308733|NCT01660230|737824|P12|NOT COMPLETED|Overall Study||0
308734|NCT01660230|737825|P11|NOT COMPLETED|Overall Study||0
308735|NCT01660230|737826|P10|NOT COMPLETED|Overall Study||0
308736|NCT01660230|737827|P9|NOT COMPLETED|Overall Study||0
308737|NCT01660230|737828|P8|NOT COMPLETED|Overall Study||0
308738|NCT01660230|737829|P7|NOT COMPLETED|Overall Study||0
308739|NCT01660230|737830|P6|NOT COMPLETED|Overall Study||0
308740|NCT01660230|737831|P5|NOT COMPLETED|Overall Study||0
308741|NCT01660230|737832|P4|NOT COMPLETED|Overall Study||0
308742|NCT01660230|737833|P3|NOT COMPLETED|Overall Study||0
308743|NCT01660230|737834|P2|NOT COMPLETED|Overall Study||0
308744|NCT01660230|737835|P1|NOT COMPLETED|Overall Study||0
308745|NCT01660230|737824|P12|COMPLETED|Overall Study||14
308746|NCT01660230|737825|P11|COMPLETED|Overall Study||6
308747|NCT01660230|737826|P10|COMPLETED|Overall Study||6
308748|NCT01660230|737827|P9|COMPLETED|Overall Study||6
308749|NCT01660230|737828|P8|COMPLETED|Overall Study||6
308750|NCT01660230|737829|P7|COMPLETED|Overall Study||4
308751|NCT01660230|737830|P6|COMPLETED|Overall Study||2
308752|NCT01660230|737831|P5|COMPLETED|Overall Study||4
308753|NCT01660230|737832|P4|COMPLETED|Overall Study||4
308754|NCT01660230|737833|P3|COMPLETED|Overall Study||4
308755|NCT01660230|737834|P2|COMPLETED|Overall Study||4
308756|NCT01660230|737835|P1|COMPLETED|Overall Study||4
308757|NCT01660230|737824|P12|STARTED|Overall Study||14
308758|NCT01660230|737825|P11|STARTED|Overall Study||6
308759|NCT01660230|737826|P10|STARTED|Overall Study||6
308760|NCT01660230|737827|P9|STARTED|Overall Study||6
308761|NCT01660230|737828|P8|STARTED|Overall Study||6
308762|NCT01660230|737829|P7|STARTED|Overall Study||4
308763|NCT01660230|737830|P6|STARTED|Overall Study||2
308764|NCT01660230|737831|P5|STARTED|Overall Study||4
308765|NCT01660230|737832|P4|STARTED|Overall Study||4
308766|NCT01660230|737833|P3|STARTED|Overall Study||4
308767|NCT01660230|737834|P2|STARTED|Overall Study||4
308768|NCT01660230|737835|P1|STARTED|Overall Study||4
308769|NCT01660191|738007|P3|NOT COMPLETED|End of Treatment||1
308770|NCT01660191|738008|P2|NOT COMPLETED|End of Treatment||6
308771|NCT01660191|738009|P1|NOT COMPLETED|End of Treatment||1
308772|NCT01660191|738007|P3|COMPLETED|End of Treatment||43
308773|NCT01660191|738008|P2|COMPLETED|End of Treatment||39
308774|NCT01660191|738009|P1|COMPLETED|End of Treatment||44
308775|NCT01660191|738007|P3|STARTED|End of Treatment||44
308776|NCT01660191|738008|P2|STARTED|End of Treatment||45
308777|NCT01660191|738009|P1|STARTED|End of Treatment||45
308778|NCT01660191|738007|P3|NOT COMPLETED|Randomization||0
308779|NCT01660191|738008|P2|NOT COMPLETED|Randomization||0
308780|NCT01660191|738009|P1|NOT COMPLETED|Randomization||0
308781|NCT01660191|738007|P3|COMPLETED|Randomization||44
308782|NCT01660191|738008|P2|COMPLETED|Randomization||45
308783|NCT01660191|738009|P1|COMPLETED|Randomization||45
308784|NCT01660191|738007|P3|STARTED|Randomization||44
308785|NCT01660191|738008|P2|STARTED|Randomization||45
308786|NCT01660191|738009|P1|STARTED|Randomization||45
308787|NCT01660191|738007|P3|NOT COMPLETED|Enrollment and Washout||0
308789|NCT01660191|738009|P1|NOT COMPLETED|Enrollment and Washout||0
308790|NCT01660191|738007|P3|COMPLETED|Enrollment and Washout||44
308791|NCT01660191|738008|P2|COMPLETED|Enrollment and Washout||45
308792|NCT01660191|738009|P1|COMPLETED|Enrollment and Washout||45
308793|NCT01660191|738007|P3|STARTED|Enrollment and Washout||44
308794|NCT01660191|738008|P2|STARTED|Enrollment and Washout||45
308795|NCT01660191|738009|P1|STARTED|Enrollment and Washout||45
308796|NCT01660022|738038|P6|NOT COMPLETED|Second Sequence (42 Days)||0
308797|NCT01660022|738039|P5|NOT COMPLETED|Second Sequence (42 Days)||0
308798|NCT01660022|738040|P4|NOT COMPLETED|Second Sequence (42 Days)||0
308799|NCT01660022|738041|P3|NOT COMPLETED|Second Sequence (42 Days)||0
308800|NCT01660022|738042|P2|NOT COMPLETED|Second Sequence (42 Days)||0
308801|NCT01660022|738043|P1|NOT COMPLETED|Second Sequence (42 Days)||0
308802|NCT01660022|738038|P6|COMPLETED|Second Sequence (42 Days)||16
308803|NCT01660022|738039|P5|COMPLETED|Second Sequence (42 Days)||6
308804|NCT01660022|738040|P4|COMPLETED|Second Sequence (42 Days)||7
308805|NCT01660022|738041|P3|COMPLETED|Second Sequence (42 Days)||8
308806|NCT01660022|738042|P2|COMPLETED|Second Sequence (42 Days)||7
308807|NCT01660022|738043|P1|COMPLETED|Second Sequence (42 Days)||8
308808|NCT01660022|738038|P6|STARTED|Second Sequence (42 Days)||16
308809|NCT01660022|738039|P5|STARTED|Second Sequence (42 Days)||6
308810|NCT01660022|738040|P4|STARTED|Second Sequence (42 Days)||7
308811|NCT01660022|738041|P3|STARTED|Second Sequence (42 Days)||8
308812|NCT01660022|738042|P2|STARTED|Second Sequence (42 Days)||7
308813|NCT01660022|738043|P1|STARTED|Second Sequence (42 Days)||8
308814|NCT01660022|738038|P6|NOT COMPLETED|First Sequence (7 Days)||4
308815|NCT01660022|738039|P5|NOT COMPLETED|First Sequence (7 Days)||1
308816|NCT01660022|738040|P4|NOT COMPLETED|First Sequence (7 Days)||1
308817|NCT01660022|738041|P3|NOT COMPLETED|First Sequence (7 Days)||0
308818|NCT01660022|738042|P2|NOT COMPLETED|First Sequence (7 Days)||1
308819|NCT01660022|738043|P1|NOT COMPLETED|First Sequence (7 Days)||0
308820|NCT01660022|738038|P6|COMPLETED|First Sequence (7 Days)||16
308821|NCT01660022|738039|P5|COMPLETED|First Sequence (7 Days)||6
308822|NCT01660022|738040|P4|COMPLETED|First Sequence (7 Days)||7
308823|NCT01660022|738041|P3|COMPLETED|First Sequence (7 Days)||8
308824|NCT01660022|738042|P2|COMPLETED|First Sequence (7 Days)||7
308825|NCT01660022|738043|P1|COMPLETED|First Sequence (7 Days)||8
308826|NCT01660022|738038|P6|STARTED|First Sequence (7 Days)||20
308827|NCT01660022|738039|P5|STARTED|First Sequence (7 Days)||7
308828|NCT01660022|738040|P4|STARTED|First Sequence (7 Days)||8
308829|NCT01660022|738041|P3|STARTED|First Sequence (7 Days)||8
308830|NCT01660022|738042|P2|STARTED|First Sequence (7 Days)||8
308831|NCT01660022|738043|P1|STARTED|First Sequence (7 Days)||8
308832|NCT01659996|738102|P3|NOT COMPLETED|Overall Study||11
308833|NCT01659996|738103|P2|NOT COMPLETED|Overall Study||7
308834|NCT01659996|738104|P1|NOT COMPLETED|Overall Study||8
308835|NCT01659996|738102|P3|COMPLETED|Overall Study||461
308836|NCT01659996|738103|P2|COMPLETED|Overall Study||388
308837|NCT01659996|738104|P1|COMPLETED|Overall Study||413
308838|NCT01659996|738102|P3|STARTED|Overall Study||472
308839|NCT01659996|738103|P2|STARTED|Overall Study||395
308840|NCT01659996|738104|P1|STARTED|Overall Study||421
308841|NCT01659853|738136|P2|NOT COMPLETED|Treatment Period 2||0
308842|NCT01659853|738137|P1|NOT COMPLETED|Treatment Period 2||0
308843|NCT01659853|738136|P2|COMPLETED|Treatment Period 2||35
308844|NCT01659853|738137|P1|COMPLETED|Treatment Period 2||33
308845|NCT01659853|738136|P2|STARTED|Treatment Period 2||35
308846|NCT01659853|738137|P1|STARTED|Treatment Period 2||33
308847|NCT01659853|738136|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
308848|NCT01659853|738137|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
308849|NCT01659853|738136|P2|COMPLETED|Washout , 3 to 7 Days||35
308850|NCT01659853|738137|P1|COMPLETED|Washout , 3 to 7 Days||33
308851|NCT01659853|738136|P2|STARTED|Washout , 3 to 7 Days||35
308852|NCT01659853|738137|P1|STARTED|Washout , 3 to 7 Days||35
308853|NCT01659853|738136|P2|NOT COMPLETED|Treatment Period 1||0
308854|NCT01659853|738137|P1|NOT COMPLETED|Treatment Period 1||0
308855|NCT01659853|738136|P2|COMPLETED|Treatment Period 1||35
308856|NCT01659853|738137|P1|COMPLETED|Treatment Period 1||35
308857|NCT01659853|738136|P2|STARTED|Treatment Period 1||35
308858|NCT01659853|738137|P1|STARTED|Treatment Period 1||35
308859|NCT01659736|738147|P2|NOT COMPLETED|3-month Follow-up||1
308860|NCT01659736|738148|P1|NOT COMPLETED|3-month Follow-up||0
308861|NCT01659736|738147|P2|COMPLETED|3-month Follow-up||9
308862|NCT01659736|738148|P1|COMPLETED|3-month Follow-up||9
308863|NCT01659736|738147|P2|STARTED|3-month Follow-up||10
308864|NCT01659736|738148|P1|STARTED|3-month Follow-up||9
308865|NCT01659736|738147|P2|NOT COMPLETED|Treatment Period||2
308866|NCT01659736|738148|P1|NOT COMPLETED|Treatment Period||5
308867|NCT01659736|738147|P2|COMPLETED|Treatment Period||10
308868|NCT01659736|738148|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
308869|NCT01659736|738147|P2|STARTED|Treatment Period||12
308870|NCT01659736|738148|P1|STARTED|Treatment Period||14
308871|NCT01659554|738162|P1|NOT COMPLETED|Overall Study||4
308872|NCT01659554|738162|P1|COMPLETED|Overall Study||0
308873|NCT01659554|738162|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
308874|NCT01659320|738169|P1|NOT COMPLETED|Overall Study||3
308875|NCT01659320|738169|P1|COMPLETED|Overall Study||13
308876|NCT01659320|738169|P1|STARTED|Overall Study||16
308877|NCT01659268|738175|P2|NOT COMPLETED|Overall Study||0
308878|NCT01659268|738176|P1|NOT COMPLETED|Overall Study||0
308879|NCT01659268|738175|P2|COMPLETED|Overall Study||8
308880|NCT01659268|738176|P1|COMPLETED|Overall Study||9
308881|NCT01659268|738175|P2|STARTED|Overall Study||8
308882|NCT01659268|738176|P1|STARTED|Overall Study||9
308883|NCT01659125|738188|P1|NOT COMPLETED|Overall Study||14
308884|NCT01659125|738188|P1|COMPLETED|Overall Study||12
308885|NCT01659125|738188|P1|Completed 6-month Follow-up|Overall Study||12
308886|NCT01659125|738188|P1|Completed 3-month Follow-up|Overall Study||16
308887|NCT01659125|738188|P1|Completed the Posttreatment Assessment|Overall Study||17
308888|NCT01659125|738188|P1|Initiated Treatment|Overall Study||24
308889|NCT01659125|738188|P1|STARTED|Overall Study||26
308890|NCT01659021|738195|P2|NOT COMPLETED|Overall Study||37
308891|NCT01659021|738196|P1|NOT COMPLETED|Overall Study||88
308892|NCT01659021|738195|P2|COMPLETED|Overall Study||50
308893|NCT01659021|738196|P1|COMPLETED|Overall Study||86
308894|NCT01659021|738195|P2|Randomized and Treated|Overall Study||86
308895|NCT01659021|738196|P1|Randomized and Treated|Overall Study||173
308896|NCT01659021|738195|P2|STARTED|Overall Study||87
308897|NCT01659021|738196|P1|STARTED|Overall Study||174
308898|NCT01658943|738214|P2|NOT COMPLETED|Overall Study||67
308899|NCT01658943|738215|P1|NOT COMPLETED|Overall Study||70
308900|NCT01658943|738214|P2|COMPLETED|Overall Study||0
308901|NCT01658943|738215|P1|COMPLETED|Overall Study||0
308902|NCT01658943|738214|P2|Eligible and Began Protocol Therapy|Overall Study||58
308903|NCT01658943|738215|P1|Eligible and Began Protocol Therapy|Overall Study||62
308904|NCT01658943|738214|P2|Eligible|Overall Study||58
308905|NCT01658943|738215|P1|Eligible|Overall Study||63
308906|NCT01658943|738214|P2|STARTED|Overall Study||67
308907|NCT01658943|738215|P1|STARTED|Overall Study||70
308908|NCT01658904|738230|P3|NOT COMPLETED|Overall Study||0
308909|NCT01658904|738231|P2|NOT COMPLETED|Overall Study||0
308910|NCT01658904|738232|P1|NOT COMPLETED|Overall Study||2
308911|NCT01658904|738230|P3|COMPLETED|Overall Study||0
308912|NCT01658904|738231|P2|COMPLETED|Overall Study||0
308913|NCT01658904|738232|P1|COMPLETED|Overall Study||1
308914|NCT01658904|738230|P3|STARTED|Overall Study||0
308915|NCT01658904|738231|P2|STARTED|Overall Study||0
308916|NCT01658904|738232|P1|STARTED|Overall Study||3
308917|NCT01658839|738249|P1|NOT COMPLETED|Overall Study||0
308918|NCT01658839|738249|P1|COMPLETED|Overall Study||25
308919|NCT01658839|738249|P1|STARTED|Overall Study||25
308920|NCT01658813|738258|P1|NOT COMPLETED|Overall Study||3
308921|NCT01658813|738258|P1|COMPLETED|Overall Study||15
308922|NCT01658813|738258|P1|Treated|Overall Study||18
308923|NCT01658813|738258|P1|Eligible|Overall Study||18
308924|NCT01658813|738258|P1|STARTED|Overall Study||18
308925|NCT01658735|738269|P3|NOT COMPLETED|Overall Study||4
308926|NCT01658735|738270|P2|NOT COMPLETED|Overall Study||7
308927|NCT01658735|738271|P1|NOT COMPLETED|Overall Study||5
308928|NCT01658735|738269|P3|COMPLETED|Overall Study||34
308929|NCT01658735|738270|P2|COMPLETED|Overall Study||29
308930|NCT01658735|738271|P1|COMPLETED|Overall Study||34
308931|NCT01658735|738269|P3|STARTED|Overall Study||38
308932|NCT01658735|738270|P2|STARTED|Overall Study||36
308933|NCT01658735|738271|P1|STARTED|Overall Study||39
308934|NCT01658657|738302|P2|NOT COMPLETED|Overall Study||3
308935|NCT01658657|738303|P1|NOT COMPLETED|Overall Study||3
308936|NCT01658657|738302|P2|COMPLETED|Overall Study||7
308937|NCT01658657|738303|P1|COMPLETED|Overall Study||4
308938|NCT01658657|738302|P2|STARTED|Overall Study||10
308939|NCT01658657|738303|P1|STARTED|Overall Study||7
308940|NCT01658579|738313|P4|NOT COMPLETED|Treatment Period B||1
308941|NCT01658579|738314|P3|NOT COMPLETED|Treatment Period B||0
308942|NCT01658579|738315|P2|NOT COMPLETED|Treatment Period B||0
308943|NCT01658579|738316|P1|NOT COMPLETED|Treatment Period B||0
308944|NCT01658579|738313|P4|COMPLETED|Treatment Period B||12
308945|NCT01658579|738314|P3|COMPLETED|Treatment Period B||14
308946|NCT01658579|738315|P2|COMPLETED|Treatment Period B||15
308947|NCT01658579|738316|P1|COMPLETED|Treatment Period B||14
308948|NCT01658579|738313|P4|STARTED|Treatment Period B||13
308949|NCT01658579|738314|P3|STARTED|Treatment Period B||14
308950|NCT01658579|738315|P2|STARTED|Treatment Period B||15
308951|NCT01658579|738316|P1|STARTED|Treatment Period B||14
308952|NCT01658579|738313|P4|NOT COMPLETED|Treatment Period A||1
308953|NCT01658579|738314|P3|NOT COMPLETED|Treatment Period A||1
308954|NCT01658579|738315|P2|NOT COMPLETED|Treatment Period A||0
308955|NCT01658579|738316|P1|NOT COMPLETED|Treatment Period A||1
308956|NCT01658579|738313|P4|COMPLETED|Treatment Period A||13
308957|NCT01658579|738314|P3|COMPLETED|Treatment Period A||14
308958|NCT01658579|738315|P2|COMPLETED|Treatment Period A||15
308959|NCT01658579|738316|P1|COMPLETED|Treatment Period A||14
308960|NCT01658579|738313|P4|STARTED|Treatment Period A||14
308961|NCT01658579|738314|P3|STARTED|Treatment Period A||15
308962|NCT01658579|738315|P2|STARTED|Treatment Period A||15
308963|NCT01658579|738316|P1|STARTED|Treatment Period A||15
308964|NCT01658514|738344|P3|NOT COMPLETED|Overall Study||2
308965|NCT01658514|738345|P2|NOT COMPLETED|Overall Study||0
308966|NCT01658514|738346|P1|NOT COMPLETED|Overall Study||1
308967|NCT01658514|738344|P3|COMPLETED|Overall Study||12
308968|NCT01658514|738345|P2|COMPLETED|Overall Study||11
308969|NCT01658514|738346|P1|COMPLETED|Overall Study||13
308970|NCT01658514|738344|P3|Completed - Severe RI Cohort Only|Overall Study||3
308971|NCT01658514|738345|P2|Completed - Severe RI Cohort Only|Overall Study||2
308972|NCT01658514|738346|P1|Completed - Severe RI Cohort Only|Overall Study||3
308973|NCT01658514|738344|P3|Started - Severe RI Cohort Only|Overall Study||3
308974|NCT01658514|738345|P2|Started - Severe RI Cohort Only|Overall Study||2
308975|NCT01658514|738346|P1|Started - Severe RI Cohort Only|Overall Study||3
308976|NCT01658514|738344|P3|Completed - Moderate RI Cohort Only|Overall Study||2
308977|NCT01658514|738345|P2|Completed - Moderate RI Cohort Only|Overall Study||4
308978|NCT01658514|738346|P1|Completed - Moderate RI Cohort Only|Overall Study||3
308979|NCT01658514|738344|P3|Started - Moderate RI Cohort Only|Overall Study||4
308980|NCT01658514|738345|P2|Started - Moderate RI Cohort Only|Overall Study||4
308981|NCT01658514|738346|P1|Started - Moderate RI Cohort Only|Overall Study||4
308982|NCT01658514|738344|P3|Completed - Mild RI Cohort Only|Overall Study||4
308983|NCT01658514|738345|P2|Completed - Mild RI Cohort Only|Overall Study||3
308984|NCT01658514|738346|P1|Completed - Mild RI Cohort Only|Overall Study||4
308985|NCT01658514|738344|P3|Started - Mild RI Cohort Only|Overall Study||4
308986|NCT01658514|738345|P2|Started - Mild RI Cohort Only|Overall Study||3
308987|NCT01658514|738346|P1|Started - Mild RI Cohort Only|Overall Study||4
308988|NCT01658514|738344|P3|Completed - Normal RF Cohort Only|Overall Study||3
308989|NCT01658514|738345|P2|Completed - Normal RF Cohort Only|Overall Study||2
308990|NCT01658514|738346|P1|Completed - Normal RF Cohort Only|Overall Study||3
308991|NCT01658514|738344|P3|Started - Normal RF Cohort Only|Overall Study||3
308992|NCT01658514|738345|P2|Started - Normal RF Cohort Only|Overall Study||2
308993|NCT01658514|738346|P1|Started - Normal RF Cohort Only|Overall Study||3
308994|NCT01658514|738344|P3|Completed Treatment C|Overall Study||12
308995|NCT01658514|738345|P2|Completed Treatment C|Overall Study||11
308996|NCT01658514|738346|P1|Completed Treatment C|Overall Study||13
308997|NCT01658514|738344|P3|Completed Treatment B|Overall Study||14
308998|NCT01658514|738345|P2|Completed Treatment B|Overall Study||11
308999|NCT01658514|738346|P1|Completed Treatment B|Overall Study||13
309000|NCT01658514|738344|P3|Completed Treatment A|Overall Study||12
309001|NCT01658514|738345|P2|Completed Treatment A|Overall Study||11
309002|NCT01658514|738346|P1|Completed Treatment A|Overall Study||14
309003|NCT01658514|738344|P3|STARTED|Overall Study||14
309004|NCT01658514|738345|P2|STARTED|Overall Study||11
309005|NCT01658514|738346|P1|STARTED|Overall Study||14
309006|NCT01658436|738357|P2|NOT COMPLETED|Overall Study||11
309007|NCT01658436|738358|P1|NOT COMPLETED|Overall Study||20
309008|NCT01658436|738357|P2|COMPLETED|Overall Study||0
309009|NCT01658436|738358|P1|COMPLETED|Overall Study||0
309010|NCT01658436|738357|P2|STARTED|Overall Study||11
309011|NCT01658436|738358|P1|STARTED|Overall Study||20
309012|NCT01658072|738367|P2|NOT COMPLETED|Overall Study||2
309013|NCT01658072|738368|P1|NOT COMPLETED|Overall Study||4
309014|NCT01658072|738367|P2|COMPLETED|Overall Study||43
309015|NCT01658072|738368|P1|COMPLETED|Overall Study||41
309016|NCT01658072|738367|P2|STARTED|Overall Study||45
309017|NCT01658072|738368|P1|STARTED|Overall Study||45
309018|NCT01658020|738376|P2|NOT COMPLETED|Overall Study||9
309019|NCT01658020|738377|P1|NOT COMPLETED|Overall Study||8
309020|NCT01658020|738376|P2|COMPLETED|Overall Study||158
309021|NCT01658020|738377|P1|COMPLETED|Overall Study||167
309022|NCT01658020|738376|P2|STARTED|Overall Study||167
309023|NCT01658020|738377|P1|STARTED|Overall Study||175
309024|NCT01657903|738393|P1|NOT COMPLETED|Overall Study||2
309025|NCT01657903|738393|P1|COMPLETED|Overall Study||54
309026|NCT01657903|738393|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
309027|NCT01657903|738393|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
309028|NCT01657903|738393|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
309029|NCT01657903|738393|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
309030|NCT01657903|738393|P1|STARTED|Overall Study||56
309031|NCT01657877|738415|P1|NOT COMPLETED|Overall Study||14
309032|NCT01657877|738415|P1|COMPLETED|Overall Study||65
309033|NCT01657877|738415|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
309034|NCT01657877|738415|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
309035|NCT01657877|738415|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
309036|NCT01657877|738415|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
309037|NCT01657877|738415|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
309038|NCT01657877|738415|P1|STARTED|Overall Study||79
309039|NCT01657461|738434|P2|NOT COMPLETED|Overall Study||20
309040|NCT01657461|738435|P1|NOT COMPLETED|Overall Study||10
309041|NCT01657461|738434|P2|COMPLETED|Overall Study||78
309042|NCT01657461|738435|P1|COMPLETED|Overall Study||88
309043|NCT01657461|738434|P2|STARTED|Overall Study||98
309044|NCT01657461|738435|P1|STARTED|Overall Study||98
309045|NCT01657370|738465|P6|NOT COMPLETED|Overall Study||4
309046|NCT01657370|738466|P5|NOT COMPLETED|Overall Study||7
309047|NCT01657370|738467|P4|NOT COMPLETED|Overall Study||5
309048|NCT01657370|738468|P3|NOT COMPLETED|Overall Study||7
309049|NCT01657370|738469|P2|NOT COMPLETED|Overall Study||4
309050|NCT01657370|738470|P1|NOT COMPLETED|Overall Study||6
309051|NCT01657370|738465|P6|COMPLETED|Overall Study||27
309052|NCT01657370|738466|P5|COMPLETED|Overall Study||27
309053|NCT01657370|738467|P4|COMPLETED|Overall Study||28
309054|NCT01657370|738468|P3|COMPLETED|Overall Study||25
309055|NCT01657370|738469|P2|COMPLETED|Overall Study||28
309056|NCT01657370|738470|P1|COMPLETED|Overall Study||27
309057|NCT01657370|738465|P6|STARTED|Overall Study||31
309058|NCT01657370|738466|P5|STARTED|Overall Study||34
309059|NCT01657370|738467|P4|STARTED|Overall Study||33
309060|NCT01657370|738468|P3|STARTED|Overall Study||32
309061|NCT01657370|738469|P2|STARTED|Overall Study||32
309062|NCT01657370|738470|P1|STARTED|Overall Study||33
309063|NCT01657292|738552|P1|NOT COMPLETED|Overall Study||10
309064|NCT01657292|738552|P1|COMPLETED|Overall Study||51
309065|NCT01657292|738552|P1|STARTED|Overall Study||61
309066|NCT01657032|738561|P2|NOT COMPLETED|Overall Study||7
309067|NCT01657032|738562|P1|NOT COMPLETED|Overall Study||0
309068|NCT01657032|738561|P2|COMPLETED|Overall Study||37
309069|NCT01657032|738562|P1|COMPLETED|Overall Study||44
309070|NCT01657032|738561|P2|STARTED|Overall Study||44
309071|NCT01657032|738562|P1|STARTED|Overall Study||44
309072|NCT01657019|738588|P1|NOT COMPLETED|Overall Study||235
309073|NCT01657019|738588|P1|COMPLETED|Overall Study||369
309074|NCT01657019|738588|P1|STARTED|Overall Study||604
309075|NCT01656967|738602|P2|NOT COMPLETED|Overall Study||2
309076|NCT01656967|738603|P1|NOT COMPLETED|Overall Study||4
309077|NCT01656967|738602|P2|COMPLETED|Overall Study||31
309078|NCT01656967|738603|P1|COMPLETED|Overall Study||29
309079|NCT01656967|738602|P2|ETT Insertion|Overall Study||31
309080|NCT01656967|738603|P1|ETT Insertion|Overall Study||29
309081|NCT01656967|738602|P2|SGA Placement|Overall Study||33
309082|NCT01656967|738603|P1|SGA Placement|Overall Study||32
309083|NCT01656967|738602|P2|STARTED|Overall Study||33
309084|NCT01656967|738603|P1|STARTED|Overall Study||33
309085|NCT01656889|738625|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
309086|NCT01656889|738626|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
309087|NCT01656889|738625|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
309088|NCT01656889|738626|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
309089|NCT01656889|738625|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
309090|NCT01656889|738626|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
309091|NCT01656889|738625|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
309092|NCT01656889|738626|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
309093|NCT01656889|738625|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
309094|NCT01656889|738626|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
309095|NCT01656889|738625|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
309096|NCT01656889|738626|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
309097|NCT01656850|738646|P2|NOT COMPLETED|Second Intervention (3 Months)||0
309098|NCT01656850|738647|P1|NOT COMPLETED|Second Intervention (3 Months)||0
309099|NCT01656850|738646|P2|COMPLETED|Second Intervention (3 Months)||16
309100|NCT01656850|738647|P1|COMPLETED|Second Intervention (3 Months)||17
309101|NCT01656850|738646|P2|STARTED|Second Intervention (3 Months)||16
309102|NCT01656850|738647|P1|STARTED|Second Intervention (3 Months)||17
309103|NCT01656850|738646|P2|NOT COMPLETED|Washout (2 Weeks)||0
309104|NCT01656850|738647|P1|NOT COMPLETED|Washout (2 Weeks)||0
309105|NCT01656850|738646|P2|COMPLETED|Washout (2 Weeks)||16
309106|NCT01656850|738647|P1|COMPLETED|Washout (2 Weeks)||17
309107|NCT01656850|738646|P2|STARTED|Washout (2 Weeks)||16
309108|NCT01656850|738647|P1|STARTED|Washout (2 Weeks)||17
309109|NCT01656850|738646|P2|NOT COMPLETED|First Intervention (3 Months)||4
309110|NCT01656850|738647|P1|NOT COMPLETED|First Intervention (3 Months)||3
309111|NCT01656850|738646|P2|COMPLETED|First Intervention (3 Months)||16
309112|NCT01656850|738647|P1|COMPLETED|First Intervention (3 Months)||17
309113|NCT01656850|738646|P2|STARTED|First Intervention (3 Months)||20
309114|NCT01656850|738647|P1|STARTED|First Intervention (3 Months)||20
309115|NCT01656772|738727|P2|NOT COMPLETED|Overall Study||0
309116|NCT01656772|738728|P1|NOT COMPLETED|Overall Study||0
309117|NCT01656772|738727|P2|COMPLETED|Overall Study||77
309118|NCT01656772|738728|P1|COMPLETED|Overall Study||43
309119|NCT01656772|738727|P2|STARTED|Overall Study||77
309120|NCT01656772|738728|P1|STARTED|Overall Study||43
309121|NCT01656759|738738|P2|NOT COMPLETED|Overall Study||3
309122|NCT01656759|738739|P1|NOT COMPLETED|Overall Study||2
309123|NCT01656759|738738|P2|COMPLETED|Overall Study||22
309124|NCT01656759|738739|P1|COMPLETED|Overall Study||25
309125|NCT01656759|738738|P2|STARTED|Overall Study||25
309126|NCT01656759|738739|P1|STARTED|Overall Study||27
309127|NCT01656486|738751|P1|NOT COMPLETED|Overall Study||0
309128|NCT01656486|738751|P1|COMPLETED|Overall Study||1
309129|NCT01656486|738751|P1|STARTED|Overall Study||1
309130|NCT01656460|738755|P4|NOT COMPLETED|Overall Study||0
309131|NCT01656460|738756|P3|NOT COMPLETED|Overall Study||0
309132|NCT01656460|738757|P2|NOT COMPLETED|Overall Study||0
309133|NCT01656460|738758|P1|NOT COMPLETED|Overall Study||0
309134|NCT01656460|738755|P4|COMPLETED|Overall Study||3
309135|NCT01656460|738756|P3|COMPLETED|Overall Study||3
309136|NCT01656460|738757|P2|COMPLETED|Overall Study||3
309137|NCT01656460|738758|P1|COMPLETED|Overall Study||3
309138|NCT01656460|738755|P4|STARTED|Overall Study||3
309139|NCT01656460|738756|P3|STARTED|Overall Study||3
309140|NCT01656460|738757|P2|STARTED|Overall Study||3
309141|NCT01656460|738758|P1|STARTED|Overall Study||3
309142|NCT01656434|738770|P2|NOT COMPLETED|Overall Study||580
309143|NCT01656434|738771|P1|NOT COMPLETED|Overall Study||2401
309144|NCT01656434|738770|P2|COMPLETED|Overall Study||40
309145|NCT01656434|738771|P1|COMPLETED|Overall Study||152
309146|NCT01656434|738770|P2|Treated|Overall Study||604
309147|NCT01656434|738771|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
309148|NCT01656434|738770|P2|STARTED|Overall Study||620
309149|NCT01656434|738771|P1|STARTED|Overall Study||2553
309150|NCT01656408|738797|P10|NOT COMPLETED|Overall Study||3
309151|NCT01656408|738798|P9|NOT COMPLETED|Overall Study||2
309152|NCT01656408|738799|P8|NOT COMPLETED|Overall Study||1
309153|NCT01656408|738800|P7|NOT COMPLETED|Overall Study||1
309154|NCT01656408|738801|P6|NOT COMPLETED|Overall Study||2
309155|NCT01656408|738802|P5|NOT COMPLETED|Overall Study||1
309156|NCT01656408|738803|P4|NOT COMPLETED|Overall Study||0
309157|NCT01656408|738804|P3|NOT COMPLETED|Overall Study||2
309158|NCT01656408|738805|P2|NOT COMPLETED|Overall Study||0
309159|NCT01656408|738806|P1|NOT COMPLETED|Overall Study||1
309160|NCT01656408|738797|P10|COMPLETED|Overall Study||15
309161|NCT01656408|738798|P9|COMPLETED|Overall Study||16
309162|NCT01656408|738799|P8|COMPLETED|Overall Study||7
309163|NCT01656408|738800|P7|COMPLETED|Overall Study||9
309164|NCT01656408|738801|P6|COMPLETED|Overall Study||7
309165|NCT01656408|738802|P5|COMPLETED|Overall Study||8
309166|NCT01656408|738803|P4|COMPLETED|Overall Study||7
309167|NCT01656408|738804|P3|COMPLETED|Overall Study||6
309168|NCT01656408|738805|P2|COMPLETED|Overall Study||8
309169|NCT01656408|738806|P1|COMPLETED|Overall Study||7
309170|NCT01656408|738797|P10|STARTED|Overall Study||18
309171|NCT01656408|738798|P9|STARTED|Overall Study||18
309172|NCT01656408|738799|P8|STARTED|Overall Study||8
309173|NCT01656408|738800|P7|STARTED|Overall Study||10
309174|NCT01656408|738801|P6|STARTED|Overall Study||9
309175|NCT01656408|738802|P5|STARTED|Overall Study||9
309176|NCT01656408|738803|P4|STARTED|Overall Study||7
309177|NCT01656408|738804|P3|STARTED|Overall Study||8
309178|NCT01656408|738805|P2|STARTED|Overall Study||8
309179|NCT01656408|738806|P1|STARTED|Overall Study||8
309180|NCT01656304|738995|P1|NOT COMPLETED|Overall Study||1
309181|NCT01656304|738995|P1|COMPLETED|Overall Study||15
309182|NCT01656304|738995|P1|STARTED|Overall Study||16
309183|NCT01656161|739001|P1|NOT COMPLETED|Overall Study||7
309184|NCT01656161|739001|P1|COMPLETED|Overall Study|Per protocol analysis set|113
309185|NCT01656161|739001|P1|Received Triptorelin at Day 169|Overall Study||115
309186|NCT01656161|739001|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
309187|NCT01656161|739001|P1|STARTED|Overall Study|Intention to treat analysis set|120
309188|NCT01656031|739015|P1|NOT COMPLETED|Overall Study||0
309189|NCT01656031|739015|P1|COMPLETED|Overall Study||39
309190|NCT01656031|739015|P1|STARTED|Overall Study||39
309191|NCT01655498|739019|P1|NOT COMPLETED|Overall Study||5
309192|NCT01655498|739019|P1|COMPLETED|Overall Study||56
309193|NCT01655498|739019|P1|STARTED|Overall Study||61
309194|NCT01655381|739026|P1|NOT COMPLETED|Overall Study||3
309195|NCT01655381|739026|P1|COMPLETED|Overall Study||12
309196|NCT01655381|739026|P1|STARTED|Overall Study||15
309197|NCT01655329|739046|P1|NOT COMPLETED|Overall Study||0
309198|NCT01655329|739046|P1|COMPLETED|Overall Study||10
309199|NCT01655329|739046|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
309200|NCT01655043|739062|P1|NOT COMPLETED|Overall Study||0
309201|NCT01655043|739062|P1|COMPLETED|Overall Study||20
309202|NCT01655043|739062|P1|STARTED|Overall Study||20
309203|NCT01654887|739068|P2|NOT COMPLETED|Overall Study||0
309204|NCT01654887|739069|P1|NOT COMPLETED|Overall Study||0
309205|NCT01654887|739068|P2|COMPLETED|Overall Study||88
309206|NCT01654887|739069|P1|COMPLETED|Overall Study||103
309207|NCT01654887|739068|P2|STARTED|Overall Study||88
309208|NCT01654887|739069|P1|STARTED|Overall Study||103
309209|NCT01654861|739085|P1|NOT COMPLETED|Overall Study||0
309210|NCT01654861|739085|P1|COMPLETED|Overall Study||3
309211|NCT01654861|739085|P1|STARTED|Overall Study||3
309212|NCT01654666|739093|P3|NOT COMPLETED|Overall Study||14
309213|NCT01654666|739094|P2|NOT COMPLETED|Overall Study||13
309214|NCT01654666|739095|P1|NOT COMPLETED|Overall Study||15
309215|NCT01654666|739093|P3|COMPLETED|Overall Study||49
309216|NCT01654666|739094|P2|COMPLETED|Overall Study||50
309217|NCT01654666|739095|P1|COMPLETED|Overall Study||48
309218|NCT01654666|739093|P3|Primary Analysis|Overall Study||54
309219|NCT01654666|739094|P2|Primary Analysis|Overall Study||56
309220|NCT01654666|739095|P1|Primary Analysis|Overall Study||52
309221|NCT01654666|739093|P3|STARTED|Overall Study||63
309222|NCT01654666|739094|P2|STARTED|Overall Study||63
309223|NCT01654666|739095|P1|STARTED|Overall Study||63
309224|NCT01654601|739120|P2|NOT COMPLETED|2nd Administration||1
309225|NCT01654601|739121|P1|NOT COMPLETED|2nd Administration||1
309226|NCT01654601|739120|P2|COMPLETED|2nd Administration||11
309227|NCT01654601|739121|P1|COMPLETED|2nd Administration||11
309228|NCT01654601|739120|P2|STARTED|2nd Administration||12
309229|NCT01654601|739121|P1|STARTED|2nd Administration||12
309230|NCT01654601|739120|P2|NOT COMPLETED|1st Administration||2
309231|NCT01654601|739121|P1|NOT COMPLETED|1st Administration||2
309232|NCT01654601|739120|P2|COMPLETED|1st Administration||12
309233|NCT01654601|739121|P1|COMPLETED|1st Administration||12
309234|NCT01654601|739120|P2|STARTED|1st Administration||14
309235|NCT01654601|739121|P1|STARTED|1st Administration||14
309236|NCT01654549|739135|P2|NOT COMPLETED|Overall Study||1
309237|NCT01654549|739136|P1|NOT COMPLETED|Overall Study||0
309238|NCT01654549|739135|P2|COMPLETED|Overall Study||19
309239|NCT01654549|739136|P1|COMPLETED|Overall Study||20
309240|NCT01654549|739135|P2|STARTED|Overall Study||20
309241|NCT01654549|739136|P1|STARTED|Overall Study||20
309242|NCT01654536|739148|P2|NOT COMPLETED|Overall Study||38
309243|NCT01654536|739149|P1|NOT COMPLETED|Overall Study||44
309244|NCT01654536|739148|P2|COMPLETED|Overall Study||331
309245|NCT01654536|739149|P1|COMPLETED|Overall Study||324
309246|NCT01654536|739148|P2|STARTED|Overall Study||369
309247|NCT01654536|739149|P1|STARTED|Overall Study||368
309248|NCT01654523|739185|P1|NOT COMPLETED|Overall Study||1
309249|NCT01654523|739185|P1|COMPLETED|Overall Study||19
309250|NCT01654523|739185|P1|STARTED|Overall Study||20
309251|NCT01654302|739191|P2|NOT COMPLETED|Second Intervention (Day 7)||1
309252|NCT01654302|739192|P1|NOT COMPLETED|Second Intervention (Day 7)||1
309253|NCT01654302|739191|P2|COMPLETED|Second Intervention (Day 7)||19
309254|NCT01654302|739192|P1|COMPLETED|Second Intervention (Day 7)||19
309255|NCT01654302|739191|P2|STARTED|Second Intervention (Day 7)||20
309256|NCT01654302|739192|P1|STARTED|Second Intervention (Day 7)||20
309257|NCT01654302|739191|P2|NOT COMPLETED|First Intervention (Day 1)||0
309258|NCT01654302|739192|P1|NOT COMPLETED|First Intervention (Day 1)||0
309259|NCT01654302|739191|P2|COMPLETED|First Intervention (Day 1)||20
309260|NCT01654302|739192|P1|COMPLETED|First Intervention (Day 1)||20
309261|NCT01654302|739191|P2|STARTED|First Intervention (Day 1)||20
309262|NCT01654302|739192|P1|STARTED|First Intervention (Day 1)||20
309263|NCT01654276|739198|P1|NOT COMPLETED|Overall Study||6
309264|NCT01654276|739198|P1|COMPLETED|Overall Study||18
309265|NCT01654276|739198|P1|Visit 4 (6months)|Overall Study||18
309266|NCT01654276|739198|P1|Visit 3 (4 Months)|Overall Study||18
309267|NCT01654276|739198|P1|Visit 2 (2 Months)|Overall Study||19
309268|NCT01654276|739198|P1|STARTED|Overall Study||24
309269|NCT01654263|739222|P6|NOT COMPLETED|Overall Study||1
309270|NCT01654263|739223|P5|NOT COMPLETED|Overall Study||1
309271|NCT01654263|739224|P4|NOT COMPLETED|Overall Study||1
309272|NCT01654263|739225|P3|NOT COMPLETED|Overall Study||2
309273|NCT01654263|739226|P2|NOT COMPLETED|Overall Study||0
309274|NCT01654263|739227|P1|NOT COMPLETED|Overall Study||0
309275|NCT01654263|739222|P6|COMPLETED|Overall Study||148
309276|NCT01654263|739223|P5|COMPLETED|Overall Study||139
309277|NCT01654263|739224|P4|COMPLETED|Overall Study||144
309278|NCT01654263|739225|P3|COMPLETED|Overall Study||137
309279|NCT01654263|739226|P2|COMPLETED|Overall Study||147
309280|NCT01654263|739227|P1|COMPLETED|Overall Study||164
309281|NCT01654263|739222|P6|STARTED|Overall Study||149
309282|NCT01654263|739223|P5|STARTED|Overall Study||140
309283|NCT01654263|739224|P4|STARTED|Overall Study||145
309284|NCT01654263|739225|P3|STARTED|Overall Study||139
309285|NCT01654263|739226|P2|STARTED|Overall Study||147
309286|NCT01654263|739227|P1|STARTED|Overall Study||164
309287|NCT01654250|739252|P2|NOT COMPLETED|Overall Study||0
309288|NCT01654250|739253|P1|NOT COMPLETED|Overall Study||1
309289|NCT01654250|739252|P2|COMPLETED|Overall Study||42
309290|NCT01654250|739253|P1|COMPLETED|Overall Study||43
309291|NCT01654250|739252|P2|STARTED|Overall Study||42
309292|NCT01654250|739253|P1|STARTED|Overall Study||44
309293|NCT01654224|739270|P2|NOT COMPLETED|Overall Study||12
309294|NCT01654224|739271|P1|NOT COMPLETED|Overall Study||6
309295|NCT01654224|739270|P2|COMPLETED|Overall Study||98
309296|NCT01654224|739271|P1|COMPLETED|Overall Study||89
309297|NCT01654224|739270|P2|STARTED|Overall Study||110
309298|NCT01654224|739271|P1|STARTED|Overall Study||95
309299|NCT01654107|739283|P2|NOT COMPLETED|Overall Study||8
309300|NCT01654107|739284|P1|NOT COMPLETED|Overall Study||3
309301|NCT01654107|739283|P2|COMPLETED|Overall Study||22
309302|NCT01654107|739284|P1|COMPLETED|Overall Study||25
309303|NCT01654107|739283|P2|STARTED|Overall Study||30
309304|NCT01654107|739284|P1|STARTED|Overall Study||28
309305|NCT01653782|739293|P3|NOT COMPLETED|Overall Study||6
309306|NCT01653782|739294|P2|NOT COMPLETED|Overall Study||18
309307|NCT01653782|739295|P1|NOT COMPLETED|Overall Study||16
309308|NCT01653782|739293|P3|COMPLETED|Overall Study||46
309309|NCT01653782|739294|P2|COMPLETED|Overall Study||37
309310|NCT01653782|739295|P1|COMPLETED|Overall Study||36
309311|NCT01653782|739293|P3|STARTED|Overall Study||52
309312|NCT01653782|739294|P2|STARTED|Overall Study||55
309313|NCT01653782|739295|P1|STARTED|Overall Study||52
309314|NCT01653743|739305|P2|NOT COMPLETED|Overall Study||0
309315|NCT01653743|739306|P1|NOT COMPLETED|Overall Study||4
309316|NCT01653743|739305|P2|COMPLETED|Overall Study||27
309317|NCT01653743|739306|P1|COMPLETED|Overall Study||50
309318|NCT01653743|739305|P2|STARTED|Overall Study||27
309319|NCT01653743|739306|P1|STARTED|Overall Study||54
309320|NCT01653509|739322|P2|NOT COMPLETED|Overall Study||0
309321|NCT01653509|739323|P1|NOT COMPLETED|Overall Study||0
309322|NCT01653509|739322|P2|COMPLETED|Overall Study||13
309323|NCT01653509|739323|P1|COMPLETED|Overall Study||12
309324|NCT01653509|739322|P2|STARTED|Overall Study||13
309325|NCT01653509|739323|P1|STARTED|Overall Study||12
309326|NCT01653418|739341|P1|NOT COMPLETED|Overall Study||0
309327|NCT01653418|739341|P1|COMPLETED|Overall Study||10
309328|NCT01653418|739341|P1|STARTED|Overall Study||10
309329|NCT01653262|739353|P1|NOT COMPLETED|Overall Study||3
309330|NCT01653262|739353|P1|COMPLETED|Overall Study||26
309331|NCT01653262|739353|P1|STARTED|Overall Study||29
309332|NCT01653158|739366|P8|NOT COMPLETED|Overall Study||15
309333|NCT01653158|739367|P7|NOT COMPLETED|Overall Study||2
309334|NCT01653158|739368|P6|NOT COMPLETED|Overall Study||1
309335|NCT01653158|739369|P5|NOT COMPLETED|Overall Study||1
309336|NCT01653158|739370|P4|NOT COMPLETED|Overall Study||2
309337|NCT01653158|739371|P3|NOT COMPLETED|Overall Study||0
309338|NCT01653158|739372|P2|NOT COMPLETED|Overall Study||0
309339|NCT01653158|739373|P1|NOT COMPLETED|Overall Study||1
309340|NCT01653158|739366|P8|COMPLETED|Overall Study||4
309341|NCT01653158|739367|P7|COMPLETED|Overall Study||7
309342|NCT01653158|739368|P6|COMPLETED|Overall Study||2
309343|NCT01653158|739369|P5|COMPLETED|Overall Study||2
309344|NCT01653158|739370|P4|COMPLETED|Overall Study||1
309345|NCT01653158|739371|P3|COMPLETED|Overall Study||3
309346|NCT01653158|739372|P2|COMPLETED|Overall Study||3
309347|NCT01653158|739373|P1|COMPLETED|Overall Study||2
309348|NCT01653158|739366|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
309349|NCT01653158|739367|P7|STARTED|Overall Study||9
309350|NCT01653158|739368|P6|STARTED|Overall Study||3
309351|NCT01653158|739369|P5|STARTED|Overall Study||3
309352|NCT01653158|739370|P4|STARTED|Overall Study||3
309353|NCT01653158|739371|P3|STARTED|Overall Study||3
309354|NCT01653158|739372|P2|STARTED|Overall Study||3
309355|NCT01653158|739373|P1|STARTED|Overall Study||3
309356|NCT01653132|739645|P2|NOT COMPLETED|Second Intervention||0
309357|NCT01653132|739646|P1|NOT COMPLETED|Second Intervention||0
309358|NCT01653132|739645|P2|COMPLETED|Second Intervention||5
309359|NCT01653132|739646|P1|COMPLETED|Second Intervention||4
309360|NCT01653132|739645|P2|STARTED|Second Intervention||5
309361|NCT01653132|739646|P1|STARTED|Second Intervention||4
309362|NCT01653132|739645|P2|NOT COMPLETED|Washout 1-2 Months||0
309363|NCT01653132|739646|P1|NOT COMPLETED|Washout 1-2 Months||0
309364|NCT01653132|739645|P2|COMPLETED|Washout 1-2 Months||5
309365|NCT01653132|739646|P1|COMPLETED|Washout 1-2 Months||4
309366|NCT01653132|739645|P2|STARTED|Washout 1-2 Months||5
309367|NCT01653132|739646|P1|STARTED|Washout 1-2 Months||4
309368|NCT01653132|739645|P2|NOT COMPLETED|First Intervention||0
309369|NCT01653132|739646|P1|NOT COMPLETED|First Intervention||1
309370|NCT01653132|739645|P2|COMPLETED|First Intervention||5
309371|NCT01653132|739646|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
309372|NCT01653132|739645|P2|STARTED|First Intervention||5
309373|NCT01653132|739646|P1|STARTED|First Intervention||5
309374|NCT01653028|739665|P5|NOT COMPLETED|Overall Study||0
309375|NCT01653028|739666|P4|NOT COMPLETED|Overall Study||0
309376|NCT01653028|739667|P3|NOT COMPLETED|Overall Study||0
309377|NCT01653028|739668|P2|NOT COMPLETED|Overall Study||0
309378|NCT01653028|739669|P1|NOT COMPLETED|Overall Study||0
309379|NCT01653028|739665|P5|COMPLETED|Overall Study||29
309380|NCT01653028|739666|P4|COMPLETED|Overall Study||10
309381|NCT01653028|739667|P3|COMPLETED|Overall Study||11
309382|NCT01653028|739668|P2|COMPLETED|Overall Study||10
309383|NCT01653028|739669|P1|COMPLETED|Overall Study||12
309384|NCT01653028|739665|P5|STARTED|Overall Study||29
309385|NCT01653028|739666|P4|STARTED|Overall Study||10
309386|NCT01653028|739667|P3|STARTED|Overall Study||11
309387|NCT01653028|739668|P2|STARTED|Overall Study||10
309388|NCT01653028|739669|P1|STARTED|Overall Study||12
309389|NCT01652885|739696|P1|NOT COMPLETED|Overall Study||1
309390|NCT01652885|739696|P1|COMPLETED|Overall Study||22
309391|NCT01652885|739696|P1|STARTED|Overall Study||23
309392|NCT01652729|739724|P3|NOT COMPLETED|Overall Study||14
309393|NCT01652729|739725|P2|NOT COMPLETED|Overall Study||13
309394|NCT01652729|739726|P1|NOT COMPLETED|Overall Study||27
309395|NCT01652729|739724|P3|COMPLETED|Overall Study||47
309396|NCT01652729|739725|P2|COMPLETED|Overall Study||109
309397|NCT01652729|739726|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
309398|NCT01652729|739724|P3|Meal Test Evaluable|Overall Study||15
309399|NCT01652729|739725|P2|Meal Test Evaluable|Overall Study||31
309400|NCT01652729|739726|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
309401|NCT01652729|739724|P3|Meal Test Subjects|Overall Study||20
309402|NCT01652729|739725|P2|Meal Test Subjects|Overall Study||41
309403|NCT01652729|739726|P1|Meal Test Subjects|Overall Study||60
309404|NCT01652729|739724|P3|Evaluable|Overall Study||43
309405|NCT01652729|739725|P2|Evaluable|Overall Study||91
309406|NCT01652729|739726|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
309407|NCT01652729|739724|P3|Treated|Overall Study||61
309408|NCT01652729|739725|P2|Treated|Overall Study||122
309409|NCT01652729|739726|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
309410|NCT01652729|739724|P3|Modified Intent-to-Treat|Overall Study||61
309411|NCT01652729|739725|P2|Modified Intent-to-Treat|Overall Study||122
309412|NCT01652729|739726|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
309413|NCT01652729|739724|P3|STARTED|Overall Study||61
309414|NCT01652729|739725|P2|STARTED|Overall Study||122
309415|NCT01652729|739726|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
309416|NCT01652716|739748|P2|NOT COMPLETED|Overall Study||46
309417|NCT01652716|739749|P1|NOT COMPLETED|Overall Study||56
309418|NCT01652716|739748|P2|COMPLETED|Overall Study|* completed study|102
309419|NCT01652716|739749|P1|COMPLETED|Overall Study|* completed study|173
309420|NCT01652716|739748|P2|Completed 28-week|Overall Study||118
309421|NCT01652716|739749|P1|Completed 28-week|Overall Study||197
309422|NCT01652716|739748|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
309423|NCT01652716|739749|P1|STARTED|Overall Study||229
309424|NCT01652703|739769|P6|NOT COMPLETED|Overall Study||2
309425|NCT01652703|739770|P5|NOT COMPLETED|Overall Study||1
309426|NCT01652703|739771|P4|NOT COMPLETED|Overall Study||2
309427|NCT01652703|739772|P3|NOT COMPLETED|Overall Study||3
309428|NCT01652703|739773|P2|NOT COMPLETED|Overall Study||1
309429|NCT01652703|739774|P1|NOT COMPLETED|Overall Study||0
309430|NCT01652703|739769|P6|COMPLETED|Overall Study||51
309431|NCT01652703|739770|P5|COMPLETED|Overall Study||51
309432|NCT01652703|739771|P4|COMPLETED|Overall Study||50
309433|NCT01652703|739772|P3|COMPLETED|Overall Study||47
309434|NCT01652703|739773|P2|COMPLETED|Overall Study||50
309435|NCT01652703|739774|P1|COMPLETED|Overall Study||52
309436|NCT01652703|739769|P6|Received Treatment|Overall Study||53
309437|NCT01652703|739770|P5|Received Treatment|Overall Study||51
309438|NCT01652703|739771|P4|Received Treatment|Overall Study||52
309439|NCT01652703|739772|P3|Received Treatment|Overall Study||49
309440|NCT01652703|739773|P2|Received Treatment|Overall Study||50
309441|NCT01652703|739774|P1|Received Treatment|Overall Study||52
309442|NCT01652703|739769|P6|STARTED|Overall Study||53
309443|NCT01652703|739770|P5|STARTED|Overall Study||52
309444|NCT01652703|739771|P4|STARTED|Overall Study||52
309445|NCT01652703|739772|P3|STARTED|Overall Study||50
309446|NCT01652703|739773|P2|STARTED|Overall Study||51
309447|NCT01652703|739774|P1|STARTED|Overall Study||52
309448|NCT01652690|739832|P2|NOT COMPLETED|Overall Study||21
309449|NCT01652690|739833|P1|NOT COMPLETED|Overall Study||35
309450|NCT01652690|739832|P2|COMPLETED|Overall Study||279
309451|NCT01652690|739833|P1|COMPLETED|Overall Study||265
309452|NCT01652690|739832|P2|STARTED|Overall Study||300
309453|NCT01652690|739833|P1|STARTED|Overall Study||300
309454|NCT01652664|739867|P2|NOT COMPLETED|Overall Study||1
309455|NCT01652664|739868|P1|NOT COMPLETED|Overall Study||6
309456|NCT01652664|739867|P2|COMPLETED|Overall Study||74
309457|NCT01652664|739868|P1|COMPLETED|Overall Study||71
309458|NCT01652664|739867|P2|STARTED|Overall Study||75
309459|NCT01652664|739868|P1|STARTED|Overall Study||77
309460|NCT01652573|739877|P2|NOT COMPLETED|Overall Study||1
309461|NCT01652573|739878|P1|NOT COMPLETED|Overall Study||0
309462|NCT01652573|739877|P2|COMPLETED|Overall Study||10
309463|NCT01652573|739878|P1|COMPLETED|Overall Study||10
309464|NCT01652573|739877|P2|STARTED|Overall Study||11
309465|NCT01652573|739878|P1|STARTED|Overall Study||10
309466|NCT01652495|739920|P2|NOT COMPLETED|Overall Study||2
309467|NCT01652495|739921|P1|NOT COMPLETED|Overall Study||2
309468|NCT01652495|739920|P2|COMPLETED|Overall Study||20
309469|NCT01652495|739921|P1|COMPLETED|Overall Study||20
309470|NCT01652495|739920|P2|STARTED|Overall Study||22
309471|NCT01652495|739921|P1|STARTED|Overall Study||22
309472|NCT01652287|739933|P2|NOT COMPLETED|Overall Study||0
309473|NCT01652287|739934|P1|NOT COMPLETED|Overall Study||2
309474|NCT01652287|739933|P2|COMPLETED|Overall Study||31
309475|NCT01652287|739934|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
309476|NCT01652287|739933|P2|STARTED|Overall Study||31
309477|NCT01652287|739934|P1|STARTED|Overall Study||31
309478|NCT01652001|739942|P2|NOT COMPLETED|Overall Study||6
309479|NCT01652001|739943|P1|NOT COMPLETED|Overall Study||9
309480|NCT01652001|739942|P2|COMPLETED|Overall Study||79
309481|NCT01652001|739943|P1|COMPLETED|Overall Study||91
309482|NCT01652001|739942|P2|STARTED|Overall Study||85
309483|NCT01652001|739943|P1|STARTED|Overall Study||100
309484|NCT01651949|739954|P3|NOT COMPLETED|Overall Study||31
309485|NCT01651949|739955|P2|NOT COMPLETED|Overall Study||86
309486|NCT01651949|739956|P1|NOT COMPLETED|Overall Study||53
309487|NCT01651949|739954|P3|COMPLETED|Overall Study||282
309488|NCT01651949|739955|P2|COMPLETED|Overall Study||1015
309489|NCT01651949|739956|P1|COMPLETED|Overall Study||1053
309490|NCT01651949|739954|P3|Vaccination 3|Overall Study||291
309491|NCT01651949|739955|P2|Vaccination 3|Overall Study||1037
309492|NCT01651949|739956|P1|Vaccination 3|Overall Study||1067
309493|NCT01651949|739954|P3|Vaccination 2|Overall Study||298
309494|NCT01651949|739955|P2|Vaccination 2|Overall Study||1069
309495|NCT01651949|739956|P1|Vaccination 2|Overall Study||1089
309496|NCT01651949|739954|P3|Vaccination 1|Overall Study||313
309497|NCT01651949|739955|P2|Vaccination 1|Overall Study||1099
309498|NCT01651949|739956|P1|Vaccination 1|Overall Study||1103
309499|NCT01651949|739954|P3|STARTED|Overall Study||313
309500|NCT01651949|739955|P2|STARTED|Overall Study||1101
309501|NCT01651949|739956|P1|STARTED|Overall Study||1106
309502|NCT01651936|739976|P3|NOT COMPLETED|Extension Study||14
309503|NCT01651936|739977|P2|NOT COMPLETED|Extension Study||0
309504|NCT01651936|739978|P1|NOT COMPLETED|Extension Study||0
309505|NCT01651936|739976|P3|COMPLETED|Extension Study||0
309506|NCT01651936|739977|P2|COMPLETED|Extension Study||0
309507|NCT01651936|739978|P1|COMPLETED|Extension Study||0
309508|NCT01651936|739976|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
309509|NCT01651936|739977|P2|STARTED|Extension Study||0
309510|NCT01651936|739978|P1|STARTED|Extension Study||0
309511|NCT01651936|739976|P3|NOT COMPLETED|Base Study||0
309512|NCT01651936|739977|P2|NOT COMPLETED|Base Study||25
309513|NCT01651936|739978|P1|NOT COMPLETED|Base Study||27
309514|NCT01651936|739976|P3|COMPLETED|Base Study||0
309515|NCT01651936|739977|P2|COMPLETED|Base Study||1
309516|NCT01651936|739978|P1|COMPLETED|Base Study||3
309517|NCT01651936|739976|P3|STARTED|Base Study||0
309518|NCT01651936|739977|P2|STARTED|Base Study||26
309519|NCT01651936|739978|P1|STARTED|Base Study||30
309520|NCT01651780|740001|P2|NOT COMPLETED|Overall Study||10
309521|NCT01651780|740002|P1|NOT COMPLETED|Overall Study||11
309522|NCT01651780|740001|P2|COMPLETED|Overall Study||388
309523|NCT01651780|740002|P1|COMPLETED|Overall Study||394
309524|NCT01651780|740001|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
309525|NCT01651780|740002|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
309526|NCT01651780|740001|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
309527|NCT01651780|740002|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
309528|NCT01651780|740001|P2|Intent-To-Treat (ITT) Population|Overall Study||398
309529|NCT01651780|740002|P1|Intent-To-Treat (ITT) Population|Overall Study||404
309530|NCT01651780|740001|P2|STARTED|Overall Study||398
309531|NCT01651780|740002|P1|STARTED|Overall Study||405
309532|NCT01651351|740034|P2|NOT COMPLETED|Overall Study||0
309533|NCT01651351|740035|P1|NOT COMPLETED|Overall Study||0
309534|NCT01651351|740034|P2|COMPLETED|Overall Study||15
309535|NCT01651351|740035|P1|COMPLETED|Overall Study||15
309536|NCT01651351|740034|P2|STARTED|Overall Study||15
309537|NCT01651351|740035|P1|STARTED|Overall Study||15
309538|NCT01651260|740052|P1|NOT COMPLETED|Overall Study||3
309539|NCT01651260|740052|P1|COMPLETED|Overall Study||62
309540|NCT01651260|740052|P1|STARTED|Overall Study||65
309541|NCT01651208|740059|P2|NOT COMPLETED|Overall Study||16
309542|NCT01651208|740060|P1|NOT COMPLETED|Overall Study||14
309543|NCT01651208|740059|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
309544|NCT01651208|740060|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
309545|NCT01651208|740059|P2|STARTED|Overall Study||225
309546|NCT01651208|740060|P1|STARTED|Overall Study||227
309547|NCT01651104|740068|P1|NOT COMPLETED|Overall Study||0
309548|NCT01651104|740068|P1|COMPLETED|Overall Study||63
309549|NCT01651104|740068|P1|STARTED|Overall Study||63
309550|NCT01651000|740077|P2|NOT COMPLETED|Overall Study||28
309551|NCT01651000|740078|P1|NOT COMPLETED|Overall Study||10
309552|NCT01651000|740077|P2|COMPLETED|Overall Study||113
309553|NCT01651000|740078|P1|COMPLETED|Overall Study||62
309554|NCT01651000|740077|P2|Entered Extension Study|Overall Study||93
309555|NCT01651000|740078|P1|Entered Extension Study|Overall Study||50
309556|NCT01651000|740077|P2|STARTED|Overall Study||141
309557|NCT01651000|740078|P1|STARTED|Overall Study||72
309558|NCT01650831|740090|P1|NOT COMPLETED|Overall Study||1
309559|NCT01650831|740090|P1|COMPLETED|Overall Study||112
309560|NCT01650831|740090|P1|STARTED|Overall Study||113
309561|NCT01650805|740100|P2|NOT COMPLETED|Overall Study||0
309562|NCT01650805|740101|P1|NOT COMPLETED|Overall Study||1
309563|NCT01650805|740100|P2|COMPLETED|Overall Study||152
309564|NCT01650805|740101|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
309565|NCT01650805|740100|P2|STARTED|Overall Study||152
309566|NCT01650805|740101|P1|STARTED|Overall Study|Started means patient has been randomized.|155
309567|NCT01650779|740111|P1|NOT COMPLETED|Overall Study||1
309568|NCT01650779|740111|P1|COMPLETED|Overall Study||14
309569|NCT01650779|740111|P1|STARTED|Overall Study||15
309570|NCT01650519|740120|P2|NOT COMPLETED|Overall Study||0
309571|NCT01650519|740121|P1|NOT COMPLETED|Overall Study||1
309572|NCT01650519|740120|P2|COMPLETED|Overall Study||31
309573|NCT01650519|740121|P1|COMPLETED|Overall Study||19
309574|NCT01650519|740120|P2|STARTED|Overall Study||31
309575|NCT01650519|740121|P1|STARTED|Overall Study||20
309576|NCT01650350|740139|P1|NOT COMPLETED|Overall Study||0
309577|NCT01650350|740139|P1|COMPLETED|Overall Study||7
309578|NCT01650350|740139|P1|STARTED|Overall Study||7
309579|NCT01650324|740148|P5|NOT COMPLETED|Overall Study||0
309580|NCT01650324|740149|P4|NOT COMPLETED|Overall Study||0
309581|NCT01650324|740150|P3|NOT COMPLETED|Overall Study||0
309582|NCT01650324|740151|P2|NOT COMPLETED|Overall Study||0
309583|NCT01650324|740152|P1|NOT COMPLETED|Overall Study||0
309584|NCT01650324|740148|P5|COMPLETED|Overall Study||6
309585|NCT01650324|740149|P4|COMPLETED|Overall Study||6
309586|NCT01650324|740150|P3|COMPLETED|Overall Study||6
309587|NCT01650324|740151|P2|COMPLETED|Overall Study||6
309588|NCT01650324|740152|P1|COMPLETED|Overall Study||8
309589|NCT01650324|740148|P5|STARTED|Overall Study||6
309590|NCT01650324|740149|P4|STARTED|Overall Study||6
309591|NCT01650324|740150|P3|STARTED|Overall Study||6
309592|NCT01650324|740151|P2|STARTED|Overall Study||6
309593|NCT01650324|740152|P1|STARTED|Overall Study||8
309594|NCT01650285|740181|P1|NOT COMPLETED|Overall Study||1
309595|NCT01650285|740181|P1|COMPLETED|Overall Study||4
309596|NCT01650285|740181|P1|STARTED|Overall Study||5
309597|NCT01650246|740185|P1|NOT COMPLETED|Overall Study||143
309598|NCT01650246|740185|P1|COMPLETED|Overall Study||0
309599|NCT01650246|740185|P1|STARTED|Overall Study||143
309600|NCT01649856|740192|P2|NOT COMPLETED|Overall Study||203
309601|NCT01649856|740193|P1|NOT COMPLETED|Overall Study||369
309602|NCT01649856|740192|P2|COMPLETED|Overall Study||0
309603|NCT01649856|740193|P1|COMPLETED|Overall Study||0
309604|NCT01649856|740192|P2|STARTED|Overall Study||203
309605|NCT01649856|740193|P1|STARTED|Overall Study||369
309606|NCT01649804|740225|P1|NOT COMPLETED|Overall Study||8
309607|NCT01649804|740225|P1|COMPLETED|Overall Study||4
309608|NCT01649804|740225|P1|STARTED|Overall Study||12
309609|NCT01649791|740237|P1|NOT COMPLETED|Overall Study||3
309610|NCT01649791|740237|P1|COMPLETED|Overall Study||5
309611|NCT01649791|740237|P1|STARTED|Overall Study||8
309612|NCT01649557|740247|P3|NOT COMPLETED|Overall Study||9
309613|NCT01649557|740248|P2|NOT COMPLETED|Overall Study||14
309614|NCT01649557|740249|P1|NOT COMPLETED|Overall Study||44
309615|NCT01649557|740247|P3|COMPLETED|Overall Study||15
309616|NCT01649557|740248|P2|COMPLETED|Overall Study||27
309617|NCT01649557|740249|P1|COMPLETED|Overall Study||135
309618|NCT01649557|740247|P3|52-week Enrollers|Overall Study||2
309619|NCT01649557|740248|P2|52-week Enrollers|Overall Study||6
309620|NCT01649557|740249|P1|52-week Enrollers|Overall Study||20
309621|NCT01649557|740247|P3|6-week Enrollers|Overall Study||22
309622|NCT01649557|740248|P2|6-week Enrollers|Overall Study||35
309623|NCT01649557|740249|P1|6-week Enrollers|Overall Study||159
309624|NCT01649557|740247|P3|STARTED|Overall Study||24
309625|NCT01649557|740248|P2|STARTED|Overall Study||41
309626|NCT01649557|740249|P1|STARTED|Overall Study||179
309627|NCT01649505|740286|P2|NOT COMPLETED|Overall Study||1
309628|NCT01649505|740287|P1|NOT COMPLETED|Overall Study||1
309629|NCT01649505|740286|P2|COMPLETED|Overall Study||0
309630|NCT01649505|740287|P1|COMPLETED|Overall Study||0
309631|NCT01649505|740286|P2|STARTED|Overall Study||1
309632|NCT01649505|740287|P1|STARTED|Overall Study||1
309633|NCT01649362|740295|P2|NOT COMPLETED|Overall Study||14
309634|NCT01649362|740296|P1|NOT COMPLETED|Overall Study||1
309635|NCT01649362|740295|P2|COMPLETED|Overall Study||40
309636|NCT01649362|740296|P1|COMPLETED|Overall Study||46
309637|NCT01649362|740295|P2|STARTED|Overall Study||54
309638|NCT01649362|740296|P1|STARTED|Overall Study||47
309639|NCT01649297|740311|P5|NOT COMPLETED|Overall Study||4
309640|NCT01649297|740312|P4|NOT COMPLETED|Overall Study||19
309641|NCT01649297|740313|P3|NOT COMPLETED|Overall Study||17
309642|NCT01649297|740314|P2|NOT COMPLETED|Overall Study||13
309643|NCT01649297|740315|P1|NOT COMPLETED|Overall Study||14
309644|NCT01649297|740311|P5|COMPLETED|Overall Study||103
309645|NCT01649297|740312|P4|COMPLETED|Overall Study||201
309646|NCT01649297|740313|P3|COMPLETED|Overall Study||202
309647|NCT01649297|740314|P2|COMPLETED|Overall Study||205
309648|NCT01649297|740315|P1|COMPLETED|Overall Study||205
309649|NCT01649297|740311|P5|STARTED|Overall Study|randomised|107
309650|NCT01649297|740312|P4|STARTED|Overall Study|randomised|220
309651|NCT01649297|740313|P3|STARTED|Overall Study|randomised|219
309652|NCT01649297|740314|P2|STARTED|Overall Study|randomised|218
309653|NCT01649297|740315|P1|STARTED|Overall Study|randomised|219
309654|NCT01649232|740334|P2|NOT COMPLETED|Overall Study||0
309655|NCT01649232|740335|P1|NOT COMPLETED|Overall Study||2
309656|NCT01649232|740334|P2|COMPLETED|Overall Study||30
309657|NCT01649232|740335|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
309658|NCT01649232|740334|P2|STARTED|Overall Study||30
309659|NCT01649232|740335|P1|STARTED|Overall Study||30
309660|NCT01649180|740355|P1|NOT COMPLETED|Overall Study||0
309661|NCT01649180|740355|P1|COMPLETED|Overall Study||3
309662|NCT01649180|740355|P1|STARTED|Overall Study||3
309663|NCT01648920|740363|P1|NOT COMPLETED|Overall Study||0
309664|NCT01648920|740363|P1|COMPLETED|Overall Study||50
309665|NCT01648920|740363|P1|STARTED|Overall Study||50
309666|NCT01648790|740387|P5|NOT COMPLETED|Treatment 5||0
309667|NCT01648790|740388|P4|NOT COMPLETED|Treatment 5||0
309668|NCT01648790|740389|P3|NOT COMPLETED|Treatment 5||0
309669|NCT01648790|740390|P2|NOT COMPLETED|Treatment 5||0
309670|NCT01648790|740391|P1|NOT COMPLETED|Treatment 5||0
309671|NCT01648790|740387|P5|COMPLETED|Treatment 5||4
309672|NCT01648790|740388|P4|COMPLETED|Treatment 5||3
309673|NCT01648790|740389|P3|COMPLETED|Treatment 5||4
309674|NCT01648790|740390|P2|COMPLETED|Treatment 5||4
309675|NCT01648790|740391|P1|COMPLETED|Treatment 5||4
309676|NCT01648790|740387|P5|STARTED|Treatment 5||4
309677|NCT01648790|740388|P4|STARTED|Treatment 5||3
309678|NCT01648790|740389|P3|STARTED|Treatment 5||4
309679|NCT01648790|740390|P2|STARTED|Treatment 5||4
309680|NCT01648790|740391|P1|STARTED|Treatment 5||4
309681|NCT01648790|740387|P5|NOT COMPLETED|Treatment 4||0
309682|NCT01648790|740388|P4|NOT COMPLETED|Treatment 4||0
309683|NCT01648790|740389|P3|NOT COMPLETED|Treatment 4||0
309684|NCT01648790|740390|P2|NOT COMPLETED|Treatment 4||0
309685|NCT01648790|740391|P1|NOT COMPLETED|Treatment 4||0
309686|NCT01648790|740387|P5|COMPLETED|Treatment 4||4
309687|NCT01648790|740388|P4|COMPLETED|Treatment 4||3
309688|NCT01648790|740389|P3|COMPLETED|Treatment 4||4
309689|NCT01648790|740390|P2|COMPLETED|Treatment 4||4
309690|NCT01648790|740391|P1|COMPLETED|Treatment 4||4
309691|NCT01648790|740387|P5|STARTED|Treatment 4||4
309692|NCT01648790|740388|P4|STARTED|Treatment 4||3
309693|NCT01648790|740389|P3|STARTED|Treatment 4||4
309694|NCT01648790|740390|P2|STARTED|Treatment 4||4
309695|NCT01648790|740391|P1|STARTED|Treatment 4||4
309696|NCT01648790|740387|P5|NOT COMPLETED|Treatment 3||0
309697|NCT01648790|740388|P4|NOT COMPLETED|Treatment 3||1
309698|NCT01648790|740389|P3|NOT COMPLETED|Treatment 3||0
309699|NCT01648790|740390|P2|NOT COMPLETED|Treatment 3||0
309700|NCT01648790|740391|P1|NOT COMPLETED|Treatment 3||0
309701|NCT01648790|740387|P5|COMPLETED|Treatment 3||4
309702|NCT01648790|740388|P4|COMPLETED|Treatment 3||3
309703|NCT01648790|740389|P3|COMPLETED|Treatment 3||4
309704|NCT01648790|740390|P2|COMPLETED|Treatment 3||4
309705|NCT01648790|740391|P1|COMPLETED|Treatment 3||4
309706|NCT01648790|740387|P5|STARTED|Treatment 3||4
309707|NCT01648790|740388|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
309708|NCT01648790|740389|P3|STARTED|Treatment 3||4
309709|NCT01648790|740390|P2|STARTED|Treatment 3||4
309710|NCT01648790|740391|P1|STARTED|Treatment 3||4
309711|NCT01648790|740387|P5|NOT COMPLETED|Treatment 2||0
309712|NCT01648790|740388|P4|NOT COMPLETED|Treatment 2||0
309713|NCT01648790|740389|P3|NOT COMPLETED|Treatment 2||0
309714|NCT01648790|740390|P2|NOT COMPLETED|Treatment 2||0
309715|NCT01648790|740391|P1|NOT COMPLETED|Treatment 2||0
309716|NCT01648790|740387|P5|COMPLETED|Treatment 2||4
309717|NCT01648790|740388|P4|COMPLETED|Treatment 2||4
309718|NCT01648790|740389|P3|COMPLETED|Treatment 2||4
309719|NCT01648790|740390|P2|COMPLETED|Treatment 2||4
309720|NCT01648790|740391|P1|COMPLETED|Treatment 2||4
309721|NCT01648790|740387|P5|STARTED|Treatment 2||4
309722|NCT01648790|740388|P4|STARTED|Treatment 2||4
309723|NCT01648790|740389|P3|STARTED|Treatment 2||4
309724|NCT01648790|740390|P2|STARTED|Treatment 2||4
309725|NCT01648790|740391|P1|STARTED|Treatment 2||4
309726|NCT01648790|740387|P5|NOT COMPLETED|Treatment 1||0
309727|NCT01648790|740388|P4|NOT COMPLETED|Treatment 1||0
309728|NCT01648790|740389|P3|NOT COMPLETED|Treatment 1||0
309729|NCT01648790|740390|P2|NOT COMPLETED|Treatment 1||0
309730|NCT01648790|740391|P1|NOT COMPLETED|Treatment 1||0
309731|NCT01648790|740387|P5|COMPLETED|Treatment 1||4
309732|NCT01648790|740388|P4|COMPLETED|Treatment 1||4
309733|NCT01648790|740389|P3|COMPLETED|Treatment 1||4
309734|NCT01648790|740390|P2|COMPLETED|Treatment 1||4
309735|NCT01648790|740391|P1|COMPLETED|Treatment 1||4
309736|NCT01648790|740387|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
309737|NCT01648790|740388|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
309738|NCT01648790|740389|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
309739|NCT01648790|740390|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
309740|NCT01648790|740391|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
309741|NCT01648790|740387|P5|STARTED|Treatment 1||4
309742|NCT01648790|740388|P4|STARTED|Treatment 1||4
309743|NCT01648790|740389|P3|STARTED|Treatment 1||4
309744|NCT01648790|740390|P2|STARTED|Treatment 1||4
309745|NCT01648790|740391|P1|STARTED|Treatment 1||4
309746|NCT01648699|740412|P1|NOT COMPLETED|Overall Study||5
309747|NCT01648699|740412|P1|COMPLETED|Overall Study||15
309748|NCT01648699|740412|P1|STARTED|Overall Study||20
309749|NCT01647542|740441|P3|NOT COMPLETED|Overall Study||72
309750|NCT01647542|740442|P2|NOT COMPLETED|Overall Study||73
309751|NCT01647542|740443|P1|NOT COMPLETED|Overall Study||76
309752|NCT01647542|740441|P3|COMPLETED|Overall Study||59
309753|NCT01647542|740442|P2|COMPLETED|Overall Study||58
309754|NCT01647542|740443|P1|COMPLETED|Overall Study||55
309755|NCT01647542|740441|P3|STARTED|Overall Study||131
309756|NCT01647542|740442|P2|STARTED|Overall Study||131
309757|NCT01647542|740443|P1|STARTED|Overall Study||131
309758|NCT01647464|740460|P1|NOT COMPLETED|Overall Study||0
309759|NCT01647464|740460|P1|COMPLETED|Overall Study||10
309760|NCT01647464|740460|P1|STARTED|Overall Study||10
309761|NCT01647438|740466|P2|NOT COMPLETED|Overall Study||0
309762|NCT01647438|740467|P1|NOT COMPLETED|Overall Study||0
309763|NCT01647438|740466|P2|COMPLETED|Overall Study||31
309764|NCT01647438|740467|P1|COMPLETED|Overall Study||32
309765|NCT01647438|740466|P2|STARTED|Overall Study||31
309766|NCT01647438|740467|P1|STARTED|Overall Study||32
309767|NCT01648582|740478|P3|NOT COMPLETED|Overall Study||32
309768|NCT01648582|740479|P2|NOT COMPLETED|Overall Study||38
309769|NCT01648582|740480|P1|NOT COMPLETED|Overall Study||32
309770|NCT01648582|740478|P3|COMPLETED|Overall Study||231
309771|NCT01648582|740479|P2|COMPLETED|Overall Study||225
309772|NCT01648582|740480|P1|COMPLETED|Overall Study||231
309773|NCT01648582|740478|P3|Modified Intent-to-Treat Population|Overall Study||254
309774|NCT01648582|740479|P2|Modified Intent-to-Treat Population|Overall Study||258
309775|NCT01648582|740480|P1|Modified Intent-to-Treat Population|Overall Study||258
309776|NCT01648582|740478|P3|Received at Least One Dose of Study Drug|Overall Study||257
309777|NCT01648582|740479|P2|Received at Least One Dose of Study Drug|Overall Study||263
309778|NCT01648582|740480|P1|Received at Least One Dose of Study Drug|Overall Study||263
309779|NCT01648582|740478|P3|STARTED|Overall Study||263
309780|NCT01648582|740479|P2|STARTED|Overall Study||263
309781|NCT01648582|740480|P1|STARTED|Overall Study||263
309782|NCT01648530|740549|P1|NOT COMPLETED|Overall Study||10874
309783|NCT01648530|740549|P1|COMPLETED|Overall Study||5915
309784|NCT01648530|740549|P1|STARTED|Overall Study||16789
309785|NCT01648491|740555|P1|NOT COMPLETED|Overall Study||0
309786|NCT01648491|740555|P1|COMPLETED|Overall Study||1
309787|NCT01648491|740555|P1|STARTED|Overall Study||1
309788|NCT01648452|740562|P1|NOT COMPLETED|Overall Study||0
309789|NCT01648452|740562|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
309790|NCT01648452|740562|P1|STARTED|Overall Study||5
309791|NCT01648140|740584|P4|NOT COMPLETED|Overall Study||2
309792|NCT01648140|740585|P3|NOT COMPLETED|Overall Study||8
309793|NCT01648140|740586|P2|NOT COMPLETED|Overall Study||12
309794|NCT01648140|740587|P1|NOT COMPLETED|Overall Study||12
309795|NCT01648140|740584|P4|COMPLETED|Overall Study||11
309796|NCT01648140|740585|P3|COMPLETED|Overall Study||9
309797|NCT01648140|740586|P2|COMPLETED|Overall Study||28
309798|NCT01648140|740587|P1|COMPLETED|Overall Study||29
309799|NCT01648140|740584|P4|STARTED|Overall Study||13
309800|NCT01648140|740585|P3|STARTED|Overall Study||17
309801|NCT01648140|740586|P2|STARTED|Overall Study||40
309802|NCT01648140|740587|P1|STARTED|Overall Study||41
309803|NCT01648101|740752|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
309804|NCT01648101|740753|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
309805|NCT01648101|740754|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
309806|NCT01648101|740752|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
309807|NCT01648101|740753|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
309808|NCT01648101|740754|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
309809|NCT01648101|740752|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
309810|NCT01648101|740753|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
309811|NCT01648101|740754|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
309812|NCT01648101|740752|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
309813|NCT01648101|740753|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
309814|NCT01648101|740754|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
309815|NCT01648101|740752|P3|COMPLETED|Transition Phase (4 Weeks)||5
309816|NCT01648101|740753|P2|COMPLETED|Transition Phase (4 Weeks)||13
309817|NCT01648101|740754|P1|COMPLETED|Transition Phase (4 Weeks)||12
309818|NCT01648101|740752|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
309819|NCT01648101|740753|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
309820|NCT01648101|740754|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
309821|NCT01648101|740752|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
309822|NCT01648101|740753|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
309823|NCT01648101|740754|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
309824|NCT01648101|740752|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
309825|NCT01648101|740753|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
309826|NCT01648101|740754|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
309827|NCT01648101|740752|P3|STARTED|Maintenance Phase (12 Weeks)||18
309828|NCT01648101|740753|P2|STARTED|Maintenance Phase (12 Weeks)||23
309829|NCT01648101|740754|P1|STARTED|Maintenance Phase (12 Weeks)||23
309830|NCT01648101|740752|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
309831|NCT01648101|740753|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
309832|NCT01648101|740754|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
309833|NCT01648101|740752|P3|COMPLETED|Titration Phase (4 Weeks)||18
309834|NCT01648101|740753|P2|COMPLETED|Titration Phase (4 Weeks)||23
309835|NCT01648101|740754|P1|COMPLETED|Titration Phase (4 Weeks)||23
309836|NCT01648101|740752|P3|STARTED|Titration Phase (4 Weeks)||24
309837|NCT01648101|740753|P2|STARTED|Titration Phase (4 Weeks)||26
309838|NCT01648101|740754|P1|STARTED|Titration Phase (4 Weeks)||25
309839|NCT01647945|740806|P4|NOT COMPLETED|Overall Study||1
309840|NCT01647945|740807|P3|NOT COMPLETED|Overall Study||2
309841|NCT01647945|740808|P2|NOT COMPLETED|Overall Study||0
309842|NCT01647945|740809|P1|NOT COMPLETED|Overall Study||0
309843|NCT01647945|740806|P4|COMPLETED|Overall Study||5
309844|NCT01647945|740807|P3|COMPLETED|Overall Study||3
309845|NCT01647945|740808|P2|COMPLETED|Overall Study||6
309846|NCT01647945|740809|P1|COMPLETED|Overall Study||6
309847|NCT01647945|740806|P4|STARTED|Overall Study||6
309848|NCT01647945|740807|P3|STARTED|Overall Study||5
309849|NCT01647945|740808|P2|STARTED|Overall Study||6
309850|NCT01647945|740809|P1|STARTED|Overall Study||6
309851|NCT01647737|740829|P2|NOT COMPLETED|Overall Study||5
309852|NCT01647737|740830|P1|NOT COMPLETED|Overall Study||4
309853|NCT01647737|740829|P2|COMPLETED|Overall Study||25
309854|NCT01647737|740830|P1|COMPLETED|Overall Study||26
309855|NCT01647737|740829|P2|STARTED|Overall Study||30
309856|NCT01647737|740830|P1|STARTED|Overall Study||30
309857|NCT01647711|740841|P5|NOT COMPLETED|Overall Study||6
309858|NCT01647711|740842|P4|NOT COMPLETED|Overall Study||11
309859|NCT01647711|740843|P3|NOT COMPLETED|Overall Study||9
309860|NCT01647711|740844|P2|NOT COMPLETED|Overall Study||3
309861|NCT01647711|740845|P1|NOT COMPLETED|Overall Study||6
309862|NCT01647711|740841|P5|COMPLETED|Overall Study||0
309863|NCT01647711|740842|P4|COMPLETED|Overall Study||0
309864|NCT01647711|740843|P3|COMPLETED|Overall Study||0
309865|NCT01647711|740844|P2|COMPLETED|Overall Study||0
309866|NCT01647711|740845|P1|COMPLETED|Overall Study||0
309867|NCT01647711|740841|P5|STARTED|Overall Study||6
309868|NCT01647711|740842|P4|STARTED|Overall Study||11
309869|NCT01647711|740843|P3|STARTED|Overall Study||9
309870|NCT01647711|740844|P2|STARTED|Overall Study||3
309871|NCT01647711|740845|P1|STARTED|Overall Study||6
309872|NCT01646827|740872|P2|NOT COMPLETED|Overall Study||5
309873|NCT01646827|740873|P1|NOT COMPLETED|Overall Study||2
309874|NCT01646827|740872|P2|COMPLETED|Overall Study||14
309875|NCT01646827|740873|P1|COMPLETED|Overall Study||16
309876|NCT01646827|740872|P2|STARTED|Overall Study||19
309877|NCT01646827|740873|P1|STARTED|Overall Study||18
309878|NCT01646814|740903|P2|NOT COMPLETED|Overall Study||6
309879|NCT01646814|740904|P1|NOT COMPLETED|Overall Study||11
309880|NCT01646814|740903|P2|COMPLETED|Overall Study||120
309881|NCT01646814|740904|P1|COMPLETED|Overall Study||110
309882|NCT01646814|740903|P2|STARTED|Overall Study||126
309883|NCT01646814|740904|P1|STARTED|Overall Study||121
309884|NCT01646671|740913|P3|NOT COMPLETED|Overall Study||0
309885|NCT01646671|740914|P2|NOT COMPLETED|Overall Study||0
309886|NCT01646671|740915|P1|NOT COMPLETED|Overall Study||0
309887|NCT01646671|740913|P3|COMPLETED|Overall Study||21
309888|NCT01646671|740914|P2|COMPLETED|Overall Study||11
309889|NCT01646671|740915|P1|COMPLETED|Overall Study||3
309890|NCT01646671|740913|P3|STARTED|Overall Study||21
309891|NCT01646671|740914|P2|STARTED|Overall Study||11
309892|NCT01646671|740915|P1|STARTED|Overall Study||3
309893|NCT01646398|740951|P2|NOT COMPLETED|Overall Study||0
309894|NCT01646398|740952|P1|NOT COMPLETED|Overall Study||1
309895|NCT01646398|740951|P2|COMPLETED|Overall Study||382
309896|NCT01646398|740952|P1|COMPLETED|Overall Study||381
309897|NCT01646398|740951|P2|STARTED|Overall Study||382
309898|NCT01646398|740952|P1|STARTED|Overall Study||382
309899|NCT01646385|740968|P2|NOT COMPLETED|Overall Study||871
309900|NCT01646385|740969|P1|NOT COMPLETED|Overall Study||838
309901|NCT01646385|740968|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
309902|NCT01646385|740969|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
309903|NCT01646385|740968|P2|STARTED|Overall Study||2864
309904|NCT01646385|740969|P1|STARTED|Overall Study||3529
309905|NCT01646320|741002|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
309906|NCT01646320|741003|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
309907|NCT01646320|741002|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
309908|NCT01646320|741003|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
309909|NCT01646320|741002|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
309910|NCT01646320|741003|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
309911|NCT01646320|741002|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
309912|NCT01646320|741003|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
309913|NCT01646320|741002|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
309914|NCT01646320|741003|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
309915|NCT01646320|741002|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
309916|NCT01646320|741003|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
309917|NCT01646268|741019|P2|NOT COMPLETED|Overall Study||16
309918|NCT01646268|741020|P1|NOT COMPLETED|Overall Study||11
309919|NCT01646268|741019|P2|COMPLETED|Overall Study||107
309920|NCT01646268|741020|P1|COMPLETED|Overall Study||113
309921|NCT01646268|741019|P2|STARTED|Overall Study||123
309922|NCT01646268|741020|P1|STARTED|Overall Study||124
309923|NCT01646255|741034|P2|NOT COMPLETED|Overall Study||14
309924|NCT01646255|741035|P1|NOT COMPLETED|Overall Study||21
309925|NCT01646255|741034|P2|COMPLETED|Overall Study||160
309926|NCT01646255|741035|P1|COMPLETED|Overall Study||151
309927|NCT01646255|741034|P2|STARTED|Overall Study||174
309928|NCT01646255|741035|P1|STARTED|Overall Study||172
309929|NCT01646177|741069|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
309930|NCT01646177|741070|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
309931|NCT01646177|741071|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
309932|NCT01646177|741072|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
309933|NCT01646177|741069|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309934|NCT01646177|741070|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309935|NCT01646177|741071|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309936|NCT01646177|741072|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309937|NCT01646177|741069|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309938|NCT01646177|741070|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309939|NCT01646177|741071|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309940|NCT01646177|741072|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
309941|NCT01646177|741069|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
309942|NCT01646177|741070|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
309943|NCT01646177|741071|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
309944|NCT01646177|741072|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
309945|NCT01646177|741069|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
309946|NCT01646177|741070|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
309947|NCT01646177|741071|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
309948|NCT01646177|741072|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
309949|NCT01646177|741069|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
309950|NCT01646177|741070|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
309951|NCT01646177|741071|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
309952|NCT01646177|741072|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
309953|NCT01646151|741150|P1|NOT COMPLETED|Overall Study||170
309954|NCT01646151|741150|P1|COMPLETED|Overall Study||2410
309955|NCT01646151|741150|P1|STARTED|Overall Study||2580
309956|NCT01646138|741166|P5|NOT COMPLETED|Overall Study||2
309957|NCT01646138|741167|P4|NOT COMPLETED|Overall Study||0
309958|NCT01646138|741168|P3|NOT COMPLETED|Overall Study||0
309959|NCT01646138|741169|P2|NOT COMPLETED|Overall Study||0
309960|NCT01646138|741170|P1|NOT COMPLETED|Overall Study||0
309961|NCT01646138|741166|P5|COMPLETED|Overall Study||13
309962|NCT01646138|741167|P4|COMPLETED|Overall Study||19
309963|NCT01646138|741168|P3|COMPLETED|Overall Study||5
309964|NCT01646138|741169|P2|COMPLETED|Overall Study||4
309965|NCT01646138|741170|P1|COMPLETED|Overall Study||5
309966|NCT01646138|741166|P5|STARTED|Overall Study||15
309967|NCT01646138|741167|P4|STARTED|Overall Study||19
309968|NCT01646138|741168|P3|STARTED|Overall Study||5
309969|NCT01646138|741169|P2|STARTED|Overall Study||4
309970|NCT01646138|741170|P1|STARTED|Overall Study||5
309971|NCT01646125|741184|P2|NOT COMPLETED|Overall Study||28
309972|NCT01646125|741185|P1|NOT COMPLETED|Overall Study||31
309973|NCT01646125|741184|P2|COMPLETED|Overall Study||0
309974|NCT01646125|741185|P1|COMPLETED|Overall Study||0
309975|NCT01646125|741184|P2|STARTED|Overall Study||28
309976|NCT01646125|741185|P1|STARTED|Overall Study||31
309977|NCT01646073|741210|P2|NOT COMPLETED|Period B (12 Weeks)||13
309978|NCT01646073|741211|P1|NOT COMPLETED|Period B (12 Weeks)||1
309979|NCT01646073|741210|P2|COMPLETED|Period B (12 Weeks)||320
309980|NCT01646073|741211|P1|COMPLETED|Period B (12 Weeks)||84
309981|NCT01646073|741210|P2|STARTED|Period B (12 Weeks)||333
309982|NCT01646073|741211|P1|STARTED|Period B (12 Weeks)||85
309983|NCT01646073|741210|P2|NOT COMPLETED|Period A (12 Weeks)||5
309984|NCT01646073|741211|P1|NOT COMPLETED|Period A (12 Weeks)||2
309985|NCT01646073|741210|P2|COMPLETED|Period A (12 Weeks)||333
309986|NCT01646073|741211|P1|COMPLETED|Period A (12 Weeks)||85
309987|NCT01646073|741210|P2|STARTED|Period A (12 Weeks)||338
309988|NCT01646073|741211|P1|STARTED|Period A (12 Weeks)||87
309989|NCT01646021|741252|P2|NOT COMPLETED|Overall Study||78
309990|NCT01646021|741253|P1|NOT COMPLETED|Overall Study||66
309991|NCT01646021|741252|P2|COMPLETED|Overall Study||63
309992|NCT01646021|741253|P1|COMPLETED|Overall Study||73
309993|NCT01646021|741252|P2|Received Treatment|Overall Study||139
309994|NCT01646021|741253|P1|Received Treatment|Overall Study||139
309995|NCT01646021|741252|P2|STARTED|Overall Study||141
309996|NCT01646021|741253|P1|STARTED|Overall Study||139
309997|NCT01645735|741286|P2|NOT COMPLETED|Overall Study||1
309998|NCT01645735|741287|P1|NOT COMPLETED|Overall Study||4
309999|NCT01645735|741286|P2|COMPLETED|Overall Study||16
310000|NCT01645735|741287|P1|COMPLETED|Overall Study||28
310001|NCT01645735|741286|P2|STARTED|Overall Study||17
310002|NCT01645735|741287|P1|STARTED|Overall Study||32
310003|NCT01645709|741301|P2|NOT COMPLETED|Overall Study||0
310004|NCT01645709|741302|P1|NOT COMPLETED|Overall Study||0
310005|NCT01645709|741301|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
310006|NCT01645709|741302|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
310007|NCT01645709|741301|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
310008|NCT01645709|741302|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
310009|NCT01645280|741329|P5|NOT COMPLETED|Overall Study||8
310010|NCT01645280|741330|P4|NOT COMPLETED|Overall Study||6
310011|NCT01645280|741331|P3|NOT COMPLETED|Overall Study||6
310012|NCT01645280|741332|P2|NOT COMPLETED|Overall Study||3
310013|NCT01645280|741333|P1|NOT COMPLETED|Overall Study||6
310014|NCT01645280|741329|P5|COMPLETED|Overall Study||47
310015|NCT01645280|741330|P4|COMPLETED|Overall Study||48
310016|NCT01645280|741331|P3|COMPLETED|Overall Study||49
310017|NCT01645280|741332|P2|COMPLETED|Overall Study||51
310018|NCT01645280|741333|P1|COMPLETED|Overall Study||49
310019|NCT01645280|741329|P5|STARTED|Overall Study||55
310020|NCT01645280|741330|P4|STARTED|Overall Study||54
310021|NCT01645280|741331|P3|STARTED|Overall Study||55
310022|NCT01645280|741332|P2|STARTED|Overall Study||54
310023|NCT01645280|741333|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
310024|NCT01645176|741361|P1|NOT COMPLETED|Overall Study||5
310025|NCT01645176|741361|P1|COMPLETED|Overall Study||16
310026|NCT01645176|741361|P1|STARTED|Overall Study||21
310027|NCT01645111|741365|P1|NOT COMPLETED|Overall Study||15
310028|NCT01645111|741365|P1|COMPLETED|Overall Study||35
310029|NCT01645111|741365|P1|STARTED|Overall Study||50
310030|NCT01645098|741371|P2|NOT COMPLETED|Overall Study||0
310031|NCT01645098|741372|P1|NOT COMPLETED|Overall Study||0
310032|NCT01645098|741371|P2|COMPLETED|Overall Study||29
310033|NCT01645098|741372|P1|COMPLETED|Overall Study||24
310034|NCT01645098|741371|P2|STARTED|Overall Study||29
310035|NCT01645098|741372|P1|STARTED|Overall Study||24
310036|NCT01645059|741386|P1|NOT COMPLETED|Overall Study||0
310037|NCT01645059|741386|P1|COMPLETED|Overall Study||129
310038|NCT01645059|741386|P1|STARTED|Overall Study||129
310039|NCT01644734|741404|P1|NOT COMPLETED|Overall Study||266
310040|NCT01644734|741404|P1|COMPLETED|Overall Study||1016
310041|NCT01644734|741404|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
310042|NCT01644695|741409|P1|NOT COMPLETED|Overall Study||0
310043|NCT01644695|741409|P1|COMPLETED|Overall Study||85
310044|NCT01644695|741409|P1|STARTED|Overall Study||85
310045|NCT01644643|741418|P4|NOT COMPLETED|Overall Study||10
310046|NCT01644643|741419|P3|NOT COMPLETED|Overall Study||5
310047|NCT01644643|741420|P2|NOT COMPLETED|Overall Study||0
310048|NCT01644643|741421|P1|NOT COMPLETED|Overall Study||2
310049|NCT01644643|741418|P4|COMPLETED|Overall Study||143
310050|NCT01644643|741419|P3|COMPLETED|Overall Study||148
310051|NCT01644643|741420|P2|COMPLETED|Overall Study||12
310052|NCT01644643|741421|P1|COMPLETED|Overall Study||13
310053|NCT01644643|741418|P4|STARTED|Overall Study||153
310054|NCT01644643|741419|P3|STARTED|Overall Study||153
310055|NCT01644643|741420|P2|STARTED|Overall Study||12
310056|NCT01644643|741421|P1|STARTED|Overall Study||15
310057|NCT01644617|741586|P3|NOT COMPLETED|Overall Study||7
310058|NCT01644617|741587|P2|NOT COMPLETED|Overall Study||5
310059|NCT01644617|741588|P1|NOT COMPLETED|Overall Study||6
310060|NCT01644617|741586|P3|COMPLETED|Overall Study||34
310061|NCT01644617|741587|P2|COMPLETED|Overall Study||36
310062|NCT01644617|741588|P1|COMPLETED|Overall Study||36
310063|NCT01644617|741586|P3|STARTED|Overall Study||41
310064|NCT01644617|741587|P2|STARTED|Overall Study||41
310065|NCT01644617|741588|P1|STARTED|Overall Study||42
310066|NCT01643525|741638|P1|NOT COMPLETED|Overall Study||0
310067|NCT01643525|741638|P1|COMPLETED|Overall Study||29
310068|NCT01643525|741638|P1|STARTED|Overall Study||29
310069|NCT01644500|741645|P3|NOT COMPLETED|Overall Study||18
310070|NCT01644500|741646|P2|NOT COMPLETED|Overall Study||28
310071|NCT01644500|741647|P1|NOT COMPLETED|Overall Study||24
310072|NCT01644500|741645|P3|COMPLETED|Overall Study||253
310073|NCT01644500|741646|P2|COMPLETED|Overall Study||240
310074|NCT01644500|741647|P1|COMPLETED|Overall Study||244
310075|NCT01644500|741645|P3|Modified Intent-to-treat Population|Overall Study||268
310076|NCT01644500|741646|P2|Modified Intent-to-treat Population|Overall Study||259
310077|NCT01644500|741647|P1|Modified Intent-to-treat Population|Overall Study||263
310078|NCT01644500|741645|P3|Received at Least One Dose of Study Drug|Overall Study||269
310079|NCT01644500|741646|P2|Received at Least One Dose of Study Drug|Overall Study||268
310080|NCT01644500|741647|P1|Received at Least One Dose of Study Drug|Overall Study||268
310081|NCT01644500|741645|P3|STARTED|Overall Study||271
310082|NCT01644500|741646|P2|STARTED|Overall Study||268
310083|NCT01644500|741647|P1|STARTED|Overall Study||268
310084|NCT01644474|741717|P2|NOT COMPLETED|Overall Study||8
310085|NCT01644474|741718|P1|NOT COMPLETED|Overall Study||7
310086|NCT01644474|741717|P2|COMPLETED|Overall Study||44
310087|NCT01644474|741718|P1|COMPLETED|Overall Study||44
310088|NCT01644474|741717|P2|Treated|Overall Study||52
310089|NCT01644474|741718|P1|Treated|Overall Study||51
310090|NCT01644474|741717|P2|STARTED|Overall Study|Randomized|52
310091|NCT01644474|741718|P1|STARTED|Overall Study|Randomized|51
310092|NCT01644396|741758|P1|NOT COMPLETED|Overall Study||0
310093|NCT01644396|741758|P1|COMPLETED|Overall Study||50
310094|NCT01644396|741758|P1|STARTED|Overall Study||50
310095|NCT01644331|741802|P2|NOT COMPLETED|Overall Study||10
310096|NCT01644331|741803|P1|NOT COMPLETED|Overall Study||11
310097|NCT01644331|741802|P2|COMPLETED|Overall Study||118
310098|NCT01644331|741803|P1|COMPLETED|Overall Study||118
310099|NCT01644331|741802|P2|STARTED|Overall Study||128
310100|NCT01644331|741803|P1|STARTED|Overall Study||129
310101|NCT01644292|741835|P1|NOT COMPLETED|Overall Study||0
310102|NCT01644292|741835|P1|COMPLETED|Overall Study||2
310103|NCT01644292|741835|P1|STARTED|Overall Study||2
310104|NCT01644188|741841|P2|NOT COMPLETED|Overall Study||75
310105|NCT01644188|741842|P1|NOT COMPLETED|Overall Study||122
310106|NCT01644188|741841|P2|COMPLETED|Overall Study||166
310107|NCT01644188|741842|P1|COMPLETED|Overall Study||357
310108|NCT01644188|741841|P2|Treated|Overall Study||241
310109|NCT01644188|741842|P1|Treated|Overall Study||479
310110|NCT01644188|741841|P2|STARTED|Overall Study|Randomized|241
310111|NCT01644188|741842|P1|STARTED|Overall Study|Randomized|479
310112|NCT01644175|741900|P2|NOT COMPLETED|Overall Study||53
310113|NCT01644175|741901|P1|NOT COMPLETED|Overall Study||32
310114|NCT01644175|741900|P2|COMPLETED|Overall Study||156
310115|NCT01644175|741901|P1|COMPLETED|Overall Study||75
310116|NCT01644175|741900|P2|Treated|Overall Study||207
310117|NCT01644175|741901|P1|Treated|Overall Study||107
310118|NCT01644175|741900|P2|STARTED|Overall Study|Randomized|209
310119|NCT01644175|741901|P1|STARTED|Overall Study|Randomized|107
310120|NCT01644058|741951|P1|NOT COMPLETED|Overall Study||0
310121|NCT01644058|741951|P1|COMPLETED|Overall Study||18
310122|NCT01644058|741951|P1|STARTED|Overall Study||18
310123|NCT01643928|741961|P5|NOT COMPLETED|Overall Study||2
310124|NCT01643928|741962|P4|NOT COMPLETED|Overall Study||3
310125|NCT01643928|741963|P3|NOT COMPLETED|Overall Study||3
310126|NCT01643928|741964|P2|NOT COMPLETED|Overall Study||2
310127|NCT01643928|741965|P1|NOT COMPLETED|Overall Study||10
310128|NCT01643928|741961|P5|COMPLETED|Overall Study||28
310129|NCT01643928|741962|P4|COMPLETED|Overall Study||27
310130|NCT01643928|741963|P3|COMPLETED|Overall Study||30
310131|NCT01643928|741964|P2|COMPLETED|Overall Study||30
310132|NCT01643928|741965|P1|COMPLETED|Overall Study||48
310133|NCT01643928|741961|P5|STARTED|Overall Study||30
310134|NCT01643928|741962|P4|STARTED|Overall Study||30
310135|NCT01643928|741963|P3|STARTED|Overall Study||33
310136|NCT01643928|741964|P2|STARTED|Overall Study||32
310137|NCT01643928|741965|P1|STARTED|Overall Study||58
310138|NCT01643902|742250|P1|NOT COMPLETED|Overall Study||0
310139|NCT01643902|742250|P1|COMPLETED|Overall Study||20
310140|NCT01643902|742250|P1|STARTED|Overall Study||20
310141|NCT01643876|742255|P1|NOT COMPLETED|Overall Study||0
310142|NCT01643876|742255|P1|COMPLETED|Overall Study||48
310143|NCT01643876|742255|P1|STARTED|Overall Study||48
310144|NCT01643798|742260|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
310145|NCT01643798|742261|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
310146|NCT01643798|742260|P2|COMPLETED|Pretreatment 2 and Stimulation||8
310147|NCT01643798|742261|P1|COMPLETED|Pretreatment 2 and Stimulation||6
310148|NCT01643798|742260|P2|STARTED|Pretreatment 2 and Stimulation||8
310149|NCT01643798|742261|P1|STARTED|Pretreatment 2 and Stimulation||6
310150|NCT01643798|742260|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
310151|NCT01643798|742261|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
310152|NCT01643798|742260|P2|COMPLETED|Pretreatment 1 and Stimulation||8
310153|NCT01643798|742261|P1|COMPLETED|Pretreatment 1 and Stimulation||6
310154|NCT01643798|742260|P2|STARTED|Pretreatment 1 and Stimulation||8
310155|NCT01643798|742261|P1|STARTED|Pretreatment 1 and Stimulation||7
310156|NCT01643616|742274|P2|NOT COMPLETED|Overall Study||0
310157|NCT01643616|742275|P1|NOT COMPLETED|Overall Study||0
310158|NCT01643616|742274|P2|COMPLETED|Overall Study||125
310159|NCT01643616|742275|P1|COMPLETED|Overall Study||125
310160|NCT01643616|742274|P2|STARTED|Overall Study||125
310161|NCT01643616|742275|P1|STARTED|Overall Study||125
310162|NCT01643213|742287|P2|NOT COMPLETED|Overall Study||0
310163|NCT01643213|742288|P1|NOT COMPLETED|Overall Study||1
310164|NCT01643213|742287|P2|COMPLETED|Overall Study||14
310165|NCT01643213|742288|P1|COMPLETED|Overall Study||12
310166|NCT01643213|742287|P2|STARTED|Overall Study||14
310167|NCT01643213|742288|P1|STARTED|Overall Study||13
310168|NCT01643044|742296|P2|NOT COMPLETED|Overall Study||5
310169|NCT01643044|742297|P1|NOT COMPLETED|Overall Study||4
310170|NCT01643044|742296|P2|COMPLETED|Overall Study||19
310171|NCT01643044|742297|P1|COMPLETED|Overall Study||20
310172|NCT01643044|742296|P2|STARTED|Overall Study||24
310173|NCT01643044|742297|P1|STARTED|Overall Study||24
310174|NCT01642914|742306|P3|NOT COMPLETED|Overall Study||40
310175|NCT01642914|742307|P2|NOT COMPLETED|Overall Study||32
310176|NCT01642914|742308|P1|NOT COMPLETED|Overall Study||46
310177|NCT01642914|742306|P3|COMPLETED|Overall Study||120
310178|NCT01642914|742307|P2|COMPLETED|Overall Study||122
310179|NCT01642914|742308|P1|COMPLETED|Overall Study||127
310180|NCT01642914|742306|P3|STARTED|Overall Study||160
310181|NCT01642914|742307|P2|STARTED|Overall Study||154
310182|NCT01642914|742308|P1|STARTED|Overall Study||173
310183|NCT01642732|742383|P1|NOT COMPLETED|Overall Study||1
310184|NCT01642732|742383|P1|COMPLETED|Overall Study||0
310185|NCT01642732|742383|P1|STARTED|Overall Study||1
310186|NCT01642615|742388|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
310187|NCT01642615|742389|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
310188|NCT01642615|742390|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
310189|NCT01642615|742388|P3|COMPLETED|Double Blind Maintenance Phase||20
310190|NCT01642615|742389|P2|COMPLETED|Double Blind Maintenance Phase||18
310191|NCT01642615|742390|P1|COMPLETED|Double Blind Maintenance Phase||0
310192|NCT01642615|742388|P3|STARTED|Double Blind Maintenance Phase||26
310193|NCT01642615|742389|P2|STARTED|Double Blind Maintenance Phase||25
310194|NCT01642615|742390|P1|STARTED|Double Blind Maintenance Phase||0
310195|NCT01642615|742388|P3|NOT COMPLETED|Open Label Maintenance Phase||0
310196|NCT01642615|742389|P2|NOT COMPLETED|Open Label Maintenance Phase||0
310197|NCT01642615|742390|P1|NOT COMPLETED|Open Label Maintenance Phase||5
310198|NCT01642615|742388|P3|COMPLETED|Open Label Maintenance Phase||0
310199|NCT01642615|742389|P2|COMPLETED|Open Label Maintenance Phase||0
310200|NCT01642615|742390|P1|COMPLETED|Open Label Maintenance Phase||58
310201|NCT01642615|742388|P3|Safety Analysis Set|Open Label Maintenance Phase||0
310202|NCT01642615|742389|P2|Safety Analysis Set|Open Label Maintenance Phase||0
310203|NCT01642615|742390|P1|Safety Analysis Set|Open Label Maintenance Phase||62
310204|NCT01642615|742388|P3|STARTED|Open Label Maintenance Phase||0
310205|NCT01642615|742389|P2|STARTED|Open Label Maintenance Phase||0
310206|NCT01642615|742390|P1|STARTED|Open Label Maintenance Phase||63
310207|NCT01642602|742404|P1|NOT COMPLETED|Overall Study||2
310208|NCT01642602|742404|P1|COMPLETED|Overall Study||102
310209|NCT01642602|742404|P1|STARTED|Overall Study||104
310210|NCT01642589|742411|P2|NOT COMPLETED|Overall Study||1
310211|NCT01642589|742412|P1|NOT COMPLETED|Overall Study||1
310212|NCT01642589|742411|P2|COMPLETED|Overall Study||99
310213|NCT01642589|742412|P1|COMPLETED|Overall Study||199
310214|NCT01642589|742411|P2|STARTED|Overall Study||100
310215|NCT01642589|742412|P1|STARTED|Overall Study||200
310216|NCT01642485|742426|P8|NOT COMPLETED|Period 2, Day 3||0
310217|NCT01642485|742427|P7|NOT COMPLETED|Period 2, Day 3||0
310218|NCT01642485|742428|P6|NOT COMPLETED|Period 2, Day 3||0
310219|NCT01642485|742429|P5|NOT COMPLETED|Period 2, Day 3||0
310220|NCT01642485|742430|P4|NOT COMPLETED|Period 2, Day 3||0
310221|NCT01642485|742431|P3|NOT COMPLETED|Period 2, Day 3||0
310222|NCT01642485|742432|P2|NOT COMPLETED|Period 2, Day 3||0
310223|NCT01642485|742433|P1|NOT COMPLETED|Period 2, Day 3||0
310224|NCT01642485|742426|P8|COMPLETED|Period 2, Day 3||4
310225|NCT01642485|742427|P7|COMPLETED|Period 2, Day 3||4
310226|NCT01642485|742428|P6|COMPLETED|Period 2, Day 3||4
310227|NCT01642485|742429|P5|COMPLETED|Period 2, Day 3||4
310228|NCT01642485|742430|P4|COMPLETED|Period 2, Day 3||4
310229|NCT01642485|742431|P3|COMPLETED|Period 2, Day 3||4
310230|NCT01642485|742432|P2|COMPLETED|Period 2, Day 3||4
310231|NCT01642485|742433|P1|COMPLETED|Period 2, Day 3||4
310232|NCT01642485|742426|P8|STARTED|Period 2, Day 3||4
310233|NCT01642485|742427|P7|STARTED|Period 2, Day 3||4
310234|NCT01642485|742428|P6|STARTED|Period 2, Day 3||4
310235|NCT01642485|742429|P5|STARTED|Period 2, Day 3||4
310236|NCT01642485|742430|P4|STARTED|Period 2, Day 3||4
310237|NCT01642485|742431|P3|STARTED|Period 2, Day 3||4
310238|NCT01642485|742432|P2|STARTED|Period 2, Day 3||4
310239|NCT01642485|742433|P1|STARTED|Period 2, Day 3||4
310240|NCT01642485|742426|P8|NOT COMPLETED|Period 2, Day 2||0
310241|NCT01642485|742427|P7|NOT COMPLETED|Period 2, Day 2||0
310242|NCT01642485|742428|P6|NOT COMPLETED|Period 2, Day 2||0
310243|NCT01642485|742429|P5|NOT COMPLETED|Period 2, Day 2||0
310244|NCT01642485|742430|P4|NOT COMPLETED|Period 2, Day 2||0
310245|NCT01642485|742431|P3|NOT COMPLETED|Period 2, Day 2||0
310246|NCT01642485|742432|P2|NOT COMPLETED|Period 2, Day 2||0
310247|NCT01642485|742433|P1|NOT COMPLETED|Period 2, Day 2||0
310248|NCT01642485|742426|P8|COMPLETED|Period 2, Day 2||4
310249|NCT01642485|742427|P7|COMPLETED|Period 2, Day 2||4
310250|NCT01642485|742428|P6|COMPLETED|Period 2, Day 2||4
310251|NCT01642485|742429|P5|COMPLETED|Period 2, Day 2||4
310252|NCT01642485|742430|P4|COMPLETED|Period 2, Day 2||4
310253|NCT01642485|742431|P3|COMPLETED|Period 2, Day 2||4
310254|NCT01642485|742432|P2|COMPLETED|Period 2, Day 2||4
310255|NCT01642485|742433|P1|COMPLETED|Period 2, Day 2||4
310256|NCT01642485|742426|P8|STARTED|Period 2, Day 2||4
310257|NCT01642485|742427|P7|STARTED|Period 2, Day 2||4
310258|NCT01642485|742428|P6|STARTED|Period 2, Day 2||4
310259|NCT01642485|742429|P5|STARTED|Period 2, Day 2||4
310260|NCT01642485|742430|P4|STARTED|Period 2, Day 2||4
310261|NCT01642485|742431|P3|STARTED|Period 2, Day 2||4
310262|NCT01642485|742432|P2|STARTED|Period 2, Day 2||4
310263|NCT01642485|742433|P1|STARTED|Period 2, Day 2||4
310264|NCT01642485|742426|P8|NOT COMPLETED|Period 2, Day 1||0
310265|NCT01642485|742427|P7|NOT COMPLETED|Period 2, Day 1||0
310266|NCT01642485|742428|P6|NOT COMPLETED|Period 2, Day 1||0
310267|NCT01642485|742429|P5|NOT COMPLETED|Period 2, Day 1||0
310268|NCT01642485|742430|P4|NOT COMPLETED|Period 2, Day 1||0
310269|NCT01642485|742431|P3|NOT COMPLETED|Period 2, Day 1||0
310270|NCT01642485|742432|P2|NOT COMPLETED|Period 2, Day 1||0
310271|NCT01642485|742433|P1|NOT COMPLETED|Period 2, Day 1||0
310272|NCT01642485|742426|P8|COMPLETED|Period 2, Day 1||4
310273|NCT01642485|742427|P7|COMPLETED|Period 2, Day 1||4
310274|NCT01642485|742428|P6|COMPLETED|Period 2, Day 1||4
310275|NCT01642485|742429|P5|COMPLETED|Period 2, Day 1||4
310276|NCT01642485|742430|P4|COMPLETED|Period 2, Day 1||4
310277|NCT01642485|742431|P3|COMPLETED|Period 2, Day 1||4
310278|NCT01642485|742432|P2|COMPLETED|Period 2, Day 1||4
310279|NCT01642485|742433|P1|COMPLETED|Period 2, Day 1||4
310280|NCT01642485|742426|P8|STARTED|Period 2, Day 1||4
310281|NCT01642485|742427|P7|STARTED|Period 2, Day 1||4
310282|NCT01642485|742428|P6|STARTED|Period 2, Day 1||4
310283|NCT01642485|742429|P5|STARTED|Period 2, Day 1||4
310284|NCT01642485|742430|P4|STARTED|Period 2, Day 1||4
310285|NCT01642485|742431|P3|STARTED|Period 2, Day 1||4
310286|NCT01642485|742432|P2|STARTED|Period 2, Day 1||4
310287|NCT01642485|742433|P1|STARTED|Period 2, Day 1||4
310288|NCT01642485|742426|P8|NOT COMPLETED|Period 1, Day 3||0
310289|NCT01642485|742427|P7|NOT COMPLETED|Period 1, Day 3||0
310290|NCT01642485|742428|P6|NOT COMPLETED|Period 1, Day 3||0
310291|NCT01642485|742429|P5|NOT COMPLETED|Period 1, Day 3||0
310292|NCT01642485|742430|P4|NOT COMPLETED|Period 1, Day 3||0
310293|NCT01642485|742431|P3|NOT COMPLETED|Period 1, Day 3||0
310294|NCT01642485|742432|P2|NOT COMPLETED|Period 1, Day 3||0
310295|NCT01642485|742433|P1|NOT COMPLETED|Period 1, Day 3||0
310296|NCT01642485|742426|P8|COMPLETED|Period 1, Day 3||4
310297|NCT01642485|742427|P7|COMPLETED|Period 1, Day 3||4
310298|NCT01642485|742428|P6|COMPLETED|Period 1, Day 3||4
310299|NCT01642485|742429|P5|COMPLETED|Period 1, Day 3||4
310300|NCT01642485|742430|P4|COMPLETED|Period 1, Day 3||4
310301|NCT01642485|742431|P3|COMPLETED|Period 1, Day 3||4
310302|NCT01642485|742432|P2|COMPLETED|Period 1, Day 3||4
310303|NCT01642485|742433|P1|COMPLETED|Period 1, Day 3||4
310304|NCT01642485|742426|P8|STARTED|Period 1, Day 3||4
310305|NCT01642485|742427|P7|STARTED|Period 1, Day 3||4
310306|NCT01642485|742428|P6|STARTED|Period 1, Day 3||4
310307|NCT01642485|742429|P5|STARTED|Period 1, Day 3||4
310308|NCT01642485|742430|P4|STARTED|Period 1, Day 3||4
310309|NCT01642485|742431|P3|STARTED|Period 1, Day 3||4
310310|NCT01642485|742432|P2|STARTED|Period 1, Day 3||4
310311|NCT01642485|742433|P1|STARTED|Period 1, Day 3||4
310312|NCT01642485|742426|P8|NOT COMPLETED|Period 1, Day 2||0
310313|NCT01642485|742427|P7|NOT COMPLETED|Period 1, Day 2||0
310314|NCT01642485|742428|P6|NOT COMPLETED|Period 1, Day 2||0
310315|NCT01642485|742429|P5|NOT COMPLETED|Period 1, Day 2||0
310316|NCT01642485|742430|P4|NOT COMPLETED|Period 1, Day 2||0
310317|NCT01642485|742431|P3|NOT COMPLETED|Period 1, Day 2||0
310318|NCT01642485|742432|P2|NOT COMPLETED|Period 1, Day 2||0
310319|NCT01642485|742433|P1|NOT COMPLETED|Period 1, Day 2||0
310320|NCT01642485|742426|P8|COMPLETED|Period 1, Day 2||4
310321|NCT01642485|742427|P7|COMPLETED|Period 1, Day 2||4
310322|NCT01642485|742428|P6|COMPLETED|Period 1, Day 2||4
310323|NCT01642485|742429|P5|COMPLETED|Period 1, Day 2||4
310324|NCT01642485|742430|P4|COMPLETED|Period 1, Day 2||4
310325|NCT01642485|742431|P3|COMPLETED|Period 1, Day 2||4
310326|NCT01642485|742432|P2|COMPLETED|Period 1, Day 2||4
310327|NCT01642485|742433|P1|COMPLETED|Period 1, Day 2||4
310328|NCT01642485|742426|P8|STARTED|Period 1, Day 2||4
310329|NCT01642485|742427|P7|STARTED|Period 1, Day 2||4
310330|NCT01642485|742428|P6|STARTED|Period 1, Day 2||4
310331|NCT01642485|742429|P5|STARTED|Period 1, Day 2||4
310332|NCT01642485|742430|P4|STARTED|Period 1, Day 2||4
310333|NCT01642485|742431|P3|STARTED|Period 1, Day 2||4
310334|NCT01642485|742432|P2|STARTED|Period 1, Day 2||4
310335|NCT01642485|742433|P1|STARTED|Period 1, Day 2||4
310336|NCT01642485|742426|P8|NOT COMPLETED|Period 1, Day 1||0
310337|NCT01642485|742427|P7|NOT COMPLETED|Period 1, Day 1||0
310338|NCT01642485|742428|P6|NOT COMPLETED|Period 1, Day 1||0
310339|NCT01642485|742429|P5|NOT COMPLETED|Period 1, Day 1||0
310340|NCT01642485|742430|P4|NOT COMPLETED|Period 1, Day 1||0
310341|NCT01642485|742431|P3|NOT COMPLETED|Period 1, Day 1||0
310342|NCT01642485|742432|P2|NOT COMPLETED|Period 1, Day 1||0
310343|NCT01642485|742433|P1|NOT COMPLETED|Period 1, Day 1||0
310344|NCT01642485|742426|P8|COMPLETED|Period 1, Day 1||4
310345|NCT01642485|742427|P7|COMPLETED|Period 1, Day 1||4
310346|NCT01642485|742428|P6|COMPLETED|Period 1, Day 1||4
310347|NCT01642485|742429|P5|COMPLETED|Period 1, Day 1||4
310348|NCT01642485|742430|P4|COMPLETED|Period 1, Day 1||4
310349|NCT01642485|742431|P3|COMPLETED|Period 1, Day 1||4
310350|NCT01642485|742432|P2|COMPLETED|Period 1, Day 1||4
310351|NCT01642485|742433|P1|COMPLETED|Period 1, Day 1||4
310352|NCT01642485|742426|P8|STARTED|Period 1, Day 1||4
310353|NCT01642485|742427|P7|STARTED|Period 1, Day 1||4
310354|NCT01642485|742428|P6|STARTED|Period 1, Day 1||4
310355|NCT01642485|742429|P5|STARTED|Period 1, Day 1||4
310356|NCT01642485|742430|P4|STARTED|Period 1, Day 1||4
310357|NCT01642485|742431|P3|STARTED|Period 1, Day 1||4
310358|NCT01642485|742432|P2|STARTED|Period 1, Day 1||4
310359|NCT01642485|742433|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
310360|NCT01642407|742451|P1|NOT COMPLETED|Overall Study||2
310361|NCT01642407|742451|P1|COMPLETED|Overall Study||4
310362|NCT01642407|742451|P1|STARTED|Overall Study||6
310363|NCT01642277|742495|P2|NOT COMPLETED|Overall Study||0
310364|NCT01642277|742496|P1|NOT COMPLETED|Overall Study||24
310365|NCT01642277|742495|P2|COMPLETED|Overall Study||60
310366|NCT01642277|742496|P1|COMPLETED|Overall Study||50
310367|NCT01642277|742495|P2|STARTED|Overall Study||60
310368|NCT01642277|742496|P1|STARTED|Overall Study||74
310369|NCT01642238|742505|P2|NOT COMPLETED|Second Intervention (1 Day)||0
310370|NCT01642238|742506|P1|NOT COMPLETED|Second Intervention (1 Day)||0
310371|NCT01642238|742505|P2|COMPLETED|Second Intervention (1 Day)||8
310372|NCT01642238|742506|P1|COMPLETED|Second Intervention (1 Day)||7
310373|NCT01642238|742505|P2|STARTED|Second Intervention (1 Day)||8
310374|NCT01642238|742506|P1|STARTED|Second Intervention (1 Day)||7
310375|NCT01642238|742505|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
310376|NCT01642238|742506|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
310377|NCT01642238|742505|P2|COMPLETED|Washout (1-2 Weeks)||8
310378|NCT01642238|742506|P1|COMPLETED|Washout (1-2 Weeks)||7
310379|NCT01642238|742505|P2|STARTED|Washout (1-2 Weeks)||8
310380|NCT01642238|742506|P1|STARTED|Washout (1-2 Weeks)||7
310381|NCT01642238|742505|P2|NOT COMPLETED|First Intervention (1 Day)||0
310382|NCT01642238|742506|P1|NOT COMPLETED|First Intervention (1 Day)||0
310383|NCT01642238|742505|P2|COMPLETED|First Intervention (1 Day)||8
310384|NCT01642238|742506|P1|COMPLETED|First Intervention (1 Day)||7
310385|NCT01642238|742505|P2|STARTED|First Intervention (1 Day)||8
310386|NCT01642238|742506|P1|STARTED|First Intervention (1 Day)||7
310387|NCT01642212|742528|P5|NOT COMPLETED|Open-label Extension||8
310388|NCT01642212|742529|P4|NOT COMPLETED|Open-label Extension||10
310389|NCT01642212|742530|P3|NOT COMPLETED|Open-label Extension||0
310390|NCT01642212|742531|P2|NOT COMPLETED|Open-label Extension||0
310391|NCT01642212|742532|P1|NOT COMPLETED|Open-label Extension||0
310392|NCT01642212|742528|P5|COMPLETED|Open-label Extension||37
310393|NCT01642212|742529|P4|COMPLETED|Open-label Extension||27
310394|NCT01642212|742530|P3|COMPLETED|Open-label Extension||0
310395|NCT01642212|742531|P2|COMPLETED|Open-label Extension||0
310396|NCT01642212|742532|P1|COMPLETED|Open-label Extension||0
310397|NCT01642212|742528|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
310398|NCT01642212|742529|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
310399|NCT01642212|742530|P3|STARTED|Open-label Extension||0
310400|NCT01642212|742531|P2|STARTED|Open-label Extension||0
310401|NCT01642212|742532|P1|STARTED|Open-label Extension||0
310402|NCT01642212|742528|P5|NOT COMPLETED|Double-blind Treatment||0
310403|NCT01642212|742529|P4|NOT COMPLETED|Double-blind Treatment||0
310404|NCT01642212|742530|P3|NOT COMPLETED|Double-blind Treatment||2
310405|NCT01642212|742531|P2|NOT COMPLETED|Double-blind Treatment||3
310406|NCT01642212|742532|P1|NOT COMPLETED|Double-blind Treatment||0
310407|NCT01642212|742528|P5|COMPLETED|Double-blind Treatment||0
310408|NCT01642212|742529|P4|COMPLETED|Double-blind Treatment||0
310409|NCT01642212|742530|P3|COMPLETED|Double-blind Treatment||49
310410|NCT01642212|742531|P2|COMPLETED|Double-blind Treatment||39
310411|NCT01642212|742532|P1|COMPLETED|Double-blind Treatment||0
310412|NCT01642212|742528|P5|STARTED|Double-blind Treatment||0
310413|NCT01642212|742529|P4|STARTED|Double-blind Treatment||0
310414|NCT01642212|742530|P3|STARTED|Double-blind Treatment||51
310415|NCT01642212|742531|P2|STARTED|Double-blind Treatment||42
310416|NCT01642212|742532|P1|STARTED|Double-blind Treatment||0
310417|NCT01642212|742528|P5|NOT COMPLETED|Single-blind Baseline||0
310418|NCT01642212|742529|P4|NOT COMPLETED|Single-blind Baseline||0
310419|NCT01642212|742530|P3|NOT COMPLETED|Single-blind Baseline||0
310420|NCT01642212|742531|P2|NOT COMPLETED|Single-blind Baseline||0
310421|NCT01642212|742532|P1|NOT COMPLETED|Single-blind Baseline||26
310422|NCT01642212|742528|P5|COMPLETED|Single-blind Baseline||0
310423|NCT01642212|742529|P4|COMPLETED|Single-blind Baseline||0
310424|NCT01642212|742530|P3|COMPLETED|Single-blind Baseline||0
310425|NCT01642212|742531|P2|COMPLETED|Single-blind Baseline||0
310426|NCT01642212|742532|P1|COMPLETED|Single-blind Baseline||93
310427|NCT01642212|742528|P5|STARTED|Single-blind Baseline||0
310428|NCT01642212|742529|P4|STARTED|Single-blind Baseline||0
310429|NCT01642212|742530|P3|STARTED|Single-blind Baseline||0
310430|NCT01642212|742531|P2|STARTED|Single-blind Baseline||0
310431|NCT01642212|742532|P1|STARTED|Single-blind Baseline||119
310432|NCT01642147|742582|P2|NOT COMPLETED|Overall Study||0
310433|NCT01642147|742583|P1|NOT COMPLETED|Overall Study||0
310434|NCT01642147|742582|P2|COMPLETED|Overall Study||30
310435|NCT01642147|742583|P1|COMPLETED|Overall Study||30
310436|NCT01642147|742582|P2|STARTED|Overall Study||30
310437|NCT01642147|742583|P1|STARTED|Overall Study||30
310438|NCT01642082|742611|P1|NOT COMPLETED|Overall Study||0
310439|NCT01642082|742611|P1|COMPLETED|Overall Study||28
310440|NCT01642082|742611|P1|STARTED|Overall Study||28
310441|NCT01642004|742621|P2|NOT COMPLETED|Treatment||127
310442|NCT01642004|742622|P1|NOT COMPLETED|Treatment||110
310443|NCT01642004|742621|P2|COMPLETED|Treatment||2
310444|NCT01642004|742622|P1|COMPLETED|Treatment||21
310445|NCT01642004|742621|P2|STARTED|Treatment||129
310446|NCT01642004|742622|P1|STARTED|Treatment||131
310447|NCT01642004|742621|P2|NOT COMPLETED|Randomization||8
310448|NCT01642004|742622|P1|NOT COMPLETED|Randomization||4
310449|NCT01642004|742621|P2|COMPLETED|Randomization||129
310450|NCT01642004|742622|P1|COMPLETED|Randomization||131
310451|NCT01642004|742621|P2|STARTED|Randomization||137
310452|NCT01642004|742622|P1|STARTED|Randomization||135
310453|NCT01641991|742656|P4|NOT COMPLETED|Overall Study||16
310454|NCT01641991|742657|P3|NOT COMPLETED|Overall Study||17
310455|NCT01641991|742658|P2|NOT COMPLETED|Overall Study||8
310456|NCT01641991|742659|P1|NOT COMPLETED|Overall Study||9
310457|NCT01641991|742656|P4|COMPLETED|Overall Study||66
310458|NCT01641991|742657|P3|COMPLETED|Overall Study||65
310459|NCT01641991|742658|P2|COMPLETED|Overall Study||74
310460|NCT01641991|742659|P1|COMPLETED|Overall Study||73
310461|NCT01641991|742656|P4|STARTED|Overall Study||82
310462|NCT01641991|742657|P3|STARTED|Overall Study||82
310463|NCT01641991|742658|P2|STARTED|Overall Study||82
310464|NCT01641991|742659|P1|STARTED|Overall Study||82
310465|NCT01641978|742735|P1|NOT COMPLETED|Overall Study||0
310466|NCT01641978|742735|P1|COMPLETED|Overall Study||125
310467|NCT01641978|742735|P1|STARTED|Overall Study||125
310468|NCT01641952|742743|P1|NOT COMPLETED|Overall Study||34
310469|NCT01641952|742743|P1|COMPLETED|Overall Study||471
310470|NCT01641952|742743|P1|Treated|Overall Study||504
310471|NCT01641952|742743|P1|STARTED|Overall Study||505
310472|NCT01641939|742759|P3|NOT COMPLETED|Overall Study||70
310473|NCT01641939|742760|P2|NOT COMPLETED|Overall Study||228
310474|NCT01641939|742761|P1|NOT COMPLETED|Overall Study||117
310475|NCT01641939|742759|P3|COMPLETED|Overall Study||0
310476|NCT01641939|742760|P2|COMPLETED|Overall Study||0
310477|NCT01641939|742761|P1|COMPLETED|Overall Study||0
310478|NCT01641939|742759|P3|Stage 2|Overall Study||0
310479|NCT01641939|742760|P2|Stage 2|Overall Study||153
310480|NCT01641939|742761|P1|Stage 2|Overall Study||80
310481|NCT01641939|742759|P3|Stage 1|Overall Study||70
310482|NCT01641939|742760|P2|Stage 1|Overall Study||75
310483|NCT01641939|742761|P1|Stage 1|Overall Study||37
310484|NCT01641939|742759|P3|STARTED|Overall Study||70
310485|NCT01641939|742760|P2|STARTED|Overall Study||228
310486|NCT01641939|742761|P1|STARTED|Overall Study||117
310487|NCT01641926|742804|P4|NOT COMPLETED|Overall Study||4
310488|NCT01641926|742805|P3|NOT COMPLETED|Overall Study||11
310489|NCT01641926|742806|P2|NOT COMPLETED|Overall Study||15
310490|NCT01641926|742807|P1|NOT COMPLETED|Overall Study||28
310491|NCT01641926|742804|P4|COMPLETED|Overall Study||53
310492|NCT01641926|742805|P3|COMPLETED|Overall Study||46
310493|NCT01641926|742806|P2|COMPLETED|Overall Study||130
310494|NCT01641926|742807|P1|COMPLETED|Overall Study||115
310495|NCT01641926|742804|P4|Treated (All Participants as Treated)|Overall Study||57
310496|NCT01641926|742805|P3|Treated (All Participants as Treated)|Overall Study||56
310497|NCT01641926|742806|P2|Treated (All Participants as Treated)|Overall Study||144
310498|NCT01641926|742807|P1|Treated (All Participants as Treated)|Overall Study||142
310499|NCT01641926|742804|P4|STARTED|Overall Study||57
310500|NCT01641926|742805|P3|STARTED|Overall Study||57
310501|NCT01641926|742806|P2|STARTED|Overall Study||145
310502|NCT01641926|742807|P1|STARTED|Overall Study||143
310503|NCT01641900|742835|P2|NOT COMPLETED|Overall Study||2
310504|NCT01641900|742836|P1|NOT COMPLETED|Overall Study||2
310505|NCT01641900|742835|P2|COMPLETED|Overall Study||29
310506|NCT01641900|742836|P1|COMPLETED|Overall Study||26
310507|NCT01641900|742835|P2|Completed Drug Intervention|Overall Study||29
310508|NCT01641900|742836|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
310509|NCT01641900|742835|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
310510|NCT01641900|742836|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
310511|NCT01641900|742835|P2|STARTED|Overall Study||31
310512|NCT01641900|742836|P1|STARTED|Overall Study||28
310513|NCT01641861|742848|P2|NOT COMPLETED|Overall Study||25
310514|NCT01641861|742849|P1|NOT COMPLETED|Overall Study||35
310515|NCT01641861|742848|P2|COMPLETED|Overall Study||217
310516|NCT01641861|742849|P1|COMPLETED|Overall Study||211
310517|NCT01641861|742848|P2|STARTED|Overall Study||242
310518|NCT01641861|742849|P1|STARTED|Overall Study||246
310519|NCT01641835|742863|P1|NOT COMPLETED|Overall Study||0
310520|NCT01641835|742863|P1|COMPLETED|Overall Study||303
310521|NCT01641835|742863|P1|STARTED|Overall Study||303
310522|NCT01641822|742870|P3|NOT COMPLETED|Comparative Phase||10
310523|NCT01641822|742871|P2|NOT COMPLETED|Comparative Phase||6
310524|NCT01641822|742872|P1|NOT COMPLETED|Comparative Phase||0
310525|NCT01641822|742870|P3|COMPLETED|Comparative Phase||37
310526|NCT01641822|742871|P2|COMPLETED|Comparative Phase||37
310527|NCT01641822|742872|P1|COMPLETED|Comparative Phase||0
310528|NCT01641822|742870|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
310529|NCT01641822|742871|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
310530|NCT01641822|742872|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
310531|NCT01641822|742870|P3|STARTED|Comparative Phase||47
310532|NCT01641822|742871|P2|STARTED|Comparative Phase||43
310666|NCT01641692|742892|P5|NOT COMPLETED|Treatment Period 1||4
310533|NCT01641822|742872|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
310534|NCT01641822|742870|P3|NOT COMPLETED|Run-in Phase||0
310535|NCT01641822|742871|P2|NOT COMPLETED|Run-in Phase||0
310536|NCT01641822|742872|P1|NOT COMPLETED|Run-in Phase||14
310537|NCT01641822|742870|P3|COMPLETED|Run-in Phase||0
310538|NCT01641822|742871|P2|COMPLETED|Run-in Phase||0
310539|NCT01641822|742872|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
310540|NCT01641822|742870|P3|STARTED|Run-in Phase||0
310541|NCT01641822|742871|P2|STARTED|Run-in Phase||0
310542|NCT01641822|742872|P1|STARTED|Run-in Phase||107
310543|NCT01641692|742889|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
310544|NCT01641692|742890|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
310545|NCT01641692|742891|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
310546|NCT01641692|742892|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
310547|NCT01641692|742893|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
310548|NCT01641692|742894|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
310549|NCT01641692|742895|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
310550|NCT01641692|742896|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
310551|NCT01641692|742889|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
310552|NCT01641692|742890|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
310553|NCT01641692|742891|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
310554|NCT01641692|742892|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
310555|NCT01641692|742893|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
310556|NCT01641692|742894|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
310557|NCT01641692|742895|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
310558|NCT01641692|742896|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
310559|NCT01641692|742889|P8|STARTED|Washout Period 3 or Follow-up||38
310560|NCT01641692|742890|P7|STARTED|Washout Period 3 or Follow-up||33
310561|NCT01641692|742891|P6|STARTED|Washout Period 3 or Follow-up||39
310562|NCT01641692|742892|P5|STARTED|Washout Period 3 or Follow-up||40
310563|NCT01641692|742893|P4|STARTED|Washout Period 3 or Follow-up||42
310564|NCT01641692|742894|P3|STARTED|Washout Period 3 or Follow-up||37
310565|NCT01641692|742895|P2|STARTED|Washout Period 3 or Follow-up||32
310566|NCT01641692|742896|P1|STARTED|Washout Period 3 or Follow-up||43
310567|NCT01641692|742889|P8|NOT COMPLETED|Treatment Period 3||0
310568|NCT01641692|742890|P7|NOT COMPLETED|Treatment Period 3||2
310569|NCT01641692|742891|P6|NOT COMPLETED|Treatment Period 3||0
310570|NCT01641692|742892|P5|NOT COMPLETED|Treatment Period 3||0
310571|NCT01641692|742893|P4|NOT COMPLETED|Treatment Period 3||0
310572|NCT01641692|742894|P3|NOT COMPLETED|Treatment Period 3||1
310573|NCT01641692|742895|P2|NOT COMPLETED|Treatment Period 3||1
310574|NCT01641692|742896|P1|NOT COMPLETED|Treatment Period 3||0
310575|NCT01641692|742889|P8|COMPLETED|Treatment Period 3||38
310576|NCT01641692|742890|P7|COMPLETED|Treatment Period 3||33
310577|NCT01641692|742891|P6|COMPLETED|Treatment Period 3||39
310578|NCT01641692|742892|P5|COMPLETED|Treatment Period 3||40
310579|NCT01641692|742893|P4|COMPLETED|Treatment Period 3||42
310580|NCT01641692|742894|P3|COMPLETED|Treatment Period 3||37
310581|NCT01641692|742895|P2|COMPLETED|Treatment Period 3||32
310582|NCT01641692|742896|P1|COMPLETED|Treatment Period 3||43
310583|NCT01641692|742889|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
310584|NCT01641692|742890|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
310585|NCT01641692|742891|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
310586|NCT01641692|742892|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
310587|NCT01641692|742893|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
310588|NCT01641692|742894|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
310589|NCT01641692|742895|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
310590|NCT01641692|742896|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
310591|NCT01641692|742889|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
310592|NCT01641692|742890|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
310593|NCT01641692|742891|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
310594|NCT01641692|742892|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
310595|NCT01641692|742893|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
310596|NCT01641692|742894|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
310597|NCT01641692|742895|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
310598|NCT01641692|742896|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
310599|NCT01641692|742889|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
310600|NCT01641692|742890|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
310601|NCT01641692|742891|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
310602|NCT01641692|742892|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
310603|NCT01641692|742893|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
310604|NCT01641692|742894|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
310605|NCT01641692|742895|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
310606|NCT01641692|742896|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
310607|NCT01641692|742889|P8|STARTED|Washout Period 2 (12-14 Days)||35
310608|NCT01641692|742890|P7|STARTED|Washout Period 2 (12-14 Days)||43
310609|NCT01641692|742891|P6|STARTED|Washout Period 2 (12-14 Days)||43
310610|NCT01641692|742892|P5|STARTED|Washout Period 2 (12-14 Days)||37
310611|NCT01641692|742893|P4|STARTED|Washout Period 2 (12-14 Days)||41
310612|NCT01641692|742894|P3|STARTED|Washout Period 2 (12-14 Days)||40
310613|NCT01641692|742895|P2|STARTED|Washout Period 2 (12-14 Days)||46
310614|NCT01641692|742896|P1|STARTED|Washout Period 2 (12-14 Days)||30
310615|NCT01641692|742889|P8|NOT COMPLETED|Treatment Period 2||1
310616|NCT01641692|742890|P7|NOT COMPLETED|Treatment Period 2||0
310617|NCT01641692|742891|P6|NOT COMPLETED|Treatment Period 2||2
310618|NCT01641692|742892|P5|NOT COMPLETED|Treatment Period 2||0
310619|NCT01641692|742893|P4|NOT COMPLETED|Treatment Period 2||0
310620|NCT01641692|742894|P3|NOT COMPLETED|Treatment Period 2||0
310621|NCT01641692|742895|P2|NOT COMPLETED|Treatment Period 2||0
310622|NCT01641692|742896|P1|NOT COMPLETED|Treatment Period 2||3
310623|NCT01641692|742889|P8|COMPLETED|Treatment Period 2||35
310624|NCT01641692|742890|P7|COMPLETED|Treatment Period 2||43
310625|NCT01641692|742891|P6|COMPLETED|Treatment Period 2||43
310626|NCT01641692|742892|P5|COMPLETED|Treatment Period 2||37
310627|NCT01641692|742893|P4|COMPLETED|Treatment Period 2||41
310628|NCT01641692|742894|P3|COMPLETED|Treatment Period 2||40
310629|NCT01641692|742895|P2|COMPLETED|Treatment Period 2||46
310630|NCT01641692|742896|P1|COMPLETED|Treatment Period 2||30
310631|NCT01641692|742889|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
310632|NCT01641692|742890|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
310633|NCT01641692|742891|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
310634|NCT01641692|742892|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
310635|NCT01641692|742893|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
310636|NCT01641692|742894|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
310637|NCT01641692|742895|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
310638|NCT01641692|742896|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
310639|NCT01641692|742889|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
310640|NCT01641692|742890|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
310641|NCT01641692|742891|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
310642|NCT01641692|742892|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
310643|NCT01641692|742893|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
310644|NCT01641692|742894|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
310645|NCT01641692|742895|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
310646|NCT01641692|742896|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
310647|NCT01641692|742889|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
310648|NCT01641692|742890|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
310649|NCT01641692|742891|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
310650|NCT01641692|742892|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
310651|NCT01641692|742893|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
310652|NCT01641692|742894|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
310653|NCT01641692|742895|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
310654|NCT01641692|742896|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
310655|NCT01641692|742889|P8|STARTED|Washout Period 1 (12-14 Days)||48
310656|NCT01641692|742890|P7|STARTED|Washout Period 1 (12-14 Days)||38
310657|NCT01641692|742891|P6|STARTED|Washout Period 1 (12-14 Days)||37
310658|NCT01641692|742892|P5|STARTED|Washout Period 1 (12-14 Days)||39
310659|NCT01641692|742893|P4|STARTED|Washout Period 1 (12-14 Days)||41
310660|NCT01641692|742894|P3|STARTED|Washout Period 1 (12-14 Days)||50
310661|NCT01641692|742895|P2|STARTED|Washout Period 1 (12-14 Days)||45
310662|NCT01641692|742896|P1|STARTED|Washout Period 1 (12-14 Days)||40
310663|NCT01641692|742889|P8|NOT COMPLETED|Treatment Period 1||3
310664|NCT01641692|742890|P7|NOT COMPLETED|Treatment Period 1||0
310665|NCT01641692|742891|P6|NOT COMPLETED|Treatment Period 1||2
310667|NCT01641692|742893|P4|NOT COMPLETED|Treatment Period 1||0
310668|NCT01641692|742894|P3|NOT COMPLETED|Treatment Period 1||1
310669|NCT01641692|742895|P2|NOT COMPLETED|Treatment Period 1||0
310670|NCT01641692|742896|P1|NOT COMPLETED|Treatment Period 1||2
310671|NCT01641692|742889|P8|COMPLETED|Treatment Period 1||48
310672|NCT01641692|742890|P7|COMPLETED|Treatment Period 1||38
310673|NCT01641692|742891|P6|COMPLETED|Treatment Period 1||37
310674|NCT01641692|742892|P5|COMPLETED|Treatment Period 1||39
310675|NCT01641692|742893|P4|COMPLETED|Treatment Period 1||41
310676|NCT01641692|742894|P3|COMPLETED|Treatment Period 1||50
310677|NCT01641692|742895|P2|COMPLETED|Treatment Period 1||45
310678|NCT01641692|742896|P1|COMPLETED|Treatment Period 1||40
310679|NCT01641692|742889|P8|STARTED|Treatment Period 1||51
310680|NCT01641692|742890|P7|STARTED|Treatment Period 1||38
310681|NCT01641692|742891|P6|STARTED|Treatment Period 1||39
310682|NCT01641692|742892|P5|STARTED|Treatment Period 1||43
310683|NCT01641692|742893|P4|STARTED|Treatment Period 1||41
310684|NCT01641692|742894|P3|STARTED|Treatment Period 1||51
310685|NCT01641692|742895|P2|STARTED|Treatment Period 1||45
310686|NCT01641692|742896|P1|STARTED|Treatment Period 1||42
310687|NCT01641653|743085|P2|NOT COMPLETED|Overall Study||0
310688|NCT01641653|743086|P1|NOT COMPLETED|Overall Study||0
310689|NCT01641653|743085|P2|COMPLETED|Overall Study||30
310690|NCT01641653|743086|P1|COMPLETED|Overall Study||30
310691|NCT01641653|743085|P2|STARTED|Overall Study||30
310692|NCT01641653|743086|P1|STARTED|Overall Study||30
310693|NCT01641640|743096|P1|NOT COMPLETED|Overall Study||36
310694|NCT01641640|743096|P1|COMPLETED|Overall Study||292
310695|NCT01641640|743096|P1|Enrolled and Treated|Overall Study||327
310696|NCT01641640|743096|P1|STARTED|Overall Study||328
310697|NCT01641471|743107|P2|NOT COMPLETED|Overall Study||27
310698|NCT01641471|743108|P1|NOT COMPLETED|Overall Study||23
310699|NCT01641471|743107|P2|COMPLETED|Overall Study||31
310700|NCT01641471|743108|P1|COMPLETED|Overall Study||35
310701|NCT01641471|743107|P2|STARTED|Overall Study||58
310702|NCT01641471|743108|P1|STARTED|Overall Study||58
310703|NCT01641237|743114|P4|NOT COMPLETED|Period IV||0
310704|NCT01641237|743115|P3|NOT COMPLETED|Period IV||0
310705|NCT01641237|743116|P2|NOT COMPLETED|Period IV||0
310706|NCT01641237|743117|P1|NOT COMPLETED|Period IV||0
310707|NCT01641237|743114|P4|COMPLETED|Period IV||15
310708|NCT01641237|743115|P3|COMPLETED|Period IV||15
310709|NCT01641237|743116|P2|COMPLETED|Period IV||15
310710|NCT01641237|743117|P1|COMPLETED|Period IV||15
310711|NCT01641237|743114|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
310712|NCT01641237|743115|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
310713|NCT01641237|743116|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
310714|NCT01641237|743117|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
310715|NCT01641237|743114|P4|NOT COMPLETED|Period III||0
310716|NCT01641237|743115|P3|NOT COMPLETED|Period III||0
310717|NCT01641237|743116|P2|NOT COMPLETED|Period III||0
310718|NCT01641237|743117|P1|NOT COMPLETED|Period III||1
310719|NCT01641237|743114|P4|COMPLETED|Period III||16
310720|NCT01641237|743115|P3|COMPLETED|Period III||15
310721|NCT01641237|743116|P2|COMPLETED|Period III||14
310722|NCT01641237|743117|P1|COMPLETED|Period III||15
310723|NCT01641237|743114|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
310724|NCT01641237|743115|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
310725|NCT01641237|743116|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
310726|NCT01641237|743117|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
310727|NCT01641237|743114|P4|NOT COMPLETED|Period II||0
310728|NCT01641237|743115|P3|NOT COMPLETED|Period II||0
310729|NCT01641237|743116|P2|NOT COMPLETED|Period II||0
310730|NCT01641237|743117|P1|NOT COMPLETED|Period II||1
310731|NCT01641237|743114|P4|COMPLETED|Period II||15
310732|NCT01641237|743115|P3|COMPLETED|Period II||16
310733|NCT01641237|743116|P2|COMPLETED|Period II||16
310734|NCT01641237|743117|P1|COMPLETED|Period II||14
310735|NCT01641237|743114|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
310736|NCT01641237|743115|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
310737|NCT01641237|743116|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
310738|NCT01641237|743117|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
310739|NCT01641237|743114|P4|NOT COMPLETED|Period I||0
310740|NCT01641237|743115|P3|NOT COMPLETED|Period I||0
310741|NCT01641237|743116|P2|NOT COMPLETED|Period I||0
310742|NCT01641237|743117|P1|NOT COMPLETED|Period I||0
310743|NCT01641237|743114|P4|COMPLETED|Period I||15
310744|NCT01641237|743115|P3|COMPLETED|Period I||15
310745|NCT01641237|743116|P2|COMPLETED|Period I||16
310746|NCT01641237|743117|P1|COMPLETED|Period I||16
310747|NCT01641237|743114|P4|STARTED|Period I||15
310748|NCT01641237|743115|P3|STARTED|Period I||15
310749|NCT01641237|743116|P2|STARTED|Period I||16
310750|NCT01641237|743117|P1|STARTED|Period I||16
310751|NCT01641159|743141|P2|NOT COMPLETED|Overall Study||2
310752|NCT01641159|743142|P1|NOT COMPLETED|Overall Study||2
310753|NCT01641159|743141|P2|COMPLETED|Overall Study||25
310754|NCT01641159|743142|P1|COMPLETED|Overall Study||33
310755|NCT01641159|743141|P2|STARTED|Overall Study||27
310756|NCT01641159|743142|P1|STARTED|Overall Study||35
310757|NCT01641133|743153|P3|NOT COMPLETED|Overall Study||8
310758|NCT01641133|743154|P2|NOT COMPLETED|Overall Study||9
310759|NCT01641133|743155|P1|NOT COMPLETED|Overall Study||10
310760|NCT01641133|743153|P3|COMPLETED|Overall Study||90
310761|NCT01641133|743154|P2|COMPLETED|Overall Study||90
310762|NCT01641133|743155|P1|COMPLETED|Overall Study||87
310763|NCT01641133|743153|P3|STARTED|Overall Study||98
310764|NCT01641133|743154|P2|STARTED|Overall Study||99
310765|NCT01641133|743155|P1|STARTED|Overall Study||97
310766|NCT01641120|743193|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
310767|NCT01641120|743193|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
310768|NCT01641120|743193|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
310769|NCT01641120|743193|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
310770|NCT01641120|743193|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
310771|NCT01641120|743193|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
310772|NCT01641081|743205|P10|NOT COMPLETED|Period 5||0
310773|NCT01641081|743206|P9|NOT COMPLETED|Period 5||0
310774|NCT01641081|743207|P8|NOT COMPLETED|Period 5||0
310775|NCT01641081|743208|P7|NOT COMPLETED|Period 5||0
310776|NCT01641081|743209|P6|NOT COMPLETED|Period 5||0
310777|NCT01641081|743210|P5|NOT COMPLETED|Period 5||0
310778|NCT01641081|743211|P4|NOT COMPLETED|Period 5||0
310779|NCT01641081|743212|P3|NOT COMPLETED|Period 5||2
310780|NCT01641081|743213|P2|NOT COMPLETED|Period 5||0
310781|NCT01641081|743214|P1|NOT COMPLETED|Period 5||0
310782|NCT01641081|743205|P10|COMPLETED|Period 5||14
310783|NCT01641081|743206|P9|COMPLETED|Period 5||14
310784|NCT01641081|743207|P8|COMPLETED|Period 5||14
310785|NCT01641081|743208|P7|COMPLETED|Period 5||16
310786|NCT01641081|743209|P6|COMPLETED|Period 5||18
310787|NCT01641081|743210|P5|COMPLETED|Period 5||16
310788|NCT01641081|743211|P4|COMPLETED|Period 5||20
310789|NCT01641081|743212|P3|COMPLETED|Period 5||12
310790|NCT01641081|743213|P2|COMPLETED|Period 5||17
310791|NCT01641081|743214|P1|COMPLETED|Period 5||16
310792|NCT01641081|743205|P10|STARTED|Period 5||14
310793|NCT01641081|743206|P9|STARTED|Period 5||14
310794|NCT01641081|743207|P8|STARTED|Period 5||14
310795|NCT01641081|743208|P7|STARTED|Period 5||16
310796|NCT01641081|743209|P6|STARTED|Period 5||18
310797|NCT01641081|743210|P5|STARTED|Period 5||16
310798|NCT01641081|743211|P4|STARTED|Period 5||20
310799|NCT01641081|743212|P3|STARTED|Period 5||14
310800|NCT01641081|743213|P2|STARTED|Period 5||17
310801|NCT01641081|743214|P1|STARTED|Period 5||16
310802|NCT01641081|743205|P10|NOT COMPLETED|Period 4||0
310803|NCT01641081|743206|P9|NOT COMPLETED|Period 4||0
310804|NCT01641081|743207|P8|NOT COMPLETED|Period 4||0
310805|NCT01641081|743208|P7|NOT COMPLETED|Period 4||0
310806|NCT01641081|743209|P6|NOT COMPLETED|Period 4||0
310807|NCT01641081|743210|P5|NOT COMPLETED|Period 4||0
310808|NCT01641081|743211|P4|NOT COMPLETED|Period 4||1
310809|NCT01641081|743212|P3|NOT COMPLETED|Period 4||0
310810|NCT01641081|743213|P2|NOT COMPLETED|Period 4||1
310811|NCT01641081|743214|P1|NOT COMPLETED|Period 4||0
310812|NCT01641081|743205|P10|COMPLETED|Period 4||14
310813|NCT01641081|743206|P9|COMPLETED|Period 4||14
310814|NCT01641081|743207|P8|COMPLETED|Period 4||14
310815|NCT01641081|743208|P7|COMPLETED|Period 4||16
310816|NCT01641081|743209|P6|COMPLETED|Period 4||18
310817|NCT01641081|743210|P5|COMPLETED|Period 4||16
310818|NCT01641081|743211|P4|COMPLETED|Period 4||20
310819|NCT01641081|743212|P3|COMPLETED|Period 4||14
310820|NCT01641081|743213|P2|COMPLETED|Period 4||17
310821|NCT01641081|743214|P1|COMPLETED|Period 4||16
310822|NCT01641081|743205|P10|STARTED|Period 4||14
310823|NCT01641081|743206|P9|STARTED|Period 4||14
310824|NCT01641081|743207|P8|STARTED|Period 4||14
310825|NCT01641081|743208|P7|STARTED|Period 4||16
310826|NCT01641081|743209|P6|STARTED|Period 4||18
310827|NCT01641081|743210|P5|STARTED|Period 4||16
310828|NCT01641081|743211|P4|STARTED|Period 4||21
310829|NCT01641081|743212|P3|STARTED|Period 4||14
310830|NCT01641081|743213|P2|STARTED|Period 4||18
310831|NCT01641081|743214|P1|STARTED|Period 4||16
310832|NCT01641081|743205|P10|NOT COMPLETED|Period 3||0
310833|NCT01641081|743206|P9|NOT COMPLETED|Period 3||1
310834|NCT01641081|743207|P8|NOT COMPLETED|Period 3||0
310835|NCT01641081|743208|P7|NOT COMPLETED|Period 3||0
310836|NCT01641081|743209|P6|NOT COMPLETED|Period 3||0
310837|NCT01641081|743210|P5|NOT COMPLETED|Period 3||0
310838|NCT01641081|743211|P4|NOT COMPLETED|Period 3||0
310839|NCT01641081|743212|P3|NOT COMPLETED|Period 3||1
310840|NCT01641081|743213|P2|NOT COMPLETED|Period 3||0
310841|NCT01641081|743214|P1|NOT COMPLETED|Period 3||0
310842|NCT01641081|743205|P10|COMPLETED|Period 3||14
310843|NCT01641081|743206|P9|COMPLETED|Period 3||14
310844|NCT01641081|743207|P8|COMPLETED|Period 3||14
310845|NCT01641081|743208|P7|COMPLETED|Period 3||16
310846|NCT01641081|743209|P6|COMPLETED|Period 3||18
310847|NCT01641081|743210|P5|COMPLETED|Period 3||16
310848|NCT01641081|743211|P4|COMPLETED|Period 3||21
310849|NCT01641081|743212|P3|COMPLETED|Period 3||14
310850|NCT01641081|743213|P2|COMPLETED|Period 3||18
310851|NCT01641081|743214|P1|COMPLETED|Period 3||16
310852|NCT01641081|743205|P10|STARTED|Period 3||14
310853|NCT01641081|743206|P9|STARTED|Period 3||15
310854|NCT01641081|743207|P8|STARTED|Period 3||14
310855|NCT01641081|743208|P7|STARTED|Period 3||16
310856|NCT01641081|743209|P6|STARTED|Period 3||18
310857|NCT01641081|743210|P5|STARTED|Period 3||16
310858|NCT01641081|743211|P4|STARTED|Period 3||21
310859|NCT01641081|743212|P3|STARTED|Period 3||15
310860|NCT01641081|743213|P2|STARTED|Period 3||18
310861|NCT01641081|743214|P1|STARTED|Period 3||16
310862|NCT01641081|743205|P10|NOT COMPLETED|Period 2||0
310863|NCT01641081|743206|P9|NOT COMPLETED|Period 2||0
310864|NCT01641081|743207|P8|NOT COMPLETED|Period 2||0
310865|NCT01641081|743208|P7|NOT COMPLETED|Period 2||2
310866|NCT01641081|743209|P6|NOT COMPLETED|Period 2||1
310867|NCT01641081|743210|P5|NOT COMPLETED|Period 2||0
310868|NCT01641081|743211|P4|NOT COMPLETED|Period 2||1
310869|NCT01641081|743212|P3|NOT COMPLETED|Period 2||0
310870|NCT01641081|743213|P2|NOT COMPLETED|Period 2||0
310871|NCT01641081|743214|P1|NOT COMPLETED|Period 2||1
310872|NCT01641081|743205|P10|COMPLETED|Period 2||14
310873|NCT01641081|743206|P9|COMPLETED|Period 2||15
310874|NCT01641081|743207|P8|COMPLETED|Period 2||14
310875|NCT01641081|743208|P7|COMPLETED|Period 2||16
310876|NCT01641081|743209|P6|COMPLETED|Period 2||18
310877|NCT01641081|743210|P5|COMPLETED|Period 2||16
310878|NCT01641081|743211|P4|COMPLETED|Period 2||21
310879|NCT01641081|743212|P3|COMPLETED|Period 2||15
310880|NCT01641081|743213|P2|COMPLETED|Period 2||18
310881|NCT01641081|743214|P1|COMPLETED|Period 2||16
310882|NCT01641081|743205|P10|STARTED|Period 2||14
310883|NCT01641081|743206|P9|STARTED|Period 2||15
310884|NCT01641081|743207|P8|STARTED|Period 2||14
310885|NCT01641081|743208|P7|STARTED|Period 2||18
310886|NCT01641081|743209|P6|STARTED|Period 2||19
310887|NCT01641081|743210|P5|STARTED|Period 2||16
310888|NCT01641081|743211|P4|STARTED|Period 2||22
310889|NCT01641081|743212|P3|STARTED|Period 2||15
310890|NCT01641081|743213|P2|STARTED|Period 2||18
310891|NCT01641081|743214|P1|STARTED|Period 2||17
310892|NCT01641081|743205|P10|NOT COMPLETED|Period 1||0
310893|NCT01641081|743206|P9|NOT COMPLETED|Period 1||0
310894|NCT01641081|743207|P8|NOT COMPLETED|Period 1||3
310895|NCT01641081|743208|P7|NOT COMPLETED|Period 1||1
310896|NCT01641081|743209|P6|NOT COMPLETED|Period 1||0
310897|NCT01641081|743210|P5|NOT COMPLETED|Period 1||1
310898|NCT01641081|743211|P4|NOT COMPLETED|Period 1||0
310899|NCT01641081|743212|P3|NOT COMPLETED|Period 1||0
310900|NCT01641081|743213|P2|NOT COMPLETED|Period 1||0
310901|NCT01641081|743214|P1|NOT COMPLETED|Period 1||1
310902|NCT01641081|743205|P10|COMPLETED|Period 1||14
310903|NCT01641081|743206|P9|COMPLETED|Period 1||15
310904|NCT01641081|743207|P8|COMPLETED|Period 1||14
310905|NCT01641081|743208|P7|COMPLETED|Period 1||18
310906|NCT01641081|743209|P6|COMPLETED|Period 1||19
310907|NCT01641081|743210|P5|COMPLETED|Period 1||16
310908|NCT01641081|743211|P4|COMPLETED|Period 1||22
310909|NCT01641081|743212|P3|COMPLETED|Period 1||15
310910|NCT01641081|743213|P2|COMPLETED|Period 1||18
310911|NCT01641081|743214|P1|COMPLETED|Period 1||17
310912|NCT01641081|743205|P10|STARTED|Period 1||14
310913|NCT01641081|743206|P9|STARTED|Period 1||15
310914|NCT01641081|743207|P8|STARTED|Period 1||17
310915|NCT01641081|743208|P7|STARTED|Period 1||19
310916|NCT01641081|743209|P6|STARTED|Period 1||19
310917|NCT01641081|743210|P5|STARTED|Period 1||17
310918|NCT01641081|743211|P4|STARTED|Period 1||22
310919|NCT01641081|743212|P3|STARTED|Period 1||15
310920|NCT01641081|743213|P2|STARTED|Period 1||18
310921|NCT01641081|743214|P1|STARTED|Period 1||18
310922|NCT01640964|743234|P3|NOT COMPLETED|Overall Study||3
310923|NCT01640964|743235|P2|NOT COMPLETED|Overall Study||1
310924|NCT01640964|743236|P1|NOT COMPLETED|Overall Study||1
310925|NCT01640964|743234|P3|COMPLETED|Overall Study||3
310926|NCT01640964|743235|P2|COMPLETED|Overall Study||19
310927|NCT01640964|743236|P1|COMPLETED|Overall Study||19
310928|NCT01640964|743234|P3|STARTED|Overall Study||6
310929|NCT01640964|743235|P2|STARTED|Overall Study||20
310930|NCT01640964|743236|P1|STARTED|Overall Study||20
310931|NCT01640925|743253|P2|NOT COMPLETED|Overall Study||11
310932|NCT01640925|743254|P1|NOT COMPLETED|Overall Study||14
310933|NCT01640925|743253|P2|COMPLETED|Overall Study||164
310934|NCT01640925|743254|P1|COMPLETED|Overall Study||161
310935|NCT01640925|743253|P2|STARTED|Overall Study||175
310936|NCT01640925|743254|P1|STARTED|Overall Study||175
310937|NCT01639729|743260|P6|NOT COMPLETED|Overall Study||0
310938|NCT01639729|743261|P5|NOT COMPLETED|Overall Study||0
310939|NCT01639729|743262|P4|NOT COMPLETED|Overall Study||1
310940|NCT01639729|743263|P3|NOT COMPLETED|Overall Study||1
310941|NCT01639729|743264|P2|NOT COMPLETED|Overall Study||0
310942|NCT01639729|743265|P1|NOT COMPLETED|Overall Study||1
310943|NCT01639729|743260|P6|COMPLETED|Overall Study||4
310944|NCT01639729|743261|P5|COMPLETED|Overall Study||4
310945|NCT01639729|743262|P4|COMPLETED|Overall Study||4
310946|NCT01639729|743263|P3|COMPLETED|Overall Study||3
310947|NCT01639729|743264|P2|COMPLETED|Overall Study||4
310948|NCT01639729|743265|P1|COMPLETED|Overall Study||3
310949|NCT01639729|743260|P6|STARTED|Overall Study||4
310950|NCT01639729|743261|P5|STARTED|Overall Study||4
310951|NCT01639729|743262|P4|STARTED|Overall Study||5
310952|NCT01639729|743263|P3|STARTED|Overall Study||4
310953|NCT01639729|743264|P2|STARTED|Overall Study||4
310954|NCT01639729|743265|P1|STARTED|Overall Study||4
310955|NCT01640548|743287|P1|NOT COMPLETED|Overall Study||0
310956|NCT01640548|743287|P1|COMPLETED|Overall Study||309
310957|NCT01640548|743287|P1|STARTED|Overall Study||309
310958|NCT01640353|743301|P1|NOT COMPLETED|Overall Study||45
310959|NCT01640353|743301|P1|COMPLETED|Overall Study||149
310960|NCT01640353|743301|P1|Month 18|Overall Study||150
310961|NCT01640353|743301|P1|Month 12|Overall Study||160
310962|NCT01640353|743301|P1|Month 6|Overall Study||168
310963|NCT01640353|743301|P1|Month 3|Overall Study||169
310964|NCT01640353|743301|P1|Month 1|Overall Study||171
310965|NCT01640353|743301|P1|Treated|Overall Study||172
310966|NCT01640353|743301|P1|STARTED|Overall Study||194
310967|NCT01640340|743313|P2|NOT COMPLETED|Overall Study||0
310968|NCT01640340|743314|P1|NOT COMPLETED|Overall Study||0
310969|NCT01640340|743313|P2|COMPLETED|Overall Study||20
310970|NCT01640340|743314|P1|COMPLETED|Overall Study||20
310971|NCT01640340|743313|P2|Overall Complete Response Rate|Overall Study||20
310972|NCT01640340|743314|P1|Overall Complete Response Rate|Overall Study||20
310973|NCT01640340|743313|P2|STARTED|Overall Study||20
310974|NCT01640340|743314|P1|STARTED|Overall Study||20
310975|NCT01640327|743334|P2|NOT COMPLETED|Overall Study||0
310976|NCT01640327|743335|P1|NOT COMPLETED|Overall Study||0
310977|NCT01640327|743334|P2|COMPLETED|Overall Study||63
310978|NCT01640327|743335|P1|COMPLETED|Overall Study||63
310979|NCT01640327|743334|P2|STARTED|Overall Study||63
310980|NCT01640327|743335|P1|STARTED|Overall Study||63
310981|NCT01640314|743349|P2|NOT COMPLETED|Overall Study||1
310982|NCT01640314|743350|P1|NOT COMPLETED|Overall Study||0
310983|NCT01640314|743349|P2|COMPLETED|Overall Study||62
310984|NCT01640314|743350|P1|COMPLETED|Overall Study||63
310985|NCT01640314|743349|P2|STARTED|Overall Study||63
310986|NCT01640314|743350|P1|STARTED|Overall Study||63
310987|NCT01640197|743366|P2|NOT COMPLETED|Overall Study||0
310988|NCT01640197|743367|P1|NOT COMPLETED|Overall Study||0
310989|NCT01640197|743366|P2|COMPLETED|Overall Study||30
310990|NCT01640197|743367|P1|COMPLETED|Overall Study||30
310991|NCT01640197|743366|P2|STARTED|Overall Study||30
310992|NCT01640197|743367|P1|STARTED|Overall Study||30
310993|NCT01640184|743388|P3|NOT COMPLETED|Overall Study||2
310994|NCT01640184|743389|P2|NOT COMPLETED|Overall Study||2
310995|NCT01640184|743390|P1|NOT COMPLETED|Overall Study||8
310996|NCT01640184|743388|P3|COMPLETED|Overall Study||20
310997|NCT01640184|743389|P2|COMPLETED|Overall Study||21
310998|NCT01640184|743390|P1|COMPLETED|Overall Study||26
310999|NCT01640184|743388|P3|STARTED|Overall Study||22
311000|NCT01640184|743389|P2|STARTED|Overall Study||23
311001|NCT01640184|743390|P1|STARTED|Overall Study||34
311002|NCT01640171|743412|P1|NOT COMPLETED|Overall Study||0
311003|NCT01640171|743412|P1|COMPLETED|Overall Study||57
311004|NCT01640171|743412|P1|STARTED|Overall Study||57
311005|NCT01640054|743419|P1|NOT COMPLETED|Overall Study||6
311006|NCT01640054|743419|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
311007|NCT01640054|743419|P1|Did Not Receive Treatment|Overall Study||0
311008|NCT01640054|743419|P1|STARTED|Overall Study|Patients who received treatment|115
311009|NCT01639833|743429|P2|NOT COMPLETED|Overall Study||4
311010|NCT01639833|743430|P1|NOT COMPLETED|Overall Study||6
311011|NCT01639833|743429|P2|COMPLETED|Overall Study||41
311012|NCT01639833|743430|P1|COMPLETED|Overall Study||39
311013|NCT01639833|743429|P2|STARTED|Overall Study||45
311014|NCT01639833|743430|P1|STARTED|Overall Study||45
311015|NCT01639755|743438|P1|NOT COMPLETED|Overall Study||19
311016|NCT01639755|743438|P1|COMPLETED|Overall Study||0
311017|NCT01639755|743438|P1|STARTED|Overall Study||19
311018|NCT01639742|743446|P1|NOT COMPLETED|Overall Study||18
311019|NCT01639742|743446|P1|COMPLETED|Overall Study||0
311020|NCT01639742|743446|P1|STARTED|Overall Study||18
311021|NCT01639560|743456|P2|NOT COMPLETED|Overall Study||29
311022|NCT01639560|743457|P1|NOT COMPLETED|Overall Study||19
311023|NCT01639560|743456|P2|COMPLETED|Overall Study||19
311024|NCT01639560|743457|P1|COMPLETED|Overall Study||26
311025|NCT01639560|743456|P2|End of Treatment|Overall Study||20
311026|NCT01639560|743457|P1|End of Treatment|Overall Study||28
311027|NCT01639560|743456|P2|STARTED|Overall Study||48
311028|NCT01639560|743457|P1|STARTED|Overall Study||45
311029|NCT01639443|743471|P2|NOT COMPLETED|Overall Study||0
311030|NCT01639443|743472|P1|NOT COMPLETED|Overall Study||0
311031|NCT01639443|743471|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
311032|NCT01639443|743472|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
311033|NCT01639443|743471|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
311034|NCT01639443|743472|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
311035|NCT01639222|743488|P1|NOT COMPLETED|Overall Study||0
311036|NCT01639222|743488|P1|COMPLETED|Overall Study||55
311037|NCT01639222|743488|P1|STARTED|Overall Study||55
311038|NCT01639157|743498|P2|NOT COMPLETED|Overall Study||0
311039|NCT01639157|743499|P1|NOT COMPLETED|Overall Study||0
311040|NCT01639157|743498|P2|COMPLETED|Overall Study||5
311041|NCT01639157|743499|P1|COMPLETED|Overall Study||4
311042|NCT01639157|743498|P2|STARTED|Overall Study||5
311043|NCT01639157|743499|P1|STARTED|Overall Study||4
311044|NCT01639144|743559|P2|NOT COMPLETED|Overall Study||5
311045|NCT01639144|743560|P1|NOT COMPLETED|Overall Study||10
311046|NCT01639144|743559|P2|COMPLETED|Overall Study||250
311047|NCT01639144|743560|P1|COMPLETED|Overall Study||250
311048|NCT01639144|743559|P2|STARTED|Overall Study||255
311049|NCT01639144|743560|P1|STARTED|Overall Study||260
311050|NCT01639001|743568|P2|NOT COMPLETED|Overall Study||103
311051|NCT01639001|743569|P1|NOT COMPLETED|Overall Study||104
311052|NCT01639001|743568|P2|COMPLETED|Overall Study||0
311053|NCT01639001|743569|P1|COMPLETED|Overall Study||0
311054|NCT01639001|743568|P2|Treated|Overall Study||101
311055|NCT01639001|743569|P1|Treated|Overall Study||104
311056|NCT01639001|743568|P2|STARTED|Overall Study||103
311057|NCT01639001|743569|P1|STARTED|Overall Study||104
311058|NCT01638559|743613|P1|NOT COMPLETED|Overall Study||0
311059|NCT01638559|743613|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint.|88
311060|NCT01638559|743613|P1|STARTED|Overall Study||88
311061|NCT01638507|743617|P1|NOT COMPLETED|Overall Study||6
311062|NCT01638507|743617|P1|COMPLETED|Overall Study||224
311063|NCT01638507|743617|P1|STARTED|Overall Study||230
311064|NCT01638468|743630|P1|NOT COMPLETED|Overall Study||0
311065|NCT01638468|743630|P1|COMPLETED|Overall Study||7
311066|NCT01638468|743630|P1|STARTED|Overall Study||7
311067|NCT01638312|743646|P2|NOT COMPLETED|Overall Study||0
311068|NCT01638312|743647|P1|NOT COMPLETED|Overall Study||0
311069|NCT01638312|743646|P2|COMPLETED|Overall Study||30
311070|NCT01638312|743647|P1|COMPLETED|Overall Study||20
311071|NCT01638312|743646|P2|STARTED|Overall Study||30
311072|NCT01638312|743647|P1|STARTED|Overall Study||20
311073|NCT01638000|743655|P2|NOT COMPLETED|Overall Study||71
311074|NCT01638000|743656|P1|NOT COMPLETED|Overall Study||60
311075|NCT01638000|743655|P2|COMPLETED|Overall Study||873
311076|NCT01638000|743656|P1|COMPLETED|Overall Study||883
311077|NCT01638000|743655|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
311078|NCT01638000|743656|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
311079|NCT01638000|743655|P2|STARTED|Overall Study||944
311080|NCT01638000|743656|P1|STARTED|Overall Study||943
311081|NCT01637961|743754|P1|NOT COMPLETED|Overall Study||2
311082|NCT01637961|743754|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
311083|NCT01637961|743754|P1|STARTED|Overall Study||23
311084|NCT01637935|743762|P2|NOT COMPLETED|Overall Study||0
311085|NCT01637935|743763|P1|NOT COMPLETED|Overall Study||0
311086|NCT01637935|743762|P2|COMPLETED|Overall Study||158918
311087|NCT01637935|743763|P1|COMPLETED|Overall Study||34181
311088|NCT01637935|743762|P2|STARTED|Overall Study||158918
311089|NCT01637935|743763|P1|STARTED|Overall Study||34181
311090|NCT01637922|743779|P2|NOT COMPLETED|Overall Study||5
311091|NCT01637922|743780|P1|NOT COMPLETED|Overall Study||2
311092|NCT01637922|743779|P2|COMPLETED|Overall Study||14
311093|NCT01637922|743780|P1|COMPLETED|Overall Study||13
311094|NCT01637922|743779|P2|STARTED|Overall Study||19
311095|NCT01637922|743780|P1|STARTED|Overall Study||15
311096|NCT01637584|743805|P2|NOT COMPLETED|Overall Study||3
311097|NCT01637584|743806|P1|NOT COMPLETED|Overall Study||1
311098|NCT01637584|743805|P2|COMPLETED|Overall Study||17
311099|NCT01637584|743806|P1|COMPLETED|Overall Study||19
311100|NCT01637584|743805|P2|STARTED|Overall Study||20
311101|NCT01637584|743806|P1|STARTED|Overall Study||20
311102|NCT01637272|743813|P1|NOT COMPLETED|Overall Study||20
311103|NCT01637272|743813|P1|COMPLETED|Overall Study||23
311104|NCT01637272|743813|P1|Completed Core But Did no Enter Ext..|Overall Study||4
311105|NCT01637272|743813|P1|Entered Extension Phase|Overall Study||27
311106|NCT01637272|743813|P1|Completed Core Phase (sc + LAR)|Overall Study||31
311107|NCT01637272|743813|P1|Completed sc Phase|Overall Study||33
311108|NCT01637272|743813|P1|STARTED|Overall Study||43
311109|NCT01637246|743875|P1|NOT COMPLETED|Overall Study||2139
311110|NCT01637246|743875|P1|COMPLETED|Overall Study||2246
311111|NCT01637246|743875|P1|STARTED|Overall Study||4385
311112|NCT01637090|743883|P1|NOT COMPLETED|Overall Study||3
311113|NCT01637090|743883|P1|COMPLETED|Overall Study||0
311114|NCT01637090|743883|P1|STARTED|Overall Study||3
311115|NCT01636986|743893|P2|NOT COMPLETED|Overall Study||2
311116|NCT01636986|743894|P1|NOT COMPLETED|Overall Study||0
311117|NCT01636986|743893|P2|COMPLETED|Overall Study||30
311118|NCT01636986|743894|P1|COMPLETED|Overall Study||30
311119|NCT01636986|743893|P2|STARTED|Overall Study||32
311120|NCT01636986|743894|P1|STARTED|Overall Study||30
311121|NCT01636960|743900|P1|NOT COMPLETED|Maintenance Phase||7
311122|NCT01636960|743900|P1|COMPLETED|Maintenance Phase||0
311123|NCT01636960|743900|P1|STARTED|Maintenance Phase||7
311124|NCT01636960|743900|P1|NOT COMPLETED|Induction Phase||2
311125|NCT01636960|743900|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
311126|NCT01636960|743900|P1|STARTED|Induction Phase||9
311127|NCT01636947|743908|P2|NOT COMPLETED|Overall Study||11
311128|NCT01636947|743909|P1|NOT COMPLETED|Overall Study||12
311129|NCT01636947|743908|P2|COMPLETED|Overall Study||239
311130|NCT01636947|743909|P1|COMPLETED|Overall Study||232
311131|NCT01636947|743908|P2|Treated|Overall Study||248
311132|NCT01636947|743909|P1|Treated|Overall Study||242
311133|NCT01636947|743908|P2|STARTED|Overall Study||250
311134|NCT01636947|743909|P1|STARTED|Overall Study||244
311135|NCT01636778|743929|P3|NOT COMPLETED|Follow-up Period After Part 2||4
311136|NCT01636778|743930|P2|NOT COMPLETED|Follow-up Period After Part 2||0
311137|NCT01636778|743931|P1|NOT COMPLETED|Follow-up Period After Part 2||0
311138|NCT01636778|743929|P3|COMPLETED|Follow-up Period After Part 2||37
311139|NCT01636778|743930|P2|COMPLETED|Follow-up Period After Part 2||0
311140|NCT01636778|743931|P1|COMPLETED|Follow-up Period After Part 2||0
311141|NCT01636778|743929|P3|STARTED|Follow-up Period After Part 2||41
311142|NCT01636778|743930|P2|STARTED|Follow-up Period After Part 2||0
311143|NCT01636778|743931|P1|STARTED|Follow-up Period After Part 2||0
311144|NCT01636778|743929|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
311145|NCT01636778|743930|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
311146|NCT01636778|743931|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
311147|NCT01636778|743929|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
311148|NCT01636778|743930|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
311149|NCT01636778|743931|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
311150|NCT01636778|743929|P3|STARTED|Antiviral Treatment Period (Part 2)||0
311151|NCT01636778|743930|P2|STARTED|Antiviral Treatment Period (Part 2)||41
311152|NCT01636778|743931|P1|STARTED|Antiviral Treatment Period (Part 2)||0
311153|NCT01636778|743929|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
311154|NCT01636778|743930|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
311155|NCT01636778|743931|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
311156|NCT01636778|743929|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
311157|NCT01636778|743930|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
311158|NCT01636778|743931|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
311159|NCT01636778|743929|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
311160|NCT01636778|743930|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
311161|NCT01636778|743931|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
311162|NCT01636765|743994|P1|NOT COMPLETED|Overall Study||0
311163|NCT01636765|743994|P1|COMPLETED|Overall Study||104
311164|NCT01636765|743994|P1|STARTED|Overall Study||104
311165|NCT01636713|744002|P3|NOT COMPLETED|Overall Study||23
311166|NCT01636713|744003|P2|NOT COMPLETED|Overall Study||28
311167|NCT01636713|744004|P1|NOT COMPLETED|Overall Study||32
311168|NCT01636713|744002|P3|COMPLETED|Overall Study||170
311169|NCT01636713|744003|P2|COMPLETED|Overall Study||166
311170|NCT01636713|744004|P1|COMPLETED|Overall Study||161
311171|NCT01636713|744002|P3|STARTED|Overall Study||193
311172|NCT01636713|744003|P2|STARTED|Overall Study||194
311173|NCT01636713|744004|P1|STARTED|Overall Study||193
311174|NCT01636661|744020|P2|NOT COMPLETED|Overall Study||0
311175|NCT01636661|744021|P1|NOT COMPLETED|Overall Study||0
311176|NCT01636661|744020|P2|COMPLETED|Overall Study||6
311177|NCT01636661|744021|P1|COMPLETED|Overall Study||5
311178|NCT01636661|744020|P2|STARTED|Overall Study||6
311179|NCT01636661|744021|P1|STARTED|Overall Study||5
311180|NCT01636466|744031|P2|NOT COMPLETED|Overall Study||0
311181|NCT01636466|744032|P1|NOT COMPLETED|Overall Study||1
311182|NCT01636466|744031|P2|COMPLETED|Overall Study||0
311183|NCT01636466|744032|P1|COMPLETED|Overall Study||0
311184|NCT01636466|744031|P2|STARTED|Overall Study||0
311185|NCT01636466|744032|P1|STARTED|Overall Study||1
311186|NCT01636414|744041|P3|NOT COMPLETED|Overall Study||9
311187|NCT01636414|744042|P2|NOT COMPLETED|Overall Study||6
311188|NCT01636414|744043|P1|NOT COMPLETED|Overall Study||3
311189|NCT01636414|744041|P3|COMPLETED|Overall Study||65
311190|NCT01636414|744042|P2|COMPLETED|Overall Study||60
311191|NCT01636414|744043|P1|COMPLETED|Overall Study||61
311192|NCT01636414|744041|P3|STARTED|Overall Study||74
311193|NCT01636414|744042|P2|STARTED|Overall Study||66
311194|NCT01636414|744043|P1|STARTED|Overall Study||64
311195|NCT01636362|744054|P1|NOT COMPLETED|Overall Study||8
311196|NCT01636362|744054|P1|COMPLETED|Overall Study||37
311197|NCT01636362|744054|P1|STARTED|Overall Study||45
311198|NCT01636258|744062|P2|NOT COMPLETED|Overall Study||0
311199|NCT01636258|744063|P1|NOT COMPLETED|Overall Study||1
311200|NCT01636258|744062|P2|COMPLETED|Overall Study||14
311201|NCT01636258|744063|P1|COMPLETED|Overall Study||12
311202|NCT01636258|744062|P2|STARTED|Overall Study||14
311203|NCT01636258|744063|P1|STARTED|Overall Study||13
311204|NCT01636206|744079|P2|NOT COMPLETED|Overall Study||51
311205|NCT01636206|744080|P1|NOT COMPLETED|Overall Study||19
311206|NCT01636206|744079|P2|COMPLETED|Overall Study||170
311207|NCT01636206|744080|P1|COMPLETED|Overall Study||92
311208|NCT01636206|744079|P2|STARTED|Overall Study||221
311209|NCT01636206|744080|P1|STARTED|Overall Study||111
311210|NCT01636102|744088|P2|NOT COMPLETED|Overall Study||0
311211|NCT01636102|744089|P1|NOT COMPLETED|Overall Study||0
311212|NCT01636102|744088|P2|COMPLETED|Overall Study||63
311213|NCT01636102|744089|P1|COMPLETED|Overall Study||63
311214|NCT01636102|744088|P2|STARTED|Overall Study||63
311215|NCT01636102|744089|P1|STARTED|Overall Study||63
311216|NCT01636076|744103|P2|NOT COMPLETED|Overall Study||25
311217|NCT01636076|744104|P1|NOT COMPLETED|Overall Study||17
311218|NCT01636076|744103|P2|COMPLETED|Overall Study||288
311219|NCT01636076|744104|P1|COMPLETED|Overall Study||299
311220|NCT01636076|744103|P2|STARTED|Overall Study||313
311221|NCT01636076|744104|P1|STARTED|Overall Study||316
311222|NCT01636063|744166|P2|NOT COMPLETED|Overall Study||0
311223|NCT01636063|744167|P1|NOT COMPLETED|Overall Study||0
311224|NCT01636063|744166|P2|COMPLETED|Overall Study||21
311225|NCT01636063|744167|P1|COMPLETED|Overall Study||21
311226|NCT01636063|744166|P2|STARTED|Overall Study||21
311227|NCT01636063|744167|P1|STARTED|Overall Study||21
311228|NCT01635933|744175|P2|NOT COMPLETED|Overall Study||8
311229|NCT01635933|744176|P1|NOT COMPLETED|Overall Study||2
311230|NCT01635933|744175|P2|COMPLETED|Overall Study||177
311231|NCT01635933|744176|P1|COMPLETED|Overall Study||176
311232|NCT01635933|744175|P2|STARTED|Overall Study||185
311233|NCT01635933|744176|P1|STARTED|Overall Study||178
311234|NCT01635920|744188|P2|NOT COMPLETED|Overall Study||1
311235|NCT01635920|744189|P1|NOT COMPLETED|Overall Study||3
311236|NCT01635920|744188|P2|COMPLETED|Overall Study||125
311237|NCT01635920|744189|P1|COMPLETED|Overall Study||122
311238|NCT01635920|744188|P2|STARTED|Overall Study||126
311239|NCT01635920|744189|P1|STARTED|Overall Study||125
311240|NCT01635881|744197|P1|NOT COMPLETED|Overall Study||0
311241|NCT01635881|744197|P1|COMPLETED|Overall Study||60
311242|NCT01635881|744197|P1|STARTED|Overall Study||60
311243|NCT01635855|744202|P1|NOT COMPLETED|Overall Study||4
311244|NCT01635855|744202|P1|COMPLETED|Overall Study||113
311245|NCT01635855|744202|P1|STARTED|Overall Study||117
311246|NCT01635504|744206|P1|NOT COMPLETED|Overall Study||0
311247|NCT01635504|744206|P1|COMPLETED|Overall Study||5
311248|NCT01635504|744206|P1|STARTED|Overall Study||5
311249|NCT01635439|744213|P2|NOT COMPLETED|Overall Study||0
311250|NCT01635439|744214|P1|NOT COMPLETED|Overall Study||0
311251|NCT01635439|744213|P2|COMPLETED|Overall Study||100
311252|NCT01635439|744214|P1|COMPLETED|Overall Study||100
311253|NCT01635439|744213|P2|STARTED|Overall Study||100
311254|NCT01635439|744214|P1|STARTED|Overall Study||100
311255|NCT01635244|744231|P3|NOT COMPLETED|Overall Study||2
311256|NCT01635244|744232|P2|NOT COMPLETED|Overall Study||1
311257|NCT01635244|744233|P1|NOT COMPLETED|Overall Study||1
311258|NCT01635244|744231|P3|COMPLETED|Overall Study||18
311259|NCT01635244|744232|P2|COMPLETED|Overall Study||21
311260|NCT01635244|744233|P1|COMPLETED|Overall Study||17
311261|NCT01635244|744231|P3|STARTED|Overall Study||20
311262|NCT01635244|744232|P2|STARTED|Overall Study||22
311263|NCT01635244|744233|P1|STARTED|Overall Study||18
311264|NCT01635218|744244|P3|NOT COMPLETED|Overall Study||6
311265|NCT01635218|744245|P2|NOT COMPLETED|Overall Study||7
311266|NCT01635218|744246|P1|NOT COMPLETED|Overall Study||3
311267|NCT01635218|744244|P3|COMPLETED|Overall Study||37
311268|NCT01635218|744245|P2|COMPLETED|Overall Study||39
311269|NCT01635218|744246|P1|COMPLETED|Overall Study||41
311270|NCT01635218|744244|P3|STARTED|Overall Study||43
311271|NCT01635218|744245|P2|STARTED|Overall Study||46
311272|NCT01635218|744246|P1|STARTED|Overall Study||44
311273|NCT01635062|744268|P2|NOT COMPLETED|Overall Study||0
311274|NCT01635062|744269|P1|NOT COMPLETED|Overall Study||0
311275|NCT01635062|744268|P2|COMPLETED|Overall Study||9
311276|NCT01635062|744269|P1|COMPLETED|Overall Study||9
311277|NCT01635062|744268|P2|Post-Randomization Sodium Loaded|Overall Study||9
311278|NCT01635062|744269|P1|Post-Randomization Sodium Loaded|Overall Study||9
311279|NCT01635062|744268|P2|Post-randomization Sodium Restriction|Overall Study||9
311280|NCT01635062|744269|P1|Post-randomization Sodium Restriction|Overall Study||9
311281|NCT01635062|744268|P2|Sodium Loading Baseline Visit|Overall Study||9
311282|NCT01635062|744269|P1|Sodium Loading Baseline Visit|Overall Study||9
311283|NCT01635062|744268|P2|Sodium Restriction Baseline Visit|Overall Study||9
311284|NCT01635062|744269|P1|Sodium Restriction Baseline Visit|Overall Study||9
311285|NCT01635062|744268|P2|STARTED|Overall Study||9
311286|NCT01635062|744269|P1|STARTED|Overall Study||9
311287|NCT01634659|744281|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
311288|NCT01634659|744282|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
311289|NCT01634659|744281|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
311290|NCT01634659|744282|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
311291|NCT01634659|744281|P2|STARTED|Period 2 - Second 8 Days of Wear||158
311292|NCT01634659|744282|P1|STARTED|Period 2 - Second 8 Days of Wear||155
311293|NCT01634659|744281|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
311294|NCT01634659|744282|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
311295|NCT01634659|744281|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
311296|NCT01634659|744282|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
311297|NCT01634659|744281|P2|STARTED|Period 1 - First 8 Days of Wear||158
311298|NCT01634659|744282|P1|STARTED|Period 1 - First 8 Days of Wear||155
311299|NCT01634620|744292|P1|NOT COMPLETED|Overall Study||0
311300|NCT01634620|744292|P1|COMPLETED|Overall Study||200
311301|NCT01634620|744292|P1|STARTED|Overall Study||200
311302|NCT01634555|744312|P1|NOT COMPLETED|Overall Study||17
311303|NCT01634555|744312|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
311304|NCT01634555|744312|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
311305|NCT01634555|744312|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
311306|NCT01634555|744312|P1|STARTED|Overall Study||29
311307|NCT01634360|744322|P2|NOT COMPLETED|Overall Study||136
311308|NCT01634360|744323|P1|NOT COMPLETED|Overall Study||49
311309|NCT01634360|744322|P2|COMPLETED|Overall Study||0
311310|NCT01634360|744323|P1|COMPLETED|Overall Study||0
311311|NCT01634360|744322|P2|STARTED|Overall Study||136
311312|NCT01634360|744323|P1|STARTED|Overall Study||49
311313|NCT01634256|744335|P2|NOT COMPLETED|Overall Study||8
311314|NCT01634256|744336|P1|NOT COMPLETED|Overall Study||4
311315|NCT01634256|744335|P2|COMPLETED|Overall Study||22
311316|NCT01634256|744336|P1|COMPLETED|Overall Study||26
311317|NCT01634256|744335|P2|STARTED|Overall Study||30
311318|NCT01634256|744336|P1|STARTED|Overall Study||30
311319|NCT01634243|744352|P2|NOT COMPLETED|Overall Study||5
311320|NCT01634243|744353|P1|NOT COMPLETED|Overall Study||6
311321|NCT01634243|744352|P2|COMPLETED|Overall Study||38
311322|NCT01634243|744353|P1|COMPLETED|Overall Study||15
311323|NCT01634243|744352|P2|STARTED|Overall Study||43
311324|NCT01634243|744353|P1|STARTED|Overall Study||21
311325|NCT01634165|744379|P4|NOT COMPLETED|Period 4||0
311326|NCT01634165|744380|P3|NOT COMPLETED|Period 4||0
311327|NCT01634165|744381|P2|NOT COMPLETED|Period 4||0
311328|NCT01634165|744382|P1|NOT COMPLETED|Period 4||0
311329|NCT01634165|744379|P4|COMPLETED|Period 4||6
311330|NCT01634165|744380|P3|COMPLETED|Period 4||6
311331|NCT01634165|744381|P2|COMPLETED|Period 4||5
311332|NCT01634165|744382|P1|COMPLETED|Period 4||6
311333|NCT01634165|744379|P4|STARTED|Period 4||6
311334|NCT01634165|744380|P3|STARTED|Period 4||6
311335|NCT01634165|744381|P2|STARTED|Period 4||5
311336|NCT01634165|744382|P1|STARTED|Period 4||6
311337|NCT01634165|744379|P4|NOT COMPLETED|Period 3||0
311338|NCT01634165|744380|P3|NOT COMPLETED|Period 3||0
311339|NCT01634165|744381|P2|NOT COMPLETED|Period 3||0
311340|NCT01634165|744382|P1|NOT COMPLETED|Period 3||0
311341|NCT01634165|744379|P4|COMPLETED|Period 3||6
311342|NCT01634165|744380|P3|COMPLETED|Period 3||6
311343|NCT01634165|744381|P2|COMPLETED|Period 3||5
311344|NCT01634165|744382|P1|COMPLETED|Period 3||6
311345|NCT01634165|744379|P4|STARTED|Period 3||6
311346|NCT01634165|744380|P3|STARTED|Period 3||6
311347|NCT01634165|744381|P2|STARTED|Period 3||5
311348|NCT01634165|744382|P1|STARTED|Period 3||6
311349|NCT01634165|744379|P4|NOT COMPLETED|Period 2||0
311350|NCT01634165|744380|P3|NOT COMPLETED|Period 2||0
311351|NCT01634165|744381|P2|NOT COMPLETED|Period 2||1
311352|NCT01634165|744382|P1|NOT COMPLETED|Period 2||0
311353|NCT01634165|744379|P4|COMPLETED|Period 2||6
311354|NCT01634165|744380|P3|COMPLETED|Period 2||6
311355|NCT01634165|744381|P2|COMPLETED|Period 2||5
311356|NCT01634165|744382|P1|COMPLETED|Period 2||6
311357|NCT01634165|744379|P4|STARTED|Period 2||6
311358|NCT01634165|744380|P3|STARTED|Period 2||6
311359|NCT01634165|744381|P2|STARTED|Period 2||6
311360|NCT01634165|744382|P1|STARTED|Period 2||6
311361|NCT01634165|744379|P4|NOT COMPLETED|Period 1||0
311362|NCT01634165|744380|P3|NOT COMPLETED|Period 1||0
311363|NCT01634165|744381|P2|NOT COMPLETED|Period 1||0
311364|NCT01634165|744382|P1|NOT COMPLETED|Period 1||0
311365|NCT01634165|744379|P4|COMPLETED|Period 1||6
311366|NCT01634165|744380|P3|COMPLETED|Period 1||6
311367|NCT01634165|744381|P2|COMPLETED|Period 1||6
311368|NCT01634165|744382|P1|COMPLETED|Period 1||6
311369|NCT01634165|744379|P4|Received at Least 1 Dose of Study Drug|Period 1||6
311370|NCT01634165|744380|P3|Received at Least 1 Dose of Study Drug|Period 1||6
311371|NCT01634165|744381|P2|Received at Least 1 Dose of Study Drug|Period 1||6
311372|NCT01634165|744382|P1|Received at Least 1 Dose of Study Drug|Period 1||6
311373|NCT01634165|744379|P4|STARTED|Period 1||6
311374|NCT01634165|744380|P3|STARTED|Period 1||6
311375|NCT01634165|744381|P2|STARTED|Period 1||6
311376|NCT01634165|744382|P1|STARTED|Period 1||6
311377|NCT01634152|744415|P3|NOT COMPLETED|Overall Study||4
311378|NCT01634152|744416|P2|NOT COMPLETED|Overall Study||1
311379|NCT01634152|744417|P1|NOT COMPLETED|Overall Study||4
311380|NCT01634152|744415|P3|COMPLETED|Overall Study||126
311381|NCT01634152|744416|P2|COMPLETED|Overall Study||136
311382|NCT01634152|744417|P1|COMPLETED|Overall Study||130
311383|NCT01634152|744415|P3|STARTED|Overall Study||130
311384|NCT01634152|744416|P2|STARTED|Overall Study||137
311385|NCT01634152|744417|P1|STARTED|Overall Study||134
311386|NCT01634139|744500|P3|NOT COMPLETED|Overall Study||5
311387|NCT01634139|744501|P2|NOT COMPLETED|Overall Study||6
311388|NCT01634139|744502|P1|NOT COMPLETED|Overall Study||10
311389|NCT01634139|744500|P3|COMPLETED|Overall Study||130
311390|NCT01634139|744501|P2|COMPLETED|Overall Study||130
311391|NCT01634139|744502|P1|COMPLETED|Overall Study||122
311392|NCT01634139|744500|P3|STARTED|Overall Study||135
311393|NCT01634139|744501|P2|STARTED|Overall Study||136
311394|NCT01634139|744502|P1|STARTED|Overall Study||132
311395|NCT01634113|744603|P3|NOT COMPLETED|Overall Study||1
311396|NCT01634113|744604|P2|NOT COMPLETED|Overall Study||0
311397|NCT01634113|744605|P1|NOT COMPLETED|Overall Study||0
311398|NCT01634113|744603|P3|COMPLETED|Overall Study||31
311399|NCT01634113|744604|P2|COMPLETED|Overall Study||36
311400|NCT01634113|744605|P1|COMPLETED|Overall Study||34
311401|NCT01634113|744603|P3|STARTED|Overall Study||32
311402|NCT01634113|744604|P2|STARTED|Overall Study||36
311403|NCT01634113|744605|P1|STARTED|Overall Study||34
311404|NCT01634100|744649|P6|NOT COMPLETED|Overall Study||0
311405|NCT01634100|744650|P5|NOT COMPLETED|Overall Study||0
311406|NCT01634100|744651|P4|NOT COMPLETED|Overall Study||0
311407|NCT01634100|744652|P3|NOT COMPLETED|Overall Study||1
311408|NCT01634100|744653|P2|NOT COMPLETED|Overall Study||0
311409|NCT01634100|744654|P1|NOT COMPLETED|Overall Study||1
311410|NCT01634100|744649|P6|COMPLETED|Overall Study||3
311411|NCT01634100|744650|P5|COMPLETED|Overall Study||3
311412|NCT01634100|744651|P4|COMPLETED|Overall Study||3
311413|NCT01634100|744652|P3|COMPLETED|Overall Study||2
311414|NCT01634100|744653|P2|COMPLETED|Overall Study||3
311415|NCT01634100|744654|P1|COMPLETED|Overall Study||2
311416|NCT01634100|744649|P6|Received Empa + Probenecid|Overall Study||3
311417|NCT01634100|744650|P5|Received Empa + Probenecid|Overall Study||3
311418|NCT01634100|744651|P4|Received Empa + Probenecid|Overall Study||3
311419|NCT01634100|744652|P3|Received Empa + Probenecid|Overall Study||2
311420|NCT01634100|744653|P2|Received Empa + Probenecid|Overall Study||3
311421|NCT01634100|744654|P1|Received Empa + Probenecid|Overall Study||2
311422|NCT01634100|744649|P6|Received Empa + Rifampicin|Overall Study||3
311423|NCT01634100|744650|P5|Received Empa + Rifampicin|Overall Study||3
311424|NCT01634100|744651|P4|Received Empa + Rifampicin|Overall Study||3
311425|NCT01634100|744652|P3|Received Empa + Rifampicin|Overall Study||3
311426|NCT01634100|744653|P2|Received Empa + Rifampicin|Overall Study||3
311427|NCT01634100|744654|P1|Received Empa + Rifampicin|Overall Study||3
311428|NCT01634100|744649|P6|Received Empa Alone|Overall Study||3
311429|NCT01634100|744650|P5|Received Empa Alone|Overall Study||3
311430|NCT01634100|744651|P4|Received Empa Alone|Overall Study||3
311431|NCT01634100|744652|P3|Received Empa Alone|Overall Study||3
311432|NCT01634100|744653|P2|Received Empa Alone|Overall Study||3
311433|NCT01634100|744654|P1|Received Empa Alone|Overall Study||3
311434|NCT01634100|744649|P6|STARTED|Overall Study||3
311435|NCT01634100|744650|P5|STARTED|Overall Study||3
311436|NCT01634100|744651|P4|STARTED|Overall Study||3
311437|NCT01634100|744652|P3|STARTED|Overall Study||3
311438|NCT01634100|744653|P2|STARTED|Overall Study||3
311439|NCT01634100|744654|P1|STARTED|Overall Study||3
311440|NCT01633944|744670|P3|NOT COMPLETED|Double-blind Treatment Phase||58
311441|NCT01633944|744671|P2|NOT COMPLETED|Double-blind Treatment Phase||54
311442|NCT01633944|744672|P1|NOT COMPLETED|Double-blind Treatment Phase||0
311443|NCT01633944|744670|P3|COMPLETED|Double-blind Treatment Phase||174
311444|NCT01633944|744671|P2|COMPLETED|Double-blind Treatment Phase||176
311445|NCT01633944|744672|P1|COMPLETED|Double-blind Treatment Phase||0
311446|NCT01633944|744670|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
311447|NCT01633944|744671|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
311448|NCT01633944|744672|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
311449|NCT01633944|744670|P3|NOT COMPLETED|Open-label Titration Phase||0
311450|NCT01633944|744671|P2|NOT COMPLETED|Open-label Titration Phase||0
311451|NCT01633944|744672|P1|NOT COMPLETED|Open-label Titration Phase||290
311452|NCT01633944|744670|P3|COMPLETED|Open-label Titration Phase||0
311453|NCT01633944|744671|P2|COMPLETED|Open-label Titration Phase||0
311454|NCT01633944|744672|P1|COMPLETED|Open-label Titration Phase||462
311455|NCT01633944|744670|P3|STARTED|Open-label Titration Phase||0
311456|NCT01633944|744671|P2|STARTED|Open-label Titration Phase||0
311457|NCT01633944|744672|P1|STARTED|Open-label Titration Phase||752
311458|NCT01633853|744694|P2|NOT COMPLETED|Overall Study||0
311459|NCT01633853|744695|P1|NOT COMPLETED|Overall Study||0
311460|NCT01633853|744694|P2|COMPLETED|Overall Study||100
311461|NCT01633853|744695|P1|COMPLETED|Overall Study||104
311462|NCT01633853|744694|P2|STARTED|Overall Study||100
311463|NCT01633853|744695|P1|STARTED|Overall Study||104
311464|NCT01633827|744709|P2|NOT COMPLETED|Second Intervention||0
311465|NCT01633827|744710|P1|NOT COMPLETED|Second Intervention||0
311466|NCT01633827|744709|P2|COMPLETED|Second Intervention||11
311467|NCT01633827|744710|P1|COMPLETED|Second Intervention||11
311468|NCT01633827|744709|P2|STARTED|Second Intervention||11
311469|NCT01633827|744710|P1|STARTED|Second Intervention||11
311470|NCT01633827|744709|P2|NOT COMPLETED|Washout Period||0
311471|NCT01633827|744710|P1|NOT COMPLETED|Washout Period||0
311472|NCT01633827|744709|P2|COMPLETED|Washout Period||11
311473|NCT01633827|744710|P1|COMPLETED|Washout Period||11
311474|NCT01633827|744709|P2|STARTED|Washout Period||11
311475|NCT01633827|744710|P1|STARTED|Washout Period||11
311476|NCT01633827|744709|P2|NOT COMPLETED|First Intervention||0
311477|NCT01633827|744710|P1|NOT COMPLETED|First Intervention||0
311478|NCT01633827|744709|P2|COMPLETED|First Intervention||11
311479|NCT01633827|744710|P1|COMPLETED|First Intervention||11
311480|NCT01633827|744709|P2|STARTED|First Intervention||11
311481|NCT01633827|744710|P1|STARTED|First Intervention||11
311482|NCT01633320|744725|P2|NOT COMPLETED|Overall Study||0
311483|NCT01633320|744726|P1|NOT COMPLETED|Overall Study||0
311484|NCT01633320|744725|P2|COMPLETED|Overall Study||68
311485|NCT01633320|744726|P1|COMPLETED|Overall Study||132
311486|NCT01633320|744725|P2|STARTED|Overall Study||68
311487|NCT01633320|744726|P1|STARTED|Overall Study||132
311488|NCT01632995|744734|P1|NOT COMPLETED|Main Study Follow-up Period||120
311489|NCT01632995|744734|P1|COMPLETED|Main Study Follow-up Period||437
311490|NCT01632995|744734|P1|STARTED|Main Study Follow-up Period||557
311491|NCT01632995|744734|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
311492|NCT01632995|744734|P1|COMPLETED|Pre-screening to Enrollment Period||557
311493|NCT01632995|744734|P1|STARTED|Pre-screening to Enrollment Period||1069
311494|NCT01632904|744749|P2|NOT COMPLETED|Overall Study||6
311495|NCT01632904|744750|P1|NOT COMPLETED|Overall Study||7
311496|NCT01632904|744749|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
311497|NCT01632904|744750|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
311498|NCT01632904|744749|P2|STARTED|Overall Study||56
311499|NCT01632904|744750|P1|STARTED|Overall Study||54
311500|NCT01632878|744760|P1|NOT COMPLETED|Treatment||158
311501|NCT01632878|744760|P1|COMPLETED|Treatment||1105
311502|NCT01632878|744760|P1|STARTED|Treatment||1263
311503|NCT01632878|744760|P1|NOT COMPLETED|Screening||268
311504|NCT01632878|744760|P1|COMPLETED|Screening||1263
311505|NCT01632878|744760|P1|STARTED|Screening||1531
311506|NCT01632800|744764|P1|NOT COMPLETED|Overall Study||1
311507|NCT01632800|744764|P1|COMPLETED|Overall Study||25
311508|NCT01632800|744764|P1|STARTED|Overall Study||26
311509|NCT01632735|744770|P2|NOT COMPLETED|Overall Study||3
311510|NCT01632735|744771|P1|NOT COMPLETED|Overall Study||4
311511|NCT01632735|744770|P2|COMPLETED|Overall Study||37
311512|NCT01632735|744771|P1|COMPLETED|Overall Study||36
311513|NCT01632735|744770|P2|STARTED|Overall Study||40
311514|NCT01632735|744771|P1|STARTED|Overall Study||40
311515|NCT01632709|744787|P4|NOT COMPLETED|Overall Study||1
311516|NCT01632709|744788|P3|NOT COMPLETED|Overall Study||0
311517|NCT01632709|744789|P2|NOT COMPLETED|Overall Study||1
311518|NCT01632709|744790|P1|NOT COMPLETED|Overall Study||2
311519|NCT01632709|744787|P4|COMPLETED|Overall Study||3
311520|NCT01632709|744788|P3|COMPLETED|Overall Study||5
311521|NCT01632709|744789|P2|COMPLETED|Overall Study||2
311522|NCT01632709|744790|P1|COMPLETED|Overall Study||2
311523|NCT01632709|744787|P4|Completed Visit 2 (Received Injection)|Overall Study||3
311524|NCT01632709|744788|P3|Completed Visit 2 (Received Injection)|Overall Study||5
311525|NCT01632709|744789|P2|Completed Visit 2 (Received Injection)|Overall Study||2
311526|NCT01632709|744790|P1|Completed Visit 2 (Received Injection)|Overall Study||4
311527|NCT01632709|744787|P4|STARTED|Overall Study||4
311528|NCT01632709|744788|P3|STARTED|Overall Study||5
311529|NCT01632709|744789|P2|STARTED|Overall Study||3
311530|NCT01632709|744790|P1|STARTED|Overall Study||4
311531|NCT01632683|744816|P2|NOT COMPLETED|Overall Study||0
311532|NCT01632683|744817|P1|NOT COMPLETED|Overall Study||0
311533|NCT01632683|744816|P2|COMPLETED|Overall Study||552
311534|NCT01632683|744817|P1|COMPLETED|Overall Study||548
311535|NCT01632683|744816|P2|STARTED|Overall Study||552
311536|NCT01632683|744817|P1|STARTED|Overall Study||548
311537|NCT01632423|744823|P1|NOT COMPLETED|Overall Study||246
311538|NCT01632423|744823|P1|COMPLETED|Overall Study||10091
311539|NCT01632423|744823|P1|STARTED|Overall Study||10337
311540|NCT01632267|744831|P1|NOT COMPLETED|Overall Study||7
311541|NCT01632267|744831|P1|COMPLETED|Overall Study||97
311542|NCT01632267|744831|P1|STARTED|Overall Study||104
311543|NCT01632215|744837|P2|NOT COMPLETED|Overall Study||1
311544|NCT01632215|744838|P1|NOT COMPLETED|Overall Study||2
311545|NCT01632215|744837|P2|COMPLETED|Overall Study||19
311546|NCT01632215|744838|P1|COMPLETED|Overall Study||18
311547|NCT01632215|744837|P2|STARTED|Overall Study||20
311548|NCT01632215|744838|P1|STARTED|Overall Study||20
311549|NCT01632150|744844|P1|NOT COMPLETED|Overall Study||40
311550|NCT01632150|744844|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
311551|NCT01632150|744844|P1|Received Cyclophosphamide|Overall Study||11
311552|NCT01632150|744844|P1|STARTED|Overall Study||40
311553|NCT01632020|744853|P2|NOT COMPLETED|Overall Study||0
311554|NCT01632020|744854|P1|NOT COMPLETED|Overall Study||2
311555|NCT01632020|744853|P2|COMPLETED|Overall Study||3
311556|NCT01632020|744854|P1|COMPLETED|Overall Study||2
311557|NCT01632020|744853|P2|STARTED|Overall Study||3
311558|NCT01632020|744854|P1|STARTED|Overall Study||4
311559|NCT01631929|744864|P2|NOT COMPLETED|Overall Study||0
311560|NCT01631929|744865|P1|NOT COMPLETED|Overall Study||0
311561|NCT01631929|744864|P2|COMPLETED|Overall Study||6
311562|NCT01631929|744865|P1|COMPLETED|Overall Study||6
311563|NCT01631929|744864|P2|STARTED|Overall Study||6
311564|NCT01631929|744865|P1|STARTED|Overall Study||6
311565|NCT01631864|744873|P2|NOT COMPLETED|Overall Study||4
311566|NCT01631864|744874|P1|NOT COMPLETED|Overall Study||2
311567|NCT01631864|744873|P2|COMPLETED|Overall Study||44
311568|NCT01631864|744874|P1|COMPLETED|Overall Study||48
311569|NCT01631864|744873|P2|STARTED|Overall Study||48
311570|NCT01631864|744874|P1|STARTED|Overall Study||50
311571|NCT01631825|744886|P1|NOT COMPLETED|Overall Study||65
311572|NCT01631825|744886|P1|COMPLETED|Overall Study||256
311573|NCT01631825|744886|P1|STARTED|Overall Study||321
311574|NCT01631812|744906|P1|NOT COMPLETED|Overall Study||37
311575|NCT01631812|744906|P1|COMPLETED|Overall Study||93
311576|NCT01631812|744906|P1|STARTED|Overall Study||130
311577|NCT01631682|744918|P4|NOT COMPLETED|Overall Study||2
311578|NCT01631682|744919|P3|NOT COMPLETED|Overall Study||31
311579|NCT01631682|744920|P2|NOT COMPLETED|Overall Study||45
311580|NCT01631682|744921|P1|NOT COMPLETED|Overall Study||31
311581|NCT01631682|744918|P4|COMPLETED|Overall Study||5
311582|NCT01631682|744919|P3|COMPLETED|Overall Study||13
311583|NCT01631682|744920|P2|COMPLETED|Overall Study||21
311584|NCT01631682|744921|P1|COMPLETED|Overall Study||24
311585|NCT01631682|744918|P4|STARTED|Overall Study||7
311586|NCT01631682|744919|P3|STARTED|Overall Study||44
311587|NCT01631682|744920|P2|STARTED|Overall Study||66
311588|NCT01631682|744921|P1|STARTED|Overall Study||55
311589|NCT01631630|744933|P2|NOT COMPLETED|Overall Study||0
311590|NCT01631630|744934|P1|NOT COMPLETED|Overall Study||3
311591|NCT01631630|744933|P2|COMPLETED|Overall Study||8
311592|NCT01631630|744934|P1|COMPLETED|Overall Study||5
311593|NCT01631630|744933|P2|STARTED|Overall Study||8
311594|NCT01631630|744934|P1|STARTED|Overall Study||8
311595|NCT01631435|745044|P1|NOT COMPLETED|Overall Study||9
311596|NCT01631435|745044|P1|COMPLETED|Overall Study||66
311597|NCT01631435|745044|P1|STARTED|Overall Study||75
311598|NCT01631227|745051|P2|NOT COMPLETED|Overall Study||22
311599|NCT01631227|745052|P1|NOT COMPLETED|Overall Study||30
311600|NCT01631227|745051|P2|COMPLETED|Overall Study||310
311601|NCT01631227|745052|P1|COMPLETED|Overall Study||303
311602|NCT01631227|745051|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
311603|NCT01631227|745052|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
311604|NCT01631227|745051|P2|Safety Subject Sample|Overall Study||332
311605|NCT01631227|745052|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
311606|NCT01631227|745051|P2|STARTED|Overall Study||332
311607|NCT01631227|745052|P1|STARTED|Overall Study||333
311608|NCT01631149|745060|P2|NOT COMPLETED|Overall Study||0
311609|NCT01631149|745061|P1|NOT COMPLETED|Overall Study||0
311610|NCT01631149|745060|P2|COMPLETED|Overall Study||12
311611|NCT01631149|745061|P1|COMPLETED|Overall Study||12
311612|NCT01631149|745060|P2|STARTED|Overall Study||12
311613|NCT01631149|745061|P1|STARTED|Overall Study||12
311614|NCT01631110|745077|P2|NOT COMPLETED|Overall Study||0
311615|NCT01631110|745078|P1|NOT COMPLETED|Overall Study||0
311616|NCT01631110|745077|P2|COMPLETED|Overall Study||55
311617|NCT01631110|745078|P1|COMPLETED|Overall Study||55
311618|NCT01631110|745077|P2|STARTED|Overall Study||55
311619|NCT01631110|745078|P1|STARTED|Overall Study||55
311620|NCT01631071|745092|P2|NOT COMPLETED|Overall Study||0
311621|NCT01631071|745093|P1|NOT COMPLETED|Overall Study||0
311622|NCT01631071|745092|P2|COMPLETED|Overall Study||55
311623|NCT01631071|745093|P1|COMPLETED|Overall Study||55
311624|NCT01631071|745092|P2|STARTED|Overall Study||55
311625|NCT01631071|745093|P1|STARTED|Overall Study||55
311626|NCT01630694|745107|P2|NOT COMPLETED|Overall Study||0
311627|NCT01630694|745108|P1|NOT COMPLETED|Overall Study||0
311628|NCT01630694|745107|P2|COMPLETED|Overall Study||16
311629|NCT01630694|745108|P1|COMPLETED|Overall Study||12
311630|NCT01630694|745107|P2|STARTED|Overall Study||16
311631|NCT01630694|745108|P1|STARTED|Overall Study||12
311632|NCT01630135|745118|P2|NOT COMPLETED|Overall Study||2
311633|NCT01630135|745119|P1|NOT COMPLETED|Overall Study||0
311634|NCT01630135|745118|P2|COMPLETED|Overall Study||128
311635|NCT01630135|745119|P1|COMPLETED|Overall Study||131
311636|NCT01630135|745118|P2|STARTED|Overall Study||130
311637|NCT01630135|745119|P1|STARTED|Overall Study||131
311638|NCT01630109|745158|P3|NOT COMPLETED|Overall Study||0
311639|NCT01630109|745159|P2|NOT COMPLETED|Overall Study||0
311640|NCT01630109|745160|P1|NOT COMPLETED|Overall Study||0
311641|NCT01630109|745158|P3|COMPLETED|Overall Study||3
311642|NCT01630109|745159|P2|COMPLETED|Overall Study||1
311643|NCT01630109|745160|P1|COMPLETED|Overall Study||1
311644|NCT01630109|745158|P3|STARTED|Overall Study||3
311645|NCT01630109|745159|P2|STARTED|Overall Study||1
311646|NCT01630109|745160|P1|STARTED|Overall Study||1
311647|NCT01629823|745183|P3|NOT COMPLETED|Washout Period||0
311648|NCT01629823|745184|P2|NOT COMPLETED|Washout Period||6
311649|NCT01629823|745185|P1|NOT COMPLETED|Washout Period||3
311650|NCT01629823|745183|P3|COMPLETED|Washout Period||50
311651|NCT01629823|745184|P2|COMPLETED|Washout Period||51
311652|NCT01629823|745185|P1|COMPLETED|Washout Period||51
311653|NCT01629823|745183|P3|STARTED|Washout Period||50
311654|NCT01629823|745184|P2|STARTED|Washout Period||57
311655|NCT01629823|745185|P1|STARTED|Washout Period||54
311656|NCT01629823|745183|P3|NOT COMPLETED|Trial Period||10
311657|NCT01629823|745184|P2|NOT COMPLETED|Trial Period||13
311658|NCT01629823|745185|P1|NOT COMPLETED|Trial Period||13
311659|NCT01629823|745183|P3|COMPLETED|Trial Period||49
311660|NCT01629823|745184|P2|COMPLETED|Trial Period||56
311661|NCT01629823|745185|P1|COMPLETED|Trial Period||53
311662|NCT01629823|745183|P3|STARTED|Trial Period||59
311663|NCT01629823|745184|P2|STARTED|Trial Period||69
311664|NCT01629823|745185|P1|STARTED|Trial Period||66
311665|NCT01629797|745193|P1|NOT COMPLETED|Overall Study||18
311666|NCT01629797|745193|P1|COMPLETED|Overall Study||82
311667|NCT01629797|745193|P1|STARTED|Overall Study||100
311668|NCT01629784|745200|P1|NOT COMPLETED|Overall Study||6
311669|NCT01629784|745200|P1|COMPLETED|Overall Study||25
311670|NCT01629784|745200|P1|STARTED|Overall Study||31
311671|NCT01629771|745209|P2|NOT COMPLETED|Overall Study||0
311672|NCT01629771|745210|P1|NOT COMPLETED|Overall Study||0
311673|NCT01629771|745209|P2|COMPLETED|Overall Study||36
311674|NCT01629771|745210|P1|COMPLETED|Overall Study||36
311675|NCT01629771|745209|P2|STARTED|Overall Study||36
311676|NCT01629771|745210|P1|STARTED|Overall Study||36
311677|NCT01629706|745220|P1|NOT COMPLETED|Phase 2 Habitual||10
311678|NCT01629706|745220|P1|COMPLETED|Phase 2 Habitual||48
311679|NCT01629706|745220|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
311680|NCT01629706|745220|P1|NOT COMPLETED|Phase 1 PureVision||9
311681|NCT01629706|745220|P1|COMPLETED|Phase 1 PureVision||35
311682|NCT01629706|745220|P1|STARTED|Phase 1 PureVision||44
311683|NCT01629693|745248|P2|NOT COMPLETED|Overall Study||10
311684|NCT01629693|745249|P1|NOT COMPLETED|Overall Study||5
311685|NCT01629693|745248|P2|COMPLETED|Overall Study||178
311686|NCT01629693|745249|P1|COMPLETED|Overall Study||188
311687|NCT01629693|745248|P2|STARTED|Overall Study||188
311688|NCT01629693|745249|P1|STARTED|Overall Study||193
311689|NCT01629667|745258|P3|NOT COMPLETED|Overall Study||45
311690|NCT01629667|745259|P2|NOT COMPLETED|Overall Study||41
311691|NCT01629667|745260|P1|NOT COMPLETED|Overall Study||47
311692|NCT01629667|745258|P3|COMPLETED|Overall Study||14
311693|NCT01629667|745259|P2|COMPLETED|Overall Study||17
311694|NCT01629667|745260|P1|COMPLETED|Overall Study||12
311695|NCT01629667|745258|P3|Randomized and Treated|Overall Study||59
311696|NCT01629667|745259|P2|Randomized and Treated|Overall Study||57
311697|NCT01629667|745260|P1|Randomized and Treated|Overall Study||57
311698|NCT01629667|745258|P3|STARTED|Overall Study||59
311699|NCT01629667|745259|P2|STARTED|Overall Study||58
311700|NCT01629667|745260|P1|STARTED|Overall Study||59
311701|NCT01629589|745344|P2|NOT COMPLETED|Overall Study||7
311702|NCT01629589|745345|P1|NOT COMPLETED|Overall Study||8
311703|NCT01629589|745344|P2|COMPLETED|Overall Study||204
311704|NCT01629589|745345|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
311705|NCT01629589|745344|P2|STARTED|Overall Study||211
311706|NCT01629589|745345|P1|STARTED|Overall Study||212
311707|NCT01629290|745361|P1|NOT COMPLETED|Overall Study||0
311708|NCT01629290|745361|P1|COMPLETED|Overall Study||15
311709|NCT01629290|745361|P1|STARTED|Overall Study||15
311710|NCT01629134|745371|P1|NOT COMPLETED|Overall Study||0
311711|NCT01629134|745371|P1|COMPLETED|Overall Study||62
311712|NCT01629134|745371|P1|STARTED|Overall Study||62
311713|NCT01628965|745384|P1|NOT COMPLETED|Overall Study||49
311714|NCT01628965|745384|P1|COMPLETED|Overall Study||94
311715|NCT01628965|745384|P1|STARTED|Overall Study||143
311716|NCT01628926|745393|P3|NOT COMPLETED|Overall Study||17
311717|NCT01628926|745394|P2|NOT COMPLETED|Overall Study||23
311718|NCT01628926|745395|P1|NOT COMPLETED|Overall Study||26
311719|NCT01628926|745393|P3|COMPLETED|Overall Study||68
311720|NCT01628926|745394|P2|COMPLETED|Overall Study||144
311721|NCT01628926|745395|P1|COMPLETED|Overall Study||142
311722|NCT01628926|745393|P3|STARTED|Overall Study||85
311723|NCT01628926|745394|P2|STARTED|Overall Study||167
311724|NCT01628926|745395|P1|STARTED|Overall Study||168
311725|NCT01628913|745444|P2|NOT COMPLETED|Overall Study||31
311726|NCT01628913|745445|P1|NOT COMPLETED|Overall Study||31
311727|NCT01628913|745444|P2|COMPLETED|Overall Study||0
311728|NCT01628913|745445|P1|COMPLETED|Overall Study||0
311729|NCT01628913|745444|P2|STARTED|Overall Study||31
311730|NCT01628913|745445|P1|STARTED|Overall Study||31
311731|NCT01628848|745459|P2|NOT COMPLETED|Overall Study||14
311732|NCT01628848|745460|P1|NOT COMPLETED|Overall Study||12
311733|NCT01628848|745459|P2|COMPLETED|Overall Study||73
311734|NCT01628848|745460|P1|COMPLETED|Overall Study||75
311735|NCT01628848|745459|P2|STARTED|Overall Study||87
311736|NCT01628848|745460|P1|STARTED|Overall Study||87
311737|NCT01628692|745494|P6|NOT COMPLETED|Overall Study||9
311738|NCT01628692|745495|P5|NOT COMPLETED|Overall Study||4
311739|NCT01628692|745496|P4|NOT COMPLETED|Overall Study||1
311740|NCT01628692|745497|P3|NOT COMPLETED|Overall Study||8
311741|NCT01628692|745498|P2|NOT COMPLETED|Overall Study||6
311742|NCT01628692|745499|P1|NOT COMPLETED|Overall Study||7
311743|NCT01628692|745494|P6|COMPLETED|Overall Study||0
311744|NCT01628692|745495|P5|COMPLETED|Overall Study||8
311745|NCT01628692|745496|P4|COMPLETED|Overall Study||19
311746|NCT01628692|745497|P3|COMPLETED|Overall Study||43
311747|NCT01628692|745498|P2|COMPLETED|Overall Study||17
311748|NCT01628692|745499|P1|COMPLETED|Overall Study||46
311749|NCT01628692|745494|P6|STARTED|Overall Study||9
311750|NCT01628692|745495|P5|STARTED|Overall Study||12
311751|NCT01628692|745496|P4|STARTED|Overall Study||20
311752|NCT01628692|745497|P3|STARTED|Overall Study||51
311753|NCT01628692|745498|P2|STARTED|Overall Study||23
311754|NCT01628692|745499|P1|STARTED|Overall Study||53
311755|NCT01628614|745543|P1|NOT COMPLETED|Overall Study||1775
311756|NCT01628614|745543|P1|COMPLETED|Overall Study||3037
311757|NCT01628614|745543|P1|STARTED|Overall Study||4812
311758|NCT01628601|745549|P1|NOT COMPLETED|Overall Study||41
311759|NCT01628601|745549|P1|COMPLETED|Overall Study||351
311760|NCT01628601|745549|P1|STARTED|Overall Study||392
311761|NCT01628588|745557|P1|NOT COMPLETED|Overall Study||16
311762|NCT01628588|745557|P1|COMPLETED|Overall Study||838
311763|NCT01628588|745557|P1|STARTED|Overall Study||854
311764|NCT01628510|745567|P2|NOT COMPLETED|Overall Study||5
311765|NCT01628510|745568|P1|NOT COMPLETED|Overall Study||3
311766|NCT01628510|745567|P2|COMPLETED|Overall Study||44
311767|NCT01628510|745568|P1|COMPLETED|Overall Study||48
311768|NCT01628510|745567|P2|STARTED|Overall Study||49
311769|NCT01628510|745568|P1|STARTED|Overall Study||51
311770|NCT01628367|745576|P2|NOT COMPLETED|Overall Study||0
311771|NCT01628367|745577|P1|NOT COMPLETED|Overall Study||1
311772|NCT01628367|745576|P2|COMPLETED|Overall Study||16
311773|NCT01628367|745577|P1|COMPLETED|Overall Study||15
311774|NCT01628367|745576|P2|STARTED|Overall Study||16
311775|NCT01628367|745577|P1|STARTED|Overall Study||16
311776|NCT01628250|745589|P2|NOT COMPLETED|Overall Study||0
311777|NCT01628250|745590|P1|NOT COMPLETED|Overall Study||0
311778|NCT01628250|745589|P2|COMPLETED|Overall Study||50
311779|NCT01628250|745590|P1|COMPLETED|Overall Study||49
311780|NCT01628250|745589|P2|STARTED|Overall Study||50
311781|NCT01628250|745590|P1|STARTED|Overall Study||49
311782|NCT01628042|745600|P4|NOT COMPLETED|Overall Study||0
311783|NCT01628042|745601|P3|NOT COMPLETED|Overall Study||0
311784|NCT01628042|745602|P2|NOT COMPLETED|Overall Study||0
311785|NCT01628042|745603|P1|NOT COMPLETED|Overall Study||0
311786|NCT01628042|745600|P4|COMPLETED|Overall Study||8
311787|NCT01628042|745601|P3|COMPLETED|Overall Study||8
311788|NCT01628042|745602|P2|COMPLETED|Overall Study||8
311789|NCT01628042|745603|P1|COMPLETED|Overall Study||8
311790|NCT01628042|745600|P4|STARTED|Overall Study||8
311791|NCT01628042|745601|P3|STARTED|Overall Study||8
311792|NCT01628042|745602|P2|STARTED|Overall Study||8
311793|NCT01628042|745603|P1|STARTED|Overall Study||8
311794|NCT01627860|745623|P2|NOT COMPLETED|Overall Study||6
311795|NCT01627860|745624|P1|NOT COMPLETED|Overall Study||12
311796|NCT01627860|745623|P2|COMPLETED|Overall Study||14
311797|NCT01627860|745624|P1|COMPLETED|Overall Study||23
311798|NCT01627860|745623|P2|STARTED|Overall Study||20
311799|NCT01627860|745624|P1|STARTED|Overall Study||35
311800|NCT01627782|745638|P4|NOT COMPLETED|Overall Study||6
311801|NCT01627782|745639|P3|NOT COMPLETED|Overall Study||15
311802|NCT01627782|745640|P2|NOT COMPLETED|Overall Study||6
311803|NCT01627782|745641|P1|NOT COMPLETED|Overall Study||16
311804|NCT01627782|745638|P4|COMPLETED|Overall Study||11
311805|NCT01627782|745639|P3|COMPLETED|Overall Study||1
311806|NCT01627782|745640|P2|COMPLETED|Overall Study||12
311807|NCT01627782|745641|P1|COMPLETED|Overall Study||1
311808|NCT01627782|745638|P4|Treated|Overall Study||17
311809|NCT01627782|745639|P3|Treated|Overall Study||16
311810|NCT01627782|745640|P2|Treated|Overall Study||18
311811|NCT01627782|745641|P1|Treated|Overall Study||16
311812|NCT01627782|745638|P4|STARTED|Overall Study||17
311813|NCT01627782|745639|P3|STARTED|Overall Study||16
311814|NCT01627782|745640|P2|STARTED|Overall Study||18
311815|NCT01627782|745641|P1|STARTED|Overall Study||17
311816|NCT01627561|745699|P2|NOT COMPLETED|Overall Study||3
311817|NCT01627561|745700|P1|NOT COMPLETED|Overall Study||0
311818|NCT01627561|745699|P2|COMPLETED|Overall Study||71
311819|NCT01627561|745700|P1|COMPLETED|Overall Study||74
311820|NCT01627561|745699|P2|STARTED|Overall Study||74
311821|NCT01627561|745700|P1|STARTED|Overall Study||74
311822|NCT01627340|745748|P2|NOT COMPLETED|Overall Study||4
311823|NCT01627340|745749|P1|NOT COMPLETED|Overall Study||12
311824|NCT01627340|745748|P2|COMPLETED|Overall Study||254
311825|NCT01627340|745749|P1|COMPLETED|Overall Study||404
311826|NCT01627340|745748|P2|STARTED|Overall Study||258
311827|NCT01627340|745749|P1|STARTED|Overall Study||416
311828|NCT01627327|745767|P2|NOT COMPLETED|Overall Study||39
311829|NCT01627327|745768|P1|NOT COMPLETED|Overall Study||19
311830|NCT01627327|745767|P2|COMPLETED|Overall Study||274
311831|NCT01627327|745768|P1|COMPLETED|Overall Study||291
311832|NCT01627327|745767|P2|STARTED|Overall Study||313
311833|NCT01627327|745768|P1|STARTED|Overall Study||310
311834|NCT01627249|745781|P3|NOT COMPLETED|Overall Study||12
311835|NCT01627249|745782|P2|NOT COMPLETED|Overall Study||12
311836|NCT01627249|745783|P1|NOT COMPLETED|Overall Study||16
311837|NCT01627249|745781|P3|COMPLETED|Overall Study||206
311838|NCT01627249|745782|P2|COMPLETED|Overall Study||206
311839|NCT01627249|745783|P1|COMPLETED|Overall Study||208
311840|NCT01627249|745781|P3|STARTED|Overall Study||218
311841|NCT01627249|745782|P2|STARTED|Overall Study||218
311842|NCT01627249|745783|P1|STARTED|Overall Study||224
311843|NCT01627002|745820|P9|NOT COMPLETED|Overall Study||0
311844|NCT01627002|745821|P8|NOT COMPLETED|Overall Study||0
311845|NCT01627002|745822|P7|NOT COMPLETED|Overall Study||0
311846|NCT01627002|745823|P6|NOT COMPLETED|Overall Study||0
311847|NCT01627002|745824|P5|NOT COMPLETED|Overall Study||0
311848|NCT01627002|745825|P4|NOT COMPLETED|Overall Study||0
311849|NCT01627002|745826|P3|NOT COMPLETED|Overall Study||0
311850|NCT01627002|745827|P2|NOT COMPLETED|Overall Study||0
311851|NCT01627002|745828|P1|NOT COMPLETED|Overall Study||0
311852|NCT01627002|745820|P9|COMPLETED|Overall Study||7
311853|NCT01627002|745821|P8|COMPLETED|Overall Study||5
311854|NCT01627002|745822|P7|COMPLETED|Overall Study||10
311855|NCT01627002|745823|P6|COMPLETED|Overall Study||9
311856|NCT01627002|745824|P5|COMPLETED|Overall Study||2
311857|NCT01627002|745825|P4|COMPLETED|Overall Study||4
311858|NCT01627002|745826|P3|COMPLETED|Overall Study||4
311859|NCT01627002|745827|P2|COMPLETED|Overall Study||4
311860|NCT01627002|745828|P1|COMPLETED|Overall Study||4
311861|NCT01627002|745820|P9|STARTED|Overall Study||7
311862|NCT01627002|745821|P8|STARTED|Overall Study||5
311863|NCT01627002|745822|P7|STARTED|Overall Study||10
311864|NCT01627002|745823|P6|STARTED|Overall Study||9
311865|NCT01627002|745824|P5|STARTED|Overall Study||2
311866|NCT01627002|745825|P4|STARTED|Overall Study||4
311867|NCT01627002|745826|P3|STARTED|Overall Study||4
311868|NCT01627002|745827|P2|STARTED|Overall Study||4
311869|NCT01627002|745828|P1|STARTED|Overall Study||4
311870|NCT01626820|745881|P2|NOT COMPLETED|Overall Study||0
311871|NCT01626820|745882|P1|NOT COMPLETED|Overall Study||0
311872|NCT01626820|745881|P2|COMPLETED|Overall Study||57
311873|NCT01626820|745882|P1|COMPLETED|Overall Study||56
311874|NCT01626820|745881|P2|STARTED|Overall Study||57
311875|NCT01626820|745882|P1|STARTED|Overall Study||56
311876|NCT01626690|745904|P2|NOT COMPLETED|Overall Study||0
311877|NCT01626690|745905|P1|NOT COMPLETED|Overall Study||2
311878|NCT01626690|745904|P2|COMPLETED|Overall Study||51
311879|NCT01626690|745905|P1|COMPLETED|Overall Study||47
311880|NCT01626690|745904|P2|STARTED|Overall Study||51
311881|NCT01626690|745905|P1|STARTED|Overall Study||49
311882|NCT01626456|745927|P2|NOT COMPLETED|Overall Study||117
311883|NCT01626456|745928|P1|NOT COMPLETED|Overall Study||35
311884|NCT01626456|745927|P2|COMPLETED|Overall Study||251
311885|NCT01626456|745928|P1|COMPLETED|Overall Study||75
311886|NCT01626456|745927|P2|STARTED|Overall Study||368
311887|NCT01626456|745928|P1|STARTED|Overall Study||110
311888|NCT01626391|745958|P2|NOT COMPLETED|Overall Study||0
311889|NCT01626391|745959|P1|NOT COMPLETED|Overall Study||2
311890|NCT01626391|745958|P2|COMPLETED|Overall Study||4
311891|NCT01626391|745959|P1|COMPLETED|Overall Study||3
311892|NCT01626391|745958|P2|STARTED|Overall Study||4
311893|NCT01626391|745959|P1|STARTED|Overall Study||5
311894|NCT01626118|745969|P4|NOT COMPLETED|Overall Study||3
311895|NCT01626118|745970|P3|NOT COMPLETED|Overall Study||2
311896|NCT01626118|745971|P2|NOT COMPLETED|Overall Study||2
311897|NCT01626118|745972|P1|NOT COMPLETED|Overall Study||2
311898|NCT01626118|745969|P4|COMPLETED|Overall Study||91
311899|NCT01626118|745970|P3|COMPLETED|Overall Study||90
311900|NCT01626118|745971|P2|COMPLETED|Overall Study||91
311901|NCT01626118|745972|P1|COMPLETED|Overall Study||92
311902|NCT01626118|745969|P4|STARTED|Overall Study||94
311903|NCT01626118|745970|P3|STARTED|Overall Study||92
311904|NCT01626118|745971|P2|STARTED|Overall Study||93
311905|NCT01626118|745972|P1|STARTED|Overall Study||94
311906|NCT01626092|746010|P1|NOT COMPLETED|Overall Study||0
311907|NCT01626092|746010|P1|COMPLETED|Overall Study||3
311908|NCT01626092|746010|P1|STARTED|Overall Study||3
311909|NCT01625910|746018|P2|NOT COMPLETED|Overall Study||4
311910|NCT01625910|746019|P1|NOT COMPLETED|Overall Study||3
311911|NCT01625910|746018|P2|COMPLETED|Overall Study||33
311912|NCT01625910|746019|P1|COMPLETED|Overall Study||32
311913|NCT01625910|746018|P2|STARTED|Overall Study||37
311914|NCT01625910|746019|P1|STARTED|Overall Study||35
311915|NCT01625845|746029|P2|NOT COMPLETED|Overall Study||3
311916|NCT01625845|746030|P1|NOT COMPLETED|Overall Study||5
311917|NCT01625845|746029|P2|COMPLETED|Overall Study||3
311918|NCT01625845|746030|P1|COMPLETED|Overall Study||5
311919|NCT01625845|746029|P2|STARTED|Overall Study||6
311920|NCT01625845|746030|P1|STARTED|Overall Study||10
311921|NCT01625689|746050|P2|NOT COMPLETED|Overall Study||1
311922|NCT01625689|746051|P1|NOT COMPLETED|Overall Study||2
311923|NCT01625689|746050|P2|COMPLETED|Overall Study||149
311924|NCT01625689|746051|P1|COMPLETED|Overall Study||148
311925|NCT01625689|746050|P2|STARTED|Overall Study||150
311926|NCT01625689|746051|P1|STARTED|Overall Study||150
311927|NCT01625507|746061|P1|NOT COMPLETED|Overall Study||10
311928|NCT01625507|746061|P1|COMPLETED|Overall Study||63
311929|NCT01625507|746061|P1|STARTED|Overall Study||73
311930|NCT01625455|746076|P2|NOT COMPLETED|Overall Study||0
311931|NCT01625455|746077|P1|NOT COMPLETED|Overall Study||0
311932|NCT01625455|746076|P2|COMPLETED|Overall Study||3
311933|NCT01625455|746077|P1|COMPLETED|Overall Study||2
311934|NCT01625455|746076|P2|STARTED|Overall Study||3
311935|NCT01625455|746077|P1|STARTED|Overall Study||2
311936|NCT01625377|746087|P2|NOT COMPLETED|Overall Study||22
311937|NCT01625377|746088|P1|NOT COMPLETED|Overall Study||7
311938|NCT01625377|746087|P2|COMPLETED|Overall Study||71
311939|NCT01625377|746088|P1|COMPLETED|Overall Study||88
311940|NCT01625377|746087|P2|Intent to Treat Population|Overall Study||90
311941|NCT01625377|746088|P1|Intent to Treat Population|Overall Study||93
311942|NCT01625377|746087|P2|Safety Set of Population|Overall Study||90
311943|NCT01625377|746088|P1|Safety Set of Population|Overall Study||94
311944|NCT01625377|746087|P2|STARTED|Overall Study||93
311945|NCT01625377|746088|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
311946|NCT01625338|746121|P3|NOT COMPLETED|Overall Study||39
311947|NCT01625338|746122|P2|NOT COMPLETED|Overall Study||44
311948|NCT01625338|746123|P1|NOT COMPLETED|Overall Study||32
311949|NCT01625338|746121|P3|COMPLETED|Overall Study||181
311950|NCT01625338|746122|P2|COMPLETED|Overall Study||156
311951|NCT01625338|746123|P1|COMPLETED|Overall Study||82
311952|NCT01625338|746121|P3|STARTED|Overall Study||220
311953|NCT01625338|746122|P2|STARTED|Overall Study||200
311954|NCT01625338|746123|P1|STARTED|Overall Study||114
311955|NCT01625221|746143|P1|NOT COMPLETED|Overall Study||7
311956|NCT01625221|746143|P1|COMPLETED|Overall Study||28
311957|NCT01625221|746143|P1|STARTED|Overall Study||35
311958|NCT01625169|746147|P1|NOT COMPLETED|Overall Study||0
311959|NCT01625169|746147|P1|COMPLETED|Overall Study||9
311960|NCT01625169|746147|P1|STARTED|Overall Study||9
311961|NCT01624948|746162|P2|NOT COMPLETED|Overall Study||0
311962|NCT01624948|746163|P1|NOT COMPLETED|Overall Study||0
311963|NCT01624948|746162|P2|COMPLETED|Overall Study||20
311964|NCT01624948|746163|P1|COMPLETED|Overall Study||20
311965|NCT01624948|746162|P2|STARTED|Overall Study||20
311966|NCT01624948|746163|P1|STARTED|Overall Study||20
311967|NCT01624740|746181|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
311968|NCT01624740|746182|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
311969|NCT01624740|746181|P2|COMPLETED|Second Intervention (3-4 Days)||9
311970|NCT01624740|746182|P1|COMPLETED|Second Intervention (3-4 Days)||8
311971|NCT01624740|746181|P2|STARTED|Second Intervention (3-4 Days)||9
311972|NCT01624740|746182|P1|STARTED|Second Intervention (3-4 Days)||9
311973|NCT01624740|746181|P2|NOT COMPLETED|Washout (1 Hour)||0
311974|NCT01624740|746182|P1|NOT COMPLETED|Washout (1 Hour)||0
311975|NCT01624740|746181|P2|COMPLETED|Washout (1 Hour)||9
311976|NCT01624740|746182|P1|COMPLETED|Washout (1 Hour)||9
311977|NCT01624740|746181|P2|STARTED|Washout (1 Hour)||9
311978|NCT01624740|746182|P1|STARTED|Washout (1 Hour)||9
311979|NCT01624740|746181|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
311980|NCT01624740|746182|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
311981|NCT01624740|746181|P2|COMPLETED|First Intervention (3-4 Days)||9
311982|NCT01624740|746182|P1|COMPLETED|First Intervention (3-4 Days)||9
311983|NCT01624740|746181|P2|STARTED|First Intervention (3-4 Days)||9
311984|NCT01624740|746182|P1|STARTED|First Intervention (3-4 Days)||9
311985|NCT01624467|746189|P1|NOT COMPLETED|Overall Study||31
311986|NCT01624467|746189|P1|COMPLETED|Overall Study||44
311987|NCT01624467|746189|P1|Received at Least One Dose of Study Drug|Overall Study||75
311988|NCT01624467|746189|P1|STARTED|Overall Study||75
311989|NCT01624363|746202|P1|NOT COMPLETED|Overall Study||0
311990|NCT01624363|746202|P1|COMPLETED|Overall Study||341
311991|NCT01624363|746202|P1|STARTED|Overall Study||341
311992|NCT01624350|746206|P1|NOT COMPLETED|Overall Study||25
311993|NCT01624350|746206|P1|COMPLETED|Overall Study||75
311994|NCT01624350|746206|P1|STARTED|Overall Study||100
311995|NCT01624259|746228|P2|NOT COMPLETED|Overall Study||31
311996|NCT01624259|746229|P1|NOT COMPLETED|Overall Study||30
311997|NCT01624259|746228|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
311998|NCT01624259|746229|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
311999|NCT01624259|746228|P2|Received at Least One Dose of Study Drug|Overall Study||300
312000|NCT01624259|746229|P1|Received at Least One Dose of Study Drug|Overall Study||299
312001|NCT01624259|746228|P2|STARTED|Overall Study||300
312002|NCT01624259|746229|P1|STARTED|Overall Study||299
312003|NCT01624233|746278|P1|NOT COMPLETED|Period 3 - Maintenance||7
312004|NCT01624233|746278|P1|COMPLETED|Period 3 - Maintenance||83
312005|NCT01624233|746278|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
312006|NCT01624233|746278|P1|STARTED|Period 3 - Maintenance||90
312007|NCT01624233|746278|P1|NOT COMPLETED|Period 2 - Induction||1
312008|NCT01624233|746278|P1|COMPLETED|Period 2 - Induction||90
312009|NCT01624233|746278|P1|Plaque Ps|Period 2 - Induction||78
312010|NCT01624233|746278|P1|Pustular Ps|Period 2 - Induction||5
312011|NCT01624233|746278|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
312012|NCT01624233|746278|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
312013|NCT01624233|746278|P1|STARTED|Period 2 - Induction||91
312014|NCT01624168|746298|P3|NOT COMPLETED|Overall Study||6
312015|NCT01624168|746299|P2|NOT COMPLETED|Overall Study||12
312016|NCT01624168|746300|P1|NOT COMPLETED|Overall Study||4
312017|NCT01624168|746298|P3|COMPLETED|Overall Study||22
312018|NCT01624168|746299|P2|COMPLETED|Overall Study||16
312019|NCT01624168|746300|P1|COMPLETED|Overall Study||15
312020|NCT01624168|746298|P3|STARTED|Overall Study||28
312021|NCT01624168|746299|P2|STARTED|Overall Study||28
312022|NCT01624168|746300|P1|STARTED|Overall Study||19
312023|NCT01623869|746323|P1|NOT COMPLETED|Overall Study||0
312024|NCT01623869|746323|P1|COMPLETED|Overall Study||16
312025|NCT01623869|746323|P1|STARTED|Overall Study||16
312026|NCT01623830|746331|P2|NOT COMPLETED|Overall Study||9
312027|NCT01623830|746332|P1|NOT COMPLETED|Overall Study||7
312028|NCT01623830|746331|P2|COMPLETED|Overall Study||35
312029|NCT01623830|746332|P1|COMPLETED|Overall Study||38
312030|NCT01623830|746331|P2|STARTED|Overall Study||44
312031|NCT01623830|746332|P1|STARTED|Overall Study||45
312032|NCT01623479|746346|P1|NOT COMPLETED|Overall Study||0
312033|NCT01623479|746346|P1|COMPLETED|Overall Study||585
312034|NCT01623479|746346|P1|STARTED|Overall Study||585
312035|NCT01623323|746352|P1|NOT COMPLETED|Overall Study||104
312036|NCT01623323|746352|P1|COMPLETED|Overall Study||601
312037|NCT01623323|746352|P1|STARTED|Overall Study||705
312038|NCT01623271|746356|P1|NOT COMPLETED|Overall Study||2
312039|NCT01623271|746356|P1|COMPLETED|Overall Study||3
312040|NCT01623271|746356|P1|STARTED|Overall Study||5
312041|NCT01623154|746360|P1|NOT COMPLETED|Overall Study||4
312042|NCT01623154|746360|P1|COMPLETED|Overall Study||95
312043|NCT01623154|746360|P1|Available for Analysis|Overall Study||95
312044|NCT01623154|746360|P1|STARTED|Overall Study||99
312045|NCT01623115|746368|P2|NOT COMPLETED|Overall Study||77
312046|NCT01623115|746369|P1|NOT COMPLETED|Overall Study||33
312047|NCT01623115|746368|P2|COMPLETED|Overall Study||246
312048|NCT01623115|746369|P1|COMPLETED|Overall Study||130
312049|NCT01623115|746368|P2|Treated|Overall Study||322
312050|NCT01623115|746369|P1|Treated|Overall Study||163
312051|NCT01623115|746368|P2|STARTED|Overall Study|Randomized|323
312052|NCT01623115|746369|P1|STARTED|Overall Study|Randomized|163
312053|NCT01623050|746429|P1|NOT COMPLETED|Overall Study||9
312054|NCT01623050|746429|P1|COMPLETED|Overall Study||27
312055|NCT01623050|746429|P1|Treated|Overall Study||34
312056|NCT01623050|746429|P1|STARTED|Overall Study||36
312057|NCT01622673|746443|P6|NOT COMPLETED|Treatment Period 5||0
312058|NCT01622673|746444|P5|NOT COMPLETED|Treatment Period 5||0
312059|NCT01622673|746445|P4|NOT COMPLETED|Treatment Period 5||0
312060|NCT01622673|746446|P3|NOT COMPLETED|Treatment Period 5||0
312061|NCT01622673|746447|P2|NOT COMPLETED|Treatment Period 5||0
312062|NCT01622673|746448|P1|NOT COMPLETED|Treatment Period 5||0
312063|NCT01622673|746443|P6|COMPLETED|Treatment Period 5||4
312064|NCT01622673|746444|P5|COMPLETED|Treatment Period 5||4
312065|NCT01622673|746445|P4|COMPLETED|Treatment Period 5||4
312066|NCT01622673|746446|P3|COMPLETED|Treatment Period 5||4
312067|NCT01622673|746447|P2|COMPLETED|Treatment Period 5||3
312068|NCT01622673|746448|P1|COMPLETED|Treatment Period 5||4
312069|NCT01622673|746443|P6|STARTED|Treatment Period 5||4
312070|NCT01622673|746444|P5|STARTED|Treatment Period 5||4
312071|NCT01622673|746445|P4|STARTED|Treatment Period 5||4
312072|NCT01622673|746446|P3|STARTED|Treatment Period 5||4
312073|NCT01622673|746447|P2|STARTED|Treatment Period 5||3
312074|NCT01622673|746448|P1|STARTED|Treatment Period 5||4
312075|NCT01622673|746443|P6|NOT COMPLETED|Treatment Period 4||0
312076|NCT01622673|746444|P5|NOT COMPLETED|Treatment Period 4||0
312077|NCT01622673|746445|P4|NOT COMPLETED|Treatment Period 4||0
312078|NCT01622673|746446|P3|NOT COMPLETED|Treatment Period 4||0
312079|NCT01622673|746447|P2|NOT COMPLETED|Treatment Period 4||0
312080|NCT01622673|746448|P1|NOT COMPLETED|Treatment Period 4||0
312081|NCT01622673|746443|P6|COMPLETED|Treatment Period 4||4
312082|NCT01622673|746444|P5|COMPLETED|Treatment Period 4||4
312083|NCT01622673|746445|P4|COMPLETED|Treatment Period 4||4
312084|NCT01622673|746446|P3|COMPLETED|Treatment Period 4||4
312085|NCT01622673|746447|P2|COMPLETED|Treatment Period 4||3
312086|NCT01622673|746448|P1|COMPLETED|Treatment Period 4||4
312087|NCT01622673|746443|P6|STARTED|Treatment Period 4||4
312088|NCT01622673|746444|P5|STARTED|Treatment Period 4||4
312089|NCT01622673|746445|P4|STARTED|Treatment Period 4||4
312090|NCT01622673|746446|P3|STARTED|Treatment Period 4||4
312091|NCT01622673|746447|P2|STARTED|Treatment Period 4||3
312092|NCT01622673|746448|P1|STARTED|Treatment Period 4||4
312093|NCT01622673|746443|P6|NOT COMPLETED|Treatment Period 3||0
312094|NCT01622673|746444|P5|NOT COMPLETED|Treatment Period 3||0
312095|NCT01622673|746445|P4|NOT COMPLETED|Treatment Period 3||0
312096|NCT01622673|746446|P3|NOT COMPLETED|Treatment Period 3||0
312097|NCT01622673|746447|P2|NOT COMPLETED|Treatment Period 3||1
312098|NCT01622673|746448|P1|NOT COMPLETED|Treatment Period 3||0
312099|NCT01622673|746443|P6|COMPLETED|Treatment Period 3||4
312100|NCT01622673|746444|P5|COMPLETED|Treatment Period 3||4
312101|NCT01622673|746445|P4|COMPLETED|Treatment Period 3||4
312102|NCT01622673|746446|P3|COMPLETED|Treatment Period 3||4
312103|NCT01622673|746447|P2|COMPLETED|Treatment Period 3||3
312104|NCT01622673|746448|P1|COMPLETED|Treatment Period 3||4
312105|NCT01622673|746443|P6|STARTED|Treatment Period 3||4
312106|NCT01622673|746444|P5|STARTED|Treatment Period 3||4
312107|NCT01622673|746445|P4|STARTED|Treatment Period 3||4
312108|NCT01622673|746446|P3|STARTED|Treatment Period 3||4
312109|NCT01622673|746447|P2|STARTED|Treatment Period 3||4
312110|NCT01622673|746448|P1|STARTED|Treatment Period 3||4
312111|NCT01622673|746443|P6|NOT COMPLETED|Treatment Period 2||0
312112|NCT01622673|746444|P5|NOT COMPLETED|Treatment Period 2||0
312113|NCT01622673|746445|P4|NOT COMPLETED|Treatment Period 2||1
312114|NCT01622673|746446|P3|NOT COMPLETED|Treatment Period 2||0
312115|NCT01622673|746447|P2|NOT COMPLETED|Treatment Period 2||0
312116|NCT01622673|746448|P1|NOT COMPLETED|Treatment Period 2||0
312117|NCT01622673|746443|P6|COMPLETED|Treatment Period 2||4
312118|NCT01622673|746444|P5|COMPLETED|Treatment Period 2||4
312119|NCT01622673|746445|P4|COMPLETED|Treatment Period 2||4
312120|NCT01622673|746446|P3|COMPLETED|Treatment Period 2||4
312121|NCT01622673|746447|P2|COMPLETED|Treatment Period 2||4
312122|NCT01622673|746448|P1|COMPLETED|Treatment Period 2||4
312123|NCT01622673|746443|P6|STARTED|Treatment Period 2||4
312124|NCT01622673|746444|P5|STARTED|Treatment Period 2||4
312125|NCT01622673|746445|P4|STARTED|Treatment Period 2||5
312126|NCT01622673|746446|P3|STARTED|Treatment Period 2||4
312127|NCT01622673|746447|P2|STARTED|Treatment Period 2||4
312128|NCT01622673|746448|P1|STARTED|Treatment Period 2||4
312129|NCT01622673|746443|P6|NOT COMPLETED|Treatment Period 1||0
312130|NCT01622673|746444|P5|NOT COMPLETED|Treatment Period 1||0
312131|NCT01622673|746445|P4|NOT COMPLETED|Treatment Period 1||1
312132|NCT01622673|746446|P3|NOT COMPLETED|Treatment Period 1||0
312133|NCT01622673|746447|P2|NOT COMPLETED|Treatment Period 1||1
312134|NCT01622673|746448|P1|NOT COMPLETED|Treatment Period 1||0
312135|NCT01622673|746443|P6|COMPLETED|Treatment Period 1||4
312136|NCT01622673|746444|P5|COMPLETED|Treatment Period 1||4
312137|NCT01622673|746445|P4|COMPLETED|Treatment Period 1||5
312138|NCT01622673|746446|P3|COMPLETED|Treatment Period 1||4
312139|NCT01622673|746447|P2|COMPLETED|Treatment Period 1||4
312140|NCT01622673|746448|P1|COMPLETED|Treatment Period 1||4
312141|NCT01622673|746443|P6|STARTED|Treatment Period 1||4
312142|NCT01622673|746444|P5|STARTED|Treatment Period 1||4
312143|NCT01622673|746445|P4|STARTED|Treatment Period 1||6
312144|NCT01622673|746446|P3|STARTED|Treatment Period 1||4
312145|NCT01622673|746447|P2|STARTED|Treatment Period 1||5
312146|NCT01622673|746448|P1|STARTED|Treatment Period 1||4
312147|NCT01622296|746483|P2|NOT COMPLETED|Second Intervention||0
312148|NCT01622296|746484|P1|NOT COMPLETED|Second Intervention||0
312149|NCT01622296|746483|P2|COMPLETED|Second Intervention||10
312150|NCT01622296|746484|P1|COMPLETED|Second Intervention||10
312151|NCT01622296|746483|P2|STARTED|Second Intervention||10
312152|NCT01622296|746484|P1|STARTED|Second Intervention||10
312153|NCT01622296|746483|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
312154|NCT01622296|746484|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
312155|NCT01622296|746483|P2|COMPLETED|Washout Period of at Least 1 Week||10
312156|NCT01622296|746484|P1|COMPLETED|Washout Period of at Least 1 Week||10
312157|NCT01622296|746483|P2|STARTED|Washout Period of at Least 1 Week||10
312158|NCT01622296|746484|P1|STARTED|Washout Period of at Least 1 Week||10
312159|NCT01622296|746483|P2|NOT COMPLETED|First Intervention||0
312160|NCT01622296|746484|P1|NOT COMPLETED|First Intervention||0
312161|NCT01622296|746483|P2|COMPLETED|First Intervention||10
312162|NCT01622296|746484|P1|COMPLETED|First Intervention||10
312163|NCT01622296|746483|P2|STARTED|First Intervention||10
312164|NCT01622296|746484|P1|STARTED|First Intervention||10
312165|NCT01622257|746492|P3|NOT COMPLETED|Overall Study||0
312166|NCT01622257|746493|P2|NOT COMPLETED|Overall Study||0
312167|NCT01622257|746494|P1|NOT COMPLETED|Overall Study||0
312168|NCT01622257|746492|P3|COMPLETED|Overall Study||66
312169|NCT01622257|746493|P2|COMPLETED|Overall Study||66
312170|NCT01622257|746494|P1|COMPLETED|Overall Study||66
312171|NCT01622257|746492|P3|STARTED|Overall Study||66
312172|NCT01622257|746493|P2|STARTED|Overall Study||66
312173|NCT01622257|746494|P1|STARTED|Overall Study||66
312174|NCT01622231|746514|P1|NOT COMPLETED|Overall Study||2
312175|NCT01622231|746514|P1|COMPLETED|Overall Study||59
312176|NCT01622231|746514|P1|STARTED|Overall Study||61
312177|NCT01621776|746545|P3|NOT COMPLETED|Overall Study||0
312178|NCT01621776|746546|P2|NOT COMPLETED|Overall Study||0
312179|NCT01621776|746547|P1|NOT COMPLETED|Overall Study||0
312180|NCT01621776|746545|P3|COMPLETED|Overall Study||18
312181|NCT01621776|746546|P2|COMPLETED|Overall Study||40
312182|NCT01621776|746547|P1|COMPLETED|Overall Study||41
312183|NCT01621776|746545|P3|STARTED|Overall Study||18
312184|NCT01621776|746546|P2|STARTED|Overall Study||40
312185|NCT01621776|746547|P1|STARTED|Overall Study||41
312186|NCT01621672|746563|P2|NOT COMPLETED|Overall Study||0
312187|NCT01621672|746564|P1|NOT COMPLETED|Overall Study||0
312188|NCT01621672|746563|P2|COMPLETED|Overall Study||17
312189|NCT01621672|746564|P1|COMPLETED|Overall Study||25
312190|NCT01621672|746563|P2|STARTED|Overall Study||17
312191|NCT01621672|746564|P1|STARTED|Overall Study||25
312192|NCT01621633|746574|P4|NOT COMPLETED|Overall Study||0
312193|NCT01621633|746575|P3|NOT COMPLETED|Overall Study||0
312194|NCT01621633|746576|P2|NOT COMPLETED|Overall Study||0
312195|NCT01621633|746577|P1|NOT COMPLETED|Overall Study||0
312196|NCT01621633|746574|P4|COMPLETED|Overall Study||8
312197|NCT01621633|746575|P3|COMPLETED|Overall Study||8
312198|NCT01621633|746576|P2|COMPLETED|Overall Study||8
312199|NCT01621633|746577|P1|COMPLETED|Overall Study||8
312200|NCT01621633|746574|P4|STARTED|Overall Study||8
312201|NCT01621633|746575|P3|STARTED|Overall Study||8
312202|NCT01621633|746576|P2|STARTED|Overall Study||8
312203|NCT01621633|746577|P1|STARTED|Overall Study||8
312204|NCT01621477|746599|P1|NOT COMPLETED|Overall Study||0
312205|NCT01621477|746599|P1|COMPLETED|Overall Study||17
312206|NCT01621477|746599|P1|STARTED|Overall Study||17
312207|NCT01621191|746609|P1|NOT COMPLETED|Overall Study||25
312208|NCT01621191|746609|P1|COMPLETED|Overall Study||124
312209|NCT01621191|746609|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
312210|NCT01621191|746609|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
312211|NCT01621191|746609|P1|STARTED|Overall Study||149
312212|NCT01621126|746620|P1|NOT COMPLETED|Overall Study||6
312213|NCT01621126|746620|P1|COMPLETED|Overall Study||34
312214|NCT01621126|746620|P1|STARTED|Overall Study||40
312215|NCT01621009|746628|P4|NOT COMPLETED|Overall Study||53
312216|NCT01621009|746629|P3|NOT COMPLETED|Overall Study||63
312217|NCT01621009|746630|P2|NOT COMPLETED|Overall Study||51
312218|NCT01621009|746631|P1|NOT COMPLETED|Overall Study||43
312219|NCT01621009|746628|P4|COMPLETED|Overall Study||60
312220|NCT01621009|746629|P3|COMPLETED|Overall Study||58
312221|NCT01621009|746630|P2|COMPLETED|Overall Study||65
312222|NCT01621009|746631|P1|COMPLETED|Overall Study||70
312223|NCT01621009|746628|P4|STARTED|Overall Study||113
312224|NCT01621009|746629|P3|STARTED|Overall Study||121
312225|NCT01621009|746630|P2|STARTED|Overall Study||116
312226|NCT01621009|746631|P1|STARTED|Overall Study||113
312227|NCT01620489|746641|P2|NOT COMPLETED|Overall Study||34
312228|NCT01620489|746642|P1|NOT COMPLETED|Overall Study||35
312229|NCT01620489|746641|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
312230|NCT01620489|746642|P1|COMPLETED|Overall Study||105
312231|NCT01620489|746641|P2|Exposed|Overall Study|2 subjects did not take trial product|137
312232|NCT01620489|746642|P1|Exposed|Overall Study||140
312233|NCT01620489|746641|P2|STARTED|Overall Study||139
312234|NCT01620489|746642|P1|STARTED|Overall Study||140
312235|NCT01620255|746663|P5|NOT COMPLETED|Overall Study||6
312236|NCT01620255|746664|P4|NOT COMPLETED|Overall Study||3
312237|NCT01620255|746665|P3|NOT COMPLETED|Overall Study||2
312238|NCT01620255|746666|P2|NOT COMPLETED|Overall Study||6
312239|NCT01620255|746667|P1|NOT COMPLETED|Overall Study||4
312240|NCT01620255|746663|P5|COMPLETED|Overall Study||64
312241|NCT01620255|746664|P4|COMPLETED|Overall Study||70
312242|NCT01620255|746665|P3|COMPLETED|Overall Study||68
312243|NCT01620255|746666|P2|COMPLETED|Overall Study||65
312244|NCT01620255|746667|P1|COMPLETED|Overall Study||69
312245|NCT01620255|746663|P5|Treated|Overall Study||70
312246|NCT01620255|746664|P4|Treated|Overall Study||73
312247|NCT01620255|746665|P3|Treated|Overall Study||70
312248|NCT01620255|746666|P2|Treated|Overall Study||71
312249|NCT01620255|746667|P1|Treated|Overall Study||73
312250|NCT01620255|746663|P5|STARTED|Overall Study||70
312251|NCT01620255|746664|P4|STARTED|Overall Study||73
312252|NCT01620255|746665|P3|STARTED|Overall Study||70
312253|NCT01620255|746666|P2|STARTED|Overall Study||71
312254|NCT01620255|746667|P1|STARTED|Overall Study||73
312255|NCT01620177|746744|P1|NOT COMPLETED|Overall Study||79
312256|NCT01620177|746744|P1|COMPLETED|Overall Study||19
312257|NCT01620177|746744|P1|STARTED|Overall Study||98
312258|NCT01620138|746769|P2|NOT COMPLETED|Overall Study||0
312259|NCT01620138|746770|P1|NOT COMPLETED|Overall Study||6
312260|NCT01620138|746769|P2|COMPLETED|Overall Study||9
312261|NCT01620138|746770|P1|COMPLETED|Overall Study||6
312262|NCT01620138|746769|P2|STARTED|Overall Study||9
312263|NCT01620138|746770|P1|STARTED|Overall Study||12
312264|NCT01620086|746778|P3|NOT COMPLETED|Overall Study||0
312265|NCT01620086|746779|P2|NOT COMPLETED|Overall Study||7
312266|NCT01620086|746780|P1|NOT COMPLETED|Overall Study||5
312267|NCT01620086|746778|P3|COMPLETED|Overall Study||2
312268|NCT01620086|746779|P2|COMPLETED|Overall Study||4
312269|NCT01620086|746780|P1|COMPLETED|Overall Study||8
312270|NCT01620086|746778|P3|STARTED|Overall Study||2
312271|NCT01620086|746779|P2|STARTED|Overall Study||11
312272|NCT01620086|746780|P1|STARTED|Overall Study||13
312273|NCT01620060|746799|P1|NOT COMPLETED|Overall Study||15
312274|NCT01620060|746799|P1|COMPLETED|Overall Study||90
312275|NCT01620060|746799|P1|STARTED|Overall Study||105
312276|NCT01620047|746808|P3|NOT COMPLETED|Overall Study||0
312277|NCT01620047|746809|P2|NOT COMPLETED|Overall Study||0
312278|NCT01620047|746810|P1|NOT COMPLETED|Overall Study||0
312279|NCT01620047|746808|P3|COMPLETED|Overall Study||20
312280|NCT01620047|746809|P2|COMPLETED|Overall Study||20
312281|NCT01620047|746810|P1|COMPLETED|Overall Study||20
312282|NCT01620047|746808|P3|STARTED|Overall Study||20
312283|NCT01620047|746809|P2|STARTED|Overall Study||20
312284|NCT01620047|746810|P1|STARTED|Overall Study||20
312285|NCT01619878|746818|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
312286|NCT01619878|746818|P1|COMPLETED|Follow-up at 12 Months of Age||17
312287|NCT01619878|746818|P1|STARTED|Follow-up at 12 Months of Age||20
312288|NCT01619878|746818|P1|NOT COMPLETED|6 Week Follow-up Phase||1
312289|NCT01619878|746818|P1|COMPLETED|6 Week Follow-up Phase||19
312290|NCT01619878|746818|P1|STARTED|6 Week Follow-up Phase||20
312291|NCT01619800|746832|P2|NOT COMPLETED|Overall Study||0
312292|NCT01619800|746833|P1|NOT COMPLETED|Overall Study||2
312293|NCT01619800|746832|P2|COMPLETED|Overall Study||0
312294|NCT01619800|746833|P1|COMPLETED|Overall Study||0
312295|NCT01619800|746832|P2|STARTED|Overall Study||0
312296|NCT01619800|746833|P1|STARTED|Overall Study||2
312297|NCT01619787|746841|P1|NOT COMPLETED|Overall Study||5
312298|NCT01619787|746841|P1|COMPLETED|Overall Study||212
312299|NCT01619787|746841|P1|STARTED|Overall Study||217
312300|NCT01619774|746850|P1|NOT COMPLETED|Overall Study||0
312301|NCT01619774|746850|P1|COMPLETED|Overall Study||23
312302|NCT01619774|746850|P1|STARTED|Overall Study||23
312303|NCT01619579|746858|P2|NOT COMPLETED|Overall Study||3
312304|NCT01619579|746859|P1|NOT COMPLETED|Overall Study||0
312305|NCT01619579|746858|P2|COMPLETED|Overall Study||14
312306|NCT01619579|746859|P1|COMPLETED|Overall Study||5
312307|NCT01619579|746858|P2|STARTED|Overall Study||17
312308|NCT01619579|746859|P1|STARTED|Overall Study||5
312309|NCT01619059|746871|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
312310|NCT01619059|746872|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
312311|NCT01619059|746871|P2|COMPLETED|Long-Term (LT) Treatment Period||133
312312|NCT01619059|746872|P1|COMPLETED|Long-Term (LT) Treatment Period||147
312313|NCT01619059|746871|P2|STARTED|Long-Term (LT) Treatment Period||142
312314|NCT01619059|746872|P1|STARTED|Long-Term (LT) Treatment Period||155
312315|NCT01619059|746871|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
312316|NCT01619059|746872|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
312317|NCT01619059|746871|P2|COMPLETED|Short-Term (ST) Treatment Period||142
312318|NCT01619059|746872|P1|COMPLETED|Short-Term (ST) Treatment Period||156
312319|NCT01619059|746871|P2|STARTED|Short-Term (ST) Treatment Period||153
312320|NCT01619059|746872|P1|STARTED|Short-Term (ST) Treatment Period||162
312321|NCT01618968|746888|P4|NOT COMPLETED|Overall Study||1
312322|NCT01618968|746889|P3|NOT COMPLETED|Overall Study||0
312323|NCT01618968|746890|P2|NOT COMPLETED|Overall Study||0
312324|NCT01618968|746891|P1|NOT COMPLETED|Overall Study||1
312325|NCT01618968|746888|P4|COMPLETED|Overall Study||11
312326|NCT01618968|746889|P3|COMPLETED|Overall Study||12
312327|NCT01618968|746890|P2|COMPLETED|Overall Study||12
312328|NCT01618968|746891|P1|COMPLETED|Overall Study||12
312329|NCT01618968|746888|P4|Received Treatment C|Overall Study||11
312330|NCT01618968|746889|P3|Received Treatment C|Overall Study||12
312331|NCT01618968|746890|P2|Received Treatment C|Overall Study||12
312332|NCT01618968|746891|P1|Received Treatment C|Overall Study||12
312333|NCT01618968|746888|P4|Received Treatment B|Overall Study||12
312334|NCT01618968|746889|P3|Received Treatment B|Overall Study||12
312335|NCT01618968|746890|P2|Received Treatment B|Overall Study||12
312336|NCT01618968|746891|P1|Received Treatment B|Overall Study||13
312337|NCT01618968|746888|P4|Received Treatment A|Overall Study||11
312338|NCT01618968|746889|P3|Received Treatment A|Overall Study||12
312339|NCT01618968|746890|P2|Received Treatment A|Overall Study||12
312340|NCT01618968|746891|P1|Received Treatment A|Overall Study||12
312341|NCT01618968|746888|P4|STARTED|Overall Study||12
312342|NCT01618968|746889|P3|STARTED|Overall Study||12
312343|NCT01618968|746890|P2|STARTED|Overall Study||12
312344|NCT01618968|746891|P1|STARTED|Overall Study||13
312345|NCT01618955|746910|P4|NOT COMPLETED|Overall Study||0
312346|NCT01618955|746911|P3|NOT COMPLETED|Overall Study||0
312347|NCT01618955|746912|P2|NOT COMPLETED|Overall Study||0
312348|NCT01618955|746913|P1|NOT COMPLETED|Overall Study||0
312349|NCT01618955|746910|P4|COMPLETED|Overall Study||20
312350|NCT01618955|746911|P3|COMPLETED|Overall Study||31
312351|NCT01618955|746912|P2|COMPLETED|Overall Study||30
312352|NCT01618955|746913|P1|COMPLETED|Overall Study||20
312353|NCT01618955|746910|P4|STARTED|Overall Study||20
312354|NCT01618955|746911|P3|STARTED|Overall Study||31
312355|NCT01618955|746912|P2|STARTED|Overall Study||30
312356|NCT01618955|746913|P1|STARTED|Overall Study||20
312357|NCT01618942|746937|P2|NOT COMPLETED|Overall Study||0
312358|NCT01618942|746938|P1|NOT COMPLETED|Overall Study||0
312359|NCT01618942|746937|P2|COMPLETED|Overall Study||50
312360|NCT01618942|746938|P1|COMPLETED|Overall Study||50
312361|NCT01618942|746937|P2|STARTED|Overall Study||50
312362|NCT01618942|746938|P1|STARTED|Overall Study||50
312363|NCT01618864|746958|P1|NOT COMPLETED|Overall Study||4
312364|NCT01618864|746958|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
312365|NCT01618864|746958|P1|Completed 2 Weeks|Overall Study||19
312366|NCT01618864|746958|P1|STARTED|Overall Study||23
312367|NCT01618838|746967|P1|NOT COMPLETED|Overall Study||4
312368|NCT01618838|746967|P1|COMPLETED|Overall Study||0
312369|NCT01618838|746967|P1|STARTED|Overall Study||4
312370|NCT01618708|746973|P2|NOT COMPLETED|Overall Study||46
312371|NCT01618708|746974|P1|NOT COMPLETED|Overall Study||44
312372|NCT01618708|746973|P2|COMPLETED|Overall Study||136
312373|NCT01618708|746974|P1|COMPLETED|Overall Study||131
312374|NCT01618708|746973|P2|Treated|Overall Study||180
312375|NCT01618708|746974|P1|Treated|Overall Study||172
312376|NCT01618708|746973|P2|STARTED|Overall Study||182
312377|NCT01618708|746974|P1|STARTED|Overall Study||175
312378|NCT01618669|746988|P2|NOT COMPLETED|Overall Study||23
312379|NCT01618669|746989|P1|NOT COMPLETED|Overall Study||34
312380|NCT01618669|746988|P2|COMPLETED|Overall Study||546
312381|NCT01618669|746989|P1|COMPLETED|Overall Study||544
312382|NCT01618669|746988|P2|Received Treatment|Overall Study||567
312383|NCT01618669|746989|P1|Received Treatment|Overall Study||575
312384|NCT01618669|746988|P2|STARTED|Overall Study||569
312385|NCT01618669|746989|P1|STARTED|Overall Study||578
312386|NCT01618422|747035|P2|NOT COMPLETED|Overall Study||0
312387|NCT01618422|747036|P1|NOT COMPLETED|Overall Study||0
312388|NCT01618422|747035|P2|COMPLETED|Overall Study||111
312389|NCT01618422|747036|P1|COMPLETED|Overall Study||114
312390|NCT01618422|747035|P2|STARTED|Overall Study||111
312391|NCT01618422|747036|P1|STARTED|Overall Study||114
312392|NCT01618266|747042|P1|NOT COMPLETED|Overall Study||96
312393|NCT01618266|747042|P1|COMPLETED|Overall Study||279
312394|NCT01618266|747042|P1|STARTED|Overall Study||375
312395|NCT01618240|747057|P1|NOT COMPLETED|Overall Study||0
312396|NCT01618240|747057|P1|COMPLETED|Overall Study||30
312397|NCT01618240|747057|P1|STARTED|Overall Study||30
312398|NCT01618227|747064|P2|NOT COMPLETED|Overall Study||2
312399|NCT01618227|747065|P1|NOT COMPLETED|Overall Study||0
312400|NCT01618227|747064|P2|COMPLETED|Overall Study||0
312401|NCT01618227|747065|P1|COMPLETED|Overall Study||2
312402|NCT01618227|747064|P2|STARTED|Overall Study||2
312403|NCT01618227|747065|P1|STARTED|Overall Study||2
312404|NCT01618214|747079|P2|NOT COMPLETED|Overall Study||13
312405|NCT01618214|747080|P1|NOT COMPLETED|Overall Study||10
312406|NCT01618214|747079|P2|COMPLETED|Overall Study||159
312407|NCT01618214|747080|P1|COMPLETED|Overall Study||162
312408|NCT01618214|747079|P2|Exposed|Overall Study||172
312409|NCT01618214|747080|P1|Exposed|Overall Study||172
312410|NCT01618214|747079|P2|STARTED|Overall Study||172
312411|NCT01618214|747080|P1|STARTED|Overall Study||172
312412|NCT01618162|747096|P2|NOT COMPLETED|Overall Study||35
312413|NCT01618162|747097|P1|NOT COMPLETED|Overall Study||38
312414|NCT01618162|747096|P2|COMPLETED|Overall Study||111
312415|NCT01618162|747097|P1|COMPLETED|Overall Study||251
312416|NCT01618162|747096|P2|Exposed|Overall Study||146
312417|NCT01618162|747097|P1|Exposed|Overall Study||288
312418|NCT01618162|747096|P2|STARTED|Overall Study||146
312419|NCT01618162|747097|P1|STARTED|Overall Study||289
312420|NCT01618019|747117|P2|NOT COMPLETED|Overall Study||14
312421|NCT01618019|747118|P1|NOT COMPLETED|Overall Study||14
312422|NCT01618019|747117|P2|COMPLETED|Overall Study||40
312423|NCT01618019|747118|P1|COMPLETED|Overall Study||41
312424|NCT01618019|747117|P2|STARTED|Overall Study||54
312425|NCT01618019|747118|P1|STARTED|Overall Study||55
312426|NCT01617668|747140|P4|NOT COMPLETED|Overall Study||15
312427|NCT01617668|747141|P3|NOT COMPLETED|Overall Study||23
312428|NCT01617668|747142|P2|NOT COMPLETED|Overall Study||9
312429|NCT01617668|747143|P1|NOT COMPLETED|Overall Study||13
312430|NCT01617668|747140|P4|COMPLETED|Overall Study||38
312431|NCT01617668|747141|P3|COMPLETED|Overall Study||32
312432|NCT01617668|747142|P2|COMPLETED|Overall Study||41
312433|NCT01617668|747143|P1|COMPLETED|Overall Study||38
312434|NCT01617668|747140|P4|Randomized Patients|Overall Study||55
312435|NCT01617668|747141|P3|Randomized Patients|Overall Study||55
312436|NCT01617668|747142|P2|Randomized Patients|Overall Study||54
312437|NCT01617668|747143|P1|Randomized Patients|Overall Study||51
312438|NCT01617668|747140|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
312439|NCT01617668|747141|P3|STARTED|Overall Study||55
312440|NCT01617668|747142|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
312441|NCT01617668|747143|P1|STARTED|Overall Study||51
312442|NCT01617655|747184|P2|NOT COMPLETED|Overall Study||29
312443|NCT01617655|747185|P1|NOT COMPLETED|Overall Study||9
312444|NCT01617655|747184|P2|COMPLETED|Overall Study||43
312445|NCT01617655|747185|P1|COMPLETED|Overall Study||26
312446|NCT01617655|747184|P2|Treated|Overall Study||72
312447|NCT01617655|747185|P1|Treated|Overall Study||35
312448|NCT01617655|747184|P2|STARTED|Overall Study|Randomized|72
312449|NCT01617655|747185|P1|STARTED|Overall Study|Randomized|35
312450|NCT01617603|747248|P3|NOT COMPLETED|Overall Study||1
312451|NCT01617603|747249|P2|NOT COMPLETED|Overall Study||2
312452|NCT01617603|747250|P1|NOT COMPLETED|Overall Study||3
312453|NCT01617603|747248|P3|COMPLETED|Overall Study||20
312454|NCT01617603|747249|P2|COMPLETED|Overall Study||19
312455|NCT01617603|747250|P1|COMPLETED|Overall Study||17
312456|NCT01617603|747248|P3|STARTED|Overall Study||21
312457|NCT01617603|747249|P2|STARTED|Overall Study||21
312458|NCT01617603|747250|P1|STARTED|Overall Study||20
312459|NCT01617577|747260|P2|NOT COMPLETED|Overall Study||0
312460|NCT01617577|747261|P1|NOT COMPLETED|Overall Study||0
312461|NCT01617577|747260|P2|COMPLETED|Overall Study||3
312462|NCT01617577|747261|P1|COMPLETED|Overall Study||5
312463|NCT01617577|747260|P2|STARTED|Overall Study||3
312464|NCT01617577|747261|P1|STARTED|Overall Study||5
312465|NCT01617447|747270|P2|NOT COMPLETED|Overall Study||3
312466|NCT01617447|747271|P1|NOT COMPLETED|Overall Study||0
312467|NCT01617447|747270|P2|COMPLETED|Overall Study||42
312468|NCT01617447|747271|P1|COMPLETED|Overall Study||47
312469|NCT01617447|747270|P2|STARTED|Overall Study||45
312470|NCT01617447|747271|P1|STARTED|Overall Study||47
312471|NCT01617434|747279|P2|NOT COMPLETED|Overall Study||51
312472|NCT01617434|747280|P1|NOT COMPLETED|Overall Study||35
312473|NCT01617434|747279|P2|COMPLETED|Overall Study||174
312474|NCT01617434|747280|P1|COMPLETED|Overall Study||191
312475|NCT01617434|747279|P2|Exposed|Overall Study||225
312476|NCT01617434|747280|P1|Exposed|Overall Study||225
312477|NCT01617434|747279|P2|STARTED|Overall Study||225
312478|NCT01617434|747280|P1|STARTED|Overall Study||226
312479|NCT01617369|747302|P1|NOT COMPLETED|Overall Study||0
312480|NCT01617369|747302|P1|COMPLETED|Overall Study||12
312481|NCT01617369|747302|P1|STARTED|Overall Study||12
312482|NCT01617187|747312|P4|NOT COMPLETED|Treatment Through Study Completion||10
312483|NCT01617187|747313|P3|NOT COMPLETED|Treatment Through Study Completion||5
312484|NCT01617187|747314|P2|NOT COMPLETED|Treatment Through Study Completion||11
312485|NCT01617187|747315|P1|NOT COMPLETED|Treatment Through Study Completion||11
312486|NCT01617187|747312|P4|COMPLETED|Treatment Through Study Completion||91
312487|NCT01617187|747313|P3|COMPLETED|Treatment Through Study Completion||41
312488|NCT01617187|747314|P2|COMPLETED|Treatment Through Study Completion||102
312489|NCT01617187|747315|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
312490|NCT01617187|747312|P4|STARTED|Treatment Through Study Completion|Treated|101
312491|NCT01617187|747313|P3|STARTED|Treatment Through Study Completion|Treated|46
312492|NCT01617187|747314|P2|STARTED|Treatment Through Study Completion|Treated|113
312493|NCT01617187|747315|P1|STARTED|Treatment Through Study Completion|Treated|97
312494|NCT01617187|747312|P4|NOT COMPLETED|Randomization Through Start Treatment||2
312495|NCT01617187|747313|P3|NOT COMPLETED|Randomization Through Start Treatment||0
312496|NCT01617187|747314|P2|NOT COMPLETED|Randomization Through Start Treatment||0
312497|NCT01617187|747315|P1|NOT COMPLETED|Randomization Through Start Treatment||1
312498|NCT01617187|747312|P4|COMPLETED|Randomization Through Start Treatment||101
312499|NCT01617187|747313|P3|COMPLETED|Randomization Through Start Treatment||46
312500|NCT01617187|747314|P2|COMPLETED|Randomization Through Start Treatment||113
312501|NCT01617187|747315|P1|COMPLETED|Randomization Through Start Treatment||97
312502|NCT01617187|747312|P4|STARTED|Randomization Through Start Treatment|Randomized|103
312503|NCT01617187|747313|P3|STARTED|Randomization Through Start Treatment|Randomized|46
312504|NCT01617187|747314|P2|STARTED|Randomization Through Start Treatment|Randomized|113
312505|NCT01617187|747315|P1|STARTED|Randomization Through Start Treatment|Randomized|98
312506|NCT01617070|747385|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
312507|NCT01617070|747385|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
312508|NCT01617070|747385|P1|STARTED|BH4 and LNAA (4 Weeks)||10
312509|NCT01617070|747385|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
312510|NCT01617070|747385|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
312511|NCT01617070|747385|P1|STARTED|BH4 Therapy (4 Weeks)||10
312512|NCT01617070|747385|P1|NOT COMPLETED|Washout (4 Weeks)||0
312513|NCT01617070|747385|P1|COMPLETED|Washout (4 Weeks)||10
312514|NCT01617070|747385|P1|STARTED|Washout (4 Weeks)||10
312515|NCT01617070|747385|P1|NOT COMPLETED|LNAA (4 Weeks)||0
312516|NCT01617070|747385|P1|COMPLETED|LNAA (4 Weeks)||10
312517|NCT01617070|747385|P1|STARTED|LNAA (4 Weeks)||10
312518|NCT01617005|747403|P1|NOT COMPLETED|Overall Study||2
312519|NCT01617005|747403|P1|COMPLETED|Overall Study||48
312520|NCT01617005|747403|P1|STARTED|Overall Study||50
312521|NCT01616953|747412|P2|NOT COMPLETED|Overall Study||0
312522|NCT01616953|747413|P1|NOT COMPLETED|Overall Study||2
312523|NCT01616953|747412|P2|COMPLETED|Overall Study||8
312524|NCT01616953|747413|P1|COMPLETED|Overall Study||8
312525|NCT01616953|747412|P2|6 Months Post-loading|Overall Study||8
312526|NCT01616953|747413|P1|6 Months Post-loading|Overall Study||8
312527|NCT01616953|747412|P2|Implant Uncovery|Overall Study||8
312528|NCT01616953|747413|P1|Implant Uncovery|Overall Study||8
312529|NCT01616953|747412|P2|Implant Placement Surgery|Overall Study||8
312530|NCT01616953|747413|P1|Implant Placement Surgery|Overall Study||9
312531|NCT01616953|747412|P2|STARTED|Overall Study||8
312532|NCT01616953|747413|P1|STARTED|Overall Study||10
312533|NCT01616771|747421|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
312534|NCT01616771|747421|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
312535|NCT01616771|747421|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
312536|NCT01616771|747421|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
312537|NCT01616771|747421|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
312538|NCT01616771|747421|P1|STARTED|GVL Selected by Weight for 5 Sec||23
312539|NCT01616771|747421|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
312540|NCT01616771|747421|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
312541|NCT01616771|747421|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
312542|NCT01616576|747432|P2|NOT COMPLETED|Overall Study||0
312543|NCT01616576|747433|P1|NOT COMPLETED|Overall Study||0
312544|NCT01616576|747432|P2|COMPLETED|Overall Study||18
312545|NCT01616576|747433|P1|COMPLETED|Overall Study||18
312546|NCT01616576|747432|P2|STARTED|Overall Study||18
312547|NCT01616576|747433|P1|STARTED|Overall Study||18
312548|NCT01616459|747446|P4|NOT COMPLETED|Overall Study||8
312549|NCT01616459|747447|P3|NOT COMPLETED|Overall Study||10
312550|NCT01616459|747448|P2|NOT COMPLETED|Overall Study||17
312551|NCT01616459|747449|P1|NOT COMPLETED|Overall Study||4
312552|NCT01616459|747446|P4|COMPLETED|Overall Study||233
312553|NCT01616459|747447|P3|COMPLETED|Overall Study||220
312554|NCT01616459|747448|P2|COMPLETED|Overall Study||223
312555|NCT01616459|747449|P1|COMPLETED|Overall Study||236
312556|NCT01616459|747446|P4|STARTED|Overall Study||241
312557|NCT01616459|747447|P3|STARTED|Overall Study||230
312558|NCT01616459|747448|P2|STARTED|Overall Study||240
312559|NCT01616459|747449|P1|STARTED|Overall Study||240
312560|NCT01616173|747538|P3|NOT COMPLETED|Overall Study||0
312561|NCT01616173|747539|P2|NOT COMPLETED|Overall Study||2
312562|NCT01616173|747540|P1|NOT COMPLETED|Overall Study||0
312563|NCT01616173|747538|P3|COMPLETED|Overall Study||27
312564|NCT01616173|747539|P2|COMPLETED|Overall Study||24
312565|NCT01616173|747540|P1|COMPLETED|Overall Study||27
312566|NCT01616173|747538|P3|STARTED|Overall Study||27
312567|NCT01616173|747539|P2|STARTED|Overall Study||26
312568|NCT01616173|747540|P1|STARTED|Overall Study||27
312569|NCT01615939|747556|P2|NOT COMPLETED|Overall Study||0
312570|NCT01615939|747557|P1|NOT COMPLETED|Overall Study||5
312571|NCT01615939|747556|P2|COMPLETED|Overall Study||4
312572|NCT01615939|747557|P1|COMPLETED|Overall Study||8
312573|NCT01615939|747556|P2|STARTED|Overall Study||4
312574|NCT01615939|747557|P1|STARTED|Overall Study||13
312575|NCT01615822|747570|P3|NOT COMPLETED|Period 2||2
312576|NCT01615822|747571|P2|NOT COMPLETED|Period 2||1
312577|NCT01615822|747572|P1|NOT COMPLETED|Period 2||0
312578|NCT01615822|747570|P3|COMPLETED|Period 2||4
312579|NCT01615822|747571|P2|COMPLETED|Period 2||8
312580|NCT01615822|747572|P1|COMPLETED|Period 2||7
312581|NCT01615822|747570|P3|STARTED|Period 2||6
312582|NCT01615822|747571|P2|STARTED|Period 2||9
312583|NCT01615822|747572|P1|STARTED|Period 2||7
312584|NCT01615822|747570|P3|NOT COMPLETED|Period 1||0
312585|NCT01615822|747571|P2|NOT COMPLETED|Period 1||2
312586|NCT01615822|747572|P1|NOT COMPLETED|Period 1||1
312587|NCT01615822|747570|P3|COMPLETED|Period 1||6
312588|NCT01615822|747571|P2|COMPLETED|Period 1||9
312589|NCT01615822|747572|P1|COMPLETED|Period 1||7
312590|NCT01615822|747570|P3|STARTED|Period 1||6
312591|NCT01615822|747571|P2|STARTED|Period 1||11
312592|NCT01615822|747572|P1|STARTED|Period 1||8
312593|NCT01615809|747589|P1|NOT COMPLETED|Overall Study||10
312594|NCT01615809|747589|P1|COMPLETED|Overall Study||22
312595|NCT01615809|747589|P1|STARTED|Overall Study|basal visit|32
312596|NCT01615731|747597|P2|NOT COMPLETED|Overall Study||2
312597|NCT01615731|747598|P1|NOT COMPLETED|Overall Study||3
312598|NCT01615731|747597|P2|COMPLETED|Overall Study||24
312599|NCT01615731|747598|P1|COMPLETED|Overall Study||21
312600|NCT01615731|747597|P2|STARTED|Overall Study||26
312601|NCT01615731|747598|P1|STARTED|Overall Study||24
312602|NCT01615328|747618|P2|NOT COMPLETED|Overall Study||5
312603|NCT01615328|747619|P1|NOT COMPLETED|Overall Study||3
312604|NCT01615328|747618|P2|COMPLETED|Overall Study||38
312605|NCT01615328|747619|P1|COMPLETED|Overall Study||39
312606|NCT01615328|747618|P2|STARTED|Overall Study||43
312607|NCT01615328|747619|P1|STARTED|Overall Study||42
312608|NCT01615263|747631|P2|NOT COMPLETED|Overall Study||2
312609|NCT01615263|747632|P1|NOT COMPLETED|Overall Study||0
312610|NCT01615263|747631|P2|COMPLETED|Overall Study||18
312611|NCT01615263|747632|P1|COMPLETED|Overall Study||20
312612|NCT01615263|747631|P2|STARTED|Overall Study||20
312613|NCT01615263|747632|P1|STARTED|Overall Study||20
312614|NCT01615198|747646|P2|NOT COMPLETED|Overall Study||19
312615|NCT01615198|747647|P1|NOT COMPLETED|Overall Study||24
312616|NCT01615198|747646|P2|COMPLETED|Overall Study||273
312617|NCT01615198|747647|P1|COMPLETED|Overall Study||272
312618|NCT01615198|747646|P2|ABPM Dipper Status Subset|Overall Study||84
312619|NCT01615198|747647|P1|ABPM Dipper Status Subset|Overall Study||82
312620|NCT01615198|747646|P2|Safety Set|Overall Study||292
312621|NCT01615198|747647|P1|Safety Set|Overall Study||296
312622|NCT01615198|747646|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
312623|NCT01615198|747647|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
312624|NCT01615198|747646|P2|Full Analysis Set|Overall Study||292
312625|NCT01615198|747647|P1|Full Analysis Set|Overall Study||296
312626|NCT01615198|747646|P2|STARTED|Overall Study||292
312627|NCT01615198|747647|P1|STARTED|Overall Study||296
312628|NCT01615029|747680|P5|NOT COMPLETED|Overall Study||32
312629|NCT01615029|747681|P4|NOT COMPLETED|Overall Study||3
312630|NCT01615029|747682|P3|NOT COMPLETED|Overall Study||4
312631|NCT01615029|747683|P2|NOT COMPLETED|Overall Study||3
312632|NCT01615029|747684|P1|NOT COMPLETED|Overall Study||3
312633|NCT01615029|747680|P5|COMPLETED|Overall Study||0
312634|NCT01615029|747681|P4|COMPLETED|Overall Study||0
312635|NCT01615029|747682|P3|COMPLETED|Overall Study||0
312636|NCT01615029|747683|P2|COMPLETED|Overall Study||0
312637|NCT01615029|747684|P1|COMPLETED|Overall Study||0
312638|NCT01615029|747680|P5|STARTED|Overall Study||32
312639|NCT01615029|747681|P4|STARTED|Overall Study||3
312640|NCT01615029|747682|P3|STARTED|Overall Study||4
312641|NCT01615029|747683|P2|STARTED|Overall Study||3
312642|NCT01615029|747684|P1|STARTED|Overall Study||3
312643|NCT01614886|747707|P2|NOT COMPLETED|Overall Study||26
312644|NCT01614886|747708|P1|NOT COMPLETED|Overall Study||20
312645|NCT01614886|747707|P2|COMPLETED|Overall Study||83
312646|NCT01614886|747708|P1|COMPLETED|Overall Study||87
312647|NCT01614886|747707|P2|Full Analysis Set (FAS)|Overall Study||105
312648|NCT01614886|747708|P1|Full Analysis Set (FAS)|Overall Study||104
312649|NCT01614886|747707|P2|Safety Population (SAF)|Overall Study||108
312650|NCT01614886|747708|P1|Safety Population (SAF)|Overall Study||107
312651|NCT01614886|747707|P2|STARTED|Overall Study||109
312652|NCT01614886|747708|P1|STARTED|Overall Study||107
312653|NCT01614795|747726|P4|NOT COMPLETED|Overall Study||12
312654|NCT01614795|747727|P3|NOT COMPLETED|Overall Study||11
312655|NCT01614795|747728|P2|NOT COMPLETED|Overall Study||12
312656|NCT01614795|747729|P1|NOT COMPLETED|Overall Study||11
312657|NCT01614795|747726|P4|COMPLETED|Overall Study||0
312658|NCT01614795|747727|P3|COMPLETED|Overall Study||0
312659|NCT01614795|747728|P2|COMPLETED|Overall Study||0
312660|NCT01614795|747729|P1|COMPLETED|Overall Study||0
312661|NCT01614795|747726|P4|STARTED|Overall Study||12
312662|NCT01614795|747727|P3|STARTED|Overall Study||11
312663|NCT01614795|747728|P2|STARTED|Overall Study||12
312664|NCT01614795|747729|P1|STARTED|Overall Study||11
312665|NCT01614769|747739|P6|NOT COMPLETED|Period 3||0
312666|NCT01614769|747740|P5|NOT COMPLETED|Period 3||0
312667|NCT01614769|747741|P4|NOT COMPLETED|Period 3||0
312668|NCT01614769|747742|P3|NOT COMPLETED|Period 3||1
312669|NCT01614769|747743|P2|NOT COMPLETED|Period 3||0
312670|NCT01614769|747744|P1|NOT COMPLETED|Period 3||0
312671|NCT01614769|747739|P6|COMPLETED|Period 3||1
312672|NCT01614769|747740|P5|COMPLETED|Period 3||1
312673|NCT01614769|747741|P4|COMPLETED|Period 3||0
312674|NCT01614769|747742|P3|COMPLETED|Period 3||1
312675|NCT01614769|747743|P2|COMPLETED|Period 3||1
312676|NCT01614769|747744|P1|COMPLETED|Period 3||1
312677|NCT01614769|747739|P6|STARTED|Period 3||1
312678|NCT01614769|747740|P5|STARTED|Period 3||1
312679|NCT01614769|747741|P4|STARTED|Period 3||0
312680|NCT01614769|747742|P3|STARTED|Period 3||2
312681|NCT01614769|747743|P2|STARTED|Period 3||1
312682|NCT01614769|747744|P1|STARTED|Period 3||1
312683|NCT01614769|747739|P6|NOT COMPLETED|7-Day Washout||0
312684|NCT01614769|747740|P5|NOT COMPLETED|7-Day Washout||0
312685|NCT01614769|747741|P4|NOT COMPLETED|7-Day Washout||0
312686|NCT01614769|747742|P3|NOT COMPLETED|7-Day Washout||0
312687|NCT01614769|747743|P2|NOT COMPLETED|7-Day Washout||0
312688|NCT01614769|747744|P1|NOT COMPLETED|7-Day Washout||0
312689|NCT01614769|747739|P6|COMPLETED|7-Day Washout||1
312690|NCT01614769|747740|P5|COMPLETED|7-Day Washout||1
312691|NCT01614769|747741|P4|COMPLETED|7-Day Washout||0
312692|NCT01614769|747742|P3|COMPLETED|7-Day Washout||2
312693|NCT01614769|747743|P2|COMPLETED|7-Day Washout||1
312694|NCT01614769|747744|P1|COMPLETED|7-Day Washout||1
312695|NCT01614769|747739|P6|STARTED|7-Day Washout||1
312696|NCT01614769|747740|P5|STARTED|7-Day Washout||1
312697|NCT01614769|747741|P4|STARTED|7-Day Washout||0
312698|NCT01614769|747742|P3|STARTED|7-Day Washout||2
312699|NCT01614769|747743|P2|STARTED|7-Day Washout||1
312700|NCT01614769|747744|P1|STARTED|7-Day Washout||1
312701|NCT01614769|747739|P6|NOT COMPLETED|Period 2||0
312702|NCT01614769|747740|P5|NOT COMPLETED|Period 2||0
312703|NCT01614769|747741|P4|NOT COMPLETED|Period 2||0
312704|NCT01614769|747742|P3|NOT COMPLETED|Period 2||0
312705|NCT01614769|747743|P2|NOT COMPLETED|Period 2||0
312706|NCT01614769|747744|P1|NOT COMPLETED|Period 2||0
312707|NCT01614769|747739|P6|COMPLETED|Period 2||1
312708|NCT01614769|747740|P5|COMPLETED|Period 2||1
312709|NCT01614769|747741|P4|COMPLETED|Period 2||0
312710|NCT01614769|747742|P3|COMPLETED|Period 2||2
312711|NCT01614769|747743|P2|COMPLETED|Period 2||1
312712|NCT01614769|747744|P1|COMPLETED|Period 2||1
312713|NCT01614769|747739|P6|STARTED|Period 2||1
312714|NCT01614769|747740|P5|STARTED|Period 2||1
312715|NCT01614769|747741|P4|STARTED|Period 2||0
312716|NCT01614769|747742|P3|STARTED|Period 2||2
312717|NCT01614769|747743|P2|STARTED|Period 2||1
312718|NCT01614769|747744|P1|STARTED|Period 2||1
312719|NCT01614769|747739|P6|NOT COMPLETED|7-Day Washout||0
312720|NCT01614769|747740|P5|NOT COMPLETED|7-Day Washout||0
312721|NCT01614769|747741|P4|NOT COMPLETED|7-Day Washout||0
312722|NCT01614769|747742|P3|NOT COMPLETED|7-Day Washout||0
312723|NCT01614769|747743|P2|NOT COMPLETED|7-Day Washout||0
312724|NCT01614769|747744|P1|NOT COMPLETED|7-Day Washout||0
312725|NCT01614769|747739|P6|COMPLETED|7-Day Washout||1
312726|NCT01614769|747740|P5|COMPLETED|7-Day Washout||1
312727|NCT01614769|747741|P4|COMPLETED|7-Day Washout||0
312728|NCT01614769|747742|P3|COMPLETED|7-Day Washout||2
312729|NCT01614769|747743|P2|COMPLETED|7-Day Washout||1
312730|NCT01614769|747744|P1|COMPLETED|7-Day Washout||1
312731|NCT01614769|747739|P6|STARTED|7-Day Washout||1
312732|NCT01614769|747740|P5|STARTED|7-Day Washout||1
312733|NCT01614769|747741|P4|STARTED|7-Day Washout||0
312734|NCT01614769|747742|P3|STARTED|7-Day Washout||2
312735|NCT01614769|747743|P2|STARTED|7-Day Washout||1
312736|NCT01614769|747744|P1|STARTED|7-Day Washout||1
312737|NCT01614769|747739|P6|NOT COMPLETED|Period 1||1
312738|NCT01614769|747740|P5|NOT COMPLETED|Period 1||0
312739|NCT01614769|747741|P4|NOT COMPLETED|Period 1||2
312740|NCT01614769|747742|P3|NOT COMPLETED|Period 1||0
312741|NCT01614769|747743|P2|NOT COMPLETED|Period 1||0
312742|NCT01614769|747744|P1|NOT COMPLETED|Period 1||1
312743|NCT01614769|747739|P6|COMPLETED|Period 1||1
312744|NCT01614769|747740|P5|COMPLETED|Period 1||1
312745|NCT01614769|747741|P4|COMPLETED|Period 1||0
312746|NCT01614769|747742|P3|COMPLETED|Period 1||2
312747|NCT01614769|747743|P2|COMPLETED|Period 1||1
312748|NCT01614769|747744|P1|COMPLETED|Period 1||1
312749|NCT01614769|747739|P6|STARTED|Period 1||2
312750|NCT01614769|747740|P5|STARTED|Period 1||1
312751|NCT01614769|747741|P4|STARTED|Period 1||2
312752|NCT01614769|747742|P3|STARTED|Period 1||2
312753|NCT01614769|747743|P2|STARTED|Period 1||1
312754|NCT01614769|747744|P1|STARTED|Period 1||2
312755|NCT01614613|747758|P1|NOT COMPLETED|Overall Study||0
312756|NCT01614613|747758|P1|COMPLETED|Overall Study||146
312757|NCT01614613|747758|P1|STARTED|Overall Study||146
312758|NCT01614600|747766|P1|NOT COMPLETED|Overall Study||4
312759|NCT01614600|747766|P1|COMPLETED|Overall Study||84
312760|NCT01614600|747766|P1|STARTED|Overall Study||88
312761|NCT01614574|747770|P1|NOT COMPLETED|Overall Study||0
312762|NCT01614574|747770|P1|COMPLETED|Overall Study||6
312763|NCT01614574|747770|P1|STARTED|Overall Study||6
312764|NCT01614509|747786|P2|NOT COMPLETED|Overall Study||3
312765|NCT01614509|747787|P1|NOT COMPLETED|Overall Study||1
312766|NCT01614509|747786|P2|COMPLETED|Overall Study||18
312767|NCT01614509|747787|P1|COMPLETED|Overall Study||23
312768|NCT01614509|747786|P2|STARTED|Overall Study||21
312769|NCT01614509|747787|P1|STARTED|Overall Study||24
312770|NCT01612702|747797|P2|NOT COMPLETED|Overall Study||11
312771|NCT01612702|747798|P1|NOT COMPLETED|Overall Study||11
312772|NCT01612702|747797|P2|COMPLETED|Overall Study||134
312773|NCT01612702|747798|P1|COMPLETED|Overall Study||135
312774|NCT01612702|747797|P2|STARTED|Overall Study||145
312775|NCT01612702|747798|P1|STARTED|Overall Study||146
312776|NCT01612676|747812|P4|NOT COMPLETED|Overall Study||3
312777|NCT01612676|747813|P3|NOT COMPLETED|Overall Study||1
312778|NCT01612676|747814|P2|NOT COMPLETED|Overall Study||4
312779|NCT01612676|747815|P1|NOT COMPLETED|Overall Study||2
312780|NCT01612676|747812|P4|COMPLETED|Overall Study||10
312781|NCT01612676|747813|P3|COMPLETED|Overall Study||4
312782|NCT01612676|747814|P2|COMPLETED|Overall Study||3
312783|NCT01612676|747815|P1|COMPLETED|Overall Study||4
312784|NCT01612676|747812|P4|Dosed|Overall Study||13
312785|NCT01612676|747813|P3|Dosed|Overall Study||5
312786|NCT01612676|747814|P2|Dosed|Overall Study||7
312787|NCT01612676|747815|P1|Dosed|Overall Study||5
312788|NCT01612676|747812|P4|STARTED|Overall Study||13
312789|NCT01612676|747813|P3|STARTED|Overall Study||5
312790|NCT01612676|747814|P2|STARTED|Overall Study||7
312791|NCT01612676|747815|P1|STARTED|Overall Study||6
312792|NCT01614470|747873|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
312793|NCT01614470|747874|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
312794|NCT01614470|747875|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
312795|NCT01614470|747873|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
312796|NCT01614470|747874|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
312797|NCT01614470|747875|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
312798|NCT01614470|747873|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
312799|NCT01614470|747874|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
312800|NCT01614470|747875|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
312801|NCT01614470|747873|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
312802|NCT01614470|747874|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
312803|NCT01614470|747875|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
312804|NCT01614470|747873|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
312805|NCT01614470|747874|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
312806|NCT01614470|747875|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
312807|NCT01614470|747873|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
312808|NCT01614470|747874|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
312809|NCT01614470|747875|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
312810|NCT01614470|747873|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
312811|NCT01614470|747874|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
312812|NCT01614470|747875|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
312813|NCT01614470|747873|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
312814|NCT01614470|747874|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
312815|NCT01614470|747875|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
312816|NCT01614470|747873|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
312817|NCT01614470|747874|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
312818|NCT01614470|747875|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
312819|NCT01614470|747873|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
312820|NCT01614470|747874|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
312821|NCT01614470|747875|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
312822|NCT01614470|747873|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
312823|NCT01614470|747874|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
312824|NCT01614470|747875|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
312825|NCT01614470|747873|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
312826|NCT01614470|747874|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
312827|NCT01614470|747875|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
312828|NCT01614457|747897|P2|NOT COMPLETED|Overall Study||0
312829|NCT01614457|747898|P1|NOT COMPLETED|Overall Study||2
312830|NCT01614457|747897|P2|COMPLETED|Overall Study||35
312831|NCT01614457|747898|P1|COMPLETED|Overall Study||32
312832|NCT01614457|747897|P2|STARTED|Overall Study||35
312833|NCT01614457|747898|P1|STARTED|Overall Study||34
312834|NCT01614249|747916|P2|NOT COMPLETED|Overall Study||23
312835|NCT01614249|747917|P1|NOT COMPLETED|Overall Study||11
312836|NCT01614249|747916|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
312837|NCT01614249|747917|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
312838|NCT01614249|747916|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
312839|NCT01614249|747917|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
312840|NCT01614249|747916|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
312841|NCT01614249|747917|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
312842|NCT01614249|747916|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
312843|NCT01614249|747917|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
312844|NCT01612494|747925|P2|NOT COMPLETED|Overall Study||0
312845|NCT01612494|747926|P1|NOT COMPLETED|Overall Study||0
312846|NCT01612494|747925|P2|COMPLETED|Overall Study||23
312847|NCT01612494|747926|P1|COMPLETED|Overall Study||21
312848|NCT01612494|747925|P2|STARTED|Overall Study||23
312849|NCT01612494|747926|P1|STARTED|Overall Study||21
312850|NCT01613599|747932|P1|NOT COMPLETED|Overall Study||97
312851|NCT01613599|747932|P1|COMPLETED|Overall Study||0
312852|NCT01613599|747932|P1|STARTED|Overall Study||97
312853|NCT01613417|747947|P2|NOT COMPLETED|Second Injection||0
312854|NCT01613417|747948|P1|NOT COMPLETED|Second Injection||0
312855|NCT01613417|747947|P2|COMPLETED|Second Injection||109
312856|NCT01613417|747948|P1|COMPLETED|Second Injection||100
312857|NCT01613417|747947|P2|STARTED|Second Injection||109
312858|NCT01613417|747948|P1|STARTED|Second Injection||100
312859|NCT01613417|747947|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
312860|NCT01613417|747948|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
312861|NCT01613417|747947|P2|COMPLETED|Washout (no Second Injection/MRI)||109
312862|NCT01613417|747948|P1|COMPLETED|Washout (no Second Injection/MRI)||100
312863|NCT01613417|747947|P2|STARTED|Washout (no Second Injection/MRI)||116
312864|NCT01613417|747948|P1|STARTED|Washout (no Second Injection/MRI)||113
312865|NCT01613417|747947|P2|NOT COMPLETED|First Injection||0
312866|NCT01613417|747948|P1|NOT COMPLETED|First Injection||0
312867|NCT01613417|747947|P2|COMPLETED|First Injection||116
312868|NCT01613417|747948|P1|COMPLETED|First Injection||113
312869|NCT01613417|747947|P2|STARTED|First Injection||116
312870|NCT01613417|747948|P1|STARTED|First Injection||113
312871|NCT01613378|747985|P1|NOT COMPLETED|Overall Study||39
312872|NCT01613378|747985|P1|COMPLETED|Overall Study||161
312873|NCT01613378|747985|P1|STARTED|Overall Study||200
312874|NCT01613339|748003|P2|NOT COMPLETED|Overall Study||1
312875|NCT01613339|748004|P1|NOT COMPLETED|Overall Study||3
312876|NCT01613339|748003|P2|COMPLETED|Overall Study||21
312877|NCT01613339|748004|P1|COMPLETED|Overall Study||21
312878|NCT01613339|748003|P2|STARTED|Overall Study||22
312879|NCT01613339|748004|P1|STARTED|Overall Study||24
312880|NCT01613326|748015|P2|NOT COMPLETED|Overall Study||14
312881|NCT01613326|748016|P1|NOT COMPLETED|Overall Study||13
312882|NCT01613326|748015|P2|COMPLETED|Overall Study||316
312883|NCT01613326|748016|P1|COMPLETED|Overall Study||314
312884|NCT01613326|748015|P2|STARTED|Overall Study||330
312885|NCT01613326|748016|P1|STARTED|Overall Study||327
312886|NCT01613313|748050|P4|NOT COMPLETED|Overall Study||0
312887|NCT01613313|748051|P3|NOT COMPLETED|Overall Study||0
312888|NCT01613313|748052|P2|NOT COMPLETED|Overall Study||0
312889|NCT01613313|748053|P1|NOT COMPLETED|Overall Study||0
312890|NCT01613313|748050|P4|COMPLETED|Overall Study||4
312891|NCT01613313|748051|P3|COMPLETED|Overall Study||4
312892|NCT01613313|748052|P2|COMPLETED|Overall Study||4
312893|NCT01613313|748053|P1|COMPLETED|Overall Study||2
312894|NCT01613313|748050|P4|STARTED|Overall Study||4
312895|NCT01613313|748051|P3|STARTED|Overall Study||4
312896|NCT01613313|748052|P2|STARTED|Overall Study||4
312897|NCT01613313|748053|P1|STARTED|Overall Study||2
312898|NCT01613248|748073|P6|NOT COMPLETED|Overall Study||38
312899|NCT01613248|748074|P5|NOT COMPLETED|Overall Study||35
312900|NCT01613248|748075|P4|NOT COMPLETED|Overall Study||38
312901|NCT01613248|748076|P3|NOT COMPLETED|Overall Study||33
312902|NCT01613248|748077|P2|NOT COMPLETED|Overall Study||34
312903|NCT01613248|748078|P1|NOT COMPLETED|Overall Study||29
312904|NCT01613248|748073|P6|COMPLETED|Overall Study||102
312905|NCT01613248|748074|P5|COMPLETED|Overall Study||104
312906|NCT01613248|748075|P4|COMPLETED|Overall Study||101
312907|NCT01613248|748076|P3|COMPLETED|Overall Study||106
312908|NCT01613248|748077|P2|COMPLETED|Overall Study||104
312909|NCT01613248|748078|P1|COMPLETED|Overall Study||110
312910|NCT01613248|748073|P6|STARTED|Overall Study||140
312911|NCT01613248|748074|P5|STARTED|Overall Study||139
312912|NCT01613248|748075|P4|STARTED|Overall Study||139
312913|NCT01613248|748076|P3|STARTED|Overall Study||139
312914|NCT01613248|748077|P2|STARTED|Overall Study||138
312915|NCT01613248|748078|P1|STARTED|Overall Study||139
312916|NCT01613131|748178|P2|NOT COMPLETED|Overall Study||5
312917|NCT01613131|748179|P1|NOT COMPLETED|Overall Study||3
312918|NCT01613131|748178|P2|COMPLETED|Overall Study||13
312919|NCT01613131|748179|P1|COMPLETED|Overall Study||17
312920|NCT01613131|748178|P2|STARTED|Overall Study||18
312921|NCT01613131|748179|P1|STARTED|Overall Study||20
312922|NCT01613027|748207|P1|NOT COMPLETED|Overall Study||8
312923|NCT01613027|748207|P1|COMPLETED|Overall Study||127
312924|NCT01613027|748207|P1|STARTED|Overall Study||135
312925|NCT01613014|748228|P2|NOT COMPLETED|Overall Study||12
312926|NCT01613014|748229|P1|NOT COMPLETED|Overall Study||18
312927|NCT01613014|748228|P2|COMPLETED|Overall Study||63
312928|NCT01613014|748229|P1|COMPLETED|Overall Study||57
312929|NCT01613014|748228|P2|STARTED|Overall Study||75
312930|NCT01613014|748229|P1|STARTED|Overall Study||75
312931|NCT01612858|748237|P2|NOT COMPLETED|Overall Study||1
312932|NCT01612858|748238|P1|NOT COMPLETED|Overall Study||5
312933|NCT01612858|748237|P2|COMPLETED|Overall Study||3
312934|NCT01612858|748238|P1|COMPLETED|Overall Study||11
312935|NCT01612858|748237|P2|STARTED|Overall Study||4
312936|NCT01612858|748238|P1|STARTED|Overall Study||16
312937|NCT01612767|748246|P1|NOT COMPLETED|Overall Study||9
312938|NCT01612767|748246|P1|COMPLETED|Overall Study||320
312939|NCT01612767|748246|P1|STARTED|Overall Study||329
312940|NCT01612156|748275|P2|NOT COMPLETED|Overall Study||0
312941|NCT01612156|748276|P1|NOT COMPLETED|Overall Study||2
312942|NCT01612156|748275|P2|COMPLETED|Overall Study||48
312943|NCT01612156|748276|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
312944|NCT01612156|748275|P2|STARTED|Overall Study||48
312945|NCT01612156|748276|P1|STARTED|Overall Study||42
312946|NCT01612000|748288|P4|NOT COMPLETED|Overall Study||10
312947|NCT01612000|748289|P3|NOT COMPLETED|Overall Study||7
312948|NCT01612000|748290|P2|NOT COMPLETED|Overall Study||5
312949|NCT01612000|748291|P1|NOT COMPLETED|Overall Study||9
312950|NCT01612000|748288|P4|COMPLETED|Overall Study||76
312951|NCT01612000|748289|P3|COMPLETED|Overall Study||78
312952|NCT01612000|748290|P2|COMPLETED|Overall Study||81
312953|NCT01612000|748291|P1|COMPLETED|Overall Study||75
312954|NCT01612000|748288|P4|STARTED|Overall Study||86
312955|NCT01612000|748289|P3|STARTED|Overall Study||85
312956|NCT01612000|748290|P2|STARTED|Overall Study||86
312957|NCT01612000|748291|P1|STARTED|Overall Study||84
312958|NCT01611974|748316|P3|NOT COMPLETED|Overall Study||16
312959|NCT01611974|748317|P2|NOT COMPLETED|Overall Study||15
312960|NCT01611974|748318|P1|NOT COMPLETED|Overall Study||15
312961|NCT01611974|748316|P3|COMPLETED|Overall Study||24
312962|NCT01611974|748317|P2|COMPLETED|Overall Study||25
312963|NCT01611974|748318|P1|COMPLETED|Overall Study||25
312964|NCT01611974|748316|P3|STARTED|Overall Study||40
312965|NCT01611974|748317|P2|STARTED|Overall Study||40
312966|NCT01611974|748318|P1|STARTED|Overall Study||40
312967|NCT01611948|748355|P2|NOT COMPLETED|Overall Study||12
312968|NCT01611948|748356|P1|NOT COMPLETED|Overall Study||14
312969|NCT01611948|748355|P2|COMPLETED|Overall Study||26
312970|NCT01611948|748356|P1|COMPLETED|Overall Study||18
312971|NCT01611948|748355|P2|STARTED|Overall Study||38
312972|NCT01611948|748356|P1|STARTED|Overall Study||32
312973|NCT01611883|748364|P2|NOT COMPLETED|Overall Study||1
312974|NCT01611883|748365|P1|NOT COMPLETED|Overall Study||1
312975|NCT01611883|748364|P2|COMPLETED|Overall Study||76
312976|NCT01611883|748365|P1|COMPLETED|Overall Study||74
312977|NCT01611883|748364|P2|STARTED|Overall Study||77
312978|NCT01611883|748365|P1|STARTED|Overall Study||75
312979|NCT01611857|748391|P2|NOT COMPLETED|Overall Study||2
312980|NCT01611857|748392|P1|NOT COMPLETED|Overall Study||0
312981|NCT01611857|748391|P2|COMPLETED|Overall Study||32
312982|NCT01611857|748392|P1|COMPLETED|Overall Study||15
312983|NCT01611857|748391|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
312984|NCT01611857|748392|P1|Tivantinib 360 mg|Overall Study||7
312985|NCT01611857|748391|P2|Tivantinib 240 mg|Overall Study||0
312986|NCT01611857|748392|P1|Tivantinib 240 mg|Overall Study||3
312987|NCT01611857|748391|P2|Tivantinib 120 mg|Overall Study||0
312988|NCT01611857|748392|P1|Tivantinib 120 mg|Overall Study||5
312989|NCT01611857|748391|P2|STARTED|Overall Study||34
312990|NCT01611857|748392|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
312991|NCT01611779|748402|P1|NOT COMPLETED|Overall Study||0
312992|NCT01611779|748402|P1|COMPLETED|Overall Study||5
312993|NCT01611779|748402|P1|STARTED|Overall Study||5
312994|NCT01611662|748411|P1|NOT COMPLETED|Overall Study||1
312995|NCT01611662|748411|P1|COMPLETED|Overall Study||31
312996|NCT01611662|748411|P1|STARTED|Overall Study||32
312997|NCT01611571|748418|P3|NOT COMPLETED|Overall Study||1
312998|NCT01611571|748419|P2|NOT COMPLETED|Overall Study||0
312999|NCT01611571|748420|P1|NOT COMPLETED|Overall Study||1
313000|NCT01611571|748418|P3|COMPLETED|Overall Study||9
313001|NCT01611571|748419|P2|COMPLETED|Overall Study||10
313002|NCT01611571|748420|P1|COMPLETED|Overall Study||10
313003|NCT01611571|748418|P3|STARTED|Overall Study||10
313004|NCT01611571|748419|P2|STARTED|Overall Study||10
313005|NCT01611571|748420|P1|STARTED|Overall Study||11
313006|NCT01611558|748440|P1|NOT COMPLETED|Maintenance Phase||2
313007|NCT01611558|748440|P1|COMPLETED|Maintenance Phase||0
313008|NCT01611558|748440|P1|STARTED|Maintenance Phase||2
313009|NCT01611558|748440|P1|NOT COMPLETED|Induction Phase||38
313010|NCT01611558|748440|P1|COMPLETED|Induction Phase||2
313011|NCT01611558|748440|P1|STARTED|Induction Phase||40
313012|NCT01610791|748446|P1|NOT COMPLETED|Overall Study||21
313013|NCT01610791|748446|P1|COMPLETED|Overall Study||100
313014|NCT01610791|748446|P1|STARTED|Overall Study||121
313015|NCT01610713|748469|P2|NOT COMPLETED|Overall Study||1
313016|NCT01610713|748470|P1|NOT COMPLETED|Overall Study||6
313017|NCT01610713|748469|P2|COMPLETED|Overall Study||76
313018|NCT01610713|748470|P1|COMPLETED|Overall Study||71
313019|NCT01610713|748469|P2|STARTED|Overall Study||77
313020|NCT01610713|748470|P1|STARTED|Overall Study||77
313021|NCT01610700|748528|P2|NOT COMPLETED|Overall Study||3
313022|NCT01610700|748529|P1|NOT COMPLETED|Overall Study||3
313023|NCT01610700|748528|P2|COMPLETED|Overall Study||77
313024|NCT01610700|748529|P1|COMPLETED|Overall Study||77
313025|NCT01610700|748528|P2|STARTED|Overall Study||80
313026|NCT01610700|748529|P1|STARTED|Overall Study||80
313027|NCT01610687|748583|P1|NOT COMPLETED|Overall Study||67
313028|NCT01610687|748583|P1|COMPLETED|Overall Study||70
313029|NCT01610687|748583|P1|STARTED|Overall Study||137
313030|NCT01610596|748596|P2|NOT COMPLETED|Overall Study||1
313031|NCT01610596|748597|P1|NOT COMPLETED|Overall Study||0
313032|NCT01610596|748596|P2|COMPLETED|Overall Study||35
313033|NCT01610596|748597|P1|COMPLETED|Overall Study||36
313034|NCT01610596|748596|P2|STARTED|Overall Study||36
313035|NCT01610596|748597|P1|STARTED|Overall Study||36
313036|NCT01610570|748613|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313037|NCT01610570|748614|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313038|NCT01610570|748615|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313039|NCT01610570|748616|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313040|NCT01610570|748613|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313041|NCT01610570|748614|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313042|NCT01610570|748615|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313043|NCT01610570|748616|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
313044|NCT01610570|748613|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
313045|NCT01610570|748614|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
313046|NCT01610570|748615|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
313047|NCT01610570|748616|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
313048|NCT01610570|748613|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313049|NCT01610570|748614|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313050|NCT01610570|748615|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313051|NCT01610570|748616|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313052|NCT01610570|748613|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
313053|NCT01610570|748614|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313054|NCT01610570|748615|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313055|NCT01610570|748616|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
313056|NCT01610570|748613|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
313057|NCT01610570|748614|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
313058|NCT01610570|748615|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
313059|NCT01610570|748616|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
313060|NCT01610570|748613|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313061|NCT01610570|748614|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313062|NCT01610570|748615|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313063|NCT01610570|748616|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313064|NCT01610570|748613|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313065|NCT01610570|748614|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313066|NCT01610570|748615|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
313067|NCT01610570|748616|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
313068|NCT01610570|748613|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
313069|NCT01610570|748614|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
313070|NCT01610570|748615|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
313071|NCT01610570|748616|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
313072|NCT01610557|748634|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
313073|NCT01610557|748635|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
313074|NCT01610557|748636|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
313075|NCT01610557|748637|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
313076|NCT01610557|748638|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
313077|NCT01610557|748634|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
313078|NCT01610557|748635|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313079|NCT01610557|748636|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313080|NCT01610557|748637|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313081|NCT01610557|748638|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313082|NCT01610557|748634|P5|STARTED|Post-36-Week Extension Phase||55
313083|NCT01610557|748635|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313084|NCT01610557|748636|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313085|NCT01610557|748637|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313086|NCT01610557|748638|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
313087|NCT01610557|748634|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
313088|NCT01610557|748635|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
313089|NCT01610557|748636|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
313090|NCT01610557|748637|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
313091|NCT01610557|748638|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
313092|NCT01610557|748634|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
313093|NCT01610557|748635|P4|COMPLETED|36-Week Randomized Crossover Phase||13
313094|NCT01610557|748636|P3|COMPLETED|36-Week Randomized Crossover Phase||14
313095|NCT01610557|748637|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
313096|NCT01610557|748638|P1|COMPLETED|36-Week Randomized Crossover Phase||16
313097|NCT01610557|748634|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
313098|NCT01610557|748635|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
313099|NCT01610557|748636|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
313100|NCT01610557|748637|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
313101|NCT01610557|748638|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
313102|NCT01610492|748651|P1|NOT COMPLETED|Overall Study||3
313103|NCT01610492|748651|P1|COMPLETED|Overall Study||11
313104|NCT01610492|748651|P1|STARTED|Overall Study||14
313105|NCT01610453|748658|P1|NOT COMPLETED|Overall Study||0
313106|NCT01610453|748658|P1|COMPLETED|Overall Study||150
313107|NCT01610453|748658|P1|STARTED|Overall Study||150
313108|NCT01610297|748663|P1|NOT COMPLETED|Overall Study||1
313109|NCT01610297|748663|P1|COMPLETED|Overall Study||26
313110|NCT01610297|748663|P1|STARTED|Overall Study||27
313111|NCT01610167|748674|P3|NOT COMPLETED|Overall Study||2
313112|NCT01610167|748675|P2|NOT COMPLETED|Overall Study||0
313113|NCT01610167|748676|P1|NOT COMPLETED|Overall Study||0
313114|NCT01610167|748674|P3|COMPLETED|Overall Study||48
313115|NCT01610167|748675|P2|COMPLETED|Overall Study||49
313116|NCT01610167|748676|P1|COMPLETED|Overall Study||52
313117|NCT01610167|748674|P3|STARTED|Overall Study||50
313118|NCT01610167|748675|P2|STARTED|Overall Study||49
313119|NCT01610167|748676|P1|STARTED|Overall Study||52
313120|NCT01610154|748696|P1|NOT COMPLETED|Overall Study||1
313121|NCT01610154|748696|P1|COMPLETED|Overall Study||84
313122|NCT01610154|748696|P1|STARTED|Overall Study||85
313123|NCT01610076|748713|P2|NOT COMPLETED|Overall Study||5
313124|NCT01610076|748714|P1|NOT COMPLETED|Overall Study||3
313125|NCT01610076|748713|P2|COMPLETED|Overall Study||100
313126|NCT01610076|748714|P1|COMPLETED|Overall Study||100
313127|NCT01610076|748713|P2|STARTED|Overall Study||105
313128|NCT01610076|748714|P1|STARTED|Overall Study||103
313129|NCT01610063|748725|P2|NOT COMPLETED|Overall Study||20
313130|NCT01610063|748726|P1|NOT COMPLETED|Overall Study||42
313131|NCT01610063|748725|P2|COMPLETED|Overall Study||93
313132|NCT01610063|748726|P1|COMPLETED|Overall Study||72
313133|NCT01610063|748725|P2|Completed 8-week|Overall Study||93
313134|NCT01610063|748726|P1|Completed 8-week|Overall Study||72
313135|NCT01610063|748725|P2|Completed 4-week|Overall Study||98
313136|NCT01610063|748726|P1|Completed 4-week|Overall Study||86
313137|NCT01610063|748725|P2|Completed 2-week|Overall Study||105
313138|NCT01610063|748726|P1|Completed 2-week|Overall Study||97
313139|NCT01610063|748725|P2|Baseline|Overall Study||113
313140|NCT01610063|748726|P1|Baseline|Overall Study||114
313141|NCT01610063|748725|P2|STARTED|Overall Study||113
313142|NCT01610063|748726|P1|STARTED|Overall Study||114
313143|NCT01610037|748749|P3|NOT COMPLETED|Treatment and Follow up Period||26
313144|NCT01610037|748750|P2|NOT COMPLETED|Treatment and Follow up Period||28
313145|NCT01610037|748751|P1|NOT COMPLETED|Treatment and Follow up Period||25
313146|NCT01610037|748749|P3|COMPLETED|Treatment and Follow up Period||378
313147|NCT01610037|748750|P2|COMPLETED|Treatment and Follow up Period||377
313148|NCT01610037|748751|P1|COMPLETED|Treatment and Follow up Period||382
313149|NCT01610037|748749|P3|STARTED|Treatment and Follow up Period||404
313150|NCT01610037|748750|P2|STARTED|Treatment and Follow up Period||405
313151|NCT01610037|748751|P1|STARTED|Treatment and Follow up Period||407
313152|NCT01610037|748749|P3|NOT COMPLETED|All Patients||84
313153|NCT01610037|748750|P2|NOT COMPLETED|All Patients||51
313154|NCT01610037|748751|P1|NOT COMPLETED|All Patients||59
313155|NCT01610037|748749|P3|COMPLETED|All Patients||320
313156|NCT01610037|748750|P2|COMPLETED|All Patients||354
313157|NCT01610037|748751|P1|COMPLETED|All Patients||348
313158|NCT01610037|748749|P3|Full Analysis Set (FAS)|All Patients||403
313159|NCT01610037|748750|P2|Full Analysis Set (FAS)|All Patients||405
313160|NCT01610037|748751|P1|Full Analysis Set (FAS)|All Patients||407
313161|NCT01610037|748749|P3|Randomized Set (RAN)|All Patients||404
313162|NCT01610037|748750|P2|Randomized Set (RAN)|All Patients||405
313163|NCT01610037|748751|P1|Randomized Set (RAN)|All Patients||407
313164|NCT01610037|748749|P3|STARTED|All Patients||404
313165|NCT01610037|748750|P2|STARTED|All Patients||405
313166|NCT01610037|748751|P1|STARTED|All Patients||407
313167|NCT01610011|748794|P2|NOT COMPLETED|Overall Study||0
313168|NCT01610011|748795|P1|NOT COMPLETED|Overall Study||10
313169|NCT01610011|748794|P2|COMPLETED|Overall Study||2
313170|NCT01610011|748795|P1|COMPLETED|Overall Study||9
313171|NCT01610011|748794|P2|STARTED|Overall Study||2
313172|NCT01610011|748795|P1|STARTED|Overall Study||19
313173|NCT01609790|748804|P3|NOT COMPLETED|Overall Study||8
313174|NCT01609790|748805|P2|NOT COMPLETED|Overall Study||7
313175|NCT01609790|748806|P1|NOT COMPLETED|Overall Study||1
313176|NCT01609790|748804|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
313177|NCT01609790|748805|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
313178|NCT01609790|748806|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
313179|NCT01609790|748804|P3|STARTED|Overall Study||65
313180|NCT01609790|748805|P2|STARTED|Overall Study||65
313181|NCT01609790|748806|P1|STARTED|Overall Study||7
313182|NCT01609582|748824|P2|NOT COMPLETED|Overall Study||1604
313183|NCT01609582|748825|P1|NOT COMPLETED|Overall Study||1603
313184|NCT01609582|748824|P2|COMPLETED|Overall Study||0
313185|NCT01609582|748825|P1|COMPLETED|Overall Study||0
313186|NCT01609582|748824|P2|Treated|Overall Study||1601
313187|NCT01609582|748825|P1|Treated|Overall Study||1603
313188|NCT01609582|748824|P2|STARTED|Overall Study||1604
313189|NCT01609582|748825|P1|STARTED|Overall Study||1603
313190|NCT01609543|748833|P1|NOT COMPLETED|Overall Study||42
313191|NCT01609543|748833|P1|COMPLETED|Overall Study||20
313192|NCT01609543|748833|P1|STARTED|Overall Study||62
313193|NCT01609478|748842|P3|NOT COMPLETED|Overall Study||9
313194|NCT01609478|748843|P2|NOT COMPLETED|Overall Study||2
313195|NCT01609478|748844|P1|NOT COMPLETED|Overall Study||7
313196|NCT01609478|748842|P3|COMPLETED|Overall Study||107
313197|NCT01609478|748843|P2|COMPLETED|Overall Study||106
313198|NCT01609478|748844|P1|COMPLETED|Overall Study||104
313199|NCT01609478|748842|P3|Full Analysis Set (FAS)|Overall Study||115
313200|NCT01609478|748843|P2|Full Analysis Set (FAS)|Overall Study||108
313201|NCT01609478|748844|P1|Full Analysis Set (FAS)|Overall Study||110
313202|NCT01609478|748842|P3|STARTED|Overall Study||116
313203|NCT01609478|748843|P2|STARTED|Overall Study||108
313204|NCT01609478|748844|P1|STARTED|Overall Study||111
313205|NCT01609257|748910|P2|NOT COMPLETED|Overall Study||8
313206|NCT01609257|748911|P1|NOT COMPLETED|Overall Study||6
313207|NCT01609257|748910|P2|COMPLETED|Overall Study||57
313208|NCT01609257|748911|P1|COMPLETED|Overall Study||61
313209|NCT01609257|748910|P2|Received Challenge Product|Overall Study||53
313210|NCT01609257|748911|P1|Received Challenge Product|Overall Study||56
313211|NCT01609257|748910|P2|Received 2 Doses|Overall Study||64
313212|NCT01609257|748911|P1|Received 2 Doses|Overall Study||63
313213|NCT01609257|748910|P2|STARTED|Overall Study||65
313214|NCT01609257|748911|P1|STARTED|Overall Study||67
313215|NCT01609062|748983|P2|NOT COMPLETED|Extension Phase||10
313216|NCT01609062|748984|P1|NOT COMPLETED|Extension Phase||15
313217|NCT01609062|748983|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
313218|NCT01609062|748984|P1|COMPLETED|Extension Phase||0
313219|NCT01609062|748983|P2|STARTED|Extension Phase||10
313220|NCT01609062|748984|P1|STARTED|Extension Phase||15
313221|NCT01609062|748983|P2|NOT COMPLETED|Primary Phase||0
313222|NCT01609062|748984|P1|NOT COMPLETED|Primary Phase||0
313223|NCT01609062|748983|P2|COMPLETED|Primary Phase||10
313224|NCT01609062|748984|P1|COMPLETED|Primary Phase||15
313225|NCT01609062|748983|P2|STARTED|Primary Phase||10
313226|NCT01609062|748984|P1|STARTED|Primary Phase||15
313227|NCT01609023|749027|P1|NOT COMPLETED|Overall Study||33
313228|NCT01609023|749027|P1|COMPLETED|Overall Study||34
313229|NCT01609023|749027|P1|STARTED|Overall Study||67
313230|NCT01609010|749039|P2|NOT COMPLETED|Overall Study||37
313231|NCT01609010|749040|P1|NOT COMPLETED|Overall Study||43
313232|NCT01609010|749039|P2|COMPLETED|Overall Study||120
313233|NCT01609010|749040|P1|COMPLETED|Overall Study||113
313234|NCT01609010|749039|P2|Entering Cycle 2|Overall Study||124
313235|NCT01609010|749040|P1|Entering Cycle 2|Overall Study||120
313236|NCT01609010|749039|P2|STARTED|Overall Study||157
313237|NCT01609010|749040|P1|STARTED|Overall Study||156
313238|NCT01608971|749066|P2|NOT COMPLETED|Overall Study||0
313239|NCT01608971|749067|P1|NOT COMPLETED|Overall Study||0
313240|NCT01608971|749066|P2|COMPLETED|Overall Study||15
313241|NCT01608971|749067|P1|COMPLETED|Overall Study||15
313242|NCT01608971|749066|P2|STARTED|Overall Study||15
313243|NCT01608971|749067|P1|STARTED|Overall Study||15
313244|NCT01608815|749082|P3|NOT COMPLETED|Overall Study||0
313245|NCT01608815|749083|P2|NOT COMPLETED|Overall Study||0
313246|NCT01608815|749084|P1|NOT COMPLETED|Overall Study||0
313247|NCT01608815|749082|P3|COMPLETED|Overall Study||5
313248|NCT01608815|749083|P2|COMPLETED|Overall Study||7
313249|NCT01608815|749084|P1|COMPLETED|Overall Study||188
313250|NCT01608815|749082|P3|STARTED|Overall Study||5
313251|NCT01608815|749083|P2|STARTED|Overall Study||7
313252|NCT01608815|749084|P1|STARTED|Overall Study||188
313253|NCT01608724|749101|P1|NOT COMPLETED|Overall Study||243
313254|NCT01608724|749101|P1|COMPLETED|Overall Study||1180
313255|NCT01608724|749101|P1|Treated|Overall Study||1361
313256|NCT01608724|749101|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
313257|NCT01608672|749108|P1|NOT COMPLETED|Overall Study||0
313258|NCT01608672|749108|P1|COMPLETED|Overall Study||207
313259|NCT01608672|749108|P1|STARTED|Overall Study||207
313260|NCT01608659|749114|P1|NOT COMPLETED|Overall Study||16
313261|NCT01608659|749114|P1|COMPLETED|Overall Study||94
313262|NCT01608659|749114|P1|STARTED|Overall Study||110
313263|NCT01608321|749122|P2|NOT COMPLETED|Overall Study||0
313264|NCT01608321|749123|P1|NOT COMPLETED|Overall Study||1
313265|NCT01608321|749122|P2|COMPLETED|Overall Study||4
313266|NCT01608321|749123|P1|COMPLETED|Overall Study||12
313267|NCT01608321|749122|P2|STARTED|Overall Study||4
313268|NCT01608321|749123|P1|STARTED|Overall Study||13
313269|NCT01608308|749131|P2|NOT COMPLETED|Overall Study||2
313270|NCT01608308|749132|P1|NOT COMPLETED|Overall Study||0
313271|NCT01608308|749131|P2|COMPLETED|Overall Study||29
313272|NCT01608308|749132|P1|COMPLETED|Overall Study||31
313273|NCT01608308|749131|P2|STARTED|Overall Study||31
313274|NCT01608308|749132|P1|STARTED|Overall Study||31
313275|NCT01608295|749156|P2|NOT COMPLETED|Overall Study||5
313276|NCT01608295|749157|P1|NOT COMPLETED|Overall Study||6
313277|NCT01608295|749156|P2|COMPLETED|Overall Study||25
313278|NCT01608295|749157|P1|COMPLETED|Overall Study||20
313279|NCT01608295|749156|P2|STARTED|Overall Study||30
313280|NCT01608295|749157|P1|STARTED|Overall Study||26
313281|NCT01608100|749167|P1|NOT COMPLETED|Overall Study||0
313282|NCT01608100|749167|P1|COMPLETED|Overall Study||1101
313283|NCT01608100|749167|P1|STARTED|Overall Study||1101
313284|NCT01607853|749191|P1|NOT COMPLETED|Overall Study||0
313285|NCT01607853|749191|P1|COMPLETED|Overall Study||24
313286|NCT01607853|749191|P1|STARTED|Overall Study||24
313287|NCT01607645|749300|P2|NOT COMPLETED|Overall Study||0
313288|NCT01607645|749301|P1|NOT COMPLETED|Overall Study||0
313289|NCT01607645|749300|P2|COMPLETED|Overall Study||3
313290|NCT01607645|749301|P1|COMPLETED|Overall Study||4
313291|NCT01607645|749300|P2|STARTED|Overall Study||3
313292|NCT01607645|749301|P1|STARTED|Overall Study||4
313293|NCT01607593|749331|P1|NOT COMPLETED|Overall Study||93
313294|NCT01607593|749331|P1|COMPLETED|Overall Study||29
313295|NCT01607593|749331|P1|STARTED|Overall Study||122
313296|NCT01607476|749340|P3|NOT COMPLETED|Overall Study||3
313297|NCT01607476|749341|P2|NOT COMPLETED|Overall Study||0
313298|NCT01607476|749342|P1|NOT COMPLETED|Overall Study||1
313299|NCT01607476|749340|P3|COMPLETED|Overall Study||30
313300|NCT01607476|749341|P2|COMPLETED|Overall Study||30
313301|NCT01607476|749342|P1|COMPLETED|Overall Study||24
313302|NCT01607476|749340|P3|STARTED|Overall Study||33
313303|NCT01607476|749341|P2|STARTED|Overall Study||30
313304|NCT01607476|749342|P1|STARTED|Overall Study||25
313305|NCT01607450|749360|P7|NOT COMPLETED|Overall Study||0
313306|NCT01607450|749361|P6|NOT COMPLETED|Overall Study||0
313307|NCT01607450|749362|P5|NOT COMPLETED|Overall Study||0
313308|NCT01607450|749363|P4|NOT COMPLETED|Overall Study||0
313309|NCT01607450|749364|P3|NOT COMPLETED|Overall Study||0
313310|NCT01607450|749365|P2|NOT COMPLETED|Overall Study||0
313311|NCT01607450|749366|P1|NOT COMPLETED|Overall Study||0
313312|NCT01607450|749360|P7|COMPLETED|Overall Study||0
313313|NCT01607450|749361|P6|COMPLETED|Overall Study||0
313314|NCT01607450|749362|P5|COMPLETED|Overall Study||1
313315|NCT01607450|749363|P4|COMPLETED|Overall Study||11
313316|NCT01607450|749364|P3|COMPLETED|Overall Study||7
313317|NCT01607450|749365|P2|COMPLETED|Overall Study||8
313318|NCT01607450|749366|P1|COMPLETED|Overall Study||6
313319|NCT01607450|749360|P7|STARTED|Overall Study||0
313320|NCT01607450|749361|P6|STARTED|Overall Study||0
313321|NCT01607450|749362|P5|STARTED|Overall Study||1
313322|NCT01607450|749363|P4|STARTED|Overall Study||11
313323|NCT01607450|749364|P3|STARTED|Overall Study||7
313324|NCT01607450|749365|P2|STARTED|Overall Study||8
313325|NCT01607450|749366|P1|STARTED|Overall Study||6
313326|NCT01607411|749410|P4|NOT COMPLETED|Period IV||0
313327|NCT01607411|749411|P3|NOT COMPLETED|Period IV||0
313328|NCT01607411|749412|P2|NOT COMPLETED|Period IV||0
313329|NCT01607411|749413|P1|NOT COMPLETED|Period IV||0
313330|NCT01607411|749410|P4|COMPLETED|Period IV||14
313331|NCT01607411|749411|P3|COMPLETED|Period IV||14
313332|NCT01607411|749412|P2|COMPLETED|Period IV||14
313333|NCT01607411|749413|P1|COMPLETED|Period IV||13
313334|NCT01607411|749410|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
313335|NCT01607411|749411|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
313336|NCT01607411|749412|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
313337|NCT01607411|749413|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
313338|NCT01607411|749410|P4|NOT COMPLETED|Period III||0
313339|NCT01607411|749411|P3|NOT COMPLETED|Period III||0
313340|NCT01607411|749412|P2|NOT COMPLETED|Period III||0
313341|NCT01607411|749413|P1|NOT COMPLETED|Period III||0
313342|NCT01607411|749410|P4|COMPLETED|Period III||13
313343|NCT01607411|749411|P3|COMPLETED|Period III||14
313344|NCT01607411|749412|P2|COMPLETED|Period III||14
313345|NCT01607411|749413|P1|COMPLETED|Period III||14
313346|NCT01607411|749410|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
313347|NCT01607411|749411|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
313348|NCT01607411|749412|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
313349|NCT01607411|749413|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
313350|NCT01607411|749410|P4|NOT COMPLETED|Period II||0
313351|NCT01607411|749411|P3|NOT COMPLETED|Period II||0
313352|NCT01607411|749412|P2|NOT COMPLETED|Period II||0
313353|NCT01607411|749413|P1|NOT COMPLETED|Period II||0
313354|NCT01607411|749410|P4|COMPLETED|Period II||14
313355|NCT01607411|749411|P3|COMPLETED|Period II||13
313356|NCT01607411|749412|P2|COMPLETED|Period II||14
313357|NCT01607411|749413|P1|COMPLETED|Period II||14
313358|NCT01607411|749410|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
313359|NCT01607411|749411|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
313360|NCT01607411|749412|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
313361|NCT01607411|749413|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
313362|NCT01607411|749410|P4|NOT COMPLETED|Period I||0
313363|NCT01607411|749411|P3|NOT COMPLETED|Period I||0
313364|NCT01607411|749412|P2|NOT COMPLETED|Period I||0
313365|NCT01607411|749413|P1|NOT COMPLETED|Period I||0
313366|NCT01607411|749410|P4|COMPLETED|Period I||14
313367|NCT01607411|749411|P3|COMPLETED|Period I||14
313368|NCT01607411|749412|P2|COMPLETED|Period I||13
313369|NCT01607411|749413|P1|COMPLETED|Period I||14
313370|NCT01607411|749410|P4|STARTED|Period I||14
313371|NCT01607411|749411|P3|STARTED|Period I||14
313372|NCT01607411|749412|P2|STARTED|Period I||13
313373|NCT01607411|749413|P1|STARTED|Period I||14
313374|NCT01607398|749436|P2|NOT COMPLETED|Overall Study||2
313375|NCT01607398|749437|P1|NOT COMPLETED|Overall Study||2
313376|NCT01607398|749436|P2|COMPLETED|Overall Study||26
313377|NCT01607398|749437|P1|COMPLETED|Overall Study||26
313378|NCT01607398|749436|P2|STARTED|Overall Study||28
313379|NCT01607398|749437|P1|STARTED|Overall Study||28
313380|NCT01607320|749481|P2|NOT COMPLETED|Overall Study||0
313381|NCT01607320|749482|P1|NOT COMPLETED|Overall Study||0
313468|NCT01606306|749622|P2|STARTED|Overall Study||49
313382|NCT01607320|749481|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
313383|NCT01607320|749482|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
313384|NCT01607320|749481|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
313385|NCT01607320|749482|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
313386|NCT01607203|749488|P2|NOT COMPLETED|Overall Study||0
313387|NCT01607203|749489|P1|NOT COMPLETED|Overall Study||0
313388|NCT01607203|749488|P2|COMPLETED|Overall Study||61
313389|NCT01607203|749489|P1|COMPLETED|Overall Study||59
313390|NCT01607203|749488|P2|STARTED|Overall Study||61
313391|NCT01607203|749489|P1|STARTED|Overall Study||59
313392|NCT01607112|749501|P2|NOT COMPLETED|Overall Study||0
313393|NCT01607112|749502|P1|NOT COMPLETED|Overall Study||0
313394|NCT01607112|749501|P2|COMPLETED|Overall Study||59
313395|NCT01607112|749502|P1|COMPLETED|Overall Study||60
313396|NCT01607112|749501|P2|STARTED|Overall Study||59
313397|NCT01607112|749502|P1|STARTED|Overall Study||60
313398|NCT01606800|749538|P2|NOT COMPLETED|Overall Study||2
313399|NCT01606800|749539|P1|NOT COMPLETED|Overall Study||5
313400|NCT01606800|749538|P2|COMPLETED|Overall Study||21
313401|NCT01606800|749539|P1|COMPLETED|Overall Study||17
313402|NCT01606800|749538|P2|Treated|Overall Study||23
313403|NCT01606800|749539|P1|Treated|Overall Study||22
313404|NCT01606800|749538|P2|STARTED|Overall Study||23
313405|NCT01606800|749539|P1|STARTED|Overall Study||22
313406|NCT01606748|749547|P2|NOT COMPLETED|Overall Study||0
313407|NCT01606748|749548|P1|NOT COMPLETED|Overall Study||3
313408|NCT01606748|749547|P2|COMPLETED|Overall Study||17
313409|NCT01606748|749548|P1|COMPLETED|Overall Study||15
313410|NCT01606748|749547|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
313411|NCT01606748|749548|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
313412|NCT01606748|749547|P2|STARTED|Overall Study||17
313413|NCT01606748|749548|P1|STARTED|Overall Study||18
313414|NCT01606735|749579|P3|NOT COMPLETED|Overall Study||0
313415|NCT01606735|749580|P2|NOT COMPLETED|Overall Study||0
313416|NCT01606735|749581|P1|NOT COMPLETED|Overall Study||0
313417|NCT01606735|749579|P3|COMPLETED|Overall Study||58
313418|NCT01606735|749580|P2|COMPLETED|Overall Study||56
313419|NCT01606735|749581|P1|COMPLETED|Overall Study||58
313420|NCT01606735|749579|P3|STARTED|Overall Study||58
313421|NCT01606735|749580|P2|STARTED|Overall Study||56
313422|NCT01606735|749581|P1|STARTED|Overall Study||58
313423|NCT01606670|749589|P1|NOT COMPLETED|Overall Study||16
313424|NCT01606670|749589|P1|COMPLETED|Overall Study||77
313425|NCT01606670|749589|P1|Full Analysis Set|Overall Study||70
313426|NCT01606670|749589|P1|Safety Set|Overall Study||93
313427|NCT01606670|749589|P1|STARTED|Overall Study||93
313428|NCT01606319|749599|P2|NOT COMPLETED|Overall Study||40
313429|NCT01606319|749600|P1|NOT COMPLETED|Overall Study||34
313430|NCT01606319|749599|P2|COMPLETED|Overall Study||110
313431|NCT01606319|749600|P1|COMPLETED|Overall Study||116
313432|NCT01606319|749599|P2|STARTED|Overall Study||150
313433|NCT01606319|749600|P1|STARTED|Overall Study||150
313434|NCT01606306|749618|P6|NOT COMPLETED|Overall Study||11
313435|NCT01606306|749619|P5|NOT COMPLETED|Overall Study||11
313436|NCT01606306|749620|P4|NOT COMPLETED|Overall Study||13
313437|NCT01606306|749621|P3|NOT COMPLETED|Overall Study||14
313438|NCT01606306|749622|P2|NOT COMPLETED|Overall Study||10
313439|NCT01606306|749623|P1|NOT COMPLETED|Overall Study||15
313440|NCT01606306|749618|P6|COMPLETED|Overall Study||36
313441|NCT01606306|749619|P5|COMPLETED|Overall Study||41
313442|NCT01606306|749620|P4|COMPLETED|Overall Study||38
313443|NCT01606306|749621|P3|COMPLETED|Overall Study||37
313444|NCT01606306|749622|P2|COMPLETED|Overall Study||39
313445|NCT01606306|749623|P1|COMPLETED|Overall Study||35
313446|NCT01606306|749618|P6|Completed Third Treatment Period|Overall Study||36
313447|NCT01606306|749619|P5|Completed Third Treatment Period|Overall Study||41
313448|NCT01606306|749620|P4|Completed Third Treatment Period|Overall Study||38
313449|NCT01606306|749621|P3|Completed Third Treatment Period|Overall Study||37
313450|NCT01606306|749622|P2|Completed Third Treatment Period|Overall Study||39
313451|NCT01606306|749623|P1|Completed Third Treatment Period|Overall Study||35
313452|NCT01606306|749618|P6|Completed Second Treatment Period|Overall Study||41
313453|NCT01606306|749619|P5|Completed Second Treatment Period|Overall Study||46
313454|NCT01606306|749620|P4|Completed Second Treatment Period|Overall Study||44
313455|NCT01606306|749621|P3|Completed Second Treatment Period|Overall Study||43
313456|NCT01606306|749622|P2|Completed Second Treatment Period|Overall Study||38
313457|NCT01606306|749623|P1|Completed Second Treatment Period|Overall Study||41
313458|NCT01606306|749618|P6|Completed First Treatment Period|Overall Study||44
313459|NCT01606306|749619|P5|Completed First Treatment Period|Overall Study||47
313460|NCT01606306|749620|P4|Completed First Treatment Period|Overall Study||45
313461|NCT01606306|749621|P3|Completed First Treatment Period|Overall Study||47
313462|NCT01606306|749622|P2|Completed First Treatment Period|Overall Study||47
313463|NCT01606306|749623|P1|Completed First Treatment Period|Overall Study||43
313464|NCT01606306|749618|P6|STARTED|Overall Study||47
313465|NCT01606306|749619|P5|STARTED|Overall Study||52
313466|NCT01606306|749620|P4|STARTED|Overall Study||51
313467|NCT01606306|749621|P3|STARTED|Overall Study||51
313469|NCT01606306|749623|P1|STARTED|Overall Study||50
313470|NCT01606254|749633|P4|NOT COMPLETED|Overall Study||3
313471|NCT01606254|749634|P3|NOT COMPLETED|Overall Study||0
313472|NCT01606254|749635|P2|NOT COMPLETED|Overall Study||4
313473|NCT01606254|749636|P1|NOT COMPLETED|Overall Study||2
313474|NCT01606254|749633|P4|COMPLETED|Overall Study||11
313475|NCT01606254|749634|P3|COMPLETED|Overall Study||14
313476|NCT01606254|749635|P2|COMPLETED|Overall Study||10
313477|NCT01606254|749636|P1|COMPLETED|Overall Study||12
313478|NCT01606254|749633|P4|STARTED|Overall Study||14
313479|NCT01606254|749634|P3|STARTED|Overall Study||14
313480|NCT01606254|749635|P2|STARTED|Overall Study||14
313481|NCT01606254|749636|P1|STARTED|Overall Study||14
313482|NCT01606228|749718|P1|NOT COMPLETED|Overall Study||29
313483|NCT01606228|749718|P1|COMPLETED|Overall Study||159
313484|NCT01606228|749718|P1|STARTED|Overall Study||188
313485|NCT01606202|749735|P2|NOT COMPLETED|Overall Study||3
313486|NCT01606202|749736|P1|NOT COMPLETED|Overall Study||7
313487|NCT01606202|749735|P2|COMPLETED|Overall Study||57
313488|NCT01606202|749736|P1|COMPLETED|Overall Study||49
313489|NCT01606202|749735|P2|STARTED|Overall Study||60
313490|NCT01606202|749736|P1|STARTED|Overall Study||56
313491|NCT01606189|749768|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
313492|NCT01606189|749769|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
313493|NCT01606189|749770|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
313494|NCT01606189|749771|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
313495|NCT01606189|749772|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
313496|NCT01606189|749773|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
313497|NCT01606189|749768|P6|COMPLETED|Third Intenvention (14-20 Days)||6
313498|NCT01606189|749769|P5|COMPLETED|Third Intenvention (14-20 Days)||8
313499|NCT01606189|749770|P4|COMPLETED|Third Intenvention (14-20 Days)||8
313500|NCT01606189|749771|P3|COMPLETED|Third Intenvention (14-20 Days)||8
313501|NCT01606189|749772|P2|COMPLETED|Third Intenvention (14-20 Days)||8
313502|NCT01606189|749773|P1|COMPLETED|Third Intenvention (14-20 Days)||8
313503|NCT01606189|749768|P6|STARTED|Third Intenvention (14-20 Days)||7
313504|NCT01606189|749769|P5|STARTED|Third Intenvention (14-20 Days)||8
313505|NCT01606189|749770|P4|STARTED|Third Intenvention (14-20 Days)||8
313506|NCT01606189|749771|P3|STARTED|Third Intenvention (14-20 Days)||8
313507|NCT01606189|749772|P2|STARTED|Third Intenvention (14-20 Days)||8
313508|NCT01606189|749773|P1|STARTED|Third Intenvention (14-20 Days)||8
313509|NCT01606189|749768|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
313510|NCT01606189|749769|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
313511|NCT01606189|749770|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
313512|NCT01606189|749771|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
313513|NCT01606189|749772|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
313514|NCT01606189|749773|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
313515|NCT01606189|749768|P6|COMPLETED|Second Intenvention (14-20 Days)||7
313516|NCT01606189|749769|P5|COMPLETED|Second Intenvention (14-20 Days)||8
313517|NCT01606189|749770|P4|COMPLETED|Second Intenvention (14-20 Days)||8
313518|NCT01606189|749771|P3|COMPLETED|Second Intenvention (14-20 Days)||8
313519|NCT01606189|749772|P2|COMPLETED|Second Intenvention (14-20 Days)||8
313520|NCT01606189|749773|P1|COMPLETED|Second Intenvention (14-20 Days)||8
313521|NCT01606189|749768|P6|STARTED|Second Intenvention (14-20 Days)||8
313522|NCT01606189|749769|P5|STARTED|Second Intenvention (14-20 Days)||8
313523|NCT01606189|749770|P4|STARTED|Second Intenvention (14-20 Days)||8
313524|NCT01606189|749771|P3|STARTED|Second Intenvention (14-20 Days)||8
313525|NCT01606189|749772|P2|STARTED|Second Intenvention (14-20 Days)||8
313526|NCT01606189|749773|P1|STARTED|Second Intenvention (14-20 Days)||8
313527|NCT01606189|749768|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
313528|NCT01606189|749769|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
313529|NCT01606189|749770|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
313530|NCT01606189|749771|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
313531|NCT01606189|749772|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
313532|NCT01606189|749773|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
313533|NCT01606189|749768|P6|COMPLETED|First Intenvention (14-20 Days)||8
313534|NCT01606189|749769|P5|COMPLETED|First Intenvention (14-20 Days)||8
313535|NCT01606189|749770|P4|COMPLETED|First Intenvention (14-20 Days)||8
313536|NCT01606189|749771|P3|COMPLETED|First Intenvention (14-20 Days)||8
313537|NCT01606189|749772|P2|COMPLETED|First Intenvention (14-20 Days)||8
313538|NCT01606189|749773|P1|COMPLETED|First Intenvention (14-20 Days)||8
313539|NCT01606189|749768|P6|STARTED|First Intenvention (14-20 Days)||8
313540|NCT01606189|749769|P5|STARTED|First Intenvention (14-20 Days)||8
313541|NCT01606189|749770|P4|STARTED|First Intenvention (14-20 Days)||8
313542|NCT01606189|749771|P3|STARTED|First Intenvention (14-20 Days)||8
313543|NCT01606189|749772|P2|STARTED|First Intenvention (14-20 Days)||8
313544|NCT01606189|749773|P1|STARTED|First Intenvention (14-20 Days)||8
313545|NCT01606176|749807|P2|NOT COMPLETED|Overall Study||3
313546|NCT01606176|749808|P1|NOT COMPLETED|Overall Study||4
313547|NCT01606176|749807|P2|COMPLETED|Overall Study||31
313548|NCT01606176|749808|P1|COMPLETED|Overall Study||32
313549|NCT01606176|749807|P2|STARTED|Overall Study||34
313550|NCT01606176|749808|P1|STARTED|Overall Study||36
313551|NCT01606150|749844|P2|NOT COMPLETED|Overall Study||0
313552|NCT01606150|749845|P1|NOT COMPLETED|Overall Study||0
313644|NCT01605370|750150|P2|NOT COMPLETED|Overall Study||0
313553|NCT01606150|749844|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
313554|NCT01606150|749845|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
313555|NCT01606150|749844|P2|STARTED|Overall Study||0
313556|NCT01606150|749845|P1|STARTED|Overall Study||0
313557|NCT01606137|749853|P1|NOT COMPLETED|Overall Study||262
313558|NCT01606137|749853|P1|COMPLETED|Overall Study||245
313559|NCT01606137|749853|P1|STARTED|Overall Study||507
313560|NCT01606007|749876|P3|NOT COMPLETED|Overall Study||10
313561|NCT01606007|749877|P2|NOT COMPLETED|Overall Study||19
313562|NCT01606007|749878|P1|NOT COMPLETED|Overall Study||15
313563|NCT01606007|749876|P3|COMPLETED|Overall Study||169
313564|NCT01606007|749877|P2|COMPLETED|Overall Study||160
313565|NCT01606007|749878|P1|COMPLETED|Overall Study||161
313566|NCT01606007|749876|P3|STARTED|Overall Study||179
313567|NCT01606007|749877|P2|STARTED|Overall Study||179
313568|NCT01606007|749878|P1|STARTED|Overall Study||176
313569|NCT01605942|749900|P2|NOT COMPLETED|Overall Study||0
313570|NCT01605942|749901|P1|NOT COMPLETED|Overall Study||0
313571|NCT01605942|749900|P2|COMPLETED|Overall Study||2
313572|NCT01605942|749901|P1|COMPLETED|Overall Study||6
313573|NCT01605942|749900|P2|STARTED|Overall Study||2
313574|NCT01605942|749901|P1|STARTED|Overall Study||6
313575|NCT01605916|749913|P5|NOT COMPLETED|Overall Study||6
313576|NCT01605916|749914|P4|NOT COMPLETED|Overall Study||6
313577|NCT01605916|749915|P3|NOT COMPLETED|Overall Study||3
313578|NCT01605916|749916|P2|NOT COMPLETED|Overall Study||4
313579|NCT01605916|749917|P1|NOT COMPLETED|Overall Study||4
313580|NCT01605916|749913|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
313581|NCT01605916|749914|P4|COMPLETED|Overall Study||0
313582|NCT01605916|749915|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
313583|NCT01605916|749916|P2|COMPLETED|Overall Study||0
313584|NCT01605916|749917|P1|COMPLETED|Overall Study||0
313585|NCT01605916|749913|P5|STARTED|Overall Study||7
313586|NCT01605916|749914|P4|STARTED|Overall Study||6
313587|NCT01605916|749915|P3|STARTED|Overall Study||4
313588|NCT01605916|749916|P2|STARTED|Overall Study||4
313589|NCT01605916|749917|P1|STARTED|Overall Study||4
313590|NCT01605877|749990|P1|NOT COMPLETED|Overall Study||1
313591|NCT01605877|749990|P1|COMPLETED|Overall Study||63
313592|NCT01605877|749990|P1|STARTED|Overall Study||64
313593|NCT01605825|750054|P2|NOT COMPLETED|Overall Study||3
313594|NCT01605825|750055|P1|NOT COMPLETED|Overall Study||10
313595|NCT01605825|750054|P2|COMPLETED|Overall Study||25
313596|NCT01605825|750055|P1|COMPLETED|Overall Study||45
313597|NCT01605825|750054|P2|STARTED|Overall Study||28
313598|NCT01605825|750055|P1|STARTED|Overall Study||55
313599|NCT01605799|750063|P2|NOT COMPLETED|Overall Study||1
313600|NCT01605799|750064|P1|NOT COMPLETED|Overall Study||2
313601|NCT01605799|750063|P2|COMPLETED|Overall Study||15
313602|NCT01605799|750064|P1|COMPLETED|Overall Study||15
313603|NCT01605799|750063|P2|STARTED|Overall Study||16
313604|NCT01605799|750064|P1|STARTED|Overall Study||17
313605|NCT01605669|750072|P1|NOT COMPLETED|Overall Study||0
313606|NCT01605669|750072|P1|COMPLETED|Overall Study||50
313607|NCT01605669|750072|P1|STARTED|Overall Study||50
313608|NCT01605617|750079|P2|NOT COMPLETED|Second Intervention||0
313609|NCT01605617|750080|P1|NOT COMPLETED|Second Intervention||0
313610|NCT01605617|750079|P2|COMPLETED|Second Intervention||0
313611|NCT01605617|750080|P1|COMPLETED|Second Intervention||0
313612|NCT01605617|750079|P2|STARTED|Second Intervention||0
313613|NCT01605617|750080|P1|STARTED|Second Intervention||0
313614|NCT01605617|750079|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
313615|NCT01605617|750080|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
313616|NCT01605617|750079|P2|COMPLETED|Washout Period of 4 Weeks||0
313617|NCT01605617|750080|P1|COMPLETED|Washout Period of 4 Weeks||0
313618|NCT01605617|750079|P2|STARTED|Washout Period of 4 Weeks||1
313619|NCT01605617|750080|P1|STARTED|Washout Period of 4 Weeks||2
313620|NCT01605617|750079|P2|NOT COMPLETED|First Intervention||1
313621|NCT01605617|750080|P1|NOT COMPLETED|First Intervention||0
313622|NCT01605617|750079|P2|COMPLETED|First Intervention||1
313623|NCT01605617|750080|P1|COMPLETED|First Intervention||2
313624|NCT01605617|750079|P2|STARTED|First Intervention||2
313625|NCT01605617|750080|P1|STARTED|First Intervention||2
313626|NCT01605552|750100|P2|NOT COMPLETED|Overall Study||2
313627|NCT01605552|750101|P1|NOT COMPLETED|Overall Study||6
313628|NCT01605552|750100|P2|COMPLETED|Overall Study||14
313629|NCT01605552|750101|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
313630|NCT01605552|750100|P2|STARTED|Overall Study||16
313631|NCT01605552|750101|P1|STARTED|Overall Study||13
313632|NCT01605539|750115|P3|NOT COMPLETED|Overall Study||0
313633|NCT01605539|750116|P2|NOT COMPLETED|Overall Study||1
313634|NCT01605539|750117|P1|NOT COMPLETED|Overall Study||0
313635|NCT01605539|750115|P3|COMPLETED|Overall Study||4
313636|NCT01605539|750116|P2|COMPLETED|Overall Study||2
313637|NCT01605539|750117|P1|COMPLETED|Overall Study||3
313638|NCT01605539|750115|P3|STARTED|Overall Study||4
313639|NCT01605539|750116|P2|STARTED|Overall Study||3
313640|NCT01605539|750117|P1|STARTED|Overall Study||3
313641|NCT01605461|750139|P1|NOT COMPLETED|Overall Study||4
313642|NCT01605461|750139|P1|COMPLETED|Overall Study||8
313643|NCT01605461|750139|P1|STARTED|Overall Study||12
313645|NCT01605370|750151|P1|NOT COMPLETED|Overall Study||1
313646|NCT01605370|750150|P2|COMPLETED|Overall Study||0
313647|NCT01605370|750151|P1|COMPLETED|Overall Study||0
313648|NCT01605370|750150|P2|STARTED|Overall Study||0
313649|NCT01605370|750151|P1|STARTED|Overall Study||1
313650|NCT01605292|750159|P2|NOT COMPLETED|Overall Study||0
313651|NCT01605292|750160|P1|NOT COMPLETED|Overall Study||0
313652|NCT01605292|750159|P2|COMPLETED|Overall Study||347
313653|NCT01605292|750160|P1|COMPLETED|Overall Study||351
313654|NCT01605292|750159|P2|STARTED|Overall Study||347
313655|NCT01605292|750160|P1|STARTED|Overall Study||351
313656|NCT01604941|750186|P6|NOT COMPLETED|Overall Study||7
313657|NCT01604941|750187|P5|NOT COMPLETED|Overall Study||1
313658|NCT01604941|750188|P4|NOT COMPLETED|Overall Study||3
313659|NCT01604941|750189|P3|NOT COMPLETED|Overall Study||3
313660|NCT01604941|750190|P2|NOT COMPLETED|Overall Study||4
313661|NCT01604941|750191|P1|NOT COMPLETED|Overall Study||11
313662|NCT01604941|750186|P6|COMPLETED|Overall Study||0
313663|NCT01604941|750187|P5|COMPLETED|Overall Study||3
313664|NCT01604941|750188|P4|COMPLETED|Overall Study||0
313665|NCT01604941|750189|P3|COMPLETED|Overall Study||0
313666|NCT01604941|750190|P2|COMPLETED|Overall Study||0
313667|NCT01604941|750191|P1|COMPLETED|Overall Study||0
313668|NCT01604941|750186|P6|STARTED|Overall Study||7
313669|NCT01604941|750187|P5|STARTED|Overall Study||4
313670|NCT01604941|750188|P4|STARTED|Overall Study||3
313671|NCT01604941|750189|P3|STARTED|Overall Study||3
313672|NCT01604941|750190|P2|STARTED|Overall Study||4
313673|NCT01604941|750191|P1|STARTED|Overall Study||11
313674|NCT01604850|750219|P2|NOT COMPLETED|Overall Study||30
313675|NCT01604850|750220|P1|NOT COMPLETED|Overall Study||52
313676|NCT01604850|750219|P2|COMPLETED|Overall Study||69
313677|NCT01604850|750220|P1|COMPLETED|Overall Study||51
313678|NCT01604850|750219|P2|Enrolled and Treated|Overall Study||98
313679|NCT01604850|750220|P1|Enrolled and Treated|Overall Study||103
313680|NCT01604850|750219|P2|STARTED|Overall Study||99
313681|NCT01604850|750220|P1|STARTED|Overall Study||103
313682|NCT01604772|750236|P1|NOT COMPLETED|Overall Study||0
313683|NCT01604772|750236|P1|COMPLETED|Overall Study||16
313684|NCT01604772|750236|P1|STARTED|Overall Study||16
313685|NCT01604278|750244|P2|NOT COMPLETED|Overall Study||13
313686|NCT01604278|750245|P1|NOT COMPLETED|Overall Study||14
313687|NCT01604278|750244|P2|COMPLETED|Overall Study||210
313688|NCT01604278|750245|P1|COMPLETED|Overall Study||212
313689|NCT01604278|750244|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
313690|NCT01604278|750245|P1|Full Analysis Set|Overall Study||226
313691|NCT01604278|750244|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
313692|NCT01604278|750245|P1|Safety Set|Overall Study||226
313693|NCT01604278|750244|P2|STARTED|Overall Study||223
313694|NCT01604278|750245|P1|STARTED|Overall Study||226
313695|NCT01604265|750271|P2|NOT COMPLETED|Overall Study||0
313696|NCT01604265|750272|P1|NOT COMPLETED|Overall Study||2
313697|NCT01604265|750271|P2|COMPLETED|Overall Study||32
313698|NCT01604265|750272|P1|COMPLETED|Overall Study||32
313699|NCT01604265|750271|P2|STARTED|Overall Study||32
313700|NCT01604265|750272|P1|STARTED|Overall Study||34
313701|NCT01604122|750308|P2|NOT COMPLETED|Overall Study||0
313702|NCT01604122|750309|P1|NOT COMPLETED|Overall Study||0
313703|NCT01604122|750308|P2|COMPLETED|Overall Study||32
313704|NCT01604122|750309|P1|COMPLETED|Overall Study||60
313705|NCT01604122|750308|P2|STARTED|Overall Study||32
313706|NCT01604122|750309|P1|STARTED|Overall Study||60
313707|NCT01604109|750356|P2|NOT COMPLETED|Overall Study||34
313708|NCT01604109|750357|P1|NOT COMPLETED|Overall Study||33
313709|NCT01604109|750356|P2|COMPLETED|Overall Study||112
313710|NCT01604109|750357|P1|COMPLETED|Overall Study||117
313711|NCT01604109|750356|P2|STARTED|Overall Study||146
313712|NCT01604109|750357|P1|STARTED|Overall Study||150
313713|NCT01603940|750365|P2|NOT COMPLETED|Overall Study||0
313714|NCT01603940|750366|P1|NOT COMPLETED|Overall Study||0
313715|NCT01603940|750365|P2|COMPLETED|Overall Study||14
313716|NCT01603940|750366|P1|COMPLETED|Overall Study||16
313717|NCT01603940|750365|P2|STARTED|Overall Study||14
313718|NCT01603940|750366|P1|STARTED|Overall Study||16
313719|NCT01603875|750383|P3|NOT COMPLETED|Overall Study||9
313720|NCT01603875|750384|P2|NOT COMPLETED|Overall Study||8
313721|NCT01603875|750385|P1|NOT COMPLETED|Overall Study||7
313722|NCT01603875|750383|P3|COMPLETED|Overall Study||26
313723|NCT01603875|750384|P2|COMPLETED|Overall Study||27
313724|NCT01603875|750385|P1|COMPLETED|Overall Study||28
313725|NCT01603875|750383|P3|STARTED|Overall Study||35
313726|NCT01603875|750384|P2|STARTED|Overall Study||35
313727|NCT01603875|750385|P1|STARTED|Overall Study||35
313728|NCT01603459|750405|P1|NOT COMPLETED|Overall Study||18
313729|NCT01603459|750405|P1|COMPLETED|Overall Study||137
313730|NCT01603459|750405|P1|STARTED|Overall Study||155
313731|NCT01603420|750527|P2|NOT COMPLETED|Overall Study||0
313732|NCT01603420|750528|P1|NOT COMPLETED|Overall Study||0
313733|NCT01603420|750527|P2|COMPLETED|Overall Study||1
313734|NCT01603420|750528|P1|COMPLETED|Overall Study||1
313735|NCT01603420|750527|P2|STARTED|Overall Study||1
313736|NCT01603420|750528|P1|STARTED|Overall Study||1
313737|NCT01603394|750556|P1|NOT COMPLETED|Overall Study||1
313738|NCT01603394|750556|P1|COMPLETED|Overall Study||8
313739|NCT01603394|750556|P1|STARTED|Overall Study||9
313740|NCT01603277|750573|P2|NOT COMPLETED|Overall Study||18
313741|NCT01603277|750574|P1|NOT COMPLETED|Overall Study||14
313742|NCT01603277|750573|P2|COMPLETED|Overall Study||64
313743|NCT01603277|750574|P1|COMPLETED|Overall Study||64
313744|NCT01603277|750573|P2|STARTED|Overall Study||82
313745|NCT01603277|750574|P1|STARTED|Overall Study||78
313746|NCT01603121|750580|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
313747|NCT01603121|750581|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
313748|NCT01603121|750580|P2|COMPLETED|Second Intervention, 10 Hours||0
313749|NCT01603121|750581|P1|COMPLETED|Second Intervention, 10 Hours||0
313750|NCT01603121|750580|P2|STARTED|Second Intervention, 10 Hours||0
313751|NCT01603121|750581|P1|STARTED|Second Intervention, 10 Hours||1
313752|NCT01603121|750580|P2|NOT COMPLETED|First Intervention, 10 Hours||0
313753|NCT01603121|750581|P1|NOT COMPLETED|First Intervention, 10 Hours||0
313754|NCT01603121|750580|P2|COMPLETED|First Intervention, 10 Hours||0
313755|NCT01603121|750581|P1|COMPLETED|First Intervention, 10 Hours||1
313756|NCT01603121|750580|P2|STARTED|First Intervention, 10 Hours||0
313757|NCT01603121|750581|P1|STARTED|First Intervention, 10 Hours||1
313758|NCT01603082|750593|P2|NOT COMPLETED|Overall Study||1
313759|NCT01603082|750594|P1|NOT COMPLETED|Overall Study||2
313760|NCT01603082|750593|P2|COMPLETED|Overall Study|Completed the study|48
313761|NCT01603082|750594|P1|COMPLETED|Overall Study|Completed the study.|49
313762|NCT01603082|750593|P2|STARTED|Overall Study|Randomized|49
313763|NCT01603082|750594|P1|STARTED|Overall Study|Randomized|51
313764|NCT01603056|750604|P2|NOT COMPLETED|Overall Study||14
313765|NCT01603056|750605|P1|NOT COMPLETED|Overall Study||34
313766|NCT01603056|750604|P2|COMPLETED|Overall Study||190
313767|NCT01603056|750605|P1|COMPLETED|Overall Study||379
313768|NCT01603056|750604|P2|STARTED|Overall Study||204
313769|NCT01603056|750605|P1|STARTED|Overall Study||413
313770|NCT01603043|750635|P2|NOT COMPLETED|Overall Study||3
313771|NCT01603043|750636|P1|NOT COMPLETED|Overall Study||7
313772|NCT01603043|750635|P2|COMPLETED|Overall Study||0
313773|NCT01603043|750636|P1|COMPLETED|Overall Study||0
313774|NCT01603043|750635|P2|STARTED|Overall Study||3
313775|NCT01603043|750636|P1|STARTED|Overall Study||7
313776|NCT01602744|750648|P2|NOT COMPLETED|Overall Study||23
313777|NCT01602744|750649|P1|NOT COMPLETED|Overall Study||30
313778|NCT01602744|750648|P2|COMPLETED|Overall Study||160
313779|NCT01602744|750649|P1|COMPLETED|Overall Study||146
313780|NCT01602744|750648|P2|STARTED|Overall Study||183
313781|NCT01602744|750649|P1|STARTED|Overall Study||176
313782|NCT01602731|750665|P1|NOT COMPLETED|Overall Study||30
313783|NCT01602731|750665|P1|COMPLETED|Overall Study||15
313784|NCT01602731|750665|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
313785|NCT01602731|750665|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
313786|NCT01602731|750665|P1|STARTED|Overall Study||45
313787|NCT01602562|750673|P2|NOT COMPLETED|Overall Study||3
313788|NCT01602562|750674|P1|NOT COMPLETED|Overall Study||5
313789|NCT01602562|750673|P2|COMPLETED|Overall Study||16
313790|NCT01602562|750674|P1|COMPLETED|Overall Study||16
313791|NCT01602562|750673|P2|STARTED|Overall Study||19
313792|NCT01602562|750674|P1|STARTED|Overall Study||21
313793|NCT01602549|750710|P2|NOT COMPLETED|Overall Study||1
313794|NCT01602549|750711|P1|NOT COMPLETED|Overall Study||1
313795|NCT01602549|750710|P2|COMPLETED|Overall Study||37
313796|NCT01602549|750711|P1|COMPLETED|Overall Study||18
313797|NCT01602549|750710|P2|STARTED|Overall Study||38
313798|NCT01602549|750711|P1|STARTED|Overall Study||19
313799|NCT01602510|750790|P3|NOT COMPLETED|Randomized Phase||73
313800|NCT01602510|750791|P2|NOT COMPLETED|Randomized Phase||74
313801|NCT01602510|750792|P1|NOT COMPLETED|Randomized Phase||0
313802|NCT01602510|750790|P3|COMPLETED|Randomized Phase||58
313803|NCT01602510|750791|P2|COMPLETED|Randomized Phase||59
313804|NCT01602510|750792|P1|COMPLETED|Randomized Phase||0
313805|NCT01602510|750790|P3|STARTED|Randomized Phase||131
313806|NCT01602510|750791|P2|STARTED|Randomized Phase||133
313807|NCT01602510|750792|P1|STARTED|Randomized Phase||0
313808|NCT01602510|750790|P3|NOT COMPLETED|Open Label Phase||0
313809|NCT01602510|750791|P2|NOT COMPLETED|Open Label Phase||0
313810|NCT01602510|750792|P1|NOT COMPLETED|Open Label Phase||303
313811|NCT01602510|750790|P3|COMPLETED|Open Label Phase||0
313812|NCT01602510|750791|P2|COMPLETED|Open Label Phase||0
313813|NCT01602510|750792|P1|COMPLETED|Open Label Phase||117
313814|NCT01602510|750790|P3|STARTED|Open Label Phase||0
313815|NCT01602510|750791|P2|STARTED|Open Label Phase||0
313816|NCT01602510|750792|P1|STARTED|Open Label Phase||420
313817|NCT01602484|750818|P2|NOT COMPLETED|Overall Study||1
313818|NCT01602484|750819|P1|NOT COMPLETED|Overall Study||0
313819|NCT01602484|750818|P2|COMPLETED|Overall Study||24
313820|NCT01602484|750819|P1|COMPLETED|Overall Study||25
313821|NCT01602484|750818|P2|STARTED|Overall Study||25
313822|NCT01602484|750819|P1|STARTED|Overall Study||25
313823|NCT01602471|750831|P1|NOT COMPLETED|Overall Study||0
313824|NCT01602471|750831|P1|COMPLETED|Overall Study||4
313825|NCT01602471|750831|P1|STARTED|Overall Study||4
313826|NCT01602380|750837|P2|NOT COMPLETED|Overall Study||101
313827|NCT01602380|750838|P1|NOT COMPLETED|Overall Study||93
313828|NCT01602380|750837|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
313829|NCT01602380|750838|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
313830|NCT01602380|750837|P2|STARTED|Overall Study||232
313831|NCT01602380|750838|P1|STARTED|Overall Study||230
313832|NCT01602341|750862|P2|NOT COMPLETED|Overall Study||1
313833|NCT01602341|750863|P1|NOT COMPLETED|Overall Study||0
313834|NCT01602341|750862|P2|COMPLETED|Overall Study||41
313835|NCT01602341|750863|P1|COMPLETED|Overall Study||44
313836|NCT01602341|750862|P2|STARTED|Overall Study||42
313837|NCT01602341|750863|P1|STARTED|Overall Study||44
313838|NCT01602198|750899|P2|NOT COMPLETED|Overall Study||0
313839|NCT01602198|750900|P1|NOT COMPLETED|Overall Study||0
313840|NCT01602198|750899|P2|COMPLETED|Overall Study||1
313841|NCT01602198|750900|P1|COMPLETED|Overall Study||0
313842|NCT01602198|750899|P2|STARTED|Overall Study||1
313843|NCT01602198|750900|P1|STARTED|Overall Study||0
313844|NCT01602016|750906|P1|NOT COMPLETED|Overall Study||0
313845|NCT01602016|750906|P1|COMPLETED|Overall Study||0
313846|NCT01602016|750906|P1|STARTED|Overall Study||0
313847|NCT01601977|750910|P1|NOT COMPLETED|Overall Study||0
313848|NCT01601977|750910|P1|COMPLETED|Overall Study||10
313849|NCT01601977|750910|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
313850|NCT01601821|750930|P2|NOT COMPLETED|Overall Study||29
313851|NCT01601821|750931|P1|NOT COMPLETED|Overall Study||29
313852|NCT01601821|750930|P2|COMPLETED|Overall Study||91
313853|NCT01601821|750931|P1|COMPLETED|Overall Study||96
313854|NCT01601821|750930|P2|STARTED|Overall Study||120
313855|NCT01601821|750931|P1|STARTED|Overall Study||125
313856|NCT01601782|750961|P1|NOT COMPLETED|Overall Study||0
313857|NCT01601782|750961|P1|COMPLETED|Overall Study||16
313858|NCT01601782|750961|P1|STARTED|Overall Study||16
313859|NCT01601704|750967|P2|NOT COMPLETED|Overall Study||4
313860|NCT01601704|750968|P1|NOT COMPLETED|Overall Study||1
313861|NCT01601704|750967|P2|COMPLETED|Overall Study||4450
313862|NCT01601704|750968|P1|COMPLETED|Overall Study||4455
313863|NCT01601704|750967|P2|Treated|Overall Study||4450
313864|NCT01601704|750968|P1|Treated|Overall Study||4455
313865|NCT01601704|750967|P2|STARTED|Overall Study||4454
313866|NCT01601704|750968|P1|STARTED|Overall Study||4456
313867|NCT01601691|750982|P1|NOT COMPLETED|Overall Study||0
313868|NCT01601691|750982|P1|COMPLETED|Overall Study||10
313869|NCT01601691|750982|P1|STARTED|Overall Study||10
313870|NCT01601470|750986|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
313871|NCT01601470|750986|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
313872|NCT01601470|750986|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
313873|NCT01601470|750986|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
313874|NCT01601470|750986|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
313875|NCT01601470|750986|P1|NOT COMPLETED|Period 2 - LCZ696||1
313876|NCT01601470|750986|P1|COMPLETED|Period 2 - LCZ696||27
313877|NCT01601470|750986|P1|Safety Set|Period 2 - LCZ696||27
313878|NCT01601470|750986|P1|PK Analysis Set|Period 2 - LCZ696||27
313879|NCT01601470|750986|P1|STARTED|Period 2 - LCZ696||28
313880|NCT01601470|750986|P1|NOT COMPLETED|Period 1 - Sildenafil||0
313881|NCT01601470|750986|P1|COMPLETED|Period 1 - Sildenafil||28
313882|NCT01601470|750986|P1|Safety Set|Period 1 - Sildenafil||28
313883|NCT01601470|750986|P1|PK Analysis Set|Period 1 - Sildenafil||28
313884|NCT01601470|750986|P1|STARTED|Period 1 - Sildenafil||28
313885|NCT01601132|751001|P1|NOT COMPLETED|Overall Study||2
313886|NCT01601132|751001|P1|COMPLETED|Overall Study||28
313887|NCT01601132|751001|P1|STARTED|Overall Study||30
313888|NCT01600950|751018|P2|NOT COMPLETED|Period 2||0
313889|NCT01600950|751019|P1|NOT COMPLETED|Period 2||0
313890|NCT01600950|751018|P2|COMPLETED|Period 2||10
313891|NCT01600950|751019|P1|COMPLETED|Period 2||10
313892|NCT01600950|751018|P2|STARTED|Period 2||10
313893|NCT01600950|751019|P1|STARTED|Period 2||10
313894|NCT01600950|751018|P2|NOT COMPLETED|Period 1||0
313895|NCT01600950|751019|P1|NOT COMPLETED|Period 1||0
313896|NCT01600950|751018|P2|COMPLETED|Period 1||10
313897|NCT01600950|751019|P1|COMPLETED|Period 1||10
313898|NCT01600950|751018|P2|STARTED|Period 1||10
313899|NCT01600950|751019|P1|STARTED|Period 1||10
313900|NCT01600885|751035|P2|NOT COMPLETED|Second Period||0
313901|NCT01600885|751036|P1|NOT COMPLETED|Second Period||0
313902|NCT01600885|751035|P2|COMPLETED|Second Period||8
313903|NCT01600885|751036|P1|COMPLETED|Second Period||8
313904|NCT01600885|751035|P2|STARTED|Second Period||8
313905|NCT01600885|751036|P1|STARTED|Second Period||8
313906|NCT01600885|751035|P2|NOT COMPLETED|Wash Out Period||0
313907|NCT01600885|751036|P1|NOT COMPLETED|Wash Out Period||0
313908|NCT01600885|751035|P2|COMPLETED|Wash Out Period||8
313909|NCT01600885|751036|P1|COMPLETED|Wash Out Period||8
313910|NCT01600885|751035|P2|STARTED|Wash Out Period||8
313911|NCT01600885|751036|P1|STARTED|Wash Out Period||8
313912|NCT01600885|751035|P2|NOT COMPLETED|First Period||1
313913|NCT01600885|751036|P1|NOT COMPLETED|First Period||2
313914|NCT01600885|751035|P2|COMPLETED|First Period||8
313915|NCT01600885|751036|P1|COMPLETED|First Period||8
313916|NCT01600885|751035|P2|STARTED|First Period||9
313917|NCT01600885|751036|P1|STARTED|First Period||10
313918|NCT01600729|751046|P1|NOT COMPLETED|Overall Study||1
313919|NCT01600729|751046|P1|COMPLETED|Overall Study||65
313920|NCT01600729|751046|P1|STARTED|Overall Study||66
313921|NCT01600716|751053|P2|NOT COMPLETED|Overall Study||7
313922|NCT01600716|751054|P1|NOT COMPLETED|Overall Study||7
313923|NCT01600716|751053|P2|COMPLETED|Overall Study||71
313924|NCT01600716|751054|P1|COMPLETED|Overall Study||59
313925|NCT01600716|751053|P2|STARTED|Overall Study||78
313926|NCT01600716|751054|P1|STARTED|Overall Study||66
313927|NCT01600703|751070|P2|NOT COMPLETED|Second Intervention||0
313928|NCT01600703|751071|P1|NOT COMPLETED|Second Intervention||0
313929|NCT01600703|751070|P2|COMPLETED|Second Intervention||8
313930|NCT01600703|751071|P1|COMPLETED|Second Intervention||7
313931|NCT01600703|751070|P2|STARTED|Second Intervention||8
313932|NCT01600703|751071|P1|STARTED|Second Intervention||7
313933|NCT01600703|751070|P2|NOT COMPLETED|First Intervention||0
313934|NCT01600703|751071|P1|NOT COMPLETED|First Intervention||0
313935|NCT01600703|751070|P2|COMPLETED|First Intervention||8
313936|NCT01600703|751071|P1|COMPLETED|First Intervention||7
313937|NCT01600703|751070|P2|STARTED|First Intervention||8
313938|NCT01600703|751071|P1|STARTED|First Intervention||7
313939|NCT01600677|751081|P2|NOT COMPLETED|Overall Study||0
313940|NCT01600677|751082|P1|NOT COMPLETED|Overall Study||0
313941|NCT01600677|751081|P2|COMPLETED|Overall Study||4
313942|NCT01600677|751082|P1|COMPLETED|Overall Study||7
313943|NCT01600677|751081|P2|STARTED|Overall Study||4
313944|NCT01600677|751082|P1|STARTED|Overall Study||7
313945|NCT01600495|751094|P2|NOT COMPLETED|Overall Study||0
313946|NCT01600495|751095|P1|NOT COMPLETED|Overall Study||0
313947|NCT01600495|751094|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
313948|NCT01600495|751095|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
313949|NCT01600495|751094|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
313950|NCT01600495|751095|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
313951|NCT01600326|751109|P2|NOT COMPLETED|Overall Study||1
313952|NCT01600326|751110|P1|NOT COMPLETED|Overall Study||1
313953|NCT01600326|751109|P2|COMPLETED|Overall Study||14
313954|NCT01600326|751110|P1|COMPLETED|Overall Study||14
313955|NCT01600326|751109|P2|Primary Outcome Measure Data Collection|Overall Study||15
313956|NCT01600326|751110|P1|Primary Outcome Measure Data Collection|Overall Study||15
313957|NCT01600326|751109|P2|STARTED|Overall Study||15
313958|NCT01600326|751110|P1|STARTED|Overall Study||15
313959|NCT01600287|751120|P2|NOT COMPLETED|Overall Study||0
313960|NCT01600287|751121|P1|NOT COMPLETED|Overall Study||0
313961|NCT01600287|751120|P2|COMPLETED|Overall Study||20
313962|NCT01600287|751121|P1|COMPLETED|Overall Study||20
313963|NCT01600287|751120|P2|STARTED|Overall Study||20
313964|NCT01600287|751121|P1|STARTED|Overall Study||20
313965|NCT01600222|751161|P1|NOT COMPLETED|Overall Study||2
313966|NCT01600222|751161|P1|COMPLETED|Overall Study||35
313967|NCT01600222|751161|P1|STARTED|Overall Study||37
313968|NCT01600092|751186|P2|NOT COMPLETED|Overall Study||16
313969|NCT01600092|751187|P1|NOT COMPLETED|Overall Study||18
313970|NCT01600092|751186|P2|COMPLETED|Overall Study||491
313971|NCT01600092|751187|P1|COMPLETED|Overall Study||495
313972|NCT01600092|751186|P2|Received All 3 Vaccinations|Overall Study||494
313973|NCT01600092|751187|P1|Received All 3 Vaccinations|Overall Study||500
313974|NCT01600092|751186|P2|Received at Least 1 Vaccination|Overall Study||504
313975|NCT01600092|751187|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
313976|NCT01600092|751186|P2|STARTED|Overall Study||507
313977|NCT01600092|751187|P1|STARTED|Overall Study||513
313978|NCT01600053|751201|P1|NOT COMPLETED|Overall Study||11
313979|NCT01600053|751201|P1|COMPLETED|Overall Study||0
313980|NCT01600053|751201|P1|STARTED|Overall Study||11
313981|NCT01600014|751206|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
313982|NCT01600014|751207|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
313983|NCT01600014|751206|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
313984|NCT01600014|751207|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
313985|NCT01600014|751206|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
313986|NCT01600014|751207|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
313987|NCT01600014|751206|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
313988|NCT01600014|751207|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
313989|NCT01600014|751206|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
313990|NCT01600014|751207|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
313991|NCT01600014|751206|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
313992|NCT01600014|751207|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
313993|NCT01600014|751206|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
313994|NCT01600014|751207|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
313995|NCT01600014|751206|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
313996|NCT01600014|751207|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
313997|NCT01600014|751206|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
313998|NCT01600014|751207|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
313999|NCT01599832|751225|P1|NOT COMPLETED|Overall Study||0
314000|NCT01599832|751225|P1|COMPLETED|Overall Study||20
314001|NCT01599832|751225|P1|STARTED|Overall Study||20
314002|NCT01599806|751235|P2|NOT COMPLETED|Overall Study||41
314003|NCT01599806|751236|P1|NOT COMPLETED|Overall Study||43
314004|NCT01599806|751235|P2|COMPLETED|Overall Study||476
314005|NCT01599806|751236|P1|COMPLETED|Overall Study||473
314006|NCT01599806|751235|P2|STARTED|Overall Study||517
314007|NCT01599806|751236|P1|STARTED|Overall Study||516
314008|NCT01599741|751360|P1|NOT COMPLETED|Overall Study||3
314009|NCT01599741|751360|P1|COMPLETED|Overall Study||48
314010|NCT01599741|751360|P1|Collected Dose and Image Information|Overall Study||48
314011|NCT01599741|751360|P1|STARTED|Overall Study||51
314012|NCT01599650|751369|P3|NOT COMPLETED|Overall Study||27
314013|NCT01599650|751370|P2|NOT COMPLETED|Overall Study||26
314014|NCT01599650|751371|P1|NOT COMPLETED|Overall Study||22
314015|NCT01599650|751369|P3|COMPLETED|Overall Study||65
314016|NCT01599650|751370|P2|COMPLETED|Overall Study||154
314017|NCT01599650|751371|P1|COMPLETED|Overall Study||161
314018|NCT01599650|751369|P3|Completed 6 Mos|Overall Study||80
314019|NCT01599650|751370|P2|Completed 6 Mos|Overall Study||170
314020|NCT01599650|751371|P1|Completed 6 Mos|Overall Study||174
314021|NCT01599650|751369|P3|STARTED|Overall Study||92
314022|NCT01599650|751370|P2|STARTED|Overall Study||180
314023|NCT01599650|751371|P1|STARTED|Overall Study||183
314024|NCT01599637|751410|P3|NOT COMPLETED|Overall Study||0
314025|NCT01599637|751411|P2|NOT COMPLETED|Overall Study||2
314026|NCT01599637|751412|P1|NOT COMPLETED|Overall Study||1
314027|NCT01599637|751410|P3|COMPLETED|Overall Study||10
314028|NCT01599637|751411|P2|COMPLETED|Overall Study||8
314029|NCT01599637|751412|P1|COMPLETED|Overall Study||19
314030|NCT01599637|751410|P3|STARTED|Overall Study||10
314031|NCT01599637|751411|P2|STARTED|Overall Study||10
314032|NCT01599637|751412|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
314033|NCT01599585|751459|P2|NOT COMPLETED|Overall Study||17
314034|NCT01599585|751460|P1|NOT COMPLETED|Overall Study||22
314035|NCT01599585|751459|P2|COMPLETED|Overall Study||42
314036|NCT01599585|751460|P1|COMPLETED|Overall Study||40
314037|NCT01599585|751459|P2|STARTED|Overall Study||59
314038|NCT01599585|751460|P1|STARTED|Overall Study||62
314039|NCT01599325|751498|P1|NOT COMPLETED|Overall Study||57
314040|NCT01599325|751498|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
314041|NCT01599325|751498|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
314042|NCT01599325|751498|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
314043|NCT01599325|751498|P1|STARTED|Overall Study||72
314044|NCT01599234|751520|P2|NOT COMPLETED|Overall Study||15
314045|NCT01599234|751521|P1|NOT COMPLETED|Overall Study||17
314046|NCT01599234|751520|P2|COMPLETED|Overall Study||155
314047|NCT01599234|751521|P1|COMPLETED|Overall Study||150
314048|NCT01599234|751520|P2|STARTED|Overall Study||170
314049|NCT01599234|751521|P1|STARTED|Overall Study||167
314050|NCT01599104|751546|P3|NOT COMPLETED|Overall Study||26
314051|NCT01599104|751547|P2|NOT COMPLETED|Overall Study||14
314052|NCT01599104|751548|P1|NOT COMPLETED|Overall Study||16
314053|NCT01599104|751546|P3|COMPLETED|Overall Study||363
314054|NCT01599104|751547|P2|COMPLETED|Overall Study||371
314055|NCT01599104|751548|P1|COMPLETED|Overall Study||371
314056|NCT01599104|751546|P3|STARTED|Overall Study||389
314057|NCT01599104|751547|P2|STARTED|Overall Study||385
314058|NCT01599104|751548|P1|STARTED|Overall Study||387
314059|NCT01598987|751586|P1|NOT COMPLETED|Baseline to 24 Month||8
314060|NCT01598987|751586|P1|COMPLETED|Baseline to 24 Month||48
314061|NCT01598987|751586|P1|STARTED|Baseline to 24 Month||56
314062|NCT01598987|751586|P1|NOT COMPLETED|Baseline to Month 12||6
314063|NCT01598987|751586|P1|COMPLETED|Baseline to Month 12||50
314064|NCT01598987|751586|P1|STARTED|Baseline to Month 12||56
314065|NCT01598779|751620|P1|NOT COMPLETED|Overall Study||0
314066|NCT01598779|751620|P1|COMPLETED|Overall Study||150
314067|NCT01598779|751620|P1|STARTED|Overall Study||150
314068|NCT01598740|751626|P2|NOT COMPLETED|Period 2||0
314069|NCT01598740|751627|P1|NOT COMPLETED|Period 2||1
314070|NCT01598740|751626|P2|COMPLETED|Period 2||9
314071|NCT01598740|751627|P1|COMPLETED|Period 2||7
314072|NCT01598740|751626|P2|STARTED|Period 2||9
314073|NCT01598740|751627|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
314074|NCT01598740|751626|P2|NOT COMPLETED|Period 1||0
314075|NCT01598740|751627|P1|NOT COMPLETED|Period 1||0
314076|NCT01598740|751626|P2|COMPLETED|Period 1||9
314077|NCT01598740|751627|P1|COMPLETED|Period 1||9
314078|NCT01598740|751626|P2|STARTED|Period 1||9
314079|NCT01598740|751627|P1|STARTED|Period 1||9
314080|NCT01598610|751635|P1|NOT COMPLETED|Overall Study||1
314081|NCT01598610|751635|P1|COMPLETED|Overall Study||219
314082|NCT01598610|751635|P1|STARTED|Overall Study||220
314083|NCT01598545|751644|P1|NOT COMPLETED|Overall Study||0
314084|NCT01598545|751644|P1|COMPLETED|Overall Study||20
314085|NCT01598545|751644|P1|STARTED|Overall Study||20
314086|NCT01598532|751652|P1|NOT COMPLETED|Overall Study||11
314087|NCT01598532|751652|P1|COMPLETED|Overall Study||11
314088|NCT01598532|751652|P1|STARTED|Overall Study||22
314089|NCT01598506|751661|P1|NOT COMPLETED|Overall Study||2
314090|NCT01598506|751661|P1|COMPLETED|Overall Study||20
314091|NCT01598506|751661|P1|STARTED|Overall Study||22
314092|NCT01598428|751667|P1|NOT COMPLETED|Overall Study||0
314093|NCT01598428|751667|P1|COMPLETED|Overall Study||20
314094|NCT01598428|751667|P1|STARTED|Overall Study||20
314095|NCT01598350|751676|P1|NOT COMPLETED|Overall Study||0
314096|NCT01598350|751676|P1|COMPLETED|Overall Study||6
314097|NCT01598350|751676|P1|STARTED|Overall Study||6
314098|NCT01598207|751682|P2|NOT COMPLETED|Overall Study||0
314099|NCT01598207|751683|P1|NOT COMPLETED|Overall Study||1
314100|NCT01598207|751682|P2|COMPLETED|Overall Study||6
314101|NCT01598207|751683|P1|COMPLETED|Overall Study||6
314102|NCT01598207|751682|P2|STARTED|Overall Study||6
314103|NCT01598207|751683|P1|STARTED|Overall Study||7
314104|NCT01598129|751701|P1|NOT COMPLETED|Overall Study||9
314105|NCT01598129|751701|P1|COMPLETED|Overall Study||3
314106|NCT01598129|751701|P1|STARTED|Overall Study||12
314107|NCT01598064|751712|P2|NOT COMPLETED|Overall Study||0
314108|NCT01598064|751713|P1|NOT COMPLETED|Overall Study||0
314109|NCT01598064|751712|P2|COMPLETED|Overall Study||24
314110|NCT01598064|751713|P1|COMPLETED|Overall Study||25
314111|NCT01598064|751712|P2|STARTED|Overall Study||24
314112|NCT01598064|751713|P1|STARTED|Overall Study||25
314113|NCT01597908|751723|P2|NOT COMPLETED|Overall Study||352
314114|NCT01597908|751724|P1|NOT COMPLETED|Overall Study||352
314115|NCT01597908|751723|P2|COMPLETED|Overall Study||0
314116|NCT01597908|751724|P1|COMPLETED|Overall Study||0
314117|NCT01597908|751723|P2|Ongoing|Overall Study||202
314118|NCT01597908|751724|P1|Ongoing|Overall Study||236
314119|NCT01597908|751723|P2|STARTED|Overall Study||352
314120|NCT01597908|751724|P1|STARTED|Overall Study||352
314121|NCT01597843|751739|P3|NOT COMPLETED|Overall Study||0
314122|NCT01597843|751740|P2|NOT COMPLETED|Overall Study||0
314123|NCT01597843|751741|P1|NOT COMPLETED|Overall Study||0
314124|NCT01597843|751739|P3|COMPLETED|Overall Study||81
314125|NCT01597843|751740|P2|COMPLETED|Overall Study||122
314126|NCT01597843|751741|P1|COMPLETED|Overall Study||79
314127|NCT01597843|751739|P3|Survey 3 Responses|Overall Study||76
314128|NCT01597843|751740|P2|Survey 3 Responses|Overall Study||56
314129|NCT01597843|751741|P1|Survey 3 Responses|Overall Study||65
314130|NCT01597843|751739|P3|Survey 2 Responses|Overall Study||58
314131|NCT01597843|751740|P2|Survey 2 Responses|Overall Study||42
314132|NCT01597843|751741|P1|Survey 2 Responses|Overall Study||52
314133|NCT01597843|751739|P3|Survey 1 Responses|Overall Study||59
314134|NCT01597843|751740|P2|Survey 1 Responses|Overall Study||71
314135|NCT01597843|751741|P1|Survey 1 Responses|Overall Study||45
314136|NCT01597843|751739|P3|STARTED|Overall Study||81
314137|NCT01597843|751740|P2|STARTED|Overall Study||122
314138|NCT01597843|751741|P1|STARTED|Overall Study||79
314139|NCT01597596|751751|P2|NOT COMPLETED|Overall Study||1
314140|NCT01597596|751752|P1|NOT COMPLETED|Overall Study||1
314141|NCT01597596|751751|P2|COMPLETED|Overall Study||2
314142|NCT01597596|751752|P1|COMPLETED|Overall Study||0
314143|NCT01597596|751751|P2|STARTED|Overall Study||3
314144|NCT01597596|751752|P1|STARTED|Overall Study||1
314145|NCT01597492|751766|P2|NOT COMPLETED|Overall Study||4
314146|NCT01597492|751767|P1|NOT COMPLETED|Overall Study||6
314147|NCT01597492|751766|P2|COMPLETED|Overall Study||41
314148|NCT01597492|751767|P1|COMPLETED|Overall Study||28
314149|NCT01597492|751766|P2|STARTED|Overall Study||45
314150|NCT01597492|751767|P1|STARTED|Overall Study||34
314151|NCT01597479|751775|P2|NOT COMPLETED|Overall Study||0
314152|NCT01597479|751776|P1|NOT COMPLETED|Overall Study||2
314153|NCT01597479|751775|P2|COMPLETED|Overall Study||26
314154|NCT01597479|751776|P1|COMPLETED|Overall Study||24
314155|NCT01597479|751775|P2|STARTED|Overall Study||26
314156|NCT01597479|751776|P1|STARTED|Overall Study||26
314157|NCT01597440|751785|P2|NOT COMPLETED|Overall Study||0
314158|NCT01597440|751786|P1|NOT COMPLETED|Overall Study||0
314159|NCT01597440|751785|P2|COMPLETED|Overall Study||0
314160|NCT01597440|751786|P1|COMPLETED|Overall Study||1
314161|NCT01597440|751785|P2|STARTED|Overall Study||0
314162|NCT01597440|751786|P1|STARTED|Overall Study||1
314163|NCT01597245|751798|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
314164|NCT01597245|751799|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
314165|NCT01597245|751800|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
314166|NCT01597245|751801|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
314167|NCT01597245|751802|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
314168|NCT01597245|751803|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
314169|NCT01597245|751804|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
314170|NCT01597245|751805|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
314171|NCT01597245|751806|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
314172|NCT01597245|751807|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314173|NCT01597245|751808|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314174|NCT01597245|751809|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314175|NCT01597245|751810|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314176|NCT01597245|751798|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
314177|NCT01597245|751799|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
314178|NCT01597245|751800|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
314179|NCT01597245|751801|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
314180|NCT01597245|751802|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
314181|NCT01597245|751803|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314182|NCT01597245|751804|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
314183|NCT01597245|751805|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
314184|NCT01597245|751806|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
314185|NCT01597245|751807|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314186|NCT01597245|751808|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314187|NCT01597245|751809|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314188|NCT01597245|751810|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
314189|NCT01597245|751798|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
314190|NCT01597245|751799|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
314191|NCT01597245|751800|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
314192|NCT01597245|751801|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
314193|NCT01597245|751802|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
314194|NCT01597245|751803|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
314195|NCT01597245|751804|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
314196|NCT01597245|751805|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
314197|NCT01597245|751806|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
314198|NCT01597245|751807|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
314199|NCT01597245|751808|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
314200|NCT01597245|751809|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
314201|NCT01597245|751810|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
314202|NCT01597245|751798|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
314203|NCT01597245|751799|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
314204|NCT01597245|751800|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
314205|NCT01597245|751801|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
314206|NCT01597245|751802|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
314207|NCT01597245|751803|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
314208|NCT01597245|751804|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
314209|NCT01597245|751805|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
314210|NCT01597245|751806|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
314211|NCT01597245|751807|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
314212|NCT01597245|751808|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
314213|NCT01597245|751809|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
314214|NCT01597245|751810|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
314215|NCT01597245|751798|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314216|NCT01597245|751799|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314217|NCT01597245|751800|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314218|NCT01597245|751801|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314219|NCT01597245|751802|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314220|NCT01597245|751803|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314221|NCT01597245|751804|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314222|NCT01597245|751805|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314223|NCT01597245|751806|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
314224|NCT01597245|751807|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
314225|NCT01597245|751808|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
314226|NCT01597245|751809|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
314227|NCT01597245|751810|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
314228|NCT01597245|751798|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
314229|NCT01597245|751799|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
314230|NCT01597245|751800|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
314231|NCT01597245|751801|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
314232|NCT01597245|751802|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
314233|NCT01597245|751803|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
314234|NCT01597245|751804|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
314235|NCT01597245|751805|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
314236|NCT01597245|751806|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
314237|NCT01597245|751807|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
314238|NCT01597245|751808|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
314239|NCT01597245|751809|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
314240|NCT01597245|751810|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
314241|NCT01597245|751798|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314242|NCT01597245|751799|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314243|NCT01597245|751800|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314244|NCT01597245|751801|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314245|NCT01597245|751802|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314246|NCT01597245|751803|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314247|NCT01597245|751804|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314248|NCT01597245|751805|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314249|NCT01597245|751806|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
314250|NCT01597245|751807|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
314251|NCT01597245|751808|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
314252|NCT01597245|751809|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
314253|NCT01597245|751810|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
314254|NCT01597245|751798|P13|STARTED|Induction Period (Week 0 - Week 12)||0
314255|NCT01597245|751799|P12|STARTED|Induction Period (Week 0 - Week 12)||0
314256|NCT01597245|751800|P11|STARTED|Induction Period (Week 0 - Week 12)||0
314257|NCT01597245|751801|P10|STARTED|Induction Period (Week 0 - Week 12)||0
314258|NCT01597245|751802|P9|STARTED|Induction Period (Week 0 - Week 12)||0
314259|NCT01597245|751803|P8|STARTED|Induction Period (Week 0 - Week 12)||0
314260|NCT01597245|751804|P7|STARTED|Induction Period (Week 0 - Week 12)||0
314261|NCT01597245|751805|P6|STARTED|Induction Period (Week 0 - Week 12)||0
314262|NCT01597245|751806|P5|STARTED|Induction Period (Week 0 - Week 12)||0
314263|NCT01597245|751807|P4|STARTED|Induction Period (Week 0 - Week 12)||351
314264|NCT01597245|751808|P3|STARTED|Induction Period (Week 0 - Week 12)||347
314265|NCT01597245|751809|P2|STARTED|Induction Period (Week 0 - Week 12)||358
314266|NCT01597245|751810|P1|STARTED|Induction Period (Week 0 - Week 12)||168
314267|NCT01597141|751895|P2|NOT COMPLETED|Overall Study||0
314268|NCT01597141|751896|P1|NOT COMPLETED|Overall Study||0
314269|NCT01597141|751895|P2|COMPLETED|Overall Study||50
314270|NCT01597141|751896|P1|COMPLETED|Overall Study||50
314271|NCT01597141|751895|P2|STARTED|Overall Study||50
314272|NCT01597141|751896|P1|STARTED|Overall Study||50
314273|NCT01597128|751906|P2|NOT COMPLETED|Overall Study||0
314274|NCT01597128|751907|P1|NOT COMPLETED|Overall Study||0
314275|NCT01597128|751906|P2|COMPLETED|Overall Study||17
314276|NCT01597128|751907|P1|COMPLETED|Overall Study||18
314277|NCT01597128|751906|P2|STARTED|Overall Study||17
314278|NCT01597128|751907|P1|STARTED|Overall Study||18
314279|NCT01597050|751933|P2|NOT COMPLETED|Overall Study||0
314280|NCT01597050|751934|P1|NOT COMPLETED|Overall Study||1
314281|NCT01597050|751933|P2|COMPLETED|Overall Study||18
314282|NCT01597050|751934|P1|COMPLETED|Overall Study||35
314283|NCT01597050|751933|P2|STARTED|Overall Study||18
314284|NCT01597050|751934|P1|STARTED|Overall Study||36
314285|NCT01596972|751942|P2|NOT COMPLETED|Overall Study||14
314286|NCT01596972|751943|P1|NOT COMPLETED|Overall Study||1
314287|NCT01596972|751942|P2|COMPLETED|Overall Study||12
314288|NCT01596972|751943|P1|COMPLETED|Overall Study||24
314289|NCT01596972|751942|P2|STARTED|Overall Study||26
314290|NCT01596972|751943|P1|STARTED|Overall Study||25
314291|NCT01596842|751955|P2|NOT COMPLETED|Overall Study||0
314292|NCT01596842|751956|P1|NOT COMPLETED|Overall Study||2
314293|NCT01596842|751955|P2|COMPLETED|Overall Study||7
314294|NCT01596842|751956|P1|COMPLETED|Overall Study||8
314295|NCT01596842|751955|P2|STARTED|Overall Study||7
314296|NCT01596842|751956|P1|STARTED|Overall Study||10
314297|NCT01596582|751966|P2|NOT COMPLETED|Overall Study||7
314298|NCT01596582|751967|P1|NOT COMPLETED|Overall Study||4
314299|NCT01596582|751966|P2|COMPLETED|Overall Study||173
314300|NCT01596582|751967|P1|COMPLETED|Overall Study||168
314301|NCT01596582|751966|P2|STARTED|Overall Study||180
314302|NCT01596582|751967|P1|STARTED|Overall Study||172
314303|NCT01596504|751994|P3|NOT COMPLETED|Overall Study||1
314304|NCT01596504|751995|P2|NOT COMPLETED|Overall Study||3
314305|NCT01596504|751996|P1|NOT COMPLETED|Overall Study||2
314306|NCT01596504|751994|P3|COMPLETED|Overall Study||46
314307|NCT01596504|751995|P2|COMPLETED|Overall Study||44
314308|NCT01596504|751996|P1|COMPLETED|Overall Study||46
314309|NCT01596504|751994|P3|STARTED|Overall Study||47
314310|NCT01596504|751995|P2|STARTED|Overall Study||47
314311|NCT01596504|751996|P1|STARTED|Overall Study||48
314312|NCT01596231|752054|P2|NOT COMPLETED|Overall Study||0
314313|NCT01596231|752055|P1|NOT COMPLETED|Overall Study||0
314314|NCT01596231|752054|P2|COMPLETED|Overall Study||10
314315|NCT01596231|752055|P1|COMPLETED|Overall Study||10
314316|NCT01596231|752054|P2|STARTED|Overall Study||10
314317|NCT01596231|752055|P1|STARTED|Overall Study||10
314318|NCT01596088|752061|P1|NOT COMPLETED|Overall Study||0
314319|NCT01596088|752061|P1|COMPLETED|Overall Study||2
314320|NCT01596088|752061|P1|STARTED|Overall Study||2
314321|NCT01596062|752068|P3|NOT COMPLETED|Overall Study||3
314322|NCT01596062|752069|P2|NOT COMPLETED|Overall Study||0
314323|NCT01596062|752070|P1|NOT COMPLETED|Overall Study||1
314324|NCT01596062|752068|P3|COMPLETED|Overall Study||4
314325|NCT01596062|752069|P2|COMPLETED|Overall Study||6
314326|NCT01596062|752070|P1|COMPLETED|Overall Study||2
314327|NCT01596062|752068|P3|STARTED|Overall Study||7
314328|NCT01596062|752069|P2|STARTED|Overall Study||6
314329|NCT01596062|752070|P1|STARTED|Overall Study||3
314330|NCT01595854|752107|P5|NOT COMPLETED|Overall Study||0
314331|NCT01595854|752108|P4|NOT COMPLETED|Overall Study||0
314332|NCT01595854|752109|P3|NOT COMPLETED|Overall Study||0
314333|NCT01595854|752110|P2|NOT COMPLETED|Overall Study||0
314334|NCT01595854|752111|P1|NOT COMPLETED|Overall Study||0
314335|NCT01595854|752107|P5|COMPLETED|Overall Study||12
314336|NCT01595854|752108|P4|COMPLETED|Overall Study||4
314337|NCT01595854|752109|P3|COMPLETED|Overall Study||8
314338|NCT01595854|752110|P2|COMPLETED|Overall Study||4
314339|NCT01595854|752111|P1|COMPLETED|Overall Study||8
314340|NCT01595854|752107|P5|STARTED|Overall Study||12
314341|NCT01595854|752108|P4|STARTED|Overall Study||4
314342|NCT01595854|752109|P3|STARTED|Overall Study||8
314343|NCT01595854|752110|P2|STARTED|Overall Study||4
314344|NCT01595854|752111|P1|STARTED|Overall Study||8
314345|NCT01595438|752133|P2|NOT COMPLETED|Overall Study||41
314346|NCT01595438|752134|P1|NOT COMPLETED|Overall Study||43
314347|NCT01595438|752133|P2|COMPLETED|Overall Study||476
314348|NCT01595438|752134|P1|COMPLETED|Overall Study||473
314349|NCT01595438|752133|P2|STARTED|Overall Study||517
314350|NCT01595438|752134|P1|STARTED|Overall Study||516
314351|NCT01595386|752260|P2|NOT COMPLETED|Overall Study||0
314352|NCT01595386|752261|P1|NOT COMPLETED|Overall Study||0
314353|NCT01595386|752260|P2|COMPLETED|Overall Study||19
314354|NCT01595386|752261|P1|COMPLETED|Overall Study||21
314355|NCT01595386|752260|P2|STARTED|Overall Study||19
314356|NCT01595386|752261|P1|STARTED|Overall Study||21
314357|NCT01595282|752289|P2|NOT COMPLETED|Overall Study||0
314358|NCT01595282|752290|P1|NOT COMPLETED|Overall Study||0
314359|NCT01595282|752289|P2|COMPLETED|Overall Study||47
314360|NCT01595282|752290|P1|COMPLETED|Overall Study||47
314361|NCT01595282|752289|P2|STARTED|Overall Study||47
314362|NCT01595282|752290|P1|STARTED|Overall Study||47
314363|NCT01594970|752303|P3|NOT COMPLETED|Overall Study||66
314364|NCT01594970|752304|P2|NOT COMPLETED|Overall Study||82
314365|NCT01594970|752305|P1|NOT COMPLETED|Overall Study||75
314366|NCT01594970|752303|P3|COMPLETED|Overall Study||191
314367|NCT01594970|752304|P2|COMPLETED|Overall Study||166
314368|NCT01594970|752305|P1|COMPLETED|Overall Study||220
314369|NCT01594970|752303|P3|STARTED|Overall Study||257
314370|NCT01594970|752304|P2|STARTED|Overall Study||248
314371|NCT01594970|752305|P1|STARTED|Overall Study||295
314372|NCT01594762|752324|P2|NOT COMPLETED|Overall Study||10
314373|NCT01594762|752325|P1|NOT COMPLETED|Overall Study||11
314374|NCT01594762|752324|P2|COMPLETED|Overall Study||93
314375|NCT01594762|752325|P1|COMPLETED|Overall Study||86
314376|NCT01594762|752324|P2|STARTED|Overall Study||103
314377|NCT01594762|752325|P1|STARTED|Overall Study||97
314378|NCT01594749|752337|P2|NOT COMPLETED|Overall Study||18
314379|NCT01594749|752338|P1|NOT COMPLETED|Overall Study||22
314380|NCT01594749|752337|P2|COMPLETED|Overall Study||490
314381|NCT01594749|752338|P1|COMPLETED|Overall Study||485
314382|NCT01594749|752337|P2|Treated|Overall Study||498
314383|NCT01594749|752338|P1|Treated|Overall Study||503
314384|NCT01594749|752337|P2|STARTED|Overall Study||508
314385|NCT01594749|752338|P1|STARTED|Overall Study||507
314386|NCT01594515|752364|P10|NOT COMPLETED|Overall Study||0
314387|NCT01594515|752365|P9|NOT COMPLETED|Overall Study||0
314388|NCT01594515|752366|P8|NOT COMPLETED|Overall Study||0
314389|NCT01594515|752367|P7|NOT COMPLETED|Overall Study||0
314390|NCT01594515|752368|P6|NOT COMPLETED|Overall Study||0
314391|NCT01594515|752369|P5|NOT COMPLETED|Overall Study||0
314392|NCT01594515|752370|P4|NOT COMPLETED|Overall Study||0
314393|NCT01594515|752371|P3|NOT COMPLETED|Overall Study||0
314394|NCT01594515|752372|P2|NOT COMPLETED|Overall Study||0
314395|NCT01594515|752373|P1|NOT COMPLETED|Overall Study||0
314396|NCT01594515|752364|P10|COMPLETED|Overall Study||16
314397|NCT01594515|752365|P9|COMPLETED|Overall Study||6
314398|NCT01594515|752366|P8|COMPLETED|Overall Study||6
314399|NCT01594515|752367|P7|COMPLETED|Overall Study||6
314400|NCT01594515|752368|P6|COMPLETED|Overall Study||6
314401|NCT01594515|752369|P5|COMPLETED|Overall Study||6
314402|NCT01594515|752370|P4|COMPLETED|Overall Study||6
314403|NCT01594515|752371|P3|COMPLETED|Overall Study||6
314404|NCT01594515|752372|P2|COMPLETED|Overall Study||6
314405|NCT01594515|752373|P1|COMPLETED|Overall Study||6
314406|NCT01594515|752364|P10|STARTED|Overall Study||16
314407|NCT01594515|752365|P9|STARTED|Overall Study||6
314408|NCT01594515|752366|P8|STARTED|Overall Study||6
314409|NCT01594515|752367|P7|STARTED|Overall Study||6
314410|NCT01594515|752368|P6|STARTED|Overall Study||6
314411|NCT01594515|752369|P5|STARTED|Overall Study||6
314412|NCT01594515|752370|P4|STARTED|Overall Study||6
314413|NCT01594515|752371|P3|STARTED|Overall Study||6
314414|NCT01594515|752372|P2|STARTED|Overall Study||6
314415|NCT01594515|752373|P1|STARTED|Overall Study||6
314416|NCT01594424|752463|P1|NOT COMPLETED|Overall Study||2
314417|NCT01594424|752463|P1|COMPLETED|Overall Study||8
314418|NCT01594424|752463|P1|STARTED|Overall Study||10
314419|NCT01594411|752467|P1|NOT COMPLETED|Overall Study||2
314420|NCT01594411|752467|P1|COMPLETED|Overall Study||249
314421|NCT01594411|752467|P1|STARTED|Overall Study||251
314422|NCT01594385|752476|P2|NOT COMPLETED|Overall Study||0
314423|NCT01594385|752477|P1|NOT COMPLETED|Overall Study||0
314424|NCT01594385|752476|P2|COMPLETED|Overall Study||13
314425|NCT01594385|752477|P1|COMPLETED|Overall Study||17
314426|NCT01594385|752476|P2|STARTED|Overall Study||13
314427|NCT01594385|752477|P1|STARTED|Overall Study||17
314428|NCT01594294|752485|P2|NOT COMPLETED|Overall Study||4
314429|NCT01594294|752486|P1|NOT COMPLETED|Overall Study||3
314430|NCT01594294|752485|P2|COMPLETED|Overall Study||36
314431|NCT01594294|752486|P1|COMPLETED|Overall Study||36
314432|NCT01594294|752485|P2|STARTED|Overall Study||40
314433|NCT01594294|752486|P1|STARTED|Overall Study||39
314434|NCT01594125|752505|P5|NOT COMPLETED|Overall Study||7
314435|NCT01594125|752506|P4|NOT COMPLETED|Overall Study||4
314436|NCT01594125|752507|P3|NOT COMPLETED|Overall Study||3
314437|NCT01594125|752508|P2|NOT COMPLETED|Overall Study||12
314438|NCT01594125|752509|P1|NOT COMPLETED|Overall Study||4
314439|NCT01594125|752505|P5|COMPLETED|Overall Study||0
314440|NCT01594125|752506|P4|COMPLETED|Overall Study||0
314441|NCT01594125|752507|P3|COMPLETED|Overall Study||0
314442|NCT01594125|752508|P2|COMPLETED|Overall Study||0
314443|NCT01594125|752509|P1|COMPLETED|Overall Study||0
314444|NCT01594125|752505|P5|STARTED|Overall Study||7
314445|NCT01594125|752506|P4|STARTED|Overall Study||4
314446|NCT01594125|752507|P3|STARTED|Overall Study||3
314447|NCT01594125|752508|P2|STARTED|Overall Study||12
314448|NCT01594125|752509|P1|STARTED|Overall Study||4
314449|NCT01593852|752543|P2|NOT COMPLETED|Overall Study||0
314450|NCT01593852|752544|P1|NOT COMPLETED|Overall Study||0
314451|NCT01593852|752543|P2|COMPLETED|Overall Study||68
314452|NCT01593852|752544|P1|COMPLETED|Overall Study||68
314453|NCT01593852|752543|P2|STARTED|Overall Study||68
314454|NCT01593852|752544|P1|STARTED|Overall Study||68
314455|NCT01593787|752569|P3|NOT COMPLETED|Overall Study||0
314456|NCT01593787|752570|P2|NOT COMPLETED|Overall Study||0
314457|NCT01593787|752571|P1|NOT COMPLETED|Overall Study||1
314458|NCT01593787|752569|P3|COMPLETED|Overall Study||18
314459|NCT01593787|752570|P2|COMPLETED|Overall Study||8
314460|NCT01593787|752571|P1|COMPLETED|Overall Study||5
314461|NCT01593787|752569|P3|STARTED|Overall Study||18
314462|NCT01593787|752570|P2|STARTED|Overall Study||8
314463|NCT01593787|752571|P1|STARTED|Overall Study||6
314464|NCT01593722|752611|P2|NOT COMPLETED|Overall Study||0
314465|NCT01593722|752612|P1|NOT COMPLETED|Overall Study||0
314466|NCT01593722|752611|P2|COMPLETED|Overall Study||6
314467|NCT01593722|752612|P1|COMPLETED|Overall Study||6
314468|NCT01593722|752611|P2|STARTED|Overall Study||6
314469|NCT01593722|752612|P1|STARTED|Overall Study||6
314470|NCT01593670|752626|P1|NOT COMPLETED|Overall Study||0
314471|NCT01593670|752626|P1|COMPLETED|Overall Study||9
314472|NCT01593670|752626|P1|STARTED|Overall Study||9
314473|NCT01593592|752636|P2|NOT COMPLETED|Overall Study||0
314474|NCT01593592|752637|P1|NOT COMPLETED|Overall Study||0
314475|NCT01593592|752636|P2|COMPLETED|Overall Study||35
314476|NCT01593592|752637|P1|COMPLETED|Overall Study||35
314477|NCT01593592|752636|P2|STARTED|Overall Study||35
314478|NCT01593592|752637|P1|STARTED|Overall Study||35
314479|NCT01593215|752649|P2|NOT COMPLETED|Overall Study||0
314480|NCT01593215|752650|P1|NOT COMPLETED|Overall Study||1
314481|NCT01593215|752649|P2|COMPLETED|Overall Study||25
314482|NCT01593215|752650|P1|COMPLETED|Overall Study||24
314483|NCT01593215|752649|P2|STARTED|Overall Study||25
314484|NCT01593215|752650|P1|STARTED|Overall Study||25
314485|NCT01592864|752658|P2|NOT COMPLETED|Overall Study||1
314486|NCT01592864|752659|P1|NOT COMPLETED|Overall Study||0
314487|NCT01592864|752658|P2|COMPLETED|Overall Study||57
314488|NCT01592864|752659|P1|COMPLETED|Overall Study||60
314489|NCT01592864|752658|P2|STARTED|Overall Study||58
314490|NCT01592864|752659|P1|STARTED|Overall Study||60
314491|NCT01592851|752673|P2|NOT COMPLETED|Overall Study||0
314492|NCT01592851|752674|P1|NOT COMPLETED|Overall Study||0
314493|NCT01592851|752673|P2|COMPLETED|Overall Study||57
314494|NCT01592851|752674|P1|COMPLETED|Overall Study||56
314495|NCT01592851|752673|P2|STARTED|Overall Study||57
314496|NCT01592851|752674|P1|STARTED|Overall Study||56
314497|NCT01592786|752690|P1|NOT COMPLETED|Overall Study||138
314498|NCT01592786|752690|P1|COMPLETED|Overall Study||765
314499|NCT01592786|752690|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
314500|NCT01592773|752694|P1|NOT COMPLETED|Overall Study||666
314501|NCT01592773|752694|P1|COMPLETED|Overall Study||81
314502|NCT01592773|752694|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
314503|NCT01592760|752701|P3|NOT COMPLETED|24-hour Follow-Up||2
314504|NCT01592760|752702|P2|NOT COMPLETED|24-hour Follow-Up||3
314505|NCT01592760|752703|P1|NOT COMPLETED|24-hour Follow-Up||4
314506|NCT01592760|752701|P3|COMPLETED|24-hour Follow-Up||43
314507|NCT01592760|752702|P2|COMPLETED|24-hour Follow-Up||87
314508|NCT01592760|752703|P1|COMPLETED|24-hour Follow-Up||86
314509|NCT01592760|752701|P3|STARTED|24-hour Follow-Up||45
314510|NCT01592760|752702|P2|STARTED|24-hour Follow-Up||90
314511|NCT01592760|752703|P1|STARTED|24-hour Follow-Up||90
314512|NCT01592760|752701|P3|NOT COMPLETED|Perioperative to Discharge||0
314513|NCT01592760|752702|P2|NOT COMPLETED|Perioperative to Discharge||0
314514|NCT01592760|752703|P1|NOT COMPLETED|Perioperative to Discharge||0
314515|NCT01592760|752701|P3|COMPLETED|Perioperative to Discharge||45
314516|NCT01592760|752702|P2|COMPLETED|Perioperative to Discharge||90
314517|NCT01592760|752703|P1|COMPLETED|Perioperative to Discharge||90
314518|NCT01592760|752701|P3|STARTED|Perioperative to Discharge||45
314519|NCT01592760|752702|P2|STARTED|Perioperative to Discharge||90
314520|NCT01592760|752703|P1|STARTED|Perioperative to Discharge||90
314521|NCT01592708|752746|P2|NOT COMPLETED|Overall Study||0
314522|NCT01592708|752747|P1|NOT COMPLETED|Overall Study||3
314523|NCT01592708|752746|P2|COMPLETED|Overall Study||137
314524|NCT01592708|752747|P1|COMPLETED|Overall Study||93
314525|NCT01592708|752746|P2|STARTED|Overall Study||137
314526|NCT01592708|752747|P1|STARTED|Overall Study||96
314527|NCT01592435|752761|P1|NOT COMPLETED|Overall Study||0
314528|NCT01592435|752761|P1|COMPLETED|Overall Study||76
314529|NCT01592435|752761|P1|STARTED|Overall Study||76
314530|NCT01592396|752769|P2|NOT COMPLETED|Overall Study||0
314531|NCT01592396|752770|P1|NOT COMPLETED|Overall Study||0
314532|NCT01592396|752769|P2|COMPLETED|Overall Study||10
314533|NCT01592396|752770|P1|COMPLETED|Overall Study||10
314534|NCT01592396|752769|P2|STARTED|Overall Study||10
314535|NCT01592396|752770|P1|STARTED|Overall Study||10
314536|NCT01592344|752787|P2|NOT COMPLETED|Overall Study||5
314537|NCT01592344|752788|P1|NOT COMPLETED|Overall Study||4
314538|NCT01592344|752787|P2|COMPLETED|Overall Study||44
314539|NCT01592344|752788|P1|COMPLETED|Overall Study||41
314540|NCT01592344|752787|P2|STARTED|Overall Study||49
314541|NCT01592344|752788|P1|STARTED|Overall Study||45
314542|NCT01592292|752802|P4|NOT COMPLETED|Overall Study||1
314543|NCT01592292|752803|P3|NOT COMPLETED|Overall Study||3
314544|NCT01592292|752804|P2|NOT COMPLETED|Overall Study||5
314545|NCT01592292|752805|P1|NOT COMPLETED|Overall Study||6
314546|NCT01592292|752802|P4|COMPLETED|Overall Study||10
314547|NCT01592292|752803|P3|COMPLETED|Overall Study||10
314548|NCT01592292|752804|P2|COMPLETED|Overall Study||15
314549|NCT01592292|752805|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
314550|NCT01592292|752802|P4|Standard Population Set (SPS)|Overall Study||7
314551|NCT01592292|752803|P3|Standard Population Set (SPS)|Overall Study||7
314552|NCT01592292|752804|P2|Standard Population Set (SPS)|Overall Study||10
314553|NCT01592292|752805|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
314554|NCT01592292|752802|P4|Intention to Treat (ITT) Set|Overall Study||8
314555|NCT01592292|752803|P3|Intention to Treat (ITT) Set|Overall Study||10
314556|NCT01592292|752804|P2|Intention to Treat (ITT) Set|Overall Study||13
314557|NCT01592292|752805|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
314558|NCT01592292|752802|P4|STARTED|Overall Study||11
314559|NCT01592292|752803|P3|STARTED|Overall Study||13
314560|NCT01592292|752804|P2|STARTED|Overall Study||20
314561|NCT01592292|752805|P1|STARTED|Overall Study||46
314562|NCT01592071|752837|P1|NOT COMPLETED|Overall Study||0
314563|NCT01592071|752837|P1|COMPLETED|Overall Study||120
314564|NCT01592071|752837|P1|STARTED|Overall Study||120
314565|NCT01592045|752850|P2|NOT COMPLETED|Overall Study||2
314566|NCT01592045|752851|P1|NOT COMPLETED|Overall Study||5
314567|NCT01592045|752850|P2|COMPLETED|Overall Study||12
314568|NCT01592045|752851|P1|COMPLETED|Overall Study||9
314569|NCT01592045|752850|P2|Completed Course 5|Overall Study||12
314570|NCT01592045|752851|P1|Completed Course 5|Overall Study||9
314571|NCT01592045|752850|P2|Completed Course 4|Overall Study||12
314572|NCT01592045|752851|P1|Completed Course 4|Overall Study||11
314573|NCT01592045|752850|P2|Completed Course 3|Overall Study||13
314574|NCT01592045|752851|P1|Completed Course 3|Overall Study||11
314575|NCT01592045|752850|P2|Completed Course 2|Overall Study||13
314576|NCT01592045|752851|P1|Completed Course 2|Overall Study||13
314577|NCT01592045|752850|P2|Completed Course 1|Overall Study||14
314578|NCT01592045|752851|P1|Completed Course 1|Overall Study||13
314579|NCT01592045|752850|P2|STARTED|Overall Study||14
314580|NCT01592045|752851|P1|STARTED|Overall Study||14
314581|NCT01592006|752859|P1|NOT COMPLETED|Overall Study||0
314582|NCT01592006|752859|P1|COMPLETED|Overall Study||3
314583|NCT01592006|752859|P1|STARTED|Overall Study||3
314584|NCT01591954|752864|P1|NOT COMPLETED|Overall Study||0
314585|NCT01591954|752864|P1|COMPLETED|Overall Study||1
314586|NCT01591954|752864|P1|STARTED|Overall Study||1
314587|NCT01591863|752869|P1|NOT COMPLETED|Overall Study||14
314588|NCT01591863|752869|P1|COMPLETED|Overall Study||24
314589|NCT01591863|752869|P1|STARTED|Overall Study||38
314590|NCT01591837|752881|P2|NOT COMPLETED|Overall Study||0
314591|NCT01591837|752882|P1|NOT COMPLETED|Overall Study||0
314592|NCT01591837|752881|P2|COMPLETED|Overall Study||60
314593|NCT01591837|752882|P1|COMPLETED|Overall Study||60
314594|NCT01591837|752881|P2|STARTED|Overall Study||60
314595|NCT01591837|752882|P1|STARTED|Overall Study||60
314596|NCT01591681|752896|P1|NOT COMPLETED|Overall Study||4
314597|NCT01591681|752896|P1|COMPLETED|Overall Study||45
314598|NCT01591681|752896|P1|STARTED|Overall Study||49
314599|NCT01591616|752922|P1|NOT COMPLETED|Overall Study||1
314600|NCT01591616|752922|P1|COMPLETED|Overall Study||15
314601|NCT01591616|752922|P1|STARTED|Overall Study||16
314602|NCT01591499|753063|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
314603|NCT01591499|753064|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
314604|NCT01591499|753065|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
314605|NCT01591499|753066|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
314606|NCT01591499|753063|P4|COMPLETED|Second Intervention (up to 24 Days)||34
314607|NCT01591499|753064|P3|COMPLETED|Second Intervention (up to 24 Days)||28
314608|NCT01591499|753065|P2|COMPLETED|Second Intervention (up to 24 Days)||34
314609|NCT01591499|753066|P1|COMPLETED|Second Intervention (up to 24 Days)||27
314610|NCT01591499|753063|P4|STARTED|Second Intervention (up to 24 Days)||37
314611|NCT01591499|753064|P3|STARTED|Second Intervention (up to 24 Days)||31
314612|NCT01591499|753065|P2|STARTED|Second Intervention (up to 24 Days)||37
314613|NCT01591499|753066|P1|STARTED|Second Intervention (up to 24 Days)||33
314614|NCT01591499|753063|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
314615|NCT01591499|753064|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
314616|NCT01591499|753065|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
314617|NCT01591499|753066|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
314618|NCT01591499|753063|P4|COMPLETED|First Intervention (up to 24 Days)||37
314619|NCT01591499|753064|P3|COMPLETED|First Intervention (up to 24 Days)||31
314620|NCT01591499|753065|P2|COMPLETED|First Intervention (up to 24 Days)||37
314621|NCT01591499|753066|P1|COMPLETED|First Intervention (up to 24 Days)||33
314622|NCT01591499|753063|P4|STARTED|First Intervention (up to 24 Days)||37
314623|NCT01591499|753064|P3|STARTED|First Intervention (up to 24 Days)||31
314624|NCT01591499|753065|P2|STARTED|First Intervention (up to 24 Days)||37
314625|NCT01591499|753066|P1|STARTED|First Intervention (up to 24 Days)||33
314626|NCT01591499|753063|P4|NOT COMPLETED|Baseline Visit||2
314627|NCT01591499|753064|P3|NOT COMPLETED|Baseline Visit||0
314628|NCT01591499|753065|P2|NOT COMPLETED|Baseline Visit||2
314629|NCT01591499|753066|P1|NOT COMPLETED|Baseline Visit||0
314630|NCT01591499|753063|P4|COMPLETED|Baseline Visit||37
314631|NCT01591499|753064|P3|COMPLETED|Baseline Visit||31
314632|NCT01591499|753065|P2|COMPLETED|Baseline Visit||37
314633|NCT01591499|753066|P1|COMPLETED|Baseline Visit||33
314634|NCT01591499|753063|P4|STARTED|Baseline Visit||39
314635|NCT01591499|753064|P3|STARTED|Baseline Visit||31
314636|NCT01591499|753065|P2|STARTED|Baseline Visit||39
314637|NCT01591499|753066|P1|STARTED|Baseline Visit||33
314638|NCT01591460|753132|P1|NOT COMPLETED|Overall Study||26
314639|NCT01591460|753132|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
314640|NCT01591460|753132|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
314641|NCT01591408|753214|P2|NOT COMPLETED|Overall Study||8
314642|NCT01591408|753215|P1|NOT COMPLETED|Overall Study||12
314643|NCT01591408|753214|P2|COMPLETED|Overall Study||24
314644|NCT01591408|753215|P1|COMPLETED|Overall Study||24
314645|NCT01591408|753214|P2|STARTED|Overall Study||32
314646|NCT01591408|753215|P1|STARTED|Overall Study||36
314647|NCT01591382|753223|P2|NOT COMPLETED|Overall Study||2
314648|NCT01591382|753224|P1|NOT COMPLETED|Overall Study||3
314649|NCT01591382|753223|P2|COMPLETED|Overall Study||30
314650|NCT01591382|753224|P1|COMPLETED|Overall Study||29
314651|NCT01591382|753223|P2|STARTED|Overall Study||32
314652|NCT01591382|753224|P1|STARTED|Overall Study||32
314653|NCT01591317|753241|P3|NOT COMPLETED|Overall Study||0
314654|NCT01591317|753242|P2|NOT COMPLETED|Overall Study||0
314655|NCT01591317|753243|P1|NOT COMPLETED|Overall Study||0
314656|NCT01591317|753241|P3|COMPLETED|Overall Study||10
314657|NCT01591317|753242|P2|COMPLETED|Overall Study||10
314658|NCT01591317|753243|P1|COMPLETED|Overall Study||10
314659|NCT01591317|753241|P3|STARTED|Overall Study||10
314660|NCT01591317|753242|P2|STARTED|Overall Study||10
314661|NCT01591317|753243|P1|STARTED|Overall Study||10
314662|NCT01591044|753272|P3|NOT COMPLETED|Overall Study||4
314663|NCT01591044|753273|P2|NOT COMPLETED|Overall Study||9
314664|NCT01591044|753274|P1|NOT COMPLETED|Overall Study||7
314665|NCT01591044|753272|P3|COMPLETED|Overall Study||96
314666|NCT01591044|753273|P2|COMPLETED|Overall Study||91
314667|NCT01591044|753274|P1|COMPLETED|Overall Study||94
314668|NCT01591044|753272|P3|STARTED|Overall Study||100
314669|NCT01591044|753273|P2|STARTED|Overall Study||100
314670|NCT01591044|753274|P1|STARTED|Overall Study||101
314671|NCT01591018|753284|P2|NOT COMPLETED|Overall Study||0
314672|NCT01591018|753285|P1|NOT COMPLETED|Overall Study||0
314673|NCT01591018|753284|P2|COMPLETED|Overall Study||60
314674|NCT01591018|753285|P1|COMPLETED|Overall Study||60
314675|NCT01591018|753284|P2|STARTED|Overall Study||60
314676|NCT01591018|753285|P1|STARTED|Overall Study||60
314677|NCT01591005|753299|P4|NOT COMPLETED|Overall Study||0
314678|NCT01591005|753300|P3|NOT COMPLETED|Overall Study||0
314679|NCT01591005|753301|P2|NOT COMPLETED|Overall Study||0
314680|NCT01591005|753302|P1|NOT COMPLETED|Overall Study||0
314681|NCT01591005|753299|P4|COMPLETED|Overall Study||68
314682|NCT01591005|753300|P3|COMPLETED|Overall Study||68
314683|NCT01591005|753301|P2|COMPLETED|Overall Study||53
314684|NCT01591005|753302|P1|COMPLETED|Overall Study||53
314685|NCT01591005|753299|P4|STARTED|Overall Study||68
314686|NCT01591005|753300|P3|STARTED|Overall Study||68
314687|NCT01591005|753301|P2|STARTED|Overall Study||53
314688|NCT01591005|753302|P1|STARTED|Overall Study||53
314689|NCT01590979|753338|P2|NOT COMPLETED|Overall Study||0
314690|NCT01590979|753339|P1|NOT COMPLETED|Overall Study||0
314691|NCT01590979|753338|P2|COMPLETED|Overall Study||27
314692|NCT01590979|753339|P1|COMPLETED|Overall Study||27
314693|NCT01590979|753338|P2|STARTED|Overall Study||27
314694|NCT01590979|753339|P1|STARTED|Overall Study||27
314695|NCT01590888|753348|P3|NOT COMPLETED|Overall Study||1
314696|NCT01590888|753349|P2|NOT COMPLETED|Overall Study||0
314697|NCT01590888|753350|P1|NOT COMPLETED|Overall Study||4
314698|NCT01590888|753348|P3|COMPLETED|Overall Study||34
314699|NCT01590888|753349|P2|COMPLETED|Overall Study||38
314700|NCT01590888|753350|P1|COMPLETED|Overall Study||32
314701|NCT01590888|753348|P3|STARTED|Overall Study||35
314702|NCT01590888|753349|P2|STARTED|Overall Study||38
314703|NCT01590888|753350|P1|STARTED|Overall Study||36
314704|NCT01590875|753396|P2|NOT COMPLETED|Overall Study||0
314705|NCT01590875|753397|P1|NOT COMPLETED|Overall Study||0
314706|NCT01590875|753396|P2|COMPLETED|Overall Study||10
314707|NCT01590875|753397|P1|COMPLETED|Overall Study||10
314708|NCT01590875|753396|P2|STARTED|Overall Study||10
314709|NCT01590875|753397|P1|STARTED|Overall Study||10
314710|NCT01590810|753414|P5|NOT COMPLETED|Overall Study||0
314711|NCT01590810|753415|P4|NOT COMPLETED|Overall Study||0
314712|NCT01590810|753416|P3|NOT COMPLETED|Overall Study||1
314713|NCT01590810|753417|P2|NOT COMPLETED|Overall Study||1
314714|NCT01590810|753418|P1|NOT COMPLETED|Overall Study||0
314715|NCT01590810|753414|P5|COMPLETED|Overall Study||2
314716|NCT01590810|753415|P4|COMPLETED|Overall Study||8
314717|NCT01590810|753416|P3|COMPLETED|Overall Study||7
314718|NCT01590810|753417|P2|COMPLETED|Overall Study||7
314719|NCT01590810|753418|P1|COMPLETED|Overall Study||8
314720|NCT01590810|753414|P5|STARTED|Overall Study||2
314721|NCT01590810|753415|P4|STARTED|Overall Study||8
314722|NCT01590810|753416|P3|STARTED|Overall Study||8
314723|NCT01590810|753417|P2|STARTED|Overall Study||8
314724|NCT01590810|753418|P1|STARTED|Overall Study||8
314725|NCT01590797|753563|P2|NOT COMPLETED|Overall Study||16
314726|NCT01590797|753564|P1|NOT COMPLETED|Overall Study||17
314727|NCT01590797|753563|P2|COMPLETED|Overall Study||217
314728|NCT01590797|753564|P1|COMPLETED|Overall Study||217
314729|NCT01590797|753563|P2|STARTED|Overall Study||233
314730|NCT01590797|753564|P1|STARTED|Overall Study||234
314731|NCT01590771|753580|P2|NOT COMPLETED|Overall Study||39
314732|NCT01590771|753581|P1|NOT COMPLETED|Overall Study||19
314733|NCT01590771|753580|P2|COMPLETED|Overall Study||210
314734|NCT01590771|753581|P1|COMPLETED|Overall Study||230
314735|NCT01590771|753580|P2|STARTED|Overall Study||249
314736|NCT01590771|753581|P1|STARTED|Overall Study||249
314737|NCT01590758|753609|P2|NOT COMPLETED|Overall Study||7
314738|NCT01590758|753610|P1|NOT COMPLETED|Overall Study||5
314739|NCT01590758|753609|P2|COMPLETED|Overall Study||97
314740|NCT01590758|753610|P1|COMPLETED|Overall Study||80
314741|NCT01590758|753609|P2|STARTED|Overall Study||104
314742|NCT01590758|753610|P1|STARTED|Overall Study||85
314743|NCT01590563|753620|P1|NOT COMPLETED|Overall Study||1
314744|NCT01590563|753620|P1|COMPLETED|Overall Study||14
314745|NCT01590563|753620|P1|STARTED|Overall Study||15
314746|NCT01590550|753626|P1|NOT COMPLETED|Overall Study||0
314747|NCT01590550|753626|P1|COMPLETED|Overall Study||18
314748|NCT01590550|753626|P1|STARTED|Overall Study||18
314749|NCT01590264|753632|P1|NOT COMPLETED|Overall Study||0
314750|NCT01590264|753632|P1|COMPLETED|Overall Study||5
314751|NCT01590264|753632|P1|STARTED|Overall Study||5
314752|NCT01590238|753637|P1|NOT COMPLETED|Overall Study||2
314753|NCT01590238|753637|P1|COMPLETED|Overall Study||13
314754|NCT01590238|753637|P1|STARTED|Overall Study||15
314755|NCT01590212|753644|P3|NOT COMPLETED|Overall Study||5
314756|NCT01590212|753645|P2|NOT COMPLETED|Overall Study||4
314757|NCT01590212|753646|P1|NOT COMPLETED|Overall Study||3
314758|NCT01590212|753644|P3|COMPLETED|Overall Study||9
314759|NCT01590212|753645|P2|COMPLETED|Overall Study||5
314760|NCT01590212|753646|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
314761|NCT01590212|753644|P3|Post-intervention|Overall Study|failed contact=1|10
314762|NCT01590212|753645|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
314763|NCT01590212|753646|P1|Post-intervention|Overall Study|failed contact=3|7
314764|NCT01590212|753644|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
314765|NCT01590212|753645|P2|Baseline (Pre-intervention)|Overall Study||9
314766|NCT01590212|753646|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
314767|NCT01590212|753644|P3|STARTED|Overall Study||14
314768|NCT01590212|753645|P2|STARTED|Overall Study||9
314769|NCT01590212|753646|P1|STARTED|Overall Study||12
314770|NCT01589978|753663|P1|NOT COMPLETED|Overall Study||0
314771|NCT01589978|753663|P1|COMPLETED|Overall Study||2681
314772|NCT01589978|753663|P1|STARTED|Overall Study||2681
314773|NCT01589822|753690|P3|NOT COMPLETED|Overall Study||1
314774|NCT01589822|753691|P2|NOT COMPLETED|Overall Study||3
314775|NCT01589822|753692|P1|NOT COMPLETED|Overall Study||4
314776|NCT01589822|753690|P3|COMPLETED|Overall Study||40
314777|NCT01589822|753691|P2|COMPLETED|Overall Study||86
314778|NCT01589822|753692|P1|COMPLETED|Overall Study||80
314779|NCT01589822|753690|P3|STARTED|Overall Study||41
314780|NCT01589822|753691|P2|STARTED|Overall Study||89
314781|NCT01589822|753692|P1|STARTED|Overall Study||84
314782|NCT01589653|753711|P2|NOT COMPLETED|Overall Study||11
314783|NCT01589653|753712|P1|NOT COMPLETED|Overall Study||7
314784|NCT01589653|753711|P2|COMPLETED|Overall Study||68
314785|NCT01589653|753712|P1|COMPLETED|Overall Study||69
314786|NCT01589653|753711|P2|Exposed|Overall Study||78
314787|NCT01589653|753712|P1|Exposed|Overall Study||76
314788|NCT01589653|753711|P2|STARTED|Overall Study||79
314789|NCT01589653|753712|P1|STARTED|Overall Study||76
314790|NCT01589510|753726|P1|NOT COMPLETED|Overall Study||33
314791|NCT01589510|753726|P1|COMPLETED|Overall Study||386
314792|NCT01589510|753726|P1|STARTED|Overall Study||419
314793|NCT01589497|753741|P4|NOT COMPLETED|Overall Study||1
314794|NCT01589497|753742|P3|NOT COMPLETED|Overall Study||1
314795|NCT01589497|753743|P2|NOT COMPLETED|Overall Study||1
314796|NCT01589497|753744|P1|NOT COMPLETED|Overall Study||1
314797|NCT01589497|753741|P4|COMPLETED|Overall Study||17
314798|NCT01589497|753742|P3|COMPLETED|Overall Study||15
314799|NCT01589497|753743|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
314800|NCT01589497|753744|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
314801|NCT01589497|753741|P4|STARTED|Overall Study||18
314802|NCT01589497|753742|P3|STARTED|Overall Study||16
314803|NCT01589497|753743|P2|STARTED|Overall Study||17
314804|NCT01589497|753744|P1|STARTED|Overall Study||18
314805|NCT01589484|753777|P1|NOT COMPLETED|Overall Study||4
314806|NCT01589484|753777|P1|COMPLETED|Overall Study||100
314807|NCT01589484|753777|P1|STARTED|Overall Study||104
314808|NCT01589445|753782|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
314809|NCT01589445|753782|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
314810|NCT01589445|753782|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
314811|NCT01589445|753782|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
314812|NCT01589445|753782|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
314813|NCT01589445|753782|P1|STARTED|001 (Pioglitazone) -3 Months||77
314814|NCT01589237|753802|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
314815|NCT01589237|753803|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
314816|NCT01589237|753804|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
314817|NCT01589237|753805|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
314818|NCT01589237|753802|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
314819|NCT01589237|753803|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
314820|NCT01589237|753804|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
314821|NCT01589237|753805|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
314822|NCT01589237|753802|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
314823|NCT01589237|753803|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
314824|NCT01589237|753804|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
314825|NCT01589237|753805|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
314826|NCT01589237|753802|P4|NOT COMPLETED|Part A (52 Weeks)||0
314827|NCT01589237|753803|P3|NOT COMPLETED|Part A (52 Weeks)||2
314828|NCT01589237|753804|P2|NOT COMPLETED|Part A (52 Weeks)||3
314829|NCT01589237|753805|P1|NOT COMPLETED|Part A (52 Weeks)||2
314830|NCT01589237|753802|P4|COMPLETED|Part A (52 Weeks)||5
314831|NCT01589237|753803|P3|COMPLETED|Part A (52 Weeks)||8
314832|NCT01589237|753804|P2|COMPLETED|Part A (52 Weeks)||9
314833|NCT01589237|753805|P1|COMPLETED|Part A (52 Weeks)||9
314834|NCT01589237|753802|P4|STARTED|Part A (52 Weeks)||5
314835|NCT01589237|753803|P3|STARTED|Part A (52 Weeks)||10
314836|NCT01589237|753804|P2|STARTED|Part A (52 Weeks)||12
314837|NCT01589237|753805|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
314838|NCT01588951|753854|P3|NOT COMPLETED|Overall Study||1
314839|NCT01588951|753855|P2|NOT COMPLETED|Overall Study||0
314840|NCT01588951|753856|P1|NOT COMPLETED|Overall Study||0
314841|NCT01588951|753854|P3|COMPLETED|Overall Study||5
314842|NCT01588951|753855|P2|COMPLETED|Overall Study||2
314843|NCT01588951|753856|P1|COMPLETED|Overall Study||2
314844|NCT01588951|753854|P3|STARTED|Overall Study||6
314845|NCT01588951|753855|P2|STARTED|Overall Study||2
314846|NCT01588951|753856|P1|STARTED|Overall Study||2
314847|NCT01588548|753870|P6|NOT COMPLETED|Overall Study||6
314848|NCT01588548|753871|P5|NOT COMPLETED|Overall Study||6
314849|NCT01588548|753872|P4|NOT COMPLETED|Overall Study||7
314850|NCT01588548|753873|P3|NOT COMPLETED|Overall Study||6
314851|NCT01588548|753874|P2|NOT COMPLETED|Overall Study||7
314852|NCT01588548|753875|P1|NOT COMPLETED|Overall Study||3
314853|NCT01588548|753870|P6|COMPLETED|Overall Study||0
314854|NCT01588548|753871|P5|COMPLETED|Overall Study||0
314855|NCT01588548|753872|P4|COMPLETED|Overall Study||0
314856|NCT01588548|753873|P3|COMPLETED|Overall Study||0
314857|NCT01588548|753874|P2|COMPLETED|Overall Study||0
314858|NCT01588548|753875|P1|COMPLETED|Overall Study||0
314859|NCT01588548|753870|P6|Cycle 1 Day 21|Overall Study||3
314860|NCT01588548|753871|P5|Cycle 1 Day 21|Overall Study||3
314861|NCT01588548|753872|P4|Cycle 1 Day 21|Overall Study||5
314862|NCT01588548|753873|P3|Cycle 1 Day 21|Overall Study||2
314863|NCT01588548|753874|P2|Cycle 1 Day 21|Overall Study||5
314864|NCT01588548|753875|P1|Cycle 1 Day 21|Overall Study||3
314865|NCT01588548|753870|P6|STARTED|Overall Study||6
314866|NCT01588548|753871|P5|STARTED|Overall Study||6
314867|NCT01588548|753872|P4|STARTED|Overall Study||7
314868|NCT01588548|753873|P3|STARTED|Overall Study||6
314869|NCT01588548|753874|P2|STARTED|Overall Study||7
314870|NCT01588548|753875|P1|STARTED|Overall Study||3
314871|NCT01588496|753892|P3|NOT COMPLETED|Overall Study||0
314872|NCT01588496|753893|P2|NOT COMPLETED|Overall Study||1
314873|NCT01588496|753894|P1|NOT COMPLETED|Overall Study||0
314874|NCT01588496|753892|P3|COMPLETED|Overall Study||33
314875|NCT01588496|753893|P2|COMPLETED|Overall Study||16
314876|NCT01588496|753894|P1|COMPLETED|Overall Study||8
314877|NCT01588496|753892|P3|Received Treatment|Overall Study||33
314878|NCT01588496|753893|P2|Received Treatment|Overall Study||16
314879|NCT01588496|753894|P1|Received Treatment|Overall Study||8
314880|NCT01588496|753892|P3|STARTED|Overall Study||33
314881|NCT01588496|753893|P2|STARTED|Overall Study||17
314882|NCT01588496|753894|P1|STARTED|Overall Study||8
314883|NCT01588444|753921|P2|NOT COMPLETED|Overall Study||0
314884|NCT01588444|753922|P1|NOT COMPLETED|Overall Study||0
314885|NCT01588444|753921|P2|COMPLETED|Overall Study||20
314886|NCT01588444|753922|P1|COMPLETED|Overall Study||20
314887|NCT01588444|753921|P2|STARTED|Overall Study||20
314888|NCT01588444|753922|P1|STARTED|Overall Study||20
314889|NCT01588418|753928|P2|NOT COMPLETED|Overall Study||0
314890|NCT01588418|753929|P1|NOT COMPLETED|Overall Study||0
314891|NCT01588418|753928|P2|COMPLETED|Overall Study||4
314892|NCT01588418|753929|P1|COMPLETED|Overall Study||11
314893|NCT01588418|753928|P2|STARTED|Overall Study||4
314894|NCT01588418|753929|P1|STARTED|Overall Study||11
314895|NCT01588405|753933|P1|NOT COMPLETED|Overall Study||2
314896|NCT01588405|753933|P1|COMPLETED|Overall Study||31
314897|NCT01588405|753933|P1|STARTED|Overall Study||33
314898|NCT01588353|753960|P3|NOT COMPLETED|Step3||2
314899|NCT01588353|753961|P2|NOT COMPLETED|Step3||0
314900|NCT01588353|753962|P1|NOT COMPLETED|Step3||0
314901|NCT01588353|753960|P3|COMPLETED|Step3||23
314902|NCT01588353|753961|P2|COMPLETED|Step3||0
314903|NCT01588353|753962|P1|COMPLETED|Step3||0
314904|NCT01588353|753960|P3|STARTED|Step3||25
314905|NCT01588353|753961|P2|STARTED|Step3||0
314906|NCT01588353|753962|P1|STARTED|Step3||0
314907|NCT01588353|753960|P3|NOT COMPLETED|Step2||0
314908|NCT01588353|753961|P2|NOT COMPLETED|Step2||1
314909|NCT01588353|753962|P1|NOT COMPLETED|Step2||0
314910|NCT01588353|753960|P3|COMPLETED|Step2||0
314911|NCT01588353|753961|P2|COMPLETED|Step2||70
314912|NCT01588353|753962|P1|COMPLETED|Step2||0
314913|NCT01588353|753960|P3|STARTED|Step2||0
314914|NCT01588353|753961|P2|STARTED|Step2||71
314915|NCT01588353|753962|P1|STARTED|Step2||0
314916|NCT01588353|753960|P3|NOT COMPLETED|Step1||0
314917|NCT01588353|753961|P2|NOT COMPLETED|Step1||0
314918|NCT01588353|753962|P1|NOT COMPLETED|Step1||0
314919|NCT01588353|753960|P3|COMPLETED|Step1||0
314920|NCT01588353|753961|P2|COMPLETED|Step1||0
314921|NCT01588353|753962|P1|COMPLETED|Step1||6
314922|NCT01588353|753960|P3|STARTED|Step1||0
314923|NCT01588353|753961|P2|STARTED|Step1||0
314924|NCT01588353|753962|P1|STARTED|Step1||6
314925|NCT01588158|753980|P2|NOT COMPLETED|Overall Study||0
314926|NCT01588158|753981|P1|NOT COMPLETED|Overall Study||0
314927|NCT01588158|753980|P2|COMPLETED|Overall Study||3
314928|NCT01588158|753981|P1|COMPLETED|Overall Study||4
314929|NCT01588158|753980|P2|STARTED|Overall Study||3
314930|NCT01588158|753981|P1|STARTED|Overall Study||4
314931|NCT01588106|754005|P2|NOT COMPLETED|Overall Study||4
314932|NCT01588106|754006|P1|NOT COMPLETED|Overall Study||5
314933|NCT01588106|754005|P2|COMPLETED|Overall Study||72
314934|NCT01588106|754006|P1|COMPLETED|Overall Study||73
314935|NCT01588106|754005|P2|STARTED|Overall Study||76
314936|NCT01588106|754006|P1|STARTED|Overall Study||78
314937|NCT01587989|754014|P3|NOT COMPLETED|Randomized Study Treatment||1
314938|NCT01587989|754015|P2|NOT COMPLETED|Randomized Study Treatment||2
314939|NCT01587989|754016|P1|NOT COMPLETED|Randomized Study Treatment||0
314940|NCT01587989|754014|P3|COMPLETED|Randomized Study Treatment||32
314941|NCT01587989|754015|P2|COMPLETED|Randomized Study Treatment||30
314942|NCT01587989|754016|P1|COMPLETED|Randomized Study Treatment||0
314943|NCT01587989|754014|P3|STARTED|Randomized Study Treatment||33
314944|NCT01587989|754015|P2|STARTED|Randomized Study Treatment||32
314945|NCT01587989|754016|P1|STARTED|Randomized Study Treatment||0
314946|NCT01587989|754014|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
314947|NCT01587989|754015|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
314948|NCT01587989|754016|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
314949|NCT01587989|754014|P3|COMPLETED|12-Week Open-Label Run-In Period||0
314950|NCT01587989|754015|P2|COMPLETED|12-Week Open-Label Run-In Period||0
314951|NCT01587989|754016|P1|COMPLETED|12-Week Open-Label Run-In Period||65
314952|NCT01587989|754014|P3|STARTED|12-Week Open-Label Run-In Period||0
314953|NCT01587989|754015|P2|STARTED|12-Week Open-Label Run-In Period||0
314954|NCT01587989|754016|P1|STARTED|12-Week Open-Label Run-In Period||77
314955|NCT01587963|754040|P2|NOT COMPLETED|Overall Study||0
314956|NCT01587963|754041|P1|NOT COMPLETED|Overall Study||1
314957|NCT01587963|754040|P2|COMPLETED|Overall Study||4
314958|NCT01587963|754041|P1|COMPLETED|Overall Study||6
314959|NCT01587963|754040|P2|STARTED|Overall Study||4
314960|NCT01587963|754041|P1|STARTED|Overall Study||7
314961|NCT01587950|754047|P1|NOT COMPLETED|Period 3||0
314962|NCT01587950|754047|P1|COMPLETED|Period 3||12
314963|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
314964|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
314965|NCT01587950|754047|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
314966|NCT01587950|754047|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
314967|NCT01587950|754047|P1|Received Sterile Water (5 Minutes)|Period 3||5
314968|NCT01587950|754047|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
314969|NCT01587950|754047|P1|Received Sterile Water (2 Minutes)|Period 3||2
314970|NCT01587950|754047|P1|Received Sterile Water (10 Minutes)|Period 3||5
314971|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
314972|NCT01587950|754047|P1|STARTED|Period 3||12
314973|NCT01587950|754047|P1|NOT COMPLETED|Washout 2||0
314974|NCT01587950|754047|P1|COMPLETED|Washout 2||12
314975|NCT01587950|754047|P1|STARTED|Washout 2||12
314976|NCT01587950|754047|P1|NOT COMPLETED|Period 2||0
314977|NCT01587950|754047|P1|COMPLETED|Period 2||12
314978|NCT01587950|754047|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
314979|NCT01587950|754047|P1|Received Sterile Water (10 Minutes)|Period 2||2
314980|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
314981|NCT01587950|754047|P1|Received Sterile Water (5 Minutes)|Period 2||2
314982|NCT01587950|754047|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
314983|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
314984|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
314985|NCT01587950|754047|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
314986|NCT01587950|754047|P1|Received Sterile Water (2 Minutes)|Period 2||8
314987|NCT01587950|754047|P1|STARTED|Period 2||12
314988|NCT01587950|754047|P1|NOT COMPLETED|Washout 1||0
314989|NCT01587950|754047|P1|COMPLETED|Washout 1||12
314990|NCT01587950|754047|P1|STARTED|Washout 1||12
314991|NCT01587950|754047|P1|NOT COMPLETED|Period 1||0
314992|NCT01587950|754047|P1|COMPLETED|Period 1||12
314993|NCT01587950|754047|P1|Received Sterile Water (5 Minutes)|Period 1||5
314994|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
314995|NCT01587950|754047|P1|Received Sterile Water (10 Minutes)|Period 1||5
314996|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
314997|NCT01587950|754047|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
314998|NCT01587950|754047|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
314999|NCT01587950|754047|P1|Received Sterile Water (2 Minutes)|Period 1||2
315000|NCT01587950|754047|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
315001|NCT01587950|754047|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
315002|NCT01587950|754047|P1|STARTED|Period 1||12
315003|NCT01587885|754077|P2|NOT COMPLETED|Treatment Period 2||0
315004|NCT01587885|754078|P1|NOT COMPLETED|Treatment Period 2||0
315005|NCT01587885|754077|P2|COMPLETED|Treatment Period 2||19
315006|NCT01587885|754078|P1|COMPLETED|Treatment Period 2||26
315007|NCT01587885|754077|P2|STARTED|Treatment Period 2||19
315008|NCT01587885|754078|P1|STARTED|Treatment Period 2||26
315009|NCT01587885|754077|P2|NOT COMPLETED|Treatment Period 1||3
315010|NCT01587885|754078|P1|NOT COMPLETED|Treatment Period 1||0
315011|NCT01587885|754077|P2|COMPLETED|Treatment Period 1||19
315012|NCT01587885|754078|P1|COMPLETED|Treatment Period 1||26
315013|NCT01587885|754077|P2|STARTED|Treatment Period 1||22
315014|NCT01587885|754078|P1|STARTED|Treatment Period 1||26
315015|NCT01587651|754094|P3|NOT COMPLETED|Overall Study||1
315016|NCT01587651|754095|P2|NOT COMPLETED|Overall Study||3
315017|NCT01587651|754096|P1|NOT COMPLETED|Overall Study||0
315018|NCT01587651|754094|P3|COMPLETED|Overall Study||34
315019|NCT01587651|754095|P2|COMPLETED|Overall Study||38
315020|NCT01587651|754096|P1|COMPLETED|Overall Study||34
315021|NCT01587651|754094|P3|STARTED|Overall Study||35
315022|NCT01587651|754095|P2|STARTED|Overall Study||41
315023|NCT01587651|754096|P1|STARTED|Overall Study||34
315024|NCT01587118|754123|P1|NOT COMPLETED|Overall Study||7
315025|NCT01587118|754123|P1|COMPLETED|Overall Study||11
315026|NCT01587118|754123|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
315027|NCT01587105|754130|P2|NOT COMPLETED|Overall Study||43
315028|NCT01587105|754131|P1|NOT COMPLETED|Overall Study||6
315029|NCT01587105|754130|P2|COMPLETED|Overall Study||138
315030|NCT01587105|754131|P1|COMPLETED|Overall Study||144
315031|NCT01587105|754130|P2|STARTED|Overall Study||181
315032|NCT01587105|754131|P1|STARTED|Overall Study||150
315033|NCT01587079|754147|P1|NOT COMPLETED|Overall Study||39
315034|NCT01587079|754147|P1|COMPLETED|Overall Study||120
315035|NCT01587079|754147|P1|STARTED|Overall Study||159
315036|NCT01587027|754271|P2|NOT COMPLETED|Discharge (1 Day)||0
315037|NCT01587027|754272|P1|NOT COMPLETED|Discharge (1 Day)||0
315038|NCT01587027|754271|P2|COMPLETED|Discharge (1 Day)||8
315039|NCT01587027|754272|P1|COMPLETED|Discharge (1 Day)||8
315040|NCT01587027|754271|P2|STARTED|Discharge (1 Day)||8
315041|NCT01587027|754272|P1|STARTED|Discharge (1 Day)||8
315042|NCT01587027|754271|P2|NOT COMPLETED|Third Intervention (1 Day)||0
315043|NCT01587027|754272|P1|NOT COMPLETED|Third Intervention (1 Day)||0
315044|NCT01587027|754271|P2|COMPLETED|Third Intervention (1 Day)||8
315045|NCT01587027|754272|P1|COMPLETED|Third Intervention (1 Day)||8
315046|NCT01587027|754271|P2|STARTED|Third Intervention (1 Day)||8
315047|NCT01587027|754272|P1|STARTED|Third Intervention (1 Day)||8
315048|NCT01587027|754271|P2|NOT COMPLETED|Washout (1 Day)||0
315049|NCT01587027|754272|P1|NOT COMPLETED|Washout (1 Day)||0
315050|NCT01587027|754271|P2|COMPLETED|Washout (1 Day)||8
315051|NCT01587027|754272|P1|COMPLETED|Washout (1 Day)||8
315052|NCT01587027|754271|P2|STARTED|Washout (1 Day)||8
315053|NCT01587027|754272|P1|STARTED|Washout (1 Day)||8
315054|NCT01587027|754271|P2|NOT COMPLETED|Second Intervention (1 Day)||0
315055|NCT01587027|754272|P1|NOT COMPLETED|Second Intervention (1 Day)||0
315056|NCT01587027|754271|P2|COMPLETED|Second Intervention (1 Day)||8
315057|NCT01587027|754272|P1|COMPLETED|Second Intervention (1 Day)||8
315058|NCT01587027|754271|P2|STARTED|Second Intervention (1 Day)||8
315059|NCT01587027|754272|P1|STARTED|Second Intervention (1 Day)||8
315060|NCT01587027|754271|P2|NOT COMPLETED|Washout (1 Day)||0
315061|NCT01587027|754272|P1|NOT COMPLETED|Washout (1 Day)||0
315062|NCT01587027|754271|P2|COMPLETED|Washout (1 Day)||8
315063|NCT01587027|754272|P1|COMPLETED|Washout (1 Day)||8
315064|NCT01587027|754271|P2|STARTED|Washout (1 Day)||8
315065|NCT01587027|754272|P1|STARTED|Washout (1 Day)||8
315066|NCT01587027|754271|P2|NOT COMPLETED|First Intervention (1 Day)||0
315067|NCT01587027|754272|P1|NOT COMPLETED|First Intervention (1 Day)||0
315068|NCT01587027|754271|P2|COMPLETED|First Intervention (1 Day)||8
315069|NCT01587027|754272|P1|COMPLETED|First Intervention (1 Day)||8
315070|NCT01587027|754271|P2|STARTED|First Intervention (1 Day)||8
315071|NCT01587027|754272|P1|STARTED|First Intervention (1 Day)||8
315072|NCT01587014|754278|P1|NOT COMPLETED|Overall Study||2
315073|NCT01587014|754278|P1|COMPLETED|Overall Study||24
315074|NCT01587014|754278|P1|STARTED|Overall Study||26
315075|NCT01587001|754285|P2|NOT COMPLETED|Overall Study||1
315076|NCT01587001|754286|P1|NOT COMPLETED|Overall Study||6
315077|NCT01587001|754285|P2|COMPLETED|Overall Study||2
315078|NCT01587001|754286|P1|COMPLETED|Overall Study||8
315079|NCT01587001|754285|P2|STARTED|Overall Study||3
315080|NCT01587001|754286|P1|STARTED|Overall Study||14
315081|NCT01586975|754297|P3|NOT COMPLETED|Overall Study||0
315082|NCT01586975|754298|P2|NOT COMPLETED|Overall Study||0
315083|NCT01586975|754299|P1|NOT COMPLETED|Overall Study||0
315084|NCT01586975|754297|P3|COMPLETED|Overall Study||46
315085|NCT01586975|754298|P2|COMPLETED|Overall Study||32
315086|NCT01586975|754299|P1|COMPLETED|Overall Study||15
315087|NCT01586975|754297|P3|STARTED|Overall Study||46
315088|NCT01586975|754298|P2|STARTED|Overall Study||32
315089|NCT01586975|754299|P1|STARTED|Overall Study||15
315090|NCT01586962|754307|P1|NOT COMPLETED|Overall Study||0
315091|NCT01586962|754307|P1|COMPLETED|Overall Study||56
315092|NCT01586962|754307|P1|STARTED|Overall Study||56
315093|NCT01586897|754315|P2|NOT COMPLETED|Overall Study||0
315094|NCT01586897|754316|P1|NOT COMPLETED|Overall Study||0
315095|NCT01586897|754315|P2|COMPLETED|Overall Study||26
315096|NCT01586897|754316|P1|COMPLETED|Overall Study||26
315097|NCT01586897|754315|P2|STARTED|Overall Study||26
315098|NCT01586897|754316|P1|STARTED|Overall Study||26
315099|NCT01586806|754335|P3|NOT COMPLETED|Overall Study||2
315100|NCT01586806|754336|P2|NOT COMPLETED|Overall Study||4
315101|NCT01586806|754337|P1|NOT COMPLETED|Overall Study||3
315102|NCT01586806|754335|P3|COMPLETED|Overall Study||63
315103|NCT01586806|754336|P2|COMPLETED|Overall Study||61
315104|NCT01586806|754337|P1|COMPLETED|Overall Study||62
315105|NCT01586806|754335|P3|STARTED|Overall Study||65
315106|NCT01586806|754336|P2|STARTED|Overall Study||65
315107|NCT01586806|754337|P1|STARTED|Overall Study||65
315108|NCT01586364|754357|P1|NOT COMPLETED|Overall Study||117
315109|NCT01586364|754357|P1|COMPLETED|Overall Study||184
315110|NCT01586364|754357|P1|STARTED|Overall Study||301
315111|NCT01586338|754410|P1|NOT COMPLETED|Overall Study||8
315112|NCT01586338|754410|P1|COMPLETED|Overall Study||229
315113|NCT01586338|754410|P1|STARTED|Overall Study||237
315114|NCT01586312|754422|P2|NOT COMPLETED|Overall Study||0
315115|NCT01586312|754423|P1|NOT COMPLETED|Overall Study||0
315116|NCT01586312|754422|P2|COMPLETED|Overall Study||15
315117|NCT01586312|754423|P1|COMPLETED|Overall Study||15
315118|NCT01586312|754422|P2|STARTED|Overall Study||15
315119|NCT01586312|754423|P1|STARTED|Overall Study||15
315120|NCT01586195|754433|P1|NOT COMPLETED|Overall Study||26
315121|NCT01586195|754433|P1|COMPLETED|Overall Study||5
315122|NCT01586195|754433|P1|STARTED|Overall Study||31
315123|NCT01586026|754444|P3|NOT COMPLETED|Overall Study||0
315124|NCT01586026|754445|P2|NOT COMPLETED|Overall Study||0
315125|NCT01586026|754446|P1|NOT COMPLETED|Overall Study||0
315126|NCT01586026|754444|P3|COMPLETED|Overall Study||271
315127|NCT01586026|754445|P2|COMPLETED|Overall Study||414
315128|NCT01586026|754446|P1|COMPLETED|Overall Study||350
315129|NCT01586026|754444|P3|STARTED|Overall Study||271
315130|NCT01586026|754445|P2|STARTED|Overall Study||414
315131|NCT01586026|754446|P1|STARTED|Overall Study||350
315132|NCT01585987|754456|P2|NOT COMPLETED|Treated||49
315133|NCT01585987|754457|P1|NOT COMPLETED|Treated||54
315134|NCT01585987|754456|P2|COMPLETED|Treated||2
315135|NCT01585987|754457|P1|COMPLETED|Treated||3
315136|NCT01585987|754456|P2|STARTED|Treated||51
315137|NCT01585987|754457|P1|STARTED|Treated||57
315138|NCT01585987|754456|P2|NOT COMPLETED|Randomized||6
315139|NCT01585987|754457|P1|NOT COMPLETED|Randomized||0
315140|NCT01585987|754456|P2|COMPLETED|Randomized||51
315141|NCT01585987|754457|P1|COMPLETED|Randomized||57
315142|NCT01585987|754456|P2|STARTED|Randomized||57
315143|NCT01585987|754457|P1|STARTED|Randomized||57
315144|NCT01585961|754472|P1|NOT COMPLETED|Overall Study||33
315145|NCT01585961|754472|P1|COMPLETED|Overall Study||478
315146|NCT01585961|754472|P1|Safety|Overall Study|Patients ablated with study catheter|508
315147|NCT01585961|754472|P1|STARTED|Overall Study||511
315148|NCT01585779|754489|P2|NOT COMPLETED|Overall Study||7
315149|NCT01585779|754490|P1|NOT COMPLETED|Overall Study||10
315150|NCT01585779|754489|P2|COMPLETED|Overall Study||21
315151|NCT01585779|754490|P1|COMPLETED|Overall Study||26
315152|NCT01585779|754489|P2|STARTED|Overall Study||28
315153|NCT01585779|754490|P1|STARTED|Overall Study||36
315154|NCT01585597|754544|P1|NOT COMPLETED|Overall Study||0
315155|NCT01585597|754544|P1|COMPLETED|Overall Study||20
315156|NCT01585597|754544|P1|STARTED|Overall Study||20
315157|NCT01585584|754549|P1|NOT COMPLETED|Overall Study||4
315158|NCT01585584|754549|P1|COMPLETED|Overall Study||6
315159|NCT01585584|754549|P1|STARTED|Overall Study||10
315160|NCT01585558|754556|P3|NOT COMPLETED|Overall Study||15
315161|NCT01585558|754557|P2|NOT COMPLETED|Overall Study||12
315162|NCT01585558|754558|P1|NOT COMPLETED|Overall Study||13
315163|NCT01585558|754556|P3|COMPLETED|Overall Study||34
315164|NCT01585558|754557|P2|COMPLETED|Overall Study||57
315165|NCT01585558|754558|P1|COMPLETED|Overall Study||49
315166|NCT01585558|754556|P3|STARTED|Overall Study||49
315167|NCT01585558|754557|P2|STARTED|Overall Study||69
315168|NCT01585558|754558|P1|STARTED|Overall Study||62
315169|NCT01585441|754739|P2|NOT COMPLETED|Overall Study||0
315170|NCT01585441|754740|P1|NOT COMPLETED|Overall Study||0
315171|NCT01585441|754739|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
315172|NCT01585441|754740|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
315261|NCT01584518|755022|P2|NOT COMPLETED|Overall Study||0
315173|NCT01585441|754739|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
315174|NCT01585441|754740|P1|Final Study Safety Visit|Overall Study||3
315175|NCT01585441|754739|P2|Received Finasteride at Month 3|Overall Study||2
315176|NCT01585441|754740|P1|Received Finasteride at Month 3|Overall Study||2
315177|NCT01585441|754739|P2|Month 3|Overall Study||3
315178|NCT01585441|754740|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
315179|NCT01585441|754739|P2|STARTED|Overall Study||3
315180|NCT01585441|754740|P1|STARTED|Overall Study||3
315181|NCT01585428|754792|P2|NOT COMPLETED|Overall Study||0
315182|NCT01585428|754793|P1|NOT COMPLETED|Overall Study||1
315183|NCT01585428|754792|P2|COMPLETED|Overall Study||11
315184|NCT01585428|754793|P1|COMPLETED|Overall Study||17
315185|NCT01585428|754792|P2|STARTED|Overall Study||11
315186|NCT01585428|754793|P1|STARTED|Overall Study||18
315187|NCT01585324|754801|P1|NOT COMPLETED|Overall Study||0
315188|NCT01585324|754801|P1|COMPLETED|Overall Study||30
315189|NCT01585324|754801|P1|STARTED|Overall Study||30
315190|NCT01585272|754817|P1|NOT COMPLETED|Overall Study||39
315191|NCT01585272|754817|P1|COMPLETED|Overall Study||82
315192|NCT01585272|754817|P1|Exelon Patch 10 cm2|Overall Study||96
315193|NCT01585272|754817|P1|Exelon Patch 5 cm2|Overall Study||114
315194|NCT01585272|754817|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
315195|NCT01585272|754817|P1|STARTED|Overall Study||121
315196|NCT01585038|754827|P2|NOT COMPLETED|Overall Study||2
315197|NCT01585038|754828|P1|NOT COMPLETED|Overall Study||2
315198|NCT01585038|754827|P2|COMPLETED|Overall Study||18
315199|NCT01585038|754828|P1|COMPLETED|Overall Study||18
315200|NCT01585038|754827|P2|STARTED|Overall Study||20
315201|NCT01585038|754828|P1|STARTED|Overall Study||20
315202|NCT01584843|754844|P6|NOT COMPLETED|Second Treatment Period||1
315203|NCT01584843|754845|P5|NOT COMPLETED|Second Treatment Period||0
315204|NCT01584843|754846|P4|NOT COMPLETED|Second Treatment Period||0
315205|NCT01584843|754847|P3|NOT COMPLETED|Second Treatment Period||0
315206|NCT01584843|754848|P2|NOT COMPLETED|Second Treatment Period||0
315207|NCT01584843|754849|P1|NOT COMPLETED|Second Treatment Period||0
315208|NCT01584843|754844|P6|COMPLETED|Second Treatment Period||0
315209|NCT01584843|754845|P5|COMPLETED|Second Treatment Period||3
315210|NCT01584843|754846|P4|COMPLETED|Second Treatment Period||6
315211|NCT01584843|754847|P3|COMPLETED|Second Treatment Period||2
315212|NCT01584843|754848|P2|COMPLETED|Second Treatment Period||1
315213|NCT01584843|754849|P1|COMPLETED|Second Treatment Period||2
315214|NCT01584843|754844|P6|STARTED|Second Treatment Period||1
315215|NCT01584843|754845|P5|STARTED|Second Treatment Period||3
315216|NCT01584843|754846|P4|STARTED|Second Treatment Period||6
315217|NCT01584843|754847|P3|STARTED|Second Treatment Period||2
315218|NCT01584843|754848|P2|STARTED|Second Treatment Period||1
315219|NCT01584843|754849|P1|STARTED|Second Treatment Period||2
315220|NCT01584843|754844|P6|NOT COMPLETED|First Treatment Period||2
315221|NCT01584843|754845|P5|NOT COMPLETED|First Treatment Period||0
315222|NCT01584843|754846|P4|NOT COMPLETED|First Treatment Period||0
315223|NCT01584843|754847|P3|NOT COMPLETED|First Treatment Period||1
315224|NCT01584843|754848|P2|NOT COMPLETED|First Treatment Period||0
315225|NCT01584843|754849|P1|NOT COMPLETED|First Treatment Period||0
315226|NCT01584843|754844|P6|COMPLETED|First Treatment Period||9
315227|NCT01584843|754845|P5|COMPLETED|First Treatment Period||10
315228|NCT01584843|754846|P4|COMPLETED|First Treatment Period||10
315229|NCT01584843|754847|P3|COMPLETED|First Treatment Period||2
315230|NCT01584843|754848|P2|COMPLETED|First Treatment Period||4
315231|NCT01584843|754849|P1|COMPLETED|First Treatment Period||3
315232|NCT01584843|754844|P6|STARTED|First Treatment Period||11
315233|NCT01584843|754845|P5|STARTED|First Treatment Period||10
315234|NCT01584843|754846|P4|STARTED|First Treatment Period||10
315235|NCT01584843|754847|P3|STARTED|First Treatment Period||3
315236|NCT01584843|754848|P2|STARTED|First Treatment Period||4
315237|NCT01584843|754849|P1|STARTED|First Treatment Period||3
315238|NCT01584648|754960|P2|NOT COMPLETED|Overall Study||212
315239|NCT01584648|754961|P1|NOT COMPLETED|Overall Study||211
315240|NCT01584648|754960|P2|COMPLETED|Overall Study||0
315241|NCT01584648|754961|P1|COMPLETED|Overall Study||0
315242|NCT01584648|754960|P2|Ongoing|Overall Study||147
315243|NCT01584648|754961|P1|Ongoing|Overall Study||154
315244|NCT01584648|754960|P2|STARTED|Overall Study||212
315245|NCT01584648|754961|P1|STARTED|Overall Study||211
315246|NCT01584544|755004|P5|NOT COMPLETED|Overall Study||0
315247|NCT01584544|755005|P4|NOT COMPLETED|Overall Study||0
315248|NCT01584544|755006|P3|NOT COMPLETED|Overall Study||0
315249|NCT01584544|755007|P2|NOT COMPLETED|Overall Study||0
315250|NCT01584544|755008|P1|NOT COMPLETED|Overall Study||0
315251|NCT01584544|755004|P5|COMPLETED|Overall Study||6
315252|NCT01584544|755005|P4|COMPLETED|Overall Study||3
315253|NCT01584544|755006|P3|COMPLETED|Overall Study||6
315254|NCT01584544|755007|P2|COMPLETED|Overall Study||6
315255|NCT01584544|755008|P1|COMPLETED|Overall Study||3
315256|NCT01584544|755004|P5|STARTED|Overall Study||6
315257|NCT01584544|755005|P4|STARTED|Overall Study||3
315258|NCT01584544|755006|P3|STARTED|Overall Study||6
315259|NCT01584544|755007|P2|STARTED|Overall Study||6
315260|NCT01584544|755008|P1|STARTED|Overall Study||3
315262|NCT01584518|755023|P1|NOT COMPLETED|Overall Study||0
315263|NCT01584518|755022|P2|COMPLETED|Overall Study||25
315264|NCT01584518|755023|P1|COMPLETED|Overall Study||25
315265|NCT01584518|755022|P2|STARTED|Overall Study||25
315266|NCT01584518|755023|P1|STARTED|Overall Study||25
315267|NCT01584479|755033|P4|NOT COMPLETED|Overall Study||0
315268|NCT01584479|755034|P3|NOT COMPLETED|Overall Study||0
315269|NCT01584479|755035|P2|NOT COMPLETED|Overall Study||0
315270|NCT01584479|755036|P1|NOT COMPLETED|Overall Study||0
315271|NCT01584479|755033|P4|COMPLETED|Overall Study||1847
315272|NCT01584479|755034|P3|COMPLETED|Overall Study||852
315273|NCT01584479|755035|P2|COMPLETED|Overall Study||1686
315274|NCT01584479|755036|P1|COMPLETED|Overall Study||732
315275|NCT01584479|755033|P4|STARTED|Overall Study||1847
315276|NCT01584479|755034|P3|STARTED|Overall Study||852
315277|NCT01584479|755035|P2|STARTED|Overall Study||1686
315278|NCT01584479|755036|P1|STARTED|Overall Study||732
315279|NCT01584232|755048|P2|NOT COMPLETED|Overall Study||3
315280|NCT01584232|755049|P1|NOT COMPLETED|Overall Study||8
315281|NCT01584232|755048|P2|COMPLETED|Overall Study||177
315282|NCT01584232|755049|P1|COMPLETED|Overall Study||173
315283|NCT01584232|755048|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
315284|NCT01584232|755049|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
315285|NCT01584232|755048|P2|STARTED|Overall Study||180
315286|NCT01584232|755049|P1|STARTED|Overall Study||181
315287|NCT01583894|755065|P1|NOT COMPLETED|Overall Study||15
315288|NCT01583894|755065|P1|COMPLETED|Overall Study||813
315289|NCT01583894|755065|P1|STARTED|Overall Study||828
315290|NCT01583647|755069|P2|NOT COMPLETED|Overall Study||0
315291|NCT01583647|755070|P1|NOT COMPLETED|Overall Study||0
315292|NCT01583647|755069|P2|COMPLETED|Overall Study||0
315293|NCT01583647|755070|P1|COMPLETED|Overall Study||10
315294|NCT01583647|755069|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
315295|NCT01583647|755070|P1|STARTED|Overall Study||10
315296|NCT01583543|755082|P1|NOT COMPLETED|Overall Study||0
315297|NCT01583543|755082|P1|COMPLETED|Overall Study||12
315298|NCT01583543|755082|P1|STARTED|Overall Study||12
315299|NCT01583530|755095|P6|NOT COMPLETED|Overall Study||3
315300|NCT01583530|755096|P5|NOT COMPLETED|Overall Study||5
315301|NCT01583530|755097|P4|NOT COMPLETED|Overall Study||1
315302|NCT01583530|755098|P3|NOT COMPLETED|Overall Study||0
315303|NCT01583530|755099|P2|NOT COMPLETED|Overall Study||3
315304|NCT01583530|755100|P1|NOT COMPLETED|Overall Study||0
315305|NCT01583530|755095|P6|COMPLETED|Overall Study||17
315306|NCT01583530|755096|P5|COMPLETED|Overall Study||15
315307|NCT01583530|755097|P4|COMPLETED|Overall Study||18
315308|NCT01583530|755098|P3|COMPLETED|Overall Study||20
315309|NCT01583530|755099|P2|COMPLETED|Overall Study||17
315310|NCT01583530|755100|P1|COMPLETED|Overall Study||19
315311|NCT01583530|755095|P6|STARTED|Overall Study||20
315312|NCT01583530|755096|P5|STARTED|Overall Study||20
315313|NCT01583530|755097|P4|STARTED|Overall Study||19
315314|NCT01583530|755098|P3|STARTED|Overall Study||20
315315|NCT01583530|755099|P2|STARTED|Overall Study||20
315316|NCT01583530|755100|P1|STARTED|Overall Study||19
315317|NCT01583452|755146|P2|NOT COMPLETED|Overall Study||0
315318|NCT01583452|755147|P1|NOT COMPLETED|Overall Study||0
315319|NCT01583452|755146|P2|COMPLETED|Overall Study||20
315320|NCT01583452|755147|P1|COMPLETED|Overall Study||21
315321|NCT01583452|755146|P2|STARTED|Overall Study||20
315322|NCT01583452|755147|P1|STARTED|Overall Study||21
315323|NCT01583374|755162|P3|NOT COMPLETED|Overall Study||25
315324|NCT01583374|755163|P2|NOT COMPLETED|Overall Study||16
315325|NCT01583374|755164|P1|NOT COMPLETED|Overall Study||19
315326|NCT01583374|755162|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
315327|NCT01583374|755163|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
315328|NCT01583374|755164|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
315329|NCT01583374|755162|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
315330|NCT01583374|755163|P2|Early Escape at Week 16|Overall Study||49
315331|NCT01583374|755164|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
315332|NCT01583374|755162|P3|Completed Week 16|Overall Study||144
315333|NCT01583374|755163|P2|Completed Week 16|Overall Study||151
315334|NCT01583374|755164|P1|Completed Week 16|Overall Study||150
315335|NCT01583374|755162|P3|Received Treatment|Overall Study||163
315336|NCT01583374|755163|P2|Received Treatment|Overall Study||163
315337|NCT01583374|755164|P1|Received Treatment|Overall Study||164
315338|NCT01583374|755162|P3|STARTED|Overall Study||163
315339|NCT01583374|755163|P2|STARTED|Overall Study||163
315340|NCT01583374|755164|P1|STARTED|Overall Study||164
315341|NCT01583101|755176|P2|NOT COMPLETED|Overall Study||0
315342|NCT01583101|755177|P1|NOT COMPLETED|Overall Study||0
315343|NCT01583101|755176|P2|COMPLETED|Overall Study||1161
315344|NCT01583101|755177|P1|COMPLETED|Overall Study||1076
315345|NCT01583101|755176|P2|STARTED|Overall Study||1161
315346|NCT01583101|755177|P1|STARTED|Overall Study||1076
315347|NCT01582945|755183|P1|NOT COMPLETED|Overall Study||2
315348|NCT01582945|755183|P1|COMPLETED|Overall Study||12
315349|NCT01582945|755183|P1|STARTED|Overall Study||14
315350|NCT01582854|755189|P2|NOT COMPLETED|Overall Study||34
315351|NCT01582854|755190|P1|NOT COMPLETED|Overall Study||36
315352|NCT01582854|755189|P2|COMPLETED|Overall Study||221
315353|NCT01582854|755190|P1|COMPLETED|Overall Study||212
315354|NCT01582854|755189|P2|STARTED|Overall Study||255
315355|NCT01582854|755190|P1|STARTED|Overall Study||248
315356|NCT01582789|755218|P2|NOT COMPLETED|Second Intervention (14 Days)||0
315357|NCT01582789|755219|P1|NOT COMPLETED|Second Intervention (14 Days)||1
315358|NCT01582789|755218|P2|COMPLETED|Second Intervention (14 Days)||27
315359|NCT01582789|755219|P1|COMPLETED|Second Intervention (14 Days)||33
315360|NCT01582789|755218|P2|STARTED|Second Intervention (14 Days)||27
315361|NCT01582789|755219|P1|STARTED|Second Intervention (14 Days)||34
315362|NCT01582789|755218|P2|NOT COMPLETED|First Intervention (14 Days)||0
315363|NCT01582789|755219|P1|NOT COMPLETED|First Intervention (14 Days)||0
315364|NCT01582789|755218|P2|COMPLETED|First Intervention (14 Days)||27
315365|NCT01582789|755219|P1|COMPLETED|First Intervention (14 Days)||34
315366|NCT01582789|755218|P2|STARTED|First Intervention (14 Days)||27
315367|NCT01582789|755219|P1|STARTED|First Intervention (14 Days)||34
315368|NCT01582490|755237|P2|NOT COMPLETED|Overall Study||1
315369|NCT01582490|755238|P1|NOT COMPLETED|Overall Study||1
315370|NCT01582490|755237|P2|COMPLETED|Overall Study||9
315371|NCT01582490|755238|P1|COMPLETED|Overall Study||8
315372|NCT01582490|755237|P2|STARTED|Overall Study||10
315373|NCT01582490|755238|P1|STARTED|Overall Study||9
315374|NCT01582477|755260|P2|NOT COMPLETED|Overall Study||0
315375|NCT01582477|755261|P1|NOT COMPLETED|Overall Study||0
315376|NCT01582477|755260|P2|COMPLETED|Overall Study||12
315377|NCT01582477|755261|P1|COMPLETED|Overall Study||12
315378|NCT01582477|755260|P2|STARTED|Overall Study||12
315379|NCT01582477|755261|P1|STARTED|Overall Study||12
315380|NCT01582308|755277|P10|NOT COMPLETED|Period 5||0
315381|NCT01582308|755278|P9|NOT COMPLETED|Period 5||0
315382|NCT01582308|755279|P8|NOT COMPLETED|Period 5||0
315383|NCT01582308|755280|P7|NOT COMPLETED|Period 5||0
315384|NCT01582308|755281|P6|NOT COMPLETED|Period 5||0
315385|NCT01582308|755282|P5|NOT COMPLETED|Period 5||0
315386|NCT01582308|755283|P4|NOT COMPLETED|Period 5||0
315387|NCT01582308|755284|P3|NOT COMPLETED|Period 5||0
315388|NCT01582308|755285|P2|NOT COMPLETED|Period 5||0
315389|NCT01582308|755286|P1|NOT COMPLETED|Period 5||0
315390|NCT01582308|755277|P10|COMPLETED|Period 5||1
315391|NCT01582308|755278|P9|COMPLETED|Period 5||2
315392|NCT01582308|755279|P8|COMPLETED|Period 5||2
315393|NCT01582308|755280|P7|COMPLETED|Period 5||2
315394|NCT01582308|755281|P6|COMPLETED|Period 5||1
315395|NCT01582308|755282|P5|COMPLETED|Period 5||2
315396|NCT01582308|755283|P4|COMPLETED|Period 5||2
315397|NCT01582308|755284|P3|COMPLETED|Period 5||2
315398|NCT01582308|755285|P2|COMPLETED|Period 5||2
315399|NCT01582308|755286|P1|COMPLETED|Period 5||1
315400|NCT01582308|755277|P10|STARTED|Period 5||1
315401|NCT01582308|755278|P9|STARTED|Period 5||2
315402|NCT01582308|755279|P8|STARTED|Period 5||2
315403|NCT01582308|755280|P7|STARTED|Period 5||2
315404|NCT01582308|755281|P6|STARTED|Period 5||1
315405|NCT01582308|755282|P5|STARTED|Period 5||2
315406|NCT01582308|755283|P4|STARTED|Period 5||2
315407|NCT01582308|755284|P3|STARTED|Period 5||2
315408|NCT01582308|755285|P2|STARTED|Period 5||2
315409|NCT01582308|755286|P1|STARTED|Period 5||1
315410|NCT01582308|755277|P10|NOT COMPLETED|10-day Washout Following Period 4||0
315411|NCT01582308|755278|P9|NOT COMPLETED|10-day Washout Following Period 4||0
315412|NCT01582308|755279|P8|NOT COMPLETED|10-day Washout Following Period 4||0
315413|NCT01582308|755280|P7|NOT COMPLETED|10-day Washout Following Period 4||0
315414|NCT01582308|755281|P6|NOT COMPLETED|10-day Washout Following Period 4||0
315415|NCT01582308|755282|P5|NOT COMPLETED|10-day Washout Following Period 4||0
315416|NCT01582308|755283|P4|NOT COMPLETED|10-day Washout Following Period 4||0
315417|NCT01582308|755284|P3|NOT COMPLETED|10-day Washout Following Period 4||0
315418|NCT01582308|755285|P2|NOT COMPLETED|10-day Washout Following Period 4||0
315419|NCT01582308|755286|P1|NOT COMPLETED|10-day Washout Following Period 4||0
315420|NCT01582308|755277|P10|COMPLETED|10-day Washout Following Period 4||1
315421|NCT01582308|755278|P9|COMPLETED|10-day Washout Following Period 4||2
315422|NCT01582308|755279|P8|COMPLETED|10-day Washout Following Period 4||2
315423|NCT01582308|755280|P7|COMPLETED|10-day Washout Following Period 4||2
315424|NCT01582308|755281|P6|COMPLETED|10-day Washout Following Period 4||1
315425|NCT01582308|755282|P5|COMPLETED|10-day Washout Following Period 4||2
315426|NCT01582308|755283|P4|COMPLETED|10-day Washout Following Period 4||2
315427|NCT01582308|755284|P3|COMPLETED|10-day Washout Following Period 4||2
315428|NCT01582308|755285|P2|COMPLETED|10-day Washout Following Period 4||2
315429|NCT01582308|755286|P1|COMPLETED|10-day Washout Following Period 4||1
315430|NCT01582308|755277|P10|STARTED|10-day Washout Following Period 4||1
315431|NCT01582308|755278|P9|STARTED|10-day Washout Following Period 4||2
315432|NCT01582308|755279|P8|STARTED|10-day Washout Following Period 4||2
315433|NCT01582308|755280|P7|STARTED|10-day Washout Following Period 4||2
315434|NCT01582308|755281|P6|STARTED|10-day Washout Following Period 4||1
315435|NCT01582308|755282|P5|STARTED|10-day Washout Following Period 4||2
315436|NCT01582308|755283|P4|STARTED|10-day Washout Following Period 4||2
315437|NCT01582308|755284|P3|STARTED|10-day Washout Following Period 4||2
315438|NCT01582308|755285|P2|STARTED|10-day Washout Following Period 4||2
315439|NCT01582308|755286|P1|STARTED|10-day Washout Following Period 4||1
315440|NCT01582308|755277|P10|NOT COMPLETED|Period 4||1
315441|NCT01582308|755278|P9|NOT COMPLETED|Period 4||0
315442|NCT01582308|755279|P8|NOT COMPLETED|Period 4||0
315443|NCT01582308|755280|P7|NOT COMPLETED|Period 4||0
315444|NCT01582308|755281|P6|NOT COMPLETED|Period 4||1
315445|NCT01582308|755282|P5|NOT COMPLETED|Period 4||0
315446|NCT01582308|755283|P4|NOT COMPLETED|Period 4||0
315447|NCT01582308|755284|P3|NOT COMPLETED|Period 4||0
315448|NCT01582308|755285|P2|NOT COMPLETED|Period 4||0
315449|NCT01582308|755286|P1|NOT COMPLETED|Period 4||1
315450|NCT01582308|755277|P10|COMPLETED|Period 4||1
315451|NCT01582308|755278|P9|COMPLETED|Period 4||2
315452|NCT01582308|755279|P8|COMPLETED|Period 4||2
315453|NCT01582308|755280|P7|COMPLETED|Period 4||2
315454|NCT01582308|755281|P6|COMPLETED|Period 4||1
315455|NCT01582308|755282|P5|COMPLETED|Period 4||2
315456|NCT01582308|755283|P4|COMPLETED|Period 4||2
315457|NCT01582308|755284|P3|COMPLETED|Period 4||2
315458|NCT01582308|755285|P2|COMPLETED|Period 4||2
315459|NCT01582308|755286|P1|COMPLETED|Period 4||1
315460|NCT01582308|755277|P10|STARTED|Period 4||2
315461|NCT01582308|755278|P9|STARTED|Period 4||2
315462|NCT01582308|755279|P8|STARTED|Period 4||2
315463|NCT01582308|755280|P7|STARTED|Period 4||2
315464|NCT01582308|755281|P6|STARTED|Period 4||2
315465|NCT01582308|755282|P5|STARTED|Period 4||2
315466|NCT01582308|755283|P4|STARTED|Period 4||2
315467|NCT01582308|755284|P3|STARTED|Period 4||2
315468|NCT01582308|755285|P2|STARTED|Period 4||2
315469|NCT01582308|755286|P1|STARTED|Period 4||2
315470|NCT01582308|755277|P10|NOT COMPLETED|10-day Washout Following Period 3||0
315471|NCT01582308|755278|P9|NOT COMPLETED|10-day Washout Following Period 3||0
315472|NCT01582308|755279|P8|NOT COMPLETED|10-day Washout Following Period 3||0
315473|NCT01582308|755280|P7|NOT COMPLETED|10-day Washout Following Period 3||0
315474|NCT01582308|755281|P6|NOT COMPLETED|10-day Washout Following Period 3||0
315475|NCT01582308|755282|P5|NOT COMPLETED|10-day Washout Following Period 3||0
315476|NCT01582308|755283|P4|NOT COMPLETED|10-day Washout Following Period 3||0
315477|NCT01582308|755284|P3|NOT COMPLETED|10-day Washout Following Period 3||0
315478|NCT01582308|755285|P2|NOT COMPLETED|10-day Washout Following Period 3||0
315479|NCT01582308|755286|P1|NOT COMPLETED|10-day Washout Following Period 3||0
315480|NCT01582308|755277|P10|COMPLETED|10-day Washout Following Period 3||2
315481|NCT01582308|755278|P9|COMPLETED|10-day Washout Following Period 3||2
315482|NCT01582308|755279|P8|COMPLETED|10-day Washout Following Period 3||2
315483|NCT01582308|755280|P7|COMPLETED|10-day Washout Following Period 3||2
315484|NCT01582308|755281|P6|COMPLETED|10-day Washout Following Period 3||2
315485|NCT01582308|755282|P5|COMPLETED|10-day Washout Following Period 3||2
315486|NCT01582308|755283|P4|COMPLETED|10-day Washout Following Period 3||2
315487|NCT01582308|755284|P3|COMPLETED|10-day Washout Following Period 3||2
315488|NCT01582308|755285|P2|COMPLETED|10-day Washout Following Period 3||2
315489|NCT01582308|755286|P1|COMPLETED|10-day Washout Following Period 3||2
315490|NCT01582308|755277|P10|STARTED|10-day Washout Following Period 3||2
315491|NCT01582308|755278|P9|STARTED|10-day Washout Following Period 3||2
315492|NCT01582308|755279|P8|STARTED|10-day Washout Following Period 3||2
315493|NCT01582308|755280|P7|STARTED|10-day Washout Following Period 3||2
315494|NCT01582308|755281|P6|STARTED|10-day Washout Following Period 3||2
315495|NCT01582308|755282|P5|STARTED|10-day Washout Following Period 3||2
315496|NCT01582308|755283|P4|STARTED|10-day Washout Following Period 3||2
315497|NCT01582308|755284|P3|STARTED|10-day Washout Following Period 3||2
315498|NCT01582308|755285|P2|STARTED|10-day Washout Following Period 3||2
315499|NCT01582308|755286|P1|STARTED|10-day Washout Following Period 3||2
315500|NCT01582308|755277|P10|NOT COMPLETED|Period 3||0
315501|NCT01582308|755278|P9|NOT COMPLETED|Period 3||0
315502|NCT01582308|755279|P8|NOT COMPLETED|Period 3||0
315503|NCT01582308|755280|P7|NOT COMPLETED|Period 3||0
315504|NCT01582308|755281|P6|NOT COMPLETED|Period 3||0
315505|NCT01582308|755282|P5|NOT COMPLETED|Period 3||0
315506|NCT01582308|755283|P4|NOT COMPLETED|Period 3||0
315507|NCT01582308|755284|P3|NOT COMPLETED|Period 3||0
315508|NCT01582308|755285|P2|NOT COMPLETED|Period 3||0
315509|NCT01582308|755286|P1|NOT COMPLETED|Period 3||0
315510|NCT01582308|755277|P10|COMPLETED|Period 3||2
315511|NCT01582308|755278|P9|COMPLETED|Period 3||2
315512|NCT01582308|755279|P8|COMPLETED|Period 3||2
315513|NCT01582308|755280|P7|COMPLETED|Period 3||2
315514|NCT01582308|755281|P6|COMPLETED|Period 3||2
315515|NCT01582308|755282|P5|COMPLETED|Period 3||2
315516|NCT01582308|755283|P4|COMPLETED|Period 3||2
315517|NCT01582308|755284|P3|COMPLETED|Period 3||2
315518|NCT01582308|755285|P2|COMPLETED|Period 3||2
315519|NCT01582308|755286|P1|COMPLETED|Period 3||2
315520|NCT01582308|755277|P10|STARTED|Period 3||2
315521|NCT01582308|755278|P9|STARTED|Period 3||2
315522|NCT01582308|755279|P8|STARTED|Period 3||2
315523|NCT01582308|755280|P7|STARTED|Period 3||2
315524|NCT01582308|755281|P6|STARTED|Period 3||2
315525|NCT01582308|755282|P5|STARTED|Period 3||2
315526|NCT01582308|755283|P4|STARTED|Period 3||2
315527|NCT01582308|755284|P3|STARTED|Period 3||2
315528|NCT01582308|755285|P2|STARTED|Period 3||2
315529|NCT01582308|755286|P1|STARTED|Period 3||2
315530|NCT01582308|755277|P10|NOT COMPLETED|10-day Washout Following Period 2||0
315531|NCT01582308|755278|P9|NOT COMPLETED|10-day Washout Following Period 2||0
315532|NCT01582308|755279|P8|NOT COMPLETED|10-day Washout Following Period 2||0
315533|NCT01582308|755280|P7|NOT COMPLETED|10-day Washout Following Period 2||0
315534|NCT01582308|755281|P6|NOT COMPLETED|10-day Washout Following Period 2||0
315535|NCT01582308|755282|P5|NOT COMPLETED|10-day Washout Following Period 2||0
315536|NCT01582308|755283|P4|NOT COMPLETED|10-day Washout Following Period 2||0
315537|NCT01582308|755284|P3|NOT COMPLETED|10-day Washout Following Period 2||0
315538|NCT01582308|755285|P2|NOT COMPLETED|10-day Washout Following Period 2||0
315539|NCT01582308|755286|P1|NOT COMPLETED|10-day Washout Following Period 2||0
315540|NCT01582308|755277|P10|COMPLETED|10-day Washout Following Period 2||2
315541|NCT01582308|755278|P9|COMPLETED|10-day Washout Following Period 2||2
315542|NCT01582308|755279|P8|COMPLETED|10-day Washout Following Period 2||2
315543|NCT01582308|755280|P7|COMPLETED|10-day Washout Following Period 2||2
315544|NCT01582308|755281|P6|COMPLETED|10-day Washout Following Period 2||2
315545|NCT01582308|755282|P5|COMPLETED|10-day Washout Following Period 2||2
315546|NCT01582308|755283|P4|COMPLETED|10-day Washout Following Period 2||2
315547|NCT01582308|755284|P3|COMPLETED|10-day Washout Following Period 2||2
315548|NCT01582308|755285|P2|COMPLETED|10-day Washout Following Period 2||2
315549|NCT01582308|755286|P1|COMPLETED|10-day Washout Following Period 2||2
315550|NCT01582308|755277|P10|STARTED|10-day Washout Following Period 2||2
315551|NCT01582308|755278|P9|STARTED|10-day Washout Following Period 2||2
315552|NCT01582308|755279|P8|STARTED|10-day Washout Following Period 2||2
315553|NCT01582308|755280|P7|STARTED|10-day Washout Following Period 2||2
315554|NCT01582308|755281|P6|STARTED|10-day Washout Following Period 2||2
315555|NCT01582308|755282|P5|STARTED|10-day Washout Following Period 2||2
315556|NCT01582308|755283|P4|STARTED|10-day Washout Following Period 2||2
315557|NCT01582308|755284|P3|STARTED|10-day Washout Following Period 2||2
315558|NCT01582308|755285|P2|STARTED|10-day Washout Following Period 2||2
315559|NCT01582308|755286|P1|STARTED|10-day Washout Following Period 2||2
315560|NCT01582308|755277|P10|NOT COMPLETED|Period 2||0
315561|NCT01582308|755278|P9|NOT COMPLETED|Period 2||0
315562|NCT01582308|755279|P8|NOT COMPLETED|Period 2||0
315563|NCT01582308|755280|P7|NOT COMPLETED|Period 2||0
315564|NCT01582308|755281|P6|NOT COMPLETED|Period 2||0
315565|NCT01582308|755282|P5|NOT COMPLETED|Period 2||0
315566|NCT01582308|755283|P4|NOT COMPLETED|Period 2||0
315567|NCT01582308|755284|P3|NOT COMPLETED|Period 2||0
315568|NCT01582308|755285|P2|NOT COMPLETED|Period 2||0
315569|NCT01582308|755286|P1|NOT COMPLETED|Period 2||0
315570|NCT01582308|755277|P10|COMPLETED|Period 2||2
315571|NCT01582308|755278|P9|COMPLETED|Period 2||2
315572|NCT01582308|755279|P8|COMPLETED|Period 2||2
315573|NCT01582308|755280|P7|COMPLETED|Period 2||2
315574|NCT01582308|755281|P6|COMPLETED|Period 2||2
315575|NCT01582308|755282|P5|COMPLETED|Period 2||2
315576|NCT01582308|755283|P4|COMPLETED|Period 2||2
315577|NCT01582308|755284|P3|COMPLETED|Period 2||2
315578|NCT01582308|755285|P2|COMPLETED|Period 2||2
315579|NCT01582308|755286|P1|COMPLETED|Period 2||2
315580|NCT01582308|755277|P10|STARTED|Period 2||2
315581|NCT01582308|755278|P9|STARTED|Period 2||2
315582|NCT01582308|755279|P8|STARTED|Period 2||2
315583|NCT01582308|755280|P7|STARTED|Period 2||2
315584|NCT01582308|755281|P6|STARTED|Period 2||2
315585|NCT01582308|755282|P5|STARTED|Period 2||2
315586|NCT01582308|755283|P4|STARTED|Period 2||2
315587|NCT01582308|755284|P3|STARTED|Period 2||2
315588|NCT01582308|755285|P2|STARTED|Period 2||2
315589|NCT01582308|755286|P1|STARTED|Period 2||2
315590|NCT01582308|755277|P10|NOT COMPLETED|10-day Washout Following Period 1||0
315591|NCT01582308|755278|P9|NOT COMPLETED|10-day Washout Following Period 1||0
315592|NCT01582308|755279|P8|NOT COMPLETED|10-day Washout Following Period 1||0
315593|NCT01582308|755280|P7|NOT COMPLETED|10-day Washout Following Period 1||0
315594|NCT01582308|755281|P6|NOT COMPLETED|10-day Washout Following Period 1||0
315595|NCT01582308|755282|P5|NOT COMPLETED|10-day Washout Following Period 1||1
315596|NCT01582308|755283|P4|NOT COMPLETED|10-day Washout Following Period 1||0
315597|NCT01582308|755284|P3|NOT COMPLETED|10-day Washout Following Period 1||0
315598|NCT01582308|755285|P2|NOT COMPLETED|10-day Washout Following Period 1||0
315599|NCT01582308|755286|P1|NOT COMPLETED|10-day Washout Following Period 1||0
315600|NCT01582308|755277|P10|COMPLETED|10-day Washout Following Period 1||2
315601|NCT01582308|755278|P9|COMPLETED|10-day Washout Following Period 1||2
315602|NCT01582308|755279|P8|COMPLETED|10-day Washout Following Period 1||2
315603|NCT01582308|755280|P7|COMPLETED|10-day Washout Following Period 1||2
315604|NCT01582308|755281|P6|COMPLETED|10-day Washout Following Period 1||2
315605|NCT01582308|755282|P5|COMPLETED|10-day Washout Following Period 1||2
315606|NCT01582308|755283|P4|COMPLETED|10-day Washout Following Period 1||2
315607|NCT01582308|755284|P3|COMPLETED|10-day Washout Following Period 1||2
315608|NCT01582308|755285|P2|COMPLETED|10-day Washout Following Period 1||2
315609|NCT01582308|755286|P1|COMPLETED|10-day Washout Following Period 1||2
315610|NCT01582308|755277|P10|STARTED|10-day Washout Following Period 1||2
315611|NCT01582308|755278|P9|STARTED|10-day Washout Following Period 1||2
315612|NCT01582308|755279|P8|STARTED|10-day Washout Following Period 1||2
315613|NCT01582308|755280|P7|STARTED|10-day Washout Following Period 1||2
315614|NCT01582308|755281|P6|STARTED|10-day Washout Following Period 1||2
315615|NCT01582308|755282|P5|STARTED|10-day Washout Following Period 1||3
315616|NCT01582308|755283|P4|STARTED|10-day Washout Following Period 1||2
315617|NCT01582308|755284|P3|STARTED|10-day Washout Following Period 1||2
315618|NCT01582308|755285|P2|STARTED|10-day Washout Following Period 1||2
315619|NCT01582308|755286|P1|STARTED|10-day Washout Following Period 1||2
315620|NCT01582308|755277|P10|NOT COMPLETED|Period 1||0
315621|NCT01582308|755278|P9|NOT COMPLETED|Period 1||0
315622|NCT01582308|755279|P8|NOT COMPLETED|Period 1||0
315623|NCT01582308|755280|P7|NOT COMPLETED|Period 1||1
315624|NCT01582308|755281|P6|NOT COMPLETED|Period 1||0
315625|NCT01582308|755282|P5|NOT COMPLETED|Period 1||0
315626|NCT01582308|755283|P4|NOT COMPLETED|Period 1||0
315627|NCT01582308|755284|P3|NOT COMPLETED|Period 1||0
315628|NCT01582308|755285|P2|NOT COMPLETED|Period 1||0
315629|NCT01582308|755286|P1|NOT COMPLETED|Period 1||0
315630|NCT01582308|755277|P10|COMPLETED|Period 1||2
315631|NCT01582308|755278|P9|COMPLETED|Period 1||2
315632|NCT01582308|755279|P8|COMPLETED|Period 1||2
315633|NCT01582308|755280|P7|COMPLETED|Period 1||2
315634|NCT01582308|755281|P6|COMPLETED|Period 1||2
315635|NCT01582308|755282|P5|COMPLETED|Period 1||3
315636|NCT01582308|755283|P4|COMPLETED|Period 1||2
315637|NCT01582308|755284|P3|COMPLETED|Period 1||2
315638|NCT01582308|755285|P2|COMPLETED|Period 1||2
315639|NCT01582308|755286|P1|COMPLETED|Period 1||2
315640|NCT01582308|755277|P10|STARTED|Period 1||2
315641|NCT01582308|755278|P9|STARTED|Period 1||2
315642|NCT01582308|755279|P8|STARTED|Period 1||2
315643|NCT01582308|755280|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
315644|NCT01582308|755281|P6|STARTED|Period 1||2
315645|NCT01582308|755282|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
315646|NCT01582308|755283|P4|STARTED|Period 1||2
315647|NCT01582308|755284|P3|STARTED|Period 1||2
315648|NCT01582308|755285|P2|STARTED|Period 1||2
315649|NCT01582308|755286|P1|STARTED|Period 1||2
315650|NCT01582282|755314|P3|NOT COMPLETED|Overall Study||0
315651|NCT01582282|755315|P2|NOT COMPLETED|Overall Study||2
315652|NCT01582282|755316|P1|NOT COMPLETED|Overall Study||2
315653|NCT01582282|755314|P3|COMPLETED|Overall Study||8
315654|NCT01582282|755315|P2|COMPLETED|Overall Study||12
315655|NCT01582282|755316|P1|COMPLETED|Overall Study||13
315656|NCT01582282|755314|P3|STARTED|Overall Study||8
315657|NCT01582282|755315|P2|STARTED|Overall Study||14
315658|NCT01582282|755316|P1|STARTED|Overall Study||15
315659|NCT01582243|755339|P1|NOT COMPLETED|Overall Study||3
315660|NCT01582243|755339|P1|COMPLETED|Overall Study||37
315661|NCT01582243|755339|P1|STARTED|Overall Study||40
315662|NCT01582178|755350|P2|NOT COMPLETED|Overall Study||5
315663|NCT01582178|755351|P1|NOT COMPLETED|Overall Study||6
315664|NCT01582178|755350|P2|COMPLETED|Overall Study||101
315665|NCT01582178|755351|P1|COMPLETED|Overall Study||100
315666|NCT01582178|755350|P2|STARTED|Overall Study||106
315667|NCT01582178|755351|P1|STARTED|Overall Study||106
315668|NCT01582139|755359|P2|NOT COMPLETED|Overall Study||0
315669|NCT01582139|755360|P1|NOT COMPLETED|Overall Study||0
315670|NCT01582139|755359|P2|COMPLETED|Overall Study||6
315671|NCT01582139|755360|P1|COMPLETED|Overall Study||6
315672|NCT01582139|755359|P2|STARTED|Overall Study||6
315673|NCT01582139|755360|P1|STARTED|Overall Study||6
315674|NCT01582100|755372|P1|NOT COMPLETED|Overall Study||2
315675|NCT01582100|755372|P1|COMPLETED|Overall Study||0
315676|NCT01582100|755372|P1|STARTED|Overall Study||2
315677|NCT01582009|755376|P1|NOT COMPLETED|Overall Study||2
315678|NCT01582009|755376|P1|COMPLETED|Overall Study||24
315679|NCT01582009|755376|P1|STARTED|Overall Study||26
315680|NCT01581931|755384|P2|NOT COMPLETED|Second Period||0
315681|NCT01581931|755385|P1|NOT COMPLETED|Second Period||0
315682|NCT01581931|755384|P2|COMPLETED|Second Period||15
315683|NCT01581931|755385|P1|COMPLETED|Second Period||16
315684|NCT01581931|755384|P2|STARTED|Second Period||15
315685|NCT01581931|755385|P1|STARTED|Second Period||16
315686|NCT01581931|755384|P2|NOT COMPLETED|Washout||1
315687|NCT01581931|755385|P1|NOT COMPLETED|Washout||0
315688|NCT01581931|755384|P2|COMPLETED|Washout||15
315689|NCT01581931|755385|P1|COMPLETED|Washout||16
315690|NCT01581931|755384|P2|STARTED|Washout||16
315691|NCT01581931|755385|P1|STARTED|Washout||16
315692|NCT01581931|755384|P2|NOT COMPLETED|First Period||0
315693|NCT01581931|755385|P1|NOT COMPLETED|First Period||0
315694|NCT01581931|755384|P2|COMPLETED|First Period||16
315695|NCT01581931|755385|P1|COMPLETED|First Period||16
315696|NCT01581931|755384|P2|STARTED|First Period||16
315697|NCT01581931|755385|P1|STARTED|First Period||16
315698|NCT01581684|755409|P10|NOT COMPLETED|Overall Study||0
315699|NCT01581684|755410|P9|NOT COMPLETED|Overall Study||1
315700|NCT01581684|755411|P8|NOT COMPLETED|Overall Study||0
315701|NCT01581684|755412|P7|NOT COMPLETED|Overall Study||0
315702|NCT01581684|755413|P6|NOT COMPLETED|Overall Study||0
315703|NCT01581684|755414|P5|NOT COMPLETED|Overall Study||0
315704|NCT01581684|755415|P4|NOT COMPLETED|Overall Study||0
315705|NCT01581684|755416|P3|NOT COMPLETED|Overall Study||0
315706|NCT01581684|755417|P2|NOT COMPLETED|Overall Study||0
315707|NCT01581684|755418|P1|NOT COMPLETED|Overall Study||0
315708|NCT01581684|755409|P10|COMPLETED|Overall Study||5
315709|NCT01581684|755410|P9|COMPLETED|Overall Study||0
315710|NCT01581684|755411|P8|COMPLETED|Overall Study||6
315711|NCT01581684|755412|P7|COMPLETED|Overall Study||6
315712|NCT01581684|755413|P6|COMPLETED|Overall Study||6
315713|NCT01581684|755414|P5|COMPLETED|Overall Study||6
315714|NCT01581684|755415|P4|COMPLETED|Overall Study||6
315715|NCT01581684|755416|P3|COMPLETED|Overall Study||6
315716|NCT01581684|755417|P2|COMPLETED|Overall Study||6
315717|NCT01581684|755418|P1|COMPLETED|Overall Study||14
315718|NCT01581684|755409|P10|STARTED|Overall Study||5
315719|NCT01581684|755410|P9|STARTED|Overall Study||1
315720|NCT01581684|755411|P8|STARTED|Overall Study||6
315721|NCT01581684|755412|P7|STARTED|Overall Study||6
315722|NCT01581684|755413|P6|STARTED|Overall Study||6
315723|NCT01581684|755414|P5|STARTED|Overall Study||6
315724|NCT01581684|755415|P4|STARTED|Overall Study||6
315725|NCT01581684|755416|P3|STARTED|Overall Study||6
315726|NCT01581684|755417|P2|STARTED|Overall Study||6
315727|NCT01581684|755418|P1|STARTED|Overall Study||14
315728|NCT01581658|755493|P4|NOT COMPLETED|Overall Study||0
315729|NCT01581658|755494|P3|NOT COMPLETED|Overall Study||0
315730|NCT01581658|755495|P2|NOT COMPLETED|Overall Study||0
315731|NCT01581658|755496|P1|NOT COMPLETED|Overall Study||0
315732|NCT01581658|755493|P4|COMPLETED|Overall Study||8
315733|NCT01581658|755494|P3|COMPLETED|Overall Study||8
315734|NCT01581658|755495|P2|COMPLETED|Overall Study||8
315735|NCT01581658|755496|P1|COMPLETED|Overall Study||8
315736|NCT01581658|755493|P4|STARTED|Overall Study||8
315737|NCT01581658|755494|P3|STARTED|Overall Study||8
315738|NCT01581658|755495|P2|STARTED|Overall Study||8
315739|NCT01581658|755496|P1|STARTED|Overall Study||8
315740|NCT01581437|755514|P1|NOT COMPLETED|Overall Study||0
315741|NCT01581437|755514|P1|COMPLETED|Overall Study||78
315742|NCT01581437|755514|P1|STARTED|Overall Study||78
315743|NCT01581307|755525|P1|NOT COMPLETED|Overall Study||1
315744|NCT01581307|755525|P1|COMPLETED|Overall Study||8
315745|NCT01581307|755525|P1|STARTED|Overall Study||9
315746|NCT01581021|755533|P2|NOT COMPLETED|Overall Study||11
315747|NCT01581021|755534|P1|NOT COMPLETED|Overall Study||10
315748|NCT01581021|755533|P2|COMPLETED|Overall Study||18
315749|NCT01581021|755534|P1|COMPLETED|Overall Study||19
315750|NCT01581021|755533|P2|STARTED|Overall Study||29
315751|NCT01581021|755534|P1|STARTED|Overall Study||29
315752|NCT01581008|755548|P2|NOT COMPLETED|Overall Study||6
315753|NCT01581008|755549|P1|NOT COMPLETED|Overall Study||1
315754|NCT01581008|755548|P2|COMPLETED|Overall Study||7
315755|NCT01581008|755549|P1|COMPLETED|Overall Study||16
315756|NCT01581008|755548|P2|STARTED|Overall Study||13
315757|NCT01581008|755549|P1|STARTED|Overall Study||17
315758|NCT01580995|755560|P2|NOT COMPLETED|Overall Study||2
315759|NCT01580995|755561|P1|NOT COMPLETED|Overall Study||2
315760|NCT01580995|755560|P2|COMPLETED|Overall Study||7
315761|NCT01580995|755561|P1|COMPLETED|Overall Study||8
315762|NCT01580995|755560|P2|STARTED|Overall Study||9
315763|NCT01580995|755561|P1|STARTED|Overall Study||10
315764|NCT01580904|755569|P2|NOT COMPLETED|Overall Study||7
315765|NCT01580904|755570|P1|NOT COMPLETED|Overall Study||4
315766|NCT01580904|755569|P2|COMPLETED|Overall Study||42
315767|NCT01580904|755570|P1|COMPLETED|Overall Study||47
315768|NCT01580904|755569|P2|STARTED|Overall Study||49
315769|NCT01580904|755570|P1|STARTED|Overall Study||51
315770|NCT01580618|755584|P2|NOT COMPLETED|Overall Study||0
315771|NCT01580618|755585|P1|NOT COMPLETED|Overall Study||1
315772|NCT01580618|755584|P2|COMPLETED|Overall Study||12
315773|NCT01580618|755585|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
315774|NCT01580618|755584|P2|STARTED|Overall Study||12
315775|NCT01580618|755585|P1|STARTED|Overall Study||8
315776|NCT01580592|755601|P3|NOT COMPLETED|Overall Study||0
315777|NCT01580592|755602|P2|NOT COMPLETED|Overall Study||0
315778|NCT01580592|755603|P1|NOT COMPLETED|Overall Study||0
315779|NCT01580592|755601|P3|COMPLETED|Overall Study||12
315780|NCT01580592|755602|P2|COMPLETED|Overall Study||9
315781|NCT01580592|755603|P1|COMPLETED|Overall Study||10
315782|NCT01580592|755601|P3|STARTED|Overall Study||12
315783|NCT01580592|755602|P2|STARTED|Overall Study||9
315784|NCT01580592|755603|P1|STARTED|Overall Study||10
315785|NCT01580488|755614|P1|NOT COMPLETED|Overall Study||1
315786|NCT01580488|755614|P1|COMPLETED|Overall Study||23
315787|NCT01580488|755614|P1|STARTED|Overall Study||24
315788|NCT01580423|755658|P2|NOT COMPLETED|Second Intervention||0
315789|NCT01580423|755659|P1|NOT COMPLETED|Second Intervention||0
315790|NCT01580423|755658|P2|COMPLETED|Second Intervention||8
315791|NCT01580423|755659|P1|COMPLETED|Second Intervention||8
315792|NCT01580423|755658|P2|STARTED|Second Intervention||8
315793|NCT01580423|755659|P1|STARTED|Second Intervention||8
315794|NCT01580423|755658|P2|NOT COMPLETED|First Intervention||0
315795|NCT01580423|755659|P1|NOT COMPLETED|First Intervention||0
315796|NCT01580423|755658|P2|COMPLETED|First Intervention||8
315797|NCT01580423|755659|P1|COMPLETED|First Intervention||8
315798|NCT01580423|755658|P2|STARTED|First Intervention||8
315799|NCT01580423|755659|P1|STARTED|First Intervention||8
315800|NCT01580306|755673|P4|NOT COMPLETED|Overall Study||0
315801|NCT01580306|755674|P3|NOT COMPLETED|Overall Study||0
315802|NCT01580306|755675|P2|NOT COMPLETED|Overall Study||0
315803|NCT01580306|755676|P1|NOT COMPLETED|Overall Study||0
315804|NCT01580306|755673|P4|COMPLETED|Overall Study||8
315805|NCT01580306|755674|P3|COMPLETED|Overall Study||8
315806|NCT01580306|755675|P2|COMPLETED|Overall Study||8
315807|NCT01580306|755676|P1|COMPLETED|Overall Study||8
315808|NCT01580306|755673|P4|STARTED|Overall Study||8
315809|NCT01580306|755674|P3|STARTED|Overall Study||8
315810|NCT01580306|755675|P2|STARTED|Overall Study||8
315811|NCT01580306|755676|P1|STARTED|Overall Study||8
315812|NCT01580098|755700|P3|NOT COMPLETED|Overall Study||3
315813|NCT01580098|755701|P2|NOT COMPLETED|Overall Study||13
315814|NCT01580098|755702|P1|NOT COMPLETED|Overall Study||15
315815|NCT01580098|755700|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
315816|NCT01580098|755701|P2|COMPLETED|Overall Study||101
315817|NCT01580098|755702|P1|COMPLETED|Overall Study||61
315818|NCT01580098|755700|P3|STARTED|Overall Study||3
315819|NCT01580098|755701|P2|STARTED|Overall Study||114
315820|NCT01580098|755702|P1|STARTED|Overall Study||76
315821|NCT01580072|755725|P3|NOT COMPLETED|Overall Study||0
315822|NCT01580072|755726|P2|NOT COMPLETED|Overall Study||9
315823|NCT01580072|755727|P1|NOT COMPLETED|Overall Study||12
315824|NCT01580072|755725|P3|COMPLETED|Overall Study||0
315825|NCT01580072|755726|P2|COMPLETED|Overall Study||28
315826|NCT01580072|755727|P1|COMPLETED|Overall Study||16
315827|NCT01580072|755725|P3|STARTED|Overall Study||0
315828|NCT01580072|755726|P2|STARTED|Overall Study||37
315829|NCT01580072|755727|P1|STARTED|Overall Study||28
315830|NCT01580020|755755|P4|NOT COMPLETED|Overall Study||2
315831|NCT01580020|755756|P3|NOT COMPLETED|Overall Study||4
315832|NCT01580020|755757|P2|NOT COMPLETED|Overall Study||7
315833|NCT01580020|755758|P1|NOT COMPLETED|Overall Study||1
315834|NCT01580020|755755|P4|COMPLETED|Overall Study||20
315835|NCT01580020|755756|P3|COMPLETED|Overall Study||57
315836|NCT01580020|755757|P2|COMPLETED|Overall Study||33
315837|NCT01580020|755758|P1|COMPLETED|Overall Study||51
315838|NCT01580020|755755|P4|STARTED|Overall Study||22
315839|NCT01580020|755756|P3|STARTED|Overall Study||61
315840|NCT01580020|755757|P2|STARTED|Overall Study||40
315841|NCT01580020|755758|P1|STARTED|Overall Study||52
315842|NCT01579916|755802|P2|NOT COMPLETED|Overall Study||2
315843|NCT01579916|755803|P1|NOT COMPLETED|Overall Study||8
315844|NCT01579916|755802|P2|COMPLETED|Overall Study||59
315845|NCT01579916|755803|P1|COMPLETED|Overall Study||234
315846|NCT01579916|755802|P2|STARTED|Overall Study||61
315847|NCT01579916|755803|P1|STARTED|Overall Study||242
315848|NCT01579747|755831|P2|NOT COMPLETED|Overall Study||0
315849|NCT01579747|755832|P1|NOT COMPLETED|Overall Study||0
315850|NCT01579747|755831|P2|COMPLETED|Overall Study||12
315851|NCT01579747|755832|P1|COMPLETED|Overall Study||12
315852|NCT01579747|755831|P2|STARTED|Overall Study||12
315853|NCT01579747|755832|P1|STARTED|Overall Study||12
315854|NCT01579669|755842|P2|NOT COMPLETED|Overall Study||0
315855|NCT01579669|755843|P1|NOT COMPLETED|Overall Study||36
315856|NCT01579669|755842|P2|COMPLETED|Overall Study||41
315857|NCT01579669|755843|P1|COMPLETED|Overall Study||134
315858|NCT01579669|755842|P2|STARTED|Overall Study||41
315859|NCT01579669|755843|P1|STARTED|Overall Study||170
315860|NCT01579578|755855|P2|NOT COMPLETED|Overall Study||12
315861|NCT01579578|755856|P1|NOT COMPLETED|Overall Study||13
315862|NCT01579578|755855|P2|COMPLETED|Overall Study||0
315863|NCT01579578|755856|P1|COMPLETED|Overall Study||0
315864|NCT01579578|755855|P2|Ongoing|Overall Study||0
315865|NCT01579578|755856|P1|Ongoing|Overall Study||3
315866|NCT01579578|755855|P2|STARTED|Overall Study||12
315867|NCT01579578|755856|P1|STARTED|Overall Study||13
315868|NCT01579565|755868|P2|NOT COMPLETED|Treated||3
315869|NCT01579565|755869|P1|NOT COMPLETED|Treated||2
315870|NCT01579565|755868|P2|COMPLETED|Treated||201
315871|NCT01579565|755869|P1|COMPLETED|Treated||200
315872|NCT01579565|755868|P2|STARTED|Treated||204
315873|NCT01579565|755869|P1|STARTED|Treated||202
315874|NCT01579565|755868|P2|NOT COMPLETED|Randomized||5
315875|NCT01579565|755869|P1|NOT COMPLETED|Randomized||5
315876|NCT01579565|755868|P2|COMPLETED|Randomized||204
315877|NCT01579565|755869|P1|COMPLETED|Randomized||202
315878|NCT01579565|755868|P2|STARTED|Randomized||209
315879|NCT01579565|755869|P1|STARTED|Randomized||207
315880|NCT01579474|755903|P6|NOT COMPLETED|Overall Study||1
315881|NCT01579474|755904|P5|NOT COMPLETED|Overall Study||1
315882|NCT01579474|755905|P4|NOT COMPLETED|Overall Study||0
315883|NCT01579474|755906|P3|NOT COMPLETED|Overall Study||2
315884|NCT01579474|755907|P2|NOT COMPLETED|Overall Study||13
315885|NCT01579474|755908|P1|NOT COMPLETED|Overall Study||3
315886|NCT01579474|755903|P6|COMPLETED|Overall Study||1
315887|NCT01579474|755904|P5|COMPLETED|Overall Study||9
315888|NCT01579474|755905|P4|COMPLETED|Overall Study||3
315889|NCT01579474|755906|P3|COMPLETED|Overall Study||27
315890|NCT01579474|755907|P2|COMPLETED|Overall Study||30
315891|NCT01579474|755908|P1|COMPLETED|Overall Study||41
315892|NCT01579474|755903|P6|STARTED|Overall Study||2
315893|NCT01579474|755904|P5|STARTED|Overall Study||10
315894|NCT01579474|755905|P4|STARTED|Overall Study||3
315895|NCT01579474|755906|P3|STARTED|Overall Study||29
315896|NCT01579474|755907|P2|STARTED|Overall Study||43
315897|NCT01579474|755908|P1|STARTED|Overall Study||44
315898|NCT01579305|755984|P2|NOT COMPLETED|Overall Study||27
315899|NCT01579305|755985|P1|NOT COMPLETED|Overall Study||21
315900|NCT01579305|755984|P2|COMPLETED|Overall Study||115
315901|NCT01579305|755985|P1|COMPLETED|Overall Study||118
315902|NCT01579305|755984|P2|Continued After Treatment|Overall Study||141
315903|NCT01579305|755985|P1|Continued After Treatment|Overall Study||139
315904|NCT01579305|755984|P2|Discontinued Before Treatment|Overall Study||1
315905|NCT01579305|755985|P1|Discontinued Before Treatment|Overall Study||0
315906|NCT01579305|755984|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
315907|NCT01579305|755985|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
315908|NCT01579084|756001|P10|NOT COMPLETED|Overall Study||0
315909|NCT01579084|756002|P9|NOT COMPLETED|Overall Study||0
315910|NCT01579084|756003|P8|NOT COMPLETED|Overall Study||0
315911|NCT01579084|756004|P7|NOT COMPLETED|Overall Study||0
315912|NCT01579084|756005|P6|NOT COMPLETED|Overall Study||0
315913|NCT01579084|756006|P5|NOT COMPLETED|Overall Study||0
315914|NCT01579084|756007|P4|NOT COMPLETED|Overall Study||0
315915|NCT01579084|756008|P3|NOT COMPLETED|Overall Study||0
315916|NCT01579084|756009|P2|NOT COMPLETED|Overall Study||0
315917|NCT01579084|756010|P1|NOT COMPLETED|Overall Study||0
315918|NCT01579084|756001|P10|COMPLETED|Overall Study||4
315919|NCT01579084|756002|P9|COMPLETED|Overall Study||4
315920|NCT01579084|756003|P8|COMPLETED|Overall Study||4
315921|NCT01579084|756004|P7|COMPLETED|Overall Study||4
315922|NCT01579084|756005|P6|COMPLETED|Overall Study||8
315923|NCT01579084|756006|P5|COMPLETED|Overall Study||8
315924|NCT01579084|756007|P4|COMPLETED|Overall Study||8
315925|NCT01579084|756008|P3|COMPLETED|Overall Study||8
315926|NCT01579084|756009|P2|COMPLETED|Overall Study||8
315927|NCT01579084|756010|P1|COMPLETED|Overall Study||8
315928|NCT01579084|756001|P10|STARTED|Overall Study||4
315929|NCT01579084|756002|P9|STARTED|Overall Study||4
315930|NCT01579084|756003|P8|STARTED|Overall Study||4
315931|NCT01579084|756004|P7|STARTED|Overall Study||4
315932|NCT01579084|756005|P6|STARTED|Overall Study||8
315933|NCT01579084|756006|P5|STARTED|Overall Study||8
315934|NCT01579084|756007|P4|STARTED|Overall Study||8
315935|NCT01579084|756008|P3|STARTED|Overall Study||8
315936|NCT01579084|756009|P2|STARTED|Overall Study||8
315937|NCT01579084|756010|P1|STARTED|Overall Study||8
315938|NCT01579045|756038|P1|NOT COMPLETED|Overall Study||0
315939|NCT01579045|756038|P1|COMPLETED|Overall Study||24
315940|NCT01579045|756038|P1|STARTED|Overall Study||24
315941|NCT01579006|756055|P1|NOT COMPLETED|Overall Study||33
315942|NCT01579006|756055|P1|COMPLETED|Overall Study||151
315943|NCT01579006|756055|P1|STARTED|Overall Study||184
315944|NCT01578993|756094|P1|NOT COMPLETED|Overall Study||0
315945|NCT01578993|756094|P1|COMPLETED|Overall Study||101
315946|NCT01578993|756094|P1|STARTED|Overall Study||101
315947|NCT01578980|756098|P1|NOT COMPLETED|Overall Study||0
315948|NCT01578980|756098|P1|COMPLETED|Overall Study||20
315949|NCT01578980|756098|P1|STARTED|Overall Study||20
315950|NCT01578850|756105|P3|NOT COMPLETED|Period 2||14
315951|NCT01578850|756106|P2|NOT COMPLETED|Period 2||13
315952|NCT01578850|756107|P1|NOT COMPLETED|Period 2||0
315953|NCT01578850|756105|P3|COMPLETED|Period 2||162
315954|NCT01578850|756106|P2|COMPLETED|Period 2||154
315955|NCT01578850|756107|P1|COMPLETED|Period 2||0
315956|NCT01578850|756105|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
315957|NCT01578850|756106|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
315958|NCT01578850|756107|P1|STARTED|Period 2||0
315959|NCT01578850|756105|P3|NOT COMPLETED|Period 1||0
315960|NCT01578850|756106|P2|NOT COMPLETED|Period 1||0
315961|NCT01578850|756107|P1|NOT COMPLETED|Period 1||37
315962|NCT01578850|756105|P3|COMPLETED|Period 1||0
315963|NCT01578850|756106|P2|COMPLETED|Period 1||0
315964|NCT01578850|756107|P1|COMPLETED|Period 1||452
315965|NCT01578850|756105|P3|STARTED|Period 1||0
315966|NCT01578850|756106|P2|STARTED|Period 1||0
315967|NCT01578850|756107|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
315968|NCT01578785|756159|P2|NOT COMPLETED|Overall Study||119
315969|NCT01578785|756160|P1|NOT COMPLETED|Overall Study||59
315970|NCT01578785|756159|P2|COMPLETED|Overall Study||0
315971|NCT01578785|756160|P1|COMPLETED|Overall Study||0
315972|NCT01578785|756159|P2|STARTED|Overall Study||119
315973|NCT01578785|756160|P1|STARTED|Overall Study||59
315974|NCT01578772|756172|P1|NOT COMPLETED|Overall Study||0
315975|NCT01578772|756172|P1|COMPLETED|Overall Study||17
315976|NCT01578772|756172|P1|STARTED|Overall Study||17
315977|NCT01578707|756181|P2|NOT COMPLETED|Overall Study||0
315978|NCT01578707|756182|P1|NOT COMPLETED|Overall Study||0
315979|NCT01578707|756181|P2|COMPLETED|Overall Study||195
315980|NCT01578707|756182|P1|COMPLETED|Overall Study||196
315981|NCT01578707|756181|P2|STARTED|Overall Study||195
315982|NCT01578707|756182|P1|STARTED|Overall Study||196
315983|NCT01578330|756190|P1|NOT COMPLETED|Overall Study||7
315984|NCT01578330|756190|P1|COMPLETED|Overall Study||35
315985|NCT01578330|756190|P1|Per Protocol Population|Overall Study||35
315986|NCT01578330|756190|P1|STARTED|Overall Study||42
315987|NCT01578187|756197|P1|NOT COMPLETED|Usability Phase||1
315988|NCT01578187|756197|P1|COMPLETED|Usability Phase||47
315989|NCT01578187|756197|P1|STARTED|Usability Phase||48
315990|NCT01578187|756197|P1|NOT COMPLETED|Label Comprehension Phase||0
315991|NCT01578187|756197|P1|COMPLETED|Label Comprehension Phase||63
315992|NCT01578187|756197|P1|STARTED|Label Comprehension Phase||63
315993|NCT01578044|756205|P2|NOT COMPLETED|Overall Study||0
315994|NCT01578044|756206|P1|NOT COMPLETED|Overall Study||0
315995|NCT01578044|756205|P2|COMPLETED|Overall Study||6
315996|NCT01578044|756206|P1|COMPLETED|Overall Study||6
315997|NCT01578044|756205|P2|STARTED|Overall Study||6
315998|NCT01578044|756206|P1|STARTED|Overall Study||6
315999|NCT01578031|756216|P4|NOT COMPLETED|Overall Study||0
316000|NCT01578031|756217|P3|NOT COMPLETED|Overall Study||0
316001|NCT01578031|756218|P2|NOT COMPLETED|Overall Study||34
316002|NCT01578031|756219|P1|NOT COMPLETED|Overall Study||62
316003|NCT01578031|756216|P4|COMPLETED|Overall Study|Only baseline data collected|30
316004|NCT01578031|756217|P3|COMPLETED|Overall Study|Only baseline data collected|12
316005|NCT01578031|756218|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
316006|NCT01578031|756219|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
316007|NCT01578031|756216|P4|STARTED|Overall Study||30
316008|NCT01578031|756217|P3|STARTED|Overall Study||12
316009|NCT01578031|756218|P2|STARTED|Overall Study||69
316010|NCT01578031|756219|P1|STARTED|Overall Study||129
316011|NCT01577966|756227|P1|NOT COMPLETED|Overall Study||0
316012|NCT01577966|756227|P1|COMPLETED|Overall Study||9
316013|NCT01577966|756227|P1|STARTED|Overall Study||9
316014|NCT01577758|756231|P8|NOT COMPLETED|mCRC Expansion Phase||25
316015|NCT01577758|756232|P7|NOT COMPLETED|mCRC Expansion Phase||0
316016|NCT01577758|756233|P6|NOT COMPLETED|mCRC Expansion Phase||0
316017|NCT01577758|756234|P5|NOT COMPLETED|mCRC Expansion Phase||0
316018|NCT01577758|756235|P4|NOT COMPLETED|mCRC Expansion Phase||0
316019|NCT01577758|756236|P3|NOT COMPLETED|mCRC Expansion Phase||0
316020|NCT01577758|756237|P2|NOT COMPLETED|mCRC Expansion Phase||0
316021|NCT01577758|756238|P1|NOT COMPLETED|mCRC Expansion Phase||0
316022|NCT01577758|756231|P8|COMPLETED|mCRC Expansion Phase||0
316023|NCT01577758|756232|P7|COMPLETED|mCRC Expansion Phase||0
316024|NCT01577758|756233|P6|COMPLETED|mCRC Expansion Phase||0
316025|NCT01577758|756234|P5|COMPLETED|mCRC Expansion Phase||0
316026|NCT01577758|756235|P4|COMPLETED|mCRC Expansion Phase||0
316027|NCT01577758|756236|P3|COMPLETED|mCRC Expansion Phase||0
316028|NCT01577758|756237|P2|COMPLETED|mCRC Expansion Phase||0
316029|NCT01577758|756238|P1|COMPLETED|mCRC Expansion Phase||0
316030|NCT01577758|756231|P8|STARTED|mCRC Expansion Phase||25
316031|NCT01577758|756232|P7|STARTED|mCRC Expansion Phase||0
316032|NCT01577758|756233|P6|STARTED|mCRC Expansion Phase||0
316033|NCT01577758|756234|P5|STARTED|mCRC Expansion Phase||0
316034|NCT01577758|756235|P4|STARTED|mCRC Expansion Phase||0
316035|NCT01577758|756236|P3|STARTED|mCRC Expansion Phase||0
316036|NCT01577758|756237|P2|STARTED|mCRC Expansion Phase||0
316037|NCT01577758|756238|P1|STARTED|mCRC Expansion Phase||0
316038|NCT01577758|756231|P8|NOT COMPLETED|Dose Escalation Phase||0
316039|NCT01577758|756232|P7|NOT COMPLETED|Dose Escalation Phase||1
316040|NCT01577758|756233|P6|NOT COMPLETED|Dose Escalation Phase||4
316041|NCT01577758|756234|P5|NOT COMPLETED|Dose Escalation Phase||6
316042|NCT01577758|756235|P4|NOT COMPLETED|Dose Escalation Phase||2
316043|NCT01577758|756236|P3|NOT COMPLETED|Dose Escalation Phase||2
316044|NCT01577758|756237|P2|NOT COMPLETED|Dose Escalation Phase||2
316045|NCT01577758|756238|P1|NOT COMPLETED|Dose Escalation Phase||2
316046|NCT01577758|756231|P8|COMPLETED|Dose Escalation Phase||0
316047|NCT01577758|756232|P7|COMPLETED|Dose Escalation Phase||0
316048|NCT01577758|756233|P6|COMPLETED|Dose Escalation Phase||0
316049|NCT01577758|756234|P5|COMPLETED|Dose Escalation Phase||0
316050|NCT01577758|756235|P4|COMPLETED|Dose Escalation Phase||0
316051|NCT01577758|756236|P3|COMPLETED|Dose Escalation Phase||0
316052|NCT01577758|756237|P2|COMPLETED|Dose Escalation Phase||0
316053|NCT01577758|756238|P1|COMPLETED|Dose Escalation Phase||0
316054|NCT01577758|756231|P8|STARTED|Dose Escalation Phase||0
316055|NCT01577758|756232|P7|STARTED|Dose Escalation Phase||1
316056|NCT01577758|756233|P6|STARTED|Dose Escalation Phase||4
316057|NCT01577758|756234|P5|STARTED|Dose Escalation Phase||6
316058|NCT01577758|756235|P4|STARTED|Dose Escalation Phase||2
316059|NCT01577758|756236|P3|STARTED|Dose Escalation Phase||2
316060|NCT01577758|756237|P2|STARTED|Dose Escalation Phase||2
316061|NCT01577758|756238|P1|STARTED|Dose Escalation Phase||2
316062|NCT01577745|756277|P6|NOT COMPLETED|Overall Study||4
316063|NCT01577745|756278|P5|NOT COMPLETED|Overall Study||5
316064|NCT01577745|756279|P4|NOT COMPLETED|Overall Study||6
316065|NCT01577745|756280|P3|NOT COMPLETED|Overall Study||2
316066|NCT01577745|756281|P2|NOT COMPLETED|Overall Study||3
316067|NCT01577745|756282|P1|NOT COMPLETED|Overall Study||3
316068|NCT01577745|756277|P6|COMPLETED|Overall Study||1
316069|NCT01577745|756278|P5|COMPLETED|Overall Study||0
316070|NCT01577745|756279|P4|COMPLETED|Overall Study||0
316071|NCT01577745|756280|P3|COMPLETED|Overall Study||1
316072|NCT01577745|756281|P2|COMPLETED|Overall Study||0
316073|NCT01577745|756282|P1|COMPLETED|Overall Study||0
316074|NCT01577745|756277|P6|STARTED|Overall Study||5
316075|NCT01577745|756278|P5|STARTED|Overall Study||5
316076|NCT01577745|756279|P4|STARTED|Overall Study||6
316077|NCT01577745|756280|P3|STARTED|Overall Study||3
316078|NCT01577745|756281|P2|STARTED|Overall Study||3
316079|NCT01577745|756282|P1|STARTED|Overall Study||3
316080|NCT01577732|756399|P1|NOT COMPLETED|Overall Study||0
316081|NCT01577732|756399|P1|COMPLETED|Overall Study||300
316082|NCT01577732|756399|P1|STARTED|Overall Study||300
316083|NCT01577706|756406|P3|NOT COMPLETED|Third Intervention (1 Day)||0
316084|NCT01577706|756407|P2|NOT COMPLETED|Third Intervention (1 Day)||0
316085|NCT01577706|756408|P1|NOT COMPLETED|Third Intervention (1 Day)||0
316086|NCT01577706|756406|P3|COMPLETED|Third Intervention (1 Day)||3
316087|NCT01577706|756407|P2|COMPLETED|Third Intervention (1 Day)||1
316088|NCT01577706|756408|P1|COMPLETED|Third Intervention (1 Day)||3
316089|NCT01577706|756406|P3|STARTED|Third Intervention (1 Day)||3
316090|NCT01577706|756407|P2|STARTED|Third Intervention (1 Day)||1
316091|NCT01577706|756408|P1|STARTED|Third Intervention (1 Day)||3
316092|NCT01577706|756406|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
316093|NCT01577706|756407|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
316094|NCT01577706|756408|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
316095|NCT01577706|756406|P3|COMPLETED|Washout (at Least 1 Week)||3
316096|NCT01577706|756407|P2|COMPLETED|Washout (at Least 1 Week)||1
316097|NCT01577706|756408|P1|COMPLETED|Washout (at Least 1 Week)||3
316098|NCT01577706|756406|P3|STARTED|Washout (at Least 1 Week)||3
316099|NCT01577706|756407|P2|STARTED|Washout (at Least 1 Week)||1
316100|NCT01577706|756408|P1|STARTED|Washout (at Least 1 Week)||3
316101|NCT01577706|756406|P3|NOT COMPLETED|Second Intervention (1 Day)||0
316102|NCT01577706|756407|P2|NOT COMPLETED|Second Intervention (1 Day)||0
316103|NCT01577706|756408|P1|NOT COMPLETED|Second Intervention (1 Day)||0
316104|NCT01577706|756406|P3|COMPLETED|Second Intervention (1 Day)||3
316105|NCT01577706|756407|P2|COMPLETED|Second Intervention (1 Day)||1
316106|NCT01577706|756408|P1|COMPLETED|Second Intervention (1 Day)||3
316107|NCT01577706|756406|P3|STARTED|Second Intervention (1 Day)||3
316108|NCT01577706|756407|P2|STARTED|Second Intervention (1 Day)||1
316109|NCT01577706|756408|P1|STARTED|Second Intervention (1 Day)||3
316110|NCT01577706|756406|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
316111|NCT01577706|756407|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
316112|NCT01577706|756408|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
316113|NCT01577706|756406|P3|COMPLETED|Washout (at Least 1 Week)||3
316114|NCT01577706|756407|P2|COMPLETED|Washout (at Least 1 Week)||1
316115|NCT01577706|756408|P1|COMPLETED|Washout (at Least 1 Week)||3
316116|NCT01577706|756406|P3|STARTED|Washout (at Least 1 Week)||3
316117|NCT01577706|756407|P2|STARTED|Washout (at Least 1 Week)||1
316118|NCT01577706|756408|P1|STARTED|Washout (at Least 1 Week)||3
316119|NCT01577706|756406|P3|NOT COMPLETED|First Intervention (1 Day)||0
316120|NCT01577706|756407|P2|NOT COMPLETED|First Intervention (1 Day)||0
316121|NCT01577706|756408|P1|NOT COMPLETED|First Intervention (1 Day)||0
316122|NCT01577706|756406|P3|COMPLETED|First Intervention (1 Day)||3
316123|NCT01577706|756407|P2|COMPLETED|First Intervention (1 Day)||1
316124|NCT01577706|756408|P1|COMPLETED|First Intervention (1 Day)||3
316125|NCT01577706|756406|P3|STARTED|First Intervention (1 Day)||3
316126|NCT01577706|756407|P2|STARTED|First Intervention (1 Day)||1
316127|NCT01577706|756408|P1|STARTED|First Intervention (1 Day)||3
316128|NCT01577628|756436|P3|NOT COMPLETED|Overall Study||2
316129|NCT01577628|756437|P2|NOT COMPLETED|Overall Study||0
316130|NCT01577628|756438|P1|NOT COMPLETED|Overall Study||0
316131|NCT01577628|756436|P3|COMPLETED|Overall Study||0
316132|NCT01577628|756437|P2|COMPLETED|Overall Study||0
316133|NCT01577628|756438|P1|COMPLETED|Overall Study||0
316134|NCT01577628|756436|P3|STARTED|Overall Study||2
316135|NCT01577628|756437|P2|STARTED|Overall Study||0
316136|NCT01577628|756438|P1|STARTED|Overall Study||0
316137|NCT01577381|756466|P4|NOT COMPLETED|Overall Study||2
316138|NCT01577381|756467|P3|NOT COMPLETED|Overall Study||3
316139|NCT01577381|756468|P2|NOT COMPLETED|Overall Study||3
316140|NCT01577381|756469|P1|NOT COMPLETED|Overall Study||2
316141|NCT01577381|756466|P4|COMPLETED|Overall Study||0
316142|NCT01577381|756467|P3|COMPLETED|Overall Study||0
316143|NCT01577381|756468|P2|COMPLETED|Overall Study||0
316144|NCT01577381|756469|P1|COMPLETED|Overall Study||0
316145|NCT01577381|756466|P4|STARTED|Overall Study||2
316146|NCT01577381|756467|P3|STARTED|Overall Study||3
316147|NCT01577381|756468|P2|STARTED|Overall Study||3
316148|NCT01577381|756469|P1|STARTED|Overall Study||2
316149|NCT01577186|756598|P1|NOT COMPLETED|Overall Study||130
316150|NCT01577186|756598|P1|COMPLETED|Overall Study||350
316151|NCT01577186|756598|P1|STARTED|Overall Study||480
316152|NCT01577160|756606|P1|NOT COMPLETED|Overall Study||98
316153|NCT01577160|756606|P1|COMPLETED|Overall Study||255
316154|NCT01577160|756606|P1|STARTED|Overall Study||353
316155|NCT01577108|756616|P2|NOT COMPLETED|Overall Study||6
316156|NCT01577108|756617|P1|NOT COMPLETED|Overall Study||5
316157|NCT01577108|756616|P2|COMPLETED|Overall Study||50
316158|NCT01577108|756617|P1|COMPLETED|Overall Study||49
316159|NCT01577108|756616|P2|STARTED|Overall Study||56
316160|NCT01577108|756617|P1|STARTED|Overall Study||54
316161|NCT01576952|756625|P2|NOT COMPLETED|Overall Study||55
316162|NCT01576952|756626|P1|NOT COMPLETED|Overall Study||41
316163|NCT01576952|756625|P2|COMPLETED|Overall Study||33
316164|NCT01576952|756626|P1|COMPLETED|Overall Study||139
316165|NCT01576952|756625|P2|mITT Population|Overall Study||85
316166|NCT01576952|756626|P1|mITT Population|Overall Study||168
316167|NCT01576952|756625|P2|Safety Population|Overall Study||85
316168|NCT01576952|756626|P1|Safety Population|Overall Study||169
316169|NCT01576952|756625|P2|STARTED|Overall Study||88
316170|NCT01576952|756626|P1|STARTED|Overall Study||180
316171|NCT01576939|756632|P1|NOT COMPLETED|Overall Study||0
316172|NCT01576939|756632|P1|COMPLETED|Overall Study||30
316173|NCT01576939|756632|P1|STARTED|Overall Study||30
316174|NCT01576809|756640|P1|NOT COMPLETED|Overall Study||0
316175|NCT01576809|756640|P1|COMPLETED|Overall Study||51
316176|NCT01576809|756640|P1|STARTED|Overall Study||51
316177|NCT01576718|756652|P7|NOT COMPLETED|Treatment Period||30
316178|NCT01576718|756653|P6|NOT COMPLETED|Treatment Period||48
316179|NCT01576718|756654|P5|NOT COMPLETED|Treatment Period||27
316180|NCT01576718|756655|P4|NOT COMPLETED|Treatment Period||31
316181|NCT01576718|756656|P3|NOT COMPLETED|Treatment Period||20
316182|NCT01576718|756657|P2|NOT COMPLETED|Treatment Period||25
316183|NCT01576718|756658|P1|NOT COMPLETED|Treatment Period||0
316184|NCT01576718|756652|P7|COMPLETED|Treatment Period||77
316185|NCT01576718|756653|P6|COMPLETED|Treatment Period||58
316186|NCT01576718|756654|P5|COMPLETED|Treatment Period||80
316187|NCT01576718|756655|P4|COMPLETED|Treatment Period||75
316188|NCT01576718|756656|P3|COMPLETED|Treatment Period||87
316189|NCT01576718|756657|P2|COMPLETED|Treatment Period||82
316190|NCT01576718|756658|P1|COMPLETED|Treatment Period||0
316191|NCT01576718|756652|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
316192|NCT01576718|756653|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
316193|NCT01576718|756654|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
316194|NCT01576718|756655|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
316195|NCT01576718|756656|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
316196|NCT01576718|756657|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
316197|NCT01576718|756658|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
316198|NCT01576718|756652|P7|Safety Population|Treatment Period||106
316199|NCT01576718|756653|P6|Safety Population|Treatment Period||106
316200|NCT01576718|756654|P5|Safety Population|Treatment Period||107
316201|NCT01576718|756655|P4|Safety Population|Treatment Period||106
316202|NCT01576718|756656|P3|Safety Population|Treatment Period||107
316203|NCT01576718|756657|P2|Safety Population|Treatment Period||107
316204|NCT01576718|756658|P1|Safety Population|Treatment Period||0
316205|NCT01576718|756652|P7|STARTED|Treatment Period||107
316206|NCT01576718|756653|P6|STARTED|Treatment Period||106
316207|NCT01576718|756654|P5|STARTED|Treatment Period||107
316208|NCT01576718|756655|P4|STARTED|Treatment Period||106
316209|NCT01576718|756656|P3|STARTED|Treatment Period||107
316210|NCT01576718|756657|P2|STARTED|Treatment Period||107
316211|NCT01576718|756658|P1|STARTED|Treatment Period||0
316212|NCT01576718|756652|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316213|NCT01576718|756653|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316214|NCT01576718|756654|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316215|NCT01576718|756655|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316216|NCT01576718|756656|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316217|NCT01576718|756657|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316218|NCT01576718|756658|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
316219|NCT01576718|756652|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316220|NCT01576718|756653|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316221|NCT01576718|756654|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316222|NCT01576718|756655|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316223|NCT01576718|756656|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316224|NCT01576718|756657|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
316225|NCT01576718|756658|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
316226|NCT01576718|756652|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
316227|NCT01576718|756653|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
316228|NCT01576718|756654|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
316229|NCT01576718|756655|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
316230|NCT01576718|756656|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
316231|NCT01576718|756657|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
316232|NCT01576718|756658|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
316233|NCT01576367|756750|P1|NOT COMPLETED|Overall Study||3
316234|NCT01576367|756750|P1|COMPLETED|Overall Study||14
316235|NCT01576367|756750|P1|STARTED|Overall Study||17
316236|NCT01576159|756762|P4|NOT COMPLETED|Overall Study||1
316237|NCT01576159|756763|P3|NOT COMPLETED|Overall Study||1
316238|NCT01576159|756764|P2|NOT COMPLETED|Overall Study||1
316239|NCT01576159|756765|P1|NOT COMPLETED|Overall Study||1
316240|NCT01576159|756762|P4|COMPLETED|Overall Study||11
316241|NCT01576159|756763|P3|COMPLETED|Overall Study||11
316242|NCT01576159|756764|P2|COMPLETED|Overall Study||11
316243|NCT01576159|756765|P1|COMPLETED|Overall Study||11
316244|NCT01576159|756762|P4|STARTED|Overall Study||12
316245|NCT01576159|756763|P3|STARTED|Overall Study||12
316246|NCT01576159|756764|P2|STARTED|Overall Study||12
316247|NCT01576159|756765|P1|STARTED|Overall Study||12
316248|NCT01576146|756783|P1|NOT COMPLETED|Extension Period 2||17
316249|NCT01576146|756783|P1|COMPLETED|Extension Period 2||0
316250|NCT01576146|756783|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
316251|NCT01576146|756783|P1|NOT COMPLETED|Extension Period 1||10
316252|NCT01576146|756783|P1|COMPLETED|Extension Period 1||20
316253|NCT01576146|756783|P1|STARTED|Extension Period 1||30
316254|NCT01576120|756792|P2|NOT COMPLETED|Overall Study||0
316255|NCT01576120|756793|P1|NOT COMPLETED|Overall Study||0
316256|NCT01576120|756792|P2|COMPLETED|Overall Study||19
316257|NCT01576120|756793|P1|COMPLETED|Overall Study||21
316258|NCT01576120|756792|P2|STARTED|Overall Study||19
316259|NCT01576120|756793|P1|STARTED|Overall Study||21
316260|NCT01576055|756801|P2|NOT COMPLETED|Overall Study||6
316261|NCT01576055|756802|P1|NOT COMPLETED|Overall Study||19
316262|NCT01576055|756801|P2|COMPLETED|Overall Study||64
316263|NCT01576055|756802|P1|COMPLETED|Overall Study||178
316264|NCT01576055|756801|P2|STARTED|Overall Study||70
316265|NCT01576055|756802|P1|STARTED|Overall Study||197
316266|NCT01576042|756816|P2|NOT COMPLETED|Overall Study||0
316267|NCT01576042|756817|P1|NOT COMPLETED|Overall Study||2
316268|NCT01576042|756816|P2|COMPLETED|Overall Study||14
316269|NCT01576042|756817|P1|COMPLETED|Overall Study||11
316270|NCT01576042|756816|P2|Switched to the Other Arm|Overall Study||1
316271|NCT01576042|756817|P1|Switched to the Other Arm|Overall Study||5
316272|NCT01576042|756816|P2|STARTED|Overall Study||14
316273|NCT01576042|756817|P1|STARTED|Overall Study||13
316274|NCT01575912|756840|P3|NOT COMPLETED|Overall Study||0
316275|NCT01575912|756841|P2|NOT COMPLETED|Overall Study||0
316276|NCT01575912|756842|P1|NOT COMPLETED|Overall Study||0
316277|NCT01575912|756840|P3|COMPLETED|Overall Study||30
316278|NCT01575912|756841|P2|COMPLETED|Overall Study||32
316279|NCT01575912|756842|P1|COMPLETED|Overall Study||30
316280|NCT01575912|756840|P3|STARTED|Overall Study||30
316281|NCT01575912|756841|P2|STARTED|Overall Study||32
316282|NCT01575912|756842|P1|STARTED|Overall Study||30
316283|NCT01575899|756853|P3|NOT COMPLETED|Overall Study||2
316284|NCT01575899|756854|P2|NOT COMPLETED|Overall Study||5
316285|NCT01575899|756855|P1|NOT COMPLETED|Overall Study||5
316286|NCT01575899|756853|P3|COMPLETED|Overall Study||60
316287|NCT01575899|756854|P2|COMPLETED|Overall Study||68
316288|NCT01575899|756855|P1|COMPLETED|Overall Study||68
316289|NCT01575899|756853|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
316290|NCT01575899|756854|P2|STARTED|Overall Study||73
316291|NCT01575899|756855|P1|STARTED|Overall Study||73
316292|NCT01575769|756865|P1|NOT COMPLETED|Overall Study||41
316293|NCT01575769|756865|P1|COMPLETED|Overall Study||0
316294|NCT01575769|756865|P1|STARTED|Overall Study||41
316295|NCT01575756|756891|P2|NOT COMPLETED|Treatment Period 2||0
316296|NCT01575756|756892|P1|NOT COMPLETED|Treatment Period 2||0
316297|NCT01575756|756891|P2|COMPLETED|Treatment Period 2||11
316298|NCT01575756|756892|P1|COMPLETED|Treatment Period 2||11
316299|NCT01575756|756891|P2|STARTED|Treatment Period 2||11
316300|NCT01575756|756892|P1|STARTED|Treatment Period 2||11
316301|NCT01575756|756891|P2|NOT COMPLETED|Treatment Period 1||0
316302|NCT01575756|756892|P1|NOT COMPLETED|Treatment Period 1||0
316303|NCT01575756|756891|P2|COMPLETED|Treatment Period 1||11
316304|NCT01575756|756892|P1|COMPLETED|Treatment Period 1||11
316305|NCT01575756|756891|P2|STARTED|Treatment Period 1||11
316306|NCT01575756|756892|P1|STARTED|Treatment Period 1||11
316307|NCT01575561|756908|P1|NOT COMPLETED|Overall Study||39
316308|NCT01575561|756908|P1|COMPLETED|Overall Study||338
316309|NCT01575561|756908|P1|STARTED|Overall Study||377
316310|NCT01575522|756920|P1|NOT COMPLETED|Overall Study||0
316311|NCT01575522|756920|P1|COMPLETED|Overall Study||22
316312|NCT01575522|756920|P1|STARTED|Overall Study||22
316313|NCT01575197|756931|P3|NOT COMPLETED|Overall Study||6
316314|NCT01575197|756932|P2|NOT COMPLETED|Overall Study||9
316315|NCT01575197|756933|P1|NOT COMPLETED|Overall Study||3
316316|NCT01575197|756931|P3|COMPLETED|Overall Study||146
316317|NCT01575197|756932|P2|COMPLETED|Overall Study||143
316318|NCT01575197|756933|P1|COMPLETED|Overall Study||149
316319|NCT01575197|756931|P3|STARTED|Overall Study||152
316320|NCT01575197|756932|P2|STARTED|Overall Study||152
316321|NCT01575197|756933|P1|STARTED|Overall Study||152
316322|NCT01575080|756946|P1|NOT COMPLETED|Overall Study||0
316323|NCT01575080|756946|P1|COMPLETED|Overall Study||102
316324|NCT01575080|756946|P1|STARTED|Overall Study||102
316325|NCT01575054|756955|P2|NOT COMPLETED|Overall Study||26
316326|NCT01575054|756956|P1|NOT COMPLETED|Overall Study||29
316327|NCT01575054|756955|P2|COMPLETED|Overall Study||209
316328|NCT01575054|756956|P1|COMPLETED|Overall Study||204
316329|NCT01575054|756955|P2|STARTED|Overall Study||235
316330|NCT01575054|756956|P1|STARTED|Overall Study||233
316331|NCT01575028|756972|P2|NOT COMPLETED|Overall Study||1
316332|NCT01575028|756973|P1|NOT COMPLETED|Overall Study||0
316333|NCT01575028|756972|P2|COMPLETED|Overall Study||0
316334|NCT01575028|756973|P1|COMPLETED|Overall Study||2
316335|NCT01575028|756972|P2|STARTED|Overall Study||1
316336|NCT01575028|756973|P1|STARTED|Overall Study||2
316337|NCT01574703|756983|P4|NOT COMPLETED|Overall Study||114
316338|NCT01574703|756984|P3|NOT COMPLETED|Overall Study||105
316339|NCT01574703|756985|P2|NOT COMPLETED|Overall Study||112
316340|NCT01574703|756986|P1|NOT COMPLETED|Overall Study||125
316341|NCT01574703|756983|P4|COMPLETED|Overall Study||1007
316342|NCT01574703|756984|P3|COMPLETED|Overall Study||1011
316343|NCT01574703|756985|P2|COMPLETED|Overall Study||1054
316344|NCT01574703|756986|P1|COMPLETED|Overall Study||1067
316345|NCT01574703|756983|P4|STARTED|Overall Study||1121
316346|NCT01574703|756984|P3|STARTED|Overall Study||1116
316347|NCT01574703|756985|P2|STARTED|Overall Study||1166
316348|NCT01574703|756986|P1|STARTED|Overall Study||1192
316349|NCT01574651|757030|P2|NOT COMPLETED|Overall Study||52
316350|NCT01574651|757031|P1|NOT COMPLETED|Overall Study||61
316351|NCT01574651|757030|P2|COMPLETED|Overall Study||406
316352|NCT01574651|757031|P1|COMPLETED|Overall Study||415
316353|NCT01574651|757030|P2|Per Protocol Set (PPS)|Overall Study||374
316354|NCT01574651|757031|P1|Per Protocol Set (PPS)|Overall Study||373
316355|NCT01574651|757030|P2|Full Analysis Set (FAS)|Overall Study||458
316356|NCT01574651|757031|P1|Full Analysis Set (FAS)|Overall Study||476
316357|NCT01574651|757030|P2|STARTED|Overall Study||458
316358|NCT01574651|757031|P1|STARTED|Overall Study||476
316359|NCT01574612|757053|P1|NOT COMPLETED|Overall Study||8
316360|NCT01574612|757053|P1|COMPLETED|Overall Study||46
316361|NCT01574612|757053|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
316362|NCT01574326|757059|P2|NOT COMPLETED|Overall Study||19
316363|NCT01574326|757060|P1|NOT COMPLETED|Overall Study||16
316364|NCT01574326|757059|P2|COMPLETED|Overall Study||31
316365|NCT01574326|757060|P1|COMPLETED|Overall Study||35
316366|NCT01574326|757059|P2|Treated|Overall Study||49
316367|NCT01574326|757060|P1|Treated|Overall Study||51
316368|NCT01574326|757059|P2|STARTED|Overall Study||50
316369|NCT01574326|757060|P1|STARTED|Overall Study||51
316370|NCT01574248|757073|P2|NOT COMPLETED|Overall Study||0
316371|NCT01574248|757074|P1|NOT COMPLETED|Overall Study||3
316372|NCT01574248|757073|P2|COMPLETED|Overall Study||18
316373|NCT01574248|757074|P1|COMPLETED|Overall Study||12
316374|NCT01574248|757073|P2|STARTED|Overall Study||18
316375|NCT01574248|757074|P1|STARTED|Overall Study||15
316376|NCT01574183|757094|P2|NOT COMPLETED|Overall Study||18
316377|NCT01574183|757095|P1|NOT COMPLETED|Overall Study||27
316378|NCT01574183|757094|P2|COMPLETED|Overall Study||17
316379|NCT01574183|757095|P1|COMPLETED|Overall Study||14
316380|NCT01574183|757094|P2|STARTED|Overall Study||35
316381|NCT01574183|757095|P1|STARTED|Overall Study||41
316382|NCT01574105|757107|P2|NOT COMPLETED|Overall Study||0
316383|NCT01574105|757108|P1|NOT COMPLETED|Overall Study||0
316384|NCT01574105|757107|P2|COMPLETED|Overall Study||37
316385|NCT01574105|757108|P1|COMPLETED|Overall Study||29
316386|NCT01574105|757107|P2|STARTED|Overall Study||37
316387|NCT01574105|757108|P1|STARTED|Overall Study||29
316388|NCT01574079|757118|P2|NOT COMPLETED|Overall Study||2
316389|NCT01574079|757119|P1|NOT COMPLETED|Overall Study||1
316390|NCT01574079|757118|P2|COMPLETED|Overall Study||13
316391|NCT01574079|757119|P1|COMPLETED|Overall Study||17
316392|NCT01574079|757118|P2|STARTED|Overall Study||15
316393|NCT01574079|757119|P1|STARTED|Overall Study||18
316394|NCT01573910|757131|P2|NOT COMPLETED|Overall Study||17
316395|NCT01573910|757132|P1|NOT COMPLETED|Overall Study||20
316396|NCT01573910|757131|P2|COMPLETED|Overall Study||476
316397|NCT01573910|757132|P1|COMPLETED|Overall Study||469
316398|NCT01573910|757131|P2|STARTED|Overall Study||493
316399|NCT01573910|757132|P1|STARTED|Overall Study||489
316400|NCT01573767|757144|P4|NOT COMPLETED|Overall Study||24
316401|NCT01573767|757145|P3|NOT COMPLETED|Overall Study||14
316402|NCT01573767|757146|P2|NOT COMPLETED|Overall Study||21
316403|NCT01573767|757147|P1|NOT COMPLETED|Overall Study||22
316404|NCT01573767|757144|P4|COMPLETED|Overall Study||90
316405|NCT01573767|757145|P3|COMPLETED|Overall Study||99
316406|NCT01573767|757146|P2|COMPLETED|Overall Study||93
316407|NCT01573767|757147|P1|COMPLETED|Overall Study||93
316408|NCT01573767|757144|P4|STARTED|Overall Study||114
316409|NCT01573767|757145|P3|STARTED|Overall Study||113
316410|NCT01573767|757146|P2|STARTED|Overall Study||114
316411|NCT01573767|757147|P1|STARTED|Overall Study||115
316412|NCT01573325|757181|P1|NOT COMPLETED|Overall Study||0
316413|NCT01573325|757181|P1|COMPLETED|Overall Study||50
316414|NCT01573325|757181|P1|STARTED|Overall Study||50
316415|NCT01573260|757188|P2|NOT COMPLETED|Overall Study||0
316416|NCT01573260|757189|P1|NOT COMPLETED|Overall Study||0
316417|NCT01573260|757188|P2|COMPLETED|Overall Study||15
316418|NCT01573260|757189|P1|COMPLETED|Overall Study||18
316419|NCT01573260|757188|P2|STARTED|Overall Study||15
316420|NCT01573260|757189|P1|STARTED|Overall Study||18
316421|NCT01573000|757223|P2|NOT COMPLETED|Long-Term Follow-Up||1
316422|NCT01573000|757224|P1|NOT COMPLETED|Long-Term Follow-Up||3
316423|NCT01573000|757223|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
316424|NCT01573000|757224|P1|COMPLETED|Long-Term Follow-Up||11
316425|NCT01573000|757223|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
316426|NCT01573000|757224|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
316427|NCT01573000|757223|P2|NOT COMPLETED|Crossover Phase||18
316428|NCT01573000|757224|P1|NOT COMPLETED|Crossover Phase||0
316429|NCT01573000|757223|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
316430|NCT01573000|757224|P1|COMPLETED|Crossover Phase||0
316431|NCT01573000|757223|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
316432|NCT01573000|757224|P1|STARTED|Crossover Phase||0
316433|NCT01573000|757223|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
316434|NCT01573000|757224|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
316435|NCT01573000|757223|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
316436|NCT01573000|757224|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
316437|NCT01573000|757223|P2|STARTED|Dosimetric and Therapeutic Treatment||36
316438|NCT01573000|757224|P1|STARTED|Dosimetric and Therapeutic Treatment||42
316439|NCT01572948|757320|P2|NOT COMPLETED|Overall Study||1
316440|NCT01572948|757321|P1|NOT COMPLETED|Overall Study||1
316441|NCT01572948|757320|P2|COMPLETED|Overall Study||15
316442|NCT01572948|757321|P1|COMPLETED|Overall Study||10
316443|NCT01572948|757320|P2|STARTED|Overall Study||16
316444|NCT01572948|757321|P1|STARTED|Overall Study||11
316445|NCT01572792|757342|P5|NOT COMPLETED|Extension Study||32
316446|NCT01572792|757343|P4|NOT COMPLETED|Extension Study||29
316447|NCT01572792|757344|P3|NOT COMPLETED|Extension Study||26
316448|NCT01572792|757345|P2|NOT COMPLETED|Extension Study||29
316449|NCT01572792|757346|P1|NOT COMPLETED|Extension Study||25
316450|NCT01572792|757342|P5|COMPLETED|Extension Study||160
316451|NCT01572792|757343|P4|COMPLETED|Extension Study||165
316452|NCT01572792|757344|P3|COMPLETED|Extension Study||179
316453|NCT01572792|757345|P2|COMPLETED|Extension Study||155
316454|NCT01572792|757346|P1|COMPLETED|Extension Study||121
316455|NCT01572792|757342|P5|STARTED|Extension Study||192
316456|NCT01572792|757343|P4|STARTED|Extension Study||194
316457|NCT01572792|757344|P3|STARTED|Extension Study||205
316458|NCT01572792|757345|P2|STARTED|Extension Study||184
316459|NCT01572792|757346|P1|STARTED|Extension Study||146
316460|NCT01572792|757342|P5|NOT COMPLETED|Lead-in Study||69
316461|NCT01572792|757343|P4|NOT COMPLETED|Lead-in Study||72
316462|NCT01572792|757344|P3|NOT COMPLETED|Lead-in Study||62
316463|NCT01572792|757345|P2|NOT COMPLETED|Lead-in Study||66
316464|NCT01572792|757346|P1|NOT COMPLETED|Lead-in Study||101
316465|NCT01572792|757342|P5|COMPLETED|Lead-in Study||270
316466|NCT01572792|757343|P4|COMPLETED|Lead-in Study||268
316467|NCT01572792|757344|P3|COMPLETED|Lead-in Study||276
316468|NCT01572792|757345|P2|COMPLETED|Lead-in Study||272
316469|NCT01572792|757346|P1|COMPLETED|Lead-in Study||236
316470|NCT01572792|757342|P5|STARTED|Lead-in Study||339
316471|NCT01572792|757343|P4|STARTED|Lead-in Study||340
316472|NCT01572792|757344|P3|STARTED|Lead-in Study||338
316473|NCT01572792|757345|P2|STARTED|Lead-in Study||338
316474|NCT01572792|757346|P1|STARTED|Lead-in Study||337
316475|NCT01572740|757395|P2|NOT COMPLETED|Overall Study||5
316476|NCT01572740|757396|P1|NOT COMPLETED|Overall Study||6
316477|NCT01572740|757395|P2|COMPLETED|Overall Study||125
316478|NCT01572740|757396|P1|COMPLETED|Overall Study||121
316479|NCT01572740|757395|P2|STARTED|Overall Study||130
316480|NCT01572740|757396|P1|STARTED|Overall Study||127
316481|NCT01572727|757426|P2|NOT COMPLETED|Overall Study||209
316482|NCT01572727|757427|P1|NOT COMPLETED|Overall Study||207
316483|NCT01572727|757426|P2|COMPLETED|Overall Study||0
316484|NCT01572727|757427|P1|COMPLETED|Overall Study||0
316485|NCT01572727|757426|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
316486|NCT01572727|757427|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
316487|NCT01572727|757426|P2|STARTED|Overall Study||209
316488|NCT01572727|757427|P1|STARTED|Overall Study||207
316489|NCT01572675|757449|P2|NOT COMPLETED|Overall Study||223
316490|NCT01572675|757450|P1|NOT COMPLETED|Overall Study||237
316491|NCT01572675|757449|P2|COMPLETED|Overall Study||56
316492|NCT01572675|757450|P1|COMPLETED|Overall Study||31
316493|NCT01572675|757449|P2|STARTED|Overall Study||279
316494|NCT01572675|757450|P1|STARTED|Overall Study||268
316495|NCT01572480|757547|P1|NOT COMPLETED|Overall Study||1
316496|NCT01572480|757547|P1|COMPLETED|Overall Study||17
316497|NCT01572480|757547|P1|STARTED|Overall Study||18
316498|NCT01572298|757558|P2|NOT COMPLETED|Overall Study||1
316499|NCT01572298|757559|P1|NOT COMPLETED|Overall Study||2
316500|NCT01572298|757558|P2|COMPLETED|Overall Study||12
316501|NCT01572298|757559|P1|COMPLETED|Overall Study||12
316502|NCT01572298|757558|P2|STARTED|Overall Study||13
316503|NCT01572298|757559|P1|STARTED|Overall Study||14
316504|NCT01572207|757567|P2|NOT COMPLETED|Overall Study||3
316505|NCT01572207|757568|P1|NOT COMPLETED|Overall Study||2
316506|NCT01572207|757567|P2|COMPLETED|Overall Study||13
316507|NCT01572207|757568|P1|COMPLETED|Overall Study||12
316508|NCT01572207|757567|P2|STARTED|Overall Study||16
316509|NCT01572207|757568|P1|STARTED|Overall Study||14
316510|NCT01571557|757578|P1|NOT COMPLETED|Overall Study||0
316511|NCT01571557|757578|P1|COMPLETED|Overall Study||573
316512|NCT01571557|757578|P1|STARTED|Overall Study||573
316513|NCT01571453|757587|P2|NOT COMPLETED|Overall Study||62
316514|NCT01571453|757588|P1|NOT COMPLETED|Overall Study||38
316515|NCT01571453|757587|P2|COMPLETED|Overall Study||164
316516|NCT01571453|757588|P1|COMPLETED|Overall Study||173
316517|NCT01571453|757587|P2|STARTED|Overall Study||226
316518|NCT01571453|757588|P1|STARTED|Overall Study||211
316519|NCT01571362|757604|P3|NOT COMPLETED|Double-Blind Treatment Period||39
316520|NCT01571362|757605|P2|NOT COMPLETED|Double-Blind Treatment Period||53
316521|NCT01571362|757606|P1|NOT COMPLETED|Double-Blind Treatment Period||0
316522|NCT01571362|757604|P3|COMPLETED|Double-Blind Treatment Period||107
316523|NCT01571362|757605|P2|COMPLETED|Double-Blind Treatment Period||81
316524|NCT01571362|757606|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
316525|NCT01571362|757604|P3|STARTED|Double-Blind Treatment Period||146
316526|NCT01571362|757605|P2|STARTED|Double-Blind Treatment Period||134
316527|NCT01571362|757606|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
316528|NCT01571362|757604|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
316529|NCT01571362|757605|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
316530|NCT01571362|757606|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
316531|NCT01571362|757604|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
316532|NCT01571362|757605|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
316797|NCT01568073|758514|P3|NOT COMPLETED|Overall Study||12
316533|NCT01571362|757606|P1|COMPLETED|Open-Label Conversion + Titration Period||281
316534|NCT01571362|757604|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
316535|NCT01571362|757605|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
316536|NCT01571362|757606|P1|STARTED|Open-Label Conversion + Titration Period||410
316537|NCT01571232|757778|P2|NOT COMPLETED|Overall Study||1
316538|NCT01571232|757779|P1|NOT COMPLETED|Overall Study||1
316539|NCT01571232|757778|P2|COMPLETED|Overall Study||9
316540|NCT01571232|757779|P1|COMPLETED|Overall Study||9
316541|NCT01571232|757778|P2|STARTED|Overall Study||10
316542|NCT01571232|757779|P1|STARTED|Overall Study||10
316543|NCT01570751|757791|P2|NOT COMPLETED|Period B (16 Weeks)||1
316544|NCT01570751|757792|P1|NOT COMPLETED|Period B (16 Weeks)||1
316545|NCT01570751|757791|P2|COMPLETED|Period B (16 Weeks)||66
316546|NCT01570751|757792|P1|COMPLETED|Period B (16 Weeks)||69
316547|NCT01570751|757791|P2|Exposed|Period B (16 Weeks)||67
316548|NCT01570751|757792|P1|Exposed|Period B (16 Weeks)||70
316549|NCT01570751|757791|P2|STARTED|Period B (16 Weeks)||67
316550|NCT01570751|757792|P1|STARTED|Period B (16 Weeks)||70
316551|NCT01570751|757791|P2|NOT COMPLETED|Period A (16 Weeks)||5
316552|NCT01570751|757792|P1|NOT COMPLETED|Period A (16 Weeks)||3
316553|NCT01570751|757791|P2|COMPLETED|Period A (16 Weeks)||67
316554|NCT01570751|757792|P1|COMPLETED|Period A (16 Weeks)||70
316555|NCT01570751|757791|P2|Exposed|Period A (16 Weeks)||72
316556|NCT01570751|757792|P1|Exposed|Period A (16 Weeks)||73
316557|NCT01570751|757791|P2|STARTED|Period A (16 Weeks)||72
316558|NCT01570751|757792|P1|STARTED|Period A (16 Weeks)||73
316559|NCT01570686|757810|P2|NOT COMPLETED|Overall Study||16
316560|NCT01570686|757811|P1|NOT COMPLETED|Overall Study||22
316561|NCT01570686|757810|P2|COMPLETED|Overall Study||278
316562|NCT01570686|757811|P1|COMPLETED|Overall Study||274
316563|NCT01570686|757810|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
316564|NCT01570686|757811|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
316565|NCT01570686|757810|P2|STARTED|Overall Study||294
316566|NCT01570686|757811|P1|STARTED|Overall Study||296
316567|NCT01570634|757837|P1|NOT COMPLETED|Overall Study||0
316568|NCT01570634|757837|P1|COMPLETED|Overall Study||2
316569|NCT01570634|757837|P1|STARTED|Overall Study||2
316570|NCT01570309|757847|P2|NOT COMPLETED|Overall Study||3
316571|NCT01570309|757848|P1|NOT COMPLETED|Overall Study||3
316572|NCT01570309|757847|P2|COMPLETED|Overall Study||45
316573|NCT01570309|757848|P1|COMPLETED|Overall Study||45
316574|NCT01570309|757847|P2|STARTED|Overall Study||48
316575|NCT01570309|757848|P1|STARTED|Overall Study||48
316576|NCT01570244|757862|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
316577|NCT01570244|757862|P1|COMPLETED|Microgynon+Faldaprevir||15
316578|NCT01570244|757862|P1|STARTED|Microgynon+Faldaprevir||16
316579|NCT01570244|757862|P1|NOT COMPLETED|Microgynon||0
316580|NCT01570244|757862|P1|COMPLETED|Microgynon||16
316581|NCT01570244|757862|P1|STARTED|Microgynon||16
316582|NCT01570192|757884|P2|NOT COMPLETED|Overall Study||13
316583|NCT01570192|757885|P1|NOT COMPLETED|Overall Study||7
316584|NCT01570192|757884|P2|COMPLETED|Overall Study||17
316585|NCT01570192|757885|P1|COMPLETED|Overall Study||6
316586|NCT01570192|757884|P2|STARTED|Overall Study||30
316587|NCT01570192|757885|P1|STARTED|Overall Study||13
316588|NCT01569841|757891|P2|NOT COMPLETED|Period B (6 Weeks)||0
316589|NCT01569841|757892|P1|NOT COMPLETED|Period B (6 Weeks)||0
316590|NCT01569841|757891|P2|COMPLETED|Period B (6 Weeks)||11
316591|NCT01569841|757892|P1|COMPLETED|Period B (6 Weeks)||12
316592|NCT01569841|757891|P2|Exposed|Period B (6 Weeks)||11
316593|NCT01569841|757892|P1|Exposed|Period B (6 Weeks)||12
316594|NCT01569841|757891|P2|STARTED|Period B (6 Weeks)||11
316595|NCT01569841|757892|P1|STARTED|Period B (6 Weeks)||12
316596|NCT01569841|757891|P2|NOT COMPLETED|Period A (6 Weeks)||1
316597|NCT01569841|757892|P1|NOT COMPLETED|Period A (6 Weeks)||0
316598|NCT01569841|757891|P2|COMPLETED|Period A (6 Weeks)||11
316599|NCT01569841|757892|P1|COMPLETED|Period A (6 Weeks)||12
316600|NCT01569841|757891|P2|Exposed|Period A (6 Weeks)||12
316601|NCT01569841|757892|P1|Exposed|Period A (6 Weeks)||12
316602|NCT01569841|757891|P2|STARTED|Period A (6 Weeks)||12
316603|NCT01569841|757892|P1|STARTED|Period A (6 Weeks)||12
316604|NCT01569828|757910|P2|NOT COMPLETED|Overall Study||0
316605|NCT01569828|757911|P1|NOT COMPLETED|Overall Study||0
316606|NCT01569828|757910|P2|COMPLETED|Overall Study||6
316607|NCT01569828|757911|P1|COMPLETED|Overall Study||6
316608|NCT01569828|757910|P2|STARTED|Overall Study||6
316609|NCT01569828|757911|P1|STARTED|Overall Study||6
316610|NCT01569815|757933|P4|NOT COMPLETED|Overall Study||0
316611|NCT01569815|757934|P3|NOT COMPLETED|Overall Study||0
316612|NCT01569815|757935|P2|NOT COMPLETED|Overall Study||0
316613|NCT01569815|757936|P1|NOT COMPLETED|Overall Study||0
316614|NCT01569815|757933|P4|COMPLETED|Overall Study||8
316615|NCT01569815|757934|P3|COMPLETED|Overall Study||8
316616|NCT01569815|757935|P2|COMPLETED|Overall Study||8
316617|NCT01569815|757936|P1|COMPLETED|Overall Study||8
316618|NCT01569815|757933|P4|STARTED|Overall Study||8
316619|NCT01569815|757934|P3|STARTED|Overall Study||8
316620|NCT01569815|757935|P2|STARTED|Overall Study||8
316621|NCT01569815|757936|P1|STARTED|Overall Study||8
316622|NCT01569763|757981|P2|NOT COMPLETED|Overall Study||7
316623|NCT01569763|757982|P1|NOT COMPLETED|Overall Study||3
316624|NCT01569763|757981|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
316625|NCT01569763|757982|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
316626|NCT01569763|757981|P2|Treated|Overall Study||51
316627|NCT01569763|757982|P1|Treated|Overall Study||102
316628|NCT01569763|757981|P2|STARTED|Overall Study||51
316629|NCT01569763|757982|P1|STARTED|Overall Study||102
316630|NCT01569568|757994|P2|NOT COMPLETED|Overall Study||2
316631|NCT01569568|757995|P1|NOT COMPLETED|Overall Study||0
316632|NCT01569568|757994|P2|COMPLETED|Overall Study||27
316633|NCT01569568|757995|P1|COMPLETED|Overall Study||20
316634|NCT01569568|757994|P2|STARTED|Overall Study||29
316635|NCT01569568|757995|P1|STARTED|Overall Study||20
316636|NCT01569529|758009|P2|NOT COMPLETED|Overall Study||0
316637|NCT01569529|758010|P1|NOT COMPLETED|Overall Study||0
316638|NCT01569529|758009|P2|COMPLETED|Overall Study||394
316639|NCT01569529|758010|P1|COMPLETED|Overall Study||2676
316640|NCT01569529|758009|P2|STARTED|Overall Study||394
316641|NCT01569529|758010|P1|STARTED|Overall Study||2676
316642|NCT01569464|758018|P2|NOT COMPLETED|Overall Study||5
316643|NCT01569464|758019|P1|NOT COMPLETED|Overall Study||10
316644|NCT01569464|758018|P2|COMPLETED|Overall Study||44
316645|NCT01569464|758019|P1|COMPLETED|Overall Study||91
316646|NCT01569464|758018|P2|STARTED|Overall Study||49
316647|NCT01569464|758019|P1|STARTED|Overall Study||101
316648|NCT01569438|758057|P2|NOT COMPLETED|Overall Study||9
316649|NCT01569438|758058|P1|NOT COMPLETED|Overall Study||2
316650|NCT01569438|758057|P2|COMPLETED|Overall Study||27
316651|NCT01569438|758058|P1|COMPLETED|Overall Study||36
316652|NCT01569438|758057|P2|STARTED|Overall Study||36
316653|NCT01569438|758058|P1|STARTED|Overall Study||38
316654|NCT01569152|758072|P3|NOT COMPLETED|Safety Extension, Period 3||55
316655|NCT01569152|758073|P2|NOT COMPLETED|Safety Extension, Period 3||0
316656|NCT01569152|758074|P1|NOT COMPLETED|Safety Extension, Period 3||0
316657|NCT01569152|758072|P3|COMPLETED|Safety Extension, Period 3||0
316658|NCT01569152|758073|P2|COMPLETED|Safety Extension, Period 3||0
316659|NCT01569152|758074|P1|COMPLETED|Safety Extension, Period 3||0
316660|NCT01569152|758072|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
316661|NCT01569152|758073|P2|STARTED|Safety Extension, Period 3||0
316662|NCT01569152|758074|P1|STARTED|Safety Extension, Period 3||0
316663|NCT01569152|758072|P3|NOT COMPLETED|Phase IIa, Period 1||0
316664|NCT01569152|758073|P2|NOT COMPLETED|Phase IIa, Period 1||32
316665|NCT01569152|758074|P1|NOT COMPLETED|Phase IIa, Period 1||21
316666|NCT01569152|758072|P3|COMPLETED|Phase IIa, Period 1||0
316667|NCT01569152|758073|P2|COMPLETED|Phase IIa, Period 1||9
316668|NCT01569152|758074|P1|COMPLETED|Phase IIa, Period 1||20
316669|NCT01569152|758072|P3|STARTED|Phase IIa, Period 1||0
316670|NCT01569152|758073|P2|STARTED|Phase IIa, Period 1||41
316671|NCT01569152|758074|P1|STARTED|Phase IIa, Period 1||41
316672|NCT01569126|758137|P6|NOT COMPLETED|Overall Study||0
316673|NCT01569126|758138|P5|NOT COMPLETED|Overall Study||0
316674|NCT01569126|758139|P4|NOT COMPLETED|Overall Study||0
316675|NCT01569126|758140|P3|NOT COMPLETED|Overall Study||0
316676|NCT01569126|758141|P2|NOT COMPLETED|Overall Study||0
316677|NCT01569126|758142|P1|NOT COMPLETED|Overall Study||0
316678|NCT01569126|758137|P6|COMPLETED|Overall Study||12
316679|NCT01569126|758138|P5|COMPLETED|Overall Study||12
316680|NCT01569126|758139|P4|COMPLETED|Overall Study||8
316681|NCT01569126|758140|P3|COMPLETED|Overall Study||8
316682|NCT01569126|758141|P2|COMPLETED|Overall Study||8
316683|NCT01569126|758142|P1|COMPLETED|Overall Study||8
316684|NCT01569126|758137|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
316685|NCT01569126|758138|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
316686|NCT01569126|758139|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
316687|NCT01569126|758140|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
316688|NCT01569126|758141|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
316689|NCT01569126|758142|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
316690|NCT01569126|758137|P6|STARTED|Overall Study||12
316691|NCT01569126|758138|P5|STARTED|Overall Study||12
316692|NCT01569126|758139|P4|STARTED|Overall Study||8
316693|NCT01569126|758140|P3|STARTED|Overall Study||8
316694|NCT01569126|758141|P2|STARTED|Overall Study||8
316695|NCT01569126|758142|P1|STARTED|Overall Study||8
316696|NCT01569087|758180|P3|NOT COMPLETED|Overall Study||1
316697|NCT01569087|758181|P2|NOT COMPLETED|Overall Study||0
316698|NCT01569087|758182|P1|NOT COMPLETED|Overall Study||1
316699|NCT01569087|758180|P3|COMPLETED|Overall Study||18
316700|NCT01569087|758181|P2|COMPLETED|Overall Study||20
316701|NCT01569087|758182|P1|COMPLETED|Overall Study||20
316702|NCT01569087|758180|P3|STARTED|Overall Study||19
316703|NCT01569087|758181|P2|STARTED|Overall Study||20
316704|NCT01569087|758182|P1|STARTED|Overall Study||21
316705|NCT01569074|758210|P5|NOT COMPLETED|Overall Study||8
316706|NCT01569074|758211|P4|NOT COMPLETED|Overall Study||8
316707|NCT01569074|758212|P3|NOT COMPLETED|Overall Study||12
316708|NCT01569074|758213|P2|NOT COMPLETED|Overall Study||9
316709|NCT01569074|758214|P1|NOT COMPLETED|Overall Study||7
316710|NCT01569074|758210|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
316711|NCT01569074|758211|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
316798|NCT01568073|758515|P2|NOT COMPLETED|Overall Study||15
316712|NCT01569074|758212|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
316713|NCT01569074|758213|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
316714|NCT01569074|758214|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
316715|NCT01569074|758210|P5|Randomised But Did Not Receive Treatment|Overall Study||0
316716|NCT01569074|758211|P4|Randomised But Did Not Receive Treatment|Overall Study||0
316717|NCT01569074|758212|P3|Randomised But Did Not Receive Treatment|Overall Study||0
316718|NCT01569074|758213|P2|Randomised But Did Not Receive Treatment|Overall Study||0
316719|NCT01569074|758214|P1|Randomised But Did Not Receive Treatment|Overall Study||0
316720|NCT01569074|758210|P5|STARTED|Overall Study|Patients who received treatment|33
316721|NCT01569074|758211|P4|STARTED|Overall Study|Patients who received treatment|33
316722|NCT01569074|758212|P3|STARTED|Overall Study|Patients who received treatment|33
316723|NCT01569074|758213|P2|STARTED|Overall Study|Patients who received treatment|33
316724|NCT01569074|758214|P1|STARTED|Overall Study|Patients who received treatment|31
316725|NCT01568905|758273|P3|NOT COMPLETED|Overall Study||0
316726|NCT01568905|758274|P2|NOT COMPLETED|Overall Study||0
316727|NCT01568905|758275|P1|NOT COMPLETED|Overall Study||1
316728|NCT01568905|758273|P3|COMPLETED|Overall Study||12
316729|NCT01568905|758274|P2|COMPLETED|Overall Study||11
316730|NCT01568905|758275|P1|COMPLETED|Overall Study||12
316731|NCT01568905|758273|P3|STARTED|Overall Study||12
316732|NCT01568905|758274|P2|STARTED|Overall Study||11
316733|NCT01568905|758275|P1|STARTED|Overall Study||13
316734|NCT01568892|758294|P2|NOT COMPLETED|Open-label Phase||16
316735|NCT01568892|758295|P1|NOT COMPLETED|Open-label Phase||13
316736|NCT01568892|758294|P2|COMPLETED|Open-label Phase||0
316737|NCT01568892|758295|P1|COMPLETED|Open-label Phase||0
316738|NCT01568892|758294|P2|Ongoing|Open-label Phase||15
316739|NCT01568892|758295|P1|Ongoing|Open-label Phase||12
316740|NCT01568892|758294|P2|STARTED|Open-label Phase||16
316741|NCT01568892|758295|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
316742|NCT01568892|758294|P2|NOT COMPLETED|Double-blind Phase||0
316743|NCT01568892|758295|P1|NOT COMPLETED|Double-blind Phase||0
316744|NCT01568892|758294|P2|COMPLETED|Double-blind Phase||16
316745|NCT01568892|758295|P1|COMPLETED|Double-blind Phase||14
316746|NCT01568892|758294|P2|STARTED|Double-blind Phase||16
316747|NCT01568892|758295|P1|STARTED|Double-blind Phase||14
316748|NCT01568866|758333|P2|NOT COMPLETED|Overall Study||264
316749|NCT01568866|758334|P1|NOT COMPLETED|Overall Study||360
316750|NCT01568866|758333|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|200
316751|NCT01568866|758334|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|105
316752|NCT01568866|758333|P2|Received Treatment|Overall Study||463
316753|NCT01568866|758334|P1|Received Treatment|Overall Study||456
316754|NCT01568866|758333|P2|STARTED|Overall Study||464
316755|NCT01568866|758334|P1|STARTED|Overall Study||465
316756|NCT01568827|758356|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
316757|NCT01568827|758357|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
316758|NCT01568827|758356|P2|COMPLETED|Intervention 2 (5 Days)||5
316759|NCT01568827|758357|P1|COMPLETED|Intervention 2 (5 Days)||5
316760|NCT01568827|758356|P2|STARTED|Intervention 2 (5 Days)||5
316761|NCT01568827|758357|P1|STARTED|Intervention 2 (5 Days)||5
316762|NCT01568827|758356|P2|NOT COMPLETED|Washout (2 Days)||0
316763|NCT01568827|758357|P1|NOT COMPLETED|Washout (2 Days)||0
316764|NCT01568827|758356|P2|COMPLETED|Washout (2 Days)||5
316765|NCT01568827|758357|P1|COMPLETED|Washout (2 Days)||5
316766|NCT01568827|758356|P2|STARTED|Washout (2 Days)||5
316767|NCT01568827|758357|P1|STARTED|Washout (2 Days)||5
316768|NCT01568827|758356|P2|NOT COMPLETED|First Intervention (6 Days)||0
316769|NCT01568827|758357|P1|NOT COMPLETED|First Intervention (6 Days)||0
316770|NCT01568827|758356|P2|COMPLETED|First Intervention (6 Days)||5
316771|NCT01568827|758357|P1|COMPLETED|First Intervention (6 Days)||5
316772|NCT01568827|758356|P2|STARTED|First Intervention (6 Days)||5
316773|NCT01568827|758357|P1|STARTED|First Intervention (6 Days)||5
316774|NCT01568593|758365|P2|NOT COMPLETED|Overall Study||3
316775|NCT01568593|758366|P1|NOT COMPLETED|Overall Study||7
316776|NCT01568593|758365|P2|COMPLETED|Overall Study||42
316777|NCT01568593|758366|P1|COMPLETED|Overall Study||41
316778|NCT01568593|758365|P2|STARTED|Overall Study||45
316779|NCT01568593|758366|P1|STARTED|Overall Study||48
316780|NCT01568424|758372|P1|NOT COMPLETED|Overall Study||0
316781|NCT01568424|758372|P1|COMPLETED|Overall Study||25
316782|NCT01568424|758372|P1|STARTED|Overall Study||25
316783|NCT01568112|758386|P4|NOT COMPLETED|Overall Study||12
316784|NCT01568112|758387|P3|NOT COMPLETED|Overall Study||7
316785|NCT01568112|758388|P2|NOT COMPLETED|Overall Study||8
316786|NCT01568112|758389|P1|NOT COMPLETED|Overall Study||5
316787|NCT01568112|758386|P4|COMPLETED|Overall Study||30
316788|NCT01568112|758387|P3|COMPLETED|Overall Study||36
316789|NCT01568112|758388|P2|COMPLETED|Overall Study||36
316790|NCT01568112|758389|P1|COMPLETED|Overall Study||39
316791|NCT01568112|758386|P4|STARTED|Overall Study||42
316792|NCT01568112|758387|P3|STARTED|Overall Study||43
316793|NCT01568112|758388|P2|STARTED|Overall Study||44
316794|NCT01568112|758389|P1|STARTED|Overall Study||44
316795|NCT01568073|758512|P5|NOT COMPLETED|Overall Study||9
316796|NCT01568073|758513|P4|NOT COMPLETED|Overall Study||11
316799|NCT01568073|758516|P1|NOT COMPLETED|Overall Study||11
316800|NCT01568073|758512|P5|COMPLETED|Overall Study||107
316801|NCT01568073|758513|P4|COMPLETED|Overall Study||108
316802|NCT01568073|758514|P3|COMPLETED|Overall Study||110
316803|NCT01568073|758515|P2|COMPLETED|Overall Study||107
316804|NCT01568073|758516|P1|COMPLETED|Overall Study||110
316805|NCT01568073|758512|P5|STARTED|Overall Study||116
316806|NCT01568073|758513|P4|STARTED|Overall Study||119
316807|NCT01568073|758514|P3|STARTED|Overall Study||122
316808|NCT01568073|758515|P2|STARTED|Overall Study||122
316809|NCT01568073|758516|P1|STARTED|Overall Study||121
316810|NCT01568047|758547|P4|NOT COMPLETED|Overall Study||1
316811|NCT01568047|758548|P3|NOT COMPLETED|Overall Study||1
316812|NCT01568047|758549|P2|NOT COMPLETED|Overall Study||1
316813|NCT01568047|758550|P1|NOT COMPLETED|Overall Study||1
316814|NCT01568047|758547|P4|COMPLETED|Overall Study||9
316815|NCT01568047|758548|P3|COMPLETED|Overall Study||9
316816|NCT01568047|758549|P2|COMPLETED|Overall Study||9
316817|NCT01568047|758550|P1|COMPLETED|Overall Study||9
316818|NCT01568047|758547|P4|STARTED|Overall Study||10
316819|NCT01568047|758548|P3|STARTED|Overall Study||10
316820|NCT01568047|758549|P2|STARTED|Overall Study||10
316821|NCT01568047|758550|P1|STARTED|Overall Study||10
316822|NCT01568034|758568|P4|NOT COMPLETED|Overall Study||0
316823|NCT01568034|758569|P3|NOT COMPLETED|Overall Study||0
316824|NCT01568034|758570|P2|NOT COMPLETED|Overall Study||0
316825|NCT01568034|758571|P1|NOT COMPLETED|Overall Study||1
316826|NCT01568034|758568|P4|COMPLETED|Overall Study||3
316827|NCT01568034|758569|P3|COMPLETED|Overall Study||3
316828|NCT01568034|758570|P2|COMPLETED|Overall Study||2
316829|NCT01568034|758571|P1|COMPLETED|Overall Study||1
316830|NCT01568034|758568|P4|Placebo|Overall Study||3
316831|NCT01568034|758569|P3|Placebo|Overall Study||3
316832|NCT01568034|758570|P2|Placebo|Overall Study||2
316833|NCT01568034|758571|P1|Placebo|Overall Study||1
316834|NCT01568034|758568|P4|100 mg BIA 9-1067|Overall Study||3
316835|NCT01568034|758569|P3|100 mg BIA 9-1067|Overall Study||3
316836|NCT01568034|758570|P2|100 mg BIA 9-1067|Overall Study||2
316837|NCT01568034|758571|P1|100 mg BIA 9-1067|Overall Study||2
316838|NCT01568034|758568|P4|50 mg BIA 9-1067|Overall Study||3
316839|NCT01568034|758569|P3|50 mg BIA 9-1067|Overall Study||3
316840|NCT01568034|758570|P2|50 mg BIA 9-1067|Overall Study||2
316841|NCT01568034|758571|P1|50 mg BIA 9-1067|Overall Study||2
316842|NCT01568034|758568|P4|25 mg BIA 9-1067|Overall Study||3
316843|NCT01568034|758569|P3|25 mg BIA 9-1067|Overall Study||3
316844|NCT01568034|758570|P2|25 mg BIA 9-1067|Overall Study||2
316845|NCT01568034|758571|P1|25 mg BIA 9-1067|Overall Study||2
316846|NCT01568034|758568|P4|STARTED|Overall Study||3
316847|NCT01568034|758569|P3|STARTED|Overall Study||3
316848|NCT01568034|758570|P2|STARTED|Overall Study||2
316849|NCT01568034|758571|P1|STARTED|Overall Study||2
316850|NCT01568021|758589|P1|NOT COMPLETED|Overall Study||16
316851|NCT01568021|758589|P1|COMPLETED|Overall Study||83
316852|NCT01568021|758589|P1|STARTED|Overall Study||99
316853|NCT01568008|758595|P1|NOT COMPLETED|Overall Study||234
316854|NCT01568008|758595|P1|COMPLETED|Overall Study||699
316855|NCT01568008|758595|P1|STARTED|Overall Study||933
316856|NCT01567943|758606|P3|NOT COMPLETED|Overall Study||0
316857|NCT01567943|758607|P2|NOT COMPLETED|Overall Study||10
316858|NCT01567943|758608|P1|NOT COMPLETED|Overall Study||14
316859|NCT01567943|758606|P3|COMPLETED|Overall Study||44
316860|NCT01567943|758607|P2|COMPLETED|Overall Study||29
316861|NCT01567943|758608|P1|COMPLETED|Overall Study||26
316862|NCT01567943|758606|P3|STARTED|Overall Study||44
316863|NCT01567943|758607|P2|STARTED|Overall Study||39
316864|NCT01567943|758608|P1|STARTED|Overall Study||40
316865|NCT01567852|758618|P2|NOT COMPLETED|Overall Study||7
316866|NCT01567852|758619|P1|NOT COMPLETED|Overall Study||4
316867|NCT01567852|758618|P2|COMPLETED|Overall Study||5
316868|NCT01567852|758619|P1|COMPLETED|Overall Study||4
316869|NCT01567852|758618|P2|STARTED|Overall Study||12
316870|NCT01567852|758619|P1|STARTED|Overall Study||8
316871|NCT01567839|758627|P1|NOT COMPLETED|Overall Study||0
316872|NCT01567839|758627|P1|COMPLETED|Overall Study||60
316873|NCT01567839|758627|P1|STARTED|Overall Study||60
316874|NCT01567826|758637|P2|NOT COMPLETED|Overall Study||2
316875|NCT01567826|758638|P1|NOT COMPLETED|Overall Study||3
316876|NCT01567826|758637|P2|COMPLETED|Overall Study||42
316877|NCT01567826|758638|P1|COMPLETED|Overall Study||40
316878|NCT01567826|758637|P2|STARTED|Overall Study||44
316879|NCT01567826|758638|P1|STARTED|Overall Study||43
316880|NCT01567371|758662|P1|NOT COMPLETED|Overall Study||0
316881|NCT01567371|758662|P1|COMPLETED|Overall Study||30
316882|NCT01567371|758662|P1|STARTED|Overall Study||30
316883|NCT01567163|758667|P1|NOT COMPLETED|Overall Study||4
316884|NCT01567163|758667|P1|COMPLETED|Overall Study||18
316885|NCT01567163|758667|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
316886|NCT01567163|758667|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
316887|NCT01567163|758667|P1|STARTED|Overall Study||22
316888|NCT01567150|758679|P2|NOT COMPLETED|Overall Study||2
316889|NCT01567150|758680|P1|NOT COMPLETED|Overall Study||2
316890|NCT01567150|758679|P2|COMPLETED|Overall Study||16
316891|NCT01567150|758680|P1|COMPLETED|Overall Study||19
316892|NCT01567150|758679|P2|STARTED|Overall Study||18
316893|NCT01567150|758680|P1|STARTED|Overall Study||21
316894|NCT01567020|758692|P4|NOT COMPLETED|Overall Study||1
316895|NCT01567020|758693|P3|NOT COMPLETED|Overall Study||2
316896|NCT01567020|758694|P2|NOT COMPLETED|Overall Study||5
316897|NCT01567020|758695|P1|NOT COMPLETED|Overall Study||7
316898|NCT01567020|758692|P4|COMPLETED|Overall Study||10
316899|NCT01567020|758693|P3|COMPLETED|Overall Study||18
316900|NCT01567020|758694|P2|COMPLETED|Overall Study||41
316901|NCT01567020|758695|P1|COMPLETED|Overall Study||21
316902|NCT01567020|758692|P4|STARTED|Overall Study||11
316903|NCT01567020|758693|P3|STARTED|Overall Study||20
316904|NCT01567020|758694|P2|STARTED|Overall Study||46
316905|NCT01567020|758695|P1|STARTED|Overall Study||28
316906|NCT01566981|758707|P2|NOT COMPLETED|Overall Study||8
316907|NCT01566981|758708|P1|NOT COMPLETED|Overall Study||5
316908|NCT01566981|758707|P2|COMPLETED|Overall Study||54
316909|NCT01566981|758708|P1|COMPLETED|Overall Study||53
316910|NCT01566981|758707|P2|STARTED|Overall Study||62
316911|NCT01566981|758708|P1|STARTED|Overall Study||58
316912|NCT01566838|758720|P2|NOT COMPLETED|Overall Study||0
316913|NCT01566838|758721|P1|NOT COMPLETED|Overall Study||3
316914|NCT01566838|758720|P2|COMPLETED|Overall Study||42
316915|NCT01566838|758721|P1|COMPLETED|Overall Study||38
316916|NCT01566838|758720|P2|STARTED|Overall Study||42
316917|NCT01566838|758721|P1|STARTED|Overall Study||41
316918|NCT01566721|758739|P2|NOT COMPLETED|Overall Study||710
316919|NCT01566721|758740|P1|NOT COMPLETED|Overall Study||1867
316920|NCT01566721|758739|P2|COMPLETED|Overall Study||0
316921|NCT01566721|758740|P1|COMPLETED|Overall Study||0
316922|NCT01566721|758739|P2|Received Treatment|Overall Study||709
316923|NCT01566721|758740|P1|Received Treatment|Overall Study||1864
316924|NCT01566721|758739|P2|STARTED|Overall Study||710
316925|NCT01566721|758740|P1|STARTED|Overall Study||1867
316926|NCT01566630|758765|P2|NOT COMPLETED|Overall Study||0
316927|NCT01566630|758766|P1|NOT COMPLETED|Overall Study||0
316928|NCT01566630|758765|P2|COMPLETED|Overall Study||1
316929|NCT01566630|758766|P1|COMPLETED|Overall Study||2
316930|NCT01566630|758765|P2|STARTED|Overall Study||1
316931|NCT01566630|758766|P1|STARTED|Overall Study||2
316932|NCT01566604|758822|P2|NOT COMPLETED|Overall Study||11
316933|NCT01566604|758823|P1|NOT COMPLETED|Overall Study||24
316934|NCT01566604|758822|P2|COMPLETED|Overall Study||143
316935|NCT01566604|758823|P1|COMPLETED|Overall Study||282
316936|NCT01566604|758822|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
316937|NCT01566604|758823|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
316938|NCT01566604|758822|P2|Full Analysis Set (FAS)|Overall Study||154
316939|NCT01566604|758823|P1|Full Analysis Set (FAS)|Overall Study||305
316940|NCT01566604|758822|P2|Safety Set|Overall Study||154
316941|NCT01566604|758823|P1|Safety Set|Overall Study||305
316942|NCT01566604|758822|P2|STARTED|Overall Study||154
316943|NCT01566604|758823|P1|STARTED|Overall Study||306
316944|NCT01566526|758849|P1|NOT COMPLETED|Overall Study||0
316945|NCT01566526|758849|P1|COMPLETED|Overall Study||26
316946|NCT01566526|758849|P1|STARTED|Overall Study||26
316947|NCT01566500|758859|P1|NOT COMPLETED|Overall Study||0
316948|NCT01566500|758859|P1|COMPLETED|Overall Study||140
316949|NCT01566500|758859|P1|STARTED|Overall Study||140
316950|NCT01566461|758865|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
316951|NCT01566461|758866|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
316952|NCT01566461|758865|P2|COMPLETED|IN.PACT SFA II Phase||55
316953|NCT01566461|758866|P1|COMPLETED|IN.PACT SFA II Phase||109
316954|NCT01566461|758865|P2|STARTED|IN.PACT SFA II Phase||60
316955|NCT01566461|758866|P1|STARTED|IN.PACT SFA II Phase||121
316956|NCT01566461|758865|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
316957|NCT01566461|758866|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
316958|NCT01566461|758865|P2|COMPLETED|IN.PACT SFA I Phase||49
316959|NCT01566461|758866|P1|COMPLETED|IN.PACT SFA I Phase||88
316960|NCT01566461|758865|P2|STARTED|IN.PACT SFA I Phase||51
316961|NCT01566461|758866|P1|STARTED|IN.PACT SFA I Phase||99
316962|NCT01566435|758910|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
316963|NCT01566435|758910|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
316964|NCT01566435|758910|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
316965|NCT01566435|758910|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
316966|NCT01566435|758910|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
316967|NCT01566435|758910|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
316968|NCT01566435|758910|P1|NOT COMPLETED|ACF Induction Therapy||0
316969|NCT01566435|758910|P1|COMPLETED|ACF Induction Therapy||30
316970|NCT01566435|758910|P1|STARTED|ACF Induction Therapy||30
316971|NCT01566409|758926|P2|NOT COMPLETED|Overall Study||5
316972|NCT01566409|758927|P1|NOT COMPLETED|Overall Study||2
316973|NCT01566409|758926|P2|COMPLETED|Overall Study||48
316974|NCT01566409|758927|P1|COMPLETED|Overall Study||47
316975|NCT01566409|758926|P2|STARTED|Overall Study||53
316976|NCT01566409|758927|P1|STARTED|Overall Study||49
316977|NCT01566370|758935|P2|NOT COMPLETED|Overall Study||1
316978|NCT01566370|758936|P1|NOT COMPLETED|Overall Study||2
316979|NCT01566370|758935|P2|COMPLETED|Overall Study||0
316980|NCT01566370|758936|P1|COMPLETED|Overall Study||0
316981|NCT01566370|758935|P2|STARTED|Overall Study||1
316982|NCT01566370|758936|P1|STARTED|Overall Study||2
316983|NCT01566331|758962|P2|NOT COMPLETED|Overall Study||0
316984|NCT01566331|758963|P1|NOT COMPLETED|Overall Study||0
316985|NCT01566331|758962|P2|COMPLETED|Overall Study||40
316986|NCT01566331|758963|P1|COMPLETED|Overall Study||40
316987|NCT01566331|758962|P2|STARTED|Overall Study||40
316988|NCT01566331|758963|P1|STARTED|Overall Study||40
316989|NCT01566162|758969|P1|NOT COMPLETED|Overall Study||36
316990|NCT01566162|758969|P1|COMPLETED|Overall Study||155
316991|NCT01566162|758969|P1|STARTED|Overall Study||191
316992|NCT01566149|758983|P2|NOT COMPLETED|Overall Study||2
316993|NCT01566149|758984|P1|NOT COMPLETED|Overall Study||3
316994|NCT01566149|758983|P2|COMPLETED|Overall Study||23
316995|NCT01566149|758984|P1|COMPLETED|Overall Study||21
316996|NCT01566149|758983|P2|STARTED|Overall Study||25
316997|NCT01566149|758984|P1|STARTED|Overall Study||24
316998|NCT01566084|759000|P2|NOT COMPLETED|Overall Study||0
316999|NCT01566084|759001|P1|NOT COMPLETED|Overall Study||0
317000|NCT01566084|759000|P2|COMPLETED|Overall Study||10
317001|NCT01566084|759001|P1|COMPLETED|Overall Study||7
317002|NCT01566084|759000|P2|STARTED|Overall Study||10
317003|NCT01566084|759001|P1|STARTED|Overall Study||7
317004|NCT01565993|759017|P2|NOT COMPLETED|Overall Study||3
317005|NCT01565993|759018|P1|NOT COMPLETED|Overall Study||0
317006|NCT01565993|759017|P2|COMPLETED|Overall Study||39
317007|NCT01565993|759018|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
317008|NCT01565993|759017|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
317009|NCT01565993|759018|P1|STARTED|Overall Study||66
317010|NCT01565980|759026|P2|NOT COMPLETED|Overall Study||4
317011|NCT01565980|759027|P1|NOT COMPLETED|Overall Study||4
317012|NCT01565980|759026|P2|COMPLETED|Overall Study||16
317013|NCT01565980|759027|P1|COMPLETED|Overall Study||16
317014|NCT01565980|759026|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
317015|NCT01565980|759027|P1|STARTED|Overall Study||20
317016|NCT01565902|759049|P4|NOT COMPLETED|Overall Study||0
317017|NCT01565902|759050|P3|NOT COMPLETED|Overall Study||0
317018|NCT01565902|759051|P2|NOT COMPLETED|Overall Study||0
317019|NCT01565902|759052|P1|NOT COMPLETED|Overall Study||0
317020|NCT01565902|759049|P4|COMPLETED|Overall Study||16
317021|NCT01565902|759050|P3|COMPLETED|Overall Study||8
317022|NCT01565902|759051|P2|COMPLETED|Overall Study||8
317023|NCT01565902|759052|P1|COMPLETED|Overall Study||8
317024|NCT01565902|759049|P4|STARTED|Overall Study||16
317025|NCT01565902|759050|P3|STARTED|Overall Study||8
317026|NCT01565902|759051|P2|STARTED|Overall Study||8
317027|NCT01565902|759052|P1|STARTED|Overall Study||8
317028|NCT01565889|759086|P6|NOT COMPLETED|Part B||4
317029|NCT01565889|759087|P5|NOT COMPLETED|Part B||0
317030|NCT01565889|759088|P4|NOT COMPLETED|Part B||0
317031|NCT01565889|759089|P3|NOT COMPLETED|Part B||0
317032|NCT01565889|759090|P2|NOT COMPLETED|Part B||0
317033|NCT01565889|759091|P1|NOT COMPLETED|Part B||0
317034|NCT01565889|759086|P6|COMPLETED|Part B||19
317035|NCT01565889|759087|P5|COMPLETED|Part B||0
317036|NCT01565889|759088|P4|COMPLETED|Part B||0
317037|NCT01565889|759089|P3|COMPLETED|Part B||0
317038|NCT01565889|759090|P2|COMPLETED|Part B||0
317039|NCT01565889|759091|P1|COMPLETED|Part B||0
317040|NCT01565889|759086|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
317041|NCT01565889|759087|P5|STARTED|Part B||0
317042|NCT01565889|759088|P4|STARTED|Part B||0
317043|NCT01565889|759089|P3|STARTED|Part B||0
317044|NCT01565889|759090|P2|STARTED|Part B||0
317045|NCT01565889|759091|P1|STARTED|Part B||0
317046|NCT01565889|759086|P6|NOT COMPLETED|Part A||0
317047|NCT01565889|759087|P5|NOT COMPLETED|Part A||0
317048|NCT01565889|759088|P4|NOT COMPLETED|Part A||0
317049|NCT01565889|759089|P3|NOT COMPLETED|Part A||0
317050|NCT01565889|759090|P2|NOT COMPLETED|Part A||0
317051|NCT01565889|759091|P1|NOT COMPLETED|Part A||1
317052|NCT01565889|759086|P6|COMPLETED|Part A||0
317053|NCT01565889|759087|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
317054|NCT01565889|759088|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
317055|NCT01565889|759089|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
317056|NCT01565889|759090|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
317057|NCT01565889|759091|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
317058|NCT01565889|759086|P6|STARTED|Part A||0
317059|NCT01565889|759087|P5|STARTED|Part A||7
317060|NCT01565889|759088|P4|STARTED|Part A||7
317061|NCT01565889|759089|P3|STARTED|Part A||8
317062|NCT01565889|759090|P2|STARTED|Part A||4
317063|NCT01565889|759091|P1|STARTED|Part A||12
317064|NCT01565850|759122|P2|NOT COMPLETED|Overall Study||8
317065|NCT01565850|759123|P1|NOT COMPLETED|Overall Study||20
317066|NCT01565850|759122|P2|COMPLETED|Overall Study||42
317067|NCT01565850|759123|P1|COMPLETED|Overall Study||83
317068|NCT01565850|759122|P2|STARTED|Overall Study||50
317069|NCT01565850|759123|P1|STARTED|Overall Study||103
317070|NCT01565707|759143|P4|NOT COMPLETED|Overall Study||5
317071|NCT01565707|759144|P3|NOT COMPLETED|Overall Study||3
317072|NCT01565707|759145|P2|NOT COMPLETED|Overall Study||8
317073|NCT01565707|759146|P1|NOT COMPLETED|Overall Study||9
317074|NCT01565707|759143|P4|COMPLETED|Overall Study||17
317075|NCT01565707|759144|P3|COMPLETED|Overall Study||16
317076|NCT01565707|759145|P2|COMPLETED|Overall Study||65
317077|NCT01565707|759146|P1|COMPLETED|Overall Study||66
317078|NCT01565707|759143|P4|Treated|Overall Study||22
317079|NCT01565707|759144|P3|Treated|Overall Study||19
317080|NCT01565707|759145|P2|Treated|Overall Study||73
317081|NCT01565707|759146|P1|Treated|Overall Study||73
317082|NCT01565707|759143|P4|STARTED|Overall Study||22
317083|NCT01565707|759144|P3|STARTED|Overall Study||19
317084|NCT01565707|759145|P2|STARTED|Overall Study||73
317085|NCT01565707|759146|P1|STARTED|Overall Study||75
317086|NCT01565564|759239|P2|NOT COMPLETED|Overall Study||1
317087|NCT01565564|759240|P1|NOT COMPLETED|Overall Study||5
317088|NCT01565564|759239|P2|COMPLETED|Overall Study||361
317089|NCT01565564|759240|P1|COMPLETED|Overall Study||339
317090|NCT01565564|759239|P2|STARTED|Overall Study||362
317091|NCT01565564|759240|P1|STARTED|Overall Study||344
317092|NCT01565551|759250|P2|NOT COMPLETED|Overall Study||0
317093|NCT01565551|759251|P1|NOT COMPLETED|Overall Study||0
317094|NCT01565551|759250|P2|COMPLETED|Overall Study||51
317095|NCT01565551|759251|P1|COMPLETED|Overall Study||586
317096|NCT01565551|759250|P2|6-Month Outcomes|Overall Study||30
317097|NCT01565551|759251|P1|6-Month Outcomes|Overall Study||412
317098|NCT01565551|759250|P2|Neuroimaging|Overall Study||25
317099|NCT01565551|759251|P1|Neuroimaging|Overall Study||233
317100|NCT01565551|759250|P2|Biospecimens/Biomarkers|Overall Study||22
317101|NCT01565551|759251|P1|Biospecimens/Biomarkers|Overall Study||479
317102|NCT01565551|759250|P2|Clinical/Demographics|Overall Study||51
317103|NCT01565551|759251|P1|Clinical/Demographics|Overall Study||586
317104|NCT01565551|759250|P2|STARTED|Overall Study||51
317105|NCT01565551|759251|P1|STARTED|Overall Study||586
317106|NCT01565538|759259|P2|NOT COMPLETED|Overall Study||0
317107|NCT01565538|759260|P1|NOT COMPLETED|Overall Study||0
317108|NCT01565538|759259|P2|COMPLETED|Overall Study||62
317109|NCT01565538|759260|P1|COMPLETED|Overall Study||61
317110|NCT01565538|759259|P2|STARTED|Overall Study||62
317111|NCT01565538|759260|P1|STARTED|Overall Study||61
317112|NCT01565382|759270|P2|NOT COMPLETED|Overall Study||0
317113|NCT01565382|759271|P1|NOT COMPLETED|Overall Study||0
317114|NCT01565382|759270|P2|COMPLETED|Overall Study||7
317115|NCT01565382|759271|P1|COMPLETED|Overall Study||40
317116|NCT01565382|759270|P2|STARTED|Overall Study||7
317117|NCT01565382|759271|P1|STARTED|Overall Study||40
317118|NCT01565369|759276|P1|NOT COMPLETED|Overall Study||0
317119|NCT01565369|759276|P1|COMPLETED|Overall Study||35
317120|NCT01565369|759276|P1|STARTED|Overall Study||35
317121|NCT01565356|759282|P1|NOT COMPLETED|Overall Study||0
317122|NCT01565356|759282|P1|COMPLETED|Overall Study||41
317123|NCT01565356|759282|P1|STARTED|Overall Study||41
317124|NCT01565343|759290|P3|NOT COMPLETED|Overall Study||0
317125|NCT01565343|759291|P2|NOT COMPLETED|Overall Study||0
317126|NCT01565343|759292|P1|NOT COMPLETED|Overall Study||1
317127|NCT01565343|759290|P3|COMPLETED|Overall Study||10
317128|NCT01565343|759291|P2|COMPLETED|Overall Study||4
317129|NCT01565343|759292|P1|COMPLETED|Overall Study||10
317130|NCT01565343|759290|P3|STARTED|Overall Study||10
317131|NCT01565343|759291|P2|STARTED|Overall Study||4
317132|NCT01565343|759292|P1|STARTED|Overall Study||11
317133|NCT01565330|759303|P4|NOT COMPLETED|Overall Study||0
317134|NCT01565330|759304|P3|NOT COMPLETED|Overall Study||0
317135|NCT01565330|759305|P2|NOT COMPLETED|Overall Study||0
317136|NCT01565330|759306|P1|NOT COMPLETED|Overall Study||0
317137|NCT01565330|759303|P4|COMPLETED|Overall Study||7
317138|NCT01565330|759304|P3|COMPLETED|Overall Study||4
317139|NCT01565330|759305|P2|COMPLETED|Overall Study||4
317140|NCT01565330|759306|P1|COMPLETED|Overall Study||5
317141|NCT01565330|759303|P4|STARTED|Overall Study||7
317142|NCT01565330|759304|P3|STARTED|Overall Study||4
317143|NCT01565330|759305|P2|STARTED|Overall Study||4
317144|NCT01565330|759306|P1|STARTED|Overall Study||5
317145|NCT01565291|759322|P2|NOT COMPLETED|Overall Study||0
317146|NCT01565291|759323|P1|NOT COMPLETED|Overall Study||1
317147|NCT01565291|759322|P2|COMPLETED|Overall Study||16
317148|NCT01565291|759323|P1|COMPLETED|Overall Study||15
317149|NCT01565291|759322|P2|STARTED|Overall Study||16
317150|NCT01565291|759323|P1|STARTED|Overall Study||16
317151|NCT01565083|759333|P2|NOT COMPLETED|Overall Study||39
317152|NCT01565083|759334|P1|NOT COMPLETED|Overall Study||33
317153|NCT01565083|759333|P2|COMPLETED|Overall Study||68
317154|NCT01565083|759334|P1|COMPLETED|Overall Study||73
317155|NCT01565083|759333|P2|STARTED|Overall Study||107
317156|NCT01565083|759334|P1|STARTED|Overall Study||106
317157|NCT01564953|759360|P1|NOT COMPLETED|Overall Study||0
317158|NCT01564953|759360|P1|COMPLETED|Overall Study||143
317159|NCT01564953|759360|P1|STARTED|Overall Study||143
317160|NCT01564862|759371|P3|NOT COMPLETED|Overall Study||30
317161|NCT01564862|759372|P2|NOT COMPLETED|Overall Study||34
317162|NCT01564862|759373|P1|NOT COMPLETED|Overall Study||30
317163|NCT01564862|759371|P3|COMPLETED|Overall Study||164
317164|NCT01564862|759372|P2|COMPLETED|Overall Study||176
317165|NCT01564862|759373|P1|COMPLETED|Overall Study||168
317166|NCT01564862|759371|P3|Received Treatment|Overall Study||191
317167|NCT01564862|759372|P2|Received Treatment|Overall Study||207
317168|NCT01564862|759373|P1|Received Treatment|Overall Study||196
317169|NCT01564862|759371|P3|STARTED|Overall Study||194
317170|NCT01564862|759372|P2|STARTED|Overall Study||210
317171|NCT01564862|759373|P1|STARTED|Overall Study||198
317172|NCT01564758|759422|P1|NOT COMPLETED|Overall Study||14
317173|NCT01564758|759422|P1|COMPLETED|Overall Study||85
317174|NCT01564758|759422|P1|STARTED|Overall Study||99
317175|NCT01564732|759429|P2|NOT COMPLETED|Overall Study||5
317176|NCT01564732|759430|P1|NOT COMPLETED|Overall Study||6
317177|NCT01564732|759429|P2|COMPLETED|Overall Study||0
317178|NCT01564732|759430|P1|COMPLETED|Overall Study||0
317179|NCT01564732|759429|P2|STARTED|Overall Study||5
317180|NCT01564732|759430|P1|STARTED|Overall Study||6
317181|NCT01564706|759446|P1|NOT COMPLETED|Overall Study||0
317182|NCT01564706|759446|P1|COMPLETED|Overall Study||9
317183|NCT01564706|759446|P1|STARTED|Overall Study||9
317184|NCT01564693|759453|P3|NOT COMPLETED|Overall Study||0
317185|NCT01564693|759454|P2|NOT COMPLETED|Overall Study||0
317186|NCT01564693|759455|P1|NOT COMPLETED|Overall Study||0
317187|NCT01564693|759453|P3|COMPLETED|Overall Study||2
317188|NCT01564693|759454|P2|COMPLETED|Overall Study||4
317189|NCT01564693|759455|P1|COMPLETED|Overall Study||9
317190|NCT01564693|759453|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
317191|NCT01564693|759454|P2|STARTED|Overall Study||4
317192|NCT01564693|759455|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
317193|NCT01563406|759467|P4|NOT COMPLETED|Overall Study||0
317194|NCT01563406|759468|P3|NOT COMPLETED|Overall Study||0
317195|NCT01563406|759469|P2|NOT COMPLETED|Overall Study||0
317196|NCT01563406|759470|P1|NOT COMPLETED|Overall Study||0
317197|NCT01563406|759467|P4|COMPLETED|Overall Study|112 hubs|29
317198|NCT01563406|759468|P3|COMPLETED|Overall Study|101 hubs|30
317199|NCT01563406|759469|P2|COMPLETED|Overall Study|102 hubs|30
317200|NCT01563406|759470|P1|COMPLETED|Overall Study|194 hubs|60
317201|NCT01563406|759467|P4|STARTED|Overall Study|112 hubs|29
317202|NCT01563406|759468|P3|STARTED|Overall Study|101 hubs|30
317203|NCT01563406|759469|P2|STARTED|Overall Study|102 hubs|30
317204|NCT01563406|759470|P1|STARTED|Overall Study|194 hubs|60
317205|NCT01564537|759490|P2|NOT COMPLETED|Overall Study||6
317206|NCT01564537|759491|P1|NOT COMPLETED|Overall Study||6
317207|NCT01564537|759490|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
317208|NCT01564537|759491|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
317209|NCT01564537|759490|P2|Safety Population: Received Study Drug|Overall Study||360
317210|NCT01564537|759491|P1|Safety Population: Received Study Drug|Overall Study||360
317211|NCT01564537|759490|P2|STARTED|Overall Study||362
317212|NCT01564537|759491|P1|STARTED|Overall Study||360
317213|NCT01564459|759514|P3|NOT COMPLETED|Double-blind Treatment||1
317214|NCT01564459|759515|P2|NOT COMPLETED|Double-blind Treatment||0
317215|NCT01564459|759516|P1|NOT COMPLETED|Double-blind Treatment||0
317216|NCT01564459|759514|P3|COMPLETED|Double-blind Treatment||82
317217|NCT01564459|759515|P2|COMPLETED|Double-blind Treatment||87
317218|NCT01564459|759516|P1|COMPLETED|Double-blind Treatment||0
317219|NCT01564459|759514|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
317220|NCT01564459|759515|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
317221|NCT01564459|759516|P1|STARTED|Double-blind Treatment||0
317222|NCT01564459|759514|P3|NOT COMPLETED|Run-In||0
317223|NCT01564459|759515|P2|NOT COMPLETED|Run-In||0
317224|NCT01564459|759516|P1|NOT COMPLETED|Run-In||12
317225|NCT01564459|759514|P3|COMPLETED|Run-In||83
317226|NCT01564459|759515|P2|COMPLETED|Run-In||87
317227|NCT01564459|759516|P1|COMPLETED|Run-In||0
317228|NCT01564459|759514|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
317229|NCT01564459|759515|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
317230|NCT01564459|759516|P1|STARTED|Run-In||12
317231|NCT01564407|759540|P5|NOT COMPLETED|Overall Study||0
317232|NCT01564407|759541|P4|NOT COMPLETED|Overall Study||1
317233|NCT01564407|759542|P3|NOT COMPLETED|Overall Study||0
317234|NCT01564407|759543|P2|NOT COMPLETED|Overall Study||2
317235|NCT01564407|759544|P1|NOT COMPLETED|Overall Study||0
317236|NCT01564407|759540|P5|COMPLETED|Overall Study||0
317237|NCT01564407|759541|P4|COMPLETED|Overall Study||1
317238|NCT01564407|759542|P3|COMPLETED|Overall Study||4
317239|NCT01564407|759543|P2|COMPLETED|Overall Study||3
317240|NCT01564407|759544|P1|COMPLETED|Overall Study||4
317241|NCT01564407|759540|P5|STARTED|Overall Study||0
317242|NCT01564407|759541|P4|STARTED|Overall Study||2
317243|NCT01564407|759542|P3|STARTED|Overall Study||4
317244|NCT01564407|759543|P2|STARTED|Overall Study||5
317245|NCT01564407|759544|P1|STARTED|Overall Study||4
317246|NCT01564394|759585|P2|NOT COMPLETED|Overall Study||10
317247|NCT01564394|759586|P1|NOT COMPLETED|Overall Study||6
317248|NCT01564394|759585|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
317249|NCT01564394|759586|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
317250|NCT01564394|759585|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
317251|NCT01564394|759586|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
317252|NCT01563978|759600|P2|NOT COMPLETED|Overall Study||2
317253|NCT01563978|759601|P1|NOT COMPLETED|Overall Study||4
317254|NCT01563978|759600|P2|COMPLETED|Overall Study||65
317255|NCT01563978|759601|P1|COMPLETED|Overall Study||64
317256|NCT01563978|759600|P2|Randomised But Did Not Receive Treatment|Overall Study||0
317257|NCT01563978|759601|P1|Randomised But Did Not Receive Treatment|Overall Study||0
317258|NCT01563978|759600|P2|STARTED|Overall Study|Patients who received treatment.|67
317259|NCT01563978|759601|P1|STARTED|Overall Study|Patients who received treatment.|68
317260|NCT01563536|759627|P2|NOT COMPLETED|Overall Study||2
317261|NCT01563536|759628|P1|NOT COMPLETED|Overall Study||1
317262|NCT01563536|759627|P2|COMPLETED|Overall Study||4
317263|NCT01563536|759628|P1|COMPLETED|Overall Study||5
317264|NCT01563536|759627|P2|STARTED|Overall Study||6
317265|NCT01563536|759628|P1|STARTED|Overall Study||6
317266|NCT01563198|759656|P1|NOT COMPLETED|After Training||0
317267|NCT01563198|759656|P1|COMPLETED|After Training||47979
317268|NCT01563198|759656|P1|STARTED|After Training||47979
317269|NCT01563198|759656|P1|NOT COMPLETED|Baseline||0
317270|NCT01563198|759656|P1|COMPLETED|Baseline||49733
317271|NCT01563198|759656|P1|STARTED|Baseline||49733
317272|NCT01563185|759662|P1|NOT COMPLETED|Overall Study||2
317273|NCT01563185|759662|P1|COMPLETED|Overall Study||10
317274|NCT01563185|759662|P1|STARTED|Overall Study||12
317275|NCT01563081|759678|P2|NOT COMPLETED|Overall Study||0
317276|NCT01563081|759679|P1|NOT COMPLETED|Overall Study||0
317277|NCT01563081|759678|P2|COMPLETED|Overall Study||30
317278|NCT01563081|759679|P1|COMPLETED|Overall Study||30
317279|NCT01563081|759678|P2|STARTED|Overall Study||30
317280|NCT01563081|759679|P1|STARTED|Overall Study||30
317281|NCT01563055|759692|P1|NOT COMPLETED|Overall Study||0
317282|NCT01563055|759692|P1|COMPLETED|Overall Study||10
317283|NCT01563055|759692|P1|STARTED|Overall Study||10
317284|NCT01563029|759755|P5|NOT COMPLETED|Overall Study||29
317285|NCT01563029|759756|P4|NOT COMPLETED|Overall Study||33
317286|NCT01563029|759757|P3|NOT COMPLETED|Overall Study||33
317287|NCT01563029|759758|P2|NOT COMPLETED|Overall Study||24
317288|NCT01563029|759759|P1|NOT COMPLETED|Overall Study||53
317289|NCT01563029|759755|P5|COMPLETED|Overall Study||89
317290|NCT01563029|759756|P4|COMPLETED|Overall Study||85
317291|NCT01563029|759757|P3|COMPLETED|Overall Study||87
317292|NCT01563029|759758|P2|COMPLETED|Overall Study||94
317293|NCT01563029|759759|P1|COMPLETED|Overall Study||66
317294|NCT01563029|759755|P5|STARTED|Overall Study||118
317295|NCT01563029|759756|P4|STARTED|Overall Study||118
317296|NCT01563029|759757|P3|STARTED|Overall Study||120
317297|NCT01563029|759758|P2|STARTED|Overall Study||118
317298|NCT01563029|759759|P1|STARTED|Overall Study||119
317299|NCT01563003|759809|P2|NOT COMPLETED|Overall Study||0
317300|NCT01563003|759810|P1|NOT COMPLETED|Overall Study||0
317301|NCT01563003|759809|P2|COMPLETED|Overall Study||15
317302|NCT01563003|759810|P1|COMPLETED|Overall Study||16
317303|NCT01563003|759809|P2|STARTED|Overall Study||15
317304|NCT01563003|759810|P1|STARTED|Overall Study||16
317305|NCT01562886|759820|P1|NOT COMPLETED|Overall Study||1
317306|NCT01562886|759820|P1|COMPLETED|Overall Study||13
317307|NCT01562886|759820|P1|STARTED|Overall Study||14
317308|NCT01562873|759825|P2|NOT COMPLETED|Overall Study||0
317309|NCT01562873|759826|P1|NOT COMPLETED|Overall Study||21
317310|NCT01562873|759825|P2|COMPLETED|Overall Study||0
317311|NCT01562873|759826|P1|COMPLETED|Overall Study||0
317312|NCT01562873|759825|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
317313|NCT01562873|759826|P1|STARTED|Overall Study||21
317314|NCT01562743|759833|P1|NOT COMPLETED|Overall Study||52
317315|NCT01562743|759833|P1|COMPLETED|Overall Study||133
317316|NCT01562743|759833|P1|STARTED|Overall Study||185
317317|NCT01562678|759845|P2|NOT COMPLETED|Overall Study||2
317318|NCT01562678|759846|P1|NOT COMPLETED|Overall Study||6
317319|NCT01562678|759845|P2|COMPLETED|Overall Study||12
317320|NCT01562678|759846|P1|COMPLETED|Overall Study||8
317321|NCT01562678|759845|P2|STARTED|Overall Study||14
317322|NCT01562678|759846|P1|STARTED|Overall Study||14
317323|NCT01562613|759852|P1|NOT COMPLETED|Overall Study||4
317324|NCT01562613|759852|P1|COMPLETED|Overall Study||529
317325|NCT01562613|759852|P1|STARTED|Overall Study||533
317326|NCT01562548|759862|P4|NOT COMPLETED|Overall Study||0
317327|NCT01562548|759863|P3|NOT COMPLETED|Overall Study||1
317328|NCT01562548|759864|P2|NOT COMPLETED|Overall Study||0
317329|NCT01562548|759865|P1|NOT COMPLETED|Overall Study||0
317330|NCT01562548|759862|P4|COMPLETED|Overall Study||14
317331|NCT01562548|759863|P3|COMPLETED|Overall Study||24
317332|NCT01562548|759864|P2|COMPLETED|Overall Study||15
317333|NCT01562548|759865|P1|COMPLETED|Overall Study||25
317334|NCT01562548|759862|P4|STARTED|Overall Study||14
317335|NCT01562548|759863|P3|STARTED|Overall Study||25
317336|NCT01562548|759864|P2|STARTED|Overall Study||15
317337|NCT01562548|759865|P1|STARTED|Overall Study||25
317338|NCT01562327|759915|P1|NOT COMPLETED|Overall Study||8
317339|NCT01562327|759915|P1|COMPLETED|Overall Study||42
317340|NCT01562327|759915|P1|STARTED|Overall Study||50
317341|NCT01562314|759945|P2|NOT COMPLETED|Overall Study||8
317342|NCT01562314|759946|P1|NOT COMPLETED|Overall Study||13
317343|NCT01562314|759945|P2|COMPLETED|Overall Study||23
317344|NCT01562314|759946|P1|COMPLETED|Overall Study||16
317345|NCT01562314|759945|P2|STARTED|Overall Study||31
317346|NCT01562314|759946|P1|STARTED|Overall Study||29
317347|NCT01562275|760033|P13|NOT COMPLETED|Stage 2||5
317348|NCT01562275|760034|P12|NOT COMPLETED|Stage 2||14
317349|NCT01562275|760035|P11|NOT COMPLETED|Stage 2||0
317350|NCT01562275|760036|P10|NOT COMPLETED|Stage 2||0
317351|NCT01562275|760037|P9|NOT COMPLETED|Stage 2||0
317352|NCT01562275|760038|P8|NOT COMPLETED|Stage 2||0
317353|NCT01562275|760039|P7|NOT COMPLETED|Stage 2||0
317354|NCT01562275|760040|P6|NOT COMPLETED|Stage 2||0
317355|NCT01562275|760041|P5|NOT COMPLETED|Stage 2||0
317356|NCT01562275|760042|P4|NOT COMPLETED|Stage 2||0
317357|NCT01562275|760043|P3|NOT COMPLETED|Stage 2||0
317358|NCT01562275|760044|P2|NOT COMPLETED|Stage 2||0
317359|NCT01562275|760045|P1|NOT COMPLETED|Stage 2||0
317360|NCT01562275|760033|P13|COMPLETED|Stage 2||0
317361|NCT01562275|760034|P12|COMPLETED|Stage 2||0
317362|NCT01562275|760035|P11|COMPLETED|Stage 2||0
317363|NCT01562275|760036|P10|COMPLETED|Stage 2||0
317364|NCT01562275|760037|P9|COMPLETED|Stage 2||0
317365|NCT01562275|760038|P8|COMPLETED|Stage 2||0
317366|NCT01562275|760039|P7|COMPLETED|Stage 2||0
317367|NCT01562275|760040|P6|COMPLETED|Stage 2||0
317368|NCT01562275|760041|P5|COMPLETED|Stage 2||0
317369|NCT01562275|760042|P4|COMPLETED|Stage 2||0
317370|NCT01562275|760043|P3|COMPLETED|Stage 2||0
317371|NCT01562275|760044|P2|COMPLETED|Stage 2||0
317372|NCT01562275|760045|P1|COMPLETED|Stage 2||0
317373|NCT01562275|760033|P13|STARTED|Stage 2||5
317374|NCT01562275|760034|P12|STARTED|Stage 2||14
317375|NCT01562275|760035|P11|STARTED|Stage 2||0
317376|NCT01562275|760036|P10|STARTED|Stage 2||0
317377|NCT01562275|760037|P9|STARTED|Stage 2||0
317378|NCT01562275|760038|P8|STARTED|Stage 2||0
317379|NCT01562275|760039|P7|STARTED|Stage 2||0
317380|NCT01562275|760040|P6|STARTED|Stage 2||0
317381|NCT01562275|760041|P5|STARTED|Stage 2||0
317382|NCT01562275|760042|P4|STARTED|Stage 2||0
317383|NCT01562275|760043|P3|STARTED|Stage 2||0
317384|NCT01562275|760044|P2|STARTED|Stage 2||0
317385|NCT01562275|760045|P1|STARTED|Stage 2||0
317386|NCT01562275|760033|P13|NOT COMPLETED|Stage 1||0
317387|NCT01562275|760034|P12|NOT COMPLETED|Stage 1||0
317388|NCT01562275|760035|P11|NOT COMPLETED|Stage 1||3
317389|NCT01562275|760036|P10|NOT COMPLETED|Stage 1||7
317390|NCT01562275|760037|P9|NOT COMPLETED|Stage 1||3
317391|NCT01562275|760038|P8|NOT COMPLETED|Stage 1||7
317392|NCT01562275|760039|P7|NOT COMPLETED|Stage 1||3
317393|NCT01562275|760040|P6|NOT COMPLETED|Stage 1||4
317394|NCT01562275|760041|P5|NOT COMPLETED|Stage 1||4
317395|NCT01562275|760042|P4|NOT COMPLETED|Stage 1||4
317396|NCT01562275|760043|P3|NOT COMPLETED|Stage 1||3
317397|NCT01562275|760044|P2|NOT COMPLETED|Stage 1||7
317398|NCT01562275|760045|P1|NOT COMPLETED|Stage 1||3
317399|NCT01562275|760033|P13|COMPLETED|Stage 1||0
317400|NCT01562275|760034|P12|COMPLETED|Stage 1||0
317401|NCT01562275|760035|P11|COMPLETED|Stage 1||0
317402|NCT01562275|760036|P10|COMPLETED|Stage 1||0
317403|NCT01562275|760037|P9|COMPLETED|Stage 1||0
317404|NCT01562275|760038|P8|COMPLETED|Stage 1||0
317405|NCT01562275|760039|P7|COMPLETED|Stage 1||0
317406|NCT01562275|760040|P6|COMPLETED|Stage 1||0
317407|NCT01562275|760041|P5|COMPLETED|Stage 1||0
317408|NCT01562275|760042|P4|COMPLETED|Stage 1||0
317409|NCT01562275|760043|P3|COMPLETED|Stage 1||0
317410|NCT01562275|760044|P2|COMPLETED|Stage 1||0
317411|NCT01562275|760045|P1|COMPLETED|Stage 1||0
317412|NCT01562275|760033|P13|STARTED|Stage 1||0
317413|NCT01562275|760034|P12|STARTED|Stage 1||0
317414|NCT01562275|760035|P11|STARTED|Stage 1||3
317415|NCT01562275|760036|P10|STARTED|Stage 1||7
317416|NCT01562275|760037|P9|STARTED|Stage 1||3
317417|NCT01562275|760038|P8|STARTED|Stage 1||7
317418|NCT01562275|760039|P7|STARTED|Stage 1||3
317419|NCT01562275|760040|P6|STARTED|Stage 1||4
317420|NCT01562275|760041|P5|STARTED|Stage 1||4
317421|NCT01562275|760042|P4|STARTED|Stage 1||4
317422|NCT01562275|760043|P3|STARTED|Stage 1||3
317423|NCT01562275|760044|P2|STARTED|Stage 1||7
317424|NCT01562275|760045|P1|STARTED|Stage 1||3
317425|NCT01562132|760177|P2|NOT COMPLETED|Overall Study||0
317426|NCT01562132|760178|P1|NOT COMPLETED|Overall Study||0
317427|NCT01562132|760177|P2|COMPLETED|Overall Study||3
317428|NCT01562132|760178|P1|COMPLETED|Overall Study||3
317429|NCT01562132|760177|P2|STARTED|Overall Study||3
317430|NCT01562132|760178|P1|STARTED|Overall Study||3
317431|NCT01561898|760188|P4|NOT COMPLETED|Overall Study||20
317432|NCT01561898|760189|P3|NOT COMPLETED|Overall Study||44
317433|NCT01561898|760190|P2|NOT COMPLETED|Overall Study||41
317434|NCT01561898|760191|P1|NOT COMPLETED|Overall Study||2
317435|NCT01561898|760188|P4|COMPLETED|Overall Study||12
317436|NCT01561898|760189|P3|COMPLETED|Overall Study||53
317437|NCT01561898|760190|P2|COMPLETED|Overall Study||51
317438|NCT01561898|760191|P1|COMPLETED|Overall Study||5
317439|NCT01561898|760188|P4|STARTED|Overall Study||32
317440|NCT01561898|760189|P3|STARTED|Overall Study||97
317441|NCT01561898|760190|P2|STARTED|Overall Study||92
317442|NCT01561898|760191|P1|STARTED|Overall Study||7
317443|NCT01561716|760209|P6|NOT COMPLETED|Overall Study||0
317444|NCT01561716|760210|P5|NOT COMPLETED|Overall Study||0
317445|NCT01561716|760211|P4|NOT COMPLETED|Overall Study||0
317446|NCT01561716|760212|P3|NOT COMPLETED|Overall Study||0
317447|NCT01561716|760213|P2|NOT COMPLETED|Overall Study||0
317448|NCT01561716|760214|P1|NOT COMPLETED|Overall Study||0
317449|NCT01561716|760209|P6|COMPLETED|Overall Study||5
317450|NCT01561716|760210|P5|COMPLETED|Overall Study||5
317451|NCT01561716|760211|P4|COMPLETED|Overall Study||5
317452|NCT01561716|760212|P3|COMPLETED|Overall Study||5
317453|NCT01561716|760213|P2|COMPLETED|Overall Study||5
317454|NCT01561716|760214|P1|COMPLETED|Overall Study||5
317455|NCT01561716|760209|P6|STARTED|Overall Study||5
317456|NCT01561716|760210|P5|STARTED|Overall Study||5
317457|NCT01561716|760211|P4|STARTED|Overall Study||5
317458|NCT01561716|760212|P3|STARTED|Overall Study||5
317459|NCT01561716|760213|P2|STARTED|Overall Study||5
317460|NCT01561716|760214|P1|STARTED|Overall Study||5
317461|NCT01561703|760230|P2|NOT COMPLETED|Overall Study||6
317462|NCT01561703|760231|P1|NOT COMPLETED|Overall Study||8
317463|NCT01561703|760230|P2|COMPLETED|Overall Study||24
317464|NCT01561703|760231|P1|COMPLETED|Overall Study||20
317465|NCT01561703|760230|P2|STARTED|Overall Study||30
317466|NCT01561703|760231|P1|STARTED|Overall Study||28
317467|NCT01561560|760237|P2|NOT COMPLETED|Second Two Weeks of Wear||1
317468|NCT01561560|760238|P1|NOT COMPLETED|Second Two Weeks of Wear||0
317469|NCT01561560|760237|P2|COMPLETED|Second Two Weeks of Wear||58
317470|NCT01561560|760238|P1|COMPLETED|Second Two Weeks of Wear||60
317471|NCT01561560|760237|P2|STARTED|Second Two Weeks of Wear||59
317472|NCT01561560|760238|P1|STARTED|Second Two Weeks of Wear||60
317473|NCT01561560|760237|P2|NOT COMPLETED|First Two Weeks of Wear||2
317474|NCT01561560|760238|P1|NOT COMPLETED|First Two Weeks of Wear||0
317475|NCT01561560|760237|P2|COMPLETED|First Two Weeks of Wear||59
317476|NCT01561560|760238|P1|COMPLETED|First Two Weeks of Wear||60
317477|NCT01561560|760237|P2|STARTED|First Two Weeks of Wear||61
317478|NCT01561560|760238|P1|STARTED|First Two Weeks of Wear||60
317479|NCT01561469|760246|P2|NOT COMPLETED|Overall Study||0
317480|NCT01561469|760247|P1|NOT COMPLETED|Overall Study||0
317481|NCT01561469|760246|P2|COMPLETED|Overall Study||87
317482|NCT01561469|760247|P1|COMPLETED|Overall Study||101
317483|NCT01561469|760246|P2|STARTED|Overall Study||87
317484|NCT01561469|760247|P1|STARTED|Overall Study||101
317485|NCT01561313|760267|P2|NOT COMPLETED|Overall Study||0
317486|NCT01561313|760268|P1|NOT COMPLETED|Overall Study||2
317487|NCT01561313|760267|P2|COMPLETED|Overall Study||31
317488|NCT01561313|760268|P1|COMPLETED|Overall Study||31
317489|NCT01561313|760267|P2|STARTED|Overall Study||31
317490|NCT01561313|760268|P1|STARTED|Overall Study||33
317491|NCT01561300|760286|P2|NOT COMPLETED|Second Intervention||0
317492|NCT01561300|760287|P1|NOT COMPLETED|Second Intervention||0
317493|NCT01561300|760286|P2|COMPLETED|Second Intervention||15
317494|NCT01561300|760287|P1|COMPLETED|Second Intervention||14
317495|NCT01561300|760286|P2|STARTED|Second Intervention||15
317496|NCT01561300|760287|P1|STARTED|Second Intervention||14
317497|NCT01561300|760286|P2|NOT COMPLETED|Washout on Placebo||0
317498|NCT01561300|760287|P1|NOT COMPLETED|Washout on Placebo||0
317499|NCT01561300|760286|P2|COMPLETED|Washout on Placebo||15
317500|NCT01561300|760287|P1|COMPLETED|Washout on Placebo||14
317501|NCT01561300|760286|P2|STARTED|Washout on Placebo||15
317502|NCT01561300|760287|P1|STARTED|Washout on Placebo||14
317503|NCT01561300|760286|P2|NOT COMPLETED|First Intervention||0
317504|NCT01561300|760287|P1|NOT COMPLETED|First Intervention||0
317505|NCT01561300|760286|P2|COMPLETED|First Intervention||15
317506|NCT01561300|760287|P1|COMPLETED|First Intervention||14
317507|NCT01561300|760286|P2|STARTED|First Intervention||15
317508|NCT01561300|760287|P1|STARTED|First Intervention||14
317509|NCT01561300|760286|P2|NOT COMPLETED|Run in on Placebo||0
317510|NCT01561300|760287|P1|NOT COMPLETED|Run in on Placebo||1
317511|NCT01561300|760286|P2|COMPLETED|Run in on Placebo||15
317512|NCT01561300|760287|P1|COMPLETED|Run in on Placebo||14
317513|NCT01561300|760286|P2|STARTED|Run in on Placebo||15
317514|NCT01561300|760287|P1|STARTED|Run in on Placebo||15
317515|NCT01560975|760298|P1|NOT COMPLETED|Overall Study||0
317516|NCT01560975|760298|P1|COMPLETED|Overall Study||10
317517|NCT01560975|760298|P1|STARTED|Overall Study||10
317518|NCT01560819|760313|P2|NOT COMPLETED|Overall Study||0
317519|NCT01560819|760314|P1|NOT COMPLETED|Overall Study||1
317520|NCT01560819|760313|P2|COMPLETED|Overall Study||10
317521|NCT01560819|760314|P1|COMPLETED|Overall Study||9
317522|NCT01560819|760313|P2|STARTED|Overall Study||10
317523|NCT01560819|760314|P1|STARTED|Overall Study||10
317524|NCT01560507|760321|P3|NOT COMPLETED|Overall Study||2
317525|NCT01560507|760322|P2|NOT COMPLETED|Overall Study||2
317526|NCT01560507|760323|P1|NOT COMPLETED|Overall Study||4
317527|NCT01560507|760321|P3|COMPLETED|Overall Study||0
317528|NCT01560507|760322|P2|COMPLETED|Overall Study||0
317529|NCT01560507|760323|P1|COMPLETED|Overall Study||1
317530|NCT01560507|760321|P3|STARTED|Overall Study||2
317531|NCT01560507|760322|P2|STARTED|Overall Study||2
317532|NCT01560507|760323|P1|STARTED|Overall Study||5
317533|NCT01560429|760336|P2|NOT COMPLETED|Overall Study||6
317534|NCT01560429|760337|P1|NOT COMPLETED|Overall Study||3
317535|NCT01560429|760336|P2|COMPLETED|Overall Study||20
317536|NCT01560429|760337|P1|COMPLETED|Overall Study||23
317537|NCT01560429|760336|P2|STARTED|Overall Study||26
317538|NCT01560429|760337|P1|STARTED|Overall Study||26
317539|NCT01560403|760347|P2|NOT COMPLETED|Overall Study||1
317540|NCT01560403|760348|P1|NOT COMPLETED|Overall Study||0
317541|NCT01560403|760347|P2|COMPLETED|Overall Study||8
317542|NCT01560403|760348|P1|COMPLETED|Overall Study||5
317543|NCT01560403|760347|P2|STARTED|Overall Study||9
317544|NCT01560403|760348|P1|STARTED|Overall Study||5
317545|NCT01560260|760354|P1|NOT COMPLETED|Overall Study||0
317546|NCT01560260|760354|P1|COMPLETED|Overall Study||20
317547|NCT01560260|760354|P1|STARTED|Overall Study||20
317548|NCT01560234|760366|P8|NOT COMPLETED|Overall Study||2
317549|NCT01560234|760367|P7|NOT COMPLETED|Overall Study||0
317550|NCT01560234|760368|P6|NOT COMPLETED|Overall Study||2
317551|NCT01560234|760369|P5|NOT COMPLETED|Overall Study||0
317552|NCT01560234|760370|P4|NOT COMPLETED|Overall Study||0
317553|NCT01560234|760371|P3|NOT COMPLETED|Overall Study||1
317554|NCT01560234|760372|P2|NOT COMPLETED|Overall Study||0
317555|NCT01560234|760373|P1|NOT COMPLETED|Overall Study||3
317556|NCT01560234|760366|P8|COMPLETED|Overall Study||6
317557|NCT01560234|760367|P7|COMPLETED|Overall Study||4
317558|NCT01560234|760368|P6|COMPLETED|Overall Study||2
317559|NCT01560234|760369|P5|COMPLETED|Overall Study||4
317560|NCT01560234|760370|P4|COMPLETED|Overall Study||3
317561|NCT01560234|760371|P3|COMPLETED|Overall Study||3
317562|NCT01560234|760372|P2|COMPLETED|Overall Study||4
317563|NCT01560234|760373|P1|COMPLETED|Overall Study||13
317564|NCT01560234|760366|P8|STARTED|Overall Study||8
317565|NCT01560234|760367|P7|STARTED|Overall Study||4
317566|NCT01560234|760368|P6|STARTED|Overall Study||4
317567|NCT01560234|760369|P5|STARTED|Overall Study||4
317568|NCT01560234|760370|P4|STARTED|Overall Study||3
317569|NCT01560234|760371|P3|STARTED|Overall Study||4
317570|NCT01560234|760372|P2|STARTED|Overall Study||4
317571|NCT01560234|760373|P1|STARTED|Overall Study||16
317572|NCT01560143|760447|P1|NOT COMPLETED|Overall Study||0
317573|NCT01560143|760447|P1|COMPLETED|Overall Study||12
317574|NCT01560143|760447|P1|STARTED|Overall Study||12
317575|NCT01559935|760451|P1|NOT COMPLETED|Maintenance Phase||54
317576|NCT01559935|760451|P1|COMPLETED|Maintenance Phase||0
317577|NCT01559935|760451|P1|STARTED|Maintenance Phase||54
317578|NCT01559935|760451|P1|NOT COMPLETED|BiRD Phase||4
317579|NCT01559935|760451|P1|COMPLETED|BiRD Phase||54
317580|NCT01559935|760451|P1|STARTED|BiRD Phase||58
317581|NCT01559935|760451|P1|NOT COMPLETED|Car Phase||14
317582|NCT01559935|760451|P1|COMPLETED|Car Phase||58
317583|NCT01559935|760451|P1|STARTED|Car Phase||72
317584|NCT01559922|760461|P2|NOT COMPLETED|Overall Study||10
317585|NCT01559922|760462|P1|NOT COMPLETED|Overall Study||4
317586|NCT01559922|760461|P2|COMPLETED|Overall Study||87
317587|NCT01559922|760462|P1|COMPLETED|Overall Study||46
317588|NCT01559922|760461|P2|STARTED|Overall Study||97
317589|NCT01559922|760462|P1|STARTED|Overall Study||50
317590|NCT01559857|760470|P2|NOT COMPLETED|Overall Study||0
317591|NCT01559857|760471|P1|NOT COMPLETED|Overall Study||0
317592|NCT01559857|760470|P2|COMPLETED|Overall Study||18
317593|NCT01559857|760471|P1|COMPLETED|Overall Study||19
317594|NCT01559857|760470|P2|STARTED|Overall Study||18
317595|NCT01559857|760471|P1|STARTED|Overall Study||19
317596|NCT01559844|760487|P1|NOT COMPLETED|Overall Study||25
317597|NCT01559844|760487|P1|COMPLETED|Overall Study||36
317598|NCT01559844|760487|P1|STARTED|Overall Study||61
317599|NCT01559675|760500|P2|NOT COMPLETED|Overall Study||14
317600|NCT01559675|760501|P1|NOT COMPLETED|Overall Study||15
317601|NCT01559675|760500|P2|COMPLETED|Overall Study||49
317602|NCT01559675|760501|P1|COMPLETED|Overall Study||43
317603|NCT01559675|760500|P2|STARTED|Overall Study||63
317604|NCT01559675|760501|P1|STARTED|Overall Study||58
317605|NCT01559649|760509|P2|NOT COMPLETED|Overall Study||6
317606|NCT01559649|760510|P1|NOT COMPLETED|Overall Study||19
317607|NCT01559649|760509|P2|COMPLETED|Overall Study||9
317608|NCT01559649|760510|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
317609|NCT01559649|760509|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
317610|NCT01559649|760510|P1|STARTED|Overall Study||269
317611|NCT01559506|760523|P2|NOT COMPLETED|Overall Study||3
317612|NCT01559506|760524|P1|NOT COMPLETED|Overall Study||0
317613|NCT01559506|760523|P2|COMPLETED|Overall Study||18
317614|NCT01559506|760524|P1|COMPLETED|Overall Study||20
317615|NCT01559506|760523|P2|STARTED|Overall Study||21
317616|NCT01559506|760524|P1|STARTED|Overall Study||20
317617|NCT01559454|760532|P2|NOT COMPLETED|Overall Study||6
317618|NCT01559454|760533|P1|NOT COMPLETED|Overall Study||3
317619|NCT01559454|760532|P2|COMPLETED|Overall Study||4
317620|NCT01559454|760533|P1|COMPLETED|Overall Study||6
317621|NCT01559454|760532|P2|STARTED|Overall Study||10
317622|NCT01559454|760533|P1|STARTED|Overall Study||9
317623|NCT01559311|760552|P3|NOT COMPLETED|Overall Study||8
317624|NCT01559311|760553|P2|NOT COMPLETED|Overall Study||6
317625|NCT01559311|760554|P1|NOT COMPLETED|Overall Study||3
317626|NCT01559311|760552|P3|COMPLETED|Overall Study|12-Month|26
317627|NCT01559311|760553|P2|COMPLETED|Overall Study|12-Month|28
317628|NCT01559311|760554|P1|COMPLETED|Overall Study|12-Month|27
317629|NCT01559311|760552|P3|6-Month|Overall Study||28
317630|NCT01559311|760553|P2|6-Month|Overall Study||33
317631|NCT01559311|760554|P1|6-Month|Overall Study||27
317632|NCT01559311|760552|P3|3-Month|Overall Study||29
317633|NCT01559311|760553|P2|3-Month|Overall Study||34
317634|NCT01559311|760554|P1|3-Month|Overall Study||27
317635|NCT01559311|760552|P3|1-Month|Overall Study||29
317636|NCT01559311|760553|P2|1-Month|Overall Study||34
317637|NCT01559311|760554|P1|1-Month|Overall Study||27
317638|NCT01559311|760552|P3|Implant|Overall Study||32
317639|NCT01559311|760553|P2|Implant|Overall Study||34
317640|NCT01559311|760554|P1|Implant|Overall Study||28
317641|NCT01559311|760552|P3|STARTED|Overall Study|Enrollment & Baseline|34
317642|NCT01559311|760553|P2|STARTED|Overall Study|Enrollment & Baseline|34
317643|NCT01559311|760554|P1|STARTED|Overall Study|Enrollment & Baseline|30
317644|NCT01559116|760565|P1|NOT COMPLETED|Overall Study||26
317645|NCT01559116|760565|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
317646|NCT01559116|760565|P1|STARTED|Overall Study|Randomised|219
317647|NCT01559064|760636|P3|NOT COMPLETED|Overall Study||2
317648|NCT01559064|760637|P2|NOT COMPLETED|Overall Study||1
317649|NCT01559064|760638|P1|NOT COMPLETED|Overall Study||1
317650|NCT01559064|760636|P3|COMPLETED|Overall Study||57
317651|NCT01559064|760637|P2|COMPLETED|Overall Study||39
317652|NCT01559064|760638|P1|COMPLETED|Overall Study||15
317653|NCT01559064|760636|P3|STARTED|Overall Study||59
317654|NCT01559064|760637|P2|STARTED|Overall Study||40
317655|NCT01559064|760638|P1|STARTED|Overall Study||16
317656|NCT01559012|760648|P2|NOT COMPLETED|Overall Study||1
317657|NCT01559012|760649|P1|NOT COMPLETED|Overall Study||0
317658|NCT01559012|760648|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
317659|NCT01559012|760649|P1|COMPLETED|Overall Study||6
317660|NCT01559012|760648|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
317661|NCT01559012|760649|P1|STARTED|Overall Study||6
317662|NCT01558791|760674|P2|NOT COMPLETED|Overall Study||0
317663|NCT01558791|760675|P1|NOT COMPLETED|Overall Study||0
317664|NCT01558791|760674|P2|COMPLETED|Overall Study||629
317665|NCT01558791|760675|P1|COMPLETED|Overall Study||607
317666|NCT01558791|760674|P2|STARTED|Overall Study||629
317667|NCT01558791|760675|P1|STARTED|Overall Study||607
317668|NCT01558739|760685|P1|NOT COMPLETED|Overall Study||17
317669|NCT01558739|760685|P1|COMPLETED|Overall Study||31
317670|NCT01558739|760685|P1|STARTED|Overall Study||48
317671|NCT01558700|760699|P2|NOT COMPLETED|Overall Study||0
317672|NCT01558700|760700|P1|NOT COMPLETED|Overall Study||0
317673|NCT01558700|760699|P2|COMPLETED|Overall Study||21
317674|NCT01558700|760700|P1|COMPLETED|Overall Study||19
317675|NCT01558700|760699|P2|STARTED|Overall Study||21
317676|NCT01558700|760700|P1|STARTED|Overall Study||19
317677|NCT01558674|760710|P2|NOT COMPLETED|Part 2||0
317678|NCT01558674|760711|P1|NOT COMPLETED|Part 2||0
317679|NCT01558674|760710|P2|COMPLETED|Part 2||0
317680|NCT01558674|760711|P1|COMPLETED|Part 2||0
317681|NCT01558674|760710|P2|STARTED|Part 2||0
317682|NCT01558674|760711|P1|STARTED|Part 2||0
317683|NCT01558674|760710|P2|NOT COMPLETED|Part 1||0
317684|NCT01558674|760711|P1|NOT COMPLETED|Part 1||11
317685|NCT01558674|760710|P2|COMPLETED|Part 1||0
317686|NCT01558674|760711|P1|COMPLETED|Part 1||0
317687|NCT01558674|760710|P2|STARTED|Part 1||0
317688|NCT01558674|760711|P1|STARTED|Part 1||11
317689|NCT01558596|760757|P2|NOT COMPLETED|Overall Study||1
317690|NCT01558596|760758|P1|NOT COMPLETED|Overall Study||3
317691|NCT01558596|760757|P2|COMPLETED|Overall Study||100
317692|NCT01558596|760758|P1|COMPLETED|Overall Study||101
317693|NCT01558596|760757|P2|STARTED|Overall Study||101
317694|NCT01558596|760758|P1|STARTED|Overall Study||104
317695|NCT01558492|760764|P1|NOT COMPLETED|Overall Study||0
317696|NCT01558492|760764|P1|COMPLETED|Overall Study||3
317697|NCT01558492|760764|P1|STARTED|Overall Study||3
317698|NCT01558297|760773|P3|NOT COMPLETED|Overall Study||1
317699|NCT01558297|760774|P2|NOT COMPLETED|Overall Study||2
317700|NCT01558297|760775|P1|NOT COMPLETED|Overall Study||2
317701|NCT01558297|760773|P3|COMPLETED|Overall Study||29
317702|NCT01558297|760774|P2|COMPLETED|Overall Study||27
317703|NCT01558297|760775|P1|COMPLETED|Overall Study||28
317704|NCT01558297|760773|P3|STARTED|Overall Study||30
317705|NCT01558297|760774|P2|STARTED|Overall Study||29
317706|NCT01558297|760775|P1|STARTED|Overall Study||30
317707|NCT01558271|760792|P3|NOT COMPLETED|Overall Study||17
317708|NCT01558271|760793|P2|NOT COMPLETED|Overall Study||11
317709|NCT01558271|760794|P1|NOT COMPLETED|Overall Study||18
317710|NCT01558271|760792|P3|COMPLETED|Overall Study||124
317711|NCT01558271|760793|P2|COMPLETED|Overall Study||59
317712|NCT01558271|760794|P1|COMPLETED|Overall Study||263
317713|NCT01558271|760792|P3|Completed 26 Weeks|Overall Study||128
317714|NCT01558271|760793|P2|Completed 26 Weeks|Overall Study||63
317715|NCT01558271|760794|P1|Completed 26 Weeks|Overall Study||271
317716|NCT01558271|760792|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
317717|NCT01558271|760793|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
317718|NCT01558271|760794|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
317719|NCT01558271|760792|P3|STARTED|Overall Study||141
317720|NCT01558271|760793|P2|STARTED|Overall Study||70
317721|NCT01558271|760794|P1|STARTED|Overall Study||281
317722|NCT01558128|760856|P1|NOT COMPLETED|Overall Study||0
317723|NCT01558128|760856|P1|COMPLETED|Overall Study||1
317724|NCT01558128|760856|P1|STARTED|Overall Study||1
317725|NCT01558089|760860|P1|NOT COMPLETED|Overall Study||13
317726|NCT01558089|760860|P1|COMPLETED|Overall Study||63
317727|NCT01558089|760860|P1|STARTED|Overall Study||76
317728|NCT01557959|760871|P1|NOT COMPLETED|Overall Study||0
317729|NCT01557959|760871|P1|COMPLETED|Overall Study||45
317730|NCT01557959|760871|P1|STARTED|Overall Study||45
317731|NCT01557920|760875|P2|NOT COMPLETED|Overall Study||3
317732|NCT01557920|760876|P1|NOT COMPLETED|Overall Study||3
317733|NCT01557920|760875|P2|COMPLETED|Overall Study||6
317734|NCT01557920|760876|P1|COMPLETED|Overall Study||6
317735|NCT01557920|760875|P2|STARTED|Overall Study||9
317736|NCT01557920|760876|P1|STARTED|Overall Study||9
317737|NCT01557894|760911|P2|NOT COMPLETED|Overall Study||5
317738|NCT01557894|760912|P1|NOT COMPLETED|Overall Study||3
317739|NCT01557894|760911|P2|COMPLETED|Overall Study||33
317740|NCT01557894|760912|P1|COMPLETED|Overall Study||35
317741|NCT01557894|760911|P2|STARTED|Overall Study||38
317742|NCT01557894|760912|P1|STARTED|Overall Study||38
317743|NCT01557868|760928|P2|NOT COMPLETED|Overall Study||30
317744|NCT01557868|760929|P1|NOT COMPLETED|Overall Study||27
317745|NCT01557868|760928|P2|COMPLETED|Overall Study||65
317746|NCT01557868|760929|P1|COMPLETED|Overall Study||76
317747|NCT01557868|760928|P2|STARTED|Overall Study||95
317748|NCT01557868|760929|P1|STARTED|Overall Study||103
317749|NCT01557842|760939|P2|NOT COMPLETED|Overall Study||6
317750|NCT01557842|760940|P1|NOT COMPLETED|Overall Study||9
317751|NCT01557842|760939|P2|COMPLETED|Overall Study||0
317752|NCT01557842|760940|P1|COMPLETED|Overall Study||0
317753|NCT01557842|760939|P2|STARTED|Overall Study||6
317754|NCT01557842|760940|P1|STARTED|Overall Study||9
317755|NCT01557699|760951|P3|NOT COMPLETED|Overall Study||0
317756|NCT01557699|760952|P2|NOT COMPLETED|Overall Study||0
317757|NCT01557699|760953|P1|NOT COMPLETED|Overall Study||0
317758|NCT01557699|760951|P3|COMPLETED|Overall Study||20
317759|NCT01557699|760952|P2|COMPLETED|Overall Study||20
317760|NCT01557699|760953|P1|COMPLETED|Overall Study||20
317761|NCT01557699|760951|P3|STARTED|Overall Study||20
317762|NCT01557699|760952|P2|STARTED|Overall Study||20
317763|NCT01557699|760953|P1|STARTED|Overall Study||20
317764|NCT01555567|760989|P4|NOT COMPLETED|Return to Activity||1
317765|NCT01555567|760990|P3|NOT COMPLETED|Return to Activity||0
317766|NCT01555567|760991|P2|NOT COMPLETED|Return to Activity||2
317767|NCT01555567|760992|P1|NOT COMPLETED|Return to Activity||1
317768|NCT01555567|760989|P4|COMPLETED|Return to Activity||8
317769|NCT01555567|760990|P3|COMPLETED|Return to Activity||8
317770|NCT01555567|760991|P2|COMPLETED|Return to Activity||10
317771|NCT01555567|760992|P1|COMPLETED|Return to Activity||10
317772|NCT01555567|760989|P4|STARTED|Return to Activity||9
317773|NCT01555567|760990|P3|STARTED|Return to Activity||8
317774|NCT01555567|760991|P2|STARTED|Return to Activity||12
317775|NCT01555567|760992|P1|STARTED|Return to Activity||11
317776|NCT01555567|760989|P4|NOT COMPLETED|12 Week||0
317777|NCT01555567|760990|P3|NOT COMPLETED|12 Week||1
317778|NCT01555567|760991|P2|NOT COMPLETED|12 Week||1
317779|NCT01555567|760992|P1|NOT COMPLETED|12 Week||1
317780|NCT01555567|760989|P4|COMPLETED|12 Week||9
317781|NCT01555567|760990|P3|COMPLETED|12 Week||8
317782|NCT01555567|760991|P2|COMPLETED|12 Week||12
317783|NCT01555567|760992|P1|COMPLETED|12 Week||11
317784|NCT01555567|760989|P4|STARTED|12 Week||9
317785|NCT01555567|760990|P3|STARTED|12 Week||9
317786|NCT01555567|760991|P2|STARTED|12 Week||13
317787|NCT01555567|760992|P1|STARTED|12 Week||12
317788|NCT01557595|761006|P1|NOT COMPLETED|Overall Study||8
317789|NCT01557595|761006|P1|COMPLETED|Overall Study||14
317790|NCT01557595|761006|P1|STARTED|Overall Study||22
317791|NCT01557582|761010|P1|NOT COMPLETED|Overall Study||6
317792|NCT01557582|761010|P1|COMPLETED|Overall Study||97
317793|NCT01557582|761010|P1|STARTED|Overall Study||103
317794|NCT01557569|761018|P2|NOT COMPLETED|Overall Study||7
317795|NCT01557569|761019|P1|NOT COMPLETED|Overall Study||5
317796|NCT01557569|761018|P2|COMPLETED|Overall Study||0
317797|NCT01557569|761019|P1|COMPLETED|Overall Study||1
317798|NCT01557569|761018|P2|Completed 2-wk Residential Stay|Overall Study||1
317799|NCT01557569|761019|P1|Completed 2-wk Residential Stay|Overall Study||3
317800|NCT01557569|761018|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
317801|NCT01557569|761019|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
317802|NCT01557504|761027|P2|NOT COMPLETED|Overall Study||0
317803|NCT01557504|761028|P1|NOT COMPLETED|Overall Study||1
317804|NCT01557504|761027|P2|COMPLETED|Overall Study||12
317805|NCT01557504|761028|P1|COMPLETED|Overall Study||12
317806|NCT01557504|761027|P2|STARTED|Overall Study||12
317807|NCT01557504|761028|P1|STARTED|Overall Study||13
317808|NCT01557348|761053|P2|NOT COMPLETED|Overall Study||90
317809|NCT01557348|761054|P1|NOT COMPLETED|Overall Study||80
317810|NCT01557348|761053|P2|COMPLETED|Overall Study||417
317811|NCT01557348|761054|P1|COMPLETED|Overall Study||524
317812|NCT01557348|761053|P2|Safety Population|Overall Study||507
317813|NCT01557348|761054|P1|Safety Population|Overall Study||604
317814|NCT01557348|761053|P2|STARTED|Overall Study||507
317815|NCT01557348|761054|P1|STARTED|Overall Study||604
317816|NCT01557322|761096|P2|NOT COMPLETED|Overall Study||0
317817|NCT01557322|761097|P1|NOT COMPLETED|Overall Study||0
317818|NCT01557322|761096|P2|COMPLETED|Overall Study||1543
317819|NCT01557322|761097|P1|COMPLETED|Overall Study||211
317820|NCT01557322|761096|P2|STARTED|Overall Study||1543
317821|NCT01557322|761097|P1|STARTED|Overall Study||211
317822|NCT01557283|761171|P1|NOT COMPLETED|Overall Study||44
317823|NCT01557283|761171|P1|COMPLETED|Overall Study||96
317824|NCT01557283|761171|P1|STARTED|Overall Study||140
317825|NCT01557166|761183|P2|NOT COMPLETED|Overall Study||37
317826|NCT01557166|761184|P1|NOT COMPLETED|Overall Study||46
317827|NCT01557166|761183|P2|COMPLETED|Overall Study||142
317828|NCT01557166|761184|P1|COMPLETED|Overall Study||134
317829|NCT01557166|761183|P2|Exposed|Overall Study||179
317830|NCT01557166|761184|P1|Exposed|Overall Study||176
317831|NCT01557166|761183|P2|STARTED|Overall Study||179
317832|NCT01557166|761184|P1|STARTED|Overall Study||180
317833|NCT01556997|761199|P3|NOT COMPLETED|Overall Study||32
317834|NCT01556997|761200|P2|NOT COMPLETED|Overall Study||28
317835|NCT01556997|761201|P1|NOT COMPLETED|Overall Study||26
317836|NCT01556997|761199|P3|COMPLETED|Overall Study||246
317837|NCT01556997|761200|P2|COMPLETED|Overall Study||252
317838|NCT01556997|761201|P1|COMPLETED|Overall Study||253
317839|NCT01556997|761199|P3|STARTED|Overall Study||278
317840|NCT01556997|761200|P2|STARTED|Overall Study||280
317841|NCT01556997|761201|P1|STARTED|Overall Study||279
317842|NCT01556932|761212|P2|NOT COMPLETED|Second Treament||0
317843|NCT01556932|761213|P1|NOT COMPLETED|Second Treament||0
317844|NCT01556932|761212|P2|COMPLETED|Second Treament||8
317845|NCT01556932|761213|P1|COMPLETED|Second Treament||12
317846|NCT01556932|761212|P2|Recieved|Second Treament||8
317847|NCT01556932|761213|P1|Recieved|Second Treament||12
317848|NCT01556932|761212|P2|STARTED|Second Treament||8
317849|NCT01556932|761213|P1|STARTED|Second Treament||12
317850|NCT01556932|761212|P2|NOT COMPLETED|Time Point 60 Minutes||1
317851|NCT01556932|761213|P1|NOT COMPLETED|Time Point 60 Minutes||1
317852|NCT01556932|761212|P2|COMPLETED|Time Point 60 Minutes||8
317853|NCT01556932|761213|P1|COMPLETED|Time Point 60 Minutes||12
317854|NCT01556932|761212|P2|Recieved|Time Point 60 Minutes||8
317855|NCT01556932|761213|P1|Recieved|Time Point 60 Minutes||12
317856|NCT01556932|761212|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
317857|NCT01556932|761213|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
317858|NCT01556932|761212|P2|NOT COMPLETED|Baseline First Treatment||0
317859|NCT01556932|761213|P1|NOT COMPLETED|Baseline First Treatment||0
317860|NCT01556932|761212|P2|COMPLETED|Baseline First Treatment||9
317861|NCT01556932|761213|P1|COMPLETED|Baseline First Treatment||13
317862|NCT01556932|761212|P2|Recieved|Baseline First Treatment||9
317863|NCT01556932|761213|P1|Recieved|Baseline First Treatment||13
317864|NCT01556932|761212|P2|STARTED|Baseline First Treatment||9
317865|NCT01556932|761213|P1|STARTED|Baseline First Treatment||13
317866|NCT01556906|761218|P1|NOT COMPLETED|Overall Study||0
317867|NCT01556906|761218|P1|COMPLETED|Overall Study||6
317868|NCT01556906|761218|P1|STARTED|Overall Study||6
317869|NCT01556763|761239|P3|NOT COMPLETED|Overall Study||0
317870|NCT01556763|761240|P2|NOT COMPLETED|Overall Study||1
317871|NCT01556763|761241|P1|NOT COMPLETED|Overall Study||0
317872|NCT01556763|761239|P3|COMPLETED|Overall Study||8
317873|NCT01556763|761240|P2|COMPLETED|Overall Study||8
317874|NCT01556763|761241|P1|COMPLETED|Overall Study||4
317875|NCT01556763|761239|P3|STARTED|Overall Study||8
317876|NCT01556763|761240|P2|STARTED|Overall Study||9
317877|NCT01556763|761241|P1|STARTED|Overall Study||4
317878|NCT01555463|761279|P2|NOT COMPLETED|Follow up||45
317879|NCT01555463|761280|P1|NOT COMPLETED|Follow up||38
317880|NCT01555463|761279|P2|COMPLETED|Follow up||394
317881|NCT01555463|761280|P1|COMPLETED|Follow up||409
317882|NCT01555463|761279|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
317883|NCT01555463|761280|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
317884|NCT01555463|761279|P2|NOT COMPLETED|Treatment||79
317885|NCT01555463|761280|P1|NOT COMPLETED|Treatment||64
317886|NCT01555463|761279|P2|COMPLETED|Treatment||399
317887|NCT01555463|761280|P1|COMPLETED|Treatment||419
317888|NCT01555463|761279|P2|STARTED|Treatment||478
317889|NCT01555463|761280|P1|STARTED|Treatment||483
317890|NCT01556724|761322|P2|NOT COMPLETED|Overall Study||0
317891|NCT01556724|761323|P1|NOT COMPLETED|Overall Study||0
317892|NCT01556724|761322|P2|COMPLETED|Overall Study||15
317893|NCT01556724|761323|P1|COMPLETED|Overall Study||15
317894|NCT01556724|761322|P2|STARTED|Overall Study||15
317895|NCT01556724|761323|P1|STARTED|Overall Study||15
317896|NCT01556633|761331|P2|NOT COMPLETED|Overall Study||0
317897|NCT01556633|761332|P1|NOT COMPLETED|Overall Study||0
317898|NCT01556633|761331|P2|COMPLETED|Overall Study||6
317899|NCT01556633|761332|P1|COMPLETED|Overall Study||10
317900|NCT01556633|761331|P2|STARTED|Overall Study||6
317901|NCT01556633|761332|P1|STARTED|Overall Study||10
317902|NCT01556594|761357|P3|NOT COMPLETED|Overall Study||0
317903|NCT01556594|761358|P2|NOT COMPLETED|Overall Study||0
317904|NCT01556594|761359|P1|NOT COMPLETED|Overall Study||0
317905|NCT01556594|761357|P3|COMPLETED|Overall Study||6
317906|NCT01556594|761358|P2|COMPLETED|Overall Study||2
317907|NCT01556594|761359|P1|COMPLETED|Overall Study||10
317908|NCT01556594|761357|P3|STARTED|Overall Study||6
317909|NCT01556594|761358|P2|STARTED|Overall Study||2
317910|NCT01556594|761359|P1|STARTED|Overall Study||10
317911|NCT01556451|761377|P1|NOT COMPLETED|Overall Study||0
317912|NCT01556451|761377|P1|COMPLETED|Overall Study||180
317913|NCT01556451|761377|P1|STARTED|Overall Study||180
317914|NCT01556204|761386|P2|NOT COMPLETED|Overall Study||0
317915|NCT01556204|761387|P1|NOT COMPLETED|Overall Study||0
317916|NCT01556204|761386|P2|COMPLETED|Overall Study||38
317917|NCT01556204|761387|P1|COMPLETED|Overall Study||35
317918|NCT01556204|761386|P2|STARTED|Overall Study||38
317919|NCT01556204|761387|P1|STARTED|Overall Study||35
317920|NCT01556165|761397|P2|NOT COMPLETED|Overall Study||7
317921|NCT01556165|761398|P1|NOT COMPLETED|Overall Study||12
317922|NCT01556165|761397|P2|COMPLETED|Overall Study||58
317923|NCT01556165|761398|P1|COMPLETED|Overall Study||53
317924|NCT01556165|761397|P2|STARTED|Overall Study||65
317925|NCT01556165|761398|P1|STARTED|Overall Study||65
317926|NCT01556061|761412|P2|NOT COMPLETED|Overall Study||0
317927|NCT01556061|761413|P1|NOT COMPLETED|Overall Study||0
317928|NCT01556061|761412|P2|COMPLETED|Overall Study||25
317929|NCT01556061|761413|P1|COMPLETED|Overall Study||25
317930|NCT01556061|761412|P2|STARTED|Overall Study||25
317931|NCT01556061|761413|P1|STARTED|Overall Study||25
317932|NCT01555983|761423|P6|NOT COMPLETED|Overall Study||1
317933|NCT01555983|761424|P5|NOT COMPLETED|Overall Study||1
317934|NCT01555983|761425|P4|NOT COMPLETED|Overall Study||0
317935|NCT01555983|761426|P3|NOT COMPLETED|Overall Study||0
317936|NCT01555983|761427|P2|NOT COMPLETED|Overall Study||0
317937|NCT01555983|761428|P1|NOT COMPLETED|Overall Study||1
317938|NCT01555983|761423|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
317939|NCT01555983|761424|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
317940|NCT01555983|761425|P4|COMPLETED|Overall Study||7
317941|NCT01555983|761426|P3|COMPLETED|Overall Study||7
317942|NCT01555983|761427|P2|COMPLETED|Overall Study||7
317943|NCT01555983|761428|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
317944|NCT01555983|761423|P6|STARTED|Overall Study||7
317945|NCT01555983|761424|P5|STARTED|Overall Study||5
317946|NCT01555983|761425|P4|STARTED|Overall Study||7
317947|NCT01555983|761426|P3|STARTED|Overall Study||7
317948|NCT01555983|761427|P2|STARTED|Overall Study||7
317949|NCT01555983|761428|P1|STARTED|Overall Study||9
317950|NCT01555931|761438|P2|NOT COMPLETED|Overall Study||5
317951|NCT01555931|761439|P1|NOT COMPLETED|Overall Study||2
317952|NCT01555931|761438|P2|COMPLETED|Overall Study||13
317953|NCT01555931|761439|P1|COMPLETED|Overall Study||15
317954|NCT01555931|761438|P2|STARTED|Overall Study||18
317955|NCT01555931|761439|P1|STARTED|Overall Study||17
317956|NCT01555164|761449|P2|NOT COMPLETED|Overall Study||35
317957|NCT01555164|761450|P1|NOT COMPLETED|Overall Study||40
317958|NCT01555164|761449|P2|COMPLETED|Overall Study||185
317959|NCT01555164|761450|P1|COMPLETED|Overall Study||182
317960|NCT01555164|761449|P2|STARTED|Overall Study||220
317961|NCT01555164|761450|P1|STARTED|Overall Study||222
317962|NCT01555151|761464|P4|NOT COMPLETED|Overall Study||10
317963|NCT01555151|761465|P3|NOT COMPLETED|Overall Study||6
317964|NCT01555151|761466|P2|NOT COMPLETED|Overall Study||8
317965|NCT01555151|761467|P1|NOT COMPLETED|Overall Study||13
317966|NCT01555151|761464|P4|COMPLETED|Overall Study||176
317967|NCT01555151|761465|P3|COMPLETED|Overall Study||178
317968|NCT01555151|761466|P2|COMPLETED|Overall Study||173
317969|NCT01555151|761467|P1|COMPLETED|Overall Study||175
317970|NCT01555151|761464|P4|Safety Set (SAF)|Overall Study||186
317971|NCT01555151|761465|P3|Safety Set (SAF)|Overall Study||183
317972|NCT01555151|761466|P2|Safety Set (SAF)|Overall Study||180
317973|NCT01555151|761467|P1|Safety Set (SAF)|Overall Study||186
317974|NCT01555151|761464|P4|STARTED|Overall Study||186
317975|NCT01555151|761465|P3|STARTED|Overall Study||184
317976|NCT01555151|761466|P2|STARTED|Overall Study||181
317977|NCT01555151|761467|P1|STARTED|Overall Study||188
317978|NCT01555138|761520|P2|NOT COMPLETED|Overall Study||38
317979|NCT01555138|761521|P1|NOT COMPLETED|Overall Study||47
317980|NCT01555138|761520|P2|COMPLETED|Overall Study||250
317981|NCT01555138|761521|P1|COMPLETED|Overall Study||246
317982|NCT01555138|761520|P2|STARTED|Overall Study||288
317983|NCT01555138|761521|P1|STARTED|Overall Study||293
317984|NCT01555073|761551|P4|NOT COMPLETED|Overall Study||5
317985|NCT01555073|761552|P3|NOT COMPLETED|Overall Study||0
317986|NCT01555073|761553|P2|NOT COMPLETED|Overall Study||2
317987|NCT01555073|761554|P1|NOT COMPLETED|Overall Study||1
317988|NCT01555073|761551|P4|COMPLETED|Overall Study||1
317989|NCT01555073|761552|P3|COMPLETED|Overall Study||7
317990|NCT01555073|761553|P2|COMPLETED|Overall Study||1
317991|NCT01555073|761554|P1|COMPLETED|Overall Study||6
317992|NCT01555073|761551|P4|STARTED|Overall Study||6
317993|NCT01555073|761552|P3|STARTED|Overall Study||7
317994|NCT01555073|761553|P2|STARTED|Overall Study||3
317995|NCT01555073|761554|P1|STARTED|Overall Study||7
317996|NCT01554982|761568|P1|NOT COMPLETED|Overall Study||43
317997|NCT01554982|761568|P1|COMPLETED|Overall Study||125
317998|NCT01554982|761568|P1|Received Drug|Overall Study||166
317999|NCT01554982|761568|P1|STARTED|Overall Study||168
318000|NCT01554904|761581|P1|NOT COMPLETED|Overall Study||4
318001|NCT01554904|761581|P1|COMPLETED|Overall Study||14
318002|NCT01554904|761581|P1|Home Sleep Study 2|Overall Study||14
318003|NCT01554904|761581|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
318004|NCT01554904|761581|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
318005|NCT01554904|761581|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
318006|NCT01554904|761581|P1|STARTED|Overall Study||18
318007|NCT01554891|761589|P3|NOT COMPLETED|Overall Study||2
318008|NCT01554891|761590|P2|NOT COMPLETED|Overall Study||5
318009|NCT01554891|761591|P1|NOT COMPLETED|Overall Study||7
318010|NCT01554891|761589|P3|COMPLETED|Overall Study||55
318011|NCT01554891|761590|P2|COMPLETED|Overall Study||115
318012|NCT01554891|761591|P1|COMPLETED|Overall Study||98
318013|NCT01554891|761589|P3|STARTED|Overall Study||57
318014|NCT01554891|761590|P2|STARTED|Overall Study||120
318015|NCT01554891|761591|P1|STARTED|Overall Study||105
318016|NCT01554579|761601|P2|NOT COMPLETED|Overall Study||27
318017|NCT01554579|761602|P1|NOT COMPLETED|Overall Study||10
318018|NCT01554579|761601|P2|COMPLETED|Overall Study||58
318019|NCT01554579|761602|P1|COMPLETED|Overall Study||76
318020|NCT01554579|761601|P2|STARTED|Overall Study||85
318021|NCT01554579|761602|P1|STARTED|Overall Study||86
318022|NCT01554241|761616|P4|NOT COMPLETED|Overall Study||1
318023|NCT01554241|761617|P3|NOT COMPLETED|Overall Study||4
318024|NCT01554241|761618|P2|NOT COMPLETED|Overall Study||1
318025|NCT01554241|761619|P1|NOT COMPLETED|Overall Study||3
318026|NCT01554241|761616|P4|COMPLETED|Overall Study||13
318027|NCT01554241|761617|P3|COMPLETED|Overall Study||20
318028|NCT01554241|761618|P2|COMPLETED|Overall Study||19
318029|NCT01554241|761619|P1|COMPLETED|Overall Study||20
318030|NCT01554241|761616|P4|STARTED|Overall Study||14
318031|NCT01554241|761617|P3|STARTED|Overall Study||24
318032|NCT01554241|761618|P2|STARTED|Overall Study||20
318033|NCT01554241|761619|P1|STARTED|Overall Study||23
318034|NCT01554176|761635|P5|NOT COMPLETED|Run-out Phase||0
318035|NCT01554176|761636|P4|NOT COMPLETED|Run-out Phase||1
318036|NCT01554176|761637|P3|NOT COMPLETED|Run-out Phase||0
318037|NCT01554176|761638|P2|NOT COMPLETED|Run-out Phase||0
318038|NCT01554176|761639|P1|NOT COMPLETED|Run-out Phase||0
318039|NCT01554176|761635|P5|COMPLETED|Run-out Phase||59
318040|NCT01554176|761636|P4|COMPLETED|Run-out Phase||27
318041|NCT01554176|761637|P3|COMPLETED|Run-out Phase||29
318042|NCT01554176|761638|P2|COMPLETED|Run-out Phase||0
318043|NCT01554176|761639|P1|COMPLETED|Run-out Phase||0
318044|NCT01554176|761635|P5|Treated|Run-out Phase||59
318045|NCT01554176|761636|P4|Treated|Run-out Phase||28
318046|NCT01554176|761637|P3|Treated|Run-out Phase||29
318047|NCT01554176|761638|P2|Treated|Run-out Phase||0
318048|NCT01554176|761639|P1|Treated|Run-out Phase||0
318049|NCT01554176|761635|P5|STARTED|Run-out Phase||59
318050|NCT01554176|761636|P4|STARTED|Run-out Phase||28
318051|NCT01554176|761637|P3|STARTED|Run-out Phase||29
318052|NCT01554176|761638|P2|STARTED|Run-out Phase||0
318053|NCT01554176|761639|P1|STARTED|Run-out Phase||0
318054|NCT01554176|761635|P5|NOT COMPLETED|Treatment Phase||0
318055|NCT01554176|761636|P4|NOT COMPLETED|Treatment Phase||0
318056|NCT01554176|761637|P3|NOT COMPLETED|Treatment Phase||0
318057|NCT01554176|761638|P2|NOT COMPLETED|Treatment Phase||5
318058|NCT01554176|761639|P1|NOT COMPLETED|Treatment Phase||8
318059|NCT01554176|761635|P5|COMPLETED|Treatment Phase||0
318060|NCT01554176|761636|P4|COMPLETED|Treatment Phase||0
318061|NCT01554176|761637|P3|COMPLETED|Treatment Phase||0
318062|NCT01554176|761638|P2|COMPLETED|Treatment Phase||59
318063|NCT01554176|761639|P1|COMPLETED|Treatment Phase||57
318064|NCT01554176|761635|P5|Treated|Treatment Phase||0
318065|NCT01554176|761636|P4|Treated|Treatment Phase||0
318066|NCT01554176|761637|P3|Treated|Treatment Phase||0
318067|NCT01554176|761638|P2|Treated|Treatment Phase||64
318068|NCT01554176|761639|P1|Treated|Treatment Phase||64
318069|NCT01554176|761635|P5|STARTED|Treatment Phase||0
318070|NCT01554176|761636|P4|STARTED|Treatment Phase||0
318071|NCT01554176|761637|P3|STARTED|Treatment Phase||0
318072|NCT01554176|761638|P2|STARTED|Treatment Phase||64
318073|NCT01554176|761639|P1|STARTED|Treatment Phase||65
318074|NCT01554163|761666|P2|NOT COMPLETED|Overall Study||10
318075|NCT01554163|761667|P1|NOT COMPLETED|Overall Study||8
318076|NCT01554163|761666|P2|COMPLETED|Overall Study||109
318077|NCT01554163|761667|P1|COMPLETED|Overall Study||112
318078|NCT01554163|761666|P2|Number Treated|Overall Study||119
318079|NCT01554163|761667|P1|Number Treated|Overall Study||119
318080|NCT01554163|761666|P2|STARTED|Overall Study||119
318081|NCT01554163|761667|P1|STARTED|Overall Study||120
318082|NCT01553851|761685|P1|NOT COMPLETED|Overall Study||3
318083|NCT01553851|761685|P1|COMPLETED|Overall Study||17
318084|NCT01553851|761685|P1|STARTED|Overall Study||20
318085|NCT01553708|761699|P2|NOT COMPLETED|Overall Study||0
318086|NCT01553708|761700|P1|NOT COMPLETED|Overall Study||0
318087|NCT01553708|761699|P2|COMPLETED|Overall Study||17
318088|NCT01553708|761700|P1|COMPLETED|Overall Study||17
318089|NCT01553708|761699|P2|STARTED|Overall Study||17
318090|NCT01553708|761700|P1|STARTED|Overall Study||17
318091|NCT01553539|761706|P1|NOT COMPLETED|Overall Study||0
318092|NCT01553539|761706|P1|COMPLETED|Overall Study||20
318093|NCT01553539|761706|P1|STARTED|Overall Study||20
318094|NCT01553318|761713|P2|NOT COMPLETED|Overall Study||2
318095|NCT01553318|761714|P1|NOT COMPLETED|Overall Study||3
318096|NCT01553318|761713|P2|COMPLETED|Overall Study||25
318097|NCT01553318|761714|P1|COMPLETED|Overall Study||21
318098|NCT01553318|761713|P2|STARTED|Overall Study||27
318099|NCT01553318|761714|P1|STARTED|Overall Study||24
318100|NCT01553292|761726|P1|NOT COMPLETED|Overall Study||0
318101|NCT01553292|761726|P1|COMPLETED|Overall Study||21
318102|NCT01553292|761726|P1|STARTED|Overall Study||21
318103|NCT01553240|761742|P1|NOT COMPLETED|Overall Study||0
318104|NCT01553240|761742|P1|COMPLETED|Overall Study||0
318105|NCT01553240|761742|P1|STARTED|Overall Study||0
318106|NCT01552954|761749|P2|NOT COMPLETED|Overall Study||6
318107|NCT01552954|761750|P1|NOT COMPLETED|Overall Study||5
318108|NCT01552954|761749|P2|COMPLETED|Overall Study||119
318109|NCT01552954|761750|P1|COMPLETED|Overall Study||126
318110|NCT01552954|761749|P2|STARTED|Overall Study||125
318111|NCT01552954|761750|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
318112|NCT01552928|761766|P4|NOT COMPLETED|Period 4||0
318113|NCT01552928|761767|P3|NOT COMPLETED|Period 4||0
318114|NCT01552928|761768|P2|NOT COMPLETED|Period 4||0
318115|NCT01552928|761769|P1|NOT COMPLETED|Period 4||0
318116|NCT01552928|761766|P4|COMPLETED|Period 4||16
318117|NCT01552928|761767|P3|COMPLETED|Period 4||14
318118|NCT01552928|761768|P2|COMPLETED|Period 4||15
318119|NCT01552928|761769|P1|COMPLETED|Period 4||14
318120|NCT01552928|761766|P4|STARTED|Period 4||16
318121|NCT01552928|761767|P3|STARTED|Period 4||14
318122|NCT01552928|761768|P2|STARTED|Period 4||15
318123|NCT01552928|761769|P1|STARTED|Period 4||14
318124|NCT01552928|761766|P4|NOT COMPLETED|Period 3||0
318125|NCT01552928|761767|P3|NOT COMPLETED|Period 3||1
318126|NCT01552928|761768|P2|NOT COMPLETED|Period 3||0
318127|NCT01552928|761769|P1|NOT COMPLETED|Period 3||0
318128|NCT01552928|761766|P4|COMPLETED|Period 3||16
318129|NCT01552928|761767|P3|COMPLETED|Period 3||14
318130|NCT01552928|761768|P2|COMPLETED|Period 3||15
318131|NCT01552928|761769|P1|COMPLETED|Period 3||14
318132|NCT01552928|761766|P4|STARTED|Period 3||16
318133|NCT01552928|761767|P3|STARTED|Period 3||15
318134|NCT01552928|761768|P2|STARTED|Period 3||15
318135|NCT01552928|761769|P1|STARTED|Period 3||14
318136|NCT01552928|761766|P4|NOT COMPLETED|Period 2||0
318137|NCT01552928|761767|P3|NOT COMPLETED|Period 2||0
318138|NCT01552928|761768|P2|NOT COMPLETED|Period 2||0
318139|NCT01552928|761769|P1|NOT COMPLETED|Period 2||0
318140|NCT01552928|761766|P4|COMPLETED|Period 2||16
318141|NCT01552928|761767|P3|COMPLETED|Period 2||15
318142|NCT01552928|761768|P2|COMPLETED|Period 2||15
318143|NCT01552928|761769|P1|COMPLETED|Period 2||14
318144|NCT01552928|761766|P4|STARTED|Period 2||16
318145|NCT01552928|761767|P3|STARTED|Period 2||15
318146|NCT01552928|761768|P2|STARTED|Period 2||15
318147|NCT01552928|761769|P1|STARTED|Period 2||14
318148|NCT01552928|761766|P4|NOT COMPLETED|Period 1||0
318149|NCT01552928|761767|P3|NOT COMPLETED|Period 1||0
318150|NCT01552928|761768|P2|NOT COMPLETED|Period 1||0
318151|NCT01552928|761769|P1|NOT COMPLETED|Period 1||0
318152|NCT01552928|761766|P4|COMPLETED|Period 1||16
318153|NCT01552928|761767|P3|COMPLETED|Period 1||15
318154|NCT01552928|761768|P2|COMPLETED|Period 1||15
318155|NCT01552928|761769|P1|COMPLETED|Period 1||14
318156|NCT01552928|761766|P4|STARTED|Period 1||16
318157|NCT01552928|761767|P3|STARTED|Period 1||15
318158|NCT01552928|761768|P2|STARTED|Period 1||15
318159|NCT01552928|761769|P1|STARTED|Period 1||14
318160|NCT01552915|761816|P3|NOT COMPLETED|Overall Study||27
318161|NCT01552915|761817|P2|NOT COMPLETED|Overall Study||29
318162|NCT01552915|761818|P1|NOT COMPLETED|Overall Study||23
318163|NCT01552915|761816|P3|COMPLETED|Overall Study||157
318164|NCT01552915|761817|P2|COMPLETED|Overall Study||155
318165|NCT01552915|761818|P1|COMPLETED|Overall Study||68
318166|NCT01552915|761816|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
318167|NCT01552915|761817|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
318168|NCT01552915|761818|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
318169|NCT01552902|761841|P3|NOT COMPLETED|Overall Study||33
318170|NCT01552902|761842|P2|NOT COMPLETED|Overall Study||37
318171|NCT01552902|761843|P1|NOT COMPLETED|Overall Study||13
318172|NCT01552902|761841|P3|COMPLETED|Overall Study||186
318173|NCT01552902|761842|P2|COMPLETED|Overall Study||181
318174|NCT01552902|761843|P1|COMPLETED|Overall Study||97
318175|NCT01552902|761841|P3|STARTED|Overall Study||219
318176|NCT01552902|761842|P2|STARTED|Overall Study||218
318177|NCT01552902|761843|P1|STARTED|Overall Study||110
318178|NCT01552889|761865|P2|NOT COMPLETED|Overall Study||5
318179|NCT01552889|761866|P1|NOT COMPLETED|Overall Study||11
318180|NCT01552889|761865|P2|COMPLETED|Overall Study||95
318181|NCT01552889|761866|P1|COMPLETED|Overall Study||90
318182|NCT01552889|761865|P2|STARTED|Overall Study||100
318183|NCT01552889|761866|P1|STARTED|Overall Study||101
318184|NCT01552876|761876|P2|NOT COMPLETED|Overall Study||0
318185|NCT01552876|761877|P1|NOT COMPLETED|Overall Study||0
318186|NCT01552876|761876|P2|COMPLETED|Overall Study||20
318187|NCT01552876|761877|P1|COMPLETED|Overall Study||20
318188|NCT01552876|761876|P2|STARTED|Overall Study||20
318189|NCT01552876|761877|P1|STARTED|Overall Study||20
318190|NCT01552772|761893|P1|NOT COMPLETED|Overall Study||4
318191|NCT01552772|761893|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
318192|NCT01552772|761893|P1|STARTED|Overall Study||60
318193|NCT01552694|761909|P2|NOT COMPLETED|Overall Study||2
318194|NCT01552694|761910|P1|NOT COMPLETED|Overall Study||0
318195|NCT01552694|761909|P2|COMPLETED|Overall Study||18
318196|NCT01552694|761910|P1|COMPLETED|Overall Study||18
318197|NCT01552694|761909|P2|STARTED|Overall Study||20
318198|NCT01552694|761910|P1|STARTED|Overall Study||18
318199|NCT01552681|761922|P2|NOT COMPLETED|Overall Study||1
318200|NCT01552681|761923|P1|NOT COMPLETED|Overall Study||5
318201|NCT01552681|761922|P2|COMPLETED|Overall Study||18
318202|NCT01552681|761923|P1|COMPLETED|Overall Study||28
318203|NCT01552681|761922|P2|STARTED|Overall Study||19
318204|NCT01552681|761923|P1|STARTED|Overall Study||33
318205|NCT01552603|761971|P1|NOT COMPLETED|Overall Study||1
318206|NCT01552603|761971|P1|COMPLETED|Overall Study||13
318207|NCT01552603|761971|P1|STARTED|Overall Study||14
318208|NCT01552343|761978|P2|NOT COMPLETED|Overall Study||0
318209|NCT01552343|761979|P1|NOT COMPLETED|Overall Study||0
318210|NCT01552343|761978|P2|COMPLETED|Overall Study||27
318211|NCT01552343|761979|P1|COMPLETED|Overall Study||29
318212|NCT01552343|761978|P2|STARTED|Overall Study||27
318213|NCT01552343|761979|P1|STARTED|Overall Study||29
318214|NCT01552057|762001|P2|NOT COMPLETED|Overall Study||48
318215|NCT01552057|762002|P1|NOT COMPLETED|Overall Study||30
318216|NCT01552057|762001|P2|COMPLETED|Overall Study||149
318217|NCT01552057|762002|P1|COMPLETED|Overall Study||166
318218|NCT01552057|762001|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
318219|NCT01552057|762002|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
318220|NCT01552057|762001|P2|STARTED|Overall Study||197
318221|NCT01552057|762002|P1|STARTED|Overall Study||196
318222|NCT01551979|762036|P2|NOT COMPLETED|Overall Study||2
318223|NCT01551979|762037|P1|NOT COMPLETED|Overall Study||2
318224|NCT01551979|762036|P2|COMPLETED|Overall Study||6
318225|NCT01551979|762037|P1|COMPLETED|Overall Study||7
318226|NCT01551979|762036|P2|1 Week Post Treatment|Overall Study||7
318227|NCT01551979|762037|P1|1 Week Post Treatment|Overall Study||9
318228|NCT01551979|762036|P2|Last Day of Treatment (After 5 Days of t|Overall Study||8
318229|NCT01551979|762037|P1|Last Day of Treatment (After 5 Days of t|Overall Study||9
318230|NCT01551979|762036|P2|STARTED|Overall Study||8
318231|NCT01551979|762037|P1|STARTED|Overall Study||9
318232|NCT01551888|762053|P2|NOT COMPLETED|Period 2||0
318233|NCT01551888|762054|P1|NOT COMPLETED|Period 2||0
318234|NCT01551888|762053|P2|COMPLETED|Period 2||12
318235|NCT01551888|762054|P1|COMPLETED|Period 2||12
318236|NCT01551888|762053|P2|STARTED|Period 2||12
318237|NCT01551888|762054|P1|STARTED|Period 2||12
318238|NCT01551888|762053|P2|NOT COMPLETED|Period 1||0
318239|NCT01551888|762054|P1|NOT COMPLETED|Period 1||0
318240|NCT01551888|762053|P2|COMPLETED|Period 1||12
318241|NCT01551888|762054|P1|COMPLETED|Period 1||12
318242|NCT01551888|762053|P2|STARTED|Period 1||12
318243|NCT01551888|762054|P1|STARTED|Period 1||12
318244|NCT01551758|762068|P2|NOT COMPLETED|Overall Study||105
318245|NCT01551758|762069|P1|NOT COMPLETED|Overall Study||94
318246|NCT01551758|762068|P2|COMPLETED|Overall Study||1291
318247|NCT01551758|762069|P1|COMPLETED|Overall Study||1309
318248|NCT01551758|762068|P2|STARTED|Overall Study||1396
318249|NCT01551758|762069|P1|STARTED|Overall Study||1403
318250|NCT01551693|762109|P2|NOT COMPLETED|Overall Study||2
318251|NCT01551693|762110|P1|NOT COMPLETED|Overall Study||1
318252|NCT01551693|762109|P2|COMPLETED|Overall Study||0
318253|NCT01551693|762110|P1|COMPLETED|Overall Study||0
318254|NCT01551693|762109|P2|STARTED|Overall Study||2
318255|NCT01551693|762110|P1|STARTED|Overall Study||1
318256|NCT01551355|762126|P6|NOT COMPLETED|Overall Study||6
318257|NCT01551355|762127|P5|NOT COMPLETED|Overall Study||9
318258|NCT01551355|762128|P4|NOT COMPLETED|Overall Study||24
318259|NCT01551355|762129|P3|NOT COMPLETED|Overall Study||34
318260|NCT01551355|762130|P2|NOT COMPLETED|Overall Study||49
318261|NCT01551355|762131|P1|NOT COMPLETED|Overall Study||51
318262|NCT01551355|762126|P6|COMPLETED|Overall Study||65
318263|NCT01551355|762127|P5|COMPLETED|Overall Study||55
318264|NCT01551355|762128|P4|COMPLETED|Overall Study||411
318265|NCT01551355|762129|P3|COMPLETED|Overall Study||459
318266|NCT01551355|762130|P2|COMPLETED|Overall Study||545
318267|NCT01551355|762131|P1|COMPLETED|Overall Study||571
318268|NCT01551355|762126|P6|STARTED|Overall Study||71
318269|NCT01551355|762127|P5|STARTED|Overall Study||64
318270|NCT01551355|762128|P4|STARTED|Overall Study||435
318271|NCT01551355|762129|P3|STARTED|Overall Study||493
318272|NCT01551355|762130|P2|STARTED|Overall Study||594
318273|NCT01551355|762131|P1|STARTED|Overall Study||622
318274|NCT01551303|762145|P2|NOT COMPLETED|Overall Study||7
318275|NCT01551303|762146|P1|NOT COMPLETED|Overall Study||4
318276|NCT01551303|762145|P2|COMPLETED|Overall Study||15
318277|NCT01551303|762146|P1|COMPLETED|Overall Study||21
318278|NCT01551303|762145|P2|STARTED|Overall Study||22
318279|NCT01551303|762146|P1|STARTED|Overall Study||25
318280|NCT01551199|762152|P1|NOT COMPLETED|Overall Study||5
318281|NCT01551199|762152|P1|COMPLETED|Overall Study||2
318282|NCT01551199|762152|P1|STARTED|Overall Study||7
318283|NCT01551173|762160|P2|NOT COMPLETED|Overall Study||32
318284|NCT01551173|762161|P1|NOT COMPLETED|Overall Study||28
318285|NCT01551173|762160|P2|COMPLETED|Overall Study||186
318286|NCT01551173|762161|P1|COMPLETED|Overall Study||190
318287|NCT01551173|762160|P2|Full Analysis Set (FAS)|Overall Study||214
318288|NCT01551173|762161|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
318289|NCT01551173|762160|P2|STARTED|Overall Study||218
318290|NCT01551173|762161|P1|STARTED|Overall Study|"Started indicates randomized"|218
318291|NCT01551095|762172|P1|NOT COMPLETED|Overall Study||0
318292|NCT01551095|762172|P1|COMPLETED|Overall Study||7
318293|NCT01551095|762172|P1|STARTED|Overall Study||7
318294|NCT01551082|762177|P1|NOT COMPLETED|Overall Study||0
318295|NCT01551082|762177|P1|COMPLETED|Overall Study||12
318296|NCT01551082|762177|P1|STARTED|Overall Study||12
318297|NCT01550965|762181|P1|NOT COMPLETED|Overall Study||110
318298|NCT01550965|762181|P1|COMPLETED|Overall Study||353
318299|NCT01550965|762181|P1|STARTED|Overall Study||463
318300|NCT01550952|762200|P1|NOT COMPLETED|Overall Study||0
318301|NCT01550952|762200|P1|COMPLETED|Overall Study||10
318302|NCT01550952|762200|P1|STARTED|Overall Study||10
318303|NCT01550809|762210|P2|NOT COMPLETED|Overall Study||0
318304|NCT01550809|762211|P1|NOT COMPLETED|Overall Study||0
318305|NCT01550809|762210|P2|COMPLETED|Overall Study||6
318306|NCT01550809|762211|P1|COMPLETED|Overall Study||6
318307|NCT01550809|762210|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
318308|NCT01550809|762211|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
318309|NCT01550744|762221|P3|NOT COMPLETED|Double-Blind||67
318310|NCT01550744|762222|P2|NOT COMPLETED|Double-Blind||17
318311|NCT01550744|762223|P1|NOT COMPLETED|Double-Blind||0
318312|NCT01550744|762221|P3|COMPLETED|Double-Blind||235
318313|NCT01550744|762222|P2|COMPLETED|Double-Blind||59
318314|NCT01550744|762223|P1|COMPLETED|Double-Blind||0
318315|NCT01550744|762221|P3|STARTED|Double-Blind||302
318316|NCT01550744|762222|P2|STARTED|Double-Blind||76
318317|NCT01550744|762223|P1|STARTED|Double-Blind||0
318318|NCT01550744|762221|P3|NOT COMPLETED|Open-Label||0
318319|NCT01550744|762222|P2|NOT COMPLETED|Open-Label||0
318320|NCT01550744|762223|P1|NOT COMPLETED|Open-Label||100
318321|NCT01550744|762221|P3|COMPLETED|Open-Label||0
318322|NCT01550744|762222|P2|COMPLETED|Open-Label||0
318323|NCT01550744|762223|P1|COMPLETED|Open-Label||378
318324|NCT01550744|762221|P3|STARTED|Open-Label||0
318325|NCT01550744|762222|P2|STARTED|Open-Label||0
318326|NCT01550744|762223|P1|STARTED|Open-Label||478
318327|NCT01550705|762236|P1|NOT COMPLETED|Overall Study||1
318328|NCT01550705|762236|P1|COMPLETED|Overall Study||10
318329|NCT01550705|762236|P1|STARTED|Overall Study||11
318330|NCT01550549|762241|P1|NOT COMPLETED|Overall Study||0
318331|NCT01550549|762241|P1|COMPLETED|Overall Study||151
318332|NCT01550549|762241|P1|STARTED|Overall Study||151
318333|NCT01550302|762255|P2|NOT COMPLETED|Overall Study||0
318334|NCT01550302|762256|P1|NOT COMPLETED|Overall Study||0
318335|NCT01550302|762255|P2|COMPLETED|Overall Study||5
318336|NCT01550302|762256|P1|COMPLETED|Overall Study||5
318337|NCT01550302|762255|P2|STARTED|Overall Study||5
318338|NCT01550302|762256|P1|STARTED|Overall Study||5
318339|NCT01550289|762264|P2|NOT COMPLETED|Overall Study||4
318340|NCT01550289|762265|P1|NOT COMPLETED|Overall Study||13
318341|NCT01550289|762264|P2|COMPLETED|Overall Study||57
318342|NCT01550289|762265|P1|COMPLETED|Overall Study||115
318343|NCT01550289|762264|P2|STARTED|Overall Study||61
318344|NCT01550289|762265|P1|STARTED|Overall Study||128
318345|NCT01549977|762297|P2|NOT COMPLETED|Overall Study||0
318346|NCT01549977|762298|P1|NOT COMPLETED|Overall Study||0
318347|NCT01549977|762297|P2|COMPLETED|Overall Study||0
318348|NCT01549977|762298|P1|COMPLETED|Overall Study||1
318349|NCT01549977|762297|P2|STARTED|Overall Study||0
318350|NCT01549977|762298|P1|STARTED|Overall Study||1
318351|NCT01549964|762316|P4|NOT COMPLETED|80-Week Extension Period||137
318352|NCT01549964|762317|P3|NOT COMPLETED|80-Week Extension Period||140
318353|NCT01549964|762318|P2|NOT COMPLETED|80-Week Extension Period||138
318354|NCT01549964|762319|P1|NOT COMPLETED|80-Week Extension Period||66
318355|NCT01549964|762316|P4|COMPLETED|80-Week Extension Period||0
318356|NCT01549964|762317|P3|COMPLETED|80-Week Extension Period||0
318357|NCT01549964|762318|P2|COMPLETED|80-Week Extension Period||0
318358|NCT01549964|762319|P1|COMPLETED|80-Week Extension Period||0
318359|NCT01549964|762316|P4|STARTED|80-Week Extension Period||137
318360|NCT01549964|762317|P3|STARTED|80-Week Extension Period||140
318361|NCT01549964|762318|P2|STARTED|80-Week Extension Period||138
318362|NCT01549964|762319|P1|STARTED|80-Week Extension Period||66
318363|NCT01549964|762316|P4|NOT COMPLETED|24-Week Treatment Period||121
318364|NCT01549964|762317|P3|NOT COMPLETED|24-Week Treatment Period||116
318365|NCT01549964|762318|P2|NOT COMPLETED|24-Week Treatment Period||111
318366|NCT01549964|762319|P1|NOT COMPLETED|24-Week Treatment Period||61
318367|NCT01549964|762316|P4|COMPLETED|24-Week Treatment Period||140
318368|NCT01549964|762317|P3|COMPLETED|24-Week Treatment Period||147
318369|NCT01549964|762318|P2|COMPLETED|24-Week Treatment Period||149
318370|NCT01549964|762319|P1|COMPLETED|24-Week Treatment Period||71
318371|NCT01549964|762316|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
318372|NCT01549964|762317|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
318373|NCT01549964|762318|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
318374|NCT01549964|762319|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
318375|NCT01549964|762316|P4|STARTED|24-Week Treatment Period||261
318376|NCT01549964|762317|P3|STARTED|24-Week Treatment Period||263
318377|NCT01549964|762318|P2|STARTED|24-Week Treatment Period||260
318378|NCT01549964|762319|P1|STARTED|24-Week Treatment Period||132
318379|NCT01549951|762337|P1|NOT COMPLETED|Overall Study||50
318380|NCT01549951|762337|P1|COMPLETED|Overall Study||0
318381|NCT01549951|762337|P1|Primary Reason Off Study Treatment|Overall Study||50
318382|NCT01549951|762337|P1|STARTED|Overall Study||50
318383|NCT01549925|762355|P2|NOT COMPLETED|Overall Study||0
318384|NCT01549925|762356|P1|NOT COMPLETED|Overall Study||0
318385|NCT01549925|762355|P2|COMPLETED|Overall Study||25
318386|NCT01549925|762356|P1|COMPLETED|Overall Study||25
318387|NCT01549925|762355|P2|STARTED|Overall Study||25
318388|NCT01549925|762356|P1|STARTED|Overall Study||25
318389|NCT01549873|762364|P2|NOT COMPLETED|Overall Study||1
318390|NCT01549873|762365|P1|NOT COMPLETED|Overall Study||0
318391|NCT01549873|762364|P2|COMPLETED|Overall Study||14
318392|NCT01549873|762365|P1|COMPLETED|Overall Study||15
318393|NCT01549873|762364|P2|STARTED|Overall Study||15
318394|NCT01549873|762365|P1|STARTED|Overall Study||15
318395|NCT01549860|762377|P2|NOT COMPLETED|Overall Study||1
318396|NCT01549860|762378|P1|NOT COMPLETED|Overall Study||2
318397|NCT01549860|762377|P2|COMPLETED|Overall Study||40
318398|NCT01549860|762378|P1|COMPLETED|Overall Study||38
318399|NCT01549860|762377|P2|STARTED|Overall Study||41
318400|NCT01549860|762378|P1|STARTED|Overall Study||40
318401|NCT01549613|762390|P2|NOT COMPLETED|Overall Study||11
318402|NCT01549613|762391|P1|NOT COMPLETED|Overall Study||11
318403|NCT01549613|762390|P2|COMPLETED|Overall Study||39
318404|NCT01549613|762391|P1|COMPLETED|Overall Study||39
318405|NCT01549613|762390|P2|STARTED|Overall Study||50
318406|NCT01549613|762391|P1|STARTED|Overall Study||50
318407|NCT01549405|762399|P2|NOT COMPLETED|Overall Study||0
318408|NCT01549405|762400|P1|NOT COMPLETED|Overall Study||0
318409|NCT01549405|762399|P2|COMPLETED|Overall Study||20
318410|NCT01549405|762400|P1|COMPLETED|Overall Study||20
318411|NCT01549405|762399|P2|STARTED|Overall Study||20
318412|NCT01549405|762400|P1|STARTED|Overall Study||20
318413|NCT01549392|762410|P2|NOT COMPLETED|Overall Study||0
318414|NCT01549392|762411|P1|NOT COMPLETED|Overall Study||1
318415|NCT01549392|762410|P2|COMPLETED|Overall Study||0
318416|NCT01549392|762411|P1|COMPLETED|Overall Study||2
318417|NCT01549392|762410|P2|STARTED|Overall Study||0
318418|NCT01549392|762411|P1|STARTED|Overall Study||3
318419|NCT01549340|762417|P1|NOT COMPLETED|Overall Study||8405
318420|NCT01549340|762417|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
318421|NCT01549340|762417|P1|Started AIT|Overall Study||3182
318422|NCT01549340|762417|P1|STARTED|Overall Study|Advised to receive AIT|8790
318423|NCT01549275|762430|P2|NOT COMPLETED|Overall Study||0
318424|NCT01549275|762431|P1|NOT COMPLETED|Overall Study||1
318425|NCT01549275|762430|P2|COMPLETED|Overall Study||29
318426|NCT01549275|762431|P1|COMPLETED|Overall Study||75
318427|NCT01549275|762430|P2|STARTED|Overall Study||29
318428|NCT01549275|762431|P1|STARTED|Overall Study||76
318429|NCT01549041|762443|P2|NOT COMPLETED|Overall Study||8
318430|NCT01549041|762444|P1|NOT COMPLETED|Overall Study||2
318431|NCT01549041|762443|P2|COMPLETED|Overall Study||10
318432|NCT01549041|762444|P1|COMPLETED|Overall Study||10
318433|NCT01549041|762443|P2|STARTED|Overall Study||18
318434|NCT01549041|762444|P1|STARTED|Overall Study||12
318435|NCT01549002|762454|P2|NOT COMPLETED|Overall Study||4
318436|NCT01549002|762455|P1|NOT COMPLETED|Overall Study||0
318437|NCT01549002|762454|P2|COMPLETED|Overall Study||6
318438|NCT01549002|762455|P1|COMPLETED|Overall Study||10
318439|NCT01549002|762454|P2|STARTED|Overall Study||10
318440|NCT01549002|762455|P1|STARTED|Overall Study||10
318441|NCT01548885|762461|P1|NOT COMPLETED|Overall Study||0
318442|NCT01548885|762461|P1|COMPLETED|Overall Study||146
318443|NCT01548885|762461|P1|STARTED|Overall Study||146
318444|NCT01548833|762466|P1|NOT COMPLETED|Overall Study||0
318445|NCT01548833|762466|P1|COMPLETED|Overall Study||39
318446|NCT01548833|762466|P1|STARTED|Overall Study||39
318447|NCT01548742|762476|P2|NOT COMPLETED|Overall Study||4
318448|NCT01548742|762477|P1|NOT COMPLETED|Overall Study||13
318449|NCT01548742|762476|P2|COMPLETED|Overall Study||54
318450|NCT01548742|762477|P1|COMPLETED|Overall Study||45
318451|NCT01548742|762476|P2|STARTED|Overall Study||58
318452|NCT01548742|762477|P1|STARTED|Overall Study||58
318453|NCT01548638|762491|P1|NOT COMPLETED|Overall Study||4
318454|NCT01548638|762491|P1|COMPLETED|Overall Study||9
318455|NCT01548638|762491|P1|STARTED|Overall Study||13
318456|NCT01548573|762498|P1|NOT COMPLETED|Overall Study||5
318457|NCT01548573|762498|P1|COMPLETED|Overall Study||14
318458|NCT01548573|762498|P1|STARTED|Overall Study||19
318459|NCT01548417|762507|P2|NOT COMPLETED|Overall Study||2
318460|NCT01548417|762508|P1|NOT COMPLETED|Overall Study||0
318461|NCT01548417|762507|P2|COMPLETED|Overall Study||26
318462|NCT01548417|762508|P1|COMPLETED|Overall Study||28
318463|NCT01548417|762507|P2|STARTED|Overall Study||28
318464|NCT01548417|762508|P1|STARTED|Overall Study||28
318465|NCT01548287|762520|P5|NOT COMPLETED|Randomized Period||0
318466|NCT01548287|762521|P4|NOT COMPLETED|Randomized Period||0
318467|NCT01548287|762522|P3|NOT COMPLETED|Randomized Period||7
318468|NCT01548287|762523|P2|NOT COMPLETED|Randomized Period||2
318469|NCT01548287|762524|P1|NOT COMPLETED|Randomized Period||0
318470|NCT01548287|762520|P5|COMPLETED|Randomized Period||0
318471|NCT01548287|762521|P4|COMPLETED|Randomized Period||20
318472|NCT01548287|762522|P3|COMPLETED|Randomized Period||13
318473|NCT01548287|762523|P2|COMPLETED|Randomized Period||20
318474|NCT01548287|762524|P1|COMPLETED|Randomized Period||19
318475|NCT01548287|762520|P5|STARTED|Randomized Period||0
318476|NCT01548287|762521|P4|STARTED|Randomized Period||20
318477|NCT01548287|762522|P3|STARTED|Randomized Period||20
318478|NCT01548287|762523|P2|STARTED|Randomized Period||22
318479|NCT01548287|762524|P1|STARTED|Randomized Period||19
318480|NCT01548287|762520|P5|NOT COMPLETED|Screening||83
318481|NCT01548287|762521|P4|NOT COMPLETED|Screening||0
318482|NCT01548287|762522|P3|NOT COMPLETED|Screening||0
318483|NCT01548287|762523|P2|NOT COMPLETED|Screening||0
318484|NCT01548287|762524|P1|NOT COMPLETED|Screening||0
318485|NCT01548287|762520|P5|COMPLETED|Screening||0
318486|NCT01548287|762521|P4|COMPLETED|Screening||20
318487|NCT01548287|762522|P3|COMPLETED|Screening||20
318488|NCT01548287|762523|P2|COMPLETED|Screening||22
318489|NCT01548287|762524|P1|COMPLETED|Screening||19
318490|NCT01548287|762520|P5|STARTED|Screening||83
318491|NCT01548287|762521|P4|STARTED|Screening||20
318492|NCT01548287|762522|P3|STARTED|Screening||20
318493|NCT01548287|762523|P2|STARTED|Screening||22
318494|NCT01548287|762524|P1|STARTED|Screening||19
318495|NCT01547728|762554|P1|NOT COMPLETED|Overall Study||41
318496|NCT01547728|762554|P1|COMPLETED|Overall Study||1
318497|NCT01547728|762554|P1|STARTED|Overall Study||42
318498|NCT01547715|762561|P3|NOT COMPLETED|Overall Study||0
318499|NCT01547715|762562|P2|NOT COMPLETED|Overall Study||0
318500|NCT01547715|762563|P1|NOT COMPLETED|Overall Study||0
318501|NCT01547715|762561|P3|COMPLETED|Overall Study||60
318502|NCT01547715|762562|P2|COMPLETED|Overall Study||60
318503|NCT01547715|762563|P1|COMPLETED|Overall Study||60
318504|NCT01547715|762561|P3|STARTED|Overall Study||60
318505|NCT01547715|762562|P2|STARTED|Overall Study||60
318506|NCT01547715|762563|P1|STARTED|Overall Study||60
318507|NCT01547598|762663|P2|NOT COMPLETED|Overall Study||5
318508|NCT01547598|762664|P1|NOT COMPLETED|Overall Study||6
318509|NCT01547598|762663|P2|COMPLETED|Overall Study||63
318510|NCT01547598|762664|P1|COMPLETED|Overall Study||61
318511|NCT01547598|762663|P2|STARTED|Overall Study||68
318512|NCT01547598|762664|P1|STARTED|Overall Study||67
318513|NCT01547299|762681|P2|NOT COMPLETED|Overall Study||2
318514|NCT01547299|762682|P1|NOT COMPLETED|Overall Study||2
318515|NCT01547299|762681|P2|COMPLETED|Overall Study||25
318516|NCT01547299|762682|P1|COMPLETED|Overall Study||23
318517|NCT01547299|762681|P2|STARTED|Overall Study||27
318518|NCT01547299|762682|P1|STARTED|Overall Study||25
318519|NCT01547286|762742|P1|NOT COMPLETED|Overall Study||2
318520|NCT01547286|762742|P1|COMPLETED|Overall Study||5
318521|NCT01547286|762742|P1|STARTED|Overall Study||7
318522|NCT01547247|762749|P2|NOT COMPLETED|Overall Study||6
318523|NCT01547247|762750|P1|NOT COMPLETED|Overall Study||6
318524|NCT01547247|762749|P2|COMPLETED|Overall Study||98
318525|NCT01547247|762750|P1|COMPLETED|Overall Study||98
318526|NCT01547247|762749|P2|STARTED|Overall Study||104
318527|NCT01547247|762750|P1|STARTED|Overall Study||104
318528|NCT01547130|762760|P2|NOT COMPLETED|Overall Study||5
318529|NCT01547130|762761|P1|NOT COMPLETED|Overall Study||9
318530|NCT01547130|762760|P2|COMPLETED|Overall Study||68
318531|NCT01547130|762761|P1|COMPLETED|Overall Study||65
318532|NCT01547130|762760|P2|STARTED|Overall Study||73
318533|NCT01547130|762761|P1|STARTED|Overall Study||74
318534|NCT01546922|762775|P2|NOT COMPLETED|Second Period of 10 Weeks||3
318535|NCT01546922|762776|P1|NOT COMPLETED|Second Period of 10 Weeks||3
318536|NCT01546922|762775|P2|COMPLETED|Second Period of 10 Weeks||25
318537|NCT01546922|762776|P1|COMPLETED|Second Period of 10 Weeks||22
318538|NCT01546922|762775|P2|STARTED|Second Period of 10 Weeks||28
318539|NCT01546922|762776|P1|STARTED|Second Period of 10 Weeks||25
318540|NCT01546922|762775|P2|NOT COMPLETED|First Period of 10 Weeks||2
318541|NCT01546922|762776|P1|NOT COMPLETED|First Period of 10 Weeks||5
318542|NCT01546922|762775|P2|COMPLETED|First Period of 10 Weeks||28
318543|NCT01546922|762776|P1|COMPLETED|First Period of 10 Weeks||25
318544|NCT01546922|762775|P2|STARTED|First Period of 10 Weeks||30
318545|NCT01546922|762776|P1|STARTED|First Period of 10 Weeks||30
318546|NCT01546883|762782|P1|NOT COMPLETED|Overall Study||12
318547|NCT01546883|762782|P1|COMPLETED|Overall Study||2
318548|NCT01546883|762782|P1|STARTED|Overall Study||14
318549|NCT01546688|762788|P2|NOT COMPLETED|Overall Study||5
318550|NCT01546688|762789|P1|NOT COMPLETED|Overall Study||3
318551|NCT01546688|762788|P2|COMPLETED|Overall Study||28
318552|NCT01546688|762789|P1|COMPLETED|Overall Study||15
318553|NCT01546688|762788|P2|STARTED|Overall Study||33
318554|NCT01546688|762789|P1|STARTED|Overall Study||18
318555|NCT01546675|762803|P2|NOT COMPLETED|Overall Study||0
318556|NCT01546675|762804|P1|NOT COMPLETED|Overall Study||0
318557|NCT01546675|762803|P2|COMPLETED|Overall Study||1
318558|NCT01546675|762804|P1|COMPLETED|Overall Study||1
318559|NCT01546675|762803|P2|STARTED|Overall Study||1
318560|NCT01546675|762804|P1|STARTED|Overall Study||1
318561|NCT01546649|762821|P2|NOT COMPLETED|Overall Study||9
318562|NCT01546649|762822|P1|NOT COMPLETED|Overall Study||8
318563|NCT01546649|762821|P2|COMPLETED|Overall Study||75
318564|NCT01546649|762822|P1|COMPLETED|Overall Study||75
318565|NCT01546649|762821|P2|STARTED|Overall Study||84
318566|NCT01546649|762822|P1|STARTED|Overall Study||83
318567|NCT01546636|762844|P2|NOT COMPLETED|Overall Study||0
318568|NCT01546636|762845|P1|NOT COMPLETED|Overall Study||0
318569|NCT01546636|762844|P2|COMPLETED|Overall Study||34
318570|NCT01546636|762845|P1|COMPLETED|Overall Study||36
318571|NCT01546636|762844|P2|STARTED|Overall Study||34
318572|NCT01546636|762845|P1|STARTED|Overall Study||36
318573|NCT01546623|762857|P2|NOT COMPLETED|Overall Study||6
318574|NCT01546623|762858|P1|NOT COMPLETED|Overall Study||6
318575|NCT01546623|762857|P2|COMPLETED|Overall Study||74
318576|NCT01546623|762858|P1|COMPLETED|Overall Study||76
318577|NCT01546623|762857|P2|Received Study Drug|Overall Study||79
318578|NCT01546623|762858|P1|Received Study Drug|Overall Study||81
318579|NCT01546623|762857|P2|STARTED|Overall Study||80
318580|NCT01546623|762858|P1|STARTED|Overall Study||82
318581|NCT01546519|762888|P4|NOT COMPLETED|Overall Study||6
318582|NCT01546519|762889|P3|NOT COMPLETED|Overall Study||8
318583|NCT01546519|762890|P2|NOT COMPLETED|Overall Study||8
318584|NCT01546519|762891|P1|NOT COMPLETED|Overall Study||9
318585|NCT01546519|762888|P4|COMPLETED|Overall Study||0
318586|NCT01546519|762889|P3|COMPLETED|Overall Study||0
318587|NCT01546519|762890|P2|COMPLETED|Overall Study||0
318588|NCT01546519|762891|P1|COMPLETED|Overall Study||0
318589|NCT01546519|762888|P4|Safety-Evaluable Participants|Overall Study||6
318590|NCT01546519|762889|P3|Safety-Evaluable Participants|Overall Study||8
318591|NCT01546519|762890|P2|Safety-Evaluable Participants|Overall Study||8
318592|NCT01546519|762891|P1|Safety-Evaluable Participants|Overall Study||9
318593|NCT01546519|762888|P4|STARTED|Overall Study||6
318594|NCT01546519|762889|P3|STARTED|Overall Study||8
318595|NCT01546519|762890|P2|STARTED|Overall Study||8
318596|NCT01546519|762891|P1|STARTED|Overall Study||9
318597|NCT01546454|762933|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
318598|NCT01546454|762933|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
318599|NCT01546454|762933|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
318600|NCT01546454|762933|P1|NOT COMPLETED|Eligard Treatment||0
318601|NCT01546454|762933|P1|COMPLETED|Eligard Treatment||4
318602|NCT01546454|762933|P1|STARTED|Eligard Treatment||4
318603|NCT01546454|762933|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
318604|NCT01546454|762933|P1|COMPLETED|Oral Contraceptive Cycle||4
318605|NCT01546454|762933|P1|STARTED|Oral Contraceptive Cycle||4
318606|NCT01546454|762933|P1|NOT COMPLETED|Natural Menstrual Cycle||0
318607|NCT01546454|762933|P1|COMPLETED|Natural Menstrual Cycle||4
318608|NCT01546454|762933|P1|STARTED|Natural Menstrual Cycle||4
318609|NCT01546402|762941|P2|NOT COMPLETED|Overall Study||0
318610|NCT01546402|762942|P1|NOT COMPLETED|Overall Study||0
318611|NCT01546402|762941|P2|COMPLETED|Overall Study||10
318612|NCT01546402|762942|P1|COMPLETED|Overall Study||10
318613|NCT01546402|762941|P2|STARTED|Overall Study||10
318614|NCT01546402|762942|P1|STARTED|Overall Study||10
318615|NCT01546285|762950|P1|NOT COMPLETED|Overall Study||0
318616|NCT01546285|762950|P1|COMPLETED|Overall Study||66
318617|NCT01546285|762950|P1|STARTED|Overall Study||66
318618|NCT01546207|762956|P1|NOT COMPLETED|Overall Study||1
318619|NCT01546207|762956|P1|COMPLETED|Overall Study||3
318620|NCT01546207|762956|P1|STARTED|Overall Study||4
318621|NCT01546194|762962|P2|NOT COMPLETED|Overall Study||35
318622|NCT01546194|762963|P1|NOT COMPLETED|Overall Study||36
318623|NCT01546194|762962|P2|COMPLETED|Overall Study||65
318624|NCT01546194|762963|P1|COMPLETED|Overall Study||64
318625|NCT01546194|762962|P2|STARTED|Overall Study||100
318626|NCT01546194|762963|P1|STARTED|Overall Study||100
318627|NCT01546155|762969|P1|NOT COMPLETED|Overall Study||3
318628|NCT01546155|762969|P1|COMPLETED|Overall Study||8
318629|NCT01546155|762969|P1|STARTED|Overall Study||11
318630|NCT01546142|762975|P2|NOT COMPLETED|Overall Study||34
318631|NCT01546142|762976|P1|NOT COMPLETED|Overall Study||44
318632|NCT01546142|762975|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
318633|NCT01546142|762976|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
318634|NCT01546142|762975|P2|Received Treatment|Overall Study||257
318635|NCT01546142|762976|P1|Received Treatment|Overall Study||257
318636|NCT01546142|762975|P2|STARTED|Overall Study||258
318637|NCT01546142|762976|P1|STARTED|Overall Study||258
318638|NCT01545843|762991|P3|NOT COMPLETED|Overall Study||4
318639|NCT01545843|762992|P2|NOT COMPLETED|Overall Study||7
318640|NCT01545843|762993|P1|NOT COMPLETED|Overall Study||3
318641|NCT01545843|762991|P3|COMPLETED|Overall Study||21
318642|NCT01545843|762992|P2|COMPLETED|Overall Study||17
318643|NCT01545843|762993|P1|COMPLETED|Overall Study||16
318644|NCT01545843|762991|P3|STARTED|Overall Study||25
318645|NCT01545843|762992|P2|STARTED|Overall Study||24
318646|NCT01545843|762993|P1|STARTED|Overall Study||19
318647|NCT01545765|763004|P1|NOT COMPLETED|Overall Study||0
318648|NCT01545765|763004|P1|COMPLETED|Overall Study||31
318649|NCT01545765|763004|P1|STARTED|Overall Study||31
318650|NCT01545700|763021|P6|NOT COMPLETED|Overall Study||0
318651|NCT01545700|763022|P5|NOT COMPLETED|Overall Study||1
318652|NCT01545700|763023|P4|NOT COMPLETED|Overall Study||0
318653|NCT01545700|763024|P3|NOT COMPLETED|Overall Study||2
318654|NCT01545700|763025|P2|NOT COMPLETED|Overall Study||1
318655|NCT01545700|763026|P1|NOT COMPLETED|Overall Study||1
318656|NCT01545700|763021|P6|COMPLETED|Overall Study||33
318657|NCT01545700|763022|P5|COMPLETED|Overall Study||32
318658|NCT01545700|763023|P4|COMPLETED|Overall Study||34
318659|NCT01545700|763024|P3|COMPLETED|Overall Study||31
318660|NCT01545700|763025|P2|COMPLETED|Overall Study||32
318661|NCT01545700|763026|P1|COMPLETED|Overall Study||33
318662|NCT01545700|763021|P6|STARTED|Overall Study||33
318663|NCT01545700|763022|P5|STARTED|Overall Study||33
318664|NCT01545700|763023|P4|STARTED|Overall Study||34
318665|NCT01545700|763024|P3|STARTED|Overall Study||33
318666|NCT01545700|763025|P2|STARTED|Overall Study||33
318667|NCT01545700|763026|P1|STARTED|Overall Study||34
318668|NCT01545518|763060|P1|NOT COMPLETED|Overall Study||0
318669|NCT01545518|763060|P1|COMPLETED|Overall Study||20
318670|NCT01545518|763060|P1|STARTED|Overall Study||20
318671|NCT01545388|763067|P3|NOT COMPLETED|Overall Study||8
318672|NCT01545388|763068|P2|NOT COMPLETED|Overall Study||11
318673|NCT01545388|763069|P1|NOT COMPLETED|Overall Study||8
318674|NCT01545388|763067|P3|COMPLETED|Overall Study||58
318675|NCT01545388|763068|P2|COMPLETED|Overall Study||122
318676|NCT01545388|763069|P1|COMPLETED|Overall Study||130
318677|NCT01545388|763067|P3|STARTED|Overall Study||66
318678|NCT01545388|763068|P2|STARTED|Overall Study||133
318679|NCT01545388|763069|P1|STARTED|Overall Study||138
318680|NCT01545336|763088|P2|NOT COMPLETED|Overall Study||0
318681|NCT01545336|763089|P1|NOT COMPLETED|Overall Study||0
318682|NCT01545336|763088|P2|COMPLETED|Overall Study||6
318683|NCT01545336|763089|P1|COMPLETED|Overall Study||12
318684|NCT01545336|763088|P2|STARTED|Overall Study||6
318685|NCT01545336|763089|P1|STARTED|Overall Study||12
318686|NCT01545232|763101|P2|NOT COMPLETED|Overall Study||0
318687|NCT01545232|763102|P1|NOT COMPLETED|Overall Study||0
318688|NCT01545232|763101|P2|COMPLETED|Overall Study||342
318689|NCT01545232|763102|P1|COMPLETED|Overall Study||338
318690|NCT01545232|763101|P2|STARTED|Overall Study||342
318691|NCT01545232|763102|P1|STARTED|Overall Study||338
318692|NCT01545193|763132|P2|NOT COMPLETED|Overall Study||1
318693|NCT01545193|763133|P1|NOT COMPLETED|Overall Study||0
318694|NCT01545193|763132|P2|COMPLETED|Overall Study||149
318695|NCT01545193|763133|P1|COMPLETED|Overall Study||150
318696|NCT01545193|763132|P2|STARTED|Overall Study||150
318697|NCT01545193|763133|P1|STARTED|Overall Study||150
318698|NCT01544153|763149|P4|NOT COMPLETED|Overall Study||0
318699|NCT01544153|763150|P3|NOT COMPLETED|Overall Study||1
318700|NCT01544153|763151|P2|NOT COMPLETED|Overall Study||1
318701|NCT01544153|763152|P1|NOT COMPLETED|Overall Study||0
318702|NCT01544153|763149|P4|COMPLETED|Overall Study||1317
318703|NCT01544153|763150|P3|COMPLETED|Overall Study||1313
318704|NCT01544153|763151|P2|COMPLETED|Overall Study||1323
318705|NCT01544153|763152|P1|COMPLETED|Overall Study||1337
318706|NCT01544153|763149|P4|STARTED|Overall Study||1317
318707|NCT01544153|763150|P3|STARTED|Overall Study||1314
318708|NCT01544153|763151|P2|STARTED|Overall Study||1324
318709|NCT01544153|763152|P1|STARTED|Overall Study||1337
318710|NCT01544062|763168|P2|NOT COMPLETED|Overall Study||0
318711|NCT01544062|763169|P1|NOT COMPLETED|Overall Study||0
318712|NCT01544062|763168|P2|COMPLETED|Overall Study||35
318713|NCT01544062|763169|P1|COMPLETED|Overall Study||33
318714|NCT01544062|763168|P2|STARTED|Overall Study||35
318715|NCT01544062|763169|P1|STARTED|Overall Study||33
318716|NCT01544023|763215|P1|NOT COMPLETED|Overall Study||0
318717|NCT01544023|763215|P1|COMPLETED|Overall Study||207
318718|NCT01544023|763215|P1|STARTED|Overall Study|retrospective|207
318719|NCT01544998|763220|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
318720|NCT01544998|763221|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
318721|NCT01544998|763220|P2|COMPLETED|Second Intervention (3 Hours)||15
318722|NCT01544998|763221|P1|COMPLETED|Second Intervention (3 Hours)||26
318723|NCT01544998|763220|P2|STARTED|Second Intervention (3 Hours)||15
318724|NCT01544998|763221|P1|STARTED|Second Intervention (3 Hours)||26
318725|NCT01544998|763220|P2|NOT COMPLETED|Washout (1 Week)||0
318726|NCT01544998|763221|P1|NOT COMPLETED|Washout (1 Week)||0
318727|NCT01544998|763220|P2|COMPLETED|Washout (1 Week)||15
318728|NCT01544998|763221|P1|COMPLETED|Washout (1 Week)||26
318729|NCT01544998|763220|P2|STARTED|Washout (1 Week)||15
318730|NCT01544998|763221|P1|STARTED|Washout (1 Week)||26
318731|NCT01544998|763220|P2|NOT COMPLETED|First Intervention (3 Hours)||0
318732|NCT01544998|763221|P1|NOT COMPLETED|First Intervention (3 Hours)||0
318733|NCT01544998|763220|P2|COMPLETED|First Intervention (3 Hours)||15
318734|NCT01544998|763221|P1|COMPLETED|First Intervention (3 Hours)||26
318735|NCT01544998|763220|P2|STARTED|First Intervention (3 Hours)||15
318736|NCT01544998|763221|P1|STARTED|First Intervention (3 Hours)||26
318737|NCT01544920|763233|P2|NOT COMPLETED|Overall Study||23
318738|NCT01544920|763234|P1|NOT COMPLETED|Overall Study||19
318739|NCT01544920|763233|P2|COMPLETED|Overall Study||346
318740|NCT01544920|763234|P1|COMPLETED|Overall Study||349
318741|NCT01544920|763233|P2|STARTED|Overall Study||369
318742|NCT01544920|763234|P1|STARTED|Overall Study||368
318743|NCT01544582|763245|P4|NOT COMPLETED|Analysis Population||39
318744|NCT01544582|763246|P3|NOT COMPLETED|Analysis Population||102
318745|NCT01544582|763247|P2|NOT COMPLETED|Analysis Population||118
318746|NCT01544582|763248|P1|NOT COMPLETED|Analysis Population||0
318747|NCT01544582|763245|P4|COMPLETED|Analysis Population||35
318748|NCT01544582|763246|P3|COMPLETED|Analysis Population||205
318749|NCT01544582|763247|P2|COMPLETED|Analysis Population||180
318750|NCT01544582|763248|P1|COMPLETED|Analysis Population||0
318751|NCT01544582|763245|P4|STARTED|Analysis Population||74
318752|NCT01544582|763246|P3|STARTED|Analysis Population||307
318753|NCT01544582|763247|P2|STARTED|Analysis Population||298
318754|NCT01544582|763248|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
318755|NCT01544582|763245|P4|NOT COMPLETED|Screening/Eligibility||0
318756|NCT01544582|763246|P3|NOT COMPLETED|Screening/Eligibility||0
318757|NCT01544582|763247|P2|NOT COMPLETED|Screening/Eligibility||0
318758|NCT01544582|763248|P1|NOT COMPLETED|Screening/Eligibility||34
318759|NCT01544582|763245|P4|COMPLETED|Screening/Eligibility||0
318760|NCT01544582|763246|P3|COMPLETED|Screening/Eligibility||0
318761|NCT01544582|763247|P2|COMPLETED|Screening/Eligibility||0
318762|NCT01544582|763248|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
318763|NCT01544582|763245|P4|Analysis Population|Screening/Eligibility||0
318764|NCT01544582|763246|P3|Analysis Population|Screening/Eligibility||0
318765|NCT01544582|763247|P2|Analysis Population|Screening/Eligibility||0
318766|NCT01544582|763248|P1|Analysis Population|Screening/Eligibility||679
318767|NCT01544582|763245|P4|STARTED|Screening/Eligibility||0
318768|NCT01544582|763246|P3|STARTED|Screening/Eligibility||0
318769|NCT01544582|763247|P2|STARTED|Screening/Eligibility||0
318770|NCT01544582|763248|P1|STARTED|Screening/Eligibility||713
318771|NCT01544361|763311|P5|NOT COMPLETED|Overall Study||0
318772|NCT01544361|763312|P4|NOT COMPLETED|Overall Study||0
318773|NCT01544361|763313|P3|NOT COMPLETED|Overall Study||0
318774|NCT01544361|763314|P2|NOT COMPLETED|Overall Study||0
318775|NCT01544361|763315|P1|NOT COMPLETED|Overall Study||0
318776|NCT01544361|763311|P5|COMPLETED|Overall Study||6
318777|NCT01544361|763312|P4|COMPLETED|Overall Study||6
318778|NCT01544361|763313|P3|COMPLETED|Overall Study||6
318779|NCT01544361|763314|P2|COMPLETED|Overall Study||6
318780|NCT01544361|763315|P1|COMPLETED|Overall Study||8
318781|NCT01544361|763311|P5|STARTED|Overall Study||6
318782|NCT01544361|763312|P4|STARTED|Overall Study||6
318783|NCT01544361|763313|P3|STARTED|Overall Study||6
318784|NCT01544361|763314|P2|STARTED|Overall Study||6
318785|NCT01544361|763315|P1|STARTED|Overall Study||8
318786|NCT01544348|763345|P8|NOT COMPLETED|Overall Study||0
318787|NCT01544348|763346|P7|NOT COMPLETED|Overall Study||2
318788|NCT01544348|763347|P6|NOT COMPLETED|Overall Study||3
318789|NCT01544348|763348|P5|NOT COMPLETED|Overall Study||1
318790|NCT01544348|763349|P4|NOT COMPLETED|Overall Study||0
318791|NCT01544348|763350|P3|NOT COMPLETED|Overall Study||0
318792|NCT01544348|763351|P2|NOT COMPLETED|Overall Study||0
318793|NCT01544348|763352|P1|NOT COMPLETED|Overall Study||2
318794|NCT01544348|763345|P8|COMPLETED|Overall Study||8
318795|NCT01544348|763346|P7|COMPLETED|Overall Study||12
318796|NCT01544348|763347|P6|COMPLETED|Overall Study||16
318797|NCT01544348|763348|P5|COMPLETED|Overall Study||15
318798|NCT01544348|763349|P4|COMPLETED|Overall Study||3
318799|NCT01544348|763350|P3|COMPLETED|Overall Study||3
318800|NCT01544348|763351|P2|COMPLETED|Overall Study||6
318801|NCT01544348|763352|P1|COMPLETED|Overall Study||15
318802|NCT01544348|763345|P8|Treated|Overall Study||8
318803|NCT01544348|763346|P7|Treated|Overall Study||14
318804|NCT01544348|763347|P6|Treated|Overall Study||18
318805|NCT01544348|763348|P5|Treated|Overall Study||15
318806|NCT01544348|763349|P4|Treated|Overall Study||3
318807|NCT01544348|763350|P3|Treated|Overall Study||3
318808|NCT01544348|763351|P2|Treated|Overall Study||6
318809|NCT01544348|763352|P1|Treated|Overall Study||17
318810|NCT01544348|763345|P8|STARTED|Overall Study||8
318811|NCT01544348|763346|P7|STARTED|Overall Study||14
318812|NCT01544348|763347|P6|STARTED|Overall Study||19
318813|NCT01544348|763348|P5|STARTED|Overall Study||16
318814|NCT01544348|763349|P4|STARTED|Overall Study||3
318815|NCT01544348|763350|P3|STARTED|Overall Study||3
318816|NCT01544348|763351|P2|STARTED|Overall Study||6
318817|NCT01544348|763352|P1|STARTED|Overall Study||17
318818|NCT01544309|763394|P2|NOT COMPLETED|Overall Study||11
318819|NCT01544309|763395|P1|NOT COMPLETED|Overall Study||20
318820|NCT01544309|763394|P2|COMPLETED|Overall Study||514
318821|NCT01544309|763395|P1|COMPLETED|Overall Study||504
318822|NCT01544309|763394|P2|STARTED|Overall Study||525
318823|NCT01544309|763395|P1|STARTED|Overall Study||524
318824|NCT01544179|763433|P2|NOT COMPLETED|Overall Study||46
318825|NCT01544179|763434|P1|NOT COMPLETED|Overall Study||63
318826|NCT01544179|763433|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
318827|NCT01544179|763434|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
318828|NCT01544179|763433|P2|Did Not Receive Treatment|Overall Study||0
318829|NCT01544179|763434|P1|Did Not Receive Treatment|Overall Study||1
318830|NCT01544179|763433|P2|Received Treatment|Overall Study||132
318831|NCT01544179|763434|P1|Received Treatment|Overall Study||132
318832|NCT01544179|763433|P2|STARTED|Overall Study||132
318833|NCT01544179|763434|P1|STARTED|Overall Study||133
318834|NCT01544166|763462|P1|NOT COMPLETED|Overall Study||0
318835|NCT01544166|763462|P1|COMPLETED|Overall Study||44
318836|NCT01544166|763462|P1|STARTED|Overall Study||44
318837|NCT01543958|763523|P1|NOT COMPLETED|Overall Study||4
318838|NCT01543958|763523|P1|COMPLETED|Overall Study||36
318839|NCT01543958|763523|P1|STARTED|Overall Study||40
318840|NCT01543828|763578|P2|NOT COMPLETED|Treatment 2||0
318841|NCT01543828|763579|P1|NOT COMPLETED|Treatment 2||1
318842|NCT01543828|763578|P2|COMPLETED|Treatment 2||19
318843|NCT01543828|763579|P1|COMPLETED|Treatment 2||19
318844|NCT01543828|763578|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
318845|NCT01543828|763579|P1|STARTED|Treatment 2||20
318846|NCT01543828|763578|P2|NOT COMPLETED|Treatment 1||0
318847|NCT01543828|763579|P1|NOT COMPLETED|Treatment 1||0
318848|NCT01543828|763578|P2|COMPLETED|Treatment 1||20
318849|NCT01543828|763579|P1|COMPLETED|Treatment 1||20
318850|NCT01543828|763578|P2|STARTED|Treatment 1||20
318851|NCT01543828|763579|P1|STARTED|Treatment 1||20
318852|NCT01543685|763592|P5|NOT COMPLETED|Overall Study||4
318853|NCT01543685|763593|P4|NOT COMPLETED|Overall Study||0
318854|NCT01543685|763594|P3|NOT COMPLETED|Overall Study||2
318855|NCT01543685|763595|P2|NOT COMPLETED|Overall Study||3
318856|NCT01543685|763596|P1|NOT COMPLETED|Overall Study||3
318857|NCT01543685|763592|P5|COMPLETED|Overall Study||90
318858|NCT01543685|763593|P4|COMPLETED|Overall Study||93
318859|NCT01543685|763594|P3|COMPLETED|Overall Study||89
318860|NCT01543685|763595|P2|COMPLETED|Overall Study||88
318861|NCT01543685|763596|P1|COMPLETED|Overall Study||90
318862|NCT01543685|763592|P5|STARTED|Overall Study||94
318863|NCT01543685|763593|P4|STARTED|Overall Study||93
318864|NCT01543685|763594|P3|STARTED|Overall Study||91
318865|NCT01543685|763595|P2|STARTED|Overall Study||91
318866|NCT01543685|763596|P1|STARTED|Overall Study||93
318867|NCT01543607|763643|P1|NOT COMPLETED|Overall Study||0
318868|NCT01543607|763643|P1|COMPLETED|Overall Study||1
318869|NCT01543607|763643|P1|STARTED|Overall Study||1
318870|NCT01543581|763649|P2|NOT COMPLETED|Overall Study||0
318871|NCT01543581|763650|P1|NOT COMPLETED|Overall Study||0
318872|NCT01543581|763649|P2|COMPLETED|Overall Study||0
318873|NCT01543581|763650|P1|COMPLETED|Overall Study||1
318874|NCT01543581|763649|P2|STARTED|Overall Study||0
318875|NCT01543581|763650|P1|STARTED|Overall Study||1
318876|NCT01543568|763656|P1|NOT COMPLETED|Overall Study||1
318877|NCT01543568|763656|P1|COMPLETED|Overall Study||45
318878|NCT01543568|763656|P1|STARTED|Overall Study||46
318879|NCT01543503|763668|P2|NOT COMPLETED|Overall Study||87
318880|NCT01543503|763669|P1|NOT COMPLETED|Overall Study||76
318881|NCT01543503|763668|P2|COMPLETED|Overall Study||711
318882|NCT01543503|763669|P1|COMPLETED|Overall Study||350
318883|NCT01543503|763668|P2|STARTED|Overall Study||798
318884|NCT01543503|763669|P1|STARTED|Overall Study||426
318885|NCT01543204|763713|P1|NOT COMPLETED|Overall Study||8
318886|NCT01543204|763713|P1|COMPLETED|Overall Study||56
318887|NCT01543204|763713|P1|STARTED|Overall Study||64
318888|NCT01543178|763760|P3|NOT COMPLETED|Double-blind Period||37
318889|NCT01543178|763761|P2|NOT COMPLETED|Double-blind Period||44
318890|NCT01543178|763762|P1|NOT COMPLETED|Double-blind Period||0
318891|NCT01543178|763760|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
318892|NCT01543178|763761|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
318893|NCT01543178|763762|P1|COMPLETED|Double-blind Period||0
318894|NCT01543178|763760|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
318895|NCT01543178|763761|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
318896|NCT01543178|763762|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
318897|NCT01543178|763760|P3|NOT COMPLETED|Open-label Period||0
318898|NCT01543178|763761|P2|NOT COMPLETED|Open-label Period||0
318899|NCT01543178|763762|P1|NOT COMPLETED|Open-label Period||1947
318900|NCT01543178|763760|P3|COMPLETED|Open-label Period||0
318901|NCT01543178|763761|P2|COMPLETED|Open-label Period||0
318902|NCT01543178|763762|P1|COMPLETED|Open-label Period||636
318903|NCT01543178|763760|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
318904|NCT01543178|763761|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
318905|NCT01543178|763762|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
318906|NCT01543074|763773|P4|NOT COMPLETED|Overall Study||0
318907|NCT01543074|763774|P3|NOT COMPLETED|Overall Study||0
318908|NCT01543074|763775|P2|NOT COMPLETED|Overall Study||0
318909|NCT01543074|763776|P1|NOT COMPLETED|Overall Study||0
318910|NCT01543074|763773|P4|COMPLETED|Overall Study||6
318911|NCT01543074|763774|P3|COMPLETED|Overall Study||5
318912|NCT01543074|763775|P2|COMPLETED|Overall Study||7
318913|NCT01543074|763776|P1|COMPLETED|Overall Study||5
318914|NCT01543074|763773|P4|STARTED|Overall Study||6
318915|NCT01543074|763774|P3|STARTED|Overall Study||5
318916|NCT01543074|763775|P2|STARTED|Overall Study||7
318917|NCT01543074|763776|P1|STARTED|Overall Study||5
318918|NCT01542957|763792|P2|NOT COMPLETED|12-month Follow-up||13
318919|NCT01542957|763793|P1|NOT COMPLETED|12-month Follow-up||16
318920|NCT01542957|763792|P2|COMPLETED|12-month Follow-up||40
318921|NCT01542957|763793|P1|COMPLETED|12-month Follow-up||37
318922|NCT01542957|763792|P2|STARTED|12-month Follow-up||53
318923|NCT01542957|763793|P1|STARTED|12-month Follow-up||53
318924|NCT01542957|763792|P2|NOT COMPLETED|3-month Follow-up||8
318925|NCT01542957|763793|P1|NOT COMPLETED|3-month Follow-up||3
318926|NCT01542957|763792|P2|COMPLETED|3-month Follow-up||45
318927|NCT01542957|763793|P1|COMPLETED|3-month Follow-up||50
318928|NCT01542957|763792|P2|STARTED|3-month Follow-up||53
318929|NCT01542957|763793|P1|STARTED|3-month Follow-up||53
318930|NCT01542957|763792|P2|NOT COMPLETED|End of Therapy||10
318931|NCT01542957|763793|P1|NOT COMPLETED|End of Therapy||12
318932|NCT01542957|763792|P2|COMPLETED|End of Therapy||53
318933|NCT01542957|763793|P1|COMPLETED|End of Therapy||53
318934|NCT01542957|763792|P2|STARTED|End of Therapy||63
318935|NCT01542957|763793|P1|STARTED|End of Therapy||65
318936|NCT01542788|763805|P2|NOT COMPLETED|Overall Study||71
318937|NCT01542788|763806|P1|NOT COMPLETED|Overall Study||55
318938|NCT01542788|763805|P2|COMPLETED|Overall Study||0
318939|NCT01542788|763806|P1|COMPLETED|Overall Study||154
318940|NCT01542788|763805|P2|Randomized and Treated|Overall Study||71
318941|NCT01542788|763806|P1|Randomized and Treated|Overall Study||207
318942|NCT01542788|763805|P2|STARTED|Overall Study||71
318943|NCT01542788|763806|P1|STARTED|Overall Study||209
318944|NCT01542684|763822|P1|NOT COMPLETED|Overall Study||0
318945|NCT01542684|763822|P1|COMPLETED|Overall Study||8
318946|NCT01542684|763822|P1|STARTED|Overall Study||8
318947|NCT01542645|763828|P2|NOT COMPLETED|Overall Study||3
318948|NCT01542645|763829|P1|NOT COMPLETED|Overall Study||5
318949|NCT01542645|763828|P2|COMPLETED|Overall Study||79
318950|NCT01542645|763829|P1|COMPLETED|Overall Study||77
318951|NCT01542645|763828|P2|STARTED|Overall Study||82
318952|NCT01542645|763829|P1|STARTED|Overall Study||82
318953|NCT01542632|763845|P6|NOT COMPLETED|Overall Study||0
318954|NCT01542632|763846|P5|NOT COMPLETED|Overall Study||4
318955|NCT01542632|763847|P4|NOT COMPLETED|Overall Study||2
318956|NCT01542632|763848|P3|NOT COMPLETED|Overall Study||1
318957|NCT01542632|763849|P2|NOT COMPLETED|Overall Study||1
318958|NCT01542632|763850|P1|NOT COMPLETED|Overall Study||0
318959|NCT01542632|763845|P6|COMPLETED|Overall Study||24
318960|NCT01542632|763846|P5|COMPLETED|Overall Study||17
318961|NCT01542632|763847|P4|COMPLETED|Overall Study||19
318962|NCT01542632|763848|P3|COMPLETED|Overall Study||23
318963|NCT01542632|763849|P2|COMPLETED|Overall Study||24
318964|NCT01542632|763850|P1|COMPLETED|Overall Study||25
318965|NCT01542632|763845|P6|STARTED|Overall Study||24
318966|NCT01542632|763846|P5|STARTED|Overall Study||21
318967|NCT01542632|763847|P4|STARTED|Overall Study||21
318968|NCT01542632|763848|P3|STARTED|Overall Study||24
318969|NCT01542632|763849|P2|STARTED|Overall Study||25
318970|NCT01542632|763850|P1|STARTED|Overall Study||25
318971|NCT01542541|763896|P2|NOT COMPLETED|Overall Study||0
318972|NCT01542541|763897|P1|NOT COMPLETED|Overall Study||8
318973|NCT01542541|763896|P2|COMPLETED|Overall Study||30
318974|NCT01542541|763897|P1|COMPLETED|Overall Study||30
318975|NCT01542541|763896|P2|STARTED|Overall Study||30
318976|NCT01542541|763897|P1|STARTED|Overall Study||38
318977|NCT01542502|763903|P2|NOT COMPLETED|Overall Study||0
318978|NCT01542502|763904|P1|NOT COMPLETED|Overall Study||0
318979|NCT01542502|763903|P2|COMPLETED|Overall Study||6
318980|NCT01542502|763904|P1|COMPLETED|Overall Study||6
318981|NCT01542502|763903|P2|STARTED|Overall Study||6
318982|NCT01542502|763904|P1|STARTED|Overall Study||6
318983|NCT01542372|763912|P2|NOT COMPLETED|Overall Study||0
318984|NCT01542372|763913|P1|NOT COMPLETED|Overall Study||0
318985|NCT01542372|763912|P2|COMPLETED|Overall Study||11
318986|NCT01542372|763913|P1|COMPLETED|Overall Study||11
318987|NCT01542372|763912|P2|STARTED|Overall Study||11
318988|NCT01542372|763913|P1|STARTED|Overall Study||11
318989|NCT01542307|763928|P2|NOT COMPLETED|Overall Study||0
318990|NCT01542307|763929|P1|NOT COMPLETED|Overall Study||0
318991|NCT01542307|763928|P2|COMPLETED|Overall Study||22
318992|NCT01542307|763929|P1|COMPLETED|Overall Study||22
318993|NCT01542307|763928|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
318994|NCT01542307|763929|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
318995|NCT01542255|763949|P1|NOT COMPLETED|Overall Study||0
318996|NCT01542255|763949|P1|COMPLETED|Overall Study||7
318997|NCT01542255|763949|P1|Analyzed for Time to Progression|Overall Study||7
318998|NCT01542255|763949|P1|STARTED|Overall Study||7
318999|NCT01542125|763955|P2|NOT COMPLETED|Overall Study||0
319000|NCT01542125|763956|P1|NOT COMPLETED|Overall Study||0
319001|NCT01542125|763955|P2|COMPLETED|Overall Study||141
319002|NCT01542125|763956|P1|COMPLETED|Overall Study||140
319003|NCT01542125|763955|P2|STARTED|Overall Study||141
319004|NCT01542125|763956|P1|STARTED|Overall Study||140
319005|NCT01542034|763964|P2|NOT COMPLETED|Overall Study||23
319006|NCT01542034|763965|P1|NOT COMPLETED|Overall Study||30
319007|NCT01542034|763964|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
319008|NCT01542034|763965|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
319009|NCT01542034|763964|P2|Received Treatment|Overall Study||249
319010|NCT01542034|763965|P1|Received Treatment|Overall Study||256
319011|NCT01542034|763964|P2|STARTED|Overall Study||250
319012|NCT01542034|763965|P1|STARTED|Overall Study||256
319013|NCT01541969|763979|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
319014|NCT01541969|763980|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
319015|NCT01541969|763979|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
319016|NCT01541969|763980|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
319017|NCT01541969|763979|P2|STARTED|Open Label Extension (12-36 Weeks)||48
319018|NCT01541969|763980|P1|STARTED|Open Label Extension (12-36 Weeks)||44
319019|NCT01541969|763979|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
319020|NCT01541969|763980|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
319021|NCT01541969|763979|P2|COMPLETED|Double-blind (0-12 Weeks)||48
319022|NCT01541969|763980|P1|COMPLETED|Double-blind (0-12 Weeks)||44
319023|NCT01541969|763979|P2|STARTED|Double-blind (0-12 Weeks)||50
319024|NCT01541969|763980|P1|STARTED|Double-blind (0-12 Weeks)||50
319025|NCT01541930|763996|P1|NOT COMPLETED|Overall Study||1
319026|NCT01541930|763996|P1|COMPLETED|Overall Study||20
319027|NCT01541930|763996|P1|STARTED|Overall Study||21
319028|NCT01541917|764018|P2|NOT COMPLETED|Overall Study||9
319029|NCT01541917|764019|P1|NOT COMPLETED|Overall Study||15
319030|NCT01541917|764018|P2|COMPLETED|Overall Study||136
319031|NCT01541917|764019|P1|COMPLETED|Overall Study||129
319032|NCT01541917|764018|P2|STARTED|Overall Study||145
319033|NCT01541917|764019|P1|STARTED|Overall Study||144
319034|NCT01541865|764035|P1|NOT COMPLETED|Overall Study||22
319035|NCT01541865|764035|P1|COMPLETED|Overall Study||124
319036|NCT01541865|764035|P1|STARTED|Overall Study||146
319037|NCT01541735|764052|P2|NOT COMPLETED|Overall Study||0
319038|NCT01541735|764053|P1|NOT COMPLETED|Overall Study||0
319039|NCT01541735|764052|P2|COMPLETED|Overall Study||7
319040|NCT01541735|764053|P1|COMPLETED|Overall Study||7
319041|NCT01541735|764052|P2|STARTED|Overall Study||7
319042|NCT01541735|764053|P1|STARTED|Overall Study||7
319043|NCT01541644|764065|P1|NOT COMPLETED|Overall Study||3
319044|NCT01541644|764065|P1|COMPLETED|Overall Study||24
319045|NCT01541644|764065|P1|STARTED|Overall Study||27
319046|NCT01541553|764071|P2|NOT COMPLETED|Overall Study||14
319047|NCT01541553|764072|P1|NOT COMPLETED|Overall Study||12
319048|NCT01541553|764071|P2|COMPLETED|Overall Study||148
319049|NCT01541553|764072|P1|COMPLETED|Overall Study||155
319050|NCT01541553|764071|P2|STARTED|Overall Study||162
319051|NCT01541553|764072|P1|STARTED|Overall Study||167
319052|NCT01541397|764084|P2|NOT COMPLETED|Overall Study||2
319053|NCT01541397|764085|P1|NOT COMPLETED|Overall Study||4
319054|NCT01541397|764084|P2|COMPLETED|Overall Study||0
319055|NCT01541397|764085|P1|COMPLETED|Overall Study||0
319056|NCT01541397|764084|P2|STARTED|Overall Study||2
319057|NCT01541397|764085|P1|STARTED|Overall Study||4
319058|NCT01541371|764097|P1|NOT COMPLETED|Overall Study||77
319059|NCT01541371|764097|P1|COMPLETED|Overall Study||326
319060|NCT01541371|764097|P1|Full Analysis Set|Overall Study||394
319061|NCT01541371|764097|P1|STARTED|Overall Study||403
319062|NCT01541358|764120|P1|NOT COMPLETED|Overall Study||0
319063|NCT01541358|764120|P1|COMPLETED|Overall Study||2
319064|NCT01541358|764120|P1|STARTED|Overall Study||2
319065|NCT01541254|764126|P1|NOT COMPLETED|Overall Study||6
319066|NCT01541254|764126|P1|COMPLETED|Overall Study||30
319067|NCT01541254|764126|P1|STARTED|Overall Study||36
319068|NCT01540981|764133|P2|NOT COMPLETED|Overall Study||0
319069|NCT01540981|764134|P1|NOT COMPLETED|Overall Study||1
319070|NCT01540981|764133|P2|COMPLETED|Overall Study||6
319071|NCT01540981|764134|P1|COMPLETED|Overall Study||5
319072|NCT01540981|764133|P2|STARTED|Overall Study||6
319073|NCT01540981|764134|P1|STARTED|Overall Study||6
319074|NCT01540851|764144|P2|NOT COMPLETED|Overall Study||18
319075|NCT01540851|764145|P1|NOT COMPLETED|Overall Study||21
319076|NCT01540851|764144|P2|COMPLETED|Overall Study||136
319077|NCT01540851|764145|P1|COMPLETED|Overall Study||133
319078|NCT01540851|764144|P2|STARTED|Overall Study||154
319079|NCT01540851|764145|P1|STARTED|Overall Study||154
319080|NCT01540825|764166|P11|NOT COMPLETED|Overall Study||0
319081|NCT01540825|764167|P10|NOT COMPLETED|Overall Study||0
319082|NCT01540825|764168|P9|NOT COMPLETED|Overall Study||0
319083|NCT01540825|764169|P8|NOT COMPLETED|Overall Study||0
319084|NCT01540825|764170|P7|NOT COMPLETED|Overall Study||0
319085|NCT01540825|764171|P6|NOT COMPLETED|Overall Study||0
319086|NCT01540825|764172|P5|NOT COMPLETED|Overall Study||0
319087|NCT01540825|764173|P4|NOT COMPLETED|Overall Study||0
319088|NCT01540825|764174|P3|NOT COMPLETED|Overall Study||0
319089|NCT01540825|764175|P2|NOT COMPLETED|Overall Study||0
319090|NCT01540825|764176|P1|NOT COMPLETED|Overall Study||0
319091|NCT01540825|764166|P11|COMPLETED|Overall Study||6
319092|NCT01540825|764167|P10|COMPLETED|Overall Study||6
319093|NCT01540825|764168|P9|COMPLETED|Overall Study||6
319094|NCT01540825|764169|P8|COMPLETED|Overall Study||6
319095|NCT01540825|764170|P7|COMPLETED|Overall Study||6
319096|NCT01540825|764171|P6|COMPLETED|Overall Study||6
319097|NCT01540825|764172|P5|COMPLETED|Overall Study||6
319098|NCT01540825|764173|P4|COMPLETED|Overall Study||6
319099|NCT01540825|764174|P3|COMPLETED|Overall Study||6
319100|NCT01540825|764175|P2|COMPLETED|Overall Study||6
319101|NCT01540825|764176|P1|COMPLETED|Overall Study||20
319102|NCT01540825|764166|P11|STARTED|Overall Study||6
319103|NCT01540825|764167|P10|STARTED|Overall Study||6
319104|NCT01540825|764168|P9|STARTED|Overall Study||6
319105|NCT01540825|764169|P8|STARTED|Overall Study||6
319106|NCT01540825|764170|P7|STARTED|Overall Study||6
319107|NCT01540825|764171|P6|STARTED|Overall Study||6
319108|NCT01540825|764172|P5|STARTED|Overall Study||6
319109|NCT01540825|764173|P4|STARTED|Overall Study||6
319110|NCT01540825|764174|P3|STARTED|Overall Study||6
319111|NCT01540825|764175|P2|STARTED|Overall Study||6
319112|NCT01540825|764176|P1|STARTED|Overall Study||20
319113|NCT01540773|764272|P2|NOT COMPLETED|Second Intervention||0
319114|NCT01540773|764273|P1|NOT COMPLETED|Second Intervention||0
319115|NCT01540773|764272|P2|COMPLETED|Second Intervention||8
319116|NCT01540773|764273|P1|COMPLETED|Second Intervention||8
319117|NCT01540773|764272|P2|STARTED|Second Intervention||8
319118|NCT01540773|764273|P1|STARTED|Second Intervention||8
319119|NCT01540773|764272|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
319120|NCT01540773|764273|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
319121|NCT01540773|764272|P2|COMPLETED|Wash Out Period of 1 Week||8
319122|NCT01540773|764273|P1|COMPLETED|Wash Out Period of 1 Week||8
319123|NCT01540773|764272|P2|STARTED|Wash Out Period of 1 Week||8
319124|NCT01540773|764273|P1|STARTED|Wash Out Period of 1 Week||8
319125|NCT01540773|764272|P2|NOT COMPLETED|First Intervention||0
319126|NCT01540773|764273|P1|NOT COMPLETED|First Intervention||0
319127|NCT01540773|764272|P2|COMPLETED|First Intervention||8
319128|NCT01540773|764273|P1|COMPLETED|First Intervention||8
319129|NCT01540773|764272|P2|STARTED|First Intervention||8
319130|NCT01540773|764273|P1|STARTED|First Intervention||8
319131|NCT01540487|764285|P2|NOT COMPLETED|Overall Study||0
319132|NCT01540487|764286|P1|NOT COMPLETED|Overall Study||1
319133|NCT01540487|764285|P2|COMPLETED|Overall Study||24
319134|NCT01540487|764286|P1|COMPLETED|Overall Study||23
319135|NCT01540487|764285|P2|STARTED|Overall Study||24
319136|NCT01540487|764286|P1|STARTED|Overall Study||24
319137|NCT01540370|764320|P1|NOT COMPLETED|Overall Study||2
319138|NCT01540370|764320|P1|COMPLETED|Overall Study||100
319139|NCT01540370|764320|P1|STARTED|Overall Study||102
319140|NCT01540266|764331|P6|NOT COMPLETED|Overall Study||0
319141|NCT01540266|764332|P5|NOT COMPLETED|Overall Study||0
319142|NCT01540266|764333|P4|NOT COMPLETED|Overall Study||0
319143|NCT01540266|764334|P3|NOT COMPLETED|Overall Study||1
319144|NCT01540266|764335|P2|NOT COMPLETED|Overall Study||1
319145|NCT01540266|764336|P1|NOT COMPLETED|Overall Study||6
319146|NCT01540266|764331|P6|COMPLETED|Overall Study||19
319147|NCT01540266|764332|P5|COMPLETED|Overall Study||20
319148|NCT01540266|764333|P4|COMPLETED|Overall Study||38
319149|NCT01540266|764334|P3|COMPLETED|Overall Study||59
319150|NCT01540266|764335|P2|COMPLETED|Overall Study||41
319151|NCT01540266|764336|P1|COMPLETED|Overall Study||57
319152|NCT01540266|764331|P6|STARTED|Overall Study||19
319153|NCT01540266|764332|P5|STARTED|Overall Study||20
319154|NCT01540266|764333|P4|STARTED|Overall Study||38
319155|NCT01540266|764334|P3|STARTED|Overall Study||60
319156|NCT01540266|764335|P2|STARTED|Overall Study||42
319157|NCT01540266|764336|P1|STARTED|Overall Study||63
319158|NCT01540162|764352|P2|NOT COMPLETED|Overall Study||0
319159|NCT01540162|764353|P1|NOT COMPLETED|Overall Study||0
319160|NCT01540162|764352|P2|COMPLETED|Overall Study||32
319161|NCT01540162|764353|P1|COMPLETED|Overall Study||30
319162|NCT01540162|764352|P2|STARTED|Overall Study||32
319163|NCT01540162|764353|P1|STARTED|Overall Study||30
319164|NCT01540045|764363|P1|NOT COMPLETED|Overall Study||0
319165|NCT01540045|764363|P1|COMPLETED|Overall Study||40
319166|NCT01540045|764363|P1|STARTED|Overall Study||40
319167|NCT01539980|764402|P1|NOT COMPLETED|Overall Study||0
319168|NCT01539980|764402|P1|COMPLETED|Overall Study||30
319169|NCT01539980|764402|P1|STARTED|Overall Study||30
319170|NCT01539811|764412|P2|NOT COMPLETED|Overall Study||0
319171|NCT01539811|764413|P1|NOT COMPLETED|Overall Study||0
319172|NCT01539811|764412|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
319173|NCT01539811|764413|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
319174|NCT01539811|764412|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
319175|NCT01539811|764413|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
319176|NCT01539759|764421|P2|NOT COMPLETED|Overall Study||8
319177|NCT01539759|764422|P1|NOT COMPLETED|Overall Study||6
319178|NCT01539759|764421|P2|COMPLETED|Overall Study||48
319179|NCT01539759|764422|P1|COMPLETED|Overall Study||50
319180|NCT01539759|764421|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
319181|NCT01539759|764422|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
319182|NCT01539759|764421|P2|IUD Removal|Overall Study||7
319183|NCT01539759|764422|P1|IUD Removal|Overall Study||2
319184|NCT01539759|764421|P2|IUD Expulsion|Overall Study||4
319185|NCT01539759|764422|P1|IUD Expulsion|Overall Study||1
319186|NCT01539759|764421|P2|Had Successful IUD Placement|Overall Study||53
319187|NCT01539759|764422|P1|Had Successful IUD Placement|Overall Study||34
319188|NCT01539759|764421|P2|STARTED|Overall Study||56
319189|NCT01539759|764422|P1|STARTED|Overall Study||56
319190|NCT01539642|764432|P2|NOT COMPLETED|Overall Study||31
319191|NCT01539642|764433|P1|NOT COMPLETED|Overall Study||36
319192|NCT01539642|764432|P2|COMPLETED|Overall Study||27
319193|NCT01539642|764433|P1|COMPLETED|Overall Study||78
319194|NCT01539642|764432|P2|STARTED|Overall Study||58
319195|NCT01539642|764433|P1|STARTED|Overall Study||114
319196|NCT01539590|764441|P2|NOT COMPLETED|Overall Study||0
319197|NCT01539590|764442|P1|NOT COMPLETED|Overall Study||3
319198|NCT01539590|764441|P2|COMPLETED|Overall Study||2
319199|NCT01539590|764442|P1|COMPLETED|Overall Study||0
319200|NCT01539590|764441|P2|Complete Study Treatment|Overall Study||2
319201|NCT01539590|764442|P1|Complete Study Treatment|Overall Study||1
319202|NCT01539590|764441|P2|STARTED|Overall Study||2
319203|NCT01539590|764442|P1|STARTED|Overall Study||3
319204|NCT01539538|764450|P2|NOT COMPLETED|Overall Study||44
319205|NCT01539538|764451|P1|NOT COMPLETED|Overall Study||31
319206|NCT01539538|764450|P2|COMPLETED|Overall Study||136
319207|NCT01539538|764451|P1|COMPLETED|Overall Study||146
319208|NCT01539538|764450|P2|STARTED|Overall Study||180
319209|NCT01539538|764451|P1|STARTED|Overall Study||177
319210|NCT01539525|764460|P3|NOT COMPLETED|Overall Study||17
319211|NCT01539525|764461|P2|NOT COMPLETED|Overall Study||16
319212|NCT01539525|764462|P1|NOT COMPLETED|Overall Study||20
319213|NCT01539525|764460|P3|COMPLETED|Overall Study||134
319214|NCT01539525|764461|P2|COMPLETED|Overall Study||127
319215|NCT01539525|764462|P1|COMPLETED|Overall Study||125
319216|NCT01539525|764460|P3|STARTED|Overall Study||151
319217|NCT01539525|764461|P2|STARTED|Overall Study||143
319218|NCT01539525|764462|P1|STARTED|Overall Study||145
319219|NCT01539512|764481|P2|NOT COMPLETED|Overall Study||13
319220|NCT01539512|764482|P1|NOT COMPLETED|Overall Study||23
319221|NCT01539512|764481|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
319222|NCT01539512|764482|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
319223|NCT01539512|764481|P2|STARTED|Overall Study||110
319224|NCT01539512|764482|P1|STARTED|Overall Study||110
319225|NCT01539317|764498|P2|NOT COMPLETED|Overall Study||0
319226|NCT01539317|764499|P1|NOT COMPLETED|Overall Study||1
319227|NCT01539317|764498|P2|COMPLETED|Overall Study||25
319228|NCT01539317|764499|P1|COMPLETED|Overall Study||24
319229|NCT01539317|764498|P2|STARTED|Overall Study||25
319230|NCT01539317|764499|P1|STARTED|Overall Study||25
319231|NCT01539135|764516|P2|NOT COMPLETED|Overall Study||0
319232|NCT01539135|764517|P1|NOT COMPLETED|Overall Study||0
319233|NCT01539135|764516|P2|COMPLETED|Overall Study||37
319234|NCT01539135|764517|P1|COMPLETED|Overall Study||43
319235|NCT01539135|764516|P2|STARTED|Overall Study||37
319236|NCT01539135|764517|P1|STARTED|Overall Study||43
319237|NCT01539083|764529|P3|NOT COMPLETED|After Randomization (TP and VTP)||11
319238|NCT01539083|764530|P2|NOT COMPLETED|After Randomization (TP and VTP)||13
319239|NCT01539083|764531|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
319240|NCT01539083|764529|P3|COMPLETED|After Randomization (TP and VTP)||92
319241|NCT01539083|764530|P2|COMPLETED|After Randomization (TP and VTP)||87
319242|NCT01539083|764531|P1|COMPLETED|After Randomization (TP and VTP)||0
319243|NCT01539083|764529|P3|Safety Population|After Randomization (TP and VTP)||103
319244|NCT01539083|764530|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
319245|NCT01539083|764531|P1|Safety Population|After Randomization (TP and VTP)||0
319328|NCT01537302|764704|P1|COMPLETED|Overall Study||199
319329|NCT01537302|764704|P1|STARTED|Overall Study||201
319246|NCT01539083|764529|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|103
319247|NCT01539083|764530|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
319248|NCT01539083|764531|P1|STARTED|After Randomization (TP and VTP)||0
319249|NCT01539083|764529|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
319250|NCT01539083|764530|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
319251|NCT01539083|764531|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
319252|NCT01539083|764529|P3|COMPLETED|Before Randomization (VCD Induction)||0
319253|NCT01539083|764530|P2|COMPLETED|Before Randomization (VCD Induction)||0
319254|NCT01539083|764531|P1|COMPLETED|Before Randomization (VCD Induction)||203
319255|NCT01539083|764529|P3|Treated|Before Randomization (VCD Induction)||0
319256|NCT01539083|764530|P2|Treated|Before Randomization (VCD Induction)||0
319257|NCT01539083|764531|P1|Treated|Before Randomization (VCD Induction)||254
319258|NCT01539083|764529|P3|STARTED|Before Randomization (VCD Induction)||0
319259|NCT01539083|764530|P2|STARTED|Before Randomization (VCD Induction)||0
319260|NCT01539083|764531|P1|STARTED|Before Randomization (VCD Induction)||256
319261|NCT01539070|764554|P2|NOT COMPLETED|Overall Study||39
319262|NCT01539070|764555|P1|NOT COMPLETED|Overall Study||59
319263|NCT01539070|764554|P2|COMPLETED|Overall Study||99
319264|NCT01539070|764555|P1|COMPLETED|Overall Study||109
319265|NCT01539070|764554|P2|STARTED|Overall Study||138
319266|NCT01539070|764555|P1|STARTED|Overall Study||168
319267|NCT01538862|764567|P1|NOT COMPLETED|Overall Study||0
319268|NCT01538862|764567|P1|COMPLETED|Overall Study||7
319269|NCT01538862|764567|P1|STARTED|Overall Study||7
319270|NCT01538472|764573|P1|NOT COMPLETED|Overall Study||4
319271|NCT01538472|764573|P1|COMPLETED|Overall Study||36
319272|NCT01538472|764573|P1|STARTED|Overall Study||40
319273|NCT01537900|764578|P1|NOT COMPLETED|Overall Study||0
319274|NCT01537900|764578|P1|COMPLETED|Overall Study||4
319275|NCT01537900|764578|P1|STARTED|Overall Study||4
319276|NCT01537835|764592|P3|NOT COMPLETED|Overall Study||0
319277|NCT01537835|764593|P2|NOT COMPLETED|Overall Study||0
319278|NCT01537835|764594|P1|NOT COMPLETED|Overall Study||0
319279|NCT01537835|764592|P3|COMPLETED|Overall Study||35
319280|NCT01537835|764593|P2|COMPLETED|Overall Study||37
319281|NCT01537835|764594|P1|COMPLETED|Overall Study||37
319282|NCT01537835|764592|P3|STARTED|Overall Study||35
319283|NCT01537835|764593|P2|STARTED|Overall Study||37
319284|NCT01537835|764594|P1|STARTED|Overall Study||37
319285|NCT01537783|764607|P2|NOT COMPLETED|Overall Study||2
319286|NCT01537783|764608|P1|NOT COMPLETED|Overall Study||11
319287|NCT01537783|764607|P2|COMPLETED|Overall Study||23
319288|NCT01537783|764608|P1|COMPLETED|Overall Study||14
319289|NCT01537783|764607|P2|STARTED|Overall Study||25
319290|NCT01537783|764608|P1|STARTED|Overall Study||25
319291|NCT01537666|764618|P4|NOT COMPLETED|Overall Study||0
319292|NCT01537666|764619|P3|NOT COMPLETED|Overall Study||0
319293|NCT01537666|764620|P2|NOT COMPLETED|Overall Study||0
319294|NCT01537666|764621|P1|NOT COMPLETED|Overall Study||0
319295|NCT01537666|764618|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
319296|NCT01537666|764619|P3|COMPLETED|Overall Study||6
319297|NCT01537666|764620|P2|COMPLETED|Overall Study||6
319298|NCT01537666|764621|P1|COMPLETED|Overall Study||6
319299|NCT01537666|764618|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
319300|NCT01537666|764619|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
319301|NCT01537666|764620|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
319302|NCT01537666|764621|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
319303|NCT01537549|764659|P1|NOT COMPLETED|Overall Study||3
319304|NCT01537549|764659|P1|COMPLETED|Overall Study||8
319305|NCT01537549|764659|P1|STARTED|Overall Study||11
319306|NCT01537432|764667|P2|NOT COMPLETED|Overall Study||2
319307|NCT01537432|764668|P1|NOT COMPLETED|Overall Study||6
319308|NCT01537432|764667|P2|COMPLETED|Overall Study||10
319309|NCT01537432|764668|P1|COMPLETED|Overall Study||18
319310|NCT01537432|764667|P2|STARTED|Overall Study||12
319311|NCT01537432|764668|P1|STARTED|Overall Study||24
319312|NCT01537367|764679|P3|NOT COMPLETED|Overall Study||0
319313|NCT01537367|764680|P2|NOT COMPLETED|Overall Study||0
319314|NCT01537367|764681|P1|NOT COMPLETED|Overall Study||0
319315|NCT01537367|764679|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
319316|NCT01537367|764680|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
319317|NCT01537367|764681|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
319318|NCT01537367|764679|P3|STARTED|Overall Study||613
319319|NCT01537367|764680|P2|STARTED|Overall Study||610
319320|NCT01537367|764681|P1|STARTED|Overall Study||615
319321|NCT01537315|764697|P2|NOT COMPLETED|Overall Study||0
319322|NCT01537315|764698|P1|NOT COMPLETED|Overall Study||0
319323|NCT01537315|764697|P2|COMPLETED|Overall Study||7
319324|NCT01537315|764698|P1|COMPLETED|Overall Study||1
319325|NCT01537315|764697|P2|STARTED|Overall Study||7
319326|NCT01537315|764698|P1|STARTED|Overall Study||1
319327|NCT01537302|764704|P1|NOT COMPLETED|Overall Study||2
319330|NCT01537198|764711|P1|NOT COMPLETED|Overall Study||154
319331|NCT01537198|764711|P1|COMPLETED|Overall Study||463
319332|NCT01537198|764711|P1|STARTED|Overall Study||617
319333|NCT01537185|764719|P4|NOT COMPLETED|Overall Study||2
319334|NCT01537185|764720|P3|NOT COMPLETED|Overall Study||6
319335|NCT01537185|764721|P2|NOT COMPLETED|Overall Study||6
319336|NCT01537185|764722|P1|NOT COMPLETED|Overall Study||3
319337|NCT01537185|764719|P4|COMPLETED|Overall Study||8
319338|NCT01537185|764720|P3|COMPLETED|Overall Study||4
319339|NCT01537185|764721|P2|COMPLETED|Overall Study||6
319340|NCT01537185|764722|P1|COMPLETED|Overall Study||7
319341|NCT01537185|764719|P4|STARTED|Overall Study||10
319342|NCT01537185|764720|P3|STARTED|Overall Study||10
319343|NCT01537185|764721|P2|STARTED|Overall Study||12
319344|NCT01537185|764722|P1|STARTED|Overall Study||10
319345|NCT01537133|764740|P4|NOT COMPLETED|Overall Study||0
319346|NCT01537133|764741|P3|NOT COMPLETED|Overall Study||0
319347|NCT01537133|764742|P2|NOT COMPLETED|Overall Study||0
319348|NCT01537133|764743|P1|NOT COMPLETED|Overall Study||3
319349|NCT01537133|764740|P4|COMPLETED|Overall Study||21
319350|NCT01537133|764741|P3|COMPLETED|Overall Study||21
319351|NCT01537133|764742|P2|COMPLETED|Overall Study||14
319352|NCT01537133|764743|P1|COMPLETED|Overall Study||25
319353|NCT01537133|764740|P4|STARTED|Overall Study||21
319354|NCT01537133|764741|P3|STARTED|Overall Study||21
319355|NCT01537133|764742|P2|STARTED|Overall Study||14
319356|NCT01537133|764743|P1|STARTED|Overall Study||28
319357|NCT01537120|764759|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
319358|NCT01537120|764759|P1|COMPLETED|12 Weeks Vildagliptin||23
319359|NCT01537120|764759|P1|STARTED|12 Weeks Vildagliptin||23
319360|NCT01537120|764759|P1|NOT COMPLETED|3 Weeks Placebo||1
319361|NCT01537120|764759|P1|COMPLETED|3 Weeks Placebo||23
319362|NCT01537120|764759|P1|STARTED|3 Weeks Placebo||24
319363|NCT01537120|764759|P1|NOT COMPLETED|8 Weeks Washout||1
319364|NCT01537120|764759|P1|COMPLETED|8 Weeks Washout||24
319365|NCT01537120|764759|P1|STARTED|8 Weeks Washout||25
319366|NCT01537120|764759|P1|NOT COMPLETED|Enrolled||0
319367|NCT01537120|764759|P1|COMPLETED|Enrolled||25
319368|NCT01537120|764759|P1|STARTED|Enrolled||25
319369|NCT01537081|764772|P3|NOT COMPLETED|Overall Study||16
319370|NCT01537081|764773|P2|NOT COMPLETED|Overall Study||38
319371|NCT01537081|764774|P1|NOT COMPLETED|Overall Study||39
319372|NCT01537081|764772|P3|COMPLETED|Overall Study||547
319373|NCT01537081|764773|P2|COMPLETED|Overall Study||1086
319374|NCT01537081|764774|P1|COMPLETED|Overall Study||1084
319375|NCT01537081|764772|P3|Modified Intent to Treat Population|Overall Study||556
319376|NCT01537081|764773|P2|Modified Intent to Treat Population|Overall Study||1109
319377|NCT01537081|764774|P1|Modified Intent to Treat Population|Overall Study||1106
319378|NCT01537081|764772|P3|Safety Population|Overall Study||561
319379|NCT01537081|764773|P2|Safety Population|Overall Study||1122
319380|NCT01537081|764774|P1|Safety Population|Overall Study||1122
319381|NCT01537081|764772|P3|STARTED|Overall Study||563
319382|NCT01537081|764773|P2|STARTED|Overall Study||1124
319383|NCT01537081|764774|P1|STARTED|Overall Study||1123
319384|NCT01537042|764787|P2|NOT COMPLETED|Overall Study||5
319385|NCT01537042|764788|P1|NOT COMPLETED|Overall Study||0
319386|NCT01537042|764787|P2|COMPLETED|Overall Study||15
319387|NCT01537042|764788|P1|COMPLETED|Overall Study||10
319388|NCT01537042|764787|P2|STARTED|Overall Study||20
319389|NCT01537042|764788|P1|STARTED|Overall Study||10
319390|NCT01536951|764826|P9|NOT COMPLETED|Third Intervention||0
319391|NCT01536951|764827|P8|NOT COMPLETED|Third Intervention||0
319392|NCT01536951|764828|P7|NOT COMPLETED|Third Intervention||0
319393|NCT01536951|764829|P6|NOT COMPLETED|Third Intervention||0
319394|NCT01536951|764830|P5|NOT COMPLETED|Third Intervention||0
319395|NCT01536951|764831|P4|NOT COMPLETED|Third Intervention||0
319396|NCT01536951|764832|P3|NOT COMPLETED|Third Intervention||0
319397|NCT01536951|764833|P2|NOT COMPLETED|Third Intervention||0
319398|NCT01536951|764834|P1|NOT COMPLETED|Third Intervention||0
319399|NCT01536951|764826|P9|COMPLETED|Third Intervention||9
319400|NCT01536951|764827|P8|COMPLETED|Third Intervention||8
319401|NCT01536951|764828|P7|COMPLETED|Third Intervention||9
319402|NCT01536951|764829|P6|COMPLETED|Third Intervention||9
319403|NCT01536951|764830|P5|COMPLETED|Third Intervention||9
319404|NCT01536951|764831|P4|COMPLETED|Third Intervention||8
319405|NCT01536951|764832|P3|COMPLETED|Third Intervention||2
319406|NCT01536951|764833|P2|COMPLETED|Third Intervention||3
319407|NCT01536951|764834|P1|COMPLETED|Third Intervention||3
319408|NCT01536951|764826|P9|STARTED|Third Intervention||9
319409|NCT01536951|764827|P8|STARTED|Third Intervention||8
319410|NCT01536951|764828|P7|STARTED|Third Intervention||9
319411|NCT01536951|764829|P6|STARTED|Third Intervention||9
319412|NCT01536951|764830|P5|STARTED|Third Intervention||9
319413|NCT01536951|764831|P4|STARTED|Third Intervention||8
319414|NCT01536951|764832|P3|STARTED|Third Intervention||2
319415|NCT01536951|764833|P2|STARTED|Third Intervention||3
319416|NCT01536951|764834|P1|STARTED|Third Intervention||3
319417|NCT01536951|764826|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
319418|NCT01536951|764827|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
319419|NCT01536951|764828|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
319420|NCT01536951|764829|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
319421|NCT01536951|764830|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
319422|NCT01536951|764831|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
319423|NCT01536951|764832|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
319424|NCT01536951|764833|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
319425|NCT01536951|764834|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
319426|NCT01536951|764826|P9|COMPLETED|Second Intervention and Washout Period 2||9
319427|NCT01536951|764827|P8|COMPLETED|Second Intervention and Washout Period 2||8
319428|NCT01536951|764828|P7|COMPLETED|Second Intervention and Washout Period 2||9
319429|NCT01536951|764829|P6|COMPLETED|Second Intervention and Washout Period 2||9
319430|NCT01536951|764830|P5|COMPLETED|Second Intervention and Washout Period 2||9
319431|NCT01536951|764831|P4|COMPLETED|Second Intervention and Washout Period 2||8
319432|NCT01536951|764832|P3|COMPLETED|Second Intervention and Washout Period 2||2
319433|NCT01536951|764833|P2|COMPLETED|Second Intervention and Washout Period 2||3
319434|NCT01536951|764834|P1|COMPLETED|Second Intervention and Washout Period 2||3
319435|NCT01536951|764826|P9|STARTED|Second Intervention and Washout Period 2||9
319436|NCT01536951|764827|P8|STARTED|Second Intervention and Washout Period 2||9
319437|NCT01536951|764828|P7|STARTED|Second Intervention and Washout Period 2||9
319438|NCT01536951|764829|P6|STARTED|Second Intervention and Washout Period 2||9
319439|NCT01536951|764830|P5|STARTED|Second Intervention and Washout Period 2||9
319440|NCT01536951|764831|P4|STARTED|Second Intervention and Washout Period 2||8
319441|NCT01536951|764832|P3|STARTED|Second Intervention and Washout Period 2||2
319442|NCT01536951|764833|P2|STARTED|Second Intervention and Washout Period 2||3
319443|NCT01536951|764834|P1|STARTED|Second Intervention and Washout Period 2||3
319444|NCT01536951|764826|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
319445|NCT01536951|764827|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
319446|NCT01536951|764828|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
319447|NCT01536951|764829|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
319448|NCT01536951|764830|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
319449|NCT01536951|764831|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
319450|NCT01536951|764832|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
319451|NCT01536951|764833|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
319452|NCT01536951|764834|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
319453|NCT01536951|764826|P9|COMPLETED|First Intervention and Washout Period 1||9
319454|NCT01536951|764827|P8|COMPLETED|First Intervention and Washout Period 1||9
319455|NCT01536951|764828|P7|COMPLETED|First Intervention and Washout Period 1||9
319456|NCT01536951|764829|P6|COMPLETED|First Intervention and Washout Period 1||9
319457|NCT01536951|764830|P5|COMPLETED|First Intervention and Washout Period 1||9
319458|NCT01536951|764831|P4|COMPLETED|First Intervention and Washout Period 1||8
319459|NCT01536951|764832|P3|COMPLETED|First Intervention and Washout Period 1||2
319460|NCT01536951|764833|P2|COMPLETED|First Intervention and Washout Period 1||3
319461|NCT01536951|764834|P1|COMPLETED|First Intervention and Washout Period 1||3
319462|NCT01536951|764826|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
319463|NCT01536951|764827|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
319464|NCT01536951|764828|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
319465|NCT01536951|764829|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
319466|NCT01536951|764830|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
319467|NCT01536951|764831|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
319468|NCT01536951|764832|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
319469|NCT01536951|764833|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
319470|NCT01536951|764834|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
319471|NCT01536951|764826|P9|STARTED|First Intervention and Washout Period 1||9
319472|NCT01536951|764827|P8|STARTED|First Intervention and Washout Period 1||9
319473|NCT01536951|764828|P7|STARTED|First Intervention and Washout Period 1||9
319474|NCT01536951|764829|P6|STARTED|First Intervention and Washout Period 1||9
319475|NCT01536951|764830|P5|STARTED|First Intervention and Washout Period 1||9
319476|NCT01536951|764831|P4|STARTED|First Intervention and Washout Period 1||8
319477|NCT01536951|764832|P3|STARTED|First Intervention and Washout Period 1||3
319478|NCT01536951|764833|P2|STARTED|First Intervention and Washout Period 1||3
319479|NCT01536951|764834|P1|STARTED|First Intervention and Washout Period 1||3
319480|NCT01536938|764864|P3|NOT COMPLETED|Overall Study||8
319481|NCT01536938|764865|P2|NOT COMPLETED|Overall Study||7
319482|NCT01536938|764866|P1|NOT COMPLETED|Overall Study||6
319483|NCT01536938|764864|P3|COMPLETED|Overall Study||93
319484|NCT01536938|764865|P2|COMPLETED|Overall Study||94
319485|NCT01536938|764866|P1|COMPLETED|Overall Study||94
319486|NCT01536938|764864|P3|STARTED|Overall Study||101
319487|NCT01536938|764865|P2|STARTED|Overall Study||101
319488|NCT01536938|764866|P1|STARTED|Overall Study||100
319489|NCT01536886|764878|P4|NOT COMPLETED|Overall Study||3
319490|NCT01536886|764879|P3|NOT COMPLETED|Overall Study||2
319491|NCT01536886|764880|P2|NOT COMPLETED|Overall Study||8
319492|NCT01536886|764881|P1|NOT COMPLETED|Overall Study||5
319493|NCT01536886|764878|P4|COMPLETED|Overall Study||48
319494|NCT01536886|764879|P3|COMPLETED|Overall Study||47
319495|NCT01536886|764880|P2|COMPLETED|Overall Study||127
319496|NCT01536886|764881|P1|COMPLETED|Overall Study||136
319497|NCT01536886|764878|P4|STARTED|Overall Study||51
319498|NCT01536886|764879|P3|STARTED|Overall Study||49
319499|NCT01536886|764880|P2|STARTED|Overall Study||135
319500|NCT01536886|764881|P1|STARTED|Overall Study||141
319501|NCT01536860|764891|P3|NOT COMPLETED|Third Intervention (1 Day)||0
319502|NCT01536860|764892|P2|NOT COMPLETED|Third Intervention (1 Day)||0
319503|NCT01536860|764893|P1|NOT COMPLETED|Third Intervention (1 Day)||0
319504|NCT01536860|764891|P3|COMPLETED|Third Intervention (1 Day)||4
319505|NCT01536860|764892|P2|COMPLETED|Third Intervention (1 Day)||4
319506|NCT01536860|764893|P1|COMPLETED|Third Intervention (1 Day)||3
319507|NCT01536860|764891|P3|STARTED|Third Intervention (1 Day)||4
319508|NCT01536860|764892|P2|STARTED|Third Intervention (1 Day)||4
319509|NCT01536860|764893|P1|STARTED|Third Intervention (1 Day)||3
319510|NCT01536860|764891|P3|NOT COMPLETED|Washout Period (3 Days)||0
319511|NCT01536860|764892|P2|NOT COMPLETED|Washout Period (3 Days)||0
319512|NCT01536860|764893|P1|NOT COMPLETED|Washout Period (3 Days)||1
319513|NCT01536860|764891|P3|COMPLETED|Washout Period (3 Days)||4
319514|NCT01536860|764892|P2|COMPLETED|Washout Period (3 Days)||4
319515|NCT01536860|764893|P1|COMPLETED|Washout Period (3 Days)||3
319516|NCT01536860|764891|P3|STARTED|Washout Period (3 Days)||4
319517|NCT01536860|764892|P2|STARTED|Washout Period (3 Days)||4
319518|NCT01536860|764893|P1|STARTED|Washout Period (3 Days)||4
319519|NCT01536860|764891|P3|NOT COMPLETED|Second Intervention (1 Day)||0
319520|NCT01536860|764892|P2|NOT COMPLETED|Second Intervention (1 Day)||0
319521|NCT01536860|764893|P1|NOT COMPLETED|Second Intervention (1 Day)||0
319522|NCT01536860|764891|P3|COMPLETED|Second Intervention (1 Day)||4
319523|NCT01536860|764892|P2|COMPLETED|Second Intervention (1 Day)||4
319524|NCT01536860|764893|P1|COMPLETED|Second Intervention (1 Day)||4
319525|NCT01536860|764891|P3|STARTED|Second Intervention (1 Day)||4
319526|NCT01536860|764892|P2|STARTED|Second Intervention (1 Day)||4
319527|NCT01536860|764893|P1|STARTED|Second Intervention (1 Day)||4
319528|NCT01536860|764891|P3|NOT COMPLETED|Washout Period (3 Days)||0
319529|NCT01536860|764892|P2|NOT COMPLETED|Washout Period (3 Days)||0
319530|NCT01536860|764893|P1|NOT COMPLETED|Washout Period (3 Days)||0
319531|NCT01536860|764891|P3|COMPLETED|Washout Period (3 Days)||4
319532|NCT01536860|764892|P2|COMPLETED|Washout Period (3 Days)||4
319533|NCT01536860|764893|P1|COMPLETED|Washout Period (3 Days)||4
319534|NCT01536860|764891|P3|STARTED|Washout Period (3 Days)||4
319535|NCT01536860|764892|P2|STARTED|Washout Period (3 Days)||4
319536|NCT01536860|764893|P1|STARTED|Washout Period (3 Days)||4
319537|NCT01536860|764891|P3|NOT COMPLETED|First Intervention (1 Day)||0
319538|NCT01536860|764892|P2|NOT COMPLETED|First Intervention (1 Day)||0
319539|NCT01536860|764893|P1|NOT COMPLETED|First Intervention (1 Day)||0
319540|NCT01536860|764891|P3|COMPLETED|First Intervention (1 Day)||4
319541|NCT01536860|764892|P2|COMPLETED|First Intervention (1 Day)||4
319542|NCT01536860|764893|P1|COMPLETED|First Intervention (1 Day)||4
319543|NCT01536860|764891|P3|STARTED|First Intervention (1 Day)||4
319544|NCT01536860|764892|P2|STARTED|First Intervention (1 Day)||4
319545|NCT01536860|764893|P1|STARTED|First Intervention (1 Day)||4
319546|NCT01536704|764901|P4|NOT COMPLETED|Period 4||0
319547|NCT01536704|764902|P3|NOT COMPLETED|Period 4||0
319548|NCT01536704|764903|P2|NOT COMPLETED|Period 4||0
319549|NCT01536704|764904|P1|NOT COMPLETED|Period 4||0
319550|NCT01536704|764901|P4|COMPLETED|Period 4||10
319551|NCT01536704|764902|P3|COMPLETED|Period 4||10
319552|NCT01536704|764903|P2|COMPLETED|Period 4||11
319553|NCT01536704|764904|P1|COMPLETED|Period 4||12
319554|NCT01536704|764901|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
319555|NCT01536704|764902|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
319556|NCT01536704|764903|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
319557|NCT01536704|764904|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
319558|NCT01536704|764901|P4|NOT COMPLETED|Washout Period 3||0
319559|NCT01536704|764902|P3|NOT COMPLETED|Washout Period 3||1
319560|NCT01536704|764903|P2|NOT COMPLETED|Washout Period 3||0
319561|NCT01536704|764904|P1|NOT COMPLETED|Washout Period 3||0
319562|NCT01536704|764901|P4|COMPLETED|Washout Period 3||10
319563|NCT01536704|764902|P3|COMPLETED|Washout Period 3||11
319564|NCT01536704|764903|P2|COMPLETED|Washout Period 3||12
319565|NCT01536704|764904|P1|COMPLETED|Washout Period 3||10
319566|NCT01536704|764901|P4|STARTED|Washout Period 3||10
319567|NCT01536704|764902|P3|STARTED|Washout Period 3||12
319568|NCT01536704|764903|P2|STARTED|Washout Period 3||12
319569|NCT01536704|764904|P1|STARTED|Washout Period 3||10
319570|NCT01536704|764901|P4|NOT COMPLETED|Period 3||1
319571|NCT01536704|764902|P3|NOT COMPLETED|Period 3||0
319572|NCT01536704|764903|P2|NOT COMPLETED|Period 3||0
319573|NCT01536704|764904|P1|NOT COMPLETED|Period 3||0
319574|NCT01536704|764901|P4|COMPLETED|Period 3||10
319575|NCT01536704|764902|P3|COMPLETED|Period 3||12
319576|NCT01536704|764903|P2|COMPLETED|Period 3||12
319577|NCT01536704|764904|P1|COMPLETED|Period 3||10
319578|NCT01536704|764901|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
319579|NCT01536704|764902|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
319666|NCT01536405|765070|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
319580|NCT01536704|764903|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
319581|NCT01536704|764904|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
319582|NCT01536704|764901|P4|NOT COMPLETED|Washout Period 2||1
319583|NCT01536704|764902|P3|NOT COMPLETED|Washout Period 2||0
319584|NCT01536704|764903|P2|NOT COMPLETED|Washout Period 2||0
319585|NCT01536704|764904|P1|NOT COMPLETED|Washout Period 2||1
319586|NCT01536704|764901|P4|COMPLETED|Washout Period 2||12
319587|NCT01536704|764902|P3|COMPLETED|Washout Period 2||10
319588|NCT01536704|764903|P2|COMPLETED|Washout Period 2||11
319589|NCT01536704|764904|P1|COMPLETED|Washout Period 2||12
319590|NCT01536704|764901|P4|STARTED|Washout Period 2||13
319591|NCT01536704|764902|P3|STARTED|Washout Period 2||10
319592|NCT01536704|764903|P2|STARTED|Washout Period 2||11
319593|NCT01536704|764904|P1|STARTED|Washout Period 2||13
319594|NCT01536704|764901|P4|NOT COMPLETED|Period 2||0
319595|NCT01536704|764902|P3|NOT COMPLETED|Period 2||0
319596|NCT01536704|764903|P2|NOT COMPLETED|Period 2||0
319597|NCT01536704|764904|P1|NOT COMPLETED|Period 2||0
319598|NCT01536704|764901|P4|COMPLETED|Period 2||13
319599|NCT01536704|764902|P3|COMPLETED|Period 2||10
319600|NCT01536704|764903|P2|COMPLETED|Period 2||11
319601|NCT01536704|764904|P1|COMPLETED|Period 2||13
319602|NCT01536704|764901|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
319603|NCT01536704|764902|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
319604|NCT01536704|764903|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
319605|NCT01536704|764904|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
319606|NCT01536704|764901|P4|NOT COMPLETED|Washout Period 1||0
319607|NCT01536704|764902|P3|NOT COMPLETED|Washout Period 1||0
319608|NCT01536704|764903|P2|NOT COMPLETED|Washout Period 1||2
319609|NCT01536704|764904|P1|NOT COMPLETED|Washout Period 1||1
319610|NCT01536704|764901|P4|COMPLETED|Washout Period 1||13
319611|NCT01536704|764902|P3|COMPLETED|Washout Period 1||13
319612|NCT01536704|764903|P2|COMPLETED|Washout Period 1||10
319613|NCT01536704|764904|P1|COMPLETED|Washout Period 1||11
319614|NCT01536704|764901|P4|STARTED|Washout Period 1||13
319615|NCT01536704|764902|P3|STARTED|Washout Period 1||13
319616|NCT01536704|764903|P2|STARTED|Washout Period 1||12
319617|NCT01536704|764904|P1|STARTED|Washout Period 1||12
319618|NCT01536704|764901|P4|NOT COMPLETED|Period 1||0
319619|NCT01536704|764902|P3|NOT COMPLETED|Period 1||0
319620|NCT01536704|764903|P2|NOT COMPLETED|Period 1||0
319621|NCT01536704|764904|P1|NOT COMPLETED|Period 1||0
319622|NCT01536704|764901|P4|COMPLETED|Period 1||13
319623|NCT01536704|764902|P3|COMPLETED|Period 1||13
319624|NCT01536704|764903|P2|COMPLETED|Period 1||12
319625|NCT01536704|764904|P1|COMPLETED|Period 1||12
319626|NCT01536704|764901|P4|STARTED|Period 1||13
319627|NCT01536704|764902|P3|STARTED|Period 1||13
319628|NCT01536704|764903|P2|STARTED|Period 1||12
319629|NCT01536704|764904|P1|STARTED|Period 1||12
319630|NCT01536587|764934|P1|NOT COMPLETED|Overall Study||2
319631|NCT01536587|764934|P1|COMPLETED|Overall Study||30
319632|NCT01536587|764934|P1|STARTED|Overall Study||32
319633|NCT01536574|764973|P2|NOT COMPLETED|Overall Study||7
319634|NCT01536574|764974|P1|NOT COMPLETED|Overall Study||6
319635|NCT01536574|764973|P2|COMPLETED|Overall Study||126
319636|NCT01536574|764974|P1|COMPLETED|Overall Study||156
319637|NCT01536574|764973|P2|STARTED|Overall Study||133
319638|NCT01536574|764974|P1|STARTED|Overall Study||162
319639|NCT01536561|764992|P1|NOT COMPLETED|Long-Term Follow-Up||0
319640|NCT01536561|764992|P1|COMPLETED|Long-Term Follow-Up||13
319641|NCT01536561|764992|P1|STARTED|Long-Term Follow-Up||13
319642|NCT01536561|764992|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
319643|NCT01536561|764992|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
319644|NCT01536561|764992|P1|STARTED|Dosimetric and Therapeutic Treatment||59
319645|NCT01536496|765032|P2|NOT COMPLETED|Overall Study||1
319646|NCT01536496|765033|P1|NOT COMPLETED|Overall Study||2
319647|NCT01536496|765032|P2|COMPLETED|Overall Study||56
319648|NCT01536496|765033|P1|COMPLETED|Overall Study||55
319649|NCT01536496|765032|P2|STARTED|Overall Study||57
319650|NCT01536496|765033|P1|STARTED|Overall Study||57
319651|NCT01536405|765069|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
319652|NCT01536405|765070|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
319653|NCT01536405|765069|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
319654|NCT01536405|765070|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
319655|NCT01536405|765069|P2|STARTED|Visit 4 to Extended Study Follow-up||618
319656|NCT01536405|765070|P1|STARTED|Visit 4 to Extended Study Follow-up||615
319657|NCT01536405|765069|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
319658|NCT01536405|765070|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
319659|NCT01536405|765069|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
319660|NCT01536405|765070|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
319661|NCT01536405|765069|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
319662|NCT01536405|765070|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
319663|NCT01536405|765069|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
319664|NCT01536405|765070|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
319665|NCT01536405|765069|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
319667|NCT01536405|765069|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
319668|NCT01536405|765070|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
319669|NCT01536405|765069|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
319670|NCT01536405|765070|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
319671|NCT01536405|765069|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
319672|NCT01536405|765070|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
319673|NCT01536405|765069|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
319674|NCT01536405|765070|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
319675|NCT01536405|765069|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
319676|NCT01536405|765070|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
319677|NCT01536405|765069|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
319678|NCT01536405|765070|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
319679|NCT01536405|765069|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
319680|NCT01536405|765070|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
319681|NCT01536405|765069|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
319682|NCT01536405|765070|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
319683|NCT01536405|765069|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
319684|NCT01536405|765070|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
319685|NCT01536379|765108|P2|NOT COMPLETED|Overall Study||3
319686|NCT01536379|765109|P1|NOT COMPLETED|Overall Study||2
319687|NCT01536379|765108|P2|COMPLETED|Overall Study||9
319688|NCT01536379|765109|P1|COMPLETED|Overall Study||11
319689|NCT01536379|765108|P2|STARTED|Overall Study||12
319690|NCT01536379|765109|P1|STARTED|Overall Study||13
319691|NCT01536366|765185|P2|NOT COMPLETED|Overall Study||4
319692|NCT01536366|765186|P1|NOT COMPLETED|Overall Study||13
319693|NCT01536366|765185|P2|COMPLETED|Overall Study||9
319694|NCT01536366|765186|P1|COMPLETED|Overall Study||1
319695|NCT01536366|765185|P2|Follow-up|Overall Study||9
319696|NCT01536366|765186|P1|Follow-up|Overall Study||13
319697|NCT01536366|765185|P2|Repaglinide|Overall Study||13
319698|NCT01536366|765186|P1|Repaglinide|Overall Study||14
319699|NCT01536366|765185|P2|BIA 9-1067 + Repaglinide|Overall Study||10
319700|NCT01536366|765186|P1|BIA 9-1067 + Repaglinide|Overall Study||14
319701|NCT01536366|765185|P2|STARTED|Overall Study||13
319702|NCT01536366|765186|P1|STARTED|Overall Study||14
319703|NCT01536262|765201|P3|NOT COMPLETED|Overall Study||2
319704|NCT01536262|765202|P2|NOT COMPLETED|Overall Study||2
319705|NCT01536262|765203|P1|NOT COMPLETED|Overall Study||8
319706|NCT01536262|765201|P3|COMPLETED|Overall Study||39
319707|NCT01536262|765202|P2|COMPLETED|Overall Study||38
319708|NCT01536262|765203|P1|COMPLETED|Overall Study||33
319709|NCT01536262|765201|P3|STARTED|Overall Study||41
319710|NCT01536262|765202|P2|STARTED|Overall Study||40
319711|NCT01536262|765203|P1|STARTED|Overall Study||41
319712|NCT01536197|765219|P2|NOT COMPLETED|Overall Study||0
319713|NCT01536197|765220|P1|NOT COMPLETED|Overall Study||0
319714|NCT01536197|765219|P2|COMPLETED|Overall Study||10
319715|NCT01536197|765220|P1|COMPLETED|Overall Study||17
319716|NCT01536197|765219|P2|STARTED|Overall Study||10
319717|NCT01536197|765220|P1|STARTED|Overall Study||17
319718|NCT01536184|765230|P2|NOT COMPLETED|Overall Study||0
319719|NCT01536184|765231|P1|NOT COMPLETED|Overall Study||0
319720|NCT01536184|765230|P2|COMPLETED|Overall Study||4
319721|NCT01536184|765231|P1|COMPLETED|Overall Study||8
319722|NCT01536184|765230|P2|STARTED|Overall Study||4
319723|NCT01536184|765231|P1|STARTED|Overall Study||8
319724|NCT01536171|765245|P1|NOT COMPLETED|Overall Study||1
319725|NCT01536171|765245|P1|COMPLETED|Overall Study||21
319726|NCT01536171|765245|P1|STARTED|Overall Study||22
319727|NCT01536145|765250|P11|NOT COMPLETED|Overall Study||10
319728|NCT01536145|765251|P10|NOT COMPLETED|Overall Study||6
319729|NCT01536145|765252|P9|NOT COMPLETED|Overall Study||3
319730|NCT01536145|765253|P8|NOT COMPLETED|Overall Study||4
319731|NCT01536145|765254|P7|NOT COMPLETED|Overall Study||2
319732|NCT01536145|765255|P6|NOT COMPLETED|Overall Study||3
319733|NCT01536145|765256|P5|NOT COMPLETED|Overall Study||2
319734|NCT01536145|765257|P4|NOT COMPLETED|Overall Study||2
319735|NCT01536145|765258|P3|NOT COMPLETED|Overall Study||2
319736|NCT01536145|765259|P2|NOT COMPLETED|Overall Study||4
319737|NCT01536145|765260|P1|NOT COMPLETED|Overall Study||3
319738|NCT01536145|765250|P11|COMPLETED|Overall Study||0
319739|NCT01536145|765251|P10|COMPLETED|Overall Study||1
319740|NCT01536145|765252|P9|COMPLETED|Overall Study||0
319741|NCT01536145|765253|P8|COMPLETED|Overall Study||0
319742|NCT01536145|765254|P7|COMPLETED|Overall Study||1
319743|NCT01536145|765255|P6|COMPLETED|Overall Study||0
319744|NCT01536145|765256|P5|COMPLETED|Overall Study||2
319745|NCT01536145|765257|P4|COMPLETED|Overall Study||1
319746|NCT01536145|765258|P3|COMPLETED|Overall Study||1
319747|NCT01536145|765259|P2|COMPLETED|Overall Study||0
319748|NCT01536145|765260|P1|COMPLETED|Overall Study||0
319749|NCT01536145|765250|P11|STARTED|Overall Study||10
319750|NCT01536145|765251|P10|STARTED|Overall Study||7
319751|NCT01536145|765252|P9|STARTED|Overall Study||3
319752|NCT01536145|765253|P8|STARTED|Overall Study||4
319753|NCT01536145|765254|P7|STARTED|Overall Study||3
319754|NCT01536145|765255|P6|STARTED|Overall Study||3
319755|NCT01536145|765256|P5|STARTED|Overall Study||4
319756|NCT01536145|765257|P4|STARTED|Overall Study||3
319757|NCT01536145|765258|P3|STARTED|Overall Study||3
319758|NCT01536145|765259|P2|STARTED|Overall Study||4
319759|NCT01536145|765260|P1|STARTED|Overall Study||3
319760|NCT01536119|765367|P2|NOT COMPLETED|Overall Study||14
319761|NCT01536119|765368|P1|NOT COMPLETED|Overall Study||17
319762|NCT01536119|765367|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
319763|NCT01536119|765368|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
319764|NCT01536119|765367|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
319765|NCT01536119|765368|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
319766|NCT01536093|765394|P2|NOT COMPLETED|Overall Study||3
319767|NCT01536093|765395|P1|NOT COMPLETED|Overall Study||3
319768|NCT01536093|765394|P2|COMPLETED|Overall Study||21
319769|NCT01536093|765395|P1|COMPLETED|Overall Study||21
319770|NCT01536093|765394|P2|STARTED|Overall Study||24
319771|NCT01536093|765395|P1|STARTED|Overall Study||24
319772|NCT01536067|765411|P1|NOT COMPLETED|Overall Study||1
319773|NCT01536067|765411|P1|COMPLETED|Overall Study||2
319774|NCT01536067|765411|P1|STARTED|Overall Study||3
319775|NCT01536015|765424|P2|NOT COMPLETED|Overall Study||10
319776|NCT01536015|765425|P1|NOT COMPLETED|Overall Study||8
319777|NCT01536015|765424|P2|COMPLETED|Overall Study||3
319778|NCT01536015|765425|P1|COMPLETED|Overall Study||4
319779|NCT01536015|765424|P2|STARTED|Overall Study||13
319780|NCT01536015|765425|P1|STARTED|Overall Study||12
319781|NCT01535976|765443|P2|NOT COMPLETED|Overall Study||1
319782|NCT01535976|765444|P1|NOT COMPLETED|Overall Study||1
319783|NCT01535976|765443|P2|COMPLETED|Overall Study||26
319784|NCT01535976|765444|P1|COMPLETED|Overall Study||26
319785|NCT01535976|765443|P2|STARTED|Overall Study||27
319786|NCT01535976|765444|P1|STARTED|Overall Study||27
319787|NCT01535807|765452|P2|NOT COMPLETED|Overall Study||2
319788|NCT01535807|765453|P1|NOT COMPLETED|Overall Study||2
319789|NCT01535807|765452|P2|COMPLETED|Overall Study||20
319790|NCT01535807|765453|P1|COMPLETED|Overall Study||20
319791|NCT01535807|765452|P2|STARTED|Overall Study||22
319792|NCT01535807|765453|P1|STARTED|Overall Study||22
319793|NCT01535729|765459|P1|NOT COMPLETED|Overall Study||416
319794|NCT01535729|765459|P1|COMPLETED|Overall Study||49
319795|NCT01535729|765459|P1|Treated|Overall Study||385
319796|NCT01535729|765459|P1|STARTED|Overall Study||465
319797|NCT01535664|765486|P1|NOT COMPLETED|Overall Study||0
319798|NCT01535664|765486|P1|COMPLETED|Overall Study||20
319799|NCT01535664|765486|P1|STARTED|Overall Study||20
319800|NCT01535638|765500|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
319801|NCT01535638|765501|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
319802|NCT01535638|765502|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
319803|NCT01535638|765503|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
319804|NCT01535638|765504|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
319805|NCT01535638|765505|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
319806|NCT01535638|765500|P6|COMPLETED|Treatment 3 (Single Dose)||2
319807|NCT01535638|765501|P5|COMPLETED|Treatment 3 (Single Dose)||3
319808|NCT01535638|765502|P4|COMPLETED|Treatment 3 (Single Dose)||2
319809|NCT01535638|765503|P3|COMPLETED|Treatment 3 (Single Dose)||3
319810|NCT01535638|765504|P2|COMPLETED|Treatment 3 (Single Dose)||3
319811|NCT01535638|765505|P1|COMPLETED|Treatment 3 (Single Dose)||3
319812|NCT01535638|765500|P6|STARTED|Treatment 3 (Single Dose)||2
319813|NCT01535638|765501|P5|STARTED|Treatment 3 (Single Dose)||3
319814|NCT01535638|765502|P4|STARTED|Treatment 3 (Single Dose)||3
319815|NCT01535638|765503|P3|STARTED|Treatment 3 (Single Dose)||3
319816|NCT01535638|765504|P2|STARTED|Treatment 3 (Single Dose)||3
319817|NCT01535638|765505|P1|STARTED|Treatment 3 (Single Dose)||3
319818|NCT01535638|765500|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
319819|NCT01535638|765501|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
319820|NCT01535638|765502|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
319821|NCT01535638|765503|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
319822|NCT01535638|765504|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
319823|NCT01535638|765505|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
319824|NCT01535638|765500|P6|COMPLETED|Treatment 2 (Single Dose)||2
319825|NCT01535638|765501|P5|COMPLETED|Treatment 2 (Single Dose)||3
319826|NCT01535638|765502|P4|COMPLETED|Treatment 2 (Single Dose)||3
319827|NCT01535638|765503|P3|COMPLETED|Treatment 2 (Single Dose)||3
319828|NCT01535638|765504|P2|COMPLETED|Treatment 2 (Single Dose)||3
319829|NCT01535638|765505|P1|COMPLETED|Treatment 2 (Single Dose)||3
319830|NCT01535638|765500|P6|STARTED|Treatment 2 (Single Dose)||2
319831|NCT01535638|765501|P5|STARTED|Treatment 2 (Single Dose)||3
319832|NCT01535638|765502|P4|STARTED|Treatment 2 (Single Dose)||3
319833|NCT01535638|765503|P3|STARTED|Treatment 2 (Single Dose)||3
319834|NCT01535638|765504|P2|STARTED|Treatment 2 (Single Dose)||3
319835|NCT01535638|765505|P1|STARTED|Treatment 2 (Single Dose)||3
319836|NCT01535638|765500|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
319837|NCT01535638|765501|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
319838|NCT01535638|765502|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
319839|NCT01535638|765503|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
319840|NCT01535638|765504|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
319841|NCT01535638|765505|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
319842|NCT01535638|765500|P6|COMPLETED|Treatment 1 (Single Dose)||2
319843|NCT01535638|765501|P5|COMPLETED|Treatment 1 (Single Dose)||3
319844|NCT01535638|765502|P4|COMPLETED|Treatment 1 (Single Dose)||3
319845|NCT01535638|765503|P3|COMPLETED|Treatment 1 (Single Dose)||3
319846|NCT01535638|765504|P2|COMPLETED|Treatment 1 (Single Dose)||3
319847|NCT01535638|765505|P1|COMPLETED|Treatment 1 (Single Dose)||3
319848|NCT01535638|765500|P6|STARTED|Treatment 1 (Single Dose)||3
319849|NCT01535638|765501|P5|STARTED|Treatment 1 (Single Dose)||3
319850|NCT01535638|765502|P4|STARTED|Treatment 1 (Single Dose)||3
319851|NCT01535638|765503|P3|STARTED|Treatment 1 (Single Dose)||3
319852|NCT01535638|765504|P2|STARTED|Treatment 1 (Single Dose)||3
319853|NCT01535638|765505|P1|STARTED|Treatment 1 (Single Dose)||3
319854|NCT01535599|765519|P2|NOT COMPLETED|Overall Study||96
319855|NCT01535599|765520|P1|NOT COMPLETED|Overall Study||50
319856|NCT01535599|765519|P2|COMPLETED|Overall Study||250
319857|NCT01535599|765520|P1|COMPLETED|Overall Study||297
319858|NCT01535599|765519|P2|STARTED|Overall Study||346
319859|NCT01535599|765520|P1|STARTED|Overall Study||347
319860|NCT01535560|765532|P2|NOT COMPLETED|Overall Study||96
319861|NCT01535560|765533|P1|NOT COMPLETED|Overall Study||37
319862|NCT01535560|765532|P2|COMPLETED|Overall Study||179
319863|NCT01535560|765533|P1|COMPLETED|Overall Study||237
319864|NCT01535560|765532|P2|STARTED|Overall Study||275
319865|NCT01535560|765533|P1|STARTED|Overall Study||274
319866|NCT01535365|765545|P2|NOT COMPLETED|Overall Study||0
319867|NCT01535365|765546|P1|NOT COMPLETED|Overall Study||0
319868|NCT01535365|765545|P2|COMPLETED|Overall Study||29
319869|NCT01535365|765546|P1|COMPLETED|Overall Study||31
319870|NCT01535365|765545|P2|STARTED|Overall Study||29
319871|NCT01535365|765546|P1|STARTED|Overall Study||31
319872|NCT01535326|765557|P3|NOT COMPLETED|Overall Study||0
319873|NCT01535326|765558|P2|NOT COMPLETED|Overall Study||0
319874|NCT01535326|765559|P1|NOT COMPLETED|Overall Study||0
319875|NCT01535326|765557|P3|COMPLETED|Overall Study||90
319876|NCT01535326|765558|P2|COMPLETED|Overall Study||90
319877|NCT01535326|765559|P1|COMPLETED|Overall Study||90
319878|NCT01535326|765557|P3|STARTED|Overall Study||90
319879|NCT01535326|765558|P2|STARTED|Overall Study||90
319880|NCT01535326|765559|P1|STARTED|Overall Study||90
319881|NCT01535261|765576|P1|NOT COMPLETED|Overall Study||50
319882|NCT01535261|765576|P1|COMPLETED|Overall Study||307
319883|NCT01535261|765576|P1|STARTED|Overall Study||357
319884|NCT01535235|765589|P2|NOT COMPLETED|Overall Study||0
319885|NCT01535235|765590|P1|NOT COMPLETED|Overall Study||1
319886|NCT01535235|765589|P2|COMPLETED|Overall Study||15
319887|NCT01535235|765590|P1|COMPLETED|Overall Study||15
319888|NCT01535235|765589|P2|STARTED|Overall Study||15
319889|NCT01535235|765590|P1|STARTED|Overall Study||16
319890|NCT01535222|765604|P6|NOT COMPLETED|Overall Study||0
319891|NCT01535222|765605|P5|NOT COMPLETED|Overall Study||0
319892|NCT01535222|765606|P4|NOT COMPLETED|Overall Study||0
319893|NCT01535222|765607|P3|NOT COMPLETED|Overall Study||1
319894|NCT01535222|765608|P2|NOT COMPLETED|Overall Study||0
319895|NCT01535222|765609|P1|NOT COMPLETED|Overall Study||0
319896|NCT01535222|765604|P6|COMPLETED|Overall Study||8
319897|NCT01535222|765605|P5|COMPLETED|Overall Study||6
319898|NCT01535222|765606|P4|COMPLETED|Overall Study||6
319899|NCT01535222|765607|P3|COMPLETED|Overall Study||6
319900|NCT01535222|765608|P2|COMPLETED|Overall Study||3
319901|NCT01535222|765609|P1|COMPLETED|Overall Study||3
319902|NCT01535222|765604|P6|STARTED|Overall Study||8
319903|NCT01535222|765605|P5|STARTED|Overall Study||6
319904|NCT01535222|765606|P4|STARTED|Overall Study||6
319905|NCT01535222|765607|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
319906|NCT01535222|765608|P2|STARTED|Overall Study||3
319907|NCT01535222|765609|P1|STARTED|Overall Study||3
319908|NCT01535118|765629|P1|NOT COMPLETED|Overall Study||0
319909|NCT01535118|765629|P1|COMPLETED|Overall Study||2765
319910|NCT01535118|765629|P1|STARTED|Overall Study||2765
319911|NCT01535040|765640|P2|NOT COMPLETED|Overall Study||21
319912|NCT01535040|765641|P1|NOT COMPLETED|Overall Study||30
319913|NCT01535040|765640|P2|COMPLETED|Overall Study||44
319914|NCT01535040|765641|P1|COMPLETED|Overall Study||35
319915|NCT01535040|765640|P2|STARTED|Overall Study||65
319916|NCT01535040|765641|P1|STARTED|Overall Study||65
319917|NCT01535001|765655|P2|NOT COMPLETED|Overall Study||6
319918|NCT01535001|765656|P1|NOT COMPLETED|Overall Study||3
319919|NCT01535001|765655|P2|COMPLETED|Overall Study||44
319920|NCT01535001|765656|P1|COMPLETED|Overall Study||47
319921|NCT01535001|765655|P2|STARTED|Overall Study||50
319922|NCT01535001|765656|P1|STARTED|Overall Study||50
319923|NCT01534962|765682|P4|NOT COMPLETED|Overall Study||32
319924|NCT01534962|765683|P3|NOT COMPLETED|Overall Study||24
319925|NCT01534962|765684|P2|NOT COMPLETED|Overall Study||26
319926|NCT01534962|765685|P1|NOT COMPLETED|Overall Study||37
319927|NCT01534962|765682|P4|COMPLETED|Overall Study||24
319928|NCT01534962|765683|P3|COMPLETED|Overall Study||34
319929|NCT01534962|765684|P2|COMPLETED|Overall Study||34
319930|NCT01534962|765685|P1|COMPLETED|Overall Study||30
319931|NCT01534962|765682|P4|STARTED|Overall Study||56
319932|NCT01534962|765683|P3|STARTED|Overall Study||58
319933|NCT01534962|765684|P2|STARTED|Overall Study||60
319934|NCT01534962|765685|P1|STARTED|Overall Study||67
319935|NCT01534910|765717|P2|NOT COMPLETED|Overall Study||4
319936|NCT01534910|765718|P1|NOT COMPLETED|Overall Study||4
319937|NCT01534910|765717|P2|COMPLETED|Overall Study||28
319938|NCT01534910|765718|P1|COMPLETED|Overall Study||29
319939|NCT01534910|765717|P2|STARTED|Overall Study||32
319940|NCT01534910|765718|P1|STARTED|Overall Study||33
319941|NCT01534897|765726|P1|NOT COMPLETED|Overall Study||0
319942|NCT01534897|765726|P1|COMPLETED|Overall Study||10
319943|NCT01534897|765726|P1|Day 37 Iodine-131 Treatment|Overall Study||6
319944|NCT01534897|765726|P1|Day 25 Iodine-131 Scan|Overall Study||10
319945|NCT01534897|765726|P1|STARTED|Overall Study||10
319946|NCT01534689|765734|P1|NOT COMPLETED|Overall Study||0
319947|NCT01534689|765734|P1|COMPLETED|Overall Study||105
319948|NCT01534689|765734|P1|STARTED|Overall Study||105
319949|NCT01534676|765742|P2|NOT COMPLETED|Overall Study||1
319950|NCT01534676|765743|P1|NOT COMPLETED|Overall Study||2
319951|NCT01534676|765742|P2|COMPLETED|Overall Study||0
319952|NCT01534676|765743|P1|COMPLETED|Overall Study||0
319953|NCT01534676|765742|P2|STARTED|Overall Study||1
319954|NCT01534676|765743|P1|STARTED|Overall Study||2
319955|NCT01534637|765749|P1|NOT COMPLETED|Overall Study||9
319956|NCT01534637|765749|P1|COMPLETED|Overall Study||13
319957|NCT01534637|765749|P1|STARTED|Overall Study||22
319958|NCT01534533|765759|P4|NOT COMPLETED|Overall Study||4
319959|NCT01534533|765760|P3|NOT COMPLETED|Overall Study||8
319960|NCT01534533|765761|P2|NOT COMPLETED|Overall Study||3
319961|NCT01534533|765762|P1|NOT COMPLETED|Overall Study||8
319962|NCT01534533|765759|P4|COMPLETED|Overall Study||44
319963|NCT01534533|765760|P3|COMPLETED|Overall Study||40
319964|NCT01534533|765761|P2|COMPLETED|Overall Study||45
319965|NCT01534533|765762|P1|COMPLETED|Overall Study||40
319966|NCT01534533|765759|P4|STARTED|Overall Study||48
319967|NCT01534533|765760|P3|STARTED|Overall Study||48
319968|NCT01534533|765761|P2|STARTED|Overall Study||48
319969|NCT01534533|765762|P1|STARTED|Overall Study||48
319970|NCT01534520|765790|P2|NOT COMPLETED|Overall Study||1
319971|NCT01534520|765791|P1|NOT COMPLETED|Overall Study||0
319972|NCT01534520|765790|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
319973|NCT01534520|765791|P1|COMPLETED|Overall Study||30
319974|NCT01534520|765790|P2|STARTED|Overall Study||29
319975|NCT01534520|765791|P1|STARTED|Overall Study||30
319976|NCT01534351|765806|P3|NOT COMPLETED|Overall Study||0
319977|NCT01534351|765807|P2|NOT COMPLETED|Overall Study||0
319978|NCT01534351|765808|P1|NOT COMPLETED|Overall Study||1
319979|NCT01534351|765806|P3|COMPLETED|Overall Study||0
319980|NCT01534351|765807|P2|COMPLETED|Overall Study||0
319981|NCT01534351|765808|P1|COMPLETED|Overall Study||0
319982|NCT01534351|765806|P3|STARTED|Overall Study||0
319983|NCT01534351|765807|P2|STARTED|Overall Study||0
319984|NCT01534351|765808|P1|STARTED|Overall Study||1
319985|NCT01534208|765827|P2|NOT COMPLETED|Overall Study||49
319986|NCT01534208|765828|P1|NOT COMPLETED|Overall Study||57
319987|NCT01534208|765827|P2|COMPLETED|Overall Study||234
319988|NCT01534208|765828|P1|COMPLETED|Overall Study||159
319989|NCT01534208|765827|P2|STARTED|Overall Study||283
319990|NCT01534208|765828|P1|STARTED|Overall Study||216
319991|NCT01534182|765846|P2|NOT COMPLETED|Overall Study||10
319992|NCT01534182|765847|P1|NOT COMPLETED|Overall Study||12
319993|NCT01534182|765846|P2|COMPLETED|Overall Study||58
319994|NCT01534182|765847|P1|COMPLETED|Overall Study||218
319995|NCT01534182|765846|P2|Full Analysis Set|Overall Study||62
319996|NCT01534182|765847|P1|Full Analysis Set|Overall Study||229
319997|NCT01534182|765846|P2|Safety Set|Overall Study||64
319998|NCT01534182|765847|P1|Safety Set|Overall Study||230
319999|NCT01534182|765846|P2|STARTED|Overall Study||68
320000|NCT01534182|765847|P1|STARTED|Overall Study||230
320001|NCT01534143|765862|P1|NOT COMPLETED|Overall Study||0
320002|NCT01534143|765862|P1|COMPLETED|Overall Study||1
320003|NCT01534143|765862|P1|STARTED|Overall Study||1
320004|NCT01533974|765880|P2|NOT COMPLETED|Overall Study||50
320005|NCT01533974|765881|P1|NOT COMPLETED|Overall Study||51
320006|NCT01533974|765880|P2|COMPLETED|Overall Study||176
320007|NCT01533974|765881|P1|COMPLETED|Overall Study||173
320008|NCT01533974|765880|P2|STARTED|Overall Study||226
320009|NCT01533974|765881|P1|STARTED|Overall Study||224
320010|NCT01533935|765887|P5|NOT COMPLETED|Overall Study||8
320011|NCT01533935|765888|P4|NOT COMPLETED|Overall Study||7
320012|NCT01533935|765889|P3|NOT COMPLETED|Overall Study||8
320013|NCT01533935|765890|P2|NOT COMPLETED|Overall Study||13
320014|NCT01533935|765891|P1|NOT COMPLETED|Overall Study||6
320015|NCT01533935|765887|P5|COMPLETED|Overall Study|All treatment periods|50
320016|NCT01533935|765888|P4|COMPLETED|Overall Study|All treatment periods|52
320017|NCT01533935|765889|P3|COMPLETED|Overall Study|All treatment periods|50
320018|NCT01533935|765890|P2|COMPLETED|Overall Study|All treatment periods|45
320019|NCT01533935|765891|P1|COMPLETED|Overall Study|All treatment periods|52
320020|NCT01533935|765887|P5|Received Tio+Olo 5/5|Overall Study||55
320021|NCT01533935|765888|P4|Received Tio+Olo 5/5|Overall Study||54
320022|NCT01533935|765889|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
320023|NCT01533935|765890|P2|Received Tio+Olo 5/5|Overall Study||58
320024|NCT01533935|765891|P1|Received Tio+Olo 5/5|Overall Study||56
320025|NCT01533935|765887|P5|Received Tio+Olo 2.5/5|Overall Study||56
320026|NCT01533935|765888|P4|Received Tio+Olo 2.5/5|Overall Study||56
320027|NCT01533935|765889|P3|Received Tio+Olo 2.5/5|Overall Study||49
320028|NCT01533935|765890|P2|Received Tio+Olo 2.5/5|Overall Study||0
320029|NCT01533935|765891|P1|Received Tio+Olo 2.5/5|Overall Study||58
320030|NCT01533935|765887|P5|Received Tio 5|Overall Study||52
320031|NCT01533935|765888|P4|Received Tio 5|Overall Study||0
320032|NCT01533935|765889|P3|Received Tio 5|Overall Study||58
320033|NCT01533935|765890|P2|Received Tio 5|Overall Study||54
320034|NCT01533935|765891|P1|Received Tio 5|Overall Study||54
320035|NCT01533935|765887|P5|Received Olo 5|Overall Study||0
320036|NCT01533935|765888|P4|Received Olo 5|Overall Study||59
320037|NCT01533935|765889|P3|Received Olo 5|Overall Study||55
320038|NCT01533935|765890|P2|Received Olo 5|Overall Study||52
320039|NCT01533935|765891|P1|Received Olo 5|Overall Study||52
320040|NCT01533935|765887|P5|Received Placebo|Overall Study||58
320041|NCT01533935|765888|P4|Received Placebo|Overall Study||57
320042|NCT01533935|765889|P3|Received Placebo|Overall Study||52
320043|NCT01533935|765890|P2|Received Placebo|Overall Study||47
320044|NCT01533935|765891|P1|Received Placebo|Overall Study||0
320045|NCT01533935|765887|P5|STARTED|Overall Study||58
320046|NCT01533935|765888|P4|STARTED|Overall Study||59
320047|NCT01533935|765889|P3|STARTED|Overall Study||58
320048|NCT01533935|765890|P2|STARTED|Overall Study||58
320049|NCT01533935|765891|P1|STARTED|Overall Study||58
320050|NCT01533922|765918|P5|NOT COMPLETED|Overall Study||6
320051|NCT01533922|765919|P4|NOT COMPLETED|Overall Study||5
320052|NCT01533922|765920|P3|NOT COMPLETED|Overall Study||10
320053|NCT01533922|765921|P2|NOT COMPLETED|Overall Study||12
320054|NCT01533922|765922|P1|NOT COMPLETED|Overall Study||10
320055|NCT01533922|765918|P5|COMPLETED|Overall Study|Completed all treatment arms|53
320056|NCT01533922|765919|P4|COMPLETED|Overall Study|Completed all treatment arms|53
320057|NCT01533922|765920|P3|COMPLETED|Overall Study|Completed all treatment arms|50
320058|NCT01533922|765921|P2|COMPLETED|Overall Study|Completed all treatment arms|47
320059|NCT01533922|765922|P1|COMPLETED|Overall Study|Completed all treatment arms|49
320060|NCT01533922|765918|P5|Received Tio+Olo 5/5|Overall Study||56
320061|NCT01533922|765919|P4|Received Tio+Olo 5/5|Overall Study||53
320062|NCT01533922|765920|P3|Received Tio+Olo 5/5|Overall Study||0
320063|NCT01533922|765921|P2|Received Tio+Olo 5/5|Overall Study||59
320064|NCT01533922|765922|P1|Received Tio+Olo 5/5|Overall Study||58
320065|NCT01533922|765918|P5|Received Tio+Olo 2.5/5|Overall Study||56
320066|NCT01533922|765919|P4|Received Tio+Olo 2.5/5|Overall Study||55
320067|NCT01533922|765920|P3|Received Tio+Olo 2.5/5|Overall Study||52
320068|NCT01533922|765921|P2|Received Tio+Olo 2.5/5|Overall Study||0
320069|NCT01533922|765922|P1|Received Tio+Olo 2.5/5|Overall Study||59
320070|NCT01533922|765918|P5|Received Tio 5|Overall Study||54
320071|NCT01533922|765919|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
320072|NCT01533922|765920|P3|Received Tio 5|Overall Study||59
320073|NCT01533922|765921|P2|Received Tio 5|Overall Study||58
320074|NCT01533922|765922|P1|Received Tio 5|Overall Study||54
320075|NCT01533922|765918|P5|Received Olo 5|Overall Study||0
320076|NCT01533922|765919|P4|Received Olo 5|Overall Study||57
320077|NCT01533922|765920|P3|Received Olo 5|Overall Study||57
320078|NCT01533922|765921|P2|Received Olo 5|Overall Study||52
320079|NCT01533922|765922|P1|Received Olo 5|Overall Study||51
320080|NCT01533922|765918|P5|Received Placebo|Overall Study||59
320081|NCT01533922|765919|P4|Received Placebo|Overall Study||57
320082|NCT01533922|765920|P3|Received Placebo|Overall Study||57
320083|NCT01533922|765921|P2|Received Placebo|Overall Study||49
320084|NCT01533922|765922|P1|Received Placebo|Overall Study||0
320085|NCT01533922|765918|P5|STARTED|Overall Study||59
320086|NCT01533922|765919|P4|STARTED|Overall Study||58
320087|NCT01533922|765920|P3|STARTED|Overall Study||60
320088|NCT01533922|765921|P2|STARTED|Overall Study||59
320089|NCT01533922|765922|P1|STARTED|Overall Study||59
320090|NCT01533753|765951|P2|NOT COMPLETED|Overall Study||0
320091|NCT01533753|765952|P1|NOT COMPLETED|Overall Study||0
320092|NCT01533753|765951|P2|COMPLETED|Overall Study||3
320093|NCT01533753|765952|P1|COMPLETED|Overall Study||2
320094|NCT01533753|765951|P2|STARTED|Overall Study||3
320095|NCT01533753|765952|P1|STARTED|Overall Study||2
320096|NCT01533597|765966|P2|NOT COMPLETED|Overall Study||10
320097|NCT01533597|765967|P1|NOT COMPLETED|Overall Study||6
320098|NCT01533597|765966|P2|COMPLETED|Overall Study||25
320099|NCT01533597|765967|P1|COMPLETED|Overall Study||29
320100|NCT01533597|765966|P2|STARTED|Overall Study||35
320101|NCT01533597|765967|P1|STARTED|Overall Study||35
320102|NCT01533493|765985|P2|NOT COMPLETED|Overall Study||3
320103|NCT01533493|765986|P1|NOT COMPLETED|Overall Study||5
320104|NCT01533493|765985|P2|COMPLETED|Overall Study||11
320105|NCT01533493|765986|P1|COMPLETED|Overall Study||7
320106|NCT01533493|765985|P2|STARTED|Overall Study||14
320107|NCT01533493|765986|P1|STARTED|Overall Study||12
320108|NCT01533428|765994|P2|NOT COMPLETED|Overall Study||8
320109|NCT01533428|765995|P1|NOT COMPLETED|Overall Study||9
320110|NCT01533428|765994|P2|COMPLETED|Overall Study||175
320111|NCT01533428|765995|P1|COMPLETED|Overall Study||177
320112|NCT01533428|765994|P2|STARTED|Overall Study||183
320113|NCT01533428|765995|P1|STARTED|Overall Study||186
320114|NCT01533259|766035|P1|NOT COMPLETED|Overall Study||0
320115|NCT01533259|766035|P1|COMPLETED|Overall Study||48
320116|NCT01533259|766035|P1|STARTED|Overall Study||48
320117|NCT01533246|766041|P1|NOT COMPLETED|Overall Study||2
320118|NCT01533246|766041|P1|COMPLETED|Overall Study||15
320119|NCT01533246|766041|P1|STARTED|Overall Study||17
320120|NCT01533181|766052|P2|NOT COMPLETED|Overall Study||1
320121|NCT01533181|766053|P1|NOT COMPLETED|Overall Study||1
320122|NCT01533181|766052|P2|COMPLETED|Overall Study||28
320123|NCT01533181|766053|P1|COMPLETED|Overall Study||14
320124|NCT01533181|766052|P2|STARTED|Overall Study||29
320125|NCT01533181|766053|P1|STARTED|Overall Study||15
320126|NCT01533116|766069|P4|NOT COMPLETED|Overall Study||0
320127|NCT01533116|766070|P3|NOT COMPLETED|Overall Study||1
320128|NCT01533116|766071|P2|NOT COMPLETED|Overall Study||1
320129|NCT01533116|766072|P1|NOT COMPLETED|Overall Study||2
320130|NCT01533116|766069|P4|COMPLETED|Overall Study||12
320131|NCT01533116|766070|P3|COMPLETED|Overall Study||12
320132|NCT01533116|766071|P2|COMPLETED|Overall Study||12
320133|NCT01533116|766072|P1|COMPLETED|Overall Study||12
320134|NCT01533116|766069|P4|STARTED|Overall Study||12
320135|NCT01533116|766070|P3|STARTED|Overall Study||13
320136|NCT01533116|766071|P2|STARTED|Overall Study||13
320137|NCT01533116|766072|P1|STARTED|Overall Study||14
320138|NCT01533077|766102|P4|NOT COMPLETED|Overall Study||0
320139|NCT01533077|766103|P3|NOT COMPLETED|Overall Study||0
320140|NCT01533077|766104|P2|NOT COMPLETED|Overall Study||1
320141|NCT01533077|766105|P1|NOT COMPLETED|Overall Study||1
320142|NCT01533077|766102|P4|COMPLETED|Overall Study||4
320143|NCT01533077|766103|P3|COMPLETED|Overall Study||4
320144|NCT01533077|766104|P2|COMPLETED|Overall Study||4
320145|NCT01533077|766105|P1|COMPLETED|Overall Study||4
320146|NCT01533077|766102|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
320147|NCT01533077|766103|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
320148|NCT01533077|766104|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
320149|NCT01533077|766105|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
320150|NCT01533077|766102|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
320151|NCT01533077|766103|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
320152|NCT01533077|766104|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
320153|NCT01533077|766105|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
320154|NCT01533077|766102|P4|Sinemet® 100/25|Overall Study||4
320155|NCT01533077|766103|P3|Sinemet® 100/25|Overall Study||4
320156|NCT01533077|766104|P2|Sinemet® 100/25|Overall Study||5
320157|NCT01533077|766105|P1|Sinemet® 100/25|Overall Study||4
320158|NCT01533077|766102|P4|BIA 9-1067 50 mg|Overall Study||4
320159|NCT01533077|766103|P3|BIA 9-1067 50 mg|Overall Study||4
320160|NCT01533077|766104|P2|BIA 9-1067 50 mg|Overall Study||5
320161|NCT01533077|766105|P1|BIA 9-1067 50 mg|Overall Study||5
320162|NCT01533077|766102|P4|STARTED|Overall Study||4
320163|NCT01533077|766103|P3|STARTED|Overall Study||4
320164|NCT01533077|766104|P2|STARTED|Overall Study||5
320165|NCT01533077|766105|P1|STARTED|Overall Study||5
320166|NCT01533038|766161|P2|NOT COMPLETED|Overall Study||1
320167|NCT01533038|766162|P1|NOT COMPLETED|Overall Study||0
320168|NCT01533038|766161|P2|COMPLETED|Overall Study||34
320169|NCT01533038|766162|P1|COMPLETED|Overall Study||45
320170|NCT01533038|766161|P2|STARTED|Overall Study||35
320171|NCT01533038|766162|P1|STARTED|Overall Study||45
320172|NCT01532999|766170|P2|NOT COMPLETED|Overall Study||18
320173|NCT01532999|766171|P1|NOT COMPLETED|Overall Study||31
320174|NCT01532999|766170|P2|COMPLETED|Overall Study||77
320175|NCT01532999|766171|P1|COMPLETED|Overall Study||65
320176|NCT01532999|766170|P2|STARTED|Overall Study||95
320177|NCT01532999|766171|P1|STARTED|Overall Study||96
320178|NCT01532973|766202|P10|NOT COMPLETED|Part 3||0
320179|NCT01532973|766203|P9|NOT COMPLETED|Part 3||0
320180|NCT01532973|766204|P8|NOT COMPLETED|Part 3||0
320181|NCT01532973|766205|P7|NOT COMPLETED|Part 3||0
320182|NCT01532973|766206|P6|NOT COMPLETED|Part 3||0
320183|NCT01532973|766207|P5|NOT COMPLETED|Part 3||0
320184|NCT01532973|766208|P4|NOT COMPLETED|Part 3||0
320185|NCT01532973|766209|P3|NOT COMPLETED|Part 3||0
320186|NCT01532973|766210|P2|NOT COMPLETED|Part 3||0
320187|NCT01532973|766211|P1|NOT COMPLETED|Part 3||0
320188|NCT01532973|766202|P10|COMPLETED|Part 3||6
320189|NCT01532973|766203|P9|COMPLETED|Part 3||6
320190|NCT01532973|766204|P8|COMPLETED|Part 3||0
320191|NCT01532973|766205|P7|COMPLETED|Part 3||0
320192|NCT01532973|766206|P6|COMPLETED|Part 3||0
320193|NCT01532973|766207|P5|COMPLETED|Part 3||0
320194|NCT01532973|766208|P4|COMPLETED|Part 3||0
320195|NCT01532973|766209|P3|COMPLETED|Part 3||0
320196|NCT01532973|766210|P2|COMPLETED|Part 3||0
320197|NCT01532973|766211|P1|COMPLETED|Part 3||0
320198|NCT01532973|766202|P10|STARTED|Part 3||6
320199|NCT01532973|766203|P9|STARTED|Part 3||6
320200|NCT01532973|766204|P8|STARTED|Part 3||0
320201|NCT01532973|766205|P7|STARTED|Part 3||0
320202|NCT01532973|766206|P6|STARTED|Part 3||0
320203|NCT01532973|766207|P5|STARTED|Part 3||0
320204|NCT01532973|766208|P4|STARTED|Part 3||0
320205|NCT01532973|766209|P3|STARTED|Part 3||0
320206|NCT01532973|766210|P2|STARTED|Part 3||0
320207|NCT01532973|766211|P1|STARTED|Part 3||0
320208|NCT01532973|766202|P10|NOT COMPLETED|Part 2||0
320209|NCT01532973|766203|P9|NOT COMPLETED|Part 2||0
320210|NCT01532973|766204|P8|NOT COMPLETED|Part 2||0
320211|NCT01532973|766205|P7|NOT COMPLETED|Part 2||0
320212|NCT01532973|766206|P6|NOT COMPLETED|Part 2||0
320213|NCT01532973|766207|P5|NOT COMPLETED|Part 2||0
320214|NCT01532973|766208|P4|NOT COMPLETED|Part 2||0
320215|NCT01532973|766209|P3|NOT COMPLETED|Part 2||0
320216|NCT01532973|766210|P2|NOT COMPLETED|Part 2||0
320217|NCT01532973|766211|P1|NOT COMPLETED|Part 2||0
320218|NCT01532973|766202|P10|COMPLETED|Part 2||0
320219|NCT01532973|766203|P9|COMPLETED|Part 2||0
320220|NCT01532973|766204|P8|COMPLETED|Part 2||0
320221|NCT01532973|766205|P7|COMPLETED|Part 2||6
320222|NCT01532973|766206|P6|COMPLETED|Part 2||6
320223|NCT01532973|766207|P5|COMPLETED|Part 2||6
320224|NCT01532973|766208|P4|COMPLETED|Part 2||0
320225|NCT01532973|766209|P3|COMPLETED|Part 2||0
320226|NCT01532973|766210|P2|COMPLETED|Part 2||0
320227|NCT01532973|766211|P1|COMPLETED|Part 2||0
320228|NCT01532973|766202|P10|STARTED|Part 2||0
320229|NCT01532973|766203|P9|STARTED|Part 2||0
320230|NCT01532973|766204|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
320231|NCT01532973|766205|P7|STARTED|Part 2||6
320232|NCT01532973|766206|P6|STARTED|Part 2||6
320233|NCT01532973|766207|P5|STARTED|Part 2||6
320234|NCT01532973|766208|P4|STARTED|Part 2||0
320235|NCT01532973|766209|P3|STARTED|Part 2||0
320236|NCT01532973|766210|P2|STARTED|Part 2||0
320237|NCT01532973|766211|P1|STARTED|Part 2||0
320238|NCT01532973|766202|P10|NOT COMPLETED|Part 1||0
320239|NCT01532973|766203|P9|NOT COMPLETED|Part 1||0
320240|NCT01532973|766204|P8|NOT COMPLETED|Part 1||0
320241|NCT01532973|766205|P7|NOT COMPLETED|Part 1||0
320242|NCT01532973|766206|P6|NOT COMPLETED|Part 1||0
320243|NCT01532973|766207|P5|NOT COMPLETED|Part 1||0
320244|NCT01532973|766208|P4|NOT COMPLETED|Part 1||0
320245|NCT01532973|766209|P3|NOT COMPLETED|Part 1||0
320246|NCT01532973|766210|P2|NOT COMPLETED|Part 1||0
320247|NCT01532973|766211|P1|NOT COMPLETED|Part 1||0
320248|NCT01532973|766202|P10|COMPLETED|Part 1||0
320249|NCT01532973|766203|P9|COMPLETED|Part 1||0
320250|NCT01532973|766204|P8|COMPLETED|Part 1||0
320251|NCT01532973|766205|P7|COMPLETED|Part 1||0
320252|NCT01532973|766206|P6|COMPLETED|Part 1||0
320253|NCT01532973|766207|P5|COMPLETED|Part 1||0
320254|NCT01532973|766208|P4|COMPLETED|Part 1||0
320255|NCT01532973|766209|P3|COMPLETED|Part 1||6
320256|NCT01532973|766210|P2|COMPLETED|Part 1||6
320257|NCT01532973|766211|P1|COMPLETED|Part 1||6
320258|NCT01532973|766202|P10|STARTED|Part 1||0
320259|NCT01532973|766203|P9|STARTED|Part 1||0
320260|NCT01532973|766204|P8|STARTED|Part 1||0
320261|NCT01532973|766205|P7|STARTED|Part 1||0
320262|NCT01532973|766206|P6|STARTED|Part 1||0
320263|NCT01532973|766207|P5|STARTED|Part 1||0
320264|NCT01532973|766208|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
320265|NCT01532973|766209|P3|STARTED|Part 1||6
320266|NCT01532973|766210|P2|STARTED|Part 1||6
320267|NCT01532973|766211|P1|STARTED|Part 1||6
320268|NCT01532934|766253|P2|NOT COMPLETED|Overall Study||13
320269|NCT01532934|766254|P1|NOT COMPLETED|Overall Study||14
320270|NCT01532934|766253|P2|COMPLETED|Overall Study||39
320271|NCT01532934|766254|P1|COMPLETED|Overall Study||39
320272|NCT01532934|766253|P2|STARTED|Overall Study||52
320273|NCT01532934|766254|P1|STARTED|Overall Study||53
320274|NCT01532869|766266|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
320275|NCT01532869|766267|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
320276|NCT01532869|766266|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
320277|NCT01532869|766267|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
320278|NCT01532869|766266|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
320279|NCT01532869|766267|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
320280|NCT01532869|766266|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
320281|NCT01532869|766267|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
320282|NCT01532869|766266|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
320283|NCT01532869|766267|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
320284|NCT01532869|766266|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
320285|NCT01532869|766267|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
320286|NCT01532869|766266|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
320287|NCT01532869|766267|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
320288|NCT01532869|766266|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
320289|NCT01532869|766267|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
320290|NCT01532869|766266|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
320291|NCT01532869|766267|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
320292|NCT01531725|766304|P1|NOT COMPLETED|Overall Study||5
320293|NCT01531725|766304|P1|COMPLETED|Overall Study||197
320294|NCT01531725|766304|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
320295|NCT01532635|766309|P1|NOT COMPLETED|Overall Study||0
320296|NCT01532635|766309|P1|COMPLETED|Overall Study||4
320297|NCT01532635|766309|P1|STARTED|Overall Study||4
320298|NCT01532570|766325|P4|NOT COMPLETED|Overall Study||0
320299|NCT01532570|766326|P3|NOT COMPLETED|Overall Study||0
320300|NCT01532570|766327|P2|NOT COMPLETED|Overall Study||1
320301|NCT01532570|766328|P1|NOT COMPLETED|Overall Study||1
320302|NCT01532570|766325|P4|COMPLETED|Overall Study||4
320303|NCT01532570|766326|P3|COMPLETED|Overall Study||1
320304|NCT01532570|766327|P2|COMPLETED|Overall Study||1
320305|NCT01532570|766328|P1|COMPLETED|Overall Study||10
320306|NCT01532570|766325|P4|STARTED|Overall Study||4
320307|NCT01532570|766326|P3|STARTED|Overall Study||1
320308|NCT01532570|766327|P2|STARTED|Overall Study||2
320309|NCT01532570|766328|P1|STARTED|Overall Study||11
320310|NCT01532453|766361|P2|NOT COMPLETED|Overall Study||70
320311|NCT01532453|766362|P1|NOT COMPLETED|Overall Study||27
320312|NCT01532453|766361|P2|COMPLETED|Overall Study||90
320313|NCT01532453|766362|P1|COMPLETED|Overall Study||54
320314|NCT01532453|766361|P2|STARTED|Overall Study||160
320315|NCT01532453|766362|P1|STARTED|Overall Study||81
320316|NCT01532414|766373|P3|NOT COMPLETED|Overall Study||3
320317|NCT01532414|766374|P2|NOT COMPLETED|Overall Study||2
320318|NCT01532414|766375|P1|NOT COMPLETED|Overall Study||7
320319|NCT01532414|766373|P3|COMPLETED|Overall Study||35
320320|NCT01532414|766374|P2|COMPLETED|Overall Study||19
320321|NCT01532414|766375|P1|COMPLETED|Overall Study||85
320322|NCT01532414|766373|P3|STARTED|Overall Study||38
320323|NCT01532414|766374|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
320324|NCT01532414|766375|P1|STARTED|Overall Study||92
320325|NCT01532362|766385|P2|NOT COMPLETED|Overall Study||0
320326|NCT01532362|766386|P1|NOT COMPLETED|Overall Study||0
320327|NCT01532362|766385|P2|COMPLETED|Overall Study||0
320328|NCT01532362|766386|P1|COMPLETED|Overall Study||1
320329|NCT01532362|766385|P2|STARTED|Overall Study||0
320330|NCT01532362|766386|P1|STARTED|Overall Study||1
320331|NCT01532349|766394|P2|NOT COMPLETED|Overall Study||5
320332|NCT01532349|766395|P1|NOT COMPLETED|Overall Study||2
320333|NCT01532349|766394|P2|COMPLETED|Overall Study||12
320334|NCT01532349|766395|P1|COMPLETED|Overall Study||15
320335|NCT01532349|766394|P2|STARTED|Overall Study||17
320336|NCT01532349|766395|P1|STARTED|Overall Study||17
320337|NCT01532141|766404|P3|NOT COMPLETED|Overall Study||0
320338|NCT01532141|766405|P2|NOT COMPLETED|Overall Study||0
320339|NCT01532141|766406|P1|NOT COMPLETED|Overall Study||1
320340|NCT01532141|766404|P3|COMPLETED|Overall Study||8
320341|NCT01532141|766405|P2|COMPLETED|Overall Study||8
320342|NCT01532141|766406|P1|COMPLETED|Overall Study||8
320343|NCT01532141|766404|P3|Period 3|Overall Study||8
320344|NCT01532141|766405|P2|Period 3|Overall Study||8
320345|NCT01532141|766406|P1|Period 3|Overall Study||8
320346|NCT01532141|766404|P3|Period 2|Overall Study||8
320347|NCT01532141|766405|P2|Period 2|Overall Study||8
320348|NCT01532141|766406|P1|Period 2|Overall Study||8
320349|NCT01532141|766404|P3|Period 1|Overall Study||8
320350|NCT01532141|766405|P2|Period 1|Overall Study||8
320351|NCT01532141|766406|P1|Period 1|Overall Study||9
320352|NCT01532141|766404|P3|STARTED|Overall Study||8
320353|NCT01532141|766405|P2|STARTED|Overall Study||8
320354|NCT01532141|766406|P1|STARTED|Overall Study||9
320355|NCT01532128|766424|P3|NOT COMPLETED|Overall Study||0
320356|NCT01532128|766425|P2|NOT COMPLETED|Overall Study||0
320357|NCT01532128|766426|P1|NOT COMPLETED|Overall Study||0
320358|NCT01532128|766424|P3|COMPLETED|Overall Study||8
320359|NCT01532128|766425|P2|COMPLETED|Overall Study||8
320360|NCT01532128|766426|P1|COMPLETED|Overall Study||8
320361|NCT01532128|766424|P3|STARTED|Overall Study||8
320362|NCT01532128|766425|P2|STARTED|Overall Study||8
320363|NCT01532128|766426|P1|STARTED|Overall Study||8
320364|NCT01531998|766441|P1|NOT COMPLETED|Overall Study||3
320365|NCT01531998|766441|P1|COMPLETED|Overall Study||8
320366|NCT01531998|766441|P1|STARTED|Overall Study||11
320367|NCT01531387|766448|P2|NOT COMPLETED|Overall Study||11
320368|NCT01531387|766449|P1|NOT COMPLETED|Overall Study||11
320369|NCT01531387|766448|P2|COMPLETED|Overall Study||0
320370|NCT01531387|766449|P1|COMPLETED|Overall Study||0
320371|NCT01531387|766448|P2|STARTED|Overall Study||11
320372|NCT01531387|766449|P1|STARTED|Overall Study||11
320373|NCT01531335|766465|P2|NOT COMPLETED|Overall Study||0
320374|NCT01531335|766466|P1|NOT COMPLETED|Overall Study||0
320375|NCT01531335|766465|P2|COMPLETED|Overall Study||40
320376|NCT01531335|766466|P1|COMPLETED|Overall Study||40
320377|NCT01531335|766465|P2|STARTED|Overall Study||40
320378|NCT01531335|766466|P1|STARTED|Overall Study||40
320379|NCT01531205|766474|P1|NOT COMPLETED|Overall Study||1
320380|NCT01531205|766474|P1|COMPLETED|Overall Study||1
320381|NCT01531205|766474|P1|STARTED|Overall Study||2
320382|NCT01530477|766486|P3|NOT COMPLETED|Overall Study||0
320383|NCT01530477|766487|P2|NOT COMPLETED|Overall Study||0
320384|NCT01530477|766488|P1|NOT COMPLETED|Overall Study||0
320385|NCT01530477|766486|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
320386|NCT01530477|766487|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
320387|NCT01530477|766488|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
320388|NCT01530477|766486|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
320389|NCT01530477|766487|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
320390|NCT01530477|766488|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
320391|NCT01530464|766496|P2|NOT COMPLETED|Washout (24h)||1
320392|NCT01530464|766497|P1|NOT COMPLETED|Washout (24h)||0
320486|NCT01529645|766601|P7|STARTED|Overall Study||42
320393|NCT01530464|766496|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
320394|NCT01530464|766497|P1|COMPLETED|Washout (24h)||9
320395|NCT01530464|766496|P2|STARTED|Washout (24h)||8
320396|NCT01530464|766497|P1|STARTED|Washout (24h)||9
320397|NCT01530464|766496|P2|NOT COMPLETED|Third Intervention (24h)||0
320398|NCT01530464|766497|P1|NOT COMPLETED|Third Intervention (24h)||0
320399|NCT01530464|766496|P2|COMPLETED|Third Intervention (24h)||8
320400|NCT01530464|766497|P1|COMPLETED|Third Intervention (24h)||9
320401|NCT01530464|766496|P2|STARTED|Third Intervention (24h)||8
320402|NCT01530464|766497|P1|STARTED|Third Intervention (24h)||9
320403|NCT01530464|766496|P2|NOT COMPLETED|Washout (24h)||0
320404|NCT01530464|766497|P1|NOT COMPLETED|Washout (24h)||1
320405|NCT01530464|766496|P2|COMPLETED|Washout (24h)||8
320406|NCT01530464|766497|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
320407|NCT01530464|766496|P2|STARTED|Washout (24h)||8
320408|NCT01530464|766497|P1|STARTED|Washout (24h)||10
320409|NCT01530464|766496|P2|NOT COMPLETED|Second Intervention (24h)||0
320410|NCT01530464|766497|P1|NOT COMPLETED|Second Intervention (24h)||0
320411|NCT01530464|766496|P2|COMPLETED|Second Intervention (24h)||8
320412|NCT01530464|766497|P1|COMPLETED|Second Intervention (24h)||10
320413|NCT01530464|766496|P2|STARTED|Second Intervention (24h)||8
320414|NCT01530464|766497|P1|STARTED|Second Intervention (24h)||10
320415|NCT01530464|766496|P2|NOT COMPLETED|Washout (24h)||0
320416|NCT01530464|766497|P1|NOT COMPLETED|Washout (24h)||0
320417|NCT01530464|766496|P2|COMPLETED|Washout (24h)||8
320418|NCT01530464|766497|P1|COMPLETED|Washout (24h)||10
320419|NCT01530464|766496|P2|STARTED|Washout (24h)||8
320420|NCT01530464|766497|P1|STARTED|Washout (24h)||10
320421|NCT01530464|766496|P2|NOT COMPLETED|First Intervention (24h)||0
320422|NCT01530464|766497|P1|NOT COMPLETED|First Intervention (24h)||0
320423|NCT01530464|766496|P2|COMPLETED|First Intervention (24h)||8
320424|NCT01530464|766497|P1|COMPLETED|First Intervention (24h)||10
320425|NCT01530464|766496|P2|STARTED|First Intervention (24h)||8
320426|NCT01530464|766497|P1|STARTED|First Intervention (24h)||10
320427|NCT01530399|766530|P6|NOT COMPLETED|Overall Study||1
320428|NCT01530399|766531|P5|NOT COMPLETED|Overall Study||0
320429|NCT01530399|766532|P4|NOT COMPLETED|Overall Study||0
320430|NCT01530399|766533|P3|NOT COMPLETED|Overall Study||1
320431|NCT01530399|766534|P2|NOT COMPLETED|Overall Study||2
320432|NCT01530399|766535|P1|NOT COMPLETED|Overall Study||1
320433|NCT01530399|766530|P6|COMPLETED|Overall Study||6
320434|NCT01530399|766531|P5|COMPLETED|Overall Study||6
320435|NCT01530399|766532|P4|COMPLETED|Overall Study||10
320436|NCT01530399|766533|P3|COMPLETED|Overall Study||7
320437|NCT01530399|766534|P2|COMPLETED|Overall Study||8
320438|NCT01530399|766535|P1|COMPLETED|Overall Study||7
320439|NCT01530399|766530|P6|STARTED|Overall Study||7
320440|NCT01530399|766531|P5|STARTED|Overall Study||6
320441|NCT01530399|766532|P4|STARTED|Overall Study||10
320442|NCT01530399|766533|P3|STARTED|Overall Study||8
320443|NCT01530399|766534|P2|STARTED|Overall Study||10
320444|NCT01530399|766535|P1|STARTED|Overall Study||8
320445|NCT01530334|766549|P1|NOT COMPLETED|Overall Study||51
320446|NCT01530334|766549|P1|COMPLETED|Overall Study||10
320447|NCT01530334|766549|P1|STARTED|Overall Study||61
320448|NCT01530243|766562|P4|NOT COMPLETED|Overall Study||2
320449|NCT01530243|766563|P3|NOT COMPLETED|Overall Study||3
320450|NCT01530243|766564|P2|NOT COMPLETED|Overall Study||3
320451|NCT01530243|766565|P1|NOT COMPLETED|Overall Study||2
320452|NCT01530243|766562|P4|COMPLETED|Overall Study||24
320453|NCT01530243|766563|P3|COMPLETED|Overall Study||23
320454|NCT01530243|766564|P2|COMPLETED|Overall Study||23
320455|NCT01530243|766565|P1|COMPLETED|Overall Study||24
320456|NCT01530243|766562|P4|STARTED|Overall Study||26
320457|NCT01530243|766563|P3|STARTED|Overall Study||26
320458|NCT01530243|766564|P2|STARTED|Overall Study||26
320459|NCT01530243|766565|P1|STARTED|Overall Study||26
320460|NCT01530087|766583|P1|NOT COMPLETED|Overall Study||2
320461|NCT01530087|766583|P1|COMPLETED|Overall Study||1
320462|NCT01530087|766583|P1|STARTED|Overall Study||3
320463|NCT01529645|766598|P10|NOT COMPLETED|Overall Study||0
320464|NCT01529645|766599|P9|NOT COMPLETED|Overall Study||1
320465|NCT01529645|766600|P8|NOT COMPLETED|Overall Study||0
320466|NCT01529645|766601|P7|NOT COMPLETED|Overall Study||2
320467|NCT01529645|766602|P6|NOT COMPLETED|Overall Study||1
320468|NCT01529645|766603|P5|NOT COMPLETED|Overall Study||2
320469|NCT01529645|766604|P4|NOT COMPLETED|Overall Study||2
320470|NCT01529645|766605|P3|NOT COMPLETED|Overall Study||2
320471|NCT01529645|766606|P2|NOT COMPLETED|Overall Study||1
320472|NCT01529645|766607|P1|NOT COMPLETED|Overall Study||2
320473|NCT01529645|766598|P10|COMPLETED|Overall Study||42
320474|NCT01529645|766599|P9|COMPLETED|Overall Study||41
320475|NCT01529645|766600|P8|COMPLETED|Overall Study||42
320476|NCT01529645|766601|P7|COMPLETED|Overall Study||40
320477|NCT01529645|766602|P6|COMPLETED|Overall Study||41
320478|NCT01529645|766603|P5|COMPLETED|Overall Study||40
320479|NCT01529645|766604|P4|COMPLETED|Overall Study||40
320480|NCT01529645|766605|P3|COMPLETED|Overall Study||40
320481|NCT01529645|766606|P2|COMPLETED|Overall Study||41
320482|NCT01529645|766607|P1|COMPLETED|Overall Study||40
320483|NCT01529645|766598|P10|STARTED|Overall Study||42
320484|NCT01529645|766599|P9|STARTED|Overall Study||42
320485|NCT01529645|766600|P8|STARTED|Overall Study||42
320487|NCT01529645|766602|P6|STARTED|Overall Study||42
320488|NCT01529645|766603|P5|STARTED|Overall Study||42
320489|NCT01529645|766604|P4|STARTED|Overall Study||42
320490|NCT01529645|766605|P3|STARTED|Overall Study||42
320491|NCT01529645|766606|P2|STARTED|Overall Study||42
320492|NCT01529645|766607|P1|STARTED|Overall Study||42
320493|NCT01529632|766705|P2|NOT COMPLETED|Overall Study||3
320494|NCT01529632|766706|P1|NOT COMPLETED|Overall Study||3
320495|NCT01529632|766705|P2|COMPLETED|Overall Study||100
320496|NCT01529632|766706|P1|COMPLETED|Overall Study||87
320497|NCT01529632|766705|P2|STARTED|Overall Study||103
320498|NCT01529632|766706|P1|STARTED|Overall Study||90
320499|NCT01529515|766726|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
320500|NCT01529515|766727|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
320501|NCT01529515|766728|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
320502|NCT01529515|766729|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
320503|NCT01529515|766726|P4|COMPLETED|DOUBLE BLIND PHASE||148
320504|NCT01529515|766727|P3|COMPLETED|DOUBLE BLIND PHASE||122
320505|NCT01529515|766728|P2|COMPLETED|DOUBLE BLIND PHASE||0
320506|NCT01529515|766729|P1|COMPLETED|DOUBLE BLIND PHASE||0
320507|NCT01529515|766726|P4|STARTED|DOUBLE BLIND PHASE||160
320508|NCT01529515|766727|P3|STARTED|DOUBLE BLIND PHASE||145
320509|NCT01529515|766728|P2|STARTED|DOUBLE BLIND PHASE||0
320510|NCT01529515|766729|P1|STARTED|DOUBLE BLIND PHASE||0
320511|NCT01529515|766726|P4|NOT COMPLETED|MAINTENANCE PHASE||0
320512|NCT01529515|766727|P3|NOT COMPLETED|MAINTENANCE PHASE||0
320513|NCT01529515|766728|P2|NOT COMPLETED|MAINTENANCE PHASE||74
320514|NCT01529515|766729|P1|NOT COMPLETED|MAINTENANCE PHASE||0
320515|NCT01529515|766726|P4|COMPLETED|MAINTENANCE PHASE||0
320516|NCT01529515|766727|P3|COMPLETED|MAINTENANCE PHASE||0
320517|NCT01529515|766728|P2|COMPLETED|MAINTENANCE PHASE||305
320518|NCT01529515|766729|P1|COMPLETED|MAINTENANCE PHASE||0
320519|NCT01529515|766726|P4|STARTED|MAINTENANCE PHASE||0
320520|NCT01529515|766727|P3|STARTED|MAINTENANCE PHASE||0
320521|NCT01529515|766728|P2|STARTED|MAINTENANCE PHASE||379
320522|NCT01529515|766729|P1|STARTED|MAINTENANCE PHASE||0
320523|NCT01529515|766726|P4|NOT COMPLETED|TRANSITION PHASE||0
320524|NCT01529515|766727|P3|NOT COMPLETED|TRANSITION PHASE||0
320525|NCT01529515|766728|P2|NOT COMPLETED|TRANSITION PHASE||0
320526|NCT01529515|766729|P1|NOT COMPLETED|TRANSITION PHASE||127
320527|NCT01529515|766726|P4|COMPLETED|TRANSITION PHASE||0
320528|NCT01529515|766727|P3|COMPLETED|TRANSITION PHASE||0
320529|NCT01529515|766728|P2|COMPLETED|TRANSITION PHASE||0
320530|NCT01529515|766729|P1|COMPLETED|TRANSITION PHASE||379
320531|NCT01529515|766726|P4|STARTED|TRANSITION PHASE||0
320532|NCT01529515|766727|P3|STARTED|TRANSITION PHASE||0
320533|NCT01529515|766728|P2|STARTED|TRANSITION PHASE||0
320534|NCT01529515|766729|P1|STARTED|TRANSITION PHASE||506
320535|NCT01529502|766748|P6|NOT COMPLETED|Overall Study||0
320536|NCT01529502|766749|P5|NOT COMPLETED|Overall Study||0
320537|NCT01529502|766750|P4|NOT COMPLETED|Overall Study||2
320538|NCT01529502|766751|P3|NOT COMPLETED|Overall Study||0
320539|NCT01529502|766752|P2|NOT COMPLETED|Overall Study||0
320540|NCT01529502|766753|P1|NOT COMPLETED|Overall Study||0
320541|NCT01529502|766748|P6|COMPLETED|Overall Study||2
320542|NCT01529502|766749|P5|COMPLETED|Overall Study||2
320543|NCT01529502|766750|P4|COMPLETED|Overall Study||1
320544|NCT01529502|766751|P3|COMPLETED|Overall Study||2
320545|NCT01529502|766752|P2|COMPLETED|Overall Study||3
320546|NCT01529502|766753|P1|COMPLETED|Overall Study||2
320547|NCT01529502|766748|P6|STARTED|Overall Study||2
320548|NCT01529502|766749|P5|STARTED|Overall Study||2
320549|NCT01529502|766750|P4|STARTED|Overall Study||3
320550|NCT01529502|766751|P3|STARTED|Overall Study||2
320551|NCT01529502|766752|P2|STARTED|Overall Study||3
320552|NCT01529502|766753|P1|STARTED|Overall Study||2
320553|NCT01529450|766766|P2|NOT COMPLETED|Overall Study||2
320554|NCT01529450|766767|P1|NOT COMPLETED|Overall Study||0
320555|NCT01529450|766766|P2|COMPLETED|Overall Study||6
320556|NCT01529450|766767|P1|COMPLETED|Overall Study||3
320557|NCT01529450|766766|P2|STARTED|Overall Study||8
320558|NCT01529450|766767|P1|STARTED|Overall Study||3
320559|NCT01529385|766776|P2|NOT COMPLETED|Overall Study||1
320560|NCT01529385|766777|P1|NOT COMPLETED|Overall Study||2
320561|NCT01529385|766776|P2|COMPLETED|Overall Study||39
320562|NCT01529385|766777|P1|COMPLETED|Overall Study||38
320563|NCT01529385|766776|P2|Received Intervention|Overall Study||40
320564|NCT01529385|766777|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
320565|NCT01529385|766776|P2|STARTED|Overall Study||40
320566|NCT01529385|766777|P1|STARTED|Overall Study||40
320567|NCT01529203|766801|P1|NOT COMPLETED|Overall Study||3
320568|NCT01529203|766801|P1|COMPLETED|Overall Study||57
320569|NCT01529203|766801|P1|STARTED|Overall Study||60
320570|NCT01529112|766809|P2|NOT COMPLETED|Overall Study||41
320571|NCT01529112|766810|P1|NOT COMPLETED|Overall Study||69
320572|NCT01529112|766809|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
320573|NCT01529112|766810|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
320574|NCT01529112|766809|P2|STARTED|Overall Study||46
320575|NCT01529112|766810|P1|STARTED|Overall Study||89
320576|NCT01528969|766837|P2|NOT COMPLETED|Overall Study||0
320577|NCT01528969|766838|P1|NOT COMPLETED|Overall Study||2
320578|NCT01528969|766837|P2|COMPLETED|Overall Study||38
320579|NCT01528969|766838|P1|COMPLETED|Overall Study||35
320580|NCT01528969|766837|P2|STARTED|Overall Study||38
320581|NCT01528969|766838|P1|STARTED|Overall Study||37
320582|NCT01528891|766846|P2|NOT COMPLETED|Overall Study||0
320583|NCT01528891|766847|P1|NOT COMPLETED|Overall Study||0
320584|NCT01528891|766846|P2|COMPLETED|Overall Study||200
320585|NCT01528891|766847|P1|COMPLETED|Overall Study||200
320586|NCT01528891|766846|P2|STARTED|Overall Study||200
320587|NCT01528891|766847|P1|STARTED|Overall Study||200
320588|NCT01528735|766861|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
320589|NCT01528735|766862|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
320590|NCT01528735|766861|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
320591|NCT01528735|766862|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
320592|NCT01528735|766861|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
320593|NCT01528735|766862|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
320594|NCT01528735|766861|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
320595|NCT01528735|766862|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
320596|NCT01528735|766861|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
320597|NCT01528735|766862|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
320598|NCT01528735|766861|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
320599|NCT01528735|766862|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
320600|NCT01528696|766964|P2|NOT COMPLETED|Overall Study||19
320601|NCT01528696|766965|P1|NOT COMPLETED|Overall Study||18
320602|NCT01528696|766964|P2|COMPLETED|Overall Study||0
320603|NCT01528696|766965|P1|COMPLETED|Overall Study||0
320604|NCT01528696|766964|P2|Hospital Stay (2-5 Days)|Overall Study||19
320605|NCT01528696|766965|P1|Hospital Stay (2-5 Days)|Overall Study||18
320606|NCT01528696|766964|P2|STARTED|Overall Study||19
320607|NCT01528696|766965|P1|STARTED|Overall Study||18
320608|NCT01528605|766981|P6|NOT COMPLETED|Overall Study||0
320609|NCT01528605|766982|P5|NOT COMPLETED|Overall Study||0
320610|NCT01528605|766983|P4|NOT COMPLETED|Overall Study||1
320611|NCT01528605|766984|P3|NOT COMPLETED|Overall Study||1
320612|NCT01528605|766985|P2|NOT COMPLETED|Overall Study||0
320613|NCT01528605|766986|P1|NOT COMPLETED|Overall Study||2
320614|NCT01528605|766981|P6|COMPLETED|Overall Study||28
320615|NCT01528605|766982|P5|COMPLETED|Overall Study||28
320616|NCT01528605|766983|P4|COMPLETED|Overall Study||27
320617|NCT01528605|766984|P3|COMPLETED|Overall Study||27
320618|NCT01528605|766985|P2|COMPLETED|Overall Study||28
320619|NCT01528605|766986|P1|COMPLETED|Overall Study||26
320620|NCT01528605|766981|P6|STARTED|Overall Study||28
320621|NCT01528605|766982|P5|STARTED|Overall Study||28
320622|NCT01528605|766983|P4|STARTED|Overall Study||28
320623|NCT01528605|766984|P3|STARTED|Overall Study||28
320624|NCT01528605|766985|P2|STARTED|Overall Study||28
320625|NCT01528605|766986|P1|STARTED|Overall Study||28
320626|NCT01528592|767010|P1|NOT COMPLETED|Overall Study||0
320627|NCT01528592|767010|P1|COMPLETED|Overall Study||18
320628|NCT01528592|767010|P1|STARTED|Overall Study||18
320629|NCT01528345|767016|P2|NOT COMPLETED|Overall Study||50
320630|NCT01528345|767017|P1|NOT COMPLETED|Overall Study||47
320631|NCT01528345|767016|P2|COMPLETED|Overall Study||0
320632|NCT01528345|767017|P1|COMPLETED|Overall Study||0
320633|NCT01528345|767016|P2|STARTED|Overall Study||50
320634|NCT01528345|767017|P1|STARTED|Overall Study||47
320635|NCT01528332|767035|P2|NOT COMPLETED|Overall Study||2
320636|NCT01528332|767036|P1|NOT COMPLETED|Overall Study||4
320637|NCT01528332|767035|P2|COMPLETED|Overall Study||84
320638|NCT01528332|767036|P1|COMPLETED|Overall Study||81
320639|NCT01528332|767035|P2|STARTED|Overall Study||86
320640|NCT01528332|767036|P1|STARTED|Overall Study||85
320641|NCT01528319|767042|P1|NOT COMPLETED|Overall Study||1
320642|NCT01528319|767042|P1|COMPLETED|Overall Study||23
320643|NCT01528319|767042|P1|12 Weeks After Surgery|Overall Study||24
320644|NCT01528319|767042|P1|STARTED|Overall Study||24
320645|NCT01528293|767053|P2|NOT COMPLETED|Overall Study||0
320646|NCT01528293|767054|P1|NOT COMPLETED|Overall Study||1
320647|NCT01528293|767053|P2|COMPLETED|Overall Study||1
320648|NCT01528293|767054|P1|COMPLETED|Overall Study||0
320649|NCT01528293|767053|P2|STARTED|Overall Study||1
320650|NCT01528293|767054|P1|STARTED|Overall Study||1
320651|NCT01528215|767068|P2|NOT COMPLETED|Overall Study||1
320652|NCT01528215|767069|P1|NOT COMPLETED|Overall Study||4
320653|NCT01528215|767068|P2|COMPLETED|Overall Study||60
320654|NCT01528215|767069|P1|COMPLETED|Overall Study||55
320655|NCT01528215|767068|P2|STARTED|Overall Study||61
320656|NCT01528215|767069|P1|STARTED|Overall Study||59
320657|NCT01528150|767075|P1|NOT COMPLETED|Overall Study||44
320658|NCT01528150|767075|P1|COMPLETED|Overall Study||422
320659|NCT01528150|767075|P1|STARTED|Overall Study||466
320660|NCT01527942|767081|P2|NOT COMPLETED|Overall Study||0
320661|NCT01527942|767082|P1|NOT COMPLETED|Overall Study||0
320662|NCT01527942|767081|P2|COMPLETED|Overall Study||18
320663|NCT01527942|767082|P1|COMPLETED|Overall Study||16
320664|NCT01527942|767081|P2|STARTED|Overall Study||18
320665|NCT01527942|767082|P1|STARTED|Overall Study||16
320666|NCT01527513|767094|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
320667|NCT01527513|767095|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
320668|NCT01527513|767094|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
320669|NCT01527513|767095|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
320670|NCT01527513|767094|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
320671|NCT01527513|767095|P1|STARTED|Eligible for 1-Year Open Label Period||0
320672|NCT01527513|767094|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
320673|NCT01527513|767095|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
320674|NCT01527513|767094|P2|COMPLETED|Double Blind Period (DB) - Part I||75
320675|NCT01527513|767095|P1|COMPLETED|Double Blind Period (DB) - Part I||37
320676|NCT01527513|767094|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
320677|NCT01527513|767095|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
320678|NCT01527513|767094|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
320679|NCT01527513|767095|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
320680|NCT01527513|767094|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
320681|NCT01527513|767095|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
320682|NCT01527513|767094|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
320683|NCT01527513|767095|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
320684|NCT01527513|767094|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
320685|NCT01527513|767095|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
320686|NCT01527513|767094|P2|Safety Population|Double Blind Period (DB) - Part I||83
320687|NCT01527513|767095|P1|Safety Population|Double Blind Period (DB) - Part I||40
320688|NCT01527513|767094|P2|Randomized|Double Blind Period (DB) - Part I||83
320689|NCT01527513|767095|P1|Randomized|Double Blind Period (DB) - Part I||40
320690|NCT01527513|767094|P2|STARTED|Double Blind Period (DB) - Part I||83
320691|NCT01527513|767095|P1|STARTED|Double Blind Period (DB) - Part I||40
320692|NCT01527487|767107|P2|NOT COMPLETED|Overall Study||7
320693|NCT01527487|767108|P1|NOT COMPLETED|Overall Study||8
320694|NCT01527487|767107|P2|COMPLETED|Overall Study||15
320695|NCT01527487|767108|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
320696|NCT01527487|767107|P2|STARTED|Overall Study||22
320697|NCT01527487|767108|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
320698|NCT01527370|767120|P1|NOT COMPLETED|Overall Study||6
320699|NCT01527370|767120|P1|COMPLETED|Overall Study||244
320700|NCT01527370|767120|P1|STARTED|Overall Study||250
320701|NCT01527162|767126|P2|NOT COMPLETED|Overall Study||0
320702|NCT01527162|767127|P1|NOT COMPLETED|Overall Study||0
320703|NCT01527162|767126|P2|COMPLETED|Overall Study||5
320704|NCT01527162|767127|P1|COMPLETED|Overall Study||6
320705|NCT01527162|767126|P2|STARTED|Overall Study||5
320706|NCT01527162|767127|P1|STARTED|Overall Study||6
320707|NCT01527006|767139|P2|NOT COMPLETED|Extension Phase||8
320708|NCT01527006|767140|P1|NOT COMPLETED|Extension Phase||6
320709|NCT01527006|767139|P2|COMPLETED|Extension Phase||14
320710|NCT01527006|767140|P1|COMPLETED|Extension Phase||13
320711|NCT01527006|767139|P2|STARTED|Extension Phase||22
320712|NCT01527006|767140|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
320713|NCT01527006|767139|P2|NOT COMPLETED|Core Study||6
320714|NCT01527006|767140|P1|NOT COMPLETED|Core Study||2
320715|NCT01527006|767139|P2|COMPLETED|Core Study||22
320716|NCT01527006|767140|P1|COMPLETED|Core Study||20
320717|NCT01527006|767139|P2|STARTED|Core Study||28
320718|NCT01527006|767140|P1|STARTED|Core Study||22
320719|NCT01526902|767190|P2|NOT COMPLETED|Overall Study||0
320720|NCT01526902|767191|P1|NOT COMPLETED|Overall Study||0
320721|NCT01526902|767190|P2|COMPLETED|Overall Study||24
320722|NCT01526902|767191|P1|COMPLETED|Overall Study||25
320723|NCT01526902|767190|P2|STARTED|Overall Study||24
320724|NCT01526902|767191|P1|STARTED|Overall Study||25
320725|NCT01526785|767207|P1|NOT COMPLETED|Overall Study||13
320726|NCT01526785|767207|P1|COMPLETED|Overall Study||100
320727|NCT01526785|767207|P1|STARTED|Overall Study||113
320728|NCT01526733|767217|P2|NOT COMPLETED|Phase 2||0
320729|NCT01526733|767218|P1|NOT COMPLETED|Phase 2||0
320730|NCT01526733|767217|P2|COMPLETED|Phase 2||12
320731|NCT01526733|767218|P1|COMPLETED|Phase 2||10
320732|NCT01526733|767217|P2|STARTED|Phase 2||12
320733|NCT01526733|767218|P1|STARTED|Phase 2||10
320734|NCT01526733|767217|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
320735|NCT01526733|767218|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
320736|NCT01526733|767217|P2|COMPLETED|Washout Period of 5 to 21 Days||12
320737|NCT01526733|767218|P1|COMPLETED|Washout Period of 5 to 21 Days||10
320738|NCT01526733|767217|P2|STARTED|Washout Period of 5 to 21 Days||12
320739|NCT01526733|767218|P1|STARTED|Washout Period of 5 to 21 Days||10
320740|NCT01526733|767217|P2|NOT COMPLETED|Phase 1||1
320741|NCT01526733|767218|P1|NOT COMPLETED|Phase 1||2
320742|NCT01526733|767217|P2|COMPLETED|Phase 1||12
320743|NCT01526733|767218|P1|COMPLETED|Phase 1||10
320744|NCT01526733|767217|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
320745|NCT01526733|767218|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
320746|NCT01526733|767217|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
320747|NCT01526733|767218|P1|STARTED|Phase 1||12
320748|NCT01526551|767236|P1|NOT COMPLETED|Overall Study||424
320749|NCT01526551|767236|P1|COMPLETED|Overall Study||511
320750|NCT01526551|767236|P1|STARTED|Overall Study||935
320751|NCT01526538|767243|P2|NOT COMPLETED|Overall Study||4
320752|NCT01526538|767244|P1|NOT COMPLETED|Overall Study||9
320753|NCT01526538|767243|P2|COMPLETED|Overall Study||18
320754|NCT01526538|767244|P1|COMPLETED|Overall Study||21
320755|NCT01526538|767243|P2|STARTED|Overall Study||22
320756|NCT01526538|767244|P1|STARTED|Overall Study||30
320757|NCT01526213|767260|P6|NOT COMPLETED|Period 3 (5 Days)||0
320758|NCT01526213|767261|P5|NOT COMPLETED|Period 3 (5 Days)||0
320759|NCT01526213|767262|P4|NOT COMPLETED|Period 3 (5 Days)||0
320760|NCT01526213|767263|P3|NOT COMPLETED|Period 3 (5 Days)||0
320761|NCT01526213|767264|P2|NOT COMPLETED|Period 3 (5 Days)||0
320762|NCT01526213|767265|P1|NOT COMPLETED|Period 3 (5 Days)||0
320763|NCT01526213|767260|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320764|NCT01526213|767261|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320765|NCT01526213|767262|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320766|NCT01526213|767263|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320767|NCT01526213|767264|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320768|NCT01526213|767265|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320769|NCT01526213|767260|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320770|NCT01526213|767261|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320771|NCT01526213|767262|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320772|NCT01526213|767263|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320773|NCT01526213|767264|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320774|NCT01526213|767265|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320775|NCT01526213|767260|P6|NOT COMPLETED|Washout 2 (10 Days)||0
320776|NCT01526213|767261|P5|NOT COMPLETED|Washout 2 (10 Days)||0
320777|NCT01526213|767262|P4|NOT COMPLETED|Washout 2 (10 Days)||0
320778|NCT01526213|767263|P3|NOT COMPLETED|Washout 2 (10 Days)||0
320779|NCT01526213|767264|P2|NOT COMPLETED|Washout 2 (10 Days)||0
320780|NCT01526213|767265|P1|NOT COMPLETED|Washout 2 (10 Days)||0
320781|NCT01526213|767260|P6|COMPLETED|Washout 2 (10 Days)||3
320782|NCT01526213|767261|P5|COMPLETED|Washout 2 (10 Days)||3
320783|NCT01526213|767262|P4|COMPLETED|Washout 2 (10 Days)||3
320784|NCT01526213|767263|P3|COMPLETED|Washout 2 (10 Days)||3
320785|NCT01526213|767264|P2|COMPLETED|Washout 2 (10 Days)||3
320786|NCT01526213|767265|P1|COMPLETED|Washout 2 (10 Days)||3
320787|NCT01526213|767260|P6|STARTED|Washout 2 (10 Days)||3
320788|NCT01526213|767261|P5|STARTED|Washout 2 (10 Days)||3
320789|NCT01526213|767262|P4|STARTED|Washout 2 (10 Days)||3
320790|NCT01526213|767263|P3|STARTED|Washout 2 (10 Days)||3
320791|NCT01526213|767264|P2|STARTED|Washout 2 (10 Days)||3
320792|NCT01526213|767265|P1|STARTED|Washout 2 (10 Days)||3
320793|NCT01526213|767260|P6|NOT COMPLETED|Period 2 (5 Days)||0
320794|NCT01526213|767261|P5|NOT COMPLETED|Period 2 (5 Days)||0
320795|NCT01526213|767262|P4|NOT COMPLETED|Period 2 (5 Days)||0
320796|NCT01526213|767263|P3|NOT COMPLETED|Period 2 (5 Days)||0
320797|NCT01526213|767264|P2|NOT COMPLETED|Period 2 (5 Days)||0
320798|NCT01526213|767265|P1|NOT COMPLETED|Period 2 (5 Days)||0
320799|NCT01526213|767260|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
320800|NCT01526213|767261|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
320801|NCT01526213|767262|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
320802|NCT01526213|767263|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
320803|NCT01526213|767264|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320804|NCT01526213|767265|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320805|NCT01526213|767260|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320806|NCT01526213|767261|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320807|NCT01526213|767262|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320808|NCT01526213|767263|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320809|NCT01526213|767264|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320810|NCT01526213|767265|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320811|NCT01526213|767260|P6|NOT COMPLETED|Washout 1 (10 Days)||0
320812|NCT01526213|767261|P5|NOT COMPLETED|Washout 1 (10 Days)||0
320813|NCT01526213|767262|P4|NOT COMPLETED|Washout 1 (10 Days)||0
320814|NCT01526213|767263|P3|NOT COMPLETED|Washout 1 (10 Days)||0
320815|NCT01526213|767264|P2|NOT COMPLETED|Washout 1 (10 Days)||0
320816|NCT01526213|767265|P1|NOT COMPLETED|Washout 1 (10 Days)||0
320817|NCT01526213|767260|P6|COMPLETED|Washout 1 (10 Days)||3
320818|NCT01526213|767261|P5|COMPLETED|Washout 1 (10 Days)||3
320819|NCT01526213|767262|P4|COMPLETED|Washout 1 (10 Days)||3
320820|NCT01526213|767263|P3|COMPLETED|Washout 1 (10 Days)||3
320821|NCT01526213|767264|P2|COMPLETED|Washout 1 (10 Days)||3
320822|NCT01526213|767265|P1|COMPLETED|Washout 1 (10 Days)||3
320823|NCT01526213|767260|P6|STARTED|Washout 1 (10 Days)||3
320824|NCT01526213|767261|P5|STARTED|Washout 1 (10 Days)||3
320825|NCT01526213|767262|P4|STARTED|Washout 1 (10 Days)||3
320826|NCT01526213|767263|P3|STARTED|Washout 1 (10 Days)||3
320827|NCT01526213|767264|P2|STARTED|Washout 1 (10 Days)||3
320828|NCT01526213|767265|P1|STARTED|Washout 1 (10 Days)||3
320829|NCT01526213|767260|P6|NOT COMPLETED|Period 1 (5 Days)||0
320830|NCT01526213|767261|P5|NOT COMPLETED|Period 1 (5 Days)||0
320831|NCT01526213|767262|P4|NOT COMPLETED|Period 1 (5 Days)||0
320832|NCT01526213|767263|P3|NOT COMPLETED|Period 1 (5 Days)||0
320833|NCT01526213|767264|P2|NOT COMPLETED|Period 1 (5 Days)||0
320834|NCT01526213|767265|P1|NOT COMPLETED|Period 1 (5 Days)||0
320835|NCT01526213|767260|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320836|NCT01526213|767261|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320837|NCT01526213|767262|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320838|NCT01526213|767263|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320839|NCT01526213|767264|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320840|NCT01526213|767265|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
320841|NCT01526213|767260|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
320842|NCT01526213|767261|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320843|NCT01526213|767262|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320844|NCT01526213|767263|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320845|NCT01526213|767264|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320846|NCT01526213|767265|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
320847|NCT01526148|767278|P2|NOT COMPLETED|Overall Study||13
320848|NCT01526148|767279|P1|NOT COMPLETED|Overall Study||15
320849|NCT01526148|767278|P2|COMPLETED|Overall Study||11
320850|NCT01526148|767279|P1|COMPLETED|Overall Study||4
320851|NCT01526148|767278|P2|STARTED|Overall Study||24
320852|NCT01526148|767279|P1|STARTED|Overall Study||19
320853|NCT01525927|767289|P1|NOT COMPLETED|Overall Study||0
320854|NCT01525927|767289|P1|COMPLETED|Overall Study||0
320855|NCT01525927|767289|P1|STARTED|Overall Study||0
320856|NCT01525849|767296|P2|NOT COMPLETED|Overall Study||16
320857|NCT01525849|767297|P1|NOT COMPLETED|Overall Study||5
320858|NCT01525849|767296|P2|COMPLETED|Overall Study||59
320859|NCT01525849|767297|P1|COMPLETED|Overall Study||71
320860|NCT01525849|767296|P2|6-Months|Overall Study||60
320861|NCT01525849|767297|P1|6-Months|Overall Study||73
320862|NCT01525849|767296|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
320863|NCT01525849|767297|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
320864|NCT01525849|767296|P2|STARTED|Overall Study||75
320865|NCT01525849|767297|P1|STARTED|Overall Study||76
320866|NCT01525745|767313|P2|NOT COMPLETED|Overall Study||1
320867|NCT01525745|767314|P1|NOT COMPLETED|Overall Study||1
320868|NCT01525745|767313|P2|COMPLETED|Overall Study||1
320869|NCT01525745|767314|P1|COMPLETED|Overall Study||3
320870|NCT01525745|767313|P2|STARTED|Overall Study||2
320871|NCT01525745|767314|P1|STARTED|Overall Study||4
320872|NCT01525667|767331|P3|NOT COMPLETED|Overall Study||0
320873|NCT01525667|767332|P2|NOT COMPLETED|Overall Study||0
320874|NCT01525667|767333|P1|NOT COMPLETED|Overall Study||0
320875|NCT01525667|767331|P3|COMPLETED|Overall Study||7
320876|NCT01525667|767332|P2|COMPLETED|Overall Study||6
320877|NCT01525667|767333|P1|COMPLETED|Overall Study||7
320878|NCT01525667|767331|P3|STARTED|Overall Study||7
320879|NCT01525667|767332|P2|STARTED|Overall Study||6
320880|NCT01525667|767333|P1|STARTED|Overall Study||7
320881|NCT01525641|767353|P1|NOT COMPLETED|Overall Study||180
320882|NCT01525641|767353|P1|COMPLETED|Overall Study||435
320883|NCT01525641|767353|P1|STARTED|Overall Study||615
320884|NCT01525628|767367|P5|NOT COMPLETED|Overall Study||3
320885|NCT01525628|767368|P4|NOT COMPLETED|Overall Study||4
320886|NCT01525628|767369|P3|NOT COMPLETED|Overall Study||5
320887|NCT01525628|767370|P2|NOT COMPLETED|Overall Study||5
320888|NCT01525628|767371|P1|NOT COMPLETED|Overall Study||2
320889|NCT01525628|767367|P5|COMPLETED|Overall Study||4
320890|NCT01525628|767368|P4|COMPLETED|Overall Study||10
320891|NCT01525628|767369|P3|COMPLETED|Overall Study||11
320892|NCT01525628|767370|P2|COMPLETED|Overall Study||14
320893|NCT01525628|767371|P1|COMPLETED|Overall Study||14
320894|NCT01525628|767367|P5|STARTED|Overall Study||7
320895|NCT01525628|767368|P4|STARTED|Overall Study||14
320896|NCT01525628|767369|P3|STARTED|Overall Study||16
320897|NCT01525628|767370|P2|STARTED|Overall Study||19
320898|NCT01525628|767371|P1|STARTED|Overall Study||16
320899|NCT01525615|767438|P3|NOT COMPLETED|Overall Study||6
320900|NCT01525615|767439|P2|NOT COMPLETED|Overall Study||7
320901|NCT01525615|767440|P1|NOT COMPLETED|Overall Study||14
320902|NCT01525615|767438|P3|COMPLETED|Overall Study||133
320903|NCT01525615|767439|P2|COMPLETED|Overall Study||126
320904|NCT01525615|767440|P1|COMPLETED|Overall Study||118
320905|NCT01525615|767438|P3|STARTED|Overall Study||139
320906|NCT01525615|767439|P2|STARTED|Overall Study||133
320907|NCT01525615|767440|P1|STARTED|Overall Study||132
320908|NCT01525563|767484|P1|NOT COMPLETED|Overall Study||212
320909|NCT01525563|767484|P1|COMPLETED|Overall Study|6 Months Follow-up|788
320910|NCT01525563|767484|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
320911|NCT01525563|767484|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
320912|NCT01525563|767484|P1|STARTED|Overall Study||1000
320913|NCT01525550|767496|P2|NOT COMPLETED|Overall Study||45
320914|NCT01525550|767497|P1|NOT COMPLETED|Overall Study||61
320915|NCT01525550|767496|P2|COMPLETED|Overall Study||0
320916|NCT01525550|767497|P1|COMPLETED|Overall Study||0
320917|NCT01525550|767496|P2|STARTED|Overall Study||45
320918|NCT01525550|767497|P1|STARTED|Overall Study||61
320919|NCT01525420|767559|P2|NOT COMPLETED|Overall Study||24
320920|NCT01525420|767560|P1|NOT COMPLETED|Overall Study||16
320921|NCT01525420|767559|P2|COMPLETED|Overall Study||38
320922|NCT01525420|767560|P1|COMPLETED|Overall Study||43
320923|NCT01525420|767559|P2|STARTED|Overall Study||62
320924|NCT01525420|767560|P1|STARTED|Overall Study||59
320925|NCT01525238|767569|P3|NOT COMPLETED|Overall Study||0
320926|NCT01525238|767570|P2|NOT COMPLETED|Overall Study||0
320927|NCT01525238|767571|P1|NOT COMPLETED|Overall Study||1
320928|NCT01525238|767569|P3|COMPLETED|Overall Study||8
320929|NCT01525238|767570|P2|COMPLETED|Overall Study||8
320930|NCT01525238|767571|P1|COMPLETED|Overall Study||7
320931|NCT01525238|767569|P3|STARTED|Overall Study||8
320932|NCT01525238|767570|P2|STARTED|Overall Study||8
320933|NCT01525238|767571|P1|STARTED|Overall Study||8
320934|NCT01525225|767636|P1|NOT COMPLETED|Treated||0
320935|NCT01525225|767636|P1|COMPLETED|Treated||2
320936|NCT01525225|767636|P1|STARTED|Treated||2
320937|NCT01525225|767636|P1|NOT COMPLETED|Enrollment||2
320938|NCT01525225|767636|P1|COMPLETED|Enrollment||2
320939|NCT01525225|767636|P1|STARTED|Enrollment||4
320940|NCT01525173|767643|P2|NOT COMPLETED|Overall Study||5
320941|NCT01525173|767644|P1|NOT COMPLETED|Overall Study||7
320942|NCT01525173|767643|P2|COMPLETED|Overall Study||62
320943|NCT01525173|767644|P1|COMPLETED|Overall Study||63
320944|NCT01525173|767643|P2|STARTED|Overall Study||67
320945|NCT01525173|767644|P1|STARTED|Overall Study||70
320946|NCT01524913|767653|P3|NOT COMPLETED|Overall Study||0
320947|NCT01524913|767654|P2|NOT COMPLETED|Overall Study||0
320948|NCT01524913|767655|P1|NOT COMPLETED|Overall Study||4
320949|NCT01524913|767653|P3|COMPLETED|Overall Study||31
320950|NCT01524913|767654|P2|COMPLETED|Overall Study||36
320951|NCT01524913|767655|P1|COMPLETED|Overall Study||31
320952|NCT01524913|767653|P3|STARTED|Overall Study||31
320953|NCT01524913|767654|P2|STARTED|Overall Study||36
320954|NCT01524913|767655|P1|STARTED|Overall Study||35
320955|NCT01524900|767677|P5|NOT COMPLETED|Overall Study||0
320956|NCT01524900|767678|P4|NOT COMPLETED|Overall Study||1
320957|NCT01524900|767679|P3|NOT COMPLETED|Overall Study||1
320958|NCT01524900|767680|P2|NOT COMPLETED|Overall Study||14
320959|NCT01524900|767681|P1|NOT COMPLETED|Overall Study||6
320960|NCT01524900|767677|P5|COMPLETED|Overall Study||40
320961|NCT01524900|767678|P4|COMPLETED|Overall Study||21
320962|NCT01524900|767679|P3|COMPLETED|Overall Study||29
320963|NCT01524900|767680|P2|COMPLETED|Overall Study||232
320964|NCT01524900|767681|P1|COMPLETED|Overall Study||43
320965|NCT01524900|767677|P5|STARTED|Overall Study||40
320966|NCT01524900|767678|P4|STARTED|Overall Study||22
320967|NCT01524900|767679|P3|STARTED|Overall Study||30
320968|NCT01524900|767680|P2|STARTED|Overall Study||246
320969|NCT01524900|767681|P1|STARTED|Overall Study||49
320970|NCT01524887|767726|P3|NOT COMPLETED|Overall Study||86
320971|NCT01524887|767727|P2|NOT COMPLETED|Overall Study||90
320972|NCT01524887|767728|P1|NOT COMPLETED|Overall Study||85
320973|NCT01524887|767726|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
320974|NCT01524887|767727|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
320975|NCT01524887|767728|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
320976|NCT01524887|767726|P3|Received Treatment|Overall Study||83
320977|NCT01524887|767727|P2|Received Treatment|Overall Study||85
320978|NCT01524887|767728|P1|Received Treatment|Overall Study||83
320979|NCT01524887|767726|P3|STARTED|Overall Study||86
320980|NCT01524887|767727|P2|STARTED|Overall Study||90
320981|NCT01524887|767728|P1|STARTED|Overall Study||85
320982|NCT01524796|767772|P1|NOT COMPLETED|Overall Study||28
320983|NCT01524796|767772|P1|COMPLETED|Overall Study||100
320984|NCT01524796|767772|P1|STARTED|Overall Study||128
320985|NCT01524783|767787|P2|NOT COMPLETED|Randomized and Treated||84
320986|NCT01524783|767788|P1|NOT COMPLETED|Randomized and Treated||155
320987|NCT01524783|767787|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
320988|NCT01524783|767788|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
320989|NCT01524783|767787|P2|STARTED|Randomized and Treated||97
320990|NCT01524783|767788|P1|STARTED|Randomized and Treated||203
320991|NCT01524783|767787|P2|NOT COMPLETED|Randomized But Not Treated||0
320992|NCT01524783|767788|P1|NOT COMPLETED|Randomized But Not Treated||2
320993|NCT01524783|767787|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
320994|NCT01524783|767788|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
320995|NCT01524783|767787|P2|STARTED|Randomized But Not Treated||97
320996|NCT01524783|767788|P1|STARTED|Randomized But Not Treated||205
320997|NCT01524770|767810|P2|NOT COMPLETED|Second Intervention||0
320998|NCT01524770|767811|P1|NOT COMPLETED|Second Intervention||0
320999|NCT01524770|767810|P2|COMPLETED|Second Intervention||23
321000|NCT01524770|767811|P1|COMPLETED|Second Intervention||23
321001|NCT01524770|767810|P2|STARTED|Second Intervention||23
321002|NCT01524770|767811|P1|STARTED|Second Intervention||23
321003|NCT01524770|767810|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
321004|NCT01524770|767811|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
321005|NCT01524770|767810|P2|COMPLETED|Washout Period of at Least 28 Days||23
321006|NCT01524770|767811|P1|COMPLETED|Washout Period of at Least 28 Days||23
321007|NCT01524770|767810|P2|STARTED|Washout Period of at Least 28 Days||23
321008|NCT01524770|767811|P1|STARTED|Washout Period of at Least 28 Days||23
321009|NCT01524770|767810|P2|NOT COMPLETED|First Intervention||1
321010|NCT01524770|767811|P1|NOT COMPLETED|First Intervention||3
321011|NCT01524770|767810|P2|COMPLETED|First Intervention||23
321012|NCT01524770|767811|P1|COMPLETED|First Intervention||23
321013|NCT01524770|767810|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
321014|NCT01524770|767811|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
321015|NCT01524770|767810|P2|STARTED|First Intervention||24
321016|NCT01524770|767811|P1|STARTED|First Intervention||26
321017|NCT01524302|767823|P2|NOT COMPLETED|Overall Study||0
321018|NCT01524302|767824|P1|NOT COMPLETED|Overall Study||0
321019|NCT01524302|767823|P2|COMPLETED|Overall Study||6
321020|NCT01524302|767824|P1|COMPLETED|Overall Study||6
321021|NCT01524302|767823|P2|STARTED|Overall Study||6
321022|NCT01524302|767824|P1|STARTED|Overall Study||6
321023|NCT01524198|767842|P2|NOT COMPLETED|Overall Study||16
321024|NCT01524198|767843|P1|NOT COMPLETED|Overall Study||23
321025|NCT01524198|767842|P2|COMPLETED|Overall Study||458
321026|NCT01524198|767843|P1|COMPLETED|Overall Study||448
321027|NCT01524198|767842|P2|STARTED|Overall Study||474
321028|NCT01524198|767843|P1|STARTED|Overall Study||471
321029|NCT01523964|767855|P4|NOT COMPLETED|Overall Study||0
321030|NCT01523964|767856|P3|NOT COMPLETED|Overall Study||0
321031|NCT01523964|767857|P2|NOT COMPLETED|Overall Study||0
321032|NCT01523964|767858|P1|NOT COMPLETED|Overall Study||0
321033|NCT01523964|767855|P4|COMPLETED|Overall Study||15
321034|NCT01523964|767856|P3|COMPLETED|Overall Study||16
321035|NCT01523964|767857|P2|COMPLETED|Overall Study||30
321036|NCT01523964|767858|P1|COMPLETED|Overall Study||31
321037|NCT01523964|767855|P4|STARTED|Overall Study||15
321038|NCT01523964|767856|P3|STARTED|Overall Study||16
321039|NCT01523964|767857|P2|STARTED|Overall Study||30
321040|NCT01523964|767858|P1|STARTED|Overall Study||31
321041|NCT01523886|767870|P2|NOT COMPLETED|Overall Study||1
321042|NCT01523886|767871|P1|NOT COMPLETED|Overall Study||0
321043|NCT01523886|767870|P2|COMPLETED|Overall Study||23
321044|NCT01523886|767871|P1|COMPLETED|Overall Study||25
321045|NCT01523886|767870|P2|STARTED|Overall Study||24
321046|NCT01523886|767871|P1|STARTED|Overall Study||25
321047|NCT01523873|767877|P1|NOT COMPLETED|Overall Study||422
321048|NCT01523873|767877|P1|COMPLETED|Overall Study||35499
321049|NCT01523873|767877|P1|Administered With Dotarem|Overall Study||35474
321050|NCT01523873|767877|P1|STARTED|Overall Study||35921
321051|NCT01523756|767884|P2|NOT COMPLETED|Test Period 2||1
321052|NCT01523756|767885|P1|NOT COMPLETED|Test Period 2||0
321053|NCT01523756|767884|P2|COMPLETED|Test Period 2||7
321054|NCT01523756|767885|P1|COMPLETED|Test Period 2||10
321055|NCT01523756|767884|P2|STARTED|Test Period 2||8
321056|NCT01523756|767885|P1|STARTED|Test Period 2||10
321057|NCT01523756|767884|P2|NOT COMPLETED|Test Period 1||0
321058|NCT01523756|767885|P1|NOT COMPLETED|Test Period 1||1
321059|NCT01523756|767884|P2|COMPLETED|Test Period 1||8
321060|NCT01523756|767885|P1|COMPLETED|Test Period 1||10
321061|NCT01523756|767884|P2|STARTED|Test Period 1||8
321062|NCT01523756|767885|P1|STARTED|Test Period 1||11
321063|NCT01523756|767884|P2|NOT COMPLETED|Baseline Period||1
321064|NCT01523756|767885|P1|NOT COMPLETED|Baseline Period||0
321065|NCT01523756|767884|P2|COMPLETED|Baseline Period||8
321066|NCT01523756|767885|P1|COMPLETED|Baseline Period||11
321067|NCT01523756|767884|P2|STARTED|Baseline Period||9
321068|NCT01523756|767885|P1|STARTED|Baseline Period||11
321069|NCT01523743|767893|P2|NOT COMPLETED|Period 2||2
321070|NCT01523743|767894|P1|NOT COMPLETED|Period 2||1
321071|NCT01523743|767893|P2|COMPLETED|Period 2||58
321072|NCT01523743|767894|P1|COMPLETED|Period 2||52
321073|NCT01523743|767893|P2|STARTED|Period 2||60
321074|NCT01523743|767894|P1|STARTED|Period 2||53
321075|NCT01523743|767893|P2|NOT COMPLETED|Period 1||2
321076|NCT01523743|767894|P1|NOT COMPLETED|Period 1||10
321077|NCT01523743|767893|P2|COMPLETED|Period 1||60
321078|NCT01523743|767894|P1|COMPLETED|Period 1||53
321079|NCT01523743|767893|P2|STARTED|Period 1||62
321080|NCT01523743|767894|P1|STARTED|Period 1||63
321081|NCT01523587|767902|P2|NOT COMPLETED|Overall Study||54
321082|NCT01523587|767903|P1|NOT COMPLETED|Overall Study||87
321083|NCT01523587|767902|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
321084|NCT01523587|767903|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
321085|NCT01523587|767902|P2|STARTED|Overall Study||334
321086|NCT01523587|767903|P1|STARTED|Overall Study||335
321087|NCT01523392|767923|P2|NOT COMPLETED|Treatment Period 2||0
321088|NCT01523392|767924|P1|NOT COMPLETED|Treatment Period 2||0
321089|NCT01523392|767923|P2|COMPLETED|Treatment Period 2||14
321090|NCT01523392|767924|P1|COMPLETED|Treatment Period 2||17
321091|NCT01523392|767923|P2|STARTED|Treatment Period 2||14
321092|NCT01523392|767924|P1|STARTED|Treatment Period 2||17
321093|NCT01523392|767923|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
321094|NCT01523392|767924|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
321095|NCT01523392|767923|P2|COMPLETED|Washout Period - 10 to 14 Days||14
321096|NCT01523392|767924|P1|COMPLETED|Washout Period - 10 to 14 Days||17
321097|NCT01523392|767923|P2|STARTED|Washout Period - 10 to 14 Days||14
321098|NCT01523392|767924|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
321099|NCT01523392|767923|P2|NOT COMPLETED|Treatment Period 1||0
321100|NCT01523392|767924|P1|NOT COMPLETED|Treatment Period 1||3
321101|NCT01523392|767923|P2|COMPLETED|Treatment Period 1||14
321102|NCT01523392|767924|P1|COMPLETED|Treatment Period 1||17
321103|NCT01523392|767923|P2|STARTED|Treatment Period 1||14
321104|NCT01523392|767924|P1|STARTED|Treatment Period 1||20
321105|NCT01523366|767940|P2|NOT COMPLETED|Treatment Period 2||0
321106|NCT01523366|767941|P1|NOT COMPLETED|Treatment Period 2||1
321107|NCT01523366|767940|P2|COMPLETED|Treatment Period 2||20
321108|NCT01523366|767941|P1|COMPLETED|Treatment Period 2||18
321109|NCT01523366|767940|P2|STARTED|Treatment Period 2||20
321110|NCT01523366|767941|P1|STARTED|Treatment Period 2||19
321111|NCT01523366|767940|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
321112|NCT01523366|767941|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
321113|NCT01523366|767940|P2|COMPLETED|Washout Period - 10-14 Days||20
321114|NCT01523366|767941|P1|COMPLETED|Washout Period - 10-14 Days||19
321115|NCT01523366|767940|P2|STARTED|Washout Period - 10-14 Days||20
321116|NCT01523366|767941|P1|STARTED|Washout Period - 10-14 Days||19
321117|NCT01523366|767940|P2|NOT COMPLETED|Treatment Period 1||0
321118|NCT01523366|767941|P1|NOT COMPLETED|Treatment Period 1||1
321119|NCT01523366|767940|P2|COMPLETED|Treatment Period 1||20
321120|NCT01523366|767941|P1|COMPLETED|Treatment Period 1||19
321121|NCT01523366|767940|P2|STARTED|Treatment Period 1||20
321122|NCT01523366|767941|P1|STARTED|Treatment Period 1||20
321123|NCT01523301|767957|P2|NOT COMPLETED|Overall Study||32
321124|NCT01523301|767958|P1|NOT COMPLETED|Overall Study||35
321125|NCT01523301|767957|P2|COMPLETED|Overall Study||164
321126|NCT01523301|767958|P1|COMPLETED|Overall Study||149
321127|NCT01523301|767957|P2|STARTED|Overall Study||196
321128|NCT01523301|767958|P1|STARTED|Overall Study||184
321129|NCT01522976|767979|P3|NOT COMPLETED|Overall Study||93
321130|NCT01522976|767980|P2|NOT COMPLETED|Overall Study||92
321131|NCT01522976|767981|P1|NOT COMPLETED|Overall Study||97
321132|NCT01522976|767979|P3|COMPLETED|Overall Study||0
321133|NCT01522976|767980|P2|COMPLETED|Overall Study||0
321134|NCT01522976|767981|P1|COMPLETED|Overall Study||0
321135|NCT01522976|767979|P3|STARTED|Overall Study||93
321136|NCT01522976|767980|P2|STARTED|Overall Study||92
321137|NCT01522976|767981|P1|STARTED|Overall Study||97
321138|NCT01522937|768001|P1|NOT COMPLETED|Overall Study||0
321139|NCT01522937|768001|P1|COMPLETED|Overall Study||146
321140|NCT01522937|768001|P1|STARTED|Overall Study||146
321141|NCT01522924|768011|P2|NOT COMPLETED|Overall Study||0
321142|NCT01522924|768012|P1|NOT COMPLETED|Overall Study||0
321143|NCT01522924|768011|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
321144|NCT01522924|768012|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
321145|NCT01522924|768011|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
321146|NCT01522924|768012|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
321147|NCT01522703|768032|P2|NOT COMPLETED|Overall Study||6
321148|NCT01522703|768033|P1|NOT COMPLETED|Overall Study||5
321149|NCT01522703|768032|P2|COMPLETED|Overall Study||20
321150|NCT01522703|768033|P1|COMPLETED|Overall Study||20
321151|NCT01522703|768032|P2|STARTED|Overall Study||26
321152|NCT01522703|768033|P1|STARTED|Overall Study||25
321153|NCT01522456|768039|P1|NOT COMPLETED|Overall Study||8
321154|NCT01522456|768039|P1|COMPLETED|Overall Study||65
321155|NCT01522456|768039|P1|STARTED|Overall Study||73
321156|NCT01522339|768100|P1|NOT COMPLETED|Overall Study||0
321157|NCT01522339|768100|P1|COMPLETED|Overall Study||15
321158|NCT01522339|768100|P1|STARTED|Overall Study||15
321159|NCT01522131|768107|P2|NOT COMPLETED|Overall Study||0
321160|NCT01522131|768108|P1|NOT COMPLETED|Overall Study||2
321161|NCT01522131|768107|P2|COMPLETED|Overall Study||17
321162|NCT01522131|768108|P1|COMPLETED|Overall Study||14
321163|NCT01522131|768107|P2|STARTED|Overall Study||17
321164|NCT01522131|768108|P1|STARTED|Overall Study||16
321165|NCT01521923|768120|P4|NOT COMPLETED|Overall Study||13
321166|NCT01521923|768121|P3|NOT COMPLETED|Overall Study||15
321167|NCT01521923|768122|P2|NOT COMPLETED|Overall Study||9
321168|NCT01521923|768123|P1|NOT COMPLETED|Overall Study||7
321169|NCT01521923|768120|P4|COMPLETED|Overall Study||70
321170|NCT01521923|768121|P3|COMPLETED|Overall Study||112
321171|NCT01521923|768122|P2|COMPLETED|Overall Study||72
321172|NCT01521923|768123|P1|COMPLETED|Overall Study||59
321173|NCT01521923|768120|P4|STARTED|Overall Study||83
321174|NCT01521923|768121|P3|STARTED|Overall Study||127
321175|NCT01521923|768122|P2|STARTED|Overall Study||81
321176|NCT01521923|768123|P1|STARTED|Overall Study||66
321177|NCT01521897|768243|P1|NOT COMPLETED|Overall Study||23
321178|NCT01521897|768243|P1|COMPLETED|Overall Study||1120
321179|NCT01521897|768243|P1|STARTED|Overall Study||1143
321180|NCT01521884|768255|P1|NOT COMPLETED|Overall Study||27
321181|NCT01521884|768255|P1|COMPLETED|Overall Study||35
321182|NCT01521884|768255|P1|STARTED|Overall Study||62
321183|NCT01521871|768274|P2|NOT COMPLETED|Overall Study||0
321184|NCT01521871|768275|P1|NOT COMPLETED|Overall Study||0
321185|NCT01521871|768274|P2|COMPLETED|Overall Study||32
321186|NCT01521871|768275|P1|COMPLETED|Overall Study||32
321187|NCT01521871|768274|P2|STARTED|Overall Study||32
321188|NCT01521871|768275|P1|STARTED|Overall Study||32
321189|NCT01521845|768315|P2|NOT COMPLETED|Overall Study||5
321190|NCT01521845|768316|P1|NOT COMPLETED|Overall Study||9
321191|NCT01521845|768315|P2|COMPLETED|Overall Study||47
321192|NCT01521845|768316|P1|COMPLETED|Overall Study||43
321193|NCT01521845|768315|P2|STARTED|Overall Study||52
321194|NCT01521845|768316|P1|STARTED|Overall Study||52
321195|NCT01521780|768326|P3|NOT COMPLETED|Overall Study||0
321196|NCT01521780|768327|P2|NOT COMPLETED|Overall Study||0
321197|NCT01521780|768328|P1|NOT COMPLETED|Overall Study||0
321198|NCT01521780|768326|P3|COMPLETED|Overall Study||2
321199|NCT01521780|768327|P2|COMPLETED|Overall Study||1
321200|NCT01521780|768328|P1|COMPLETED|Overall Study||9
321201|NCT01521780|768326|P3|STARTED|Overall Study||2
321202|NCT01521780|768327|P2|STARTED|Overall Study||1
321203|NCT01521780|768328|P1|STARTED|Overall Study||9
321204|NCT01521559|768352|P2|NOT COMPLETED|Overall Study||18
321205|NCT01521559|768353|P1|NOT COMPLETED|Overall Study||15
321206|NCT01521559|768352|P2|COMPLETED|Overall Study||73
321207|NCT01521559|768353|P1|COMPLETED|Overall Study||77
321208|NCT01521559|768352|P2|Completed Week 52|Overall Study||73
321209|NCT01521559|768353|P1|Completed Week 52|Overall Study||77
321210|NCT01521559|768352|P2|Completed Week 24|Overall Study||85
321211|NCT01521559|768353|P1|Completed Week 24|Overall Study||83
321212|NCT01521559|768352|P2|STARTED|Overall Study||91
321213|NCT01521559|768353|P1|STARTED|Overall Study||92
321214|NCT01521546|768367|P2|NOT COMPLETED|Overall Study||0
321215|NCT01521546|768368|P1|NOT COMPLETED|Overall Study||2
321216|NCT01521546|768367|P2|COMPLETED|Overall Study||20
321217|NCT01521546|768368|P1|COMPLETED|Overall Study||20
321218|NCT01521546|768367|P2|STARTED|Overall Study||20
321219|NCT01521546|768368|P1|STARTED|Overall Study||22
321220|NCT01521507|768376|P2|NOT COMPLETED|Stage 2: Observational Design||2
321221|NCT01521507|768377|P1|NOT COMPLETED|Stage 2: Observational Design||4
321222|NCT01521507|768376|P2|COMPLETED|Stage 2: Observational Design||92
321223|NCT01521507|768377|P1|COMPLETED|Stage 2: Observational Design||94
321224|NCT01521507|768376|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
321225|NCT01521507|768377|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
321226|NCT01521507|768376|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
321227|NCT01521507|768377|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
321228|NCT01521507|768376|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
321229|NCT01521507|768377|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
321230|NCT01521507|768376|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
321231|NCT01521507|768377|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
321232|NCT01521507|768376|P2|STARTED|Stage 2: Observational Design||94
321233|NCT01521507|768377|P1|STARTED|Stage 2: Observational Design||98
321234|NCT01521507|768376|P2|NOT COMPLETED|Stage 1: Randomized Design||5
321235|NCT01521507|768377|P1|NOT COMPLETED|Stage 1: Randomized Design||3
321236|NCT01521507|768376|P2|COMPLETED|Stage 1: Randomized Design||94
321237|NCT01521507|768377|P1|COMPLETED|Stage 1: Randomized Design||98
321238|NCT01521507|768376|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
321239|NCT01521507|768377|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
321240|NCT01521507|768376|P2|STARTED|Stage 1: Randomized Design||99
321241|NCT01521507|768377|P1|STARTED|Stage 1: Randomized Design||101
321242|NCT01521364|768394|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
321243|NCT01521364|768394|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
321244|NCT01521364|768394|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
321245|NCT01521364|768394|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
321246|NCT01521364|768394|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
321247|NCT01521364|768394|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
321248|NCT01521364|768394|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
321249|NCT01521364|768394|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
321250|NCT01521364|768394|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
321251|NCT01521260|768407|P2|NOT COMPLETED|Overall Study||0
321252|NCT01521260|768408|P1|NOT COMPLETED|Overall Study||0
321253|NCT01521260|768407|P2|COMPLETED|Overall Study||15
321254|NCT01521260|768408|P1|COMPLETED|Overall Study||15
321255|NCT01521260|768407|P2|STARTED|Overall Study||15
321256|NCT01521260|768408|P1|STARTED|Overall Study||15
321257|NCT01521143|768418|P4|NOT COMPLETED|Overall Study||7
321258|NCT01521143|768419|P3|NOT COMPLETED|Overall Study||8
321259|NCT01521143|768420|P2|NOT COMPLETED|Overall Study||26
321260|NCT01521143|768421|P1|NOT COMPLETED|Overall Study||29
321261|NCT01521143|768418|P4|COMPLETED|Overall Study||0
321262|NCT01521143|768419|P3|COMPLETED|Overall Study||0
321263|NCT01521143|768420|P2|COMPLETED|Overall Study||10
321264|NCT01521143|768421|P1|COMPLETED|Overall Study||11
321265|NCT01521143|768418|P4|Received Treatment|Overall Study||4
321266|NCT01521143|768419|P3|Received Treatment|Overall Study||3
321267|NCT01521143|768420|P2|Received Treatment|Overall Study||20
321268|NCT01521143|768421|P1|Received Treatment|Overall Study||20
321269|NCT01521143|768418|P4|STARTED|Overall Study||7
321270|NCT01521143|768419|P3|STARTED|Overall Study||8
321271|NCT01521143|768420|P2|STARTED|Overall Study||36
321272|NCT01521143|768421|P1|STARTED|Overall Study||40
321273|NCT01521026|768453|P2|NOT COMPLETED|Overall Study||3
321274|NCT01521026|768454|P1|NOT COMPLETED|Overall Study||15
321275|NCT01521026|768453|P2|COMPLETED|Overall Study||28
321276|NCT01521026|768454|P1|COMPLETED|Overall Study||23
321277|NCT01521026|768453|P2|STARTED|Overall Study||31
321278|NCT01521026|768454|P1|STARTED|Overall Study||38
321279|NCT01520987|768470|P8|NOT COMPLETED|Overall Study||0
321280|NCT01520987|768471|P7|NOT COMPLETED|Overall Study||0
321281|NCT01520987|768472|P6|NOT COMPLETED|Overall Study||1
321282|NCT01520987|768473|P5|NOT COMPLETED|Overall Study||0
321283|NCT01520987|768474|P4|NOT COMPLETED|Overall Study||0
321284|NCT01520987|768475|P3|NOT COMPLETED|Overall Study||0
321285|NCT01520987|768476|P2|NOT COMPLETED|Overall Study||0
321286|NCT01520987|768477|P1|NOT COMPLETED|Overall Study||1
321287|NCT01520987|768470|P8|COMPLETED|Overall Study||14
321288|NCT01520987|768471|P7|COMPLETED|Overall Study||12
321289|NCT01520987|768472|P6|COMPLETED|Overall Study||13
321290|NCT01520987|768473|P5|COMPLETED|Overall Study||14
321291|NCT01520987|768474|P4|COMPLETED|Overall Study||15
321292|NCT01520987|768475|P3|COMPLETED|Overall Study||11
321293|NCT01520987|768476|P2|COMPLETED|Overall Study||12
321294|NCT01520987|768477|P1|COMPLETED|Overall Study||12
321295|NCT01520987|768470|P8|Dosed|Overall Study||14
321296|NCT01520987|768471|P7|Dosed|Overall Study||12
321297|NCT01520987|768472|P6|Dosed|Overall Study||14
321298|NCT01520987|768473|P5|Dosed|Overall Study||14
321299|NCT01520987|768474|P4|Dosed|Overall Study||15
321300|NCT01520987|768475|P3|Dosed|Overall Study||11
321301|NCT01520987|768476|P2|Dosed|Overall Study||12
321302|NCT01520987|768477|P1|Dosed|Overall Study||13
321303|NCT01520987|768470|P8|STARTED|Overall Study||14
321304|NCT01520987|768471|P7|STARTED|Overall Study||12
321305|NCT01520987|768472|P6|STARTED|Overall Study||14
321306|NCT01520987|768473|P5|STARTED|Overall Study||14
321307|NCT01520987|768474|P4|STARTED|Overall Study||15
321308|NCT01520987|768475|P3|STARTED|Overall Study||11
321309|NCT01520987|768476|P2|STARTED|Overall Study||12
321310|NCT01520987|768477|P1|STARTED|Overall Study||13
321311|NCT01520922|768537|P2|NOT COMPLETED|Survival Follow-up||0
321312|NCT01520922|768538|P1|NOT COMPLETED|Survival Follow-up||1
321313|NCT01520922|768537|P2|COMPLETED|Survival Follow-up||40
321314|NCT01520922|768538|P1|COMPLETED|Survival Follow-up||20
321315|NCT01520922|768537|P2|STARTED|Survival Follow-up||40
321316|NCT01520922|768538|P1|STARTED|Survival Follow-up||21
321317|NCT01520922|768537|P2|NOT COMPLETED|Follow up||1
321318|NCT01520922|768538|P1|NOT COMPLETED|Follow up||0
321319|NCT01520922|768537|P2|COMPLETED|Follow up||44
321320|NCT01520922|768538|P1|COMPLETED|Follow up||44
321321|NCT01520922|768537|P2|STARTED|Follow up||45
321322|NCT01520922|768538|P1|STARTED|Follow up||44
321323|NCT01520922|768537|P2|NOT COMPLETED|Treatment Phase||8
321324|NCT01520922|768538|P1|NOT COMPLETED|Treatment Phase||5
321325|NCT01520922|768537|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
321326|NCT01520922|768538|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
321327|NCT01520922|768537|P2|STARTED|Treatment Phase||53
321328|NCT01520922|768538|P1|STARTED|Treatment Phase||44
321329|NCT01520909|768600|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
321330|NCT01520909|768601|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
321331|NCT01520909|768602|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
321332|NCT01520909|768600|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
321333|NCT01520909|768601|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
321334|NCT01520909|768602|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
321335|NCT01520909|768600|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
321336|NCT01520909|768601|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
321337|NCT01520909|768602|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
321338|NCT01520909|768600|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
321339|NCT01520909|768601|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
321340|NCT01520909|768602|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
321341|NCT01520909|768600|P3|COMPLETED|Part 1 (Randomized Period)||0
321342|NCT01520909|768601|P2|COMPLETED|Part 1 (Randomized Period)||61
321343|NCT01520909|768602|P1|COMPLETED|Part 1 (Randomized Period)||28
321344|NCT01520909|768600|P3|STARTED|Part 1 (Randomized Period)||0
321345|NCT01520909|768601|P2|STARTED|Part 1 (Randomized Period)||63
321346|NCT01520909|768602|P1|STARTED|Part 1 (Randomized Period)||29
321347|NCT01520727|768673|P9|NOT COMPLETED|Overall Study||0
321348|NCT01520727|768674|P8|NOT COMPLETED|Overall Study||0
321349|NCT01520727|768675|P7|NOT COMPLETED|Overall Study||0
321350|NCT01520727|768676|P6|NOT COMPLETED|Overall Study||0
321351|NCT01520727|768677|P5|NOT COMPLETED|Overall Study||0
321352|NCT01520727|768678|P4|NOT COMPLETED|Overall Study||0
321353|NCT01520727|768679|P3|NOT COMPLETED|Overall Study||0
321354|NCT01520727|768680|P2|NOT COMPLETED|Overall Study||0
321355|NCT01520727|768681|P1|NOT COMPLETED|Overall Study||0
321356|NCT01520727|768673|P9|COMPLETED|Overall Study||16
321357|NCT01520727|768674|P8|COMPLETED|Overall Study||6
321358|NCT01520727|768675|P7|COMPLETED|Overall Study||6
321359|NCT01520727|768676|P6|COMPLETED|Overall Study||6
321360|NCT01520727|768677|P5|COMPLETED|Overall Study||6
321361|NCT01520727|768678|P4|COMPLETED|Overall Study||6
321362|NCT01520727|768679|P3|COMPLETED|Overall Study||6
321363|NCT01520727|768680|P2|COMPLETED|Overall Study||6
321364|NCT01520727|768681|P1|COMPLETED|Overall Study||6
321365|NCT01520727|768673|P9|STARTED|Overall Study||16
321366|NCT01520727|768674|P8|STARTED|Overall Study||6
321367|NCT01520727|768675|P7|STARTED|Overall Study||6
321368|NCT01520727|768676|P6|STARTED|Overall Study||6
321369|NCT01520727|768677|P5|STARTED|Overall Study||6
321370|NCT01520727|768678|P4|STARTED|Overall Study||6
321371|NCT01520727|768679|P3|STARTED|Overall Study||6
321372|NCT01520727|768680|P2|STARTED|Overall Study||6
321373|NCT01520727|768681|P1|STARTED|Overall Study||6
321374|NCT01520714|768719|P2|NOT COMPLETED|Overall Study||6
321375|NCT01520714|768720|P1|NOT COMPLETED|Overall Study||0
321376|NCT01520714|768719|P2|COMPLETED|Overall Study||5
321377|NCT01520714|768720|P1|COMPLETED|Overall Study||0
321378|NCT01520714|768719|P2|STARTED|Overall Study||11
321379|NCT01520714|768720|P1|STARTED|Overall Study||0
321380|NCT01520532|768726|P1|NOT COMPLETED|Overall Study||0
321381|NCT01520532|768726|P1|COMPLETED|Overall Study||60
321382|NCT01520532|768726|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
321383|NCT01520506|768732|P1|NOT COMPLETED|Overall Study||6
321384|NCT01520506|768732|P1|COMPLETED|Overall Study||44
321385|NCT01520506|768732|P1|STARTED|Overall Study||50
321386|NCT01520454|768742|P4|NOT COMPLETED|Overall Study||0
321387|NCT01520454|768743|P3|NOT COMPLETED|Overall Study||0
321388|NCT01520454|768744|P2|NOT COMPLETED|Overall Study||0
321389|NCT01520454|768745|P1|NOT COMPLETED|Overall Study||0
321390|NCT01520454|768742|P4|COMPLETED|Overall Study||6
321391|NCT01520454|768743|P3|COMPLETED|Overall Study||5
321392|NCT01520454|768744|P2|COMPLETED|Overall Study||6
321393|NCT01520454|768745|P1|COMPLETED|Overall Study||9
321394|NCT01520454|768742|P4|STARTED|Overall Study||6
321395|NCT01520454|768743|P3|STARTED|Overall Study||5
321396|NCT01520454|768744|P2|STARTED|Overall Study||6
321397|NCT01520454|768745|P1|STARTED|Overall Study||9
321398|NCT01520402|768783|P1|NOT COMPLETED|Overall Study||5
321399|NCT01520402|768783|P1|COMPLETED|Overall Study||30
321400|NCT01520402|768783|P1|STARTED|Overall Study||35
321401|NCT01519960|768797|P3|NOT COMPLETED|Overall Study||10
321402|NCT01519960|768798|P2|NOT COMPLETED|Overall Study||50
321403|NCT01519960|768799|P1|NOT COMPLETED|Overall Study||101
321404|NCT01519960|768797|P3|COMPLETED|Overall Study||0
321405|NCT01519960|768798|P2|COMPLETED|Overall Study||0
321406|NCT01519960|768799|P1|COMPLETED|Overall Study||0
321407|NCT01519960|768797|P3|Completed FU Week 24|Overall Study||10
321408|NCT01519960|768798|P2|Completed FU Week 24|Overall Study||15
321409|NCT01519960|768799|P1|Completed FU Week 24|Overall Study||101
321410|NCT01519960|768797|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
321411|NCT01519960|768798|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
321412|NCT01519960|768799|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
321413|NCT01519960|768797|P3|Completed Week 48|Overall Study||10
321414|NCT01519960|768798|P2|Completed Week 48|Overall Study||47
321415|NCT01519960|768799|P1|Completed Week 48|Overall Study||99
321416|NCT01519960|768797|P3|STARTED|Overall Study||10
321417|NCT01519960|768798|P2|STARTED|Overall Study||50
321418|NCT01519960|768799|P1|STARTED|Overall Study||101
321419|NCT01519934|768905|P1|NOT COMPLETED|Overall Study||3
321420|NCT01519934|768905|P1|COMPLETED|Overall Study||45
321421|NCT01519934|768905|P1|STARTED|Overall Study||48
321422|NCT01519921|768914|P2|NOT COMPLETED|Overall Study||15
321423|NCT01519921|768915|P1|NOT COMPLETED|Overall Study||21
321424|NCT01519921|768914|P2|COMPLETED|Overall Study||49
321425|NCT01519921|768915|P1|COMPLETED|Overall Study||65
321426|NCT01519921|768914|P2|STARTED|Overall Study||64
321427|NCT01519921|768915|P1|STARTED|Overall Study||86
321428|NCT01519882|768939|P2|NOT COMPLETED|Overall Study||0
321429|NCT01519882|768940|P1|NOT COMPLETED|Overall Study||0
321430|NCT01519882|768939|P2|COMPLETED|Overall Study||0
321431|NCT01519882|768940|P1|COMPLETED|Overall Study||1
321432|NCT01519882|768939|P2|STARTED|Overall Study||0
321433|NCT01519882|768940|P1|STARTED|Overall Study||1
321434|NCT01519791|768966|P2|NOT COMPLETED|Overall Study||368
321435|NCT01519791|768967|P1|NOT COMPLETED|Overall Study||152
321436|NCT01519791|768966|P2|COMPLETED|Overall Study||292
321437|NCT01519791|768967|P1|COMPLETED|Overall Study||67
321438|NCT01519791|768966|P2|Completed Week 52|Overall Study||500
321439|NCT01519791|768967|P1|Completed Week 52|Overall Study||143
321440|NCT01519791|768966|P2|STARTED|Overall Study||660
321441|NCT01519791|768967|P1|STARTED|Overall Study||219
321442|NCT01519778|769031|P1|NOT COMPLETED|Overall Study||14
321443|NCT01519778|769031|P1|COMPLETED|Overall Study||186
321444|NCT01519778|769031|P1|STARTED|Overall Study||200
321445|NCT01519765|769037|P2|NOT COMPLETED|Overall Study||2
321446|NCT01519765|769038|P1|NOT COMPLETED|Overall Study||3
321447|NCT01519765|769037|P2|COMPLETED|Overall Study||34
321448|NCT01519765|769038|P1|COMPLETED|Overall Study||34
321449|NCT01519765|769037|P2|STARTED|Overall Study||36
321450|NCT01519765|769038|P1|STARTED|Overall Study||37
321451|NCT01519713|769087|P3|NOT COMPLETED|Overall Study||0
321452|NCT01519713|769088|P2|NOT COMPLETED|Overall Study||0
321453|NCT01519713|769089|P1|NOT COMPLETED|Overall Study||0
321454|NCT01519713|769087|P3|COMPLETED|Overall Study||4
321455|NCT01519713|769088|P2|COMPLETED|Overall Study||2
321456|NCT01519713|769089|P1|COMPLETED|Overall Study||194
321457|NCT01519713|769087|P3|STARTED|Overall Study||4
321458|NCT01519713|769088|P2|STARTED|Overall Study||2
321459|NCT01519713|769089|P1|STARTED|Overall Study||194
321460|NCT01519700|769116|P4|NOT COMPLETED|Overall Study||7
321461|NCT01519700|769117|P3|NOT COMPLETED|Overall Study||7
321462|NCT01519700|769118|P2|NOT COMPLETED|Overall Study||6
321463|NCT01519700|769119|P1|NOT COMPLETED|Overall Study||9
321464|NCT01519700|769116|P4|COMPLETED|Overall Study||47
321465|NCT01519700|769117|P3|COMPLETED|Overall Study||48
321466|NCT01519700|769118|P2|COMPLETED|Overall Study||49
321467|NCT01519700|769119|P1|COMPLETED|Overall Study||45
321468|NCT01519700|769116|P4|Treated Cycle 6 Neupogen|Overall Study||49
321469|NCT01519700|769117|P3|Treated Cycle 6 Neupogen|Overall Study||0
321470|NCT01519700|769118|P2|Treated Cycle 6 Neupogen|Overall Study||49
321471|NCT01519700|769119|P1|Treated Cycle 6 Neupogen|Overall Study||0
321472|NCT01519700|769116|P4|Treated Cycle 6 EP2006|Overall Study||0
321473|NCT01519700|769117|P3|Treated Cycle 6 EP2006|Overall Study||48
321474|NCT01519700|769118|P2|Treated Cycle 6 EP2006|Overall Study||0
321475|NCT01519700|769119|P1|Treated Cycle 6 EP2006|Overall Study||45
321476|NCT01519700|769116|P4|Treated Cycle 5 Neupogen|Overall Study||50
321477|NCT01519700|769117|P3|Treated Cycle 5 Neupogen|Overall Study||48
321478|NCT01519700|769118|P2|Treated Cycle 5 Neupogen|Overall Study||0
321479|NCT01519700|769119|P1|Treated Cycle 5 Neupogen|Overall Study||0
321480|NCT01519700|769116|P4|Treated Cycle 5 EP2006|Overall Study||0
321481|NCT01519700|769117|P3|Treated Cycle 5 EP2006|Overall Study||0
321482|NCT01519700|769118|P2|Treated Cycle 5 EP2006|Overall Study||49
321483|NCT01519700|769119|P1|Treated Cycle 5 EP2006|Overall Study||46
321484|NCT01519700|769116|P4|Treated Cycle 4 Neupogen|Overall Study||50
321485|NCT01519700|769117|P3|Treated Cycle 4 Neupogen|Overall Study||0
321486|NCT01519700|769118|P2|Treated Cycle 4 Neupogen|Overall Study||51
321487|NCT01519700|769119|P1|Treated Cycle 4 Neupogen|Overall Study||0
321488|NCT01519700|769116|P4|Treated Cycle 4 EP2006|Overall Study||0
321489|NCT01519700|769117|P3|Treated Cycle 4 EP2006|Overall Study||50
321490|NCT01519700|769118|P2|Treated Cycle 4 EP2006|Overall Study||0
321491|NCT01519700|769119|P1|Treated Cycle 4 EP2006|Overall Study||51
321492|NCT01519700|769116|P4|Treated Cycle 3 Neupogen|Overall Study||51
321493|NCT01519700|769117|P3|Treated Cycle 3 Neupogen|Overall Study||54
321494|NCT01519700|769118|P2|Treated Cycle 3 Neupogen|Overall Study||0
321495|NCT01519700|769119|P1|Treated Cycle 3 Neupogen|Overall Study||0
321496|NCT01519700|769116|P4|Treated Cycle 3 EP2006|Overall Study||0
321497|NCT01519700|769117|P3|Treated Cycle 3 EP2006|Overall Study||0
321498|NCT01519700|769118|P2|Treated Cycle 3 EP2006|Overall Study||51
321499|NCT01519700|769119|P1|Treated Cycle 3 EP2006|Overall Study||51
321500|NCT01519700|769116|P4|Treated Cycle 2 Neupogen|Overall Study||51
321501|NCT01519700|769117|P3|Treated Cycle 2 Neupogen|Overall Study||0
321502|NCT01519700|769118|P2|Treated Cycle 2 Neupogen|Overall Study||52
321503|NCT01519700|769119|P1|Treated Cycle 2 Neupogen|Overall Study||0
321504|NCT01519700|769116|P4|Treated Cycle 2 EP2006|Overall Study||0
321505|NCT01519700|769117|P3|Treated Cycle 2 EP2006|Overall Study||55
321506|NCT01519700|769118|P2|Treated Cycle 2 EP2006|Overall Study||0
321507|NCT01519700|769119|P1|Treated Cycle 2 EP2006|Overall Study||52
321508|NCT01519700|769116|P4|Treated Cycle 1 Neupogen|Overall Study||52
321509|NCT01519700|769117|P3|Treated Cycle 1 Neupogen|Overall Study||55
321510|NCT01519700|769118|P2|Treated Cycle 1 Neupogen|Overall Study||0
321511|NCT01519700|769119|P1|Treated Cycle 1 Neupogen|Overall Study||0
321512|NCT01519700|769116|P4|Treated Cycle 1 EP2006|Overall Study||0
321513|NCT01519700|769117|P3|Treated Cycle 1 EP2006|Overall Study||0
321514|NCT01519700|769118|P2|Treated Cycle 1 EP2006|Overall Study||54
321515|NCT01519700|769119|P1|Treated Cycle 1 EP2006|Overall Study||53
321516|NCT01519700|769116|P4|STARTED|Overall Study||54
321517|NCT01519700|769117|P3|STARTED|Overall Study||55
321518|NCT01519700|769118|P2|STARTED|Overall Study||55
321519|NCT01519700|769119|P1|STARTED|Overall Study||54
321520|NCT01519674|769154|P3|NOT COMPLETED|Overall Study||12
321521|NCT01519674|769155|P2|NOT COMPLETED|Overall Study||13
321522|NCT01519674|769156|P1|NOT COMPLETED|Overall Study||21
321523|NCT01519674|769154|P3|COMPLETED|Overall Study||181
321524|NCT01519674|769155|P2|COMPLETED|Overall Study||182
321525|NCT01519674|769156|P1|COMPLETED|Overall Study||173
321526|NCT01519674|769154|P3|Exposed|Overall Study||190
321527|NCT01519674|769155|P2|Exposed|Overall Study||193
321528|NCT01519674|769156|P1|Exposed|Overall Study||192
321529|NCT01519674|769154|P3|STARTED|Overall Study||193
321530|NCT01519674|769155|P2|STARTED|Overall Study||195
321531|NCT01519674|769156|P1|STARTED|Overall Study||194
321532|NCT01519661|769194|P1|NOT COMPLETED|Overall Study||61
321533|NCT01519661|769194|P1|COMPLETED|Overall Study||96
321534|NCT01519661|769194|P1|STARTED|Overall Study||157
321535|NCT01519648|769211|P2|NOT COMPLETED|Overall Study||0
321536|NCT01519648|769212|P1|NOT COMPLETED|Overall Study||0
321537|NCT01519648|769211|P2|COMPLETED|Overall Study||306
321538|NCT01519648|769212|P1|COMPLETED|Overall Study||502
321539|NCT01519648|769211|P2|STARTED|Overall Study||306
321540|NCT01519648|769212|P1|STARTED|Overall Study||502
321541|NCT01519518|769220|P2|NOT COMPLETED|Overall Study||10
321542|NCT01519518|769221|P1|NOT COMPLETED|Overall Study||7
321543|NCT01519518|769220|P2|COMPLETED|Overall Study||905
321544|NCT01519518|769221|P1|COMPLETED|Overall Study||907
321545|NCT01519518|769220|P2|STARTED|Overall Study||915
321546|NCT01519518|769221|P1|STARTED|Overall Study||914
321547|NCT01519466|769235|P2|NOT COMPLETED|Overall Study||0
321548|NCT01519466|769236|P1|NOT COMPLETED|Overall Study||0
321549|NCT01519466|769235|P2|COMPLETED|Overall Study||16
321550|NCT01519466|769236|P1|COMPLETED|Overall Study||33
321551|NCT01519466|769235|P2|STARTED|Overall Study||16
321552|NCT01519466|769236|P1|STARTED|Overall Study||33
321553|NCT01519427|769246|P1|NOT COMPLETED|Overall Study||2
321554|NCT01519427|769246|P1|COMPLETED|Overall Study||0
321555|NCT01519427|769246|P1|STARTED|Overall Study||2
321556|NCT01519323|769253|P2|NOT COMPLETED|Overall Study||3
321557|NCT01519323|769254|P1|NOT COMPLETED|Overall Study||3
321558|NCT01519323|769253|P2|COMPLETED|Overall Study||0
321559|NCT01519323|769254|P1|COMPLETED|Overall Study||0
321560|NCT01519323|769253|P2|STARTED|Overall Study||3
321561|NCT01519323|769254|P1|STARTED|Overall Study||3
321562|NCT01519284|769270|P5|NOT COMPLETED|Overall Study||0
321563|NCT01519284|769271|P4|NOT COMPLETED|Overall Study||0
321564|NCT01519284|769272|P3|NOT COMPLETED|Overall Study||2
321565|NCT01519284|769273|P2|NOT COMPLETED|Overall Study||0
321566|NCT01519284|769274|P1|NOT COMPLETED|Overall Study||0
321567|NCT01519284|769270|P5|COMPLETED|Overall Study||16
321568|NCT01519284|769271|P4|COMPLETED|Overall Study||16
321569|NCT01519284|769272|P3|COMPLETED|Overall Study||16
321570|NCT01519284|769273|P2|COMPLETED|Overall Study||16
321571|NCT01519284|769274|P1|COMPLETED|Overall Study||16
321572|NCT01519284|769270|P5|STARTED|Overall Study||16
321573|NCT01519284|769271|P4|STARTED|Overall Study||16
321574|NCT01519284|769272|P3|STARTED|Overall Study||18
321575|NCT01519284|769273|P2|STARTED|Overall Study||16
321576|NCT01519284|769274|P1|STARTED|Overall Study||16
321577|NCT01519271|769303|P2|NOT COMPLETED|Phase 2||0
321578|NCT01519271|769304|P1|NOT COMPLETED|Phase 2||0
321579|NCT01519271|769303|P2|COMPLETED|Phase 2||14
321580|NCT01519271|769304|P1|COMPLETED|Phase 2||12
321581|NCT01519271|769303|P2|STARTED|Phase 2||14
321582|NCT01519271|769304|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
321583|NCT01519271|769303|P2|NOT COMPLETED|Phase 1||1
321584|NCT01519271|769304|P1|NOT COMPLETED|Phase 1||0
321585|NCT01519271|769303|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
321586|NCT01519271|769304|P1|COMPLETED|Phase 1||14
321587|NCT01519271|769303|P2|STARTED|Phase 1||14
321588|NCT01519271|769304|P1|STARTED|Phase 1||14
321589|NCT01519245|769314|P2|NOT COMPLETED|Overall Study||2
321590|NCT01519245|769315|P1|NOT COMPLETED|Overall Study||1
321591|NCT01519245|769314|P2|COMPLETED|Overall Study||18
321592|NCT01519245|769315|P1|COMPLETED|Overall Study||23
321593|NCT01519245|769314|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
321594|NCT01519245|769315|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
321595|NCT01519245|769314|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
321596|NCT01519245|769315|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
321597|NCT01519245|769314|P2|STARTED|Overall Study||20
321598|NCT01519245|769315|P1|STARTED|Overall Study||24
321599|NCT01519206|769327|P1|NOT COMPLETED|Overall Study||5
321600|NCT01519206|769327|P1|COMPLETED|Overall Study||27
321601|NCT01519206|769327|P1|STARTED|Overall Study||32
321602|NCT01519167|769341|P2|NOT COMPLETED|Overall Study||8
321603|NCT01519167|769342|P1|NOT COMPLETED|Overall Study||0
321604|NCT01519167|769341|P2|COMPLETED|Overall Study||81
321605|NCT01519167|769342|P1|COMPLETED|Overall Study||1
321606|NCT01519167|769341|P2|STARTED|Overall Study||89
321607|NCT01519167|769342|P1|STARTED|Overall Study||1
321608|NCT01519089|769368|P2|NOT COMPLETED|Overall Study||15
321609|NCT01519089|769369|P1|NOT COMPLETED|Overall Study||7
321610|NCT01519089|769368|P2|COMPLETED|Overall Study||33
321611|NCT01519089|769369|P1|COMPLETED|Overall Study||40
321612|NCT01519089|769368|P2|Received Treatment|Overall Study||47
321613|NCT01519089|769369|P1|Received Treatment|Overall Study||47
321614|NCT01519089|769368|P2|STARTED|Overall Study||48
321615|NCT01519089|769369|P1|STARTED|Overall Study||47
321616|NCT01518946|769490|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
321617|NCT01518946|769491|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
321618|NCT01518946|769492|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
321619|NCT01518946|769490|P3|COMPLETED|Randomized Phase (Second Intervention)||10
321620|NCT01518946|769491|P2|COMPLETED|Randomized Phase (Second Intervention)||9
321621|NCT01518946|769492|P1|COMPLETED|Randomized Phase (Second Intervention)||0
321622|NCT01518946|769490|P3|STARTED|Randomized Phase (Second Intervention)||10
321623|NCT01518946|769491|P2|STARTED|Randomized Phase (Second Intervention)||9
321624|NCT01518946|769492|P1|STARTED|Randomized Phase (Second Intervention)||0
321625|NCT01518946|769490|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
321626|NCT01518946|769491|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
321627|NCT01518946|769492|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
321628|NCT01518946|769490|P3|COMPLETED|Randomized Phase (First Intervention)||10
321629|NCT01518946|769491|P2|COMPLETED|Randomized Phase (First Intervention)||9
321630|NCT01518946|769492|P1|COMPLETED|Randomized Phase (First Intervention)||0
321631|NCT01518946|769490|P3|STARTED|Randomized Phase (First Intervention)||10
321632|NCT01518946|769491|P2|STARTED|Randomized Phase (First Intervention)||10
321633|NCT01518946|769492|P1|STARTED|Randomized Phase (First Intervention)||0
321634|NCT01518946|769490|P3|NOT COMPLETED|Open-label Phase||0
321635|NCT01518946|769491|P2|NOT COMPLETED|Open-label Phase||0
321636|NCT01518946|769492|P1|NOT COMPLETED|Open-label Phase||4
321637|NCT01518946|769490|P3|COMPLETED|Open-label Phase||0
321638|NCT01518946|769491|P2|COMPLETED|Open-label Phase||0
321639|NCT01518946|769492|P1|COMPLETED|Open-label Phase||20
321640|NCT01518946|769490|P3|STARTED|Open-label Phase||0
321641|NCT01518946|769491|P2|STARTED|Open-label Phase||0
321642|NCT01518946|769492|P1|STARTED|Open-label Phase||24
321643|NCT01518530|769499|P1|NOT COMPLETED|Post-Treatment Follow-up||0
321644|NCT01518530|769499|P1|COMPLETED|Post-Treatment Follow-up||9
321645|NCT01518530|769499|P1|STARTED|Post-Treatment Follow-up||9
321646|NCT01518530|769499|P1|NOT COMPLETED|Active Treatment Period||1
321647|NCT01518530|769499|P1|COMPLETED|Active Treatment Period||9
321648|NCT01518530|769499|P1|STARTED|Active Treatment Period||10
321649|NCT01518322|769503|P1|NOT COMPLETED|Overall Study||13
321650|NCT01518322|769503|P1|COMPLETED|Overall Study||222
321651|NCT01518322|769503|P1|STARTED|Overall Study||235
321652|NCT01518270|769516|P1|NOT COMPLETED|Overall Study||0
321653|NCT01518270|769516|P1|COMPLETED|Overall Study||179
321654|NCT01518270|769516|P1|STARTED|Overall Study||179
321655|NCT01518257|769524|P2|NOT COMPLETED|Overall Study||0
321656|NCT01518257|769525|P1|NOT COMPLETED|Overall Study||2
321657|NCT01518257|769524|P2|COMPLETED|Overall Study||60
321658|NCT01518257|769525|P1|COMPLETED|Overall Study||59
321659|NCT01518257|769524|P2|STARTED|Overall Study||60
321660|NCT01518257|769525|P1|STARTED|Overall Study||61
321661|NCT01518244|769547|P1|NOT COMPLETED|Overall Study||3
321662|NCT01518244|769547|P1|COMPLETED|Overall Study||47
321663|NCT01518244|769547|P1|STARTED|Overall Study||50
321664|NCT01518192|769555|P3|NOT COMPLETED|Overall Study||35
321665|NCT01518192|769556|P2|NOT COMPLETED|Overall Study||26
321666|NCT01518192|769557|P1|NOT COMPLETED|Overall Study||29
321667|NCT01518192|769555|P3|COMPLETED|Overall Study||224
321668|NCT01518192|769556|P2|COMPLETED|Overall Study||114
321669|NCT01518192|769557|P1|COMPLETED|Overall Study||116
321670|NCT01518192|769555|P3|STARTED|Overall Study||259
321671|NCT01518192|769556|P2|STARTED|Overall Study||140
321672|NCT01518192|769557|P1|STARTED|Overall Study||145
321673|NCT01518153|769578|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
321674|NCT01518153|769579|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
321675|NCT01518153|769580|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
321676|NCT01518153|769578|P3|COMPLETED|Donor Lymphocyte Infusion||3
321677|NCT01518153|769579|P2|COMPLETED|Donor Lymphocyte Infusion||1
321678|NCT01518153|769580|P1|COMPLETED|Donor Lymphocyte Infusion||0
321679|NCT01518153|769578|P3|STARTED|Donor Lymphocyte Infusion||4
321680|NCT01518153|769579|P2|STARTED|Donor Lymphocyte Infusion||3
321681|NCT01518153|769580|P1|STARTED|Donor Lymphocyte Infusion||0
321682|NCT01518153|769578|P3|NOT COMPLETED|Stem Cell Transplant||0
321683|NCT01518153|769579|P2|NOT COMPLETED|Stem Cell Transplant||0
321684|NCT01518153|769580|P1|NOT COMPLETED|Stem Cell Transplant||9
321685|NCT01518153|769578|P3|COMPLETED|Stem Cell Transplant||0
321686|NCT01518153|769579|P2|COMPLETED|Stem Cell Transplant||0
321687|NCT01518153|769580|P1|COMPLETED|Stem Cell Transplant||7
321688|NCT01518153|769578|P3|STARTED|Stem Cell Transplant||0
321689|NCT01518153|769579|P2|STARTED|Stem Cell Transplant||0
321690|NCT01518153|769580|P1|STARTED|Stem Cell Transplant||16
321691|NCT01517984|769591|P4|NOT COMPLETED|Overall Study||1
321692|NCT01517984|769592|P3|NOT COMPLETED|Overall Study||4
321693|NCT01517984|769593|P2|NOT COMPLETED|Overall Study||23
321694|NCT01517984|769594|P1|NOT COMPLETED|Overall Study||5
321695|NCT01517984|769591|P4|COMPLETED|Overall Study||6
321696|NCT01517984|769592|P3|COMPLETED|Overall Study||10
321697|NCT01517984|769593|P2|COMPLETED|Overall Study||3
321698|NCT01517984|769594|P1|COMPLETED|Overall Study||0
321699|NCT01517984|769591|P4|STARTED|Overall Study||7
321700|NCT01517984|769592|P3|STARTED|Overall Study||14
321701|NCT01517984|769593|P2|STARTED|Overall Study||26
321702|NCT01517984|769594|P1|STARTED|Overall Study||5
321703|NCT01517893|769620|P2|NOT COMPLETED|Overall Study||1
321704|NCT01517893|769621|P1|NOT COMPLETED|Overall Study||2
321705|NCT01517893|769620|P2|COMPLETED|Overall Study||6
321706|NCT01517893|769621|P1|COMPLETED|Overall Study||6
321707|NCT01517893|769620|P2|STARTED|Overall Study||7
321708|NCT01517893|769621|P1|STARTED|Overall Study||8
321709|NCT01517750|769631|P4|NOT COMPLETED|Overall Study||1
321710|NCT01517750|769632|P3|NOT COMPLETED|Overall Study||4
321711|NCT01517750|769633|P2|NOT COMPLETED|Overall Study||2
321712|NCT01517750|769634|P1|NOT COMPLETED|Overall Study||1
321713|NCT01517750|769631|P4|COMPLETED|Overall Study||18
321714|NCT01517750|769632|P3|COMPLETED|Overall Study||17
321715|NCT01517750|769633|P2|COMPLETED|Overall Study||17
321716|NCT01517750|769634|P1|COMPLETED|Overall Study||20
321717|NCT01517750|769631|P4|STARTED|Overall Study||19
321718|NCT01517750|769632|P3|STARTED|Overall Study||21
321719|NCT01517750|769633|P2|STARTED|Overall Study||19
321720|NCT01517750|769634|P1|STARTED|Overall Study||21
321721|NCT01517529|769664|P1|NOT COMPLETED|Overall Study||0
321722|NCT01517529|769664|P1|COMPLETED|Overall Study||10
321723|NCT01517529|769664|P1|STARTED|Overall Study||10
321724|NCT01516437|769673|P4|NOT COMPLETED|Overall Study||1
321725|NCT01516437|769674|P3|NOT COMPLETED|Overall Study||1
321726|NCT01516437|769675|P2|NOT COMPLETED|Overall Study||0
321727|NCT01516437|769676|P1|NOT COMPLETED|Overall Study||0
321728|NCT01516437|769673|P4|COMPLETED|Overall Study||6
321729|NCT01516437|769674|P3|COMPLETED|Overall Study||14
321730|NCT01516437|769675|P2|COMPLETED|Overall Study||24
321731|NCT01516437|769676|P1|COMPLETED|Overall Study||24
321732|NCT01516437|769673|P4|STARTED|Overall Study||7
321733|NCT01516437|769674|P3|STARTED|Overall Study||15
321734|NCT01516437|769675|P2|STARTED|Overall Study||24
321735|NCT01516437|769676|P1|STARTED|Overall Study||24
321736|NCT01516268|769732|P2|NOT COMPLETED|Overall Study||0
321737|NCT01516268|769733|P1|NOT COMPLETED|Overall Study||0
321738|NCT01516268|769732|P2|COMPLETED|Overall Study||25
321739|NCT01516268|769733|P1|COMPLETED|Overall Study||25
321740|NCT01516268|769732|P2|STARTED|Overall Study||25
321741|NCT01516268|769733|P1|STARTED|Overall Study||25
321742|NCT01517412|769741|P2|NOT COMPLETED|Overall Study||24
321743|NCT01517412|769742|P1|NOT COMPLETED|Overall Study||36
321744|NCT01517412|769741|P2|COMPLETED|Overall Study||202
321745|NCT01517412|769742|P1|COMPLETED|Overall Study||189
321746|NCT01517412|769741|P2|STARTED|Overall Study||226
321747|NCT01517412|769742|P1|STARTED|Overall Study||225
321748|NCT01517373|769771|P6|NOT COMPLETED|Treatment Period||7
321749|NCT01517373|769772|P5|NOT COMPLETED|Treatment Period||6
321750|NCT01517373|769773|P4|NOT COMPLETED|Treatment Period||7
321751|NCT01517373|769774|P3|NOT COMPLETED|Treatment Period||6
321752|NCT01517373|769775|P2|NOT COMPLETED|Treatment Period||4
321753|NCT01517373|769776|P1|NOT COMPLETED|Treatment Period||0
321754|NCT01517373|769771|P6|COMPLETED|Treatment Period||54
321755|NCT01517373|769772|P5|COMPLETED|Treatment Period||55
321756|NCT01517373|769773|P4|COMPLETED|Treatment Period||54
321757|NCT01517373|769774|P3|COMPLETED|Treatment Period||54
321758|NCT01517373|769775|P2|COMPLETED|Treatment Period||57
321759|NCT01517373|769776|P1|COMPLETED|Treatment Period||0
321760|NCT01517373|769771|P6|STARTED|Treatment Period||61
321761|NCT01517373|769772|P5|STARTED|Treatment Period||61
321762|NCT01517373|769773|P4|STARTED|Treatment Period||61
321763|NCT01517373|769774|P3|STARTED|Treatment Period||60
321764|NCT01517373|769775|P2|STARTED|Treatment Period||61
321765|NCT01517373|769776|P1|STARTED|Treatment Period||0
321766|NCT01517373|769771|P6|NOT COMPLETED|Run-in Period||0
321767|NCT01517373|769772|P5|NOT COMPLETED|Run-in Period||0
321768|NCT01517373|769773|P4|NOT COMPLETED|Run-in Period||0
321769|NCT01517373|769774|P3|NOT COMPLETED|Run-in Period||0
321770|NCT01517373|769775|P2|NOT COMPLETED|Run-in Period||0
321771|NCT01517373|769776|P1|NOT COMPLETED|Run-in Period||57
321772|NCT01517373|769771|P6|COMPLETED|Run-in Period||0
321773|NCT01517373|769772|P5|COMPLETED|Run-in Period||0
321774|NCT01517373|769773|P4|COMPLETED|Run-in Period||0
321775|NCT01517373|769774|P3|COMPLETED|Run-in Period||0
321776|NCT01517373|769775|P2|COMPLETED|Run-in Period||0
321777|NCT01517373|769776|P1|COMPLETED|Run-in Period||304
321778|NCT01517373|769771|P6|STARTED|Run-in Period||0
321779|NCT01517373|769772|P5|STARTED|Run-in Period||0
321780|NCT01517373|769773|P4|STARTED|Run-in Period||0
321781|NCT01517373|769774|P3|STARTED|Run-in Period||0
321782|NCT01517373|769775|P2|STARTED|Run-in Period||0
321783|NCT01517373|769776|P1|STARTED|Run-in Period||361
321784|NCT01517295|769846|P2|NOT COMPLETED|Overall Study||0
321785|NCT01517295|769847|P1|NOT COMPLETED|Overall Study||1
321786|NCT01517295|769846|P2|COMPLETED|Overall Study||14
321787|NCT01517295|769847|P1|COMPLETED|Overall Study||15
321788|NCT01517295|769846|P2|STARTED|Overall Study||14
321789|NCT01517295|769847|P1|STARTED|Overall Study||16
321790|NCT01517282|769861|P4|NOT COMPLETED|Overall Study||1
321791|NCT01517282|769862|P3|NOT COMPLETED|Overall Study||1
321792|NCT01517282|769863|P2|NOT COMPLETED|Overall Study||1
321793|NCT01517282|769864|P1|NOT COMPLETED|Overall Study||1
321794|NCT01517282|769861|P4|COMPLETED|Overall Study||5
321795|NCT01517282|769862|P3|COMPLETED|Overall Study||8
321796|NCT01517282|769863|P2|COMPLETED|Overall Study||7
321797|NCT01517282|769864|P1|COMPLETED|Overall Study||8
321798|NCT01517282|769861|P4|STARTED|Overall Study||6
321799|NCT01517282|769862|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
321800|NCT01517282|769863|P2|STARTED|Overall Study||8
321801|NCT01517282|769864|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
321802|NCT01517178|769898|P2|NOT COMPLETED|Period 2||2
321803|NCT01517178|769899|P1|NOT COMPLETED|Period 2||6
321804|NCT01517178|769898|P2|COMPLETED|Period 2||4
321805|NCT01517178|769899|P1|COMPLETED|Period 2||5
321806|NCT01517178|769898|P2|STARTED|Period 2||6
321807|NCT01517178|769899|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
321808|NCT01517178|769898|P2|NOT COMPLETED|Period 1||5
321809|NCT01517178|769899|P1|NOT COMPLETED|Period 1||4
321810|NCT01517178|769898|P2|COMPLETED|Period 1||6
321811|NCT01517178|769899|P1|COMPLETED|Period 1||12
321812|NCT01517178|769898|P2|STARTED|Period 1||11
321813|NCT01517178|769899|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
321814|NCT01517074|769905|P1|NOT COMPLETED|Overall Study||0
321815|NCT01517074|769905|P1|COMPLETED|Overall Study||5
321816|NCT01517074|769905|P1|STARTED|Overall Study||5
321817|NCT01516970|769918|P2|NOT COMPLETED|Overall Study||21
321818|NCT01516970|769919|P1|NOT COMPLETED|Overall Study||18
321819|NCT01516970|769918|P2|COMPLETED|Overall Study||132
321820|NCT01516970|769919|P1|COMPLETED|Overall Study||141
321821|NCT01516970|769918|P2|STARTED|Overall Study||153
321822|NCT01516970|769919|P1|STARTED|Overall Study||159
321823|NCT01516892|769931|P1|NOT COMPLETED|Overall Study||343
321824|NCT01516892|769931|P1|COMPLETED|Overall Study||373
321825|NCT01516892|769931|P1|STARTED|Overall Study||716
321826|NCT01516879|769939|P2|NOT COMPLETED|Overall Study||34
321827|NCT01516879|769940|P1|NOT COMPLETED|Overall Study||16
321828|NCT01516879|769939|P2|COMPLETED|Overall Study||568
321829|NCT01516879|769940|P1|COMPLETED|Overall Study||287
321830|NCT01516879|769939|P2|Received Treatment|Overall Study||599
321831|NCT01516879|769940|P1|Received Treatment|Overall Study||302
321832|NCT01516879|769939|P2|STARTED|Overall Study||602
321833|NCT01516879|769940|P1|STARTED|Overall Study||303
321834|NCT01516749|769974|P1|NOT COMPLETED|Follow-up Off Therapy||1
321835|NCT01516749|769974|P1|COMPLETED|Follow-up Off Therapy||4
321836|NCT01516749|769974|P1|STARTED|Follow-up Off Therapy||5
321837|NCT01516749|769974|P1|NOT COMPLETED|Active Therapy||1
321838|NCT01516749|769974|P1|COMPLETED|Active Therapy||5
321839|NCT01516749|769974|P1|STARTED|Active Therapy||6
321840|NCT01516632|769983|P2|NOT COMPLETED|Overall Study||15
321841|NCT01516632|769984|P1|NOT COMPLETED|Overall Study||24
321842|NCT01516632|769983|P2|COMPLETED|Overall Study||48
321843|NCT01516632|769984|P1|COMPLETED|Overall Study||77
321844|NCT01516632|769983|P2|STARTED|Overall Study||63
321845|NCT01516632|769984|P1|STARTED|Overall Study||101
321846|NCT01516034|769994|P1|NOT COMPLETED|Overall Study||8
321847|NCT01516034|769994|P1|COMPLETED|Overall Study||0
321848|NCT01516034|769994|P1|STARTED|Overall Study||8
321849|NCT01516008|770001|P3|NOT COMPLETED|Overall Study||18
321850|NCT01516008|770002|P2|NOT COMPLETED|Overall Study||16
321851|NCT01516008|770003|P1|NOT COMPLETED|Overall Study||45
321852|NCT01516008|770001|P3|COMPLETED|Overall Study||99
321853|NCT01516008|770002|P2|COMPLETED|Overall Study||105
321854|NCT01516008|770003|P1|COMPLETED|Overall Study||69
321855|NCT01516008|770001|P3|STARTED|Overall Study||117
321856|NCT01516008|770002|P2|STARTED|Overall Study||121
321857|NCT01516008|770003|P1|STARTED|Overall Study||114
321858|NCT01515943|770038|P3|NOT COMPLETED|Overall Study||13
321859|NCT01515943|770039|P2|NOT COMPLETED|Overall Study||16
321860|NCT01515943|770040|P1|NOT COMPLETED|Overall Study||6
321861|NCT01515943|770038|P3|COMPLETED|Overall Study||31
321862|NCT01515943|770039|P2|COMPLETED|Overall Study||69
321863|NCT01515943|770040|P1|COMPLETED|Overall Study||69
321864|NCT01515943|770038|P3|STARTED|Overall Study||44
321865|NCT01515943|770039|P2|STARTED|Overall Study||85
321866|NCT01515943|770040|P1|STARTED|Overall Study||75
321867|NCT01515891|770086|P1|NOT COMPLETED|Overall Study||0
321868|NCT01515891|770086|P1|COMPLETED|Overall Study||4
321869|NCT01515891|770086|P1|STARTED|Overall Study||4
321870|NCT01515865|770093|P3|NOT COMPLETED|Part C (Randomized)||0
321871|NCT01515865|770094|P2|NOT COMPLETED|Part C (Randomized)||0
321872|NCT01515865|770095|P1|NOT COMPLETED|Part C (Randomized)||0
321873|NCT01515865|770093|P3|COMPLETED|Part C (Randomized)||34
321874|NCT01515865|770094|P2|COMPLETED|Part C (Randomized)||33
321875|NCT01515865|770095|P1|COMPLETED|Part C (Randomized)||0
321876|NCT01515865|770093|P3|STARTED|Part C (Randomized)||34
321877|NCT01515865|770094|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
321878|NCT01515865|770095|P1|STARTED|Part C (Randomized)||0
321879|NCT01515865|770093|P3|NOT COMPLETED|Part B (Open-label)||0
321880|NCT01515865|770094|P2|NOT COMPLETED|Part B (Open-label)||0
321881|NCT01515865|770095|P1|NOT COMPLETED|Part B (Open-label)||2
321882|NCT01515865|770093|P3|COMPLETED|Part B (Open-label)||0
321883|NCT01515865|770094|P2|COMPLETED|Part B (Open-label)||0
321884|NCT01515865|770095|P1|COMPLETED|Part B (Open-label)||69
321885|NCT01515865|770093|P3|STARTED|Part B (Open-label)||0
321886|NCT01515865|770094|P2|STARTED|Part B (Open-label)||0
321887|NCT01515865|770095|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
321888|NCT01515865|770093|P3|NOT COMPLETED|Part A (Open-label)||0
321889|NCT01515865|770094|P2|NOT COMPLETED|Part A (Open-label)||0
321890|NCT01515865|770095|P1|NOT COMPLETED|Part A (Open-label)||3
321891|NCT01515865|770093|P3|COMPLETED|Part A (Open-label)||0
321892|NCT01515865|770094|P2|COMPLETED|Part A (Open-label)||0
321893|NCT01515865|770095|P1|COMPLETED|Part A (Open-label)||95
321894|NCT01515865|770093|P3|STARTED|Part A (Open-label)||0
321895|NCT01515865|770094|P2|STARTED|Part A (Open-label)||0
321896|NCT01515865|770095|P1|STARTED|Part A (Open-label)||98
321897|NCT01515696|770105|P2|NOT COMPLETED|Overall Study||10
321898|NCT01515696|770106|P1|NOT COMPLETED|Overall Study||8
321899|NCT01515696|770105|P2|COMPLETED|Overall Study||39
321900|NCT01515696|770106|P1|COMPLETED|Overall Study||39
321901|NCT01515696|770105|P2|STARTED|Overall Study||49
321902|NCT01515696|770106|P1|STARTED|Overall Study||47
321903|NCT01515657|770116|P3|NOT COMPLETED|Third Intervention||0
321904|NCT01515657|770117|P2|NOT COMPLETED|Third Intervention||0
321905|NCT01515657|770118|P1|NOT COMPLETED|Third Intervention||1
321906|NCT01515657|770116|P3|COMPLETED|Third Intervention||13
321907|NCT01515657|770117|P2|COMPLETED|Third Intervention||11
321908|NCT01515657|770118|P1|COMPLETED|Third Intervention||13
321909|NCT01515657|770116|P3|STARTED|Third Intervention||13
321910|NCT01515657|770117|P2|STARTED|Third Intervention||11
321911|NCT01515657|770118|P1|STARTED|Third Intervention||14
321912|NCT01515657|770116|P3|NOT COMPLETED|Second Intervention||0
321913|NCT01515657|770117|P2|NOT COMPLETED|Second Intervention||1
321914|NCT01515657|770118|P1|NOT COMPLETED|Second Intervention||0
321915|NCT01515657|770116|P3|COMPLETED|Second Intervention||13
321916|NCT01515657|770117|P2|COMPLETED|Second Intervention||11
321917|NCT01515657|770118|P1|COMPLETED|Second Intervention||14
321918|NCT01515657|770116|P3|STARTED|Second Intervention||13
321919|NCT01515657|770117|P2|STARTED|Second Intervention||12
321920|NCT01515657|770118|P1|STARTED|Second Intervention||14
321921|NCT01515657|770116|P3|NOT COMPLETED|First Intervention||0
321922|NCT01515657|770117|P2|NOT COMPLETED|First Intervention||1
321923|NCT01515657|770118|P1|NOT COMPLETED|First Intervention||0
321924|NCT01515657|770116|P3|COMPLETED|First Intervention||13
321925|NCT01515657|770117|P2|COMPLETED|First Intervention||12
321926|NCT01515657|770118|P1|COMPLETED|First Intervention||14
321927|NCT01515657|770116|P3|STARTED|First Intervention||13
321928|NCT01515657|770117|P2|STARTED|First Intervention||13
321929|NCT01515657|770118|P1|STARTED|First Intervention||14
321930|NCT01515566|770128|P2|NOT COMPLETED|Overall Study||0
321931|NCT01515566|770129|P1|NOT COMPLETED|Overall Study||0
321932|NCT01515566|770128|P2|COMPLETED|Overall Study||10
321933|NCT01515566|770129|P1|COMPLETED|Overall Study||10
321934|NCT01515566|770128|P2|STARTED|Overall Study||10
321935|NCT01515566|770129|P1|STARTED|Overall Study||10
321936|NCT01515540|770141|P2|NOT COMPLETED|Overall Study||3
321937|NCT01515540|770142|P1|NOT COMPLETED|Overall Study||5
321938|NCT01515540|770141|P2|COMPLETED|Overall Study||15
321939|NCT01515540|770142|P1|COMPLETED|Overall Study||15
321940|NCT01515540|770141|P2|STARTED|Overall Study||18
321941|NCT01515540|770142|P1|STARTED|Overall Study||20
321942|NCT01515488|770150|P2|NOT COMPLETED|Overall Study||0
321943|NCT01515488|770151|P1|NOT COMPLETED|Overall Study||0
321944|NCT01515488|770150|P2|COMPLETED|Overall Study||200
321945|NCT01515488|770151|P1|COMPLETED|Overall Study||200
321946|NCT01515488|770150|P2|STARTED|Overall Study||200
321947|NCT01515488|770151|P1|STARTED|Overall Study||200
321948|NCT01515423|770163|P3|NOT COMPLETED|DOUBLE BLIND||92
321949|NCT01515423|770164|P2|NOT COMPLETED|DOUBLE BLIND||82
321950|NCT01515423|770165|P1|NOT COMPLETED|DOUBLE BLIND||0
321951|NCT01515423|770163|P3|COMPLETED|DOUBLE BLIND||420
321952|NCT01515423|770164|P2|COMPLETED|DOUBLE BLIND||422
321953|NCT01515423|770165|P1|COMPLETED|DOUBLE BLIND||0
321954|NCT01515423|770163|P3|STARTED|DOUBLE BLIND||512
321955|NCT01515423|770164|P2|STARTED|DOUBLE BLIND||504
321956|NCT01515423|770165|P1|STARTED|DOUBLE BLIND||0
321957|NCT01515423|770163|P3|NOT COMPLETED|Open Label Phase||0
321958|NCT01515423|770164|P2|NOT COMPLETED|Open Label Phase||0
321959|NCT01515423|770165|P1|NOT COMPLETED|Open Label Phase||413
321960|NCT01515423|770163|P3|COMPLETED|Open Label Phase||0
321961|NCT01515423|770164|P2|COMPLETED|Open Label Phase||0
321962|NCT01515423|770165|P1|COMPLETED|Open Label Phase||1016
321963|NCT01515423|770163|P3|STARTED|Open Label Phase||0
321964|NCT01515423|770164|P2|STARTED|Open Label Phase||0
321965|NCT01515423|770165|P1|STARTED|Open Label Phase||1429
321966|NCT01515410|770184|P2|NOT COMPLETED|Overall Study||0
321967|NCT01515410|770185|P1|NOT COMPLETED|Overall Study||0
321968|NCT01515410|770184|P2|COMPLETED|Overall Study||15
321969|NCT01515410|770185|P1|COMPLETED|Overall Study||19
321970|NCT01515410|770184|P2|STARTED|Overall Study||15
321971|NCT01515410|770185|P1|STARTED|Overall Study||19
321972|NCT01515345|770193|P2|NOT COMPLETED|Overall Study||0
321973|NCT01515345|770194|P1|NOT COMPLETED|Overall Study||1
321974|NCT01515345|770193|P2|COMPLETED|Overall Study||343
321975|NCT01515345|770194|P1|COMPLETED|Overall Study||664
321976|NCT01515345|770193|P2|STARTED|Overall Study||343
321977|NCT01515345|770194|P1|STARTED|Overall Study||665
321978|NCT01515306|770206|P2|NOT COMPLETED|Overall Study||14
321979|NCT01515306|770207|P1|NOT COMPLETED|Overall Study||12
321980|NCT01515306|770206|P2|COMPLETED|Overall Study||2
321981|NCT01515306|770207|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
321982|NCT01515306|770206|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
321983|NCT01515306|770207|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
321984|NCT01515306|770206|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
321985|NCT01515306|770207|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
321986|NCT01515306|770206|P2|STARTED|Overall Study||16
321987|NCT01515306|770207|P1|STARTED|Overall Study||24
321988|NCT01515189|770220|P2|NOT COMPLETED|First Re-Induction Phase||15
321989|NCT01515189|770221|P1|NOT COMPLETED|First Re-Induction Phase||14
321990|NCT01515189|770220|P2|COMPLETED|First Re-Induction Phase||17
321991|NCT01515189|770221|P1|COMPLETED|First Re-Induction Phase||9
321992|NCT01515189|770220|P2|STARTED|First Re-Induction Phase||32
321993|NCT01515189|770221|P1|STARTED|First Re-Induction Phase||23
321994|NCT01515189|770220|P2|NOT COMPLETED|Induction||232
321995|NCT01515189|770221|P1|NOT COMPLETED|Induction||237
321996|NCT01515189|770220|P2|COMPLETED|Induction||130
321997|NCT01515189|770221|P1|COMPLETED|Induction||128
321998|NCT01515189|770220|P2|STARTED|Induction||362
321999|NCT01515189|770221|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
322000|NCT01515046|770241|P1|NOT COMPLETED|Overall Study||0
322001|NCT01515046|770241|P1|COMPLETED|Overall Study||1
322002|NCT01515046|770241|P1|STARTED|Overall Study||1
322003|NCT01514864|770251|P2|NOT COMPLETED|Overall Study||5
322004|NCT01514864|770252|P1|NOT COMPLETED|Overall Study||9
322005|NCT01514864|770251|P2|COMPLETED|Overall Study||0
322006|NCT01514864|770252|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
322007|NCT01514864|770251|P2|STARTED|Overall Study||5
322008|NCT01514864|770252|P1|STARTED|Overall Study||9
322009|NCT01514760|770268|P1|NOT COMPLETED|Overall Study||2
322010|NCT01514760|770268|P1|COMPLETED|Overall Study||20
322011|NCT01514760|770268|P1|STARTED|Overall Study||22
322012|NCT01514734|770275|P1|NOT COMPLETED|Overall Study||0
322013|NCT01514734|770275|P1|COMPLETED|Overall Study||9
322014|NCT01514734|770275|P1|STARTED|Overall Study||9
322015|NCT01514630|770279|P1|NOT COMPLETED|Overall Study||3
322016|NCT01514630|770279|P1|COMPLETED|Overall Study||11
322017|NCT01514630|770279|P1|STARTED|Overall Study||14
322018|NCT01514513|770285|P2|NOT COMPLETED|Overall Study||1
322019|NCT01514513|770286|P1|NOT COMPLETED|Overall Study||1
322020|NCT01514513|770285|P2|COMPLETED|Overall Study||20
322021|NCT01514513|770286|P1|COMPLETED|Overall Study||20
322022|NCT01514513|770285|P2|STARTED|Overall Study||21
322023|NCT01514513|770286|P1|STARTED|Overall Study||21
322024|NCT01514461|770297|P3|NOT COMPLETED|Overall Study||4
322025|NCT01514461|770298|P2|NOT COMPLETED|Overall Study||3
322026|NCT01514461|770299|P1|NOT COMPLETED|Overall Study||5
322027|NCT01514461|770297|P3|COMPLETED|Overall Study||11
322028|NCT01514461|770298|P2|COMPLETED|Overall Study||12
322029|NCT01514461|770299|P1|COMPLETED|Overall Study||10
322030|NCT01514461|770297|P3|STARTED|Overall Study||15
322031|NCT01514461|770298|P2|STARTED|Overall Study||15
322032|NCT01514461|770299|P1|STARTED|Overall Study||15
322033|NCT01514422|770336|P1|NOT COMPLETED|Overall Study||1
322034|NCT01514422|770336|P1|COMPLETED|Overall Study||19
322035|NCT01514422|770336|P1|STARTED|Overall Study||20
322036|NCT01514318|770342|P1|NOT COMPLETED|Overall Study||0
322037|NCT01514318|770342|P1|COMPLETED|Overall Study||8
322038|NCT01514318|770342|P1|STARTED|Overall Study||8
322039|NCT01514292|770348|P1|NOT COMPLETED|Overall Study||0
322040|NCT01514292|770348|P1|COMPLETED|Overall Study||72
322041|NCT01514292|770348|P1|STARTED|Overall Study||72
322042|NCT01514240|770354|P2|NOT COMPLETED|Overall Study||11
322043|NCT01514240|770355|P1|NOT COMPLETED|Overall Study||6
322044|NCT01514240|770354|P2|COMPLETED|Overall Study||45
322045|NCT01514240|770355|P1|COMPLETED|Overall Study||50
322046|NCT01514240|770354|P2|STARTED|Overall Study||56
322047|NCT01514240|770355|P1|STARTED|Overall Study||56
322048|NCT01514162|770429|P1|NOT COMPLETED|Overall Study||85
322049|NCT01514162|770429|P1|COMPLETED|Overall Study||160
322050|NCT01514162|770429|P1|STARTED|Overall Study||245
322051|NCT01514136|770437|P8|NOT COMPLETED|Test Period; Test D*||0
322052|NCT01514136|770438|P7|NOT COMPLETED|Test Period; Test D*||0
322053|NCT01514136|770439|P6|NOT COMPLETED|Test Period; Test D*||0
322054|NCT01514136|770440|P5|NOT COMPLETED|Test Period; Test D*||0
322055|NCT01514136|770441|P4|NOT COMPLETED|Test Period; Test D*||0
322056|NCT01514136|770442|P3|NOT COMPLETED|Test Period; Test D*||0
322057|NCT01514136|770443|P2|NOT COMPLETED|Test Period; Test D*||0
322058|NCT01514136|770444|P1|NOT COMPLETED|Test Period; Test D*||0
322059|NCT01514136|770437|P8|COMPLETED|Test Period; Test D*||23
322060|NCT01514136|770438|P7|COMPLETED|Test Period; Test D*||0
322061|NCT01514136|770439|P6|COMPLETED|Test Period; Test D*||0
322062|NCT01514136|770440|P5|COMPLETED|Test Period; Test D*||0
322063|NCT01514136|770441|P4|COMPLETED|Test Period; Test D*||0
322064|NCT01514136|770442|P3|COMPLETED|Test Period; Test D*||0
322065|NCT01514136|770443|P2|COMPLETED|Test Period; Test D*||0
322066|NCT01514136|770444|P1|COMPLETED|Test Period; Test D*||0
322067|NCT01514136|770437|P8|STARTED|Test Period; Test D*||23
322068|NCT01514136|770438|P7|STARTED|Test Period; Test D*||0
322069|NCT01514136|770439|P6|STARTED|Test Period; Test D*||0
322070|NCT01514136|770440|P5|STARTED|Test Period; Test D*||0
322071|NCT01514136|770441|P4|STARTED|Test Period; Test D*||0
322072|NCT01514136|770442|P3|STARTED|Test Period; Test D*||0
322073|NCT01514136|770443|P2|STARTED|Test Period; Test D*||0
322074|NCT01514136|770444|P1|STARTED|Test Period; Test D*||0
322075|NCT01514136|770437|P8|NOT COMPLETED|Test Period 2; Test C*||0
322076|NCT01514136|770438|P7|NOT COMPLETED|Test Period 2; Test C*||3
322077|NCT01514136|770439|P6|NOT COMPLETED|Test Period 2; Test C*||0
322078|NCT01514136|770440|P5|NOT COMPLETED|Test Period 2; Test C*||0
322079|NCT01514136|770441|P4|NOT COMPLETED|Test Period 2; Test C*||0
322080|NCT01514136|770442|P3|NOT COMPLETED|Test Period 2; Test C*||0
322081|NCT01514136|770443|P2|NOT COMPLETED|Test Period 2; Test C*||0
322082|NCT01514136|770444|P1|NOT COMPLETED|Test Period 2; Test C*||0
322083|NCT01514136|770437|P8|COMPLETED|Test Period 2; Test C*||0
322084|NCT01514136|770438|P7|COMPLETED|Test Period 2; Test C*||23
322085|NCT01514136|770439|P6|COMPLETED|Test Period 2; Test C*||0
322086|NCT01514136|770440|P5|COMPLETED|Test Period 2; Test C*||0
322087|NCT01514136|770441|P4|COMPLETED|Test Period 2; Test C*||0
322088|NCT01514136|770442|P3|COMPLETED|Test Period 2; Test C*||0
322089|NCT01514136|770443|P2|COMPLETED|Test Period 2; Test C*||0
322090|NCT01514136|770444|P1|COMPLETED|Test Period 2; Test C*||0
322091|NCT01514136|770437|P8|STARTED|Test Period 2; Test C*||0
322092|NCT01514136|770438|P7|STARTED|Test Period 2; Test C*||26
322093|NCT01514136|770439|P6|STARTED|Test Period 2; Test C*||0
322094|NCT01514136|770440|P5|STARTED|Test Period 2; Test C*||0
322095|NCT01514136|770441|P4|STARTED|Test Period 2; Test C*||0
322096|NCT01514136|770442|P3|STARTED|Test Period 2; Test C*||0
322097|NCT01514136|770443|P2|STARTED|Test Period 2; Test C*||0
322098|NCT01514136|770444|P1|STARTED|Test Period 2; Test C*||0
322099|NCT01514136|770437|P8|NOT COMPLETED|Test Period 2; Test B*||0
322100|NCT01514136|770438|P7|NOT COMPLETED|Test Period 2; Test B*||0
322101|NCT01514136|770439|P6|NOT COMPLETED|Test Period 2; Test B*||2
322102|NCT01514136|770440|P5|NOT COMPLETED|Test Period 2; Test B*||0
322103|NCT01514136|770441|P4|NOT COMPLETED|Test Period 2; Test B*||0
322104|NCT01514136|770442|P3|NOT COMPLETED|Test Period 2; Test B*||0
322105|NCT01514136|770443|P2|NOT COMPLETED|Test Period 2; Test B*||0
322106|NCT01514136|770444|P1|NOT COMPLETED|Test Period 2; Test B*||0
322107|NCT01514136|770437|P8|COMPLETED|Test Period 2; Test B*||0
322108|NCT01514136|770438|P7|COMPLETED|Test Period 2; Test B*||0
322109|NCT01514136|770439|P6|COMPLETED|Test Period 2; Test B*||26
322110|NCT01514136|770440|P5|COMPLETED|Test Period 2; Test B*||0
322111|NCT01514136|770441|P4|COMPLETED|Test Period 2; Test B*||0
322112|NCT01514136|770442|P3|COMPLETED|Test Period 2; Test B*||0
322113|NCT01514136|770443|P2|COMPLETED|Test Period 2; Test B*||0
322114|NCT01514136|770444|P1|COMPLETED|Test Period 2; Test B*||0
322115|NCT01514136|770437|P8|STARTED|Test Period 2; Test B*||0
322116|NCT01514136|770438|P7|STARTED|Test Period 2; Test B*||0
322117|NCT01514136|770439|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
322118|NCT01514136|770440|P5|STARTED|Test Period 2; Test B*||0
322119|NCT01514136|770441|P4|STARTED|Test Period 2; Test B*||0
322120|NCT01514136|770442|P3|STARTED|Test Period 2; Test B*||0
322121|NCT01514136|770443|P2|STARTED|Test Period 2; Test B*||0
322122|NCT01514136|770444|P1|STARTED|Test Period 2; Test B*||0
322123|NCT01514136|770437|P8|NOT COMPLETED|Test Period 2; Test A*||0
322124|NCT01514136|770438|P7|NOT COMPLETED|Test Period 2; Test A*||0
322125|NCT01514136|770439|P6|NOT COMPLETED|Test Period 2; Test A*||0
322126|NCT01514136|770440|P5|NOT COMPLETED|Test Period 2; Test A*||2
322127|NCT01514136|770441|P4|NOT COMPLETED|Test Period 2; Test A*||0
322128|NCT01514136|770442|P3|NOT COMPLETED|Test Period 2; Test A*||0
322129|NCT01514136|770443|P2|NOT COMPLETED|Test Period 2; Test A*||0
322130|NCT01514136|770444|P1|NOT COMPLETED|Test Period 2; Test A*||0
322131|NCT01514136|770437|P8|COMPLETED|Test Period 2; Test A*||0
322132|NCT01514136|770438|P7|COMPLETED|Test Period 2; Test A*||0
322133|NCT01514136|770439|P6|COMPLETED|Test Period 2; Test A*||0
322134|NCT01514136|770440|P5|COMPLETED|Test Period 2; Test A*||26
322135|NCT01514136|770441|P4|COMPLETED|Test Period 2; Test A*||0
322136|NCT01514136|770442|P3|COMPLETED|Test Period 2; Test A*||0
322137|NCT01514136|770443|P2|COMPLETED|Test Period 2; Test A*||0
322138|NCT01514136|770444|P1|COMPLETED|Test Period 2; Test A*||0
322139|NCT01514136|770437|P8|STARTED|Test Period 2; Test A*||0
322140|NCT01514136|770438|P7|STARTED|Test Period 2; Test A*||0
322141|NCT01514136|770439|P6|STARTED|Test Period 2; Test A*||0
322142|NCT01514136|770440|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
322143|NCT01514136|770441|P4|STARTED|Test Period 2; Test A*||0
322144|NCT01514136|770442|P3|STARTED|Test Period 2; Test A*||0
322145|NCT01514136|770443|P2|STARTED|Test Period 2; Test A*||0
322146|NCT01514136|770444|P1|STARTED|Test Period 2; Test A*||0
322147|NCT01514136|770437|P8|NOT COMPLETED|Test Period 1; Test D||0
322148|NCT01514136|770438|P7|NOT COMPLETED|Test Period 1; Test D||0
322149|NCT01514136|770439|P6|NOT COMPLETED|Test Period 1; Test D||0
322150|NCT01514136|770440|P5|NOT COMPLETED|Test Period 1; Test D||0
322151|NCT01514136|770441|P4|NOT COMPLETED|Test Period 1; Test D||2
322152|NCT01514136|770442|P3|NOT COMPLETED|Test Period 1; Test D||0
322153|NCT01514136|770443|P2|NOT COMPLETED|Test Period 1; Test D||0
322154|NCT01514136|770444|P1|NOT COMPLETED|Test Period 1; Test D||0
322155|NCT01514136|770437|P8|COMPLETED|Test Period 1; Test D||0
322156|NCT01514136|770438|P7|COMPLETED|Test Period 1; Test D||0
322157|NCT01514136|770439|P6|COMPLETED|Test Period 1; Test D||0
322158|NCT01514136|770440|P5|COMPLETED|Test Period 1; Test D||0
322159|NCT01514136|770441|P4|COMPLETED|Test Period 1; Test D||24
322160|NCT01514136|770442|P3|COMPLETED|Test Period 1; Test D||0
322161|NCT01514136|770443|P2|COMPLETED|Test Period 1; Test D||0
322162|NCT01514136|770444|P1|COMPLETED|Test Period 1; Test D||0
322163|NCT01514136|770437|P8|STARTED|Test Period 1; Test D||0
322164|NCT01514136|770438|P7|STARTED|Test Period 1; Test D||0
322165|NCT01514136|770439|P6|STARTED|Test Period 1; Test D||0
322166|NCT01514136|770440|P5|STARTED|Test Period 1; Test D||0
322167|NCT01514136|770441|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
322168|NCT01514136|770442|P3|STARTED|Test Period 1; Test D||0
322169|NCT01514136|770443|P2|STARTED|Test Period 1; Test D||0
322170|NCT01514136|770444|P1|STARTED|Test Period 1; Test D||0
322171|NCT01514136|770437|P8|NOT COMPLETED|Test Period 1; Test C||0
322172|NCT01514136|770438|P7|NOT COMPLETED|Test Period 1; Test C||0
322173|NCT01514136|770439|P6|NOT COMPLETED|Test Period 1; Test C||0
322174|NCT01514136|770440|P5|NOT COMPLETED|Test Period 1; Test C||0
322175|NCT01514136|770441|P4|NOT COMPLETED|Test Period 1; Test C||0
322176|NCT01514136|770442|P3|NOT COMPLETED|Test Period 1; Test C||0
322177|NCT01514136|770443|P2|NOT COMPLETED|Test Period 1; Test C||0
322178|NCT01514136|770444|P1|NOT COMPLETED|Test Period 1; Test C||0
322179|NCT01514136|770437|P8|COMPLETED|Test Period 1; Test C||0
322180|NCT01514136|770438|P7|COMPLETED|Test Period 1; Test C||0
322181|NCT01514136|770439|P6|COMPLETED|Test Period 1; Test C||0
322182|NCT01514136|770440|P5|COMPLETED|Test Period 1; Test C||0
322183|NCT01514136|770441|P4|COMPLETED|Test Period 1; Test C||0
322184|NCT01514136|770442|P3|COMPLETED|Test Period 1; Test C||24
322185|NCT01514136|770443|P2|COMPLETED|Test Period 1; Test C||0
322186|NCT01514136|770444|P1|COMPLETED|Test Period 1; Test C||0
322187|NCT01514136|770437|P8|STARTED|Test Period 1; Test C||0
322188|NCT01514136|770438|P7|STARTED|Test Period 1; Test C||0
322189|NCT01514136|770439|P6|STARTED|Test Period 1; Test C||0
322190|NCT01514136|770440|P5|STARTED|Test Period 1; Test C||0
322191|NCT01514136|770441|P4|STARTED|Test Period 1; Test C||0
322192|NCT01514136|770442|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
322193|NCT01514136|770443|P2|STARTED|Test Period 1; Test C||0
322194|NCT01514136|770444|P1|STARTED|Test Period 1; Test C||0
322195|NCT01514136|770437|P8|NOT COMPLETED|Test Period 1; Test B||0
322196|NCT01514136|770438|P7|NOT COMPLETED|Test Period 1; Test B||0
322197|NCT01514136|770439|P6|NOT COMPLETED|Test Period 1; Test B||0
322198|NCT01514136|770440|P5|NOT COMPLETED|Test Period 1; Test B||0
322199|NCT01514136|770441|P4|NOT COMPLETED|Test Period 1; Test B||0
322200|NCT01514136|770442|P3|NOT COMPLETED|Test Period 1; Test B||0
322201|NCT01514136|770443|P2|NOT COMPLETED|Test Period 1; Test B||1
322202|NCT01514136|770444|P1|NOT COMPLETED|Test Period 1; Test B||0
322203|NCT01514136|770437|P8|COMPLETED|Test Period 1; Test B||0
322204|NCT01514136|770438|P7|COMPLETED|Test Period 1; Test B||0
322205|NCT01514136|770439|P6|COMPLETED|Test Period 1; Test B||0
322206|NCT01514136|770440|P5|COMPLETED|Test Period 1; Test B||0
322207|NCT01514136|770441|P4|COMPLETED|Test Period 1; Test B||0
322208|NCT01514136|770442|P3|COMPLETED|Test Period 1; Test B||0
322209|NCT01514136|770443|P2|COMPLETED|Test Period 1; Test B||23
322210|NCT01514136|770444|P1|COMPLETED|Test Period 1; Test B||0
322211|NCT01514136|770437|P8|STARTED|Test Period 1; Test B||0
322212|NCT01514136|770438|P7|STARTED|Test Period 1; Test B||0
322213|NCT01514136|770439|P6|STARTED|Test Period 1; Test B||0
322214|NCT01514136|770440|P5|STARTED|Test Period 1; Test B||0
322215|NCT01514136|770441|P4|STARTED|Test Period 1; Test B||0
322216|NCT01514136|770442|P3|STARTED|Test Period 1; Test B||0
322217|NCT01514136|770443|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
322218|NCT01514136|770444|P1|STARTED|Test Period 1; Test B||0
322219|NCT01514136|770437|P8|NOT COMPLETED|Test Period 1; Test A||0
322220|NCT01514136|770438|P7|NOT COMPLETED|Test Period 1; Test A||0
322221|NCT01514136|770439|P6|NOT COMPLETED|Test Period 1; Test A||0
322222|NCT01514136|770440|P5|NOT COMPLETED|Test Period 1; Test A||0
322223|NCT01514136|770441|P4|NOT COMPLETED|Test Period 1; Test A||0
322224|NCT01514136|770442|P3|NOT COMPLETED|Test Period 1; Test A||0
322225|NCT01514136|770443|P2|NOT COMPLETED|Test Period 1; Test A||0
322226|NCT01514136|770444|P1|NOT COMPLETED|Test Period 1; Test A||3
322227|NCT01514136|770437|P8|COMPLETED|Test Period 1; Test A||0
322228|NCT01514136|770438|P7|COMPLETED|Test Period 1; Test A||0
322229|NCT01514136|770439|P6|COMPLETED|Test Period 1; Test A||0
322230|NCT01514136|770440|P5|COMPLETED|Test Period 1; Test A||0
322231|NCT01514136|770441|P4|COMPLETED|Test Period 1; Test A||0
322232|NCT01514136|770442|P3|COMPLETED|Test Period 1; Test A||0
322233|NCT01514136|770443|P2|COMPLETED|Test Period 1; Test A||0
322234|NCT01514136|770444|P1|COMPLETED|Test Period 1; Test A||22
322235|NCT01514136|770437|P8|STARTED|Test Period 1; Test A||0
322236|NCT01514136|770438|P7|STARTED|Test Period 1; Test A||0
322237|NCT01514136|770439|P6|STARTED|Test Period 1; Test A||0
322238|NCT01514136|770440|P5|STARTED|Test Period 1; Test A||0
322239|NCT01514136|770441|P4|STARTED|Test Period 1; Test A||0
322240|NCT01514136|770442|P3|STARTED|Test Period 1; Test A||0
322241|NCT01514136|770443|P2|STARTED|Test Period 1; Test A||0
322242|NCT01514136|770444|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
322243|NCT01513902|770473|P3|NOT COMPLETED|Overall Study||0
322244|NCT01513902|770474|P2|NOT COMPLETED|Overall Study||0
322245|NCT01513902|770475|P1|NOT COMPLETED|Overall Study||0
322246|NCT01513902|770473|P3|COMPLETED|Overall Study||9
322247|NCT01513902|770474|P2|COMPLETED|Overall Study||9
322248|NCT01513902|770475|P1|COMPLETED|Overall Study||8
322249|NCT01513902|770473|P3|STARTED|Overall Study||9
322250|NCT01513902|770474|P2|STARTED|Overall Study||9
322251|NCT01513902|770475|P1|STARTED|Overall Study||8
322252|NCT01513590|770512|P2|NOT COMPLETED|Overall Study||13
322253|NCT01513590|770513|P1|NOT COMPLETED|Overall Study||10
322254|NCT01513590|770512|P2|COMPLETED|Overall Study||184
322255|NCT01513590|770513|P1|COMPLETED|Overall Study||187
322256|NCT01513590|770512|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
322257|NCT01513590|770513|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
322258|NCT01513590|770512|P2|STARTED|Overall Study||197
322259|NCT01513590|770513|P1|STARTED|Overall Study||197
322260|NCT01513473|770533|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
322261|NCT01513473|770534|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
322262|NCT01513473|770533|P2|COMPLETED|Extension Trial (26 Weeks)||122
322263|NCT01513473|770534|P1|COMPLETED|Extension Trial (26 Weeks)||151
322264|NCT01513473|770533|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
322265|NCT01513473|770534|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
322266|NCT01513473|770533|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
322267|NCT01513473|770534|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
322268|NCT01513473|770533|P2|COMPLETED|Main Trial (26 Weeks)||165
322269|NCT01513473|770534|P1|COMPLETED|Main Trial (26 Weeks)||170
322270|NCT01513473|770533|P2|Exposed|Main Trial (26 Weeks)||175
322271|NCT01513473|770534|P1|Exposed|Main Trial (26 Weeks)||174
322272|NCT01513473|770533|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
322273|NCT01513473|770534|P1|STARTED|Main Trial (26 Weeks)||174
322274|NCT01513460|770561|P3|NOT COMPLETED|Overall Study||56
322275|NCT01513460|770562|P2|NOT COMPLETED|Overall Study||32
322276|NCT01513460|770563|P1|NOT COMPLETED|Overall Study||29
322277|NCT01513460|770561|P3|COMPLETED|Overall Study||201
322278|NCT01513460|770562|P2|COMPLETED|Overall Study||226
322279|NCT01513460|770563|P1|COMPLETED|Overall Study||229
322280|NCT01513460|770561|P3|Per-protocol Set|Overall Study||166
322281|NCT01513460|770562|P2|Per-protocol Set|Overall Study||186
322282|NCT01513460|770563|P1|Per-protocol Set|Overall Study||196
322283|NCT01513460|770561|P3|Full Analysis Set|Overall Study||257
322284|NCT01513460|770562|P2|Full Analysis Set|Overall Study||258
322285|NCT01513460|770563|P1|Full Analysis Set|Overall Study||257
322286|NCT01513460|770561|P3|STARTED|Overall Study||257
322287|NCT01513460|770562|P2|STARTED|Overall Study||258
322288|NCT01513460|770563|P1|STARTED|Overall Study||258
322289|NCT01513447|770589|P2|NOT COMPLETED|Overall Study||0
322290|NCT01513447|770590|P1|NOT COMPLETED|Overall Study||0
322291|NCT01513447|770589|P2|COMPLETED|Overall Study||5
322292|NCT01513447|770590|P1|COMPLETED|Overall Study||3
322293|NCT01513447|770589|P2|STARTED|Overall Study||5
322294|NCT01513447|770590|P1|STARTED|Overall Study||3
322295|NCT01513330|770598|P2|NOT COMPLETED|Standard Care First,||4
322296|NCT01513330|770599|P1|NOT COMPLETED|Standard Care First,||4
322297|NCT01513330|770598|P2|COMPLETED|Standard Care First,||52
322298|NCT01513330|770599|P1|COMPLETED|Standard Care First,||56
322299|NCT01513330|770598|P2|STARTED|Standard Care First,||56
322300|NCT01513330|770599|P1|STARTED|Standard Care First,||60
322301|NCT01513330|770598|P2|NOT COMPLETED|SenSura Mio First,||2
322302|NCT01513330|770599|P1|NOT COMPLETED|SenSura Mio First,||4
322303|NCT01513330|770598|P2|COMPLETED|SenSura Mio First,||56
322304|NCT01513330|770599|P1|COMPLETED|SenSura Mio First,||60
322305|NCT01513330|770598|P2|STARTED|SenSura Mio First,||58
322306|NCT01513330|770599|P1|STARTED|SenSura Mio First,||64
322307|NCT01513317|770607|P2|NOT COMPLETED|Overall Study||24
322308|NCT01513317|770608|P1|NOT COMPLETED|Overall Study||34
322309|NCT01513317|770607|P2|COMPLETED|Overall Study||2
322310|NCT01513317|770608|P1|COMPLETED|Overall Study||16
322311|NCT01513317|770607|P2|STARTED|Overall Study||26
322312|NCT01513317|770608|P1|STARTED|Overall Study||50
322313|NCT01513291|770626|P5|NOT COMPLETED|Run-out Period||0
322314|NCT01513291|770627|P4|NOT COMPLETED|Run-out Period||2
322315|NCT01513291|770628|P3|NOT COMPLETED|Run-out Period||0
322316|NCT01513291|770629|P2|NOT COMPLETED|Run-out Period||0
322317|NCT01513291|770630|P1|NOT COMPLETED|Run-out Period||0
322318|NCT01513291|770626|P5|COMPLETED|Run-out Period||101
322319|NCT01513291|770627|P4|COMPLETED|Run-out Period||45
322320|NCT01513291|770628|P3|COMPLETED|Run-out Period||50
322321|NCT01513291|770629|P2|COMPLETED|Run-out Period||0
322322|NCT01513291|770630|P1|COMPLETED|Run-out Period||0
322323|NCT01513291|770626|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
322324|NCT01513291|770627|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
322325|NCT01513291|770628|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
322326|NCT01513291|770629|P2|STARTED|Run-out Period||0
322327|NCT01513291|770630|P1|STARTED|Run-out Period||0
322328|NCT01513291|770626|P5|NOT COMPLETED|Treatment Period||0
322329|NCT01513291|770627|P4|NOT COMPLETED|Treatment Period||0
322330|NCT01513291|770628|P3|NOT COMPLETED|Treatment Period||0
322331|NCT01513291|770629|P2|NOT COMPLETED|Treatment Period||16
322332|NCT01513291|770630|P1|NOT COMPLETED|Treatment Period||23
322333|NCT01513291|770626|P5|COMPLETED|Treatment Period||0
322334|NCT01513291|770627|P4|COMPLETED|Treatment Period||0
322335|NCT01513291|770628|P3|COMPLETED|Treatment Period||0
322336|NCT01513291|770629|P2|COMPLETED|Treatment Period||101
322337|NCT01513291|770630|P1|COMPLETED|Treatment Period||97
322338|NCT01513291|770626|P5|Treated|Treatment Period||0
322339|NCT01513291|770627|P4|Treated|Treatment Period||0
322340|NCT01513291|770628|P3|Treated|Treatment Period||0
322341|NCT01513291|770629|P2|Treated|Treatment Period||115
322342|NCT01513291|770630|P1|Treated|Treatment Period||120
322343|NCT01513291|770626|P5|STARTED|Treatment Period||0
322344|NCT01513291|770627|P4|STARTED|Treatment Period||0
322345|NCT01513291|770628|P3|STARTED|Treatment Period||0
322346|NCT01513291|770629|P2|STARTED|Treatment Period||117
322347|NCT01513291|770630|P1|STARTED|Treatment Period||120
322348|NCT01513239|770658|P3|NOT COMPLETED|Overall Study||88
322349|NCT01513239|770659|P2|NOT COMPLETED|Overall Study||70
322350|NCT01513239|770660|P1|NOT COMPLETED|Overall Study||75
322351|NCT01513239|770658|P3|COMPLETED|Overall Study||311
322352|NCT01513239|770659|P2|COMPLETED|Overall Study||337
322353|NCT01513239|770660|P1|COMPLETED|Overall Study||322
322354|NCT01513239|770658|P3|All Participants as Treated|Overall Study|Treatment actually received|381
322355|NCT01513239|770659|P2|All Participants as Treated|Overall Study|Treatment actually received|396
322356|NCT01513239|770660|P1|All Participants as Treated|Overall Study|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
322357|NCT01513239|770658|P3|Treated|Overall Study|Treated participants|381
322358|NCT01513239|770659|P2|Treated|Overall Study|Treated participants|396
322359|NCT01513239|770660|P1|Treated|Overall Study|Treated participants|391
322360|NCT01513239|770658|P3|STARTED|Overall Study|Randomized participants|399
322361|NCT01513239|770659|P2|STARTED|Overall Study|Randomized participants|407
322362|NCT01513239|770660|P1|STARTED|Overall Study|Randomized participants|397
322363|NCT01513148|770710|P2|NOT COMPLETED|Overall Study||2
322364|NCT01513148|770711|P1|NOT COMPLETED|Overall Study||2
322365|NCT01513148|770710|P2|COMPLETED|Overall Study||14
322366|NCT01513148|770711|P1|COMPLETED|Overall Study||14
322367|NCT01513148|770710|P2|STARTED|Overall Study||16
322368|NCT01513148|770711|P1|STARTED|Overall Study||16
322369|NCT01513122|770759|P2|NOT COMPLETED|Overall Study||3
322370|NCT01513122|770760|P1|NOT COMPLETED|Overall Study||11
322371|NCT01513122|770759|P2|COMPLETED|Overall Study||105
322372|NCT01513122|770760|P1|COMPLETED|Overall Study||91
322373|NCT01513122|770759|P2|STARTED|Overall Study||108
322374|NCT01513122|770760|P1|STARTED|Overall Study||102
322375|NCT01512979|770778|P2|NOT COMPLETED|Overall Study||22
322376|NCT01512979|770779|P1|NOT COMPLETED|Overall Study||19
322377|NCT01512979|770778|P2|COMPLETED|Overall Study||135
322378|NCT01512979|770779|P1|COMPLETED|Overall Study||140
322379|NCT01512979|770778|P2|STARTED|Overall Study|Randomised and treated|157
322380|NCT01512979|770779|P1|STARTED|Overall Study|Randomised and treated|159
322381|NCT01512849|770799|P4|NOT COMPLETED|Crossover Period 2||0
322382|NCT01512849|770800|P3|NOT COMPLETED|Crossover Period 2||0
322383|NCT01512849|770801|P2|NOT COMPLETED|Crossover Period 2||0
322384|NCT01512849|770802|P1|NOT COMPLETED|Crossover Period 2||0
322385|NCT01512849|770799|P4|COMPLETED|Crossover Period 2||6
322386|NCT01512849|770800|P3|COMPLETED|Crossover Period 2||6
322387|NCT01512849|770801|P2|COMPLETED|Crossover Period 2||6
322388|NCT01512849|770802|P1|COMPLETED|Crossover Period 2||6
322389|NCT01512849|770799|P4|STARTED|Crossover Period 2||6
322390|NCT01512849|770800|P3|STARTED|Crossover Period 2||6
322391|NCT01512849|770801|P2|STARTED|Crossover Period 2||6
322392|NCT01512849|770802|P1|STARTED|Crossover Period 2||6
322393|NCT01512849|770799|P4|NOT COMPLETED|Crossover Period 1||0
322394|NCT01512849|770800|P3|NOT COMPLETED|Crossover Period 1||0
322395|NCT01512849|770801|P2|NOT COMPLETED|Crossover Period 1||0
322396|NCT01512849|770802|P1|NOT COMPLETED|Crossover Period 1||0
322397|NCT01512849|770799|P4|COMPLETED|Crossover Period 1||6
322398|NCT01512849|770800|P3|COMPLETED|Crossover Period 1||6
322399|NCT01512849|770801|P2|COMPLETED|Crossover Period 1||6
322400|NCT01512849|770802|P1|COMPLETED|Crossover Period 1||6
322401|NCT01512849|770799|P4|STARTED|Crossover Period 1||6
322402|NCT01512849|770800|P3|STARTED|Crossover Period 1||6
322403|NCT01512849|770801|P2|STARTED|Crossover Period 1||6
322404|NCT01512849|770802|P1|STARTED|Crossover Period 1||6
322405|NCT01512745|770826|P2|NOT COMPLETED|Overall Study||20
322406|NCT01512745|770827|P1|NOT COMPLETED|Overall Study||40
322407|NCT01512745|770826|P2|COMPLETED|Overall Study||71
322408|NCT01512745|770827|P1|COMPLETED|Overall Study||136
322409|NCT01512745|770826|P2|STARTED|Overall Study||91
322410|NCT01512745|770827|P1|STARTED|Overall Study||176
322411|NCT01512368|770841|P1|NOT COMPLETED|Overall Study||3
322412|NCT01512368|770841|P1|COMPLETED|Overall Study||60
322413|NCT01512368|770841|P1|STARTED|Overall Study||63
322414|NCT01512225|770852|P2|NOT COMPLETED|Overall Study||0
322415|NCT01512225|770853|P1|NOT COMPLETED|Overall Study||0
322416|NCT01512225|770852|P2|COMPLETED|Overall Study||45
322417|NCT01512225|770853|P1|COMPLETED|Overall Study||45
322418|NCT01512225|770852|P2|Provided Day 14 Volume|Overall Study||40
322419|NCT01512225|770853|P1|Provided Day 14 Volume|Overall Study||45
322420|NCT01512225|770852|P2|STARTED|Overall Study||45
322421|NCT01512225|770853|P1|STARTED|Overall Study||45
322422|NCT01512160|770877|P4|NOT COMPLETED|Overall Study||1
322423|NCT01512160|770878|P3|NOT COMPLETED|Overall Study||0
322424|NCT01512160|770879|P2|NOT COMPLETED|Overall Study||0
322425|NCT01512160|770880|P1|NOT COMPLETED|Overall Study||2
322426|NCT01512160|770877|P4|COMPLETED|Overall Study||22
322427|NCT01512160|770878|P3|COMPLETED|Overall Study||22
322428|NCT01512160|770879|P2|COMPLETED|Overall Study||23
322429|NCT01512160|770880|P1|COMPLETED|Overall Study||20
322430|NCT01512160|770877|P4|STARTED|Overall Study||23
322431|NCT01512160|770878|P3|STARTED|Overall Study||22
322432|NCT01512160|770879|P2|STARTED|Overall Study||23
322433|NCT01512160|770880|P1|STARTED|Overall Study||22
322434|NCT01512108|770972|P2|NOT COMPLETED|Overall Study||9
322435|NCT01512108|770973|P1|NOT COMPLETED|Overall Study||22
322436|NCT01512108|770972|P2|COMPLETED|Overall Study||111
322437|NCT01512108|770973|P1|COMPLETED|Overall Study||221
322438|NCT01512108|770972|P2|Exposed|Overall Study||120
322439|NCT01512108|770973|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
322440|NCT01512108|770972|P2|STARTED|Overall Study||120
322441|NCT01512108|770973|P1|STARTED|Overall Study||243
322442|NCT01511939|770988|P3|NOT COMPLETED|Overall Study||0
322443|NCT01511939|770989|P2|NOT COMPLETED|Overall Study||1
322444|NCT01511939|770990|P1|NOT COMPLETED|Overall Study||2
322445|NCT01511939|770988|P3|COMPLETED|Overall Study||8
322446|NCT01511939|770989|P2|COMPLETED|Overall Study||4
322447|NCT01511939|770990|P1|COMPLETED|Overall Study||7
322448|NCT01511939|770988|P3|STARTED|Overall Study||8
322449|NCT01511939|770989|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
322450|NCT01511939|770990|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
322451|NCT01511809|771009|P2|NOT COMPLETED|Overall Study||7
322452|NCT01511809|771010|P1|NOT COMPLETED|Overall Study||7
322453|NCT01511809|771009|P2|COMPLETED|Overall Study||52
322454|NCT01511809|771010|P1|COMPLETED|Overall Study||51
322455|NCT01511809|771009|P2|STARTED|Overall Study||59
322456|NCT01511809|771010|P1|STARTED|Overall Study||58
322457|NCT01511536|771019|P3|NOT COMPLETED|Phase 2||9
322458|NCT01511536|771020|P2|NOT COMPLETED|Phase 2||0
322459|NCT01511536|771021|P1|NOT COMPLETED|Phase 2||0
322460|NCT01511536|771019|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
322461|NCT01511536|771020|P2|COMPLETED|Phase 2||0
322462|NCT01511536|771021|P1|COMPLETED|Phase 2||0
322463|NCT01511536|771019|P3|STARTED|Phase 2||27
322464|NCT01511536|771020|P2|STARTED|Phase 2||0
322465|NCT01511536|771021|P1|STARTED|Phase 2||0
322466|NCT01511536|771019|P3|NOT COMPLETED|Phase 1||0
322467|NCT01511536|771020|P2|NOT COMPLETED|Phase 1||1
322468|NCT01511536|771021|P1|NOT COMPLETED|Phase 1||0
322469|NCT01511536|771019|P3|COMPLETED|Phase 1||0
322470|NCT01511536|771020|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
322471|NCT01511536|771021|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
322472|NCT01511536|771019|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
322473|NCT01511536|771020|P2|STARTED|Phase 1||7
322474|NCT01511536|771021|P1|STARTED|Phase 1||3
322475|NCT01511445|771043|P2|NOT COMPLETED|Overall Study||4
322476|NCT01511445|771044|P1|NOT COMPLETED|Overall Study||5
322477|NCT01511445|771043|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
322478|NCT01511445|771044|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
322479|NCT01511445|771043|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
322480|NCT01511445|771044|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
322481|NCT01511445|771043|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
322482|NCT01511445|771044|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
322483|NCT01511445|771043|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
322484|NCT01511445|771044|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
322485|NCT01511445|771043|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
322486|NCT01511445|771044|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
322487|NCT01511315|771052|P1|NOT COMPLETED|Overall Study||4
322488|NCT01511315|771052|P1|COMPLETED|Overall Study||32
322489|NCT01511315|771052|P1|STARTED|Overall Study||36
322490|NCT01511107|771064|P2|NOT COMPLETED|Overall Study||41
322491|NCT01511107|771065|P1|NOT COMPLETED|Overall Study||22
322492|NCT01511107|771064|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
322493|NCT01511107|771065|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
322494|NCT01511107|771064|P2|STARTED|Overall Study|Randomized to the treatment group.|260
322495|NCT01511107|771065|P1|STARTED|Overall Study|Randomized to the treatment group.|260
322496|NCT01511016|771115|P2|NOT COMPLETED|Overall Study||2
322497|NCT01511016|771116|P1|NOT COMPLETED|Overall Study||2
322498|NCT01511016|771115|P2|COMPLETED|Overall Study||7
322499|NCT01511016|771116|P1|COMPLETED|Overall Study||6
322500|NCT01511016|771115|P2|STARTED|Overall Study||9
322501|NCT01511016|771116|P1|STARTED|Overall Study||8
322502|NCT01510912|771132|P1|NOT COMPLETED|Overall Study||242
322503|NCT01510912|771132|P1|COMPLETED|Overall Study||360
322504|NCT01510912|771132|P1|STARTED|Overall Study||602
322505|NCT01510834|771138|P1|NOT COMPLETED|Overall Study||33
322506|NCT01510834|771138|P1|COMPLETED|Overall Study||57
322507|NCT01510834|771138|P1|STARTED|Overall Study||90
322508|NCT01510769|771148|P3|NOT COMPLETED|Overall Study||22
322509|NCT01510769|771149|P2|NOT COMPLETED|Overall Study||25
322510|NCT01510769|771150|P1|NOT COMPLETED|Overall Study||27
322511|NCT01510769|771148|P3|COMPLETED|Overall Study||87
322512|NCT01510769|771149|P2|COMPLETED|Overall Study||84
322513|NCT01510769|771150|P1|COMPLETED|Overall Study||79
322514|NCT01510769|771148|P3|STARTED|Overall Study||109
322515|NCT01510769|771149|P2|STARTED|Overall Study||109
322516|NCT01510769|771150|P1|STARTED|Overall Study||106
322517|NCT01510756|771167|P1|NOT COMPLETED|Overall Study||4
322518|NCT01510756|771167|P1|COMPLETED|Overall Study||0
322519|NCT01510756|771167|P1|STARTED|Overall Study||4
322520|NCT01510717|771175|P2|NOT COMPLETED|Overall Study||5
322521|NCT01510717|771176|P1|NOT COMPLETED|Overall Study||2
322522|NCT01510717|771175|P2|COMPLETED|Overall Study||160
322523|NCT01510717|771176|P1|COMPLETED|Overall Study||153
322524|NCT01510717|771175|P2|STARTED|Overall Study||165
322525|NCT01510717|771176|P1|STARTED|Overall Study||155
322526|NCT01510704|771204|P4|NOT COMPLETED|Overall Study||0
322527|NCT01510704|771205|P3|NOT COMPLETED|Overall Study||0
322528|NCT01510704|771206|P2|NOT COMPLETED|Overall Study||0
322529|NCT01510704|771207|P1|NOT COMPLETED|Overall Study||0
322530|NCT01510704|771204|P4|COMPLETED|Overall Study||53
322531|NCT01510704|771205|P3|COMPLETED|Overall Study||50
322532|NCT01510704|771206|P2|COMPLETED|Overall Study||58
322533|NCT01510704|771207|P1|COMPLETED|Overall Study||54
322534|NCT01510704|771204|P4|STARTED|Overall Study||53
322535|NCT01510704|771205|P3|STARTED|Overall Study||50
322536|NCT01510704|771206|P2|STARTED|Overall Study||58
322537|NCT01510704|771207|P1|STARTED|Overall Study||54
322538|NCT01510652|771219|P2|NOT COMPLETED|Overall Study||67
322539|NCT01510652|771220|P1|NOT COMPLETED|Overall Study||92
322540|NCT01510652|771219|P2|COMPLETED|Overall Study||288
322541|NCT01510652|771220|P1|COMPLETED|Overall Study||627
322542|NCT01510652|771219|P2|Baseline|Overall Study||348
322543|NCT01510652|771220|P1|Baseline|Overall Study||718
322544|NCT01510652|771219|P2|STARTED|Overall Study||355
322545|NCT01510652|771220|P1|STARTED|Overall Study||719
322546|NCT01510457|771232|P2|NOT COMPLETED|Overall Study||3
322547|NCT01510457|771233|P1|NOT COMPLETED|Overall Study||5
322548|NCT01510457|771232|P2|COMPLETED|Overall Study||26
322549|NCT01510457|771233|P1|COMPLETED|Overall Study||12
322550|NCT01510457|771232|P2|STARTED|Overall Study||29
322551|NCT01510457|771233|P1|STARTED|Overall Study||17
322552|NCT01510379|771253|P2|NOT COMPLETED|Overall Study||0
322553|NCT01510379|771254|P1|NOT COMPLETED|Overall Study||0
322554|NCT01510379|771253|P2|COMPLETED|Overall Study||51
322555|NCT01510379|771254|P1|COMPLETED|Overall Study||49
322556|NCT01510379|771253|P2|STARTED|Overall Study||51
322557|NCT01510379|771254|P1|STARTED|Overall Study||49
322558|NCT01510327|771262|P1|NOT COMPLETED|Overall Study||0
322559|NCT01510327|771262|P1|COMPLETED|Overall Study||22
322560|NCT01510327|771262|P1|STARTED|Overall Study||22
322561|NCT01510158|771296|P3|NOT COMPLETED|Overall Study||50
322562|NCT01510158|771297|P2|NOT COMPLETED|Overall Study||53
322563|NCT01510158|771298|P1|NOT COMPLETED|Overall Study||51
322564|NCT01510158|771296|P3|COMPLETED|Overall Study||152
322565|NCT01510158|771297|P2|COMPLETED|Overall Study||150
322566|NCT01510158|771298|P1|COMPLETED|Overall Study||151
322567|NCT01510158|771296|P3|STARTED|Overall Study||202
322568|NCT01510158|771297|P2|STARTED|Overall Study||203
322569|NCT01510158|771298|P1|STARTED|Overall Study||202
322570|NCT01510145|771312|P1|NOT COMPLETED|Overall Study||18
322571|NCT01510145|771312|P1|COMPLETED|Overall Study||173
322572|NCT01510145|771312|P1|STARTED|Overall Study||191
322573|NCT01509807|771319|P2|NOT COMPLETED|Overall Study||1
322574|NCT01509807|771320|P1|NOT COMPLETED|Overall Study||1
322575|NCT01509807|771319|P2|COMPLETED|Overall Study||16
322576|NCT01509807|771320|P1|COMPLETED|Overall Study||15
322577|NCT01509807|771319|P2|STARTED|Overall Study||17
322578|NCT01509807|771320|P1|STARTED|Overall Study||16
322579|NCT01509664|771346|P2|NOT COMPLETED|Overall Study||21
322580|NCT01509664|771347|P1|NOT COMPLETED|Overall Study||15
322581|NCT01509664|771346|P2|COMPLETED|Overall Study||28
322582|NCT01509664|771347|P1|COMPLETED|Overall Study||34
322583|NCT01509664|771346|P2|T3 Follow-up|Overall Study||33
322584|NCT01509664|771347|P1|T3 Follow-up|Overall Study||40
322585|NCT01509664|771346|P2|T2 Follow-up|Overall Study||38
322586|NCT01509664|771347|P1|T2 Follow-up|Overall Study||45
322587|NCT01509664|771346|P2|STARTED|Overall Study||49
322588|NCT01509664|771347|P1|STARTED|Overall Study||49
322589|NCT01509638|771355|P2|NOT COMPLETED|Overall Study||2
322590|NCT01509638|771356|P1|NOT COMPLETED|Overall Study||3
322591|NCT01509638|771355|P2|COMPLETED|Overall Study||24
322592|NCT01509638|771356|P1|COMPLETED|Overall Study||20
322593|NCT01509638|771355|P2|STARTED|Overall Study||26
322594|NCT01509638|771356|P1|STARTED|Overall Study||23
322595|NCT01509625|771380|P1|NOT COMPLETED|Overall Study||9
322596|NCT01509625|771380|P1|COMPLETED|Overall Study||263
322597|NCT01509625|771380|P1|STARTED|Overall Study||272
322598|NCT01509586|771398|P2|NOT COMPLETED|Overall Study||0
322599|NCT01509586|771399|P1|NOT COMPLETED|Overall Study||0
322600|NCT01509586|771398|P2|COMPLETED|Overall Study|final intent to treat sample|610
322601|NCT01509586|771399|P1|COMPLETED|Overall Study|final intent to treat sample|626
322602|NCT01509586|771398|P2|Week 58 (Month 12)|Overall Study||499
322603|NCT01509586|771399|P1|Week 58 (Month 12)|Overall Study||492
322604|NCT01509586|771398|P2|Week 46|Overall Study||494
322605|NCT01509586|771399|P1|Week 46|Overall Study||483
322606|NCT01509586|771398|P2|Week 32 (Month 6)|Overall Study||523
322607|NCT01509586|771399|P1|Week 32 (Month 6)|Overall Study||504
322608|NCT01509586|771398|P2|Week18|Overall Study||555
322609|NCT01509586|771399|P1|Week18|Overall Study||529
322610|NCT01509586|771398|P2|Week 14|Overall Study||566
322611|NCT01509586|771399|P1|Week 14|Overall Study||528
322612|NCT01509586|771398|P2|Week 10|Overall Study||574
322613|NCT01509586|771399|P1|Week 10|Overall Study||537
322614|NCT01509586|771398|P2|Week 6|Overall Study||585
322615|NCT01509586|771399|P1|Week 6|Overall Study||551
322616|NCT01509586|771398|P2|Week 3|Overall Study||585
322617|NCT01509586|771399|P1|Week 3|Overall Study||574
322618|NCT01509586|771398|P2|STARTED|Overall Study|Week 0|610
322619|NCT01509586|771399|P1|STARTED|Overall Study|Week 0|626
322620|NCT01509105|771405|P1|NOT COMPLETED|Overall Study||0
322621|NCT01509105|771405|P1|COMPLETED|Overall Study||649
322622|NCT01509105|771405|P1|STARTED|Overall Study||649
322623|NCT01509079|771422|P2|NOT COMPLETED|Overall Study||3
322624|NCT01509079|771423|P1|NOT COMPLETED|Overall Study||0
322625|NCT01509079|771422|P2|COMPLETED|Overall Study||56
322626|NCT01509079|771423|P1|COMPLETED|Overall Study||57
322627|NCT01509079|771422|P2|STARTED|Overall Study||59
322628|NCT01509079|771423|P1|STARTED|Overall Study||57
322629|NCT01509053|771439|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
322630|NCT01509053|771439|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
322631|NCT01509053|771439|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
322632|NCT01509053|771439|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
322633|NCT01509053|771439|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
322634|NCT01509053|771439|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
322635|NCT01509053|771439|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
322636|NCT01509053|771439|P1|COMPLETED|Oral Aripirazole (Phase A)||8
322637|NCT01509053|771439|P1|STARTED|Oral Aripirazole (Phase A)||19
322638|NCT01509040|771453|P3|NOT COMPLETED|Overall Study||0
322639|NCT01509040|771454|P2|NOT COMPLETED|Overall Study||1
322640|NCT01509040|771455|P1|NOT COMPLETED|Overall Study||0
322641|NCT01509040|771453|P3|COMPLETED|Overall Study||0
322642|NCT01509040|771454|P2|COMPLETED|Overall Study||1
322643|NCT01509040|771455|P1|COMPLETED|Overall Study||0
322644|NCT01509040|771453|P3|STARTED|Overall Study||0
322645|NCT01509040|771454|P2|STARTED|Overall Study||2
322646|NCT01509040|771455|P1|STARTED|Overall Study||0
322647|NCT01508936|771501|P2|NOT COMPLETED|Overall Study||79
322648|NCT01508936|771502|P1|NOT COMPLETED|Overall Study||23
322649|NCT01508936|771501|P2|COMPLETED|Overall Study||330
322650|NCT01508936|771502|P1|COMPLETED|Overall Study||79
322651|NCT01508936|771501|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
322652|NCT01508936|771502|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
322653|NCT01508936|771501|P2|Full Analysis Set|Overall Study||395
322654|NCT01508936|771502|P1|Full Analysis Set|Overall Study||97
322655|NCT01508936|771501|P2|Safety Analysis Set|Overall Study||395
322656|NCT01508936|771502|P1|Safety Analysis Set|Overall Study||97
322657|NCT01508936|771501|P2|Randomized, Not Treated|Overall Study||3
322658|NCT01508936|771502|P1|Randomized, Not Treated|Overall Study||1
322659|NCT01508936|771501|P2|Randomized|Overall Study||398
322660|NCT01508936|771502|P1|Randomized|Overall Study||98
322661|NCT01508936|771501|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
322662|NCT01508936|771502|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
322663|NCT01508936|771501|P2|STARTED|Overall Study||409
322664|NCT01508936|771502|P1|STARTED|Overall Study||102
322665|NCT01508910|771541|P4|NOT COMPLETED|Treatment||3
322666|NCT01508910|771542|P3|NOT COMPLETED|Treatment||10
322667|NCT01508910|771543|P2|NOT COMPLETED|Treatment||4
322668|NCT01508910|771544|P1|NOT COMPLETED|Treatment||2
322669|NCT01508910|771541|P4|COMPLETED|Treatment||3
322670|NCT01508910|771542|P3|COMPLETED|Treatment||18
322671|NCT01508910|771543|P2|COMPLETED|Treatment||24
322672|NCT01508910|771544|P1|COMPLETED|Treatment||48
322673|NCT01508910|771541|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
322674|NCT01508910|771542|P3|STARTED|Treatment||28
322675|NCT01508910|771543|P2|STARTED|Treatment||28
322676|NCT01508910|771544|P1|STARTED|Treatment||50
322677|NCT01508910|771541|P4|NOT COMPLETED|Randomization||0
322678|NCT01508910|771542|P3|NOT COMPLETED|Randomization||0
322679|NCT01508910|771543|P2|NOT COMPLETED|Randomization||0
322680|NCT01508910|771544|P1|NOT COMPLETED|Randomization||0
322681|NCT01508910|771541|P4|COMPLETED|Randomization||0
322682|NCT01508910|771542|P3|COMPLETED|Randomization||28
322683|NCT01508910|771543|P2|COMPLETED|Randomization||27
322684|NCT01508910|771544|P1|COMPLETED|Randomization||57
322685|NCT01508910|771541|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
322686|NCT01508910|771542|P3|STARTED|Randomization||28
322687|NCT01508910|771543|P2|STARTED|Randomization||27
322688|NCT01508910|771544|P1|STARTED|Randomization||57
322689|NCT01508832|771568|P2|NOT COMPLETED|Overall Study||0
322690|NCT01508832|771569|P1|NOT COMPLETED|Overall Study||0
322691|NCT01508832|771568|P2|COMPLETED|Overall Study||6
322692|NCT01508832|771569|P1|COMPLETED|Overall Study||6
322693|NCT01508832|771568|P2|STARTED|Overall Study||6
322694|NCT01508832|771569|P1|STARTED|Overall Study||6
322695|NCT01508702|771577|P2|NOT COMPLETED|Overall Study||13
322696|NCT01508702|771578|P1|NOT COMPLETED|Overall Study||23
322697|NCT01508702|771577|P2|COMPLETED|Overall Study||94
322698|NCT01508702|771578|P1|COMPLETED|Overall Study||84
322699|NCT01508702|771577|P2|STARTED|Overall Study||107
322700|NCT01508702|771578|P1|STARTED|Overall Study||107
322701|NCT01508676|771586|P2|NOT COMPLETED|Phase II (2 Weeks)||1
322702|NCT01508676|771587|P1|NOT COMPLETED|Phase II (2 Weeks)||1
322703|NCT01508676|771586|P2|COMPLETED|Phase II (2 Weeks)||13
322704|NCT01508676|771587|P1|COMPLETED|Phase II (2 Weeks)||15
322705|NCT01508676|771586|P2|STARTED|Phase II (2 Weeks)||14
322706|NCT01508676|771587|P1|STARTED|Phase II (2 Weeks)||16
322707|NCT01508676|771586|P2|NOT COMPLETED|Washout Period (1 Week)||0
322708|NCT01508676|771587|P1|NOT COMPLETED|Washout Period (1 Week)||0
322709|NCT01508676|771586|P2|COMPLETED|Washout Period (1 Week)||14
322710|NCT01508676|771587|P1|COMPLETED|Washout Period (1 Week)||16
322711|NCT01508676|771586|P2|STARTED|Washout Period (1 Week)||14
322712|NCT01508676|771587|P1|STARTED|Washout Period (1 Week)||16
322713|NCT01508676|771586|P2|NOT COMPLETED|Phase I (2 Weeks)||3
322714|NCT01508676|771587|P1|NOT COMPLETED|Phase I (2 Weeks)||2
322715|NCT01508676|771586|P2|COMPLETED|Phase I (2 Weeks)||14
322716|NCT01508676|771587|P1|COMPLETED|Phase I (2 Weeks)||16
322717|NCT01508676|771586|P2|STARTED|Phase I (2 Weeks)||17
322718|NCT01508676|771587|P1|STARTED|Phase I (2 Weeks)||18
322719|NCT01508455|771597|P1|NOT COMPLETED|Overall Study||0
322720|NCT01508455|771597|P1|COMPLETED|Overall Study||6
322721|NCT01508455|771597|P1|STARTED|Overall Study||6
322722|NCT01508325|771608|P2|NOT COMPLETED|Overall Study||21
322723|NCT01508325|771609|P1|NOT COMPLETED|Overall Study||18
322724|NCT01508325|771608|P2|COMPLETED|Overall Study||72
322725|NCT01508325|771609|P1|COMPLETED|Overall Study||75
322726|NCT01508325|771608|P2|STARTED|Overall Study||93
322727|NCT01508325|771609|P1|STARTED|Overall Study||93
322728|NCT01508169|771639|P2|NOT COMPLETED|Overall Study||2
322729|NCT01508169|771640|P1|NOT COMPLETED|Overall Study||3
322730|NCT01508169|771639|P2|COMPLETED|Overall Study||45
322731|NCT01508169|771640|P1|COMPLETED|Overall Study||44
322732|NCT01508169|771639|P2|STARTED|Overall Study||47
322733|NCT01508169|771640|P1|STARTED|Overall Study||47
322734|NCT01508130|771654|P2|NOT COMPLETED|Overall Study||69
322735|NCT01508130|771655|P1|NOT COMPLETED|Overall Study||227
322736|NCT01508130|771654|P2|COMPLETED|Overall Study||73
322737|NCT01508130|771655|P1|COMPLETED|Overall Study||266
322738|NCT01508130|771654|P2|mTRT|Overall Study||142
322739|NCT01508130|771655|P1|mTRT|Overall Study||493
322740|NCT01508130|771654|P2|STARTED|Overall Study||142
322741|NCT01508130|771655|P1|STARTED|Overall Study||493
322742|NCT01508052|771699|P2|NOT COMPLETED|Overall Study||0
322743|NCT01508052|771700|P1|NOT COMPLETED|Overall Study||0
322744|NCT01508052|771699|P2|COMPLETED|Overall Study||20
322745|NCT01508052|771700|P1|COMPLETED|Overall Study||20
322746|NCT01508052|771699|P2|STARTED|Overall Study||20
322747|NCT01508052|771700|P1|STARTED|Overall Study||20
322748|NCT01508013|771708|P2|NOT COMPLETED|Overall Study||23
322749|NCT01508013|771709|P1|NOT COMPLETED|Overall Study||32
322750|NCT01508013|771708|P2|COMPLETED|Overall Study||206
322751|NCT01508013|771709|P1|COMPLETED|Overall Study||182
322752|NCT01508013|771708|P2|STARTED|Overall Study||229
322753|NCT01508013|771709|P1|STARTED|Overall Study||214
322754|NCT01507896|771719|P1|NOT COMPLETED|Overall Study||2
322755|NCT01507896|771719|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
322756|NCT01507896|771719|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
322757|NCT01507831|771762|P2|NOT COMPLETED|Overall Study||440
322758|NCT01507831|771763|P1|NOT COMPLETED|Overall Study||193
322759|NCT01507831|771762|P2|COMPLETED|Overall Study||1113
322760|NCT01507831|771763|P1|COMPLETED|Overall Study||595
322761|NCT01507831|771762|P2|Treated|Overall Study||1550
322762|NCT01507831|771763|P1|Treated|Overall Study||788
322763|NCT01507831|771762|P2|STARTED|Overall Study|Randomized|1553
322764|NCT01507831|771763|P1|STARTED|Overall Study|Randomized|788
322765|NCT01507662|771833|P2|NOT COMPLETED|Overall Study||831
322766|NCT01507662|771834|P1|NOT COMPLETED|Overall Study||816
322767|NCT01507662|771833|P2|COMPLETED|Overall Study||3020
322768|NCT01507662|771834|P1|COMPLETED|Overall Study||3082
322769|NCT01507662|771833|P2|STARTED|Overall Study||3851
322770|NCT01507662|771834|P1|STARTED|Overall Study||3898
322771|NCT01507493|771842|P2|NOT COMPLETED|Overall Study||0
322772|NCT01507493|771843|P1|NOT COMPLETED|Overall Study||0
322773|NCT01507493|771842|P2|COMPLETED|Overall Study||178
322774|NCT01507493|771843|P1|COMPLETED|Overall Study||22
322775|NCT01507493|771842|P2|STARTED|Overall Study||178
322776|NCT01507493|771843|P1|STARTED|Overall Study||22
322777|NCT01507246|771859|P2|NOT COMPLETED|Overall Study||1
322778|NCT01507246|771860|P1|NOT COMPLETED|Overall Study||2
322779|NCT01507246|771859|P2|COMPLETED|Overall Study||21
322780|NCT01507246|771860|P1|COMPLETED|Overall Study||18
322781|NCT01507246|771859|P2|STARTED|Overall Study||22
322782|NCT01507246|771860|P1|STARTED|Overall Study||20
322783|NCT01507233|771874|P2|NOT COMPLETED|Overall Study||0
322784|NCT01507233|771875|P1|NOT COMPLETED|Overall Study||0
322785|NCT01507233|771874|P2|COMPLETED|Overall Study||0
322786|NCT01507233|771875|P1|COMPLETED|Overall Study||5
322787|NCT01507233|771874|P2|STARTED|Overall Study||0
322788|NCT01507233|771875|P1|STARTED|Overall Study||5
322789|NCT01507220|771887|P2|NOT COMPLETED|Overall Study||0
322790|NCT01507220|771888|P1|NOT COMPLETED|Overall Study||0
322791|NCT01507220|771887|P2|COMPLETED|Overall Study||0
322792|NCT01507220|771888|P1|COMPLETED|Overall Study||2
322793|NCT01507220|771887|P2|STARTED|Overall Study||0
322794|NCT01507220|771888|P1|STARTED|Overall Study||2
322795|NCT01507181|771902|P2|NOT COMPLETED|Overall Study||0
322796|NCT01507181|771903|P1|NOT COMPLETED|Overall Study||0
322797|NCT01507181|771902|P2|COMPLETED|Overall Study||12
322798|NCT01507181|771903|P1|COMPLETED|Overall Study||12
322799|NCT01507181|771902|P2|STARTED|Overall Study||12
322800|NCT01507181|771903|P1|STARTED|Overall Study||12
322801|NCT01507155|771923|P2|NOT COMPLETED|Overall Study||0
322802|NCT01507155|771924|P1|NOT COMPLETED|Overall Study||0
322803|NCT01507155|771923|P2|COMPLETED|Overall Study||60
322804|NCT01507155|771924|P1|COMPLETED|Overall Study||625
322805|NCT01507155|771923|P2|STARTED|Overall Study||60
322806|NCT01507155|771924|P1|STARTED|Overall Study||625
322807|NCT01507103|771933|P3|NOT COMPLETED|Overall Study||0
322808|NCT01507103|771934|P2|NOT COMPLETED|Overall Study||0
322809|NCT01507103|771935|P1|NOT COMPLETED|Overall Study||0
322810|NCT01507103|771933|P3|COMPLETED|Overall Study||42
322811|NCT01507103|771934|P2|COMPLETED|Overall Study||41
322812|NCT01507103|771935|P1|COMPLETED|Overall Study||41
322813|NCT01507103|771933|P3|STARTED|Overall Study||42
322814|NCT01507103|771934|P2|STARTED|Overall Study||41
322815|NCT01507103|771935|P1|STARTED|Overall Study||41
322816|NCT01507090|771958|P1|NOT COMPLETED|Overall Study||18
322817|NCT01507090|771958|P1|COMPLETED|Overall Study||624
322818|NCT01507090|771958|P1|STARTED|Overall Study||642
322819|NCT01507051|771997|P4|NOT COMPLETED|Overall Study||7
322820|NCT01507051|771998|P3|NOT COMPLETED|Overall Study||1
322821|NCT01507051|771999|P2|NOT COMPLETED|Overall Study||3
322822|NCT01507051|772000|P1|NOT COMPLETED|Overall Study||2
322823|NCT01507051|771997|P4|COMPLETED|Overall Study||0
322824|NCT01507051|771998|P3|COMPLETED|Overall Study||28
322825|NCT01507051|771999|P2|COMPLETED|Overall Study||28
322826|NCT01507051|772000|P1|COMPLETED|Overall Study||27
322827|NCT01507051|771997|P4|Received Placebo or Rivaroxaban|Overall Study||0
322828|NCT01507051|771998|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
322829|NCT01507051|771999|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
322830|NCT01507051|772000|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
322831|NCT01507051|771997|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
322832|NCT01507051|771998|P3|Warfarin run-in Phase|Overall Study||0
322833|NCT01507051|771999|P2|Warfarin run-in Phase|Overall Study||28
322834|NCT01507051|772000|P1|Warfarin run-in Phase|Overall Study||28
322835|NCT01507051|771997|P4|STARTED|Overall Study||7
322836|NCT01507051|771998|P3|STARTED|Overall Study||29
322837|NCT01507051|771999|P2|STARTED|Overall Study||31
322838|NCT01507051|772000|P1|STARTED|Overall Study||29
322839|NCT01506960|772118|P1|NOT COMPLETED|Overall Study||47
322840|NCT01506960|772118|P1|COMPLETED|Overall Study||17
322841|NCT01506960|772118|P1|STARTED|Overall Study||64
322842|NCT01506947|772124|P1|NOT COMPLETED|Overall Study||16
322843|NCT01506947|772124|P1|COMPLETED|Overall Study||49
322844|NCT01506947|772124|P1|STARTED|Overall Study||65
322845|NCT01506908|772142|P2|NOT COMPLETED|Overall Study||0
322846|NCT01506908|772143|P1|NOT COMPLETED|Overall Study||1
322847|NCT01506908|772142|P2|COMPLETED|Overall Study||161
322848|NCT01506908|772143|P1|COMPLETED|Overall Study||161
322849|NCT01506908|772142|P2|STARTED|Overall Study||161
322850|NCT01506908|772143|P1|STARTED|Overall Study||162
322851|NCT01506882|772161|P2|NOT COMPLETED|Overall Study||7
322852|NCT01506882|772162|P1|NOT COMPLETED|Overall Study||22
322853|NCT01506882|772161|P2|COMPLETED|Overall Study||3
322854|NCT01506882|772162|P1|COMPLETED|Overall Study||39
322855|NCT01506882|772161|P2|STARTED|Overall Study||10
322856|NCT01506882|772162|P1|STARTED|Overall Study||61
322857|NCT01506726|772176|P2|NOT COMPLETED|Overall Study||2
322858|NCT01506726|772177|P1|NOT COMPLETED|Overall Study||1
322859|NCT01506726|772176|P2|COMPLETED|Overall Study||3
322860|NCT01506726|772177|P1|COMPLETED|Overall Study||5
322861|NCT01506726|772176|P2|STARTED|Overall Study||5
322862|NCT01506726|772177|P1|STARTED|Overall Study||6
322863|NCT01506596|772217|P1|NOT COMPLETED|Overall Study||1
322864|NCT01506596|772217|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
322865|NCT01506596|772217|P1|STARTED|Overall Study||42
322866|NCT01506362|772225|P1|NOT COMPLETED|Overall Study||6
322867|NCT01506362|772225|P1|COMPLETED|Overall Study||16
322868|NCT01506362|772225|P1|STARTED|Overall Study||22
322869|NCT01506323|772231|P2|NOT COMPLETED|Overall Study||13
322870|NCT01506323|772232|P1|NOT COMPLETED|Overall Study||24
322871|NCT01506323|772231|P2|COMPLETED|Overall Study||71
322872|NCT01506323|772232|P1|COMPLETED|Overall Study||65
322873|NCT01506323|772231|P2|Post-treatment Completed CAPS|Overall Study||72
322874|NCT01506323|772232|P1|Post-treatment Completed CAPS|Overall Study||68
322875|NCT01506323|772231|P2|Post-treatment Completers|Overall Study||72
322876|NCT01506323|772232|P1|Post-treatment Completers|Overall Study||69
322877|NCT01506323|772231|P2|STARTED|Overall Study||84
322878|NCT01506323|772232|P1|STARTED|Overall Study||89
322879|NCT01506193|772261|P3|NOT COMPLETED|Overall Study||14
322880|NCT01506193|772262|P2|NOT COMPLETED|Overall Study||4
322881|NCT01506193|772263|P1|NOT COMPLETED|Overall Study||14
322882|NCT01506193|772261|P3|COMPLETED|Overall Study||168
322883|NCT01506193|772262|P2|COMPLETED|Overall Study||179
322884|NCT01506193|772263|P1|COMPLETED|Overall Study||337
322885|NCT01506193|772261|P3|STARTED|Overall Study||182
322886|NCT01506193|772262|P2|STARTED|Overall Study||183
322887|NCT01506193|772263|P1|STARTED|Overall Study||351
322888|NCT01505881|772296|P2|NOT COMPLETED|Overall Study||1
322889|NCT01505881|772297|P1|NOT COMPLETED|Overall Study||4
322890|NCT01505881|772296|P2|COMPLETED|Overall Study||58
322891|NCT01505881|772297|P1|COMPLETED|Overall Study||95
322892|NCT01505881|772296|P2|STARTED|Overall Study||59
322893|NCT01505881|772297|P1|STARTED|Overall Study||99
322894|NCT01505764|772311|P2|NOT COMPLETED|Overall Study||1
322895|NCT01505764|772312|P1|NOT COMPLETED|Overall Study||3
322896|NCT01505764|772311|P2|COMPLETED|Overall Study||2
322897|NCT01505764|772312|P1|COMPLETED|Overall Study||3
322898|NCT01505764|772311|P2|STARTED|Overall Study||3
322899|NCT01505764|772312|P1|STARTED|Overall Study||6
322900|NCT01505647|772320|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
322901|NCT01505647|772321|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
322902|NCT01505647|772320|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
322903|NCT01505647|772321|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
322904|NCT01505647|772320|P2|STARTED|Day 43 Through Day 182 Follow-up||166
322905|NCT01505647|772321|P1|STARTED|Day 43 Through Day 182 Follow-up||329
322906|NCT01505647|772320|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
322907|NCT01505647|772321|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
322908|NCT01505647|772320|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
322909|NCT01505647|772321|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
322910|NCT01505647|772320|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
322911|NCT01505647|772321|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
322912|NCT01505647|772320|P2|STARTED|Day 1 Through Day 42 Follow-up||166
322913|NCT01505647|772321|P1|STARTED|Day 1 Through Day 42 Follow-up||332
322914|NCT01505608|772337|P2|NOT COMPLETED|Phase II||2
322915|NCT01505608|772338|P1|NOT COMPLETED|Phase II||2
322916|NCT01505608|772337|P2|COMPLETED|Phase II||2
322917|NCT01505608|772338|P1|COMPLETED|Phase II||0
322918|NCT01505608|772337|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
322919|NCT01505608|772338|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
322920|NCT01505608|772337|P2|NOT COMPLETED|Phase I||6
322921|NCT01505608|772338|P1|NOT COMPLETED|Phase I||0
322922|NCT01505608|772337|P2|COMPLETED|Phase I||2
322923|NCT01505608|772338|P1|COMPLETED|Phase I||0
322924|NCT01505608|772337|P2|STARTED|Phase I||8
322925|NCT01505608|772338|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
322926|NCT01505387|772356|P2|NOT COMPLETED|Overall Study||1
322927|NCT01505387|772357|P1|NOT COMPLETED|Overall Study||2
322928|NCT01505387|772356|P2|COMPLETED|Overall Study||24
322929|NCT01505387|772357|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
322930|NCT01505387|772356|P2|Treated|Overall Study||24
322931|NCT01505387|772357|P1|Treated|Overall Study||24
322932|NCT01505387|772356|P2|STARTED|Overall Study||25
322933|NCT01505387|772357|P1|STARTED|Overall Study||25
322934|NCT01505374|772363|P2|NOT COMPLETED|Overall Study||0
322935|NCT01505374|772364|P1|NOT COMPLETED|Overall Study||1
322936|NCT01505374|772363|P2|COMPLETED|Overall Study||30
322937|NCT01505374|772364|P1|COMPLETED|Overall Study||29
322938|NCT01505374|772363|P2|STARTED|Overall Study||30
322939|NCT01505374|772364|P1|STARTED|Overall Study||30
322940|NCT01504997|772378|P1|NOT COMPLETED|Overall Study||0
322941|NCT01504997|772378|P1|COMPLETED|Overall Study||18
322942|NCT01504997|772378|P1|STARTED|Overall Study||18
322943|NCT01504971|772382|P1|NOT COMPLETED|Overall Study||13
322944|NCT01504971|772382|P1|COMPLETED|Overall Study||82
322945|NCT01504971|772382|P1|STARTED|Overall Study||95
322946|NCT01504958|772393|P3|NOT COMPLETED|Overall Study||0
322947|NCT01504958|772394|P2|NOT COMPLETED|Overall Study||0
322948|NCT01504958|772395|P1|NOT COMPLETED|Overall Study||0
322949|NCT01504958|772393|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
322950|NCT01504958|772394|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
322951|NCT01504958|772395|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
322952|NCT01504958|772393|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
322953|NCT01504958|772394|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
322954|NCT01504958|772395|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
322955|NCT01504867|772411|P2|NOT COMPLETED|Overall Study||3
322956|NCT01504867|772412|P1|NOT COMPLETED|Overall Study||7
322957|NCT01504867|772411|P2|COMPLETED|Overall Study||195
322958|NCT01504867|772412|P1|COMPLETED|Overall Study||195
322959|NCT01504867|772411|P2|STARTED|Overall Study||198
322960|NCT01504867|772412|P1|STARTED|Overall Study||202
322961|NCT01504854|772432|P2|NOT COMPLETED|Overall Study||7
322962|NCT01504854|772433|P1|NOT COMPLETED|Overall Study||8
322963|NCT01504854|772432|P2|COMPLETED|Overall Study||48
322964|NCT01504854|772433|P1|COMPLETED|Overall Study||56
322965|NCT01504854|772432|P2|STARTED|Overall Study||55
322966|NCT01504854|772433|P1|STARTED|Overall Study||64
322967|NCT01503749|772450|P3|NOT COMPLETED|Overall Study||0
322968|NCT01503749|772451|P2|NOT COMPLETED|Overall Study||0
322969|NCT01503749|772452|P1|NOT COMPLETED|Overall Study||0
322970|NCT01503749|772450|P3|COMPLETED|Overall Study||3
322971|NCT01503749|772451|P2|COMPLETED|Overall Study||3
322972|NCT01503749|772452|P1|COMPLETED|Overall Study||3
322973|NCT01503749|772450|P3|STARTED|Overall Study||3
322974|NCT01503749|772451|P2|STARTED|Overall Study||3
322975|NCT01503749|772452|P1|STARTED|Overall Study||3
322976|NCT01503021|772465|P2|NOT COMPLETED|Overall Study||26
322977|NCT01503021|772466|P1|NOT COMPLETED|Overall Study||27
322978|NCT01503021|772465|P2|COMPLETED|Overall Study||332
322979|NCT01503021|772466|P1|COMPLETED|Overall Study||333
322980|NCT01503021|772465|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
322981|NCT01503021|772466|P1|Completed Treatment|Overall Study||333
322982|NCT01503021|772465|P2|Dosed|Overall Study||352
322983|NCT01503021|772466|P1|Dosed|Overall Study||351
322984|NCT01503021|772465|P2|STARTED|Overall Study||358
322985|NCT01503021|772466|P1|STARTED|Overall Study||360
322986|NCT01502787|772513|P2|NOT COMPLETED|Overall Study||0
322987|NCT01502787|772514|P1|NOT COMPLETED|Overall Study||0
322988|NCT01502787|772513|P2|COMPLETED|Overall Study||10
322989|NCT01502787|772514|P1|COMPLETED|Overall Study||11
322990|NCT01502787|772513|P2|STARTED|Overall Study||10
322991|NCT01502787|772514|P1|STARTED|Overall Study||11
322992|NCT01502709|772522|P2|NOT COMPLETED|Overall Study||0
322993|NCT01502709|772523|P1|NOT COMPLETED|Overall Study||4
322994|NCT01502709|772522|P2|COMPLETED|Overall Study||0
322995|NCT01502709|772523|P1|COMPLETED|Overall Study||1
322996|NCT01502709|772522|P2|STARTED|Overall Study||0
322997|NCT01502709|772523|P1|STARTED|Overall Study||5
322998|NCT01502644|772536|P4|NOT COMPLETED|Assigned to NA Groups||8
322999|NCT01502644|772537|P3|NOT COMPLETED|Assigned to NA Groups||3
323000|NCT01502644|772538|P2|NOT COMPLETED|Assigned to NA Groups||6
323001|NCT01502644|772539|P1|NOT COMPLETED|Assigned to NA Groups||0
323002|NCT01502644|772536|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
323003|NCT01502644|772537|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
323004|NCT01502644|772538|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
323005|NCT01502644|772539|P1|COMPLETED|Assigned to NA Groups||0
323006|NCT01502644|772536|P4|STARTED|Assigned to NA Groups||32
323007|NCT01502644|772537|P3|STARTED|Assigned to NA Groups||10
323008|NCT01502644|772538|P2|STARTED|Assigned to NA Groups||30
323009|NCT01502644|772539|P1|STARTED|Assigned to NA Groups||0
323010|NCT01502644|772536|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
323011|NCT01502644|772537|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
323012|NCT01502644|772538|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
323013|NCT01502644|772539|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
323014|NCT01502644|772536|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
323015|NCT01502644|772537|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
323016|NCT01502644|772538|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
323017|NCT01502644|772539|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
323018|NCT01502644|772536|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
323019|NCT01502644|772537|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
323020|NCT01502644|772538|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
323021|NCT01502644|772539|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
323022|NCT01502423|772549|P2|NOT COMPLETED|Overall Study||1
323023|NCT01502423|772550|P1|NOT COMPLETED|Overall Study||0
323024|NCT01502423|772549|P2|COMPLETED|Overall Study||29
323025|NCT01502423|772550|P1|COMPLETED|Overall Study||31
323026|NCT01502423|772549|P2|STARTED|Overall Study||30
323027|NCT01502423|772550|P1|STARTED|Overall Study||31
323028|NCT01502410|772572|P4|NOT COMPLETED|Overall Study||0
323029|NCT01502410|772573|P3|NOT COMPLETED|Overall Study||0
323030|NCT01502410|772574|P2|NOT COMPLETED|Overall Study||10
323031|NCT01502410|772575|P1|NOT COMPLETED|Overall Study||10
323032|NCT01502410|772572|P4|COMPLETED|Overall Study||0
323033|NCT01502410|772573|P3|COMPLETED|Overall Study||0
323034|NCT01502410|772574|P2|COMPLETED|Overall Study||0
323035|NCT01502410|772575|P1|COMPLETED|Overall Study||0
323036|NCT01502410|772572|P4|STARTED|Overall Study||0
323037|NCT01502410|772573|P3|STARTED|Overall Study||0
323038|NCT01502410|772574|P2|STARTED|Overall Study||10
323039|NCT01502410|772575|P1|STARTED|Overall Study||10
323040|NCT01502371|772588|P5|NOT COMPLETED|Overall Study||52
323041|NCT01502371|772589|P4|NOT COMPLETED|Overall Study||37
323042|NCT01502371|772590|P3|NOT COMPLETED|Overall Study||25
323043|NCT01502371|772591|P2|NOT COMPLETED|Overall Study||32
323044|NCT01502371|772592|P1|NOT COMPLETED|Overall Study||41
323045|NCT01502371|772588|P5|COMPLETED|Overall Study||60
323046|NCT01502371|772589|P4|COMPLETED|Overall Study||88
323047|NCT01502371|772590|P3|COMPLETED|Overall Study||83
323048|NCT01502371|772591|P2|COMPLETED|Overall Study||81
323049|NCT01502371|772592|P1|COMPLETED|Overall Study||79
323050|NCT01502371|772588|P5|STARTED|Overall Study||112
323051|NCT01502371|772589|P4|STARTED|Overall Study||125
323052|NCT01502371|772590|P3|STARTED|Overall Study||108
323053|NCT01502371|772591|P2|STARTED|Overall Study||113
323054|NCT01502371|772592|P1|STARTED|Overall Study||120
323055|NCT01502332|772617|P2|NOT COMPLETED|Overall Study||0
323056|NCT01502332|772618|P1|NOT COMPLETED|Overall Study||0
323057|NCT01502332|772617|P2|COMPLETED|Overall Study||163
323058|NCT01502332|772618|P1|COMPLETED|Overall Study||157
323059|NCT01502332|772617|P2|STARTED|Overall Study||163
323060|NCT01502332|772618|P1|STARTED|Overall Study||157
323061|NCT01502228|772632|P1|NOT COMPLETED|Overall Study||1
323062|NCT01502228|772632|P1|COMPLETED|Overall Study||13
323063|NCT01502228|772632|P1|STARTED|Overall Study||14
323064|NCT01502033|772637|P1|NOT COMPLETED|Overall Study||3
323065|NCT01502033|772637|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
323066|NCT01502033|772637|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
323067|NCT01501162|772645|P2|NOT COMPLETED|Overall Study||5
323068|NCT01501162|772646|P1|NOT COMPLETED|Overall Study||8
323069|NCT01501162|772645|P2|COMPLETED|Overall Study||60
323070|NCT01501162|772646|P1|COMPLETED|Overall Study||57
323071|NCT01501162|772645|P2|STARTED|Overall Study||65
323072|NCT01501162|772646|P1|STARTED|Overall Study||65
323073|NCT01501110|772656|P2|NOT COMPLETED|Overall Study||1
323074|NCT01501110|772657|P1|NOT COMPLETED|Overall Study||0
323075|NCT01501110|772656|P2|COMPLETED|Overall Study||33
323076|NCT01501110|772657|P1|COMPLETED|Overall Study||34
323077|NCT01501110|772656|P2|STARTED|Overall Study||34
323078|NCT01501110|772657|P1|STARTED|Overall Study||34
323079|NCT01500772|772663|P1|NOT COMPLETED|Overall Study||6
323080|NCT01500772|772663|P1|COMPLETED|Overall Study||0
323081|NCT01500772|772663|P1|STARTED|Overall Study||6
323082|NCT01500746|772672|P2|NOT COMPLETED|Overall Study||0
323083|NCT01500746|772673|P1|NOT COMPLETED|Overall Study||0
323084|NCT01500746|772672|P2|COMPLETED|Overall Study||4
323085|NCT01500746|772673|P1|COMPLETED|Overall Study||4
323086|NCT01500746|772672|P2|STARTED|Overall Study||4
323087|NCT01500746|772673|P1|STARTED|Overall Study||4
323088|NCT01500720|772681|P2|NOT COMPLETED|Overall Study||9
323089|NCT01500720|772682|P1|NOT COMPLETED|Overall Study||5
323090|NCT01500720|772681|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
323091|NCT01500720|772682|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
323092|NCT01500720|772681|P2|Treated|Overall Study||88
323093|NCT01500720|772682|P1|Treated|Overall Study||89
323094|NCT01500720|772681|P2|STARTED|Overall Study|Randomized|89
323095|NCT01500720|772682|P1|STARTED|Overall Study|Randomized|90
323096|NCT01500694|772696|P2|NOT COMPLETED|Overall Study||29
323097|NCT01500694|772697|P1|NOT COMPLETED|Overall Study||52
323098|NCT01500694|772696|P2|COMPLETED|Overall Study||54
323099|NCT01500694|772697|P1|COMPLETED|Overall Study||79
323100|NCT01500694|772696|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
323101|NCT01500694|772697|P1|STARTED|Overall Study||131
323102|NCT01500629|772723|P2|NOT COMPLETED|Period 2 (Single Dose)||0
323103|NCT01500629|772724|P1|NOT COMPLETED|Period 2 (Single Dose)||0
323104|NCT01500629|772723|P2|COMPLETED|Period 2 (Single Dose)||10
323105|NCT01500629|772724|P1|COMPLETED|Period 2 (Single Dose)||10
323106|NCT01500629|772723|P2|STARTED|Period 2 (Single Dose)||10
323107|NCT01500629|772724|P1|STARTED|Period 2 (Single Dose)||10
323108|NCT01500629|772723|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
323109|NCT01500629|772724|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
323110|NCT01500629|772723|P2|COMPLETED|Washout Period of 14 to 30 Days||10
323111|NCT01500629|772724|P1|COMPLETED|Washout Period of 14 to 30 Days||10
323112|NCT01500629|772723|P2|STARTED|Washout Period of 14 to 30 Days||10
323113|NCT01500629|772724|P1|STARTED|Washout Period of 14 to 30 Days||11
323114|NCT01500629|772723|P2|NOT COMPLETED|Period 1 (Single Dose)||0
323115|NCT01500629|772724|P1|NOT COMPLETED|Period 1 (Single Dose)||0
323116|NCT01500629|772723|P2|COMPLETED|Period 1 (Single Dose)||10
323117|NCT01500629|772724|P1|COMPLETED|Period 1 (Single Dose)||11
323118|NCT01500629|772723|P2|STARTED|Period 1 (Single Dose)||10
323119|NCT01500629|772724|P1|STARTED|Period 1 (Single Dose)||11
323120|NCT01500434|772808|P1|NOT COMPLETED|Overall Study||7
323121|NCT01500434|772808|P1|COMPLETED|Overall Study||95
323122|NCT01500434|772808|P1|STARTED|Overall Study||102
323123|NCT01500382|772841|P4|NOT COMPLETED|Treatment Period 2||0
323124|NCT01500382|772842|P3|NOT COMPLETED|Treatment Period 2||0
323125|NCT01500382|772843|P2|NOT COMPLETED|Treatment Period 2||0
323126|NCT01500382|772844|P1|NOT COMPLETED|Treatment Period 2||0
323127|NCT01500382|772841|P4|COMPLETED|Treatment Period 2||1
323128|NCT01500382|772842|P3|COMPLETED|Treatment Period 2||0
323129|NCT01500382|772843|P2|COMPLETED|Treatment Period 2||1
323130|NCT01500382|772844|P1|COMPLETED|Treatment Period 2||1
323131|NCT01500382|772841|P4|STARTED|Treatment Period 2||1
323132|NCT01500382|772842|P3|STARTED|Treatment Period 2||0
323133|NCT01500382|772843|P2|STARTED|Treatment Period 2||1
323134|NCT01500382|772844|P1|STARTED|Treatment Period 2||1
323135|NCT01500382|772841|P4|NOT COMPLETED|Washout Period||0
323136|NCT01500382|772842|P3|NOT COMPLETED|Washout Period||1
323137|NCT01500382|772843|P2|NOT COMPLETED|Washout Period||0
323138|NCT01500382|772844|P1|NOT COMPLETED|Washout Period||0
323139|NCT01500382|772841|P4|COMPLETED|Washout Period||1
323140|NCT01500382|772842|P3|COMPLETED|Washout Period||0
323141|NCT01500382|772843|P2|COMPLETED|Washout Period||1
323142|NCT01500382|772844|P1|COMPLETED|Washout Period||1
323143|NCT01500382|772841|P4|STARTED|Washout Period||1
323144|NCT01500382|772842|P3|STARTED|Washout Period||1
323145|NCT01500382|772843|P2|STARTED|Washout Period||1
323146|NCT01500382|772844|P1|STARTED|Washout Period||1
323147|NCT01500382|772841|P4|NOT COMPLETED|Treatment Period 1||0
323148|NCT01500382|772842|P3|NOT COMPLETED|Treatment Period 1||0
323149|NCT01500382|772843|P2|NOT COMPLETED|Treatment Period 1||0
323150|NCT01500382|772844|P1|NOT COMPLETED|Treatment Period 1||0
323151|NCT01500382|772841|P4|COMPLETED|Treatment Period 1||1
323152|NCT01500382|772842|P3|COMPLETED|Treatment Period 1||1
323153|NCT01500382|772843|P2|COMPLETED|Treatment Period 1||1
323154|NCT01500382|772844|P1|COMPLETED|Treatment Period 1||1
323155|NCT01500382|772841|P4|STARTED|Treatment Period 1||1
323156|NCT01500382|772842|P3|STARTED|Treatment Period 1||1
323157|NCT01500382|772843|P2|STARTED|Treatment Period 1||1
323158|NCT01500382|772844|P1|STARTED|Treatment Period 1||1
323159|NCT01500317|772869|P3|NOT COMPLETED|Overall Study||0
323160|NCT01500317|772870|P2|NOT COMPLETED|Overall Study||2
323161|NCT01500317|772871|P1|NOT COMPLETED|Overall Study||3
323162|NCT01500317|772869|P3|COMPLETED|Overall Study||13
323163|NCT01500317|772870|P2|COMPLETED|Overall Study||10
323164|NCT01500317|772871|P1|COMPLETED|Overall Study||10
323165|NCT01500317|772869|P3|STARTED|Overall Study||13
323166|NCT01500317|772870|P2|STARTED|Overall Study||12
323167|NCT01500317|772871|P1|STARTED|Overall Study||13
323168|NCT01500278|772893|P2|NOT COMPLETED|Week 13 - Week 104||126
323169|NCT01500278|772894|P1|NOT COMPLETED|Week 13 - Week 104||139
323170|NCT01500278|772893|P2|COMPLETED|Week 13 - Week 104||302
323171|NCT01500278|772894|P1|COMPLETED|Week 13 - Week 104||287
323172|NCT01500278|772893|P2|STARTED|Week 13 - Week 104||428
323173|NCT01500278|772894|P1|STARTED|Week 13 - Week 104||426
323174|NCT01500278|772893|P2|NOT COMPLETED|Week 0 - Week 12||30
323175|NCT01500278|772894|P1|NOT COMPLETED|Week 0 - Week 12||31
323176|NCT01500278|772893|P2|COMPLETED|Week 0 - Week 12||428
323177|NCT01500278|772894|P1|COMPLETED|Week 0 - Week 12||426
323178|NCT01500278|772893|P2|STARTED|Week 0 - Week 12||458
323179|NCT01500278|772894|P1|STARTED|Week 0 - Week 12||457
323180|NCT01500252|772918|P2|NOT COMPLETED|Overall Study||6
323181|NCT01500252|772919|P1|NOT COMPLETED|Overall Study||9
323182|NCT01500252|772918|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
323183|NCT01500252|772919|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
323184|NCT01500252|772918|P2|Ten Years|Overall Study||11
323185|NCT01500252|772919|P1|Ten Years|Overall Study||12
323186|NCT01500252|772918|P2|Five Years|Overall Study||13
323187|NCT01500252|772919|P1|Five Years|Overall Study||17
323188|NCT01500252|772918|P2|One Years|Overall Study||16
323189|NCT01500252|772919|P1|One Years|Overall Study||20
323190|NCT01500252|772918|P2|STARTED|Overall Study||17
323191|NCT01500252|772919|P1|STARTED|Overall Study||21
323192|NCT01500226|772945|P2|NOT COMPLETED|Overall Study||494
323193|NCT01500226|772946|P1|NOT COMPLETED|Overall Study||499
323194|NCT01500226|772945|P2|COMPLETED|Overall Study||191
323195|NCT01500226|772946|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
323196|NCT01500226|772945|P2|STARTED|Overall Study||685
323197|NCT01500226|772946|P1|STARTED|Overall Study|Number of randomized patients|684
323198|NCT01500213|772958|P2|NOT COMPLETED|Overall Study||224
323199|NCT01500213|772959|P1|NOT COMPLETED|Overall Study||217
323200|NCT01500213|772958|P2|COMPLETED|Overall Study||53
323201|NCT01500213|772959|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
323202|NCT01500213|772958|P2|STARTED|Overall Study||277
323203|NCT01500213|772959|P1|STARTED|Overall Study|Number of randomized patients|278
323204|NCT01500135|772971|P2|NOT COMPLETED|Overall Study||11
323205|NCT01500135|772972|P1|NOT COMPLETED|Overall Study||17
323206|NCT01500135|772971|P2|COMPLETED|Overall Study||39
323207|NCT01500135|772972|P1|COMPLETED|Overall Study||83
323208|NCT01500135|772971|P2|STARTED|Overall Study||50
323209|NCT01500135|772972|P1|STARTED|Overall Study||100
323210|NCT01500109|772985|P3|NOT COMPLETED|Overall Study||0
323211|NCT01500109|772986|P2|NOT COMPLETED|Overall Study||0
323212|NCT01500109|772987|P1|NOT COMPLETED|Overall Study||0
323213|NCT01500109|772985|P3|COMPLETED|Overall Study||16
323214|NCT01500109|772986|P2|COMPLETED|Overall Study||14
323215|NCT01500109|772987|P1|COMPLETED|Overall Study||15
323216|NCT01500109|772985|P3|STARTED|Overall Study||16
323217|NCT01500109|772986|P2|STARTED|Overall Study||14
323218|NCT01500109|772987|P1|STARTED|Overall Study||15
323219|NCT01500083|772997|P2|NOT COMPLETED|Overall Study||43
323220|NCT01500083|772998|P1|NOT COMPLETED|Overall Study||12
323221|NCT01500083|772997|P2|COMPLETED|Overall Study||31
323222|NCT01500083|772998|P1|COMPLETED|Overall Study||4
323223|NCT01500083|772997|P2|STARTED|Overall Study||74
323224|NCT01500083|772998|P1|STARTED|Overall Study||16
323225|NCT01500031|773004|P1|NOT COMPLETED|Overall Study||5
323226|NCT01500031|773004|P1|COMPLETED|Overall Study||87
323227|NCT01500031|773004|P1|STARTED|Overall Study||92
323228|NCT01499862|773019|P1|NOT COMPLETED|Overall Study||0
323229|NCT01499862|773019|P1|COMPLETED|Overall Study||3
323230|NCT01499862|773019|P1|STARTED|Overall Study||3
323231|NCT01499849|773039|P2|NOT COMPLETED|Overall Study||226
323232|NCT01499849|773040|P1|NOT COMPLETED|Overall Study||224
323233|NCT01499849|773039|P2|COMPLETED|Overall Study||40
323234|NCT01499849|773040|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
323235|NCT01499849|773039|P2|STARTED|Overall Study||266
323236|NCT01499849|773040|P1|STARTED|Overall Study|Number of randomized patients|266
323237|NCT01499810|773050|P1|NOT COMPLETED|Overall Study||12
323238|NCT01499810|773050|P1|COMPLETED|Overall Study||41
323239|NCT01499810|773050|P1|STARTED|Overall Study||53
323240|NCT01499667|773100|P3|NOT COMPLETED|Overall Study||10
323241|NCT01499667|773101|P2|NOT COMPLETED|Overall Study||11
323242|NCT01499667|773102|P1|NOT COMPLETED|Overall Study||9
323243|NCT01499667|773100|P3|COMPLETED|Overall Study||40
323244|NCT01499667|773101|P2|COMPLETED|Overall Study||31
323245|NCT01499667|773102|P1|COMPLETED|Overall Study||41
323246|NCT01499667|773100|P3|Modified Full Analysis Set|Overall Study||39
323247|NCT01499667|773101|P2|Modified Full Analysis Set|Overall Study||29
323248|NCT01499667|773102|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
323249|NCT01499667|773100|P3|Full Analysis Set (FAS)|Overall Study||50
323250|NCT01499667|773101|P2|Full Analysis Set (FAS)|Overall Study||42
323251|NCT01499667|773102|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
323252|NCT01499667|773100|P3|STARTED|Overall Study||50
323253|NCT01499667|773101|P2|STARTED|Overall Study||42
323254|NCT01499667|773102|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
323255|NCT01499654|773131|P1|NOT COMPLETED|Overall Study||0
323256|NCT01499654|773131|P1|COMPLETED|Overall Study||64
323257|NCT01499654|773131|P1|STARTED|Overall Study||64
323258|NCT01499576|773150|P1|NOT COMPLETED|Overall Study||21
323259|NCT01499576|773150|P1|COMPLETED|Overall Study||105
323260|NCT01499576|773150|P1|STARTED|Overall Study||126
323261|NCT01499498|773156|P1|NOT COMPLETED|Overall Study||0
323262|NCT01499498|773156|P1|COMPLETED|Overall Study||13
323263|NCT01499498|773156|P1|STARTED|Overall Study||13
323264|NCT01499355|773164|P4|NOT COMPLETED|Double-Blind Period||23
323265|NCT01499355|773165|P3|NOT COMPLETED|Double-Blind Period||25
323266|NCT01499355|773166|P2|NOT COMPLETED|Double-Blind Period||23
323267|NCT01499355|773167|P1|NOT COMPLETED|Double-Blind Period||0
323268|NCT01499355|773164|P4|COMPLETED|Double-Blind Period||39
323269|NCT01499355|773165|P3|COMPLETED|Double-Blind Period||38
323270|NCT01499355|773166|P2|COMPLETED|Double-Blind Period||40
323271|NCT01499355|773167|P1|COMPLETED|Double-Blind Period||0
323272|NCT01499355|773164|P4|STARTED|Double-Blind Period||62
323273|NCT01499355|773165|P3|STARTED|Double-Blind Period||63
323274|NCT01499355|773166|P2|STARTED|Double-Blind Period||63
323275|NCT01499355|773167|P1|STARTED|Double-Blind Period||0
323276|NCT01499355|773164|P4|NOT COMPLETED|Run-In Period||0
323277|NCT01499355|773165|P3|NOT COMPLETED|Run-In Period||0
323278|NCT01499355|773166|P2|NOT COMPLETED|Run-In Period||0
323279|NCT01499355|773167|P1|NOT COMPLETED|Run-In Period||31
323280|NCT01499355|773164|P4|COMPLETED|Run-In Period||0
323281|NCT01499355|773165|P3|COMPLETED|Run-In Period||0
323282|NCT01499355|773166|P2|COMPLETED|Run-In Period||0
323283|NCT01499355|773167|P1|COMPLETED|Run-In Period||245
323284|NCT01499355|773164|P4|STARTED|Run-In Period||0
323285|NCT01499355|773165|P3|STARTED|Run-In Period||0
323286|NCT01499355|773166|P2|STARTED|Run-In Period||0
323287|NCT01499355|773167|P1|STARTED|Run-In Period||276
323288|NCT01499303|773200|P2|NOT COMPLETED|Overall Study||7
323289|NCT01499303|773201|P1|NOT COMPLETED|Overall Study||3
323290|NCT01499303|773200|P2|COMPLETED|Overall Study||40
323291|NCT01499303|773201|P1|COMPLETED|Overall Study||18
323292|NCT01499303|773200|P2|STARTED|Overall Study||47
323293|NCT01499303|773201|P1|STARTED|Overall Study||21
323294|NCT01499290|773209|P2|NOT COMPLETED|Overall Study||35
323295|NCT01499290|773210|P1|NOT COMPLETED|Overall Study||55
323296|NCT01499290|773209|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
323297|NCT01499290|773210|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
323298|NCT01499290|773209|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
323299|NCT01499290|773210|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
323300|NCT01499277|773260|P2|NOT COMPLETED|Overall Study||32
323301|NCT01499277|773261|P1|NOT COMPLETED|Overall Study||47
323302|NCT01499277|773260|P2|COMPLETED|Overall Study||223
323303|NCT01499277|773261|P1|COMPLETED|Overall Study||459
323304|NCT01499277|773260|P2|STARTED|Overall Study||255
323305|NCT01499277|773261|P1|STARTED|Overall Study||506
323306|NCT01499199|773283|P1|NOT COMPLETED|Overall Study||2
323307|NCT01499199|773283|P1|COMPLETED|Overall Study||11
323308|NCT01499199|773283|P1|STARTED|Overall Study||13
323309|NCT01499147|773304|P2|NOT COMPLETED|Overall Study||5
323310|NCT01499147|773305|P1|NOT COMPLETED|Overall Study||15
323311|NCT01499147|773304|P2|COMPLETED|Overall Study||12
323312|NCT01499147|773305|P1|COMPLETED|Overall Study||18
323313|NCT01499147|773304|P2|STARTED|Overall Study||17
323314|NCT01499147|773305|P1|STARTED|Overall Study||33
323315|NCT01499134|773320|P2|NOT COMPLETED|Overall Study||1
323316|NCT01499134|773321|P1|NOT COMPLETED|Overall Study||0
323317|NCT01499134|773320|P2|COMPLETED|Overall Study||7
323318|NCT01499134|773321|P1|COMPLETED|Overall Study||9
323319|NCT01499134|773320|P2|STARTED|Overall Study||8
323320|NCT01499134|773321|P1|STARTED|Overall Study||9
323321|NCT01499095|773343|P2|NOT COMPLETED|Overall Study||93
323322|NCT01499095|773344|P1|NOT COMPLETED|Overall Study||89
323323|NCT01499095|773343|P2|COMPLETED|Overall Study||314
323324|NCT01499095|773344|P1|COMPLETED|Overall Study||315
323325|NCT01499095|773343|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
323326|NCT01499095|773344|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
323327|NCT01499095|773343|P2|Participated in Substudy|Overall Study||0
323328|NCT01499095|773344|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
323329|NCT01499095|773343|P2|Treated|Overall Study||406
323330|NCT01499095|773344|P1|Treated|Overall Study||403
323331|NCT01499095|773343|P2|STARTED|Overall Study||407
323332|NCT01499095|773344|P1|STARTED|Overall Study||404
323333|NCT01499082|773374|P2|NOT COMPLETED|Overall Study||48
323334|NCT01499082|773375|P1|NOT COMPLETED|Overall Study||45
323335|NCT01499082|773374|P2|COMPLETED|Overall Study||355
323336|NCT01499082|773375|P1|COMPLETED|Overall Study||359
323337|NCT01499082|773374|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
323338|NCT01499082|773375|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
323339|NCT01499082|773374|P2|Participated in Substudy|Overall Study||0
323340|NCT01499082|773375|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
323341|NCT01499082|773374|P2|Treated|Overall Study||402
323342|NCT01499082|773375|P1|Treated|Overall Study||404
323343|NCT01499082|773374|P2|STARTED|Overall Study||403
323344|NCT01499082|773375|P1|STARTED|Overall Study||404
323345|NCT01498822|773405|P2|NOT COMPLETED|Overall Study||56
323346|NCT01498822|773406|P1|NOT COMPLETED|Overall Study||54
323347|NCT01498822|773405|P2|COMPLETED|Overall Study||122
323348|NCT01498822|773406|P1|COMPLETED|Overall Study||121
323349|NCT01498822|773405|P2|STARTED|Overall Study||178
323350|NCT01498822|773406|P1|STARTED|Overall Study||175
323351|NCT01498744|773420|P2|NOT COMPLETED|Overall Study||0
323352|NCT01498744|773421|P1|NOT COMPLETED|Overall Study||0
323353|NCT01498744|773420|P2|COMPLETED|Overall Study||31
323354|NCT01498744|773421|P1|COMPLETED|Overall Study||22
323355|NCT01498744|773420|P2|STARTED|Overall Study||31
323356|NCT01498744|773421|P1|STARTED|Overall Study||22
323357|NCT01498692|773433|P1|NOT COMPLETED|Overall Study||8
323358|NCT01498692|773433|P1|COMPLETED|Overall Study||86
323359|NCT01498692|773433|P1|STARTED|Overall Study||94
323360|NCT01498679|773464|P2|NOT COMPLETED|Overall Study||22
323361|NCT01498679|773465|P1|NOT COMPLETED|Overall Study||89
323362|NCT01498679|773464|P2|COMPLETED|Overall Study||131
323363|NCT01498679|773465|P1|COMPLETED|Overall Study||65
323364|NCT01498679|773464|P2|STARTED|Overall Study||153
323365|NCT01498679|773465|P1|STARTED|Overall Study||154
323366|NCT01498653|773481|P2|NOT COMPLETED|Overall Study||35
323367|NCT01498653|773482|P1|NOT COMPLETED|Overall Study||19
323368|NCT01498653|773481|P2|COMPLETED|Overall Study||119
323369|NCT01498653|773482|P1|COMPLETED|Overall Study||136
323370|NCT01498653|773481|P2|STARTED|Overall Study||154
323371|NCT01498653|773482|P1|STARTED|Overall Study||155
323372|NCT01498640|773496|P1|NOT COMPLETED|Overall Study||5
323373|NCT01498640|773496|P1|COMPLETED|Overall Study||47
323374|NCT01498640|773496|P1|STARTED|Overall Study||52
323375|NCT01498601|773512|P2|NOT COMPLETED|Overall Study||0
323376|NCT01498601|773513|P1|NOT COMPLETED|Overall Study||0
323377|NCT01498601|773512|P2|COMPLETED|Overall Study||32
323378|NCT01498601|773513|P1|COMPLETED|Overall Study||51
323379|NCT01498601|773512|P2|STARTED|Overall Study||32
323380|NCT01498601|773513|P1|STARTED|Overall Study||51
323381|NCT01498588|773519|P1|NOT COMPLETED|Overall Study||0
323382|NCT01498588|773519|P1|COMPLETED|Overall Study||7
323383|NCT01498588|773519|P1|STARTED|Overall Study||7
323384|NCT01498575|773526|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
323385|NCT01498575|773527|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
323386|NCT01498575|773526|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
323387|NCT01498575|773527|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
323388|NCT01498575|773526|P2|STARTED|On the Road Driving Assessment (ODA)||89
323389|NCT01498575|773527|P1|STARTED|On the Road Driving Assessment (ODA)||128
323390|NCT01498575|773526|P2|NOT COMPLETED|Overall Sample||14
323391|NCT01498575|773527|P1|NOT COMPLETED|Overall Sample||60
323392|NCT01498575|773526|P2|COMPLETED|Overall Sample||400
323393|NCT01498575|773527|P1|COMPLETED|Overall Sample||550
323394|NCT01498575|773526|P2|STARTED|Overall Sample||414
323395|NCT01498575|773527|P1|STARTED|Overall Sample||610
323396|NCT01498549|773533|P1|NOT COMPLETED|Overall Study||4
323397|NCT01498549|773533|P1|COMPLETED|Overall Study||35
323398|NCT01498549|773533|P1|Sugar Pill 0 mg|Overall Study||36
323399|NCT01498549|773533|P1|Atomoxetine 80 mg|Overall Study||37
323400|NCT01498549|773533|P1|Atomoxetine 40 mg|Overall Study||39
323401|NCT01498549|773533|P1|STARTED|Overall Study||39
323402|NCT01498458|773544|P1|NOT COMPLETED|Overall Study||7
323403|NCT01498458|773544|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
323404|NCT01498458|773544|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
323405|NCT01498419|773557|P4|NOT COMPLETED|Overall Study||19
323406|NCT01498419|773558|P3|NOT COMPLETED|Overall Study||18
323407|NCT01498419|773559|P2|NOT COMPLETED|Overall Study||23
323408|NCT01498419|773560|P1|NOT COMPLETED|Overall Study||18
323409|NCT01498419|773557|P4|COMPLETED|Overall Study||7
323410|NCT01498419|773558|P3|COMPLETED|Overall Study||41
323411|NCT01498419|773559|P2|COMPLETED|Overall Study||39
323412|NCT01498419|773560|P1|COMPLETED|Overall Study||42
323413|NCT01498419|773557|P4|STARTED|Overall Study||26
323414|NCT01498419|773558|P3|STARTED|Overall Study||59
323415|NCT01498419|773559|P2|STARTED|Overall Study||62
323416|NCT01498419|773560|P1|STARTED|Overall Study||60
323417|NCT01498185|773599|P5|NOT COMPLETED|Overall Study||3
323418|NCT01498185|773600|P4|NOT COMPLETED|Overall Study||3
323419|NCT01498185|773601|P3|NOT COMPLETED|Overall Study||0
323420|NCT01498185|773602|P2|NOT COMPLETED|Overall Study||1
323421|NCT01498185|773603|P1|NOT COMPLETED|Overall Study||1
323422|NCT01498185|773599|P5|COMPLETED|Overall Study||12
323423|NCT01498185|773600|P4|COMPLETED|Overall Study||11
323424|NCT01498185|773601|P3|COMPLETED|Overall Study||15
323425|NCT01498185|773602|P2|COMPLETED|Overall Study||12
323426|NCT01498185|773603|P1|COMPLETED|Overall Study||12
323427|NCT01498185|773599|P5|STARTED|Overall Study||15
323428|NCT01498185|773600|P4|STARTED|Overall Study||14
323429|NCT01498185|773601|P3|STARTED|Overall Study||15
323430|NCT01498185|773602|P2|STARTED|Overall Study||13
323431|NCT01498185|773603|P1|STARTED|Overall Study||13
323432|NCT01498120|773643|P1|NOT COMPLETED|Overall Study||13
323433|NCT01498120|773643|P1|COMPLETED|Overall Study||1
323434|NCT01498120|773643|P1|STARTED|Overall Study||14
323435|NCT01498068|773650|P2|NOT COMPLETED|Overall Study||1
323436|NCT01498068|773651|P1|NOT COMPLETED|Overall Study||1
323437|NCT01498068|773650|P2|COMPLETED|Overall Study||19
323438|NCT01498068|773651|P1|COMPLETED|Overall Study||15
323439|NCT01498068|773650|P2|STARTED|Overall Study||20
323440|NCT01498068|773651|P1|STARTED|Overall Study||16
323441|NCT01497938|773669|P2|NOT COMPLETED|Overall Study||2
323442|NCT01497938|773670|P1|NOT COMPLETED|Overall Study||5
323443|NCT01497938|773669|P2|COMPLETED|Overall Study||124
323444|NCT01497938|773670|P1|COMPLETED|Overall Study||116
323445|NCT01497938|773669|P2|STARTED|Overall Study||126
323446|NCT01497938|773670|P1|STARTED|Overall Study||121
323447|NCT01497899|773682|P4|NOT COMPLETED|Open-Label Extension Phase||38
323448|NCT01497899|773683|P3|NOT COMPLETED|Open-Label Extension Phase||70
323449|NCT01497899|773684|P2|NOT COMPLETED|Open-Label Extension Phase||53
323450|NCT01497899|773685|P1|NOT COMPLETED|Open-Label Extension Phase||105
323451|NCT01497899|773682|P4|COMPLETED|Open-Label Extension Phase||0
323452|NCT01497899|773683|P3|COMPLETED|Open-Label Extension Phase||0
323453|NCT01497899|773684|P2|COMPLETED|Open-Label Extension Phase||0
323454|NCT01497899|773685|P1|COMPLETED|Open-Label Extension Phase||0
323455|NCT01497899|773682|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored studies.|38
323456|NCT01497899|773683|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored studies.|70
323457|NCT01497899|773684|P2|STARTED|Open-Label Extension Phase||53
323550|NCT01496248|773975|P1|NOT COMPLETED|Overall Study||10
323458|NCT01497899|773685|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
323459|NCT01497899|773682|P4|NOT COMPLETED|Double-Blind Phase||0
323460|NCT01497899|773683|P3|NOT COMPLETED|Double-Blind Phase||0
323461|NCT01497899|773684|P2|NOT COMPLETED|Double-Blind Phase||5
323462|NCT01497899|773685|P1|NOT COMPLETED|Double-Blind Phase||6
323463|NCT01497899|773682|P4|COMPLETED|Double-Blind Phase||0
323464|NCT01497899|773683|P3|COMPLETED|Double-Blind Phase||0
323465|NCT01497899|773684|P2|COMPLETED|Double-Blind Phase||53
323466|NCT01497899|773685|P1|COMPLETED|Double-Blind Phase||107
323467|NCT01497899|773682|P4|STARTED|Double-Blind Phase||0
323468|NCT01497899|773683|P3|STARTED|Double-Blind Phase||0
323469|NCT01497899|773684|P2|STARTED|Double-Blind Phase||58
323470|NCT01497899|773685|P1|STARTED|Double-Blind Phase||113
323471|NCT01497756|773698|P1|NOT COMPLETED|Overall Study||0
323472|NCT01497756|773698|P1|COMPLETED|Overall Study||10
323473|NCT01497756|773698|P1|STARTED|Overall Study||10
323474|NCT01497665|773703|P1|NOT COMPLETED|Overall Study||0
323475|NCT01497665|773703|P1|COMPLETED|Overall Study||16
323476|NCT01497665|773703|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
323477|NCT01497665|773703|P1|STARTED|Overall Study||16
323478|NCT01497366|773713|P2|NOT COMPLETED|Overall Study||88
323479|NCT01497366|773714|P1|NOT COMPLETED|Overall Study||39
323480|NCT01497366|773713|P2|COMPLETED|Overall Study||176
323481|NCT01497366|773714|P1|COMPLETED|Overall Study||224
323482|NCT01497366|773713|P2|Randomized But Not Treated|Overall Study||21
323483|NCT01497366|773714|P1|Randomized But Not Treated|Overall Study||7
323484|NCT01497366|773713|P2|STARTED|Overall Study||264
323485|NCT01497366|773714|P1|STARTED|Overall Study||263
323486|NCT01497275|773732|P1|NOT COMPLETED|Overall Study||2
323487|NCT01497275|773732|P1|COMPLETED|Overall Study||3
323488|NCT01497275|773732|P1|STARTED|Overall Study||5
323489|NCT01497262|773739|P1|NOT COMPLETED|Overall Study||11
323490|NCT01497262|773739|P1|COMPLETED|Overall Study||151
323491|NCT01497262|773739|P1|STARTED|Overall Study||162
323492|NCT01497197|773746|P2|NOT COMPLETED|Overall Study||15
323493|NCT01497197|773747|P1|NOT COMPLETED|Overall Study||17
323494|NCT01497197|773746|P2|COMPLETED|Overall Study||70
323495|NCT01497197|773747|P1|COMPLETED|Overall Study||72
323496|NCT01497197|773746|P2|STARTED|Overall Study||85
323497|NCT01497197|773747|P1|STARTED|Overall Study||89
323498|NCT01497171|773775|P2|NOT COMPLETED|Overall Study||0
323499|NCT01497171|773776|P1|NOT COMPLETED|Overall Study||0
323500|NCT01497171|773775|P2|COMPLETED|Overall Study||3
323501|NCT01497171|773776|P1|COMPLETED|Overall Study||2
323502|NCT01497171|773775|P2|STARTED|Overall Study||3
323503|NCT01497171|773776|P1|STARTED|Overall Study||2
323504|NCT01496807|773782|P1|NOT COMPLETED|Overall Study||30
323505|NCT01496807|773782|P1|COMPLETED|Overall Study||1
323506|NCT01496807|773782|P1|STARTED|Overall Study||31
323507|NCT01496469|773794|P2|NOT COMPLETED|Overall Study||8
323508|NCT01496469|773795|P1|NOT COMPLETED|Overall Study||10
323509|NCT01496469|773794|P2|COMPLETED|Overall Study||53
323510|NCT01496469|773795|P1|COMPLETED|Overall Study||50
323511|NCT01496469|773794|P2|STARTED|Overall Study||61
323512|NCT01496469|773795|P1|STARTED|Overall Study||60
323513|NCT01496456|773805|P1|NOT COMPLETED|Overall Study||8
323514|NCT01496456|773805|P1|COMPLETED|Overall Study||9
323515|NCT01496456|773805|P1|3-yr Final Recall|Overall Study||9
323516|NCT01496456|773805|P1|2-yr Recall|Overall Study||10
323517|NCT01496456|773805|P1|1-yr Recall|Overall Study||12
323518|NCT01496456|773805|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
323519|NCT01496456|773805|P1|STARTED|Overall Study||17
323520|NCT01496430|773818|P3|NOT COMPLETED|Overall Study||10
323521|NCT01496430|773819|P2|NOT COMPLETED|Overall Study||5
323522|NCT01496430|773820|P1|NOT COMPLETED|Overall Study||6
323523|NCT01496430|773818|P3|COMPLETED|Overall Study||25
323524|NCT01496430|773819|P2|COMPLETED|Overall Study||30
323525|NCT01496430|773820|P1|COMPLETED|Overall Study||29
323526|NCT01496430|773818|P3|STARTED|Overall Study||35
323527|NCT01496430|773819|P2|STARTED|Overall Study||35
323528|NCT01496430|773820|P1|STARTED|Overall Study||35
323529|NCT01496352|773896|P2|NOT COMPLETED|Overall Study||0
323530|NCT01496352|773897|P1|NOT COMPLETED|Overall Study||0
323531|NCT01496352|773896|P2|COMPLETED|Overall Study||6
323532|NCT01496352|773897|P1|COMPLETED|Overall Study||24
323533|NCT01496352|773896|P2|STARTED|Overall Study||6
323534|NCT01496352|773897|P1|STARTED|Overall Study||24
323535|NCT01496313|773915|P2|NOT COMPLETED|Overall Study||15
323536|NCT01496313|773916|P1|NOT COMPLETED|Overall Study||5
323537|NCT01496313|773915|P2|COMPLETED|Overall Study||26
323538|NCT01496313|773916|P1|COMPLETED|Overall Study||35
323539|NCT01496313|773915|P2|STARTED|Overall Study||41
323540|NCT01496313|773916|P1|STARTED|Overall Study||40
323541|NCT01496287|773932|P1|NOT COMPLETED|Overall Study||6
323542|NCT01496287|773932|P1|COMPLETED|Overall Study||64
323543|NCT01496287|773932|P1|STARTED|Overall Study||70
323544|NCT01496274|773942|P2|NOT COMPLETED|Overall Study||5
323545|NCT01496274|773943|P1|NOT COMPLETED|Overall Study||3
323546|NCT01496274|773942|P2|COMPLETED|Overall Study||18
323547|NCT01496274|773943|P1|COMPLETED|Overall Study||37
323548|NCT01496274|773942|P2|STARTED|Overall Study||23
323549|NCT01496274|773943|P1|STARTED|Overall Study||40
323551|NCT01496248|773975|P1|COMPLETED|Overall Study||25
323552|NCT01496248|773975|P1|STARTED|Overall Study||35
323553|NCT01496183|773988|P2|NOT COMPLETED|Overall Study||2
323554|NCT01496183|773989|P1|NOT COMPLETED|Overall Study||3
323555|NCT01496183|773988|P2|COMPLETED|Overall Study||13
323556|NCT01496183|773989|P1|COMPLETED|Overall Study||6
323557|NCT01496183|773988|P2|STARTED|Overall Study||15
323558|NCT01496183|773989|P1|STARTED|Overall Study||9
323559|NCT01495975|773997|P2|NOT COMPLETED|Overall Study||0
323560|NCT01495975|773998|P1|NOT COMPLETED|Overall Study||1
323561|NCT01495975|773997|P2|COMPLETED|Overall Study||14
323562|NCT01495975|773998|P1|COMPLETED|Overall Study||14
323563|NCT01495975|773997|P2|STARTED|Overall Study||14
323564|NCT01495975|773998|P1|STARTED|Overall Study||15
323565|NCT01495923|774006|P2|NOT COMPLETED|Overall Study||0
323566|NCT01495923|774007|P1|NOT COMPLETED|Overall Study||0
323567|NCT01495923|774006|P2|COMPLETED|Overall Study||72
323568|NCT01495923|774007|P1|COMPLETED|Overall Study||73
323569|NCT01495923|774006|P2|STARTED|Overall Study||72
323570|NCT01495923|774007|P1|STARTED|Overall Study||73
323571|NCT01495858|774040|P3|NOT COMPLETED|Overall Study||0
323572|NCT01495858|774041|P2|NOT COMPLETED|Overall Study||0
323573|NCT01495858|774042|P1|NOT COMPLETED|Overall Study||0
323574|NCT01495858|774040|P3|COMPLETED|Overall Study||54
323575|NCT01495858|774041|P2|COMPLETED|Overall Study||106
323576|NCT01495858|774042|P1|COMPLETED|Overall Study||107
323577|NCT01495858|774040|P3|STARTED|Overall Study||54
323578|NCT01495858|774041|P2|STARTED|Overall Study||106
323579|NCT01495858|774042|P1|STARTED|Overall Study||107
323580|NCT01495793|774122|P1|NOT COMPLETED|Overall Study||2
323581|NCT01495793|774122|P1|COMPLETED|Overall Study||22
323582|NCT01495793|774122|P1|STARTED|Overall Study||24
323583|NCT01495702|774135|P2|NOT COMPLETED|Extension Phase||0
323584|NCT01495702|774136|P1|NOT COMPLETED|Extension Phase||0
323585|NCT01495702|774135|P2|COMPLETED|Extension Phase||2
323586|NCT01495702|774136|P1|COMPLETED|Extension Phase||26
323587|NCT01495702|774135|P2|STARTED|Extension Phase||2
323588|NCT01495702|774136|P1|STARTED|Extension Phase||26
323589|NCT01495702|774135|P2|NOT COMPLETED|Randomized Phase||28
323590|NCT01495702|774136|P1|NOT COMPLETED|Randomized Phase||26
323591|NCT01495702|774135|P2|COMPLETED|Randomized Phase||119
323592|NCT01495702|774136|P1|COMPLETED|Randomized Phase||266
323593|NCT01495702|774135|P2|STARTED|Randomized Phase||147
323594|NCT01495702|774136|P1|STARTED|Randomized Phase||292
323595|NCT01495689|774151|P2|NOT COMPLETED|Overall Study||7
323596|NCT01495689|774152|P1|NOT COMPLETED|Overall Study||10
323597|NCT01495689|774151|P2|COMPLETED|Overall Study||16
323598|NCT01495689|774152|P1|COMPLETED|Overall Study||16
323599|NCT01495689|774151|P2|STARTED|Overall Study||23
323600|NCT01495689|774152|P1|STARTED|Overall Study||26
323601|NCT01495585|774161|P3|NOT COMPLETED|Overall Study||0
323602|NCT01495585|774162|P2|NOT COMPLETED|Overall Study||0
323603|NCT01495585|774163|P1|NOT COMPLETED|Overall Study||0
323604|NCT01495585|774161|P3|COMPLETED|Overall Study||4
323605|NCT01495585|774162|P2|COMPLETED|Overall Study||6
323606|NCT01495585|774163|P1|COMPLETED|Overall Study||4
323607|NCT01495585|774161|P3|Open Label Lonafarnib 200 mg|Overall Study||0
323608|NCT01495585|774162|P2|Open Label Lonafarnib 200 mg|Overall Study||0
323609|NCT01495585|774163|P1|Open Label Lonafarnib 200 mg|Overall Study||2
323610|NCT01495585|774161|P3|STARTED|Overall Study||4
323611|NCT01495585|774162|P2|STARTED|Overall Study||6
323612|NCT01495585|774163|P1|STARTED|Overall Study||4
323613|NCT01495572|774176|P2|NOT COMPLETED|Overall Study||0
323614|NCT01495572|774177|P1|NOT COMPLETED|Overall Study||0
323615|NCT01495572|774176|P2|COMPLETED|Overall Study||5
323616|NCT01495572|774177|P1|COMPLETED|Overall Study||0
323617|NCT01495572|774176|P2|STARTED|Overall Study||5
323618|NCT01495572|774177|P1|STARTED|Overall Study||0
323619|NCT01495481|774185|P1|NOT COMPLETED|Dexmedetomidine||0
323620|NCT01495481|774185|P1|COMPLETED|Dexmedetomidine||22
323621|NCT01495481|774185|P1|STARTED|Dexmedetomidine||22
323622|NCT01495481|774185|P1|NOT COMPLETED|Washout||0
323623|NCT01495481|774185|P1|COMPLETED|Washout||22
323624|NCT01495481|774185|P1|STARTED|Washout||22
323625|NCT01495481|774185|P1|NOT COMPLETED|Adenosine||0
323626|NCT01495481|774185|P1|COMPLETED|Adenosine||22
323627|NCT01495481|774185|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
323628|NCT01495286|774197|P1|NOT COMPLETED|Overall Study||0
323629|NCT01495286|774197|P1|COMPLETED|Overall Study||30
323630|NCT01495286|774197|P1|STARTED|Overall Study||30
323631|NCT01495000|774207|P2|NOT COMPLETED|Overall Study||12
323632|NCT01495000|774208|P1|NOT COMPLETED|Overall Study||13
323633|NCT01495000|774207|P2|COMPLETED|Overall Study||114
323634|NCT01495000|774208|P1|COMPLETED|Overall Study||111
323635|NCT01495000|774207|P2|STARTED|Overall Study||126
323636|NCT01495000|774208|P1|STARTED|Overall Study||124
323637|NCT01494987|774250|P2|NOT COMPLETED|Overall Study||28
323638|NCT01494987|774251|P1|NOT COMPLETED|Overall Study||28
323639|NCT01494987|774250|P2|COMPLETED|Overall Study||187
323640|NCT01494987|774251|P1|COMPLETED|Overall Study||188
323641|NCT01494987|774250|P2|STARTED|Overall Study||215
323642|NCT01494987|774251|P1|STARTED|Overall Study||216
323643|NCT01494818|774265|P2|NOT COMPLETED|Overall Study||2
323644|NCT01494818|774266|P1|NOT COMPLETED|Overall Study||2
323645|NCT01494818|774265|P2|COMPLETED|Overall Study||37
323646|NCT01494818|774266|P1|COMPLETED|Overall Study||37
323647|NCT01494818|774265|P2|STARTED|Overall Study||39
323648|NCT01494818|774266|P1|STARTED|Overall Study||39
323649|NCT01494753|774288|P2|NOT COMPLETED|Day42-Day84||0
323650|NCT01494753|774289|P1|NOT COMPLETED|Day42-Day84||0
323651|NCT01494753|774288|P2|COMPLETED|Day42-Day84||15
323652|NCT01494753|774289|P1|COMPLETED|Day42-Day84||15
323653|NCT01494753|774288|P2|STARTED|Day42-Day84||15
323654|NCT01494753|774289|P1|STARTED|Day42-Day84||15
323655|NCT01494753|774288|P2|NOT COMPLETED|Day0-Day42||0
323656|NCT01494753|774289|P1|NOT COMPLETED|Day0-Day42||0
323657|NCT01494753|774288|P2|COMPLETED|Day0-Day42||15
323658|NCT01494753|774289|P1|COMPLETED|Day0-Day42||15
323659|NCT01494753|774288|P2|STARTED|Day0-Day42||15
323660|NCT01494753|774289|P1|STARTED|Day0-Day42||15
323661|NCT01494649|774297|P2|NOT COMPLETED|Overall Study||1
323662|NCT01494649|774298|P1|NOT COMPLETED|Overall Study||0
323663|NCT01494649|774297|P2|COMPLETED|Overall Study||58
323664|NCT01494649|774298|P1|COMPLETED|Overall Study||59
323665|NCT01494649|774297|P2|STARTED|Overall Study||59
323666|NCT01494649|774298|P1|STARTED|Overall Study||59
323667|NCT01494610|774314|P2|NOT COMPLETED|Period 4||0
323668|NCT01494610|774315|P1|NOT COMPLETED|Period 4||1
323669|NCT01494610|774314|P2|COMPLETED|Period 4||28
323670|NCT01494610|774315|P1|COMPLETED|Period 4||27
323671|NCT01494610|774314|P2|STARTED|Period 4||28
323672|NCT01494610|774315|P1|STARTED|Period 4||28
323673|NCT01494610|774314|P2|NOT COMPLETED|Period 3||0
323674|NCT01494610|774315|P1|NOT COMPLETED|Period 3||2
323675|NCT01494610|774314|P2|COMPLETED|Period 3||28
323676|NCT01494610|774315|P1|COMPLETED|Period 3||28
323677|NCT01494610|774314|P2|STARTED|Period 3||28
323678|NCT01494610|774315|P1|STARTED|Period 3||30
323679|NCT01494610|774314|P2|NOT COMPLETED|Period 2||0
323680|NCT01494610|774315|P1|NOT COMPLETED|Period 2||0
323681|NCT01494610|774314|P2|COMPLETED|Period 2||28
323682|NCT01494610|774315|P1|COMPLETED|Period 2||30
323683|NCT01494610|774314|P2|STARTED|Period 2||28
323684|NCT01494610|774315|P1|STARTED|Period 2||30
323685|NCT01494610|774314|P2|NOT COMPLETED|Period 1||1
323686|NCT01494610|774315|P1|NOT COMPLETED|Period 1||1
323687|NCT01494610|774314|P2|COMPLETED|Period 1||28
323688|NCT01494610|774315|P1|COMPLETED|Period 1||30
323689|NCT01494610|774314|P2|STARTED|Period 1||29
323690|NCT01494610|774315|P1|STARTED|Period 1||31
323691|NCT01494584|774383|P1|NOT COMPLETED|Overall Study||1
323692|NCT01494584|774383|P1|COMPLETED|Overall Study||4
323693|NCT01494584|774383|P1|STARTED|Overall Study||5
323694|NCT01494545|774472|P1|NOT COMPLETED|Overall Study||10
323695|NCT01494545|774472|P1|COMPLETED|Overall Study||92
323696|NCT01494545|774472|P1|STARTED|Overall Study||102
323697|NCT01494532|774515|P6|NOT COMPLETED|Overall Study||0
323698|NCT01494532|774516|P5|NOT COMPLETED|Overall Study||12
323699|NCT01494532|774517|P4|NOT COMPLETED|Overall Study||15
323700|NCT01494532|774518|P3|NOT COMPLETED|Overall Study||17
323701|NCT01494532|774519|P2|NOT COMPLETED|Overall Study||4
323702|NCT01494532|774520|P1|NOT COMPLETED|Overall Study||10
323703|NCT01494532|774515|P6|COMPLETED|Overall Study||25
323704|NCT01494532|774516|P5|COMPLETED|Overall Study||64
323705|NCT01494532|774517|P4|COMPLETED|Overall Study||60
323706|NCT01494532|774518|P3|COMPLETED|Overall Study||59
323707|NCT01494532|774519|P2|COMPLETED|Overall Study||21
323708|NCT01494532|774520|P1|COMPLETED|Overall Study||65
323709|NCT01494532|774515|P6|STARTED|Overall Study||25
323710|NCT01494532|774516|P5|STARTED|Overall Study||76
323711|NCT01494532|774517|P4|STARTED|Overall Study||75
323712|NCT01494532|774518|P3|STARTED|Overall Study||76
323713|NCT01494532|774519|P2|STARTED|Overall Study||25
323714|NCT01494532|774520|P1|STARTED|Overall Study||75
323715|NCT01494506|774675|P3|NOT COMPLETED|Overall Study||103
323716|NCT01494506|774676|P2|NOT COMPLETED|Overall Study||143
323717|NCT01494506|774677|P1|NOT COMPLETED|Overall Study||148
323718|NCT01494506|774675|P3|COMPLETED|Overall Study||14
323719|NCT01494506|774676|P2|COMPLETED|Overall Study||6
323720|NCT01494506|774677|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
323721|NCT01494506|774675|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
323722|NCT01494506|774676|P2|Treated Population|Overall Study||134
323723|NCT01494506|774677|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
323724|NCT01494506|774675|P3|STARTED|Overall Study||117
323725|NCT01494506|774676|P2|STARTED|Overall Study||149
323726|NCT01494506|774677|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
323727|NCT01494467|774714|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
323728|NCT01494467|774715|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
323729|NCT01494467|774714|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
323730|NCT01494467|774715|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
323731|NCT01494467|774714|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
323732|NCT01494467|774715|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
323733|NCT01494467|774714|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
323734|NCT01494467|774715|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
323735|NCT01494467|774714|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
323736|NCT01494467|774715|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
323901|NCT01491737|775076|P2|STARTED|Overall Study||129
323737|NCT01494467|774714|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
323738|NCT01494467|774715|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
323739|NCT01494467|774714|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
323740|NCT01494467|774715|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
323741|NCT01494467|774714|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
323742|NCT01494467|774715|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
323743|NCT01494467|774714|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
323744|NCT01494467|774715|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
323745|NCT01494350|774731|P1|NOT COMPLETED|Overall Study||1
323746|NCT01494350|774731|P1|COMPLETED|Overall Study||49
323747|NCT01494350|774731|P1|STARTED|Overall Study||50
323748|NCT01494298|774741|P2|NOT COMPLETED|Overall Study||8
323749|NCT01494298|774742|P1|NOT COMPLETED|Overall Study||2
323750|NCT01494298|774741|P2|COMPLETED|Overall Study||47
323751|NCT01494298|774742|P1|COMPLETED|Overall Study||54
323752|NCT01494298|774741|P2|STARTED|Overall Study||55
323753|NCT01494298|774742|P1|STARTED|Overall Study||56
323754|NCT01493947|774754|P2|NOT COMPLETED|Period B Extension Period||32
323755|NCT01493947|774755|P1|NOT COMPLETED|Period B Extension Period||33
323756|NCT01493947|774754|P2|COMPLETED|Period B Extension Period||326
323757|NCT01493947|774755|P1|COMPLETED|Period B Extension Period||366
323758|NCT01493947|774754|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
323759|NCT01493947|774755|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
323760|NCT01493947|774754|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
323761|NCT01493947|774755|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
323762|NCT01493947|774754|P2|COMPLETED|Period A Efficacy and Safety Data||456
323763|NCT01493947|774755|P1|COMPLETED|Period A Efficacy and Safety Data||446
323764|NCT01493947|774754|P2|STARTED|Period A Efficacy and Safety Data||484
323765|NCT01493947|774755|P1|STARTED|Period A Efficacy and Safety Data||478
323766|NCT01493687|774767|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
323767|NCT01493687|774768|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
323768|NCT01493687|774767|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
323769|NCT01493687|774768|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
323770|NCT01493687|774767|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
323771|NCT01493687|774768|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
323772|NCT01493687|774767|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
323773|NCT01493687|774768|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
323774|NCT01493687|774767|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
323775|NCT01493687|774768|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
323776|NCT01493687|774767|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
323777|NCT01493687|774768|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
323778|NCT01493687|774767|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
323779|NCT01493687|774768|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
323780|NCT01493687|774767|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
323781|NCT01493687|774768|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
323782|NCT01493687|774767|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
323783|NCT01493687|774768|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
323784|NCT01493557|774787|P3|NOT COMPLETED|Adding the Second Strategy||0
323785|NCT01493557|774788|P2|NOT COMPLETED|Adding the Second Strategy||4
323786|NCT01493557|774789|P1|NOT COMPLETED|Adding the Second Strategy||2
323787|NCT01493557|774787|P3|COMPLETED|Adding the Second Strategy||0
323788|NCT01493557|774788|P2|COMPLETED|Adding the Second Strategy||11
323789|NCT01493557|774789|P1|COMPLETED|Adding the Second Strategy||12
323790|NCT01493557|774787|P3|STARTED|Adding the Second Strategy||0
323791|NCT01493557|774788|P2|STARTED|Adding the Second Strategy||15
323792|NCT01493557|774789|P1|STARTED|Adding the Second Strategy||14
323793|NCT01493557|774787|P3|NOT COMPLETED|Randomized to Management Strategies||0
323794|NCT01493557|774788|P2|NOT COMPLETED|Randomized to Management Strategies||11
323795|NCT01493557|774789|P1|NOT COMPLETED|Randomized to Management Strategies||15
323796|NCT01493557|774787|P3|COMPLETED|Randomized to Management Strategies||0
323797|NCT01493557|774788|P2|COMPLETED|Randomized to Management Strategies||47
323798|NCT01493557|774789|P1|COMPLETED|Randomized to Management Strategies||44
323799|NCT01493557|774787|P3|STARTED|Randomized to Management Strategies||0
323800|NCT01493557|774788|P2|STARTED|Randomized to Management Strategies||58
323801|NCT01493557|774789|P1|STARTED|Randomized to Management Strategies||59
323802|NCT01493557|774787|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
323803|NCT01493557|774788|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
323804|NCT01493557|774789|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
323805|NCT01493557|774787|P3|COMPLETED|Not Randomized to Management Strategies||816
323806|NCT01493557|774788|P2|COMPLETED|Not Randomized to Management Strategies||0
323807|NCT01493557|774789|P1|COMPLETED|Not Randomized to Management Strategies||0
323808|NCT01493557|774787|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
323809|NCT01493557|774788|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
323810|NCT01493557|774789|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
323811|NCT01493557|774787|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
323812|NCT01493557|774788|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
323813|NCT01493557|774789|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
323814|NCT01493557|774787|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
323815|NCT01493557|774788|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
323816|NCT01493557|774789|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
323817|NCT01493557|774787|P3|STARTED|Not Randomized to Management Strategies||950
323818|NCT01493557|774788|P2|STARTED|Not Randomized to Management Strategies||0
323819|NCT01493557|774789|P1|STARTED|Not Randomized to Management Strategies||0
323820|NCT01493531|774817|P3|NOT COMPLETED|Overall Study||48
323821|NCT01493531|774818|P2|NOT COMPLETED|Overall Study||50
323822|NCT01493531|774819|P1|NOT COMPLETED|Overall Study||41
323823|NCT01493531|774817|P3|COMPLETED|Overall Study||158
323824|NCT01493531|774818|P2|COMPLETED|Overall Study||150
323825|NCT01493531|774819|P1|COMPLETED|Overall Study||163
323826|NCT01493531|774817|P3|STARTED|Overall Study||206
323827|NCT01493531|774818|P2|STARTED|Overall Study||200
323828|NCT01493531|774819|P1|STARTED|Overall Study||204
323829|NCT01493427|774833|P1|NOT COMPLETED|Overall Study||20
323830|NCT01493427|774833|P1|COMPLETED|Overall Study||179
323831|NCT01493427|774833|P1|STARTED|Overall Study||199
323832|NCT01493180|774840|P2|NOT COMPLETED|Overall Study||2
323833|NCT01493180|774841|P1|NOT COMPLETED|Overall Study||3
323834|NCT01493180|774840|P2|COMPLETED|Overall Study||49
323835|NCT01493180|774841|P1|COMPLETED|Overall Study||48
323836|NCT01493180|774840|P2|STARTED|Overall Study||51
323837|NCT01493180|774841|P1|STARTED|Overall Study||51
323838|NCT01493167|774847|P1|NOT COMPLETED|Overall Study||0
323839|NCT01493167|774847|P1|COMPLETED|Overall Study||97
323840|NCT01493167|774847|P1|STARTED|Overall Study||97
323841|NCT01493089|774853|P2|NOT COMPLETED|Overall Study||3
323842|NCT01493089|774854|P1|NOT COMPLETED|Overall Study||3
323843|NCT01493089|774853|P2|COMPLETED|Overall Study||114
323844|NCT01493089|774854|P1|COMPLETED|Overall Study||119
323845|NCT01493089|774853|P2|STARTED|Overall Study||117
323846|NCT01493089|774854|P1|STARTED|Overall Study||122
323847|NCT01492439|774872|P2|NOT COMPLETED|Overall Study||9
323848|NCT01492439|774873|P1|NOT COMPLETED|Overall Study||4
323849|NCT01492439|774872|P2|COMPLETED|Overall Study||9
323850|NCT01492439|774873|P1|COMPLETED|Overall Study||15
323851|NCT01492439|774872|P2|Post-intervention|Overall Study||13
323852|NCT01492439|774873|P1|Post-intervention|Overall Study||18
323853|NCT01492439|774872|P2|STARTED|Overall Study||18
323854|NCT01492439|774873|P1|STARTED|Overall Study||19
323855|NCT01492426|774921|P2|NOT COMPLETED|Follow-Up||10
323856|NCT01492426|774922|P1|NOT COMPLETED|Follow-Up||25
323857|NCT01492426|774921|P2|COMPLETED|Follow-Up||181
323858|NCT01492426|774922|P1|COMPLETED|Follow-Up||359
323859|NCT01492426|774921|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
323860|NCT01492426|774922|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
323861|NCT01492426|774921|P2|NOT COMPLETED|Treatment||40
323862|NCT01492426|774922|P1|NOT COMPLETED|Treatment||83
323863|NCT01492426|774921|P2|COMPLETED|Treatment||160
323864|NCT01492426|774922|P1|COMPLETED|Treatment||319
323865|NCT01492426|774921|P2|STARTED|Treatment||200
323866|NCT01492426|774922|P1|STARTED|Treatment||402
323867|NCT01492400|774940|P2|NOT COMPLETED|Overall Study||16
323868|NCT01492400|774941|P1|NOT COMPLETED|Overall Study||16
323869|NCT01492400|774940|P2|COMPLETED|Overall Study||166
323870|NCT01492400|774941|P1|COMPLETED|Overall Study||165
323871|NCT01492400|774940|P2|STARTED|Overall Study||182
323872|NCT01492400|774941|P1|STARTED|Overall Study||181
323873|NCT01492088|774954|P3|NOT COMPLETED|Overall Study||13
323874|NCT01492088|774955|P2|NOT COMPLETED|Overall Study||14
323875|NCT01492088|774956|P1|NOT COMPLETED|Overall Study||3
323876|NCT01492088|774954|P3|COMPLETED|Overall Study||4
323877|NCT01492088|774955|P2|COMPLETED|Overall Study||2
323878|NCT01492088|774956|P1|COMPLETED|Overall Study||0
323879|NCT01492088|774954|P3|STARTED|Overall Study||17
323880|NCT01492088|774955|P2|STARTED|Overall Study||16
323881|NCT01492088|774956|P1|STARTED|Overall Study||3
323882|NCT01491984|775016|P2|NOT COMPLETED|Overall Study||1
323883|NCT01491984|775017|P1|NOT COMPLETED|Overall Study||2
323884|NCT01491984|775016|P2|COMPLETED|Overall Study||44
323885|NCT01491984|775017|P1|COMPLETED|Overall Study||47
323886|NCT01491984|775016|P2|STARTED|Overall Study||45
323887|NCT01491984|775017|P1|STARTED|Overall Study||49
323888|NCT01491919|775026|P3|NOT COMPLETED|Overall Study||1
323889|NCT01491919|775027|P2|NOT COMPLETED|Overall Study||2
323890|NCT01491919|775028|P1|NOT COMPLETED|Overall Study||1
323891|NCT01491919|775026|P3|COMPLETED|Overall Study||2
323892|NCT01491919|775027|P2|COMPLETED|Overall Study||8
323893|NCT01491919|775028|P1|COMPLETED|Overall Study||12
323894|NCT01491919|775026|P3|STARTED|Overall Study||3
323895|NCT01491919|775027|P2|STARTED|Overall Study||10
323896|NCT01491919|775028|P1|STARTED|Overall Study||13
323897|NCT01491737|775076|P2|NOT COMPLETED|Overall Study||50
323898|NCT01491737|775077|P1|NOT COMPLETED|Overall Study||49
323899|NCT01491737|775076|P2|COMPLETED|Overall Study||79
323900|NCT01491737|775077|P1|COMPLETED|Overall Study||80
323902|NCT01491737|775077|P1|STARTED|Overall Study||129
323903|NCT01491672|775100|P3|NOT COMPLETED|Overall Study||11
323904|NCT01491672|775101|P2|NOT COMPLETED|Overall Study||60
323905|NCT01491672|775102|P1|NOT COMPLETED|Overall Study||56
323906|NCT01491672|775100|P3|COMPLETED|Overall Study||3
323907|NCT01491672|775101|P2|COMPLETED|Overall Study||2
323908|NCT01491672|775102|P1|COMPLETED|Overall Study||2
323909|NCT01491672|775100|P3|Safety Set|Overall Study||14
323910|NCT01491672|775101|P2|Safety Set|Overall Study||61
323911|NCT01491672|775102|P1|Safety Set|Overall Study||58
323912|NCT01491672|775100|P3|STARTED|Overall Study||14
323913|NCT01491672|775101|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
323914|NCT01491672|775102|P1|STARTED|Overall Study||58
323915|NCT01491633|775127|P1|NOT COMPLETED|Overall Study||5
323916|NCT01491633|775127|P1|COMPLETED|Overall Study||0
323917|NCT01491633|775127|P1|STARTED|Overall Study||5
323918|NCT01491607|775139|P1|NOT COMPLETED|Overall Study||10
323919|NCT01491607|775139|P1|COMPLETED|Overall Study||190
323920|NCT01491607|775139|P1|STARTED|Overall Study||200
323921|NCT01491490|775237|P2|NOT COMPLETED|Overall Study||0
323922|NCT01491490|775238|P1|NOT COMPLETED|Overall Study||0
323923|NCT01491490|775237|P2|COMPLETED|Overall Study||1
323924|NCT01491490|775238|P1|COMPLETED|Overall Study||1
323925|NCT01491490|775237|P2|STARTED|Overall Study||1
323926|NCT01491490|775238|P1|STARTED|Overall Study||1
323927|NCT01491113|775249|P5|NOT COMPLETED|Overall Study||0
323928|NCT01491113|775250|P4|NOT COMPLETED|Overall Study||0
323929|NCT01491113|775251|P3|NOT COMPLETED|Overall Study||0
323930|NCT01491113|775252|P2|NOT COMPLETED|Overall Study||0
323931|NCT01491113|775253|P1|NOT COMPLETED|Overall Study||0
323932|NCT01491113|775249|P5|COMPLETED|Overall Study||6
323933|NCT01491113|775250|P4|COMPLETED|Overall Study||6
323934|NCT01491113|775251|P3|COMPLETED|Overall Study||6
323935|NCT01491113|775252|P2|COMPLETED|Overall Study||6
323936|NCT01491113|775253|P1|COMPLETED|Overall Study||6
323937|NCT01491113|775249|P5|STARTED|Overall Study||6
323938|NCT01491113|775250|P4|STARTED|Overall Study||6
323939|NCT01491113|775251|P3|STARTED|Overall Study||6
323940|NCT01491113|775252|P2|STARTED|Overall Study||6
323941|NCT01491113|775253|P1|STARTED|Overall Study||6
323942|NCT01491035|775348|P8|NOT COMPLETED|Overall Study||0
323943|NCT01491035|775349|P7|NOT COMPLETED|Overall Study||0
323944|NCT01491035|775350|P6|NOT COMPLETED|Overall Study||0
323945|NCT01491035|775351|P5|NOT COMPLETED|Overall Study||1
323946|NCT01491035|775352|P4|NOT COMPLETED|Overall Study||0
323947|NCT01491035|775353|P3|NOT COMPLETED|Overall Study||0
323948|NCT01491035|775354|P2|NOT COMPLETED|Overall Study||0
323949|NCT01491035|775355|P1|NOT COMPLETED|Overall Study||0
323950|NCT01491035|775348|P8|COMPLETED|Overall Study||6
323951|NCT01491035|775349|P7|COMPLETED|Overall Study||6
323952|NCT01491035|775350|P6|COMPLETED|Overall Study||6
323953|NCT01491035|775351|P5|COMPLETED|Overall Study||5
323954|NCT01491035|775352|P4|COMPLETED|Overall Study||6
323955|NCT01491035|775353|P3|COMPLETED|Overall Study||6
323956|NCT01491035|775354|P2|COMPLETED|Overall Study||6
323957|NCT01491035|775355|P1|COMPLETED|Overall Study||6
323958|NCT01491035|775348|P8|STARTED|Overall Study||6
323959|NCT01491035|775349|P7|STARTED|Overall Study||6
323960|NCT01491035|775350|P6|STARTED|Overall Study||6
323961|NCT01491035|775351|P5|STARTED|Overall Study||6
323962|NCT01491035|775352|P4|STARTED|Overall Study||6
323963|NCT01491035|775353|P3|STARTED|Overall Study||6
323964|NCT01491035|775354|P2|STARTED|Overall Study||6
323965|NCT01491035|775355|P1|STARTED|Overall Study||6
323966|NCT01491022|775423|P2|NOT COMPLETED|Intervention 2||0
323967|NCT01491022|775424|P1|NOT COMPLETED|Intervention 2||1
323968|NCT01491022|775423|P2|COMPLETED|Intervention 2||11
323969|NCT01491022|775424|P1|COMPLETED|Intervention 2||8
323970|NCT01491022|775423|P2|STARTED|Intervention 2||11
323971|NCT01491022|775424|P1|STARTED|Intervention 2||9
323972|NCT01491022|775423|P2|NOT COMPLETED|2 Week Washout||0
323973|NCT01491022|775424|P1|NOT COMPLETED|2 Week Washout||0
323974|NCT01491022|775423|P2|COMPLETED|2 Week Washout||11
323975|NCT01491022|775424|P1|COMPLETED|2 Week Washout||9
323976|NCT01491022|775423|P2|STARTED|2 Week Washout||11
323977|NCT01491022|775424|P1|STARTED|2 Week Washout||9
323978|NCT01491022|775423|P2|NOT COMPLETED|Intervention 1||1
323979|NCT01491022|775424|P1|NOT COMPLETED|Intervention 1||1
323980|NCT01491022|775423|P2|COMPLETED|Intervention 1||11
323981|NCT01491022|775424|P1|COMPLETED|Intervention 1||9
323982|NCT01491022|775423|P2|STARTED|Intervention 1||12
323983|NCT01491022|775424|P1|STARTED|Intervention 1||10
323984|NCT01489956|775442|P3|NOT COMPLETED|Overall Study||1
323985|NCT01489956|775443|P2|NOT COMPLETED|Overall Study||0
323986|NCT01489956|775444|P1|NOT COMPLETED|Overall Study||1
323987|NCT01489956|775442|P3|COMPLETED|Overall Study||5
323988|NCT01489956|775443|P2|COMPLETED|Overall Study||0
323989|NCT01489956|775444|P1|COMPLETED|Overall Study||12
323990|NCT01489956|775442|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
323991|NCT01489956|775443|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
323992|NCT01489956|775444|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
323993|NCT01489891|775481|P2|NOT COMPLETED|Overall Study||0
323994|NCT01489891|775482|P1|NOT COMPLETED|Overall Study||1
323995|NCT01489891|775481|P2|COMPLETED|Overall Study||60
323996|NCT01489891|775482|P1|COMPLETED|Overall Study||59
323997|NCT01489891|775481|P2|STARTED|Overall Study||60
323998|NCT01489891|775482|P1|STARTED|Overall Study||60
323999|NCT01489826|775503|P9|NOT COMPLETED|Overall Study||0
324000|NCT01489826|775504|P8|NOT COMPLETED|Overall Study||0
324001|NCT01489826|775505|P7|NOT COMPLETED|Overall Study||0
324002|NCT01489826|775506|P6|NOT COMPLETED|Overall Study||0
324003|NCT01489826|775507|P5|NOT COMPLETED|Overall Study||0
324004|NCT01489826|775508|P4|NOT COMPLETED|Overall Study||0
324005|NCT01489826|775509|P3|NOT COMPLETED|Overall Study||0
324006|NCT01489826|775510|P2|NOT COMPLETED|Overall Study||0
324007|NCT01489826|775511|P1|NOT COMPLETED|Overall Study||0
324008|NCT01489826|775503|P9|COMPLETED|Overall Study||6
324009|NCT01489826|775504|P8|COMPLETED|Overall Study||3
324010|NCT01489826|775505|P7|COMPLETED|Overall Study||9
324011|NCT01489826|775506|P6|COMPLETED|Overall Study||3
324012|NCT01489826|775507|P5|COMPLETED|Overall Study||3
324013|NCT01489826|775508|P4|COMPLETED|Overall Study||7
324014|NCT01489826|775509|P3|COMPLETED|Overall Study||3
324015|NCT01489826|775510|P2|COMPLETED|Overall Study||3
324016|NCT01489826|775511|P1|COMPLETED|Overall Study||3
324017|NCT01489826|775503|P9|STARTED|Overall Study||6
324018|NCT01489826|775504|P8|STARTED|Overall Study||3
324019|NCT01489826|775505|P7|STARTED|Overall Study||9
324020|NCT01489826|775506|P6|STARTED|Overall Study||3
324021|NCT01489826|775507|P5|STARTED|Overall Study||3
324022|NCT01489826|775508|P4|STARTED|Overall Study||7
324023|NCT01489826|775509|P3|STARTED|Overall Study||3
324024|NCT01489826|775510|P2|STARTED|Overall Study||3
324025|NCT01489826|775511|P1|STARTED|Overall Study||3
324026|NCT01490931|775608|P1|NOT COMPLETED|Overall Study||0
324027|NCT01490931|775608|P1|COMPLETED|Overall Study||25
324028|NCT01490931|775608|P1|STARTED|Overall Study||25
324029|NCT01490866|775624|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
324030|NCT01490866|775624|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
324031|NCT01490866|775624|P1|STARTED|Axitinib Maintenance Therapy||49
324032|NCT01490866|775624|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
324033|NCT01490866|775624|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
324034|NCT01490866|775624|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
324035|NCT01490840|775635|P2|NOT COMPLETED|Phase 2||6
324036|NCT01490840|775636|P1|NOT COMPLETED|Phase 2||6
324037|NCT01490840|775635|P2|COMPLETED|Phase 2||68
324038|NCT01490840|775636|P1|COMPLETED|Phase 2||75
324039|NCT01490840|775635|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
324040|NCT01490840|775636|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
324041|NCT01490840|775635|P2|NOT COMPLETED|Phase 1||6
324042|NCT01490840|775636|P1|NOT COMPLETED|Phase 1||10
324043|NCT01490840|775635|P2|COMPLETED|Phase 1||78
324044|NCT01490840|775636|P1|COMPLETED|Phase 1||84
324045|NCT01490840|775635|P2|Modified Full Analysis Set|Phase 1||83
324046|NCT01490840|775636|P1|Modified Full Analysis Set|Phase 1||56
324047|NCT01490840|775635|P2|STARTED|Phase 1||84
324048|NCT01490840|775636|P1|STARTED|Phase 1||94
324049|NCT01490294|775662|P4|NOT COMPLETED|Overall Study||1
324050|NCT01490294|775663|P3|NOT COMPLETED|Overall Study||1
324051|NCT01490294|775664|P2|NOT COMPLETED|Overall Study||0
324052|NCT01490294|775665|P1|NOT COMPLETED|Overall Study||5
324053|NCT01490294|775662|P4|COMPLETED|Overall Study||54
324054|NCT01490294|775663|P3|COMPLETED|Overall Study||58
324055|NCT01490294|775664|P2|COMPLETED|Overall Study||60
324056|NCT01490294|775665|P1|COMPLETED|Overall Study||53
324057|NCT01490294|775662|P4|Participant Received Treatment|Overall Study||54
324058|NCT01490294|775663|P3|Participant Received Treatment|Overall Study||58
324059|NCT01490294|775664|P2|Participant Received Treatment|Overall Study||60
324060|NCT01490294|775665|P1|Participant Received Treatment|Overall Study||54
324061|NCT01490294|775662|P4|STARTED|Overall Study||55
324062|NCT01490294|775663|P3|STARTED|Overall Study||59
324063|NCT01490294|775664|P2|STARTED|Overall Study||60
324064|NCT01490294|775665|P1|STARTED|Overall Study||58
324065|NCT01490190|775899|P1|NOT COMPLETED|Overall Study||48
324066|NCT01490190|775899|P1|COMPLETED|Overall Study||204
324067|NCT01490190|775899|P1|STARTED|Overall Study||252
324068|NCT01490125|775920|P6|NOT COMPLETED|Period III||0
324069|NCT01490125|775921|P5|NOT COMPLETED|Period III||1
324070|NCT01490125|775922|P4|NOT COMPLETED|Period III||2
324071|NCT01490125|775923|P3|NOT COMPLETED|Period III||0
324072|NCT01490125|775924|P2|NOT COMPLETED|Period III||1
324073|NCT01490125|775925|P1|NOT COMPLETED|Period III||3
324074|NCT01490125|775920|P6|COMPLETED|Period III||35
324075|NCT01490125|775921|P5|COMPLETED|Period III||31
324076|NCT01490125|775922|P4|COMPLETED|Period III||28
324077|NCT01490125|775923|P3|COMPLETED|Period III||34
324078|NCT01490125|775924|P2|COMPLETED|Period III||32
324079|NCT01490125|775925|P1|COMPLETED|Period III||31
324080|NCT01490125|775920|P6|STARTED|Period III||35
324081|NCT01490125|775921|P5|STARTED|Period III||32
324082|NCT01490125|775922|P4|STARTED|Period III||30
324083|NCT01490125|775923|P3|STARTED|Period III||34
324084|NCT01490125|775924|P2|STARTED|Period III||33
324085|NCT01490125|775925|P1|STARTED|Period III||34
324086|NCT01490125|775920|P6|NOT COMPLETED|Period II||2
324087|NCT01490125|775921|P5|NOT COMPLETED|Period II||4
324088|NCT01490125|775922|P4|NOT COMPLETED|Period II||3
324089|NCT01490125|775923|P3|NOT COMPLETED|Period II||3
324090|NCT01490125|775924|P2|NOT COMPLETED|Period II||4
324091|NCT01490125|775925|P1|NOT COMPLETED|Period II||3
324092|NCT01490125|775920|P6|COMPLETED|Period II||35
324093|NCT01490125|775921|P5|COMPLETED|Period II||32
324094|NCT01490125|775922|P4|COMPLETED|Period II||30
324095|NCT01490125|775923|P3|COMPLETED|Period II||34
324096|NCT01490125|775924|P2|COMPLETED|Period II||33
324097|NCT01490125|775925|P1|COMPLETED|Period II||34
324098|NCT01490125|775920|P6|STARTED|Period II||37
324099|NCT01490125|775921|P5|STARTED|Period II||36
324100|NCT01490125|775922|P4|STARTED|Period II||33
324101|NCT01490125|775923|P3|STARTED|Period II||37
324102|NCT01490125|775924|P2|STARTED|Period II||37
324103|NCT01490125|775925|P1|STARTED|Period II||37
324104|NCT01490125|775920|P6|NOT COMPLETED|Period I||5
324105|NCT01490125|775921|P5|NOT COMPLETED|Period I||4
324106|NCT01490125|775922|P4|NOT COMPLETED|Period I||5
324107|NCT01490125|775923|P3|NOT COMPLETED|Period I||4
324108|NCT01490125|775924|P2|NOT COMPLETED|Period I||5
324109|NCT01490125|775925|P1|NOT COMPLETED|Period I||6
324110|NCT01490125|775920|P6|COMPLETED|Period I||37
324111|NCT01490125|775921|P5|COMPLETED|Period I||36
324112|NCT01490125|775922|P4|COMPLETED|Period I||33
324113|NCT01490125|775923|P3|COMPLETED|Period I||37
324114|NCT01490125|775924|P2|COMPLETED|Period I||37
324115|NCT01490125|775925|P1|COMPLETED|Period I||37
324116|NCT01490125|775920|P6|STARTED|Period I||42
324117|NCT01490125|775921|P5|STARTED|Period I||40
324118|NCT01490125|775922|P4|STARTED|Period I||38
324119|NCT01490125|775923|P3|STARTED|Period I||41
324120|NCT01490125|775924|P2|STARTED|Period I||42
324121|NCT01490125|775925|P1|STARTED|Period I||43
324122|NCT01490086|775953|P5|NOT COMPLETED|Overall Study||11
324123|NCT01490086|775954|P4|NOT COMPLETED|Overall Study||7
324124|NCT01490086|775955|P3|NOT COMPLETED|Overall Study||7
324125|NCT01490086|775956|P2|NOT COMPLETED|Overall Study||15
324126|NCT01490086|775957|P1|NOT COMPLETED|Overall Study||8
324127|NCT01490086|775953|P5|COMPLETED|Overall Study||28
324128|NCT01490086|775954|P4|COMPLETED|Overall Study||13
324129|NCT01490086|775955|P3|COMPLETED|Overall Study||51
324130|NCT01490086|775956|P2|COMPLETED|Overall Study||44
324131|NCT01490086|775957|P1|COMPLETED|Overall Study||50
324132|NCT01490086|775953|P5|STARTED|Overall Study||39
324133|NCT01490086|775954|P4|STARTED|Overall Study||20
324134|NCT01490086|775955|P3|STARTED|Overall Study||58
324135|NCT01490086|775956|P2|STARTED|Overall Study||59
324136|NCT01490086|775957|P1|STARTED|Overall Study||58
324137|NCT01490060|775991|P4|NOT COMPLETED|Cycle 2||0
324138|NCT01490060|775992|P3|NOT COMPLETED|Cycle 2||1
324139|NCT01490060|775993|P2|NOT COMPLETED|Cycle 2||1
324140|NCT01490060|775994|P1|NOT COMPLETED|Cycle 2||2
324141|NCT01490060|775991|P4|COMPLETED|Cycle 2||8
324142|NCT01490060|775992|P3|COMPLETED|Cycle 2||8
324143|NCT01490060|775993|P2|COMPLETED|Cycle 2||11
324144|NCT01490060|775994|P1|COMPLETED|Cycle 2||9
324145|NCT01490060|775991|P4|STARTED|Cycle 2||8
324146|NCT01490060|775992|P3|STARTED|Cycle 2||9
324147|NCT01490060|775993|P2|STARTED|Cycle 2||12
324148|NCT01490060|775994|P1|STARTED|Cycle 2||11
324149|NCT01490060|775991|P4|NOT COMPLETED|Cycle 1||3
324150|NCT01490060|775992|P3|NOT COMPLETED|Cycle 1||3
324151|NCT01490060|775993|P2|NOT COMPLETED|Cycle 1||1
324152|NCT01490060|775994|P1|NOT COMPLETED|Cycle 1||0
324153|NCT01490060|775991|P4|COMPLETED|Cycle 1||8
324154|NCT01490060|775992|P3|COMPLETED|Cycle 1||9
324155|NCT01490060|775993|P2|COMPLETED|Cycle 1||12
324156|NCT01490060|775994|P1|COMPLETED|Cycle 1||11
324157|NCT01490060|775991|P4|STARTED|Cycle 1||11
324158|NCT01490060|775992|P3|STARTED|Cycle 1||12
324159|NCT01490060|775993|P2|STARTED|Cycle 1||13
324160|NCT01490060|775994|P1|STARTED|Cycle 1||11
324161|NCT01489670|776002|P1|NOT COMPLETED|Overall Study||53
324162|NCT01489670|776002|P1|COMPLETED|Overall Study||334
324163|NCT01489670|776002|P1|STARTED|Overall Study||387
324164|NCT01489527|776014|P2|NOT COMPLETED|Overall Study||26
324165|NCT01489527|776015|P1|NOT COMPLETED|Overall Study||22
324166|NCT01489527|776014|P2|COMPLETED|Overall Study||175
324167|NCT01489527|776015|P1|COMPLETED|Overall Study||183
324168|NCT01489527|776014|P2|STARTED|Overall Study||201
324169|NCT01489527|776015|P1|STARTED|Overall Study||205
324170|NCT01489358|776032|P3|NOT COMPLETED|Overall Study||2
324171|NCT01489358|776033|P2|NOT COMPLETED|Overall Study||0
324172|NCT01489358|776034|P1|NOT COMPLETED|Overall Study||0
324173|NCT01489358|776032|P3|COMPLETED|Overall Study||8
324174|NCT01489358|776033|P2|COMPLETED|Overall Study||10
324175|NCT01489358|776034|P1|COMPLETED|Overall Study||5
324176|NCT01489358|776032|P3|STARTED|Overall Study||10
324177|NCT01489358|776033|P2|STARTED|Overall Study||10
324178|NCT01489358|776034|P1|STARTED|Overall Study||5
324179|NCT01489254|776084|P4|NOT COMPLETED|Open-label Extension Part||58
324180|NCT01489254|776085|P3|NOT COMPLETED|Open-label Extension Part||0
324181|NCT01489254|776086|P2|NOT COMPLETED|Open-label Extension Part||0
324182|NCT01489254|776087|P1|NOT COMPLETED|Open-label Extension Part||0
324183|NCT01489254|776084|P4|COMPLETED|Open-label Extension Part||670
324184|NCT01489254|776085|P3|COMPLETED|Open-label Extension Part||0
324185|NCT01489254|776086|P2|COMPLETED|Open-label Extension Part||0
324186|NCT01489254|776087|P1|COMPLETED|Open-label Extension Part||0
324277|NCT01488071|776366|P2|STARTED|Overall Study|APTS|242
324187|NCT01489254|776084|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
324188|NCT01489254|776085|P3|STARTED|Open-label Extension Part||0
324189|NCT01489254|776086|P2|STARTED|Open-label Extension Part||0
324190|NCT01489254|776087|P1|STARTED|Open-label Extension Part||0
324191|NCT01489254|776084|P4|NOT COMPLETED|Double-blind Part||0
324192|NCT01489254|776085|P3|NOT COMPLETED|Double-blind Part||3
324193|NCT01489254|776086|P2|NOT COMPLETED|Double-blind Part||33
324194|NCT01489254|776087|P1|NOT COMPLETED|Double-blind Part||25
324195|NCT01489254|776084|P4|COMPLETED|Double-blind Part||0
324196|NCT01489254|776085|P3|COMPLETED|Double-blind Part||81
324197|NCT01489254|776086|P2|COMPLETED|Double-blind Part||324
324198|NCT01489254|776087|P1|COMPLETED|Double-blind Part||330
324199|NCT01489254|776084|P4|STARTED|Double-blind Part||0
324200|NCT01489254|776085|P3|STARTED|Double-blind Part||84
324201|NCT01489254|776086|P2|STARTED|Double-blind Part||357
324202|NCT01489254|776087|P1|STARTED|Double-blind Part||355
324203|NCT01489189|776098|P2|NOT COMPLETED|Overall Study||35
324204|NCT01489189|776099|P1|NOT COMPLETED|Overall Study||31
324205|NCT01489189|776098|P2|COMPLETED|Overall Study|Number of Eyes|168
324206|NCT01489189|776099|P1|COMPLETED|Overall Study|Number of Eyes|160
324207|NCT01489189|776098|P2|STARTED|Overall Study|Number of Eyes|203
324208|NCT01489189|776099|P1|STARTED|Overall Study|Number of Eyes|191
324209|NCT01488994|776126|P2|NOT COMPLETED|Overall Study||1
324210|NCT01488994|776127|P1|NOT COMPLETED|Overall Study||0
324211|NCT01488994|776126|P2|COMPLETED|Overall Study||11
324212|NCT01488994|776127|P1|COMPLETED|Overall Study||11
324213|NCT01488994|776126|P2|STARTED|Overall Study||12
324214|NCT01488994|776127|P1|STARTED|Overall Study||11
324215|NCT01488877|776214|P3|NOT COMPLETED|Re-randomization||0
324216|NCT01488877|776215|P2|NOT COMPLETED|Re-randomization||0
324217|NCT01488877|776216|P1|NOT COMPLETED|Re-randomization||0
324218|NCT01488877|776214|P3|COMPLETED|Re-randomization||3
324219|NCT01488877|776215|P2|COMPLETED|Re-randomization||0
324220|NCT01488877|776216|P1|COMPLETED|Re-randomization||0
324221|NCT01488877|776214|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
324222|NCT01488877|776215|P2|STARTED|Re-randomization||0
324223|NCT01488877|776216|P1|STARTED|Re-randomization||0
324224|NCT01488877|776214|P3|NOT COMPLETED|Initial Randomization||0
324225|NCT01488877|776215|P2|NOT COMPLETED|Initial Randomization||0
324226|NCT01488877|776216|P1|NOT COMPLETED|Initial Randomization||0
324227|NCT01488877|776214|P3|COMPLETED|Initial Randomization||0
324228|NCT01488877|776215|P2|COMPLETED|Initial Randomization||5
324229|NCT01488877|776216|P1|COMPLETED|Initial Randomization||1
324230|NCT01488877|776214|P3|STARTED|Initial Randomization||0
324231|NCT01488877|776215|P2|STARTED|Initial Randomization||5
324232|NCT01488877|776216|P1|STARTED|Initial Randomization||1
324233|NCT01488578|776231|P1|NOT COMPLETED|Overall Study||1836
324234|NCT01488578|776231|P1|COMPLETED|Overall Study||9321
324235|NCT01488578|776231|P1|STARTED|Overall Study||11157
324236|NCT01488487|776265|P1|NOT COMPLETED|Overall Study||9
324237|NCT01488487|776265|P1|COMPLETED|Overall Study||15
324238|NCT01488487|776265|P1|Received Treatment|Overall Study||24
324239|NCT01488487|776265|P1|STARTED|Overall Study||24
324240|NCT01488448|776274|P2|NOT COMPLETED|Overall Study||17
324241|NCT01488448|776275|P1|NOT COMPLETED|Overall Study||20
324242|NCT01488448|776274|P2|COMPLETED|Overall Study||97
324243|NCT01488448|776275|P1|COMPLETED|Overall Study||93
324244|NCT01488448|776274|P2|STARTED|Overall Study||114
324245|NCT01488448|776275|P1|STARTED|Overall Study||113
324246|NCT01488409|776299|P2|NOT COMPLETED|Overall Study||4
324247|NCT01488409|776300|P1|NOT COMPLETED|Overall Study||4
324248|NCT01488409|776299|P2|COMPLETED|Overall Study||15
324249|NCT01488409|776300|P1|COMPLETED|Overall Study||16
324250|NCT01488409|776299|P2|STARTED|Overall Study||19
324251|NCT01488409|776300|P1|STARTED|Overall Study||20
324252|NCT01488370|776317|P3|NOT COMPLETED|Overall Study||1
324253|NCT01488370|776318|P2|NOT COMPLETED|Overall Study||1
324254|NCT01488370|776319|P1|NOT COMPLETED|Overall Study||0
324255|NCT01488370|776317|P3|COMPLETED|Overall Study||19
324256|NCT01488370|776318|P2|COMPLETED|Overall Study||22
324257|NCT01488370|776319|P1|COMPLETED|Overall Study||22
324258|NCT01488370|776317|P3|STARTED|Overall Study||20
324259|NCT01488370|776318|P2|STARTED|Overall Study||23
324260|NCT01488370|776319|P1|STARTED|Overall Study||22
324261|NCT01488188|776341|P2|NOT COMPLETED|Overall Study||0
324262|NCT01488188|776342|P1|NOT COMPLETED|Overall Study||0
324263|NCT01488188|776341|P2|COMPLETED|Overall Study||20
324264|NCT01488188|776342|P1|COMPLETED|Overall Study||20
324265|NCT01488188|776341|P2|STARTED|Overall Study||20
324266|NCT01488188|776342|P1|STARTED|Overall Study||20
324267|NCT01488097|776354|P1|NOT COMPLETED|Long-term Treatment (Beyond Week 104)||6
324268|NCT01488097|776354|P1|COMPLETED|Long-term Treatment (Beyond Week 104)|This period is ongoing.|2
324269|NCT01488097|776354|P1|STARTED|Long-term Treatment (Beyond Week 104)||8
324270|NCT01488097|776354|P1|NOT COMPLETED|Long-term Treatment (up to Week 104)||0
324271|NCT01488097|776354|P1|COMPLETED|Long-term Treatment (up to Week 104)||8
324272|NCT01488097|776354|P1|STARTED|Long-term Treatment (up to Week 104)||8
324273|NCT01488071|776366|P2|NOT COMPLETED|Overall Study||63
324274|NCT01488071|776367|P1|NOT COMPLETED|Overall Study||53
324275|NCT01488071|776366|P2|COMPLETED|Overall Study||179
324276|NCT01488071|776367|P1|COMPLETED|Overall Study||200
324278|NCT01488071|776367|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
324279|NCT01488019|776401|P2|NOT COMPLETED|Overall Study||304
324280|NCT01488019|776402|P1|NOT COMPLETED|Overall Study||247
324281|NCT01488019|776401|P2|COMPLETED|Overall Study||226
324282|NCT01488019|776402|P1|COMPLETED|Overall Study||294
324283|NCT01488019|776401|P2|STARTED|Overall Study||530
324284|NCT01488019|776402|P1|STARTED|Overall Study||541
324285|NCT01487954|776436|P2|NOT COMPLETED|Overall Study||0
324286|NCT01487954|776437|P1|NOT COMPLETED|Overall Study||0
324287|NCT01487954|776436|P2|COMPLETED|Overall Study||16
324288|NCT01487954|776437|P1|COMPLETED|Overall Study||29
324289|NCT01487954|776436|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
324290|NCT01487954|776437|P1|Safety lead-in|Overall Study||10
324291|NCT01487954|776436|P2|STARTED|Overall Study||16
324292|NCT01487954|776437|P1|STARTED|Overall Study||29
324293|NCT01487863|776447|P2|NOT COMPLETED|Overall Study||19
324294|NCT01487863|776448|P1|NOT COMPLETED|Overall Study||19
324295|NCT01487863|776447|P2|COMPLETED|Overall Study||15
324296|NCT01487863|776448|P1|COMPLETED|Overall Study||16
324297|NCT01487863|776447|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
324298|NCT01487863|776448|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
324299|NCT01487863|776447|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
324300|NCT01487863|776448|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
324301|NCT01487863|776447|P2|STARTED|Overall Study||34
324302|NCT01487863|776448|P1|STARTED|Overall Study||35
324303|NCT01487668|776456|P2|NOT COMPLETED|Overall Study||17
324304|NCT01487668|776457|P1|NOT COMPLETED|Overall Study||25
324305|NCT01487668|776456|P2|COMPLETED|Overall Study||124
324306|NCT01487668|776457|P1|COMPLETED|Overall Study||121
324307|NCT01487668|776456|P2|STARTED|Overall Study||141
324308|NCT01487668|776457|P1|STARTED|Overall Study||146
324309|NCT01487577|776465|P1|NOT COMPLETED|Overall Study||1
324310|NCT01487577|776465|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
324311|NCT01487577|776465|P1|STARTED|Overall Study||19
324312|NCT01487525|776479|P2|NOT COMPLETED|Overall Study||1
324313|NCT01487525|776480|P1|NOT COMPLETED|Overall Study||0
324314|NCT01487525|776479|P2|COMPLETED|Overall Study||19
324315|NCT01487525|776480|P1|COMPLETED|Overall Study||22
324316|NCT01487525|776479|P2|STARTED|Overall Study||20
324317|NCT01487525|776480|P1|STARTED|Overall Study||22
324318|NCT01487499|776490|P1|NOT COMPLETED|Overall Study||0
324319|NCT01487499|776490|P1|COMPLETED|Overall Study||4
324320|NCT01487499|776490|P1|STARTED|Overall Study||4
324321|NCT01486966|776498|P2|NOT COMPLETED|Overall Study||2
324322|NCT01486966|776499|P1|NOT COMPLETED|Overall Study||0
324323|NCT01486966|776498|P2|COMPLETED|Overall Study||27
324324|NCT01486966|776499|P1|COMPLETED|Overall Study||29
324325|NCT01486966|776498|P2|STARTED|Overall Study||29
324326|NCT01486966|776499|P1|STARTED|Overall Study||29
324327|NCT01486927|776523|P1|NOT COMPLETED|Overall Study||13
324328|NCT01486927|776523|P1|COMPLETED|Overall Study||161
324329|NCT01486927|776523|P1|STARTED|Overall Study||174
324330|NCT01486758|776556|P2|NOT COMPLETED|Overall Study||1
324331|NCT01486758|776557|P1|NOT COMPLETED|Overall Study||0
324332|NCT01486758|776556|P2|COMPLETED|Overall Study||19
324333|NCT01486758|776557|P1|COMPLETED|Overall Study||20
324334|NCT01486758|776556|P2|STARTED|Overall Study||20
324335|NCT01486758|776557|P1|STARTED|Overall Study||20
324336|NCT01486615|776581|P4|NOT COMPLETED|Overall Study||2
324337|NCT01486615|776582|P3|NOT COMPLETED|Overall Study||2
324338|NCT01486615|776583|P2|NOT COMPLETED|Overall Study||1
324339|NCT01486615|776584|P1|NOT COMPLETED|Overall Study||0
324340|NCT01486615|776581|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
324341|NCT01486615|776582|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
324342|NCT01486615|776583|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
324343|NCT01486615|776584|P1|COMPLETED|Overall Study||20
324344|NCT01486615|776581|P4|STARTED|Overall Study||20
324345|NCT01486615|776582|P3|STARTED|Overall Study||20
324346|NCT01486615|776583|P2|STARTED|Overall Study||20
324347|NCT01486615|776584|P1|STARTED|Overall Study||20
324348|NCT01486446|776624|P2|NOT COMPLETED|Overall Study||0
324349|NCT01486446|776625|P1|NOT COMPLETED|Overall Study||1
324350|NCT01486446|776624|P2|COMPLETED|Overall Study||1
324351|NCT01486446|776625|P1|COMPLETED|Overall Study||6
324352|NCT01486446|776624|P2|STARTED|Overall Study||1
324353|NCT01486446|776625|P1|STARTED|Overall Study||7
324354|NCT01486238|776647|P2|NOT COMPLETED|Overall Study||6
324355|NCT01486238|776648|P1|NOT COMPLETED|Overall Study||2
324356|NCT01486238|776647|P2|COMPLETED|Overall Study||43
324357|NCT01486238|776648|P1|COMPLETED|Overall Study||21
324358|NCT01486238|776647|P2|STARTED|Overall Study||49
324359|NCT01486238|776648|P1|STARTED|Overall Study||23
324360|NCT01486043|776654|P1|NOT COMPLETED|Overall Study||2
324361|NCT01486043|776654|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
324362|NCT01486043|776654|P1|STARTED|Overall Study||4
324363|NCT01485991|776662|P2|NOT COMPLETED|Overall Study||36
324364|NCT01485991|776663|P1|NOT COMPLETED|Overall Study||32
324365|NCT01485991|776662|P2|COMPLETED|Overall Study||350
324366|NCT01485991|776663|P1|COMPLETED|Overall Study||353
324367|NCT01485991|776662|P2|Treated|Overall Study||384
324368|NCT01485991|776663|P1|Treated|Overall Study||379
324369|NCT01485991|776662|P2|STARTED|Overall Study||386
324370|NCT01485991|776663|P1|STARTED|Overall Study||385
324371|NCT01485887|776673|P1|NOT COMPLETED|Overall Study||12
324372|NCT01485887|776673|P1|COMPLETED|Overall Study||38
324373|NCT01485887|776673|P1|STARTED|Overall Study||50
324374|NCT01485796|776685|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
324375|NCT01485796|776685|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
324376|NCT01485796|776685|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
324377|NCT01485796|776685|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
324378|NCT01485796|776685|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
324379|NCT01485796|776685|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
324380|NCT01485796|776685|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
324381|NCT01485796|776685|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
324382|NCT01485796|776685|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
324383|NCT01485796|776685|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
324384|NCT01485796|776685|P1|NOT COMPLETED|Period 2: Epoch 2||35
324385|NCT01485796|776685|P1|COMPLETED|Period 2: Epoch 2||1
324386|NCT01485796|776685|P1|Treated in Epoch 2|Period 2: Epoch 2||36
324387|NCT01485796|776685|P1|STARTED|Period 2: Epoch 2||36
324388|NCT01485796|776685|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
324389|NCT01485796|776685|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
324390|NCT01485796|776685|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
324391|NCT01485796|776685|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
324392|NCT01485640|776707|P1|NOT COMPLETED|Overall Study||122
324393|NCT01485640|776707|P1|COMPLETED|Overall Study||40
324394|NCT01485640|776707|P1|STARTED|Overall Study||162
324395|NCT01485536|776712|P1|NOT COMPLETED|Overall Study||4
324396|NCT01485536|776712|P1|COMPLETED|Overall Study||17
324397|NCT01485536|776712|P1|STARTED|Overall Study||21
324398|NCT01485380|776717|P1|NOT COMPLETED|Overall Study||3
324399|NCT01485380|776717|P1|COMPLETED|Overall Study||17
324400|NCT01485380|776717|P1|STARTED|Overall Study||20
324401|NCT01485172|776727|P6|NOT COMPLETED|Overall Study||4
324402|NCT01485172|776728|P5|NOT COMPLETED|Overall Study||5
324403|NCT01485172|776729|P4|NOT COMPLETED|Overall Study||8
324404|NCT01485172|776730|P3|NOT COMPLETED|Overall Study||7
324405|NCT01485172|776731|P2|NOT COMPLETED|Overall Study||1
324406|NCT01485172|776732|P1|NOT COMPLETED|Overall Study||7
324407|NCT01485172|776727|P6|COMPLETED|Overall Study||9
324408|NCT01485172|776728|P5|COMPLETED|Overall Study||34
324409|NCT01485172|776729|P4|COMPLETED|Overall Study||32
324410|NCT01485172|776730|P3|COMPLETED|Overall Study||34
324411|NCT01485172|776731|P2|COMPLETED|Overall Study||12
324412|NCT01485172|776732|P1|COMPLETED|Overall Study||33
324413|NCT01485172|776727|P6|STARTED|Overall Study||13
324414|NCT01485172|776728|P5|STARTED|Overall Study||39
324415|NCT01485172|776729|P4|STARTED|Overall Study||40
324416|NCT01485172|776730|P3|STARTED|Overall Study||41
324417|NCT01485172|776731|P2|STARTED|Overall Study||13
324418|NCT01485172|776732|P1|STARTED|Overall Study||40
324419|NCT01485094|776809|P3|NOT COMPLETED|Overall Study||1
324420|NCT01485094|776810|P2|NOT COMPLETED|Overall Study||2
324421|NCT01485094|776811|P1|NOT COMPLETED|Overall Study||3
324422|NCT01485094|776809|P3|COMPLETED|Overall Study||18
324423|NCT01485094|776810|P2|COMPLETED|Overall Study||18
324424|NCT01485094|776811|P1|COMPLETED|Overall Study||17
324425|NCT01485094|776809|P3|STARTED|Overall Study||19
324426|NCT01485094|776810|P2|STARTED|Overall Study||20
324427|NCT01485094|776811|P1|STARTED|Overall Study||20
324428|NCT01484977|776852|P1|NOT COMPLETED|Overall Study||27
324429|NCT01484977|776852|P1|COMPLETED|Overall Study||93
324430|NCT01484977|776852|P1|STARTED|Overall Study||120
324431|NCT01484951|776856|P1|NOT COMPLETED|Overall Study||5
324432|NCT01484951|776856|P1|COMPLETED|Overall Study||69
324433|NCT01484951|776856|P1|STARTED|Overall Study||74
324434|NCT01484938|776861|P1|NOT COMPLETED|Overall Study||4
324435|NCT01484938|776861|P1|COMPLETED|Overall Study||171
324436|NCT01484938|776861|P1|STARTED|Overall Study||175
324437|NCT01484912|776868|P2|NOT COMPLETED|Overall Study||1
324438|NCT01484912|776869|P1|NOT COMPLETED|Overall Study||1
324439|NCT01484912|776868|P2|COMPLETED|Overall Study||39
324440|NCT01484912|776869|P1|COMPLETED|Overall Study||38
324441|NCT01484912|776868|P2|STARTED|Overall Study||40
324442|NCT01484912|776869|P1|STARTED|Overall Study||39
324443|NCT01484873|776879|P1|NOT COMPLETED|Overall Study||2
324444|NCT01484873|776879|P1|COMPLETED|Overall Study||8
324445|NCT01484873|776879|P1|STARTED|Overall Study||10
324446|NCT01484652|776889|P2|NOT COMPLETED|Overall Study||21
324447|NCT01484652|776890|P1|NOT COMPLETED|Overall Study||15
324448|NCT01484652|776889|P2|COMPLETED|Overall Study||142
324449|NCT01484652|776890|P1|COMPLETED|Overall Study||151
324450|NCT01484652|776889|P2|STARTED|Overall Study||163
324451|NCT01484652|776890|P1|STARTED|Overall Study||166
324452|NCT01484561|776898|P2|NOT COMPLETED|Overall Study||6
324453|NCT01484561|776899|P1|NOT COMPLETED|Overall Study||9
324454|NCT01484561|776898|P2|COMPLETED|Overall Study||45
324455|NCT01484561|776899|P1|COMPLETED|Overall Study||88
324456|NCT01484561|776898|P2|STARTED|Overall Study||51
324457|NCT01484561|776899|P1|STARTED|Overall Study||97
324458|NCT01484314|776987|P1|NOT COMPLETED|Overall Study||0
324459|NCT01484314|776987|P1|COMPLETED|Overall Study||1
324460|NCT01484314|776987|P1|STARTED|Overall Study||1
324461|NCT01484197|776993|P4|NOT COMPLETED|Treatment Period 4||0
324462|NCT01484197|776994|P3|NOT COMPLETED|Treatment Period 4||0
324463|NCT01484197|776995|P2|NOT COMPLETED|Treatment Period 4||0
324464|NCT01484197|776996|P1|NOT COMPLETED|Treatment Period 4||0
324465|NCT01484197|776993|P4|COMPLETED|Treatment Period 4||6
324466|NCT01484197|776994|P3|COMPLETED|Treatment Period 4||9
324467|NCT01484197|776995|P2|COMPLETED|Treatment Period 4||8
324468|NCT01484197|776996|P1|COMPLETED|Treatment Period 4||7
324469|NCT01484197|776993|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
324470|NCT01484197|776994|P3|STARTED|Treatment Period 4||9
324471|NCT01484197|776995|P2|STARTED|Treatment Period 4||8
324472|NCT01484197|776996|P1|STARTED|Treatment Period 4||7
324473|NCT01484197|776993|P4|NOT COMPLETED|Treatment Period 3||0
324474|NCT01484197|776994|P3|NOT COMPLETED|Treatment Period 3||0
324475|NCT01484197|776995|P2|NOT COMPLETED|Treatment Period 3||0
324476|NCT01484197|776996|P1|NOT COMPLETED|Treatment Period 3||0
324477|NCT01484197|776993|P4|COMPLETED|Treatment Period 3||8
324478|NCT01484197|776994|P3|COMPLETED|Treatment Period 3||9
324479|NCT01484197|776995|P2|COMPLETED|Treatment Period 3||8
324480|NCT01484197|776996|P1|COMPLETED|Treatment Period 3||7
324481|NCT01484197|776993|P4|STARTED|Treatment Period 3||8
324482|NCT01484197|776994|P3|STARTED|Treatment Period 3||9
324483|NCT01484197|776995|P2|STARTED|Treatment Period 3||8
324484|NCT01484197|776996|P1|STARTED|Treatment Period 3||7
324485|NCT01484197|776993|P4|NOT COMPLETED|Treatment Period 2||1
324486|NCT01484197|776994|P3|NOT COMPLETED|Treatment Period 2||0
324487|NCT01484197|776995|P2|NOT COMPLETED|Treatment Period 2||0
324488|NCT01484197|776996|P1|NOT COMPLETED|Treatment Period 2||0
324489|NCT01484197|776993|P4|COMPLETED|Treatment Period 2||8
324490|NCT01484197|776994|P3|COMPLETED|Treatment Period 2||9
324491|NCT01484197|776995|P2|COMPLETED|Treatment Period 2||8
324492|NCT01484197|776996|P1|COMPLETED|Treatment Period 2||7
324493|NCT01484197|776993|P4|STARTED|Treatment Period 2||9
324494|NCT01484197|776994|P3|STARTED|Treatment Period 2||9
324589|NCT01483820|777282|P1|COMPLETED|Overall Study||0
324495|NCT01484197|776995|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
324496|NCT01484197|776996|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
324497|NCT01484197|776993|P4|NOT COMPLETED|Treatment Period 1||0
324498|NCT01484197|776994|P3|NOT COMPLETED|Treatment Period 1||0
324499|NCT01484197|776995|P2|NOT COMPLETED|Treatment Period 1||0
324500|NCT01484197|776996|P1|NOT COMPLETED|Treatment Period 1||1
324501|NCT01484197|776993|P4|COMPLETED|Treatment Period 1||9
324502|NCT01484197|776994|P3|COMPLETED|Treatment Period 1||9
324503|NCT01484197|776995|P2|COMPLETED|Treatment Period 1||9
324504|NCT01484197|776996|P1|COMPLETED|Treatment Period 1||8
324505|NCT01484197|776993|P4|STARTED|Treatment Period 1||9
324506|NCT01484197|776994|P3|STARTED|Treatment Period 1||9
324507|NCT01484197|776995|P2|STARTED|Treatment Period 1||9
324508|NCT01484197|776996|P1|STARTED|Treatment Period 1||9
324509|NCT01484132|777079|P1|NOT COMPLETED|Overall Study||22
324510|NCT01484132|777079|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
324511|NCT01484132|777079|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
324512|NCT01484132|777079|P1|STARTED|Overall Study||113
324513|NCT01484054|777087|P2|NOT COMPLETED|Period 2||0
324514|NCT01484054|777088|P1|NOT COMPLETED|Period 2||0
324515|NCT01484054|777087|P2|COMPLETED|Period 2||49
324516|NCT01484054|777088|P1|COMPLETED|Period 2||50
324517|NCT01484054|777087|P2|STARTED|Period 2||49
324518|NCT01484054|777088|P1|STARTED|Period 2||50
324519|NCT01484054|777087|P2|NOT COMPLETED|Period 1||1
324520|NCT01484054|777088|P1|NOT COMPLETED|Period 1||0
324521|NCT01484054|777087|P2|COMPLETED|Period 1||49
324522|NCT01484054|777088|P1|COMPLETED|Period 1||50
324523|NCT01484054|777087|P2|STARTED|Period 1||50
324524|NCT01484054|777088|P1|STARTED|Period 1||50
324525|NCT01484041|777098|P1|NOT COMPLETED|Overall Study||0
324526|NCT01484041|777098|P1|COMPLETED|Overall Study||12
324527|NCT01484041|777098|P1|STARTED|Overall Study||12
324528|NCT01484028|777106|P4|NOT COMPLETED|Period 2||0
324529|NCT01484028|777107|P3|NOT COMPLETED|Period 2||0
324530|NCT01484028|777108|P2|NOT COMPLETED|Period 2||0
324531|NCT01484028|777109|P1|NOT COMPLETED|Period 2||0
324532|NCT01484028|777106|P4|COMPLETED|Period 2||66
324533|NCT01484028|777107|P3|COMPLETED|Period 2||64
324534|NCT01484028|777108|P2|COMPLETED|Period 2||67
324535|NCT01484028|777109|P1|COMPLETED|Period 2||66
324536|NCT01484028|777106|P4|STARTED|Period 2||66
324537|NCT01484028|777107|P3|STARTED|Period 2||64
324538|NCT01484028|777108|P2|STARTED|Period 2||67
324539|NCT01484028|777109|P1|STARTED|Period 2||66
324540|NCT01484028|777106|P4|NOT COMPLETED|Period 1||1
324541|NCT01484028|777107|P3|NOT COMPLETED|Period 1||0
324542|NCT01484028|777108|P2|NOT COMPLETED|Period 1||3
324543|NCT01484028|777109|P1|NOT COMPLETED|Period 1||0
324544|NCT01484028|777106|P4|COMPLETED|Period 1||66
324545|NCT01484028|777107|P3|COMPLETED|Period 1||64
324546|NCT01484028|777108|P2|COMPLETED|Period 1||67
324547|NCT01484028|777109|P1|COMPLETED|Period 1||66
324548|NCT01484028|777106|P4|STARTED|Period 1||67
324549|NCT01484028|777107|P3|STARTED|Period 1||64
324550|NCT01484028|777108|P2|STARTED|Period 1||70
324551|NCT01484028|777109|P1|STARTED|Period 1||66
324552|NCT01483963|777124|P5|NOT COMPLETED|Overall Study||0
324553|NCT01483963|777125|P4|NOT COMPLETED|Overall Study||0
324554|NCT01483963|777126|P3|NOT COMPLETED|Overall Study||0
324555|NCT01483963|777127|P2|NOT COMPLETED|Overall Study||0
324556|NCT01483963|777128|P1|NOT COMPLETED|Overall Study||0
324557|NCT01483963|777124|P5|COMPLETED|Overall Study||10
324558|NCT01483963|777125|P4|COMPLETED|Overall Study||10
324559|NCT01483963|777126|P3|COMPLETED|Overall Study||10
324560|NCT01483963|777127|P2|COMPLETED|Overall Study||10
324561|NCT01483963|777128|P1|COMPLETED|Overall Study||10
324562|NCT01483963|777124|P5|STARTED|Overall Study||10
324563|NCT01483963|777125|P4|STARTED|Overall Study||10
324564|NCT01483963|777126|P3|STARTED|Overall Study||10
324565|NCT01483963|777127|P2|STARTED|Overall Study||10
324566|NCT01483963|777128|P1|STARTED|Overall Study||10
324567|NCT01483937|777202|P2|NOT COMPLETED|Overall Study||3
324568|NCT01483937|777203|P1|NOT COMPLETED|Overall Study||4
324569|NCT01483937|777202|P2|COMPLETED|Overall Study||14
324570|NCT01483937|777203|P1|COMPLETED|Overall Study||11
324571|NCT01483937|777202|P2|STARTED|Overall Study||17
324572|NCT01483937|777203|P1|STARTED|Overall Study||15
324573|NCT01483924|777230|P5|NOT COMPLETED|Overall Study||2
324574|NCT01483924|777231|P4|NOT COMPLETED|Overall Study||4
324575|NCT01483924|777232|P3|NOT COMPLETED|Overall Study||1
324576|NCT01483924|777233|P2|NOT COMPLETED|Overall Study||0
324577|NCT01483924|777234|P1|NOT COMPLETED|Overall Study||2
324578|NCT01483924|777230|P5|COMPLETED|Overall Study||10
324579|NCT01483924|777231|P4|COMPLETED|Overall Study||8
324580|NCT01483924|777232|P3|COMPLETED|Overall Study||11
324581|NCT01483924|777233|P2|COMPLETED|Overall Study||12
324582|NCT01483924|777234|P1|COMPLETED|Overall Study||10
324583|NCT01483924|777230|P5|STARTED|Overall Study||12
324584|NCT01483924|777231|P4|STARTED|Overall Study||12
324585|NCT01483924|777232|P3|STARTED|Overall Study||12
324586|NCT01483924|777233|P2|STARTED|Overall Study||12
324587|NCT01483924|777234|P1|STARTED|Overall Study||12
324588|NCT01483820|777282|P1|NOT COMPLETED|Overall Study||8
324590|NCT01483820|777282|P1|STARTED|Overall Study||8
324591|NCT01483651|777291|P6|NOT COMPLETED|Overall Study||1
324592|NCT01483651|777292|P5|NOT COMPLETED|Overall Study||0
324593|NCT01483651|777293|P4|NOT COMPLETED|Overall Study||0
324594|NCT01483651|777294|P3|NOT COMPLETED|Overall Study||1
324595|NCT01483651|777295|P2|NOT COMPLETED|Overall Study||1
324596|NCT01483651|777296|P1|NOT COMPLETED|Overall Study||0
324597|NCT01483651|777291|P6|COMPLETED|Overall Study||1
324598|NCT01483651|777292|P5|COMPLETED|Overall Study||2
324599|NCT01483651|777293|P4|COMPLETED|Overall Study||1
324600|NCT01483651|777294|P3|COMPLETED|Overall Study||1
324601|NCT01483651|777295|P2|COMPLETED|Overall Study||2
324602|NCT01483651|777296|P1|COMPLETED|Overall Study||1
324603|NCT01483651|777291|P6|STARTED|Overall Study||2
324604|NCT01483651|777292|P5|STARTED|Overall Study||2
324605|NCT01483651|777293|P4|STARTED|Overall Study||1
324606|NCT01483651|777294|P3|STARTED|Overall Study||2
324607|NCT01483651|777295|P2|STARTED|Overall Study||3
324608|NCT01483651|777296|P1|STARTED|Overall Study||1
324609|NCT01483625|777306|P2|NOT COMPLETED|Overall Study||2
324610|NCT01483625|777307|P1|NOT COMPLETED|Overall Study||4
324611|NCT01483625|777306|P2|COMPLETED|Overall Study||66
324612|NCT01483625|777307|P1|COMPLETED|Overall Study||68
324613|NCT01483625|777306|P2|STARTED|Overall Study||68
324614|NCT01483625|777307|P1|STARTED|Overall Study||72
324615|NCT01483378|777323|P2|NOT COMPLETED|Overall Study||0
324616|NCT01483378|777324|P1|NOT COMPLETED|Overall Study||0
324617|NCT01483378|777323|P2|COMPLETED|Overall Study||66
324618|NCT01483378|777324|P1|COMPLETED|Overall Study||100
324619|NCT01483378|777323|P2|STARTED|Overall Study||66
324620|NCT01483378|777324|P1|STARTED|Overall Study||100
324621|NCT01483352|777330|P1|NOT COMPLETED|Overall Study||0
324622|NCT01483352|777330|P1|COMPLETED|Overall Study||12
324623|NCT01483352|777330|P1|STARTED|Overall Study||12
324624|NCT01483209|777349|P1|NOT COMPLETED|Overall Study||1
324625|NCT01483209|777349|P1|COMPLETED|Overall Study||1
324626|NCT01483209|777349|P1|STARTED|Overall Study||2
324627|NCT01483183|777364|P10|NOT COMPLETED|Overall Study||1
324628|NCT01483183|777365|P9|NOT COMPLETED|Overall Study||0
324629|NCT01483183|777366|P8|NOT COMPLETED|Overall Study||0
324630|NCT01483183|777367|P7|NOT COMPLETED|Overall Study||2
324631|NCT01483183|777368|P6|NOT COMPLETED|Overall Study||0
324632|NCT01483183|777369|P5|NOT COMPLETED|Overall Study||0
324633|NCT01483183|777370|P4|NOT COMPLETED|Overall Study||0
324634|NCT01483183|777371|P3|NOT COMPLETED|Overall Study||0
324635|NCT01483183|777372|P2|NOT COMPLETED|Overall Study||0
324636|NCT01483183|777373|P1|NOT COMPLETED|Overall Study||0
324637|NCT01483183|777364|P10|COMPLETED|Overall Study||4
324638|NCT01483183|777365|P9|COMPLETED|Overall Study||4
324639|NCT01483183|777366|P8|COMPLETED|Overall Study||4
324640|NCT01483183|777367|P7|COMPLETED|Overall Study||4
324641|NCT01483183|777368|P6|COMPLETED|Overall Study||4
324642|NCT01483183|777369|P5|COMPLETED|Overall Study||4
324643|NCT01483183|777370|P4|COMPLETED|Overall Study||3
324644|NCT01483183|777371|P3|COMPLETED|Overall Study||5
324645|NCT01483183|777372|P2|COMPLETED|Overall Study||1
324646|NCT01483183|777373|P1|COMPLETED|Overall Study||4
324647|NCT01483183|777364|P10|STARTED|Overall Study||5
324648|NCT01483183|777365|P9|STARTED|Overall Study||4
324649|NCT01483183|777366|P8|STARTED|Overall Study||4
324650|NCT01483183|777367|P7|STARTED|Overall Study||6
324651|NCT01483183|777368|P6|STARTED|Overall Study||4
324652|NCT01483183|777369|P5|STARTED|Overall Study||4
324653|NCT01483183|777370|P4|STARTED|Overall Study||3
324654|NCT01483183|777371|P3|STARTED|Overall Study||5
324655|NCT01483183|777372|P2|STARTED|Overall Study||1
324656|NCT01483183|777373|P1|STARTED|Overall Study||4
324657|NCT01482910|777443|P2|NOT COMPLETED|Overall Study||9
324658|NCT01482910|777444|P1|NOT COMPLETED|Overall Study||15
324659|NCT01482910|777443|P2|COMPLETED|Overall Study||67
324660|NCT01482910|777444|P1|COMPLETED|Overall Study||213
324661|NCT01482910|777443|P2|Completed Week 28|Overall Study||71
324662|NCT01482910|777444|P1|Completed Week 28|Overall Study||216
324663|NCT01482910|777443|P2|STARTED|Overall Study||76
324664|NCT01482910|777444|P1|STARTED|Overall Study||228
324665|NCT01482884|777456|P2|NOT COMPLETED|Overall Study||18
324666|NCT01482884|777457|P1|NOT COMPLETED|Overall Study||13
324667|NCT01482884|777456|P2|COMPLETED|Overall Study||37
324668|NCT01482884|777457|P1|COMPLETED|Overall Study||43
324669|NCT01482884|777456|P2|STARTED|Overall Study||55
324670|NCT01482884|777457|P1|STARTED|Overall Study|One participant did not receive study treatment|56
324671|NCT01482819|777483|P1|NOT COMPLETED|Overall Study||2
324672|NCT01482819|777483|P1|COMPLETED|Overall Study||19
324673|NCT01482819|777483|P1|STARTED|Overall Study||21
324674|NCT01482767|777503|P2|NOT COMPLETED|Overall Study||49
324675|NCT01482767|777504|P1|NOT COMPLETED|Overall Study||54
324676|NCT01482767|777503|P2|COMPLETED|Overall Study||78
324677|NCT01482767|777504|P1|COMPLETED|Overall Study||81
324678|NCT01482767|777503|P2|STARTED|Overall Study||127
324679|NCT01482767|777504|P1|STARTED|Overall Study||135
324680|NCT01482429|777526|P2|NOT COMPLETED|Protocol||0
324681|NCT01482429|777527|P1|NOT COMPLETED|Protocol||275
324682|NCT01482429|777526|P2|COMPLETED|Protocol||0
324683|NCT01482429|777527|P1|COMPLETED|Protocol||139
324684|NCT01482429|777526|P2|STARTED|Protocol||0
324685|NCT01482429|777527|P1|STARTED|Protocol||414
324686|NCT01482429|777526|P2|NOT COMPLETED|Care Usual||173
324687|NCT01482429|777527|P1|NOT COMPLETED|Care Usual||0
324688|NCT01482429|777526|P2|COMPLETED|Care Usual||96
324689|NCT01482429|777527|P1|COMPLETED|Care Usual||0
324690|NCT01482429|777526|P2|STARTED|Care Usual||269
324691|NCT01482429|777527|P1|STARTED|Care Usual||0
324692|NCT01482325|777535|P1|NOT COMPLETED|Overall Study||0
324693|NCT01482325|777535|P1|COMPLETED|Overall Study||31
324694|NCT01482325|777535|P1|STARTED|Overall Study||31
324695|NCT01482312|777539|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
324696|NCT01482312|777540|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
324697|NCT01482312|777541|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
324698|NCT01482312|777539|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
324699|NCT01482312|777540|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
324700|NCT01482312|777541|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
324701|NCT01482312|777539|P3|STARTED|Period 3, 90 Minutes of Wear||9
324702|NCT01482312|777540|P2|STARTED|Period 3, 90 Minutes of Wear||9
324703|NCT01482312|777541|P1|STARTED|Period 3, 90 Minutes of Wear||8
324704|NCT01482312|777539|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
324705|NCT01482312|777540|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
324706|NCT01482312|777541|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
324707|NCT01482312|777539|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
324708|NCT01482312|777540|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
324709|NCT01482312|777541|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
324710|NCT01482312|777539|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
324711|NCT01482312|777540|P2|STARTED|Period 2, 90 Minutes of Wear||9
324712|NCT01482312|777541|P1|STARTED|Period 2, 90 Minutes of Wear||9
324713|NCT01482312|777539|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
324714|NCT01482312|777540|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
324715|NCT01482312|777541|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
324716|NCT01482312|777539|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
324717|NCT01482312|777540|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
324718|NCT01482312|777541|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
324719|NCT01482312|777539|P3|STARTED|Period 1, 90 Minutes of Wear||10
324720|NCT01482312|777540|P2|STARTED|Period 1, 90 Minutes of Wear||9
324721|NCT01482312|777541|P1|STARTED|Period 1, 90 Minutes of Wear||10
324722|NCT01482221|777555|P3|NOT COMPLETED|Overall Study||23
324723|NCT01482221|777556|P2|NOT COMPLETED|Overall Study||20
324724|NCT01482221|777557|P1|NOT COMPLETED|Overall Study||21
324725|NCT01482221|777555|P3|COMPLETED|Overall Study||77
324726|NCT01482221|777556|P2|COMPLETED|Overall Study||81
324727|NCT01482221|777557|P1|COMPLETED|Overall Study||80
324728|NCT01482221|777555|P3|STARTED|Overall Study||100
324729|NCT01482221|777556|P2|STARTED|Overall Study||101
324730|NCT01482221|777557|P1|STARTED|Overall Study||101
324731|NCT01482091|777600|P2|NOT COMPLETED|Overall Study||0
324732|NCT01482091|777601|P1|NOT COMPLETED|Overall Study||0
324733|NCT01482091|777600|P2|COMPLETED|Overall Study||24
324734|NCT01482091|777601|P1|COMPLETED|Overall Study||25
324735|NCT01482091|777600|P2|STARTED|Overall Study||24
324736|NCT01482091|777601|P1|STARTED|Overall Study||25
324737|NCT01482065|777633|P2|NOT COMPLETED|Overall Study||1
324738|NCT01482065|777634|P1|NOT COMPLETED|Overall Study||0
324739|NCT01482065|777633|P2|COMPLETED|Overall Study||4
324740|NCT01482065|777634|P1|COMPLETED|Overall Study||4
324741|NCT01482065|777633|P2|STARTED|Overall Study||5
324742|NCT01482065|777634|P1|STARTED|Overall Study||4
324743|NCT01481935|777648|P2|NOT COMPLETED|Overall Study||0
324744|NCT01481935|777649|P1|NOT COMPLETED|Overall Study||0
324745|NCT01481935|777648|P2|COMPLETED|Overall Study||93
324746|NCT01481935|777649|P1|COMPLETED|Overall Study||97
324747|NCT01481935|777648|P2|STARTED|Overall Study||93
324748|NCT01481935|777649|P1|STARTED|Overall Study||97
324749|NCT01481896|777655|P1|NOT COMPLETED|Overall Study||12
324750|NCT01481896|777655|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
324751|NCT01481896|777655|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
324752|NCT01481896|777655|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
324753|NCT01481740|777671|P2|NOT COMPLETED|Overall Study||7
324754|NCT01481740|777672|P1|NOT COMPLETED|Overall Study||11
324755|NCT01481740|777671|P2|COMPLETED|Overall Study||81
324756|NCT01481740|777672|P1|COMPLETED|Overall Study||79
324757|NCT01481740|777671|P2|STARTED|Overall Study||88
324758|NCT01481740|777672|P1|STARTED|Overall Study||90
324759|NCT01481558|777690|P2|NOT COMPLETED|Overall Study||0
324760|NCT01481558|777691|P1|NOT COMPLETED|Overall Study||0
324761|NCT01481558|777690|P2|COMPLETED|Overall Study||20
324762|NCT01481558|777691|P1|COMPLETED|Overall Study||20
324763|NCT01481558|777690|P2|STARTED|Overall Study||20
324764|NCT01481558|777691|P1|STARTED|Overall Study||20
324765|NCT01481376|777697|P1|NOT COMPLETED|Overall Study||31
324766|NCT01481376|777697|P1|COMPLETED|Overall Study||169
324767|NCT01481376|777697|P1|STARTED|Overall Study||200
324768|NCT01481324|777708|P3|NOT COMPLETED|Overall Study||2
324769|NCT01481324|777709|P2|NOT COMPLETED|Overall Study||2
324770|NCT01481324|777710|P1|NOT COMPLETED|Overall Study||0
324771|NCT01481324|777708|P3|COMPLETED|Overall Study||20
324772|NCT01481324|777709|P2|COMPLETED|Overall Study||22
324773|NCT01481324|777710|P1|COMPLETED|Overall Study||21
324774|NCT01481324|777708|P3|Month 3-Wear Rate Data|Overall Study||6
324775|NCT01481324|777709|P2|Month 3-Wear Rate Data|Overall Study||11
324776|NCT01481324|777710|P1|Month 3-Wear Rate Data|Overall Study||7
324777|NCT01481324|777708|P3|Month 2-Wear Rate Data|Overall Study||7
324778|NCT01481324|777709|P2|Month 2-Wear Rate Data|Overall Study||13
324779|NCT01481324|777710|P1|Month 2-Wear Rate Data|Overall Study||9
324780|NCT01481324|777708|P3|Month 1-Wear Rate Data|Overall Study||8
324781|NCT01481324|777709|P2|Month 1-Wear Rate Data|Overall Study||16
324782|NCT01481324|777710|P1|Month 1-Wear Rate Data|Overall Study||15
324783|NCT01481324|777708|P3|STARTED|Overall Study||22
324784|NCT01481324|777709|P2|STARTED|Overall Study||24
324785|NCT01481324|777710|P1|STARTED|Overall Study||21
324786|NCT01481129|777718|P1|NOT COMPLETED|Overall Study||0
324787|NCT01481129|777718|P1|COMPLETED|Overall Study||22
324788|NCT01481129|777718|P1|STARTED|Overall Study||22
324789|NCT01481116|777729|P3|NOT COMPLETED|Overall Study||813
324790|NCT01481116|777730|P2|NOT COMPLETED|Overall Study||817
324791|NCT01481116|777731|P1|NOT COMPLETED|Overall Study||824
324792|NCT01481116|777729|P3|COMPLETED|Overall Study||0
324793|NCT01481116|777730|P2|COMPLETED|Overall Study||0
324794|NCT01481116|777731|P1|COMPLETED|Overall Study||0
324795|NCT01481116|777729|P3|Treated|Overall Study||813
324796|NCT01481116|777730|P2|Treated|Overall Study||816
324797|NCT01481116|777731|P1|Treated|Overall Study||822
324798|NCT01481116|777729|P3|STARTED|Overall Study||813
324799|NCT01481116|777730|P2|STARTED|Overall Study||817
324800|NCT01481116|777731|P1|STARTED|Overall Study||824
324801|NCT01480674|777757|P1|NOT COMPLETED|Overall Study||35
324802|NCT01480674|777757|P1|COMPLETED|Overall Study||125
324803|NCT01480674|777757|P1|Analysed Set|Overall Study||128
324804|NCT01480674|777757|P1|Safety Set|Overall Study||154
324805|NCT01480674|777757|P1|STARTED|Overall Study||160
324806|NCT01480596|777771|P2|NOT COMPLETED|Overall Study||2
324807|NCT01480596|777772|P1|NOT COMPLETED|Overall Study||5
324808|NCT01480596|777771|P2|COMPLETED|Overall Study||16
324809|NCT01480596|777772|P1|COMPLETED|Overall Study||17
324810|NCT01480596|777771|P2|STARTED|Overall Study||18
324811|NCT01480596|777772|P1|STARTED|Overall Study||22
324812|NCT01480297|777814|P1|NOT COMPLETED|Overall Study||0
324813|NCT01480297|777814|P1|COMPLETED|Overall Study||8
324814|NCT01480297|777814|P1|STARTED|Overall Study||8
324815|NCT01480284|777820|P2|NOT COMPLETED|Overall Study||0
324816|NCT01480284|777821|P1|NOT COMPLETED|Overall Study||8
324817|NCT01480284|777820|P2|COMPLETED|Overall Study||56
324818|NCT01480284|777821|P1|COMPLETED|Overall Study||102
324819|NCT01480284|777820|P2|STARTED|Overall Study||56
324820|NCT01480284|777821|P1|STARTED|Overall Study||110
324821|NCT01480232|777853|P4|NOT COMPLETED|Overall Study||19
324822|NCT01480232|777854|P3|NOT COMPLETED|Overall Study||17
324823|NCT01480232|777855|P2|NOT COMPLETED|Overall Study||22
324824|NCT01480232|777856|P1|NOT COMPLETED|Overall Study||18
324825|NCT01480232|777853|P4|COMPLETED|Overall Study||22
324826|NCT01480232|777854|P3|COMPLETED|Overall Study||21
324827|NCT01480232|777855|P2|COMPLETED|Overall Study||19
324828|NCT01480232|777856|P1|COMPLETED|Overall Study||22
324829|NCT01480232|777853|P4|STARTED|Overall Study||41
324830|NCT01480232|777854|P3|STARTED|Overall Study||38
324831|NCT01480232|777855|P2|STARTED|Overall Study||41
324832|NCT01480232|777856|P1|STARTED|Overall Study||40
324833|NCT01480219|777884|P2|NOT COMPLETED|Overall Study||0
324834|NCT01480219|777885|P1|NOT COMPLETED|Overall Study||0
324835|NCT01480219|777884|P2|COMPLETED|Overall Study||142
324836|NCT01480219|777885|P1|COMPLETED|Overall Study||325
324837|NCT01480219|777884|P2|STARTED|Overall Study||142
324838|NCT01480219|777885|P1|STARTED|Overall Study||325
324839|NCT01480089|777893|P2|NOT COMPLETED|Overall Study||0
324840|NCT01480089|777894|P1|NOT COMPLETED|Overall Study||0
324841|NCT01480089|777893|P2|COMPLETED|Overall Study||30
324842|NCT01480089|777894|P1|COMPLETED|Overall Study||25
324843|NCT01480089|777893|P2|STARTED|Overall Study||30
324844|NCT01480089|777894|P1|STARTED|Overall Study||25
324845|NCT01480076|777904|P1|NOT COMPLETED|Overall Study||290
324846|NCT01480076|777904|P1|COMPLETED|Overall Study||611
324847|NCT01480076|777904|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
324848|NCT01480076|777904|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
324849|NCT01479868|778023|P1|NOT COMPLETED|Overall Study||9
324850|NCT01479868|778023|P1|COMPLETED|Overall Study||97
324851|NCT01479868|778023|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
324852|NCT01479777|778038|P1|NOT COMPLETED|Overall Study||2
324853|NCT01479777|778038|P1|COMPLETED|Overall Study||10
324854|NCT01479777|778038|P1|STARTED|Overall Study||12
324855|NCT01479764|778050|P2|NOT COMPLETED|Treated||2
324856|NCT01479764|778051|P1|NOT COMPLETED|Treated||0
324857|NCT01479764|778050|P2|COMPLETED|Treated||75
324858|NCT01479764|778051|P1|COMPLETED|Treated||74
324859|NCT01479764|778050|P2|STARTED|Treated||77
324860|NCT01479764|778051|P1|STARTED|Treated||74
324861|NCT01479764|778050|P2|NOT COMPLETED|Randomized||1
324862|NCT01479764|778051|P1|NOT COMPLETED|Randomized||2
324863|NCT01479764|778050|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
324864|NCT01479764|778051|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
324865|NCT01479764|778050|P2|STARTED|Randomized||78
324866|NCT01479764|778051|P1|STARTED|Randomized||76
324867|NCT01479725|778061|P2|NOT COMPLETED|Overall Study||1
324868|NCT01479725|778062|P1|NOT COMPLETED|Overall Study||2
324869|NCT01479725|778061|P2|COMPLETED|Overall Study||1
324870|NCT01479725|778062|P1|COMPLETED|Overall Study||4
324871|NCT01479725|778061|P2|STARTED|Overall Study||2
324872|NCT01479725|778062|P1|STARTED|Overall Study||6
324873|NCT01479621|778074|P7|NOT COMPLETED|Treatment Period||20
324874|NCT01479621|778075|P6|NOT COMPLETED|Treatment Period||41
324875|NCT01479621|778076|P5|NOT COMPLETED|Treatment Period||21
324876|NCT01479621|778077|P4|NOT COMPLETED|Treatment Period||12
324877|NCT01479621|778078|P3|NOT COMPLETED|Treatment Period||21
324878|NCT01479621|778079|P2|NOT COMPLETED|Treatment Period||24
324879|NCT01479621|778080|P1|NOT COMPLETED|Treatment Period||0
324880|NCT01479621|778074|P7|COMPLETED|Treatment Period||84
324881|NCT01479621|778075|P6|COMPLETED|Treatment Period||63
324882|NCT01479621|778076|P5|COMPLETED|Treatment Period||82
324883|NCT01479621|778077|P4|COMPLETED|Treatment Period||92
324884|NCT01479621|778078|P3|COMPLETED|Treatment Period||83
324885|NCT01479621|778079|P2|COMPLETED|Treatment Period||79
324886|NCT01479621|778080|P1|COMPLETED|Treatment Period||0
324887|NCT01479621|778074|P7|Full Analysis Set|Treatment Period||102
324888|NCT01479621|778075|P6|Full Analysis Set|Treatment Period||102
324889|NCT01479621|778076|P5|Full Analysis Set|Treatment Period||102
324890|NCT01479621|778077|P4|Full Analysis Set|Treatment Period||102
324891|NCT01479621|778078|P3|Full Analysis Set|Treatment Period||101
324892|NCT01479621|778079|P2|Full Analysis Set|Treatment Period||102
324893|NCT01479621|778080|P1|Full Analysis Set|Treatment Period||0
324894|NCT01479621|778074|P7|Safety Population|Treatment Period||104
324895|NCT01479621|778075|P6|Safety Population|Treatment Period||104
324896|NCT01479621|778076|P5|Safety Population|Treatment Period||103
324897|NCT01479621|778077|P4|Safety Population|Treatment Period||104
324898|NCT01479621|778078|P3|Safety Population|Treatment Period||104
324899|NCT01479621|778079|P2|Safety Population|Treatment Period||103
324900|NCT01479621|778080|P1|Safety Population|Treatment Period||0
324901|NCT01479621|778074|P7|STARTED|Treatment Period||104
324902|NCT01479621|778075|P6|STARTED|Treatment Period||104
324903|NCT01479621|778076|P5|STARTED|Treatment Period||103
324904|NCT01479621|778077|P4|STARTED|Treatment Period||104
324905|NCT01479621|778078|P3|STARTED|Treatment Period||104
324906|NCT01479621|778079|P2|STARTED|Treatment Period||103
324907|NCT01479621|778080|P1|STARTED|Treatment Period||0
324908|NCT01479621|778074|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324909|NCT01479621|778075|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324910|NCT01479621|778076|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324911|NCT01479621|778077|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324912|NCT01479621|778078|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324913|NCT01479621|778079|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324914|NCT01479621|778080|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
324915|NCT01479621|778074|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324916|NCT01479621|778075|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324917|NCT01479621|778076|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324918|NCT01479621|778077|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324919|NCT01479621|778078|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324920|NCT01479621|778079|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
324921|NCT01479621|778080|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
324922|NCT01479621|778074|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
324923|NCT01479621|778075|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
324924|NCT01479621|778076|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
324925|NCT01479621|778077|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
324926|NCT01479621|778078|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
324927|NCT01479621|778079|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
324928|NCT01479621|778080|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
324929|NCT01479595|778168|P2|NOT COMPLETED|Overall Study||2
324930|NCT01479595|778169|P1|NOT COMPLETED|Overall Study||2
324931|NCT01479595|778168|P2|COMPLETED|Overall Study||19
324932|NCT01479595|778169|P1|COMPLETED|Overall Study||42
324933|NCT01479595|778168|P2|Per Protocol Analysis Set|Overall Study||20
324934|NCT01479595|778169|P1|Per Protocol Analysis Set|Overall Study||41
324935|NCT01479595|778168|P2|PK Analysis Set|Overall Study||0
324936|NCT01479595|778169|P1|PK Analysis Set|Overall Study||42
324937|NCT01479595|778168|P2|STARTED|Overall Study||21
324938|NCT01479595|778169|P1|STARTED|Overall Study||44
324939|NCT01479543|778196|P5|NOT COMPLETED|Overall Study||1
324940|NCT01479543|778197|P4|NOT COMPLETED|Overall Study||0
324941|NCT01479543|778198|P3|NOT COMPLETED|Overall Study||1
324942|NCT01479543|778199|P2|NOT COMPLETED|Overall Study||0
324943|NCT01479543|778200|P1|NOT COMPLETED|Overall Study||1
324944|NCT01479543|778196|P5|COMPLETED|Overall Study||20
324945|NCT01479543|778197|P4|COMPLETED|Overall Study||20
324946|NCT01479543|778198|P3|COMPLETED|Overall Study||20
324947|NCT01479543|778199|P2|COMPLETED|Overall Study||20
324948|NCT01479543|778200|P1|COMPLETED|Overall Study||20
324949|NCT01479543|778196|P5|STARTED|Overall Study||21
324950|NCT01479543|778197|P4|STARTED|Overall Study||20
324951|NCT01479543|778198|P3|STARTED|Overall Study||21
324952|NCT01479543|778199|P2|STARTED|Overall Study||20
324953|NCT01479543|778200|P1|STARTED|Overall Study||21
324954|NCT01479530|778214|P2|NOT COMPLETED|Overall Study||12
324955|NCT01479530|778215|P1|NOT COMPLETED|Overall Study||10
324956|NCT01479530|778214|P2|COMPLETED|Overall Study||151
324957|NCT01479530|778215|P1|COMPLETED|Overall Study||148
324958|NCT01479530|778214|P2|STARTED|Overall Study||163
324959|NCT01479530|778215|P1|STARTED|Overall Study||158
324960|NCT01479517|778230|P3|NOT COMPLETED|Overall Study||0
324961|NCT01479517|778231|P2|NOT COMPLETED|Overall Study||0
324962|NCT01479517|778232|P1|NOT COMPLETED|Overall Study||0
324963|NCT01479517|778230|P3|COMPLETED|Overall Study||10
324964|NCT01479517|778231|P2|COMPLETED|Overall Study||10
324965|NCT01479517|778232|P1|COMPLETED|Overall Study||10
324966|NCT01479517|778230|P3|STARTED|Overall Study||10
324967|NCT01479517|778231|P2|STARTED|Overall Study||10
324968|NCT01479517|778232|P1|STARTED|Overall Study||10
324969|NCT01479374|778252|P3|NOT COMPLETED|Overall Study||5
324970|NCT01479374|778253|P2|NOT COMPLETED|Overall Study||8
324971|NCT01479374|778254|P1|NOT COMPLETED|Overall Study||3
324972|NCT01479374|778252|P3|COMPLETED|Overall Study||63
324973|NCT01479374|778253|P2|COMPLETED|Overall Study||60
324974|NCT01479374|778254|P1|COMPLETED|Overall Study||63
324975|NCT01479374|778252|P3|STARTED|Overall Study||68
324976|NCT01479374|778253|P2|STARTED|Overall Study||68
324977|NCT01479374|778254|P1|STARTED|Overall Study||66
324978|NCT01479127|778280|P1|NOT COMPLETED|Overall Study||3
324979|NCT01479127|778280|P1|COMPLETED|Overall Study||5
324980|NCT01479127|778280|P1|Started LCIG|Overall Study||6
324981|NCT01479127|778280|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
324982|NCT01479010|778314|P1|NOT COMPLETED|Overall Study||1
324983|NCT01479010|778314|P1|COMPLETED|Overall Study||1
324984|NCT01479010|778314|P1|STARTED|Overall Study||2
324985|NCT01478971|778319|P1|NOT COMPLETED|Peginesatide Treatment Period||14
324986|NCT01478971|778319|P1|COMPLETED|Peginesatide Treatment Period||143
324987|NCT01478971|778319|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
324988|NCT01478971|778319|P1|NOT COMPLETED|Standard of Care Period||25
324989|NCT01478971|778319|P1|COMPLETED|Standard of Care Period||159
324990|NCT01478971|778319|P1|Received Treatment|Standard of Care Period||178
324991|NCT01478971|778319|P1|STARTED|Standard of Care Period||184
324992|NCT01478958|778336|P3|NOT COMPLETED|Overall Study||3
324993|NCT01478958|778337|P2|NOT COMPLETED|Overall Study||2
324994|NCT01478958|778338|P1|NOT COMPLETED|Overall Study||2
324995|NCT01478958|778336|P3|COMPLETED|Overall Study||66
324996|NCT01478958|778337|P2|COMPLETED|Overall Study||64
324997|NCT01478958|778338|P1|COMPLETED|Overall Study||65
324998|NCT01478958|778336|P3|STARTED|Overall Study||69
324999|NCT01478958|778337|P2|STARTED|Overall Study||66
325000|NCT01478958|778338|P1|STARTED|Overall Study||67
325001|NCT01478828|778346|P1|NOT COMPLETED|Overall Study||1
325002|NCT01478828|778346|P1|COMPLETED|Overall Study||1
325003|NCT01478828|778346|P1|STARTED|Overall Study||2
325004|NCT01478620|778351|P1|NOT COMPLETED|Overall Study||6
325005|NCT01478620|778351|P1|COMPLETED|Overall Study||119
325006|NCT01478620|778351|P1|STARTED|Overall Study||125
325007|NCT01478594|778357|P2|NOT COMPLETED|Overall Study||28
325008|NCT01478594|778358|P1|NOT COMPLETED|Overall Study||65
325009|NCT01478594|778357|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
325010|NCT01478594|778358|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
325011|NCT01478594|778357|P2|Treated|Overall Study||87
325012|NCT01478594|778358|P1|Treated|Overall Study||177
325013|NCT01478594|778357|P2|STARTED|Overall Study||88
325014|NCT01478594|778358|P1|STARTED|Overall Study||177
325015|NCT01478373|778430|P1|NOT COMPLETED|Survival Phase||38
325016|NCT01478373|778430|P1|COMPLETED|Survival Phase||0
325017|NCT01478373|778430|P1|STARTED|Survival Phase||38
325018|NCT01478373|778430|P1|NOT COMPLETED|Treatment Phase||1
325019|NCT01478373|778430|P1|COMPLETED|Treatment Phase||38
325020|NCT01478373|778430|P1|STARTED|Treatment Phase||39
325021|NCT01478360|778443|P2|NOT COMPLETED|Overall Study||3
325022|NCT01478360|778444|P1|NOT COMPLETED|Overall Study||2
325023|NCT01478360|778443|P2|COMPLETED|Overall Study||12
325024|NCT01478360|778444|P1|COMPLETED|Overall Study||29
325025|NCT01478360|778443|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
325026|NCT01478360|778444|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
325027|NCT01478360|778443|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
325028|NCT01478360|778444|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
325029|NCT01478360|778443|P2|STARTED|Overall Study||15
325030|NCT01478360|778444|P1|STARTED|Overall Study||31
325031|NCT01478347|778450|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
325032|NCT01478347|778450|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
325033|NCT01478347|778450|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
325034|NCT01478347|778450|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
325035|NCT01478347|778450|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
325036|NCT01478347|778450|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
325037|NCT01478256|778457|P2|NOT COMPLETED|Overall Study||0
325038|NCT01478256|778458|P1|NOT COMPLETED|Overall Study||0
325039|NCT01478256|778457|P2|COMPLETED|Overall Study||15
325040|NCT01478256|778458|P1|COMPLETED|Overall Study||15
325041|NCT01478256|778457|P2|STARTED|Overall Study||15
325042|NCT01478256|778458|P1|STARTED|Overall Study||15
325043|NCT01478113|778468|P2|NOT COMPLETED|Overall Study||1
325044|NCT01478113|778469|P1|NOT COMPLETED|Overall Study||1
325045|NCT01478113|778468|P2|COMPLETED|Overall Study||1
325046|NCT01478113|778469|P1|COMPLETED|Overall Study||1
325047|NCT01478113|778468|P2|STARTED|Overall Study||2
325048|NCT01478113|778469|P1|STARTED|Overall Study||2
325049|NCT01478087|778487|P1|NOT COMPLETED|Overall Study||1
325050|NCT01478087|778487|P1|COMPLETED|Overall Study||2
325051|NCT01478087|778487|P1|STARTED|Overall Study||3
325052|NCT01478048|778494|P2|NOT COMPLETED|Overall Study||68
325053|NCT01478048|778495|P1|NOT COMPLETED|Overall Study||63
325054|NCT01478048|778494|P2|COMPLETED|Overall Study|completed=treatment on-going|7
325055|NCT01478048|778495|P1|COMPLETED|Overall Study|completed=treatment on-going|14
325056|NCT01478048|778494|P2|Received Treatment|Overall Study||75
325057|NCT01478048|778495|P1|Received Treatment|Overall Study||75
325058|NCT01478048|778494|P2|STARTED|Overall Study||75
325059|NCT01478048|778495|P1|STARTED|Overall Study||77
325060|NCT01478009|778513|P2|NOT COMPLETED|Overall Study||1
325061|NCT01478009|778514|P1|NOT COMPLETED|Overall Study||1
325062|NCT01478009|778513|P2|COMPLETED|Overall Study||49
325063|NCT01478009|778514|P1|COMPLETED|Overall Study||49
325064|NCT01478009|778513|P2|STARTED|Overall Study||50
325065|NCT01478009|778514|P1|STARTED|Overall Study||50
325066|NCT01477892|778524|P2|NOT COMPLETED|Overall Study||2
325067|NCT01477892|778525|P1|NOT COMPLETED|Overall Study||0
325068|NCT01477892|778524|P2|COMPLETED|Overall Study||5
325069|NCT01477892|778525|P1|COMPLETED|Overall Study||7
325070|NCT01477892|778524|P2|STARTED|Overall Study||7
325071|NCT01477892|778525|P1|STARTED|Overall Study||7
325072|NCT01477853|778536|P3|NOT COMPLETED|Phase B||11
325073|NCT01477853|778537|P2|NOT COMPLETED|Phase B||11
325074|NCT01477853|778538|P1|NOT COMPLETED|Phase B||12
325075|NCT01477853|778536|P3|COMPLETED|Phase B||0
325076|NCT01477853|778537|P2|COMPLETED|Phase B||0
325077|NCT01477853|778538|P1|COMPLETED|Phase B||0
325078|NCT01477853|778536|P3|STARTED|Phase B||11
325079|NCT01477853|778537|P2|STARTED|Phase B||11
325080|NCT01477853|778538|P1|STARTED|Phase B||12
325081|NCT01477853|778536|P3|NOT COMPLETED|Phase A||44
325082|NCT01477853|778537|P2|NOT COMPLETED|Phase A||45
325083|NCT01477853|778538|P1|NOT COMPLETED|Phase A||43
325084|NCT01477853|778536|P3|COMPLETED|Phase A||11
325085|NCT01477853|778537|P2|COMPLETED|Phase A||11
325086|NCT01477853|778538|P1|COMPLETED|Phase A||12
325087|NCT01477853|778536|P3|STARTED|Phase A||55
325088|NCT01477853|778537|P2|STARTED|Phase A||56
325089|NCT01477853|778538|P1|STARTED|Phase A||55
325090|NCT01477762|778580|P4|NOT COMPLETED|Overall Study||2
325091|NCT01477762|778581|P3|NOT COMPLETED|Overall Study||4
325092|NCT01477762|778582|P2|NOT COMPLETED|Overall Study||13
325093|NCT01477762|778583|P1|NOT COMPLETED|Overall Study||9
325094|NCT01477762|778580|P4|COMPLETED|Overall Study||11
325095|NCT01477762|778581|P3|COMPLETED|Overall Study||16
325096|NCT01477762|778582|P2|COMPLETED|Overall Study||20
325097|NCT01477762|778583|P1|COMPLETED|Overall Study||16
325098|NCT01477762|778580|P4|STARTED|Overall Study||13
325099|NCT01477762|778581|P3|STARTED|Overall Study||20
325100|NCT01477762|778582|P2|STARTED|Overall Study||33
325101|NCT01477762|778583|P1|STARTED|Overall Study||25
325102|NCT01477749|778605|P1|NOT COMPLETED|Overall Study||4
325103|NCT01477749|778605|P1|COMPLETED|Overall Study||43
325104|NCT01477749|778605|P1|STARTED|Overall Study||47
325105|NCT01477710|778612|P1|NOT COMPLETED|Overall Study||0
325106|NCT01477710|778612|P1|COMPLETED|Overall Study||30
325107|NCT01477710|778612|P1|STARTED|Overall Study||30
325108|NCT01477567|778627|P7|NOT COMPLETED|Overall Study||0
325109|NCT01477567|778628|P6|NOT COMPLETED|Overall Study||0
325110|NCT01477567|778629|P5|NOT COMPLETED|Overall Study||0
325111|NCT01477567|778630|P4|NOT COMPLETED|Overall Study||0
325112|NCT01477567|778631|P3|NOT COMPLETED|Overall Study||0
325113|NCT01477567|778632|P2|NOT COMPLETED|Overall Study||0
325114|NCT01477567|778633|P1|NOT COMPLETED|Overall Study||0
325115|NCT01477567|778627|P7|COMPLETED|Overall Study||6
325116|NCT01477567|778628|P6|COMPLETED|Overall Study||5
325117|NCT01477567|778629|P5|COMPLETED|Overall Study||6
325118|NCT01477567|778630|P4|COMPLETED|Overall Study||6
325119|NCT01477567|778631|P3|COMPLETED|Overall Study||6
325120|NCT01477567|778632|P2|COMPLETED|Overall Study||6
325121|NCT01477567|778633|P1|COMPLETED|Overall Study||5
325122|NCT01477567|778627|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
325123|NCT01477567|778628|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
325124|NCT01477567|778629|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
325125|NCT01477567|778630|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
325126|NCT01477567|778631|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
325127|NCT01477567|778632|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
325128|NCT01477567|778633|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
325129|NCT01477567|778627|P7|STARTED|Overall Study||6
325130|NCT01477567|778628|P6|STARTED|Overall Study||5
325131|NCT01477567|778629|P5|STARTED|Overall Study||6
325132|NCT01477567|778630|P4|STARTED|Overall Study||6
325133|NCT01477567|778631|P3|STARTED|Overall Study||6
325134|NCT01477567|778632|P2|STARTED|Overall Study||6
325135|NCT01477567|778633|P1|STARTED|Overall Study||5
325136|NCT01477463|778689|P2|NOT COMPLETED|Overall Study||0
325137|NCT01477463|778690|P1|NOT COMPLETED|Overall Study||0
325138|NCT01477463|778689|P2|COMPLETED|Overall Study||6
325139|NCT01477463|778690|P1|COMPLETED|Overall Study||18
325140|NCT01477463|778689|P2|STARTED|Overall Study||6
325141|NCT01477463|778690|P1|STARTED|Overall Study||18
325142|NCT01477450|778703|P3|NOT COMPLETED|Overall Study||0
325143|NCT01477450|778704|P2|NOT COMPLETED|Overall Study||0
325144|NCT01477450|778705|P1|NOT COMPLETED|Overall Study||0
325145|NCT01477450|778703|P3|COMPLETED|Overall Study||10
325146|NCT01477450|778704|P2|COMPLETED|Overall Study||10
325147|NCT01477450|778705|P1|COMPLETED|Overall Study||10
325148|NCT01477450|778703|P3|STARTED|Overall Study||10
325149|NCT01477450|778704|P2|STARTED|Overall Study||10
325150|NCT01477450|778705|P1|STARTED|Overall Study||10
325151|NCT01477333|778713|P1|NOT COMPLETED|Overall Study||3
325152|NCT01477333|778713|P1|COMPLETED|Overall Study||15
325153|NCT01477333|778713|P1|STARTED|Overall Study||18
325154|NCT01475734|778731|P2|NOT COMPLETED|Overall Study||1
325155|NCT01475734|778732|P1|NOT COMPLETED|Overall Study||2
325156|NCT01475734|778731|P2|COMPLETED|Overall Study||21
325157|NCT01475734|778732|P1|COMPLETED|Overall Study||20
325158|NCT01475734|778731|P2|STARTED|Overall Study||22
325159|NCT01475734|778732|P1|STARTED|Overall Study||22
325160|NCT01475721|778760|P2|NOT COMPLETED|Overall Study||14
325161|NCT01475721|778761|P1|NOT COMPLETED|Overall Study||11
325162|NCT01475721|778760|P2|COMPLETED|Overall Study||5831
325163|NCT01475721|778761|P1|COMPLETED|Overall Study||5823
325164|NCT01475721|778760|P2|STARTED|Overall Study||5845
325165|NCT01475721|778761|P1|STARTED|Overall Study||5834
325166|NCT01476748|778778|P3|NOT COMPLETED|Overall Study||0
325167|NCT01476748|778779|P2|NOT COMPLETED|Overall Study||0
325168|NCT01476748|778780|P1|NOT COMPLETED|Overall Study||0
325169|NCT01476748|778778|P3|COMPLETED|Overall Study||5
325170|NCT01476748|778779|P2|COMPLETED|Overall Study||5
325171|NCT01476748|778780|P1|COMPLETED|Overall Study||5
325172|NCT01476748|778778|P3|STARTED|Overall Study||5
325173|NCT01476748|778779|P2|STARTED|Overall Study||5
325174|NCT01476748|778780|P1|STARTED|Overall Study||5
325175|NCT01476722|778791|P1|NOT COMPLETED|Overall Study||1
325176|NCT01476722|778791|P1|COMPLETED|Overall Study||124
325177|NCT01476722|778791|P1|STARTED|Overall Study||125
325178|NCT01476696|778798|P3|NOT COMPLETED|Overall Study||0
325179|NCT01476696|778799|P2|NOT COMPLETED|Overall Study||1
325180|NCT01476696|778800|P1|NOT COMPLETED|Overall Study||3
325181|NCT01476696|778798|P3|COMPLETED|Overall Study||9
325182|NCT01476696|778799|P2|COMPLETED|Overall Study||8
325183|NCT01476696|778800|P1|COMPLETED|Overall Study||12
325184|NCT01476696|778798|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
325185|NCT01476696|778799|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
325186|NCT01476696|778800|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
325187|NCT01476696|778798|P3|STARTED|Overall Study||9
325188|NCT01476696|778799|P2|STARTED|Overall Study||9
325189|NCT01476696|778800|P1|STARTED|Overall Study||15
325190|NCT01476475|778816|P2|NOT COMPLETED|Overall Study||3
325191|NCT01476475|778817|P1|NOT COMPLETED|Overall Study||11
325192|NCT01476475|778816|P2|COMPLETED|Overall Study||159
325193|NCT01476475|778817|P1|COMPLETED|Overall Study||150
325194|NCT01476475|778816|P2|STARTED|Overall Study||162
325195|NCT01476475|778817|P1|STARTED|Overall Study||161
325196|NCT01476345|778849|P2|NOT COMPLETED|Period 4||0
325197|NCT01476345|778850|P1|NOT COMPLETED|Period 4||0
325198|NCT01476345|778849|P2|COMPLETED|Period 4||39
325199|NCT01476345|778850|P1|COMPLETED|Period 4||39
325200|NCT01476345|778849|P2|STARTED|Period 4||39
325201|NCT01476345|778850|P1|STARTED|Period 4||39
325202|NCT01476345|778849|P2|NOT COMPLETED|Period 3||0
325203|NCT01476345|778850|P1|NOT COMPLETED|Period 3||0
325204|NCT01476345|778849|P2|COMPLETED|Period 3||39
325205|NCT01476345|778850|P1|COMPLETED|Period 3||39
325206|NCT01476345|778849|P2|STARTED|Period 3||39
325207|NCT01476345|778850|P1|STARTED|Period 3||39
325208|NCT01476345|778849|P2|NOT COMPLETED|Period 2||0
325209|NCT01476345|778850|P1|NOT COMPLETED|Period 2||0
325210|NCT01476345|778849|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
325211|NCT01476345|778850|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
325212|NCT01476345|778849|P2|STARTED|Period 2||40
325213|NCT01476345|778850|P1|STARTED|Period 2||40
325214|NCT01476345|778849|P2|NOT COMPLETED|Period 1||0
325215|NCT01476345|778850|P1|NOT COMPLETED|Period 1||0
325216|NCT01476345|778849|P2|COMPLETED|Period 1||40
325217|NCT01476345|778850|P1|COMPLETED|Period 1||40
325218|NCT01476345|778849|P2|Received at Least 1 Dose of Study Drug|Period 1||40
325219|NCT01476345|778850|P1|Received at Least 1 Dose of Study Drug|Period 1||40
325220|NCT01476345|778849|P2|STARTED|Period 1||40
325221|NCT01476345|778850|P1|STARTED|Period 1||40
325222|NCT01476202|778865|P3|NOT COMPLETED|Overall Study||0
325223|NCT01476202|778866|P2|NOT COMPLETED|Overall Study||0
325224|NCT01476202|778867|P1|NOT COMPLETED|Overall Study||0
325225|NCT01476202|778865|P3|COMPLETED|Overall Study||40
325226|NCT01476202|778866|P2|COMPLETED|Overall Study||40
325227|NCT01476202|778867|P1|COMPLETED|Overall Study||40
325228|NCT01476202|778865|P3|STARTED|Overall Study||40
325229|NCT01476202|778866|P2|STARTED|Overall Study||40
325230|NCT01476202|778867|P1|STARTED|Overall Study||40
325231|NCT01475955|778883|P5|NOT COMPLETED|Overall Study||0
325232|NCT01475955|778884|P4|NOT COMPLETED|Overall Study||0
325233|NCT01475955|778885|P3|NOT COMPLETED|Overall Study||3
325234|NCT01475955|778886|P2|NOT COMPLETED|Overall Study||0
325235|NCT01475955|778887|P1|NOT COMPLETED|Overall Study||1
325236|NCT01475955|778883|P5|COMPLETED|Overall Study||46
325237|NCT01475955|778884|P4|COMPLETED|Overall Study||46
325238|NCT01475955|778885|P3|COMPLETED|Overall Study||44
325239|NCT01475955|778886|P2|COMPLETED|Overall Study||48
325240|NCT01475955|778887|P1|COMPLETED|Overall Study||47
325241|NCT01475955|778883|P5|STARTED|Overall Study||46
325242|NCT01475955|778884|P4|STARTED|Overall Study||46
325243|NCT01475955|778885|P3|STARTED|Overall Study||47
325244|NCT01475955|778886|P2|STARTED|Overall Study||48
325245|NCT01475955|778887|P1|STARTED|Overall Study||48
325246|NCT01475851|779246|P2|NOT COMPLETED|Overall Study||0
325247|NCT01475851|779247|P1|NOT COMPLETED|Overall Study||1
325248|NCT01475851|779246|P2|COMPLETED|Overall Study||21
325249|NCT01475851|779247|P1|COMPLETED|Overall Study||12
325250|NCT01475851|779246|P2|STARTED|Overall Study||21
325251|NCT01475851|779247|P1|STARTED|Overall Study||13
325252|NCT01475838|779275|P2|NOT COMPLETED|Extension Phase||0
325253|NCT01475838|779276|P1|NOT COMPLETED|Extension Phase||1
325254|NCT01475838|779275|P2|COMPLETED|Extension Phase||20
325255|NCT01475838|779276|P1|COMPLETED|Extension Phase||41
325256|NCT01475838|779275|P2|STARTED|Extension Phase||20
325257|NCT01475838|779276|P1|STARTED|Extension Phase||42
325258|NCT01475838|779275|P2|NOT COMPLETED|Randomized Phase||36
325259|NCT01475838|779276|P1|NOT COMPLETED|Randomized Phase||30
325260|NCT01475838|779275|P2|COMPLETED|Randomized Phase||109
325261|NCT01475838|779276|P1|COMPLETED|Randomized Phase||263
325262|NCT01475838|779275|P2|STARTED|Randomized Phase||145
325263|NCT01475838|779276|P1|STARTED|Randomized Phase||293
325264|NCT01475487|779291|P2|NOT COMPLETED|Overall Study||1
325265|NCT01475487|779292|P1|NOT COMPLETED|Overall Study||2
325266|NCT01475487|779291|P2|COMPLETED|Overall Study||24
325267|NCT01475487|779292|P1|COMPLETED|Overall Study||23
325268|NCT01475487|779291|P2|STARTED|Overall Study||25
325269|NCT01475487|779292|P1|STARTED|Overall Study||25
325270|NCT01475474|779304|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
325271|NCT01475474|779304|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
325272|NCT01475474|779304|P1|STARTED|Return to Baseline Period - 4 Weeks||73
325273|NCT01475474|779304|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
325274|NCT01475474|779304|P1|COMPLETED|Treatment Period - 12 Weeks||73
325275|NCT01475474|779304|P1|STARTED|Treatment Period - 12 Weeks||91
325276|NCT01475474|779304|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
325277|NCT01475474|779304|P1|COMPLETED|Baseline Period - 4 Weeks||91
325278|NCT01475474|779304|P1|STARTED|Baseline Period - 4 Weeks||97
325279|NCT01475461|779315|P7|NOT COMPLETED|Treatment Period||2
325280|NCT01475461|779316|P6|NOT COMPLETED|Treatment Period||5
325281|NCT01475461|779317|P5|NOT COMPLETED|Treatment Period||4
325282|NCT01475461|779318|P4|NOT COMPLETED|Treatment Period||8
325283|NCT01475461|779319|P3|NOT COMPLETED|Treatment Period||4
325284|NCT01475461|779320|P2|NOT COMPLETED|Treatment Period||9
325285|NCT01475461|779321|P1|NOT COMPLETED|Treatment Period||0
325286|NCT01475461|779315|P7|COMPLETED|Treatment Period||53
325287|NCT01475461|779316|P6|COMPLETED|Treatment Period||51
325288|NCT01475461|779317|P5|COMPLETED|Treatment Period||52
325289|NCT01475461|779318|P4|COMPLETED|Treatment Period||46
325290|NCT01475461|779319|P3|COMPLETED|Treatment Period||53
325291|NCT01475461|779320|P2|COMPLETED|Treatment Period||48
325292|NCT01475461|779321|P1|COMPLETED|Treatment Period||0
325293|NCT01475461|779315|P7|STARTED|Treatment Period||55
325294|NCT01475461|779316|P6|STARTED|Treatment Period||56
325295|NCT01475461|779317|P5|STARTED|Treatment Period||56
325296|NCT01475461|779318|P4|STARTED|Treatment Period||54
325297|NCT01475461|779319|P3|STARTED|Treatment Period||57
325298|NCT01475461|779320|P2|STARTED|Treatment Period||57
325299|NCT01475461|779321|P1|STARTED|Treatment Period||0
325300|NCT01475461|779315|P7|NOT COMPLETED|Run-in Period||0
325301|NCT01475461|779316|P6|NOT COMPLETED|Run-in Period||0
325302|NCT01475461|779317|P5|NOT COMPLETED|Run-in Period||0
325303|NCT01475461|779318|P4|NOT COMPLETED|Run-in Period||0
325304|NCT01475461|779319|P3|NOT COMPLETED|Run-in Period||0
325305|NCT01475461|779320|P2|NOT COMPLETED|Run-in Period||0
325306|NCT01475461|779321|P1|NOT COMPLETED|Run-in Period||41
325307|NCT01475461|779315|P7|COMPLETED|Run-in Period||0
325308|NCT01475461|779316|P6|COMPLETED|Run-in Period||0
325309|NCT01475461|779317|P5|COMPLETED|Run-in Period||0
325310|NCT01475461|779318|P4|COMPLETED|Run-in Period||0
325311|NCT01475461|779319|P3|COMPLETED|Run-in Period||0
325312|NCT01475461|779320|P2|COMPLETED|Run-in Period||0
325313|NCT01475461|779321|P1|COMPLETED|Run-in Period||335
325314|NCT01475461|779315|P7|STARTED|Run-in Period||0
325315|NCT01475461|779316|P6|STARTED|Run-in Period||0
325316|NCT01475461|779317|P5|STARTED|Run-in Period||0
325317|NCT01475461|779318|P4|STARTED|Run-in Period||0
325318|NCT01475461|779319|P3|STARTED|Run-in Period||0
325319|NCT01475461|779320|P2|STARTED|Run-in Period||0
325320|NCT01475461|779321|P1|STARTED|Run-in Period||376
325321|NCT01475253|779402|P4|NOT COMPLETED|Open Label Extension||0
325322|NCT01475253|779403|P3|NOT COMPLETED|Open Label Extension||0
325323|NCT01475253|779404|P2|NOT COMPLETED|Open Label Extension||0
325324|NCT01475253|779405|P1|NOT COMPLETED|Open Label Extension||0
325325|NCT01475253|779402|P4|COMPLETED|Open Label Extension||56
325326|NCT01475253|779403|P3|COMPLETED|Open Label Extension||0
325327|NCT01475253|779404|P2|COMPLETED|Open Label Extension||0
325328|NCT01475253|779405|P1|COMPLETED|Open Label Extension||0
325329|NCT01475253|779402|P4|STARTED|Open Label Extension||56
325330|NCT01475253|779403|P3|STARTED|Open Label Extension||0
325331|NCT01475253|779404|P2|STARTED|Open Label Extension||0
325332|NCT01475253|779405|P1|STARTED|Open Label Extension||0
325333|NCT01475253|779402|P4|NOT COMPLETED|Randomized, Blinded Study||0
325334|NCT01475253|779403|P3|NOT COMPLETED|Randomized, Blinded Study||0
325335|NCT01475253|779404|P2|NOT COMPLETED|Randomized, Blinded Study||1
325336|NCT01475253|779405|P1|NOT COMPLETED|Randomized, Blinded Study||2
325337|NCT01475253|779402|P4|COMPLETED|Randomized, Blinded Study||0
325338|NCT01475253|779403|P3|COMPLETED|Randomized, Blinded Study||11
325339|NCT01475253|779404|P2|COMPLETED|Randomized, Blinded Study||45
325340|NCT01475253|779405|P1|COMPLETED|Randomized, Blinded Study||45
325341|NCT01475253|779402|P4|STARTED|Randomized, Blinded Study||0
325342|NCT01475253|779403|P3|STARTED|Randomized, Blinded Study||11
325343|NCT01475253|779404|P2|STARTED|Randomized, Blinded Study||46
325344|NCT01475253|779405|P1|STARTED|Randomized, Blinded Study||47
325345|NCT01475214|779434|P3|NOT COMPLETED|Overall Study||2
325346|NCT01475214|779435|P2|NOT COMPLETED|Overall Study||4
325347|NCT01475214|779436|P1|NOT COMPLETED|Overall Study||5
325348|NCT01475214|779434|P3|COMPLETED|Overall Study||79
325349|NCT01475214|779435|P2|COMPLETED|Overall Study||75
325350|NCT01475214|779436|P1|COMPLETED|Overall Study||79
325351|NCT01475214|779434|P3|STARTED|Overall Study||81
325352|NCT01475214|779435|P2|STARTED|Overall Study||79
325353|NCT01475214|779436|P1|STARTED|Overall Study||84
325354|NCT01475175|779447|P1|NOT COMPLETED|Overall Study||0
325355|NCT01475175|779447|P1|COMPLETED|Overall Study||12
325356|NCT01475175|779447|P1|STARTED|Overall Study||12
325357|NCT01475097|779461|P2|NOT COMPLETED|Overall Study||1
325358|NCT01475097|779462|P1|NOT COMPLETED|Overall Study||1
325359|NCT01475097|779461|P2|COMPLETED|Overall Study||126
325360|NCT01475097|779462|P1|COMPLETED|Overall Study||127
325361|NCT01475097|779461|P2|STARTED|Overall Study||127
325362|NCT01475097|779462|P1|STARTED|Overall Study||128
325363|NCT01475071|779470|P1|NOT COMPLETED|Overall Study||8
325364|NCT01475071|779470|P1|COMPLETED|Overall Study||92
325365|NCT01475071|779470|P1|STARTED|Overall Study||100
325366|NCT01474993|779480|P2|NOT COMPLETED|Overall Study||3
325367|NCT01474993|779481|P1|NOT COMPLETED|Overall Study||1
325368|NCT01474993|779480|P2|COMPLETED|Overall Study||26
325369|NCT01474993|779481|P1|COMPLETED|Overall Study||14
325370|NCT01474993|779480|P2|STARTED|Overall Study||29
325371|NCT01474993|779481|P1|STARTED|Overall Study||15
325372|NCT01474915|779507|P2|NOT COMPLETED|Overall Study||10
325373|NCT01474915|779508|P1|NOT COMPLETED|Overall Study||10
325374|NCT01474915|779507|P2|COMPLETED|Overall Study||51
325375|NCT01474915|779508|P1|COMPLETED|Overall Study||50
325376|NCT01474915|779507|P2|STARTED|Overall Study||61
325377|NCT01474915|779508|P1|STARTED|Overall Study||60
325378|NCT01474876|779519|P3|NOT COMPLETED|Overall Study||0
325379|NCT01474876|779520|P2|NOT COMPLETED|Overall Study||23
325380|NCT01474876|779521|P1|NOT COMPLETED|Overall Study||66
325381|NCT01474876|779519|P3|COMPLETED|Overall Study||1
325382|NCT01474876|779520|P2|COMPLETED|Overall Study||128
325383|NCT01474876|779521|P1|COMPLETED|Overall Study||337
325384|NCT01474876|779519|P3|STARTED|Overall Study||1
325385|NCT01474876|779520|P2|STARTED|Overall Study||151
325386|NCT01474876|779521|P1|STARTED|Overall Study||403
325387|NCT01474863|779555|P3|NOT COMPLETED|Overall Study||0
325388|NCT01474863|779556|P2|NOT COMPLETED|Overall Study||0
325389|NCT01474863|779557|P1|NOT COMPLETED|Overall Study||0
325390|NCT01474863|779555|P3|COMPLETED|Overall Study||24
325391|NCT01474863|779556|P2|COMPLETED|Overall Study||22
325392|NCT01474863|779557|P1|COMPLETED|Overall Study||26
325393|NCT01474863|779555|P3|STARTED|Overall Study||24
325394|NCT01474863|779556|P2|STARTED|Overall Study||22
325395|NCT01474863|779557|P1|STARTED|Overall Study||26
325396|NCT01474772|779567|P2|NOT COMPLETED|Follow-up||1
325397|NCT01474772|779568|P1|NOT COMPLETED|Follow-up||0
325398|NCT01474772|779567|P2|COMPLETED|Follow-up||86
325399|NCT01474772|779568|P1|COMPLETED|Follow-up||77
325400|NCT01474772|779567|P2|STARTED|Follow-up||87
325401|NCT01474772|779568|P1|STARTED|Follow-up||77
325402|NCT01474772|779567|P2|NOT COMPLETED|Period 2||10
325403|NCT01474772|779568|P1|NOT COMPLETED|Period 2||9
325404|NCT01474772|779567|P2|COMPLETED|Period 2||87
325405|NCT01474772|779568|P1|COMPLETED|Period 2||77
325406|NCT01474772|779567|P2|STARTED|Period 2||97
325407|NCT01474772|779568|P1|STARTED|Period 2||86
325408|NCT01474772|779567|P2|NOT COMPLETED|Washout||2
325409|NCT01474772|779568|P1|NOT COMPLETED|Washout||3
325410|NCT01474772|779567|P2|COMPLETED|Washout||97
325411|NCT01474772|779568|P1|COMPLETED|Washout||86
325412|NCT01474772|779567|P2|STARTED|Washout||99
325413|NCT01474772|779568|P1|STARTED|Washout||89
325414|NCT01474772|779567|P2|NOT COMPLETED|Period 1||3
325415|NCT01474772|779568|P1|NOT COMPLETED|Period 1||12
325416|NCT01474772|779567|P2|COMPLETED|Period 1||99
325417|NCT01474772|779568|P1|COMPLETED|Period 1||89
325418|NCT01474772|779567|P2|STARTED|Period 1|STARTED=treated|102
325419|NCT01474772|779568|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
325420|NCT01474681|779618|P4|NOT COMPLETED|Overall Study||6
325421|NCT01474681|779619|P3|NOT COMPLETED|Overall Study||2
325422|NCT01474681|779620|P2|NOT COMPLETED|Overall Study||3
325423|NCT01474681|779621|P1|NOT COMPLETED|Overall Study||0
325424|NCT01474681|779618|P4|COMPLETED|Overall Study||9
325425|NCT01474681|779619|P3|COMPLETED|Overall Study||1
325426|NCT01474681|779620|P2|COMPLETED|Overall Study||5
325427|NCT01474681|779621|P1|COMPLETED|Overall Study||1
325428|NCT01474681|779618|P4|STARTED|Overall Study||15
325429|NCT01474681|779619|P3|STARTED|Overall Study||3
325430|NCT01474681|779620|P2|STARTED|Overall Study||8
325431|NCT01474681|779621|P1|STARTED|Overall Study||1
325432|NCT01474551|779663|P1|NOT COMPLETED|Overall Study||1
325433|NCT01474551|779663|P1|COMPLETED|Overall Study||1
325434|NCT01474551|779663|P1|STARTED|Overall Study||2
325435|NCT01474538|779669|P2|NOT COMPLETED|Treatment Period 2||2
325436|NCT01474538|779670|P1|NOT COMPLETED|Treatment Period 2||6
325437|NCT01474538|779669|P2|COMPLETED|Treatment Period 2||56
325438|NCT01474538|779670|P1|COMPLETED|Treatment Period 2||51
325439|NCT01474538|779669|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
325440|NCT01474538|779670|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
325441|NCT01474538|779669|P2|STARTED|Treatment Period 2||58
325442|NCT01474538|779670|P1|STARTED|Treatment Period 2||57
325443|NCT01474538|779669|P2|NOT COMPLETED|Treatment Period 1||4
325444|NCT01474538|779670|P1|NOT COMPLETED|Treatment Period 1||3
325445|NCT01474538|779669|P2|COMPLETED|Treatment Period 1||58
325446|NCT01474538|779670|P1|COMPLETED|Treatment Period 1||57
325447|NCT01474538|779669|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
325448|NCT01474538|779670|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
325449|NCT01474538|779669|P2|STARTED|Treatment Period 1||62
325450|NCT01474538|779670|P1|STARTED|Treatment Period 1||60
325451|NCT01474512|779687|P10|NOT COMPLETED|Maintenance Period||18
325452|NCT01474512|779688|P9|NOT COMPLETED|Maintenance Period||16
325453|NCT01474512|779689|P8|NOT COMPLETED|Maintenance Period||41
325454|NCT01474512|779690|P7|NOT COMPLETED|Maintenance Period||10
325455|NCT01474512|779691|P6|NOT COMPLETED|Maintenance Period||52
325456|NCT01474512|779692|P5|NOT COMPLETED|Maintenance Period||119
325457|NCT01474512|779693|P4|NOT COMPLETED|Maintenance Period||202
325458|NCT01474512|779694|P3|NOT COMPLETED|Maintenance Period||0
325459|NCT01474512|779695|P2|NOT COMPLETED|Maintenance Period||0
325460|NCT01474512|779696|P1|NOT COMPLETED|Maintenance Period||0
325461|NCT01474512|779687|P10|COMPLETED|Maintenance Period||44
325462|NCT01474512|779688|P9|COMPLETED|Maintenance Period||62
325463|NCT01474512|779689|P8|COMPLETED|Maintenance Period||350
325464|NCT01474512|779690|P7|COMPLETED|Maintenance Period||6
325465|NCT01474512|779691|P6|COMPLETED|Maintenance Period||177
325466|NCT01474512|779692|P5|COMPLETED|Maintenance Period||108
325467|NCT01474512|779693|P4|COMPLETED|Maintenance Period||24
325468|NCT01474512|779694|P3|COMPLETED|Maintenance Period||0
325469|NCT01474512|779695|P2|COMPLETED|Maintenance Period||0
325470|NCT01474512|779696|P1|COMPLETED|Maintenance Period||0
325471|NCT01474512|779687|P10|Received Study Drug|Maintenance Period||62
325472|NCT01474512|779688|P9|Received Study Drug|Maintenance Period||78
325473|NCT01474512|779689|P8|Received Study Drug|Maintenance Period||391
325474|NCT01474512|779690|P7|Received Study Drug|Maintenance Period||16
325475|NCT01474512|779691|P6|Received Study Drug|Maintenance Period||229
325476|NCT01474512|779692|P5|Received Study Drug|Maintenance Period||227
325477|NCT01474512|779693|P4|Received Study Drug|Maintenance Period||226
325478|NCT01474512|779694|P3|Received Study Drug|Maintenance Period||0
325479|NCT01474512|779695|P2|Received Study Drug|Maintenance Period||0
325480|NCT01474512|779696|P1|Received Study Drug|Maintenance Period||0
325481|NCT01474512|779687|P10|STARTED|Maintenance Period||62
325482|NCT01474512|779688|P9|STARTED|Maintenance Period||78
325483|NCT01474512|779689|P8|STARTED|Maintenance Period||391
325484|NCT01474512|779690|P7|STARTED|Maintenance Period||16
325485|NCT01474512|779691|P6|STARTED|Maintenance Period||229
325486|NCT01474512|779692|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
325487|NCT01474512|779693|P4|STARTED|Maintenance Period||226
325488|NCT01474512|779694|P3|STARTED|Maintenance Period||0
325489|NCT01474512|779695|P2|STARTED|Maintenance Period||0
325490|NCT01474512|779696|P1|STARTED|Maintenance Period||0
325491|NCT01474512|779687|P10|NOT COMPLETED|Induction Period||0
325492|NCT01474512|779688|P9|NOT COMPLETED|Induction Period||0
325493|NCT01474512|779689|P8|NOT COMPLETED|Induction Period||0
325494|NCT01474512|779690|P7|NOT COMPLETED|Induction Period||0
325495|NCT01474512|779691|P6|NOT COMPLETED|Induction Period||0
325496|NCT01474512|779692|P5|NOT COMPLETED|Induction Period||0
325497|NCT01474512|779693|P4|NOT COMPLETED|Induction Period||0
325498|NCT01474512|779694|P3|NOT COMPLETED|Induction Period||18
325499|NCT01474512|779695|P2|NOT COMPLETED|Induction Period||24
325500|NCT01474512|779696|P1|NOT COMPLETED|Induction Period||24
325501|NCT01474512|779687|P10|COMPLETED|Induction Period||0
325502|NCT01474512|779688|P9|COMPLETED|Induction Period||0
325503|NCT01474512|779689|P8|COMPLETED|Induction Period||0
325504|NCT01474512|779690|P7|COMPLETED|Induction Period||0
325505|NCT01474512|779691|P6|COMPLETED|Induction Period||0
325506|NCT01474512|779692|P5|COMPLETED|Induction Period||0
325507|NCT01474512|779693|P4|COMPLETED|Induction Period||0
325508|NCT01474512|779694|P3|COMPLETED|Induction Period||415
325509|NCT01474512|779695|P2|COMPLETED|Induction Period||408
325510|NCT01474512|779696|P1|COMPLETED|Induction Period||407
325511|NCT01474512|779687|P10|Received Study Drug|Induction Period||0
325512|NCT01474512|779688|P9|Received Study Drug|Induction Period||0
325513|NCT01474512|779689|P8|Received Study Drug|Induction Period||0
325514|NCT01474512|779690|P7|Received Study Drug|Induction Period||0
325515|NCT01474512|779691|P6|Received Study Drug|Induction Period||0
325516|NCT01474512|779692|P5|Received Study Drug|Induction Period||0
325517|NCT01474512|779693|P4|Received Study Drug|Induction Period||0
325518|NCT01474512|779694|P3|Received Study Drug|Induction Period||433
325519|NCT01474512|779695|P2|Received Study Drug|Induction Period||432
325520|NCT01474512|779696|P1|Received Study Drug|Induction Period||431
325521|NCT01474512|779687|P10|STARTED|Induction Period||0
325522|NCT01474512|779688|P9|STARTED|Induction Period||0
325523|NCT01474512|779689|P8|STARTED|Induction Period||0
325524|NCT01474512|779690|P7|STARTED|Induction Period||0
325525|NCT01474512|779691|P6|STARTED|Induction Period||0
325526|NCT01474512|779692|P5|STARTED|Induction Period||0
325527|NCT01474512|779693|P4|STARTED|Induction Period||0
325528|NCT01474512|779694|P3|STARTED|Induction Period||433
325529|NCT01474512|779695|P2|STARTED|Induction Period||432
325530|NCT01474512|779696|P1|STARTED|Induction Period||431
325531|NCT01474434|779765|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
325532|NCT01474434|779766|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
325533|NCT01474434|779767|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
325534|NCT01474434|779768|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
325535|NCT01474434|779765|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
325536|NCT01474434|779766|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
325537|NCT01474434|779767|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
325538|NCT01474434|779768|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
325539|NCT01474434|779765|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
325540|NCT01474434|779766|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
325541|NCT01474434|779767|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
325542|NCT01474434|779768|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
325543|NCT01474434|779765|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
325544|NCT01474434|779766|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
325545|NCT01474434|779767|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
325546|NCT01474434|779768|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
325547|NCT01474434|779765|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
325548|NCT01474434|779766|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
325549|NCT01474434|779767|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
325550|NCT01474434|779768|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
325551|NCT01474434|779765|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
325552|NCT01474434|779766|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
325553|NCT01474434|779767|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
325554|NCT01474434|779768|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
325555|NCT01474317|779810|P1|NOT COMPLETED|Overall Study||2
325556|NCT01474317|779810|P1|COMPLETED|Overall Study||224
325557|NCT01474317|779810|P1|STARTED|Overall Study||226
325558|NCT01474291|779819|P1|NOT COMPLETED|Overall Study||220
325559|NCT01474291|779819|P1|COMPLETED|Overall Study||383
325560|NCT01474291|779819|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
325561|NCT01474291|779819|P1|STARTED|Overall Study||603
325562|NCT01474239|779863|P2|NOT COMPLETED|Overall Study||32
325563|NCT01474239|779864|P1|NOT COMPLETED|Overall Study||59
325564|NCT01474239|779863|P2|COMPLETED|Overall Study||0
325565|NCT01474239|779864|P1|COMPLETED|Overall Study||0
325566|NCT01474239|779863|P2|STARTED|Overall Study||32
325567|NCT01474239|779864|P1|STARTED|Overall Study||59
325568|NCT01474213|779902|P2|NOT COMPLETED|Overall Study||0
325569|NCT01474213|779903|P1|NOT COMPLETED|Overall Study||0
325570|NCT01474213|779902|P2|COMPLETED|Overall Study||20
325571|NCT01474213|779903|P1|COMPLETED|Overall Study||20
325572|NCT01474213|779902|P2|STARTED|Overall Study||20
325573|NCT01474213|779903|P1|STARTED|Overall Study||20
325574|NCT01474200|779927|P2|NOT COMPLETED|Overall Study||30
325575|NCT01474200|779928|P1|NOT COMPLETED|Overall Study||29
325576|NCT01474200|779927|P2|COMPLETED|Overall Study||84
325577|NCT01474200|779928|P1|COMPLETED|Overall Study||81
325578|NCT01474200|779927|P2|STARTED|Overall Study||114
325579|NCT01474200|779928|P1|STARTED|Overall Study||110
325580|NCT01474122|779981|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
325581|NCT01474122|779982|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
325582|NCT01474122|779983|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
325583|NCT01474122|779981|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
325584|NCT01474122|779982|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
325585|NCT01474122|779983|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
325586|NCT01474122|779981|P3|STARTED|Period 2: Week 16 to End of Study||88
325587|NCT01474122|779982|P2|STARTED|Period 2: Week 16 to End of Study||86
325588|NCT01474122|779983|P1|STARTED|Period 2: Week 16 to End of Study||87
325589|NCT01474122|779981|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
325590|NCT01474122|779982|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
325591|NCT01474122|779983|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
325592|NCT01474122|779981|P3|COMPLETED|Period 1: Baseline to Week 16||88
325593|NCT01474122|779982|P2|COMPLETED|Period 1: Baseline to Week 16||86
325594|NCT01474122|779983|P1|COMPLETED|Period 1: Baseline to Week 16||87
325595|NCT01474122|779981|P3|STARTED|Period 1: Baseline to Week 16||89
325596|NCT01474122|779982|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
325597|NCT01474122|779983|P1|STARTED|Period 1: Baseline to Week 16||88
325598|NCT01474109|780009|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
325599|NCT01474109|780010|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
325600|NCT01474109|780011|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
325601|NCT01474109|780009|P3|COMPLETED|Period 2: Week 16 to End of Study||83
325602|NCT01474109|780010|P2|COMPLETED|Period 2: Week 16 to End of Study||73
325603|NCT01474109|780011|P1|COMPLETED|Period 2: Week 16 to End of Study||70
325604|NCT01474109|780009|P3|STARTED|Period 2: Week 16 to End of Study||95
325605|NCT01474109|780010|P2|STARTED|Period 2: Week 16 to End of Study||91
325606|NCT01474109|780011|P1|STARTED|Period 2: Week 16 to End of Study||88
325607|NCT01474109|780009|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
325608|NCT01474109|780010|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
325609|NCT01474109|780011|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
325610|NCT01474109|780009|P3|COMPLETED|Period 1: Baseline to Week 16||95
325611|NCT01474109|780010|P2|COMPLETED|Period 1: Baseline to Week 16||91
325612|NCT01474109|780011|P1|COMPLETED|Period 1: Baseline to Week 16||88
325613|NCT01474109|780009|P3|STARTED|Period 1: Baseline to Week 16||97
325614|NCT01474109|780010|P2|STARTED|Period 1: Baseline to Week 16||97
325615|NCT01474109|780011|P1|STARTED|Period 1: Baseline to Week 16||95
325616|NCT01473992|780036|P3|NOT COMPLETED|Overall Study||0
325617|NCT01473992|780037|P2|NOT COMPLETED|Overall Study||0
325618|NCT01473992|780038|P1|NOT COMPLETED|Overall Study||0
325619|NCT01473992|780036|P3|COMPLETED|Overall Study||5
325620|NCT01473992|780037|P2|COMPLETED|Overall Study||10
325621|NCT01473992|780038|P1|COMPLETED|Overall Study||10
325622|NCT01473992|780036|P3|STARTED|Overall Study||5
325623|NCT01473992|780037|P2|STARTED|Overall Study||10
325624|NCT01473992|780038|P1|STARTED|Overall Study||10
325625|NCT01473953|780058|P5|NOT COMPLETED|Overall Study||0
325626|NCT01473953|780059|P4|NOT COMPLETED|Overall Study||0
325627|NCT01473953|780060|P3|NOT COMPLETED|Overall Study||0
325628|NCT01473953|780061|P2|NOT COMPLETED|Overall Study||0
325629|NCT01473953|780062|P1|NOT COMPLETED|Overall Study||1
325630|NCT01473953|780058|P5|COMPLETED|Overall Study||8
325631|NCT01473953|780059|P4|COMPLETED|Overall Study||5
325632|NCT01473953|780060|P3|COMPLETED|Overall Study||6
325633|NCT01473953|780061|P2|COMPLETED|Overall Study||6
325634|NCT01473953|780062|P1|COMPLETED|Overall Study||5
325635|NCT01473953|780058|P5|STARTED|Overall Study||8
325636|NCT01473953|780059|P4|STARTED|Overall Study||5
325637|NCT01473953|780060|P3|STARTED|Overall Study||6
325638|NCT01473953|780061|P2|STARTED|Overall Study||6
325639|NCT01473953|780062|P1|STARTED|Overall Study||6
325640|NCT01473836|780104|P1|NOT COMPLETED|Overall Study||6
325641|NCT01473836|780104|P1|COMPLETED|Overall Study||32
325642|NCT01473836|780104|P1|STARTED|Overall Study||38
325643|NCT01473758|780115|P4|NOT COMPLETED|Cycle 2||0
325644|NCT01473758|780116|P3|NOT COMPLETED|Cycle 2||5
325645|NCT01473758|780117|P2|NOT COMPLETED|Cycle 2||0
325646|NCT01473758|780118|P1|NOT COMPLETED|Cycle 2||0
325647|NCT01473758|780115|P4|COMPLETED|Cycle 2||4
325648|NCT01473758|780116|P3|COMPLETED|Cycle 2||5
325649|NCT01473758|780117|P2|COMPLETED|Cycle 2||0
325650|NCT01473758|780118|P1|COMPLETED|Cycle 2||0
325651|NCT01473758|780115|P4|STARTED|Cycle 2||4
325652|NCT01473758|780116|P3|STARTED|Cycle 2||10
325653|NCT01473758|780117|P2|STARTED|Cycle 2||0
325654|NCT01473758|780118|P1|STARTED|Cycle 2||0
325655|NCT01473758|780115|P4|NOT COMPLETED|Cycle 1||0
325656|NCT01473758|780116|P3|NOT COMPLETED|Cycle 1||0
325657|NCT01473758|780117|P2|NOT COMPLETED|Cycle 1||3
325658|NCT01473758|780118|P1|NOT COMPLETED|Cycle 1||11
325659|NCT01473758|780115|P4|COMPLETED|Cycle 1||0
325660|NCT01473758|780116|P3|COMPLETED|Cycle 1||0
325661|NCT01473758|780117|P2|COMPLETED|Cycle 1||40
325662|NCT01473758|780118|P1|COMPLETED|Cycle 1||27
325663|NCT01473758|780115|P4|STARTED|Cycle 1||0
325664|NCT01473758|780116|P3|STARTED|Cycle 1||0
325665|NCT01473758|780117|P2|STARTED|Cycle 1||43
325666|NCT01473758|780118|P1|STARTED|Cycle 1||38
325667|NCT01473745|780242|P2|NOT COMPLETED|Overall Study||0
325668|NCT01473745|780243|P1|NOT COMPLETED|Overall Study||0
325669|NCT01473745|780242|P2|COMPLETED|Overall Study||24
325670|NCT01473745|780243|P1|COMPLETED|Overall Study||24
325671|NCT01473745|780242|P2|STARTED|Overall Study||24
325672|NCT01473745|780243|P1|STARTED|Overall Study||24
325673|NCT01473602|780255|P2|NOT COMPLETED|Overall Study||8
325674|NCT01473602|780256|P1|NOT COMPLETED|Overall Study||8
325675|NCT01473602|780255|P2|COMPLETED|Overall Study||13
325676|NCT01473602|780256|P1|COMPLETED|Overall Study||10
325677|NCT01473602|780255|P2|Completed 12 Months|Overall Study||13
325678|NCT01473602|780256|P1|Completed 12 Months|Overall Study||10
325679|NCT01473602|780255|P2|Completed 6 Months|Overall Study||15
325680|NCT01473602|780256|P1|Completed 6 Months|Overall Study||12
325681|NCT01473602|780255|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
325682|NCT01473602|780256|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
325683|NCT01473602|780255|P2|STARTED|Overall Study||21
325684|NCT01473602|780256|P1|STARTED|Overall Study||18
325685|NCT01473589|780292|P2|NOT COMPLETED|Overall Study||16
325686|NCT01473589|780293|P1|NOT COMPLETED|Overall Study||11
325687|NCT01473589|780292|P2|COMPLETED|Overall Study||46
325688|NCT01473589|780293|P1|COMPLETED|Overall Study||49
325689|NCT01473589|780292|P2|Completed 12 Months|Overall Study||48
325690|NCT01473589|780293|P1|Completed 12 Months|Overall Study||49
325691|NCT01473589|780292|P2|Completed 6 Months|Overall Study||54
325692|NCT01473589|780293|P1|Completed 6 Months|Overall Study||51
325693|NCT01473589|780292|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
325694|NCT01473589|780293|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
325695|NCT01473589|780292|P2|STARTED|Overall Study||62
325696|NCT01473589|780293|P1|STARTED|Overall Study||60
325697|NCT01473563|780327|P1|NOT COMPLETED|Overall Study||1
325698|NCT01473563|780327|P1|COMPLETED|Overall Study||51
325699|NCT01473563|780327|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
325700|NCT01473563|780327|P1|STARTED|Overall Study||52
325701|NCT01473524|780349|P3|NOT COMPLETED|Overall Study||3
325702|NCT01473524|780350|P2|NOT COMPLETED|Overall Study||9
325703|NCT01473524|780351|P1|NOT COMPLETED|Overall Study||7
325704|NCT01473524|780349|P3|COMPLETED|Overall Study||70
325705|NCT01473524|780350|P2|COMPLETED|Overall Study||64
325706|NCT01473524|780351|P1|COMPLETED|Overall Study||64
325707|NCT01473524|780349|P3|STARTED|Overall Study||73
325708|NCT01473524|780350|P2|STARTED|Overall Study||73
325709|NCT01473524|780351|P1|STARTED|Overall Study||71
325710|NCT01473394|780384|P2|NOT COMPLETED|Overall Study||43
325711|NCT01473394|780385|P1|NOT COMPLETED|Overall Study||45
325712|NCT01473394|780384|P2|COMPLETED|Overall Study||212
325713|NCT01473394|780385|P1|COMPLETED|Overall Study||208
325714|NCT01473394|780384|P2|STARTED|Overall Study||255
325715|NCT01473394|780385|P1|STARTED|Overall Study||253
325716|NCT01473381|780399|P4|NOT COMPLETED|Overall Study||89
325717|NCT01473381|780400|P3|NOT COMPLETED|Overall Study||102
325718|NCT01473381|780401|P2|NOT COMPLETED|Overall Study||93
325719|NCT01473381|780402|P1|NOT COMPLETED|Overall Study||80
325720|NCT01473381|780399|P4|COMPLETED|Overall Study||200
325721|NCT01473381|780400|P3|COMPLETED|Overall Study||189
325722|NCT01473381|780401|P2|COMPLETED|Overall Study||199
325723|NCT01473381|780402|P1|COMPLETED|Overall Study||210
325724|NCT01473381|780399|P4|Safety Population|Overall Study||282
325725|NCT01473381|780400|P3|Safety Population|Overall Study||287
325726|NCT01473381|780401|P2|Safety Population|Overall Study||288
325727|NCT01473381|780402|P1|Safety Population|Overall Study||281
325728|NCT01473381|780399|P4|STARTED|Overall Study||289
325729|NCT01473381|780400|P3|STARTED|Overall Study||291
325730|NCT01473381|780401|P2|STARTED|Overall Study||292
325731|NCT01473381|780402|P1|STARTED|Overall Study||290
325732|NCT01473368|780424|P4|NOT COMPLETED|Overall Study||0
325733|NCT01473368|780425|P3|NOT COMPLETED|Overall Study||3
325734|NCT01473368|780426|P2|NOT COMPLETED|Overall Study||0
325735|NCT01473368|780427|P1|NOT COMPLETED|Overall Study||1
325736|NCT01473368|780424|P4|COMPLETED|Overall Study||12
325737|NCT01473368|780425|P3|COMPLETED|Overall Study||12
325738|NCT01473368|780426|P2|COMPLETED|Overall Study||12
325739|NCT01473368|780427|P1|COMPLETED|Overall Study||13
325740|NCT01473368|780424|P4|STARTED|Overall Study||12
325741|NCT01473368|780425|P3|STARTED|Overall Study||15
325742|NCT01473368|780426|P2|STARTED|Overall Study||12
325743|NCT01473368|780427|P1|STARTED|Overall Study||14
325744|NCT01473160|780464|P1|NOT COMPLETED|Overall Study||0
325745|NCT01473160|780464|P1|COMPLETED|Overall Study||9
325746|NCT01473160|780464|P1|STARTED|Overall Study||9
325747|NCT01472939|780486|P4|NOT COMPLETED|Overall Study||20
325748|NCT01472939|780487|P3|NOT COMPLETED|Overall Study||11
325749|NCT01472939|780488|P2|NOT COMPLETED|Overall Study||14
325750|NCT01472939|780489|P1|NOT COMPLETED|Overall Study||20
325751|NCT01472939|780486|P4|COMPLETED|Overall Study||99
325752|NCT01472939|780487|P3|COMPLETED|Overall Study||108
325753|NCT01472939|780488|P2|COMPLETED|Overall Study||105
325754|NCT01472939|780489|P1|COMPLETED|Overall Study||103
325755|NCT01472939|780486|P4|STARTED|Overall Study||119
325756|NCT01472939|780487|P3|STARTED|Overall Study||119
325757|NCT01472939|780488|P2|STARTED|Overall Study||119
325758|NCT01472939|780489|P1|STARTED|Overall Study||123
325759|NCT01472874|780516|P1|NOT COMPLETED|Overall Study||0
325760|NCT01472874|780516|P1|COMPLETED|Overall Study||8
325761|NCT01472874|780516|P1|STARTED|Overall Study||8
325762|NCT01472835|780533|P2|NOT COMPLETED|Overall Study||0
325763|NCT01472835|780534|P1|NOT COMPLETED|Overall Study||2
325764|NCT01472835|780533|P2|COMPLETED|Overall Study||36
325765|NCT01472835|780534|P1|COMPLETED|Overall Study||35
325766|NCT01472835|780533|P2|STARTED|Overall Study||36
325767|NCT01472835|780534|P1|STARTED|Overall Study||37
325768|NCT01472822|780550|P2|NOT COMPLETED|Overall Study||2
325769|NCT01472822|780551|P1|NOT COMPLETED|Overall Study||2
325770|NCT01472822|780550|P2|COMPLETED|Overall Study||28
325771|NCT01472822|780551|P1|COMPLETED|Overall Study||28
325772|NCT01472822|780550|P2|STARTED|Overall Study||30
325773|NCT01472822|780551|P1|STARTED|Overall Study||30
325774|NCT01472562|780565|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
325775|NCT01472562|780565|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
325776|NCT01472562|780565|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
325777|NCT01472562|780565|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
325778|NCT01472562|780565|P1|COMPLETED|Induction Phase (Week 1- 48)||27
325779|NCT01472562|780565|P1|STARTED|Induction Phase (Week 1- 48)||38
325780|NCT01472432|780572|P2|NOT COMPLETED|Overall Study||0
325781|NCT01472432|780573|P1|NOT COMPLETED|Overall Study||0
325782|NCT01472432|780572|P2|COMPLETED|Overall Study||53
325783|NCT01472432|780573|P1|COMPLETED|Overall Study||53
325784|NCT01472432|780572|P2|Ulcer Reduction|Overall Study||33
325785|NCT01472432|780573|P1|Ulcer Reduction|Overall Study||13
325786|NCT01472432|780572|P2|STARTED|Overall Study||53
325787|NCT01472432|780573|P1|STARTED|Overall Study||53
325788|NCT01472380|780589|P1|NOT COMPLETED|Efavirenz and FFA||0
325789|NCT01472380|780589|P1|COMPLETED|Efavirenz and FFA||28
325790|NCT01472380|780589|P1|STARTED|Efavirenz and FFA||28
325791|NCT01472380|780589|P1|NOT COMPLETED|1 Day Period Between Dosing||1
325792|NCT01472380|780589|P1|COMPLETED|1 Day Period Between Dosing||28
325793|NCT01472380|780589|P1|STARTED|1 Day Period Between Dosing||29
325794|NCT01472380|780589|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
325795|NCT01472380|780589|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
325796|NCT01472380|780589|P1|STARTED|Fenofibric Acid (FFA) Alone||29
325797|NCT01472380|780589|P1|NOT COMPLETED|Efavirenz Alone||1
325798|NCT01472380|780589|P1|COMPLETED|Efavirenz Alone||29
325799|NCT01472380|780589|P1|STARTED|Efavirenz Alone||30
325800|NCT01472341|780600|P1|NOT COMPLETED|Overall Study||272
325801|NCT01472341|780600|P1|COMPLETED|Overall Study||235
325802|NCT01472341|780600|P1|STARTED|Overall Study||507
325803|NCT01472289|780606|P1|NOT COMPLETED|Overall Study||2
325804|NCT01472289|780606|P1|COMPLETED|Overall Study||15
325805|NCT01472289|780606|P1|STARTED|Overall Study||17
325806|NCT01472185|780618|P2|NOT COMPLETED|Overall Study||34
325807|NCT01472185|780619|P1|NOT COMPLETED|Overall Study||34
325808|NCT01472185|780618|P2|COMPLETED|Overall Study||199
325809|NCT01472185|780619|P1|COMPLETED|Overall Study||198
325810|NCT01472185|780618|P2|STARTED|Overall Study||233
325811|NCT01472185|780619|P1|STARTED|Overall Study||232
325812|NCT01471782|780639|P6|NOT COMPLETED|Overall Study||41
325813|NCT01471782|780640|P5|NOT COMPLETED|Overall Study||26
325814|NCT01471782|780641|P4|NOT COMPLETED|Overall Study||5
325815|NCT01471782|780642|P3|NOT COMPLETED|Overall Study||5
325816|NCT01471782|780643|P2|NOT COMPLETED|Overall Study||6
325817|NCT01471782|780644|P1|NOT COMPLETED|Overall Study||5
325818|NCT01471782|780639|P6|COMPLETED|Overall Study|Completed 5 cycles|3
325819|NCT01471782|780640|P5|COMPLETED|Overall Study|Completed 5 cycles|0
325820|NCT01471782|780641|P4|COMPLETED|Overall Study|Completed 5 cycles|1
325821|NCT01471782|780642|P3|COMPLETED|Overall Study|Completed 5 cycles|0
325822|NCT01471782|780643|P2|COMPLETED|Overall Study|Completed 5 cycles|1
325823|NCT01471782|780644|P1|COMPLETED|Overall Study|Completed 5 cycles|0
325824|NCT01471782|780639|P6|STARTED|Overall Study||44
325825|NCT01471782|780640|P5|STARTED|Overall Study||26
325826|NCT01471782|780641|P4|STARTED|Overall Study||6
325827|NCT01471782|780642|P3|STARTED|Overall Study||5
325828|NCT01471782|780643|P2|STARTED|Overall Study||7
325829|NCT01471782|780644|P1|STARTED|Overall Study||5
325830|NCT01471691|780698|P2|NOT COMPLETED|Overall Study||1
325831|NCT01471691|780699|P1|NOT COMPLETED|Overall Study||0
325832|NCT01471691|780698|P2|COMPLETED|Overall Study||5
325833|NCT01471691|780699|P1|COMPLETED|Overall Study||8
325834|NCT01471691|780698|P2|STARTED|Overall Study||6
325835|NCT01471691|780699|P1|STARTED|Overall Study||8
325836|NCT01471626|780705|P1|NOT COMPLETED|Overall Study||0
325837|NCT01471626|780705|P1|COMPLETED|Overall Study||21
325838|NCT01471626|780705|P1|STARTED|Overall Study||21
325839|NCT01471574|780713|P4|NOT COMPLETED|Follow-up Period||3
325840|NCT01471574|780714|P3|NOT COMPLETED|Follow-up Period||7
325841|NCT01471574|780715|P2|NOT COMPLETED|Follow-up Period||2
325842|NCT01471574|780716|P1|NOT COMPLETED|Follow-up Period||7
325843|NCT01471574|780713|P4|COMPLETED|Follow-up Period||21
325844|NCT01471574|780714|P3|COMPLETED|Follow-up Period||95
325845|NCT01471574|780715|P2|COMPLETED|Follow-up Period||32
325846|NCT01471574|780716|P1|COMPLETED|Follow-up Period||114
325847|NCT01471574|780713|P4|STARTED|Follow-up Period||24
325848|NCT01471574|780714|P3|STARTED|Follow-up Period||102
325849|NCT01471574|780715|P2|STARTED|Follow-up Period||34
325850|NCT01471574|780716|P1|STARTED|Follow-up Period||121
325851|NCT01471574|780713|P4|NOT COMPLETED|Treatment Period||3
325852|NCT01471574|780714|P3|NOT COMPLETED|Treatment Period||24
325853|NCT01471574|780715|P2|NOT COMPLETED|Treatment Period||10
325854|NCT01471574|780716|P1|NOT COMPLETED|Treatment Period||31
325855|NCT01471574|780713|P4|COMPLETED|Treatment Period||21
325856|NCT01471574|780714|P3|COMPLETED|Treatment Period||82
325857|NCT01471574|780715|P2|COMPLETED|Treatment Period||29
325858|NCT01471574|780716|P1|COMPLETED|Treatment Period||101
325859|NCT01471574|780713|P4|STARTED|Treatment Period||24
325860|NCT01471574|780714|P3|STARTED|Treatment Period||106
325861|NCT01471574|780715|P2|STARTED|Treatment Period||39
325862|NCT01471574|780716|P1|STARTED|Treatment Period||132
325863|NCT01471379|780748|P3|NOT COMPLETED|Overall Study||0
325864|NCT01471379|780749|P2|NOT COMPLETED|Overall Study||1
325865|NCT01471379|780750|P1|NOT COMPLETED|Overall Study||1
325866|NCT01471379|780748|P3|COMPLETED|Overall Study||0
325867|NCT01471379|780749|P2|COMPLETED|Overall Study||0
325868|NCT01471379|780750|P1|COMPLETED|Overall Study||0
325869|NCT01471379|780748|P3|STARTED|Overall Study||0
325870|NCT01471379|780749|P2|STARTED|Overall Study||1
325871|NCT01471379|780750|P1|STARTED|Overall Study||1
325872|NCT01471353|780770|P1|NOT COMPLETED|Overall Study||3
325873|NCT01471353|780770|P1|COMPLETED|Overall Study||39
325874|NCT01471353|780770|P1|STARTED|Overall Study||42
325875|NCT01471197|780778|P2|NOT COMPLETED|Overall Study||2
325876|NCT01471197|780779|P1|NOT COMPLETED|Overall Study||6
325877|NCT01471197|780778|P2|COMPLETED|Overall Study||0
325878|NCT01471197|780779|P1|COMPLETED|Overall Study||0
325879|NCT01471197|780778|P2|STARTED|Overall Study||2
325880|NCT01471197|780779|P1|STARTED|Overall Study||6
325881|NCT01471171|780789|P2|NOT COMPLETED|Treatment Period 2||0
325882|NCT01471171|780790|P1|NOT COMPLETED|Treatment Period 2||1
325883|NCT01471171|780789|P2|COMPLETED|Treatment Period 2||54
325884|NCT01471171|780790|P1|COMPLETED|Treatment Period 2||52
325885|NCT01471171|780789|P2|STARTED|Treatment Period 2||54
325886|NCT01471171|780790|P1|STARTED|Treatment Period 2||53
325887|NCT01471171|780789|P2|NOT COMPLETED|Treatment Period 1||1
325888|NCT01471171|780790|P1|NOT COMPLETED|Treatment Period 1||4
325889|NCT01471171|780789|P2|COMPLETED|Treatment Period 1||54
325890|NCT01471171|780790|P1|COMPLETED|Treatment Period 1||53
325891|NCT01471171|780789|P2|STARTED|Treatment Period 1||55
325892|NCT01471171|780790|P1|STARTED|Treatment Period 1||57
325893|NCT01471041|780800|P1|NOT COMPLETED|Overall Study||7
325894|NCT01471041|780800|P1|COMPLETED|Overall Study||47
325895|NCT01471041|780800|P1|STARTED|Overall Study||54
325896|NCT01471015|780808|P3|NOT COMPLETED|Overall Study||1
325897|NCT01471015|780809|P2|NOT COMPLETED|Overall Study||1
325898|NCT01471015|780810|P1|NOT COMPLETED|Overall Study||0
325899|NCT01471015|780808|P3|COMPLETED|Overall Study||9
325900|NCT01471015|780809|P2|COMPLETED|Overall Study||9
325901|NCT01471015|780810|P1|COMPLETED|Overall Study||10
325902|NCT01471015|780808|P3|STARTED|Overall Study||10
325903|NCT01471015|780809|P2|STARTED|Overall Study||10
325904|NCT01471015|780810|P1|STARTED|Overall Study||10
325905|NCT01470859|780824|P2|NOT COMPLETED|Overall Study||0
325906|NCT01470859|780825|P1|NOT COMPLETED|Overall Study||1
325907|NCT01470859|780824|P2|COMPLETED|Overall Study||15
325908|NCT01470859|780825|P1|COMPLETED|Overall Study||14
325909|NCT01470859|780824|P2|STARTED|Overall Study||15
325910|NCT01470859|780825|P1|STARTED|Overall Study||15
325911|NCT01470651|780841|P2|NOT COMPLETED|Overall Study||3
325912|NCT01470651|780842|P1|NOT COMPLETED|Overall Study||7
325913|NCT01470651|780841|P2|COMPLETED|Overall Study||10
325914|NCT01470651|780842|P1|COMPLETED|Overall Study||6
325915|NCT01470651|780841|P2|STARTED|Overall Study||13
325916|NCT01470651|780842|P1|STARTED|Overall Study||13
325917|NCT01470469|780852|P2|NOT COMPLETED|Overall Study||24
325918|NCT01470469|780853|P1|NOT COMPLETED|Overall Study||10
325919|NCT01470469|780852|P2|COMPLETED|Overall Study||38
325920|NCT01470469|780853|P1|COMPLETED|Overall Study||11
325921|NCT01470469|780852|P2|STARTED|Overall Study||62
325922|NCT01470469|780853|P1|STARTED|Overall Study||21
325923|NCT01470417|780873|P2|NOT COMPLETED|Overall Study||2
325924|NCT01470417|780874|P1|NOT COMPLETED|Overall Study||0
325925|NCT01470417|780873|P2|COMPLETED|Overall Study||5
325926|NCT01470417|780874|P1|COMPLETED|Overall Study||3
325927|NCT01470417|780873|P2|STARTED|Overall Study||7
325928|NCT01470417|780874|P1|STARTED|Overall Study||3
325929|NCT01470248|780886|P1|NOT COMPLETED|Overall Study||1
325930|NCT01470248|780886|P1|COMPLETED|Overall Study||19
325931|NCT01470248|780886|P1|STARTED|Overall Study||20
325932|NCT01470196|780893|P1|NOT COMPLETED|Overall Study||0
325933|NCT01470196|780893|P1|COMPLETED|Overall Study||31
325934|NCT01470196|780893|P1|STARTED|Overall Study||31
325935|NCT01470170|780906|P5|NOT COMPLETED|Overall Study||0
325936|NCT01470170|780907|P4|NOT COMPLETED|Overall Study||0
325937|NCT01470170|780908|P3|NOT COMPLETED|Overall Study||0
325938|NCT01470170|780909|P2|NOT COMPLETED|Overall Study||0
325939|NCT01470170|780910|P1|NOT COMPLETED|Overall Study||0
325940|NCT01470170|780906|P5|COMPLETED|Overall Study||34
325941|NCT01470170|780907|P4|COMPLETED|Overall Study||36
325942|NCT01470170|780908|P3|COMPLETED|Overall Study||34
325943|NCT01470170|780909|P2|COMPLETED|Overall Study||35
325944|NCT01470170|780910|P1|COMPLETED|Overall Study||34
325945|NCT01470170|780906|P5|STARTED|Overall Study||34
325946|NCT01470170|780907|P4|STARTED|Overall Study||36
325947|NCT01470170|780908|P3|STARTED|Overall Study||34
325948|NCT01470170|780909|P2|STARTED|Overall Study||35
325949|NCT01470170|780910|P1|STARTED|Overall Study||34
325950|NCT01470144|780942|P1|NOT COMPLETED|Overall Study||10
325951|NCT01470144|780942|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
325952|NCT01470144|780942|P1|STARTED|Overall Study||41
325953|NCT01470118|780950|P3|NOT COMPLETED|Overall Study||2
325954|NCT01470118|780951|P2|NOT COMPLETED|Overall Study||5
325955|NCT01470118|780952|P1|NOT COMPLETED|Overall Study||5
325956|NCT01470118|780950|P3|COMPLETED|Overall Study||39
325957|NCT01470118|780951|P2|COMPLETED|Overall Study||38
325958|NCT01470118|780952|P1|COMPLETED|Overall Study||38
325959|NCT01470118|780950|P3|STARTED|Overall Study||41
325960|NCT01470118|780951|P2|STARTED|Overall Study||43
325961|NCT01470118|780952|P1|STARTED|Overall Study||43
325962|NCT01469819|780981|P1|NOT COMPLETED|Overall Study||8
325963|NCT01469819|780981|P1|COMPLETED|Overall Study||29
325964|NCT01469819|780981|P1|STARTED|Overall Study||37
325965|NCT01469767|780991|P1|NOT COMPLETED|Overall Study||0
325966|NCT01469767|780991|P1|COMPLETED|Overall Study||10
325967|NCT01469767|780991|P1|STARTED|Overall Study||10
325968|NCT01469715|780999|P1|NOT COMPLETED|Overall Study||0
325969|NCT01469715|780999|P1|COMPLETED|Overall Study||16
325970|NCT01469715|780999|P1|STARTED|Overall Study||16
325971|NCT01469637|781005|P2|NOT COMPLETED|Second Intervention||0
325972|NCT01469637|781006|P1|NOT COMPLETED|Second Intervention||1
325973|NCT01469637|781005|P2|COMPLETED|Second Intervention||21
325974|NCT01469637|781006|P1|COMPLETED|Second Intervention||21
325975|NCT01469637|781005|P2|STARTED|Second Intervention||21
325976|NCT01469637|781006|P1|STARTED|Second Intervention||22
325977|NCT01469637|781005|P2|NOT COMPLETED|First Intervention||1
325978|NCT01469637|781006|P1|NOT COMPLETED|First Intervention||0
325979|NCT01469637|781005|P2|COMPLETED|First Intervention||21
325980|NCT01469637|781006|P1|COMPLETED|First Intervention||22
325981|NCT01469637|781005|P2|STARTED|First Intervention||22
325982|NCT01469637|781006|P1|STARTED|First Intervention||22
325983|NCT01469546|781014|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
325984|NCT01469546|781014|P1|COMPLETED|Dose Escalation to 10 mg||19
325985|NCT01469546|781014|P1|STARTED|Dose Escalation to 10 mg||19
325986|NCT01469546|781014|P1|NOT COMPLETED|Received 5 mg Dose||23
325987|NCT01469546|781014|P1|COMPLETED|Received 5 mg Dose||19
325988|NCT01469546|781014|P1|Completed First Cycle|Received 5 mg Dose||30
325989|NCT01469546|781014|P1|STARTED|Received 5 mg Dose||42
325990|NCT01469364|781021|P1|NOT COMPLETED|Overall Study||2
325991|NCT01469364|781021|P1|COMPLETED|Overall Study||28
325992|NCT01469364|781021|P1|STARTED|Overall Study||30
325993|NCT01469234|781039|P3|NOT COMPLETED|Overall Study||0
325994|NCT01469234|781040|P2|NOT COMPLETED|Overall Study||0
325995|NCT01469234|781041|P1|NOT COMPLETED|Overall Study||0
325996|NCT01469234|781039|P3|COMPLETED|Overall Study||85
325997|NCT01469234|781040|P2|COMPLETED|Overall Study||85
325998|NCT01469234|781041|P1|COMPLETED|Overall Study||85
325999|NCT01469234|781039|P3|STARTED|Overall Study||85
326000|NCT01469234|781040|P2|STARTED|Overall Study||85
326001|NCT01469234|781041|P1|STARTED|Overall Study||85
326002|NCT01469182|781072|P2|NOT COMPLETED|Overall Study||6
326003|NCT01469182|781073|P1|NOT COMPLETED|Overall Study||35
326004|NCT01469182|781072|P2|COMPLETED|Overall Study||298
326005|NCT01469182|781073|P1|COMPLETED|Overall Study||575
326006|NCT01469182|781072|P2|Treated|Overall Study||304
326007|NCT01469182|781073|P1|Treated|Overall Study||609
326008|NCT01469182|781072|P2|STARTED|Overall Study||304
326009|NCT01469182|781073|P1|STARTED|Overall Study||610
326010|NCT01469065|781100|P5|NOT COMPLETED|Overall Study||1
326011|NCT01469065|781101|P4|NOT COMPLETED|Overall Study||0
326012|NCT01469065|781102|P3|NOT COMPLETED|Overall Study||0
326013|NCT01469065|781103|P2|NOT COMPLETED|Overall Study||1
326014|NCT01469065|781104|P1|NOT COMPLETED|Overall Study||0
326015|NCT01469065|781100|P5|COMPLETED|Overall Study||16
326016|NCT01469065|781101|P4|COMPLETED|Overall Study||16
326017|NCT01469065|781102|P3|COMPLETED|Overall Study||16
326018|NCT01469065|781103|P2|COMPLETED|Overall Study||16
326019|NCT01469065|781104|P1|COMPLETED|Overall Study||16
326020|NCT01469065|781100|P5|STARTED|Overall Study||17
326021|NCT01469065|781101|P4|STARTED|Overall Study||16
326022|NCT01469065|781102|P3|STARTED|Overall Study||16
326023|NCT01469065|781103|P2|STARTED|Overall Study||17
326024|NCT01469065|781104|P1|STARTED|Overall Study||16
326025|NCT01469052|781200|P6|NOT COMPLETED|Overall Study||6
326026|NCT01469052|781201|P5|NOT COMPLETED|Overall Study||8
326027|NCT01469052|781202|P4|NOT COMPLETED|Overall Study||5
326028|NCT01469052|781203|P3|NOT COMPLETED|Overall Study||6
326029|NCT01469052|781204|P2|NOT COMPLETED|Overall Study||4
326030|NCT01469052|781205|P1|NOT COMPLETED|Overall Study||6
326031|NCT01469052|781200|P6|COMPLETED|Overall Study||0
326032|NCT01469052|781201|P5|COMPLETED|Overall Study||0
326033|NCT01469052|781202|P4|COMPLETED|Overall Study||1
326034|NCT01469052|781203|P3|COMPLETED|Overall Study||0
326035|NCT01469052|781204|P2|COMPLETED|Overall Study||0
326036|NCT01469052|781205|P1|COMPLETED|Overall Study||0
326037|NCT01469052|781200|P6|STARTED|Overall Study||6
326038|NCT01469052|781201|P5|STARTED|Overall Study||8
326039|NCT01469052|781202|P4|STARTED|Overall Study||6
326040|NCT01469052|781203|P3|STARTED|Overall Study||6
326041|NCT01469052|781204|P2|STARTED|Overall Study||4
326042|NCT01469052|781205|P1|STARTED|Overall Study||6
326043|NCT01469039|781252|P3|NOT COMPLETED|Overall Study||113
326044|NCT01469039|781253|P2|NOT COMPLETED|Overall Study||73
326045|NCT01469039|781254|P1|NOT COMPLETED|Overall Study||77
326046|NCT01469039|781252|P3|COMPLETED|Overall Study||95
326047|NCT01469039|781253|P2|COMPLETED|Overall Study||135
326048|NCT01469039|781254|P1|COMPLETED|Overall Study||130
326049|NCT01469039|781252|P3|STARTED|Overall Study||208
326050|NCT01469039|781253|P2|STARTED|Overall Study||208
326051|NCT01469039|781254|P1|STARTED|Overall Study||207
326052|NCT01469000|781267|P2|NOT COMPLETED|Overall Study||9
326053|NCT01469000|781268|P1|NOT COMPLETED|Overall Study||33
326054|NCT01469000|781267|P2|COMPLETED|Overall Study||57
326055|NCT01469000|781268|P1|COMPLETED|Overall Study||96
326056|NCT01469000|781267|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
326145|NCT01468207|781379|P6|NOT COMPLETED|Treatment Period 2||20
326057|NCT01469000|781268|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
326058|NCT01469000|781267|P2|STARTED|Overall Study||66
326059|NCT01469000|781268|P1|STARTED|Overall Study||129
326060|NCT01468818|781282|P1|NOT COMPLETED|Overall Study||2
326061|NCT01468818|781282|P1|COMPLETED|Overall Study||16
326062|NCT01468818|781282|P1|STARTED|Overall Study||18
326063|NCT01468675|781289|P2|NOT COMPLETED|Overall Study||1372
326064|NCT01468675|781290|P1|NOT COMPLETED|Overall Study||1000
326065|NCT01468675|781289|P2|COMPLETED|Overall Study||2004
326066|NCT01468675|781290|P1|COMPLETED|Overall Study||1699
326067|NCT01468675|781289|P2|STARTED|Overall Study||3376
326068|NCT01468675|781290|P1|STARTED|Overall Study||2699
326069|NCT01468584|781296|P1|NOT COMPLETED|Overall Study||0
326070|NCT01468584|781296|P1|COMPLETED|Overall Study||10
326071|NCT01468584|781296|P1|STARTED|Overall Study||10
326072|NCT01468558|781300|P1|NOT COMPLETED|Overall Study||2
326073|NCT01468558|781300|P1|COMPLETED|Overall Study||22
326074|NCT01468558|781300|P1|STARTED|Overall Study||24
326075|NCT01468350|781315|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
326076|NCT01468350|781316|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
326077|NCT01468350|781317|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
326078|NCT01468350|781318|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
326079|NCT01468350|781315|P4|COMPLETED|(PART B) Day 1, Day 15||12
326080|NCT01468350|781316|P3|COMPLETED|(PART B) Day 1, Day 15||12
326081|NCT01468350|781317|P2|COMPLETED|(PART B) Day 1, Day 15||0
326082|NCT01468350|781318|P1|COMPLETED|(PART B) Day 1, Day 15||0
326083|NCT01468350|781315|P4|STARTED|(PART B) Day 1, Day 15||12
326084|NCT01468350|781316|P3|STARTED|(PART B) Day 1, Day 15||12
326085|NCT01468350|781317|P2|STARTED|(PART B) Day 1, Day 15||0
326086|NCT01468350|781318|P1|STARTED|(PART B) Day 1, Day 15||0
326087|NCT01468350|781315|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
326088|NCT01468350|781316|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
326089|NCT01468350|781317|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
326090|NCT01468350|781318|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
326091|NCT01468350|781315|P4|COMPLETED|(PART A) Day 1, Day 3||0
326092|NCT01468350|781316|P3|COMPLETED|(PART A) Day 1, Day 3||0
326093|NCT01468350|781317|P2|COMPLETED|(PART A) Day 1, Day 3||5
326094|NCT01468350|781318|P1|COMPLETED|(PART A) Day 1, Day 3||6
326095|NCT01468350|781315|P4|STARTED|(PART A) Day 1, Day 3||0
326096|NCT01468350|781316|P3|STARTED|(PART A) Day 1, Day 3||0
326097|NCT01468350|781317|P2|STARTED|(PART A) Day 1, Day 3||5
326098|NCT01468350|781318|P1|STARTED|(PART A) Day 1, Day 3||6
326099|NCT01468337|781328|P1|NOT COMPLETED|Overall Study||0
326100|NCT01468337|781328|P1|COMPLETED|Overall Study||5
326101|NCT01468337|781328|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
326102|NCT01468337|781328|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
326103|NCT01468337|781328|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
326104|NCT01468337|781328|P1|Week 2|Overall Study||5
326105|NCT01468337|781328|P1|STARTED|Overall Study||5
326106|NCT01468311|781340|P1|NOT COMPLETED|Overall Study||2
326107|NCT01468311|781340|P1|COMPLETED|Overall Study||4
326108|NCT01468311|781340|P1|STARTED|Overall Study||6
326109|NCT01468233|781352|P6|NOT COMPLETED|Treatment Period 2||23
326110|NCT01468233|781353|P5|NOT COMPLETED|Treatment Period 2||28
326111|NCT01468233|781354|P4|NOT COMPLETED|Treatment Period 2||28
326112|NCT01468233|781355|P3|NOT COMPLETED|Treatment Period 2||111
326113|NCT01468233|781356|P2|NOT COMPLETED|Treatment Period 2||0
326114|NCT01468233|781357|P1|NOT COMPLETED|Treatment Period 2||0
326115|NCT01468233|781352|P6|COMPLETED|Treatment Period 2||28
326116|NCT01468233|781353|P5|COMPLETED|Treatment Period 2||25
326117|NCT01468233|781354|P4|COMPLETED|Treatment Period 2||23
326118|NCT01468233|781355|P3|COMPLETED|Treatment Period 2||40
326119|NCT01468233|781356|P2|COMPLETED|Treatment Period 2||0
326120|NCT01468233|781357|P1|COMPLETED|Treatment Period 2||0
326121|NCT01468233|781352|P6|STARTED|Treatment Period 2||51
326122|NCT01468233|781353|P5|STARTED|Treatment Period 2||53
326123|NCT01468233|781354|P4|STARTED|Treatment Period 2||51
326124|NCT01468233|781355|P3|STARTED|Treatment Period 2||151
326125|NCT01468233|781356|P2|STARTED|Treatment Period 2||0
326126|NCT01468233|781357|P1|STARTED|Treatment Period 2||0
326127|NCT01468233|781352|P6|NOT COMPLETED|Treatment Period 1||0
326128|NCT01468233|781353|P5|NOT COMPLETED|Treatment Period 1||0
326129|NCT01468233|781354|P4|NOT COMPLETED|Treatment Period 1||0
326130|NCT01468233|781355|P3|NOT COMPLETED|Treatment Period 1||0
326131|NCT01468233|781356|P2|NOT COMPLETED|Treatment Period 1||8
326132|NCT01468233|781357|P1|NOT COMPLETED|Treatment Period 1||12
326133|NCT01468233|781352|P6|COMPLETED|Treatment Period 1||0
326134|NCT01468233|781353|P5|COMPLETED|Treatment Period 1||0
326135|NCT01468233|781354|P4|COMPLETED|Treatment Period 1||0
326136|NCT01468233|781355|P3|COMPLETED|Treatment Period 1||0
326137|NCT01468233|781356|P2|COMPLETED|Treatment Period 1||155
326138|NCT01468233|781357|P1|COMPLETED|Treatment Period 1||151
326139|NCT01468233|781352|P6|STARTED|Treatment Period 1||0
326140|NCT01468233|781353|P5|STARTED|Treatment Period 1||0
326141|NCT01468233|781354|P4|STARTED|Treatment Period 1||0
326142|NCT01468233|781355|P3|STARTED|Treatment Period 1||0
326143|NCT01468233|781356|P2|STARTED|Treatment Period 1||163
326144|NCT01468233|781357|P1|STARTED|Treatment Period 1||163
326146|NCT01468207|781380|P5|NOT COMPLETED|Treatment Period 2||21
326147|NCT01468207|781381|P4|NOT COMPLETED|Treatment Period 2||27
326148|NCT01468207|781382|P3|NOT COMPLETED|Treatment Period 2||52
326149|NCT01468207|781383|P2|NOT COMPLETED|Treatment Period 2||0
326150|NCT01468207|781384|P1|NOT COMPLETED|Treatment Period 2||0
326151|NCT01468207|781379|P6|COMPLETED|Treatment Period 2||28
326152|NCT01468207|781380|P5|COMPLETED|Treatment Period 2||27
326153|NCT01468207|781381|P4|COMPLETED|Treatment Period 2||22
326154|NCT01468207|781382|P3|COMPLETED|Treatment Period 2||93
326155|NCT01468207|781383|P2|COMPLETED|Treatment Period 2||0
326156|NCT01468207|781384|P1|COMPLETED|Treatment Period 2||0
326157|NCT01468207|781379|P6|STARTED|Treatment Period 2||48
326158|NCT01468207|781380|P5|STARTED|Treatment Period 2||48
326159|NCT01468207|781381|P4|STARTED|Treatment Period 2||49
326160|NCT01468207|781382|P3|STARTED|Treatment Period 2||145
326161|NCT01468207|781383|P2|STARTED|Treatment Period 2||0
326162|NCT01468207|781384|P1|STARTED|Treatment Period 2||0
326163|NCT01468207|781379|P6|NOT COMPLETED|Treatment Period 1||0
326164|NCT01468207|781380|P5|NOT COMPLETED|Treatment Period 1||0
326165|NCT01468207|781381|P4|NOT COMPLETED|Treatment Period 1||0
326166|NCT01468207|781382|P3|NOT COMPLETED|Treatment Period 1||0
326167|NCT01468207|781383|P2|NOT COMPLETED|Treatment Period 1||8
326168|NCT01468207|781384|P1|NOT COMPLETED|Treatment Period 1||9
326169|NCT01468207|781379|P6|COMPLETED|Treatment Period 1||0
326170|NCT01468207|781380|P5|COMPLETED|Treatment Period 1||0
326171|NCT01468207|781381|P4|COMPLETED|Treatment Period 1||0
326172|NCT01468207|781382|P3|COMPLETED|Treatment Period 1||0
326173|NCT01468207|781383|P2|COMPLETED|Treatment Period 1||145
326174|NCT01468207|781384|P1|COMPLETED|Treatment Period 1||145
326175|NCT01468207|781379|P6|Received Study Drug|Treatment Period 1||0
326176|NCT01468207|781380|P5|Received Study Drug|Treatment Period 1||0
326177|NCT01468207|781381|P4|Received Study Drug|Treatment Period 1||0
326178|NCT01468207|781382|P3|Received Study Drug|Treatment Period 1||0
326179|NCT01468207|781383|P2|Received Study Drug|Treatment Period 1||153
326180|NCT01468207|781384|P1|Received Study Drug|Treatment Period 1||152
326181|NCT01468207|781379|P6|STARTED|Treatment Period 1||0
326182|NCT01468207|781380|P5|STARTED|Treatment Period 1||0
326183|NCT01468207|781381|P4|STARTED|Treatment Period 1||0
326184|NCT01468207|781382|P3|STARTED|Treatment Period 1||0
326185|NCT01468207|781383|P2|STARTED|Treatment Period 1||153
326186|NCT01468207|781384|P1|STARTED|Treatment Period 1||154
326187|NCT01468181|781409|P5|NOT COMPLETED|Overall Study||5
326188|NCT01468181|781410|P4|NOT COMPLETED|Overall Study||3
326189|NCT01468181|781411|P3|NOT COMPLETED|Overall Study||8
326190|NCT01468181|781412|P2|NOT COMPLETED|Overall Study||2
326191|NCT01468181|781413|P1|NOT COMPLETED|Overall Study||10
326192|NCT01468181|781409|P5|COMPLETED|Overall Study||66
326193|NCT01468181|781410|P4|COMPLETED|Overall Study||63
326194|NCT01468181|781411|P3|COMPLETED|Overall Study||57
326195|NCT01468181|781412|P2|COMPLETED|Overall Study||59
326196|NCT01468181|781413|P1|COMPLETED|Overall Study||121
326197|NCT01468181|781409|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
326198|NCT01468181|781410|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
326199|NCT01468181|781411|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
326200|NCT01468181|781412|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
326201|NCT01468181|781413|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
326202|NCT01468181|781409|P5|STARTED|Overall Study||71
326203|NCT01468181|781410|P4|STARTED|Overall Study||66
326204|NCT01468181|781411|P3|STARTED|Overall Study||65
326205|NCT01468181|781412|P2|STARTED|Overall Study||61
326206|NCT01468181|781413|P1|STARTED|Overall Study||131
326207|NCT01468077|781462|P2|NOT COMPLETED|Overall Study||3
326208|NCT01468077|781463|P1|NOT COMPLETED|Overall Study||4
326209|NCT01468077|781462|P2|COMPLETED|Overall Study||22
326210|NCT01468077|781463|P1|COMPLETED|Overall Study||18
326211|NCT01468077|781462|P2|STARTED|Overall Study||25
326212|NCT01468077|781463|P1|STARTED|Overall Study||22
326213|NCT01468012|781502|P3|NOT COMPLETED|Overall Study||4
326214|NCT01468012|781503|P2|NOT COMPLETED|Overall Study||1
326215|NCT01468012|781504|P1|NOT COMPLETED|Overall Study||2
326216|NCT01468012|781502|P3|COMPLETED|Overall Study||0
326217|NCT01468012|781503|P2|COMPLETED|Overall Study||9
326218|NCT01468012|781504|P1|COMPLETED|Overall Study||7
326219|NCT01468012|781502|P3|STARTED|Overall Study||4
326220|NCT01468012|781503|P2|STARTED|Overall Study||10
326221|NCT01468012|781504|P1|STARTED|Overall Study||9
326222|NCT01467960|781516|P6|NOT COMPLETED|Overall Study||30
326223|NCT01467960|781517|P5|NOT COMPLETED|Overall Study||30
326224|NCT01467960|781518|P4|NOT COMPLETED|Overall Study||30
326225|NCT01467960|781519|P3|NOT COMPLETED|Overall Study||0
326226|NCT01467960|781520|P2|NOT COMPLETED|Overall Study||0
326227|NCT01467960|781521|P1|NOT COMPLETED|Overall Study||0
326228|NCT01467960|781516|P6|COMPLETED|Overall Study||0
326229|NCT01467960|781517|P5|COMPLETED|Overall Study||0
326230|NCT01467960|781518|P4|COMPLETED|Overall Study||0
326231|NCT01467960|781519|P3|COMPLETED|Overall Study||30
326232|NCT01467960|781520|P2|COMPLETED|Overall Study||30
326233|NCT01467960|781521|P1|COMPLETED|Overall Study||30
326234|NCT01467960|781516|P6|STARTED|Overall Study||30
326235|NCT01467960|781517|P5|STARTED|Overall Study||30
326236|NCT01467960|781518|P4|STARTED|Overall Study||30
326237|NCT01467960|781519|P3|STARTED|Overall Study||30
326238|NCT01467960|781520|P2|STARTED|Overall Study||30
326239|NCT01467960|781521|P1|STARTED|Overall Study||30
326240|NCT01467947|781535|P1|NOT COMPLETED|Overall Study||0
326241|NCT01467947|781535|P1|COMPLETED|Overall Study||46
326242|NCT01467947|781535|P1|STARTED|Overall Study||46
326243|NCT01467934|781543|P3|NOT COMPLETED|Overall Study||0
326244|NCT01467934|781544|P2|NOT COMPLETED|Overall Study||0
326245|NCT01467934|781545|P1|NOT COMPLETED|Overall Study||0
326246|NCT01467934|781543|P3|COMPLETED|Overall Study||110
326247|NCT01467934|781544|P2|COMPLETED|Overall Study||212
326248|NCT01467934|781545|P1|COMPLETED|Overall Study||208
326249|NCT01467934|781543|P3|STARTED|Overall Study||110
326250|NCT01467934|781544|P2|STARTED|Overall Study||212
326251|NCT01467934|781545|P1|STARTED|Overall Study||208
326252|NCT01467882|781553|P1|NOT COMPLETED|Overall Study||0
326253|NCT01467882|781553|P1|COMPLETED|Overall Study||44
326254|NCT01467882|781553|P1|STARTED|Overall Study||44
326255|NCT01467713|781580|P4|NOT COMPLETED|Overall Study||109
326256|NCT01467713|781581|P3|NOT COMPLETED|Overall Study||102
326257|NCT01467713|781582|P2|NOT COMPLETED|Overall Study||104
326258|NCT01467713|781583|P1|NOT COMPLETED|Overall Study||102
326259|NCT01467713|781580|P4|COMPLETED|Overall Study||45
326260|NCT01467713|781581|P3|COMPLETED|Overall Study||58
326261|NCT01467713|781582|P2|COMPLETED|Overall Study||60
326262|NCT01467713|781583|P1|COMPLETED|Overall Study||62
326263|NCT01467713|781580|P4|Safety Analysis Set: Received Treatment|Overall Study||154
326264|NCT01467713|781581|P3|Safety Analysis Set: Received Treatment|Overall Study||159
326265|NCT01467713|781582|P2|Safety Analysis Set: Received Treatment|Overall Study||164
326266|NCT01467713|781583|P1|Safety Analysis Set: Received Treatment|Overall Study||163
326267|NCT01467713|781580|P4|STARTED|Overall Study||154
326268|NCT01467713|781581|P3|STARTED|Overall Study||160
326269|NCT01467713|781582|P2|STARTED|Overall Study||164
326270|NCT01467713|781583|P1|STARTED|Overall Study||164
326271|NCT01467700|781637|P4|NOT COMPLETED|Overall Study||27
326272|NCT01467700|781638|P3|NOT COMPLETED|Overall Study||27
326273|NCT01467700|781639|P2|NOT COMPLETED|Overall Study||28
326274|NCT01467700|781640|P1|NOT COMPLETED|Overall Study||29
326275|NCT01467700|781637|P4|COMPLETED|Overall Study||96
326276|NCT01467700|781638|P3|COMPLETED|Overall Study||97
326277|NCT01467700|781639|P2|COMPLETED|Overall Study||100
326278|NCT01467700|781640|P1|COMPLETED|Overall Study||86
326279|NCT01467700|781637|P4|Safety Set - Received Treatment|Overall Study||123
326280|NCT01467700|781638|P3|Safety Set - Received Treatment|Overall Study||124
326281|NCT01467700|781639|P2|Safety Set - Received Treatment|Overall Study||127
326282|NCT01467700|781640|P1|Safety Set - Received Treatment|Overall Study||115
326283|NCT01467700|781637|P4|STARTED|Overall Study||123
326284|NCT01467700|781638|P3|STARTED|Overall Study||124
326285|NCT01467700|781639|P2|STARTED|Overall Study||128
326286|NCT01467700|781640|P1|STARTED|Overall Study||115
326287|NCT01467661|781682|P1|NOT COMPLETED|Overall Study||21
326288|NCT01467661|781682|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
326289|NCT01467661|781682|P1|Started Post Marketing Trial|Overall Study||33
326290|NCT01467661|781682|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
326291|NCT01467661|781682|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
326292|NCT01467661|781682|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
326293|NCT01467583|781702|P3|NOT COMPLETED|Overall Study||2
326294|NCT01467583|781703|P2|NOT COMPLETED|Overall Study||1
326295|NCT01467583|781704|P1|NOT COMPLETED|Overall Study||2
326296|NCT01467583|781702|P3|COMPLETED|Overall Study||10
326297|NCT01467583|781703|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
326298|NCT01467583|781704|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
326299|NCT01467583|781702|P3|STARTED|Overall Study||12
326300|NCT01467583|781703|P2|STARTED|Overall Study||4
326301|NCT01467583|781704|P1|STARTED|Overall Study||16
326302|NCT01467570|781717|P2|NOT COMPLETED|Overall Study||9
326303|NCT01467570|781718|P1|NOT COMPLETED|Overall Study||8
326304|NCT01467570|781717|P2|COMPLETED|Overall Study||63
326305|NCT01467570|781718|P1|COMPLETED|Overall Study||67
326306|NCT01467570|781717|P2|STARTED|Overall Study||72
326307|NCT01467570|781718|P1|STARTED|Overall Study||75
326308|NCT01467557|781744|P2|NOT COMPLETED|Overall Study||107
326309|NCT01467557|781745|P1|NOT COMPLETED|Overall Study||99
326310|NCT01467557|781744|P2|COMPLETED|Overall Study||463
326311|NCT01467557|781745|P1|COMPLETED|Overall Study||502
326312|NCT01467557|781744|P2|12 Month Survey Completed|Overall Study||463
326313|NCT01467557|781745|P1|12 Month Survey Completed|Overall Study||502
326314|NCT01467557|781744|P2|4 Month Survey Completed|Overall Study||493
326315|NCT01467557|781745|P1|4 Month Survey Completed|Overall Study||533
326316|NCT01467557|781744|P2|2 Week Survey Completed|Overall Study||522
326317|NCT01467557|781745|P1|2 Week Survey Completed|Overall Study||551
326318|NCT01467557|781744|P2|STARTED|Overall Study||570
326319|NCT01467557|781745|P1|STARTED|Overall Study||601
326320|NCT01467505|781755|P2|NOT COMPLETED|Overall Study||3
326321|NCT01467505|781756|P1|NOT COMPLETED|Overall Study||33
326322|NCT01467505|781755|P2|COMPLETED|Overall Study||7
326323|NCT01467505|781756|P1|COMPLETED|Overall Study||18
326324|NCT01467505|781755|P2|STARTED|Overall Study||10
326325|NCT01467505|781756|P1|STARTED|Overall Study||51
326326|NCT01467492|781788|P2|NOT COMPLETED|Overall Study||13
326327|NCT01467492|781789|P1|NOT COMPLETED|Overall Study||22
326328|NCT01467492|781788|P2|COMPLETED|Overall Study||25
326329|NCT01467492|781789|P1|COMPLETED|Overall Study||61
326330|NCT01467492|781788|P2|STARTED|Overall Study||38
326331|NCT01467492|781789|P1|STARTED|Overall Study||83
326332|NCT01467479|781813|P3|NOT COMPLETED|Overall Study||16
326333|NCT01467479|781814|P2|NOT COMPLETED|Overall Study||17
326334|NCT01467479|781815|P1|NOT COMPLETED|Overall Study||9
326335|NCT01467479|781813|P3|COMPLETED|Overall Study||45
326336|NCT01467479|781814|P2|COMPLETED|Overall Study||52
326337|NCT01467479|781815|P1|COMPLETED|Overall Study||46
326338|NCT01467479|781813|P3|Treated|Overall Study||59
326339|NCT01467479|781814|P2|Treated|Overall Study||69
326340|NCT01467479|781815|P1|Treated|Overall Study||54
326341|NCT01467479|781813|P3|STARTED|Overall Study||61
326342|NCT01467479|781814|P2|STARTED|Overall Study||69
326343|NCT01467479|781815|P1|STARTED|Overall Study||55
326344|NCT01467076|781845|P3|NOT COMPLETED|Overall Study||0
326345|NCT01467076|781846|P2|NOT COMPLETED|Overall Study||0
326346|NCT01467076|781847|P1|NOT COMPLETED|Overall Study||1
326347|NCT01467076|781845|P3|COMPLETED|Overall Study||2
326348|NCT01467076|781846|P2|COMPLETED|Overall Study||2
326349|NCT01467076|781847|P1|COMPLETED|Overall Study||2
326350|NCT01467076|781845|P3|STARTED|Overall Study||2
326351|NCT01467076|781846|P2|STARTED|Overall Study||2
326352|NCT01467076|781847|P1|STARTED|Overall Study||3
326353|NCT01467037|781857|P1|NOT COMPLETED|Overall Study||0
326354|NCT01467037|781857|P1|COMPLETED|Overall Study||374
326355|NCT01467037|781857|P1|STARTED|Overall Study||374
326356|NCT01466881|781864|P1|NOT COMPLETED|Overall Study||40
326357|NCT01466881|781864|P1|COMPLETED|Overall Study||2
326358|NCT01466881|781864|P1|Eligible and Treated|Overall Study||37
326359|NCT01466881|781864|P1|STARTED|Overall Study||42
326360|NCT01466790|781881|P8|NOT COMPLETED|Overall Study||1
326361|NCT01466790|781882|P7|NOT COMPLETED|Overall Study||1
326362|NCT01466790|781883|P6|NOT COMPLETED|Overall Study||0
326363|NCT01466790|781884|P5|NOT COMPLETED|Overall Study||3
326364|NCT01466790|781885|P4|NOT COMPLETED|Overall Study||0
326365|NCT01466790|781886|P3|NOT COMPLETED|Overall Study||0
326366|NCT01466790|781887|P2|NOT COMPLETED|Overall Study||1
326367|NCT01466790|781888|P1|NOT COMPLETED|Overall Study||4
326368|NCT01466790|781881|P8|COMPLETED|Overall Study||13
326369|NCT01466790|781882|P7|COMPLETED|Overall Study||26
326370|NCT01466790|781883|P6|COMPLETED|Overall Study||16
326371|NCT01466790|781884|P5|COMPLETED|Overall Study||27
326372|NCT01466790|781885|P4|COMPLETED|Overall Study||14
326373|NCT01466790|781886|P3|COMPLETED|Overall Study||27
326374|NCT01466790|781887|P2|COMPLETED|Overall Study||14
326375|NCT01466790|781888|P1|COMPLETED|Overall Study||20
326376|NCT01466790|781881|P8|STARTED|Overall Study||14
326377|NCT01466790|781882|P7|STARTED|Overall Study||27
326378|NCT01466790|781883|P6|STARTED|Overall Study||16
326379|NCT01466790|781884|P5|STARTED|Overall Study||30
326380|NCT01466790|781885|P4|STARTED|Overall Study||14
326381|NCT01466790|781886|P3|STARTED|Overall Study||27
326382|NCT01466790|781887|P2|STARTED|Overall Study||15
326383|NCT01466790|781888|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
326384|NCT01466673|781952|P2|NOT COMPLETED|Overall Study||6
326385|NCT01466673|781953|P1|NOT COMPLETED|Overall Study||7
326386|NCT01466673|781952|P2|COMPLETED|Overall Study||95
326387|NCT01466673|781953|P1|COMPLETED|Overall Study||93
326388|NCT01466673|781952|P2|STARTED|Overall Study||101
326389|NCT01466673|781953|P1|STARTED|Overall Study||100
326390|NCT01466595|781979|P2|NOT COMPLETED|Overall Study||1
326391|NCT01466595|781980|P1|NOT COMPLETED|Overall Study||0
326392|NCT01466595|781979|P2|COMPLETED|Overall Study||23
326393|NCT01466595|781980|P1|COMPLETED|Overall Study||49
326394|NCT01466595|781979|P2|STARTED|Overall Study||24
326395|NCT01466595|781980|P1|STARTED|Overall Study||49
326396|NCT01466387|782076|P6|NOT COMPLETED|Overall Study||1
326397|NCT01466387|782077|P5|NOT COMPLETED|Overall Study||0
326398|NCT01466387|782078|P4|NOT COMPLETED|Overall Study||2
326399|NCT01466387|782079|P3|NOT COMPLETED|Overall Study||1
326400|NCT01466387|782080|P2|NOT COMPLETED|Overall Study||0
326401|NCT01466387|782081|P1|NOT COMPLETED|Overall Study||1
326402|NCT01466387|782076|P6|COMPLETED|Overall Study||99
326403|NCT01466387|782077|P5|COMPLETED|Overall Study||51
326404|NCT01466387|782078|P4|COMPLETED|Overall Study||99
326405|NCT01466387|782079|P3|COMPLETED|Overall Study||98
326406|NCT01466387|782080|P2|COMPLETED|Overall Study||100
326407|NCT01466387|782081|P1|COMPLETED|Overall Study||100
326408|NCT01466387|782076|P6|STARTED|Overall Study||100
326409|NCT01466387|782077|P5|STARTED|Overall Study||51
326410|NCT01466387|782078|P4|STARTED|Overall Study||101
326411|NCT01466387|782079|P3|STARTED|Overall Study||99
326412|NCT01466387|782080|P2|STARTED|Overall Study||100
326413|NCT01466387|782081|P1|STARTED|Overall Study||101
326414|NCT01466361|782123|P4|NOT COMPLETED|Overall Study||0
326415|NCT01466361|782124|P3|NOT COMPLETED|Overall Study||0
326416|NCT01466361|782125|P2|NOT COMPLETED|Overall Study||0
326417|NCT01466361|782126|P1|NOT COMPLETED|Overall Study||0
326418|NCT01466361|782123|P4|COMPLETED|Overall Study||41
326419|NCT01466361|782124|P3|COMPLETED|Overall Study||60
326420|NCT01466361|782125|P2|COMPLETED|Overall Study||34
326421|NCT01466361|782126|P1|COMPLETED|Overall Study||52
326422|NCT01466361|782123|P4|STARTED|Overall Study||41
326423|NCT01466361|782124|P3|STARTED|Overall Study||60
326424|NCT01466361|782125|P2|STARTED|Overall Study||34
326425|NCT01466361|782126|P1|STARTED|Overall Study||52
326426|NCT01466348|782142|P2|NOT COMPLETED|Period II - Second Intervention||0
326427|NCT01466348|782143|P1|NOT COMPLETED|Period II - Second Intervention||0
326428|NCT01466348|782142|P2|COMPLETED|Period II - Second Intervention||36
326429|NCT01466348|782143|P1|COMPLETED|Period II - Second Intervention||35
326430|NCT01466348|782142|P2|STARTED|Period II - Second Intervention||36
326431|NCT01466348|782143|P1|STARTED|Period II - Second Intervention||35
326432|NCT01466348|782142|P2|NOT COMPLETED|Period I - First Intervention||1
326433|NCT01466348|782143|P1|NOT COMPLETED|Period I - First Intervention||0
326434|NCT01466348|782142|P2|COMPLETED|Period I - First Intervention||35
326435|NCT01466348|782143|P1|COMPLETED|Period I - First Intervention||36
326436|NCT01466348|782142|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
326437|NCT01466348|782143|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
326438|NCT01466348|782142|P2|STARTED|Period I - First Intervention||36
326439|NCT01466348|782143|P1|STARTED|Period I - First Intervention||36
326440|NCT01466270|782171|P2|NOT COMPLETED|Overall Study||6
326441|NCT01466270|782172|P1|NOT COMPLETED|Overall Study||12
326442|NCT01466270|782171|P2|COMPLETED|Overall Study||25
326443|NCT01466270|782172|P1|COMPLETED|Overall Study||19
326444|NCT01466270|782171|P2|STARTED|Overall Study||31
326445|NCT01466270|782172|P1|STARTED|Overall Study||31
326446|NCT01466192|782184|P1|NOT COMPLETED|Overall Study||4
326447|NCT01466192|782184|P1|COMPLETED|Overall Study||104
326448|NCT01466192|782184|P1|STARTED|Overall Study||108
326449|NCT01466179|782188|P1|NOT COMPLETED|Overall Study||179
326450|NCT01466179|782188|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
326451|NCT01466179|782188|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
326452|NCT01466153|782211|P3|NOT COMPLETED|Overall Study||25
326453|NCT01466153|782212|P2|NOT COMPLETED|Overall Study||24
326454|NCT01466153|782213|P1|NOT COMPLETED|Overall Study||29
326455|NCT01466153|782211|P3|COMPLETED|Overall Study||36
326456|NCT01466153|782212|P2|COMPLETED|Overall Study||12
326457|NCT01466153|782213|P1|COMPLETED|Overall Study||33
326458|NCT01466153|782211|P3|STARTED|Overall Study||61
326459|NCT01466153|782212|P2|STARTED|Overall Study||36
326460|NCT01466153|782213|P1|STARTED|Overall Study||62
326461|NCT01466127|782254|P2|NOT COMPLETED|Overall Study||16
326462|NCT01466127|782255|P1|NOT COMPLETED|Overall Study||14
326463|NCT01466127|782254|P2|COMPLETED|Overall Study||14
326464|NCT01466127|782255|P1|COMPLETED|Overall Study||16
326465|NCT01466127|782254|P2|STARTED|Overall Study||30
326466|NCT01466127|782255|P1|STARTED|Overall Study||30
326467|NCT01466075|782261|P1|NOT COMPLETED|Overall Study||0
326468|NCT01466075|782261|P1|COMPLETED|Overall Study||207
326469|NCT01466075|782261|P1|STARTED|Overall Study||207
326470|NCT01466062|782268|P1|NOT COMPLETED|Overall Study||2
326471|NCT01466062|782268|P1|COMPLETED|Overall Study||26
326472|NCT01466062|782268|P1|STARTED|Overall Study||28
326473|NCT01465958|782289|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
326474|NCT01465958|782290|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
326475|NCT01465958|782289|P2|COMPLETED|Subcutaneous (SC) Phase||10
326476|NCT01465958|782290|P1|COMPLETED|Subcutaneous (SC) Phase||0
326477|NCT01465958|782289|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
326478|NCT01465958|782290|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
326479|NCT01465958|782289|P2|NOT COMPLETED|Intravenous (IV) Phase||0
326480|NCT01465958|782290|P1|NOT COMPLETED|Intravenous (IV) Phase||0
326481|NCT01465958|782289|P2|COMPLETED|Intravenous (IV) Phase||0
326482|NCT01465958|782290|P1|COMPLETED|Intravenous (IV) Phase||11
326483|NCT01465958|782289|P2|STARTED|Intravenous (IV) Phase||0
326484|NCT01465958|782290|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
326485|NCT01465958|782289|P2|NOT COMPLETED|Run-in Phase||0
326486|NCT01465958|782290|P1|NOT COMPLETED|Run-in Phase||1
326487|NCT01465958|782289|P2|COMPLETED|Run-in Phase||0
326488|NCT01465958|782290|P1|COMPLETED|Run-in Phase||10
326489|NCT01465958|782289|P2|STARTED|Run-in Phase||0
326490|NCT01465958|782290|P1|STARTED|Run-in Phase||11
326491|NCT01465802|782303|P5|NOT COMPLETED|Overall Study||12
326492|NCT01465802|782304|P4|NOT COMPLETED|Overall Study||29
326493|NCT01465802|782305|P3|NOT COMPLETED|Overall Study||0
326494|NCT01465802|782306|P2|NOT COMPLETED|Overall Study||24
326495|NCT01465802|782307|P1|NOT COMPLETED|Overall Study||33
326496|NCT01465802|782303|P5|COMPLETED|Overall Study||13
326497|NCT01465802|782304|P4|COMPLETED|Overall Study||38
326498|NCT01465802|782305|P3|COMPLETED|Overall Study||7
326499|NCT01465802|782306|P2|COMPLETED|Overall Study||42
326500|NCT01465802|782307|P1|COMPLETED|Overall Study||33
326501|NCT01465802|782303|P5|STARTED|Overall Study||25
326502|NCT01465802|782304|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
326503|NCT01465802|782305|P3|STARTED|Overall Study||7
326504|NCT01465802|782306|P2|STARTED|Overall Study||66
326505|NCT01465802|782307|P1|STARTED|Overall Study||66
326506|NCT01465763|782359|P3|NOT COMPLETED|Overall Study||4
326507|NCT01465763|782360|P2|NOT COMPLETED|Overall Study||1
326508|NCT01465763|782361|P1|NOT COMPLETED|Overall Study||31
326509|NCT01465763|782359|P3|COMPLETED|Overall Study||118
326510|NCT01465763|782360|P2|COMPLETED|Overall Study||15
326511|NCT01465763|782361|P1|COMPLETED|Overall Study||445
326512|NCT01465763|782359|P3|STARTED|Overall Study||122
326513|NCT01465763|782360|P2|STARTED|Overall Study||16
326514|NCT01465763|782361|P1|STARTED|Overall Study||476
326515|NCT01465412|782390|P4|NOT COMPLETED|Overall Study||0
326516|NCT01465412|782391|P3|NOT COMPLETED|Overall Study||0
326517|NCT01465412|782392|P2|NOT COMPLETED|Overall Study||0
326518|NCT01465412|782393|P1|NOT COMPLETED|Overall Study||0
326519|NCT01465412|782390|P4|COMPLETED|Overall Study||9
326520|NCT01465412|782391|P3|COMPLETED|Overall Study||9
326521|NCT01465412|782392|P2|COMPLETED|Overall Study||12
326522|NCT01465412|782393|P1|COMPLETED|Overall Study||12
326523|NCT01465412|782390|P4|STARTED|Overall Study||9
326524|NCT01465412|782391|P3|STARTED|Overall Study||9
326525|NCT01465412|782392|P2|STARTED|Overall Study||12
326526|NCT01465412|782393|P1|STARTED|Overall Study||12
326527|NCT01465386|782431|P1|NOT COMPLETED|Overall Study||4
326528|NCT01465386|782431|P1|COMPLETED|Overall Study||2
326529|NCT01465386|782431|P1|STARTED|Overall Study||6
326530|NCT01465230|782435|P1|NOT COMPLETED|Overall Study||2
326531|NCT01465230|782435|P1|COMPLETED|Overall Study||0
326532|NCT01465230|782435|P1|STARTED|Overall Study||2
326533|NCT01465178|782441|P2|NOT COMPLETED|Overall Study||0
326534|NCT01465178|782442|P1|NOT COMPLETED|Overall Study||1
326535|NCT01465178|782441|P2|COMPLETED|Overall Study||31
326536|NCT01465178|782442|P1|COMPLETED|Overall Study||30
326537|NCT01465178|782441|P2|STARTED|Overall Study||31
326538|NCT01465178|782442|P1|STARTED|Overall Study||31
326539|NCT01465048|782453|P3|NOT COMPLETED|Overall Study||0
326540|NCT01465048|782454|P2|NOT COMPLETED|Overall Study||0
326541|NCT01465048|782455|P1|NOT COMPLETED|Overall Study||0
326542|NCT01465048|782453|P3|COMPLETED|Overall Study||6
326543|NCT01465048|782454|P2|COMPLETED|Overall Study||6
326544|NCT01465048|782455|P1|COMPLETED|Overall Study||6
326545|NCT01465048|782453|P3|STARTED|Overall Study||6
326546|NCT01465048|782454|P2|STARTED|Overall Study||6
326547|NCT01465048|782455|P1|STARTED|Overall Study||6
326548|NCT01465022|782466|P3|NOT COMPLETED|Overall Study||70
326549|NCT01465022|782467|P2|NOT COMPLETED|Overall Study||23
326550|NCT01465022|782468|P1|NOT COMPLETED|Overall Study||23
326551|NCT01465022|782466|P3|COMPLETED|Overall Study||0
326552|NCT01465022|782467|P2|COMPLETED|Overall Study||40
326553|NCT01465022|782468|P1|COMPLETED|Overall Study||41
326554|NCT01465022|782466|P3|STARTED|Overall Study||70
326555|NCT01465022|782467|P2|STARTED|Overall Study||63
326556|NCT01465022|782468|P1|STARTED|Overall Study||64
326557|NCT01464996|782482|P1|NOT COMPLETED|Overall Study||0
326558|NCT01464996|782482|P1|COMPLETED|Overall Study||24
326559|NCT01464996|782482|P1|OptiBond FL|Overall Study||24
326560|NCT01464996|782482|P1|OptiBond XTR|Overall Study||23
326561|NCT01464996|782482|P1|STARTED|Overall Study||24
326562|NCT01464931|782502|P2|NOT COMPLETED|Overall Study||0
326563|NCT01464931|782503|P1|NOT COMPLETED|Overall Study||1
326564|NCT01464931|782502|P2|COMPLETED|Overall Study||16
326565|NCT01464931|782503|P1|COMPLETED|Overall Study||15
326566|NCT01464931|782502|P2|STARTED|Overall Study||16
326567|NCT01464931|782503|P1|STARTED|Overall Study||16
326568|NCT01464840|782543|P3|NOT COMPLETED|Overall Study||0
326569|NCT01464840|782544|P2|NOT COMPLETED|Overall Study||0
326570|NCT01464840|782545|P1|NOT COMPLETED|Overall Study||0
326571|NCT01464840|782543|P3|COMPLETED|Overall Study||10
326572|NCT01464840|782544|P2|COMPLETED|Overall Study||10
326573|NCT01464840|782545|P1|COMPLETED|Overall Study||10
326574|NCT01464840|782543|P3|STARTED|Overall Study||10
326575|NCT01464840|782544|P2|STARTED|Overall Study||10
326576|NCT01464840|782545|P1|STARTED|Overall Study||10
326577|NCT01464827|782567|P14|NOT COMPLETED|Overall Study||3
326578|NCT01464827|782568|P13|NOT COMPLETED|Overall Study||2
326579|NCT01464827|782569|P12|NOT COMPLETED|Overall Study||2
326580|NCT01464827|782570|P11|NOT COMPLETED|Overall Study||2
326581|NCT01464827|782571|P10|NOT COMPLETED|Overall Study||3
326582|NCT01464827|782572|P9|NOT COMPLETED|Overall Study||3
326583|NCT01464827|782573|P8|NOT COMPLETED|Overall Study||3
326584|NCT01464827|782574|P7|NOT COMPLETED|Overall Study||4
326585|NCT01464827|782575|P6|NOT COMPLETED|Overall Study||1
326586|NCT01464827|782576|P5|NOT COMPLETED|Overall Study||8
326587|NCT01464827|782577|P4|NOT COMPLETED|Overall Study||4
326588|NCT01464827|782578|P3|NOT COMPLETED|Overall Study||0
326589|NCT01464827|782579|P2|NOT COMPLETED|Overall Study||7
326590|NCT01464827|782580|P1|NOT COMPLETED|Overall Study||3
326591|NCT01464827|782567|P14|COMPLETED|Overall Study||19
326592|NCT01464827|782568|P13|COMPLETED|Overall Study||21
326593|NCT01464827|782569|P12|COMPLETED|Overall Study||21
326594|NCT01464827|782570|P11|COMPLETED|Overall Study||21
326595|NCT01464827|782571|P10|COMPLETED|Overall Study||44
326596|NCT01464827|782572|P9|COMPLETED|Overall Study||37
326597|NCT01464827|782573|P8|COMPLETED|Overall Study||37
326598|NCT01464827|782574|P7|COMPLETED|Overall Study||37
326599|NCT01464827|782575|P6|COMPLETED|Overall Study||38
326600|NCT01464827|782576|P5|COMPLETED|Overall Study||72
326601|NCT01464827|782577|P4|COMPLETED|Overall Study||36
326602|NCT01464827|782578|P3|COMPLETED|Overall Study||39
326603|NCT01464827|782579|P2|COMPLETED|Overall Study||36
326604|NCT01464827|782580|P1|COMPLETED|Overall Study||77
326605|NCT01464827|782567|P14|Treated|Overall Study||20
326606|NCT01464827|782568|P13|Treated|Overall Study||23
326607|NCT01464827|782569|P12|Treated|Overall Study||22
326608|NCT01464827|782570|P11|Treated|Overall Study||23
326609|NCT01464827|782571|P10|Treated|Overall Study||45
326610|NCT01464827|782572|P9|Treated|Overall Study||40
326611|NCT01464827|782573|P8|Treated|Overall Study||40
326612|NCT01464827|782574|P7|Treated|Overall Study||40
326613|NCT01464827|782575|P6|Treated|Overall Study||39
326614|NCT01464827|782576|P5|Treated|Overall Study||79
326615|NCT01464827|782577|P4|Treated|Overall Study||40
326616|NCT01464827|782578|P3|Treated|Overall Study||39
326617|NCT01464827|782579|P2|Treated|Overall Study||41
326618|NCT01464827|782580|P1|Treated|Overall Study||80
326619|NCT01464827|782567|P14|STARTED|Overall Study||22
326620|NCT01464827|782568|P13|STARTED|Overall Study||23
326621|NCT01464827|782569|P12|STARTED|Overall Study||23
326622|NCT01464827|782570|P11|STARTED|Overall Study||23
326623|NCT01464827|782571|P10|STARTED|Overall Study||47
326624|NCT01464827|782572|P9|STARTED|Overall Study||40
326625|NCT01464827|782573|P8|STARTED|Overall Study||40
326626|NCT01464827|782574|P7|STARTED|Overall Study||41
326627|NCT01464827|782575|P6|STARTED|Overall Study||39
326628|NCT01464827|782576|P5|STARTED|Overall Study||80
326629|NCT01464827|782577|P4|STARTED|Overall Study||40
326630|NCT01464827|782578|P3|STARTED|Overall Study||39
326631|NCT01464827|782579|P2|STARTED|Overall Study||43
326632|NCT01464827|782580|P1|STARTED|Overall Study||80
326633|NCT01464788|782627|P3|NOT COMPLETED|Overall Study||0
326634|NCT01464788|782628|P2|NOT COMPLETED|Overall Study||2
326635|NCT01464788|782629|P1|NOT COMPLETED|Overall Study||0
326636|NCT01464788|782627|P3|COMPLETED|Overall Study||29
326637|NCT01464788|782628|P2|COMPLETED|Overall Study||29
326638|NCT01464788|782629|P1|COMPLETED|Overall Study||30
326639|NCT01464788|782627|P3|STARTED|Overall Study||29
326640|NCT01464788|782628|P2|STARTED|Overall Study||31
326641|NCT01464788|782629|P1|STARTED|Overall Study||30
326642|NCT01464619|782642|P2|NOT COMPLETED|Overall Study||4
326643|NCT01464619|782643|P1|NOT COMPLETED|Overall Study||3
326644|NCT01464619|782642|P2|COMPLETED|Overall Study||25
326645|NCT01464619|782643|P1|COMPLETED|Overall Study||29
326646|NCT01464619|782642|P2|STARTED|Overall Study||29
326647|NCT01464619|782643|P1|STARTED|Overall Study||32
326648|NCT01464424|782663|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
326649|NCT01464424|782664|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
326650|NCT01464424|782663|P2|COMPLETED|Period 2, Second 6 Weeks||41
326651|NCT01464424|782664|P1|COMPLETED|Period 2, Second 6 Weeks||42
326652|NCT01464424|782663|P2|STARTED|Period 2, Second 6 Weeks||41
326653|NCT01464424|782664|P1|STARTED|Period 2, Second 6 Weeks||42
326654|NCT01464424|782663|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
326655|NCT01464424|782664|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
326656|NCT01464424|782663|P2|COMPLETED|Period 1, First 6 Weeks||41
326657|NCT01464424|782664|P1|COMPLETED|Period 1, First 6 Weeks||42
326658|NCT01464424|782663|P2|STARTED|Period 1, First 6 Weeks||42
326659|NCT01464424|782664|P1|STARTED|Period 1, First 6 Weeks||42
326660|NCT01464359|782672|P1|NOT COMPLETED|Overall Study||0
326661|NCT01464359|782672|P1|COMPLETED|Overall Study||3
326662|NCT01464359|782672|P1|STARTED|Overall Study||3
326663|NCT01464307|782686|P2|NOT COMPLETED|Open-Label Extension Period||0
326664|NCT01464307|782687|P1|NOT COMPLETED|Open-Label Extension Period||51
326665|NCT01464307|782686|P2|COMPLETED|Open-Label Extension Period||0
326666|NCT01464307|782687|P1|COMPLETED|Open-Label Extension Period||218
326667|NCT01464307|782686|P2|Treated|Open-Label Extension Period||0
326668|NCT01464307|782687|P1|Treated|Open-Label Extension Period||269
326669|NCT01464307|782686|P2|STARTED|Open-Label Extension Period||0
326670|NCT01464307|782687|P1|STARTED|Open-Label Extension Period||269
326671|NCT01464307|782686|P2|NOT COMPLETED|Main Period||5
326672|NCT01464307|782687|P1|NOT COMPLETED|Main Period||15
326673|NCT01464307|782686|P2|COMPLETED|Main Period||140
326674|NCT01464307|782687|P1|COMPLETED|Main Period||129
326675|NCT01464307|782686|P2|Treated|Main Period||145
326676|NCT01464307|782687|P1|Treated|Main Period||144
326677|NCT01464307|782686|P2|STARTED|Main Period||145
326678|NCT01464307|782687|P1|STARTED|Main Period||144
326679|NCT01464255|782702|P2|NOT COMPLETED|Overall Study||1
326680|NCT01464255|782703|P1|NOT COMPLETED|Overall Study||0
326681|NCT01464255|782702|P2|COMPLETED|Overall Study||24
326682|NCT01464255|782703|P1|COMPLETED|Overall Study||25
326683|NCT01464255|782702|P2|STARTED|Overall Study||25
326684|NCT01464255|782703|P1|STARTED|Overall Study||25
326685|NCT01464229|782728|P2|NOT COMPLETED|Overall Study||2
326686|NCT01464229|782729|P1|NOT COMPLETED|Overall Study||5
326687|NCT01464229|782728|P2|COMPLETED|Overall Study||8
326688|NCT01464229|782729|P1|COMPLETED|Overall Study||5
326689|NCT01464229|782728|P2|STARTED|Overall Study||10
326690|NCT01464229|782729|P1|STARTED|Overall Study||10
326691|NCT01464190|782737|P2|NOT COMPLETED|Overall Study||41
326692|NCT01464190|782738|P1|NOT COMPLETED|Overall Study||69
326693|NCT01464190|782737|P2|COMPLETED|Overall Study||227
326694|NCT01464190|782738|P1|COMPLETED|Overall Study||322
326695|NCT01464190|782737|P2|STARTED|Overall Study||268
326696|NCT01464190|782738|P1|STARTED|Overall Study||391
326697|NCT01464021|782748|P1|NOT COMPLETED|Overall Study||26
326698|NCT01464021|782748|P1|COMPLETED|Overall Study||0
326699|NCT01464021|782748|P1|STARTED|Overall Study||26
326700|NCT01463982|782764|P4|NOT COMPLETED|Overall Study||0
326701|NCT01463982|782765|P3|NOT COMPLETED|Overall Study||2
326702|NCT01463982|782766|P2|NOT COMPLETED|Overall Study||1
326703|NCT01463982|782767|P1|NOT COMPLETED|Overall Study||0
326704|NCT01463982|782764|P4|COMPLETED|Overall Study||6
326705|NCT01463982|782765|P3|COMPLETED|Overall Study||2
326706|NCT01463982|782766|P2|COMPLETED|Overall Study||7
326707|NCT01463982|782767|P1|COMPLETED|Overall Study||3
326708|NCT01463982|782764|P4|STARTED|Overall Study||6
326709|NCT01463982|782765|P3|STARTED|Overall Study||4
326710|NCT01463982|782766|P2|STARTED|Overall Study||8
326711|NCT01463982|782767|P1|STARTED|Overall Study||3
326712|NCT01463878|782783|P2|NOT COMPLETED|Overall Study||2
326713|NCT01463878|782784|P1|NOT COMPLETED|Overall Study||2
326714|NCT01463878|782783|P2|COMPLETED|Overall Study||7
326715|NCT01463878|782784|P1|COMPLETED|Overall Study||7
326716|NCT01463878|782783|P2|STARTED|Overall Study||9
326717|NCT01463878|782784|P1|STARTED|Overall Study||9
326718|NCT01463696|782798|P8|NOT COMPLETED|Overall Study||4
326719|NCT01463696|782799|P7|NOT COMPLETED|Overall Study||10
326720|NCT01463696|782800|P6|NOT COMPLETED|Overall Study||3
326721|NCT01463696|782801|P5|NOT COMPLETED|Overall Study||1
326722|NCT01463696|782802|P4|NOT COMPLETED|Overall Study||4
326723|NCT01463696|782803|P3|NOT COMPLETED|Overall Study||1
326724|NCT01463696|782804|P2|NOT COMPLETED|Overall Study||2
326725|NCT01463696|782805|P1|NOT COMPLETED|Overall Study||0
326726|NCT01463696|782798|P8|COMPLETED|Overall Study||2
326727|NCT01463696|782799|P7|COMPLETED|Overall Study||6
326728|NCT01463696|782800|P6|COMPLETED|Overall Study||3
326729|NCT01463696|782801|P5|COMPLETED|Overall Study||2
326730|NCT01463696|782802|P4|COMPLETED|Overall Study||3
326731|NCT01463696|782803|P3|COMPLETED|Overall Study||2
326732|NCT01463696|782804|P2|COMPLETED|Overall Study||4
326733|NCT01463696|782805|P1|COMPLETED|Overall Study||1
326734|NCT01463696|782798|P8|Treated|Overall Study||6
326735|NCT01463696|782799|P7|Treated|Overall Study||15
326736|NCT01463696|782800|P6|Treated|Overall Study||6
326737|NCT01463696|782801|P5|Treated|Overall Study||3
326738|NCT01463696|782802|P4|Treated|Overall Study||7
326739|NCT01463696|782803|P3|Treated|Overall Study||3
326740|NCT01463696|782804|P2|Treated|Overall Study||6
326741|NCT01463696|782805|P1|Treated|Overall Study||1
326742|NCT01463696|782798|P8|STARTED|Overall Study||6
326743|NCT01463696|782799|P7|STARTED|Overall Study||16
326744|NCT01463696|782800|P6|STARTED|Overall Study||6
326745|NCT01463696|782801|P5|STARTED|Overall Study||3
326746|NCT01463696|782802|P4|STARTED|Overall Study||7
326747|NCT01463696|782803|P3|STARTED|Overall Study||3
326748|NCT01463696|782804|P2|STARTED|Overall Study||6
326749|NCT01463696|782805|P1|STARTED|Overall Study||1
326750|NCT01463683|782858|P3|NOT COMPLETED|Overall Study||11
326751|NCT01463683|782859|P2|NOT COMPLETED|Overall Study||31
326752|NCT01463683|782860|P1|NOT COMPLETED|Overall Study||19
326753|NCT01463683|782858|P3|COMPLETED|Overall Study||93
326754|NCT01463683|782859|P2|COMPLETED|Overall Study||278
326755|NCT01463683|782860|P1|COMPLETED|Overall Study||290
326756|NCT01463683|782858|P3|Received Vaccination 3 (Month 6)|Overall Study||93
326757|NCT01463683|782859|P2|Received Vaccination 3 (Month 6)|Overall Study||281
326758|NCT01463683|782860|P1|Received Vaccination 3 (Month 6)|Overall Study||290
326759|NCT01463683|782858|P3|Received Vaccination 2 (Month 1)|Overall Study||103
326760|NCT01463683|782859|P2|Received Vaccination 2 (Month 1)|Overall Study||300
326761|NCT01463683|782860|P1|Received Vaccination 2 (Month 1)|Overall Study||302
326762|NCT01463683|782858|P3|Received Vaccination 1 (Day 1)|Overall Study||104
326763|NCT01463683|782859|P2|Received Vaccination 1 (Day 1)|Overall Study||308
326764|NCT01463683|782860|P1|Received Vaccination 1 (Day 1)|Overall Study||309
326765|NCT01463683|782858|P3|STARTED|Overall Study||104
326766|NCT01463683|782859|P2|STARTED|Overall Study||309
326767|NCT01463683|782860|P1|STARTED|Overall Study||309
326768|NCT01463527|782875|P2|NOT COMPLETED|Overall Study||7
326769|NCT01463527|782876|P1|NOT COMPLETED|Overall Study||6
326770|NCT01463527|782875|P2|COMPLETED|Overall Study||77
326771|NCT01463527|782876|P1|COMPLETED|Overall Study||77
326772|NCT01463527|782875|P2|STARTED|Overall Study||84
326773|NCT01463527|782876|P1|STARTED|Overall Study||83
326774|NCT01463384|782882|P1|NOT COMPLETED|Overall Study||0
326775|NCT01463384|782882|P1|COMPLETED|Overall Study||13
326776|NCT01463384|782882|P1|STARTED|Overall Study||13
326777|NCT01463293|782897|P3|NOT COMPLETED|Overall Study||12
326778|NCT01463293|782898|P2|NOT COMPLETED|Overall Study||16
326779|NCT01463293|782899|P1|NOT COMPLETED|Overall Study||6
326780|NCT01463293|782897|P3|COMPLETED|Overall Study||59
326781|NCT01463293|782898|P2|COMPLETED|Overall Study||63
326782|NCT01463293|782899|P1|COMPLETED|Overall Study||68
326783|NCT01463293|782897|P3|STARTED|Overall Study||71
326784|NCT01463293|782898|P2|STARTED|Overall Study||79
326785|NCT01463293|782899|P1|STARTED|Overall Study||74
326786|NCT01463111|782907|P1|NOT COMPLETED|Overall Study||9
326787|NCT01463111|782907|P1|COMPLETED|Overall Study||17
326788|NCT01463111|782907|P1|STARTED|Overall Study||26
326789|NCT01463033|782917|P2|NOT COMPLETED|Overall Study||6
326790|NCT01463033|782918|P1|NOT COMPLETED|Overall Study||7
326791|NCT01463033|782917|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
326890|NCT01462357|783103|P1|NOT COMPLETED|Month 12||3
326792|NCT01463033|782918|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
326793|NCT01463033|782917|P2|STARTED|Overall Study||60
326794|NCT01463033|782918|P1|STARTED|Overall Study||66
326795|NCT01463007|782925|P1|NOT COMPLETED|Overall Study||1
326796|NCT01463007|782925|P1|COMPLETED|Overall Study||40
326797|NCT01463007|782925|P1|STARTED|Overall Study||41
326798|NCT01462942|782936|P5|NOT COMPLETED|Overall Study||45
326799|NCT01462942|782937|P4|NOT COMPLETED|Overall Study||50
326800|NCT01462942|782938|P3|NOT COMPLETED|Overall Study||40
326801|NCT01462942|782939|P2|NOT COMPLETED|Overall Study||34
326802|NCT01462942|782940|P1|NOT COMPLETED|Overall Study||34
326803|NCT01462942|782936|P5|COMPLETED|Overall Study||339
326804|NCT01462942|782937|P4|COMPLETED|Overall Study||335
326805|NCT01462942|782938|P3|COMPLETED|Overall Study||341
326806|NCT01462942|782939|P2|COMPLETED|Overall Study||351
326807|NCT01462942|782940|P1|COMPLETED|Overall Study||160
326808|NCT01462942|782936|P5|STARTED|Overall Study||384
326809|NCT01462942|782937|P4|STARTED|Overall Study||385
326810|NCT01462942|782938|P3|STARTED|Overall Study||381
326811|NCT01462942|782939|P2|STARTED|Overall Study||385
326812|NCT01462942|782940|P1|STARTED|Overall Study||194
326813|NCT01462929|782970|P3|NOT COMPLETED|Overall Study||5
326814|NCT01462929|782971|P2|NOT COMPLETED|Overall Study||4
326815|NCT01462929|782972|P1|NOT COMPLETED|Overall Study||5
326816|NCT01462929|782970|P3|COMPLETED|Overall Study||80
326817|NCT01462929|782971|P2|COMPLETED|Overall Study||154
326818|NCT01462929|782972|P1|COMPLETED|Overall Study||166
326819|NCT01462929|782970|P3|STARTED|Overall Study||85
326820|NCT01462929|782971|P2|STARTED|Overall Study||158
326821|NCT01462929|782972|P1|STARTED|Overall Study||171
326822|NCT01462877|782983|P1|NOT COMPLETED|Overall Study||71
326823|NCT01462877|782983|P1|COMPLETED|Overall Study||435
326824|NCT01462877|782983|P1|Per-protocol Set|Overall Study||364
326825|NCT01462877|782983|P1|Full Analysis Set|Overall Study||468
326826|NCT01462877|782983|P1|Safety Set|Overall Study||492
326827|NCT01462877|782983|P1|STARTED|Overall Study||506
326828|NCT01462812|782999|P2|NOT COMPLETED|Overall Study||1
326829|NCT01462812|783000|P1|NOT COMPLETED|Overall Study||0
326830|NCT01462812|782999|P2|COMPLETED|Overall Study||111
326831|NCT01462812|783000|P1|COMPLETED|Overall Study||111
326832|NCT01462812|782999|P2|STARTED|Overall Study||112
326833|NCT01462812|783000|P1|STARTED|Overall Study||111
326834|NCT01462773|783006|P1|NOT COMPLETED|Overall Study||0
326835|NCT01462773|783006|P1|COMPLETED|Overall Study||16
326836|NCT01462773|783006|P1|STARTED|Overall Study||16
326837|NCT01462695|783013|P2|NOT COMPLETED|Overall Study||13
326838|NCT01462695|783014|P1|NOT COMPLETED|Overall Study||17
326839|NCT01462695|783013|P2|COMPLETED|Overall Study||0
326840|NCT01462695|783014|P1|COMPLETED|Overall Study||0
326841|NCT01462695|783013|P2|STARTED|Overall Study||13
326842|NCT01462695|783014|P1|STARTED|Overall Study||17
326843|NCT01462435|783024|P4|NOT COMPLETED|Overall Study||5
326844|NCT01462435|783025|P3|NOT COMPLETED|Overall Study||1
326845|NCT01462435|783026|P2|NOT COMPLETED|Overall Study||0
326846|NCT01462435|783027|P1|NOT COMPLETED|Overall Study||1
326847|NCT01462435|783024|P4|COMPLETED|Overall Study||101
326848|NCT01462435|783025|P3|COMPLETED|Overall Study||106
326849|NCT01462435|783026|P2|COMPLETED|Overall Study||109
326850|NCT01462435|783027|P1|COMPLETED|Overall Study||105
326851|NCT01462435|783024|P4|STARTED|Overall Study||106
326852|NCT01462435|783025|P3|STARTED|Overall Study||107
326853|NCT01462435|783026|P2|STARTED|Overall Study||109
326854|NCT01462435|783027|P1|STARTED|Overall Study||106
326855|NCT01462370|783065|P2|NOT COMPLETED|Overall Study||5
326856|NCT01462370|783066|P1|NOT COMPLETED|Overall Study||1
326857|NCT01462370|783065|P2|COMPLETED|Overall Study||65
326858|NCT01462370|783066|P1|COMPLETED|Overall Study||68
326859|NCT01462370|783065|P2|STARTED|Overall Study||70
326860|NCT01462370|783066|P1|STARTED|Overall Study||69
326861|NCT01462357|783101|P3|NOT COMPLETED|Month 36||0
326862|NCT01462357|783102|P2|NOT COMPLETED|Month 36||0
326863|NCT01462357|783103|P1|NOT COMPLETED|Month 36||0
326864|NCT01462357|783101|P3|COMPLETED|Month 36||346
326865|NCT01462357|783102|P2|COMPLETED|Month 36||339
326866|NCT01462357|783103|P1|COMPLETED|Month 36||351
326867|NCT01462357|783101|P3|STARTED|Month 36||346
326868|NCT01462357|783102|P2|STARTED|Month 36||339
326869|NCT01462357|783103|P1|STARTED|Month 36||351
326870|NCT01462357|783101|P3|NOT COMPLETED|Month 24||9
326871|NCT01462357|783102|P2|NOT COMPLETED|Month 24||14
326872|NCT01462357|783103|P1|NOT COMPLETED|Month 24||4
326873|NCT01462357|783101|P3|COMPLETED|Month 24||349
326874|NCT01462357|783102|P2|COMPLETED|Month 24||344
326875|NCT01462357|783103|P1|COMPLETED|Month 24||355
326876|NCT01462357|783101|P3|STARTED|Month 24||358
326877|NCT01462357|783102|P2|STARTED|Month 24||358
326878|NCT01462357|783103|P1|STARTED|Month 24||359
326879|NCT01462357|783101|P3|NOT COMPLETED|Month 18||9
326880|NCT01462357|783102|P2|NOT COMPLETED|Month 18||11
326881|NCT01462357|783103|P1|NOT COMPLETED|Month 18||3
326882|NCT01462357|783101|P3|COMPLETED|Month 18||349
326883|NCT01462357|783102|P2|COMPLETED|Month 18||347
326884|NCT01462357|783103|P1|COMPLETED|Month 18||356
326885|NCT01462357|783101|P3|STARTED|Month 18||358
326886|NCT01462357|783102|P2|STARTED|Month 18||358
326887|NCT01462357|783103|P1|STARTED|Month 18||359
326888|NCT01462357|783101|P3|NOT COMPLETED|Month 12||8
326889|NCT01462357|783102|P2|NOT COMPLETED|Month 12||10
326891|NCT01462357|783101|P3|COMPLETED|Month 12||350
326892|NCT01462357|783102|P2|COMPLETED|Month 12||348
326893|NCT01462357|783103|P1|COMPLETED|Month 12||356
326894|NCT01462357|783101|P3|STARTED|Month 12||358
326895|NCT01462357|783102|P2|STARTED|Month 12||358
326896|NCT01462357|783103|P1|STARTED|Month 12||359
326897|NCT01462357|783101|P3|NOT COMPLETED|Month 7||6
326898|NCT01462357|783102|P2|NOT COMPLETED|Month 7||5
326899|NCT01462357|783103|P1|NOT COMPLETED|Month 7||1
326900|NCT01462357|783101|P3|COMPLETED|Month 7||352
326901|NCT01462357|783102|P2|COMPLETED|Month 7||353
326902|NCT01462357|783103|P1|COMPLETED|Month 7||358
326903|NCT01462357|783101|P3|STARTED|Month 7||358
326904|NCT01462357|783102|P2|STARTED|Month 7||358
326905|NCT01462357|783103|P1|STARTED|Month 7||359
326906|NCT01462344|783176|P2|NOT COMPLETED|Overall Study||350
326907|NCT01462344|783177|P1|NOT COMPLETED|Overall Study||383
326908|NCT01462344|783176|P2|COMPLETED|Overall Study||2751
326909|NCT01462344|783177|P1|COMPLETED|Overall Study||2724
326910|NCT01462344|783176|P2|STARTED|Overall Study||3101
326911|NCT01462344|783177|P1|STARTED|Overall Study||3107
326912|NCT01462318|783199|P3|NOT COMPLETED|Extension Phase||45
326913|NCT01462318|783200|P2|NOT COMPLETED|Extension Phase||0
326914|NCT01462318|783201|P1|NOT COMPLETED|Extension Phase||0
326915|NCT01462318|783199|P3|COMPLETED|Extension Phase||70
326916|NCT01462318|783200|P2|COMPLETED|Extension Phase||0
326917|NCT01462318|783201|P1|COMPLETED|Extension Phase||0
326918|NCT01462318|783199|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
326919|NCT01462318|783200|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
326920|NCT01462318|783201|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
326921|NCT01462318|783199|P3|NOT COMPLETED|Main Study / TP-DI Study||0
326922|NCT01462318|783200|P2|NOT COMPLETED|Main Study / TP-DI Study||0
326923|NCT01462318|783201|P1|NOT COMPLETED|Main Study / TP-DI Study||8
326924|NCT01462318|783199|P3|COMPLETED|Main Study / TP-DI Study||0
326925|NCT01462318|783200|P2|COMPLETED|Main Study / TP-DI Study||20
326926|NCT01462318|783201|P1|COMPLETED|Main Study / TP-DI Study||105
326927|NCT01462318|783199|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
326928|NCT01462318|783200|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
326929|NCT01462318|783201|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
326930|NCT01462318|783199|P3|STARTED|Main Study / TP-DI Study||0
326931|NCT01462318|783200|P2|STARTED|Main Study / TP-DI Study||20
326932|NCT01462318|783201|P1|STARTED|Main Study / TP-DI Study||113
326933|NCT01462279|783218|P1|NOT COMPLETED|Overall Study||3
326934|NCT01462279|783218|P1|COMPLETED|Overall Study||17
326935|NCT01462279|783218|P1|STARTED|Overall Study||20
326936|NCT01462266|783224|P2|NOT COMPLETED|Overall Study||27
326937|NCT01462266|783225|P1|NOT COMPLETED|Overall Study||35
326938|NCT01462266|783224|P2|COMPLETED|Overall Study||303
326939|NCT01462266|783225|P1|COMPLETED|Overall Study||295
326940|NCT01462266|783224|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
326941|NCT01462266|783225|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
326942|NCT01462266|783224|P2|STARTED|Overall Study||330
326943|NCT01462266|783225|P1|STARTED|Overall Study||330
326944|NCT01462227|783241|P4|NOT COMPLETED|Second Assignment||0
326945|NCT01462227|783242|P3|NOT COMPLETED|Second Assignment||1
326946|NCT01462227|783243|P2|NOT COMPLETED|Second Assignment||1
326947|NCT01462227|783244|P1|NOT COMPLETED|Second Assignment||1
326948|NCT01462227|783241|P4|COMPLETED|Second Assignment||5
326949|NCT01462227|783242|P3|COMPLETED|Second Assignment||5
326950|NCT01462227|783243|P2|COMPLETED|Second Assignment||1
326951|NCT01462227|783244|P1|COMPLETED|Second Assignment||3
326952|NCT01462227|783241|P4|STARTED|Second Assignment||5
326953|NCT01462227|783242|P3|STARTED|Second Assignment||6
326954|NCT01462227|783243|P2|STARTED|Second Assignment||2
326955|NCT01462227|783244|P1|STARTED|Second Assignment||4
326956|NCT01462227|783241|P4|NOT COMPLETED|First Assignment||0
326957|NCT01462227|783242|P3|NOT COMPLETED|First Assignment||0
326958|NCT01462227|783243|P2|NOT COMPLETED|First Assignment||0
326959|NCT01462227|783244|P1|NOT COMPLETED|First Assignment||0
326960|NCT01462227|783241|P4|COMPLETED|First Assignment||5
326961|NCT01462227|783242|P3|COMPLETED|First Assignment||6
326962|NCT01462227|783243|P2|COMPLETED|First Assignment||2
326963|NCT01462227|783244|P1|COMPLETED|First Assignment||4
326964|NCT01462227|783241|P4|STARTED|First Assignment||5
326965|NCT01462227|783242|P3|STARTED|First Assignment||6
326966|NCT01462227|783243|P2|STARTED|First Assignment||2
326967|NCT01462227|783244|P1|STARTED|First Assignment||4
326968|NCT01462162|783262|P1|NOT COMPLETED|Overall Study||12
326969|NCT01462162|783262|P1|COMPLETED|Overall Study||108
326970|NCT01462162|783262|P1|STARTED|Overall Study||120
326971|NCT01462084|783287|P2|NOT COMPLETED|Overall Study||1
326972|NCT01462084|783288|P1|NOT COMPLETED|Overall Study||2
326973|NCT01462084|783287|P2|COMPLETED|Overall Study||9
326974|NCT01462084|783288|P1|COMPLETED|Overall Study||9
326975|NCT01462084|783287|P2|Included for Analysis|Overall Study||9
326976|NCT01462084|783288|P1|Included for Analysis|Overall Study||9
326977|NCT01462084|783287|P2|STARTED|Overall Study||10
326978|NCT01462084|783288|P1|STARTED|Overall Study||11
326979|NCT01462045|783299|P3|NOT COMPLETED|Overall Study||0
326980|NCT01462045|783300|P2|NOT COMPLETED|Overall Study||1
326981|NCT01462045|783301|P1|NOT COMPLETED|Overall Study||0
326982|NCT01462045|783299|P3|COMPLETED|Overall Study||7
326983|NCT01462045|783300|P2|COMPLETED|Overall Study||10
326984|NCT01462045|783301|P1|COMPLETED|Overall Study||11
326985|NCT01462045|783299|P3|STARTED|Overall Study||7
326986|NCT01462045|783300|P2|STARTED|Overall Study||11
326987|NCT01462045|783301|P1|STARTED|Overall Study||11
326988|NCT01461993|783315|P3|NOT COMPLETED|Overall Study||64
326989|NCT01461993|783316|P2|NOT COMPLETED|Overall Study||157
326990|NCT01461993|783317|P1|NOT COMPLETED|Overall Study||151
326991|NCT01461993|783315|P3|COMPLETED|Overall Study||438
326992|NCT01461993|783316|P2|COMPLETED|Overall Study||841
326993|NCT01461993|783317|P1|COMPLETED|Overall Study||848
326994|NCT01461993|783315|P3|STARTED|Overall Study||502
326995|NCT01461993|783316|P2|STARTED|Overall Study||998
326996|NCT01461993|783317|P1|STARTED|Overall Study||999
326997|NCT01461980|783342|P3|NOT COMPLETED|Overall Study||165
326998|NCT01461980|783343|P2|NOT COMPLETED|Overall Study||145
326999|NCT01461980|783344|P1|NOT COMPLETED|Overall Study||166
327000|NCT01461980|783342|P3|COMPLETED|Overall Study||717
327001|NCT01461980|783343|P2|COMPLETED|Overall Study||733
327002|NCT01461980|783344|P1|COMPLETED|Overall Study||722
327003|NCT01461980|783342|P3|Vaccination 3|Overall Study||748
327004|NCT01461980|783343|P2|Vaccination 3|Overall Study||777
327005|NCT01461980|783344|P1|Vaccination 3|Overall Study||757
327006|NCT01461980|783342|P3|Vaccination 2|Overall Study||799
327007|NCT01461980|783343|P2|Vaccination 2|Overall Study||819
327008|NCT01461980|783344|P1|Vaccination 2|Overall Study||802
327009|NCT01461980|783342|P3|Vaccination 1|Overall Study||875
327010|NCT01461980|783343|P2|Vaccination 1|Overall Study||870
327011|NCT01461980|783344|P1|Vaccination 1|Overall Study||884
327012|NCT01461980|783342|P3|STARTED|Overall Study||882
327013|NCT01461980|783343|P2|STARTED|Overall Study||878
327014|NCT01461980|783344|P1|STARTED|Overall Study||888
327015|NCT01461811|783376|P2|NOT COMPLETED|Overall Study||3
327016|NCT01461811|783377|P1|NOT COMPLETED|Overall Study||4
327017|NCT01461811|783376|P2|COMPLETED|Overall Study||46
327018|NCT01461811|783377|P1|COMPLETED|Overall Study||91
327019|NCT01461811|783376|P2|STARTED|Overall Study||49
327020|NCT01461811|783377|P1|STARTED|Overall Study||95
327021|NCT01461733|783407|P2|NOT COMPLETED|Overall Study||4
327022|NCT01461733|783408|P1|NOT COMPLETED|Overall Study||4
327023|NCT01461733|783407|P2|COMPLETED|Overall Study||8
327024|NCT01461733|783408|P1|COMPLETED|Overall Study||8
327025|NCT01461733|783407|P2|STARTED|Overall Study||12
327026|NCT01461733|783408|P1|STARTED|Overall Study||12
327027|NCT01461707|783416|P2|NOT COMPLETED|Overall Study||0
327028|NCT01461707|783417|P1|NOT COMPLETED|Overall Study||1
327029|NCT01461707|783416|P2|COMPLETED|Overall Study||15
327030|NCT01461707|783417|P1|COMPLETED|Overall Study||14
327031|NCT01461707|783416|P2|STARTED|Overall Study||15
327032|NCT01461707|783417|P1|STARTED|Overall Study||15
327033|NCT01461655|783425|P1|NOT COMPLETED|Overall Study||0
327034|NCT01461655|783425|P1|COMPLETED|Overall Study||40
327035|NCT01461655|783425|P1|STARTED|Overall Study||40
327036|NCT01461551|783445|P3|NOT COMPLETED|Overall Study||2
327037|NCT01461551|783446|P2|NOT COMPLETED|Overall Study||1
327038|NCT01461551|783447|P1|NOT COMPLETED|Overall Study||2
327039|NCT01461551|783445|P3|COMPLETED|Overall Study||33
327040|NCT01461551|783446|P2|COMPLETED|Overall Study||34
327041|NCT01461551|783447|P1|COMPLETED|Overall Study||33
327042|NCT01461551|783445|P3|STARTED|Overall Study||35
327043|NCT01461551|783446|P2|STARTED|Overall Study||35
327044|NCT01461551|783447|P1|STARTED|Overall Study||35
327045|NCT01461538|783458|P3|NOT COMPLETED|Overall Study||2
327046|NCT01461538|783459|P2|NOT COMPLETED|Overall Study||8
327047|NCT01461538|783460|P1|NOT COMPLETED|Overall Study||18
327048|NCT01461538|783458|P3|COMPLETED|Overall Study||7
327049|NCT01461538|783459|P2|COMPLETED|Overall Study||20
327050|NCT01461538|783460|P1|COMPLETED|Overall Study||28
327051|NCT01461538|783458|P3|STARTED|Overall Study||9
327052|NCT01461538|783459|P2|STARTED|Overall Study||28
327053|NCT01461538|783460|P1|STARTED|Overall Study||46
327054|NCT01461473|783498|P2|NOT COMPLETED|Overall Study||4
327055|NCT01461473|783499|P1|NOT COMPLETED|Overall Study||5
327056|NCT01461473|783498|P2|COMPLETED|Overall Study||55
327057|NCT01461473|783499|P1|COMPLETED|Overall Study||67
327058|NCT01461473|783498|P2|STARTED|Overall Study||59
327059|NCT01461473|783499|P1|STARTED|Overall Study||72
327060|NCT01461369|783518|P3|NOT COMPLETED|Overall Study||17
327061|NCT01461369|783519|P2|NOT COMPLETED|Overall Study||17
327062|NCT01461369|783520|P1|NOT COMPLETED|Overall Study||13
327063|NCT01461369|783518|P3|COMPLETED|Overall Study||86
327064|NCT01461369|783519|P2|COMPLETED|Overall Study||81
327065|NCT01461369|783520|P1|COMPLETED|Overall Study||91
327066|NCT01461369|783518|P3|STARTED|Overall Study||103
327067|NCT01461369|783519|P2|STARTED|Overall Study||98
327068|NCT01461369|783520|P1|STARTED|Overall Study||104
327069|NCT01461096|783545|P2|NOT COMPLETED|Overall Study||61
327070|NCT01461096|783546|P1|NOT COMPLETED|Overall Study||62
327071|NCT01461096|783545|P2|COMPLETED|Overall Study||226
327072|NCT01461096|783546|P1|COMPLETED|Overall Study||226
327073|NCT01461096|783545|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
327074|NCT01461096|783546|P1|Did Not Start Treatment|Overall Study||0
327075|NCT01461096|783545|P2|STARTED|Overall Study||287
327076|NCT01461096|783546|P1|STARTED|Overall Study||288
327077|NCT01461057|783562|P2|NOT COMPLETED|Overall Study||15
327078|NCT01461057|783563|P1|NOT COMPLETED|Overall Study||15
327079|NCT01461057|783562|P2|COMPLETED|Overall Study||0
327080|NCT01461057|783563|P1|COMPLETED|Overall Study||0
327081|NCT01461057|783562|P2|STARTED|Overall Study||15
327082|NCT01461057|783563|P1|STARTED|Overall Study||15
327083|NCT01461044|783573|P2|NOT COMPLETED|Overall Study||40
327084|NCT01461044|783574|P1|NOT COMPLETED|Overall Study||70
327085|NCT01461044|783573|P2|COMPLETED|Overall Study||37
327086|NCT01461044|783574|P1|COMPLETED|Overall Study||80
327087|NCT01461044|783573|P2|Participants Alive at Inclusion|Overall Study||58
327088|NCT01461044|783574|P1|Participants Alive at Inclusion|Overall Study||127
327089|NCT01461044|783573|P2|STARTED|Overall Study||77
327090|NCT01461044|783574|P1|STARTED|Overall Study||150
327091|NCT01460940|783647|P1|NOT COMPLETED|Overall Study||0
327092|NCT01460940|783647|P1|COMPLETED|Overall Study||24
327093|NCT01460940|783647|P1|STARTED|Overall Study||24
327094|NCT01460927|783653|P1|NOT COMPLETED|Overall Study||0
327095|NCT01460927|783653|P1|COMPLETED|Overall Study||25
327096|NCT01460927|783653|P1|STARTED|Overall Study||25
327097|NCT01460732|783661|P1|NOT COMPLETED|Overall Study||0
327098|NCT01460732|783661|P1|COMPLETED|Overall Study||81
327099|NCT01460732|783661|P1|STARTED|Overall Study||81
327100|NCT01460628|783674|P1|NOT COMPLETED|Overall Study||5
327101|NCT01460628|783674|P1|COMPLETED|Overall Study||20
327102|NCT01460628|783674|P1|STARTED|Overall Study||25
327103|NCT01460446|783686|P2|NOT COMPLETED|Overall Study||20
327104|NCT01460446|783687|P1|NOT COMPLETED|Overall Study||5
327105|NCT01460446|783686|P2|COMPLETED|Overall Study||93
327106|NCT01460446|783687|P1|COMPLETED|Overall Study||100
327107|NCT01460446|783686|P2|STARTED|Overall Study||113
327108|NCT01460446|783687|P1|STARTED|Overall Study||105
327109|NCT01460342|783716|P2|NOT COMPLETED|Overall Study||14
327110|NCT01460342|783717|P1|NOT COMPLETED|Overall Study||11
327111|NCT01460342|783716|P2|COMPLETED|Overall Study||292
327112|NCT01460342|783717|P1|COMPLETED|Overall Study||293
327113|NCT01460342|783716|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
327114|NCT01460342|783717|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
327115|NCT01460342|783716|P2|STARTED|Overall Study||306
327116|NCT01460342|783717|P1|STARTED|Overall Study||304
327117|NCT01460290|783737|P1|NOT COMPLETED|Overall Study||4
327118|NCT01460290|783737|P1|COMPLETED|Overall Study||11
327119|NCT01460290|783737|P1|STARTED|Overall Study||15
327120|NCT01459913|783761|P4|NOT COMPLETED|Overall Study||33
327121|NCT01459913|783762|P3|NOT COMPLETED|Overall Study||13
327122|NCT01459913|783763|P2|NOT COMPLETED|Overall Study||20
327123|NCT01459913|783764|P1|NOT COMPLETED|Overall Study||41
327124|NCT01459913|783761|P4|COMPLETED|Overall Study||29
327125|NCT01459913|783762|P3|COMPLETED|Overall Study||6
327126|NCT01459913|783763|P2|COMPLETED|Overall Study||32
327127|NCT01459913|783764|P1|COMPLETED|Overall Study||65
327128|NCT01459913|783761|P4|STARTED|Overall Study||62
327129|NCT01459913|783762|P3|STARTED|Overall Study||19
327130|NCT01459913|783763|P2|STARTED|Overall Study||52
327131|NCT01459913|783764|P1|STARTED|Overall Study||106
327132|NCT01459783|783795|P2|NOT COMPLETED|6 Months to 12 Months||30
327133|NCT01459783|783796|P1|NOT COMPLETED|6 Months to 12 Months||19
327134|NCT01459783|783795|P2|COMPLETED|6 Months to 12 Months||23
327135|NCT01459783|783796|P1|COMPLETED|6 Months to 12 Months||20
327136|NCT01459783|783795|P2|STARTED|6 Months to 12 Months||53
327137|NCT01459783|783796|P1|STARTED|6 Months to 12 Months||39
327138|NCT01459783|783795|P2|NOT COMPLETED|Baseline to 6 Months||20
327139|NCT01459783|783796|P1|NOT COMPLETED|Baseline to 6 Months||32
327140|NCT01459783|783795|P2|COMPLETED|Baseline to 6 Months||53
327141|NCT01459783|783796|P1|COMPLETED|Baseline to 6 Months||39
327142|NCT01459783|783795|P2|STARTED|Baseline to 6 Months||73
327143|NCT01459783|783796|P1|STARTED|Baseline to 6 Months||71
327144|NCT01459705|783807|P3|NOT COMPLETED|Overall Study||7
327145|NCT01459705|783808|P2|NOT COMPLETED|Overall Study||24
327146|NCT01459705|783809|P1|NOT COMPLETED|Overall Study||22
327147|NCT01459705|783807|P3|COMPLETED|Overall Study||47
327148|NCT01459705|783808|P2|COMPLETED|Overall Study||30
327149|NCT01459705|783809|P1|COMPLETED|Overall Study||32
327150|NCT01459705|783807|P3|STARTED|Overall Study||54
327151|NCT01459705|783808|P2|STARTED|Overall Study||54
327152|NCT01459705|783809|P1|STARTED|Overall Study||54
327153|NCT01459653|783827|P1|NOT COMPLETED|Overall Study||668
327154|NCT01459653|783827|P1|COMPLETED|Overall Study||828
327155|NCT01459653|783827|P1|STARTED|Overall Study||1496
327156|NCT01459588|783977|P4|NOT COMPLETED|Overall Study||1
327157|NCT01459588|783978|P3|NOT COMPLETED|Overall Study||1
327158|NCT01459588|783979|P2|NOT COMPLETED|Overall Study||2
327159|NCT01459588|783980|P1|NOT COMPLETED|Overall Study||1
327160|NCT01459588|783977|P4|COMPLETED|Overall Study||55
327161|NCT01459588|783978|P3|COMPLETED|Overall Study||102
327162|NCT01459588|783979|P2|COMPLETED|Overall Study||49
327163|NCT01459588|783980|P1|COMPLETED|Overall Study||104
327164|NCT01459588|783977|P4|STARTED|Overall Study||56
327165|NCT01459588|783978|P3|STARTED|Overall Study||103
327166|NCT01459588|783979|P2|STARTED|Overall Study||51
327167|NCT01459588|783980|P1|STARTED|Overall Study||105
327168|NCT01459068|784008|P2|NOT COMPLETED|Overall Study||34
327169|NCT01459068|784009|P1|NOT COMPLETED|Overall Study||39
327170|NCT01459068|784008|P2|COMPLETED|Overall Study||148
327171|NCT01459068|784009|P1|COMPLETED|Overall Study||126
327172|NCT01459068|784008|P2|STARTED|Overall Study||182
327173|NCT01459068|784009|P1|STARTED|Overall Study||165
327174|NCT01459016|784025|P1|NOT COMPLETED|Overall Study||15
327175|NCT01459016|784025|P1|COMPLETED|Overall Study||41
327176|NCT01459016|784025|P1|STARTED|Overall Study||56
327177|NCT01458951|784042|P3|NOT COMPLETED|Overall Study||15
327178|NCT01458951|784043|P2|NOT COMPLETED|Overall Study||1
327179|NCT01458951|784044|P1|NOT COMPLETED|Overall Study||32
327180|NCT01458951|784042|P3|COMPLETED|Overall Study||97
327181|NCT01458951|784043|P2|COMPLETED|Overall Study||5
327182|NCT01458951|784044|P1|COMPLETED|Overall Study||397
327183|NCT01458951|784042|P3|STARTED|Overall Study||112
327184|NCT01458951|784043|P2|STARTED|Overall Study||6
327185|NCT01458951|784044|P1|STARTED|Overall Study||429
327186|NCT01458639|784069|P1|NOT COMPLETED|Overall Study||6
327187|NCT01458639|784069|P1|COMPLETED|Overall Study||12
327188|NCT01458639|784069|P1|STARTED|Overall Study||18
327189|NCT01458587|784081|P2|NOT COMPLETED|Overall Study||0
327190|NCT01458587|784082|P1|NOT COMPLETED|Overall Study||1
327191|NCT01458587|784081|P2|COMPLETED|Overall Study||35
327192|NCT01458587|784082|P1|COMPLETED|Overall Study||34
327193|NCT01458587|784081|P2|STARTED|Overall Study||35
327194|NCT01458587|784082|P1|STARTED|Overall Study||35
327195|NCT01458574|784245|P3|NOT COMPLETED|Overall Study||145
327196|NCT01458574|784246|P2|NOT COMPLETED|Overall Study||71
327197|NCT01458574|784247|P1|NOT COMPLETED|Overall Study||87
327198|NCT01458574|784245|P3|COMPLETED|Overall Study||53
327199|NCT01458574|784246|P2|COMPLETED|Overall Study||126
327200|NCT01458574|784247|P1|COMPLETED|Overall Study||111
327201|NCT01458574|784245|P3|Treated|Overall Study||198
327202|NCT01458574|784246|P2|Treated|Overall Study||196
327203|NCT01458574|784247|P1|Treated|Overall Study||198
327204|NCT01458574|784245|P3|STARTED|Overall Study||198
327205|NCT01458574|784246|P2|STARTED|Overall Study||197
327206|NCT01458574|784247|P1|STARTED|Overall Study||198
327207|NCT01458561|784332|P2|NOT COMPLETED|Overall Study||0
327208|NCT01458561|784333|P1|NOT COMPLETED|Overall Study||0
327209|NCT01458561|784332|P2|COMPLETED|Overall Study||1
327210|NCT01458561|784333|P1|COMPLETED|Overall Study||0
327211|NCT01458561|784332|P2|STARTED|Overall Study||1
327212|NCT01458561|784333|P1|STARTED|Overall Study||0
327213|NCT01458535|784377|P6|NOT COMPLETED|Overall Study||4
327214|NCT01458535|784378|P5|NOT COMPLETED|Overall Study||4
327215|NCT01458535|784379|P4|NOT COMPLETED|Overall Study||4
327216|NCT01458535|784380|P3|NOT COMPLETED|Overall Study||2
327217|NCT01458535|784381|P2|NOT COMPLETED|Overall Study||2
327218|NCT01458535|784382|P1|NOT COMPLETED|Overall Study||0
327219|NCT01458535|784377|P6|COMPLETED|Overall Study||7
327220|NCT01458535|784378|P5|COMPLETED|Overall Study||6
327221|NCT01458535|784379|P4|COMPLETED|Overall Study||6
327222|NCT01458535|784380|P3|COMPLETED|Overall Study||8
327223|NCT01458535|784381|P2|COMPLETED|Overall Study||8
327224|NCT01458535|784382|P1|COMPLETED|Overall Study||10
327225|NCT01458535|784377|P6|STARTED|Overall Study||11
327226|NCT01458535|784378|P5|STARTED|Overall Study||10
327227|NCT01458535|784379|P4|STARTED|Overall Study||10
327228|NCT01458535|784380|P3|STARTED|Overall Study||10
327229|NCT01458535|784381|P2|STARTED|Overall Study||10
327230|NCT01458535|784382|P1|STARTED|Overall Study||10
327231|NCT01458288|784432|P1|NOT COMPLETED|Overall Study||0
327232|NCT01458288|784432|P1|COMPLETED|Overall Study||12
327233|NCT01458288|784432|P1|STARTED|Overall Study||12
327234|NCT01458275|784440|P3|NOT COMPLETED|Overall Study||9
327235|NCT01458275|784441|P2|NOT COMPLETED|Overall Study||13
327236|NCT01458275|784442|P1|NOT COMPLETED|Overall Study||14
327237|NCT01458275|784440|P3|COMPLETED|Overall Study||273
327238|NCT01458275|784441|P2|COMPLETED|Overall Study||269
327239|NCT01458275|784442|P1|COMPLETED|Overall Study||269
327240|NCT01458275|784440|P3|STARTED|Overall Study||282
327241|NCT01458275|784441|P2|STARTED|Overall Study||282
327242|NCT01458275|784442|P1|STARTED|Overall Study||283
327243|NCT01458249|784484|P1|NOT COMPLETED|Overall Study||8
327244|NCT01458249|784484|P1|COMPLETED|Overall Study||44
327245|NCT01458249|784484|P1|Participants Treated|Overall Study||51
327246|NCT01458249|784484|P1|STARTED|Overall Study||52
327247|NCT01458210|784503|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
327248|NCT01458210|784503|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
327249|NCT01458210|784503|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
327250|NCT01458210|784503|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
327251|NCT01458210|784503|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
327252|NCT01458210|784503|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
327253|NCT01458210|784503|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
327254|NCT01458210|784503|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
327255|NCT01458210|784503|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
327256|NCT01458210|784503|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
327257|NCT01458171|784520|P1|NOT COMPLETED|Overall Study||1
327258|NCT01458171|784520|P1|COMPLETED|Overall Study||22
327259|NCT01458171|784520|P1|STARTED|Overall Study||23
327260|NCT01458106|784543|P2|NOT COMPLETED|Overall Study||1
327261|NCT01458106|784544|P1|NOT COMPLETED|Overall Study||3
327262|NCT01458106|784543|P2|COMPLETED|Overall Study||34
327263|NCT01458106|784544|P1|COMPLETED|Overall Study||33
327264|NCT01458106|784543|P2|Non-PK Subgroup|Overall Study||0
327265|NCT01458106|784544|P1|Non-PK Subgroup|Overall Study||11
327266|NCT01458106|784543|P2|PK Subgroup|Overall Study||35
327267|NCT01458106|784544|P1|PK Subgroup|Overall Study||25
327268|NCT01458106|784543|P2|STARTED|Overall Study||35
327269|NCT01458106|784544|P1|STARTED|Overall Study||36
327270|NCT01457950|784621|P4|NOT COMPLETED|Open-Label Phase||2
327271|NCT01457950|784622|P3|NOT COMPLETED|Open-Label Phase||2
327272|NCT01457950|784623|P2|NOT COMPLETED|Open-Label Phase||0
327273|NCT01457950|784624|P1|NOT COMPLETED|Open-Label Phase||0
327274|NCT01457950|784621|P4|COMPLETED|Open-Label Phase||61
327275|NCT01457950|784622|P3|COMPLETED|Open-Label Phase||58
327276|NCT01457950|784623|P2|COMPLETED|Open-Label Phase||0
327277|NCT01457950|784624|P1|COMPLETED|Open-Label Phase||0
327278|NCT01457950|784621|P4|STARTED|Open-Label Phase||63
327279|NCT01457950|784622|P3|STARTED|Open-Label Phase||60
327280|NCT01457950|784623|P2|STARTED|Open-Label Phase||0
327281|NCT01457950|784624|P1|STARTED|Open-Label Phase||0
327282|NCT01457950|784621|P4|NOT COMPLETED|Double-Blind Phase||0
327283|NCT01457950|784622|P3|NOT COMPLETED|Double-Blind Phase||0
327284|NCT01457950|784623|P2|NOT COMPLETED|Double-Blind Phase||3
327285|NCT01457950|784624|P1|NOT COMPLETED|Double-Blind Phase||9
327286|NCT01457950|784621|P4|COMPLETED|Double-Blind Phase||0
327287|NCT01457950|784622|P3|COMPLETED|Double-Blind Phase||0
327288|NCT01457950|784623|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
327289|NCT01457950|784624|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
327290|NCT01457950|784621|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
327291|NCT01457950|784622|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
327292|NCT01457950|784623|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
327293|NCT01457950|784624|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
327294|NCT01457950|784621|P4|STARTED|Double-Blind Phase||0
327295|NCT01457950|784622|P3|STARTED|Double-Blind Phase||0
327296|NCT01457950|784623|P2|STARTED|Double-Blind Phase||66
327297|NCT01457950|784624|P1|STARTED|Double-Blind Phase||69
327298|NCT01457885|784698|P1|NOT COMPLETED|Overall Study||0
327299|NCT01457885|784698|P1|COMPLETED|Overall Study||74
327300|NCT01457885|784698|P1|STARTED|Overall Study||74
327301|NCT01457846|784706|P2|NOT COMPLETED|Overall Study||30
327302|NCT01457846|784707|P1|NOT COMPLETED|Overall Study||41
327303|NCT01457846|784706|P2|COMPLETED|Overall Study||0
327304|NCT01457846|784707|P1|COMPLETED|Overall Study||0
327305|NCT01457846|784706|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
327306|NCT01457846|784707|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
327307|NCT01457846|784706|P2|Did Not Receive Treatment|Overall Study||3
327308|NCT01457846|784707|P1|Did Not Receive Treatment|Overall Study||1
327309|NCT01457846|784706|P2|Received Treatment|Overall Study||27
327310|NCT01457846|784707|P1|Received Treatment|Overall Study||40
327311|NCT01457846|784706|P2|STARTED|Overall Study||30
327312|NCT01457846|784707|P1|STARTED|Overall Study||41
327313|NCT01457703|784723|P2|NOT COMPLETED|Overall Study||11
327314|NCT01457703|784724|P1|NOT COMPLETED|Overall Study||6
327315|NCT01457703|784723|P2|COMPLETED|Overall Study||22
327316|NCT01457703|784724|P1|COMPLETED|Overall Study||23
327317|NCT01457703|784723|P2|STARTED|Overall Study||33
327318|NCT01457703|784724|P1|STARTED|Overall Study||29
327319|NCT01457521|784740|P2|NOT COMPLETED|Overall Study||10
327320|NCT01457521|784741|P1|NOT COMPLETED|Overall Study||12
327321|NCT01457521|784740|P2|COMPLETED|Overall Study||117
327322|NCT01457521|784741|P1|COMPLETED|Overall Study||111
327323|NCT01457521|784740|P2|STARTED|Overall Study||127
327324|NCT01457521|784741|P1|STARTED|Overall Study||123
327325|NCT01457430|784747|P1|NOT COMPLETED|Overall Study||0
327326|NCT01457430|784747|P1|COMPLETED|Overall Study||19
327327|NCT01457430|784747|P1|STARTED|Overall Study||19
327328|NCT01457417|784759|P5|NOT COMPLETED|Overall Study||0
327329|NCT01457417|784760|P4|NOT COMPLETED|Overall Study||0
327330|NCT01457417|784761|P3|NOT COMPLETED|Overall Study||0
327331|NCT01457417|784762|P2|NOT COMPLETED|Overall Study||0
327332|NCT01457417|784763|P1|NOT COMPLETED|Overall Study||0
327333|NCT01457417|784759|P5|COMPLETED|Overall Study||19
327334|NCT01457417|784760|P4|COMPLETED|Overall Study||3
327335|NCT01457417|784761|P3|COMPLETED|Overall Study||4
327336|NCT01457417|784762|P2|COMPLETED|Overall Study||3
327337|NCT01457417|784763|P1|COMPLETED|Overall Study||3
327338|NCT01457417|784759|P5|STARTED|Overall Study||19
327339|NCT01457417|784760|P4|STARTED|Overall Study||3
327340|NCT01457417|784761|P3|STARTED|Overall Study||4
327341|NCT01457417|784762|P2|STARTED|Overall Study||3
327342|NCT01457417|784763|P1|STARTED|Overall Study||3
327343|NCT01457339|784821|P2|NOT COMPLETED|Period 6 (250 mg)||1
327344|NCT01457339|784822|P1|NOT COMPLETED|Period 6 (250 mg)||1
327345|NCT01457339|784821|P2|COMPLETED|Period 6 (250 mg)||21
327346|NCT01457339|784822|P1|COMPLETED|Period 6 (250 mg)||6
327347|NCT01457339|784821|P2|STARTED|Period 6 (250 mg)||22
327348|NCT01457339|784822|P1|STARTED|Period 6 (250 mg)||7
327349|NCT01457339|784821|P2|NOT COMPLETED|Period 5 (200 mg)||1
327350|NCT01457339|784822|P1|NOT COMPLETED|Period 5 (200 mg)||0
327351|NCT01457339|784821|P2|COMPLETED|Period 5 (200 mg)||22
327352|NCT01457339|784822|P1|COMPLETED|Period 5 (200 mg)||7
327353|NCT01457339|784821|P2|STARTED|Period 5 (200 mg)||23
327354|NCT01457339|784822|P1|STARTED|Period 5 (200 mg)||7
327355|NCT01457339|784821|P2|NOT COMPLETED|Period 4 (150 mg)||0
327356|NCT01457339|784822|P1|NOT COMPLETED|Period 4 (150 mg)||0
327357|NCT01457339|784821|P2|COMPLETED|Period 4 (150 mg)||23
327358|NCT01457339|784822|P1|COMPLETED|Period 4 (150 mg)||7
327359|NCT01457339|784821|P2|STARTED|Period 4 (150 mg)||23
327360|NCT01457339|784822|P1|STARTED|Period 4 (150 mg)||7
327361|NCT01457339|784821|P2|NOT COMPLETED|Period 3 (100 mg)||1
327362|NCT01457339|784822|P1|NOT COMPLETED|Period 3 (100 mg)||0
327363|NCT01457339|784821|P2|COMPLETED|Period 3 (100 mg)||23
327364|NCT01457339|784822|P1|COMPLETED|Period 3 (100 mg)||7
327365|NCT01457339|784821|P2|STARTED|Period 3 (100 mg)||24
327366|NCT01457339|784822|P1|STARTED|Period 3 (100 mg)||7
327367|NCT01457339|784821|P2|NOT COMPLETED|Period 2 (70 mg)||0
327368|NCT01457339|784822|P1|NOT COMPLETED|Period 2 (70 mg)||0
327369|NCT01457339|784821|P2|COMPLETED|Period 2 (70 mg)||24
327370|NCT01457339|784822|P1|COMPLETED|Period 2 (70 mg)||7
327371|NCT01457339|784821|P2|STARTED|Period 2 (70 mg)||24
327372|NCT01457339|784822|P1|STARTED|Period 2 (70 mg)||7
327373|NCT01457339|784821|P2|NOT COMPLETED|Period 1 (50 mg)||0
327374|NCT01457339|784822|P1|NOT COMPLETED|Period 1 (50 mg)||0
327375|NCT01457339|784821|P2|COMPLETED|Period 1 (50 mg)||24
327376|NCT01457339|784822|P1|COMPLETED|Period 1 (50 mg)||7
327377|NCT01457339|784821|P2|STARTED|Period 1 (50 mg)||24
327378|NCT01457339|784822|P1|STARTED|Period 1 (50 mg)||7
327379|NCT01457053|784988|P2|NOT COMPLETED|Overall Study||1
327380|NCT01457053|784989|P1|NOT COMPLETED|Overall Study||1
327381|NCT01457053|784988|P2|COMPLETED|Overall Study||1
327382|NCT01457053|784989|P1|COMPLETED|Overall Study||1
327383|NCT01457053|784988|P2|STARTED|Overall Study||2
327384|NCT01457053|784989|P1|STARTED|Overall Study||2
327385|NCT01457014|784995|P4|NOT COMPLETED|Fourth Night||0
327386|NCT01457014|784996|P3|NOT COMPLETED|Fourth Night||0
327387|NCT01457014|784997|P2|NOT COMPLETED|Fourth Night||0
327388|NCT01457014|784998|P1|NOT COMPLETED|Fourth Night||0
327389|NCT01457014|784995|P4|COMPLETED|Fourth Night||11
327390|NCT01457014|784996|P3|COMPLETED|Fourth Night||12
327391|NCT01457014|784997|P2|COMPLETED|Fourth Night||11
327392|NCT01457014|784998|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
327393|NCT01457014|784995|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
327394|NCT01457014|784996|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
327395|NCT01457014|784997|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
327396|NCT01457014|784998|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
327397|NCT01457014|784995|P4|NOT COMPLETED|Third Night||0
327398|NCT01457014|784996|P3|NOT COMPLETED|Third Night||0
327399|NCT01457014|784997|P2|NOT COMPLETED|Third Night||0
327400|NCT01457014|784998|P1|NOT COMPLETED|Third Night||0
327401|NCT01457014|784995|P4|COMPLETED|Third Night||12
327402|NCT01457014|784996|P3|COMPLETED|Third Night||11
327403|NCT01457014|784997|P2|COMPLETED|Third Night||11
327404|NCT01457014|784998|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
327405|NCT01457014|784995|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
327406|NCT01457014|784996|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
327407|NCT01457014|784997|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
327408|NCT01457014|784998|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
327409|NCT01457014|784995|P4|NOT COMPLETED|Second Night||0
327410|NCT01457014|784996|P3|NOT COMPLETED|Second Night||0
327411|NCT01457014|784997|P2|NOT COMPLETED|Second Night||0
327412|NCT01457014|784998|P1|NOT COMPLETED|Second Night||0
327413|NCT01457014|784995|P4|COMPLETED|Second Night||11
327414|NCT01457014|784996|P3|COMPLETED|Second Night||11
327415|NCT01457014|784997|P2|COMPLETED|Second Night||12
327416|NCT01457014|784998|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
327417|NCT01457014|784995|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
327418|NCT01457014|784996|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
327419|NCT01457014|784997|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
327420|NCT01457014|784998|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
327421|NCT01457014|784995|P4|NOT COMPLETED|First Night||0
327422|NCT01457014|784996|P3|NOT COMPLETED|First Night||0
327423|NCT01457014|784997|P2|NOT COMPLETED|First Night||0
327424|NCT01457014|784998|P1|NOT COMPLETED|First Night||40
327425|NCT01457014|784995|P4|COMPLETED|First Night||0
327426|NCT01457014|784996|P3|COMPLETED|First Night||0
327427|NCT01457014|784997|P2|COMPLETED|First Night||0
327428|NCT01457014|784998|P1|COMPLETED|First Night||34
327429|NCT01457014|784995|P4|STARTED|First Night||0
327430|NCT01457014|784996|P3|STARTED|First Night||0
327431|NCT01457014|784997|P2|STARTED|First Night||0
327432|NCT01457014|784998|P1|STARTED|First Night||74
327433|NCT01456962|785015|P2|NOT COMPLETED|Overall Study||1
327434|NCT01456962|785016|P1|NOT COMPLETED|Overall Study||2
327435|NCT01456962|785015|P2|COMPLETED|Overall Study||19
327436|NCT01456962|785016|P1|COMPLETED|Overall Study||14
327437|NCT01456962|785015|P2|STARTED|Overall Study||20
327438|NCT01456962|785016|P1|STARTED|Overall Study||16
327439|NCT01456936|785026|P4|NOT COMPLETED|Overall Study||483
327440|NCT01456936|785027|P3|NOT COMPLETED|Overall Study||481
327441|NCT01456936|785028|P2|NOT COMPLETED|Overall Study||448
327442|NCT01456936|785029|P1|NOT COMPLETED|Overall Study||439
327443|NCT01456936|785026|P4|COMPLETED|Overall Study||1552
327444|NCT01456936|785027|P3|COMPLETED|Overall Study||1557
327445|NCT01456936|785028|P2|COMPLETED|Overall Study||1586
327446|NCT01456936|785029|P1|COMPLETED|Overall Study||1598
327447|NCT01456936|785026|P4|Randomized and Treated|Overall Study||2014
327448|NCT01456936|785027|P3|Randomized and Treated|Overall Study||2022
327449|NCT01456936|785028|P2|Randomized and Treated|Overall Study||2006
327450|NCT01456936|785029|P1|Randomized and Treated|Overall Study||2016
327451|NCT01456936|785026|P4|STARTED|Overall Study||2035
327452|NCT01456936|785027|P3|STARTED|Overall Study||2038
327453|NCT01456936|785028|P2|STARTED|Overall Study||2034
327454|NCT01456936|785029|P1|STARTED|Overall Study||2037
327455|NCT01456299|785138|P3|NOT COMPLETED|Overall Study||1
327456|NCT01456299|785139|P2|NOT COMPLETED|Overall Study||1
327457|NCT01456299|785140|P1|NOT COMPLETED|Overall Study||0
327458|NCT01456299|785138|P3|COMPLETED|Overall Study||33
327459|NCT01456299|785139|P2|COMPLETED|Overall Study||33
327460|NCT01456299|785140|P1|COMPLETED|Overall Study||34
327461|NCT01456299|785138|P3|STARTED|Overall Study||34
327462|NCT01456299|785139|P2|STARTED|Overall Study||34
327463|NCT01456299|785140|P1|STARTED|Overall Study||34
327464|NCT01456195|785151|P3|NOT COMPLETED|Overall Study||14
327465|NCT01456195|785152|P2|NOT COMPLETED|Overall Study||10
327466|NCT01456195|785153|P1|NOT COMPLETED|Overall Study||11
327467|NCT01456195|785151|P3|COMPLETED|Overall Study||127
327468|NCT01456195|785152|P2|COMPLETED|Overall Study||127
327469|NCT01456195|785153|P1|COMPLETED|Overall Study||132
327470|NCT01456195|785151|P3|STARTED|Overall Study||141
327471|NCT01456195|785152|P2|STARTED|Overall Study||137
327472|NCT01456195|785153|P1|STARTED|Overall Study||143
327473|NCT01456169|785173|P3|NOT COMPLETED|Overall Study||12
327474|NCT01456169|785174|P2|NOT COMPLETED|Overall Study||5
327475|NCT01456169|785175|P1|NOT COMPLETED|Overall Study||10
327476|NCT01456169|785173|P3|COMPLETED|Overall Study||123
327477|NCT01456169|785174|P2|COMPLETED|Overall Study||122
327478|NCT01456169|785175|P1|COMPLETED|Overall Study||123
327479|NCT01456169|785173|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
327480|NCT01456169|785174|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
327481|NCT01456169|785175|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
327482|NCT01456143|785226|P1|NOT COMPLETED|Overall Study||0
327483|NCT01456143|785226|P1|COMPLETED|Overall Study||33
327484|NCT01456143|785226|P1|STARTED|Overall Study||33
327485|NCT01456130|785235|P1|NOT COMPLETED|Overall Study||10
327486|NCT01456130|785235|P1|COMPLETED|Overall Study||57
327487|NCT01456130|785235|P1|STARTED|Overall Study||67
327488|NCT01456052|785245|P3|NOT COMPLETED|Overall Study||5
327489|NCT01456052|785246|P2|NOT COMPLETED|Overall Study||5
327490|NCT01456052|785247|P1|NOT COMPLETED|Overall Study||2
327491|NCT01456052|785245|P3|COMPLETED|Overall Study||19
327492|NCT01456052|785246|P2|COMPLETED|Overall Study||20
327493|NCT01456052|785247|P1|COMPLETED|Overall Study||8
327494|NCT01456052|785245|P3|STARTED|Overall Study||24
327495|NCT01456052|785246|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
327496|NCT01456052|785247|P1|STARTED|Overall Study||10
327497|NCT01456039|785267|P3|NOT COMPLETED|Phase 2 (Second Step)||33
327498|NCT01456039|785268|P2|NOT COMPLETED|Phase 2 (Second Step)||0
327499|NCT01456039|785269|P1|NOT COMPLETED|Phase 2 (Second Step)||0
327500|NCT01456039|785267|P3|COMPLETED|Phase 2 (Second Step)||7
327501|NCT01456039|785268|P2|COMPLETED|Phase 2 (Second Step)||0
327502|NCT01456039|785269|P1|COMPLETED|Phase 2 (Second Step)||0
327503|NCT01456039|785267|P3|STARTED|Phase 2 (Second Step)||40
327504|NCT01456039|785268|P2|STARTED|Phase 2 (Second Step)||0
327505|NCT01456039|785269|P1|STARTED|Phase 2 (Second Step)||0
327506|NCT01456039|785267|P3|NOT COMPLETED|Phase 1 (First Step)||0
327507|NCT01456039|785268|P2|NOT COMPLETED|Phase 1 (First Step)||7
327508|NCT01456039|785269|P1|NOT COMPLETED|Phase 1 (First Step)||2
327509|NCT01456039|785267|P3|COMPLETED|Phase 1 (First Step)||0
327510|NCT01456039|785268|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
327511|NCT01456039|785269|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
327512|NCT01456039|785267|P3|STARTED|Phase 1 (First Step)||0
327513|NCT01456039|785268|P2|STARTED|Phase 1 (First Step)||8
327514|NCT01456039|785269|P1|STARTED|Phase 1 (First Step)||3
327515|NCT01456000|785341|P2|NOT COMPLETED|Overall Study||3
327516|NCT01456000|785342|P1|NOT COMPLETED|Overall Study||8
327517|NCT01456000|785341|P2|COMPLETED|Overall Study||172
327518|NCT01456000|785342|P1|COMPLETED|Overall Study||170
327519|NCT01456000|785341|P2|STARTED|Overall Study||175
327520|NCT01456000|785342|P1|STARTED|Overall Study||178
327521|NCT01455545|785348|P2|NOT COMPLETED|Overall Study||0
327522|NCT01455545|785349|P1|NOT COMPLETED|Overall Study||0
327523|NCT01455545|785348|P2|COMPLETED|Overall Study||45
327524|NCT01455545|785349|P1|COMPLETED|Overall Study||55
327525|NCT01455545|785348|P2|STARTED|Overall Study||45
327526|NCT01455545|785349|P1|STARTED|Overall Study||55
327527|NCT01455519|785379|P2|NOT COMPLETED|Overall Study||5
327528|NCT01455519|785380|P1|NOT COMPLETED|Overall Study||4
327529|NCT01455519|785379|P2|COMPLETED|Overall Study||18
327530|NCT01455519|785380|P1|COMPLETED|Overall Study||8
327531|NCT01455519|785379|P2|STARTED|Overall Study||23
327532|NCT01455519|785380|P1|STARTED|Overall Study||12
327533|NCT01455428|785412|P2|NOT COMPLETED|Overall Study||18
327534|NCT01455428|785413|P1|NOT COMPLETED|Overall Study||14
327535|NCT01455428|785412|P2|COMPLETED|Overall Study||92
327536|NCT01455428|785413|P1|COMPLETED|Overall Study||98
327537|NCT01455428|785412|P2|Treated|Overall Study||109
327538|NCT01455428|785413|P1|Treated|Overall Study||111
327539|NCT01455428|785412|P2|STARTED|Overall Study||110
327540|NCT01455428|785413|P1|STARTED|Overall Study||112
327541|NCT01455415|785469|P2|NOT COMPLETED|Follow-up||2
327542|NCT01455415|785470|P1|NOT COMPLETED|Follow-up||3
327543|NCT01455415|785469|P2|COMPLETED|Follow-up||104
327544|NCT01455415|785470|P1|COMPLETED|Follow-up||111
327545|NCT01455415|785469|P2|STARTED|Follow-up||106
327546|NCT01455415|785470|P1|STARTED|Follow-up||114
327547|NCT01455415|785469|P2|NOT COMPLETED|Period 2||10
327548|NCT01455415|785470|P1|NOT COMPLETED|Period 2||13
327549|NCT01455415|785469|P2|COMPLETED|Period 2||106
327550|NCT01455415|785470|P1|COMPLETED|Period 2||114
327551|NCT01455415|785469|P2|STARTED|Period 2||116
327552|NCT01455415|785470|P1|STARTED|Period 2||127
327553|NCT01455415|785469|P2|NOT COMPLETED|Washout||7
327554|NCT01455415|785470|P1|NOT COMPLETED|Washout||8
327555|NCT01455415|785469|P2|COMPLETED|Washout||116
327556|NCT01455415|785470|P1|COMPLETED|Washout||127
327557|NCT01455415|785469|P2|STARTED|Washout||123
327558|NCT01455415|785470|P1|STARTED|Washout||135
327559|NCT01455415|785469|P2|NOT COMPLETED|Period 1||24
327560|NCT01455415|785470|P1|NOT COMPLETED|Period 1||19
327561|NCT01455415|785469|P2|COMPLETED|Period 1||123
327562|NCT01455415|785470|P1|COMPLETED|Period 1||135
327563|NCT01455415|785469|P2|STARTED|Period 1|Started=Treated|147
327564|NCT01455415|785470|P1|STARTED|Period 1|Started=Treated|154
327565|NCT01455220|785520|P1|NOT COMPLETED|Overall Study||30
327566|NCT01455220|785520|P1|COMPLETED|Overall Study||15
327567|NCT01455220|785520|P1|STARTED|Overall Study||45
327568|NCT01455194|785530|P4|NOT COMPLETED|Overall Study||28
327569|NCT01455194|785531|P3|NOT COMPLETED|Overall Study||30
327570|NCT01455194|785532|P2|NOT COMPLETED|Overall Study||31
327571|NCT01455194|785533|P1|NOT COMPLETED|Overall Study||153
327572|NCT01455194|785530|P4|COMPLETED|Overall Study||97
327573|NCT01455194|785531|P3|COMPLETED|Overall Study||92
327574|NCT01455194|785532|P2|COMPLETED|Overall Study||89
327575|NCT01455194|785533|P1|COMPLETED|Overall Study||0
327576|NCT01455194|785530|P4|STARTED|Overall Study||125
327577|NCT01455194|785531|P3|STARTED|Overall Study||122
327578|NCT01455194|785532|P2|STARTED|Overall Study||120
327579|NCT01455194|785533|P1|STARTED|Overall Study||153
327580|NCT01455181|785582|P1|NOT COMPLETED|Overall Study||0
327581|NCT01455181|785582|P1|COMPLETED|Overall Study||24
327582|NCT01455181|785582|P1|STARTED|Overall Study||24
327583|NCT01455064|785590|P1|NOT COMPLETED|Overall Study||1
327584|NCT01455064|785590|P1|COMPLETED|Overall Study||30
327585|NCT01455064|785590|P1|STARTED|Overall Study||31
327586|NCT01455012|785596|P2|NOT COMPLETED|Overall Study||4
327587|NCT01455012|785597|P1|NOT COMPLETED|Overall Study||11
327588|NCT01455012|785596|P2|COMPLETED|Overall Study||36
327589|NCT01455012|785597|P1|COMPLETED|Overall Study||30
327590|NCT01455012|785596|P2|STARTED|Overall Study||40
327591|NCT01455012|785597|P1|STARTED|Overall Study||41
327592|NCT01454934|785631|P2|NOT COMPLETED|Overall Study||270
327593|NCT01454934|785632|P1|NOT COMPLETED|Overall Study||270
327594|NCT01454934|785631|P2|COMPLETED|Overall Study||0
327595|NCT01454934|785632|P1|COMPLETED|Overall Study||0
327596|NCT01454934|785631|P2|STARTED|Overall Study||270
327597|NCT01454934|785632|P1|STARTED|Overall Study||270
327598|NCT01454830|785644|P2|NOT COMPLETED|Overall Study||27
327599|NCT01454830|785645|P1|NOT COMPLETED|Overall Study||31
327600|NCT01454830|785644|P2|COMPLETED|Overall Study||30
327601|NCT01454830|785645|P1|COMPLETED|Overall Study||30
327602|NCT01454830|785644|P2|STARTED|Overall Study||57
327603|NCT01454830|785645|P1|STARTED|Overall Study||61
327604|NCT01454791|785665|P2|NOT COMPLETED|Overall Study||0
327605|NCT01454791|785666|P1|NOT COMPLETED|Overall Study||0
327606|NCT01454791|785665|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
327607|NCT01454791|785666|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
327608|NCT01454791|785665|P2|STARTED|Overall Study||20
327609|NCT01454791|785666|P1|STARTED|Overall Study||20
327610|NCT01454778|785676|P1|NOT COMPLETED|Overall Study||3
327611|NCT01454778|785676|P1|COMPLETED|Overall Study||47
327612|NCT01454778|785676|P1|STARTED|Overall Study||50
327613|NCT01454726|785687|P2|NOT COMPLETED|Overall Study||1
327614|NCT01454726|785688|P1|NOT COMPLETED|Overall Study||0
327615|NCT01454726|785687|P2|COMPLETED|Overall Study||10
327616|NCT01454726|785688|P1|COMPLETED|Overall Study||16
327617|NCT01454726|785687|P2|STARTED|Overall Study||11
327618|NCT01454726|785688|P1|STARTED|Overall Study||16
327619|NCT01454583|785697|P3|NOT COMPLETED|3rd Year||297
327620|NCT01454583|785698|P2|NOT COMPLETED|3rd Year||512
327621|NCT01454583|785699|P1|NOT COMPLETED|3rd Year||1959
327622|NCT01454583|785697|P3|COMPLETED|3rd Year||285
327623|NCT01454583|785698|P2|COMPLETED|3rd Year||470
327624|NCT01454583|785699|P1|COMPLETED|3rd Year||1832
327625|NCT01454583|785697|P3|STARTED|3rd Year||582
327626|NCT01454583|785698|P2|STARTED|3rd Year||982
327627|NCT01454583|785699|P1|STARTED|3rd Year||3791
327628|NCT01454583|785697|P3|NOT COMPLETED|2nd Year||737
327629|NCT01454583|785698|P2|NOT COMPLETED|2nd Year||1049
327630|NCT01454583|785699|P1|NOT COMPLETED|2nd Year||3965
327631|NCT01454583|785697|P3|COMPLETED|2nd Year||1376
327632|NCT01454583|785698|P2|COMPLETED|2nd Year||1647
327633|NCT01454583|785699|P1|COMPLETED|2nd Year||6212
327634|NCT01454583|785697|P3|STARTED|2nd Year||2113
327635|NCT01454583|785698|P2|STARTED|2nd Year||2696
327636|NCT01454583|785699|P1|STARTED|2nd Year||10177
327637|NCT01454583|785697|P3|NOT COMPLETED|1st Year||180
327638|NCT01454583|785698|P2|NOT COMPLETED|1st Year||318
327639|NCT01454583|785699|P1|NOT COMPLETED|1st Year||1057
327640|NCT01454583|785697|P3|COMPLETED|1st Year||1933
327641|NCT01454583|785698|P2|COMPLETED|1st Year||2378
327642|NCT01454583|785699|P1|COMPLETED|1st Year||9120
327643|NCT01454583|785697|P3|STARTED|1st Year||2113
327644|NCT01454583|785698|P2|STARTED|1st Year||2696
327645|NCT01454583|785699|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
327646|NCT01454531|785767|P1|NOT COMPLETED|Overall Study||23
327647|NCT01454531|785767|P1|COMPLETED|Overall Study||173
327648|NCT01454531|785767|P1|Subjects Treated|Overall Study||192
327649|NCT01454531|785767|P1|STARTED|Overall Study||196
327650|NCT01454505|785779|P4|NOT COMPLETED|Overall Study||0
327651|NCT01454505|785780|P3|NOT COMPLETED|Overall Study||0
327652|NCT01454505|785781|P2|NOT COMPLETED|Overall Study||0
327653|NCT01454505|785782|P1|NOT COMPLETED|Overall Study||0
327654|NCT01454505|785779|P4|COMPLETED|Overall Study||20
327655|NCT01454505|785780|P3|COMPLETED|Overall Study||40
327656|NCT01454505|785781|P2|COMPLETED|Overall Study||15
327657|NCT01454505|785782|P1|COMPLETED|Overall Study||35
327658|NCT01454505|785779|P4|STARTED|Overall Study||20
327659|NCT01454505|785780|P3|STARTED|Overall Study||40
327660|NCT01454505|785781|P2|STARTED|Overall Study||15
327661|NCT01454505|785782|P1|STARTED|Overall Study||35
327662|NCT01454414|785796|P2|NOT COMPLETED|Overall Study||16
327663|NCT01454414|785797|P1|NOT COMPLETED|Overall Study||13
327664|NCT01454414|785796|P2|COMPLETED|Overall Study||64
327665|NCT01454414|785797|P1|COMPLETED|Overall Study||66
327666|NCT01454414|785796|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
327667|NCT01454414|785797|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
327668|NCT01454414|785796|P2|STARTED|Overall Study||80
327669|NCT01454414|785797|P1|STARTED|Overall Study||79
327670|NCT01454401|785803|P1|NOT COMPLETED|Overall Study||5
327671|NCT01454401|785803|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
327672|NCT01454401|785803|P1|STARTED|Overall Study|ITT|44
327673|NCT01454258|785808|P1|NOT COMPLETED|Overall Study||997
327674|NCT01454258|785808|P1|COMPLETED|Overall Study||9103
327675|NCT01454258|785808|P1|STARTED|Overall Study||10100
327676|NCT01454063|785816|P2|NOT COMPLETED|Treated||0
327677|NCT01454063|785817|P1|NOT COMPLETED|Treated||2
327678|NCT01454063|785816|P2|COMPLETED|Treated||201
327679|NCT01454063|785817|P1|COMPLETED|Treated||199
327680|NCT01454063|785816|P2|STARTED|Treated||201
327681|NCT01454063|785817|P1|STARTED|Treated||201
327682|NCT01454063|785816|P2|NOT COMPLETED|Randomized||2
327683|NCT01454063|785817|P1|NOT COMPLETED|Randomized||1
327684|NCT01454063|785816|P2|COMPLETED|Randomized||201
327685|NCT01454063|785817|P1|COMPLETED|Randomized||201
327686|NCT01454063|785816|P2|STARTED|Randomized||203
327687|NCT01454063|785817|P1|STARTED|Randomized||202
327688|NCT01453998|785838|P3|NOT COMPLETED|After Protocol Amendment 2.||0
327689|NCT01453998|785839|P2|NOT COMPLETED|After Protocol Amendment 2.||0
327690|NCT01453998|785840|P1|NOT COMPLETED|After Protocol Amendment 2.||1
327691|NCT01453998|785838|P3|COMPLETED|After Protocol Amendment 2.||183
327692|NCT01453998|785839|P2|COMPLETED|After Protocol Amendment 2.||99
327693|NCT01453998|785840|P1|COMPLETED|After Protocol Amendment 2.||102
327694|NCT01453998|785838|P3|STARTED|After Protocol Amendment 2.||183
327695|NCT01453998|785839|P2|STARTED|After Protocol Amendment 2.||99
327696|NCT01453998|785840|P1|STARTED|After Protocol Amendment 2.||103
327697|NCT01453998|785838|P3|NOT COMPLETED|Before Protocol Amendment 2||0
327698|NCT01453998|785839|P2|NOT COMPLETED|Before Protocol Amendment 2||0
327699|NCT01453998|785840|P1|NOT COMPLETED|Before Protocol Amendment 2||0
327700|NCT01453998|785838|P3|COMPLETED|Before Protocol Amendment 2||99
327701|NCT01453998|785839|P2|COMPLETED|Before Protocol Amendment 2||88
327702|NCT01453998|785840|P1|COMPLETED|Before Protocol Amendment 2||85
327703|NCT01453998|785838|P3|STARTED|Before Protocol Amendment 2||99
327704|NCT01453998|785839|P2|STARTED|Before Protocol Amendment 2||88
327705|NCT01453998|785840|P1|STARTED|Before Protocol Amendment 2||85
327706|NCT01453946|785905|P1|NOT COMPLETED|Overall Study||9
327707|NCT01453946|785905|P1|COMPLETED|Overall Study||41
327708|NCT01453946|785905|P1|STARTED|Overall Study||50
327709|NCT01453894|785913|P2|NOT COMPLETED|Overall Study||0
327710|NCT01453894|785914|P1|NOT COMPLETED|Overall Study||0
327711|NCT01453894|785913|P2|COMPLETED|Overall Study||225
327712|NCT01453894|785914|P1|COMPLETED|Overall Study||225
327713|NCT01453894|785913|P2|STARTED|Overall Study||225
327714|NCT01453894|785914|P1|STARTED|Overall Study||225
327715|NCT01453855|785922|P2|NOT COMPLETED|Overall Study||14
327716|NCT01453855|785923|P1|NOT COMPLETED|Overall Study||10
327717|NCT01453855|785922|P2|COMPLETED|Overall Study||408
327718|NCT01453855|785923|P1|COMPLETED|Overall Study||432
327719|NCT01453855|785922|P2|STARTED|Overall Study||422
327720|NCT01453855|785923|P1|STARTED|Overall Study||442
327721|NCT01453725|785931|P2|NOT COMPLETED|Overall Study||11
327722|NCT01453725|785932|P1|NOT COMPLETED|Overall Study||13
327723|NCT01453725|785931|P2|COMPLETED|Overall Study||89
327724|NCT01453725|785932|P1|COMPLETED|Overall Study||85
327725|NCT01453725|785931|P2|STARTED|Overall Study||100
327726|NCT01453725|785932|P1|STARTED|Overall Study||98
327727|NCT01452529|785954|P3|NOT COMPLETED|Double-blind (DB) Period||82
327728|NCT01452529|785955|P2|NOT COMPLETED|Double-blind (DB) Period||67
327729|NCT01452529|785956|P1|NOT COMPLETED|Double-blind (DB) Period||0
327730|NCT01452529|785954|P3|COMPLETED|Double-blind (DB) Period||210
327731|NCT01452529|785955|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
327732|NCT01452529|785956|P1|COMPLETED|Double-blind (DB) Period||0
327733|NCT01452529|785954|P3|STARTED|Double-blind (DB) Period||292
327734|NCT01452529|785955|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
327735|NCT01452529|785956|P1|STARTED|Double-blind (DB) Period||0
327736|NCT01452529|785954|P3|NOT COMPLETED|Run-in Period||0
327737|NCT01452529|785955|P2|NOT COMPLETED|Run-in Period||0
327738|NCT01452529|785956|P1|NOT COMPLETED|Run-in Period||313
327739|NCT01452529|785954|P3|COMPLETED|Run-in Period||0
327740|NCT01452529|785955|P2|COMPLETED|Run-in Period||0
327741|NCT01452529|785956|P1|COMPLETED|Run-in Period||592
327742|NCT01452529|785954|P3|STARTED|Run-in Period||0
327743|NCT01452529|785955|P2|STARTED|Run-in Period||0
327744|NCT01452529|785956|P1|STARTED|Run-in Period||905
327745|NCT01453595|785966|P3|NOT COMPLETED|Overall Study||2
327746|NCT01453595|785967|P2|NOT COMPLETED|Overall Study||1
327747|NCT01453595|785968|P1|NOT COMPLETED|Overall Study||2
327748|NCT01453595|785966|P3|COMPLETED|Overall Study||0
327749|NCT01453595|785967|P2|COMPLETED|Overall Study||5
327750|NCT01453595|785968|P1|COMPLETED|Overall Study||0
327751|NCT01453595|785966|P3|STARTED|Overall Study||2
327752|NCT01453595|785967|P2|STARTED|Overall Study||6
327753|NCT01453595|785968|P1|STARTED|Overall Study||2
327754|NCT01453569|785977|P3|NOT COMPLETED|Overall Study||7
327755|NCT01453569|785978|P2|NOT COMPLETED|Overall Study||14
327756|NCT01453569|785979|P1|NOT COMPLETED|Overall Study||11
327757|NCT01453569|785977|P3|COMPLETED|Overall Study||78
327758|NCT01453569|785978|P2|COMPLETED|Overall Study||70
327759|NCT01453569|785979|P1|COMPLETED|Overall Study||75
327760|NCT01453569|785977|P3|STARTED|Overall Study||85
327761|NCT01453569|785978|P2|STARTED|Overall Study||84
327762|NCT01453569|785979|P1|STARTED|Overall Study||86
327763|NCT01453413|785996|P1|NOT COMPLETED|Overall Study||0
327764|NCT01453413|785996|P1|COMPLETED|Overall Study||297
327765|NCT01453413|785996|P1|STARTED|Overall Study||297
327766|NCT01453387|786003|P2|NOT COMPLETED|Overall Study||0
327767|NCT01453387|786004|P1|NOT COMPLETED|Overall Study||0
327768|NCT01453387|786003|P2|COMPLETED|Overall Study||7
327769|NCT01453387|786004|P1|COMPLETED|Overall Study||21
327770|NCT01453387|786003|P2|STARTED|Overall Study||7
327771|NCT01453387|786004|P1|STARTED|Overall Study||21
327772|NCT01453374|786087|P1|NOT COMPLETED|Overall Study||18
327773|NCT01453374|786087|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
327774|NCT01453374|786087|P1|STARTED|Overall Study||27
327775|NCT01453348|786106|P3|NOT COMPLETED|Overall Study||1
327776|NCT01453348|786107|P2|NOT COMPLETED|Overall Study||1
327777|NCT01453348|786108|P1|NOT COMPLETED|Overall Study||1
327778|NCT01453348|786106|P3|COMPLETED|Overall Study||83
327779|NCT01453348|786107|P2|COMPLETED|Overall Study||83
327780|NCT01453348|786108|P1|COMPLETED|Overall Study||83
327781|NCT01453348|786106|P3|STARTED|Overall Study||84
327782|NCT01453348|786107|P2|STARTED|Overall Study||84
327783|NCT01453348|786108|P1|STARTED|Overall Study||84
327784|NCT01453296|786124|P2|NOT COMPLETED|Treatment Period 2||0
327785|NCT01453296|786125|P1|NOT COMPLETED|Treatment Period 2||2
327786|NCT01453296|786124|P2|COMPLETED|Treatment Period 2||13
327787|NCT01453296|786125|P1|COMPLETED|Treatment Period 2||11
327788|NCT01453296|786124|P2|STARTED|Treatment Period 2||13
327789|NCT01453296|786125|P1|STARTED|Treatment Period 2||13
327790|NCT01453296|786124|P2|NOT COMPLETED|Washout Period||0
327791|NCT01453296|786125|P1|NOT COMPLETED|Washout Period||0
327792|NCT01453296|786124|P2|COMPLETED|Washout Period||13
327793|NCT01453296|786125|P1|COMPLETED|Washout Period||13
327794|NCT01453296|786124|P2|STARTED|Washout Period||13
327795|NCT01453296|786125|P1|STARTED|Washout Period||13
327796|NCT01453296|786124|P2|NOT COMPLETED|Treatment Period 1||1
327797|NCT01453296|786125|P1|NOT COMPLETED|Treatment Period 1||1
327798|NCT01453296|786124|P2|COMPLETED|Treatment Period 1||13
327799|NCT01453296|786125|P1|COMPLETED|Treatment Period 1||13
327800|NCT01453296|786124|P2|STARTED|Treatment Period 1||14
327801|NCT01453296|786125|P1|STARTED|Treatment Period 1||14
327802|NCT01453166|786192|P3|NOT COMPLETED|Overall Study||1
327803|NCT01453166|786193|P2|NOT COMPLETED|Overall Study||2
327804|NCT01453166|786194|P1|NOT COMPLETED|Overall Study||2
327805|NCT01453166|786192|P3|COMPLETED|Overall Study||38
327806|NCT01453166|786193|P2|COMPLETED|Overall Study||39
327807|NCT01453166|786194|P1|COMPLETED|Overall Study||40
327808|NCT01453166|786192|P3|STARTED|Overall Study||39
327809|NCT01453166|786193|P2|STARTED|Overall Study||41
327810|NCT01453166|786194|P1|STARTED|Overall Study||42
327811|NCT01453075|786216|P2|NOT COMPLETED|Overall Study||1
327812|NCT01453075|786217|P1|NOT COMPLETED|Overall Study||5
327813|NCT01453075|786216|P2|COMPLETED|Overall Study||14
327814|NCT01453075|786217|P1|COMPLETED|Overall Study||11
327815|NCT01453075|786216|P2|STARTED|Overall Study||15
327816|NCT01453075|786217|P1|STARTED|Overall Study||16
327817|NCT01453049|786225|P2|NOT COMPLETED|Overall Study||42
327818|NCT01453049|786226|P1|NOT COMPLETED|Overall Study||41
327819|NCT01453049|786225|P2|COMPLETED|Overall Study||2
327820|NCT01453049|786226|P1|COMPLETED|Overall Study||1
327821|NCT01453049|786225|P2|STARTED|Overall Study||44
327822|NCT01453049|786226|P1|STARTED|Overall Study||42
327823|NCT01453036|786299|P3|NOT COMPLETED|Overall Study||31
327824|NCT01453036|786300|P2|NOT COMPLETED|Overall Study||115
327825|NCT01453036|786301|P1|NOT COMPLETED|Overall Study||26
327826|NCT01453036|786299|P3|COMPLETED|Overall Study||277
327827|NCT01453036|786300|P2|COMPLETED|Overall Study||193
327828|NCT01453036|786301|P1|COMPLETED|Overall Study||282
327829|NCT01453036|786299|P3|STARTED|Overall Study||308
327830|NCT01453036|786300|P2|STARTED|Overall Study||308
327831|NCT01453036|786301|P1|STARTED|Overall Study||308
327832|NCT01453023|786309|P2|NOT COMPLETED|Treatment Period 2||1
327833|NCT01453023|786310|P1|NOT COMPLETED|Treatment Period 2||0
327834|NCT01453023|786309|P2|COMPLETED|Treatment Period 2||11
327835|NCT01453023|786310|P1|COMPLETED|Treatment Period 2||12
327836|NCT01453023|786309|P2|STARTED|Treatment Period 2||12
327837|NCT01453023|786310|P1|STARTED|Treatment Period 2||12
327838|NCT01453023|786309|P2|NOT COMPLETED|Washout Period||0
327839|NCT01453023|786310|P1|NOT COMPLETED|Washout Period||0
327840|NCT01453023|786309|P2|COMPLETED|Washout Period||12
327841|NCT01453023|786310|P1|COMPLETED|Washout Period||12
327842|NCT01453023|786309|P2|STARTED|Washout Period||12
327843|NCT01453023|786310|P1|STARTED|Washout Period||12
327844|NCT01453023|786309|P2|NOT COMPLETED|Treatment Period (TP) 1||1
327845|NCT01453023|786310|P1|NOT COMPLETED|Treatment Period (TP) 1||1
327846|NCT01453023|786309|P2|COMPLETED|Treatment Period (TP) 1||12
327847|NCT01453023|786310|P1|COMPLETED|Treatment Period (TP) 1||12
327848|NCT01453023|786309|P2|STARTED|Treatment Period (TP) 1||13
327849|NCT01453023|786310|P1|STARTED|Treatment Period (TP) 1||13
327850|NCT01452854|786378|P1|NOT COMPLETED|Overall Study||0
327851|NCT01452854|786378|P1|COMPLETED|Overall Study||2
327852|NCT01452854|786378|P1|STARTED|Overall Study||2
327853|NCT01452425|786382|P1|NOT COMPLETED|Overall Study||0
327854|NCT01452425|786382|P1|COMPLETED|Overall Study||10
327855|NCT01452425|786382|P1|STARTED|Overall Study||10
327856|NCT01452347|786389|P2|NOT COMPLETED|Overall Study||7
327857|NCT01452347|786390|P1|NOT COMPLETED|Overall Study||17
327858|NCT01452347|786389|P2|COMPLETED|Overall Study||77
327859|NCT01452347|786390|P1|COMPLETED|Overall Study||151
327860|NCT01452347|786389|P2|STARTED|Overall Study||84
327861|NCT01452347|786390|P1|STARTED|Overall Study||168
327862|NCT01452269|786408|P2|NOT COMPLETED|Overall Study||5
327863|NCT01452269|786409|P1|NOT COMPLETED|Overall Study||1
327864|NCT01452269|786408|P2|COMPLETED|Overall Study||51
327865|NCT01452269|786409|P1|COMPLETED|Overall Study||47
327866|NCT01452269|786408|P2|STARTED|Overall Study||56
327867|NCT01452269|786409|P1|STARTED|Overall Study||48
327868|NCT01452152|786422|P3|NOT COMPLETED|Overall Study||4
327869|NCT01452152|786423|P2|NOT COMPLETED|Overall Study||0
327870|NCT01452152|786424|P1|NOT COMPLETED|Overall Study||5
327871|NCT01452152|786422|P3|COMPLETED|Overall Study||0
327872|NCT01452152|786423|P2|COMPLETED|Overall Study||0
327873|NCT01452152|786424|P1|COMPLETED|Overall Study||0
327874|NCT01452152|786422|P3|STARTED|Overall Study||4
327875|NCT01452152|786423|P2|STARTED|Overall Study||0
327876|NCT01452152|786424|P1|STARTED|Overall Study||5
327877|NCT01452126|786432|P1|NOT COMPLETED|Overall Study||0
327878|NCT01452126|786432|P1|COMPLETED|Overall Study||49
327879|NCT01452126|786432|P1|STARTED|Overall Study||49
327880|NCT01451983|786444|P4|NOT COMPLETED|Overall Study||0
327881|NCT01451983|786445|P3|NOT COMPLETED|Overall Study||0
327882|NCT01451983|786446|P2|NOT COMPLETED|Overall Study||0
327883|NCT01451983|786447|P1|NOT COMPLETED|Overall Study||0
327884|NCT01451983|786444|P4|COMPLETED|Overall Study||24
327885|NCT01451983|786445|P3|COMPLETED|Overall Study||61
327886|NCT01451983|786446|P2|COMPLETED|Overall Study||27
327887|NCT01451983|786447|P1|COMPLETED|Overall Study||26
327888|NCT01451983|786444|P4|STARTED|Overall Study||24
327889|NCT01451983|786445|P3|STARTED|Overall Study||61
327890|NCT01451983|786446|P2|STARTED|Overall Study||27
327891|NCT01451983|786447|P1|STARTED|Overall Study||26
327892|NCT01451931|786460|P3|NOT COMPLETED|Overall Study||43
327893|NCT01451931|786461|P2|NOT COMPLETED|Overall Study||58
327894|NCT01451931|786462|P1|NOT COMPLETED|Overall Study||33
327895|NCT01451931|786460|P3|COMPLETED|Overall Study||923
327896|NCT01451931|786461|P2|COMPLETED|Overall Study||843
327897|NCT01451931|786462|P1|COMPLETED|Overall Study||876
327898|NCT01451931|786460|P3|6-month Follow up|Overall Study||923
327899|NCT01451931|786461|P2|6-month Follow up|Overall Study||843
327900|NCT01451931|786462|P1|6-month Follow up|Overall Study||876
327901|NCT01451931|786460|P3|Baseline Data Collection|Overall Study||958
327902|NCT01451931|786461|P2|Baseline Data Collection|Overall Study||893
327903|NCT01451931|786462|P1|Baseline Data Collection|Overall Study||908
327904|NCT01451931|786460|P3|STARTED|Overall Study||966
327905|NCT01451931|786461|P2|STARTED|Overall Study||901
327906|NCT01451931|786462|P1|STARTED|Overall Study||909
327907|NCT01451814|786484|P2|NOT COMPLETED|Overall Study||5
327908|NCT01451814|786485|P1|NOT COMPLETED|Overall Study||6
327909|NCT01451814|786484|P2|COMPLETED|Overall Study||26
327910|NCT01451814|786485|P1|COMPLETED|Overall Study||29
327911|NCT01451814|786484|P2|Attended a Session|Overall Study||31
327912|NCT01451814|786485|P1|Attended a Session|Overall Study||35
327913|NCT01451814|786484|P2|STARTED|Overall Study||31
327914|NCT01451814|786485|P1|STARTED|Overall Study||35
327915|NCT01451775|786495|P6|NOT COMPLETED|Overall Study||0
327916|NCT01451775|786496|P5|NOT COMPLETED|Overall Study||0
327917|NCT01451775|786497|P4|NOT COMPLETED|Overall Study||0
327918|NCT01451775|786498|P3|NOT COMPLETED|Overall Study||0
327919|NCT01451775|786499|P2|NOT COMPLETED|Overall Study||0
327920|NCT01451775|786500|P1|NOT COMPLETED|Overall Study||0
327921|NCT01451775|786495|P6|COMPLETED|Overall Study||3
327922|NCT01451775|786496|P5|COMPLETED|Overall Study||3
327923|NCT01451775|786497|P4|COMPLETED|Overall Study||3
327924|NCT01451775|786498|P3|COMPLETED|Overall Study||3
327925|NCT01451775|786499|P2|COMPLETED|Overall Study||3
327926|NCT01451775|786500|P1|COMPLETED|Overall Study||3
327927|NCT01451775|786495|P6|STARTED|Overall Study||3
327928|NCT01451775|786496|P5|STARTED|Overall Study||3
327929|NCT01451775|786497|P4|STARTED|Overall Study||3
327930|NCT01451775|786498|P3|STARTED|Overall Study||3
327931|NCT01451775|786499|P2|STARTED|Overall Study||3
327932|NCT01451775|786500|P1|STARTED|Overall Study||3
327933|NCT01451762|786517|P3|NOT COMPLETED|Overall Study||6
327934|NCT01451762|786518|P2|NOT COMPLETED|Overall Study||6
327935|NCT01451762|786519|P1|NOT COMPLETED|Overall Study||3
327936|NCT01451762|786517|P3|COMPLETED|Overall Study||24
327937|NCT01451762|786518|P2|COMPLETED|Overall Study||24
327938|NCT01451762|786519|P1|COMPLETED|Overall Study||27
327939|NCT01451762|786517|P3|STARTED|Overall Study||30
327940|NCT01451762|786518|P2|STARTED|Overall Study||30
327941|NCT01451762|786519|P1|STARTED|Overall Study||30
327942|NCT01451749|786529|P2|NOT COMPLETED|Overall Study||14
327943|NCT01451749|786530|P1|NOT COMPLETED|Overall Study||32
327944|NCT01451749|786529|P2|COMPLETED|Overall Study||94
327945|NCT01451749|786530|P1|COMPLETED|Overall Study||184
327946|NCT01451749|786529|P2|STARTED|Overall Study||108
327947|NCT01451749|786530|P1|STARTED|Overall Study||216
327948|NCT01451723|786542|P2|NOT COMPLETED|Overall Study||5
327949|NCT01451723|786543|P1|NOT COMPLETED|Overall Study||6
327950|NCT01451723|786542|P2|COMPLETED|Overall Study||0
327951|NCT01451723|786543|P1|COMPLETED|Overall Study||0
327952|NCT01451723|786542|P2|STARTED|Overall Study||5
327953|NCT01451723|786543|P1|STARTED|Overall Study||6
327954|NCT01451645|786553|P2|NOT COMPLETED|Overall Study||8
327955|NCT01451645|786554|P1|NOT COMPLETED|Overall Study||9
327956|NCT01451645|786553|P2|COMPLETED|Overall Study||33
327957|NCT01451645|786554|P1|COMPLETED|Overall Study||32
327958|NCT01451645|786553|P2|STARTED|Overall Study||41
327959|NCT01451645|786554|P1|STARTED|Overall Study||41
327960|NCT01451632|786568|P10|NOT COMPLETED|Overall Study||0
327961|NCT01451632|786569|P9|NOT COMPLETED|Overall Study||0
327962|NCT01451632|786570|P8|NOT COMPLETED|Overall Study||0
327963|NCT01451632|786571|P7|NOT COMPLETED|Overall Study||0
327964|NCT01451632|786572|P6|NOT COMPLETED|Overall Study||0
327965|NCT01451632|786573|P5|NOT COMPLETED|Overall Study||0
327966|NCT01451632|786574|P4|NOT COMPLETED|Overall Study||0
327967|NCT01451632|786575|P3|NOT COMPLETED|Overall Study||0
327968|NCT01451632|786576|P2|NOT COMPLETED|Overall Study||0
327969|NCT01451632|786577|P1|NOT COMPLETED|Overall Study||0
327970|NCT01451632|786568|P10|COMPLETED|Overall Study||4
327971|NCT01451632|786569|P9|COMPLETED|Overall Study||4
327972|NCT01451632|786570|P8|COMPLETED|Overall Study||6
327973|NCT01451632|786571|P7|COMPLETED|Overall Study||8
327974|NCT01451632|786572|P6|COMPLETED|Overall Study||4
327975|NCT01451632|786573|P5|COMPLETED|Overall Study||4
327976|NCT01451632|786574|P4|COMPLETED|Overall Study||3
327977|NCT01451632|786575|P3|COMPLETED|Overall Study||3
327978|NCT01451632|786576|P2|COMPLETED|Overall Study||4
327979|NCT01451632|786577|P1|COMPLETED|Overall Study||8
327980|NCT01451632|786568|P10|STARTED|Overall Study||4
327981|NCT01451632|786569|P9|STARTED|Overall Study||4
327982|NCT01451632|786570|P8|STARTED|Overall Study||6
327983|NCT01451632|786571|P7|STARTED|Overall Study||8
327984|NCT01451632|786572|P6|STARTED|Overall Study||4
327985|NCT01451632|786573|P5|STARTED|Overall Study||4
327986|NCT01451632|786574|P4|STARTED|Overall Study||3
327987|NCT01451632|786575|P3|STARTED|Overall Study||3
327988|NCT01451632|786576|P2|STARTED|Overall Study||4
327989|NCT01451632|786577|P1|STARTED|Overall Study||8
327990|NCT01451554|786625|P2|NOT COMPLETED|Overall Study||9
327991|NCT01451554|786626|P1|NOT COMPLETED|Overall Study||14
327992|NCT01451554|786625|P2|COMPLETED|Overall Study||23
327993|NCT01451554|786626|P1|COMPLETED|Overall Study||19
327994|NCT01451554|786625|P2|STARTED|Overall Study||32
327995|NCT01451554|786626|P1|STARTED|Overall Study||33
327996|NCT01451541|786637|P3|NOT COMPLETED|Overall Study||27
327997|NCT01451541|786638|P2|NOT COMPLETED|Overall Study||25
327998|NCT01451541|786639|P1|NOT COMPLETED|Overall Study||36
327999|NCT01451541|786637|P3|COMPLETED|Overall Study||254
328000|NCT01451541|786638|P2|COMPLETED|Overall Study||257
328001|NCT01451541|786639|P1|COMPLETED|Overall Study||247
328002|NCT01451541|786637|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
328003|NCT01451541|786638|P2|STARTED|Overall Study||282
328004|NCT01451541|786639|P1|STARTED|Overall Study||283
328005|NCT01451437|786688|P9|NOT COMPLETED|Overall Study||4
328006|NCT01451437|786689|P8|NOT COMPLETED|Overall Study||3
328007|NCT01451437|786690|P7|NOT COMPLETED|Overall Study||6
328008|NCT01451437|786691|P6|NOT COMPLETED|Overall Study||3
328009|NCT01451437|786692|P5|NOT COMPLETED|Overall Study||4
328010|NCT01451437|786693|P4|NOT COMPLETED|Overall Study||1
328011|NCT01451437|786694|P3|NOT COMPLETED|Overall Study||3
328012|NCT01451437|786695|P2|NOT COMPLETED|Overall Study||1
328013|NCT01451437|786696|P1|NOT COMPLETED|Overall Study||1
328014|NCT01451437|786688|P9|COMPLETED|Overall Study||0
328015|NCT01451437|786689|P8|COMPLETED|Overall Study||0
328016|NCT01451437|786690|P7|COMPLETED|Overall Study||0
328017|NCT01451437|786691|P6|COMPLETED|Overall Study||0
328018|NCT01451437|786692|P5|COMPLETED|Overall Study||0
328019|NCT01451437|786693|P4|COMPLETED|Overall Study||0
328020|NCT01451437|786694|P3|COMPLETED|Overall Study||0
328021|NCT01451437|786695|P2|COMPLETED|Overall Study||0
328022|NCT01451437|786696|P1|COMPLETED|Overall Study||0
328023|NCT01451437|786688|P9|STARTED|Overall Study||4
328024|NCT01451437|786689|P8|STARTED|Overall Study||3
328025|NCT01451437|786690|P7|STARTED|Overall Study||6
328026|NCT01451437|786691|P6|STARTED|Overall Study||3
328027|NCT01451437|786692|P5|STARTED|Overall Study||4
328028|NCT01451437|786693|P4|STARTED|Overall Study||1
328029|NCT01451437|786694|P3|STARTED|Overall Study||3
328030|NCT01451437|786695|P2|STARTED|Overall Study||1
328031|NCT01451437|786696|P1|STARTED|Overall Study||1
328032|NCT01451424|786828|P4|NOT COMPLETED|Overall Study||5
328033|NCT01451424|786829|P3|NOT COMPLETED|Overall Study||1
328034|NCT01451424|786830|P2|NOT COMPLETED|Overall Study||2
328035|NCT01451424|786831|P1|NOT COMPLETED|Overall Study||1
328036|NCT01451424|786828|P4|COMPLETED|Overall Study||5
328037|NCT01451424|786829|P3|COMPLETED|Overall Study||11
328038|NCT01451424|786830|P2|COMPLETED|Overall Study||7
328039|NCT01451424|786831|P1|COMPLETED|Overall Study||8
328040|NCT01451424|786828|P4|STARTED|Overall Study||10
328041|NCT01451424|786829|P3|STARTED|Overall Study||12
328042|NCT01451424|786830|P2|STARTED|Overall Study||9
328043|NCT01451424|786831|P1|STARTED|Overall Study||9
328044|NCT01451411|786864|P2|NOT COMPLETED|Overall Study||0
328045|NCT01451411|786865|P1|NOT COMPLETED|Overall Study||0
328046|NCT01451411|786864|P2|COMPLETED|Overall Study||1
328047|NCT01451411|786865|P1|COMPLETED|Overall Study||3
328048|NCT01451411|786864|P2|STARTED|Overall Study||1
328049|NCT01451411|786865|P1|STARTED|Overall Study||3
328050|NCT01451398|786889|P2|NOT COMPLETED|Overall Study||37
328051|NCT01451398|786890|P1|NOT COMPLETED|Overall Study||27
328052|NCT01451398|786889|P2|COMPLETED|Overall Study||139
328053|NCT01451398|786890|P1|COMPLETED|Overall Study||150
328054|NCT01451398|786889|P2|STARTED|Overall Study||176
328055|NCT01451398|786890|P1|STARTED|Overall Study||177
328056|NCT01451203|786924|P2|NOT COMPLETED|Post-treatment Period||34
328057|NCT01451203|786925|P1|NOT COMPLETED|Post-treatment Period||14
328058|NCT01451203|786924|P2|COMPLETED|Post-treatment Period||74
328059|NCT01451203|786925|P1|COMPLETED|Post-treatment Period||57
328060|NCT01451203|786924|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
328061|NCT01451203|786925|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
328062|NCT01451203|786924|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
328063|NCT01451203|786925|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
328064|NCT01451203|786924|P2|NOT COMPLETED|Double-blind Treatment Period||50
328065|NCT01451203|786925|P1|NOT COMPLETED|Double-blind Treatment Period||85
328066|NCT01451203|786924|P2|COMPLETED|Double-blind Treatment Period||111
328067|NCT01451203|786925|P1|COMPLETED|Double-blind Treatment Period||73
328068|NCT01451203|786924|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
328069|NCT01451203|786925|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
328070|NCT01451203|786924|P2|Received Treatment|Double-blind Treatment Period||159
328071|NCT01451203|786925|P1|Received Treatment|Double-blind Treatment Period||157
328072|NCT01451203|786924|P2|STARTED|Double-blind Treatment Period||161
328073|NCT01451203|786925|P1|STARTED|Double-blind Treatment Period||158
328074|NCT01450813|786943|P4|NOT COMPLETED|Overall Study||3
328075|NCT01450813|786944|P3|NOT COMPLETED|Overall Study||0
328076|NCT01450813|786945|P2|NOT COMPLETED|Overall Study||1
328077|NCT01450813|786946|P1|NOT COMPLETED|Overall Study||1
328078|NCT01450813|786943|P4|COMPLETED|Overall Study||17
328079|NCT01450813|786944|P3|COMPLETED|Overall Study||20
328080|NCT01450813|786945|P2|COMPLETED|Overall Study||19
328081|NCT01450813|786946|P1|COMPLETED|Overall Study||19
328082|NCT01450813|786943|P4|STARTED|Overall Study||20
328083|NCT01450813|786944|P3|STARTED|Overall Study||20
328084|NCT01450813|786945|P2|STARTED|Overall Study||20
328085|NCT01450813|786946|P1|STARTED|Overall Study||20
328086|NCT01450800|786960|P2|NOT COMPLETED|Overall Study||3
328087|NCT01450800|786961|P1|NOT COMPLETED|Overall Study||1
328088|NCT01450800|786960|P2|COMPLETED|Overall Study||78
328089|NCT01450800|786961|P1|COMPLETED|Overall Study||81
328090|NCT01450800|786960|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
328091|NCT01450800|786961|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
328092|NCT01450787|786977|P2|NOT COMPLETED|Overall Study||0
328093|NCT01450787|786978|P1|NOT COMPLETED|Overall Study||0
328094|NCT01450787|786977|P2|COMPLETED|Overall Study||25
328095|NCT01450787|786978|P1|COMPLETED|Overall Study||38
328096|NCT01450787|786977|P2|STARTED|Overall Study||25
328097|NCT01450787|786978|P1|STARTED|Overall Study||38
328098|NCT01450761|786996|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||466
328099|NCT01450761|786997|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||464
328100|NCT01450761|786996|P2|COMPLETED|Treatment With Blinded Study Therapy||10
328101|NCT01450761|786997|P1|COMPLETED|Treatment With Blinded Study Therapy||14
328102|NCT01450761|786996|P2|STARTED|Treatment With Blinded Study Therapy||476
328103|NCT01450761|786997|P1|STARTED|Treatment With Blinded Study Therapy||478
328104|NCT01450761|786996|P2|NOT COMPLETED|Lead-in Chemotherapy||85
328105|NCT01450761|786997|P1|NOT COMPLETED|Lead-in Chemotherapy||84
328106|NCT01450761|786996|P2|COMPLETED|Lead-in Chemotherapy||476
328107|NCT01450761|786997|P1|COMPLETED|Lead-in Chemotherapy||478
328108|NCT01450761|786996|P2|STARTED|Lead-in Chemotherapy||561
328109|NCT01450761|786997|P1|STARTED|Lead-in Chemotherapy||562
328110|NCT01450761|786996|P2|NOT COMPLETED|Randomization||5
328111|NCT01450761|786997|P1|NOT COMPLETED|Randomization||4
328112|NCT01450761|786996|P2|COMPLETED|Randomization||561
328113|NCT01450761|786997|P1|COMPLETED|Randomization||562
328114|NCT01450761|786996|P2|STARTED|Randomization||566
328115|NCT01450761|786997|P1|STARTED|Randomization||566
328116|NCT01450696|787009|P2|NOT COMPLETED|Overall Study||148
328117|NCT01450696|787010|P1|NOT COMPLETED|Overall Study||148
328118|NCT01450696|787009|P2|COMPLETED|Overall Study||0
328119|NCT01450696|787010|P1|COMPLETED|Overall Study||0
328120|NCT01450696|787009|P2|Treated (Safety Population)|Overall Study||147
328121|NCT01450696|787010|P1|Treated (Safety Population)|Overall Study||147
328122|NCT01450696|787009|P2|STARTED|Overall Study||148
328123|NCT01450696|787010|P1|STARTED|Overall Study||148
328124|NCT01450683|787032|P1|NOT COMPLETED|Overall Study||2
328125|NCT01450683|787032|P1|COMPLETED|Overall Study||2
328126|NCT01450683|787032|P1|STARTED|Overall Study||4
328127|NCT01450631|787038|P2|NOT COMPLETED|Overall Study||4
328128|NCT01450631|787039|P1|NOT COMPLETED|Overall Study||3
328129|NCT01450631|787038|P2|COMPLETED|Overall Study||42
328130|NCT01450631|787039|P1|COMPLETED|Overall Study||43
328131|NCT01450631|787038|P2|STARTED|Overall Study||46
328132|NCT01450631|787039|P1|STARTED|Overall Study||46
328133|NCT01450397|787047|P1|NOT COMPLETED|Overall Study||0
328134|NCT01450397|787047|P1|COMPLETED|Overall Study||5
328135|NCT01450397|787047|P1|STARTED|Overall Study||5
328136|NCT01450319|787051|P1|NOT COMPLETED|Overall Study||0
328137|NCT01450319|787051|P1|COMPLETED|Overall Study||70
328138|NCT01450319|787051|P1|STARTED|Overall Study||70
328139|NCT01450306|787064|P2|NOT COMPLETED|Overall Study||0
328140|NCT01450306|787065|P1|NOT COMPLETED|Overall Study||0
328141|NCT01450306|787064|P2|COMPLETED|Overall Study||10
328142|NCT01450306|787065|P1|COMPLETED|Overall Study||10
328143|NCT01450306|787064|P2|STARTED|Overall Study||10
328144|NCT01450306|787065|P1|STARTED|Overall Study||10
328145|NCT01450189|787078|P3|NOT COMPLETED|Overall Study||0
328146|NCT01450189|787079|P2|NOT COMPLETED|Overall Study||0
328147|NCT01450189|787080|P1|NOT COMPLETED|Overall Study||0
328148|NCT01450189|787078|P3|COMPLETED|Overall Study||19
328149|NCT01450189|787079|P2|COMPLETED|Overall Study||18
328150|NCT01450189|787080|P1|COMPLETED|Overall Study||9
328151|NCT01450189|787078|P3|STARTED|Overall Study||19
328152|NCT01450189|787079|P2|STARTED|Overall Study||18
328153|NCT01450189|787080|P1|STARTED|Overall Study||9
328154|NCT01450007|787170|P3|NOT COMPLETED|Overall Study||3
328155|NCT01450007|787171|P2|NOT COMPLETED|Overall Study||5
328156|NCT01450007|787172|P1|NOT COMPLETED|Overall Study||2
328157|NCT01450007|787170|P3|COMPLETED|Overall Study||41
328158|NCT01450007|787171|P2|COMPLETED|Overall Study||37
328159|NCT01450007|787172|P1|COMPLETED|Overall Study||42
328160|NCT01450007|787170|P3|STARTED|Overall Study||44
328161|NCT01450007|787171|P2|STARTED|Overall Study||42
328162|NCT01450007|787172|P1|STARTED|Overall Study||44
328163|NCT01449955|787191|P2|NOT COMPLETED|Overall Study||2
328164|NCT01449955|787192|P1|NOT COMPLETED|Overall Study||1
328165|NCT01449955|787191|P2|COMPLETED|Overall Study||24
328166|NCT01449955|787192|P1|COMPLETED|Overall Study||27
328167|NCT01449955|787191|P2|STARTED|Overall Study||26
328168|NCT01449955|787192|P1|STARTED|Overall Study||28
328169|NCT01449929|787200|P2|NOT COMPLETED|Overall Study||242
328170|NCT01449929|787201|P1|NOT COMPLETED|Overall Study||242
328171|NCT01449929|787200|P2|COMPLETED|Overall Study||0
328172|NCT01449929|787201|P1|COMPLETED|Overall Study||0
328173|NCT01449929|787200|P2|Ongoing|Overall Study||213
328174|NCT01449929|787201|P1|Ongoing|Overall Study||224
328175|NCT01449929|787200|P2|STARTED|Overall Study||242
328176|NCT01449929|787201|P1|STARTED|Overall Study||242
328177|NCT01449812|787240|P3|NOT COMPLETED|Overall Study||1
328178|NCT01449812|787241|P2|NOT COMPLETED|Overall Study||0
328179|NCT01449812|787242|P1|NOT COMPLETED|Overall Study||2
328180|NCT01449812|787240|P3|COMPLETED|Overall Study||279
328181|NCT01449812|787241|P2|COMPLETED|Overall Study||273
328182|NCT01449812|787242|P1|COMPLETED|Overall Study||270
328183|NCT01449812|787240|P3|STARTED|Overall Study||280
328184|NCT01449812|787241|P2|STARTED|Overall Study||273
328185|NCT01449812|787242|P1|STARTED|Overall Study||272
328186|NCT01449747|787336|P2|NOT COMPLETED|Overall Study||0
328187|NCT01449747|787337|P1|NOT COMPLETED|Overall Study||0
328188|NCT01449747|787336|P2|COMPLETED|Overall Study||12
328189|NCT01449747|787337|P1|COMPLETED|Overall Study||12
328190|NCT01449747|787336|P2|STARTED|Overall Study||12
328191|NCT01449747|787337|P1|STARTED|Overall Study||12
328192|NCT01449734|787351|P1|NOT COMPLETED|Overall Study||0
328193|NCT01449734|787351|P1|COMPLETED|Overall Study||215
328194|NCT01449734|787351|P1|STARTED|Overall Study||215
328195|NCT01449708|787357|P2|NOT COMPLETED|Overall Study||3
328196|NCT01449708|787358|P1|NOT COMPLETED|Overall Study||2
328197|NCT01449708|787357|P2|COMPLETED|Overall Study||60
328198|NCT01449708|787358|P1|COMPLETED|Overall Study||59
328199|NCT01449708|787357|P2|STARTED|Overall Study||63
328200|NCT01449708|787358|P1|STARTED|Overall Study||61
328201|NCT01449682|787369|P2|NOT COMPLETED|Overall Study||1
328202|NCT01449682|787370|P1|NOT COMPLETED|Overall Study||1
328203|NCT01449682|787369|P2|COMPLETED|Overall Study||4
328204|NCT01449682|787370|P1|COMPLETED|Overall Study||4
328205|NCT01449682|787369|P2|STARTED|Overall Study||5
328206|NCT01449682|787370|P1|STARTED|Overall Study||5
328207|NCT01449539|787382|P1|NOT COMPLETED|Overall Study||4
328208|NCT01449539|787382|P1|COMPLETED|Overall Study||4
328209|NCT01449539|787382|P1|STARTED|Overall Study||8
328210|NCT01449526|787388|P2|NOT COMPLETED|Overall Study||6
328211|NCT01449526|787389|P1|NOT COMPLETED|Overall Study||2
328212|NCT01449526|787388|P2|COMPLETED|Overall Study||77
328213|NCT01449526|787389|P1|COMPLETED|Overall Study||81
328214|NCT01449526|787388|P2|STARTED|Overall Study||83
328215|NCT01449526|787389|P1|STARTED|Overall Study||83
328216|NCT01449513|787399|P2|NOT COMPLETED|Overall Study||0
328217|NCT01449513|787400|P1|NOT COMPLETED|Overall Study||0
328218|NCT01449513|787399|P2|COMPLETED|Overall Study||8
328219|NCT01449513|787400|P1|COMPLETED|Overall Study||16
328220|NCT01449513|787399|P2|STARTED|Overall Study||8
328221|NCT01449513|787400|P1|STARTED|Overall Study||16
328222|NCT01449370|787477|P25|NOT COMPLETED|Overall Study||8
328223|NCT01449370|787478|P24|NOT COMPLETED|Overall Study||10
328224|NCT01449370|787479|P23|NOT COMPLETED|Overall Study||4
328225|NCT01449370|787480|P22|NOT COMPLETED|Overall Study||4
328226|NCT01449370|787481|P21|NOT COMPLETED|Overall Study||6
328227|NCT01449370|787482|P20|NOT COMPLETED|Overall Study||3
328228|NCT01449370|787483|P19|NOT COMPLETED|Overall Study||3
328229|NCT01449370|787484|P18|NOT COMPLETED|Overall Study||3
328230|NCT01449370|787485|P17|NOT COMPLETED|Overall Study||7
328231|NCT01449370|787486|P16|NOT COMPLETED|Overall Study||3
328232|NCT01449370|787487|P15|NOT COMPLETED|Overall Study||3
328233|NCT01449370|787488|P14|NOT COMPLETED|Overall Study||11
328234|NCT01449370|787489|P13|NOT COMPLETED|Overall Study||3
328235|NCT01449370|787490|P12|NOT COMPLETED|Overall Study||3
328236|NCT01449370|787491|P11|NOT COMPLETED|Overall Study||3
328237|NCT01449370|787492|P10|NOT COMPLETED|Overall Study||3
328238|NCT01449370|787493|P9|NOT COMPLETED|Overall Study||12
328239|NCT01449370|787494|P8|NOT COMPLETED|Overall Study||3
328240|NCT01449370|787495|P7|NOT COMPLETED|Overall Study||3
328241|NCT01449370|787496|P6|NOT COMPLETED|Overall Study||3
328242|NCT01449370|787497|P5|NOT COMPLETED|Overall Study||3
328243|NCT01449370|787498|P4|NOT COMPLETED|Overall Study||4
328244|NCT01449370|787499|P3|NOT COMPLETED|Overall Study||8
328245|NCT01449370|787500|P2|NOT COMPLETED|Overall Study||6
328246|NCT01449370|787501|P1|NOT COMPLETED|Overall Study||6
328247|NCT01449370|787477|P25|COMPLETED|Overall Study||0
328248|NCT01449370|787478|P24|COMPLETED|Overall Study||0
328249|NCT01449370|787479|P23|COMPLETED|Overall Study||0
328250|NCT01449370|787480|P22|COMPLETED|Overall Study||0
328251|NCT01449370|787481|P21|COMPLETED|Overall Study||0
328252|NCT01449370|787482|P20|COMPLETED|Overall Study||0
328253|NCT01449370|787483|P19|COMPLETED|Overall Study||0
328254|NCT01449370|787484|P18|COMPLETED|Overall Study||0
328255|NCT01449370|787485|P17|COMPLETED|Overall Study||0
328256|NCT01449370|787486|P16|COMPLETED|Overall Study||0
328257|NCT01449370|787487|P15|COMPLETED|Overall Study||0
328258|NCT01449370|787488|P14|COMPLETED|Overall Study||0
328259|NCT01449370|787489|P13|COMPLETED|Overall Study||0
328260|NCT01449370|787490|P12|COMPLETED|Overall Study||0
328261|NCT01449370|787491|P11|COMPLETED|Overall Study||0
328262|NCT01449370|787492|P10|COMPLETED|Overall Study||0
328263|NCT01449370|787493|P9|COMPLETED|Overall Study||0
328264|NCT01449370|787494|P8|COMPLETED|Overall Study||0
328265|NCT01449370|787495|P7|COMPLETED|Overall Study||0
328266|NCT01449370|787496|P6|COMPLETED|Overall Study||0
328267|NCT01449370|787497|P5|COMPLETED|Overall Study||0
328268|NCT01449370|787498|P4|COMPLETED|Overall Study||0
328269|NCT01449370|787499|P3|COMPLETED|Overall Study||0
328270|NCT01449370|787500|P2|COMPLETED|Overall Study||0
328271|NCT01449370|787501|P1|COMPLETED|Overall Study||0
328272|NCT01449370|787477|P25|STARTED|Overall Study||8
328273|NCT01449370|787478|P24|STARTED|Overall Study||10
328274|NCT01449370|787479|P23|STARTED|Overall Study||4
328275|NCT01449370|787480|P22|STARTED|Overall Study||4
328276|NCT01449370|787481|P21|STARTED|Overall Study||6
328277|NCT01449370|787482|P20|STARTED|Overall Study||3
328278|NCT01449370|787483|P19|STARTED|Overall Study||3
328279|NCT01449370|787484|P18|STARTED|Overall Study||3
328280|NCT01449370|787485|P17|STARTED|Overall Study||7
328281|NCT01449370|787486|P16|STARTED|Overall Study||3
328282|NCT01449370|787487|P15|STARTED|Overall Study||3
328283|NCT01449370|787488|P14|STARTED|Overall Study||11
328284|NCT01449370|787489|P13|STARTED|Overall Study||3
328285|NCT01449370|787490|P12|STARTED|Overall Study||3
328286|NCT01449370|787491|P11|STARTED|Overall Study||3
328287|NCT01449370|787492|P10|STARTED|Overall Study||3
328288|NCT01449370|787493|P9|STARTED|Overall Study||12
328289|NCT01449370|787494|P8|STARTED|Overall Study||3
328290|NCT01449370|787495|P7|STARTED|Overall Study||3
328291|NCT01449370|787496|P6|STARTED|Overall Study||3
328292|NCT01449370|787497|P5|STARTED|Overall Study||3
328293|NCT01449370|787498|P4|STARTED|Overall Study||4
328294|NCT01449370|787499|P3|STARTED|Overall Study||8
328295|NCT01449370|787500|P2|STARTED|Overall Study||6
328296|NCT01449370|787501|P1|STARTED|Overall Study||6
328297|NCT01449305|787874|P1|NOT COMPLETED|Overall Study||2
328298|NCT01449305|787874|P1|COMPLETED|Overall Study||42
328299|NCT01449305|787874|P1|STARTED|Overall Study||44
328300|NCT01449279|787879|P1|NOT COMPLETED|Overall Study||7
328301|NCT01449279|787879|P1|COMPLETED|Overall Study||15
328302|NCT01449279|787879|P1|STARTED|Overall Study||22
328303|NCT01449266|787890|P1|NOT COMPLETED|Overall Study||0
328304|NCT01449266|787890|P1|COMPLETED|Overall Study||10
328305|NCT01449266|787890|P1|STARTED|Overall Study||10
328306|NCT01449240|787897|P1|NOT COMPLETED|Overall Study||0
328307|NCT01449240|787897|P1|COMPLETED|Overall Study||10
328308|NCT01449240|787897|P1|STARTED|Overall Study||10
328309|NCT01449006|787904|P2|NOT COMPLETED|Overall Study||0
328310|NCT01449006|787905|P1|NOT COMPLETED|Overall Study||3
328311|NCT01449006|787904|P2|COMPLETED|Overall Study||9
328312|NCT01449006|787905|P1|COMPLETED|Overall Study||5
328313|NCT01449006|787904|P2|STARTED|Overall Study||9
328314|NCT01449006|787905|P1|STARTED|Overall Study||8
328315|NCT01448850|787919|P2|NOT COMPLETED|Overall Study||40
328316|NCT01448850|787920|P1|NOT COMPLETED|Overall Study||34
328317|NCT01448850|787919|P2|COMPLETED|Overall Study||120
328318|NCT01448850|787920|P1|COMPLETED|Overall Study||130
328319|NCT01448850|787919|P2|STARTED|Overall Study||160
328320|NCT01448850|787920|P1|STARTED|Overall Study||164
328321|NCT01448707|787945|P2|NOT COMPLETED|Overall Study||18
328322|NCT01448707|787946|P1|NOT COMPLETED|Overall Study||18
328323|NCT01448707|787945|P2|COMPLETED|Overall Study||118
328324|NCT01448707|787946|P1|COMPLETED|Overall Study||119
328325|NCT01448707|787945|P2|STARTED|Overall Study||136
328326|NCT01448707|787946|P1|STARTED|Overall Study||137
328327|NCT01448616|787967|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
328328|NCT01448616|787968|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
328329|NCT01448616|787969|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
328330|NCT01448616|787970|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
328331|NCT01448616|787967|P4|COMPLETED|Study Drug (Treatment Phase)||9
328332|NCT01448616|787968|P3|COMPLETED|Study Drug (Treatment Phase)||23
328333|NCT01448616|787969|P2|COMPLETED|Study Drug (Treatment Phase)||22
328334|NCT01448616|787970|P1|COMPLETED|Study Drug (Treatment Phase)||0
328335|NCT01448616|787967|P4|STARTED|Study Drug (Treatment Phase)||13
328336|NCT01448616|787968|P3|STARTED|Study Drug (Treatment Phase)||27
328337|NCT01448616|787969|P2|STARTED|Study Drug (Treatment Phase)||24
328338|NCT01448616|787970|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
328339|NCT01448616|787967|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
328340|NCT01448616|787968|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
328341|NCT01448616|787969|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
328342|NCT01448616|787970|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
328343|NCT01448616|787967|P4|COMPLETED|Lead-In (Observational Phase)||0
328344|NCT01448616|787968|P3|COMPLETED|Lead-In (Observational Phase)||0
328345|NCT01448616|787969|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
328346|NCT01448616|787970|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
328347|NCT01448616|787967|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
328348|NCT01448616|787968|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
328349|NCT01448616|787969|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
328350|NCT01448616|787970|P1|STARTED|Lead-In (Observational Phase)||73
328351|NCT01448525|787990|P2|NOT COMPLETED|Overall Study||2
328352|NCT01448525|787991|P1|NOT COMPLETED|Overall Study||1
328353|NCT01448525|787990|P2|COMPLETED|Overall Study||42
328354|NCT01448525|787991|P1|COMPLETED|Overall Study||43
328355|NCT01448525|787990|P2|STARTED|Overall Study||44
328356|NCT01448525|787991|P1|STARTED|Overall Study||44
328357|NCT01448486|788001|P2|NOT COMPLETED|Overall Study||0
328358|NCT01448486|788002|P1|NOT COMPLETED|Overall Study||0
328359|NCT01448486|788001|P2|COMPLETED|Overall Study||3
328360|NCT01448486|788002|P1|COMPLETED|Overall Study||3
328361|NCT01448486|788001|P2|STARTED|Overall Study||3
328362|NCT01448486|788002|P1|STARTED|Overall Study||3
328363|NCT01448356|788010|P1|NOT COMPLETED|Overall Study||0
328364|NCT01448356|788010|P1|COMPLETED|Overall Study|cross-over|10
328365|NCT01448356|788010|P1|STARTED|Overall Study||10
328366|NCT01448213|788017|P2|NOT COMPLETED|Overall Study||22
328367|NCT01448213|788018|P1|NOT COMPLETED|Overall Study||17
328368|NCT01448213|788017|P2|COMPLETED|Overall Study||112
328369|NCT01448213|788018|P1|COMPLETED|Overall Study||113
328370|NCT01448213|788017|P2|STARTED|Overall Study||134
328371|NCT01448213|788018|P1|STARTED|Overall Study||130
328372|NCT01448057|788028|P2|NOT COMPLETED|Overall Study||4
328373|NCT01448057|788029|P1|NOT COMPLETED|Overall Study||8
328374|NCT01448057|788028|P2|COMPLETED|Overall Study||167
328375|NCT01448057|788029|P1|COMPLETED|Overall Study||162
328376|NCT01448057|788028|P2|STARTED|Overall Study||171
328377|NCT01448057|788029|P1|STARTED|Overall Study||170
328378|NCT01448044|788039|P2|NOT COMPLETED|Follow Up Period||14
328379|NCT01448044|788040|P1|NOT COMPLETED|Follow Up Period||12
328380|NCT01448044|788039|P2|COMPLETED|Follow Up Period||26
328381|NCT01448044|788040|P1|COMPLETED|Follow Up Period||65
328382|NCT01448044|788039|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
328383|NCT01448044|788040|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
328384|NCT01448044|788039|P2|NOT COMPLETED|Treatment Period||16
328385|NCT01448044|788040|P1|NOT COMPLETED|Treatment Period||23
328386|NCT01448044|788039|P2|COMPLETED|Treatment Period||26
328387|NCT01448044|788040|P1|COMPLETED|Treatment Period||59
328388|NCT01448044|788039|P2|STARTED|Treatment Period||42
328389|NCT01448044|788040|P1|STARTED|Treatment Period||82
328390|NCT01447927|788056|P2|NOT COMPLETED|Overall Study||3
328391|NCT01447927|788057|P1|NOT COMPLETED|Overall Study||5
328392|NCT01447927|788056|P2|COMPLETED|Overall Study||33
328393|NCT01447927|788057|P1|COMPLETED|Overall Study||33
328394|NCT01447927|788056|P2|STARTED|Overall Study||36
328395|NCT01447927|788057|P1|STARTED|Overall Study||38
328396|NCT01447914|788065|P1|NOT COMPLETED|Overall Study||0
328397|NCT01447914|788065|P1|COMPLETED|Overall Study||16
328398|NCT01447914|788065|P1|STARTED|Overall Study||16
328399|NCT01447849|788074|P4|NOT COMPLETED|Second Intervention||0
328400|NCT01447849|788075|P3|NOT COMPLETED|Second Intervention||0
328401|NCT01447849|788076|P2|NOT COMPLETED|Second Intervention||0
328402|NCT01447849|788077|P1|NOT COMPLETED|Second Intervention||0
328403|NCT01447849|788074|P4|COMPLETED|Second Intervention||10
328404|NCT01447849|788075|P3|COMPLETED|Second Intervention||10
328405|NCT01447849|788076|P2|COMPLETED|Second Intervention||10
328406|NCT01447849|788077|P1|COMPLETED|Second Intervention||10
328407|NCT01447849|788074|P4|STARTED|Second Intervention||10
328408|NCT01447849|788075|P3|STARTED|Second Intervention||10
328409|NCT01447849|788076|P2|STARTED|Second Intervention||10
328410|NCT01447849|788077|P1|STARTED|Second Intervention||10
328411|NCT01447849|788074|P4|NOT COMPLETED|Washout Period for 1 Week||0
328412|NCT01447849|788075|P3|NOT COMPLETED|Washout Period for 1 Week||0
328413|NCT01447849|788076|P2|NOT COMPLETED|Washout Period for 1 Week||0
328414|NCT01447849|788077|P1|NOT COMPLETED|Washout Period for 1 Week||0
328415|NCT01447849|788074|P4|COMPLETED|Washout Period for 1 Week||10
328416|NCT01447849|788075|P3|COMPLETED|Washout Period for 1 Week||10
328417|NCT01447849|788076|P2|COMPLETED|Washout Period for 1 Week||10
328418|NCT01447849|788077|P1|COMPLETED|Washout Period for 1 Week||10
328419|NCT01447849|788074|P4|STARTED|Washout Period for 1 Week||10
328420|NCT01447849|788075|P3|STARTED|Washout Period for 1 Week||10
328421|NCT01447849|788076|P2|STARTED|Washout Period for 1 Week||10
328422|NCT01447849|788077|P1|STARTED|Washout Period for 1 Week||10
328423|NCT01447849|788074|P4|NOT COMPLETED|First Intervention||0
328424|NCT01447849|788075|P3|NOT COMPLETED|First Intervention||0
328425|NCT01447849|788076|P2|NOT COMPLETED|First Intervention||0
328426|NCT01447849|788077|P1|NOT COMPLETED|First Intervention||0
328427|NCT01447849|788074|P4|COMPLETED|First Intervention||10
328428|NCT01447849|788075|P3|COMPLETED|First Intervention||10
328429|NCT01447849|788076|P2|COMPLETED|First Intervention||10
328430|NCT01447849|788077|P1|COMPLETED|First Intervention||10
328431|NCT01447849|788074|P4|STARTED|First Intervention||10
328432|NCT01447849|788075|P3|STARTED|First Intervention||10
328433|NCT01447849|788076|P2|STARTED|First Intervention||10
328434|NCT01447849|788077|P1|STARTED|First Intervention||10
328435|NCT01447719|788087|P1|NOT COMPLETED|Overall Study||93
328436|NCT01447719|788087|P1|COMPLETED|Overall Study||59
328437|NCT01447719|788087|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
328438|NCT01447719|788087|P1|Valid AV-45 Scan Acquired|Overall Study||147
328439|NCT01447719|788087|P1|STARTED|Overall Study||152
328440|NCT01447706|788100|P2|NOT COMPLETED|Overall Study||3
328441|NCT01447706|788101|P1|NOT COMPLETED|Overall Study||0
328442|NCT01447706|788100|P2|COMPLETED|Overall Study||80
328443|NCT01447706|788101|P1|COMPLETED|Overall Study||140
328444|NCT01447706|788100|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
328445|NCT01447706|788101|P1|STARTED|Overall Study||140
328446|NCT01447576|788113|P1|NOT COMPLETED|Overall Study||476
328447|NCT01447576|788113|P1|COMPLETED|Overall Study||560
328448|NCT01447576|788113|P1|STARTED|Overall Study||1036
328449|NCT01447511|788124|P5|NOT COMPLETED|Rifampin Period||0
328450|NCT01447511|788125|P4|NOT COMPLETED|Rifampin Period||1
328451|NCT01447511|788126|P3|NOT COMPLETED|Rifampin Period||0
328452|NCT01447511|788127|P2|NOT COMPLETED|Rifampin Period||0
328453|NCT01447511|788128|P1|NOT COMPLETED|Rifampin Period||0
328454|NCT01447511|788124|P5|COMPLETED|Rifampin Period||4
328455|NCT01447511|788125|P4|COMPLETED|Rifampin Period||2
328456|NCT01447511|788126|P3|COMPLETED|Rifampin Period||8
328457|NCT01447511|788127|P2|COMPLETED|Rifampin Period||5
328458|NCT01447511|788128|P1|COMPLETED|Rifampin Period||8
328459|NCT01447511|788124|P5|STARTED|Rifampin Period||4
328460|NCT01447511|788125|P4|STARTED|Rifampin Period||3
328461|NCT01447511|788126|P3|STARTED|Rifampin Period||8
328462|NCT01447511|788127|P2|STARTED|Rifampin Period||5
328463|NCT01447511|788128|P1|STARTED|Rifampin Period||8
328464|NCT01447511|788124|P5|NOT COMPLETED|Fluconazole Period||0
328465|NCT01447511|788125|P4|NOT COMPLETED|Fluconazole Period||0
328466|NCT01447511|788126|P3|NOT COMPLETED|Fluconazole Period||1
328467|NCT01447511|788127|P2|NOT COMPLETED|Fluconazole Period||0
328468|NCT01447511|788128|P1|NOT COMPLETED|Fluconazole Period||0
328469|NCT01447511|788124|P5|COMPLETED|Fluconazole Period||4
328470|NCT01447511|788125|P4|COMPLETED|Fluconazole Period||3
328471|NCT01447511|788126|P3|COMPLETED|Fluconazole Period||8
328472|NCT01447511|788127|P2|COMPLETED|Fluconazole Period||0
328473|NCT01447511|788128|P1|COMPLETED|Fluconazole Period||8
328474|NCT01447511|788124|P5|STARTED|Fluconazole Period||4
328475|NCT01447511|788125|P4|STARTED|Fluconazole Period||3
328476|NCT01447511|788126|P3|STARTED|Fluconazole Period||9
328477|NCT01447511|788127|P2|STARTED|Fluconazole Period||0
328478|NCT01447511|788128|P1|STARTED|Fluconazole Period||8
328479|NCT01447511|788124|P5|NOT COMPLETED|Control Period||0
328480|NCT01447511|788125|P4|NOT COMPLETED|Control Period||0
328481|NCT01447511|788126|P3|NOT COMPLETED|Control Period||0
328482|NCT01447511|788127|P2|NOT COMPLETED|Control Period||0
328483|NCT01447511|788128|P1|NOT COMPLETED|Control Period||0
328484|NCT01447511|788124|P5|COMPLETED|Control Period||4
328485|NCT01447511|788125|P4|COMPLETED|Control Period||3
328486|NCT01447511|788126|P3|COMPLETED|Control Period||9
328487|NCT01447511|788127|P2|COMPLETED|Control Period||5
328488|NCT01447511|788128|P1|COMPLETED|Control Period||8
328489|NCT01447511|788124|P5|STARTED|Control Period||4
328490|NCT01447511|788125|P4|STARTED|Control Period||3
328491|NCT01447511|788126|P3|STARTED|Control Period||9
328492|NCT01447511|788127|P2|STARTED|Control Period||5
328493|NCT01447511|788128|P1|STARTED|Control Period||8
328494|NCT01447446|788146|P6|NOT COMPLETED|Overall Study||32
328495|NCT01447446|788147|P5|NOT COMPLETED|Overall Study||211
328496|NCT01447446|788148|P4|NOT COMPLETED|Overall Study||33
328497|NCT01447446|788149|P3|NOT COMPLETED|Overall Study||100
328498|NCT01447446|788150|P2|NOT COMPLETED|Overall Study||165
328499|NCT01447446|788151|P1|NOT COMPLETED|Overall Study||722
328500|NCT01447446|788146|P6|COMPLETED|Overall Study||54
328501|NCT01447446|788147|P5|COMPLETED|Overall Study||610
328502|NCT01447446|788148|P4|COMPLETED|Overall Study||60
328503|NCT01447446|788149|P3|COMPLETED|Overall Study||192
328504|NCT01447446|788150|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
328505|NCT01447446|788151|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
328506|NCT01447446|788146|P6|STARTED|Overall Study||86
328507|NCT01447446|788147|P5|STARTED|Overall Study||821
328508|NCT01447446|788148|P4|STARTED|Overall Study||93
328509|NCT01447446|788149|P3|STARTED|Overall Study||292
328510|NCT01447446|788150|P2|STARTED|Overall Study||496
328511|NCT01447446|788151|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
328512|NCT01447433|788241|P2|NOT COMPLETED|Overall Study||6
328513|NCT01447433|788242|P1|NOT COMPLETED|Overall Study||4
328514|NCT01447433|788241|P2|COMPLETED|Overall Study||21
328515|NCT01447433|788242|P1|COMPLETED|Overall Study||22
328516|NCT01447433|788241|P2|STARTED|Overall Study||27
328517|NCT01447433|788242|P1|STARTED|Overall Study||26
328518|NCT01447420|788269|P3|NOT COMPLETED|Overall Study||10
328519|NCT01447420|788270|P2|NOT COMPLETED|Overall Study||27
328520|NCT01447420|788271|P1|NOT COMPLETED|Overall Study||10
328521|NCT01447420|788269|P3|COMPLETED|Overall Study||8
328522|NCT01447420|788270|P2|COMPLETED|Overall Study||45
328523|NCT01447420|788271|P1|COMPLETED|Overall Study||29
328524|NCT01447420|788269|P3|STARTED|Overall Study||18
328525|NCT01447420|788270|P2|STARTED|Overall Study||72
328526|NCT01447420|788271|P1|STARTED|Overall Study||39
328527|NCT01447225|788291|P10|NOT COMPLETED|Overall Study||0
328528|NCT01447225|788292|P9|NOT COMPLETED|Overall Study||0
328529|NCT01447225|788293|P8|NOT COMPLETED|Overall Study||0
328530|NCT01447225|788294|P7|NOT COMPLETED|Overall Study||0
328531|NCT01447225|788295|P6|NOT COMPLETED|Overall Study||0
328532|NCT01447225|788296|P5|NOT COMPLETED|Overall Study||0
328533|NCT01447225|788297|P4|NOT COMPLETED|Overall Study||0
328534|NCT01447225|788298|P3|NOT COMPLETED|Overall Study||0
328535|NCT01447225|788299|P2|NOT COMPLETED|Overall Study||0
328536|NCT01447225|788300|P1|NOT COMPLETED|Overall Study||0
328537|NCT01447225|788291|P10|COMPLETED|Overall Study||4
328538|NCT01447225|788292|P9|COMPLETED|Overall Study||3
328539|NCT01447225|788293|P8|COMPLETED|Overall Study||4
328540|NCT01447225|788294|P7|COMPLETED|Overall Study||7
328541|NCT01447225|788295|P6|COMPLETED|Overall Study||3
328542|NCT01447225|788296|P5|COMPLETED|Overall Study||3
328543|NCT01447225|788297|P4|COMPLETED|Overall Study||3
328544|NCT01447225|788298|P3|COMPLETED|Overall Study||5
328545|NCT01447225|788299|P2|COMPLETED|Overall Study||8
328546|NCT01447225|788300|P1|COMPLETED|Overall Study||3
328547|NCT01447225|788291|P10|STARTED|Overall Study||4
328548|NCT01447225|788292|P9|STARTED|Overall Study||3
328549|NCT01447225|788293|P8|STARTED|Overall Study||4
328550|NCT01447225|788294|P7|STARTED|Overall Study||7
328551|NCT01447225|788295|P6|STARTED|Overall Study||3
328552|NCT01447225|788296|P5|STARTED|Overall Study||3
328553|NCT01447225|788297|P4|STARTED|Overall Study||3
328554|NCT01447225|788298|P3|STARTED|Overall Study||5
328555|NCT01447225|788299|P2|STARTED|Overall Study||8
328556|NCT01447225|788300|P1|STARTED|Overall Study||3
328557|NCT01447121|788370|P1|NOT COMPLETED|Overall Study||0
328558|NCT01447121|788370|P1|COMPLETED|Overall Study||118
328559|NCT01447121|788370|P1|STARTED|Overall Study||118
328560|NCT01447017|788377|P2|NOT COMPLETED|Overall Study||10
328561|NCT01447017|788378|P1|NOT COMPLETED|Overall Study||10
328562|NCT01447017|788377|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
328563|NCT01447017|788378|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
328564|NCT01447017|788377|P2|Performed Visit 2|Overall Study||24
328565|NCT01447017|788378|P1|Performed Visit 2|Overall Study||43
328566|NCT01447017|788377|P2|STARTED|Overall Study||24
328567|NCT01447017|788378|P1|STARTED|Overall Study||45
328568|NCT01446796|788384|P2|NOT COMPLETED|Overall Study||0
328569|NCT01446796|788385|P1|NOT COMPLETED|Overall Study||1
328570|NCT01446796|788384|P2|COMPLETED|Overall Study|Study terminated early|0
328571|NCT01446796|788385|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
328572|NCT01446796|788384|P2|STARTED|Overall Study||0
328573|NCT01446796|788385|P1|STARTED|Overall Study||3
328574|NCT01446705|788399|P2|NOT COMPLETED|Overall Study||0
328575|NCT01446705|788400|P1|NOT COMPLETED|Overall Study||0
328576|NCT01446705|788399|P2|COMPLETED|Overall Study||6627
328577|NCT01446705|788400|P1|COMPLETED|Overall Study||50446
328578|NCT01446705|788399|P2|STARTED|Overall Study||6627
328579|NCT01446705|788400|P1|STARTED|Overall Study||50446
328580|NCT01446419|788410|P2|NOT COMPLETED|Overall Study||1
328581|NCT01446419|788411|P1|NOT COMPLETED|Overall Study||5
328582|NCT01446419|788410|P2|COMPLETED|Overall Study||77
328583|NCT01446419|788411|P1|COMPLETED|Overall Study||142
328584|NCT01446419|788410|P2|12 Month Follow-up|Overall Study||77
328585|NCT01446419|788411|P1|12 Month Follow-up|Overall Study||142
328586|NCT01446419|788410|P2|6 Month Follow-up|Overall Study||77
328587|NCT01446419|788411|P1|6 Month Follow-up|Overall Study||144
328588|NCT01446419|788410|P2|3 Month Follow-up|Overall Study||77
328589|NCT01446419|788411|P1|3 Month Follow-up|Overall Study||146
328590|NCT01446419|788410|P2|STARTED|Overall Study||78
328591|NCT01446419|788411|P1|STARTED|Overall Study||147
328592|NCT01446289|788425|P4|NOT COMPLETED|Overall Study||0
328593|NCT01446289|788426|P3|NOT COMPLETED|Overall Study||1
328594|NCT01446289|788427|P2|NOT COMPLETED|Overall Study||0
328595|NCT01446289|788428|P1|NOT COMPLETED|Overall Study||1
328596|NCT01446289|788425|P4|COMPLETED|Overall Study||35
328597|NCT01446289|788426|P3|COMPLETED|Overall Study||50
328598|NCT01446289|788427|P2|COMPLETED|Overall Study||35
328599|NCT01446289|788428|P1|COMPLETED|Overall Study||50
328600|NCT01446289|788425|P4|STARTED|Overall Study||35
328601|NCT01446289|788426|P3|STARTED|Overall Study||51
328602|NCT01446289|788427|P2|STARTED|Overall Study||35
328603|NCT01446289|788428|P1|STARTED|Overall Study||51
328604|NCT01446250|788456|P4|NOT COMPLETED|Follow-up||6
328605|NCT01446250|788457|P3|NOT COMPLETED|Follow-up||0
328606|NCT01446250|788458|P2|NOT COMPLETED|Follow-up||0
328607|NCT01446250|788459|P1|NOT COMPLETED|Follow-up||0
328608|NCT01446250|788456|P4|COMPLETED|Follow-up||0
328609|NCT01446250|788457|P3|COMPLETED|Follow-up||0
328610|NCT01446250|788458|P2|COMPLETED|Follow-up||0
328611|NCT01446250|788459|P1|COMPLETED|Follow-up||0
328612|NCT01446250|788456|P4|STARTED|Follow-up||6
328613|NCT01446250|788457|P3|STARTED|Follow-up||0
328614|NCT01446250|788458|P2|STARTED|Follow-up||0
328615|NCT01446250|788459|P1|STARTED|Follow-up||0
328616|NCT01446250|788456|P4|NOT COMPLETED|Treatment Period 2||0
328617|NCT01446250|788457|P3|NOT COMPLETED|Treatment Period 2||0
328618|NCT01446250|788458|P2|NOT COMPLETED|Treatment Period 2||1
328619|NCT01446250|788459|P1|NOT COMPLETED|Treatment Period 2||0
328620|NCT01446250|788456|P4|COMPLETED|Treatment Period 2||0
328621|NCT01446250|788457|P3|COMPLETED|Treatment Period 2||0
328622|NCT01446250|788458|P2|COMPLETED|Treatment Period 2||6
328623|NCT01446250|788459|P1|COMPLETED|Treatment Period 2||0
328624|NCT01446250|788456|P4|STARTED|Treatment Period 2||0
328625|NCT01446250|788457|P3|STARTED|Treatment Period 2||0
328626|NCT01446250|788458|P2|STARTED|Treatment Period 2||7
328627|NCT01446250|788459|P1|STARTED|Treatment Period 2||0
328628|NCT01446250|788456|P4|NOT COMPLETED|Clinical Hold||0
328629|NCT01446250|788457|P3|NOT COMPLETED|Clinical Hold||0
328630|NCT01446250|788458|P2|NOT COMPLETED|Clinical Hold||0
328631|NCT01446250|788459|P1|NOT COMPLETED|Clinical Hold||0
328632|NCT01446250|788456|P4|COMPLETED|Clinical Hold||0
328633|NCT01446250|788457|P3|COMPLETED|Clinical Hold||5
328634|NCT01446250|788458|P2|COMPLETED|Clinical Hold||2
328635|NCT01446250|788459|P1|COMPLETED|Clinical Hold||0
328636|NCT01446250|788456|P4|STARTED|Clinical Hold||0
328637|NCT01446250|788457|P3|STARTED|Clinical Hold||5
328638|NCT01446250|788458|P2|STARTED|Clinical Hold||2
328639|NCT01446250|788459|P1|STARTED|Clinical Hold||0
328640|NCT01446250|788456|P4|NOT COMPLETED|Treatment Period 1||0
328641|NCT01446250|788457|P3|NOT COMPLETED|Treatment Period 1||0
328642|NCT01446250|788458|P2|NOT COMPLETED|Treatment Period 1||1
328643|NCT01446250|788459|P1|NOT COMPLETED|Treatment Period 1||0
328644|NCT01446250|788456|P4|COMPLETED|Treatment Period 1||0
328645|NCT01446250|788457|P3|COMPLETED|Treatment Period 1||0
328646|NCT01446250|788458|P2|COMPLETED|Treatment Period 1||2
328647|NCT01446250|788459|P1|COMPLETED|Treatment Period 1||5
328648|NCT01446250|788456|P4|STARTED|Treatment Period 1||0
328649|NCT01446250|788457|P3|STARTED|Treatment Period 1||0
328650|NCT01446250|788458|P2|STARTED|Treatment Period 1||3
328651|NCT01446250|788459|P1|STARTED|Treatment Period 1||5
328652|NCT01446237|788471|P1|NOT COMPLETED|Overall Study||10
328653|NCT01446237|788471|P1|COMPLETED|Overall Study||115
328654|NCT01446237|788471|P1|STARTED|Overall Study||125
328655|NCT01446003|788479|P2|NOT COMPLETED|Period 2||0
328656|NCT01446003|788480|P1|NOT COMPLETED|Period 2||1
328657|NCT01446003|788479|P2|COMPLETED|Period 2||15
328658|NCT01446003|788480|P1|COMPLETED|Period 2||13
328659|NCT01446003|788479|P2|STARTED|Period 2||15
328660|NCT01446003|788480|P1|STARTED|Period 2||14
328661|NCT01446003|788479|P2|NOT COMPLETED|Period 1||0
328662|NCT01446003|788480|P1|NOT COMPLETED|Period 1||2
328663|NCT01446003|788479|P2|COMPLETED|Period 1||15
328664|NCT01446003|788480|P1|COMPLETED|Period 1||14
328665|NCT01446003|788479|P2|STARTED|Period 1||15
328666|NCT01446003|788480|P1|STARTED|Period 1||16
328667|NCT01445951|788501|P3|NOT COMPLETED|Overall Study||19
328668|NCT01445951|788502|P2|NOT COMPLETED|Overall Study||36
328669|NCT01445951|788503|P1|NOT COMPLETED|Overall Study||44
328670|NCT01445951|788501|P3|COMPLETED|Overall Study||151
328671|NCT01445951|788502|P2|COMPLETED|Overall Study||138
328672|NCT01445951|788503|P1|COMPLETED|Overall Study||130
328673|NCT01445951|788501|P3|STARTED|Overall Study||170
328674|NCT01445951|788502|P2|STARTED|Overall Study||174
328675|NCT01445951|788503|P1|STARTED|Overall Study||174
328676|NCT01445873|788541|P1|NOT COMPLETED|Overall Study||0
328677|NCT01445873|788541|P1|COMPLETED|Overall Study||36
328678|NCT01445873|788541|P1|STARTED|Overall Study||36
328679|NCT01445847|788571|P2|NOT COMPLETED|Overall Study||14
328680|NCT01445847|788572|P1|NOT COMPLETED|Overall Study||14
328681|NCT01445847|788571|P2|COMPLETED|Overall Study||36
328682|NCT01445847|788572|P1|COMPLETED|Overall Study||36
328683|NCT01445847|788571|P2|STARTED|Overall Study||50
328684|NCT01445847|788572|P1|STARTED|Overall Study||50
328685|NCT01445769|788578|P1|NOT COMPLETED|Overall Study||8
328686|NCT01445769|788578|P1|COMPLETED|Overall Study||37
328687|NCT01445769|788578|P1|STARTED|Overall Study||45
328688|NCT01445678|788598|P2|NOT COMPLETED|Overall Study||21
328689|NCT01445678|788599|P1|NOT COMPLETED|Overall Study||30
328690|NCT01445678|788598|P2|COMPLETED|Overall Study||476
328691|NCT01445678|788599|P1|COMPLETED|Overall Study||452
328692|NCT01445678|788598|P2|STARTED|Overall Study||497
328693|NCT01445678|788599|P1|STARTED|Overall Study||482
328694|NCT01445652|788617|P2|NOT COMPLETED|Overall Study||3
328695|NCT01445652|788618|P1|NOT COMPLETED|Overall Study||10
328696|NCT01445652|788617|P2|COMPLETED|Overall Study||50
328697|NCT01445652|788618|P1|COMPLETED|Overall Study||47
328698|NCT01445652|788617|P2|STARTED|Overall Study||53
328699|NCT01445652|788618|P1|STARTED|Overall Study||57
328700|NCT01445626|788626|P1|NOT COMPLETED|Overall Study||0
328701|NCT01445626|788626|P1|COMPLETED|Overall Study||87
328702|NCT01445626|788626|P1|STARTED|Overall Study||87
328703|NCT01445613|788636|P1|NOT COMPLETED|1-year Follow-up||77
328704|NCT01445613|788636|P1|COMPLETED|1-year Follow-up||1088
328705|NCT01445613|788636|P1|STARTED|1-year Follow-up||1165
328706|NCT01445613|788636|P1|NOT COMPLETED|30-day Follow-up||35
328707|NCT01445613|788636|P1|COMPLETED|30-day Follow-up||1165
328708|NCT01445613|788636|P1|STARTED|30-day Follow-up||1200
328709|NCT01445548|788654|P1|NOT COMPLETED|Overall Study||1
328710|NCT01445548|788654|P1|COMPLETED|Overall Study||5
328711|NCT01445548|788654|P1|STARTED|Overall Study||6
328712|NCT01445028|788677|P2|NOT COMPLETED|Overall Study||3
328713|NCT01445028|788678|P1|NOT COMPLETED|Overall Study||0
328714|NCT01445028|788677|P2|COMPLETED|Overall Study||51
328715|NCT01445028|788678|P1|COMPLETED|Overall Study||58
328716|NCT01445028|788677|P2|STARTED|Overall Study||54
328717|NCT01445028|788678|P1|STARTED|Overall Study||58
328718|NCT01444924|788686|P2|NOT COMPLETED|Overall Study||0
328719|NCT01444924|788687|P1|NOT COMPLETED|Overall Study||0
328720|NCT01444924|788686|P2|COMPLETED|Overall Study||33
328721|NCT01444924|788687|P1|COMPLETED|Overall Study||31
328722|NCT01444924|788686|P2|STARTED|Overall Study||33
328723|NCT01444924|788687|P1|STARTED|Overall Study||31
328724|NCT01444898|788693|P1|NOT COMPLETED|Overall Study||1
328725|NCT01444898|788693|P1|COMPLETED|Overall Study||9
328726|NCT01444898|788693|P1|STARTED|Overall Study||10
328727|NCT01444781|788708|P3|NOT COMPLETED|Overall Study||3
328728|NCT01444781|788709|P2|NOT COMPLETED|Overall Study||4
328729|NCT01444781|788710|P1|NOT COMPLETED|Overall Study||3
328730|NCT01444781|788708|P3|COMPLETED|Overall Study||272
328731|NCT01444781|788709|P2|COMPLETED|Overall Study||411
328732|NCT01444781|788710|P1|COMPLETED|Overall Study||413
328733|NCT01444781|788708|P3|STARTED|Overall Study||275
328734|NCT01444781|788709|P2|STARTED|Overall Study||415
328735|NCT01444781|788710|P1|STARTED|Overall Study||416
328736|NCT01444651|788750|P2|NOT COMPLETED|Overall Study||9
328737|NCT01444651|788751|P1|NOT COMPLETED|Overall Study||11
328738|NCT01444651|788750|P2|COMPLETED|Overall Study||28
328739|NCT01444651|788751|P1|COMPLETED|Overall Study||25
328740|NCT01444651|788750|P2|STARTED|Overall Study||37
328741|NCT01444651|788751|P1|STARTED|Overall Study||36
328742|NCT01444456|788767|P1|NOT COMPLETED|Overall Study||285
328743|NCT01444456|788767|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
328744|NCT01444456|788767|P1|Received Darbepoetin Alfa|Overall Study||1134
328745|NCT01444456|788767|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
328746|NCT01444456|788767|P1|STARTED|Overall Study||1262
328747|NCT01444430|788778|P2|NOT COMPLETED|Overall Study||81
328748|NCT01444430|788779|P1|NOT COMPLETED|Overall Study||61
328749|NCT01444430|788778|P2|COMPLETED|Overall Study||5766
328750|NCT01444430|788779|P1|COMPLETED|Overall Study||5785
328751|NCT01444430|788778|P2|STARTED|Overall Study||5847
328752|NCT01444430|788779|P1|STARTED|Overall Study||5846
328753|NCT01444417|788801|P2|NOT COMPLETED|Overall Study||1
328754|NCT01444417|788802|P1|NOT COMPLETED|Overall Study||2
328755|NCT01444417|788801|P2|COMPLETED|Overall Study||41
328756|NCT01444417|788802|P1|COMPLETED|Overall Study||18
328757|NCT01444417|788801|P2|Received Treatment|Overall Study||42
328758|NCT01444417|788802|P1|Received Treatment|Overall Study||19
328759|NCT01444417|788801|P2|STARTED|Overall Study||42
328760|NCT01444417|788802|P1|STARTED|Overall Study||20
328761|NCT01444391|788818|P1|NOT COMPLETED|Overall Study||1
328762|NCT01444391|788818|P1|COMPLETED|Overall Study||41
328763|NCT01444391|788818|P1|STARTED|Overall Study||42
328764|NCT01444378|788826|P1|NOT COMPLETED|Overall Study||17
328765|NCT01444378|788826|P1|COMPLETED|Overall Study||124
328766|NCT01444378|788826|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
328767|NCT01444300|788938|P2|NOT COMPLETED|Overall Study||0
328768|NCT01444300|788939|P1|NOT COMPLETED|Overall Study||4
328769|NCT01444300|788938|P2|COMPLETED|Overall Study||12
328770|NCT01444300|788939|P1|COMPLETED|Overall Study||8
328771|NCT01444300|788938|P2|STARTED|Overall Study||12
328772|NCT01444300|788939|P1|STARTED|Overall Study||12
328773|NCT01444287|788949|P1|NOT COMPLETED|Period 4||0
328774|NCT01444287|788949|P1|COMPLETED|Period 4||22
328775|NCT01444287|788949|P1|STARTED|Period 4||22
328776|NCT01444287|788949|P1|NOT COMPLETED|Period 3||0
328777|NCT01444287|788949|P1|COMPLETED|Period 3||22
328778|NCT01444287|788949|P1|STARTED|Period 3||22
328779|NCT01444287|788949|P1|NOT COMPLETED|Period 2||0
328780|NCT01444287|788949|P1|COMPLETED|Period 2||22
328781|NCT01444287|788949|P1|STARTED|Period 2||22
328782|NCT01444287|788949|P1|NOT COMPLETED|Period 1||0
328783|NCT01444287|788949|P1|COMPLETED|Period 1||22
328784|NCT01444287|788949|P1|STARTED|Period 1||22
328785|NCT01444092|788971|P1|NOT COMPLETED|Overall Study||17
328786|NCT01444092|788971|P1|COMPLETED|Overall Study||91
328787|NCT01444092|788971|P1|INFORMED CONSENT OBTAINED|Overall Study||108
328788|NCT01444092|788971|P1|STARTED|Overall Study||108
328789|NCT01443923|788979|P2|NOT COMPLETED|Overall Study||0
328790|NCT01443923|788980|P1|NOT COMPLETED|Overall Study||1
328791|NCT01443923|788979|P2|COMPLETED|Overall Study||1
328792|NCT01443923|788980|P1|COMPLETED|Overall Study||2
328793|NCT01443923|788979|P2|STARTED|Overall Study||1
328794|NCT01443923|788980|P1|STARTED|Overall Study||3
328795|NCT01443858|788997|P3|NOT COMPLETED|Overall Study||7
328796|NCT01443858|788998|P2|NOT COMPLETED|Overall Study||13
328797|NCT01443858|788999|P1|NOT COMPLETED|Overall Study||15
328798|NCT01443858|788997|P3|COMPLETED|Overall Study||18
328799|NCT01443858|788998|P2|COMPLETED|Overall Study||12
328800|NCT01443858|788999|P1|COMPLETED|Overall Study||10
328801|NCT01443858|788997|P3|STARTED|Overall Study||25
328802|NCT01443858|788998|P2|STARTED|Overall Study||25
328803|NCT01443858|788999|P1|STARTED|Overall Study||25
328804|NCT01443845|789021|P2|NOT COMPLETED|Overall Study||337
328805|NCT01443845|789022|P1|NOT COMPLETED|Overall Study||254
328806|NCT01443845|789021|P2|COMPLETED|Overall Study||841
328807|NCT01443845|789022|P1|COMPLETED|Overall Study||922
328808|NCT01443845|789021|P2|STARTED|Overall Study||1178
328809|NCT01443845|789022|P1|STARTED|Overall Study||1176
328810|NCT01443494|789034|P1|NOT COMPLETED|Overall Study||0
328811|NCT01443494|789034|P1|COMPLETED|Overall Study||19
328812|NCT01443494|789034|P1|STARTED|Overall Study||19
328813|NCT01443403|789043|P4|NOT COMPLETED|Overall Study||9
328814|NCT01443403|789044|P3|NOT COMPLETED|Overall Study||7
328815|NCT01443403|789045|P2|NOT COMPLETED|Overall Study||6
328816|NCT01443403|789046|P1|NOT COMPLETED|Overall Study||6
328817|NCT01443403|789043|P4|COMPLETED|Overall Study||52
328818|NCT01443403|789044|P3|COMPLETED|Overall Study||54
328819|NCT01443403|789045|P2|COMPLETED|Overall Study||55
328820|NCT01443403|789046|P1|COMPLETED|Overall Study||55
328821|NCT01443403|789043|P4|Received Treatment|Overall Study||61
328822|NCT01443403|789044|P3|Received Treatment|Overall Study||60
328823|NCT01443403|789045|P2|Received Treatment|Overall Study||61
328824|NCT01443403|789046|P1|Received Treatment|Overall Study||61
328825|NCT01443403|789043|P4|STARTED|Overall Study||61
328826|NCT01443403|789044|P3|STARTED|Overall Study||61
328827|NCT01443403|789045|P2|STARTED|Overall Study||61
328828|NCT01443403|789046|P1|STARTED|Overall Study||61
328829|NCT01443364|789193|P1|NOT COMPLETED|Overall Study||41
328830|NCT01443364|789193|P1|COMPLETED|Overall Study||91
328831|NCT01443364|789193|P1|STARTED|Overall Study||132
328832|NCT01443130|789322|P6|NOT COMPLETED|Overall Study||34
328833|NCT01443130|789323|P5|NOT COMPLETED|Overall Study||44
328834|NCT01443130|789324|P4|NOT COMPLETED|Overall Study||39
328835|NCT01443130|789325|P3|NOT COMPLETED|Overall Study||77
328836|NCT01443130|789326|P2|NOT COMPLETED|Overall Study||69
328837|NCT01443130|789327|P1|NOT COMPLETED|Overall Study||68
328838|NCT01443130|789322|P6|COMPLETED|Overall Study||225
328839|NCT01443130|789323|P5|COMPLETED|Overall Study||230
328840|NCT01443130|789324|P4|COMPLETED|Overall Study||231
328841|NCT01443130|789325|P3|COMPLETED|Overall Study||223
328842|NCT01443130|789326|P2|COMPLETED|Overall Study||231
328843|NCT01443130|789327|P1|COMPLETED|Overall Study||232
328844|NCT01443130|789322|P6|STARTED|Overall Study||259
328845|NCT01443130|789323|P5|STARTED|Overall Study||274
328846|NCT01443130|789324|P4|STARTED|Overall Study||270
328847|NCT01443130|789325|P3|STARTED|Overall Study||300
328848|NCT01443130|789326|P2|STARTED|Overall Study||300
328849|NCT01443130|789327|P1|STARTED|Overall Study||300
328850|NCT01443078|789377|P1|NOT COMPLETED|Overall Study||29
328851|NCT01443078|789377|P1|COMPLETED|Overall Study||13
328852|NCT01443078|789377|P1|STARTED|Overall Study||42
328853|NCT01443026|789383|P2|NOT COMPLETED|Overall Study||5
328854|NCT01443026|789384|P1|NOT COMPLETED|Overall Study||3
328855|NCT01443026|789383|P2|COMPLETED|Overall Study||32
328856|NCT01443026|789384|P1|COMPLETED|Overall Study||26
328857|NCT01443026|789383|P2|STARTED|Overall Study||37
328858|NCT01443026|789384|P1|STARTED|Overall Study||29
328859|NCT01442844|789392|P2|NOT COMPLETED|Overall Study||0
328860|NCT01442844|789393|P1|NOT COMPLETED|Overall Study||0
328861|NCT01442844|789392|P2|COMPLETED|Overall Study||2
328862|NCT01442844|789393|P1|COMPLETED|Overall Study||1
328863|NCT01442844|789392|P2|STARTED|Overall Study||2
328864|NCT01442844|789393|P1|STARTED|Overall Study||1
328865|NCT01442779|789399|P1|NOT COMPLETED|Overall Study||7
328866|NCT01442779|789399|P1|COMPLETED|Overall Study||11
328867|NCT01442779|789399|P1|STARTED|Overall Study||18
328868|NCT01442688|789407|P2|NOT COMPLETED|Second Intervention||0
328869|NCT01442688|789408|P1|NOT COMPLETED|Second Intervention||1
328870|NCT01442688|789407|P2|COMPLETED|Second Intervention||31
328871|NCT01442688|789408|P1|COMPLETED|Second Intervention||28
328872|NCT01442688|789407|P2|STARTED|Second Intervention||31
328873|NCT01442688|789408|P1|STARTED|Second Intervention||29
328874|NCT01442688|789407|P2|NOT COMPLETED|First Intervention||0
328875|NCT01442688|789408|P1|NOT COMPLETED|First Intervention||2
328876|NCT01442688|789407|P2|COMPLETED|First Intervention||31
328877|NCT01442688|789408|P1|COMPLETED|First Intervention||29
328878|NCT01442688|789407|P2|STARTED|First Intervention||31
328879|NCT01442688|789408|P1|STARTED|First Intervention||31
328880|NCT01442675|789416|P1|NOT COMPLETED|Overall Study||12
328881|NCT01442675|789416|P1|COMPLETED|Overall Study||822
328882|NCT01442675|789416|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
328883|NCT01442675|789416|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
328884|NCT01442675|789416|P1|STARTED|Overall Study||834
328885|NCT01442376|789429|P3|NOT COMPLETED|Overall Study||5
328886|NCT01442376|789430|P2|NOT COMPLETED|Overall Study||9
328887|NCT01442376|789431|P1|NOT COMPLETED|Overall Study||3
328888|NCT01442376|789429|P3|COMPLETED|Overall Study||159
328889|NCT01442376|789430|P2|COMPLETED|Overall Study||160
328890|NCT01442376|789431|P1|COMPLETED|Overall Study||166
328891|NCT01442376|789429|P3|STARTED|Overall Study|Randomized patients|164
328892|NCT01442376|789430|P2|STARTED|Overall Study|Randomized patients|169
328893|NCT01442376|789431|P1|STARTED|Overall Study|Randomized patients|169
328894|NCT01442181|789444|P2|NOT COMPLETED|Overall Study||3
328895|NCT01442181|789445|P1|NOT COMPLETED|Overall Study||4
328896|NCT01442181|789444|P2|COMPLETED|Overall Study||8
328897|NCT01442181|789445|P1|COMPLETED|Overall Study||10
328898|NCT01442181|789444|P2|STARTED|Overall Study||11
328899|NCT01442181|789445|P1|STARTED|Overall Study||14
328900|NCT01442155|789469|P1|NOT COMPLETED|Overall Study||65
328901|NCT01442155|789469|P1|COMPLETED|Overall Study||9
328902|NCT01442155|789469|P1|STARTED|Overall Study||74
328903|NCT01442129|789476|P2|NOT COMPLETED|Overall Study||0
328904|NCT01442129|789477|P1|NOT COMPLETED|Overall Study||0
328905|NCT01442129|789476|P2|COMPLETED|Overall Study||10
328906|NCT01442129|789477|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
328907|NCT01442129|789476|P2|STARTED|Overall Study||10
328908|NCT01442129|789477|P1|STARTED|Overall Study||20
328909|NCT01442103|789485|P1|NOT COMPLETED|Overall Study||2
328910|NCT01442103|789485|P1|COMPLETED|Overall Study||8
328911|NCT01442103|789485|P1|STARTED|Overall Study||10
328912|NCT01442064|789495|P6|NOT COMPLETED|Overall Study||99
328913|NCT01442064|789496|P5|NOT COMPLETED|Overall Study||106
328914|NCT01442064|789497|P4|NOT COMPLETED|Overall Study||98
328915|NCT01442064|789498|P3|NOT COMPLETED|Overall Study||104
328916|NCT01442064|789499|P2|NOT COMPLETED|Overall Study||101
328917|NCT01442064|789500|P1|NOT COMPLETED|Overall Study||97
328918|NCT01442064|789495|P6|COMPLETED|Overall Study||0
328919|NCT01442064|789496|P5|COMPLETED|Overall Study||1
328920|NCT01442064|789497|P4|COMPLETED|Overall Study||0
328921|NCT01442064|789498|P3|COMPLETED|Overall Study||0
328922|NCT01442064|789499|P2|COMPLETED|Overall Study||2
328923|NCT01442064|789500|P1|COMPLETED|Overall Study||0
328924|NCT01442064|789495|P6|Received Study Drug in Extension Study|Overall Study||81
328925|NCT01442064|789496|P5|Received Study Drug in Extension Study|Overall Study||89
328926|NCT01442064|789497|P4|Received Study Drug in Extension Study|Overall Study||70
328927|NCT01442064|789498|P3|Received Study Drug in Extension Study|Overall Study||60
328928|NCT01442064|789499|P2|Received Study Drug in Extension Study|Overall Study||70
328929|NCT01442064|789500|P1|Received Study Drug in Extension Study|Overall Study||61
328930|NCT01442064|789495|P6|Ranibizumab-Treated Subjects|Overall Study||99
328931|NCT01442064|789496|P5|Ranibizumab-Treated Subjects|Overall Study||107
328932|NCT01442064|789497|P4|Ranibizumab-Treated Subjects|Overall Study||96
328933|NCT01442064|789498|P3|Ranibizumab-Treated Subjects|Overall Study||104
328934|NCT01442064|789499|P2|Ranibizumab-Treated Subjects|Overall Study||103
328935|NCT01442064|789500|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
328936|NCT01442064|789495|P6|STARTED|Overall Study||99
328937|NCT01442064|789496|P5|STARTED|Overall Study||107
328938|NCT01442064|789497|P4|STARTED|Overall Study||98
328939|NCT01442064|789498|P3|STARTED|Overall Study||104
328940|NCT01442064|789499|P2|STARTED|Overall Study||103
328941|NCT01442064|789500|P1|STARTED|Overall Study||97
328942|NCT01442038|789537|P2|NOT COMPLETED|Overall Study||279
328943|NCT01442038|789538|P1|NOT COMPLETED|Overall Study||303
328944|NCT01442038|789537|P2|COMPLETED|Overall Study||1040
328945|NCT01442038|789538|P1|COMPLETED|Overall Study||1029
328946|NCT01442038|789537|P2|STARTED|Overall Study||1319
328947|NCT01442038|789538|P1|STARTED|Overall Study||1332
328948|NCT01441973|789552|P2|NOT COMPLETED|Overall Study||5
328949|NCT01441973|789553|P1|NOT COMPLETED|Overall Study||8
328950|NCT01441973|789552|P2|COMPLETED|Overall Study|Still receiving treatment|11
328951|NCT01441973|789553|P1|COMPLETED|Overall Study|Still receiving treatment|7
328952|NCT01441973|789552|P2|STARTED|Overall Study||16
328953|NCT01441973|789553|P1|STARTED|Overall Study||15
328954|NCT01441960|789567|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
328955|NCT01441960|789568|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
328956|NCT01441960|789567|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
328957|NCT01441960|789568|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
328958|NCT01441960|789567|P2|STARTED|Second Neuromuscular Blocking Agent||13
328959|NCT01441960|789568|P1|STARTED|Second Neuromuscular Blocking Agent||18
328960|NCT01441960|789567|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
328961|NCT01441960|789568|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
328962|NCT01441960|789567|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
328963|NCT01441960|789568|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
328964|NCT01441960|789567|P2|STARTED|First Neuromuscular Blocking Agent:||19
328965|NCT01441960|789568|P1|STARTED|First Neuromuscular Blocking Agent:||26
328966|NCT01441843|789580|P2|NOT COMPLETED|Overall Study||5
328967|NCT01441843|789581|P1|NOT COMPLETED|Overall Study||12
328968|NCT01441843|789580|P2|COMPLETED|Overall Study||195
328969|NCT01441843|789581|P1|COMPLETED|Overall Study||188
328970|NCT01441843|789580|P2|STARTED|Overall Study||200
328971|NCT01441843|789581|P1|STARTED|Overall Study||200
328972|NCT01441765|789589|P2|NOT COMPLETED|Overall Study||0
328973|NCT01441765|789590|P1|NOT COMPLETED|Overall Study||1
328974|NCT01441765|789589|P2|COMPLETED|Overall Study|not opened|0
328975|NCT01441765|789590|P1|COMPLETED|Overall Study||10
328976|NCT01441765|789589|P2|STARTED|Overall Study|not opened|0
328977|NCT01441765|789590|P1|STARTED|Overall Study||11
328978|NCT01441596|789607|P3|NOT COMPLETED|Overall Study||4
328979|NCT01441596|789608|P2|NOT COMPLETED|Overall Study||3
328980|NCT01441596|789609|P1|NOT COMPLETED|Overall Study||4
328981|NCT01441596|789607|P3|COMPLETED|Overall Study||39
328982|NCT01441596|789608|P2|COMPLETED|Overall Study||35
328983|NCT01441596|789609|P1|COMPLETED|Overall Study||36
328984|NCT01441596|789607|P3|STARTED|Overall Study||43
328985|NCT01441596|789608|P2|STARTED|Overall Study||38
328986|NCT01441596|789609|P1|STARTED|Overall Study||40
328987|NCT01441570|789625|P2|NOT COMPLETED|Overall Study||0
328988|NCT01441570|789626|P1|NOT COMPLETED|Overall Study||0
328989|NCT01441570|789625|P2|COMPLETED|Overall Study||5
328990|NCT01441570|789626|P1|COMPLETED|Overall Study||6
328991|NCT01441570|789625|P2|STARTED|Overall Study||5
328992|NCT01441570|789626|P1|STARTED|Overall Study||6
328993|NCT01441466|789636|P2|NOT COMPLETED|Overall Study||0
328994|NCT01441466|789637|P1|NOT COMPLETED|Overall Study||0
328995|NCT01441466|789636|P2|COMPLETED|Overall Study||11
328996|NCT01441466|789637|P1|COMPLETED|Overall Study||37
328997|NCT01441466|789636|P2|STARTED|Overall Study||11
328998|NCT01441466|789637|P1|STARTED|Overall Study||37
328999|NCT01441440|789656|P3|NOT COMPLETED|Overall Study||22
329000|NCT01441440|789657|P2|NOT COMPLETED|Overall Study||23
329001|NCT01441440|789658|P1|NOT COMPLETED|Overall Study||17
329002|NCT01441440|789656|P3|COMPLETED|Overall Study||158
329003|NCT01441440|789657|P2|COMPLETED|Overall Study||151
329004|NCT01441440|789658|P1|COMPLETED|Overall Study||166
329005|NCT01441440|789656|P3|STARTED|Overall Study|Safety analysis set|180
329006|NCT01441440|789657|P2|STARTED|Overall Study|Safety analysis set|174
329007|NCT01441440|789658|P1|STARTED|Overall Study|Safety analysis set|183
329008|NCT01441414|789681|P1|NOT COMPLETED|Overall Study||15
329009|NCT01441414|789681|P1|COMPLETED|Overall Study||3
329010|NCT01441414|789681|P1|STARTED|Overall Study||18
329011|NCT01441401|789706|P1|NOT COMPLETED|Overall Study||0
329012|NCT01441401|789706|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
329013|NCT01441401|789706|P1|STARTED|Overall Study||82
329014|NCT01441245|789734|P2|NOT COMPLETED|Overall Study||0
329015|NCT01441245|789735|P1|NOT COMPLETED|Overall Study||0
329016|NCT01441245|789734|P2|COMPLETED|Overall Study||27
329017|NCT01441245|789735|P1|COMPLETED|Overall Study||30
329018|NCT01441245|789734|P2|STARTED|Overall Study||27
329019|NCT01441245|789735|P1|STARTED|Overall Study||30
329020|NCT01441180|789760|P3|NOT COMPLETED|Overall Study||3
329021|NCT01441180|789761|P2|NOT COMPLETED|Overall Study||1
329022|NCT01441180|789762|P1|NOT COMPLETED|Overall Study||1
329023|NCT01441180|789760|P3|COMPLETED|Overall Study||22
329024|NCT01441180|789761|P2|COMPLETED|Overall Study||24
329025|NCT01441180|789762|P1|COMPLETED|Overall Study||9
329026|NCT01441180|789760|P3|STARTED|Overall Study||25
329027|NCT01441180|789761|P2|STARTED|Overall Study||25
329028|NCT01441180|789762|P1|STARTED|Overall Study||10
329029|NCT01441102|789773|P1|NOT COMPLETED|Overall Study||3
329030|NCT01441102|789773|P1|COMPLETED|Overall Study||4
329031|NCT01441102|789773|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
329032|NCT01441076|789793|P1|NOT COMPLETED|Overall Study||2
329033|NCT01441076|789793|P1|COMPLETED|Overall Study||4
329034|NCT01441076|789793|P1|STARTED|Overall Study||6
329035|NCT01440972|789813|P2|NOT COMPLETED|Overall Study||2
329036|NCT01440972|789814|P1|NOT COMPLETED|Overall Study||3
329037|NCT01440972|789813|P2|COMPLETED|Overall Study||19
329038|NCT01440972|789814|P1|COMPLETED|Overall Study||21
329039|NCT01440972|789813|P2|STARTED|Overall Study||21
329040|NCT01440972|789814|P1|STARTED|Overall Study||24
329041|NCT01440959|789828|P1|NOT COMPLETED|Overall Study||0
329042|NCT01440959|789828|P1|COMPLETED|Overall Study||30
329043|NCT01440959|789828|P1|STARTED|Overall Study||30
329044|NCT01440946|789838|P2|NOT COMPLETED|Overall Study||1
329045|NCT01440946|789839|P1|NOT COMPLETED|Overall Study||2
329046|NCT01440946|789838|P2|COMPLETED|Overall Study||14
329047|NCT01440946|789839|P1|COMPLETED|Overall Study||13
329048|NCT01440946|789838|P2|STARTED|Overall Study||15
329049|NCT01440946|789839|P1|STARTED|Overall Study||15
329050|NCT01440881|789878|P2|NOT COMPLETED|Overall Study||1
329051|NCT01440881|789879|P1|NOT COMPLETED|Overall Study||0
329052|NCT01440881|789878|P2|COMPLETED|Overall Study||14
329053|NCT01440881|789879|P1|COMPLETED|Overall Study||14
329054|NCT01440881|789878|P2|STARTED|Overall Study||15
329055|NCT01440881|789879|P1|STARTED|Overall Study||14
329056|NCT01440764|789893|P7|NOT COMPLETED|Test Day 3||0
329057|NCT01440764|789894|P6|NOT COMPLETED|Test Day 3||0
329058|NCT01440764|789895|P5|NOT COMPLETED|Test Day 3||0
329059|NCT01440764|789896|P4|NOT COMPLETED|Test Day 3||0
329060|NCT01440764|789897|P3|NOT COMPLETED|Test Day 3||0
329061|NCT01440764|789898|P2|NOT COMPLETED|Test Day 3||0
329062|NCT01440764|789899|P1|NOT COMPLETED|Test Day 3||0
329063|NCT01440764|789893|P7|COMPLETED|Test Day 3||3
329064|NCT01440764|789894|P6|COMPLETED|Test Day 3||5
329065|NCT01440764|789895|P5|COMPLETED|Test Day 3||3
329066|NCT01440764|789896|P4|COMPLETED|Test Day 3||1
329067|NCT01440764|789897|P3|COMPLETED|Test Day 3||6
329068|NCT01440764|789898|P2|COMPLETED|Test Day 3||2
329069|NCT01440764|789899|P1|COMPLETED|Test Day 3||3
329070|NCT01440764|789893|P7|STARTED|Test Day 3||3
329071|NCT01440764|789894|P6|STARTED|Test Day 3||5
329072|NCT01440764|789895|P5|STARTED|Test Day 3||3
329073|NCT01440764|789896|P4|STARTED|Test Day 3||1
329074|NCT01440764|789897|P3|STARTED|Test Day 3||6
329075|NCT01440764|789898|P2|STARTED|Test Day 3||2
329076|NCT01440764|789899|P1|STARTED|Test Day 3||3
329077|NCT01440764|789893|P7|NOT COMPLETED|Test Day 2||0
329078|NCT01440764|789894|P6|NOT COMPLETED|Test Day 2||0
329079|NCT01440764|789895|P5|NOT COMPLETED|Test Day 2||0
329080|NCT01440764|789896|P4|NOT COMPLETED|Test Day 2||0
329081|NCT01440764|789897|P3|NOT COMPLETED|Test Day 2||0
329082|NCT01440764|789898|P2|NOT COMPLETED|Test Day 2||0
329083|NCT01440764|789899|P1|NOT COMPLETED|Test Day 2||0
329084|NCT01440764|789893|P7|COMPLETED|Test Day 2||3
329085|NCT01440764|789894|P6|COMPLETED|Test Day 2||5
329086|NCT01440764|789895|P5|COMPLETED|Test Day 2||3
329087|NCT01440764|789896|P4|COMPLETED|Test Day 2||1
329088|NCT01440764|789897|P3|COMPLETED|Test Day 2||6
329089|NCT01440764|789898|P2|COMPLETED|Test Day 2||2
329090|NCT01440764|789899|P1|COMPLETED|Test Day 2||3
329091|NCT01440764|789893|P7|STARTED|Test Day 2||3
329092|NCT01440764|789894|P6|STARTED|Test Day 2||5
329093|NCT01440764|789895|P5|STARTED|Test Day 2||3
329094|NCT01440764|789896|P4|STARTED|Test Day 2||1
329095|NCT01440764|789897|P3|STARTED|Test Day 2||6
329096|NCT01440764|789898|P2|STARTED|Test Day 2||2
329097|NCT01440764|789899|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
329098|NCT01440764|789893|P7|NOT COMPLETED|Test Day 1||0
329099|NCT01440764|789894|P6|NOT COMPLETED|Test Day 1||0
329100|NCT01440764|789895|P5|NOT COMPLETED|Test Day 1||0
329101|NCT01440764|789896|P4|NOT COMPLETED|Test Day 1||0
329102|NCT01440764|789897|P3|NOT COMPLETED|Test Day 1||0
329103|NCT01440764|789898|P2|NOT COMPLETED|Test Day 1||0
329104|NCT01440764|789899|P1|NOT COMPLETED|Test Day 1||0
329105|NCT01440764|789893|P7|COMPLETED|Test Day 1||3
329106|NCT01440764|789894|P6|COMPLETED|Test Day 1||5
329107|NCT01440764|789895|P5|COMPLETED|Test Day 1||3
329108|NCT01440764|789896|P4|COMPLETED|Test Day 1||1
329109|NCT01440764|789897|P3|COMPLETED|Test Day 1||6
329110|NCT01440764|789898|P2|COMPLETED|Test Day 1||2
329111|NCT01440764|789899|P1|COMPLETED|Test Day 1||4
329112|NCT01440764|789893|P7|STARTED|Test Day 1||3
329113|NCT01440764|789894|P6|STARTED|Test Day 1||5
329114|NCT01440764|789895|P5|STARTED|Test Day 1||3
329115|NCT01440764|789896|P4|STARTED|Test Day 1||1
329116|NCT01440764|789897|P3|STARTED|Test Day 1||6
329117|NCT01440764|789898|P2|STARTED|Test Day 1||2
329118|NCT01440764|789899|P1|STARTED|Test Day 1||4
329119|NCT01440647|789920|P2|NOT COMPLETED|Overall Study||3
329120|NCT01440647|789921|P1|NOT COMPLETED|Overall Study||2
329121|NCT01440647|789920|P2|COMPLETED|Overall Study||15
329122|NCT01440647|789921|P1|COMPLETED|Overall Study||14
329123|NCT01440647|789920|P2|STARTED|Overall Study||18
329124|NCT01440647|789921|P1|STARTED|Overall Study||16
329125|NCT01440634|789931|P2|NOT COMPLETED|Randomization Phase||10
329126|NCT01440634|789932|P1|NOT COMPLETED|Randomization Phase||6
329127|NCT01440634|789931|P2|COMPLETED|Randomization Phase||14
329128|NCT01440634|789932|P1|COMPLETED|Randomization Phase||24
329129|NCT01440634|789931|P2|STARTED|Randomization Phase||24
329130|NCT01440634|789932|P1|STARTED|Randomization Phase||30
329131|NCT01440634|789931|P2|NOT COMPLETED|Cross Sectional Phase||0
329132|NCT01440634|789932|P1|NOT COMPLETED|Cross Sectional Phase||0
329133|NCT01440634|789931|P2|COMPLETED|Cross Sectional Phase||347
329134|NCT01440634|789932|P1|COMPLETED|Cross Sectional Phase||0
329135|NCT01440634|789931|P2|STARTED|Cross Sectional Phase||347
329136|NCT01440634|789932|P1|STARTED|Cross Sectional Phase||0
329137|NCT01440595|789940|P3|NOT COMPLETED|Overall Study||1
329138|NCT01440595|789941|P2|NOT COMPLETED|Overall Study||3
329139|NCT01440595|789942|P1|NOT COMPLETED|Overall Study||1
329140|NCT01440595|789940|P3|COMPLETED|Overall Study||0
329141|NCT01440595|789941|P2|COMPLETED|Overall Study||0
329142|NCT01440595|789942|P1|COMPLETED|Overall Study||0
329143|NCT01440595|789940|P3|STARTED|Overall Study||1
329144|NCT01440595|789941|P2|STARTED|Overall Study||3
329145|NCT01440595|789942|P1|STARTED|Overall Study||1
329146|NCT01440569|789962|P2|NOT COMPLETED|Open-Label Rollover Phase||6
329147|NCT01440569|789963|P1|NOT COMPLETED|Open-Label Rollover Phase||47
329148|NCT01440569|789962|P2|COMPLETED|Open-Label Rollover Phase||7
329149|NCT01440569|789963|P1|COMPLETED|Open-Label Rollover Phase||204
329150|NCT01440569|789962|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
329151|NCT01440569|789963|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
329152|NCT01440569|789962|P2|NOT COMPLETED|Main Study||4
329153|NCT01440569|789963|P1|NOT COMPLETED|Main Study||36
329154|NCT01440569|789962|P2|COMPLETED|Main Study||14
329155|NCT01440569|789963|P1|COMPLETED|Main Study||260
329156|NCT01440569|789962|P2|Enrolled and Treated|Main Study||18
329157|NCT01440569|789963|P1|Enrolled and Treated|Main Study||295
329158|NCT01440569|789962|P2|STARTED|Main Study||18
329159|NCT01440569|789963|P1|STARTED|Main Study||296
329160|NCT01440543|789985|P4|NOT COMPLETED|Overall Study||6
329161|NCT01440543|789986|P3|NOT COMPLETED|Overall Study||2
329162|NCT01440543|789987|P2|NOT COMPLETED|Overall Study||4
329163|NCT01440543|789988|P1|NOT COMPLETED|Overall Study||4
329164|NCT01440543|789985|P4|COMPLETED|Overall Study||101
329165|NCT01440543|789986|P3|COMPLETED|Overall Study||100
329166|NCT01440543|789987|P2|COMPLETED|Overall Study||101
329167|NCT01440543|789988|P1|COMPLETED|Overall Study||102
329168|NCT01440543|789985|P4|STARTED|Overall Study||107
329169|NCT01440543|789986|P3|STARTED|Overall Study||102
329170|NCT01440543|789987|P2|STARTED|Overall Study||105
329171|NCT01440543|789988|P1|STARTED|Overall Study||106
329172|NCT01440517|789998|P1|NOT COMPLETED|Overall Study||1
329173|NCT01440517|789998|P1|COMPLETED|Overall Study||4
329174|NCT01440517|789998|P1|STARTED|Overall Study||5
329175|NCT01440387|790005|P2|NOT COMPLETED|Overall Study||0
329176|NCT01440387|790006|P1|NOT COMPLETED|Overall Study||0
329177|NCT01440387|790005|P2|COMPLETED|Overall Study||56
329178|NCT01440387|790006|P1|COMPLETED|Overall Study||56
329179|NCT01440387|790005|P2|STARTED|Overall Study||56
329180|NCT01440387|790006|P1|STARTED|Overall Study||56
329181|NCT01440374|790029|P4|NOT COMPLETED|Part 3: Extension||32
329182|NCT01440374|790030|P3|NOT COMPLETED|Part 3: Extension||0
329183|NCT01440374|790031|P2|NOT COMPLETED|Part 3: Extension||0
329184|NCT01440374|790032|P1|NOT COMPLETED|Part 3: Extension||0
329185|NCT01440374|790029|P4|COMPLETED|Part 3: Extension||27
329186|NCT01440374|790030|P3|COMPLETED|Part 3: Extension||0
329187|NCT01440374|790031|P2|COMPLETED|Part 3: Extension||0
329188|NCT01440374|790032|P1|COMPLETED|Part 3: Extension||0
329189|NCT01440374|790029|P4|STARTED|Part 3: Extension||59
329190|NCT01440374|790030|P3|STARTED|Part 3: Extension||0
329191|NCT01440374|790031|P2|STARTED|Part 3: Extension||0
329192|NCT01440374|790032|P1|STARTED|Part 3: Extension||0
329193|NCT01440374|790029|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
329194|NCT01440374|790030|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
329195|NCT01440374|790031|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
329196|NCT01440374|790032|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
329197|NCT01440374|790029|P4|COMPLETED|Part 2; Double-blind Phase||0
329198|NCT01440374|790030|P3|COMPLETED|Part 2; Double-blind Phase||43
329199|NCT01440374|790031|P2|COMPLETED|Part 2; Double-blind Phase||27
329200|NCT01440374|790032|P1|COMPLETED|Part 2; Double-blind Phase||0
329201|NCT01440374|790029|P4|STARTED|Part 2; Double-blind Phase||0
329202|NCT01440374|790030|P3|STARTED|Part 2; Double-blind Phase||98
329203|NCT01440374|790031|P2|STARTED|Part 2; Double-blind Phase||47
329204|NCT01440374|790032|P1|STARTED|Part 2; Double-blind Phase||0
329205|NCT01440374|790029|P4|NOT COMPLETED|Part 1: Open-label Phase||0
329206|NCT01440374|790030|P3|NOT COMPLETED|Part 1: Open-label Phase||0
329207|NCT01440374|790031|P2|NOT COMPLETED|Part 1: Open-label Phase||0
329208|NCT01440374|790032|P1|NOT COMPLETED|Part 1: Open-label Phase||6
329209|NCT01440374|790029|P4|COMPLETED|Part 1: Open-label Phase||0
329210|NCT01440374|790030|P3|COMPLETED|Part 1: Open-label Phase||0
329211|NCT01440374|790031|P2|COMPLETED|Part 1: Open-label Phase||0
329212|NCT01440374|790032|P1|COMPLETED|Part 1: Open-label Phase||11
329213|NCT01440374|790029|P4|STARTED|Part 1: Open-label Phase||0
329214|NCT01440374|790030|P3|STARTED|Part 1: Open-label Phase||0
329215|NCT01440374|790031|P2|STARTED|Part 1: Open-label Phase||0
329216|NCT01440374|790032|P1|STARTED|Part 1: Open-label Phase||17
329217|NCT01440322|790067|P2|NOT COMPLETED|Overall Study||1
329218|NCT01440322|790068|P1|NOT COMPLETED|Overall Study||7
329219|NCT01440322|790067|P2|COMPLETED|Overall Study||49
329220|NCT01440322|790068|P1|COMPLETED|Overall Study||90
329221|NCT01440322|790067|P2|STARTED|Overall Study||50
329222|NCT01440322|790068|P1|STARTED|Overall Study||97
329223|NCT01440283|790090|P1|NOT COMPLETED|Overall Study||10
329224|NCT01440283|790090|P1|COMPLETED|Overall Study||4
329225|NCT01440283|790090|P1|STARTED|Overall Study||14
329226|NCT01440101|790105|P3|NOT COMPLETED|Overall Study||1
329227|NCT01440101|790106|P2|NOT COMPLETED|Overall Study||4
329228|NCT01440101|790107|P1|NOT COMPLETED|Overall Study||2
329229|NCT01440101|790105|P3|COMPLETED|Overall Study||46
329230|NCT01440101|790106|P2|COMPLETED|Overall Study||43
329231|NCT01440101|790107|P1|COMPLETED|Overall Study||10
329232|NCT01440101|790105|P3|STARTED|Overall Study||47
329233|NCT01440101|790106|P2|STARTED|Overall Study||47
329234|NCT01440101|790107|P1|STARTED|Overall Study||12
329235|NCT01440049|790140|P1|NOT COMPLETED|Overall Study||5
329236|NCT01440049|790140|P1|COMPLETED|Overall Study||155
329237|NCT01440049|790140|P1|STARTED|Overall Study||160
329238|NCT01439971|790172|P5|NOT COMPLETED|Overall Study||1
329239|NCT01439971|790173|P4|NOT COMPLETED|Overall Study||0
329240|NCT01439971|790174|P3|NOT COMPLETED|Overall Study||2
329241|NCT01439971|790175|P2|NOT COMPLETED|Overall Study||1
329242|NCT01439971|790176|P1|NOT COMPLETED|Overall Study||0
329243|NCT01439971|790172|P5|COMPLETED|Overall Study||6
329244|NCT01439971|790173|P4|COMPLETED|Overall Study||6
329245|NCT01439971|790174|P3|COMPLETED|Overall Study||6
329246|NCT01439971|790175|P2|COMPLETED|Overall Study||6
329247|NCT01439971|790176|P1|COMPLETED|Overall Study||1
329248|NCT01439971|790172|P5|Received Treatment|Overall Study||6
329249|NCT01439971|790173|P4|Received Treatment|Overall Study||6
329250|NCT01439971|790174|P3|Received Treatment|Overall Study||6
329251|NCT01439971|790175|P2|Received Treatment|Overall Study||6
329252|NCT01439971|790176|P1|Received Treatment|Overall Study||1
329253|NCT01439971|790172|P5|STARTED|Overall Study||7
329254|NCT01439971|790173|P4|STARTED|Overall Study||6
329255|NCT01439971|790174|P3|STARTED|Overall Study||8
329256|NCT01439971|790175|P2|STARTED|Overall Study||7
329257|NCT01439971|790176|P1|STARTED|Overall Study||1
329258|NCT01439945|790356|P4|NOT COMPLETED|Optional Continuation Phase||0
329259|NCT01439945|790357|P3|NOT COMPLETED|Optional Continuation Phase||0
329260|NCT01439945|790358|P2|NOT COMPLETED|Optional Continuation Phase||0
329261|NCT01439945|790359|P1|NOT COMPLETED|Optional Continuation Phase||0
329262|NCT01439945|790356|P4|COMPLETED|Optional Continuation Phase||0
329263|NCT01439945|790357|P3|COMPLETED|Optional Continuation Phase||0
329264|NCT01439945|790358|P2|COMPLETED|Optional Continuation Phase||44
329265|NCT01439945|790359|P1|COMPLETED|Optional Continuation Phase||72
329266|NCT01439945|790356|P4|STARTED|Optional Continuation Phase||0
329267|NCT01439945|790357|P3|STARTED|Optional Continuation Phase||0
329268|NCT01439945|790358|P2|STARTED|Optional Continuation Phase||44
329269|NCT01439945|790359|P1|STARTED|Optional Continuation Phase||72
329270|NCT01439945|790356|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
329271|NCT01439945|790357|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
329272|NCT01439945|790358|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
329273|NCT01439945|790359|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
329274|NCT01439945|790356|P4|COMPLETED|Double-Blind Treatment Phase||46
329275|NCT01439945|790357|P3|COMPLETED|Double-Blind Treatment Phase||45
329276|NCT01439945|790358|P2|COMPLETED|Double-Blind Treatment Phase||91
329277|NCT01439945|790359|P1|COMPLETED|Double-Blind Treatment Phase||93
329278|NCT01439945|790356|P4|STARTED|Double-Blind Treatment Phase||48
329279|NCT01439945|790357|P3|STARTED|Double-Blind Treatment Phase||48
329280|NCT01439945|790358|P2|STARTED|Double-Blind Treatment Phase||96
329281|NCT01439945|790359|P1|STARTED|Double-Blind Treatment Phase||97
329282|NCT01439724|790384|P2|NOT COMPLETED|Overall Study||8
329283|NCT01439724|790385|P1|NOT COMPLETED|Overall Study||9
329284|NCT01439724|790384|P2|COMPLETED|Overall Study||39
329285|NCT01439724|790385|P1|COMPLETED|Overall Study||38
329286|NCT01439724|790384|P2|STARTED|Overall Study||47
329287|NCT01439724|790385|P1|STARTED|Overall Study||47
329288|NCT01439672|790391|P1|NOT COMPLETED|Overall Study||24
329289|NCT01439672|790391|P1|COMPLETED|Overall Study||11
329290|NCT01439672|790391|P1|STARTED|Overall Study||35
329291|NCT01439360|790397|P2|NOT COMPLETED|Overall Study||208
329292|NCT01439360|790398|P1|NOT COMPLETED|Overall Study||198
329293|NCT01439360|790397|P2|COMPLETED|Overall Study||5804
329294|NCT01439360|790398|P1|COMPLETED|Overall Study||5808
329295|NCT01439360|790397|P2|STARTED|Overall Study||6012
329296|NCT01439360|790398|P1|STARTED|Overall Study||6006
329297|NCT01439282|790448|P2|NOT COMPLETED|Overall Study||1
329298|NCT01439282|790449|P1|NOT COMPLETED|Overall Study||8
329299|NCT01439282|790448|P2|COMPLETED|Overall Study||9
329300|NCT01439282|790449|P1|COMPLETED|Overall Study||59
329301|NCT01439282|790448|P2|STARTED|Overall Study||10
329302|NCT01439282|790449|P1|STARTED|Overall Study||67
329303|NCT01439204|790459|P2|NOT COMPLETED|Overall Study||3
329304|NCT01439204|790460|P1|NOT COMPLETED|Overall Study||4
329305|NCT01439204|790459|P2|COMPLETED|Overall Study||33
329306|NCT01439204|790460|P1|COMPLETED|Overall Study||32
329307|NCT01439204|790459|P2|STARTED|Overall Study||36
329308|NCT01439204|790460|P1|STARTED|Overall Study||36
329309|NCT01439126|790494|P2|NOT COMPLETED|Overall Study||42
329310|NCT01439126|790495|P1|NOT COMPLETED|Overall Study||31
329311|NCT01439126|790494|P2|COMPLETED|Overall Study||25
329312|NCT01439126|790495|P1|COMPLETED|Overall Study||37
329313|NCT01439126|790494|P2|STARTED|Overall Study||67
329314|NCT01439126|790495|P1|STARTED|Overall Study||68
329315|NCT01439074|790517|P2|NOT COMPLETED|Overall Study||13
329316|NCT01439074|790518|P1|NOT COMPLETED|Overall Study||9
329317|NCT01439074|790517|P2|COMPLETED|Overall Study||74
329318|NCT01439074|790518|P1|COMPLETED|Overall Study||66
329319|NCT01439074|790517|P2|STARTED|Overall Study||87
329320|NCT01439074|790518|P1|STARTED|Overall Study||75
329321|NCT01438996|790533|P3|NOT COMPLETED|Overall Study||0
329322|NCT01438996|790534|P2|NOT COMPLETED|Overall Study||1
329323|NCT01438996|790535|P1|NOT COMPLETED|Overall Study||4
329324|NCT01438996|790533|P3|COMPLETED|Overall Study||20
329325|NCT01438996|790534|P2|COMPLETED|Overall Study||12
329326|NCT01438996|790535|P1|COMPLETED|Overall Study||14
329327|NCT01438996|790533|P3|STARTED|Overall Study||20
329328|NCT01438996|790534|P2|STARTED|Overall Study||13
329329|NCT01438996|790535|P1|STARTED|Overall Study||18
329330|NCT01438814|790569|P2|NOT COMPLETED|Overall Study||14
329331|NCT01438814|790570|P1|NOT COMPLETED|Overall Study||14
329332|NCT01438814|790569|P2|COMPLETED|Overall Study||331
329333|NCT01438814|790570|P1|COMPLETED|Overall Study||330
329334|NCT01438814|790569|P2|STARTED|Overall Study||345
329335|NCT01438814|790570|P1|STARTED|Overall Study||344
329336|NCT01438710|790600|P2|NOT COMPLETED|Second Week of Treatment||0
329337|NCT01438710|790601|P1|NOT COMPLETED|Second Week of Treatment||1
329338|NCT01438710|790600|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
329339|NCT01438710|790601|P1|COMPLETED|Second Week of Treatment||40
329340|NCT01438710|790600|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
329341|NCT01438710|790601|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
329342|NCT01438710|790600|P2|NOT COMPLETED|First Week of Treatment||3
329343|NCT01438710|790601|P1|NOT COMPLETED|First Week of Treatment||0
329344|NCT01438710|790600|P2|COMPLETED|First Week of Treatment||41
329345|NCT01438710|790601|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
329346|NCT01438710|790600|P2|STARTED|First Week of Treatment||44
329347|NCT01438710|790601|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
329348|NCT01438541|790606|P1|NOT COMPLETED|Overall Study||7
329349|NCT01438541|790606|P1|COMPLETED|Overall Study||22
329350|NCT01438541|790606|P1|STARTED|Overall Study||29
329351|NCT01438489|790615|P3|NOT COMPLETED|Overall Study||19
329352|NCT01438489|790616|P2|NOT COMPLETED|Overall Study||16
329353|NCT01438489|790617|P1|NOT COMPLETED|Overall Study||26
329354|NCT01438489|790615|P3|COMPLETED|Overall Study||85
329355|NCT01438489|790616|P2|COMPLETED|Overall Study||84
329356|NCT01438489|790617|P1|COMPLETED|Overall Study||77
329357|NCT01438489|790615|P3|STARTED|Overall Study||104
329358|NCT01438489|790616|P2|STARTED|Overall Study||100
329359|NCT01438489|790617|P1|STARTED|Overall Study||103
329360|NCT01438424|790660|P1|NOT COMPLETED|Overall Study||417
329361|NCT01438424|790660|P1|COMPLETED|Overall Study|Completed treatment|634
329362|NCT01438424|790660|P1|STARTED|Overall Study|Received treatment|1051
329363|NCT01438307|790698|P2|NOT COMPLETED|Overall Study||1
329364|NCT01438307|790699|P1|NOT COMPLETED|Overall Study||1
329365|NCT01438307|790698|P2|COMPLETED|Overall Study||13
329366|NCT01438307|790699|P1|COMPLETED|Overall Study||13
329367|NCT01438307|790698|P2|STARTED|Overall Study||14
329368|NCT01438307|790699|P1|STARTED|Overall Study||14
329369|NCT01438294|790713|P2|NOT COMPLETED|Overall Study||7
329370|NCT01438294|790714|P1|NOT COMPLETED|Overall Study||3
329371|NCT01438294|790713|P2|COMPLETED|Overall Study||13
329372|NCT01438294|790714|P1|COMPLETED|Overall Study||13
329373|NCT01438294|790713|P2|STARTED|Overall Study||20
329374|NCT01438294|790714|P1|STARTED|Overall Study||16
329375|NCT01438229|790724|P1|NOT COMPLETED|Overall Study||3
329376|NCT01438229|790724|P1|COMPLETED|Overall Study||44
329377|NCT01438229|790724|P1|Underwent Procedure|Overall Study||46
329378|NCT01438229|790724|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
329379|NCT01438229|790724|P1|STARTED|Overall Study||47
329380|NCT01438177|790757|P1|NOT COMPLETED|Overall Study||2
329381|NCT01438177|790757|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
329382|NCT01438177|790757|P1|STARTED|Overall Study||11
329383|NCT01438151|790763|P1|NOT COMPLETED|Overall Study||8
329384|NCT01438151|790763|P1|COMPLETED|Overall Study||3
329385|NCT01438151|790763|P1|STARTED|Overall Study||11
329386|NCT01438060|790769|P2|NOT COMPLETED|On Study Beyond Week 140||8
329387|NCT01438060|790770|P1|NOT COMPLETED|On Study Beyond Week 140||0
329388|NCT01438060|790769|P2|COMPLETED|On Study Beyond Week 140||1
329389|NCT01438060|790770|P1|COMPLETED|On Study Beyond Week 140||0
329390|NCT01438060|790769|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
329391|NCT01438060|790770|P1|STARTED|On Study Beyond Week 140||0
329392|NCT01438060|790769|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
329393|NCT01438060|790770|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
329394|NCT01438060|790769|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
329395|NCT01438060|790770|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
329396|NCT01438060|790769|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
329397|NCT01438060|790770|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
329398|NCT01438060|790769|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
329399|NCT01438060|790770|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
329400|NCT01438060|790769|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
329401|NCT01438060|790770|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
329402|NCT01438060|790769|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
329403|NCT01438060|790770|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
329404|NCT01437995|790851|P3|NOT COMPLETED|Overall Study||20
329405|NCT01437995|790852|P2|NOT COMPLETED|Overall Study||18
329406|NCT01437995|790853|P1|NOT COMPLETED|Overall Study||11
329407|NCT01437995|790851|P3|COMPLETED|Overall Study||135
329408|NCT01437995|790852|P2|COMPLETED|Overall Study||131
329409|NCT01437995|790853|P1|COMPLETED|Overall Study||140
329410|NCT01437995|790851|P3|Included in Treatment Failure Analysis|Overall Study||151
329411|NCT01437995|790852|P2|Included in Treatment Failure Analysis|Overall Study||146
329412|NCT01437995|790853|P1|Included in Treatment Failure Analysis|Overall Study||150
329413|NCT01437995|790851|P3|STARTED|Overall Study||155
329414|NCT01437995|790852|P2|STARTED|Overall Study||149
329415|NCT01437995|790853|P1|STARTED|Overall Study||151
329416|NCT01437943|790875|P2|NOT COMPLETED|Overall Study||2
329417|NCT01437943|790876|P1|NOT COMPLETED|Overall Study||7
329418|NCT01437943|790875|P2|COMPLETED|Overall Study||1
329419|NCT01437943|790876|P1|COMPLETED|Overall Study||0
329420|NCT01437943|790875|P2|STARTED|Overall Study||3
329421|NCT01437943|790876|P1|STARTED|Overall Study||7
329422|NCT01437878|790884|P2|NOT COMPLETED|Overall Study||0
329423|NCT01437878|790885|P1|NOT COMPLETED|Overall Study||1
329424|NCT01437878|790884|P2|COMPLETED|Overall Study||1
329425|NCT01437878|790885|P1|COMPLETED|Overall Study||0
329426|NCT01437878|790884|P2|STARTED|Overall Study||1
329427|NCT01437878|790885|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
329428|NCT01437540|790927|P2|NOT COMPLETED|Overall Study||65
329429|NCT01437540|790928|P1|NOT COMPLETED|Overall Study||127
329430|NCT01437540|790927|P2|COMPLETED|Overall Study||133
329431|NCT01437540|790928|P1|COMPLETED|Overall Study||265
329432|NCT01437540|790927|P2|STARTED|Overall Study||198
329433|NCT01437540|790928|P1|STARTED|Overall Study||392
329434|NCT01437501|790942|P2|NOT COMPLETED|Overall Study||11
329435|NCT01437501|790943|P1|NOT COMPLETED|Overall Study||13
329436|NCT01437501|790942|P2|COMPLETED|Overall Study||132
329437|NCT01437501|790943|P1|COMPLETED|Overall Study||135
329438|NCT01437501|790942|P2|STARTED|Overall Study||143
329439|NCT01437501|790943|P1|STARTED|Overall Study||148
329440|NCT01437423|790949|P1|NOT COMPLETED|Overall Study||15
329441|NCT01437423|790949|P1|COMPLETED|Overall Study||647
329442|NCT01437423|790949|P1|STARTED|Overall Study||662
329443|NCT01437397|790961|P5|NOT COMPLETED|Overall Study||101
329444|NCT01437397|790962|P4|NOT COMPLETED|Overall Study||69
329445|NCT01437397|790963|P3|NOT COMPLETED|Overall Study||72
329446|NCT01437397|790964|P2|NOT COMPLETED|Overall Study||62
329447|NCT01437397|790965|P1|NOT COMPLETED|Overall Study||66
329448|NCT01437397|790961|P5|COMPLETED|Overall Study||236
329449|NCT01437397|790962|P4|COMPLETED|Overall Study||270
329450|NCT01437397|790963|P3|COMPLETED|Overall Study||268
329451|NCT01437397|790964|P2|COMPLETED|Overall Study||276
329452|NCT01437397|790965|P1|COMPLETED|Overall Study||272
329453|NCT01437397|790961|P5|STARTED|Overall Study||337
329454|NCT01437397|790962|P4|STARTED|Overall Study||339
329455|NCT01437397|790963|P3|STARTED|Overall Study||340
329456|NCT01437397|790964|P2|STARTED|Overall Study||338
329457|NCT01437397|790965|P1|STARTED|Overall Study||338
329458|NCT01437319|790992|P3|NOT COMPLETED|Phase II||37
329459|NCT01437319|790993|P2|NOT COMPLETED|Phase II||44
329460|NCT01437319|790994|P1|NOT COMPLETED|Phase II||0
329461|NCT01437319|790992|P3|COMPLETED|Phase II||75
329462|NCT01437319|790993|P2|COMPLETED|Phase II||71
329463|NCT01437319|790994|P1|COMPLETED|Phase II||0
329464|NCT01437319|790992|P3|STARTED|Phase II||112
329465|NCT01437319|790993|P2|STARTED|Phase II||115
329466|NCT01437319|790994|P1|STARTED|Phase II||0
329467|NCT01437319|790992|P3|NOT COMPLETED|Phase I||0
329468|NCT01437319|790993|P2|NOT COMPLETED|Phase I||0
329469|NCT01437319|790994|P1|NOT COMPLETED|Phase I||55
329470|NCT01437319|790992|P3|COMPLETED|Phase I||0
329471|NCT01437319|790993|P2|COMPLETED|Phase I||0
329472|NCT01437319|790994|P1|COMPLETED|Phase I||227
329473|NCT01437319|790992|P3|STARTED|Phase I||0
329474|NCT01437319|790993|P2|STARTED|Phase I||0
329475|NCT01437319|790994|P1|STARTED|Phase I||282
329476|NCT01437267|791009|P6|NOT COMPLETED|Overall Study||0
329477|NCT01437267|791010|P5|NOT COMPLETED|Overall Study||0
329478|NCT01437267|791011|P4|NOT COMPLETED|Overall Study||1
329479|NCT01437267|791012|P3|NOT COMPLETED|Overall Study||0
329480|NCT01437267|791013|P2|NOT COMPLETED|Overall Study||1
329481|NCT01437267|791014|P1|NOT COMPLETED|Overall Study||0
329482|NCT01437267|791009|P6|COMPLETED|Overall Study||20
329483|NCT01437267|791010|P5|COMPLETED|Overall Study||20
329484|NCT01437267|791011|P4|COMPLETED|Overall Study||19
329485|NCT01437267|791012|P3|COMPLETED|Overall Study||20
329486|NCT01437267|791013|P2|COMPLETED|Overall Study||19
329487|NCT01437267|791014|P1|COMPLETED|Overall Study||20
329488|NCT01437267|791009|P6|STARTED|Overall Study||20
329489|NCT01437267|791010|P5|STARTED|Overall Study||20
329490|NCT01437267|791011|P4|STARTED|Overall Study||20
329491|NCT01437267|791012|P3|STARTED|Overall Study||20
329492|NCT01437267|791013|P2|STARTED|Overall Study||20
329493|NCT01437267|791014|P1|STARTED|Overall Study||20
329494|NCT01437124|791052|P1|NOT COMPLETED|Overall Study||0
329495|NCT01437124|791052|P1|COMPLETED|Overall Study||83
329496|NCT01437124|791052|P1|STARTED|Overall Study||83
329497|NCT01437111|791057|P1|NOT COMPLETED|Overall Study||18
329498|NCT01437111|791057|P1|COMPLETED|Overall Study||182
329499|NCT01437111|791057|P1|Treated Participants|Overall Study||198
329500|NCT01437111|791057|P1|STARTED|Overall Study||200
329501|NCT01437098|791068|P1|NOT COMPLETED|Overall Study||13
329502|NCT01437098|791068|P1|COMPLETED|Overall Study||42
329503|NCT01437098|791068|P1|36 Months|Overall Study||36
329504|NCT01437098|791068|P1|24 Months|Overall Study||42
329505|NCT01437098|791068|P1|12 Months|Overall Study||45
329506|NCT01437098|791068|P1|6 Months|Overall Study||47
329507|NCT01437098|791068|P1|30 Days|Overall Study||51
329508|NCT01437098|791068|P1|STARTED|Overall Study||55
329509|NCT01436799|791125|P2|NOT COMPLETED|Overall Study||0
329510|NCT01436799|791126|P1|NOT COMPLETED|Overall Study||0
329511|NCT01436799|791125|P2|COMPLETED|Overall Study||20
329512|NCT01436799|791126|P1|COMPLETED|Overall Study||20
329513|NCT01436799|791125|P2|STARTED|Overall Study||20
329514|NCT01436799|791126|P1|STARTED|Overall Study||20
329515|NCT01436643|791135|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
329516|NCT01436643|791136|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
329517|NCT01436643|791137|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
329518|NCT01436643|791138|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
329519|NCT01436643|791135|P4|COMPLETED|Core Phase (16 Weeks)||0
329520|NCT01436643|791136|P3|COMPLETED|Core Phase (16 Weeks)||17
329521|NCT01436643|791137|P2|COMPLETED|Core Phase (16 Weeks)||11
329522|NCT01436643|791138|P1|COMPLETED|Core Phase (16 Weeks)||16
329523|NCT01436643|791135|P4|STARTED|Core Phase (16 Weeks)||0
329524|NCT01436643|791136|P3|STARTED|Core Phase (16 Weeks)||20
329525|NCT01436643|791137|P2|STARTED|Core Phase (16 Weeks)||15
329526|NCT01436643|791138|P1|STARTED|Core Phase (16 Weeks)||17
329527|NCT01436643|791135|P4|NOT COMPLETED|2-week Pre-treatment||10
329528|NCT01436643|791136|P3|NOT COMPLETED|2-week Pre-treatment||0
329529|NCT01436643|791137|P2|NOT COMPLETED|2-week Pre-treatment||0
329530|NCT01436643|791138|P1|NOT COMPLETED|2-week Pre-treatment||0
329531|NCT01436643|791135|P4|COMPLETED|2-week Pre-treatment||44
329532|NCT01436643|791136|P3|COMPLETED|2-week Pre-treatment||0
329533|NCT01436643|791137|P2|COMPLETED|2-week Pre-treatment||0
329534|NCT01436643|791138|P1|COMPLETED|2-week Pre-treatment||0
329535|NCT01436643|791135|P4|STARTED|2-week Pre-treatment||54
329536|NCT01436643|791136|P3|STARTED|2-week Pre-treatment||0
329537|NCT01436643|791137|P2|STARTED|2-week Pre-treatment||0
329538|NCT01436643|791138|P1|STARTED|2-week Pre-treatment||0
329539|NCT01436526|791150|P2|NOT COMPLETED|Period 2||0
329540|NCT01436526|791151|P1|NOT COMPLETED|Period 2||0
329541|NCT01436526|791150|P2|COMPLETED|Period 2||13
329542|NCT01436526|791151|P1|COMPLETED|Period 2||13
329543|NCT01436526|791150|P2|Participants Received Treatment|Period 2||13
329544|NCT01436526|791151|P1|Participants Received Treatment|Period 2||13
329545|NCT01436526|791150|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
329546|NCT01436526|791151|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
329547|NCT01436526|791150|P2|NOT COMPLETED|Period 1||0
329548|NCT01436526|791151|P1|NOT COMPLETED|Period 1||0
329549|NCT01436526|791150|P2|COMPLETED|Period 1||14
329550|NCT01436526|791151|P1|COMPLETED|Period 1||14
329551|NCT01436526|791150|P2|Participants Received Treatment|Period 1||14
329552|NCT01436526|791151|P1|Participants Received Treatment|Period 1||14
329553|NCT01436526|791150|P2|STARTED|Period 1||14
329554|NCT01436526|791151|P1|STARTED|Period 1||14
329555|NCT01436500|791173|P5|NOT COMPLETED|Overall Study||4
329556|NCT01436500|791174|P4|NOT COMPLETED|Overall Study||1
329557|NCT01436500|791175|P3|NOT COMPLETED|Overall Study||5
329558|NCT01436500|791176|P2|NOT COMPLETED|Overall Study||3
329559|NCT01436500|791177|P1|NOT COMPLETED|Overall Study||3
329560|NCT01436500|791173|P5|COMPLETED|Overall Study||9
329561|NCT01436500|791174|P4|COMPLETED|Overall Study||5
329562|NCT01436500|791175|P3|COMPLETED|Overall Study||7
329563|NCT01436500|791176|P2|COMPLETED|Overall Study||9
329564|NCT01436500|791177|P1|COMPLETED|Overall Study||9
329565|NCT01436500|791173|P5|STARTED|Overall Study||13
329566|NCT01436500|791174|P4|STARTED|Overall Study||6
329567|NCT01436500|791175|P3|STARTED|Overall Study||12
329568|NCT01436500|791176|P2|STARTED|Overall Study||12
329569|NCT01436500|791177|P1|STARTED|Overall Study||12
329570|NCT01436435|791210|P1|NOT COMPLETED|Overall Study||64
329571|NCT01436435|791210|P1|COMPLETED|Overall Study||177
329572|NCT01436435|791210|P1|STARTED|Overall Study||241
329573|NCT01436370|791227|P8|NOT COMPLETED|Overall Study||0
329574|NCT01436370|791228|P7|NOT COMPLETED|Overall Study||0
329575|NCT01436370|791229|P6|NOT COMPLETED|Overall Study||0
329576|NCT01436370|791230|P5|NOT COMPLETED|Overall Study||1
329577|NCT01436370|791231|P4|NOT COMPLETED|Overall Study||0
329578|NCT01436370|791232|P3|NOT COMPLETED|Overall Study||0
329579|NCT01436370|791233|P2|NOT COMPLETED|Overall Study||0
329580|NCT01436370|791234|P1|NOT COMPLETED|Overall Study||0
329581|NCT01436370|791227|P8|COMPLETED|Overall Study||16
329582|NCT01436370|791228|P7|COMPLETED|Overall Study||16
329583|NCT01436370|791229|P6|COMPLETED|Overall Study||19
329584|NCT01436370|791230|P5|COMPLETED|Overall Study||18
329585|NCT01436370|791231|P4|COMPLETED|Overall Study||10
329586|NCT01436370|791232|P3|COMPLETED|Overall Study||10
329587|NCT01436370|791233|P2|COMPLETED|Overall Study||6
329588|NCT01436370|791234|P1|COMPLETED|Overall Study||6
329589|NCT01436370|791227|P8|STARTED|Overall Study||16
329590|NCT01436370|791228|P7|STARTED|Overall Study||16
329591|NCT01436370|791229|P6|STARTED|Overall Study||19
329592|NCT01436370|791230|P5|STARTED|Overall Study||19
329593|NCT01436370|791231|P4|STARTED|Overall Study||10
329594|NCT01436370|791232|P3|STARTED|Overall Study||10
329595|NCT01436370|791233|P2|STARTED|Overall Study||6
329596|NCT01436370|791234|P1|STARTED|Overall Study||6
329597|NCT01436279|791314|P2|NOT COMPLETED|Overall Study||0
329598|NCT01436279|791315|P1|NOT COMPLETED|Overall Study||0
329599|NCT01436279|791314|P2|COMPLETED|Overall Study||20
329600|NCT01436279|791315|P1|COMPLETED|Overall Study||30
329601|NCT01436279|791314|P2|STARTED|Overall Study||20
329602|NCT01436279|791315|P1|STARTED|Overall Study||30
329603|NCT01436266|791337|P2|NOT COMPLETED|Overall Study||0
329604|NCT01436266|791338|P1|NOT COMPLETED|Overall Study||0
329605|NCT01436266|791337|P2|COMPLETED|Overall Study||1
329606|NCT01436266|791338|P1|COMPLETED|Overall Study||1
329607|NCT01436266|791337|P2|STARTED|Overall Study||1
329608|NCT01436266|791338|P1|STARTED|Overall Study||1
329609|NCT01436253|791344|P1|NOT COMPLETED|Overall Study||299
329610|NCT01436253|791344|P1|COMPLETED|Overall Study||1897
329611|NCT01436253|791344|P1|STARTED|Overall Study||2196
329612|NCT01436201|791349|P1|NOT COMPLETED|Overall Study||4
329613|NCT01436201|791349|P1|COMPLETED|Overall Study||20
329614|NCT01436201|791349|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
329615|NCT01436201|791349|P1|STARTED|Overall Study||24
329616|NCT01436175|791359|P1|NOT COMPLETED|Overall Study||1270
329617|NCT01436175|791359|P1|COMPLETED|Overall Study||300
329618|NCT01436175|791359|P1|STARTED|Overall Study||1570
329619|NCT01436162|791386|P3|NOT COMPLETED|Randomized Phase||25
329620|NCT01436162|791387|P2|NOT COMPLETED|Randomized Phase||31
329621|NCT01436162|791388|P1|NOT COMPLETED|Randomized Phase||44
329622|NCT01436162|791386|P3|COMPLETED|Randomized Phase||189
329623|NCT01436162|791387|P2|COMPLETED|Randomized Phase||181
329624|NCT01436162|791388|P1|COMPLETED|Randomized Phase||353
329625|NCT01436162|791386|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
329626|NCT01436162|791387|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
329627|NCT01436162|791388|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
329628|NCT01436162|791386|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
329629|NCT01436162|791387|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
329630|NCT01436162|791388|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
329631|NCT01436162|791386|P3|COMPLETED|Single-blind Lead-in Phase||0
329632|NCT01436162|791387|P2|COMPLETED|Single-blind Lead-in Phase||0
329633|NCT01436162|791388|P1|COMPLETED|Single-blind Lead-in Phase||823
329634|NCT01436162|791386|P3|STARTED|Single-blind Lead-in Phase||0
329635|NCT01436162|791387|P2|STARTED|Single-blind Lead-in Phase||0
329636|NCT01436162|791388|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
329637|NCT01436149|791422|P3|NOT COMPLETED|Randomized Phase||42
329638|NCT01436149|791423|P2|NOT COMPLETED|Randomized Phase||38
329639|NCT01436149|791424|P1|NOT COMPLETED|Randomized Phase||77
329717|NCT01435759|791582|P1|NOT COMPLETED|Double-blind Phase||66
329640|NCT01436149|791422|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
329641|NCT01436149|791423|P2|COMPLETED|Randomized Phase||164
329642|NCT01436149|791424|P1|COMPLETED|Randomized Phase||415
329643|NCT01436149|791422|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
329644|NCT01436149|791423|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
329645|NCT01436149|791424|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
329646|NCT01436149|791422|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
329647|NCT01436149|791423|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
329648|NCT01436149|791424|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
329649|NCT01436149|791422|P3|COMPLETED|Antidepressant Lead-in Phase||0
329650|NCT01436149|791423|P2|COMPLETED|Antidepressant Lead-in Phase||0
329651|NCT01436149|791424|P1|COMPLETED|Antidepressant Lead-in Phase||896
329652|NCT01436149|791422|P3|STARTED|Antidepressant Lead-in Phase||0
329653|NCT01436149|791423|P2|STARTED|Antidepressant Lead-in Phase||0
329654|NCT01436149|791424|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
329655|NCT01436110|791455|P3|NOT COMPLETED|Overall Study||23
329656|NCT01436110|791456|P2|NOT COMPLETED|Overall Study||26
329657|NCT01436110|791457|P1|NOT COMPLETED|Overall Study||39
329658|NCT01436110|791455|P3|COMPLETED|Overall Study||95
329659|NCT01436110|791456|P2|COMPLETED|Overall Study||91
329660|NCT01436110|791457|P1|COMPLETED|Overall Study||77
329661|NCT01436110|791455|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
329662|NCT01436110|791456|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
329663|NCT01436110|791457|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
329664|NCT01436110|791455|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
329665|NCT01436110|791456|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
329666|NCT01436110|791457|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
329667|NCT01436084|791480|P1|NOT COMPLETED|Overall Study||4
329668|NCT01436084|791480|P1|COMPLETED|Overall Study||0
329669|NCT01436084|791480|P1|STARTED|Overall Study||4
329670|NCT01436071|791486|P2|NOT COMPLETED|Overall Study||14
329671|NCT01436071|791487|P1|NOT COMPLETED|Overall Study||26
329672|NCT01436071|791486|P2|COMPLETED|Overall Study||110
329673|NCT01436071|791487|P1|COMPLETED|Overall Study||98
329674|NCT01436071|791486|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
329675|NCT01436071|791487|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
329676|NCT01436071|791486|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
329677|NCT01436071|791487|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
329678|NCT01436045|791503|P2|NOT COMPLETED|Overall Study||0
329679|NCT01436045|791504|P1|NOT COMPLETED|Overall Study||0
329680|NCT01436045|791503|P2|COMPLETED|Overall Study||6
329681|NCT01436045|791504|P1|COMPLETED|Overall Study||6
329682|NCT01436045|791503|P2|STARTED|Overall Study||6
329683|NCT01436045|791504|P1|STARTED|Overall Study||6
329684|NCT01436006|791515|P1|NOT COMPLETED|Overall Study||37
329685|NCT01436006|791515|P1|COMPLETED|Overall Study||6663
329686|NCT01436006|791515|P1|STARTED|Overall Study||6700
329687|NCT01435928|791529|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
329688|NCT01435928|791530|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
329689|NCT01435928|791531|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
329690|NCT01435928|791529|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
329691|NCT01435928|791530|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
329692|NCT01435928|791531|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
329693|NCT01435928|791529|P3|STARTED|Double Blind Phase - 28 Weeks||141
329694|NCT01435928|791530|P2|STARTED|Double Blind Phase - 28 Weeks||144
329695|NCT01435928|791531|P1|STARTED|Double Blind Phase - 28 Weeks||0
329696|NCT01435928|791529|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
329697|NCT01435928|791530|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
329698|NCT01435928|791531|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
329699|NCT01435928|791529|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
329700|NCT01435928|791530|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
329701|NCT01435928|791531|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
329702|NCT01435928|791529|P3|STARTED|Open Label Phase - up to 24 Weeks||0
329703|NCT01435928|791530|P2|STARTED|Open Label Phase - up to 24 Weeks||0
329704|NCT01435928|791531|P1|STARTED|Open Label Phase - up to 24 Weeks||676
329705|NCT01435798|791558|P1|NOT COMPLETED|Overall Study||1
329706|NCT01435798|791558|P1|COMPLETED|Overall Study|Crossover design|25
329707|NCT01435798|791558|P1|100% MTD|Overall Study||25
329708|NCT01435798|791558|P1|50% MTD|Overall Study||25
329709|NCT01435798|791558|P1|25% MTD|Overall Study||26
329710|NCT01435798|791558|P1|0% MTD|Overall Study||25
329711|NCT01435798|791558|P1|STARTED|Overall Study|Crossover design|26
329712|NCT01435759|791577|P6|NOT COMPLETED|Double-blind Phase||9
329713|NCT01435759|791578|P5|NOT COMPLETED|Double-blind Phase||9
329714|NCT01435759|791579|P4|NOT COMPLETED|Double-blind Phase||9
329715|NCT01435759|791580|P3|NOT COMPLETED|Double-blind Phase||7
329716|NCT01435759|791581|P2|NOT COMPLETED|Double-blind Phase||7
329718|NCT01435759|791577|P6|COMPLETED|Double-blind Phase||71
329719|NCT01435759|791578|P5|COMPLETED|Double-blind Phase||69
329720|NCT01435759|791579|P4|COMPLETED|Double-blind Phase||69
329721|NCT01435759|791580|P3|COMPLETED|Double-blind Phase||71
329722|NCT01435759|791581|P2|COMPLETED|Double-blind Phase||71
329723|NCT01435759|791582|P1|COMPLETED|Double-blind Phase||397
329724|NCT01435759|791577|P6|STARTED|Double-blind Phase||80
329725|NCT01435759|791578|P5|STARTED|Double-blind Phase||78
329726|NCT01435759|791579|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
329727|NCT01435759|791580|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
329728|NCT01435759|791581|P2|STARTED|Double-blind Phase||78
329729|NCT01435759|791582|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
329730|NCT01435759|791577|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
329731|NCT01435759|791578|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
329732|NCT01435759|791579|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
329733|NCT01435759|791580|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
329734|NCT01435759|791581|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
329735|NCT01435759|791582|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
329736|NCT01435759|791577|P6|COMPLETED|Antidepressant Lead-in Phase||0
329737|NCT01435759|791578|P5|COMPLETED|Antidepressant Lead-in Phase||0
329738|NCT01435759|791579|P4|COMPLETED|Antidepressant Lead-in Phase||0
329739|NCT01435759|791580|P3|COMPLETED|Antidepressant Lead-in Phase||0
329740|NCT01435759|791581|P2|COMPLETED|Antidepressant Lead-in Phase||0
329741|NCT01435759|791582|P1|COMPLETED|Antidepressant Lead-in Phase||855
329742|NCT01435759|791577|P6|STARTED|Antidepressant Lead-in Phase||0
329743|NCT01435759|791578|P5|STARTED|Antidepressant Lead-in Phase||0
329744|NCT01435759|791579|P4|STARTED|Antidepressant Lead-in Phase||0
329745|NCT01435759|791580|P3|STARTED|Antidepressant Lead-in Phase||0
329746|NCT01435759|791581|P2|STARTED|Antidepressant Lead-in Phase||0
329747|NCT01435759|791582|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
329748|NCT01435655|791609|P1|NOT COMPLETED|Overall Study||3
329749|NCT01435655|791609|P1|COMPLETED|Overall Study||7
329750|NCT01435655|791609|P1|STARTED|Overall Study||10
329751|NCT01435577|791623|P2|NOT COMPLETED|Overall Study||52
329752|NCT01435577|791624|P1|NOT COMPLETED|Overall Study||17
329753|NCT01435577|791623|P2|COMPLETED|Overall Study||13
329754|NCT01435577|791624|P1|COMPLETED|Overall Study||47
329755|NCT01435577|791623|P2|STARTED|Overall Study||65
329756|NCT01435577|791624|P1|STARTED|Overall Study||64
329757|NCT01435460|791674|P2|NOT COMPLETED|Overall Study||6
329758|NCT01435460|791675|P1|NOT COMPLETED|Overall Study||11
329759|NCT01435460|791674|P2|COMPLETED|Overall Study||143
329760|NCT01435460|791675|P1|COMPLETED|Overall Study||140
329761|NCT01435460|791674|P2|STARTED|Overall Study||149
329762|NCT01435460|791675|P1|STARTED|Overall Study||151
329763|NCT01435265|791689|P2|NOT COMPLETED|Overall Study||1
329764|NCT01435265|791690|P1|NOT COMPLETED|Overall Study||0
329765|NCT01435265|791689|P2|COMPLETED|Overall Study||3
329766|NCT01435265|791690|P1|COMPLETED|Overall Study||3
329767|NCT01435265|791689|P2|STARTED|Overall Study||4
329768|NCT01435265|791690|P1|STARTED|Overall Study||3
329769|NCT01435174|791700|P1|NOT COMPLETED|Overall Study||9
329770|NCT01435174|791700|P1|COMPLETED|Overall Study||8
329771|NCT01435174|791700|P1|STARTED|Overall Study||17
329772|NCT01435122|791704|P1|NOT COMPLETED|Overall Study||8
329773|NCT01435122|791704|P1|COMPLETED|Overall Study||22
329774|NCT01435122|791704|P1|STARTED|Overall Study||30
329775|NCT01435031|791713|P1|NOT COMPLETED|ITT at 2 Years||9
329776|NCT01435031|791713|P1|COMPLETED|ITT at 2 Years||194
329777|NCT01435031|791713|P1|STARTED|ITT at 2 Years||203
329778|NCT01435031|791713|P1|NOT COMPLETED|ITT at 1 Year||8
329779|NCT01435031|791713|P1|COMPLETED|ITT at 1 Year||203
329780|NCT01435031|791713|P1|STARTED|ITT at 1 Year||211
329781|NCT01435031|791713|P1|NOT COMPLETED|ITT at 6 Months||5
329782|NCT01435031|791713|P1|COMPLETED|ITT at 6 Months||211
329783|NCT01435031|791713|P1|STARTED|ITT at 6 Months||216
329784|NCT01435031|791713|P1|NOT COMPLETED|ITT at 1 Month||6
329785|NCT01435031|791713|P1|COMPLETED|ITT at 1 Month||216
329786|NCT01435031|791713|P1|STARTED|ITT at 1 Month|ITT population|222
329787|NCT01434823|791793|P2|NOT COMPLETED|Overall Study||7
329788|NCT01434823|791794|P1|NOT COMPLETED|Overall Study||4
329789|NCT01434823|791793|P2|COMPLETED|Overall Study||778
329790|NCT01434823|791794|P1|COMPLETED|Overall Study||820
329791|NCT01434823|791793|P2|STARTED|Overall Study||785
329792|NCT01434823|791794|P1|STARTED|Overall Study||824
329793|NCT01434693|791812|P4|NOT COMPLETED|Overall Study||1
329794|NCT01434693|791813|P3|NOT COMPLETED|Overall Study||1
329795|NCT01434693|791814|P2|NOT COMPLETED|Overall Study||0
329796|NCT01434693|791815|P1|NOT COMPLETED|Overall Study||3
329797|NCT01434693|791812|P4|COMPLETED|Overall Study||8
329798|NCT01434693|791813|P3|COMPLETED|Overall Study||8
329799|NCT01434693|791814|P2|COMPLETED|Overall Study||9
329800|NCT01434693|791815|P1|COMPLETED|Overall Study||6
329801|NCT01434693|791812|P4|STARTED|Overall Study||9
329802|NCT01434693|791813|P3|STARTED|Overall Study||9
329803|NCT01434693|791814|P2|STARTED|Overall Study||9
329804|NCT01434693|791815|P1|STARTED|Overall Study||9
329805|NCT01434680|791829|P4|NOT COMPLETED|Overall Study||0
329806|NCT01434680|791830|P3|NOT COMPLETED|Overall Study||2
329807|NCT01434680|791831|P2|NOT COMPLETED|Overall Study||2
329808|NCT01434680|791832|P1|NOT COMPLETED|Overall Study||3
329809|NCT01434680|791829|P4|COMPLETED|Overall Study||119
329810|NCT01434680|791830|P3|COMPLETED|Overall Study||304
329811|NCT01434680|791831|P2|COMPLETED|Overall Study||266
329812|NCT01434680|791832|P1|COMPLETED|Overall Study||296
329813|NCT01434680|791829|P4|STARTED|Overall Study||119
329814|NCT01434680|791830|P3|STARTED|Overall Study||306
329815|NCT01434680|791831|P2|STARTED|Overall Study||268
329816|NCT01434680|791832|P1|STARTED|Overall Study||299
329817|NCT01434654|791849|P2|NOT COMPLETED|Overall Study||0
329818|NCT01434654|791850|P1|NOT COMPLETED|Overall Study||2
329819|NCT01434654|791849|P2|COMPLETED|Overall Study||12
329820|NCT01434654|791850|P1|COMPLETED|Overall Study||5
329821|NCT01434654|791849|P2|STARTED|Overall Study||12
329822|NCT01434654|791850|P1|STARTED|Overall Study||7
329823|NCT01434641|791862|P1|NOT COMPLETED|Overall Study||0
329824|NCT01434641|791862|P1|COMPLETED|Overall Study||102
329825|NCT01434641|791862|P1|STARTED|Overall Study||102
329826|NCT01434511|791867|P1|NOT COMPLETED|Overall Study||0
329827|NCT01434511|791867|P1|COMPLETED|Overall Study||1
329828|NCT01434511|791867|P1|STARTED|Overall Study||1
329829|NCT01434342|791886|P2|NOT COMPLETED|Overall Study||17
329830|NCT01434342|791887|P1|NOT COMPLETED|Overall Study||48
329831|NCT01434342|791886|P2|COMPLETED|Overall Study||31
329832|NCT01434342|791887|P1|COMPLETED|Overall Study||50
329833|NCT01434342|791886|P2|STARTED|Overall Study||48
329834|NCT01434342|791887|P1|STARTED|Overall Study||98
329835|NCT01434186|791897|P2|NOT COMPLETED|Overall Study||0
329836|NCT01434186|791898|P1|NOT COMPLETED|Overall Study||0
329837|NCT01434186|791897|P2|COMPLETED|Overall Study||4
329838|NCT01434186|791898|P1|COMPLETED|Overall Study||2
329839|NCT01434186|791897|P2|STARTED|Overall Study||4
329840|NCT01434186|791898|P1|STARTED|Overall Study||2
329841|NCT01434121|791907|P3|NOT COMPLETED|Overall Study||0
329842|NCT01434121|791908|P2|NOT COMPLETED|Overall Study||0
329843|NCT01434121|791909|P1|NOT COMPLETED|Overall Study||0
329844|NCT01434121|791907|P3|COMPLETED|Overall Study||8
329845|NCT01434121|791908|P2|COMPLETED|Overall Study||8
329846|NCT01434121|791909|P1|COMPLETED|Overall Study||8
329847|NCT01434121|791907|P3|STARTED|Overall Study||8
329848|NCT01434121|791908|P2|STARTED|Overall Study||8
329849|NCT01434121|791909|P1|STARTED|Overall Study||8
329850|NCT01434030|791917|P1|NOT COMPLETED|Overall Study||1
329851|NCT01434030|791917|P1|COMPLETED|Overall Study||56
329852|NCT01434030|791917|P1|STARTED|Overall Study||57
329853|NCT01433913|791924|P2|NOT COMPLETED|Overall Study||0
329854|NCT01433913|791925|P1|NOT COMPLETED|Overall Study||1
329855|NCT01433913|791924|P2|COMPLETED|Overall Study||10
329856|NCT01433913|791925|P1|COMPLETED|Overall Study||9
329857|NCT01433913|791924|P2|STARTED|Overall Study||10
329858|NCT01433913|791925|P1|STARTED|Overall Study||10
329859|NCT01433731|791935|P4|NOT COMPLETED|Overall Study||0
329860|NCT01433731|791936|P3|NOT COMPLETED|Overall Study||0
329861|NCT01433731|791937|P2|NOT COMPLETED|Overall Study||0
329862|NCT01433731|791938|P1|NOT COMPLETED|Overall Study||0
329863|NCT01433731|791935|P4|COMPLETED|Overall Study||5
329864|NCT01433731|791936|P3|COMPLETED|Overall Study||5
329865|NCT01433731|791937|P2|COMPLETED|Overall Study||5
329866|NCT01433731|791938|P1|COMPLETED|Overall Study||3
329867|NCT01433731|791935|P4|STARTED|Overall Study||5
329868|NCT01433731|791936|P3|STARTED|Overall Study||5
329869|NCT01433731|791937|P2|STARTED|Overall Study||5
329870|NCT01433731|791938|P1|STARTED|Overall Study||3
329871|NCT01433549|791946|P2|NOT COMPLETED|Phase 2: Second Study Product||1
329872|NCT01433549|791947|P1|NOT COMPLETED|Phase 2: Second Study Product||0
329873|NCT01433549|791946|P2|COMPLETED|Phase 2: Second Study Product||12
329874|NCT01433549|791947|P1|COMPLETED|Phase 2: Second Study Product||12
329875|NCT01433549|791946|P2|STARTED|Phase 2: Second Study Product||13
329876|NCT01433549|791947|P1|STARTED|Phase 2: Second Study Product||12
329877|NCT01433549|791946|P2|NOT COMPLETED|Phase 1: First Study Product||0
329878|NCT01433549|791947|P1|NOT COMPLETED|Phase 1: First Study Product||0
329879|NCT01433549|791946|P2|COMPLETED|Phase 1: First Study Product||13
329880|NCT01433549|791947|P1|COMPLETED|Phase 1: First Study Product||12
329881|NCT01433549|791946|P2|STARTED|Phase 1: First Study Product||13
329882|NCT01433549|791947|P1|STARTED|Phase 1: First Study Product||12
329883|NCT01433471|791957|P2|NOT COMPLETED|Overall Study||1
329884|NCT01433471|791958|P1|NOT COMPLETED|Overall Study||0
329885|NCT01433471|791957|P2|COMPLETED|Overall Study||1
329886|NCT01433471|791958|P1|COMPLETED|Overall Study||2
329887|NCT01433471|791957|P2|STARTED|Overall Study||2
329888|NCT01433471|791958|P1|STARTED|Overall Study||2
329889|NCT01433354|791974|P1|NOT COMPLETED|Overall Study||119
329890|NCT01433354|791974|P1|COMPLETED|Overall Study||0
329891|NCT01433354|791974|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
329892|NCT01433263|791990|P2|NOT COMPLETED|Overall Study||12
329893|NCT01433263|791991|P1|NOT COMPLETED|Overall Study||19
329894|NCT01433263|791990|P2|COMPLETED|Overall Study||16
329895|NCT01433263|791991|P1|COMPLETED|Overall Study||10
329896|NCT01433263|791990|P2|STARTED|Overall Study||28
329897|NCT01433263|791991|P1|STARTED|Overall Study||29
329898|NCT01433250|792020|P2|NOT COMPLETED|Overall Study||3
329899|NCT01433250|792021|P1|NOT COMPLETED|Overall Study||3
329900|NCT01433250|792020|P2|COMPLETED|Overall Study||14
329901|NCT01433250|792021|P1|COMPLETED|Overall Study||19
329902|NCT01433250|792020|P2|STARTED|Overall Study||17
329903|NCT01433250|792021|P1|STARTED|Overall Study||22
329904|NCT01433172|792040|P3|NOT COMPLETED|Overall Study||1
329905|NCT01433172|792041|P2|NOT COMPLETED|Overall Study||3
329906|NCT01433172|792042|P1|NOT COMPLETED|Overall Study||0
329907|NCT01433172|792040|P3|COMPLETED|Overall Study||32
329908|NCT01433172|792041|P2|COMPLETED|Overall Study||34
329909|NCT01433172|792042|P1|COMPLETED|Overall Study||3
329910|NCT01433172|792040|P3|STARTED|Overall Study||33
329911|NCT01433172|792041|P2|STARTED|Overall Study||37
329912|NCT01433172|792042|P1|STARTED|Overall Study||3
329913|NCT01433159|792054|P2|NOT COMPLETED|Overall Study||1
329914|NCT01433159|792055|P1|NOT COMPLETED|Overall Study||2
329915|NCT01433159|792054|P2|COMPLETED|Overall Study||9
329916|NCT01433159|792055|P1|COMPLETED|Overall Study||7
329917|NCT01433159|792054|P2|STARTED|Overall Study||10
329918|NCT01433159|792055|P1|STARTED|Overall Study||9
329919|NCT01433107|792063|P2|NOT COMPLETED|Overall Study||17
329920|NCT01433107|792064|P1|NOT COMPLETED|Overall Study||27
329921|NCT01433107|792063|P2|COMPLETED|Overall Study||128
329922|NCT01433107|792064|P1|COMPLETED|Overall Study||118
329923|NCT01433107|792063|P2|STARTED|Overall Study||145
329924|NCT01433107|792064|P1|STARTED|Overall Study||145
329925|NCT01433081|792076|P2|NOT COMPLETED|Overall Study||2
329926|NCT01433081|792077|P1|NOT COMPLETED|Overall Study||2
329927|NCT01433081|792076|P2|COMPLETED|Overall Study||23
329928|NCT01433081|792077|P1|COMPLETED|Overall Study||23
329929|NCT01433081|792076|P2|STARTED|Overall Study||25
329930|NCT01433081|792077|P1|STARTED|Overall Study||25
329931|NCT01433055|792087|P2|NOT COMPLETED|Overall Study||0
329932|NCT01433055|792088|P1|NOT COMPLETED|Overall Study||2
329933|NCT01433055|792087|P2|COMPLETED|Overall Study||23
329934|NCT01433055|792088|P1|COMPLETED|Overall Study||27
329935|NCT01433055|792087|P2|STARTED|Overall Study||23
329936|NCT01433055|792088|P1|STARTED|Overall Study||29
329937|NCT01433042|792102|P1|NOT COMPLETED|Overall Study||1
329938|NCT01433042|792102|P1|COMPLETED|Overall Study||224
329939|NCT01433042|792102|P1|STARTED|Overall Study||225
329940|NCT01433016|792106|P1|NOT COMPLETED|Overall Study||0
329941|NCT01433016|792106|P1|COMPLETED|Overall Study||20
329942|NCT01433016|792106|P1|STARTED|Overall Study||20
329943|NCT01432938|792110|P2|NOT COMPLETED|Second Intervention||0
329944|NCT01432938|792111|P1|NOT COMPLETED|Second Intervention||1
329945|NCT01432938|792110|P2|COMPLETED|Second Intervention||14
329946|NCT01432938|792111|P1|COMPLETED|Second Intervention||11
329947|NCT01432938|792110|P2|STARTED|Second Intervention||14
329948|NCT01432938|792111|P1|STARTED|Second Intervention||12
329949|NCT01432938|792110|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
329950|NCT01432938|792111|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
329951|NCT01432938|792110|P2|COMPLETED|Washout Period of at Least 24 Days||14
329952|NCT01432938|792111|P1|COMPLETED|Washout Period of at Least 24 Days||12
329953|NCT01432938|792110|P2|STARTED|Washout Period of at Least 24 Days||14
329954|NCT01432938|792111|P1|STARTED|Washout Period of at Least 24 Days||12
329955|NCT01432938|792110|P2|NOT COMPLETED|First Intervention||0
329956|NCT01432938|792111|P1|NOT COMPLETED|First Intervention||2
329957|NCT01432938|792110|P2|COMPLETED|First Intervention||14
329958|NCT01432938|792111|P1|COMPLETED|First Intervention||12
329959|NCT01432938|792110|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
329960|NCT01432938|792111|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
329961|NCT01432938|792110|P2|STARTED|First Intervention||14
329962|NCT01432938|792111|P1|STARTED|First Intervention||14
329963|NCT01432886|792128|P2|NOT COMPLETED|Overall Study||0
329964|NCT01432886|792129|P1|NOT COMPLETED|Overall Study||0
329965|NCT01432886|792128|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
329966|NCT01432886|792129|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
329967|NCT01432886|792128|P2|STARTED|Overall Study||6
329968|NCT01432886|792129|P1|STARTED|Overall Study||6
329969|NCT01432756|792141|P4|NOT COMPLETED|Overall Study||1
329970|NCT01432756|792142|P3|NOT COMPLETED|Overall Study||2
329971|NCT01432756|792143|P2|NOT COMPLETED|Overall Study||0
329972|NCT01432756|792144|P1|NOT COMPLETED|Overall Study||1
329973|NCT01432756|792141|P4|COMPLETED|Overall Study||33
329974|NCT01432756|792142|P3|COMPLETED|Overall Study||30
329975|NCT01432756|792143|P2|COMPLETED|Overall Study||34
329976|NCT01432756|792144|P1|COMPLETED|Overall Study||31
329977|NCT01432756|792141|P4|STARTED|Overall Study||34
329978|NCT01432756|792142|P3|STARTED|Overall Study||32
329979|NCT01432756|792143|P2|STARTED|Overall Study||34
329980|NCT01432756|792144|P1|STARTED|Overall Study||32
329981|NCT01432626|792152|P1|NOT COMPLETED|Overall Study||7
329982|NCT01432626|792152|P1|COMPLETED|Overall Study|Completed both images|3
329983|NCT01432626|792152|P1|STARTED|Overall Study||10
329984|NCT01432600|792159|P3|NOT COMPLETED|Overall Study||1
329985|NCT01432600|792160|P2|NOT COMPLETED|Overall Study||1
329986|NCT01432600|792161|P1|NOT COMPLETED|Overall Study||0
329987|NCT01432600|792159|P3|COMPLETED|Overall Study||33
329988|NCT01432600|792160|P2|COMPLETED|Overall Study||35
329989|NCT01432600|792161|P1|COMPLETED|Overall Study||10
329990|NCT01432600|792159|P3|STARTED|Overall Study||34
329991|NCT01432600|792160|P2|STARTED|Overall Study||36
329992|NCT01432600|792161|P1|STARTED|Overall Study||10
329993|NCT01432574|792177|P1|NOT COMPLETED|Overall Study||3
329994|NCT01432574|792177|P1|COMPLETED|Overall Study||147
329995|NCT01432574|792177|P1|STARTED|Overall Study||150
329996|NCT01432561|792183|P1|NOT COMPLETED|Overall Study||0
329997|NCT01432561|792183|P1|COMPLETED|Overall Study||8
329998|NCT01432561|792183|P1|STARTED|Overall Study||8
329999|NCT01432535|792192|P3|NOT COMPLETED|Overall Study||0
330000|NCT01432535|792193|P2|NOT COMPLETED|Overall Study||0
330001|NCT01432535|792194|P1|NOT COMPLETED|Overall Study||0
330002|NCT01432535|792192|P3|COMPLETED|Overall Study||6
330003|NCT01432535|792193|P2|COMPLETED|Overall Study||7
330004|NCT01432535|792194|P1|COMPLETED|Overall Study||12
330005|NCT01432535|792192|P3|STARTED|Overall Study||6
330006|NCT01432535|792193|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
330007|NCT01432535|792194|P1|STARTED|Overall Study||12
330008|NCT01432457|792223|P3|NOT COMPLETED|Overall Study||59
330009|NCT01432457|792224|P2|NOT COMPLETED|Overall Study||48
330010|NCT01432457|792225|P1|NOT COMPLETED|Overall Study||37
330011|NCT01432457|792223|P3|COMPLETED|Overall Study||253
330012|NCT01432457|792224|P2|COMPLETED|Overall Study||258
330013|NCT01432457|792225|P1|COMPLETED|Overall Study||269
330014|NCT01432457|792223|P3|STARTED|Overall Study||312
330015|NCT01432457|792224|P2|STARTED|Overall Study||306
330016|NCT01432457|792225|P1|STARTED|Overall Study||306
330017|NCT01432444|792254|P3|NOT COMPLETED|Extension Phase||192
330018|NCT01432444|792255|P2|NOT COMPLETED|Extension Phase||0
330019|NCT01432444|792256|P1|NOT COMPLETED|Extension Phase||0
330020|NCT01432444|792254|P3|COMPLETED|Extension Phase||0
330021|NCT01432444|792255|P2|COMPLETED|Extension Phase||0
330022|NCT01432444|792256|P1|COMPLETED|Extension Phase||0
330023|NCT01432444|792254|P3|STARTED|Extension Phase||192
330024|NCT01432444|792255|P2|STARTED|Extension Phase||0
330025|NCT01432444|792256|P1|STARTED|Extension Phase||0
330026|NCT01432444|792254|P3|NOT COMPLETED|Treatment Phase||0
330027|NCT01432444|792255|P2|NOT COMPLETED|Treatment Phase||140
330028|NCT01432444|792256|P1|NOT COMPLETED|Treatment Phase||0
330029|NCT01432444|792254|P3|COMPLETED|Treatment Phase||0
330030|NCT01432444|792255|P2|COMPLETED|Treatment Phase||293
330031|NCT01432444|792256|P1|COMPLETED|Treatment Phase||0
330032|NCT01432444|792254|P3|STARTED|Treatment Phase||0
330033|NCT01432444|792255|P2|STARTED|Treatment Phase||433
330034|NCT01432444|792256|P1|STARTED|Treatment Phase||0
330035|NCT01432444|792254|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
330036|NCT01432444|792255|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
330037|NCT01432444|792256|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
330038|NCT01432444|792254|P3|COMPLETED|Tolerability/Cross-titration Phase||0
330039|NCT01432444|792255|P2|COMPLETED|Tolerability/Cross-titration Phase||0
330040|NCT01432444|792256|P1|COMPLETED|Tolerability/Cross-titration Phase||265
330041|NCT01432444|792254|P3|STARTED|Tolerability/Cross-titration Phase||0
330042|NCT01432444|792255|P2|STARTED|Tolerability/Cross-titration Phase||0
330043|NCT01432444|792256|P1|STARTED|Tolerability/Cross-titration Phase||325
330044|NCT01432405|792268|P2|NOT COMPLETED|Overall Study||2
330045|NCT01432405|792269|P1|NOT COMPLETED|Overall Study||1
330046|NCT01432405|792268|P2|COMPLETED|Overall Study||10
330047|NCT01432405|792269|P1|COMPLETED|Overall Study||11
330048|NCT01432405|792268|P2|STARTED|Overall Study||12
330049|NCT01432405|792269|P1|STARTED|Overall Study||12
330050|NCT01432379|792277|P1|NOT COMPLETED|Overall Study||385
330051|NCT01432379|792277|P1|COMPLETED|Overall Study||783
330052|NCT01432379|792277|P1|STARTED|Overall Study||1168
330053|NCT01432366|792282|P1|NOT COMPLETED|Overall Study||68
330054|NCT01432366|792282|P1|COMPLETED|Overall Study||392
330055|NCT01432366|792282|P1|STARTED|Overall Study||460
330056|NCT01432327|792304|P4|NOT COMPLETED|Posttest 1 Year||23
330057|NCT01432327|792305|P3|NOT COMPLETED|Posttest 1 Year||20
330058|NCT01432327|792306|P2|NOT COMPLETED|Posttest 1 Year||28
330059|NCT01432327|792307|P1|NOT COMPLETED|Posttest 1 Year||24
330060|NCT01432327|792304|P4|COMPLETED|Posttest 1 Year||31
330061|NCT01432327|792305|P3|COMPLETED|Posttest 1 Year||30
330062|NCT01432327|792306|P2|COMPLETED|Posttest 1 Year||27
330063|NCT01432327|792307|P1|COMPLETED|Posttest 1 Year||28
330064|NCT01432327|792304|P4|STARTED|Posttest 1 Year||54
330065|NCT01432327|792305|P3|STARTED|Posttest 1 Year||50
330066|NCT01432327|792306|P2|STARTED|Posttest 1 Year||55
330067|NCT01432327|792307|P1|STARTED|Posttest 1 Year||52
330068|NCT01432327|792304|P4|NOT COMPLETED|Posttest 6 Months||2
330069|NCT01432327|792305|P3|NOT COMPLETED|Posttest 6 Months||5
330070|NCT01432327|792306|P2|NOT COMPLETED|Posttest 6 Months||0
330071|NCT01432327|792307|P1|NOT COMPLETED|Posttest 6 Months||0
330072|NCT01432327|792304|P4|COMPLETED|Posttest 6 Months||54
330073|NCT01432327|792305|P3|COMPLETED|Posttest 6 Months||50
330074|NCT01432327|792306|P2|COMPLETED|Posttest 6 Months||55
330075|NCT01432327|792307|P1|COMPLETED|Posttest 6 Months||52
330076|NCT01432327|792304|P4|STARTED|Posttest 6 Months||56
330077|NCT01432327|792305|P3|STARTED|Posttest 6 Months||55
330078|NCT01432327|792306|P2|STARTED|Posttest 6 Months||55
330079|NCT01432327|792307|P1|STARTED|Posttest 6 Months||52
330080|NCT01432327|792304|P4|NOT COMPLETED|Posttest 3 Months||1
330081|NCT01432327|792305|P3|NOT COMPLETED|Posttest 3 Months||2
330082|NCT01432327|792306|P2|NOT COMPLETED|Posttest 3 Months||2
330083|NCT01432327|792307|P1|NOT COMPLETED|Posttest 3 Months||4
330084|NCT01432327|792304|P4|COMPLETED|Posttest 3 Months||56
330085|NCT01432327|792305|P3|COMPLETED|Posttest 3 Months||55
330086|NCT01432327|792306|P2|COMPLETED|Posttest 3 Months||55
330087|NCT01432327|792307|P1|COMPLETED|Posttest 3 Months||52
330088|NCT01432327|792304|P4|STARTED|Posttest 3 Months||57
330089|NCT01432327|792305|P3|STARTED|Posttest 3 Months||57
330090|NCT01432327|792306|P2|STARTED|Posttest 3 Months||57
330091|NCT01432327|792307|P1|STARTED|Posttest 3 Months||56
330092|NCT01432327|792304|P4|NOT COMPLETED|Baseline||0
330093|NCT01432327|792305|P3|NOT COMPLETED|Baseline||0
330094|NCT01432327|792306|P2|NOT COMPLETED|Baseline||0
330095|NCT01432327|792307|P1|NOT COMPLETED|Baseline||0
330096|NCT01432327|792304|P4|COMPLETED|Baseline||57
330097|NCT01432327|792305|P3|COMPLETED|Baseline||57
330098|NCT01432327|792306|P2|COMPLETED|Baseline||57
330099|NCT01432327|792307|P1|COMPLETED|Baseline||56
330100|NCT01432327|792304|P4|STARTED|Baseline||57
330101|NCT01432327|792305|P3|STARTED|Baseline||57
330102|NCT01432327|792306|P2|STARTED|Baseline||57
330103|NCT01432327|792307|P1|STARTED|Baseline||56
330104|NCT01432262|792319|P2|NOT COMPLETED|Overall Study||1
330105|NCT01432262|792320|P1|NOT COMPLETED|Overall Study||2
330106|NCT01432262|792319|P2|COMPLETED|Overall Study||161
330107|NCT01432262|792320|P1|COMPLETED|Overall Study||160
330108|NCT01432262|792319|P2|Vaccinated|Overall Study||161
330109|NCT01432262|792320|P1|Vaccinated|Overall Study||162
330110|NCT01432262|792319|P2|STARTED|Overall Study||162
330111|NCT01432262|792320|P1|STARTED|Overall Study||162
330112|NCT01432236|792338|P2|NOT COMPLETED|Overall Study||18
330113|NCT01432236|792339|P1|NOT COMPLETED|Overall Study||26
330114|NCT01432236|792338|P2|COMPLETED|Overall Study||79
330115|NCT01432236|792339|P1|COMPLETED|Overall Study||70
330116|NCT01432236|792338|P2|STARTED|Overall Study||97
330117|NCT01432236|792339|P1|STARTED|Overall Study||96
330118|NCT01432015|792386|P2|NOT COMPLETED|Overall Study||0
330119|NCT01432015|792387|P1|NOT COMPLETED|Overall Study||0
330120|NCT01432015|792386|P2|COMPLETED|Overall Study||10
330121|NCT01432015|792387|P1|COMPLETED|Overall Study||10
330122|NCT01432015|792386|P2|STARTED|Overall Study||10
330123|NCT01432015|792387|P1|STARTED|Overall Study||10
330124|NCT01431989|792395|P2|NOT COMPLETED|Period 2||0
330125|NCT01431989|792396|P1|NOT COMPLETED|Period 2||0
330126|NCT01431989|792395|P2|COMPLETED|Period 2||14
330127|NCT01431989|792396|P1|COMPLETED|Period 2||14
330128|NCT01431989|792395|P2|STARTED|Period 2||14
330129|NCT01431989|792396|P1|STARTED|Period 2||14
330130|NCT01431989|792395|P2|NOT COMPLETED|14-Day Washout Period||0
330131|NCT01431989|792396|P1|NOT COMPLETED|14-Day Washout Period||0
330132|NCT01431989|792395|P2|COMPLETED|14-Day Washout Period||14
330133|NCT01431989|792396|P1|COMPLETED|14-Day Washout Period||14
330134|NCT01431989|792395|P2|STARTED|14-Day Washout Period||14
330135|NCT01431989|792396|P1|STARTED|14-Day Washout Period||14
330136|NCT01431989|792395|P2|NOT COMPLETED|Period 1||0
330137|NCT01431989|792396|P1|NOT COMPLETED|Period 1||0
330138|NCT01431989|792395|P2|COMPLETED|Period 1||14
330139|NCT01431989|792396|P1|COMPLETED|Period 1||14
330140|NCT01431989|792395|P2|STARTED|Period 1||14
330141|NCT01431989|792396|P1|STARTED|Period 1||14
330142|NCT01431976|792414|P1|NOT COMPLETED|Overall Study||14
330143|NCT01431976|792414|P1|COMPLETED|Overall Study||6
330144|NCT01431976|792414|P1|STARTED|Overall Study||20
330145|NCT01431963|792425|P1|NOT COMPLETED|Overall Study||35
330146|NCT01431963|792425|P1|COMPLETED|Overall Study||32
330147|NCT01431963|792425|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
330148|NCT01431963|792425|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
330149|NCT01431963|792425|P1|Complete MP (24 Weeks)|Overall Study||42
330150|NCT01431963|792425|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
330151|NCT01431963|792425|P1|Complete EP (6 Weeks)|Overall Study||52
330152|NCT01431963|792425|P1|Received Treatment|Overall Study||65
330153|NCT01431963|792425|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
330154|NCT01431963|792425|P1|STARTED|Overall Study||67
330155|NCT01431950|792433|P2|NOT COMPLETED|Overall Study||15
330156|NCT01431950|792434|P1|NOT COMPLETED|Overall Study||19
330157|NCT01431950|792433|P2|COMPLETED|Overall Study||104
330158|NCT01431950|792434|P1|COMPLETED|Overall Study||100
330159|NCT01431950|792433|P2|STARTED|Overall Study||119
330160|NCT01431950|792434|P1|STARTED|Overall Study||119
330161|NCT01431846|792451|P3|NOT COMPLETED|Overall Study||0
330162|NCT01431846|792452|P2|NOT COMPLETED|Overall Study||0
330163|NCT01431846|792453|P1|NOT COMPLETED|Overall Study||0
330164|NCT01431846|792451|P3|COMPLETED|Overall Study||8
330165|NCT01431846|792452|P2|COMPLETED|Overall Study||3
330166|NCT01431846|792453|P1|COMPLETED|Overall Study||8
330167|NCT01431846|792451|P3|STARTED|Overall Study||8
330168|NCT01431846|792452|P2|STARTED|Overall Study||3
330169|NCT01431846|792453|P1|STARTED|Overall Study||8
330170|NCT01431755|792461|P1|NOT COMPLETED|Overall Study||5
330171|NCT01431755|792461|P1|COMPLETED|Overall Study||49
330172|NCT01431755|792461|P1|STARTED|Overall Study||54
330173|NCT01431716|792472|P1|NOT COMPLETED|Overall Study||1
330174|NCT01431716|792472|P1|COMPLETED|Overall Study||41
330175|NCT01431716|792472|P1|STARTED|Overall Study||42
330176|NCT01431703|792489|P1|NOT COMPLETED|Overall Study||0
330177|NCT01431703|792489|P1|COMPLETED|Overall Study||326
330178|NCT01431703|792489|P1|STARTED|Overall Study||326
330179|NCT01431521|792497|P4|NOT COMPLETED|Overall Study||0
330180|NCT01431521|792498|P3|NOT COMPLETED|Overall Study||1
330181|NCT01431521|792499|P2|NOT COMPLETED|Overall Study||0
330182|NCT01431521|792500|P1|NOT COMPLETED|Overall Study||0
330183|NCT01431521|792497|P4|COMPLETED|Overall Study||5
330184|NCT01431521|792498|P3|COMPLETED|Overall Study||10
330185|NCT01431521|792499|P2|COMPLETED|Overall Study||5
330186|NCT01431521|792500|P1|COMPLETED|Overall Study||10
330187|NCT01431521|792497|P4|Treated|Overall Study||5
330188|NCT01431521|792498|P3|Treated|Overall Study||10
330189|NCT01431521|792499|P2|Treated|Overall Study||5
330190|NCT01431521|792500|P1|Treated|Overall Study||10
330191|NCT01431521|792497|P4|STARTED|Overall Study||5
330192|NCT01431521|792498|P3|STARTED|Overall Study||11
330193|NCT01431521|792499|P2|STARTED|Overall Study||5
330194|NCT01431521|792500|P1|STARTED|Overall Study||10
330195|NCT01431508|792521|P1|NOT COMPLETED|Overall Study||2
330196|NCT01431508|792521|P1|COMPLETED|Overall Study||13
330197|NCT01431508|792521|P1|STARTED|Overall Study||15
330198|NCT01431391|792527|P2|NOT COMPLETED|Overall Study||4
330199|NCT01431391|792528|P1|NOT COMPLETED|Overall Study||8
330200|NCT01431391|792527|P2|COMPLETED|Overall Study||30
330201|NCT01431391|792528|P1|COMPLETED|Overall Study||26
330202|NCT01431391|792527|P2|Received ≥1 Leaukapheresis|Overall Study||34
330203|NCT01431391|792528|P1|Received ≥1 Leaukapheresis|Overall Study||34
330204|NCT01431391|792527|P2|STARTED|Overall Study||34
330205|NCT01431391|792528|P1|STARTED|Overall Study||34
330206|NCT01431339|792538|P2|NOT COMPLETED|Overall Study||35
330207|NCT01431339|792539|P1|NOT COMPLETED|Overall Study||39
330208|NCT01431339|792538|P2|COMPLETED|Overall Study||333
330209|NCT01431339|792539|P1|COMPLETED|Overall Study||332
330210|NCT01431339|792538|P2|Safety Population|Overall Study||367
330211|NCT01431339|792539|P1|Safety Population|Overall Study||368
330212|NCT01431339|792538|P2|STARTED|Overall Study||368
330213|NCT01431339|792539|P1|STARTED|Overall Study||371
330214|NCT01431300|792554|P3|NOT COMPLETED|Overall Study||0
330215|NCT01431300|792555|P2|NOT COMPLETED|Overall Study||0
330216|NCT01431300|792556|P1|NOT COMPLETED|Overall Study||1
330217|NCT01431300|792554|P3|COMPLETED|Overall Study||10
330218|NCT01431300|792555|P2|COMPLETED|Overall Study||10
330219|NCT01431300|792556|P1|COMPLETED|Overall Study||10
330220|NCT01431300|792554|P3|STARTED|Overall Study||10
330221|NCT01431300|792555|P2|STARTED|Overall Study||10
330222|NCT01431300|792556|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
330223|NCT01431287|792572|P5|NOT COMPLETED|Overall Study||77
330224|NCT01431287|792573|P4|NOT COMPLETED|Overall Study||63
330225|NCT01431287|792574|P3|NOT COMPLETED|Overall Study||97
330226|NCT01431287|792575|P2|NOT COMPLETED|Overall Study||98
330227|NCT01431287|792576|P1|NOT COMPLETED|Overall Study||98
330228|NCT01431287|792572|P5|COMPLETED|Overall Study||430
330229|NCT01431287|792573|P4|COMPLETED|Overall Study||445
330230|NCT01431287|792574|P3|COMPLETED|Overall Study||410
330231|NCT01431287|792575|P2|COMPLETED|Overall Study||409
330232|NCT01431287|792576|P1|COMPLETED|Overall Study||412
330233|NCT01431287|792572|P5|STARTED|Overall Study||507
330234|NCT01431287|792573|P4|STARTED|Overall Study||508
330235|NCT01431287|792574|P3|STARTED|Overall Study||507
330236|NCT01431287|792575|P2|STARTED|Overall Study||507
330237|NCT01431287|792576|P1|STARTED|Overall Study|started are actually the randomized|510
330238|NCT01431274|792738|P5|NOT COMPLETED|Overall Study||56
330239|NCT01431274|792739|P4|NOT COMPLETED|Overall Study||60
330240|NCT01431274|792740|P3|NOT COMPLETED|Overall Study||72
330241|NCT01431274|792741|P2|NOT COMPLETED|Overall Study||77
330242|NCT01431274|792742|P1|NOT COMPLETED|Overall Study||97
330243|NCT01431274|792738|P5|COMPLETED|Overall Study||466
330244|NCT01431274|792739|P4|COMPLETED|Overall Study||462
330245|NCT01431274|792740|P3|COMPLETED|Overall Study||455
330246|NCT01431274|792741|P2|COMPLETED|Overall Study||448
330247|NCT01431274|792742|P1|COMPLETED|Overall Study||431
330248|NCT01431274|792738|P5|STARTED|Overall Study||522
330249|NCT01431274|792739|P4|STARTED|Overall Study||522
330250|NCT01431274|792740|P3|STARTED|Overall Study||527
330251|NCT01431274|792741|P2|STARTED|Overall Study||525
330252|NCT01431274|792742|P1|STARTED|Overall Study||528
330253|NCT01431170|792901|P2|NOT COMPLETED|Overall Study||1
330254|NCT01431170|792902|P1|NOT COMPLETED|Overall Study||3
330255|NCT01431170|792901|P2|COMPLETED|Overall Study||11
330256|NCT01431170|792902|P1|COMPLETED|Overall Study||9
330257|NCT01431170|792901|P2|STARTED|Overall Study||12
330258|NCT01431170|792902|P1|STARTED|Overall Study||12
330259|NCT01431144|792920|P2|NOT COMPLETED|Overall Study||0
330260|NCT01431144|792921|P1|NOT COMPLETED|Overall Study||2
330261|NCT01431144|792920|P2|COMPLETED|Overall Study||14
330262|NCT01431144|792921|P1|COMPLETED|Overall Study||11
330263|NCT01431144|792920|P2|STARTED|Overall Study||14
330264|NCT01431144|792921|P1|STARTED|Overall Study||13
330265|NCT01431131|792929|P2|NOT COMPLETED|Overall Study||0
330266|NCT01431131|792930|P1|NOT COMPLETED|Overall Study||0
330267|NCT01431131|792929|P2|COMPLETED|Overall Study||12
330268|NCT01431131|792930|P1|COMPLETED|Overall Study||12
330269|NCT01431131|792929|P2|STARTED|Overall Study||12
330270|NCT01431131|792930|P1|STARTED|Overall Study||12
330271|NCT01431079|792940|P2|NOT COMPLETED|Overall Study||39
330272|NCT01431079|792941|P1|NOT COMPLETED|Overall Study||35
330273|NCT01431079|792940|P2|COMPLETED|Overall Study||6
330274|NCT01431079|792941|P1|COMPLETED|Overall Study||10
330275|NCT01431079|792940|P2|Post-test|Overall Study||45
330276|NCT01431079|792941|P1|Post-test|Overall Study||45
330277|NCT01431079|792940|P2|STARTED|Overall Study||45
330278|NCT01431079|792941|P1|STARTED|Overall Study||45
330279|NCT01431014|792995|P2|NOT COMPLETED|Overall Study||9
330280|NCT01431014|792996|P1|NOT COMPLETED|Overall Study||3
330281|NCT01431014|792995|P2|COMPLETED|Overall Study||25
330282|NCT01431014|792996|P1|COMPLETED|Overall Study||31
330283|NCT01431014|792995|P2|STARTED|Overall Study||34
330284|NCT01431014|792996|P1|STARTED|Overall Study||34
330285|NCT01430819|793004|P2|NOT COMPLETED|Overall Study||0
330286|NCT01430819|793005|P1|NOT COMPLETED|Overall Study||0
330287|NCT01430819|793004|P2|COMPLETED|Overall Study||150
330288|NCT01430819|793005|P1|COMPLETED|Overall Study||150
330289|NCT01430819|793004|P2|STARTED|Overall Study||150
330290|NCT01430819|793005|P1|STARTED|Overall Study||150
330291|NCT01430754|793020|P2|NOT COMPLETED|Randomized Phase||0
330292|NCT01430754|793021|P1|NOT COMPLETED|Randomized Phase||0
330293|NCT01430754|793020|P2|COMPLETED|Randomized Phase||10
330294|NCT01430754|793021|P1|COMPLETED|Randomized Phase||10
330295|NCT01430754|793020|P2|STARTED|Randomized Phase||10
330296|NCT01430754|793021|P1|STARTED|Randomized Phase||10
330297|NCT01430754|793020|P2|NOT COMPLETED|Run-In Phase||0
330298|NCT01430754|793021|P1|NOT COMPLETED|Run-In Phase||37
330299|NCT01430754|793020|P2|COMPLETED|Run-In Phase||0
330300|NCT01430754|793021|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
330301|NCT01430754|793020|P2|Entrained - After Run-In Phase|Run-In Phase||0
330302|NCT01430754|793021|P1|Entrained - After Run-In Phase|Run-In Phase||24
330303|NCT01430754|793020|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
330304|NCT01430754|793021|P1|STARTED|Run-In Phase||57
330305|NCT01430741|793043|P4|NOT COMPLETED|Overall Study||0
330306|NCT01430741|793044|P3|NOT COMPLETED|Overall Study||10
330307|NCT01430741|793045|P2|NOT COMPLETED|Overall Study||0
330308|NCT01430741|793046|P1|NOT COMPLETED|Overall Study||0
330309|NCT01430741|793043|P4|COMPLETED|Overall Study||81
330310|NCT01430741|793044|P3|COMPLETED|Overall Study||37
330311|NCT01430741|793045|P2|COMPLETED|Overall Study||87
330312|NCT01430741|793046|P1|COMPLETED|Overall Study||22
330313|NCT01430741|793043|P4|STARTED|Overall Study||81
330314|NCT01430741|793044|P3|STARTED|Overall Study||47
330315|NCT01430741|793045|P2|STARTED|Overall Study||87
330316|NCT01430741|793046|P1|STARTED|Overall Study||22
330317|NCT01430624|793079|P3|NOT COMPLETED|Overall Study||29
330318|NCT01430624|793080|P2|NOT COMPLETED|Overall Study||34
330319|NCT01430624|793081|P1|NOT COMPLETED|Overall Study||28
330320|NCT01430624|793079|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
330321|NCT01430624|793080|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
330322|NCT01430624|793081|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
330323|NCT01430624|793079|P3|Eligible Baseline Completes|Overall Study||79
330324|NCT01430624|793080|P2|Eligible Baseline Completes|Overall Study||77
330325|NCT01430624|793081|P1|Eligible Baseline Completes|Overall Study||77
330326|NCT01430624|793079|P3|STARTED|Overall Study||81
330327|NCT01430624|793080|P2|STARTED|Overall Study||82
330328|NCT01430624|793081|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
330329|NCT01430611|793112|P2|NOT COMPLETED|Overall Study||15
330330|NCT01430611|793113|P1|NOT COMPLETED|Overall Study||17
330331|NCT01430611|793112|P2|COMPLETED|Overall Study||318
330332|NCT01430611|793113|P1|COMPLETED|Overall Study||315
330333|NCT01430611|793112|P2|STARTED|Overall Study||333
330334|NCT01430611|793113|P1|STARTED|Overall Study||332
330335|NCT01430585|793131|P1|NOT COMPLETED|Overall Study||14
330336|NCT01430585|793131|P1|COMPLETED|Overall Study||0
330337|NCT01430585|793131|P1|STARTED|Overall Study||14
330338|NCT01430468|793166|P2|NOT COMPLETED|Overall Study||2
330339|NCT01430468|793167|P1|NOT COMPLETED|Overall Study||3
330340|NCT01430468|793166|P2|COMPLETED|Overall Study||16
330341|NCT01430468|793167|P1|COMPLETED|Overall Study||15
330342|NCT01430468|793166|P2|STARTED|Overall Study||18
330343|NCT01430468|793167|P1|STARTED|Overall Study||18
330344|NCT01430403|793176|P3|NOT COMPLETED|Overall Study||8
330345|NCT01430403|793177|P2|NOT COMPLETED|Overall Study||9
330346|NCT01430403|793178|P1|NOT COMPLETED|Overall Study||17
330347|NCT01430403|793176|P3|COMPLETED|Overall Study||81
330348|NCT01430403|793177|P2|COMPLETED|Overall Study||121
330349|NCT01430403|793178|P1|COMPLETED|Overall Study||242
330350|NCT01430403|793176|P3|STARTED|Overall Study|Intent-to-treat|89
330351|NCT01430403|793177|P2|STARTED|Overall Study|Intent-to-treat|130
330352|NCT01430403|793178|P1|STARTED|Overall Study|Intent-to-treat|259
330353|NCT01430325|793231|P4|NOT COMPLETED|Overall Study||0
330354|NCT01430325|793232|P3|NOT COMPLETED|Overall Study||0
330355|NCT01430325|793233|P2|NOT COMPLETED|Overall Study||0
330356|NCT01430325|793234|P1|NOT COMPLETED|Overall Study||0
330357|NCT01430325|793231|P4|COMPLETED|Overall Study||12
330358|NCT01430325|793232|P3|COMPLETED|Overall Study||8
330359|NCT01430325|793233|P2|COMPLETED|Overall Study||12
330360|NCT01430325|793234|P1|COMPLETED|Overall Study||10
330361|NCT01430325|793231|P4|STARTED|Overall Study||12
330362|NCT01430325|793232|P3|STARTED|Overall Study||8
330363|NCT01430325|793233|P2|STARTED|Overall Study||12
330364|NCT01430325|793234|P1|STARTED|Overall Study||10
330365|NCT01430182|793254|P2|NOT COMPLETED|Overall Study||0
330366|NCT01430182|793255|P1|NOT COMPLETED|Overall Study||0
330367|NCT01430182|793254|P2|COMPLETED|Overall Study||8
330368|NCT01430182|793255|P1|COMPLETED|Overall Study||9
330369|NCT01430182|793254|P2|STARTED|Overall Study||8
330370|NCT01430182|793255|P1|STARTED|Overall Study||9
330371|NCT01430169|793261|P1|NOT COMPLETED|Overall Study||0
330372|NCT01430169|793261|P1|COMPLETED|Overall Study||20
330373|NCT01430169|793261|P1|STARTED|Overall Study||20
330374|NCT01430130|793276|P1|NOT COMPLETED|Overall Study||2
330375|NCT01430130|793276|P1|COMPLETED|Overall Study||10
330376|NCT01430130|793276|P1|STARTED|Overall Study||12
330377|NCT01430104|793282|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
330378|NCT01430104|793282|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
330379|NCT01430104|793282|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
330380|NCT01430104|793282|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
330381|NCT01430104|793282|P1|NOT COMPLETED|14-Day Lead-In Period||0
330382|NCT01430104|793282|P1|COMPLETED|14-Day Lead-In Period||30
330383|NCT01430104|793282|P1|STARTED|14-Day Lead-In Period||30
330384|NCT01430091|793294|P1|NOT COMPLETED|Overall Study||0
330385|NCT01430091|793294|P1|COMPLETED|Overall Study||18
330386|NCT01430091|793294|P1|STARTED|Overall Study||18
330387|NCT01429623|793318|P2|NOT COMPLETED|Overall Study||59
330388|NCT01429623|793319|P1|NOT COMPLETED|Overall Study||51
330389|NCT01429623|793318|P2|COMPLETED|Overall Study||48
330390|NCT01429623|793319|P1|COMPLETED|Overall Study||51
330391|NCT01429623|793318|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
330392|NCT01429623|793319|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
330393|NCT01429623|793318|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
330394|NCT01429623|793319|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
330395|NCT01429584|793333|P2|NOT COMPLETED|Overall Study||1
330396|NCT01429584|793334|P1|NOT COMPLETED|Overall Study||1
330397|NCT01429584|793333|P2|COMPLETED|Overall Study||14
330398|NCT01429584|793334|P1|COMPLETED|Overall Study||14
330399|NCT01429584|793333|P2|STARTED|Overall Study||15
330400|NCT01429584|793334|P1|STARTED|Overall Study||15
330401|NCT01429532|793347|P3|NOT COMPLETED|Overall Study||0
330402|NCT01429532|793348|P2|NOT COMPLETED|Overall Study||0
330403|NCT01429532|793349|P1|NOT COMPLETED|Overall Study||0
330404|NCT01429532|793347|P3|COMPLETED|Overall Study||40
330405|NCT01429532|793348|P2|COMPLETED|Overall Study||40
330406|NCT01429532|793349|P1|COMPLETED|Overall Study||40
330407|NCT01429532|793347|P3|STARTED|Overall Study||40
330408|NCT01429532|793348|P2|STARTED|Overall Study||40
330409|NCT01429532|793349|P1|STARTED|Overall Study||40
330410|NCT01429441|793365|P2|NOT COMPLETED|Overall Study||23
330411|NCT01429441|793366|P1|NOT COMPLETED|Overall Study||38
330412|NCT01429441|793365|P2|COMPLETED|Overall Study||51
330413|NCT01429441|793366|P1|COMPLETED|Overall Study||108
330414|NCT01429441|793365|P2|STARTED|Overall Study||74
330415|NCT01429441|793366|P1|STARTED|Overall Study||146
330416|NCT01429259|793374|P1|NOT COMPLETED|Overall Study||0
330417|NCT01429259|793374|P1|COMPLETED|Overall Study||30
330418|NCT01429259|793374|P1|STARTED|Overall Study||30
330419|NCT01429077|793381|P2|NOT COMPLETED|Overall Study||3
330420|NCT01429077|793382|P1|NOT COMPLETED|Overall Study||0
330421|NCT01429077|793381|P2|COMPLETED|Overall Study||14
330422|NCT01429077|793382|P1|COMPLETED|Overall Study||19
330423|NCT01429077|793381|P2|Completed 6-week Intervention|Overall Study||17
330424|NCT01429077|793382|P1|Completed 6-week Intervention|Overall Study||19
330425|NCT01429077|793381|P2|STARTED|Overall Study||17
330426|NCT01429077|793382|P1|STARTED|Overall Study||19
330427|NCT01429064|793392|P4|NOT COMPLETED|Overall Study||0
330428|NCT01429064|793393|P3|NOT COMPLETED|Overall Study||0
330429|NCT01429064|793394|P2|NOT COMPLETED|Overall Study||0
330430|NCT01429064|793395|P1|NOT COMPLETED|Overall Study||0
330431|NCT01429064|793392|P4|COMPLETED|Overall Study||16
330432|NCT01429064|793393|P3|COMPLETED|Overall Study||19
330433|NCT01429064|793394|P2|COMPLETED|Overall Study||22
330434|NCT01429064|793395|P1|COMPLETED|Overall Study||19
330435|NCT01429064|793392|P4|STARTED|Overall Study||16
330436|NCT01429064|793393|P3|STARTED|Overall Study||19
330437|NCT01429064|793394|P2|STARTED|Overall Study||22
330438|NCT01429064|793395|P1|STARTED|Overall Study||19
330439|NCT01429051|793405|P1|NOT COMPLETED|Tolerability Phase||15
330440|NCT01429051|793405|P1|COMPLETED|Tolerability Phase||16
330441|NCT01429051|793405|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
330442|NCT01429051|793405|P1|NOT COMPLETED|Efficacy Phase||2
330443|NCT01429051|793405|P1|COMPLETED|Efficacy Phase||13
330444|NCT01429051|793405|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
330445|NCT01429051|793405|P1|NOT COMPLETED|Titration Phase||12
330446|NCT01429051|793405|P1|COMPLETED|Titration Phase||33
330447|NCT01429051|793405|P1|STARTED|Titration Phase||45
330448|NCT01428882|793428|P2|NOT COMPLETED|Overall Study||10
330449|NCT01428882|793429|P1|NOT COMPLETED|Overall Study||6
330450|NCT01428882|793428|P2|COMPLETED|Overall Study||58
330451|NCT01428882|793429|P1|COMPLETED|Overall Study||61
330452|NCT01428882|793428|P2|STARTED|Overall Study||68
330453|NCT01428882|793429|P1|STARTED|Overall Study||67
330454|NCT01428765|793441|P1|NOT COMPLETED|Overall Study||0
330455|NCT01428765|793441|P1|COMPLETED|Overall Study||1063
330456|NCT01428765|793441|P1|STARTED|Overall Study||1063
330457|NCT01428713|793452|P2|NOT COMPLETED|Overall Study||5
330458|NCT01428713|793453|P1|NOT COMPLETED|Overall Study||3
330459|NCT01428713|793452|P2|COMPLETED|Overall Study||3
330460|NCT01428713|793453|P1|COMPLETED|Overall Study||6
330461|NCT01428713|793452|P2|STARTED|Overall Study||8
330462|NCT01428713|793453|P1|STARTED|Overall Study||9
330463|NCT01428661|793462|P3|NOT COMPLETED|Open Label Extension||320
330464|NCT01428661|793463|P2|NOT COMPLETED|Open Label Extension||0
330465|NCT01428661|793464|P1|NOT COMPLETED|Open Label Extension||0
330466|NCT01428661|793462|P3|COMPLETED|Open Label Extension||19
330467|NCT01428661|793463|P2|COMPLETED|Open Label Extension|Does not apply.|0
330468|NCT01428661|793464|P1|COMPLETED|Open Label Extension|Does not apply.|0
330469|NCT01428661|793462|P3|STARTED|Open Label Extension||339
330470|NCT01428661|793463|P2|STARTED|Open Label Extension|Does not apply.|0
330471|NCT01428661|793464|P1|STARTED|Open Label Extension|Does not apply.|0
330472|NCT01428661|793462|P3|NOT COMPLETED|Double-Masked Phase||0
330473|NCT01428661|793463|P2|NOT COMPLETED|Double-Masked Phase||49
330474|NCT01428661|793464|P1|NOT COMPLETED|Double-Masked Phase||57
330475|NCT01428661|793462|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
330476|NCT01428661|793463|P2|COMPLETED|Double-Masked Phase||204
330477|NCT01428661|793464|P1|COMPLETED|Double-Masked Phase||197
330478|NCT01428661|793462|P3|STARTED|Double-Masked Phase|Does not apply.|0
330479|NCT01428661|793463|P2|STARTED|Double-Masked Phase||253
330480|NCT01428661|793464|P1|STARTED|Double-Masked Phase||254
330481|NCT01428583|793472|P1|NOT COMPLETED|Overall Study||237
330482|NCT01428583|793472|P1|COMPLETED|Overall Study||158
330483|NCT01428583|793472|P1|STARTED|Overall Study||395
330484|NCT01428258|793496|P2|NOT COMPLETED|Intervention 2||0
330485|NCT01428258|793497|P1|NOT COMPLETED|Intervention 2||0
330486|NCT01428258|793496|P2|COMPLETED|Intervention 2||15
330487|NCT01428258|793497|P1|COMPLETED|Intervention 2||15
330488|NCT01428258|793496|P2|STARTED|Intervention 2||15
330489|NCT01428258|793497|P1|STARTED|Intervention 2||15
330490|NCT01428258|793496|P2|NOT COMPLETED|Intervention 1||0
330491|NCT01428258|793497|P1|NOT COMPLETED|Intervention 1||2
330492|NCT01428258|793496|P2|COMPLETED|Intervention 1||15
330493|NCT01428258|793497|P1|COMPLETED|Intervention 1||15
330494|NCT01428258|793496|P2|STARTED|Intervention 1||15
330495|NCT01428258|793497|P1|STARTED|Intervention 1||17
330496|NCT01428219|793515|P1|NOT COMPLETED|Overall Study||0
330497|NCT01428219|793515|P1|COMPLETED|Overall Study||25
330498|NCT01428219|793515|P1|STARTED|Overall Study||25
330499|NCT01428128|793519|P1|NOT COMPLETED|Overall Study||17
330500|NCT01428128|793519|P1|COMPLETED|Overall Study||33
330501|NCT01428128|793519|P1|STARTED|Overall Study||50
330502|NCT01428115|793523|P1|NOT COMPLETED|Overall Study||21
330503|NCT01428115|793523|P1|COMPLETED|Overall Study||62
330504|NCT01428115|793523|P1|STARTED|Overall Study||83
330505|NCT01428076|793538|P2|NOT COMPLETED|Overall Study||1
330506|NCT01428076|793539|P1|NOT COMPLETED|Overall Study||0
330507|NCT01428076|793538|P2|COMPLETED|Overall Study||11
330508|NCT01428076|793539|P1|COMPLETED|Overall Study||9
330509|NCT01428076|793538|P2|STARTED|Overall Study||12
330510|NCT01428076|793539|P1|STARTED|Overall Study||9
330511|NCT01428063|793550|P3|NOT COMPLETED|Overall Study||1
330512|NCT01428063|793551|P2|NOT COMPLETED|Overall Study||10
330513|NCT01428063|793552|P1|NOT COMPLETED|Overall Study||10
330514|NCT01428063|793550|P3|COMPLETED|Overall Study||5
330515|NCT01428063|793551|P2|COMPLETED|Overall Study||112
330516|NCT01428063|793552|P1|COMPLETED|Overall Study||89
330517|NCT01428063|793550|P3|STARTED|Overall Study||6
330518|NCT01428063|793551|P2|STARTED|Overall Study||122
330519|NCT01428063|793552|P1|STARTED|Overall Study||99
330520|NCT01427933|793623|P2|NOT COMPLETED|Overall Study||13
330521|NCT01427933|793624|P1|NOT COMPLETED|Overall Study||8
330522|NCT01427933|793623|P2|COMPLETED|Overall Study||57
330523|NCT01427933|793624|P1|COMPLETED|Overall Study||63
330524|NCT01427933|793623|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
330525|NCT01427933|793624|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
330526|NCT01427933|793623|P2|STARTED|Overall Study||70
330527|NCT01427933|793624|P1|STARTED|Overall Study||71
330528|NCT01427920|793644|P2|NOT COMPLETED|Overall Study||17
330529|NCT01427920|793645|P1|NOT COMPLETED|Overall Study||9
330530|NCT01427920|793644|P2|COMPLETED|Overall Study||157
330531|NCT01427920|793645|P1|COMPLETED|Overall Study||165
330532|NCT01427920|793644|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
330533|NCT01427920|793645|P1|Exposed|Overall Study||174
330534|NCT01427920|793644|P2|STARTED|Overall Study||174
330535|NCT01427920|793645|P1|STARTED|Overall Study||174
330536|NCT01427907|793665|P2|NOT COMPLETED|Overall Study||4
330537|NCT01427907|793666|P1|NOT COMPLETED|Overall Study||3
330538|NCT01427907|793665|P2|COMPLETED|Overall Study|Completed study|14
330539|NCT01427907|793666|P1|COMPLETED|Overall Study|Completed study|17
330540|NCT01427907|793665|P2|STARTED|Overall Study|Randomized|18
330541|NCT01427907|793666|P1|STARTED|Overall Study|Randomized|20
330542|NCT01427881|793672|P1|NOT COMPLETED|Overall Study||0
330543|NCT01427881|793672|P1|COMPLETED|Overall Study||43
330544|NCT01427881|793672|P1|STARTED|Overall Study||43
330545|NCT01427803|793687|P2|NOT COMPLETED|Overall Study||26
330546|NCT01427803|793688|P1|NOT COMPLETED|Overall Study||63
330547|NCT01427803|793687|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
330548|NCT01427803|793688|P1|COMPLETED|Overall Study||463
330549|NCT01427803|793687|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
330550|NCT01427803|793688|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
330551|NCT01427803|793687|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
330552|NCT01427803|793688|P1|Baseline Assessment|Overall Study||516
330553|NCT01427803|793687|P2|Purchased Product|Overall Study||252
330554|NCT01427803|793688|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
330555|NCT01427803|793687|P2|STARTED|Overall Study||252
330556|NCT01427803|793688|P1|STARTED|Overall Study||526
330557|NCT01427751|793702|P2|NOT COMPLETED|Overall Study||14
330558|NCT01427751|793703|P1|NOT COMPLETED|Overall Study||42
330559|NCT01427751|793702|P2|COMPLETED|Overall Study||139
330560|NCT01427751|793703|P1|COMPLETED|Overall Study||112
330561|NCT01427751|793702|P2|STARTED|Overall Study||153
330562|NCT01427751|793703|P1|STARTED|Overall Study||154
330563|NCT01427738|793723|P2|NOT COMPLETED|Overall Study||21
330564|NCT01427738|793724|P1|NOT COMPLETED|Overall Study||19
330565|NCT01427738|793723|P2|COMPLETED|Overall Study||90
330566|NCT01427738|793724|P1|COMPLETED|Overall Study||91
330567|NCT01427738|793723|P2|STARTED|Overall Study||111
330568|NCT01427738|793724|P1|STARTED|Overall Study||110
330569|NCT01427517|793745|P3|NOT COMPLETED|Overall Study||0
330570|NCT01427517|793746|P2|NOT COMPLETED|Overall Study||0
330571|NCT01427517|793747|P1|NOT COMPLETED|Overall Study||0
330572|NCT01427517|793745|P3|COMPLETED|Overall Study||3
330573|NCT01427517|793746|P2|COMPLETED|Overall Study||3
330574|NCT01427517|793747|P1|COMPLETED|Overall Study||3
330575|NCT01427517|793745|P3|STARTED|Overall Study||3
330576|NCT01427517|793746|P2|STARTED|Overall Study||3
330577|NCT01427517|793747|P1|STARTED|Overall Study||3
330578|NCT01427504|793761|P6|NOT COMPLETED|Overall Study||2
330579|NCT01427504|793762|P5|NOT COMPLETED|Overall Study||1
330580|NCT01427504|793763|P4|NOT COMPLETED|Overall Study||1
330581|NCT01427504|793764|P3|NOT COMPLETED|Overall Study||1
330582|NCT01427504|793765|P2|NOT COMPLETED|Overall Study||1
330583|NCT01427504|793766|P1|NOT COMPLETED|Overall Study||0
330584|NCT01427504|793761|P6|COMPLETED|Overall Study||4
330585|NCT01427504|793762|P5|COMPLETED|Overall Study||2
330586|NCT01427504|793763|P4|COMPLETED|Overall Study||5
330587|NCT01427504|793764|P3|COMPLETED|Overall Study||3
330588|NCT01427504|793765|P2|COMPLETED|Overall Study||2
330589|NCT01427504|793766|P1|COMPLETED|Overall Study||4
330590|NCT01427504|793761|P6|Received Combination|Overall Study||6
330591|NCT01427504|793762|P5|Received Combination|Overall Study||3
330592|NCT01427504|793763|P4|Received Combination|Overall Study||6
330593|NCT01427504|793764|P3|Received Combination|Overall Study||3
330594|NCT01427504|793765|P2|Received Combination|Overall Study||3
330595|NCT01427504|793766|P1|Received Combination|Overall Study||4
330596|NCT01427504|793761|P6|Received Etravirine|Overall Study||4
330597|NCT01427504|793762|P5|Received Etravirine|Overall Study||2
330598|NCT01427504|793763|P4|Received Etravirine|Overall Study||6
330599|NCT01427504|793764|P3|Received Etravirine|Overall Study||4
330600|NCT01427504|793765|P2|Received Etravirine|Overall Study||2
330601|NCT01427504|793766|P1|Received Etravirine|Overall Study||4
330602|NCT01427504|793761|P6|Received Boceprevir|Overall Study||4
330603|NCT01427504|793762|P5|Received Boceprevir|Overall Study||2
330604|NCT01427504|793763|P4|Received Boceprevir|Overall Study||5
330605|NCT01427504|793764|P3|Received Boceprevir|Overall Study||3
330606|NCT01427504|793765|P2|Received Boceprevir|Overall Study||3
330607|NCT01427504|793766|P1|Received Boceprevir|Overall Study||4
330608|NCT01427504|793761|P6|STARTED|Overall Study||6
330609|NCT01427504|793762|P5|STARTED|Overall Study||3
330610|NCT01427504|793763|P4|STARTED|Overall Study||6
330611|NCT01427504|793764|P3|STARTED|Overall Study||4
330612|NCT01427504|793765|P2|STARTED|Overall Study||3
330613|NCT01427504|793766|P1|STARTED|Overall Study||4
330614|NCT01427309|793787|P4|NOT COMPLETED|Overall Study||376
330615|NCT01427309|793788|P3|NOT COMPLETED|Overall Study||361
330616|NCT01427309|793789|P2|NOT COMPLETED|Overall Study||407
330617|NCT01427309|793790|P1|NOT COMPLETED|Overall Study||372
330618|NCT01427309|793787|P4|COMPLETED|Overall Study||8373
330619|NCT01427309|793788|P3|COMPLETED|Overall Study||8376
330620|NCT01427309|793789|P2|COMPLETED|Overall Study||6837
330621|NCT01427309|793790|P1|COMPLETED|Overall Study||6881
330622|NCT01427309|793787|P4|STARTED|Overall Study||8749
330623|NCT01427309|793788|P3|STARTED|Overall Study||8737
330624|NCT01427309|793789|P2|STARTED|Overall Study||7244
330625|NCT01427309|793790|P1|STARTED|Overall Study||7253
330626|NCT01426958|793828|P1|NOT COMPLETED|Overall Study||2
330627|NCT01426958|793828|P1|COMPLETED|Overall Study||22
330628|NCT01426958|793828|P1|STARTED|Overall Study||24
330629|NCT01426867|793845|P3|NOT COMPLETED|Overall Study||0
330630|NCT01426867|793846|P2|NOT COMPLETED|Overall Study||0
330631|NCT01426867|793847|P1|NOT COMPLETED|Overall Study||0
330632|NCT01426867|793845|P3|COMPLETED|Overall Study||34
330633|NCT01426867|793846|P2|COMPLETED|Overall Study||34
330634|NCT01426867|793847|P1|COMPLETED|Overall Study||33
330635|NCT01426867|793845|P3|STARTED|Overall Study||34
330636|NCT01426867|793846|P2|STARTED|Overall Study||34
330637|NCT01426867|793847|P1|STARTED|Overall Study||33
330638|NCT01426854|793857|P2|NOT COMPLETED|Overall Study||31
330639|NCT01426854|793858|P1|NOT COMPLETED|Overall Study||12
330640|NCT01426854|793857|P2|COMPLETED|Overall Study||98
330641|NCT01426854|793858|P1|COMPLETED|Overall Study||119
330642|NCT01426854|793857|P2|STARTED|Overall Study||129
330643|NCT01426854|793858|P1|STARTED|Overall Study||131
330644|NCT01426789|793868|P6|NOT COMPLETED|Part 2||0
330645|NCT01426789|793869|P5|NOT COMPLETED|Part 2||8
330646|NCT01426789|793870|P4|NOT COMPLETED|Part 2||1
330647|NCT01426789|793871|P3|NOT COMPLETED|Part 2||15
330648|NCT01426789|793872|P2|NOT COMPLETED|Part 2||0
330649|NCT01426789|793873|P1|NOT COMPLETED|Part 2||0
330650|NCT01426789|793868|P6|COMPLETED|Part 2||1
330651|NCT01426789|793869|P5|COMPLETED|Part 2||19
330652|NCT01426789|793870|P4|COMPLETED|Part 2||12
330653|NCT01426789|793871|P3|COMPLETED|Part 2||34
330654|NCT01426789|793872|P2|COMPLETED|Part 2||0
330655|NCT01426789|793873|P1|COMPLETED|Part 2||0
330656|NCT01426789|793868|P6|STARTED|Part 2||1
330657|NCT01426789|793869|P5|STARTED|Part 2||27
330658|NCT01426789|793870|P4|STARTED|Part 2||13
330659|NCT01426789|793871|P3|STARTED|Part 2||49
330660|NCT01426789|793872|P2|STARTED|Part 2||0
330661|NCT01426789|793873|P1|STARTED|Part 2||0
330662|NCT01426789|793868|P6|NOT COMPLETED|Part 1||0
330663|NCT01426789|793869|P5|NOT COMPLETED|Part 1||0
330664|NCT01426789|793870|P4|NOT COMPLETED|Part 1||0
330665|NCT01426789|793871|P3|NOT COMPLETED|Part 1||0
330666|NCT01426789|793872|P2|NOT COMPLETED|Part 1||4
330667|NCT01426789|793873|P1|NOT COMPLETED|Part 1||6
330668|NCT01426789|793868|P6|COMPLETED|Part 1||0
330669|NCT01426789|793869|P5|COMPLETED|Part 1||0
330670|NCT01426789|793870|P4|COMPLETED|Part 1||0
330671|NCT01426789|793871|P3|COMPLETED|Part 1||0
330672|NCT01426789|793872|P2|COMPLETED|Part 1||28
330673|NCT01426789|793873|P1|COMPLETED|Part 1||62
330674|NCT01426789|793868|P6|STARTED|Part 1||0
330675|NCT01426789|793869|P5|STARTED|Part 1||0
330676|NCT01426789|793870|P4|STARTED|Part 1||0
330677|NCT01426789|793871|P3|STARTED|Part 1||0
330678|NCT01426789|793872|P2|STARTED|Part 1||32
330679|NCT01426789|793873|P1|STARTED|Part 1||68
330680|NCT01426763|793889|P2|NOT COMPLETED|Overall Study||0
330681|NCT01426763|793890|P1|NOT COMPLETED|Overall Study||0
330682|NCT01426763|793889|P2|COMPLETED|Overall Study||6
330683|NCT01426763|793890|P1|COMPLETED|Overall Study||6
330684|NCT01426763|793889|P2|STARTED|Overall Study||6
330685|NCT01426763|793890|P1|STARTED|Overall Study||6
330686|NCT01426555|793898|P2|NOT COMPLETED|Overall Study||15
330687|NCT01426555|793899|P1|NOT COMPLETED|Overall Study||18
330688|NCT01426555|793898|P2|COMPLETED|Overall Study||20
330689|NCT01426555|793899|P1|COMPLETED|Overall Study||17
330690|NCT01426555|793898|P2|STARTED|Overall Study||35
330691|NCT01426555|793899|P1|STARTED|Overall Study||35
330692|NCT01426516|793909|P2|NOT COMPLETED|Overall Study||0
330693|NCT01426516|793910|P1|NOT COMPLETED|Overall Study||0
330694|NCT01426516|793909|P2|COMPLETED|Overall Study||17
330695|NCT01426516|793910|P1|COMPLETED|Overall Study||12
330696|NCT01426516|793909|P2|STARTED|Overall Study||17
330697|NCT01426516|793910|P1|STARTED|Overall Study||12
330698|NCT01426438|793918|P2|NOT COMPLETED|Overall Study||10
330699|NCT01426438|793919|P1|NOT COMPLETED|Overall Study||15
330700|NCT01426438|793918|P2|COMPLETED|Overall Study||39
330701|NCT01426438|793919|P1|COMPLETED|Overall Study||35
330702|NCT01426438|793918|P2|STARTED|Overall Study||49
330703|NCT01426438|793919|P1|STARTED|Overall Study||50
330704|NCT01426425|793951|P1|NOT COMPLETED|Overall Study||175
330705|NCT01426425|793951|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
330706|NCT01426425|793951|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
330707|NCT01426425|793951|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
330708|NCT01426425|793951|P1|STARTED|Overall Study||572
330709|NCT01426373|793957|P1|NOT COMPLETED|Overall Study||34
330710|NCT01426373|793957|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
330711|NCT01426373|793957|P1|STARTED|Overall Study||165
330712|NCT01426360|793975|P2|NOT COMPLETED|Overall Study||0
330713|NCT01426360|793976|P1|NOT COMPLETED|Overall Study||0
330714|NCT01426360|793975|P2|COMPLETED|Overall Study||41
330715|NCT01426360|793976|P1|COMPLETED|Overall Study||38
330716|NCT01426360|793975|P2|STARTED|Overall Study||41
330717|NCT01426360|793976|P1|STARTED|Overall Study||38
330718|NCT01426347|793990|P2|NOT COMPLETED|Overall Study||3
330719|NCT01426347|793991|P1|NOT COMPLETED|Overall Study||7
330720|NCT01426347|793990|P2|COMPLETED|Overall Study||39
330721|NCT01426347|793991|P1|COMPLETED|Overall Study||34
330722|NCT01426347|793990|P2|STARTED|Overall Study||42
330723|NCT01426347|793991|P1|STARTED|Overall Study||41
330724|NCT01426269|793999|P3|NOT COMPLETED|Period 2: 40 Weeks||47
330725|NCT01426269|794000|P2|NOT COMPLETED|Period 2: 40 Weeks||38
330726|NCT01426269|794001|P1|NOT COMPLETED|Period 2: 40 Weeks||0
330727|NCT01426269|793999|P3|COMPLETED|Period 2: 40 Weeks||18
330728|NCT01426269|794000|P2|COMPLETED|Period 2: 40 Weeks||27
330729|NCT01426269|794001|P1|COMPLETED|Period 2: 40 Weeks||0
330730|NCT01426269|793999|P3|STARTED|Period 2: 40 Weeks||65
330731|NCT01426269|794000|P2|STARTED|Period 2: 40 Weeks||65
330732|NCT01426269|794001|P1|STARTED|Period 2: 40 Weeks||0
330733|NCT01426269|793999|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
330734|NCT01426269|794000|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
330735|NCT01426269|794001|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
330736|NCT01426269|793999|P3|COMPLETED|Eligibility for Period 2, Randomization||0
330737|NCT01426269|794000|P2|COMPLETED|Eligibility for Period 2, Randomization||0
330738|NCT01426269|794001|P1|COMPLETED|Eligibility for Period 2, Randomization||130
330739|NCT01426269|793999|P3|STARTED|Eligibility for Period 2, Randomization||0
330740|NCT01426269|794000|P2|STARTED|Eligibility for Period 2, Randomization||0
330741|NCT01426269|794001|P1|STARTED|Eligibility for Period 2, Randomization||180
330742|NCT01426269|793999|P3|NOT COMPLETED|Period 1: 12 Weeks||0
330743|NCT01426269|794000|P2|NOT COMPLETED|Period 1: 12 Weeks||0
330744|NCT01426269|794001|P1|NOT COMPLETED|Period 1: 12 Weeks||55
330745|NCT01426269|793999|P3|COMPLETED|Period 1: 12 Weeks||0
330746|NCT01426269|794000|P2|COMPLETED|Period 1: 12 Weeks||0
330747|NCT01426269|794001|P1|COMPLETED|Period 1: 12 Weeks||180
330748|NCT01426269|793999|P3|STARTED|Period 1: 12 Weeks||0
330749|NCT01426269|794000|P2|STARTED|Period 1: 12 Weeks||0
330750|NCT01426269|794001|P1|STARTED|Period 1: 12 Weeks||235
330751|NCT01426230|794028|P2|NOT COMPLETED|Overall Study||27
330752|NCT01426230|794029|P1|NOT COMPLETED|Overall Study||31
330753|NCT01426230|794028|P2|COMPLETED|Overall Study||84
330754|NCT01426230|794029|P1|COMPLETED|Overall Study||55
330755|NCT01426230|794028|P2|STARTED|Overall Study||111
330756|NCT01426230|794029|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
330757|NCT01426113|794036|P2|NOT COMPLETED|Overall Study||2
330758|NCT01426113|794037|P1|NOT COMPLETED|Overall Study||1
330759|NCT01426113|794036|P2|COMPLETED|Overall Study||1
330760|NCT01426113|794037|P1|COMPLETED|Overall Study||2
330761|NCT01426113|794036|P2|STARTED|Overall Study||3
330762|NCT01426113|794037|P1|STARTED|Overall Study||3
330763|NCT01425879|794043|P1|NOT COMPLETED|Overall Study||0
330764|NCT01425879|794043|P1|COMPLETED|Overall Study||8
330765|NCT01425879|794043|P1|STARTED|Overall Study||8
330766|NCT01425853|794052|P2|NOT COMPLETED|Overall Study||77
330767|NCT01425853|794053|P1|NOT COMPLETED|Overall Study||64
330768|NCT01425853|794052|P2|COMPLETED|Overall Study||225
330769|NCT01425853|794053|P1|COMPLETED|Overall Study||240
330770|NCT01425853|794052|P2|Per Protocol (PP)|Overall Study||258
330771|NCT01425853|794053|P1|Per Protocol (PP)|Overall Study||264
330772|NCT01425853|794052|P2|Safety Population|Overall Study||299
330773|NCT01425853|794053|P1|Safety Population|Overall Study||304
330774|NCT01425853|794052|P2|STARTED|Overall Study||302
330775|NCT01425853|794053|P1|STARTED|Overall Study||304
330776|NCT01425814|794083|P6|NOT COMPLETED|Period 5||1
330777|NCT01425814|794084|P5|NOT COMPLETED|Period 5||0
330778|NCT01425814|794085|P4|NOT COMPLETED|Period 5||0
330779|NCT01425814|794086|P3|NOT COMPLETED|Period 5||1
330780|NCT01425814|794087|P2|NOT COMPLETED|Period 5||0
330781|NCT01425814|794088|P1|NOT COMPLETED|Period 5||0
330782|NCT01425814|794083|P6|COMPLETED|Period 5||11
330783|NCT01425814|794084|P5|COMPLETED|Period 5||12
330784|NCT01425814|794085|P4|COMPLETED|Period 5||10
330785|NCT01425814|794086|P3|COMPLETED|Period 5||10
330786|NCT01425814|794087|P2|COMPLETED|Period 5||9
330787|NCT01425814|794088|P1|COMPLETED|Period 5||11
330788|NCT01425814|794083|P6|STARTED|Period 5||12
330789|NCT01425814|794084|P5|STARTED|Period 5||12
330790|NCT01425814|794085|P4|STARTED|Period 5||10
330791|NCT01425814|794086|P3|STARTED|Period 5||11
330792|NCT01425814|794087|P2|STARTED|Period 5||9
330793|NCT01425814|794088|P1|STARTED|Period 5||11
330794|NCT01425814|794083|P6|NOT COMPLETED|Period 4||0
330795|NCT01425814|794084|P5|NOT COMPLETED|Period 4||0
330796|NCT01425814|794085|P4|NOT COMPLETED|Period 4||0
330797|NCT01425814|794086|P3|NOT COMPLETED|Period 4||1
330798|NCT01425814|794087|P2|NOT COMPLETED|Period 4||0
330799|NCT01425814|794088|P1|NOT COMPLETED|Period 4||1
330800|NCT01425814|794083|P6|COMPLETED|Period 4||12
330801|NCT01425814|794084|P5|COMPLETED|Period 4||12
330802|NCT01425814|794085|P4|COMPLETED|Period 4||10
330803|NCT01425814|794086|P3|COMPLETED|Period 4||11
330804|NCT01425814|794087|P2|COMPLETED|Period 4||9
330805|NCT01425814|794088|P1|COMPLETED|Period 4||11
330806|NCT01425814|794083|P6|STARTED|Period 4||12
330807|NCT01425814|794084|P5|STARTED|Period 4||12
330808|NCT01425814|794085|P4|STARTED|Period 4||10
330809|NCT01425814|794086|P3|STARTED|Period 4||12
330810|NCT01425814|794087|P2|STARTED|Period 4||9
330811|NCT01425814|794088|P1|STARTED|Period 4||12
330812|NCT01425814|794083|P6|NOT COMPLETED|Period 3||1
330813|NCT01425814|794084|P5|NOT COMPLETED|Period 3||0
330814|NCT01425814|794085|P4|NOT COMPLETED|Period 3||0
330815|NCT01425814|794086|P3|NOT COMPLETED|Period 3||0
330816|NCT01425814|794087|P2|NOT COMPLETED|Period 3||0
330817|NCT01425814|794088|P1|NOT COMPLETED|Period 3||0
330818|NCT01425814|794083|P6|COMPLETED|Period 3||12
330819|NCT01425814|794084|P5|COMPLETED|Period 3||12
330820|NCT01425814|794085|P4|COMPLETED|Period 3||10
330821|NCT01425814|794086|P3|COMPLETED|Period 3||12
330822|NCT01425814|794087|P2|COMPLETED|Period 3||9
330823|NCT01425814|794088|P1|COMPLETED|Period 3||12
330824|NCT01425814|794083|P6|STARTED|Period 3||13
330825|NCT01425814|794084|P5|STARTED|Period 3||12
330826|NCT01425814|794085|P4|STARTED|Period 3||10
330827|NCT01425814|794086|P3|STARTED|Period 3||12
330828|NCT01425814|794087|P2|STARTED|Period 3||9
330829|NCT01425814|794088|P1|STARTED|Period 3||12
330830|NCT01425814|794083|P6|NOT COMPLETED|Period 2||0
330831|NCT01425814|794084|P5|NOT COMPLETED|Period 2||0
330832|NCT01425814|794085|P4|NOT COMPLETED|Period 2||0
330833|NCT01425814|794086|P3|NOT COMPLETED|Period 2||0
330834|NCT01425814|794087|P2|NOT COMPLETED|Period 2||1
330835|NCT01425814|794088|P1|NOT COMPLETED|Period 2||0
330836|NCT01425814|794083|P6|COMPLETED|Period 2||13
330837|NCT01425814|794084|P5|COMPLETED|Period 2||12
330838|NCT01425814|794085|P4|COMPLETED|Period 2||10
330839|NCT01425814|794086|P3|COMPLETED|Period 2||12
330840|NCT01425814|794087|P2|COMPLETED|Period 2||9
330841|NCT01425814|794088|P1|COMPLETED|Period 2||12
330842|NCT01425814|794083|P6|STARTED|Period 2||13
330843|NCT01425814|794084|P5|STARTED|Period 2||12
330844|NCT01425814|794085|P4|STARTED|Period 2||10
330845|NCT01425814|794086|P3|STARTED|Period 2||12
330846|NCT01425814|794087|P2|STARTED|Period 2||10
330847|NCT01425814|794088|P1|STARTED|Period 2||12
330848|NCT01425814|794083|P6|NOT COMPLETED|Period 1||0
330849|NCT01425814|794084|P5|NOT COMPLETED|Period 1||0
330850|NCT01425814|794085|P4|NOT COMPLETED|Period 1||0
330851|NCT01425814|794086|P3|NOT COMPLETED|Period 1||0
330852|NCT01425814|794087|P2|NOT COMPLETED|Period 1||1
330853|NCT01425814|794088|P1|NOT COMPLETED|Period 1||0
330854|NCT01425814|794083|P6|COMPLETED|Period 1||13
330855|NCT01425814|794084|P5|COMPLETED|Period 1||12
330856|NCT01425814|794085|P4|COMPLETED|Period 1||10
330857|NCT01425814|794086|P3|COMPLETED|Period 1||12
330858|NCT01425814|794087|P2|COMPLETED|Period 1||10
330859|NCT01425814|794088|P1|COMPLETED|Period 1||12
330860|NCT01425814|794083|P6|STARTED|Period 1||13
330861|NCT01425814|794084|P5|STARTED|Period 1||12
330862|NCT01425814|794085|P4|STARTED|Period 1||10
330863|NCT01425814|794086|P3|STARTED|Period 1||12
330864|NCT01425814|794087|P2|STARTED|Period 1||11
330865|NCT01425814|794088|P1|STARTED|Period 1||12
330866|NCT01425749|794182|P2|NOT COMPLETED|Overall Study||1
330867|NCT01425749|794183|P1|NOT COMPLETED|Overall Study||0
330868|NCT01425749|794182|P2|COMPLETED|Overall Study||11
330869|NCT01425749|794183|P1|COMPLETED|Overall Study||13
330870|NCT01425749|794182|P2|STARTED|Overall Study||12
330871|NCT01425749|794183|P1|STARTED|Overall Study||13
330872|NCT01425632|794201|P3|NOT COMPLETED|Overall Study||4
330873|NCT01425632|794202|P2|NOT COMPLETED|Overall Study||1
330874|NCT01425632|794203|P1|NOT COMPLETED|Overall Study||1
330875|NCT01425632|794201|P3|COMPLETED|Overall Study||159
330876|NCT01425632|794202|P2|COMPLETED|Overall Study||165
330877|NCT01425632|794203|P1|COMPLETED|Overall Study||160
330878|NCT01425632|794201|P3|STARTED|Overall Study||163
330879|NCT01425632|794202|P2|STARTED|Overall Study||166
330880|NCT01425632|794203|P1|STARTED|Overall Study||161
330881|NCT01425528|794213|P2|NOT COMPLETED|Overall Study||1
330882|NCT01425528|794214|P1|NOT COMPLETED|Overall Study||1
330883|NCT01425528|794213|P2|COMPLETED|Overall Study||5
330884|NCT01425528|794214|P1|COMPLETED|Overall Study||5
330885|NCT01425528|794213|P2|STARTED|Overall Study||6
330886|NCT01425528|794214|P1|STARTED|Overall Study||6
330887|NCT01425463|794222|P2|NOT COMPLETED|Overall Study||24
330888|NCT01425463|794223|P1|NOT COMPLETED|Overall Study||24
330889|NCT01425463|794222|P2|COMPLETED|Overall Study||102
330890|NCT01425463|794223|P1|COMPLETED|Overall Study||106
330891|NCT01425463|794222|P2|Full Analysis Set|Overall Study||116
330892|NCT01425463|794223|P1|Full Analysis Set|Overall Study||122
330893|NCT01425463|794222|P2|Safety Set|Overall Study||122
330894|NCT01425463|794223|P1|Safety Set|Overall Study||126
330895|NCT01425463|794222|P2|STARTED|Overall Study||126
330896|NCT01425463|794223|P1|STARTED|Overall Study||130
330897|NCT01425359|794239|P2|NOT COMPLETED|Overall Study||22
330898|NCT01425359|794240|P1|NOT COMPLETED|Overall Study||19
330899|NCT01425359|794239|P2|COMPLETED|Overall Study||451
330900|NCT01425359|794240|P1|COMPLETED|Overall Study||457
330901|NCT01425359|794239|P2|STARTED|Overall Study||473
330902|NCT01425359|794240|P1|STARTED|Overall Study||476
330903|NCT01425307|794258|P2|NOT COMPLETED|Overall Study||19
330904|NCT01425307|794259|P1|NOT COMPLETED|Overall Study||19
330905|NCT01425307|794258|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
330906|NCT01425307|794259|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
330907|NCT01425307|794258|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
330908|NCT01425307|794259|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
330909|NCT01425229|794269|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
330910|NCT01425229|794269|P1|COMPLETED|Bosentan During Clarithromycin||16
330911|NCT01425229|794269|P1|STARTED|Bosentan During Clarithromycin||16
330912|NCT01425229|794269|P1|NOT COMPLETED|Bosentan Steady-state||0
330913|NCT01425229|794269|P1|COMPLETED|Bosentan Steady-state||16
330914|NCT01425229|794269|P1|STARTED|Bosentan Steady-state||16
330915|NCT01425229|794269|P1|NOT COMPLETED|Bosentan Single Dose||0
330916|NCT01425229|794269|P1|COMPLETED|Bosentan Single Dose||16
330917|NCT01425229|794269|P1|STARTED|Bosentan Single Dose||16
330918|NCT01425203|794282|P3|NOT COMPLETED|Follow-up Phase||0
330919|NCT01425203|794283|P2|NOT COMPLETED|Follow-up Phase||0
330920|NCT01425203|794284|P1|NOT COMPLETED|Follow-up Phase||0
330921|NCT01425203|794282|P3|COMPLETED|Follow-up Phase||27
330922|NCT01425203|794283|P2|COMPLETED|Follow-up Phase||49
330923|NCT01425203|794284|P1|COMPLETED|Follow-up Phase||153
330924|NCT01425203|794282|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
330925|NCT01425203|794283|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
330926|NCT01425203|794284|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
330927|NCT01425203|794282|P3|NOT COMPLETED|Crossover Phase||6
330928|NCT01425203|794283|P2|NOT COMPLETED|Crossover Phase||0
330929|NCT01425203|794284|P1|NOT COMPLETED|Crossover Phase||0
330930|NCT01425203|794282|P3|COMPLETED|Crossover Phase||21
330931|NCT01425203|794283|P2|COMPLETED|Crossover Phase||0
330932|NCT01425203|794284|P1|COMPLETED|Crossover Phase||0
330933|NCT01425203|794282|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
330934|NCT01425203|794283|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
330935|NCT01425203|794284|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
330936|NCT01425203|794282|P3|NOT COMPLETED|Treatment Phase||0
330937|NCT01425203|794283|P2|NOT COMPLETED|Treatment Phase||37
330938|NCT01425203|794284|P1|NOT COMPLETED|Treatment Phase||27
330939|NCT01425203|794282|P3|COMPLETED|Treatment Phase||0
330940|NCT01425203|794283|P2|COMPLETED|Treatment Phase||42
330941|NCT01425203|794284|P1|COMPLETED|Treatment Phase||132
330942|NCT01425203|794282|P3|Treated (FAS)|Treatment Phase||0
330943|NCT01425203|794283|P2|Treated (FAS)|Treatment Phase||78
330944|NCT01425203|794284|P1|Treated (FAS)|Treatment Phase||159
330945|NCT01425203|794282|P3|STARTED|Treatment Phase||0
330946|NCT01425203|794283|P2|STARTED|Treatment Phase||79
330947|NCT01425203|794284|P1|STARTED|Treatment Phase||159
330948|NCT01425190|794301|P3|NOT COMPLETED|Overall Study||0
330949|NCT01425190|794302|P2|NOT COMPLETED|Overall Study||0
330950|NCT01425190|794303|P1|NOT COMPLETED|Overall Study||1
330951|NCT01425190|794301|P3|COMPLETED|Overall Study||0
330952|NCT01425190|794302|P2|COMPLETED|Overall Study||0
330953|NCT01425190|794303|P1|COMPLETED|Overall Study||15
330954|NCT01425190|794301|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
330955|NCT01425190|794302|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
330956|NCT01425190|794303|P1|STARTED|Overall Study||16
330957|NCT01424943|794322|P2|NOT COMPLETED|Overall Study||1
330958|NCT01424943|794323|P1|NOT COMPLETED|Overall Study||13
330959|NCT01424943|794322|P2|COMPLETED|Overall Study||23
330960|NCT01424943|794323|P1|COMPLETED|Overall Study||12
330961|NCT01424943|794322|P2|STARTED|Overall Study||24
330962|NCT01424943|794323|P1|STARTED|Overall Study||25
330963|NCT01424930|794339|P2|NOT COMPLETED|Overall Study||14
330964|NCT01424930|794340|P1|NOT COMPLETED|Overall Study||4
330965|NCT01424930|794339|P2|COMPLETED|Overall Study||4
330966|NCT01424930|794340|P1|COMPLETED|Overall Study||3
330967|NCT01424930|794339|P2|Completed Food Safety Evaluation|Overall Study||18
330968|NCT01424930|794340|P1|Completed Food Safety Evaluation|Overall Study||6
330969|NCT01424930|794339|P2|STARTED|Overall Study||18
330970|NCT01424930|794340|P1|STARTED|Overall Study||7
330971|NCT01424813|794354|P2|NOT COMPLETED|Overall Study||2
330972|NCT01424813|794355|P1|NOT COMPLETED|Overall Study||5
330973|NCT01424813|794354|P2|COMPLETED|Overall Study||77
330974|NCT01424813|794355|P1|COMPLETED|Overall Study||74
330975|NCT01424813|794354|P2|Treated|Overall Study|Safety set and full analysis set|78
330976|NCT01424813|794355|P1|Treated|Overall Study|Safety set and full analysis set|79
330977|NCT01424813|794354|P2|STARTED|Overall Study||79
330978|NCT01424813|794355|P1|STARTED|Overall Study||79
330979|NCT01424644|794375|P2|NOT COMPLETED|Overall Study||27
330980|NCT01424644|794376|P1|NOT COMPLETED|Overall Study||33
330981|NCT01424644|794375|P2|COMPLETED|Overall Study||372
330982|NCT01424644|794376|P1|COMPLETED|Overall Study||369
330983|NCT01424644|794375|P2|STARTED|Overall Study||399
330984|NCT01424644|794376|P1|STARTED|Overall Study||402
330985|NCT01424501|794396|P6|NOT COMPLETED|Overall Study||0
330986|NCT01424501|794397|P5|NOT COMPLETED|Overall Study||0
330987|NCT01424501|794398|P4|NOT COMPLETED|Overall Study||0
330988|NCT01424501|794399|P3|NOT COMPLETED|Overall Study||2
330989|NCT01424501|794400|P2|NOT COMPLETED|Overall Study||1
330990|NCT01424501|794401|P1|NOT COMPLETED|Overall Study||1
330991|NCT01424501|794396|P6|COMPLETED|Overall Study||40
330992|NCT01424501|794397|P5|COMPLETED|Overall Study||40
330993|NCT01424501|794398|P4|COMPLETED|Overall Study||25
330994|NCT01424501|794399|P3|COMPLETED|Overall Study||22
330995|NCT01424501|794400|P2|COMPLETED|Overall Study||5
330996|NCT01424501|794401|P1|COMPLETED|Overall Study||6
330997|NCT01424501|794396|P6|STARTED|Overall Study||40
330998|NCT01424501|794397|P5|STARTED|Overall Study||40
330999|NCT01424501|794398|P4|STARTED|Overall Study||25
331000|NCT01424501|794399|P3|STARTED|Overall Study||24
331001|NCT01424501|794400|P2|STARTED|Overall Study||6
331002|NCT01424501|794401|P1|STARTED|Overall Study||7
331003|NCT01424228|794567|P2|NOT COMPLETED|Overall Study||47
331004|NCT01424228|794568|P1|NOT COMPLETED|Overall Study||56
331005|NCT01424228|794567|P2|COMPLETED|Overall Study||135
331006|NCT01424228|794568|P1|COMPLETED|Overall Study||126
331007|NCT01424228|794567|P2|STARTED|Overall Study||182
331008|NCT01424228|794568|P1|STARTED|Overall Study||182
331009|NCT01424189|794608|P2|NOT COMPLETED|Overall Study||6
331010|NCT01424189|794609|P1|NOT COMPLETED|Overall Study||13
331011|NCT01424189|794608|P2|COMPLETED|Overall Study||182
331012|NCT01424189|794609|P1|COMPLETED|Overall Study||373
331013|NCT01424189|794608|P2|STARTED|Overall Study||188
331014|NCT01424189|794609|P1|STARTED|Overall Study||386
331015|NCT01424072|794624|P3|NOT COMPLETED|Overall Study||0
331016|NCT01424072|794625|P2|NOT COMPLETED|Overall Study||0
331017|NCT01424072|794626|P1|NOT COMPLETED|Overall Study||0
331018|NCT01424072|794624|P3|COMPLETED|Overall Study||22
331019|NCT01424072|794625|P2|COMPLETED|Overall Study||26
331020|NCT01424072|794626|P1|COMPLETED|Overall Study||27
331021|NCT01424072|794624|P3|STARTED|Overall Study||22
331022|NCT01424072|794625|P2|STARTED|Overall Study||26
331023|NCT01424072|794626|P1|STARTED|Overall Study||27
331024|NCT01424033|794643|P1|NOT COMPLETED|Overall Study||5
331025|NCT01424033|794643|P1|COMPLETED|Overall Study||0
331026|NCT01424033|794643|P1|STARTED|Overall Study||5
331027|NCT01423916|794650|P3|NOT COMPLETED|Overall Study||7
331028|NCT01423916|794651|P2|NOT COMPLETED|Overall Study||20
331029|NCT01423916|794652|P1|NOT COMPLETED|Overall Study||11
331030|NCT01423916|794650|P3|COMPLETED|Overall Study||64
331031|NCT01423916|794651|P2|COMPLETED|Overall Study||53
331032|NCT01423916|794652|P1|COMPLETED|Overall Study||63
331033|NCT01423916|794650|P3|STARTED|Overall Study||71
331034|NCT01423916|794651|P2|STARTED|Overall Study||73
331035|NCT01423916|794652|P1|STARTED|Overall Study||74
331036|NCT01423773|794706|P2|NOT COMPLETED|Period 2, 2 Days||0
331037|NCT01423773|794707|P1|NOT COMPLETED|Period 2, 2 Days||0
331038|NCT01423773|794706|P2|COMPLETED|Period 2, 2 Days||10
331039|NCT01423773|794707|P1|COMPLETED|Period 2, 2 Days||10
331040|NCT01423773|794706|P2|STARTED|Period 2, 2 Days||10
331041|NCT01423773|794707|P1|STARTED|Period 2, 2 Days||10
331042|NCT01423773|794706|P2|NOT COMPLETED|Period One, 2 Days||0
331043|NCT01423773|794707|P1|NOT COMPLETED|Period One, 2 Days||0
331044|NCT01423773|794706|P2|COMPLETED|Period One, 2 Days||10
331045|NCT01423773|794707|P1|COMPLETED|Period One, 2 Days||10
331046|NCT01423773|794706|P2|STARTED|Period One, 2 Days||10
331047|NCT01423773|794707|P1|STARTED|Period One, 2 Days||10
331048|NCT01423760|794715|P2|NOT COMPLETED|Overall Study||0
331049|NCT01423760|794716|P1|NOT COMPLETED|Overall Study||0
331050|NCT01423760|794715|P2|COMPLETED|Overall Study||13
331051|NCT01423760|794716|P1|COMPLETED|Overall Study||14
331052|NCT01423760|794715|P2|Safety Analysis Set|Overall Study||8
331053|NCT01423760|794716|P1|Safety Analysis Set|Overall Study||12
331054|NCT01423760|794715|P2|Number of Non-treatment Subjects|Overall Study||5
331055|NCT01423760|794716|P1|Number of Non-treatment Subjects|Overall Study||2
331056|NCT01423760|794715|P2|Number of Tecemotide Subjects|Overall Study||8
331057|NCT01423760|794716|P1|Number of Tecemotide Subjects|Overall Study||12
331058|NCT01423760|794715|P2|STARTED|Overall Study||13
331059|NCT01423760|794716|P1|STARTED|Overall Study||14
331060|NCT01423617|794726|P2|NOT COMPLETED|Overall Study||1
331061|NCT01423617|794727|P1|NOT COMPLETED|Overall Study||0
331062|NCT01423617|794726|P2|COMPLETED|Overall Study||45
331063|NCT01423617|794727|P1|COMPLETED|Overall Study||46
331064|NCT01423617|794726|P2|STARTED|Overall Study||46
331065|NCT01423617|794727|P1|STARTED|Overall Study||46
331066|NCT01423604|794744|P2|NOT COMPLETED|Randomized||63
331067|NCT01423604|794745|P1|NOT COMPLETED|Randomized||63
331068|NCT01423604|794744|P2|COMPLETED|Randomized||0
331069|NCT01423604|794745|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
331070|NCT01423604|794744|P2|STARTED|Randomized||63
331071|NCT01423604|794745|P1|STARTED|Randomized||64
331072|NCT01423604|794744|P2|NOT COMPLETED|Safety Run-In||0
331073|NCT01423604|794745|P1|NOT COMPLETED|Safety Run-In||9
331074|NCT01423604|794744|P2|COMPLETED|Safety Run-In||0
331075|NCT01423604|794745|P1|COMPLETED|Safety Run-In||0
331076|NCT01423604|794744|P2|STARTED|Safety Run-In||0
331077|NCT01423604|794745|P1|STARTED|Safety Run-In||9
331078|NCT01423253|794760|P1|NOT COMPLETED|Overall Study||9
331079|NCT01423253|794760|P1|COMPLETED|Overall Study||39
331080|NCT01423253|794760|P1|STARTED|Overall Study||48
331081|NCT01423162|794773|P2|NOT COMPLETED|Overall Study||0
331082|NCT01423162|794774|P1|NOT COMPLETED|Overall Study||0
331083|NCT01423162|794773|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
331084|NCT01423162|794774|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
331085|NCT01423162|794773|P2|STARTED|Overall Study||9
331086|NCT01423162|794774|P1|STARTED|Overall Study||11
331087|NCT01423084|794782|P2|NOT COMPLETED|Overall Study||4
331088|NCT01423084|794783|P1|NOT COMPLETED|Overall Study||2
331089|NCT01423084|794782|P2|COMPLETED|Overall Study||170
331090|NCT01423084|794783|P1|COMPLETED|Overall Study||168
331091|NCT01423084|794782|P2|STARTED|Overall Study||174
331092|NCT01423084|794783|P1|STARTED|Overall Study||170
331093|NCT01422915|794813|P1|NOT COMPLETED|Overall Study||1
331094|NCT01422915|794813|P1|COMPLETED|Overall Study||3
331095|NCT01422915|794813|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
331096|NCT01422889|794818|P1|NOT COMPLETED|Overall Study||9
331097|NCT01422889|794818|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
331098|NCT01422889|794818|P1|STARTED|Overall Study||1120
331099|NCT01422876|794833|P10|NOT COMPLETED|Week 52||17
331100|NCT01422876|794834|P9|NOT COMPLETED|Week 52||21
331101|NCT01422876|794835|P8|NOT COMPLETED|Week 52||23
331102|NCT01422876|794836|P7|NOT COMPLETED|Week 52||16
331103|NCT01422876|794837|P6|NOT COMPLETED|Week 52||17
331104|NCT01422876|794838|P5|NOT COMPLETED|Week 52||15
331105|NCT01422876|794839|P4|NOT COMPLETED|Week 52||18
331106|NCT01422876|794840|P3|NOT COMPLETED|Week 52||13
331107|NCT01422876|794841|P2|NOT COMPLETED|Week 52||10
331108|NCT01422876|794842|P1|NOT COMPLETED|Week 52||12
331109|NCT01422876|794833|P10|COMPLETED|Week 52||118
331110|NCT01422876|794834|P9|COMPLETED|Week 52||113
331111|NCT01422876|794835|P8|COMPLETED|Week 52||112
331112|NCT01422876|794836|P7|COMPLETED|Week 52||120
331113|NCT01422876|794837|P6|COMPLETED|Week 52||120
331114|NCT01422876|794838|P5|COMPLETED|Week 52||117
331115|NCT01422876|794839|P4|COMPLETED|Week 52||122
331116|NCT01422876|794840|P3|COMPLETED|Week 52||128
331117|NCT01422876|794841|P2|COMPLETED|Week 52||126
331118|NCT01422876|794842|P1|COMPLETED|Week 52||125
331119|NCT01422876|794833|P10|STARTED|Week 52||135
331120|NCT01422876|794834|P9|STARTED|Week 52||134
331121|NCT01422876|794835|P8|STARTED|Week 52||135
331122|NCT01422876|794836|P7|STARTED|Week 52||136
331123|NCT01422876|794837|P6|STARTED|Week 52||137
331124|NCT01422876|794838|P5|STARTED|Week 52||132
331125|NCT01422876|794839|P4|STARTED|Week 52||140
331126|NCT01422876|794840|P3|STARTED|Week 52||141
331127|NCT01422876|794841|P2|STARTED|Week 52||136
331128|NCT01422876|794842|P1|STARTED|Week 52||137
331129|NCT01422876|794833|P10|NOT COMPLETED|Week 24||10
331130|NCT01422876|794834|P9|NOT COMPLETED|Week 24||6
331131|NCT01422876|794835|P8|NOT COMPLETED|Week 24||7
331132|NCT01422876|794836|P7|NOT COMPLETED|Week 24||6
331133|NCT01422876|794837|P6|NOT COMPLETED|Week 24||6
331134|NCT01422876|794838|P5|NOT COMPLETED|Week 24||7
331135|NCT01422876|794839|P4|NOT COMPLETED|Week 24||8
331136|NCT01422876|794840|P3|NOT COMPLETED|Week 24||5
331137|NCT01422876|794841|P2|NOT COMPLETED|Week 24||3
331138|NCT01422876|794842|P1|NOT COMPLETED|Week 24||6
331139|NCT01422876|794833|P10|COMPLETED|Week 24||125
331140|NCT01422876|794834|P9|COMPLETED|Week 24||128
331141|NCT01422876|794835|P8|COMPLETED|Week 24||128
331142|NCT01422876|794836|P7|COMPLETED|Week 24||130
331143|NCT01422876|794837|P6|COMPLETED|Week 24||131
331144|NCT01422876|794838|P5|COMPLETED|Week 24||125
331145|NCT01422876|794839|P4|COMPLETED|Week 24||132
331146|NCT01422876|794840|P3|COMPLETED|Week 24||136
331147|NCT01422876|794841|P2|COMPLETED|Week 24||133
331148|NCT01422876|794842|P1|COMPLETED|Week 24||131
331149|NCT01422876|794833|P10|STARTED|Week 24||135
331150|NCT01422876|794834|P9|STARTED|Week 24||134
331151|NCT01422876|794835|P8|STARTED|Week 24||135
331152|NCT01422876|794836|P7|STARTED|Week 24||136
331153|NCT01422876|794837|P6|STARTED|Week 24||137
331154|NCT01422876|794838|P5|STARTED|Week 24||132
331155|NCT01422876|794839|P4|STARTED|Week 24||140
331156|NCT01422876|794840|P3|STARTED|Week 24||141
331157|NCT01422876|794841|P2|STARTED|Week 24||136
331158|NCT01422876|794842|P1|STARTED|Week 24||137
331159|NCT01422850|794889|P1|NOT COMPLETED|Overall Study||3
331160|NCT01422850|794889|P1|COMPLETED|Overall Study||18
331161|NCT01422850|794889|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
331162|NCT01422850|794889|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
331163|NCT01422850|794889|P1|Week 9 - Second Treatment|Overall Study||20
331164|NCT01422850|794889|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
331165|NCT01422850|794889|P1|Week 4 - First Treatment|Overall Study||21
331166|NCT01422850|794889|P1|STARTED|Overall Study||21
331167|NCT01422824|794895|P1|NOT COMPLETED|Overall Study||38
331168|NCT01422824|794895|P1|COMPLETED|Overall Study||147
331169|NCT01422824|794895|P1|Treated|Overall Study||184
331170|NCT01422824|794895|P1|STARTED|Overall Study||185
331171|NCT01422720|794900|P1|NOT COMPLETED|Overall Study||22
331172|NCT01422720|794900|P1|COMPLETED|Overall Study||50
331173|NCT01422720|794900|P1|Per-Protocol Set (PPS)|Overall Study||55
331174|NCT01422720|794900|P1|Full Analysis Set (FAS)|Overall Study||71
331175|NCT01422720|794900|P1|Safety Set|Overall Study||72
331176|NCT01422720|794900|P1|STARTED|Overall Study||72
331177|NCT01422538|794911|P3|NOT COMPLETED|Overall Study||2
331178|NCT01422538|794912|P2|NOT COMPLETED|Overall Study||2
331179|NCT01422538|794913|P1|NOT COMPLETED|Overall Study||0
331180|NCT01422538|794911|P3|COMPLETED|Overall Study||8
331181|NCT01422538|794912|P2|COMPLETED|Overall Study||8
331182|NCT01422538|794913|P1|COMPLETED|Overall Study||10
331183|NCT01422538|794911|P3|STARTED|Overall Study||10
331184|NCT01422538|794912|P2|STARTED|Overall Study||10
331185|NCT01422538|794913|P1|STARTED|Overall Study||10
331186|NCT01422434|794938|P3|NOT COMPLETED|Overall Study||6
331187|NCT01422434|794939|P2|NOT COMPLETED|Overall Study||5
331188|NCT01422434|794940|P1|NOT COMPLETED|Overall Study||11
331189|NCT01422434|794938|P3|COMPLETED|Overall Study||217
331190|NCT01422434|794939|P2|COMPLETED|Overall Study||221
331191|NCT01422434|794940|P1|COMPLETED|Overall Study||216
331192|NCT01422434|794938|P3|STARTED|Overall Study||223
331193|NCT01422434|794939|P2|STARTED|Overall Study||226
331194|NCT01422434|794940|P1|STARTED|Overall Study||227
331195|NCT01422382|794957|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
331196|NCT01422382|794957|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
331197|NCT01422382|794957|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
331198|NCT01422382|794957|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
331199|NCT01422382|794957|P1|COMPLETED|Diltiazem 240 mg QD||28
331200|NCT01422382|794957|P1|STARTED|Diltiazem 240 mg QD||28
331201|NCT01422382|794957|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
331202|NCT01422382|794957|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
331203|NCT01422382|794957|P1|STARTED|NK-104 4mg Once Daily (QD)||28
331204|NCT01422369|794962|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
331205|NCT01422369|794962|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
331206|NCT01422369|794962|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
331207|NCT01422369|794962|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
331208|NCT01422369|794962|P1|COMPLETED|Prezista 800mg/100mg QD||28
331209|NCT01422369|794962|P1|STARTED|Prezista 800mg/100mg QD||28
331210|NCT01422369|794962|P1|NOT COMPLETED|NK-104 4mg QD||0
331211|NCT01422369|794962|P1|COMPLETED|NK-104 4mg QD||28
331212|NCT01422369|794962|P1|STARTED|NK-104 4mg QD||28
331213|NCT01422356|794967|P1|NOT COMPLETED|Overall Study||31
331214|NCT01422356|794967|P1|COMPLETED|Overall Study||169
331215|NCT01422356|794967|P1|STARTED|Overall Study||200
331216|NCT01422304|794973|P2|NOT COMPLETED|Overall Study||37
331217|NCT01422304|794974|P1|NOT COMPLETED|Overall Study||24
331218|NCT01422304|794973|P2|COMPLETED|Overall Study||563
331219|NCT01422304|794974|P1|COMPLETED|Overall Study||574
331220|NCT01422304|794973|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
331221|NCT01422304|794974|P1|Treated|Overall Study||595
331222|NCT01422304|794973|P2|STARTED|Overall Study|Randomized|600
331223|NCT01422304|794974|P1|STARTED|Overall Study|Randomized|598
331224|NCT01422239|795006|P2|NOT COMPLETED|Overall Study||3
331225|NCT01422239|795007|P1|NOT COMPLETED|Overall Study||4
331226|NCT01422239|795006|P2|COMPLETED|Overall Study||3
331227|NCT01422239|795007|P1|COMPLETED|Overall Study||10
331228|NCT01422239|795006|P2|STARTED|Overall Study||6
331229|NCT01422239|795007|P1|STARTED|Overall Study||14
331230|NCT01422226|795019|P2|NOT COMPLETED|Overall Study||0
331231|NCT01422226|795020|P1|NOT COMPLETED|Overall Study||0
331232|NCT01422226|795019|P2|COMPLETED|Overall Study||2
331233|NCT01422226|795020|P1|COMPLETED|Overall Study||1
331234|NCT01422226|795019|P2|STARTED|Overall Study||2
331235|NCT01422226|795020|P1|STARTED|Overall Study||1
331236|NCT01422213|795029|P3|NOT COMPLETED|Overall Study||29
331237|NCT01422213|795030|P2|NOT COMPLETED|Overall Study||22
331238|NCT01422213|795031|P1|NOT COMPLETED|Overall Study||33
331239|NCT01422213|795029|P3|COMPLETED|Overall Study||178
331240|NCT01422213|795030|P2|COMPLETED|Overall Study||173
331241|NCT01422213|795031|P1|COMPLETED|Overall Study||163
331242|NCT01422213|795029|P3|STARTED|Overall Study||207
331243|NCT01422213|795030|P2|STARTED|Overall Study||195
331244|NCT01422213|795031|P1|STARTED|Overall Study||196
331245|NCT01422187|795092|P3|NOT COMPLETED|Overall Study||0
331246|NCT01422187|795093|P2|NOT COMPLETED|Overall Study||1
331247|NCT01422187|795094|P1|NOT COMPLETED|Overall Study||1
331248|NCT01422187|795092|P3|COMPLETED|Overall Study||2
331249|NCT01422187|795093|P2|COMPLETED|Overall Study||8
331250|NCT01422187|795094|P1|COMPLETED|Overall Study||7
331251|NCT01422187|795092|P3|STARTED|Overall Study||2
331252|NCT01422187|795093|P2|STARTED|Overall Study||9
331253|NCT01422187|795094|P1|STARTED|Overall Study||8
331254|NCT01422070|795113|P2|NOT COMPLETED|Overall Study||0
331255|NCT01422070|795114|P1|NOT COMPLETED|Overall Study||0
331256|NCT01422070|795113|P2|COMPLETED|Overall Study||803
331257|NCT01422070|795114|P1|COMPLETED|Overall Study||5031
331258|NCT01422070|795113|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
331259|NCT01422070|795114|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
331260|NCT01421719|795125|P1|NOT COMPLETED|Overall Study||4
331261|NCT01421719|795125|P1|COMPLETED|Overall Study||16
331262|NCT01421719|795125|P1|STARTED|Overall Study||20
331263|NCT01421667|795134|P4|NOT COMPLETED|Overall Study||1
331264|NCT01421667|795135|P3|NOT COMPLETED|Overall Study||2
331265|NCT01421667|795136|P2|NOT COMPLETED|Overall Study||2
331266|NCT01421667|795137|P1|NOT COMPLETED|Overall Study||0
331267|NCT01421667|795134|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
331268|NCT01421667|795135|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
331269|NCT01421667|795136|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
331270|NCT01421667|795137|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
331271|NCT01421667|795134|P4|STARTED|Overall Study||16
331272|NCT01421667|795135|P3|STARTED|Overall Study||53
331273|NCT01421667|795136|P2|STARTED|Overall Study||68
331274|NCT01421667|795137|P1|STARTED|Overall Study||35
331275|NCT01421654|795189|P2|NOT COMPLETED|Overall Study||0
331276|NCT01421654|795190|P1|NOT COMPLETED|Overall Study||0
331277|NCT01421654|795189|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
331278|NCT01421654|795190|P1|COMPLETED|Overall Study||11
331279|NCT01421654|795189|P2|STARTED|Overall Study||9
331280|NCT01421654|795190|P1|STARTED|Overall Study||11
331281|NCT01421641|795198|P2|NOT COMPLETED|Overall Study||2
331282|NCT01421641|795199|P1|NOT COMPLETED|Overall Study||2
331283|NCT01421641|795198|P2|COMPLETED|Overall Study||35
331284|NCT01421641|795199|P1|COMPLETED|Overall Study||35
331285|NCT01421641|795198|P2|STARTED|Overall Study||37
331286|NCT01421641|795199|P1|STARTED|Overall Study||37
331287|NCT01421589|795209|P1|NOT COMPLETED|Overall Study||0
331288|NCT01421589|795209|P1|COMPLETED|Overall Study||15
331289|NCT01421589|795209|P1|STARTED|Overall Study||15
331290|NCT01421511|795221|P2|NOT COMPLETED|Overall Study||28
331291|NCT01421511|795222|P1|NOT COMPLETED|Overall Study||19
331292|NCT01421511|795221|P2|COMPLETED|Overall Study||306
331293|NCT01421511|795222|P1|COMPLETED|Overall Study||313
331294|NCT01421511|795221|P2|STARTED|Overall Study||334
331295|NCT01421511|795222|P1|STARTED|Overall Study||332
331296|NCT01421498|795244|P2|NOT COMPLETED|Overall Study||11
331297|NCT01421498|795245|P1|NOT COMPLETED|Overall Study||12
331298|NCT01421498|795244|P2|COMPLETED|Overall Study||284
331299|NCT01421498|795245|P1|COMPLETED|Overall Study||281
331300|NCT01421498|795244|P2|STARTED|Overall Study||295
331301|NCT01421498|795245|P1|STARTED|Overall Study||293
331302|NCT01421472|795257|P4|NOT COMPLETED|Overall Study||0
331303|NCT01421472|795258|P3|NOT COMPLETED|Overall Study||0
331304|NCT01421472|795259|P2|NOT COMPLETED|Overall Study||0
331305|NCT01421472|795260|P1|NOT COMPLETED|Overall Study||0
331306|NCT01421472|795257|P4|COMPLETED|Overall Study||32
331307|NCT01421472|795258|P3|COMPLETED|Overall Study||64
331308|NCT01421472|795259|P2|COMPLETED|Overall Study||33
331309|NCT01421472|795260|P1|COMPLETED|Overall Study||67
331310|NCT01421472|795257|P4|STARTED|Overall Study||32
331311|NCT01421472|795258|P3|STARTED|Overall Study||64
331312|NCT01421472|795259|P2|STARTED|Overall Study||33
331313|NCT01421472|795260|P1|STARTED|Overall Study||67
331314|NCT01421459|795272|P2|NOT COMPLETED|Overall Study||52
331315|NCT01421459|795273|P1|NOT COMPLETED|Overall Study||45
331316|NCT01421459|795272|P2|COMPLETED|Overall Study||328
331317|NCT01421459|795273|P1|COMPLETED|Overall Study||334
331318|NCT01421459|795272|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
331319|NCT01421459|795273|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
331320|NCT01421459|795272|P2|STARTED|Overall Study||380
331321|NCT01421459|795273|P1|STARTED|Overall Study||379
331322|NCT01421355|795307|P1|NOT COMPLETED|Overall Study||6
331323|NCT01421355|795307|P1|COMPLETED|Overall Study||15
331324|NCT01421355|795307|P1|STARTED|Overall Study||21
331325|NCT01421303|795311|P1|NOT COMPLETED|Overall Study||22
331326|NCT01421303|795311|P1|COMPLETED|Overall Study||58
331327|NCT01421303|795311|P1|STARTED|Overall Study||80
331328|NCT01421277|795338|P2|NOT COMPLETED|Overall Study||92
331329|NCT01421277|795339|P1|NOT COMPLETED|Overall Study||0
331330|NCT01421277|795338|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
331331|NCT01421277|795339|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
331332|NCT01421277|795338|P2|STARTED|Overall Study||191
331333|NCT01421277|795339|P1|STARTED|Overall Study||25
331334|NCT01421147|795351|P2|NOT COMPLETED|Extension Period||11
331335|NCT01421147|795352|P1|NOT COMPLETED|Extension Period||8
331336|NCT01421147|795351|P2|COMPLETED|Extension Period||245
331337|NCT01421147|795352|P1|COMPLETED|Extension Period||245
331338|NCT01421147|795351|P2|STARTED|Extension Period||256
331339|NCT01421147|795352|P1|STARTED|Extension Period||253
331340|NCT01421147|795351|P2|NOT COMPLETED|Treatment Period||11
331341|NCT01421147|795352|P1|NOT COMPLETED|Treatment Period||16
331342|NCT01421147|795351|P2|COMPLETED|Treatment Period||256
331343|NCT01421147|795352|P1|COMPLETED|Treatment Period||253
331344|NCT01421147|795351|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
331345|NCT01421147|795352|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
331346|NCT01421147|795351|P2|STARTED|Treatment Period||267
331347|NCT01421147|795352|P1|STARTED|Treatment Period||269
331348|NCT01421134|795384|P2|NOT COMPLETED|Overall Study||15
331349|NCT01421134|795385|P1|NOT COMPLETED|Overall Study||7
331350|NCT01421134|795384|P2|COMPLETED|Overall Study||87
331351|NCT01421134|795385|P1|COMPLETED|Overall Study||102
331352|NCT01421134|795384|P2|STARTED|Overall Study||102
331353|NCT01421134|795385|P1|STARTED|Overall Study||109
331354|NCT01420926|795405|P2|NOT COMPLETED|Overall Study||65
331355|NCT01420926|795406|P1|NOT COMPLETED|Overall Study||60
331356|NCT01420926|795405|P2|COMPLETED|Overall Study||16
331357|NCT01420926|795406|P1|COMPLETED|Overall Study||22
331358|NCT01420926|795405|P2|STARTED|Overall Study||81
331359|NCT01420926|795406|P1|STARTED|Overall Study||82
331360|NCT01420848|795423|P3|NOT COMPLETED|Overall Study||0
331361|NCT01420848|795424|P2|NOT COMPLETED|Overall Study||0
331362|NCT01420848|795425|P1|NOT COMPLETED|Overall Study||0
331363|NCT01420848|795423|P3|COMPLETED|Overall Study||22
331364|NCT01420848|795424|P2|COMPLETED|Overall Study||25
331365|NCT01420848|795425|P1|COMPLETED|Overall Study||24
331366|NCT01420848|795423|P3|STARTED|Overall Study||22
331367|NCT01420848|795424|P2|STARTED|Overall Study||25
331368|NCT01420848|795425|P1|STARTED|Overall Study||24
331369|NCT01420289|795438|P2|NOT COMPLETED|Overall Study||0
331370|NCT01420289|795439|P1|NOT COMPLETED|Overall Study||0
331371|NCT01420289|795438|P2|COMPLETED|Overall Study||16
331372|NCT01420289|795439|P1|COMPLETED|Overall Study||18
331373|NCT01420289|795438|P2|STARTED|Overall Study||16
331374|NCT01420289|795439|P1|STARTED|Overall Study||18
331375|NCT01420146|795451|P1|NOT COMPLETED|Overall Study||0
331376|NCT01420146|795451|P1|COMPLETED|Overall Study||20
331377|NCT01420146|795451|P1|STARTED|Overall Study||20
331378|NCT01420081|795464|P9|NOT COMPLETED|Overall Study||3
331379|NCT01420081|795465|P8|NOT COMPLETED|Overall Study||3
331380|NCT01420081|795466|P7|NOT COMPLETED|Overall Study||3
331381|NCT01420081|795467|P6|NOT COMPLETED|Overall Study||20
331382|NCT01420081|795468|P5|NOT COMPLETED|Overall Study||20
331383|NCT01420081|795469|P4|NOT COMPLETED|Overall Study||3
331384|NCT01420081|795470|P3|NOT COMPLETED|Overall Study||11
331385|NCT01420081|795471|P2|NOT COMPLETED|Overall Study||1
331386|NCT01420081|795472|P1|NOT COMPLETED|Overall Study||3
331387|NCT01420081|795464|P9|COMPLETED|Overall Study||0
331388|NCT01420081|795465|P8|COMPLETED|Overall Study||0
331389|NCT01420081|795466|P7|COMPLETED|Overall Study||0
331390|NCT01420081|795467|P6|COMPLETED|Overall Study||0
331391|NCT01420081|795468|P5|COMPLETED|Overall Study||0
331392|NCT01420081|795469|P4|COMPLETED|Overall Study||0
331393|NCT01420081|795470|P3|COMPLETED|Overall Study||0
331394|NCT01420081|795471|P2|COMPLETED|Overall Study||0
331395|NCT01420081|795472|P1|COMPLETED|Overall Study||0
331396|NCT01420081|795464|P9|STARTED|Overall Study||3
331397|NCT01420081|795465|P8|STARTED|Overall Study||3
331398|NCT01420081|795466|P7|STARTED|Overall Study||3
331399|NCT01420081|795467|P6|STARTED|Overall Study||20
331400|NCT01420081|795468|P5|STARTED|Overall Study||20
331401|NCT01420081|795469|P4|STARTED|Overall Study||3
331402|NCT01420081|795470|P3|STARTED|Overall Study||11
331403|NCT01420081|795471|P2|STARTED|Overall Study||1
331404|NCT01420081|795472|P1|STARTED|Overall Study||3
331405|NCT01419977|795506|P2|NOT COMPLETED|Overall Study||0
331406|NCT01419977|795507|P1|NOT COMPLETED|Overall Study||0
331407|NCT01419977|795506|P2|COMPLETED|Overall Study||13
331408|NCT01419977|795507|P1|COMPLETED|Overall Study||16
331409|NCT01419977|795506|P2|STARTED|Overall Study||13
331410|NCT01419977|795507|P1|STARTED|Overall Study||16
331411|NCT01419795|795521|P2|NOT COMPLETED|Overall Study||0
331412|NCT01419795|795522|P1|NOT COMPLETED|Overall Study||0
331413|NCT01419795|795521|P2|COMPLETED|Overall Study||0
331414|NCT01419795|795522|P1|COMPLETED|Overall Study||3
331415|NCT01419795|795521|P2|STARTED|Overall Study||0
331416|NCT01419795|795522|P1|STARTED|Overall Study||3
331417|NCT01419769|795544|P1|NOT COMPLETED|Overall Study||4
331418|NCT01419769|795544|P1|COMPLETED|Overall Study||29
331419|NCT01419769|795544|P1|STARTED|Overall Study||33
331420|NCT01419639|795557|P1|NOT COMPLETED|Overall Study||1
331421|NCT01419639|795557|P1|COMPLETED|Overall Study||9
331422|NCT01419639|795557|P1|STARTED|Overall Study||10
331423|NCT01419314|795565|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
331424|NCT01419314|795566|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
331425|NCT01419314|795565|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
331426|NCT01419314|795566|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
331427|NCT01419314|795565|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
331428|NCT01419314|795566|P1|STARTED|Follow-up at Week 6 of the Trial||17
331429|NCT01419314|795565|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
331430|NCT01419314|795566|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
331431|NCT01419314|795565|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
331432|NCT01419314|795566|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
331433|NCT01419314|795565|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
331434|NCT01419314|795566|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
331435|NCT01419314|795565|P2|NOT COMPLETED|Start of Study||0
331436|NCT01419314|795566|P1|NOT COMPLETED|Start of Study||0
331437|NCT01419314|795565|P2|COMPLETED|Start of Study||22
331438|NCT01419314|795566|P1|COMPLETED|Start of Study||23
331439|NCT01419314|795565|P2|STARTED|Start of Study|No comfort issues reported.|22
331440|NCT01419314|795566|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
331441|NCT01419249|795588|P2|NOT COMPLETED|Overall Study||0
331442|NCT01419249|795589|P1|NOT COMPLETED|Overall Study||0
331443|NCT01419249|795588|P2|COMPLETED|Overall Study||140
331444|NCT01419249|795589|P1|COMPLETED|Overall Study||318
331445|NCT01419249|795588|P2|STARTED|Overall Study||140
331446|NCT01419249|795589|P1|STARTED|Overall Study||318
331447|NCT01419236|795603|P2|NOT COMPLETED|Overall Study||5
331448|NCT01419236|795604|P1|NOT COMPLETED|Overall Study||5
331449|NCT01419236|795603|P2|COMPLETED|Overall Study||35
331450|NCT01419236|795604|P1|COMPLETED|Overall Study||31
331451|NCT01419236|795603|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
331452|NCT01419236|795604|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
331453|NCT01419236|795603|P2|STARTED|Overall Study||40
331454|NCT01419236|795604|P1|STARTED|Overall Study||36
331455|NCT01419197|795628|P2|NOT COMPLETED|Overall Study||198
331456|NCT01419197|795629|P1|NOT COMPLETED|Overall Study||404
331457|NCT01419197|795628|P2|COMPLETED|Overall Study||0
331458|NCT01419197|795629|P1|COMPLETED|Overall Study||0
331459|NCT01419197|795628|P2|Switched to Trastuzumab Emtansine|Overall Study||94
331460|NCT01419197|795629|P1|Switched to Trastuzumab Emtansine|Overall Study||0
331461|NCT01419197|795628|P2|STARTED|Overall Study||198
331462|NCT01419197|795629|P1|STARTED|Overall Study||404
331463|NCT01419184|795654|P2|NOT COMPLETED|Overall Study||15
331464|NCT01419184|795655|P1|NOT COMPLETED|Overall Study||10
331465|NCT01419184|795654|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
331558|NCT01417455|795827|P6|STARTED|Overall Study||13
331466|NCT01419184|795655|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
331467|NCT01419184|795654|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
331468|NCT01419184|795655|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
331469|NCT01419184|795654|P2|STARTED|Overall Study||121
331470|NCT01419184|795655|P1|STARTED|Overall Study||128
331471|NCT01419171|795671|P1|NOT COMPLETED|Overall Study||0
331472|NCT01419171|795671|P1|COMPLETED|Overall Study||328
331473|NCT01419171|795671|P1|STARTED|Overall Study||328
331474|NCT01419028|795688|P1|NOT COMPLETED|Overall Study||0
331475|NCT01419028|795688|P1|COMPLETED|Overall Study||48
331476|NCT01419028|795688|P1|STARTED|Overall Study||48
331477|NCT01418937|795693|P1|NOT COMPLETED|Overall Study||8
331478|NCT01418937|795693|P1|COMPLETED|Overall Study||156
331479|NCT01418937|795693|P1|STARTED|Overall Study||164
331480|NCT01418703|795702|P4|NOT COMPLETED|Overall Study||0
331481|NCT01418703|795703|P3|NOT COMPLETED|Overall Study||0
331482|NCT01418703|795704|P2|NOT COMPLETED|Overall Study||0
331483|NCT01418703|795705|P1|NOT COMPLETED|Overall Study||0
331484|NCT01418703|795702|P4|COMPLETED|Overall Study||6
331485|NCT01418703|795703|P3|COMPLETED|Overall Study||6
331486|NCT01418703|795704|P2|COMPLETED|Overall Study||13
331487|NCT01418703|795705|P1|COMPLETED|Overall Study||13
331488|NCT01418703|795702|P4|STARTED|Overall Study||6
331489|NCT01418703|795703|P3|STARTED|Overall Study||6
331490|NCT01418703|795704|P2|STARTED|Overall Study||13
331491|NCT01418703|795705|P1|STARTED|Overall Study||13
331492|NCT01418482|795716|P1|NOT COMPLETED|Overall Study||0
331493|NCT01418482|795716|P1|COMPLETED|Overall Study||15
331494|NCT01418482|795716|P1|STARTED|Overall Study||15
331495|NCT01418365|795724|P2|NOT COMPLETED|Second Intervention||1
331496|NCT01418365|795725|P1|NOT COMPLETED|Second Intervention||0
331497|NCT01418365|795724|P2|COMPLETED|Second Intervention||13
331498|NCT01418365|795725|P1|COMPLETED|Second Intervention||14
331499|NCT01418365|795724|P2|STARTED|Second Intervention||14
331500|NCT01418365|795725|P1|STARTED|Second Intervention||14
331501|NCT01418365|795724|P2|NOT COMPLETED|First Intervention||1
331502|NCT01418365|795725|P1|NOT COMPLETED|First Intervention||1
331503|NCT01418365|795724|P2|COMPLETED|First Intervention||14
331504|NCT01418365|795725|P1|COMPLETED|First Intervention||14
331505|NCT01418365|795724|P2|STARTED|First Intervention||15
331506|NCT01418365|795725|P1|STARTED|First Intervention||15
331507|NCT01418209|795736|P3|NOT COMPLETED|Overall Study||4
331508|NCT01418209|795737|P2|NOT COMPLETED|Overall Study||3
331509|NCT01418209|795738|P1|NOT COMPLETED|Overall Study||2
331510|NCT01418209|795736|P3|COMPLETED|Overall Study||142
331511|NCT01418209|795737|P2|COMPLETED|Overall Study||93
331512|NCT01418209|795738|P1|COMPLETED|Overall Study||95
331513|NCT01418209|795736|P3|STARTED|Overall Study||146
331514|NCT01418209|795737|P2|STARTED|Overall Study||96
331515|NCT01418209|795738|P1|STARTED|Overall Study||97
331516|NCT01418001|795767|P1|NOT COMPLETED|Overall Study||0
331517|NCT01418001|795767|P1|COMPLETED|Overall Study||5
331518|NCT01418001|795767|P1|STARTED|Overall Study||5
331519|NCT01417936|795771|P1|NOT COMPLETED|Overall Study||0
331520|NCT01417936|795771|P1|COMPLETED|Overall Study||26
331521|NCT01417936|795771|P1|STARTED|Overall Study||26
331522|NCT01417481|795792|P2|NOT COMPLETED|Second Period (8 Weeks)||0
331523|NCT01417481|795793|P1|NOT COMPLETED|Second Period (8 Weeks)||0
331524|NCT01417481|795792|P2|COMPLETED|Second Period (8 Weeks)||5
331525|NCT01417481|795793|P1|COMPLETED|Second Period (8 Weeks)||8
331526|NCT01417481|795792|P2|STARTED|Second Period (8 Weeks)||5
331527|NCT01417481|795793|P1|STARTED|Second Period (8 Weeks)||8
331528|NCT01417481|795792|P2|NOT COMPLETED|Washout (2 Weeks)||0
331529|NCT01417481|795793|P1|NOT COMPLETED|Washout (2 Weeks)||0
331530|NCT01417481|795792|P2|COMPLETED|Washout (2 Weeks)||5
331531|NCT01417481|795793|P1|COMPLETED|Washout (2 Weeks)||8
331532|NCT01417481|795792|P2|STARTED|Washout (2 Weeks)||5
331533|NCT01417481|795793|P1|STARTED|Washout (2 Weeks)||8
331534|NCT01417481|795792|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
331535|NCT01417481|795793|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
331536|NCT01417481|795792|P2|COMPLETED|First Intervention (8 Weeks)||5
331537|NCT01417481|795793|P1|COMPLETED|First Intervention (8 Weeks)||8
331538|NCT01417481|795792|P2|STARTED|First Intervention (8 Weeks)||7
331539|NCT01417481|795793|P1|STARTED|First Intervention (8 Weeks)||8
331540|NCT01417455|795825|P8|NOT COMPLETED|Overall Study||0
331541|NCT01417455|795826|P7|NOT COMPLETED|Overall Study||0
331542|NCT01417455|795827|P6|NOT COMPLETED|Overall Study||0
331543|NCT01417455|795828|P5|NOT COMPLETED|Overall Study||0
331544|NCT01417455|795829|P4|NOT COMPLETED|Overall Study||0
331545|NCT01417455|795830|P3|NOT COMPLETED|Overall Study||0
331546|NCT01417455|795831|P2|NOT COMPLETED|Overall Study||0
331547|NCT01417455|795832|P1|NOT COMPLETED|Overall Study||0
331548|NCT01417455|795825|P8|COMPLETED|Overall Study||25
331549|NCT01417455|795826|P7|COMPLETED|Overall Study||13
331550|NCT01417455|795827|P6|COMPLETED|Overall Study||13
331551|NCT01417455|795828|P5|COMPLETED|Overall Study||30
331552|NCT01417455|795829|P4|COMPLETED|Overall Study||17
331553|NCT01417455|795830|P3|COMPLETED|Overall Study||17
331554|NCT01417455|795831|P2|COMPLETED|Overall Study||16
331555|NCT01417455|795832|P1|COMPLETED|Overall Study||16
331556|NCT01417455|795825|P8|STARTED|Overall Study||25
331557|NCT01417455|795826|P7|STARTED|Overall Study||13
331559|NCT01417455|795828|P5|STARTED|Overall Study||30
331560|NCT01417455|795829|P4|STARTED|Overall Study||17
331561|NCT01417455|795830|P3|STARTED|Overall Study||17
331562|NCT01417455|795831|P2|STARTED|Overall Study||16
331563|NCT01417455|795832|P1|STARTED|Overall Study||16
331564|NCT01417377|795858|P1|NOT COMPLETED|Overall Study||13
331565|NCT01417377|795858|P1|COMPLETED|Overall Study||9
331566|NCT01417377|795858|P1|Treated|Overall Study||21
331567|NCT01417377|795858|P1|STARTED|Overall Study||22
331568|NCT01417195|795867|P2|NOT COMPLETED|Overall Study||1
331569|NCT01417195|795868|P1|NOT COMPLETED|Overall Study||3
331570|NCT01417195|795867|P2|COMPLETED|Overall Study||61
331571|NCT01417195|795868|P1|COMPLETED|Overall Study||57
331572|NCT01417195|795867|P2|STARTED|Overall Study||62
331573|NCT01417195|795868|P1|STARTED|Overall Study||60
331574|NCT01417156|795884|P1|NOT COMPLETED|Overall Study||14
331575|NCT01417156|795884|P1|COMPLETED|Overall Study||6
331576|NCT01417156|795884|P1|STARTED|Overall Study||20
331577|NCT01417104|795894|P2|NOT COMPLETED|Overall Study||2
331578|NCT01417104|795895|P1|NOT COMPLETED|Overall Study||6
331579|NCT01417104|795894|P2|COMPLETED|Overall Study||35
331580|NCT01417104|795895|P1|COMPLETED|Overall Study||28
331581|NCT01417104|795894|P2|STARTED|Overall Study||37
331582|NCT01417104|795895|P1|STARTED|Overall Study||34
331583|NCT01417078|795905|P1|NOT COMPLETED|Overall Study||1
331584|NCT01417078|795905|P1|COMPLETED|Overall Study||30
331585|NCT01417078|795905|P1|STARTED|Overall Study||31
331586|NCT01417026|795917|P2|NOT COMPLETED|Overall Study||0
331587|NCT01417026|795918|P1|NOT COMPLETED|Overall Study||2
331588|NCT01417026|795917|P2|COMPLETED|Overall Study||13
331589|NCT01417026|795918|P1|COMPLETED|Overall Study||14
331590|NCT01417026|795917|P2|STARTED|Overall Study||13
331591|NCT01417026|795918|P1|STARTED|Overall Study||16
331592|NCT01416610|795928|P1|NOT COMPLETED|Overall Study||43
331593|NCT01416610|795928|P1|COMPLETED|Overall Study||45
331594|NCT01416610|795928|P1|Completed Follow-up|Overall Study||45
331595|NCT01416610|795928|P1|Completed Treatment|Overall Study||47
331596|NCT01416610|795928|P1|Per Protocol|Overall Study||83
331597|NCT01416610|795928|P1|Safety Population|Overall Study||86
331598|NCT01416610|795928|P1|Intention to Treat|Overall Study||88
331599|NCT01416610|795928|P1|STARTED|Overall Study||88
331600|NCT01416571|795942|P1|NOT COMPLETED|Overall Study||2
331601|NCT01416571|795942|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
331602|NCT01416571|795942|P1|STARTED|Overall Study||78
331603|NCT01416272|795969|P1|NOT COMPLETED|Overall Study||4
331604|NCT01416272|795969|P1|COMPLETED|Overall Study||8
331605|NCT01416272|795969|P1|STARTED|Overall Study||12
331606|NCT01416155|795975|P1|NOT COMPLETED|Overall Study||58
331607|NCT01416155|795975|P1|COMPLETED|Overall Study||39
331608|NCT01416155|795975|P1|STARTED|Overall Study||97
331609|NCT01416142|795982|P3|NOT COMPLETED|PureVision2 HD||1
331610|NCT01416142|795983|P2|NOT COMPLETED|PureVision2 HD||0
331611|NCT01416142|795984|P1|NOT COMPLETED|PureVision2 HD||0
331612|NCT01416142|795982|P3|COMPLETED|PureVision2 HD||62
331613|NCT01416142|795983|P2|COMPLETED|PureVision2 HD||0
331614|NCT01416142|795984|P1|COMPLETED|PureVision2 HD||0
331615|NCT01416142|795982|P3|STARTED|PureVision2 HD||63
331616|NCT01416142|795983|P2|STARTED|PureVision2 HD||0
331617|NCT01416142|795984|P1|STARTED|PureVision2 HD||0
331618|NCT01416142|795982|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
331619|NCT01416142|795983|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
331620|NCT01416142|795984|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
331621|NCT01416142|795982|P3|COMPLETED|Cross Over at Movie Intermission||0
331622|NCT01416142|795983|P2|COMPLETED|Cross Over at Movie Intermission||31
331623|NCT01416142|795984|P1|COMPLETED|Cross Over at Movie Intermission||32
331624|NCT01416142|795982|P3|STARTED|Cross Over at Movie Intermission||0
331625|NCT01416142|795983|P2|STARTED|Cross Over at Movie Intermission||31
331626|NCT01416142|795984|P1|STARTED|Cross Over at Movie Intermission||32
331627|NCT01416129|795995|P2|NOT COMPLETED|Experimental Condition: Brimless||0
331628|NCT01416129|795996|P1|NOT COMPLETED|Experimental Condition: Brimless||0
331629|NCT01416129|795995|P2|COMPLETED|Experimental Condition: Brimless||5
331630|NCT01416129|795996|P1|COMPLETED|Experimental Condition: Brimless||5
331631|NCT01416129|795995|P2|STARTED|Experimental Condition: Brimless||5
331632|NCT01416129|795996|P1|STARTED|Experimental Condition: Brimless||5
331633|NCT01416129|795995|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
331634|NCT01416129|795996|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
331635|NCT01416129|795995|P2|COMPLETED|Control Condition: Ischial Containment||5
331636|NCT01416129|795996|P1|COMPLETED|Control Condition: Ischial Containment||5
331637|NCT01416129|795995|P2|STARTED|Control Condition: Ischial Containment||5
331638|NCT01416129|795996|P1|STARTED|Control Condition: Ischial Containment||5
331639|NCT01416025|796004|P2|NOT COMPLETED|Overall Study||0
331640|NCT01416025|796005|P1|NOT COMPLETED|Overall Study||0
331641|NCT01416025|796004|P2|COMPLETED|Overall Study||15
331642|NCT01416025|796005|P1|COMPLETED|Overall Study||14
331643|NCT01416025|796004|P2|STARTED|Overall Study||15
331644|NCT01416025|796005|P1|STARTED|Overall Study||14
331645|NCT01415986|796011|P1|NOT COMPLETED|Overall Study||1
331646|NCT01415986|796011|P1|COMPLETED|Overall Study|Study terminated|0
331647|NCT01415986|796011|P1|STARTED|Overall Study||1
331648|NCT01415960|796016|P1|NOT COMPLETED|Overall Study||12
331649|NCT01415960|796016|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
331650|NCT01415960|796016|P1|PK Subgroup|Overall Study||30
331651|NCT01415960|796016|P1|ITT|Overall Study||161
331652|NCT01415960|796016|P1|STARTED|Overall Study||163
331653|NCT01415921|796028|P2|NOT COMPLETED|Overall Study||3
331654|NCT01415921|796029|P1|NOT COMPLETED|Overall Study||3
331655|NCT01415921|796028|P2|COMPLETED|Overall Study||14
331656|NCT01415921|796029|P1|COMPLETED|Overall Study||13
331657|NCT01415921|796028|P2|STARTED|Overall Study||17
331658|NCT01415921|796029|P1|STARTED|Overall Study||16
331659|NCT01415908|796039|P2|NOT COMPLETED|Overall Study||0
331660|NCT01415908|796040|P1|NOT COMPLETED|Overall Study||1
331661|NCT01415908|796039|P2|COMPLETED|Overall Study||4
331662|NCT01415908|796040|P1|COMPLETED|Overall Study||10
331663|NCT01415908|796039|P2|STARTED|Overall Study||4
331664|NCT01415908|796040|P1|STARTED|Overall Study||11
331665|NCT01415531|796068|P2|NOT COMPLETED|Overall Study||37
331666|NCT01415531|796069|P1|NOT COMPLETED|Overall Study||25
331667|NCT01415531|796068|P2|COMPLETED|Overall Study||390
331668|NCT01415531|796069|P1|COMPLETED|Overall Study||189
331669|NCT01415531|796068|P2|STARTED|Overall Study||427
331670|NCT01415531|796069|P1|STARTED|Overall Study||214
331671|NCT01415518|796079|P2|NOT COMPLETED|Overall Study||31
331672|NCT01415518|796080|P1|NOT COMPLETED|Overall Study||16
331673|NCT01415518|796079|P2|COMPLETED|Overall Study||261
331674|NCT01415518|796080|P1|COMPLETED|Overall Study||276
331675|NCT01415518|796079|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
331676|NCT01415518|796080|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
331677|NCT01415518|796079|P2|Patients Who Received Study Treatment|Overall Study||292
331678|NCT01415518|796080|P1|Patients Who Received Study Treatment|Overall Study||290
331679|NCT01415518|796079|P2|STARTED|Overall Study||292
331680|NCT01415518|796080|P1|STARTED|Overall Study||292
331681|NCT01415453|796132|P1|NOT COMPLETED|Overall Study||0
331682|NCT01415453|796132|P1|COMPLETED|Overall Study||1
331683|NCT01415453|796132|P1|Imaging Study|Overall Study||1
331684|NCT01415453|796132|P1|STARTED|Overall Study||1
331685|NCT01415427|796140|P4|NOT COMPLETED|Overall Study||56
331686|NCT01415427|796141|P3|NOT COMPLETED|Overall Study||58
331687|NCT01415427|796142|P2|NOT COMPLETED|Overall Study||29
331688|NCT01415427|796143|P1|NOT COMPLETED|Overall Study||29
331689|NCT01415427|796140|P4|COMPLETED|Overall Study||0
331690|NCT01415427|796141|P3|COMPLETED|Overall Study||1
331691|NCT01415427|796142|P2|COMPLETED|Overall Study||0
331692|NCT01415427|796143|P1|COMPLETED|Overall Study||0
331693|NCT01415427|796140|P4|STARTED|Overall Study||56
331694|NCT01415427|796141|P3|STARTED|Overall Study||59
331695|NCT01415427|796142|P2|STARTED|Overall Study||29
331696|NCT01415427|796143|P1|STARTED|Overall Study||29
331697|NCT01415401|796180|P1|NOT COMPLETED|Overall Study||7
331698|NCT01415401|796180|P1|COMPLETED|Overall Study||47
331699|NCT01415401|796180|P1|STARTED|Overall Study||54
331700|NCT01415349|796185|P2|NOT COMPLETED|Treatment Period 2||0
331701|NCT01415349|796186|P1|NOT COMPLETED|Treatment Period 2||0
331702|NCT01415349|796185|P2|COMPLETED|Treatment Period 2||19
331703|NCT01415349|796186|P1|COMPLETED|Treatment Period 2||21
331704|NCT01415349|796185|P2|STARTED|Treatment Period 2||19
331705|NCT01415349|796186|P1|STARTED|Treatment Period 2||21
331706|NCT01415349|796185|P2|NOT COMPLETED|Treatment Period 1||2
331707|NCT01415349|796186|P1|NOT COMPLETED|Treatment Period 1||0
331708|NCT01415349|796185|P2|COMPLETED|Treatment Period 1||19
331709|NCT01415349|796186|P1|COMPLETED|Treatment Period 1||21
331710|NCT01415349|796185|P2|STARTED|Treatment Period 1||21
331711|NCT01415349|796186|P1|STARTED|Treatment Period 1||21
331712|NCT01415232|796194|P1|NOT COMPLETED|Overall Study||0
331713|NCT01415232|796194|P1|COMPLETED|Overall Study||160
331714|NCT01415232|796194|P1|STARTED|Overall Study||160
331715|NCT01414855|796198|P1|NOT COMPLETED|Overall Study||13
331716|NCT01414855|796198|P1|COMPLETED|Overall Study|Completed=Completed treatment.|87
331717|NCT01414855|796198|P1|STARTED|Overall Study||100
331718|NCT01414634|796214|P8|NOT COMPLETED|Overall Study||0
331719|NCT01414634|796215|P7|NOT COMPLETED|Overall Study||0
331720|NCT01414634|796216|P6|NOT COMPLETED|Overall Study||0
331721|NCT01414634|796217|P5|NOT COMPLETED|Overall Study||0
331722|NCT01414634|796218|P4|NOT COMPLETED|Overall Study||0
331723|NCT01414634|796219|P3|NOT COMPLETED|Overall Study||0
331724|NCT01414634|796220|P2|NOT COMPLETED|Overall Study||0
331725|NCT01414634|796221|P1|NOT COMPLETED|Overall Study||0
331726|NCT01414634|796214|P8|COMPLETED|Overall Study||1
331727|NCT01414634|796215|P7|COMPLETED|Overall Study||1
331728|NCT01414634|796216|P6|COMPLETED|Overall Study||2
331729|NCT01414634|796217|P5|COMPLETED|Overall Study||1
331730|NCT01414634|796218|P4|COMPLETED|Overall Study||1
331731|NCT01414634|796219|P3|COMPLETED|Overall Study||1
331732|NCT01414634|796220|P2|COMPLETED|Overall Study||1
331733|NCT01414634|796221|P1|COMPLETED|Overall Study||1
331734|NCT01414634|796214|P8|STARTED|Overall Study||1
331735|NCT01414634|796215|P7|STARTED|Overall Study||1
331736|NCT01414634|796216|P6|STARTED|Overall Study||2
331737|NCT01414634|796217|P5|STARTED|Overall Study||1
331738|NCT01414634|796218|P4|STARTED|Overall Study||1
331739|NCT01414634|796219|P3|STARTED|Overall Study||1
331740|NCT01414634|796220|P2|STARTED|Overall Study||1
331741|NCT01414634|796221|P1|STARTED|Overall Study||1
331742|NCT01414413|796234|P2|NOT COMPLETED|Overall Study||0
331743|NCT01414413|796235|P1|NOT COMPLETED|Overall Study||0
331744|NCT01414413|796234|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
331745|NCT01414413|796235|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
331746|NCT01414413|796234|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
331747|NCT01414413|796235|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
331748|NCT01414205|796249|P2|NOT COMPLETED|Overall Study||7
331749|NCT01414205|796250|P1|NOT COMPLETED|Overall Study||7
331750|NCT01414205|796249|P2|COMPLETED|Overall Study||32
331751|NCT01414205|796250|P1|COMPLETED|Overall Study||34
331752|NCT01414205|796249|P2|Received Study Drug|Overall Study||38
331753|NCT01414205|796250|P1|Received Study Drug|Overall Study||40
331754|NCT01414205|796249|P2|STARTED|Overall Study||39
331755|NCT01414205|796250|P1|STARTED|Overall Study||41
331756|NCT01414192|796286|P4|NOT COMPLETED|Overall Study||0
331757|NCT01414192|796287|P3|NOT COMPLETED|Overall Study||0
331758|NCT01414192|796288|P2|NOT COMPLETED|Overall Study||0
331759|NCT01414192|796289|P1|NOT COMPLETED|Overall Study||0
331760|NCT01414192|796286|P4|COMPLETED|Overall Study||1726
331761|NCT01414192|796287|P3|COMPLETED|Overall Study||424
331762|NCT01414192|796288|P2|COMPLETED|Overall Study||575
331763|NCT01414192|796289|P1|COMPLETED|Overall Study||490
331764|NCT01414192|796286|P4|STARTED|Overall Study||1726
331765|NCT01414192|796287|P3|STARTED|Overall Study||424
331766|NCT01414192|796288|P2|STARTED|Overall Study||575
331767|NCT01414192|796289|P1|STARTED|Overall Study||490
331768|NCT01414166|796319|P2|NOT COMPLETED|Overall Study||83
331769|NCT01414166|796320|P1|NOT COMPLETED|Overall Study||91
331770|NCT01414166|796319|P2|COMPLETED|Overall Study||39
331771|NCT01414166|796320|P1|COMPLETED|Overall Study||31
331772|NCT01414166|796319|P2|Treated|Overall Study||121
331773|NCT01414166|796320|P1|Treated|Overall Study||120
331774|NCT01414166|796319|P2|STARTED|Overall Study||122
331775|NCT01414166|796320|P1|STARTED|Overall Study||122
331776|NCT01414153|796346|P4|NOT COMPLETED|Overall Study||4
331777|NCT01414153|796347|P3|NOT COMPLETED|Overall Study||4
331778|NCT01414153|796348|P2|NOT COMPLETED|Overall Study||2
331779|NCT01414153|796349|P1|NOT COMPLETED|Overall Study||8
331780|NCT01414153|796346|P4|COMPLETED|Overall Study||37
331781|NCT01414153|796347|P3|COMPLETED|Overall Study||35
331782|NCT01414153|796348|P2|COMPLETED|Overall Study||38
331783|NCT01414153|796349|P1|COMPLETED|Overall Study||30
331784|NCT01414153|796346|P4|STARTED|Overall Study||41
331785|NCT01414153|796347|P3|STARTED|Overall Study||39
331786|NCT01414153|796348|P2|STARTED|Overall Study||40
331787|NCT01414153|796349|P1|STARTED|Overall Study||38
331788|NCT01414114|796383|P1|NOT COMPLETED|Overall Study||5
331789|NCT01414114|796383|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
331790|NCT01414114|796383|P1|STARTED|Overall Study||37
331791|NCT01414036|796403|P2|NOT COMPLETED|Completed 3 Month Survey||5
331792|NCT01414036|796404|P1|NOT COMPLETED|Completed 3 Month Survey||9
331793|NCT01414036|796403|P2|COMPLETED|Completed 3 Month Survey||19
331794|NCT01414036|796404|P1|COMPLETED|Completed 3 Month Survey||14
331795|NCT01414036|796403|P2|STARTED|Completed 3 Month Survey||24
331796|NCT01414036|796404|P1|STARTED|Completed 3 Month Survey||23
331797|NCT01414036|796403|P2|NOT COMPLETED|Received Allocated Intervention||13
331798|NCT01414036|796404|P1|NOT COMPLETED|Received Allocated Intervention||0
331799|NCT01414036|796403|P2|COMPLETED|Received Allocated Intervention||11
331800|NCT01414036|796404|P1|COMPLETED|Received Allocated Intervention||23
331801|NCT01414036|796403|P2|STARTED|Received Allocated Intervention||24
331802|NCT01414036|796404|P1|STARTED|Received Allocated Intervention||23
331803|NCT01413958|796416|P2|NOT COMPLETED|Overall Study||1
331804|NCT01413958|796417|P1|NOT COMPLETED|Overall Study||0
331805|NCT01413958|796416|P2|COMPLETED|Overall Study||286
331806|NCT01413958|796417|P1|COMPLETED|Overall Study||288
331807|NCT01413958|796416|P2|STARTED|Overall Study||287
331808|NCT01413958|796417|P1|STARTED|Overall Study||288
331809|NCT01413750|796452|P4|NOT COMPLETED|Overall Study||0
331810|NCT01413750|796453|P3|NOT COMPLETED|Overall Study||0
331811|NCT01413750|796454|P2|NOT COMPLETED|Overall Study||0
331812|NCT01413750|796455|P1|NOT COMPLETED|Overall Study||0
331813|NCT01413750|796452|P4|COMPLETED|Overall Study||7
331814|NCT01413750|796453|P3|COMPLETED|Overall Study||4
331815|NCT01413750|796454|P2|COMPLETED|Overall Study||6
331816|NCT01413750|796455|P1|COMPLETED|Overall Study||6
331817|NCT01413750|796452|P4|STARTED|Overall Study||7
331818|NCT01413750|796453|P3|STARTED|Overall Study||4
331819|NCT01413750|796454|P2|STARTED|Overall Study||6
331820|NCT01413750|796455|P1|STARTED|Overall Study||6
331821|NCT01413542|796468|P4|NOT COMPLETED|Overall Study||1
331822|NCT01413542|796469|P3|NOT COMPLETED|Overall Study||3
331823|NCT01413542|796470|P2|NOT COMPLETED|Overall Study||0
331824|NCT01413542|796471|P1|NOT COMPLETED|Overall Study||1
331825|NCT01413542|796468|P4|COMPLETED|Overall Study||7
331826|NCT01413542|796469|P3|COMPLETED|Overall Study||6
331827|NCT01413542|796470|P2|COMPLETED|Overall Study||6
331828|NCT01413542|796471|P1|COMPLETED|Overall Study||5
331829|NCT01413542|796468|P4|STARTED|Overall Study||8
331830|NCT01413542|796469|P3|STARTED|Overall Study||9
331831|NCT01413542|796470|P2|STARTED|Overall Study||6
331832|NCT01413542|796471|P1|STARTED|Overall Study||6
331833|NCT01413516|796486|P2|NOT COMPLETED|Overall Study||0
331834|NCT01413516|796487|P1|NOT COMPLETED|Overall Study||0
331835|NCT01413516|796486|P2|COMPLETED|Overall Study||9
331836|NCT01413516|796487|P1|COMPLETED|Overall Study||8
331837|NCT01413516|796486|P2|STARTED|Overall Study||9
331838|NCT01413516|796487|P1|STARTED|Overall Study||8
331839|NCT01413360|796493|P1|NOT COMPLETED|Overall Study||3
331840|NCT01413360|796493|P1|COMPLETED|Overall Study||7
331841|NCT01413360|796493|P1|STARTED|Overall Study||10
331842|NCT01413204|796501|P3|NOT COMPLETED|Overall Study||19
331843|NCT01413204|796502|P2|NOT COMPLETED|Overall Study||6
331844|NCT01413204|796503|P1|NOT COMPLETED|Overall Study||6
331845|NCT01413204|796501|P3|COMPLETED|Overall Study||74
331846|NCT01413204|796502|P2|COMPLETED|Overall Study||83
331847|NCT01413204|796503|P1|COMPLETED|Overall Study||84
331848|NCT01413204|796501|P3|STARTED|Overall Study||93
331849|NCT01413204|796502|P2|STARTED|Overall Study||89
331850|NCT01413204|796503|P1|STARTED|Overall Study||90
331851|NCT01413191|796511|P1|NOT COMPLETED|Overall Study||11
331852|NCT01413191|796511|P1|COMPLETED|Overall Study||7
331853|NCT01413191|796511|P1|STARTED|Overall Study||18
331854|NCT01412983|796515|P2|NOT COMPLETED|2nd Period||0
331855|NCT01412983|796516|P1|NOT COMPLETED|2nd Period||0
331856|NCT01412983|796515|P2|COMPLETED|2nd Period||46
331857|NCT01412983|796516|P1|COMPLETED|2nd Period||50
331858|NCT01412983|796515|P2|STARTED|2nd Period||46
331859|NCT01412983|796516|P1|STARTED|2nd Period||50
331860|NCT01412983|796515|P2|NOT COMPLETED|1st Period||4
331861|NCT01412983|796516|P1|NOT COMPLETED|1st Period||0
331862|NCT01412983|796515|P2|COMPLETED|1st Period||46
331863|NCT01412983|796516|P1|COMPLETED|1st Period||50
331864|NCT01412983|796515|P2|STARTED|1st Period||50
331865|NCT01412983|796516|P1|STARTED|1st Period||50
331866|NCT01412957|796526|P2|NOT COMPLETED|Overall Study||157
331867|NCT01412957|796527|P1|NOT COMPLETED|Overall Study||149
331868|NCT01412957|796526|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
331869|NCT01412957|796527|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
331870|NCT01412957|796526|P2|STARTED|Overall Study||188
331871|NCT01412957|796527|P1|STARTED|Overall Study||189
331872|NCT01412944|796549|P6|NOT COMPLETED|Follow-up||0
331873|NCT01412944|796550|P5|NOT COMPLETED|Follow-up||0
331874|NCT01412944|796551|P4|NOT COMPLETED|Follow-up||0
331875|NCT01412944|796552|P3|NOT COMPLETED|Follow-up||0
331876|NCT01412944|796553|P2|NOT COMPLETED|Follow-up||0
331877|NCT01412944|796554|P1|NOT COMPLETED|Follow-up||0
331878|NCT01412944|796549|P6|COMPLETED|Follow-up||0
331879|NCT01412944|796550|P5|COMPLETED|Follow-up||2
331880|NCT01412944|796551|P4|COMPLETED|Follow-up||1
331881|NCT01412944|796552|P3|COMPLETED|Follow-up||2
331882|NCT01412944|796553|P2|COMPLETED|Follow-up||0
331883|NCT01412944|796554|P1|COMPLETED|Follow-up||0
331884|NCT01412944|796549|P6|STARTED|Follow-up||0
331885|NCT01412944|796550|P5|STARTED|Follow-up||2
331886|NCT01412944|796551|P4|STARTED|Follow-up||1
331887|NCT01412944|796552|P3|STARTED|Follow-up||2
331888|NCT01412944|796553|P2|STARTED|Follow-up||0
331889|NCT01412944|796554|P1|STARTED|Follow-up||0
331890|NCT01412944|796549|P6|NOT COMPLETED|Entire: IV + Maintenance||0
331891|NCT01412944|796550|P5|NOT COMPLETED|Entire: IV + Maintenance||0
331892|NCT01412944|796551|P4|NOT COMPLETED|Entire: IV + Maintenance||0
331893|NCT01412944|796552|P3|NOT COMPLETED|Entire: IV + Maintenance||0
331894|NCT01412944|796553|P2|NOT COMPLETED|Entire: IV + Maintenance||5
331895|NCT01412944|796554|P1|NOT COMPLETED|Entire: IV + Maintenance||2
331896|NCT01412944|796549|P6|COMPLETED|Entire: IV + Maintenance||0
331897|NCT01412944|796550|P5|COMPLETED|Entire: IV + Maintenance||0
331898|NCT01412944|796551|P4|COMPLETED|Entire: IV + Maintenance||0
331899|NCT01412944|796552|P3|COMPLETED|Entire: IV + Maintenance||0
331900|NCT01412944|796553|P2|COMPLETED|Entire: IV + Maintenance||17
331901|NCT01412944|796554|P1|COMPLETED|Entire: IV + Maintenance||19
331902|NCT01412944|796549|P6|STARTED|Entire: IV + Maintenance||0
331903|NCT01412944|796550|P5|STARTED|Entire: IV + Maintenance||0
331904|NCT01412944|796551|P4|STARTED|Entire: IV + Maintenance||0
331905|NCT01412944|796552|P3|STARTED|Entire: IV + Maintenance||0
331906|NCT01412944|796553|P2|STARTED|Entire: IV + Maintenance||22
331907|NCT01412944|796554|P1|STARTED|Entire: IV + Maintenance||21
331908|NCT01412944|796549|P6|NOT COMPLETED|Entire: IV + Maintenance||2
331909|NCT01412944|796550|P5|NOT COMPLETED|Entire: IV + Maintenance||3
331910|NCT01412944|796551|P4|NOT COMPLETED|Entire: IV + Maintenance||1
331911|NCT01412944|796552|P3|NOT COMPLETED|Entire: IV + Maintenance||1
331912|NCT01412944|796553|P2|NOT COMPLETED|Entire: IV + Maintenance||0
331913|NCT01412944|796554|P1|NOT COMPLETED|Entire: IV + Maintenance||0
331914|NCT01412944|796549|P6|COMPLETED|Entire: IV + Maintenance||6
331915|NCT01412944|796550|P5|COMPLETED|Entire: IV + Maintenance||11
331916|NCT01412944|796551|P4|COMPLETED|Entire: IV + Maintenance||5
331917|NCT01412944|796552|P3|COMPLETED|Entire: IV + Maintenance||14
331918|NCT01412944|796553|P2|COMPLETED|Entire: IV + Maintenance||0
331919|NCT01412944|796554|P1|COMPLETED|Entire: IV + Maintenance||0
331920|NCT01412944|796549|P6|STARTED|Entire: IV + Maintenance||8
331921|NCT01412944|796550|P5|STARTED|Entire: IV + Maintenance||14
331922|NCT01412944|796551|P4|STARTED|Entire: IV + Maintenance||6
331923|NCT01412944|796552|P3|STARTED|Entire: IV + Maintenance||15
331924|NCT01412944|796553|P2|STARTED|Entire: IV + Maintenance||0
331925|NCT01412944|796554|P1|STARTED|Entire: IV + Maintenance||0
331926|NCT01412944|796549|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
331927|NCT01412944|796550|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
331928|NCT01412944|796551|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
331929|NCT01412944|796552|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
331930|NCT01412944|796553|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
331931|NCT01412944|796554|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
331932|NCT01412944|796549|P6|COMPLETED|IV: Per CAIN457A2307||0
331933|NCT01412944|796550|P5|COMPLETED|IV: Per CAIN457A2307||0
331934|NCT01412944|796551|P4|COMPLETED|IV: Per CAIN457A2307||0
331935|NCT01412944|796552|P3|COMPLETED|IV: Per CAIN457A2307||0
331936|NCT01412944|796553|P2|COMPLETED|IV: Per CAIN457A2307||20
331937|NCT01412944|796554|P1|COMPLETED|IV: Per CAIN457A2307||20
331938|NCT01412944|796549|P6|STARTED|IV: Per CAIN457A2307||0
331939|NCT01412944|796550|P5|STARTED|IV: Per CAIN457A2307||0
331940|NCT01412944|796551|P4|STARTED|IV: Per CAIN457A2307||0
331941|NCT01412944|796552|P3|STARTED|IV: Per CAIN457A2307||0
331942|NCT01412944|796553|P2|STARTED|IV: Per CAIN457A2307||22
331943|NCT01412944|796554|P1|STARTED|IV: Per CAIN457A2307||21
331944|NCT01412944|796549|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
331945|NCT01412944|796550|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
331946|NCT01412944|796551|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
331947|NCT01412944|796552|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
331948|NCT01412944|796553|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
331949|NCT01412944|796554|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
331950|NCT01412944|796549|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
331951|NCT01412944|796550|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
331952|NCT01412944|796551|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
331953|NCT01412944|796552|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
331954|NCT01412944|796553|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
331955|NCT01412944|796554|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
331956|NCT01412944|796549|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
331957|NCT01412944|796550|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
331958|NCT01412944|796551|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
331959|NCT01412944|796552|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
331960|NCT01412944|796553|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
331961|NCT01412944|796554|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
331962|NCT01412918|796590|P2|NOT COMPLETED|Overall Study||0
331963|NCT01412918|796591|P1|NOT COMPLETED|Overall Study||0
331964|NCT01412918|796590|P2|COMPLETED|Overall Study||1
331965|NCT01412918|796591|P1|COMPLETED|Overall Study||20
331966|NCT01412918|796590|P2|STARTED|Overall Study||1
331967|NCT01412918|796591|P1|STARTED|Overall Study||20
331968|NCT01412879|796600|P3|NOT COMPLETED|Consolidation Therapy||0
331969|NCT01412879|796601|P2|NOT COMPLETED|Consolidation Therapy||0
331970|NCT01412879|796602|P1|NOT COMPLETED|Consolidation Therapy||0
331971|NCT01412879|796600|P3|COMPLETED|Consolidation Therapy||26
331972|NCT01412879|796601|P2|COMPLETED|Consolidation Therapy||0
331973|NCT01412879|796602|P1|COMPLETED|Consolidation Therapy||0
331974|NCT01412879|796600|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
331975|NCT01412879|796601|P2|STARTED|Consolidation Therapy||0
331976|NCT01412879|796602|P1|STARTED|Consolidation Therapy||0
331977|NCT01412879|796600|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
331978|NCT01412879|796601|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
331979|NCT01412879|796602|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
331980|NCT01412879|796600|P3|COMPLETED|Initial Registration (Induction Therapy)||0
331981|NCT01412879|796601|P2|COMPLETED|Initial Registration (Induction Therapy)||27
331982|NCT01412879|796602|P1|COMPLETED|Initial Registration (Induction Therapy)||5
331983|NCT01412879|796600|P3|Treatment Started|Initial Registration (Induction Therapy)||0
331984|NCT01412879|796601|P2|Treatment Started|Initial Registration (Induction Therapy)||35
331985|NCT01412879|796602|P1|Treatment Started|Initial Registration (Induction Therapy)||17
331986|NCT01412879|796600|P3|STARTED|Initial Registration (Induction Therapy)||0
331987|NCT01412879|796601|P2|STARTED|Initial Registration (Induction Therapy)||35
331988|NCT01412879|796602|P1|STARTED|Initial Registration (Induction Therapy)||18
331989|NCT01412801|796622|P6|NOT COMPLETED|Overall Study||3
331990|NCT01412801|796623|P5|NOT COMPLETED|Overall Study||3
331991|NCT01412801|796624|P4|NOT COMPLETED|Overall Study||4
331992|NCT01412801|796625|P3|NOT COMPLETED|Overall Study||7
331993|NCT01412801|796626|P2|NOT COMPLETED|Overall Study||5
331994|NCT01412801|796627|P1|NOT COMPLETED|Overall Study||4
331995|NCT01412801|796622|P6|COMPLETED|Overall Study||84
331996|NCT01412801|796623|P5|COMPLETED|Overall Study||85
331997|NCT01412801|796624|P4|COMPLETED|Overall Study||87
331998|NCT01412801|796625|P3|COMPLETED|Overall Study||83
331999|NCT01412801|796626|P2|COMPLETED|Overall Study||84
332000|NCT01412801|796627|P1|COMPLETED|Overall Study||87
332001|NCT01412801|796622|P6|STARTED|Overall Study||87
332002|NCT01412801|796623|P5|STARTED|Overall Study||88
332003|NCT01412801|796624|P4|STARTED|Overall Study||91
332004|NCT01412801|796625|P3|STARTED|Overall Study||90
332005|NCT01412801|796626|P2|STARTED|Overall Study||89
332006|NCT01412801|796627|P1|STARTED|Overall Study||91
332007|NCT01412541|796666|P2|NOT COMPLETED|Overall Study||20
332008|NCT01412541|796667|P1|NOT COMPLETED|Overall Study||36
332009|NCT01412541|796666|P2|COMPLETED|Overall Study||140
332010|NCT01412541|796667|P1|COMPLETED|Overall Study||280
332011|NCT01412541|796666|P2|STARTED|Overall Study||160
332012|NCT01412541|796667|P1|STARTED|Overall Study||316
332013|NCT01412424|796775|P1|NOT COMPLETED|Extension Treatment Period||6
332014|NCT01412424|796775|P1|COMPLETED|Extension Treatment Period||82
332015|NCT01412424|796775|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
332016|NCT01412424|796775|P1|NOT COMPLETED|Core Treatment Period||53
332017|NCT01412424|796775|P1|COMPLETED|Core Treatment Period||102
332018|NCT01412424|796775|P1|STARTED|Core Treatment Period||155
332019|NCT01412281|796795|P4|NOT COMPLETED|Overall Study||0
332020|NCT01412281|796796|P3|NOT COMPLETED|Overall Study||0
332021|NCT01412281|796797|P2|NOT COMPLETED|Overall Study||0
332022|NCT01412281|796798|P1|NOT COMPLETED|Overall Study||0
332023|NCT01412281|796795|P4|COMPLETED|Overall Study||110
332024|NCT01412281|796796|P3|COMPLETED|Overall Study||110
332025|NCT01412281|796797|P2|COMPLETED|Overall Study||110
332026|NCT01412281|796798|P1|COMPLETED|Overall Study||110
332027|NCT01412281|796795|P4|STARTED|Overall Study||110
332028|NCT01412281|796796|P3|STARTED|Overall Study||110
332029|NCT01412281|796797|P2|STARTED|Overall Study||110
332030|NCT01412281|796798|P1|STARTED|Overall Study||110
332031|NCT01412164|796820|P1|NOT COMPLETED|Overall Study||18
332032|NCT01412164|796820|P1|COMPLETED|Overall Study||712
332033|NCT01412164|796820|P1|STARTED|Overall Study||730
332034|NCT01412151|796824|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
332035|NCT01412151|796824|P1|COMPLETED|Week 306 - 310 - Washout Period||3
332036|NCT01412151|796824|P1|STARTED|Week 306 - 310 - Washout Period||5
332037|NCT01412151|796824|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
332038|NCT01412151|796824|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
332039|NCT01412151|796824|P1|STARTED|Week 0 - 306 - Treatment Period||10
332040|NCT01412086|796828|P1|NOT COMPLETED|Overall Study||0
332041|NCT01412086|796828|P1|COMPLETED|Overall Study||112
332042|NCT01412086|796828|P1|STARTED|Overall Study||112
332043|NCT01411891|796835|P2|NOT COMPLETED|Overall Study||2
332044|NCT01411891|796836|P1|NOT COMPLETED|Overall Study||3
332045|NCT01411891|796835|P2|COMPLETED|Overall Study||48
332046|NCT01411891|796836|P1|COMPLETED|Overall Study||47
332047|NCT01411891|796835|P2|STARTED|Overall Study||50
332048|NCT01411891|796836|P1|STARTED|Overall Study||50
332049|NCT01411852|796844|P2|NOT COMPLETED|Hospital Intervention Phase||18
332050|NCT01411852|796845|P1|NOT COMPLETED|Hospital Intervention Phase||24
332051|NCT01411852|796844|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
332052|NCT01411852|796845|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
332053|NCT01411852|796844|P2|STARTED|Hospital Intervention Phase||89
332054|NCT01411852|796845|P1|STARTED|Hospital Intervention Phase||83
332055|NCT01411852|796844|P2|NOT COMPLETED|Prehospital Intervention Phase||7
332056|NCT01411852|796845|P1|NOT COMPLETED|Prehospital Intervention Phase||12
332057|NCT01411852|796844|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
332058|NCT01411852|796845|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
332059|NCT01411852|796844|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
332060|NCT01411852|796845|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
332061|NCT01411696|796888|P1|NOT COMPLETED|Overall Study||0
332062|NCT01411696|796888|P1|COMPLETED|Overall Study||289
332063|NCT01411696|796888|P1|STARTED|Overall Study||289
332064|NCT01411592|796897|P2|NOT COMPLETED|Overall Study||0
332065|NCT01411592|796898|P1|NOT COMPLETED|Overall Study||0
332066|NCT01411592|796897|P2|COMPLETED|Overall Study||16
332067|NCT01411592|796898|P1|COMPLETED|Overall Study||14
332068|NCT01411592|796897|P2|5-Year Time Frame|Overall Study||16
332069|NCT01411592|796898|P1|5-Year Time Frame|Overall Study||14
332070|NCT01411592|796897|P2|STARTED|Overall Study||16
332071|NCT01411592|796898|P1|STARTED|Overall Study||14
332072|NCT01411501|796910|P4|NOT COMPLETED|Overall Study||7
332073|NCT01411501|796911|P3|NOT COMPLETED|Overall Study||6
332074|NCT01411501|796912|P2|NOT COMPLETED|Overall Study||6
332075|NCT01411501|796913|P1|NOT COMPLETED|Overall Study||10
332076|NCT01411501|796910|P4|COMPLETED|Overall Study||163
332077|NCT01411501|796911|P3|COMPLETED|Overall Study||159
332078|NCT01411501|796912|P2|COMPLETED|Overall Study||166
332079|NCT01411501|796913|P1|COMPLETED|Overall Study||158
332080|NCT01411501|796910|P4|STARTED|Overall Study||170
332081|NCT01411501|796911|P3|STARTED|Overall Study||165
332082|NCT01411501|796912|P2|STARTED|Overall Study||172
332083|NCT01411501|796913|P1|STARTED|Overall Study||168
332084|NCT01411228|796946|P3|NOT COMPLETED|Overall Study||1
332085|NCT01411228|796947|P2|NOT COMPLETED|Overall Study||0
332086|NCT01411228|796948|P1|NOT COMPLETED|Overall Study||1
332087|NCT01411228|796946|P3|COMPLETED|Overall Study||4
332088|NCT01411228|796947|P2|COMPLETED|Overall Study||5
332089|NCT01411228|796948|P1|COMPLETED|Overall Study||4
332090|NCT01411228|796946|P3|STARTED|Overall Study||5
332091|NCT01411228|796947|P2|STARTED|Overall Study||5
332092|NCT01411228|796948|P1|STARTED|Overall Study||5
332093|NCT01411215|796970|P2|NOT COMPLETED|Overall Study||84
332094|NCT01411215|796971|P1|NOT COMPLETED|Overall Study||66
332095|NCT01411215|796970|P2|COMPLETED|Overall Study||7
332096|NCT01411215|796971|P1|COMPLETED|Overall Study||3
332097|NCT01411215|796970|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
332098|NCT01411215|796971|P1|Treated|Overall Study||69
332099|NCT01411215|796970|P2|STARTED|Overall Study||91
332100|NCT01411215|796971|P1|STARTED|Overall Study||69
332101|NCT01411137|797004|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
332102|NCT01411137|797004|P1|COMPLETED|Part 3: Open-Label Extension||12
332103|NCT01411137|797004|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
332104|NCT01411137|797004|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
332105|NCT01411137|797004|P1|COMPLETED|Part 2: Open-Label Extension||25
332106|NCT01411137|797004|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
332107|NCT01411137|797004|P1|NOT COMPLETED|Part 1: Dose Conversion||10
332108|NCT01411137|797004|P1|COMPLETED|Part 1: Dose Conversion||33
332109|NCT01411137|797004|P1|STARTED|Part 1: Dose Conversion||43
332110|NCT01410773|797023|P1|NOT COMPLETED|Overall Study||0
332111|NCT01410773|797023|P1|COMPLETED|Overall Study||110
332112|NCT01410773|797023|P1|STARTED|Overall Study||110
332113|NCT01410604|797030|P2|NOT COMPLETED|Overall Study||2
332114|NCT01410604|797031|P1|NOT COMPLETED|Overall Study||3
332115|NCT01410604|797030|P2|COMPLETED|Overall Study||14
332116|NCT01410604|797031|P1|COMPLETED|Overall Study||12
332117|NCT01410604|797030|P2|STARTED|Overall Study||16
332118|NCT01410604|797031|P1|STARTED|Overall Study||15
332119|NCT01410565|797053|P3|NOT COMPLETED|Double Blind Phase||0
332120|NCT01410565|797054|P2|NOT COMPLETED|Double Blind Phase||15
332121|NCT01410565|797055|P1|NOT COMPLETED|Double Blind Phase||13
332122|NCT01410565|797053|P3|COMPLETED|Double Blind Phase||0
332123|NCT01410565|797054|P2|COMPLETED|Double Blind Phase||0
332124|NCT01410565|797055|P1|COMPLETED|Double Blind Phase||0
332125|NCT01410565|797053|P3|STARTED|Double Blind Phase||0
332126|NCT01410565|797054|P2|STARTED|Double Blind Phase||15
332127|NCT01410565|797055|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
332128|NCT01410565|797053|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
332129|NCT01410565|797054|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
332130|NCT01410565|797055|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
332131|NCT01410565|797053|P3|COMPLETED|Open Label Phase Apaziquone||58
332132|NCT01410565|797054|P2|COMPLETED|Open Label Phase Apaziquone||0
332133|NCT01410565|797055|P1|COMPLETED|Open Label Phase Apaziquone||0
332134|NCT01410565|797053|P3|STARTED|Open Label Phase Apaziquone||66
332135|NCT01410565|797054|P2|STARTED|Open Label Phase Apaziquone||0
332136|NCT01410565|797055|P1|STARTED|Open Label Phase Apaziquone||0
332137|NCT01410474|797067|P2|NOT COMPLETED|Overall Study||1
332138|NCT01410474|797068|P1|NOT COMPLETED|Overall Study||0
332139|NCT01410474|797067|P2|COMPLETED|Overall Study||167
332140|NCT01410474|797068|P1|COMPLETED|Overall Study||173
332141|NCT01410474|797067|P2|STARTED|Overall Study||168
332142|NCT01410474|797068|P1|STARTED|Overall Study||173
332143|NCT01410448|797091|P2|NOT COMPLETED|Overall Study||35
332144|NCT01410448|797092|P1|NOT COMPLETED|Overall Study||12
332145|NCT01410448|797091|P2|COMPLETED|Overall Study||155
332146|NCT01410448|797092|P1|COMPLETED|Overall Study||181
332147|NCT01410448|797091|P2|Modified ITT Analysis Set|Overall Study||149
332148|NCT01410448|797092|P1|Modified ITT Analysis Set|Overall Study||161
332149|NCT01410448|797091|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
332150|NCT01410448|797092|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
332151|NCT01410448|797091|P2|STARTED|Overall Study||190
332152|NCT01410448|797092|P1|STARTED|Overall Study||193
332153|NCT01410409|797132|P2|NOT COMPLETED|Overall Study||4
332154|NCT01410409|797133|P1|NOT COMPLETED|Overall Study||1
332155|NCT01410409|797132|P2|COMPLETED|Overall Study||46
332156|NCT01410409|797133|P1|COMPLETED|Overall Study||49
332157|NCT01410409|797132|P2|STARTED|Overall Study||50
332158|NCT01410409|797133|P1|STARTED|Overall Study||50
332159|NCT01410240|797158|P3|NOT COMPLETED|Overall Study||2
332160|NCT01410240|797159|P2|NOT COMPLETED|Overall Study||1
332161|NCT01410240|797160|P1|NOT COMPLETED|Overall Study||1
332162|NCT01410240|797158|P3|COMPLETED|Overall Study||10
332163|NCT01410240|797159|P2|COMPLETED|Overall Study||52
332164|NCT01410240|797160|P1|COMPLETED|Overall Study||52
332165|NCT01410240|797158|P3|STARTED|Overall Study||12
332166|NCT01410240|797159|P2|STARTED|Overall Study||53
332167|NCT01410240|797160|P1|STARTED|Overall Study||53
332168|NCT01410227|797231|P4|NOT COMPLETED|Overall Study||1
332169|NCT01410227|797232|P3|NOT COMPLETED|Overall Study||2
332170|NCT01410227|797233|P2|NOT COMPLETED|Overall Study||0
332171|NCT01410227|797234|P1|NOT COMPLETED|Overall Study||4
332172|NCT01410227|797231|P4|COMPLETED|Overall Study||5
332173|NCT01410227|797232|P3|COMPLETED|Overall Study||13
332174|NCT01410227|797233|P2|COMPLETED|Overall Study||8
332175|NCT01410227|797234|P1|COMPLETED|Overall Study||4
332176|NCT01410227|797231|P4|STARTED|Overall Study||6
332177|NCT01410227|797232|P3|STARTED|Overall Study||15
332178|NCT01410227|797233|P2|STARTED|Overall Study||8
332179|NCT01410227|797234|P1|STARTED|Overall Study||8
332180|NCT01410110|797306|P2|NOT COMPLETED|Overall Study||2
332181|NCT01410110|797307|P1|NOT COMPLETED|Overall Study||4
332182|NCT01410110|797306|P2|COMPLETED|Overall Study||22
332183|NCT01410110|797307|P1|COMPLETED|Overall Study||20
332184|NCT01410110|797306|P2|6 Month Follow-up|Overall Study||22
332185|NCT01410110|797307|P1|6 Month Follow-up|Overall Study||20
332186|NCT01410110|797306|P2|3 Months (End of Intervention)|Overall Study||22
332187|NCT01410110|797307|P1|3 Months (End of Intervention)|Overall Study||20
332188|NCT01410110|797306|P2|Randomization|Overall Study||24
332189|NCT01410110|797307|P1|Randomization|Overall Study||24
332190|NCT01410110|797306|P2|STARTED|Overall Study||24
332191|NCT01410110|797307|P1|STARTED|Overall Study||24
332192|NCT01409993|797331|P4|NOT COMPLETED|Overall Study||5
332193|NCT01409993|797332|P3|NOT COMPLETED|Overall Study||3
332194|NCT01409993|797333|P2|NOT COMPLETED|Overall Study||5
332195|NCT01409993|797334|P1|NOT COMPLETED|Overall Study||4
332196|NCT01409993|797331|P4|COMPLETED|Overall Study||8
332197|NCT01409993|797332|P3|COMPLETED|Overall Study||11
332198|NCT01409993|797333|P2|COMPLETED|Overall Study||21
332199|NCT01409993|797334|P1|COMPLETED|Overall Study||21
332200|NCT01409993|797331|P4|STARTED|Overall Study||13
332201|NCT01409993|797332|P3|STARTED|Overall Study||14
332202|NCT01409993|797333|P2|STARTED|Overall Study||26
332203|NCT01409993|797334|P1|STARTED|Overall Study||25
332204|NCT01409837|797354|P2|NOT COMPLETED|Overall Study||2
332205|NCT01409837|797355|P1|NOT COMPLETED|Overall Study||3
332206|NCT01409837|797354|P2|COMPLETED|Overall Study||14
332207|NCT01409837|797355|P1|COMPLETED|Overall Study||14
332208|NCT01409837|797354|P2|282nd Week|Overall Study||14
332209|NCT01409837|797355|P1|282nd Week|Overall Study||14
332210|NCT01409837|797354|P2|186th Week|Overall Study||14
332211|NCT01409837|797355|P1|186th Week|Overall Study|Moved away to another location|14
332212|NCT01409837|797354|P2|138th Week|Overall Study||14
332213|NCT01409837|797355|P1|138th Week|Overall Study||15
332214|NCT01409837|797354|P2|114th Week|Overall Study||14
332215|NCT01409837|797355|P1|114th Week|Overall Study||15
332216|NCT01409837|797354|P2|102nd Week|Overall Study|Married another wife|14
332217|NCT01409837|797355|P1|102nd Week|Overall Study||15
332218|NCT01409837|797354|P2|96th Week|Overall Study||15
332219|NCT01409837|797355|P1|96th Week|Overall Study||15
332220|NCT01409837|797354|P2|48th Week|Overall Study||15
332221|NCT01409837|797355|P1|48th Week|Overall Study|Lost to follow-up|15
332222|NCT01409837|797354|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
332223|NCT01409837|797355|P1|24th Week|Overall Study||16
332224|NCT01409837|797354|P2|12th Week|Overall Study||16
332225|NCT01409837|797355|P1|12th Week|Overall Study|Moved away to another location|16
332226|NCT01409837|797354|P2|6th Week|Overall Study||16
332227|NCT01409837|797355|P1|6th Week|Overall Study||17
332228|NCT01409837|797354|P2|STARTED|Overall Study||16
332229|NCT01409837|797355|P1|STARTED|Overall Study||17
332230|NCT01409707|797380|P3|NOT COMPLETED|Overall Study||16
332231|NCT01409707|797381|P2|NOT COMPLETED|Overall Study||17
332232|NCT01409707|797382|P1|NOT COMPLETED|Overall Study||5
332233|NCT01409707|797380|P3|COMPLETED|Overall Study||24
332234|NCT01409707|797381|P2|COMPLETED|Overall Study||28
332235|NCT01409707|797382|P1|COMPLETED|Overall Study||36
332236|NCT01409707|797380|P3|STARTED|Overall Study||40
332237|NCT01409707|797381|P2|STARTED|Overall Study||45
332238|NCT01409707|797382|P1|STARTED|Overall Study||41
332239|NCT01409564|797394|P2|NOT COMPLETED|Overall Study||5
332240|NCT01409564|797395|P1|NOT COMPLETED|Overall Study||5
332241|NCT01409564|797394|P2|COMPLETED|Overall Study||18
332242|NCT01409564|797395|P1|COMPLETED|Overall Study||18
332243|NCT01409564|797394|P2|STARTED|Overall Study||23
332244|NCT01409564|797395|P1|STARTED|Overall Study||23
332245|NCT01409434|797413|P1|NOT COMPLETED|Overall Study||4
332246|NCT01409434|797413|P1|COMPLETED|Overall Study||40
332247|NCT01409434|797413|P1|STARTED|Overall Study||44
332248|NCT01409382|797423|P2|NOT COMPLETED|Overall Study||80
332249|NCT01409382|797424|P1|NOT COMPLETED|Overall Study||81
332250|NCT01409382|797423|P2|COMPLETED|Overall Study||160
332251|NCT01409382|797424|P1|COMPLETED|Overall Study||159
332252|NCT01409382|797423|P2|STARTED|Overall Study||240
332253|NCT01409382|797424|P1|STARTED|Overall Study||240
332254|NCT01409291|797438|P2|NOT COMPLETED|Overall Study||9
332255|NCT01409291|797439|P1|NOT COMPLETED|Overall Study||7
332256|NCT01409291|797438|P2|COMPLETED|Overall Study||19
332257|NCT01409291|797439|P1|COMPLETED|Overall Study||29
332258|NCT01409291|797438|P2|STARTED|Overall Study||28
332259|NCT01409291|797439|P1|STARTED|Overall Study||36
332260|NCT01409239|797449|P2|NOT COMPLETED|Overall Study||0
332261|NCT01409239|797450|P1|NOT COMPLETED|Overall Study||0
332262|NCT01409239|797449|P2|COMPLETED|Overall Study||17
332263|NCT01409239|797450|P1|COMPLETED|Overall Study||16
332264|NCT01409239|797449|P2|STARTED|Overall Study||17
332265|NCT01409239|797450|P1|STARTED|Overall Study||16
332266|NCT01409213|797456|P1|NOT COMPLETED|Overall Study||0
332267|NCT01409213|797456|P1|COMPLETED|Overall Study||1523
332268|NCT01409213|797456|P1|STARTED|Overall Study||1523
332269|NCT01409096|797463|P2|NOT COMPLETED|Overall Study||5
332270|NCT01409096|797464|P1|NOT COMPLETED|Overall Study||2
332271|NCT01409096|797463|P2|COMPLETED|Overall Study||35
332272|NCT01409096|797464|P1|COMPLETED|Overall Study||38
332273|NCT01409096|797463|P2|STARTED|Overall Study||40
332274|NCT01409096|797464|P1|STARTED|Overall Study||40
332275|NCT01408992|797476|P1|NOT COMPLETED|Overall Study||0
332276|NCT01408992|797476|P1|COMPLETED|Overall Study||558
332277|NCT01408992|797476|P1|STARTED|Overall Study||558
332278|NCT01408888|797488|P2|NOT COMPLETED|Second Intervention||0
332279|NCT01408888|797489|P1|NOT COMPLETED|Second Intervention||2
332280|NCT01408888|797488|P2|COMPLETED|Second Intervention||8
332281|NCT01408888|797489|P1|COMPLETED|Second Intervention||16
332282|NCT01408888|797488|P2|STARTED|Second Intervention||8
332283|NCT01408888|797489|P1|STARTED|Second Intervention||18
332284|NCT01408888|797488|P2|NOT COMPLETED|Washout of at Least 21 Days||0
332285|NCT01408888|797489|P1|NOT COMPLETED|Washout of at Least 21 Days||0
332286|NCT01408888|797488|P2|COMPLETED|Washout of at Least 21 Days||8
332287|NCT01408888|797489|P1|COMPLETED|Washout of at Least 21 Days||18
332288|NCT01408888|797488|P2|STARTED|Washout of at Least 21 Days||8
332289|NCT01408888|797489|P1|STARTED|Washout of at Least 21 Days||18
332290|NCT01408888|797488|P2|NOT COMPLETED|First Intervention||3
332291|NCT01408888|797489|P1|NOT COMPLETED|First Intervention||0
332292|NCT01408888|797488|P2|COMPLETED|First Intervention||8
332293|NCT01408888|797489|P1|COMPLETED|First Intervention||18
332294|NCT01408888|797488|P2|Received at Least 1 Dose of Drug|First Intervention||11
332295|NCT01408888|797489|P1|Received at Least 1 Dose of Drug|First Intervention||18
332296|NCT01408888|797488|P2|STARTED|First Intervention||11
332297|NCT01408888|797489|P1|STARTED|First Intervention||18
332298|NCT01408862|797512|P1|NOT COMPLETED|Overall Study||0
332299|NCT01408862|797512|P1|COMPLETED|Overall Study||20
332300|NCT01408862|797512|P1|STARTED|Overall Study||20
332301|NCT01408719|797537|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
332302|NCT01408719|797538|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
332303|NCT01408719|797539|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
332304|NCT01408719|797540|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
332305|NCT01408719|797541|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
332306|NCT01408719|797542|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
332307|NCT01408719|797543|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
332308|NCT01408719|797544|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
332309|NCT01408719|797545|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
332310|NCT01408719|797546|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
332311|NCT01408719|797547|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
332312|NCT01408719|797548|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
332313|NCT01408719|797549|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
332314|NCT01408719|797550|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
332315|NCT01408719|797551|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
332316|NCT01408719|797552|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
332317|NCT01408719|797553|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
332318|NCT01408719|797554|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
332319|NCT01408719|797555|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
332320|NCT01408719|797556|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
332321|NCT01408719|797537|P20|COMPLETED|Fourth Intervention (35 Days)||1
332322|NCT01408719|797538|P19|COMPLETED|Fourth Intervention (35 Days)||0
332323|NCT01408719|797539|P18|COMPLETED|Fourth Intervention (35 Days)||2
332324|NCT01408719|797540|P17|COMPLETED|Fourth Intervention (35 Days)||2
332325|NCT01408719|797541|P16|COMPLETED|Fourth Intervention (35 Days)||1
332326|NCT01408719|797542|P15|COMPLETED|Fourth Intervention (35 Days)||1
332327|NCT01408719|797543|P14|COMPLETED|Fourth Intervention (35 Days)||3
332328|NCT01408719|797544|P13|COMPLETED|Fourth Intervention (35 Days)||1
332329|NCT01408719|797545|P12|COMPLETED|Fourth Intervention (35 Days)||2
332330|NCT01408719|797546|P11|COMPLETED|Fourth Intervention (35 Days)||2
332331|NCT01408719|797547|P10|COMPLETED|Fourth Intervention (35 Days)||1
332332|NCT01408719|797548|P9|COMPLETED|Fourth Intervention (35 Days)||1
332333|NCT01408719|797549|P8|COMPLETED|Fourth Intervention (35 Days)||2
332334|NCT01408719|797550|P7|COMPLETED|Fourth Intervention (35 Days)||2
332335|NCT01408719|797551|P6|COMPLETED|Fourth Intervention (35 Days)||3
332336|NCT01408719|797552|P5|COMPLETED|Fourth Intervention (35 Days)||3
332337|NCT01408719|797553|P4|COMPLETED|Fourth Intervention (35 Days)||2
332338|NCT01408719|797554|P3|COMPLETED|Fourth Intervention (35 Days)||1
332339|NCT01408719|797555|P2|COMPLETED|Fourth Intervention (35 Days)||3
332340|NCT01408719|797556|P1|COMPLETED|Fourth Intervention (35 Days)||2
332341|NCT01408719|797537|P20|STARTED|Fourth Intervention (35 Days)||1
332342|NCT01408719|797538|P19|STARTED|Fourth Intervention (35 Days)||0
332343|NCT01408719|797539|P18|STARTED|Fourth Intervention (35 Days)||2
332344|NCT01408719|797540|P17|STARTED|Fourth Intervention (35 Days)||2
332345|NCT01408719|797541|P16|STARTED|Fourth Intervention (35 Days)||1
332346|NCT01408719|797542|P15|STARTED|Fourth Intervention (35 Days)||1
332347|NCT01408719|797543|P14|STARTED|Fourth Intervention (35 Days)||3
332348|NCT01408719|797544|P13|STARTED|Fourth Intervention (35 Days)||1
332349|NCT01408719|797545|P12|STARTED|Fourth Intervention (35 Days)||2
332350|NCT01408719|797546|P11|STARTED|Fourth Intervention (35 Days)||2
332351|NCT01408719|797547|P10|STARTED|Fourth Intervention (35 Days)||1
332352|NCT01408719|797548|P9|STARTED|Fourth Intervention (35 Days)||1
332353|NCT01408719|797549|P8|STARTED|Fourth Intervention (35 Days)||2
332354|NCT01408719|797550|P7|STARTED|Fourth Intervention (35 Days)||2
332355|NCT01408719|797551|P6|STARTED|Fourth Intervention (35 Days)||3
332356|NCT01408719|797552|P5|STARTED|Fourth Intervention (35 Days)||3
332357|NCT01408719|797553|P4|STARTED|Fourth Intervention (35 Days)||2
332358|NCT01408719|797554|P3|STARTED|Fourth Intervention (35 Days)||1
332359|NCT01408719|797555|P2|STARTED|Fourth Intervention (35 Days)||3
332360|NCT01408719|797556|P1|STARTED|Fourth Intervention (35 Days)||2
332361|NCT01408719|797537|P20|NOT COMPLETED|Washout Period (28 Days)||0
332362|NCT01408719|797538|P19|NOT COMPLETED|Washout Period (28 Days)||0
332363|NCT01408719|797539|P18|NOT COMPLETED|Washout Period (28 Days)||0
332364|NCT01408719|797540|P17|NOT COMPLETED|Washout Period (28 Days)||0
332365|NCT01408719|797541|P16|NOT COMPLETED|Washout Period (28 Days)||0
332366|NCT01408719|797542|P15|NOT COMPLETED|Washout Period (28 Days)||0
332367|NCT01408719|797543|P14|NOT COMPLETED|Washout Period (28 Days)||0
332368|NCT01408719|797544|P13|NOT COMPLETED|Washout Period (28 Days)||0
332369|NCT01408719|797545|P12|NOT COMPLETED|Washout Period (28 Days)||0
332370|NCT01408719|797546|P11|NOT COMPLETED|Washout Period (28 Days)||0
332371|NCT01408719|797547|P10|NOT COMPLETED|Washout Period (28 Days)||0
332372|NCT01408719|797548|P9|NOT COMPLETED|Washout Period (28 Days)||0
332373|NCT01408719|797549|P8|NOT COMPLETED|Washout Period (28 Days)||0
332374|NCT01408719|797550|P7|NOT COMPLETED|Washout Period (28 Days)||0
332375|NCT01408719|797551|P6|NOT COMPLETED|Washout Period (28 Days)||0
332376|NCT01408719|797552|P5|NOT COMPLETED|Washout Period (28 Days)||0
332377|NCT01408719|797553|P4|NOT COMPLETED|Washout Period (28 Days)||0
332378|NCT01408719|797554|P3|NOT COMPLETED|Washout Period (28 Days)||0
332379|NCT01408719|797555|P2|NOT COMPLETED|Washout Period (28 Days)||0
332380|NCT01408719|797556|P1|NOT COMPLETED|Washout Period (28 Days)||0
332381|NCT01408719|797537|P20|COMPLETED|Washout Period (28 Days)||1
332382|NCT01408719|797538|P19|COMPLETED|Washout Period (28 Days)||0
332383|NCT01408719|797539|P18|COMPLETED|Washout Period (28 Days)||2
332384|NCT01408719|797540|P17|COMPLETED|Washout Period (28 Days)||2
332385|NCT01408719|797541|P16|COMPLETED|Washout Period (28 Days)||1
332386|NCT01408719|797542|P15|COMPLETED|Washout Period (28 Days)||1
332387|NCT01408719|797543|P14|COMPLETED|Washout Period (28 Days)||3
332388|NCT01408719|797544|P13|COMPLETED|Washout Period (28 Days)||1
332389|NCT01408719|797545|P12|COMPLETED|Washout Period (28 Days)||2
332390|NCT01408719|797546|P11|COMPLETED|Washout Period (28 Days)||2
332391|NCT01408719|797547|P10|COMPLETED|Washout Period (28 Days)||1
332392|NCT01408719|797548|P9|COMPLETED|Washout Period (28 Days)||1
332393|NCT01408719|797549|P8|COMPLETED|Washout Period (28 Days)||2
332394|NCT01408719|797550|P7|COMPLETED|Washout Period (28 Days)||2
332395|NCT01408719|797551|P6|COMPLETED|Washout Period (28 Days)||3
332396|NCT01408719|797552|P5|COMPLETED|Washout Period (28 Days)||3
332397|NCT01408719|797553|P4|COMPLETED|Washout Period (28 Days)||2
332398|NCT01408719|797554|P3|COMPLETED|Washout Period (28 Days)||1
332399|NCT01408719|797555|P2|COMPLETED|Washout Period (28 Days)||3
332400|NCT01408719|797556|P1|COMPLETED|Washout Period (28 Days)||2
332401|NCT01408719|797537|P20|STARTED|Washout Period (28 Days)||1
332402|NCT01408719|797538|P19|STARTED|Washout Period (28 Days)||0
332403|NCT01408719|797539|P18|STARTED|Washout Period (28 Days)||2
332404|NCT01408719|797540|P17|STARTED|Washout Period (28 Days)||2
332405|NCT01408719|797541|P16|STARTED|Washout Period (28 Days)||1
332406|NCT01408719|797542|P15|STARTED|Washout Period (28 Days)||1
332407|NCT01408719|797543|P14|STARTED|Washout Period (28 Days)||3
332408|NCT01408719|797544|P13|STARTED|Washout Period (28 Days)||1
332409|NCT01408719|797545|P12|STARTED|Washout Period (28 Days)||2
332410|NCT01408719|797546|P11|STARTED|Washout Period (28 Days)||2
332411|NCT01408719|797547|P10|STARTED|Washout Period (28 Days)||1
332412|NCT01408719|797548|P9|STARTED|Washout Period (28 Days)||1
332413|NCT01408719|797549|P8|STARTED|Washout Period (28 Days)||2
332414|NCT01408719|797550|P7|STARTED|Washout Period (28 Days)||2
332415|NCT01408719|797551|P6|STARTED|Washout Period (28 Days)||3
332416|NCT01408719|797552|P5|STARTED|Washout Period (28 Days)||3
332417|NCT01408719|797553|P4|STARTED|Washout Period (28 Days)||2
332418|NCT01408719|797554|P3|STARTED|Washout Period (28 Days)||1
332419|NCT01408719|797555|P2|STARTED|Washout Period (28 Days)||3
332420|NCT01408719|797556|P1|STARTED|Washout Period (28 Days)||2
332421|NCT01408719|797537|P20|NOT COMPLETED|Third Intervention (35 Days)||0
332422|NCT01408719|797538|P19|NOT COMPLETED|Third Intervention (35 Days)||0
332423|NCT01408719|797539|P18|NOT COMPLETED|Third Intervention (35 Days)||0
332424|NCT01408719|797540|P17|NOT COMPLETED|Third Intervention (35 Days)||0
332425|NCT01408719|797541|P16|NOT COMPLETED|Third Intervention (35 Days)||0
332426|NCT01408719|797542|P15|NOT COMPLETED|Third Intervention (35 Days)||0
332427|NCT01408719|797543|P14|NOT COMPLETED|Third Intervention (35 Days)||0
332428|NCT01408719|797544|P13|NOT COMPLETED|Third Intervention (35 Days)||0
332429|NCT01408719|797545|P12|NOT COMPLETED|Third Intervention (35 Days)||0
332430|NCT01408719|797546|P11|NOT COMPLETED|Third Intervention (35 Days)||0
332431|NCT01408719|797547|P10|NOT COMPLETED|Third Intervention (35 Days)||0
332432|NCT01408719|797548|P9|NOT COMPLETED|Third Intervention (35 Days)||0
332433|NCT01408719|797549|P8|NOT COMPLETED|Third Intervention (35 Days)||1
332434|NCT01408719|797550|P7|NOT COMPLETED|Third Intervention (35 Days)||0
332435|NCT01408719|797551|P6|NOT COMPLETED|Third Intervention (35 Days)||0
332436|NCT01408719|797552|P5|NOT COMPLETED|Third Intervention (35 Days)||0
332437|NCT01408719|797553|P4|NOT COMPLETED|Third Intervention (35 Days)||0
332438|NCT01408719|797554|P3|NOT COMPLETED|Third Intervention (35 Days)||0
332439|NCT01408719|797555|P2|NOT COMPLETED|Third Intervention (35 Days)||0
332440|NCT01408719|797556|P1|NOT COMPLETED|Third Intervention (35 Days)||0
332441|NCT01408719|797537|P20|COMPLETED|Third Intervention (35 Days)||1
332442|NCT01408719|797538|P19|COMPLETED|Third Intervention (35 Days)||0
332443|NCT01408719|797539|P18|COMPLETED|Third Intervention (35 Days)||2
332444|NCT01408719|797540|P17|COMPLETED|Third Intervention (35 Days)||2
332445|NCT01408719|797541|P16|COMPLETED|Third Intervention (35 Days)||1
332446|NCT01408719|797542|P15|COMPLETED|Third Intervention (35 Days)||1
332447|NCT01408719|797543|P14|COMPLETED|Third Intervention (35 Days)||3
332448|NCT01408719|797544|P13|COMPLETED|Third Intervention (35 Days)||2
332449|NCT01408719|797545|P12|COMPLETED|Third Intervention (35 Days)||2
332450|NCT01408719|797546|P11|COMPLETED|Third Intervention (35 Days)||2
332451|NCT01408719|797547|P10|COMPLETED|Third Intervention (35 Days)||1
332452|NCT01408719|797548|P9|COMPLETED|Third Intervention (35 Days)||1
332453|NCT01408719|797549|P8|COMPLETED|Third Intervention (35 Days)||2
332454|NCT01408719|797550|P7|COMPLETED|Third Intervention (35 Days)||2
332455|NCT01408719|797551|P6|COMPLETED|Third Intervention (35 Days)||3
332456|NCT01408719|797552|P5|COMPLETED|Third Intervention (35 Days)||3
332457|NCT01408719|797553|P4|COMPLETED|Third Intervention (35 Days)||2
332458|NCT01408719|797554|P3|COMPLETED|Third Intervention (35 Days)||1
332459|NCT01408719|797555|P2|COMPLETED|Third Intervention (35 Days)||3
332460|NCT01408719|797556|P1|COMPLETED|Third Intervention (35 Days)||2
332461|NCT01408719|797537|P20|STARTED|Third Intervention (35 Days)||1
332462|NCT01408719|797538|P19|STARTED|Third Intervention (35 Days)||0
332463|NCT01408719|797539|P18|STARTED|Third Intervention (35 Days)||2
332464|NCT01408719|797540|P17|STARTED|Third Intervention (35 Days)||2
332465|NCT01408719|797541|P16|STARTED|Third Intervention (35 Days)||1
332466|NCT01408719|797542|P15|STARTED|Third Intervention (35 Days)||1
332467|NCT01408719|797543|P14|STARTED|Third Intervention (35 Days)||3
332468|NCT01408719|797544|P13|STARTED|Third Intervention (35 Days)||2
332469|NCT01408719|797545|P12|STARTED|Third Intervention (35 Days)||2
332470|NCT01408719|797546|P11|STARTED|Third Intervention (35 Days)||2
332471|NCT01408719|797547|P10|STARTED|Third Intervention (35 Days)||1
332472|NCT01408719|797548|P9|STARTED|Third Intervention (35 Days)||1
332473|NCT01408719|797549|P8|STARTED|Third Intervention (35 Days)||3
332474|NCT01408719|797550|P7|STARTED|Third Intervention (35 Days)||2
332475|NCT01408719|797551|P6|STARTED|Third Intervention (35 Days)||3
332476|NCT01408719|797552|P5|STARTED|Third Intervention (35 Days)||3
332477|NCT01408719|797553|P4|STARTED|Third Intervention (35 Days)||2
332478|NCT01408719|797554|P3|STARTED|Third Intervention (35 Days)||1
332479|NCT01408719|797555|P2|STARTED|Third Intervention (35 Days)||3
332480|NCT01408719|797556|P1|STARTED|Third Intervention (35 Days)||2
332481|NCT01408719|797537|P20|NOT COMPLETED|Washout Period (28 Days)||0
332482|NCT01408719|797538|P19|NOT COMPLETED|Washout Period (28 Days)||0
332483|NCT01408719|797539|P18|NOT COMPLETED|Washout Period (28 Days)||0
332484|NCT01408719|797540|P17|NOT COMPLETED|Washout Period (28 Days)||0
332485|NCT01408719|797541|P16|NOT COMPLETED|Washout Period (28 Days)||0
332486|NCT01408719|797542|P15|NOT COMPLETED|Washout Period (28 Days)||0
332487|NCT01408719|797543|P14|NOT COMPLETED|Washout Period (28 Days)||0
332488|NCT01408719|797544|P13|NOT COMPLETED|Washout Period (28 Days)||0
332489|NCT01408719|797545|P12|NOT COMPLETED|Washout Period (28 Days)||0
332490|NCT01408719|797546|P11|NOT COMPLETED|Washout Period (28 Days)||0
332491|NCT01408719|797547|P10|NOT COMPLETED|Washout Period (28 Days)||0
332492|NCT01408719|797548|P9|NOT COMPLETED|Washout Period (28 Days)||0
332493|NCT01408719|797549|P8|NOT COMPLETED|Washout Period (28 Days)||0
332494|NCT01408719|797550|P7|NOT COMPLETED|Washout Period (28 Days)||0
332495|NCT01408719|797551|P6|NOT COMPLETED|Washout Period (28 Days)||0
332496|NCT01408719|797552|P5|NOT COMPLETED|Washout Period (28 Days)||0
332497|NCT01408719|797553|P4|NOT COMPLETED|Washout Period (28 Days)||0
332498|NCT01408719|797554|P3|NOT COMPLETED|Washout Period (28 Days)||0
332499|NCT01408719|797555|P2|NOT COMPLETED|Washout Period (28 Days)||0
332500|NCT01408719|797556|P1|NOT COMPLETED|Washout Period (28 Days)||0
332501|NCT01408719|797537|P20|COMPLETED|Washout Period (28 Days)||1
332502|NCT01408719|797538|P19|COMPLETED|Washout Period (28 Days)||0
332503|NCT01408719|797539|P18|COMPLETED|Washout Period (28 Days)||2
332504|NCT01408719|797540|P17|COMPLETED|Washout Period (28 Days)||2
332505|NCT01408719|797541|P16|COMPLETED|Washout Period (28 Days)||1
332506|NCT01408719|797542|P15|COMPLETED|Washout Period (28 Days)||1
332507|NCT01408719|797543|P14|COMPLETED|Washout Period (28 Days)||3
332508|NCT01408719|797544|P13|COMPLETED|Washout Period (28 Days)||2
332509|NCT01408719|797545|P12|COMPLETED|Washout Period (28 Days)||2
332510|NCT01408719|797546|P11|COMPLETED|Washout Period (28 Days)||2
332511|NCT01408719|797547|P10|COMPLETED|Washout Period (28 Days)||1
332512|NCT01408719|797548|P9|COMPLETED|Washout Period (28 Days)||1
332513|NCT01408719|797549|P8|COMPLETED|Washout Period (28 Days)||3
332514|NCT01408719|797550|P7|COMPLETED|Washout Period (28 Days)||2
332515|NCT01408719|797551|P6|COMPLETED|Washout Period (28 Days)||3
332516|NCT01408719|797552|P5|COMPLETED|Washout Period (28 Days)||3
332517|NCT01408719|797553|P4|COMPLETED|Washout Period (28 Days)||2
332518|NCT01408719|797554|P3|COMPLETED|Washout Period (28 Days)||1
332519|NCT01408719|797555|P2|COMPLETED|Washout Period (28 Days)||3
332520|NCT01408719|797556|P1|COMPLETED|Washout Period (28 Days)||2
332521|NCT01408719|797537|P20|STARTED|Washout Period (28 Days)||1
332522|NCT01408719|797538|P19|STARTED|Washout Period (28 Days)||0
332523|NCT01408719|797539|P18|STARTED|Washout Period (28 Days)||2
332524|NCT01408719|797540|P17|STARTED|Washout Period (28 Days)||2
332525|NCT01408719|797541|P16|STARTED|Washout Period (28 Days)||1
332526|NCT01408719|797542|P15|STARTED|Washout Period (28 Days)||1
332527|NCT01408719|797543|P14|STARTED|Washout Period (28 Days)||3
332528|NCT01408719|797544|P13|STARTED|Washout Period (28 Days)||2
332529|NCT01408719|797545|P12|STARTED|Washout Period (28 Days)||2
332530|NCT01408719|797546|P11|STARTED|Washout Period (28 Days)||2
332531|NCT01408719|797547|P10|STARTED|Washout Period (28 Days)||1
332532|NCT01408719|797548|P9|STARTED|Washout Period (28 Days)||1
332533|NCT01408719|797549|P8|STARTED|Washout Period (28 Days)||3
332534|NCT01408719|797550|P7|STARTED|Washout Period (28 Days)||2
332535|NCT01408719|797551|P6|STARTED|Washout Period (28 Days)||3
332536|NCT01408719|797552|P5|STARTED|Washout Period (28 Days)||3
332537|NCT01408719|797553|P4|STARTED|Washout Period (28 Days)||2
332538|NCT01408719|797554|P3|STARTED|Washout Period (28 Days)||1
332539|NCT01408719|797555|P2|STARTED|Washout Period (28 Days)||3
332540|NCT01408719|797556|P1|STARTED|Washout Period (28 Days)||2
332541|NCT01408719|797537|P20|NOT COMPLETED|Second Intervention (35 Days)||0
332542|NCT01408719|797538|P19|NOT COMPLETED|Second Intervention (35 Days)||0
332543|NCT01408719|797539|P18|NOT COMPLETED|Second Intervention (35 Days)||0
332544|NCT01408719|797540|P17|NOT COMPLETED|Second Intervention (35 Days)||0
332545|NCT01408719|797541|P16|NOT COMPLETED|Second Intervention (35 Days)||0
332546|NCT01408719|797542|P15|NOT COMPLETED|Second Intervention (35 Days)||0
332547|NCT01408719|797543|P14|NOT COMPLETED|Second Intervention (35 Days)||1
332548|NCT01408719|797544|P13|NOT COMPLETED|Second Intervention (35 Days)||0
332549|NCT01408719|797545|P12|NOT COMPLETED|Second Intervention (35 Days)||0
332550|NCT01408719|797546|P11|NOT COMPLETED|Second Intervention (35 Days)||0
332551|NCT01408719|797547|P10|NOT COMPLETED|Second Intervention (35 Days)||0
332552|NCT01408719|797548|P9|NOT COMPLETED|Second Intervention (35 Days)||0
332553|NCT01408719|797549|P8|NOT COMPLETED|Second Intervention (35 Days)||0
332554|NCT01408719|797550|P7|NOT COMPLETED|Second Intervention (35 Days)||0
332555|NCT01408719|797551|P6|NOT COMPLETED|Second Intervention (35 Days)||0
332556|NCT01408719|797552|P5|NOT COMPLETED|Second Intervention (35 Days)||0
332557|NCT01408719|797553|P4|NOT COMPLETED|Second Intervention (35 Days)||0
332558|NCT01408719|797554|P3|NOT COMPLETED|Second Intervention (35 Days)||0
332559|NCT01408719|797555|P2|NOT COMPLETED|Second Intervention (35 Days)||0
332560|NCT01408719|797556|P1|NOT COMPLETED|Second Intervention (35 Days)||0
332561|NCT01408719|797537|P20|COMPLETED|Second Intervention (35 Days)||1
332562|NCT01408719|797538|P19|COMPLETED|Second Intervention (35 Days)||0
332563|NCT01408719|797539|P18|COMPLETED|Second Intervention (35 Days)||2
332564|NCT01408719|797540|P17|COMPLETED|Second Intervention (35 Days)||2
332565|NCT01408719|797541|P16|COMPLETED|Second Intervention (35 Days)||2
332566|NCT01408719|797542|P15|COMPLETED|Second Intervention (35 Days)||1
332567|NCT01408719|797543|P14|COMPLETED|Second Intervention (35 Days)||3
332568|NCT01408719|797544|P13|COMPLETED|Second Intervention (35 Days)||2
332569|NCT01408719|797545|P12|COMPLETED|Second Intervention (35 Days)||2
332570|NCT01408719|797546|P11|COMPLETED|Second Intervention (35 Days)||2
332571|NCT01408719|797547|P10|COMPLETED|Second Intervention (35 Days)||1
332572|NCT01408719|797548|P9|COMPLETED|Second Intervention (35 Days)||1
332573|NCT01408719|797549|P8|COMPLETED|Second Intervention (35 Days)||3
332574|NCT01408719|797550|P7|COMPLETED|Second Intervention (35 Days)||2
332575|NCT01408719|797551|P6|COMPLETED|Second Intervention (35 Days)||3
332576|NCT01408719|797552|P5|COMPLETED|Second Intervention (35 Days)||3
332577|NCT01408719|797553|P4|COMPLETED|Second Intervention (35 Days)||2
332578|NCT01408719|797554|P3|COMPLETED|Second Intervention (35 Days)||1
332579|NCT01408719|797555|P2|COMPLETED|Second Intervention (35 Days)||3
332580|NCT01408719|797556|P1|COMPLETED|Second Intervention (35 Days)||2
332581|NCT01408719|797537|P20|STARTED|Second Intervention (35 Days)||1
332582|NCT01408719|797538|P19|STARTED|Second Intervention (35 Days)||0
332583|NCT01408719|797539|P18|STARTED|Second Intervention (35 Days)||2
332584|NCT01408719|797540|P17|STARTED|Second Intervention (35 Days)||2
332585|NCT01408719|797541|P16|STARTED|Second Intervention (35 Days)||2
332586|NCT01408719|797542|P15|STARTED|Second Intervention (35 Days)||1
332587|NCT01408719|797543|P14|STARTED|Second Intervention (35 Days)||4
332588|NCT01408719|797544|P13|STARTED|Second Intervention (35 Days)||2
332589|NCT01408719|797545|P12|STARTED|Second Intervention (35 Days)||2
332590|NCT01408719|797546|P11|STARTED|Second Intervention (35 Days)||2
332591|NCT01408719|797547|P10|STARTED|Second Intervention (35 Days)||1
332592|NCT01408719|797548|P9|STARTED|Second Intervention (35 Days)||1
332593|NCT01408719|797549|P8|STARTED|Second Intervention (35 Days)||3
332594|NCT01408719|797550|P7|STARTED|Second Intervention (35 Days)||2
332595|NCT01408719|797551|P6|STARTED|Second Intervention (35 Days)||3
332596|NCT01408719|797552|P5|STARTED|Second Intervention (35 Days)||3
332597|NCT01408719|797553|P4|STARTED|Second Intervention (35 Days)||2
332598|NCT01408719|797554|P3|STARTED|Second Intervention (35 Days)||1
332599|NCT01408719|797555|P2|STARTED|Second Intervention (35 Days)||3
332600|NCT01408719|797556|P1|STARTED|Second Intervention (35 Days)||2
332601|NCT01408719|797537|P20|NOT COMPLETED|Washout Period (28 Days)||0
332602|NCT01408719|797538|P19|NOT COMPLETED|Washout Period (28 Days)||0
332603|NCT01408719|797539|P18|NOT COMPLETED|Washout Period (28 Days)||0
332604|NCT01408719|797540|P17|NOT COMPLETED|Washout Period (28 Days)||0
332605|NCT01408719|797541|P16|NOT COMPLETED|Washout Period (28 Days)||0
332606|NCT01408719|797542|P15|NOT COMPLETED|Washout Period (28 Days)||0
332607|NCT01408719|797543|P14|NOT COMPLETED|Washout Period (28 Days)||0
332608|NCT01408719|797544|P13|NOT COMPLETED|Washout Period (28 Days)||0
332609|NCT01408719|797545|P12|NOT COMPLETED|Washout Period (28 Days)||0
332610|NCT01408719|797546|P11|NOT COMPLETED|Washout Period (28 Days)||0
332611|NCT01408719|797547|P10|NOT COMPLETED|Washout Period (28 Days)||0
332612|NCT01408719|797548|P9|NOT COMPLETED|Washout Period (28 Days)||0
332613|NCT01408719|797549|P8|NOT COMPLETED|Washout Period (28 Days)||0
332614|NCT01408719|797550|P7|NOT COMPLETED|Washout Period (28 Days)||0
332615|NCT01408719|797551|P6|NOT COMPLETED|Washout Period (28 Days)||0
332616|NCT01408719|797552|P5|NOT COMPLETED|Washout Period (28 Days)||0
332617|NCT01408719|797553|P4|NOT COMPLETED|Washout Period (28 Days)||0
332618|NCT01408719|797554|P3|NOT COMPLETED|Washout Period (28 Days)||0
332619|NCT01408719|797555|P2|NOT COMPLETED|Washout Period (28 Days)||0
332620|NCT01408719|797556|P1|NOT COMPLETED|Washout Period (28 Days)||0
332621|NCT01408719|797537|P20|COMPLETED|Washout Period (28 Days)||1
332622|NCT01408719|797538|P19|COMPLETED|Washout Period (28 Days)||0
332623|NCT01408719|797539|P18|COMPLETED|Washout Period (28 Days)||2
332624|NCT01408719|797540|P17|COMPLETED|Washout Period (28 Days)||2
332625|NCT01408719|797541|P16|COMPLETED|Washout Period (28 Days)||2
332626|NCT01408719|797542|P15|COMPLETED|Washout Period (28 Days)||1
332627|NCT01408719|797543|P14|COMPLETED|Washout Period (28 Days)||4
332628|NCT01408719|797544|P13|COMPLETED|Washout Period (28 Days)||2
332629|NCT01408719|797545|P12|COMPLETED|Washout Period (28 Days)||2
332630|NCT01408719|797546|P11|COMPLETED|Washout Period (28 Days)||2
332631|NCT01408719|797547|P10|COMPLETED|Washout Period (28 Days)||1
332632|NCT01408719|797548|P9|COMPLETED|Washout Period (28 Days)||1
332633|NCT01408719|797549|P8|COMPLETED|Washout Period (28 Days)||3
332634|NCT01408719|797550|P7|COMPLETED|Washout Period (28 Days)||2
332635|NCT01408719|797551|P6|COMPLETED|Washout Period (28 Days)||3
332636|NCT01408719|797552|P5|COMPLETED|Washout Period (28 Days)||3
332637|NCT01408719|797553|P4|COMPLETED|Washout Period (28 Days)||2
332638|NCT01408719|797554|P3|COMPLETED|Washout Period (28 Days)||1
332639|NCT01408719|797555|P2|COMPLETED|Washout Period (28 Days)||3
332640|NCT01408719|797556|P1|COMPLETED|Washout Period (28 Days)||2
332641|NCT01408719|797537|P20|STARTED|Washout Period (28 Days)||1
332642|NCT01408719|797538|P19|STARTED|Washout Period (28 Days)||0
332643|NCT01408719|797539|P18|STARTED|Washout Period (28 Days)||2
332644|NCT01408719|797540|P17|STARTED|Washout Period (28 Days)||2
332645|NCT01408719|797541|P16|STARTED|Washout Period (28 Days)||2
332646|NCT01408719|797542|P15|STARTED|Washout Period (28 Days)||1
332647|NCT01408719|797543|P14|STARTED|Washout Period (28 Days)||4
332648|NCT01408719|797544|P13|STARTED|Washout Period (28 Days)||2
332649|NCT01408719|797545|P12|STARTED|Washout Period (28 Days)||2
332650|NCT01408719|797546|P11|STARTED|Washout Period (28 Days)||2
332651|NCT01408719|797547|P10|STARTED|Washout Period (28 Days)||1
332652|NCT01408719|797548|P9|STARTED|Washout Period (28 Days)||1
332653|NCT01408719|797549|P8|STARTED|Washout Period (28 Days)||3
332654|NCT01408719|797550|P7|STARTED|Washout Period (28 Days)||2
332655|NCT01408719|797551|P6|STARTED|Washout Period (28 Days)||3
332656|NCT01408719|797552|P5|STARTED|Washout Period (28 Days)||3
332657|NCT01408719|797553|P4|STARTED|Washout Period (28 Days)||2
332658|NCT01408719|797554|P3|STARTED|Washout Period (28 Days)||1
332659|NCT01408719|797555|P2|STARTED|Washout Period (28 Days)||3
332660|NCT01408719|797556|P1|STARTED|Washout Period (28 Days)||2
332661|NCT01408719|797537|P20|NOT COMPLETED|First Intervention (35 Days)||0
332662|NCT01408719|797538|P19|NOT COMPLETED|First Intervention (35 Days)||1
332663|NCT01408719|797539|P18|NOT COMPLETED|First Intervention (35 Days)||0
332664|NCT01408719|797540|P17|NOT COMPLETED|First Intervention (35 Days)||1
332665|NCT01408719|797541|P16|NOT COMPLETED|First Intervention (35 Days)||0
332666|NCT01408719|797542|P15|NOT COMPLETED|First Intervention (35 Days)||0
332667|NCT01408719|797543|P14|NOT COMPLETED|First Intervention (35 Days)||1
332668|NCT01408719|797544|P13|NOT COMPLETED|First Intervention (35 Days)||0
332669|NCT01408719|797545|P12|NOT COMPLETED|First Intervention (35 Days)||0
332670|NCT01408719|797546|P11|NOT COMPLETED|First Intervention (35 Days)||0
332671|NCT01408719|797547|P10|NOT COMPLETED|First Intervention (35 Days)||0
332672|NCT01408719|797548|P9|NOT COMPLETED|First Intervention (35 Days)||1
332673|NCT01408719|797549|P8|NOT COMPLETED|First Intervention (35 Days)||0
332674|NCT01408719|797550|P7|NOT COMPLETED|First Intervention (35 Days)||0
332675|NCT01408719|797551|P6|NOT COMPLETED|First Intervention (35 Days)||0
332676|NCT01408719|797552|P5|NOT COMPLETED|First Intervention (35 Days)||1
332677|NCT01408719|797553|P4|NOT COMPLETED|First Intervention (35 Days)||0
332678|NCT01408719|797554|P3|NOT COMPLETED|First Intervention (35 Days)||1
332679|NCT01408719|797555|P2|NOT COMPLETED|First Intervention (35 Days)||0
332680|NCT01408719|797556|P1|NOT COMPLETED|First Intervention (35 Days)||0
332681|NCT01408719|797537|P20|COMPLETED|First Intervention (35 Days)||1
332682|NCT01408719|797538|P19|COMPLETED|First Intervention (35 Days)||0
332683|NCT01408719|797539|P18|COMPLETED|First Intervention (35 Days)||2
332684|NCT01408719|797540|P17|COMPLETED|First Intervention (35 Days)||2
332685|NCT01408719|797541|P16|COMPLETED|First Intervention (35 Days)||2
332686|NCT01408719|797542|P15|COMPLETED|First Intervention (35 Days)||1
332687|NCT01408719|797543|P14|COMPLETED|First Intervention (35 Days)||4
332688|NCT01408719|797544|P13|COMPLETED|First Intervention (35 Days)||2
332689|NCT01408719|797545|P12|COMPLETED|First Intervention (35 Days)||2
332690|NCT01408719|797546|P11|COMPLETED|First Intervention (35 Days)||2
332691|NCT01408719|797547|P10|COMPLETED|First Intervention (35 Days)||1
332692|NCT01408719|797548|P9|COMPLETED|First Intervention (35 Days)||1
332693|NCT01408719|797549|P8|COMPLETED|First Intervention (35 Days)||3
332694|NCT01408719|797550|P7|COMPLETED|First Intervention (35 Days)||2
332695|NCT01408719|797551|P6|COMPLETED|First Intervention (35 Days)||3
332696|NCT01408719|797552|P5|COMPLETED|First Intervention (35 Days)||3
332697|NCT01408719|797553|P4|COMPLETED|First Intervention (35 Days)||2
332698|NCT01408719|797554|P3|COMPLETED|First Intervention (35 Days)||1
332699|NCT01408719|797555|P2|COMPLETED|First Intervention (35 Days)||3
332700|NCT01408719|797556|P1|COMPLETED|First Intervention (35 Days)||2
332701|NCT01408719|797537|P20|STARTED|First Intervention (35 Days)||1
332702|NCT01408719|797538|P19|STARTED|First Intervention (35 Days)||1
332703|NCT01408719|797539|P18|STARTED|First Intervention (35 Days)||2
332704|NCT01408719|797540|P17|STARTED|First Intervention (35 Days)||3
332705|NCT01408719|797541|P16|STARTED|First Intervention (35 Days)||2
332706|NCT01408719|797542|P15|STARTED|First Intervention (35 Days)||1
332707|NCT01408719|797543|P14|STARTED|First Intervention (35 Days)||5
332708|NCT01408719|797544|P13|STARTED|First Intervention (35 Days)||2
332709|NCT01408719|797545|P12|STARTED|First Intervention (35 Days)||2
332710|NCT01408719|797546|P11|STARTED|First Intervention (35 Days)||2
332711|NCT01408719|797547|P10|STARTED|First Intervention (35 Days)||1
332712|NCT01408719|797548|P9|STARTED|First Intervention (35 Days)||2
332713|NCT01408719|797549|P8|STARTED|First Intervention (35 Days)||3
332714|NCT01408719|797550|P7|STARTED|First Intervention (35 Days)||2
332715|NCT01408719|797551|P6|STARTED|First Intervention (35 Days)||3
332716|NCT01408719|797552|P5|STARTED|First Intervention (35 Days)||4
332717|NCT01408719|797553|P4|STARTED|First Intervention (35 Days)||2
332718|NCT01408719|797554|P3|STARTED|First Intervention (35 Days)||2
332719|NCT01408719|797555|P2|STARTED|First Intervention (35 Days)||3
332720|NCT01408719|797556|P1|STARTED|First Intervention (35 Days)||2
332721|NCT01408628|797566|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
332722|NCT01408628|797566|P1|COMPLETED|Completed 6 Month Follow-Up||25
332723|NCT01408628|797566|P1|STARTED|Completed 6 Month Follow-Up||39
332724|NCT01408628|797566|P1|NOT COMPLETED|Started Classes/Intervention||0
332725|NCT01408628|797566|P1|COMPLETED|Started Classes/Intervention||39
332726|NCT01408628|797566|P1|STARTED|Started Classes/Intervention||39
332727|NCT01408628|797566|P1|NOT COMPLETED|Consented||12
332728|NCT01408628|797566|P1|COMPLETED|Consented||39
332729|NCT01408628|797566|P1|STARTED|Consented||51
332730|NCT01408537|797572|P1|NOT COMPLETED|Overall Study||8
332731|NCT01408537|797572|P1|COMPLETED|Overall Study||144
332732|NCT01408537|797572|P1|STARTED|Overall Study||152
332733|NCT01408485|797588|P1|NOT COMPLETED|Overall Study||21
332734|NCT01408485|797588|P1|COMPLETED|Overall Study||179
332735|NCT01408485|797588|P1|STARTED|Overall Study||200
332736|NCT01408329|797596|P2|NOT COMPLETED|Overall Study||4
332737|NCT01408329|797597|P1|NOT COMPLETED|Overall Study||3
332738|NCT01408329|797596|P2|COMPLETED|Overall Study||11
332739|NCT01408329|797597|P1|COMPLETED|Overall Study||10
332740|NCT01408329|797596|P2|STARTED|Overall Study||15
332741|NCT01408329|797597|P1|STARTED|Overall Study||13
332742|NCT01408303|797606|P3|NOT COMPLETED|Overall Study||6
332743|NCT01408303|797607|P2|NOT COMPLETED|Overall Study||12
332744|NCT01408303|797608|P1|NOT COMPLETED|Overall Study||6
332745|NCT01408303|797606|P3|COMPLETED|Overall Study||210
332746|NCT01408303|797607|P2|COMPLETED|Overall Study||204
332747|NCT01408303|797608|P1|COMPLETED|Overall Study||209
332748|NCT01408303|797606|P3|STARTED|Overall Study||216
332749|NCT01408303|797607|P2|STARTED|Overall Study||216
332750|NCT01408303|797608|P1|STARTED|Overall Study||215
332751|NCT01408277|797618|P2|NOT COMPLETED|Overall Study||4
332752|NCT01408277|797619|P1|NOT COMPLETED|Overall Study||8
332753|NCT01408277|797618|P2|COMPLETED|Overall Study||23
332754|NCT01408277|797619|P1|COMPLETED|Overall Study||20
332755|NCT01408277|797618|P2|STARTED|Overall Study||27
332756|NCT01408277|797619|P1|STARTED|Overall Study||28
332757|NCT01407354|797625|P2|NOT COMPLETED|Second Intervention||2
332758|NCT01407354|797626|P1|NOT COMPLETED|Second Intervention||0
332759|NCT01407354|797625|P2|COMPLETED|Second Intervention||13
332760|NCT01407354|797626|P1|COMPLETED|Second Intervention||18
332761|NCT01407354|797625|P2|STARTED|Second Intervention||15
332762|NCT01407354|797626|P1|STARTED|Second Intervention||18
332763|NCT01407354|797625|P2|NOT COMPLETED|First Intervention||2
332764|NCT01407354|797626|P1|NOT COMPLETED|First Intervention||2
332765|NCT01407354|797625|P2|COMPLETED|First Intervention||15
332766|NCT01407354|797626|P1|COMPLETED|First Intervention||18
332767|NCT01407354|797625|P2|STARTED|First Intervention||17
332768|NCT01407354|797626|P1|STARTED|First Intervention||20
332769|NCT01407276|797642|P8|NOT COMPLETED|Overall Study||1
332770|NCT01407276|797643|P7|NOT COMPLETED|Overall Study||0
332771|NCT01407276|797644|P6|NOT COMPLETED|Overall Study||0
332772|NCT01407276|797645|P5|NOT COMPLETED|Overall Study||0
332773|NCT01407276|797646|P4|NOT COMPLETED|Overall Study||0
332774|NCT01407276|797647|P3|NOT COMPLETED|Overall Study||0
332775|NCT01407276|797648|P2|NOT COMPLETED|Overall Study||0
332776|NCT01407276|797649|P1|NOT COMPLETED|Overall Study||0
332777|NCT01407276|797642|P8|COMPLETED|Overall Study||6
332778|NCT01407276|797643|P7|COMPLETED|Overall Study||6
332779|NCT01407276|797644|P6|COMPLETED|Overall Study||6
332780|NCT01407276|797645|P5|COMPLETED|Overall Study||6
332781|NCT01407276|797646|P4|COMPLETED|Overall Study||6
332782|NCT01407276|797647|P3|COMPLETED|Overall Study||6
332783|NCT01407276|797648|P2|COMPLETED|Overall Study||6
332784|NCT01407276|797649|P1|COMPLETED|Overall Study||6
332785|NCT01407276|797642|P8|STARTED|Overall Study||7
332786|NCT01407276|797643|P7|STARTED|Overall Study||6
332787|NCT01407276|797644|P6|STARTED|Overall Study||6
332788|NCT01407276|797645|P5|STARTED|Overall Study||6
332789|NCT01407276|797646|P4|STARTED|Overall Study||6
332790|NCT01407276|797647|P3|STARTED|Overall Study||6
332791|NCT01407276|797648|P2|STARTED|Overall Study||6
332792|NCT01407276|797649|P1|STARTED|Overall Study||6
332793|NCT01407575|797775|P2|NOT COMPLETED|Overall Study||1
332794|NCT01407575|797776|P1|NOT COMPLETED|Overall Study||2
332795|NCT01407575|797775|P2|COMPLETED|Overall Study||5
332796|NCT01407575|797776|P1|COMPLETED|Overall Study||5
332797|NCT01407575|797775|P2|STARTED|Overall Study||6
332798|NCT01407575|797776|P1|STARTED|Overall Study||7
332799|NCT01407523|797794|P1|NOT COMPLETED|Overall Study||0
332800|NCT01407523|797794|P1|COMPLETED|Overall Study||16
332801|NCT01407523|797794|P1|STARTED|Overall Study||16
332802|NCT01407068|797804|P1|NOT COMPLETED|Overall Study||0
332803|NCT01407068|797804|P1|COMPLETED|Overall Study||60
332804|NCT01407068|797804|P1|STARTED|Overall Study||60
332805|NCT01406990|797813|P1|NOT COMPLETED|Overall Study||0
332806|NCT01406990|797813|P1|COMPLETED|Overall Study||15
332807|NCT01406990|797813|P1|STARTED|Overall Study||15
332808|NCT01406938|797819|P6|NOT COMPLETED|Follow up||3
332809|NCT01406938|797820|P5|NOT COMPLETED|Follow up||9
332810|NCT01406938|797821|P4|NOT COMPLETED|Follow up||3
332811|NCT01406938|797822|P3|NOT COMPLETED|Follow up||8
332812|NCT01406938|797823|P2|NOT COMPLETED|Follow up||5
332813|NCT01406938|797824|P1|NOT COMPLETED|Follow up||8
332814|NCT01406938|797819|P6|COMPLETED|Follow up||32
332815|NCT01406938|797820|P5|COMPLETED|Follow up||31
332816|NCT01406938|797821|P4|COMPLETED|Follow up||36
332817|NCT01406938|797822|P3|COMPLETED|Follow up||32
332818|NCT01406938|797823|P2|COMPLETED|Follow up||18
332819|NCT01406938|797824|P1|COMPLETED|Follow up||18
332820|NCT01406938|797819|P6|STARTED|Follow up||35
332821|NCT01406938|797820|P5|STARTED|Follow up||40
332822|NCT01406938|797821|P4|STARTED|Follow up||39
332823|NCT01406938|797822|P3|STARTED|Follow up||40
332824|NCT01406938|797823|P2|STARTED|Follow up||23
332825|NCT01406938|797824|P1|STARTED|Follow up||26
332826|NCT01406938|797819|P6|NOT COMPLETED|Maintenance Period||16
332827|NCT01406938|797820|P5|NOT COMPLETED|Maintenance Period||25
332828|NCT01406938|797821|P4|NOT COMPLETED|Maintenance Period||18
332829|NCT01406938|797822|P3|NOT COMPLETED|Maintenance Period||17
332830|NCT01406938|797823|P2|NOT COMPLETED|Maintenance Period||0
332831|NCT01406938|797824|P1|NOT COMPLETED|Maintenance Period||0
332832|NCT01406938|797819|P6|COMPLETED|Maintenance Period||201
332833|NCT01406938|797820|P5|COMPLETED|Maintenance Period||181
332834|NCT01406938|797821|P4|COMPLETED|Maintenance Period||199
332835|NCT01406938|797822|P3|COMPLETED|Maintenance Period||186
332836|NCT01406938|797823|P2|COMPLETED|Maintenance Period||0
332837|NCT01406938|797824|P1|COMPLETED|Maintenance Period||0
332838|NCT01406938|797819|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
332839|NCT01406938|797820|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
332840|NCT01406938|797821|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
332841|NCT01406938|797822|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
332842|NCT01406938|797823|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
332843|NCT01406938|797824|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
332844|NCT01406938|797819|P6|STARTED|Maintenance Period||217
332845|NCT01406938|797820|P5|STARTED|Maintenance Period||206
332846|NCT01406938|797821|P4|STARTED|Maintenance Period||217
332847|NCT01406938|797822|P3|STARTED|Maintenance Period||203
332848|NCT01406938|797823|P2|STARTED|Maintenance Period||0
332849|NCT01406938|797824|P1|STARTED|Maintenance Period||0
332850|NCT01406938|797819|P6|NOT COMPLETED|Induction Period||0
332851|NCT01406938|797820|P5|NOT COMPLETED|Induction Period||0
332852|NCT01406938|797821|P4|NOT COMPLETED|Induction Period||0
332853|NCT01406938|797822|P3|NOT COMPLETED|Induction Period||0
332854|NCT01406938|797823|P2|NOT COMPLETED|Induction Period||20
332855|NCT01406938|797824|P1|NOT COMPLETED|Induction Period||18
332856|NCT01406938|797819|P6|COMPLETED|Induction Period||0
332857|NCT01406938|797820|P5|COMPLETED|Induction Period||0
332858|NCT01406938|797821|P4|COMPLETED|Induction Period||0
332859|NCT01406938|797822|P3|COMPLETED|Induction Period||0
332860|NCT01406938|797823|P2|COMPLETED|Induction Period||464
332861|NCT01406938|797824|P1|COMPLETED|Induction Period||464
332862|NCT01406938|797819|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
332863|NCT01406938|797820|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
332864|NCT01406938|797821|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
332865|NCT01406938|797822|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
332866|NCT01406938|797823|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
332867|NCT01406938|797824|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
332868|NCT01406938|797819|P6|STARTED|Induction Period||0
332869|NCT01406938|797820|P5|STARTED|Induction Period||0
332870|NCT01406938|797821|P4|STARTED|Induction Period||0
332871|NCT01406938|797822|P3|STARTED|Induction Period||0
332872|NCT01406938|797823|P2|STARTED|Induction Period||484
332873|NCT01406938|797824|P1|STARTED|Induction Period||482
332874|NCT01406795|797940|P1|NOT COMPLETED|Overall Study||1
332875|NCT01406795|797940|P1|COMPLETED|Overall Study||0
332876|NCT01406795|797940|P1|STARTED|Overall Study||1
332877|NCT01406574|797954|P4|NOT COMPLETED|Overall Study||4
332878|NCT01406574|797955|P3|NOT COMPLETED|Overall Study||1
332879|NCT01406574|797956|P2|NOT COMPLETED|Overall Study||1
332880|NCT01406574|797957|P1|NOT COMPLETED|Overall Study||1
332881|NCT01406574|797954|P4|COMPLETED|Overall Study||1
332882|NCT01406574|797955|P3|COMPLETED|Overall Study||6
332883|NCT01406574|797956|P2|COMPLETED|Overall Study||3
332884|NCT01406574|797957|P1|COMPLETED|Overall Study||6
332885|NCT01406574|797954|P4|STARTED|Overall Study||5
332886|NCT01406574|797955|P3|STARTED|Overall Study||7
332887|NCT01406574|797956|P2|STARTED|Overall Study||4
332888|NCT01406574|797957|P1|STARTED|Overall Study||7
332889|NCT01406015|797971|P2|NOT COMPLETED|Overall Study||3
332890|NCT01406015|797972|P1|NOT COMPLETED|Overall Study||3
332891|NCT01406015|797971|P2|COMPLETED|Overall Study||16
332892|NCT01406015|797972|P1|COMPLETED|Overall Study||16
332893|NCT01406015|797971|P2|STARTED|Overall Study||19
332894|NCT01406015|797972|P1|STARTED|Overall Study||19
332895|NCT01405950|797988|P4|NOT COMPLETED|Overall Study||0
332896|NCT01405950|797989|P3|NOT COMPLETED|Overall Study||0
332897|NCT01405950|797990|P2|NOT COMPLETED|Overall Study||0
332898|NCT01405950|797991|P1|NOT COMPLETED|Overall Study||1
332899|NCT01405950|797988|P4|COMPLETED|Overall Study||0
332900|NCT01405950|797989|P3|COMPLETED|Overall Study||0
332901|NCT01405950|797990|P2|COMPLETED|Overall Study||2
332902|NCT01405950|797991|P1|COMPLETED|Overall Study||7
332903|NCT01405950|797988|P4|STARTED|Overall Study||0
332904|NCT01405950|797989|P3|STARTED|Overall Study||0
332905|NCT01405950|797990|P2|STARTED|Overall Study||2
332906|NCT01405950|797991|P1|STARTED|Overall Study||8
332907|NCT01405937|798005|P2|NOT COMPLETED|Overall Study||0
332908|NCT01405937|798006|P1|NOT COMPLETED|Overall Study||0
332909|NCT01405937|798005|P2|COMPLETED|Overall Study||26
332910|NCT01405937|798006|P1|COMPLETED|Overall Study||25
332911|NCT01405937|798005|P2|STARTED|Overall Study||26
332912|NCT01405937|798006|P1|STARTED|Overall Study||25
332913|NCT01405924|798026|P1|NOT COMPLETED|Overall Study||10
332914|NCT01405924|798026|P1|COMPLETED|Overall Study||101
332915|NCT01405924|798026|P1|STARTED|Overall Study||111
332916|NCT01405898|798038|P2|NOT COMPLETED|Overall Study||2
332917|NCT01405898|798039|P1|NOT COMPLETED|Overall Study||2
332918|NCT01405898|798038|P2|COMPLETED|Overall Study||32
332919|NCT01405898|798039|P1|COMPLETED|Overall Study||32
332920|NCT01405898|798038|P2|STARTED|Overall Study||34
332921|NCT01405898|798039|P1|STARTED|Overall Study||34
332922|NCT01405820|798063|P6|NOT COMPLETED|Open-Label Treatment Period||2
332923|NCT01405820|798064|P5|NOT COMPLETED|Open-Label Treatment Period||2
332924|NCT01405820|798065|P4|NOT COMPLETED|Open-Label Treatment Period||5
332925|NCT01405820|798066|P3|NOT COMPLETED|Open-Label Treatment Period||3
332926|NCT01405820|798067|P2|NOT COMPLETED|Open-Label Treatment Period||2
332927|NCT01405820|798068|P1|NOT COMPLETED|Open-Label Treatment Period||4
332928|NCT01405820|798063|P6|COMPLETED|Open-Label Treatment Period||30
332929|NCT01405820|798064|P5|COMPLETED|Open-Label Treatment Period||40
332930|NCT01405820|798065|P4|COMPLETED|Open-Label Treatment Period||37
332931|NCT01405820|798066|P3|COMPLETED|Open-Label Treatment Period||39
332932|NCT01405820|798067|P2|COMPLETED|Open-Label Treatment Period||33
332933|NCT01405820|798068|P1|COMPLETED|Open-Label Treatment Period||40
332934|NCT01405820|798063|P6|STARTED|Open-Label Treatment Period||32
332935|NCT01405820|798064|P5|STARTED|Open-Label Treatment Period||42
332936|NCT01405820|798065|P4|STARTED|Open-Label Treatment Period||42
332937|NCT01405820|798066|P3|STARTED|Open-Label Treatment Period||42
332938|NCT01405820|798067|P2|STARTED|Open-Label Treatment Period||35
332939|NCT01405820|798068|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
332940|NCT01405820|798063|P6|NOT COMPLETED|Randomized Treatment Period||37
332941|NCT01405820|798064|P5|NOT COMPLETED|Randomized Treatment Period||45
332942|NCT01405820|798065|P4|NOT COMPLETED|Randomized Treatment Period||51
332943|NCT01405820|798066|P3|NOT COMPLETED|Randomized Treatment Period||43
332944|NCT01405820|798067|P2|NOT COMPLETED|Randomized Treatment Period||10
332945|NCT01405820|798068|P1|NOT COMPLETED|Randomized Treatment Period||11
332946|NCT01405820|798063|P6|COMPLETED|Randomized Treatment Period||1
332947|NCT01405820|798064|P5|COMPLETED|Randomized Treatment Period||2
332948|NCT01405820|798065|P4|COMPLETED|Randomized Treatment Period||3
332949|NCT01405820|798066|P3|COMPLETED|Randomized Treatment Period||9
332950|NCT01405820|798067|P2|COMPLETED|Randomized Treatment Period||35
332951|NCT01405820|798068|P1|COMPLETED|Randomized Treatment Period||43
332952|NCT01405820|798063|P6|Safety Population|Randomized Treatment Period||38
332953|NCT01405820|798064|P5|Safety Population|Randomized Treatment Period||47
332954|NCT01405820|798065|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
332955|NCT01405820|798066|P3|Safety Population|Randomized Treatment Period||52
332956|NCT01405820|798067|P2|Safety Population|Randomized Treatment Period||45
332957|NCT01405820|798068|P1|Safety Population|Randomized Treatment Period||54
332958|NCT01405820|798063|P6|STARTED|Randomized Treatment Period||38
332959|NCT01405820|798064|P5|STARTED|Randomized Treatment Period||47
332960|NCT01405820|798065|P4|STARTED|Randomized Treatment Period||54
332961|NCT01405820|798066|P3|STARTED|Randomized Treatment Period||52
332962|NCT01405820|798067|P2|STARTED|Randomized Treatment Period||45
332963|NCT01405820|798068|P1|STARTED|Randomized Treatment Period||54
332964|NCT01405794|798088|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
332965|NCT01405794|798088|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
332966|NCT01405794|798088|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
332967|NCT01405794|798088|P1|NOT COMPLETED|72 hr Washout||0
332968|NCT01405794|798088|P1|COMPLETED|72 hr Washout||12
332969|NCT01405794|798088|P1|STARTED|72 hr Washout||12
332970|NCT01405794|798088|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
332971|NCT01405794|798088|P1|COMPLETED|First Dose Placebo (14 Days)||12
332972|NCT01405794|798088|P1|STARTED|First Dose Placebo (14 Days)||12
332973|NCT01405768|798164|P2|NOT COMPLETED|Overall Study||0
332974|NCT01405768|798165|P1|NOT COMPLETED|Overall Study||4
332975|NCT01405768|798164|P2|COMPLETED|Overall Study||28
332976|NCT01405768|798165|P1|COMPLETED|Overall Study||24
332977|NCT01405768|798164|P2|STARTED|Overall Study||28
332978|NCT01405768|798165|P1|STARTED|Overall Study||28
332979|NCT01405742|798177|P2|NOT COMPLETED|Overall Study||0
332980|NCT01405742|798178|P1|NOT COMPLETED|Overall Study||1
332981|NCT01405742|798177|P2|COMPLETED|Overall Study||2
332982|NCT01405742|798178|P1|COMPLETED|Overall Study||1
332983|NCT01405742|798177|P2|STARTED|Overall Study||2
332984|NCT01405742|798178|P1|STARTED|Overall Study||2
332985|NCT01405560|798188|P1|NOT COMPLETED|Overall Study||1
332986|NCT01405560|798188|P1|COMPLETED|Overall Study||41
332987|NCT01405560|798188|P1|STARTED|Overall Study||42
332988|NCT01405508|798203|P4|NOT COMPLETED|Overall Study||0
332989|NCT01405508|798204|P3|NOT COMPLETED|Overall Study||0
332990|NCT01405508|798205|P2|NOT COMPLETED|Overall Study||1
332991|NCT01405508|798206|P1|NOT COMPLETED|Overall Study||1
332992|NCT01405508|798203|P4|COMPLETED|Overall Study||26
332993|NCT01405508|798204|P3|COMPLETED|Overall Study||27
332994|NCT01405508|798205|P2|COMPLETED|Overall Study||25
332995|NCT01405508|798206|P1|COMPLETED|Overall Study||25
332996|NCT01405508|798203|P4|STARTED|Overall Study||26
332997|NCT01405508|798204|P3|STARTED|Overall Study||27
332998|NCT01405508|798205|P2|STARTED|Overall Study||26
332999|NCT01405508|798206|P1|STARTED|Overall Study||26
333000|NCT01405469|798224|P1|NOT COMPLETED|Overall Study||0
333001|NCT01405469|798224|P1|COMPLETED|Overall Study||16
333002|NCT01405469|798224|P1|STARTED|Overall Study||16
333003|NCT01405313|798236|P1|NOT COMPLETED|Overall Study||0
333004|NCT01405313|798236|P1|COMPLETED|Overall Study||21
333005|NCT01405313|798236|P1|STARTED|Overall Study||21
333006|NCT01405027|798246|P2|NOT COMPLETED|Overall Study||51
333007|NCT01405027|798247|P1|NOT COMPLETED|Overall Study||32
333008|NCT01405027|798246|P2|COMPLETED|Overall Study||62
333009|NCT01405027|798247|P1|COMPLETED|Overall Study||52
333010|NCT01405027|798246|P2|STARTED|Overall Study||113
333011|NCT01405027|798247|P1|STARTED|Overall Study||84
333012|NCT01404988|798264|P3|NOT COMPLETED|Overall Study||3
333013|NCT01404988|798265|P2|NOT COMPLETED|Overall Study||4
333014|NCT01404988|798266|P1|NOT COMPLETED|Overall Study||6
333015|NCT01404988|798264|P3|COMPLETED|Overall Study||30
333016|NCT01404988|798265|P2|COMPLETED|Overall Study||29
333017|NCT01404988|798266|P1|COMPLETED|Overall Study||27
333018|NCT01404988|798264|P3|STARTED|Overall Study||33
333019|NCT01404988|798265|P2|STARTED|Overall Study||33
333020|NCT01404988|798266|P1|STARTED|Overall Study||33
333021|NCT01404936|798283|P1|NOT COMPLETED|Overall Study||0
333022|NCT01404936|798283|P1|COMPLETED|Overall Study||30
333023|NCT01404936|798283|P1|STARTED|Overall Study||30
333024|NCT01404923|798289|P2|NOT COMPLETED|Overall Study||17
333025|NCT01404923|798290|P1|NOT COMPLETED|Overall Study||23
333026|NCT01404923|798289|P2|COMPLETED|Overall Study||197
333027|NCT01404923|798290|P1|COMPLETED|Overall Study||199
333028|NCT01404923|798289|P2|STARTED|Overall Study||214
333029|NCT01404923|798290|P1|STARTED|Overall Study||222
333030|NCT01404832|798298|P1|NOT COMPLETED|Overall Study||0
333031|NCT01404832|798298|P1|COMPLETED|Overall Study||21
333032|NCT01404832|798298|P1|STARTED|Overall Study||21
333033|NCT01404650|798303|P1|NOT COMPLETED|Overall Study||0
333034|NCT01404650|798303|P1|COMPLETED|Overall Study||25
333035|NCT01404650|798303|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
333036|NCT01404611|798313|P3|NOT COMPLETED|Overall Study||5
333037|NCT01404611|798314|P2|NOT COMPLETED|Overall Study||19
333038|NCT01404611|798315|P1|NOT COMPLETED|Overall Study||8
333039|NCT01404611|798313|P3|COMPLETED|Overall Study||106
333040|NCT01404611|798314|P2|COMPLETED|Overall Study||89
333041|NCT01404611|798315|P1|COMPLETED|Overall Study||104
333042|NCT01404611|798313|P3|STARTED|Overall Study||111
333043|NCT01404611|798314|P2|STARTED|Overall Study||108
333044|NCT01404611|798315|P1|STARTED|Overall Study||112
333045|NCT01404572|798323|P3|NOT COMPLETED|Overall Study||0
333046|NCT01404572|798324|P2|NOT COMPLETED|Overall Study||0
333047|NCT01404572|798325|P1|NOT COMPLETED|Overall Study||0
333048|NCT01404572|798323|P3|COMPLETED|Overall Study||4
333049|NCT01404572|798324|P2|COMPLETED|Overall Study||4
333050|NCT01404572|798325|P1|COMPLETED|Overall Study||4
333051|NCT01404572|798323|P3|STARTED|Overall Study||4
333052|NCT01404572|798324|P2|STARTED|Overall Study||4
333053|NCT01404572|798325|P1|STARTED|Overall Study||4
333054|NCT01404559|798356|P4|NOT COMPLETED|Overall Study||0
333055|NCT01404559|798357|P3|NOT COMPLETED|Overall Study||0
333056|NCT01404559|798358|P2|NOT COMPLETED|Overall Study||0
333057|NCT01404559|798359|P1|NOT COMPLETED|Overall Study||0
333058|NCT01404559|798356|P4|COMPLETED|Overall Study||14
333059|NCT01404559|798357|P3|COMPLETED|Overall Study||4
333060|NCT01404559|798358|P2|COMPLETED|Overall Study||5
333061|NCT01404559|798359|P1|COMPLETED|Overall Study||5
333062|NCT01404559|798356|P4|STARTED|Overall Study||14
333063|NCT01404559|798357|P3|STARTED|Overall Study||4
333064|NCT01404559|798358|P2|STARTED|Overall Study||5
333065|NCT01404559|798359|P1|STARTED|Overall Study||5
333066|NCT01404429|798372|P2|NOT COMPLETED|Overall Study||7
333067|NCT01404429|798373|P1|NOT COMPLETED|Overall Study||9
333068|NCT01404429|798372|P2|COMPLETED|Overall Study||46
333069|NCT01404429|798373|P1|COMPLETED|Overall Study||38
333070|NCT01404429|798372|P2|STARTED|Overall Study||53
333071|NCT01404429|798373|P1|STARTED|Overall Study||47
333072|NCT01404260|798387|P2|NOT COMPLETED|Overall Study||9
333073|NCT01404260|798388|P1|NOT COMPLETED|Overall Study||3
333074|NCT01404260|798387|P2|COMPLETED|Overall Study||101
333075|NCT01404260|798388|P1|COMPLETED|Overall Study||106
333076|NCT01404260|798387|P2|STARTED|Overall Study||110
333077|NCT01404260|798388|P1|STARTED|Overall Study||109
333078|NCT01404234|798394|P1|NOT COMPLETED|Overall Study||2
333079|NCT01404234|798394|P1|COMPLETED|Overall Study||59
333080|NCT01404234|798394|P1|STARTED|Overall Study||61
333081|NCT01404208|798410|P2|NOT COMPLETED|Overall Study||0
333082|NCT01404208|798411|P1|NOT COMPLETED|Overall Study||3
333083|NCT01404208|798410|P2|COMPLETED|Overall Study||72
333084|NCT01404208|798411|P1|COMPLETED|Overall Study||67
333085|NCT01404208|798410|P2|STARTED|Overall Study||72
333086|NCT01404208|798411|P1|STARTED|Overall Study||70
333087|NCT01404078|798421|P2|NOT COMPLETED|Overall Study||20
333088|NCT01404078|798422|P1|NOT COMPLETED|Overall Study||18
333089|NCT01404078|798421|P2|COMPLETED|Overall Study||237
333090|NCT01404078|798422|P1|COMPLETED|Overall Study||243
333091|NCT01404078|798421|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
333092|NCT01404078|798422|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
333093|NCT01404039|798437|P13|NOT COMPLETED|Overall Study||0
333094|NCT01404039|798438|P12|NOT COMPLETED|Overall Study||0
333095|NCT01404039|798439|P11|NOT COMPLETED|Overall Study||1
333096|NCT01404039|798440|P10|NOT COMPLETED|Overall Study||1
333097|NCT01404039|798441|P9|NOT COMPLETED|Overall Study||0
333098|NCT01404039|798442|P8|NOT COMPLETED|Overall Study||0
333099|NCT01404039|798443|P7|NOT COMPLETED|Overall Study||0
333100|NCT01404039|798444|P6|NOT COMPLETED|Overall Study||0
333101|NCT01404039|798445|P5|NOT COMPLETED|Overall Study||0
333102|NCT01404039|798446|P4|NOT COMPLETED|Overall Study||0
333103|NCT01404039|798447|P3|NOT COMPLETED|Overall Study||0
333104|NCT01404039|798448|P2|NOT COMPLETED|Overall Study||0
333105|NCT01404039|798449|P1|NOT COMPLETED|Overall Study||1
333106|NCT01404039|798437|P13|COMPLETED|Overall Study||0
333107|NCT01404039|798438|P12|COMPLETED|Overall Study||0
333108|NCT01404039|798439|P11|COMPLETED|Overall Study||14
333109|NCT01404039|798440|P10|COMPLETED|Overall Study||14
333110|NCT01404039|798441|P9|COMPLETED|Overall Study||15
333111|NCT01404039|798442|P8|COMPLETED|Overall Study||15
333112|NCT01404039|798443|P7|COMPLETED|Overall Study||10
333113|NCT01404039|798444|P6|COMPLETED|Overall Study||10
333114|NCT01404039|798445|P5|COMPLETED|Overall Study||10
333115|NCT01404039|798446|P4|COMPLETED|Overall Study||10
333116|NCT01404039|798447|P3|COMPLETED|Overall Study||5
333117|NCT01404039|798448|P2|COMPLETED|Overall Study||5
333118|NCT01404039|798449|P1|COMPLETED|Overall Study||4
333119|NCT01404039|798437|P13|STARTED|Overall Study||0
333120|NCT01404039|798438|P12|STARTED|Overall Study||0
333121|NCT01404039|798439|P11|STARTED|Overall Study||15
333122|NCT01404039|798440|P10|STARTED|Overall Study||15
333123|NCT01404039|798441|P9|STARTED|Overall Study||15
333124|NCT01404039|798442|P8|STARTED|Overall Study||15
333125|NCT01404039|798443|P7|STARTED|Overall Study||10
333126|NCT01404039|798444|P6|STARTED|Overall Study||10
333127|NCT01404039|798445|P5|STARTED|Overall Study||10
333128|NCT01404039|798446|P4|STARTED|Overall Study||10
333129|NCT01404039|798447|P3|STARTED|Overall Study||5
333130|NCT01404039|798448|P2|STARTED|Overall Study||5
333131|NCT01404039|798449|P1|STARTED|Overall Study||5
333132|NCT01403987|798476|P3|NOT COMPLETED|Overall Study||18
333133|NCT01403987|798477|P2|NOT COMPLETED|Overall Study||17
333134|NCT01403987|798478|P1|NOT COMPLETED|Overall Study||18
333135|NCT01403987|798476|P3|COMPLETED|Overall Study||50
333136|NCT01403987|798477|P2|COMPLETED|Overall Study||17
333137|NCT01403987|798478|P1|COMPLETED|Overall Study||16
333138|NCT01403987|798476|P3|STARTED|Overall Study||68
333139|NCT01403987|798477|P2|STARTED|Overall Study||34
333140|NCT01403987|798478|P1|STARTED|Overall Study||34
333141|NCT01403805|798494|P2|NOT COMPLETED|Overall Study||7
333142|NCT01403805|798495|P1|NOT COMPLETED|Overall Study||0
333143|NCT01403805|798494|P2|COMPLETED|Overall Study||98
333144|NCT01403805|798495|P1|COMPLETED|Overall Study||94
333145|NCT01403805|798494|P2|Pneumonia Diagnosis|Overall Study||2
333146|NCT01403805|798495|P1|Pneumonia Diagnosis|Overall Study||21
333147|NCT01403805|798494|P2|STARTED|Overall Study||105
333148|NCT01403805|798495|P1|STARTED|Overall Study||94
333149|NCT01403376|798510|P3|NOT COMPLETED|Overall Study||0
333150|NCT01403376|798511|P2|NOT COMPLETED|Overall Study||0
333151|NCT01403376|798512|P1|NOT COMPLETED|Overall Study||0
333152|NCT01403376|798510|P3|COMPLETED|Overall Study||46
333153|NCT01403376|798511|P2|COMPLETED|Overall Study||41
333154|NCT01403376|798512|P1|COMPLETED|Overall Study||41
333155|NCT01403376|798510|P3|STARTED|Overall Study||46
333156|NCT01403376|798511|P2|STARTED|Overall Study||41
333157|NCT01403376|798512|P1|STARTED|Overall Study||41
333158|NCT01403194|798532|P1|NOT COMPLETED|Overall Study||10
333159|NCT01403194|798532|P1|COMPLETED|Overall Study||1
333160|NCT01403194|798532|P1|STARTED|Overall Study||11
333161|NCT01403090|798538|P1|NOT COMPLETED|Overall Study||0
333162|NCT01403090|798538|P1|COMPLETED|Overall Study||8
333163|NCT01403090|798538|P1|STARTED|Overall Study||8
333164|NCT01403051|798544|P2|NOT COMPLETED|Overall Study||6
333165|NCT01403051|798545|P1|NOT COMPLETED|Overall Study||10
333166|NCT01403051|798544|P2|COMPLETED|Overall Study||80
333167|NCT01403051|798545|P1|COMPLETED|Overall Study||71
333168|NCT01403051|798544|P2|Initiated Study Treatment|Overall Study||86
333169|NCT01403051|798545|P1|Initiated Study Treatment|Overall Study||81
333170|NCT01403051|798544|P2|STARTED|Overall Study||86
333171|NCT01403051|798545|P1|STARTED|Overall Study||81
333172|NCT01402986|798581|P4|NOT COMPLETED|Overall Study||22
333173|NCT01402986|798582|P3|NOT COMPLETED|Overall Study||8
333174|NCT01402986|798583|P2|NOT COMPLETED|Overall Study||15
333175|NCT01402986|798584|P1|NOT COMPLETED|Overall Study||9
333176|NCT01402986|798581|P4|COMPLETED|Overall Study||129
333177|NCT01402986|798582|P3|COMPLETED|Overall Study||67
333178|NCT01402986|798583|P2|COMPLETED|Overall Study||135
333179|NCT01402986|798584|P1|COMPLETED|Overall Study||67
333180|NCT01402986|798581|P4|STARTED|Overall Study||151
333181|NCT01402986|798582|P3|STARTED|Overall Study||75
333182|NCT01402986|798583|P2|STARTED|Overall Study||150
333183|NCT01402986|798584|P1|STARTED|Overall Study||76
333184|NCT01402947|798719|P2|NOT COMPLETED|Second Intervention||0
333185|NCT01402947|798720|P1|NOT COMPLETED|Second Intervention||0
333186|NCT01402947|798719|P2|COMPLETED|Second Intervention||14
333187|NCT01402947|798720|P1|COMPLETED|Second Intervention||15
333188|NCT01402947|798719|P2|STARTED|Second Intervention||14
333189|NCT01402947|798720|P1|STARTED|Second Intervention||15
333190|NCT01402947|798719|P2|NOT COMPLETED|First Intervention||1
333191|NCT01402947|798720|P1|NOT COMPLETED|First Intervention||0
333192|NCT01402947|798719|P2|COMPLETED|First Intervention||14
333193|NCT01402947|798720|P1|COMPLETED|First Intervention||15
333194|NCT01402947|798719|P2|STARTED|First Intervention||15
333195|NCT01402947|798720|P1|STARTED|First Intervention||15
333196|NCT01402869|798731|P3|NOT COMPLETED|Overall Study||1
333197|NCT01402869|798732|P2|NOT COMPLETED|Overall Study||0
333198|NCT01402869|798733|P1|NOT COMPLETED|Overall Study||0
333199|NCT01402869|798731|P3|COMPLETED|Overall Study||30
333200|NCT01402869|798732|P2|COMPLETED|Overall Study||30
333201|NCT01402869|798733|P1|COMPLETED|Overall Study||30
333202|NCT01402869|798731|P3|STARTED|Overall Study||31
333203|NCT01402869|798732|P2|STARTED|Overall Study||30
333204|NCT01402869|798733|P1|STARTED|Overall Study||30
333205|NCT01402817|798747|P1|NOT COMPLETED|Overall Study||11
333206|NCT01402817|798747|P1|COMPLETED|Overall Study||8
333207|NCT01402817|798747|P1|STARTED|Overall Study||19
333208|NCT01402700|798752|P1|NOT COMPLETED|Overall Study||7
333209|NCT01402700|798752|P1|COMPLETED|Overall Study||68
333210|NCT01402700|798752|P1|STARTED|Overall Study||75
333211|NCT01402570|798756|P1|NOT COMPLETED|Overall Study||1
333212|NCT01402570|798756|P1|COMPLETED|Overall Study||19
333213|NCT01402570|798756|P1|STARTED|Overall Study||20
333214|NCT01402427|798765|P2|NOT COMPLETED|Overall Study||0
333215|NCT01402427|798766|P1|NOT COMPLETED|Overall Study||0
333216|NCT01402427|798765|P2|COMPLETED|Overall Study||294
333217|NCT01402427|798766|P1|COMPLETED|Overall Study||297
333218|NCT01402427|798765|P2|STARTED|Overall Study||294
333219|NCT01402427|798766|P1|STARTED|Overall Study||297
333220|NCT01402284|798784|P1|NOT COMPLETED|Overall Study||15
333221|NCT01402284|798784|P1|COMPLETED|Overall Study||30
333222|NCT01402284|798784|P1|STARTED|Overall Study||45
333223|NCT01402141|798797|P2|NOT COMPLETED|Overall Study||2
333224|NCT01402141|798798|P1|NOT COMPLETED|Overall Study||1
333225|NCT01402141|798797|P2|COMPLETED|Overall Study||28
333226|NCT01402141|798798|P1|COMPLETED|Overall Study||29
333227|NCT01402141|798797|P2|STARTED|Overall Study||30
333228|NCT01402141|798798|P1|STARTED|Overall Study||30
333229|NCT01402128|798820|P2|NOT COMPLETED|Overall Study||0
333230|NCT01402128|798821|P1|NOT COMPLETED|Overall Study||1
333231|NCT01402128|798820|P2|COMPLETED|Overall Study||40
333232|NCT01402128|798821|P1|COMPLETED|Overall Study||39
333233|NCT01402128|798820|P2|STARTED|Overall Study||40
333234|NCT01402128|798821|P1|STARTED|Overall Study||40
333235|NCT01402115|798849|P2|NOT COMPLETED|Overall Study||1
333236|NCT01402115|798850|P1|NOT COMPLETED|Overall Study||1
333237|NCT01402115|798849|P2|COMPLETED|Overall Study||29
333238|NCT01402115|798850|P1|COMPLETED|Overall Study||29
333239|NCT01402115|798849|P2|STARTED|Overall Study||30
333240|NCT01402115|798850|P1|STARTED|Overall Study||30
333241|NCT01402102|798866|P2|NOT COMPLETED|Overall Study||3
333242|NCT01402102|798867|P1|NOT COMPLETED|Overall Study||2
333243|NCT01402102|798866|P2|COMPLETED|Overall Study||27
333244|NCT01402102|798867|P1|COMPLETED|Overall Study||28
333245|NCT01402102|798866|P2|STARTED|Overall Study||30
333246|NCT01402102|798867|P1|STARTED|Overall Study||30
333247|NCT01402063|798887|P2|NOT COMPLETED|Overall Study||3
333248|NCT01402063|798888|P1|NOT COMPLETED|Overall Study||3
333249|NCT01402063|798887|P2|COMPLETED|Overall Study||18
333250|NCT01402063|798888|P1|COMPLETED|Overall Study||39
333251|NCT01402063|798887|P2|STARTED|Overall Study||21
333252|NCT01402063|798888|P1|STARTED|Overall Study||42
333253|NCT01401842|798896|P2|NOT COMPLETED|Overall Study||67
333254|NCT01401842|798897|P1|NOT COMPLETED|Overall Study||68
333255|NCT01401842|798896|P2|COMPLETED|Overall Study||217
333256|NCT01401842|798897|P1|COMPLETED|Overall Study||230
333257|NCT01401842|798896|P2|STARTED|Overall Study||284
333258|NCT01401842|798897|P1|STARTED|Overall Study||298
333259|NCT01401647|798910|P3|NOT COMPLETED|Overall Study||3
333260|NCT01401647|798911|P2|NOT COMPLETED|Overall Study||8
333261|NCT01401647|798912|P1|NOT COMPLETED|Overall Study||4
333262|NCT01401647|798910|P3|COMPLETED|Overall Study||1056
333263|NCT01401647|798911|P2|COMPLETED|Overall Study||985
333264|NCT01401647|798912|P1|COMPLETED|Overall Study||968
333265|NCT01401647|798910|P3|STARTED|Overall Study||1059
333266|NCT01401647|798911|P2|STARTED|Overall Study||993
333267|NCT01401647|798912|P1|STARTED|Overall Study||972
333268|NCT01401595|798925|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
333269|NCT01401595|798926|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
333270|NCT01401595|798925|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
333271|NCT01401595|798926|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
333272|NCT01401595|798925|P2|STARTED|Imaging and Treatment (for NE Arm)||10
333273|NCT01401595|798926|P1|STARTED|Imaging and Treatment (for NE Arm)||32
333274|NCT01401595|798925|P2|NOT COMPLETED|Recruitment and Screening||2
333275|NCT01401595|798926|P1|NOT COMPLETED|Recruitment and Screening||43
333276|NCT01401595|798925|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
333277|NCT01401595|798926|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
333278|NCT01401595|798925|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
333279|NCT01401595|798926|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
333280|NCT01401582|798937|P2|NOT COMPLETED|Overall Study||117
333281|NCT01401582|798938|P1|NOT COMPLETED|Overall Study||110
333282|NCT01401582|798937|P2|COMPLETED|Overall Study||291
333283|NCT01401582|798938|P1|COMPLETED|Overall Study||116
333284|NCT01401582|798937|P2|Baseline Completed|Overall Study||348
333285|NCT01401582|798938|P1|Baseline Completed|Overall Study||168
333286|NCT01401582|798937|P2|STARTED|Overall Study||408
333287|NCT01401582|798938|P1|STARTED|Overall Study||226
333288|NCT01401517|798957|P3|NOT COMPLETED|Overall Study||3
333289|NCT01401517|798958|P2|NOT COMPLETED|Overall Study||2
333290|NCT01401517|798959|P1|NOT COMPLETED|Overall Study||3
333291|NCT01401517|798957|P3|COMPLETED|Overall Study||15
333292|NCT01401517|798958|P2|COMPLETED|Overall Study||17
333293|NCT01401517|798959|P1|COMPLETED|Overall Study||15
333294|NCT01401517|798957|P3|STARTED|Overall Study||18
333295|NCT01401517|798958|P2|STARTED|Overall Study||19
333296|NCT01401517|798959|P1|STARTED|Overall Study||18
333297|NCT01401478|798967|P1|NOT COMPLETED|Overall Study||31
333298|NCT01401478|798967|P1|COMPLETED|Overall Study||55
333299|NCT01401478|798967|P1|STARTED|Overall Study||86
333300|NCT01401465|798980|P2|NOT COMPLETED|Treatment Period 2||2
333301|NCT01401465|798981|P1|NOT COMPLETED|Treatment Period 2||0
333302|NCT01401465|798980|P2|COMPLETED|Treatment Period 2||144
333303|NCT01401465|798981|P1|COMPLETED|Treatment Period 2||150
333304|NCT01401465|798980|P2|STARTED|Treatment Period 2||146
333305|NCT01401465|798981|P1|STARTED|Treatment Period 2||150
333306|NCT01401465|798980|P2|NOT COMPLETED|Washout||0
333307|NCT01401465|798981|P1|NOT COMPLETED|Washout||0
333308|NCT01401465|798980|P2|COMPLETED|Washout||146
333309|NCT01401465|798981|P1|COMPLETED|Washout||150
333310|NCT01401465|798980|P2|STARTED|Washout||146
333311|NCT01401465|798981|P1|STARTED|Washout||150
333312|NCT01401465|798980|P2|NOT COMPLETED|Treatment Period 1||16
333313|NCT01401465|798981|P1|NOT COMPLETED|Treatment Period 1||15
333314|NCT01401465|798980|P2|COMPLETED|Treatment Period 1||146
333315|NCT01401465|798981|P1|COMPLETED|Treatment Period 1||150
333316|NCT01401465|798980|P2|STARTED|Treatment Period 1||162
333317|NCT01401465|798981|P1|STARTED|Treatment Period 1||165
333318|NCT01401361|799044|P1|NOT COMPLETED|Overall Study||28
333319|NCT01401361|799044|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
333320|NCT01401361|799044|P1|STARTED|Overall Study||150
333321|NCT01401322|799050|P1|NOT COMPLETED|Overall Study||2
333322|NCT01401322|799050|P1|COMPLETED|Overall Study||3
333323|NCT01401322|799050|P1|STARTED|Overall Study||5
333324|NCT01401283|799056|P2|NOT COMPLETED|Overall Study||10
333325|NCT01401283|799057|P1|NOT COMPLETED|Overall Study||10
333326|NCT01401283|799056|P2|COMPLETED|Overall Study||81
333327|NCT01401283|799057|P1|COMPLETED|Overall Study||79
333328|NCT01401283|799056|P2|STARTED|Overall Study||91
333329|NCT01401283|799057|P1|STARTED|Overall Study||89
333330|NCT01401257|799069|P4|NOT COMPLETED|Overall Study||2
333331|NCT01401257|799070|P3|NOT COMPLETED|Overall Study||3
333332|NCT01401257|799071|P2|NOT COMPLETED|Overall Study||2
333333|NCT01401257|799072|P1|NOT COMPLETED|Overall Study||0
333334|NCT01401257|799069|P4|COMPLETED|Overall Study||17
333335|NCT01401257|799070|P3|COMPLETED|Overall Study||16
333336|NCT01401257|799071|P2|COMPLETED|Overall Study||19
333337|NCT01401257|799072|P1|COMPLETED|Overall Study||21
333338|NCT01401257|799069|P4|STARTED|Overall Study||19
333339|NCT01401257|799070|P3|STARTED|Overall Study||19
333340|NCT01401257|799071|P2|STARTED|Overall Study||21
333341|NCT01401257|799072|P1|STARTED|Overall Study||21
333342|NCT01401166|799084|P4|NOT COMPLETED|Safety Follow-Up Period||19
333343|NCT01401166|799085|P3|NOT COMPLETED|Safety Follow-Up Period||17
333344|NCT01401166|799086|P2|NOT COMPLETED|Safety Follow-Up Period||18
333345|NCT01401166|799087|P1|NOT COMPLETED|Safety Follow-Up Period||25
333346|NCT01401166|799084|P4|COMPLETED|Safety Follow-Up Period||100
333347|NCT01401166|799085|P3|COMPLETED|Safety Follow-Up Period||104
333348|NCT01401166|799086|P2|COMPLETED|Safety Follow-Up Period||106
333349|NCT01401166|799087|P1|COMPLETED|Safety Follow-Up Period||99
333350|NCT01401166|799084|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
333351|NCT01401166|799085|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
333352|NCT01401166|799086|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
333353|NCT01401166|799087|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
333354|NCT01401166|799084|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
333355|NCT01401166|799085|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
333356|NCT01401166|799086|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
333357|NCT01401166|799087|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
333358|NCT01401166|799084|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
333359|NCT01401166|799085|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
333360|NCT01401166|799086|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
333361|NCT01401166|799087|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
333362|NCT01401166|799084|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
333363|NCT01401166|799085|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
333364|NCT01401166|799086|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
333365|NCT01401166|799087|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
333366|NCT01401166|799084|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
333367|NCT01401166|799085|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
333368|NCT01401166|799086|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
333369|NCT01401166|799087|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
333370|NCT01401166|799084|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
333371|NCT01401166|799085|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
333372|NCT01401166|799086|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
333373|NCT01401166|799087|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
333374|NCT01401166|799084|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
333375|NCT01401166|799085|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
333376|NCT01401166|799086|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
333377|NCT01401166|799087|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
333378|NCT01401166|799084|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
333379|NCT01401166|799085|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
333380|NCT01401166|799086|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
333381|NCT01401166|799087|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
333382|NCT01401166|799084|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
333383|NCT01401166|799085|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
333384|NCT01401166|799086|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
333385|NCT01401166|799087|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
333386|NCT01401166|799084|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
333387|NCT01401166|799085|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
333388|NCT01401166|799086|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
333389|NCT01401166|799087|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
333390|NCT01401153|799123|P2|NOT COMPLETED|Second Test Day||5
333391|NCT01401153|799124|P1|NOT COMPLETED|Second Test Day||0
333392|NCT01401153|799123|P2|COMPLETED|Second Test Day||60
333393|NCT01401153|799124|P1|COMPLETED|Second Test Day||45
333394|NCT01401153|799123|P2|STARTED|Second Test Day||65
333395|NCT01401153|799124|P1|STARTED|Second Test Day||45
333396|NCT01401153|799123|P2|NOT COMPLETED|First Test Day||10
333397|NCT01401153|799124|P1|NOT COMPLETED|First Test Day||1
333398|NCT01401153|799123|P2|COMPLETED|First Test Day||45
333399|NCT01401153|799124|P1|COMPLETED|First Test Day||65
333400|NCT01401153|799123|P2|STARTED|First Test Day||55
333401|NCT01401153|799124|P1|STARTED|First Test Day||66
333402|NCT01401101|799158|P2|NOT COMPLETED|Overall Study||27
333403|NCT01401101|799159|P1|NOT COMPLETED|Overall Study||22
333404|NCT01401101|799158|P2|COMPLETED|Overall Study||171
333405|NCT01401101|799159|P1|COMPLETED|Overall Study||184
333406|NCT01401101|799158|P2|STARTED|Overall Study||198
333407|NCT01401101|799159|P1|STARTED|Overall Study||206
333408|NCT01401062|799171|P2|NOT COMPLETED|Overall Study||8
333409|NCT01401062|799172|P1|NOT COMPLETED|Overall Study||11
333410|NCT01401062|799171|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
333411|NCT01401062|799172|P1|COMPLETED|Overall Study||0
333412|NCT01401062|799171|P2|STARTED|Overall Study||12
333413|NCT01401062|799172|P1|STARTED|Overall Study||11
333414|NCT01401049|799180|P2|NOT COMPLETED|Overall Study||0
333415|NCT01401049|799181|P1|NOT COMPLETED|Overall Study||0
333416|NCT01401049|799180|P2|COMPLETED|Overall Study||0
333417|NCT01401049|799181|P1|COMPLETED|Overall Study||0
333418|NCT01401049|799180|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
333419|NCT01401049|799181|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
333420|NCT01401023|799187|P1|NOT COMPLETED|Overall Study||0
333421|NCT01401023|799187|P1|COMPLETED|Overall Study||10
333422|NCT01401023|799187|P1|STARTED|Overall Study||10
333423|NCT01401010|799195|P2|NOT COMPLETED|Overall Study||0
333424|NCT01401010|799196|P1|NOT COMPLETED|Overall Study||1
333425|NCT01401010|799195|P2|COMPLETED|Overall Study||6
333426|NCT01401010|799196|P1|COMPLETED|Overall Study||5
333427|NCT01401010|799195|P2|STARTED|Overall Study||6
333428|NCT01401010|799196|P1|STARTED|Overall Study||6
333429|NCT01400958|799221|P2|NOT COMPLETED|Overall Study||2
333430|NCT01400958|799222|P1|NOT COMPLETED|Overall Study||1
333431|NCT01400958|799221|P2|COMPLETED|Overall Study||1
333432|NCT01400958|799222|P1|COMPLETED|Overall Study||2
333433|NCT01400958|799221|P2|STARTED|Overall Study||3
333434|NCT01400958|799222|P1|STARTED|Overall Study||3
333435|NCT01400932|799232|P2|NOT COMPLETED|Overall Study||15
333436|NCT01400932|799233|P1|NOT COMPLETED|Overall Study||14
333437|NCT01400932|799232|P2|COMPLETED|Overall Study||167
333438|NCT01400932|799233|P1|COMPLETED|Overall Study||164
333439|NCT01400932|799232|P2|STARTED|Overall Study||182
333440|NCT01400932|799233|P1|STARTED|Overall Study||178
333441|NCT01400919|799255|P1|NOT COMPLETED|Overall Study||8
333442|NCT01400919|799255|P1|COMPLETED|Overall Study||67
333443|NCT01400919|799255|P1|STARTED|Overall Study||75
333444|NCT01400906|799259|P6|NOT COMPLETED|Treatment Period 3||0
333445|NCT01400906|799260|P5|NOT COMPLETED|Treatment Period 3||0
333446|NCT01400906|799261|P4|NOT COMPLETED|Treatment Period 3||0
333447|NCT01400906|799262|P3|NOT COMPLETED|Treatment Period 3||0
333448|NCT01400906|799263|P2|NOT COMPLETED|Treatment Period 3||0
333449|NCT01400906|799264|P1|NOT COMPLETED|Treatment Period 3||0
333450|NCT01400906|799259|P6|COMPLETED|Treatment Period 3||5
333451|NCT01400906|799260|P5|COMPLETED|Treatment Period 3||6
333452|NCT01400906|799261|P4|COMPLETED|Treatment Period 3||6
333453|NCT01400906|799262|P3|COMPLETED|Treatment Period 3||6
333454|NCT01400906|799263|P2|COMPLETED|Treatment Period 3||6
333455|NCT01400906|799264|P1|COMPLETED|Treatment Period 3||6
333456|NCT01400906|799259|P6|STARTED|Treatment Period 3||5
333457|NCT01400906|799260|P5|STARTED|Treatment Period 3||6
333458|NCT01400906|799261|P4|STARTED|Treatment Period 3||6
333459|NCT01400906|799262|P3|STARTED|Treatment Period 3||6
333460|NCT01400906|799263|P2|STARTED|Treatment Period 3||6
333461|NCT01400906|799264|P1|STARTED|Treatment Period 3||6
333462|NCT01400906|799259|P6|NOT COMPLETED|Washout Period 2||0
333463|NCT01400906|799260|P5|NOT COMPLETED|Washout Period 2||0
333464|NCT01400906|799261|P4|NOT COMPLETED|Washout Period 2||0
333465|NCT01400906|799262|P3|NOT COMPLETED|Washout Period 2||0
333466|NCT01400906|799263|P2|NOT COMPLETED|Washout Period 2||0
333467|NCT01400906|799264|P1|NOT COMPLETED|Washout Period 2||0
333468|NCT01400906|799259|P6|COMPLETED|Washout Period 2||5
333469|NCT01400906|799260|P5|COMPLETED|Washout Period 2||6
333470|NCT01400906|799261|P4|COMPLETED|Washout Period 2||6
333471|NCT01400906|799262|P3|COMPLETED|Washout Period 2||6
333472|NCT01400906|799263|P2|COMPLETED|Washout Period 2||6
333473|NCT01400906|799264|P1|COMPLETED|Washout Period 2||6
333474|NCT01400906|799259|P6|STARTED|Washout Period 2||5
333475|NCT01400906|799260|P5|STARTED|Washout Period 2||6
333476|NCT01400906|799261|P4|STARTED|Washout Period 2||6
333477|NCT01400906|799262|P3|STARTED|Washout Period 2||6
333478|NCT01400906|799263|P2|STARTED|Washout Period 2||6
333479|NCT01400906|799264|P1|STARTED|Washout Period 2||6
333480|NCT01400906|799259|P6|NOT COMPLETED|Treatment Period 2||0
333481|NCT01400906|799260|P5|NOT COMPLETED|Treatment Period 2||0
333482|NCT01400906|799261|P4|NOT COMPLETED|Treatment Period 2||0
333483|NCT01400906|799262|P3|NOT COMPLETED|Treatment Period 2||0
333484|NCT01400906|799263|P2|NOT COMPLETED|Treatment Period 2||0
333485|NCT01400906|799264|P1|NOT COMPLETED|Treatment Period 2||0
333486|NCT01400906|799259|P6|COMPLETED|Treatment Period 2||5
333487|NCT01400906|799260|P5|COMPLETED|Treatment Period 2||6
333488|NCT01400906|799261|P4|COMPLETED|Treatment Period 2||6
333489|NCT01400906|799262|P3|COMPLETED|Treatment Period 2||6
333490|NCT01400906|799263|P2|COMPLETED|Treatment Period 2||6
333491|NCT01400906|799264|P1|COMPLETED|Treatment Period 2||6
333492|NCT01400906|799259|P6|STARTED|Treatment Period 2||5
333493|NCT01400906|799260|P5|STARTED|Treatment Period 2||6
333494|NCT01400906|799261|P4|STARTED|Treatment Period 2||6
333495|NCT01400906|799262|P3|STARTED|Treatment Period 2||6
333496|NCT01400906|799263|P2|STARTED|Treatment Period 2||6
333497|NCT01400906|799264|P1|STARTED|Treatment Period 2||6
333498|NCT01400906|799259|P6|NOT COMPLETED|Washout Period 1||0
333499|NCT01400906|799260|P5|NOT COMPLETED|Washout Period 1||0
333500|NCT01400906|799261|P4|NOT COMPLETED|Washout Period 1||0
333501|NCT01400906|799262|P3|NOT COMPLETED|Washout Period 1||0
333502|NCT01400906|799263|P2|NOT COMPLETED|Washout Period 1||0
333503|NCT01400906|799264|P1|NOT COMPLETED|Washout Period 1||0
333504|NCT01400906|799259|P6|COMPLETED|Washout Period 1||5
333505|NCT01400906|799260|P5|COMPLETED|Washout Period 1||6
333506|NCT01400906|799261|P4|COMPLETED|Washout Period 1||6
333507|NCT01400906|799262|P3|COMPLETED|Washout Period 1||6
333508|NCT01400906|799263|P2|COMPLETED|Washout Period 1||6
333509|NCT01400906|799264|P1|COMPLETED|Washout Period 1||6
333510|NCT01400906|799259|P6|STARTED|Washout Period 1||5
333511|NCT01400906|799260|P5|STARTED|Washout Period 1||6
333512|NCT01400906|799261|P4|STARTED|Washout Period 1||6
333513|NCT01400906|799262|P3|STARTED|Washout Period 1||6
333514|NCT01400906|799263|P2|STARTED|Washout Period 1||6
333515|NCT01400906|799264|P1|STARTED|Washout Period 1||6
333516|NCT01400906|799259|P6|NOT COMPLETED|Treatment Period 1||0
333517|NCT01400906|799260|P5|NOT COMPLETED|Treatment Period 1||0
333518|NCT01400906|799261|P4|NOT COMPLETED|Treatment Period 1||0
333519|NCT01400906|799262|P3|NOT COMPLETED|Treatment Period 1||0
333520|NCT01400906|799263|P2|NOT COMPLETED|Treatment Period 1||0
333521|NCT01400906|799264|P1|NOT COMPLETED|Treatment Period 1||0
333522|NCT01400906|799259|P6|COMPLETED|Treatment Period 1||5
333523|NCT01400906|799260|P5|COMPLETED|Treatment Period 1||6
333524|NCT01400906|799261|P4|COMPLETED|Treatment Period 1||6
333525|NCT01400906|799262|P3|COMPLETED|Treatment Period 1||6
333526|NCT01400906|799263|P2|COMPLETED|Treatment Period 1||6
333527|NCT01400906|799264|P1|COMPLETED|Treatment Period 1||6
333528|NCT01400906|799259|P6|STARTED|Treatment Period 1||5
333529|NCT01400906|799260|P5|STARTED|Treatment Period 1||6
333530|NCT01400906|799261|P4|STARTED|Treatment Period 1||6
333531|NCT01400906|799262|P3|STARTED|Treatment Period 1||6
333532|NCT01400906|799263|P2|STARTED|Treatment Period 1||6
333533|NCT01400906|799264|P1|STARTED|Treatment Period 1||6
333534|NCT01400880|799296|P1|NOT COMPLETED|Overall Study||2
333535|NCT01400880|799296|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
333536|NCT01400880|799296|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
333537|NCT01400841|799300|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
333538|NCT01400841|799300|P1|COMPLETED|Extended Study Phase (2 Years)||11
333539|NCT01400841|799300|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
333540|NCT01400841|799300|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
333541|NCT01400841|799300|P1|COMPLETED|Initial Study Phase (6 Months)||15
333542|NCT01400841|799300|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
333543|NCT01400698|799338|P6|NOT COMPLETED|Overall Study||6
333544|NCT01400698|799339|P5|NOT COMPLETED|Overall Study||7
333545|NCT01400698|799340|P4|NOT COMPLETED|Overall Study||8
333546|NCT01400698|799341|P3|NOT COMPLETED|Overall Study||2
333547|NCT01400698|799342|P2|NOT COMPLETED|Overall Study||11
333548|NCT01400698|799343|P1|NOT COMPLETED|Overall Study||15
333549|NCT01400698|799338|P6|COMPLETED|Overall Study||9
333550|NCT01400698|799339|P5|COMPLETED|Overall Study||7
333551|NCT01400698|799340|P4|COMPLETED|Overall Study||6
333552|NCT01400698|799341|P3|COMPLETED|Overall Study||0
333553|NCT01400698|799342|P2|COMPLETED|Overall Study||12
333554|NCT01400698|799343|P1|COMPLETED|Overall Study||8
333555|NCT01400698|799338|P6|STARTED|Overall Study||15
333556|NCT01400698|799339|P5|STARTED|Overall Study||14
333557|NCT01400698|799340|P4|STARTED|Overall Study||14
333558|NCT01400698|799341|P3|STARTED|Overall Study||2
333559|NCT01400698|799342|P2|STARTED|Overall Study||23
333560|NCT01400698|799343|P1|STARTED|Overall Study||23
333561|NCT01400516|799367|P2|NOT COMPLETED|Extension Trial||0
333562|NCT01400516|799368|P1|NOT COMPLETED|Extension Trial||0
333563|NCT01400516|799367|P2|COMPLETED|Extension Trial||7
333564|NCT01400516|799368|P1|COMPLETED|Extension Trial||6
333565|NCT01400516|799367|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
333566|NCT01400516|799368|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
333567|NCT01400516|799367|P2|NOT COMPLETED|Primary Trial||2
333568|NCT01400516|799368|P1|NOT COMPLETED|Primary Trial||0
333569|NCT01400516|799367|P2|COMPLETED|Primary Trial||12
333570|NCT01400516|799368|P1|COMPLETED|Primary Trial||12
333571|NCT01400516|799367|P2|STARTED|Primary Trial||14
333572|NCT01400516|799368|P1|STARTED|Primary Trial||12
333573|NCT01400451|799381|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
333574|NCT01400451|799382|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
333575|NCT01400451|799383|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
333576|NCT01400451|799381|P3|COMPLETED|Combination Treatment (or Intended)||0
333577|NCT01400451|799382|P2|COMPLETED|Combination Treatment (or Intended)||0
333578|NCT01400451|799383|P1|COMPLETED|Combination Treatment (or Intended)||0
333579|NCT01400451|799381|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
333580|NCT01400451|799382|P2|STARTED|Combination Treatment (or Intended)||4
333581|NCT01400451|799383|P1|STARTED|Combination Treatment (or Intended)||6
333582|NCT01400451|799381|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
333583|NCT01400451|799382|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
333584|NCT01400451|799383|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
333585|NCT01400451|799381|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
333586|NCT01400451|799382|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
333587|NCT01400451|799383|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
333588|NCT01400451|799381|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
333589|NCT01400451|799382|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
333590|NCT01400451|799383|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
333591|NCT01400425|799397|P1|NOT COMPLETED|Overall Study||10
333592|NCT01400425|799397|P1|COMPLETED|Overall Study||229
333593|NCT01400425|799397|P1|STARTED|Overall Study||239
333594|NCT01400412|799410|P2|NOT COMPLETED|Overall Study||17
333595|NCT01400412|799411|P1|NOT COMPLETED|Overall Study||10
333596|NCT01400412|799410|P2|COMPLETED|Overall Study||115
333597|NCT01400412|799411|P1|COMPLETED|Overall Study||120
333598|NCT01400412|799410|P2|STARTED|Overall Study||132
333599|NCT01400412|799411|P1|STARTED|Overall Study||130
333600|NCT01400243|799457|P2|NOT COMPLETED|Overall Study||11
333601|NCT01400243|799458|P1|NOT COMPLETED|Overall Study||8
333602|NCT01400243|799457|P2|COMPLETED|Overall Study||52
333603|NCT01400243|799458|P1|COMPLETED|Overall Study||56
333604|NCT01400243|799457|P2|STARTED|Overall Study||63
333605|NCT01400243|799458|P1|STARTED|Overall Study||64
333606|NCT01400139|799480|P1|NOT COMPLETED|HYD Extension Period||23
333607|NCT01400139|799480|P1|COMPLETED|HYD Extension Period||83
333608|NCT01400139|799480|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
333609|NCT01400139|799480|P1|NOT COMPLETED|HYD Core Study||512
333610|NCT01400139|799480|P1|COMPLETED|HYD Core Study||410
333611|NCT01400139|799480|P1|STARTED|HYD Core Study||922
333612|NCT01400113|799490|P2|NOT COMPLETED|Overall Study||1
333613|NCT01400113|799491|P1|NOT COMPLETED|Overall Study||1
333614|NCT01400113|799490|P2|COMPLETED|Overall Study||59
333615|NCT01400113|799491|P1|COMPLETED|Overall Study||59
333616|NCT01400113|799490|P2|STARTED|Overall Study||60
333617|NCT01400113|799491|P1|STARTED|Overall Study||60
333618|NCT01399866|799499|P2|NOT COMPLETED|Overall Study||2
333619|NCT01399866|799500|P1|NOT COMPLETED|Overall Study||4
333620|NCT01399866|799499|P2|COMPLETED|Overall Study||28
333621|NCT01399866|799500|P1|COMPLETED|Overall Study||28
333622|NCT01399866|799499|P2|STARTED|Overall Study||30
333623|NCT01399866|799500|P1|STARTED|Overall Study||32
333624|NCT01399788|799506|P2|NOT COMPLETED|Second Intervention Period||0
333625|NCT01399788|799507|P1|NOT COMPLETED|Second Intervention Period||0
333626|NCT01399788|799506|P2|COMPLETED|Second Intervention Period||18
333627|NCT01399788|799507|P1|COMPLETED|Second Intervention Period||17
333628|NCT01399788|799506|P2|STARTED|Second Intervention Period||18
333629|NCT01399788|799507|P1|STARTED|Second Intervention Period||17
333630|NCT01399788|799506|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
333631|NCT01399788|799507|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
333632|NCT01399788|799506|P2|COMPLETED|Washout Period (at Least 1 Week)||18
333633|NCT01399788|799507|P1|COMPLETED|Washout Period (at Least 1 Week)||17
333634|NCT01399788|799506|P2|STARTED|Washout Period (at Least 1 Week)||18
333635|NCT01399788|799507|P1|STARTED|Washout Period (at Least 1 Week)||17
333636|NCT01399788|799506|P2|NOT COMPLETED|First Intervention Period||0
333637|NCT01399788|799507|P1|NOT COMPLETED|First Intervention Period||1
333638|NCT01399788|799506|P2|COMPLETED|First Intervention Period||18
333639|NCT01399788|799507|P1|COMPLETED|First Intervention Period||17
333640|NCT01399788|799506|P2|STARTED|First Intervention Period||18
333641|NCT01399788|799507|P1|STARTED|First Intervention Period||18
333642|NCT01399723|799529|P2|NOT COMPLETED|Overall Study||1
333643|NCT01399723|799530|P1|NOT COMPLETED|Overall Study||0
333644|NCT01399723|799529|P2|COMPLETED|Overall Study||263
333645|NCT01399723|799530|P1|COMPLETED|Overall Study||263
333646|NCT01399723|799529|P2|STARTED|Overall Study||264
333647|NCT01399723|799530|P1|STARTED|Overall Study||263
333648|NCT01399697|799543|P3|NOT COMPLETED|Overall Study||4
333649|NCT01399697|799544|P2|NOT COMPLETED|Overall Study||3
333650|NCT01399697|799545|P1|NOT COMPLETED|Overall Study||41
333651|NCT01399697|799543|P3|COMPLETED|Overall Study||78
333652|NCT01399697|799544|P2|COMPLETED|Overall Study||80
333653|NCT01399697|799545|P1|COMPLETED|Overall Study||55
333654|NCT01399697|799543|P3|STARTED|Overall Study||82
333655|NCT01399697|799544|P2|STARTED|Overall Study||83
333656|NCT01399697|799545|P1|STARTED|Overall Study||96
333657|NCT01399619|799572|P4|NOT COMPLETED|Overall Study||17
333658|NCT01399619|799573|P3|NOT COMPLETED|Overall Study||12
333659|NCT01399619|799574|P2|NOT COMPLETED|Overall Study||0
333660|NCT01399619|799575|P1|NOT COMPLETED|Overall Study||25
333661|NCT01399619|799572|P4|COMPLETED|Overall Study||0
333662|NCT01399619|799573|P3|COMPLETED|Overall Study||74
333663|NCT01399619|799574|P2|COMPLETED|Overall Study||84
333664|NCT01399619|799575|P1|COMPLETED|Overall Study||98
333665|NCT01399619|799572|P4|STARTED|Overall Study||17
333666|NCT01399619|799573|P3|STARTED|Overall Study||86
333667|NCT01399619|799574|P2|STARTED|Overall Study||84
333668|NCT01399619|799575|P1|STARTED|Overall Study||123
333669|NCT01399593|799638|P2|NOT COMPLETED|Overall Study||2
333670|NCT01399593|799639|P1|NOT COMPLETED|Overall Study||3
333671|NCT01399593|799638|P2|COMPLETED|Overall Study||49
333672|NCT01399593|799639|P1|COMPLETED|Overall Study||48
333673|NCT01399593|799638|P2|STARTED|Overall Study||51
333674|NCT01399593|799639|P1|STARTED|Overall Study||51
333675|NCT01399229|799645|P3|NOT COMPLETED|Overall Study||0
333676|NCT01399229|799646|P2|NOT COMPLETED|Overall Study||0
333677|NCT01399229|799647|P1|NOT COMPLETED|Overall Study||0
333678|NCT01399229|799645|P3|COMPLETED|Overall Study||5
333679|NCT01399229|799646|P2|COMPLETED|Overall Study||5
333680|NCT01399229|799647|P1|COMPLETED|Overall Study||20
333681|NCT01399229|799645|P3|STARTED|Overall Study||5
333682|NCT01399229|799646|P2|STARTED|Overall Study||5
333683|NCT01399229|799647|P1|STARTED|Overall Study||20
333684|NCT01399190|799651|P1|NOT COMPLETED|Overall Study||20
333685|NCT01399190|799651|P1|COMPLETED|Overall Study||48
333686|NCT01399190|799651|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
333687|NCT01399190|799651|P1|Included in Final Analysis|Overall Study||63
333688|NCT01399190|799651|P1|STARTED|Overall Study||68
333689|NCT01399125|799659|P2|NOT COMPLETED|Overall Study||60
333690|NCT01399125|799660|P1|NOT COMPLETED|Overall Study||51
333691|NCT01399125|799659|P2|COMPLETED|Overall Study||193
333692|NCT01399125|799660|P1|COMPLETED|Overall Study||197
333693|NCT01399125|799659|P2|Per Protocol (PP) Population|Overall Study||188
333694|NCT01399125|799660|P1|Per Protocol (PP) Population|Overall Study||192
333695|NCT01399125|799659|P2|STARTED|Overall Study||253
333696|NCT01399125|799660|P1|STARTED|Overall Study||248
333697|NCT01399099|799674|P1|NOT COMPLETED|Overall Study||31
333698|NCT01399099|799674|P1|COMPLETED|Overall Study||36
333699|NCT01399099|799674|P1|6 Months|Overall Study||47
333700|NCT01399099|799674|P1|STARTED|Overall Study||67
333701|NCT01399047|799681|P2|NOT COMPLETED|Overall Study||1
333702|NCT01399047|799682|P1|NOT COMPLETED|Overall Study||0
333703|NCT01399047|799681|P2|COMPLETED|Overall Study||8
333704|NCT01399047|799682|P1|COMPLETED|Overall Study||10
333705|NCT01399047|799681|P2|STARTED|Overall Study||9
333706|NCT01399047|799682|P1|STARTED|Overall Study||10
333707|NCT01399008|799691|P3|NOT COMPLETED|Overall Study||2
333708|NCT01399008|799692|P2|NOT COMPLETED|Overall Study||5
333709|NCT01399008|799693|P1|NOT COMPLETED|Overall Study||3
333710|NCT01399008|799691|P3|COMPLETED|Overall Study||31
333711|NCT01399008|799692|P2|COMPLETED|Overall Study||27
333712|NCT01399008|799693|P1|COMPLETED|Overall Study||32
333713|NCT01399008|799691|P3|STARTED|Overall Study||33
333714|NCT01399008|799692|P2|STARTED|Overall Study||32
333715|NCT01399008|799693|P1|STARTED|Overall Study||35
333716|NCT01398982|799703|P2|NOT COMPLETED|Overall Study||2
333717|NCT01398982|799704|P1|NOT COMPLETED|Overall Study||6
333718|NCT01398982|799703|P2|COMPLETED|Overall Study||47
333719|NCT01398982|799704|P1|COMPLETED|Overall Study||38
333720|NCT01398982|799703|P2|STARTED|Overall Study||49
333721|NCT01398982|799704|P1|STARTED|Overall Study||44
333722|NCT01398956|799710|P1|NOT COMPLETED|Overall Study||10
333723|NCT01398956|799710|P1|COMPLETED|Overall Study||34
333724|NCT01398956|799710|P1|STARTED|Overall Study||44
333725|NCT01398852|799716|P1|NOT COMPLETED|Overall Study||372
333726|NCT01398852|799716|P1|COMPLETED|Overall Study||0
333727|NCT01398852|799716|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
333728|NCT01398839|799722|P2|NOT COMPLETED|Overall Study||0
333729|NCT01398839|799723|P1|NOT COMPLETED|Overall Study||0
333730|NCT01398839|799722|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
333731|NCT01398839|799723|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
333732|NCT01398839|799722|P2|STARTED|Overall Study||37
333733|NCT01398839|799723|P1|STARTED|Overall Study||35
333734|NCT01398787|799729|P1|NOT COMPLETED|Overall Study||1
333735|NCT01398787|799729|P1|COMPLETED|Overall Study||197
333736|NCT01398787|799729|P1|STARTED|Overall Study||198
333737|NCT01398514|799747|P2|NOT COMPLETED|Overall Study||6
333738|NCT01398514|799748|P1|NOT COMPLETED|Overall Study||8
333739|NCT01398514|799747|P2|COMPLETED|Overall Study||20
333740|NCT01398514|799748|P1|COMPLETED|Overall Study||18
333741|NCT01398514|799747|P2|STARTED|Overall Study||26
333742|NCT01398514|799748|P1|STARTED|Overall Study||26
333743|NCT01398475|799760|P4|NOT COMPLETED|Overall Study||0
333744|NCT01398475|799761|P3|NOT COMPLETED|Overall Study||0
333745|NCT01398475|799762|P2|NOT COMPLETED|Overall Study||0
333746|NCT01398475|799763|P1|NOT COMPLETED|Overall Study||0
333747|NCT01398475|799760|P4|COMPLETED|Overall Study||4
333748|NCT01398475|799761|P3|COMPLETED|Overall Study||4
333749|NCT01398475|799762|P2|COMPLETED|Overall Study||3
333750|NCT01398475|799763|P1|COMPLETED|Overall Study||4
333751|NCT01398475|799760|P4|Received Fourth Intervention|Overall Study||4
333752|NCT01398475|799761|P3|Received Fourth Intervention|Overall Study||4
333753|NCT01398475|799762|P2|Received Fourth Intervention|Overall Study||3
333754|NCT01398475|799763|P1|Received Fourth Intervention|Overall Study||4
333755|NCT01398475|799760|P4|Received Third Intervention|Overall Study||4
333756|NCT01398475|799761|P3|Received Third Intervention|Overall Study||4
333757|NCT01398475|799762|P2|Received Third Intervention|Overall Study||3
333758|NCT01398475|799763|P1|Received Third Intervention|Overall Study||4
333759|NCT01398475|799760|P4|Received Second Intervention|Overall Study||4
333760|NCT01398475|799761|P3|Received Second Intervention|Overall Study||4
333761|NCT01398475|799762|P2|Received Second Intervention|Overall Study||3
333762|NCT01398475|799763|P1|Received Second Intervention|Overall Study||4
333763|NCT01398475|799760|P4|Received First Intervention|Overall Study||4
333764|NCT01398475|799761|P3|Received First Intervention|Overall Study||4
333765|NCT01398475|799762|P2|Received First Intervention|Overall Study||3
333766|NCT01398475|799763|P1|Received First Intervention|Overall Study||4
333767|NCT01398475|799760|P4|STARTED|Overall Study||4
333768|NCT01398475|799761|P3|STARTED|Overall Study||4
333769|NCT01398475|799762|P2|STARTED|Overall Study||3
333770|NCT01398475|799763|P1|STARTED|Overall Study||4
333771|NCT01398410|799783|P2|NOT COMPLETED|Overall Study||56
333772|NCT01398410|799784|P1|NOT COMPLETED|Overall Study||58
333773|NCT01398410|799783|P2|COMPLETED|Overall Study||148
333774|NCT01398410|799784|P1|COMPLETED|Overall Study||143
333775|NCT01398410|799783|P2|STARTED|Overall Study||204
333776|NCT01398410|799784|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
333777|NCT01398176|799794|P2|NOT COMPLETED|Overall Study||6
333778|NCT01398176|799795|P1|NOT COMPLETED|Overall Study||3
333779|NCT01398176|799794|P2|COMPLETED|Overall Study||19
333780|NCT01398176|799795|P1|COMPLETED|Overall Study||23
333781|NCT01398176|799794|P2|STARTED|Overall Study||25
333782|NCT01398176|799795|P1|STARTED|Overall Study||26
333783|NCT01397890|799803|P2|NOT COMPLETED|Overall Study||31
333784|NCT01397890|799804|P1|NOT COMPLETED|Overall Study||23
333785|NCT01397890|799803|P2|COMPLETED|Overall Study||260
333786|NCT01397890|799804|P1|COMPLETED|Overall Study||264
333787|NCT01397890|799803|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
333788|NCT01397890|799804|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
333789|NCT01397890|799803|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
333790|NCT01397890|799804|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
333791|NCT01397890|799803|P2|STARTED|Overall Study||291
333792|NCT01397890|799804|P1|STARTED|Overall Study||287
333793|NCT01397851|799858|P2|NOT COMPLETED|Overall Study||46
333794|NCT01397851|799859|P1|NOT COMPLETED|Overall Study||79
333795|NCT01397851|799858|P2|COMPLETED|Overall Study||39917
333796|NCT01397851|799859|P1|COMPLETED|Overall Study||41555
333797|NCT01397851|799858|P2|STARTED|Overall Study||39963
333798|NCT01397851|799859|P1|STARTED|Overall Study||41634
333799|NCT01397786|799874|P3|NOT COMPLETED|Phase B||138
333800|NCT01397786|799875|P2|NOT COMPLETED|Phase B||95
333801|NCT01397786|799876|P1|NOT COMPLETED|Phase B||303
333802|NCT01397786|799874|P3|COMPLETED|Phase B||91
333803|NCT01397786|799875|P2|COMPLETED|Phase B||109
333804|NCT01397786|799876|P1|COMPLETED|Phase B||308
333805|NCT01397786|799874|P3|STARTED|Phase B||229
333806|NCT01397786|799875|P2|STARTED|Phase B||204
333807|NCT01397786|799876|P1|STARTED|Phase B||611
333808|NCT01397786|799874|P3|NOT COMPLETED|Phase A||28
333809|NCT01397786|799875|P2|NOT COMPLETED|Phase A||0
333810|NCT01397786|799876|P1|NOT COMPLETED|Phase A||0
333811|NCT01397786|799874|P3|COMPLETED|Phase A||199
333812|NCT01397786|799875|P2|COMPLETED|Phase A||0
333813|NCT01397786|799876|P1|COMPLETED|Phase A||12
333814|NCT01397786|799874|P3|STARTED|Phase A||227
333815|NCT01397786|799875|P2|STARTED|Phase A||0
333816|NCT01397786|799876|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
333817|NCT01397747|799942|P1|NOT COMPLETED|Overall Study||1027
333818|NCT01397747|799942|P1|COMPLETED|Overall Study||9989
333819|NCT01397747|799942|P1|STARTED|Overall Study||11016
333820|NCT01397617|799950|P3|NOT COMPLETED|Overall Study||29
333821|NCT01397617|799951|P2|NOT COMPLETED|Overall Study||23
333822|NCT01397617|799952|P1|NOT COMPLETED|Overall Study||31
333823|NCT01397617|799950|P3|COMPLETED|Overall Study||31
333824|NCT01397617|799951|P2|COMPLETED|Overall Study||30
333825|NCT01397617|799952|P1|COMPLETED|Overall Study||33
333826|NCT01397617|799950|P3|STARTED|Overall Study||60
333827|NCT01397617|799951|P2|STARTED|Overall Study||53
333828|NCT01397617|799952|P1|STARTED|Overall Study||64
333829|NCT01397591|799963|P1|NOT COMPLETED|Overall Study||0
333830|NCT01397591|799963|P1|COMPLETED|Overall Study||2
333831|NCT01397591|799963|P1|STARTED|Overall Study||2
333832|NCT01397461|799974|P3|NOT COMPLETED|Overall Study||2
333833|NCT01397461|799975|P2|NOT COMPLETED|Overall Study||6
333834|NCT01397461|799976|P1|NOT COMPLETED|Overall Study||2
333835|NCT01397461|799974|P3|COMPLETED|Overall Study||152
333836|NCT01397461|799975|P2|COMPLETED|Overall Study||150
333837|NCT01397461|799976|P1|COMPLETED|Overall Study||153
333838|NCT01397461|799974|P3|STARTED|Overall Study||154
333839|NCT01397461|799975|P2|STARTED|Overall Study||156
333840|NCT01397461|799976|P1|STARTED|Overall Study||155
333841|NCT01397448|799987|P3|NOT COMPLETED|Overall Study||18
333842|NCT01397448|799988|P2|NOT COMPLETED|Overall Study||15
333843|NCT01397448|799989|P1|NOT COMPLETED|Overall Study||18
333844|NCT01397448|799987|P3|COMPLETED|Overall Study||140
333845|NCT01397448|799988|P2|COMPLETED|Overall Study||142
333846|NCT01397448|799989|P1|COMPLETED|Overall Study||138
333847|NCT01397448|799987|P3|STARTED|Overall Study||158
333848|NCT01397448|799988|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
333849|NCT01397448|799989|P1|STARTED|Overall Study||156
333850|NCT01397409|800010|P10|NOT COMPLETED|Stage 3||0
333851|NCT01397409|800011|P9|NOT COMPLETED|Stage 3||0
333852|NCT01397409|800012|P8|NOT COMPLETED|Stage 3||2
333853|NCT01397409|800013|P7|NOT COMPLETED|Stage 3||0
333854|NCT01397409|800014|P6|NOT COMPLETED|Stage 3||0
333855|NCT01397409|800015|P5|NOT COMPLETED|Stage 3||0
333856|NCT01397409|800016|P4|NOT COMPLETED|Stage 3||0
333857|NCT01397409|800017|P3|NOT COMPLETED|Stage 3||0
333858|NCT01397409|800018|P2|NOT COMPLETED|Stage 3||0
333859|NCT01397409|800019|P1|NOT COMPLETED|Stage 3||0
333860|NCT01397409|800010|P10|COMPLETED|Stage 3||16
333861|NCT01397409|800011|P9|COMPLETED|Stage 3||25
333862|NCT01397409|800012|P8|COMPLETED|Stage 3||21
333863|NCT01397409|800013|P7|COMPLETED|Stage 3||0
333864|NCT01397409|800014|P6|COMPLETED|Stage 3||0
333865|NCT01397409|800015|P5|COMPLETED|Stage 3||0
333866|NCT01397409|800016|P4|COMPLETED|Stage 3||0
333867|NCT01397409|800017|P3|COMPLETED|Stage 3||0
333868|NCT01397409|800018|P2|COMPLETED|Stage 3||0
333869|NCT01397409|800019|P1|COMPLETED|Stage 3||0
333870|NCT01397409|800010|P10|STARTED|Stage 3||16
333871|NCT01397409|800011|P9|STARTED|Stage 3||25
333872|NCT01397409|800012|P8|STARTED|Stage 3||23
333873|NCT01397409|800013|P7|STARTED|Stage 3||0
333874|NCT01397409|800014|P6|STARTED|Stage 3||0
333875|NCT01397409|800015|P5|STARTED|Stage 3||0
333876|NCT01397409|800016|P4|STARTED|Stage 3||0
333877|NCT01397409|800017|P3|STARTED|Stage 3||0
333878|NCT01397409|800018|P2|STARTED|Stage 3||0
333879|NCT01397409|800019|P1|STARTED|Stage 3||0
333880|NCT01397409|800010|P10|NOT COMPLETED|Stage 2||0
333881|NCT01397409|800011|P9|NOT COMPLETED|Stage 2||0
333882|NCT01397409|800012|P8|NOT COMPLETED|Stage 2||0
333883|NCT01397409|800013|P7|NOT COMPLETED|Stage 2||0
333884|NCT01397409|800014|P6|NOT COMPLETED|Stage 2||4
333885|NCT01397409|800015|P5|NOT COMPLETED|Stage 2||8
333886|NCT01397409|800016|P4|NOT COMPLETED|Stage 2||0
333887|NCT01397409|800017|P3|NOT COMPLETED|Stage 2||0
333888|NCT01397409|800018|P2|NOT COMPLETED|Stage 2||0
333889|NCT01397409|800019|P1|NOT COMPLETED|Stage 2||0
333890|NCT01397409|800010|P10|COMPLETED|Stage 2||0
333891|NCT01397409|800011|P9|COMPLETED|Stage 2||0
333892|NCT01397409|800012|P8|COMPLETED|Stage 2||0
333893|NCT01397409|800013|P7|COMPLETED|Stage 2||58
333894|NCT01397409|800014|P6|COMPLETED|Stage 2||54
333895|NCT01397409|800015|P5|COMPLETED|Stage 2||59
333896|NCT01397409|800016|P4|COMPLETED|Stage 2||0
333897|NCT01397409|800017|P3|COMPLETED|Stage 2||0
333898|NCT01397409|800018|P2|COMPLETED|Stage 2||0
333899|NCT01397409|800019|P1|COMPLETED|Stage 2||0
333900|NCT01397409|800010|P10|STARTED|Stage 2||0
333901|NCT01397409|800011|P9|STARTED|Stage 2||0
333902|NCT01397409|800012|P8|STARTED|Stage 2||0
333903|NCT01397409|800013|P7|STARTED|Stage 2||58
333904|NCT01397409|800014|P6|STARTED|Stage 2||58
333905|NCT01397409|800015|P5|STARTED|Stage 2||67
333906|NCT01397409|800016|P4|STARTED|Stage 2||0
333907|NCT01397409|800017|P3|STARTED|Stage 2||0
333908|NCT01397409|800018|P2|STARTED|Stage 2||0
333909|NCT01397409|800019|P1|STARTED|Stage 2||0
333910|NCT01397409|800010|P10|NOT COMPLETED|Stage 1||0
333911|NCT01397409|800011|P9|NOT COMPLETED|Stage 1||0
333912|NCT01397409|800012|P8|NOT COMPLETED|Stage 1||0
333913|NCT01397409|800013|P7|NOT COMPLETED|Stage 1||0
333914|NCT01397409|800014|P6|NOT COMPLETED|Stage 1||0
333915|NCT01397409|800015|P5|NOT COMPLETED|Stage 1||0
333916|NCT01397409|800016|P4|NOT COMPLETED|Stage 1||0
333917|NCT01397409|800017|P3|NOT COMPLETED|Stage 1||0
333918|NCT01397409|800018|P2|NOT COMPLETED|Stage 1||0
333919|NCT01397409|800019|P1|NOT COMPLETED|Stage 1||0
333920|NCT01397409|800010|P10|COMPLETED|Stage 1||0
333921|NCT01397409|800011|P9|COMPLETED|Stage 1||0
333922|NCT01397409|800012|P8|COMPLETED|Stage 1||0
333923|NCT01397409|800013|P7|COMPLETED|Stage 1||0
333924|NCT01397409|800014|P6|COMPLETED|Stage 1||0
333925|NCT01397409|800015|P5|COMPLETED|Stage 1||0
333926|NCT01397409|800016|P4|COMPLETED|Stage 1||3
333927|NCT01397409|800017|P3|COMPLETED|Stage 1||6
333928|NCT01397409|800018|P2|COMPLETED|Stage 1||6
333929|NCT01397409|800019|P1|COMPLETED|Stage 1||9
333930|NCT01397409|800010|P10|STARTED|Stage 1||0
333931|NCT01397409|800011|P9|STARTED|Stage 1||0
333932|NCT01397409|800012|P8|STARTED|Stage 1||0
333933|NCT01397409|800013|P7|STARTED|Stage 1||0
333934|NCT01397409|800014|P6|STARTED|Stage 1||0
333935|NCT01397409|800015|P5|STARTED|Stage 1||0
333936|NCT01397409|800016|P4|STARTED|Stage 1||3
333937|NCT01397409|800017|P3|STARTED|Stage 1||6
333938|NCT01397409|800018|P2|STARTED|Stage 1||6
333939|NCT01397409|800019|P1|STARTED|Stage 1||9
333940|NCT01397253|800059|P2|NOT COMPLETED|Overall Study||149
333941|NCT01397253|800060|P1|NOT COMPLETED|Overall Study||126
333942|NCT01397253|800059|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
333943|NCT01397253|800060|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
333944|NCT01397253|800059|P2|STARTED|Overall Study||392
333945|NCT01397253|800060|P1|STARTED|Overall Study||443
333946|NCT01397084|800066|P1|NOT COMPLETED|Overall Study||8
333947|NCT01397084|800066|P1|COMPLETED|Overall Study||100
333948|NCT01397084|800066|P1|STARTED|Overall Study||108
333949|NCT01396525|800073|P1|NOT COMPLETED|Overall Study||26
333950|NCT01396525|800073|P1|COMPLETED|Overall Study||127
333951|NCT01396525|800073|P1|STARTED|Overall Study||153
333952|NCT01396512|800173|P2|NOT COMPLETED|Overall Study||1
333953|NCT01396512|800174|P1|NOT COMPLETED|Overall Study||0
333954|NCT01396512|800173|P2|COMPLETED|Overall Study||136
333955|NCT01396512|800174|P1|COMPLETED|Overall Study||137
333956|NCT01396512|800173|P2|STARTED|Overall Study||137
333957|NCT01396512|800174|P1|STARTED|Overall Study||137
333958|NCT01396434|800189|P3|NOT COMPLETED|Overall Study||0
333959|NCT01396434|800190|P2|NOT COMPLETED|Overall Study||0
333960|NCT01396434|800191|P1|NOT COMPLETED|Overall Study||11
333961|NCT01396434|800189|P3|COMPLETED|Overall Study||14
333962|NCT01396434|800190|P2|COMPLETED|Overall Study||175
333963|NCT01396434|800191|P1|COMPLETED|Overall Study||2806
333964|NCT01396434|800189|P3|STARTED|Overall Study||14
333965|NCT01396434|800190|P2|STARTED|Overall Study||175
333966|NCT01396434|800191|P1|STARTED|Overall Study||2817
333967|NCT01396421|800203|P4|NOT COMPLETED|Overall Study||75
333968|NCT01396421|800204|P3|NOT COMPLETED|Overall Study||34
333969|NCT01396421|800205|P2|NOT COMPLETED|Overall Study||58
333970|NCT01396421|800206|P1|NOT COMPLETED|Overall Study||59
333971|NCT01396421|800203|P4|COMPLETED|Overall Study||109
333972|NCT01396421|800204|P3|COMPLETED|Overall Study||56
333973|NCT01396421|800205|P2|COMPLETED|Overall Study||124
333974|NCT01396421|800206|P1|COMPLETED|Overall Study||121
333975|NCT01396421|800203|P4|STARTED|Overall Study||184
333976|NCT01396421|800204|P3|STARTED|Overall Study||90
333977|NCT01396421|800205|P2|STARTED|Overall Study||182
333978|NCT01396421|800206|P1|STARTED|Overall Study||180
333979|NCT01396395|800278|P2|NOT COMPLETED|Overall Study||27
333980|NCT01396395|800279|P1|NOT COMPLETED|Overall Study||40
333981|NCT01396395|800278|P2|COMPLETED|Overall Study||175
333982|NCT01396395|800279|P1|COMPLETED|Overall Study||160
333983|NCT01396395|800278|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
333984|NCT01396395|800279|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
333985|NCT01396395|800278|P2|STARTED|Overall Study||202
333986|NCT01396395|800279|P1|STARTED|Overall Study||200
333987|NCT01396382|800314|P1|NOT COMPLETED|Overall Study||0
333988|NCT01396382|800314|P1|COMPLETED|Overall Study||97
333989|NCT01396382|800314|P1|STARTED|Overall Study||97
333990|NCT01396265|800319|P1|NOT COMPLETED|Rifa+Afatinib||1
333991|NCT01396265|800319|P1|COMPLETED|Rifa+Afatinib||21
333992|NCT01396265|800319|P1|STARTED|Rifa+Afatinib||22
333993|NCT01396265|800319|P1|NOT COMPLETED|Washout||0
333994|NCT01396265|800319|P1|COMPLETED|Washout||22
333995|NCT01396265|800319|P1|STARTED|Washout||22
333996|NCT01396265|800319|P1|NOT COMPLETED|Afatinib||0
333997|NCT01396265|800319|P1|COMPLETED|Afatinib||22
333998|NCT01396265|800319|P1|STARTED|Afatinib||22
333999|NCT01396239|800346|P4|NOT COMPLETED|Overall Study||0
334000|NCT01396239|800347|P3|NOT COMPLETED|Overall Study||0
334001|NCT01396239|800348|P2|NOT COMPLETED|Overall Study||0
334002|NCT01396239|800349|P1|NOT COMPLETED|Overall Study||0
334003|NCT01396239|800346|P4|COMPLETED|Overall Study||2
334004|NCT01396239|800347|P3|COMPLETED|Overall Study||4
334005|NCT01396239|800348|P2|COMPLETED|Overall Study||2
334006|NCT01396239|800349|P1|COMPLETED|Overall Study||4
334007|NCT01396239|800346|P4|STARTED|Overall Study||2
334008|NCT01396239|800347|P3|STARTED|Overall Study||4
334009|NCT01396239|800348|P2|STARTED|Overall Study||2
334010|NCT01396239|800349|P1|STARTED|Overall Study||4
334011|NCT01396226|800372|P2|NOT COMPLETED|Overall Study||0
334012|NCT01396226|800373|P1|NOT COMPLETED|Overall Study||0
334013|NCT01396226|800372|P2|COMPLETED|Overall Study||6
334014|NCT01396226|800373|P1|COMPLETED|Overall Study||12
334015|NCT01396226|800372|P2|Patients Who Completed Treatment|Overall Study||6
334016|NCT01396226|800373|P1|Patients Who Completed Treatment|Overall Study||12
334017|NCT01396226|800372|P2|Patients Who Received Treatment|Overall Study||6
334018|NCT01396226|800373|P1|Patients Who Received Treatment|Overall Study||12
334019|NCT01396226|800372|P2|STARTED|Overall Study||6
334020|NCT01396226|800373|P1|STARTED|Overall Study||12
334021|NCT01396187|800408|P5|NOT COMPLETED|Overall Study||1
334022|NCT01396187|800409|P4|NOT COMPLETED|Overall Study||0
334023|NCT01396187|800410|P3|NOT COMPLETED|Overall Study||1
334024|NCT01396187|800411|P2|NOT COMPLETED|Overall Study||3
334025|NCT01396187|800412|P1|NOT COMPLETED|Overall Study||1
334026|NCT01396187|800408|P5|COMPLETED|Overall Study||9
334027|NCT01396187|800409|P4|COMPLETED|Overall Study||10
334028|NCT01396187|800410|P3|COMPLETED|Overall Study||9
334029|NCT01396187|800411|P2|COMPLETED|Overall Study||9
334030|NCT01396187|800412|P1|COMPLETED|Overall Study||7
334031|NCT01396187|800408|P5|STARTED|Overall Study||10
334032|NCT01396187|800409|P4|STARTED|Overall Study||10
334033|NCT01396187|800410|P3|STARTED|Overall Study||10
334034|NCT01396187|800411|P2|STARTED|Overall Study||12
334035|NCT01396187|800412|P1|STARTED|Overall Study||8
334036|NCT01396161|800512|P7|NOT COMPLETED|Overall Study||1
334037|NCT01396161|800513|P6|NOT COMPLETED|Overall Study||0
334038|NCT01396161|800514|P5|NOT COMPLETED|Overall Study||1
334039|NCT01396161|800515|P4|NOT COMPLETED|Overall Study||0
334040|NCT01396161|800516|P3|NOT COMPLETED|Overall Study||0
334041|NCT01396161|800517|P2|NOT COMPLETED|Overall Study||0
334042|NCT01396161|800518|P1|NOT COMPLETED|Overall Study||0
334043|NCT01396161|800512|P7|COMPLETED|Overall Study||10
334044|NCT01396161|800513|P6|COMPLETED|Overall Study||9
334045|NCT01396161|800514|P5|COMPLETED|Overall Study||8
334046|NCT01396161|800515|P4|COMPLETED|Overall Study||9
334047|NCT01396161|800516|P3|COMPLETED|Overall Study||9
334048|NCT01396161|800517|P2|COMPLETED|Overall Study||5
334049|NCT01396161|800518|P1|COMPLETED|Overall Study||12
334050|NCT01396161|800512|P7|STARTED|Overall Study||11
334051|NCT01396161|800513|P6|STARTED|Overall Study||9
334052|NCT01396161|800514|P5|STARTED|Overall Study||9
334053|NCT01396161|800515|P4|STARTED|Overall Study||9
334054|NCT01396161|800516|P3|STARTED|Overall Study||9
334055|NCT01396161|800517|P2|STARTED|Overall Study||5
334056|NCT01396161|800518|P1|STARTED|Overall Study||12
334057|NCT01396083|800573|P2|NOT COMPLETED|Overall Study||47
334058|NCT01396083|800574|P1|NOT COMPLETED|Overall Study||11
334059|NCT01396083|800573|P2|COMPLETED|Overall Study||72
334060|NCT01396083|800574|P1|COMPLETED|Overall Study||113
334061|NCT01396083|800573|P2|STARTED|Overall Study||119
334062|NCT01396083|800574|P1|STARTED|Overall Study||124
334063|NCT01396070|800598|P1|NOT COMPLETED|Overall Study||19
334064|NCT01396070|800598|P1|COMPLETED|Overall Study||17
334065|NCT01396070|800598|P1|STARTED|Overall Study||36
334066|NCT01396057|800607|P2|NOT COMPLETED|Overall Study||18
334067|NCT01396057|800608|P1|NOT COMPLETED|Overall Study||11
334068|NCT01396057|800607|P2|COMPLETED|Overall Study||100
334069|NCT01396057|800608|P1|COMPLETED|Overall Study||115
334070|NCT01396057|800607|P2|STARTED|Overall Study||118
334071|NCT01396057|800608|P1|STARTED|Overall Study||126
334072|NCT01396044|800634|P2|NOT COMPLETED|Overall Study||0
334073|NCT01396044|800635|P1|NOT COMPLETED|Overall Study||0
334074|NCT01396044|800634|P2|COMPLETED|Overall Study||171
334075|NCT01396044|800635|P1|COMPLETED|Overall Study||125
334076|NCT01396044|800634|P2|STARTED|Overall Study||171
334077|NCT01396044|800635|P1|STARTED|Overall Study||125
334078|NCT01396005|800657|P2|NOT COMPLETED|Overall Study||2
334079|NCT01396005|800658|P1|NOT COMPLETED|Overall Study||0
334080|NCT01396005|800657|P2|COMPLETED|Overall Study||9
334081|NCT01396005|800658|P1|COMPLETED|Overall Study||10
334082|NCT01396005|800657|P2|STARTED|Overall Study||11
334083|NCT01396005|800658|P1|STARTED|Overall Study||10
334084|NCT01395966|800677|P3|NOT COMPLETED|Overall Study||8
334085|NCT01395966|800678|P2|NOT COMPLETED|Overall Study||19
334086|NCT01395966|800679|P1|NOT COMPLETED|Overall Study||10
334087|NCT01395966|800677|P3|COMPLETED|Overall Study||104
334088|NCT01395966|800678|P2|COMPLETED|Overall Study||91
334089|NCT01395966|800679|P1|COMPLETED|Overall Study||99
334090|NCT01395966|800677|P3|STARTED|Overall Study||112
334091|NCT01395966|800678|P2|STARTED|Overall Study||110
334092|NCT01395966|800679|P1|STARTED|Overall Study||109
334093|NCT01395901|800689|P2|NOT COMPLETED|Overall Study||5
334094|NCT01395901|800690|P1|NOT COMPLETED|Overall Study||10
334095|NCT01395901|800689|P2|COMPLETED|Overall Study|Treated patients completing the study|329
334096|NCT01395901|800690|P1|COMPLETED|Overall Study|Treated patients completing the study|326
334097|NCT01395901|800689|P2|STARTED|Overall Study|Randomized Population|334
334098|NCT01395901|800690|P1|STARTED|Overall Study|Randomized Population|336
334099|NCT01395888|800706|P3|NOT COMPLETED|Treatment Period (TP)||17
334100|NCT01395888|800707|P2|NOT COMPLETED|Treatment Period (TP)||15
334101|NCT01395888|800708|P1|NOT COMPLETED|Treatment Period (TP)||0
334102|NCT01395888|800706|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
334103|NCT01395888|800707|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
334104|NCT01395888|800708|P1|COMPLETED|Treatment Period (TP)||0
334105|NCT01395888|800706|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
334106|NCT01395888|800707|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
334107|NCT01395888|800708|P1|Completed the Treatment Period|Treatment Period (TP)||0
334108|NCT01395888|800706|P3|STARTED|Treatment Period (TP)||130
334109|NCT01395888|800707|P2|STARTED|Treatment Period (TP)||127
334110|NCT01395888|800708|P1|STARTED|Treatment Period (TP)||0
334111|NCT01395888|800706|P3|NOT COMPLETED|2-week Run-in Period||0
334112|NCT01395888|800707|P2|NOT COMPLETED|2-week Run-in Period||0
334113|NCT01395888|800708|P1|NOT COMPLETED|2-week Run-in Period||22
334114|NCT01395888|800706|P3|COMPLETED|2-week Run-in Period||0
334115|NCT01395888|800707|P2|COMPLETED|2-week Run-in Period||0
334116|NCT01395888|800708|P1|COMPLETED|2-week Run-in Period||257
334117|NCT01395888|800706|P3|STARTED|2-week Run-in Period||0
334118|NCT01395888|800707|P2|STARTED|2-week Run-in Period||0
334119|NCT01395888|800708|P1|STARTED|2-week Run-in Period||279
334120|NCT01395823|800716|P2|NOT COMPLETED|Overall Study||9
334121|NCT01395823|800717|P1|NOT COMPLETED|Overall Study||15
334122|NCT01395823|800716|P2|COMPLETED|Overall Study||130
334123|NCT01395823|800717|P1|COMPLETED|Overall Study||122
334124|NCT01395823|800716|P2|STARTED|Overall Study||139
334125|NCT01395823|800717|P1|STARTED|Overall Study||137
334126|NCT01395784|800723|P1|NOT COMPLETED|Overall Study||15
334127|NCT01395784|800723|P1|COMPLETED|Overall Study||17
334128|NCT01395784|800723|P1|STARTED|Overall Study||32
334129|NCT01394510|800728|P1|NOT COMPLETED|Overall Study||0
334130|NCT01394510|800728|P1|COMPLETED|Overall Study||13
334131|NCT01394510|800728|P1|STARTED|Overall Study||13
334132|NCT01395524|800737|P3|NOT COMPLETED|Overall Study||17
334133|NCT01395524|800738|P2|NOT COMPLETED|Overall Study||16
334134|NCT01395524|800739|P1|NOT COMPLETED|Overall Study||18
334135|NCT01395524|800737|P3|COMPLETED|Overall Study||89
334136|NCT01395524|800738|P2|COMPLETED|Overall Study||83
334137|NCT01395524|800739|P1|COMPLETED|Overall Study||79
334138|NCT01395524|800737|P3|STARTED|Overall Study||106
334139|NCT01395524|800738|P2|STARTED|Overall Study||99
334140|NCT01395524|800739|P1|STARTED|Overall Study||97
334141|NCT01395394|800762|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
334142|NCT01395394|800763|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
334143|NCT01395394|800764|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
334144|NCT01395394|800762|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
334145|NCT01395394|800763|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
334146|NCT01395394|800764|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
334147|NCT01395394|800762|P3|STARTED|Study Visit 2 (Non-responders Only)||0
334148|NCT01395394|800763|P2|STARTED|Study Visit 2 (Non-responders Only)||0
334149|NCT01395394|800764|P1|STARTED|Study Visit 2 (Non-responders Only)||3
334150|NCT01395394|800762|P3|NOT COMPLETED|Baseline Study Visit||0
334151|NCT01395394|800763|P2|NOT COMPLETED|Baseline Study Visit||0
334152|NCT01395394|800764|P1|NOT COMPLETED|Baseline Study Visit||1
334153|NCT01395394|800762|P3|COMPLETED|Baseline Study Visit||5
334154|NCT01395394|800763|P2|COMPLETED|Baseline Study Visit||3
334155|NCT01395394|800764|P1|COMPLETED|Baseline Study Visit||3
334156|NCT01395394|800762|P3|STARTED|Baseline Study Visit||5
334157|NCT01395394|800763|P2|STARTED|Baseline Study Visit||3
334158|NCT01395394|800764|P1|STARTED|Baseline Study Visit||4
334159|NCT01395368|800775|P1|NOT COMPLETED|Overall Study||16
334160|NCT01395368|800775|P1|COMPLETED|Overall Study||92
334161|NCT01395368|800775|P1|STARTED|Overall Study||108
334162|NCT01395277|800781|P2|NOT COMPLETED|Overall Study||0
334163|NCT01395277|800782|P1|NOT COMPLETED|Overall Study||0
334164|NCT01395277|800781|P2|COMPLETED|Overall Study||15
334165|NCT01395277|800782|P1|COMPLETED|Overall Study||15
334166|NCT01395277|800781|P2|STARTED|Overall Study||15
334167|NCT01395277|800782|P1|STARTED|Overall Study||15
334168|NCT01395043|800790|P1|NOT COMPLETED|Overall Study||0
334169|NCT01395043|800790|P1|COMPLETED|Overall Study||15
334170|NCT01395043|800790|P1|STARTED|Overall Study||15
334171|NCT01395017|800797|P2|NOT COMPLETED|Overall Study||102
334172|NCT01395017|800798|P1|NOT COMPLETED|Overall Study||100
334173|NCT01395017|800797|P2|COMPLETED|Overall Study||0
334174|NCT01395017|800798|P1|COMPLETED|Overall Study||0
334175|NCT01395017|800797|P2|Treated|Overall Study||101
334176|NCT01395017|800798|P1|Treated|Overall Study||98
334177|NCT01395017|800797|P2|STARTED|Overall Study||102
334178|NCT01395017|800798|P1|STARTED|Overall Study||100
334179|NCT01394991|800808|P2|NOT COMPLETED|Overall Study||72
334180|NCT01394991|800809|P1|NOT COMPLETED|Overall Study||59
334181|NCT01394991|800808|P2|COMPLETED|Overall Study||190
334182|NCT01394991|800809|P1|COMPLETED|Overall Study||183
334183|NCT01394991|800808|P2|STARTED|Overall Study||262
334184|NCT01394991|800809|P1|STARTED|Overall Study||242
334185|NCT01394926|800829|P1|NOT COMPLETED|Overall Study||0
334186|NCT01394926|800829|P1|COMPLETED|Overall Study||21
334187|NCT01394926|800829|P1|STARTED|Overall Study||21
334188|NCT01394718|800840|P2|NOT COMPLETED|Overall Study||1
334189|NCT01394718|800841|P1|NOT COMPLETED|Overall Study||2
334190|NCT01394718|800840|P2|COMPLETED|Overall Study||29
334191|NCT01394718|800841|P1|COMPLETED|Overall Study||28
334192|NCT01394718|800840|P2|STARTED|Overall Study||30
334193|NCT01394718|800841|P1|STARTED|Overall Study||30
334194|NCT01394692|800855|P2|NOT COMPLETED|Overall Study||0
334195|NCT01394692|800856|P1|NOT COMPLETED|Overall Study||0
334196|NCT01394692|800855|P2|COMPLETED|Overall Study||29
334197|NCT01394692|800856|P1|COMPLETED|Overall Study||29
334198|NCT01394692|800855|P2|STARTED|Overall Study||29
334199|NCT01394692|800856|P1|STARTED|Overall Study||29
334200|NCT01394614|800864|P2|NOT COMPLETED|Overall Study||0
334201|NCT01394614|800865|P1|NOT COMPLETED|Overall Study||0
334202|NCT01394614|800864|P2|COMPLETED|Overall Study||16
334203|NCT01394614|800865|P1|COMPLETED|Overall Study||8
334204|NCT01394614|800864|P2|STARTED|Overall Study||16
334205|NCT01394614|800865|P1|STARTED|Overall Study||8
334206|NCT01394276|800871|P1|NOT COMPLETED|Overall Study||62
334207|NCT01394276|800871|P1|COMPLETED|Overall Study||260
334208|NCT01394276|800871|P1|STARTED|Overall Study||322
334209|NCT01394250|800895|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
334210|NCT01394250|800896|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
334211|NCT01394250|800895|P2|COMPLETED|Successful IV Placement & Follow-Up||110
334212|NCT01394250|800896|P1|COMPLETED|Successful IV Placement & Follow-Up||114
334213|NCT01394250|800895|P2|STARTED|Successful IV Placement & Follow-Up||121
334214|NCT01394250|800896|P1|STARTED|Successful IV Placement & Follow-Up||120
334215|NCT01394250|800895|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
334216|NCT01394250|800896|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
334217|NCT01394250|800895|P2|COMPLETED|Randomization and IV Placement Attempt||121
334218|NCT01394250|800896|P1|COMPLETED|Randomization and IV Placement Attempt||120
334219|NCT01394250|800895|P2|STARTED|Randomization and IV Placement Attempt||134
334220|NCT01394250|800896|P1|STARTED|Randomization and IV Placement Attempt||134
334221|NCT01394159|800906|P2|NOT COMPLETED|Overall Study||0
334222|NCT01394159|800907|P1|NOT COMPLETED|Overall Study||0
334223|NCT01394159|800906|P2|COMPLETED|Overall Study||28
334224|NCT01394159|800907|P1|COMPLETED|Overall Study||28
334225|NCT01394159|800906|P2|STARTED|Overall Study||28
334226|NCT01394159|800907|P1|STARTED|Overall Study||28
334227|NCT01393964|800920|P3|NOT COMPLETED|Overall Study||5
334228|NCT01393964|800921|P2|NOT COMPLETED|Overall Study||4
334229|NCT01393964|800922|P1|NOT COMPLETED|Overall Study||6
334230|NCT01393964|800920|P3|COMPLETED|Overall Study|completed=treatment on-going|4
334231|NCT01393964|800921|P2|COMPLETED|Overall Study|Completed=Treatment on-going|5
334232|NCT01393964|800922|P1|COMPLETED|Overall Study|Completed=treatment on-going|2
334233|NCT01393964|800920|P3|STARTED|Overall Study||9
334234|NCT01393964|800921|P2|STARTED|Overall Study||9
334235|NCT01393964|800922|P1|STARTED|Overall Study||8
334236|NCT01393899|800963|P3|NOT COMPLETED|Overall Study||23
334237|NCT01393899|800964|P2|NOT COMPLETED|Overall Study||28
334238|NCT01393899|800965|P1|NOT COMPLETED|Overall Study||32
334239|NCT01393899|800963|P3|COMPLETED|Overall Study||38
334240|NCT01393899|800964|P2|COMPLETED|Overall Study||32
334241|NCT01393899|800965|P1|COMPLETED|Overall Study||27
334242|NCT01393899|800963|P3|STARTED|Overall Study||61
334243|NCT01393899|800964|P2|STARTED|Overall Study||60
334244|NCT01393899|800965|P1|STARTED|Overall Study||59
334245|NCT01393743|801019|P2|NOT COMPLETED|Overall Study||13
334246|NCT01393743|801020|P1|NOT COMPLETED|Overall Study||10
334247|NCT01393743|801019|P2|COMPLETED|Overall Study||68
334248|NCT01393743|801020|P1|COMPLETED|Overall Study||72
334249|NCT01393743|801019|P2|STARTED|Overall Study|A total of 82 participants were enrolled but one participant withdrew prior to receiving treatment.|81
334250|NCT01393743|801020|P1|STARTED|Overall Study||82
334251|NCT01393730|801038|P1|NOT COMPLETED|Overall Study||6
334252|NCT01393730|801038|P1|COMPLETED|Overall Study||34
334253|NCT01393730|801038|P1|Evaluable AR Mutation|Overall Study||14
334254|NCT01393730|801038|P1|Evaluable AR Amplification|Overall Study||21
334255|NCT01393730|801038|P1|Treated|Overall Study||38
334256|NCT01393730|801038|P1|STARTED|Overall Study||40
334257|NCT01393704|801052|P2|NOT COMPLETED|Overall Study||0
334258|NCT01393704|801053|P1|NOT COMPLETED|Overall Study||0
334259|NCT01393704|801052|P2|COMPLETED|Overall Study||76
334260|NCT01393704|801053|P1|COMPLETED|Overall Study||76
334261|NCT01393704|801052|P2|STARTED|Overall Study||76
334262|NCT01393704|801053|P1|STARTED|Overall Study||76
334263|NCT01393626|801071|P4|NOT COMPLETED|Overall Study||1
334264|NCT01393626|801072|P3|NOT COMPLETED|Overall Study||12
334265|NCT01393626|801073|P2|NOT COMPLETED|Overall Study||12
334266|NCT01393626|801074|P1|NOT COMPLETED|Overall Study||18
334267|NCT01393626|801071|P4|COMPLETED|Overall Study||15
334268|NCT01393626|801072|P3|COMPLETED|Overall Study||74
334269|NCT01393626|801073|P2|COMPLETED|Overall Study||74
334270|NCT01393626|801074|P1|COMPLETED|Overall Study||73
334271|NCT01393626|801071|P4|STARTED|Overall Study||16
334272|NCT01393626|801072|P3|STARTED|Overall Study||86
334273|NCT01393626|801073|P2|STARTED|Overall Study||86
334274|NCT01393626|801074|P1|STARTED|Overall Study||91
334275|NCT01393613|801154|P4|NOT COMPLETED|Overall Study||66
334276|NCT01393613|801155|P3|NOT COMPLETED|Overall Study||54
334277|NCT01393613|801156|P2|NOT COMPLETED|Overall Study||57
334278|NCT01393613|801157|P1|NOT COMPLETED|Overall Study||39
334279|NCT01393613|801154|P4|COMPLETED|Overall Study||118
334280|NCT01393613|801155|P3|COMPLETED|Overall Study||130
334281|NCT01393613|801156|P2|COMPLETED|Overall Study||129
334282|NCT01393613|801157|P1|COMPLETED|Overall Study||81
334283|NCT01393613|801154|P4|STARTED|Overall Study||184
334284|NCT01393613|801155|P3|STARTED|Overall Study||184
334285|NCT01393613|801156|P2|STARTED|Overall Study||186
334286|NCT01393613|801157|P1|STARTED|Overall Study||120
334287|NCT01393444|801219|P1|NOT COMPLETED|Overall Study||3
334288|NCT01393444|801219|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
334289|NCT01393444|801219|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
334290|NCT01393444|801219|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
334291|NCT01393444|801219|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
334292|NCT01393444|801219|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
334293|NCT01393444|801219|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
334294|NCT01393444|801219|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
334295|NCT01393444|801219|P1|STARTED|Overall Study||6
334296|NCT01393132|801226|P2|NOT COMPLETED|Overall Study||0
334297|NCT01393132|801227|P1|NOT COMPLETED|Overall Study||0
334298|NCT01393132|801226|P2|COMPLETED|Overall Study||3
334299|NCT01393132|801227|P1|COMPLETED|Overall Study||6
334300|NCT01393132|801226|P2|STARTED|Overall Study||3
334301|NCT01393132|801227|P1|STARTED|Overall Study||6
334302|NCT01393106|801239|P1|NOT COMPLETED|Overall Study||5
334303|NCT01393106|801239|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
334304|NCT01393106|801239|P1|STARTED|Overall Study||25
334305|NCT01392742|801256|P1|NOT COMPLETED|Overall Study||201
334306|NCT01392742|801256|P1|COMPLETED|Overall Study||242
334307|NCT01392742|801256|P1|STARTED|Overall Study||443
334308|NCT01392703|801271|P3|NOT COMPLETED|Day 9||0
334309|NCT01392703|801272|P2|NOT COMPLETED|Day 9||0
334310|NCT01392703|801273|P1|NOT COMPLETED|Day 9||0
334311|NCT01392703|801271|P3|COMPLETED|Day 9||25
334312|NCT01392703|801272|P2|COMPLETED|Day 9||26
334313|NCT01392703|801273|P1|COMPLETED|Day 9||26
334314|NCT01392703|801271|P3|STARTED|Day 9||25
334315|NCT01392703|801272|P2|STARTED|Day 9||26
334316|NCT01392703|801273|P1|STARTED|Day 9||26
334317|NCT01392703|801271|P3|NOT COMPLETED|Day 5||0
334318|NCT01392703|801272|P2|NOT COMPLETED|Day 5||0
334319|NCT01392703|801273|P1|NOT COMPLETED|Day 5||0
334320|NCT01392703|801271|P3|COMPLETED|Day 5||26
334321|NCT01392703|801272|P2|COMPLETED|Day 5||25
334322|NCT01392703|801273|P1|COMPLETED|Day 5||26
334323|NCT01392703|801271|P3|STARTED|Day 5||26
334324|NCT01392703|801272|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
334325|NCT01392703|801273|P1|STARTED|Day 5||26
334326|NCT01392703|801271|P3|NOT COMPLETED|Day 1||0
334327|NCT01392703|801272|P2|NOT COMPLETED|Day 1||0
334328|NCT01392703|801273|P1|NOT COMPLETED|Day 1||0
334329|NCT01392703|801271|P3|COMPLETED|Day 1||26
334330|NCT01392703|801272|P2|COMPLETED|Day 1||26
334331|NCT01392703|801273|P1|COMPLETED|Day 1||26
334332|NCT01392703|801271|P3|STARTED|Day 1||26
334333|NCT01392703|801272|P2|STARTED|Day 1||26
334334|NCT01392703|801273|P1|STARTED|Day 1||26
334335|NCT01392677|801302|P2|NOT COMPLETED|Overall Study||8
334336|NCT01392677|801303|P1|NOT COMPLETED|Overall Study||8
334337|NCT01392677|801302|P2|COMPLETED|Overall Study||101
334338|NCT01392677|801303|P1|COMPLETED|Overall Study||101
334339|NCT01392677|801302|P2|STARTED|Overall Study||109
334340|NCT01392677|801303|P1|STARTED|Overall Study||109
334341|NCT01392573|801319|P2|NOT COMPLETED|Overall Study||35
334342|NCT01392573|801320|P1|NOT COMPLETED|Overall Study||32
334343|NCT01392573|801319|P2|COMPLETED|Overall Study||171
334344|NCT01392573|801320|P1|COMPLETED|Overall Study||175
334345|NCT01392573|801319|P2|Exposed|Overall Study||206
334346|NCT01392573|801320|P1|Exposed|Overall Study||207
334347|NCT01392573|801319|P2|STARTED|Overall Study||206
334348|NCT01392573|801320|P1|STARTED|Overall Study||207
334349|NCT01392560|801328|P1|NOT COMPLETED|Overall Study||12
334350|NCT01392560|801328|P1|COMPLETED|Overall Study||40
334351|NCT01392560|801328|P1|STARTED|Overall Study||52
334352|NCT01392547|801334|P1|NOT COMPLETED|Overall Study||8
334353|NCT01392547|801334|P1|COMPLETED|Overall Study||64
334354|NCT01392547|801334|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
334355|NCT01392495|801348|P1|NOT COMPLETED|Overall Study||16
334356|NCT01392495|801348|P1|COMPLETED|Overall Study||1
334357|NCT01392495|801348|P1|Received 400 mg|Overall Study||13
334358|NCT01392495|801348|P1|Received 200 mg|Overall Study||4
334359|NCT01392495|801348|P1|STARTED|Overall Study||17
334360|NCT01392378|801365|P5|NOT COMPLETED|Toddler Dose||1
334361|NCT01392378|801366|P4|NOT COMPLETED|Toddler Dose||2
334362|NCT01392378|801367|P3|NOT COMPLETED|Toddler Dose||0
334363|NCT01392378|801368|P2|NOT COMPLETED|Toddler Dose||1
334364|NCT01392378|801369|P1|NOT COMPLETED|Toddler Dose||0
334365|NCT01392378|801365|P5|COMPLETED|Toddler Dose||208
334366|NCT01392378|801366|P4|COMPLETED|Toddler Dose||173
334367|NCT01392378|801367|P3|COMPLETED|Toddler Dose||170
334368|NCT01392378|801368|P2|COMPLETED|Toddler Dose||172
334369|NCT01392378|801369|P1|COMPLETED|Toddler Dose||169
334370|NCT01392378|801365|P5|STARTED|Toddler Dose||209
334371|NCT01392378|801366|P4|STARTED|Toddler Dose||175
334372|NCT01392378|801367|P3|STARTED|Toddler Dose||170
334373|NCT01392378|801368|P2|STARTED|Toddler Dose||173
334374|NCT01392378|801369|P1|STARTED|Toddler Dose||169
334375|NCT01392378|801365|P5|NOT COMPLETED|After Infant Series||1
334376|NCT01392378|801366|P4|NOT COMPLETED|After Infant Series||0
334377|NCT01392378|801367|P3|NOT COMPLETED|After Infant Series||2
334378|NCT01392378|801368|P2|NOT COMPLETED|After Infant Series||1
334379|NCT01392378|801369|P1|NOT COMPLETED|After Infant Series||0
334380|NCT01392378|801365|P5|COMPLETED|After Infant Series||209
334381|NCT01392378|801366|P4|COMPLETED|After Infant Series||175
334382|NCT01392378|801367|P3|COMPLETED|After Infant Series||170
334383|NCT01392378|801368|P2|COMPLETED|After Infant Series||173
334384|NCT01392378|801369|P1|COMPLETED|After Infant Series||169
334385|NCT01392378|801365|P5|STARTED|After Infant Series||210
334386|NCT01392378|801366|P4|STARTED|After Infant Series||175
334387|NCT01392378|801367|P3|STARTED|After Infant Series||172
334388|NCT01392378|801368|P2|STARTED|After Infant Series||174
334389|NCT01392378|801369|P1|STARTED|After Infant Series||169
334390|NCT01392378|801365|P5|NOT COMPLETED|Infant Series||0
334391|NCT01392378|801366|P4|NOT COMPLETED|Infant Series||2
334392|NCT01392378|801367|P3|NOT COMPLETED|Infant Series||0
334393|NCT01392378|801368|P2|NOT COMPLETED|Infant Series||2
334394|NCT01392378|801369|P1|NOT COMPLETED|Infant Series||4
334395|NCT01392378|801365|P5|COMPLETED|Infant Series||210
334396|NCT01392378|801366|P4|COMPLETED|Infant Series||175
334397|NCT01392378|801367|P3|COMPLETED|Infant Series||172
334398|NCT01392378|801368|P2|COMPLETED|Infant Series||174
334399|NCT01392378|801369|P1|COMPLETED|Infant Series||169
334400|NCT01392378|801365|P5|Vaccinated Dose 3|Infant Series||210
334401|NCT01392378|801366|P4|Vaccinated Dose 3|Infant Series||176
334402|NCT01392378|801367|P3|Vaccinated Dose 3|Infant Series||172
334403|NCT01392378|801368|P2|Vaccinated Dose 3|Infant Series||174
334404|NCT01392378|801369|P1|Vaccinated Dose 3|Infant Series||170
334405|NCT01392378|801365|P5|Vaccinated Dose 2|Infant Series||210
334406|NCT01392378|801366|P4|Vaccinated Dose 2|Infant Series||177
334407|NCT01392378|801367|P3|Vaccinated Dose 2|Infant Series||172
334408|NCT01392378|801368|P2|Vaccinated Dose 2|Infant Series||174
334409|NCT01392378|801369|P1|Vaccinated Dose 2|Infant Series||171
334410|NCT01392378|801365|P5|Vaccinated Dose 1|Infant Series||210
334411|NCT01392378|801366|P4|Vaccinated Dose 1|Infant Series||177
334412|NCT01392378|801367|P3|Vaccinated Dose 1|Infant Series||172
334413|NCT01392378|801368|P2|Vaccinated Dose 1|Infant Series||176
334414|NCT01392378|801369|P1|Vaccinated Dose 1|Infant Series||173
334415|NCT01392378|801365|P5|STARTED|Infant Series||210
334416|NCT01392378|801366|P4|STARTED|Infant Series||177
334417|NCT01392378|801367|P3|STARTED|Infant Series||172
334418|NCT01392378|801368|P2|STARTED|Infant Series||176
334419|NCT01392378|801369|P1|STARTED|Infant Series||173
334420|NCT01392326|801509|P3|NOT COMPLETED|Overall Study||48
334421|NCT01392326|801510|P2|NOT COMPLETED|Overall Study||35
334422|NCT01392326|801511|P1|NOT COMPLETED|Overall Study||47
334423|NCT01392326|801509|P3|COMPLETED|Overall Study||154
334424|NCT01392326|801510|P2|COMPLETED|Overall Study||167
334425|NCT01392326|801511|P1|COMPLETED|Overall Study||155
334426|NCT01392326|801509|P3|STARTED|Overall Study||202
334427|NCT01392326|801510|P2|STARTED|Overall Study||202
334428|NCT01392326|801511|P1|STARTED|Overall Study||202
334429|NCT01392300|801548|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
334430|NCT01392300|801549|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
334431|NCT01392300|801550|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
334432|NCT01392300|801548|P3|COMPLETED|Open Label Extension (OLEX) Period||248
334433|NCT01392300|801549|P2|COMPLETED|Open Label Extension (OLEX) Period||0
334434|NCT01392300|801550|P1|COMPLETED|Open Label Extension (OLEX) Period||0
334435|NCT01392300|801548|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
334436|NCT01392300|801549|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
334437|NCT01392300|801550|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
334438|NCT01392300|801548|P3|NOT COMPLETED|Main Period (MP)||0
334439|NCT01392300|801549|P2|NOT COMPLETED|Main Period (MP)||7
334440|NCT01392300|801550|P1|NOT COMPLETED|Main Period (MP)||11
334441|NCT01392300|801548|P3|COMPLETED|Main Period (MP)||0
334442|NCT01392300|801549|P2|COMPLETED|Main Period (MP)||100
334443|NCT01392300|801550|P1|COMPLETED|Main Period (MP)||199
334444|NCT01392300|801548|P3|STARTED|Main Period (MP)||0
334445|NCT01392300|801549|P2|STARTED|Main Period (MP)||107
334446|NCT01392300|801550|P1|STARTED|Main Period (MP)||210
334447|NCT01390259|801655|P2|NOT COMPLETED|Overall Study||0
334448|NCT01390259|801656|P1|NOT COMPLETED|Overall Study||0
334449|NCT01390259|801655|P2|COMPLETED|Overall Study||6
334450|NCT01390259|801656|P1|COMPLETED|Overall Study||5
334451|NCT01390259|801655|P2|STARTED|Overall Study||6
334452|NCT01390259|801656|P1|STARTED|Overall Study||5
334453|NCT01390233|801668|P3|NOT COMPLETED|Overall Study||6
334454|NCT01390233|801669|P2|NOT COMPLETED|Overall Study||2
334455|NCT01390233|801670|P1|NOT COMPLETED|Overall Study||5
334456|NCT01390233|801668|P3|COMPLETED|Overall Study||30
334457|NCT01390233|801669|P2|COMPLETED|Overall Study||29
334458|NCT01390233|801670|P1|COMPLETED|Overall Study||30
334459|NCT01390233|801668|P3|STARTED|Overall Study||36
334460|NCT01390233|801669|P2|STARTED|Overall Study||31
334461|NCT01390233|801670|P1|STARTED|Overall Study||35
334462|NCT01392170|801678|P1|NOT COMPLETED|Overall Study||2
334463|NCT01392170|801678|P1|COMPLETED|Overall Study||0
334464|NCT01392170|801678|P1|STARTED|Overall Study||2
334465|NCT01392053|801684|P2|NOT COMPLETED|Overall Study||0
334466|NCT01392053|801685|P1|NOT COMPLETED|Overall Study||0
334467|NCT01392053|801684|P2|COMPLETED|Overall Study||23
334468|NCT01392053|801685|P1|COMPLETED|Overall Study||23
334469|NCT01392053|801684|P2|STARTED|Overall Study||23
334470|NCT01392053|801685|P1|STARTED|Overall Study||23
334471|NCT01391858|801705|P2|NOT COMPLETED|Overall Study||0
334472|NCT01391858|801706|P1|NOT COMPLETED|Overall Study||2
334473|NCT01391858|801705|P2|COMPLETED|Overall Study||24
334474|NCT01391858|801706|P1|COMPLETED|Overall Study||23
334475|NCT01391858|801705|P2|STARTED|Overall Study||24
334476|NCT01391858|801706|P1|STARTED|Overall Study||25
334477|NCT01391819|801726|P1|NOT COMPLETED|Overall Study||402
334478|NCT01391819|801726|P1|COMPLETED|Overall Study||1714
334479|NCT01391819|801726|P1|STARTED|Overall Study||2116
334480|NCT01391663|801757|P4|NOT COMPLETED|Overall Study||0
334481|NCT01391663|801758|P3|NOT COMPLETED|Overall Study||1
334482|NCT01391663|801759|P2|NOT COMPLETED|Overall Study||0
334483|NCT01391663|801760|P1|NOT COMPLETED|Overall Study||0
334484|NCT01391663|801757|P4|COMPLETED|Overall Study||12
334485|NCT01391663|801758|P3|COMPLETED|Overall Study||11
334486|NCT01391663|801759|P2|COMPLETED|Overall Study||12
334487|NCT01391663|801760|P1|COMPLETED|Overall Study||12
334488|NCT01391663|801757|P4|STARTED|Overall Study||12
334489|NCT01391663|801758|P3|STARTED|Overall Study||12
334490|NCT01391663|801759|P2|STARTED|Overall Study||12
334491|NCT01391663|801760|P1|STARTED|Overall Study||12
334492|NCT01391611|801790|P1|NOT COMPLETED|Overall Study||22
334493|NCT01391611|801790|P1|COMPLETED|Overall Study||3
334494|NCT01391611|801790|P1|STARTED|Overall Study||25
334495|NCT01391559|801795|P2|NOT COMPLETED|Second Intervention||0
334496|NCT01391559|801796|P1|NOT COMPLETED|Second Intervention||0
334497|NCT01391559|801795|P2|COMPLETED|Second Intervention||10
334498|NCT01391559|801796|P1|COMPLETED|Second Intervention||10
334499|NCT01391559|801795|P2|STARTED|Second Intervention||10
334500|NCT01391559|801796|P1|STARTED|Second Intervention||10
334501|NCT01391559|801795|P2|NOT COMPLETED|First Intervention||0
334502|NCT01391559|801796|P1|NOT COMPLETED|First Intervention||0
334503|NCT01391559|801795|P2|COMPLETED|First Intervention||10
334504|NCT01391559|801796|P1|COMPLETED|First Intervention||10
334505|NCT01391559|801795|P2|STARTED|First Intervention||10
334506|NCT01391559|801796|P1|STARTED|First Intervention||10
334507|NCT01391507|801806|P4|NOT COMPLETED|Overall Study||7
334508|NCT01391507|801807|P3|NOT COMPLETED|Overall Study||4
334509|NCT01391507|801808|P2|NOT COMPLETED|Overall Study||4
334510|NCT01391507|801809|P1|NOT COMPLETED|Overall Study||4
334511|NCT01391507|801806|P4|COMPLETED|Overall Study||5
334512|NCT01391507|801807|P3|COMPLETED|Overall Study||2
334513|NCT01391507|801808|P2|COMPLETED|Overall Study||4
334514|NCT01391507|801809|P1|COMPLETED|Overall Study||6
334515|NCT01391507|801806|P4|STARTED|Overall Study||12
334516|NCT01391507|801807|P3|STARTED|Overall Study||6
334517|NCT01391507|801808|P2|STARTED|Overall Study||8
334518|NCT01391507|801809|P1|STARTED|Overall Study||10
334519|NCT01391468|801857|P2|NOT COMPLETED|Overall Study||2
334520|NCT01391468|801858|P1|NOT COMPLETED|Overall Study||6
334521|NCT01391468|801857|P2|COMPLETED|Overall Study||21
334522|NCT01391468|801858|P1|COMPLETED|Overall Study||18
334523|NCT01391468|801857|P2|STARTED|Overall Study||23
334524|NCT01391468|801858|P1|STARTED|Overall Study||24
334525|NCT01390181|801870|P1|NOT COMPLETED|Overall Study||4
334526|NCT01390181|801870|P1|COMPLETED|Overall Study||0
334527|NCT01390181|801870|P1|STARTED|Overall Study||4
334528|NCT01391325|801874|P1|NOT COMPLETED|Overall Study||494
334529|NCT01391325|801874|P1|COMPLETED|Overall Study||1238
334530|NCT01391325|801874|P1|STARTED|Overall Study||1732
334531|NCT01391312|801883|P2|NOT COMPLETED|Overall Study||1
334532|NCT01391312|801884|P1|NOT COMPLETED|Overall Study||2
334533|NCT01391312|801883|P2|COMPLETED|Overall Study||19
334534|NCT01391312|801884|P1|COMPLETED|Overall Study||18
334535|NCT01391312|801883|P2|STARTED|Overall Study||20
334536|NCT01391312|801884|P1|STARTED|Overall Study||20
334537|NCT01391299|801897|P3|NOT COMPLETED|Overall Study||2
334538|NCT01391299|801898|P2|NOT COMPLETED|Overall Study||1
334539|NCT01391299|801899|P1|NOT COMPLETED|Overall Study||0
334540|NCT01391299|801897|P3|COMPLETED|Overall Study||56
334541|NCT01391299|801898|P2|COMPLETED|Overall Study||59
334542|NCT01391299|801899|P1|COMPLETED|Overall Study||57
334543|NCT01391299|801897|P3|STARTED|Overall Study||58
334544|NCT01391299|801898|P2|STARTED|Overall Study||60
334545|NCT01391299|801899|P1|STARTED|Overall Study||57
334546|NCT01391286|801921|P2|NOT COMPLETED|Overall Study||0
334547|NCT01391286|801922|P1|NOT COMPLETED|Overall Study||0
334548|NCT01391286|801921|P2|COMPLETED|Overall Study||18
334549|NCT01391286|801922|P1|COMPLETED|Overall Study||18
334550|NCT01391286|801921|P2|STARTED|Overall Study||18
334551|NCT01391286|801922|P1|STARTED|Overall Study||18
334552|NCT01391273|801936|P2|NOT COMPLETED|Overall Study||2
334553|NCT01391273|801937|P1|NOT COMPLETED|Overall Study||4
334554|NCT01391273|801936|P2|COMPLETED|Overall Study||83
334555|NCT01391273|801937|P1|COMPLETED|Overall Study||84
334556|NCT01391273|801936|P2|STARTED|Overall Study||85
334557|NCT01391273|801937|P1|STARTED|Overall Study||88
334558|NCT01391013|801951|P2|NOT COMPLETED|Overall Study||0
334559|NCT01391013|801952|P1|NOT COMPLETED|Overall Study||0
334560|NCT01391013|801951|P2|COMPLETED|Overall Study||15
334561|NCT01391013|801952|P1|COMPLETED|Overall Study||15
334562|NCT01391013|801951|P2|STARTED|Overall Study||15
334563|NCT01391013|801952|P1|STARTED|Overall Study||15
334564|NCT01390909|801996|P6|NOT COMPLETED|Overall Study||0
334565|NCT01390909|801997|P5|NOT COMPLETED|Overall Study||0
334566|NCT01390909|801998|P4|NOT COMPLETED|Overall Study||0
334567|NCT01390909|801999|P3|NOT COMPLETED|Overall Study||0
334568|NCT01390909|802000|P2|NOT COMPLETED|Overall Study||0
334569|NCT01390909|802001|P1|NOT COMPLETED|Overall Study||0
334570|NCT01390909|801996|P6|COMPLETED|Overall Study||613
334571|NCT01390909|801997|P5|COMPLETED|Overall Study||613
334572|NCT01390909|801998|P4|COMPLETED|Overall Study||602
334573|NCT01390909|801999|P3|COMPLETED|Overall Study||3552
334574|NCT01390909|802000|P2|COMPLETED|Overall Study||3552
334575|NCT01390909|802001|P1|COMPLETED|Overall Study||3454
334576|NCT01390909|801996|P6|Participants in Subgroup|Overall Study||0
334577|NCT01390909|801997|P5|Participants in Subgroup|Overall Study||602
334578|NCT01390909|801998|P4|Participants in Subgroup|Overall Study||0
334579|NCT01390909|801999|P3|Participants in Subgroup|Overall Study||0
334580|NCT01390909|802000|P2|Participants in Subgroup|Overall Study||3454
334581|NCT01390909|802001|P1|Participants in Subgroup|Overall Study||0
334582|NCT01390909|801996|P6|STARTED|Overall Study||613
334583|NCT01390909|801997|P5|STARTED|Overall Study||613
334584|NCT01390909|801998|P4|STARTED|Overall Study||602
334585|NCT01390909|801999|P3|STARTED|Overall Study||3552
334586|NCT01390909|802000|P2|STARTED|Overall Study||3552
334587|NCT01390909|802001|P1|STARTED|Overall Study||3454
334588|NCT01390870|802019|P1|NOT COMPLETED|Overall Study||0
334589|NCT01390870|802019|P1|COMPLETED|Overall Study||400
334590|NCT01390870|802019|P1|STARTED|Overall Study||400
334591|NCT01390857|802023|P1|NOT COMPLETED|Overall Study||10
334592|NCT01390857|802023|P1|COMPLETED|Overall Study||369
334593|NCT01390857|802023|P1|STARTED|Overall Study||379
334594|NCT01390844|802034|P4|NOT COMPLETED|Follow-Up Phase||0
334595|NCT01390844|802035|P3|NOT COMPLETED|Follow-Up Phase||1
334596|NCT01390844|802036|P2|NOT COMPLETED|Follow-Up Phase||1
334597|NCT01390844|802037|P1|NOT COMPLETED|Follow-Up Phase||1
334598|NCT01390844|802034|P4|COMPLETED|Follow-Up Phase||8
334599|NCT01390844|802035|P3|COMPLETED|Follow-Up Phase||25
334600|NCT01390844|802036|P2|COMPLETED|Follow-Up Phase||36
334601|NCT01390844|802037|P1|COMPLETED|Follow-Up Phase||92
334602|NCT01390844|802034|P4|STARTED|Follow-Up Phase||8
334603|NCT01390844|802035|P3|STARTED|Follow-Up Phase||26
334604|NCT01390844|802036|P2|STARTED|Follow-Up Phase||37
334605|NCT01390844|802037|P1|STARTED|Follow-Up Phase||93
334606|NCT01390844|802034|P4|NOT COMPLETED|Treatment Phase||19
334607|NCT01390844|802035|P3|NOT COMPLETED|Treatment Phase||31
334608|NCT01390844|802036|P2|NOT COMPLETED|Treatment Phase||28
334609|NCT01390844|802037|P1|NOT COMPLETED|Treatment Phase||40
334610|NCT01390844|802034|P4|COMPLETED|Treatment Phase||8
334611|NCT01390844|802035|P3|COMPLETED|Treatment Phase||26
334612|NCT01390844|802036|P2|COMPLETED|Treatment Phase||37
334613|NCT01390844|802037|P1|COMPLETED|Treatment Phase||93
334614|NCT01390844|802034|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
334615|NCT01390844|802035|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
334616|NCT01390844|802036|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
334617|NCT01390844|802037|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
334618|NCT01390844|802034|P4|STARTED|Treatment Phase||27
334619|NCT01390844|802035|P3|STARTED|Treatment Phase||57
334620|NCT01390844|802036|P2|STARTED|Treatment Phase||65
334621|NCT01390844|802037|P1|STARTED|Treatment Phase||133
334622|NCT01390818|802078|P15|NOT COMPLETED|Overall Study||0
334623|NCT01390818|802079|P14|NOT COMPLETED|Overall Study||0
334624|NCT01390818|802080|P13|NOT COMPLETED|Overall Study||0
334625|NCT01390818|802081|P12|NOT COMPLETED|Overall Study||0
334626|NCT01390818|802082|P11|NOT COMPLETED|Overall Study||0
334627|NCT01390818|802083|P10|NOT COMPLETED|Overall Study||0
334628|NCT01390818|802084|P9|NOT COMPLETED|Overall Study||0
334629|NCT01390818|802085|P8|NOT COMPLETED|Overall Study||0
334630|NCT01390818|802086|P7|NOT COMPLETED|Overall Study||0
334631|NCT01390818|802087|P6|NOT COMPLETED|Overall Study||0
334632|NCT01390818|802088|P5|NOT COMPLETED|Overall Study||0
334633|NCT01390818|802089|P4|NOT COMPLETED|Overall Study||0
334634|NCT01390818|802090|P3|NOT COMPLETED|Overall Study||0
334635|NCT01390818|802091|P2|NOT COMPLETED|Overall Study||0
334636|NCT01390818|802092|P1|NOT COMPLETED|Overall Study||0
334637|NCT01390818|802078|P15|COMPLETED|Overall Study||15
334638|NCT01390818|802079|P14|COMPLETED|Overall Study||18
334639|NCT01390818|802080|P13|COMPLETED|Overall Study||24
334640|NCT01390818|802081|P12|COMPLETED|Overall Study||26
334641|NCT01390818|802082|P11|COMPLETED|Overall Study||4
334642|NCT01390818|802083|P10|COMPLETED|Overall Study||3
334643|NCT01390818|802084|P9|COMPLETED|Overall Study||3
334644|NCT01390818|802085|P8|COMPLETED|Overall Study||14
334645|NCT01390818|802086|P7|COMPLETED|Overall Study||19
334646|NCT01390818|802087|P6|COMPLETED|Overall Study||3
334647|NCT01390818|802088|P5|COMPLETED|Overall Study||4
334648|NCT01390818|802089|P4|COMPLETED|Overall Study||4
334649|NCT01390818|802090|P3|COMPLETED|Overall Study||3
334650|NCT01390818|802091|P2|COMPLETED|Overall Study||3
334651|NCT01390818|802092|P1|COMPLETED|Overall Study||3
334652|NCT01390818|802078|P15|STARTED|Overall Study||15
334653|NCT01390818|802079|P14|STARTED|Overall Study||18
334654|NCT01390818|802080|P13|STARTED|Overall Study||24
334655|NCT01390818|802081|P12|STARTED|Overall Study||26
334656|NCT01390818|802082|P11|STARTED|Overall Study||4
334657|NCT01390818|802083|P10|STARTED|Overall Study||3
334658|NCT01390818|802084|P9|STARTED|Overall Study||3
334659|NCT01390818|802085|P8|STARTED|Overall Study||14
334660|NCT01390818|802086|P7|STARTED|Overall Study||19
334661|NCT01390818|802087|P6|STARTED|Overall Study||3
334662|NCT01390818|802088|P5|STARTED|Overall Study||4
334663|NCT01390818|802089|P4|STARTED|Overall Study||4
334664|NCT01390818|802090|P3|STARTED|Overall Study||3
334665|NCT01390818|802091|P2|STARTED|Overall Study||3
334666|NCT01390818|802092|P1|STARTED|Overall Study||3
334667|NCT01390779|802364|P1|NOT COMPLETED|Overall Study||1
334668|NCT01390779|802364|P1|COMPLETED|Overall Study||32
334669|NCT01390779|802364|P1|STARTED|Overall Study||33
334670|NCT01390649|802369|P1|NOT COMPLETED|Overall Study||1
334671|NCT01390649|802369|P1|COMPLETED|Overall Study||56
334672|NCT01390649|802369|P1|STARTED|Overall Study|Subjects treated with Privigen|57
334673|NCT01390441|802379|P5|NOT COMPLETED|Extension Period||0
334674|NCT01390441|802380|P4|NOT COMPLETED|Extension Period||1
334675|NCT01390441|802381|P3|NOT COMPLETED|Extension Period||0
334676|NCT01390441|802382|P2|NOT COMPLETED|Extension Period||1
334677|NCT01390441|802383|P1|NOT COMPLETED|Extension Period||3
334678|NCT01390441|802379|P5|COMPLETED|Extension Period||3
334679|NCT01390441|802380|P4|COMPLETED|Extension Period||0
334680|NCT01390441|802381|P3|COMPLETED|Extension Period||1
334681|NCT01390441|802382|P2|COMPLETED|Extension Period||12
334682|NCT01390441|802383|P1|COMPLETED|Extension Period||12
334683|NCT01390441|802379|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
334773|NCT01389323|802709|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
334684|NCT01390441|802380|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
334685|NCT01390441|802381|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
334686|NCT01390441|802382|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
334687|NCT01390441|802383|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
334688|NCT01390441|802379|P5|NOT COMPLETED|Treatment Period||11
334689|NCT01390441|802380|P4|NOT COMPLETED|Treatment Period||13
334690|NCT01390441|802381|P3|NOT COMPLETED|Treatment Period||10
334691|NCT01390441|802382|P2|NOT COMPLETED|Treatment Period||1
334692|NCT01390441|802383|P1|NOT COMPLETED|Treatment Period||1
334693|NCT01390441|802379|P5|COMPLETED|Treatment Period||7
334694|NCT01390441|802380|P4|COMPLETED|Treatment Period||6
334695|NCT01390441|802381|P3|COMPLETED|Treatment Period||8
334696|NCT01390441|802382|P2|COMPLETED|Treatment Period||21
334697|NCT01390441|802383|P1|COMPLETED|Treatment Period||22
334698|NCT01390441|802379|P5|STARTED|Treatment Period||18
334699|NCT01390441|802380|P4|STARTED|Treatment Period||19
334700|NCT01390441|802381|P3|STARTED|Treatment Period||18
334701|NCT01390441|802382|P2|STARTED|Treatment Period||22
334702|NCT01390441|802383|P1|STARTED|Treatment Period||23
334703|NCT01390428|802448|P6|NOT COMPLETED|Overall Study||0
334704|NCT01390428|802449|P5|NOT COMPLETED|Overall Study||1
334705|NCT01390428|802450|P4|NOT COMPLETED|Overall Study||0
334706|NCT01390428|802451|P3|NOT COMPLETED|Overall Study||1
334707|NCT01390428|802452|P2|NOT COMPLETED|Overall Study||0
334708|NCT01390428|802453|P1|NOT COMPLETED|Overall Study||0
334709|NCT01390428|802448|P6|COMPLETED|Overall Study||8
334710|NCT01390428|802449|P5|COMPLETED|Overall Study||7
334711|NCT01390428|802450|P4|COMPLETED|Overall Study||9
334712|NCT01390428|802451|P3|COMPLETED|Overall Study||8
334713|NCT01390428|802452|P2|COMPLETED|Overall Study||8
334714|NCT01390428|802453|P1|COMPLETED|Overall Study||8
334715|NCT01390428|802448|P6|STARTED|Overall Study||8
334716|NCT01390428|802449|P5|STARTED|Overall Study||8
334717|NCT01390428|802450|P4|STARTED|Overall Study||9
334718|NCT01390428|802451|P3|STARTED|Overall Study||9
334719|NCT01390428|802452|P2|STARTED|Overall Study||8
334720|NCT01390428|802453|P1|STARTED|Overall Study||8
334721|NCT01390415|802505|P2|NOT COMPLETED|Overall Study||0
334722|NCT01390415|802506|P1|NOT COMPLETED|Overall Study||0
334723|NCT01390415|802505|P2|COMPLETED|Overall Study||37
334724|NCT01390415|802506|P1|COMPLETED|Overall Study||99
334725|NCT01390415|802505|P2|STARTED|Overall Study||37
334726|NCT01390415|802506|P1|STARTED|Overall Study||99
334727|NCT01390402|802516|P1|NOT COMPLETED|Overall Study||5
334728|NCT01390402|802516|P1|COMPLETED|Overall Study||1
334729|NCT01390402|802516|P1|STARTED|Overall Study||6
334730|NCT01390389|802522|P2|NOT COMPLETED|Overall Study||1
334731|NCT01390389|802523|P1|NOT COMPLETED|Overall Study||4
334732|NCT01390389|802522|P2|COMPLETED|Overall Study||8
334733|NCT01390389|802523|P1|COMPLETED|Overall Study||6
334734|NCT01390389|802522|P2|STARTED|Overall Study||9
334735|NCT01390389|802523|P1|STARTED|Overall Study||10
334736|NCT01390038|802529|P1|NOT COMPLETED|Overall Study||8
334737|NCT01390038|802529|P1|COMPLETED|Overall Study||149
334738|NCT01390038|802529|P1|STARTED|Overall Study||157
334739|NCT01389973|802539|P1|NOT COMPLETED|Overall Study||20
334740|NCT01389973|802539|P1|COMPLETED|Overall Study||0
334741|NCT01389973|802539|P1|STARTED|Overall Study||20
334742|NCT01389882|802549|P2|NOT COMPLETED|Overall Study||4
334743|NCT01389882|802550|P1|NOT COMPLETED|Overall Study||1
334744|NCT01389882|802549|P2|COMPLETED|Overall Study||7
334745|NCT01389882|802550|P1|COMPLETED|Overall Study||12
334746|NCT01389882|802549|P2|STARTED|Overall Study||11
334747|NCT01389882|802550|P1|STARTED|Overall Study||13
334748|NCT01389856|802580|P2|NOT COMPLETED|Overall Study||0
334749|NCT01389856|802581|P1|NOT COMPLETED|Overall Study||0
334750|NCT01389856|802580|P2|COMPLETED|Overall Study||8
334751|NCT01389856|802581|P1|COMPLETED|Overall Study||13
334752|NCT01389856|802580|P2|STARTED|Overall Study|Randomized and treated.|8
334753|NCT01389856|802581|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
334754|NCT01389817|802638|P2|NOT COMPLETED|Overall Study||0
334755|NCT01389817|802639|P1|NOT COMPLETED|Overall Study||4
334756|NCT01389817|802638|P2|COMPLETED|Overall Study||0
334757|NCT01389817|802639|P1|COMPLETED|Overall Study||0
334758|NCT01389817|802638|P2|STARTED|Overall Study||0
334759|NCT01389817|802639|P1|STARTED|Overall Study||4
334760|NCT01389596|802648|P3|NOT COMPLETED|Overall Study||10
334761|NCT01389596|802649|P2|NOT COMPLETED|Overall Study||16
334762|NCT01389596|802650|P1|NOT COMPLETED|Overall Study||10
334763|NCT01389596|802648|P3|COMPLETED|Overall Study||84
334764|NCT01389596|802649|P2|COMPLETED|Overall Study||81
334765|NCT01389596|802650|P1|COMPLETED|Overall Study||94
334766|NCT01389596|802648|P3|STARTED|Overall Study||94
334767|NCT01389596|802649|P2|STARTED|Overall Study||97
334768|NCT01389596|802650|P1|STARTED|Overall Study||104
334769|NCT01389323|802709|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
334770|NCT01389323|802709|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
334771|NCT01389323|802709|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
334772|NCT01389323|802709|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
334774|NCT01389323|802709|P1|STARTED|Treatment Period (up to 48 Weeks)||246
334775|NCT01389284|802732|P3|NOT COMPLETED|Overall Study||0
334776|NCT01389284|802733|P2|NOT COMPLETED|Overall Study||0
334777|NCT01389284|802734|P1|NOT COMPLETED|Overall Study||0
334778|NCT01389284|802732|P3|COMPLETED|Overall Study||60
334779|NCT01389284|802733|P2|COMPLETED|Overall Study||120
334780|NCT01389284|802734|P1|COMPLETED|Overall Study||120
334781|NCT01389284|802732|P3|STARTED|Overall Study||60
334782|NCT01389284|802733|P2|STARTED|Overall Study||120
334783|NCT01389284|802734|P1|STARTED|Overall Study||120
334784|NCT01389102|802772|P6|NOT COMPLETED|Overall Study||8
334785|NCT01389102|802773|P5|NOT COMPLETED|Overall Study||13
334786|NCT01389102|802774|P4|NOT COMPLETED|Overall Study||7
334787|NCT01389102|802775|P3|NOT COMPLETED|Overall Study||19
334788|NCT01389102|802776|P2|NOT COMPLETED|Overall Study||12
334789|NCT01389102|802777|P1|NOT COMPLETED|Overall Study||18
334790|NCT01389102|802772|P6|COMPLETED|Overall Study||68
334791|NCT01389102|802773|P5|COMPLETED|Overall Study||61
334792|NCT01389102|802774|P4|COMPLETED|Overall Study||69
334793|NCT01389102|802775|P3|COMPLETED|Overall Study||58
334794|NCT01389102|802776|P2|COMPLETED|Overall Study||64
334795|NCT01389102|802777|P1|COMPLETED|Overall Study||57
334796|NCT01389102|802772|P6|STARTED|Overall Study||76
334797|NCT01389102|802773|P5|STARTED|Overall Study||74
334798|NCT01389102|802774|P4|STARTED|Overall Study||76
334799|NCT01389102|802775|P3|STARTED|Overall Study||77
334800|NCT01389102|802776|P2|STARTED|Overall Study||76
334801|NCT01389102|802777|P1|STARTED|Overall Study||75
334802|NCT01389076|802797|P1|NOT COMPLETED|Overall Study||0
334803|NCT01389076|802797|P1|COMPLETED|Overall Study||22
334804|NCT01389076|802797|P1|STARTED|Overall Study||22
334805|NCT01388946|802807|P2|NOT COMPLETED|Overall Study||3
334806|NCT01388946|802808|P1|NOT COMPLETED|Overall Study||6
334807|NCT01388946|802807|P2|COMPLETED|Overall Study||52
334808|NCT01388946|802808|P1|COMPLETED|Overall Study||49
334809|NCT01388946|802807|P2|STARTED|Overall Study||55
334810|NCT01388946|802808|P1|STARTED|Overall Study||55
334811|NCT01388920|802843|P3|NOT COMPLETED|Overall Study||0
334812|NCT01388920|802844|P2|NOT COMPLETED|Overall Study||0
334813|NCT01388920|802845|P1|NOT COMPLETED|Overall Study||0
334814|NCT01388920|802843|P3|COMPLETED|Overall Study||0
334815|NCT01388920|802844|P2|COMPLETED|Overall Study||1
334816|NCT01388920|802845|P1|COMPLETED|Overall Study||1
334817|NCT01388920|802843|P3|STARTED|Overall Study||0
334818|NCT01388920|802844|P2|STARTED|Overall Study||1
334819|NCT01388920|802845|P1|STARTED|Overall Study||1
334820|NCT01388907|802855|P2|NOT COMPLETED|Overall Study||0
334821|NCT01388907|802856|P1|NOT COMPLETED|Overall Study||2
334822|NCT01388907|802855|P2|COMPLETED|Overall Study||28
334823|NCT01388907|802856|P1|COMPLETED|Overall Study||31
334824|NCT01388907|802855|P2|STARTED|Overall Study||28
334825|NCT01388907|802856|P1|STARTED|Overall Study||33
334826|NCT01388816|802872|P4|NOT COMPLETED|Overall Study||0
334827|NCT01388816|802873|P3|NOT COMPLETED|Overall Study||3
334828|NCT01388816|802874|P2|NOT COMPLETED|Overall Study||4
334829|NCT01388816|802875|P1|NOT COMPLETED|Overall Study||2
334830|NCT01388816|802872|P4|COMPLETED|Overall Study||44
334831|NCT01388816|802873|P3|COMPLETED|Overall Study||41
334832|NCT01388816|802874|P2|COMPLETED|Overall Study||39
334833|NCT01388816|802875|P1|COMPLETED|Overall Study||43
334834|NCT01388816|802872|P4|STARTED|Overall Study||44
334835|NCT01388816|802873|P3|STARTED|Overall Study||44
334836|NCT01388816|802874|P2|STARTED|Overall Study||43
334837|NCT01388816|802875|P1|STARTED|Overall Study||45
334838|NCT01388790|802904|P1|NOT COMPLETED|Overall Study||8
334839|NCT01388790|802904|P1|COMPLETED|Overall Study||32
334840|NCT01388790|802904|P1|STARTED|Overall Study||40
334841|NCT01388647|802911|P2|NOT COMPLETED|Overall Study||2
334842|NCT01388647|802912|P1|NOT COMPLETED|Overall Study||1
334843|NCT01388647|802911|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
334844|NCT01388647|802912|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
334845|NCT01388647|802911|P2|STARTED|Overall Study||6
334846|NCT01388647|802912|P1|STARTED|Overall Study||6
334847|NCT01388530|802923|P1|NOT COMPLETED|Overall Study||5
334848|NCT01388530|802923|P1|COMPLETED|Overall Study||20
334849|NCT01388530|802923|P1|STARTED|Overall Study||25
334850|NCT01388491|802932|P2|NOT COMPLETED|Overall Study||29
334851|NCT01388491|802933|P1|NOT COMPLETED|Overall Study||34
334852|NCT01388491|802932|P2|COMPLETED|Overall Study||114
334853|NCT01388491|802933|P1|COMPLETED|Overall Study||116
334854|NCT01388491|802932|P2|Per Protocol (PP) Population|Overall Study||121
334855|NCT01388491|802933|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
334856|NCT01388491|802932|P2|Intent-to-Treat (ITT) Population|Overall Study||136
334857|NCT01388491|802933|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
334858|NCT01388491|802932|P2|Safety Population|Overall Study||142
334859|NCT01388491|802933|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
334860|NCT01388491|802932|P2|STARTED|Overall Study||143
334861|NCT01388491|802933|P1|STARTED|Overall Study|number randomized|150
334862|NCT01388361|802968|P3|NOT COMPLETED|Overall Study||14
334863|NCT01388361|802969|P2|NOT COMPLETED|Overall Study||12
334864|NCT01388361|802970|P1|NOT COMPLETED|Overall Study||12
334865|NCT01388361|802968|P3|COMPLETED|Overall Study||75
334866|NCT01388361|802969|P2|COMPLETED|Overall Study||76
334867|NCT01388361|802970|P1|COMPLETED|Overall Study||224
334868|NCT01388361|802968|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
334869|NCT01388361|802969|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
334870|NCT01388361|802970|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
334871|NCT01388361|802968|P3|STARTED|Overall Study||89
334872|NCT01388361|802969|P2|STARTED|Overall Study||88
334873|NCT01388361|802970|P1|STARTED|Overall Study||236
334874|NCT01388166|802987|P1|NOT COMPLETED|Overall Study||59
334875|NCT01388166|802987|P1|COMPLETED|Overall Study||1194
334876|NCT01388166|802987|P1|STARTED|Overall Study||1253
334877|NCT01387789|802993|P1|NOT COMPLETED|Overall Study||8
334878|NCT01387789|802993|P1|COMPLETED|Overall Study||63
334879|NCT01387789|802993|P1|STARTED|Overall Study||71
334880|NCT01387737|803007|P2|NOT COMPLETED|Overall Study||74
334881|NCT01387737|803008|P1|NOT COMPLETED|Overall Study||52
334882|NCT01387737|803007|P2|COMPLETED|Overall Study||641
334883|NCT01387737|803008|P1|COMPLETED|Overall Study||532
334884|NCT01387737|803007|P2|STARTED|Overall Study||715
334885|NCT01387737|803008|P1|STARTED|Overall Study||584
334886|NCT01387672|803020|P6|NOT COMPLETED|Overall Study||0
334887|NCT01387672|803021|P5|NOT COMPLETED|Overall Study||4
334888|NCT01387672|803022|P4|NOT COMPLETED|Overall Study||4
334889|NCT01387672|803023|P3|NOT COMPLETED|Overall Study||5
334890|NCT01387672|803024|P2|NOT COMPLETED|Overall Study||7
334891|NCT01387672|803025|P1|NOT COMPLETED|Overall Study||7
334892|NCT01387672|803020|P6|COMPLETED|Overall Study||37
334893|NCT01387672|803021|P5|COMPLETED|Overall Study||34
334894|NCT01387672|803022|P4|COMPLETED|Overall Study||35
334895|NCT01387672|803023|P3|COMPLETED|Overall Study||33
334896|NCT01387672|803024|P2|COMPLETED|Overall Study||31
334897|NCT01387672|803025|P1|COMPLETED|Overall Study||32
334898|NCT01387672|803020|P6|STARTED|Overall Study||37
334899|NCT01387672|803021|P5|STARTED|Overall Study||38
334900|NCT01387672|803022|P4|STARTED|Overall Study||39
334901|NCT01387672|803023|P3|STARTED|Overall Study||38
334902|NCT01387672|803024|P2|STARTED|Overall Study||38
334903|NCT01387672|803025|P1|STARTED|Overall Study||39
334904|NCT01387594|803042|P2|NOT COMPLETED|Overall Study||3
334905|NCT01387594|803043|P1|NOT COMPLETED|Overall Study||0
334906|NCT01387594|803042|P2|COMPLETED|Overall Study||36
334907|NCT01387594|803043|P1|COMPLETED|Overall Study||10
334908|NCT01387594|803042|P2|STARTED|Overall Study||39
334909|NCT01387594|803043|P1|STARTED|Overall Study||10
334910|NCT01387581|803058|P3|NOT COMPLETED|Overall Study||3
334911|NCT01387581|803059|P2|NOT COMPLETED|Overall Study||6
334912|NCT01387581|803060|P1|NOT COMPLETED|Overall Study||7
334913|NCT01387581|803058|P3|COMPLETED|Overall Study||9
334914|NCT01387581|803059|P2|COMPLETED|Overall Study||101
334915|NCT01387581|803060|P1|COMPLETED|Overall Study||101
334916|NCT01387581|803058|P3|STARTED|Overall Study||12
334917|NCT01387581|803059|P2|STARTED|Overall Study||107
334918|NCT01387581|803060|P1|STARTED|Overall Study||108
334919|NCT01387542|803071|P1|NOT COMPLETED|Overall Study||8
334920|NCT01387542|803071|P1|COMPLETED|Overall Study||32
334921|NCT01387542|803071|P1|Treated|Overall Study||38
334922|NCT01387542|803071|P1|STARTED|Overall Study||40
334923|NCT01387464|803080|P2|NOT COMPLETED|Overall Study||1
334924|NCT01387464|803081|P1|NOT COMPLETED|Overall Study||1
334925|NCT01387464|803080|P2|COMPLETED|Overall Study||29
334926|NCT01387464|803081|P1|COMPLETED|Overall Study||29
334927|NCT01387464|803080|P2|Per-Protocol Population|Overall Study||29
334928|NCT01387464|803081|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
334929|NCT01387464|803080|P2|Safety Population|Overall Study||29
334930|NCT01387464|803081|P1|Safety Population|Overall Study||30
334931|NCT01387464|803080|P2|STARTED|Overall Study||30
334932|NCT01387464|803081|P1|STARTED|Overall Study||30
334933|NCT01387347|803089|P2|NOT COMPLETED|Overall Study||1
334934|NCT01387347|803090|P1|NOT COMPLETED|Overall Study||2
334935|NCT01387347|803089|P2|COMPLETED|Overall Study||35
334936|NCT01387347|803090|P1|COMPLETED|Overall Study||34
334937|NCT01387347|803089|P2|STARTED|Overall Study||36
334938|NCT01387347|803090|P1|STARTED|Overall Study||36
334939|NCT01387230|803103|P3|NOT COMPLETED|Overall Study||13
334940|NCT01387230|803104|P2|NOT COMPLETED|Overall Study||7
334941|NCT01387230|803105|P1|NOT COMPLETED|Overall Study||18
334942|NCT01387230|803103|P3|COMPLETED|Overall Study||56
334943|NCT01387230|803104|P2|COMPLETED|Overall Study||62
334944|NCT01387230|803105|P1|COMPLETED|Overall Study||50
334945|NCT01387230|803103|P3|STARTED|Overall Study||69
334946|NCT01387230|803104|P2|STARTED|Overall Study||69
334947|NCT01387230|803105|P1|STARTED|Overall Study||68
334948|NCT01387178|803121|P2|NOT COMPLETED|Overall Study||0
334949|NCT01387178|803122|P1|NOT COMPLETED|Overall Study||0
334950|NCT01387178|803121|P2|COMPLETED|Overall Study||10641
334951|NCT01387178|803122|P1|COMPLETED|Overall Study||11582
334952|NCT01387178|803121|P2|STARTED|Overall Study||10641
334953|NCT01387178|803122|P1|STARTED|Overall Study||11582
334954|NCT01387139|803134|P2|NOT COMPLETED|Overall Study||0
334955|NCT01387139|803135|P1|NOT COMPLETED|Overall Study||0
334956|NCT01387139|803134|P2|COMPLETED|Overall Study||84
334957|NCT01387139|803135|P1|COMPLETED|Overall Study||99
334958|NCT01387139|803134|P2|STARTED|Overall Study||84
334959|NCT01387139|803135|P1|STARTED|Overall Study||99
334960|NCT01387074|803151|P1|NOT COMPLETED|Overall Study||8
334961|NCT01387074|803151|P1|COMPLETED|Overall Study||100
334962|NCT01387074|803151|P1|STARTED|Overall Study||108
334963|NCT01387022|803164|P2|NOT COMPLETED|Overall Study||4
334964|NCT01387022|803165|P1|NOT COMPLETED|Overall Study||1
334965|NCT01387022|803164|P2|COMPLETED|Overall Study||26
334966|NCT01387022|803165|P1|COMPLETED|Overall Study||28
334967|NCT01387022|803164|P2|STARTED|Overall Study||30
334968|NCT01387022|803165|P1|STARTED|Overall Study||29
334969|NCT01386983|803183|P2|NOT COMPLETED|Overall Study||0
334970|NCT01386983|803184|P1|NOT COMPLETED|Overall Study||0
334971|NCT01386983|803183|P2|COMPLETED|Overall Study||68
334972|NCT01386983|803184|P1|COMPLETED|Overall Study||264
334973|NCT01386983|803183|P2|STARTED|Overall Study||68
334974|NCT01386983|803184|P1|STARTED|Overall Study||264
334975|NCT01386944|803192|P1|NOT COMPLETED|Overall Study||56
334976|NCT01386944|803192|P1|COMPLETED|Overall Study||46
334977|NCT01386944|803192|P1|STARTED|Overall Study||102
334978|NCT01386788|803202|P1|NOT COMPLETED|Overall Study||2
334979|NCT01386788|803202|P1|COMPLETED|Overall Study||100
334980|NCT01386788|803202|P1|STARTED|Overall Study||102
334981|NCT01386632|803209|P2|NOT COMPLETED|Overall Study||4
334982|NCT01386632|803210|P1|NOT COMPLETED|Overall Study||5
334983|NCT01386632|803209|P2|COMPLETED|Overall Study||21
334984|NCT01386632|803210|P1|COMPLETED|Overall Study||20
334985|NCT01386632|803209|P2|STARTED|Overall Study||25
334986|NCT01386632|803210|P1|STARTED|Overall Study||25
334987|NCT01386606|803222|P4|NOT COMPLETED|Overall Study||1
334988|NCT01386606|803223|P3|NOT COMPLETED|Overall Study||3
334989|NCT01386606|803224|P2|NOT COMPLETED|Overall Study||4
334990|NCT01386606|803225|P1|NOT COMPLETED|Overall Study||4
334991|NCT01386606|803222|P4|COMPLETED|Overall Study||13
334992|NCT01386606|803223|P3|COMPLETED|Overall Study||13
334993|NCT01386606|803224|P2|COMPLETED|Overall Study||10
334994|NCT01386606|803225|P1|COMPLETED|Overall Study||12
334995|NCT01386606|803222|P4|STARTED|Overall Study||14
334996|NCT01386606|803223|P3|STARTED|Overall Study||16
334997|NCT01386606|803224|P2|STARTED|Overall Study||14
334998|NCT01386606|803225|P1|STARTED|Overall Study||16
334999|NCT01386125|803255|P2|NOT COMPLETED|Overall Study||37
335000|NCT01386125|803256|P1|NOT COMPLETED|Overall Study||25
335001|NCT01386125|803255|P2|COMPLETED|Overall Study||336
335002|NCT01386125|803256|P1|COMPLETED|Overall Study||350
335003|NCT01386125|803255|P2|STARTED|Overall Study||373
335004|NCT01386125|803256|P1|STARTED|Overall Study||375
335005|NCT01386008|803264|P1|NOT COMPLETED|Overall Study||20
335006|NCT01386008|803264|P1|COMPLETED|Overall Study||0
335007|NCT01386008|803264|P1|STARTED|Overall Study||20
335008|NCT01385995|803273|P2|NOT COMPLETED|Period 2, 2 Months||0
335009|NCT01385995|803274|P1|NOT COMPLETED|Period 2, 2 Months||0
335010|NCT01385995|803273|P2|COMPLETED|Period 2, 2 Months||25
335011|NCT01385995|803274|P1|COMPLETED|Period 2, 2 Months||24
335012|NCT01385995|803273|P2|STARTED|Period 2, 2 Months||25
335013|NCT01385995|803274|P1|STARTED|Period 2, 2 Months||24
335014|NCT01385995|803273|P2|NOT COMPLETED|Washout Period, 1 Month||0
335015|NCT01385995|803274|P1|NOT COMPLETED|Washout Period, 1 Month||0
335016|NCT01385995|803273|P2|COMPLETED|Washout Period, 1 Month||25
335017|NCT01385995|803274|P1|COMPLETED|Washout Period, 1 Month||24
335018|NCT01385995|803273|P2|STARTED|Washout Period, 1 Month||25
335019|NCT01385995|803274|P1|STARTED|Washout Period, 1 Month||24
335020|NCT01385995|803273|P2|NOT COMPLETED|Period 1, 2 Months||0
335021|NCT01385995|803274|P1|NOT COMPLETED|Period 1, 2 Months||1
335022|NCT01385995|803273|P2|COMPLETED|Period 1, 2 Months||25
335023|NCT01385995|803274|P1|COMPLETED|Period 1, 2 Months||24
335024|NCT01385995|803273|P2|STARTED|Period 1, 2 Months||25
335025|NCT01385995|803274|P1|STARTED|Period 1, 2 Months||25
335026|NCT01385696|803288|P2|NOT COMPLETED|Overall Study||0
335027|NCT01385696|803289|P1|NOT COMPLETED|Overall Study||0
335028|NCT01385696|803288|P2|COMPLETED|Overall Study||64
335029|NCT01385696|803289|P1|COMPLETED|Overall Study||66
335030|NCT01385696|803288|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
335031|NCT01385696|803289|P1|STARTED|Overall Study||66
335032|NCT01385644|803300|P2|NOT COMPLETED|Overall Study||0
335033|NCT01385644|803301|P1|NOT COMPLETED|Overall Study||0
335034|NCT01385644|803300|P2|COMPLETED|Overall Study||4
335035|NCT01385644|803301|P1|COMPLETED|Overall Study||4
335036|NCT01385644|803300|P2|STARTED|Overall Study||4
335037|NCT01385644|803301|P1|STARTED|Overall Study||4
335038|NCT01385579|803315|P2|NOT COMPLETED|Overall Study||0
335039|NCT01385579|803316|P1|NOT COMPLETED|Overall Study||0
335040|NCT01385579|803315|P2|COMPLETED|Overall Study||104
335041|NCT01385579|803316|P1|COMPLETED|Overall Study||98
335042|NCT01385579|803315|P2|STARTED|Overall Study||104
335043|NCT01385579|803316|P1|STARTED|Overall Study||98
335044|NCT01385566|803328|P6|NOT COMPLETED|Overall Study||0
335045|NCT01385566|803329|P5|NOT COMPLETED|Overall Study||0
335046|NCT01385566|803330|P4|NOT COMPLETED|Overall Study||1
335047|NCT01385566|803331|P3|NOT COMPLETED|Overall Study||0
335048|NCT01385566|803332|P2|NOT COMPLETED|Overall Study||0
335049|NCT01385566|803333|P1|NOT COMPLETED|Overall Study||1
335050|NCT01385566|803328|P6|COMPLETED|Overall Study||34
335051|NCT01385566|803329|P5|COMPLETED|Overall Study||34
335052|NCT01385566|803330|P4|COMPLETED|Overall Study||34
335053|NCT01385566|803331|P3|COMPLETED|Overall Study||34
335054|NCT01385566|803332|P2|COMPLETED|Overall Study||34
335055|NCT01385566|803333|P1|COMPLETED|Overall Study||51
335056|NCT01385566|803328|P6|STARTED|Overall Study||34
335057|NCT01385566|803329|P5|STARTED|Overall Study||34
335058|NCT01385566|803330|P4|STARTED|Overall Study||35
335059|NCT01385566|803331|P3|STARTED|Overall Study||34
335060|NCT01385566|803332|P2|STARTED|Overall Study||34
335061|NCT01385566|803333|P1|STARTED|Overall Study||52
335062|NCT01385371|803387|P2|NOT COMPLETED|Overall Study||97
335063|NCT01385371|803388|P1|NOT COMPLETED|Overall Study||149
335064|NCT01385371|803387|P2|COMPLETED|Overall Study||652
335065|NCT01385371|803388|P1|COMPLETED|Overall Study||603
335066|NCT01385371|803387|P2|STARTED|Overall Study||749
335067|NCT01385371|803388|P1|STARTED|Overall Study||752
335068|NCT01385293|803408|P1|NOT COMPLETED|Overall Study||0
335069|NCT01385293|803408|P1|COMPLETED|Overall Study||30
335070|NCT01385293|803408|P1|STARTED|Overall Study||30
335071|NCT01385202|803418|P1|NOT COMPLETED|Overall Study||18
335072|NCT01385202|803418|P1|COMPLETED|Overall Study||154
335073|NCT01385202|803418|P1|Undergoing Ablation|Overall Study||160
335074|NCT01385202|803418|P1|Study Catheter Inserted|Overall Study||161
335075|NCT01385202|803418|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
335076|NCT01385189|803430|P5|NOT COMPLETED|Overall Study||2
335077|NCT01385189|803431|P4|NOT COMPLETED|Overall Study||1
335078|NCT01385189|803432|P3|NOT COMPLETED|Overall Study||0
335079|NCT01385189|803433|P2|NOT COMPLETED|Overall Study||1
335080|NCT01385189|803434|P1|NOT COMPLETED|Overall Study||1
335081|NCT01385189|803430|P5|COMPLETED|Overall Study||6
335082|NCT01385189|803431|P4|COMPLETED|Overall Study||3
335083|NCT01385189|803432|P3|COMPLETED|Overall Study||4
335084|NCT01385189|803433|P2|COMPLETED|Overall Study||11
335085|NCT01385189|803434|P1|COMPLETED|Overall Study||11
335086|NCT01385189|803430|P5|STARTED|Overall Study||8
335087|NCT01385189|803431|P4|STARTED|Overall Study||4
335088|NCT01385189|803432|P3|STARTED|Overall Study||4
335089|NCT01385189|803433|P2|STARTED|Overall Study||12
335090|NCT01385189|803434|P1|STARTED|Overall Study||12
335091|NCT01385137|803455|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
335092|NCT01385137|803456|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
335093|NCT01385137|803455|P2|COMPLETED|Evaluable for Primary Endpoint||107
335094|NCT01385137|803456|P1|COMPLETED|Evaluable for Primary Endpoint||102
335095|NCT01385137|803455|P2|STARTED|Evaluable for Primary Endpoint||131
335096|NCT01385137|803456|P1|STARTED|Evaluable for Primary Endpoint||131
335097|NCT01385137|803455|P2|NOT COMPLETED|Evaluable at Baseline||4
335098|NCT01385137|803456|P1|NOT COMPLETED|Evaluable at Baseline||9
335099|NCT01385137|803455|P2|COMPLETED|Evaluable at Baseline||127
335100|NCT01385137|803456|P1|COMPLETED|Evaluable at Baseline||122
335101|NCT01385137|803455|P2|STARTED|Evaluable at Baseline||131
335102|NCT01385137|803456|P1|STARTED|Evaluable at Baseline||131
335103|NCT01385033|803472|P6|NOT COMPLETED|Part III||0
335104|NCT01385033|803473|P5|NOT COMPLETED|Part III||0
335105|NCT01385033|803474|P4|NOT COMPLETED|Part III||0
335106|NCT01385033|803475|P3|NOT COMPLETED|Part III||0
335107|NCT01385033|803476|P2|NOT COMPLETED|Part III||0
335108|NCT01385033|803477|P1|NOT COMPLETED|Part III||0
335109|NCT01385033|803472|P6|COMPLETED|Part III||0
335110|NCT01385033|803473|P5|COMPLETED|Part III||0
335111|NCT01385033|803474|P4|COMPLETED|Part III||0
335112|NCT01385033|803475|P3|COMPLETED|Part III||0
335113|NCT01385033|803476|P2|COMPLETED|Part III||0
335114|NCT01385033|803477|P1|COMPLETED|Part III||0
335115|NCT01385033|803472|P6|STARTED|Part III||0
335116|NCT01385033|803473|P5|STARTED|Part III||0
335117|NCT01385033|803474|P4|STARTED|Part III||0
335118|NCT01385033|803475|P3|STARTED|Part III||0
335119|NCT01385033|803476|P2|STARTED|Part III||0
335120|NCT01385033|803477|P1|STARTED|Part III||0
335121|NCT01385033|803472|P6|NOT COMPLETED|Part II||0
335122|NCT01385033|803473|P5|NOT COMPLETED|Part II||0
335123|NCT01385033|803474|P4|NOT COMPLETED|Part II||0
335124|NCT01385033|803475|P3|NOT COMPLETED|Part II||0
335125|NCT01385033|803476|P2|NOT COMPLETED|Part II||0
335126|NCT01385033|803477|P1|NOT COMPLETED|Part II||0
335127|NCT01385033|803472|P6|COMPLETED|Part II||0
335128|NCT01385033|803473|P5|COMPLETED|Part II||0
335129|NCT01385033|803474|P4|COMPLETED|Part II||0
335130|NCT01385033|803475|P3|COMPLETED|Part II||0
335131|NCT01385033|803476|P2|COMPLETED|Part II||0
335132|NCT01385033|803477|P1|COMPLETED|Part II||0
335133|NCT01385033|803472|P6|STARTED|Part II||0
335134|NCT01385033|803473|P5|STARTED|Part II||0
335135|NCT01385033|803474|P4|STARTED|Part II||0
335136|NCT01385033|803475|P3|STARTED|Part II||0
335137|NCT01385033|803476|P2|STARTED|Part II||0
335138|NCT01385033|803477|P1|STARTED|Part II||0
335139|NCT01385033|803472|P6|NOT COMPLETED|Part I||0
335140|NCT01385033|803473|P5|NOT COMPLETED|Part I||0
335141|NCT01385033|803474|P4|NOT COMPLETED|Part I||0
335142|NCT01385033|803475|P3|NOT COMPLETED|Part I||0
335143|NCT01385033|803476|P2|NOT COMPLETED|Part I||0
335144|NCT01385033|803477|P1|NOT COMPLETED|Part I||0
335145|NCT01385033|803472|P6|COMPLETED|Part I||0
335146|NCT01385033|803473|P5|COMPLETED|Part I||0
335147|NCT01385033|803474|P4|COMPLETED|Part I||0
335148|NCT01385033|803475|P3|COMPLETED|Part I||0
335149|NCT01385033|803476|P2|COMPLETED|Part I||14
335150|NCT01385033|803477|P1|COMPLETED|Part I||6
335151|NCT01385033|803472|P6|STARTED|Part I||0
335152|NCT01385033|803473|P5|STARTED|Part I||0
335153|NCT01385033|803474|P4|STARTED|Part I||0
335154|NCT01385033|803475|P3|STARTED|Part I||0
335155|NCT01385033|803476|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
335156|NCT01385033|803477|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
335157|NCT01384760|803486|P2|NOT COMPLETED|Overall Study||6
335158|NCT01384760|803487|P1|NOT COMPLETED|Overall Study||16
335159|NCT01384760|803486|P2|COMPLETED|Overall Study||37
335160|NCT01384760|803487|P1|COMPLETED|Overall Study||45
335161|NCT01384760|803486|P2|Randomized|Overall Study||43
335162|NCT01384760|803487|P1|Randomized|Overall Study||61
335163|NCT01384760|803486|P2|STARTED|Overall Study||43
335164|NCT01384760|803487|P1|STARTED|Overall Study||61
335165|NCT01384292|803498|P3|NOT COMPLETED|Part B||0
335166|NCT01384292|803499|P2|NOT COMPLETED|Part B||0
335167|NCT01384292|803500|P1|NOT COMPLETED|Part B||1
335168|NCT01384292|803498|P3|COMPLETED|Part B||0
335169|NCT01384292|803499|P2|COMPLETED|Part B||6
335170|NCT01384292|803500|P1|COMPLETED|Part B||2
335171|NCT01384292|803498|P3|STARTED|Part B||0
335172|NCT01384292|803499|P2|STARTED|Part B||6
335173|NCT01384292|803500|P1|STARTED|Part B||3
335174|NCT01384292|803498|P3|NOT COMPLETED|Part A||0
335175|NCT01384292|803499|P2|NOT COMPLETED|Part A||0
335176|NCT01384292|803500|P1|NOT COMPLETED|Part A||0
335177|NCT01384292|803498|P3|COMPLETED|Part A||4
335178|NCT01384292|803499|P2|COMPLETED|Part A||5
335179|NCT01384292|803500|P1|COMPLETED|Part A||5
335180|NCT01384292|803498|P3|STARTED|Part A||4
335181|NCT01384292|803499|P2|STARTED|Part A||5
335182|NCT01384292|803500|P1|STARTED|Part A||5
335183|NCT01384019|803512|P2|NOT COMPLETED|Overall Study||6
335184|NCT01384019|803513|P1|NOT COMPLETED|Overall Study||10
335185|NCT01384019|803512|P2|COMPLETED|Overall Study||55
335186|NCT01384019|803513|P1|COMPLETED|Overall Study||55
335187|NCT01384019|803512|P2|STARTED|Overall Study||61
335188|NCT01384019|803513|P1|STARTED|Overall Study||65
335189|NCT01383993|803522|P3|NOT COMPLETED|Overall Study||1
335190|NCT01383993|803523|P2|NOT COMPLETED|Overall Study||1
335191|NCT01383993|803524|P1|NOT COMPLETED|Overall Study||3
335192|NCT01383993|803522|P3|COMPLETED|Overall Study||1
335193|NCT01383993|803523|P2|COMPLETED|Overall Study||3
335194|NCT01383993|803524|P1|COMPLETED|Overall Study||12
335195|NCT01383993|803522|P3|STARTED|Overall Study||2
335196|NCT01383993|803523|P2|STARTED|Overall Study||4
335197|NCT01383993|803524|P1|STARTED|Overall Study||15
335198|NCT01383928|803574|P3|NOT COMPLETED|Phase 2||40
335199|NCT01383928|803575|P2|NOT COMPLETED|Phase 2||0
335200|NCT01383928|803576|P1|NOT COMPLETED|Phase 2||0
335201|NCT01383928|803574|P3|COMPLETED|Phase 2||10
335202|NCT01383928|803575|P2|COMPLETED|Phase 2||0
335203|NCT01383928|803576|P1|COMPLETED|Phase 2||0
335204|NCT01383928|803574|P3|STARTED|Phase 2||50
335205|NCT01383928|803575|P2|STARTED|Phase 2||0
335206|NCT01383928|803576|P1|STARTED|Phase 2||0
335207|NCT01383928|803574|P3|NOT COMPLETED|Phase 1||0
335208|NCT01383928|803575|P2|NOT COMPLETED|Phase 1||7
335209|NCT01383928|803576|P1|NOT COMPLETED|Phase 1||5
335210|NCT01383928|803574|P3|COMPLETED|Phase 1||0
335211|NCT01383928|803575|P2|COMPLETED|Phase 1||0
335212|NCT01383928|803576|P1|COMPLETED|Phase 1||2
335213|NCT01383928|803574|P3|STARTED|Phase 1||0
335214|NCT01383928|803575|P2|STARTED|Phase 1||7
335215|NCT01383928|803576|P1|STARTED|Phase 1||7
335216|NCT01383720|803618|P1|NOT COMPLETED|Overall Study||0
335217|NCT01383720|803618|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
335218|NCT01383720|803618|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
335219|NCT01383720|803618|P1|STARTED|Overall Study||11
335220|NCT01383707|803640|P1|NOT COMPLETED|Overall Study||72
335221|NCT01383707|803640|P1|COMPLETED|Overall Study||5
335222|NCT01383707|803640|P1|STARTED|Overall Study||77
335223|NCT01383681|803649|P1|NOT COMPLETED|Overall Study||46
335224|NCT01383681|803649|P1|COMPLETED|Overall Study||189
335225|NCT01383681|803649|P1|STARTED|Overall Study||235
335226|NCT01383499|803654|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
335227|NCT01383499|803655|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
335228|NCT01383499|803656|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
335229|NCT01383499|803657|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
335230|NCT01383499|803654|P4|COMPLETED|Period 3 (4 Weeks)||25
335231|NCT01383499|803655|P3|COMPLETED|Period 3 (4 Weeks)||25
335232|NCT01383499|803656|P2|COMPLETED|Period 3 (4 Weeks)||24
335233|NCT01383499|803657|P1|COMPLETED|Period 3 (4 Weeks)||26
335234|NCT01383499|803654|P4|STARTED|Period 3 (4 Weeks)||25
335235|NCT01383499|803655|P3|STARTED|Period 3 (4 Weeks)||25
335236|NCT01383499|803656|P2|STARTED|Period 3 (4 Weeks)||24
335237|NCT01383499|803657|P1|STARTED|Period 3 (4 Weeks)||26
335238|NCT01383499|803654|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
335239|NCT01383499|803655|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
335240|NCT01383499|803656|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
335241|NCT01383499|803657|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
335242|NCT01383499|803654|P4|COMPLETED|Period 2 (4 Weeks)||25
335243|NCT01383499|803655|P3|COMPLETED|Period 2 (4 Weeks)||25
335244|NCT01383499|803656|P2|COMPLETED|Period 2 (4 Weeks)||24
335245|NCT01383499|803657|P1|COMPLETED|Period 2 (4 Weeks)||26
335246|NCT01383499|803654|P4|STARTED|Period 2 (4 Weeks)||25
335247|NCT01383499|803655|P3|STARTED|Period 2 (4 Weeks)||25
335248|NCT01383499|803656|P2|STARTED|Period 2 (4 Weeks)||24
335249|NCT01383499|803657|P1|STARTED|Period 2 (4 Weeks)||26
335250|NCT01383499|803654|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
335251|NCT01383499|803655|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
335252|NCT01383499|803656|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
335253|NCT01383499|803657|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
335254|NCT01383499|803654|P4|COMPLETED|Period 1 (4 Weeks)||25
335255|NCT01383499|803655|P3|COMPLETED|Period 1 (4 Weeks)||25
335256|NCT01383499|803656|P2|COMPLETED|Period 1 (4 Weeks)||24
335257|NCT01383499|803657|P1|COMPLETED|Period 1 (4 Weeks)||26
335258|NCT01383499|803654|P4|STARTED|Period 1 (4 Weeks)||25
335259|NCT01383499|803655|P3|STARTED|Period 1 (4 Weeks)||25
335260|NCT01383499|803656|P2|STARTED|Period 1 (4 Weeks)||24
335261|NCT01383499|803657|P1|STARTED|Period 1 (4 Weeks)||27
335262|NCT01383486|803707|P1|NOT COMPLETED|Overall Study||18
335263|NCT01383486|803707|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
335264|NCT01383486|803707|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
335265|NCT01383486|803707|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
335266|NCT01383356|803713|P2|NOT COMPLETED|Period 2||0
335267|NCT01383356|803714|P1|NOT COMPLETED|Period 2||0
335268|NCT01383356|803713|P2|COMPLETED|Period 2|Completed period 2.|23
335269|NCT01383356|803714|P1|COMPLETED|Period 2|Completed period 2.|21
335270|NCT01383356|803713|P2|STARTED|Period 2|Entered and treated.|23
335271|NCT01383356|803714|P1|STARTED|Period 2|Entered and treated.|21
335272|NCT01383356|803713|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
335273|NCT01383356|803714|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
335274|NCT01383356|803713|P2|COMPLETED|Washout Period (at Least 35 Days)||23
335275|NCT01383356|803714|P1|COMPLETED|Washout Period (at Least 35 Days)||21
335276|NCT01383356|803713|P2|STARTED|Washout Period (at Least 35 Days)||23
335277|NCT01383356|803714|P1|STARTED|Washout Period (at Least 35 Days)||21
335278|NCT01383356|803713|P2|NOT COMPLETED|Period 1||6
335279|NCT01383356|803714|P1|NOT COMPLETED|Period 1||8
335280|NCT01383356|803713|P2|COMPLETED|Period 1|Completed period 1.|23
335281|NCT01383356|803714|P1|COMPLETED|Period 1|Completed period 1.|21
335282|NCT01383356|803713|P2|STARTED|Period 1|Entered and treated.|29
335283|NCT01383356|803714|P1|STARTED|Period 1|Entered and treated.|29
335284|NCT01383213|803726|P2|NOT COMPLETED|Overall Study||0
335285|NCT01383213|803727|P1|NOT COMPLETED|Overall Study||0
335286|NCT01383213|803726|P2|COMPLETED|Overall Study||41
335287|NCT01383213|803727|P1|COMPLETED|Overall Study||40
335288|NCT01383213|803726|P2|STARTED|Overall Study||41
335289|NCT01383213|803727|P1|STARTED|Overall Study||40
335290|NCT01383200|803735|P2|NOT COMPLETED|Overall Study||0
335291|NCT01383200|803736|P1|NOT COMPLETED|Overall Study||0
335292|NCT01383200|803735|P2|COMPLETED|Overall Study||6
335293|NCT01383200|803736|P1|COMPLETED|Overall Study||5
335294|NCT01383200|803735|P2|STARTED|Overall Study||6
335295|NCT01383200|803736|P1|STARTED|Overall Study||5
335296|NCT01383174|803744|P2|NOT COMPLETED|6 Month Assessment||1
335297|NCT01383174|803745|P1|NOT COMPLETED|6 Month Assessment||5
335298|NCT01383174|803744|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
335299|NCT01383174|803745|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
335300|NCT01383174|803744|P2|STARTED|6 Month Assessment||74
335301|NCT01383174|803745|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
335302|NCT01383174|803744|P2|NOT COMPLETED|3 Month Assessment||1
335303|NCT01383174|803745|P1|NOT COMPLETED|3 Month Assessment||6
335304|NCT01383174|803744|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
335305|NCT01383174|803745|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
335306|NCT01383174|803744|P2|STARTED|3 Month Assessment||75
335307|NCT01383174|803745|P1|STARTED|3 Month Assessment||76
335308|NCT01383174|803744|P2|NOT COMPLETED|Baseline Assessment||0
335309|NCT01383174|803745|P1|NOT COMPLETED|Baseline Assessment||0
335310|NCT01383174|803744|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
335311|NCT01383174|803745|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
335312|NCT01383174|803744|P2|STARTED|Baseline Assessment||75
335313|NCT01383174|803745|P1|STARTED|Baseline Assessment||76
335314|NCT01383096|803772|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
335315|NCT01383096|803773|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
335316|NCT01383096|803774|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
335317|NCT01383096|803772|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
335318|NCT01383096|803773|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
335319|NCT01383096|803774|P1|COMPLETED|Fifth Intervention (8 Days)||11
335320|NCT01383096|803772|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
335321|NCT01383096|803773|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
335322|NCT01383096|803774|P1|STARTED|Fifth Intervention (8 Days)||13
335323|NCT01383096|803772|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
335324|NCT01383096|803773|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
335325|NCT01383096|803774|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
335326|NCT01383096|803772|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
335327|NCT01383096|803773|P2|COMPLETED|Fourth Intervention (8 Days)||12
335328|NCT01383096|803774|P1|COMPLETED|Fourth Intervention (8 Days)||13
335329|NCT01383096|803772|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
335330|NCT01383096|803773|P2|STARTED|Fourth Intervention (8 Days)||12
335331|NCT01383096|803774|P1|STARTED|Fourth Intervention (8 Days)||15
335332|NCT01383096|803772|P3|NOT COMPLETED|Third Intervention (8 Days)||0
335333|NCT01383096|803773|P2|NOT COMPLETED|Third Intervention (8 Days)||4
335334|NCT01383096|803774|P1|NOT COMPLETED|Third Intervention (8 Days)||4
335335|NCT01383096|803772|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
335336|NCT01383096|803773|P2|COMPLETED|Third Intervention (8 Days)||12
335337|NCT01383096|803774|P1|COMPLETED|Third Intervention (8 Days)||15
335338|NCT01383096|803772|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
335339|NCT01383096|803773|P2|STARTED|Third Intervention (8 Days)||16
335340|NCT01383096|803774|P1|STARTED|Third Intervention (8 Days)||19
335341|NCT01383096|803772|P3|NOT COMPLETED|Second Intervention (8 Days)||2
335342|NCT01383096|803773|P2|NOT COMPLETED|Second Intervention (8 Days)||1
335343|NCT01383096|803774|P1|NOT COMPLETED|Second Intervention (8 Days)||0
335344|NCT01383096|803772|P3|COMPLETED|Second Intervention (8 Days)||14
335345|NCT01383096|803773|P2|COMPLETED|Second Intervention (8 Days)||16
335346|NCT01383096|803774|P1|COMPLETED|Second Intervention (8 Days)||19
335347|NCT01383096|803772|P3|STARTED|Second Intervention (8 Days)||16
335348|NCT01383096|803773|P2|STARTED|Second Intervention (8 Days)||17
335349|NCT01383096|803774|P1|STARTED|Second Intervention (8 Days)||19
335350|NCT01383096|803772|P3|NOT COMPLETED|First Intervention (8 Days)||0
335351|NCT01383096|803773|P2|NOT COMPLETED|First Intervention (8 Days)||0
335352|NCT01383096|803774|P1|NOT COMPLETED|First Intervention (8 Days)||0
335353|NCT01383096|803772|P3|COMPLETED|First Intervention (8 Days)||16
335354|NCT01383096|803773|P2|COMPLETED|First Intervention (8 Days)||17
335355|NCT01383096|803774|P1|COMPLETED|First Intervention (8 Days)||19
335356|NCT01383096|803772|P3|STARTED|First Intervention (8 Days)||16
335357|NCT01383096|803773|P2|STARTED|First Intervention (8 Days)||17
335358|NCT01383096|803774|P1|STARTED|First Intervention (8 Days)||19
335359|NCT01383005|803822|P2|NOT COMPLETED|Overall Study||0
335360|NCT01383005|803823|P1|NOT COMPLETED|Overall Study||0
335361|NCT01383005|803822|P2|COMPLETED|Overall Study||60
335362|NCT01383005|803823|P1|COMPLETED|Overall Study||34
335363|NCT01383005|803822|P2|STARTED|Overall Study||60
335364|NCT01383005|803823|P1|STARTED|Overall Study||34
335365|NCT01382940|803842|P1|NOT COMPLETED|Overall Study||73
335366|NCT01382940|803842|P1|COMPLETED|Overall Study||278
335367|NCT01382940|803842|P1|Received Day 182 Infusion|Overall Study||278
335368|NCT01382940|803842|P1|Received Day 168 Infusion|Overall Study||290
335369|NCT01382940|803842|P1|Received Day 15 Infusions|Overall Study||341
335370|NCT01382940|803842|P1|Received Day 1 Infusion|Overall Study||351
335371|NCT01382940|803842|P1|STARTED|Overall Study||351
335372|NCT01382901|803854|P2|NOT COMPLETED|Overall Study||14
335373|NCT01382901|803855|P1|NOT COMPLETED|Overall Study||17
335374|NCT01382901|803854|P2|COMPLETED|Overall Study||7
335375|NCT01382901|803855|P1|COMPLETED|Overall Study||7
335376|NCT01382901|803854|P2|STARTED|Overall Study||21
335377|NCT01382901|803855|P1|STARTED|Overall Study||24
335378|NCT01382719|803865|P4|NOT COMPLETED|Overall Study||33
335379|NCT01382719|803866|P3|NOT COMPLETED|Overall Study||34
335380|NCT01382719|803867|P2|NOT COMPLETED|Overall Study||19
335381|NCT01382719|803868|P1|NOT COMPLETED|Overall Study||18
335382|NCT01382719|803865|P4|COMPLETED|Overall Study||66
335383|NCT01382719|803866|P3|COMPLETED|Overall Study||66
335384|NCT01382719|803867|P2|COMPLETED|Overall Study||81
335385|NCT01382719|803868|P1|COMPLETED|Overall Study||80
335386|NCT01382719|803865|P4|Subjects Not Dosed|Overall Study||1
335387|NCT01382719|803866|P3|Subjects Not Dosed|Overall Study||1
335388|NCT01382719|803867|P2|Subjects Not Dosed|Overall Study||0
335389|NCT01382719|803868|P1|Subjects Not Dosed|Overall Study||1
335390|NCT01382719|803865|P4|STARTED|Overall Study||99
335391|NCT01382719|803866|P3|STARTED|Overall Study||100
335392|NCT01382719|803867|P2|STARTED|Overall Study||100
335393|NCT01382719|803868|P1|STARTED|Overall Study||98
335394|NCT01382446|803904|P2|NOT COMPLETED|Overall Study||4
335395|NCT01382446|803905|P1|NOT COMPLETED|Overall Study||3
335396|NCT01382446|803904|P2|COMPLETED|Overall Study||29
335397|NCT01382446|803905|P1|COMPLETED|Overall Study||30
335398|NCT01382446|803904|P2|STARTED|Overall Study||33
335399|NCT01382446|803905|P1|STARTED|Overall Study||33
335400|NCT01382303|803913|P2|NOT COMPLETED|Overall Study||17
335401|NCT01382303|803914|P1|NOT COMPLETED|Overall Study||35
335402|NCT01382303|803913|P2|COMPLETED|Overall Study||70
335403|NCT01382303|803914|P1|COMPLETED|Overall Study||52
335404|NCT01382303|803913|P2|STARTED|Overall Study||87
335405|NCT01382303|803914|P1|STARTED|Overall Study||87
335406|NCT01382251|803932|P2|NOT COMPLETED|Overall Study||21
335407|NCT01382251|803933|P1|NOT COMPLETED|Overall Study||21
335408|NCT01382251|803932|P2|COMPLETED|Overall Study||102
335409|NCT01382251|803933|P1|COMPLETED|Overall Study||102
335410|NCT01382251|803932|P2|STARTED|Overall Study||123
335411|NCT01382251|803933|P1|STARTED|Overall Study||123
335412|NCT01382225|803946|P2|NOT COMPLETED|Overall Study||7
335413|NCT01382225|803947|P1|NOT COMPLETED|Overall Study||14
335414|NCT01382225|803946|P2|COMPLETED|Overall Study||722
335415|NCT01382225|803947|P1|COMPLETED|Overall Study||711
335416|NCT01382225|803946|P2|STARTED|Overall Study||729
335417|NCT01382225|803947|P1|STARTED|Overall Study||725
335418|NCT01382212|803969|P1|NOT COMPLETED|Overall Study||2
335419|NCT01382212|803969|P1|COMPLETED|Overall Study||11
335420|NCT01382212|803969|P1|STARTED|Overall Study||13
335421|NCT01382186|803995|P2|NOT COMPLETED|Overall Study||0
335422|NCT01382186|803996|P1|NOT COMPLETED|Overall Study||1
335423|NCT01382186|803995|P2|COMPLETED|Overall Study||819
335424|NCT01382186|803996|P1|COMPLETED|Overall Study||32
335425|NCT01382186|803995|P2|STARTED|Overall Study||819
335426|NCT01382186|803996|P1|STARTED|Overall Study||33
335427|NCT01382108|804012|P2|NOT COMPLETED|Overall Study||0
335428|NCT01382108|804013|P1|NOT COMPLETED|Overall Study||0
335429|NCT01382108|804012|P2|COMPLETED|Overall Study||19
335430|NCT01382108|804013|P1|COMPLETED|Overall Study||20
335431|NCT01382108|804012|P2|STARTED|Overall Study||19
335432|NCT01382108|804013|P1|STARTED|Overall Study||20
335433|NCT01381952|804023|P1|NOT COMPLETED|Overall Study||0
335434|NCT01381952|804023|P1|COMPLETED|Overall Study||20
335435|NCT01381952|804023|P1|Collected Dose and Image Information|Overall Study||20
335436|NCT01381952|804023|P1|STARTED|Overall Study||20
335437|NCT01381926|804032|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
335438|NCT01381926|804033|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
335439|NCT01381926|804032|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
335440|NCT01381926|804033|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
335441|NCT01381926|804032|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
335442|NCT01381926|804033|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
335443|NCT01381926|804032|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
335444|NCT01381926|804033|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
335445|NCT01381926|804032|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
335446|NCT01381926|804033|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
335447|NCT01381926|804032|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
335448|NCT01381926|804033|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
335449|NCT01381900|804046|P3|NOT COMPLETED|Overall Study||12
335450|NCT01381900|804047|P2|NOT COMPLETED|Overall Study||9
335451|NCT01381900|804048|P1|NOT COMPLETED|Overall Study||9
335452|NCT01381900|804046|P3|COMPLETED|Overall Study||215
335453|NCT01381900|804047|P2|COMPLETED|Overall Study||214
335454|NCT01381900|804048|P1|COMPLETED|Overall Study||217
335455|NCT01381900|804046|P3|STARTED|Overall Study||227
335456|NCT01381900|804047|P2|STARTED|Overall Study||223
335457|NCT01381900|804048|P1|STARTED|Overall Study||226
335458|NCT01381679|804068|P1|NOT COMPLETED|Overall Study||888
335459|NCT01381679|804068|P1|COMPLETED|Overall Study||794
335460|NCT01381679|804068|P1|STARTED|Overall Study||1682
335461|NCT01381575|804083|P3|NOT COMPLETED|Overall Study||7
335462|NCT01381575|804084|P2|NOT COMPLETED|Overall Study||10
335463|NCT01381575|804085|P1|NOT COMPLETED|Overall Study||2
335464|NCT01381575|804083|P3|COMPLETED|Overall Study||408
335465|NCT01381575|804084|P2|COMPLETED|Overall Study||472
335466|NCT01381575|804085|P1|COMPLETED|Overall Study||548
335467|NCT01381575|804083|P3|STARTED|Overall Study||415
335468|NCT01381575|804084|P2|STARTED|Overall Study||482
335469|NCT01381575|804085|P1|STARTED|Overall Study||550
335470|NCT01381471|804139|P1|NOT COMPLETED|Overall Study||0
335471|NCT01381471|804139|P1|COMPLETED|Overall Study||11060
335472|NCT01381471|804139|P1|STARTED|Overall Study||11060
335473|NCT01381406|804146|P2|NOT COMPLETED|Overall Study||0
335474|NCT01381406|804147|P1|NOT COMPLETED|Overall Study||0
335475|NCT01381406|804146|P2|COMPLETED|Overall Study||852
335476|NCT01381406|804147|P1|COMPLETED|Overall Study||2481
335477|NCT01381406|804146|P2|STARTED|Overall Study||852
335478|NCT01381406|804147|P1|STARTED|Overall Study||2481
335479|NCT01381120|804159|P2|NOT COMPLETED|Overall Study||9
335480|NCT01381120|804160|P1|NOT COMPLETED|Overall Study||11
335481|NCT01381120|804159|P2|COMPLETED|Overall Study||18
335482|NCT01381120|804160|P1|COMPLETED|Overall Study||39
335483|NCT01381120|804159|P2|STARTED|Overall Study||27
335484|NCT01381120|804160|P1|STARTED|Overall Study||50
335485|NCT01381016|804170|P2|NOT COMPLETED|Overall Study||6
335486|NCT01381016|804171|P1|NOT COMPLETED|Overall Study||3
335487|NCT01381016|804170|P2|COMPLETED|Overall Study||11
335488|NCT01381016|804171|P1|COMPLETED|Overall Study||10
335489|NCT01381016|804170|P2|STARTED|Overall Study||17
335490|NCT01381016|804171|P1|STARTED|Overall Study||13
335491|NCT01380834|804181|P2|NOT COMPLETED|Overall Study||0
335492|NCT01380834|804182|P1|NOT COMPLETED|Overall Study||1
335493|NCT01380834|804181|P2|COMPLETED|Overall Study||42
335494|NCT01380834|804182|P1|COMPLETED|Overall Study||41
335495|NCT01380834|804181|P2|STARTED|Overall Study||42
335496|NCT01380834|804182|P1|STARTED|Overall Study||42
335497|NCT01380782|804194|P4|NOT COMPLETED|Overall Study||4
335498|NCT01380782|804195|P3|NOT COMPLETED|Overall Study||11
335499|NCT01380782|804196|P2|NOT COMPLETED|Overall Study||10
335500|NCT01380782|804197|P1|NOT COMPLETED|Overall Study||12
335501|NCT01380782|804194|P4|COMPLETED|Overall Study||0
335502|NCT01380782|804195|P3|COMPLETED|Overall Study||0
335503|NCT01380782|804196|P2|COMPLETED|Overall Study||0
335504|NCT01380782|804197|P1|COMPLETED|Overall Study||0
335505|NCT01380782|804194|P4|STARTED|Overall Study||4
335506|NCT01380782|804195|P3|STARTED|Overall Study||11
335507|NCT01380782|804196|P2|STARTED|Overall Study||10
335508|NCT01380782|804197|P1|STARTED|Overall Study||12
335509|NCT01380769|804220|P2|NOT COMPLETED|Overall Study||14
335510|NCT01380769|804221|P1|NOT COMPLETED|Overall Study||9
335511|NCT01380769|804220|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
335512|NCT01380769|804221|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
335513|NCT01380769|804220|P2|STARTED|Overall Study||57
335514|NCT01380769|804221|P1|STARTED|Overall Study||100
335515|NCT01380730|804237|P8|NOT COMPLETED|Overall Study||0
335516|NCT01380730|804238|P7|NOT COMPLETED|Overall Study||0
335517|NCT01380730|804239|P6|NOT COMPLETED|Overall Study||0
335518|NCT01380730|804240|P5|NOT COMPLETED|Overall Study||1
335519|NCT01380730|804241|P4|NOT COMPLETED|Overall Study||0
335520|NCT01380730|804242|P3|NOT COMPLETED|Overall Study||0
335521|NCT01380730|804243|P2|NOT COMPLETED|Overall Study||0
335522|NCT01380730|804244|P1|NOT COMPLETED|Overall Study||0
335523|NCT01380730|804237|P8|COMPLETED|Overall Study||80
335524|NCT01380730|804238|P7|COMPLETED|Overall Study||79
335525|NCT01380730|804239|P6|COMPLETED|Overall Study||79
335526|NCT01380730|804240|P5|COMPLETED|Overall Study||77
335527|NCT01380730|804241|P4|COMPLETED|Overall Study||79
335528|NCT01380730|804242|P3|COMPLETED|Overall Study||79
335529|NCT01380730|804243|P2|COMPLETED|Overall Study||79
335530|NCT01380730|804244|P1|COMPLETED|Overall Study||78
335531|NCT01380730|804237|P8|Received Treatment|Overall Study||80
335532|NCT01380730|804238|P7|Received Treatment|Overall Study||79
335533|NCT01380730|804239|P6|Received Treatment|Overall Study||79
335534|NCT01380730|804240|P5|Received Treatment|Overall Study||78
335535|NCT01380730|804241|P4|Received Treatment|Overall Study||79
335536|NCT01380730|804242|P3|Received Treatment|Overall Study||79
335537|NCT01380730|804243|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
335538|NCT01380730|804244|P1|Received Treatment|Overall Study||78
335539|NCT01380730|804237|P8|STARTED|Overall Study||80
335540|NCT01380730|804238|P7|STARTED|Overall Study||79
335541|NCT01380730|804239|P6|STARTED|Overall Study||79
335542|NCT01380730|804240|P5|STARTED|Overall Study||78
335543|NCT01380730|804241|P4|STARTED|Overall Study||79
335544|NCT01380730|804242|P3|STARTED|Overall Study||79
335545|NCT01380730|804243|P2|STARTED|Overall Study||79
335546|NCT01380730|804244|P1|STARTED|Overall Study||78
335547|NCT01380639|804304|P2|NOT COMPLETED|Overall Study||4
335548|NCT01380639|804305|P1|NOT COMPLETED|Overall Study||6
335549|NCT01380639|804304|P2|COMPLETED|Overall Study||36
335550|NCT01380639|804305|P1|COMPLETED|Overall Study||36
335551|NCT01380639|804304|P2|STARTED|Overall Study||40
335552|NCT01380639|804305|P1|STARTED|Overall Study||42
335553|NCT01380379|804311|P1|NOT COMPLETED|Overall Study||1
335554|NCT01380379|804311|P1|COMPLETED|Overall Study||8
335555|NCT01380379|804311|P1|STARTED|Overall Study||9
335556|NCT01380366|804316|P1|NOT COMPLETED|Overall Study||0
335557|NCT01380366|804316|P1|COMPLETED|Overall Study||15
335558|NCT01380366|804316|P1|STARTED|Overall Study||15
335559|NCT01380327|804324|P3|NOT COMPLETED|Overall Study||7
335560|NCT01380327|804325|P2|NOT COMPLETED|Overall Study||3
335561|NCT01380327|804326|P1|NOT COMPLETED|Overall Study||3
335562|NCT01380327|804324|P3|COMPLETED|Overall Study||21
335563|NCT01380327|804325|P2|COMPLETED|Overall Study||28
335564|NCT01380327|804326|P1|COMPLETED|Overall Study||27
335565|NCT01380327|804324|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
335566|NCT01380327|804325|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
335567|NCT01380327|804326|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
335568|NCT01380197|804348|P2|NOT COMPLETED|Overall Study||0
335569|NCT01380197|804349|P1|NOT COMPLETED|Overall Study||0
335570|NCT01380197|804348|P2|COMPLETED|Overall Study||20
335571|NCT01380197|804349|P1|COMPLETED|Overall Study||20
335572|NCT01380197|804348|P2|STARTED|Overall Study||20
335573|NCT01380197|804349|P1|STARTED|Overall Study||20
335574|NCT01380145|804357|P1|NOT COMPLETED|Overall Study||4
335575|NCT01380145|804357|P1|COMPLETED|Overall Study||9
335576|NCT01380145|804357|P1|STARTED|Overall Study||13
335577|NCT01380093|804365|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
335578|NCT01380093|804366|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
335579|NCT01380093|804367|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
335580|NCT01380093|804368|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
335581|NCT01380093|804369|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
335582|NCT01380093|804370|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
335583|NCT01380093|804371|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
335584|NCT01380093|804372|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
335585|NCT01380093|804373|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
335586|NCT01380093|804365|P9|COMPLETED|Treatment Phase: Third Intervention||4
335587|NCT01380093|804366|P8|COMPLETED|Treatment Phase: Third Intervention||6
335588|NCT01380093|804367|P7|COMPLETED|Treatment Phase: Third Intervention||6
335589|NCT01380093|804368|P6|COMPLETED|Treatment Phase: Third Intervention||6
335590|NCT01380093|804369|P5|COMPLETED|Treatment Phase: Third Intervention||6
335591|NCT01380093|804370|P4|COMPLETED|Treatment Phase: Third Intervention||5
335592|NCT01380093|804371|P3|COMPLETED|Treatment Phase: Third Intervention||0
335593|NCT01380093|804372|P2|COMPLETED|Treatment Phase: Third Intervention||0
335594|NCT01380093|804373|P1|COMPLETED|Treatment Phase: Third Intervention||0
335595|NCT01380093|804365|P9|STARTED|Treatment Phase: Third Intervention||6
335596|NCT01380093|804366|P8|STARTED|Treatment Phase: Third Intervention||6
335597|NCT01380093|804367|P7|STARTED|Treatment Phase: Third Intervention||6
335598|NCT01380093|804368|P6|STARTED|Treatment Phase: Third Intervention||6
335599|NCT01380093|804369|P5|STARTED|Treatment Phase: Third Intervention||6
335600|NCT01380093|804370|P4|STARTED|Treatment Phase: Third Intervention||5
335601|NCT01380093|804371|P3|STARTED|Treatment Phase: Third Intervention||0
335602|NCT01380093|804372|P2|STARTED|Treatment Phase: Third Intervention||0
335603|NCT01380093|804373|P1|STARTED|Treatment Phase: Third Intervention||0
335604|NCT01380093|804365|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
335605|NCT01380093|804366|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
335606|NCT01380093|804367|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
335607|NCT01380093|804368|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
335608|NCT01380093|804369|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
335609|NCT01380093|804370|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
335610|NCT01380093|804371|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
335611|NCT01380093|804372|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
335612|NCT01380093|804373|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
335613|NCT01380093|804365|P9|COMPLETED|Treatment Phase: Washout Period||6
335614|NCT01380093|804366|P8|COMPLETED|Treatment Phase: Washout Period||6
335615|NCT01380093|804367|P7|COMPLETED|Treatment Phase: Washout Period||6
335616|NCT01380093|804368|P6|COMPLETED|Treatment Phase: Washout Period||6
335617|NCT01380093|804369|P5|COMPLETED|Treatment Phase: Washout Period||6
335618|NCT01380093|804370|P4|COMPLETED|Treatment Phase: Washout Period||5
335619|NCT01380093|804371|P3|COMPLETED|Treatment Phase: Washout Period||0
335620|NCT01380093|804372|P2|COMPLETED|Treatment Phase: Washout Period||0
335621|NCT01380093|804373|P1|COMPLETED|Treatment Phase: Washout Period||0
335622|NCT01380093|804365|P9|STARTED|Treatment Phase: Washout Period||6
335623|NCT01380093|804366|P8|STARTED|Treatment Phase: Washout Period||6
335624|NCT01380093|804367|P7|STARTED|Treatment Phase: Washout Period||6
335625|NCT01380093|804368|P6|STARTED|Treatment Phase: Washout Period||6
335626|NCT01380093|804369|P5|STARTED|Treatment Phase: Washout Period||6
335627|NCT01380093|804370|P4|STARTED|Treatment Phase: Washout Period||5
335628|NCT01380093|804371|P3|STARTED|Treatment Phase: Washout Period||0
335629|NCT01380093|804372|P2|STARTED|Treatment Phase: Washout Period||0
335630|NCT01380093|804373|P1|STARTED|Treatment Phase: Washout Period||0
335631|NCT01380093|804365|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
335632|NCT01380093|804366|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
335633|NCT01380093|804367|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
335634|NCT01380093|804368|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
335635|NCT01380093|804369|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
335636|NCT01380093|804370|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
335637|NCT01380093|804371|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
335638|NCT01380093|804372|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
335639|NCT01380093|804373|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
335640|NCT01380093|804365|P9|COMPLETED|Treatment Phase: Second Intervention||6
335641|NCT01380093|804366|P8|COMPLETED|Treatment Phase: Second Intervention||6
335642|NCT01380093|804367|P7|COMPLETED|Treatment Phase: Second Intervention||6
335643|NCT01380093|804368|P6|COMPLETED|Treatment Phase: Second Intervention||6
335644|NCT01380093|804369|P5|COMPLETED|Treatment Phase: Second Intervention||6
335645|NCT01380093|804370|P4|COMPLETED|Treatment Phase: Second Intervention||5
335646|NCT01380093|804371|P3|COMPLETED|Treatment Phase: Second Intervention||0
335647|NCT01380093|804372|P2|COMPLETED|Treatment Phase: Second Intervention||0
335648|NCT01380093|804373|P1|COMPLETED|Treatment Phase: Second Intervention||0
335649|NCT01380093|804365|P9|STARTED|Treatment Phase: Second Intervention||6
335650|NCT01380093|804366|P8|STARTED|Treatment Phase: Second Intervention||6
335651|NCT01380093|804367|P7|STARTED|Treatment Phase: Second Intervention||6
335652|NCT01380093|804368|P6|STARTED|Treatment Phase: Second Intervention||6
335653|NCT01380093|804369|P5|STARTED|Treatment Phase: Second Intervention||6
335654|NCT01380093|804370|P4|STARTED|Treatment Phase: Second Intervention||6
335655|NCT01380093|804371|P3|STARTED|Treatment Phase: Second Intervention||0
335656|NCT01380093|804372|P2|STARTED|Treatment Phase: Second Intervention||0
335657|NCT01380093|804373|P1|STARTED|Treatment Phase: Second Intervention||0
335658|NCT01380093|804365|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
335659|NCT01380093|804366|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
335660|NCT01380093|804367|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
335661|NCT01380093|804368|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
335662|NCT01380093|804369|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
335663|NCT01380093|804370|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
335664|NCT01380093|804371|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
335665|NCT01380093|804372|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
335666|NCT01380093|804373|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
335667|NCT01380093|804365|P9|COMPLETED|Treatment Phase: Washout Period||6
335668|NCT01380093|804366|P8|COMPLETED|Treatment Phase: Washout Period||6
335669|NCT01380093|804367|P7|COMPLETED|Treatment Phase: Washout Period||6
335670|NCT01380093|804368|P6|COMPLETED|Treatment Phase: Washout Period||6
335671|NCT01380093|804369|P5|COMPLETED|Treatment Phase: Washout Period||6
335672|NCT01380093|804370|P4|COMPLETED|Treatment Phase: Washout Period||6
335673|NCT01380093|804371|P3|COMPLETED|Treatment Phase: Washout Period||0
335674|NCT01380093|804372|P2|COMPLETED|Treatment Phase: Washout Period||0
335675|NCT01380093|804373|P1|COMPLETED|Treatment Phase: Washout Period||0
335676|NCT01380093|804365|P9|STARTED|Treatment Phase: Washout Period||6
335677|NCT01380093|804366|P8|STARTED|Treatment Phase: Washout Period||6
335678|NCT01380093|804367|P7|STARTED|Treatment Phase: Washout Period||6
335679|NCT01380093|804368|P6|STARTED|Treatment Phase: Washout Period||6
335680|NCT01380093|804369|P5|STARTED|Treatment Phase: Washout Period||6
335681|NCT01380093|804370|P4|STARTED|Treatment Phase: Washout Period||6
335682|NCT01380093|804371|P3|STARTED|Treatment Phase: Washout Period||0
335683|NCT01380093|804372|P2|STARTED|Treatment Phase: Washout Period||0
335684|NCT01380093|804373|P1|STARTED|Treatment Phase: Washout Period||0
335685|NCT01380093|804365|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
335686|NCT01380093|804366|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
335687|NCT01380093|804367|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
335688|NCT01380093|804368|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
335689|NCT01380093|804369|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
335690|NCT01380093|804370|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
335691|NCT01380093|804371|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
335692|NCT01380093|804372|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
335693|NCT01380093|804373|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
335694|NCT01380093|804365|P9|COMPLETED|Treatment Phase: First Intervention||6
335695|NCT01380093|804366|P8|COMPLETED|Treatment Phase: First Intervention||6
335696|NCT01380093|804367|P7|COMPLETED|Treatment Phase: First Intervention||6
335697|NCT01380093|804368|P6|COMPLETED|Treatment Phase: First Intervention||6
335698|NCT01380093|804369|P5|COMPLETED|Treatment Phase: First Intervention||6
335699|NCT01380093|804370|P4|COMPLETED|Treatment Phase: First Intervention||6
335700|NCT01380093|804371|P3|COMPLETED|Treatment Phase: First Intervention||0
335701|NCT01380093|804372|P2|COMPLETED|Treatment Phase: First Intervention||0
335702|NCT01380093|804373|P1|COMPLETED|Treatment Phase: First Intervention||0
335703|NCT01380093|804365|P9|STARTED|Treatment Phase: First Intervention||6
335704|NCT01380093|804366|P8|STARTED|Treatment Phase: First Intervention||6
335705|NCT01380093|804367|P7|STARTED|Treatment Phase: First Intervention||6
335706|NCT01380093|804368|P6|STARTED|Treatment Phase: First Intervention||6
335707|NCT01380093|804369|P5|STARTED|Treatment Phase: First Intervention||6
335708|NCT01380093|804370|P4|STARTED|Treatment Phase: First Intervention||6
335709|NCT01380093|804371|P3|STARTED|Treatment Phase: First Intervention||0
335710|NCT01380093|804372|P2|STARTED|Treatment Phase: First Intervention||0
335711|NCT01380093|804373|P1|STARTED|Treatment Phase: First Intervention||0
335712|NCT01380093|804365|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335713|NCT01380093|804366|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335714|NCT01380093|804367|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335715|NCT01380093|804368|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335716|NCT01380093|804369|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335717|NCT01380093|804370|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335718|NCT01380093|804371|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
335719|NCT01380093|804372|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
335720|NCT01380093|804373|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
335721|NCT01380093|804365|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
335722|NCT01380093|804366|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
335723|NCT01380093|804367|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
335724|NCT01380093|804368|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
335725|NCT01380093|804369|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
335726|NCT01380093|804370|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
335727|NCT01380093|804371|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
335728|NCT01380093|804372|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
335729|NCT01380093|804373|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
335730|NCT01380093|804365|P9|STARTED|Drug Discrimination Phase: Day 2||0
335731|NCT01380093|804366|P8|STARTED|Drug Discrimination Phase: Day 2||0
335732|NCT01380093|804367|P7|STARTED|Drug Discrimination Phase: Day 2||0
335733|NCT01380093|804368|P6|STARTED|Drug Discrimination Phase: Day 2||0
335734|NCT01380093|804369|P5|STARTED|Drug Discrimination Phase: Day 2||0
335735|NCT01380093|804370|P4|STARTED|Drug Discrimination Phase: Day 2||0
335736|NCT01380093|804371|P3|STARTED|Drug Discrimination Phase: Day 2||29
335737|NCT01380093|804372|P2|STARTED|Drug Discrimination Phase: Day 2||29
335738|NCT01380093|804373|P1|STARTED|Drug Discrimination Phase: Day 2||0
335739|NCT01380093|804365|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335740|NCT01380093|804366|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335741|NCT01380093|804367|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335742|NCT01380093|804368|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335743|NCT01380093|804369|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335744|NCT01380093|804370|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335745|NCT01380093|804371|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335746|NCT01380093|804372|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
335747|NCT01380093|804373|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
335748|NCT01380093|804365|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
335749|NCT01380093|804366|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
335750|NCT01380093|804367|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
335751|NCT01380093|804368|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
335752|NCT01380093|804369|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
335753|NCT01380093|804370|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
335754|NCT01380093|804371|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
335755|NCT01380093|804372|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
335756|NCT01380093|804373|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
335757|NCT01380093|804365|P9|STARTED|Drug Discrimination Phase: Day 1||0
335758|NCT01380093|804366|P8|STARTED|Drug Discrimination Phase: Day 1||0
335759|NCT01380093|804367|P7|STARTED|Drug Discrimination Phase: Day 1||0
335760|NCT01380093|804368|P6|STARTED|Drug Discrimination Phase: Day 1||0
335761|NCT01380093|804369|P5|STARTED|Drug Discrimination Phase: Day 1||0
335762|NCT01380093|804370|P4|STARTED|Drug Discrimination Phase: Day 1||0
335763|NCT01380093|804371|P3|STARTED|Drug Discrimination Phase: Day 1||29
335764|NCT01380093|804372|P2|STARTED|Drug Discrimination Phase: Day 1||30
335765|NCT01380093|804373|P1|STARTED|Drug Discrimination Phase: Day 1||0
335766|NCT01380093|804365|P9|NOT COMPLETED|Naloxone Challenge Phase||0
335767|NCT01380093|804366|P8|NOT COMPLETED|Naloxone Challenge Phase||0
335768|NCT01380093|804367|P7|NOT COMPLETED|Naloxone Challenge Phase||0
335769|NCT01380093|804368|P6|NOT COMPLETED|Naloxone Challenge Phase||0
335770|NCT01380093|804369|P5|NOT COMPLETED|Naloxone Challenge Phase||0
335771|NCT01380093|804370|P4|NOT COMPLETED|Naloxone Challenge Phase||0
335772|NCT01380093|804371|P3|NOT COMPLETED|Naloxone Challenge Phase||0
335773|NCT01380093|804372|P2|NOT COMPLETED|Naloxone Challenge Phase||0
335774|NCT01380093|804373|P1|NOT COMPLETED|Naloxone Challenge Phase||21
335775|NCT01380093|804365|P9|COMPLETED|Naloxone Challenge Phase||0
335776|NCT01380093|804366|P8|COMPLETED|Naloxone Challenge Phase||0
335777|NCT01380093|804367|P7|COMPLETED|Naloxone Challenge Phase||0
335778|NCT01380093|804368|P6|COMPLETED|Naloxone Challenge Phase||0
335779|NCT01380093|804369|P5|COMPLETED|Naloxone Challenge Phase||0
335780|NCT01380093|804370|P4|COMPLETED|Naloxone Challenge Phase||0
335781|NCT01380093|804371|P3|COMPLETED|Naloxone Challenge Phase||0
335782|NCT01380093|804372|P2|COMPLETED|Naloxone Challenge Phase||0
335783|NCT01380093|804373|P1|COMPLETED|Naloxone Challenge Phase||59
335784|NCT01380093|804365|P9|TREATED|Naloxone Challenge Phase||0
335785|NCT01380093|804366|P8|TREATED|Naloxone Challenge Phase||0
335786|NCT01380093|804367|P7|TREATED|Naloxone Challenge Phase||0
335787|NCT01380093|804368|P6|TREATED|Naloxone Challenge Phase||0
335788|NCT01380093|804369|P5|TREATED|Naloxone Challenge Phase||0
335789|NCT01380093|804370|P4|TREATED|Naloxone Challenge Phase||0
335790|NCT01380093|804371|P3|TREATED|Naloxone Challenge Phase||0
335791|NCT01380093|804372|P2|TREATED|Naloxone Challenge Phase||0
335792|NCT01380093|804373|P1|TREATED|Naloxone Challenge Phase||59
335793|NCT01380093|804365|P9|STARTED|Naloxone Challenge Phase||0
335794|NCT01380093|804366|P8|STARTED|Naloxone Challenge Phase||0
335795|NCT01380093|804367|P7|STARTED|Naloxone Challenge Phase||0
335796|NCT01380093|804368|P6|STARTED|Naloxone Challenge Phase||0
335797|NCT01380093|804369|P5|STARTED|Naloxone Challenge Phase||0
335798|NCT01380093|804370|P4|STARTED|Naloxone Challenge Phase||0
335799|NCT01380093|804371|P3|STARTED|Naloxone Challenge Phase||0
335800|NCT01380093|804372|P2|STARTED|Naloxone Challenge Phase||0
335801|NCT01380093|804373|P1|STARTED|Naloxone Challenge Phase||80
335802|NCT01380080|804665|P2|NOT COMPLETED|Overall Study||23
335803|NCT01380080|804666|P1|NOT COMPLETED|Overall Study||33
335804|NCT01380080|804665|P2|COMPLETED|Overall Study||403
335805|NCT01380080|804666|P1|COMPLETED|Overall Study||391
335806|NCT01380080|804665|P2|STARTED|Overall Study||426
335807|NCT01380080|804666|P1|STARTED|Overall Study||424
335808|NCT01379963|804682|P1|NOT COMPLETED|Overall Study||0
335809|NCT01379963|804682|P1|COMPLETED|Overall Study||780
335810|NCT01379963|804682|P1|STARTED|Overall Study||780
335811|NCT01379937|804691|P4|NOT COMPLETED|Overall Study||1
335812|NCT01379937|804692|P3|NOT COMPLETED|Overall Study||2
335813|NCT01379937|804693|P2|NOT COMPLETED|Overall Study||3
335814|NCT01379937|804694|P1|NOT COMPLETED|Overall Study||1
335815|NCT01379937|804691|P4|COMPLETED|Overall Study||103
335816|NCT01379937|804692|P3|COMPLETED|Overall Study||102
335817|NCT01379937|804693|P2|COMPLETED|Overall Study||153
335818|NCT01379937|804694|P1|COMPLETED|Overall Study||155
335819|NCT01379937|804691|P4|STARTED|Overall Study||104
335820|NCT01379937|804692|P3|STARTED|Overall Study||104
335821|NCT01379937|804693|P2|STARTED|Overall Study||156
335822|NCT01379937|804694|P1|STARTED|Overall Study||156
335823|NCT01379781|804776|P2|NOT COMPLETED|Overall Study||8
335824|NCT01379781|804777|P1|NOT COMPLETED|Overall Study||11
335825|NCT01379781|804776|P2|COMPLETED|Overall Study||19
335826|NCT01379781|804777|P1|COMPLETED|Overall Study||16
335827|NCT01379781|804776|P2|STARTED|Overall Study||27
335828|NCT01379781|804777|P1|STARTED|Overall Study||27
335829|NCT01379768|804786|P3|NOT COMPLETED|Overall Study||0
335830|NCT01379768|804787|P2|NOT COMPLETED|Overall Study||1
335831|NCT01379768|804788|P1|NOT COMPLETED|Overall Study||3
335832|NCT01379768|804786|P3|COMPLETED|Overall Study||20
335833|NCT01379768|804787|P2|COMPLETED|Overall Study||21
335834|NCT01379768|804788|P1|COMPLETED|Overall Study||20
335835|NCT01379768|804786|P3|STARTED|Overall Study||20
335836|NCT01379768|804787|P2|STARTED|Overall Study||22
335837|NCT01379768|804788|P1|STARTED|Overall Study||23
335838|NCT01379703|804811|P3|NOT COMPLETED|9 Months Through 18 Months||0
335839|NCT01379703|804812|P2|NOT COMPLETED|9 Months Through 18 Months||230
335840|NCT01379703|804813|P1|NOT COMPLETED|9 Months Through 18 Months||0
335841|NCT01379703|804811|P3|COMPLETED|9 Months Through 18 Months||0
335842|NCT01379703|804812|P2|COMPLETED|9 Months Through 18 Months||854
335843|NCT01379703|804813|P1|COMPLETED|9 Months Through 18 Months||0
335844|NCT01379703|804811|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
335845|NCT01379703|804812|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
335846|NCT01379703|804813|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
335847|NCT01379703|804811|P3|NOT COMPLETED|Study Start Through 9 Months||143
335848|NCT01379703|804812|P2|NOT COMPLETED|Study Start Through 9 Months||122
335849|NCT01379703|804813|P1|NOT COMPLETED|Study Start Through 9 Months||4
335850|NCT01379703|804811|P3|COMPLETED|Study Start Through 9 Months||873
335851|NCT01379703|804812|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
335852|NCT01379703|804813|P1|COMPLETED|Study Start Through 9 Months||62
335853|NCT01379703|804811|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
335854|NCT01379703|804812|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
335855|NCT01379703|804813|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
335856|NCT01379664|804876|P2|NOT COMPLETED|Overall Study||0
335857|NCT01379664|804877|P1|NOT COMPLETED|Overall Study||0
335858|NCT01379664|804876|P2|COMPLETED|Overall Study||870
335859|NCT01379664|804877|P1|COMPLETED|Overall Study||714
335860|NCT01379664|804876|P2|STARTED|Overall Study||870
335861|NCT01379664|804877|P1|STARTED|Overall Study||714
335862|NCT01379651|804889|P2|NOT COMPLETED|Overall Study||0
335863|NCT01379651|804890|P1|NOT COMPLETED|Overall Study||0
335864|NCT01379651|804889|P2|COMPLETED|Overall Study||10
335865|NCT01379651|804890|P1|COMPLETED|Overall Study||10
335866|NCT01379651|804889|P2|STARTED|Overall Study||10
335867|NCT01379651|804890|P1|STARTED|Overall Study||10
335868|NCT01379625|804900|P2|NOT COMPLETED|Overall Study||0
335869|NCT01379625|804901|P1|NOT COMPLETED|Overall Study||0
335870|NCT01379625|804900|P2|COMPLETED|Overall Study||16
335871|NCT01379625|804901|P1|COMPLETED|Overall Study||16
335872|NCT01379625|804900|P2|STARTED|Overall Study||16
335873|NCT01379625|804901|P1|STARTED|Overall Study||16
335874|NCT01379534|804913|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
335875|NCT01379534|804914|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
335876|NCT01379534|804913|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
335877|NCT01379534|804914|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
335878|NCT01379534|804913|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
335879|NCT01379534|804914|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
335880|NCT01379534|804913|P2|NOT COMPLETED|Treatment Phase||31
335881|NCT01379534|804914|P1|NOT COMPLETED|Treatment Phase||22
335882|NCT01379534|804913|P2|COMPLETED|Treatment Phase||0
335883|NCT01379534|804914|P1|COMPLETED|Treatment Phase||0
335884|NCT01379534|804913|P2|STARTED|Treatment Phase||31
335885|NCT01379534|804914|P1|STARTED|Treatment Phase||22
335886|NCT01379521|804934|P2|NOT COMPLETED|Post-Treatment Evaluations||21
335887|NCT01379521|804935|P1|NOT COMPLETED|Post-Treatment Evaluations||25
335888|NCT01379521|804934|P2|COMPLETED|Post-Treatment Evaluations||0
335889|NCT01379521|804935|P1|COMPLETED|Post-Treatment Evaluations||0
335890|NCT01379521|804934|P2|STARTED|Post-Treatment Evaluations||21
335891|NCT01379521|804935|P1|STARTED|Post-Treatment Evaluations||25
335892|NCT01379521|804934|P2|NOT COMPLETED|Overall Study -Treatment Period||26
335893|NCT01379521|804935|P1|NOT COMPLETED|Overall Study -Treatment Period||33
335894|NCT01379521|804934|P2|COMPLETED|Overall Study -Treatment Period||0
335895|NCT01379521|804935|P1|COMPLETED|Overall Study -Treatment Period||0
335896|NCT01379521|804934|P2|STARTED|Overall Study -Treatment Period||26
335897|NCT01379521|804935|P1|STARTED|Overall Study -Treatment Period||33
335898|NCT01379183|804955|P2|NOT COMPLETED|Overall Study||0
335899|NCT01379183|804956|P1|NOT COMPLETED|Overall Study||0
335900|NCT01379183|804955|P2|COMPLETED|Overall Study||21
335901|NCT01379183|804956|P1|COMPLETED|Overall Study||19
335902|NCT01379183|804955|P2|STARTED|Overall Study||21
335903|NCT01379183|804956|P1|STARTED|Overall Study||19
335904|NCT01378988|804974|P2|NOT COMPLETED|Overall Study||0
335905|NCT01378988|804975|P1|NOT COMPLETED|Overall Study||0
335906|NCT01378988|804974|P2|COMPLETED|Overall Study||3
335907|NCT01378988|804975|P1|COMPLETED|Overall Study||2
335908|NCT01378988|804974|P2|STARTED|Overall Study||3
335909|NCT01378988|804975|P1|STARTED|Overall Study||2
335910|NCT01378975|805005|P2|NOT COMPLETED|Overall Study||50
335911|NCT01378975|805006|P1|NOT COMPLETED|Overall Study||86
335912|NCT01378975|805005|P2|COMPLETED|Overall Study||6
335913|NCT01378975|805006|P1|COMPLETED|Overall Study||4
335914|NCT01378975|805005|P2|STARTED|Overall Study||56
335915|NCT01378975|805006|P1|STARTED|Overall Study||90
335916|NCT01378962|805032|P1|NOT COMPLETED|Overall Study||17
335917|NCT01378962|805032|P1|COMPLETED|Overall Study||33
335918|NCT01378962|805032|P1|STARTED|Overall Study||50
335919|NCT01378520|805045|P2|NOT COMPLETED|Second Intervention||0
335920|NCT01378520|805046|P1|NOT COMPLETED|Second Intervention||0
335921|NCT01378520|805045|P2|COMPLETED|Second Intervention||10
335922|NCT01378520|805046|P1|COMPLETED|Second Intervention||10
335923|NCT01378520|805045|P2|STARTED|Second Intervention||10
335924|NCT01378520|805046|P1|STARTED|Second Intervention||10
335925|NCT01378520|805045|P2|NOT COMPLETED|First Intervention||0
335926|NCT01378520|805046|P1|NOT COMPLETED|First Intervention||0
335927|NCT01378520|805045|P2|COMPLETED|First Intervention||10
335928|NCT01378520|805046|P1|COMPLETED|First Intervention||10
335929|NCT01378520|805045|P2|STARTED|First Intervention||10
335930|NCT01378520|805046|P1|STARTED|First Intervention||10
335931|NCT01378429|805058|P2|NOT COMPLETED|Overall Study||0
335932|NCT01378429|805059|P1|NOT COMPLETED|Overall Study||1
335933|NCT01378429|805058|P2|COMPLETED|Overall Study||47
335934|NCT01378429|805059|P1|COMPLETED|Overall Study||41
335935|NCT01378429|805058|P2|STARTED|Overall Study||47
335936|NCT01378429|805059|P1|STARTED|Overall Study||42
335937|NCT01378416|805091|P1|NOT COMPLETED|Overall Study||0
335938|NCT01378416|805091|P1|COMPLETED|Overall Study||16
335939|NCT01378416|805091|P1|STARTED|Overall Study||16
335940|NCT01378325|805101|P2|NOT COMPLETED|Overall Study||1
335941|NCT01378325|805102|P1|NOT COMPLETED|Overall Study||0
335942|NCT01378325|805101|P2|COMPLETED|Overall Study||39
335943|NCT01378325|805102|P1|COMPLETED|Overall Study||40
335944|NCT01378325|805101|P2|STARTED|Overall Study||40
335945|NCT01378325|805102|P1|STARTED|Overall Study||40
335946|NCT01378221|805110|P2|NOT COMPLETED|Overall Study||9
335947|NCT01378221|805111|P1|NOT COMPLETED|Overall Study||7
335948|NCT01378221|805110|P2|COMPLETED|Overall Study||30
335949|NCT01378221|805111|P1|COMPLETED|Overall Study||29
335950|NCT01378221|805110|P2|STARTED|Overall Study||39
335951|NCT01378221|805111|P1|STARTED|Overall Study||36
335952|NCT01378195|805119|P2|NOT COMPLETED|Overall Study||18
335953|NCT01378195|805120|P1|NOT COMPLETED|Overall Study||29
335954|NCT01378195|805119|P2|COMPLETED|Overall Study||57
335955|NCT01378195|805120|P1|COMPLETED|Overall Study||46
335956|NCT01378195|805119|P2|STARTED|Overall Study||75
335957|NCT01378195|805120|P1|STARTED|Overall Study||75
335958|NCT01378117|805133|P3|NOT COMPLETED|Overall Study||3
335959|NCT01378117|805134|P2|NOT COMPLETED|Overall Study||1
335960|NCT01378117|805135|P1|NOT COMPLETED|Overall Study||4
335961|NCT01378117|805133|P3|COMPLETED|Overall Study||26
335962|NCT01378117|805134|P2|COMPLETED|Overall Study||29
335963|NCT01378117|805135|P1|COMPLETED|Overall Study||27
335964|NCT01378117|805133|P3|STARTED|Overall Study||29
335965|NCT01378117|805134|P2|STARTED|Overall Study||30
335966|NCT01378117|805135|P1|STARTED|Overall Study||31
335967|NCT01378104|805145|P2|NOT COMPLETED|Overall Study||26
335968|NCT01378104|805146|P1|NOT COMPLETED|Overall Study||27
335969|NCT01378104|805145|P2|COMPLETED|Overall Study||60
335970|NCT01378104|805146|P1|COMPLETED|Overall Study||65
335971|NCT01378104|805145|P2|STARTED|Overall Study||86
335972|NCT01378104|805146|P1|STARTED|Overall Study||92
335973|NCT01378065|805154|P1|NOT COMPLETED|Overall Study||0
335974|NCT01378065|805154|P1|COMPLETED|Overall Study||30
335975|NCT01378065|805154|P1|12 Months|Overall Study||30
335976|NCT01378065|805154|P1|6 Months|Overall Study||30
335977|NCT01378065|805154|P1|3 Months|Overall Study||30
335978|NCT01378065|805154|P1|6 Week|Overall Study||30
335979|NCT01378065|805154|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
335980|NCT01377636|805191|P1|NOT COMPLETED|Overall Study||0
335981|NCT01377636|805191|P1|COMPLETED|Overall Study||20
335982|NCT01377636|805191|P1|STARTED|Overall Study||20
335983|NCT01377623|805205|P2|NOT COMPLETED|Overall Study||5
335984|NCT01377623|805206|P1|NOT COMPLETED|Overall Study||7
335985|NCT01377623|805205|P2|COMPLETED|Overall Study||28
335986|NCT01377623|805206|P1|COMPLETED|Overall Study||26
335987|NCT01377623|805205|P2|STARTED|Overall Study||33
335988|NCT01377623|805206|P1|STARTED|Overall Study||33
335989|NCT01377480|805224|P4|NOT COMPLETED|Overall Study||11
335990|NCT01377480|805225|P3|NOT COMPLETED|Overall Study||10
335991|NCT01377480|805226|P2|NOT COMPLETED|Overall Study||1
335992|NCT01377480|805227|P1|NOT COMPLETED|Overall Study||0
335993|NCT01377480|805224|P4|COMPLETED|Overall Study||19
335994|NCT01377480|805225|P3|COMPLETED|Overall Study||18
335995|NCT01377480|805226|P2|COMPLETED|Overall Study||29
335996|NCT01377480|805227|P1|COMPLETED|Overall Study||32
335997|NCT01377480|805224|P4|STARTED|Overall Study||30
335998|NCT01377480|805225|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
335999|NCT01377480|805226|P2|STARTED|Overall Study||30
336000|NCT01377480|805227|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
336001|NCT01377467|805239|P2|NOT COMPLETED|Overall Study||0
336002|NCT01377467|805240|P1|NOT COMPLETED|Overall Study||0
336003|NCT01377467|805239|P2|COMPLETED|Overall Study||44
336004|NCT01377467|805240|P1|COMPLETED|Overall Study||46
336005|NCT01377467|805239|P2|STARTED|Overall Study||44
336006|NCT01377467|805240|P1|STARTED|Overall Study||46
336007|NCT01377441|805288|P2|NOT COMPLETED|Overall Study||0
336008|NCT01377441|805289|P1|NOT COMPLETED|Overall Study||0
336009|NCT01377441|805288|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
336010|NCT01377441|805289|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
336011|NCT01377441|805288|P2|STARTED|Overall Study||0
336012|NCT01377441|805289|P1|STARTED|Overall Study||0
336013|NCT01377402|805295|P1|NOT COMPLETED|Overall Study||0
336014|NCT01377402|805295|P1|COMPLETED|Overall Study||982
336015|NCT01377402|805295|P1|STARTED|Overall Study||982
336016|NCT01377233|805306|P5|NOT COMPLETED|Double-blind||2
336017|NCT01377233|805307|P4|NOT COMPLETED|Double-blind||4
336018|NCT01377233|805308|P3|NOT COMPLETED|Double-blind||2
336019|NCT01377233|805309|P2|NOT COMPLETED|Double-blind||1
336020|NCT01377233|805310|P1|NOT COMPLETED|Double-blind||0
336021|NCT01377233|805306|P5|COMPLETED|Double-blind||8
336022|NCT01377233|805307|P4|COMPLETED|Double-blind||7
336023|NCT01377233|805308|P3|COMPLETED|Double-blind||8
336024|NCT01377233|805309|P2|COMPLETED|Double-blind||10
336025|NCT01377233|805310|P1|COMPLETED|Double-blind||0
336026|NCT01377233|805306|P5|STARTED|Double-blind||10
336027|NCT01377233|805307|P4|STARTED|Double-blind||11
336028|NCT01377233|805308|P3|STARTED|Double-blind||10
336029|NCT01377233|805309|P2|STARTED|Double-blind||11
336030|NCT01377233|805310|P1|STARTED|Double-blind||0
336031|NCT01377233|805306|P5|NOT COMPLETED|Open-label||0
336032|NCT01377233|805307|P4|NOT COMPLETED|Open-label||0
336033|NCT01377233|805308|P3|NOT COMPLETED|Open-label||0
336034|NCT01377233|805309|P2|NOT COMPLETED|Open-label||0
336035|NCT01377233|805310|P1|NOT COMPLETED|Open-label||4
336036|NCT01377233|805306|P5|COMPLETED|Open-label||0
336037|NCT01377233|805307|P4|COMPLETED|Open-label||0
336038|NCT01377233|805308|P3|COMPLETED|Open-label||0
336039|NCT01377233|805309|P2|COMPLETED|Open-label||0
336040|NCT01377233|805310|P1|COMPLETED|Open-label||42
336041|NCT01377233|805306|P5|STARTED|Open-label||0
336042|NCT01377233|805307|P4|STARTED|Open-label||0
336043|NCT01377233|805308|P3|STARTED|Open-label||0
336044|NCT01377233|805309|P2|STARTED|Open-label||0
336045|NCT01377233|805310|P1|STARTED|Open-label||46
336046|NCT01377194|805337|P3|NOT COMPLETED|Overall Study||46
336047|NCT01377194|805338|P2|NOT COMPLETED|Overall Study||43
336048|NCT01377194|805339|P1|NOT COMPLETED|Overall Study||32
336049|NCT01377194|805337|P3|COMPLETED|Overall Study||142
336050|NCT01377194|805338|P2|COMPLETED|Overall Study||145
336051|NCT01377194|805339|P1|COMPLETED|Overall Study||154
336052|NCT01377194|805337|P3|STARTED|Overall Study||188
336053|NCT01377194|805338|P2|STARTED|Overall Study||188
336054|NCT01377194|805339|P1|STARTED|Overall Study||186
336055|NCT01377012|805353|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
336056|NCT01377012|805354|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
336057|NCT01377012|805355|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
336058|NCT01377012|805353|P3|COMPLETED|Extension Study, Weeks 104-260||0
336059|NCT01377012|805354|P2|COMPLETED|Extension Study, Weeks 104-260||0
336060|NCT01377012|805355|P1|COMPLETED|Extension Study, Weeks 104-260||0
336061|NCT01377012|805353|P3|STARTED|Extension Study, Weeks 104-260||68
336062|NCT01377012|805354|P2|STARTED|Extension Study, Weeks 104-260||71
336063|NCT01377012|805355|P1|STARTED|Extension Study, Weeks 104-260||57
336064|NCT01377012|805353|P3|NOT COMPLETED|Core Study||134
336065|NCT01377012|805354|P2|NOT COMPLETED|Core Study||132
336066|NCT01377012|805355|P1|NOT COMPLETED|Core Study||134
336067|NCT01377012|805353|P3|COMPLETED|Core Study||80
336068|NCT01377012|805354|P2|COMPLETED|Core Study||81
336069|NCT01377012|805355|P1|COMPLETED|Core Study||76
336070|NCT01377012|805353|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
336071|NCT01377012|805354|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
336072|NCT01377012|805355|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
336073|NCT01377012|805353|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
336074|NCT01377012|805354|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
336075|NCT01377012|805355|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
336076|NCT01377012|805353|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
336077|NCT01377012|805354|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
336078|NCT01377012|805355|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
336079|NCT01377012|805353|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
336080|NCT01377012|805354|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
336081|NCT01377012|805355|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
336082|NCT01377012|805353|P3|STARTED|Core Study||214
336083|NCT01377012|805354|P2|STARTED|Core Study||213
336084|NCT01377012|805355|P1|STARTED|Core Study||210
336085|NCT01376908|805392|P2|NOT COMPLETED|Overall Study||3
336086|NCT01376908|805393|P1|NOT COMPLETED|Overall Study||2
336087|NCT01376908|805392|P2|COMPLETED|Overall Study||26
336088|NCT01376908|805393|P1|COMPLETED|Overall Study||25
336089|NCT01376908|805392|P2|STARTED|Overall Study||29
336090|NCT01376908|805393|P1|STARTED|Overall Study||27
336091|NCT01376804|805426|P1|NOT COMPLETED|Follow-up Period||0
336092|NCT01376804|805426|P1|COMPLETED|Follow-up Period||55
336093|NCT01376804|805426|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
336094|NCT01376804|805426|P1|NOT COMPLETED|Treatment Period||8
336095|NCT01376804|805426|P1|COMPLETED|Treatment Period||49
336096|NCT01376804|805426|P1|Received Study Drug|Treatment Period||56
336097|NCT01376804|805426|P1|STARTED|Treatment Period||57
336098|NCT01376700|805437|P1|NOT COMPLETED|Overall Study||16
336099|NCT01376700|805437|P1|COMPLETED|Overall Study||3
336100|NCT01376700|805437|P1|STARTED|Overall Study||19
336101|NCT01376557|805458|P5|NOT COMPLETED|Overall Study||7
336102|NCT01376557|805459|P4|NOT COMPLETED|Overall Study||6
336103|NCT01376557|805460|P3|NOT COMPLETED|Overall Study||5
336104|NCT01376557|805461|P2|NOT COMPLETED|Overall Study||6
336105|NCT01376557|805462|P1|NOT COMPLETED|Overall Study||8
336106|NCT01376557|805458|P5|COMPLETED|Overall Study||53
336107|NCT01376557|805459|P4|COMPLETED|Overall Study||54
336108|NCT01376557|805460|P3|COMPLETED|Overall Study||55
336109|NCT01376557|805461|P2|COMPLETED|Overall Study||54
336110|NCT01376557|805462|P1|COMPLETED|Overall Study||51
336111|NCT01376557|805458|P5|STARTED|Overall Study||60
336112|NCT01376557|805459|P4|STARTED|Overall Study||60
336113|NCT01376557|805460|P3|STARTED|Overall Study||60
336114|NCT01376557|805461|P2|STARTED|Overall Study||60
336115|NCT01376557|805462|P1|STARTED|Overall Study||59
336116|NCT01376388|805499|P1|NOT COMPLETED|Overall Study||18
336117|NCT01376388|805499|P1|COMPLETED|Overall Study||112
336118|NCT01376388|805499|P1|STARTED|Overall Study||130
336119|NCT01376362|805514|P1|NOT COMPLETED|Overall Study||0
336120|NCT01376362|805514|P1|COMPLETED|Overall Study||5
336121|NCT01376362|805514|P1|STARTED|Overall Study||5
336122|NCT01376297|805536|P2|NOT COMPLETED|Overall Study||49
336123|NCT01376297|805537|P1|NOT COMPLETED|Overall Study||128
336124|NCT01376297|805536|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
336125|NCT01376297|805537|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
336126|NCT01376297|805536|P2|STARTED|Overall Study|number of randomised patients|104
336127|NCT01376297|805537|P1|STARTED|Overall Study|number of randomised patients|309
336128|NCT01376245|805547|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
336129|NCT01376245|805548|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
336130|NCT01376245|805549|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
336131|NCT01376245|805550|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
336132|NCT01376245|805551|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
336133|NCT01376245|805547|P5|COMPLETED|24-week, Double-blind Treatment Period||134
336134|NCT01376245|805548|P4|COMPLETED|24-week, Double-blind Treatment Period||138
336135|NCT01376245|805549|P3|COMPLETED|24-week, Double-blind Treatment Period||135
336136|NCT01376245|805550|P2|COMPLETED|24-week, Double-blind Treatment Period||130
336137|NCT01376245|805551|P1|COMPLETED|24-week, Double-blind Treatment Period||0
336138|NCT01376245|805547|P5|STARTED|24-week, Double-blind Treatment Period||160
336139|NCT01376245|805548|P4|STARTED|24-week, Double-blind Treatment Period||161
336140|NCT01376245|805549|P3|STARTED|24-week, Double-blind Treatment Period||160
336141|NCT01376245|805550|P2|STARTED|24-week, Double-blind Treatment Period||162
336142|NCT01376245|805551|P1|STARTED|24-week, Double-blind Treatment Period||0
336143|NCT01376245|805547|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336144|NCT01376245|805548|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336145|NCT01376245|805549|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336146|NCT01376245|805550|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336147|NCT01376245|805551|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
336148|NCT01376245|805547|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336149|NCT01376245|805548|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336150|NCT01376245|805549|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336151|NCT01376245|805550|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
336152|NCT01376245|805551|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
336153|NCT01376245|805547|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
336154|NCT01376245|805548|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
336155|NCT01376245|805549|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
336156|NCT01376245|805550|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
336157|NCT01376245|805551|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
336158|NCT01376089|805567|P2|NOT COMPLETED|Overall Study||4
336159|NCT01376089|805568|P1|NOT COMPLETED|Overall Study||3
336160|NCT01376089|805567|P2|COMPLETED|Overall Study||144
336161|NCT01376089|805568|P1|COMPLETED|Overall Study||148
336162|NCT01376089|805567|P2|STARTED|Overall Study||148
336163|NCT01376089|805568|P1|STARTED|Overall Study||151
336164|NCT01376050|805580|P2|NOT COMPLETED|Overall Study||0
336165|NCT01376050|805581|P1|NOT COMPLETED|Overall Study||0
336166|NCT01376050|805580|P2|COMPLETED|Overall Study||11
336167|NCT01376050|805581|P1|COMPLETED|Overall Study||13
336168|NCT01376050|805580|P2|STARTED|Overall Study||11
336169|NCT01376050|805581|P1|STARTED|Overall Study||13
336170|NCT01376037|805591|P2|NOT COMPLETED|Overall Study||2
336171|NCT01376037|805592|P1|NOT COMPLETED|Overall Study||0
336172|NCT01376037|805591|P2|COMPLETED|Overall Study||29
336173|NCT01376037|805592|P1|COMPLETED|Overall Study||31
336174|NCT01376037|805591|P2|STARTED|Overall Study||31
336175|NCT01376037|805592|P1|STARTED|Overall Study||31
336176|NCT01375777|805607|P9|NOT COMPLETED|Overall Study||2
336177|NCT01375777|805608|P8|NOT COMPLETED|Overall Study||2
336178|NCT01375777|805609|P7|NOT COMPLETED|Overall Study||2
336179|NCT01375777|805610|P6|NOT COMPLETED|Overall Study||1
336180|NCT01375777|805611|P5|NOT COMPLETED|Overall Study||1
336181|NCT01375777|805612|P4|NOT COMPLETED|Overall Study||0
336182|NCT01375777|805613|P3|NOT COMPLETED|Overall Study||1
336183|NCT01375777|805614|P2|NOT COMPLETED|Overall Study||3
336184|NCT01375777|805615|P1|NOT COMPLETED|Overall Study||2
336185|NCT01375777|805607|P9|COMPLETED|Overall Study||44
336186|NCT01375777|805608|P8|COMPLETED|Overall Study||44
336187|NCT01375777|805609|P7|COMPLETED|Overall Study||44
336188|NCT01375777|805610|P6|COMPLETED|Overall Study||44
336189|NCT01375777|805611|P5|COMPLETED|Overall Study||45
336190|NCT01375777|805612|P4|COMPLETED|Overall Study||45
336191|NCT01375777|805613|P3|COMPLETED|Overall Study||45
336192|NCT01375777|805614|P2|COMPLETED|Overall Study||42
336193|NCT01375777|805615|P1|COMPLETED|Overall Study||44
336194|NCT01375777|805607|P9|Received Treatment|Overall Study||45
336195|NCT01375777|805608|P8|Received Treatment|Overall Study||45
336196|NCT01375777|805609|P7|Received Treatment|Overall Study||45
336197|NCT01375777|805610|P6|Received Treatment|Overall Study||45
336198|NCT01375777|805611|P5|Received Treatment|Overall Study||46
336199|NCT01375777|805612|P4|Received Treatment|Overall Study||45
336200|NCT01375777|805613|P3|Received Treatment|Overall Study||45
336201|NCT01375777|805614|P2|Received Treatment|Overall Study||45
336202|NCT01375777|805615|P1|Received Treatment|Overall Study||45
336203|NCT01375777|805607|P9|STARTED|Overall Study||46
336204|NCT01375777|805608|P8|STARTED|Overall Study||46
336205|NCT01375777|805609|P7|STARTED|Overall Study||46
336206|NCT01375777|805610|P6|STARTED|Overall Study||45
336207|NCT01375777|805611|P5|STARTED|Overall Study||46
336208|NCT01375777|805612|P4|STARTED|Overall Study||45
336209|NCT01375777|805613|P3|STARTED|Overall Study||46
336210|NCT01375777|805614|P2|STARTED|Overall Study||45
336211|NCT01375777|805615|P1|STARTED|Overall Study||46
336212|NCT01375764|805685|P5|NOT COMPLETED|Overall Study||1
336213|NCT01375764|805686|P4|NOT COMPLETED|Overall Study||1
336214|NCT01375764|805687|P3|NOT COMPLETED|Overall Study||0
336215|NCT01375764|805688|P2|NOT COMPLETED|Overall Study||1
336216|NCT01375764|805689|P1|NOT COMPLETED|Overall Study||2
336217|NCT01375764|805685|P5|COMPLETED|Overall Study||31
336218|NCT01375764|805686|P4|COMPLETED|Overall Study||31
336219|NCT01375764|805687|P3|COMPLETED|Overall Study||32
336220|NCT01375764|805688|P2|COMPLETED|Overall Study||30
336221|NCT01375764|805689|P1|COMPLETED|Overall Study||31
336222|NCT01375764|805685|P5|Received Treatment|Overall Study||32
336223|NCT01375764|805686|P4|Received Treatment|Overall Study||31
336224|NCT01375764|805687|P3|Received Treatment|Overall Study||32
336225|NCT01375764|805688|P2|Received Treatment|Overall Study||30
336226|NCT01375764|805689|P1|Received Treatment|Overall Study||32
336227|NCT01375764|805685|P5|STARTED|Overall Study||32
336228|NCT01375764|805686|P4|STARTED|Overall Study||32
336229|NCT01375764|805687|P3|STARTED|Overall Study||32
336230|NCT01375764|805688|P2|STARTED|Overall Study||31
336231|NCT01375764|805689|P1|STARTED|Overall Study||33
336232|NCT01375751|805735|P3|NOT COMPLETED|Overall Study||0
336233|NCT01375751|805736|P2|NOT COMPLETED|Overall Study||1
336234|NCT01375751|805737|P1|NOT COMPLETED|Overall Study||0
336235|NCT01375751|805735|P3|COMPLETED|Overall Study||56
336236|NCT01375751|805736|P2|COMPLETED|Overall Study||55
336237|NCT01375751|805737|P1|COMPLETED|Overall Study||56
336238|NCT01375751|805735|P3|Received Treatment|Overall Study||56
336239|NCT01375751|805736|P2|Received Treatment|Overall Study||55
336240|NCT01375751|805737|P1|Received Treatment|Overall Study||56
336241|NCT01375751|805735|P3|STARTED|Overall Study||56
336242|NCT01375751|805736|P2|STARTED|Overall Study||56
336243|NCT01375751|805737|P1|STARTED|Overall Study||56
336244|NCT01375660|805762|P2|NOT COMPLETED|Overall Study||16
336245|NCT01375660|805763|P1|NOT COMPLETED|Overall Study||16
336246|NCT01375660|805762|P2|COMPLETED|Overall Study||87
336247|NCT01375660|805763|P1|COMPLETED|Overall Study||86
336248|NCT01375660|805762|P2|STARTED|Overall Study||103
336249|NCT01375660|805763|P1|STARTED|Overall Study||102
336250|NCT01375608|805781|P1|NOT COMPLETED|Overall Study||2
336251|NCT01375608|805781|P1|COMPLETED|Overall Study||8
336252|NCT01375608|805781|P1|STARTED|Overall Study||10
336253|NCT01375569|805785|P1|NOT COMPLETED|Overall Study||0
336254|NCT01375569|805785|P1|COMPLETED|Overall Study||11
336255|NCT01375569|805785|P1|STARTED|Overall Study||11
336256|NCT01375374|805790|P1|NOT COMPLETED|Overall Study||1
336257|NCT01375374|805790|P1|COMPLETED|Overall Study||10
336258|NCT01375374|805790|P1|STARTED|Overall Study||11
336259|NCT01375127|805803|P6|NOT COMPLETED|Overall Study||0
336260|NCT01375127|805804|P5|NOT COMPLETED|Overall Study||0
336261|NCT01375127|805805|P4|NOT COMPLETED|Overall Study||0
336262|NCT01375127|805806|P3|NOT COMPLETED|Overall Study||0
336263|NCT01375127|805807|P2|NOT COMPLETED|Overall Study||0
336264|NCT01375127|805808|P1|NOT COMPLETED|Overall Study||0
336265|NCT01375127|805803|P6|COMPLETED|Overall Study||3
336266|NCT01375127|805804|P5|COMPLETED|Overall Study||5
336267|NCT01375127|805805|P4|COMPLETED|Overall Study||33
336268|NCT01375127|805806|P3|COMPLETED|Overall Study||40
336269|NCT01375127|805807|P2|COMPLETED|Overall Study||1
336270|NCT01375127|805808|P1|COMPLETED|Overall Study||1
336271|NCT01375127|805803|P6|STARTED|Overall Study||3
336272|NCT01375127|805804|P5|STARTED|Overall Study||5
336273|NCT01375127|805805|P4|STARTED|Overall Study||33
336274|NCT01375127|805806|P3|STARTED|Overall Study||40
336275|NCT01375127|805807|P2|STARTED|Overall Study||1
336276|NCT01375127|805808|P1|STARTED|Overall Study||1
336277|NCT01375049|805840|P1|NOT COMPLETED|Overall Study||50
336278|NCT01375049|805840|P1|COMPLETED|Overall Study||55
336279|NCT01375049|805840|P1|STARTED|Overall Study||105
336280|NCT01374971|805855|P1|NOT COMPLETED|Overall Study||1
336281|NCT01374971|805855|P1|COMPLETED|Overall Study||11
336282|NCT01374971|805855|P1|STARTED|Overall Study||12
336283|NCT01374919|805860|P1|NOT COMPLETED|Overall Study||2
336284|NCT01374919|805860|P1|COMPLETED|Overall Study||58
336285|NCT01374919|805860|P1|STARTED|Overall Study||60
336286|NCT01374802|805865|P1|NOT COMPLETED|Overall Study||0
336287|NCT01374802|805865|P1|COMPLETED|Overall Study||14
336288|NCT01374802|805865|P1|STARTED|Overall Study||14
336289|NCT01374568|805879|P2|NOT COMPLETED|Overall Study||2
336290|NCT01374568|805880|P1|NOT COMPLETED|Overall Study||0
336291|NCT01374568|805879|P2|COMPLETED|Overall Study||1
336292|NCT01374568|805880|P1|COMPLETED|Overall Study||2
336293|NCT01374568|805879|P2|STARTED|Overall Study||3
336294|NCT01374568|805880|P1|STARTED|Overall Study||2
336295|NCT01374451|805890|P2|NOT COMPLETED|Overall Study||0
336296|NCT01374451|805891|P1|NOT COMPLETED|Overall Study||1
336297|NCT01374451|805890|P2|COMPLETED|Overall Study||81
336298|NCT01374451|805891|P1|COMPLETED|Overall Study||78
336299|NCT01374451|805890|P2|STARTED|Overall Study||81
336300|NCT01374451|805891|P1|STARTED|Overall Study||79
336301|NCT01374438|805920|P2|NOT COMPLETED|Overall Study||0
336302|NCT01374438|805921|P1|NOT COMPLETED|Overall Study||0
336303|NCT01374438|805920|P2|COMPLETED|Overall Study||13
336304|NCT01374438|805921|P1|COMPLETED|Overall Study||16
336305|NCT01374438|805920|P2|STARTED|Overall Study||13
336306|NCT01374438|805921|P1|STARTED|Overall Study||16
336307|NCT01374425|805937|P2|NOT COMPLETED|Overall Study||188
336308|NCT01374425|805938|P1|NOT COMPLETED|Overall Study||188
336309|NCT01374425|805937|P2|COMPLETED|Overall Study||0
336310|NCT01374425|805938|P1|COMPLETED|Overall Study||0
336311|NCT01374425|805937|P2|STARTED|Overall Study||188
336312|NCT01374425|805938|P1|STARTED|Overall Study||188
336313|NCT01373671|806016|P1|NOT COMPLETED|Overall Study||92
336314|NCT01373671|806016|P1|COMPLETED|Overall Study||672
336315|NCT01373671|806016|P1|STARTED|Overall Study||764
336316|NCT01374269|806023|P2|NOT COMPLETED|Overall Study||5
336317|NCT01374269|806024|P1|NOT COMPLETED|Overall Study||6
336318|NCT01374269|806023|P2|COMPLETED|Overall Study||39
336319|NCT01374269|806024|P1|COMPLETED|Overall Study||40
336320|NCT01374269|806023|P2|STARTED|Overall Study||44
336321|NCT01374269|806024|P1|STARTED|Overall Study||46
336322|NCT01374178|806152|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
336323|NCT01374178|806153|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
336324|NCT01374178|806152|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
336325|NCT01374178|806153|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
336326|NCT01374178|806152|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
336327|NCT01374178|806153|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
336328|NCT01374178|806152|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
336329|NCT01374178|806153|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
336330|NCT01374178|806152|P2|COMPLETED|Washout Period of at Least 7 Days||5
336331|NCT01374178|806153|P1|COMPLETED|Washout Period of at Least 7 Days||10
336332|NCT01374178|806152|P2|STARTED|Washout Period of at Least 7 Days||5
336333|NCT01374178|806153|P1|STARTED|Washout Period of at Least 7 Days||11
336334|NCT01374178|806152|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
336335|NCT01374178|806153|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
336336|NCT01374178|806152|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
336337|NCT01374178|806153|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
336338|NCT01374178|806152|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
336339|NCT01374178|806153|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
336340|NCT01374178|806152|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
336341|NCT01374178|806153|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
336342|NCT01374087|806171|P2|NOT COMPLETED|Overall Study||16
336343|NCT01374087|806172|P1|NOT COMPLETED|Overall Study||15
336344|NCT01374087|806171|P2|COMPLETED|Overall Study||0
336345|NCT01374087|806172|P1|COMPLETED|Overall Study||0
336346|NCT01374087|806171|P2|STARTED|Overall Study||16
336347|NCT01374087|806172|P1|STARTED|Overall Study||15
336348|NCT01373918|806182|P2|NOT COMPLETED|Overall Study||1
336349|NCT01373918|806183|P1|NOT COMPLETED|Overall Study||0
336350|NCT01373918|806182|P2|COMPLETED|Overall Study||15
336351|NCT01373918|806183|P1|COMPLETED|Overall Study||20
336352|NCT01373918|806182|P2|STARTED|Overall Study||16
336353|NCT01373918|806183|P1|STARTED|Overall Study||20
336354|NCT01373450|806195|P6|NOT COMPLETED|Crossover Period 4||0
336355|NCT01373450|806196|P5|NOT COMPLETED|Crossover Period 4||0
336356|NCT01373450|806197|P4|NOT COMPLETED|Crossover Period 4||0
336357|NCT01373450|806198|P3|NOT COMPLETED|Crossover Period 4||0
336358|NCT01373450|806199|P2|NOT COMPLETED|Crossover Period 4||0
336359|NCT01373450|806200|P1|NOT COMPLETED|Crossover Period 4||0
336360|NCT01373450|806195|P6|COMPLETED|Crossover Period 4||2
336361|NCT01373450|806196|P5|COMPLETED|Crossover Period 4||2
336362|NCT01373450|806197|P4|COMPLETED|Crossover Period 4||2
336363|NCT01373450|806198|P3|COMPLETED|Crossover Period 4||2
336364|NCT01373450|806199|P2|COMPLETED|Crossover Period 4||2
336365|NCT01373450|806200|P1|COMPLETED|Crossover Period 4||2
336366|NCT01373450|806195|P6|STARTED|Crossover Period 4||2
336367|NCT01373450|806196|P5|STARTED|Crossover Period 4||2
336368|NCT01373450|806197|P4|STARTED|Crossover Period 4||2
336369|NCT01373450|806198|P3|STARTED|Crossover Period 4||2
336370|NCT01373450|806199|P2|STARTED|Crossover Period 4||2
336371|NCT01373450|806200|P1|STARTED|Crossover Period 4||2
336372|NCT01373450|806195|P6|NOT COMPLETED|7 Day Wash-out||0
336373|NCT01373450|806196|P5|NOT COMPLETED|7 Day Wash-out||0
336374|NCT01373450|806197|P4|NOT COMPLETED|7 Day Wash-out||0
336375|NCT01373450|806198|P3|NOT COMPLETED|7 Day Wash-out||0
336376|NCT01373450|806199|P2|NOT COMPLETED|7 Day Wash-out||0
336377|NCT01373450|806200|P1|NOT COMPLETED|7 Day Wash-out||0
336378|NCT01373450|806195|P6|COMPLETED|7 Day Wash-out||2
336379|NCT01373450|806196|P5|COMPLETED|7 Day Wash-out||2
336380|NCT01373450|806197|P4|COMPLETED|7 Day Wash-out||2
336381|NCT01373450|806198|P3|COMPLETED|7 Day Wash-out||2
336382|NCT01373450|806199|P2|COMPLETED|7 Day Wash-out||2
336383|NCT01373450|806200|P1|COMPLETED|7 Day Wash-out||2
336384|NCT01373450|806195|P6|STARTED|7 Day Wash-out||2
336385|NCT01373450|806196|P5|STARTED|7 Day Wash-out||2
336386|NCT01373450|806197|P4|STARTED|7 Day Wash-out||2
336387|NCT01373450|806198|P3|STARTED|7 Day Wash-out||2
336388|NCT01373450|806199|P2|STARTED|7 Day Wash-out||2
336389|NCT01373450|806200|P1|STARTED|7 Day Wash-out||2
336390|NCT01373450|806195|P6|NOT COMPLETED|Crossover Period 3||0
336391|NCT01373450|806196|P5|NOT COMPLETED|Crossover Period 3||0
336392|NCT01373450|806197|P4|NOT COMPLETED|Crossover Period 3||0
336393|NCT01373450|806198|P3|NOT COMPLETED|Crossover Period 3||0
336394|NCT01373450|806199|P2|NOT COMPLETED|Crossover Period 3||0
336395|NCT01373450|806200|P1|NOT COMPLETED|Crossover Period 3||0
336396|NCT01373450|806195|P6|COMPLETED|Crossover Period 3||2
336397|NCT01373450|806196|P5|COMPLETED|Crossover Period 3||2
336398|NCT01373450|806197|P4|COMPLETED|Crossover Period 3||2
336399|NCT01373450|806198|P3|COMPLETED|Crossover Period 3||2
336400|NCT01373450|806199|P2|COMPLETED|Crossover Period 3||2
336401|NCT01373450|806200|P1|COMPLETED|Crossover Period 3||2
336402|NCT01373450|806195|P6|STARTED|Crossover Period 3||2
336403|NCT01373450|806196|P5|STARTED|Crossover Period 3||2
336404|NCT01373450|806197|P4|STARTED|Crossover Period 3||2
336405|NCT01373450|806198|P3|STARTED|Crossover Period 3||2
336406|NCT01373450|806199|P2|STARTED|Crossover Period 3||2
336407|NCT01373450|806200|P1|STARTED|Crossover Period 3||2
336408|NCT01373450|806195|P6|NOT COMPLETED|7 Day Wash-out||0
336409|NCT01373450|806196|P5|NOT COMPLETED|7 Day Wash-out||0
336410|NCT01373450|806197|P4|NOT COMPLETED|7 Day Wash-out||0
336411|NCT01373450|806198|P3|NOT COMPLETED|7 Day Wash-out||0
336412|NCT01373450|806199|P2|NOT COMPLETED|7 Day Wash-out||0
336413|NCT01373450|806200|P1|NOT COMPLETED|7 Day Wash-out||0
336414|NCT01373450|806195|P6|COMPLETED|7 Day Wash-out||2
336415|NCT01373450|806196|P5|COMPLETED|7 Day Wash-out||2
336416|NCT01373450|806197|P4|COMPLETED|7 Day Wash-out||2
336417|NCT01373450|806198|P3|COMPLETED|7 Day Wash-out||2
336418|NCT01373450|806199|P2|COMPLETED|7 Day Wash-out||2
336419|NCT01373450|806200|P1|COMPLETED|7 Day Wash-out||2
336420|NCT01373450|806195|P6|STARTED|7 Day Wash-out||2
336421|NCT01373450|806196|P5|STARTED|7 Day Wash-out||2
336422|NCT01373450|806197|P4|STARTED|7 Day Wash-out||2
336423|NCT01373450|806198|P3|STARTED|7 Day Wash-out||2
336424|NCT01373450|806199|P2|STARTED|7 Day Wash-out||2
336425|NCT01373450|806200|P1|STARTED|7 Day Wash-out||2
336426|NCT01373450|806195|P6|NOT COMPLETED|Crossover Period 2||0
336427|NCT01373450|806196|P5|NOT COMPLETED|Crossover Period 2||0
336428|NCT01373450|806197|P4|NOT COMPLETED|Crossover Period 2||0
336429|NCT01373450|806198|P3|NOT COMPLETED|Crossover Period 2||0
336430|NCT01373450|806199|P2|NOT COMPLETED|Crossover Period 2||0
336431|NCT01373450|806200|P1|NOT COMPLETED|Crossover Period 2||0
336432|NCT01373450|806195|P6|COMPLETED|Crossover Period 2||2
336433|NCT01373450|806196|P5|COMPLETED|Crossover Period 2||2
336434|NCT01373450|806197|P4|COMPLETED|Crossover Period 2||2
336435|NCT01373450|806198|P3|COMPLETED|Crossover Period 2||2
336436|NCT01373450|806199|P2|COMPLETED|Crossover Period 2||2
336437|NCT01373450|806200|P1|COMPLETED|Crossover Period 2||2
336438|NCT01373450|806195|P6|STARTED|Crossover Period 2||2
336439|NCT01373450|806196|P5|STARTED|Crossover Period 2||2
336440|NCT01373450|806197|P4|STARTED|Crossover Period 2||2
336441|NCT01373450|806198|P3|STARTED|Crossover Period 2||2
336442|NCT01373450|806199|P2|STARTED|Crossover Period 2||2
336443|NCT01373450|806200|P1|STARTED|Crossover Period 2||2
336444|NCT01373450|806195|P6|NOT COMPLETED|7 Day Wash-out||0
336445|NCT01373450|806196|P5|NOT COMPLETED|7 Day Wash-out||0
336446|NCT01373450|806197|P4|NOT COMPLETED|7 Day Wash-out||0
336447|NCT01373450|806198|P3|NOT COMPLETED|7 Day Wash-out||0
336448|NCT01373450|806199|P2|NOT COMPLETED|7 Day Wash-out||0
336449|NCT01373450|806200|P1|NOT COMPLETED|7 Day Wash-out||0
336450|NCT01373450|806195|P6|COMPLETED|7 Day Wash-out||2
336451|NCT01373450|806196|P5|COMPLETED|7 Day Wash-out||2
336452|NCT01373450|806197|P4|COMPLETED|7 Day Wash-out||2
336453|NCT01373450|806198|P3|COMPLETED|7 Day Wash-out||2
336454|NCT01373450|806199|P2|COMPLETED|7 Day Wash-out||2
336455|NCT01373450|806200|P1|COMPLETED|7 Day Wash-out||2
336456|NCT01373450|806195|P6|STARTED|7 Day Wash-out||2
336457|NCT01373450|806196|P5|STARTED|7 Day Wash-out||2
336458|NCT01373450|806197|P4|STARTED|7 Day Wash-out||2
336459|NCT01373450|806198|P3|STARTED|7 Day Wash-out||2
336460|NCT01373450|806199|P2|STARTED|7 Day Wash-out||2
336461|NCT01373450|806200|P1|STARTED|7 Day Wash-out||2
336462|NCT01373450|806195|P6|NOT COMPLETED|Crossover Period 1||0
336463|NCT01373450|806196|P5|NOT COMPLETED|Crossover Period 1||0
336464|NCT01373450|806197|P4|NOT COMPLETED|Crossover Period 1||0
336465|NCT01373450|806198|P3|NOT COMPLETED|Crossover Period 1||0
336466|NCT01373450|806199|P2|NOT COMPLETED|Crossover Period 1||0
336467|NCT01373450|806200|P1|NOT COMPLETED|Crossover Period 1||0
336468|NCT01373450|806195|P6|COMPLETED|Crossover Period 1||2
336469|NCT01373450|806196|P5|COMPLETED|Crossover Period 1||2
336470|NCT01373450|806197|P4|COMPLETED|Crossover Period 1||2
336471|NCT01373450|806198|P3|COMPLETED|Crossover Period 1||2
336472|NCT01373450|806199|P2|COMPLETED|Crossover Period 1||2
336473|NCT01373450|806200|P1|COMPLETED|Crossover Period 1||2
336474|NCT01373450|806195|P6|STARTED|Crossover Period 1||2
336475|NCT01373450|806196|P5|STARTED|Crossover Period 1||2
336476|NCT01373450|806197|P4|STARTED|Crossover Period 1||2
336477|NCT01373450|806198|P3|STARTED|Crossover Period 1||2
336478|NCT01373450|806199|P2|STARTED|Crossover Period 1||2
336479|NCT01373450|806200|P1|STARTED|Crossover Period 1||2
336480|NCT01373346|806222|P1|NOT COMPLETED|Overall Study||1
336481|NCT01373346|806222|P1|COMPLETED|Overall Study||14
336482|NCT01373346|806222|P1|STARTED|Overall Study||15
336483|NCT01373294|806245|P2|NOT COMPLETED|Overall Study||0
336484|NCT01373294|806246|P1|NOT COMPLETED|Overall Study||1
336485|NCT01373294|806245|P2|COMPLETED|Overall Study||2
336486|NCT01373294|806246|P1|COMPLETED|Overall Study||14
336487|NCT01373294|806245|P2|STARTED|Overall Study||2
336488|NCT01373294|806246|P1|STARTED|Overall Study||15
336489|NCT01373281|806255|P2|NOT COMPLETED|Overall Study||45
336490|NCT01373281|806256|P1|NOT COMPLETED|Overall Study||79
336491|NCT01373281|806255|P2|COMPLETED|Overall Study||3379
336492|NCT01373281|806256|P1|COMPLETED|Overall Study||6772
336493|NCT01373281|806255|P2|STARTED|Overall Study||3424
336494|NCT01373281|806256|P1|STARTED|Overall Study||6851
336495|NCT01372995|806275|P3|NOT COMPLETED|Overall Study||1
336496|NCT01372995|806276|P2|NOT COMPLETED|Overall Study||1
336497|NCT01372995|806277|P1|NOT COMPLETED|Overall Study||0
336498|NCT01372995|806275|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
336499|NCT01372995|806276|P2|COMPLETED|Overall Study||9
336500|NCT01372995|806277|P1|COMPLETED|Overall Study||10
336501|NCT01372995|806275|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
336502|NCT01372995|806276|P2|STARTED|Overall Study||10
336503|NCT01372995|806277|P1|STARTED|Overall Study||10
336504|NCT01372878|806324|P1|NOT COMPLETED|Overall Study||184
336505|NCT01372878|806324|P1|COMPLETED|Overall Study||700
336506|NCT01372878|806324|P1|STARTED|Overall Study||884
336507|NCT01372813|806329|P1|NOT COMPLETED|Overall Study||0
336508|NCT01372813|806329|P1|COMPLETED|Overall Study||3
336509|NCT01372813|806329|P1|STARTED|Overall Study||3
336510|NCT01372748|806344|P2|NOT COMPLETED|Overall Study||39
336511|NCT01372748|806345|P1|NOT COMPLETED|Overall Study||23
336512|NCT01372748|806344|P2|COMPLETED|Overall Study|defined as having vital status|12603
336513|NCT01372748|806345|P1|COMPLETED|Overall Study|defined as having vital status|11022
336514|NCT01372748|806344|P2|STARTED|Overall Study||12642
336515|NCT01372748|806345|P1|STARTED|Overall Study||11045
336516|NCT01372605|806355|P2|NOT COMPLETED|Overall Study||10
336517|NCT01372605|806356|P1|NOT COMPLETED|Overall Study||12
336518|NCT01372605|806355|P2|COMPLETED|Overall Study||145
336519|NCT01372605|806356|P1|COMPLETED|Overall Study||137
336520|NCT01372605|806355|P2|STARTED|Overall Study||155
336521|NCT01372605|806356|P1|STARTED|Overall Study||149
336522|NCT01372501|806382|P1|NOT COMPLETED|Overall Study||5
336523|NCT01372501|806382|P1|COMPLETED|Overall Study||14
336524|NCT01372501|806382|P1|STARTED|Overall Study||19
336525|NCT01372462|806387|P1|NOT COMPLETED|No Treatment Control||0
336526|NCT01372462|806387|P1|COMPLETED|No Treatment Control||15
336527|NCT01372462|806387|P1|STARTED|No Treatment Control||15
336528|NCT01372462|806387|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
336529|NCT01372462|806387|P1|COMPLETED|Oxygen Nasal Cannula||15
336530|NCT01372462|806387|P1|STARTED|Oxygen Nasal Cannula||15
336531|NCT01372462|806387|P1|NOT COMPLETED|NIOV - Oxygen||0
336532|NCT01372462|806387|P1|COMPLETED|NIOV - Oxygen||15
336533|NCT01372462|806387|P1|STARTED|NIOV - Oxygen||15
336534|NCT01372462|806387|P1|NOT COMPLETED|NIOV - Room Air||0
336535|NCT01372462|806387|P1|COMPLETED|NIOV - Room Air||15
336536|NCT01372462|806387|P1|STARTED|NIOV - Room Air||15
336537|NCT01372410|806405|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
336538|NCT01372410|806406|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
336539|NCT01372410|806407|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
336540|NCT01372410|806408|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
336541|NCT01372410|806409|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
336542|NCT01372410|806410|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
336543|NCT01372410|806411|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
336544|NCT01372410|806412|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
336545|NCT01372410|806405|P8|COMPLETED|Treatment Period 3 (7 Days)||18
336546|NCT01372410|806406|P7|COMPLETED|Treatment Period 3 (7 Days)||15
336547|NCT01372410|806407|P6|COMPLETED|Treatment Period 3 (7 Days)||18
336548|NCT01372410|806408|P5|COMPLETED|Treatment Period 3 (7 Days)||20
336549|NCT01372410|806409|P4|COMPLETED|Treatment Period 3 (7 Days)||22
336550|NCT01372410|806410|P3|COMPLETED|Treatment Period 3 (7 Days)||15
336551|NCT01372410|806411|P2|COMPLETED|Treatment Period 3 (7 Days)||18
336552|NCT01372410|806412|P1|COMPLETED|Treatment Period 3 (7 Days)||21
336553|NCT01372410|806405|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
336554|NCT01372410|806406|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
336555|NCT01372410|806407|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
336556|NCT01372410|806408|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
336557|NCT01372410|806409|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
336558|NCT01372410|806410|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
336559|NCT01372410|806411|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
336560|NCT01372410|806412|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
336561|NCT01372410|806405|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
336562|NCT01372410|806406|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
336563|NCT01372410|806407|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
336564|NCT01372410|806408|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
336565|NCT01372410|806409|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
336566|NCT01372410|806410|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
336567|NCT01372410|806411|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
336568|NCT01372410|806412|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
336569|NCT01372410|806405|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
336570|NCT01372410|806406|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
336571|NCT01372410|806407|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
336572|NCT01372410|806408|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
336573|NCT01372410|806409|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
336574|NCT01372410|806410|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
336575|NCT01372410|806411|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
336576|NCT01372410|806412|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
336577|NCT01372410|806405|P8|STARTED|Washout Period 2 (10-14 Days)||19
336578|NCT01372410|806406|P7|STARTED|Washout Period 2 (10-14 Days)||21
336579|NCT01372410|806407|P6|STARTED|Washout Period 2 (10-14 Days)||16
336580|NCT01372410|806408|P5|STARTED|Washout Period 2 (10-14 Days)||19
336581|NCT01372410|806409|P4|STARTED|Washout Period 2 (10-14 Days)||17
336582|NCT01372410|806410|P3|STARTED|Washout Period 2 (10-14 Days)||22
336583|NCT01372410|806411|P2|STARTED|Washout Period 2 (10-14 Days)||21
336584|NCT01372410|806412|P1|STARTED|Washout Period 2 (10-14 Days)||19
336585|NCT01372410|806405|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336586|NCT01372410|806406|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336587|NCT01372410|806407|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336588|NCT01372410|806408|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336589|NCT01372410|806409|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336590|NCT01372410|806410|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336591|NCT01372410|806411|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336592|NCT01372410|806412|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
336593|NCT01372410|806405|P8|COMPLETED|Treatment Period 2 (7 Days)||19
336594|NCT01372410|806406|P7|COMPLETED|Treatment Period 2 (7 Days)||21
336595|NCT01372410|806407|P6|COMPLETED|Treatment Period 2 (7 Days)||16
336596|NCT01372410|806408|P5|COMPLETED|Treatment Period 2 (7 Days)||19
336597|NCT01372410|806409|P4|COMPLETED|Treatment Period 2 (7 Days)||17
336598|NCT01372410|806410|P3|COMPLETED|Treatment Period 2 (7 Days)||22
336599|NCT01372410|806411|P2|COMPLETED|Treatment Period 2 (7 Days)||21
336600|NCT01372410|806412|P1|COMPLETED|Treatment Period 2 (7 Days)||19
336601|NCT01372410|806405|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
336602|NCT01372410|806406|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
336603|NCT01372410|806407|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
336604|NCT01372410|806408|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
336605|NCT01372410|806409|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
336606|NCT01372410|806410|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
336607|NCT01372410|806411|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
336608|NCT01372410|806412|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
336609|NCT01372410|806405|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
336610|NCT01372410|806406|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
336611|NCT01372410|806407|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
336612|NCT01372410|806408|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
336613|NCT01372410|806409|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
336614|NCT01372410|806410|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
336615|NCT01372410|806411|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
336616|NCT01372410|806412|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
336617|NCT01372410|806405|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
336618|NCT01372410|806406|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
336619|NCT01372410|806407|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
336620|NCT01372410|806408|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
336621|NCT01372410|806409|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
336622|NCT01372410|806410|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
336623|NCT01372410|806411|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
336624|NCT01372410|806412|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
336625|NCT01372410|806405|P8|STARTED|Washout Period 1 (10-14 Days)||19
336626|NCT01372410|806406|P7|STARTED|Washout Period 1 (10-14 Days)||20
336627|NCT01372410|806407|P6|STARTED|Washout Period 1 (10-14 Days)||21
336628|NCT01372410|806408|P5|STARTED|Washout Period 1 (10-14 Days)||19
336629|NCT01372410|806409|P4|STARTED|Washout Period 1 (10-14 Days)||20
336630|NCT01372410|806410|P3|STARTED|Washout Period 1 (10-14 Days)||19
336631|NCT01372410|806411|P2|STARTED|Washout Period 1 (10-14 Days)||19
336632|NCT01372410|806412|P1|STARTED|Washout Period 1 (10-14 Days)||19
336633|NCT01372410|806405|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
336634|NCT01372410|806406|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
336635|NCT01372410|806407|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
336636|NCT01372410|806408|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
336637|NCT01372410|806409|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
336638|NCT01372410|806410|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
336639|NCT01372410|806411|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
336640|NCT01372410|806412|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
336641|NCT01372410|806405|P8|COMPLETED|Treatment Period 1 (7 Days)||19
336642|NCT01372410|806406|P7|COMPLETED|Treatment Period 1 (7 Days)||20
336643|NCT01372410|806407|P6|COMPLETED|Treatment Period 1 (7 Days)||21
336644|NCT01372410|806408|P5|COMPLETED|Treatment Period 1 (7 Days)||19
336645|NCT01372410|806409|P4|COMPLETED|Treatment Period 1 (7 Days)||20
336646|NCT01372410|806410|P3|COMPLETED|Treatment Period 1 (7 Days)||19
336647|NCT01372410|806411|P2|COMPLETED|Treatment Period 1 (7 Days)||19
336648|NCT01372410|806412|P1|COMPLETED|Treatment Period 1 (7 Days)||19
336649|NCT01372410|806405|P8|STARTED|Treatment Period 1 (7 Days)||19
336650|NCT01372410|806406|P7|STARTED|Treatment Period 1 (7 Days)||22
336651|NCT01372410|806407|P6|STARTED|Treatment Period 1 (7 Days)||21
336652|NCT01372410|806408|P5|STARTED|Treatment Period 1 (7 Days)||21
336653|NCT01372410|806409|P4|STARTED|Treatment Period 1 (7 Days)||20
336654|NCT01372410|806410|P3|STARTED|Treatment Period 1 (7 Days)||19
336655|NCT01372410|806411|P2|STARTED|Treatment Period 1 (7 Days)||21
336656|NCT01372410|806412|P1|STARTED|Treatment Period 1 (7 Days)||20
336657|NCT01372384|806449|P1|NOT COMPLETED|Overall Study||3
336658|NCT01372384|806449|P1|COMPLETED|Overall Study||3
336659|NCT01372384|806449|P1|STARTED|Overall Study||6
336660|NCT01372150|806459|P3|NOT COMPLETED|Overall Study||16
336661|NCT01372150|806460|P2|NOT COMPLETED|Overall Study||14
336662|NCT01372150|806461|P1|NOT COMPLETED|Overall Study||13
336663|NCT01372150|806459|P3|COMPLETED|Overall Study||99
336664|NCT01372150|806460|P2|COMPLETED|Overall Study||99
336665|NCT01372150|806461|P1|COMPLETED|Overall Study||99
336666|NCT01372150|806459|P3|Treated|Overall Study||115
336667|NCT01372150|806460|P2|Treated|Overall Study||112
336668|NCT01372150|806461|P1|Treated|Overall Study||112
336669|NCT01372150|806459|P3|STARTED|Overall Study||115
336670|NCT01372150|806460|P2|STARTED|Overall Study||113
336671|NCT01372150|806461|P1|STARTED|Overall Study||112
336672|NCT01371994|806480|P2|NOT COMPLETED|Overall Study||42
336673|NCT01371994|806481|P1|NOT COMPLETED|Overall Study||57
336674|NCT01371994|806480|P2|COMPLETED|Overall Study||278
336675|NCT01371994|806481|P1|COMPLETED|Overall Study||263
336676|NCT01371994|806480|P2|Received Treatment|Overall Study||313
336677|NCT01371994|806481|P1|Received Treatment|Overall Study||310
336678|NCT01371994|806480|P2|STARTED|Overall Study||320
336679|NCT01371994|806481|P1|STARTED|Overall Study||320
336680|NCT01371877|806525|P2|NOT COMPLETED|Overall Study||4
336681|NCT01371877|806526|P1|NOT COMPLETED|Overall Study||0
336682|NCT01371877|806525|P2|COMPLETED|Overall Study||17
336683|NCT01371877|806526|P1|COMPLETED|Overall Study||21
336684|NCT01371877|806525|P2|STARTED|Overall Study||21
336685|NCT01371877|806526|P1|STARTED|Overall Study||21
336686|NCT01371851|806538|P2|NOT COMPLETED|Overall Study||9
336687|NCT01371851|806539|P1|NOT COMPLETED|Overall Study||8
336688|NCT01371851|806538|P2|COMPLETED|Overall Study||2
336689|NCT01371851|806539|P1|COMPLETED|Overall Study||3
336782|NCT01371552|806795|P6|STARTED|Part 2, One Week||18
336690|NCT01371851|806538|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
336691|NCT01371851|806539|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
336692|NCT01371838|806547|P2|NOT COMPLETED|Overall Study||66
336693|NCT01371838|806548|P1|NOT COMPLETED|Overall Study||49
336694|NCT01371838|806547|P2|COMPLETED|Overall Study||317
336695|NCT01371838|806548|P1|COMPLETED|Overall Study||332
336696|NCT01371838|806547|P2|STARTED|Overall Study||383
336697|NCT01371838|806548|P1|STARTED|Overall Study||381
336698|NCT01371825|806584|P1|NOT COMPLETED|Long-term Treatment Period||0
336699|NCT01371825|806584|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
336700|NCT01371825|806584|P1|STARTED|Long-term Treatment Period||6
336701|NCT01371825|806584|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
336702|NCT01371825|806584|P1|COMPLETED|Primary Efficacy Analysis Period||6
336703|NCT01371825|806584|P1|STARTED|Primary Efficacy Analysis Period||9
336704|NCT01371786|806598|P2|NOT COMPLETED|Overall Study||0
336705|NCT01371786|806599|P1|NOT COMPLETED|Overall Study||0
336706|NCT01371786|806598|P2|COMPLETED|Overall Study||7
336707|NCT01371786|806599|P1|COMPLETED|Overall Study||7
336708|NCT01371786|806598|P2|STARTED|Overall Study||7
336709|NCT01371786|806599|P1|STARTED|Overall Study||7
336710|NCT01371747|806619|P6|NOT COMPLETED|Overall Study||14
336711|NCT01371747|806620|P5|NOT COMPLETED|Overall Study||7
336712|NCT01371747|806621|P4|NOT COMPLETED|Overall Study||9
336713|NCT01371747|806622|P3|NOT COMPLETED|Overall Study||24
336714|NCT01371747|806623|P2|NOT COMPLETED|Overall Study||23
336715|NCT01371747|806624|P1|NOT COMPLETED|Overall Study||18
336716|NCT01371747|806619|P6|COMPLETED|Overall Study||16
336717|NCT01371747|806620|P5|COMPLETED|Overall Study||21
336718|NCT01371747|806621|P4|COMPLETED|Overall Study||17
336719|NCT01371747|806622|P3|COMPLETED|Overall Study||50
336720|NCT01371747|806623|P2|COMPLETED|Overall Study||51
336721|NCT01371747|806624|P1|COMPLETED|Overall Study||56
336722|NCT01371747|806619|P6|STARTED|Overall Study||30
336723|NCT01371747|806620|P5|STARTED|Overall Study||28
336724|NCT01371747|806621|P4|STARTED|Overall Study||26
336725|NCT01371747|806622|P3|STARTED|Overall Study||74
336726|NCT01371747|806623|P2|STARTED|Overall Study||74
336727|NCT01371747|806624|P1|STARTED|Overall Study||74
336728|NCT01371734|806689|P3|NOT COMPLETED|Overall Study||17
336729|NCT01371734|806690|P2|NOT COMPLETED|Overall Study||19
336730|NCT01371734|806691|P1|NOT COMPLETED|Overall Study||23
336731|NCT01371734|806689|P3|COMPLETED|Overall Study||104
336732|NCT01371734|806690|P2|COMPLETED|Overall Study||103
336733|NCT01371734|806691|P1|COMPLETED|Overall Study||97
336734|NCT01371734|806689|P3|STARTED|Overall Study||121
336735|NCT01371734|806690|P2|STARTED|Overall Study||122
336736|NCT01371734|806691|P1|STARTED|Overall Study||120
336737|NCT01371721|806711|P3|NOT COMPLETED|Overall Study||30
336738|NCT01371721|806712|P2|NOT COMPLETED|Overall Study||24
336739|NCT01371721|806713|P1|NOT COMPLETED|Overall Study||29
336740|NCT01371721|806711|P3|COMPLETED|Overall Study||62
336741|NCT01371721|806712|P2|COMPLETED|Overall Study||65
336742|NCT01371721|806713|P1|COMPLETED|Overall Study||59
336743|NCT01371721|806711|P3|Treated|Overall Study||92
336744|NCT01371721|806712|P2|Treated|Overall Study||89
336745|NCT01371721|806713|P1|Treated|Overall Study||87
336746|NCT01371721|806711|P3|STARTED|Overall Study||92
336747|NCT01371721|806712|P2|STARTED|Overall Study||89
336748|NCT01371721|806713|P1|STARTED|Overall Study||88
336749|NCT01371708|806746|P3|NOT COMPLETED|Overall Study||39
336750|NCT01371708|806747|P2|NOT COMPLETED|Overall Study||30
336751|NCT01371708|806748|P1|NOT COMPLETED|Overall Study||26
336752|NCT01371708|806746|P3|COMPLETED|Overall Study||59
336753|NCT01371708|806747|P2|COMPLETED|Overall Study||63
336754|NCT01371708|806748|P1|COMPLETED|Overall Study||66
336755|NCT01371708|806746|P3|Received Treatment|Overall Study||97
336756|NCT01371708|806747|P2|Received Treatment|Overall Study||93
336757|NCT01371708|806748|P1|Received Treatment|Overall Study||91
336758|NCT01371708|806746|P3|STARTED|Overall Study||98
336759|NCT01371708|806747|P2|STARTED|Overall Study||93
336760|NCT01371708|806748|P1|STARTED|Overall Study||92
336761|NCT01371643|806780|P2|NOT COMPLETED|Overall Study||0
336762|NCT01371643|806781|P1|NOT COMPLETED|Overall Study||3
336763|NCT01371643|806780|P2|COMPLETED|Overall Study||26
336764|NCT01371643|806781|P1|COMPLETED|Overall Study||12
336765|NCT01371643|806780|P2|STARTED|Overall Study||26
336766|NCT01371643|806781|P1|STARTED|Overall Study||15
336767|NCT01371565|806791|P1|NOT COMPLETED|Overall Study||3
336768|NCT01371565|806791|P1|COMPLETED|Overall Study||1
336769|NCT01371565|806791|P1|STARTED|Overall Study||4
336770|NCT01371552|806795|P6|NOT COMPLETED|Part 2, One Week||0
336771|NCT01371552|806796|P5|NOT COMPLETED|Part 2, One Week||0
336772|NCT01371552|806797|P4|NOT COMPLETED|Part 2, One Week||0
336773|NCT01371552|806798|P3|NOT COMPLETED|Part 2, One Week||0
336774|NCT01371552|806799|P2|NOT COMPLETED|Part 2, One Week||0
336775|NCT01371552|806800|P1|NOT COMPLETED|Part 2, One Week||0
336776|NCT01371552|806795|P6|COMPLETED|Part 2, One Week||18
336777|NCT01371552|806796|P5|COMPLETED|Part 2, One Week||15
336778|NCT01371552|806797|P4|COMPLETED|Part 2, One Week||20
336779|NCT01371552|806798|P3|COMPLETED|Part 2, One Week||18
336780|NCT01371552|806799|P2|COMPLETED|Part 2, One Week||17
336781|NCT01371552|806800|P1|COMPLETED|Part 2, One Week||18
336783|NCT01371552|806796|P5|STARTED|Part 2, One Week||15
336784|NCT01371552|806797|P4|STARTED|Part 2, One Week||20
336785|NCT01371552|806798|P3|STARTED|Part 2, One Week||18
336786|NCT01371552|806799|P2|STARTED|Part 2, One Week||17
336787|NCT01371552|806800|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
336788|NCT01371552|806795|P6|NOT COMPLETED|Part 1, Third 3 Days||1
336789|NCT01371552|806796|P5|NOT COMPLETED|Part 1, Third 3 Days||1
336790|NCT01371552|806797|P4|NOT COMPLETED|Part 1, Third 3 Days||0
336791|NCT01371552|806798|P3|NOT COMPLETED|Part 1, Third 3 Days||0
336792|NCT01371552|806799|P2|NOT COMPLETED|Part 1, Third 3 Days||0
336793|NCT01371552|806800|P1|NOT COMPLETED|Part 1, Third 3 Days||0
336794|NCT01371552|806795|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
336795|NCT01371552|806796|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
336796|NCT01371552|806797|P4|COMPLETED|Part 1, Third 3 Days||20
336797|NCT01371552|806798|P3|COMPLETED|Part 1, Third 3 Days||18
336798|NCT01371552|806799|P2|COMPLETED|Part 1, Third 3 Days||17
336799|NCT01371552|806800|P1|COMPLETED|Part 1, Third 3 Days||19
336800|NCT01371552|806795|P6|STARTED|Part 1, Third 3 Days||18
336801|NCT01371552|806796|P5|STARTED|Part 1, Third 3 Days||15
336802|NCT01371552|806797|P4|STARTED|Part 1, Third 3 Days||20
336803|NCT01371552|806798|P3|STARTED|Part 1, Third 3 Days||18
336804|NCT01371552|806799|P2|STARTED|Part 1, Third 3 Days||17
336805|NCT01371552|806800|P1|STARTED|Part 1, Third 3 Days||19
336806|NCT01371552|806795|P6|NOT COMPLETED|Part 1, Second 3 Days||0
336807|NCT01371552|806796|P5|NOT COMPLETED|Part 1, Second 3 Days||0
336808|NCT01371552|806797|P4|NOT COMPLETED|Part 1, Second 3 Days||0
336809|NCT01371552|806798|P3|NOT COMPLETED|Part 1, Second 3 Days||0
336810|NCT01371552|806799|P2|NOT COMPLETED|Part 1, Second 3 Days||0
336811|NCT01371552|806800|P1|NOT COMPLETED|Part 1, Second 3 Days||1
336812|NCT01371552|806795|P6|COMPLETED|Part 1, Second 3 Days||18
336813|NCT01371552|806796|P5|COMPLETED|Part 1, Second 3 Days||15
336814|NCT01371552|806797|P4|COMPLETED|Part 1, Second 3 Days||20
336815|NCT01371552|806798|P3|COMPLETED|Part 1, Second 3 Days||18
336816|NCT01371552|806799|P2|COMPLETED|Part 1, Second 3 Days||17
336817|NCT01371552|806800|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
336818|NCT01371552|806795|P6|STARTED|Part 1, Second 3 Days||18
336819|NCT01371552|806796|P5|STARTED|Part 1, Second 3 Days||15
336820|NCT01371552|806797|P4|STARTED|Part 1, Second 3 Days||20
336821|NCT01371552|806798|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
336822|NCT01371552|806799|P2|STARTED|Part 1, Second 3 Days||17
336823|NCT01371552|806800|P1|STARTED|Part 1, Second 3 Days||19
336824|NCT01371552|806795|P6|NOT COMPLETED|Part 1, First 3 Days||0
336825|NCT01371552|806796|P5|NOT COMPLETED|Part 1, First 3 Days||0
336826|NCT01371552|806797|P4|NOT COMPLETED|Part 1, First 3 Days||0
336827|NCT01371552|806798|P3|NOT COMPLETED|Part 1, First 3 Days||1
336828|NCT01371552|806799|P2|NOT COMPLETED|Part 1, First 3 Days||0
336829|NCT01371552|806800|P1|NOT COMPLETED|Part 1, First 3 Days||0
336830|NCT01371552|806795|P6|COMPLETED|Part 1, First 3 Days||18
336831|NCT01371552|806796|P5|COMPLETED|Part 1, First 3 Days||15
336832|NCT01371552|806797|P4|COMPLETED|Part 1, First 3 Days||20
336833|NCT01371552|806798|P3|COMPLETED|Part 1, First 3 Days||19
336834|NCT01371552|806799|P2|COMPLETED|Part 1, First 3 Days||17
336835|NCT01371552|806800|P1|COMPLETED|Part 1, First 3 Days||19
336836|NCT01371552|806795|P6|STARTED|Part 1, First 3 Days||18
336837|NCT01371552|806796|P5|STARTED|Part 1, First 3 Days||15
336838|NCT01371552|806797|P4|STARTED|Part 1, First 3 Days||20
336839|NCT01371552|806798|P3|STARTED|Part 1, First 3 Days||20
336840|NCT01371552|806799|P2|STARTED|Part 1, First 3 Days||17
336841|NCT01371552|806800|P1|STARTED|Part 1, First 3 Days||19
336842|NCT01371539|806827|P2|NOT COMPLETED|Period Two: One Week||3
336843|NCT01371539|806828|P1|NOT COMPLETED|Period Two: One Week||0
336844|NCT01371539|806827|P2|COMPLETED|Period Two: One Week||47
336845|NCT01371539|806828|P1|COMPLETED|Period Two: One Week||53
336846|NCT01371539|806827|P2|STARTED|Period Two: One Week||50
336847|NCT01371539|806828|P1|STARTED|Period Two: One Week||53
336848|NCT01371539|806827|P2|NOT COMPLETED|Period One: One Week||1
336849|NCT01371539|806828|P1|NOT COMPLETED|Period One: One Week||0
336850|NCT01371539|806827|P2|COMPLETED|Period One: One Week||50
336851|NCT01371539|806828|P1|COMPLETED|Period One: One Week||53
336852|NCT01371539|806827|P2|STARTED|Period One: One Week||51
336853|NCT01371539|806828|P1|STARTED|Period One: One Week||53
336854|NCT01371006|806838|P2|NOT COMPLETED|Overall Study||0
336855|NCT01371006|806839|P1|NOT COMPLETED|Overall Study||1
336856|NCT01371006|806838|P2|COMPLETED|Overall Study||15
336857|NCT01371006|806839|P1|COMPLETED|Overall Study||13
336858|NCT01371006|806838|P2|STARTED|Overall Study||15
336859|NCT01371006|806839|P1|STARTED|Overall Study||14
336860|NCT01370863|806880|P2|NOT COMPLETED|Overall Study||3
336861|NCT01370863|806881|P1|NOT COMPLETED|Overall Study||2
336862|NCT01370863|806880|P2|COMPLETED|Overall Study||30
336863|NCT01370863|806881|P1|COMPLETED|Overall Study||32
336864|NCT01370863|806880|P2|STARTED|Overall Study||33
336865|NCT01370863|806881|P1|STARTED|Overall Study||34
336866|NCT01370837|806894|P3|NOT COMPLETED|Overall Study||0
336867|NCT01370837|806895|P2|NOT COMPLETED|Overall Study||0
336868|NCT01370837|806896|P1|NOT COMPLETED|Overall Study||0
336869|NCT01370837|806894|P3|COMPLETED|Overall Study||17
336870|NCT01370837|806895|P2|COMPLETED|Overall Study||12
336871|NCT01370837|806896|P1|COMPLETED|Overall Study||12
336872|NCT01370837|806894|P3|STARTED|Overall Study||17
336873|NCT01370837|806895|P2|STARTED|Overall Study||12
336874|NCT01370837|806896|P1|STARTED|Overall Study||12
336875|NCT01370733|806906|P2|NOT COMPLETED|Overall Study||22
336876|NCT01370733|806907|P1|NOT COMPLETED|Overall Study||17
336877|NCT01370733|806906|P2|COMPLETED|Overall Study||77
336878|NCT01370733|806907|P1|COMPLETED|Overall Study||86
336879|NCT01370733|806906|P2|STARTED|Overall Study||99
336880|NCT01370733|806907|P1|STARTED|Overall Study||103
336881|NCT01370694|806929|P1|NOT COMPLETED|Overall Study||6
336882|NCT01370694|806929|P1|COMPLETED|Overall Study||1
336883|NCT01370694|806929|P1|STARTED|Overall Study||7
336884|NCT01370655|806951|P12|NOT COMPLETED|Period 2||0
336885|NCT01370655|806952|P11|NOT COMPLETED|Period 2||1
336886|NCT01370655|806953|P10|NOT COMPLETED|Period 2||0
336887|NCT01370655|806954|P9|NOT COMPLETED|Period 2||2
336888|NCT01370655|806955|P8|NOT COMPLETED|Period 2||1
336889|NCT01370655|806956|P7|NOT COMPLETED|Period 2||1
336890|NCT01370655|806957|P6|NOT COMPLETED|Period 2||0
336891|NCT01370655|806958|P5|NOT COMPLETED|Period 2||1
336892|NCT01370655|806959|P4|NOT COMPLETED|Period 2||0
336893|NCT01370655|806960|P3|NOT COMPLETED|Period 2||2
336894|NCT01370655|806961|P2|NOT COMPLETED|Period 2||0
336895|NCT01370655|806962|P1|NOT COMPLETED|Period 2||0
336896|NCT01370655|806951|P12|COMPLETED|Period 2||3
336897|NCT01370655|806952|P11|COMPLETED|Period 2||2
336898|NCT01370655|806953|P10|COMPLETED|Period 2||2
336899|NCT01370655|806954|P9|COMPLETED|Period 2||1
336900|NCT01370655|806955|P8|COMPLETED|Period 2||3
336901|NCT01370655|806956|P7|COMPLETED|Period 2||2
336902|NCT01370655|806957|P6|COMPLETED|Period 2||4
336903|NCT01370655|806958|P5|COMPLETED|Period 2||2
336904|NCT01370655|806959|P4|COMPLETED|Period 2||3
336905|NCT01370655|806960|P3|COMPLETED|Period 2||1
336906|NCT01370655|806961|P2|COMPLETED|Period 2||7
336907|NCT01370655|806962|P1|COMPLETED|Period 2||5
336908|NCT01370655|806951|P12|STARTED|Period 2||3
336909|NCT01370655|806952|P11|STARTED|Period 2||3
336910|NCT01370655|806953|P10|STARTED|Period 2||2
336911|NCT01370655|806954|P9|STARTED|Period 2||3
336912|NCT01370655|806955|P8|STARTED|Period 2||4
336913|NCT01370655|806956|P7|STARTED|Period 2||3
336914|NCT01370655|806957|P6|STARTED|Period 2||4
336915|NCT01370655|806958|P5|STARTED|Period 2||3
336916|NCT01370655|806959|P4|STARTED|Period 2||3
336917|NCT01370655|806960|P3|STARTED|Period 2||3
336918|NCT01370655|806961|P2|STARTED|Period 2||7
336919|NCT01370655|806962|P1|STARTED|Period 2||5
336920|NCT01370655|806951|P12|NOT COMPLETED|Period 1||0
336921|NCT01370655|806952|P11|NOT COMPLETED|Period 1||0
336922|NCT01370655|806953|P10|NOT COMPLETED|Period 1||0
336923|NCT01370655|806954|P9|NOT COMPLETED|Period 1||0
336924|NCT01370655|806955|P8|NOT COMPLETED|Period 1||0
336925|NCT01370655|806956|P7|NOT COMPLETED|Period 1||1
336926|NCT01370655|806957|P6|NOT COMPLETED|Period 1||0
336927|NCT01370655|806958|P5|NOT COMPLETED|Period 1||0
336928|NCT01370655|806959|P4|NOT COMPLETED|Period 1||0
336929|NCT01370655|806960|P3|NOT COMPLETED|Period 1||0
336930|NCT01370655|806961|P2|NOT COMPLETED|Period 1||0
336931|NCT01370655|806962|P1|NOT COMPLETED|Period 1||2
336932|NCT01370655|806951|P12|COMPLETED|Period 1||3
336933|NCT01370655|806952|P11|COMPLETED|Period 1||3
336934|NCT01370655|806953|P10|COMPLETED|Period 1||2
336935|NCT01370655|806954|P9|COMPLETED|Period 1||3
336936|NCT01370655|806955|P8|COMPLETED|Period 1||4
336937|NCT01370655|806956|P7|COMPLETED|Period 1||3
336938|NCT01370655|806957|P6|COMPLETED|Period 1||4
336939|NCT01370655|806958|P5|COMPLETED|Period 1||3
336940|NCT01370655|806959|P4|COMPLETED|Period 1||3
336941|NCT01370655|806960|P3|COMPLETED|Period 1||3
336942|NCT01370655|806961|P2|COMPLETED|Period 1||7
336943|NCT01370655|806962|P1|COMPLETED|Period 1||5
336944|NCT01370655|806951|P12|STARTED|Period 1||3
336945|NCT01370655|806952|P11|STARTED|Period 1||3
336946|NCT01370655|806953|P10|STARTED|Period 1||2
336947|NCT01370655|806954|P9|STARTED|Period 1||3
336948|NCT01370655|806955|P8|STARTED|Period 1||4
336949|NCT01370655|806956|P7|STARTED|Period 1||4
336950|NCT01370655|806957|P6|STARTED|Period 1||4
336951|NCT01370655|806958|P5|STARTED|Period 1||3
336952|NCT01370655|806959|P4|STARTED|Period 1||3
336953|NCT01370655|806960|P3|STARTED|Period 1||3
336954|NCT01370655|806961|P2|STARTED|Period 1||7
336955|NCT01370655|806962|P1|STARTED|Period 1||7
336956|NCT01370642|806999|P3|NOT COMPLETED|Overall Study||29
336957|NCT01370642|807000|P2|NOT COMPLETED|Overall Study||6
336958|NCT01370642|807001|P1|NOT COMPLETED|Overall Study||8
336959|NCT01370642|806999|P3|COMPLETED|Overall Study||69
336960|NCT01370642|807000|P2|COMPLETED|Overall Study||92
336961|NCT01370642|807001|P1|COMPLETED|Overall Study||90
336962|NCT01370642|806999|P3|FAS Population|Overall Study||98
336963|NCT01370642|807000|P2|FAS Population|Overall Study||97
336964|NCT01370642|807001|P1|FAS Population|Overall Study||98
336965|NCT01370642|806999|P3|STARTED|Overall Study||98
336966|NCT01370642|807000|P2|STARTED|Overall Study||98
336967|NCT01370642|807001|P1|STARTED|Overall Study||98
336968|NCT01370616|807032|P2|NOT COMPLETED|Overall Study||67
336969|NCT01370616|807033|P1|NOT COMPLETED|Overall Study||62
336970|NCT01370616|807032|P2|COMPLETED|Overall Study||216
336971|NCT01370616|807033|P1|COMPLETED|Overall Study||220
336972|NCT01370616|807032|P2|Treated|Overall Study||275
336973|NCT01370616|807033|P1|Treated|Overall Study||275
336974|NCT01370616|807032|P2|STARTED|Overall Study|Participants randomized|283
336975|NCT01370616|807033|P1|STARTED|Overall Study|Participants randomized|282
336976|NCT01370603|807057|P2|NOT COMPLETED|Period 2||4
336977|NCT01370603|807058|P1|NOT COMPLETED|Period 2||3
336978|NCT01370603|807057|P2|COMPLETED|Period 2||146
336979|NCT01370603|807058|P1|COMPLETED|Period 2||138
336980|NCT01370603|807057|P2|STARTED|Period 2||150
336981|NCT01370603|807058|P1|STARTED|Period 2||141
336982|NCT01370603|807057|P2|NOT COMPLETED|Crossover Washout||4
336983|NCT01370603|807058|P1|NOT COMPLETED|Crossover Washout||9
336984|NCT01370603|807057|P2|COMPLETED|Crossover Washout||150
336985|NCT01370603|807058|P1|COMPLETED|Crossover Washout||141
336986|NCT01370603|807057|P2|STARTED|Crossover Washout||154
336987|NCT01370603|807058|P1|STARTED|Crossover Washout||150
336988|NCT01370603|807057|P2|NOT COMPLETED|Period 1||10
336989|NCT01370603|807058|P1|NOT COMPLETED|Period 1||14
336990|NCT01370603|807057|P2|COMPLETED|Period 1||154
336991|NCT01370603|807058|P1|COMPLETED|Period 1||150
336992|NCT01370603|807057|P2|STARTED|Period 1||164
336993|NCT01370603|807058|P1|STARTED|Period 1||164
336994|NCT01370590|807076|P2|NOT COMPLETED|Period 2||2
336995|NCT01370590|807077|P1|NOT COMPLETED|Period 2||1
336996|NCT01370590|807076|P2|COMPLETED|Period 2||184
336997|NCT01370590|807077|P1|COMPLETED|Period 2||180
336998|NCT01370590|807076|P2|STARTED|Period 2||186
336999|NCT01370590|807077|P1|STARTED|Period 2||181
337000|NCT01370590|807076|P2|NOT COMPLETED|Crossover Washout Period||6
337001|NCT01370590|807077|P1|NOT COMPLETED|Crossover Washout Period||6
337002|NCT01370590|807076|P2|COMPLETED|Crossover Washout Period||186
337003|NCT01370590|807077|P1|COMPLETED|Crossover Washout Period||181
337004|NCT01370590|807076|P2|STARTED|Crossover Washout Period||192
337005|NCT01370590|807077|P1|STARTED|Crossover Washout Period||187
337006|NCT01370590|807076|P2|NOT COMPLETED|Period 1||11
337007|NCT01370590|807077|P1|NOT COMPLETED|Period 1||16
337008|NCT01370590|807076|P2|COMPLETED|Period 1||192
337009|NCT01370590|807077|P1|COMPLETED|Period 1||187
337010|NCT01370590|807076|P2|STARTED|Period 1||203
337011|NCT01370590|807077|P1|STARTED|Period 1||203
337012|NCT01370538|807095|P2|NOT COMPLETED|Overall Study||19
337013|NCT01370538|807096|P1|NOT COMPLETED|Overall Study||19
337014|NCT01370538|807095|P2|COMPLETED|Overall Study||152
337015|NCT01370538|807096|P1|COMPLETED|Overall Study||151
337016|NCT01370538|807095|P2|Patients Who Completed Treatment|Overall Study||152
337017|NCT01370538|807096|P1|Patients Who Completed Treatment|Overall Study||151
337018|NCT01370538|807095|P2|Patients Who Received Treatment|Overall Study||161
337019|NCT01370538|807096|P1|Patients Who Received Treatment|Overall Study||165
337020|NCT01370538|807095|P2|STARTED|Overall Study||171
337021|NCT01370538|807096|P1|STARTED|Overall Study||170
337022|NCT01370525|807112|P2|NOT COMPLETED|Overall Study||11
337023|NCT01370525|807113|P1|NOT COMPLETED|Overall Study||8
337024|NCT01370525|807112|P2|COMPLETED|Overall Study||158
337025|NCT01370525|807113|P1|COMPLETED|Overall Study||163
337026|NCT01370525|807112|P2|Patients Who Completed Treatment|Overall Study||158
337027|NCT01370525|807113|P1|Patients Who Completed Treatment|Overall Study||163
337028|NCT01370525|807112|P2|Patients Who Received Treatment|Overall Study||163
337029|NCT01370525|807113|P1|Patients Who Received Treatment|Overall Study||168
337030|NCT01370525|807112|P2|STARTED|Overall Study||169
337031|NCT01370525|807113|P1|STARTED|Overall Study||171
337032|NCT01370460|807129|P2|NOT COMPLETED|Overall Study||0
337033|NCT01370460|807130|P1|NOT COMPLETED|Overall Study||0
337034|NCT01370460|807129|P2|COMPLETED|Overall Study||51
337035|NCT01370460|807130|P1|COMPLETED|Overall Study||50
337036|NCT01370460|807129|P2|STARTED|Overall Study||51
337037|NCT01370460|807130|P1|STARTED|Overall Study||50
337038|NCT01370408|807137|P1|NOT COMPLETED|Overall Study||9
337039|NCT01370408|807137|P1|COMPLETED|Overall Study||76
337040|NCT01370408|807137|P1|STARTED|Overall Study||85
337041|NCT01370356|807150|P2|NOT COMPLETED|Overall Study||227
337042|NCT01370356|807151|P1|NOT COMPLETED|Overall Study||192
337043|NCT01370356|807150|P2|COMPLETED|Overall Study||515
337044|NCT01370356|807151|P1|COMPLETED|Overall Study||559
337045|NCT01370356|807150|P2|STARTED|Overall Study||742
337046|NCT01370356|807151|P1|STARTED|Overall Study||751
337047|NCT01370265|807165|P2|NOT COMPLETED|Second Intervention||0
337048|NCT01370265|807166|P1|NOT COMPLETED|Second Intervention||0
337049|NCT01370265|807165|P2|COMPLETED|Second Intervention||5
337050|NCT01370265|807166|P1|COMPLETED|Second Intervention||5
337051|NCT01370265|807165|P2|STARTED|Second Intervention||5
337052|NCT01370265|807166|P1|STARTED|Second Intervention||5
337053|NCT01370265|807165|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
337054|NCT01370265|807166|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
337055|NCT01370265|807165|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
337056|NCT01370265|807166|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
337057|NCT01370265|807165|P2|STARTED|Washout Period (50-minute Period Decay)||5
337058|NCT01370265|807166|P1|STARTED|Washout Period (50-minute Period Decay)||5
337059|NCT01370265|807165|P2|NOT COMPLETED|First Intervention||1
337060|NCT01370265|807166|P1|NOT COMPLETED|First Intervention||1
337061|NCT01370265|807165|P2|COMPLETED|First Intervention||5
337062|NCT01370265|807166|P1|COMPLETED|First Intervention||5
337063|NCT01370265|807165|P2|STARTED|First Intervention||6
337064|NCT01370265|807166|P1|STARTED|First Intervention||6
337065|NCT01370265|807165|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
337066|NCT01370265|807166|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
337067|NCT01370265|807165|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
337068|NCT01370265|807166|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
337069|NCT01370265|807165|P2|STARTED|Washout Period (50-minute Period Decay)||6
337070|NCT01370265|807166|P1|STARTED|Washout Period (50-minute Period Decay)||6
337071|NCT01370265|807165|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
337072|NCT01370265|807166|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
337073|NCT01370265|807165|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
337074|NCT01370265|807166|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
337075|NCT01370265|807165|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
337076|NCT01370265|807166|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
337077|NCT01370083|807185|P2|NOT COMPLETED|Overall Study||1
337078|NCT01370083|807186|P1|NOT COMPLETED|Overall Study||2
337079|NCT01370083|807185|P2|COMPLETED|Overall Study||6
337080|NCT01370083|807186|P1|COMPLETED|Overall Study||5
337081|NCT01370083|807185|P2|STARTED|Overall Study||7
337082|NCT01370083|807186|P1|STARTED|Overall Study||7
337083|NCT01370005|807199|P3|NOT COMPLETED|Overall Study||11
337084|NCT01370005|807200|P2|NOT COMPLETED|Overall Study||11
337085|NCT01370005|807201|P1|NOT COMPLETED|Overall Study||16
337086|NCT01370005|807199|P3|COMPLETED|Overall Study||266
337087|NCT01370005|807200|P2|COMPLETED|Overall Study||265
337088|NCT01370005|807201|P1|COMPLETED|Overall Study||256
337089|NCT01370005|807199|P3|STARTED|Overall Study||277
337090|NCT01370005|807200|P2|STARTED|Overall Study||276
337091|NCT01370005|807201|P1|STARTED|Overall Study||272
337092|NCT01369888|807258|P4|NOT COMPLETED|Overall Study||0
337093|NCT01369888|807259|P3|NOT COMPLETED|Overall Study||0
337094|NCT01369888|807260|P2|NOT COMPLETED|Overall Study||0
337095|NCT01369888|807261|P1|NOT COMPLETED|Overall Study||0
337096|NCT01369888|807258|P4|COMPLETED|Overall Study||0
337097|NCT01369888|807259|P3|COMPLETED|Overall Study||0
337098|NCT01369888|807260|P2|COMPLETED|Overall Study||2
337099|NCT01369888|807261|P1|COMPLETED|Overall Study||1
337100|NCT01369888|807258|P4|STARTED|Overall Study||0
337101|NCT01369888|807259|P3|STARTED|Overall Study||0
337102|NCT01369888|807260|P2|STARTED|Overall Study||2
337103|NCT01369888|807261|P1|STARTED|Overall Study||1
337104|NCT01369875|807271|P2|NOT COMPLETED|Overall Study||0
337105|NCT01369875|807272|P1|NOT COMPLETED|Overall Study||0
337106|NCT01369875|807271|P2|COMPLETED|Overall Study||1
337107|NCT01369875|807272|P1|COMPLETED|Overall Study||1
337108|NCT01369875|807271|P2|STARTED|Overall Study||1
337109|NCT01369875|807272|P1|STARTED|Overall Study||1
337110|NCT01369849|807283|P3|NOT COMPLETED|Overall Study||1
337111|NCT01369849|807284|P2|NOT COMPLETED|Overall Study||0
337112|NCT01369849|807285|P1|NOT COMPLETED|Overall Study||0
337113|NCT01369849|807283|P3|COMPLETED|Overall Study||4
337114|NCT01369849|807284|P2|COMPLETED|Overall Study||4
337115|NCT01369849|807285|P1|COMPLETED|Overall Study||6
337116|NCT01369849|807283|P3|STARTED|Overall Study||5
337117|NCT01369849|807284|P2|STARTED|Overall Study||4
337118|NCT01369849|807285|P1|STARTED|Overall Study||6
337119|NCT01369784|807294|P1|NOT COMPLETED|Overall Study||12
337120|NCT01369784|807294|P1|COMPLETED|Overall Study||146
337121|NCT01369784|807294|P1|STARTED|Overall Study||158
337122|NCT01369745|807324|P5|NOT COMPLETED|Overall Study||18
337123|NCT01369745|807325|P4|NOT COMPLETED|Overall Study||20
337124|NCT01369745|807326|P3|NOT COMPLETED|Overall Study||2
337125|NCT01369745|807327|P2|NOT COMPLETED|Overall Study||13
337126|NCT01369745|807328|P1|NOT COMPLETED|Overall Study||7
337127|NCT01369745|807324|P5|COMPLETED|Overall Study||65
337128|NCT01369745|807325|P4|COMPLETED|Overall Study||64
337129|NCT01369745|807326|P3|COMPLETED|Overall Study||16
337130|NCT01369745|807327|P2|COMPLETED|Overall Study||28
337131|NCT01369745|807328|P1|COMPLETED|Overall Study||25
337132|NCT01369745|807324|P5|STARTED|Overall Study||83
337133|NCT01369745|807325|P4|STARTED|Overall Study||84
337134|NCT01369745|807326|P3|STARTED|Overall Study||18
337135|NCT01369745|807327|P2|STARTED|Overall Study||41
337136|NCT01369745|807328|P1|STARTED|Overall Study||32
337137|NCT01369732|807362|P2|NOT COMPLETED|Overall Study||2
337138|NCT01369732|807363|P1|NOT COMPLETED|Overall Study||4
337139|NCT01369732|807362|P2|COMPLETED|Overall Study||31
337140|NCT01369732|807363|P1|COMPLETED|Overall Study||29
337141|NCT01369732|807362|P2|STARTED|Overall Study||33
337142|NCT01369732|807363|P1|STARTED|Overall Study||33
337143|NCT01369706|807369|P1|NOT COMPLETED|Overall Study||0
337144|NCT01369706|807369|P1|COMPLETED|Overall Study||388
337145|NCT01369706|807369|P1|STARTED|Overall Study||388
337146|NCT01369680|807377|P4|NOT COMPLETED|Overall Study||2
337147|NCT01369680|807378|P3|NOT COMPLETED|Overall Study||1
337148|NCT01369680|807379|P2|NOT COMPLETED|Overall Study||0
337149|NCT01369680|807380|P1|NOT COMPLETED|Overall Study||0
337150|NCT01369680|807377|P4|COMPLETED|Overall Study||1
337151|NCT01369680|807378|P3|COMPLETED|Overall Study||2
337152|NCT01369680|807379|P2|COMPLETED|Overall Study||3
337153|NCT01369680|807380|P1|COMPLETED|Overall Study||3
337154|NCT01369680|807377|P4|STARTED|Overall Study||3
337155|NCT01369680|807378|P3|STARTED|Overall Study||3
337156|NCT01369680|807379|P2|STARTED|Overall Study||3
337157|NCT01369680|807380|P1|STARTED|Overall Study||3
337158|NCT01369641|807401|P1|NOT COMPLETED|Overall Study||1
337159|NCT01369641|807401|P1|COMPLETED|Overall Study||0
337160|NCT01369641|807401|P1|STARTED|Overall Study||1
337161|NCT01369615|807407|P2|NOT COMPLETED|Overall Study||2
337162|NCT01369615|807408|P1|NOT COMPLETED|Overall Study||0
337163|NCT01369615|807407|P2|COMPLETED|Overall Study||12
337164|NCT01369615|807408|P1|COMPLETED|Overall Study||9
337165|NCT01369615|807407|P2|STARTED|Overall Study||14
337166|NCT01369615|807408|P1|STARTED|Overall Study||9
337167|NCT01369485|807416|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
337168|NCT01369485|807417|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
337169|NCT01369485|807416|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
337170|NCT01369485|807417|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
337171|NCT01369485|807416|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
337172|NCT01369485|807417|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
337173|NCT01369485|807416|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
337174|NCT01369485|807417|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
337175|NCT01369485|807416|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
337176|NCT01369485|807417|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
337177|NCT01369485|807416|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
337178|NCT01369485|807417|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
337179|NCT01369355|807463|P6|NOT COMPLETED|Overall Study||272
337180|NCT01369355|807464|P5|NOT COMPLETED|Overall Study||154
337181|NCT01369355|807465|P4|NOT COMPLETED|Overall Study||30
337182|NCT01369355|807466|P3|NOT COMPLETED|Overall Study||31
337183|NCT01369355|807467|P2|NOT COMPLETED|Overall Study||29
337184|NCT01369355|807468|P1|NOT COMPLETED|Overall Study||31
337185|NCT01369355|807463|P6|COMPLETED|Overall Study||204
337186|NCT01369355|807464|P5|COMPLETED|Overall Study||131
337187|NCT01369355|807465|P4|COMPLETED|Overall Study||93
337188|NCT01369355|807466|P3|COMPLETED|Overall Study||101
337189|NCT01369355|807467|P2|COMPLETED|Overall Study||103
337190|NCT01369355|807468|P1|COMPLETED|Overall Study||102
337191|NCT01369355|807463|P6|Treated|Overall Study||476
337192|NCT01369355|807464|P5|Treated|Overall Study||285
337193|NCT01369355|807465|P4|Treated|Overall Study||123
337194|NCT01369355|807466|P3|Treated|Overall Study||131
337195|NCT01369355|807467|P2|Treated|Overall Study||132
337196|NCT01369355|807468|P1|Treated|Overall Study||133
337197|NCT01369355|807463|P6|STARTED|Overall Study||476
337198|NCT01369355|807464|P5|STARTED|Overall Study||285
337199|NCT01369355|807465|P4|STARTED|Overall Study||123
337200|NCT01369355|807466|P3|STARTED|Overall Study||132
337201|NCT01369355|807467|P2|STARTED|Overall Study||132
337202|NCT01369355|807468|P1|STARTED|Overall Study||133
337203|NCT01369342|807497|P3|NOT COMPLETED|Overall Study||3
337204|NCT01369342|807498|P2|NOT COMPLETED|Overall Study||9
337205|NCT01369342|807499|P1|NOT COMPLETED|Overall Study||13
337206|NCT01369342|807497|P3|COMPLETED|Overall Study||210
337207|NCT01369342|807498|P2|COMPLETED|Overall Study||204
337208|NCT01369342|807499|P1|COMPLETED|Overall Study||201
337209|NCT01369342|807497|P3|STARTED|Overall Study||213
337210|NCT01369342|807498|P2|STARTED|Overall Study||213
337211|NCT01369342|807499|P1|STARTED|Overall Study||214
337212|NCT01369329|807522|P3|NOT COMPLETED|Overall Study||14
337213|NCT01369329|807523|P2|NOT COMPLETED|Overall Study||11
337214|NCT01369329|807524|P1|NOT COMPLETED|Overall Study||12
337215|NCT01369329|807522|P3|COMPLETED|Overall Study||245
337216|NCT01369329|807523|P2|COMPLETED|Overall Study||243
337217|NCT01369329|807524|P1|COMPLETED|Overall Study||244
337218|NCT01369329|807522|P3|STARTED|Overall Study||259
337219|NCT01369329|807523|P2|STARTED|Overall Study||254
337220|NCT01369329|807524|P1|STARTED|Overall Study||256
337221|NCT01369225|807550|P6|NOT COMPLETED|Overall Study||0
337222|NCT01369225|807551|P5|NOT COMPLETED|Overall Study||2
337223|NCT01369225|807552|P4|NOT COMPLETED|Overall Study||2
337224|NCT01369225|807553|P3|NOT COMPLETED|Overall Study||3
337225|NCT01369225|807554|P2|NOT COMPLETED|Overall Study||0
337226|NCT01369225|807555|P1|NOT COMPLETED|Overall Study||2
337227|NCT01369225|807550|P6|COMPLETED|Overall Study||9
337228|NCT01369225|807551|P5|COMPLETED|Overall Study||10
337229|NCT01369225|807552|P4|COMPLETED|Overall Study||8
337230|NCT01369225|807553|P3|COMPLETED|Overall Study||9
337231|NCT01369225|807554|P2|COMPLETED|Overall Study||3
337232|NCT01369225|807555|P1|COMPLETED|Overall Study||4
337233|NCT01369225|807550|P6|STARTED|Overall Study||9
337234|NCT01369225|807551|P5|STARTED|Overall Study||12
337235|NCT01369225|807552|P4|STARTED|Overall Study||10
337236|NCT01369225|807553|P3|STARTED|Overall Study||12
337237|NCT01369225|807554|P2|STARTED|Overall Study||3
337238|NCT01369225|807555|P1|STARTED|Overall Study||6
337239|NCT01369030|807647|P1|NOT COMPLETED|Overall Study||40
337240|NCT01369030|807647|P1|COMPLETED|Overall Study||554
337241|NCT01369030|807647|P1|STARTED|Overall Study||594
337242|NCT01368965|807653|P1|NOT COMPLETED|Overall Study||12
337243|NCT01368965|807653|P1|COMPLETED|Overall Study||40
337244|NCT01368965|807653|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
337245|NCT01368965|807653|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
337246|NCT01368900|807662|P1|NOT COMPLETED|Overall Study||7
337247|NCT01368900|807662|P1|COMPLETED|Overall Study||61
337248|NCT01368900|807662|P1|STARTED|Overall Study||68
337249|NCT01368874|807675|P3|NOT COMPLETED|Overall Study||1
337250|NCT01368874|807676|P2|NOT COMPLETED|Overall Study||0
337251|NCT01368874|807677|P1|NOT COMPLETED|Overall Study||3
337252|NCT01368874|807675|P3|COMPLETED|Overall Study||24
337253|NCT01368874|807676|P2|COMPLETED|Overall Study||5
337254|NCT01368874|807677|P1|COMPLETED|Overall Study||31
337255|NCT01368874|807675|P3|STARTED|Overall Study||25
337256|NCT01368874|807676|P2|STARTED|Overall Study||5
337257|NCT01368874|807677|P1|STARTED|Overall Study||34
337258|NCT01368835|807737|P1|NOT COMPLETED|Overall Study||33
337259|NCT01368835|807737|P1|COMPLETED|Overall Study||70
337260|NCT01368835|807737|P1|STARTED|Overall Study|103 Subjects Enrolled|103
337261|NCT01368809|807746|P2|NOT COMPLETED|Overall Study||0
337262|NCT01368809|807747|P1|NOT COMPLETED|Overall Study||0
337263|NCT01368809|807746|P2|COMPLETED|Overall Study||50
337264|NCT01368809|807747|P1|COMPLETED|Overall Study||50
337265|NCT01368809|807746|P2|STARTED|Overall Study||50
337266|NCT01368809|807747|P1|STARTED|Overall Study||50
337267|NCT01368653|807759|P2|NOT COMPLETED|Overall Study||9
337268|NCT01368653|807760|P1|NOT COMPLETED|Overall Study||6
337269|NCT01368653|807759|P2|COMPLETED|Overall Study||37
337270|NCT01368653|807760|P1|COMPLETED|Overall Study||41
337271|NCT01368653|807759|P2|Randomized to Advice Only in Phase 2|Overall Study||10
337272|NCT01368653|807760|P1|Randomized to Advice Only in Phase 2|Overall Study||10
337273|NCT01368653|807759|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
337274|NCT01368653|807760|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
337275|NCT01368653|807759|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
337276|NCT01368653|807760|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
337277|NCT01368653|807759|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
337278|NCT01368653|807760|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
337279|NCT01368653|807759|P2|Completed 4-week Follow-up|Overall Study||37
337280|NCT01368653|807760|P1|Completed 4-week Follow-up|Overall Study||44
337281|NCT01368653|807759|P2|STARTED|Overall Study||46
337282|NCT01368653|807760|P1|STARTED|Overall Study||47
337283|NCT01368536|807779|P3|NOT COMPLETED|Overall Study||59
337284|NCT01368536|807780|P2|NOT COMPLETED|Overall Study||59
337285|NCT01368536|807781|P1|NOT COMPLETED|Overall Study||51
337286|NCT01368536|807779|P3|COMPLETED|Overall Study||83
337287|NCT01368536|807780|P2|COMPLETED|Overall Study||78
337288|NCT01368536|807781|P1|COMPLETED|Overall Study||87
337289|NCT01368536|807779|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
337290|NCT01368536|807780|P2|Full Analysis Set|Overall Study||137
337291|NCT01368536|807781|P1|Full Analysis Set|Overall Study||138
337292|NCT01368536|807779|P3|STARTED|Overall Study||142
337293|NCT01368536|807780|P2|STARTED|Overall Study||137
337294|NCT01368536|807781|P1|STARTED|Overall Study||138
337295|NCT01368432|807804|P2|NOT COMPLETED|Overall Study||1
337296|NCT01368432|807805|P1|NOT COMPLETED|Overall Study||0
337297|NCT01368432|807804|P2|COMPLETED|Overall Study||7
337298|NCT01368432|807805|P1|COMPLETED|Overall Study||6
337299|NCT01368432|807804|P2|STARTED|Overall Study||8
337300|NCT01368432|807805|P1|STARTED|Overall Study||6
337301|NCT01368406|807839|P2|NOT COMPLETED|Overall Study||13
337302|NCT01368406|807840|P1|NOT COMPLETED|Overall Study||21
337303|NCT01368406|807839|P2|COMPLETED|Overall Study||66
337304|NCT01368406|807840|P1|COMPLETED|Overall Study||60
337305|NCT01368406|807839|P2|STARTED|Overall Study||79
337306|NCT01368406|807840|P1|STARTED|Overall Study||81
337307|NCT01368276|807848|P2|NOT COMPLETED|Overall Study||10
337308|NCT01368276|807849|P1|NOT COMPLETED|Overall Study||1
337309|NCT01368276|807848|P2|COMPLETED|Overall Study||18
337310|NCT01368276|807849|P1|COMPLETED|Overall Study||2
337311|NCT01368276|807848|P2|STARTED|Overall Study||28
337312|NCT01368276|807849|P1|STARTED|Overall Study||3
337313|NCT01368263|807862|P3|NOT COMPLETED|Overall Study||0
337314|NCT01368263|807863|P2|NOT COMPLETED|Overall Study||0
337315|NCT01368263|807864|P1|NOT COMPLETED|Overall Study||0
337316|NCT01368263|807862|P3|COMPLETED|Overall Study||1
337317|NCT01368263|807863|P2|COMPLETED|Overall Study||1
337318|NCT01368263|807864|P1|COMPLETED|Overall Study||6
337319|NCT01368263|807862|P3|STARTED|Overall Study||1
337320|NCT01368263|807863|P2|STARTED|Overall Study||1
337321|NCT01368263|807864|P1|STARTED|Overall Study||6
337322|NCT01368211|807886|P2|NOT COMPLETED|Second Platelets Transfusion||2
337323|NCT01368211|807887|P1|NOT COMPLETED|Second Platelets Transfusion||1
337324|NCT01368211|807886|P2|COMPLETED|Second Platelets Transfusion||5
337325|NCT01368211|807887|P1|COMPLETED|Second Platelets Transfusion||7
337326|NCT01368211|807886|P2|STARTED|Second Platelets Transfusion||7
337327|NCT01368211|807887|P1|STARTED|Second Platelets Transfusion||8
337328|NCT01368211|807886|P2|NOT COMPLETED|First Platelets Transfusion||0
337329|NCT01368211|807887|P1|NOT COMPLETED|First Platelets Transfusion||0
337330|NCT01368211|807886|P2|COMPLETED|First Platelets Transfusion||7
337331|NCT01368211|807887|P1|COMPLETED|First Platelets Transfusion||8
337332|NCT01368211|807886|P2|STARTED|First Platelets Transfusion||7
337333|NCT01368211|807887|P1|STARTED|First Platelets Transfusion||8
337334|NCT01368185|807895|P1|NOT COMPLETED|Overall Study||0
337335|NCT01368185|807895|P1|COMPLETED|Overall Study||1705
337336|NCT01368185|807895|P1|STARTED|Overall Study||1705
337337|NCT01368081|807915|P13|NOT COMPLETED|Overall Study||7
337338|NCT01368081|807916|P12|NOT COMPLETED|Overall Study||3
337339|NCT01368081|807917|P11|NOT COMPLETED|Overall Study||9
337340|NCT01368081|807918|P10|NOT COMPLETED|Overall Study||10
337341|NCT01368081|807919|P9|NOT COMPLETED|Overall Study||8
337342|NCT01368081|807920|P8|NOT COMPLETED|Overall Study||7
337343|NCT01368081|807921|P7|NOT COMPLETED|Overall Study||12
337344|NCT01368081|807922|P6|NOT COMPLETED|Overall Study||10
337345|NCT01368081|807923|P5|NOT COMPLETED|Overall Study||2
337346|NCT01368081|807924|P4|NOT COMPLETED|Overall Study||5
337347|NCT01368081|807925|P3|NOT COMPLETED|Overall Study||4
337348|NCT01368081|807926|P2|NOT COMPLETED|Overall Study||9
337349|NCT01368081|807927|P1|NOT COMPLETED|Overall Study||10
337350|NCT01368081|807915|P13|COMPLETED|Overall Study||63
337351|NCT01368081|807916|P12|COMPLETED|Overall Study||67
337352|NCT01368081|807917|P11|COMPLETED|Overall Study||62
337353|NCT01368081|807918|P10|COMPLETED|Overall Study||58
337354|NCT01368081|807919|P9|COMPLETED|Overall Study||62
337355|NCT01368081|807920|P8|COMPLETED|Overall Study||62
337356|NCT01368081|807921|P7|COMPLETED|Overall Study||124
337357|NCT01368081|807922|P6|COMPLETED|Overall Study||127
337358|NCT01368081|807923|P5|COMPLETED|Overall Study||63
337359|NCT01368081|807924|P4|COMPLETED|Overall Study||63
337360|NCT01368081|807925|P3|COMPLETED|Overall Study||59
337361|NCT01368081|807926|P2|COMPLETED|Overall Study||128
337362|NCT01368081|807927|P1|COMPLETED|Overall Study||126
337363|NCT01368081|807915|P13|STARTED|Overall Study||70
337364|NCT01368081|807916|P12|STARTED|Overall Study||70
337365|NCT01368081|807917|P11|STARTED|Overall Study||71
337366|NCT01368081|807918|P10|STARTED|Overall Study||68
337367|NCT01368081|807919|P9|STARTED|Overall Study||70
337368|NCT01368081|807920|P8|STARTED|Overall Study||69
337369|NCT01368081|807921|P7|STARTED|Overall Study||136
337370|NCT01368081|807922|P6|STARTED|Overall Study||137
337371|NCT01368081|807923|P5|STARTED|Overall Study||65
337372|NCT01368081|807924|P4|STARTED|Overall Study||68
337373|NCT01368081|807925|P3|STARTED|Overall Study||63
337374|NCT01368081|807926|P2|STARTED|Overall Study||137
337375|NCT01368081|807927|P1|STARTED|Overall Study||136
337376|NCT01368042|807981|P1|NOT COMPLETED|Overall Study||30
337377|NCT01368042|807981|P1|COMPLETED|Overall Study||235
337378|NCT01368042|807981|P1|STARTED|Overall Study||265
337379|NCT01367886|808001|P1|NOT COMPLETED|Overall Study||7
337380|NCT01367886|808001|P1|COMPLETED|Overall Study||14
337381|NCT01367886|808001|P1|STARTED|Overall Study||21
337382|NCT01367860|808010|P2|NOT COMPLETED|Overall Study||0
337383|NCT01367860|808011|P1|NOT COMPLETED|Overall Study||0
337384|NCT01367860|808010|P2|COMPLETED|Overall Study||20
337385|NCT01367860|808011|P1|COMPLETED|Overall Study||20
337386|NCT01367860|808010|P2|STARTED|Overall Study||20
337387|NCT01367860|808011|P1|STARTED|Overall Study||20
337388|NCT01367834|808051|P2|NOT COMPLETED|Overall Study||3
337389|NCT01367834|808052|P1|NOT COMPLETED|Overall Study||2
337390|NCT01367834|808051|P2|COMPLETED|Overall Study||3
337391|NCT01367834|808052|P1|COMPLETED|Overall Study||9
337392|NCT01367834|808051|P2|STARTED|Overall Study||6
337393|NCT01367834|808052|P1|STARTED|Overall Study||11
337394|NCT01367704|808076|P2|NOT COMPLETED|Overall Study||161
337395|NCT01367704|808077|P1|NOT COMPLETED|Overall Study||47
337396|NCT01367704|808076|P2|COMPLETED|Overall Study||847
337397|NCT01367704|808077|P1|COMPLETED|Overall Study||951
337398|NCT01367704|808076|P2|STARTED|Overall Study||1008
337399|NCT01367704|808077|P1|STARTED|Overall Study||998
337400|NCT01367665|808089|P2|NOT COMPLETED|Overall Study||24
337401|NCT01367665|808090|P1|NOT COMPLETED|Overall Study||377
337402|NCT01367665|808089|P2|COMPLETED|Overall Study||7
337403|NCT01367665|808090|P1|COMPLETED|Overall Study||93
337404|NCT01367665|808089|P2|STARTED|Overall Study||31
337405|NCT01367665|808090|P1|STARTED|Overall Study||470
337406|NCT01367457|808099|P3|NOT COMPLETED|Overall Study||0
337407|NCT01367457|808100|P2|NOT COMPLETED|Overall Study||0
337408|NCT01367457|808101|P1|NOT COMPLETED|Overall Study||188
337409|NCT01367457|808099|P3|COMPLETED|Overall Study||26
337410|NCT01367457|808100|P2|COMPLETED|Overall Study||23
337411|NCT01367457|808101|P1|COMPLETED|Overall Study||5
337412|NCT01367457|808099|P3|STARTED|Overall Study||26
337413|NCT01367457|808100|P2|STARTED|Overall Study||23
337414|NCT01367457|808101|P1|STARTED|Overall Study||193
337415|NCT01367249|808123|P2|NOT COMPLETED|Overall Study||16
337416|NCT01367249|808124|P1|NOT COMPLETED|Overall Study||9
337417|NCT01367249|808123|P2|COMPLETED|Overall Study||202
337418|NCT01367249|808124|P1|COMPLETED|Overall Study||213
337419|NCT01367249|808123|P2|STARTED|Overall Study||218
337420|NCT01367249|808124|P1|STARTED|Overall Study||222
337421|NCT01367158|808143|P11|NOT COMPLETED|Overall Study||1
337422|NCT01367158|808144|P10|NOT COMPLETED|Overall Study||0
337423|NCT01367158|808145|P9|NOT COMPLETED|Overall Study||0
337424|NCT01367158|808146|P8|NOT COMPLETED|Overall Study||2
337425|NCT01367158|808147|P7|NOT COMPLETED|Overall Study||0
337426|NCT01367158|808148|P6|NOT COMPLETED|Overall Study||2
337427|NCT01367158|808149|P5|NOT COMPLETED|Overall Study||2
337428|NCT01367158|808150|P4|NOT COMPLETED|Overall Study||1
337429|NCT01367158|808151|P3|NOT COMPLETED|Overall Study||1
337430|NCT01367158|808152|P2|NOT COMPLETED|Overall Study||3
337431|NCT01367158|808153|P1|NOT COMPLETED|Overall Study||0
337432|NCT01367158|808143|P11|COMPLETED|Overall Study||72
337433|NCT01367158|808144|P10|COMPLETED|Overall Study||50
337434|NCT01367158|808145|P9|COMPLETED|Overall Study||23
337435|NCT01367158|808146|P8|COMPLETED|Overall Study||47
337436|NCT01367158|808147|P7|COMPLETED|Overall Study||25
337437|NCT01367158|808148|P6|COMPLETED|Overall Study||46
337438|NCT01367158|808149|P5|COMPLETED|Overall Study||23
337439|NCT01367158|808150|P4|COMPLETED|Overall Study||48
337440|NCT01367158|808151|P3|COMPLETED|Overall Study||23
337441|NCT01367158|808152|P2|COMPLETED|Overall Study||46
337442|NCT01367158|808153|P1|COMPLETED|Overall Study||25
337443|NCT01367158|808143|P11|STARTED|Overall Study||73
337444|NCT01367158|808144|P10|STARTED|Overall Study||50
337445|NCT01367158|808145|P9|STARTED|Overall Study||23
337446|NCT01367158|808146|P8|STARTED|Overall Study||49
337447|NCT01367158|808147|P7|STARTED|Overall Study||25
337448|NCT01367158|808148|P6|STARTED|Overall Study||48
337449|NCT01367158|808149|P5|STARTED|Overall Study||25
337450|NCT01367158|808150|P4|STARTED|Overall Study||49
337451|NCT01367158|808151|P3|STARTED|Overall Study||24
337452|NCT01367158|808152|P2|STARTED|Overall Study||49
337453|NCT01367158|808153|P1|STARTED|Overall Study||25
337454|NCT01367119|808297|P2|NOT COMPLETED|Overall Study||1
337455|NCT01367119|808298|P1|NOT COMPLETED|Overall Study||2
337456|NCT01367119|808297|P2|COMPLETED|Overall Study||16
337457|NCT01367119|808298|P1|COMPLETED|Overall Study||19
337458|NCT01367119|808297|P2|STARTED|Overall Study||17
337459|NCT01367119|808298|P1|STARTED|Overall Study||21
337460|NCT01367080|808310|P2|NOT COMPLETED|2nd Administration||0
337461|NCT01367080|808311|P1|NOT COMPLETED|2nd Administration||0
337462|NCT01367080|808310|P2|COMPLETED|2nd Administration||6
337463|NCT01367080|808311|P1|COMPLETED|2nd Administration||6
337464|NCT01367080|808310|P2|STARTED|2nd Administration||6
337465|NCT01367080|808311|P1|STARTED|2nd Administration||6
337466|NCT01367080|808310|P2|NOT COMPLETED|1st Administration||0
337467|NCT01367080|808311|P1|NOT COMPLETED|1st Administration||0
337468|NCT01367080|808310|P2|COMPLETED|1st Administration||6
337469|NCT01367080|808311|P1|COMPLETED|1st Administration||6
337470|NCT01367080|808310|P2|STARTED|1st Administration||6
337471|NCT01367080|808311|P1|STARTED|1st Administration||6
337472|NCT01366976|808325|P2|NOT COMPLETED|Overall Study||0
337473|NCT01366976|808326|P1|NOT COMPLETED|Overall Study||0
337474|NCT01366976|808325|P2|COMPLETED|Overall Study||30
337475|NCT01366976|808326|P1|COMPLETED|Overall Study||30
337476|NCT01366976|808325|P2|STARTED|Overall Study||30
337477|NCT01366976|808326|P1|STARTED|Overall Study||30
337478|NCT01366885|808338|P1|NOT COMPLETED|Overall Study||1
337479|NCT01366885|808338|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
337566|NCT01365845|808586|P2|STARTED|Induction Phase||0
337480|NCT01366885|808338|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
337481|NCT01366872|808343|P1|NOT COMPLETED|Overall Study||0
337482|NCT01366872|808343|P1|COMPLETED|Overall Study||50
337483|NCT01366872|808343|P1|STARTED|Overall Study||50
337484|NCT01366846|808353|P4|NOT COMPLETED|Overall Study||1
337485|NCT01366846|808354|P3|NOT COMPLETED|Overall Study||1
337486|NCT01366846|808355|P2|NOT COMPLETED|Overall Study||4
337487|NCT01366846|808356|P1|NOT COMPLETED|Overall Study||3
337488|NCT01366846|808353|P4|COMPLETED|Overall Study||45
337489|NCT01366846|808354|P3|COMPLETED|Overall Study||46
337490|NCT01366846|808355|P2|COMPLETED|Overall Study||224
337491|NCT01366846|808356|P1|COMPLETED|Overall Study||232
337492|NCT01366846|808353|P4|STARTED|Overall Study||46
337493|NCT01366846|808354|P3|STARTED|Overall Study||47
337494|NCT01366846|808355|P2|STARTED|Overall Study||228
337495|NCT01366846|808356|P1|STARTED|Overall Study||235
337496|NCT01366638|808379|P3|NOT COMPLETED|Overall Study||6
337497|NCT01366638|808380|P2|NOT COMPLETED|Overall Study||0
337498|NCT01366638|808381|P1|NOT COMPLETED|Overall Study||1
337499|NCT01366638|808379|P3|COMPLETED|Overall Study||20
337500|NCT01366638|808380|P2|COMPLETED|Overall Study||29
337501|NCT01366638|808381|P1|COMPLETED|Overall Study||23
337502|NCT01366638|808379|P3|STARTED|Overall Study||26
337503|NCT01366638|808380|P2|STARTED|Overall Study||29
337504|NCT01366638|808381|P1|STARTED|Overall Study||24
337505|NCT01366534|808418|P3|NOT COMPLETED|Overall Study||0
337506|NCT01366534|808419|P2|NOT COMPLETED|Overall Study||2
337507|NCT01366534|808420|P1|NOT COMPLETED|Overall Study||2
337508|NCT01366534|808418|P3|COMPLETED|Overall Study||12
337509|NCT01366534|808419|P2|COMPLETED|Overall Study||25
337510|NCT01366534|808420|P1|COMPLETED|Overall Study||26
337511|NCT01366534|808418|P3|STARTED|Overall Study||12
337512|NCT01366534|808419|P2|STARTED|Overall Study||27
337513|NCT01366534|808420|P1|STARTED|Overall Study||28
337514|NCT01366521|808470|P4|NOT COMPLETED|Overall Study||0
337515|NCT01366521|808471|P3|NOT COMPLETED|Overall Study||2
337516|NCT01366521|808472|P2|NOT COMPLETED|Overall Study||1
337517|NCT01366521|808473|P1|NOT COMPLETED|Overall Study||1
337518|NCT01366521|808470|P4|COMPLETED|Overall Study||11
337519|NCT01366521|808471|P3|COMPLETED|Overall Study||21
337520|NCT01366521|808472|P2|COMPLETED|Overall Study||14
337521|NCT01366521|808473|P1|COMPLETED|Overall Study||20
337522|NCT01366521|808470|P4|STARTED|Overall Study||11
337523|NCT01366521|808471|P3|STARTED|Overall Study||23
337524|NCT01366521|808472|P2|STARTED|Overall Study||15
337525|NCT01366521|808473|P1|STARTED|Overall Study||21
337526|NCT01366443|808548|P1|NOT COMPLETED|Overall Study||3
337527|NCT01366443|808548|P1|COMPLETED|Overall Study||285
337528|NCT01366443|808548|P1|STARTED|Overall Study||288
337529|NCT01366417|808553|P1|NOT COMPLETED|Overall Study||18
337530|NCT01366417|808553|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
337531|NCT01366417|808553|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
337532|NCT01366417|808553|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
337533|NCT01366417|808553|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
337534|NCT01366417|808553|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
337535|NCT01366417|808553|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
337536|NCT01366417|808553|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
337537|NCT01366417|808553|P1|STARTED|Overall Study||43
337538|NCT01366209|808562|P2|NOT COMPLETED|Overall Study||36
337539|NCT01366209|808563|P1|NOT COMPLETED|Overall Study||35
337540|NCT01366209|808562|P2|COMPLETED|Overall Study||241
337541|NCT01366209|808563|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
337542|NCT01366209|808562|P2|STARTED|Overall Study||277
337543|NCT01366209|808563|P1|STARTED|Overall Study||278
337544|NCT01366092|808569|P1|NOT COMPLETED|Overall Study||4
337545|NCT01366092|808569|P1|COMPLETED|Overall Study||31
337546|NCT01366092|808569|P1|STARTED|Overall Study||35
337547|NCT01365910|808578|P1|NOT COMPLETED|Overall Study||30
337548|NCT01365910|808578|P1|COMPLETED|Overall Study||0
337549|NCT01365910|808578|P1|STARTED|Overall Study||30
337550|NCT01365845|808585|P3|NOT COMPLETED|Treatment Phase||0
337551|NCT01365845|808586|P2|NOT COMPLETED|Treatment Phase||0
337552|NCT01365845|808587|P1|NOT COMPLETED|Treatment Phase||0
337553|NCT01365845|808585|P3|COMPLETED|Treatment Phase||18
337554|NCT01365845|808586|P2|COMPLETED|Treatment Phase||0
337555|NCT01365845|808587|P1|COMPLETED|Treatment Phase||0
337556|NCT01365845|808585|P3|STARTED|Treatment Phase||18
337557|NCT01365845|808586|P2|STARTED|Treatment Phase||0
337558|NCT01365845|808587|P1|STARTED|Treatment Phase||0
337559|NCT01365845|808585|P3|NOT COMPLETED|Induction Phase||0
337560|NCT01365845|808586|P2|NOT COMPLETED|Induction Phase||0
337561|NCT01365845|808587|P1|NOT COMPLETED|Induction Phase||0
337562|NCT01365845|808585|P3|COMPLETED|Induction Phase||0
337563|NCT01365845|808586|P2|COMPLETED|Induction Phase||0
337564|NCT01365845|808587|P1|COMPLETED|Induction Phase||18
337565|NCT01365845|808585|P3|STARTED|Induction Phase||0
337567|NCT01365845|808587|P1|STARTED|Induction Phase||18
337568|NCT01365819|808594|P2|NOT COMPLETED|Overall Study||13
337569|NCT01365819|808595|P1|NOT COMPLETED|Overall Study||13
337570|NCT01365819|808594|P2|COMPLETED|Overall Study||14
337571|NCT01365819|808595|P1|COMPLETED|Overall Study||12
337572|NCT01365819|808594|P2|STARTED|Overall Study||27
337573|NCT01365819|808595|P1|STARTED|Overall Study||25
337574|NCT01365650|808601|P1|NOT COMPLETED|Treatment C||0
337575|NCT01365650|808601|P1|COMPLETED|Treatment C||24
337576|NCT01365650|808601|P1|STARTED|Treatment C||24
337577|NCT01365650|808601|P1|NOT COMPLETED|Treatment B||0
337578|NCT01365650|808601|P1|COMPLETED|Treatment B||24
337579|NCT01365650|808601|P1|STARTED|Treatment B||24
337580|NCT01365650|808601|P1|NOT COMPLETED|Treatment A||0
337581|NCT01365650|808601|P1|COMPLETED|Treatment A||24
337582|NCT01365650|808601|P1|STARTED|Treatment A||24
337583|NCT01365624|808626|P2|NOT COMPLETED|Overall Study||0
337584|NCT01365624|808627|P1|NOT COMPLETED|Overall Study||0
337585|NCT01365624|808626|P2|COMPLETED|Overall Study||15
337586|NCT01365624|808627|P1|COMPLETED|Overall Study||15
337587|NCT01365624|808626|P2|STARTED|Overall Study||15
337588|NCT01365624|808627|P1|STARTED|Overall Study||15
337589|NCT01365611|808643|P1|NOT COMPLETED|Overall Study||0
337590|NCT01365611|808643|P1|COMPLETED|Overall Study||36
337591|NCT01365611|808643|P1|STARTED|Overall Study||36
337592|NCT01365585|808659|P1|NOT COMPLETED|Overall Study||0
337593|NCT01365585|808659|P1|COMPLETED|Overall Study||227
337594|NCT01365585|808659|P1|STARTED|Overall Study||227
337595|NCT01365546|808673|P1|NOT COMPLETED|Overall Study||11
337596|NCT01365546|808673|P1|COMPLETED|Overall Study||30
337597|NCT01365546|808673|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
337598|NCT01365507|808683|P2|NOT COMPLETED|Overall Study||9
337599|NCT01365507|808684|P1|NOT COMPLETED|Overall Study||9
337600|NCT01365507|808683|P2|COMPLETED|Overall Study||131
337601|NCT01365507|808684|P1|COMPLETED|Overall Study||127
337602|NCT01365507|808683|P2|Exposed|Overall Study||140
337603|NCT01365507|808684|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
337604|NCT01365507|808683|P2|STARTED|Overall Study||140
337605|NCT01365507|808684|P1|STARTED|Overall Study||136
337606|NCT01365494|808700|P2|NOT COMPLETED|Overall Study||3
337607|NCT01365494|808701|P1|NOT COMPLETED|Overall Study||2
337608|NCT01365494|808700|P2|COMPLETED|Overall Study||121
337609|NCT01365494|808701|P1|COMPLETED|Overall Study||124
337610|NCT01365494|808700|P2|STARTED|Overall Study||124
337611|NCT01365494|808701|P1|STARTED|Overall Study||126
337612|NCT01365481|808717|P4|NOT COMPLETED|Overall Study||7
337613|NCT01365481|808718|P3|NOT COMPLETED|Overall Study||4
337614|NCT01365481|808719|P2|NOT COMPLETED|Overall Study||15
337615|NCT01365481|808720|P1|NOT COMPLETED|Overall Study||7
337616|NCT01365481|808717|P4|COMPLETED|Overall Study||50
337617|NCT01365481|808718|P3|COMPLETED|Overall Study||14
337618|NCT01365481|808719|P2|COMPLETED|Overall Study||37
337619|NCT01365481|808720|P1|COMPLETED|Overall Study||16
337620|NCT01365481|808717|P4|STARTED|Overall Study||57
337621|NCT01365481|808718|P3|STARTED|Overall Study||18
337622|NCT01365481|808719|P2|STARTED|Overall Study||52
337623|NCT01365481|808720|P1|STARTED|Overall Study||23
337624|NCT01365468|808740|P2|NOT COMPLETED|Overall Study||0
337625|NCT01365468|808741|P1|NOT COMPLETED|Overall Study||4
337626|NCT01365468|808740|P2|COMPLETED|Overall Study||5
337627|NCT01365468|808741|P1|COMPLETED|Overall Study||0
337628|NCT01365468|808740|P2|STARTED|Overall Study||5
337629|NCT01365468|808741|P1|STARTED|Overall Study||4
337630|NCT01365455|808756|P5|NOT COMPLETED|Follow-up Period||0
337631|NCT01365455|808757|P4|NOT COMPLETED|Follow-up Period||0
337632|NCT01365455|808758|P3|NOT COMPLETED|Follow-up Period||0
337633|NCT01365455|808759|P2|NOT COMPLETED|Follow-up Period||0
337634|NCT01365455|808760|P1|NOT COMPLETED|Follow-up Period||0
337635|NCT01365455|808756|P5|COMPLETED|Follow-up Period||0
337636|NCT01365455|808757|P4|COMPLETED|Follow-up Period||0
337637|NCT01365455|808758|P3|COMPLETED|Follow-up Period||18
337638|NCT01365455|808759|P2|COMPLETED|Follow-up Period||47
337639|NCT01365455|808760|P1|COMPLETED|Follow-up Period||58
337640|NCT01365455|808756|P5|STARTED|Follow-up Period||0
337641|NCT01365455|808757|P4|STARTED|Follow-up Period||0
337642|NCT01365455|808758|P3|STARTED|Follow-up Period||18
337643|NCT01365455|808759|P2|STARTED|Follow-up Period||47
337644|NCT01365455|808760|P1|STARTED|Follow-up Period||58
337645|NCT01365455|808756|P5|NOT COMPLETED|Maintenance Period||13
337646|NCT01365455|808757|P4|NOT COMPLETED|Maintenance Period||9
337647|NCT01365455|808758|P3|NOT COMPLETED|Maintenance Period||3
337648|NCT01365455|808759|P2|NOT COMPLETED|Maintenance Period||23
337649|NCT01365455|808760|P1|NOT COMPLETED|Maintenance Period||29
337650|NCT01365455|808756|P5|COMPLETED|Maintenance Period||92
337651|NCT01365455|808757|P4|COMPLETED|Maintenance Period||100
337652|NCT01365455|808758|P3|COMPLETED|Maintenance Period||15
337653|NCT01365455|808759|P2|COMPLETED|Maintenance Period||215
337654|NCT01365455|808760|P1|COMPLETED|Maintenance Period||201
337655|NCT01365455|808756|P5|STARTED|Maintenance Period||105
337656|NCT01365455|808757|P4|STARTED|Maintenance Period||109
337657|NCT01365455|808758|P3|STARTED|Maintenance Period||18
337658|NCT01365455|808759|P2|STARTED|Maintenance Period||238
337659|NCT01365455|808760|P1|STARTED|Maintenance Period||230
337660|NCT01365455|808756|P5|NOT COMPLETED|Induction Period||0
337661|NCT01365455|808757|P4|NOT COMPLETED|Induction Period||0
337662|NCT01365455|808758|P3|NOT COMPLETED|Induction Period||16
337663|NCT01365455|808759|P2|NOT COMPLETED|Induction Period||7
337664|NCT01365455|808760|P1|NOT COMPLETED|Induction Period||15
337665|NCT01365455|808756|P5|COMPLETED|Induction Period||0
337666|NCT01365455|808757|P4|COMPLETED|Induction Period||0
337667|NCT01365455|808758|P3|COMPLETED|Induction Period||232
337668|NCT01365455|808759|P2|COMPLETED|Induction Period||238
337669|NCT01365455|808760|P1|COMPLETED|Induction Period||230
337670|NCT01365455|808756|P5|STARTED|Induction Period||0
337671|NCT01365455|808757|P4|STARTED|Induction Period||0
337672|NCT01365455|808758|P3|STARTED|Induction Period||248
337673|NCT01365455|808759|P2|STARTED|Induction Period||245
337674|NCT01365455|808760|P1|STARTED|Induction Period||245
337675|NCT01365273|808850|P2|NOT COMPLETED|Overall Study||1
337676|NCT01365273|808851|P1|NOT COMPLETED|Overall Study||2
337677|NCT01365273|808850|P2|COMPLETED|Overall Study||20
337678|NCT01365273|808851|P1|COMPLETED|Overall Study||20
337679|NCT01365273|808850|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
337680|NCT01365273|808851|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
337681|NCT01365273|808850|P2|STARTED|Overall Study||21
337682|NCT01365273|808851|P1|STARTED|Overall Study||22
337683|NCT01365130|808861|P1|NOT COMPLETED|Overall Study||2
337684|NCT01365130|808861|P1|COMPLETED|Overall Study||13
337685|NCT01365130|808861|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
337686|NCT01365091|808869|P4|NOT COMPLETED|Period 2||0
337687|NCT01365091|808870|P3|NOT COMPLETED|Period 2||1
337688|NCT01365091|808871|P2|NOT COMPLETED|Period 2||0
337689|NCT01365091|808872|P1|NOT COMPLETED|Period 2||1
337690|NCT01365091|808869|P4|COMPLETED|Period 2||25
337691|NCT01365091|808870|P3|COMPLETED|Period 2||24
337692|NCT01365091|808871|P2|COMPLETED|Period 2||26
337693|NCT01365091|808872|P1|COMPLETED|Period 2||25
337694|NCT01365091|808869|P4|STARTED|Period 2||25
337695|NCT01365091|808870|P3|STARTED|Period 2||25
337696|NCT01365091|808871|P2|STARTED|Period 2||26
337697|NCT01365091|808872|P1|STARTED|Period 2||26
337698|NCT01365091|808869|P4|NOT COMPLETED|Period 1||3
337699|NCT01365091|808870|P3|NOT COMPLETED|Period 1||3
337700|NCT01365091|808871|P2|NOT COMPLETED|Period 1||2
337701|NCT01365091|808872|P1|NOT COMPLETED|Period 1||2
337702|NCT01365091|808869|P4|COMPLETED|Period 1||25
337703|NCT01365091|808870|P3|COMPLETED|Period 1||25
337704|NCT01365091|808871|P2|COMPLETED|Period 1||26
337705|NCT01365091|808872|P1|COMPLETED|Period 1||26
337706|NCT01365091|808869|P4|STARTED|Period 1||28
337707|NCT01365091|808870|P3|STARTED|Period 1||28
337708|NCT01365091|808871|P2|STARTED|Period 1||28
337709|NCT01365091|808872|P1|STARTED|Period 1||28
337710|NCT01365052|808900|P2|NOT COMPLETED|Overall Study||4
337711|NCT01365052|808901|P1|NOT COMPLETED|Overall Study||4
337712|NCT01365052|808900|P2|COMPLETED|Overall Study||105
337713|NCT01365052|808901|P1|COMPLETED|Overall Study||213
337714|NCT01365052|808900|P2|STARTED|Overall Study||109
337715|NCT01365052|808901|P1|STARTED|Overall Study||217
337716|NCT01365039|808917|P2|NOT COMPLETED|Overall Study||0
337717|NCT01365039|808918|P1|NOT COMPLETED|Overall Study||1
337718|NCT01365039|808917|P2|COMPLETED|Overall Study||87
337719|NCT01365039|808918|P1|COMPLETED|Overall Study||85
337720|NCT01365039|808917|P2|STARTED|Overall Study||87
337721|NCT01365039|808918|P1|STARTED|Overall Study||86
337722|NCT01364922|808929|P3|NOT COMPLETED|Double-Blind (DB) Period||5
337723|NCT01364922|808930|P2|NOT COMPLETED|Double-Blind (DB) Period||5
337724|NCT01364922|808931|P1|NOT COMPLETED|Double-Blind (DB) Period||0
337725|NCT01364922|808929|P3|COMPLETED|Double-Blind (DB) Period||42
337726|NCT01364922|808930|P2|COMPLETED|Double-Blind (DB) Period||94
337727|NCT01364922|808931|P1|COMPLETED|Double-Blind (DB) Period||0
337728|NCT01364922|808929|P3|STARTED|Double-Blind (DB) Period||47
337729|NCT01364922|808930|P2|STARTED|Double-Blind (DB) Period||99
337730|NCT01364922|808931|P1|STARTED|Double-Blind (DB) Period||0
337731|NCT01364922|808929|P3|NOT COMPLETED|Open-label (OL) Period||0
337732|NCT01364922|808930|P2|NOT COMPLETED|Open-label (OL) Period||0
337733|NCT01364922|808931|P1|NOT COMPLETED|Open-label (OL) Period||22
337734|NCT01364922|808929|P3|COMPLETED|Open-label (OL) Period||0
337735|NCT01364922|808930|P2|COMPLETED|Open-label (OL) Period||0
337736|NCT01364922|808931|P1|COMPLETED|Open-label (OL) Period||146
337737|NCT01364922|808929|P3|STARTED|Open-label (OL) Period||0
337738|NCT01364922|808930|P2|STARTED|Open-label (OL) Period||0
337739|NCT01364922|808931|P1|STARTED|Open-label (OL) Period||168
337740|NCT01364896|808942|P1|NOT COMPLETED|Overall Study||0
337741|NCT01364896|808942|P1|COMPLETED|Overall Study||46
337742|NCT01364896|808942|P1|STARTED|Overall Study||46
337743|NCT01364740|808950|P1|NOT COMPLETED|Overall Study||0
337744|NCT01364740|808950|P1|COMPLETED|Overall Study||10
337745|NCT01364740|808950|P1|STARTED|Overall Study||10
337746|NCT01364727|808958|P1|NOT COMPLETED|Overall Study||2
337747|NCT01364727|808958|P1|COMPLETED|Overall Study||33
337748|NCT01364727|808958|P1|STARTED|Overall Study||35
337749|NCT01364649|808966|P2|NOT COMPLETED|Overall Study||43
337750|NCT01364649|808967|P1|NOT COMPLETED|Overall Study||56
337751|NCT01364649|808966|P2|COMPLETED|Overall Study||179
337752|NCT01364649|808967|P1|COMPLETED|Overall Study||169
337753|NCT01364649|808966|P2|STARTED|Overall Study||222
337754|NCT01364649|808967|P1|STARTED|Overall Study||225
337755|NCT01364558|808977|P3|NOT COMPLETED|Dose Three||0
337756|NCT01364558|808978|P2|NOT COMPLETED|Dose Three||0
337757|NCT01364558|808979|P1|NOT COMPLETED|Dose Three||0
337758|NCT01364558|808977|P3|COMPLETED|Dose Three||8
337759|NCT01364558|808978|P2|COMPLETED|Dose Three||8
337760|NCT01364558|808979|P1|COMPLETED|Dose Three||8
337761|NCT01364558|808977|P3|STARTED|Dose Three||8
337762|NCT01364558|808978|P2|STARTED|Dose Three||8
337763|NCT01364558|808979|P1|STARTED|Dose Three||8
337764|NCT01364558|808977|P3|NOT COMPLETED|Dose Two||0
337765|NCT01364558|808978|P2|NOT COMPLETED|Dose Two||0
337766|NCT01364558|808979|P1|NOT COMPLETED|Dose Two||0
337767|NCT01364558|808977|P3|COMPLETED|Dose Two||8
337768|NCT01364558|808978|P2|COMPLETED|Dose Two||8
337769|NCT01364558|808979|P1|COMPLETED|Dose Two||8
337770|NCT01364558|808977|P3|STARTED|Dose Two||8
337771|NCT01364558|808978|P2|STARTED|Dose Two||8
337772|NCT01364558|808979|P1|STARTED|Dose Two||8
337773|NCT01364558|808977|P3|NOT COMPLETED|Dose One||0
337774|NCT01364558|808978|P2|NOT COMPLETED|Dose One||0
337775|NCT01364558|808979|P1|NOT COMPLETED|Dose One||0
337776|NCT01364558|808977|P3|COMPLETED|Dose One||8
337777|NCT01364558|808978|P2|COMPLETED|Dose One||8
337778|NCT01364558|808979|P1|COMPLETED|Dose One||8
337779|NCT01364558|808977|P3|STARTED|Dose One||8
337780|NCT01364558|808978|P2|STARTED|Dose One||8
337781|NCT01364558|808979|P1|STARTED|Dose One||8
337782|NCT01364428|808989|P2|NOT COMPLETED|Overall Study||15
337783|NCT01364428|808990|P1|NOT COMPLETED|Overall Study||20
337784|NCT01364428|808989|P2|COMPLETED|Overall Study||172
337785|NCT01364428|808990|P1|COMPLETED|Overall Study||166
337786|NCT01364428|808989|P2|Exposed|Overall Study||187
337787|NCT01364428|808990|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
337788|NCT01364428|808989|P2|STARTED|Overall Study||187
337789|NCT01364428|808990|P1|STARTED|Overall Study||186
337790|NCT01364389|809007|P3|NOT COMPLETED|Overall Study||1
337791|NCT01364389|809008|P2|NOT COMPLETED|Overall Study||1
337792|NCT01364389|809009|P1|NOT COMPLETED|Overall Study||2
337793|NCT01364389|809007|P3|COMPLETED|Overall Study||4
337794|NCT01364389|809008|P2|COMPLETED|Overall Study||5
337795|NCT01364389|809009|P1|COMPLETED|Overall Study||3
337958|NCT01363297|809268|P2|STARTED|Overall Study||12
337796|NCT01364389|809007|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
337797|NCT01364389|809008|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
337798|NCT01364389|809009|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
337799|NCT01364389|809007|P3|STARTED|Overall Study||5
337800|NCT01364389|809008|P2|STARTED|Overall Study||6
337801|NCT01364389|809009|P1|STARTED|Overall Study||5
337802|NCT01364298|809028|P2|NOT COMPLETED|Overall Study||23
337803|NCT01364298|809029|P1|NOT COMPLETED|Overall Study||14
337804|NCT01364298|809028|P2|COMPLETED|Overall Study||154
337805|NCT01364298|809029|P1|COMPLETED|Overall Study||162
337806|NCT01364298|809028|P2|Treated|Overall Study||174
337807|NCT01364298|809029|P1|Treated|Overall Study||174
337808|NCT01364298|809028|P2|STARTED|Overall Study||177
337809|NCT01364298|809029|P1|STARTED|Overall Study||176
337810|NCT01364259|809053|P2|NOT COMPLETED|Overall Study||0
337811|NCT01364259|809054|P1|NOT COMPLETED|Overall Study||0
337812|NCT01364259|809053|P2|COMPLETED|Overall Study||8
337813|NCT01364259|809054|P1|COMPLETED|Overall Study||9
337814|NCT01364259|809053|P2|STARTED|Overall Study||8
337815|NCT01364259|809054|P1|STARTED|Overall Study||9
337816|NCT01364207|809062|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
337817|NCT01364207|809063|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
337818|NCT01364207|809062|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
337819|NCT01364207|809063|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
337820|NCT01364207|809062|P2|STARTED|Second Visit (~1.5-2 Hours)||54
337821|NCT01364207|809063|P1|STARTED|Second Visit (~1.5-2 Hours)||52
337822|NCT01364207|809062|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
337823|NCT01364207|809063|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
337824|NCT01364207|809062|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
337825|NCT01364207|809063|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
337826|NCT01364207|809062|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
337827|NCT01364207|809063|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
337828|NCT01364207|809062|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
337829|NCT01364207|809063|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
337830|NCT01364207|809062|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
337831|NCT01364207|809063|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
337832|NCT01364207|809062|P2|STARTED|First Visit (~1.5-2 Hours)||58
337833|NCT01364207|809063|P1|STARTED|First Visit (~1.5-2 Hours)||54
337834|NCT01363986|809071|P1|NOT COMPLETED|Overall Study||1
337835|NCT01363986|809071|P1|COMPLETED|Overall Study||2
337836|NCT01363986|809071|P1|STARTED|Overall Study||3
337837|NCT01363908|809081|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
337838|NCT01363908|809082|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
337839|NCT01363908|809081|P2|COMPLETED|Chronic Dosing (CD) Phase||10
337840|NCT01363908|809082|P1|COMPLETED|Chronic Dosing (CD) Phase||3
337841|NCT01363908|809081|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
337842|NCT01363908|809082|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
337843|NCT01363908|809081|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
337844|NCT01363908|809082|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
337845|NCT01363908|809081|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
337846|NCT01363908|809082|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
337847|NCT01363908|809081|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
337848|NCT01363908|809082|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
337849|NCT01363908|809081|P2|NOT COMPLETED|Screening/Enrollment||0
337850|NCT01363908|809082|P1|NOT COMPLETED|Screening/Enrollment||1
337851|NCT01363908|809081|P2|COMPLETED|Screening/Enrollment||16
337852|NCT01363908|809082|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
337853|NCT01363908|809081|P2|STARTED|Screening/Enrollment||16
337854|NCT01363908|809082|P1|STARTED|Screening/Enrollment||14
337855|NCT01363843|809112|P1|NOT COMPLETED|Overall Study||1
337856|NCT01363843|809112|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
337857|NCT01363843|809112|P1|STARTED|Overall Study||39
337858|NCT01363765|809118|P2|NOT COMPLETED|Overall Study||4731
337859|NCT01363765|809119|P1|NOT COMPLETED|Overall Study||5800
337860|NCT01363765|809118|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
337861|NCT01363765|809119|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
337862|NCT01363765|809118|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
337863|NCT01363765|809119|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
337864|NCT01363713|809131|P1|NOT COMPLETED|Overall Study||6
337865|NCT01363713|809131|P1|COMPLETED|Overall Study|Analysed (n=130)|124
337866|NCT01363713|809131|P1|ALLOCATED|Overall Study||130
337867|NCT01363713|809131|P1|STARTED|Overall Study|Assessed for eligibility|130
337868|NCT01363700|809140|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
337869|NCT01363700|809141|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
337870|NCT01363700|809142|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
337871|NCT01363700|809143|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
337872|NCT01363700|809144|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
337873|NCT01363700|809140|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
337874|NCT01363700|809141|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
337875|NCT01363700|809142|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
337876|NCT01363700|809143|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
337877|NCT01363700|809144|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
337878|NCT01363700|809140|P5|STARTED|Epinastine vs Olopatadine Period2||43
337879|NCT01363700|809141|P4|STARTED|Epinastine vs Olopatadine Period2||43
337880|NCT01363700|809142|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
337881|NCT01363700|809143|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
337882|NCT01363700|809144|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
337883|NCT01363700|809140|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
337884|NCT01363700|809141|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
337885|NCT01363700|809142|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
337886|NCT01363700|809143|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
337887|NCT01363700|809144|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
337888|NCT01363700|809140|P5|COMPLETED|Epinastine vs Placebo Period1||0
337889|NCT01363700|809141|P4|COMPLETED|Epinastine vs Placebo Period1||0
337890|NCT01363700|809142|P3|COMPLETED|Epinastine vs Placebo Period1||22
337891|NCT01363700|809143|P2|COMPLETED|Epinastine vs Placebo Period1||21
337892|NCT01363700|809144|P1|COMPLETED|Epinastine vs Placebo Period1||43
337893|NCT01363700|809140|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
337894|NCT01363700|809141|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
337895|NCT01363700|809142|P3|STARTED|Epinastine vs Placebo Period1||22
337896|NCT01363700|809143|P2|STARTED|Epinastine vs Placebo Period1||22
337897|NCT01363700|809144|P1|STARTED|Epinastine vs Placebo Period1||43
337898|NCT01363661|809163|P2|NOT COMPLETED|Overall Study||4
337899|NCT01363661|809164|P1|NOT COMPLETED|Overall Study||14
337900|NCT01363661|809163|P2|COMPLETED|Overall Study||28
337901|NCT01363661|809164|P1|COMPLETED|Overall Study||18
337902|NCT01363661|809163|P2|STARTED|Overall Study||32
337903|NCT01363661|809164|P1|STARTED|Overall Study||32
337904|NCT01363492|809180|P1|NOT COMPLETED|Overall Study||0
337905|NCT01363492|809180|P1|COMPLETED|Overall Study||14
337906|NCT01363492|809180|P1|STARTED|Overall Study||14
337907|NCT01363479|809195|P2|NOT COMPLETED|Overall Study||21
337908|NCT01363479|809196|P1|NOT COMPLETED|Overall Study||12
337909|NCT01363479|809195|P2|COMPLETED|Overall Study||351
337910|NCT01363479|809196|P1|COMPLETED|Overall Study||359
337911|NCT01363479|809195|P2|STARTED|Overall Study|number of randomised patients|372
337912|NCT01363479|809196|P1|STARTED|Overall Study|number of randomised patients|371
337913|NCT01363440|809205|P3|NOT COMPLETED|Overall Study||27
337914|NCT01363440|809206|P2|NOT COMPLETED|Overall Study||31
337915|NCT01363440|809207|P1|NOT COMPLETED|Overall Study||23
337916|NCT01363440|809205|P3|COMPLETED|Overall Study|Completed Week 100|127
337917|NCT01363440|809206|P2|COMPLETED|Overall Study|Completed Week 100|125
337918|NCT01363440|809207|P1|COMPLETED|Overall Study|Completed Week 100|133
337919|NCT01363440|809205|P3|Completed Week 100|Overall Study||127
337920|NCT01363440|809206|P2|Completed Week 100|Overall Study||125
337921|NCT01363440|809207|P1|Completed Week 100|Overall Study||133
337922|NCT01363440|809205|P3|Completed Week 52|Overall Study||144
337923|NCT01363440|809206|P2|Completed Week 52|Overall Study||146
337924|NCT01363440|809207|P1|Completed Week 52|Overall Study||145
337925|NCT01363440|809205|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
337926|NCT01363440|809206|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
337927|NCT01363440|809207|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
337928|NCT01363440|809205|P3|STARTED|Overall Study|randomized|154
337929|NCT01363440|809206|P2|STARTED|Overall Study|randomized|156
337930|NCT01363440|809207|P1|STARTED|Overall Study|randomized|156
337931|NCT01363401|809238|P2|NOT COMPLETED|Overall Study||4
337932|NCT01363401|809239|P1|NOT COMPLETED|Overall Study||2
337933|NCT01363401|809238|P2|COMPLETED|Overall Study||27
337934|NCT01363401|809239|P1|COMPLETED|Overall Study||39
337935|NCT01363401|809238|P2|STARTED|Overall Study||31
337936|NCT01363401|809239|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
337937|NCT01363349|809253|P2|NOT COMPLETED|Overall Study||70
337938|NCT01363349|809254|P1|NOT COMPLETED|Overall Study||67
337939|NCT01363349|809253|P2|COMPLETED|Overall Study||66
337940|NCT01363349|809254|P1|COMPLETED|Overall Study||66
337941|NCT01363349|809253|P2|Randomized|Overall Study||136
337942|NCT01363349|809254|P1|Randomized|Overall Study||133
337943|NCT01363349|809253|P2|STARTED|Overall Study||136
337944|NCT01363349|809254|P1|STARTED|Overall Study||133
337945|NCT01363297|809265|P5|NOT COMPLETED|Overall Study||31
337946|NCT01363297|809266|P4|NOT COMPLETED|Overall Study||10
337947|NCT01363297|809267|P3|NOT COMPLETED|Overall Study||6
337948|NCT01363297|809268|P2|NOT COMPLETED|Overall Study||6
337949|NCT01363297|809269|P1|NOT COMPLETED|Overall Study||3
337950|NCT01363297|809265|P5|COMPLETED|Overall Study||4
337951|NCT01363297|809266|P4|COMPLETED|Overall Study||3
337952|NCT01363297|809267|P3|COMPLETED|Overall Study||3
337953|NCT01363297|809268|P2|COMPLETED|Overall Study||6
337954|NCT01363297|809269|P1|COMPLETED|Overall Study||0
337955|NCT01363297|809265|P5|STARTED|Overall Study||35
337956|NCT01363297|809266|P4|STARTED|Overall Study||13
337957|NCT01363297|809267|P3|STARTED|Overall Study||9
337959|NCT01363297|809269|P1|STARTED|Overall Study||3
337960|NCT01363076|809361|P2|NOT COMPLETED|Overall Study||1
337961|NCT01363076|809362|P1|NOT COMPLETED|Overall Study||0
337962|NCT01363076|809361|P2|COMPLETED|Overall Study||12
337963|NCT01363076|809362|P1|COMPLETED|Overall Study||7
337964|NCT01363076|809361|P2|STARTED|Overall Study||13
337965|NCT01363076|809362|P1|STARTED|Overall Study||7
337966|NCT01363050|809380|P1|NOT COMPLETED|Overall Study||0
337967|NCT01363050|809380|P1|COMPLETED|Overall Study||15
337968|NCT01363050|809380|P1|STARTED|Overall Study||15
337969|NCT01363011|809394|P2|NOT COMPLETED|Extension Phase||8
337970|NCT01363011|809395|P1|NOT COMPLETED|Extension Phase||5
337971|NCT01363011|809394|P2|COMPLETED|Extension Phase||41
337972|NCT01363011|809395|P1|COMPLETED|Extension Phase||13
337973|NCT01363011|809394|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
337974|NCT01363011|809395|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
337975|NCT01363011|809394|P2|NOT COMPLETED|Main Study||9
337976|NCT01363011|809395|P1|NOT COMPLETED|Main Study||4
337977|NCT01363011|809394|P2|COMPLETED|Main Study||64
337978|NCT01363011|809395|P1|COMPLETED|Main Study||29
337979|NCT01363011|809394|P2|STARTED|Main Study||73
337980|NCT01363011|809395|P1|STARTED|Main Study||33
337981|NCT01362946|809435|P2|NOT COMPLETED|Second Behavior Modification Block||0
337982|NCT01362946|809436|P1|NOT COMPLETED|Second Behavior Modification Block||0
337983|NCT01362946|809435|P2|COMPLETED|Second Behavior Modification Block||24
337984|NCT01362946|809436|P1|COMPLETED|Second Behavior Modification Block||23
337985|NCT01362946|809435|P2|STARTED|Second Behavior Modification Block||24
337986|NCT01362946|809436|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
337987|NCT01362946|809435|P2|NOT COMPLETED|First Behavior Modification Block||0
337988|NCT01362946|809436|P1|NOT COMPLETED|First Behavior Modification Block||0
337989|NCT01362946|809435|P2|COMPLETED|First Behavior Modification Block||24
337990|NCT01362946|809436|P1|COMPLETED|First Behavior Modification Block||24
337991|NCT01362946|809435|P2|STARTED|First Behavior Modification Block||24
337992|NCT01362946|809436|P1|STARTED|First Behavior Modification Block||24
337993|NCT01362907|809469|P2|NOT COMPLETED|Period 2, One Week||0
337994|NCT01362907|809470|P1|NOT COMPLETED|Period 2, One Week||0
337995|NCT01362907|809469|P2|COMPLETED|Period 2, One Week||20
337996|NCT01362907|809470|P1|COMPLETED|Period 2, One Week||20
337997|NCT01362907|809469|P2|STARTED|Period 2, One Week||20
337998|NCT01362907|809470|P1|STARTED|Period 2, One Week||20
337999|NCT01362907|809469|P2|NOT COMPLETED|Period 1, One Week||0
338000|NCT01362907|809470|P1|NOT COMPLETED|Period 1, One Week||0
338001|NCT01362907|809469|P2|COMPLETED|Period 1, One Week||20
338002|NCT01362907|809470|P1|COMPLETED|Period 1, One Week||20
338003|NCT01362907|809469|P2|STARTED|Period 1, One Week||20
338004|NCT01362907|809470|P1|STARTED|Period 1, One Week||20
338005|NCT01362894|809484|P2|NOT COMPLETED|Period Two, 1 Week||0
338006|NCT01362894|809485|P1|NOT COMPLETED|Period Two, 1 Week||0
338007|NCT01362894|809484|P2|COMPLETED|Period Two, 1 Week||115
338008|NCT01362894|809485|P1|COMPLETED|Period Two, 1 Week||118
338009|NCT01362894|809484|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
338010|NCT01362894|809485|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
338011|NCT01362894|809484|P2|NOT COMPLETED|Period One, 1 Week||0
338012|NCT01362894|809485|P1|NOT COMPLETED|Period One, 1 Week||0
338013|NCT01362894|809484|P2|COMPLETED|Period One, 1 Week||117
338014|NCT01362894|809485|P1|COMPLETED|Period One, 1 Week||119
338015|NCT01362894|809484|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
338016|NCT01362894|809485|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
338017|NCT01362686|809502|P3|NOT COMPLETED|Overall Study||10
338018|NCT01362686|809503|P2|NOT COMPLETED|Overall Study||12
338019|NCT01362686|809504|P1|NOT COMPLETED|Overall Study||8
338020|NCT01362686|809502|P3|COMPLETED|Overall Study||53
338021|NCT01362686|809503|P2|COMPLETED|Overall Study||54
338022|NCT01362686|809504|P1|COMPLETED|Overall Study||59
338023|NCT01362686|809502|P3|STARTED|Overall Study||63
338024|NCT01362686|809503|P2|STARTED|Overall Study||66
338025|NCT01362686|809504|P1|STARTED|Overall Study||67
338026|NCT01362608|809520|P2|NOT COMPLETED|Overall Study||8
338027|NCT01362608|809521|P1|NOT COMPLETED|Overall Study||4
338028|NCT01362608|809520|P2|COMPLETED|Overall Study||61
338029|NCT01362608|809521|P1|COMPLETED|Overall Study||63
338030|NCT01362608|809520|P2|STARTED|Overall Study||69
338031|NCT01362608|809521|P1|STARTED|Overall Study||67
338032|NCT01362530|809559|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
338033|NCT01362530|809560|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
338034|NCT01362530|809559|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
338035|NCT01362530|809560|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
338036|NCT01362530|809559|P2|STARTED|Optional Extension (Cycles 2-6)||0
338037|NCT01362530|809560|P1|STARTED|Optional Extension (Cycles 2-6)||171
338038|NCT01362530|809559|P2|NOT COMPLETED|Base Study (Cycle 1)||3
338039|NCT01362530|809560|P1|NOT COMPLETED|Base Study (Cycle 1)||5
338040|NCT01362530|809559|P2|COMPLETED|Base Study (Cycle 1)||149
338041|NCT01362530|809560|P1|COMPLETED|Base Study (Cycle 1)||150
338042|NCT01362530|809559|P2|Received Study Treatment|Base Study (Cycle 1)||150
338043|NCT01362530|809560|P1|Received Study Treatment|Base Study (Cycle 1)||152
338044|NCT01362530|809559|P2|STARTED|Base Study (Cycle 1)||152
338045|NCT01362530|809560|P1|STARTED|Base Study (Cycle 1)||155
338046|NCT01362517|809573|P1|NOT COMPLETED|Overall Study||2
338047|NCT01362517|809573|P1|COMPLETED|Overall Study||129
338048|NCT01362517|809573|P1|STARTED|Overall Study||131
338049|NCT01362491|809584|P3|NOT COMPLETED|Overall Study||0
338050|NCT01362491|809585|P2|NOT COMPLETED|Overall Study||0
338051|NCT01362491|809586|P1|NOT COMPLETED|Overall Study||1
338052|NCT01362491|809584|P3|COMPLETED|Overall Study||46
338053|NCT01362491|809585|P2|COMPLETED|Overall Study||89
338054|NCT01362491|809586|P1|COMPLETED|Overall Study||90
338055|NCT01362491|809584|P3|STARTED|Overall Study||46
338056|NCT01362491|809585|P2|STARTED|Overall Study||89
338057|NCT01362491|809586|P1|STARTED|Overall Study||91
338058|NCT01362439|809634|P1|NOT COMPLETED|Overall Study||15
338059|NCT01362439|809634|P1|COMPLETED|Overall Study||118
338060|NCT01362439|809634|P1|STARTED|Overall Study||133
338061|NCT01362296|809651|P4|NOT COMPLETED|Crossover Phase||2
338062|NCT01362296|809652|P3|NOT COMPLETED|Crossover Phase||23
338063|NCT01362296|809653|P2|NOT COMPLETED|Crossover Phase||0
338064|NCT01362296|809654|P1|NOT COMPLETED|Crossover Phase||0
338065|NCT01362296|809651|P4|COMPLETED|Crossover Phase||0
338066|NCT01362296|809652|P3|COMPLETED|Crossover Phase||0
338067|NCT01362296|809653|P2|COMPLETED|Crossover Phase||0
338068|NCT01362296|809654|P1|COMPLETED|Crossover Phase||0
338069|NCT01362296|809651|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
338070|NCT01362296|809652|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
338071|NCT01362296|809653|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
338072|NCT01362296|809654|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
338073|NCT01362296|809651|P4|NOT COMPLETED|Randomized Phase (RP)||0
338074|NCT01362296|809652|P3|NOT COMPLETED|Randomized Phase (RP)||0
338075|NCT01362296|809653|P2|NOT COMPLETED|Randomized Phase (RP)||43
338076|NCT01362296|809654|P1|NOT COMPLETED|Randomized Phase (RP)||87
338077|NCT01362296|809651|P4|COMPLETED|Randomized Phase (RP)||0
338078|NCT01362296|809652|P3|COMPLETED|Randomized Phase (RP)||0
338079|NCT01362296|809653|P2|COMPLETED|Randomized Phase (RP)||0
338080|NCT01362296|809654|P1|COMPLETED|Randomized Phase (RP)||0
338081|NCT01362296|809651|P4|STARTED|Randomized Phase (RP)||0
338082|NCT01362296|809652|P3|STARTED|Randomized Phase (RP)||0
338083|NCT01362296|809653|P2|STARTED|Randomized Phase (RP)||43
338084|NCT01362296|809654|P1|STARTED|Randomized Phase (RP)||87
338085|NCT01362244|809702|P2|NOT COMPLETED|Overall Study||32
338086|NCT01362244|809703|P1|NOT COMPLETED|Overall Study||32
338087|NCT01362244|809702|P2|COMPLETED|Overall Study||19
338088|NCT01362244|809703|P1|COMPLETED|Overall Study||22
338089|NCT01362244|809702|P2|STARTED|Overall Study||51
338090|NCT01362244|809703|P1|STARTED|Overall Study||54
338091|NCT01362192|809774|P1|NOT COMPLETED|Overall Study||4
338092|NCT01362192|809774|P1|COMPLETED|Overall Study||16
338093|NCT01362192|809774|P1|STARTED|Overall Study||20
338094|NCT01362140|809786|P2|NOT COMPLETED|Overall Study||11
338095|NCT01362140|809787|P1|NOT COMPLETED|Overall Study||10
338096|NCT01362140|809786|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
338097|NCT01362140|809787|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
338098|NCT01362140|809786|P2|Received Treatment|Overall Study||97
338099|NCT01362140|809787|P1|Received Treatment|Overall Study||49
338100|NCT01362140|809786|P2|STARTED|Overall Study||98
338101|NCT01362140|809787|P1|STARTED|Overall Study||49
338102|NCT01362062|809811|P2|NOT COMPLETED|Overall Study||0
338103|NCT01362062|809812|P1|NOT COMPLETED|Overall Study||26
338104|NCT01362062|809811|P2|COMPLETED|Overall Study||62
338105|NCT01362062|809812|P1|COMPLETED|Overall Study||22
338106|NCT01362062|809811|P2|STARTED|Overall Study||62
338107|NCT01362062|809812|P1|STARTED|Overall Study||48
338108|NCT01362049|809833|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
338109|NCT01362049|809834|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
338110|NCT01362049|809835|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
338111|NCT01362049|809836|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
338112|NCT01362049|809833|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
338113|NCT01362049|809834|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
338114|NCT01362049|809835|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
338115|NCT01362049|809836|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
338116|NCT01362049|809833|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
338117|NCT01362049|809834|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
338118|NCT01362049|809835|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
338119|NCT01362049|809836|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
338120|NCT01362049|809833|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
338121|NCT01362049|809834|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
338122|NCT01362049|809835|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
338123|NCT01362049|809836|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
338124|NCT01362049|809833|P4|COMPLETED|Follow-Up at 7 Weeks||24
338125|NCT01362049|809834|P3|COMPLETED|Follow-Up at 7 Weeks||30
338126|NCT01362049|809835|P2|COMPLETED|Follow-Up at 7 Weeks||16
338127|NCT01362049|809836|P1|COMPLETED|Follow-Up at 7 Weeks||23
338128|NCT01362049|809833|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
338129|NCT01362049|809834|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
338130|NCT01362049|809835|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
338131|NCT01362049|809836|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
338132|NCT01362049|809833|P4|STARTED|Follow-Up at 7 Weeks||25
338133|NCT01362049|809834|P3|STARTED|Follow-Up at 7 Weeks||32
338134|NCT01362049|809835|P2|STARTED|Follow-Up at 7 Weeks||19
338135|NCT01362049|809836|P1|STARTED|Follow-Up at 7 Weeks||26
338136|NCT01361867|809874|P1|NOT COMPLETED|Overall Study||0
338137|NCT01361867|809874|P1|COMPLETED|Overall Study||15
338138|NCT01361867|809874|P1|STARTED|Overall Study||15
338139|NCT01361854|809879|P2|NOT COMPLETED|Second Intervention||0
338140|NCT01361854|809880|P1|NOT COMPLETED|Second Intervention||0
338141|NCT01361854|809879|P2|COMPLETED|Second Intervention||48
338142|NCT01361854|809880|P1|COMPLETED|Second Intervention||47
338143|NCT01361854|809879|P2|STARTED|Second Intervention||48
338144|NCT01361854|809880|P1|STARTED|Second Intervention||47
338145|NCT01361854|809879|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
338146|NCT01361854|809880|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
338147|NCT01361854|809879|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
338148|NCT01361854|809880|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
338149|NCT01361854|809879|P2|STARTED|Wash-out, Maximum 2 Weeks||48
338150|NCT01361854|809880|P1|STARTED|Wash-out, Maximum 2 Weeks||47
338151|NCT01361854|809879|P2|NOT COMPLETED|Day 1||3
338152|NCT01361854|809880|P1|NOT COMPLETED|Day 1||4
338153|NCT01361854|809879|P2|COMPLETED|Day 1||48
338154|NCT01361854|809880|P1|COMPLETED|Day 1||47
338155|NCT01361854|809879|P2|STARTED|Day 1||51
338156|NCT01361854|809880|P1|STARTED|Day 1||51
338157|NCT01360645|809888|P4|NOT COMPLETED|Phase A+||24
338158|NCT01360645|809889|P3|NOT COMPLETED|Phase A+||0
338159|NCT01360645|809890|P2|NOT COMPLETED|Phase A+||0
338160|NCT01360645|809891|P1|NOT COMPLETED|Phase A+||0
338161|NCT01360645|809888|P4|COMPLETED|Phase A+||307
338162|NCT01360645|809889|P3|COMPLETED|Phase A+||0
338163|NCT01360645|809890|P2|COMPLETED|Phase A+||0
338164|NCT01360645|809891|P1|COMPLETED|Phase A+||0
338165|NCT01360645|809888|P4|STARTED|Phase A+||331
338166|NCT01360645|809889|P3|STARTED|Phase A+||0
338167|NCT01360645|809890|P2|STARTED|Phase A+||0
338168|NCT01360645|809891|P1|STARTED|Phase A+||0
338169|NCT01360645|809888|P4|NOT COMPLETED|Phase B (6 Weeks)||0
338170|NCT01360645|809889|P3|NOT COMPLETED|Phase B (6 Weeks)||13
338171|NCT01360645|809890|P2|NOT COMPLETED|Phase B (6 Weeks)||14
338172|NCT01360645|809891|P1|NOT COMPLETED|Phase B (6 Weeks)||0
338173|NCT01360645|809888|P4|COMPLETED|Phase B (6 Weeks)||0
338174|NCT01360645|809889|P3|COMPLETED|Phase B (6 Weeks)||178
338175|NCT01360645|809890|P2|COMPLETED|Phase B (6 Weeks)||174
338176|NCT01360645|809891|P1|COMPLETED|Phase B (6 Weeks)||0
338177|NCT01360645|809888|P4|STARTED|Phase B (6 Weeks)||0
338178|NCT01360645|809889|P3|STARTED|Phase B (6 Weeks)||191
338179|NCT01360645|809890|P2|STARTED|Phase B (6 Weeks)||188
338180|NCT01360645|809891|P1|STARTED|Phase B (6 Weeks)||0
338181|NCT01360645|809888|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338182|NCT01360645|809889|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338183|NCT01360645|809890|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338184|NCT01360645|809891|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
338185|NCT01360645|809888|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338186|NCT01360645|809889|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338187|NCT01360645|809890|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338188|NCT01360645|809891|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
338189|NCT01360645|809888|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338190|NCT01360645|809889|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338191|NCT01360645|809890|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
338192|NCT01360645|809891|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
338193|NCT01360632|809946|P5|NOT COMPLETED|Phase A+||25
338194|NCT01360632|809947|P4|NOT COMPLETED|Phase A+||0
338195|NCT01360632|809948|P3|NOT COMPLETED|Phase A+||0
338196|NCT01360632|809949|P2|NOT COMPLETED|Phase A+||0
338197|NCT01360632|809950|P1|NOT COMPLETED|Phase A+||0
338198|NCT01360632|809946|P5|COMPLETED|Phase A+||575
338199|NCT01360632|809947|P4|COMPLETED|Phase A+||0
338200|NCT01360632|809948|P3|COMPLETED|Phase A+||0
338201|NCT01360632|809949|P2|COMPLETED|Phase A+||0
338202|NCT01360632|809950|P1|COMPLETED|Phase A+||0
338203|NCT01360632|809946|P5|STARTED|Phase A+||600
338204|NCT01360632|809947|P4|STARTED|Phase A+||0
338205|NCT01360632|809948|P3|STARTED|Phase A+||0
338206|NCT01360632|809949|P2|STARTED|Phase A+||0
338207|NCT01360632|809950|P1|STARTED|Phase A+||0
338208|NCT01360632|809946|P5|NOT COMPLETED|Phase B (6 Weeks)||0
338209|NCT01360632|809947|P4|NOT COMPLETED|Phase B (6 Weeks)||13
338210|NCT01360632|809948|P3|NOT COMPLETED|Phase B (6 Weeks)||20
338211|NCT01360632|809949|P2|NOT COMPLETED|Phase B (6 Weeks)||10
338212|NCT01360632|809950|P1|NOT COMPLETED|Phase B (6 Weeks)||0
338213|NCT01360632|809946|P5|COMPLETED|Phase B (6 Weeks)||0
338214|NCT01360632|809947|P4|COMPLETED|Phase B (6 Weeks)||208
338215|NCT01360632|809948|P3|COMPLETED|Phase B (6 Weeks)||210
338216|NCT01360632|809949|P2|COMPLETED|Phase B (6 Weeks)||216
338217|NCT01360632|809950|P1|COMPLETED|Phase B (6 Weeks)||0
338218|NCT01360632|809946|P5|STARTED|Phase B (6 Weeks)||0
338219|NCT01360632|809947|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
338220|NCT01360632|809948|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
338221|NCT01360632|809949|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
338222|NCT01360632|809950|P1|STARTED|Phase B (6 Weeks)||0
338223|NCT01360632|809946|P5|NOT COMPLETED|Phase A (8 Weeks)||0
338224|NCT01360632|809947|P4|NOT COMPLETED|Phase A (8 Weeks)||0
338225|NCT01360632|809948|P3|NOT COMPLETED|Phase A (8 Weeks)||0
338226|NCT01360632|809949|P2|NOT COMPLETED|Phase A (8 Weeks)||0
338227|NCT01360632|809950|P1|NOT COMPLETED|Phase A (8 Weeks)||255
338228|NCT01360632|809946|P5|COMPLETED|Phase A (8 Weeks)||0
338229|NCT01360632|809947|P4|COMPLETED|Phase A (8 Weeks)||0
338230|NCT01360632|809948|P3|COMPLETED|Phase A (8 Weeks)||0
338231|NCT01360632|809949|P2|COMPLETED|Phase A (8 Weeks)||0
338232|NCT01360632|809950|P1|COMPLETED|Phase A (8 Weeks)||1277
338233|NCT01360632|809946|P5|STARTED|Phase A (8 Weeks)||0
338234|NCT01360632|809947|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
338235|NCT01360632|809948|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
338236|NCT01360632|809949|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
338237|NCT01360632|809950|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
338238|NCT01361633|810029|P2|NOT COMPLETED|Overall Study||3
338239|NCT01361633|810030|P1|NOT COMPLETED|Overall Study||6
338240|NCT01361633|810029|P2|COMPLETED|Overall Study||23
338241|NCT01361633|810030|P1|COMPLETED|Overall Study||19
338242|NCT01361633|810029|P2|STARTED|Overall Study||26
338243|NCT01361633|810030|P1|STARTED|Overall Study||25
338244|NCT01361620|810036|P1|NOT COMPLETED|Overall Study||0
338245|NCT01361620|810036|P1|COMPLETED|Overall Study||132
338246|NCT01361620|810036|P1|STARTED|Overall Study||132
338247|NCT01361594|810042|P2|NOT COMPLETED|Overall Study||2
338248|NCT01361594|810043|P1|NOT COMPLETED|Overall Study||1
338249|NCT01361594|810042|P2|COMPLETED|Overall Study||151
338250|NCT01361594|810043|P1|COMPLETED|Overall Study||151
338251|NCT01361594|810042|P2|STARTED|Overall Study||153
338252|NCT01361594|810043|P1|STARTED|Overall Study||152
338253|NCT01361568|810057|P6|NOT COMPLETED|Overall Study||2
338254|NCT01361568|810058|P5|NOT COMPLETED|Overall Study||1
338255|NCT01361568|810059|P4|NOT COMPLETED|Overall Study||0
338256|NCT01361568|810060|P3|NOT COMPLETED|Overall Study||0
338257|NCT01361568|810061|P2|NOT COMPLETED|Overall Study||1
338258|NCT01361568|810062|P1|NOT COMPLETED|Overall Study||2
338259|NCT01361568|810057|P6|COMPLETED|Overall Study||11
338260|NCT01361568|810058|P5|COMPLETED|Overall Study||6
338261|NCT01361568|810059|P4|COMPLETED|Overall Study||21
338262|NCT01361568|810060|P3|COMPLETED|Overall Study||20
338263|NCT01361568|810061|P2|COMPLETED|Overall Study||70
338264|NCT01361568|810062|P1|COMPLETED|Overall Study||69
338265|NCT01361568|810057|P6|STARTED|Overall Study||13
338266|NCT01361568|810058|P5|STARTED|Overall Study||7
338267|NCT01361568|810059|P4|STARTED|Overall Study||21
338268|NCT01361568|810060|P3|STARTED|Overall Study||20
338269|NCT01361568|810061|P2|STARTED|Overall Study||71
338270|NCT01361568|810062|P1|STARTED|Overall Study||71
338271|NCT01361464|810092|P1|NOT COMPLETED|Overall Study||3
338272|NCT01361464|810092|P1|COMPLETED|Overall Study||18
338273|NCT01361464|810092|P1|STARTED|Overall Study||21
338274|NCT01361308|810101|P2|NOT COMPLETED|Overall Study||30
338275|NCT01361308|810102|P1|NOT COMPLETED|Overall Study||35
338276|NCT01361308|810101|P2|COMPLETED|Overall Study||278
338277|NCT01361308|810102|P1|COMPLETED|Overall Study||271
338278|NCT01361308|810101|P2|STARTED|Overall Study||308
338279|NCT01361308|810102|P1|STARTED|Overall Study||306
338280|NCT01361178|810144|P2|NOT COMPLETED|Overall Study||0
338281|NCT01361178|810145|P1|NOT COMPLETED|Overall Study||13
338282|NCT01361178|810144|P2|COMPLETED|Overall Study||11
338283|NCT01361178|810145|P1|COMPLETED|Overall Study||109
338284|NCT01361178|810144|P2|STARTED|Overall Study||11
338285|NCT01361178|810145|P1|STARTED|Overall Study||122
338286|NCT01361126|810153|P2|NOT COMPLETED|Overall Study||2
338287|NCT01361126|810154|P1|NOT COMPLETED|Overall Study||0
338288|NCT01361126|810153|P2|COMPLETED|Overall Study||2
338289|NCT01361126|810154|P1|COMPLETED|Overall Study||13
338290|NCT01361126|810153|P2|STARTED|Overall Study||4
338291|NCT01361126|810154|P1|STARTED|Overall Study||13
338292|NCT01361113|810169|P1|NOT COMPLETED|Overall Study||0
338293|NCT01361113|810169|P1|COMPLETED|Overall Study||21
338294|NCT01361113|810169|P1|STARTED|Overall Study||21
338295|NCT01361048|810177|P3|NOT COMPLETED|Overall Study||1
338296|NCT01361048|810178|P2|NOT COMPLETED|Overall Study||0
338297|NCT01361048|810179|P1|NOT COMPLETED|Overall Study||0
338298|NCT01361048|810177|P3|COMPLETED|Overall Study||9
338299|NCT01361048|810178|P2|COMPLETED|Overall Study||10
338300|NCT01361048|810179|P1|COMPLETED|Overall Study||20
338301|NCT01361048|810177|P3|STARTED|Overall Study||10
338302|NCT01361048|810178|P2|STARTED|Overall Study||10
338303|NCT01361048|810179|P1|STARTED|Overall Study||20
338304|NCT01361009|810187|P1|NOT COMPLETED|Overall Study||116
338305|NCT01361009|810187|P1|COMPLETED|Overall Study||1901
338306|NCT01361009|810187|P1|STARTED|Overall Study||2017
338307|NCT01360996|810197|P3|NOT COMPLETED|Overall Study||2
338308|NCT01360996|810198|P2|NOT COMPLETED|Overall Study||3
338309|NCT01360996|810199|P1|NOT COMPLETED|Overall Study||6
338310|NCT01360996|810197|P3|COMPLETED|Overall Study||21
338311|NCT01360996|810198|P2|COMPLETED|Overall Study||18
338312|NCT01360996|810199|P1|COMPLETED|Overall Study||14
338313|NCT01360996|810197|P3|STARTED|Overall Study||23
338314|NCT01360996|810198|P2|STARTED|Overall Study||21
338315|NCT01360996|810199|P1|STARTED|Overall Study||20
338316|NCT01360840|810221|P3|NOT COMPLETED|Overall Study||9
338317|NCT01360840|810222|P2|NOT COMPLETED|Overall Study||10
338318|NCT01360840|810223|P1|NOT COMPLETED|Overall Study||10
338319|NCT01360840|810221|P3|COMPLETED|Overall Study||51
338320|NCT01360840|810222|P2|COMPLETED|Overall Study||50
338321|NCT01360840|810223|P1|COMPLETED|Overall Study||50
338322|NCT01360840|810221|P3|STARTED|Overall Study||60
338323|NCT01360840|810222|P2|STARTED|Overall Study||60
338324|NCT01360840|810223|P1|STARTED|Overall Study||60
338325|NCT01360554|810275|P2|NOT COMPLETED|Overall Study||439
338326|NCT01360554|810276|P1|NOT COMPLETED|Overall Study||439
338327|NCT01360554|810275|P2|COMPLETED|Overall Study||0
338328|NCT01360554|810276|P1|COMPLETED|Overall Study||0
338329|NCT01360554|810275|P2|Treated|Overall Study||436
338330|NCT01360554|810276|P1|Treated|Overall Study||436
338331|NCT01360554|810275|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
338332|NCT01360554|810276|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
338333|NCT01360021|810315|P3|NOT COMPLETED|Overall Study||7
338334|NCT01360021|810316|P2|NOT COMPLETED|Overall Study||4
338335|NCT01360021|810317|P1|NOT COMPLETED|Overall Study||8
338336|NCT01360021|810315|P3|COMPLETED|Overall Study|Patients who completed study|65
338337|NCT01360021|810316|P2|COMPLETED|Overall Study|Patients who completed study|67
338338|NCT01360021|810317|P1|COMPLETED|Overall Study|Patients who completed study|63
338339|NCT01360021|810315|P3|STARTED|Overall Study|Patients randomized|72
338340|NCT01360021|810316|P2|STARTED|Overall Study|Patients randomized|71
338341|NCT01360021|810317|P1|STARTED|Overall Study|Patients randomized|71
338342|NCT01359943|810343|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
338343|NCT01359943|810344|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
338344|NCT01359943|810345|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
338345|NCT01359943|810343|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
338346|NCT01359943|810344|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
338347|NCT01359943|810345|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
338348|NCT01359943|810343|P3|STARTED|Follow-up (Weeks 52 - 60)||44
338349|NCT01359943|810344|P2|STARTED|Follow-up (Weeks 52 - 60)||84
338350|NCT01359943|810345|P1|STARTED|Follow-up (Weeks 52 - 60)||86
338351|NCT01359943|810343|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
338352|NCT01359943|810344|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
338353|NCT01359943|810345|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
338354|NCT01359943|810343|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
338355|NCT01359943|810344|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
338356|NCT01359943|810345|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
338357|NCT01359943|810343|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
338450|NCT01359449|810485|P1|COMPLETED|Overall Study||57
338358|NCT01359943|810344|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
338359|NCT01359943|810345|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
338360|NCT01359943|810343|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
338361|NCT01359943|810344|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
338362|NCT01359943|810345|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
338363|NCT01359943|810343|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
338364|NCT01359943|810344|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
338365|NCT01359943|810345|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
338366|NCT01359943|810343|P3|STARTED|Double-blind (Weeks 0 - 16)||44
338367|NCT01359943|810344|P2|STARTED|Double-blind (Weeks 0 - 16)||89
338368|NCT01359943|810345|P1|STARTED|Double-blind (Weeks 0 - 16)||88
338369|NCT01359904|810393|P2|NOT COMPLETED|Overall Study||0
338370|NCT01359904|810394|P1|NOT COMPLETED|Overall Study||1
338371|NCT01359904|810393|P2|COMPLETED|Overall Study||19
338372|NCT01359904|810394|P1|COMPLETED|Overall Study||14
338373|NCT01359904|810393|P2|STARTED|Overall Study||19
338374|NCT01359904|810394|P1|STARTED|Overall Study||15
338375|NCT01359748|810410|P4|NOT COMPLETED|Overall Study||0
338376|NCT01359748|810411|P3|NOT COMPLETED|Overall Study||0
338377|NCT01359748|810412|P2|NOT COMPLETED|Overall Study||0
338378|NCT01359748|810413|P1|NOT COMPLETED|Overall Study||0
338379|NCT01359748|810410|P4|COMPLETED|Overall Study||11
338380|NCT01359748|810411|P3|COMPLETED|Overall Study||10
338381|NCT01359748|810412|P2|COMPLETED|Overall Study||20
338382|NCT01359748|810413|P1|COMPLETED|Overall Study||48
338383|NCT01359748|810410|P4|STARTED|Overall Study||11
338384|NCT01359748|810411|P3|STARTED|Overall Study||10
338385|NCT01359748|810412|P2|STARTED|Overall Study||20
338386|NCT01359748|810413|P1|STARTED|Overall Study||48
338387|NCT01359644|810431|P10|NOT COMPLETED|Follow-up Period||0
338388|NCT01359644|810432|P9|NOT COMPLETED|Follow-up Period||0
338389|NCT01359644|810433|P8|NOT COMPLETED|Follow-up Period||2
338390|NCT01359644|810434|P7|NOT COMPLETED|Follow-up Period||1
338391|NCT01359644|810435|P6|NOT COMPLETED|Follow-up Period||1
338392|NCT01359644|810436|P5|NOT COMPLETED|Follow-up Period||0
338393|NCT01359644|810437|P4|NOT COMPLETED|Follow-up Period||0
338394|NCT01359644|810438|P3|NOT COMPLETED|Follow-up Period||0
338395|NCT01359644|810439|P2|NOT COMPLETED|Follow-up Period||0
338396|NCT01359644|810440|P1|NOT COMPLETED|Follow-up Period||0
338397|NCT01359644|810431|P10|COMPLETED|Follow-up Period||20
338398|NCT01359644|810432|P9|COMPLETED|Follow-up Period||21
338399|NCT01359644|810433|P8|COMPLETED|Follow-up Period||39
338400|NCT01359644|810434|P7|COMPLETED|Follow-up Period||40
338401|NCT01359644|810435|P6|COMPLETED|Follow-up Period||12
338402|NCT01359644|810436|P5|COMPLETED|Follow-up Period||15
338403|NCT01359644|810437|P4|COMPLETED|Follow-up Period||14
338404|NCT01359644|810438|P3|COMPLETED|Follow-up Period||14
338405|NCT01359644|810439|P2|COMPLETED|Follow-up Period||16
338406|NCT01359644|810440|P1|COMPLETED|Follow-up Period||15
338407|NCT01359644|810431|P10|STARTED|Follow-up Period||20
338408|NCT01359644|810432|P9|STARTED|Follow-up Period||21
338409|NCT01359644|810433|P8|STARTED|Follow-up Period||41
338410|NCT01359644|810434|P7|STARTED|Follow-up Period||41
338411|NCT01359644|810435|P6|STARTED|Follow-up Period||13
338412|NCT01359644|810436|P5|STARTED|Follow-up Period||15
338413|NCT01359644|810437|P4|STARTED|Follow-up Period||14
338414|NCT01359644|810438|P3|STARTED|Follow-up Period||14
338415|NCT01359644|810439|P2|STARTED|Follow-up Period||16
338416|NCT01359644|810440|P1|STARTED|Follow-up Period||15
338417|NCT01359644|810431|P10|NOT COMPLETED|Treatment Period||0
338418|NCT01359644|810432|P9|NOT COMPLETED|Treatment Period||0
338419|NCT01359644|810433|P8|NOT COMPLETED|Treatment Period||0
338420|NCT01359644|810434|P7|NOT COMPLETED|Treatment Period||0
338421|NCT01359644|810435|P6|NOT COMPLETED|Treatment Period||2
338422|NCT01359644|810436|P5|NOT COMPLETED|Treatment Period||0
338423|NCT01359644|810437|P4|NOT COMPLETED|Treatment Period||0
338424|NCT01359644|810438|P3|NOT COMPLETED|Treatment Period||1
338425|NCT01359644|810439|P2|NOT COMPLETED|Treatment Period||1
338426|NCT01359644|810440|P1|NOT COMPLETED|Treatment Period||0
338427|NCT01359644|810431|P10|COMPLETED|Treatment Period||20
338428|NCT01359644|810432|P9|COMPLETED|Treatment Period||21
338429|NCT01359644|810433|P8|COMPLETED|Treatment Period||41
338430|NCT01359644|810434|P7|COMPLETED|Treatment Period||41
338431|NCT01359644|810435|P6|COMPLETED|Treatment Period||12
338432|NCT01359644|810436|P5|COMPLETED|Treatment Period||15
338433|NCT01359644|810437|P4|COMPLETED|Treatment Period||14
338434|NCT01359644|810438|P3|COMPLETED|Treatment Period||13
338435|NCT01359644|810439|P2|COMPLETED|Treatment Period||15
338436|NCT01359644|810440|P1|COMPLETED|Treatment Period||15
338437|NCT01359644|810431|P10|STARTED|Treatment Period||20
338438|NCT01359644|810432|P9|STARTED|Treatment Period||21
338439|NCT01359644|810433|P8|STARTED|Treatment Period||41
338440|NCT01359644|810434|P7|STARTED|Treatment Period||41
338441|NCT01359644|810435|P6|STARTED|Treatment Period||14
338442|NCT01359644|810436|P5|STARTED|Treatment Period||15
338443|NCT01359644|810437|P4|STARTED|Treatment Period||14
338444|NCT01359644|810438|P3|STARTED|Treatment Period||14
338445|NCT01359644|810439|P2|STARTED|Treatment Period||16
338446|NCT01359644|810440|P1|STARTED|Treatment Period||15
338447|NCT01359449|810484|P2|NOT COMPLETED|Overall Study||4
338448|NCT01359449|810485|P1|NOT COMPLETED|Overall Study||4
338449|NCT01359449|810484|P2|COMPLETED|Overall Study||58
338451|NCT01359449|810484|P2|STARTED|Overall Study||62
338452|NCT01359449|810485|P1|STARTED|Overall Study||61
338453|NCT01359410|810509|P2|NOT COMPLETED|Overall Study||0
338454|NCT01359410|810510|P1|NOT COMPLETED|Overall Study||0
338455|NCT01359410|810509|P2|COMPLETED|Overall Study||46
338456|NCT01359410|810510|P1|COMPLETED|Overall Study||54
338457|NCT01359410|810509|P2|STARTED|Overall Study||46
338458|NCT01359410|810510|P1|STARTED|Overall Study||54
338459|NCT01359371|810524|P1|NOT COMPLETED|Overall Study||0
338460|NCT01359371|810524|P1|COMPLETED|Overall Study||41
338461|NCT01359371|810524|P1|STARTED|Overall Study||41
338462|NCT01359254|810531|P2|NOT COMPLETED|Overall Study||0
338463|NCT01359254|810532|P1|NOT COMPLETED|Overall Study||1
338464|NCT01359254|810531|P2|COMPLETED|Overall Study||0
338465|NCT01359254|810532|P1|COMPLETED|Overall Study||0
338466|NCT01359254|810531|P2|STARTED|Overall Study||0
338467|NCT01359254|810532|P1|STARTED|Overall Study||1
338468|NCT01359150|810542|P2|NOT COMPLETED|Overall Study||5
338469|NCT01359150|810543|P1|NOT COMPLETED|Overall Study||7
338470|NCT01359150|810542|P2|COMPLETED|Overall Study||106
338471|NCT01359150|810543|P1|COMPLETED|Overall Study||105
338472|NCT01359150|810542|P2|STARTED|Overall Study||111
338473|NCT01359150|810543|P1|STARTED|Overall Study||112
338474|NCT01359111|810565|P1|NOT COMPLETED|Overall Study||0
338475|NCT01359111|810565|P1|COMPLETED|Overall Study||20
338476|NCT01359111|810565|P1|STARTED|Overall Study||20
338477|NCT01358864|810580|P8|NOT COMPLETED|Overall Study||55
338478|NCT01358864|810581|P7|NOT COMPLETED|Overall Study||65
338479|NCT01358864|810582|P6|NOT COMPLETED|Overall Study||13
338480|NCT01358864|810583|P5|NOT COMPLETED|Overall Study||11
338481|NCT01358864|810584|P4|NOT COMPLETED|Overall Study||19
338482|NCT01358864|810585|P3|NOT COMPLETED|Overall Study||16
338483|NCT01358864|810586|P2|NOT COMPLETED|Overall Study||13
338484|NCT01358864|810587|P1|NOT COMPLETED|Overall Study||31
338485|NCT01358864|810580|P8|COMPLETED|Overall Study||85
338486|NCT01358864|810581|P7|COMPLETED|Overall Study||81
338487|NCT01358864|810582|P6|COMPLETED|Overall Study||42
338488|NCT01358864|810583|P5|COMPLETED|Overall Study||46
338489|NCT01358864|810584|P4|COMPLETED|Overall Study||10
338490|NCT01358864|810585|P3|COMPLETED|Overall Study||87
338491|NCT01358864|810586|P2|COMPLETED|Overall Study||86
338492|NCT01358864|810587|P1|COMPLETED|Overall Study||18
338493|NCT01358864|810580|P8|STARTED|Overall Study||140
338494|NCT01358864|810581|P7|STARTED|Overall Study||146
338495|NCT01358864|810582|P6|STARTED|Overall Study||55
338496|NCT01358864|810583|P5|STARTED|Overall Study||57
338497|NCT01358864|810584|P4|STARTED|Overall Study||29
338498|NCT01358864|810585|P3|STARTED|Overall Study||103
338499|NCT01358864|810586|P2|STARTED|Overall Study||99
338500|NCT01358864|810587|P1|STARTED|Overall Study||49
338501|NCT01358825|810678|P2|NOT COMPLETED|Overall Study||1
338502|NCT01358825|810679|P1|NOT COMPLETED|Overall Study||0
338503|NCT01358825|810678|P2|COMPLETED|Overall Study||45
338504|NCT01358825|810679|P1|COMPLETED|Overall Study||12
338505|NCT01358825|810678|P2|STARTED|Overall Study||46
338506|NCT01358825|810679|P1|STARTED|Overall Study||12
338507|NCT01358760|810703|P3|NOT COMPLETED|Overall Study||25
338508|NCT01358760|810704|P2|NOT COMPLETED|Overall Study||20
338509|NCT01358760|810705|P1|NOT COMPLETED|Overall Study||22
338510|NCT01358760|810703|P3|COMPLETED|Overall Study||125
338511|NCT01358760|810704|P2|COMPLETED|Overall Study||128
338512|NCT01358760|810705|P1|COMPLETED|Overall Study||130
338513|NCT01358760|810703|P3|ITT Population|Overall Study||134
338514|NCT01358760|810704|P2|ITT Population|Overall Study||134
338515|NCT01358760|810705|P1|ITT Population|Overall Study||139
338516|NCT01358760|810703|P3|Safety Population|Overall Study||148
338517|NCT01358760|810704|P2|Safety Population|Overall Study||143
338518|NCT01358760|810705|P1|Safety Population|Overall Study||150
338519|NCT01358760|810703|P3|STARTED|Overall Study||150
338520|NCT01358760|810704|P2|STARTED|Overall Study||148
338521|NCT01358760|810705|P1|STARTED|Overall Study||152
338522|NCT01358734|810740|P3|NOT COMPLETED|Overall Study||29
338523|NCT01358734|810741|P2|NOT COMPLETED|Overall Study||37
338524|NCT01358734|810742|P1|NOT COMPLETED|Overall Study||15
338525|NCT01358734|810740|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
338526|NCT01358734|810741|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
338527|NCT01358734|810742|P1|COMPLETED|Overall Study||0
338528|NCT01358734|810740|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
338529|NCT01358734|810741|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
338530|NCT01358734|810742|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
338531|NCT01358734|810740|P3|STARTED|Overall Study||34
338532|NCT01358734|810741|P2|STARTED|Overall Study||39
338533|NCT01358734|810742|P1|STARTED|Overall Study||15
338534|NCT01358708|810761|P2|NOT COMPLETED|Open-Label Treatment Phase||0
338535|NCT01358708|810762|P1|NOT COMPLETED|Open-Label Treatment Phase||0
338536|NCT01358708|810761|P2|COMPLETED|Open-Label Treatment Phase||12
338537|NCT01358708|810762|P1|COMPLETED|Open-Label Treatment Phase||5
338538|NCT01358708|810761|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
338613|NCT01358526|810842|P3|NOT COMPLETED|Open-label Titration Period||0
338539|NCT01358708|810762|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
338540|NCT01358708|810761|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
338541|NCT01358708|810762|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
338542|NCT01358708|810761|P2|COMPLETED|Double-Blind Treatment Phase||13
338543|NCT01358708|810762|P1|COMPLETED|Double-Blind Treatment Phase||10
338544|NCT01358708|810761|P2|Received Study Medication|Double-Blind Treatment Phase||13
338545|NCT01358708|810762|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
338546|NCT01358708|810761|P2|Randomized|Double-Blind Treatment Phase||13
338547|NCT01358708|810762|P1|Randomized|Double-Blind Treatment Phase||13
338548|NCT01358708|810761|P2|STARTED|Double-Blind Treatment Phase||13
338549|NCT01358708|810762|P1|STARTED|Double-Blind Treatment Phase||13
338550|NCT01358578|810785|P6|NOT COMPLETED|Follow-up Period||0
338551|NCT01358578|810786|P5|NOT COMPLETED|Follow-up Period||0
338552|NCT01358578|810787|P4|NOT COMPLETED|Follow-up Period||19
338553|NCT01358578|810788|P3|NOT COMPLETED|Follow-up Period||5
338554|NCT01358578|810789|P2|NOT COMPLETED|Follow-up Period||6
338555|NCT01358578|810790|P1|NOT COMPLETED|Follow-up Period||10
338556|NCT01358578|810785|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
338557|NCT01358578|810786|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
338558|NCT01358578|810787|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
338559|NCT01358578|810788|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
338560|NCT01358578|810789|P2|COMPLETED|Follow-up Period||119
338561|NCT01358578|810790|P1|COMPLETED|Follow-up Period||138
338562|NCT01358578|810785|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
338563|NCT01358578|810786|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
338564|NCT01358578|810787|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
338565|NCT01358578|810788|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
338566|NCT01358578|810789|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
338567|NCT01358578|810790|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
338568|NCT01358578|810785|P6|NOT COMPLETED|Maintenance Period||11
338569|NCT01358578|810786|P5|NOT COMPLETED|Maintenance Period||17
338570|NCT01358578|810787|P4|NOT COMPLETED|Maintenance Period||42
338571|NCT01358578|810788|P3|NOT COMPLETED|Maintenance Period||2
338572|NCT01358578|810789|P2|NOT COMPLETED|Maintenance Period||22
338573|NCT01358578|810790|P1|NOT COMPLETED|Maintenance Period||39
338574|NCT01358578|810785|P6|COMPLETED|Maintenance Period||131
338575|NCT01358578|810786|P5|COMPLETED|Maintenance Period||125
338576|NCT01358578|810787|P4|COMPLETED|Maintenance Period||263
338577|NCT01358578|810788|P3|COMPLETED|Maintenance Period||15
338578|NCT01358578|810789|P2|COMPLETED|Maintenance Period||290
338579|NCT01358578|810790|P1|COMPLETED|Maintenance Period||276
338580|NCT01358578|810785|P6|STARTED|Maintenance Period||142
338581|NCT01358578|810786|P5|STARTED|Maintenance Period||142
338582|NCT01358578|810787|P4|STARTED|Maintenance Period||305
338583|NCT01358578|810788|P3|STARTED|Maintenance Period||17
338584|NCT01358578|810789|P2|STARTED|Maintenance Period||312
338585|NCT01358578|810790|P1|STARTED|Maintenance Period||315
338586|NCT01358578|810785|P6|NOT COMPLETED|Induction Period||0
338587|NCT01358578|810786|P5|NOT COMPLETED|Induction Period||0
338588|NCT01358578|810787|P4|NOT COMPLETED|Induction Period||21
338589|NCT01358578|810788|P3|NOT COMPLETED|Induction Period||25
338590|NCT01358578|810789|P2|NOT COMPLETED|Induction Period||15
338591|NCT01358578|810790|P1|NOT COMPLETED|Induction Period||12
338592|NCT01358578|810785|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
338593|NCT01358578|810786|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
338594|NCT01358578|810787|P4|COMPLETED|Induction Period||305
338595|NCT01358578|810788|P3|COMPLETED|Induction Period||301
338596|NCT01358578|810789|P2|COMPLETED|Induction Period||312
338597|NCT01358578|810790|P1|COMPLETED|Induction Period||315
338598|NCT01358578|810785|P6|STARTED|Induction Period|These groups are populated after the induction period|0
338599|NCT01358578|810786|P5|STARTED|Induction Period|These groups are populated after the induction period|0
338600|NCT01358578|810787|P4|STARTED|Induction Period||326
338601|NCT01358578|810788|P3|STARTED|Induction Period||326
338602|NCT01358578|810789|P2|STARTED|Induction Period||327
338603|NCT01358578|810790|P1|STARTED|Induction Period||327
338604|NCT01358526|810842|P3|NOT COMPLETED|Double-blind Phase||121
338605|NCT01358526|810843|P2|NOT COMPLETED|Double-blind Phase||80
338606|NCT01358526|810844|P1|NOT COMPLETED|Double-blind Phase||0
338607|NCT01358526|810842|P3|COMPLETED|Double-blind Phase||181
338608|NCT01358526|810843|P2|COMPLETED|Double-blind Phase||218
338609|NCT01358526|810844|P1|COMPLETED|Double-blind Phase||0
338610|NCT01358526|810842|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
338611|NCT01358526|810843|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
338612|NCT01358526|810844|P1|STARTED|Double-blind Phase||0
338614|NCT01358526|810843|P2|NOT COMPLETED|Open-label Titration Period||0
338615|NCT01358526|810844|P1|NOT COMPLETED|Open-label Titration Period||494
338616|NCT01358526|810842|P3|COMPLETED|Open-label Titration Period||0
338617|NCT01358526|810843|P2|COMPLETED|Open-label Titration Period||0
338618|NCT01358526|810844|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
338619|NCT01358526|810842|P3|STARTED|Open-label Titration Period||0
338620|NCT01358526|810843|P2|STARTED|Open-label Titration Period||0
338621|NCT01358526|810844|P1|STARTED|Open-label Titration Period||1095
338622|NCT01358357|810861|P3|NOT COMPLETED|Double-Blind Phase||0
338623|NCT01358357|810862|P2|NOT COMPLETED|Double-Blind Phase||100
338624|NCT01358357|810863|P1|NOT COMPLETED|Double-Blind Phase||80
338625|NCT01358357|810861|P3|COMPLETED|Double-Blind Phase||0
338626|NCT01358357|810862|P2|COMPLETED|Double-Blind Phase||150
338627|NCT01358357|810863|P1|COMPLETED|Double-Blind Phase||166
338628|NCT01358357|810861|P3|STARTED|Double-Blind Phase||0
338629|NCT01358357|810862|P2|STARTED|Double-Blind Phase||250
338630|NCT01358357|810863|P1|STARTED|Double-Blind Phase||246
338631|NCT01358357|810861|P3|NOT COMPLETED|Open Label Phase||462
338632|NCT01358357|810862|P2|NOT COMPLETED|Open Label Phase||0
338633|NCT01358357|810863|P1|NOT COMPLETED|Open Label Phase||0
338634|NCT01358357|810861|P3|COMPLETED|Open Label Phase||503
338635|NCT01358357|810862|P2|COMPLETED|Open Label Phase||0
338636|NCT01358357|810863|P1|COMPLETED|Open Label Phase||0
338637|NCT01358357|810861|P3|STARTED|Open Label Phase||965
338638|NCT01358357|810862|P2|STARTED|Open Label Phase||0
338639|NCT01358357|810863|P1|STARTED|Open Label Phase||0
338640|NCT01358175|810899|P3|NOT COMPLETED|Overall Study||32
338641|NCT01358175|810900|P2|NOT COMPLETED|Overall Study||28
338642|NCT01358175|810901|P1|NOT COMPLETED|Overall Study||21
338643|NCT01358175|810899|P3|COMPLETED|Overall Study||90
338644|NCT01358175|810900|P2|COMPLETED|Overall Study||97
338645|NCT01358175|810901|P1|COMPLETED|Overall Study||103
338646|NCT01358175|810899|P3|STARTED|Overall Study||122
338647|NCT01358175|810900|P2|STARTED|Overall Study||125
338648|NCT01358175|810901|P1|STARTED|Overall Study||124
338649|NCT01357980|810938|P4|NOT COMPLETED|Overall Study||0
338650|NCT01357980|810939|P3|NOT COMPLETED|Overall Study||1
338651|NCT01357980|810940|P2|NOT COMPLETED|Overall Study||1
338652|NCT01357980|810941|P1|NOT COMPLETED|Overall Study||0
338653|NCT01357980|810938|P4|COMPLETED|Overall Study||7
338654|NCT01357980|810939|P3|COMPLETED|Overall Study||16
338655|NCT01357980|810940|P2|COMPLETED|Overall Study||6
338656|NCT01357980|810941|P1|COMPLETED|Overall Study||16
338657|NCT01357980|810938|P4|STARTED|Overall Study||7
338658|NCT01357980|810939|P3|STARTED|Overall Study||17
338659|NCT01357980|810940|P2|STARTED|Overall Study||7
338660|NCT01357980|810941|P1|STARTED|Overall Study||16
338661|NCT01357889|810985|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
338662|NCT01357889|810986|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
338663|NCT01357889|810985|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
338664|NCT01357889|810986|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
338665|NCT01357889|810985|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
338666|NCT01357889|810986|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
338667|NCT01357889|810985|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
338668|NCT01357889|810986|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
338669|NCT01357889|810985|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
338670|NCT01357889|810986|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
338671|NCT01357889|810985|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
338672|NCT01357889|810986|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
338673|NCT01357889|810985|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
338674|NCT01357889|810986|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
338675|NCT01357889|810985|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
338676|NCT01357889|810986|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
338677|NCT01357889|810985|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
338678|NCT01357889|810986|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
338679|NCT01357850|811030|P4|NOT COMPLETED|Overall Study||0
338680|NCT01357850|811031|P3|NOT COMPLETED|Overall Study||0
338681|NCT01357850|811032|P2|NOT COMPLETED|Overall Study||0
338682|NCT01357850|811033|P1|NOT COMPLETED|Overall Study||1
338683|NCT01357850|811030|P4|COMPLETED|Overall Study||27
338684|NCT01357850|811031|P3|COMPLETED|Overall Study||13
338685|NCT01357850|811032|P2|COMPLETED|Overall Study||12
338686|NCT01357850|811033|P1|COMPLETED|Overall Study||29
338687|NCT01357850|811030|P4|STARTED|Overall Study||27
338688|NCT01357850|811031|P3|STARTED|Overall Study||13
338689|NCT01357850|811032|P2|STARTED|Overall Study||12
338690|NCT01357850|811033|P1|STARTED|Overall Study||30
338691|NCT01357720|811107|P2|NOT COMPLETED|Overall Study||5
338692|NCT01357720|811108|P1|NOT COMPLETED|Overall Study||2
338693|NCT01357720|811107|P2|COMPLETED|Overall Study||195
338694|NCT01357720|811108|P1|COMPLETED|Overall Study||198
338695|NCT01357720|811107|P2|STARTED|Overall Study||200
338696|NCT01357720|811108|P1|STARTED|Overall Study||200
338697|NCT01357655|811124|P2|NOT COMPLETED|Overall Study||0
338698|NCT01357655|811125|P1|NOT COMPLETED|Overall Study||66
338699|NCT01357655|811124|P2|COMPLETED|Overall Study||0
338700|NCT01357655|811125|P1|COMPLETED|Overall Study||0
338701|NCT01357655|811124|P2|STARTED|Overall Study||0
338702|NCT01357655|811125|P1|STARTED|Overall Study||66
338703|NCT01357616|811142|P2|NOT COMPLETED|Overall Study||9
338704|NCT01357616|811143|P1|NOT COMPLETED|Overall Study||10
338705|NCT01357616|811142|P2|COMPLETED|Overall Study||153
338706|NCT01357616|811143|P1|COMPLETED|Overall Study||156
338707|NCT01357616|811142|P2|STARTED|Overall Study||162
338708|NCT01357616|811143|P1|STARTED|Overall Study||166
338709|NCT01357551|811157|P2|NOT COMPLETED|Overall Study||11
338710|NCT01357551|811158|P1|NOT COMPLETED|Overall Study||22
338711|NCT01357551|811157|P2|COMPLETED|Overall Study||101
338712|NCT01357551|811158|P1|COMPLETED|Overall Study||88
338713|NCT01357551|811157|P2|STARTED|Overall Study||112
338714|NCT01357551|811158|P1|STARTED|Overall Study||110
338715|NCT01357512|811172|P2|NOT COMPLETED|Overall Study||5
338716|NCT01357512|811173|P1|NOT COMPLETED|Overall Study||12
338717|NCT01357512|811172|P2|COMPLETED|Overall Study||60
338718|NCT01357512|811173|P1|COMPLETED|Overall Study||53
338719|NCT01357512|811172|P2|STARTED|Overall Study||65
338720|NCT01357512|811173|P1|STARTED|Overall Study||65
338721|NCT01357239|811185|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
338722|NCT01357239|811186|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
338723|NCT01357239|811187|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
338724|NCT01357239|811188|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
338725|NCT01357239|811185|P4|COMPLETED|Stratum II: Partially-Methylated||18
338726|NCT01357239|811186|P3|COMPLETED|Stratum II: Partially-Methylated||21
338727|NCT01357239|811187|P2|COMPLETED|Stratum II: Partially-Methylated||21
338728|NCT01357239|811188|P1|COMPLETED|Stratum II: Partially-Methylated||23
338729|NCT01357239|811185|P4|STARTED|Stratum II: Partially-Methylated||20
338730|NCT01357239|811186|P3|STARTED|Stratum II: Partially-Methylated||22
338731|NCT01357239|811187|P2|STARTED|Stratum II: Partially-Methylated||21
338732|NCT01357239|811188|P1|STARTED|Stratum II: Partially-Methylated||23
338733|NCT01357239|811185|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
338734|NCT01357239|811186|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
338735|NCT01357239|811187|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
338736|NCT01357239|811188|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
338737|NCT01357239|811185|P4|COMPLETED|Stratum I: Fully-Methylated||22
338738|NCT01357239|811186|P3|COMPLETED|Stratum I: Fully-Methylated||16
338739|NCT01357239|811187|P2|COMPLETED|Stratum I: Fully-Methylated||6
338740|NCT01357239|811188|P1|COMPLETED|Stratum I: Fully-Methylated||8
338741|NCT01357239|811185|P4|STARTED|Stratum I: Fully-Methylated||22
338742|NCT01357239|811186|P3|STARTED|Stratum I: Fully-Methylated||17
338743|NCT01357239|811187|P2|STARTED|Stratum I: Fully-Methylated||6
338744|NCT01357239|811188|P1|STARTED|Stratum I: Fully-Methylated||8
338745|NCT01357239|811185|P4|NOT COMPLETED|Stratum: All Patients||2
338746|NCT01357239|811186|P3|NOT COMPLETED|Stratum: All Patients||2
338747|NCT01357239|811187|P2|NOT COMPLETED|Stratum: All Patients||0
338748|NCT01357239|811188|P1|NOT COMPLETED|Stratum: All Patients||0
338749|NCT01357239|811185|P4|COMPLETED|Stratum: All Patients||40
338750|NCT01357239|811186|P3|COMPLETED|Stratum: All Patients||37
338751|NCT01357239|811187|P2|COMPLETED|Stratum: All Patients||27
338752|NCT01357239|811188|P1|COMPLETED|Stratum: All Patients||31
338753|NCT01357239|811185|P4|STARTED|Stratum: All Patients||42
338754|NCT01357239|811186|P3|STARTED|Stratum: All Patients||39
338755|NCT01357239|811187|P2|STARTED|Stratum: All Patients||27
338756|NCT01357239|811188|P1|STARTED|Stratum: All Patients||31
338757|NCT01357148|811243|P1|NOT COMPLETED|Overall Study||0
338758|NCT01357148|811243|P1|COMPLETED|Overall Study||143
338759|NCT01357148|811243|P1|STARTED|Overall Study||143
338760|NCT01357135|811253|P3|NOT COMPLETED|Overall Study||263
338761|NCT01357135|811254|P2|NOT COMPLETED|Overall Study||223
338762|NCT01357135|811255|P1|NOT COMPLETED|Overall Study||598
338763|NCT01357135|811253|P3|COMPLETED|Overall Study||583
338764|NCT01357135|811254|P2|COMPLETED|Overall Study||510
338765|NCT01357135|811255|P1|COMPLETED|Overall Study||1276
338766|NCT01357135|811253|P3|STARTED|Overall Study||846
338767|NCT01357135|811254|P2|STARTED|Overall Study||733
338768|NCT01357135|811255|P1|STARTED|Overall Study||1874
338769|NCT01356966|811266|P2|NOT COMPLETED|Overall Study||2
338770|NCT01356966|811267|P1|NOT COMPLETED|Overall Study||2
338771|NCT01356966|811266|P2|COMPLETED|Overall Study||12
338772|NCT01356966|811267|P1|COMPLETED|Overall Study||16
338773|NCT01356966|811266|P2|STARTED|Overall Study||14
338774|NCT01356966|811267|P1|STARTED|Overall Study||18
338775|NCT01356940|811279|P2|NOT COMPLETED|Second Intervention (28 Days)||0
338776|NCT01356940|811280|P1|NOT COMPLETED|Second Intervention (28 Days)||1
338777|NCT01356940|811279|P2|COMPLETED|Second Intervention (28 Days)||21
338778|NCT01356940|811280|P1|COMPLETED|Second Intervention (28 Days)||20
338779|NCT01356940|811279|P2|STARTED|Second Intervention (28 Days)||21
338780|NCT01356940|811280|P1|STARTED|Second Intervention (28 Days)||21
338781|NCT01356940|811279|P2|NOT COMPLETED|Washout (14 Days)||0
338782|NCT01356940|811280|P1|NOT COMPLETED|Washout (14 Days)||0
338783|NCT01356940|811279|P2|COMPLETED|Washout (14 Days)||21
338784|NCT01356940|811280|P1|COMPLETED|Washout (14 Days)||21
338785|NCT01356940|811279|P2|STARTED|Washout (14 Days)||21
338786|NCT01356940|811280|P1|STARTED|Washout (14 Days)||21
338787|NCT01356940|811279|P2|NOT COMPLETED|First Intervention (28 Days)||0
338788|NCT01356940|811280|P1|NOT COMPLETED|First Intervention (28 Days)||1
338789|NCT01356940|811279|P2|COMPLETED|First Intervention (28 Days)||21
338790|NCT01356940|811280|P1|COMPLETED|First Intervention (28 Days)||21
338791|NCT01356940|811279|P2|STARTED|First Intervention (28 Days)||21
338792|NCT01356940|811280|P1|STARTED|First Intervention (28 Days)||22
338793|NCT01356667|811288|P2|NOT COMPLETED|Overall Study||6
338794|NCT01356667|811289|P1|NOT COMPLETED|Overall Study||4
338795|NCT01356667|811288|P2|COMPLETED|Overall Study||0
338796|NCT01356667|811289|P1|COMPLETED|Overall Study||0
338797|NCT01356667|811288|P2|STARTED|Overall Study||6
338798|NCT01356667|811289|P1|STARTED|Overall Study||4
338799|NCT01356602|811302|P3|NOT COMPLETED|Overall Study||24
338800|NCT01356602|811303|P2|NOT COMPLETED|Overall Study||15
338801|NCT01356602|811304|P1|NOT COMPLETED|Overall Study||9
338802|NCT01356602|811302|P3|COMPLETED|Overall Study||108
338803|NCT01356602|811303|P2|COMPLETED|Overall Study||117
338804|NCT01356602|811304|P1|COMPLETED|Overall Study||124
338805|NCT01356602|811302|P3|Full Analysis Set|Overall Study||129
338806|NCT01356602|811303|P2|Full Analysis Set|Overall Study||129
338807|NCT01356602|811304|P1|Full Analysis Set|Overall Study||131
338808|NCT01356602|811302|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
338809|NCT01356602|811303|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
338810|NCT01356602|811304|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
338811|NCT01356602|811302|P3|STARTED|Overall Study||132
338812|NCT01356602|811303|P2|STARTED|Overall Study||132
338813|NCT01356602|811304|P1|STARTED|Overall Study||133
338814|NCT01356589|811363|P1|NOT COMPLETED|Overall Study||5
338815|NCT01356589|811363|P1|COMPLETED|Overall Study||1283
338816|NCT01356589|811363|P1|Treated|Overall Study||1285
338817|NCT01356589|811363|P1|STARTED|Overall Study||1288
338818|NCT01356498|811375|P6|NOT COMPLETED|Overall Study||14
338819|NCT01356498|811376|P5|NOT COMPLETED|Overall Study||20
338820|NCT01356498|811377|P4|NOT COMPLETED|Overall Study||14
338821|NCT01356498|811378|P3|NOT COMPLETED|Overall Study||12
338822|NCT01356498|811379|P2|NOT COMPLETED|Overall Study||8
338823|NCT01356498|811380|P1|NOT COMPLETED|Overall Study||11
338824|NCT01356498|811375|P6|COMPLETED|Overall Study||2
338825|NCT01356498|811376|P5|COMPLETED|Overall Study||8
338826|NCT01356498|811377|P4|COMPLETED|Overall Study||8
338827|NCT01356498|811378|P3|COMPLETED|Overall Study||11
338828|NCT01356498|811379|P2|COMPLETED|Overall Study||17
338829|NCT01356498|811380|P1|COMPLETED|Overall Study||24
338830|NCT01356498|811375|P6|STARTED|Overall Study||16
338831|NCT01356498|811376|P5|STARTED|Overall Study||28
338832|NCT01356498|811377|P4|STARTED|Overall Study||22
338833|NCT01356498|811378|P3|STARTED|Overall Study||23
338834|NCT01356498|811379|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
338835|NCT01356498|811380|P1|STARTED|Overall Study||35
338836|NCT01356407|811420|P2|NOT COMPLETED|Overall Study||4
338837|NCT01356407|811421|P1|NOT COMPLETED|Overall Study||6
338838|NCT01356407|811420|P2|COMPLETED|Overall Study||146
338839|NCT01356407|811421|P1|COMPLETED|Overall Study||144
338840|NCT01356407|811420|P2|STARTED|Overall Study||150
338841|NCT01356407|811421|P1|STARTED|Overall Study||150
338842|NCT01356147|811439|P2|NOT COMPLETED|Overall Study||0
338843|NCT01356147|811440|P1|NOT COMPLETED|Overall Study||0
338844|NCT01356147|811439|P2|COMPLETED|Overall Study||6
338845|NCT01356147|811440|P1|COMPLETED|Overall Study||5
338846|NCT01356147|811439|P2|STARTED|Overall Study||6
338847|NCT01356147|811440|P1|STARTED|Overall Study||5
338848|NCT01355978|811446|P1|NOT COMPLETED|Overall Study||4
338849|NCT01355978|811446|P1|COMPLETED|Overall Study||18
338850|NCT01355978|811446|P1|STARTED|Overall Study||22
338851|NCT01355705|811452|P1|NOT COMPLETED|Overall Study||0
338852|NCT01355705|811452|P1|COMPLETED|Overall Study||14
338853|NCT01355705|811452|P1|STARTED|Overall Study||14
338854|NCT01355679|811459|P1|NOT COMPLETED|Overall Study||2
338855|NCT01355679|811459|P1|COMPLETED|Overall Study||14
338856|NCT01355679|811459|P1|STARTED|Overall Study||16
338857|NCT01355627|811468|P2|NOT COMPLETED|Overall Study||38
338858|NCT01355627|811469|P1|NOT COMPLETED|Overall Study||33
338859|NCT01355627|811468|P2|COMPLETED|Overall Study||326
338860|NCT01355627|811469|P1|COMPLETED|Overall Study||329
338861|NCT01355627|811468|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
338862|NCT01355627|811469|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
338863|NCT01355627|811468|P2|Safety Analysis Set|Overall Study||364
338864|NCT01355627|811469|P1|Safety Analysis Set|Overall Study||362
338865|NCT01355627|811468|P2|STARTED|Overall Study||364
338866|NCT01355627|811469|P1|STARTED|Overall Study||362
338867|NCT01355588|811481|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
338868|NCT01355588|811482|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
338869|NCT01355588|811483|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
338870|NCT01355588|811484|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
338871|NCT01355588|811481|P4|COMPLETED|Fourth Intervention (After Washout)||4
338872|NCT01355588|811482|P3|COMPLETED|Fourth Intervention (After Washout)||4
338873|NCT01355588|811483|P2|COMPLETED|Fourth Intervention (After Washout)||4
338874|NCT01355588|811484|P1|COMPLETED|Fourth Intervention (After Washout)||4
338875|NCT01355588|811481|P4|STARTED|Fourth Intervention (After Washout)||4
338876|NCT01355588|811482|P3|STARTED|Fourth Intervention (After Washout)||4
338877|NCT01355588|811483|P2|STARTED|Fourth Intervention (After Washout)||4
338878|NCT01355588|811484|P1|STARTED|Fourth Intervention (After Washout)||4
338879|NCT01355588|811481|P4|NOT COMPLETED|Washout (3-7 Days)||0
338880|NCT01355588|811482|P3|NOT COMPLETED|Washout (3-7 Days)||0
338881|NCT01355588|811483|P2|NOT COMPLETED|Washout (3-7 Days)||0
338882|NCT01355588|811484|P1|NOT COMPLETED|Washout (3-7 Days)||0
338883|NCT01355588|811481|P4|COMPLETED|Washout (3-7 Days)||4
338884|NCT01355588|811482|P3|COMPLETED|Washout (3-7 Days)||4
338885|NCT01355588|811483|P2|COMPLETED|Washout (3-7 Days)||4
338886|NCT01355588|811484|P1|COMPLETED|Washout (3-7 Days)||4
338887|NCT01355588|811481|P4|STARTED|Washout (3-7 Days)||4
338888|NCT01355588|811482|P3|STARTED|Washout (3-7 Days)||4
338889|NCT01355588|811483|P2|STARTED|Washout (3-7 Days)||4
338890|NCT01355588|811484|P1|STARTED|Washout (3-7 Days)||4
338891|NCT01355588|811481|P4|NOT COMPLETED|Third Intervention (After Washout)||0
338892|NCT01355588|811482|P3|NOT COMPLETED|Third Intervention (After Washout)||0
338893|NCT01355588|811483|P2|NOT COMPLETED|Third Intervention (After Washout)||0
338894|NCT01355588|811484|P1|NOT COMPLETED|Third Intervention (After Washout)||0
338895|NCT01355588|811481|P4|COMPLETED|Third Intervention (After Washout)||4
338896|NCT01355588|811482|P3|COMPLETED|Third Intervention (After Washout)||4
338897|NCT01355588|811483|P2|COMPLETED|Third Intervention (After Washout)||4
338898|NCT01355588|811484|P1|COMPLETED|Third Intervention (After Washout)||4
338899|NCT01355588|811481|P4|STARTED|Third Intervention (After Washout)||4
338900|NCT01355588|811482|P3|STARTED|Third Intervention (After Washout)||4
338901|NCT01355588|811483|P2|STARTED|Third Intervention (After Washout)||4
338902|NCT01355588|811484|P1|STARTED|Third Intervention (After Washout)||4
338903|NCT01355588|811481|P4|NOT COMPLETED|Washout (3-7 Days)||0
338904|NCT01355588|811482|P3|NOT COMPLETED|Washout (3-7 Days)||0
338905|NCT01355588|811483|P2|NOT COMPLETED|Washout (3-7 Days)||0
338906|NCT01355588|811484|P1|NOT COMPLETED|Washout (3-7 Days)||0
338907|NCT01355588|811481|P4|COMPLETED|Washout (3-7 Days)||4
338908|NCT01355588|811482|P3|COMPLETED|Washout (3-7 Days)||4
338909|NCT01355588|811483|P2|COMPLETED|Washout (3-7 Days)||4
338910|NCT01355588|811484|P1|COMPLETED|Washout (3-7 Days)||4
338911|NCT01355588|811481|P4|STARTED|Washout (3-7 Days)||4
338912|NCT01355588|811482|P3|STARTED|Washout (3-7 Days)||4
338913|NCT01355588|811483|P2|STARTED|Washout (3-7 Days)||4
338914|NCT01355588|811484|P1|STARTED|Washout (3-7 Days)||4
338915|NCT01355588|811481|P4|NOT COMPLETED|Second Intervention (After Washout)||0
338916|NCT01355588|811482|P3|NOT COMPLETED|Second Intervention (After Washout)||0
338917|NCT01355588|811483|P2|NOT COMPLETED|Second Intervention (After Washout)||0
338918|NCT01355588|811484|P1|NOT COMPLETED|Second Intervention (After Washout)||0
338919|NCT01355588|811481|P4|COMPLETED|Second Intervention (After Washout)||4
338920|NCT01355588|811482|P3|COMPLETED|Second Intervention (After Washout)||4
338921|NCT01355588|811483|P2|COMPLETED|Second Intervention (After Washout)||4
338922|NCT01355588|811484|P1|COMPLETED|Second Intervention (After Washout)||4
338923|NCT01355588|811481|P4|STARTED|Second Intervention (After Washout)||4
338924|NCT01355588|811482|P3|STARTED|Second Intervention (After Washout)||4
338925|NCT01355588|811483|P2|STARTED|Second Intervention (After Washout)||4
338926|NCT01355588|811484|P1|STARTED|Second Intervention (After Washout)||4
338927|NCT01355588|811481|P4|NOT COMPLETED|Washout (3-7 Days)||0
338928|NCT01355588|811482|P3|NOT COMPLETED|Washout (3-7 Days)||0
338929|NCT01355588|811483|P2|NOT COMPLETED|Washout (3-7 Days)||0
338930|NCT01355588|811484|P1|NOT COMPLETED|Washout (3-7 Days)||0
338931|NCT01355588|811481|P4|COMPLETED|Washout (3-7 Days)||4
338932|NCT01355588|811482|P3|COMPLETED|Washout (3-7 Days)||4
338933|NCT01355588|811483|P2|COMPLETED|Washout (3-7 Days)||4
338934|NCT01355588|811484|P1|COMPLETED|Washout (3-7 Days)||4
338935|NCT01355588|811481|P4|STARTED|Washout (3-7 Days)||4
338936|NCT01355588|811482|P3|STARTED|Washout (3-7 Days)||4
338937|NCT01355588|811483|P2|STARTED|Washout (3-7 Days)||4
338938|NCT01355588|811484|P1|STARTED|Washout (3-7 Days)||4
338939|NCT01355588|811481|P4|NOT COMPLETED|First Intervention (Day 1)||0
338940|NCT01355588|811482|P3|NOT COMPLETED|First Intervention (Day 1)||0
338941|NCT01355588|811483|P2|NOT COMPLETED|First Intervention (Day 1)||0
338942|NCT01355588|811484|P1|NOT COMPLETED|First Intervention (Day 1)||0
338943|NCT01355588|811481|P4|COMPLETED|First Intervention (Day 1)||4
338944|NCT01355588|811482|P3|COMPLETED|First Intervention (Day 1)||4
338945|NCT01355588|811483|P2|COMPLETED|First Intervention (Day 1)||4
338946|NCT01355588|811484|P1|COMPLETED|First Intervention (Day 1)||4
338947|NCT01355588|811481|P4|STARTED|First Intervention (Day 1)||4
338948|NCT01355588|811482|P3|STARTED|First Intervention (Day 1)||4
338949|NCT01355588|811483|P2|STARTED|First Intervention (Day 1)||4
338950|NCT01355588|811484|P1|STARTED|First Intervention (Day 1)||4
338951|NCT01355523|811508|P2|NOT COMPLETED|Overall Study||10
338952|NCT01355523|811509|P1|NOT COMPLETED|Overall Study||1
338953|NCT01355523|811508|P2|COMPLETED|Overall Study||16
338954|NCT01355523|811509|P1|COMPLETED|Overall Study||27
338955|NCT01355523|811508|P2|STARTED|Overall Study||26
338956|NCT01355523|811509|P1|STARTED|Overall Study||28
338957|NCT01355484|811553|P2|NOT COMPLETED|Overall Study||54
338958|NCT01355484|811554|P1|NOT COMPLETED|Overall Study||51
338959|NCT01355484|811553|P2|COMPLETED|Overall Study||107
338960|NCT01355484|811554|P1|COMPLETED|Overall Study||109
338961|NCT01355484|811553|P2|STARTED|Overall Study||161
338962|NCT01355484|811554|P1|STARTED|Overall Study||160
338963|NCT01355471|811564|P2|NOT COMPLETED|Overall Study||3
338964|NCT01355471|811565|P1|NOT COMPLETED|Overall Study||7
338965|NCT01355471|811564|P2|COMPLETED|Overall Study||142
338966|NCT01355471|811565|P1|COMPLETED|Overall Study||141
338967|NCT01355471|811564|P2|STARTED|Overall Study||145
338968|NCT01355471|811565|P1|STARTED|Overall Study||148
338969|NCT01355458|811573|P2|NOT COMPLETED|Overall Study||4
338970|NCT01355458|811574|P1|NOT COMPLETED|Overall Study||2
338971|NCT01355458|811573|P2|COMPLETED|Overall Study||127
338972|NCT01355458|811574|P1|COMPLETED|Overall Study||127
338973|NCT01355458|811573|P2|STARTED|Overall Study||131
338974|NCT01355458|811574|P1|STARTED|Overall Study||129
338975|NCT01355419|811580|P1|NOT COMPLETED|Overall Study||8
338976|NCT01355419|811580|P1|COMPLETED|Overall Study||142
338977|NCT01355419|811580|P1|STARTED|Overall Study||150
338978|NCT01355302|811585|P3|NOT COMPLETED|Phase 2||0
338979|NCT01355302|811586|P2|NOT COMPLETED|Phase 2||0
338980|NCT01355302|811587|P1|NOT COMPLETED|Phase 2||0
338981|NCT01355302|811585|P3|COMPLETED|Phase 2||0
338982|NCT01355302|811586|P2|COMPLETED|Phase 2||0
338983|NCT01355302|811587|P1|COMPLETED|Phase 2||0
338984|NCT01355302|811585|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
338985|NCT01355302|811586|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
338986|NCT01355302|811587|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
338987|NCT01355302|811585|P3|NOT COMPLETED|Phase 1b||0
338988|NCT01355302|811586|P2|NOT COMPLETED|Phase 1b||0
338989|NCT01355302|811587|P1|NOT COMPLETED|Phase 1b||6
338990|NCT01355302|811585|P3|COMPLETED|Phase 1b||0
338991|NCT01355302|811586|P2|COMPLETED|Phase 1b||0
338992|NCT01355302|811587|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
338993|NCT01355302|811585|P3|STARTED|Phase 1b||0
338994|NCT01355302|811586|P2|STARTED|Phase 1b||0
338995|NCT01355302|811587|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
338996|NCT01355224|811602|P4|NOT COMPLETED|Overall Study||29
338997|NCT01355224|811603|P3|NOT COMPLETED|Overall Study||19
338998|NCT01355224|811604|P2|NOT COMPLETED|Overall Study||23
338999|NCT01355224|811605|P1|NOT COMPLETED|Overall Study||31
339000|NCT01355224|811602|P4|COMPLETED|Overall Study||172
339001|NCT01355224|811603|P3|COMPLETED|Overall Study||177
339002|NCT01355224|811604|P2|COMPLETED|Overall Study||180
339003|NCT01355224|811605|P1|COMPLETED|Overall Study||167
339004|NCT01355224|811602|P4|Competed Baseline|Overall Study||193
339005|NCT01355224|811603|P3|Competed Baseline|Overall Study||193
339006|NCT01355224|811604|P2|Competed Baseline|Overall Study||200
339007|NCT01355224|811605|P1|Competed Baseline|Overall Study||191
339008|NCT01355224|811602|P4|STARTED|Overall Study||201
339009|NCT01355224|811603|P3|STARTED|Overall Study||196
339010|NCT01355224|811604|P2|STARTED|Overall Study||203
339011|NCT01355224|811605|P1|STARTED|Overall Study||198
339012|NCT01355081|811628|P3|NOT COMPLETED|Overall Study||11
339013|NCT01355081|811629|P2|NOT COMPLETED|Overall Study||10
339014|NCT01355081|811630|P1|NOT COMPLETED|Overall Study||7
339015|NCT01355081|811628|P3|COMPLETED|Overall Study||113
339016|NCT01355081|811629|P2|COMPLETED|Overall Study||113
339017|NCT01355081|811630|P1|COMPLETED|Overall Study||112
339018|NCT01355081|811628|P3|STARTED|Overall Study||124
339019|NCT01355081|811629|P2|STARTED|Overall Study||123
339020|NCT01355081|811630|P1|STARTED|Overall Study||119
339021|NCT01355068|811653|P2|NOT COMPLETED|Second Intervention Period||0
339022|NCT01355068|811654|P1|NOT COMPLETED|Second Intervention Period||0
339023|NCT01355068|811653|P2|COMPLETED|Second Intervention Period||11
339024|NCT01355068|811654|P1|COMPLETED|Second Intervention Period||13
339025|NCT01355068|811653|P2|STARTED|Second Intervention Period||11
339026|NCT01355068|811654|P1|STARTED|Second Intervention Period||13
339027|NCT01355068|811653|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
339028|NCT01355068|811654|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
339029|NCT01355068|811653|P2|COMPLETED|Washout Period (at Least 7 Days)||11
339030|NCT01355068|811654|P1|COMPLETED|Washout Period (at Least 7 Days)||13
339031|NCT01355068|811653|P2|STARTED|Washout Period (at Least 7 Days)||11
339032|NCT01355068|811654|P1|STARTED|Washout Period (at Least 7 Days)||13
339033|NCT01355068|811653|P2|NOT COMPLETED|First Intervention Period||2
339034|NCT01355068|811654|P1|NOT COMPLETED|First Intervention Period||0
339035|NCT01355068|811653|P2|COMPLETED|First Intervention Period||11
339036|NCT01355068|811654|P1|COMPLETED|First Intervention Period||13
339037|NCT01355068|811653|P2|STARTED|First Intervention Period||13
339038|NCT01355068|811654|P1|STARTED|First Intervention Period||13
339039|NCT01354990|811670|P1|NOT COMPLETED|Overall Study||0
339040|NCT01354990|811670|P1|COMPLETED|Overall Study||2974
339041|NCT01354990|811670|P1|STARTED|Overall Study||2974
339042|NCT01354938|811677|P1|NOT COMPLETED|Overall Study||1
339043|NCT01354938|811677|P1|COMPLETED|Overall Study||219
339044|NCT01354938|811677|P1|STARTED|Overall Study||220
339045|NCT01354899|811683|P1|NOT COMPLETED|Overall Study||3
339046|NCT01354899|811683|P1|COMPLETED|Overall Study||21
339047|NCT01354899|811683|P1|STARTED|Overall Study||24
339048|NCT01354652|811691|P3|NOT COMPLETED|Overall Study||0
339049|NCT01354652|811692|P2|NOT COMPLETED|Overall Study||2
339050|NCT01354652|811693|P1|NOT COMPLETED|Overall Study||3
339051|NCT01354652|811691|P3|COMPLETED|Overall Study||0
339052|NCT01354652|811692|P2|COMPLETED|Overall Study||0
339053|NCT01354652|811693|P1|COMPLETED|Overall Study||0
339054|NCT01354652|811691|P3|STARTED|Overall Study||0
339055|NCT01354652|811692|P2|STARTED|Overall Study||2
339056|NCT01354652|811693|P1|STARTED|Overall Study||3
339057|NCT01354431|811704|P3|NOT COMPLETED|Participants Treated||54
339058|NCT01354431|811705|P2|NOT COMPLETED|Participants Treated||54
339059|NCT01354431|811706|P1|NOT COMPLETED|Participants Treated||59
339060|NCT01354431|811704|P3|COMPLETED|Participants Treated||0
339061|NCT01354431|811705|P2|COMPLETED|Participants Treated||0
339062|NCT01354431|811706|P1|COMPLETED|Participants Treated||0
339063|NCT01354431|811704|P3|STARTED|Participants Treated||54
339064|NCT01354431|811705|P2|STARTED|Participants Treated||54
339065|NCT01354431|811706|P1|STARTED|Participants Treated||59
339066|NCT01354431|811704|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
339067|NCT01354431|811705|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
339068|NCT01354431|811706|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
339069|NCT01354431|811704|P3|COMPLETED|Randomized to Enter Treatment Period||54
339070|NCT01354431|811705|P2|COMPLETED|Randomized to Enter Treatment Period||54
339071|NCT01354431|811706|P1|COMPLETED|Randomized to Enter Treatment Period||59
339072|NCT01354431|811704|P3|STARTED|Randomized to Enter Treatment Period||54
339073|NCT01354431|811705|P2|STARTED|Randomized to Enter Treatment Period||54
339074|NCT01354431|811706|P1|STARTED|Randomized to Enter Treatment Period||60
339075|NCT01354314|811730|P4|NOT COMPLETED|Overall Study||6
339076|NCT01354314|811731|P3|NOT COMPLETED|Overall Study||8
339077|NCT01354314|811732|P2|NOT COMPLETED|Overall Study||3
339078|NCT01354314|811733|P1|NOT COMPLETED|Overall Study||6
339079|NCT01354314|811730|P4|COMPLETED|Overall Study||5
339080|NCT01354314|811731|P3|COMPLETED|Overall Study||3
339081|NCT01354314|811732|P2|COMPLETED|Overall Study||8
339082|NCT01354314|811733|P1|COMPLETED|Overall Study||6
339083|NCT01354314|811730|P4|Completed (ITT)|Overall Study||10
339084|NCT01354314|811731|P3|Completed (ITT)|Overall Study||9
339085|NCT01354314|811732|P2|Completed (ITT)|Overall Study||11
339086|NCT01354314|811733|P1|Completed (ITT)|Overall Study||11
339087|NCT01354314|811730|P4|STARTED|Overall Study||11
339088|NCT01354314|811731|P3|STARTED|Overall Study||11
339089|NCT01354314|811732|P2|STARTED|Overall Study||11
339090|NCT01354314|811733|P1|STARTED|Overall Study||12
339091|NCT01354223|811869|P2|NOT COMPLETED|Overall Study||1
339092|NCT01354223|811870|P1|NOT COMPLETED|Overall Study||3
339093|NCT01354223|811869|P2|COMPLETED|Overall Study||29
339094|NCT01354223|811870|P1|COMPLETED|Overall Study||57
339095|NCT01354223|811869|P2|STARTED|Overall Study||30
339096|NCT01354223|811870|P1|STARTED|Overall Study||60
339097|NCT01354197|811886|P1|NOT COMPLETED|Overall Study||0
339098|NCT01354197|811886|P1|COMPLETED|Overall Study||4652
339099|NCT01354197|811886|P1|STARTED|Overall Study||4652
339100|NCT01354145|811894|P2|NOT COMPLETED|Overall Study||34
339101|NCT01354145|811895|P1|NOT COMPLETED|Overall Study||39
339102|NCT01354145|811894|P2|COMPLETED|Overall Study||63
339103|NCT01354145|811895|P1|COMPLETED|Overall Study||58
339104|NCT01354145|811894|P2|STARTED|Overall Study||97
339105|NCT01354145|811895|P1|STARTED|Overall Study||97
339106|NCT01354132|811929|P2|NOT COMPLETED|1 Month Post Study Medication||3
339107|NCT01354132|811930|P1|NOT COMPLETED|1 Month Post Study Medication||1
339108|NCT01354132|811929|P2|COMPLETED|1 Month Post Study Medication||16
339109|NCT01354132|811930|P1|COMPLETED|1 Month Post Study Medication||21
339110|NCT01354132|811929|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
339111|NCT01354132|811930|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
339112|NCT01354132|811929|P2|STARTED|1 Month Post Study Medication||19
339113|NCT01354132|811930|P1|STARTED|1 Month Post Study Medication||22
339114|NCT01354132|811929|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
339115|NCT01354132|811930|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
339116|NCT01354132|811929|P2|COMPLETED|Double Blind (Visits 1-7)||19
339117|NCT01354132|811930|P1|COMPLETED|Double Blind (Visits 1-7)||22
339118|NCT01354132|811929|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
339119|NCT01354132|811930|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
339120|NCT01354132|811929|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
339121|NCT01354132|811930|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
339122|NCT01354132|811929|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
339123|NCT01354132|811930|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
339124|NCT01354132|811929|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
339125|NCT01354132|811930|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
339126|NCT01354132|811929|P2|NOT COMPLETED|Randomization||1
339127|NCT01354132|811930|P1|NOT COMPLETED|Randomization||1
339128|NCT01354132|811929|P2|COMPLETED|Randomization||30
339129|NCT01354132|811930|P1|COMPLETED|Randomization||31
339130|NCT01354132|811929|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
339131|NCT01354132|811930|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
339132|NCT01354106|811968|P1|NOT COMPLETED|Overall Study||2
339133|NCT01354106|811968|P1|COMPLETED|Overall Study||24
339134|NCT01354106|811968|P1|STARTED|Overall Study||26
339135|NCT01354028|811974|P2|NOT COMPLETED|Overall Study||5
339136|NCT01354028|811975|P1|NOT COMPLETED|Overall Study||2
339137|NCT01354028|811974|P2|COMPLETED|Overall Study||10
339138|NCT01354028|811975|P1|COMPLETED|Overall Study||13
339139|NCT01354028|811974|P2|STARTED|Overall Study||15
339140|NCT01354028|811975|P1|STARTED|Overall Study||15
339141|NCT01354015|811989|P2|NOT COMPLETED|Overall Study||5
339142|NCT01354015|811990|P1|NOT COMPLETED|Overall Study||6
339143|NCT01354015|811989|P2|COMPLETED|Overall Study||43
339144|NCT01354015|811990|P1|COMPLETED|Overall Study||44
339145|NCT01354015|811989|P2|STARTED|Overall Study||48
339146|NCT01354015|811990|P1|STARTED|Overall Study||50
339147|NCT01353976|812000|P2|NOT COMPLETED|Overall Study||51
339148|NCT01353976|812001|P1|NOT COMPLETED|Overall Study||48
339149|NCT01353976|812000|P2|COMPLETED|Overall Study||83
339150|NCT01353976|812001|P1|COMPLETED|Overall Study||82
339151|NCT01353976|812000|P2|STARTED|Overall Study||134
339152|NCT01353976|812001|P1|STARTED|Overall Study||130
339153|NCT01353963|812011|P1|NOT COMPLETED|Overall Study||2
339154|NCT01353963|812011|P1|COMPLETED|Overall Study||11
339155|NCT01353963|812011|P1|STARTED|Overall Study||13
339156|NCT01353911|812029|P8|NOT COMPLETED|Overall Study||15
339157|NCT01353911|812030|P7|NOT COMPLETED|Overall Study||6
339158|NCT01353911|812031|P6|NOT COMPLETED|Overall Study||7
339159|NCT01353911|812032|P5|NOT COMPLETED|Overall Study||6
339160|NCT01353911|812033|P4|NOT COMPLETED|Overall Study||2
339161|NCT01353911|812034|P3|NOT COMPLETED|Overall Study||9
339162|NCT01353911|812035|P2|NOT COMPLETED|Overall Study||9
339163|NCT01353911|812036|P1|NOT COMPLETED|Overall Study||8
339164|NCT01353911|812029|P8|COMPLETED|Overall Study||51
339165|NCT01353911|812030|P7|COMPLETED|Overall Study||30
339166|NCT01353911|812031|P6|COMPLETED|Overall Study||36
339167|NCT01353911|812032|P5|COMPLETED|Overall Study||23
339168|NCT01353911|812033|P4|COMPLETED|Overall Study||22
339169|NCT01353911|812034|P3|COMPLETED|Overall Study||59
339170|NCT01353911|812035|P2|COMPLETED|Overall Study||57
339171|NCT01353911|812036|P1|COMPLETED|Overall Study||28
339172|NCT01353911|812029|P8|STARTED|Overall Study||66
339173|NCT01353911|812030|P7|STARTED|Overall Study||36
339174|NCT01353911|812031|P6|STARTED|Overall Study||43
339175|NCT01353911|812032|P5|STARTED|Overall Study||29
339176|NCT01353911|812033|P4|STARTED|Overall Study||24
339177|NCT01353911|812034|P3|STARTED|Overall Study||68
339178|NCT01353911|812035|P2|STARTED|Overall Study||66
339179|NCT01353911|812036|P1|STARTED|Overall Study||36
339180|NCT01353898|812116|P6|NOT COMPLETED|Overall Study||1
339181|NCT01353898|812117|P5|NOT COMPLETED|Overall Study||0
339182|NCT01353898|812118|P4|NOT COMPLETED|Overall Study||0
339183|NCT01353898|812119|P3|NOT COMPLETED|Overall Study||0
339184|NCT01353898|812120|P2|NOT COMPLETED|Overall Study||0
339185|NCT01353898|812121|P1|NOT COMPLETED|Overall Study||0
339186|NCT01353898|812116|P6|COMPLETED|Overall Study||1
339187|NCT01353898|812117|P5|COMPLETED|Overall Study||2
339188|NCT01353898|812118|P4|COMPLETED|Overall Study||2
339189|NCT01353898|812119|P3|COMPLETED|Overall Study||2
339190|NCT01353898|812120|P2|COMPLETED|Overall Study||2
339191|NCT01353898|812121|P1|COMPLETED|Overall Study||2
339192|NCT01353898|812116|P6|STARTED|Overall Study||2
339193|NCT01353898|812117|P5|STARTED|Overall Study||2
339194|NCT01353898|812118|P4|STARTED|Overall Study||2
339195|NCT01353898|812119|P3|STARTED|Overall Study||2
339196|NCT01353898|812120|P2|STARTED|Overall Study||2
339197|NCT01353898|812121|P1|STARTED|Overall Study||2
339198|NCT01353859|812147|P1|NOT COMPLETED|Overall Study||4
339199|NCT01353859|812147|P1|COMPLETED|Overall Study||35
339200|NCT01353859|812147|P1|STARTED|Overall Study||39
339201|NCT01353664|812160|P1|NOT COMPLETED|Overall Study||19
339202|NCT01353664|812160|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
339203|NCT01353664|812160|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
339204|NCT01353586|812166|P2|NOT COMPLETED|Overall Study||2
339205|NCT01353586|812167|P1|NOT COMPLETED|Overall Study||7
339206|NCT01353586|812166|P2|COMPLETED|Overall Study||17
339207|NCT01353586|812167|P1|COMPLETED|Overall Study||160
339208|NCT01353586|812166|P2|Participated in SNA Substudy|Overall Study||19
339209|NCT01353586|812167|P1|Participated in SNA Substudy|Overall Study||19
339210|NCT01353586|812166|P2|Participated in Roll-in Phase|Overall Study||0
339211|NCT01353586|812167|P1|Participated in Roll-in Phase|Overall Study||22
339212|NCT01353586|812166|P2|Participated in Workflow Phase|Overall Study||0
339213|NCT01353586|812167|P1|Participated in Workflow Phase|Overall Study||20
339214|NCT01353586|812166|P2|STARTED|Overall Study||19
339215|NCT01353586|812167|P1|STARTED|Overall Study||167
339216|NCT01353508|812185|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
339217|NCT01353508|812186|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
339218|NCT01353508|812187|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
339219|NCT01353508|812188|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
339220|NCT01353508|812185|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
339221|NCT01353508|812186|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
339222|NCT01353508|812187|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
339223|NCT01353508|812188|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
339224|NCT01353508|812185|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
339225|NCT01353508|812186|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
339226|NCT01353508|812187|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
339227|NCT01353508|812188|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
339228|NCT01353508|812185|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
339229|NCT01353508|812186|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
339230|NCT01353508|812187|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
339231|NCT01353508|812188|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
339232|NCT01353508|812185|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
339233|NCT01353508|812186|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
339234|NCT01353508|812187|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
339235|NCT01353508|812188|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
339236|NCT01353508|812185|P4|STARTED|Period 1 - First Intervention (7 Days)||8
339237|NCT01353508|812186|P3|STARTED|Period 1 - First Intervention (7 Days)||8
339238|NCT01353508|812187|P2|STARTED|Period 1 - First Intervention (7 Days)||8
339239|NCT01353508|812188|P1|STARTED|Period 1 - First Intervention (7 Days)||8
339240|NCT01353274|812266|P1|NOT COMPLETED|Overall Study||28
339241|NCT01353274|812266|P1|COMPLETED|Overall Study||1129
339242|NCT01353274|812266|P1|STARTED|Overall Study||1157
339243|NCT01353222|812276|P2|NOT COMPLETED|Overall Study||72
339244|NCT01353222|812277|P1|NOT COMPLETED|Overall Study||70
339245|NCT01353222|812276|P2|COMPLETED|Overall Study||0
339246|NCT01353222|812277|P1|COMPLETED|Overall Study||0
339247|NCT01353222|812276|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
339248|NCT01353222|812277|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
339249|NCT01353222|812276|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
339250|NCT01353222|812277|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
339251|NCT01353222|812276|P2|STARTED|Overall Study||72
339252|NCT01353222|812277|P1|STARTED|Overall Study||70
339253|NCT01353144|812285|P2|NOT COMPLETED|Overall Study||8
339254|NCT01353144|812286|P1|NOT COMPLETED|Overall Study||9
339255|NCT01353144|812285|P2|COMPLETED|Overall Study||81
339256|NCT01353144|812286|P1|COMPLETED|Overall Study||80
339257|NCT01353144|812285|P2|STARTED|Overall Study||89
339258|NCT01353144|812286|P1|STARTED|Overall Study||89
339259|NCT01353079|812296|P2|NOT COMPLETED|Overall Study||21
339260|NCT01353079|812297|P1|NOT COMPLETED|Overall Study||27
339261|NCT01353079|812296|P2|COMPLETED|Overall Study||190
339262|NCT01353079|812297|P1|COMPLETED|Overall Study||191
339263|NCT01353079|812296|P2|STARTED|Overall Study||211
339264|NCT01353079|812297|P1|STARTED|Overall Study||218
339265|NCT01352845|812311|P2|NOT COMPLETED|Overall Study||203
339266|NCT01352845|812312|P1|NOT COMPLETED|Overall Study||671
339267|NCT01352845|812311|P2|COMPLETED|Overall Study||619
339268|NCT01352845|812312|P1|COMPLETED|Overall Study||1800
339269|NCT01352845|812311|P2|STARTED|Overall Study||822
339270|NCT01352845|812312|P1|STARTED|Overall Study||2471
339271|NCT01352793|812401|P2|NOT COMPLETED|Overall Study||245
339272|NCT01352793|812402|P1|NOT COMPLETED|Overall Study||585
339273|NCT01352793|812401|P2|COMPLETED|Overall Study||1663
339274|NCT01352793|812402|P1|COMPLETED|Overall Study||3219
339275|NCT01352793|812401|P2|Vaccination 3|Overall Study||1710
339276|NCT01352793|812402|P1|Vaccination 3|Overall Study||3314
339277|NCT01352793|812401|P2|Vaccination 2|Overall Study||1806
339278|NCT01352793|812402|P1|Vaccination 2|Overall Study||3530
339279|NCT01352793|812401|P2|Vaccination 1|Overall Study||1908
339280|NCT01352793|812402|P1|Vaccination 1|Overall Study||3796
339281|NCT01352793|812401|P2|STARTED|Overall Study||1908
339282|NCT01352793|812402|P1|STARTED|Overall Study||3804
339283|NCT01352741|812426|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
339284|NCT01352741|812427|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
339285|NCT01352741|812426|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
339286|NCT01352741|812427|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
339287|NCT01352741|812426|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
339288|NCT01352741|812427|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
339289|NCT01352741|812426|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
339290|NCT01352741|812427|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
339291|NCT01352741|812426|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
339292|NCT01352741|812427|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
339293|NCT01352741|812426|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
339294|NCT01352741|812427|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
339295|NCT01352741|812426|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
339296|NCT01352741|812427|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
339297|NCT01352741|812426|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
339298|NCT01352741|812427|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
339299|NCT01352741|812426|P2|NOT COMPLETED|Double-blind Comparative Period||26
339300|NCT01352741|812427|P1|NOT COMPLETED|Double-blind Comparative Period||28
339301|NCT01352741|812426|P2|COMPLETED|Double-blind Comparative Period||133
339302|NCT01352741|812427|P1|COMPLETED|Double-blind Comparative Period||126
339303|NCT01352741|812426|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
339304|NCT01352741|812427|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
339305|NCT01352741|812426|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
339306|NCT01352741|812427|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
339307|NCT01352741|812426|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
339308|NCT01352741|812427|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
339309|NCT01352741|812426|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
339310|NCT01352741|812427|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
339311|NCT01352741|812426|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
339312|NCT01352741|812427|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
339313|NCT01352741|812426|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
339314|NCT01352741|812427|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
339315|NCT01352741|812426|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
339316|NCT01352741|812427|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
339317|NCT01352741|812426|P2|Per Protocol Set|Double-blind Comparative Period||149
339318|NCT01352741|812427|P1|Per Protocol Set|Double-blind Comparative Period||139
339319|NCT01352741|812426|P2|Major Protocol Deviations|Double-blind Comparative Period||8
339320|NCT01352741|812427|P1|Major Protocol Deviations|Double-blind Comparative Period||13
339321|NCT01352741|812426|P2|Full Analysis Set|Double-blind Comparative Period||157
339322|NCT01352741|812427|P1|Full Analysis Set|Double-blind Comparative Period||152
339323|NCT01352741|812426|P2|No Pain Assessments Available|Double-blind Comparative Period||2
339324|NCT01352741|812427|P1|No Pain Assessments Available|Double-blind Comparative Period||2
339325|NCT01352741|812426|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
339326|NCT01352741|812427|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
339327|NCT01352741|812426|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
339328|NCT01352741|812427|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
339329|NCT01352741|812426|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
339330|NCT01352741|812427|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
339331|NCT01352741|812426|P2|COMPLETED|Open-label Tapentadol Titration Period||0
339332|NCT01352741|812427|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
339333|NCT01352741|812426|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
339334|NCT01352741|812427|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
339425|NCT01351025|812677|P1|NOT COMPLETED|Week 24 - 44||1
339335|NCT01352741|812426|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
339336|NCT01352741|812427|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
339337|NCT01352741|812426|P2|STARTED|Open-label Tapentadol Titration Period||0
339338|NCT01352741|812427|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
339339|NCT01352715|812521|P2|NOT COMPLETED|Overall Study||46
339340|NCT01352715|812522|P1|NOT COMPLETED|Overall Study||45
339341|NCT01352715|812521|P2|COMPLETED|Overall Study||209
339342|NCT01352715|812522|P1|COMPLETED|Overall Study||215
339343|NCT01352715|812521|P2|STARTED|Overall Study||255
339344|NCT01352715|812522|P1|STARTED|Overall Study||260
339345|NCT01352585|812544|P1|NOT COMPLETED|Overall Study||11
339346|NCT01352585|812544|P1|COMPLETED|Overall Study||36
339347|NCT01352585|812544|P1|STARTED|Overall Study||47
339348|NCT01352507|812557|P2|NOT COMPLETED|Extension Phase||0
339349|NCT01352507|812558|P1|NOT COMPLETED|Extension Phase||0
339350|NCT01352507|812557|P2|COMPLETED|Extension Phase||173
339351|NCT01352507|812558|P1|COMPLETED|Extension Phase||164
339352|NCT01352507|812557|P2|STARTED|Extension Phase||173
339353|NCT01352507|812558|P1|STARTED|Extension Phase||164
339354|NCT01352507|812557|P2|NOT COMPLETED|Treatment Period 2||3
339355|NCT01352507|812558|P1|NOT COMPLETED|Treatment Period 2||6
339356|NCT01352507|812557|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
339357|NCT01352507|812558|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
339358|NCT01352507|812557|P2|Received Treatment|Treatment Period 2||181
339359|NCT01352507|812558|P1|Received Treatment|Treatment Period 2||173
339360|NCT01352507|812557|P2|STARTED|Treatment Period 2||183
339361|NCT01352507|812558|P1|STARTED|Treatment Period 2||176
339362|NCT01352507|812557|P2|NOT COMPLETED|Washout Period||1
339363|NCT01352507|812558|P1|NOT COMPLETED|Washout Period||0
339364|NCT01352507|812557|P2|COMPLETED|Washout Period||183
339365|NCT01352507|812558|P1|COMPLETED|Washout Period||176
339366|NCT01352507|812557|P2|STARTED|Washout Period||184
339367|NCT01352507|812558|P1|STARTED|Washout Period||176
339368|NCT01352507|812557|P2|NOT COMPLETED|Treatment Period 1||9
339369|NCT01352507|812558|P1|NOT COMPLETED|Treatment Period 1||14
339370|NCT01352507|812557|P2|COMPLETED|Treatment Period 1||184
339371|NCT01352507|812558|P1|COMPLETED|Treatment Period 1||176
339372|NCT01352507|812557|P2|Received Treatment|Treatment Period 1||188
339373|NCT01352507|812558|P1|Received Treatment|Treatment Period 1||182
339374|NCT01352507|812557|P2|STARTED|Treatment Period 1||193
339375|NCT01352507|812558|P1|STARTED|Treatment Period 1||190
339376|NCT01352442|812589|P1|NOT COMPLETED|Overall Study||12
339377|NCT01352442|812589|P1|COMPLETED|Overall Study||139
339378|NCT01352442|812589|P1|STARTED|Overall Study||151
339379|NCT01352416|812598|P4|NOT COMPLETED|Overall Study||1
339380|NCT01352416|812599|P3|NOT COMPLETED|Overall Study||2
339381|NCT01352416|812600|P2|NOT COMPLETED|Overall Study||2
339382|NCT01352416|812601|P1|NOT COMPLETED|Overall Study||1
339383|NCT01352416|812598|P4|COMPLETED|Overall Study||1
339384|NCT01352416|812599|P3|COMPLETED|Overall Study||0
339385|NCT01352416|812600|P2|COMPLETED|Overall Study||5
339386|NCT01352416|812601|P1|COMPLETED|Overall Study||3
339387|NCT01352416|812598|P4|STARTED|Overall Study||2
339388|NCT01352416|812599|P3|STARTED|Overall Study||2
339389|NCT01352416|812600|P2|STARTED|Overall Study||7
339390|NCT01352416|812601|P1|STARTED|Overall Study||4
339391|NCT01351623|812611|P1|NOT COMPLETED|Overall Study||9
339392|NCT01351623|812611|P1|COMPLETED|Overall Study||35
339393|NCT01351623|812611|P1|STARTED|Overall Study||44
339394|NCT01351506|812617|P1|NOT COMPLETED|Overall Study||137
339395|NCT01351506|812617|P1|COMPLETED|Overall Study||465
339396|NCT01351506|812617|P1|STARTED|Overall Study||602
339397|NCT01351480|812627|P1|NOT COMPLETED|Overall Study||8
339398|NCT01351480|812627|P1|COMPLETED|Overall Study||26
339399|NCT01351480|812627|P1|STARTED|Overall Study||34
339400|NCT01351337|812635|P1|NOT COMPLETED|Overall Study||0
339401|NCT01351337|812635|P1|COMPLETED|Overall Study||58
339402|NCT01351337|812635|P1|STARTED|Overall Study||58
339403|NCT01351090|812644|P3|NOT COMPLETED|Overall Study||6
339404|NCT01351090|812645|P2|NOT COMPLETED|Overall Study||11
339405|NCT01351090|812646|P1|NOT COMPLETED|Overall Study||11
339406|NCT01351090|812644|P3|COMPLETED|Overall Study||36
339407|NCT01351090|812645|P2|COMPLETED|Overall Study||31
339408|NCT01351090|812646|P1|COMPLETED|Overall Study||32
339409|NCT01351090|812644|P3|STARTED|Overall Study||42
339410|NCT01351090|812645|P2|STARTED|Overall Study||42
339411|NCT01351090|812646|P1|STARTED|Overall Study||43
339412|NCT01351064|812665|P2|NOT COMPLETED|Overall Study||0
339413|NCT01351064|812666|P1|NOT COMPLETED|Overall Study||0
339414|NCT01351064|812665|P2|COMPLETED|Overall Study||42
339415|NCT01351064|812666|P1|COMPLETED|Overall Study||42
339416|NCT01351064|812665|P2|STARTED|Overall Study||42
339417|NCT01351064|812666|P1|STARTED|Overall Study||42
339418|NCT01351025|812676|P2|NOT COMPLETED|Week 44 - 48||0
339419|NCT01351025|812677|P1|NOT COMPLETED|Week 44 - 48||0
339420|NCT01351025|812676|P2|COMPLETED|Week 44 - 48||43
339421|NCT01351025|812677|P1|COMPLETED|Week 44 - 48||42
339422|NCT01351025|812676|P2|STARTED|Week 44 - 48||43
339423|NCT01351025|812677|P1|STARTED|Week 44 - 48||42
339424|NCT01351025|812676|P2|NOT COMPLETED|Week 24 - 44||4
339426|NCT01351025|812676|P2|COMPLETED|Week 24 - 44||43
339427|NCT01351025|812677|P1|COMPLETED|Week 24 - 44||42
339428|NCT01351025|812676|P2|STARTED|Week 24 - 44||47
339429|NCT01351025|812677|P1|STARTED|Week 24 - 44||43
339430|NCT01351025|812676|P2|NOT COMPLETED|Week 20 - 24||0
339431|NCT01351025|812677|P1|NOT COMPLETED|Week 20 - 24||0
339432|NCT01351025|812676|P2|COMPLETED|Week 20 - 24||47
339433|NCT01351025|812677|P1|COMPLETED|Week 20 - 24||43
339434|NCT01351025|812676|P2|STARTED|Week 20 - 24||47
339435|NCT01351025|812677|P1|STARTED|Week 20 - 24||43
339436|NCT01351025|812676|P2|NOT COMPLETED|Week 0 - 20||1
339437|NCT01351025|812677|P1|NOT COMPLETED|Week 0 - 20||3
339438|NCT01351025|812676|P2|COMPLETED|Week 0 - 20||47
339439|NCT01351025|812677|P1|COMPLETED|Week 0 - 20||43
339440|NCT01351025|812676|P2|STARTED|Week 0 - 20||48
339441|NCT01351025|812677|P1|STARTED|Week 0 - 20||46
339442|NCT01350999|812710|P3|NOT COMPLETED|Overall Study||21
339443|NCT01350999|812711|P2|NOT COMPLETED|Overall Study||14
339444|NCT01350999|812712|P1|NOT COMPLETED|Overall Study||8
339445|NCT01350999|812710|P3|COMPLETED|Overall Study||146
339446|NCT01350999|812711|P2|COMPLETED|Overall Study||157
339447|NCT01350999|812712|P1|COMPLETED|Overall Study||157
339448|NCT01350999|812710|P3|Treated|Overall Study||167
339449|NCT01350999|812711|P2|Treated|Overall Study||171
339450|NCT01350999|812712|P1|Treated|Overall Study||165
339451|NCT01350999|812710|P3|STARTED|Overall Study||167
339452|NCT01350999|812711|P2|STARTED|Overall Study||171
339453|NCT01350999|812712|P1|STARTED|Overall Study||165
339454|NCT01350973|812750|P3|NOT COMPLETED|Overall Study||8
339455|NCT01350973|812751|P2|NOT COMPLETED|Overall Study||8
339456|NCT01350973|812752|P1|NOT COMPLETED|Overall Study||6
339457|NCT01350973|812750|P3|COMPLETED|Overall Study||187
339458|NCT01350973|812751|P2|COMPLETED|Overall Study||202
339459|NCT01350973|812752|P1|COMPLETED|Overall Study||200
339460|NCT01350973|812750|P3|Received Treatment|Overall Study||195
339461|NCT01350973|812751|P2|Received Treatment|Overall Study||210
339462|NCT01350973|812752|P1|Received Treatment|Overall Study||205
339463|NCT01350973|812750|P3|STARTED|Overall Study||195
339464|NCT01350973|812751|P2|STARTED|Overall Study||210
339465|NCT01350973|812752|P1|STARTED|Overall Study||206
339466|NCT01350947|812787|P1|NOT COMPLETED|Overall Study||0
339467|NCT01350947|812787|P1|COMPLETED|Overall Study||11
339468|NCT01350947|812787|P1|STARTED|Overall Study||11
339469|NCT01350934|812793|P2|NOT COMPLETED|Extension Study||4
339470|NCT01350934|812794|P1|NOT COMPLETED|Extension Study||5
339471|NCT01350934|812793|P2|COMPLETED|Extension Study||101
339472|NCT01350934|812794|P1|COMPLETED|Extension Study||95
339473|NCT01350934|812793|P2|STARTED|Extension Study||105
339474|NCT01350934|812794|P1|STARTED|Extension Study||100
339475|NCT01350934|812793|P2|NOT COMPLETED|Base Study||3
339476|NCT01350934|812794|P1|NOT COMPLETED|Base Study||11
339477|NCT01350934|812793|P2|COMPLETED|Base Study||105
339478|NCT01350934|812794|P1|COMPLETED|Base Study||100
339479|NCT01350934|812793|P2|STARTED|Base Study||108
339480|NCT01350934|812794|P1|STARTED|Base Study||111
339481|NCT01350804|812816|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
339482|NCT01350804|812817|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
339483|NCT01350804|812818|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
339484|NCT01350804|812819|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
339485|NCT01350804|812816|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
339486|NCT01350804|812817|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
339487|NCT01350804|812818|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
339488|NCT01350804|812819|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
339489|NCT01350804|812816|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
339490|NCT01350804|812817|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
339491|NCT01350804|812818|P2|STARTED|Extension Study, Weeks 52 - 260||79
339492|NCT01350804|812819|P1|STARTED|Extension Study, Weeks 52 - 260||80
339493|NCT01350804|812816|P4|NOT COMPLETED|Core Study||26
339494|NCT01350804|812817|P3|NOT COMPLETED|Core Study||47
339495|NCT01350804|812818|P2|NOT COMPLETED|Core Study||47
339496|NCT01350804|812819|P1|NOT COMPLETED|Core Study||41
339497|NCT01350804|812816|P4|COMPLETED|Core Study||112
339498|NCT01350804|812817|P3|COMPLETED|Core Study||91
339499|NCT01350804|812818|P2|COMPLETED|Core Study||90
339500|NCT01350804|812819|P1|COMPLETED|Core Study||97
339501|NCT01350804|812816|P4|Full Analysis Set|Core Study||138
339502|NCT01350804|812817|P3|Full Analysis Set|Core Study||138
339503|NCT01350804|812818|P2|Full Analysis Set|Core Study||137
339504|NCT01350804|812819|P1|Full Analysis Set|Core Study||138
339505|NCT01350804|812816|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
339506|NCT01350804|812817|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
339507|NCT01350804|812818|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
339508|NCT01350804|812819|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
339509|NCT01350804|812816|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
339510|NCT01350804|812817|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
339511|NCT01350804|812818|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
339512|NCT01350804|812819|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
339513|NCT01350804|812816|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
339514|NCT01350804|812817|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
339515|NCT01350804|812818|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
339516|NCT01350804|812819|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
339517|NCT01350804|812816|P4|STARTED|Core Study||138
339518|NCT01350804|812817|P3|STARTED|Core Study||138
339519|NCT01350804|812818|P2|STARTED|Core Study||137
339520|NCT01350804|812819|P1|STARTED|Core Study||138
339521|NCT01350583|812908|P1|NOT COMPLETED|Overall Study||0
339522|NCT01350583|812908|P1|COMPLETED|Overall Study||2
339523|NCT01350583|812908|P1|STARTED|Overall Study||2
339524|NCT01350544|812916|P2|NOT COMPLETED|Overall Study||22
339525|NCT01350544|812917|P1|NOT COMPLETED|Overall Study||23
339526|NCT01350544|812916|P2|COMPLETED|Overall Study||86
339527|NCT01350544|812917|P1|COMPLETED|Overall Study||85
339528|NCT01350544|812916|P2|STARTED|Overall Study||108
339529|NCT01350544|812917|P1|STARTED|Overall Study||108
339530|NCT01350479|812925|P2|NOT COMPLETED|Overall Study||0
339531|NCT01350479|812926|P1|NOT COMPLETED|Overall Study||0
339532|NCT01350479|812925|P2|COMPLETED|Overall Study||106
339533|NCT01350479|812926|P1|COMPLETED|Overall Study||94
339534|NCT01350479|812925|P2|STARTED|Overall Study||106
339535|NCT01350479|812926|P1|STARTED|Overall Study||94
339536|NCT01350414|812932|P1|NOT COMPLETED|Overall Study||19
339537|NCT01350414|812932|P1|COMPLETED|Overall Study||162
339538|NCT01350414|812932|P1|Year 5|Overall Study||162
339539|NCT01350414|812932|P1|Year 4|Overall Study||159
339540|NCT01350414|812932|P1|Year 3|Overall Study||162
339541|NCT01350414|812932|P1|Year 2|Overall Study||165
339542|NCT01350414|812932|P1|STARTED|Overall Study||181
339543|NCT01350388|812951|P2|NOT COMPLETED|Overall Study||1
339544|NCT01350388|812952|P1|NOT COMPLETED|Overall Study||3
339545|NCT01350388|812951|P2|COMPLETED|Overall Study||39
339546|NCT01350388|812952|P1|COMPLETED|Overall Study||37
339547|NCT01350388|812951|P2|STARTED|Overall Study||40
339548|NCT01350388|812952|P1|STARTED|Overall Study||40
339549|NCT01350271|812971|P3|NOT COMPLETED|Overall Study||26
339550|NCT01350271|812972|P2|NOT COMPLETED|Overall Study||17
339551|NCT01350271|812973|P1|NOT COMPLETED|Overall Study||21
339552|NCT01350271|812971|P3|COMPLETED|Overall Study||48
339553|NCT01350271|812972|P2|COMPLETED|Overall Study||53
339554|NCT01350271|812973|P1|COMPLETED|Overall Study||49
339555|NCT01350271|812971|P3|STARTED|Overall Study||74
339556|NCT01350271|812972|P2|STARTED|Overall Study||70
339557|NCT01350271|812973|P1|STARTED|Overall Study||70
339558|NCT01350258|812987|P1|NOT COMPLETED|Overall Study||0
339559|NCT01350258|812987|P1|COMPLETED|Overall Study||8
339560|NCT01350258|812987|P1|STARTED|Overall Study||8
339561|NCT01350245|812996|P1|NOT COMPLETED|Overall Study||0
339562|NCT01350245|812996|P1|COMPLETED|Overall Study||28
339563|NCT01350245|812996|P1|STARTED|Overall Study||28
339564|NCT01350232|813001|P1|NOT COMPLETED|Overall Study||0
339565|NCT01350232|813001|P1|COMPLETED|Overall Study||2
339566|NCT01350232|813001|P1|STARTED|Overall Study||2
339567|NCT01350128|813012|P1|NOT COMPLETED|Overall Study||14
339568|NCT01350128|813012|P1|COMPLETED|Overall Study||89
339569|NCT01350128|813012|P1|Atrovent HFA 34 µg BID|Overall Study||48
339570|NCT01350128|813012|P1|Placebo MDI BID|Overall Study||48
339571|NCT01350128|813012|P1|GP MDI 4.6 µg BID|Overall Study||45
339572|NCT01350128|813012|P1|GP MDI 9 µg BID|Overall Study||49
339573|NCT01350128|813012|P1|GP MDI 18 µg BID|Overall Study||49
339574|NCT01350128|813012|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
339575|NCT01350128|813012|P1|STARTED|Overall Study||103
339576|NCT01350115|813076|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
339577|NCT01350115|813077|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
339578|NCT01350115|813076|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
339579|NCT01350115|813077|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
339580|NCT01350115|813076|P2|STARTED|Long Term Follow-Up (All Patients)||2
339581|NCT01350115|813077|P1|STARTED|Long Term Follow-Up (All Patients)||8
339582|NCT01350115|813076|P2|NOT COMPLETED|Core Study (All Patients)||0
339583|NCT01350115|813077|P1|NOT COMPLETED|Core Study (All Patients)||0
339584|NCT01350115|813076|P2|COMPLETED|Core Study (All Patients)||2
339585|NCT01350115|813077|P1|COMPLETED|Core Study (All Patients)||8
339586|NCT01350115|813076|P2|Pharmacodynamic Set|Core Study (All Patients)||2
339587|NCT01350115|813077|P1|Pharmacodynamic Set|Core Study (All Patients)||7
339588|NCT01350115|813076|P2|Safety Anlysis Set|Core Study (All Patients)||2
339589|NCT01350115|813077|P1|Safety Anlysis Set|Core Study (All Patients)||8
339590|NCT01350115|813076|P2|STARTED|Core Study (All Patients)||2
339591|NCT01350115|813077|P1|STARTED|Core Study (All Patients)||8
339592|NCT01349972|813091|P2|NOT COMPLETED|Overall Study||2
339593|NCT01349972|813092|P1|NOT COMPLETED|Overall Study||5
339594|NCT01349972|813091|P2|COMPLETED|Overall Study||56
339595|NCT01349972|813092|P1|COMPLETED|Overall Study||109
339596|NCT01349972|813091|P2|STARTED|Overall Study||58
339597|NCT01349972|813092|P1|STARTED|Overall Study||114
339598|NCT01349959|813108|P1|NOT COMPLETED|Overall Study||7
339599|NCT01349959|813108|P1|COMPLETED|Overall Study||33
339600|NCT01349959|813108|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
339601|NCT01349933|813114|P1|NOT COMPLETED|Overall Study||0
339602|NCT01349933|813114|P1|COMPLETED|Overall Study||21
339603|NCT01349933|813114|P1|STARTED|Overall Study||21
339604|NCT01349920|813119|P1|NOT COMPLETED|Overall Study||0
339605|NCT01349920|813119|P1|COMPLETED|Overall Study||15
339606|NCT01349920|813119|P1|STARTED|Overall Study||15
339607|NCT01349907|813139|P2|NOT COMPLETED|Overall Study||43
339608|NCT01349907|813140|P1|NOT COMPLETED|Overall Study||139
339609|NCT01349907|813139|P2|COMPLETED|Overall Study||38
339610|NCT01349907|813140|P1|COMPLETED|Overall Study||102
339611|NCT01349907|813139|P2|STARTED|Overall Study|Enrolled and Treated|81
339612|NCT01349907|813140|P1|STARTED|Overall Study|Enrolled and Treated|241
339613|NCT01349829|813178|P2|NOT COMPLETED|Overall Study||23
339614|NCT01349829|813179|P1|NOT COMPLETED|Overall Study||9
339615|NCT01349829|813178|P2|COMPLETED|Overall Study||102
339616|NCT01349829|813179|P1|COMPLETED|Overall Study||117
339617|NCT01349829|813178|P2|STARTED|Overall Study||125
339618|NCT01349829|813179|P1|STARTED|Overall Study||126
339619|NCT01349816|813197|P1|NOT COMPLETED|Overall Study||30
339620|NCT01349816|813197|P1|COMPLETED|Overall Study||155
339621|NCT01349816|813197|P1|FF MDI 9.6 µg|Overall Study||61
339622|NCT01349816|813197|P1|GFF MDI 9/9.6 µg|Overall Study||57
339623|NCT01349816|813197|P1|GFF MDI 18/9.6 µg|Overall Study||57
339624|NCT01349816|813197|P1|GFF MDI 36/9.6 µg|Overall Study||56
339625|NCT01349816|813197|P1|GFF MDI 36/7.2 µg|Overall Study||58
339626|NCT01349816|813197|P1|GP MDI 36 µg|Overall Study||61
339627|NCT01349816|813197|P1|STARTED|Overall Study||185
339628|NCT01349803|813263|P4|NOT COMPLETED|Overall Study||2
339629|NCT01349803|813264|P3|NOT COMPLETED|Overall Study||3
339630|NCT01349803|813265|P2|NOT COMPLETED|Overall Study||1
339631|NCT01349803|813266|P1|NOT COMPLETED|Overall Study||1
339632|NCT01349803|813263|P4|COMPLETED|Overall Study||57
339633|NCT01349803|813264|P3|COMPLETED|Overall Study||57
339634|NCT01349803|813265|P2|COMPLETED|Overall Study||57
339635|NCT01349803|813266|P1|COMPLETED|Overall Study||59
339636|NCT01349803|813263|P4|STARTED|Overall Study||59
339637|NCT01349803|813264|P3|STARTED|Overall Study||60
339638|NCT01349803|813265|P2|STARTED|Overall Study||58
339639|NCT01349803|813266|P1|STARTED|Overall Study||60
339640|NCT01349790|813336|P1|NOT COMPLETED|Overall Study||9
339641|NCT01349790|813336|P1|COMPLETED|Overall Study||31
339642|NCT01349790|813336|P1|STARTED|Overall Study||40
339643|NCT01349595|813357|P2|NOT COMPLETED|Overall Study||2
339644|NCT01349595|813358|P1|NOT COMPLETED|Overall Study||2
339645|NCT01349595|813357|P2|COMPLETED|Overall Study||0
339646|NCT01349595|813358|P1|COMPLETED|Overall Study||0
339647|NCT01349595|813357|P2|STARTED|Overall Study||2
339648|NCT01349595|813358|P1|STARTED|Overall Study||2
339649|NCT01349491|813366|P2|NOT COMPLETED|Overall Study||0
339650|NCT01349491|813367|P1|NOT COMPLETED|Overall Study||0
339651|NCT01349491|813366|P2|COMPLETED|Overall Study||5
339652|NCT01349491|813367|P1|COMPLETED|Overall Study||5
339653|NCT01349491|813366|P2|STARTED|Overall Study||5
339654|NCT01349491|813367|P1|STARTED|Overall Study||5
339655|NCT01349465|813375|P2|NOT COMPLETED|Overall Study||22
339656|NCT01349465|813376|P1|NOT COMPLETED|Overall Study||18
339657|NCT01349465|813375|P2|COMPLETED|Overall Study||27
339658|NCT01349465|813376|P1|COMPLETED|Overall Study||182
339659|NCT01349465|813375|P2|STARTED|Overall Study||49
339660|NCT01349465|813376|P1|STARTED|Overall Study||200
339661|NCT01349231|813388|P1|NOT COMPLETED|Overall Study||0
339662|NCT01349231|813388|P1|COMPLETED|Overall Study||10
339663|NCT01349231|813388|P1|STARTED|Overall Study||10
339664|NCT01349192|813397|P2|NOT COMPLETED|Overall Study||6
339665|NCT01349192|813398|P1|NOT COMPLETED|Overall Study||3
339666|NCT01349192|813397|P2|COMPLETED|Overall Study||17
339667|NCT01349192|813398|P1|COMPLETED|Overall Study||21
339668|NCT01349192|813397|P2|Withdrawals|Overall Study||6
339669|NCT01349192|813398|P1|Withdrawals|Overall Study||3
339670|NCT01349192|813397|P2|Evaluable for Primary Endpoint|Overall Study||19
339671|NCT01349192|813398|P1|Evaluable for Primary Endpoint|Overall Study||22
339672|NCT01349192|813397|P2|STARTED|Overall Study||23
339673|NCT01349192|813398|P1|STARTED|Overall Study||24
339674|NCT01349114|813412|P2|NOT COMPLETED|Overall Study||0
339675|NCT01349114|813413|P1|NOT COMPLETED|Overall Study||0
339676|NCT01349114|813412|P2|COMPLETED|Overall Study||11
339677|NCT01349114|813413|P1|COMPLETED|Overall Study||10
339678|NCT01349114|813412|P2|STARTED|Overall Study||11
339679|NCT01349114|813413|P1|STARTED|Overall Study||10
339680|NCT01348854|813423|P2|NOT COMPLETED|Overall Study||1
339681|NCT01348854|813424|P1|NOT COMPLETED|Overall Study||3
339682|NCT01348854|813423|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
339683|NCT01348854|813424|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
339684|NCT01348854|813423|P2|STARTED|Overall Study|10 eyes of 6 participants|6
339685|NCT01348854|813424|P1|STARTED|Overall Study|53 eyes of 34 participants|34
339686|NCT01348789|813432|P1|NOT COMPLETED|Overall Study||4
339687|NCT01348789|813432|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
339688|NCT01348789|813432|P1|STARTED|Overall Study||37
339689|NCT01348776|813443|P1|NOT COMPLETED|Overall Study||3
339690|NCT01348776|813443|P1|COMPLETED|Overall Study||84
339691|NCT01348776|813443|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
339692|NCT01348607|813459|P3|NOT COMPLETED|Overall Study||0
339693|NCT01348607|813460|P2|NOT COMPLETED|Overall Study||0
339694|NCT01348607|813461|P1|NOT COMPLETED|Overall Study||0
339695|NCT01348607|813459|P3|COMPLETED|Overall Study||0
339696|NCT01348607|813460|P2|COMPLETED|Overall Study||0
339697|NCT01348607|813461|P1|COMPLETED|Overall Study||1
339698|NCT01348607|813459|P3|STARTED|Overall Study||0
339699|NCT01348607|813460|P2|STARTED|Overall Study||0
339700|NCT01348607|813461|P1|STARTED|Overall Study||1
339701|NCT01348425|813474|P2|NOT COMPLETED|Overall Study||1
339702|NCT01348425|813475|P1|NOT COMPLETED|Overall Study||1
339703|NCT01348425|813474|P2|COMPLETED|Overall Study||13
339704|NCT01348425|813475|P1|COMPLETED|Overall Study||30
339705|NCT01348425|813474|P2|STARTED|Overall Study||14
339706|NCT01348425|813475|P1|STARTED|Overall Study||31
339707|NCT01348165|813487|P7|NOT COMPLETED|Overall Study||1
339708|NCT01348165|813488|P6|NOT COMPLETED|Overall Study||0
339709|NCT01348165|813489|P5|NOT COMPLETED|Overall Study||0
339710|NCT01348165|813490|P4|NOT COMPLETED|Overall Study||0
339711|NCT01348165|813491|P3|NOT COMPLETED|Overall Study||0
339712|NCT01348165|813492|P2|NOT COMPLETED|Overall Study||0
339713|NCT01348165|813493|P1|NOT COMPLETED|Overall Study||0
339714|NCT01348165|813487|P7|COMPLETED|Overall Study||5
339715|NCT01348165|813488|P6|COMPLETED|Overall Study||1
339716|NCT01348165|813489|P5|COMPLETED|Overall Study||6
339717|NCT01348165|813490|P4|COMPLETED|Overall Study||6
339718|NCT01348165|813491|P3|COMPLETED|Overall Study||6
339719|NCT01348165|813492|P2|COMPLETED|Overall Study||5
339720|NCT01348165|813493|P1|COMPLETED|Overall Study||10
339721|NCT01348165|813487|P7|STARTED|Overall Study||6
339722|NCT01348165|813488|P6|STARTED|Overall Study||1
339723|NCT01348165|813489|P5|STARTED|Overall Study||6
339724|NCT01348165|813490|P4|STARTED|Overall Study||6
339725|NCT01348165|813491|P3|STARTED|Overall Study||6
339726|NCT01348165|813492|P2|STARTED|Overall Study||5
339727|NCT01348165|813493|P1|STARTED|Overall Study||10
339728|NCT01348139|813622|P6|NOT COMPLETED|Period 6||0
339729|NCT01348139|813623|P5|NOT COMPLETED|Period 6||0
339730|NCT01348139|813624|P4|NOT COMPLETED|Period 6||0
339731|NCT01348139|813625|P3|NOT COMPLETED|Period 6||0
339732|NCT01348139|813626|P2|NOT COMPLETED|Period 6||0
339733|NCT01348139|813627|P1|NOT COMPLETED|Period 6||0
339734|NCT01348139|813622|P6|COMPLETED|Period 6||4
339735|NCT01348139|813623|P5|COMPLETED|Period 6||5
339736|NCT01348139|813624|P4|COMPLETED|Period 6||4
339737|NCT01348139|813625|P3|COMPLETED|Period 6||4
339738|NCT01348139|813626|P2|COMPLETED|Period 6||4
339739|NCT01348139|813627|P1|COMPLETED|Period 6||4
339740|NCT01348139|813622|P6|STARTED|Period 6||4
339741|NCT01348139|813623|P5|STARTED|Period 6||5
339742|NCT01348139|813624|P4|STARTED|Period 6||4
339743|NCT01348139|813625|P3|STARTED|Period 6||4
339744|NCT01348139|813626|P2|STARTED|Period 6||4
339745|NCT01348139|813627|P1|STARTED|Period 6||4
339746|NCT01348139|813622|P6|NOT COMPLETED|Period 5||0
339747|NCT01348139|813623|P5|NOT COMPLETED|Period 5||0
339748|NCT01348139|813624|P4|NOT COMPLETED|Period 5||0
339749|NCT01348139|813625|P3|NOT COMPLETED|Period 5||0
339750|NCT01348139|813626|P2|NOT COMPLETED|Period 5||0
339751|NCT01348139|813627|P1|NOT COMPLETED|Period 5||0
339752|NCT01348139|813622|P6|COMPLETED|Period 5||4
339753|NCT01348139|813623|P5|COMPLETED|Period 5||5
339754|NCT01348139|813624|P4|COMPLETED|Period 5||4
339755|NCT01348139|813625|P3|COMPLETED|Period 5||4
339756|NCT01348139|813626|P2|COMPLETED|Period 5||4
339757|NCT01348139|813627|P1|COMPLETED|Period 5||4
339758|NCT01348139|813622|P6|STARTED|Period 5||4
339759|NCT01348139|813623|P5|STARTED|Period 5||5
339760|NCT01348139|813624|P4|STARTED|Period 5||4
339761|NCT01348139|813625|P3|STARTED|Period 5||4
339762|NCT01348139|813626|P2|STARTED|Period 5||4
339763|NCT01348139|813627|P1|STARTED|Period 5||4
339764|NCT01348139|813622|P6|NOT COMPLETED|Period 4||0
339765|NCT01348139|813623|P5|NOT COMPLETED|Period 4||0
339766|NCT01348139|813624|P4|NOT COMPLETED|Period 4||0
339767|NCT01348139|813625|P3|NOT COMPLETED|Period 4||0
339768|NCT01348139|813626|P2|NOT COMPLETED|Period 4||0
339769|NCT01348139|813627|P1|NOT COMPLETED|Period 4||0
339770|NCT01348139|813622|P6|COMPLETED|Period 4||4
339771|NCT01348139|813623|P5|COMPLETED|Period 4||5
339772|NCT01348139|813624|P4|COMPLETED|Period 4||4
339773|NCT01348139|813625|P3|COMPLETED|Period 4||4
339774|NCT01348139|813626|P2|COMPLETED|Period 4||4
339775|NCT01348139|813627|P1|COMPLETED|Period 4||4
339776|NCT01348139|813622|P6|STARTED|Period 4||4
339777|NCT01348139|813623|P5|STARTED|Period 4||5
339778|NCT01348139|813624|P4|STARTED|Period 4||4
339779|NCT01348139|813625|P3|STARTED|Period 4||4
339780|NCT01348139|813626|P2|STARTED|Period 4||4
339781|NCT01348139|813627|P1|STARTED|Period 4||4
339782|NCT01348139|813622|P6|NOT COMPLETED|Period 3||0
339783|NCT01348139|813623|P5|NOT COMPLETED|Period 3||0
339784|NCT01348139|813624|P4|NOT COMPLETED|Period 3||0
339785|NCT01348139|813625|P3|NOT COMPLETED|Period 3||0
339786|NCT01348139|813626|P2|NOT COMPLETED|Period 3||0
339787|NCT01348139|813627|P1|NOT COMPLETED|Period 3||0
339788|NCT01348139|813622|P6|COMPLETED|Period 3||4
339789|NCT01348139|813623|P5|COMPLETED|Period 3||5
339790|NCT01348139|813624|P4|COMPLETED|Period 3||4
339791|NCT01348139|813625|P3|COMPLETED|Period 3||4
339792|NCT01348139|813626|P2|COMPLETED|Period 3||4
339793|NCT01348139|813627|P1|COMPLETED|Period 3||4
339794|NCT01348139|813622|P6|STARTED|Period 3||4
339795|NCT01348139|813623|P5|STARTED|Period 3||5
339796|NCT01348139|813624|P4|STARTED|Period 3||4
339797|NCT01348139|813625|P3|STARTED|Period 3||4
339798|NCT01348139|813626|P2|STARTED|Period 3||4
339799|NCT01348139|813627|P1|STARTED|Period 3||4
339800|NCT01348139|813622|P6|NOT COMPLETED|Period 2||0
339801|NCT01348139|813623|P5|NOT COMPLETED|Period 2||0
339802|NCT01348139|813624|P4|NOT COMPLETED|Period 2||0
339803|NCT01348139|813625|P3|NOT COMPLETED|Period 2||0
339804|NCT01348139|813626|P2|NOT COMPLETED|Period 2||0
339805|NCT01348139|813627|P1|NOT COMPLETED|Period 2||0
339806|NCT01348139|813622|P6|COMPLETED|Period 2||4
339807|NCT01348139|813623|P5|COMPLETED|Period 2||5
339808|NCT01348139|813624|P4|COMPLETED|Period 2||4
339809|NCT01348139|813625|P3|COMPLETED|Period 2||4
339810|NCT01348139|813626|P2|COMPLETED|Period 2||4
339811|NCT01348139|813627|P1|COMPLETED|Period 2||4
339812|NCT01348139|813622|P6|STARTED|Period 2||4
339813|NCT01348139|813623|P5|STARTED|Period 2||5
339814|NCT01348139|813624|P4|STARTED|Period 2||4
339815|NCT01348139|813625|P3|STARTED|Period 2||4
339816|NCT01348139|813626|P2|STARTED|Period 2||4
339817|NCT01348139|813627|P1|STARTED|Period 2||4
339818|NCT01348139|813622|P6|NOT COMPLETED|Period 1||0
339819|NCT01348139|813623|P5|NOT COMPLETED|Period 1||0
339820|NCT01348139|813624|P4|NOT COMPLETED|Period 1||0
339821|NCT01348139|813625|P3|NOT COMPLETED|Period 1||0
339822|NCT01348139|813626|P2|NOT COMPLETED|Period 1||0
339823|NCT01348139|813627|P1|NOT COMPLETED|Period 1||1
339824|NCT01348139|813622|P6|COMPLETED|Period 1||4
339825|NCT01348139|813623|P5|COMPLETED|Period 1||5
339826|NCT01348139|813624|P4|COMPLETED|Period 1||4
339827|NCT01348139|813625|P3|COMPLETED|Period 1||4
339828|NCT01348139|813626|P2|COMPLETED|Period 1||4
339829|NCT01348139|813627|P1|COMPLETED|Period 1||4
339830|NCT01348139|813622|P6|STARTED|Period 1||4
339831|NCT01348139|813623|P5|STARTED|Period 1||5
339832|NCT01348139|813624|P4|STARTED|Period 1||4
339833|NCT01348139|813625|P3|STARTED|Period 1||4
339834|NCT01348139|813626|P2|STARTED|Period 1||4
339835|NCT01348139|813627|P1|STARTED|Period 1||5
339836|NCT01348100|813708|P7|NOT COMPLETED|Overall Study||3
339837|NCT01348100|813709|P6|NOT COMPLETED|Overall Study||2
339838|NCT01348100|813710|P5|NOT COMPLETED|Overall Study||1
339839|NCT01348100|813711|P4|NOT COMPLETED|Overall Study||1
339840|NCT01348100|813712|P3|NOT COMPLETED|Overall Study||2
339841|NCT01348100|813713|P2|NOT COMPLETED|Overall Study||0
339842|NCT01348100|813714|P1|NOT COMPLETED|Overall Study||0
339843|NCT01348100|813708|P7|COMPLETED|Overall Study||13
339844|NCT01348100|813709|P6|COMPLETED|Overall Study||14
339845|NCT01348100|813710|P5|COMPLETED|Overall Study||14
339846|NCT01348100|813711|P4|COMPLETED|Overall Study||14
339847|NCT01348100|813712|P3|COMPLETED|Overall Study||13
339848|NCT01348100|813713|P2|COMPLETED|Overall Study||2
339849|NCT01348100|813714|P1|COMPLETED|Overall Study||2
339850|NCT01348100|813708|P7|STARTED|Overall Study||16
339851|NCT01348100|813709|P6|STARTED|Overall Study||16
339852|NCT01348100|813710|P5|STARTED|Overall Study||15
339853|NCT01348100|813711|P4|STARTED|Overall Study||15
339854|NCT01348100|813712|P3|STARTED|Overall Study||15
339855|NCT01348100|813713|P2|STARTED|Overall Study||2
339856|NCT01348100|813714|P1|STARTED|Overall Study||2
339857|NCT01348087|813759|P1|NOT COMPLETED|Overall Study||148
339858|NCT01348087|813759|P1|COMPLETED|Overall Study||0
339859|NCT01348087|813759|P1|STARTED|Overall Study||148
339860|NCT01347931|813773|P1|NOT COMPLETED|NIOV System||0
339861|NCT01347931|813773|P1|COMPLETED|NIOV System||29
339862|NCT01347931|813773|P1|STARTED|NIOV System||29
339863|NCT01347931|813773|P1|NOT COMPLETED|Standard Oxygen Therapy||1
339864|NCT01347931|813773|P1|COMPLETED|Standard Oxygen Therapy||29
339865|NCT01347931|813773|P1|STARTED|Standard Oxygen Therapy||30
339866|NCT01347879|813785|P2|NOT COMPLETED|Overall Study||17
339867|NCT01347879|813786|P1|NOT COMPLETED|Overall Study||7
339868|NCT01347879|813785|P2|COMPLETED|Overall Study||83
339869|NCT01347879|813786|P1|COMPLETED|Overall Study||46
339870|NCT01347879|813785|P2|STARTED|Overall Study||100
339871|NCT01347879|813786|P1|STARTED|Overall Study||53
339872|NCT01347840|813818|P1|NOT COMPLETED|Overall Study||1
339873|NCT01347840|813818|P1|COMPLETED|Overall Study||0
339874|NCT01347840|813818|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
339875|NCT01347788|813831|P3|NOT COMPLETED|Overall Study||0
339876|NCT01347788|813832|P2|NOT COMPLETED|Overall Study||0
339877|NCT01347788|813833|P1|NOT COMPLETED|Overall Study||0
339878|NCT01347788|813831|P3|COMPLETED|Overall Study||13
339879|NCT01347788|813832|P2|COMPLETED|Overall Study||10
339880|NCT01347788|813833|P1|COMPLETED|Overall Study||11
339881|NCT01347788|813831|P3|STARTED|Overall Study||13
339882|NCT01347788|813832|P2|STARTED|Overall Study||10
339883|NCT01347788|813833|P1|STARTED|Overall Study||11
339884|NCT01347710|813841|P1|NOT COMPLETED|Overall Study||31
339885|NCT01347710|813841|P1|COMPLETED|Overall Study||764
339886|NCT01347710|813841|P1|STARTED|Overall Study||795
339887|NCT01347632|813856|P1|NOT COMPLETED|Overall Study||2
339888|NCT01347632|813856|P1|COMPLETED|Overall Study||33
339889|NCT01347632|813856|P1|STARTED|Overall Study||35
339890|NCT01347580|813862|P2|NOT COMPLETED|Overall Study||56
339891|NCT01347580|813863|P1|NOT COMPLETED|Overall Study||65
339892|NCT01347580|813862|P2|COMPLETED|Overall Study|based on randomized treatment|897
339893|NCT01347580|813863|P1|COMPLETED|Overall Study|based on randomized treatment|844
339894|NCT01347580|813862|P2|Safety Population|Overall Study|based on actual treatment|950
339895|NCT01347580|813863|P1|Safety Population|Overall Study|based on actual treatment|908
339896|NCT01347580|813862|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
339897|NCT01347580|813863|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
339898|NCT01347580|813862|P2|STARTED|Overall Study|based on randomized treatment|953
339899|NCT01347580|813863|P1|STARTED|Overall Study|based on randomized treatment|909
339900|NCT01347554|813893|P2|NOT COMPLETED|Overall Study||11
339901|NCT01347554|813894|P1|NOT COMPLETED|Overall Study||7
339902|NCT01347554|813893|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
339903|NCT01347554|813894|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
339904|NCT01347554|813893|P2|STARTED|Overall Study||242
339905|NCT01347554|813894|P1|STARTED|Overall Study||237
339906|NCT01347255|813906|P1|NOT COMPLETED|Overall Study||0
339907|NCT01347255|813906|P1|COMPLETED|Overall Study||24
339908|NCT01347255|813906|P1|STARTED|Overall Study||24
339909|NCT01347112|813931|P2|NOT COMPLETED|Overall Study||12
339910|NCT01347112|813932|P1|NOT COMPLETED|Overall Study||4
339911|NCT01347112|813931|P2|COMPLETED|Overall Study||5
339912|NCT01347112|813932|P1|COMPLETED|Overall Study||12
339913|NCT01347112|813931|P2|STARTED|Overall Study||17
339914|NCT01347112|813932|P1|STARTED|Overall Study||16
339915|NCT01347086|813952|P10|NOT COMPLETED|Overall Study||1
339916|NCT01347086|813953|P9|NOT COMPLETED|Overall Study||0
339917|NCT01347086|813954|P8|NOT COMPLETED|Overall Study||1
339918|NCT01347086|813955|P7|NOT COMPLETED|Overall Study||1
339919|NCT01347086|813956|P6|NOT COMPLETED|Overall Study||0
339920|NCT01347086|813957|P5|NOT COMPLETED|Overall Study||0
339921|NCT01347086|813958|P4|NOT COMPLETED|Overall Study||0
339922|NCT01347086|813959|P3|NOT COMPLETED|Overall Study||1
339923|NCT01347086|813960|P2|NOT COMPLETED|Overall Study||0
339924|NCT01347086|813961|P1|NOT COMPLETED|Overall Study||0
339925|NCT01347086|813952|P10|COMPLETED|Overall Study||6
339926|NCT01347086|813953|P9|COMPLETED|Overall Study||6
339927|NCT01347086|813954|P8|COMPLETED|Overall Study||6
339928|NCT01347086|813955|P7|COMPLETED|Overall Study||6
339929|NCT01347086|813956|P6|COMPLETED|Overall Study||6
339930|NCT01347086|813957|P5|COMPLETED|Overall Study||6
339931|NCT01347086|813958|P4|COMPLETED|Overall Study||6
339932|NCT01347086|813959|P3|COMPLETED|Overall Study||6
339933|NCT01347086|813960|P2|COMPLETED|Overall Study||6
339934|NCT01347086|813961|P1|COMPLETED|Overall Study||2
339935|NCT01347086|813952|P10|STARTED|Overall Study|One subject was not treated.|7
339936|NCT01347086|813953|P9|STARTED|Overall Study||6
339937|NCT01347086|813954|P8|STARTED|Overall Study|One subject was not treated.|7
339938|NCT01347086|813955|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
339939|NCT01347086|813956|P6|STARTED|Overall Study||6
339940|NCT01347086|813957|P5|STARTED|Overall Study||6
339941|NCT01347086|813958|P4|STARTED|Overall Study||6
339942|NCT01347086|813959|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
339943|NCT01347086|813960|P2|STARTED|Overall Study||6
339944|NCT01347086|813961|P1|STARTED|Overall Study||2
339945|NCT01347073|814060|P1|NOT COMPLETED|Overall Study||2
339946|NCT01347073|814060|P1|COMPLETED|Overall Study||21
339947|NCT01347073|814060|P1|STARTED|Overall Study||23
339948|NCT01347060|814074|P2|NOT COMPLETED|Overall Study||0
339949|NCT01347060|814075|P1|NOT COMPLETED|Overall Study||0
339950|NCT01347060|814074|P2|COMPLETED|Overall Study||7580
339951|NCT01347060|814075|P1|COMPLETED|Overall Study||9868
339952|NCT01347060|814074|P2|STARTED|Overall Study||7580
339953|NCT01347060|814075|P1|STARTED|Overall Study||9868
339954|NCT01347034|814087|P2|NOT COMPLETED|Overall Study||0
339955|NCT01347034|814088|P1|NOT COMPLETED|Overall Study||0
339956|NCT01347034|814087|P2|COMPLETED|Overall Study||14
339957|NCT01347034|814088|P1|COMPLETED|Overall Study||6
339958|NCT01347034|814087|P2|STARTED|Overall Study||14
339959|NCT01347034|814088|P1|STARTED|Overall Study||6
339960|NCT01347008|814098|P2|NOT COMPLETED|Overall Study||0
339961|NCT01347008|814099|P1|NOT COMPLETED|Overall Study||0
339962|NCT01347008|814098|P2|COMPLETED|Overall Study||20
339963|NCT01347008|814099|P1|COMPLETED|Overall Study||21
339964|NCT01347008|814098|P2|STARTED|Overall Study||20
339965|NCT01347008|814099|P1|STARTED|Overall Study||21
339966|NCT01346852|814111|P2|NOT COMPLETED|Overall Study||0
339967|NCT01346852|814112|P1|NOT COMPLETED|Overall Study||0
339968|NCT01346852|814111|P2|COMPLETED|Overall Study||59684
339969|NCT01346852|814112|P1|COMPLETED|Overall Study||41753
339970|NCT01346852|814111|P2|STARTED|Overall Study||59684
339971|NCT01346852|814112|P1|STARTED|Overall Study||41753
339972|NCT01346839|814122|P2|NOT COMPLETED|Overall Study||209
339973|NCT01346839|814123|P1|NOT COMPLETED|Overall Study||314
339974|NCT01346839|814122|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
339975|NCT01346839|814123|P1|COMPLETED|Overall Study||369
339976|NCT01346839|814122|P2|STARTED|Overall Study||573
339977|NCT01346839|814123|P1|STARTED|Overall Study||683
339978|NCT01346774|814139|P2|NOT COMPLETED|Overall Study||17
339979|NCT01346774|814140|P1|NOT COMPLETED|Overall Study||13
339980|NCT01346774|814139|P2|COMPLETED|Overall Study||63
339981|NCT01346774|814140|P1|COMPLETED|Overall Study||67
339982|NCT01346774|814139|P2|STARTED|Overall Study||80
339983|NCT01346774|814140|P1|STARTED|Overall Study||80
339984|NCT01346592|814149|P3|NOT COMPLETED|Overall Study||78
339985|NCT01346592|814150|P2|NOT COMPLETED|Overall Study||89
339986|NCT01346592|814151|P1|NOT COMPLETED|Overall Study||153
339987|NCT01346592|814149|P3|COMPLETED|Overall Study||1408
339988|NCT01346592|814150|P2|COMPLETED|Overall Study||1389
339989|NCT01346592|814151|P1|COMPLETED|Overall Study||2983
339990|NCT01346592|814149|P3|STARTED|Overall Study||1486
339991|NCT01346592|814150|P2|STARTED|Overall Study||1478
339992|NCT01346592|814151|P1|STARTED|Overall Study||3136
339993|NCT01346514|814243|P2|NOT COMPLETED|Overall Study||37
339994|NCT01346514|814244|P1|NOT COMPLETED|Overall Study||29
339995|NCT01346514|814243|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
339996|NCT01346514|814244|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
339997|NCT01346514|814243|P2|12 Month Assessment|Overall Study||53
339998|NCT01346514|814244|P1|12 Month Assessment|Overall Study||62
339999|NCT01346514|814243|P2|9 Month Assessment|Overall Study||59
340000|NCT01346514|814244|P1|9 Month Assessment|Overall Study||67
340001|NCT01346514|814243|P2|6 Month Assessment|Overall Study||61
340002|NCT01346514|814244|P1|6 Month Assessment|Overall Study||74
340003|NCT01346514|814243|P2|3 Month Assessment|Overall Study||68
340004|NCT01346514|814244|P1|3 Month Assessment|Overall Study||83
340005|NCT01346514|814243|P2|STARTED|Overall Study||90
340006|NCT01346514|814244|P1|STARTED|Overall Study||91
340007|NCT01346501|814264|P2|NOT COMPLETED|Overall Study||13
340008|NCT01346501|814265|P1|NOT COMPLETED|Overall Study||11
340009|NCT01346501|814264|P2|COMPLETED|Overall Study||80
340010|NCT01346501|814265|P1|COMPLETED|Overall Study||68
340011|NCT01346501|814264|P2|STARTED|Overall Study||93
340012|NCT01346501|814265|P1|STARTED|Overall Study||79
340013|NCT01346488|814278|P1|NOT COMPLETED|Overall Study||706
340014|NCT01346488|814278|P1|COMPLETED|Overall Study||1262
340015|NCT01346488|814278|P1|STARTED|Overall Study||1968
340016|NCT01346475|814298|P2|NOT COMPLETED|Second Intervention||0
340017|NCT01346475|814299|P1|NOT COMPLETED|Second Intervention||0
340018|NCT01346475|814298|P2|COMPLETED|Second Intervention||25
340019|NCT01346475|814299|P1|COMPLETED|Second Intervention||18
340020|NCT01346475|814298|P2|STARTED|Second Intervention||25
340021|NCT01346475|814299|P1|STARTED|Second Intervention||18
340022|NCT01346475|814298|P2|NOT COMPLETED|First Intervention||3
340023|NCT01346475|814299|P1|NOT COMPLETED|First Intervention||4
340024|NCT01346475|814298|P2|COMPLETED|First Intervention||25
340025|NCT01346475|814299|P1|COMPLETED|First Intervention||18
340026|NCT01346475|814298|P2|STARTED|First Intervention||28
340027|NCT01346475|814299|P1|STARTED|First Intervention||22
340028|NCT01346397|814313|P2|NOT COMPLETED|Overall Study||0
340029|NCT01346397|814314|P1|NOT COMPLETED|Overall Study||0
340030|NCT01346397|814313|P2|COMPLETED|Overall Study||85
340031|NCT01346397|814314|P1|COMPLETED|Overall Study||85
340032|NCT01346397|814313|P2|STARTED|Overall Study||85
340033|NCT01346397|814314|P1|STARTED|Overall Study||85
340034|NCT01346293|814324|P2|NOT COMPLETED|Overall Study||21
340035|NCT01346293|814325|P1|NOT COMPLETED|Overall Study||67
340036|NCT01346293|814324|P2|COMPLETED|Overall Study||608
340037|NCT01346293|814325|P1|COMPLETED|Overall Study||2676
340038|NCT01346293|814324|P2|STARTED|Overall Study||629
340039|NCT01346293|814325|P1|STARTED|Overall Study||2743
340040|NCT01346176|814354|P3|NOT COMPLETED|Completed Satisfaction Survey||6
340041|NCT01346176|814355|P2|NOT COMPLETED|Completed Satisfaction Survey||4
340042|NCT01346176|814356|P1|NOT COMPLETED|Completed Satisfaction Survey||6
340043|NCT01346176|814354|P3|COMPLETED|Completed Satisfaction Survey||27
340044|NCT01346176|814355|P2|COMPLETED|Completed Satisfaction Survey||22
340045|NCT01346176|814356|P1|COMPLETED|Completed Satisfaction Survey||29
340046|NCT01346176|814354|P3|STARTED|Completed Satisfaction Survey||33
340047|NCT01346176|814355|P2|STARTED|Completed Satisfaction Survey||26
340048|NCT01346176|814356|P1|STARTED|Completed Satisfaction Survey||35
340049|NCT01346176|814354|P3|NOT COMPLETED|Completed Advance Directive||10
340050|NCT01346176|814355|P2|NOT COMPLETED|Completed Advance Directive||14
340051|NCT01346176|814356|P1|NOT COMPLETED|Completed Advance Directive||13
340052|NCT01346176|814354|P3|COMPLETED|Completed Advance Directive||33
340053|NCT01346176|814355|P2|COMPLETED|Completed Advance Directive||26
340054|NCT01346176|814356|P1|COMPLETED|Completed Advance Directive||35
340055|NCT01346176|814354|P3|STARTED|Completed Advance Directive||43
340056|NCT01346176|814355|P2|STARTED|Completed Advance Directive||40
340057|NCT01346176|814356|P1|STARTED|Completed Advance Directive||48
340058|NCT01346176|814354|P3|NOT COMPLETED|Recruited||0
340059|NCT01346176|814355|P2|NOT COMPLETED|Recruited||0
340060|NCT01346176|814356|P1|NOT COMPLETED|Recruited||1
340061|NCT01346176|814354|P3|COMPLETED|Recruited||43
340062|NCT01346176|814355|P2|COMPLETED|Recruited||40
340063|NCT01346176|814356|P1|COMPLETED|Recruited||48
340064|NCT01346176|814354|P3|STARTED|Recruited||43
340065|NCT01346176|814355|P2|STARTED|Recruited||40
340066|NCT01346176|814356|P1|STARTED|Recruited||49
340067|NCT01346085|814367|P1|NOT COMPLETED|Overall Study||0
340068|NCT01346085|814367|P1|COMPLETED|Overall Study||10
340069|NCT01346085|814367|P1|STARTED|Overall Study||10
340070|NCT01346072|814374|P2|NOT COMPLETED|Overall Study||0
340071|NCT01346072|814375|P1|NOT COMPLETED|Overall Study||0
340072|NCT01346072|814374|P2|COMPLETED|Overall Study||10
340073|NCT01346072|814375|P1|COMPLETED|Overall Study||11
340074|NCT01346072|814374|P2|STARTED|Overall Study||10
340075|NCT01346072|814375|P1|STARTED|Overall Study||11
340076|NCT01346059|814385|P2|NOT COMPLETED|Overall Study||0
340077|NCT01346059|814386|P1|NOT COMPLETED|Overall Study||1
340078|NCT01346059|814385|P2|COMPLETED|Overall Study||1
340079|NCT01346059|814386|P1|COMPLETED|Overall Study||0
340080|NCT01346059|814385|P2|STARTED|Overall Study||1
340081|NCT01346059|814386|P1|STARTED|Overall Study||1
340082|NCT01345929|814398|P2|NOT COMPLETED|Overall Study||19
340083|NCT01345929|814399|P1|NOT COMPLETED|Overall Study||21
340084|NCT01345929|814398|P2|COMPLETED|Overall Study||516
340085|NCT01345929|814399|P1|COMPLETED|Overall Study||512
340086|NCT01345929|814398|P2|STARTED|Overall Study||535
340087|NCT01345929|814399|P1|STARTED|Overall Study||533
340088|NCT01345786|814411|P4|NOT COMPLETED|Overall Study||3
340089|NCT01345786|814412|P3|NOT COMPLETED|Overall Study||5
340090|NCT01345786|814413|P2|NOT COMPLETED|Overall Study||8
340091|NCT01345786|814414|P1|NOT COMPLETED|Overall Study||6
340092|NCT01345786|814411|P4|COMPLETED|Overall Study||35
340093|NCT01345786|814412|P3|COMPLETED|Overall Study||33
340094|NCT01345786|814413|P2|COMPLETED|Overall Study||33
340095|NCT01345786|814414|P1|COMPLETED|Overall Study||35
340096|NCT01345786|814411|P4|Treated|Overall Study||37
340097|NCT01345786|814412|P3|Treated|Overall Study||37
340098|NCT01345786|814413|P2|Treated|Overall Study||41
340099|NCT01345786|814414|P1|Treated|Overall Study||41
340100|NCT01345786|814411|P4|STARTED|Overall Study|Number randomized|38
340101|NCT01345786|814412|P3|STARTED|Overall Study|Number randomized|38
340102|NCT01345786|814413|P2|STARTED|Overall Study|Number randomized|41
340103|NCT01345786|814414|P1|STARTED|Overall Study|Number randomized|41
340104|NCT01345721|814463|P3|NOT COMPLETED|Overall Study||0
340105|NCT01345721|814464|P2|NOT COMPLETED|Overall Study||0
340106|NCT01345721|814465|P1|NOT COMPLETED|Overall Study||0
340107|NCT01345721|814463|P3|COMPLETED|Overall Study||65
340108|NCT01345721|814464|P2|COMPLETED|Overall Study||66
340109|NCT01345721|814465|P1|COMPLETED|Overall Study||74
340110|NCT01345721|814463|P3|STARTED|Overall Study||65
340111|NCT01345721|814464|P2|STARTED|Overall Study||66
340112|NCT01345721|814465|P1|STARTED|Overall Study||74
340113|NCT01345682|814494|P2|NOT COMPLETED|Overall Study||157
340114|NCT01345682|814495|P1|NOT COMPLETED|Overall Study||306
340115|NCT01345682|814494|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|4
340116|NCT01345682|814495|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|16
340117|NCT01345682|814494|P2|STARTED|Overall Study|Randomised|161
340118|NCT01345682|814495|P1|STARTED|Overall Study|Randomised|322
340119|NCT01345630|814529|P2|NOT COMPLETED|Overall Study||359
340120|NCT01345630|814530|P1|NOT COMPLETED|Overall Study||361
340121|NCT01345630|814529|P2|COMPLETED|Overall Study||42
340122|NCT01345630|814530|P1|COMPLETED|Overall Study||35
340123|NCT01345630|814529|P2|STARTED|Overall Study||401
340124|NCT01345630|814530|P1|STARTED|Overall Study||396
340125|NCT01345591|814586|P1|NOT COMPLETED|Overall Study||1
340126|NCT01345591|814586|P1|COMPLETED|Overall Study||19
340127|NCT01345591|814586|P1|STARTED|Overall Study||20
340128|NCT01345318|814595|P1|NOT COMPLETED|Overall Study||80
340129|NCT01345318|814595|P1|COMPLETED|Overall Study||111
340130|NCT01345318|814595|P1|STARTED|Overall Study||191
340131|NCT01345292|814603|P3|NOT COMPLETED|Overall Study||1
340132|NCT01345292|814604|P2|NOT COMPLETED|Overall Study||0
340133|NCT01345292|814605|P1|NOT COMPLETED|Overall Study||2
340134|NCT01345292|814603|P3|COMPLETED|Overall Study||74
340135|NCT01345292|814604|P2|COMPLETED|Overall Study||76
340136|NCT01345292|814605|P1|COMPLETED|Overall Study||73
340137|NCT01345292|814603|P3|STARTED|Overall Study||75
340138|NCT01345292|814604|P2|STARTED|Overall Study||76
340139|NCT01345292|814605|P1|STARTED|Overall Study||75
340140|NCT01345253|814636|P2|NOT COMPLETED|Overall Study||79
340141|NCT01345253|814637|P1|NOT COMPLETED|Overall Study||56
340142|NCT01345253|814636|P2|COMPLETED|Overall Study||372
340143|NCT01345253|814637|P1|COMPLETED|Overall Study||170
340144|NCT01345253|814636|P2|STARTED|Overall Study||451
340145|NCT01345253|814637|P1|STARTED|Overall Study||226
340146|NCT01345240|814656|P5|NOT COMPLETED|Overall Study||7
340147|NCT01345240|814657|P4|NOT COMPLETED|Overall Study||10
340148|NCT01345240|814658|P3|NOT COMPLETED|Overall Study||10
340149|NCT01345240|814659|P2|NOT COMPLETED|Overall Study||14
340150|NCT01345240|814660|P1|NOT COMPLETED|Overall Study||2
340151|NCT01345240|814656|P5|COMPLETED|Overall Study||132
340152|NCT01345240|814657|P4|COMPLETED|Overall Study||131
340153|NCT01345240|814658|P3|COMPLETED|Overall Study||131
340154|NCT01345240|814659|P2|COMPLETED|Overall Study||128
340155|NCT01345240|814660|P1|COMPLETED|Overall Study||140
340156|NCT01345240|814656|P5|STARTED|Overall Study||139
340157|NCT01345240|814657|P4|STARTED|Overall Study||141
340158|NCT01345240|814658|P3|STARTED|Overall Study||141
340159|NCT01345240|814659|P2|STARTED|Overall Study||142
340160|NCT01345240|814660|P1|STARTED|Overall Study||142
340161|NCT01345162|814755|P2|NOT COMPLETED|Overall Study||4
340162|NCT01345162|814756|P1|NOT COMPLETED|Overall Study||2
340163|NCT01345162|814755|P2|COMPLETED|Overall Study||96
340164|NCT01345162|814756|P1|COMPLETED|Overall Study||98
340165|NCT01345162|814755|P2|STARTED|Overall Study||100
340166|NCT01345162|814756|P1|STARTED|Overall Study||100
340167|NCT01345123|814765|P3|NOT COMPLETED|Overall Study||88
340168|NCT01345123|814766|P2|NOT COMPLETED|Overall Study||85
340169|NCT01345123|814767|P1|NOT COMPLETED|Overall Study||79
340170|NCT01345123|814765|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
340171|NCT01345123|814766|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
340172|NCT01345123|814767|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
340173|NCT01345123|814765|P3|STARTED|Overall Study||3291
340174|NCT01345123|814766|P2|STARTED|Overall Study||3311
340175|NCT01345123|814767|P1|STARTED|Overall Study||3323
340176|NCT01345058|814789|P2|NOT COMPLETED|Overall Study||0
340177|NCT01345058|814790|P1|NOT COMPLETED|Overall Study||5
340178|NCT01345058|814789|P2|COMPLETED|Overall Study||36
340179|NCT01345058|814790|P1|COMPLETED|Overall Study||15
340180|NCT01345058|814789|P2|Received Lacosamide|Overall Study||0
340181|NCT01345058|814790|P1|Received Lacosamide|Overall Study||19
340182|NCT01345058|814789|P2|STARTED|Overall Study||36
340183|NCT01345058|814790|P1|STARTED|Overall Study||20
340184|NCT01344876|814804|P5|NOT COMPLETED|Overall Study||1
340185|NCT01344876|814805|P4|NOT COMPLETED|Overall Study||3
340186|NCT01344876|814806|P3|NOT COMPLETED|Overall Study||1
340187|NCT01344876|814807|P2|NOT COMPLETED|Overall Study||0
340188|NCT01344876|814808|P1|NOT COMPLETED|Overall Study||1
340189|NCT01344876|814804|P5|COMPLETED|Overall Study||2
340190|NCT01344876|814805|P4|COMPLETED|Overall Study||3
340191|NCT01344876|814806|P3|COMPLETED|Overall Study||3
340192|NCT01344876|814807|P2|COMPLETED|Overall Study||3
340193|NCT01344876|814808|P1|COMPLETED|Overall Study||3
340194|NCT01344876|814804|P5|STARTED|Overall Study||3
340195|NCT01344876|814805|P4|STARTED|Overall Study||6
340196|NCT01344876|814806|P3|STARTED|Overall Study||4
340197|NCT01344876|814807|P2|STARTED|Overall Study||3
340198|NCT01344876|814808|P1|STARTED|Overall Study||4
340199|NCT01344759|814824|P2|NOT COMPLETED|Overall Study||2
340200|NCT01344759|814825|P1|NOT COMPLETED|Overall Study||0
340201|NCT01344759|814824|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
340202|NCT01344759|814825|P1|COMPLETED|Overall Study||30
340203|NCT01344759|814824|P2|STARTED|Overall Study||30
340204|NCT01344759|814825|P1|STARTED|Overall Study||30
340205|NCT01344629|814857|P2|NOT COMPLETED|Crossover Period 4||0
340206|NCT01344629|814858|P1|NOT COMPLETED|Crossover Period 4||0
340207|NCT01344629|814857|P2|COMPLETED|Crossover Period 4||31
340208|NCT01344629|814858|P1|COMPLETED|Crossover Period 4||32
340209|NCT01344629|814857|P2|STARTED|Crossover Period 4||31
340210|NCT01344629|814858|P1|STARTED|Crossover Period 4||32
340211|NCT01344629|814857|P2|NOT COMPLETED|Crossover Period 3||0
340212|NCT01344629|814858|P1|NOT COMPLETED|Crossover Period 3||0
340213|NCT01344629|814857|P2|COMPLETED|Crossover Period 3||31
340214|NCT01344629|814858|P1|COMPLETED|Crossover Period 3||32
340215|NCT01344629|814857|P2|STARTED|Crossover Period 3||31
340216|NCT01344629|814858|P1|STARTED|Crossover Period 3||32
340217|NCT01344629|814857|P2|NOT COMPLETED|Crossover Period 2||1
340218|NCT01344629|814858|P1|NOT COMPLETED|Crossover Period 2||0
340219|NCT01344629|814857|P2|COMPLETED|Crossover Period 2||31
340220|NCT01344629|814858|P1|COMPLETED|Crossover Period 2||32
340221|NCT01344629|814857|P2|STARTED|Crossover Period 2||32
340222|NCT01344629|814858|P1|STARTED|Crossover Period 2||32
340223|NCT01344629|814857|P2|NOT COMPLETED|Crossover Period 1||0
340224|NCT01344629|814858|P1|NOT COMPLETED|Crossover Period 1||0
340225|NCT01344629|814857|P2|COMPLETED|Crossover Period 1||32
340226|NCT01344629|814858|P1|COMPLETED|Crossover Period 1||32
340227|NCT01344629|814857|P2|STARTED|Crossover Period 1||32
340228|NCT01344629|814858|P1|STARTED|Crossover Period 1||32
340229|NCT01344616|814878|P2|NOT COMPLETED|Overall Study||44
340230|NCT01344616|814879|P1|NOT COMPLETED|Overall Study||35
340231|NCT01344616|814878|P2|COMPLETED|Overall Study||194
340232|NCT01344616|814879|P1|COMPLETED|Overall Study||209
340233|NCT01344616|814878|P2|STARTED|Overall Study||238
340234|NCT01344616|814879|P1|STARTED|Overall Study||244
340235|NCT01344538|814887|P2|NOT COMPLETED|Overall Study||1
340236|NCT01344538|814888|P1|NOT COMPLETED|Overall Study||2
340237|NCT01344538|814887|P2|COMPLETED|Overall Study||16
340238|NCT01344538|814888|P1|COMPLETED|Overall Study||14
340239|NCT01344538|814887|P2|STARTED|Overall Study||17
340240|NCT01344538|814888|P1|STARTED|Overall Study||16
340241|NCT01344460|814894|P1|NOT COMPLETED|Overall Study||3
340242|NCT01344460|814894|P1|COMPLETED|Overall Study||312
340243|NCT01344460|814894|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
340244|NCT01344460|814894|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
340245|NCT01344447|814939|P1|NOT COMPLETED|Overall Study||8
340246|NCT01344447|814939|P1|COMPLETED|Overall Study||471
340247|NCT01344447|814939|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
340248|NCT01344447|814939|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
340249|NCT01344369|814983|P2|NOT COMPLETED|Second Intervention||1
340250|NCT01344369|814984|P1|NOT COMPLETED|Second Intervention||0
340251|NCT01344369|814983|P2|COMPLETED|Second Intervention||16
340252|NCT01344369|814984|P1|COMPLETED|Second Intervention||17
340253|NCT01344369|814983|P2|STARTED|Second Intervention||17
340254|NCT01344369|814984|P1|STARTED|Second Intervention||17
340255|NCT01344369|814983|P2|NOT COMPLETED|Washout of 28 Days||1
340256|NCT01344369|814984|P1|NOT COMPLETED|Washout of 28 Days||1
340257|NCT01344369|814983|P2|COMPLETED|Washout of 28 Days||17
340258|NCT01344369|814984|P1|COMPLETED|Washout of 28 Days||17
340259|NCT01344369|814983|P2|STARTED|Washout of 28 Days||18
340260|NCT01344369|814984|P1|STARTED|Washout of 28 Days||18
340261|NCT01344369|814983|P2|NOT COMPLETED|First Intervention||0
340262|NCT01344369|814984|P1|NOT COMPLETED|First Intervention||0
340263|NCT01344369|814983|P2|COMPLETED|First Intervention||18
340264|NCT01344369|814984|P1|COMPLETED|First Intervention||18
340265|NCT01344369|814983|P2|STARTED|First Intervention||18
340266|NCT01344369|814984|P1|STARTED|First Intervention||18
340267|NCT01344161|815002|P2|NOT COMPLETED|Overall Study||3
340268|NCT01344161|815003|P1|NOT COMPLETED|Overall Study||5
340269|NCT01344161|815002|P2|COMPLETED|Overall Study||39
340270|NCT01344161|815003|P1|COMPLETED|Overall Study||38
340271|NCT01344161|815002|P2|STARTED|Overall Study||42
340272|NCT01344161|815003|P1|STARTED|Overall Study||43
340273|NCT01344057|815015|P1|NOT COMPLETED|Overall Study||1
340274|NCT01344057|815015|P1|COMPLETED|Overall Study||62
340275|NCT01344057|815015|P1|STARTED|Overall Study||63
340276|NCT01343901|815022|P1|NOT COMPLETED|Overall Study||113
340277|NCT01343901|815022|P1|COMPLETED|Overall Study||97
340278|NCT01343901|815022|P1|Efficacy Population|Overall Study||205
340279|NCT01343901|815022|P1|STARTED|Overall Study||210
340280|NCT01343888|815046|P3|NOT COMPLETED|Overall Study||22
340281|NCT01343888|815047|P2|NOT COMPLETED|Overall Study||39
340282|NCT01343888|815048|P1|NOT COMPLETED|Overall Study||25
340283|NCT01343888|815046|P3|COMPLETED|Overall Study||110
340284|NCT01343888|815047|P2|COMPLETED|Overall Study||222
340285|NCT01343888|815048|P1|COMPLETED|Overall Study||234
340286|NCT01343888|815046|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
340287|NCT01343888|815047|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
340288|NCT01343888|815048|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
340289|NCT01342770|815086|P1|NOT COMPLETED|Overall Study||0
340290|NCT01342770|815086|P1|COMPLETED|Overall Study||6
340291|NCT01342770|815086|P1|STARTED|Overall Study||6
340292|NCT01342757|815099|P1|NOT COMPLETED|Overall Study||0
340293|NCT01342757|815099|P1|COMPLETED|Overall Study||12
340294|NCT01342757|815099|P1|STARTED|Overall Study||12
340295|NCT01343823|815108|P4|NOT COMPLETED|Overall Study||1
340296|NCT01343823|815109|P3|NOT COMPLETED|Overall Study||0
340297|NCT01343823|815110|P2|NOT COMPLETED|Overall Study||0
340298|NCT01343823|815111|P1|NOT COMPLETED|Overall Study||2
340299|NCT01343823|815108|P4|COMPLETED|Overall Study||19
340300|NCT01343823|815109|P3|COMPLETED|Overall Study||19
340301|NCT01343823|815110|P2|COMPLETED|Overall Study||20
340302|NCT01343823|815111|P1|COMPLETED|Overall Study||18
340303|NCT01343823|815108|P4|STARTED|Overall Study||20
340304|NCT01343823|815109|P3|STARTED|Overall Study||19
340305|NCT01343823|815110|P2|STARTED|Overall Study||20
340306|NCT01343823|815111|P1|STARTED|Overall Study||20
340307|NCT01343667|815127|P2|NOT COMPLETED|Overall Study||56
340308|NCT01343667|815128|P1|NOT COMPLETED|Overall Study||12
340309|NCT01343667|815127|P2|COMPLETED|Overall Study||916
340310|NCT01343667|815128|P1|COMPLETED|Overall Study||413
340311|NCT01343667|815127|P2|STARTED|Overall Study||972
340312|NCT01343667|815128|P1|STARTED|Overall Study||425
340313|NCT01343485|815136|P2|NOT COMPLETED|Overall Study||134
340314|NCT01343485|815137|P1|NOT COMPLETED|Overall Study||149
340315|NCT01343485|815136|P2|COMPLETED|Overall Study||46
340316|NCT01343485|815137|P1|COMPLETED|Overall Study||36
340317|NCT01343485|815136|P2|STARTED|Overall Study||180
340318|NCT01343485|815137|P1|STARTED|Overall Study||185
340319|NCT01343277|815145|P2|NOT COMPLETED|Overall Study||193
340320|NCT01343277|815146|P1|NOT COMPLETED|Overall Study||384
340321|NCT01343277|815145|P2|COMPLETED|Overall Study||0
340322|NCT01343277|815146|P1|COMPLETED|Overall Study||0
340323|NCT01343277|815145|P2|Treated|Overall Study||172
340324|NCT01343277|815146|P1|Treated|Overall Study||378
340325|NCT01343277|815145|P2|STARTED|Overall Study||193
340326|NCT01343277|815146|P1|STARTED|Overall Study||384
340327|NCT01343251|815164|P2|NOT COMPLETED|Overall Study||0
340328|NCT01343251|815165|P1|NOT COMPLETED|Overall Study||0
340329|NCT01343251|815164|P2|COMPLETED|Overall Study||17
340330|NCT01343251|815165|P1|COMPLETED|Overall Study||16
340331|NCT01343251|815164|P2|STARTED|Overall Study||17
340332|NCT01343251|815165|P1|STARTED|Overall Study||16
340333|NCT01343082|815179|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
340334|NCT01343082|815180|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
340335|NCT01343082|815181|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
340336|NCT01343082|815179|P3|COMPLETED|Treatment Period , Switched to DE-111||31
340337|NCT01343082|815180|P2|COMPLETED|Treatment Period , Switched to DE-111||36
340338|NCT01343082|815181|P1|COMPLETED|Treatment Period , Switched to DE-111||43
340339|NCT01343082|815179|P3|STARTED|Treatment Period , Switched to DE-111||43
340340|NCT01343082|815180|P2|STARTED|Treatment Period , Switched to DE-111||45
340341|NCT01343082|815181|P1|STARTED|Treatment Period , Switched to DE-111||48
340342|NCT01343082|815179|P3|NOT COMPLETED|The run-in Period||5
340343|NCT01343082|815180|P2|NOT COMPLETED|The run-in Period||4
340344|NCT01343082|815181|P1|NOT COMPLETED|The run-in Period||3
340345|NCT01343082|815179|P3|COMPLETED|The run-in Period||43
340346|NCT01343082|815180|P2|COMPLETED|The run-in Period||45
340347|NCT01343082|815181|P1|COMPLETED|The run-in Period||48
340348|NCT01343082|815179|P3|STARTED|The run-in Period||48
340349|NCT01343082|815180|P2|STARTED|The run-in Period||49
340350|NCT01343082|815181|P1|STARTED|The run-in Period||51
340351|NCT01343056|815189|P4|NOT COMPLETED|Overall Study||9
340352|NCT01343056|815190|P3|NOT COMPLETED|Overall Study||3
340353|NCT01343056|815191|P2|NOT COMPLETED|Overall Study||5
340354|NCT01343056|815192|P1|NOT COMPLETED|Overall Study||7
340355|NCT01343056|815189|P4|COMPLETED|Overall Study||29
340356|NCT01343056|815190|P3|COMPLETED|Overall Study||29
340357|NCT01343056|815191|P2|COMPLETED|Overall Study||31
340358|NCT01343056|815192|P1|COMPLETED|Overall Study||28
340359|NCT01343056|815189|P4|STARTED|Overall Study||38
340360|NCT01343056|815190|P3|STARTED|Overall Study||32
340361|NCT01343056|815191|P2|STARTED|Overall Study||36
340362|NCT01343056|815192|P1|STARTED|Overall Study||35
340363|NCT01343004|815233|P3|NOT COMPLETED|Overall Study||160
340364|NCT01343004|815234|P2|NOT COMPLETED|Overall Study||218
340365|NCT01343004|815235|P1|NOT COMPLETED|Overall Study||184
340366|NCT01343004|815233|P3|COMPLETED|Overall Study||658
340367|NCT01343004|815234|P2|COMPLETED|Overall Study||606
340368|NCT01343004|815235|P1|COMPLETED|Overall Study||637
340369|NCT01343004|815233|P3|STARTED|Overall Study||818
340370|NCT01343004|815234|P2|STARTED|Overall Study||824
340371|NCT01343004|815235|P1|STARTED|Overall Study||821
340372|NCT01342965|815260|P2|NOT COMPLETED|Overall Study||107
340373|NCT01342965|815261|P1|NOT COMPLETED|Overall Study||109
340374|NCT01342965|815260|P2|COMPLETED|Overall Study||0
340375|NCT01342965|815261|P1|COMPLETED|Overall Study||1
340376|NCT01342965|815260|P2|Received Treatment|Overall Study||104
340377|NCT01342965|815261|P1|Received Treatment|Overall Study||110
340378|NCT01342965|815260|P2|STARTED|Overall Study||107
340379|NCT01342965|815261|P1|STARTED|Overall Study||110
340380|NCT01342926|815279|P4|NOT COMPLETED|Overall Study||12
340381|NCT01342926|815280|P3|NOT COMPLETED|Overall Study||14
340382|NCT01342926|815281|P2|NOT COMPLETED|Overall Study||15
340383|NCT01342926|815282|P1|NOT COMPLETED|Overall Study||9
340384|NCT01342926|815279|P4|COMPLETED|Overall Study||39
340385|NCT01342926|815280|P3|COMPLETED|Overall Study||34
340386|NCT01342926|815281|P2|COMPLETED|Overall Study||31
340387|NCT01342926|815282|P1|COMPLETED|Overall Study||37
340388|NCT01342926|815279|P4|STARTED|Overall Study||51
340389|NCT01342926|815280|P3|STARTED|Overall Study||48
340390|NCT01342926|815281|P2|STARTED|Overall Study||46
340391|NCT01342926|815282|P1|STARTED|Overall Study||46
340392|NCT01342913|815362|P3|NOT COMPLETED|Double-Blind Treatment Period||23
340393|NCT01342913|815363|P2|NOT COMPLETED|Double-Blind Treatment Period||16
340394|NCT01342913|815364|P1|NOT COMPLETED|Double-Blind Treatment Period||0
340395|NCT01342913|815362|P3|COMPLETED|Double-Blind Treatment Period||243
340396|NCT01342913|815363|P2|COMPLETED|Double-Blind Treatment Period||246
340397|NCT01342913|815364|P1|COMPLETED|Double-Blind Treatment Period||0
340398|NCT01342913|815362|P3|STARTED|Double-Blind Treatment Period||266
340399|NCT01342913|815363|P2|STARTED|Double-Blind Treatment Period||262
340400|NCT01342913|815364|P1|STARTED|Double-Blind Treatment Period||0
340401|NCT01342913|815362|P3|NOT COMPLETED|2-week Run-in Period||0
340402|NCT01342913|815363|P2|NOT COMPLETED|2-week Run-in Period||0
340403|NCT01342913|815364|P1|NOT COMPLETED|2-week Run-in Period||174
340404|NCT01342913|815362|P3|COMPLETED|2-week Run-in Period||0
340405|NCT01342913|815363|P2|COMPLETED|2-week Run-in Period||0
340406|NCT01342913|815364|P1|COMPLETED|2-week Run-in Period||528
340407|NCT01342913|815362|P3|STARTED|2-week Run-in Period||0
340408|NCT01342913|815363|P2|STARTED|2-week Run-in Period||0
340409|NCT01342913|815364|P1|STARTED|2-week Run-in Period||702
340410|NCT01342666|815376|P2|NOT COMPLETED|Overall Study||0
340411|NCT01342666|815377|P1|NOT COMPLETED|Overall Study||0
340412|NCT01342666|815376|P2|COMPLETED|Overall Study||24
340413|NCT01342666|815377|P1|COMPLETED|Overall Study||26
340414|NCT01342666|815376|P2|STARTED|Overall Study||24
340415|NCT01342666|815377|P1|STARTED|Overall Study||26
340416|NCT01342640|815383|P1|NOT COMPLETED|Overall Study||41
340417|NCT01342640|815383|P1|COMPLETED|Overall Study||29
340418|NCT01342640|815383|P1|STARTED|Overall Study||70
340419|NCT01342549|815391|P2|NOT COMPLETED|Overall Study||0
340420|NCT01342549|815392|P1|NOT COMPLETED|Overall Study||0
340421|NCT01342549|815391|P2|COMPLETED|Overall Study||31
340422|NCT01342549|815392|P1|COMPLETED|Overall Study||31
340423|NCT01342549|815391|P2|STARTED|Overall Study||31
340424|NCT01342549|815392|P1|STARTED|Overall Study||31
340425|NCT01342523|815430|P32|NOT COMPLETED|Overall Study||1
340426|NCT01342523|815431|P31|NOT COMPLETED|Overall Study||1
340427|NCT01342523|815432|P30|NOT COMPLETED|Overall Study||1
340428|NCT01342523|815433|P29|NOT COMPLETED|Overall Study||1
340429|NCT01342523|815434|P28|NOT COMPLETED|Overall Study||1
340430|NCT01342523|815435|P27|NOT COMPLETED|Overall Study||1
340431|NCT01342523|815436|P26|NOT COMPLETED|Overall Study||2
340432|NCT01342523|815437|P25|NOT COMPLETED|Overall Study||1
340433|NCT01342523|815438|P24|NOT COMPLETED|Overall Study||1
340434|NCT01342523|815439|P23|NOT COMPLETED|Overall Study||0
340435|NCT01342523|815440|P22|NOT COMPLETED|Overall Study||0
340436|NCT01342523|815441|P21|NOT COMPLETED|Overall Study||0
340437|NCT01342523|815442|P20|NOT COMPLETED|Overall Study||0
340438|NCT01342523|815443|P19|NOT COMPLETED|Overall Study||0
340439|NCT01342523|815444|P18|NOT COMPLETED|Overall Study||0
340440|NCT01342523|815445|P17|NOT COMPLETED|Overall Study||1
340441|NCT01342523|815446|P16|NOT COMPLETED|Overall Study||0
340442|NCT01342523|815447|P15|NOT COMPLETED|Overall Study||1
340443|NCT01342523|815448|P14|NOT COMPLETED|Overall Study||2
340444|NCT01342523|815449|P13|NOT COMPLETED|Overall Study||0
340445|NCT01342523|815450|P12|NOT COMPLETED|Overall Study||2
340446|NCT01342523|815451|P11|NOT COMPLETED|Overall Study||0
340447|NCT01342523|815452|P10|NOT COMPLETED|Overall Study||0
340448|NCT01342523|815453|P9|NOT COMPLETED|Overall Study||0
340449|NCT01342523|815454|P8|NOT COMPLETED|Overall Study||0
340450|NCT01342523|815455|P7|NOT COMPLETED|Overall Study||0
340451|NCT01342523|815456|P6|NOT COMPLETED|Overall Study||0
340452|NCT01342523|815457|P5|NOT COMPLETED|Overall Study||0
340453|NCT01342523|815458|P4|NOT COMPLETED|Overall Study||1
340454|NCT01342523|815459|P3|NOT COMPLETED|Overall Study||0
340455|NCT01342523|815460|P2|NOT COMPLETED|Overall Study||0
340456|NCT01342523|815461|P1|NOT COMPLETED|Overall Study||1
340457|NCT01342523|815430|P32|COMPLETED|Overall Study||27
340458|NCT01342523|815431|P31|COMPLETED|Overall Study||30
340459|NCT01342523|815432|P30|COMPLETED|Overall Study||28
340460|NCT01342523|815433|P29|COMPLETED|Overall Study||34
340461|NCT01342523|815434|P28|COMPLETED|Overall Study||30
340462|NCT01342523|815435|P27|COMPLETED|Overall Study||33
340463|NCT01342523|815436|P26|COMPLETED|Overall Study||36
340464|NCT01342523|815437|P25|COMPLETED|Overall Study||36
340465|NCT01342523|815438|P24|COMPLETED|Overall Study||35
340466|NCT01342523|815439|P23|COMPLETED|Overall Study||36
340467|NCT01342523|815440|P22|COMPLETED|Overall Study||30
340468|NCT01342523|815441|P21|COMPLETED|Overall Study||29
340469|NCT01342523|815442|P20|COMPLETED|Overall Study||27
340470|NCT01342523|815443|P19|COMPLETED|Overall Study||21
340471|NCT01342523|815444|P18|COMPLETED|Overall Study||27
340472|NCT01342523|815445|P17|COMPLETED|Overall Study||28
340473|NCT01342523|815446|P16|COMPLETED|Overall Study||32
340474|NCT01342523|815447|P15|COMPLETED|Overall Study||37
340475|NCT01342523|815448|P14|COMPLETED|Overall Study||36
340476|NCT01342523|815449|P13|COMPLETED|Overall Study||39
340477|NCT01342523|815450|P12|COMPLETED|Overall Study||36
340478|NCT01342523|815451|P11|COMPLETED|Overall Study||38
340479|NCT01342523|815452|P10|COMPLETED|Overall Study||28
340480|NCT01342523|815453|P9|COMPLETED|Overall Study||28
340481|NCT01342523|815454|P8|COMPLETED|Overall Study||27
340482|NCT01342523|815455|P7|COMPLETED|Overall Study||22
340483|NCT01342523|815456|P6|COMPLETED|Overall Study||36
340484|NCT01342523|815457|P5|COMPLETED|Overall Study||36
340485|NCT01342523|815458|P4|COMPLETED|Overall Study||32
340486|NCT01342523|815459|P3|COMPLETED|Overall Study||36
340487|NCT01342523|815460|P2|COMPLETED|Overall Study||32
340488|NCT01342523|815461|P1|COMPLETED|Overall Study||34
340489|NCT01342523|815430|P32|STARTED|Overall Study||28
340490|NCT01342523|815431|P31|STARTED|Overall Study||31
340491|NCT01342523|815432|P30|STARTED|Overall Study||29
340492|NCT01342523|815433|P29|STARTED|Overall Study||35
340493|NCT01342523|815434|P28|STARTED|Overall Study||31
340494|NCT01342523|815435|P27|STARTED|Overall Study||34
340495|NCT01342523|815436|P26|STARTED|Overall Study||38
340496|NCT01342523|815437|P25|STARTED|Overall Study||37
340497|NCT01342523|815438|P24|STARTED|Overall Study||36
340498|NCT01342523|815439|P23|STARTED|Overall Study||36
340499|NCT01342523|815440|P22|STARTED|Overall Study||30
340500|NCT01342523|815441|P21|STARTED|Overall Study||29
340501|NCT01342523|815442|P20|STARTED|Overall Study||27
340502|NCT01342523|815443|P19|STARTED|Overall Study||21
340503|NCT01342523|815444|P18|STARTED|Overall Study||27
340504|NCT01342523|815445|P17|STARTED|Overall Study||29
340505|NCT01342523|815446|P16|STARTED|Overall Study||32
340506|NCT01342523|815447|P15|STARTED|Overall Study||38
340507|NCT01342523|815448|P14|STARTED|Overall Study||38
340508|NCT01342523|815449|P13|STARTED|Overall Study||39
340509|NCT01342523|815450|P12|STARTED|Overall Study||38
340510|NCT01342523|815451|P11|STARTED|Overall Study||38
340511|NCT01342523|815452|P10|STARTED|Overall Study||28
340512|NCT01342523|815453|P9|STARTED|Overall Study||28
340513|NCT01342523|815454|P8|STARTED|Overall Study||27
340514|NCT01342523|815455|P7|STARTED|Overall Study||22
340515|NCT01342523|815456|P6|STARTED|Overall Study||36
340516|NCT01342523|815457|P5|STARTED|Overall Study||36
340517|NCT01342523|815458|P4|STARTED|Overall Study||33
340518|NCT01342523|815459|P3|STARTED|Overall Study||36
340519|NCT01342523|815460|P2|STARTED|Overall Study||32
340520|NCT01342523|815461|P1|STARTED|Overall Study||35
340521|NCT01342510|815478|P4|NOT COMPLETED|Overall Study||11
340522|NCT01342510|815479|P3|NOT COMPLETED|Overall Study||13
340523|NCT01342510|815480|P2|NOT COMPLETED|Overall Study||6
340524|NCT01342510|815481|P1|NOT COMPLETED|Overall Study||12
340525|NCT01342510|815478|P4|COMPLETED|Overall Study||39
340526|NCT01342510|815479|P3|COMPLETED|Overall Study||37
340527|NCT01342510|815480|P2|COMPLETED|Overall Study||44
340528|NCT01342510|815481|P1|COMPLETED|Overall Study||38
340529|NCT01342510|815478|P4|STARTED|Overall Study||50
340530|NCT01342510|815479|P3|STARTED|Overall Study||50
340531|NCT01342510|815480|P2|STARTED|Overall Study||50
340532|NCT01342510|815481|P1|STARTED|Overall Study||50
340533|NCT01342484|815494|P3|NOT COMPLETED|Overall Study||1
340534|NCT01342484|815495|P2|NOT COMPLETED|Overall Study||0
340535|NCT01342484|815496|P1|NOT COMPLETED|Overall Study||2
340536|NCT01342484|815494|P3|COMPLETED|Overall Study||13
340537|NCT01342484|815495|P2|COMPLETED|Overall Study||10
340538|NCT01342484|815496|P1|COMPLETED|Overall Study||13
340539|NCT01342484|815494|P3|STARTED|Overall Study||14
340540|NCT01342484|815495|P2|STARTED|Overall Study||10
340541|NCT01342484|815496|P1|STARTED|Overall Study||15
340542|NCT01342471|815512|P2|NOT COMPLETED|Overall Study||6
340543|NCT01342471|815513|P1|NOT COMPLETED|Overall Study||5
340544|NCT01342471|815512|P2|COMPLETED|Overall Study||23
340545|NCT01342471|815513|P1|COMPLETED|Overall Study||24
340546|NCT01342471|815512|P2|STARTED|Overall Study||29
340547|NCT01342471|815513|P1|STARTED|Overall Study||29
340548|NCT01342458|815529|P2|NOT COMPLETED|Overall Study||4
340549|NCT01342458|815530|P1|NOT COMPLETED|Overall Study||2
340550|NCT01342458|815529|P2|COMPLETED|Overall Study||24
340551|NCT01342458|815530|P1|COMPLETED|Overall Study||26
340552|NCT01342458|815529|P2|STARTED|Overall Study||28
340553|NCT01342458|815530|P1|STARTED|Overall Study||28
340554|NCT01342445|815552|P2|NOT COMPLETED|Overall Study||2
340555|NCT01342445|815553|P1|NOT COMPLETED|Overall Study||0
340556|NCT01342445|815552|P2|COMPLETED|Overall Study||22
340557|NCT01342445|815553|P1|COMPLETED|Overall Study||26
340558|NCT01342445|815552|P2|STARTED|Overall Study||24
340559|NCT01342445|815553|P1|STARTED|Overall Study||26
340560|NCT01342341|815569|P2|NOT COMPLETED|Overall Study||4
340561|NCT01342341|815570|P1|NOT COMPLETED|Overall Study||4
340562|NCT01342341|815569|P2|COMPLETED|Overall Study||20
340563|NCT01342341|815570|P1|COMPLETED|Overall Study||20
340564|NCT01342341|815569|P2|STARTED|Overall Study||24
340565|NCT01342341|815570|P1|STARTED|Overall Study||24
340566|NCT01342172|815576|P1|NOT COMPLETED|Overall Study||0
340567|NCT01342172|815576|P1|COMPLETED|Overall Study||9
340568|NCT01342172|815576|P1|STARTED|Overall Study||9
340569|NCT01342107|815582|P2|NOT COMPLETED|Overall Study||0
340570|NCT01342107|815583|P1|NOT COMPLETED|Overall Study||0
340571|NCT01342107|815582|P2|COMPLETED|Overall Study||32
340572|NCT01342107|815583|P1|COMPLETED|Overall Study||34
340573|NCT01342107|815582|P2|STARTED|Overall Study||32
340574|NCT01342107|815583|P1|STARTED|Overall Study||34
340575|NCT01342094|815591|P2|NOT COMPLETED|Overall Study||3
340576|NCT01342094|815592|P1|NOT COMPLETED|Overall Study||5
340577|NCT01342094|815591|P2|COMPLETED|Overall Study||81
340578|NCT01342094|815592|P1|COMPLETED|Overall Study||77
340579|NCT01342094|815591|P2|STARTED|Overall Study||84
340580|NCT01342094|815592|P1|STARTED|Overall Study||82
340581|NCT01342081|815601|P3|NOT COMPLETED|Overall Study||1
340582|NCT01342081|815602|P2|NOT COMPLETED|Overall Study||2
340583|NCT01342081|815603|P1|NOT COMPLETED|Overall Study||2
340584|NCT01342081|815601|P3|COMPLETED|Overall Study||163
340585|NCT01342081|815602|P2|COMPLETED|Overall Study||162
340586|NCT01342081|815603|P1|COMPLETED|Overall Study||159
340587|NCT01342081|815601|P3|STARTED|Overall Study||164
340588|NCT01342081|815602|P2|STARTED|Overall Study||164
340589|NCT01342081|815603|P1|STARTED|Overall Study||161
340590|NCT01341990|815613|P2|NOT COMPLETED|Overall Study||1
340591|NCT01341990|815614|P1|NOT COMPLETED|Overall Study||3
340592|NCT01341990|815613|P2|COMPLETED|Overall Study||32
340593|NCT01341990|815614|P1|COMPLETED|Overall Study||32
340594|NCT01341990|815613|P2|STARTED|Overall Study||33
340595|NCT01341990|815614|P1|STARTED|Overall Study||35
340596|NCT01341977|815624|P2|NOT COMPLETED|Overall Study||15
340597|NCT01341977|815625|P1|NOT COMPLETED|Overall Study||14
340598|NCT01341977|815624|P2|COMPLETED|Overall Study||270
340599|NCT01341977|815625|P1|COMPLETED|Overall Study||274
340600|NCT01341977|815624|P2|STARTED|Overall Study||285
340601|NCT01341977|815625|P1|STARTED|Overall Study||288
340602|NCT01341912|815631|P1|NOT COMPLETED|Overall Study||0
340603|NCT01341912|815631|P1|COMPLETED|Overall Study||3
340604|NCT01341912|815631|P1|STARTED|Overall Study||3
340605|NCT01341782|815638|P2|NOT COMPLETED|Overall Study||14
340606|NCT01341782|815639|P1|NOT COMPLETED|Overall Study||15
340607|NCT01341782|815638|P2|COMPLETED|Overall Study||114
340608|NCT01341782|815639|P1|COMPLETED|Overall Study||112
340609|NCT01341782|815638|P2|STARTED|Overall Study||128
340610|NCT01341782|815639|P1|STARTED|Overall Study||127
340611|NCT01341067|815655|P1|NOT COMPLETED|Overall Study||4
340612|NCT01341067|815655|P1|COMPLETED|Overall Study||26
340613|NCT01341067|815655|P1|STARTED|Overall Study||30
340614|NCT01340937|815666|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
340615|NCT01340937|815667|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
340616|NCT01340937|815668|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
340617|NCT01340937|815669|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
340618|NCT01340937|815666|P4|COMPLETED|Period 3: Toddler Vaccinations||319
340619|NCT01340937|815667|P3|COMPLETED|Period 3: Toddler Vaccinations||660
340620|NCT01340937|815668|P2|COMPLETED|Period 3: Toddler Vaccinations||641
340621|NCT01340937|815669|P1|COMPLETED|Period 3: Toddler Vaccinations||666
340622|NCT01340937|815666|P4|STARTED|Period 3: Toddler Vaccinations||329
340623|NCT01340937|815667|P3|STARTED|Period 3: Toddler Vaccinations||669
340624|NCT01340937|815668|P2|STARTED|Period 3: Toddler Vaccinations||658
340625|NCT01340937|815669|P1|STARTED|Period 3: Toddler Vaccinations||675
340626|NCT01340937|815666|P4|NOT COMPLETED|Period 2: Interim Period||41
340627|NCT01340937|815667|P3|NOT COMPLETED|Period 2: Interim Period||84
340628|NCT01340937|815668|P2|NOT COMPLETED|Period 2: Interim Period||79
340629|NCT01340937|815669|P1|NOT COMPLETED|Period 2: Interim Period||67
340630|NCT01340937|815666|P4|COMPLETED|Period 2: Interim Period||329
340631|NCT01340937|815667|P3|COMPLETED|Period 2: Interim Period||669
340632|NCT01340937|815668|P2|COMPLETED|Period 2: Interim Period||658
340633|NCT01340937|815669|P1|COMPLETED|Period 2: Interim Period||675
340634|NCT01340937|815666|P4|STARTED|Period 2: Interim Period||370
340635|NCT01340937|815667|P3|STARTED|Period 2: Interim Period||753
340636|NCT01340937|815668|P2|STARTED|Period 2: Interim Period||737
340637|NCT01340937|815669|P1|STARTED|Period 2: Interim Period||742
340638|NCT01340937|815666|P4|NOT COMPLETED|Period 1: Infant Series||32
340639|NCT01340937|815667|P3|NOT COMPLETED|Period 1: Infant Series||56
340640|NCT01340937|815668|P2|NOT COMPLETED|Period 1: Infant Series||60
340641|NCT01340937|815669|P1|NOT COMPLETED|Period 1: Infant Series||58
340642|NCT01340937|815666|P4|COMPLETED|Period 1: Infant Series||370
340643|NCT01340937|815667|P3|COMPLETED|Period 1: Infant Series||753
340644|NCT01340937|815668|P2|COMPLETED|Period 1: Infant Series||737
340645|NCT01340937|815669|P1|COMPLETED|Period 1: Infant Series||742
340646|NCT01340937|815666|P4|STARTED|Period 1: Infant Series||402
340647|NCT01340937|815667|P3|STARTED|Period 1: Infant Series||809
340648|NCT01340937|815668|P2|STARTED|Period 1: Infant Series||797
340649|NCT01340937|815669|P1|STARTED|Period 1: Infant Series||800
340650|NCT01340794|815828|P2|NOT COMPLETED|Overall Study||1
340651|NCT01340794|815829|P1|NOT COMPLETED|Overall Study||0
340652|NCT01340794|815828|P2|COMPLETED|Overall Study||4
340653|NCT01340794|815829|P1|COMPLETED|Overall Study||2
340654|NCT01340794|815828|P2|STARTED|Overall Study||5
340655|NCT01340794|815829|P1|STARTED|Overall Study||2
340656|NCT01340768|815845|P2|NOT COMPLETED|Overall Study||5
340657|NCT01340768|815846|P1|NOT COMPLETED|Overall Study||17
340658|NCT01340768|815845|P2|COMPLETED|Overall Study||429
340659|NCT01340768|815846|P1|COMPLETED|Overall Study||419
340660|NCT01340768|815845|P2|STARTED|Overall Study||434
340661|NCT01340768|815846|P1|STARTED|Overall Study||436
340662|NCT01340664|815857|P3|NOT COMPLETED|Overall Study||13
340663|NCT01340664|815858|P2|NOT COMPLETED|Overall Study||8
340664|NCT01340664|815859|P1|NOT COMPLETED|Overall Study||7
340665|NCT01340664|815857|P3|COMPLETED|Overall Study||80
340666|NCT01340664|815858|P2|COMPLETED|Overall Study||85
340667|NCT01340664|815859|P1|COMPLETED|Overall Study||86
340668|NCT01340664|815857|P3|STARTED|Overall Study||93
340669|NCT01340664|815858|P2|STARTED|Overall Study||93
340670|NCT01340664|815859|P1|STARTED|Overall Study||93
340671|NCT01340651|815876|P1|NOT COMPLETED|Overall Study||17
340672|NCT01340651|815876|P1|COMPLETED|Overall Study||24
340673|NCT01340651|815876|P1|STARTED|Overall Study||41
340674|NCT01340625|815892|P2|NOT COMPLETED|Second Intervention||0
340675|NCT01340625|815893|P1|NOT COMPLETED|Second Intervention||0
340676|NCT01340625|815892|P2|COMPLETED|Second Intervention||18
340677|NCT01340625|815893|P1|COMPLETED|Second Intervention||16
340678|NCT01340625|815892|P2|STARTED|Second Intervention||18
340679|NCT01340625|815893|P1|STARTED|Second Intervention||16
340680|NCT01340625|815892|P2|NOT COMPLETED|Washout Period of 28 Days||0
340681|NCT01340625|815893|P1|NOT COMPLETED|Washout Period of 28 Days||1
340682|NCT01340625|815892|P2|COMPLETED|Washout Period of 28 Days||18
340683|NCT01340625|815893|P1|COMPLETED|Washout Period of 28 Days||16
340684|NCT01340625|815892|P2|STARTED|Washout Period of 28 Days||18
340685|NCT01340625|815893|P1|STARTED|Washout Period of 28 Days||17
340686|NCT01340625|815892|P2|NOT COMPLETED|First Intervention||0
340687|NCT01340625|815893|P1|NOT COMPLETED|First Intervention||1
340688|NCT01340625|815892|P2|COMPLETED|First Intervention||18
340689|NCT01340625|815893|P1|COMPLETED|First Intervention||17
340690|NCT01340625|815892|P2|STARTED|First Intervention||18
340691|NCT01340625|815893|P1|STARTED|First Intervention||18
340692|NCT01340586|815911|P2|NOT COMPLETED|Overall Study||0
340693|NCT01340586|815912|P1|NOT COMPLETED|Overall Study||0
340694|NCT01340586|815911|P2|COMPLETED|Overall Study||8
340695|NCT01340586|815912|P1|COMPLETED|Overall Study||8
340696|NCT01340586|815911|P2|STARTED|Overall Study||8
340697|NCT01340586|815912|P1|STARTED|Overall Study||8
340698|NCT01340573|815977|P1|NOT COMPLETED|Overall Study||3
340699|NCT01340573|815977|P1|COMPLETED|Overall Study||0
340700|NCT01340573|815977|P1|STARTED|Overall Study||3
340701|NCT01340209|816001|P3|NOT COMPLETED|Overall Study||8
340702|NCT01340209|816002|P2|NOT COMPLETED|Overall Study||8
340703|NCT01340209|816003|P1|NOT COMPLETED|Overall Study||5
340704|NCT01340209|816001|P3|COMPLETED|Overall Study||106
340705|NCT01340209|816002|P2|COMPLETED|Overall Study||106
340706|NCT01340209|816003|P1|COMPLETED|Overall Study||52
340707|NCT01340209|816001|P3|STARTED|Overall Study||114
340708|NCT01340209|816002|P2|STARTED|Overall Study||114
340709|NCT01340209|816003|P1|STARTED|Overall Study||57
340710|NCT01340196|816038|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
340711|NCT01340196|816038|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
340712|NCT01340196|816038|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
340713|NCT01340196|816038|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
340714|NCT01340196|816038|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
340715|NCT01340196|816038|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
340716|NCT01340196|816038|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
340717|NCT01340196|816038|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
340718|NCT01340196|816038|P1|STARTED|Treat. Period 1 (Tenofovir)||16
340719|NCT01340144|816069|P2|NOT COMPLETED|Overall Study||58
340720|NCT01340144|816070|P1|NOT COMPLETED|Overall Study||72
340721|NCT01340144|816069|P2|COMPLETED|Overall Study||567
340722|NCT01340144|816070|P1|COMPLETED|Overall Study||553
340723|NCT01340144|816069|P2|STARTED|Overall Study||625
340724|NCT01340144|816070|P1|STARTED|Overall Study||625
340725|NCT01340066|816078|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
340726|NCT01340066|816079|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
340727|NCT01340066|816080|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
340728|NCT01340066|816078|P3|COMPLETED|5 Week Double Blind Randomization Period||31
340729|NCT01340066|816079|P2|COMPLETED|5 Week Double Blind Randomization Period||28
340730|NCT01340066|816080|P1|COMPLETED|5 Week Double Blind Randomization Period||0
340731|NCT01340066|816078|P3|STARTED|5 Week Double Blind Randomization Period||34
340732|NCT01340066|816079|P2|STARTED|5 Week Double Blind Randomization Period||33
340733|NCT01340066|816080|P1|STARTED|5 Week Double Blind Randomization Period||0
340734|NCT01340066|816078|P3|NOT COMPLETED|Placebo Run in Period||0
340735|NCT01340066|816079|P2|NOT COMPLETED|Placebo Run in Period||0
340736|NCT01340066|816080|P1|NOT COMPLETED|Placebo Run in Period||27
340737|NCT01340066|816078|P3|COMPLETED|Placebo Run in Period||0
340738|NCT01340066|816079|P2|COMPLETED|Placebo Run in Period||0
340739|NCT01340066|816080|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
340740|NCT01340066|816078|P3|STARTED|Placebo Run in Period||0
340741|NCT01340066|816079|P2|STARTED|Placebo Run in Period||0
340742|NCT01340066|816080|P1|STARTED|Placebo Run in Period||94
340743|NCT01340027|816099|P12|NOT COMPLETED|Overall Study||4
340744|NCT01340027|816100|P11|NOT COMPLETED|Overall Study||2
340745|NCT01340027|816101|P10|NOT COMPLETED|Overall Study||6
340746|NCT01340027|816102|P9|NOT COMPLETED|Overall Study||8
340747|NCT01340027|816103|P8|NOT COMPLETED|Overall Study||7
340748|NCT01340027|816104|P7|NOT COMPLETED|Overall Study||7
340749|NCT01340027|816105|P6|NOT COMPLETED|Overall Study||4
340750|NCT01340027|816106|P5|NOT COMPLETED|Overall Study||10
340751|NCT01340027|816107|P4|NOT COMPLETED|Overall Study||4
340752|NCT01340027|816108|P3|NOT COMPLETED|Overall Study||4
340753|NCT01340027|816109|P2|NOT COMPLETED|Overall Study||7
340754|NCT01340027|816110|P1|NOT COMPLETED|Overall Study||5
340755|NCT01340027|816099|P12|COMPLETED|Overall Study||77
340756|NCT01340027|816100|P11|COMPLETED|Overall Study||79
340757|NCT01340027|816101|P10|COMPLETED|Overall Study||146
340758|NCT01340027|816102|P9|COMPLETED|Overall Study||136
340759|NCT01340027|816103|P8|COMPLETED|Overall Study||142
340760|NCT01340027|816104|P7|COMPLETED|Overall Study||142
340761|NCT01340027|816105|P6|COMPLETED|Overall Study||74
340762|NCT01340027|816106|P5|COMPLETED|Overall Study||146
340763|NCT01340027|816107|P4|COMPLETED|Overall Study||75
340764|NCT01340027|816108|P3|COMPLETED|Overall Study||75
340765|NCT01340027|816109|P2|COMPLETED|Overall Study||71
340766|NCT01340027|816110|P1|COMPLETED|Overall Study||76
340767|NCT01340027|816099|P12|Received Treatment|Overall Study||81
340768|NCT01340027|816100|P11|Received Treatment|Overall Study||81
340769|NCT01340027|816101|P10|Received Treatment|Overall Study||152
340770|NCT01340027|816102|P9|Received Treatment|Overall Study||144
340771|NCT01340027|816103|P8|Received Treatment|Overall Study||149
340772|NCT01340027|816104|P7|Received Treatment|Overall Study||149
340773|NCT01340027|816105|P6|Received Treatment|Overall Study||78
340774|NCT01340027|816106|P5|Received Treatment|Overall Study||156
340775|NCT01340027|816107|P4|Received Treatment|Overall Study||79
340776|NCT01340027|816108|P3|Received Treatment|Overall Study||78
340777|NCT01340027|816109|P2|Received Treatment|Overall Study||78
340778|NCT01340027|816110|P1|Received Treatment|Overall Study||81
340779|NCT01340027|816099|P12|STARTED|Overall Study||81
340780|NCT01340027|816100|P11|STARTED|Overall Study||81
340781|NCT01340027|816101|P10|STARTED|Overall Study||152
340782|NCT01340027|816102|P9|STARTED|Overall Study||144
340783|NCT01340027|816103|P8|STARTED|Overall Study||149
340784|NCT01340027|816104|P7|STARTED|Overall Study||149
340785|NCT01340027|816105|P6|STARTED|Overall Study||78
340786|NCT01340027|816106|P5|STARTED|Overall Study||156
340787|NCT01340027|816107|P4|STARTED|Overall Study||79
340788|NCT01340027|816108|P3|STARTED|Overall Study||79
340789|NCT01340027|816109|P2|STARTED|Overall Study||78
340790|NCT01340027|816110|P1|STARTED|Overall Study||81
340791|NCT01340014|816486|P2|NOT COMPLETED|Period 2, Second 7 Days||1
340792|NCT01340014|816487|P1|NOT COMPLETED|Period 2, Second 7 Days||0
340793|NCT01340014|816486|P2|COMPLETED|Period 2, Second 7 Days||56
340794|NCT01340014|816487|P1|COMPLETED|Period 2, Second 7 Days||53
340795|NCT01340014|816486|P2|STARTED|Period 2, Second 7 Days||57
340796|NCT01340014|816487|P1|STARTED|Period 2, Second 7 Days||53
340797|NCT01340014|816486|P2|NOT COMPLETED|Period 1, First 7 Days||0
340798|NCT01340014|816487|P1|NOT COMPLETED|Period 1, First 7 Days||2
340799|NCT01340014|816486|P2|COMPLETED|Period 1, First 7 Days||57
340800|NCT01340014|816487|P1|COMPLETED|Period 1, First 7 Days||53
340801|NCT01340014|816486|P2|STARTED|Period 1, First 7 Days||57
340802|NCT01340014|816487|P1|STARTED|Period 1, First 7 Days||55
340803|NCT01339936|816495|P1|NOT COMPLETED|Overall Study||2
340804|NCT01339936|816495|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
340805|NCT01339936|816495|P1|STARTED|Overall Study|plus 2 screen failures|38
340806|NCT01339923|816508|P7|NOT COMPLETED|Overall Study||14
340807|NCT01339923|816509|P6|NOT COMPLETED|Overall Study||9
340808|NCT01339923|816510|P5|NOT COMPLETED|Overall Study||5
340809|NCT01339923|816511|P4|NOT COMPLETED|Overall Study||4
340810|NCT01339923|816512|P3|NOT COMPLETED|Overall Study||8
340811|NCT01339923|816513|P2|NOT COMPLETED|Overall Study||16
340812|NCT01339923|816514|P1|NOT COMPLETED|Overall Study||14
340813|NCT01339923|816508|P7|COMPLETED|Overall Study||111
340814|NCT01339923|816509|P6|COMPLETED|Overall Study||117
340815|NCT01339923|816510|P5|COMPLETED|Overall Study||295
340816|NCT01339923|816511|P4|COMPLETED|Overall Study||100
340817|NCT01339923|816512|P3|COMPLETED|Overall Study||243
340818|NCT01339923|816513|P2|COMPLETED|Overall Study||234
340819|NCT01339923|816514|P1|COMPLETED|Overall Study||239
340820|NCT01339923|816508|P7|STARTED|Overall Study||125
340821|NCT01339923|816509|P6|STARTED|Overall Study||126
340822|NCT01339923|816510|P5|STARTED|Overall Study||300
340823|NCT01339923|816511|P4|STARTED|Overall Study||104
340824|NCT01339923|816512|P3|STARTED|Overall Study||251
340825|NCT01339923|816513|P2|STARTED|Overall Study||250
340826|NCT01339923|816514|P1|STARTED|Overall Study||253
340827|NCT01339897|816587|P4|NOT COMPLETED|Overall Study||1
340828|NCT01339897|816588|P3|NOT COMPLETED|Overall Study||0
340829|NCT01339897|816589|P2|NOT COMPLETED|Overall Study||0
340830|NCT01339897|816590|P1|NOT COMPLETED|Overall Study||1
340831|NCT01339897|816587|P4|COMPLETED|Overall Study||5
340832|NCT01339897|816588|P3|COMPLETED|Overall Study||6
340833|NCT01339897|816589|P2|COMPLETED|Overall Study||6
340834|NCT01339897|816590|P1|COMPLETED|Overall Study||6
340835|NCT01339897|816587|P4|STARTED|Overall Study||6
340836|NCT01339897|816588|P3|STARTED|Overall Study||6
340837|NCT01339897|816589|P2|STARTED|Overall Study||6
340838|NCT01339897|816590|P1|STARTED|Overall Study||7
340839|NCT01339832|816616|P1|NOT COMPLETED|Overall Study||14
340840|NCT01339832|816616|P1|COMPLETED|Overall Study||37
340841|NCT01339832|816616|P1|STARTED|Overall Study||51
340842|NCT01339429|816627|P1|NOT COMPLETED|Overall Study||4
340843|NCT01339429|816627|P1|COMPLETED|Overall Study||37
340844|NCT01339429|816627|P1|STARTED|Overall Study||41
340845|NCT01339416|816632|P1|NOT COMPLETED|Overall Study||0
340846|NCT01339416|816632|P1|COMPLETED|Overall Study||8202
340847|NCT01339416|816632|P1|STARTED|Overall Study||8202
340848|NCT01339403|816644|P2|NOT COMPLETED|Overall Study||0
340849|NCT01339403|816645|P1|NOT COMPLETED|Overall Study||0
340850|NCT01339403|816644|P2|COMPLETED|Overall Study||257600
340851|NCT01339403|816645|P1|COMPLETED|Overall Study||24768
340852|NCT01339403|816644|P2|STARTED|Overall Study||257600
340853|NCT01339403|816645|P1|STARTED|Overall Study||24768
340854|NCT01339390|816667|P2|NOT COMPLETED|Overall Study||156
340855|NCT01339390|816668|P1|NOT COMPLETED|Overall Study||157
340856|NCT01339390|816667|P2|COMPLETED|Overall Study||1442
340857|NCT01339390|816668|P1|COMPLETED|Overall Study||1414
340858|NCT01339390|816667|P2|STARTED|Overall Study||1598
340859|NCT01339390|816668|P1|STARTED|Overall Study||1571
340860|NCT01339299|816676|P2|NOT COMPLETED|Overall Study||0
340861|NCT01339299|816677|P1|NOT COMPLETED|Overall Study||0
340862|NCT01339299|816676|P2|COMPLETED|Overall Study||50
340863|NCT01339299|816677|P1|COMPLETED|Overall Study||50
340864|NCT01339299|816676|P2|STARTED|Overall Study||50
340865|NCT01339299|816677|P1|STARTED|Overall Study||50
340866|NCT01339260|816685|P2|NOT COMPLETED|Multi-cycle Extension||193
340867|NCT01339260|816686|P1|NOT COMPLETED|Multi-cycle Extension||186
340868|NCT01339260|816685|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
340869|NCT01339260|816686|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
340870|NCT01339260|816685|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
340871|NCT01339260|816686|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
340872|NCT01339260|816685|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
340873|NCT01339260|816686|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
340874|NCT01339260|816685|P2|NOT COMPLETED|Cycle 1||10
340875|NCT01339260|816686|P1|NOT COMPLETED|Cycle 1||7
340876|NCT01339260|816685|P2|COMPLETED|Cycle 1||719
340877|NCT01339260|816686|P1|COMPLETED|Cycle 1||719
340878|NCT01339260|816685|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
340879|NCT01339260|816686|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
340880|NCT01339260|816685|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
340881|NCT01339260|816686|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
340882|NCT01339260|816685|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
340883|NCT01339260|816686|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
340884|NCT01339247|816698|P2|NOT COMPLETED|Period 2||0
340885|NCT01339247|816699|P1|NOT COMPLETED|Period 2||0
340886|NCT01339247|816698|P2|COMPLETED|Period 2||30
340887|NCT01339247|816699|P1|COMPLETED|Period 2||30
340888|NCT01339247|816698|P2|STARTED|Period 2||30
340889|NCT01339247|816699|P1|STARTED|Period 2||30
340890|NCT01339247|816698|P2|NOT COMPLETED|Period 1||0
340891|NCT01339247|816699|P1|NOT COMPLETED|Period 1||0
340892|NCT01339247|816698|P2|COMPLETED|Period 1||30
340893|NCT01339247|816699|P1|COMPLETED|Period 1||30
340894|NCT01339247|816698|P2|STARTED|Period 1||30
340895|NCT01339247|816699|P1|STARTED|Period 1||30
340896|NCT01339091|816711|P2|NOT COMPLETED|Overall Study||28
340897|NCT01339091|816712|P1|NOT COMPLETED|Overall Study||27
340898|NCT01339091|816711|P2|COMPLETED|Overall Study||257
340899|NCT01339091|816712|P1|COMPLETED|Overall Study||261
340900|NCT01339091|816711|P2|Safety Population|Overall Study||284
340901|NCT01339091|816712|P1|Safety Population|Overall Study||284
340902|NCT01339091|816711|P2|STARTED|Overall Study||285
340903|NCT01339091|816712|P1|STARTED|Overall Study||288
340904|NCT01339052|816726|P2|NOT COMPLETED|Overall Study||50
340905|NCT01339052|816727|P1|NOT COMPLETED|Overall Study||15
340906|NCT01339052|816726|P2|COMPLETED|Overall Study||0
340907|NCT01339052|816727|P1|COMPLETED|Overall Study||0
340908|NCT01339052|816726|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
340909|NCT01339052|816727|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
340910|NCT01339052|816726|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
340911|NCT01339052|816727|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
340912|NCT01339052|816726|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
340913|NCT01339052|816727|P1|Measurable Disease|Overall Study||11
340914|NCT01339052|816726|P2|STARTED|Overall Study||50
340915|NCT01339052|816727|P1|STARTED|Overall Study||15
340916|NCT01339013|816743|P1|NOT COMPLETED|Overall Study||0
340917|NCT01339013|816743|P1|COMPLETED|Overall Study||6
340918|NCT01339013|816743|P1|STARTED|Overall Study||6
340919|NCT01339000|816749|P2|NOT COMPLETED|Overall Study||0
340920|NCT01339000|816750|P1|NOT COMPLETED|Overall Study||1
340921|NCT01339000|816749|P2|COMPLETED|Overall Study||0
340922|NCT01339000|816750|P1|COMPLETED|Overall Study||0
340923|NCT01339000|816749|P2|STARTED|Overall Study||0
340924|NCT01339000|816750|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
340925|NCT01338870|816770|P6|NOT COMPLETED|Overall Study||6
340926|NCT01338870|816771|P5|NOT COMPLETED|Overall Study||6
340927|NCT01338870|816772|P4|NOT COMPLETED|Overall Study||9
340928|NCT01338870|816773|P3|NOT COMPLETED|Overall Study||11
340929|NCT01338870|816774|P2|NOT COMPLETED|Overall Study||12
340930|NCT01338870|816775|P1|NOT COMPLETED|Overall Study||9
340931|NCT01338870|816770|P6|COMPLETED|Overall Study||44
340932|NCT01338870|816771|P5|COMPLETED|Overall Study||46
340933|NCT01338870|816772|P4|COMPLETED|Overall Study||41
340934|NCT01338870|816773|P3|COMPLETED|Overall Study||39
340935|NCT01338870|816774|P2|COMPLETED|Overall Study||37
340936|NCT01338870|816775|P1|COMPLETED|Overall Study||41
340937|NCT01338870|816770|P6|STARTED|Overall Study||50
340938|NCT01338870|816771|P5|STARTED|Overall Study||52
340939|NCT01338870|816772|P4|STARTED|Overall Study||50
340940|NCT01338870|816773|P3|STARTED|Overall Study||50
340941|NCT01338870|816774|P2|STARTED|Overall Study||49
340942|NCT01338870|816775|P1|STARTED|Overall Study||50
340943|NCT01338857|816825|P1|NOT COMPLETED|Overall Study||11
340944|NCT01338857|816825|P1|COMPLETED|Overall Study||1
340945|NCT01338857|816825|P1|STARTED|Overall Study||12
340946|NCT01338818|816830|P1|NOT COMPLETED|Overall Study||36
340947|NCT01338818|816830|P1|COMPLETED|Overall Study||262
340948|NCT01338818|816830|P1|STARTED|Overall Study||298
340949|NCT01338792|816836|P1|NOT COMPLETED|Overall Study||4
340950|NCT01338792|816836|P1|COMPLETED|Overall Study||43
340951|NCT01338792|816836|P1|STARTED|Overall Study||47
340952|NCT01338649|816844|P2|NOT COMPLETED|Overall Study||0
340953|NCT01338649|816845|P1|NOT COMPLETED|Overall Study||0
340954|NCT01338649|816844|P2|COMPLETED|Overall Study||14
340955|NCT01338649|816845|P1|COMPLETED|Overall Study||13
340956|NCT01338649|816844|P2|STARTED|Overall Study||14
340957|NCT01338649|816845|P1|STARTED|Overall Study||13
340958|NCT01338636|816851|P1|NOT COMPLETED|Overall Study||8
340959|NCT01338636|816851|P1|COMPLETED|Overall Study||22
340960|NCT01338636|816851|P1|STARTED|Overall Study||30
340961|NCT01338610|816865|P3|NOT COMPLETED|Overall Study||1
340962|NCT01338610|816866|P2|NOT COMPLETED|Overall Study||1
340963|NCT01338610|816867|P1|NOT COMPLETED|Overall Study||5
340964|NCT01338610|816865|P3|COMPLETED|Overall Study||28
340965|NCT01338610|816866|P2|COMPLETED|Overall Study||55
340966|NCT01338610|816867|P1|COMPLETED|Overall Study||34
340967|NCT01338610|816865|P3|STARTED|Overall Study||29
340968|NCT01338610|816866|P2|STARTED|Overall Study||56
340969|NCT01338610|816867|P1|STARTED|Overall Study||39
340970|NCT01338493|816874|P1|NOT COMPLETED|24 Months Follow up||0
340971|NCT01338493|816874|P1|COMPLETED|24 Months Follow up||104
340972|NCT01338493|816874|P1|STARTED|24 Months Follow up||104
340973|NCT01338493|816874|P1|NOT COMPLETED|12 Months Follow up||9
340974|NCT01338493|816874|P1|COMPLETED|12 Months Follow up||104
340975|NCT01338493|816874|P1|STARTED|12 Months Follow up||113
340976|NCT01338493|816874|P1|NOT COMPLETED|6 Months Follow up||19
340977|NCT01338493|816874|P1|COMPLETED|6 Months Follow up||113
340978|NCT01338493|816874|P1|STARTED|6 Months Follow up||132
340979|NCT01338493|816874|P1|NOT COMPLETED|Discharge||2
340980|NCT01338493|816874|P1|COMPLETED|Discharge||132
340981|NCT01338493|816874|P1|STARTED|Discharge||134
340982|NCT01338493|816874|P1|NOT COMPLETED|Implant||0
340983|NCT01338493|816874|P1|COMPLETED|Implant||134
340984|NCT01338493|816874|P1|STARTED|Implant||134
340985|NCT01338493|816874|P1|NOT COMPLETED|Enrolled||5
340986|NCT01338493|816874|P1|COMPLETED|Enrolled||134
340987|NCT01338493|816874|P1|STARTED|Enrolled||139
340988|NCT01338025|816881|P2|NOT COMPLETED|Overall Study||11
340989|NCT01338025|816882|P1|NOT COMPLETED|Overall Study||11
340990|NCT01338025|816881|P2|COMPLETED|Overall Study||6
340991|NCT01338025|816882|P1|COMPLETED|Overall Study||5
340992|NCT01338025|816881|P2|STARTED|Overall Study||17
340993|NCT01338025|816882|P1|STARTED|Overall Study||16
340994|NCT01338012|816894|P1|NOT COMPLETED|Overall Study||8
340995|NCT01338012|816894|P1|COMPLETED|Overall Study||0
340996|NCT01338012|816894|P1|STARTED|Overall Study||8
340997|NCT01337960|816901|P3|NOT COMPLETED|Overall Study||0
340998|NCT01337960|816902|P2|NOT COMPLETED|Overall Study||0
340999|NCT01337960|816903|P1|NOT COMPLETED|Overall Study||2
341000|NCT01337960|816901|P3|COMPLETED|Overall Study||6
341001|NCT01337960|816902|P2|COMPLETED|Overall Study||14
341002|NCT01337960|816903|P1|COMPLETED|Overall Study||12
341003|NCT01337960|816901|P3|STARTED|Overall Study||6
341004|NCT01337960|816902|P2|STARTED|Overall Study||14
341005|NCT01337960|816903|P1|STARTED|Overall Study||14
341006|NCT01337739|816925|P2|NOT COMPLETED|Overall Study||0
341007|NCT01337739|816926|P1|NOT COMPLETED|Overall Study||0
341008|NCT01337739|816925|P2|COMPLETED|Overall Study||4
341009|NCT01337739|816926|P1|COMPLETED|Overall Study||6
341010|NCT01337739|816925|P2|STARTED|Overall Study||4
341011|NCT01337739|816926|P1|STARTED|Overall Study||6
341012|NCT01337674|816936|P4|NOT COMPLETED|Treatment Period 2||0
341013|NCT01337674|816937|P3|NOT COMPLETED|Treatment Period 2||1
341014|NCT01337674|816938|P2|NOT COMPLETED|Treatment Period 2||0
341015|NCT01337674|816939|P1|NOT COMPLETED|Treatment Period 2||0
341016|NCT01337674|816936|P4|COMPLETED|Treatment Period 2||6
341017|NCT01337674|816937|P3|COMPLETED|Treatment Period 2||5
341018|NCT01337674|816938|P2|COMPLETED|Treatment Period 2||6
341019|NCT01337674|816939|P1|COMPLETED|Treatment Period 2||6
341020|NCT01337674|816936|P4|STARTED|Treatment Period 2||6
341021|NCT01337674|816937|P3|STARTED|Treatment Period 2||6
341022|NCT01337674|816938|P2|STARTED|Treatment Period 2||6
341023|NCT01337674|816939|P1|STARTED|Treatment Period 2||6
341024|NCT01337674|816936|P4|NOT COMPLETED|Two-week Washout Period||0
341025|NCT01337674|816937|P3|NOT COMPLETED|Two-week Washout Period||0
341026|NCT01337674|816938|P2|NOT COMPLETED|Two-week Washout Period||0
341027|NCT01337674|816939|P1|NOT COMPLETED|Two-week Washout Period||0
341028|NCT01337674|816936|P4|COMPLETED|Two-week Washout Period||6
341029|NCT01337674|816937|P3|COMPLETED|Two-week Washout Period||6
341030|NCT01337674|816938|P2|COMPLETED|Two-week Washout Period||6
341031|NCT01337674|816939|P1|COMPLETED|Two-week Washout Period||6
341032|NCT01337674|816936|P4|STARTED|Two-week Washout Period||6
341033|NCT01337674|816937|P3|STARTED|Two-week Washout Period||6
341034|NCT01337674|816938|P2|STARTED|Two-week Washout Period||6
341035|NCT01337674|816939|P1|STARTED|Two-week Washout Period||6
341036|NCT01337674|816936|P4|NOT COMPLETED|Treatment Period 1||1
341037|NCT01337674|816937|P3|NOT COMPLETED|Treatment Period 1||0
341038|NCT01337674|816938|P2|NOT COMPLETED|Treatment Period 1||1
341039|NCT01337674|816939|P1|NOT COMPLETED|Treatment Period 1||0
341040|NCT01337674|816936|P4|COMPLETED|Treatment Period 1||6
341041|NCT01337674|816937|P3|COMPLETED|Treatment Period 1||6
341042|NCT01337674|816938|P2|COMPLETED|Treatment Period 1||6
341043|NCT01337674|816939|P1|COMPLETED|Treatment Period 1||6
341044|NCT01337674|816936|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
341045|NCT01337674|816937|P3|STARTED|Treatment Period 1||6
341046|NCT01337674|816938|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
341047|NCT01337674|816939|P1|STARTED|Treatment Period 1||6
341048|NCT01337635|816957|P2|NOT COMPLETED|Overall Study||1
341049|NCT01337635|816958|P1|NOT COMPLETED|Overall Study||0
341050|NCT01337635|816957|P2|COMPLETED|Overall Study||2
341051|NCT01337635|816958|P1|COMPLETED|Overall Study||4
341052|NCT01337635|816957|P2|STARTED|Overall Study||3
341053|NCT01337635|816958|P1|STARTED|Overall Study||4
341054|NCT01337609|816967|P3|NOT COMPLETED|Overall Study||0
341055|NCT01337609|816968|P2|NOT COMPLETED|Overall Study||0
341056|NCT01337609|816969|P1|NOT COMPLETED|Overall Study||1
341057|NCT01337609|816967|P3|COMPLETED|Overall Study||2
341058|NCT01337609|816968|P2|COMPLETED|Overall Study||2
341059|NCT01337609|816969|P1|COMPLETED|Overall Study||0
341060|NCT01337609|816967|P3|STARTED|Overall Study||2
341061|NCT01337609|816968|P2|STARTED|Overall Study||2
341062|NCT01337609|816969|P1|STARTED|Overall Study||1
341063|NCT01337336|816991|P2|NOT COMPLETED|Overall Study||0
341064|NCT01337336|816992|P1|NOT COMPLETED|Overall Study||0
341065|NCT01337336|816991|P2|COMPLETED|Overall Study||2923
341066|NCT01337336|816992|P1|COMPLETED|Overall Study||1078
341067|NCT01337336|816991|P2|STARTED|Overall Study||2923
341068|NCT01337336|816992|P1|STARTED|Overall Study||1078
341069|NCT01337297|817006|P2|NOT COMPLETED|Overall Study||6
341070|NCT01337297|817007|P1|NOT COMPLETED|Overall Study||5
341071|NCT01337297|817006|P2|COMPLETED|Overall Study||3
341072|NCT01337297|817007|P1|COMPLETED|Overall Study||6
341073|NCT01337297|817006|P2|STARTED|Overall Study||9
341074|NCT01337297|817007|P1|STARTED|Overall Study||11
341075|NCT01337167|817015|P2|NOT COMPLETED|Toddler Vaccinations||13
341076|NCT01337167|817016|P1|NOT COMPLETED|Toddler Vaccinations||14
341077|NCT01337167|817015|P2|COMPLETED|Toddler Vaccinations||407
341078|NCT01337167|817016|P1|COMPLETED|Toddler Vaccinations||829
341079|NCT01337167|817015|P2|STARTED|Toddler Vaccinations||420
341080|NCT01337167|817016|P1|STARTED|Toddler Vaccinations||843
341081|NCT01337167|817015|P2|NOT COMPLETED|Interim Period||40
341082|NCT01337167|817016|P1|NOT COMPLETED|Interim Period||81
341083|NCT01337167|817015|P2|COMPLETED|Interim Period||420
341084|NCT01337167|817016|P1|COMPLETED|Interim Period||843
341085|NCT01337167|817015|P2|STARTED|Interim Period||460
341086|NCT01337167|817016|P1|STARTED|Interim Period||924
341087|NCT01337167|817015|P2|NOT COMPLETED|Infant Series||27
341088|NCT01337167|817016|P1|NOT COMPLETED|Infant Series||62
341089|NCT01337167|817015|P2|COMPLETED|Infant Series||460
341090|NCT01337167|817016|P1|COMPLETED|Infant Series||924
341091|NCT01337167|817015|P2|STARTED|Infant Series||487
341092|NCT01337167|817016|P1|STARTED|Infant Series||986
341093|NCT01337115|817084|P2|NOT COMPLETED|Overall Study||0
341094|NCT01337115|817085|P1|NOT COMPLETED|Overall Study||2
341095|NCT01337115|817084|P2|COMPLETED|Overall Study||25
341096|NCT01337115|817085|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
341097|NCT01337115|817084|P2|STARTED|Overall Study||25
341098|NCT01337115|817085|P1|STARTED|Overall Study||25
341099|NCT01337076|817097|P1|NOT COMPLETED|Overall Study||2
341100|NCT01337076|817097|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
341101|NCT01337076|817097|P1|STARTED|Overall Study|subjects implanted|21
341102|NCT01337050|817104|P3|NOT COMPLETED|Overall Study||19
341103|NCT01337050|817105|P2|NOT COMPLETED|Overall Study||13
341104|NCT01337050|817106|P1|NOT COMPLETED|Overall Study||4
341105|NCT01337050|817104|P3|COMPLETED|Overall Study||0
341106|NCT01337050|817105|P2|COMPLETED|Overall Study||0
341107|NCT01337050|817106|P1|COMPLETED|Overall Study||0
341108|NCT01337050|817104|P3|STARTED|Overall Study||19
341109|NCT01337050|817105|P2|STARTED|Overall Study||13
341110|NCT01337050|817106|P1|STARTED|Overall Study||4
341111|NCT01336894|817166|P2|NOT COMPLETED|Follow-up||7
341112|NCT01336894|817167|P1|NOT COMPLETED|Follow-up||2
341113|NCT01336894|817166|P2|COMPLETED|Follow-up||0
341114|NCT01336894|817167|P1|COMPLETED|Follow-up||2
341115|NCT01336894|817166|P2|STARTED|Follow-up||7
341116|NCT01336894|817167|P1|STARTED|Follow-up||4
341117|NCT01336894|817166|P2|NOT COMPLETED|Protocol Interventions||0
341118|NCT01336894|817167|P1|NOT COMPLETED|Protocol Interventions||0
341119|NCT01336894|817166|P2|COMPLETED|Protocol Interventions||7
341120|NCT01336894|817167|P1|COMPLETED|Protocol Interventions||4
341121|NCT01336894|817166|P2|STARTED|Protocol Interventions||7
341122|NCT01336894|817167|P1|STARTED|Protocol Interventions||4
341123|NCT01336764|817187|P2|NOT COMPLETED|Overall Study||5
341124|NCT01336764|817188|P1|NOT COMPLETED|Overall Study||5
341125|NCT01336764|817187|P2|COMPLETED|Overall Study||5
341126|NCT01336764|817188|P1|COMPLETED|Overall Study||7
341127|NCT01336764|817187|P2|STARTED|Overall Study||10
341128|NCT01336764|817188|P1|STARTED|Overall Study||12
341129|NCT01336738|817199|P5|NOT COMPLETED|Overall Study||10
341130|NCT01336738|817200|P4|NOT COMPLETED|Overall Study||7
341131|NCT01336738|817201|P3|NOT COMPLETED|Overall Study||8
341132|NCT01336738|817202|P2|NOT COMPLETED|Overall Study||9
341133|NCT01336738|817203|P1|NOT COMPLETED|Overall Study||7
341134|NCT01336738|817199|P5|COMPLETED|Overall Study||43
341135|NCT01336738|817200|P4|COMPLETED|Overall Study||47
341136|NCT01336738|817201|P3|COMPLETED|Overall Study||45
341137|NCT01336738|817202|P2|COMPLETED|Overall Study||45
341138|NCT01336738|817203|P1|COMPLETED|Overall Study||45
341139|NCT01336738|817199|P5|STARTED|Overall Study||53
341140|NCT01336738|817200|P4|STARTED|Overall Study||54
341141|NCT01336738|817201|P3|STARTED|Overall Study||53
341142|NCT01336738|817202|P2|STARTED|Overall Study||54
341143|NCT01336738|817203|P1|STARTED|Overall Study||52
341144|NCT01336712|817245|P1|NOT COMPLETED|Overall Study||3
341145|NCT01336712|817245|P1|COMPLETED|Overall Study||27
341146|NCT01336712|817245|P1|STARTED|Overall Study||30
341147|NCT01336647|817258|P3|NOT COMPLETED|Overall Study||3
341148|NCT01336647|817259|P2|NOT COMPLETED|Overall Study||1
341149|NCT01336647|817260|P1|NOT COMPLETED|Overall Study||4
341150|NCT01336647|817258|P3|COMPLETED|Overall Study||44
341151|NCT01336647|817259|P2|COMPLETED|Overall Study||48
341152|NCT01336647|817260|P1|COMPLETED|Overall Study||42
341153|NCT01336647|817258|P3|STARTED|Overall Study||47
341154|NCT01336647|817259|P2|STARTED|Overall Study||49
341155|NCT01336647|817260|P1|STARTED|Overall Study||46
341156|NCT01336608|817274|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
341157|NCT01336608|817275|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
341158|NCT01336608|817276|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
341159|NCT01336608|817277|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
341160|NCT01336608|817274|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
341161|NCT01336608|817275|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
341162|NCT01336608|817276|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
341163|NCT01336608|817277|P1|COMPLETED|24-week, Double-blind Treatment Period||0
341164|NCT01336608|817274|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
341165|NCT01336608|817275|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
341166|NCT01336608|817276|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
341167|NCT01336608|817277|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
341168|NCT01336608|817274|P4|STARTED|24-week, Double-blind Treatment Period||135
341169|NCT01336608|817275|P3|STARTED|24-week, Double-blind Treatment Period||154
341170|NCT01336608|817276|P2|STARTED|24-week, Double-blind Treatment Period||141
341171|NCT01336608|817277|P1|STARTED|24-week, Double-blind Treatment Period||0
341172|NCT01336608|817274|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
341173|NCT01336608|817275|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
341174|NCT01336608|817276|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
341175|NCT01336608|817277|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
341176|NCT01336608|817274|P4|COMPLETED|2-week, Single-blind Run-In Period||0
341177|NCT01336608|817275|P3|COMPLETED|2-week, Single-blind Run-In Period||0
341178|NCT01336608|817276|P2|COMPLETED|2-week, Single-blind Run-In Period||0
341179|NCT01336608|817277|P1|COMPLETED|2-week, Single-blind Run-In Period||444
341180|NCT01336608|817274|P4|STARTED|2-week, Single-blind Run-In Period||0
341181|NCT01336608|817275|P3|STARTED|2-week, Single-blind Run-In Period||0
341182|NCT01336608|817276|P2|STARTED|2-week, Single-blind Run-In Period||0
341183|NCT01336608|817277|P1|STARTED|2-week, Single-blind Run-In Period||559
341184|NCT01336569|817291|P1|NOT COMPLETED|Overall Study||4
341185|NCT01336569|817291|P1|COMPLETED|Overall Study||45
341186|NCT01336569|817291|P1|STARTED|Overall Study||49
341187|NCT01336296|817297|P2|NOT COMPLETED|Overall Study||4
341188|NCT01336296|817298|P1|NOT COMPLETED|Overall Study||5
341189|NCT01336296|817297|P2|COMPLETED|Overall Study||17
341190|NCT01336296|817298|P1|COMPLETED|Overall Study||35
341191|NCT01336296|817297|P2|STARTED|Overall Study||21
341192|NCT01336296|817298|P1|STARTED|Overall Study||40
341193|NCT01336205|817314|P2|NOT COMPLETED|Overall Study||89
341194|NCT01336205|817315|P1|NOT COMPLETED|Overall Study||233
341195|NCT01336205|817314|P2|COMPLETED|Overall Study||192
341196|NCT01336205|817315|P1|COMPLETED|Overall Study||330
341197|NCT01336205|817314|P2|STARTED|Overall Study||281
341198|NCT01336205|817315|P1|STARTED|Overall Study||563
341199|NCT01336140|817327|P2|NOT COMPLETED|Overall Study||0
341200|NCT01336140|817328|P1|NOT COMPLETED|Overall Study||0
341201|NCT01336140|817327|P2|COMPLETED|Overall Study||150
341202|NCT01336140|817328|P1|COMPLETED|Overall Study||150
341203|NCT01336140|817327|P2|STARTED|Overall Study||150
341204|NCT01336140|817328|P1|STARTED|Overall Study||150
341205|NCT01336023|817343|P3|NOT COMPLETED|Week 27 to 52||28
341206|NCT01336023|817344|P2|NOT COMPLETED|Week 27 to 52||44
341207|NCT01336023|817345|P1|NOT COMPLETED|Week 27 to 52||28
341208|NCT01336023|817343|P3|COMPLETED|Week 27 to 52||285
341209|NCT01336023|817344|P2|COMPLETED|Week 27 to 52||621
341210|NCT01336023|817345|P1|COMPLETED|Week 27 to 52||305
341211|NCT01336023|817343|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
341212|NCT01336023|817344|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
341304|NCT01335477|817540|P2|NOT COMPLETED|Overall Study||59
341213|NCT01336023|817345|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
341214|NCT01336023|817343|P3|NOT COMPLETED|Week 0 to Week 26||73
341215|NCT01336023|817344|P2|NOT COMPLETED|Week 0 to Week 26||98
341216|NCT01336023|817345|P1|NOT COMPLETED|Week 0 to Week 26||48
341217|NCT01336023|817343|P3|COMPLETED|Week 0 to Week 26||342
341218|NCT01336023|817344|P2|COMPLETED|Week 0 to Week 26||736
341219|NCT01336023|817345|P1|COMPLETED|Week 0 to Week 26||366
341220|NCT01336023|817343|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
341221|NCT01336023|817344|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
341222|NCT01336023|817345|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
341223|NCT01336023|817343|P3|STARTED|Week 0 to Week 26||415
341224|NCT01336023|817344|P2|STARTED|Week 0 to Week 26||834
341225|NCT01336023|817345|P1|STARTED|Week 0 to Week 26||414
341226|NCT01335997|817366|P2|NOT COMPLETED|Period III||79
341227|NCT01335997|817367|P1|NOT COMPLETED|Period III||78
341228|NCT01335997|817366|P2|COMPLETED|Period III||4
341229|NCT01335997|817367|P1|COMPLETED|Period III||6
341230|NCT01335997|817366|P2|STARTED|Period III||83
341231|NCT01335997|817367|P1|STARTED|Period III||84
341232|NCT01335997|817366|P2|NOT COMPLETED|Period I and II||479
341233|NCT01335997|817367|P1|NOT COMPLETED|Period I and II||493
341234|NCT01335997|817366|P2|COMPLETED|Period I and II||83
341235|NCT01335997|817367|P1|COMPLETED|Period I and II||84
341236|NCT01335997|817366|P2|STARTED|Period I and II||562
341237|NCT01335997|817367|P1|STARTED|Period I and II||577
341238|NCT01335971|817380|P3|NOT COMPLETED|Overall Study||1
341239|NCT01335971|817381|P2|NOT COMPLETED|Overall Study||1
341240|NCT01335971|817382|P1|NOT COMPLETED|Overall Study||2
341241|NCT01335971|817380|P3|COMPLETED|Overall Study||28
341242|NCT01335971|817381|P2|COMPLETED|Overall Study||28
341243|NCT01335971|817382|P1|COMPLETED|Overall Study||29
341244|NCT01335971|817380|P3|STARTED|Overall Study||29
341245|NCT01335971|817381|P2|STARTED|Overall Study||29
341246|NCT01335971|817382|P1|STARTED|Overall Study||31
341247|NCT01335867|817419|P2|NOT COMPLETED|Overall Study||4
341248|NCT01335867|817420|P1|NOT COMPLETED|Overall Study||7
341249|NCT01335867|817419|P2|COMPLETED|Overall Study||12
341250|NCT01335867|817420|P1|COMPLETED|Overall Study||9
341251|NCT01335867|817419|P2|STARTED|Overall Study||16
341252|NCT01335867|817420|P1|STARTED|Overall Study||16
341253|NCT01335789|817430|P2|NOT COMPLETED|Overall Study||0
341254|NCT01335789|817431|P1|NOT COMPLETED|Overall Study||0
341255|NCT01335789|817430|P2|COMPLETED|Overall Study||8
341256|NCT01335789|817431|P1|COMPLETED|Overall Study||8
341257|NCT01335789|817430|P2|STARTED|Overall Study||8
341258|NCT01335789|817431|P1|STARTED|Overall Study||8
341259|NCT01335750|817441|P1|NOT COMPLETED|Overall Study||0
341260|NCT01335750|817441|P1|COMPLETED|Overall Study||32
341261|NCT01335750|817441|P1|STARTED|Overall Study||32
341262|NCT01335724|817462|P2|NOT COMPLETED|Overall Study||0
341263|NCT01335724|817463|P1|NOT COMPLETED|Overall Study||0
341264|NCT01335724|817462|P2|COMPLETED|Overall Study||36
341265|NCT01335724|817463|P1|COMPLETED|Overall Study||36
341266|NCT01335724|817462|P2|STARTED|Overall Study||36
341267|NCT01335724|817463|P1|STARTED|Overall Study||36
341268|NCT01335698|817478|P5|NOT COMPLETED|Treatment Stage 2||6
341269|NCT01335698|817479|P4|NOT COMPLETED|Treatment Stage 2||24
341270|NCT01335698|817480|P3|NOT COMPLETED|Treatment Stage 2||16
341271|NCT01335698|817481|P2|NOT COMPLETED|Treatment Stage 2||4
341272|NCT01335698|817482|P1|NOT COMPLETED|Treatment Stage 2||15
341273|NCT01335698|817478|P5|COMPLETED|Treatment Stage 2||0
341274|NCT01335698|817479|P4|COMPLETED|Treatment Stage 2||2
341275|NCT01335698|817480|P3|COMPLETED|Treatment Stage 2||0
341276|NCT01335698|817481|P2|COMPLETED|Treatment Stage 2||0
341277|NCT01335698|817482|P1|COMPLETED|Treatment Stage 2||0
341278|NCT01335698|817478|P5|STARTED|Treatment Stage 2||6
341279|NCT01335698|817479|P4|STARTED|Treatment Stage 2||26
341280|NCT01335698|817480|P3|STARTED|Treatment Stage 2||16
341281|NCT01335698|817481|P2|STARTED|Treatment Stage 2||4
341282|NCT01335698|817482|P1|STARTED|Treatment Stage 2||15
341283|NCT01335698|817478|P5|NOT COMPLETED|Treatment Stage 1||2
341284|NCT01335698|817479|P4|NOT COMPLETED|Treatment Stage 1||9
341285|NCT01335698|817480|P3|NOT COMPLETED|Treatment Stage 1||5
341286|NCT01335698|817481|P2|NOT COMPLETED|Treatment Stage 1||8
341287|NCT01335698|817482|P1|NOT COMPLETED|Treatment Stage 1||8
341288|NCT01335698|817478|P5|COMPLETED|Treatment Stage 1||6
341289|NCT01335698|817479|P4|COMPLETED|Treatment Stage 1||26
341290|NCT01335698|817480|P3|COMPLETED|Treatment Stage 1||16
341291|NCT01335698|817481|P2|COMPLETED|Treatment Stage 1||4
341292|NCT01335698|817482|P1|COMPLETED|Treatment Stage 1||15
341293|NCT01335698|817478|P5|STARTED|Treatment Stage 1||8
341294|NCT01335698|817479|P4|STARTED|Treatment Stage 1||35
341295|NCT01335698|817480|P3|STARTED|Treatment Stage 1||21
341296|NCT01335698|817481|P2|STARTED|Treatment Stage 1||12
341297|NCT01335698|817482|P1|STARTED|Treatment Stage 1||23
341298|NCT01335542|817531|P2|NOT COMPLETED|Overall Study||0
341299|NCT01335542|817532|P1|NOT COMPLETED|Overall Study||0
341300|NCT01335542|817531|P2|COMPLETED|Overall Study||45
341301|NCT01335542|817532|P1|COMPLETED|Overall Study||45
341302|NCT01335542|817531|P2|STARTED|Overall Study||45
341303|NCT01335542|817532|P1|STARTED|Overall Study||45
341305|NCT01335477|817541|P1|NOT COMPLETED|Overall Study||41
341306|NCT01335477|817540|P2|COMPLETED|Overall Study||272
341307|NCT01335477|817541|P1|COMPLETED|Overall Study||179
341308|NCT01335477|817540|P2|STARTED|Overall Study||331
341309|NCT01335477|817541|P1|STARTED|Overall Study||220
341310|NCT01335464|817605|P2|NOT COMPLETED|Overall Study||49
341311|NCT01335464|817606|P1|NOT COMPLETED|Overall Study||32
341312|NCT01335464|817605|P2|COMPLETED|Overall Study||260
341313|NCT01335464|817606|P1|COMPLETED|Overall Study||174
341314|NCT01335464|817605|P2|STARTED|Overall Study||309
341315|NCT01335464|817606|P1|STARTED|Overall Study||206
341316|NCT01335230|817672|P4|NOT COMPLETED|Overall Study||0
341317|NCT01335230|817673|P3|NOT COMPLETED|Overall Study||0
341318|NCT01335230|817674|P2|NOT COMPLETED|Overall Study||0
341319|NCT01335230|817675|P1|NOT COMPLETED|Overall Study||0
341320|NCT01335230|817672|P4|COMPLETED|Overall Study|subjects|10
341321|NCT01335230|817673|P3|COMPLETED|Overall Study|subjects|10
341322|NCT01335230|817674|P2|COMPLETED|Overall Study|subjects|10
341323|NCT01335230|817675|P1|COMPLETED|Overall Study|subjects|10
341324|NCT01335230|817672|P4|STARTED|Overall Study|subjects|10
341325|NCT01335230|817673|P3|STARTED|Overall Study|subjects|10
341326|NCT01335230|817674|P2|STARTED|Overall Study|subjects|10
341327|NCT01335230|817675|P1|STARTED|Overall Study|subjects|10
341328|NCT01335191|817687|P2|NOT COMPLETED|Overall Study||0
341329|NCT01335191|817688|P1|NOT COMPLETED|Overall Study||0
341330|NCT01335191|817687|P2|COMPLETED|Overall Study||11
341331|NCT01335191|817688|P1|COMPLETED|Overall Study||16
341332|NCT01335191|817687|P2|STARTED|Overall Study||11
341333|NCT01335191|817688|P1|STARTED|Overall Study||16
341334|NCT01335061|817694|P1|NOT COMPLETED|Overall Study||0
341335|NCT01335061|817694|P1|COMPLETED|Overall Study||25
341336|NCT01335061|817694|P1|STARTED|Overall Study||25
341337|NCT01334957|817709|P1|NOT COMPLETED|Overall Study||0
341338|NCT01334957|817709|P1|COMPLETED|Overall Study||300
341339|NCT01334957|817709|P1|Received Multiple Doses|Overall Study||48
341340|NCT01334957|817709|P1|Received Single Dose|Overall Study||252
341341|NCT01334957|817709|P1|STARTED|Overall Study||300
341342|NCT01334944|817717|P2|NOT COMPLETED|Overall Study||0
341343|NCT01334944|817718|P1|NOT COMPLETED|Overall Study||0
341344|NCT01334944|817717|P2|COMPLETED|Overall Study||139
341345|NCT01334944|817718|P1|COMPLETED|Overall Study||11
341346|NCT01334944|817717|P2|Received Multiple Doses|Overall Study||43
341347|NCT01334944|817718|P1|Received Multiple Doses|Overall Study||10
341348|NCT01334944|817717|P2|Received Singel Dose|Overall Study||96
341349|NCT01334944|817718|P1|Received Singel Dose|Overall Study||1
341350|NCT01334944|817717|P2|STARTED|Overall Study||139
341351|NCT01334944|817718|P1|STARTED|Overall Study||11
341352|NCT01334918|817744|P2|NOT COMPLETED|Overall Study||1
341353|NCT01334918|817745|P1|NOT COMPLETED|Overall Study||8
341354|NCT01334918|817744|P2|COMPLETED|Overall Study||60
341355|NCT01334918|817745|P1|COMPLETED|Overall Study||55
341356|NCT01334918|817744|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
341357|NCT01334918|817745|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
341358|NCT01334918|817744|P2|STARTED|Overall Study||61
341359|NCT01334918|817745|P1|STARTED|Overall Study||63
341360|NCT01334866|817771|P1|NOT COMPLETED|Overall Study||19
341361|NCT01334866|817771|P1|COMPLETED|Overall Study||72
341362|NCT01334866|817771|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
341363|NCT01334723|817781|P2|NOT COMPLETED|Overall Study||0
341364|NCT01334723|817782|P1|NOT COMPLETED|Overall Study||0
341365|NCT01334723|817781|P2|COMPLETED|Overall Study||17739
341366|NCT01334723|817782|P1|COMPLETED|Overall Study||17293
341367|NCT01334723|817781|P2|STARTED|Overall Study||17739
341368|NCT01334723|817782|P1|STARTED|Overall Study||17293
341369|NCT01334710|817808|P1|NOT COMPLETED|Overall Study||3
341370|NCT01334710|817808|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in Hepatocellular cancer the trial was stopped.|0
341371|NCT01334710|817808|P1|STARTED|Overall Study||3
341372|NCT01334606|817812|P1|NOT COMPLETED|Overall Study||18
341373|NCT01334606|817812|P1|COMPLETED|Overall Study||3
341374|NCT01334606|817812|P1|STARTED|Overall Study||21
341375|NCT01334554|817820|P2|NOT COMPLETED|Overall Study||2
341376|NCT01334554|817821|P1|NOT COMPLETED|Overall Study||4
341377|NCT01334554|817820|P2|COMPLETED|Overall Study||21
341378|NCT01334554|817821|P1|COMPLETED|Overall Study||19
341379|NCT01334554|817820|P2|STARTED|Overall Study||23
341380|NCT01334554|817821|P1|STARTED|Overall Study||23
341381|NCT01334515|817831|P2|NOT COMPLETED|Overall Study||29
341382|NCT01334515|817832|P1|NOT COMPLETED|Overall Study||12
341383|NCT01334515|817831|P2|COMPLETED|Overall Study||7
341384|NCT01334515|817832|P1|COMPLETED|Overall Study||4
341385|NCT01334515|817831|P2|STARTED|Overall Study||36
341386|NCT01334515|817832|P1|STARTED|Overall Study||16
341387|NCT01334229|817842|P2|NOT COMPLETED|Overall Study||0
341388|NCT01334229|817843|P1|NOT COMPLETED|Overall Study||0
341389|NCT01334229|817842|P2|COMPLETED|Overall Study||11
341390|NCT01334229|817843|P1|COMPLETED|Overall Study||11
341391|NCT01334229|817842|P2|STARTED|Overall Study||11
341392|NCT01334229|817843|P1|STARTED|Overall Study||11
341393|NCT01334216|817861|P2|NOT COMPLETED|Overall Study||0
341394|NCT01334216|817862|P1|NOT COMPLETED|Overall Study||0
341395|NCT01334216|817861|P2|COMPLETED|Overall Study||194
341396|NCT01334216|817862|P1|COMPLETED|Overall Study||168
341397|NCT01334216|817861|P2|STARTED|Overall Study||194
341398|NCT01334216|817862|P1|STARTED|Overall Study||168
341399|NCT01334125|817870|P2|NOT COMPLETED|Overall Study||3
341400|NCT01334125|817871|P1|NOT COMPLETED|Overall Study||3
341401|NCT01334125|817870|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
341402|NCT01334125|817871|P1|COMPLETED|Overall Study|3 subjects move to another city|12
341403|NCT01334125|817870|P2|STARTED|Overall Study||13
341404|NCT01334125|817871|P1|STARTED|Overall Study||15
341405|NCT01333956|817887|P4|NOT COMPLETED|Overall Study||2
341406|NCT01333956|817888|P3|NOT COMPLETED|Overall Study||1
341407|NCT01333956|817889|P2|NOT COMPLETED|Overall Study||4
341408|NCT01333956|817890|P1|NOT COMPLETED|Overall Study||2
341409|NCT01333956|817887|P4|COMPLETED|Overall Study||28
341410|NCT01333956|817888|P3|COMPLETED|Overall Study||29
341411|NCT01333956|817889|P2|COMPLETED|Overall Study||26
341412|NCT01333956|817890|P1|COMPLETED|Overall Study||28
341413|NCT01333956|817887|P4|STARTED|Overall Study||30
341414|NCT01333956|817888|P3|STARTED|Overall Study||30
341415|NCT01333956|817889|P2|STARTED|Overall Study||30
341416|NCT01333956|817890|P1|STARTED|Overall Study||30
341417|NCT01333865|817924|P1|NOT COMPLETED|Overall Study||2
341418|NCT01333865|817924|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
341419|NCT01333865|817924|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
341420|NCT01333813|817929|P1|NOT COMPLETED|Overall Study||0
341421|NCT01333813|817929|P1|COMPLETED|Overall Study||297
341422|NCT01333813|817929|P1|STARTED|Overall Study||297
341423|NCT01333722|817944|P2|NOT COMPLETED|Overall Study||3
341424|NCT01333722|817945|P1|NOT COMPLETED|Overall Study||0
341425|NCT01333722|817944|P2|COMPLETED|Overall Study||46
341426|NCT01333722|817945|P1|COMPLETED|Overall Study||51
341427|NCT01333722|817944|P2|STARTED|Overall Study||49
341428|NCT01333722|817945|P1|STARTED|Overall Study||51
341429|NCT01333592|817959|P2|NOT COMPLETED|Overall Study||17
341430|NCT01333592|817960|P1|NOT COMPLETED|Overall Study||9
341431|NCT01333592|817959|P2|COMPLETED|Overall Study||52
341432|NCT01333592|817960|P1|COMPLETED|Overall Study||58
341433|NCT01333592|817959|P2|STARTED|Overall Study||69
341434|NCT01333592|817960|P1|STARTED|Overall Study||67
341435|NCT01333501|817970|P2|NOT COMPLETED|Overall Study||21
341436|NCT01333501|817971|P1|NOT COMPLETED|Overall Study||9
341437|NCT01333501|817970|P2|COMPLETED|Overall Study||30
341438|NCT01333501|817971|P1|COMPLETED|Overall Study||97
341439|NCT01333501|817970|P2|Safety Population|Overall Study||47
341440|NCT01333501|817971|P1|Safety Population|Overall Study||104
341441|NCT01333501|817970|P2|Full Analysis Set (FAS)|Overall Study||28
341442|NCT01333501|817971|P1|Full Analysis Set (FAS)|Overall Study||80
341443|NCT01333501|817970|P2|STARTED|Overall Study||51
341444|NCT01333501|817971|P1|STARTED|Overall Study||106
341445|NCT01333488|818020|P3|NOT COMPLETED|Overall Study||0
341446|NCT01333488|818021|P2|NOT COMPLETED|Overall Study||0
341447|NCT01333488|818022|P1|NOT COMPLETED|Overall Study||0
341448|NCT01333488|818020|P3|COMPLETED|Overall Study||3
341449|NCT01333488|818021|P2|COMPLETED|Overall Study||1
341450|NCT01333488|818022|P1|COMPLETED|Overall Study||2
341451|NCT01333488|818020|P3|STARTED|Overall Study||3
341452|NCT01333488|818021|P2|STARTED|Overall Study||1
341453|NCT01333488|818022|P1|STARTED|Overall Study||2
341454|NCT01333475|818038|P2|NOT COMPLETED|Overall Study||3
341455|NCT01333475|818039|P1|NOT COMPLETED|Overall Study||2
341456|NCT01333475|818038|P2|COMPLETED|Overall Study||6
341457|NCT01333475|818039|P1|COMPLETED|Overall Study||10
341458|NCT01333475|818038|P2|STARTED|Overall Study||9
341459|NCT01333475|818039|P1|STARTED|Overall Study||12
341460|NCT01333436|818049|P2|NOT COMPLETED|Overall Study||0
341461|NCT01333436|818050|P1|NOT COMPLETED|Overall Study||0
341462|NCT01333436|818049|P2|COMPLETED|Overall Study||50
341463|NCT01333436|818050|P1|COMPLETED|Overall Study||43
341464|NCT01333436|818049|P2|STARTED|Overall Study||50
341465|NCT01333436|818050|P1|STARTED|Overall Study||43
341466|NCT01333397|818065|P5|NOT COMPLETED|Overall Study||0
341467|NCT01333397|818066|P4|NOT COMPLETED|Overall Study||1
341468|NCT01333397|818067|P3|NOT COMPLETED|Overall Study||0
341469|NCT01333397|818068|P2|NOT COMPLETED|Overall Study||0
341470|NCT01333397|818069|P1|NOT COMPLETED|Overall Study||1
341471|NCT01333397|818065|P5|COMPLETED|Overall Study||35
341472|NCT01333397|818066|P4|COMPLETED|Overall Study||34
341473|NCT01333397|818067|P3|COMPLETED|Overall Study||35
341474|NCT01333397|818068|P2|COMPLETED|Overall Study||36
341475|NCT01333397|818069|P1|COMPLETED|Overall Study||34
341476|NCT01333397|818065|P5|STARTED|Overall Study||35
341477|NCT01333397|818066|P4|STARTED|Overall Study||35
341478|NCT01333397|818067|P3|STARTED|Overall Study||35
341479|NCT01333397|818068|P2|STARTED|Overall Study||36
341480|NCT01333397|818069|P1|STARTED|Overall Study||35
341481|NCT01333189|818143|P2|NOT COMPLETED|Overall Study||2
341482|NCT01333189|818144|P1|NOT COMPLETED|Overall Study||2
341483|NCT01333189|818143|P2|COMPLETED|Overall Study||11
341484|NCT01333189|818144|P1|COMPLETED|Overall Study||11
341485|NCT01333189|818143|P2|STARTED|Overall Study||13
341486|NCT01333189|818144|P1|STARTED|Overall Study||13
341487|NCT01332994|818172|P1|NOT COMPLETED|Overall Study||71
341488|NCT01332994|818172|P1|COMPLETED|Overall Study||448
341489|NCT01332994|818172|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
341490|NCT01332994|818172|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
341491|NCT01332994|818172|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
341492|NCT01332994|818172|P1|Completed Week 16|Overall Study||463
341493|NCT01332994|818172|P1|STARTED|Overall Study||519
341494|NCT01332981|818228|P1|NOT COMPLETED|Overall Study||0
341495|NCT01332981|818228|P1|COMPLETED|Overall Study||220
341496|NCT01332981|818228|P1|STARTED|Overall Study||220
341497|NCT01332968|818241|P8|NOT COMPLETED|Follow-Up Period||531
341498|NCT01332968|818242|P7|NOT COMPLETED|Follow-Up Period||542
341499|NCT01332968|818243|P6|NOT COMPLETED|Follow-Up Period||0
341500|NCT01332968|818244|P5|NOT COMPLETED|Follow-Up Period||0
341501|NCT01332968|818245|P4|NOT COMPLETED|Follow-Up Period||0
341502|NCT01332968|818246|P3|NOT COMPLETED|Follow-Up Period||0
341503|NCT01332968|818247|P2|NOT COMPLETED|Follow-Up Period||0
341504|NCT01332968|818248|P1|NOT COMPLETED|Follow-Up Period||0
341505|NCT01332968|818241|P8|COMPLETED|Follow-Up Period||0
341506|NCT01332968|818242|P7|COMPLETED|Follow-Up Period||0
341507|NCT01332968|818243|P6|COMPLETED|Follow-Up Period||0
341508|NCT01332968|818244|P5|COMPLETED|Follow-Up Period||0
341509|NCT01332968|818245|P4|COMPLETED|Follow-Up Period||0
341510|NCT01332968|818246|P3|COMPLETED|Follow-Up Period||0
341511|NCT01332968|818247|P2|COMPLETED|Follow-Up Period||0
341512|NCT01332968|818248|P1|COMPLETED|Follow-Up Period||0
341513|NCT01332968|818241|P8|STARTED|Follow-Up Period||531
341514|NCT01332968|818242|P7|STARTED|Follow-Up Period||542
341515|NCT01332968|818243|P6|STARTED|Follow-Up Period||0
341516|NCT01332968|818244|P5|STARTED|Follow-Up Period||0
341517|NCT01332968|818245|P4|STARTED|Follow-Up Period||0
341518|NCT01332968|818246|P3|STARTED|Follow-Up Period||0
341519|NCT01332968|818247|P2|STARTED|Follow-Up Period||0
341520|NCT01332968|818248|P1|STARTED|Follow-Up Period||0
341521|NCT01332968|818241|P8|NOT COMPLETED|Maintenance/Observation Period||0
341522|NCT01332968|818242|P7|NOT COMPLETED|Maintenance/Observation Period||0
341523|NCT01332968|818243|P6|NOT COMPLETED|Maintenance/Observation Period||9
341524|NCT01332968|818244|P5|NOT COMPLETED|Maintenance/Observation Period||10
341525|NCT01332968|818245|P4|NOT COMPLETED|Maintenance/Observation Period||207
341526|NCT01332968|818246|P3|NOT COMPLETED|Maintenance/Observation Period||213
341527|NCT01332968|818247|P2|NOT COMPLETED|Maintenance/Observation Period||0
341528|NCT01332968|818248|P1|NOT COMPLETED|Maintenance/Observation Period||0
341529|NCT01332968|818241|P8|COMPLETED|Maintenance/Observation Period||0
341530|NCT01332968|818242|P7|COMPLETED|Maintenance/Observation Period||0
341531|NCT01332968|818243|P6|COMPLETED|Maintenance/Observation Period||2
341532|NCT01332968|818244|P5|COMPLETED|Maintenance/Observation Period||2
341533|NCT01332968|818245|P4|COMPLETED|Maintenance/Observation Period||417
341534|NCT01332968|818246|P3|COMPLETED|Maintenance/Observation Period||399
341535|NCT01332968|818247|P2|COMPLETED|Maintenance/Observation Period||0
341536|NCT01332968|818248|P1|COMPLETED|Maintenance/Observation Period||0
341537|NCT01332968|818241|P8|STARTED|Maintenance/Observation Period||0
341538|NCT01332968|818242|P7|STARTED|Maintenance/Observation Period||0
341539|NCT01332968|818243|P6|STARTED|Maintenance/Observation Period||11
341540|NCT01332968|818244|P5|STARTED|Maintenance/Observation Period||12
341541|NCT01332968|818245|P4|STARTED|Maintenance/Observation Period||624
341542|NCT01332968|818246|P3|STARTED|Maintenance/Observation Period||612
341543|NCT01332968|818247|P2|STARTED|Maintenance/Observation Period||0
341544|NCT01332968|818248|P1|STARTED|Maintenance/Observation Period||0
341545|NCT01332968|818241|P8|NOT COMPLETED|Induction Period||0
341546|NCT01332968|818242|P7|NOT COMPLETED|Induction Period||0
341547|NCT01332968|818243|P6|NOT COMPLETED|Induction Period||0
341548|NCT01332968|818244|P5|NOT COMPLETED|Induction Period||0
341549|NCT01332968|818245|P4|NOT COMPLETED|Induction Period||0
341550|NCT01332968|818246|P3|NOT COMPLETED|Induction Period||0
341551|NCT01332968|818247|P2|NOT COMPLETED|Induction Period||56
341552|NCT01332968|818248|P1|NOT COMPLETED|Induction Period||58
341553|NCT01332968|818241|P8|COMPLETED|Induction Period||0
341554|NCT01332968|818242|P7|COMPLETED|Induction Period||0
341555|NCT01332968|818243|P6|COMPLETED|Induction Period||0
341556|NCT01332968|818244|P5|COMPLETED|Induction Period||0
341557|NCT01332968|818245|P4|COMPLETED|Induction Period||0
341558|NCT01332968|818246|P3|COMPLETED|Induction Period||0
341559|NCT01332968|818247|P2|COMPLETED|Induction Period||646
341560|NCT01332968|818248|P1|COMPLETED|Induction Period||641
341561|NCT01332968|818241|P8|STARTED|Induction Period||0
341562|NCT01332968|818242|P7|STARTED|Induction Period||0
341563|NCT01332968|818243|P6|STARTED|Induction Period||0
341564|NCT01332968|818244|P5|STARTED|Induction Period||0
341565|NCT01332968|818245|P4|STARTED|Induction Period||0
341566|NCT01332968|818246|P3|STARTED|Induction Period||0
341567|NCT01332968|818247|P2|STARTED|Induction Period||702
341568|NCT01332968|818248|P1|STARTED|Induction Period||699
341569|NCT01332721|818312|P1|NOT COMPLETED|Overall Study||0
341570|NCT01332721|818312|P1|COMPLETED|Overall Study||38
341571|NCT01332721|818312|P1|STARTED|Overall Study||38
341572|NCT01332578|818318|P2|NOT COMPLETED|Period II||0
341573|NCT01332578|818319|P1|NOT COMPLETED|Period II||0
341574|NCT01332578|818318|P2|COMPLETED|Period II||13
341575|NCT01332578|818319|P1|COMPLETED|Period II||12
341576|NCT01332578|818318|P2|STARTED|Period II||13
341577|NCT01332578|818319|P1|STARTED|Period II||12
341578|NCT01332578|818318|P2|NOT COMPLETED|Washout Period||0
341579|NCT01332578|818319|P1|NOT COMPLETED|Washout Period||0
341580|NCT01332578|818318|P2|COMPLETED|Washout Period||13
341581|NCT01332578|818319|P1|COMPLETED|Washout Period||12
341582|NCT01332578|818318|P2|STARTED|Washout Period||13
341583|NCT01332578|818319|P1|STARTED|Washout Period||12
341584|NCT01332578|818318|P2|NOT COMPLETED|Period I||0
341585|NCT01332578|818319|P1|NOT COMPLETED|Period I||0
341586|NCT01332578|818318|P2|COMPLETED|Period I||13
341587|NCT01332578|818319|P1|COMPLETED|Period I||12
341588|NCT01332578|818318|P2|STARTED|Period I||13
341589|NCT01332578|818319|P1|STARTED|Period I||12
341590|NCT01332500|818342|P4|NOT COMPLETED|Overall Study||0
341591|NCT01332500|818343|P3|NOT COMPLETED|Overall Study||0
341592|NCT01332500|818344|P2|NOT COMPLETED|Overall Study||0
341593|NCT01332500|818345|P1|NOT COMPLETED|Overall Study||0
341594|NCT01332500|818342|P4|COMPLETED|Overall Study||5806
341595|NCT01332500|818343|P3|COMPLETED|Overall Study||2903
341596|NCT01332500|818344|P2|COMPLETED|Overall Study||39771
341597|NCT01332500|818345|P1|COMPLETED|Overall Study||13257
341598|NCT01332500|818342|P4|STARTED|Overall Study||5806
341599|NCT01332500|818343|P3|STARTED|Overall Study||2903
341600|NCT01332500|818344|P2|STARTED|Overall Study||39771
341601|NCT01332500|818345|P1|STARTED|Overall Study||13257
341602|NCT01332487|818365|P2|NOT COMPLETED|Overall Study||0
341603|NCT01332487|818366|P1|NOT COMPLETED|Overall Study||0
341604|NCT01332487|818365|P2|COMPLETED|Overall Study||3063
341605|NCT01332487|818366|P1|COMPLETED|Overall Study||5554
341606|NCT01332487|818365|P2|STARTED|Overall Study||3063
341607|NCT01332487|818366|P1|STARTED|Overall Study||5554
341608|NCT01332461|818376|P2|NOT COMPLETED|Overall Study||0
341609|NCT01332461|818377|P1|NOT COMPLETED|Overall Study||0
341610|NCT01332461|818376|P2|COMPLETED|Overall Study||4386
341611|NCT01332461|818377|P1|COMPLETED|Overall Study||1291
341612|NCT01332461|818376|P2|STARTED|Overall Study||4386
341613|NCT01332461|818377|P1|STARTED|Overall Study||1291
341614|NCT01332435|818391|P4|NOT COMPLETED|Overall Study||0
341615|NCT01332435|818392|P3|NOT COMPLETED|Overall Study||0
341616|NCT01332435|818393|P2|NOT COMPLETED|Overall Study||0
341617|NCT01332435|818394|P1|NOT COMPLETED|Overall Study||0
341618|NCT01332435|818391|P4|COMPLETED|Overall Study||1656
341619|NCT01332435|818392|P3|COMPLETED|Overall Study||2604
341620|NCT01332435|818393|P2|COMPLETED|Overall Study||1064
341621|NCT01332435|818394|P1|COMPLETED|Overall Study||1572
341622|NCT01332435|818391|P4|STARTED|Overall Study||1656
341623|NCT01332435|818392|P3|STARTED|Overall Study||2604
341624|NCT01332435|818393|P2|STARTED|Overall Study||1064
341625|NCT01332435|818394|P1|STARTED|Overall Study||1572
341626|NCT01332357|818424|P1|NOT COMPLETED|Overall Study||0
341627|NCT01332357|818424|P1|COMPLETED|Overall Study||6139
341628|NCT01332357|818424|P1|STARTED|Overall Study||6139
341629|NCT01332318|818432|P4|NOT COMPLETED|Overall Study||2
341630|NCT01332318|818433|P3|NOT COMPLETED|Overall Study||1
341631|NCT01332318|818434|P2|NOT COMPLETED|Overall Study||4
341632|NCT01332318|818435|P1|NOT COMPLETED|Overall Study||2
341633|NCT01332318|818432|P4|COMPLETED|Overall Study||28
341634|NCT01332318|818433|P3|COMPLETED|Overall Study||33
341635|NCT01332318|818434|P2|COMPLETED|Overall Study||28
341636|NCT01332318|818435|P1|COMPLETED|Overall Study||32
341637|NCT01332318|818432|P4|STARTED|Overall Study||30
341638|NCT01332318|818433|P3|STARTED|Overall Study||34
341639|NCT01332318|818434|P2|STARTED|Overall Study||32
341640|NCT01332318|818435|P1|STARTED|Overall Study||34
341641|NCT01332305|818546|P5|NOT COMPLETED|Overall Study||12
341642|NCT01332305|818547|P4|NOT COMPLETED|Overall Study||8
341643|NCT01332305|818548|P3|NOT COMPLETED|Overall Study||14
341644|NCT01332305|818549|P2|NOT COMPLETED|Overall Study||14
341645|NCT01332305|818550|P1|NOT COMPLETED|Overall Study||10
341646|NCT01332305|818546|P5|COMPLETED|Overall Study||33
341647|NCT01332305|818547|P4|COMPLETED|Overall Study||30
341648|NCT01332305|818548|P3|COMPLETED|Overall Study||31
341649|NCT01332305|818549|P2|COMPLETED|Overall Study||34
341650|NCT01332305|818550|P1|COMPLETED|Overall Study||31
341651|NCT01332305|818546|P5|STARTED|Overall Study||45
341652|NCT01332305|818547|P4|STARTED|Overall Study||38
341653|NCT01332305|818548|P3|STARTED|Overall Study||45
341654|NCT01332305|818549|P2|STARTED|Overall Study||48
341655|NCT01332305|818550|P1|STARTED|Overall Study||41
341656|NCT01332292|818572|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
341657|NCT01332292|818573|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
341658|NCT01332292|818572|P2|COMPLETED|Treatment Period 2 (14 Days)||11
341659|NCT01332292|818573|P1|COMPLETED|Treatment Period 2 (14 Days)||11
341660|NCT01332292|818572|P2|STARTED|Treatment Period 2 (14 Days)||12
341661|NCT01332292|818573|P1|STARTED|Treatment Period 2 (14 Days)||12
341662|NCT01332292|818572|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
341663|NCT01332292|818573|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
341664|NCT01332292|818572|P2|COMPLETED|Washout Period (>=7 Days)||12
341665|NCT01332292|818573|P1|COMPLETED|Washout Period (>=7 Days)||12
341666|NCT01332292|818572|P2|STARTED|Washout Period (>=7 Days)||12
341667|NCT01332292|818573|P1|STARTED|Washout Period (>=7 Days)||12
341668|NCT01332292|818572|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
341669|NCT01332292|818573|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
341670|NCT01332292|818572|P2|COMPLETED|Treatment Period 1 (14 Days)||12
341671|NCT01332292|818573|P1|COMPLETED|Treatment Period 1 (14 Days)||12
341672|NCT01332292|818572|P2|STARTED|Treatment Period 1 (14 Days)||13
341673|NCT01332292|818573|P1|STARTED|Treatment Period 1 (14 Days)||14
341674|NCT01332253|818635|P2|NOT COMPLETED|Overall Study||0
341675|NCT01332253|818636|P1|NOT COMPLETED|Overall Study||0
341676|NCT01332253|818635|P2|COMPLETED|Overall Study||79
341677|NCT01332253|818636|P1|COMPLETED|Overall Study||82
341678|NCT01332253|818635|P2|STARTED|Overall Study||79
341679|NCT01332253|818636|P1|STARTED|Overall Study||82
341680|NCT01332227|818664|P2|NOT COMPLETED|Overall Study||5
341681|NCT01332227|818665|P1|NOT COMPLETED|Overall Study||16
341682|NCT01332227|818664|P2|COMPLETED|Overall Study||32
341683|NCT01332227|818665|P1|COMPLETED|Overall Study||56
341684|NCT01332227|818664|P2|STARTED|Overall Study|Participants who received treatment|37
341685|NCT01332227|818665|P1|STARTED|Overall Study|Participants who received treatment|72
341686|NCT01332149|818685|P2|NOT COMPLETED|Overall Study||38
341687|NCT01332149|818686|P1|NOT COMPLETED|Overall Study||30
341688|NCT01332149|818685|P2|COMPLETED|Overall Study||271
341689|NCT01332149|818686|P1|COMPLETED|Overall Study||284
341690|NCT01332149|818685|P2|Treated|Overall Study||307
341691|NCT01332149|818686|P1|Treated|Overall Study||313
341692|NCT01332149|818685|P2|STARTED|Overall Study|Assigned to study treatment.|309
341693|NCT01332149|818686|P1|STARTED|Overall Study|Assigned to study treatment.|314
341694|NCT01332123|818740|P1|NOT COMPLETED|Overall Study||0
341695|NCT01332123|818740|P1|COMPLETED|Overall Study||10
341696|NCT01332123|818740|P1|STARTED|Overall Study||10
341697|NCT01332071|818745|P2|NOT COMPLETED|Period 2||0
341698|NCT01332071|818746|P1|NOT COMPLETED|Period 2||0
341699|NCT01332071|818745|P2|COMPLETED|Period 2||13
341700|NCT01332071|818746|P1|COMPLETED|Period 2||13
341701|NCT01332071|818745|P2|STARTED|Period 2||13
341702|NCT01332071|818746|P1|STARTED|Period 2||13
341703|NCT01332071|818745|P2|NOT COMPLETED|7-Day Washout Period||0
341704|NCT01332071|818746|P1|NOT COMPLETED|7-Day Washout Period||0
341705|NCT01332071|818745|P2|COMPLETED|7-Day Washout Period||13
341706|NCT01332071|818746|P1|COMPLETED|7-Day Washout Period||13
341707|NCT01332071|818745|P2|STARTED|7-Day Washout Period||13
341708|NCT01332071|818746|P1|STARTED|7-Day Washout Period||13
341709|NCT01332071|818745|P2|NOT COMPLETED|Period 1||0
341710|NCT01332071|818746|P1|NOT COMPLETED|Period 1||0
341711|NCT01332071|818745|P2|COMPLETED|Period 1||13
341712|NCT01332071|818746|P1|COMPLETED|Period 1||13
341713|NCT01332071|818745|P2|STARTED|Period 1||13
341714|NCT01332071|818746|P1|STARTED|Period 1||13
341715|NCT01332019|818764|P2|NOT COMPLETED|Overall Study||122
341716|NCT01332019|818765|P1|NOT COMPLETED|Overall Study||113
341717|NCT01332019|818764|P2|COMPLETED|Overall Study||425
341718|NCT01332019|818765|P1|COMPLETED|Overall Study||417
341719|NCT01332019|818764|P2|STARTED|Overall Study||547
341720|NCT01332019|818765|P1|STARTED|Overall Study||530
341721|NCT01331824|818847|P1|NOT COMPLETED|Overall Study||13
341722|NCT01331824|818847|P1|COMPLETED|Overall Study||9
341723|NCT01331824|818847|P1|STARTED|Overall Study||22
341724|NCT01331694|818859|P6|NOT COMPLETED|Overall Study||0
341725|NCT01331694|818860|P5|NOT COMPLETED|Overall Study||0
341726|NCT01331694|818861|P4|NOT COMPLETED|Overall Study||0
341727|NCT01331694|818862|P3|NOT COMPLETED|Overall Study||0
341728|NCT01331694|818863|P2|NOT COMPLETED|Overall Study||0
341729|NCT01331694|818864|P1|NOT COMPLETED|Overall Study||0
341730|NCT01331694|818859|P6|COMPLETED|Overall Study||9126
341731|NCT01331694|818860|P5|COMPLETED|Overall Study||10617
341732|NCT01331694|818861|P4|COMPLETED|Overall Study||12595
341733|NCT01331694|818862|P3|COMPLETED|Overall Study||12659
341734|NCT01331694|818863|P2|COMPLETED|Overall Study||14449
341735|NCT01331694|818864|P1|COMPLETED|Overall Study||16684
341736|NCT01331694|818859|P6|STARTED|Overall Study||9126
341737|NCT01331694|818860|P5|STARTED|Overall Study||10617
341738|NCT01331694|818861|P4|STARTED|Overall Study||12595
341739|NCT01331694|818862|P3|STARTED|Overall Study||12659
341740|NCT01331694|818863|P2|STARTED|Overall Study||14449
341741|NCT01331694|818864|P1|STARTED|Overall Study||16684
341742|NCT01331681|818881|P3|NOT COMPLETED|Overall Study||35
341743|NCT01331681|818882|P2|NOT COMPLETED|Overall Study||34
341744|NCT01331681|818883|P1|NOT COMPLETED|Overall Study||35
341745|NCT01331681|818881|P3|COMPLETED|Overall Study|Completed Week 148|100
341746|NCT01331681|818882|P2|COMPLETED|Overall Study|Completed Week 148|101
341747|NCT01331681|818883|P1|COMPLETED|Overall Study|Completed Week 148|101
341748|NCT01331681|818881|P3|Completed Week 148|Overall Study||100
341749|NCT01331681|818882|P2|Completed Week 148|Overall Study||101
341750|NCT01331681|818883|P1|Completed Week 148|Overall Study||101
341751|NCT01331681|818881|P3|Completed Week 100|Overall Study||105
341752|NCT01331681|818882|P2|Completed Week 100|Overall Study||110
341753|NCT01331681|818883|P1|Completed Week 100|Overall Study||115
341754|NCT01331681|818881|P3|Completed Week 52|Overall Study||115
341755|NCT01331681|818882|P2|Completed Week 52|Overall Study||121
341756|NCT01331681|818883|P1|Completed Week 52|Overall Study||125
341757|NCT01331681|818881|P3|Participants Received Treatment|Overall Study|safety population|133
341758|NCT01331681|818882|P2|Participants Received Treatment|Overall Study|safety population|135
341759|NCT01331681|818883|P1|Participants Received Treatment|Overall Study|safety population|136
341760|NCT01331681|818881|P3|STARTED|Overall Study|randomized|135
341761|NCT01331681|818882|P2|STARTED|Overall Study|randomized|135
341762|NCT01331681|818883|P1|STARTED|Overall Study|randomized|136
341763|NCT01331304|818911|P2|NOT COMPLETED|Overall Study||60
341764|NCT01331304|818912|P1|NOT COMPLETED|Overall Study||58
341765|NCT01331304|818911|P2|COMPLETED|Overall Study||182
341766|NCT01331304|818912|P1|COMPLETED|Overall Study||182
341767|NCT01331304|818911|P2|STARTED|Overall Study||242
341768|NCT01331304|818912|P1|STARTED|Overall Study||240
341769|NCT01331291|818922|P2|NOT COMPLETED|Overall Study||9
341770|NCT01331291|818923|P1|NOT COMPLETED|Overall Study||2
341771|NCT01331291|818922|P2|COMPLETED|Overall Study||0
341772|NCT01331291|818923|P1|COMPLETED|Overall Study||0
341773|NCT01331291|818922|P2|STARTED|Overall Study||9
341774|NCT01331291|818923|P1|STARTED|Overall Study||2
341775|NCT01331213|818936|P2|NOT COMPLETED|Overall Study||0
341776|NCT01331213|818937|P1|NOT COMPLETED|Overall Study||0
341777|NCT01331213|818936|P2|COMPLETED|Overall Study||10
341778|NCT01331213|818937|P1|COMPLETED|Overall Study||8
341779|NCT01331213|818936|P2|STARTED|Overall Study||10
341780|NCT01331213|818937|P1|STARTED|Overall Study||8
341781|NCT01331161|818957|P2|NOT COMPLETED|Overall Study||2
341782|NCT01331161|818958|P1|NOT COMPLETED|Overall Study||1
341783|NCT01331161|818957|P2|COMPLETED|Overall Study||31
341784|NCT01331161|818958|P1|COMPLETED|Overall Study||43
341785|NCT01331161|818957|P2|STARTED|Overall Study||33
341786|NCT01331161|818958|P1|STARTED|Overall Study||44
341787|NCT01331109|818966|P1|NOT COMPLETED|Overall Study||57
341788|NCT01331109|818966|P1|COMPLETED|Overall Study||0
341789|NCT01331109|818966|P1|STARTED|Overall Study||57
341790|NCT01331005|818978|P2|NOT COMPLETED|Overall Study||4
341791|NCT01331005|818979|P1|NOT COMPLETED|Overall Study||4
341792|NCT01331005|818978|P2|COMPLETED|Overall Study||57
341793|NCT01331005|818979|P1|COMPLETED|Overall Study||60
341794|NCT01331005|818978|P2|STARTED|Overall Study||61
341795|NCT01331005|818979|P1|STARTED|Overall Study||64
341796|NCT01330914|818985|P1|NOT COMPLETED|Overall Study||7
341797|NCT01330914|818985|P1|COMPLETED|Overall Study||48
341798|NCT01330914|818985|P1|STARTED|Overall Study||55
341799|NCT01330628|818991|P2|NOT COMPLETED|Overall Study||40
341800|NCT01330628|818992|P1|NOT COMPLETED|Overall Study||70
341801|NCT01330628|818991|P2|COMPLETED|Overall Study||42
341802|NCT01330628|818992|P1|COMPLETED|Overall Study||100
341803|NCT01330628|818991|P2|6 Month Follow-up|Overall Study||60
341804|NCT01330628|818992|P1|6 Month Follow-up|Overall Study||135
341805|NCT01330628|818991|P2|30 Day Follow-up|Overall Study||73
341806|NCT01330628|818992|P1|30 Day Follow-up|Overall Study||165
341807|NCT01330628|818991|P2|STARTED|Overall Study||82
341808|NCT01330628|818992|P1|STARTED|Overall Study||170
341809|NCT01330433|819002|P2|NOT COMPLETED|Overall Study||3
341810|NCT01330433|819003|P1|NOT COMPLETED|Overall Study||2
341811|NCT01330433|819002|P2|COMPLETED|Overall Study||16
341812|NCT01330433|819003|P1|COMPLETED|Overall Study||14
341813|NCT01330433|819002|P2|STARTED|Overall Study||19
341814|NCT01330433|819003|P1|STARTED|Overall Study||16
341815|NCT01330420|819023|P1|NOT COMPLETED|Overall Study||4
341816|NCT01330420|819023|P1|COMPLETED|Overall Study||24
341817|NCT01330420|819023|P1|STARTED|Overall Study||28
341818|NCT01330394|819033|P2|NOT COMPLETED|Overall Study||0
341819|NCT01330394|819034|P1|NOT COMPLETED|Overall Study||0
341820|NCT01330394|819033|P2|COMPLETED|Overall Study||16
341821|NCT01330394|819034|P1|COMPLETED|Overall Study||17
341822|NCT01330394|819033|P2|STARTED|Overall Study||16
341823|NCT01330394|819034|P1|STARTED|Overall Study||17
341824|NCT01330381|819042|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
341825|NCT01330381|819043|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
341826|NCT01330381|819044|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
341827|NCT01330381|819042|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
341828|NCT01330381|819043|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
341829|NCT01330381|819044|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
341830|NCT01330381|819042|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
341831|NCT01330381|819043|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
341832|NCT01330381|819044|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
341833|NCT01330381|819042|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
341834|NCT01330381|819043|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
341835|NCT01330381|819044|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
341836|NCT01330381|819042|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
341837|NCT01330381|819043|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
341838|NCT01330381|819044|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
341839|NCT01330381|819042|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
341840|NCT01330381|819043|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
341841|NCT01330381|819044|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
341842|NCT01330381|819042|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
341843|NCT01330381|819043|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
341844|NCT01330381|819044|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
341845|NCT01330355|819090|P2|NOT COMPLETED|Overall Study||0
341846|NCT01330355|819091|P1|NOT COMPLETED|Overall Study||0
341847|NCT01330355|819090|P2|COMPLETED|Overall Study||17
341848|NCT01330355|819091|P1|COMPLETED|Overall Study||16
341849|NCT01330355|819090|P2|STARTED|Overall Study||17
341850|NCT01330355|819091|P1|STARTED|Overall Study||16
341851|NCT01330316|819105|P2|NOT COMPLETED|Overall Study||15
341852|NCT01330316|819106|P1|NOT COMPLETED|Overall Study||2
341853|NCT01330316|819105|P2|COMPLETED|Overall Study||60
341854|NCT01330316|819106|P1|COMPLETED|Overall Study||41
341855|NCT01330316|819105|P2|STARTED|Overall Study||75
341856|NCT01330316|819106|P1|STARTED|Overall Study||43
341857|NCT01330303|819142|P2|NOT COMPLETED|Period 2||0
341858|NCT01330303|819143|P1|NOT COMPLETED|Period 2||0
341859|NCT01330303|819142|P2|COMPLETED|Period 2||18
341860|NCT01330303|819143|P1|COMPLETED|Period 2||19
341861|NCT01330303|819142|P2|STARTED|Period 2||18
341862|NCT01330303|819143|P1|STARTED|Period 2||19
341863|NCT01330303|819142|P2|NOT COMPLETED|7-Day Washout Period||0
341864|NCT01330303|819143|P1|NOT COMPLETED|7-Day Washout Period||0
341865|NCT01330303|819142|P2|COMPLETED|7-Day Washout Period||18
341866|NCT01330303|819143|P1|COMPLETED|7-Day Washout Period||19
341867|NCT01330303|819142|P2|STARTED|7-Day Washout Period||18
341868|NCT01330303|819143|P1|STARTED|7-Day Washout Period||19
341869|NCT01330303|819142|P2|NOT COMPLETED|Period 1||2
341870|NCT01330303|819143|P1|NOT COMPLETED|Period 1||1
341871|NCT01330303|819142|P2|COMPLETED|Period 1||18
341872|NCT01330303|819143|P1|COMPLETED|Period 1||19
341873|NCT01330303|819142|P2|STARTED|Period 1||20
341874|NCT01330303|819143|P1|STARTED|Period 1||20
341875|NCT01330290|819153|P1|NOT COMPLETED|Overall Study||0
341876|NCT01330290|819153|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
341877|NCT01330290|819153|P1|STARTED|Overall Study||148
341878|NCT01330108|819177|P1|NOT COMPLETED|Overall Study||4
341879|NCT01330108|819177|P1|COMPLETED|Overall Study||28
341880|NCT01330108|819177|P1|STARTED|Overall Study||32
341881|NCT01330030|819184|P2|NOT COMPLETED|Overall Study||17
341882|NCT01330030|819185|P1|NOT COMPLETED|Overall Study||16
341883|NCT01330030|819184|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
341884|NCT01330030|819185|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
341885|NCT01330030|819184|P2|STARTED|Overall Study||122
341886|NCT01330030|819185|P1|STARTED|Overall Study||121
341887|NCT01330017|819196|P5|NOT COMPLETED|Overall Study||3
341888|NCT01330017|819197|P4|NOT COMPLETED|Overall Study||12
341889|NCT01330017|819198|P3|NOT COMPLETED|Overall Study||8
341890|NCT01330017|819199|P2|NOT COMPLETED|Overall Study||4
341891|NCT01330017|819200|P1|NOT COMPLETED|Overall Study||5
341892|NCT01330017|819196|P5|COMPLETED|Overall Study||100
341893|NCT01330017|819197|P4|COMPLETED|Overall Study||100
341894|NCT01330017|819198|P3|COMPLETED|Overall Study||99
341895|NCT01330017|819199|P2|COMPLETED|Overall Study||104
341896|NCT01330017|819200|P1|COMPLETED|Overall Study||104
341897|NCT01330017|819196|P5|STARTED|Overall Study||103
341898|NCT01330017|819197|P4|STARTED|Overall Study||112
341899|NCT01330017|819198|P3|STARTED|Overall Study||107
341900|NCT01330017|819199|P2|STARTED|Overall Study||108
341901|NCT01330017|819200|P1|STARTED|Overall Study||109
341902|NCT01329978|819249|P5|NOT COMPLETED|Rerandomization Treatment Period||4
341903|NCT01329978|819250|P4|NOT COMPLETED|Rerandomization Treatment Period||5
341904|NCT01329978|819251|P3|NOT COMPLETED|Rerandomization Treatment Period||0
341905|NCT01329978|819252|P2|NOT COMPLETED|Rerandomization Treatment Period||0
341906|NCT01329978|819253|P1|NOT COMPLETED|Rerandomization Treatment Period||0
341907|NCT01329978|819249|P5|COMPLETED|Rerandomization Treatment Period||71
341908|NCT01329978|819250|P4|COMPLETED|Rerandomization Treatment Period||70
341909|NCT01329978|819251|P3|COMPLETED|Rerandomization Treatment Period||0
341910|NCT01329978|819252|P2|COMPLETED|Rerandomization Treatment Period||0
341911|NCT01329978|819253|P1|COMPLETED|Rerandomization Treatment Period||0
341912|NCT01329978|819249|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
341913|NCT01329978|819250|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
341914|NCT01329978|819251|P3|STARTED|Rerandomization Treatment Period||0
341915|NCT01329978|819252|P2|STARTED|Rerandomization Treatment Period||0
341916|NCT01329978|819253|P1|STARTED|Rerandomization Treatment Period||0
341917|NCT01329978|819249|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
341918|NCT01329978|819250|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
341919|NCT01329978|819251|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
341920|NCT01329978|819252|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
341921|NCT01329978|819253|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
341922|NCT01329978|819249|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
341923|NCT01329978|819250|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
341924|NCT01329978|819251|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
341925|NCT01329978|819252|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
341926|NCT01329978|819253|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
341927|NCT01329978|819249|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
341928|NCT01329978|819250|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
341929|NCT01329978|819251|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
341930|NCT01329978|819252|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
341931|NCT01329978|819253|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
341932|NCT01329939|819327|P4|NOT COMPLETED|Overall Study||5
341933|NCT01329939|819328|P3|NOT COMPLETED|Overall Study||1
341934|NCT01329939|819329|P2|NOT COMPLETED|Overall Study||1
341935|NCT01329939|819330|P1|NOT COMPLETED|Overall Study||3
341936|NCT01329939|819327|P4|COMPLETED|Overall Study||4
341937|NCT01329939|819328|P3|COMPLETED|Overall Study||4
341938|NCT01329939|819329|P2|COMPLETED|Overall Study||4
341939|NCT01329939|819330|P1|COMPLETED|Overall Study||4
341940|NCT01329939|819327|P4|STARTED|Overall Study||9
341941|NCT01329939|819328|P3|STARTED|Overall Study||5
341942|NCT01329939|819329|P2|STARTED|Overall Study||5
341943|NCT01329939|819330|P1|STARTED|Overall Study||7
341944|NCT01329848|819368|P1|NOT COMPLETED|Overall Study||29
341945|NCT01329848|819368|P1|COMPLETED|Overall Study||54
341946|NCT01329848|819368|P1|STARTED|Overall Study||83
341947|NCT01329679|819373|P2|NOT COMPLETED|Overall Study||0
341948|NCT01329679|819374|P1|NOT COMPLETED|Overall Study||0
341949|NCT01329679|819373|P2|COMPLETED|Overall Study||13
341950|NCT01329679|819374|P1|COMPLETED|Overall Study||13
341951|NCT01329679|819373|P2|STARTED|Overall Study||13
341952|NCT01329679|819374|P1|STARTED|Overall Study||13
341953|NCT01329562|819394|P2|NOT COMPLETED|Overall Study||7
341954|NCT01329562|819395|P1|NOT COMPLETED|Overall Study||9
341955|NCT01329562|819394|P2|COMPLETED|Overall Study||14
341956|NCT01329562|819395|P1|COMPLETED|Overall Study||11
341957|NCT01329562|819394|P2|STARTED|Overall Study||21
341958|NCT01329562|819395|P1|STARTED|Overall Study||20
341959|NCT01329549|819444|P1|NOT COMPLETED|Overall Study||2
341960|NCT01329549|819444|P1|COMPLETED|Overall Study||0
341961|NCT01329549|819444|P1|STARTED|Overall Study||2
341962|NCT01329419|819455|P1|NOT COMPLETED|Overall Study||235
341963|NCT01329419|819455|P1|COMPLETED|Overall Study||4158
341964|NCT01329419|819455|P1|STARTED|Overall Study||4393
341965|NCT01329263|819463|P2|NOT COMPLETED|Overall Study||23
341966|NCT01329263|819464|P1|NOT COMPLETED|Overall Study||5
341967|NCT01329263|819463|P2|COMPLETED|Overall Study||22
341968|NCT01329263|819464|P1|COMPLETED|Overall Study||10
341969|NCT01329263|819463|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
341970|NCT01329263|819464|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
341971|NCT01329263|819463|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
341972|NCT01329263|819464|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
341973|NCT01329263|819463|P2|Completed Period 1 Own Menthol|Overall Study||45
341974|NCT01329263|819464|P1|Completed Period 1 Own Menthol|Overall Study||15
341975|NCT01329263|819463|P2|STARTED|Overall Study||45
341976|NCT01329263|819464|P1|STARTED|Overall Study||15
341977|NCT01329198|819478|P2|NOT COMPLETED|Overall Study||0
341978|NCT01329198|819479|P1|NOT COMPLETED|Overall Study||0
341979|NCT01329198|819478|P2|COMPLETED|Overall Study||2
341980|NCT01329198|819479|P1|COMPLETED|Overall Study||3
341981|NCT01329198|819478|P2|STARTED|Overall Study||2
341982|NCT01329198|819479|P1|STARTED|Overall Study||3
341983|NCT01329185|819492|P2|NOT COMPLETED|Overall Study||0
341984|NCT01329185|819493|P1|NOT COMPLETED|Overall Study||0
341985|NCT01329185|819492|P2|COMPLETED|Overall Study||7
341986|NCT01329185|819493|P1|COMPLETED|Overall Study||10
341987|NCT01329185|819492|P2|PTLD|Overall Study||0
341988|NCT01329185|819493|P1|PTLD|Overall Study||1
341989|NCT01329185|819492|P2|CMV Disease|Overall Study||0
341990|NCT01329185|819493|P1|CMV Disease|Overall Study||1
341991|NCT01329185|819492|P2|STARTED|Overall Study||7
341992|NCT01329185|819493|P1|STARTED|Overall Study||10
341993|NCT01329029|819501|P2|NOT COMPLETED|Overall Study||192
341994|NCT01329029|819502|P1|NOT COMPLETED|Overall Study||269
341995|NCT01329029|819501|P2|COMPLETED|Overall Study||780
341996|NCT01329029|819502|P1|COMPLETED|Overall Study||704
341997|NCT01329029|819501|P2|Safety Population|Overall Study||967
341998|NCT01329029|819502|P1|Safety Population|Overall Study||968
341999|NCT01329029|819501|P2|Full Analysis Set (FAS)|Overall Study||966
342000|NCT01329029|819502|P1|Full Analysis Set (FAS)|Overall Study||969
342001|NCT01329029|819501|P2|STARTED|Overall Study||972
342002|NCT01329029|819502|P1|STARTED|Overall Study||973
342003|NCT01328964|819575|P3|NOT COMPLETED|Overall Study||0
342004|NCT01328964|819576|P2|NOT COMPLETED|Overall Study||0
342005|NCT01328964|819577|P1|NOT COMPLETED|Overall Study||0
342006|NCT01328964|819575|P3|COMPLETED|Overall Study||4424
342007|NCT01328964|819576|P2|COMPLETED|Overall Study||3270
342008|NCT01328964|819577|P1|COMPLETED|Overall Study||2212
342009|NCT01328964|819575|P3|STARTED|Overall Study||4424
342010|NCT01328964|819576|P2|STARTED|Overall Study||3270
342011|NCT01328964|819577|P1|STARTED|Overall Study||2212
342012|NCT01328951|819592|P2|NOT COMPLETED|Overall Study||322
342013|NCT01328951|819593|P1|NOT COMPLETED|Overall Study||321
342014|NCT01328951|819592|P2|COMPLETED|Overall Study||0
342015|NCT01328951|819593|P1|COMPLETED|Overall Study||0
342016|NCT01328951|819592|P2|STARTED|Overall Study||322
342017|NCT01328951|819593|P1|STARTED|Overall Study||321
342018|NCT01328873|819617|P1|NOT COMPLETED|Overall Study||0
342019|NCT01328873|819617|P1|COMPLETED|Overall Study||49
342020|NCT01328873|819617|P1|STARTED|Overall Study||49
342021|NCT01328782|819629|P3|NOT COMPLETED|Overall Study||0
342022|NCT01328782|819630|P2|NOT COMPLETED|Overall Study||0
342023|NCT01328782|819631|P1|NOT COMPLETED|Overall Study||0
342024|NCT01328782|819629|P3|COMPLETED|Overall Study||39
342025|NCT01328782|819630|P2|COMPLETED|Overall Study||42
342026|NCT01328782|819631|P1|COMPLETED|Overall Study||43
342027|NCT01328782|819629|P3|STARTED|Overall Study||39
342028|NCT01328782|819630|P2|STARTED|Overall Study||42
342029|NCT01328782|819631|P1|STARTED|Overall Study||43
342030|NCT01328769|819653|P2|NOT COMPLETED|Overall Study||1
342031|NCT01328769|819654|P1|NOT COMPLETED|Overall Study||0
342032|NCT01328769|819653|P2|COMPLETED|Overall Study||23
342033|NCT01328769|819654|P1|COMPLETED|Overall Study||25
342034|NCT01328769|819653|P2|STARTED|Overall Study||24
342035|NCT01328769|819654|P1|STARTED|Overall Study||25
342036|NCT01328756|819662|P1|NOT COMPLETED|Overall Study||123
342037|NCT01328756|819662|P1|COMPLETED|Overall Study||191
342038|NCT01328756|819662|P1|STARTED|Overall Study||314
342039|NCT01328717|819679|P1|NOT COMPLETED|Overall Study||1
342040|NCT01328717|819679|P1|COMPLETED|Overall Study||77
342041|NCT01328717|819679|P1|STARTED|Overall Study||78
342042|NCT01328574|819684|P1|NOT COMPLETED|Overall Study||1
342043|NCT01328574|819684|P1|COMPLETED|Overall Study||12
342044|NCT01328574|819684|P1|STARTED|Overall Study||13
342045|NCT01328548|819698|P2|NOT COMPLETED|Overall Study||0
342046|NCT01328548|819699|P1|NOT COMPLETED|Overall Study||4
342047|NCT01328548|819698|P2|COMPLETED|Overall Study||50
342048|NCT01328548|819699|P1|COMPLETED|Overall Study||187
342049|NCT01328548|819698|P2|STARTED|Overall Study||50
342050|NCT01328548|819699|P1|STARTED|Overall Study||191
342051|NCT01328496|819719|P2|NOT COMPLETED|Overall Study||0
342052|NCT01328496|819720|P1|NOT COMPLETED|Overall Study||1
342053|NCT01328496|819719|P2|COMPLETED|Overall Study||4
342054|NCT01328496|819720|P1|COMPLETED|Overall Study||9
342055|NCT01328496|819719|P2|STARTED|Overall Study||4
342056|NCT01328496|819720|P1|STARTED|Overall Study||10
342057|NCT01328444|819738|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
342058|NCT01328444|819739|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
342059|NCT01328444|819740|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
342060|NCT01328444|819741|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
342061|NCT01328444|819742|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
342062|NCT01328444|819743|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
342063|NCT01328444|819738|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
342064|NCT01328444|819739|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
342065|NCT01328444|819740|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
342066|NCT01328444|819741|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
342067|NCT01328444|819742|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
342068|NCT01328444|819743|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
342069|NCT01328444|819738|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
342070|NCT01328444|819739|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
342071|NCT01328444|819740|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
342072|NCT01328444|819741|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
342073|NCT01328444|819742|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
342074|NCT01328444|819743|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
342075|NCT01328444|819738|P6|NOT COMPLETED|Washout Period (14 Days)||4
342076|NCT01328444|819739|P5|NOT COMPLETED|Washout Period (14 Days)||1
342077|NCT01328444|819740|P4|NOT COMPLETED|Washout Period (14 Days)||1
342078|NCT01328444|819741|P3|NOT COMPLETED|Washout Period (14 Days)||0
342079|NCT01328444|819742|P2|NOT COMPLETED|Washout Period (14 Days)||1
342080|NCT01328444|819743|P1|NOT COMPLETED|Washout Period (14 Days)||1
342081|NCT01328444|819738|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
342082|NCT01328444|819739|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
342083|NCT01328444|819740|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
342084|NCT01328444|819741|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
342085|NCT01328444|819742|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
342086|NCT01328444|819743|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
342087|NCT01328444|819738|P6|STARTED|Washout Period (14 Days)||72
342088|NCT01328444|819739|P5|STARTED|Washout Period (14 Days)||67
342089|NCT01328444|819740|P4|STARTED|Washout Period (14 Days)||33
342090|NCT01328444|819741|P3|STARTED|Washout Period (14 Days)||25
342091|NCT01328444|819742|P2|STARTED|Washout Period (14 Days)||21
342092|NCT01328444|819743|P1|STARTED|Washout Period (14 Days)||83
342093|NCT01328444|819738|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
342094|NCT01328444|819739|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
342095|NCT01328444|819740|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
342096|NCT01328444|819741|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
342097|NCT01328444|819742|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
342098|NCT01328444|819743|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
342099|NCT01328444|819738|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
342100|NCT01328444|819739|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
342101|NCT01328444|819740|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
342102|NCT01328444|819741|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
342103|NCT01328444|819742|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
342104|NCT01328444|819743|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
342105|NCT01328444|819738|P6|STARTED|Treatment Period 1 (12 Weeks)||78
342106|NCT01328444|819739|P5|STARTED|Treatment Period 1 (12 Weeks)||81
342107|NCT01328444|819740|P4|STARTED|Treatment Period 1 (12 Weeks)||41
342108|NCT01328444|819741|P3|STARTED|Treatment Period 1 (12 Weeks)||28
342109|NCT01328444|819742|P2|STARTED|Treatment Period 1 (12 Weeks)||26
342110|NCT01328444|819743|P1|STARTED|Treatment Period 1 (12 Weeks)||94
342111|NCT01328431|819789|P2|NOT COMPLETED|12 Month (12M)||97
342112|NCT01328431|819790|P1|NOT COMPLETED|12 Month (12M)||84
342113|NCT01328431|819789|P2|COMPLETED|12 Month (12M)||289
342114|NCT01328431|819790|P1|COMPLETED|12 Month (12M)||304
342115|NCT01328431|819789|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
342116|NCT01328431|819790|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
342117|NCT01328431|819789|P2|NOT COMPLETED|3 Month (3M)||72
342118|NCT01328431|819790|P1|NOT COMPLETED|3 Month (3M)||77
342119|NCT01328431|819789|P2|COMPLETED|3 Month (3M)||316
342120|NCT01328431|819790|P1|COMPLETED|3 Month (3M)||313
342121|NCT01328431|819789|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
342122|NCT01328431|819790|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
342123|NCT01328431|819789|P2|NOT COMPLETED|1 Month (1M)||58
342124|NCT01328431|819790|P1|NOT COMPLETED|1 Month (1M)||55
342125|NCT01328431|819789|P2|COMPLETED|1 Month (1M)||330
342126|NCT01328431|819790|P1|COMPLETED|1 Month (1M)||335
342127|NCT01328431|819789|P2|STARTED|1 Month (1M)||388
342128|NCT01328431|819790|P1|STARTED|1 Month (1M)||390
342129|NCT01328431|819789|P2|NOT COMPLETED|Baseline||2
342130|NCT01328431|819790|P1|NOT COMPLETED|Baseline||0
342131|NCT01328431|819789|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
342132|NCT01328431|819790|P1|COMPLETED|Baseline||390
342133|NCT01328431|819789|P2|STARTED|Baseline||390
342134|NCT01328431|819790|P1|STARTED|Baseline||390
342135|NCT01328405|819800|P2|NOT COMPLETED|Overall Study||0
342136|NCT01328405|819801|P1|NOT COMPLETED|Overall Study||0
342137|NCT01328405|819800|P2|COMPLETED|Overall Study||48
342138|NCT01328405|819801|P1|COMPLETED|Overall Study||52
342139|NCT01328405|819800|P2|STARTED|Overall Study||48
342140|NCT01328405|819801|P1|STARTED|Overall Study||52
342141|NCT01328379|819818|P3|NOT COMPLETED|Overall Study||0
342142|NCT01328379|819819|P2|NOT COMPLETED|Overall Study||0
342143|NCT01328379|819820|P1|NOT COMPLETED|Overall Study||1
342144|NCT01328379|819818|P3|COMPLETED|Overall Study||143
342145|NCT01328379|819819|P2|COMPLETED|Overall Study||144
342146|NCT01328379|819820|P1|COMPLETED|Overall Study||142
342147|NCT01328379|819818|P3|STARTED|Overall Study||143
342148|NCT01328379|819819|P2|STARTED|Overall Study||144
342149|NCT01328379|819820|P1|STARTED|Overall Study||143
342150|NCT01328366|819846|P1|NOT COMPLETED|Overall Study||10
342151|NCT01328366|819846|P1|COMPLETED|Overall Study||143
342152|NCT01328366|819846|P1|STARTED|Overall Study||153
342153|NCT01328184|819864|P1|NOT COMPLETED|Overall Study||0
342154|NCT01328184|819864|P1|COMPLETED|Overall Study||18
342155|NCT01328184|819864|P1|STARTED|Overall Study||18
342156|NCT01328158|819904|P1|NOT COMPLETED|Overall Study||0
342157|NCT01328158|819904|P1|COMPLETED|Overall Study||220
342158|NCT01328158|819904|P1|STARTED|Overall Study||220
342159|NCT01328080|819942|P1|NOT COMPLETED|Overall Study||5
342160|NCT01328080|819942|P1|COMPLETED|Overall Study||6
342161|NCT01328080|819942|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
342162|NCT01328054|819946|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
342163|NCT01328054|819947|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
342164|NCT01328054|819946|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
342165|NCT01328054|819947|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
342166|NCT01328054|819946|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
342167|NCT01328054|819947|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
342168|NCT01328054|819946|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
342169|NCT01328054|819947|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
342170|NCT01328054|819946|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
342171|NCT01328054|819947|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
342172|NCT01328054|819946|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
342173|NCT01328054|819947|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
342174|NCT01328041|819972|P1|NOT COMPLETED|Overall Study||57
342175|NCT01328041|819972|P1|COMPLETED|Overall Study||126
342176|NCT01328041|819972|P1|STARTED|Overall Study||183
342177|NCT01327989|819994|P1|NOT COMPLETED|Overall Study||14
342178|NCT01327989|819994|P1|COMPLETED|Overall Study||188
342179|NCT01327989|819994|P1|STARTED|Overall Study||202
342180|NCT01327976|820008|P2|NOT COMPLETED|Overall Study||7
342181|NCT01327976|820009|P1|NOT COMPLETED|Overall Study||8
342182|NCT01327976|820008|P2|COMPLETED|Overall Study||70
342183|NCT01327976|820009|P1|COMPLETED|Overall Study||154
342184|NCT01327976|820008|P2|STARTED|Overall Study||77
342185|NCT01327976|820009|P1|STARTED|Overall Study||162
342186|NCT01327885|820021|P2|NOT COMPLETED|Overall Study||224
342187|NCT01327885|820022|P1|NOT COMPLETED|Overall Study||228
342188|NCT01327885|820021|P2|COMPLETED|Overall Study||0
342189|NCT01327885|820022|P1|COMPLETED|Overall Study||0
342190|NCT01327885|820021|P2|STARTED|Overall Study||224
342191|NCT01327885|820022|P1|STARTED|Overall Study||228
342192|NCT01327703|820034|P2|NOT COMPLETED|Second Treatment Period||2
342193|NCT01327703|820035|P1|NOT COMPLETED|Second Treatment Period||1
342194|NCT01327703|820034|P2|COMPLETED|Second Treatment Period||42
342195|NCT01327703|820035|P1|COMPLETED|Second Treatment Period||39
342196|NCT01327703|820034|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
342197|NCT01327703|820035|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
342198|NCT01327703|820034|P2|NOT COMPLETED|First Treatment Period||0
342199|NCT01327703|820035|P1|NOT COMPLETED|First Treatment Period||0
342200|NCT01327703|820034|P2|COMPLETED|First Treatment Period||45
342201|NCT01327703|820035|P1|COMPLETED|First Treatment Period||42
342202|NCT01327703|820034|P2|STARTED|First Treatment Period||45
342203|NCT01327703|820035|P1|STARTED|First Treatment Period||42
342204|NCT01327677|820069|P2|NOT COMPLETED|Overall Study||13
342205|NCT01327677|820070|P1|NOT COMPLETED|Overall Study||20
342206|NCT01327677|820069|P2|COMPLETED|Overall Study||56
342207|NCT01327677|820070|P1|COMPLETED|Overall Study||48
342208|NCT01327677|820069|P2|STARTED|Overall Study||69
342209|NCT01327677|820070|P1|STARTED|Overall Study||68
342210|NCT01327651|820091|P9|NOT COMPLETED|Post Study Follow-up||2
342211|NCT01327651|820092|P8|NOT COMPLETED|Post Study Follow-up||1
342212|NCT01327651|820093|P7|NOT COMPLETED|Post Study Follow-up||4
342213|NCT01327651|820094|P6|NOT COMPLETED|Post Study Follow-up||0
342214|NCT01327651|820095|P5|NOT COMPLETED|Post Study Follow-up||0
342215|NCT01327651|820096|P4|NOT COMPLETED|Post Study Follow-up||0
342216|NCT01327651|820097|P3|NOT COMPLETED|Post Study Follow-up||1
342217|NCT01327651|820098|P2|NOT COMPLETED|Post Study Follow-up||1
342218|NCT01327651|820099|P1|NOT COMPLETED|Post Study Follow-up||0
342219|NCT01327651|820091|P9|COMPLETED|Post Study Follow-up||47
342220|NCT01327651|820092|P8|COMPLETED|Post Study Follow-up||49
342221|NCT01327651|820093|P7|COMPLETED|Post Study Follow-up||45
342222|NCT01327651|820094|P6|COMPLETED|Post Study Follow-up||59
342223|NCT01327651|820095|P5|COMPLETED|Post Study Follow-up||56
342224|NCT01327651|820096|P4|COMPLETED|Post Study Follow-up||57
342225|NCT01327651|820097|P3|COMPLETED|Post Study Follow-up||55
342226|NCT01327651|820098|P2|COMPLETED|Post Study Follow-up||55
342227|NCT01327651|820099|P1|COMPLETED|Post Study Follow-up||56
342228|NCT01327651|820091|P9|STARTED|Post Study Follow-up||49
342229|NCT01327651|820092|P8|STARTED|Post Study Follow-up||50
342230|NCT01327651|820093|P7|STARTED|Post Study Follow-up||49
342231|NCT01327651|820094|P6|STARTED|Post Study Follow-up||59
342232|NCT01327651|820095|P5|STARTED|Post Study Follow-up||56
342233|NCT01327651|820096|P4|STARTED|Post Study Follow-up||57
342234|NCT01327651|820097|P3|STARTED|Post Study Follow-up||56
342235|NCT01327651|820098|P2|STARTED|Post Study Follow-up||56
342236|NCT01327651|820099|P1|STARTED|Post Study Follow-up||56
342237|NCT01327651|820091|P9|NOT COMPLETED|Self-administered Dosing Period||11
342238|NCT01327651|820092|P8|NOT COMPLETED|Self-administered Dosing Period||10
342239|NCT01327651|820093|P7|NOT COMPLETED|Self-administered Dosing Period||10
342240|NCT01327651|820094|P6|NOT COMPLETED|Self-administered Dosing Period||0
342241|NCT01327651|820095|P5|NOT COMPLETED|Self-administered Dosing Period||3
342242|NCT01327651|820096|P4|NOT COMPLETED|Self-administered Dosing Period||3
342243|NCT01327651|820097|P3|NOT COMPLETED|Self-administered Dosing Period||4
342244|NCT01327651|820098|P2|NOT COMPLETED|Self-administered Dosing Period||3
342245|NCT01327651|820099|P1|NOT COMPLETED|Self-administered Dosing Period||4
342246|NCT01327651|820091|P9|COMPLETED|Self-administered Dosing Period||49
342247|NCT01327651|820092|P8|COMPLETED|Self-administered Dosing Period||50
342248|NCT01327651|820093|P7|COMPLETED|Self-administered Dosing Period||49
342249|NCT01327651|820094|P6|COMPLETED|Self-administered Dosing Period||59
342250|NCT01327651|820095|P5|COMPLETED|Self-administered Dosing Period||56
342251|NCT01327651|820096|P4|COMPLETED|Self-administered Dosing Period||57
342252|NCT01327651|820097|P3|COMPLETED|Self-administered Dosing Period||56
342253|NCT01327651|820098|P2|COMPLETED|Self-administered Dosing Period||56
342254|NCT01327651|820099|P1|COMPLETED|Self-administered Dosing Period||56
342255|NCT01327651|820091|P9|Week 26|Self-administered Dosing Period||49
342256|NCT01327651|820092|P8|Week 26|Self-administered Dosing Period||51
342257|NCT01327651|820093|P7|Week 26|Self-administered Dosing Period||50
342258|NCT01327651|820094|P6|Week 26|Self-administered Dosing Period||58
342259|NCT01327651|820095|P5|Week 26|Self-administered Dosing Period||56
342260|NCT01327651|820096|P4|Week 26|Self-administered Dosing Period||57
342261|NCT01327651|820097|P3|Week 26|Self-administered Dosing Period||53
342262|NCT01327651|820098|P2|Week 26|Self-administered Dosing Period||56
342263|NCT01327651|820099|P1|Week 26|Self-administered Dosing Period||58
342264|NCT01327651|820091|P9|Week 22|Self-administered Dosing Period||51
342265|NCT01327651|820092|P8|Week 22|Self-administered Dosing Period||50
342266|NCT01327651|820093|P7|Week 22|Self-administered Dosing Period||50
342267|NCT01327651|820094|P6|Week 22|Self-administered Dosing Period||59
342268|NCT01327651|820095|P5|Week 22|Self-administered Dosing Period||56
342269|NCT01327651|820096|P4|Week 22|Self-administered Dosing Period||58
342270|NCT01327651|820097|P3|Week 22|Self-administered Dosing Period||55
342271|NCT01327651|820098|P2|Week 22|Self-administered Dosing Period||56
342272|NCT01327651|820099|P1|Week 22|Self-administered Dosing Period||59
342273|NCT01327651|820091|P9|Week 18|Self-administered Dosing Period||53
342274|NCT01327651|820092|P8|Week 18|Self-administered Dosing Period||49
342275|NCT01327651|820093|P7|Week 18|Self-administered Dosing Period||53
342276|NCT01327651|820094|P6|Week 18|Self-administered Dosing Period||59
342277|NCT01327651|820095|P5|Week 18|Self-administered Dosing Period||57
342278|NCT01327651|820096|P4|Week 18|Self-administered Dosing Period||60
342279|NCT01327651|820097|P3|Week 18|Self-administered Dosing Period||56
342280|NCT01327651|820098|P2|Week 18|Self-administered Dosing Period||56
342281|NCT01327651|820099|P1|Week 18|Self-administered Dosing Period||57
342282|NCT01327651|820091|P9|Week 14|Self-administered Dosing Period||54
342283|NCT01327651|820092|P8|Week 14|Self-administered Dosing Period||51
342284|NCT01327651|820093|P7|Week 14|Self-administered Dosing Period||54
342285|NCT01327651|820094|P6|Week 14|Self-administered Dosing Period||59
342286|NCT01327651|820095|P5|Week 14|Self-administered Dosing Period||58
342287|NCT01327651|820096|P4|Week 14|Self-administered Dosing Period||60
342288|NCT01327651|820097|P3|Week 14|Self-administered Dosing Period||57
342289|NCT01327651|820098|P2|Week 14|Self-administered Dosing Period||55
342290|NCT01327651|820099|P1|Week 14|Self-administered Dosing Period||59
342291|NCT01327651|820091|P9|Week 10|Self-administered Dosing Period||56
342292|NCT01327651|820092|P8|Week 10|Self-administered Dosing Period||57
342293|NCT01327651|820093|P7|Week 10|Self-administered Dosing Period||57
342294|NCT01327651|820094|P6|Week 10|Self-administered Dosing Period||59
342295|NCT01327651|820095|P5|Week 10|Self-administered Dosing Period||59
342296|NCT01327651|820096|P4|Week 10|Self-administered Dosing Period||60
342297|NCT01327651|820097|P3|Week 10|Self-administered Dosing Period||60
342298|NCT01327651|820098|P2|Week 10|Self-administered Dosing Period||58
342299|NCT01327651|820099|P1|Week 10|Self-administered Dosing Period||59
342300|NCT01327651|820091|P9|STARTED|Self-administered Dosing Period||60
342301|NCT01327651|820092|P8|STARTED|Self-administered Dosing Period||60
342302|NCT01327651|820093|P7|STARTED|Self-administered Dosing Period||59
342303|NCT01327651|820094|P6|STARTED|Self-administered Dosing Period||59
342304|NCT01327651|820095|P5|STARTED|Self-administered Dosing Period||59
342305|NCT01327651|820096|P4|STARTED|Self-administered Dosing Period||60
342306|NCT01327651|820097|P3|STARTED|Self-administered Dosing Period||60
342307|NCT01327651|820098|P2|STARTED|Self-administered Dosing Period||59
342308|NCT01327651|820099|P1|STARTED|Self-administered Dosing Period||60
342309|NCT01327599|820218|P1|NOT COMPLETED|Overall Study||3
342310|NCT01327599|820218|P1|COMPLETED|Overall Study||57
342311|NCT01327599|820218|P1|STARTED|Overall Study||60
342312|NCT01327547|820228|P2|NOT COMPLETED|Overall Study||67
342313|NCT01327547|820229|P1|NOT COMPLETED|Overall Study||70
342314|NCT01327547|820228|P2|COMPLETED|Overall Study||0
342315|NCT01327547|820229|P1|COMPLETED|Overall Study||0
342316|NCT01327547|820228|P2|In Study, Off Drug|Overall Study||2
342317|NCT01327547|820229|P1|In Study, Off Drug|Overall Study||2
342318|NCT01327547|820228|P2|STARTED|Overall Study||67
342319|NCT01327547|820229|P1|STARTED|Overall Study||70
342320|NCT01327508|820265|P2|NOT COMPLETED|Overall Study||0
342321|NCT01327508|820266|P1|NOT COMPLETED|Overall Study||0
342322|NCT01327508|820265|P2|COMPLETED|Overall Study||30
342323|NCT01327508|820266|P1|COMPLETED|Overall Study||30
342324|NCT01327508|820265|P2|STARTED|Overall Study||30
342325|NCT01327508|820266|P1|STARTED|Overall Study||30
342326|NCT01327482|820274|P1|NOT COMPLETED|Overall Study||1
342327|NCT01327482|820274|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
342328|NCT01327482|820274|P1|STARTED|Overall Study||10
342329|NCT01327339|820279|P1|NOT COMPLETED|Overall Study||8
342330|NCT01327339|820279|P1|COMPLETED|Overall Study||747
342331|NCT01327339|820279|P1|STARTED|Overall Study||755
342332|NCT01327313|820289|P4|NOT COMPLETED|Overall Study||0
342333|NCT01327313|820290|P3|NOT COMPLETED|Overall Study||0
342334|NCT01327313|820291|P2|NOT COMPLETED|Overall Study||0
342335|NCT01327313|820292|P1|NOT COMPLETED|Overall Study||0
342336|NCT01327313|820289|P4|COMPLETED|Overall Study||7
342337|NCT01327313|820290|P3|COMPLETED|Overall Study||6
342338|NCT01327313|820291|P2|COMPLETED|Overall Study||6
342339|NCT01327313|820292|P1|COMPLETED|Overall Study||8
342340|NCT01327313|820289|P4|STARTED|Overall Study||7
342341|NCT01327313|820290|P3|STARTED|Overall Study||6
342342|NCT01327313|820291|P2|STARTED|Overall Study||6
342343|NCT01327313|820292|P1|STARTED|Overall Study||8
342344|NCT01327300|820414|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
342345|NCT01327300|820415|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
342346|NCT01327300|820414|P2|COMPLETED|Second Intervention (12 Weeks)||2
342347|NCT01327300|820415|P1|COMPLETED|Second Intervention (12 Weeks)||4
342348|NCT01327300|820414|P2|STARTED|Second Intervention (12 Weeks)||2
342349|NCT01327300|820415|P1|STARTED|Second Intervention (12 Weeks)||4
342350|NCT01327300|820414|P2|NOT COMPLETED|Washout (3 Weeks)||0
342351|NCT01327300|820415|P1|NOT COMPLETED|Washout (3 Weeks)||1
342352|NCT01327300|820414|P2|COMPLETED|Washout (3 Weeks)||2
342353|NCT01327300|820415|P1|COMPLETED|Washout (3 Weeks)||4
342354|NCT01327300|820414|P2|STARTED|Washout (3 Weeks)||2
342355|NCT01327300|820415|P1|STARTED|Washout (3 Weeks)||5
342356|NCT01327300|820414|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
342357|NCT01327300|820415|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
342358|NCT01327300|820414|P2|COMPLETED|First Intervention (12 Weeks)||2
342359|NCT01327300|820415|P1|COMPLETED|First Intervention (12 Weeks)||5
342360|NCT01327300|820414|P2|STARTED|First Intervention (12 Weeks)||2
342361|NCT01327300|820415|P1|STARTED|First Intervention (12 Weeks)||5
342362|NCT01327053|820433|P2|NOT COMPLETED|Overall Study||105
342363|NCT01327053|820434|P1|NOT COMPLETED|Overall Study||40
342364|NCT01327053|820433|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
342365|NCT01327053|820434|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
342366|NCT01327053|820433|P2|STARTED|Overall Study||151
342367|NCT01327053|820434|P1|STARTED|Overall Study||79
342368|NCT01326962|820462|P1|NOT COMPLETED|Overall Study||7
342369|NCT01326962|820462|P1|COMPLETED|Overall Study||21
342370|NCT01326962|820462|P1|STARTED|Overall Study||28
342371|NCT01326910|820480|P2|NOT COMPLETED|Overall Study||3
342372|NCT01326910|820481|P1|NOT COMPLETED|Overall Study||4
342373|NCT01326910|820480|P2|COMPLETED|Overall Study||42
342374|NCT01326910|820481|P1|COMPLETED|Overall Study||41
342375|NCT01326910|820480|P2|STARTED|Overall Study||45
342376|NCT01326910|820481|P1|STARTED|Overall Study||45
342377|NCT01326845|820495|P2|NOT COMPLETED|Overall Study||5
342378|NCT01326845|820496|P1|NOT COMPLETED|Overall Study||7
342379|NCT01326845|820495|P2|COMPLETED|Overall Study|Study terminated early|0
342380|NCT01326845|820496|P1|COMPLETED|Overall Study|Study terminated early|0
342381|NCT01326845|820495|P2|STARTED|Overall Study||5
342382|NCT01326845|820496|P1|STARTED|Overall Study||7
342383|NCT01326533|820520|P2|NOT COMPLETED|Overall Study||0
342384|NCT01326533|820521|P1|NOT COMPLETED|Overall Study||4
342385|NCT01326533|820520|P2|COMPLETED|Overall Study||15
342386|NCT01326533|820521|P1|COMPLETED|Overall Study||13
342387|NCT01326533|820520|P2|STARTED|Overall Study||15
342388|NCT01326533|820521|P1|STARTED|Overall Study||17
342389|NCT01326026|820531|P2|NOT COMPLETED|Overall Study||13
342390|NCT01326026|820532|P1|NOT COMPLETED|Overall Study||12
342391|NCT01326026|820531|P2|COMPLETED|Overall Study||98
342392|NCT01326026|820532|P1|COMPLETED|Overall Study||99
342393|NCT01326026|820531|P2|Exposed|Overall Study||111
342394|NCT01326026|820532|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
342395|NCT01326026|820531|P2|STARTED|Overall Study||111
342396|NCT01326026|820532|P1|STARTED|Overall Study||111
342397|NCT01325870|820549|P3|NOT COMPLETED|Overall Study||8
342398|NCT01325870|820550|P2|NOT COMPLETED|Overall Study||13
342399|NCT01325870|820551|P1|NOT COMPLETED|Overall Study||11
342400|NCT01325870|820549|P3|COMPLETED|Overall Study||6
342401|NCT01325870|820550|P2|COMPLETED|Overall Study||3
342402|NCT01325870|820551|P1|COMPLETED|Overall Study||7
342403|NCT01325870|820549|P3|STARTED|Overall Study||14
342404|NCT01325870|820550|P2|STARTED|Overall Study||16
342405|NCT01325870|820551|P1|STARTED|Overall Study||18
342406|NCT01325792|820565|P1|NOT COMPLETED|Overall Study||17
342407|NCT01325792|820565|P1|COMPLETED|Overall Study||87
342408|NCT01325792|820565|P1|STARTED|Overall Study||104
342409|NCT01325714|820572|P2|NOT COMPLETED|Overall Study||31
342410|NCT01325714|820573|P1|NOT COMPLETED|Overall Study||34
342411|NCT01325714|820572|P2|COMPLETED|Overall Study||71
342412|NCT01325714|820573|P1|COMPLETED|Overall Study||67
342413|NCT01325714|820572|P2|12 Month Assessment|Overall Study||71
342414|NCT01325714|820573|P1|12 Month Assessment|Overall Study||67
342415|NCT01325714|820572|P2|6 Month Asessment|Overall Study||82
342416|NCT01325714|820573|P1|6 Month Asessment|Overall Study||75
342417|NCT01325714|820572|P2|3 Month Assessment|Overall Study||86
342418|NCT01325714|820573|P1|3 Month Assessment|Overall Study||82
342419|NCT01325714|820572|P2|STARTED|Overall Study||102
342420|NCT01325714|820573|P1|STARTED|Overall Study||101
342421|NCT01325701|820597|P2|NOT COMPLETED|Overall Study||3
342422|NCT01325701|820598|P1|NOT COMPLETED|Overall Study||21
342423|NCT01325701|820597|P2|COMPLETED|Overall Study||5
342424|NCT01325701|820598|P1|COMPLETED|Overall Study||49
342425|NCT01325701|820597|P2|STARTED|Overall Study||8
342426|NCT01325701|820598|P1|STARTED|Overall Study||70
342427|NCT01325623|820608|P1|NOT COMPLETED|Overall Study||3
342428|NCT01325623|820608|P1|COMPLETED|Overall Study||28
342429|NCT01325623|820608|P1|STARTED|Overall Study||31
342430|NCT01325532|820652|P2|NOT COMPLETED|Overall Study||0
342431|NCT01325532|820653|P1|NOT COMPLETED|Overall Study||2
342432|NCT01325532|820652|P2|COMPLETED|Overall Study||13
342433|NCT01325532|820653|P1|COMPLETED|Overall Study||15
342434|NCT01325532|820652|P2|STARTED|Overall Study||13
342435|NCT01325532|820653|P1|STARTED|Overall Study||17
342436|NCT01325493|820665|P2|NOT COMPLETED|Overall Study||3
342437|NCT01325493|820666|P1|NOT COMPLETED|Overall Study||1
342438|NCT01325493|820665|P2|COMPLETED|Overall Study||21
342439|NCT01325493|820666|P1|COMPLETED|Overall Study||29
342440|NCT01325493|820665|P2|STARTED|Overall Study||24
342441|NCT01325493|820666|P1|STARTED|Overall Study||30
342442|NCT01325428|820678|P1|NOT COMPLETED|Part B||3
342443|NCT01325428|820678|P1|COMPLETED|Part B||7
342444|NCT01325428|820678|P1|STARTED|Part B||10
342445|NCT01325428|820678|P1|NOT COMPLETED|Part A||16
342446|NCT01325428|820678|P1|COMPLETED|Part A||10
342447|NCT01325428|820678|P1|STARTED|Part A||26
342448|NCT01325350|820698|P5|NOT COMPLETED|Overall Study||12
342449|NCT01325350|820699|P4|NOT COMPLETED|Overall Study||9
342450|NCT01325350|820700|P3|NOT COMPLETED|Overall Study||17
342451|NCT01325350|820701|P2|NOT COMPLETED|Overall Study||5
342452|NCT01325350|820702|P1|NOT COMPLETED|Overall Study||6
342453|NCT01325350|820698|P5|COMPLETED|Overall Study||50
342454|NCT01325350|820699|P4|COMPLETED|Overall Study||52
342455|NCT01325350|820700|P3|COMPLETED|Overall Study||44
342456|NCT01325350|820701|P2|COMPLETED|Overall Study||56
342457|NCT01325350|820702|P1|COMPLETED|Overall Study||55
342458|NCT01325350|820698|P5|STARTED|Overall Study||62
342459|NCT01325350|820699|P4|STARTED|Overall Study||61
342460|NCT01325350|820700|P3|STARTED|Overall Study||61
342461|NCT01325350|820701|P2|STARTED|Overall Study||61
342462|NCT01325350|820702|P1|STARTED|Overall Study||61
342463|NCT01325337|820744|P5|NOT COMPLETED|Overall Study||8
342464|NCT01325337|820745|P4|NOT COMPLETED|Overall Study||10
342465|NCT01325337|820746|P3|NOT COMPLETED|Overall Study||9
342466|NCT01325337|820747|P2|NOT COMPLETED|Overall Study||9
342467|NCT01325337|820748|P1|NOT COMPLETED|Overall Study||5
342468|NCT01325337|820744|P5|COMPLETED|Overall Study||53
342469|NCT01325337|820745|P4|COMPLETED|Overall Study||52
342470|NCT01325337|820746|P3|COMPLETED|Overall Study||53
342471|NCT01325337|820747|P2|COMPLETED|Overall Study||52
342472|NCT01325337|820748|P1|COMPLETED|Overall Study||56
342473|NCT01325337|820744|P5|STARTED|Overall Study||61
342474|NCT01325337|820745|P4|STARTED|Overall Study||62
342475|NCT01325337|820746|P3|STARTED|Overall Study||62
342476|NCT01325337|820747|P2|STARTED|Overall Study||61
342477|NCT01325337|820748|P1|STARTED|Overall Study||61
342478|NCT01325311|820787|P2|NOT COMPLETED|Overall Study||0
342479|NCT01325311|820788|P1|NOT COMPLETED|Overall Study||0
342480|NCT01325311|820787|P2|COMPLETED|Overall Study||7
342481|NCT01325311|820788|P1|COMPLETED|Overall Study||8
342482|NCT01325311|820787|P2|STARTED|Overall Study||7
342483|NCT01325311|820788|P1|STARTED|Overall Study||8
342484|NCT01324310|820822|P1|NOT COMPLETED|Overall Study||2
342485|NCT01324310|820822|P1|COMPLETED|Overall Study||13
342486|NCT01324310|820822|P1|STARTED|Overall Study||15
342487|NCT01324271|820842|P2|NOT COMPLETED|Overall Study||0
342488|NCT01324271|820843|P1|NOT COMPLETED|Overall Study||4
342489|NCT01324271|820842|P2|COMPLETED|Overall Study||28
342490|NCT01324271|820843|P1|COMPLETED|Overall Study||53
342491|NCT01324271|820842|P2|STARTED|Overall Study||28
342492|NCT01324271|820843|P1|STARTED|Overall Study||57
342493|NCT01325181|820851|P2|NOT COMPLETED|Overall Study||2
342494|NCT01325181|820852|P1|NOT COMPLETED|Overall Study||0
342495|NCT01325181|820851|P2|COMPLETED|Overall Study||14
342496|NCT01325181|820852|P1|COMPLETED|Overall Study||18
342497|NCT01325181|820851|P2|STARTED|Overall Study||16
342498|NCT01325181|820852|P1|STARTED|Overall Study||18
342499|NCT01324947|820858|P1|NOT COMPLETED|Overall Study||74
342500|NCT01324947|820858|P1|COMPLETED|Overall Study||0
342501|NCT01324947|820858|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
342502|NCT01324947|820858|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
342503|NCT01324947|820858|P1|STARTED|Overall Study||74
342504|NCT01324882|820871|P2|NOT COMPLETED|Overall Study||0
342505|NCT01324882|820872|P1|NOT COMPLETED|Overall Study||0
342506|NCT01324882|820871|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
342507|NCT01324882|820872|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
342508|NCT01324882|820871|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
342509|NCT01324882|820872|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
342510|NCT01324687|820880|P2|NOT COMPLETED|Overall Study||15
342511|NCT01324687|820881|P1|NOT COMPLETED|Overall Study||0
342512|NCT01324687|820880|P2|COMPLETED|Overall Study||479
342513|NCT01324687|820881|P1|COMPLETED|Overall Study||1058
342514|NCT01324687|820880|P2|STARTED|Overall Study||494
342515|NCT01324687|820881|P1|STARTED|Overall Study||1058
342516|NCT01324622|820891|P2|NOT COMPLETED|Overall Study||7
342517|NCT01324622|820892|P1|NOT COMPLETED|Overall Study||9
342518|NCT01324622|820891|P2|COMPLETED|Overall Study||4
342519|NCT01324622|820892|P1|COMPLETED|Overall Study||4
342520|NCT01324622|820891|P2|STARTED|Overall Study||11
342521|NCT01324622|820892|P1|STARTED|Overall Study||13
342522|NCT01324440|820922|P2|NOT COMPLETED|Overall Study||1
342523|NCT01324440|820923|P1|NOT COMPLETED|Overall Study||0
342524|NCT01324440|820922|P2|COMPLETED|Overall Study||31
342525|NCT01324440|820923|P1|COMPLETED|Overall Study||32
342526|NCT01324440|820922|P2|STARTED|Overall Study||32
342527|NCT01324440|820923|P1|STARTED|Overall Study||32
342528|NCT01324401|820937|P2|NOT COMPLETED|Overall Study||3
342529|NCT01324401|820938|P1|NOT COMPLETED|Overall Study||1
342530|NCT01324401|820937|P2|COMPLETED|Overall Study||20
342531|NCT01324401|820938|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose despite initially meeting inclusion / exclusion.|3
342532|NCT01324401|820937|P2|STARTED|Overall Study|one (1) screen fail -- could not tolerate blood draw; two (2) withdrew pre treatment, not analyzed|23
342533|NCT01324401|820938|P1|STARTED|Overall Study||4
342534|NCT01324388|820949|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
342535|NCT01324388|820950|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
342536|NCT01324388|820951|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
342537|NCT01324388|820952|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
342538|NCT01324388|820949|P4|COMPLETED|Part 2 of Study: Second Intervention||9
342539|NCT01324388|820950|P3|COMPLETED|Part 2 of Study: Second Intervention||9
342540|NCT01324388|820951|P2|COMPLETED|Part 2 of Study: Second Intervention||0
342541|NCT01324388|820952|P1|COMPLETED|Part 2 of Study: Second Intervention||0
342542|NCT01324388|820949|P4|STARTED|Part 2 of Study: Second Intervention||9
342543|NCT01324388|820950|P3|STARTED|Part 2 of Study: Second Intervention||10
342544|NCT01324388|820951|P2|STARTED|Part 2 of Study: Second Intervention||0
342545|NCT01324388|820952|P1|STARTED|Part 2 of Study: Second Intervention||0
342546|NCT01324388|820949|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
342547|NCT01324388|820950|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
342548|NCT01324388|820951|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
342549|NCT01324388|820952|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
342550|NCT01324388|820949|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
342551|NCT01324388|820950|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
342552|NCT01324388|820951|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
342553|NCT01324388|820952|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
342554|NCT01324388|820949|P4|STARTED|Part 2: Washout of at Least 21 Days||9
342555|NCT01324388|820950|P3|STARTED|Part 2: Washout of at Least 21 Days||10
342556|NCT01324388|820951|P2|STARTED|Part 2: Washout of at Least 21 Days||0
342557|NCT01324388|820952|P1|STARTED|Part 2: Washout of at Least 21 Days||0
342558|NCT01324388|820949|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
342559|NCT01324388|820950|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
342560|NCT01324388|820951|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
342561|NCT01324388|820952|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
342562|NCT01324388|820949|P4|COMPLETED|Part 2 of Study: First Intervention||9
342563|NCT01324388|820950|P3|COMPLETED|Part 2 of Study: First Intervention||10
342564|NCT01324388|820951|P2|COMPLETED|Part 2 of Study: First Intervention||0
342565|NCT01324388|820952|P1|COMPLETED|Part 2 of Study: First Intervention||0
342566|NCT01324388|820949|P4|STARTED|Part 2 of Study: First Intervention||10
342567|NCT01324388|820950|P3|STARTED|Part 2 of Study: First Intervention||10
342568|NCT01324388|820951|P2|STARTED|Part 2 of Study: First Intervention||0
342569|NCT01324388|820952|P1|STARTED|Part 2 of Study: First Intervention||0
342570|NCT01324388|820949|P4|NOT COMPLETED|Part 1 of Study||0
342571|NCT01324388|820950|P3|NOT COMPLETED|Part 1 of Study||0
342572|NCT01324388|820951|P2|NOT COMPLETED|Part 1 of Study||2
342573|NCT01324388|820952|P1|NOT COMPLETED|Part 1 of Study||4
342574|NCT01324388|820949|P4|COMPLETED|Part 1 of Study||0
342575|NCT01324388|820950|P3|COMPLETED|Part 1 of Study||0
342576|NCT01324388|820951|P2|COMPLETED|Part 1 of Study||6
342577|NCT01324388|820952|P1|COMPLETED|Part 1 of Study||19
342578|NCT01324388|820949|P4|Received at Least 1 Dose|Part 1 of Study||0
342579|NCT01324388|820950|P3|Received at Least 1 Dose|Part 1 of Study||0
342580|NCT01324388|820951|P2|Received at Least 1 Dose|Part 1 of Study||8
342581|NCT01324388|820952|P1|Received at Least 1 Dose|Part 1 of Study||23
342582|NCT01324388|820949|P4|STARTED|Part 1 of Study||0
342583|NCT01324388|820950|P3|STARTED|Part 1 of Study||0
342584|NCT01324388|820951|P2|STARTED|Part 1 of Study||8
342585|NCT01324388|820952|P1|STARTED|Part 1 of Study||23
342586|NCT01324349|820973|P2|NOT COMPLETED|Overall Study||2
342587|NCT01324349|820974|P1|NOT COMPLETED|Overall Study||1
342588|NCT01324349|820973|P2|COMPLETED|Overall Study||16
342589|NCT01324349|820974|P1|COMPLETED|Overall Study||31
342590|NCT01324349|820973|P2|STARTED|Overall Study||18
342591|NCT01324349|820974|P1|STARTED|Overall Study||32
342592|NCT01324323|820984|P1|NOT COMPLETED|Overall Study||1
342593|NCT01324323|820984|P1|COMPLETED|Overall Study||13
342594|NCT01324323|820984|P1|STARTED|Overall Study||14
342595|NCT01324128|821006|P4|NOT COMPLETED|Stage 2||3
342596|NCT01324128|821007|P3|NOT COMPLETED|Stage 2||8
342597|NCT01324128|821008|P2|NOT COMPLETED|Stage 2||0
342598|NCT01324128|821009|P1|NOT COMPLETED|Stage 2||0
342599|NCT01324128|821006|P4|COMPLETED|Stage 2||46
342600|NCT01324128|821007|P3|COMPLETED|Stage 2||42
342601|NCT01324128|821008|P2|COMPLETED|Stage 2||0
342602|NCT01324128|821009|P1|COMPLETED|Stage 2||0
342603|NCT01324128|821006|P4|STARTED|Stage 2||49
342604|NCT01324128|821007|P3|STARTED|Stage 2||50
342605|NCT01324128|821008|P2|STARTED|Stage 2||0
342606|NCT01324128|821009|P1|STARTED|Stage 2||0
342607|NCT01324128|821006|P4|NOT COMPLETED|Stage 1||0
342608|NCT01324128|821007|P3|NOT COMPLETED|Stage 1||0
342609|NCT01324128|821008|P2|NOT COMPLETED|Stage 1||56
342610|NCT01324128|821009|P1|NOT COMPLETED|Stage 1||195
342611|NCT01324128|821006|P4|COMPLETED|Stage 1||0
342612|NCT01324128|821007|P3|COMPLETED|Stage 1||0
342613|NCT01324128|821008|P2|COMPLETED|Stage 1||293
342614|NCT01324128|821009|P1|COMPLETED|Stage 1||515
342615|NCT01324128|821006|P4|STARTED|Stage 1||0
342616|NCT01324128|821007|P3|STARTED|Stage 1||0
342617|NCT01324128|821008|P2|STARTED|Stage 1||349
342618|NCT01324128|821009|P1|STARTED|Stage 1||710
342619|NCT01324102|821021|P2|NOT COMPLETED|Overall Study||6
342620|NCT01324102|821022|P1|NOT COMPLETED|Overall Study||1
342621|NCT01324102|821021|P2|COMPLETED|Overall Study||6
342622|NCT01324102|821022|P1|COMPLETED|Overall Study||10
342623|NCT01324102|821021|P2|STARTED|Overall Study|Yoga group 4 and 6|12
342624|NCT01324102|821022|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
342625|NCT01323998|821034|P5|NOT COMPLETED|Overall Study||0
342626|NCT01323998|821035|P4|NOT COMPLETED|Overall Study||0
342627|NCT01323998|821036|P3|NOT COMPLETED|Overall Study||0
342628|NCT01323998|821037|P2|NOT COMPLETED|Overall Study||0
342629|NCT01323998|821038|P1|NOT COMPLETED|Overall Study||0
342630|NCT01323998|821034|P5|COMPLETED|Overall Study||6735
342631|NCT01323998|821035|P4|COMPLETED|Overall Study||12052
342632|NCT01323998|821036|P3|COMPLETED|Overall Study||10294
342633|NCT01323998|821037|P2|COMPLETED|Overall Study||18681
342634|NCT01323998|821038|P1|COMPLETED|Overall Study||200631
342635|NCT01323998|821034|P5|STARTED|Overall Study||6735
342636|NCT01323998|821035|P4|STARTED|Overall Study||12052
342637|NCT01323998|821036|P3|STARTED|Overall Study||10294
342638|NCT01323998|821037|P2|STARTED|Overall Study||18681
342639|NCT01323998|821038|P1|STARTED|Overall Study||200631
342640|NCT01323920|821050|P1|NOT COMPLETED|Overall Study||6
342641|NCT01323920|821050|P1|COMPLETED|Overall Study||29
342642|NCT01323920|821050|P1|STARTED|Overall Study||35
342643|NCT01323855|821062|P5|NOT COMPLETED|Overall Study||0
342644|NCT01323855|821063|P4|NOT COMPLETED|Overall Study||0
342645|NCT01323855|821064|P3|NOT COMPLETED|Overall Study||0
342646|NCT01323855|821065|P2|NOT COMPLETED|Overall Study||0
342647|NCT01323855|821066|P1|NOT COMPLETED|Overall Study||0
342648|NCT01323855|821062|P5|COMPLETED|Overall Study||11
342649|NCT01323855|821063|P4|COMPLETED|Overall Study||9
342650|NCT01323855|821064|P3|COMPLETED|Overall Study||8
342651|NCT01323855|821065|P2|COMPLETED|Overall Study||9
342652|NCT01323855|821066|P1|COMPLETED|Overall Study||9
342653|NCT01323855|821062|P5|STARTED|Overall Study||11
342654|NCT01323855|821063|P4|STARTED|Overall Study||9
342655|NCT01323855|821064|P3|STARTED|Overall Study||8
342656|NCT01323855|821065|P2|STARTED|Overall Study||9
342657|NCT01323855|821066|P1|STARTED|Overall Study||9
342658|NCT01323790|821091|P3|NOT COMPLETED|Overall Study||45
342659|NCT01323790|821092|P2|NOT COMPLETED|Overall Study||60
342660|NCT01323790|821093|P1|NOT COMPLETED|Overall Study||55
342661|NCT01323790|821091|P3|COMPLETED|Overall Study||188
342662|NCT01323790|821092|P2|COMPLETED|Overall Study||174
342663|NCT01323790|821093|P1|COMPLETED|Overall Study||178
342664|NCT01323790|821091|P3|STARTED|Overall Study||233
342665|NCT01323790|821092|P2|STARTED|Overall Study||234
342666|NCT01323790|821093|P1|STARTED|Overall Study||233
342667|NCT01323777|821131|P1|NOT COMPLETED|Overall Study||0
342668|NCT01323777|821131|P1|COMPLETED|Overall Study||65
342669|NCT01323777|821131|P1|STARTED|Overall Study||65
342670|NCT01323673|821144|P2|NOT COMPLETED|Overall Study||5
342671|NCT01323673|821145|P1|NOT COMPLETED|Overall Study||3
342672|NCT01323673|821144|P2|COMPLETED|Overall Study||58
342673|NCT01323673|821145|P1|COMPLETED|Overall Study||59
342674|NCT01323673|821144|P2|STARTED|Overall Study||63
342675|NCT01323673|821145|P1|STARTED|Overall Study||62
342676|NCT01323660|821165|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
342677|NCT01323660|821166|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
342678|NCT01323660|821167|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
342679|NCT01323660|821168|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
342680|NCT01323660|821169|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
342681|NCT01323660|821170|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
342682|NCT01323660|821165|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
342683|NCT01323660|821166|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
342684|NCT01323660|821167|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
342685|NCT01323660|821168|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
342686|NCT01323660|821169|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
342687|NCT01323660|821170|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
342688|NCT01323660|821165|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
342689|NCT01323660|821166|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
342690|NCT01323660|821167|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
342691|NCT01323660|821168|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
342692|NCT01323660|821169|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
342693|NCT01323660|821170|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
342694|NCT01323660|821165|P6|NOT COMPLETED|Washout Period (14 Days)||2
342695|NCT01323660|821166|P5|NOT COMPLETED|Washout Period (14 Days)||3
342696|NCT01323660|821167|P4|NOT COMPLETED|Washout Period (14 Days)||3
342697|NCT01323660|821168|P3|NOT COMPLETED|Washout Period (14 Days)||1
342698|NCT01323660|821169|P2|NOT COMPLETED|Washout Period (14 Days)||0
342699|NCT01323660|821170|P1|NOT COMPLETED|Washout Period (14 Days)||0
342700|NCT01323660|821165|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
342701|NCT01323660|821166|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
342702|NCT01323660|821167|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
342703|NCT01323660|821168|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
342704|NCT01323660|821169|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
342705|NCT01323660|821170|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
342706|NCT01323660|821165|P6|STARTED|Washout Period (14 Days)||61
342707|NCT01323660|821166|P5|STARTED|Washout Period (14 Days)||61
342708|NCT01323660|821167|P4|STARTED|Washout Period (14 Days)||31
342709|NCT01323660|821168|P3|STARTED|Washout Period (14 Days)||19
342710|NCT01323660|821169|P2|STARTED|Washout Period (14 Days)||21
342711|NCT01323660|821170|P1|STARTED|Washout Period (14 Days)||65
342712|NCT01323660|821165|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
342713|NCT01323660|821166|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
342714|NCT01323660|821167|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
342715|NCT01323660|821168|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
342716|NCT01323660|821169|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
342717|NCT01323660|821170|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
342718|NCT01323660|821165|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
342719|NCT01323660|821166|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
342720|NCT01323660|821167|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
342721|NCT01323660|821168|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
342722|NCT01323660|821169|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
342723|NCT01323660|821170|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
342724|NCT01323660|821165|P6|STARTED|Treatment Period 1 (12 Weeks)||70
342725|NCT01323660|821166|P5|STARTED|Treatment Period 1 (12 Weeks)||71
342726|NCT01323660|821167|P4|STARTED|Treatment Period 1 (12 Weeks)||36
342727|NCT01323660|821168|P3|STARTED|Treatment Period 1 (12 Weeks)||24
342728|NCT01323660|821169|P2|STARTED|Treatment Period 1 (12 Weeks)||22
342729|NCT01323660|821170|P1|STARTED|Treatment Period 1 (12 Weeks)||84
342730|NCT01323647|821216|P2|NOT COMPLETED|Overall Study||0
342731|NCT01323647|821217|P1|NOT COMPLETED|Overall Study||9
342732|NCT01323647|821216|P2|COMPLETED|Overall Study||487
342733|NCT01323647|821217|P1|COMPLETED|Overall Study||461
342734|NCT01323647|821216|P2|STARTED|Overall Study||487
342735|NCT01323647|821217|P1|STARTED|Overall Study||470
342736|NCT01323634|821234|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
342737|NCT01323634|821235|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
342738|NCT01323634|821236|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
342739|NCT01323634|821234|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
342740|NCT01323634|821235|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
342741|NCT01323634|821236|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
342742|NCT01323634|821234|P3|STARTED|Double-Blind (DB) Treatment Period||261
342743|NCT01323634|821235|P2|STARTED|Double-Blind (DB) Treatment Period||260
342744|NCT01323634|821236|P1|STARTED|Double-Blind (DB) Treatment Period||0
342745|NCT01323634|821234|P3|NOT COMPLETED|2-week Run-in Period||0
342746|NCT01323634|821235|P2|NOT COMPLETED|2-week Run-in Period||0
342747|NCT01323634|821236|P1|NOT COMPLETED|2-week Run-in Period||212
342748|NCT01323634|821234|P3|COMPLETED|2-week Run-in Period||0
342749|NCT01323634|821235|P2|COMPLETED|2-week Run-in Period||0
342750|NCT01323634|821236|P1|COMPLETED|2-week Run-in Period||521
342751|NCT01323634|821234|P3|STARTED|2-week Run-in Period||0
342752|NCT01323634|821235|P2|STARTED|2-week Run-in Period||0
342753|NCT01323634|821236|P1|STARTED|2-week Run-in Period||733
342754|NCT01323621|821246|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
342755|NCT01323621|821247|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
342756|NCT01323621|821248|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
342757|NCT01323621|821246|P3|COMPLETED|12-week, Double-blind Treatment Period||239
342758|NCT01323621|821247|P2|COMPLETED|12-week, Double-blind Treatment Period||237
342759|NCT01323621|821248|P1|COMPLETED|12-week, Double-blind Treatment Period||0
342760|NCT01323621|821246|P3|STARTED|12-week, Double-blind Treatment Period||259
342761|NCT01323621|821247|P2|STARTED|12-week, Double-blind Treatment Period||252
342762|NCT01323621|821248|P1|STARTED|12-week, Double-blind Treatment Period||0
342763|NCT01323621|821246|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
342764|NCT01323621|821247|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
342765|NCT01323621|821248|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
342766|NCT01323621|821246|P3|COMPLETED|2-week, Single-blind Run In Period||0
342767|NCT01323621|821247|P2|COMPLETED|2-week, Single-blind Run In Period||0
342768|NCT01323621|821248|P1|COMPLETED|2-week, Single-blind Run In Period||511
342769|NCT01323621|821246|P3|STARTED|2-week, Single-blind Run In Period||0
342770|NCT01323621|821247|P2|STARTED|2-week, Single-blind Run In Period||0
342771|NCT01323621|821248|P1|STARTED|2-week, Single-blind Run In Period||739
342772|NCT01323595|821258|P2|NOT COMPLETED|Overall Study||21
342773|NCT01323595|821259|P1|NOT COMPLETED|Overall Study||23
342774|NCT01323595|821258|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
342775|NCT01323595|821259|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
342776|NCT01323595|821258|P2|STARTED|Overall Study||39
342777|NCT01323595|821259|P1|STARTED|Overall Study||39
342778|NCT01323582|821267|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
342779|NCT01323582|821268|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
342780|NCT01323582|821267|P2|COMPLETED|Weeks 8-11 (Period 2)||10
342781|NCT01323582|821268|P1|COMPLETED|Weeks 8-11 (Period 2)||10
342782|NCT01323582|821267|P2|STARTED|Weeks 8-11 (Period 2)||11
342783|NCT01323582|821268|P1|STARTED|Weeks 8-11 (Period 2)||10
342784|NCT01323582|821267|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
342785|NCT01323582|821268|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
342786|NCT01323582|821267|P2|COMPLETED|Weeks 5-7 (Washout)||11
342787|NCT01323582|821268|P1|COMPLETED|Weeks 5-7 (Washout)||10
342788|NCT01323582|821267|P2|STARTED|Weeks 5-7 (Washout)||12
342789|NCT01323582|821268|P1|STARTED|Weeks 5-7 (Washout)||10
342790|NCT01323582|821267|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
342791|NCT01323582|821268|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
342792|NCT01323582|821267|P2|COMPLETED|Weeks 1-4 (First Period)||12
342793|NCT01323582|821268|P1|COMPLETED|Weeks 1-4 (First Period)||10
342794|NCT01323582|821267|P2|STARTED|Weeks 1-4 (First Period)||14
342795|NCT01323582|821268|P1|STARTED|Weeks 1-4 (First Period)||12
342796|NCT01323478|821284|P1|NOT COMPLETED|Overall Study||24
342797|NCT01323478|821284|P1|COMPLETED|Overall Study||47
342798|NCT01323478|821284|P1|STARTED|Overall Study||71
342799|NCT01323387|821297|P1|NOT COMPLETED|Overall Study||84
342800|NCT01323387|821297|P1|COMPLETED|Overall Study||94
342801|NCT01323387|821297|P1|STARTED|Overall Study|178 subjects enrolled, 162 subjects treated, 150 subjects analyzed per protocol.|178
342802|NCT01323270|821310|P2|NOT COMPLETED|Overall Study||29
342803|NCT01323270|821311|P1|NOT COMPLETED|Overall Study||43
342804|NCT01323270|821310|P2|COMPLETED|Overall Study||347
342805|NCT01323270|821311|P1|COMPLETED|Overall Study||330
342806|NCT01323270|821310|P2|STARTED|Overall Study||376
342807|NCT01323270|821311|P1|STARTED|Overall Study||373
342808|NCT01323192|821333|P2|NOT COMPLETED|Overall Study||6
342809|NCT01323192|821334|P1|NOT COMPLETED|Overall Study||9
342810|NCT01323192|821333|P2|COMPLETED|Overall Study||135
342811|NCT01323192|821334|P1|COMPLETED|Overall Study||134
342812|NCT01323192|821333|P2|STARTED|Overall Study||141
342813|NCT01323192|821334|P1|STARTED|Overall Study||143
342814|NCT01323140|821350|P1|NOT COMPLETED|Overall Study||2
342815|NCT01323140|821350|P1|COMPLETED|Overall Study||38
342816|NCT01323140|821350|P1|STARTED|Overall Study||40
342817|NCT01323010|821356|P2|NOT COMPLETED|Overall Study||0
342818|NCT01323010|821357|P1|NOT COMPLETED|Overall Study||0
342819|NCT01323010|821356|P2|COMPLETED|Overall Study||59
342820|NCT01323010|821357|P1|COMPLETED|Overall Study||60
342821|NCT01323010|821356|P2|STARTED|Overall Study||59
342822|NCT01323010|821357|P1|STARTED|Overall Study||60
342823|NCT01322971|821408|P2|NOT COMPLETED|Overall Study||1
342824|NCT01322971|821409|P1|NOT COMPLETED|Overall Study||1
342825|NCT01322971|821408|P2|COMPLETED|Overall Study||0
342826|NCT01322971|821409|P1|COMPLETED|Overall Study||0
342827|NCT01322971|821408|P2|STARTED|Overall Study||1
342828|NCT01322971|821409|P1|STARTED|Overall Study||1
342829|NCT01322945|821423|P2|NOT COMPLETED|Overall Study||0
342830|NCT01322945|821424|P1|NOT COMPLETED|Overall Study||0
342831|NCT01322945|821423|P2|COMPLETED|Overall Study||42
342832|NCT01322945|821424|P1|COMPLETED|Overall Study||52
342833|NCT01322945|821423|P2|STARTED|Overall Study||42
342834|NCT01322945|821424|P1|STARTED|Overall Study||52
342835|NCT01322841|821434|P2|NOT COMPLETED|Overall Study||0
342836|NCT01322841|821435|P1|NOT COMPLETED|Overall Study||0
342837|NCT01322841|821434|P2|COMPLETED|Overall Study||1123
342838|NCT01322841|821435|P1|COMPLETED|Overall Study||1116
342839|NCT01322841|821434|P2|STARTED|Overall Study||1123
342840|NCT01322841|821435|P1|STARTED|Overall Study||1116
342841|NCT01322815|821445|P2|NOT COMPLETED|Overall Study||0
342842|NCT01322815|821446|P1|NOT COMPLETED|Overall Study||0
342843|NCT01322815|821445|P2|COMPLETED|Overall Study||4
342844|NCT01322815|821446|P1|COMPLETED|Overall Study||7
342845|NCT01322815|821445|P2|STARTED|Overall Study||4
342846|NCT01322815|821446|P1|STARTED|Overall Study||7
342847|NCT01322633|821454|P2|NOT COMPLETED|Overall Study||0
342848|NCT01322633|821455|P1|NOT COMPLETED|Overall Study||0
342849|NCT01322633|821454|P2|COMPLETED|Overall Study||27686
342850|NCT01322633|821455|P1|COMPLETED|Overall Study||34178
342851|NCT01322633|821454|P2|STARTED|Overall Study||27686
342852|NCT01322633|821455|P1|STARTED|Overall Study||34178
342853|NCT01322607|821467|P2|NOT COMPLETED|Overall Study||0
342854|NCT01322607|821468|P1|NOT COMPLETED|Overall Study||1
342855|NCT01322607|821467|P2|COMPLETED|Overall Study||9
342856|NCT01322607|821468|P1|COMPLETED|Overall Study||10
342857|NCT01322607|821467|P2|STARTED|Overall Study||9
342858|NCT01322607|821468|P1|STARTED|Overall Study||11
342859|NCT01322594|821486|P6|NOT COMPLETED|Overall Study||0
342860|NCT01322594|821487|P5|NOT COMPLETED|Overall Study||0
342861|NCT01322594|821488|P4|NOT COMPLETED|Overall Study||0
342862|NCT01322594|821489|P3|NOT COMPLETED|Overall Study||0
342863|NCT01322594|821490|P2|NOT COMPLETED|Overall Study||0
342864|NCT01322594|821491|P1|NOT COMPLETED|Overall Study||0
342865|NCT01322594|821486|P6|COMPLETED|Overall Study||6
342866|NCT01322594|821487|P5|COMPLETED|Overall Study||7
342867|NCT01322594|821488|P4|COMPLETED|Overall Study||6
342868|NCT01322594|821489|P3|COMPLETED|Overall Study||3
342869|NCT01322594|821490|P2|COMPLETED|Overall Study||3
342870|NCT01322594|821491|P1|COMPLETED|Overall Study||6
342871|NCT01322594|821486|P6|STARTED|Overall Study||6
342872|NCT01322594|821487|P5|STARTED|Overall Study||7
342873|NCT01322594|821488|P4|STARTED|Overall Study||6
342874|NCT01322594|821489|P3|STARTED|Overall Study||3
342875|NCT01322594|821490|P2|STARTED|Overall Study||3
342876|NCT01322594|821491|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
342877|NCT01322386|821573|P2|NOT COMPLETED|Overall Study||2
342878|NCT01322386|821574|P1|NOT COMPLETED|Overall Study||0
342879|NCT01322386|821573|P2|COMPLETED|Overall Study||9
342880|NCT01322386|821574|P1|COMPLETED|Overall Study||10
342881|NCT01322386|821573|P2|STARTED|Overall Study||11
342882|NCT01322386|821574|P1|STARTED|Overall Study||10
342883|NCT01322360|821582|P1|NOT COMPLETED|Overall Study||0
342884|NCT01322360|821582|P1|COMPLETED|Overall Study||50
342885|NCT01322360|821582|P1|STARTED|Overall Study||50
342886|NCT01322347|821589|P2|NOT COMPLETED|Overall Study||35
342887|NCT01322347|821590|P1|NOT COMPLETED|Overall Study||51
342888|NCT01322347|821589|P2|COMPLETED|Overall Study||112
342889|NCT01322347|821590|P1|COMPLETED|Overall Study||96
342890|NCT01322347|821589|P2|Completed St 3|Overall Study||86
342891|NCT01322347|821590|P1|Completed St 3|Overall Study||82
342892|NCT01322347|821589|P2|Enrolled in St 3|Overall Study||113
342893|NCT01322347|821590|P1|Enrolled in St 3|Overall Study||101
342894|NCT01322347|821589|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
342895|NCT01322347|821590|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
342896|NCT01322347|821589|P2|Completed 48 Wks in St 2|Overall Study||22
342897|NCT01322347|821590|P1|Completed 48 Wks in St 2|Overall Study||28
342898|NCT01322347|821589|P2|STARTED|Overall Study||147
342899|NCT01322347|821590|P1|STARTED|Overall Study||147
342900|NCT01322048|821627|P2|NOT COMPLETED|Overall Study||0
342901|NCT01322048|821628|P1|NOT COMPLETED|Overall Study||0
342902|NCT01322048|821627|P2|COMPLETED|Overall Study||26
342903|NCT01322048|821628|P1|COMPLETED|Overall Study||21
342904|NCT01322048|821627|P2|STARTED|Overall Study||26
342905|NCT01322048|821628|P1|STARTED|Overall Study||21
342906|NCT01322022|821636|P2|NOT COMPLETED|Overall Study||2
342907|NCT01322022|821637|P1|NOT COMPLETED|Overall Study||5
342908|NCT01322022|821636|P2|COMPLETED|Overall Study||18
342909|NCT01322022|821637|P1|COMPLETED|Overall Study||15
342910|NCT01322022|821636|P2|Week 4|Overall Study||18
342911|NCT01322022|821637|P1|Week 4|Overall Study||15
342912|NCT01322022|821636|P2|STARTED|Overall Study||20
342913|NCT01322022|821637|P1|STARTED|Overall Study||20
342914|NCT01322009|821651|P2|NOT COMPLETED|Overall Study||3
342915|NCT01322009|821652|P1|NOT COMPLETED|Overall Study||0
342916|NCT01322009|821651|P2|COMPLETED|Overall Study||4
342917|NCT01322009|821652|P1|COMPLETED|Overall Study||7
342918|NCT01322009|821651|P2|STARTED|Overall Study||7
342919|NCT01322009|821652|P1|STARTED|Overall Study||7
342920|NCT01321749|821662|P2|NOT COMPLETED|Overall Study||22
342921|NCT01321749|821663|P1|NOT COMPLETED|Overall Study||13
342922|NCT01321749|821662|P2|COMPLETED|Overall Study||30
342923|NCT01321749|821663|P1|COMPLETED|Overall Study||38
342924|NCT01321749|821662|P2|STARTED|Overall Study||52
342925|NCT01321749|821663|P1|STARTED|Overall Study||51
342926|NCT01321723|821672|P3|NOT COMPLETED|Overall Study||4
342927|NCT01321723|821673|P2|NOT COMPLETED|Overall Study||5
342928|NCT01321723|821674|P1|NOT COMPLETED|Overall Study||5
342929|NCT01321723|821672|P3|COMPLETED|Overall Study||28
342930|NCT01321723|821673|P2|COMPLETED|Overall Study||28
342931|NCT01321723|821674|P1|COMPLETED|Overall Study||27
342932|NCT01321723|821672|P3|STARTED|Overall Study||32
342933|NCT01321723|821673|P2|STARTED|Overall Study||33
342934|NCT01321723|821674|P1|STARTED|Overall Study||32
342935|NCT01321710|821696|P3|NOT COMPLETED|Overall Study||0
342936|NCT01321710|821697|P2|NOT COMPLETED|Overall Study||5
342937|NCT01321710|821698|P1|NOT COMPLETED|Overall Study||4
342938|NCT01321710|821696|P3|COMPLETED|Overall Study||44
342939|NCT01321710|821697|P2|COMPLETED|Overall Study||53
342940|NCT01321710|821698|P1|COMPLETED|Overall Study||46
342941|NCT01321710|821696|P3|STARTED|Overall Study||44
342942|NCT01321710|821697|P2|STARTED|Overall Study||58
342943|NCT01321710|821698|P1|STARTED|Overall Study||50
342944|NCT01321697|821713|P1|NOT COMPLETED|Overall Study||7
342945|NCT01321697|821713|P1|COMPLETED|Overall Study||0
342946|NCT01321697|821713|P1|STARTED|Overall Study||7
342947|NCT01321554|821719|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
342948|NCT01321554|821720|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
342949|NCT01321554|821721|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
342950|NCT01321554|821722|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
342951|NCT01321554|821719|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
342952|NCT01321554|821720|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
342953|NCT01321554|821721|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
342954|NCT01321554|821722|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
342955|NCT01321554|821719|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
342956|NCT01321554|821720|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
342957|NCT01321554|821721|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
342958|NCT01321554|821722|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
342959|NCT01321554|821719|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
342960|NCT01321554|821720|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
342961|NCT01321554|821721|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
342962|NCT01321554|821722|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
342963|NCT01321554|821719|P4|STARTED|OOL Lenvatinib Treatment Period||27
342964|NCT01321554|821720|P3|STARTED|OOL Lenvatinib Treatment Period||82
342965|NCT01321554|821721|P2|STARTED|OOL Lenvatinib Treatment Period||0
342966|NCT01321554|821722|P1|STARTED|OOL Lenvatinib Treatment Period||0
342967|NCT01321554|821719|P4|NOT COMPLETED|Randomization Phase||0
342968|NCT01321554|821720|P3|NOT COMPLETED|Randomization Phase||0
342969|NCT01321554|821721|P2|NOT COMPLETED|Randomization Phase||4
342970|NCT01321554|821722|P1|NOT COMPLETED|Randomization Phase||45
342971|NCT01321554|821719|P4|COMPLETED|Randomization Phase||0
342972|NCT01321554|821720|P3|COMPLETED|Randomization Phase||0
342973|NCT01321554|821721|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
342974|NCT01321554|821722|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
342975|NCT01321554|821719|P4|Discontinued Due to Disease Progression|Randomization Phase||0
342976|NCT01321554|821720|P3|Discontinued Due to Disease Progression|Randomization Phase||0
342977|NCT01321554|821721|P2|Discontinued Due to Disease Progression|Randomization Phase||119
342978|NCT01321554|821722|P1|Discontinued Due to Disease Progression|Randomization Phase||94
342979|NCT01321554|821719|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
342980|NCT01321554|821720|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
342981|NCT01321554|821721|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
342982|NCT01321554|821722|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
342983|NCT01321554|821719|P4|STARTED|Randomization Phase||0
342984|NCT01321554|821720|P3|STARTED|Randomization Phase||0
342985|NCT01321554|821721|P2|STARTED|Randomization Phase||131
342986|NCT01321554|821722|P1|STARTED|Randomization Phase||261
342987|NCT01321008|821735|P1|NOT COMPLETED|Overall Study||1
342988|NCT01321008|821735|P1|COMPLETED|Overall Study||0
342989|NCT01321008|821735|P1|STARTED|Overall Study||1
342990|NCT01320826|821739|P1|NOT COMPLETED|Overall Study||0
342991|NCT01320826|821739|P1|COMPLETED|Overall Study||577
342992|NCT01320826|821739|P1|STARTED|Overall Study||577
342993|NCT01320735|821754|P1|NOT COMPLETED|Overall Study||106
342994|NCT01320735|821754|P1|COMPLETED|Overall Study||194
342995|NCT01320735|821754|P1|STARTED|Overall Study||300
342996|NCT01320683|821771|P1|NOT COMPLETED|Overall Study||1
342997|NCT01320683|821771|P1|COMPLETED|Overall Study||0
342998|NCT01320683|821771|P1|STARTED|Overall Study||1
342999|NCT01320553|821780|P4|NOT COMPLETED|Overall Study||1
343000|NCT01320553|821781|P3|NOT COMPLETED|Overall Study||2
343001|NCT01320553|821782|P2|NOT COMPLETED|Overall Study||4
343002|NCT01320553|821783|P1|NOT COMPLETED|Overall Study||1
343003|NCT01320553|821780|P4|COMPLETED|Overall Study||29
343004|NCT01320553|821781|P3|COMPLETED|Overall Study||29
343005|NCT01320553|821782|P2|COMPLETED|Overall Study||26
343006|NCT01320553|821783|P1|COMPLETED|Overall Study||30
343007|NCT01320553|821780|P4|STARTED|Overall Study||30
343008|NCT01320553|821781|P3|STARTED|Overall Study||31
343009|NCT01320553|821782|P2|STARTED|Overall Study||30
343010|NCT01320553|821783|P1|STARTED|Overall Study||31
343011|NCT01320293|821797|P1|NOT COMPLETED|Overall Study||2
343012|NCT01320293|821797|P1|COMPLETED|Overall Study||16
343013|NCT01320293|821797|P1|STARTED|Overall Study||18
343014|NCT01320202|821805|P2|NOT COMPLETED|Overall Study||44
343015|NCT01320202|821806|P1|NOT COMPLETED|Overall Study||56
343016|NCT01320202|821805|P2|COMPLETED|Overall Study||109
343017|NCT01320202|821806|P1|COMPLETED|Overall Study||96
343018|NCT01320202|821805|P2|Completed St 3|Overall Study||82
343019|NCT01320202|821806|P1|Completed St 3|Overall Study||79
343020|NCT01320202|821805|P2|Enrolled in St 3|Overall Study||109
343021|NCT01320202|821806|P1|Enrolled in St 3|Overall Study||98
343022|NCT01320202|821805|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
343023|NCT01320202|821806|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
343024|NCT01320202|821805|P2|Comp 48 Wks in St 2|Overall Study||27
343025|NCT01320202|821806|P1|Comp 48 Wks in St 2|Overall Study||27
343026|NCT01320202|821805|P2|STARTED|Overall Study||153
343027|NCT01320202|821806|P1|STARTED|Overall Study||152
343028|NCT01320137|821843|P2|NOT COMPLETED|Overall Study||0
343029|NCT01320137|821844|P1|NOT COMPLETED|Overall Study||0
343030|NCT01320137|821843|P2|COMPLETED|Overall Study||40
343031|NCT01320137|821844|P1|COMPLETED|Overall Study||40
343032|NCT01320137|821843|P2|STARTED|Overall Study||40
343033|NCT01320137|821844|P1|STARTED|Overall Study||40
343034|NCT01320072|821858|P2|NOT COMPLETED|Overall Study||0
343035|NCT01320072|821859|P1|NOT COMPLETED|Overall Study||0
343036|NCT01320072|821858|P2|COMPLETED|Overall Study||13
343037|NCT01320072|821859|P1|COMPLETED|Overall Study||16
343038|NCT01320072|821858|P2|STARTED|Overall Study||13
343039|NCT01320072|821859|P1|STARTED|Overall Study||16
343040|NCT01319877|821870|P2|NOT COMPLETED|Overall Study||45
343041|NCT01319877|821871|P1|NOT COMPLETED|Overall Study||108
343042|NCT01319877|821870|P2|COMPLETED|Overall Study||108
343043|NCT01319877|821871|P1|COMPLETED|Overall Study||345
343044|NCT01319877|821870|P2|STARTED|Overall Study||153
343045|NCT01319877|821871|P1|STARTED|Overall Study||453
343046|NCT01319851|821906|P1|NOT COMPLETED|Overall Study||0
343047|NCT01319851|821906|P1|COMPLETED|Overall Study||3
343048|NCT01319851|821906|P1|STARTED|Overall Study||3
343049|NCT01319812|821918|P2|NOT COMPLETED|Overall Study||22
343050|NCT01319812|821919|P1|NOT COMPLETED|Overall Study||16
343051|NCT01319812|821918|P2|COMPLETED|Overall Study||280
343052|NCT01319812|821919|P1|COMPLETED|Overall Study||145
343053|NCT01319812|821918|P2|STARTED|Overall Study||302
343054|NCT01319812|821919|P1|STARTED|Overall Study||161
343055|NCT01319799|821991|P1|NOT COMPLETED|Overall Study||0
343056|NCT01319799|821991|P1|COMPLETED|Overall Study||10
343057|NCT01319799|821991|P1|STARTED|Overall Study||10
343058|NCT01319773|822001|P5|NOT COMPLETED|Overall Study||0
343059|NCT01319773|822002|P4|NOT COMPLETED|Overall Study||0
343060|NCT01319773|822003|P3|NOT COMPLETED|Overall Study||0
343061|NCT01319773|822004|P2|NOT COMPLETED|Overall Study||0
343062|NCT01319773|822005|P1|NOT COMPLETED|Overall Study||0
343063|NCT01319773|822001|P5|COMPLETED|Overall Study||8
343064|NCT01319773|822002|P4|COMPLETED|Overall Study||8
343065|NCT01319773|822003|P3|COMPLETED|Overall Study||8
343066|NCT01319773|822004|P2|COMPLETED|Overall Study||10
343067|NCT01319773|822005|P1|COMPLETED|Overall Study||10
343068|NCT01319773|822001|P5|STARTED|Overall Study||8
343069|NCT01319773|822002|P4|STARTED|Overall Study||8
343070|NCT01319773|822003|P3|STARTED|Overall Study||8
343071|NCT01319773|822004|P2|STARTED|Overall Study||10
343072|NCT01319773|822005|P1|STARTED|Overall Study||10
343073|NCT01319721|822021|P2|NOT COMPLETED|Overall Study||6
343074|NCT01319721|822022|P1|NOT COMPLETED|Overall Study||1
343075|NCT01319721|822021|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
343076|NCT01319721|822022|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
343077|NCT01319721|822021|P2|STARTED|Overall Study|The unit of measure is eyes.|48
343078|NCT01319721|822022|P1|STARTED|Overall Study|The unit of measure is eyes.|48
343079|NCT01319617|822036|P1|NOT COMPLETED|Overall Study||1
343080|NCT01319617|822036|P1|COMPLETED|Overall Study||40
343081|NCT01319617|822036|P1|STARTED|Overall Study||41
343082|NCT01319552|822040|P1|NOT COMPLETED|Overall Study||0
343083|NCT01319552|822040|P1|COMPLETED|Overall Study||14
343084|NCT01319552|822040|P1|STARTED|Overall Study||14
343085|NCT01319500|822047|P2|NOT COMPLETED|Overall Study||0
343086|NCT01319500|822048|P1|NOT COMPLETED|Overall Study||0
343087|NCT01319500|822047|P2|COMPLETED|Overall Study||2589
343088|NCT01319500|822048|P1|COMPLETED|Overall Study||1187
343089|NCT01319500|822047|P2|STARTED|Overall Study||2589
343090|NCT01319500|822048|P1|STARTED|Overall Study||1187
343091|NCT01319422|822067|P2|NOT COMPLETED|Overall Study||0
343092|NCT01319422|822068|P1|NOT COMPLETED|Overall Study||1
343093|NCT01319422|822067|P2|COMPLETED|Overall Study||20
343094|NCT01319422|822068|P1|COMPLETED|Overall Study||19
343095|NCT01319422|822067|P2|STARTED|Overall Study||20
343096|NCT01319422|822068|P1|STARTED|Overall Study||20
343097|NCT01319396|822082|P1|NOT COMPLETED|Overall Study||0
343098|NCT01319396|822082|P1|COMPLETED|Overall Study||24
343099|NCT01319396|822082|P1|STARTED|Overall Study||24
343100|NCT01319318|822086|P1|NOT COMPLETED|Overall Study||0
343101|NCT01319318|822086|P1|COMPLETED|Overall Study||25
343102|NCT01319318|822086|P1|STARTED|Overall Study||25
343103|NCT01319110|822092|P2|NOT COMPLETED|Overall Study||0
343104|NCT01319110|822093|P1|NOT COMPLETED|Overall Study||0
343105|NCT01319110|822092|P2|COMPLETED|Overall Study||5
343106|NCT01319110|822093|P1|COMPLETED|Overall Study||5
343107|NCT01319110|822092|P2|STARTED|Overall Study||5
343108|NCT01319110|822093|P1|STARTED|Overall Study||5
343109|NCT01319045|822099|P1|NOT COMPLETED|Overall Study||2
343110|NCT01319045|822099|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
343111|NCT01319045|822099|P1|STARTED|Overall Study||5
343112|NCT01318967|822106|P1|NOT COMPLETED|Overall Study||0
343113|NCT01318967|822106|P1|COMPLETED|Overall Study||10
343114|NCT01318967|822106|P1|STARTED|Overall Study||10
343115|NCT01318876|822111|P1|NOT COMPLETED|Day 29 Survey||1825
343116|NCT01318876|822111|P1|COMPLETED|Day 29 Survey||5724
343117|NCT01318876|822111|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
343118|NCT01318876|822111|P1|NOT COMPLETED|Day 8 Survey||1820
343119|NCT01318876|822111|P1|COMPLETED|Day 8 Survey||5825
343120|NCT01318876|822111|P1|STARTED|Day 8 Survey||7645
343121|NCT01318733|822116|P1|NOT COMPLETED|Overall Study||170
343122|NCT01318733|822116|P1|COMPLETED|Overall Study||279
343123|NCT01318733|822116|P1|STARTED|Overall Study||449
343124|NCT01318694|822124|P4|NOT COMPLETED|Overall Study||68
343125|NCT01318694|822125|P3|NOT COMPLETED|Overall Study||43
343126|NCT01318694|822126|P2|NOT COMPLETED|Overall Study||58
343127|NCT01318694|822127|P1|NOT COMPLETED|Overall Study||52
343128|NCT01318694|822124|P4|COMPLETED|Overall Study||200
343129|NCT01318694|822125|P3|COMPLETED|Overall Study||225
343130|NCT01318694|822126|P2|COMPLETED|Overall Study||212
343131|NCT01318694|822127|P1|COMPLETED|Overall Study||223
343132|NCT01318694|822124|P4|Safety Set|Overall Study||265
343133|NCT01318694|822125|P3|Safety Set|Overall Study||265
343134|NCT01318694|822126|P2|Safety Set|Overall Study||268
343135|NCT01318694|822127|P1|Safety Set|Overall Study||273
343136|NCT01318694|822124|P4|Full Analysis Set|Overall Study||268
343137|NCT01318694|822125|P3|Full Analysis Set|Overall Study||265
343138|NCT01318694|822126|P2|Full Analysis Set|Overall Study||270
343139|NCT01318694|822127|P1|Full Analysis Set|Overall Study||274
343140|NCT01318694|822124|P4|STARTED|Overall Study||268
343141|NCT01318694|822125|P3|STARTED|Overall Study||268
343142|NCT01318694|822126|P2|STARTED|Overall Study||270
343143|NCT01318694|822127|P1|STARTED|Overall Study||275
343144|NCT01318538|822183|P3|NOT COMPLETED|Overall Study||0
343145|NCT01318538|822184|P2|NOT COMPLETED|Overall Study||0
343146|NCT01318538|822185|P1|NOT COMPLETED|Overall Study||0
343147|NCT01318538|822183|P3|COMPLETED|Overall Study||8
343148|NCT01318538|822184|P2|COMPLETED|Overall Study||106
343149|NCT01318538|822185|P1|COMPLETED|Overall Study||52
343150|NCT01318538|822183|P3|STARTED|Overall Study||8
343151|NCT01318538|822184|P2|STARTED|Overall Study||106
343152|NCT01318538|822185|P1|STARTED|Overall Study||52
343153|NCT01318512|822209|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
343154|NCT01318512|822209|P1|COMPLETED|Maintenance Period (6 Months)||329
343155|NCT01318512|822209|P1|STARTED|Maintenance Period (6 Months)||340
343156|NCT01318512|822209|P1|NOT COMPLETED|Titration Period (4 Months)||0
343157|NCT01318512|822209|P1|COMPLETED|Titration Period (4 Months)||340
343158|NCT01318512|822209|P1|STARTED|Titration Period (4 Months)||340
343159|NCT01318499|822228|P3|NOT COMPLETED|Overall Study||147
343160|NCT01318499|822229|P2|NOT COMPLETED|Overall Study||76
343161|NCT01318499|822230|P1|NOT COMPLETED|Overall Study||65
343162|NCT01318499|822228|P3|COMPLETED|Overall Study||121
343163|NCT01318499|822229|P2|COMPLETED|Overall Study||458
343164|NCT01318499|822230|P1|COMPLETED|Overall Study||475
343165|NCT01318499|822228|P3|STARTED|Overall Study||268
343166|NCT01318499|822229|P2|STARTED|Overall Study||534
343167|NCT01318499|822230|P1|STARTED|Overall Study||540
343168|NCT01318408|822248|P1|NOT COMPLETED|Overall Study||8
343169|NCT01318408|822248|P1|COMPLETED|Overall Study||16
343170|NCT01318408|822248|P1|STARTED|Overall Study||24
343171|NCT01318382|822253|P1|NOT COMPLETED|Overall Study||13
343172|NCT01318382|822253|P1|COMPLETED|Overall Study||289
343173|NCT01318382|822253|P1|STARTED|Overall Study||302
343174|NCT01318278|822263|P3|NOT COMPLETED|Overall Study||0
343175|NCT01318278|822264|P2|NOT COMPLETED|Overall Study||0
343176|NCT01318278|822265|P1|NOT COMPLETED|Overall Study||0
343177|NCT01318278|822263|P3|COMPLETED|Overall Study||50
343178|NCT01318278|822264|P2|COMPLETED|Overall Study||10
343179|NCT01318278|822265|P1|COMPLETED|Overall Study||10
343180|NCT01318278|822263|P3|STARTED|Overall Study||50
343181|NCT01318278|822264|P2|STARTED|Overall Study||10
343182|NCT01318278|822265|P1|STARTED|Overall Study||10
343183|NCT01318135|822311|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
343184|NCT01318135|822312|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
343185|NCT01318135|822313|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
343186|NCT01318135|822314|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
343187|NCT01318135|822315|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
343188|NCT01318135|822316|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
343189|NCT01318135|822317|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
343190|NCT01318135|822318|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
343191|NCT01318135|822311|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
343192|NCT01318135|822312|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
343193|NCT01318135|822313|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
343257|NCT01318109|822524|P1|NOT COMPLETED|Overall Study||1
343258|NCT01318109|822522|P3|COMPLETED|Overall Study||100
343194|NCT01318135|822314|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
343195|NCT01318135|822315|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
343196|NCT01318135|822316|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
343197|NCT01318135|822317|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
343198|NCT01318135|822318|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
343199|NCT01318135|822311|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
343200|NCT01318135|822312|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
343201|NCT01318135|822313|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
343202|NCT01318135|822314|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
343203|NCT01318135|822315|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
343204|NCT01318135|822316|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
343205|NCT01318135|822317|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
343206|NCT01318135|822318|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
343207|NCT01318135|822311|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343208|NCT01318135|822312|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343209|NCT01318135|822313|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343210|NCT01318135|822314|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343211|NCT01318135|822315|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343212|NCT01318135|822316|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343213|NCT01318135|822317|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343214|NCT01318135|822318|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
343215|NCT01318135|822311|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
343216|NCT01318135|822312|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
343217|NCT01318135|822313|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
343218|NCT01318135|822314|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
343219|NCT01318135|822315|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
343220|NCT01318135|822316|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
343221|NCT01318135|822317|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
343222|NCT01318135|822318|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
343223|NCT01318135|822311|P8|STARTED|Enrolled - Long-Term Extension Study||49
343224|NCT01318135|822312|P7|STARTED|Enrolled - Long-Term Extension Study||50
343225|NCT01318135|822313|P6|STARTED|Enrolled - Long-Term Extension Study||90
343226|NCT01318135|822314|P5|STARTED|Enrolled - Long-Term Extension Study||91
343227|NCT01318135|822315|P4|STARTED|Enrolled - Long-Term Extension Study||49
343228|NCT01318135|822316|P3|STARTED|Enrolled - Long-Term Extension Study||46
343229|NCT01318135|822317|P2|STARTED|Enrolled - Long-Term Extension Study||102
343230|NCT01318135|822318|P1|STARTED|Enrolled - Long-Term Extension Study||99
343231|NCT01318122|822450|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
343232|NCT01318122|822451|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
343233|NCT01318122|822452|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
343234|NCT01318122|822453|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
343235|NCT01318122|822450|P4|COMPLETED|Entered - Long-Term Extension Study||48
343236|NCT01318122|822451|P3|COMPLETED|Entered - Long-Term Extension Study||49
343237|NCT01318122|822452|P2|COMPLETED|Entered - Long-Term Extension Study||99
343238|NCT01318122|822453|P1|COMPLETED|Entered - Long-Term Extension Study||96
343239|NCT01318122|822450|P4|STARTED|Entered - Long-Term Extension Study||52
343240|NCT01318122|822451|P3|STARTED|Entered - Long-Term Extension Study||55
343241|NCT01318122|822452|P2|STARTED|Entered - Long-Term Extension Study||110
343242|NCT01318122|822453|P1|STARTED|Entered - Long-Term Extension Study||105
343243|NCT01318122|822450|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
343244|NCT01318122|822451|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
343245|NCT01318122|822452|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
343246|NCT01318122|822453|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
343247|NCT01318122|822450|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
343248|NCT01318122|822451|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
343249|NCT01318122|822452|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
343250|NCT01318122|822453|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
343251|NCT01318122|822450|P4|STARTED|Enrolled - Long-Term Extension Study||53
343252|NCT01318122|822451|P3|STARTED|Enrolled - Long-Term Extension Study||57
343253|NCT01318122|822452|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
343254|NCT01318122|822453|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
343255|NCT01318109|822522|P3|NOT COMPLETED|Overall Study||0
343256|NCT01318109|822523|P2|NOT COMPLETED|Overall Study||3
343259|NCT01318109|822523|P2|COMPLETED|Overall Study||93
343260|NCT01318109|822524|P1|COMPLETED|Overall Study||91
343261|NCT01318109|822522|P3|STARTED|Overall Study||100
343262|NCT01318109|822523|P2|STARTED|Overall Study||96
343263|NCT01318109|822524|P1|STARTED|Overall Study||92
343264|NCT01318083|822559|P3|NOT COMPLETED|Overall Study||5
343265|NCT01318083|822560|P2|NOT COMPLETED|Overall Study||2
343266|NCT01318083|822561|P1|NOT COMPLETED|Overall Study||6
343267|NCT01318083|822559|P3|COMPLETED|Overall Study||98
343268|NCT01318083|822560|P2|COMPLETED|Overall Study||102
343269|NCT01318083|822561|P1|COMPLETED|Overall Study||99
343270|NCT01318083|822559|P3|STARTED|Overall Study||103
343271|NCT01318083|822560|P2|STARTED|Overall Study||104
343272|NCT01318083|822561|P1|STARTED|Overall Study||105
343273|NCT01318070|822596|P3|NOT COMPLETED|Overall Study||7
343274|NCT01318070|822597|P2|NOT COMPLETED|Overall Study||2
343275|NCT01318070|822598|P1|NOT COMPLETED|Overall Study||2
343276|NCT01318070|822596|P3|COMPLETED|Overall Study||108
343277|NCT01318070|822597|P2|COMPLETED|Overall Study||111
343278|NCT01318070|822598|P1|COMPLETED|Overall Study||109
343279|NCT01318070|822596|P3|STARTED|Overall Study||115
343280|NCT01318070|822597|P2|STARTED|Overall Study||113
343281|NCT01318070|822598|P1|STARTED|Overall Study||111
343288|NCT01317797|822642|P3|NOT COMPLETED|Overall Study||1
343289|NCT01317797|822643|P2|NOT COMPLETED|Overall Study||1
343290|NCT01317797|822644|P1|NOT COMPLETED|Overall Study||0
343291|NCT01317797|822642|P3|COMPLETED|Overall Study||8
343292|NCT01317797|822643|P2|COMPLETED|Overall Study||6
343293|NCT01317797|822644|P1|COMPLETED|Overall Study||8
343294|NCT01317797|822642|P3|STARTED|Overall Study||9
343295|NCT01317797|822643|P2|STARTED|Overall Study||7
343296|NCT01317797|822644|P1|STARTED|Overall Study||8
343297|NCT01317667|822699|P3|NOT COMPLETED|Overall Study||0
343298|NCT01317667|822700|P2|NOT COMPLETED|Overall Study||0
343299|NCT01317667|822701|P1|NOT COMPLETED|Overall Study||0
343300|NCT01317667|822699|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
343301|NCT01317667|822700|P2|COMPLETED|Overall Study||10
343302|NCT01317667|822701|P1|COMPLETED|Overall Study||10
343303|NCT01317667|822699|P3|STARTED|Overall Study||10
343304|NCT01317667|822700|P2|STARTED|Overall Study||10
343305|NCT01317667|822701|P1|STARTED|Overall Study||10
343306|NCT01317641|822721|P9|NOT COMPLETED|Overall Study||5
343307|NCT01317641|822722|P8|NOT COMPLETED|Overall Study||5
343308|NCT01317641|822723|P7|NOT COMPLETED|Overall Study||3
343309|NCT01317641|822724|P6|NOT COMPLETED|Overall Study||0
343310|NCT01317641|822725|P5|NOT COMPLETED|Overall Study||0
343311|NCT01317641|822726|P4|NOT COMPLETED|Overall Study||1
343312|NCT01317641|822727|P3|NOT COMPLETED|Overall Study||0
343313|NCT01317641|822728|P2|NOT COMPLETED|Overall Study||1
343314|NCT01317641|822729|P1|NOT COMPLETED|Overall Study||1
343315|NCT01317641|822721|P9|COMPLETED|Overall Study||31
343316|NCT01317641|822722|P8|COMPLETED|Overall Study||33
343317|NCT01317641|822723|P7|COMPLETED|Overall Study||35
343318|NCT01317641|822724|P6|COMPLETED|Overall Study||3
343319|NCT01317641|822725|P5|COMPLETED|Overall Study||3
343320|NCT01317641|822726|P4|COMPLETED|Overall Study||3
343321|NCT01317641|822727|P3|COMPLETED|Overall Study||3
343322|NCT01317641|822728|P2|COMPLETED|Overall Study||6
343323|NCT01317641|822729|P1|COMPLETED|Overall Study||3
343324|NCT01317641|822721|P9|STARTED|Overall Study||36
343325|NCT01317641|822722|P8|STARTED|Overall Study||38
343326|NCT01317641|822723|P7|STARTED|Overall Study||38
343327|NCT01317641|822724|P6|STARTED|Overall Study||3
343328|NCT01317641|822725|P5|STARTED|Overall Study||3
343329|NCT01317641|822726|P4|STARTED|Overall Study||4
343330|NCT01317641|822727|P3|STARTED|Overall Study||3
343331|NCT01317641|822728|P2|STARTED|Overall Study||7
343332|NCT01317641|822729|P1|STARTED|Overall Study||4
343333|NCT01317615|822831|P1|NOT COMPLETED|Overall Study||49
343334|NCT01317615|822831|P1|COMPLETED|Overall Study||0
343335|NCT01317615|822831|P1|STARTED|Overall Study||49
343336|NCT01317160|822842|P2|NOT COMPLETED|Overall Study||6
343337|NCT01317160|822843|P1|NOT COMPLETED|Overall Study||4
343338|NCT01317160|822842|P2|COMPLETED|Overall Study||69
343339|NCT01317160|822843|P1|COMPLETED|Overall Study||71
343340|NCT01317160|822842|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
343341|NCT01317160|822843|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
343342|NCT01317160|822842|P2|STARTED|Overall Study||75
343343|NCT01317160|822843|P1|STARTED|Overall Study||75
343344|NCT01317004|822853|P2|NOT COMPLETED|Overall Study||9
343345|NCT01317004|822854|P1|NOT COMPLETED|Overall Study||4
343346|NCT01317004|822853|P2|COMPLETED|Overall Study||5
343347|NCT01317004|822854|P1|COMPLETED|Overall Study||47
343348|NCT01317004|822853|P2|Safety Set|Overall Study||11
343349|NCT01317004|822854|P1|Safety Set|Overall Study||50
343350|NCT01317004|822853|P2|STARTED|Overall Study||14
343351|NCT01317004|822854|P1|STARTED|Overall Study||51
343352|NCT01316926|822872|P2|NOT COMPLETED|Period 2||0
343353|NCT01316926|822873|P1|NOT COMPLETED|Period 2||0
343354|NCT01316926|822872|P2|COMPLETED|Period 2||30
343355|NCT01316926|822873|P1|COMPLETED|Period 2||29
343356|NCT01316926|822872|P2|STARTED|Period 2||30
343357|NCT01316926|822873|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
343358|NCT01316926|822872|P2|NOT COMPLETED|Period 1||0
343359|NCT01316926|822873|P1|NOT COMPLETED|Period 1||0
343360|NCT01316926|822872|P2|COMPLETED|Period 1||30
343361|NCT01316926|822873|P1|COMPLETED|Period 1||30
343362|NCT01316926|822872|P2|STARTED|Period 1||30
343363|NCT01316926|822873|P1|STARTED|Period 1||30
343364|NCT01316913|822887|P4|NOT COMPLETED|Overall Study||39
343365|NCT01316913|822888|P3|NOT COMPLETED|Overall Study||49
343366|NCT01316913|822889|P2|NOT COMPLETED|Overall Study||54
343367|NCT01316913|822890|P1|NOT COMPLETED|Overall Study||57
343368|NCT01316913|822887|P4|COMPLETED|Overall Study||176
343369|NCT01316913|822888|P3|COMPLETED|Overall Study||166
343370|NCT01316913|822889|P2|COMPLETED|Overall Study||163
343371|NCT01316913|822890|P1|COMPLETED|Overall Study||165
343372|NCT01316913|822887|P4|STARTED|Overall Study||215
343373|NCT01316913|822888|P3|STARTED|Overall Study||215
343374|NCT01316913|822889|P2|STARTED|Overall Study||217
343375|NCT01316913|822890|P1|STARTED|Overall Study||222
343376|NCT01316900|822912|P4|NOT COMPLETED|Overall Study||31
343377|NCT01316900|822913|P3|NOT COMPLETED|Overall Study||41
343378|NCT01316900|822914|P2|NOT COMPLETED|Overall Study||31
343379|NCT01316900|822915|P1|NOT COMPLETED|Overall Study||44
343380|NCT01316900|822912|P4|COMPLETED|Overall Study||177
343381|NCT01316900|822913|P3|COMPLETED|Overall Study||173
343382|NCT01316900|822914|P2|COMPLETED|Overall Study||181
343383|NCT01316900|822915|P1|COMPLETED|Overall Study||165
343384|NCT01316900|822912|P4|STARTED|Overall Study||208
343385|NCT01316900|822913|P3|STARTED|Overall Study||214
343386|NCT01316900|822914|P2|STARTED|Overall Study||212
343387|NCT01316900|822915|P1|STARTED|Overall Study||209
343388|NCT01316887|822936|P3|NOT COMPLETED|Overall Study||83
343389|NCT01316887|822937|P2|NOT COMPLETED|Overall Study||94
343390|NCT01316887|822938|P1|NOT COMPLETED|Overall Study||43
343391|NCT01316887|822936|P3|COMPLETED|Overall Study||143
343392|NCT01316887|822937|P2|COMPLETED|Overall Study||133
343393|NCT01316887|822938|P1|COMPLETED|Overall Study||66
343394|NCT01316887|822936|P3|STARTED|Overall Study||226
343395|NCT01316887|822937|P2|STARTED|Overall Study||227
343396|NCT01316887|822938|P1|STARTED|Overall Study||109
343397|NCT01316692|823000|P1|NOT COMPLETED|Overall Study||12
343398|NCT01316692|823000|P1|COMPLETED|Overall Study||0
343399|NCT01316692|823000|P1|STARTED|Overall Study||12
343400|NCT01316614|823009|P1|NOT COMPLETED|Overall Study||37
343401|NCT01316614|823009|P1|COMPLETED|Overall Study||100
343402|NCT01316614|823009|P1|STARTED|Overall Study||137
343403|NCT01316575|823026|P2|NOT COMPLETED|Overall Study||1
343404|NCT01316575|823027|P1|NOT COMPLETED|Overall Study||2
343405|NCT01316575|823026|P2|COMPLETED|Overall Study||19
343406|NCT01316575|823027|P1|COMPLETED|Overall Study||18
343407|NCT01316575|823026|P2|STARTED|Overall Study||20
343408|NCT01316575|823027|P1|STARTED|Overall Study||20
343409|NCT01316419|823039|P1|NOT COMPLETED|Overall Study||265
343410|NCT01316419|823039|P1|COMPLETED|Overall Study||1824
343411|NCT01316419|823039|P1|STARTED|Overall Study||2089
343412|NCT01316380|823065|P3|NOT COMPLETED|Overall Study||3
343413|NCT01316380|823066|P2|NOT COMPLETED|Overall Study||5
343414|NCT01316380|823067|P1|NOT COMPLETED|Overall Study||2
343415|NCT01316380|823065|P3|COMPLETED|Overall Study||152
343416|NCT01316380|823066|P2|COMPLETED|Overall Study||149
343417|NCT01316380|823067|P1|COMPLETED|Overall Study||154
343418|NCT01316380|823065|P3|STARTED|Overall Study||155
343419|NCT01316380|823066|P2|STARTED|Overall Study||154
343420|NCT01316380|823067|P1|STARTED|Overall Study||156
343421|NCT01316341|823108|P3|NOT COMPLETED|Overall Study||0
343422|NCT01316341|823109|P2|NOT COMPLETED|Overall Study||0
343423|NCT01316341|823110|P1|NOT COMPLETED|Overall Study||0
343424|NCT01316341|823108|P3|COMPLETED|Overall Study||9
343425|NCT01316341|823109|P2|COMPLETED|Overall Study||9
343426|NCT01316341|823110|P1|COMPLETED|Overall Study||6
343427|NCT01316341|823108|P3|STARTED|Overall Study||9
343428|NCT01316341|823109|P2|STARTED|Overall Study||9
343429|NCT01316341|823110|P1|STARTED|Overall Study||6
343430|NCT01316315|823178|P2|NOT COMPLETED|Sequence 2||0
343431|NCT01316315|823179|P1|NOT COMPLETED|Sequence 2||0
343432|NCT01316315|823178|P2|COMPLETED|Sequence 2||7
343433|NCT01316315|823179|P1|COMPLETED|Sequence 2||7
343434|NCT01316315|823178|P2|STARTED|Sequence 2||7
343435|NCT01316315|823179|P1|STARTED|Sequence 2||7
343436|NCT01316315|823178|P2|NOT COMPLETED|Sequence 1||0
343437|NCT01316315|823179|P1|NOT COMPLETED|Sequence 1||0
343438|NCT01316315|823178|P2|COMPLETED|Sequence 1||7
343439|NCT01316315|823179|P1|COMPLETED|Sequence 1||7
343440|NCT01316315|823178|P2|STARTED|Sequence 1||7
343441|NCT01316315|823179|P1|STARTED|Sequence 1||7
343442|NCT01316302|823193|P2|NOT COMPLETED|Overall Study||11
343443|NCT01316302|823194|P1|NOT COMPLETED|Overall Study||10
343444|NCT01316302|823193|P2|COMPLETED|Overall Study||22
343445|NCT01316302|823194|P1|COMPLETED|Overall Study||20
343446|NCT01316302|823193|P2|STARTED|Overall Study||33
343447|NCT01316302|823194|P1|STARTED|Overall Study||30
343448|NCT01316263|823206|P2|NOT COMPLETED|Overall Study||0
343449|NCT01316263|823207|P1|NOT COMPLETED|Overall Study||0
343450|NCT01316263|823206|P2|COMPLETED|Overall Study||14
343451|NCT01316263|823207|P1|COMPLETED|Overall Study||7
343452|NCT01316263|823206|P2|Received Any Study Drug|Overall Study||14
343453|NCT01316263|823207|P1|Received Any Study Drug|Overall Study||7
343454|NCT01316263|823206|P2|STARTED|Overall Study||14
343455|NCT01316263|823207|P1|STARTED|Overall Study||7
343456|NCT01316224|823233|P1|NOT COMPLETED|Overall Study||10
343457|NCT01316224|823233|P1|COMPLETED|Overall Study||42
343458|NCT01316224|823233|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
343459|NCT01316224|823233|P1|Completed Visit 4 to Dermatologist|Overall Study||42
343460|NCT01316224|823233|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
343461|NCT01316224|823233|P1|Completed Visit 3 to Dermatologist|Overall Study||48
343462|NCT01316224|823233|P1|Completed Visit 2 to Dermatologist|Overall Study||51
343463|NCT01316224|823233|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
343464|NCT01316224|823233|P1|Completed Visit 1 to Dermatologist|Overall Study||52
343465|NCT01316224|823233|P1|STARTED|Overall Study||52
343466|NCT01316055|823250|P3|NOT COMPLETED|Overall Study||0
343467|NCT01316055|823251|P2|NOT COMPLETED|Overall Study||0
343468|NCT01316055|823252|P1|NOT COMPLETED|Overall Study||1
343469|NCT01316055|823250|P3|COMPLETED|Overall Study||12
343470|NCT01316055|823251|P2|COMPLETED|Overall Study||17
343471|NCT01316055|823252|P1|COMPLETED|Overall Study||12
343472|NCT01316055|823250|P3|STARTED|Overall Study||12
343473|NCT01316055|823251|P2|STARTED|Overall Study||17
343474|NCT01316055|823252|P1|STARTED|Overall Study||13
343475|NCT01316042|823268|P2|NOT COMPLETED|Overall Study||1
343476|NCT01316042|823269|P1|NOT COMPLETED|Overall Study||0
343477|NCT01316042|823268|P2|COMPLETED|Overall Study||1
343478|NCT01316042|823269|P1|COMPLETED|Overall Study||2
343479|NCT01316042|823268|P2|STARTED|Overall Study||2
343480|NCT01316042|823269|P1|STARTED|Overall Study||2
343481|NCT01315847|823277|P2|NOT COMPLETED|Part III, Period 2||0
343482|NCT01315847|823278|P1|NOT COMPLETED|Part III, Period 2||0
343483|NCT01315847|823277|P2|COMPLETED|Part III, Period 2||3
343484|NCT01315847|823278|P1|COMPLETED|Part III, Period 2||0
343485|NCT01315847|823277|P2|Received [11C]MK-4232|Part III, Period 2||3
343486|NCT01315847|823278|P1|Received [11C]MK-4232|Part III, Period 2||0
343487|NCT01315847|823277|P2|Received Telcagepant|Part III, Period 2||3
343488|NCT01315847|823278|P1|Received Telcagepant|Part III, Period 2||0
343489|NCT01315847|823277|P2|STARTED|Part III, Period 2||3
343490|NCT01315847|823278|P1|STARTED|Part III, Period 2||0
343491|NCT01315847|823277|P2|NOT COMPLETED|Part III, Period 1||1
343492|NCT01315847|823278|P1|NOT COMPLETED|Part III, Period 1||0
343493|NCT01315847|823277|P2|COMPLETED|Part III, Period 1||3
343494|NCT01315847|823278|P1|COMPLETED|Part III, Period 1||0
343495|NCT01315847|823277|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
343496|NCT01315847|823278|P1|Received [11C]MK-4232|Part III, Period 1||0
343497|NCT01315847|823277|P2|Received Telcagepant|Part III, Period 1||4
343498|NCT01315847|823278|P1|Received Telcagepant|Part III, Period 1||0
343499|NCT01315847|823277|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
343500|NCT01315847|823278|P1|STARTED|Part III, Period 1||0
343501|NCT01315847|823277|P2|NOT COMPLETED|Part I, Period 2||0
343502|NCT01315847|823278|P1|NOT COMPLETED|Part I, Period 2||0
343503|NCT01315847|823277|P2|COMPLETED|Part I, Period 2||0
343504|NCT01315847|823278|P1|COMPLETED|Part I, Period 2||3
343505|NCT01315847|823277|P2|Received [11C]MK-4232|Part I, Period 2||0
343506|NCT01315847|823278|P1|Received [11C]MK-4232|Part I, Period 2||3
343507|NCT01315847|823277|P2|Received Telcagepant|Part I, Period 2||0
343508|NCT01315847|823278|P1|Received Telcagepant|Part I, Period 2||3
343509|NCT01315847|823277|P2|STARTED|Part I, Period 2||0
343510|NCT01315847|823278|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
343511|NCT01315847|823277|P2|NOT COMPLETED|Part I, Period 1||0
343512|NCT01315847|823278|P1|NOT COMPLETED|Part I, Period 1||3
343513|NCT01315847|823277|P2|COMPLETED|Part I, Period 1||0
343514|NCT01315847|823278|P1|COMPLETED|Part I, Period 1||2
343515|NCT01315847|823277|P2|Received [11C]MK-4232|Part I, Period 1||0
343516|NCT01315847|823278|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
343517|NCT01315847|823277|P2|Received Telcagepant|Part I, Period 1||0
343518|NCT01315847|823278|P1|Received Telcagepant|Part I, Period 1||5
343519|NCT01315847|823277|P2|STARTED|Part I, Period 1||0
343520|NCT01315847|823278|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
343521|NCT01315665|823292|P2|NOT COMPLETED|Overall Study||0
343522|NCT01315665|823293|P1|NOT COMPLETED|Overall Study||0
343523|NCT01315665|823292|P2|COMPLETED|Overall Study||5
343524|NCT01315665|823293|P1|COMPLETED|Overall Study||10
343525|NCT01315665|823292|P2|STARTED|Overall Study||5
343526|NCT01315665|823293|P1|STARTED|Overall Study||10
343527|NCT01315574|823309|P2|NOT COMPLETED|Overall Study||0
343528|NCT01315574|823310|P1|NOT COMPLETED|Overall Study||0
343529|NCT01315574|823309|P2|COMPLETED|Overall Study||7
343530|NCT01315574|823310|P1|COMPLETED|Overall Study||7
343531|NCT01315574|823309|P2|STARTED|Overall Study||7
343532|NCT01315574|823310|P1|STARTED|Overall Study||7
343533|NCT01315249|823322|P2|NOT COMPLETED|Overall Study||47
343534|NCT01315249|823323|P1|NOT COMPLETED|Overall Study||44
343535|NCT01315249|823322|P2|COMPLETED|Overall Study||217
343536|NCT01315249|823323|P1|COMPLETED|Overall Study||215
343537|NCT01315249|823322|P2|STARTED|Overall Study||264
343538|NCT01315249|823323|P1|STARTED|Overall Study||259
343539|NCT01315158|823351|P2|NOT COMPLETED|Overall Study||0
343540|NCT01315158|823352|P1|NOT COMPLETED|Overall Study||0
343541|NCT01315158|823351|P2|COMPLETED|Overall Study||19
343542|NCT01315158|823352|P1|COMPLETED|Overall Study||17
343543|NCT01315158|823351|P2|STARTED|Overall Study||19
343544|NCT01315158|823352|P1|STARTED|Overall Study||17
343545|NCT01315145|823376|P2|NOT COMPLETED|Overall Study||5
343546|NCT01315145|823377|P1|NOT COMPLETED|Overall Study||17
343547|NCT01315145|823376|P2|COMPLETED|Overall Study||11
343548|NCT01315145|823377|P1|COMPLETED|Overall Study||105
343549|NCT01315145|823376|P2|STARTED|Overall Study||16
343550|NCT01315145|823377|P1|STARTED|Overall Study||122
343551|NCT01315028|823385|P2|NOT COMPLETED|Overall Study||1
343552|NCT01315028|823386|P1|NOT COMPLETED|Overall Study||1
343553|NCT01315028|823385|P2|COMPLETED|Overall Study||9
343554|NCT01315028|823386|P1|COMPLETED|Overall Study||9
343555|NCT01315028|823385|P2|STARTED|Overall Study||10
343556|NCT01315028|823386|P1|STARTED|Overall Study||10
343557|NCT01315002|823398|P2|NOT COMPLETED|Overall Study||5
343558|NCT01315002|823399|P1|NOT COMPLETED|Overall Study||5
343559|NCT01315002|823398|P2|COMPLETED|Overall Study||55
343560|NCT01315002|823399|P1|COMPLETED|Overall Study||56
343561|NCT01315002|823398|P2|STARTED|Overall Study||60
343562|NCT01315002|823399|P1|STARTED|Overall Study||61
343563|NCT01314872|823416|P15|NOT COMPLETED|Period 2||24
343564|NCT01314872|823417|P14|NOT COMPLETED|Period 2||53
343565|NCT01314872|823418|P13|NOT COMPLETED|Period 2||60
343566|NCT01314872|823419|P12|NOT COMPLETED|Period 2||48
343567|NCT01314872|823420|P11|NOT COMPLETED|Period 2||0
343568|NCT01314872|823421|P10|NOT COMPLETED|Period 2||0
343569|NCT01314872|823422|P9|NOT COMPLETED|Period 2||0
343570|NCT01314872|823423|P8|NOT COMPLETED|Period 2||0
343571|NCT01314872|823424|P7|NOT COMPLETED|Period 2||0
343572|NCT01314872|823425|P6|NOT COMPLETED|Period 2||0
343573|NCT01314872|823426|P5|NOT COMPLETED|Period 2||0
343574|NCT01314872|823427|P4|NOT COMPLETED|Period 2||0
343575|NCT01314872|823428|P3|NOT COMPLETED|Period 2||0
343576|NCT01314872|823429|P2|NOT COMPLETED|Period 2||0
343577|NCT01314872|823430|P1|NOT COMPLETED|Period 2||0
343578|NCT01314872|823416|P15|COMPLETED|Period 2||110
343579|NCT01314872|823417|P14|COMPLETED|Period 2||187
343580|NCT01314872|823418|P13|COMPLETED|Period 2||188
343581|NCT01314872|823419|P12|COMPLETED|Period 2||175
343582|NCT01314872|823420|P11|COMPLETED|Period 2||0
343583|NCT01314872|823421|P10|COMPLETED|Period 2||0
343584|NCT01314872|823422|P9|COMPLETED|Period 2||0
343585|NCT01314872|823423|P8|COMPLETED|Period 2||0
343586|NCT01314872|823424|P7|COMPLETED|Period 2||0
343587|NCT01314872|823425|P6|COMPLETED|Period 2||0
343588|NCT01314872|823426|P5|COMPLETED|Period 2||0
343589|NCT01314872|823427|P4|COMPLETED|Period 2||0
343590|NCT01314872|823428|P3|COMPLETED|Period 2||0
343591|NCT01314872|823429|P2|COMPLETED|Period 2||0
343592|NCT01314872|823430|P1|COMPLETED|Period 2||0
343593|NCT01314872|823416|P15|STARTED|Period 2||134
343594|NCT01314872|823417|P14|STARTED|Period 2||240
343595|NCT01314872|823418|P13|STARTED|Period 2||248
343596|NCT01314872|823419|P12|STARTED|Period 2||223
343597|NCT01314872|823420|P11|STARTED|Period 2||0
343598|NCT01314872|823421|P10|STARTED|Period 2||0
343599|NCT01314872|823422|P9|STARTED|Period 2||0
343600|NCT01314872|823423|P8|STARTED|Period 2||0
343601|NCT01314872|823424|P7|STARTED|Period 2||0
343602|NCT01314872|823425|P6|STARTED|Period 2||0
343603|NCT01314872|823426|P5|STARTED|Period 2||0
343604|NCT01314872|823427|P4|STARTED|Period 2||0
343605|NCT01314872|823428|P3|STARTED|Period 2||0
343606|NCT01314872|823429|P2|STARTED|Period 2||0
343607|NCT01314872|823430|P1|STARTED|Period 2||0
343608|NCT01314872|823416|P15|NOT COMPLETED|Treatment Period 1||0
343609|NCT01314872|823417|P14|NOT COMPLETED|Treatment Period 1||0
343610|NCT01314872|823418|P13|NOT COMPLETED|Treatment Period 1||0
343611|NCT01314872|823419|P12|NOT COMPLETED|Treatment Period 1||0
343612|NCT01314872|823420|P11|NOT COMPLETED|Treatment Period 1||3
343613|NCT01314872|823421|P10|NOT COMPLETED|Treatment Period 1||4
343614|NCT01314872|823422|P9|NOT COMPLETED|Treatment Period 1||6
343615|NCT01314872|823423|P8|NOT COMPLETED|Treatment Period 1||7
343616|NCT01314872|823424|P7|NOT COMPLETED|Treatment Period 1||8
343617|NCT01314872|823425|P6|NOT COMPLETED|Treatment Period 1||7
343618|NCT01314872|823426|P5|NOT COMPLETED|Treatment Period 1||7
343619|NCT01314872|823427|P4|NOT COMPLETED|Treatment Period 1||7
343620|NCT01314872|823428|P3|NOT COMPLETED|Treatment Period 1||6
343621|NCT01314872|823429|P2|NOT COMPLETED|Treatment Period 1||6
343622|NCT01314872|823430|P1|NOT COMPLETED|Treatment Period 1||10
343623|NCT01314872|823416|P15|COMPLETED|Treatment Period 1||0
343624|NCT01314872|823417|P14|COMPLETED|Treatment Period 1||0
343625|NCT01314872|823418|P13|COMPLETED|Treatment Period 1||0
343626|NCT01314872|823419|P12|COMPLETED|Treatment Period 1||0
343627|NCT01314872|823420|P11|COMPLETED|Treatment Period 1||107
343628|NCT01314872|823421|P10|COMPLETED|Treatment Period 1||118
343629|NCT01314872|823422|P9|COMPLETED|Treatment Period 1||106
343630|NCT01314872|823423|P8|COMPLETED|Treatment Period 1||57
343631|NCT01314872|823424|P7|COMPLETED|Treatment Period 1||126
343632|NCT01314872|823425|P6|COMPLETED|Treatment Period 1||128
343633|NCT01314872|823426|P5|COMPLETED|Treatment Period 1||142
343634|NCT01314872|823427|P4|COMPLETED|Treatment Period 1||143
343635|NCT01314872|823428|P3|COMPLETED|Treatment Period 1||128
343636|NCT01314872|823429|P2|COMPLETED|Treatment Period 1||138
343637|NCT01314872|823430|P1|COMPLETED|Treatment Period 1||131
343638|NCT01314872|823416|P15|STARTED|Treatment Period 1||0
343639|NCT01314872|823417|P14|STARTED|Treatment Period 1||0
343640|NCT01314872|823418|P13|STARTED|Treatment Period 1||0
343641|NCT01314872|823419|P12|STARTED|Treatment Period 1||0
343642|NCT01314872|823420|P11|STARTED|Treatment Period 1||110
343643|NCT01314872|823421|P10|STARTED|Treatment Period 1||122
343644|NCT01314872|823422|P9|STARTED|Treatment Period 1||112
343645|NCT01314872|823423|P8|STARTED|Treatment Period 1||64
343646|NCT01314872|823424|P7|STARTED|Treatment Period 1||134
343647|NCT01314872|823425|P6|STARTED|Treatment Period 1||135
343648|NCT01314872|823426|P5|STARTED|Treatment Period 1||149
343649|NCT01314872|823427|P4|STARTED|Treatment Period 1||150
343650|NCT01314872|823428|P3|STARTED|Treatment Period 1||134
343651|NCT01314872|823429|P2|STARTED|Treatment Period 1||144
343652|NCT01314872|823430|P1|STARTED|Treatment Period 1||141
343653|NCT01314742|823523|P2|NOT COMPLETED|Overall Study||0
343654|NCT01314742|823524|P1|NOT COMPLETED|Overall Study||0
343655|NCT01314742|823523|P2|COMPLETED|Overall Study||21
343656|NCT01314742|823524|P1|COMPLETED|Overall Study||20
343657|NCT01314742|823523|P2|STARTED|Overall Study||21
343658|NCT01314742|823524|P1|STARTED|Overall Study||20
343659|NCT01314716|823534|P2|NOT COMPLETED|Open-Label Phase||12
343660|NCT01314716|823535|P1|NOT COMPLETED|Open-Label Phase||10
343661|NCT01314716|823534|P2|COMPLETED|Open-Label Phase||98
343662|NCT01314716|823535|P1|COMPLETED|Open-Label Phase||102
343663|NCT01314716|823534|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
343664|NCT01314716|823535|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
343665|NCT01314716|823534|P2|NOT COMPLETED|Double-Blind Phase||15
343666|NCT01314716|823535|P1|NOT COMPLETED|Double-Blind Phase||17
343667|NCT01314716|823534|P2|COMPLETED|Double-Blind Phase||123
343668|NCT01314716|823535|P1|COMPLETED|Double-Blind Phase||119
343669|NCT01314716|823534|P2|Randomized and Treated|Double-Blind Phase||137
343670|NCT01314716|823535|P1|Randomized and Treated|Double-Blind Phase||135
343671|NCT01314716|823534|P2|STARTED|Double-Blind Phase||138
343672|NCT01314716|823535|P1|STARTED|Double-Blind Phase||136
343673|NCT01314703|823547|P1|NOT COMPLETED|Overall Study||8
343674|NCT01314703|823547|P1|COMPLETED|Overall Study||27
343675|NCT01314703|823547|P1|Discontinued When Enrollment Completed|Overall Study||3
343676|NCT01314703|823547|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
343677|NCT01314703|823547|P1|Excluded Prior to Screening Baseline|Overall Study||2
343678|NCT01314703|823547|P1|Completed Study|Overall Study||27
343679|NCT01314703|823547|P1|Completed Treatment Visit|Overall Study||27
343680|NCT01314703|823547|P1|Completed Screen Visit|Overall Study||33
343681|NCT01314703|823547|P1|Signed Informed Consent|Overall Study||35
343682|NCT01314703|823547|P1|STARTED|Overall Study||35
343683|NCT01314443|823556|P4|NOT COMPLETED|Overall Study||2
343684|NCT01314443|823557|P3|NOT COMPLETED|Overall Study||2
343685|NCT01314443|823558|P2|NOT COMPLETED|Overall Study||3
343686|NCT01314443|823559|P1|NOT COMPLETED|Overall Study||4
343687|NCT01314443|823556|P4|COMPLETED|Overall Study||13
343688|NCT01314443|823557|P3|COMPLETED|Overall Study||13
343689|NCT01314443|823558|P2|COMPLETED|Overall Study||16
343690|NCT01314443|823559|P1|COMPLETED|Overall Study||14
343691|NCT01314443|823556|P4|STARTED|Overall Study||15
343692|NCT01314443|823557|P3|STARTED|Overall Study||15
343693|NCT01314443|823558|P2|STARTED|Overall Study||19
343694|NCT01314443|823559|P1|STARTED|Overall Study||18
343695|NCT01314417|823577|P1|NOT COMPLETED|Overall Study||0
343696|NCT01314417|823577|P1|COMPLETED|Overall Study||2
343697|NCT01314417|823577|P1|STARTED|Overall Study||2
343698|NCT01314261|823608|P4|NOT COMPLETED|Overall Study||3
343699|NCT01314261|823609|P3|NOT COMPLETED|Overall Study||3
343700|NCT01314261|823610|P2|NOT COMPLETED|Overall Study||4
343701|NCT01314261|823611|P1|NOT COMPLETED|Overall Study||2
343702|NCT01314261|823608|P4|COMPLETED|Overall Study||6
343703|NCT01314261|823609|P3|COMPLETED|Overall Study||7
343704|NCT01314261|823610|P2|COMPLETED|Overall Study||5
343705|NCT01314261|823611|P1|COMPLETED|Overall Study||7
343706|NCT01314261|823608|P4|Discontinued pegIFN/RBV|Overall Study||1
343707|NCT01314261|823609|P3|Discontinued pegIFN/RBV|Overall Study||5
343708|NCT01314261|823610|P2|Discontinued pegIFN/RBV|Overall Study||4
343709|NCT01314261|823611|P1|Discontinued pegIFN/RBV|Overall Study||1
343710|NCT01314261|823608|P4|Discontinued ABT-267 or Placebo|Overall Study||0
343711|NCT01314261|823609|P3|Discontinued ABT-267 or Placebo|Overall Study||1
343712|NCT01314261|823610|P2|Discontinued ABT-267 or Placebo|Overall Study||0
343713|NCT01314261|823611|P1|Discontinued ABT-267 or Placebo|Overall Study||1
343714|NCT01314261|823608|P4|STARTED|Overall Study||9
343715|NCT01314261|823609|P3|STARTED|Overall Study||10
343716|NCT01314261|823610|P2|STARTED|Overall Study||9
343717|NCT01314261|823611|P1|STARTED|Overall Study||9
343718|NCT01314118|823662|P1|NOT COMPLETED|Overall Study||131
343719|NCT01314118|823662|P1|COMPLETED|Overall Study||0
343720|NCT01314118|823662|P1|STARTED|Overall Study||131
343721|NCT01314105|823671|P2|NOT COMPLETED|Overall Study||4
343722|NCT01314105|823672|P1|NOT COMPLETED|Overall Study||6
343723|NCT01314105|823671|P2|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|2
343724|NCT01314105|823672|P1|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|1
343725|NCT01314105|823671|P2|STARTED|Overall Study||6
343726|NCT01314105|823672|P1|STARTED|Overall Study||7
343727|NCT01314014|823694|P1|NOT COMPLETED|Overall Study||0
343816|NCT01313689|823840|P3|COMPLETED|24-Week Randomization 1||0
343728|NCT01314014|823694|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
343729|NCT01314014|823694|P1|STARTED|Overall Study||22
343730|NCT01314001|823705|P6|NOT COMPLETED|Overall Study||71
343731|NCT01314001|823706|P5|NOT COMPLETED|Overall Study||72
343732|NCT01314001|823707|P4|NOT COMPLETED|Overall Study||69
343733|NCT01314001|823708|P3|NOT COMPLETED|Overall Study||69
343734|NCT01314001|823709|P2|NOT COMPLETED|Overall Study||69
343735|NCT01314001|823710|P1|NOT COMPLETED|Overall Study||75
343736|NCT01314001|823705|P6|COMPLETED|Overall Study||129
343737|NCT01314001|823706|P5|COMPLETED|Overall Study||148
343738|NCT01314001|823707|P4|COMPLETED|Overall Study||122
343739|NCT01314001|823708|P3|COMPLETED|Overall Study||158
343740|NCT01314001|823709|P2|COMPLETED|Overall Study||124
343741|NCT01314001|823710|P1|COMPLETED|Overall Study||140
343742|NCT01314001|823705|P6|6-Month Follow Up Survey|Overall Study||139
343743|NCT01314001|823706|P5|6-Month Follow Up Survey|Overall Study||157
343744|NCT01314001|823707|P4|6-Month Follow Up Survey|Overall Study||135
343745|NCT01314001|823708|P3|6-Month Follow Up Survey|Overall Study||165
343746|NCT01314001|823709|P2|6-Month Follow Up Survey|Overall Study||137
343747|NCT01314001|823710|P1|6-Month Follow Up Survey|Overall Study||146
343748|NCT01314001|823705|P6|End-of-Treatment Visit|Overall Study||160
343749|NCT01314001|823706|P5|End-of-Treatment Visit|Overall Study||174
343750|NCT01314001|823707|P4|End-of-Treatment Visit|Overall Study||146
343751|NCT01314001|823708|P3|End-of-Treatment Visit|Overall Study||179
343752|NCT01314001|823709|P2|End-of-Treatment Visit|Overall Study||141
343753|NCT01314001|823710|P1|End-of-Treatment Visit|Overall Study||156
343754|NCT01314001|823705|P6|STARTED|Overall Study||200
343755|NCT01314001|823706|P5|STARTED|Overall Study||220
343756|NCT01314001|823707|P4|STARTED|Overall Study||191
343757|NCT01314001|823708|P3|STARTED|Overall Study||227
343758|NCT01314001|823709|P2|STARTED|Overall Study||193
343759|NCT01314001|823710|P1|STARTED|Overall Study||215
343760|NCT01313936|823756|P2|NOT COMPLETED|Overall Study||0
343761|NCT01313936|823757|P1|NOT COMPLETED|Overall Study||0
343762|NCT01313936|823756|P2|COMPLETED|Overall Study||26
343763|NCT01313936|823757|P1|COMPLETED|Overall Study||6
343764|NCT01313936|823756|P2|STARTED|Overall Study||26
343765|NCT01313936|823757|P1|STARTED|Overall Study||6
343766|NCT01313923|823765|P1|NOT COMPLETED|Overall Study||3
343767|NCT01313923|823765|P1|COMPLETED|Overall Study||0
343768|NCT01313923|823765|P1|STARTED|Overall Study||3
343769|NCT01313910|823769|P1|NOT COMPLETED|Overall Study||0
343770|NCT01313910|823769|P1|COMPLETED|Overall Study||8
343771|NCT01313910|823769|P1|STARTED|Overall Study||8
343772|NCT01313897|823777|P1|NOT COMPLETED|Overall Study||2
343773|NCT01313897|823777|P1|COMPLETED|Overall Study||8
343774|NCT01313897|823777|P1|STARTED|Overall Study||10
343775|NCT01313884|823781|P1|NOT COMPLETED|Overall Study||1
343776|NCT01313884|823781|P1|COMPLETED|Overall Study||2
343777|NCT01313884|823781|P1|STARTED|Overall Study||3
343778|NCT01313858|823788|P3|NOT COMPLETED|Overall Study||238
343779|NCT01313858|823789|P2|NOT COMPLETED|Overall Study||270
343780|NCT01313858|823790|P1|NOT COMPLETED|Overall Study||286
343781|NCT01313858|823788|P3|COMPLETED|Overall Study||305
343782|NCT01313858|823789|P2|COMPLETED|Overall Study||276
343783|NCT01313858|823790|P1|COMPLETED|Overall Study||238
343784|NCT01313858|823788|P3|STARTED|Overall Study||543
343785|NCT01313858|823789|P2|STARTED|Overall Study||546
343786|NCT01313858|823790|P1|STARTED|Overall Study||524
343787|NCT01313780|823813|P2|NOT COMPLETED|Overall Study||28
343788|NCT01313780|823814|P1|NOT COMPLETED|Overall Study||25
343789|NCT01313780|823813|P2|COMPLETED|Overall Study|PPS|31
343790|NCT01313780|823814|P1|COMPLETED|Overall Study|PPS|33
343791|NCT01313780|823813|P2|STARTED|Overall Study|FAS|59
343792|NCT01313780|823814|P1|STARTED|Overall Study|FAS|58
343793|NCT01313728|823822|P1|NOT COMPLETED|Baseline to Completion||0
343794|NCT01313728|823822|P1|COMPLETED|Baseline to Completion||25
343795|NCT01313728|823822|P1|STARTED|Baseline to Completion||25
343796|NCT01313728|823822|P1|NOT COMPLETED|Informed Consent to Baseline||1
343797|NCT01313728|823822|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
343798|NCT01313728|823822|P1|STARTED|Informed Consent to Baseline||26
343799|NCT01313689|823839|P4|NOT COMPLETED|24-Week Randomization 2||1
343800|NCT01313689|823840|P3|NOT COMPLETED|24-Week Randomization 2||3
343801|NCT01313689|823841|P2|NOT COMPLETED|24-Week Randomization 2||0
343802|NCT01313689|823842|P1|NOT COMPLETED|24-Week Randomization 2||0
343803|NCT01313689|823839|P4|COMPLETED|24-Week Randomization 2||12
343804|NCT01313689|823840|P3|COMPLETED|24-Week Randomization 2||21
343805|NCT01313689|823841|P2|COMPLETED|24-Week Randomization 2||0
343806|NCT01313689|823842|P1|COMPLETED|24-Week Randomization 2||0
343807|NCT01313689|823839|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
343808|NCT01313689|823840|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
343809|NCT01313689|823841|P2|STARTED|24-Week Randomization 2||0
343810|NCT01313689|823842|P1|STARTED|24-Week Randomization 2||0
343811|NCT01313689|823839|P4|NOT COMPLETED|24-Week Randomization 1||0
343812|NCT01313689|823840|P3|NOT COMPLETED|24-Week Randomization 1||0
343813|NCT01313689|823841|P2|NOT COMPLETED|24-Week Randomization 1||10
343814|NCT01313689|823842|P1|NOT COMPLETED|24-Week Randomization 1||19
343815|NCT01313689|823839|P4|COMPLETED|24-Week Randomization 1||0
343817|NCT01313689|823841|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
343818|NCT01313689|823842|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
343819|NCT01313689|823839|P4|STARTED|24-Week Randomization 1||0
343820|NCT01313689|823840|P3|STARTED|24-Week Randomization 1||0
343821|NCT01313689|823841|P2|STARTED|24-Week Randomization 1||43
343822|NCT01313689|823842|P1|STARTED|24-Week Randomization 1||79
343823|NCT01313676|823909|P4|NOT COMPLETED|Overall Study||994
343824|NCT01313676|823910|P3|NOT COMPLETED|Overall Study||1088
343825|NCT01313676|823911|P2|NOT COMPLETED|Overall Study||1113
343826|NCT01313676|823912|P1|NOT COMPLETED|Overall Study||1250
343827|NCT01313676|823909|P4|COMPLETED|Overall Study||3146
343828|NCT01313676|823910|P3|COMPLETED|Overall Study||3052
343829|NCT01313676|823911|P2|COMPLETED|Overall Study||3044
343830|NCT01313676|823912|P1|COMPLETED|Overall Study||2881
343831|NCT01313676|823909|P4|STARTED|Overall Study||4140
343832|NCT01313676|823910|P3|STARTED|Overall Study||4140
343833|NCT01313676|823911|P2|STARTED|Overall Study||4157
343834|NCT01313676|823912|P1|STARTED|Overall Study||4131
343835|NCT01313663|823932|P2|NOT COMPLETED|Overall Study||8
343836|NCT01313663|823933|P1|NOT COMPLETED|Overall Study||4
343837|NCT01313663|823932|P2|COMPLETED|Overall Study||3
343838|NCT01313663|823933|P1|COMPLETED|Overall Study||5
343839|NCT01313663|823932|P2|STARTED|Overall Study||11
343840|NCT01313663|823933|P1|STARTED|Overall Study||9
343841|NCT01313650|823971|P4|NOT COMPLETED|Overall Study||81
343842|NCT01313650|823972|P3|NOT COMPLETED|Overall Study||103
343843|NCT01313650|823973|P2|NOT COMPLETED|Overall Study||94
343844|NCT01313650|823974|P1|NOT COMPLETED|Overall Study||76
343845|NCT01313650|823971|P4|COMPLETED|Overall Study||332
343846|NCT01313650|823972|P3|COMPLETED|Overall Study||318
343847|NCT01313650|823973|P2|COMPLETED|Overall Study||324
343848|NCT01313650|823974|P1|COMPLETED|Overall Study||204
343849|NCT01313650|823971|P4|STARTED|Overall Study||413
343850|NCT01313650|823972|P3|STARTED|Overall Study||421
343851|NCT01313650|823973|P2|STARTED|Overall Study||418
343852|NCT01313650|823974|P1|STARTED|Overall Study||280
343853|NCT01313637|824000|P4|NOT COMPLETED|Overall Study||78
343854|NCT01313637|824001|P3|NOT COMPLETED|Overall Study||106
343855|NCT01313637|824002|P2|NOT COMPLETED|Overall Study||95
343856|NCT01313637|824003|P1|NOT COMPLETED|Overall Study||92
343857|NCT01313637|824000|P4|COMPLETED|Overall Study||325
343858|NCT01313637|824001|P3|COMPLETED|Overall Study||298
343859|NCT01313637|824002|P2|COMPLETED|Overall Study||312
343860|NCT01313637|824003|P1|COMPLETED|Overall Study||183
343861|NCT01313637|824000|P4|STARTED|Overall Study||403
343862|NCT01313637|824001|P3|STARTED|Overall Study||404
343863|NCT01313637|824002|P2|STARTED|Overall Study||407
343864|NCT01313637|824003|P1|STARTED|Overall Study||275
343865|NCT01313624|824027|P2|NOT COMPLETED|Open-Label Phase||13
343866|NCT01313624|824028|P1|NOT COMPLETED|Open-Label Phase||4
343867|NCT01313624|824027|P2|COMPLETED|Open-Label Phase||109
343868|NCT01313624|824028|P1|COMPLETED|Open-Label Phase||92
343869|NCT01313624|824027|P2|STARTED|Open-Label Phase||122
343870|NCT01313624|824028|P1|STARTED|Open-Label Phase||96
343871|NCT01313624|824027|P2|NOT COMPLETED|Double-Blind Phase||10
343872|NCT01313624|824028|P1|NOT COMPLETED|Double-Blind Phase||38
343873|NCT01313624|824027|P2|COMPLETED|Double-Blind Phase||122
343874|NCT01313624|824028|P1|COMPLETED|Double-Blind Phase||96
343875|NCT01313624|824027|P2|STARTED|Double-Blind Phase||132
343876|NCT01313624|824028|P1|STARTED|Double-Blind Phase||134
343877|NCT01313520|824042|P2|NOT COMPLETED|Overall Study||0
343878|NCT01313520|824043|P1|NOT COMPLETED|Overall Study||0
343879|NCT01313520|824042|P2|COMPLETED|Overall Study||31
343880|NCT01313520|824043|P1|COMPLETED|Overall Study||30
343881|NCT01313520|824042|P2|STARTED|Overall Study||31
343882|NCT01313520|824043|P1|STARTED|Overall Study||30
343883|NCT01313507|824063|P1|NOT COMPLETED|Overall Study||0
343884|NCT01313507|824063|P1|COMPLETED|Overall Study||21
343885|NCT01313507|824063|P1|STARTED|Overall Study||21
343886|NCT01313494|824071|P2|NOT COMPLETED|Overall Study||50
343887|NCT01313494|824072|P1|NOT COMPLETED|Overall Study||67
343888|NCT01313494|824071|P2|COMPLETED|Overall Study||263
343889|NCT01313494|824072|P1|COMPLETED|Overall Study||246
343890|NCT01313494|824071|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
343891|NCT01313494|824072|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
343892|NCT01313494|824071|P2|STARTED|Overall Study||313
343893|NCT01313494|824072|P1|STARTED|Overall Study||313
343894|NCT01313312|824124|P1|NOT COMPLETED|Overall Study||36
343895|NCT01313312|824124|P1|COMPLETED|Overall Study||222
343896|NCT01313312|824124|P1|Cycle 5|Overall Study||11
343897|NCT01313312|824124|P1|Cycle 4|Overall Study||81
343898|NCT01313312|824124|P1|Cycle 3|Overall Study||175
343899|NCT01313312|824124|P1|Cycle 2|Overall Study||229
343900|NCT01313312|824124|P1|Cycle 1|Overall Study||254
343901|NCT01313312|824124|P1|STARTED|Overall Study||258
343902|NCT01313299|824171|P3|NOT COMPLETED|Overall Study||4
343903|NCT01313299|824172|P2|NOT COMPLETED|Overall Study||3
343904|NCT01313299|824173|P1|NOT COMPLETED|Overall Study||7
343905|NCT01313299|824171|P3|COMPLETED|Overall Study||77
343906|NCT01313299|824172|P2|COMPLETED|Overall Study||78
343907|NCT01313299|824173|P1|COMPLETED|Overall Study||74
343908|NCT01313299|824171|P3|STARTED|Overall Study||81
343909|NCT01313299|824172|P2|STARTED|Overall Study||81
343910|NCT01313299|824173|P1|STARTED|Overall Study||81
343911|NCT01313273|824189|P2|NOT COMPLETED|Overall Study||1
343912|NCT01313273|824190|P1|NOT COMPLETED|Overall Study||2
343913|NCT01313273|824189|P2|COMPLETED|Overall Study||0
343914|NCT01313273|824190|P1|COMPLETED|Overall Study||0
343915|NCT01313273|824189|P2|STARTED|Overall Study||1
343916|NCT01313273|824190|P1|STARTED|Overall Study||2
343917|NCT01313221|824205|P3|NOT COMPLETED|Overall Study||23
343918|NCT01313221|824206|P2|NOT COMPLETED|Overall Study||8
343919|NCT01313221|824207|P1|NOT COMPLETED|Overall Study||12
343920|NCT01313221|824205|P3|COMPLETED|Overall Study||0
343921|NCT01313221|824206|P2|COMPLETED|Overall Study||135
343922|NCT01313221|824207|P1|COMPLETED|Overall Study||132
343923|NCT01313221|824205|P3|Randomized|Overall Study||0
343924|NCT01313221|824206|P2|Randomized|Overall Study||143
343925|NCT01313221|824207|P1|Randomized|Overall Study||144
343926|NCT01313221|824205|P3|STARTED|Overall Study||23
343927|NCT01313221|824206|P2|STARTED|Overall Study||143
343928|NCT01313221|824207|P1|STARTED|Overall Study||144
343929|NCT01313208|824259|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
343930|NCT01313208|824260|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
343931|NCT01313208|824259|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
343932|NCT01313208|824260|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
343933|NCT01313208|824259|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
343934|NCT01313208|824260|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
343935|NCT01313208|824259|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
343936|NCT01313208|824260|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
343937|NCT01313208|824259|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
343938|NCT01313208|824260|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
343939|NCT01313208|824259|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
343940|NCT01313208|824260|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
343941|NCT01313182|824350|P2|NOT COMPLETED|Overall Study||92
343942|NCT01313182|824351|P1|NOT COMPLETED|Overall Study||66
343943|NCT01313182|824350|P2|COMPLETED|Overall Study||763
343944|NCT01313182|824351|P1|COMPLETED|Overall Study||776
343945|NCT01313182|824350|P2|STARTED|Overall Study||855
343946|NCT01313182|824351|P1|STARTED|Overall Study||842
343947|NCT01313117|824357|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
343948|NCT01313117|824357|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
343949|NCT01313117|824357|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
343950|NCT01313117|824357|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
343951|NCT01313117|824357|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
343952|NCT01313117|824357|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
343953|NCT01313117|824357|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
343954|NCT01313117|824357|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
343955|NCT01313117|824357|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
343956|NCT01313117|824357|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
343957|NCT01313117|824357|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
343958|NCT01313117|824357|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
343959|NCT01313117|824357|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
343960|NCT01313117|824357|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
343961|NCT01313117|824357|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
343962|NCT01313078|824364|P1|NOT COMPLETED|Overall Study||3
343963|NCT01313078|824364|P1|COMPLETED|Overall Study||1
343964|NCT01313078|824364|P1|STARTED|Overall Study||4
343965|NCT01313039|824369|P1|NOT COMPLETED|Overall Study||2
343966|NCT01313039|824369|P1|COMPLETED|Overall Study||2
343967|NCT01313039|824369|P1|STARTED|Overall Study||4
343968|NCT01312961|824375|P2|NOT COMPLETED|Overall Study||7
343969|NCT01312961|824376|P1|NOT COMPLETED|Overall Study||17
343970|NCT01312961|824375|P2|COMPLETED|Overall Study||45
343971|NCT01312961|824376|P1|COMPLETED|Overall Study||35
343972|NCT01312961|824375|P2|Treated|Overall Study||52
343973|NCT01312961|824376|P1|Treated|Overall Study||52
343974|NCT01312961|824375|P2|STARTED|Overall Study||52
343975|NCT01312961|824376|P1|STARTED|Overall Study||52
343976|NCT01312948|824402|P1|NOT COMPLETED|Overall Study||0
343977|NCT01312948|824402|P1|COMPLETED|Overall Study||6
343978|NCT01312948|824402|P1|STARTED|Overall Study||6
343979|NCT01312844|824411|P2|NOT COMPLETED|Overall Study||0
343980|NCT01312844|824412|P1|NOT COMPLETED|Overall Study||0
343981|NCT01312844|824411|P2|COMPLETED|Overall Study||3
343982|NCT01312844|824412|P1|COMPLETED|Overall Study||4
343983|NCT01312844|824411|P2|STARTED|Overall Study||3
343984|NCT01312844|824412|P1|STARTED|Overall Study||4
343985|NCT01312818|824434|P1|NOT COMPLETED|Overall Study||0
343986|NCT01312818|824434|P1|COMPLETED|Overall Study||2
343987|NCT01312818|824434|P1|STARTED|Overall Study||2
343988|NCT01312805|824442|P2|NOT COMPLETED|Overall Study||0
343989|NCT01312805|824443|P1|NOT COMPLETED|Overall Study||0
343990|NCT01312805|824442|P2|COMPLETED|Overall Study||1082
343991|NCT01312805|824443|P1|COMPLETED|Overall Study||1016
343992|NCT01312805|824442|P2|STARTED|Overall Study||1082
343993|NCT01312805|824443|P1|STARTED|Overall Study||1016
343994|NCT01312766|824451|P2|NOT COMPLETED|Overall Study||5
343995|NCT01312766|824452|P1|NOT COMPLETED|Overall Study||6
343996|NCT01312766|824451|P2|COMPLETED|Overall Study||130
343997|NCT01312766|824452|P1|COMPLETED|Overall Study||129
343998|NCT01312766|824451|P2|STARTED|Overall Study||135
343999|NCT01312766|824452|P1|STARTED|Overall Study||135
344000|NCT01312519|824484|P2|NOT COMPLETED|Overall Study||0
344001|NCT01312519|824485|P1|NOT COMPLETED|Overall Study||0
344002|NCT01312519|824484|P2|COMPLETED|Overall Study||24
344003|NCT01312519|824485|P1|COMPLETED|Overall Study||26
344004|NCT01312519|824484|P2|STARTED|Overall Study||24
344005|NCT01312519|824485|P1|STARTED|Overall Study||26
344006|NCT01312467|824493|P1|NOT COMPLETED|Overall Study||13
344007|NCT01312467|824493|P1|COMPLETED|Overall Study||32
344008|NCT01312467|824493|P1|STARTED|Overall Study||45
344009|NCT01312428|824499|P2|NOT COMPLETED|Overall Study||4
344010|NCT01312428|824500|P1|NOT COMPLETED|Overall Study||3
344011|NCT01312428|824499|P2|COMPLETED|Overall Study||0
344012|NCT01312428|824500|P1|COMPLETED|Overall Study||0
344013|NCT01312428|824499|P2|STARTED|Overall Study||4
344014|NCT01312428|824500|P1|STARTED|Overall Study||3
344015|NCT01312272|824508|P2|NOT COMPLETED|Overall Study||1
344016|NCT01312272|824509|P1|NOT COMPLETED|Overall Study||0
344017|NCT01312272|824508|P2|COMPLETED|Overall Study||11
344018|NCT01312272|824509|P1|COMPLETED|Overall Study||12
344019|NCT01312272|824508|P2|STARTED|Overall Study||12
344020|NCT01312272|824509|P1|STARTED|Overall Study||12
344021|NCT01312129|824527|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
344022|NCT01312129|824528|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
344023|NCT01312129|824527|P2|COMPLETED|Second Intervention (24 Hours)||6
344024|NCT01312129|824528|P1|COMPLETED|Second Intervention (24 Hours)||6
344025|NCT01312129|824527|P2|Alcohol Cue|Second Intervention (24 Hours)||6
344026|NCT01312129|824528|P1|Alcohol Cue|Second Intervention (24 Hours)||6
344027|NCT01312129|824527|P2|Control Cue|Second Intervention (24 Hours)||6
344028|NCT01312129|824528|P1|Control Cue|Second Intervention (24 Hours)||6
344029|NCT01312129|824527|P2|STARTED|Second Intervention (24 Hours)||7
344030|NCT01312129|824528|P1|STARTED|Second Intervention (24 Hours)||6
344031|NCT01312129|824527|P2|NOT COMPLETED|Washout (1 Week)||0
344032|NCT01312129|824528|P1|NOT COMPLETED|Washout (1 Week)||0
344033|NCT01312129|824527|P2|COMPLETED|Washout (1 Week)||7
344034|NCT01312129|824528|P1|COMPLETED|Washout (1 Week)||6
344035|NCT01312129|824527|P2|STARTED|Washout (1 Week)||7
344036|NCT01312129|824528|P1|STARTED|Washout (1 Week)||6
344037|NCT01312129|824527|P2|NOT COMPLETED|First Intervention (24 Hours)||0
344038|NCT01312129|824528|P1|NOT COMPLETED|First Intervention (24 Hours)||0
344039|NCT01312129|824527|P2|COMPLETED|First Intervention (24 Hours)||7
344040|NCT01312129|824528|P1|COMPLETED|First Intervention (24 Hours)||6
344041|NCT01312129|824527|P2|Alcohol Cue|First Intervention (24 Hours)||7
344042|NCT01312129|824528|P1|Alcohol Cue|First Intervention (24 Hours)||6
344043|NCT01312129|824527|P2|Control Cue|First Intervention (24 Hours)||7
344044|NCT01312129|824528|P1|Control Cue|First Intervention (24 Hours)||6
344045|NCT01312129|824527|P2|STARTED|First Intervention (24 Hours)||7
344046|NCT01312129|824528|P1|STARTED|First Intervention (24 Hours)||6
344047|NCT01312038|824536|P2|NOT COMPLETED|Overall Study||0
344048|NCT01312038|824537|P1|NOT COMPLETED|Overall Study||0
344049|NCT01312038|824536|P2|COMPLETED|Overall Study||12
344050|NCT01312038|824537|P1|COMPLETED|Overall Study||13
344051|NCT01312038|824536|P2|STARTED|Overall Study||12
344052|NCT01312038|824537|P1|STARTED|Overall Study||13
344053|NCT01310855|824545|P2|NOT COMPLETED|Overall Study||0
344054|NCT01310855|824546|P1|NOT COMPLETED|Overall Study||0
344055|NCT01310855|824545|P2|COMPLETED|Overall Study||19
344056|NCT01310855|824546|P1|COMPLETED|Overall Study||19
344057|NCT01310855|824545|P2|STARTED|Overall Study||19
344058|NCT01310855|824546|P1|STARTED|Overall Study||19
344059|NCT01311687|824554|P2|NOT COMPLETED|PFS Follow-up Phase||1
344060|NCT01311687|824555|P1|NOT COMPLETED|PFS Follow-up Phase||3
344061|NCT01311687|824554|P2|COMPLETED|PFS Follow-up Phase||7
344062|NCT01311687|824555|P1|COMPLETED|PFS Follow-up Phase||5
344063|NCT01311687|824554|P2|STARTED|PFS Follow-up Phase||8
344064|NCT01311687|824555|P1|STARTED|PFS Follow-up Phase||8
344065|NCT01311687|824554|P2|NOT COMPLETED|Treatment Phase||11
344066|NCT01311687|824555|P1|NOT COMPLETED|Treatment Phase||60
344067|NCT01311687|824554|P2|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|142
344068|NCT01311687|824555|P1|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|242
344069|NCT01311687|824554|P2|Received Study Treatment|Treatment Phase||150
344070|NCT01311687|824555|P1|Received Study Treatment|Treatment Phase||300
344071|NCT01311687|824554|P2|STARTED|Treatment Phase||153
344072|NCT01311687|824555|P1|STARTED|Treatment Phase||302
344073|NCT01311661|824605|P1|NOT COMPLETED|Overall Study||7
344074|NCT01311661|824605|P1|COMPLETED|Overall Study||199
344075|NCT01311661|824605|P1|Received Olo 10 mcg qd|Overall Study||102
344076|NCT01311661|824605|P1|Received Olo 5 mcg Bid|Overall Study||101
344077|NCT01311661|824605|P1|Received Olo 5 mcg qd|Overall Study||101
344078|NCT01311661|824605|P1|Received Olo 2.5 mcg Bid|Overall Study||101
344079|NCT01311661|824605|P1|Received Placebo|Overall Study||201
344080|NCT01311661|824605|P1|STARTED|Overall Study|Entered and treated|206
344081|NCT01311557|824749|P2|NOT COMPLETED|Overall Study||6
344082|NCT01311557|824750|P1|NOT COMPLETED|Overall Study||5
344083|NCT01311557|824749|P2|COMPLETED|Overall Study||645
344084|NCT01311557|824750|P1|COMPLETED|Overall Study||646
344085|NCT01311557|824749|P2|STARTED|Overall Study||651
344086|NCT01311557|824750|P1|STARTED|Overall Study||651
344087|NCT01311505|824766|P2|NOT COMPLETED|Second Intervention Period||0
344088|NCT01311505|824767|P1|NOT COMPLETED|Second Intervention Period||0
344089|NCT01311505|824766|P2|COMPLETED|Second Intervention Period||10
344090|NCT01311505|824767|P1|COMPLETED|Second Intervention Period||10
344091|NCT01311505|824766|P2|STARTED|Second Intervention Period||10
344092|NCT01311505|824767|P1|STARTED|Second Intervention Period||10
344093|NCT01311505|824766|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
344094|NCT01311505|824767|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
344095|NCT01311505|824766|P2|COMPLETED|Washout Period (at Least 7 Days)||10
344096|NCT01311505|824767|P1|COMPLETED|Washout Period (at Least 7 Days)||10
344097|NCT01311505|824766|P2|STARTED|Washout Period (at Least 7 Days)||10
344098|NCT01311505|824767|P1|STARTED|Washout Period (at Least 7 Days)||10
344099|NCT01311505|824766|P2|NOT COMPLETED|First Intervention Period||1
344100|NCT01311505|824767|P1|NOT COMPLETED|First Intervention Period||0
344101|NCT01311505|824766|P2|COMPLETED|First Intervention Period||10
344102|NCT01311505|824767|P1|COMPLETED|First Intervention Period||10
344103|NCT01311505|824766|P2|STARTED|First Intervention Period||11
344104|NCT01311505|824767|P1|STARTED|First Intervention Period||10
344105|NCT01311362|824795|P1|NOT COMPLETED|Ambrisentan and SJW||0
344106|NCT01311362|824795|P1|COMPLETED|Ambrisentan and SJW||20
344107|NCT01311362|824795|P1|STARTED|Ambrisentan and SJW||20
344108|NCT01311362|824795|P1|NOT COMPLETED|Ambrisentan Steady-state||0
344109|NCT01311362|824795|P1|COMPLETED|Ambrisentan Steady-state||20
344110|NCT01311362|824795|P1|STARTED|Ambrisentan Steady-state||20
344111|NCT01311362|824795|P1|NOT COMPLETED|Ambrisentan Single Dose||0
344112|NCT01311362|824795|P1|COMPLETED|Ambrisentan Single Dose||20
344113|NCT01311362|824795|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
344114|NCT01311102|824808|P2|NOT COMPLETED|Overall Study||0
344115|NCT01311102|824809|P1|NOT COMPLETED|Overall Study||0
344116|NCT01311102|824808|P2|COMPLETED|Overall Study||20
344117|NCT01311102|824809|P1|COMPLETED|Overall Study||20
344118|NCT01311102|824808|P2|STARTED|Overall Study||20
344119|NCT01311102|824809|P1|STARTED|Overall Study||20
344120|NCT01311024|824823|P2|NOT COMPLETED|Overall Study||22
344121|NCT01311024|824824|P1|NOT COMPLETED|Overall Study||35
344122|NCT01311024|824823|P2|COMPLETED|Overall Study||789
344123|NCT01311024|824824|P1|COMPLETED|Overall Study||1495
344124|NCT01311024|824823|P2|STARTED|Overall Study||811
344125|NCT01311024|824824|P1|STARTED|Overall Study||1530
344126|NCT01310803|824832|P2|NOT COMPLETED|Overall Study||0
344127|NCT01310803|824833|P1|NOT COMPLETED|Overall Study||1
344128|NCT01310803|824832|P2|COMPLETED|Overall Study||0
344129|NCT01310803|824833|P1|COMPLETED|Overall Study||0
344130|NCT01310803|824832|P2|STARTED|Overall Study||0
344131|NCT01310803|824833|P1|STARTED|Overall Study||1
344132|NCT01310777|824844|P3|NOT COMPLETED|Overall Study||30
344133|NCT01310777|824845|P2|NOT COMPLETED|Overall Study||14
344134|NCT01310777|824846|P1|NOT COMPLETED|Overall Study||33
344135|NCT01310777|824844|P3|COMPLETED|Overall Study||145
344136|NCT01310777|824845|P2|COMPLETED|Overall Study||178
344137|NCT01310777|824846|P1|COMPLETED|Overall Study||160
344138|NCT01310777|824844|P3|STARTED|Overall Study||175
344139|NCT01310777|824845|P2|STARTED|Overall Study||192
344140|NCT01310777|824846|P1|STARTED|Overall Study||193
344141|NCT01310699|824856|P2|NOT COMPLETED|Overall Study||6
344142|NCT01310699|824857|P1|NOT COMPLETED|Overall Study||4
344143|NCT01310699|824856|P2|COMPLETED|Overall Study||143
344144|NCT01310699|824857|P1|COMPLETED|Overall Study||128
344145|NCT01310699|824856|P2|STARTED|Overall Study||149
344146|NCT01310699|824857|P1|STARTED|Overall Study||132
344147|NCT01310582|824865|P2|NOT COMPLETED|Overall Study||0
344148|NCT01310582|824866|P1|NOT COMPLETED|Overall Study||0
344149|NCT01310582|824865|P2|COMPLETED|Overall Study||26
344150|NCT01310582|824866|P1|COMPLETED|Overall Study||31
344151|NCT01310582|824865|P2|STARTED|Overall Study||26
344152|NCT01310582|824866|P1|STARTED|Overall Study||31
344153|NCT01310413|824880|P7|NOT COMPLETED|From Day U0 to Day U385||3
344154|NCT01310413|824881|P6|NOT COMPLETED|From Day U0 to Day U385||0
344155|NCT01310413|824882|P5|NOT COMPLETED|From Day U0 to Day U385||0
344156|NCT01310413|824883|P4|NOT COMPLETED|From Day U0 to Day U385||0
344157|NCT01310413|824884|P3|NOT COMPLETED|From Day U0 to Day U385||0
344158|NCT01310413|824885|P2|NOT COMPLETED|From Day U0 to Day U385||0
344159|NCT01310413|824886|P1|NOT COMPLETED|From Day U0 to Day U385||0
344160|NCT01310413|824880|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
344161|NCT01310413|824881|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
344162|NCT01310413|824882|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
344163|NCT01310413|824883|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
344164|NCT01310413|824884|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
344165|NCT01310413|824885|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
344166|NCT01310413|824886|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
344167|NCT01310413|824880|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
344168|NCT01310413|824881|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
344169|NCT01310413|824882|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
344170|NCT01310413|824883|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
344171|NCT01310413|824884|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
344172|NCT01310413|824885|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
344173|NCT01310413|824886|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
344174|NCT01310413|824880|P7|NOT COMPLETED|Day 0 to Day 385||0
344175|NCT01310413|824881|P6|NOT COMPLETED|Day 0 to Day 385||3
344176|NCT01310413|824882|P5|NOT COMPLETED|Day 0 to Day 385||3
344177|NCT01310413|824883|P4|NOT COMPLETED|Day 0 to Day 385||8
344178|NCT01310413|824884|P3|NOT COMPLETED|Day 0 to Day 385||7
344179|NCT01310413|824885|P2|NOT COMPLETED|Day 0 to Day 385||8
344180|NCT01310413|824886|P1|NOT COMPLETED|Day 0 to Day 385||27
344181|NCT01310413|824880|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
344182|NCT01310413|824881|P6|COMPLETED|Day 0 to Day 385||77
344183|NCT01310413|824882|P5|COMPLETED|Day 0 to Day 385||73
344184|NCT01310413|824883|P4|COMPLETED|Day 0 to Day 385||67
344185|NCT01310413|824884|P3|COMPLETED|Day 0 to Day 385||203
344186|NCT01310413|824885|P2|COMPLETED|Day 0 to Day 385||190
344187|NCT01310413|824886|P1|COMPLETED|Day 0 to Day 385||172
344188|NCT01310413|824880|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
344189|NCT01310413|824881|P6|STARTED|Day 0 to Day 385||80
344190|NCT01310413|824882|P5|STARTED|Day 0 to Day 385||76
344191|NCT01310413|824883|P4|STARTED|Day 0 to Day 385||75
344192|NCT01310413|824884|P3|STARTED|Day 0 to Day 385||210
344193|NCT01310413|824885|P2|STARTED|Day 0 to Day 385||198
344194|NCT01310413|824886|P1|STARTED|Day 0 to Day 385||199
344195|NCT01310400|825042|P3|NOT COMPLETED|Overall Study||30
344196|NCT01310400|825043|P2|NOT COMPLETED|Overall Study||32
344197|NCT01310400|825044|P1|NOT COMPLETED|Overall Study||28
344198|NCT01310400|825042|P3|COMPLETED|Overall Study||422
344199|NCT01310400|825043|P2|COMPLETED|Overall Study||420
344200|NCT01310400|825044|P1|COMPLETED|Overall Study||424
344201|NCT01310400|825042|P3|STARTED|Overall Study||452
344202|NCT01310400|825043|P2|STARTED|Overall Study||452
344203|NCT01310400|825044|P1|STARTED|Overall Study||452
344204|NCT01310179|825061|P1|NOT COMPLETED|Overall Study||0
344205|NCT01310179|825061|P1|COMPLETED|Overall Study||12
344206|NCT01310179|825061|P1|STARTED|Overall Study||12
344207|NCT01310127|825068|P2|NOT COMPLETED|Overall Study||1
344208|NCT01310127|825069|P1|NOT COMPLETED|Overall Study||2
344209|NCT01310127|825068|P2|COMPLETED|Overall Study||10
344210|NCT01310127|825069|P1|COMPLETED|Overall Study||10
344211|NCT01310127|825068|P2|STARTED|Overall Study||11
344212|NCT01310127|825069|P1|STARTED|Overall Study||12
344213|NCT01309997|825083|P2|NOT COMPLETED|Overall Study||6
344214|NCT01309997|825084|P1|NOT COMPLETED|Overall Study||5
344215|NCT01309997|825083|P2|COMPLETED|Overall Study||31
344216|NCT01309997|825084|P1|COMPLETED|Overall Study||30
344217|NCT01309997|825083|P2|Crossed Over to Second Arm|Overall Study||23
344218|NCT01309997|825084|P1|Crossed Over to Second Arm|Overall Study||19
344219|NCT01309997|825083|P2|Remained on First Arm Only|Overall Study||14
344220|NCT01309997|825084|P1|Remained on First Arm Only|Overall Study||16
344221|NCT01309997|825083|P2|STARTED|Overall Study||37
344222|NCT01309997|825084|P1|STARTED|Overall Study||35
344223|NCT01309919|825108|P2|NOT COMPLETED|Overall Study||48
344224|NCT01309919|825109|P1|NOT COMPLETED|Overall Study||17
344225|NCT01309919|825108|P2|COMPLETED|Overall Study||27
344226|NCT01309919|825109|P1|COMPLETED|Overall Study||58
344227|NCT01309919|825108|P2|STARTED|Overall Study||75
344228|NCT01309919|825109|P1|STARTED|Overall Study||75
344229|NCT01309893|825121|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
344230|NCT01309893|825122|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
344231|NCT01309893|825121|P2|COMPLETED|Week 2 - Crossover Intervention||32
344232|NCT01309893|825122|P1|COMPLETED|Week 2 - Crossover Intervention||32
344233|NCT01309893|825121|P2|STARTED|Week 2 - Crossover Intervention||33
344234|NCT01309893|825122|P1|STARTED|Week 2 - Crossover Intervention||33
344235|NCT01309893|825121|P2|NOT COMPLETED|Week 1 - First Intervention||0
344236|NCT01309893|825122|P1|NOT COMPLETED|Week 1 - First Intervention||0
344237|NCT01309893|825121|P2|COMPLETED|Week 1 - First Intervention||33
344238|NCT01309893|825122|P1|COMPLETED|Week 1 - First Intervention||33
344239|NCT01309893|825121|P2|STARTED|Week 1 - First Intervention||33
344240|NCT01309893|825122|P1|STARTED|Week 1 - First Intervention||33
344241|NCT01309880|825132|P2|NOT COMPLETED|Overall Study||0
344242|NCT01309880|825133|P1|NOT COMPLETED|Overall Study||0
344243|NCT01309880|825132|P2|COMPLETED|Overall Study||33
344244|NCT01309880|825133|P1|COMPLETED|Overall Study||33
344245|NCT01309880|825132|P2|STARTED|Overall Study||33
344246|NCT01309880|825133|P1|STARTED|Overall Study||33
344247|NCT01308788|825145|P2|NOT COMPLETED|2-year Treatment||11
344248|NCT01308788|825146|P1|NOT COMPLETED|2-year Treatment||4
344249|NCT01308788|825145|P2|COMPLETED|2-year Treatment||10
344250|NCT01308788|825146|P1|COMPLETED|2-year Treatment||10
344251|NCT01308788|825145|P2|STARTED|2-year Treatment||21
344252|NCT01308788|825146|P1|STARTED|2-year Treatment||14
344253|NCT01308788|825145|P2|NOT COMPLETED|6-month Treatment||0
344254|NCT01308788|825146|P1|NOT COMPLETED|6-month Treatment||0
344255|NCT01308788|825145|P2|COMPLETED|6-month Treatment||21
344256|NCT01308788|825146|P1|COMPLETED|6-month Treatment||14
344257|NCT01308788|825145|P2|STARTED|6-month Treatment||21
344258|NCT01308788|825146|P1|STARTED|6-month Treatment||14
344259|NCT01308762|825181|P3|NOT COMPLETED|Overall Study||0
344260|NCT01308762|825182|P2|NOT COMPLETED|Overall Study||1
344261|NCT01308762|825183|P1|NOT COMPLETED|Overall Study||0
344262|NCT01308762|825181|P3|COMPLETED|Overall Study||6
344263|NCT01308762|825182|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
344264|NCT01308762|825183|P1|COMPLETED|Overall Study||6
344265|NCT01308762|825181|P3|STARTED|Overall Study||6
344266|NCT01308762|825182|P2|STARTED|Overall Study||7
344267|NCT01308762|825183|P1|STARTED|Overall Study||6
344268|NCT01308736|825196|P2|NOT COMPLETED|Overall Study||5
344269|NCT01308736|825197|P1|NOT COMPLETED|Overall Study||6
344270|NCT01308736|825196|P2|COMPLETED|Overall Study||27
344271|NCT01308736|825197|P1|COMPLETED|Overall Study||25
344272|NCT01308736|825196|P2|STARTED|Overall Study||32
344273|NCT01308736|825197|P1|STARTED|Overall Study||31
344274|NCT01309841|825206|P3|NOT COMPLETED|Overall Study||37
344275|NCT01309841|825207|P2|NOT COMPLETED|Overall Study||41
344276|NCT01309841|825208|P1|NOT COMPLETED|Overall Study||39
344277|NCT01309841|825206|P3|COMPLETED|Overall Study||180
344278|NCT01309841|825207|P2|COMPLETED|Overall Study||177
344279|NCT01309841|825208|P1|COMPLETED|Overall Study||178
344280|NCT01309841|825206|P3|STARTED|Overall Study||217
344281|NCT01309841|825207|P2|STARTED|Overall Study||218
344282|NCT01309841|825208|P1|STARTED|Overall Study||217
344283|NCT01309828|825248|P2|NOT COMPLETED|Overall Study||16
344284|NCT01309828|825249|P1|NOT COMPLETED|Overall Study||16
344285|NCT01309828|825248|P2|COMPLETED|Overall Study||60
344286|NCT01309828|825249|P1|COMPLETED|Overall Study||61
344287|NCT01309828|825248|P2|STARTED|Overall Study||76
344288|NCT01309828|825249|P1|STARTED|Overall Study||77
344289|NCT01309802|825263|P2|NOT COMPLETED|Overall Study||9
344290|NCT01309802|825264|P1|NOT COMPLETED|Overall Study||12
344291|NCT01309802|825263|P2|COMPLETED|Overall Study||14
344292|NCT01309802|825264|P1|COMPLETED|Overall Study||13
344293|NCT01309802|825263|P2|STARTED|Overall Study||23
344294|NCT01309802|825264|P1|STARTED|Overall Study||25
344295|NCT01309737|825283|P5|NOT COMPLETED|Week 16 to 52||33
344296|NCT01309737|825284|P4|NOT COMPLETED|Week 16 to 52||34
344297|NCT01309737|825285|P3|NOT COMPLETED|Week 16 to 52||0
344298|NCT01309737|825286|P2|NOT COMPLETED|Week 16 to 52||103
344299|NCT01309737|825287|P1|NOT COMPLETED|Week 16 to 52||133
344300|NCT01309737|825283|P5|COMPLETED|Week 16 to 52||44
344301|NCT01309737|825284|P4|COMPLETED|Week 16 to 52||41
344302|NCT01309737|825285|P3|COMPLETED|Week 16 to 52||0
344303|NCT01309737|825286|P2|COMPLETED|Week 16 to 52||238
344304|NCT01309737|825287|P1|COMPLETED|Week 16 to 52||198
344305|NCT01309737|825283|P5|STARTED|Week 16 to 52||77
344306|NCT01309737|825284|P4|STARTED|Week 16 to 52||75
344307|NCT01309737|825285|P3|STARTED|Week 16 to 52||0
344308|NCT01309737|825286|P2|STARTED|Week 16 to 52||341
344309|NCT01309737|825287|P1|STARTED|Week 16 to 52||331
344310|NCT01309737|825283|P5|NOT COMPLETED|Week 0 to 16||0
344311|NCT01309737|825284|P4|NOT COMPLETED|Week 0 to 16||0
344312|NCT01309737|825285|P3|NOT COMPLETED|Week 0 to 16||44
344313|NCT01309737|825286|P2|NOT COMPLETED|Week 0 to 16||40
344314|NCT01309737|825287|P1|NOT COMPLETED|Week 0 to 16||52
344315|NCT01309737|825283|P5|COMPLETED|Week 0 to 16||0
344316|NCT01309737|825284|P4|COMPLETED|Week 0 to 16||0
344317|NCT01309737|825285|P3|COMPLETED|Week 0 to 16||152
344318|NCT01309737|825286|P2|COMPLETED|Week 0 to 16||341
344319|NCT01309737|825287|P1|COMPLETED|Week 0 to 16||331
344320|NCT01309737|825283|P5|Treated|Week 0 to 16||0
344321|NCT01309737|825284|P4|Treated|Week 0 to 16||0
344322|NCT01309737|825285|P3|Treated|Week 0 to 16||196
344323|NCT01309737|825286|P2|Treated|Week 0 to 16||381
344324|NCT01309737|825287|P1|Treated|Week 0 to 16||382
344325|NCT01309737|825283|P5|STARTED|Week 0 to 16||0
344326|NCT01309737|825284|P4|STARTED|Week 0 to 16||0
344327|NCT01309737|825285|P3|STARTED|Week 0 to 16||196
344328|NCT01309737|825286|P2|STARTED|Week 0 to 16||381
344329|NCT01309737|825287|P1|STARTED|Week 0 to 16||383
344330|NCT01309672|825482|P1|NOT COMPLETED|Overall Study||37
344331|NCT01309672|825482|P1|COMPLETED|Overall Study||4
344332|NCT01309672|825482|P1|Received Protocol Treatment|Overall Study||40
344333|NCT01309672|825482|P1|STARTED|Overall Study||41
344334|NCT01309659|825492|P2|NOT COMPLETED|Overall Study||1
344335|NCT01309659|825493|P1|NOT COMPLETED|Overall Study||0
344336|NCT01309659|825492|P2|COMPLETED|Overall Study||9
344337|NCT01309659|825493|P1|COMPLETED|Overall Study||9
344338|NCT01309659|825492|P2|STARTED|Overall Study||10
344339|NCT01309659|825493|P1|STARTED|Overall Study||9
344340|NCT01309646|825535|P2|NOT COMPLETED|Overall Study||0
344341|NCT01309646|825536|P1|NOT COMPLETED|Overall Study||0
344342|NCT01309646|825535|P2|COMPLETED|Overall Study||227
344343|NCT01309646|825536|P1|COMPLETED|Overall Study||224
344344|NCT01309646|825535|P2|STARTED|Overall Study||227
344345|NCT01309646|825536|P1|STARTED|Overall Study||224
344346|NCT01309581|825576|P2|NOT COMPLETED|Overall Study||0
344347|NCT01309581|825577|P1|NOT COMPLETED|Overall Study||0
344348|NCT01309581|825576|P2|COMPLETED|Overall Study||1
344349|NCT01309581|825577|P1|COMPLETED|Overall Study||2
344350|NCT01309581|825576|P2|STARTED|Overall Study||1
344351|NCT01309581|825577|P1|STARTED|Overall Study||2
344352|NCT01309451|825587|P2|NOT COMPLETED|Overall Study||3
344353|NCT01309451|825588|P1|NOT COMPLETED|Overall Study||2
344354|NCT01309451|825587|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
344355|NCT01309451|825588|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
344356|NCT01309451|825587|P2|STARTED|Overall Study|unit of measure is number of eyes|21
344357|NCT01309451|825588|P1|STARTED|Overall Study|unit of measure is number of eyes|19
344358|NCT01309386|825598|P2|NOT COMPLETED|Overall Study||21
344359|NCT01309386|825599|P1|NOT COMPLETED|Overall Study||22
344360|NCT01309386|825598|P2|COMPLETED|Overall Study||29
344361|NCT01309386|825599|P1|COMPLETED|Overall Study||28
344362|NCT01309386|825598|P2|STARTED|Overall Study||50
344363|NCT01309386|825599|P1|STARTED|Overall Study||50
344364|NCT01309360|825620|P3|NOT COMPLETED|Overall Study||0
344365|NCT01309360|825621|P2|NOT COMPLETED|Overall Study||0
344366|NCT01309360|825622|P1|NOT COMPLETED|Overall Study||0
344367|NCT01309360|825620|P3|COMPLETED|Overall Study||40
344368|NCT01309360|825621|P2|COMPLETED|Overall Study||40
344369|NCT01309360|825622|P1|COMPLETED|Overall Study||40
344370|NCT01309360|825620|P3|STARTED|Overall Study||40
344371|NCT01309360|825621|P2|STARTED|Overall Study||40
344372|NCT01309360|825622|P1|STARTED|Overall Study||40
344373|NCT01309308|825647|P2|NOT COMPLETED|Overall Study||4
344374|NCT01309308|825648|P1|NOT COMPLETED|Overall Study||6
344375|NCT01309308|825647|P2|COMPLETED|Overall Study||71
344376|NCT01309308|825648|P1|COMPLETED|Overall Study||69
344377|NCT01309308|825647|P2|STARTED|Overall Study||75
344378|NCT01309308|825648|P1|STARTED|Overall Study||75
344379|NCT01309282|825656|P1|NOT COMPLETED|Overall Study||1
344380|NCT01309282|825656|P1|COMPLETED|Overall Study||8
344381|NCT01309282|825656|P1|STARTED|Overall Study||9
344382|NCT01309269|825673|P1|NOT COMPLETED|Overall Study||840
344383|NCT01309269|825673|P1|COMPLETED|Overall Study||245
344384|NCT01309269|825673|P1|Treated|Overall Study||978
344385|NCT01309269|825673|P1|STARTED|Overall Study||1085
344386|NCT01309243|825681|P2|NOT COMPLETED|Extension Phase||0
344387|NCT01309243|825682|P1|NOT COMPLETED|Extension Phase||6
344388|NCT01309243|825681|P2|COMPLETED|Extension Phase||117
344389|NCT01309243|825682|P1|COMPLETED|Extension Phase||34
344470|NCT01308424|825878|P2|NOT COMPLETED|Randomization||3
344390|NCT01309243|825681|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
344391|NCT01309243|825682|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
344392|NCT01309243|825681|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
344393|NCT01309243|825682|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
344394|NCT01309243|825681|P2|COMPLETED|Randomized Phase Through Week 96||290
344395|NCT01309243|825682|P1|COMPLETED|Randomized Phase Through Week 96||316
344396|NCT01309243|825681|P2|Randomized and Treated|Randomized Phase Through Week 96||392
344397|NCT01309243|825682|P1|Randomized and Treated|Randomized Phase Through Week 96||394
344398|NCT01309243|825681|P2|STARTED|Randomized Phase Through Week 96||399
344399|NCT01309243|825682|P1|STARTED|Randomized Phase Through Week 96||400
344400|NCT01309204|825708|P2|NOT COMPLETED|Overall Study||75
344401|NCT01309204|825709|P1|NOT COMPLETED|Overall Study||67
344402|NCT01309204|825708|P2|COMPLETED|Overall Study||361
344403|NCT01309204|825709|P1|COMPLETED|Overall Study||385
344404|NCT01309204|825708|P2|STARTED|Overall Study||436
344405|NCT01309204|825709|P1|STARTED|Overall Study||452
344406|NCT01309100|825715|P1|NOT COMPLETED|Overall Study||2
344407|NCT01309100|825715|P1|COMPLETED|Overall Study||142
344408|NCT01309100|825715|P1|STARTED|Overall Study||144
344409|NCT01308918|825726|P1|NOT COMPLETED|Overall Study||0
344410|NCT01308918|825726|P1|COMPLETED|Overall Study||50
344411|NCT01308918|825726|P1|STARTED|Overall Study||50
344412|NCT01308840|825733|P1|NOT COMPLETED|Overall Study||0
344413|NCT01308840|825733|P1|COMPLETED|Overall Study||31
344414|NCT01308840|825733|P1|STARTED|Overall Study||31
344415|NCT01308619|825742|P2|NOT COMPLETED|Overall Study||3
344416|NCT01308619|825743|P1|NOT COMPLETED|Overall Study||7
344417|NCT01308619|825742|P2|COMPLETED|Overall Study||83
344418|NCT01308619|825743|P1|COMPLETED|Overall Study||77
344419|NCT01308619|825742|P2|STARTED|Overall Study||86
344420|NCT01308619|825743|P1|STARTED|Overall Study||84
344421|NCT01308580|825757|P2|NOT COMPLETED|Overall Study||7
344422|NCT01308580|825758|P1|NOT COMPLETED|Overall Study||12
344423|NCT01308580|825757|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
344424|NCT01308580|825758|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
344425|NCT01308580|825757|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
344426|NCT01308580|825758|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
344427|NCT01308580|825757|P2|STARTED|Overall Study||602
344428|NCT01308580|825758|P1|STARTED|Overall Study||598
344429|NCT01308567|825801|P3|NOT COMPLETED|Overall Study||4
344430|NCT01308567|825802|P2|NOT COMPLETED|Overall Study||4
344431|NCT01308567|825803|P1|NOT COMPLETED|Overall Study||2
344432|NCT01308567|825801|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
344433|NCT01308567|825802|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
344434|NCT01308567|825803|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
344435|NCT01308567|825801|P3|Ongoing Treatment at Data Cut-off|Overall Study||3
344436|NCT01308567|825802|P2|Ongoing Treatment at Data Cut-off|Overall Study||6
344437|NCT01308567|825803|P1|Ongoing Treatment at Data Cut-off|Overall Study||4
344438|NCT01308567|825801|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
344439|NCT01308567|825802|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
344440|NCT01308567|825803|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
344441|NCT01308567|825801|P3|STARTED|Overall Study|Randomized|388
344442|NCT01308567|825802|P2|STARTED|Overall Study|Randomized|389
344443|NCT01308567|825803|P1|STARTED|Overall Study|Randomized|391
344444|NCT01308476|825843|P2|NOT COMPLETED|Overall Study||2
344445|NCT01308476|825844|P1|NOT COMPLETED|Overall Study||3
344446|NCT01308476|825843|P2|COMPLETED|Overall Study||45
344447|NCT01308476|825844|P1|COMPLETED|Overall Study||45
344448|NCT01308476|825843|P2|STARTED|Overall Study|Entered and treated.|47
344449|NCT01308476|825844|P1|STARTED|Overall Study|Entered and treated.|48
344450|NCT01308463|825864|P1|NOT COMPLETED|Overall Study||29
344451|NCT01308463|825864|P1|COMPLETED|Overall Study||0
344452|NCT01308463|825864|P1|12 Years|Overall Study||2
344453|NCT01308463|825864|P1|11 Years|Overall Study||8
344454|NCT01308463|825864|P1|10 Years|Overall Study||8
344455|NCT01308463|825864|P1|9 Years|Overall Study||11
344456|NCT01308463|825864|P1|8 Years|Overall Study||14
344457|NCT01308463|825864|P1|7 Years|Overall Study||12
344458|NCT01308463|825864|P1|6 Years|Overall Study||11
344459|NCT01308463|825864|P1|5 Years|Overall Study||20
344460|NCT01308463|825864|P1|4 Years|Overall Study||20
344461|NCT01308463|825864|P1|3 Years|Overall Study||17
344462|NCT01308463|825864|P1|2 Years|Overall Study||18
344463|NCT01308463|825864|P1|1 Year|Overall Study||21
344464|NCT01308463|825864|P1|6 Months|Overall Study||23
344465|NCT01308463|825864|P1|STARTED|Overall Study||29
344466|NCT01308450|825871|P1|NOT COMPLETED|Overall Study||2
344467|NCT01308450|825871|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
344468|NCT01308450|825871|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
344469|NCT01308424|825877|P3|NOT COMPLETED|Randomization||2
344471|NCT01308424|825879|P1|NOT COMPLETED|Randomization||0
344472|NCT01308424|825877|P3|COMPLETED|Randomization||82
344473|NCT01308424|825878|P2|COMPLETED|Randomization||84
344474|NCT01308424|825879|P1|COMPLETED|Randomization||0
344475|NCT01308424|825877|P3|STARTED|Randomization||84
344476|NCT01308424|825878|P2|STARTED|Randomization||87
344477|NCT01308424|825879|P1|STARTED|Randomization||0
344478|NCT01308424|825877|P3|NOT COMPLETED|Baseline Eligibility||0
344479|NCT01308424|825878|P2|NOT COMPLETED|Baseline Eligibility||0
344480|NCT01308424|825879|P1|NOT COMPLETED|Baseline Eligibility||71
344481|NCT01308424|825877|P3|COMPLETED|Baseline Eligibility||0
344482|NCT01308424|825878|P2|COMPLETED|Baseline Eligibility||0
344483|NCT01308424|825879|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
344484|NCT01308424|825877|P3|STARTED|Baseline Eligibility||0
344485|NCT01308424|825878|P2|STARTED|Baseline Eligibility||0
344486|NCT01308424|825879|P1|STARTED|Baseline Eligibility||242
344487|NCT01307787|825888|P2|NOT COMPLETED|Overall Study||0
344488|NCT01307787|825889|P1|NOT COMPLETED|Overall Study||2
344489|NCT01307787|825888|P2|COMPLETED|Overall Study||15
344490|NCT01307787|825889|P1|COMPLETED|Overall Study||17
344491|NCT01307787|825888|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
344492|NCT01307787|825889|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
344493|NCT01307787|825888|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
344494|NCT01307787|825889|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
344495|NCT01307787|825888|P2|STARTED|Overall Study||15
344496|NCT01307787|825889|P1|STARTED|Overall Study||19
344497|NCT01307618|825911|P2|NOT COMPLETED|Overall Study||0
344498|NCT01307618|825912|P1|NOT COMPLETED|Overall Study||0
344499|NCT01307618|825911|P2|COMPLETED|Overall Study||5
344500|NCT01307618|825912|P1|COMPLETED|Overall Study||5
344501|NCT01307618|825911|P2|STARTED|Overall Study||5
344502|NCT01307618|825912|P1|STARTED|Overall Study||5
344503|NCT01307423|825931|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
344504|NCT01307423|825932|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
344505|NCT01307423|825933|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
344506|NCT01307423|825934|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
344507|NCT01307423|825935|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
344508|NCT01307423|825936|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
344509|NCT01307423|825937|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
344510|NCT01307423|825931|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
344511|NCT01307423|825932|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
344512|NCT01307423|825933|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
344513|NCT01307423|825934|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
344514|NCT01307423|825935|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
344515|NCT01307423|825936|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
344516|NCT01307423|825937|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
344517|NCT01307423|825931|P7|STARTED|Active Treatment Phase (Week 25-52)||26
344518|NCT01307423|825932|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
344519|NCT01307423|825933|P5|STARTED|Active Treatment Phase (Week 25-52)||26
344520|NCT01307423|825934|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
344521|NCT01307423|825935|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
344522|NCT01307423|825936|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
344523|NCT01307423|825937|P1|STARTED|Active Treatment Phase (Week 25-52)||0
344524|NCT01307423|825931|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344525|NCT01307423|825932|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344526|NCT01307423|825933|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344527|NCT01307423|825934|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344528|NCT01307423|825935|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
344529|NCT01307423|825936|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
344530|NCT01307423|825937|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
344531|NCT01307423|825931|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344532|NCT01307423|825932|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344533|NCT01307423|825933|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344534|NCT01307423|825934|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
344535|NCT01307423|825935|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
344536|NCT01307423|825936|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
344537|NCT01307423|825937|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
344538|NCT01307423|825931|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344539|NCT01307423|825932|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344540|NCT01307423|825933|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344541|NCT01307423|825934|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344542|NCT01307423|825935|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
344543|NCT01307423|825936|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
344544|NCT01307423|825937|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
344545|NCT01307423|825931|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344546|NCT01307423|825932|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344547|NCT01307423|825933|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344548|NCT01307423|825934|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
344549|NCT01307423|825935|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
344550|NCT01307423|825936|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
344551|NCT01307423|825937|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
344552|NCT01307423|825931|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
344553|NCT01307423|825932|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
344554|NCT01307423|825933|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
344555|NCT01307423|825934|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
344556|NCT01307423|825935|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
344557|NCT01307423|825936|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
344558|NCT01307423|825937|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
344559|NCT01307423|825931|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
344560|NCT01307423|825932|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
344561|NCT01307423|825933|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
344562|NCT01307423|825934|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
344563|NCT01307423|825935|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
344564|NCT01307423|825936|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
344565|NCT01307423|825937|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
344566|NCT01307319|826049|P3|NOT COMPLETED|Overall Study||7
344567|NCT01307319|826050|P2|NOT COMPLETED|Overall Study||8
344568|NCT01307319|826051|P1|NOT COMPLETED|Overall Study||4
344569|NCT01307319|826049|P3|COMPLETED|Overall Study||227
344570|NCT01307319|826050|P2|COMPLETED|Overall Study||234
344571|NCT01307319|826051|P1|COMPLETED|Overall Study||235
344572|NCT01307319|826049|P3|ITT Population|Overall Study||234
344573|NCT01307319|826050|P2|ITT Population|Overall Study||241
344574|NCT01307319|826051|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
344575|NCT01307319|826049|P3|Safety Population|Overall Study||234
344576|NCT01307319|826050|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
344577|NCT01307319|826051|P1|Safety Population|Overall Study||239
344578|NCT01307319|826049|P3|STARTED|Overall Study|Randomized|234
344579|NCT01307319|826050|P2|STARTED|Overall Study|Randomized|242
344580|NCT01307319|826051|P1|STARTED|Overall Study|Randomized|239
344581|NCT01307111|826065|P2|NOT COMPLETED|1-2 Week IUD Check up||2
344582|NCT01307111|826066|P1|NOT COMPLETED|1-2 Week IUD Check up||2
344583|NCT01307111|826065|P2|COMPLETED|1-2 Week IUD Check up||38
344584|NCT01307111|826066|P1|COMPLETED|1-2 Week IUD Check up||38
344585|NCT01307111|826065|P2|STARTED|1-2 Week IUD Check up||40
344586|NCT01307111|826066|P1|STARTED|1-2 Week IUD Check up||40
344587|NCT01307111|826065|P2|NOT COMPLETED|IUD Insertion||0
344588|NCT01307111|826066|P1|NOT COMPLETED|IUD Insertion||2
344589|NCT01307111|826065|P2|COMPLETED|IUD Insertion||40
344590|NCT01307111|826066|P1|COMPLETED|IUD Insertion||40
344591|NCT01307111|826065|P2|STARTED|IUD Insertion||40
344592|NCT01307111|826066|P1|STARTED|IUD Insertion||42
344593|NCT01307046|826076|P2|NOT COMPLETED|Overall Study||11
344594|NCT01307046|826077|P1|NOT COMPLETED|Overall Study||12
344595|NCT01307046|826076|P2|COMPLETED|Overall Study||159
344596|NCT01307046|826077|P1|COMPLETED|Overall Study||154
344597|NCT01307046|826076|P2|STARTED|Overall Study||170
344598|NCT01307046|826077|P1|STARTED|Overall Study||166
344599|NCT01307033|826089|P4|NOT COMPLETED|44-week Open-label Extension||12
344600|NCT01307033|826090|P3|NOT COMPLETED|44-week Open-label Extension||11
344601|NCT01307033|826091|P2|NOT COMPLETED|44-week Open-label Extension||0
344602|NCT01307033|826092|P1|NOT COMPLETED|44-week Open-label Extension||0
344603|NCT01307033|826089|P4|COMPLETED|44-week Open-label Extension||115
344604|NCT01307033|826090|P3|COMPLETED|44-week Open-label Extension||120
344605|NCT01307033|826091|P2|COMPLETED|44-week Open-label Extension||0
344606|NCT01307033|826092|P1|COMPLETED|44-week Open-label Extension||0
344607|NCT01307033|826089|P4|STARTED|44-week Open-label Extension||127
344608|NCT01307033|826090|P3|STARTED|44-week Open-label Extension||131
344609|NCT01307033|826091|P2|STARTED|44-week Open-label Extension||0
344610|NCT01307033|826092|P1|STARTED|44-week Open-label Extension||0
344611|NCT01307033|826089|P4|NOT COMPLETED|8-week Double-blind Period||0
344612|NCT01307033|826090|P3|NOT COMPLETED|8-week Double-blind Period||0
344613|NCT01307033|826091|P2|NOT COMPLETED|8-week Double-blind Period||7
344614|NCT01307033|826092|P1|NOT COMPLETED|8-week Double-blind Period||13
344615|NCT01307033|826089|P4|COMPLETED|8-week Double-blind Period||0
344616|NCT01307033|826090|P3|COMPLETED|8-week Double-blind Period||0
344617|NCT01307033|826091|P2|COMPLETED|8-week Double-blind Period||127
344618|NCT01307033|826092|P1|COMPLETED|8-week Double-blind Period||131
344619|NCT01307033|826089|P4|STARTED|8-week Double-blind Period||0
344620|NCT01307033|826090|P3|STARTED|8-week Double-blind Period||0
344621|NCT01307033|826091|P2|STARTED|8-week Double-blind Period||134
344622|NCT01307033|826092|P1|STARTED|8-week Double-blind Period||144
344623|NCT01307020|826114|P10|NOT COMPLETED|Overall Study||0
344624|NCT01307020|826115|P9|NOT COMPLETED|Overall Study||0
344625|NCT01307020|826116|P8|NOT COMPLETED|Overall Study||0
344626|NCT01307020|826117|P7|NOT COMPLETED|Overall Study||1
344627|NCT01307020|826118|P6|NOT COMPLETED|Overall Study||0
344628|NCT01307020|826119|P5|NOT COMPLETED|Overall Study||0
344629|NCT01307020|826120|P4|NOT COMPLETED|Overall Study||1
344630|NCT01307020|826121|P3|NOT COMPLETED|Overall Study||1
344631|NCT01307020|826122|P2|NOT COMPLETED|Overall Study||1
344632|NCT01307020|826123|P1|NOT COMPLETED|Overall Study||0
344633|NCT01307020|826114|P10|COMPLETED|Overall Study||62
344634|NCT01307020|826115|P9|COMPLETED|Overall Study||61
344635|NCT01307020|826116|P8|COMPLETED|Overall Study||60
344636|NCT01307020|826117|P7|COMPLETED|Overall Study||58
344637|NCT01307020|826118|P6|COMPLETED|Overall Study||61
344638|NCT01307020|826119|P5|COMPLETED|Overall Study||60
344639|NCT01307020|826120|P4|COMPLETED|Overall Study||60
344640|NCT01307020|826121|P3|COMPLETED|Overall Study||62
344641|NCT01307020|826122|P2|COMPLETED|Overall Study||62
344642|NCT01307020|826123|P1|COMPLETED|Overall Study||61
344643|NCT01307020|826114|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
344644|NCT01307020|826115|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
344645|NCT01307020|826116|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
344646|NCT01307020|826117|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
344647|NCT01307020|826118|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
344648|NCT01307020|826119|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
344649|NCT01307020|826120|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
344650|NCT01307020|826121|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
344651|NCT01307020|826122|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
344652|NCT01307020|826123|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
344653|NCT01307020|826114|P10|Safety Population|Overall Study||62
344654|NCT01307020|826115|P9|Safety Population|Overall Study||61
344655|NCT01307020|826116|P8|Safety Population|Overall Study||60
344656|NCT01307020|826117|P7|Safety Population|Overall Study||59
344657|NCT01307020|826118|P6|Safety Population|Overall Study||61
344658|NCT01307020|826119|P5|Safety Population|Overall Study||60
344659|NCT01307020|826120|P4|Safety Population|Overall Study||61
344660|NCT01307020|826121|P3|Safety Population|Overall Study||63
344661|NCT01307020|826122|P2|Safety Population|Overall Study||63
344662|NCT01307020|826123|P1|Safety Population|Overall Study||61
344663|NCT01307020|826114|P10|STARTED|Overall Study||62
344664|NCT01307020|826115|P9|STARTED|Overall Study||61
344665|NCT01307020|826116|P8|STARTED|Overall Study||60
344666|NCT01307020|826117|P7|STARTED|Overall Study||59
344667|NCT01307020|826118|P6|STARTED|Overall Study||61
344668|NCT01307020|826119|P5|STARTED|Overall Study||60
344669|NCT01307020|826120|P4|STARTED|Overall Study||61
344670|NCT01307020|826121|P3|STARTED|Overall Study||63
344671|NCT01307020|826122|P2|STARTED|Overall Study||63
344672|NCT01307020|826123|P1|STARTED|Overall Study||61
344673|NCT01306968|826169|P4|NOT COMPLETED|Overall Study||4
344674|NCT01306968|826170|P3|NOT COMPLETED|Overall Study||1
344675|NCT01306968|826171|P2|NOT COMPLETED|Overall Study||3
344676|NCT01306968|826172|P1|NOT COMPLETED|Overall Study||1
344677|NCT01306968|826169|P4|COMPLETED|Overall Study||21
344678|NCT01306968|826170|P3|COMPLETED|Overall Study||23
344679|NCT01306968|826171|P2|COMPLETED|Overall Study||20
344680|NCT01306968|826172|P1|COMPLETED|Overall Study||6
344681|NCT01306968|826169|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
344682|NCT01306968|826170|P3|STARTED|Overall Study||24
344683|NCT01306968|826171|P2|STARTED|Overall Study||23
344684|NCT01306968|826172|P1|STARTED|Overall Study||7
344685|NCT01306877|826196|P2|NOT COMPLETED|Overall Study||4
344686|NCT01306877|826197|P1|NOT COMPLETED|Overall Study||3
344687|NCT01306877|826196|P2|COMPLETED|Overall Study||67
344688|NCT01306877|826197|P1|COMPLETED|Overall Study||75
344689|NCT01306877|826196|P2|STARTED|Overall Study||71
344690|NCT01306877|826197|P1|STARTED|Overall Study||78
344691|NCT01306643|826215|P1|NOT COMPLETED|Overall Study||13
344692|NCT01306643|826215|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
344693|NCT01306643|826215|P1|STARTED|Overall Study||18
344694|NCT01306617|826227|P3|NOT COMPLETED|Overall Study||5
344695|NCT01306617|826228|P2|NOT COMPLETED|Overall Study||1
344696|NCT01306617|826229|P1|NOT COMPLETED|Overall Study||1
344697|NCT01306617|826227|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
344698|NCT01306617|826228|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
344699|NCT01306617|826229|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
344700|NCT01306617|826227|P3|STARTED|Overall Study||17
344701|NCT01306617|826228|P2|STARTED|Overall Study||14
344702|NCT01306617|826229|P1|STARTED|Overall Study||19
344703|NCT01306305|826272|P2|NOT COMPLETED|Overall Study||0
344704|NCT01306305|826273|P1|NOT COMPLETED|Overall Study||2
344705|NCT01306305|826272|P2|COMPLETED|Overall Study||55
344706|NCT01306305|826273|P1|COMPLETED|Overall Study||53
344707|NCT01306305|826272|P2|STARTED|Overall Study||55
344708|NCT01306305|826273|P1|STARTED|Overall Study||55
344709|NCT01306292|826289|P4|NOT COMPLETED|Second Injection||0
344710|NCT01306292|826290|P3|NOT COMPLETED|Second Injection||1
344711|NCT01306292|826291|P2|NOT COMPLETED|Second Injection||0
344712|NCT01306292|826292|P1|NOT COMPLETED|Second Injection||0
344713|NCT01306292|826289|P4|COMPLETED|Second Injection||10
344804|NCT01306162|826369|P4|STARTED|Period 3||8
344714|NCT01306292|826290|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
344715|NCT01306292|826291|P2|COMPLETED|Second Injection||8
344716|NCT01306292|826292|P1|COMPLETED|Second Injection||10
344717|NCT01306292|826289|P4|STARTED|Second Injection||10
344718|NCT01306292|826290|P3|STARTED|Second Injection||8
344719|NCT01306292|826291|P2|STARTED|Second Injection||8
344720|NCT01306292|826292|P1|STARTED|Second Injection||10
344721|NCT01306292|826289|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
344722|NCT01306292|826290|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
344723|NCT01306292|826291|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
344724|NCT01306292|826292|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
344725|NCT01306292|826289|P4|COMPLETED|Washout (at Least 10 Minutes)||10
344726|NCT01306292|826290|P3|COMPLETED|Washout (at Least 10 Minutes)||8
344727|NCT01306292|826291|P2|COMPLETED|Washout (at Least 10 Minutes)||8
344728|NCT01306292|826292|P1|COMPLETED|Washout (at Least 10 Minutes)||10
344729|NCT01306292|826289|P4|STARTED|Washout (at Least 10 Minutes)||10
344730|NCT01306292|826290|P3|STARTED|Washout (at Least 10 Minutes)||8
344731|NCT01306292|826291|P2|STARTED|Washout (at Least 10 Minutes)||8
344732|NCT01306292|826292|P1|STARTED|Washout (at Least 10 Minutes)||10
344733|NCT01306292|826289|P4|NOT COMPLETED|First Injection||0
344734|NCT01306292|826290|P3|NOT COMPLETED|First Injection||0
344735|NCT01306292|826291|P2|NOT COMPLETED|First Injection||0
344736|NCT01306292|826292|P1|NOT COMPLETED|First Injection||0
344737|NCT01306292|826289|P4|COMPLETED|First Injection||10
344738|NCT01306292|826290|P3|COMPLETED|First Injection||8
344739|NCT01306292|826291|P2|COMPLETED|First Injection||8
344740|NCT01306292|826292|P1|COMPLETED|First Injection||10
344741|NCT01306292|826289|P4|STARTED|First Injection||10
344742|NCT01306292|826290|P3|STARTED|First Injection||8
344743|NCT01306292|826291|P2|STARTED|First Injection||8
344744|NCT01306292|826292|P1|STARTED|First Injection||10
344745|NCT01306253|826310|P2|NOT COMPLETED|Overall Study||1
344746|NCT01306253|826311|P1|NOT COMPLETED|Overall Study||1
344747|NCT01306253|826310|P2|COMPLETED|Overall Study||56
344748|NCT01306253|826311|P1|COMPLETED|Overall Study||56
344749|NCT01306253|826310|P2|STARTED|Overall Study||57
344750|NCT01306253|826311|P1|STARTED|Overall Study||57
344751|NCT01306214|826328|P3|NOT COMPLETED|Overall Study||22
344752|NCT01306214|826329|P2|NOT COMPLETED|Overall Study||28
344753|NCT01306214|826330|P1|NOT COMPLETED|Overall Study||28
344754|NCT01306214|826328|P3|COMPLETED|Overall Study||168
344755|NCT01306214|826329|P2|COMPLETED|Overall Study||159
344756|NCT01306214|826330|P1|COMPLETED|Overall Study||161
344757|NCT01306214|826328|P3|STARTED|Overall Study||190
344758|NCT01306214|826329|P2|STARTED|Overall Study||187
344759|NCT01306214|826330|P1|STARTED|Overall Study||189
344760|NCT01306201|826347|P1|NOT COMPLETED|Overall Study||10
344761|NCT01306201|826347|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
344762|NCT01306201|826347|P1|STARTED|Overall Study||63
344763|NCT01306175|826355|P1|NOT COMPLETED|Second Intervention||0
344764|NCT01306175|826355|P1|COMPLETED|Second Intervention||20
344765|NCT01306175|826355|P1|STARTED|Second Intervention||20
344766|NCT01306175|826355|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
344767|NCT01306175|826355|P1|COMPLETED|Washout Period of at Least 14 Days||20
344768|NCT01306175|826355|P1|STARTED|Washout Period of at Least 14 Days||20
344769|NCT01306175|826355|P1|NOT COMPLETED|First Intervention||0
344770|NCT01306175|826355|P1|COMPLETED|First Intervention||20
344771|NCT01306175|826355|P1|STARTED|First Intervention||20
344772|NCT01306162|826369|P4|NOT COMPLETED|Period 4||0
344773|NCT01306162|826370|P3|NOT COMPLETED|Period 4||0
344774|NCT01306162|826371|P2|NOT COMPLETED|Period 4||0
344775|NCT01306162|826372|P1|NOT COMPLETED|Period 4||0
344776|NCT01306162|826369|P4|COMPLETED|Period 4||8
344777|NCT01306162|826370|P3|COMPLETED|Period 4||9
344778|NCT01306162|826371|P2|COMPLETED|Period 4||8
344779|NCT01306162|826372|P1|COMPLETED|Period 4||9
344780|NCT01306162|826369|P4|STARTED|Period 4||8
344781|NCT01306162|826370|P3|STARTED|Period 4||9
344782|NCT01306162|826371|P2|STARTED|Period 4||8
344783|NCT01306162|826372|P1|STARTED|Period 4||9
344784|NCT01306162|826369|P4|NOT COMPLETED|Washout 2||0
344785|NCT01306162|826370|P3|NOT COMPLETED|Washout 2||0
344786|NCT01306162|826371|P2|NOT COMPLETED|Washout 2||0
344787|NCT01306162|826372|P1|NOT COMPLETED|Washout 2||0
344788|NCT01306162|826369|P4|COMPLETED|Washout 2||8
344789|NCT01306162|826370|P3|COMPLETED|Washout 2||9
344790|NCT01306162|826371|P2|COMPLETED|Washout 2||8
344791|NCT01306162|826372|P1|COMPLETED|Washout 2||9
344792|NCT01306162|826369|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
344793|NCT01306162|826370|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
344794|NCT01306162|826371|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
344795|NCT01306162|826372|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
344796|NCT01306162|826369|P4|NOT COMPLETED|Period 3||0
344797|NCT01306162|826370|P3|NOT COMPLETED|Period 3||0
344798|NCT01306162|826371|P2|NOT COMPLETED|Period 3||0
344799|NCT01306162|826372|P1|NOT COMPLETED|Period 3||0
344800|NCT01306162|826369|P4|COMPLETED|Period 3||8
344801|NCT01306162|826370|P3|COMPLETED|Period 3||9
344802|NCT01306162|826371|P2|COMPLETED|Period 3||8
344803|NCT01306162|826372|P1|COMPLETED|Period 3||9
344805|NCT01306162|826370|P3|STARTED|Period 3||9
344806|NCT01306162|826371|P2|STARTED|Period 3||8
344807|NCT01306162|826372|P1|STARTED|Period 3||9
344808|NCT01306162|826369|P4|NOT COMPLETED|Period 2||0
344809|NCT01306162|826370|P3|NOT COMPLETED|Period 2||0
344810|NCT01306162|826371|P2|NOT COMPLETED|Period 2||0
344811|NCT01306162|826372|P1|NOT COMPLETED|Period 2||0
344812|NCT01306162|826369|P4|COMPLETED|Period 2||8
344813|NCT01306162|826370|P3|COMPLETED|Period 2||9
344814|NCT01306162|826371|P2|COMPLETED|Period 2||8
344815|NCT01306162|826372|P1|COMPLETED|Period 2||9
344816|NCT01306162|826369|P4|STARTED|Period 2|No washout phase after Period 2.|8
344817|NCT01306162|826370|P3|STARTED|Period 2|No washout phase after Period 2.|9
344818|NCT01306162|826371|P2|STARTED|Period 2|No washout phase after Period 2.|8
344819|NCT01306162|826372|P1|STARTED|Period 2|No washout phase after Period 2.|9
344820|NCT01306162|826369|P4|NOT COMPLETED|Washout 1||0
344821|NCT01306162|826370|P3|NOT COMPLETED|Washout 1||0
344822|NCT01306162|826371|P2|NOT COMPLETED|Washout 1||1
344823|NCT01306162|826372|P1|NOT COMPLETED|Washout 1||0
344824|NCT01306162|826369|P4|COMPLETED|Washout 1||8
344825|NCT01306162|826370|P3|COMPLETED|Washout 1||9
344826|NCT01306162|826371|P2|COMPLETED|Washout 1||8
344827|NCT01306162|826372|P1|COMPLETED|Washout 1||9
344828|NCT01306162|826369|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
344829|NCT01306162|826370|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
344830|NCT01306162|826371|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
344831|NCT01306162|826372|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
344832|NCT01306162|826369|P4|NOT COMPLETED|Period 1||1
344833|NCT01306162|826370|P3|NOT COMPLETED|Period 1||0
344834|NCT01306162|826371|P2|NOT COMPLETED|Period 1||0
344835|NCT01306162|826372|P1|NOT COMPLETED|Period 1||0
344836|NCT01306162|826369|P4|COMPLETED|Period 1||8
344837|NCT01306162|826370|P3|COMPLETED|Period 1||9
344838|NCT01306162|826371|P2|COMPLETED|Period 1||9
344839|NCT01306162|826372|P1|COMPLETED|Period 1||9
344840|NCT01306162|826369|P4|STARTED|Period 1||9
344841|NCT01306162|826370|P3|STARTED|Period 1||9
344842|NCT01306162|826371|P2|STARTED|Period 1||9
344843|NCT01306162|826372|P1|STARTED|Period 1||9
344844|NCT01306032|826406|P6|NOT COMPLETED|Disease Progression/Crossover||0
344845|NCT01306032|826407|P5|NOT COMPLETED|Disease Progression/Crossover||0
344846|NCT01306032|826408|P4|NOT COMPLETED|Disease Progression/Crossover||3
344847|NCT01306032|826409|P3|NOT COMPLETED|Disease Progression/Crossover||0
344848|NCT01306032|826410|P2|NOT COMPLETED|Disease Progression/Crossover||2
344849|NCT01306032|826411|P1|NOT COMPLETED|Disease Progression/Crossover||0
344850|NCT01306032|826406|P6|COMPLETED|Disease Progression/Crossover||0
344851|NCT01306032|826407|P5|COMPLETED|Disease Progression/Crossover||0
344852|NCT01306032|826408|P4|COMPLETED|Disease Progression/Crossover||26
344853|NCT01306032|826409|P3|COMPLETED|Disease Progression/Crossover||0
344854|NCT01306032|826410|P2|COMPLETED|Disease Progression/Crossover||14
344855|NCT01306032|826411|P1|COMPLETED|Disease Progression/Crossover||0
344856|NCT01306032|826406|P6|STARTED|Disease Progression/Crossover||0
344857|NCT01306032|826407|P5|STARTED|Disease Progression/Crossover||0
344858|NCT01306032|826408|P4|STARTED|Disease Progression/Crossover||29
344859|NCT01306032|826409|P3|STARTED|Disease Progression/Crossover||0
344860|NCT01306032|826410|P2|STARTED|Disease Progression/Crossover||16
344861|NCT01306032|826411|P1|STARTED|Disease Progression/Crossover||0
344862|NCT01306032|826406|P6|NOT COMPLETED|First Intervention||2
344863|NCT01306032|826407|P5|NOT COMPLETED|First Intervention||2
344864|NCT01306032|826408|P4|NOT COMPLETED|First Intervention||1
344865|NCT01306032|826409|P3|NOT COMPLETED|First Intervention||2
344866|NCT01306032|826410|P2|NOT COMPLETED|First Intervention||2
344867|NCT01306032|826411|P1|NOT COMPLETED|First Intervention||1
344868|NCT01306032|826406|P6|COMPLETED|First Intervention||0
344869|NCT01306032|826407|P5|COMPLETED|First Intervention||0
344870|NCT01306032|826408|P4|COMPLETED|First Intervention||37
344871|NCT01306032|826409|P3|COMPLETED|First Intervention||35
344872|NCT01306032|826410|P2|COMPLETED|First Intervention||18
344873|NCT01306032|826411|P1|COMPLETED|First Intervention||21
344874|NCT01306032|826406|P6|STARTED|First Intervention||2
344875|NCT01306032|826407|P5|STARTED|First Intervention||2
344876|NCT01306032|826408|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
344877|NCT01306032|826409|P3|STARTED|First Intervention||37
344878|NCT01306032|826410|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
344879|NCT01306032|826411|P1|STARTED|First Intervention||22
344880|NCT01305811|826465|P2|NOT COMPLETED|Overall Study||11
344881|NCT01305811|826466|P1|NOT COMPLETED|Overall Study||8
344882|NCT01305811|826465|P2|COMPLETED|Overall Study||41
344883|NCT01305811|826466|P1|COMPLETED|Overall Study||44
344884|NCT01305811|826465|P2|STARTED|Overall Study||52
344885|NCT01305811|826466|P1|STARTED|Overall Study||52
344886|NCT01305772|826476|P2|NOT COMPLETED|Overall Study||0
344887|NCT01305772|826477|P1|NOT COMPLETED|Overall Study||0
344888|NCT01305772|826476|P2|COMPLETED|Overall Study||1
344889|NCT01305772|826477|P1|COMPLETED|Overall Study||5
344890|NCT01305772|826476|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
344980|NCT01304693|826711|P3|COMPLETED|Overall Study||47
344981|NCT01304693|826712|P2|COMPLETED|Overall Study||35
344891|NCT01305772|826477|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
344892|NCT01305772|826476|P2|Surgery/Biopsy #2|Overall Study||1
344893|NCT01305772|826477|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
344894|NCT01305772|826476|P2|Research PET/CT #2|Overall Study||1
344895|NCT01305772|826477|P1|Research PET/CT #2|Overall Study||5
344896|NCT01305772|826476|P2|Panitumumab Dose #1|Overall Study||1
344897|NCT01305772|826477|P1|Panitumumab Dose #1|Overall Study||5
344898|NCT01305772|826476|P2|Research PET/CT #1|Overall Study||1
344899|NCT01305772|826477|P1|Research PET/CT #1|Overall Study||5
344900|NCT01305772|826476|P2|Genomic Screening + Biopsy #1|Overall Study||1
344901|NCT01305772|826477|P1|Genomic Screening + Biopsy #1|Overall Study||5
344902|NCT01305772|826476|P2|STARTED|Overall Study||1
344903|NCT01305772|826477|P1|STARTED|Overall Study||5
344904|NCT01305655|826484|P1|NOT COMPLETED|Overall Study||0
344905|NCT01305655|826484|P1|COMPLETED|Overall Study|December 31, 2014|47
344906|NCT01305655|826484|P1|STARTED|Overall Study|July 2008|47
344907|NCT01305577|826491|P3|NOT COMPLETED|Overall Study||10
344908|NCT01305577|826492|P2|NOT COMPLETED|Overall Study||11
344909|NCT01305577|826493|P1|NOT COMPLETED|Overall Study||13
344910|NCT01305577|826491|P3|COMPLETED|Overall Study||112
344911|NCT01305577|826492|P2|COMPLETED|Overall Study||110
344912|NCT01305577|826493|P1|COMPLETED|Overall Study||107
344913|NCT01305577|826491|P3|Received Treatment|Overall Study||122
344914|NCT01305577|826492|P2|Received Treatment|Overall Study||121
344915|NCT01305577|826493|P1|Received Treatment|Overall Study||119
344916|NCT01305577|826491|P3|STARTED|Overall Study||122
344917|NCT01305577|826492|P2|STARTED|Overall Study||121
344918|NCT01305577|826493|P1|STARTED|Overall Study||120
344919|NCT01305564|826522|P1|NOT COMPLETED|Overall Study||37
344920|NCT01305564|826522|P1|COMPLETED|Overall Study||163
344921|NCT01305564|826522|P1|STARTED|Overall Study||200
344922|NCT01305473|826537|P1|NOT COMPLETED|Overall Study||0
344923|NCT01305473|826537|P1|COMPLETED|Overall Study||90
344924|NCT01305473|826537|P1|STARTED|Overall Study||90
344925|NCT01305408|826549|P2|NOT COMPLETED|Overall Study||31
344926|NCT01305408|826550|P1|NOT COMPLETED|Overall Study||32
344927|NCT01305408|826549|P2|COMPLETED|Overall Study||169
344928|NCT01305408|826550|P1|COMPLETED|Overall Study||167
344929|NCT01305408|826549|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
344930|NCT01305408|826550|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
344931|NCT01305408|826549|P2|Safety Population|Overall Study|Treated participants.|200
344932|NCT01305408|826550|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
344933|NCT01305408|826549|P2|STARTED|Overall Study||200
344934|NCT01305408|826550|P1|STARTED|Overall Study||199
344935|NCT01305265|826602|P2|NOT COMPLETED|Overall Study||6
344936|NCT01305265|826603|P1|NOT COMPLETED|Overall Study||2
344937|NCT01305265|826602|P2|COMPLETED|Overall Study||64
344938|NCT01305265|826603|P1|COMPLETED|Overall Study||69
344939|NCT01305265|826602|P2|STARTED|Overall Study||70
344940|NCT01305265|826603|P1|STARTED|Overall Study||71
344941|NCT01305252|826611|P2|NOT COMPLETED|Overall Study||0
344942|NCT01305252|826612|P1|NOT COMPLETED|Overall Study||1
344943|NCT01305252|826611|P2|COMPLETED|Overall Study||11
344944|NCT01305252|826612|P1|COMPLETED|Overall Study||9
344945|NCT01305252|826611|P2|STARTED|Overall Study||11
344946|NCT01305252|826612|P1|STARTED|Overall Study||10
344947|NCT01305239|826626|P1|NOT COMPLETED|Overall Study||23
344948|NCT01305239|826626|P1|COMPLETED|Overall Study||375
344949|NCT01305239|826626|P1|Intent to Treat Population|Overall Study||287
344950|NCT01305239|826626|P1|Safety Set|Overall Study||397
344951|NCT01305239|826626|P1|STARTED|Overall Study||398
344952|NCT01305200|826637|P3|NOT COMPLETED|Overall Study||3
344953|NCT01305200|826638|P2|NOT COMPLETED|Overall Study||31
344954|NCT01305200|826639|P1|NOT COMPLETED|Overall Study||29
344955|NCT01305200|826637|P3|COMPLETED|Overall Study||0
344956|NCT01305200|826638|P2|COMPLETED|Overall Study||81
344957|NCT01305200|826639|P1|COMPLETED|Overall Study||82
344958|NCT01305200|826637|P3|STARTED|Overall Study||3
344959|NCT01305200|826638|P2|STARTED|Overall Study||112
344960|NCT01305200|826639|P1|STARTED|Overall Study||111
344961|NCT01305044|826669|P2|NOT COMPLETED|Overall Study||6
344962|NCT01305044|826670|P1|NOT COMPLETED|Overall Study||3
344963|NCT01305044|826669|P2|COMPLETED|Overall Study||25
344964|NCT01305044|826670|P1|COMPLETED|Overall Study||29
344965|NCT01305044|826669|P2|STARTED|Overall Study||31
344966|NCT01305044|826670|P1|STARTED|Overall Study||32
344967|NCT01304966|826694|P1|NOT COMPLETED|Overall Study||0
344968|NCT01304966|826694|P1|COMPLETED|Overall Study||15
344969|NCT01304966|826694|P1|STARTED|Overall Study||15
344970|NCT01304706|826700|P1|NOT COMPLETED|Overall Study||17
344971|NCT01304706|826700|P1|COMPLETED|Overall Study||104
344972|NCT01304706|826700|P1|STARTED|Overall Study||121
344973|NCT01304693|826709|P5|NOT COMPLETED|Overall Study||1
344974|NCT01304693|826710|P4|NOT COMPLETED|Overall Study||1
344975|NCT01304693|826711|P3|NOT COMPLETED|Overall Study||1
344976|NCT01304693|826712|P2|NOT COMPLETED|Overall Study||0
344977|NCT01304693|826713|P1|NOT COMPLETED|Overall Study||0
344978|NCT01304693|826709|P5|COMPLETED|Overall Study||60
344979|NCT01304693|826710|P4|COMPLETED|Overall Study||39
344982|NCT01304693|826713|P1|COMPLETED|Overall Study||10
344983|NCT01304693|826709|P5|STARTED|Overall Study||61
344984|NCT01304693|826710|P4|STARTED|Overall Study||40
344985|NCT01304693|826711|P3|STARTED|Overall Study||48
344986|NCT01304693|826712|P2|STARTED|Overall Study||35
344987|NCT01304693|826713|P1|STARTED|Overall Study||10
344988|NCT01304641|826732|P2|NOT COMPLETED|Overall Study||0
344989|NCT01304641|826733|P1|NOT COMPLETED|Overall Study||0
344990|NCT01304641|826732|P2|COMPLETED|Overall Study||20132
344991|NCT01304641|826733|P1|COMPLETED|Overall Study||11470
344992|NCT01304641|826732|P2|STARTED|Overall Study||20132
344993|NCT01304641|826733|P1|STARTED|Overall Study||11470
344994|NCT01304589|826751|P1|NOT COMPLETED|Overall Study||13
344995|NCT01304589|826751|P1|COMPLETED|Overall Study||18
344996|NCT01304589|826751|P1|STARTED|Overall Study||31
344997|NCT01304329|826758|P6|NOT COMPLETED|Third Intervention (3 Days)||0
344998|NCT01304329|826759|P5|NOT COMPLETED|Third Intervention (3 Days)||0
344999|NCT01304329|826760|P4|NOT COMPLETED|Third Intervention (3 Days)||0
345000|NCT01304329|826761|P3|NOT COMPLETED|Third Intervention (3 Days)||0
345001|NCT01304329|826762|P2|NOT COMPLETED|Third Intervention (3 Days)||1
345002|NCT01304329|826763|P1|NOT COMPLETED|Third Intervention (3 Days)||0
345003|NCT01304329|826758|P6|COMPLETED|Third Intervention (3 Days)||3
345004|NCT01304329|826759|P5|COMPLETED|Third Intervention (3 Days)||3
345005|NCT01304329|826760|P4|COMPLETED|Third Intervention (3 Days)||3
345006|NCT01304329|826761|P3|COMPLETED|Third Intervention (3 Days)||3
345007|NCT01304329|826762|P2|COMPLETED|Third Intervention (3 Days)||2
345008|NCT01304329|826763|P1|COMPLETED|Third Intervention (3 Days)||3
345009|NCT01304329|826758|P6|STARTED|Third Intervention (3 Days)||3
345010|NCT01304329|826759|P5|STARTED|Third Intervention (3 Days)||3
345011|NCT01304329|826760|P4|STARTED|Third Intervention (3 Days)||3
345012|NCT01304329|826761|P3|STARTED|Third Intervention (3 Days)||3
345013|NCT01304329|826762|P2|STARTED|Third Intervention (3 Days)||3
345014|NCT01304329|826763|P1|STARTED|Third Intervention (3 Days)||3
345015|NCT01304329|826758|P6|NOT COMPLETED|Second Intervention (3 Days)||0
345016|NCT01304329|826759|P5|NOT COMPLETED|Second Intervention (3 Days)||0
345017|NCT01304329|826760|P4|NOT COMPLETED|Second Intervention (3 Days)||0
345018|NCT01304329|826761|P3|NOT COMPLETED|Second Intervention (3 Days)||0
345019|NCT01304329|826762|P2|NOT COMPLETED|Second Intervention (3 Days)||0
345020|NCT01304329|826763|P1|NOT COMPLETED|Second Intervention (3 Days)||0
345021|NCT01304329|826758|P6|COMPLETED|Second Intervention (3 Days)||3
345022|NCT01304329|826759|P5|COMPLETED|Second Intervention (3 Days)||3
345023|NCT01304329|826760|P4|COMPLETED|Second Intervention (3 Days)||3
345024|NCT01304329|826761|P3|COMPLETED|Second Intervention (3 Days)||3
345025|NCT01304329|826762|P2|COMPLETED|Second Intervention (3 Days)||3
345026|NCT01304329|826763|P1|COMPLETED|Second Intervention (3 Days)||3
345027|NCT01304329|826758|P6|STARTED|Second Intervention (3 Days)||3
345028|NCT01304329|826759|P5|STARTED|Second Intervention (3 Days)||3
345029|NCT01304329|826760|P4|STARTED|Second Intervention (3 Days)||3
345030|NCT01304329|826761|P3|STARTED|Second Intervention (3 Days)||3
345031|NCT01304329|826762|P2|STARTED|Second Intervention (3 Days)||3
345032|NCT01304329|826763|P1|STARTED|Second Intervention (3 Days)||3
345033|NCT01304329|826758|P6|NOT COMPLETED|First Intervention (3 Days)||0
345034|NCT01304329|826759|P5|NOT COMPLETED|First Intervention (3 Days)||0
345035|NCT01304329|826760|P4|NOT COMPLETED|First Intervention (3 Days)||0
345036|NCT01304329|826761|P3|NOT COMPLETED|First Intervention (3 Days)||0
345037|NCT01304329|826762|P2|NOT COMPLETED|First Intervention (3 Days)||0
345038|NCT01304329|826763|P1|NOT COMPLETED|First Intervention (3 Days)||0
345039|NCT01304329|826758|P6|COMPLETED|First Intervention (3 Days)||3
345040|NCT01304329|826759|P5|COMPLETED|First Intervention (3 Days)||3
345041|NCT01304329|826760|P4|COMPLETED|First Intervention (3 Days)||3
345042|NCT01304329|826761|P3|COMPLETED|First Intervention (3 Days)||3
345043|NCT01304329|826762|P2|COMPLETED|First Intervention (3 Days)||3
345044|NCT01304329|826763|P1|COMPLETED|First Intervention (3 Days)||3
345045|NCT01304329|826758|P6|STARTED|First Intervention (3 Days)||3
345046|NCT01304329|826759|P5|STARTED|First Intervention (3 Days)||3
345047|NCT01304329|826760|P4|STARTED|First Intervention (3 Days)||3
345048|NCT01304329|826761|P3|STARTED|First Intervention (3 Days)||3
345049|NCT01304329|826762|P2|STARTED|First Intervention (3 Days)||3
345050|NCT01304329|826763|P1|STARTED|First Intervention (3 Days)||3
345051|NCT01304277|826780|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
345052|NCT01304277|826780|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
345053|NCT01304277|826780|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
345054|NCT01304277|826780|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
345055|NCT01304277|826780|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
345056|NCT01304277|826780|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
345057|NCT01304238|826802|P10|NOT COMPLETED|Overall Study||0
345058|NCT01304238|826803|P9|NOT COMPLETED|Overall Study||0
345059|NCT01304238|826804|P8|NOT COMPLETED|Overall Study||0
345060|NCT01304238|826805|P7|NOT COMPLETED|Overall Study||0
345061|NCT01304238|826806|P6|NOT COMPLETED|Overall Study||0
345062|NCT01304238|826807|P5|NOT COMPLETED|Overall Study||0
345063|NCT01304238|826808|P4|NOT COMPLETED|Overall Study||0
345064|NCT01304238|826809|P3|NOT COMPLETED|Overall Study||0
345065|NCT01304238|826810|P2|NOT COMPLETED|Overall Study||0
345066|NCT01304238|826811|P1|NOT COMPLETED|Overall Study||0
345067|NCT01304238|826802|P10|COMPLETED|Overall Study||3
345068|NCT01304238|826803|P9|COMPLETED|Overall Study||1
345069|NCT01304238|826804|P8|COMPLETED|Overall Study||4
345070|NCT01304238|826805|P7|COMPLETED|Overall Study||5
345071|NCT01304238|826806|P6|COMPLETED|Overall Study||11
345072|NCT01304238|826807|P5|COMPLETED|Overall Study||11
345073|NCT01304238|826808|P4|COMPLETED|Overall Study||78
345074|NCT01304238|826809|P3|COMPLETED|Overall Study||46
345075|NCT01304238|826810|P2|COMPLETED|Overall Study||4
345076|NCT01304238|826811|P1|COMPLETED|Overall Study||32
345077|NCT01304238|826802|P10|STARTED|Overall Study||3
345078|NCT01304238|826803|P9|STARTED|Overall Study||1
345079|NCT01304238|826804|P8|STARTED|Overall Study||4
345080|NCT01304238|826805|P7|STARTED|Overall Study||5
345081|NCT01304238|826806|P6|STARTED|Overall Study||11
345082|NCT01304238|826807|P5|STARTED|Overall Study||11
345083|NCT01304238|826808|P4|STARTED|Overall Study||78
345084|NCT01304238|826809|P3|STARTED|Overall Study||46
345085|NCT01304238|826810|P2|STARTED|Overall Study||4
345086|NCT01304238|826811|P1|STARTED|Overall Study||32
345087|NCT01304147|826883|P2|NOT COMPLETED|Second Intervention (7days)||1
345088|NCT01304147|826884|P1|NOT COMPLETED|Second Intervention (7days)||1
345089|NCT01304147|826883|P2|COMPLETED|Second Intervention (7days)||9
345090|NCT01304147|826884|P1|COMPLETED|Second Intervention (7days)||9
345091|NCT01304147|826883|P2|STARTED|Second Intervention (7days)||10
345092|NCT01304147|826884|P1|STARTED|Second Intervention (7days)||10
345093|NCT01304147|826883|P2|NOT COMPLETED|Washout (1 Day)||0
345094|NCT01304147|826884|P1|NOT COMPLETED|Washout (1 Day)||0
345095|NCT01304147|826883|P2|COMPLETED|Washout (1 Day)||10
345096|NCT01304147|826884|P1|COMPLETED|Washout (1 Day)||10
345097|NCT01304147|826883|P2|STARTED|Washout (1 Day)||10
345098|NCT01304147|826884|P1|STARTED|Washout (1 Day)||10
345099|NCT01304147|826883|P2|NOT COMPLETED|First Intervention (7days)||0
345100|NCT01304147|826884|P1|NOT COMPLETED|First Intervention (7days)||0
345101|NCT01304147|826883|P2|COMPLETED|First Intervention (7days)||10
345102|NCT01304147|826884|P1|COMPLETED|First Intervention (7days)||10
345103|NCT01304147|826883|P2|STARTED|First Intervention (7days)||10
345104|NCT01304147|826884|P1|STARTED|First Intervention (7days)||10
345105|NCT01304082|826892|P5|NOT COMPLETED|Overall Study||0
345106|NCT01304082|826893|P4|NOT COMPLETED|Overall Study||0
345107|NCT01304082|826894|P3|NOT COMPLETED|Overall Study||0
345108|NCT01304082|826895|P2|NOT COMPLETED|Overall Study||0
345109|NCT01304082|826896|P1|NOT COMPLETED|Overall Study||0
345110|NCT01304082|826892|P5|COMPLETED|Overall Study||5
345111|NCT01304082|826893|P4|COMPLETED|Overall Study||8
345112|NCT01304082|826894|P3|COMPLETED|Overall Study||11
345113|NCT01304082|826895|P2|COMPLETED|Overall Study||2
345114|NCT01304082|826896|P1|COMPLETED|Overall Study||3
345115|NCT01304082|826892|P5|Third Intervention|Overall Study||5
345116|NCT01304082|826893|P4|Third Intervention|Overall Study||8
345117|NCT01304082|826894|P3|Third Intervention|Overall Study||11
345118|NCT01304082|826895|P2|Third Intervention|Overall Study||2
345119|NCT01304082|826896|P1|Third Intervention|Overall Study||3
345120|NCT01304082|826892|P5|Second Intervention|Overall Study||5
345121|NCT01304082|826893|P4|Second Intervention|Overall Study||8
345122|NCT01304082|826894|P3|Second Intervention|Overall Study||11
345123|NCT01304082|826895|P2|Second Intervention|Overall Study||2
345124|NCT01304082|826896|P1|Second Intervention|Overall Study||3
345125|NCT01304082|826892|P5|First Intervention|Overall Study||5
345126|NCT01304082|826893|P4|First Intervention|Overall Study||8
345127|NCT01304082|826894|P3|First Intervention|Overall Study||11
345128|NCT01304082|826895|P2|First Intervention|Overall Study||2
345129|NCT01304082|826896|P1|First Intervention|Overall Study||3
345130|NCT01304082|826892|P5|STARTED|Overall Study||5
345131|NCT01304082|826893|P4|STARTED|Overall Study||8
345132|NCT01304082|826894|P3|STARTED|Overall Study||11
345133|NCT01304082|826895|P2|STARTED|Overall Study||2
345134|NCT01304082|826896|P1|STARTED|Overall Study||3
345135|NCT01303861|826918|P4|NOT COMPLETED|Overall Study||59
345136|NCT01303861|826919|P3|NOT COMPLETED|Overall Study||36
345137|NCT01303861|826920|P2|NOT COMPLETED|Overall Study||25
345138|NCT01303861|826921|P1|NOT COMPLETED|Overall Study||58
345139|NCT01303861|826918|P4|COMPLETED|Overall Study||54
345140|NCT01303861|826919|P3|COMPLETED|Overall Study||19
345141|NCT01303861|826920|P2|COMPLETED|Overall Study||25
345142|NCT01303861|826921|P1|COMPLETED|Overall Study||51
345143|NCT01303861|826918|P4|Finished Treatment Phase|Overall Study||72
345144|NCT01303861|826919|P3|Finished Treatment Phase|Overall Study||39
345145|NCT01303861|826920|P2|Finished Treatment Phase|Overall Study||34
345146|NCT01303861|826921|P1|Finished Treatment Phase|Overall Study||71
345147|NCT01303861|826918|P4|STARTED|Overall Study||113
345148|NCT01303861|826919|P3|STARTED|Overall Study||55
345149|NCT01303861|826920|P2|STARTED|Overall Study||50
345150|NCT01303861|826921|P1|STARTED|Overall Study||109
345151|NCT01303835|826942|P2|NOT COMPLETED|Overall Study||25
345152|NCT01303835|826943|P1|NOT COMPLETED|Overall Study||19
345153|NCT01303835|826942|P2|COMPLETED|Overall Study||31
345154|NCT01303835|826943|P1|COMPLETED|Overall Study||35
345155|NCT01303835|826942|P2|STARTED|Overall Study||56
345156|NCT01303835|826943|P1|STARTED|Overall Study||54
345157|NCT01303744|826957|P4|NOT COMPLETED|Overall Study||0
345158|NCT01303744|826958|P3|NOT COMPLETED|Overall Study||0
345159|NCT01303744|826959|P2|NOT COMPLETED|Overall Study||0
345160|NCT01303744|826960|P1|NOT COMPLETED|Overall Study||0
345161|NCT01303744|826957|P4|COMPLETED|Overall Study||24
345162|NCT01303744|826958|P3|COMPLETED|Overall Study||24
345163|NCT01303744|826959|P2|COMPLETED|Overall Study||24
345164|NCT01303744|826960|P1|COMPLETED|Overall Study||24
345165|NCT01303744|826957|P4|STARTED|Overall Study||24
345166|NCT01303744|826958|P3|STARTED|Overall Study||24
345167|NCT01303744|826959|P2|STARTED|Overall Study||24
345168|NCT01303744|826960|P1|STARTED|Overall Study||24
345169|NCT01303627|826980|P2|NOT COMPLETED|Overall Study||1
345170|NCT01303627|826981|P1|NOT COMPLETED|Overall Study||0
345171|NCT01303627|826980|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
345172|NCT01303627|826981|P1|COMPLETED|Overall Study||21
345173|NCT01303627|826980|P2|STARTED|Overall Study||21
345174|NCT01303627|826981|P1|STARTED|Overall Study||21
345175|NCT01303510|826989|P2|NOT COMPLETED|Overall Study||0
345176|NCT01303510|826990|P1|NOT COMPLETED|Overall Study||1
345177|NCT01303510|826989|P2|COMPLETED|Overall Study||56
345178|NCT01303510|826990|P1|COMPLETED|Overall Study||54
345179|NCT01303510|826989|P2|STARTED|Overall Study||56
345180|NCT01303510|826990|P1|STARTED|Overall Study||55
345181|NCT01303445|827004|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
345182|NCT01303445|827005|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
345183|NCT01303445|827004|P2|COMPLETED|Follow-up Period (14 Days)||25
345184|NCT01303445|827005|P1|COMPLETED|Follow-up Period (14 Days)||26
345185|NCT01303445|827004|P2|STARTED|Follow-up Period (14 Days)||26
345186|NCT01303445|827005|P1|STARTED|Follow-up Period (14 Days)||26
345187|NCT01303445|827004|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
345188|NCT01303445|827005|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
345189|NCT01303445|827004|P2|COMPLETED|Fourth Intervention (7 Days)||26
345190|NCT01303445|827005|P1|COMPLETED|Fourth Intervention (7 Days)||26
345191|NCT01303445|827004|P2|STARTED|Fourth Intervention (7 Days)||26
345192|NCT01303445|827005|P1|STARTED|Fourth Intervention (7 Days)||27
345193|NCT01303445|827004|P2|NOT COMPLETED|Third Intervention (7 Days)||0
345194|NCT01303445|827005|P1|NOT COMPLETED|Third Intervention (7 Days)||0
345195|NCT01303445|827004|P2|COMPLETED|Third Intervention (7 Days)||26
345196|NCT01303445|827005|P1|COMPLETED|Third Intervention (7 Days)||27
345197|NCT01303445|827004|P2|STARTED|Third Intervention (7 Days)||26
345198|NCT01303445|827005|P1|STARTED|Third Intervention (7 Days)||27
345199|NCT01303445|827004|P2|NOT COMPLETED|Washout (14 Days)||2
345200|NCT01303445|827005|P1|NOT COMPLETED|Washout (14 Days)||1
345201|NCT01303445|827004|P2|COMPLETED|Washout (14 Days)||26
345202|NCT01303445|827005|P1|COMPLETED|Washout (14 Days)||27
345203|NCT01303445|827004|P2|STARTED|Washout (14 Days)||28
345204|NCT01303445|827005|P1|STARTED|Washout (14 Days)||28
345205|NCT01303445|827004|P2|NOT COMPLETED|Second Intervention (7 Days)||2
345206|NCT01303445|827005|P1|NOT COMPLETED|Second Intervention (7 Days)||1
345207|NCT01303445|827004|P2|COMPLETED|Second Intervention (7 Days)||28
345208|NCT01303445|827005|P1|COMPLETED|Second Intervention (7 Days)||28
345209|NCT01303445|827004|P2|STARTED|Second Intervention (7 Days)||30
345210|NCT01303445|827005|P1|STARTED|Second Intervention (7 Days)||29
345211|NCT01303445|827004|P2|NOT COMPLETED|First Intervention (7 Days)||0
345212|NCT01303445|827005|P1|NOT COMPLETED|First Intervention (7 Days)||1
345213|NCT01303445|827004|P2|COMPLETED|First Intervention (7 Days)||30
345214|NCT01303445|827005|P1|COMPLETED|First Intervention (7 Days)||29
345215|NCT01303445|827004|P2|STARTED|First Intervention (7 Days)||30
345216|NCT01303445|827005|P1|STARTED|First Intervention (7 Days)||30
345217|NCT01303406|827037|P2|NOT COMPLETED|Overall Study||1
345218|NCT01303406|827038|P1|NOT COMPLETED|Overall Study||0
345219|NCT01303406|827037|P2|COMPLETED|Overall Study||15
345220|NCT01303406|827038|P1|COMPLETED|Overall Study||13
345221|NCT01303406|827037|P2|STARTED|Overall Study||16
345222|NCT01303406|827038|P1|STARTED|Overall Study||13
345223|NCT01303380|827046|P1|NOT COMPLETED|Overall Study||1
345224|NCT01303380|827046|P1|COMPLETED|Overall Study||8
345225|NCT01303380|827046|P1|STARTED|Overall Study||9
345226|NCT01303224|827076|P4|NOT COMPLETED|Overall Study||10
345227|NCT01303224|827077|P3|NOT COMPLETED|Overall Study||6
345228|NCT01303224|827078|P2|NOT COMPLETED|Overall Study||11
345229|NCT01303224|827079|P1|NOT COMPLETED|Overall Study||11
345230|NCT01303224|827076|P4|COMPLETED|Overall Study||133
345231|NCT01303224|827077|P3|COMPLETED|Overall Study||133
345232|NCT01303224|827078|P2|COMPLETED|Overall Study||131
345233|NCT01303224|827079|P1|COMPLETED|Overall Study||130
345234|NCT01303224|827076|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
345235|NCT01303224|827077|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
345236|NCT01303224|827078|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
345237|NCT01303224|827079|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
345238|NCT01303224|827076|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
345239|NCT01303224|827077|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
345240|NCT01303224|827078|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
345241|NCT01303224|827079|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
345242|NCT01303159|827105|P1|NOT COMPLETED|Overall Study||23
345243|NCT01303159|827105|P1|COMPLETED|Overall Study||6
345244|NCT01303159|827105|P1|STARTED|Overall Study||29
345245|NCT01302938|827112|P2|NOT COMPLETED|Overall Study||0
345246|NCT01302938|827113|P1|NOT COMPLETED|Overall Study||2
345247|NCT01302938|827112|P2|COMPLETED|Overall Study||6
345248|NCT01302938|827113|P1|COMPLETED|Overall Study||10
345249|NCT01302938|827112|P2|STARTED|Overall Study||6
345250|NCT01302938|827113|P1|STARTED|Overall Study||12
345251|NCT01302899|827158|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
345252|NCT01302899|827159|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
345253|NCT01302899|827158|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
345254|NCT01302899|827159|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
345255|NCT01302899|827158|P2|STARTED|Period 4 (Weeks 19 to 26)||3
345256|NCT01302899|827159|P1|STARTED|Period 4 (Weeks 19 to 26)||3
345257|NCT01302899|827158|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
345258|NCT01302899|827159|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
345259|NCT01302899|827158|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
345260|NCT01302899|827159|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
345261|NCT01302899|827158|P2|STARTED|Period 3 (Weeks 13 to 18)||3
345262|NCT01302899|827159|P1|STARTED|Period 3 (Weeks 13 to 18)||3
345263|NCT01302899|827158|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
345264|NCT01302899|827159|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
345265|NCT01302899|827158|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
345266|NCT01302899|827159|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
345267|NCT01302899|827158|P2|STARTED|Period 2 (Weeks 7 to 12)||4
345268|NCT01302899|827159|P1|STARTED|Period 2 (Weeks 7 to 12)||4
345269|NCT01302899|827158|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
345270|NCT01302899|827159|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
345271|NCT01302899|827158|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
345272|NCT01302899|827159|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
345273|NCT01302899|827158|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
345274|NCT01302899|827159|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
345275|NCT01302860|827209|P1|NOT COMPLETED|Overall Study||0
345276|NCT01302860|827209|P1|COMPLETED|Overall Study||17
345277|NCT01302860|827209|P1|STARTED|Overall Study||17
345278|NCT01302743|827224|P3|NOT COMPLETED|Overall Study||2
345279|NCT01302743|827225|P2|NOT COMPLETED|Overall Study||1
345280|NCT01302743|827226|P1|NOT COMPLETED|Overall Study||1
345281|NCT01302743|827224|P3|COMPLETED|Overall Study||8
345282|NCT01302743|827225|P2|COMPLETED|Overall Study||7
345283|NCT01302743|827226|P1|COMPLETED|Overall Study||6
345284|NCT01302743|827224|P3|STARTED|Overall Study||10
345285|NCT01302743|827225|P2|STARTED|Overall Study||8
345286|NCT01302743|827226|P1|STARTED|Overall Study||7
345287|NCT01302691|827239|P2|NOT COMPLETED|Overall Study||6
345288|NCT01302691|827240|P1|NOT COMPLETED|Overall Study||10
345289|NCT01302691|827239|P2|COMPLETED|Overall Study||157
345290|NCT01302691|827240|P1|COMPLETED|Overall Study||154
345291|NCT01302691|827239|P2|STARTED|Overall Study||163
345292|NCT01302691|827240|P1|STARTED|Overall Study||164
345293|NCT01302548|827260|P2|NOT COMPLETED|Overall Study||1
345294|NCT01302548|827261|P1|NOT COMPLETED|Overall Study||2
345295|NCT01302548|827260|P2|COMPLETED|Overall Study||18
345296|NCT01302548|827261|P1|COMPLETED|Overall Study||12
345297|NCT01302548|827260|P2|STARTED|Overall Study||19
345298|NCT01302548|827261|P1|STARTED|Overall Study||14
345299|NCT01302483|827273|P2|NOT COMPLETED|Overall Study||0
345300|NCT01302483|827274|P1|NOT COMPLETED|Overall Study||0
345301|NCT01302483|827273|P2|COMPLETED|Overall Study||15
345302|NCT01302483|827274|P1|COMPLETED|Overall Study||30
345303|NCT01302483|827273|P2|STARTED|Overall Study||15
345304|NCT01302483|827274|P1|STARTED|Overall Study||30
345305|NCT01302444|827290|P2|NOT COMPLETED|Overall Study||0
345306|NCT01302444|827291|P1|NOT COMPLETED|Overall Study||0
345307|NCT01302444|827290|P2|COMPLETED|Overall Study||0
345308|NCT01302444|827291|P1|COMPLETED|Overall Study||1
345309|NCT01302444|827290|P2|STARTED|Overall Study||0
345310|NCT01302444|827291|P1|STARTED|Overall Study||1
345311|NCT01302418|827311|P1|NOT COMPLETED|Overall Study||18
345312|NCT01302418|827311|P1|COMPLETED|Overall Study||254
345313|NCT01302418|827311|P1|STARTED|Overall Study||272
345314|NCT01302392|827317|P2|NOT COMPLETED|Overall Study||1
345315|NCT01302392|827318|P1|NOT COMPLETED|Overall Study||7
345316|NCT01302392|827317|P2|COMPLETED|Overall Study||156
345317|NCT01302392|827318|P1|COMPLETED|Overall Study||151
345318|NCT01302392|827317|P2|Treated|Overall Study||157
345319|NCT01302392|827318|P1|Treated|Overall Study||153
345320|NCT01302392|827317|P2|STARTED|Overall Study||157
345321|NCT01302392|827318|P1|STARTED|Overall Study||158
345322|NCT01302366|827338|P1|NOT COMPLETED|Overall Study||5
345323|NCT01302366|827338|P1|COMPLETED|Overall Study||15
345324|NCT01302366|827338|P1|STARTED|Overall Study||20
345325|NCT01302119|827346|P2|NOT COMPLETED|Overall Study||28
345326|NCT01302119|827347|P1|NOT COMPLETED|Overall Study||50
345327|NCT01302119|827346|P2|COMPLETED|Overall Study||177
345328|NCT01302119|827347|P1|COMPLETED|Overall Study||349
345329|NCT01302119|827346|P2|STARTED|Overall Study||205
345330|NCT01302119|827347|P1|STARTED|Overall Study||399
345331|NCT01302067|827362|P3|NOT COMPLETED|Overall Study||98
345332|NCT01302067|827363|P2|NOT COMPLETED|Overall Study||34
345333|NCT01302067|827364|P1|NOT COMPLETED|Overall Study||78
345334|NCT01302067|827362|P3|COMPLETED|Overall Study||681
345335|NCT01302067|827363|P2|COMPLETED|Overall Study||352
345336|NCT01302067|827364|P1|COMPLETED|Overall Study||712
345337|NCT01302067|827362|P3|STARTED|Overall Study||779
345338|NCT01302067|827363|P2|STARTED|Overall Study||386
345339|NCT01302067|827364|P1|STARTED|Overall Study||790
345340|NCT01302054|827435|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
345341|NCT01302054|827436|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
345342|NCT01302054|827437|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
345343|NCT01302054|827435|P3|COMPLETED|Double-Blind Treatment Phase||255
345344|NCT01302054|827436|P2|COMPLETED|Double-Blind Treatment Phase||281
345345|NCT01302054|827437|P1|COMPLETED|Double-Blind Treatment Phase||0
345346|NCT01302054|827435|P3|STARTED|Double-Blind Treatment Phase||301
345347|NCT01302054|827436|P2|STARTED|Double-Blind Treatment Phase||308
345348|NCT01302054|827437|P1|STARTED|Double-Blind Treatment Phase||0
345349|NCT01302054|827435|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
345350|NCT01302054|827436|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
345351|NCT01302054|827437|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
345352|NCT01302054|827435|P3|COMPLETED|Between Open-Label and Double Blind||0
345353|NCT01302054|827436|P2|COMPLETED|Between Open-Label and Double Blind||0
345354|NCT01302054|827437|P1|COMPLETED|Between Open-Label and Double Blind||609
345355|NCT01302054|827435|P3|STARTED|Between Open-Label and Double Blind||0
345356|NCT01302054|827436|P2|STARTED|Between Open-Label and Double Blind||0
345357|NCT01302054|827437|P1|STARTED|Between Open-Label and Double Blind||611
345358|NCT01302054|827435|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
345359|NCT01302054|827436|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
345360|NCT01302054|827437|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
345361|NCT01302054|827435|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
345362|NCT01302054|827436|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
345363|NCT01302054|827437|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
345364|NCT01302054|827435|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
345365|NCT01302054|827436|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
345366|NCT01302054|827437|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
345367|NCT01302041|827464|P1|NOT COMPLETED|Overall Study||50
345368|NCT01302041|827464|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|17
345369|NCT01302041|827464|P1|STARTED|Overall Study||67
345370|NCT01301963|827495|P2|NOT COMPLETED|Overall Study||0
345371|NCT01301963|827496|P1|NOT COMPLETED|Overall Study||0
345372|NCT01301963|827495|P2|COMPLETED|Overall Study||4
345373|NCT01301963|827496|P1|COMPLETED|Overall Study||5
345374|NCT01301963|827495|P2|STARTED|Overall Study||4
345375|NCT01301963|827496|P1|STARTED|Overall Study||5
345376|NCT01301950|827506|P2|NOT COMPLETED|Overall Study||1
345377|NCT01301950|827507|P1|NOT COMPLETED|Overall Study||0
345378|NCT01301950|827506|P2|COMPLETED|Overall Study||14
345379|NCT01301950|827507|P1|COMPLETED|Overall Study||15
345380|NCT01301950|827506|P2|STARTED|Overall Study||15
345381|NCT01301950|827507|P1|STARTED|Overall Study||15
345382|NCT01301833|827525|P4|NOT COMPLETED|Overall Study||7
345383|NCT01301833|827526|P3|NOT COMPLETED|Overall Study||7
345384|NCT01301833|827527|P2|NOT COMPLETED|Overall Study||8
345385|NCT01301833|827528|P1|NOT COMPLETED|Overall Study||15
345386|NCT01301833|827525|P4|COMPLETED|Overall Study||68
345387|NCT01301833|827526|P3|COMPLETED|Overall Study||88
345388|NCT01301833|827527|P2|COMPLETED|Overall Study||72
345389|NCT01301833|827528|P1|COMPLETED|Overall Study||197
345390|NCT01301833|827525|P4|STARTED|Overall Study||75
345391|NCT01301833|827526|P3|STARTED|Overall Study||95
345392|NCT01301833|827527|P2|STARTED|Overall Study||80
345393|NCT01301833|827528|P1|STARTED|Overall Study||212
345394|NCT01301742|827554|P2|NOT COMPLETED|Second Intervention||0
345395|NCT01301742|827555|P1|NOT COMPLETED|Second Intervention||0
345396|NCT01301742|827554|P2|COMPLETED|Second Intervention||9
345397|NCT01301742|827555|P1|COMPLETED|Second Intervention||9
345398|NCT01301742|827554|P2|STARTED|Second Intervention||9
345399|NCT01301742|827555|P1|STARTED|Second Intervention||9
345400|NCT01301742|827554|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
345401|NCT01301742|827555|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
345402|NCT01301742|827554|P2|COMPLETED|Washout Period of at Least 7 Days||9
345403|NCT01301742|827555|P1|COMPLETED|Washout Period of at Least 7 Days||9
345404|NCT01301742|827554|P2|STARTED|Washout Period of at Least 7 Days||9
345405|NCT01301742|827555|P1|STARTED|Washout Period of at Least 7 Days||9
345406|NCT01301742|827554|P2|NOT COMPLETED|First Intervention||0
345407|NCT01301742|827555|P1|NOT COMPLETED|First Intervention||0
345408|NCT01301742|827554|P2|COMPLETED|First Intervention||9
345409|NCT01301742|827555|P1|COMPLETED|First Intervention||9
345410|NCT01301742|827554|P2|STARTED|First Intervention||9
345411|NCT01301742|827555|P1|STARTED|First Intervention||9
345412|NCT01301729|827566|P1|NOT COMPLETED|Overall Study||4
345413|NCT01301729|827566|P1|COMPLETED|Overall Study||28
345414|NCT01301729|827566|P1|STARTED|Overall Study||32
345415|NCT01301508|827579|P2|NOT COMPLETED|Overall Study||3
345416|NCT01301508|827580|P1|NOT COMPLETED|Overall Study||1
345417|NCT01301508|827579|P2|COMPLETED|Overall Study||22
345418|NCT01301508|827580|P1|COMPLETED|Overall Study||20
345419|NCT01301508|827579|P2|STARTED|Overall Study||25
345420|NCT01301508|827580|P1|STARTED|Overall Study||21
345421|NCT01301274|827600|P2|NOT COMPLETED|Overall Study||1
345422|NCT01301274|827601|P1|NOT COMPLETED|Overall Study||2
345423|NCT01301274|827600|P2|COMPLETED|Overall Study||31
345424|NCT01301274|827601|P1|COMPLETED|Overall Study||32
345425|NCT01301274|827600|P2|STARTED|Overall Study||32
345426|NCT01301274|827601|P1|STARTED|Overall Study||34
345427|NCT01301092|827616|P3|NOT COMPLETED|Overall Study||1
345428|NCT01301092|827617|P2|NOT COMPLETED|Overall Study||0
345429|NCT01301092|827618|P1|NOT COMPLETED|Overall Study||0
345430|NCT01301092|827616|P3|COMPLETED|Overall Study||7
345431|NCT01301092|827617|P2|COMPLETED|Overall Study||16
345432|NCT01301092|827618|P1|COMPLETED|Overall Study||6
345433|NCT01301092|827616|P3|STARTED|Overall Study||8
345434|NCT01301092|827617|P2|STARTED|Overall Study||16
345435|NCT01301092|827618|P1|STARTED|Overall Study||6
345436|NCT01301079|827635|P2|NOT COMPLETED|Overall Study||2
345437|NCT01301079|827636|P1|NOT COMPLETED|Overall Study||2
345438|NCT01301079|827635|P2|COMPLETED|Overall Study||28
345439|NCT01301079|827636|P1|COMPLETED|Overall Study||28
345440|NCT01301079|827635|P2|STARTED|Overall Study||30
345441|NCT01301079|827636|P1|STARTED|Overall Study||30
345442|NCT01301066|827714|P2|NOT COMPLETED|Overall Study||35
345443|NCT01301066|827715|P1|NOT COMPLETED|Overall Study||27
345444|NCT01301066|827714|P2|COMPLETED|Overall Study||91
345445|NCT01301066|827715|P1|COMPLETED|Overall Study||99
345446|NCT01301066|827714|P2|STARTED|Overall Study||126
345447|NCT01301066|827715|P1|STARTED|Overall Study||126
345448|NCT01301027|827723|P2|NOT COMPLETED|Overall Study||10
345449|NCT01301027|827724|P1|NOT COMPLETED|Overall Study||8
345450|NCT01301027|827723|P2|COMPLETED|Overall Study||37
345451|NCT01301027|827724|P1|COMPLETED|Overall Study||40
345452|NCT01301027|827723|P2|STARTED|Overall Study||47
345453|NCT01301027|827724|P1|STARTED|Overall Study||48
345454|NCT01300923|827736|P2|NOT COMPLETED|Overall Study||2
345455|NCT01300923|827737|P1|NOT COMPLETED|Overall Study||0
345456|NCT01300923|827736|P2|COMPLETED|Overall Study||0
345457|NCT01300923|827737|P1|COMPLETED|Overall Study||12
345458|NCT01300923|827736|P2|STARTED|Overall Study||2
345459|NCT01300923|827737|P1|STARTED|Overall Study||12
345460|NCT01300819|827750|P2|NOT COMPLETED|Overall Study||44
345461|NCT01300819|827751|P1|NOT COMPLETED|Overall Study||22
345462|NCT01300819|827750|P2|COMPLETED|Overall Study||180
345463|NCT01300819|827751|P1|COMPLETED|Overall Study||103
345464|NCT01300819|827750|P2|STARTED|Overall Study||224
345465|NCT01300819|827751|P1|STARTED|Overall Study||125
345466|NCT01300767|827779|P1|NOT COMPLETED|Overall Study||4
345467|NCT01300767|827779|P1|COMPLETED|Overall Study||70
345468|NCT01300767|827779|P1|STARTED|Overall Study||74
345469|NCT01300741|827807|P1|NOT COMPLETED|Overall Study||3
345470|NCT01300741|827807|P1|COMPLETED|Overall Study||72
345471|NCT01300741|827807|P1|STARTED|Overall Study||75
345472|NCT01300728|827837|P2|NOT COMPLETED|Overall Study||1
345473|NCT01300728|827838|P1|NOT COMPLETED|Overall Study||2
345474|NCT01300728|827837|P2|COMPLETED|Overall Study||25
345475|NCT01300728|827838|P1|COMPLETED|Overall Study||24
345476|NCT01300728|827837|P2|STARTED|Overall Study||26
345477|NCT01300728|827838|P1|STARTED|Overall Study||26
345478|NCT01300650|827852|P1|NOT COMPLETED|Overall Study||1
345479|NCT01300650|827852|P1|COMPLETED|Overall Study||7
345480|NCT01300650|827852|P1|STARTED|Overall Study||8
345481|NCT01300624|827858|P1|NOT COMPLETED|Overall Study||0
345482|NCT01300624|827858|P1|COMPLETED|Overall Study||11
345483|NCT01300624|827858|P1|STARTED|Overall Study||11
345484|NCT01300559|827870|P2|NOT COMPLETED|Overall Study||0
345485|NCT01300559|827871|P1|NOT COMPLETED|Overall Study||0
345486|NCT01300559|827870|P2|COMPLETED|Overall Study||30
345487|NCT01300559|827871|P1|COMPLETED|Overall Study||30
345488|NCT01300559|827870|P2|STARTED|Overall Study||30
345489|NCT01300559|827871|P1|STARTED|Overall Study||30
345490|NCT01300546|827879|P2|NOT COMPLETED|Overall Study||6
345491|NCT01300546|827880|P1|NOT COMPLETED|Overall Study||1
345492|NCT01300546|827879|P2|COMPLETED|Overall Study||14
345493|NCT01300546|827880|P1|COMPLETED|Overall Study||18
345494|NCT01300546|827879|P2|STARTED|Overall Study||20
345495|NCT01300546|827880|P1|STARTED|Overall Study||19
345496|NCT01300455|827910|P2|NOT COMPLETED|Period 2||0
345497|NCT01300455|827911|P1|NOT COMPLETED|Period 2||0
345498|NCT01300455|827910|P2|COMPLETED|Period 2||13
345499|NCT01300455|827911|P1|COMPLETED|Period 2||12
345500|NCT01300455|827910|P2|STARTED|Period 2||13
345501|NCT01300455|827911|P1|STARTED|Period 2||12
345502|NCT01300455|827910|P2|NOT COMPLETED|Washout||0
345503|NCT01300455|827911|P1|NOT COMPLETED|Washout||1
345504|NCT01300455|827910|P2|COMPLETED|Washout||13
345505|NCT01300455|827911|P1|COMPLETED|Washout||12
345506|NCT01300455|827910|P2|STARTED|Washout||13
345507|NCT01300455|827911|P1|STARTED|Washout||13
345508|NCT01300455|827910|P2|NOT COMPLETED|Period 1||0
345509|NCT01300455|827911|P1|NOT COMPLETED|Period 1||0
345510|NCT01300455|827910|P2|COMPLETED|Period 1||13
345511|NCT01300455|827911|P1|COMPLETED|Period 1||13
345512|NCT01300455|827910|P2|STARTED|Period 1||13
345513|NCT01300455|827911|P1|STARTED|Period 1||13
345514|NCT01300351|827931|P2|NOT COMPLETED|Overall Study||38
345515|NCT01300351|827932|P1|NOT COMPLETED|Overall Study||36
345516|NCT01300351|827931|P2|COMPLETED|Overall Study||72
345517|NCT01300351|827932|P1|COMPLETED|Overall Study||75
345518|NCT01300351|827931|P2|Received Study Treatment|Overall Study||110
345519|NCT01300351|827932|P1|Received Study Treatment|Overall Study||109
345520|NCT01300351|827931|P2|STARTED|Overall Study||110
345521|NCT01300351|827932|P1|STARTED|Overall Study||111
345522|NCT01300338|827948|P2|NOT COMPLETED|Overall Study||0
345523|NCT01300338|827949|P1|NOT COMPLETED|Overall Study||5
345524|NCT01300338|827948|P2|COMPLETED|Overall Study||25
345525|NCT01300338|827949|P1|COMPLETED|Overall Study||20
345526|NCT01300338|827948|P2|STARTED|Overall Study||25
345527|NCT01300338|827949|P1|STARTED|Overall Study||25
345528|NCT01300286|827957|P1|NOT COMPLETED|Overall Study||1
345529|NCT01300286|827957|P1|COMPLETED|Overall Study||22
345530|NCT01300286|827957|P1|STARTED|Overall Study||23
345531|NCT01300260|827967|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
345532|NCT01300260|827968|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
345533|NCT01300260|827967|P2|COMPLETED|Period 2 of Study: Second Intervention||15
345534|NCT01300260|827968|P1|COMPLETED|Period 2 of Study: Second Intervention||14
345535|NCT01300260|827967|P2|STARTED|Period 2 of Study: Second Intervention||16
345536|NCT01300260|827968|P1|STARTED|Period 2 of Study: Second Intervention||14
345537|NCT01300260|827967|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
345538|NCT01300260|827968|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
345539|NCT01300260|827967|P2|COMPLETED|Washout Period of at Least 28 Days||16
345540|NCT01300260|827968|P1|COMPLETED|Washout Period of at Least 28 Days||14
345541|NCT01300260|827967|P2|STARTED|Washout Period of at Least 28 Days||16
345542|NCT01300260|827968|P1|STARTED|Washout Period of at Least 28 Days||14
345543|NCT01300260|827967|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
345544|NCT01300260|827968|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
345545|NCT01300260|827967|P2|COMPLETED|Period 1 of Study: First Intervention||16
345546|NCT01300260|827968|P1|COMPLETED|Period 1 of Study: First Intervention||14
345547|NCT01300260|827967|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
345548|NCT01300260|827968|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
345549|NCT01300260|827967|P2|STARTED|Period 1 of Study: First Intervention||17
345550|NCT01300260|827968|P1|STARTED|Period 1 of Study: First Intervention||15
345551|NCT01300247|828000|P2|NOT COMPLETED|Overall Study||2
345552|NCT01300247|828001|P1|NOT COMPLETED|Overall Study||4
345553|NCT01300247|828000|P2|COMPLETED|Overall Study||18
345554|NCT01300247|828001|P1|COMPLETED|Overall Study||17
345555|NCT01300247|828000|P2|STARTED|Overall Study||20
345556|NCT01300247|828001|P1|STARTED|Overall Study||21
345557|NCT01300234|828033|P2|NOT COMPLETED|Overall Study||10
345558|NCT01300234|828034|P1|NOT COMPLETED|Overall Study||4
345559|NCT01300234|828033|P2|COMPLETED|Overall Study||245
345560|NCT01300234|828034|P1|COMPLETED|Overall Study||253
345561|NCT01300234|828033|P2|STARTED|Overall Study||255
345562|NCT01300234|828034|P1|STARTED|Overall Study||257
345563|NCT01300052|828066|P2|NOT COMPLETED|Overall Study||3
345564|NCT01300052|828067|P1|NOT COMPLETED|Overall Study||6
345565|NCT01300052|828066|P2|COMPLETED|Overall Study||19
345566|NCT01300052|828067|P1|COMPLETED|Overall Study||40
345567|NCT01300052|828066|P2|STARTED|Overall Study||22
345568|NCT01300052|828067|P1|STARTED|Overall Study||46
345569|NCT01299961|828085|P1|NOT COMPLETED|Overall Study||6
345570|NCT01299961|828085|P1|COMPLETED|Overall Study||19
345571|NCT01299961|828085|P1|STARTED|Overall Study||25
345572|NCT01299909|828094|P3|NOT COMPLETED|Overall Study||17
345573|NCT01299909|828095|P2|NOT COMPLETED|Overall Study||18
345574|NCT01299909|828096|P1|NOT COMPLETED|Overall Study||22
345575|NCT01299909|828094|P3|COMPLETED|Overall Study||23
345576|NCT01299909|828095|P2|COMPLETED|Overall Study||49
345577|NCT01299909|828096|P1|COMPLETED|Overall Study||46
345578|NCT01299909|828094|P3|STARTED|Overall Study||40
345579|NCT01299909|828095|P2|STARTED|Overall Study||67
345580|NCT01299909|828096|P1|STARTED|Overall Study||68
345581|NCT01299896|828105|P2|NOT COMPLETED|Overall Study||18
345582|NCT01299896|828106|P1|NOT COMPLETED|Overall Study||1
345583|NCT01299896|828105|P2|COMPLETED|Overall Study||296
345584|NCT01299896|828106|P1|COMPLETED|Overall Study||318
345585|NCT01299896|828105|P2|STARTED|Overall Study||314
345586|NCT01299896|828106|P1|STARTED|Overall Study||319
345587|NCT01299805|828114|P2|NOT COMPLETED|Overall Study||0
345588|NCT01299805|828115|P1|NOT COMPLETED|Overall Study||2
345589|NCT01299805|828114|P2|COMPLETED|Overall Study||5
345590|NCT01299805|828115|P1|COMPLETED|Overall Study||10
345591|NCT01299805|828114|P2|STARTED|Overall Study||5
345592|NCT01299805|828115|P1|STARTED|Overall Study||12
345593|NCT01299584|828143|P1|NOT COMPLETED|Overall Study||9
345594|NCT01299584|828143|P1|COMPLETED|Overall Study||766
345595|NCT01299584|828143|P1|STARTED|Overall Study||775
345596|NCT01299571|828150|P1|NOT COMPLETED|Overall Study||107
345597|NCT01299571|828150|P1|COMPLETED|Overall Study||3870
345598|NCT01299571|828150|P1|STARTED|Overall Study||3977
345599|NCT01299480|828161|P5|NOT COMPLETED|Overall Study||20
345600|NCT01299480|828162|P4|NOT COMPLETED|Overall Study||25
345601|NCT01299480|828163|P3|NOT COMPLETED|Overall Study||41
345602|NCT01299480|828164|P2|NOT COMPLETED|Overall Study||35
345603|NCT01299480|828165|P1|NOT COMPLETED|Overall Study||42
345604|NCT01299480|828161|P5|COMPLETED|Overall Study||123
345605|NCT01299480|828162|P4|COMPLETED|Overall Study||261
345606|NCT01299480|828163|P3|COMPLETED|Overall Study||386
345607|NCT01299480|828164|P2|COMPLETED|Overall Study||395
345608|NCT01299480|828165|P1|COMPLETED|Overall Study||385
345609|NCT01299480|828161|P5|STARTED|Overall Study||143
345610|NCT01299480|828162|P4|STARTED|Overall Study||286
345611|NCT01299480|828163|P3|STARTED|Overall Study||427
345612|NCT01299480|828164|P2|STARTED|Overall Study||430
345613|NCT01299480|828165|P1|STARTED|Overall Study||427
345614|NCT01299454|828204|P4|NOT COMPLETED|Overall Study||0
345615|NCT01299454|828205|P3|NOT COMPLETED|Overall Study||0
345616|NCT01299454|828206|P2|NOT COMPLETED|Overall Study||0
345617|NCT01299454|828207|P1|NOT COMPLETED|Overall Study||0
345618|NCT01299454|828204|P4|COMPLETED|Overall Study||23
345619|NCT01299454|828205|P3|COMPLETED|Overall Study||6
345620|NCT01299454|828206|P2|COMPLETED|Overall Study||8
345621|NCT01299454|828207|P1|COMPLETED|Overall Study||8
345622|NCT01299454|828204|P4|STARTED|Overall Study||23
345623|NCT01299454|828205|P3|STARTED|Overall Study||6
345624|NCT01299454|828206|P2|STARTED|Overall Study||8
345625|NCT01299454|828207|P1|STARTED|Overall Study||8
345626|NCT01299389|828367|P4|NOT COMPLETED|Post-observational||6
345627|NCT01299389|828368|P3|NOT COMPLETED|Post-observational||12
345628|NCT01299389|828369|P2|NOT COMPLETED|Post-observational||0
345629|NCT01299389|828370|P1|NOT COMPLETED|Post-observational||0
345630|NCT01299389|828367|P4|COMPLETED|Post-observational||149
345631|NCT01299389|828368|P3|COMPLETED|Post-observational||144
345632|NCT01299389|828369|P2|COMPLETED|Post-observational||0
345633|NCT01299389|828370|P1|COMPLETED|Post-observational||0
345634|NCT01299389|828367|P4|STARTED|Post-observational||155
345635|NCT01299389|828368|P3|STARTED|Post-observational||156
345636|NCT01299389|828369|P2|STARTED|Post-observational||0
345637|NCT01299389|828370|P1|STARTED|Post-observational||0
345638|NCT01299389|828367|P4|NOT COMPLETED|Double-blind||0
345639|NCT01299389|828368|P3|NOT COMPLETED|Double-blind||0
345640|NCT01299389|828369|P2|NOT COMPLETED|Double-blind||64
345641|NCT01299389|828370|P1|NOT COMPLETED|Double-blind||109
345642|NCT01299389|828367|P4|COMPLETED|Double-blind||0
345643|NCT01299389|828368|P3|COMPLETED|Double-blind||0
345644|NCT01299389|828369|P2|COMPLETED|Double-blind||95
345645|NCT01299389|828370|P1|COMPLETED|Double-blind||55
345646|NCT01299389|828367|P4|STARTED|Double-blind||0
345647|NCT01299389|828368|P3|STARTED|Double-blind||0
345648|NCT01299389|828369|P2|STARTED|Double-blind||159
345649|NCT01299389|828370|P1|STARTED|Double-blind||164
345650|NCT01299376|828392|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
345651|NCT01299376|828393|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
345652|NCT01299376|828392|P2|COMPLETED|Extension (Weeks 9 to 52)||118
345653|NCT01299376|828393|P1|COMPLETED|Extension (Weeks 9 to 52)||124
345654|NCT01299376|828392|P2|STARTED|Extension (Weeks 9 to 52)||133
345655|NCT01299376|828393|P1|STARTED|Extension (Weeks 9 to 52)||134
345656|NCT01299376|828392|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
345657|NCT01299376|828393|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
345658|NCT01299376|828392|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
345659|NCT01299376|828393|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
345660|NCT01299376|828392|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
345661|NCT01299376|828393|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
345662|NCT01299285|828423|P1|NOT COMPLETED|Overall Study||0
345663|NCT01299285|828423|P1|COMPLETED|Overall Study||6
345664|NCT01299285|828423|P1|STARTED|Overall Study||6
345665|NCT01299103|828439|P3|NOT COMPLETED|Overall Study||2
345666|NCT01299103|828440|P2|NOT COMPLETED|Overall Study||2
345667|NCT01299103|828441|P1|NOT COMPLETED|Overall Study||0
345668|NCT01299103|828439|P3|COMPLETED|Overall Study||8
345669|NCT01299103|828440|P2|COMPLETED|Overall Study||13
345670|NCT01299103|828441|P1|COMPLETED|Overall Study||15
345671|NCT01299103|828439|P3|STARTED|Overall Study||10
345672|NCT01299103|828440|P2|STARTED|Overall Study||15
345673|NCT01299103|828441|P1|STARTED|Overall Study||15
345674|NCT01299090|828452|P1|NOT COMPLETED|Overall Study||0
345675|NCT01299090|828452|P1|COMPLETED|Overall Study||49
345676|NCT01299090|828452|P1|STARTED|Overall Study||49
345677|NCT01299077|828457|P1|NOT COMPLETED|Overall Study||0
345678|NCT01299077|828457|P1|COMPLETED|Overall Study||478
345679|NCT01299077|828457|P1|STARTED|Overall Study||478
345680|NCT01299025|828467|P2|NOT COMPLETED|Overall Study||1
345681|NCT01299025|828468|P1|NOT COMPLETED|Overall Study||3
345682|NCT01299025|828467|P2|COMPLETED|Overall Study||41
345683|NCT01299025|828468|P1|COMPLETED|Overall Study||39
345684|NCT01299025|828467|P2|STARTED|Overall Study||42
345685|NCT01299025|828468|P1|STARTED|Overall Study||42
345686|NCT01298778|828482|P2|NOT COMPLETED|Overall Study||6
345687|NCT01298778|828483|P1|NOT COMPLETED|Overall Study||3
345688|NCT01298778|828482|P2|COMPLETED|Overall Study||30
345689|NCT01298778|828483|P1|COMPLETED|Overall Study||30
345690|NCT01298778|828482|P2|STARTED|Overall Study||36
345691|NCT01298778|828483|P1|STARTED|Overall Study||33
345692|NCT01298661|828506|P3|NOT COMPLETED|Overall Study||2
345693|NCT01298661|828507|P2|NOT COMPLETED|Overall Study||0
345694|NCT01298661|828508|P1|NOT COMPLETED|Overall Study||2
345695|NCT01298661|828506|P3|COMPLETED|Overall Study||32
345696|NCT01298661|828507|P2|COMPLETED|Overall Study||24
345697|NCT01298661|828508|P1|COMPLETED|Overall Study||31
345698|NCT01298661|828506|P3|STARTED|Overall Study||34
345699|NCT01298661|828507|P2|STARTED|Overall Study||24
345700|NCT01298661|828508|P1|STARTED|Overall Study||33
345701|NCT01298648|828586|P1|NOT COMPLETED|Overall Study||23
345702|NCT01298648|828586|P1|COMPLETED|Overall Study||1693
345703|NCT01298648|828586|P1|STARTED|Overall Study||1716
345704|NCT01298544|828595|P1|NOT COMPLETED|Overall Study||0
345705|NCT01298544|828595|P1|COMPLETED|Overall Study||335
345706|NCT01298544|828595|P1|STARTED|Overall Study||335
345707|NCT01298531|828606|P2|NOT COMPLETED|Overall Study||7
345708|NCT01298531|828607|P1|NOT COMPLETED|Overall Study||9
345709|NCT01298531|828606|P2|COMPLETED|Overall Study||41
345710|NCT01298531|828607|P1|COMPLETED|Overall Study||33
345711|NCT01298531|828606|P2|STARTED|Overall Study||48
345712|NCT01298531|828607|P1|STARTED|Overall Study||42
345713|NCT01298518|828736|P3|NOT COMPLETED|Overall Study||1
345714|NCT01298518|828737|P2|NOT COMPLETED|Overall Study||0
345715|NCT01298518|828738|P1|NOT COMPLETED|Overall Study||0
345716|NCT01298518|828736|P3|COMPLETED|Overall Study||15
345717|NCT01298518|828737|P2|COMPLETED|Overall Study||16
345718|NCT01298518|828738|P1|COMPLETED|Overall Study||16
345719|NCT01298518|828736|P3|STARTED|Overall Study||16
345720|NCT01298518|828737|P2|STARTED|Overall Study||16
345721|NCT01298518|828738|P1|STARTED|Overall Study||16
345722|NCT01298362|828792|P2|NOT COMPLETED|Overall Study||43
345723|NCT01298362|828793|P1|NOT COMPLETED|Overall Study||38
345724|NCT01298362|828792|P2|COMPLETED|Overall Study||123
345725|NCT01298362|828793|P1|COMPLETED|Overall Study||86
345726|NCT01298362|828792|P2|STARTED|Overall Study||166
345727|NCT01298362|828793|P1|STARTED|Overall Study||124
345728|NCT01298323|828813|P2|NOT COMPLETED|Overall Study||88
345729|NCT01298323|828814|P1|NOT COMPLETED|Overall Study||86
345730|NCT01298323|828813|P2|COMPLETED|Overall Study||15
345731|NCT01298323|828814|P1|COMPLETED|Overall Study||16
345732|NCT01298323|828813|P2|Ongoing|Overall Study||55
345733|NCT01298323|828814|P1|Ongoing|Overall Study||55
345734|NCT01298323|828813|P2|STARTED|Overall Study||103
345735|NCT01298323|828814|P1|STARTED|Overall Study||102
345736|NCT01298167|828822|P2|NOT COMPLETED|Overall Study||0
345737|NCT01298167|828823|P1|NOT COMPLETED|Overall Study||1
345738|NCT01298167|828822|P2|COMPLETED|Overall Study||8
345739|NCT01298167|828823|P1|COMPLETED|Overall Study||5
345740|NCT01298167|828822|P2|STARTED|Overall Study||8
345741|NCT01298167|828823|P1|STARTED|Overall Study||6
345742|NCT01298128|828831|P2|NOT COMPLETED|Overall Study||8
345743|NCT01298128|828832|P1|NOT COMPLETED|Overall Study||9
345744|NCT01298128|828831|P2|COMPLETED|Overall Study||27
345745|NCT01298128|828832|P1|COMPLETED|Overall Study||26
345746|NCT01298128|828831|P2|STARTED|Overall Study||35
345747|NCT01298128|828832|P1|STARTED|Overall Study||35
345748|NCT01298063|828843|P5|NOT COMPLETED|Overall Study||0
345749|NCT01298063|828844|P4|NOT COMPLETED|Overall Study||0
345750|NCT01298063|828845|P3|NOT COMPLETED|Overall Study||0
345751|NCT01298063|828846|P2|NOT COMPLETED|Overall Study||0
345752|NCT01298063|828847|P1|NOT COMPLETED|Overall Study||0
345753|NCT01298063|828843|P5|COMPLETED|Overall Study||8
345754|NCT01298063|828844|P4|COMPLETED|Overall Study||8
345755|NCT01298063|828845|P3|COMPLETED|Overall Study||8
345756|NCT01298063|828846|P2|COMPLETED|Overall Study||3
345757|NCT01298063|828847|P1|COMPLETED|Overall Study||8
345758|NCT01298063|828843|P5|STARTED|Overall Study||8
345759|NCT01298063|828844|P4|STARTED|Overall Study||8
345760|NCT01298063|828845|P3|STARTED|Overall Study||8
345761|NCT01298063|828846|P2|STARTED|Overall Study||3
345762|NCT01298063|828847|P1|STARTED|Overall Study||8
345763|NCT01297920|828877|P3|NOT COMPLETED|Overall Study||57
345764|NCT01297920|828878|P2|NOT COMPLETED|Overall Study||27
345765|NCT01297920|828879|P1|NOT COMPLETED|Overall Study||58
345766|NCT01297920|828877|P3|COMPLETED|Overall Study||178
345767|NCT01297920|828878|P2|COMPLETED|Overall Study||207
345768|NCT01297920|828879|P1|COMPLETED|Overall Study||163
345769|NCT01297920|828877|P3|STARTED|Overall Study||235
345770|NCT01297920|828878|P2|STARTED|Overall Study||234
345771|NCT01297920|828879|P1|STARTED|Overall Study||221
345772|NCT01297595|828887|P2|NOT COMPLETED|Second Intervention Period||0
345773|NCT01297595|828888|P1|NOT COMPLETED|Second Intervention Period||0
345774|NCT01297595|828887|P2|COMPLETED|Second Intervention Period||11
345775|NCT01297595|828888|P1|COMPLETED|Second Intervention Period||11
345776|NCT01297595|828887|P2|STARTED|Second Intervention Period||11
345777|NCT01297595|828888|P1|STARTED|Second Intervention Period||11
345778|NCT01297595|828887|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
345779|NCT01297595|828888|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
345780|NCT01297595|828887|P2|COMPLETED|Washout Period (At Least 14 Days)||11
345781|NCT01297595|828888|P1|COMPLETED|Washout Period (At Least 14 Days)||11
345782|NCT01297595|828887|P2|STARTED|Washout Period (At Least 14 Days)||11
345783|NCT01297595|828888|P1|STARTED|Washout Period (At Least 14 Days)||11
345784|NCT01297595|828887|P2|NOT COMPLETED|First Intervention Period||0
345785|NCT01297595|828888|P1|NOT COMPLETED|First Intervention Period||0
345786|NCT01297595|828887|P2|COMPLETED|First Intervention Period||11
345787|NCT01297595|828888|P1|COMPLETED|First Intervention Period||11
345788|NCT01297595|828887|P2|STARTED|First Intervention Period||11
345789|NCT01297595|828888|P1|STARTED|First Intervention Period||11
345790|NCT01297517|828923|P3|NOT COMPLETED|Overall Study||27
345791|NCT01297517|828924|P2|NOT COMPLETED|Overall Study||12
345792|NCT01297517|828925|P1|NOT COMPLETED|Overall Study||27
345793|NCT01297517|828923|P3|COMPLETED|Overall Study||193
345794|NCT01297517|828924|P2|COMPLETED|Overall Study||214
345795|NCT01297517|828925|P1|COMPLETED|Overall Study||187
345796|NCT01297517|828923|P3|STARTED|Overall Study||220
345797|NCT01297517|828924|P2|STARTED|Overall Study||226
345798|NCT01297517|828925|P1|STARTED|Overall Study||214
345799|NCT01297504|828933|P1|NOT COMPLETED|Overall Study||67
345800|NCT01297504|828933|P1|COMPLETED|Overall Study||397
345801|NCT01297504|828933|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
345802|NCT01297504|828933|P1|STARTED|Overall Study||464
345803|NCT01297491|828947|P2|NOT COMPLETED|Overall Study||33
345804|NCT01297491|828948|P1|NOT COMPLETED|Overall Study||30
345805|NCT01297491|828947|P2|COMPLETED|Overall Study||0
345806|NCT01297491|828948|P1|COMPLETED|Overall Study||0
345807|NCT01297491|828947|P2|STARTED|Overall Study||33
345808|NCT01297491|828948|P1|STARTED|Overall Study||30
345809|NCT01297465|828966|P2|NOT COMPLETED|Overall Study||10
345810|NCT01297465|828967|P1|NOT COMPLETED|Overall Study||8
345811|NCT01297465|828966|P2|COMPLETED|Overall Study||93
345812|NCT01297465|828967|P1|COMPLETED|Overall Study||91
345813|NCT01297465|828966|P2|STARTED|Overall Study||103
345814|NCT01297465|828967|P1|STARTED|Overall Study||99
345815|NCT01297348|829001|P2|NOT COMPLETED|Overall Study||0
345816|NCT01297348|829002|P1|NOT COMPLETED|Overall Study||0
345817|NCT01297348|829001|P2|COMPLETED|Overall Study||586401
345818|NCT01297348|829002|P1|COMPLETED|Overall Study||12281
345819|NCT01297348|829001|P2|STARTED|Overall Study||586401
345820|NCT01297348|829002|P1|STARTED|Overall Study||12281
345821|NCT01297335|829012|P1|NOT COMPLETED|Overall Study||0
345822|NCT01297335|829012|P1|COMPLETED|Overall Study||10
345823|NCT01297335|829012|P1|STARTED|Overall Study||10
345824|NCT01297322|829020|P2|NOT COMPLETED|Overall Study||1
345825|NCT01297322|829021|P1|NOT COMPLETED|Overall Study||1
345826|NCT01297322|829020|P2|COMPLETED|Overall Study||274
345827|NCT01297322|829021|P1|COMPLETED|Overall Study||141
345828|NCT01297322|829020|P2|STARTED|Overall Study||275
345829|NCT01297322|829021|P1|STARTED|Overall Study||142
345830|NCT01297283|829041|P1|NOT COMPLETED|Overall Study||19
345831|NCT01297283|829041|P1|COMPLETED|Overall Study||176
345832|NCT01297283|829041|P1|STARTED|Overall Study||195
345833|NCT01297270|829049|P3|NOT COMPLETED|Overall Study||29
345834|NCT01297270|829050|P2|NOT COMPLETED|Overall Study||72
345835|NCT01297270|829051|P1|NOT COMPLETED|Overall Study||45
345836|NCT01297270|829049|P3|COMPLETED|Overall Study||103
345837|NCT01297270|829050|P2|COMPLETED|Overall Study||192
345838|NCT01297270|829051|P1|COMPLETED|Overall Study||217
345839|NCT01297270|829049|P3|STARTED|Overall Study||132
345840|NCT01297270|829050|P2|STARTED|Overall Study||264
345841|NCT01297270|829051|P1|STARTED|Overall Study||262
345842|NCT01297257|829089|P1|NOT COMPLETED|Overall Study||0
345843|NCT01297257|829089|P1|COMPLETED|Overall Study||7740
345844|NCT01297257|829089|P1|STARTED|Overall Study||7740
345845|NCT01297062|829100|P7|NOT COMPLETED|Overall Study||8
345846|NCT01297062|829101|P6|NOT COMPLETED|Overall Study||1
345847|NCT01297062|829102|P5|NOT COMPLETED|Overall Study||2
345848|NCT01297062|829103|P4|NOT COMPLETED|Overall Study||1
345849|NCT01297062|829104|P3|NOT COMPLETED|Overall Study||2
345850|NCT01297062|829105|P2|NOT COMPLETED|Overall Study||1
345851|NCT01297062|829106|P1|NOT COMPLETED|Overall Study||4
345852|NCT01297062|829100|P7|COMPLETED|Overall Study||0
345853|NCT01297062|829101|P6|COMPLETED|Overall Study||13
345854|NCT01297062|829102|P5|COMPLETED|Overall Study||13
345855|NCT01297062|829103|P4|COMPLETED|Overall Study||13
345856|NCT01297062|829104|P3|COMPLETED|Overall Study||12
345857|NCT01297062|829105|P2|COMPLETED|Overall Study||13
345858|NCT01297062|829106|P1|COMPLETED|Overall Study||11
345859|NCT01297062|829100|P7|Evaluable Population|Overall Study||0
345860|NCT01297062|829101|P6|Evaluable Population|Overall Study||13
345861|NCT01297062|829102|P5|Evaluable Population|Overall Study||13
345862|NCT01297062|829103|P4|Evaluable Population|Overall Study||13
345863|NCT01297062|829104|P3|Evaluable Population|Overall Study||12
345864|NCT01297062|829105|P2|Evaluable Population|Overall Study||12
345865|NCT01297062|829106|P1|Evaluable Population|Overall Study||11
345866|NCT01297062|829100|P7|Intent to Treat (ITT)|Overall Study||0
345867|NCT01297062|829101|P6|Intent to Treat (ITT)|Overall Study||14
345868|NCT01297062|829102|P5|Intent to Treat (ITT)|Overall Study||15
345869|NCT01297062|829103|P4|Intent to Treat (ITT)|Overall Study||14
345870|NCT01297062|829104|P3|Intent to Treat (ITT)|Overall Study||14
345871|NCT01297062|829105|P2|Intent to Treat (ITT)|Overall Study||14
345872|NCT01297062|829106|P1|Intent to Treat (ITT)|Overall Study||15
345873|NCT01297062|829100|P7|STARTED|Overall Study||8
345874|NCT01297062|829101|P6|STARTED|Overall Study||14
345875|NCT01297062|829102|P5|STARTED|Overall Study||15
345876|NCT01297062|829103|P4|STARTED|Overall Study||14
345877|NCT01297062|829104|P3|STARTED|Overall Study||14
345878|NCT01297062|829105|P2|STARTED|Overall Study||14
345879|NCT01297062|829106|P1|STARTED|Overall Study||15
345880|NCT01296841|829130|P2|NOT COMPLETED|Overall Study||0
345881|NCT01296841|829131|P1|NOT COMPLETED|Overall Study||0
345882|NCT01296841|829130|P2|COMPLETED|Overall Study||15
345883|NCT01296841|829131|P1|COMPLETED|Overall Study||19
345884|NCT01296841|829130|P2|STARTED|Overall Study||15
345885|NCT01296841|829131|P1|STARTED|Overall Study||19
345886|NCT01296815|829143|P2|NOT COMPLETED|Overall Study||0
345887|NCT01296815|829144|P1|NOT COMPLETED|Overall Study||0
345888|NCT01296815|829143|P2|COMPLETED|Overall Study||7
345889|NCT01296815|829144|P1|COMPLETED|Overall Study||7
345890|NCT01296815|829143|P2|STARTED|Overall Study||7
345891|NCT01296815|829144|P1|STARTED|Overall Study||7
345892|NCT01296763|829153|P3|NOT COMPLETED|Overall Study||0
345893|NCT01296763|829154|P2|NOT COMPLETED|Overall Study||0
345894|NCT01296763|829155|P1|NOT COMPLETED|Overall Study||0
345895|NCT01296763|829153|P3|COMPLETED|Overall Study||6
345896|NCT01296763|829154|P2|COMPLETED|Overall Study||5
345897|NCT01296763|829155|P1|COMPLETED|Overall Study||7
345898|NCT01296763|829153|P3|STARTED|Overall Study||6
345899|NCT01296763|829154|P2|STARTED|Overall Study||5
345900|NCT01296763|829155|P1|STARTED|Overall Study||7
345901|NCT01296698|829168|P2|NOT COMPLETED|Overall Study||13
345902|NCT01296698|829169|P1|NOT COMPLETED|Overall Study||244
345903|NCT01296698|829168|P2|COMPLETED|Overall Study||0
345904|NCT01296698|829169|P1|COMPLETED|Overall Study||0
345905|NCT01296698|829168|P2|STARTED|Overall Study||13
345906|NCT01296698|829169|P1|STARTED|Overall Study||244
345907|NCT01296646|829223|P2|NOT COMPLETED|Overall Study||11
345908|NCT01296646|829224|P1|NOT COMPLETED|Overall Study||11
345909|NCT01296646|829223|P2|COMPLETED|Overall Study||29
345910|NCT01296646|829224|P1|COMPLETED|Overall Study||29
345911|NCT01296646|829223|P2|STARTED|Overall Study||40
345912|NCT01296646|829224|P1|STARTED|Overall Study||40
345913|NCT01296412|829234|P2|NOT COMPLETED|Overall Study||70
345914|NCT01296412|829235|P1|NOT COMPLETED|Overall Study||51
345915|NCT01296412|829234|P2|COMPLETED|Overall Study||257
345916|NCT01296412|829235|P1|COMPLETED|Overall Study||275
345917|NCT01296412|829234|P2|STARTED|Overall Study||327
345918|NCT01296412|829235|P1|STARTED|Overall Study||326
345919|NCT01296360|829249|P2|NOT COMPLETED|Overall Study||8
345920|NCT01296360|829250|P1|NOT COMPLETED|Overall Study||6
345921|NCT01296360|829249|P2|COMPLETED|Overall Study||142
345922|NCT01296360|829250|P1|COMPLETED|Overall Study||144
345923|NCT01296360|829249|P2|Visit 2a (Month 13)|Overall Study||0
345924|NCT01296360|829250|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
345925|NCT01296360|829249|P2|Visit 2 (Month 12)|Overall Study||149
345926|NCT01296360|829250|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
345927|NCT01296360|829249|P2|STARTED|Overall Study||150
345928|NCT01296360|829250|P1|STARTED|Overall Study||150
345929|NCT01296347|829258|P2|NOT COMPLETED|Overall Study||5
345930|NCT01296347|829259|P1|NOT COMPLETED|Overall Study||0
345931|NCT01296347|829258|P2|COMPLETED|Overall Study||47
345932|NCT01296347|829259|P1|COMPLETED|Overall Study||52
345933|NCT01296347|829258|P2|6 Weeks Afer Surgery|Overall Study||47
345934|NCT01296347|829259|P1|6 Weeks Afer Surgery|Overall Study||52
345935|NCT01296347|829258|P2|STARTED|Overall Study||52
345936|NCT01296347|829259|P1|STARTED|Overall Study||52
345937|NCT01296152|829265|P1|NOT COMPLETED|Overall Study||1
345938|NCT01296152|829265|P1|COMPLETED|Overall Study||24
345939|NCT01296152|829265|P1|STARTED|Overall Study||25
345940|NCT01296035|829292|P1|NOT COMPLETED|Overall Study||1
345941|NCT01296035|829292|P1|COMPLETED|Overall Study||7
345942|NCT01296035|829292|P1|STARTED|Overall Study||8
345943|NCT01295905|829299|P2|NOT COMPLETED|Overall Study||0
345944|NCT01295905|829300|P1|NOT COMPLETED|Overall Study||2
345945|NCT01295905|829299|P2|COMPLETED|Overall Study||30
345946|NCT01295905|829300|P1|COMPLETED|Overall Study||58
345947|NCT01295905|829299|P2|STARTED|Overall Study||30
345948|NCT01295905|829300|P1|STARTED|Overall Study||60
345949|NCT01295879|829312|P1|NOT COMPLETED|Overall Study||0
345950|NCT01295879|829312|P1|COMPLETED|Overall Study||29
345951|NCT01295879|829312|P1|STARTED|Overall Study||29
345952|NCT01295840|829318|P1|NOT COMPLETED|Overall Study||1
345953|NCT01295840|829318|P1|COMPLETED|Overall Study||50
345954|NCT01295840|829318|P1|STARTED|Overall Study||51
345955|NCT01295814|829334|P2|NOT COMPLETED|Overall Study||2
345956|NCT01295814|829335|P1|NOT COMPLETED|Overall Study||2
345957|NCT01295814|829334|P2|COMPLETED|Overall Study||19
345958|NCT01295814|829335|P1|COMPLETED|Overall Study||20
345959|NCT01295814|829334|P2|STARTED|Overall Study||21
345960|NCT01295814|829335|P1|STARTED|Overall Study||22
345961|NCT01295281|829351|P2|NOT COMPLETED|Second Intervention (7days)||0
345962|NCT01295281|829352|P1|NOT COMPLETED|Second Intervention (7days)||0
345963|NCT01295281|829351|P2|COMPLETED|Second Intervention (7days)||51
345964|NCT01295281|829352|P1|COMPLETED|Second Intervention (7days)||53
345965|NCT01295281|829351|P2|STARTED|Second Intervention (7days)||51
345966|NCT01295281|829352|P1|STARTED|Second Intervention (7days)||53
345967|NCT01295281|829351|P2|NOT COMPLETED|First Intervention (7 Days)||1
345968|NCT01295281|829352|P1|NOT COMPLETED|First Intervention (7 Days)||0
345969|NCT01295281|829351|P2|COMPLETED|First Intervention (7 Days)||51
345970|NCT01295281|829352|P1|COMPLETED|First Intervention (7 Days)||53
345971|NCT01295281|829351|P2|STARTED|First Intervention (7 Days)||52
345972|NCT01295281|829352|P1|STARTED|First Intervention (7 Days)||53
345973|NCT01295216|829360|P2|NOT COMPLETED|Overall Study||34
345974|NCT01295216|829361|P1|NOT COMPLETED|Overall Study||50
345975|NCT01295216|829360|P2|COMPLETED|Overall Study||287
345976|NCT01295216|829361|P1|COMPLETED|Overall Study||266
345977|NCT01295216|829360|P2|STARTED|Overall Study||321
345978|NCT01295216|829361|P1|STARTED|Overall Study||316
345979|NCT01295034|829379|P2|NOT COMPLETED|Overall Study||5
345980|NCT01295034|829380|P1|NOT COMPLETED|Overall Study||5
345981|NCT01295034|829379|P2|COMPLETED|Overall Study||25
345982|NCT01295034|829380|P1|COMPLETED|Overall Study||27
345983|NCT01295034|829379|P2|STARTED|Overall Study||30
345984|NCT01295034|829380|P1|STARTED|Overall Study||32
345985|NCT01294917|829388|P1|NOT COMPLETED|Overall Study||6
345986|NCT01294917|829388|P1|COMPLETED|Overall Study||36
345987|NCT01294917|829388|P1|Received OptiFree RepleniSH MPS|Overall Study||36
345988|NCT01294917|829388|P1|Received Clear Care|Overall Study||36
345989|NCT01294917|829388|P1|Received Investigational MPS|Overall Study||36
345990|NCT01294917|829388|P1|STARTED|Overall Study||42
345991|NCT01294800|829398|P4|NOT COMPLETED|Overall Study||16
345992|NCT01294800|829399|P3|NOT COMPLETED|Overall Study||17
345993|NCT01294800|829400|P2|NOT COMPLETED|Overall Study||10
345994|NCT01294800|829401|P1|NOT COMPLETED|Overall Study||11
345995|NCT01294800|829398|P4|COMPLETED|Overall Study||97
345996|NCT01294800|829399|P3|COMPLETED|Overall Study||96
345997|NCT01294800|829400|P2|COMPLETED|Overall Study||103
345998|NCT01294800|829401|P1|COMPLETED|Overall Study||100
345999|NCT01294800|829398|P4|STARTED|Overall Study||113
346000|NCT01294800|829399|P3|STARTED|Overall Study||113
346001|NCT01294800|829400|P2|STARTED|Overall Study||113
346002|NCT01294800|829401|P1|STARTED|Overall Study||111
346003|NCT01294787|829427|P6|NOT COMPLETED|Period 3||0
346004|NCT01294787|829428|P5|NOT COMPLETED|Period 3||1
346005|NCT01294787|829429|P4|NOT COMPLETED|Period 3||0
346006|NCT01294787|829430|P3|NOT COMPLETED|Period 3||0
346007|NCT01294787|829431|P2|NOT COMPLETED|Period 3||0
346008|NCT01294787|829432|P1|NOT COMPLETED|Period 3||0
346009|NCT01294787|829427|P6|COMPLETED|Period 3||13
346010|NCT01294787|829428|P5|COMPLETED|Period 3||13
346011|NCT01294787|829429|P4|COMPLETED|Period 3||9
346012|NCT01294787|829430|P3|COMPLETED|Period 3||13
346013|NCT01294787|829431|P2|COMPLETED|Period 3||13
346014|NCT01294787|829432|P1|COMPLETED|Period 3||12
346015|NCT01294787|829427|P6|STARTED|Period 3||13
346016|NCT01294787|829428|P5|STARTED|Period 3||14
346017|NCT01294787|829429|P4|STARTED|Period 3||9
346018|NCT01294787|829430|P3|STARTED|Period 3||13
346019|NCT01294787|829431|P2|STARTED|Period 3||13
346020|NCT01294787|829432|P1|STARTED|Period 3||12
346021|NCT01294787|829427|P6|NOT COMPLETED|Period 2||0
346022|NCT01294787|829428|P5|NOT COMPLETED|Period 2||0
346023|NCT01294787|829429|P4|NOT COMPLETED|Period 2||2
346024|NCT01294787|829430|P3|NOT COMPLETED|Period 2||0
346025|NCT01294787|829431|P2|NOT COMPLETED|Period 2||3
346026|NCT01294787|829432|P1|NOT COMPLETED|Period 2||0
346027|NCT01294787|829427|P6|COMPLETED|Period 2||13
346028|NCT01294787|829428|P5|COMPLETED|Period 2||14
346029|NCT01294787|829429|P4|COMPLETED|Period 2||9
346030|NCT01294787|829430|P3|COMPLETED|Period 2||13
346031|NCT01294787|829431|P2|COMPLETED|Period 2||13
346032|NCT01294787|829432|P1|COMPLETED|Period 2||12
346033|NCT01294787|829427|P6|STARTED|Period 2||13
346034|NCT01294787|829428|P5|STARTED|Period 2||14
346035|NCT01294787|829429|P4|STARTED|Period 2||11
346036|NCT01294787|829430|P3|STARTED|Period 2||13
346037|NCT01294787|829431|P2|STARTED|Period 2||16
346038|NCT01294787|829432|P1|STARTED|Period 2||12
346039|NCT01294787|829427|P6|NOT COMPLETED|Period 1||2
346040|NCT01294787|829428|P5|NOT COMPLETED|Period 1||2
346041|NCT01294787|829429|P4|NOT COMPLETED|Period 1||1
346042|NCT01294787|829430|P3|NOT COMPLETED|Period 1||1
346043|NCT01294787|829431|P2|NOT COMPLETED|Period 1||0
346044|NCT01294787|829432|P1|NOT COMPLETED|Period 1||0
346045|NCT01294787|829427|P6|COMPLETED|Period 1||13
346046|NCT01294787|829428|P5|COMPLETED|Period 1||14
346047|NCT01294787|829429|P4|COMPLETED|Period 1||11
346048|NCT01294787|829430|P3|COMPLETED|Period 1||13
346049|NCT01294787|829431|P2|COMPLETED|Period 1||16
346050|NCT01294787|829432|P1|COMPLETED|Period 1||12
346051|NCT01294787|829427|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
346052|NCT01294787|829428|P5|STARTED|Period 1||16
346053|NCT01294787|829429|P4|STARTED|Period 1||12
346054|NCT01294787|829430|P3|STARTED|Period 1||14
346055|NCT01294787|829431|P2|STARTED|Period 1||16
346056|NCT01294787|829432|P1|STARTED|Period 1||12
346057|NCT01294748|829476|P2|NOT COMPLETED|Overall Study||2
346058|NCT01294748|829477|P1|NOT COMPLETED|Overall Study||5
346059|NCT01294748|829476|P2|COMPLETED|Overall Study|At 270 days|59
346060|NCT01294748|829477|P1|COMPLETED|Overall Study|At 270 days|118
346061|NCT01294748|829476|P2|STARTED|Overall Study||61
346062|NCT01294748|829477|P1|STARTED|Overall Study||123
346063|NCT01294709|829503|P2|NOT COMPLETED|Period 2||0
346064|NCT01294709|829504|P1|NOT COMPLETED|Period 2||1
346065|NCT01294709|829503|P2|COMPLETED|Period 2||31
346066|NCT01294709|829504|P1|COMPLETED|Period 2||28
346067|NCT01294709|829503|P2|STARTED|Period 2||31
346068|NCT01294709|829504|P1|STARTED|Period 2||29
346069|NCT01294709|829503|P2|NOT COMPLETED|Washout Period||1
346070|NCT01294709|829504|P1|NOT COMPLETED|Washout Period||1
346071|NCT01294709|829503|P2|COMPLETED|Washout Period||31
346072|NCT01294709|829504|P1|COMPLETED|Washout Period||29
346073|NCT01294709|829503|P2|STARTED|Washout Period||32
346074|NCT01294709|829504|P1|STARTED|Washout Period||30
346075|NCT01294709|829503|P2|NOT COMPLETED|Period 1||1
346076|NCT01294709|829504|P1|NOT COMPLETED|Period 1||1
346077|NCT01294709|829503|P2|COMPLETED|Period 1||32
346078|NCT01294709|829504|P1|COMPLETED|Period 1||30
346079|NCT01294709|829503|P2|STARTED|Period 1||33
346080|NCT01294709|829504|P1|STARTED|Period 1||31
346081|NCT01294696|829523|P1|NOT COMPLETED|Overall Study||74
346082|NCT01294696|829523|P1|COMPLETED|Overall Study||1187
346083|NCT01294696|829523|P1|STARTED|Overall Study||1261
346084|NCT01294683|829537|P2|NOT COMPLETED|Post Crossover (Period III)||32
346085|NCT01294683|829538|P1|NOT COMPLETED|Post Crossover (Period III)||33
346086|NCT01294683|829537|P2|COMPLETED|Post Crossover (Period III)||190
346087|NCT01294683|829538|P1|COMPLETED|Post Crossover (Period III)||199
346088|NCT01294683|829537|P2|STARTED|Post Crossover (Period III)||222
346089|NCT01294683|829538|P1|STARTED|Post Crossover (Period III)||232
346090|NCT01294683|829537|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
346091|NCT01294683|829538|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
346092|NCT01294683|829537|P2|COMPLETED|Precrossover (Periods I/II)||222
346093|NCT01294683|829538|P1|COMPLETED|Precrossover (Periods I/II)||232
346094|NCT01294683|829537|P2|Treated|Precrossover (Periods I/II)||486
346095|NCT01294683|829538|P1|Treated|Precrossover (Periods I/II)||486
346096|NCT01294683|829537|P2|STARTED|Precrossover (Periods I/II)||488
346097|NCT01294683|829538|P1|STARTED|Precrossover (Periods I/II)||489
346098|NCT01294644|829591|P3|NOT COMPLETED|Overall Study||14
346099|NCT01294644|829592|P2|NOT COMPLETED|Overall Study||10
346100|NCT01294644|829593|P1|NOT COMPLETED|Overall Study||10
346101|NCT01294644|829591|P3|COMPLETED|Overall Study||103
346102|NCT01294644|829592|P2|COMPLETED|Overall Study||112
346103|NCT01294644|829593|P1|COMPLETED|Overall Study||111
346104|NCT01294644|829591|P3|Received Treatment|Overall Study||114
346105|NCT01294644|829592|P2|Received Treatment|Overall Study||122
346106|NCT01294644|829593|P1|Received Treatment|Overall Study||118
346107|NCT01294644|829591|P3|STARTED|Overall Study||117
346108|NCT01294644|829592|P2|STARTED|Overall Study||122
346109|NCT01294644|829593|P1|STARTED|Overall Study||121
346110|NCT01294592|829624|P2|NOT COMPLETED|Overall Study||73
346111|NCT01294592|829625|P1|NOT COMPLETED|Overall Study||77
346112|NCT01294592|829624|P2|COMPLETED|Overall Study||300
346113|NCT01294592|829625|P1|COMPLETED|Overall Study||292
346114|NCT01294592|829624|P2|STARTED|Overall Study||373
346115|NCT01294592|829625|P1|STARTED|Overall Study||369
346116|NCT01294553|829653|P1|NOT COMPLETED|Overall Study||269
346117|NCT01294553|829653|P1|COMPLETED|Overall Study||713
346118|NCT01294553|829653|P1|STARTED|Overall Study||982
346119|NCT01294514|829659|P1|NOT COMPLETED|Overall Study||1
346120|NCT01294514|829659|P1|COMPLETED|Overall Study||26
346121|NCT01294514|829659|P1|STARTED|Overall Study||27
346122|NCT01294462|829669|P2|NOT COMPLETED|Overall Study||63
346123|NCT01294462|829670|P1|NOT COMPLETED|Overall Study||66
346124|NCT01294462|829669|P2|COMPLETED|Overall Study||337
346125|NCT01294462|829670|P1|COMPLETED|Overall Study||335
346126|NCT01294462|829669|P2|Received Randomized Treatment|Overall Study||380
346127|NCT01294462|829670|P1|Received Randomized Treatment|Overall Study||387
346128|NCT01294462|829669|P2|STARTED|Overall Study||400
346129|NCT01294462|829670|P1|STARTED|Overall Study||401
346130|NCT01294449|829684|P2|NOT COMPLETED|Overall Study||15
346131|NCT01294449|829685|P1|NOT COMPLETED|Overall Study||12
346132|NCT01294449|829684|P2|COMPLETED|Overall Study||237
346133|NCT01294449|829685|P1|COMPLETED|Overall Study||144
346134|NCT01294449|829684|P2|Consent to Registry|Overall Study||245
346135|NCT01294449|829685|P1|Consent to Registry|Overall Study||149
346136|NCT01294449|829684|P2|STARTED|Overall Study||252
346137|NCT01294449|829685|P1|STARTED|Overall Study||156
346138|NCT01294436|829693|P2|NOT COMPLETED|Overall Study||70
346139|NCT01294436|829694|P1|NOT COMPLETED|Overall Study||28
346140|NCT01294436|829693|P2|COMPLETED|Overall Study||409
346141|NCT01294436|829694|P1|COMPLETED|Overall Study||221
346142|NCT01294436|829693|P2|STARTED|Overall Study||479
346143|NCT01294436|829694|P1|STARTED|Overall Study||249
346144|NCT01294423|829729|P3|NOT COMPLETED|Overall Study||8
346145|NCT01294423|829730|P2|NOT COMPLETED|Overall Study||9
346146|NCT01294423|829731|P1|NOT COMPLETED|Overall Study||5
346147|NCT01294423|829729|P3|COMPLETED|Overall Study||79
346148|NCT01294423|829730|P2|COMPLETED|Overall Study||79
346149|NCT01294423|829731|P1|COMPLETED|Overall Study||81
346150|NCT01294423|829729|P3|STARTED|Overall Study||87
346151|NCT01294423|829730|P2|STARTED|Overall Study||88
346152|NCT01294423|829731|P1|STARTED|Overall Study||86
346153|NCT01294384|829748|P3|NOT COMPLETED|Overall Study||9
346154|NCT01294384|829749|P2|NOT COMPLETED|Overall Study||6
346155|NCT01294384|829750|P1|NOT COMPLETED|Overall Study||4
346156|NCT01294384|829748|P3|COMPLETED|Overall Study||95
346157|NCT01294384|829749|P2|COMPLETED|Overall Study||94
346158|NCT01294384|829750|P1|COMPLETED|Overall Study||97
346159|NCT01294384|829748|P3|STARTED|Overall Study||104
346160|NCT01294384|829749|P2|STARTED|Overall Study||100
346161|NCT01294384|829750|P1|STARTED|Overall Study||101
346162|NCT01294371|829779|P1|NOT COMPLETED|Overall Study||34
346163|NCT01294371|829779|P1|COMPLETED|Overall Study||357
346164|NCT01294371|829779|P1|Treated|Overall Study||390
346165|NCT01294371|829779|P1|STARTED|Overall Study||391
346166|NCT01294306|829789|P2|NOT COMPLETED|Overall Study||0
346167|NCT01294306|829790|P1|NOT COMPLETED|Overall Study||0
346168|NCT01294306|829789|P2|COMPLETED|Overall Study||35
346169|NCT01294306|829790|P1|COMPLETED|Overall Study||45
346170|NCT01294306|829789|P2|STARTED|Overall Study||35
346171|NCT01294306|829790|P1|STARTED|Overall Study||45
346172|NCT01294228|829804|P1|NOT COMPLETED|Overall Study||0
346173|NCT01294228|829804|P1|COMPLETED|Overall Study||1001
346174|NCT01294228|829804|P1|STARTED|Overall Study||1001
346175|NCT01294163|829811|P3|NOT COMPLETED|Overall Study||3
346176|NCT01294163|829812|P2|NOT COMPLETED|Overall Study||0
346177|NCT01294163|829813|P1|NOT COMPLETED|Overall Study||1
346178|NCT01294163|829811|P3|COMPLETED|Overall Study||163
346179|NCT01294163|829812|P2|COMPLETED|Overall Study||165
346180|NCT01294163|829813|P1|COMPLETED|Overall Study||177
346181|NCT01294163|829811|P3|STARTED|Overall Study||166
346182|NCT01294163|829812|P2|STARTED|Overall Study||165
346183|NCT01294163|829813|P1|STARTED|Overall Study||178
346184|NCT01294150|829824|P2|NOT COMPLETED|Overall Study||2
346185|NCT01294150|829825|P1|NOT COMPLETED|Overall Study||2
346186|NCT01294150|829824|P2|COMPLETED|Overall Study||64
346187|NCT01294150|829825|P1|COMPLETED|Overall Study||138
346188|NCT01294150|829824|P2|STARTED|Overall Study||66
346189|NCT01294150|829825|P1|STARTED|Overall Study||140
346190|NCT01294046|829834|P1|NOT COMPLETED|Overall Study||3
346191|NCT01294046|829834|P1|COMPLETED|Overall Study||0
346192|NCT01294046|829834|P1|STARTED|Overall Study||3
346193|NCT01293968|829849|P2|NOT COMPLETED|Overall Study||3
346194|NCT01293968|829850|P1|NOT COMPLETED|Overall Study||3
346195|NCT01293968|829849|P2|COMPLETED|Overall Study||14
346196|NCT01293968|829850|P1|COMPLETED|Overall Study||17
346197|NCT01293968|829849|P2|STARTED|Overall Study||17
346198|NCT01293968|829850|P1|STARTED|Overall Study||20
346199|NCT01293825|829856|P1|NOT COMPLETED|Overall Study||10
346200|NCT01293825|829856|P1|COMPLETED|Overall Study||20
346201|NCT01293825|829856|P1|STARTED|Overall Study||30
346202|NCT01293695|829870|P2|NOT COMPLETED|Overall Study||7
346203|NCT01293695|829871|P1|NOT COMPLETED|Overall Study||15
346204|NCT01293695|829870|P2|COMPLETED|Overall Study||87
346205|NCT01293695|829871|P1|COMPLETED|Overall Study||78
346206|NCT01293695|829870|P2|STARTED|Overall Study||94
346207|NCT01293695|829871|P1|STARTED|Overall Study||93
346208|NCT01293240|829885|P1|NOT COMPLETED|Overall Study||2
346209|NCT01293240|829885|P1|COMPLETED|Overall Study||115
346210|NCT01293240|829885|P1|STARTED|Overall Study||117
346211|NCT01293084|829900|P1|NOT COMPLETED|Overall Study||5
346212|NCT01293084|829900|P1|COMPLETED|Overall Study||12
346213|NCT01293084|829900|P1|STARTED|Overall Study||17
346214|NCT01293032|829912|P4|NOT COMPLETED|Treatment||1
346215|NCT01293032|829913|P3|NOT COMPLETED|Treatment||1
346216|NCT01293032|829914|P2|NOT COMPLETED|Treatment||5
346217|NCT01293032|829915|P1|NOT COMPLETED|Treatment||2
346218|NCT01293032|829912|P4|COMPLETED|Treatment||13
346219|NCT01293032|829913|P3|COMPLETED|Treatment||10
346220|NCT01293032|829914|P2|COMPLETED|Treatment||14
346221|NCT01293032|829915|P1|COMPLETED|Treatment||10
346222|NCT01293032|829912|P4|STARTED|Treatment||14
346223|NCT01293032|829913|P3|STARTED|Treatment||11
346224|NCT01293032|829914|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
346225|NCT01293032|829915|P1|STARTED|Treatment||12
346226|NCT01293032|829912|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
346227|NCT01293032|829913|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
346228|NCT01293032|829914|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
346229|NCT01293032|829915|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
346230|NCT01293032|829912|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
346231|NCT01293032|829913|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
346232|NCT01293032|829914|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
346233|NCT01293032|829915|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
346234|NCT01293032|829912|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
346235|NCT01293032|829913|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
346236|NCT01293032|829914|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
346237|NCT01293032|829915|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
346238|NCT01293032|829912|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
346239|NCT01293032|829913|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
346240|NCT01293032|829914|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
346241|NCT01293032|829915|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
346242|NCT01293006|829926|P4|NOT COMPLETED|Period 2||0
346243|NCT01293006|829927|P3|NOT COMPLETED|Period 2||0
346244|NCT01293006|829928|P2|NOT COMPLETED|Period 2||0
346245|NCT01293006|829929|P1|NOT COMPLETED|Period 2||1
346246|NCT01293006|829926|P4|COMPLETED|Period 2||3
346247|NCT01293006|829927|P3|COMPLETED|Period 2||9
346248|NCT01293006|829928|P2|COMPLETED|Period 2||2
346249|NCT01293006|829929|P1|COMPLETED|Period 2||10
346250|NCT01293006|829926|P4|STARTED|Period 2||3
346251|NCT01293006|829927|P3|STARTED|Period 2||9
346252|NCT01293006|829928|P2|STARTED|Period 2||2
346253|NCT01293006|829929|P1|STARTED|Period 2||11
346254|NCT01293006|829926|P4|NOT COMPLETED|Washout||0
346255|NCT01293006|829927|P3|NOT COMPLETED|Washout||0
346256|NCT01293006|829928|P2|NOT COMPLETED|Washout||0
346257|NCT01293006|829929|P1|NOT COMPLETED|Washout||0
346258|NCT01293006|829926|P4|COMPLETED|Washout||3
346259|NCT01293006|829927|P3|COMPLETED|Washout||9
346260|NCT01293006|829928|P2|COMPLETED|Washout||2
346261|NCT01293006|829929|P1|COMPLETED|Washout||11
346262|NCT01293006|829926|P4|STARTED|Washout||3
346263|NCT01293006|829927|P3|STARTED|Washout||9
346264|NCT01293006|829928|P2|STARTED|Washout||2
346265|NCT01293006|829929|P1|STARTED|Washout||11
346266|NCT01293006|829926|P4|NOT COMPLETED|Period 1||0
346267|NCT01293006|829927|P3|NOT COMPLETED|Period 1||0
346268|NCT01293006|829928|P2|NOT COMPLETED|Period 1||0
346269|NCT01293006|829929|P1|NOT COMPLETED|Period 1||0
346270|NCT01293006|829926|P4|COMPLETED|Period 1||3
346271|NCT01293006|829927|P3|COMPLETED|Period 1||9
346272|NCT01293006|829928|P2|COMPLETED|Period 1||2
346273|NCT01293006|829929|P1|COMPLETED|Period 1||11
346274|NCT01293006|829926|P4|STARTED|Period 1||3
346275|NCT01293006|829927|P3|STARTED|Period 1||9
346276|NCT01293006|829928|P2|STARTED|Period 1||2
346277|NCT01293006|829929|P1|STARTED|Period 1||11
346278|NCT01292928|829950|P1|NOT COMPLETED|Overall Study||24
346279|NCT01292928|829950|P1|COMPLETED|Overall Study||275
346280|NCT01292928|829950|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
346281|NCT01292928|829950|P1|STARTED|Overall Study||299
346282|NCT01292837|829967|P1|NOT COMPLETED|Overall Study||2
346283|NCT01292837|829967|P1|COMPLETED|Overall Study||11
346284|NCT01292837|829967|P1|STARTED|Overall Study||13
346285|NCT01292798|829976|P1|NOT COMPLETED|Overall Study||0
346286|NCT01292798|829976|P1|COMPLETED|Overall Study||43
346287|NCT01292798|829976|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
346288|NCT01292798|829976|P1|STARTED|Overall Study||43
346289|NCT01292746|829982|P1|NOT COMPLETED|Overall Study||0
346290|NCT01292746|829982|P1|COMPLETED|Overall Study||14
346291|NCT01292746|829982|P1|STARTED|Overall Study||14
346292|NCT01292642|829986|P1|NOT COMPLETED|Overall Study||5
346293|NCT01292642|829986|P1|COMPLETED|Overall Study||7
346294|NCT01292642|829986|P1|STARTED|Overall Study||12
346295|NCT01292629|829994|P1|NOT COMPLETED|Overall Study||0
346296|NCT01292629|829994|P1|COMPLETED|Overall Study||125
346297|NCT01292629|829994|P1|STARTED|Overall Study||125
346298|NCT01292603|830004|P6|NOT COMPLETED|Part 2: Survival Follow-UP||13
346299|NCT01292603|830005|P5|NOT COMPLETED|Part 2: Survival Follow-UP||11
346300|NCT01292603|830006|P4|NOT COMPLETED|Part 2: Survival Follow-UP||0
346301|NCT01292603|830007|P3|NOT COMPLETED|Part 2: Survival Follow-UP||0
346302|NCT01292603|830008|P2|NOT COMPLETED|Part 2: Survival Follow-UP||0
346303|NCT01292603|830009|P1|NOT COMPLETED|Part 2: Survival Follow-UP||0
346304|NCT01292603|830004|P6|COMPLETED|Part 2: Survival Follow-UP||0
346305|NCT01292603|830005|P5|COMPLETED|Part 2: Survival Follow-UP||0
346306|NCT01292603|830006|P4|COMPLETED|Part 2: Survival Follow-UP||0
346307|NCT01292603|830007|P3|COMPLETED|Part 2: Survival Follow-UP||0
346308|NCT01292603|830008|P2|COMPLETED|Part 2: Survival Follow-UP||0
346309|NCT01292603|830009|P1|COMPLETED|Part 2: Survival Follow-UP||0
346310|NCT01292603|830004|P6|STARTED|Part 2: Survival Follow-UP||13
346311|NCT01292603|830005|P5|STARTED|Part 2: Survival Follow-UP||11
346312|NCT01292603|830006|P4|STARTED|Part 2: Survival Follow-UP||0
346313|NCT01292603|830007|P3|STARTED|Part 2: Survival Follow-UP||0
346314|NCT01292603|830008|P2|STARTED|Part 2: Survival Follow-UP||0
346315|NCT01292603|830009|P1|STARTED|Part 2: Survival Follow-UP||0
346316|NCT01292603|830004|P6|NOT COMPLETED|Part 2: Regular Follow-Up||78
346317|NCT01292603|830005|P5|NOT COMPLETED|Part 2: Regular Follow-Up||78
346318|NCT01292603|830006|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
346319|NCT01292603|830007|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
346320|NCT01292603|830008|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
346321|NCT01292603|830009|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
346322|NCT01292603|830004|P6|COMPLETED|Part 2: Regular Follow-Up||0
346323|NCT01292603|830005|P5|COMPLETED|Part 2: Regular Follow-Up||0
346324|NCT01292603|830006|P4|COMPLETED|Part 2: Regular Follow-Up||0
346325|NCT01292603|830007|P3|COMPLETED|Part 2: Regular Follow-Up||0
346326|NCT01292603|830008|P2|COMPLETED|Part 2: Regular Follow-Up||0
346327|NCT01292603|830009|P1|COMPLETED|Part 2: Regular Follow-Up||0
346328|NCT01292603|830004|P6|STARTED|Part 2: Regular Follow-Up||78
346329|NCT01292603|830005|P5|STARTED|Part 2: Regular Follow-Up||78
346330|NCT01292603|830006|P4|STARTED|Part 2: Regular Follow-Up||0
346331|NCT01292603|830007|P3|STARTED|Part 2: Regular Follow-Up||0
346332|NCT01292603|830008|P2|STARTED|Part 2: Regular Follow-Up||0
346333|NCT01292603|830009|P1|STARTED|Part 2: Regular Follow-Up||0
346334|NCT01292603|830004|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
346335|NCT01292603|830005|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
346336|NCT01292603|830006|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
346337|NCT01292603|830007|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
346338|NCT01292603|830008|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
346339|NCT01292603|830009|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
346340|NCT01292603|830004|P6|COMPLETED|Part 2: Dose Confirmation Period||73
346341|NCT01292603|830005|P5|COMPLETED|Part 2: Dose Confirmation Period||72
346342|NCT01292603|830006|P4|COMPLETED|Part 2: Dose Confirmation Period||0
346343|NCT01292603|830007|P3|COMPLETED|Part 2: Dose Confirmation Period||0
346344|NCT01292603|830008|P2|COMPLETED|Part 2: Dose Confirmation Period||0
346345|NCT01292603|830009|P1|COMPLETED|Part 2: Dose Confirmation Period||0
346346|NCT01292603|830004|P6|STARTED|Part 2: Dose Confirmation Period||88
346347|NCT01292603|830005|P5|STARTED|Part 2: Dose Confirmation Period||88
346348|NCT01292603|830006|P4|STARTED|Part 2: Dose Confirmation Period||0
346349|NCT01292603|830007|P3|STARTED|Part 2: Dose Confirmation Period||0
346350|NCT01292603|830008|P2|STARTED|Part 2: Dose Confirmation Period||0
346351|NCT01292603|830009|P1|STARTED|Part 2: Dose Confirmation Period||0
346352|NCT01292603|830004|P6|NOT COMPLETED|Part 1: Survival Follow-Up||0
346353|NCT01292603|830005|P5|NOT COMPLETED|Part 1: Survival Follow-Up||0
346354|NCT01292603|830006|P4|NOT COMPLETED|Part 1: Survival Follow-Up||0
346355|NCT01292603|830007|P3|NOT COMPLETED|Part 1: Survival Follow-Up||2
346356|NCT01292603|830008|P2|NOT COMPLETED|Part 1: Survival Follow-Up||2
346357|NCT01292603|830009|P1|NOT COMPLETED|Part 1: Survival Follow-Up||4
346358|NCT01292603|830004|P6|COMPLETED|Part 1: Survival Follow-Up||0
346359|NCT01292603|830005|P5|COMPLETED|Part 1: Survival Follow-Up||0
346360|NCT01292603|830006|P4|COMPLETED|Part 1: Survival Follow-Up||0
346361|NCT01292603|830007|P3|COMPLETED|Part 1: Survival Follow-Up||0
346362|NCT01292603|830008|P2|COMPLETED|Part 1: Survival Follow-Up||0
346363|NCT01292603|830009|P1|COMPLETED|Part 1: Survival Follow-Up||0
346364|NCT01292603|830004|P6|STARTED|Part 1: Survival Follow-Up||0
346365|NCT01292603|830005|P5|STARTED|Part 1: Survival Follow-Up||0
346366|NCT01292603|830006|P4|STARTED|Part 1: Survival Follow-Up||0
346367|NCT01292603|830007|P3|STARTED|Part 1: Survival Follow-Up||2
346368|NCT01292603|830008|P2|STARTED|Part 1: Survival Follow-Up||2
346369|NCT01292603|830009|P1|STARTED|Part 1: Survival Follow-Up||4
346370|NCT01292603|830004|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
346371|NCT01292603|830005|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
346372|NCT01292603|830006|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
346373|NCT01292603|830007|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||23
346374|NCT01292603|830008|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||17
346375|NCT01292603|830009|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||16
346376|NCT01292603|830004|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
346377|NCT01292603|830005|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
346378|NCT01292603|830006|P4|COMPLETED|Part 1: Regular Follow-Up Period||0
346379|NCT01292603|830007|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
346380|NCT01292603|830008|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
346381|NCT01292603|830009|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
346382|NCT01292603|830004|P6|STARTED|Part 1: Regular Follow-Up Period||0
346383|NCT01292603|830005|P5|STARTED|Part 1: Regular Follow-Up Period||0
346384|NCT01292603|830006|P4|STARTED|Part 1: Regular Follow-Up Period||0
346385|NCT01292603|830007|P3|STARTED|Part 1: Regular Follow-Up Period||23
346386|NCT01292603|830008|P2|STARTED|Part 1: Regular Follow-Up Period||17
346387|NCT01292603|830009|P1|STARTED|Part 1: Regular Follow-Up Period||16
346388|NCT01292603|830004|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
346389|NCT01292603|830005|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
346390|NCT01292603|830006|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
346391|NCT01292603|830007|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
346392|NCT01292603|830008|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
346393|NCT01292603|830009|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
346394|NCT01292603|830004|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
346395|NCT01292603|830005|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
346396|NCT01292603|830006|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
346397|NCT01292603|830007|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
346398|NCT01292603|830008|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
346399|NCT01292603|830009|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
346400|NCT01292603|830004|P6|STARTED|Part 1: Pilot Dose Selection Period||0
346401|NCT01292603|830005|P5|STARTED|Part 1: Pilot Dose Selection Period||0
346402|NCT01292603|830006|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
346403|NCT01292603|830007|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
346404|NCT01292603|830008|P2|STARTED|Part 1: Pilot Dose Selection Period||17
346405|NCT01292603|830009|P1|STARTED|Part 1: Pilot Dose Selection Period||16
346406|NCT01292538|830055|P2|NOT COMPLETED|Overall Study||0
346407|NCT01292538|830056|P1|NOT COMPLETED|Overall Study||0
346408|NCT01292538|830055|P2|COMPLETED|Overall Study||32
346409|NCT01292538|830056|P1|COMPLETED|Overall Study||35
346410|NCT01292538|830055|P2|STARTED|Overall Study||32
346411|NCT01292538|830056|P1|STARTED|Overall Study||35
346412|NCT01292486|830062|P1|NOT COMPLETED|Overall Study||6
346413|NCT01292486|830062|P1|COMPLETED|Overall Study||26
346414|NCT01292486|830062|P1|STARTED|Overall Study||32
346415|NCT01292473|830076|P4|NOT COMPLETED|Overall Study||12
346416|NCT01292473|830077|P3|NOT COMPLETED|Overall Study||9
346417|NCT01292473|830078|P2|NOT COMPLETED|Overall Study||7
346418|NCT01292473|830079|P1|NOT COMPLETED|Overall Study||5
346419|NCT01292473|830076|P4|COMPLETED|Overall Study||67
346420|NCT01292473|830077|P3|COMPLETED|Overall Study||74
346421|NCT01292473|830078|P2|COMPLETED|Overall Study||75
346422|NCT01292473|830079|P1|COMPLETED|Overall Study||74
346423|NCT01292473|830076|P4|STARTED|Overall Study||79
346424|NCT01292473|830077|P3|STARTED|Overall Study||83
346425|NCT01292473|830078|P2|STARTED|Overall Study||82
346426|NCT01292473|830079|P1|STARTED|Overall Study||79
346427|NCT01292304|830121|P1|NOT COMPLETED|Overall Study||0
346428|NCT01292304|830121|P1|COMPLETED|Overall Study||10
346429|NCT01292304|830121|P1|STARTED|Overall Study||10
346430|NCT01292265|830129|P1|NOT COMPLETED|Overall Study||0
346431|NCT01292265|830129|P1|COMPLETED|Overall Study||3
346432|NCT01292265|830129|P1|STARTED|Overall Study||3
346433|NCT01292239|830138|P2|NOT COMPLETED|Overall Study||7
346434|NCT01292239|830139|P1|NOT COMPLETED|Overall Study||4
346435|NCT01292239|830138|P2|COMPLETED|Overall Study||53
346436|NCT01292239|830139|P1|COMPLETED|Overall Study||119
346437|NCT01292239|830138|P2|STARTED|Overall Study||60
346438|NCT01292239|830139|P1|STARTED|Overall Study||123
346439|NCT01292226|830160|P1|NOT COMPLETED|Overall Study||13
346440|NCT01292226|830160|P1|COMPLETED|Overall Study||32
346441|NCT01292226|830160|P1|STARTED|Overall Study||45
346442|NCT01292187|830193|P2|NOT COMPLETED|Overall Study||13
346443|NCT01292187|830194|P1|NOT COMPLETED|Overall Study||17
346444|NCT01292187|830193|P2|COMPLETED|Overall Study||30
346445|NCT01292187|830194|P1|COMPLETED|Overall Study||69
346446|NCT01292187|830193|P2|STARTED|Overall Study||43
346447|NCT01292187|830194|P1|STARTED|Overall Study||86
346448|NCT01292135|830204|P2|NOT COMPLETED|Overall Study||9
346449|NCT01292135|830205|P1|NOT COMPLETED|Overall Study||0
346450|NCT01292135|830204|P2|COMPLETED|Overall Study||21
346451|NCT01292135|830205|P1|COMPLETED|Overall Study||3
346452|NCT01292135|830204|P2|STARTED|Overall Study||30
346453|NCT01292135|830205|P1|STARTED|Overall Study||3
346454|NCT01292070|830223|P1|NOT COMPLETED|Overall Study||0
346455|NCT01292070|830223|P1|COMPLETED|Overall Study||4
346456|NCT01292070|830223|P1|STARTED|Overall Study||4
346457|NCT01292005|830229|P2|NOT COMPLETED|Overall Study||0
346458|NCT01292005|830230|P1|NOT COMPLETED|Overall Study||0
346459|NCT01292005|830229|P2|COMPLETED|Overall Study||14
346460|NCT01292005|830230|P1|COMPLETED|Overall Study||14
346461|NCT01292005|830229|P2|STARTED|Overall Study||14
346462|NCT01292005|830230|P1|STARTED|Overall Study||14
346463|NCT01291784|830254|P3|NOT COMPLETED|Overall Study||0
346464|NCT01291784|830255|P2|NOT COMPLETED|Overall Study||1
346465|NCT01291784|830256|P1|NOT COMPLETED|Overall Study||0
346466|NCT01291784|830254|P3|COMPLETED|Overall Study||1
346467|NCT01291784|830255|P2|COMPLETED|Overall Study||0
346468|NCT01291784|830256|P1|COMPLETED|Overall Study||1
346469|NCT01291784|830254|P3|STARTED|Overall Study||1
346470|NCT01291784|830255|P2|STARTED|Overall Study||1
346471|NCT01291784|830256|P1|STARTED|Overall Study||1
346472|NCT01291498|830276|P1|NOT COMPLETED|Overall Study||1
346473|NCT01291498|830276|P1|COMPLETED|Overall Study||0
346474|NCT01291498|830276|P1|STARTED|Overall Study||1
346475|NCT01291277|830284|P2|NOT COMPLETED|Overall Study||3
346476|NCT01291277|830285|P1|NOT COMPLETED|Overall Study||5
346477|NCT01291277|830284|P2|COMPLETED|Overall Study||42
346478|NCT01291277|830285|P1|COMPLETED|Overall Study||40
346479|NCT01291277|830284|P2|STARTED|Overall Study||45
346480|NCT01291277|830285|P1|STARTED|Overall Study||45
346481|NCT01291264|830291|P1|NOT COMPLETED|Overall Study||0
346482|NCT01291264|830291|P1|COMPLETED|Overall Study||260
346483|NCT01291264|830291|P1|STARTED|Overall Study||260
346484|NCT01291225|830297|P2|NOT COMPLETED|Overall Study||39
346485|NCT01291225|830298|P1|NOT COMPLETED|Overall Study||85
346486|NCT01291225|830297|P2|COMPLETED|Overall Study||121
346487|NCT01291225|830298|P1|COMPLETED|Overall Study||66
346488|NCT01291225|830297|P2|STARTED|Overall Study||160
346489|NCT01291225|830298|P1|STARTED|Overall Study||151
346490|NCT01291173|830312|P4|NOT COMPLETED|Overall Study||13
346491|NCT01291173|830313|P3|NOT COMPLETED|Overall Study||13
346492|NCT01291173|830314|P2|NOT COMPLETED|Overall Study||15
346493|NCT01291173|830315|P1|NOT COMPLETED|Overall Study||17
346494|NCT01291173|830312|P4|COMPLETED|Overall Study||52
346495|NCT01291173|830313|P3|COMPLETED|Overall Study||52
346496|NCT01291173|830314|P2|COMPLETED|Overall Study||51
346497|NCT01291173|830315|P1|COMPLETED|Overall Study||47
346498|NCT01291173|830312|P4|STARTED|Overall Study||65
346499|NCT01291173|830313|P3|STARTED|Overall Study||65
346500|NCT01291173|830314|P2|STARTED|Overall Study||66
346501|NCT01291173|830315|P1|STARTED|Overall Study||64
346502|NCT01291160|830379|P2|NOT COMPLETED|Overall Study||16
346503|NCT01291160|830380|P1|NOT COMPLETED|Overall Study||18
346504|NCT01291160|830379|P2|COMPLETED|Overall Study||48
346505|NCT01291160|830380|P1|COMPLETED|Overall Study||48
346506|NCT01291160|830379|P2|STARTED|Overall Study||64
346507|NCT01291160|830380|P1|STARTED|Overall Study||66
346508|NCT01291108|830390|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
346509|NCT01291108|830391|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
346510|NCT01291108|830392|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
346511|NCT01291108|830393|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
346512|NCT01291108|830394|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
346513|NCT01291108|830395|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
346514|NCT01291108|830390|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
346515|NCT01291108|830391|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
346516|NCT01291108|830392|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
346517|NCT01291108|830393|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
346518|NCT01291108|830394|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
346519|NCT01291108|830395|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
346520|NCT01291108|830390|P6|STARTED|Month 2 (Adjunctive Therapy)||26
346521|NCT01291108|830391|P5|STARTED|Month 2 (Adjunctive Therapy)||34
346522|NCT01291108|830392|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
346523|NCT01291108|830393|P3|STARTED|Month 2 (Adjunctive Therapy)||24
346524|NCT01291108|830394|P2|STARTED|Month 2 (Adjunctive Therapy)||40
346525|NCT01291108|830395|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
346526|NCT01291108|830390|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
346527|NCT01291108|830391|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
346528|NCT01291108|830392|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
346529|NCT01291108|830393|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
346530|NCT01291108|830394|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
346531|NCT01291108|830395|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
346532|NCT01291108|830390|P6|COMPLETED|Month 1 (Monotherapy)||0
346533|NCT01291108|830391|P5|COMPLETED|Month 1 (Monotherapy)||0
346534|NCT01291108|830392|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
346535|NCT01291108|830393|P3|COMPLETED|Month 1 (Monotherapy)||0
346536|NCT01291108|830394|P2|COMPLETED|Month 1 (Monotherapy)||0
346537|NCT01291108|830395|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
346538|NCT01291108|830390|P6|STARTED|Month 1 (Monotherapy)||0
346539|NCT01291108|830391|P5|STARTED|Month 1 (Monotherapy)||0
346540|NCT01291108|830392|P4|STARTED|Month 1 (Monotherapy)||60
346541|NCT01291108|830393|P3|STARTED|Month 1 (Monotherapy)||0
346542|NCT01291108|830394|P2|STARTED|Month 1 (Monotherapy)||0
346543|NCT01291108|830395|P1|STARTED|Month 1 (Monotherapy)||65
346544|NCT01291056|830411|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
346545|NCT01291056|830412|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
346546|NCT01291056|830411|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
346547|NCT01291056|830412|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
346548|NCT01291056|830411|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
346549|NCT01291056|830412|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
346550|NCT01291056|830411|P2|NOT COMPLETED|Washout||0
346551|NCT01291056|830412|P1|NOT COMPLETED|Washout||0
346552|NCT01291056|830411|P2|COMPLETED|Washout||10
346553|NCT01291056|830412|P1|COMPLETED|Washout||10
346554|NCT01291056|830411|P2|STARTED|Washout||10
346555|NCT01291056|830412|P1|STARTED|Washout||10
346556|NCT01291056|830411|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
346557|NCT01291056|830412|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
346558|NCT01291056|830411|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
346559|NCT01291056|830412|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
346560|NCT01291056|830411|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
346561|NCT01291056|830412|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
346562|NCT01291017|830424|P1|NOT COMPLETED|Overall Study||5
346563|NCT01291017|830424|P1|COMPLETED|Overall Study||14
346564|NCT01291017|830424|P1|STARTED|Overall Study||19
346565|NCT01290978|830432|P1|NOT COMPLETED|Overall Study||0
346566|NCT01290978|830432|P1|COMPLETED|Overall Study||22
346567|NCT01290978|830432|P1|STARTED|Overall Study||22
346568|NCT01290952|830441|P2|NOT COMPLETED|Overall Study||14
346569|NCT01290952|830442|P1|NOT COMPLETED|Overall Study||12
346570|NCT01290952|830441|P2|COMPLETED|Overall Study||193
346571|NCT01290952|830442|P1|COMPLETED|Overall Study||192
346572|NCT01290952|830441|P2|STARTED|Overall Study||207
346573|NCT01290952|830442|P1|STARTED|Overall Study||204
346574|NCT01290913|830450|P1|NOT COMPLETED|Overall Study||1
346575|NCT01290913|830450|P1|COMPLETED|Overall Study||12
346576|NCT01290913|830450|P1|STARTED|Overall Study||13
346577|NCT01290887|830457|P2|NOT COMPLETED|Overall Study||536
346578|NCT01290887|830458|P1|NOT COMPLETED|Overall Study||466
346579|NCT01290887|830457|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
346580|NCT01290887|830458|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
346581|NCT01290887|830457|P2|Safety Analysis Set|Overall Study||571
346582|NCT01290887|830458|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
346583|NCT01290887|830457|P2|STARTED|Overall Study||571
346584|NCT01290887|830458|P1|STARTED|Overall Study||481
346585|NCT01290822|830496|P1|NOT COMPLETED|Overall Study||11
346586|NCT01290822|830496|P1|COMPLETED|Overall Study||1
346587|NCT01290822|830496|P1|STARTED|Overall Study||12
346588|NCT01290796|830505|P1|NOT COMPLETED|Overall Study||30
346589|NCT01290796|830505|P1|COMPLETED|Overall Study||123
346590|NCT01290796|830505|P1|STARTED|Overall Study||153
346591|NCT01290757|830521|P2|NOT COMPLETED|Overall Study||2
346592|NCT01290757|830522|P1|NOT COMPLETED|Overall Study||2
346593|NCT01290757|830521|P2|COMPLETED|Overall Study||88
346594|NCT01290757|830522|P1|COMPLETED|Overall Study||88
346595|NCT01290757|830521|P2|STARTED|Overall Study||90
346596|NCT01290757|830522|P1|STARTED|Overall Study||90
346597|NCT01290731|830538|P1|NOT COMPLETED|Overall Study||1
346598|NCT01290731|830538|P1|COMPLETED|Overall Study||48
346599|NCT01290731|830538|P1|STARTED|Overall Study||49
346600|NCT01290718|830550|P1|NOT COMPLETED|Overall Study||4
346601|NCT01290718|830550|P1|COMPLETED|Overall Study||0
346602|NCT01290718|830550|P1|STARTED|Overall Study||4
346603|NCT01290679|830559|P2|NOT COMPLETED|Overall Study||21
346604|NCT01290679|830560|P1|NOT COMPLETED|Overall Study||16
346605|NCT01290679|830559|P2|COMPLETED|Overall Study||113
346606|NCT01290679|830560|P1|COMPLETED|Overall Study||241
346607|NCT01290679|830559|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
346608|NCT01290679|830560|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
346609|NCT01290666|830629|P1|NOT COMPLETED|Overall Study||38
346610|NCT01290666|830629|P1|COMPLETED|Overall Study||55
346611|NCT01290666|830629|P1|STARTED|Overall Study||93
346612|NCT01290640|830635|P2|NOT COMPLETED|Overall Study||0
346613|NCT01290640|830636|P1|NOT COMPLETED|Overall Study||0
346614|NCT01290640|830635|P2|COMPLETED|Overall Study||10
346615|NCT01290640|830636|P1|COMPLETED|Overall Study||12
346616|NCT01290640|830635|P2|STARTED|Overall Study||10
346617|NCT01290640|830636|P1|STARTED|Overall Study||12
346618|NCT01290627|830647|P3|NOT COMPLETED|Overall Study||0
346619|NCT01290627|830648|P2|NOT COMPLETED|Overall Study||0
346620|NCT01290627|830649|P1|NOT COMPLETED|Overall Study||0
346621|NCT01290627|830647|P3|COMPLETED|Overall Study||10
346622|NCT01290627|830648|P2|COMPLETED|Overall Study||10
346623|NCT01290627|830649|P1|COMPLETED|Overall Study||10
346624|NCT01290627|830647|P3|STARTED|Overall Study||10
346625|NCT01290627|830648|P2|STARTED|Overall Study||10
346626|NCT01290627|830649|P1|STARTED|Overall Study||10
346627|NCT01290614|830671|P2|NOT COMPLETED|Overall Study||0
346628|NCT01290614|830672|P1|NOT COMPLETED|Overall Study||552
346629|NCT01290614|830671|P2|COMPLETED|Overall Study||1129
346630|NCT01290614|830672|P1|COMPLETED|Overall Study||518
346631|NCT01290614|830671|P2|STARTED|Overall Study||1129
346632|NCT01290614|830672|P1|STARTED|Overall Study||1070
346633|NCT01290536|830680|P1|NOT COMPLETED|Overall Study||0
346634|NCT01290536|830680|P1|COMPLETED|Overall Study||42
346635|NCT01290536|830680|P1|STARTED|Overall Study||42
346636|NCT01290523|830687|P1|NOT COMPLETED|Overall Study||0
346637|NCT01290523|830687|P1|COMPLETED|Overall Study||14
346638|NCT01290523|830687|P1|STARTED|Overall Study||14
346639|NCT01290484|830692|P1|NOT COMPLETED|Overall Study||0
346640|NCT01290484|830692|P1|COMPLETED|Overall Study||7
346641|NCT01290484|830692|P1|STARTED|Overall Study||7
346642|NCT01290341|830698|P2|NOT COMPLETED|Overall Study||29
346643|NCT01290341|830699|P1|NOT COMPLETED|Overall Study||92
346644|NCT01290341|830698|P2|COMPLETED|Overall Study||258
346645|NCT01290341|830699|P1|COMPLETED|Overall Study||481
346646|NCT01290341|830698|P2|STARTED|Overall Study||287
346647|NCT01290341|830699|P1|STARTED|Overall Study||573
346648|NCT01290263|830709|P5|NOT COMPLETED|Overall Study||37
346649|NCT01290263|830710|P4|NOT COMPLETED|Overall Study||27
346650|NCT01290263|830711|P3|NOT COMPLETED|Overall Study||7
346651|NCT01290263|830712|P2|NOT COMPLETED|Overall Study||3
346652|NCT01290263|830713|P1|NOT COMPLETED|Overall Study||11
346653|NCT01290263|830709|P5|COMPLETED|Overall Study||0
346654|NCT01290263|830710|P4|COMPLETED|Overall Study||0
346655|NCT01290263|830711|P3|COMPLETED|Overall Study||0
346656|NCT01290263|830712|P2|COMPLETED|Overall Study||0
346657|NCT01290263|830713|P1|COMPLETED|Overall Study||0
346658|NCT01290263|830709|P5|STARTED|Overall Study||37
346659|NCT01290263|830710|P4|STARTED|Overall Study||27
346660|NCT01290263|830711|P3|STARTED|Overall Study||7
346661|NCT01290263|830712|P2|STARTED|Overall Study||3
346662|NCT01290263|830713|P1|STARTED|Overall Study||11
346663|NCT01290224|830729|P1|NOT COMPLETED|Overall Study||5
346664|NCT01290224|830729|P1|COMPLETED|Overall Study||5
346665|NCT01290224|830729|P1|STARTED|Overall Study||10
346666|NCT01290094|830740|P1|NOT COMPLETED|Overall Study||6
346667|NCT01290094|830740|P1|COMPLETED|Overall Study||35
346668|NCT01290094|830740|P1|STARTED|Overall Study||41
346669|NCT01290068|830753|P2|NOT COMPLETED|Overall Study||6
346670|NCT01290068|830754|P1|NOT COMPLETED|Overall Study||7
346671|NCT01290068|830753|P2|COMPLETED|Overall Study||94
346672|NCT01290068|830754|P1|COMPLETED|Overall Study||101
346673|NCT01290068|830753|P2|Implanted|Overall Study||98
346674|NCT01290068|830754|P1|Implanted|Overall Study||108
346675|NCT01290068|830753|P2|STARTED|Overall Study||100
346676|NCT01290068|830754|P1|STARTED|Overall Study||108
346677|NCT01290029|830766|P1|NOT COMPLETED|Overall Study||2
346678|NCT01290029|830766|P1|COMPLETED|Overall Study||12
346679|NCT01290029|830766|P1|Received Study Treatment|Overall Study||12
346680|NCT01290029|830766|P1|STARTED|Overall Study||14
346681|NCT01289990|830792|P13|NOT COMPLETED|Overall Study||98
346682|NCT01289990|830793|P12|NOT COMPLETED|Overall Study||68
346683|NCT01289990|830794|P11|NOT COMPLETED|Overall Study||76
346684|NCT01289990|830795|P10|NOT COMPLETED|Overall Study||86
346685|NCT01289990|830796|P9|NOT COMPLETED|Overall Study||75
346686|NCT01289990|830797|P8|NOT COMPLETED|Overall Study||55
346687|NCT01289990|830798|P7|NOT COMPLETED|Overall Study||88
346688|NCT01289990|830799|P6|NOT COMPLETED|Overall Study||74
346689|NCT01289990|830800|P5|NOT COMPLETED|Overall Study||72
346690|NCT01289990|830801|P4|NOT COMPLETED|Overall Study||87
346691|NCT01289990|830802|P3|NOT COMPLETED|Overall Study||109
346692|NCT01289990|830803|P2|NOT COMPLETED|Overall Study||81
346693|NCT01289990|830804|P1|NOT COMPLETED|Overall Study||77
346694|NCT01289990|830792|P13|COMPLETED|Overall Study||127
346695|NCT01289990|830793|P12|COMPLETED|Overall Study||150
346696|NCT01289990|830794|P11|COMPLETED|Overall Study||150
346697|NCT01289990|830795|P10|COMPLETED|Overall Study||121
346698|NCT01289990|830796|P9|COMPLETED|Overall Study||139
346699|NCT01289990|830797|P8|COMPLETED|Overall Study||162
346700|NCT01289990|830798|P7|COMPLETED|Overall Study||78
346701|NCT01289990|830799|P6|COMPLETED|Overall Study||94
346702|NCT01289990|830800|P5|COMPLETED|Overall Study||93
346703|NCT01289990|830801|P4|COMPLETED|Overall Study||136
346704|NCT01289990|830802|P3|COMPLETED|Overall Study||119
346705|NCT01289990|830803|P2|COMPLETED|Overall Study||143
346706|NCT01289990|830804|P1|COMPLETED|Overall Study||147
346707|NCT01289990|830792|P13|STARTED|Overall Study||225
346708|NCT01289990|830793|P12|STARTED|Overall Study||218
346709|NCT01289990|830794|P11|STARTED|Overall Study||226
346710|NCT01289990|830795|P10|STARTED|Overall Study||207
346711|NCT01289990|830796|P9|STARTED|Overall Study||214
346712|NCT01289990|830797|P8|STARTED|Overall Study||217
346713|NCT01289990|830798|P7|STARTED|Overall Study||166
346714|NCT01289990|830799|P6|STARTED|Overall Study||168
346715|NCT01289990|830800|P5|STARTED|Overall Study||165
346716|NCT01289990|830801|P4|STARTED|Overall Study||223
346717|NCT01289990|830802|P3|STARTED|Overall Study||228
346718|NCT01289990|830803|P2|STARTED|Overall Study||224
346719|NCT01289990|830804|P1|STARTED|Overall Study||224
346720|NCT01289847|830988|P1|NOT COMPLETED|Overall Study||1
346721|NCT01289847|830988|P1|COMPLETED|Overall Study||24
346722|NCT01289847|830988|P1|STARTED|Overall Study||25
346723|NCT01289821|830997|P1|NOT COMPLETED|Survival Follow-up Period||18
346724|NCT01289821|830997|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
346725|NCT01289821|830997|P1|STARTED|Survival Follow-up Period||52
346726|NCT01289821|830997|P1|NOT COMPLETED|Safety Follow-up Period||5
346727|NCT01289821|830997|P1|COMPLETED|Safety Follow-up Period||49
346728|NCT01289821|830997|P1|STARTED|Safety Follow-up Period||54
346729|NCT01289821|830997|P1|NOT COMPLETED|Treatment Period||54
346730|NCT01289821|830997|P1|COMPLETED|Treatment Period||0
346731|NCT01289821|830997|P1|Participants Received Regorafenib|Treatment Period||54
346732|NCT01289821|830997|P1|STARTED|Treatment Period||54
346733|NCT01289782|831008|P2|NOT COMPLETED|Overall Study||12
346734|NCT01289782|831009|P1|NOT COMPLETED|Overall Study||25
346735|NCT01289782|831008|P2|COMPLETED|Overall Study||118
346736|NCT01289782|831009|P1|COMPLETED|Overall Study||239
346737|NCT01289782|831008|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
346738|NCT01289782|831009|P1|STARTED|Overall Study||264
346739|NCT01289639|831081|P3|NOT COMPLETED|Overall Study||0
346740|NCT01289639|831082|P2|NOT COMPLETED|Overall Study||0
346741|NCT01289639|831083|P1|NOT COMPLETED|Overall Study||1
346742|NCT01289639|831081|P3|COMPLETED|Overall Study||0
346743|NCT01289639|831082|P2|COMPLETED|Overall Study||6
346744|NCT01289639|831083|P1|COMPLETED|Overall Study||4
346745|NCT01289639|831081|P3|STARTED|Overall Study||0
346746|NCT01289639|831082|P2|STARTED|Overall Study||6
346747|NCT01289639|831083|P1|STARTED|Overall Study||5
346748|NCT01289574|831109|P3|NOT COMPLETED|Overall Study||3
346749|NCT01289574|831110|P2|NOT COMPLETED|Overall Study||3
346750|NCT01289574|831111|P1|NOT COMPLETED|Overall Study||7
346751|NCT01289574|831109|P3|COMPLETED|Overall Study||60
346752|NCT01289574|831110|P2|COMPLETED|Overall Study||57
346753|NCT01289574|831111|P1|COMPLETED|Overall Study||51
346754|NCT01289574|831109|P3|STARTED|Overall Study||63
346755|NCT01289574|831110|P2|STARTED|Overall Study||60
346756|NCT01289574|831111|P1|STARTED|Overall Study||58
346757|NCT01289548|831128|P3|NOT COMPLETED|Overall Study||0
346758|NCT01289548|831129|P2|NOT COMPLETED|Overall Study||0
346759|NCT01289548|831130|P1|NOT COMPLETED|Overall Study||0
346760|NCT01289548|831128|P3|COMPLETED|Overall Study||40
346761|NCT01289548|831129|P2|COMPLETED|Overall Study||40
346762|NCT01289548|831130|P1|COMPLETED|Overall Study||40
346763|NCT01289548|831128|P3|Recipients|Overall Study||20
346764|NCT01289548|831129|P2|Recipients|Overall Study||20
346765|NCT01289548|831130|P1|Recipients|Overall Study||20
346766|NCT01289548|831128|P3|Donors|Overall Study||20
346767|NCT01289548|831129|P2|Donors|Overall Study||20
346768|NCT01289548|831130|P1|Donors|Overall Study||20
346769|NCT01289548|831128|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
346770|NCT01289548|831129|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
346771|NCT01289548|831130|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
346772|NCT01289522|831174|P1|NOT COMPLETED|Overall Study||11
346773|NCT01289522|831174|P1|COMPLETED|Overall Study||43
346774|NCT01289522|831174|P1|STARTED|Overall Study||54
346775|NCT01289418|831183|P1|NOT COMPLETED|Day 29 Survey||2468
346776|NCT01289418|831183|P1|COMPLETED|Day 29 Survey||4057
346777|NCT01289418|831183|P1|STARTED|Day 29 Survey||6525
346778|NCT01289418|831183|P1|NOT COMPLETED|Day 8 Survey||2218
346779|NCT01289418|831183|P1|COMPLETED|Day 8 Survey||4307
346780|NCT01289418|831183|P1|STARTED|Day 8 Survey||6525
346781|NCT01289392|831192|P3|NOT COMPLETED|Overall Study||0
346782|NCT01289392|831193|P2|NOT COMPLETED|Overall Study||0
346783|NCT01289392|831194|P1|NOT COMPLETED|Overall Study||0
346784|NCT01289392|831192|P3|COMPLETED|Overall Study||7
346785|NCT01289392|831193|P2|COMPLETED|Overall Study||9
346786|NCT01289392|831194|P1|COMPLETED|Overall Study||9
346787|NCT01289392|831192|P3|STARTED|Overall Study||7
346788|NCT01289392|831193|P2|STARTED|Overall Study||9
346789|NCT01289392|831194|P1|STARTED|Overall Study||9
346790|NCT01289210|831202|P1|NOT COMPLETED|Overall Study||1
346791|NCT01289210|831202|P1|COMPLETED|Overall Study||1
346792|NCT01289210|831202|P1|STARTED|Overall Study||2
346793|NCT01289119|831212|P6|NOT COMPLETED|Overall Study||4
346794|NCT01289119|831213|P5|NOT COMPLETED|Overall Study||5
346795|NCT01289119|831214|P4|NOT COMPLETED|Overall Study||6
346796|NCT01289119|831215|P3|NOT COMPLETED|Overall Study||9
346797|NCT01289119|831216|P2|NOT COMPLETED|Overall Study||9
346798|NCT01289119|831217|P1|NOT COMPLETED|Overall Study||9
346799|NCT01289119|831212|P6|COMPLETED|Overall Study||57
346800|NCT01289119|831213|P5|COMPLETED|Overall Study||58
346801|NCT01289119|831214|P4|COMPLETED|Overall Study||93
346802|NCT01289119|831215|P3|COMPLETED|Overall Study||89
346803|NCT01289119|831216|P2|COMPLETED|Overall Study||83
346804|NCT01289119|831217|P1|COMPLETED|Overall Study||84
346805|NCT01289119|831212|P6|Treated|Overall Study||61
346806|NCT01289119|831213|P5|Treated|Overall Study||63
346807|NCT01289119|831214|P4|Treated|Overall Study||99
346808|NCT01289119|831215|P3|Treated|Overall Study||98
346809|NCT01289119|831216|P2|Treated|Overall Study||92
346810|NCT01289119|831217|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
346811|NCT01289119|831212|P6|STARTED|Overall Study||61
346812|NCT01289119|831213|P5|STARTED|Overall Study||63
346813|NCT01289119|831214|P4|STARTED|Overall Study||99
346814|NCT01289119|831215|P3|STARTED|Overall Study||98
346815|NCT01289119|831216|P2|STARTED|Overall Study||92
346816|NCT01289119|831217|P1|STARTED|Overall Study||93
346817|NCT01289080|831299|P2|NOT COMPLETED|Overall Study||0
346818|NCT01289080|831300|P1|NOT COMPLETED|Overall Study||0
346819|NCT01289080|831299|P2|COMPLETED|Overall Study||10
346820|NCT01289080|831300|P1|COMPLETED|Overall Study||9
346821|NCT01289080|831299|P2|STARTED|Overall Study||10
346822|NCT01289080|831300|P1|STARTED|Overall Study||9
346823|NCT01289041|831331|P1|NOT COMPLETED|Overall Study||70
346824|NCT01289041|831331|P1|COMPLETED|Overall Study||0
346825|NCT01289041|831331|P1|STARTED|Overall Study||70
346826|NCT01289028|831343|P1|NOT COMPLETED|Overall Study||83
346827|NCT01289028|831343|P1|COMPLETED|Overall Study||42
346828|NCT01289028|831343|P1|STARTED|Overall Study||125
346829|NCT01289015|831357|P2|NOT COMPLETED|Overall Study||54
346830|NCT01289015|831358|P1|NOT COMPLETED|Overall Study||99
346831|NCT01289015|831357|P2|COMPLETED|Overall Study||230
346832|NCT01289015|831358|P1|COMPLETED|Overall Study||472
346833|NCT01289015|831357|P2|STARTED|Overall Study||284
346834|NCT01289015|831358|P1|STARTED|Overall Study||571
346835|NCT01288911|831368|P2|NOT COMPLETED|Overall Study||170
346836|NCT01288911|831369|P1|NOT COMPLETED|Overall Study||125
346837|NCT01288911|831368|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|21
346838|NCT01288911|831369|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|59
346839|NCT01288911|831368|P2|Received Treatment|Overall Study||189
346840|NCT01288911|831369|P1|Received Treatment|Overall Study||183
346841|NCT01288911|831368|P2|STARTED|Overall Study||191
346842|NCT01288911|831369|P1|STARTED|Overall Study||184
346843|NCT01288859|831397|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346844|NCT01288859|831398|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346845|NCT01288859|831399|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346846|NCT01288859|831400|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346847|NCT01288859|831401|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346848|NCT01288859|831402|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346849|NCT01288859|831397|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346850|NCT01288859|831398|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
346851|NCT01288859|831399|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
346852|NCT01288859|831400|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346853|NCT01288859|831401|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346854|NCT01288859|831402|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
346855|NCT01288859|831397|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
346856|NCT01288859|831398|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
346857|NCT01288859|831399|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
346858|NCT01288859|831400|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
346859|NCT01288859|831401|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
346860|NCT01288859|831402|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
346861|NCT01288859|831397|P6|NOT COMPLETED|Washout Period of 1 Week||0
346862|NCT01288859|831398|P5|NOT COMPLETED|Washout Period of 1 Week||0
346863|NCT01288859|831399|P4|NOT COMPLETED|Washout Period of 1 Week||0
346864|NCT01288859|831400|P3|NOT COMPLETED|Washout Period of 1 Week||0
346865|NCT01288859|831401|P2|NOT COMPLETED|Washout Period of 1 Week||0
346866|NCT01288859|831402|P1|NOT COMPLETED|Washout Period of 1 Week||0
346867|NCT01288859|831397|P6|COMPLETED|Washout Period of 1 Week||0
346868|NCT01288859|831398|P5|COMPLETED|Washout Period of 1 Week||5
346869|NCT01288859|831399|P4|COMPLETED|Washout Period of 1 Week||5
346870|NCT01288859|831400|P3|COMPLETED|Washout Period of 1 Week||0
346871|NCT01288859|831401|P2|COMPLETED|Washout Period of 1 Week||0
346872|NCT01288859|831402|P1|COMPLETED|Washout Period of 1 Week||0
346873|NCT01288859|831397|P6|STARTED|Washout Period of 1 Week||0
346874|NCT01288859|831398|P5|STARTED|Washout Period of 1 Week||5
346875|NCT01288859|831399|P4|STARTED|Washout Period of 1 Week||5
346876|NCT01288859|831400|P3|STARTED|Washout Period of 1 Week||0
346877|NCT01288859|831401|P2|STARTED|Washout Period of 1 Week||0
346878|NCT01288859|831402|P1|STARTED|Washout Period of 1 Week||0
346879|NCT01288859|831397|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346880|NCT01288859|831398|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346881|NCT01288859|831399|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346882|NCT01288859|831400|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346883|NCT01288859|831401|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346884|NCT01288859|831402|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346885|NCT01288859|831397|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346886|NCT01288859|831398|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
346887|NCT01288859|831399|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
346888|NCT01288859|831400|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346889|NCT01288859|831401|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346890|NCT01288859|831402|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
346891|NCT01288859|831397|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
346892|NCT01288859|831398|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
346893|NCT01288859|831399|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
346894|NCT01288859|831400|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
346895|NCT01288859|831401|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
346896|NCT01288859|831402|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
346897|NCT01288859|831397|P6|NOT COMPLETED|Washout Period of 1 Week||0
346898|NCT01288859|831398|P5|NOT COMPLETED|Washout Period of 1 Week||0
346899|NCT01288859|831399|P4|NOT COMPLETED|Washout Period of 1 Week||0
346900|NCT01288859|831400|P3|NOT COMPLETED|Washout Period of 1 Week||0
346901|NCT01288859|831401|P2|NOT COMPLETED|Washout Period of 1 Week||0
346902|NCT01288859|831402|P1|NOT COMPLETED|Washout Period of 1 Week||0
346903|NCT01288859|831397|P6|COMPLETED|Washout Period of 1 Week||0
346904|NCT01288859|831398|P5|COMPLETED|Washout Period of 1 Week||5
346905|NCT01288859|831399|P4|COMPLETED|Washout Period of 1 Week||5
346906|NCT01288859|831400|P3|COMPLETED|Washout Period of 1 Week||0
346907|NCT01288859|831401|P2|COMPLETED|Washout Period of 1 Week||0
346908|NCT01288859|831402|P1|COMPLETED|Washout Period of 1 Week||0
346909|NCT01288859|831397|P6|STARTED|Washout Period of 1 Week||0
346910|NCT01288859|831398|P5|STARTED|Washout Period of 1 Week||5
346911|NCT01288859|831399|P4|STARTED|Washout Period of 1 Week||5
346912|NCT01288859|831400|P3|STARTED|Washout Period of 1 Week||0
346913|NCT01288859|831401|P2|STARTED|Washout Period of 1 Week||0
346914|NCT01288859|831402|P1|STARTED|Washout Period of 1 Week||0
346915|NCT01288859|831397|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346916|NCT01288859|831398|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346917|NCT01288859|831399|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346918|NCT01288859|831400|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346919|NCT01288859|831401|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346920|NCT01288859|831402|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346921|NCT01288859|831397|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346922|NCT01288859|831398|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346923|NCT01288859|831399|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346924|NCT01288859|831400|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
346925|NCT01288859|831401|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
346926|NCT01288859|831402|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346927|NCT01288859|831397|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346928|NCT01288859|831398|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346929|NCT01288859|831399|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346930|NCT01288859|831400|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
346931|NCT01288859|831401|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
346932|NCT01288859|831402|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
346933|NCT01288859|831397|P6|NOT COMPLETED|Washout Period of 1 Week||0
346934|NCT01288859|831398|P5|NOT COMPLETED|Washout Period of 1 Week||0
346935|NCT01288859|831399|P4|NOT COMPLETED|Washout Period of 1 Week||0
346936|NCT01288859|831400|P3|NOT COMPLETED|Washout Period of 1 Week||0
346937|NCT01288859|831401|P2|NOT COMPLETED|Washout Period of 1 Week||0
346938|NCT01288859|831402|P1|NOT COMPLETED|Washout Period of 1 Week||0
346939|NCT01288859|831397|P6|COMPLETED|Washout Period of 1 Week||0
346940|NCT01288859|831398|P5|COMPLETED|Washout Period of 1 Week||0
346941|NCT01288859|831399|P4|COMPLETED|Washout Period of 1 Week||0
346942|NCT01288859|831400|P3|COMPLETED|Washout Period of 1 Week||5
346943|NCT01288859|831401|P2|COMPLETED|Washout Period of 1 Week||5
346944|NCT01288859|831402|P1|COMPLETED|Washout Period of 1 Week||0
346945|NCT01288859|831397|P6|STARTED|Washout Period of 1 Week||0
346946|NCT01288859|831398|P5|STARTED|Washout Period of 1 Week||0
346947|NCT01288859|831399|P4|STARTED|Washout Period of 1 Week||0
346948|NCT01288859|831400|P3|STARTED|Washout Period of 1 Week||5
346949|NCT01288859|831401|P2|STARTED|Washout Period of 1 Week||5
346950|NCT01288859|831402|P1|STARTED|Washout Period of 1 Week||0
346951|NCT01288859|831397|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346952|NCT01288859|831398|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346953|NCT01288859|831399|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346954|NCT01288859|831400|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346955|NCT01288859|831401|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346956|NCT01288859|831402|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346957|NCT01288859|831397|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346958|NCT01288859|831398|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346959|NCT01288859|831399|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346960|NCT01288859|831400|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
346961|NCT01288859|831401|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
346962|NCT01288859|831402|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346963|NCT01288859|831397|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346964|NCT01288859|831398|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346965|NCT01288859|831399|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346966|NCT01288859|831400|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
346967|NCT01288859|831401|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
346968|NCT01288859|831402|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
346969|NCT01288859|831397|P6|NOT COMPLETED|Washout Period of 1 Week||0
346970|NCT01288859|831398|P5|NOT COMPLETED|Washout Period of 1 Week||0
346971|NCT01288859|831399|P4|NOT COMPLETED|Washout Period of 1 Week||0
346972|NCT01288859|831400|P3|NOT COMPLETED|Washout Period of 1 Week||0
346973|NCT01288859|831401|P2|NOT COMPLETED|Washout Period of 1 Week||0
346974|NCT01288859|831402|P1|NOT COMPLETED|Washout Period of 1 Week||0
346975|NCT01288859|831397|P6|COMPLETED|Washout Period of 1 Week||5
346976|NCT01288859|831398|P5|COMPLETED|Washout Period of 1 Week||0
346977|NCT01288859|831399|P4|COMPLETED|Washout Period of 1 Week||0
346978|NCT01288859|831400|P3|COMPLETED|Washout Period of 1 Week||0
346979|NCT01288859|831401|P2|COMPLETED|Washout Period of 1 Week||0
346980|NCT01288859|831402|P1|COMPLETED|Washout Period of 1 Week||5
346981|NCT01288859|831397|P6|STARTED|Washout Period of 1 Week||5
346982|NCT01288859|831398|P5|STARTED|Washout Period of 1 Week||0
346983|NCT01288859|831399|P4|STARTED|Washout Period of 1 Week||0
346984|NCT01288859|831400|P3|STARTED|Washout Period of 1 Week||0
346985|NCT01288859|831401|P2|STARTED|Washout Period of 1 Week||0
346986|NCT01288859|831402|P1|STARTED|Washout Period of 1 Week||5
346987|NCT01288859|831397|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346988|NCT01288859|831398|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346989|NCT01288859|831399|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346990|NCT01288859|831400|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346991|NCT01288859|831401|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346992|NCT01288859|831402|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346993|NCT01288859|831397|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
346994|NCT01288859|831398|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346995|NCT01288859|831399|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346996|NCT01288859|831400|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346997|NCT01288859|831401|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
346998|NCT01288859|831402|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
346999|NCT01288859|831397|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
347000|NCT01288859|831398|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
347001|NCT01288859|831399|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
347002|NCT01288859|831400|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
347003|NCT01288859|831401|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
347004|NCT01288859|831402|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
347005|NCT01288859|831397|P6|NOT COMPLETED|Washout Period of 1 Week||0
347006|NCT01288859|831398|P5|NOT COMPLETED|Washout Period of 1 Week||0
347007|NCT01288859|831399|P4|NOT COMPLETED|Washout Period of 1 Week||0
347008|NCT01288859|831400|P3|NOT COMPLETED|Washout Period of 1 Week||0
347009|NCT01288859|831401|P2|NOT COMPLETED|Washout Period of 1 Week||0
347010|NCT01288859|831402|P1|NOT COMPLETED|Washout Period of 1 Week||0
347011|NCT01288859|831397|P6|COMPLETED|Washout Period of 1 Week||5
347012|NCT01288859|831398|P5|COMPLETED|Washout Period of 1 Week||0
347013|NCT01288859|831399|P4|COMPLETED|Washout Period of 1 Week||0
347014|NCT01288859|831400|P3|COMPLETED|Washout Period of 1 Week||0
347015|NCT01288859|831401|P2|COMPLETED|Washout Period of 1 Week||0
347016|NCT01288859|831402|P1|COMPLETED|Washout Period of 1 Week||5
347017|NCT01288859|831397|P6|STARTED|Washout Period of 1 Week||5
347018|NCT01288859|831398|P5|STARTED|Washout Period of 1 Week||0
347019|NCT01288859|831399|P4|STARTED|Washout Period of 1 Week||0
347020|NCT01288859|831400|P3|STARTED|Washout Period of 1 Week||0
347021|NCT01288859|831401|P2|STARTED|Washout Period of 1 Week||0
347022|NCT01288859|831402|P1|STARTED|Washout Period of 1 Week||5
347023|NCT01288859|831397|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347024|NCT01288859|831398|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347025|NCT01288859|831399|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347026|NCT01288859|831400|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347027|NCT01288859|831401|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347028|NCT01288859|831402|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347029|NCT01288859|831397|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
347030|NCT01288859|831398|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347031|NCT01288859|831399|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347032|NCT01288859|831400|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347033|NCT01288859|831401|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
347034|NCT01288859|831402|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
347035|NCT01288859|831397|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
347036|NCT01288859|831398|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
347037|NCT01288859|831399|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
347038|NCT01288859|831400|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
347039|NCT01288859|831401|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
347040|NCT01288859|831402|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
347041|NCT01288781|831430|P2|NOT COMPLETED|Overall Study||0
347042|NCT01288781|831431|P1|NOT COMPLETED|Overall Study||0
347043|NCT01288781|831430|P2|COMPLETED|Overall Study||12
347044|NCT01288781|831431|P1|COMPLETED|Overall Study||11
347045|NCT01288781|831430|P2|STARTED|Overall Study||12
347046|NCT01288781|831431|P1|STARTED|Overall Study||11
347047|NCT01288729|831451|P2|NOT COMPLETED|Overall Study||0
347048|NCT01288729|831452|P1|NOT COMPLETED|Overall Study||1
347049|NCT01288729|831451|P2|COMPLETED|Overall Study||10
347050|NCT01288729|831452|P1|COMPLETED|Overall Study||9
347051|NCT01288729|831451|P2|STARTED|Overall Study||10
347052|NCT01288729|831452|P1|STARTED|Overall Study||10
347053|NCT01288612|831461|P3|NOT COMPLETED|Overall Study||82
347054|NCT01288612|831462|P2|NOT COMPLETED|Overall Study||82
347055|NCT01288612|831463|P1|NOT COMPLETED|Overall Study||89
347056|NCT01288612|831461|P3|COMPLETED|Overall Study||76
347057|NCT01288612|831462|P2|COMPLETED|Overall Study||69
347058|NCT01288612|831463|P1|COMPLETED|Overall Study||61
347059|NCT01288612|831461|P3|Agreed to Take Part|Overall Study||76
347060|NCT01288612|831462|P2|Agreed to Take Part|Overall Study||72
347061|NCT01288612|831463|P1|Agreed to Take Part|Overall Study||61
347062|NCT01288612|831461|P3|Contacted|Overall Study||138
347063|NCT01288612|831462|P2|Contacted|Overall Study||135
347064|NCT01288612|831463|P1|Contacted|Overall Study||139
347065|NCT01288612|831461|P3|STARTED|Overall Study||158
347066|NCT01288612|831462|P2|STARTED|Overall Study||151
347067|NCT01288612|831463|P1|STARTED|Overall Study||150
347068|NCT01288534|831492|P1|NOT COMPLETED|Overall Study||0
347069|NCT01288534|831492|P1|COMPLETED|Overall Study||68
347070|NCT01288534|831492|P1|STARTED|Overall Study||68
347071|NCT01288469|831499|P3|NOT COMPLETED|Overall Study||2
347072|NCT01288469|831500|P2|NOT COMPLETED|Overall Study||3
347073|NCT01288469|831501|P1|NOT COMPLETED|Overall Study||7
347074|NCT01288469|831499|P3|COMPLETED|Overall Study||28
347075|NCT01288469|831500|P2|COMPLETED|Overall Study||28
347076|NCT01288469|831501|P1|COMPLETED|Overall Study||24
347077|NCT01288469|831499|P3|Treated|Overall Study||30
347078|NCT01288469|831500|P2|Treated|Overall Study||31
347079|NCT01288469|831501|P1|Treated|Overall Study||31
347080|NCT01288469|831499|P3|STARTED|Overall Study|Randomized|30
347081|NCT01288469|831500|P2|STARTED|Overall Study|Randomized|31
347082|NCT01288469|831501|P1|STARTED|Overall Study|Randomized|31
347083|NCT01288443|831533|P6|NOT COMPLETED|Overall Study||5
347084|NCT01288443|831534|P5|NOT COMPLETED|Overall Study||7
347085|NCT01288443|831535|P4|NOT COMPLETED|Overall Study||4
347086|NCT01288443|831536|P3|NOT COMPLETED|Overall Study||1
347087|NCT01288443|831537|P2|NOT COMPLETED|Overall Study||1
347088|NCT01288443|831538|P1|NOT COMPLETED|Overall Study||0
347089|NCT01288443|831533|P6|COMPLETED|Overall Study||25
347090|NCT01288443|831534|P5|COMPLETED|Overall Study||23
347091|NCT01288443|831535|P4|COMPLETED|Overall Study||27
347092|NCT01288443|831536|P3|COMPLETED|Overall Study||30
347093|NCT01288443|831537|P2|COMPLETED|Overall Study||29
347094|NCT01288443|831538|P1|COMPLETED|Overall Study||31
347095|NCT01288443|831533|P6|Treated|Overall Study||30
347096|NCT01288443|831534|P5|Treated|Overall Study||29
347097|NCT01288443|831535|P4|Treated|Overall Study||31
347098|NCT01288443|831536|P3|Treated|Overall Study||31
347099|NCT01288443|831537|P2|Treated|Overall Study||30
347100|NCT01288443|831538|P1|Treated|Overall Study||31
347101|NCT01288443|831533|P6|STARTED|Overall Study|Randomized|30
347102|NCT01288443|831534|P5|STARTED|Overall Study|Randomized|30
347103|NCT01288443|831535|P4|STARTED|Overall Study|Randomized|31
347104|NCT01288443|831536|P3|STARTED|Overall Study|Randomized|31
347105|NCT01288443|831537|P2|STARTED|Overall Study|Randomized|30
347106|NCT01288443|831538|P1|STARTED|Overall Study|Randomized|31
347107|NCT01288287|831588|P1|NOT COMPLETED|Overall Study||46
347108|NCT01288287|831588|P1|COMPLETED|Overall Study||103
347109|NCT01288287|831588|P1|Full Analysis Set|Overall Study||111
347110|NCT01288287|831588|P1|Safety Set|Overall Study||147
347111|NCT01288287|831588|P1|STARTED|Overall Study||149
347112|NCT01288209|831603|P2|NOT COMPLETED|Overall Study||3
347113|NCT01288209|831604|P1|NOT COMPLETED|Overall Study||2
347114|NCT01288209|831603|P2|COMPLETED|Overall Study||50
347115|NCT01288209|831604|P1|COMPLETED|Overall Study||51
347116|NCT01288209|831603|P2|STARTED|Overall Study||53
347117|NCT01288209|831604|P1|STARTED|Overall Study||53
347118|NCT01288079|831634|P4|NOT COMPLETED|Overall Study||17
347119|NCT01288079|831635|P3|NOT COMPLETED|Overall Study||19
347120|NCT01288079|831636|P2|NOT COMPLETED|Overall Study||27
347121|NCT01288079|831637|P1|NOT COMPLETED|Overall Study||20
347122|NCT01288079|831634|P4|COMPLETED|Overall Study||18
347123|NCT01288079|831635|P3|COMPLETED|Overall Study||18
347124|NCT01288079|831636|P2|COMPLETED|Overall Study||9
347125|NCT01288079|831637|P1|COMPLETED|Overall Study||17
347126|NCT01288079|831634|P4|STARTED|Overall Study||35
347127|NCT01288079|831635|P3|STARTED|Overall Study||37
347128|NCT01288079|831636|P2|STARTED|Overall Study||36
347129|NCT01288079|831637|P1|STARTED|Overall Study||37
347130|NCT01288027|831647|P1|NOT COMPLETED|Overall Study||0
347131|NCT01288027|831647|P1|COMPLETED|Overall Study||16
347132|NCT01288027|831647|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
347133|NCT01288027|831647|P1|STARTED|Overall Study||16
347134|NCT01287897|831661|P4|NOT COMPLETED|Overall Study||7
347135|NCT01287897|831662|P3|NOT COMPLETED|Overall Study||12
347136|NCT01287897|831663|P2|NOT COMPLETED|Overall Study||11
347137|NCT01287897|831664|P1|NOT COMPLETED|Overall Study||11
347218|NCT01287403|831785|P1|STARTED|3rd Intervention (1 Day)||13
347138|NCT01287897|831661|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
347139|NCT01287897|831662|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
347140|NCT01287897|831663|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
347141|NCT01287897|831664|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
347142|NCT01287897|831661|P4|Enrolled in NCT01345318|Overall Study||29
347143|NCT01287897|831662|P3|Enrolled in NCT01345318|Overall Study||56
347144|NCT01287897|831663|P2|Enrolled in NCT01345318|Overall Study||50
347145|NCT01287897|831664|P1|Enrolled in NCT01345318|Overall Study||56
347146|NCT01287897|831661|P4|Completed Follow-up Period|Overall Study||4
347147|NCT01287897|831662|P3|Completed Follow-up Period|Overall Study||3
347148|NCT01287897|831663|P2|Completed Follow-up Period|Overall Study||8
347149|NCT01287897|831664|P1|Completed Follow-up Period|Overall Study||3
347150|NCT01287897|831661|P4|Completed Treatment Period|Overall Study||29
347151|NCT01287897|831662|P3|Completed Treatment Period|Overall Study||58
347152|NCT01287897|831663|P2|Completed Treatment Period|Overall Study||52
347153|NCT01287897|831664|P1|Completed Treatment Period|Overall Study||58
347154|NCT01287897|831661|P4|Treated|Overall Study||40
347155|NCT01287897|831662|P3|Treated|Overall Study||71
347156|NCT01287897|831663|P2|Treated|Overall Study||67
347157|NCT01287897|831664|P1|Treated|Overall Study||69
347158|NCT01287897|831661|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
347159|NCT01287897|831662|P3|STARTED|Overall Study||71
347160|NCT01287897|831663|P2|STARTED|Overall Study||69
347161|NCT01287897|831664|P1|STARTED|Overall Study||70
347162|NCT01287832|831715|P2|NOT COMPLETED|Overall Study||1
347163|NCT01287832|831716|P1|NOT COMPLETED|Overall Study||1
347164|NCT01287832|831715|P2|COMPLETED|Overall Study||4
347165|NCT01287832|831716|P1|COMPLETED|Overall Study||5
347166|NCT01287832|831715|P2|STARTED|Overall Study||5
347167|NCT01287832|831716|P1|STARTED|Overall Study||6
347168|NCT01287754|831724|P2|NOT COMPLETED|Overall Study||21
347169|NCT01287754|831725|P1|NOT COMPLETED|Overall Study||3
347170|NCT01287754|831724|P2|COMPLETED|Overall Study||0
347171|NCT01287754|831725|P1|COMPLETED|Overall Study||0
347172|NCT01287754|831724|P2|STARTED|Overall Study||21
347173|NCT01287754|831725|P1|STARTED|Overall Study||3
347174|NCT01287611|831737|P2|NOT COMPLETED|Overall Study||19
347175|NCT01287611|831738|P1|NOT COMPLETED|Overall Study||33
347176|NCT01287611|831737|P2|COMPLETED|Overall Study||65
347177|NCT01287611|831738|P1|COMPLETED|Overall Study||51
347178|NCT01287611|831737|P2|The Number of Patients Who Underwent C/S|Overall Study||84
347179|NCT01287611|831738|P1|The Number of Patients Who Underwent C/S|Overall Study||84
347180|NCT01287611|831737|P2|STARTED|Overall Study||84
347181|NCT01287611|831738|P1|STARTED|Overall Study||84
347182|NCT01287416|831748|P2|NOT COMPLETED|6 Month Follow-up||2
347183|NCT01287416|831749|P1|NOT COMPLETED|6 Month Follow-up||3
347184|NCT01287416|831748|P2|COMPLETED|6 Month Follow-up||22
347185|NCT01287416|831749|P1|COMPLETED|6 Month Follow-up||28
347186|NCT01287416|831748|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
347187|NCT01287416|831749|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
347188|NCT01287416|831748|P2|NOT COMPLETED|Pre-post Training||25
347189|NCT01287416|831749|P1|NOT COMPLETED|Pre-post Training||22
347190|NCT01287416|831748|P2|COMPLETED|Pre-post Training||23
347191|NCT01287416|831749|P1|COMPLETED|Pre-post Training||26
347192|NCT01287416|831748|P2|Post Training Questionnaire|Pre-post Training||23
347193|NCT01287416|831749|P1|Post Training Questionnaire|Pre-post Training||26
347194|NCT01287416|831748|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
347195|NCT01287416|831749|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
347196|NCT01287416|831748|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
347197|NCT01287416|831749|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
347198|NCT01287403|831785|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
347199|NCT01287403|831785|P1|COMPLETED|6th and Last Intervention (1 Day)||13
347200|NCT01287403|831785|P1|STARTED|6th and Last Intervention (1 Day)||13
347201|NCT01287403|831785|P1|NOT COMPLETED|Washout (7 Days)||0
347202|NCT01287403|831785|P1|COMPLETED|Washout (7 Days)||13
347203|NCT01287403|831785|P1|STARTED|Washout (7 Days)||13
347204|NCT01287403|831785|P1|NOT COMPLETED|5th Intervention (1 Day)||0
347205|NCT01287403|831785|P1|COMPLETED|5th Intervention (1 Day)||13
347206|NCT01287403|831785|P1|STARTED|5th Intervention (1 Day)||13
347207|NCT01287403|831785|P1|NOT COMPLETED|Washout (7 Days)||0
347208|NCT01287403|831785|P1|COMPLETED|Washout (7 Days)||13
347209|NCT01287403|831785|P1|STARTED|Washout (7 Days)||13
347210|NCT01287403|831785|P1|NOT COMPLETED|4th Intervention (1 Day)||0
347211|NCT01287403|831785|P1|COMPLETED|4th Intervention (1 Day)||13
347212|NCT01287403|831785|P1|STARTED|4th Intervention (1 Day)||13
347213|NCT01287403|831785|P1|NOT COMPLETED|Washout (7 Days)||0
347214|NCT01287403|831785|P1|COMPLETED|Washout (7 Days)||13
347215|NCT01287403|831785|P1|STARTED|Washout (7 Days)||13
347216|NCT01287403|831785|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
347217|NCT01287403|831785|P1|COMPLETED|3rd Intervention (1 Day)||13
347219|NCT01287403|831785|P1|NOT COMPLETED|Washout (7 Days)||0
347220|NCT01287403|831785|P1|COMPLETED|Washout (7 Days)||13
347221|NCT01287403|831785|P1|STARTED|Washout (7 Days)||13
347222|NCT01287403|831785|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
347223|NCT01287403|831785|P1|COMPLETED|2nd Intervention (1 Day)||13
347224|NCT01287403|831785|P1|STARTED|2nd Intervention (1 Day)||13
347225|NCT01287403|831785|P1|NOT COMPLETED|Washout 7 Days||0
347226|NCT01287403|831785|P1|COMPLETED|Washout 7 Days||13
347227|NCT01287403|831785|P1|STARTED|Washout 7 Days||13
347228|NCT01287403|831785|P1|NOT COMPLETED|1st Intervention (1 Day)||1
347229|NCT01287403|831785|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
347230|NCT01287403|831785|P1|STARTED|1st Intervention (1 Day)||14
347231|NCT01287403|831785|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
347232|NCT01287403|831785|P1|COMPLETED|Diet Restriction (7 Days)||14
347233|NCT01287403|831785|P1|STARTED|Diet Restriction (7 Days)||14
347234|NCT01287364|831801|P2|NOT COMPLETED|Overall Study||10
347235|NCT01287364|831802|P1|NOT COMPLETED|Overall Study||9
347236|NCT01287364|831801|P2|COMPLETED|Overall Study||81
347237|NCT01287364|831802|P1|COMPLETED|Overall Study||85
347238|NCT01287364|831801|P2|STARTED|Overall Study||91
347239|NCT01287364|831802|P1|STARTED|Overall Study||94
347240|NCT01287221|831824|P2|NOT COMPLETED|Overall Study||5
347241|NCT01287221|831825|P1|NOT COMPLETED|Overall Study||4
347242|NCT01287221|831824|P2|COMPLETED|Overall Study||45
347243|NCT01287221|831825|P1|COMPLETED|Overall Study||46
347244|NCT01287221|831824|P2|Completed 12 Months Follow-up|Overall Study||39
347245|NCT01287221|831825|P1|Completed 12 Months Follow-up|Overall Study||40
347246|NCT01287221|831824|P2|Completed 9 Months Follow-up|Overall Study||40
347247|NCT01287221|831825|P1|Completed 9 Months Follow-up|Overall Study||42
347248|NCT01287221|831824|P2|Completed 6 Months Follow-up|Overall Study||43
347249|NCT01287221|831825|P1|Completed 6 Months Follow-up|Overall Study||47
347250|NCT01287221|831824|P2|Completed 3 Months Follow-up|Overall Study||50
347251|NCT01287221|831825|P1|Completed 3 Months Follow-up|Overall Study||49
347252|NCT01287221|831824|P2|STARTED|Overall Study||50
347253|NCT01287221|831825|P1|STARTED|Overall Study||50
347254|NCT01287208|831845|P2|NOT COMPLETED|Phase 2: Team Competition||0
347255|NCT01287208|831846|P1|NOT COMPLETED|Phase 2: Team Competition||0
347256|NCT01287208|831845|P2|COMPLETED|Phase 2: Team Competition||49
347257|NCT01287208|831846|P1|COMPLETED|Phase 2: Team Competition||50
347258|NCT01287208|831845|P2|STARTED|Phase 2: Team Competition||49
347259|NCT01287208|831846|P1|STARTED|Phase 2: Team Competition||50
347260|NCT01287208|831845|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
347261|NCT01287208|831846|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
347262|NCT01287208|831845|P2|COMPLETED|Phase 1: Randomized Phase||49
347263|NCT01287208|831846|P1|COMPLETED|Phase 1: Randomized Phase||50
347264|NCT01287208|831845|P2|STARTED|Phase 1: Randomized Phase||52
347265|NCT01287208|831846|P1|STARTED|Phase 1: Randomized Phase||52
347266|NCT01287195|831852|P1|NOT COMPLETED|Overall Study||2
347267|NCT01287195|831852|P1|COMPLETED|Overall Study||4
347268|NCT01287195|831852|P1|STARTED|Overall Study||6
347269|NCT01287117|831867|P4|NOT COMPLETED|Overall Study||12
347270|NCT01287117|831868|P3|NOT COMPLETED|Overall Study||16
347271|NCT01287117|831869|P2|NOT COMPLETED|Overall Study||14
347272|NCT01287117|831870|P1|NOT COMPLETED|Overall Study||15
347273|NCT01287117|831867|P4|COMPLETED|Overall Study||69
347274|NCT01287117|831868|P3|COMPLETED|Overall Study||64
347275|NCT01287117|831869|P2|COMPLETED|Overall Study||64
347276|NCT01287117|831870|P1|COMPLETED|Overall Study||65
347277|NCT01287117|831867|P4|Received Treatment|Overall Study||81
347278|NCT01287117|831868|P3|Received Treatment|Overall Study||80
347279|NCT01287117|831869|P2|Received Treatment|Overall Study||77
347280|NCT01287117|831870|P1|Received Treatment|Overall Study||80
347281|NCT01287117|831867|P4|STARTED|Overall Study||81
347282|NCT01287117|831868|P3|STARTED|Overall Study||80
347283|NCT01287117|831869|P2|STARTED|Overall Study||78
347284|NCT01287117|831870|P1|STARTED|Overall Study||80
347285|NCT01287065|831916|P6|NOT COMPLETED|Treatment Period 3||0
347286|NCT01287065|831917|P5|NOT COMPLETED|Treatment Period 3||0
347287|NCT01287065|831918|P4|NOT COMPLETED|Treatment Period 3||0
347288|NCT01287065|831919|P3|NOT COMPLETED|Treatment Period 3||0
347289|NCT01287065|831920|P2|NOT COMPLETED|Treatment Period 3||0
347290|NCT01287065|831921|P1|NOT COMPLETED|Treatment Period 3||0
347291|NCT01287065|831916|P6|COMPLETED|Treatment Period 3||4
347292|NCT01287065|831917|P5|COMPLETED|Treatment Period 3||4
347293|NCT01287065|831918|P4|COMPLETED|Treatment Period 3||4
347294|NCT01287065|831919|P3|COMPLETED|Treatment Period 3||4
347295|NCT01287065|831920|P2|COMPLETED|Treatment Period 3||4
347296|NCT01287065|831921|P1|COMPLETED|Treatment Period 3||4
347297|NCT01287065|831916|P6|STARTED|Treatment Period 3||4
347298|NCT01287065|831917|P5|STARTED|Treatment Period 3||4
347299|NCT01287065|831918|P4|STARTED|Treatment Period 3||4
347300|NCT01287065|831919|P3|STARTED|Treatment Period 3||4
347301|NCT01287065|831920|P2|STARTED|Treatment Period 3||4
347302|NCT01287065|831921|P1|STARTED|Treatment Period 3||4
347303|NCT01287065|831916|P6|NOT COMPLETED|Washout Period 2||0
347304|NCT01287065|831917|P5|NOT COMPLETED|Washout Period 2||0
347305|NCT01287065|831918|P4|NOT COMPLETED|Washout Period 2||0
347306|NCT01287065|831919|P3|NOT COMPLETED|Washout Period 2||0
347307|NCT01287065|831920|P2|NOT COMPLETED|Washout Period 2||0
347308|NCT01287065|831921|P1|NOT COMPLETED|Washout Period 2||0
347309|NCT01287065|831916|P6|COMPLETED|Washout Period 2||4
347310|NCT01287065|831917|P5|COMPLETED|Washout Period 2||4
347311|NCT01287065|831918|P4|COMPLETED|Washout Period 2||4
347312|NCT01287065|831919|P3|COMPLETED|Washout Period 2||4
347313|NCT01287065|831920|P2|COMPLETED|Washout Period 2||4
347314|NCT01287065|831921|P1|COMPLETED|Washout Period 2||4
347315|NCT01287065|831916|P6|STARTED|Washout Period 2||4
347316|NCT01287065|831917|P5|STARTED|Washout Period 2||4
347317|NCT01287065|831918|P4|STARTED|Washout Period 2||4
347318|NCT01287065|831919|P3|STARTED|Washout Period 2||4
347319|NCT01287065|831920|P2|STARTED|Washout Period 2||4
347320|NCT01287065|831921|P1|STARTED|Washout Period 2||4
347321|NCT01287065|831916|P6|NOT COMPLETED|Treatment Period 2||0
347322|NCT01287065|831917|P5|NOT COMPLETED|Treatment Period 2||0
347323|NCT01287065|831918|P4|NOT COMPLETED|Treatment Period 2||0
347324|NCT01287065|831919|P3|NOT COMPLETED|Treatment Period 2||0
347325|NCT01287065|831920|P2|NOT COMPLETED|Treatment Period 2||0
347326|NCT01287065|831921|P1|NOT COMPLETED|Treatment Period 2||0
347327|NCT01287065|831916|P6|COMPLETED|Treatment Period 2||4
347328|NCT01287065|831917|P5|COMPLETED|Treatment Period 2||4
347329|NCT01287065|831918|P4|COMPLETED|Treatment Period 2||4
347330|NCT01287065|831919|P3|COMPLETED|Treatment Period 2||4
347331|NCT01287065|831920|P2|COMPLETED|Treatment Period 2||4
347332|NCT01287065|831921|P1|COMPLETED|Treatment Period 2||4
347333|NCT01287065|831916|P6|STARTED|Treatment Period 2||4
347334|NCT01287065|831917|P5|STARTED|Treatment Period 2||4
347335|NCT01287065|831918|P4|STARTED|Treatment Period 2||4
347336|NCT01287065|831919|P3|STARTED|Treatment Period 2||4
347337|NCT01287065|831920|P2|STARTED|Treatment Period 2||4
347338|NCT01287065|831921|P1|STARTED|Treatment Period 2||4
347339|NCT01287065|831916|P6|NOT COMPLETED|Washout Period 1||0
347340|NCT01287065|831917|P5|NOT COMPLETED|Washout Period 1||0
347341|NCT01287065|831918|P4|NOT COMPLETED|Washout Period 1||0
347342|NCT01287065|831919|P3|NOT COMPLETED|Washout Period 1||0
347343|NCT01287065|831920|P2|NOT COMPLETED|Washout Period 1||0
347344|NCT01287065|831921|P1|NOT COMPLETED|Washout Period 1||0
347345|NCT01287065|831916|P6|COMPLETED|Washout Period 1||4
347346|NCT01287065|831917|P5|COMPLETED|Washout Period 1||4
347347|NCT01287065|831918|P4|COMPLETED|Washout Period 1||4
347348|NCT01287065|831919|P3|COMPLETED|Washout Period 1||4
347349|NCT01287065|831920|P2|COMPLETED|Washout Period 1||4
347350|NCT01287065|831921|P1|COMPLETED|Washout Period 1||4
347351|NCT01287065|831916|P6|STARTED|Washout Period 1||4
347352|NCT01287065|831917|P5|STARTED|Washout Period 1||4
347353|NCT01287065|831918|P4|STARTED|Washout Period 1||4
347354|NCT01287065|831919|P3|STARTED|Washout Period 1||4
347355|NCT01287065|831920|P2|STARTED|Washout Period 1||4
347356|NCT01287065|831921|P1|STARTED|Washout Period 1||4
347357|NCT01287065|831916|P6|NOT COMPLETED|Treatment Period 1||1
347358|NCT01287065|831917|P5|NOT COMPLETED|Treatment Period 1||1
347359|NCT01287065|831918|P4|NOT COMPLETED|Treatment Period 1||0
347360|NCT01287065|831919|P3|NOT COMPLETED|Treatment Period 1||0
347361|NCT01287065|831920|P2|NOT COMPLETED|Treatment Period 1||0
347362|NCT01287065|831921|P1|NOT COMPLETED|Treatment Period 1||0
347363|NCT01287065|831916|P6|COMPLETED|Treatment Period 1||4
347364|NCT01287065|831917|P5|COMPLETED|Treatment Period 1||4
347365|NCT01287065|831918|P4|COMPLETED|Treatment Period 1||4
347366|NCT01287065|831919|P3|COMPLETED|Treatment Period 1||4
347367|NCT01287065|831920|P2|COMPLETED|Treatment Period 1||4
347368|NCT01287065|831921|P1|COMPLETED|Treatment Period 1||4
347369|NCT01287065|831916|P6|STARTED|Treatment Period 1||5
347370|NCT01287065|831917|P5|STARTED|Treatment Period 1||5
347371|NCT01287065|831918|P4|STARTED|Treatment Period 1||4
347372|NCT01287065|831919|P3|STARTED|Treatment Period 1||4
347373|NCT01287065|831920|P2|STARTED|Treatment Period 1||4
347374|NCT01287065|831921|P1|STARTED|Treatment Period 1||4
347375|NCT01287039|831940|P2|NOT COMPLETED|Overall Study||27
347376|NCT01287039|831941|P1|NOT COMPLETED|Overall Study||29
347377|NCT01287039|831940|P2|COMPLETED|Overall Study||218
347378|NCT01287039|831941|P1|COMPLETED|Overall Study||215
347379|NCT01287039|831940|P2|STARTED|Overall Study||245
347380|NCT01287039|831941|P1|STARTED|Overall Study||244
347381|NCT01286818|831971|P1|NOT COMPLETED|Overall Study||0
347382|NCT01286818|831971|P1|COMPLETED|Overall Study||6
347383|NCT01286818|831971|P1|Completed DLT Assessment Period|Overall Study||5
347384|NCT01286818|831971|P1|STARTED|Overall Study||6
347385|NCT01286805|831985|P2|NOT COMPLETED|Overall Study||1
347386|NCT01286805|831986|P1|NOT COMPLETED|Overall Study||0
347387|NCT01286805|831985|P2|COMPLETED|Overall Study||41
347388|NCT01286805|831986|P1|COMPLETED|Overall Study||41
347389|NCT01286805|831985|P2|STARTED|Overall Study||42
347390|NCT01286805|831986|P1|STARTED|Overall Study||41
347391|NCT01286753|832008|P2|NOT COMPLETED|Overall Study||25
347392|NCT01286753|832009|P1|NOT COMPLETED|Overall Study||26
347393|NCT01286753|832008|P2|COMPLETED|Overall Study||0
347394|NCT01286753|832009|P1|COMPLETED|Overall Study||0
347395|NCT01286753|832008|P2|STARTED|Overall Study||25
347396|NCT01286753|832009|P1|STARTED|Overall Study||26
347397|NCT01286740|832027|P1|NOT COMPLETED|Overall Study||2
347398|NCT01286740|832027|P1|COMPLETED|Overall Study||48
347399|NCT01286740|832027|P1|Week 12 (Primary Endpoint)|Overall Study||49
347400|NCT01286740|832027|P1|Enrolled and Treated|Overall Study||49
347401|NCT01286740|832027|P1|STARTED|Overall Study||50
347402|NCT01286558|832045|P2|NOT COMPLETED|Overall Study||2
347403|NCT01286558|832046|P1|NOT COMPLETED|Overall Study||1
347404|NCT01286558|832045|P2|COMPLETED|Overall Study||111
347405|NCT01286558|832046|P1|COMPLETED|Overall Study||111
347406|NCT01286558|832045|P2|STARTED|Overall Study||113
347407|NCT01286558|832046|P1|STARTED|Overall Study||112
347408|NCT01286493|832076|P1|NOT COMPLETED|Overall Study||3
347409|NCT01286493|832076|P1|COMPLETED|Overall Study||30
347410|NCT01286493|832076|P1|STARTED|Overall Study||33
347411|NCT01286454|832080|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
347412|NCT01286454|832081|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
347413|NCT01286454|832082|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
347414|NCT01286454|832083|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
347415|NCT01286454|832084|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
347416|NCT01286454|832085|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
347417|NCT01286454|832086|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
347418|NCT01286454|832087|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
347419|NCT01286454|832088|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
347420|NCT01286454|832089|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
347421|NCT01286454|832090|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
347422|NCT01286454|832080|P11|COMPLETED|Part II- Sixth Intervention Period||20
347423|NCT01286454|832081|P10|COMPLETED|Part II- Sixth Intervention Period||0
347424|NCT01286454|832082|P9|COMPLETED|Part II- Sixth Intervention Period||0
347425|NCT01286454|832083|P8|COMPLETED|Part II- Sixth Intervention Period||0
347426|NCT01286454|832084|P7|COMPLETED|Part II- Sixth Intervention Period||0
347427|NCT01286454|832085|P6|COMPLETED|Part II- Sixth Intervention Period||0
347428|NCT01286454|832086|P5|COMPLETED|Part II- Sixth Intervention Period||0
347429|NCT01286454|832087|P4|COMPLETED|Part II- Sixth Intervention Period||0
347430|NCT01286454|832088|P3|COMPLETED|Part II- Sixth Intervention Period||0
347431|NCT01286454|832089|P2|COMPLETED|Part II- Sixth Intervention Period||0
347432|NCT01286454|832090|P1|COMPLETED|Part II- Sixth Intervention Period||0
347433|NCT01286454|832080|P11|STARTED|Part II- Sixth Intervention Period||20
347434|NCT01286454|832081|P10|STARTED|Part II- Sixth Intervention Period||0
347435|NCT01286454|832082|P9|STARTED|Part II- Sixth Intervention Period||0
347436|NCT01286454|832083|P8|STARTED|Part II- Sixth Intervention Period||0
347437|NCT01286454|832084|P7|STARTED|Part II- Sixth Intervention Period||0
347438|NCT01286454|832085|P6|STARTED|Part II- Sixth Intervention Period||0
347439|NCT01286454|832086|P5|STARTED|Part II- Sixth Intervention Period||0
347440|NCT01286454|832087|P4|STARTED|Part II- Sixth Intervention Period||0
347441|NCT01286454|832088|P3|STARTED|Part II- Sixth Intervention Period||0
347442|NCT01286454|832089|P2|STARTED|Part II- Sixth Intervention Period||0
347443|NCT01286454|832090|P1|STARTED|Part II- Sixth Intervention Period||0
347444|NCT01286454|832080|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347445|NCT01286454|832081|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347446|NCT01286454|832082|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347447|NCT01286454|832083|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347448|NCT01286454|832084|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347449|NCT01286454|832085|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347450|NCT01286454|832086|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347451|NCT01286454|832087|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347452|NCT01286454|832088|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347453|NCT01286454|832089|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347454|NCT01286454|832090|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
347455|NCT01286454|832080|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
347456|NCT01286454|832081|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347457|NCT01286454|832082|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347458|NCT01286454|832083|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347459|NCT01286454|832084|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347460|NCT01286454|832085|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347461|NCT01286454|832086|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347462|NCT01286454|832087|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347463|NCT01286454|832088|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347464|NCT01286454|832089|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347465|NCT01286454|832090|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
347466|NCT01286454|832080|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
347467|NCT01286454|832081|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
347468|NCT01286454|832082|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
347469|NCT01286454|832083|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
347470|NCT01286454|832084|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
347471|NCT01286454|832085|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
347472|NCT01286454|832086|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
347473|NCT01286454|832087|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
347474|NCT01286454|832088|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
347475|NCT01286454|832089|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
347476|NCT01286454|832090|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
347477|NCT01286454|832080|P11|NOT COMPLETED|Fifth Intervention Period||0
347478|NCT01286454|832081|P10|NOT COMPLETED|Fifth Intervention Period||0
347479|NCT01286454|832082|P9|NOT COMPLETED|Fifth Intervention Period||0
347480|NCT01286454|832083|P8|NOT COMPLETED|Fifth Intervention Period||0
347481|NCT01286454|832084|P7|NOT COMPLETED|Fifth Intervention Period||0
347482|NCT01286454|832085|P6|NOT COMPLETED|Fifth Intervention Period||0
347483|NCT01286454|832086|P5|NOT COMPLETED|Fifth Intervention Period||0
347484|NCT01286454|832087|P4|NOT COMPLETED|Fifth Intervention Period||0
347485|NCT01286454|832088|P3|NOT COMPLETED|Fifth Intervention Period||0
347486|NCT01286454|832089|P2|NOT COMPLETED|Fifth Intervention Period||0
347487|NCT01286454|832090|P1|NOT COMPLETED|Fifth Intervention Period||0
347488|NCT01286454|832080|P11|COMPLETED|Fifth Intervention Period||0
347489|NCT01286454|832081|P10|COMPLETED|Fifth Intervention Period||2
347490|NCT01286454|832082|P9|COMPLETED|Fifth Intervention Period||2
347491|NCT01286454|832083|P8|COMPLETED|Fifth Intervention Period||2
347492|NCT01286454|832084|P7|COMPLETED|Fifth Intervention Period||2
347493|NCT01286454|832085|P6|COMPLETED|Fifth Intervention Period||2
347494|NCT01286454|832086|P5|COMPLETED|Fifth Intervention Period||2
347495|NCT01286454|832087|P4|COMPLETED|Fifth Intervention Period||2
347496|NCT01286454|832088|P3|COMPLETED|Fifth Intervention Period||2
347497|NCT01286454|832089|P2|COMPLETED|Fifth Intervention Period||2
347498|NCT01286454|832090|P1|COMPLETED|Fifth Intervention Period||2
347499|NCT01286454|832080|P11|STARTED|Fifth Intervention Period||0
347500|NCT01286454|832081|P10|STARTED|Fifth Intervention Period||2
347501|NCT01286454|832082|P9|STARTED|Fifth Intervention Period||2
347502|NCT01286454|832083|P8|STARTED|Fifth Intervention Period||2
347503|NCT01286454|832084|P7|STARTED|Fifth Intervention Period||2
347504|NCT01286454|832085|P6|STARTED|Fifth Intervention Period||2
347505|NCT01286454|832086|P5|STARTED|Fifth Intervention Period||2
347506|NCT01286454|832087|P4|STARTED|Fifth Intervention Period||2
347507|NCT01286454|832088|P3|STARTED|Fifth Intervention Period||2
347508|NCT01286454|832089|P2|STARTED|Fifth Intervention Period||2
347509|NCT01286454|832090|P1|STARTED|Fifth Intervention Period||2
347510|NCT01286454|832080|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347511|NCT01286454|832081|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347512|NCT01286454|832082|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347513|NCT01286454|832083|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347514|NCT01286454|832084|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347515|NCT01286454|832085|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347516|NCT01286454|832086|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347517|NCT01286454|832087|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347518|NCT01286454|832088|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347519|NCT01286454|832089|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347520|NCT01286454|832090|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347521|NCT01286454|832080|P11|COMPLETED|Washout Period (At Least 3 Days)||0
347522|NCT01286454|832081|P10|COMPLETED|Washout Period (At Least 3 Days)||2
347523|NCT01286454|832082|P9|COMPLETED|Washout Period (At Least 3 Days)||2
347524|NCT01286454|832083|P8|COMPLETED|Washout Period (At Least 3 Days)||2
347525|NCT01286454|832084|P7|COMPLETED|Washout Period (At Least 3 Days)||2
347526|NCT01286454|832085|P6|COMPLETED|Washout Period (At Least 3 Days)||2
347527|NCT01286454|832086|P5|COMPLETED|Washout Period (At Least 3 Days)||2
347528|NCT01286454|832087|P4|COMPLETED|Washout Period (At Least 3 Days)||2
347529|NCT01286454|832088|P3|COMPLETED|Washout Period (At Least 3 Days)||2
347530|NCT01286454|832089|P2|COMPLETED|Washout Period (At Least 3 Days)||2
347531|NCT01286454|832090|P1|COMPLETED|Washout Period (At Least 3 Days)||2
347532|NCT01286454|832080|P11|STARTED|Washout Period (At Least 3 Days)||0
347533|NCT01286454|832081|P10|STARTED|Washout Period (At Least 3 Days)||2
347534|NCT01286454|832082|P9|STARTED|Washout Period (At Least 3 Days)||2
347535|NCT01286454|832083|P8|STARTED|Washout Period (At Least 3 Days)||2
347536|NCT01286454|832084|P7|STARTED|Washout Period (At Least 3 Days)||2
347537|NCT01286454|832085|P6|STARTED|Washout Period (At Least 3 Days)||2
347538|NCT01286454|832086|P5|STARTED|Washout Period (At Least 3 Days)||2
347539|NCT01286454|832087|P4|STARTED|Washout Period (At Least 3 Days)||2
347540|NCT01286454|832088|P3|STARTED|Washout Period (At Least 3 Days)||2
347541|NCT01286454|832089|P2|STARTED|Washout Period (At Least 3 Days)||2
347542|NCT01286454|832090|P1|STARTED|Washout Period (At Least 3 Days)||2
347543|NCT01286454|832080|P11|NOT COMPLETED|Fourth Intervention Period||0
347544|NCT01286454|832081|P10|NOT COMPLETED|Fourth Intervention Period||0
347545|NCT01286454|832082|P9|NOT COMPLETED|Fourth Intervention Period||0
347546|NCT01286454|832083|P8|NOT COMPLETED|Fourth Intervention Period||0
347547|NCT01286454|832084|P7|NOT COMPLETED|Fourth Intervention Period||0
347548|NCT01286454|832085|P6|NOT COMPLETED|Fourth Intervention Period||0
347549|NCT01286454|832086|P5|NOT COMPLETED|Fourth Intervention Period||0
347550|NCT01286454|832087|P4|NOT COMPLETED|Fourth Intervention Period||0
347551|NCT01286454|832088|P3|NOT COMPLETED|Fourth Intervention Period||0
347552|NCT01286454|832089|P2|NOT COMPLETED|Fourth Intervention Period||0
347553|NCT01286454|832090|P1|NOT COMPLETED|Fourth Intervention Period||0
347554|NCT01286454|832080|P11|COMPLETED|Fourth Intervention Period||0
347555|NCT01286454|832081|P10|COMPLETED|Fourth Intervention Period||2
347556|NCT01286454|832082|P9|COMPLETED|Fourth Intervention Period||2
347557|NCT01286454|832083|P8|COMPLETED|Fourth Intervention Period||2
347558|NCT01286454|832084|P7|COMPLETED|Fourth Intervention Period||2
347559|NCT01286454|832085|P6|COMPLETED|Fourth Intervention Period||2
347560|NCT01286454|832086|P5|COMPLETED|Fourth Intervention Period||2
347561|NCT01286454|832087|P4|COMPLETED|Fourth Intervention Period||2
347562|NCT01286454|832088|P3|COMPLETED|Fourth Intervention Period||2
347563|NCT01286454|832089|P2|COMPLETED|Fourth Intervention Period||2
347564|NCT01286454|832090|P1|COMPLETED|Fourth Intervention Period||2
347565|NCT01286454|832080|P11|STARTED|Fourth Intervention Period||0
347566|NCT01286454|832081|P10|STARTED|Fourth Intervention Period||2
347567|NCT01286454|832082|P9|STARTED|Fourth Intervention Period||2
347568|NCT01286454|832083|P8|STARTED|Fourth Intervention Period||2
347569|NCT01286454|832084|P7|STARTED|Fourth Intervention Period||2
347570|NCT01286454|832085|P6|STARTED|Fourth Intervention Period||2
347571|NCT01286454|832086|P5|STARTED|Fourth Intervention Period||2
347572|NCT01286454|832087|P4|STARTED|Fourth Intervention Period||2
347573|NCT01286454|832088|P3|STARTED|Fourth Intervention Period||2
347574|NCT01286454|832089|P2|STARTED|Fourth Intervention Period||2
347575|NCT01286454|832090|P1|STARTED|Fourth Intervention Period||2
347576|NCT01286454|832080|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347577|NCT01286454|832081|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347578|NCT01286454|832082|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347579|NCT01286454|832083|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347580|NCT01286454|832084|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347581|NCT01286454|832085|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347582|NCT01286454|832086|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347583|NCT01286454|832087|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347584|NCT01286454|832088|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347585|NCT01286454|832089|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347586|NCT01286454|832090|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347587|NCT01286454|832080|P11|COMPLETED|Washout Period (At Least 3 Days)||0
347588|NCT01286454|832081|P10|COMPLETED|Washout Period (At Least 3 Days)||2
347589|NCT01286454|832082|P9|COMPLETED|Washout Period (At Least 3 Days)||2
347590|NCT01286454|832083|P8|COMPLETED|Washout Period (At Least 3 Days)||2
347591|NCT01286454|832084|P7|COMPLETED|Washout Period (At Least 3 Days)||2
347592|NCT01286454|832085|P6|COMPLETED|Washout Period (At Least 3 Days)||2
347593|NCT01286454|832086|P5|COMPLETED|Washout Period (At Least 3 Days)||2
347594|NCT01286454|832087|P4|COMPLETED|Washout Period (At Least 3 Days)||2
347595|NCT01286454|832088|P3|COMPLETED|Washout Period (At Least 3 Days)||2
347596|NCT01286454|832089|P2|COMPLETED|Washout Period (At Least 3 Days)||2
347597|NCT01286454|832090|P1|COMPLETED|Washout Period (At Least 3 Days)||2
347598|NCT01286454|832080|P11|STARTED|Washout Period (At Least 3 Days)||0
347599|NCT01286454|832081|P10|STARTED|Washout Period (At Least 3 Days)||2
347600|NCT01286454|832082|P9|STARTED|Washout Period (At Least 3 Days)||2
347601|NCT01286454|832083|P8|STARTED|Washout Period (At Least 3 Days)||2
347602|NCT01286454|832084|P7|STARTED|Washout Period (At Least 3 Days)||2
347603|NCT01286454|832085|P6|STARTED|Washout Period (At Least 3 Days)||2
347604|NCT01286454|832086|P5|STARTED|Washout Period (At Least 3 Days)||2
347605|NCT01286454|832087|P4|STARTED|Washout Period (At Least 3 Days)||2
347606|NCT01286454|832088|P3|STARTED|Washout Period (At Least 3 Days)||2
347607|NCT01286454|832089|P2|STARTED|Washout Period (At Least 3 Days)||2
347608|NCT01286454|832090|P1|STARTED|Washout Period (At Least 3 Days)||2
347609|NCT01286454|832080|P11|NOT COMPLETED|Third Intervention Period||0
347610|NCT01286454|832081|P10|NOT COMPLETED|Third Intervention Period||0
347611|NCT01286454|832082|P9|NOT COMPLETED|Third Intervention Period||0
347612|NCT01286454|832083|P8|NOT COMPLETED|Third Intervention Period||0
347613|NCT01286454|832084|P7|NOT COMPLETED|Third Intervention Period||0
347614|NCT01286454|832085|P6|NOT COMPLETED|Third Intervention Period||0
347615|NCT01286454|832086|P5|NOT COMPLETED|Third Intervention Period||0
347616|NCT01286454|832087|P4|NOT COMPLETED|Third Intervention Period||0
347617|NCT01286454|832088|P3|NOT COMPLETED|Third Intervention Period||0
347618|NCT01286454|832089|P2|NOT COMPLETED|Third Intervention Period||0
347619|NCT01286454|832090|P1|NOT COMPLETED|Third Intervention Period||0
347620|NCT01286454|832080|P11|COMPLETED|Third Intervention Period||0
347621|NCT01286454|832081|P10|COMPLETED|Third Intervention Period||2
347622|NCT01286454|832082|P9|COMPLETED|Third Intervention Period||2
347623|NCT01286454|832083|P8|COMPLETED|Third Intervention Period||2
347624|NCT01286454|832084|P7|COMPLETED|Third Intervention Period||2
347625|NCT01286454|832085|P6|COMPLETED|Third Intervention Period||2
347626|NCT01286454|832086|P5|COMPLETED|Third Intervention Period||2
347627|NCT01286454|832087|P4|COMPLETED|Third Intervention Period||2
347628|NCT01286454|832088|P3|COMPLETED|Third Intervention Period||2
347629|NCT01286454|832089|P2|COMPLETED|Third Intervention Period||2
347630|NCT01286454|832090|P1|COMPLETED|Third Intervention Period||2
347631|NCT01286454|832080|P11|STARTED|Third Intervention Period||0
347632|NCT01286454|832081|P10|STARTED|Third Intervention Period||2
347633|NCT01286454|832082|P9|STARTED|Third Intervention Period||2
347634|NCT01286454|832083|P8|STARTED|Third Intervention Period||2
347635|NCT01286454|832084|P7|STARTED|Third Intervention Period||2
347636|NCT01286454|832085|P6|STARTED|Third Intervention Period||2
347637|NCT01286454|832086|P5|STARTED|Third Intervention Period||2
347638|NCT01286454|832087|P4|STARTED|Third Intervention Period||2
347639|NCT01286454|832088|P3|STARTED|Third Intervention Period||2
347640|NCT01286454|832089|P2|STARTED|Third Intervention Period||2
347641|NCT01286454|832090|P1|STARTED|Third Intervention Period||2
347642|NCT01286454|832080|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347643|NCT01286454|832081|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347644|NCT01286454|832082|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347645|NCT01286454|832083|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347646|NCT01286454|832084|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347647|NCT01286454|832085|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347648|NCT01286454|832086|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347649|NCT01286454|832087|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347650|NCT01286454|832088|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347651|NCT01286454|832089|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347652|NCT01286454|832090|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347653|NCT01286454|832080|P11|COMPLETED|Washout Period (At Least 3 Days)||0
347654|NCT01286454|832081|P10|COMPLETED|Washout Period (At Least 3 Days)||2
347655|NCT01286454|832082|P9|COMPLETED|Washout Period (At Least 3 Days)||2
347656|NCT01286454|832083|P8|COMPLETED|Washout Period (At Least 3 Days)||2
347657|NCT01286454|832084|P7|COMPLETED|Washout Period (At Least 3 Days)||2
347658|NCT01286454|832085|P6|COMPLETED|Washout Period (At Least 3 Days)||2
347659|NCT01286454|832086|P5|COMPLETED|Washout Period (At Least 3 Days)||2
347660|NCT01286454|832087|P4|COMPLETED|Washout Period (At Least 3 Days)||2
347661|NCT01286454|832088|P3|COMPLETED|Washout Period (At Least 3 Days)||2
347662|NCT01286454|832089|P2|COMPLETED|Washout Period (At Least 3 Days)||2
347663|NCT01286454|832090|P1|COMPLETED|Washout Period (At Least 3 Days)||2
347664|NCT01286454|832080|P11|STARTED|Washout Period (At Least 3 Days)||0
347665|NCT01286454|832081|P10|STARTED|Washout Period (At Least 3 Days)||2
347666|NCT01286454|832082|P9|STARTED|Washout Period (At Least 3 Days)||2
347667|NCT01286454|832083|P8|STARTED|Washout Period (At Least 3 Days)||2
347668|NCT01286454|832084|P7|STARTED|Washout Period (At Least 3 Days)||2
347669|NCT01286454|832085|P6|STARTED|Washout Period (At Least 3 Days)||2
347670|NCT01286454|832086|P5|STARTED|Washout Period (At Least 3 Days)||2
347671|NCT01286454|832087|P4|STARTED|Washout Period (At Least 3 Days)||2
347672|NCT01286454|832088|P3|STARTED|Washout Period (At Least 3 Days)||2
347673|NCT01286454|832089|P2|STARTED|Washout Period (At Least 3 Days)||2
347674|NCT01286454|832090|P1|STARTED|Washout Period (At Least 3 Days)||2
347675|NCT01286454|832080|P11|NOT COMPLETED|Second Intervention Period||0
347676|NCT01286454|832081|P10|NOT COMPLETED|Second Intervention Period||0
347677|NCT01286454|832082|P9|NOT COMPLETED|Second Intervention Period||0
347678|NCT01286454|832083|P8|NOT COMPLETED|Second Intervention Period||0
347679|NCT01286454|832084|P7|NOT COMPLETED|Second Intervention Period||0
347680|NCT01286454|832085|P6|NOT COMPLETED|Second Intervention Period||0
347681|NCT01286454|832086|P5|NOT COMPLETED|Second Intervention Period||0
347682|NCT01286454|832087|P4|NOT COMPLETED|Second Intervention Period||0
347683|NCT01286454|832088|P3|NOT COMPLETED|Second Intervention Period||0
347684|NCT01286454|832089|P2|NOT COMPLETED|Second Intervention Period||0
347685|NCT01286454|832090|P1|NOT COMPLETED|Second Intervention Period||0
347686|NCT01286454|832080|P11|COMPLETED|Second Intervention Period||0
347687|NCT01286454|832081|P10|COMPLETED|Second Intervention Period||2
347688|NCT01286454|832082|P9|COMPLETED|Second Intervention Period||2
347689|NCT01286454|832083|P8|COMPLETED|Second Intervention Period||2
347690|NCT01286454|832084|P7|COMPLETED|Second Intervention Period||2
347691|NCT01286454|832085|P6|COMPLETED|Second Intervention Period||2
347692|NCT01286454|832086|P5|COMPLETED|Second Intervention Period||2
347693|NCT01286454|832087|P4|COMPLETED|Second Intervention Period||2
347694|NCT01286454|832088|P3|COMPLETED|Second Intervention Period||2
347695|NCT01286454|832089|P2|COMPLETED|Second Intervention Period||2
347696|NCT01286454|832090|P1|COMPLETED|Second Intervention Period||2
347697|NCT01286454|832080|P11|STARTED|Second Intervention Period||0
347698|NCT01286454|832081|P10|STARTED|Second Intervention Period||2
347699|NCT01286454|832082|P9|STARTED|Second Intervention Period||2
347700|NCT01286454|832083|P8|STARTED|Second Intervention Period||2
347701|NCT01286454|832084|P7|STARTED|Second Intervention Period||2
347702|NCT01286454|832085|P6|STARTED|Second Intervention Period||2
347703|NCT01286454|832086|P5|STARTED|Second Intervention Period||2
347704|NCT01286454|832087|P4|STARTED|Second Intervention Period||2
347705|NCT01286454|832088|P3|STARTED|Second Intervention Period||2
347706|NCT01286454|832089|P2|STARTED|Second Intervention Period||2
347707|NCT01286454|832090|P1|STARTED|Second Intervention Period||2
347708|NCT01286454|832080|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347709|NCT01286454|832081|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347710|NCT01286454|832082|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347711|NCT01286454|832083|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347712|NCT01286454|832084|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347713|NCT01286454|832085|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347714|NCT01286454|832086|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347715|NCT01286454|832087|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347716|NCT01286454|832088|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347717|NCT01286454|832089|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347718|NCT01286454|832090|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
347719|NCT01286454|832080|P11|COMPLETED|Washout Period (At Least 3 Days)||0
347720|NCT01286454|832081|P10|COMPLETED|Washout Period (At Least 3 Days)||2
347721|NCT01286454|832082|P9|COMPLETED|Washout Period (At Least 3 Days)||2
347722|NCT01286454|832083|P8|COMPLETED|Washout Period (At Least 3 Days)||2
347723|NCT01286454|832084|P7|COMPLETED|Washout Period (At Least 3 Days)||2
347724|NCT01286454|832085|P6|COMPLETED|Washout Period (At Least 3 Days)||2
347725|NCT01286454|832086|P5|COMPLETED|Washout Period (At Least 3 Days)||2
347726|NCT01286454|832087|P4|COMPLETED|Washout Period (At Least 3 Days)||2
347727|NCT01286454|832088|P3|COMPLETED|Washout Period (At Least 3 Days)||2
347728|NCT01286454|832089|P2|COMPLETED|Washout Period (At Least 3 Days)||2
347729|NCT01286454|832090|P1|COMPLETED|Washout Period (At Least 3 Days)||2
347730|NCT01286454|832080|P11|STARTED|Washout Period (At Least 3 Days)||0
347731|NCT01286454|832081|P10|STARTED|Washout Period (At Least 3 Days)||2
347732|NCT01286454|832082|P9|STARTED|Washout Period (At Least 3 Days)||2
347733|NCT01286454|832083|P8|STARTED|Washout Period (At Least 3 Days)||2
347734|NCT01286454|832084|P7|STARTED|Washout Period (At Least 3 Days)||2
347735|NCT01286454|832085|P6|STARTED|Washout Period (At Least 3 Days)||2
347736|NCT01286454|832086|P5|STARTED|Washout Period (At Least 3 Days)||2
347737|NCT01286454|832087|P4|STARTED|Washout Period (At Least 3 Days)||2
347738|NCT01286454|832088|P3|STARTED|Washout Period (At Least 3 Days)||2
347739|NCT01286454|832089|P2|STARTED|Washout Period (At Least 3 Days)||2
347740|NCT01286454|832090|P1|STARTED|Washout Period (At Least 3 Days)||2
347741|NCT01286454|832080|P11|NOT COMPLETED|Part I- First Intervention Period||0
347742|NCT01286454|832081|P10|NOT COMPLETED|Part I- First Intervention Period||0
347743|NCT01286454|832082|P9|NOT COMPLETED|Part I- First Intervention Period||0
347744|NCT01286454|832083|P8|NOT COMPLETED|Part I- First Intervention Period||0
347745|NCT01286454|832084|P7|NOT COMPLETED|Part I- First Intervention Period||0
347746|NCT01286454|832085|P6|NOT COMPLETED|Part I- First Intervention Period||0
347747|NCT01286454|832086|P5|NOT COMPLETED|Part I- First Intervention Period||0
347748|NCT01286454|832087|P4|NOT COMPLETED|Part I- First Intervention Period||0
347749|NCT01286454|832088|P3|NOT COMPLETED|Part I- First Intervention Period||0
347750|NCT01286454|832089|P2|NOT COMPLETED|Part I- First Intervention Period||0
347751|NCT01286454|832090|P1|NOT COMPLETED|Part I- First Intervention Period||0
347752|NCT01286454|832080|P11|COMPLETED|Part I- First Intervention Period||0
347753|NCT01286454|832081|P10|COMPLETED|Part I- First Intervention Period||2
347754|NCT01286454|832082|P9|COMPLETED|Part I- First Intervention Period||2
347755|NCT01286454|832083|P8|COMPLETED|Part I- First Intervention Period||2
347756|NCT01286454|832084|P7|COMPLETED|Part I- First Intervention Period||2
347757|NCT01286454|832085|P6|COMPLETED|Part I- First Intervention Period||2
347758|NCT01286454|832086|P5|COMPLETED|Part I- First Intervention Period||2
347759|NCT01286454|832087|P4|COMPLETED|Part I- First Intervention Period||2
347760|NCT01286454|832088|P3|COMPLETED|Part I- First Intervention Period||2
347761|NCT01286454|832089|P2|COMPLETED|Part I- First Intervention Period||2
347762|NCT01286454|832090|P1|COMPLETED|Part I- First Intervention Period||2
347763|NCT01286454|832080|P11|STARTED|Part I- First Intervention Period||0
347764|NCT01286454|832081|P10|STARTED|Part I- First Intervention Period||2
347765|NCT01286454|832082|P9|STARTED|Part I- First Intervention Period||2
347766|NCT01286454|832083|P8|STARTED|Part I- First Intervention Period||2
347767|NCT01286454|832084|P7|STARTED|Part I- First Intervention Period||2
347768|NCT01286454|832085|P6|STARTED|Part I- First Intervention Period||2
347769|NCT01286454|832086|P5|STARTED|Part I- First Intervention Period||2
347770|NCT01286454|832087|P4|STARTED|Part I- First Intervention Period||2
347771|NCT01286454|832088|P3|STARTED|Part I- First Intervention Period||2
347772|NCT01286454|832089|P2|STARTED|Part I- First Intervention Period||2
347773|NCT01286454|832090|P1|STARTED|Part I- First Intervention Period||2
347774|NCT01286402|832130|P2|NOT COMPLETED|Overall Study||0
347775|NCT01286402|832131|P1|NOT COMPLETED|Overall Study||0
347776|NCT01286402|832130|P2|COMPLETED|Overall Study||6
347777|NCT01286402|832131|P1|COMPLETED|Overall Study||5
347778|NCT01286402|832130|P2|STARTED|Overall Study||6
347779|NCT01286402|832131|P1|STARTED|Overall Study||5
347780|NCT01286324|832139|P2|NOT COMPLETED|Overall Study||0
347781|NCT01286324|832140|P1|NOT COMPLETED|Overall Study||0
347782|NCT01286324|832139|P2|COMPLETED|Overall Study||17
347783|NCT01286324|832140|P1|COMPLETED|Overall Study||17
347784|NCT01286324|832139|P2|STARTED|Overall Study||17
347785|NCT01286324|832140|P1|STARTED|Overall Study||17
347786|NCT01286311|832148|P2|NOT COMPLETED|Overall Study||0
347787|NCT01286311|832149|P1|NOT COMPLETED|Overall Study||14
347788|NCT01286311|832148|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
347789|NCT01286311|832149|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
347790|NCT01286311|832148|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
347791|NCT01286311|832149|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
347792|NCT01286207|832166|P3|NOT COMPLETED|Overall Study||90
347793|NCT01286207|832167|P2|NOT COMPLETED|Overall Study||248
347794|NCT01286207|832168|P1|NOT COMPLETED|Overall Study||298
347795|NCT01286207|832166|P3|COMPLETED|Overall Study||261
347796|NCT01286207|832167|P2|COMPLETED|Overall Study||609
347797|NCT01286207|832168|P1|COMPLETED|Overall Study||453
347798|NCT01286207|832166|P3|STARTED|Overall Study||351
347799|NCT01286207|832167|P2|STARTED|Overall Study||857
347800|NCT01286207|832168|P1|STARTED|Overall Study||751
347801|NCT01286168|832188|P1|NOT COMPLETED|Overall Study||3
347802|NCT01286168|832188|P1|COMPLETED|Overall Study||101
347803|NCT01286168|832188|P1|STARTED|Overall Study||104
347804|NCT01286129|832202|P2|NOT COMPLETED|Overall Study||5
347805|NCT01286129|832203|P1|NOT COMPLETED|Overall Study||8
347806|NCT01286129|832202|P2|COMPLETED|Overall Study||13
347807|NCT01286129|832203|P1|COMPLETED|Overall Study||19
347808|NCT01286129|832202|P2|STARTED|Overall Study||18
347809|NCT01286129|832203|P1|STARTED|Overall Study||27
347810|NCT01286077|832213|P2|NOT COMPLETED|Overall Study||7
347811|NCT01286077|832214|P1|NOT COMPLETED|Overall Study||10
347812|NCT01286077|832213|P2|COMPLETED|Overall Study||46
347813|NCT01286077|832214|P1|COMPLETED|Overall Study||41
347814|NCT01286077|832213|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
347815|NCT01286077|832214|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
347816|NCT01286012|832250|P2|NOT COMPLETED|Overall Study||14
347817|NCT01286012|832251|P1|NOT COMPLETED|Overall Study||13
347818|NCT01286012|832250|P2|COMPLETED|Overall Study||40
347819|NCT01286012|832251|P1|COMPLETED|Overall Study||41
347820|NCT01286012|832250|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
347821|NCT01286012|832251|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
347822|NCT01285947|832261|P2|NOT COMPLETED|Overall Study||0
347823|NCT01285947|832262|P1|NOT COMPLETED|Overall Study||0
347824|NCT01285947|832261|P2|COMPLETED|Overall Study||10
347825|NCT01285947|832262|P1|COMPLETED|Overall Study||10
347826|NCT01285947|832261|P2|STARTED|Overall Study||10
347827|NCT01285947|832262|P1|STARTED|Overall Study||10
347828|NCT01285908|832268|P3|NOT COMPLETED|Treatment Crossover||0
347829|NCT01285908|832269|P2|NOT COMPLETED|Treatment Crossover||0
347830|NCT01285908|832270|P1|NOT COMPLETED|Treatment Crossover||0
347831|NCT01285908|832268|P3|COMPLETED|Treatment Crossover||2
347832|NCT01285908|832269|P2|COMPLETED|Treatment Crossover||2
347833|NCT01285908|832270|P1|COMPLETED|Treatment Crossover||0
347834|NCT01285908|832268|P3|STARTED|Treatment Crossover||2
347835|NCT01285908|832269|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
347836|NCT01285908|832270|P1|STARTED|Treatment Crossover||0
347837|NCT01285908|832268|P3|NOT COMPLETED|Baseline Measurement||0
347838|NCT01285908|832269|P2|NOT COMPLETED|Baseline Measurement||0
347839|NCT01285908|832270|P1|NOT COMPLETED|Baseline Measurement||3
347840|NCT01285908|832268|P3|COMPLETED|Baseline Measurement||0
347841|NCT01285908|832269|P2|COMPLETED|Baseline Measurement||0
347842|NCT01285908|832270|P1|COMPLETED|Baseline Measurement||3
347843|NCT01285908|832268|P3|STARTED|Baseline Measurement||0
347844|NCT01285908|832269|P2|STARTED|Baseline Measurement||0
347845|NCT01285908|832270|P1|STARTED|Baseline Measurement||6
347846|NCT01285843|832304|P2|NOT COMPLETED|Overall Study||2
347847|NCT01285843|832305|P1|NOT COMPLETED|Overall Study||2
347848|NCT01285843|832304|P2|COMPLETED|Overall Study||18
347849|NCT01285843|832305|P1|COMPLETED|Overall Study||18
347850|NCT01285843|832304|P2|STARTED|Overall Study||20
347851|NCT01285843|832305|P1|STARTED|Overall Study||20
347852|NCT01285791|832320|P3|NOT COMPLETED|Overall Study||0
347853|NCT01285791|832321|P2|NOT COMPLETED|Overall Study||0
347854|NCT01285791|832322|P1|NOT COMPLETED|Overall Study||0
347855|NCT01285791|832320|P3|COMPLETED|Overall Study||13
347856|NCT01285791|832321|P2|COMPLETED|Overall Study||15
347857|NCT01285791|832322|P1|COMPLETED|Overall Study||11
347858|NCT01285791|832320|P3|STARTED|Overall Study||13
347859|NCT01285791|832321|P2|STARTED|Overall Study||15
347860|NCT01285791|832322|P1|STARTED|Overall Study||11
347861|NCT01285713|832332|P2|NOT COMPLETED|Overall Study||0
347862|NCT01285713|832333|P1|NOT COMPLETED|Overall Study||0
347863|NCT01285713|832332|P2|COMPLETED|Overall Study||41
347864|NCT01285713|832333|P1|COMPLETED|Overall Study||42
347865|NCT01285713|832332|P2|STARTED|Overall Study||41
347866|NCT01285713|832333|P1|STARTED|Overall Study||42
347867|NCT01285635|832342|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
347868|NCT01285635|832343|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
347869|NCT01285635|832344|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
347870|NCT01285635|832342|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
347871|NCT01285635|832343|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
347872|NCT01285635|832344|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
347873|NCT01285635|832342|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
347874|NCT01285635|832343|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
347875|NCT01285635|832344|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
347876|NCT01285635|832342|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
347877|NCT01285635|832343|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
347878|NCT01285635|832344|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
347879|NCT01285635|832342|P3|COMPLETED|First Intervention (2 Weeks)||11
347880|NCT01285635|832343|P2|COMPLETED|First Intervention (2 Weeks)||11
347881|NCT01285635|832344|P1|COMPLETED|First Intervention (2 Weeks)||13
347882|NCT01285635|832342|P3|STARTED|First Intervention (2 Weeks)||11
347883|NCT01285635|832343|P2|STARTED|First Intervention (2 Weeks)||11
347884|NCT01285635|832344|P1|STARTED|First Intervention (2 Weeks)||13
347885|NCT01285609|832364|P2|NOT COMPLETED|Treated With Blinded Therapy||353
347886|NCT01285609|832365|P1|NOT COMPLETED|Treated With Blinded Therapy||379
347887|NCT01285609|832364|P2|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|8
347888|NCT01285609|832365|P1|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|9
347889|NCT01285609|832364|P2|STARTED|Treated With Blinded Therapy||361
347890|NCT01285609|832365|P1|STARTED|Treated With Blinded Therapy||388
347891|NCT01285609|832364|P2|NOT COMPLETED|Randomized||116
347892|NCT01285609|832365|P1|NOT COMPLETED|Randomized||91
347893|NCT01285609|832364|P2|COMPLETED|Randomized||361
347894|NCT01285609|832365|P1|COMPLETED|Randomized||388
347895|NCT01285609|832364|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
347896|NCT01285609|832365|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
347897|NCT01285609|832364|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
347898|NCT01285609|832365|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
347899|NCT01285518|832383|P8|NOT COMPLETED|Overall Study||0
347900|NCT01285518|832384|P7|NOT COMPLETED|Overall Study||0
347901|NCT01285518|832385|P6|NOT COMPLETED|Overall Study||1
347902|NCT01285518|832386|P5|NOT COMPLETED|Overall Study||0
347903|NCT01285518|832387|P4|NOT COMPLETED|Overall Study||0
347904|NCT01285518|832388|P3|NOT COMPLETED|Overall Study||0
347905|NCT01285518|832389|P2|NOT COMPLETED|Overall Study||0
347906|NCT01285518|832390|P1|NOT COMPLETED|Overall Study||0
347907|NCT01285518|832383|P8|COMPLETED|Overall Study||14
347908|NCT01285518|832384|P7|COMPLETED|Overall Study||10
347909|NCT01285518|832385|P6|COMPLETED|Overall Study||9
347910|NCT01285518|832386|P5|COMPLETED|Overall Study||10
347911|NCT01285518|832387|P4|COMPLETED|Overall Study||10
347912|NCT01285518|832388|P3|COMPLETED|Overall Study||10
347913|NCT01285518|832389|P2|COMPLETED|Overall Study||10
347914|NCT01285518|832390|P1|COMPLETED|Overall Study||10
347915|NCT01285518|832383|P8|STARTED|Overall Study||14
347916|NCT01285518|832384|P7|STARTED|Overall Study||10
347917|NCT01285518|832385|P6|STARTED|Overall Study||10
347918|NCT01285518|832386|P5|STARTED|Overall Study||10
347919|NCT01285518|832387|P4|STARTED|Overall Study||10
347920|NCT01285518|832388|P3|STARTED|Overall Study||10
347921|NCT01285518|832389|P2|STARTED|Overall Study||10
347922|NCT01285518|832390|P1|STARTED|Overall Study||10
347923|NCT01285492|832650|P2|NOT COMPLETED|Overall Study||1
347924|NCT01285492|832651|P1|NOT COMPLETED|Overall Study||17
347925|NCT01285492|832650|P2|COMPLETED|Overall Study||38
347926|NCT01285492|832651|P1|COMPLETED|Overall Study||104
347927|NCT01285492|832650|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
347928|NCT01285492|832651|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
347929|NCT01285492|832650|P2|STARTED|Overall Study|All patients randomized to this group|39
347930|NCT01285492|832651|P1|STARTED|Overall Study|All patients randomized to this group|121
347931|NCT01285427|832669|P1|NOT COMPLETED|Overall Study||1
347932|NCT01285427|832669|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
347933|NCT01285427|832669|P1|STARTED|Overall Study||300
347934|NCT01285401|832683|P2|NOT COMPLETED|Overall Study||29
347935|NCT01285401|832684|P1|NOT COMPLETED|Overall Study||17
347936|NCT01285401|832683|P2|COMPLETED|Overall Study||88
347937|NCT01285401|832684|P1|COMPLETED|Overall Study||98
347938|NCT01285401|832683|P2|Treated|Overall Study||116
347939|NCT01285401|832684|P1|Treated|Overall Study||113
347940|NCT01285401|832683|P2|STARTED|Overall Study||117
347941|NCT01285401|832684|P1|STARTED|Overall Study||115
347942|NCT01285323|832724|P2|NOT COMPLETED|Overall Study||30
347943|NCT01285323|832725|P1|NOT COMPLETED|Overall Study||33
347944|NCT01285323|832724|P2|COMPLETED|Overall Study||202
347945|NCT01285323|832725|P1|COMPLETED|Overall Study||199
347946|NCT01285323|832724|P2|Safety Analysis Set|Overall Study||232
347947|NCT01285323|832725|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
347948|NCT01285323|832724|P2|Full Analysis Set|Overall Study||232
347949|NCT01285323|832725|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
347950|NCT01285323|832724|P2|STARTED|Overall Study||232
347951|NCT01285323|832725|P1|STARTED|Overall Study||232
347952|NCT01285310|832760|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
347953|NCT01285310|832761|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
347954|NCT01285310|832762|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
347955|NCT01285310|832763|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
347956|NCT01285310|832764|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
347957|NCT01285310|832760|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
347958|NCT01285310|832761|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
347959|NCT01285310|832762|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
347960|NCT01285310|832763|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
347961|NCT01285310|832764|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
347962|NCT01285310|832760|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
347963|NCT01285310|832761|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
347964|NCT01285310|832762|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
347965|NCT01285310|832763|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
347966|NCT01285310|832764|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
347967|NCT01285310|832760|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
347968|NCT01285310|832761|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
347969|NCT01285310|832762|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
347970|NCT01285310|832763|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
347971|NCT01285310|832764|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
347972|NCT01285310|832760|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
347973|NCT01285310|832761|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
347974|NCT01285310|832762|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
347975|NCT01285310|832763|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
347976|NCT01285310|832764|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
347977|NCT01285310|832760|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
347978|NCT01285310|832761|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
347979|NCT01285310|832762|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
347980|NCT01285310|832763|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
347981|NCT01285310|832764|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
347982|NCT01285076|832997|P1|NOT COMPLETED|Overall Study||0
347983|NCT01285076|832997|P1|COMPLETED|Overall Study||834
347984|NCT01285076|832997|P1|STARTED|Overall Study||834
347985|NCT01285050|833010|P1|NOT COMPLETED|Overall Study||1
347986|NCT01285050|833010|P1|COMPLETED|Overall Study||19
347987|NCT01285050|833010|P1|STARTED|Overall Study||20
347988|NCT01285024|833017|P2|NOT COMPLETED|Overall Study||0
347989|NCT01285024|833018|P1|NOT COMPLETED|Overall Study||0
347990|NCT01285024|833017|P2|COMPLETED|Overall Study||60
347991|NCT01285024|833018|P1|COMPLETED|Overall Study||49
347992|NCT01285024|833017|P2|STARTED|Overall Study||60
347993|NCT01285024|833018|P1|STARTED|Overall Study||49
347994|NCT01284959|833029|P3|NOT COMPLETED|Overall Study||1
347995|NCT01284959|833030|P2|NOT COMPLETED|Overall Study||0
347996|NCT01284959|833031|P1|NOT COMPLETED|Overall Study||1
347997|NCT01284959|833029|P3|COMPLETED|Overall Study||10
347998|NCT01284959|833030|P2|COMPLETED|Overall Study||12
347999|NCT01284959|833031|P1|COMPLETED|Overall Study||10
348000|NCT01284959|833029|P3|STARTED|Overall Study||11
348001|NCT01284959|833030|P2|STARTED|Overall Study||12
348002|NCT01284959|833031|P1|STARTED|Overall Study||11
348003|NCT01284634|833061|P4|NOT COMPLETED|Overall Study||1
348004|NCT01284634|833062|P3|NOT COMPLETED|Overall Study||2
348005|NCT01284634|833063|P2|NOT COMPLETED|Overall Study||0
348006|NCT01284634|833064|P1|NOT COMPLETED|Overall Study||1
348007|NCT01284634|833061|P4|COMPLETED|Overall Study||4
348008|NCT01284634|833062|P3|COMPLETED|Overall Study||5
348009|NCT01284634|833063|P2|COMPLETED|Overall Study||6
348010|NCT01284634|833064|P1|COMPLETED|Overall Study||6
348011|NCT01284634|833061|P4|STARTED|Overall Study||5
348012|NCT01284634|833062|P3|STARTED|Overall Study||7
348013|NCT01284634|833063|P2|STARTED|Overall Study||6
348014|NCT01284634|833064|P1|STARTED|Overall Study||7
348015|NCT01284621|833206|P6|NOT COMPLETED|Third Intervention (8 Days)||0
348016|NCT01284621|833207|P5|NOT COMPLETED|Third Intervention (8 Days)||0
348017|NCT01284621|833208|P4|NOT COMPLETED|Third Intervention (8 Days)||0
348018|NCT01284621|833209|P3|NOT COMPLETED|Third Intervention (8 Days)||0
348019|NCT01284621|833210|P2|NOT COMPLETED|Third Intervention (8 Days)||0
348020|NCT01284621|833211|P1|NOT COMPLETED|Third Intervention (8 Days)||0
348021|NCT01284621|833206|P6|COMPLETED|Third Intervention (8 Days)||4
348022|NCT01284621|833207|P5|COMPLETED|Third Intervention (8 Days)||3
348023|NCT01284621|833208|P4|COMPLETED|Third Intervention (8 Days)||4
348024|NCT01284621|833209|P3|COMPLETED|Third Intervention (8 Days)||4
348025|NCT01284621|833210|P2|COMPLETED|Third Intervention (8 Days)||4
348026|NCT01284621|833211|P1|COMPLETED|Third Intervention (8 Days)||3
348027|NCT01284621|833206|P6|STARTED|Third Intervention (8 Days)||4
348028|NCT01284621|833207|P5|STARTED|Third Intervention (8 Days)||3
348029|NCT01284621|833208|P4|STARTED|Third Intervention (8 Days)||4
348030|NCT01284621|833209|P3|STARTED|Third Intervention (8 Days)||4
348031|NCT01284621|833210|P2|STARTED|Third Intervention (8 Days)||4
348032|NCT01284621|833211|P1|STARTED|Third Intervention (8 Days)||3
348033|NCT01284621|833206|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
348034|NCT01284621|833207|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
348035|NCT01284621|833208|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
348036|NCT01284621|833209|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
348037|NCT01284621|833210|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
348038|NCT01284621|833211|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
348039|NCT01284621|833206|P6|COMPLETED|Washout Period 2 (7 Days)||4
348040|NCT01284621|833207|P5|COMPLETED|Washout Period 2 (7 Days)||3
348041|NCT01284621|833208|P4|COMPLETED|Washout Period 2 (7 Days)||4
348042|NCT01284621|833209|P3|COMPLETED|Washout Period 2 (7 Days)||4
348043|NCT01284621|833210|P2|COMPLETED|Washout Period 2 (7 Days)||4
348044|NCT01284621|833211|P1|COMPLETED|Washout Period 2 (7 Days)||3
348045|NCT01284621|833206|P6|STARTED|Washout Period 2 (7 Days)||4
348046|NCT01284621|833207|P5|STARTED|Washout Period 2 (7 Days)||3
348047|NCT01284621|833208|P4|STARTED|Washout Period 2 (7 Days)||4
348048|NCT01284621|833209|P3|STARTED|Washout Period 2 (7 Days)||4
348049|NCT01284621|833210|P2|STARTED|Washout Period 2 (7 Days)||4
348050|NCT01284621|833211|P1|STARTED|Washout Period 2 (7 Days)||3
348051|NCT01284621|833206|P6|NOT COMPLETED|Second Intervention (8 Days)||0
348052|NCT01284621|833207|P5|NOT COMPLETED|Second Intervention (8 Days)||0
348053|NCT01284621|833208|P4|NOT COMPLETED|Second Intervention (8 Days)||0
348054|NCT01284621|833209|P3|NOT COMPLETED|Second Intervention (8 Days)||0
348055|NCT01284621|833210|P2|NOT COMPLETED|Second Intervention (8 Days)||0
348056|NCT01284621|833211|P1|NOT COMPLETED|Second Intervention (8 Days)||0
348057|NCT01284621|833206|P6|COMPLETED|Second Intervention (8 Days)||4
348058|NCT01284621|833207|P5|COMPLETED|Second Intervention (8 Days)||3
348059|NCT01284621|833208|P4|COMPLETED|Second Intervention (8 Days)||4
348060|NCT01284621|833209|P3|COMPLETED|Second Intervention (8 Days)||4
348061|NCT01284621|833210|P2|COMPLETED|Second Intervention (8 Days)||4
348062|NCT01284621|833211|P1|COMPLETED|Second Intervention (8 Days)||3
348063|NCT01284621|833206|P6|STARTED|Second Intervention (8 Days)||4
348064|NCT01284621|833207|P5|STARTED|Second Intervention (8 Days)||3
348065|NCT01284621|833208|P4|STARTED|Second Intervention (8 Days)||4
348066|NCT01284621|833209|P3|STARTED|Second Intervention (8 Days)||4
348067|NCT01284621|833210|P2|STARTED|Second Intervention (8 Days)||4
348068|NCT01284621|833211|P1|STARTED|Second Intervention (8 Days)||3
348069|NCT01284621|833206|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
348070|NCT01284621|833207|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
348071|NCT01284621|833208|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
348072|NCT01284621|833209|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
348073|NCT01284621|833210|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
348074|NCT01284621|833211|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
348075|NCT01284621|833206|P6|COMPLETED|Washout Period 1 (7 Days)||4
348076|NCT01284621|833207|P5|COMPLETED|Washout Period 1 (7 Days)||3
348077|NCT01284621|833208|P4|COMPLETED|Washout Period 1 (7 Days)||4
348078|NCT01284621|833209|P3|COMPLETED|Washout Period 1 (7 Days)||4
348079|NCT01284621|833210|P2|COMPLETED|Washout Period 1 (7 Days)||4
348080|NCT01284621|833211|P1|COMPLETED|Washout Period 1 (7 Days)||3
348081|NCT01284621|833206|P6|STARTED|Washout Period 1 (7 Days)||4
348082|NCT01284621|833207|P5|STARTED|Washout Period 1 (7 Days)||4
348083|NCT01284621|833208|P4|STARTED|Washout Period 1 (7 Days)||4
348084|NCT01284621|833209|P3|STARTED|Washout Period 1 (7 Days)||4
348085|NCT01284621|833210|P2|STARTED|Washout Period 1 (7 Days)||4
348086|NCT01284621|833211|P1|STARTED|Washout Period 1 (7 Days)||3
348087|NCT01284621|833206|P6|NOT COMPLETED|First Intervention (8 Days)||0
348088|NCT01284621|833207|P5|NOT COMPLETED|First Intervention (8 Days)||0
348089|NCT01284621|833208|P4|NOT COMPLETED|First Intervention (8 Days)||0
348090|NCT01284621|833209|P3|NOT COMPLETED|First Intervention (8 Days)||0
348091|NCT01284621|833210|P2|NOT COMPLETED|First Intervention (8 Days)||0
348092|NCT01284621|833211|P1|NOT COMPLETED|First Intervention (8 Days)||0
348093|NCT01284621|833206|P6|COMPLETED|First Intervention (8 Days)||4
348094|NCT01284621|833207|P5|COMPLETED|First Intervention (8 Days)||4
348095|NCT01284621|833208|P4|COMPLETED|First Intervention (8 Days)||4
348096|NCT01284621|833209|P3|COMPLETED|First Intervention (8 Days)||4
348097|NCT01284621|833210|P2|COMPLETED|First Intervention (8 Days)||4
348098|NCT01284621|833211|P1|COMPLETED|First Intervention (8 Days)||3
348099|NCT01284621|833206|P6|STARTED|First Intervention (8 Days)||4
348100|NCT01284621|833207|P5|STARTED|First Intervention (8 Days)||4
348101|NCT01284621|833208|P4|STARTED|First Intervention (8 Days)||4
348102|NCT01284621|833209|P3|STARTED|First Intervention (8 Days)||4
348103|NCT01284621|833210|P2|STARTED|First Intervention (8 Days)||4
348104|NCT01284621|833211|P1|STARTED|First Intervention (8 Days)||3
348105|NCT01284517|833255|P2|NOT COMPLETED|Overall Study||36
348106|NCT01284517|833256|P1|NOT COMPLETED|Overall Study||32
348107|NCT01284517|833255|P2|COMPLETED|Overall Study||140
348108|NCT01284517|833256|P1|COMPLETED|Overall Study||148
348109|NCT01284517|833255|P2|STARTED|Overall Study||176
348110|NCT01284517|833256|P1|STARTED|Overall Study||180
348111|NCT01284504|833268|P2|NOT COMPLETED|Overall Study||0
348112|NCT01284504|833269|P1|NOT COMPLETED|Overall Study||1
348113|NCT01284504|833268|P2|COMPLETED|Overall Study||0
348114|NCT01284504|833269|P1|COMPLETED|Overall Study||0
348115|NCT01284504|833268|P2|STARTED|Overall Study||0
348116|NCT01284504|833269|P1|STARTED|Overall Study|Patient changed her mind before randomization to any of the treatment groups|1
348117|NCT01284491|833275|P1|NOT COMPLETED|Overall Study||13
348118|NCT01284491|833275|P1|COMPLETED|Overall Study||0
348119|NCT01284491|833275|P1|STARTED|Overall Study||13
348120|NCT01284426|833281|P1|NOT COMPLETED|Overall Study||2
348121|NCT01284426|833281|P1|COMPLETED|Overall Study||92
348122|NCT01284426|833281|P1|STARTED|Overall Study||94
348123|NCT01284361|833285|P1|NOT COMPLETED|Overall Study||9
348124|NCT01284361|833285|P1|COMPLETED|Overall Study||82
348125|NCT01284361|833285|P1|STARTED|Overall Study||91
348126|NCT01284296|833292|P1|NOT COMPLETED|Overall Study||0
348127|NCT01284296|833292|P1|COMPLETED|Overall Study||20
348128|NCT01284296|833292|P1|STARTED|Overall Study||20
348129|NCT01284244|833299|P2|NOT COMPLETED|Overall Study||0
348130|NCT01284244|833300|P1|NOT COMPLETED|Overall Study||0
348131|NCT01284244|833299|P2|COMPLETED|Overall Study||18
348132|NCT01284244|833300|P1|COMPLETED|Overall Study||18
348133|NCT01284244|833299|P2|STARTED|Overall Study||18
348134|NCT01284244|833300|P1|STARTED|Overall Study||18
348135|NCT01284114|833306|P1|NOT COMPLETED|Overall Study||4
348136|NCT01284114|833306|P1|COMPLETED|Overall Study||19
348137|NCT01284114|833306|P1|STARTED|Overall Study||23
348138|NCT01284062|833318|P4|NOT COMPLETED|Overall Study||14
348139|NCT01284062|833319|P3|NOT COMPLETED|Overall Study||6
348140|NCT01284062|833320|P2|NOT COMPLETED|Overall Study||8
348141|NCT01284062|833321|P1|NOT COMPLETED|Overall Study||11
348142|NCT01284062|833318|P4|COMPLETED|Overall Study||7
348143|NCT01284062|833319|P3|COMPLETED|Overall Study||15
348144|NCT01284062|833320|P2|COMPLETED|Overall Study||13
348145|NCT01284062|833321|P1|COMPLETED|Overall Study||10
348146|NCT01284062|833318|P4|STARTED|Overall Study||21
348147|NCT01284062|833319|P3|STARTED|Overall Study||21
348148|NCT01284062|833320|P2|STARTED|Overall Study||21
348149|NCT01284062|833321|P1|STARTED|Overall Study||21
348150|NCT01283971|833395|P2|NOT COMPLETED|Overall Study||12
348151|NCT01283971|833396|P1|NOT COMPLETED|Overall Study||15
348152|NCT01283971|833395|P2|COMPLETED|Overall Study||36
348153|NCT01283971|833396|P1|COMPLETED|Overall Study||33
348154|NCT01283971|833395|P2|Intent to Treat Population|Overall Study||48
348155|NCT01283971|833396|P1|Intent to Treat Population|Overall Study||46
348156|NCT01283971|833395|P2|STARTED|Overall Study||48
348157|NCT01283971|833396|P1|STARTED|Overall Study||48
348158|NCT01282866|833440|P1|NOT COMPLETED|Overall Study||1
348159|NCT01282866|833440|P1|COMPLETED|Overall Study||34
348160|NCT01282866|833440|P1|STARTED|Overall Study||35
348161|NCT01283581|833449|P3|NOT COMPLETED|Overall Study||20
348162|NCT01283581|833450|P2|NOT COMPLETED|Overall Study||14
348163|NCT01283581|833451|P1|NOT COMPLETED|Overall Study||12
348164|NCT01283581|833449|P3|COMPLETED|Overall Study||78
348165|NCT01283581|833450|P2|COMPLETED|Overall Study||63
348166|NCT01283581|833451|P1|COMPLETED|Overall Study||69
348167|NCT01283581|833449|P3|STARTED|Overall Study||98
348168|NCT01283581|833450|P2|STARTED|Overall Study||77
348169|NCT01283581|833451|P1|STARTED|Overall Study||81
348170|NCT01283555|833462|P2|NOT COMPLETED|Second Intervention||0
348171|NCT01283555|833463|P1|NOT COMPLETED|Second Intervention||0
348172|NCT01283555|833462|P2|COMPLETED|Second Intervention||12
348173|NCT01283555|833463|P1|COMPLETED|Second Intervention||13
348174|NCT01283555|833462|P2|STARTED|Second Intervention||12
348175|NCT01283555|833463|P1|STARTED|Second Intervention||13
348176|NCT01283555|833462|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
348177|NCT01283555|833463|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
348178|NCT01283555|833462|P2|COMPLETED|Washout Period of at Least 21 Days||12
348179|NCT01283555|833463|P1|COMPLETED|Washout Period of at Least 21 Days||13
348180|NCT01283555|833462|P2|STARTED|Washout Period of at Least 21 Days||12
348181|NCT01283555|833463|P1|STARTED|Washout Period of at Least 21 Days||13
348182|NCT01283555|833462|P2|NOT COMPLETED|First Intervention||0
348183|NCT01283555|833463|P1|NOT COMPLETED|First Intervention||0
348184|NCT01283555|833462|P2|COMPLETED|First Intervention||12
348185|NCT01283555|833463|P1|COMPLETED|First Intervention||13
348186|NCT01283555|833462|P2|STARTED|First Intervention||12
348187|NCT01283555|833463|P1|STARTED|First Intervention||13
348188|NCT01283516|833515|P9|NOT COMPLETED|Overall Study||122
348189|NCT01283516|833516|P8|NOT COMPLETED|Overall Study||3
348190|NCT01283516|833517|P7|NOT COMPLETED|Overall Study||8
348191|NCT01283516|833518|P6|NOT COMPLETED|Overall Study||8
348192|NCT01283516|833519|P5|NOT COMPLETED|Overall Study||13
348193|NCT01283516|833520|P4|NOT COMPLETED|Overall Study||3
348194|NCT01283516|833521|P3|NOT COMPLETED|Overall Study||2
348195|NCT01283516|833522|P2|NOT COMPLETED|Overall Study||2
348196|NCT01283516|833523|P1|NOT COMPLETED|Overall Study||2
348197|NCT01283516|833515|P9|COMPLETED|Overall Study||133
348198|NCT01283516|833516|P8|COMPLETED|Overall Study||2
348199|NCT01283516|833517|P7|COMPLETED|Overall Study||2
348200|NCT01283516|833518|P6|COMPLETED|Overall Study||2
348201|NCT01283516|833519|P5|COMPLETED|Overall Study||1
348202|NCT01283516|833520|P4|COMPLETED|Overall Study||0
348203|NCT01283516|833521|P3|COMPLETED|Overall Study||1
348204|NCT01283516|833522|P2|COMPLETED|Overall Study||0
348205|NCT01283516|833523|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
348206|NCT01283516|833515|P9|Dose-Determining Set (DDS)|Overall Study||8
348207|NCT01283516|833516|P8|Dose-Determining Set (DDS)|Overall Study||5
348208|NCT01283516|833517|P7|Dose-Determining Set (DDS)|Overall Study||10
348209|NCT01283516|833518|P6|Dose-Determining Set (DDS)|Overall Study||8
348210|NCT01283516|833519|P5|Dose-Determining Set (DDS)|Overall Study||14
348211|NCT01283516|833520|P4|Dose-Determining Set (DDS)|Overall Study||3
348212|NCT01283516|833521|P3|Dose-Determining Set (DDS)|Overall Study||3
348213|NCT01283516|833522|P2|Dose-Determining Set (DDS)|Overall Study||1
348214|NCT01283516|833523|P1|Dose-Determining Set (DDS)|Overall Study||2
348215|NCT01283516|833515|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
348216|NCT01283516|833516|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
348217|NCT01283516|833517|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
348218|NCT01283516|833518|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
348219|NCT01283516|833519|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
348220|NCT01283516|833520|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
348221|NCT01283516|833521|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
348222|NCT01283516|833522|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
348223|NCT01283516|833523|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
348224|NCT01283516|833515|P9|STARTED|Overall Study||255
348225|NCT01283516|833516|P8|STARTED|Overall Study||5
348226|NCT01283516|833517|P7|STARTED|Overall Study||10
348227|NCT01283516|833518|P6|STARTED|Overall Study||10
348228|NCT01283516|833519|P5|STARTED|Overall Study||14
348229|NCT01283516|833520|P4|STARTED|Overall Study||3
348230|NCT01283516|833521|P3|STARTED|Overall Study||3
348231|NCT01283516|833522|P2|STARTED|Overall Study||2
348232|NCT01283516|833523|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
348233|NCT01283464|833547|P2|NOT COMPLETED|Overall Study||1
348234|NCT01283464|833548|P1|NOT COMPLETED|Overall Study||2
348235|NCT01283464|833547|P2|COMPLETED|Overall Study||11
348236|NCT01283464|833548|P1|COMPLETED|Overall Study||10
348237|NCT01283464|833547|P2|STARTED|Overall Study||12
348238|NCT01283464|833548|P1|STARTED|Overall Study||12
348239|NCT01283334|833554|P1|NOT COMPLETED|Overall Study||7
348240|NCT01283334|833554|P1|COMPLETED|Overall Study||13
348241|NCT01283334|833554|P1|STARTED|Overall Study||20
348242|NCT01283321|833562|P2|NOT COMPLETED|Overall Study||0
348243|NCT01283321|833563|P1|NOT COMPLETED|Overall Study||0
348244|NCT01283321|833562|P2|COMPLETED|Overall Study||10
348245|NCT01283321|833563|P1|COMPLETED|Overall Study||10
348246|NCT01283321|833562|P2|STARTED|Overall Study||10
348247|NCT01283321|833563|P1|STARTED|Overall Study||10
348248|NCT01283282|833569|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
348249|NCT01283282|833570|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
348250|NCT01283282|833569|P2|COMPLETED|Second Intervention (6 Weeks)||19
348251|NCT01283282|833570|P1|COMPLETED|Second Intervention (6 Weeks)||22
348252|NCT01283282|833569|P2|STARTED|Second Intervention (6 Weeks)||19
348253|NCT01283282|833570|P1|STARTED|Second Intervention (6 Weeks)||22
348254|NCT01283282|833569|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
348255|NCT01283282|833570|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
348256|NCT01283282|833569|P2|COMPLETED|First Intervention (6 Weeks)||19
348257|NCT01283282|833570|P1|COMPLETED|First Intervention (6 Weeks)||22
348258|NCT01283282|833569|P2|STARTED|First Intervention (6 Weeks)||23
348259|NCT01283282|833570|P1|STARTED|First Intervention (6 Weeks)||25
348260|NCT01283152|833590|P2|NOT COMPLETED|Overall Study||0
348261|NCT01283152|833591|P1|NOT COMPLETED|Overall Study||2
348262|NCT01283152|833590|P2|COMPLETED|Overall Study||25
348263|NCT01283152|833591|P1|COMPLETED|Overall Study||23
348264|NCT01283152|833590|P2|24-hr HESA Attempted|Overall Study||25
348265|NCT01283152|833591|P1|24-hr HESA Attempted|Overall Study||25
348266|NCT01283152|833590|P2|Study Treatment Received|Overall Study||25
348267|NCT01283152|833591|P1|Study Treatment Received|Overall Study||25
348268|NCT01283152|833590|P2|ITT Population|Overall Study||25
348269|NCT01283152|833591|P1|ITT Population|Overall Study||25
348270|NCT01283152|833590|P2|STARTED|Overall Study||25
348271|NCT01283152|833591|P1|STARTED|Overall Study||25
348272|NCT01283139|833605|P4|NOT COMPLETED|Overall Study||15
348273|NCT01283139|833606|P3|NOT COMPLETED|Overall Study||18
348274|NCT01283139|833607|P2|NOT COMPLETED|Overall Study||18
348275|NCT01283139|833608|P1|NOT COMPLETED|Overall Study||17
348276|NCT01283139|833605|P4|COMPLETED|Overall Study||92
348277|NCT01283139|833606|P3|COMPLETED|Overall Study||91
348278|NCT01283139|833607|P2|COMPLETED|Overall Study||90
348279|NCT01283139|833608|P1|COMPLETED|Overall Study||91
348280|NCT01283139|833605|P4|STARTED|Overall Study||107
348281|NCT01283139|833606|P3|STARTED|Overall Study||109
348282|NCT01283139|833607|P2|STARTED|Overall Study||108
348283|NCT01283139|833608|P1|STARTED|Overall Study||108
348284|NCT01283035|833650|P1|NOT COMPLETED|Overall Study||1
348285|NCT01283035|833650|P1|COMPLETED|Overall Study||5
348286|NCT01283035|833650|P1|STARTED|Overall Study||6
348287|NCT01283022|833659|P1|NOT COMPLETED|Overall Study||0
348288|NCT01283022|833659|P1|COMPLETED|Overall Study||24
348289|NCT01283022|833659|P1|STARTED|Overall Study||24
348290|NCT01282814|833667|P2|NOT COMPLETED|Second Intervention||0
348291|NCT01282814|833668|P1|NOT COMPLETED|Second Intervention||0
348292|NCT01282814|833667|P2|COMPLETED|Second Intervention||9
348293|NCT01282814|833668|P1|COMPLETED|Second Intervention||10
348294|NCT01282814|833667|P2|STARTED|Second Intervention||9
348295|NCT01282814|833668|P1|STARTED|Second Intervention||10
348296|NCT01282814|833667|P2|NOT COMPLETED|Washout of 7 Days||0
348297|NCT01282814|833668|P1|NOT COMPLETED|Washout of 7 Days||2
348298|NCT01282814|833667|P2|COMPLETED|Washout of 7 Days||9
348299|NCT01282814|833668|P1|COMPLETED|Washout of 7 Days||10
348300|NCT01282814|833667|P2|STARTED|Washout of 7 Days||9
348301|NCT01282814|833668|P1|STARTED|Washout of 7 Days||12
348302|NCT01282814|833667|P2|NOT COMPLETED|First Intervention||3
348303|NCT01282814|833668|P1|NOT COMPLETED|First Intervention||0
348304|NCT01282814|833667|P2|COMPLETED|First Intervention||9
348305|NCT01282814|833668|P1|COMPLETED|First Intervention||12
348306|NCT01282814|833667|P2|STARTED|First Intervention||12
348307|NCT01282814|833668|P1|STARTED|First Intervention||12
348308|NCT01282801|833680|P2|NOT COMPLETED|Second Intervention||1
348309|NCT01282801|833681|P1|NOT COMPLETED|Second Intervention||0
348310|NCT01282801|833680|P2|COMPLETED|Second Intervention||8
348311|NCT01282801|833681|P1|COMPLETED|Second Intervention||9
348312|NCT01282801|833680|P2|STARTED|Second Intervention||9
348313|NCT01282801|833681|P1|STARTED|Second Intervention||9
348314|NCT01282801|833680|P2|NOT COMPLETED|Washout of 7 Days||0
348315|NCT01282801|833681|P1|NOT COMPLETED|Washout of 7 Days||0
348316|NCT01282801|833680|P2|COMPLETED|Washout of 7 Days||9
348317|NCT01282801|833681|P1|COMPLETED|Washout of 7 Days||9
348318|NCT01282801|833680|P2|STARTED|Washout of 7 Days||9
348319|NCT01282801|833681|P1|STARTED|Washout of 7 Days||9
348320|NCT01282801|833680|P2|NOT COMPLETED|First Intervention||0
348321|NCT01282801|833681|P1|NOT COMPLETED|First Intervention||0
348322|NCT01282801|833680|P2|COMPLETED|First Intervention||9
348323|NCT01282801|833681|P1|COMPLETED|First Intervention||9
348324|NCT01282801|833680|P2|STARTED|First Intervention||9
348325|NCT01282801|833681|P1|STARTED|First Intervention||9
348326|NCT01282723|833697|P1|NOT COMPLETED|Overall Study||0
348327|NCT01282723|833697|P1|COMPLETED|Overall Study||20
348328|NCT01282723|833697|P1|STARTED|Overall Study||20
348329|NCT01282710|833701|P1|NOT COMPLETED|Overall Study||0
348330|NCT01282710|833701|P1|COMPLETED|Overall Study||20
348331|NCT01282710|833701|P1|STARTED|Overall Study||20
348332|NCT01282476|833705|P1|NOT COMPLETED|Overall Study||11
348333|NCT01282476|833705|P1|COMPLETED|Overall Study||7
348334|NCT01282476|833705|P1|STARTED|Overall Study||18
348335|NCT01282424|833711|P1|NOT COMPLETED|Overall Study||76
348336|NCT01282424|833711|P1|COMPLETED|Overall Study||49
348337|NCT01282424|833711|P1|Completed: Death|Overall Study||8
348338|NCT01282424|833711|P1|Completed: Disease Progression|Overall Study||41
348339|NCT01282424|833711|P1|STARTED|Overall Study||125
348340|NCT01282372|833728|P1|NOT COMPLETED|Overall Study||79
348341|NCT01282372|833728|P1|COMPLETED|Overall Study||421
348342|NCT01282372|833728|P1|STARTED|Overall Study||500
348343|NCT01282294|833756|P1|NOT COMPLETED|Overall Study||19
348344|NCT01282294|833756|P1|COMPLETED|Overall Study||81
348345|NCT01282294|833756|P1|12 Months|Overall Study||86
348346|NCT01282294|833756|P1|6 Months|Overall Study||94
348347|NCT01282294|833756|P1|3 Months|Overall Study||95
348348|NCT01282294|833756|P1|6 Weeks|Overall Study||95
348349|NCT01282294|833756|P1|Post-operative|Overall Study||99
348350|NCT01282294|833756|P1|Intra-operative|Overall Study||99
348351|NCT01282294|833756|P1|STARTED|Overall Study||100
348352|NCT01282242|833776|P2|NOT COMPLETED|Overall Study||0
348353|NCT01282242|833777|P1|NOT COMPLETED|Overall Study||0
348354|NCT01282242|833776|P2|COMPLETED|Overall Study||8
348355|NCT01282242|833777|P1|COMPLETED|Overall Study||80
348356|NCT01282242|833776|P2|STARTED|Overall Study||8
348357|NCT01282242|833777|P1|STARTED|Overall Study||80
348358|NCT01282229|833785|P1|NOT COMPLETED|Overall Study||2
348359|NCT01282229|833785|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
348360|NCT01282229|833785|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
348361|NCT01282203|833815|P1|NOT COMPLETED|Overall Study||1
348362|NCT01282203|833815|P1|COMPLETED|Overall Study||1121
348363|NCT01282203|833815|P1|STARTED|Overall Study||1122
348364|NCT01282164|833837|P2|NOT COMPLETED|Overall Study||0
348365|NCT01282164|833838|P1|NOT COMPLETED|Overall Study||1
348366|NCT01282164|833837|P2|COMPLETED|Overall Study||14
348367|NCT01282164|833838|P1|COMPLETED|Overall Study||28
348368|NCT01282164|833837|P2|STARTED|Overall Study||14
348369|NCT01282164|833838|P1|STARTED|Overall Study||29
348370|NCT01282138|833863|P2|NOT COMPLETED|CAPT||0
348371|NCT01282138|833864|P1|NOT COMPLETED|CAPT||0
348372|NCT01282138|833863|P2|COMPLETED|CAPT||7
348373|NCT01282138|833864|P1|COMPLETED|CAPT||6
348374|NCT01282138|833863|P2|STARTED|CAPT||7
348375|NCT01282138|833864|P1|STARTED|CAPT||6
348376|NCT01282138|833863|P2|NOT COMPLETED|EEC||0
348377|NCT01282138|833864|P1|NOT COMPLETED|EEC||0
348378|NCT01282138|833863|P2|COMPLETED|EEC||7
348379|NCT01282138|833864|P1|COMPLETED|EEC||6
348380|NCT01282138|833863|P2|STARTED|EEC||7
348381|NCT01282138|833864|P1|STARTED|EEC||6
348382|NCT01282086|833872|P1|NOT COMPLETED|Overall Study||0
348383|NCT01282086|833872|P1|COMPLETED|Overall Study||1365
348384|NCT01282086|833872|P1|STARTED|Overall Study||1365
348385|NCT01281865|833891|P2|NOT COMPLETED|Overall Study||1
348386|NCT01281865|833892|P1|NOT COMPLETED|Overall Study||3
348387|NCT01281865|833891|P2|COMPLETED|Overall Study||1
348388|NCT01281865|833892|P1|COMPLETED|Overall Study||9
348389|NCT01281865|833891|P2|STARTED|Overall Study||2
348390|NCT01281865|833892|P1|STARTED|Overall Study||12
348391|NCT01281839|833900|P2|NOT COMPLETED|Overall Study||14
348392|NCT01281839|833901|P1|NOT COMPLETED|Overall Study||10
348393|NCT01281839|833900|P2|COMPLETED|Overall Study||119
348394|NCT01281839|833901|P1|COMPLETED|Overall Study||250
348395|NCT01281839|833900|P2|STARTED|Overall Study||133
348396|NCT01281839|833901|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
348397|NCT01281644|833962|P1|NOT COMPLETED|Overall Study||5
348398|NCT01281644|833962|P1|COMPLETED|Overall Study||18
348399|NCT01281644|833962|P1|STARTED|Overall Study||23
348400|NCT01281501|833972|P2|NOT COMPLETED|Overall Study||0
348401|NCT01281501|833973|P1|NOT COMPLETED|Overall Study||0
348402|NCT01281501|833972|P2|COMPLETED|Overall Study||43
348403|NCT01281501|833973|P1|COMPLETED|Overall Study||44
348404|NCT01281501|833972|P2|STARTED|Overall Study||43
348405|NCT01281501|833973|P1|STARTED|Overall Study||44
348406|NCT01281475|833987|P2|NOT COMPLETED|Overall Study||8
348407|NCT01281475|833988|P1|NOT COMPLETED|Overall Study||4
348408|NCT01281475|833987|P2|COMPLETED|Overall Study||26
348409|NCT01281475|833988|P1|COMPLETED|Overall Study||29
348410|NCT01281475|833987|P2|STARTED|Overall Study||34
348411|NCT01281475|833988|P1|STARTED|Overall Study||33
348412|NCT01281306|834003|P7|NOT COMPLETED|Overall Study||7
348413|NCT01281306|834004|P6|NOT COMPLETED|Overall Study||7
348414|NCT01281306|834005|P5|NOT COMPLETED|Overall Study||9
348415|NCT01281306|834006|P4|NOT COMPLETED|Overall Study||11
348416|NCT01281306|834007|P3|NOT COMPLETED|Overall Study||8
348417|NCT01281306|834008|P2|NOT COMPLETED|Overall Study||4
348418|NCT01281306|834009|P1|NOT COMPLETED|Overall Study||8
348419|NCT01281306|834003|P7|COMPLETED|Overall Study||51
348420|NCT01281306|834004|P6|COMPLETED|Overall Study||135
348421|NCT01281306|834005|P5|COMPLETED|Overall Study||134
348422|NCT01281306|834006|P4|COMPLETED|Overall Study||123
348423|NCT01281306|834007|P3|COMPLETED|Overall Study||133
348424|NCT01281306|834008|P2|COMPLETED|Overall Study||141
348425|NCT01281306|834009|P1|COMPLETED|Overall Study||136
348426|NCT01281306|834003|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
348427|NCT01281306|834004|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
348428|NCT01281306|834005|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
348429|NCT01281306|834006|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
348430|NCT01281306|834007|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
348431|NCT01281306|834008|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
348432|NCT01281306|834009|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
348433|NCT01281306|834003|P7|Safety Set|Overall Study||58
348434|NCT01281306|834004|P6|Safety Set|Overall Study||142
348435|NCT01281306|834005|P5|Safety Set|Overall Study||143
348436|NCT01281306|834006|P4|Safety Set|Overall Study||133
348437|NCT01281306|834007|P3|Safety Set|Overall Study||141
348438|NCT01281306|834008|P2|Safety Set|Overall Study||145
348439|NCT01281306|834009|P1|Safety Set|Overall Study||143
348440|NCT01281306|834003|P7|Full Analysis Set|Overall Study||58
348441|NCT01281306|834004|P6|Full Analysis Set|Overall Study||142
348442|NCT01281306|834005|P5|Full Analysis Set|Overall Study||143
348443|NCT01281306|834006|P4|Full Analysis Set|Overall Study||133
348444|NCT01281306|834007|P3|Full Analysis Set|Overall Study||141
348445|NCT01281306|834008|P2|Full Analysis Set|Overall Study||145
348446|NCT01281306|834009|P1|Full Analysis Set|Overall Study||143
348447|NCT01281306|834003|P7|STARTED|Overall Study||58
348448|NCT01281306|834004|P6|STARTED|Overall Study||142
348449|NCT01281306|834005|P5|STARTED|Overall Study||143
348450|NCT01281306|834006|P4|STARTED|Overall Study||134
348451|NCT01281306|834007|P3|STARTED|Overall Study||141
348452|NCT01281306|834008|P2|STARTED|Overall Study||145
348453|NCT01281306|834009|P1|STARTED|Overall Study||144
348454|NCT01281202|834125|P2|NOT COMPLETED|Overall Study||36
348455|NCT01281202|834126|P1|NOT COMPLETED|Overall Study||28
348456|NCT01281202|834125|P2|COMPLETED|Overall Study||68
348457|NCT01281202|834126|P1|COMPLETED|Overall Study||75
348458|NCT01281202|834125|P2|STARTED|Overall Study||104
348459|NCT01281202|834126|P1|STARTED|Overall Study||103
348460|NCT01281124|834134|P1|NOT COMPLETED|Overall Study||1
348461|NCT01281124|834134|P1|COMPLETED|Overall Study||0
348462|NCT01281124|834134|P1|STARTED|Overall Study||1
348463|NCT01281007|834142|P2|NOT COMPLETED|Overall Study||8
348464|NCT01281007|834143|P1|NOT COMPLETED|Overall Study||4
348465|NCT01281007|834142|P2|COMPLETED|Overall Study||67
348466|NCT01281007|834143|P1|COMPLETED|Overall Study||71
348467|NCT01281007|834142|P2|STARTED|Overall Study||75
348468|NCT01281007|834143|P1|STARTED|Overall Study||75
348469|NCT01280981|834149|P1|NOT COMPLETED|Overall Study||92
348470|NCT01280981|834149|P1|COMPLETED|Overall Study||196
348471|NCT01280981|834149|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
348472|NCT01280981|834149|P1|STARTED|Overall Study||288
348473|NCT01280968|834160|P2|NOT COMPLETED|Overall Study||3
348474|NCT01280968|834161|P1|NOT COMPLETED|Overall Study||18
348475|NCT01280968|834160|P2|COMPLETED|Overall Study||4
348476|NCT01280968|834161|P1|COMPLETED|Overall Study||27
348477|NCT01280968|834160|P2|STARTED|Overall Study||7
348478|NCT01280968|834161|P1|STARTED|Overall Study||45
348479|NCT01280955|834177|P1|NOT COMPLETED|Overall Study||3
348480|NCT01280955|834177|P1|COMPLETED|Overall Study||27
348481|NCT01280955|834177|P1|STARTED|Overall Study||30
348482|NCT01280695|834213|P5|NOT COMPLETED|Overall Study||2
348483|NCT01280695|834214|P4|NOT COMPLETED|Overall Study||4
348484|NCT01280695|834215|P3|NOT COMPLETED|Overall Study||5
348485|NCT01280695|834216|P2|NOT COMPLETED|Overall Study||1
348486|NCT01280695|834217|P1|NOT COMPLETED|Overall Study||0
348487|NCT01280695|834213|P5|COMPLETED|Overall Study||24
348488|NCT01280695|834214|P4|COMPLETED|Overall Study||22
348489|NCT01280695|834215|P3|COMPLETED|Overall Study||21
348490|NCT01280695|834216|P2|COMPLETED|Overall Study||24
348491|NCT01280695|834217|P1|COMPLETED|Overall Study||26
348492|NCT01280695|834213|P5|STARTED|Overall Study||26
348493|NCT01280695|834214|P4|STARTED|Overall Study||26
348494|NCT01280695|834215|P3|STARTED|Overall Study||26
348495|NCT01280695|834216|P2|STARTED|Overall Study||25
348496|NCT01280695|834217|P1|STARTED|Overall Study||26
348497|NCT01280656|834257|P3|NOT COMPLETED|Overall Study||63
348498|NCT01280656|834258|P2|NOT COMPLETED|Overall Study||47
348499|NCT01280656|834259|P1|NOT COMPLETED|Overall Study||3
348500|NCT01280656|834257|P3|COMPLETED|Overall Study||223
348501|NCT01280656|834258|P2|COMPLETED|Overall Study||265
348502|NCT01280656|834259|P1|COMPLETED|Overall Study||59
348503|NCT01280656|834257|P3|STARTED|Overall Study||286
348504|NCT01280656|834258|P2|STARTED|Overall Study||312
348505|NCT01280656|834259|P1|STARTED|Overall Study||62
348506|NCT01280604|834305|P2|NOT COMPLETED|Overall Study||5
348507|NCT01280604|834306|P1|NOT COMPLETED|Overall Study||9
348508|NCT01280604|834305|P2|COMPLETED|Overall Study||28
348509|NCT01280604|834306|P1|COMPLETED|Overall Study||24
348510|NCT01280604|834305|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
348511|NCT01280604|834306|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
348512|NCT01280604|834305|P2|STARTED|Overall Study||33
348513|NCT01280604|834306|P1|STARTED|Overall Study||33
348514|NCT01280591|834326|P4|NOT COMPLETED|Overall Study||3
348515|NCT01280591|834327|P3|NOT COMPLETED|Overall Study||0
348516|NCT01280591|834328|P2|NOT COMPLETED|Overall Study||0
348517|NCT01280591|834329|P1|NOT COMPLETED|Overall Study||0
348518|NCT01280591|834326|P4|COMPLETED|Overall Study||99
348519|NCT01280591|834327|P3|COMPLETED|Overall Study||203
348520|NCT01280591|834328|P2|COMPLETED|Overall Study||204
348521|NCT01280591|834329|P1|COMPLETED|Overall Study||203
348522|NCT01280591|834326|P4|STARTED|Overall Study||102
348523|NCT01280591|834327|P3|STARTED|Overall Study||203
348524|NCT01280591|834328|P2|STARTED|Overall Study||204
348525|NCT01280591|834329|P1|STARTED|Overall Study||203
348526|NCT01280552|834421|P2|NOT COMPLETED|Overall Study||1
348527|NCT01280552|834422|P1|NOT COMPLETED|Overall Study||6
348528|NCT01280552|834421|P2|COMPLETED|Overall Study||42
348529|NCT01280552|834422|P1|COMPLETED|Overall Study|Survival is still being assessed|75
348530|NCT01280552|834421|P2|STARTED|Overall Study||43
348531|NCT01280552|834422|P1|STARTED|Overall Study||81
348532|NCT01280357|834434|P1|NOT COMPLETED|Overall Study||26
348533|NCT01280357|834434|P1|COMPLETED|Overall Study||34
348534|NCT01280357|834434|P1|STARTED|Overall Study||60
348535|NCT01280266|834443|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
348536|NCT01280266|834444|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
348537|NCT01280266|834443|P2|COMPLETED|Second Intervention (Week 5-9)||12
348538|NCT01280266|834444|P1|COMPLETED|Second Intervention (Week 5-9)||14
348539|NCT01280266|834443|P2|STARTED|Second Intervention (Week 5-9)||12
348540|NCT01280266|834444|P1|STARTED|Second Intervention (Week 5-9)||14
348541|NCT01280266|834443|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
348542|NCT01280266|834444|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
348543|NCT01280266|834443|P2|COMPLETED|Washout Period (Week 4-5)||12
348544|NCT01280266|834444|P1|COMPLETED|Washout Period (Week 4-5)||14
348545|NCT01280266|834443|P2|STARTED|Washout Period (Week 4-5)||12
348546|NCT01280266|834444|P1|STARTED|Washout Period (Week 4-5)||14
348547|NCT01280266|834443|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
348548|NCT01280266|834444|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
348549|NCT01280266|834443|P2|COMPLETED|First Intervention (Week 1-4)||12
348550|NCT01280266|834444|P1|COMPLETED|First Intervention (Week 1-4)||14
348551|NCT01280266|834443|P2|STARTED|First Intervention (Week 1-4)||14
348552|NCT01280266|834444|P1|STARTED|First Intervention (Week 1-4)||15
348553|NCT01280123|834469|P3|NOT COMPLETED|Overall Study||1
348554|NCT01280123|834470|P2|NOT COMPLETED|Overall Study||4
348555|NCT01280123|834471|P1|NOT COMPLETED|Overall Study||1
348556|NCT01280123|834469|P3|COMPLETED|Overall Study||70
348557|NCT01280123|834470|P2|COMPLETED|Overall Study||63
348558|NCT01280123|834471|P1|COMPLETED|Overall Study||71
348559|NCT01280123|834469|P3|STARTED|Overall Study||71
348560|NCT01280123|834470|P2|STARTED|Overall Study||67
348561|NCT01280123|834471|P1|STARTED|Overall Study||72
348562|NCT01280110|834496|P2|NOT COMPLETED|Overall Study||0
348563|NCT01280110|834497|P1|NOT COMPLETED|Overall Study||0
348564|NCT01280110|834496|P2|COMPLETED|Overall Study||22
348565|NCT01280110|834497|P1|COMPLETED|Overall Study||22
348566|NCT01280110|834496|P2|STARTED|Overall Study||22
348567|NCT01280110|834497|P1|STARTED|Overall Study||22
348568|NCT01279564|834507|P2|NOT COMPLETED|Overall Study||0
348569|NCT01279564|834508|P1|NOT COMPLETED|Overall Study||0
348570|NCT01279564|834507|P2|COMPLETED|Overall Study||32
348571|NCT01279564|834508|P1|COMPLETED|Overall Study||40
348572|NCT01279564|834507|P2|STARTED|Overall Study||32
348573|NCT01279564|834508|P1|STARTED|Overall Study||40
348574|NCT01279447|834516|P2|NOT COMPLETED|Overall Study||1
348575|NCT01279447|834517|P1|NOT COMPLETED|Overall Study||3
348576|NCT01279447|834516|P2|COMPLETED|Overall Study||33
348577|NCT01279447|834517|P1|COMPLETED|Overall Study||31
348578|NCT01279447|834516|P2|STARTED|Overall Study||34
348579|NCT01279447|834517|P1|STARTED|Overall Study||34
348580|NCT01279317|834523|P2|NOT COMPLETED|Period 2||0
348581|NCT01279317|834524|P1|NOT COMPLETED|Period 2||0
348582|NCT01279317|834523|P2|COMPLETED|Period 2||6
348583|NCT01279317|834524|P1|COMPLETED|Period 2||6
348584|NCT01279317|834523|P2|STARTED|Period 2||6
348585|NCT01279317|834524|P1|STARTED|Period 2||6
348586|NCT01279317|834523|P2|NOT COMPLETED|Washout||0
348587|NCT01279317|834524|P1|NOT COMPLETED|Washout||0
348588|NCT01279317|834523|P2|COMPLETED|Washout||6
348589|NCT01279317|834524|P1|COMPLETED|Washout||6
348590|NCT01279317|834523|P2|STARTED|Washout||6
348591|NCT01279317|834524|P1|STARTED|Washout||6
348592|NCT01279317|834523|P2|NOT COMPLETED|Period 1||0
348593|NCT01279317|834524|P1|NOT COMPLETED|Period 1||0
348594|NCT01279317|834523|P2|COMPLETED|Period 1||6
348595|NCT01279317|834524|P1|COMPLETED|Period 1||6
348596|NCT01279317|834523|P2|STARTED|Period 1||6
348597|NCT01279317|834524|P1|STARTED|Period 1||6
348598|NCT01279265|834531|P2|NOT COMPLETED|Overall Study||6
348599|NCT01279265|834532|P1|NOT COMPLETED|Overall Study||4
348600|NCT01279265|834531|P2|COMPLETED|Overall Study||11
348601|NCT01279265|834532|P1|COMPLETED|Overall Study||9
348602|NCT01279265|834531|P2|STARTED|Overall Study||17
348603|NCT01279265|834532|P1|STARTED|Overall Study||13
348604|NCT01279200|834544|P2|NOT COMPLETED|Overall Study||7
348605|NCT01279200|834545|P1|NOT COMPLETED|Overall Study||2
348606|NCT01279200|834544|P2|COMPLETED|Overall Study||4
348607|NCT01279200|834545|P1|COMPLETED|Overall Study||8
348608|NCT01279200|834544|P2|STARTED|Overall Study||11
348609|NCT01279200|834545|P1|STARTED|Overall Study||10
348610|NCT01279109|834555|P2|NOT COMPLETED|Overall Study||12
348611|NCT01279109|834556|P1|NOT COMPLETED|Overall Study||13
348612|NCT01279109|834555|P2|COMPLETED|Overall Study||55
348613|NCT01279109|834556|P1|COMPLETED|Overall Study||55
348614|NCT01279109|834555|P2|STARTED|Overall Study||67
348615|NCT01279109|834556|P1|STARTED|Overall Study||68
348616|NCT01279070|834566|P2|NOT COMPLETED|Overall Study||4
348617|NCT01279070|834567|P1|NOT COMPLETED|Overall Study||5
348618|NCT01279070|834566|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
348619|NCT01279070|834567|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
348620|NCT01279070|834566|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
348621|NCT01279070|834567|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
348622|NCT01279044|834586|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
348623|NCT01279044|834587|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
348624|NCT01279044|834588|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
348625|NCT01279044|834586|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
348626|NCT01279044|834587|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
348627|NCT01279044|834588|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
348628|NCT01279044|834586|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
348629|NCT01279044|834587|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
348630|NCT01279044|834588|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
348631|NCT01279044|834586|P3|NOT COMPLETED|PHASE 1 - Formative||0
348632|NCT01279044|834587|P2|NOT COMPLETED|PHASE 1 - Formative||0
348633|NCT01279044|834588|P1|NOT COMPLETED|PHASE 1 - Formative||0
348634|NCT01279044|834586|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
348635|NCT01279044|834587|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
348636|NCT01279044|834588|P1|COMPLETED|PHASE 1 - Formative||59
348637|NCT01279044|834586|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
348638|NCT01279044|834587|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
348639|NCT01279044|834588|P1|STARTED|PHASE 1 - Formative||59
348640|NCT01278953|834608|P2|NOT COMPLETED|Overall Study||11
348641|NCT01278953|834609|P1|NOT COMPLETED|Overall Study||9
348642|NCT01278953|834608|P2|COMPLETED|Overall Study||134
348643|NCT01278953|834609|P1|COMPLETED|Overall Study||146
348644|NCT01278953|834608|P2|STARTED|Overall Study||145
348645|NCT01278953|834609|P1|STARTED|Overall Study||155
348646|NCT01278927|834621|P4|NOT COMPLETED|Overall Study||0
348647|NCT01278927|834622|P3|NOT COMPLETED|Overall Study||0
348648|NCT01278927|834623|P2|NOT COMPLETED|Overall Study||0
348649|NCT01278927|834624|P1|NOT COMPLETED|Overall Study||0
348650|NCT01278927|834621|P4|COMPLETED|Overall Study||175
348651|NCT01278927|834622|P3|COMPLETED|Overall Study||178
348652|NCT01278927|834623|P2|COMPLETED|Overall Study||178
348653|NCT01278927|834624|P1|COMPLETED|Overall Study||180
348654|NCT01278927|834621|P4|STARTED|Overall Study||175
348655|NCT01278927|834622|P3|STARTED|Overall Study||178
348656|NCT01278927|834623|P2|STARTED|Overall Study||178
348657|NCT01278927|834624|P1|STARTED|Overall Study||180
348658|NCT01278797|834662|P2|NOT COMPLETED|Period 2||0
348659|NCT01278797|834663|P1|NOT COMPLETED|Period 2||0
348660|NCT01278797|834662|P2|COMPLETED|Period 2||13
348661|NCT01278797|834663|P1|COMPLETED|Period 2||13
348662|NCT01278797|834662|P2|STARTED|Period 2||13
348663|NCT01278797|834663|P1|STARTED|Period 2||13
348664|NCT01278797|834662|P2|NOT COMPLETED|Washout Period of 21 Days||0
348665|NCT01278797|834663|P1|NOT COMPLETED|Washout Period of 21 Days||0
348666|NCT01278797|834662|P2|COMPLETED|Washout Period of 21 Days||13
348667|NCT01278797|834663|P1|COMPLETED|Washout Period of 21 Days||13
348668|NCT01278797|834662|P2|STARTED|Washout Period of 21 Days||13
348669|NCT01278797|834663|P1|STARTED|Washout Period of 21 Days||13
348670|NCT01278797|834662|P2|NOT COMPLETED|Period 1||1
348671|NCT01278797|834663|P1|NOT COMPLETED|Period 1||1
348672|NCT01278797|834662|P2|COMPLETED|Period 1||13
348673|NCT01278797|834663|P1|COMPLETED|Period 1||13
348674|NCT01278797|834662|P2|STARTED|Period 1||14
348675|NCT01278797|834663|P1|STARTED|Period 1||14
348676|NCT01278745|834675|P4|NOT COMPLETED|Overall Study||78
348677|NCT01278745|834676|P3|NOT COMPLETED|Overall Study||121
348678|NCT01278745|834677|P2|NOT COMPLETED|Overall Study||6
348679|NCT01278745|834678|P1|NOT COMPLETED|Overall Study||5
348680|NCT01278745|834675|P4|COMPLETED|Overall Study||0
348681|NCT01278745|834676|P3|COMPLETED|Overall Study||0
348682|NCT01278745|834677|P2|COMPLETED|Overall Study||68
348683|NCT01278745|834678|P1|COMPLETED|Overall Study||84
348684|NCT01278745|834675|P4|STARTED|Overall Study||78
348685|NCT01278745|834676|P3|STARTED|Overall Study||121
348686|NCT01278745|834677|P2|STARTED|Overall Study||74
348687|NCT01278745|834678|P1|STARTED|Overall Study||89
348688|NCT01278615|834710|P1|NOT COMPLETED|Overall Study||2
348689|NCT01278615|834710|P1|COMPLETED|Overall Study||14
348690|NCT01278615|834710|P1|STARTED|Overall Study||16
348691|NCT01278485|834720|P1|NOT COMPLETED|Overall Study||0
348692|NCT01278485|834720|P1|COMPLETED|Overall Study||719
348693|NCT01278485|834720|P1|STARTED|Overall Study||719
348694|NCT01278407|834736|P5|NOT COMPLETED|Extension Phase||30
348695|NCT01278407|834737|P4|NOT COMPLETED|Extension Phase||12
348696|NCT01278407|834738|P3|NOT COMPLETED|Extension Phase||0
348697|NCT01278407|834739|P2|NOT COMPLETED|Extension Phase||0
348698|NCT01278407|834740|P1|NOT COMPLETED|Extension Phase||0
348699|NCT01278407|834736|P5|COMPLETED|Extension Phase||66
348700|NCT01278407|834737|P4|COMPLETED|Extension Phase||34
348701|NCT01278407|834738|P3|COMPLETED|Extension Phase||0
348702|NCT01278407|834739|P2|COMPLETED|Extension Phase||0
348703|NCT01278407|834740|P1|COMPLETED|Extension Phase||0
348704|NCT01278407|834736|P5|STARTED|Extension Phase||96
348705|NCT01278407|834737|P4|STARTED|Extension Phase||46
348706|NCT01278407|834738|P3|STARTED|Extension Phase||0
348707|NCT01278407|834739|P2|STARTED|Extension Phase||0
348708|NCT01278407|834740|P1|STARTED|Extension Phase||0
348709|NCT01278407|834736|P5|NOT COMPLETED|Confirmatory Phase||0
348710|NCT01278407|834737|P4|NOT COMPLETED|Confirmatory Phase||0
348711|NCT01278407|834738|P3|NOT COMPLETED|Confirmatory Phase||6
348712|NCT01278407|834739|P2|NOT COMPLETED|Confirmatory Phase||16
348713|NCT01278407|834740|P1|NOT COMPLETED|Confirmatory Phase||9
348714|NCT01278407|834736|P5|COMPLETED|Confirmatory Phase||0
348715|NCT01278407|834737|P4|COMPLETED|Confirmatory Phase||0
348716|NCT01278407|834738|P3|COMPLETED|Confirmatory Phase||43
348717|NCT01278407|834739|P2|COMPLETED|Confirmatory Phase||31
348718|NCT01278407|834740|P1|COMPLETED|Confirmatory Phase||37
348719|NCT01278407|834736|P5|STARTED|Confirmatory Phase||0
348720|NCT01278407|834737|P4|STARTED|Confirmatory Phase||0
348721|NCT01278407|834738|P3|STARTED|Confirmatory Phase||49
348722|NCT01278407|834739|P2|STARTED|Confirmatory Phase||47
348723|NCT01278407|834740|P1|STARTED|Confirmatory Phase||46
348724|NCT01278394|834753|P1|NOT COMPLETED|Overall Study||1
348725|NCT01278394|834753|P1|COMPLETED|Overall Study||28
348726|NCT01278394|834753|P1|STARTED|Overall Study||29
348727|NCT01278342|834766|P3|NOT COMPLETED|Overall Study||0
348728|NCT01278342|834767|P2|NOT COMPLETED|Overall Study||1
348729|NCT01278342|834768|P1|NOT COMPLETED|Overall Study||4
348730|NCT01278342|834766|P3|COMPLETED|Overall Study||32
348731|NCT01278342|834767|P2|COMPLETED|Overall Study||30
348732|NCT01278342|834768|P1|COMPLETED|Overall Study||3
348733|NCT01278342|834766|P3|STARTED|Overall Study||32
348734|NCT01278342|834767|P2|STARTED|Overall Study||31
348735|NCT01278342|834768|P1|STARTED|Overall Study||7
348736|NCT01278303|834782|P1|NOT COMPLETED|Overall Study||0
348737|NCT01278303|834782|P1|COMPLETED|Overall Study||82
348738|NCT01278303|834782|P1|STARTED|Overall Study||82
348739|NCT01277211|834790|P2|NOT COMPLETED|Overall Study||63
348740|NCT01277211|834791|P1|NOT COMPLETED|Overall Study||150
348741|NCT01277211|834790|P2|COMPLETED|Overall Study||182
348742|NCT01277211|834791|P1|COMPLETED|Overall Study||588
348743|NCT01277211|834790|P2|Treated|Overall Study||232
348744|NCT01277211|834791|P1|Treated|Overall Study||714
348745|NCT01277211|834790|P2|STARTED|Overall Study||245
348746|NCT01277211|834791|P1|STARTED|Overall Study||738
348747|NCT01277081|834803|P2|NOT COMPLETED|Overall Study||0
348748|NCT01277081|834804|P1|NOT COMPLETED|Overall Study||0
348749|NCT01277081|834803|P2|COMPLETED|Overall Study||100
348750|NCT01277081|834804|P1|COMPLETED|Overall Study||100
348751|NCT01277081|834803|P2|STARTED|Overall Study||100
348752|NCT01277081|834804|P1|STARTED|Overall Study||100
348753|NCT01277042|834822|P2|NOT COMPLETED|Overall Study||5
348754|NCT01277042|834823|P1|NOT COMPLETED|Overall Study||8
348755|NCT01277042|834822|P2|COMPLETED|Overall Study||601
348756|NCT01277042|834823|P1|COMPLETED|Overall Study||598
348757|NCT01277042|834822|P2|STARTED|Overall Study||606
348758|NCT01277042|834823|P1|STARTED|Overall Study||606
348759|NCT01278173|834845|P1|NOT COMPLETED|Overall Study||27
348760|NCT01278173|834845|P1|COMPLETED|Overall Study||38
348761|NCT01278173|834845|P1|STARTED|Overall Study||65
348762|NCT01278160|834852|P2|NOT COMPLETED|Overall Study||6
348763|NCT01278160|834853|P1|NOT COMPLETED|Overall Study||5
348764|NCT01278160|834852|P2|COMPLETED|Overall Study||84
348765|NCT01278160|834853|P1|COMPLETED|Overall Study||84
348766|NCT01278160|834852|P2|STARTED|Overall Study||90
348767|NCT01278160|834853|P1|STARTED|Overall Study||89
348768|NCT01278030|834869|P2|NOT COMPLETED|Overall Study||4
348769|NCT01278030|834870|P1|NOT COMPLETED|Overall Study||8
348770|NCT01278030|834869|P2|COMPLETED|Overall Study||31
348771|NCT01278030|834870|P1|COMPLETED|Overall Study||35
348772|NCT01278030|834869|P2|STARTED|Overall Study||35
348773|NCT01278030|834870|P1|STARTED|Overall Study||43
348774|NCT01277861|834878|P2|NOT COMPLETED|Overall Study||2
348775|NCT01277861|834879|P1|NOT COMPLETED|Overall Study||2
348776|NCT01277861|834878|P2|COMPLETED|Overall Study||47
348777|NCT01277861|834879|P1|COMPLETED|Overall Study||49
348778|NCT01277861|834878|P2|STARTED|Overall Study||49
348779|NCT01277861|834879|P1|STARTED|Overall Study||51
348780|NCT01277822|834891|P2|NOT COMPLETED|Overall Study||11
348781|NCT01277822|834892|P1|NOT COMPLETED|Overall Study||15
348782|NCT01277822|834891|P2|COMPLETED|Overall Study||155
348783|NCT01277822|834892|P1|COMPLETED|Overall Study||153
348784|NCT01277822|834891|P2|STARTED|Overall Study||166
348785|NCT01277822|834892|P1|STARTED|Overall Study||168
348786|NCT01277757|834912|P1|NOT COMPLETED|Overall Study||2
348787|NCT01277757|834912|P1|COMPLETED|Overall Study||28
348788|NCT01277757|834912|P1|STARTED|Overall Study||30
348789|NCT01277718|834919|P2|NOT COMPLETED|Period 3 - Third Intervention||0
348790|NCT01277718|834920|P1|NOT COMPLETED|Period 3 - Third Intervention||0
348791|NCT01277718|834919|P2|COMPLETED|Period 3 - Third Intervention||7
348792|NCT01277718|834920|P1|COMPLETED|Period 3 - Third Intervention||10
348793|NCT01277718|834919|P2|STARTED|Period 3 - Third Intervention||7
348794|NCT01277718|834920|P1|STARTED|Period 3 - Third Intervention||10
348795|NCT01277718|834919|P2|NOT COMPLETED|Washout Period of 13 Days||0
348796|NCT01277718|834920|P1|NOT COMPLETED|Washout Period of 13 Days||0
348797|NCT01277718|834919|P2|COMPLETED|Washout Period of 13 Days||7
348798|NCT01277718|834920|P1|COMPLETED|Washout Period of 13 Days||10
348799|NCT01277718|834919|P2|STARTED|Washout Period of 13 Days||7
348800|NCT01277718|834920|P1|STARTED|Washout Period of 13 Days||10
348801|NCT01277718|834919|P2|NOT COMPLETED|Period 2 - Second Intervention||3
348802|NCT01277718|834920|P1|NOT COMPLETED|Period 2 - Second Intervention||0
348803|NCT01277718|834919|P2|COMPLETED|Period 2 - Second Intervention||7
348804|NCT01277718|834920|P1|COMPLETED|Period 2 - Second Intervention||10
348805|NCT01277718|834919|P2|STARTED|Period 2 - Second Intervention||10
348806|NCT01277718|834920|P1|STARTED|Period 2 - Second Intervention||10
348807|NCT01277718|834919|P2|NOT COMPLETED|Washout Period of 13 Days||0
348808|NCT01277718|834920|P1|NOT COMPLETED|Washout Period of 13 Days||0
348809|NCT01277718|834919|P2|COMPLETED|Washout Period of 13 Days||10
348810|NCT01277718|834920|P1|COMPLETED|Washout Period of 13 Days||10
348811|NCT01277718|834919|P2|STARTED|Washout Period of 13 Days||10
348812|NCT01277718|834920|P1|STARTED|Washout Period of 13 Days||10
348813|NCT01277718|834919|P2|NOT COMPLETED|Period 1 - First Intervention||0
348814|NCT01277718|834920|P1|NOT COMPLETED|Period 1 - First Intervention||0
348815|NCT01277718|834919|P2|COMPLETED|Period 1 - First Intervention||10
348816|NCT01277718|834920|P1|COMPLETED|Period 1 - First Intervention||10
348817|NCT01277718|834919|P2|STARTED|Period 1 - First Intervention||10
348818|NCT01277718|834920|P1|STARTED|Period 1 - First Intervention||10
348819|NCT01277601|834935|P4|NOT COMPLETED|Overall Study||36
348820|NCT01277601|834936|P3|NOT COMPLETED|Overall Study||27
348821|NCT01277601|834937|P2|NOT COMPLETED|Overall Study||48
348822|NCT01277601|834938|P1|NOT COMPLETED|Overall Study||37
348823|NCT01277601|834935|P4|COMPLETED|Overall Study||150
348824|NCT01277601|834936|P3|COMPLETED|Overall Study||163
348825|NCT01277601|834937|P2|COMPLETED|Overall Study||139
348826|NCT01277601|834938|P1|COMPLETED|Overall Study||151
348827|NCT01277601|834935|P4|STARTED|Overall Study||186
348828|NCT01277601|834936|P3|STARTED|Overall Study||190
348829|NCT01277601|834937|P2|STARTED|Overall Study||187
348830|NCT01277601|834938|P1|STARTED|Overall Study||188
348831|NCT01277549|835029|P2|NOT COMPLETED|Overall Study||14
348832|NCT01277549|835030|P1|NOT COMPLETED|Overall Study||26
348833|NCT01277549|835029|P2|COMPLETED|Overall Study||15
348834|NCT01277549|835030|P1|COMPLETED|Overall Study||15
348835|NCT01277549|835029|P2|STARTED|Overall Study||29
348836|NCT01277549|835030|P1|STARTED|Overall Study||41
348837|NCT01277523|835047|P3|NOT COMPLETED|Overall Study||0
348838|NCT01277523|835048|P2|NOT COMPLETED|Overall Study||1
348839|NCT01277523|835049|P1|NOT COMPLETED|Overall Study||3
348840|NCT01277523|835047|P3|COMPLETED|Overall Study||130
348841|NCT01277523|835048|P2|COMPLETED|Overall Study||126
348842|NCT01277523|835049|P1|COMPLETED|Overall Study||132
348843|NCT01277523|835047|P3|STARTED|Overall Study||130
348844|NCT01277523|835048|P2|STARTED|Overall Study||127
348845|NCT01277523|835049|P1|STARTED|Overall Study||135
348846|NCT01277510|835101|P2|NOT COMPLETED|Open-label Phase||3
348847|NCT01277510|835102|P1|NOT COMPLETED|Open-label Phase||7
348848|NCT01277510|835101|P2|COMPLETED|Open-label Phase|Completed investigational product|1
348849|NCT01277510|835102|P1|COMPLETED|Open-label Phase|Completed investigational product|1
348850|NCT01277510|835101|P2|Received Investigational Product|Open-label Phase||4
348851|NCT01277510|835102|P1|Received Investigational Product|Open-label Phase||6
348852|NCT01277510|835101|P2|STARTED|Open-label Phase||4
348853|NCT01277510|835102|P1|STARTED|Open-label Phase||8
348854|NCT01277510|835101|P2|NOT COMPLETED|Double-blind Phase||18
348855|NCT01277510|835102|P1|NOT COMPLETED|Double-blind Phase||13
348856|NCT01277510|835101|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
348857|NCT01277510|835102|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
348858|NCT01277510|835101|P2|Received Investigational Product|Double-blind Phase||22
348859|NCT01277510|835102|P1|Received Investigational Product|Double-blind Phase||21
348860|NCT01277510|835101|P2|STARTED|Double-blind Phase||22
348861|NCT01277510|835102|P1|STARTED|Double-blind Phase||21
348862|NCT01277354|835126|P2|NOT COMPLETED|Overall Study||0
348863|NCT01277354|835127|P1|NOT COMPLETED|Overall Study||0
348864|NCT01277354|835126|P2|COMPLETED|Overall Study||1
348865|NCT01277354|835127|P1|COMPLETED|Overall Study||1
348866|NCT01277354|835126|P2|STARTED|Overall Study||1
348867|NCT01277354|835127|P1|STARTED|Overall Study||1
348868|NCT01277302|835136|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
348869|NCT01277302|835137|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
348870|NCT01277302|835138|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
348871|NCT01277302|835136|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
348872|NCT01277302|835137|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
348873|NCT01277302|835138|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
348874|NCT01277302|835136|P3|STARTED|8-Month Alternate Dose Regimen Period||19
348875|NCT01277302|835137|P2|STARTED|8-Month Alternate Dose Regimen Period||86
348876|NCT01277302|835138|P1|STARTED|8-Month Alternate Dose Regimen Period||85
348877|NCT01277302|835136|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
348878|NCT01277302|835137|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
348879|NCT01277302|835138|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
348880|NCT01277302|835136|P3|COMPLETED|7-Month Fixed Treatment Period||19
348881|NCT01277302|835137|P2|COMPLETED|7-Month Fixed Treatment Period||86
348882|NCT01277302|835138|P1|COMPLETED|7-Month Fixed Treatment Period||85
348883|NCT01277302|835136|P3|STARTED|7-Month Fixed Treatment Period||31
348884|NCT01277302|835137|P2|STARTED|7-Month Fixed Treatment Period||86
348885|NCT01277302|835138|P1|STARTED|7-Month Fixed Treatment Period||85
348886|NCT01276847|835171|P3|NOT COMPLETED|Overall Study||0
348887|NCT01276847|835172|P2|NOT COMPLETED|Overall Study||0
348888|NCT01276847|835173|P1|NOT COMPLETED|Overall Study||1
348889|NCT01276847|835171|P3|COMPLETED|Overall Study||20
348890|NCT01276847|835172|P2|COMPLETED|Overall Study||10
348891|NCT01276847|835173|P1|COMPLETED|Overall Study||9
348892|NCT01276847|835171|P3|STARTED|Overall Study||20
348893|NCT01276847|835172|P2|STARTED|Overall Study||10
348894|NCT01276847|835173|P1|STARTED|Overall Study||10
348895|NCT01276821|835183|P2|NOT COMPLETED|Overall Study||1
348896|NCT01276821|835184|P1|NOT COMPLETED|Overall Study||0
348897|NCT01276821|835183|P2|COMPLETED|Overall Study||49
348898|NCT01276821|835184|P1|COMPLETED|Overall Study||50
348899|NCT01276821|835183|P2|STARTED|Overall Study||50
348900|NCT01276821|835184|P1|STARTED|Overall Study||50
348901|NCT01276756|835204|P2|NOT COMPLETED|Overall Study||2
348902|NCT01276756|835205|P1|NOT COMPLETED|Overall Study||5
348903|NCT01276756|835204|P2|COMPLETED|Overall Study||48
348904|NCT01276756|835205|P1|COMPLETED|Overall Study||45
348905|NCT01276756|835204|P2|STARTED|Overall Study||50
348906|NCT01276756|835205|P1|STARTED|Overall Study||50
348907|NCT01276639|835222|P5|NOT COMPLETED|Week 16 to 52||21
348908|NCT01276639|835223|P4|NOT COMPLETED|Week 16 to 52||16
348909|NCT01276639|835224|P3|NOT COMPLETED|Week 16 to 52||0
348910|NCT01276639|835225|P2|NOT COMPLETED|Week 16 to 52||101
348911|NCT01276639|835226|P1|NOT COMPLETED|Week 16 to 52||127
348912|NCT01276639|835222|P5|COMPLETED|Week 16 to 52||45
348913|NCT01276639|835223|P4|COMPLETED|Week 16 to 52||50
348914|NCT01276639|835224|P3|COMPLETED|Week 16 to 52||0
348915|NCT01276639|835225|P2|COMPLETED|Week 16 to 52||219
348916|NCT01276639|835226|P1|COMPLETED|Week 16 to 52||186
348917|NCT01276639|835222|P5|STARTED|Week 16 to 52||66
348918|NCT01276639|835223|P4|STARTED|Week 16 to 52||66
348919|NCT01276639|835224|P3|STARTED|Week 16 to 52||0
348920|NCT01276639|835225|P2|STARTED|Week 16 to 52||320
348921|NCT01276639|835226|P1|STARTED|Week 16 to 52||313
348922|NCT01276639|835222|P5|NOT COMPLETED|Week 0 to 16||0
348923|NCT01276639|835223|P4|NOT COMPLETED|Week 0 to 16||0
348924|NCT01276639|835224|P3|NOT COMPLETED|Week 0 to 16||45
348925|NCT01276639|835225|P2|NOT COMPLETED|Week 0 to 16||41
348926|NCT01276639|835226|P1|NOT COMPLETED|Week 0 to 16||50
348927|NCT01276639|835222|P5|COMPLETED|Week 0 to 16||0
348928|NCT01276639|835223|P4|COMPLETED|Week 0 to 16||0
348929|NCT01276639|835224|P3|COMPLETED|Week 0 to 16||132
348930|NCT01276639|835225|P2|COMPLETED|Week 0 to 16||320
348931|NCT01276639|835226|P1|COMPLETED|Week 0 to 16||313
348932|NCT01276639|835222|P5|Treated|Week 0 to 16||0
348933|NCT01276639|835223|P4|Treated|Week 0 to 16||0
348934|NCT01276639|835224|P3|Treated|Week 0 to 16||177
348935|NCT01276639|835225|P2|Treated|Week 0 to 16||360
348936|NCT01276639|835226|P1|Treated|Week 0 to 16||363
348937|NCT01276639|835222|P5|STARTED|Week 0 to 16||0
348938|NCT01276639|835223|P4|STARTED|Week 0 to 16||0
348939|NCT01276639|835224|P3|STARTED|Week 0 to 16||177
348940|NCT01276639|835225|P2|STARTED|Week 0 to 16||361
348941|NCT01276639|835226|P1|STARTED|Week 0 to 16||363
348942|NCT01276535|835421|P1|NOT COMPLETED|Overall Study||0
348943|NCT01276535|835421|P1|COMPLETED|Overall Study||12
348944|NCT01276535|835421|P1|STARTED|Overall Study||12
348945|NCT01276509|835431|P4|NOT COMPLETED|Overall Study||5
348946|NCT01276509|835432|P3|NOT COMPLETED|Overall Study||5
348947|NCT01276509|835433|P2|NOT COMPLETED|Overall Study||12
348948|NCT01276509|835434|P1|NOT COMPLETED|Overall Study||13
348949|NCT01276509|835431|P4|COMPLETED|Overall Study||58
348950|NCT01276509|835432|P3|COMPLETED|Overall Study||63
348951|NCT01276509|835433|P2|COMPLETED|Overall Study||53
348952|NCT01276509|835434|P1|COMPLETED|Overall Study||53
348953|NCT01276509|835431|P4|STARTED|Overall Study||63
348954|NCT01276509|835432|P3|STARTED|Overall Study||68
348955|NCT01276509|835433|P2|STARTED|Overall Study||65
348956|NCT01276509|835434|P1|STARTED|Overall Study||66
348957|NCT01276457|835487|P2|NOT COMPLETED|Extension Study||2
348958|NCT01276457|835488|P1|NOT COMPLETED|Extension Study||6
348959|NCT01276457|835487|P2|COMPLETED|Extension Study||110
348960|NCT01276457|835488|P1|COMPLETED|Extension Study||105
348961|NCT01276457|835487|P2|STARTED|Extension Study||112
348962|NCT01276457|835488|P1|STARTED|Extension Study||111
348963|NCT01276457|835487|P2|NOT COMPLETED|Core Study||20
348964|NCT01276457|835488|P1|NOT COMPLETED|Core Study||13
348965|NCT01276457|835487|P2|COMPLETED|Core Study||123
348966|NCT01276457|835488|P1|COMPLETED|Core Study||129
348967|NCT01276457|835487|P2|STARTED|Core Study||143
348968|NCT01276457|835488|P1|STARTED|Core Study||142
348969|NCT01276353|835502|P2|NOT COMPLETED|Extension||9
348970|NCT01276353|835503|P1|NOT COMPLETED|Extension||7
348971|NCT01276353|835502|P2|COMPLETED|Extension||14
348972|NCT01276353|835503|P1|COMPLETED|Extension||12
348973|NCT01276353|835502|P2|STARTED|Extension||23
348974|NCT01276353|835503|P1|STARTED|Extension||19
348975|NCT01276353|835502|P2|NOT COMPLETED|Double-blind||0
348976|NCT01276353|835503|P1|NOT COMPLETED|Double-blind||3
348977|NCT01276353|835502|P2|COMPLETED|Double-blind||23
348978|NCT01276353|835503|P1|COMPLETED|Double-blind||19
348979|NCT01276353|835502|P2|STARTED|Double-blind||23
348980|NCT01276353|835503|P1|STARTED|Double-blind||22
348981|NCT01276327|835515|P2|NOT COMPLETED|Overall Study||3
348982|NCT01276327|835516|P1|NOT COMPLETED|Overall Study||2
348983|NCT01276327|835515|P2|COMPLETED|Overall Study||29
348984|NCT01276327|835516|P1|COMPLETED|Overall Study||30
348985|NCT01276327|835515|P2|STARTED|Overall Study||32
348986|NCT01276327|835516|P1|STARTED|Overall Study||32
348987|NCT01276301|835538|P2|NOT COMPLETED|Second Intervention||0
348988|NCT01276301|835539|P1|NOT COMPLETED|Second Intervention||0
348989|NCT01276301|835538|P2|COMPLETED|Second Intervention||8
348990|NCT01276301|835539|P1|COMPLETED|Second Intervention||8
348991|NCT01276301|835538|P2|STARTED|Second Intervention||8
348992|NCT01276301|835539|P1|STARTED|Second Intervention||8
348993|NCT01276301|835538|P2|NOT COMPLETED|Washout Period of 7 Days||0
348994|NCT01276301|835539|P1|NOT COMPLETED|Washout Period of 7 Days||0
348995|NCT01276301|835538|P2|COMPLETED|Washout Period of 7 Days||8
348996|NCT01276301|835539|P1|COMPLETED|Washout Period of 7 Days||8
348997|NCT01276301|835538|P2|STARTED|Washout Period of 7 Days||8
348998|NCT01276301|835539|P1|STARTED|Washout Period of 7 Days||8
348999|NCT01276301|835538|P2|NOT COMPLETED|First Intervention||0
349000|NCT01276301|835539|P1|NOT COMPLETED|First Intervention||0
349001|NCT01276301|835538|P2|COMPLETED|First Intervention||8
349002|NCT01276301|835539|P1|COMPLETED|First Intervention||8
349003|NCT01276301|835538|P2|STARTED|First Intervention||8
349004|NCT01276301|835539|P1|STARTED|First Intervention||8
349005|NCT01276288|835566|P4|NOT COMPLETED|Overall Study||0
349006|NCT01276288|835567|P3|NOT COMPLETED|Overall Study||0
349007|NCT01276288|835568|P2|NOT COMPLETED|Overall Study||1
349008|NCT01276288|835569|P1|NOT COMPLETED|Overall Study||2
349009|NCT01276288|835566|P4|COMPLETED|Overall Study||5
349010|NCT01276288|835567|P3|COMPLETED|Overall Study||5
349011|NCT01276288|835568|P2|COMPLETED|Overall Study||5
349012|NCT01276288|835569|P1|COMPLETED|Overall Study||5
349013|NCT01276288|835566|P4|Received EMPA+TOR|Overall Study||5
349014|NCT01276288|835567|P3|Received EMPA+TOR|Overall Study||5
349015|NCT01276288|835568|P2|Received EMPA+TOR|Overall Study||0
349016|NCT01276288|835569|P1|Received EMPA+TOR|Overall Study||0
349017|NCT01276288|835566|P4|Received EMPA+HCT|Overall Study||0
349018|NCT01276288|835567|P3|Received EMPA+HCT|Overall Study||0
349019|NCT01276288|835568|P2|Received EMPA+HCT|Overall Study||5
349020|NCT01276288|835569|P1|Received EMPA+HCT|Overall Study||5
349021|NCT01276288|835566|P4|Received EMPA|Overall Study||5
349022|NCT01276288|835567|P3|Received EMPA|Overall Study||5
349023|NCT01276288|835568|P2|Received EMPA|Overall Study||5
349024|NCT01276288|835569|P1|Received EMPA|Overall Study||6
349025|NCT01276288|835566|P4|STARTED|Overall Study||5
349026|NCT01276288|835567|P3|STARTED|Overall Study||5
349027|NCT01276288|835568|P2|STARTED|Overall Study||6
349028|NCT01276288|835569|P1|STARTED|Overall Study||7
349029|NCT01276223|835696|P3|NOT COMPLETED|Overall Study||3
349030|NCT01276223|835697|P2|NOT COMPLETED|Overall Study||4
349031|NCT01276223|835698|P1|NOT COMPLETED|Overall Study||11
349032|NCT01276223|835696|P3|COMPLETED|Overall Study||101
349033|NCT01276223|835697|P2|COMPLETED|Overall Study||103
349034|NCT01276223|835698|P1|COMPLETED|Overall Study||67
349035|NCT01276223|835696|P3|STARTED|Overall Study||104
349036|NCT01276223|835697|P2|STARTED|Overall Study||107
349037|NCT01276223|835698|P1|STARTED|Overall Study||78
349038|NCT01276197|835707|P2|NOT COMPLETED|Overall Study||110
349039|NCT01276197|835708|P1|NOT COMPLETED|Overall Study||108
349040|NCT01276197|835707|P2|COMPLETED|Overall Study||200
349041|NCT01276197|835708|P1|COMPLETED|Overall Study||200
349042|NCT01276197|835707|P2|STARTED|Overall Study||310
349043|NCT01276197|835708|P1|STARTED|Overall Study||308
349044|NCT01276106|835720|P4|NOT COMPLETED|Overall Study||13
349045|NCT01276106|835721|P3|NOT COMPLETED|Overall Study||16
349046|NCT01276106|835722|P2|NOT COMPLETED|Overall Study||9
349047|NCT01276106|835723|P1|NOT COMPLETED|Overall Study||12
349048|NCT01276106|835720|P4|COMPLETED|Overall Study||52
349049|NCT01276106|835721|P3|COMPLETED|Overall Study||49
349050|NCT01276106|835722|P2|COMPLETED|Overall Study||55
349051|NCT01276106|835723|P1|COMPLETED|Overall Study||53
349052|NCT01276106|835720|P4|STARTED|Overall Study||65
349053|NCT01276106|835721|P3|STARTED|Overall Study||65
349054|NCT01276106|835722|P2|STARTED|Overall Study||64
349055|NCT01276106|835723|P1|STARTED|Overall Study||65
349056|NCT01276054|835735|P2|NOT COMPLETED|Overall Study||2
349057|NCT01276054|835736|P1|NOT COMPLETED|Overall Study||2
349058|NCT01276054|835735|P2|COMPLETED|Overall Study||0
349059|NCT01276054|835736|P1|COMPLETED|Overall Study||0
349060|NCT01276054|835735|P2|STARTED|Overall Study||2
349061|NCT01276054|835736|P1|STARTED|Overall Study||2
349062|NCT01275755|835744|P2|NOT COMPLETED|Run-out Placebo Period||0
349063|NCT01275755|835745|P1|NOT COMPLETED|Run-out Placebo Period||1
349064|NCT01275755|835744|P2|COMPLETED|Run-out Placebo Period||37
349065|NCT01275755|835745|P1|COMPLETED|Run-out Placebo Period||38
349066|NCT01275755|835744|P2|STARTED|Run-out Placebo Period||37
349067|NCT01275755|835745|P1|STARTED|Run-out Placebo Period||39
349068|NCT01275755|835744|P2|NOT COMPLETED|Double-blind Treatment Period||3
349069|NCT01275755|835745|P1|NOT COMPLETED|Double-blind Treatment Period||2
349070|NCT01275755|835744|P2|COMPLETED|Double-blind Treatment Period||37
349071|NCT01275755|835745|P1|COMPLETED|Double-blind Treatment Period||39
349072|NCT01275755|835744|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
349073|NCT01275755|835745|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
349074|NCT01275755|835744|P2|STARTED|Double-blind Treatment Period||40
349075|NCT01275755|835745|P1|STARTED|Double-blind Treatment Period||41
349076|NCT01275755|835744|P2|NOT COMPLETED|Run-in Placebo Period||0
349077|NCT01275755|835745|P1|NOT COMPLETED|Run-in Placebo Period||0
349078|NCT01275755|835744|P2|COMPLETED|Run-in Placebo Period||40
349079|NCT01275755|835745|P1|COMPLETED|Run-in Placebo Period||41
349080|NCT01275755|835744|P2|STARTED|Run-in Placebo Period||40
349081|NCT01275755|835745|P1|STARTED|Run-in Placebo Period||41
349082|NCT01275625|835751|P1|NOT COMPLETED|Overall Study||13
349083|NCT01275625|835751|P1|COMPLETED|Overall Study||64
349084|NCT01275625|835751|P1|Treated|Overall Study||77
349085|NCT01275625|835751|P1|STARTED|Overall Study||77
349086|NCT01275586|835765|P1|NOT COMPLETED|Overall Study||3
349087|NCT01275586|835765|P1|COMPLETED|Overall Study||3
349088|NCT01275586|835765|P1|STARTED|Overall Study||6
349089|NCT01275430|835769|P1|NOT COMPLETED|Overall Study||9
349090|NCT01275430|835769|P1|COMPLETED|Overall Study||18
349091|NCT01275430|835769|P1|STARTED|Overall Study||27
349092|NCT01275313|835779|P2|NOT COMPLETED|Overall Study||52
349093|NCT01275313|835780|P1|NOT COMPLETED|Overall Study||25
349094|NCT01275313|835779|P2|COMPLETED|Overall Study||79
349095|NCT01275313|835780|P1|COMPLETED|Overall Study||102
349096|NCT01275313|835779|P2|STARTED|Overall Study||131
349097|NCT01275313|835780|P1|STARTED|Overall Study||127
349098|NCT01275196|835788|P2|NOT COMPLETED|Overall Study||21
349099|NCT01275196|835789|P1|NOT COMPLETED|Overall Study||20
349100|NCT01275196|835788|P2|COMPLETED|Overall Study||113
349101|NCT01275196|835789|P1|COMPLETED|Overall Study||113
349102|NCT01275196|835788|P2|Intended to Continue Into Extension|Overall Study||113
349103|NCT01275196|835789|P1|Intended to Continue Into Extension|Overall Study||112
349104|NCT01275196|835788|P2|STARTED|Overall Study||134
349105|NCT01275196|835789|P1|STARTED|Overall Study||133
349106|NCT01275131|835832|P4|NOT COMPLETED|Period 2 (Crossover)||2
349107|NCT01275131|835833|P3|NOT COMPLETED|Period 2 (Crossover)||1
349108|NCT01275131|835834|P2|NOT COMPLETED|Period 2 (Crossover)||1
349109|NCT01275131|835835|P1|NOT COMPLETED|Period 2 (Crossover)||1
349110|NCT01275131|835832|P4|COMPLETED|Period 2 (Crossover)||8
349111|NCT01275131|835833|P3|COMPLETED|Period 2 (Crossover)||9
349112|NCT01275131|835834|P2|COMPLETED|Period 2 (Crossover)||8
349113|NCT01275131|835835|P1|COMPLETED|Period 2 (Crossover)||8
349114|NCT01275131|835832|P4|STARTED|Period 2 (Crossover)||10
349115|NCT01275131|835833|P3|STARTED|Period 2 (Crossover)||10
349116|NCT01275131|835834|P2|STARTED|Period 2 (Crossover)||9
349117|NCT01275131|835835|P1|STARTED|Period 2 (Crossover)||9
349118|NCT01275131|835832|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
349119|NCT01275131|835833|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
349120|NCT01275131|835834|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
349121|NCT01275131|835835|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
349122|NCT01275131|835832|P4|COMPLETED|5- to 14-Day Washout Period||10
349123|NCT01275131|835833|P3|COMPLETED|5- to 14-Day Washout Period||10
349124|NCT01275131|835834|P2|COMPLETED|5- to 14-Day Washout Period||9
349125|NCT01275131|835835|P1|COMPLETED|5- to 14-Day Washout Period||9
349126|NCT01275131|835832|P4|STARTED|5- to 14-Day Washout Period||10
349127|NCT01275131|835833|P3|STARTED|5- to 14-Day Washout Period||10
349128|NCT01275131|835834|P2|STARTED|5- to 14-Day Washout Period||9
349129|NCT01275131|835835|P1|STARTED|5- to 14-Day Washout Period||9
349130|NCT01275131|835832|P4|NOT COMPLETED|Period 1||2
349131|NCT01275131|835833|P3|NOT COMPLETED|Period 1||3
349132|NCT01275131|835834|P2|NOT COMPLETED|Period 1||0
349133|NCT01275131|835835|P1|NOT COMPLETED|Period 1||2
349134|NCT01275131|835832|P4|COMPLETED|Period 1||10
349135|NCT01275131|835833|P3|COMPLETED|Period 1||10
349136|NCT01275131|835834|P2|COMPLETED|Period 1||9
349137|NCT01275131|835835|P1|COMPLETED|Period 1||9
349138|NCT01275131|835832|P4|Received at Least One Dose of Study Drug|Period 1||12
349139|NCT01275131|835833|P3|Received at Least One Dose of Study Drug|Period 1||13
349140|NCT01275131|835834|P2|Received at Least One Dose of Study Drug|Period 1||9
349141|NCT01275131|835835|P1|Received at Least One Dose of Study Drug|Period 1||11
349142|NCT01275131|835832|P4|STARTED|Period 1||12
349143|NCT01275131|835833|P3|STARTED|Period 1||13
349144|NCT01275131|835834|P2|STARTED|Period 1||9
349145|NCT01275131|835835|P1|STARTED|Period 1||11
349146|NCT01275092|835869|P1|NOT COMPLETED|Overall Study||0
349147|NCT01275092|835869|P1|COMPLETED|Overall Study||164
349148|NCT01275092|835869|P1|STARTED|Overall Study||164
349149|NCT01275066|835878|P3|NOT COMPLETED|Overall Study||1
349150|NCT01275066|835879|P2|NOT COMPLETED|Overall Study||0
349151|NCT01275066|835880|P1|NOT COMPLETED|Overall Study||1
349152|NCT01275066|835878|P3|COMPLETED|Overall Study||57
349153|NCT01275066|835879|P2|COMPLETED|Overall Study||59
349154|NCT01275066|835880|P1|COMPLETED|Overall Study||59
349155|NCT01275066|835878|P3|Treated|Overall Study||58
349156|NCT01275066|835879|P2|Treated|Overall Study||59
349157|NCT01275066|835880|P1|Treated|Overall Study||59
349158|NCT01275066|835878|P3|STARTED|Overall Study||58
349159|NCT01275066|835879|P2|STARTED|Overall Study||59
349160|NCT01275066|835880|P1|STARTED|Overall Study||60
349161|NCT01274897|835896|P2|NOT COMPLETED|Overall Study||0
349162|NCT01274897|835897|P1|NOT COMPLETED|Overall Study||0
349163|NCT01274897|835896|P2|COMPLETED|Overall Study||153
349164|NCT01274897|835897|P1|COMPLETED|Overall Study||297
349165|NCT01274897|835896|P2|STARTED|Overall Study||153
349166|NCT01274897|835897|P1|STARTED|Overall Study||297
349167|NCT01274715|835909|P1|NOT COMPLETED|Overall Study||4
349168|NCT01274715|835909|P1|COMPLETED|Overall Study||8
349169|NCT01274715|835909|P1|Screened Out at Baseline|Overall Study||3
349170|NCT01274715|835909|P1|STARTED|Overall Study||12
349171|NCT01274611|835914|P1|NOT COMPLETED|Overall Study||0
349172|NCT01274611|835914|P1|COMPLETED|Overall Study||20
349173|NCT01274611|835914|P1|STARTED|Overall Study||20
349174|NCT01274585|835924|P2|NOT COMPLETED|Overall Study||0
349175|NCT01274585|835925|P1|NOT COMPLETED|Overall Study||0
349176|NCT01274585|835924|P2|COMPLETED|Overall Study||3
349177|NCT01274585|835925|P1|COMPLETED|Overall Study||2
349178|NCT01274585|835924|P2|STARTED|Overall Study||3
349179|NCT01274585|835925|P1|STARTED|Overall Study||2
349180|NCT01274559|835933|P2|NOT COMPLETED|Overall Study||145
349181|NCT01274559|835934|P1|NOT COMPLETED|Overall Study||197
349182|NCT01274559|835933|P2|COMPLETED|Overall Study||441
349183|NCT01274559|835934|P1|COMPLETED|Overall Study||390
349184|NCT01274559|835933|P2|Treated|Overall Study||572
349185|NCT01274559|835934|P1|Treated|Overall Study||572
349186|NCT01274559|835933|P2|STARTED|Overall Study||586
349187|NCT01274559|835934|P1|STARTED|Overall Study||587
349188|NCT01274533|835984|P1|NOT COMPLETED|Overall Study||4
349189|NCT01274533|835984|P1|COMPLETED|Overall Study||0
349190|NCT01274533|835984|P1|STARTED|Overall Study||4
349191|NCT01274429|835989|P1|NOT COMPLETED|Overall Study||5
349192|NCT01274429|835989|P1|COMPLETED|Overall Study||0
349193|NCT01274429|835989|P1|STARTED|Overall Study||5
349194|NCT01273896|835994|P1|NOT COMPLETED|Overall Study||0
349195|NCT01273896|835994|P1|COMPLETED|Overall Study||22
349196|NCT01273896|835994|P1|STARTED|Overall Study||22
349197|NCT01273883|835998|P2|NOT COMPLETED|Second Intervention||1
349198|NCT01273883|835999|P1|NOT COMPLETED|Second Intervention||2
349199|NCT01273883|835998|P2|COMPLETED|Second Intervention||17
349200|NCT01273883|835999|P1|COMPLETED|Second Intervention||15
349201|NCT01273883|835998|P2|STARTED|Second Intervention||18
349202|NCT01273883|835999|P1|STARTED|Second Intervention||17
349203|NCT01273883|835998|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
349204|NCT01273883|835999|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
349205|NCT01273883|835998|P2|COMPLETED|Washout Period of 2 Weeks||18
349206|NCT01273883|835999|P1|COMPLETED|Washout Period of 2 Weeks||17
349207|NCT01273883|835998|P2|STARTED|Washout Period of 2 Weeks||18
349208|NCT01273883|835999|P1|STARTED|Washout Period of 2 Weeks||17
349209|NCT01273883|835998|P2|NOT COMPLETED|First Intervention||1
349210|NCT01273883|835999|P1|NOT COMPLETED|First Intervention||2
349211|NCT01273883|835998|P2|COMPLETED|First Intervention||18
349212|NCT01273883|835999|P1|COMPLETED|First Intervention||17
349213|NCT01273883|835998|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
349214|NCT01273883|835999|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
349215|NCT01273857|836013|P2|NOT COMPLETED|Overall Study||0
349216|NCT01273857|836014|P1|NOT COMPLETED|Overall Study||0
349217|NCT01273857|836013|P2|COMPLETED|Overall Study||7
349218|NCT01273857|836014|P1|COMPLETED|Overall Study||7
349219|NCT01273857|836013|P2|STARTED|Overall Study||7
349220|NCT01273857|836014|P1|STARTED|Overall Study||7
349221|NCT01273818|836025|P3|NOT COMPLETED|Overall Study||9
349222|NCT01273818|836026|P2|NOT COMPLETED|Overall Study||2
349223|NCT01273818|836027|P1|NOT COMPLETED|Overall Study||13
349224|NCT01273818|836025|P3|COMPLETED|Overall Study||91
349225|NCT01273818|836026|P2|COMPLETED|Overall Study||98
349226|NCT01273818|836027|P1|COMPLETED|Overall Study||87
349227|NCT01273818|836025|P3|STARTED|Overall Study||100
349228|NCT01273818|836026|P2|STARTED|Overall Study||100
349229|NCT01273818|836027|P1|STARTED|Overall Study||100
349230|NCT01273805|836037|P2|NOT COMPLETED|Overall Study||10
349231|NCT01273805|836038|P1|NOT COMPLETED|Overall Study||10
349232|NCT01273805|836037|P2|COMPLETED|Overall Study||0
349233|NCT01273805|836038|P1|COMPLETED|Overall Study||0
349234|NCT01273805|836037|P2|STARTED|Overall Study||10
349235|NCT01273805|836038|P1|STARTED|Overall Study||10
349236|NCT01273766|836057|P3|NOT COMPLETED|Overall Study||0
349237|NCT01273766|836058|P2|NOT COMPLETED|Overall Study||0
349238|NCT01273766|836059|P1|NOT COMPLETED|Overall Study||0
349239|NCT01273766|836057|P3|COMPLETED|Overall Study||5
349240|NCT01273766|836058|P2|COMPLETED|Overall Study||7
349241|NCT01273766|836059|P1|COMPLETED|Overall Study||4
349242|NCT01273766|836057|P3|STARTED|Overall Study||5
349243|NCT01273766|836058|P2|STARTED|Overall Study||7
349244|NCT01273766|836059|P1|STARTED|Overall Study||4
349245|NCT01273623|836065|P1|NOT COMPLETED|Overall Study||29
349246|NCT01273623|836065|P1|COMPLETED|Overall Study|met IVUS criteria|26
349247|NCT01273623|836065|P1|STARTED|Overall Study|met angiographic criteria|55
349248|NCT01273597|836072|P1|NOT COMPLETED|Overall Study||8
349249|NCT01273597|836072|P1|COMPLETED|Overall Study||52
349250|NCT01273597|836072|P1|STARTED|Overall Study||60
349251|NCT01273519|836087|P3|NOT COMPLETED|Overall Study||8
349252|NCT01273519|836088|P2|NOT COMPLETED|Overall Study||5
349253|NCT01273519|836089|P1|NOT COMPLETED|Overall Study||19
349254|NCT01273519|836087|P3|COMPLETED|Overall Study||39
349255|NCT01273519|836088|P2|COMPLETED|Overall Study||25
349256|NCT01273519|836089|P1|COMPLETED|Overall Study||59
349257|NCT01273519|836087|P3|STARTED|Overall Study||47
349258|NCT01273519|836088|P2|STARTED|Overall Study||30
349259|NCT01273519|836089|P1|STARTED|Overall Study||78
349260|NCT01273181|836126|P4|NOT COMPLETED|Phase 2, Dose 2||1
349261|NCT01273181|836127|P3|NOT COMPLETED|Phase 2, Dose 2||0
349262|NCT01273181|836128|P2|NOT COMPLETED|Phase 2, Dose 2||0
349263|NCT01273181|836129|P1|NOT COMPLETED|Phase 2, Dose 2||0
349264|NCT01273181|836126|P4|COMPLETED|Phase 2, Dose 2||0
349265|NCT01273181|836127|P3|COMPLETED|Phase 2, Dose 2||0
349266|NCT01273181|836128|P2|COMPLETED|Phase 2, Dose 2||0
349267|NCT01273181|836129|P1|COMPLETED|Phase 2, Dose 2||0
349268|NCT01273181|836126|P4|STARTED|Phase 2, Dose 2||1
349269|NCT01273181|836127|P3|STARTED|Phase 2, Dose 2||0
349270|NCT01273181|836128|P2|STARTED|Phase 2, Dose 2||0
349271|NCT01273181|836129|P1|STARTED|Phase 2, Dose 2||0
349272|NCT01273181|836126|P4|NOT COMPLETED|Phase 2, Dose 1||0
349273|NCT01273181|836127|P3|NOT COMPLETED|Phase 2, Dose 1||1
349274|NCT01273181|836128|P2|NOT COMPLETED|Phase 2, Dose 1||0
349275|NCT01273181|836129|P1|NOT COMPLETED|Phase 2, Dose 1||0
349276|NCT01273181|836126|P4|COMPLETED|Phase 2, Dose 1||0
349277|NCT01273181|836127|P3|COMPLETED|Phase 2, Dose 1||1
349278|NCT01273181|836128|P2|COMPLETED|Phase 2, Dose 1||0
349279|NCT01273181|836129|P1|COMPLETED|Phase 2, Dose 1||0
349280|NCT01273181|836126|P4|STARTED|Phase 2, Dose 1||0
349281|NCT01273181|836127|P3|STARTED|Phase 2, Dose 1||2
349282|NCT01273181|836128|P2|STARTED|Phase 2, Dose 1||0
349283|NCT01273181|836129|P1|STARTED|Phase 2, Dose 1||0
349284|NCT01273181|836126|P4|NOT COMPLETED|Phase I, Dose 2||0
349285|NCT01273181|836127|P3|NOT COMPLETED|Phase I, Dose 2||0
349286|NCT01273181|836128|P2|NOT COMPLETED|Phase I, Dose 2||1
349287|NCT01273181|836129|P1|NOT COMPLETED|Phase I, Dose 2||0
349288|NCT01273181|836126|P4|COMPLETED|Phase I, Dose 2||0
349289|NCT01273181|836127|P3|COMPLETED|Phase I, Dose 2||0
349290|NCT01273181|836128|P2|COMPLETED|Phase I, Dose 2||2
349291|NCT01273181|836129|P1|COMPLETED|Phase I, Dose 2||0
349292|NCT01273181|836126|P4|STARTED|Phase I, Dose 2||0
349293|NCT01273181|836127|P3|STARTED|Phase I, Dose 2||0
349294|NCT01273181|836128|P2|STARTED|Phase I, Dose 2||3
349295|NCT01273181|836129|P1|STARTED|Phase I, Dose 2||0
349296|NCT01273181|836126|P4|NOT COMPLETED|Phase I, Dose 1||0
349297|NCT01273181|836127|P3|NOT COMPLETED|Phase I, Dose 1||0
349298|NCT01273181|836128|P2|NOT COMPLETED|Phase I, Dose 1||0
349299|NCT01273181|836129|P1|NOT COMPLETED|Phase I, Dose 1||1
349300|NCT01273181|836126|P4|COMPLETED|Phase I, Dose 1||0
349301|NCT01273181|836127|P3|COMPLETED|Phase I, Dose 1||0
349302|NCT01273181|836128|P2|COMPLETED|Phase I, Dose 1||0
349303|NCT01273181|836129|P1|COMPLETED|Phase I, Dose 1||2
349304|NCT01273181|836126|P4|STARTED|Phase I, Dose 1||0
349305|NCT01273181|836127|P3|STARTED|Phase I, Dose 1||0
349306|NCT01273181|836128|P2|STARTED|Phase I, Dose 1||0
349307|NCT01273181|836129|P1|STARTED|Phase I, Dose 1||3
349308|NCT01273064|836148|P5|NOT COMPLETED|Overall Study||10
349309|NCT01273064|836149|P4|NOT COMPLETED|Overall Study||20
349310|NCT01273064|836150|P3|NOT COMPLETED|Overall Study||31
349311|NCT01273064|836151|P2|NOT COMPLETED|Overall Study||30
349312|NCT01273064|836152|P1|NOT COMPLETED|Overall Study||23
349313|NCT01273064|836148|P5|COMPLETED|Overall Study||0
349314|NCT01273064|836149|P4|COMPLETED|Overall Study||0
349315|NCT01273064|836150|P3|COMPLETED|Overall Study||0
349316|NCT01273064|836151|P2|COMPLETED|Overall Study||0
349317|NCT01273064|836152|P1|COMPLETED|Overall Study||0
349318|NCT01273064|836148|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
349319|NCT01273064|836149|P4|STARTED|Overall Study||20
349320|NCT01273064|836150|P3|STARTED|Overall Study||31
349321|NCT01273064|836151|P2|STARTED|Overall Study||30
349322|NCT01273064|836152|P1|STARTED|Overall Study||23
349323|NCT01273038|836171|P2|NOT COMPLETED|Second Intervention (14 Days)||2
349324|NCT01273038|836172|P1|NOT COMPLETED|Second Intervention (14 Days)||0
349325|NCT01273038|836171|P2|COMPLETED|Second Intervention (14 Days)||8
349326|NCT01273038|836172|P1|COMPLETED|Second Intervention (14 Days)||10
349327|NCT01273038|836171|P2|STARTED|Second Intervention (14 Days)||10
349328|NCT01273038|836172|P1|STARTED|Second Intervention (14 Days)||10
349329|NCT01273038|836171|P2|NOT COMPLETED|First Intervention (14 Days)||0
349330|NCT01273038|836172|P1|NOT COMPLETED|First Intervention (14 Days)||0
349331|NCT01273038|836171|P2|COMPLETED|First Intervention (14 Days)||10
349332|NCT01273038|836172|P1|COMPLETED|First Intervention (14 Days)||10
349333|NCT01273038|836171|P2|STARTED|First Intervention (14 Days)||10
349334|NCT01273038|836172|P1|STARTED|First Intervention (14 Days)||10
349335|NCT01272947|836180|P2|NOT COMPLETED|Overall Study||2
349336|NCT01272947|836181|P1|NOT COMPLETED|Overall Study||2
349337|NCT01272947|836180|P2|COMPLETED|Overall Study||98
349338|NCT01272947|836181|P1|COMPLETED|Overall Study||102
349339|NCT01272947|836180|P2|STARTED|Overall Study||100
349340|NCT01272947|836181|P1|STARTED|Overall Study||104
349341|NCT01272934|836191|P2|NOT COMPLETED|Overall Study||2
349342|NCT01272934|836192|P1|NOT COMPLETED|Overall Study||0
349343|NCT01272934|836191|P2|COMPLETED|Overall Study||101
349344|NCT01272934|836192|P1|COMPLETED|Overall Study||102
349345|NCT01272934|836191|P2|STARTED|Overall Study||103
349346|NCT01272934|836192|P1|STARTED|Overall Study||102
349347|NCT01272921|836202|P2|NOT COMPLETED|Overall Study||1
349348|NCT01272921|836203|P1|NOT COMPLETED|Overall Study||2
349349|NCT01272921|836202|P2|COMPLETED|Overall Study||70
349350|NCT01272921|836203|P1|COMPLETED|Overall Study||69
349351|NCT01272921|836202|P2|STARTED|Overall Study||71
349352|NCT01272921|836203|P1|STARTED|Overall Study||71
349353|NCT01272908|836211|P1|NOT COMPLETED|Re-Treatment Period||6
349354|NCT01272908|836211|P1|COMPLETED|Re-Treatment Period||71
349355|NCT01272908|836211|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
349356|NCT01272908|836211|P1|NOT COMPLETED|Initial Treatment Period||8
349357|NCT01272908|836211|P1|COMPLETED|Initial Treatment Period||112
349358|NCT01272908|836211|P1|STARTED|Initial Treatment Period||120
349359|NCT01272882|836245|P1|NOT COMPLETED|Overall Study||0
349360|NCT01272882|836245|P1|COMPLETED|Overall Study||13
349361|NCT01272882|836245|P1|STARTED|Overall Study||13
349362|NCT01272869|836251|P2|NOT COMPLETED|Period 2 (14 Days)||0
349363|NCT01272869|836252|P1|NOT COMPLETED|Period 2 (14 Days)||1
349364|NCT01272869|836251|P2|COMPLETED|Period 2 (14 Days)||10
349365|NCT01272869|836252|P1|COMPLETED|Period 2 (14 Days)||9
349366|NCT01272869|836251|P2|STARTED|Period 2 (14 Days)||10
349367|NCT01272869|836252|P1|STARTED|Period 2 (14 Days)||10
349368|NCT01272869|836251|P2|NOT COMPLETED|Period 1 (14 Days)||0
349369|NCT01272869|836252|P1|NOT COMPLETED|Period 1 (14 Days)||0
349370|NCT01272869|836251|P2|COMPLETED|Period 1 (14 Days)||10
349371|NCT01272869|836252|P1|COMPLETED|Period 1 (14 Days)||10
349372|NCT01272869|836251|P2|STARTED|Period 1 (14 Days)||10
349373|NCT01272869|836252|P1|STARTED|Period 1 (14 Days)||10
349374|NCT01272804|836264|P6|NOT COMPLETED|Overall Study||1
349375|NCT01272804|836265|P5|NOT COMPLETED|Overall Study||2
349376|NCT01272804|836266|P4|NOT COMPLETED|Overall Study||0
349377|NCT01272804|836267|P3|NOT COMPLETED|Overall Study||0
349378|NCT01272804|836268|P2|NOT COMPLETED|Overall Study||0
349379|NCT01272804|836269|P1|NOT COMPLETED|Overall Study||1
349380|NCT01272804|836264|P6|COMPLETED|Overall Study||15
349381|NCT01272804|836265|P5|COMPLETED|Overall Study||7
349382|NCT01272804|836266|P4|COMPLETED|Overall Study||9
349383|NCT01272804|836267|P3|COMPLETED|Overall Study||9
349384|NCT01272804|836268|P2|COMPLETED|Overall Study||9
349385|NCT01272804|836269|P1|COMPLETED|Overall Study||8
349386|NCT01272804|836264|P6|STARTED|Overall Study||16
349387|NCT01272804|836265|P5|STARTED|Overall Study||9
349388|NCT01272804|836266|P4|STARTED|Overall Study||9
349389|NCT01272804|836267|P3|STARTED|Overall Study||9
349390|NCT01272804|836268|P2|STARTED|Overall Study||9
349391|NCT01272804|836269|P1|STARTED|Overall Study||9
349392|NCT01272661|836427|P3|NOT COMPLETED|Overall Study||72
349393|NCT01272661|836428|P2|NOT COMPLETED|Overall Study||209
349394|NCT01272661|836429|P1|NOT COMPLETED|Overall Study||126
349395|NCT01272661|836427|P3|COMPLETED|Overall Study||314
349396|NCT01272661|836428|P2|COMPLETED|Overall Study||288
349397|NCT01272661|836429|P1|COMPLETED|Overall Study||287
349398|NCT01272661|836427|P3|STARTED|Overall Study||386
349399|NCT01272661|836428|P2|STARTED|Overall Study||497
349400|NCT01272661|836429|P1|STARTED|Overall Study||413
349401|NCT01272635|836454|P4|NOT COMPLETED|Overall Study||23
349402|NCT01272635|836455|P3|NOT COMPLETED|Overall Study||31
349403|NCT01272635|836456|P2|NOT COMPLETED|Overall Study||20
349404|NCT01272635|836457|P1|NOT COMPLETED|Overall Study||31
349405|NCT01272635|836454|P4|COMPLETED|Overall Study||129
349406|NCT01272635|836455|P3|COMPLETED|Overall Study||117
349407|NCT01272635|836456|P2|COMPLETED|Overall Study||134
349408|NCT01272635|836457|P1|COMPLETED|Overall Study||122
349409|NCT01272635|836454|P4|STARTED|Overall Study||152
349410|NCT01272635|836455|P3|STARTED|Overall Study||148
349411|NCT01272635|836456|P2|STARTED|Overall Study||154
349412|NCT01272635|836457|P1|STARTED|Overall Study||153
349413|NCT01272583|836475|P2|NOT COMPLETED|Overall Study||0
349414|NCT01272583|836476|P1|NOT COMPLETED|Overall Study||0
349415|NCT01272583|836475|P2|COMPLETED|Overall Study||8
349416|NCT01272583|836476|P1|COMPLETED|Overall Study||8
349417|NCT01272583|836475|P2|STARTED|Overall Study||8
349418|NCT01272583|836476|P1|STARTED|Overall Study||8
349419|NCT01272284|836505|P1|NOT COMPLETED|12-month Follow-up Visit||4
349420|NCT01272284|836505|P1|COMPLETED|12-month Follow-up Visit||105
349421|NCT01272284|836505|P1|STARTED|12-month Follow-up Visit||109
349422|NCT01272284|836505|P1|NOT COMPLETED|6-month Follow-up Visit||3
349423|NCT01272284|836505|P1|COMPLETED|6-month Follow-up Visit||109
349424|NCT01272284|836505|P1|STARTED|6-month Follow-up Visit||112
349425|NCT01272284|836505|P1|NOT COMPLETED|3-month Follow-up Visit||1
349426|NCT01272284|836505|P1|COMPLETED|3-month Follow-up Visit||112
349427|NCT01272284|836505|P1|STARTED|3-month Follow-up Visit||113
349428|NCT01272232|836522|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
349587|NCT01271803|836747|P12|STARTED|Stage 2||39
349429|NCT01272232|836523|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
349430|NCT01272232|836524|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
349431|NCT01272232|836522|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
349432|NCT01272232|836523|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
349433|NCT01272232|836524|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
349434|NCT01272232|836522|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
349435|NCT01272232|836523|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
349436|NCT01272232|836524|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
349437|NCT01272232|836522|P3|NOT COMPLETED|Weeks 0-56||72
349438|NCT01272232|836523|P2|NOT COMPLETED|Weeks 0-56||47
349439|NCT01272232|836524|P1|NOT COMPLETED|Weeks 0-56||99
349440|NCT01272232|836522|P3|COMPLETED|Weeks 0-56||140
349441|NCT01272232|836523|P2|COMPLETED|Weeks 0-56||164
349442|NCT01272232|836524|P1|COMPLETED|Weeks 0-56||324
349443|NCT01272232|836522|P3|Exposed|Weeks 0-56||212
349444|NCT01272232|836523|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
349445|NCT01272232|836524|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
349446|NCT01272232|836522|P3|STARTED|Weeks 0-56||212
349447|NCT01272232|836523|P2|STARTED|Weeks 0-56||211
349448|NCT01272232|836524|P1|STARTED|Weeks 0-56||423
349449|NCT01272219|836569|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
349450|NCT01272219|836570|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
349451|NCT01272219|836571|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
349452|NCT01272219|836572|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
349453|NCT01272219|836573|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
349454|NCT01272219|836574|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
349455|NCT01272219|836569|P6|COMPLETED|Main + Extension Period: Week 0-172||327
349456|NCT01272219|836570|P5|COMPLETED|Main + Extension Period: Week 0-172||783
349457|NCT01272219|836571|P4|COMPLETED|Main + Extension Period: Week 0-172||0
349458|NCT01272219|836572|P3|COMPLETED|Main + Extension Period: Week 0-172||0
349459|NCT01272219|836573|P2|COMPLETED|Main + Extension Period: Week 0-172||0
349460|NCT01272219|836574|P1|COMPLETED|Main + Extension Period: Week 0-172||0
349461|NCT01272219|836569|P6|Exposed|Main + Extension Period: Week 0-172||747
349462|NCT01272219|836570|P5|Exposed|Main + Extension Period: Week 0-172||1501
349463|NCT01272219|836571|P4|Exposed|Main + Extension Period: Week 0-172||0
349464|NCT01272219|836572|P3|Exposed|Main + Extension Period: Week 0-172||0
349465|NCT01272219|836573|P2|Exposed|Main + Extension Period: Week 0-172||0
349466|NCT01272219|836574|P1|Exposed|Main + Extension Period: Week 0-172||0
349467|NCT01272219|836569|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
349468|NCT01272219|836570|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
349469|NCT01272219|836571|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
349470|NCT01272219|836572|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
349471|NCT01272219|836573|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
349472|NCT01272219|836574|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
349473|NCT01272219|836569|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
349474|NCT01272219|836570|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
349475|NCT01272219|836571|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
349476|NCT01272219|836572|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
349477|NCT01272219|836573|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
349478|NCT01272219|836574|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
349479|NCT01272219|836569|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
349480|NCT01272219|836570|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
349481|NCT01272219|836571|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
349482|NCT01272219|836572|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
349483|NCT01272219|836573|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
349484|NCT01272219|836574|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
349485|NCT01272219|836569|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
349486|NCT01272219|836570|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
349487|NCT01272219|836571|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
349488|NCT01272219|836572|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
349489|NCT01272219|836573|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
349490|NCT01272219|836574|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
349491|NCT01272219|836569|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
349492|NCT01272219|836570|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
349493|NCT01272219|836571|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
349494|NCT01272219|836572|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
349588|NCT01271803|836748|P11|STARTED|Stage 2||27
349495|NCT01272219|836573|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
349496|NCT01272219|836574|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
349497|NCT01272219|836569|P6|COMPLETED|Main Period: Week 0 to Week 56||505
349498|NCT01272219|836570|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
349499|NCT01272219|836571|P4|COMPLETED|Main Period: Week 0 to Week 56||296
349500|NCT01272219|836572|P3|COMPLETED|Main Period: Week 0 to Week 56||0
349501|NCT01272219|836573|P2|COMPLETED|Main Period: Week 0 to Week 56||0
349502|NCT01272219|836574|P1|COMPLETED|Main Period: Week 0 to Week 56||679
349503|NCT01272219|836569|P6|Exposed|Main Period: Week 0 to Week 56||755
349504|NCT01272219|836570|P5|Exposed|Main Period: Week 0 to Week 56||1524
349505|NCT01272219|836571|P4|Exposed|Main Period: Week 0 to Week 56||487
349506|NCT01272219|836572|P3|Exposed|Main Period: Week 0 to Week 56||0
349507|NCT01272219|836573|P2|Exposed|Main Period: Week 0 to Week 56||0
349508|NCT01272219|836574|P1|Exposed|Main Period: Week 0 to Week 56||957
349509|NCT01272219|836569|P6|STARTED|Main Period: Week 0 to Week 56||757
349510|NCT01272219|836570|P5|STARTED|Main Period: Week 0 to Week 56||1528
349511|NCT01272219|836571|P4|STARTED|Main Period: Week 0 to Week 56||487
349512|NCT01272219|836572|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
349513|NCT01272219|836573|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
349514|NCT01272219|836574|P1|STARTED|Main Period: Week 0 to Week 56||959
349515|NCT01272193|836608|P2|NOT COMPLETED|Overall Study||12
349516|NCT01272193|836609|P1|NOT COMPLETED|Overall Study||10
349517|NCT01272193|836608|P2|COMPLETED|Overall Study||137
349518|NCT01272193|836609|P1|COMPLETED|Overall Study||137
349519|NCT01272193|836608|P2|STARTED|Overall Study||149
349520|NCT01272193|836609|P1|STARTED|Overall Study||147
349521|NCT01272180|836629|P4|NOT COMPLETED|Overall Study||14
349522|NCT01272180|836630|P3|NOT COMPLETED|Overall Study||13
349523|NCT01272180|836631|P2|NOT COMPLETED|Overall Study||21
349524|NCT01272180|836632|P1|NOT COMPLETED|Overall Study||17
349525|NCT01272180|836629|P4|COMPLETED|Overall Study||107
349526|NCT01272180|836630|P3|COMPLETED|Overall Study||109
349527|NCT01272180|836631|P2|COMPLETED|Overall Study||100
349528|NCT01272180|836632|P1|COMPLETED|Overall Study||103
349529|NCT01272180|836629|P4|STARTED|Overall Study||121
349530|NCT01272180|836630|P3|STARTED|Overall Study||122
349531|NCT01272180|836631|P2|STARTED|Overall Study||121
349532|NCT01272180|836632|P1|STARTED|Overall Study||120
349533|NCT01272141|836669|P1|NOT COMPLETED|Overall Study||0
349534|NCT01272141|836669|P1|COMPLETED|Overall Study||5
349535|NCT01272141|836669|P1|STARTED|Overall Study||5
349536|NCT01272076|836674|P1|NOT COMPLETED|Overall Study||0
349537|NCT01272076|836674|P1|COMPLETED|Overall Study||52
349538|NCT01272076|836674|P1|STARTED|Overall Study||52
349539|NCT01272011|836681|P3|NOT COMPLETED|Overall Study||0
349540|NCT01272011|836682|P2|NOT COMPLETED|Overall Study||2
349541|NCT01272011|836683|P1|NOT COMPLETED|Overall Study||0
349542|NCT01272011|836681|P3|COMPLETED|Overall Study||3
349543|NCT01272011|836682|P2|COMPLETED|Overall Study||8
349544|NCT01272011|836683|P1|COMPLETED|Overall Study||3
349545|NCT01272011|836681|P3|STARTED|Overall Study||3
349546|NCT01272011|836682|P2|STARTED|Overall Study||10
349547|NCT01272011|836683|P1|STARTED|Overall Study||3
349548|NCT01271946|836696|P2|NOT COMPLETED|Overall Study||0
349549|NCT01271946|836697|P1|NOT COMPLETED|Overall Study||0
349550|NCT01271946|836696|P2|COMPLETED|Overall Study||5
349551|NCT01271946|836697|P1|COMPLETED|Overall Study||346
349552|NCT01271946|836696|P2|STARTED|Overall Study||5
349553|NCT01271946|836697|P1|STARTED|Overall Study||346
349554|NCT01271907|836722|P3|NOT COMPLETED|Overall Study||0
349555|NCT01271907|836723|P2|NOT COMPLETED|Overall Study||0
349556|NCT01271907|836724|P1|NOT COMPLETED|Overall Study||0
349557|NCT01271907|836722|P3|COMPLETED|Overall Study||0
349558|NCT01271907|836723|P2|COMPLETED|Overall Study||0
349559|NCT01271907|836724|P1|COMPLETED|Overall Study||3
349560|NCT01271907|836722|P3|STARTED|Overall Study||0
349561|NCT01271907|836723|P2|STARTED|Overall Study||0
349562|NCT01271907|836724|P1|STARTED|Overall Study||3
349563|NCT01271803|836747|P12|NOT COMPLETED|Stage 2||39
349564|NCT01271803|836748|P11|NOT COMPLETED|Stage 2||27
349565|NCT01271803|836749|P10|NOT COMPLETED|Stage 2||0
349566|NCT01271803|836750|P9|NOT COMPLETED|Stage 2||0
349567|NCT01271803|836751|P8|NOT COMPLETED|Stage 2||0
349568|NCT01271803|836752|P7|NOT COMPLETED|Stage 2||0
349569|NCT01271803|836753|P6|NOT COMPLETED|Stage 2||0
349570|NCT01271803|836754|P5|NOT COMPLETED|Stage 2||0
349571|NCT01271803|836755|P4|NOT COMPLETED|Stage 2||0
349572|NCT01271803|836756|P3|NOT COMPLETED|Stage 2||0
349573|NCT01271803|836757|P2|NOT COMPLETED|Stage 2||0
349574|NCT01271803|836758|P1|NOT COMPLETED|Stage 2||0
349575|NCT01271803|836747|P12|COMPLETED|Stage 2||0
349576|NCT01271803|836748|P11|COMPLETED|Stage 2||0
349577|NCT01271803|836749|P10|COMPLETED|Stage 2||0
349578|NCT01271803|836750|P9|COMPLETED|Stage 2||0
349579|NCT01271803|836751|P8|COMPLETED|Stage 2||0
349580|NCT01271803|836752|P7|COMPLETED|Stage 2||0
349581|NCT01271803|836753|P6|COMPLETED|Stage 2||0
349582|NCT01271803|836754|P5|COMPLETED|Stage 2||0
349583|NCT01271803|836755|P4|COMPLETED|Stage 2||0
349584|NCT01271803|836756|P3|COMPLETED|Stage 2||0
349585|NCT01271803|836757|P2|COMPLETED|Stage 2||0
349586|NCT01271803|836758|P1|COMPLETED|Stage 2||0
349589|NCT01271803|836749|P10|STARTED|Stage 2||0
349590|NCT01271803|836750|P9|STARTED|Stage 2||0
349591|NCT01271803|836751|P8|STARTED|Stage 2||0
349592|NCT01271803|836752|P7|STARTED|Stage 2||0
349593|NCT01271803|836753|P6|STARTED|Stage 2||0
349594|NCT01271803|836754|P5|STARTED|Stage 2||0
349595|NCT01271803|836755|P4|STARTED|Stage 2||0
349596|NCT01271803|836756|P3|STARTED|Stage 2||0
349597|NCT01271803|836757|P2|STARTED|Stage 2||0
349598|NCT01271803|836758|P1|STARTED|Stage 2||0
349599|NCT01271803|836747|P12|NOT COMPLETED|Stage 1||0
349600|NCT01271803|836748|P11|NOT COMPLETED|Stage 1||0
349601|NCT01271803|836749|P10|NOT COMPLETED|Stage 1||2
349602|NCT01271803|836750|P9|NOT COMPLETED|Stage 1||5
349603|NCT01271803|836751|P8|NOT COMPLETED|Stage 1||3
349604|NCT01271803|836752|P7|NOT COMPLETED|Stage 1||4
349605|NCT01271803|836753|P6|NOT COMPLETED|Stage 1||4
349606|NCT01271803|836754|P5|NOT COMPLETED|Stage 1||4
349607|NCT01271803|836755|P4|NOT COMPLETED|Stage 1||3
349608|NCT01271803|836756|P3|NOT COMPLETED|Stage 1||27
349609|NCT01271803|836757|P2|NOT COMPLETED|Stage 1||8
349610|NCT01271803|836758|P1|NOT COMPLETED|Stage 1||5
349611|NCT01271803|836747|P12|COMPLETED|Stage 1||0
349612|NCT01271803|836748|P11|COMPLETED|Stage 1||0
349613|NCT01271803|836749|P10|COMPLETED|Stage 1||0
349614|NCT01271803|836750|P9|COMPLETED|Stage 1||0
349615|NCT01271803|836751|P8|COMPLETED|Stage 1||0
349616|NCT01271803|836752|P7|COMPLETED|Stage 1||0
349617|NCT01271803|836753|P6|COMPLETED|Stage 1||0
349618|NCT01271803|836754|P5|COMPLETED|Stage 1||0
349619|NCT01271803|836755|P4|COMPLETED|Stage 1||0
349620|NCT01271803|836756|P3|COMPLETED|Stage 1||0
349621|NCT01271803|836757|P2|COMPLETED|Stage 1||0
349622|NCT01271803|836758|P1|COMPLETED|Stage 1||0
349623|NCT01271803|836747|P12|STARTED|Stage 1||0
349624|NCT01271803|836748|P11|STARTED|Stage 1||0
349625|NCT01271803|836749|P10|STARTED|Stage 1||2
349626|NCT01271803|836750|P9|STARTED|Stage 1||5
349627|NCT01271803|836751|P8|STARTED|Stage 1||3
349628|NCT01271803|836752|P7|STARTED|Stage 1||4
349629|NCT01271803|836753|P6|STARTED|Stage 1||4
349630|NCT01271803|836754|P5|STARTED|Stage 1||4
349631|NCT01271803|836755|P4|STARTED|Stage 1||3
349632|NCT01271803|836756|P3|STARTED|Stage 1||27
349633|NCT01271803|836757|P2|STARTED|Stage 1||8
349634|NCT01271803|836758|P1|STARTED|Stage 1||5
349635|NCT01271712|836931|P2|NOT COMPLETED|Survival Follow-up||4
349636|NCT01271712|836932|P1|NOT COMPLETED|Survival Follow-up||27
349637|NCT01271712|836931|P2|COMPLETED|Survival Follow-up||0
349638|NCT01271712|836932|P1|COMPLETED|Survival Follow-up||0
349639|NCT01271712|836931|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up 30 days after discontinuation of study drug|4
349640|NCT01271712|836932|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up 30 days after discontinuation of study drug|27
349641|NCT01271712|836931|P2|NOT COMPLETED|Safety Follow-up||3
349642|NCT01271712|836932|P1|NOT COMPLETED|Safety Follow-up||9
349643|NCT01271712|836931|P2|COMPLETED|Safety Follow-up||4
349644|NCT01271712|836932|P1|COMPLETED|Safety Follow-up||27
349645|NCT01271712|836931|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|7
349646|NCT01271712|836932|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|36
349647|NCT01271712|836931|P2|NOT COMPLETED|Open Label Treatment||56
349648|NCT01271712|836932|P1|NOT COMPLETED|Open Label Treatment||41
349649|NCT01271712|836931|P2|COMPLETED|Open Label Treatment||0
349650|NCT01271712|836932|P1|COMPLETED|Open Label Treatment||0
349651|NCT01271712|836931|P2|Participants Received Treatment|Open Label Treatment||56
349652|NCT01271712|836932|P1|Participants Received Treatment|Open Label Treatment||41
349653|NCT01271712|836931|P2|STARTED|Open Label Treatment||56
349654|NCT01271712|836932|P1|STARTED|Open Label Treatment||41
349655|NCT01271712|836931|P2|NOT COMPLETED|Double Blind Treatment||10
349656|NCT01271712|836932|P1|NOT COMPLETED|Double Blind Treatment||92
349657|NCT01271712|836931|P2|COMPLETED|Double Blind Treatment|56 participants started open-label treatment with regorafenib|56
349658|NCT01271712|836932|P1|COMPLETED|Double Blind Treatment|41 participants started open-label treatment with regorafenib|41
349659|NCT01271712|836931|P2|Participants Received Treatment|Double Blind Treatment||66
349660|NCT01271712|836932|P1|Participants Received Treatment|Double Blind Treatment||132
349661|NCT01271712|836931|P2|STARTED|Double Blind Treatment||66
349662|NCT01271712|836932|P1|STARTED|Double Blind Treatment||133
349663|NCT01271686|836952|P1|NOT COMPLETED|Overall Study||0
349664|NCT01271686|836952|P1|COMPLETED|Overall Study||16
349665|NCT01271686|836952|P1|STARTED|Overall Study||16
349666|NCT01271543|836958|P2|NOT COMPLETED|Overall Study||1
349667|NCT01271543|836959|P1|NOT COMPLETED|Overall Study||1
349668|NCT01271543|836958|P2|COMPLETED|Overall Study||29
349669|NCT01271543|836959|P1|COMPLETED|Overall Study||29
349670|NCT01271543|836958|P2|STARTED|Overall Study||30
349671|NCT01271543|836959|P1|STARTED|Overall Study||30
349672|NCT01271452|836969|P2|NOT COMPLETED|Overall Study||8
349673|NCT01271452|836970|P1|NOT COMPLETED|Overall Study||7
349674|NCT01271452|836969|P2|COMPLETED|Overall Study||104
349675|NCT01271452|836970|P1|COMPLETED|Overall Study||105
349676|NCT01271452|836969|P2|STARTED|Overall Study||112
349677|NCT01271452|836970|P1|STARTED|Overall Study||112
349678|NCT01271413|836992|P2|NOT COMPLETED|Overall Study||8
349679|NCT01271413|836993|P1|NOT COMPLETED|Overall Study||9
349680|NCT01271413|836992|P2|COMPLETED|Overall Study||28
349681|NCT01271413|836993|P1|COMPLETED|Overall Study||28
349682|NCT01271413|836992|P2|STARTED|Overall Study||36
349683|NCT01271413|836993|P1|STARTED|Overall Study||37
349684|NCT01271244|837001|P2|NOT COMPLETED|Overall Study||3
349685|NCT01271244|837002|P1|NOT COMPLETED|Overall Study||7
349686|NCT01271244|837001|P2|COMPLETED|Overall Study||5
349687|NCT01271244|837002|P1|COMPLETED|Overall Study||11
349688|NCT01271244|837001|P2|STARTED|Overall Study||8
349689|NCT01271244|837002|P1|STARTED|Overall Study||18
349690|NCT01271036|837010|P2|NOT COMPLETED|Overall Study||0
349691|NCT01271036|837011|P1|NOT COMPLETED|Overall Study||0
349692|NCT01271036|837010|P2|COMPLETED|Overall Study||62
349693|NCT01271036|837011|P1|COMPLETED|Overall Study||62
349694|NCT01271036|837010|P2|STARTED|Overall Study||62
349695|NCT01271036|837011|P1|STARTED|Overall Study||62
349696|NCT01270971|837027|P2|NOT COMPLETED|Overall Study||23
349697|NCT01270971|837028|P1|NOT COMPLETED|Overall Study||52
349698|NCT01270971|837027|P2|COMPLETED|Overall Study||171
349699|NCT01270971|837028|P1|COMPLETED|Overall Study||348
349700|NCT01270971|837027|P2|STARTED|Overall Study||194
349701|NCT01270971|837028|P1|STARTED|Overall Study||400
349702|NCT01270958|837040|P1|NOT COMPLETED|Overall Study||4
349703|NCT01270958|837040|P1|COMPLETED|Overall Study||56
349704|NCT01270958|837040|P1|STARTED|Overall Study||60
349705|NCT01270919|837064|P1|NOT COMPLETED|Overall Study||0
349706|NCT01270919|837064|P1|COMPLETED|Overall Study||0
349707|NCT01270919|837064|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
349708|NCT01270880|837069|P1|NOT COMPLETED|Overall Study||1
349709|NCT01270880|837069|P1|COMPLETED|Overall Study||17
349710|NCT01270880|837069|P1|STARTED|Overall Study||18
349711|NCT01270867|837075|P2|NOT COMPLETED|Overall Study||0
349712|NCT01270867|837076|P1|NOT COMPLETED|Overall Study||1
349713|NCT01270867|837075|P2|COMPLETED|Overall Study||88
349714|NCT01270867|837076|P1|COMPLETED|Overall Study||89
349715|NCT01270867|837075|P2|STARTED|Overall Study||88
349716|NCT01270867|837076|P1|STARTED|Overall Study||90
349717|NCT01270841|837094|P4|NOT COMPLETED|Overall Study||13
349718|NCT01270841|837095|P3|NOT COMPLETED|Overall Study||11
349719|NCT01270841|837096|P2|NOT COMPLETED|Overall Study||14
349720|NCT01270841|837097|P1|NOT COMPLETED|Overall Study||13
349721|NCT01270841|837094|P4|COMPLETED|Overall Study||20
349722|NCT01270841|837095|P3|COMPLETED|Overall Study||18
349723|NCT01270841|837096|P2|COMPLETED|Overall Study||19
349724|NCT01270841|837097|P1|COMPLETED|Overall Study||16
349725|NCT01270841|837094|P4|STARTED|Overall Study||33
349726|NCT01270841|837095|P3|STARTED|Overall Study||29
349727|NCT01270841|837096|P2|STARTED|Overall Study||33
349728|NCT01270841|837097|P1|STARTED|Overall Study||29
349729|NCT01270828|837121|P3|NOT COMPLETED|Double Blind Phase||0
349730|NCT01270828|837122|P2|NOT COMPLETED|Double Blind Phase||45
349731|NCT01270828|837123|P1|NOT COMPLETED|Double Blind Phase||26
349732|NCT01270828|837121|P3|COMPLETED|Double Blind Phase||0
349733|NCT01270828|837122|P2|COMPLETED|Double Blind Phase||160
349734|NCT01270828|837123|P1|COMPLETED|Double Blind Phase||182
349735|NCT01270828|837121|P3|STARTED|Double Blind Phase||0
349736|NCT01270828|837122|P2|STARTED|Double Blind Phase||205
349737|NCT01270828|837123|P1|STARTED|Double Blind Phase||208
349738|NCT01270828|837121|P3|NOT COMPLETED|Pregabalin CR SB||146
349739|NCT01270828|837122|P2|NOT COMPLETED|Pregabalin CR SB||0
349740|NCT01270828|837123|P1|NOT COMPLETED|Pregabalin CR SB||0
349741|NCT01270828|837121|P3|COMPLETED|Pregabalin CR SB||660
349742|NCT01270828|837122|P2|COMPLETED|Pregabalin CR SB||0
349743|NCT01270828|837123|P1|COMPLETED|Pregabalin CR SB||0
349744|NCT01270828|837121|P3|STARTED|Pregabalin CR SB||806
349745|NCT01270828|837122|P2|STARTED|Pregabalin CR SB||0
349746|NCT01270828|837123|P1|STARTED|Pregabalin CR SB||0
349747|NCT01270802|837165|P2|NOT COMPLETED|Overall Study||1
349748|NCT01270802|837166|P1|NOT COMPLETED|Overall Study||2
349749|NCT01270802|837165|P2|COMPLETED|Overall Study||14
349750|NCT01270802|837166|P1|COMPLETED|Overall Study||13
349751|NCT01270802|837165|P2|STARTED|Overall Study||15
349752|NCT01270802|837166|P1|STARTED|Overall Study||15
349753|NCT01270711|837182|P8|NOT COMPLETED|Part 2: Effectiveness||0
349754|NCT01270711|837183|P7|NOT COMPLETED|Part 2: Effectiveness||0
349755|NCT01270711|837184|P6|NOT COMPLETED|Part 2: Effectiveness||0
349756|NCT01270711|837185|P5|NOT COMPLETED|Part 2: Effectiveness||0
349757|NCT01270711|837186|P4|NOT COMPLETED|Part 2: Effectiveness||0
349758|NCT01270711|837187|P3|NOT COMPLETED|Part 2: Effectiveness||0
349759|NCT01270711|837188|P2|NOT COMPLETED|Part 2: Effectiveness||0
349760|NCT01270711|837189|P1|NOT COMPLETED|Part 2: Effectiveness||0
349761|NCT01270711|837182|P8|COMPLETED|Part 2: Effectiveness||48
349762|NCT01270711|837183|P7|COMPLETED|Part 2: Effectiveness||2
349763|NCT01270711|837184|P6|COMPLETED|Part 2: Effectiveness||11
349764|NCT01270711|837185|P5|COMPLETED|Part 2: Effectiveness||0
349765|NCT01270711|837186|P4|COMPLETED|Part 2: Effectiveness||0
349766|NCT01270711|837187|P3|COMPLETED|Part 2: Effectiveness||0
349767|NCT01270711|837188|P2|COMPLETED|Part 2: Effectiveness||0
349768|NCT01270711|837189|P1|COMPLETED|Part 2: Effectiveness||0
349769|NCT01270711|837182|P8|STARTED|Part 2: Effectiveness||48
349770|NCT01270711|837183|P7|STARTED|Part 2: Effectiveness||2
349771|NCT01270711|837184|P6|STARTED|Part 2: Effectiveness||11
349772|NCT01270711|837185|P5|STARTED|Part 2: Effectiveness||0
349773|NCT01270711|837186|P4|STARTED|Part 2: Effectiveness||0
349774|NCT01270711|837187|P3|STARTED|Part 2: Effectiveness||0
349775|NCT01270711|837188|P2|STARTED|Part 2: Effectiveness||0
349776|NCT01270711|837189|P1|STARTED|Part 2: Effectiveness||0
349777|NCT01270711|837182|P8|NOT COMPLETED|Part 1: Compliance||0
349778|NCT01270711|837183|P7|NOT COMPLETED|Part 1: Compliance||0
349779|NCT01270711|837184|P6|NOT COMPLETED|Part 1: Compliance||0
349780|NCT01270711|837185|P5|NOT COMPLETED|Part 1: Compliance||0
349781|NCT01270711|837186|P4|NOT COMPLETED|Part 1: Compliance||0
349782|NCT01270711|837187|P3|NOT COMPLETED|Part 1: Compliance||0
349783|NCT01270711|837188|P2|NOT COMPLETED|Part 1: Compliance||0
349784|NCT01270711|837189|P1|NOT COMPLETED|Part 1: Compliance||0
349785|NCT01270711|837182|P8|COMPLETED|Part 1: Compliance||0
349786|NCT01270711|837183|P7|COMPLETED|Part 1: Compliance||0
349787|NCT01270711|837184|P6|COMPLETED|Part 1: Compliance||0
349788|NCT01270711|837185|P5|COMPLETED|Part 1: Compliance||2024
349789|NCT01270711|837186|P4|COMPLETED|Part 1: Compliance||5486
349790|NCT01270711|837187|P3|COMPLETED|Part 1: Compliance||326
349791|NCT01270711|837188|P2|COMPLETED|Part 1: Compliance||6580
349792|NCT01270711|837189|P1|COMPLETED|Part 1: Compliance||7537
349793|NCT01270711|837182|P8|STARTED|Part 1: Compliance||0
349794|NCT01270711|837183|P7|STARTED|Part 1: Compliance||0
349795|NCT01270711|837184|P6|STARTED|Part 1: Compliance||0
349796|NCT01270711|837185|P5|STARTED|Part 1: Compliance||2024
349797|NCT01270711|837186|P4|STARTED|Part 1: Compliance||5486
349798|NCT01270711|837187|P3|STARTED|Part 1: Compliance||326
349799|NCT01270711|837188|P2|STARTED|Part 1: Compliance||6580
349800|NCT01270711|837189|P1|STARTED|Part 1: Compliance||7537
349801|NCT01270620|837288|P2|NOT COMPLETED|Overall Study||3
349802|NCT01270620|837289|P1|NOT COMPLETED|Overall Study||1
349803|NCT01270620|837288|P2|COMPLETED|Overall Study||47
349804|NCT01270620|837289|P1|COMPLETED|Overall Study||49
349805|NCT01270620|837288|P2|STARTED|Overall Study||50
349806|NCT01270620|837289|P1|STARTED|Overall Study||50
349807|NCT01270581|837341|P2|NOT COMPLETED|Overall Study||0
349808|NCT01270581|837342|P1|NOT COMPLETED|Overall Study||1
349809|NCT01270581|837341|P2|COMPLETED|Overall Study||3
349810|NCT01270581|837342|P1|COMPLETED|Overall Study||3
349811|NCT01270581|837341|P2|STARTED|Overall Study||3
349812|NCT01270581|837342|P1|STARTED|Overall Study||4
349813|NCT01270555|837348|P1|NOT COMPLETED|Overall Study||13
349814|NCT01270555|837348|P1|COMPLETED|Overall Study||19
349815|NCT01270555|837348|P1|STARTED|Overall Study||32
349816|NCT01270529|837361|P3|NOT COMPLETED|Overall Study||0
349817|NCT01270529|837362|P2|NOT COMPLETED|Overall Study||0
349818|NCT01270529|837363|P1|NOT COMPLETED|Overall Study||0
349819|NCT01270529|837361|P3|COMPLETED|Overall Study||25
349820|NCT01270529|837362|P2|COMPLETED|Overall Study||7
349821|NCT01270529|837363|P1|COMPLETED|Overall Study||12
349822|NCT01270529|837361|P3|STARTED|Overall Study||25
349823|NCT01270529|837362|P2|STARTED|Overall Study||7
349824|NCT01270529|837363|P1|STARTED|Overall Study||12
349825|NCT01270503|837371|P1|NOT COMPLETED|Overall Study||1
349826|NCT01270503|837371|P1|COMPLETED|Overall Study||537
349827|NCT01270503|837371|P1|STARTED|Overall Study||538
349828|NCT01270464|837379|P3|NOT COMPLETED|Overall Study||18
349829|NCT01270464|837380|P2|NOT COMPLETED|Overall Study||12
349830|NCT01270464|837381|P1|NOT COMPLETED|Overall Study||20
349831|NCT01270464|837379|P3|COMPLETED|Overall Study||88
349832|NCT01270464|837380|P2|COMPLETED|Overall Study||92
349833|NCT01270464|837381|P1|COMPLETED|Overall Study||85
349834|NCT01270464|837379|P3|Pharmacokinetic Analysis Set|Overall Study||103
349835|NCT01270464|837380|P2|Pharmacokinetic Analysis Set|Overall Study||103
349836|NCT01270464|837381|P1|Pharmacokinetic Analysis Set|Overall Study||105
349837|NCT01270464|837379|P3|Full Analysis Set|Overall Study||103
349838|NCT01270464|837380|P2|Full Analysis Set|Overall Study||103
349839|NCT01270464|837381|P1|Full Analysis Set|Overall Study||105
349840|NCT01270464|837379|P3|Safety Analysis Set|Overall Study||103
349841|NCT01270464|837380|P2|Safety Analysis Set|Overall Study||103
349842|NCT01270464|837381|P1|Safety Analysis Set|Overall Study||105
349843|NCT01270464|837379|P3|STARTED|Overall Study||106
349844|NCT01270464|837380|P2|STARTED|Overall Study||104
349845|NCT01270464|837381|P1|STARTED|Overall Study||105
349846|NCT01270256|837430|P2|NOT COMPLETED|Overall Study||0
349847|NCT01270256|837431|P1|NOT COMPLETED|Overall Study||1
349848|NCT01270256|837430|P2|COMPLETED|Overall Study||20
349849|NCT01270256|837431|P1|COMPLETED|Overall Study||20
349850|NCT01270256|837430|P2|STARTED|Overall Study||20
349851|NCT01270256|837431|P1|STARTED|Overall Study||21
349852|NCT01270139|837440|P3|NOT COMPLETED|Overall Study||20
349853|NCT01270139|837441|P2|NOT COMPLETED|Overall Study||26
349854|NCT01270139|837442|P1|NOT COMPLETED|Overall Study||18
349855|NCT01270139|837440|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
349856|NCT01270139|837441|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
349857|NCT01270139|837442|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
349858|NCT01270139|837440|P3|STARTED|Overall Study|Intention-to-treat population|60
349859|NCT01270139|837441|P2|STARTED|Overall Study|Intention-to-treat population|60
349860|NCT01270139|837442|P1|STARTED|Overall Study|Intention-to-treat population|60
349861|NCT01270126|837485|P2|NOT COMPLETED|Overall Study||0
349862|NCT01270126|837486|P1|NOT COMPLETED|Overall Study||0
349863|NCT01270126|837485|P2|COMPLETED|Overall Study||10
349864|NCT01270126|837486|P1|COMPLETED|Overall Study||12
349865|NCT01270126|837485|P2|STARTED|Overall Study||10
349866|NCT01270126|837486|P1|STARTED|Overall Study||12
349867|NCT01269918|837494|P2|NOT COMPLETED|Overall Study||3
349868|NCT01269918|837495|P1|NOT COMPLETED|Overall Study||0
349869|NCT01269918|837494|P2|COMPLETED|Overall Study||68
349870|NCT01269918|837495|P1|COMPLETED|Overall Study||71
349871|NCT01269918|837494|P2|STARTED|Overall Study||71
349872|NCT01269918|837495|P1|STARTED|Overall Study||71
349873|NCT01269801|837529|P2|NOT COMPLETED|Overall Study||3
349874|NCT01269801|837530|P1|NOT COMPLETED|Overall Study||0
349875|NCT01269801|837529|P2|COMPLETED|Overall Study||77
349876|NCT01269801|837530|P1|COMPLETED|Overall Study||74
349877|NCT01269801|837529|P2|STARTED|Overall Study||80
349878|NCT01269801|837530|P1|STARTED|Overall Study||74
349879|NCT01269710|837536|P1|NOT COMPLETED|Overall Study||3
349880|NCT01269710|837536|P1|COMPLETED|Overall Study|This refers to Week 52.|1
349881|NCT01269710|837536|P1|Week 36|Overall Study||2
349882|NCT01269710|837536|P1|Week 12|Overall Study||3
349883|NCT01269710|837536|P1|STARTED|Overall Study||4
349884|NCT01269346|837544|P1|NOT COMPLETED|Extension Phase||43
349885|NCT01269346|837544|P1|COMPLETED|Extension Phase||0
349886|NCT01269346|837544|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
349887|NCT01269346|837544|P1|NOT COMPLETED|Treatment Phase||9
349888|NCT01269346|837544|P1|COMPLETED|Treatment Phase||43
349889|NCT01269346|837544|P1|Completed 6 Cycles|Treatment Phase||45
349890|NCT01269346|837544|P1|STARTED|Treatment Phase||52
349891|NCT01269125|837555|P3|NOT COMPLETED|Overall Study||0
349892|NCT01269125|837556|P2|NOT COMPLETED|Overall Study||5
349893|NCT01269125|837557|P1|NOT COMPLETED|Overall Study||7
349894|NCT01269125|837555|P3|COMPLETED|Overall Study||60
349895|NCT01269125|837556|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
349896|NCT01269125|837557|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
349897|NCT01269125|837555|P3|STARTED|Overall Study||60
349898|NCT01269125|837556|P2|STARTED|Overall Study||60
349899|NCT01269125|837557|P1|STARTED|Overall Study||60
349900|NCT01268943|837581|P4|NOT COMPLETED|Overall Study||0
349901|NCT01268943|837582|P3|NOT COMPLETED|Overall Study||0
349902|NCT01268943|837583|P2|NOT COMPLETED|Overall Study||0
349903|NCT01268943|837584|P1|NOT COMPLETED|Overall Study||0
349904|NCT01268943|837581|P4|COMPLETED|Overall Study||6
349905|NCT01268943|837582|P3|COMPLETED|Overall Study||3
349906|NCT01268943|837583|P2|COMPLETED|Overall Study||3
349907|NCT01268943|837584|P1|COMPLETED|Overall Study||6
349908|NCT01268943|837581|P4|STARTED|Overall Study||6
349909|NCT01268943|837582|P3|STARTED|Overall Study||3
349910|NCT01268943|837583|P2|STARTED|Overall Study||3
349911|NCT01268943|837584|P1|STARTED|Overall Study||6
349912|NCT01268891|837596|P2|NOT COMPLETED|Overall Study||8
349913|NCT01268891|837597|P1|NOT COMPLETED|Overall Study||8
349914|NCT01268891|837596|P2|COMPLETED|Overall Study||58
349915|NCT01268891|837597|P1|COMPLETED|Overall Study||58
349916|NCT01268891|837596|P2|STARTED|Overall Study||66
349917|NCT01268891|837597|P1|STARTED|Overall Study||66
349918|NCT01268683|837609|P1|NOT COMPLETED|Overall Study||0
349919|NCT01268683|837609|P1|COMPLETED|Overall Study||10
349920|NCT01268683|837609|P1|STARTED|Overall Study||10
349921|NCT01268566|837616|P1|NOT COMPLETED|Overall Study||43
349922|NCT01268566|837616|P1|COMPLETED|Overall Study||13
349923|NCT01268566|837616|P1|STARTED|Overall Study||56
349924|NCT01268501|837634|P1|NOT COMPLETED|Overall Study||9
349925|NCT01268501|837634|P1|COMPLETED|Overall Study||87
349926|NCT01268501|837634|P1|STARTED|Overall Study||96
349927|NCT01268488|837638|P1|NOT COMPLETED|Overall Study||5
349928|NCT01268488|837638|P1|COMPLETED|Overall Study||93
349929|NCT01268488|837638|P1|STARTED|Overall Study||98
349930|NCT01268306|837645|P1|NOT COMPLETED|Overall Study||1
349931|NCT01268306|837645|P1|COMPLETED|Overall Study||7
349932|NCT01268306|837645|P1|STARTED|Overall Study||8
349933|NCT01268293|837649|P1|NOT COMPLETED|Overall Study||9
349934|NCT01268293|837649|P1|COMPLETED|Overall Study||0
349935|NCT01268293|837649|P1|Completed Cycle 1|Overall Study||9
349936|NCT01268293|837649|P1|STARTED|Overall Study||9
349937|NCT01268267|837654|P1|NOT COMPLETED|Overall Study||1
349938|NCT01268267|837654|P1|COMPLETED|Overall Study||93
349939|NCT01268267|837654|P1|STARTED|Overall Study||94
349940|NCT01268189|837661|P1|NOT COMPLETED|Overall Study||3
349941|NCT01268189|837661|P1|COMPLETED|Overall Study||17
349942|NCT01268189|837661|P1|STARTED|Overall Study||20
349943|NCT01268150|837675|P1|NOT COMPLETED|Extension Phase||27
349944|NCT01268150|837675|P1|COMPLETED|Extension Phase||1
349945|NCT01268150|837675|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
349946|NCT01268150|837675|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
349947|NCT01268150|837675|P1|NOT COMPLETED|Treatment Phase||28
349948|NCT01268150|837675|P1|COMPLETED|Treatment Phase||28
349949|NCT01268150|837675|P1|STARTED|Treatment Phase||56
349950|NCT01268111|837685|P2|NOT COMPLETED|Overall Study||0
349951|NCT01268111|837686|P1|NOT COMPLETED|Overall Study||0
349952|NCT01268111|837685|P2|COMPLETED|Overall Study||6
349953|NCT01268111|837686|P1|COMPLETED|Overall Study||6
349954|NCT01268111|837685|P2|STARTED|Overall Study||6
349955|NCT01268111|837686|P1|STARTED|Overall Study||6
349956|NCT01268098|837694|P2|NOT COMPLETED|Overall Study||0
349957|NCT01268098|837695|P1|NOT COMPLETED|Overall Study||1
349958|NCT01268098|837694|P2|COMPLETED|Overall Study||23
349959|NCT01268098|837695|P1|COMPLETED|Overall Study||18
349960|NCT01268098|837694|P2|STARTED|Overall Study||23
349961|NCT01268098|837695|P1|STARTED|Overall Study||19
349962|NCT01267994|837703|P1|NOT COMPLETED|Overall Study||2
349963|NCT01267994|837703|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
349964|NCT01267994|837703|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
349965|NCT01267929|837709|P2|NOT COMPLETED|Overall Study||0
349966|NCT01267929|837710|P1|NOT COMPLETED|Overall Study||0
349967|NCT01267929|837709|P2|COMPLETED|Overall Study||15
349968|NCT01267929|837710|P1|COMPLETED|Overall Study||15
349969|NCT01267929|837709|P2|STARTED|Overall Study||15
349970|NCT01267929|837710|P1|STARTED|Overall Study||15
349971|NCT01267422|837716|P2|NOT COMPLETED|Safety and Efficacy Study||0
349972|NCT01267422|837717|P1|NOT COMPLETED|Safety and Efficacy Study||0
349973|NCT01267422|837716|P2|COMPLETED|Safety and Efficacy Study||4
349974|NCT01267422|837717|P1|COMPLETED|Safety and Efficacy Study||5
349975|NCT01267422|837716|P2|STARTED|Safety and Efficacy Study||4
349976|NCT01267422|837717|P1|STARTED|Safety and Efficacy Study||5
349977|NCT01267422|837716|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
349978|NCT01267422|837717|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
349979|NCT01267422|837716|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
349980|NCT01267422|837717|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
349981|NCT01267422|837716|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
349982|NCT01267422|837717|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
349983|NCT01267292|837737|P2|NOT COMPLETED|Overall Study||6
349984|NCT01267292|837738|P1|NOT COMPLETED|Overall Study||4
349985|NCT01267292|837737|P2|COMPLETED|Overall Study||20
349986|NCT01267292|837738|P1|COMPLETED|Overall Study||20
349987|NCT01267292|837737|P2|STARTED|Overall Study||26
349988|NCT01267292|837738|P1|STARTED|Overall Study||24
349989|NCT01267266|837772|P2|NOT COMPLETED|Randomized Phase||0
349990|NCT01267266|837773|P1|NOT COMPLETED|Randomized Phase||0
349991|NCT01267266|837772|P2|COMPLETED|Randomized Phase||5
349992|NCT01267266|837773|P1|COMPLETED|Randomized Phase||3
349993|NCT01267266|837772|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
349994|NCT01267266|837773|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
349995|NCT01267266|837772|P2|NOT COMPLETED|Lead-in Phase||0
349996|NCT01267266|837773|P1|NOT COMPLETED|Lead-in Phase||23
349997|NCT01267266|837772|P2|COMPLETED|Lead-in Phase||0
349998|NCT01267266|837773|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
349999|NCT01267266|837772|P2|STARTED|Lead-in Phase||0
350000|NCT01267266|837773|P1|STARTED|Lead-in Phase||31
350001|NCT01267266|837772|P2|NOT COMPLETED|Enrollment Phase||0
350002|NCT01267266|837773|P1|NOT COMPLETED|Enrollment Phase||2
350003|NCT01267266|837772|P2|COMPLETED|Enrollment Phase||0
350004|NCT01267266|837773|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
350005|NCT01267266|837772|P2|STARTED|Enrollment Phase||0
350006|NCT01267266|837773|P1|STARTED|Enrollment Phase||33
350007|NCT01267253|837786|P1|NOT COMPLETED|Overall Study||3
350008|NCT01267253|837786|P1|COMPLETED|Overall Study|Eligible and treated patients|28
350009|NCT01267253|837786|P1|STARTED|Overall Study||31
350010|NCT01267240|837794|P1|NOT COMPLETED|Overall Study||0
350011|NCT01267240|837794|P1|COMPLETED|Overall Study||25
350012|NCT01267240|837794|P1|STARTED|Overall Study||25
350013|NCT01267227|837804|P4|NOT COMPLETED|Overall Study||3
350014|NCT01267227|837805|P3|NOT COMPLETED|Overall Study||2
350015|NCT01267227|837806|P2|NOT COMPLETED|Overall Study||1
350016|NCT01267227|837807|P1|NOT COMPLETED|Overall Study||1
350017|NCT01267227|837804|P4|COMPLETED|Overall Study||17
350018|NCT01267227|837805|P3|COMPLETED|Overall Study||18
350019|NCT01267227|837806|P2|COMPLETED|Overall Study||19
350020|NCT01267227|837807|P1|COMPLETED|Overall Study||19
350021|NCT01267227|837804|P4|STARTED|Overall Study||20
350022|NCT01267227|837805|P3|STARTED|Overall Study||20
350023|NCT01267227|837806|P2|STARTED|Overall Study||20
350024|NCT01267227|837807|P1|STARTED|Overall Study||20
350025|NCT01267201|837821|P6|NOT COMPLETED|Third Intervention Period||0
350026|NCT01267201|837822|P5|NOT COMPLETED|Third Intervention Period||0
350027|NCT01267201|837823|P4|NOT COMPLETED|Third Intervention Period||0
350028|NCT01267201|837824|P3|NOT COMPLETED|Third Intervention Period||0
350029|NCT01267201|837825|P2|NOT COMPLETED|Third Intervention Period||0
350030|NCT01267201|837826|P1|NOT COMPLETED|Third Intervention Period||0
350031|NCT01267201|837821|P6|COMPLETED|Third Intervention Period||4
350032|NCT01267201|837822|P5|COMPLETED|Third Intervention Period||4
350033|NCT01267201|837823|P4|COMPLETED|Third Intervention Period||4
350034|NCT01267201|837824|P3|COMPLETED|Third Intervention Period||4
350035|NCT01267201|837825|P2|COMPLETED|Third Intervention Period||3
350036|NCT01267201|837826|P1|COMPLETED|Third Intervention Period||3
350037|NCT01267201|837821|P6|STARTED|Third Intervention Period||4
350038|NCT01267201|837822|P5|STARTED|Third Intervention Period||4
350039|NCT01267201|837823|P4|STARTED|Third Intervention Period||4
350040|NCT01267201|837824|P3|STARTED|Third Intervention Period||4
350041|NCT01267201|837825|P2|STARTED|Third Intervention Period||3
350042|NCT01267201|837826|P1|STARTED|Third Intervention Period||3
350126|NCT01267045|837861|P2|COMPLETED|6-month Outcome||23
350043|NCT01267201|837821|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350044|NCT01267201|837822|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350045|NCT01267201|837823|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350046|NCT01267201|837824|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350047|NCT01267201|837825|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350048|NCT01267201|837826|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350049|NCT01267201|837821|P6|COMPLETED|Washout Period (At Least 2 Days)||4
350050|NCT01267201|837822|P5|COMPLETED|Washout Period (At Least 2 Days)||4
350051|NCT01267201|837823|P4|COMPLETED|Washout Period (At Least 2 Days)||4
350052|NCT01267201|837824|P3|COMPLETED|Washout Period (At Least 2 Days)||4
350053|NCT01267201|837825|P2|COMPLETED|Washout Period (At Least 2 Days)||3
350054|NCT01267201|837826|P1|COMPLETED|Washout Period (At Least 2 Days)||3
350055|NCT01267201|837821|P6|STARTED|Washout Period (At Least 2 Days)||4
350056|NCT01267201|837822|P5|STARTED|Washout Period (At Least 2 Days)||4
350057|NCT01267201|837823|P4|STARTED|Washout Period (At Least 2 Days)||4
350058|NCT01267201|837824|P3|STARTED|Washout Period (At Least 2 Days)||4
350059|NCT01267201|837825|P2|STARTED|Washout Period (At Least 2 Days)||3
350060|NCT01267201|837826|P1|STARTED|Washout Period (At Least 2 Days)||3
350061|NCT01267201|837821|P6|NOT COMPLETED|Second Intervention Period||0
350062|NCT01267201|837822|P5|NOT COMPLETED|Second Intervention Period||0
350063|NCT01267201|837823|P4|NOT COMPLETED|Second Intervention Period||0
350064|NCT01267201|837824|P3|NOT COMPLETED|Second Intervention Period||0
350065|NCT01267201|837825|P2|NOT COMPLETED|Second Intervention Period||1
350066|NCT01267201|837826|P1|NOT COMPLETED|Second Intervention Period||0
350067|NCT01267201|837821|P6|COMPLETED|Second Intervention Period||4
350068|NCT01267201|837822|P5|COMPLETED|Second Intervention Period||4
350069|NCT01267201|837823|P4|COMPLETED|Second Intervention Period||4
350070|NCT01267201|837824|P3|COMPLETED|Second Intervention Period||4
350071|NCT01267201|837825|P2|COMPLETED|Second Intervention Period||3
350072|NCT01267201|837826|P1|COMPLETED|Second Intervention Period||3
350073|NCT01267201|837821|P6|STARTED|Second Intervention Period||4
350074|NCT01267201|837822|P5|STARTED|Second Intervention Period||4
350075|NCT01267201|837823|P4|STARTED|Second Intervention Period||4
350076|NCT01267201|837824|P3|STARTED|Second Intervention Period||4
350077|NCT01267201|837825|P2|STARTED|Second Intervention Period||4
350078|NCT01267201|837826|P1|STARTED|Second Intervention Period||3
350079|NCT01267201|837821|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350080|NCT01267201|837822|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350081|NCT01267201|837823|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350082|NCT01267201|837824|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350083|NCT01267201|837825|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350084|NCT01267201|837826|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
350085|NCT01267201|837821|P6|COMPLETED|Washout Period (At Least 2 Days)||4
350086|NCT01267201|837822|P5|COMPLETED|Washout Period (At Least 2 Days)||4
350087|NCT01267201|837823|P4|COMPLETED|Washout Period (At Least 2 Days)||4
350088|NCT01267201|837824|P3|COMPLETED|Washout Period (At Least 2 Days)||4
350089|NCT01267201|837825|P2|COMPLETED|Washout Period (At Least 2 Days)||4
350090|NCT01267201|837826|P1|COMPLETED|Washout Period (At Least 2 Days)||3
350091|NCT01267201|837821|P6|STARTED|Washout Period (At Least 2 Days)||4
350092|NCT01267201|837822|P5|STARTED|Washout Period (At Least 2 Days)||4
350093|NCT01267201|837823|P4|STARTED|Washout Period (At Least 2 Days)||4
350094|NCT01267201|837824|P3|STARTED|Washout Period (At Least 2 Days)||4
350095|NCT01267201|837825|P2|STARTED|Washout Period (At Least 2 Days)||4
350096|NCT01267201|837826|P1|STARTED|Washout Period (At Least 2 Days)||3
350097|NCT01267201|837821|P6|NOT COMPLETED|First Intervention Period||0
350098|NCT01267201|837822|P5|NOT COMPLETED|First Intervention Period||0
350099|NCT01267201|837823|P4|NOT COMPLETED|First Intervention Period||0
350100|NCT01267201|837824|P3|NOT COMPLETED|First Intervention Period||0
350101|NCT01267201|837825|P2|NOT COMPLETED|First Intervention Period||0
350102|NCT01267201|837826|P1|NOT COMPLETED|First Intervention Period||1
350103|NCT01267201|837821|P6|COMPLETED|First Intervention Period||4
350104|NCT01267201|837822|P5|COMPLETED|First Intervention Period||4
350105|NCT01267201|837823|P4|COMPLETED|First Intervention Period||4
350106|NCT01267201|837824|P3|COMPLETED|First Intervention Period||4
350107|NCT01267201|837825|P2|COMPLETED|First Intervention Period||4
350108|NCT01267201|837826|P1|COMPLETED|First Intervention Period||3
350109|NCT01267201|837821|P6|STARTED|First Intervention Period||4
350110|NCT01267201|837822|P5|STARTED|First Intervention Period||4
350111|NCT01267201|837823|P4|STARTED|First Intervention Period||4
350112|NCT01267201|837824|P3|STARTED|First Intervention Period||4
350113|NCT01267201|837825|P2|STARTED|First Intervention Period||4
350114|NCT01267201|837826|P1|STARTED|First Intervention Period||4
350115|NCT01267175|837843|P1|NOT COMPLETED|Overall Study||2
350116|NCT01267175|837843|P1|COMPLETED|Overall Study||29
350117|NCT01267175|837843|P1|STARTED|Overall Study||31
350118|NCT01267136|837850|P2|NOT COMPLETED|Overall Study||6
350119|NCT01267136|837851|P1|NOT COMPLETED|Overall Study||4
350120|NCT01267136|837850|P2|COMPLETED|Overall Study||36
350121|NCT01267136|837851|P1|COMPLETED|Overall Study||38
350122|NCT01267136|837850|P2|STARTED|Overall Study||42
350123|NCT01267136|837851|P1|STARTED|Overall Study||42
350124|NCT01267045|837861|P2|NOT COMPLETED|6-month Outcome||3
350125|NCT01267045|837862|P1|NOT COMPLETED|6-month Outcome||0
350127|NCT01267045|837862|P1|COMPLETED|6-month Outcome||22
350128|NCT01267045|837861|P2|STARTED|6-month Outcome||26
350129|NCT01267045|837862|P1|STARTED|6-month Outcome||22
350130|NCT01267045|837861|P2|NOT COMPLETED|2-month Outcomes||3
350131|NCT01267045|837862|P1|NOT COMPLETED|2-month Outcomes||4
350132|NCT01267045|837861|P2|COMPLETED|2-month Outcomes||26
350133|NCT01267045|837862|P1|COMPLETED|2-month Outcomes||22
350134|NCT01267045|837861|P2|STARTED|2-month Outcomes||29
350135|NCT01267045|837862|P1|STARTED|2-month Outcomes||26
350136|NCT01267019|837897|P3|NOT COMPLETED|Overall Study||6
350137|NCT01267019|837898|P2|NOT COMPLETED|Overall Study||6
350138|NCT01267019|837899|P1|NOT COMPLETED|Overall Study||6
350139|NCT01267019|837897|P3|COMPLETED|Overall Study||47
350140|NCT01267019|837898|P2|COMPLETED|Overall Study||47
350141|NCT01267019|837899|P1|COMPLETED|Overall Study||41
350142|NCT01267019|837897|P3|STARTED|Overall Study||53
350143|NCT01267019|837898|P2|STARTED|Overall Study||53
350144|NCT01267019|837899|P1|STARTED|Overall Study||47
350145|NCT01266967|837915|P2|NOT COMPLETED|Overall Study||83
350146|NCT01266967|837916|P1|NOT COMPLETED|Overall Study||89
350147|NCT01266967|837915|P2|COMPLETED|Overall Study||0
350148|NCT01266967|837916|P1|COMPLETED|Overall Study||0
350149|NCT01266967|837915|P2|STARTED|Overall Study||83
350150|NCT01266967|837916|P1|STARTED|Overall Study||89
350151|NCT01266876|837968|P5|NOT COMPLETED|Overall Study||0
350152|NCT01266876|837969|P4|NOT COMPLETED|Overall Study||1
350153|NCT01266876|837970|P3|NOT COMPLETED|Overall Study||0
350154|NCT01266876|837971|P2|NOT COMPLETED|Overall Study||0
350155|NCT01266876|837972|P1|NOT COMPLETED|Overall Study||0
350156|NCT01266876|837968|P5|COMPLETED|Overall Study||16
350157|NCT01266876|837969|P4|COMPLETED|Overall Study||14
350158|NCT01266876|837970|P3|COMPLETED|Overall Study||16
350159|NCT01266876|837971|P2|COMPLETED|Overall Study||15
350160|NCT01266876|837972|P1|COMPLETED|Overall Study||15
350161|NCT01266876|837968|P5|STARTED|Overall Study||16
350162|NCT01266876|837969|P4|STARTED|Overall Study||15
350163|NCT01266876|837970|P3|STARTED|Overall Study||16
350164|NCT01266876|837971|P2|STARTED|Overall Study||15
350165|NCT01266876|837972|P1|STARTED|Overall Study||15
350166|NCT01266850|838079|P5|NOT COMPLETED|Overall Study||30
350167|NCT01266850|838080|P4|NOT COMPLETED|Overall Study||28
350168|NCT01266850|838081|P3|NOT COMPLETED|Overall Study||24
350169|NCT01266850|838082|P2|NOT COMPLETED|Overall Study||36
350170|NCT01266850|838083|P1|NOT COMPLETED|Overall Study||30
350171|NCT01266850|838079|P5|COMPLETED|Overall Study||297
350172|NCT01266850|838080|P4|COMPLETED|Overall Study||301
350173|NCT01266850|838081|P3|COMPLETED|Overall Study||214
350174|NCT01266850|838082|P2|COMPLETED|Overall Study||212
350175|NCT01266850|838083|P1|COMPLETED|Overall Study||212
350176|NCT01266850|838079|P5|Received Third Vaccine|Overall Study||299
350177|NCT01266850|838080|P4|Received Third Vaccine|Overall Study||0
350178|NCT01266850|838081|P3|Received Third Vaccine|Overall Study||217
350179|NCT01266850|838082|P2|Received Third Vaccine|Overall Study||221
350180|NCT01266850|838083|P1|Received Third Vaccine|Overall Study||221
350181|NCT01266850|838079|P5|Received Second Vaccine|Overall Study||307
350182|NCT01266850|838080|P4|Received Second Vaccine|Overall Study||311
350183|NCT01266850|838081|P3|Received Second Vaccine|Overall Study||227
350184|NCT01266850|838082|P2|Received Second Vaccine|Overall Study||233
350185|NCT01266850|838083|P1|Received Second Vaccine|Overall Study||231
350186|NCT01266850|838079|P5|STARTED|Overall Study||327
350187|NCT01266850|838080|P4|STARTED|Overall Study||329
350188|NCT01266850|838081|P3|STARTED|Overall Study||238
350189|NCT01266850|838082|P2|STARTED|Overall Study||248
350190|NCT01266850|838083|P1|STARTED|Overall Study||242
350191|NCT01266824|838137|P2|NOT COMPLETED|Overall Study||3
350192|NCT01266824|838138|P1|NOT COMPLETED|Overall Study||2
350193|NCT01266824|838137|P2|COMPLETED|Overall Study||0
350194|NCT01266824|838138|P1|COMPLETED|Overall Study||0
350195|NCT01266824|838137|P2|STARTED|Overall Study||3
350196|NCT01266824|838138|P1|STARTED|Overall Study||2
350197|NCT01266447|838150|P1|NOT COMPLETED|Overall Study||0
350198|NCT01266447|838150|P1|COMPLETED|Overall Study|Eligible and treated patients|27
350199|NCT01266447|838150|P1|STARTED|Overall Study||27
350200|NCT01266265|838161|P2|NOT COMPLETED|Overall Study||190
350201|NCT01266265|838162|P1|NOT COMPLETED|Overall Study||205
350202|NCT01266265|838161|P2|COMPLETED|Overall Study||477
350203|NCT01266265|838162|P1|COMPLETED|Overall Study||461
350204|NCT01266265|838161|P2|STARTED|Overall Study||667
350205|NCT01266265|838162|P1|STARTED|Overall Study||666
350206|NCT01266148|838170|P2|NOT COMPLETED|Overall Study||3
350207|NCT01266148|838171|P1|NOT COMPLETED|Overall Study||7
350208|NCT01266148|838170|P2|COMPLETED|Overall Study||56
350209|NCT01266148|838171|P1|COMPLETED|Overall Study||49
350210|NCT01266148|838170|P2|STARTED|Overall Study||59
350211|NCT01266148|838171|P1|STARTED|Overall Study||56
350212|NCT01266122|838199|P2|NOT COMPLETED|Overall Study||6
350213|NCT01266122|838200|P1|NOT COMPLETED|Overall Study||6
350214|NCT01266122|838199|P2|COMPLETED|Overall Study||42
350215|NCT01266122|838200|P1|COMPLETED|Overall Study||42
350216|NCT01266122|838199|P2|STARTED|Overall Study||48
350217|NCT01266122|838200|P1|STARTED|Overall Study||48
350218|NCT01266070|838208|P1|NOT COMPLETED|Overall Study||4
350219|NCT01266070|838208|P1|COMPLETED|Overall Study||2
350220|NCT01266070|838208|P1|STARTED|Overall Study||6
350221|NCT01266031|838216|P3|NOT COMPLETED|Overall Study||3
350222|NCT01266031|838217|P2|NOT COMPLETED|Overall Study||3
350223|NCT01266031|838218|P1|NOT COMPLETED|Overall Study||0
350224|NCT01266031|838216|P3|COMPLETED|Overall Study||46
350225|NCT01266031|838217|P2|COMPLETED|Overall Study||38
350226|NCT01266031|838218|P1|COMPLETED|Overall Study||6
350227|NCT01266031|838216|P3|STARTED|Overall Study||49
350228|NCT01266031|838217|P2|STARTED|Overall Study||41
350229|NCT01266031|838218|P1|STARTED|Overall Study||6
350230|NCT01266018|838226|P2|NOT COMPLETED|Overall Study||1
350231|NCT01266018|838227|P1|NOT COMPLETED|Overall Study||1
350232|NCT01266018|838226|P2|COMPLETED|Overall Study||12
350233|NCT01266018|838227|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
350234|NCT01266018|838226|P2|STARTED|Overall Study||13
350235|NCT01266018|838227|P1|STARTED|Overall Study||9
350236|NCT01265992|838238|P1|NOT COMPLETED|Overall Study||9
350237|NCT01265992|838238|P1|COMPLETED|Overall Study||41
350238|NCT01265992|838238|P1|Received Treatment|Overall Study||49
350239|NCT01265992|838238|P1|STARTED|Overall Study||50
350240|NCT01265966|838254|P3|NOT COMPLETED|Overall Study||2
350241|NCT01265966|838255|P2|NOT COMPLETED|Overall Study||2
350242|NCT01265966|838256|P1|NOT COMPLETED|Overall Study||3
350243|NCT01265966|838254|P3|COMPLETED|Overall Study||27
350244|NCT01265966|838255|P2|COMPLETED|Overall Study||39
350245|NCT01265966|838256|P1|COMPLETED|Overall Study||44
350246|NCT01265966|838254|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
350247|NCT01265966|838255|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
350248|NCT01265966|838256|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
350249|NCT01265966|838254|P3|STARTED|Overall Study||29
350250|NCT01265966|838255|P2|STARTED|Overall Study||41
350251|NCT01265966|838256|P1|STARTED|Overall Study||47
350252|NCT01265875|838264|P1|NOT COMPLETED|Overall Study||1
350253|NCT01265875|838264|P1|COMPLETED|Overall Study||11
350254|NCT01265875|838264|P1|STARTED|Overall Study||12
350255|NCT01265823|838272|P1|NOT COMPLETED|Overall Study||7
350256|NCT01265823|838272|P1|COMPLETED|Overall Study||143
350257|NCT01265823|838272|P1|STARTED|Overall Study||150
350258|NCT01265797|838301|P2|NOT COMPLETED|Open Label Month||1
350259|NCT01265797|838302|P1|NOT COMPLETED|Open Label Month||0
350260|NCT01265797|838301|P2|COMPLETED|Open Label Month||26
350261|NCT01265797|838302|P1|COMPLETED|Open Label Month||24
350262|NCT01265797|838301|P2|STARTED|Open Label Month||27
350263|NCT01265797|838302|P1|STARTED|Open Label Month||24
350264|NCT01265797|838301|P2|NOT COMPLETED|Blinded Month||2
350265|NCT01265797|838302|P1|NOT COMPLETED|Blinded Month||10
350266|NCT01265797|838301|P2|COMPLETED|Blinded Month||27
350267|NCT01265797|838302|P1|COMPLETED|Blinded Month||24
350268|NCT01265797|838301|P2|STARTED|Blinded Month||29
350269|NCT01265797|838302|P1|STARTED|Blinded Month||34
350270|NCT01265797|838301|P2|NOT COMPLETED|Run-in Month||5
350271|NCT01265797|838302|P1|NOT COMPLETED|Run-in Month||0
350272|NCT01265797|838301|P2|COMPLETED|Run-in Month||29
350273|NCT01265797|838302|P1|COMPLETED|Run-in Month||34
350274|NCT01265797|838301|P2|STARTED|Run-in Month||34
350275|NCT01265797|838302|P1|STARTED|Run-in Month||34
350276|NCT01265784|838333|P3|NOT COMPLETED|Overall Study||4
350277|NCT01265784|838334|P2|NOT COMPLETED|Overall Study||8
350278|NCT01265784|838335|P1|NOT COMPLETED|Overall Study||12
350279|NCT01265784|838333|P3|COMPLETED|Overall Study||26
350280|NCT01265784|838334|P2|COMPLETED|Overall Study||49
350281|NCT01265784|838335|P1|COMPLETED|Overall Study||44
350282|NCT01265784|838333|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
350283|NCT01265784|838334|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
350284|NCT01265784|838335|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
350285|NCT01265784|838333|P3|STARTED|Overall Study||30
350286|NCT01265784|838334|P2|STARTED|Overall Study||57
350287|NCT01265784|838335|P1|STARTED|Overall Study||56
350288|NCT01265615|838405|P4|NOT COMPLETED|Overall Study||3
350289|NCT01265615|838406|P3|NOT COMPLETED|Overall Study||4
350290|NCT01265615|838407|P2|NOT COMPLETED|Overall Study||2
350291|NCT01265615|838408|P1|NOT COMPLETED|Overall Study||2
350292|NCT01265615|838405|P4|COMPLETED|Overall Study||27
350293|NCT01265615|838406|P3|COMPLETED|Overall Study||26
350294|NCT01265615|838407|P2|COMPLETED|Overall Study||28
350295|NCT01265615|838408|P1|COMPLETED|Overall Study||28
350296|NCT01265615|838405|P4|STARTED|Overall Study||30
350297|NCT01265615|838406|P3|STARTED|Overall Study||30
350298|NCT01265615|838407|P2|STARTED|Overall Study||30
350299|NCT01265615|838408|P1|STARTED|Overall Study||30
350300|NCT01265563|838459|P5|NOT COMPLETED|Overall Study||2
350301|NCT01265563|838460|P4|NOT COMPLETED|Overall Study||0
350302|NCT01265563|838461|P3|NOT COMPLETED|Overall Study||1
350303|NCT01265563|838462|P2|NOT COMPLETED|Overall Study||1
350304|NCT01265563|838463|P1|NOT COMPLETED|Overall Study||0
350305|NCT01265563|838459|P5|COMPLETED|Overall Study||14
350306|NCT01265563|838460|P4|COMPLETED|Overall Study||16
350307|NCT01265563|838461|P3|COMPLETED|Overall Study||16
350308|NCT01265563|838462|P2|COMPLETED|Overall Study||12
350309|NCT01265563|838463|P1|COMPLETED|Overall Study||16
350310|NCT01265563|838459|P5|STARTED|Overall Study||16
350311|NCT01265563|838460|P4|STARTED|Overall Study||16
350312|NCT01265563|838461|P3|STARTED|Overall Study||17
350313|NCT01265563|838462|P2|STARTED|Overall Study||13
350314|NCT01265563|838463|P1|STARTED|Overall Study||16
350315|NCT01265524|838482|P2|NOT COMPLETED|Overall Study||6
350316|NCT01265524|838483|P1|NOT COMPLETED|Overall Study||18
350317|NCT01265524|838482|P2|COMPLETED|Overall Study||46
350318|NCT01265524|838483|P1|COMPLETED|Overall Study||41
350319|NCT01265524|838482|P2|STARTED|Overall Study||52
350320|NCT01265524|838483|P1|STARTED|Overall Study||59
350321|NCT01265498|838503|P2|NOT COMPLETED|Overall Study||33
350322|NCT01265498|838504|P1|NOT COMPLETED|Overall Study||31
350323|NCT01265498|838503|P2|COMPLETED|Overall Study||109
350324|NCT01265498|838504|P1|COMPLETED|Overall Study||110
350325|NCT01265498|838503|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
350326|NCT01265498|838504|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
350327|NCT01265498|838503|P2|STARTED|Overall Study||142
350328|NCT01265498|838504|P1|STARTED|Overall Study||141
350329|NCT01265459|838607|P3|NOT COMPLETED|Overall Study||2
350330|NCT01265459|838608|P2|NOT COMPLETED|Overall Study||0
350331|NCT01265459|838609|P1|NOT COMPLETED|Overall Study||0
350332|NCT01265459|838607|P3|COMPLETED|Overall Study||20
350333|NCT01265459|838608|P2|COMPLETED|Overall Study||23
350334|NCT01265459|838609|P1|COMPLETED|Overall Study||23
350335|NCT01265459|838607|P3|STARTED|Overall Study||22
350336|NCT01265459|838608|P2|STARTED|Overall Study||23
350337|NCT01265459|838609|P1|STARTED|Overall Study||23
350338|NCT01265446|838631|P2|NOT COMPLETED|Overall Study||0
350339|NCT01265446|838632|P1|NOT COMPLETED|Overall Study||1
350340|NCT01265446|838631|P2|COMPLETED|Overall Study||125
350341|NCT01265446|838632|P1|COMPLETED|Overall Study||124
350342|NCT01265446|838631|P2|STARTED|Overall Study||125
350343|NCT01265446|838632|P1|STARTED|Overall Study||125
350344|NCT01265420|838640|P1|NOT COMPLETED|Overall Study||1
350345|NCT01265420|838640|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
350346|NCT01265420|838640|P1|STARTED|Overall Study||7
350347|NCT01265394|838644|P1|NOT COMPLETED|Overall Study||37
350348|NCT01265394|838644|P1|COMPLETED|Overall Study||181
350349|NCT01265394|838644|P1|STARTED|Overall Study||218
350350|NCT01265056|838651|P2|NOT COMPLETED|Overall Study||2
350351|NCT01265056|838652|P1|NOT COMPLETED|Overall Study||2
350352|NCT01265056|838651|P2|COMPLETED|Overall Study||25
350353|NCT01265056|838652|P1|COMPLETED|Overall Study||24
350354|NCT01265056|838651|P2|STARTED|Overall Study||27
350355|NCT01265056|838652|P1|STARTED|Overall Study||26
350356|NCT01264952|838661|P3|NOT COMPLETED|Overall Study||0
350357|NCT01264952|838662|P2|NOT COMPLETED|Overall Study||0
350358|NCT01264952|838663|P1|NOT COMPLETED|Overall Study||0
350359|NCT01264952|838661|P3|COMPLETED|Overall Study||8
350360|NCT01264952|838662|P2|COMPLETED|Overall Study||2
350361|NCT01264952|838663|P1|COMPLETED|Overall Study||6
350362|NCT01264952|838661|P3|STARTED|Overall Study||8
350363|NCT01264952|838662|P2|STARTED|Overall Study||2
350364|NCT01264952|838663|P1|STARTED|Overall Study||6
350365|NCT01264939|838679|P2|NOT COMPLETED|Overall Study||28
350366|NCT01264939|838680|P1|NOT COMPLETED|Overall Study||18
350367|NCT01264939|838679|P2|COMPLETED|Overall Study||224
350368|NCT01264939|838680|P1|COMPLETED|Overall Study||66
350369|NCT01264939|838679|P2|STARTED|Overall Study||252
350370|NCT01264939|838680|P1|STARTED|Overall Study||84
350371|NCT01264887|838706|P1|NOT COMPLETED|Overall Study||31
350372|NCT01264887|838706|P1|COMPLETED|Overall Study||0
350373|NCT01264887|838706|P1|STARTED|Overall Study||31
350374|NCT01264835|838717|P1|NOT COMPLETED|Overall Study||1
350375|NCT01264835|838717|P1|COMPLETED|Overall Study||1
350376|NCT01264835|838717|P1|STARTED|Overall Study||2
350377|NCT01264770|838727|P6|NOT COMPLETED|Overall Study||6
350378|NCT01264770|838728|P5|NOT COMPLETED|Overall Study||8
350379|NCT01264770|838729|P4|NOT COMPLETED|Overall Study||6
350380|NCT01264770|838730|P3|NOT COMPLETED|Overall Study||16
350381|NCT01264770|838731|P2|NOT COMPLETED|Overall Study||10
350382|NCT01264770|838732|P1|NOT COMPLETED|Overall Study||18
350383|NCT01264770|838727|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
350384|NCT01264770|838728|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
350385|NCT01264770|838729|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
350386|NCT01264770|838730|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
350387|NCT01264770|838731|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
350388|NCT01264770|838732|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
350389|NCT01264770|838727|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
350390|NCT01264770|838728|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
350391|NCT01264770|838729|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
350392|NCT01264770|838730|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
350393|NCT01264770|838731|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
350489|NCT01263639|839072|P2|NOT COMPLETED|Overall Study||79
350394|NCT01264770|838732|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
350395|NCT01264770|838727|P6|STARTED|Overall Study|Patients who received treatment|25
350396|NCT01264770|838728|P5|STARTED|Overall Study|Patients who received treatment|27
350397|NCT01264770|838729|P4|STARTED|Overall Study|Patients who received treatment|54
350398|NCT01264770|838730|P3|STARTED|Overall Study|Patients who received treatment|57
350399|NCT01264770|838731|P2|STARTED|Overall Study|Patients who received treatment|48
350400|NCT01264770|838732|P1|STARTED|Overall Study|Patients who received treatment|54
350401|NCT01264614|838818|P2|NOT COMPLETED|Overall Study||2
350402|NCT01264614|838819|P1|NOT COMPLETED|Overall Study||1
350403|NCT01264614|838818|P2|COMPLETED|Overall Study||7
350404|NCT01264614|838819|P1|COMPLETED|Overall Study||12
350405|NCT01264614|838818|P2|STARTED|Overall Study||9
350406|NCT01264614|838819|P1|STARTED|Overall Study||13
350407|NCT01264380|838833|P3|NOT COMPLETED|Period C||14
350408|NCT01264380|838834|P2|NOT COMPLETED|Period C||0
350409|NCT01264380|838835|P1|NOT COMPLETED|Period C||0
350410|NCT01264380|838833|P3|COMPLETED|Period C||2
350411|NCT01264380|838834|P2|COMPLETED|Period C||0
350412|NCT01264380|838835|P1|COMPLETED|Period C||0
350413|NCT01264380|838833|P3|STARTED|Period C||16
350414|NCT01264380|838834|P2|STARTED|Period C||0
350415|NCT01264380|838835|P1|STARTED|Period C||0
350416|NCT01264380|838833|P3|NOT COMPLETED|Period B||0
350417|NCT01264380|838834|P2|NOT COMPLETED|Period B||0
350418|NCT01264380|838835|P1|NOT COMPLETED|Period B||0
350419|NCT01264380|838833|P3|COMPLETED|Period B||0
350420|NCT01264380|838834|P2|COMPLETED|Period B||8
350421|NCT01264380|838835|P1|COMPLETED|Period B||8
350422|NCT01264380|838833|P3|STARTED|Period B||0
350423|NCT01264380|838834|P2|STARTED|Period B||8
350424|NCT01264380|838835|P1|STARTED|Period B||8
350425|NCT01264380|838833|P3|NOT COMPLETED|Period A||0
350426|NCT01264380|838834|P2|NOT COMPLETED|Period A||0
350427|NCT01264380|838835|P1|NOT COMPLETED|Period A||0
350428|NCT01264380|838833|P3|COMPLETED|Period A||0
350429|NCT01264380|838834|P2|COMPLETED|Period A||8
350430|NCT01264380|838835|P1|COMPLETED|Period A||8
350431|NCT01264380|838833|P3|STARTED|Period A||0
350432|NCT01264380|838834|P2|STARTED|Period A||8
350433|NCT01264380|838835|P1|STARTED|Period A||8
350434|NCT01264081|838856|P1|NOT COMPLETED|Analysis||0
350435|NCT01264081|838856|P1|COMPLETED|Analysis||2
350436|NCT01264081|838856|P1|STARTED|Analysis||2
350437|NCT01264081|838856|P1|NOT COMPLETED|Started Treatment||2
350438|NCT01264081|838856|P1|COMPLETED|Started Treatment||2
350439|NCT01264081|838856|P1|STARTED|Started Treatment||4
350440|NCT01264081|838856|P1|NOT COMPLETED|Participants Screened||30
350441|NCT01264081|838856|P1|COMPLETED|Participants Screened||4
350442|NCT01264081|838856|P1|STARTED|Participants Screened||34
350443|NCT01264016|838861|P1|NOT COMPLETED|Overall Study||2
350444|NCT01264016|838861|P1|COMPLETED|Overall Study||94
350445|NCT01264016|838861|P1|STARTED|Overall Study||96
350446|NCT01263925|838869|P2|NOT COMPLETED|Overall Study||52
350447|NCT01263925|838870|P1|NOT COMPLETED|Overall Study||51
350448|NCT01263925|838869|P2|COMPLETED|Overall Study||233
350449|NCT01263925|838870|P1|COMPLETED|Overall Study||225
350450|NCT01263925|838869|P2|Full Analysis Set|Overall Study||272
350451|NCT01263925|838870|P1|Full Analysis Set|Overall Study||269
350452|NCT01263925|838869|P2|STARTED|Overall Study||285
350453|NCT01263925|838870|P1|STARTED|Overall Study||276
350454|NCT01263873|838904|P2|NOT COMPLETED|Overall Study||1
350455|NCT01263873|838905|P1|NOT COMPLETED|Overall Study||1
350456|NCT01263873|838904|P2|COMPLETED|Overall Study||29
350457|NCT01263873|838905|P1|COMPLETED|Overall Study||29
350458|NCT01263873|838904|P2|STARTED|Overall Study||30
350459|NCT01263873|838905|P1|STARTED|Overall Study||30
350460|NCT01263717|838917|P2|NOT COMPLETED|Overall Study||6
350461|NCT01263717|838918|P1|NOT COMPLETED|Overall Study||5
350462|NCT01263717|838917|P2|COMPLETED|Overall Study||20
350463|NCT01263717|838918|P1|COMPLETED|Overall Study||23
350464|NCT01263717|838917|P2|Baseline Visit|Overall Study||22
350465|NCT01263717|838918|P1|Baseline Visit|Overall Study||28
350466|NCT01263717|838917|P2|STARTED|Overall Study||26
350467|NCT01263717|838918|P1|STARTED|Overall Study||28
350468|NCT01263691|838950|P6|NOT COMPLETED|Overall Study||0
350469|NCT01263691|838951|P5|NOT COMPLETED|Overall Study||0
350470|NCT01263691|838952|P4|NOT COMPLETED|Overall Study||1
350471|NCT01263691|838953|P3|NOT COMPLETED|Overall Study||1
350472|NCT01263691|838954|P2|NOT COMPLETED|Overall Study||0
350473|NCT01263691|838955|P1|NOT COMPLETED|Overall Study||3
350474|NCT01263691|838950|P6|COMPLETED|Overall Study||15
350475|NCT01263691|838951|P5|COMPLETED|Overall Study||18
350476|NCT01263691|838952|P4|COMPLETED|Overall Study||18
350477|NCT01263691|838953|P3|COMPLETED|Overall Study||16
350478|NCT01263691|838954|P2|COMPLETED|Overall Study||18
350479|NCT01263691|838955|P1|COMPLETED|Overall Study||15
350480|NCT01263691|838950|P6|STARTED|Overall Study||15
350481|NCT01263691|838951|P5|STARTED|Overall Study||18
350482|NCT01263691|838952|P4|STARTED|Overall Study||19
350483|NCT01263691|838953|P3|STARTED|Overall Study||17
350484|NCT01263691|838954|P2|STARTED|Overall Study||18
350485|NCT01263691|838955|P1|STARTED|Overall Study||18
350486|NCT01263665|839065|P1|NOT COMPLETED|Overall Study||9
350487|NCT01263665|839065|P1|COMPLETED|Overall Study||62
350488|NCT01263665|839065|P1|STARTED|Overall Study||71
350490|NCT01263639|839073|P1|NOT COMPLETED|Overall Study||73
350491|NCT01263639|839072|P2|COMPLETED|Overall Study||42
350492|NCT01263639|839073|P1|COMPLETED|Overall Study||34
350493|NCT01263639|839072|P2|STARTED|Overall Study||121
350494|NCT01263639|839073|P1|STARTED|Overall Study||107
350495|NCT01263561|839081|P2|NOT COMPLETED|Overall Study||2
350496|NCT01263561|839082|P1|NOT COMPLETED|Overall Study||1
350497|NCT01263561|839081|P2|COMPLETED|Overall Study||31
350498|NCT01263561|839082|P1|COMPLETED|Overall Study||30
350499|NCT01263561|839081|P2|STARTED|Overall Study||33
350500|NCT01263561|839082|P1|STARTED|Overall Study||31
350501|NCT01263509|839094|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
350502|NCT01263509|839095|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
350503|NCT01263509|839096|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
350504|NCT01263509|839097|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
350505|NCT01263509|839094|P4|COMPLETED|Entered - Long-Term Extension Study||24
350506|NCT01263509|839095|P3|COMPLETED|Entered - Long-Term Extension Study||27
350507|NCT01263509|839096|P2|COMPLETED|Entered - Long-Term Extension Study||48
350508|NCT01263509|839097|P1|COMPLETED|Entered - Long-Term Extension Study||53
350509|NCT01263509|839094|P4|STARTED|Entered - Long-Term Extension Study||26
350510|NCT01263509|839095|P3|STARTED|Entered - Long-Term Extension Study||32
350511|NCT01263509|839096|P2|STARTED|Entered - Long-Term Extension Study||60
350512|NCT01263509|839097|P1|STARTED|Entered - Long-Term Extension Study||61
350513|NCT01263509|839094|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350514|NCT01263509|839095|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350515|NCT01263509|839096|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350516|NCT01263509|839097|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350517|NCT01263509|839094|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
350518|NCT01263509|839095|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
350519|NCT01263509|839096|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
350520|NCT01263509|839097|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
350521|NCT01263509|839094|P4|STARTED|Enrolled - Long-Term Extension Study||26
350522|NCT01263509|839095|P3|STARTED|Enrolled - Long-Term Extension Study||32
350523|NCT01263509|839096|P2|STARTED|Enrolled - Long-Term Extension Study||60
350524|NCT01263509|839097|P1|STARTED|Enrolled - Long-Term Extension Study||61
350525|NCT01263496|839226|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
350526|NCT01263496|839227|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
350527|NCT01263496|839228|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
350528|NCT01263496|839229|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
350529|NCT01263496|839230|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
350530|NCT01263496|839231|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
350531|NCT01263496|839232|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
350532|NCT01263496|839233|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
350533|NCT01263496|839234|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
350534|NCT01263496|839226|P9|COMPLETED|Entered - Long-Term Extension Study||15
350535|NCT01263496|839227|P8|COMPLETED|Entered - Long-Term Extension Study||16
350536|NCT01263496|839228|P7|COMPLETED|Entered - Long-Term Extension Study||16
350537|NCT01263496|839229|P6|COMPLETED|Entered - Long-Term Extension Study||16
350538|NCT01263496|839230|P5|COMPLETED|Entered - Long-Term Extension Study||61
350539|NCT01263496|839231|P4|COMPLETED|Entered - Long-Term Extension Study||68
350540|NCT01263496|839232|P3|COMPLETED|Entered - Long-Term Extension Study||62
350541|NCT01263496|839233|P2|COMPLETED|Entered - Long-Term Extension Study||59
350542|NCT01263496|839234|P1|COMPLETED|Entered - Long-Term Extension Study||62
350543|NCT01263496|839226|P9|STARTED|Entered - Long-Term Extension Study||18
350544|NCT01263496|839227|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
350545|NCT01263496|839228|P7|STARTED|Entered - Long-Term Extension Study||17
350546|NCT01263496|839229|P6|STARTED|Entered - Long-Term Extension Study||17
350547|NCT01263496|839230|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
350548|NCT01263496|839231|P4|STARTED|Entered - Long-Term Extension Study||74
350549|NCT01263496|839232|P3|STARTED|Entered - Long-Term Extension Study||72
350550|NCT01263496|839233|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
350551|NCT01263496|839234|P1|STARTED|Entered - Long-Term Extension Study||71
350552|NCT01263496|839226|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350553|NCT01263496|839227|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350554|NCT01263496|839228|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350555|NCT01263496|839229|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350556|NCT01263496|839230|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
350557|NCT01263496|839231|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
350558|NCT01263496|839232|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350559|NCT01263496|839233|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
350560|NCT01263496|839234|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
350561|NCT01263496|839226|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
350562|NCT01263496|839227|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
350563|NCT01263496|839228|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
350564|NCT01263496|839229|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
350565|NCT01263496|839230|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
350566|NCT01263496|839231|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
350567|NCT01263496|839232|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
350568|NCT01263496|839233|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
350569|NCT01263496|839234|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
350570|NCT01263496|839226|P9|STARTED|Enrolled - Long-Term Extension Study||18
350571|NCT01263496|839227|P8|STARTED|Enrolled - Long-Term Extension Study||18
350572|NCT01263496|839228|P7|STARTED|Enrolled - Long-Term Extension Study||17
350573|NCT01263496|839229|P6|STARTED|Enrolled - Long-Term Extension Study||17
350574|NCT01263496|839230|P5|STARTED|Enrolled - Long-Term Extension Study||74
350575|NCT01263496|839231|P4|STARTED|Enrolled - Long-Term Extension Study||75
350576|NCT01263496|839232|P3|STARTED|Enrolled - Long-Term Extension Study||72
350577|NCT01263496|839233|P2|STARTED|Enrolled - Long-Term Extension Study||75
350578|NCT01263496|839234|P1|STARTED|Enrolled - Long-Term Extension Study||72
350579|NCT01263483|839529|P3|NOT COMPLETED|Overall Study||5
350580|NCT01263483|839530|P2|NOT COMPLETED|Overall Study||2
350581|NCT01263483|839531|P1|NOT COMPLETED|Overall Study||7
350582|NCT01263483|839529|P3|COMPLETED|Overall Study||74
350583|NCT01263483|839530|P2|COMPLETED|Overall Study||74
350584|NCT01263483|839531|P1|COMPLETED|Overall Study||68
350585|NCT01263483|839529|P3|STARTED|Overall Study||79
350586|NCT01263483|839530|P2|STARTED|Overall Study||76
350587|NCT01263483|839531|P1|STARTED|Overall Study||75
350588|NCT01263470|839593|P6|NOT COMPLETED|Overall Study||5
350589|NCT01263470|839594|P5|NOT COMPLETED|Overall Study||3
350590|NCT01263470|839595|P4|NOT COMPLETED|Overall Study||3
350591|NCT01263470|839596|P3|NOT COMPLETED|Overall Study||4
350592|NCT01263470|839597|P2|NOT COMPLETED|Overall Study||5
350593|NCT01263470|839598|P1|NOT COMPLETED|Overall Study||2
350594|NCT01263470|839593|P6|COMPLETED|Overall Study||78
350595|NCT01263470|839594|P5|COMPLETED|Overall Study||76
350596|NCT01263470|839595|P4|COMPLETED|Overall Study||77
350597|NCT01263470|839596|P3|COMPLETED|Overall Study||80
350598|NCT01263470|839597|P2|COMPLETED|Overall Study||74
350599|NCT01263470|839598|P1|COMPLETED|Overall Study||73
350600|NCT01263470|839593|P6|STARTED|Overall Study||83
350601|NCT01263470|839594|P5|STARTED|Overall Study||79
350602|NCT01263470|839595|P4|STARTED|Overall Study||80
350603|NCT01263470|839596|P3|STARTED|Overall Study||84
350604|NCT01263470|839597|P2|STARTED|Overall Study||79
350605|NCT01263470|839598|P1|STARTED|Overall Study||75
350606|NCT01263444|839708|P1|NOT COMPLETED|Overall Study||10
350607|NCT01263444|839708|P1|COMPLETED|Overall Study||37
350608|NCT01263444|839708|P1|STARTED|Overall Study||47
350609|NCT01263301|839717|P2|NOT COMPLETED|Overall Study||0
350610|NCT01263301|839718|P1|NOT COMPLETED|Overall Study||0
350611|NCT01263301|839717|P2|COMPLETED|Overall Study||11
350612|NCT01263301|839718|P1|COMPLETED|Overall Study||5
350613|NCT01263301|839717|P2|STARTED|Overall Study||11
350614|NCT01263301|839718|P1|STARTED|Overall Study||5
350615|NCT01263132|839732|P2|NOT COMPLETED|Overall Study||0
350616|NCT01263132|839733|P1|NOT COMPLETED|Overall Study||0
350617|NCT01263132|839732|P2|COMPLETED|Overall Study||37
350618|NCT01263132|839733|P1|COMPLETED|Overall Study||38
350619|NCT01263132|839732|P2|STARTED|Overall Study||37
350620|NCT01263132|839733|P1|STARTED|Overall Study||38
350621|NCT01263054|839749|P2|NOT COMPLETED|Overall Study||6
350622|NCT01263054|839750|P1|NOT COMPLETED|Overall Study||5
350623|NCT01263054|839749|P2|COMPLETED|Overall Study||28
350624|NCT01263054|839750|P1|COMPLETED|Overall Study||24
350625|NCT01263054|839749|P2|STARTED|Overall Study||34
350626|NCT01263054|839750|P1|STARTED|Overall Study||29
350627|NCT01263028|839768|P1|NOT COMPLETED|Overall Study||6
350628|NCT01263028|839768|P1|COMPLETED|Overall Study||0
350629|NCT01263028|839768|P1|STARTED|Overall Study||6
350630|NCT01263015|839778|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
350631|NCT01263015|839779|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
350632|NCT01263015|839778|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
350633|NCT01263015|839779|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
350634|NCT01263015|839778|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
350635|NCT01263015|839779|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
350636|NCT01263015|839778|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
350637|NCT01263015|839779|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
350638|NCT01263015|839778|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
350639|NCT01263015|839779|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
350640|NCT01263015|839778|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
350641|NCT01263015|839779|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
350642|NCT01262989|839805|P2|NOT COMPLETED|Period 2||1
350643|NCT01262989|839806|P1|NOT COMPLETED|Period 2||0
350644|NCT01262989|839805|P2|COMPLETED|Period 2||16
350645|NCT01262989|839806|P1|COMPLETED|Period 2||19
350646|NCT01262989|839805|P2|STARTED|Period 2||17
350647|NCT01262989|839806|P1|STARTED|Period 2||19
350648|NCT01262989|839805|P2|NOT COMPLETED|7-Day Washout Period||0
350649|NCT01262989|839806|P1|NOT COMPLETED|7-Day Washout Period||0
350650|NCT01262989|839805|P2|COMPLETED|7-Day Washout Period||17
350651|NCT01262989|839806|P1|COMPLETED|7-Day Washout Period||19
350652|NCT01262989|839805|P2|STARTED|7-Day Washout Period||17
350653|NCT01262989|839806|P1|STARTED|7-Day Washout Period||19
350654|NCT01262989|839805|P2|NOT COMPLETED|Period 1||3
350655|NCT01262989|839806|P1|NOT COMPLETED|Period 1||1
350656|NCT01262989|839805|P2|COMPLETED|Period 1||17
350657|NCT01262989|839806|P1|COMPLETED|Period 1||19
350658|NCT01262989|839805|P2|STARTED|Period 1||20
350659|NCT01262989|839806|P1|STARTED|Period 1||20
350660|NCT01262872|839824|P8|NOT COMPLETED|Step 2||6
350661|NCT01262872|839825|P7|NOT COMPLETED|Step 2||9
350662|NCT01262872|839826|P6|NOT COMPLETED|Step 2||9
350663|NCT01262872|839827|P5|NOT COMPLETED|Step 2||5
350664|NCT01262872|839828|P4|NOT COMPLETED|Step 2||10
350665|NCT01262872|839829|P3|NOT COMPLETED|Step 2||9
350666|NCT01262872|839830|P2|NOT COMPLETED|Step 2||0
350667|NCT01262872|839831|P1|NOT COMPLETED|Step 2||0
350668|NCT01262872|839824|P8|COMPLETED|Step 2||194
350669|NCT01262872|839825|P7|COMPLETED|Step 2||191
350670|NCT01262872|839826|P6|COMPLETED|Step 2||191
350671|NCT01262872|839827|P5|COMPLETED|Step 2||195
350672|NCT01262872|839828|P4|COMPLETED|Step 2||190
350673|NCT01262872|839829|P3|COMPLETED|Step 2||191
350674|NCT01262872|839830|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350675|NCT01262872|839831|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350676|NCT01262872|839824|P8|STARTED|Step 2||200
350677|NCT01262872|839825|P7|STARTED|Step 2||200
350678|NCT01262872|839826|P6|STARTED|Step 2||200
350679|NCT01262872|839827|P5|STARTED|Step 2||200
350680|NCT01262872|839828|P4|STARTED|Step 2||200
350681|NCT01262872|839829|P3|STARTED|Step 2||200
350682|NCT01262872|839830|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350683|NCT01262872|839831|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350684|NCT01262872|839824|P8|NOT COMPLETED|Step 1||0
350685|NCT01262872|839825|P7|NOT COMPLETED|Step 1||0
350686|NCT01262872|839826|P6|NOT COMPLETED|Step 1||0
350687|NCT01262872|839827|P5|NOT COMPLETED|Step 1||0
350688|NCT01262872|839828|P4|NOT COMPLETED|Step 1||0
350689|NCT01262872|839829|P3|NOT COMPLETED|Step 1||0
350690|NCT01262872|839830|P2|NOT COMPLETED|Step 1||0
350691|NCT01262872|839831|P1|NOT COMPLETED|Step 1||0
350692|NCT01262872|839824|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350693|NCT01262872|839825|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350694|NCT01262872|839826|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350695|NCT01262872|839827|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350696|NCT01262872|839828|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
350769|NCT01262352|840184|P1|STARTED|Period 2||9
350697|NCT01262872|839829|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350698|NCT01262872|839830|P2|COMPLETED|Step 1||60
350699|NCT01262872|839831|P1|COMPLETED|Step 1||60
350700|NCT01262872|839824|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350701|NCT01262872|839825|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350702|NCT01262872|839826|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350703|NCT01262872|839827|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350704|NCT01262872|839828|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350705|NCT01262872|839829|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
350706|NCT01262872|839830|P2|STARTED|Step 1||60
350707|NCT01262872|839831|P1|STARTED|Step 1||60
350708|NCT01262846|840086|P2|NOT COMPLETED|Overall Study||3
350709|NCT01262846|840087|P1|NOT COMPLETED|Overall Study||2
350710|NCT01262846|840086|P2|COMPLETED|Overall Study||97
350711|NCT01262846|840087|P1|COMPLETED|Overall Study||93
350712|NCT01262846|840086|P2|STARTED|Overall Study||100
350713|NCT01262846|840087|P1|STARTED|Overall Study||95
350714|NCT01262820|840093|P1|NOT COMPLETED|Overall Study||15
350715|NCT01262820|840093|P1|COMPLETED|Overall Study||0
350716|NCT01262820|840093|P1|STARTED|Overall Study||15
350717|NCT01262755|840100|P1|NOT COMPLETED|Overall Study||0
350718|NCT01262755|840100|P1|COMPLETED|Overall Study||450
350719|NCT01262755|840100|P1|STARTED|Overall Study||450
350720|NCT01262599|840106|P2|NOT COMPLETED|Overall Study||0
350721|NCT01262599|840107|P1|NOT COMPLETED|Overall Study||0
350722|NCT01262599|840106|P2|COMPLETED|Overall Study||16
350723|NCT01262599|840107|P1|COMPLETED|Overall Study||16
350724|NCT01262599|840106|P2|STARTED|Overall Study||16
350725|NCT01262599|840107|P1|STARTED|Overall Study||16
350726|NCT01262573|840115|P2|NOT COMPLETED|Overall Study||1
350727|NCT01262573|840116|P1|NOT COMPLETED|Overall Study||0
350728|NCT01262573|840115|P2|COMPLETED|Overall Study||31
350729|NCT01262573|840116|P1|COMPLETED|Overall Study||32
350730|NCT01262573|840115|P2|STARTED|Overall Study||32
350731|NCT01262573|840116|P1|STARTED|Overall Study||32
350732|NCT01262547|840124|P1|NOT COMPLETED|Overall Study||0
350733|NCT01262547|840124|P1|COMPLETED|Overall Study||3
350734|NCT01262547|840124|P1|STARTED|Overall Study||3
350735|NCT01262456|840138|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
350736|NCT01262456|840139|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
350737|NCT01262456|840140|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
350738|NCT01262456|840138|P3|COMPLETED|1-Month Open-Label Extension Period||98
350739|NCT01262456|840139|P2|COMPLETED|1-Month Open-Label Extension Period||97
350740|NCT01262456|840140|P1|COMPLETED|1-Month Open-Label Extension Period||120
350741|NCT01262456|840138|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
350742|NCT01262456|840139|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
350743|NCT01262456|840140|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
350744|NCT01262456|840138|P3|STARTED|1-Month Open-Label Extension Period||103
350745|NCT01262456|840139|P2|STARTED|1-Month Open-Label Extension Period||100
350746|NCT01262456|840140|P1|STARTED|1-Month Open-Label Extension Period||124
350747|NCT01262456|840138|P3|NOT COMPLETED|3-Month Double-Blind Period||26
350748|NCT01262456|840139|P2|NOT COMPLETED|3-Month Double-Blind Period||23
350749|NCT01262456|840140|P1|NOT COMPLETED|3-Month Double-Blind Period||19
350750|NCT01262456|840138|P3|COMPLETED|3-Month Double-Blind Period||103
350751|NCT01262456|840139|P2|COMPLETED|3-Month Double-Blind Period||100
350752|NCT01262456|840140|P1|COMPLETED|3-Month Double-Blind Period||124
350753|NCT01262456|840138|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
350754|NCT01262456|840139|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
350755|NCT01262456|840140|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
350756|NCT01262456|840138|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
350757|NCT01262456|840139|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
350758|NCT01262456|840140|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
350759|NCT01262456|840138|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
350760|NCT01262456|840139|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
350761|NCT01262456|840140|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
350762|NCT01262352|840183|P2|NOT COMPLETED|Period 2||0
350763|NCT01262352|840184|P1|NOT COMPLETED|Period 2||0
350764|NCT01262352|840183|P2|COMPLETED|Period 2||8
350765|NCT01262352|840184|P1|COMPLETED|Period 2||9
350766|NCT01262352|840183|P2|Dosed|Period 2||8
350767|NCT01262352|840184|P1|Dosed|Period 2||9
350768|NCT01262352|840183|P2|STARTED|Period 2||8
350770|NCT01262352|840183|P2|NOT COMPLETED|Washout||2
350771|NCT01262352|840184|P1|NOT COMPLETED|Washout||1
350772|NCT01262352|840183|P2|COMPLETED|Washout||8
350773|NCT01262352|840184|P1|COMPLETED|Washout||9
350774|NCT01262352|840183|P2|STARTED|Washout||10
350775|NCT01262352|840184|P1|STARTED|Washout||10
350776|NCT01262352|840183|P2|NOT COMPLETED|Period 1||0
350777|NCT01262352|840184|P1|NOT COMPLETED|Period 1||1
350778|NCT01262352|840183|P2|COMPLETED|Period 1||10
350779|NCT01262352|840184|P1|COMPLETED|Period 1||10
350780|NCT01262352|840183|P2|Dosed|Period 1||10
350781|NCT01262352|840184|P1|Dosed|Period 1||10
350782|NCT01262352|840183|P2|STARTED|Period 1||10
350783|NCT01262352|840184|P1|STARTED|Period 1||11
350784|NCT01262339|840196|P1|NOT COMPLETED|Overall Study||0
350785|NCT01262339|840196|P1|COMPLETED|Overall Study||2
350786|NCT01262339|840196|P1|STARTED|Overall Study||2
350787|NCT01262287|840202|P2|NOT COMPLETED|Overall Study||1
350788|NCT01262287|840203|P1|NOT COMPLETED|Overall Study||2
350789|NCT01262287|840202|P2|COMPLETED|Overall Study||18
350790|NCT01262287|840203|P1|COMPLETED|Overall Study||18
350791|NCT01262287|840202|P2|STARTED|Overall Study||19
350792|NCT01262287|840203|P1|STARTED|Overall Study||20
350793|NCT01262131|840216|P3|NOT COMPLETED|Overall Study||0
350794|NCT01262131|840217|P2|NOT COMPLETED|Overall Study||0
350795|NCT01262131|840218|P1|NOT COMPLETED|Overall Study||0
350796|NCT01262131|840216|P3|COMPLETED|Overall Study||4
350797|NCT01262131|840217|P2|COMPLETED|Overall Study||4
350798|NCT01262131|840218|P1|COMPLETED|Overall Study||5
350799|NCT01262131|840216|P3|STARTED|Overall Study||4
350800|NCT01262131|840217|P2|STARTED|Overall Study||4
350801|NCT01262131|840218|P1|STARTED|Overall Study||5
350802|NCT01262118|840228|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
350803|NCT01262118|840229|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
350804|NCT01262118|840228|P2|COMPLETED|Treatment Period (6 Weeks)||0
350805|NCT01262118|840229|P1|COMPLETED|Treatment Period (6 Weeks)||36
350806|NCT01262118|840228|P2|STARTED|Treatment Period (6 Weeks)||0
350807|NCT01262118|840229|P1|STARTED|Treatment Period (6 Weeks)||36
350808|NCT01262118|840228|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
350809|NCT01262118|840229|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
350810|NCT01262118|840228|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
350811|NCT01262118|840229|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
350812|NCT01262118|840228|P2|STARTED|Baseline Assessment Period (3 Days)||33
350813|NCT01262118|840229|P1|STARTED|Baseline Assessment Period (3 Days)||36
350814|NCT01262105|840255|P2|NOT COMPLETED|Overall Study||0
350815|NCT01262105|840256|P1|NOT COMPLETED|Overall Study||0
350816|NCT01262105|840255|P2|COMPLETED|Overall Study||10
350817|NCT01262105|840256|P1|COMPLETED|Overall Study||13
350818|NCT01262105|840255|P2|STARTED|Overall Study||10
350819|NCT01262105|840256|P1|STARTED|Overall Study||13
350820|NCT01262092|840264|P2|NOT COMPLETED|Gabapentin Taper||0
350821|NCT01262092|840265|P1|NOT COMPLETED|Gabapentin Taper||1
350822|NCT01262092|840264|P2|COMPLETED|Gabapentin Taper||11
350823|NCT01262092|840265|P1|COMPLETED|Gabapentin Taper||9
350824|NCT01262092|840264|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
350825|NCT01262092|840265|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
350826|NCT01262092|840264|P2|NOT COMPLETED|Buprenorphine Taper||1
350827|NCT01262092|840265|P1|NOT COMPLETED|Buprenorphine Taper||1
350828|NCT01262092|840264|P2|COMPLETED|Buprenorphine Taper||12
350829|NCT01262092|840265|P1|COMPLETED|Buprenorphine Taper||11
350830|NCT01262092|840264|P2|STARTED|Buprenorphine Taper||13
350831|NCT01262092|840265|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
350832|NCT01262092|840264|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
350833|NCT01262092|840265|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
350834|NCT01262092|840264|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
350835|NCT01262092|840265|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
350836|NCT01262092|840264|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
350837|NCT01262092|840265|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
350838|NCT01262027|840271|P1|NOT COMPLETED|Overall Study||5
350839|NCT01262027|840271|P1|COMPLETED|Overall Study||17
350840|NCT01262027|840271|P1|STARTED|Overall Study||22
350841|NCT01261975|840276|P1|NOT COMPLETED|Overall Study||1
350842|NCT01261975|840276|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
350843|NCT01261975|840276|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
350844|NCT01261624|840297|P2|NOT COMPLETED|Week 13 to Week 24||1
350845|NCT01261624|840298|P1|NOT COMPLETED|Week 13 to Week 24||0
350846|NCT01261624|840297|P2|COMPLETED|Week 13 to Week 24||10
350847|NCT01261624|840298|P1|COMPLETED|Week 13 to Week 24||1
350848|NCT01261624|840297|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
350849|NCT01261624|840298|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
350850|NCT01261624|840297|P2|NOT COMPLETED|Week 0 to Week 12||3
350851|NCT01261624|840298|P1|NOT COMPLETED|Week 0 to Week 12||1
350852|NCT01261624|840297|P2|COMPLETED|Week 0 to Week 12||3
350853|NCT01261624|840298|P1|COMPLETED|Week 0 to Week 12||9
350854|NCT01261624|840297|P2|STARTED|Week 0 to Week 12||6
350855|NCT01261624|840298|P1|STARTED|Week 0 to Week 12||10
350856|NCT01261559|840317|P2|NOT COMPLETED|Overall Study||0
350857|NCT01261559|840318|P1|NOT COMPLETED|Overall Study||0
350858|NCT01261559|840317|P2|COMPLETED|Overall Study||36
350859|NCT01261559|840318|P1|COMPLETED|Overall Study||36
350860|NCT01261559|840317|P2|STARTED|Overall Study||36
350861|NCT01261559|840318|P1|STARTED|Overall Study||36
350862|NCT01261507|840326|P1|NOT COMPLETED|Overall Study||0
350863|NCT01261507|840326|P1|COMPLETED|Overall Study||15
350864|NCT01261507|840326|P1|STARTED|Overall Study||15
350865|NCT01261390|840339|P4|NOT COMPLETED|Overall Study||8
350866|NCT01261390|840340|P3|NOT COMPLETED|Overall Study||7
350867|NCT01261390|840341|P2|NOT COMPLETED|Overall Study||9
350868|NCT01261390|840342|P1|NOT COMPLETED|Overall Study||7
350869|NCT01261390|840339|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
350870|NCT01261390|840340|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
350871|NCT01261390|840341|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
350872|NCT01261390|840342|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
350873|NCT01261390|840339|P4|12-Month Visit|Overall Study||19
350874|NCT01261390|840340|P3|12-Month Visit|Overall Study||19
350875|NCT01261390|840341|P2|12-Month Visit|Overall Study||21
350876|NCT01261390|840342|P1|12-Month Visit|Overall Study||23
350877|NCT01261390|840339|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
350878|NCT01261390|840340|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
350879|NCT01261390|840341|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
350880|NCT01261390|840342|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
350881|NCT01261390|840339|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
350882|NCT01261390|840340|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
350883|NCT01261390|840341|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
350884|NCT01261390|840342|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
350894|NCT01261052|840541|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
350895|NCT01261052|840541|P1|COMPLETED|APD Only Intervention (33 Hours)||14
350896|NCT01261052|840541|P1|STARTED|APD Only Intervention (33 Hours)||14
350897|NCT01261052|840541|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
350898|NCT01261052|840541|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
350899|NCT01261052|840541|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
350900|NCT01260948|840549|P2|NOT COMPLETED|Second Intervention||1
350901|NCT01260948|840550|P1|NOT COMPLETED|Second Intervention||0
350902|NCT01260948|840549|P2|COMPLETED|Second Intervention||9
350903|NCT01260948|840550|P1|COMPLETED|Second Intervention||12
350904|NCT01260948|840549|P2|STARTED|Second Intervention||10
350905|NCT01260948|840550|P1|STARTED|Second Intervention||12
350906|NCT01260948|840549|P2|NOT COMPLETED|Washout of 28 Days||3
350907|NCT01260948|840550|P1|NOT COMPLETED|Washout of 28 Days||1
350908|NCT01260948|840549|P2|COMPLETED|Washout of 28 Days||10
350909|NCT01260948|840550|P1|COMPLETED|Washout of 28 Days||12
350910|NCT01260948|840549|P2|STARTED|Washout of 28 Days||13
350911|NCT01260948|840550|P1|STARTED|Washout of 28 Days||13
350912|NCT01260948|840549|P2|NOT COMPLETED|First Intervention||0
350913|NCT01260948|840550|P1|NOT COMPLETED|First Intervention||0
350914|NCT01260948|840549|P2|COMPLETED|First Intervention||13
350915|NCT01260948|840550|P1|COMPLETED|First Intervention||13
350916|NCT01260948|840549|P2|STARTED|First Intervention||13
350917|NCT01260948|840550|P1|STARTED|First Intervention||13
350918|NCT01260922|840560|P2|NOT COMPLETED|Second Intervention||2
350919|NCT01260922|840561|P1|NOT COMPLETED|Second Intervention||0
350920|NCT01260922|840560|P2|COMPLETED|Second Intervention||8
350921|NCT01260922|840561|P1|COMPLETED|Second Intervention||9
350922|NCT01260922|840560|P2|STARTED|Second Intervention||10
350923|NCT01260922|840561|P1|STARTED|Second Intervention||9
350924|NCT01260922|840560|P2|NOT COMPLETED|Washout of 28 Days||2
350925|NCT01260922|840561|P1|NOT COMPLETED|Washout of 28 Days||4
350926|NCT01260922|840560|P2|COMPLETED|Washout of 28 Days||10
350927|NCT01260922|840561|P1|COMPLETED|Washout of 28 Days||9
350928|NCT01260922|840560|P2|STARTED|Washout of 28 Days||12
350929|NCT01260922|840561|P1|STARTED|Washout of 28 Days||13
350930|NCT01260922|840560|P2|NOT COMPLETED|First Intervention||1
350931|NCT01260922|840561|P1|NOT COMPLETED|First Intervention||0
350932|NCT01260922|840560|P2|COMPLETED|First Intervention||12
350933|NCT01260922|840561|P1|COMPLETED|First Intervention||13
350934|NCT01260922|840560|P2|STARTED|First Intervention||13
350935|NCT01260922|840561|P1|STARTED|First Intervention||13
350936|NCT01260896|840571|P2|NOT COMPLETED|Second Intervention||0
350937|NCT01260896|840572|P1|NOT COMPLETED|Second Intervention||0
350938|NCT01260896|840571|P2|COMPLETED|Second Intervention||12
350939|NCT01260896|840572|P1|COMPLETED|Second Intervention||10
350940|NCT01260896|840571|P2|STARTED|Second Intervention||12
350941|NCT01260896|840572|P1|STARTED|Second Intervention||10
350942|NCT01260896|840571|P2|NOT COMPLETED|Washout of 7 Days||0
350943|NCT01260896|840572|P1|NOT COMPLETED|Washout of 7 Days||0
350944|NCT01260896|840571|P2|COMPLETED|Washout of 7 Days||12
350945|NCT01260896|840572|P1|COMPLETED|Washout of 7 Days||10
350946|NCT01260896|840571|P2|STARTED|Washout of 7 Days||12
350947|NCT01260896|840572|P1|STARTED|Washout of 7 Days||10
350948|NCT01260896|840571|P2|NOT COMPLETED|First Intervention||0
350949|NCT01260896|840572|P1|NOT COMPLETED|First Intervention||2
350950|NCT01260896|840571|P2|COMPLETED|First Intervention||12
350951|NCT01260896|840572|P1|COMPLETED|First Intervention||10
350952|NCT01260896|840571|P2|STARTED|First Intervention||12
350953|NCT01260896|840572|P1|STARTED|First Intervention||12
350954|NCT01260883|840591|P3|NOT COMPLETED|Overall Study||0
350955|NCT01260883|840592|P2|NOT COMPLETED|Overall Study||0
350956|NCT01260883|840593|P1|NOT COMPLETED|Overall Study||0
350957|NCT01260883|840591|P3|COMPLETED|Overall Study||18
350958|NCT01260883|840592|P2|COMPLETED|Overall Study||11
350959|NCT01260883|840593|P1|COMPLETED|Overall Study||22
350960|NCT01260883|840591|P3|STARTED|Overall Study||18
350961|NCT01260883|840592|P2|STARTED|Overall Study||11
350962|NCT01260883|840593|P1|STARTED|Overall Study||22
350963|NCT01260701|840630|P1|NOT COMPLETED|Overall Study||75
350964|NCT01260701|840630|P1|COMPLETED|Overall Study||0
350965|NCT01260701|840630|P1|Eligible and Began Protocol Therapy|Overall Study||70
350966|NCT01260701|840630|P1|Eligible|Overall Study||71
350967|NCT01260701|840630|P1|STARTED|Overall Study||75
350968|NCT01260688|840639|P2|NOT COMPLETED|Overall Study||0
350969|NCT01260688|840640|P1|NOT COMPLETED|Overall Study||0
350970|NCT01260688|840639|P2|COMPLETED|Overall Study||11
350971|NCT01260688|840640|P1|COMPLETED|Overall Study||11
350972|NCT01260688|840639|P2|STARTED|Overall Study||11
350973|NCT01260688|840640|P1|STARTED|Overall Study||11
350974|NCT01260662|840649|P3|NOT COMPLETED|Overall Study||0
350975|NCT01260662|840650|P2|NOT COMPLETED|Overall Study||0
350976|NCT01260662|840651|P1|NOT COMPLETED|Overall Study||0
350977|NCT01260662|840649|P3|COMPLETED|Overall Study||96
350978|NCT01260662|840650|P2|COMPLETED|Overall Study||85
350979|NCT01260662|840651|P1|COMPLETED|Overall Study||90
350980|NCT01260662|840649|P3|STARTED|Overall Study||96
350981|NCT01260662|840650|P2|STARTED|Overall Study||85
350982|NCT01260662|840651|P1|STARTED|Overall Study||90
350983|NCT01260649|840670|P2|NOT COMPLETED|Overall Study||1
350984|NCT01260649|840671|P1|NOT COMPLETED|Overall Study||2
350985|NCT01260649|840670|P2|COMPLETED|Overall Study||8
350986|NCT01260649|840671|P1|COMPLETED|Overall Study||6
350987|NCT01260649|840670|P2|STARTED|Overall Study||9
350988|NCT01260649|840671|P1|STARTED|Overall Study||8
350989|NCT01260584|840683|P4|NOT COMPLETED|Period 2||1
350990|NCT01260584|840684|P3|NOT COMPLETED|Period 2||5
350991|NCT01260584|840685|P2|NOT COMPLETED|Period 2||3
350992|NCT01260584|840686|P1|NOT COMPLETED|Period 2||1
350993|NCT01260584|840683|P4|COMPLETED|Period 2||26
350994|NCT01260584|840684|P3|COMPLETED|Period 2||20
350995|NCT01260584|840685|P2|COMPLETED|Period 2||25
350996|NCT01260584|840686|P1|COMPLETED|Period 2||26
350997|NCT01260584|840683|P4|STARTED|Period 2||27
350998|NCT01260584|840684|P3|STARTED|Period 2||25
350999|NCT01260584|840685|P2|STARTED|Period 2||28
351000|NCT01260584|840686|P1|STARTED|Period 2||27
351001|NCT01260584|840683|P4|NOT COMPLETED|Period 1||1
351002|NCT01260584|840684|P3|NOT COMPLETED|Period 1||2
351003|NCT01260584|840685|P2|NOT COMPLETED|Period 1||0
351004|NCT01260584|840686|P1|NOT COMPLETED|Period 1||0
351005|NCT01260584|840683|P4|COMPLETED|Period 1||27
351006|NCT01260584|840684|P3|COMPLETED|Period 1||25
351007|NCT01260584|840685|P2|COMPLETED|Period 1||28
351008|NCT01260584|840686|P1|COMPLETED|Period 1||27
351009|NCT01260584|840683|P4|STARTED|Period 1||28
351010|NCT01260584|840684|P3|STARTED|Period 1||27
351011|NCT01260584|840685|P2|STARTED|Period 1||28
351012|NCT01260584|840686|P1|STARTED|Period 1||27
351013|NCT01260493|840722|P2|NOT COMPLETED|Overall Study||4
351014|NCT01260493|840723|P1|NOT COMPLETED|Overall Study||16
351015|NCT01260493|840722|P2|COMPLETED|Overall Study||85
351016|NCT01260493|840723|P1|COMPLETED|Overall Study||76
351017|NCT01260493|840722|P2|STARTED|Overall Study||89
351018|NCT01260493|840723|P1|STARTED|Overall Study||92
351019|NCT01260467|840729|P1|NOT COMPLETED|Overall Study||2
351020|NCT01260467|840729|P1|COMPLETED|Overall Study||2
351021|NCT01260467|840729|P1|STARTED|Overall Study||4
351022|NCT01260454|840735|P1|NOT COMPLETED|Overall Study||0
351023|NCT01260454|840735|P1|COMPLETED|Overall Study||6
351024|NCT01260454|840735|P1|STARTED|Overall Study||6
351025|NCT01260350|840761|P22|NOT COMPLETED|Overall Study||0
351026|NCT01260350|840762|P21|NOT COMPLETED|Overall Study||3
351027|NCT01260350|840763|P20|NOT COMPLETED|Overall Study||0
351028|NCT01260350|840764|P19|NOT COMPLETED|Overall Study||0
351029|NCT01260350|840765|P18|NOT COMPLETED|Overall Study||1
351030|NCT01260350|840766|P17|NOT COMPLETED|Overall Study||0
351031|NCT01260350|840767|P16|NOT COMPLETED|Overall Study||0
351032|NCT01260350|840768|P15|NOT COMPLETED|Overall Study||0
351033|NCT01260350|840769|P14|NOT COMPLETED|Overall Study||0
351034|NCT01260350|840770|P13|NOT COMPLETED|Overall Study||0
351035|NCT01260350|840771|P12|NOT COMPLETED|Overall Study||0
351036|NCT01260350|840772|P11|NOT COMPLETED|Overall Study||0
351037|NCT01260350|840773|P10|NOT COMPLETED|Overall Study||0
351038|NCT01260350|840774|P9|NOT COMPLETED|Overall Study||1
351039|NCT01260350|840775|P8|NOT COMPLETED|Overall Study||0
351040|NCT01260350|840776|P7|NOT COMPLETED|Overall Study||0
351041|NCT01260350|840777|P6|NOT COMPLETED|Overall Study||0
351042|NCT01260350|840778|P5|NOT COMPLETED|Overall Study||0
351043|NCT01260350|840779|P4|NOT COMPLETED|Overall Study||0
351044|NCT01260350|840780|P3|NOT COMPLETED|Overall Study||0
351045|NCT01260350|840781|P2|NOT COMPLETED|Overall Study||0
351046|NCT01260350|840782|P1|NOT COMPLETED|Overall Study||0
351047|NCT01260350|840761|P22|COMPLETED|Overall Study||0
351048|NCT01260350|840762|P21|COMPLETED|Overall Study||22
351049|NCT01260350|840763|P20|COMPLETED|Overall Study||14
351050|NCT01260350|840764|P19|COMPLETED|Overall Study||0
351051|NCT01260350|840765|P18|COMPLETED|Overall Study||9
351052|NCT01260350|840766|P17|COMPLETED|Overall Study||9
351053|NCT01260350|840767|P16|COMPLETED|Overall Study||10
351054|NCT01260350|840768|P15|COMPLETED|Overall Study||25
351055|NCT01260350|840769|P14|COMPLETED|Overall Study||10
351056|NCT01260350|840770|P13|COMPLETED|Overall Study||25
351057|NCT01260350|840771|P12|COMPLETED|Overall Study||9
351058|NCT01260350|840772|P11|COMPLETED|Overall Study||10
351059|NCT01260350|840773|P10|COMPLETED|Overall Study||25
351060|NCT01260350|840774|P9|COMPLETED|Overall Study||24
351061|NCT01260350|840775|P8|COMPLETED|Overall Study||25
351062|NCT01260350|840776|P7|COMPLETED|Overall Study||10
351063|NCT01260350|840777|P6|COMPLETED|Overall Study||10
351064|NCT01260350|840778|P5|COMPLETED|Overall Study||10
351065|NCT01260350|840779|P4|COMPLETED|Overall Study||11
351066|NCT01260350|840780|P3|COMPLETED|Overall Study||10
351067|NCT01260350|840781|P2|COMPLETED|Overall Study||9
351068|NCT01260350|840782|P1|COMPLETED|Overall Study||10
351069|NCT01260350|840761|P22|STARTED|Overall Study||0
351070|NCT01260350|840762|P21|STARTED|Overall Study||25
351071|NCT01260350|840763|P20|STARTED|Overall Study||14
351072|NCT01260350|840764|P19|STARTED|Overall Study||0
351073|NCT01260350|840765|P18|STARTED|Overall Study||10
351074|NCT01260350|840766|P17|STARTED|Overall Study||9
351075|NCT01260350|840767|P16|STARTED|Overall Study||10
351076|NCT01260350|840768|P15|STARTED|Overall Study||25
351077|NCT01260350|840769|P14|STARTED|Overall Study||10
351078|NCT01260350|840770|P13|STARTED|Overall Study||25
351079|NCT01260350|840771|P12|STARTED|Overall Study||9
351080|NCT01260350|840772|P11|STARTED|Overall Study||10
351081|NCT01260350|840773|P10|STARTED|Overall Study||25
351082|NCT01260350|840774|P9|STARTED|Overall Study||25
351083|NCT01260350|840775|P8|STARTED|Overall Study||25
351084|NCT01260350|840776|P7|STARTED|Overall Study||10
351085|NCT01260350|840777|P6|STARTED|Overall Study||10
351086|NCT01260350|840778|P5|STARTED|Overall Study||10
351087|NCT01260350|840779|P4|STARTED|Overall Study||11
351088|NCT01260350|840780|P3|STARTED|Overall Study||10
351089|NCT01260350|840781|P2|STARTED|Overall Study||9
351090|NCT01260350|840782|P1|STARTED|Overall Study||10
351091|NCT01260324|840974|P2|NOT COMPLETED|Overall Study||0
351092|NCT01260324|840975|P1|NOT COMPLETED|Overall Study||0
351093|NCT01260324|840974|P2|COMPLETED|Overall Study||20000
351094|NCT01260324|840975|P1|COMPLETED|Overall Study||1283
351095|NCT01260324|840974|P2|STARTED|Overall Study||20000
351096|NCT01260324|840975|P1|STARTED|Overall Study||1283
351097|NCT01260311|840989|P1|NOT COMPLETED|Overall Study||127
351098|NCT01260311|840989|P1|COMPLETED|Overall Study||381
351099|NCT01260311|840989|P1|STARTED|Overall Study||508
351100|NCT01260272|840999|P2|NOT COMPLETED|Overall Study||2
351101|NCT01260272|841000|P1|NOT COMPLETED|Overall Study||2
351102|NCT01260272|840999|P2|COMPLETED|Overall Study||30
351103|NCT01260272|841000|P1|COMPLETED|Overall Study||15
351104|NCT01260272|840999|P2|STARTED|Overall Study||32
351105|NCT01260272|841000|P1|STARTED|Overall Study||17
351106|NCT01260194|841020|P1|NOT COMPLETED|Overall Study||1
351107|NCT01260194|841020|P1|COMPLETED|Overall Study||3
351108|NCT01260194|841020|P1|STARTED|Overall Study||4
351109|NCT01260142|841038|P6|NOT COMPLETED|Treatment Period 2||0
351110|NCT01260142|841039|P5|NOT COMPLETED|Treatment Period 2||0
351111|NCT01260142|841040|P4|NOT COMPLETED|Treatment Period 2||0
351112|NCT01260142|841041|P3|NOT COMPLETED|Treatment Period 2||0
351113|NCT01260142|841042|P2|NOT COMPLETED|Treatment Period 2||0
351114|NCT01260142|841043|P1|NOT COMPLETED|Treatment Period 2||0
351115|NCT01260142|841038|P6|COMPLETED|Treatment Period 2||3
351116|NCT01260142|841039|P5|COMPLETED|Treatment Period 2||4
351117|NCT01260142|841040|P4|COMPLETED|Treatment Period 2||6
351118|NCT01260142|841041|P3|COMPLETED|Treatment Period 2||6
351119|NCT01260142|841042|P2|COMPLETED|Treatment Period 2||5
351120|NCT01260142|841043|P1|COMPLETED|Treatment Period 2||5
351121|NCT01260142|841038|P6|STARTED|Treatment Period 2||3
351122|NCT01260142|841039|P5|STARTED|Treatment Period 2||4
351123|NCT01260142|841040|P4|STARTED|Treatment Period 2||6
351124|NCT01260142|841041|P3|STARTED|Treatment Period 2||6
351125|NCT01260142|841042|P2|STARTED|Treatment Period 2||5
351126|NCT01260142|841043|P1|STARTED|Treatment Period 2||5
351127|NCT01260142|841038|P6|NOT COMPLETED|Treatment Period 1||3
351128|NCT01260142|841039|P5|NOT COMPLETED|Treatment Period 1||2
351129|NCT01260142|841040|P4|NOT COMPLETED|Treatment Period 1||0
351130|NCT01260142|841041|P3|NOT COMPLETED|Treatment Period 1||0
351131|NCT01260142|841042|P2|NOT COMPLETED|Treatment Period 1||1
351132|NCT01260142|841043|P1|NOT COMPLETED|Treatment Period 1||1
351133|NCT01260142|841038|P6|COMPLETED|Treatment Period 1||3
351134|NCT01260142|841039|P5|COMPLETED|Treatment Period 1||4
351135|NCT01260142|841040|P4|COMPLETED|Treatment Period 1||6
351136|NCT01260142|841041|P3|COMPLETED|Treatment Period 1||6
351137|NCT01260142|841042|P2|COMPLETED|Treatment Period 1||5
351138|NCT01260142|841043|P1|COMPLETED|Treatment Period 1||5
351139|NCT01260142|841038|P6|STARTED|Treatment Period 1||6
351140|NCT01260142|841039|P5|STARTED|Treatment Period 1||6
351141|NCT01260142|841040|P4|STARTED|Treatment Period 1||6
351142|NCT01260142|841041|P3|STARTED|Treatment Period 1||6
351143|NCT01260142|841042|P2|STARTED|Treatment Period 1||6
351144|NCT01260142|841043|P1|STARTED|Treatment Period 1||6
351145|NCT01259726|841097|P4|NOT COMPLETED|Overall Study||5
351146|NCT01259726|841098|P3|NOT COMPLETED|Overall Study||4
351147|NCT01259726|841099|P2|NOT COMPLETED|Overall Study||4
351148|NCT01259726|841100|P1|NOT COMPLETED|Overall Study||5
351149|NCT01259726|841097|P4|COMPLETED|Overall Study||36
351150|NCT01259726|841098|P3|COMPLETED|Overall Study||39
351151|NCT01259726|841099|P2|COMPLETED|Overall Study||37
351152|NCT01259726|841100|P1|COMPLETED|Overall Study||38
351153|NCT01259726|841097|P4|Treated|Overall Study||39
351154|NCT01259726|841098|P3|Treated|Overall Study||41
351155|NCT01259726|841099|P2|Treated|Overall Study||37
351156|NCT01259726|841100|P1|Treated|Overall Study||40
351157|NCT01259726|841097|P4|STARTED|Overall Study||41
351158|NCT01259726|841098|P3|STARTED|Overall Study||43
351159|NCT01259726|841099|P2|STARTED|Overall Study||41
351160|NCT01259726|841100|P1|STARTED|Overall Study||43
351161|NCT01259713|841132|P2|NOT COMPLETED|Overall Study||41
351162|NCT01259713|841133|P1|NOT COMPLETED|Overall Study||95
351163|NCT01259713|841132|P2|COMPLETED|Overall Study||77
351164|NCT01259713|841133|P1|COMPLETED|Overall Study||142
351165|NCT01259713|841132|P2|STARTED|Overall Study||118
351166|NCT01259713|841133|P1|STARTED|Overall Study||237
351167|NCT01259492|841159|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
351168|NCT01259492|841160|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
351169|NCT01259492|841161|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
351170|NCT01259492|841162|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
351171|NCT01259492|841159|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
351253|NCT01259297|841277|P7|COMPLETED|Double Blind Randomized Period||190
351172|NCT01259492|841160|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
351173|NCT01259492|841161|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
351174|NCT01259492|841162|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
351175|NCT01259492|841159|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
351176|NCT01259492|841160|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
351177|NCT01259492|841161|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
351178|NCT01259492|841162|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
351179|NCT01259492|841159|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
351180|NCT01259492|841160|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
351181|NCT01259492|841161|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
351182|NCT01259492|841162|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
351183|NCT01259492|841159|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
351184|NCT01259492|841160|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
351185|NCT01259492|841161|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
351186|NCT01259492|841162|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
351187|NCT01259492|841159|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
351188|NCT01259492|841160|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
351189|NCT01259492|841161|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
351190|NCT01259492|841162|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
351191|NCT01259492|841159|P4|STARTED|Period 2 (Week 10 to Week 14)||153
351192|NCT01259492|841160|P3|STARTED|Period 2 (Week 10 to Week 14)||138
351193|NCT01259492|841161|P2|STARTED|Period 2 (Week 10 to Week 14)||141
351194|NCT01259492|841162|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
351195|NCT01259492|841159|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
351196|NCT01259492|841160|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
351197|NCT01259492|841161|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
351198|NCT01259492|841162|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
351199|NCT01259492|841159|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
351200|NCT01259492|841160|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
351201|NCT01259492|841161|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
351202|NCT01259492|841162|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
351203|NCT01259492|841159|P4|Full Analysis Set|Period 1 (9 Weeks)||172
351204|NCT01259492|841160|P3|Full Analysis Set|Period 1 (9 Weeks)||179
351205|NCT01259492|841161|P2|Full Analysis Set|Period 1 (9 Weeks)||175
351206|NCT01259492|841162|P1|Full Analysis Set|Period 1 (9 Weeks)||174
351207|NCT01259492|841159|P4|STARTED|Period 1 (9 Weeks)||181
351208|NCT01259492|841160|P3|STARTED|Period 1 (9 Weeks)||181
351209|NCT01259492|841161|P2|STARTED|Period 1 (9 Weeks)||182
351210|NCT01259492|841162|P1|STARTED|Period 1 (9 Weeks)||181
351211|NCT01259466|841211|P2|NOT COMPLETED|Overall Study||9
351212|NCT01259466|841212|P1|NOT COMPLETED|Overall Study||1
351213|NCT01259466|841211|P2|COMPLETED|Overall Study||18
351214|NCT01259466|841212|P1|COMPLETED|Overall Study||26
351215|NCT01259466|841211|P2|STARTED|Overall Study||27
351216|NCT01259466|841212|P1|STARTED|Overall Study||27
351217|NCT01259440|841222|P2|NOT COMPLETED|Overall Study||0
351218|NCT01259440|841223|P1|NOT COMPLETED|Overall Study||0
351219|NCT01259440|841222|P2|COMPLETED|Overall Study||10
351220|NCT01259440|841223|P1|COMPLETED|Overall Study||13
351221|NCT01259440|841222|P2|STARTED|Overall Study||10
351222|NCT01259440|841223|P1|STARTED|Overall Study||13
351223|NCT01259427|841231|P2|NOT COMPLETED|Overall Study||14
351224|NCT01259427|841232|P1|NOT COMPLETED|Overall Study||18
351225|NCT01259427|841231|P2|COMPLETED|Overall Study||110
351226|NCT01259427|841232|P1|COMPLETED|Overall Study||106
351227|NCT01259427|841231|P2|STARTED|Overall Study||124
351228|NCT01259427|841232|P1|STARTED|Overall Study||124
351229|NCT01259401|841250|P2|NOT COMPLETED|4-month Follow-up||2
351230|NCT01259401|841251|P1|NOT COMPLETED|4-month Follow-up||0
351231|NCT01259401|841250|P2|COMPLETED|4-month Follow-up||19
351232|NCT01259401|841251|P1|COMPLETED|4-month Follow-up||21
351233|NCT01259401|841250|P2|STARTED|4-month Follow-up||21
351234|NCT01259401|841251|P1|STARTED|4-month Follow-up||21
351235|NCT01259401|841250|P2|NOT COMPLETED|End of 4-week Intervention||0
351236|NCT01259401|841251|P1|NOT COMPLETED|End of 4-week Intervention||0
351237|NCT01259401|841250|P2|COMPLETED|End of 4-week Intervention||21
351238|NCT01259401|841251|P1|COMPLETED|End of 4-week Intervention||21
351239|NCT01259401|841250|P2|STARTED|End of 4-week Intervention||21
351240|NCT01259401|841251|P1|STARTED|End of 4-week Intervention||21
351241|NCT01259375|841259|P1|NOT COMPLETED|Overall Study||1
351242|NCT01259375|841259|P1|COMPLETED|Overall Study||23
351243|NCT01259375|841259|P1|STARTED|Overall Study||24
351244|NCT01259297|841276|P8|NOT COMPLETED|Double Blind Randomized Period||3
351245|NCT01259297|841277|P7|NOT COMPLETED|Double Blind Randomized Period||6
351246|NCT01259297|841278|P6|NOT COMPLETED|Double Blind Randomized Period||8
351247|NCT01259297|841279|P5|NOT COMPLETED|Double Blind Randomized Period||4
351248|NCT01259297|841280|P4|NOT COMPLETED|Double Blind Randomized Period||4
351249|NCT01259297|841281|P3|NOT COMPLETED|Double Blind Randomized Period||1
351250|NCT01259297|841282|P2|NOT COMPLETED|Double Blind Randomized Period||3
351251|NCT01259297|841283|P1|NOT COMPLETED|Double Blind Randomized Period||2
351252|NCT01259297|841276|P8|COMPLETED|Double Blind Randomized Period||196
351254|NCT01259297|841278|P6|COMPLETED|Double Blind Randomized Period||245
351255|NCT01259297|841279|P5|COMPLETED|Double Blind Randomized Period||247
351256|NCT01259297|841280|P4|COMPLETED|Double Blind Randomized Period||191
351257|NCT01259297|841281|P3|COMPLETED|Double Blind Randomized Period||188
351258|NCT01259297|841282|P2|COMPLETED|Double Blind Randomized Period||229
351259|NCT01259297|841283|P1|COMPLETED|Double Blind Randomized Period||242
351260|NCT01259297|841276|P8|STARTED|Double Blind Randomized Period||199
351261|NCT01259297|841277|P7|STARTED|Double Blind Randomized Period||196
351262|NCT01259297|841278|P6|STARTED|Double Blind Randomized Period||253
351263|NCT01259297|841279|P5|STARTED|Double Blind Randomized Period||251
351264|NCT01259297|841280|P4|STARTED|Double Blind Randomized Period||195
351265|NCT01259297|841281|P3|STARTED|Double Blind Randomized Period||189
351266|NCT01259297|841282|P2|STARTED|Double Blind Randomized Period||232
351267|NCT01259297|841283|P1|STARTED|Double Blind Randomized Period||244
351268|NCT01259297|841276|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351269|NCT01259297|841277|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351270|NCT01259297|841278|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351271|NCT01259297|841279|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351272|NCT01259297|841280|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351273|NCT01259297|841281|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
351274|NCT01259297|841282|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351275|NCT01259297|841283|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
351276|NCT01259297|841276|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351277|NCT01259297|841277|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351278|NCT01259297|841278|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351279|NCT01259297|841279|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351280|NCT01259297|841280|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351281|NCT01259297|841281|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
351282|NCT01259297|841282|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
351283|NCT01259297|841283|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
351284|NCT01259297|841276|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
351285|NCT01259297|841277|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
351286|NCT01259297|841278|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
351287|NCT01259297|841279|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
351288|NCT01259297|841280|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
351289|NCT01259297|841281|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
351290|NCT01259297|841282|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
351291|NCT01259297|841283|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
351292|NCT01259284|841314|P3|NOT COMPLETED|Overall Study||0
351293|NCT01259284|841315|P2|NOT COMPLETED|Overall Study||0
351294|NCT01259284|841316|P1|NOT COMPLETED|Overall Study||2
351295|NCT01259284|841314|P3|COMPLETED|Overall Study||0
351296|NCT01259284|841315|P2|COMPLETED|Overall Study||0
351297|NCT01259284|841316|P1|COMPLETED|Overall Study||0
351298|NCT01259284|841314|P3|STARTED|Overall Study||0
351299|NCT01259284|841315|P2|STARTED|Overall Study||0
351300|NCT01259284|841316|P1|STARTED|Overall Study||2
351301|NCT01259245|841326|P2|NOT COMPLETED|Overall Study||26
351302|NCT01259245|841327|P1|NOT COMPLETED|Overall Study||28
351303|NCT01259245|841326|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
351304|NCT01259245|841327|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
351305|NCT01259245|841326|P2|STARTED|Overall Study||94
351306|NCT01259245|841327|P1|STARTED|Overall Study||98
351307|NCT01256983|841353|P2|NOT COMPLETED|Overall Study||3
351308|NCT01256983|841354|P1|NOT COMPLETED|Overall Study||1
351309|NCT01256983|841353|P2|COMPLETED|Overall Study||12
351310|NCT01256983|841354|P1|COMPLETED|Overall Study||14
351311|NCT01256983|841353|P2|STARTED|Overall Study||15
351312|NCT01256983|841354|P1|STARTED|Overall Study||15
351313|NCT01256944|841362|P2|NOT COMPLETED|Overall Study||0
351314|NCT01256944|841363|P1|NOT COMPLETED|Overall Study||0
351315|NCT01256944|841362|P2|COMPLETED|Overall Study||220
351316|NCT01256944|841363|P1|COMPLETED|Overall Study||70
351317|NCT01256944|841362|P2|STARTED|Overall Study||220
351318|NCT01256944|841363|P1|STARTED|Overall Study||70
351319|NCT01256918|841391|P1|NOT COMPLETED|Overall Study||0
351320|NCT01256918|841391|P1|COMPLETED|Overall Study||200
351321|NCT01256918|841391|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
351322|NCT01256918|841391|P1|STARTED|Overall Study||200
351323|NCT01259115|841402|P2|NOT COMPLETED|Period 2||0
351324|NCT01259115|841403|P1|NOT COMPLETED|Period 2||1
351325|NCT01259115|841402|P2|COMPLETED|Period 2||9
351326|NCT01259115|841403|P1|COMPLETED|Period 2||6
351327|NCT01259115|841402|P2|STARTED|Period 2||9
351328|NCT01259115|841403|P1|STARTED|Period 2||7
351329|NCT01259115|841402|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
351330|NCT01259115|841403|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
351331|NCT01259115|841402|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
351332|NCT01259115|841403|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
351333|NCT01259115|841402|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
351334|NCT01259115|841403|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
351335|NCT01259115|841402|P2|NOT COMPLETED|Period 1||1
351336|NCT01259115|841403|P1|NOT COMPLETED|Period 1||3
351337|NCT01259115|841402|P2|COMPLETED|Period 1||9
351338|NCT01259115|841403|P1|COMPLETED|Period 1||7
351339|NCT01259115|841402|P2|STARTED|Period 1||10
351340|NCT01259115|841403|P1|STARTED|Period 1||10
351341|NCT01259102|841439|P5|NOT COMPLETED|Overall Study||1
351342|NCT01259102|841440|P4|NOT COMPLETED|Overall Study||2
351343|NCT01259102|841441|P3|NOT COMPLETED|Overall Study||2
351344|NCT01259102|841442|P2|NOT COMPLETED|Overall Study||0
351345|NCT01259102|841443|P1|NOT COMPLETED|Overall Study||1
351346|NCT01259102|841439|P5|COMPLETED|Overall Study||13
351347|NCT01259102|841440|P4|COMPLETED|Overall Study||12
351348|NCT01259102|841441|P3|COMPLETED|Overall Study||13
351349|NCT01259102|841442|P2|COMPLETED|Overall Study||14
351350|NCT01259102|841443|P1|COMPLETED|Overall Study||12
351351|NCT01259102|841439|P5|STARTED|Overall Study||14
351352|NCT01259102|841440|P4|STARTED|Overall Study||14
351353|NCT01259102|841441|P3|STARTED|Overall Study||15
351354|NCT01259102|841442|P2|STARTED|Overall Study||14
351355|NCT01259102|841443|P1|STARTED|Overall Study||13
351356|NCT01258998|841500|P1|NOT COMPLETED|Overall Study||1
351357|NCT01258998|841500|P1|COMPLETED|Overall Study||59
351358|NCT01258998|841500|P1|STARTED|Overall Study||60
351359|NCT01258985|841506|P2|NOT COMPLETED|Overall Study||0
351360|NCT01258985|841507|P1|NOT COMPLETED|Overall Study||0
351361|NCT01258985|841506|P2|COMPLETED|Overall Study||98
351362|NCT01258985|841507|P1|COMPLETED|Overall Study||106
351363|NCT01258985|841506|P2|STARTED|Overall Study||98
351364|NCT01258985|841507|P1|STARTED|Overall Study||106
351365|NCT01258803|841533|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
351366|NCT01258803|841534|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
351367|NCT01258803|841535|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
351368|NCT01258803|841536|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
351369|NCT01258803|841537|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
351370|NCT01258803|841538|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
351371|NCT01258803|841533|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
351372|NCT01258803|841534|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
351373|NCT01258803|841535|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
351374|NCT01258803|841536|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
351375|NCT01258803|841537|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
351376|NCT01258803|841538|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
351377|NCT01258803|841533|P6|STARTED|Treatment Period 4 (1 Dose)||15
351378|NCT01258803|841534|P5|STARTED|Treatment Period 4 (1 Dose)||15
351379|NCT01258803|841535|P4|STARTED|Treatment Period 4 (1 Dose)||15
351380|NCT01258803|841536|P3|STARTED|Treatment Period 4 (1 Dose)||14
351381|NCT01258803|841537|P2|STARTED|Treatment Period 4 (1 Dose)||14
351382|NCT01258803|841538|P1|STARTED|Treatment Period 4 (1 Dose)||14
351383|NCT01258803|841533|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
351384|NCT01258803|841534|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
351385|NCT01258803|841535|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
351386|NCT01258803|841536|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
351387|NCT01258803|841537|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
351388|NCT01258803|841538|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
351389|NCT01258803|841533|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
351390|NCT01258803|841534|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
351391|NCT01258803|841535|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
351392|NCT01258803|841536|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
351393|NCT01258803|841537|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
351394|NCT01258803|841538|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
351395|NCT01258803|841533|P6|STARTED|Treatment Period 3 (1 Dose)||15
351396|NCT01258803|841534|P5|STARTED|Treatment Period 3 (1 Dose)||15
351397|NCT01258803|841535|P4|STARTED|Treatment Period 3 (1 Dose)||15
351398|NCT01258803|841536|P3|STARTED|Treatment Period 3 (1 Dose)||15
351399|NCT01258803|841537|P2|STARTED|Treatment Period 3 (1 Dose)||14
351400|NCT01258803|841538|P1|STARTED|Treatment Period 3 (1 Dose)||14
351401|NCT01258803|841533|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
351402|NCT01258803|841534|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
351403|NCT01258803|841535|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
351404|NCT01258803|841536|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
351405|NCT01258803|841537|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
351406|NCT01258803|841538|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
351407|NCT01258803|841533|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
351408|NCT01258803|841534|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
351409|NCT01258803|841535|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
351410|NCT01258803|841536|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
351411|NCT01258803|841537|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
351412|NCT01258803|841538|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
351413|NCT01258803|841533|P6|STARTED|Treatment Period 2 (1 Dose)||16
351414|NCT01258803|841534|P5|STARTED|Treatment Period 2 (1 Dose)||15
351415|NCT01258803|841535|P4|STARTED|Treatment Period 2 (1 Dose)||15
351416|NCT01258803|841536|P3|STARTED|Treatment Period 2 (1 Dose)||15
351417|NCT01258803|841537|P2|STARTED|Treatment Period 2 (1 Dose)||16
351418|NCT01258803|841538|P1|STARTED|Treatment Period 2 (1 Dose)||15
351419|NCT01258803|841533|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
351420|NCT01258803|841534|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
351421|NCT01258803|841535|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
351422|NCT01258803|841536|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
351423|NCT01258803|841537|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
351424|NCT01258803|841538|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
351425|NCT01258803|841533|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
351426|NCT01258803|841534|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
351427|NCT01258803|841535|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
351428|NCT01258803|841536|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
351429|NCT01258803|841537|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
351430|NCT01258803|841538|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
351431|NCT01258803|841533|P6|STARTED|Treatment Period 1 (1 Dose)||16
351432|NCT01258803|841534|P5|STARTED|Treatment Period 1 (1 Dose)||15
351433|NCT01258803|841535|P4|STARTED|Treatment Period 1 (1 Dose)||15
351434|NCT01258803|841536|P3|STARTED|Treatment Period 1 (1 Dose)||15
351435|NCT01258803|841537|P2|STARTED|Treatment Period 1 (1 Dose)||16
351436|NCT01258803|841538|P1|STARTED|Treatment Period 1 (1 Dose)||15
351437|NCT01258790|841566|P2|NOT COMPLETED|Overall Study||0
351438|NCT01258790|841567|P1|NOT COMPLETED|Overall Study||0
351439|NCT01258790|841566|P2|COMPLETED|Overall Study||6
351440|NCT01258790|841567|P1|COMPLETED|Overall Study||6
351441|NCT01258790|841566|P2|STARTED|Overall Study||6
351442|NCT01258790|841567|P1|STARTED|Overall Study||6
351443|NCT01258738|841575|P2|NOT COMPLETED|Open-label Period||21
351444|NCT01258738|841576|P1|NOT COMPLETED|Open-label Period||17
351445|NCT01258738|841575|P2|COMPLETED|Open-label Period||85
351446|NCT01258738|841576|P1|COMPLETED|Open-label Period||85
351447|NCT01258738|841575|P2|STARTED|Open-label Period||106
351448|NCT01258738|841576|P1|STARTED|Open-label Period||102
351449|NCT01258738|841575|P2|NOT COMPLETED|Double-blind Period||7
351450|NCT01258738|841576|P1|NOT COMPLETED|Double-blind Period||9
351451|NCT01258738|841575|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
351452|NCT01258738|841576|P1|COMPLETED|Double-blind Period||102
351453|NCT01258738|841575|P2|Treated|Double-blind Period||113
351454|NCT01258738|841576|P1|Treated|Double-blind Period||111
351455|NCT01258738|841575|P2|STARTED|Double-blind Period||114
351456|NCT01258738|841576|P1|STARTED|Double-blind Period||111
351457|NCT01258660|841714|P2|NOT COMPLETED|Overall Study||11
351458|NCT01258660|841715|P1|NOT COMPLETED|Overall Study||11
351459|NCT01258660|841714|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
351460|NCT01258660|841715|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
351461|NCT01258660|841714|P2|Completed Treatment|Overall Study||81
351462|NCT01258660|841715|P1|Completed Treatment|Overall Study||79
351463|NCT01258660|841714|P2|Received Treatment|Overall Study||82
351464|NCT01258660|841715|P1|Received Treatment|Overall Study||79
351465|NCT01258660|841714|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
351466|NCT01258660|841715|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
351467|NCT01258595|841734|P2|NOT COMPLETED|Overall Study||1
351468|NCT01258595|841735|P1|NOT COMPLETED|Overall Study||1
351469|NCT01258595|841734|P2|COMPLETED|Overall Study||151
351470|NCT01258595|841735|P1|COMPLETED|Overall Study||147
351471|NCT01258595|841734|P2|STARTED|Overall Study||152
351472|NCT01258595|841735|P1|STARTED|Overall Study||148
351473|NCT01258582|841751|P2|NOT COMPLETED|Overall Study||258
351474|NCT01258582|841752|P1|NOT COMPLETED|Overall Study||282
351475|NCT01258582|841751|P2|COMPLETED|Overall Study||563
351476|NCT01258582|841752|P1|COMPLETED|Overall Study||548
351477|NCT01258582|841751|P2|STARTED|Overall Study||821
351478|NCT01258582|841752|P1|STARTED|Overall Study||830
351479|NCT01258504|841758|P1|NOT COMPLETED|Bosentan and SJW||0
351480|NCT01258504|841758|P1|COMPLETED|Bosentan and SJW||13
351481|NCT01258504|841758|P1|STARTED|Bosentan and SJW||13
351482|NCT01258504|841758|P1|NOT COMPLETED|Bosentan Steady-state||0
351483|NCT01258504|841758|P1|COMPLETED|Bosentan Steady-state||13
351484|NCT01258504|841758|P1|STARTED|Bosentan Steady-state||13
351485|NCT01258504|841758|P1|NOT COMPLETED|Bosentan Single Dose||0
351486|NCT01258504|841758|P1|COMPLETED|Bosentan Single Dose||13
351487|NCT01258504|841758|P1|STARTED|Bosentan Single Dose||13
351488|NCT01256684|841772|P3|NOT COMPLETED|Overall Study||11
351489|NCT01256684|841773|P2|NOT COMPLETED|Overall Study||13
351490|NCT01256684|841774|P1|NOT COMPLETED|Overall Study||9
351491|NCT01256684|841772|P3|COMPLETED|Overall Study||76
351492|NCT01256684|841773|P2|COMPLETED|Overall Study||74
351493|NCT01256684|841774|P1|COMPLETED|Overall Study||72
351494|NCT01256684|841772|P3|ITT Population|Overall Study||81
351495|NCT01256684|841773|P2|ITT Population|Overall Study||79
351496|NCT01256684|841774|P1|ITT Population|Overall Study||77
351497|NCT01256684|841772|P3|Safety Population|Overall Study||87
351498|NCT01256684|841773|P2|Safety Population|Overall Study||86
351499|NCT01256684|841774|P1|Safety Population|Overall Study||80
351500|NCT01256684|841772|P3|STARTED|Overall Study||87
351501|NCT01256684|841773|P2|STARTED|Overall Study||87
351502|NCT01256684|841774|P1|STARTED|Overall Study||81
351503|NCT01256658|841808|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
351504|NCT01256658|841809|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
351505|NCT01256658|841808|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
351506|NCT01256658|841809|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
351507|NCT01256658|841808|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
351508|NCT01256658|841809|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
351509|NCT01256658|841808|P2|Death|Period 2 - Follow up Only - No Treatment||8
351510|NCT01256658|841809|P1|Death|Period 2 - Follow up Only - No Treatment||6
351511|NCT01256658|841808|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
351512|NCT01256658|841809|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
351513|NCT01256658|841808|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
351514|NCT01256658|841809|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
351515|NCT01256658|841808|P2|NOT COMPLETED|Period 1||748
351516|NCT01256658|841809|P1|NOT COMPLETED|Period 1||920
351517|NCT01256658|841808|P2|COMPLETED|Period 1||6510
351518|NCT01256658|841809|P1|COMPLETED|Period 1||5897
351519|NCT01256658|841808|P2|STARTED|Period 1||7258
351520|NCT01256658|841809|P1|STARTED|Period 1||6817
351521|NCT01256567|841859|P1|NOT COMPLETED|Overall Study||1
351522|NCT01256567|841859|P1|COMPLETED|Overall Study||6
351523|NCT01256567|841859|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
351524|NCT01256567|841859|P1|STARTED|Overall Study||7
351525|NCT01256502|841869|P1|NOT COMPLETED|Overall Study||10
351526|NCT01256502|841869|P1|COMPLETED|Overall Study||129
351527|NCT01256502|841869|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
351528|NCT01256476|841881|P2|NOT COMPLETED|Overall Study||7
351529|NCT01256476|841882|P1|NOT COMPLETED|Overall Study||6
351530|NCT01256476|841881|P2|COMPLETED|Overall Study||157
351531|NCT01256476|841882|P1|COMPLETED|Overall Study||158
351532|NCT01256476|841881|P2|STARTED|Overall Study||164
351533|NCT01256476|841882|P1|STARTED|Overall Study||164
351534|NCT01258387|841896|P7|NOT COMPLETED|Overall Study||0
351535|NCT01258387|841897|P6|NOT COMPLETED|Overall Study||0
351536|NCT01258387|841898|P5|NOT COMPLETED|Overall Study||0
351537|NCT01258387|841899|P4|NOT COMPLETED|Overall Study||0
351538|NCT01258387|841900|P3|NOT COMPLETED|Overall Study||0
351539|NCT01258387|841901|P2|NOT COMPLETED|Overall Study||0
351540|NCT01258387|841902|P1|NOT COMPLETED|Overall Study||0
351541|NCT01258387|841896|P7|COMPLETED|Overall Study||4
351542|NCT01258387|841897|P6|COMPLETED|Overall Study||6
351543|NCT01258387|841898|P5|COMPLETED|Overall Study||6
351544|NCT01258387|841899|P4|COMPLETED|Overall Study||6
351545|NCT01258387|841900|P3|COMPLETED|Overall Study||6
351546|NCT01258387|841901|P2|COMPLETED|Overall Study||6
351547|NCT01258387|841902|P1|COMPLETED|Overall Study||6
351548|NCT01258387|841896|P7|Patients Randomized to Placebo|Overall Study||1
351549|NCT01258387|841897|P6|Patients Randomized to Placebo|Overall Study||2
351550|NCT01258387|841898|P5|Patients Randomized to Placebo|Overall Study||2
351551|NCT01258387|841899|P4|Patients Randomized to Placebo|Overall Study||2
351552|NCT01258387|841900|P3|Patients Randomized to Placebo|Overall Study||2
351553|NCT01258387|841901|P2|Patients Randomized to Placebo|Overall Study||2
351554|NCT01258387|841902|P1|Patients Randomized to Placebo|Overall Study||2
351555|NCT01258387|841896|P7|Patients Randomized to GGF2|Overall Study||3
351556|NCT01258387|841897|P6|Patients Randomized to GGF2|Overall Study||4
351557|NCT01258387|841898|P5|Patients Randomized to GGF2|Overall Study||4
351558|NCT01258387|841899|P4|Patients Randomized to GGF2|Overall Study||4
351559|NCT01258387|841900|P3|Patients Randomized to GGF2|Overall Study||4
351560|NCT01258387|841901|P2|Patients Randomized to GGF2|Overall Study||4
351561|NCT01258387|841902|P1|Patients Randomized to GGF2|Overall Study||4
351562|NCT01258387|841896|P7|STARTED|Overall Study||4
351563|NCT01258387|841897|P6|STARTED|Overall Study||6
351564|NCT01258387|841898|P5|STARTED|Overall Study||6
351565|NCT01258387|841899|P4|STARTED|Overall Study||6
351566|NCT01258387|841900|P3|STARTED|Overall Study||6
351567|NCT01258387|841901|P2|STARTED|Overall Study||6
351568|NCT01258387|841902|P1|STARTED|Overall Study||6
351569|NCT01258153|841947|P3|NOT COMPLETED|Overall Study||1
351570|NCT01258153|841948|P2|NOT COMPLETED|Overall Study||1
351571|NCT01258153|841949|P1|NOT COMPLETED|Overall Study||1
351572|NCT01258153|841947|P3|COMPLETED|Overall Study||36
351573|NCT01258153|841948|P2|COMPLETED|Overall Study||37
351574|NCT01258153|841949|P1|COMPLETED|Overall Study||39
351575|NCT01258153|841947|P3|STARTED|Overall Study||37
351576|NCT01258153|841948|P2|STARTED|Overall Study||38
351577|NCT01258153|841949|P1|STARTED|Overall Study||40
351578|NCT01258101|841976|P4|NOT COMPLETED|Overall Study||25
351579|NCT01258101|841977|P3|NOT COMPLETED|Overall Study||11
351580|NCT01258101|841978|P2|NOT COMPLETED|Overall Study||34
351581|NCT01258101|841979|P1|NOT COMPLETED|Overall Study||33
351582|NCT01258101|841976|P4|COMPLETED|Overall Study||27
351583|NCT01258101|841977|P3|COMPLETED|Overall Study||22
351584|NCT01258101|841978|P2|COMPLETED|Overall Study||110
351585|NCT01258101|841979|P1|COMPLETED|Overall Study||118
351586|NCT01258101|841976|P4|Standard Analysis Population|Overall Study||26
351587|NCT01258101|841977|P3|Standard Analysis Population|Overall Study||21
351588|NCT01258101|841978|P2|Standard Analysis Population|Overall Study||110
351589|NCT01258101|841979|P1|Standard Analysis Population|Overall Study||115
351590|NCT01258101|841976|P4|Safety Analysis Population|Overall Study||48
351591|NCT01258101|841977|P3|Safety Analysis Population|Overall Study||30
351592|NCT01258101|841978|P2|Safety Analysis Population|Overall Study||141
351593|NCT01258101|841979|P1|Safety Analysis Population|Overall Study||144
351594|NCT01258101|841976|P4|STARTED|Overall Study||52
351595|NCT01258101|841977|P3|STARTED|Overall Study||33
351596|NCT01258101|841978|P2|STARTED|Overall Study||144
351597|NCT01258101|841979|P1|STARTED|Overall Study||151
351598|NCT01258049|842031|P2|NOT COMPLETED|Overall Study||2
351599|NCT01258049|842032|P1|NOT COMPLETED|Overall Study||2
351600|NCT01258049|842031|P2|COMPLETED|Overall Study||72
351601|NCT01258049|842032|P1|COMPLETED|Overall Study||75
351602|NCT01258049|842031|P2|STARTED|Overall Study||74
351603|NCT01258049|842032|P1|STARTED|Overall Study||77
351604|NCT01257880|842070|P2|NOT COMPLETED|Overall Study||0
351605|NCT01257880|842071|P1|NOT COMPLETED|Overall Study||0
351606|NCT01257880|842070|P2|COMPLETED|Overall Study||19
351607|NCT01257880|842071|P1|COMPLETED|Overall Study||12
351608|NCT01257880|842070|P2|STARTED|Overall Study||19
351609|NCT01257880|842071|P1|STARTED|Overall Study||12
351610|NCT01257750|842079|P1|NOT COMPLETED|Overall Study||0
351611|NCT01257750|842079|P1|COMPLETED|Overall Study||20
351612|NCT01257750|842079|P1|STARTED|Overall Study||20
351613|NCT01257581|842087|P3|NOT COMPLETED|Overall Study||6
351614|NCT01257581|842088|P2|NOT COMPLETED|Overall Study||3
351615|NCT01257581|842089|P1|NOT COMPLETED|Overall Study||5
351616|NCT01257581|842087|P3|COMPLETED|Overall Study||11
351617|NCT01257581|842088|P2|COMPLETED|Overall Study||18
351618|NCT01257581|842089|P1|COMPLETED|Overall Study||17
351619|NCT01257581|842087|P3|STARTED|Overall Study||17
351620|NCT01257581|842088|P2|STARTED|Overall Study||21
351621|NCT01257581|842089|P1|STARTED|Overall Study||22
351622|NCT01257542|842129|P2|NOT COMPLETED|Overall Study||7
351623|NCT01257542|842130|P1|NOT COMPLETED|Overall Study||3
351624|NCT01257542|842129|P2|COMPLETED|Overall Study||45
351625|NCT01257542|842130|P1|COMPLETED|Overall Study||52
351626|NCT01257542|842129|P2|STARTED|Overall Study||52
351627|NCT01257542|842130|P1|STARTED|Overall Study||55
351628|NCT01257503|842150|P2|NOT COMPLETED|Overall Study||11
351629|NCT01257503|842151|P1|NOT COMPLETED|Overall Study||8
351630|NCT01257503|842150|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
351631|NCT01257503|842151|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
351632|NCT01257503|842150|P2|Returned Dosage Logbooks|Overall Study||80
351633|NCT01257503|842151|P1|Returned Dosage Logbooks|Overall Study||75
351634|NCT01257503|842150|P2|Returned Symptom Diaries|Overall Study||83
351635|NCT01257503|842151|P1|Returned Symptom Diaries|Overall Study||80
351636|NCT01257503|842150|P2|STARTED|Overall Study||130
351637|NCT01257503|842151|P1|STARTED|Overall Study||133
351638|NCT01257438|842167|P2|NOT COMPLETED|Overall Study||46
351639|NCT01257438|842168|P1|NOT COMPLETED|Overall Study||30
351640|NCT01257438|842167|P2|COMPLETED|Overall Study||97
351641|NCT01257438|842168|P1|COMPLETED|Overall Study||102
351642|NCT01257438|842167|P2|STARTED|Overall Study||143
351643|NCT01257438|842168|P1|STARTED|Overall Study||132
351644|NCT01257425|842180|P2|NOT COMPLETED|Overall Study||6
351645|NCT01257425|842181|P1|NOT COMPLETED|Overall Study||6
351646|NCT01257425|842180|P2|COMPLETED|Overall Study||45
351647|NCT01257425|842181|P1|COMPLETED|Overall Study||46
351648|NCT01257425|842180|P2|STARTED|Overall Study||51
351649|NCT01257425|842181|P1|STARTED|Overall Study||52
351650|NCT01257347|842203|P4|NOT COMPLETED|Overall Study||0
351651|NCT01257347|842204|P3|NOT COMPLETED|Overall Study||0
351652|NCT01257347|842205|P2|NOT COMPLETED|Overall Study||0
351653|NCT01257347|842206|P1|NOT COMPLETED|Overall Study||0
351654|NCT01257347|842203|P4|COMPLETED|Overall Study||65
351655|NCT01257347|842204|P3|COMPLETED|Overall Study||35
351656|NCT01257347|842205|P2|COMPLETED|Overall Study||12
351657|NCT01257347|842206|P1|COMPLETED|Overall Study||12
351658|NCT01257347|842203|P4|STARTED|Overall Study||65
351659|NCT01257347|842204|P3|STARTED|Overall Study||35
351660|NCT01257347|842205|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
351661|NCT01257347|842206|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
351662|NCT01257230|842223|P3|NOT COMPLETED|Overall Study||6
351663|NCT01257230|842224|P2|NOT COMPLETED|Overall Study||10
351664|NCT01257230|842225|P1|NOT COMPLETED|Overall Study||6
351665|NCT01257230|842223|P3|COMPLETED|Overall Study||129
351666|NCT01257230|842224|P2|COMPLETED|Overall Study||115
351667|NCT01257230|842225|P1|COMPLETED|Overall Study||132
351668|NCT01257230|842223|P3|STARTED|Overall Study||135
351669|NCT01257230|842224|P2|STARTED|Overall Study||125
351670|NCT01257230|842225|P1|STARTED|Overall Study||138
351671|NCT01257217|842280|P2|NOT COMPLETED|Overall Study||0
351672|NCT01257217|842281|P1|NOT COMPLETED|Overall Study||2
351673|NCT01257217|842280|P2|COMPLETED|Overall Study||10
351674|NCT01257217|842281|P1|COMPLETED|Overall Study||13
351675|NCT01257217|842280|P2|STARTED|Overall Study||10
351676|NCT01257217|842281|P1|STARTED|Overall Study||15
351677|NCT01257204|842302|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
351678|NCT01257204|842303|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
351679|NCT01257204|842304|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
351680|NCT01257204|842302|P3|COMPLETED|Follow-up Period (up to Week 48)||39
351681|NCT01257204|842303|P2|COMPLETED|Follow-up Period (up to Week 48)||41
351682|NCT01257204|842304|P1|COMPLETED|Follow-up Period (up to Week 48)||48
351683|NCT01257204|842302|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
351684|NCT01257204|842303|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
351685|NCT01257204|842304|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
351686|NCT01257204|842302|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
351687|NCT01257204|842303|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
351688|NCT01257204|842304|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
351689|NCT01257204|842302|P3|COMPLETED|Treatment Period (up to Week 24)||42
351690|NCT01257204|842303|P2|COMPLETED|Treatment Period (up to Week 24)||44
351691|NCT01257204|842304|P1|COMPLETED|Treatment Period (up to Week 24)||45
351692|NCT01257204|842302|P3|STARTED|Treatment Period (up to Week 24)||51
351693|NCT01257204|842303|P2|STARTED|Treatment Period (up to Week 24)||50
351694|NCT01257204|842304|P1|STARTED|Treatment Period (up to Week 24)||50
351695|NCT01256450|842350|P3|NOT COMPLETED|Double-blind Treatment||37
351696|NCT01256450|842351|P2|NOT COMPLETED|Double-blind Treatment||28
351697|NCT01256450|842352|P1|NOT COMPLETED|Double-blind Treatment||0
351698|NCT01256450|842350|P3|COMPLETED|Double-blind Treatment||81
351699|NCT01256450|842351|P2|COMPLETED|Double-blind Treatment||89
351700|NCT01256450|842352|P1|COMPLETED|Double-blind Treatment||0
351701|NCT01256450|842350|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
351702|NCT01256450|842351|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
351703|NCT01256450|842352|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
351704|NCT01256450|842350|P3|NOT COMPLETED|Open-label Titration||0
351705|NCT01256450|842351|P2|NOT COMPLETED|Open-label Titration||0
351706|NCT01256450|842352|P1|NOT COMPLETED|Open-label Titration||99
351707|NCT01256450|842350|P3|COMPLETED|Open-label Titration||0
351708|NCT01256450|842351|P2|COMPLETED|Open-label Titration||0
351709|NCT01256450|842352|P1|COMPLETED|Open-label Titration||235
351710|NCT01256450|842350|P3|STARTED|Open-label Titration||0
351711|NCT01256450|842351|P2|STARTED|Open-label Titration||0
351712|NCT01256450|842352|P1|STARTED|Open-label Titration||334
351713|NCT01256424|842381|P4|NOT COMPLETED|Overall Study||7
351714|NCT01256424|842382|P3|NOT COMPLETED|Overall Study||7
351715|NCT01256424|842383|P2|NOT COMPLETED|Overall Study||8
351716|NCT01256424|842384|P1|NOT COMPLETED|Overall Study||9
351717|NCT01256424|842381|P4|COMPLETED|Overall Study||61
351718|NCT01256424|842382|P3|COMPLETED|Overall Study||55
351719|NCT01256424|842383|P2|COMPLETED|Overall Study||59
351720|NCT01256424|842384|P1|COMPLETED|Overall Study||56
351721|NCT01256424|842381|P4|STARTED|Overall Study||68
351722|NCT01256424|842382|P3|STARTED|Overall Study||62
351723|NCT01256424|842383|P2|STARTED|Overall Study||67
351724|NCT01256424|842384|P1|STARTED|Overall Study||65
351725|NCT01256411|842410|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
351726|NCT01256411|842411|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
351727|NCT01256411|842412|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
351728|NCT01256411|842413|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
351729|NCT01256411|842414|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
351730|NCT01256411|842415|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
351731|NCT01256411|842410|P6|COMPLETED|Extension by Mono or Combination Therapy||109
351732|NCT01256411|842411|P5|COMPLETED|Extension by Mono or Combination Therapy||211
351733|NCT01256411|842412|P4|COMPLETED|Extension by Mono or Combination Therapy||0
351734|NCT01256411|842413|P3|COMPLETED|Extension by Mono or Combination Therapy||0
351735|NCT01256411|842414|P2|COMPLETED|Extension by Mono or Combination Therapy||0
351736|NCT01256411|842415|P1|COMPLETED|Extension by Mono or Combination Therapy||0
351737|NCT01256411|842410|P6|STARTED|Extension by Mono or Combination Therapy||113
351738|NCT01256411|842411|P5|STARTED|Extension by Mono or Combination Therapy||228
351739|NCT01256411|842412|P4|STARTED|Extension by Mono or Combination Therapy||0
351740|NCT01256411|842413|P3|STARTED|Extension by Mono or Combination Therapy||0
351741|NCT01256411|842414|P2|STARTED|Extension by Mono or Combination Therapy||0
351742|NCT01256411|842415|P1|STARTED|Extension by Mono or Combination Therapy||0
351743|NCT01256411|842410|P6|NOT COMPLETED|Extension by Maximum Treatment||0
351744|NCT01256411|842411|P5|NOT COMPLETED|Extension by Maximum Treatment||0
351745|NCT01256411|842412|P4|NOT COMPLETED|Extension by Maximum Treatment||0
351746|NCT01256411|842413|P3|NOT COMPLETED|Extension by Maximum Treatment||4
351747|NCT01256411|842414|P2|NOT COMPLETED|Extension by Maximum Treatment||10
351748|NCT01256411|842415|P1|NOT COMPLETED|Extension by Maximum Treatment||7
351749|NCT01256411|842410|P6|COMPLETED|Extension by Maximum Treatment||0
351750|NCT01256411|842411|P5|COMPLETED|Extension by Maximum Treatment||0
351751|NCT01256411|842412|P4|COMPLETED|Extension by Maximum Treatment||4
351752|NCT01256411|842413|P3|COMPLETED|Extension by Maximum Treatment||105
351753|NCT01256411|842414|P2|COMPLETED|Extension by Maximum Treatment||79
351754|NCT01256411|842415|P1|COMPLETED|Extension by Maximum Treatment||132
351755|NCT01256411|842410|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
351756|NCT01256411|842411|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
351757|NCT01256411|842412|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
351758|NCT01256411|842413|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
351759|NCT01256411|842414|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
351760|NCT01256411|842415|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
351761|NCT01256411|842410|P6|STARTED|Extension by Maximum Treatment||0
351762|NCT01256411|842411|P5|STARTED|Extension by Maximum Treatment||0
351763|NCT01256411|842412|P4|STARTED|Extension by Maximum Treatment||4
351764|NCT01256411|842413|P3|STARTED|Extension by Maximum Treatment||109
351765|NCT01256411|842414|P2|STARTED|Extension by Maximum Treatment||89
351766|NCT01256411|842415|P1|STARTED|Extension by Maximum Treatment||139
351767|NCT01256385|842441|P2|NOT COMPLETED|Overall Study||3
351768|NCT01256385|842442|P1|NOT COMPLETED|Overall Study||3
351769|NCT01256385|842441|P2|COMPLETED|Overall Study||40
351770|NCT01256385|842442|P1|COMPLETED|Overall Study||40
351771|NCT01256385|842441|P2|Crossover From Arm B to Arm A|Overall Study||15
351772|NCT01256385|842442|P1|Crossover From Arm B to Arm A|Overall Study||0
351773|NCT01256385|842441|P2|STARTED|Overall Study||43
351774|NCT01256385|842442|P1|STARTED|Overall Study||43
351775|NCT01256294|842462|P2|NOT COMPLETED|Overall Study||2
351776|NCT01256294|842463|P1|NOT COMPLETED|Overall Study||4
351777|NCT01256294|842462|P2|COMPLETED|Overall Study||33
351778|NCT01256294|842463|P1|COMPLETED|Overall Study||32
351779|NCT01256294|842462|P2|STARTED|Overall Study||35
351780|NCT01256294|842463|P1|STARTED|Overall Study||36
351781|NCT01256281|842479|P1|NOT COMPLETED|Overall Study||0
351782|NCT01256281|842479|P1|COMPLETED|Overall Study||2
351783|NCT01256281|842479|P1|STARTED|Overall Study||2
351784|NCT01256190|842485|P2|NOT COMPLETED|Overall Study||0
351785|NCT01256190|842486|P1|NOT COMPLETED|Overall Study||2
351786|NCT01256190|842485|P2|COMPLETED|Overall Study||17
351787|NCT01256190|842486|P1|COMPLETED|Overall Study||37
351788|NCT01256190|842485|P2|STARTED|Overall Study||17
351789|NCT01256190|842486|P1|STARTED|Overall Study||39
351790|NCT01256177|842502|P2|NOT COMPLETED|Overall Study||37
351791|NCT01256177|842503|P1|NOT COMPLETED|Overall Study||50
351792|NCT01256177|842502|P2|COMPLETED|Overall Study||111
351793|NCT01256177|842503|P1|COMPLETED|Overall Study||98
351794|NCT01256177|842502|P2|STARTED|Overall Study||148
351795|NCT01256177|842503|P1|STARTED|Overall Study||148
351796|NCT01256164|842527|P2|NOT COMPLETED|Overall Study||0
351797|NCT01256164|842528|P1|NOT COMPLETED|Overall Study||0
351798|NCT01256164|842527|P2|COMPLETED|Overall Study||23
351799|NCT01256164|842528|P1|COMPLETED|Overall Study||47
351800|NCT01256164|842527|P2|STARTED|Overall Study||23
351801|NCT01256164|842528|P1|STARTED|Overall Study||47
351802|NCT01256086|842546|P4|NOT COMPLETED|Treatment Day 4||0
351803|NCT01256086|842547|P3|NOT COMPLETED|Treatment Day 4||0
351804|NCT01256086|842548|P2|NOT COMPLETED|Treatment Day 4||0
351805|NCT01256086|842549|P1|NOT COMPLETED|Treatment Day 4||0
351806|NCT01256086|842546|P4|COMPLETED|Treatment Day 4||11
351807|NCT01256086|842547|P3|COMPLETED|Treatment Day 4||9
351808|NCT01256086|842548|P2|COMPLETED|Treatment Day 4||10
351809|NCT01256086|842549|P1|COMPLETED|Treatment Day 4||11
351810|NCT01256086|842546|P4|STARTED|Treatment Day 4||11
351811|NCT01256086|842547|P3|STARTED|Treatment Day 4||9
351812|NCT01256086|842548|P2|STARTED|Treatment Day 4||10
351813|NCT01256086|842549|P1|STARTED|Treatment Day 4||11
351814|NCT01256086|842546|P4|NOT COMPLETED|Treatment Day 3||0
351815|NCT01256086|842547|P3|NOT COMPLETED|Treatment Day 3||0
351816|NCT01256086|842548|P2|NOT COMPLETED|Treatment Day 3||0
351817|NCT01256086|842549|P1|NOT COMPLETED|Treatment Day 3||0
351818|NCT01256086|842546|P4|COMPLETED|Treatment Day 3||11
351819|NCT01256086|842547|P3|COMPLETED|Treatment Day 3||9
351820|NCT01256086|842548|P2|COMPLETED|Treatment Day 3||10
351821|NCT01256086|842549|P1|COMPLETED|Treatment Day 3||11
351822|NCT01256086|842546|P4|STARTED|Treatment Day 3||11
351823|NCT01256086|842547|P3|STARTED|Treatment Day 3||9
351824|NCT01256086|842548|P2|STARTED|Treatment Day 3||10
351825|NCT01256086|842549|P1|STARTED|Treatment Day 3||11
351826|NCT01256086|842546|P4|NOT COMPLETED|Treatment Day 2||0
351827|NCT01256086|842547|P3|NOT COMPLETED|Treatment Day 2||0
351828|NCT01256086|842548|P2|NOT COMPLETED|Treatment Day 2||0
351829|NCT01256086|842549|P1|NOT COMPLETED|Treatment Day 2||0
351830|NCT01256086|842546|P4|COMPLETED|Treatment Day 2||11
351831|NCT01256086|842547|P3|COMPLETED|Treatment Day 2||9
351832|NCT01256086|842548|P2|COMPLETED|Treatment Day 2||10
351833|NCT01256086|842549|P1|COMPLETED|Treatment Day 2||11
351834|NCT01256086|842546|P4|STARTED|Treatment Day 2||11
351835|NCT01256086|842547|P3|STARTED|Treatment Day 2||9
351836|NCT01256086|842548|P2|STARTED|Treatment Day 2||10
351837|NCT01256086|842549|P1|STARTED|Treatment Day 2||11
351838|NCT01256086|842546|P4|NOT COMPLETED|Treatment Day 1||0
351839|NCT01256086|842547|P3|NOT COMPLETED|Treatment Day 1||0
351840|NCT01256086|842548|P2|NOT COMPLETED|Treatment Day 1||0
351841|NCT01256086|842549|P1|NOT COMPLETED|Treatment Day 1||0
351842|NCT01256086|842546|P4|COMPLETED|Treatment Day 1||11
351843|NCT01256086|842547|P3|COMPLETED|Treatment Day 1||11
351844|NCT01256086|842548|P2|COMPLETED|Treatment Day 1||11
351845|NCT01256086|842549|P1|COMPLETED|Treatment Day 1||11
351846|NCT01256086|842546|P4|STARTED|Treatment Day 1||11
351847|NCT01256086|842547|P3|STARTED|Treatment Day 1||11
351848|NCT01256086|842548|P2|STARTED|Treatment Day 1||11
351849|NCT01256086|842549|P1|STARTED|Treatment Day 1||11
351850|NCT01256060|842559|P4|NOT COMPLETED|Overall Study||0
351851|NCT01256060|842560|P3|NOT COMPLETED|Overall Study||0
351852|NCT01256060|842561|P2|NOT COMPLETED|Overall Study||1
351853|NCT01256060|842562|P1|NOT COMPLETED|Overall Study||0
351854|NCT01256060|842559|P4|COMPLETED|Overall Study||6
351855|NCT01256060|842560|P3|COMPLETED|Overall Study||3
351856|NCT01256060|842561|P2|COMPLETED|Overall Study||2
351857|NCT01256060|842562|P1|COMPLETED|Overall Study||3
351858|NCT01256060|842559|P4|STARTED|Overall Study||6
351859|NCT01256060|842560|P3|STARTED|Overall Study||3
351860|NCT01256060|842561|P2|STARTED|Overall Study||3
351861|NCT01256060|842562|P1|STARTED|Overall Study||3
351862|NCT01256034|842571|P2|NOT COMPLETED|Overall Study||25
351863|NCT01256034|842572|P1|NOT COMPLETED|Overall Study||25
351864|NCT01256034|842571|P2|COMPLETED|Overall Study||0
351865|NCT01256034|842572|P1|COMPLETED|Overall Study||0
351866|NCT01256034|842571|P2|STARTED|Overall Study||25
351867|NCT01256034|842572|P1|STARTED|Overall Study||25
351868|NCT01256008|842581|P3|NOT COMPLETED|Overall Study||21
351869|NCT01256008|842582|P2|NOT COMPLETED|Overall Study||7
351870|NCT01256008|842583|P1|NOT COMPLETED|Overall Study||8
351871|NCT01256008|842581|P3|COMPLETED|Overall Study||175
351872|NCT01256008|842582|P2|COMPLETED|Overall Study||91
351873|NCT01256008|842583|P1|COMPLETED|Overall Study||90
351874|NCT01256008|842581|P3|STARTED|Overall Study||196
351875|NCT01256008|842582|P2|STARTED|Overall Study||98
351876|NCT01256008|842583|P1|STARTED|Overall Study||98
351877|NCT01255904|842605|P2|NOT COMPLETED|Overall Study||4
351878|NCT01255904|842606|P1|NOT COMPLETED|Overall Study||1
351879|NCT01255904|842605|P2|COMPLETED|Overall Study||41
351880|NCT01255904|842606|P1|COMPLETED|Overall Study||44
351881|NCT01255904|842605|P2|STARTED|Overall Study||45
351882|NCT01255904|842606|P1|STARTED|Overall Study||45
351883|NCT01255787|842616|P4|NOT COMPLETED|Overall Study||22
351884|NCT01255787|842617|P3|NOT COMPLETED|Overall Study||18
351885|NCT01255787|842618|P2|NOT COMPLETED|Overall Study||17
351886|NCT01255787|842619|P1|NOT COMPLETED|Overall Study||16
351887|NCT01255787|842616|P4|COMPLETED|Overall Study||132
351888|NCT01255787|842617|P3|COMPLETED|Overall Study||132
351889|NCT01255787|842618|P2|COMPLETED|Overall Study||127
351890|NCT01255787|842619|P1|COMPLETED|Overall Study||136
351891|NCT01255787|842616|P4|Treated|Overall Study||150
351892|NCT01255787|842617|P3|Treated|Overall Study||148
351893|NCT01255787|842618|P2|Treated|Overall Study||144
351894|NCT01255787|842619|P1|Treated|Overall Study||152
351895|NCT01255787|842616|P4|STARTED|Overall Study||154
351896|NCT01255787|842617|P3|STARTED|Overall Study||150
351897|NCT01255787|842618|P2|STARTED|Overall Study||144
351898|NCT01255787|842619|P1|STARTED|Overall Study||152
351899|NCT01255761|842647|P2|NOT COMPLETED|Overall Study||175
351900|NCT01255761|842648|P1|NOT COMPLETED|Overall Study||182
351901|NCT01255761|842647|P2|COMPLETED|Overall Study||192
351902|NCT01255761|842648|P1|COMPLETED|Overall Study||187
351903|NCT01255761|842647|P2|STARTED|Overall Study||367
351904|NCT01255761|842648|P1|STARTED|Overall Study||369
351905|NCT01255722|842733|P3|NOT COMPLETED|Overall Study||1
351906|NCT01255722|842734|P2|NOT COMPLETED|Overall Study||1
351907|NCT01255722|842735|P1|NOT COMPLETED|Overall Study||3
351908|NCT01255722|842733|P3|COMPLETED|Overall Study||152
351909|NCT01255722|842734|P2|COMPLETED|Overall Study||159
351910|NCT01255722|842735|P1|COMPLETED|Overall Study||152
351911|NCT01255722|842733|P3|STARTED|Overall Study||153
351912|NCT01255722|842734|P2|STARTED|Overall Study||160
351913|NCT01255722|842735|P1|STARTED|Overall Study||155
351914|NCT01255631|842760|P2|NOT COMPLETED|Overall Study||6
351915|NCT01255631|842761|P1|NOT COMPLETED|Overall Study||9
351916|NCT01255631|842760|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
351917|NCT01255631|842761|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
351918|NCT01255631|842760|P2|STARTED|Overall Study||9
351919|NCT01255631|842761|P1|STARTED|Overall Study||13
351920|NCT01255592|842779|P2|NOT COMPLETED|Overall Study||1
351921|NCT01255592|842780|P1|NOT COMPLETED|Overall Study||6
351922|NCT01255592|842779|P2|COMPLETED|Overall Study||25
351923|NCT01255592|842780|P1|COMPLETED|Overall Study||20
351924|NCT01255592|842779|P2|STARTED|Overall Study||26
351925|NCT01255592|842780|P1|STARTED|Overall Study||26
351926|NCT01255449|842836|P1|NOT COMPLETED|Overall Study||0
351927|NCT01255449|842836|P1|COMPLETED|Overall Study||26
351928|NCT01255449|842836|P1|STARTED|Overall Study||26
351929|NCT01255436|842843|P2|NOT COMPLETED|Overall Study||194
351930|NCT01255436|842844|P1|NOT COMPLETED|Overall Study||182
351931|NCT01255436|842843|P2|COMPLETED|Overall Study||135
351932|NCT01255436|842844|P1|COMPLETED|Overall Study||151
351933|NCT01255436|842843|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
351934|NCT01255436|842844|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
351935|NCT01255423|842858|P2|NOT COMPLETED|Overall Study||3
351936|NCT01255423|842859|P1|NOT COMPLETED|Overall Study||3
351937|NCT01255423|842858|P2|COMPLETED|Overall Study||99
351938|NCT01255423|842859|P1|COMPLETED|Overall Study||101
351939|NCT01255423|842858|P2|STARTED|Overall Study||102
351940|NCT01255423|842859|P1|STARTED|Overall Study||104
351941|NCT01255306|842875|P2|NOT COMPLETED|Overall Study||1
351942|NCT01255306|842876|P1|NOT COMPLETED|Overall Study||1
351943|NCT01255306|842875|P2|COMPLETED|Overall Study||32
351944|NCT01255306|842876|P1|COMPLETED|Overall Study||25
351945|NCT01255306|842875|P2|STARTED|Overall Study||33
351946|NCT01255306|842876|P1|STARTED|Overall Study||26
351947|NCT01255137|842885|P1|NOT COMPLETED|Overall Study||0
351948|NCT01255137|842885|P1|COMPLETED|Overall Study||13
351949|NCT01255137|842885|P1|STARTED|Overall Study||13
351950|NCT01254890|842892|P2|NOT COMPLETED|Overall Study||10
351951|NCT01254890|842893|P1|NOT COMPLETED|Overall Study||1
351952|NCT01254890|842892|P2|COMPLETED|Overall Study||47
351953|NCT01254890|842893|P1|COMPLETED|Overall Study||2
351954|NCT01254890|842892|P2|STARTED|Overall Study||57
351955|NCT01254890|842893|P1|STARTED|Overall Study||3
351956|NCT01254851|842901|P2|NOT COMPLETED|Overall Study||9
351957|NCT01254851|842902|P1|NOT COMPLETED|Overall Study||8
351958|NCT01254851|842901|P2|COMPLETED|Overall Study||68
351959|NCT01254851|842902|P1|COMPLETED|Overall Study||61
351960|NCT01254851|842901|P2|STARTED|Overall Study||77
351961|NCT01254851|842902|P1|STARTED|Overall Study||69
351962|NCT01254760|842908|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
351963|NCT01254760|842909|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
351964|NCT01254760|842908|P2|COMPLETED|Second Period, 5 Days of Wear||38
351965|NCT01254760|842909|P1|COMPLETED|Second Period, 5 Days of Wear||34
351966|NCT01254760|842908|P2|STARTED|Second Period, 5 Days of Wear||38
351967|NCT01254760|842909|P1|STARTED|Second Period, 5 Days of Wear||34
351968|NCT01254760|842908|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
351969|NCT01254760|842909|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
351970|NCT01254760|842908|P2|COMPLETED|First Period, 5 Days of Wear||38
351971|NCT01254760|842909|P1|COMPLETED|First Period, 5 Days of Wear||34
351972|NCT01254760|842908|P2|STARTED|First Period, 5 Days of Wear||38
351973|NCT01254760|842909|P1|STARTED|First Period, 5 Days of Wear||34
351974|NCT01254747|842927|P4|NOT COMPLETED|Overall Study||2
351975|NCT01254747|842928|P3|NOT COMPLETED|Overall Study||4
351976|NCT01254747|842929|P2|NOT COMPLETED|Overall Study||6
351977|NCT01254747|842930|P1|NOT COMPLETED|Overall Study||0
351978|NCT01254747|842927|P4|COMPLETED|Overall Study||28
351979|NCT01254747|842928|P3|COMPLETED|Overall Study||26
351980|NCT01254747|842929|P2|COMPLETED|Overall Study||23
351981|NCT01254747|842930|P1|COMPLETED|Overall Study||40
351982|NCT01254747|842927|P4|STARTED|Overall Study||30
351983|NCT01254747|842928|P3|STARTED|Overall Study||30
351984|NCT01254747|842929|P2|STARTED|Overall Study||29
351985|NCT01254747|842930|P1|STARTED|Overall Study||40
351986|NCT01254721|842970|P2|NOT COMPLETED|Overall Study||22
351987|NCT01254721|842971|P1|NOT COMPLETED|Overall Study||15
351988|NCT01254721|842970|P2|COMPLETED|Overall Study||42
351989|NCT01254721|842971|P1|COMPLETED|Overall Study||52
351990|NCT01254721|842970|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
351991|NCT01254721|842971|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
351992|NCT01254669|842981|P2|NOT COMPLETED|Overall Study||4
351993|NCT01254669|842982|P1|NOT COMPLETED|Overall Study||3
351994|NCT01254669|842981|P2|COMPLETED|Overall Study||96
351995|NCT01254669|842982|P1|COMPLETED|Overall Study||97
351996|NCT01254669|842981|P2|STARTED|Overall Study||100
351997|NCT01254669|842982|P1|STARTED|Overall Study||100
351998|NCT01254656|842993|P3|NOT COMPLETED|Overall Study||18
351999|NCT01254656|842994|P2|NOT COMPLETED|Overall Study||43
352000|NCT01254656|842995|P1|NOT COMPLETED|Overall Study||47
352001|NCT01254656|842993|P3|COMPLETED|Overall Study||0
352002|NCT01254656|842994|P2|COMPLETED|Overall Study||0
352003|NCT01254656|842995|P1|COMPLETED|Overall Study||0
352004|NCT01254656|842993|P3|Treated|Overall Study||18
352005|NCT01254656|842994|P2|Treated|Overall Study||43
352006|NCT01254656|842995|P1|Treated|Overall Study||47
352007|NCT01254656|842993|P3|STARTED|Overall Study||18
352008|NCT01254656|842994|P2|STARTED|Overall Study||43
352009|NCT01254656|842995|P1|STARTED|Overall Study||47
352010|NCT01254643|843021|P1|NOT COMPLETED|Overall Study||1
352011|NCT01254643|843021|P1|COMPLETED|Overall Study||99
352012|NCT01254643|843021|P1|Vaccination 3|Overall Study||99
352013|NCT01254643|843021|P1|Vaccination 2|Overall Study||99
352014|NCT01254643|843021|P1|Vaccination 1|Overall Study||100
352015|NCT01254643|843021|P1|STARTED|Overall Study||100
352016|NCT01254604|843031|P2|NOT COMPLETED|Overall Study||9
352017|NCT01254604|843032|P1|NOT COMPLETED|Overall Study||8
352018|NCT01254604|843031|P2|COMPLETED|Overall Study||86
352019|NCT01254604|843032|P1|COMPLETED|Overall Study||87
352020|NCT01254604|843031|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
352021|NCT01254604|843032|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
352022|NCT01254604|843031|P2|STARTED|Overall Study||95
352023|NCT01254604|843032|P1|STARTED|Overall Study||95
352024|NCT01254565|843050|P6|NOT COMPLETED|Overall Study||4
352025|NCT01254565|843051|P5|NOT COMPLETED|Overall Study||4
352026|NCT01254565|843052|P4|NOT COMPLETED|Overall Study||1
352027|NCT01254565|843053|P3|NOT COMPLETED|Overall Study||0
352028|NCT01254565|843054|P2|NOT COMPLETED|Overall Study||1
352029|NCT01254565|843055|P1|NOT COMPLETED|Overall Study||1
352030|NCT01254565|843050|P6|COMPLETED|Overall Study||13
352031|NCT01254565|843051|P5|COMPLETED|Overall Study||12
352032|NCT01254565|843052|P4|COMPLETED|Overall Study||20
352033|NCT01254565|843053|P3|COMPLETED|Overall Study||21
352034|NCT01254565|843054|P2|COMPLETED|Overall Study||6
352035|NCT01254565|843055|P1|COMPLETED|Overall Study||4
352036|NCT01254565|843050|P6|Received Treatment|Overall Study||13
352037|NCT01254565|843051|P5|Received Treatment|Overall Study||13
352038|NCT01254565|843052|P4|Received Treatment|Overall Study||21
352039|NCT01254565|843053|P3|Received Treatment|Overall Study||21
352040|NCT01254565|843054|P2|Received Treatment|Overall Study||6
352041|NCT01254565|843055|P1|Received Treatment|Overall Study||4
352042|NCT01254565|843050|P6|STARTED|Overall Study||17
352043|NCT01254565|843051|P5|STARTED|Overall Study||16
352044|NCT01254565|843052|P4|STARTED|Overall Study||21
352045|NCT01254565|843053|P3|STARTED|Overall Study||21
352046|NCT01254565|843054|P2|STARTED|Overall Study||7
352047|NCT01254565|843055|P1|STARTED|Overall Study||5
352048|NCT01254409|843109|P4|NOT COMPLETED|Overall Study||0
352049|NCT01254409|843110|P3|NOT COMPLETED|Overall Study||0
352050|NCT01254409|843111|P2|NOT COMPLETED|Overall Study||1
352051|NCT01254409|843112|P1|NOT COMPLETED|Overall Study||0
352052|NCT01254409|843109|P4|COMPLETED|Overall Study||4
352053|NCT01254409|843110|P3|COMPLETED|Overall Study||5
352054|NCT01254409|843111|P2|COMPLETED|Overall Study||5
352055|NCT01254409|843112|P1|COMPLETED|Overall Study||6
352056|NCT01254409|843109|P4|STARTED|Overall Study||4
352057|NCT01254409|843110|P3|STARTED|Overall Study||5
352058|NCT01254409|843111|P2|STARTED|Overall Study||6
352059|NCT01254409|843112|P1|STARTED|Overall Study||6
352060|NCT01254396|843164|P2|NOT COMPLETED|Second Intervention Period||0
352061|NCT01254396|843165|P1|NOT COMPLETED|Second Intervention Period||0
352062|NCT01254396|843164|P2|COMPLETED|Second Intervention Period||6
352063|NCT01254396|843165|P1|COMPLETED|Second Intervention Period||6
352064|NCT01254396|843164|P2|STARTED|Second Intervention Period||6
352065|NCT01254396|843165|P1|STARTED|Second Intervention Period||6
352066|NCT01254396|843164|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
352067|NCT01254396|843165|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
352068|NCT01254396|843164|P2|COMPLETED|Washout Period (at Least 1 Day)||6
352069|NCT01254396|843165|P1|COMPLETED|Washout Period (at Least 1 Day)||6
352070|NCT01254396|843164|P2|STARTED|Washout Period (at Least 1 Day)||6
352071|NCT01254396|843165|P1|STARTED|Washout Period (at Least 1 Day)||6
352072|NCT01254396|843164|P2|NOT COMPLETED|First Intervention Period||0
352073|NCT01254396|843165|P1|NOT COMPLETED|First Intervention Period||0
352074|NCT01254396|843164|P2|COMPLETED|First Intervention Period||6
352075|NCT01254396|843165|P1|COMPLETED|First Intervention Period||6
352076|NCT01254396|843164|P2|STARTED|First Intervention Period||6
352077|NCT01254396|843165|P1|STARTED|First Intervention Period||6
352078|NCT01254344|843181|P2|NOT COMPLETED|Overall Study||19
352079|NCT01254344|843182|P1|NOT COMPLETED|Overall Study||13
352080|NCT01254344|843181|P2|COMPLETED|Overall Study||281
352081|NCT01254344|843182|P1|COMPLETED|Overall Study||286
352082|NCT01254344|843181|P2|Treated|Overall Study||297
352083|NCT01254344|843182|P1|Treated|Overall Study||290
352084|NCT01254344|843181|P2|STARTED|Overall Study||300
352085|NCT01254344|843182|P1|STARTED|Overall Study||299
352086|NCT01254331|843190|P1|NOT COMPLETED|Extension Phase||4
352087|NCT01254331|843190|P1|COMPLETED|Extension Phase||41
352088|NCT01254331|843190|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
352089|NCT01254331|843190|P1|NOT COMPLETED|Initial Phase||5
352090|NCT01254331|843190|P1|COMPLETED|Initial Phase||46
352091|NCT01254331|843190|P1|STARTED|Initial Phase||51
352092|NCT01254318|843208|P1|NOT COMPLETED|Overall Study||52
352093|NCT01254318|843208|P1|COMPLETED|Overall Study|Alive at end of study|78
352094|NCT01254318|843208|P1|STARTED|Overall Study|Alive at start of study|130
352095|NCT01254305|843217|P3|NOT COMPLETED|Overall Study||17
352096|NCT01254305|843218|P2|NOT COMPLETED|Overall Study||18
352097|NCT01254305|843219|P1|NOT COMPLETED|Overall Study||22
352098|NCT01254305|843217|P3|COMPLETED|Overall Study||62
352099|NCT01254305|843218|P2|COMPLETED|Overall Study||72
352100|NCT01254305|843219|P1|COMPLETED|Overall Study||71
352101|NCT01254305|843217|P3|Safety Population|Overall Study||77
352102|NCT01254305|843218|P2|Safety Population|Overall Study||85
352103|NCT01254305|843219|P1|Safety Population|Overall Study||89
352104|NCT01254305|843217|P3|STARTED|Overall Study||79
352105|NCT01254305|843218|P2|STARTED|Overall Study||90
352106|NCT01254305|843219|P1|STARTED|Overall Study||93
352107|NCT01254292|843235|P2|NOT COMPLETED|LCS12 Extension Phase||0
352108|NCT01254292|843236|P1|NOT COMPLETED|LCS12 Extension Phase||37
352109|NCT01254292|843235|P2|COMPLETED|LCS12 Extension Phase||0
352110|NCT01254292|843236|P1|COMPLETED|LCS12 Extension Phase||163
352111|NCT01254292|843235|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
352112|NCT01254292|843236|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
352113|NCT01254292|843235|P2|NOT COMPLETED|Comparative Phase||81
352114|NCT01254292|843236|P1|NOT COMPLETED|Comparative Phase||55
352115|NCT01254292|843235|P2|COMPLETED|Comparative Phase||204
352116|NCT01254292|843236|P1|COMPLETED|Comparative Phase||227
352117|NCT01254292|843235|P2|Participants Received Treatment|Comparative Phase|safety population|281
352118|NCT01254292|843236|P1|Participants Received Treatment|Comparative Phase|safety population|279
352119|NCT01254292|843235|P2|STARTED|Comparative Phase||285
352120|NCT01254292|843236|P1|STARTED|Comparative Phase||282
352121|NCT01254214|843294|P2|NOT COMPLETED|Overall Study||1
352122|NCT01254214|843295|P1|NOT COMPLETED|Overall Study||3
352123|NCT01254214|843294|P2|COMPLETED|Overall Study||27
352124|NCT01254214|843295|P1|COMPLETED|Overall Study||24
352125|NCT01254214|843294|P2|STARTED|Overall Study||28
352126|NCT01254214|843295|P1|STARTED|Overall Study||27
352127|NCT01254188|843309|P1|NOT COMPLETED|Overall Study||93
352128|NCT01254188|843309|P1|COMPLETED|Overall Study||328
352129|NCT01254188|843309|P1|STARTED|Overall Study||421
352130|NCT01254045|843320|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
352131|NCT01254045|843321|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
352132|NCT01254045|843322|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
352133|NCT01254045|843323|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
352134|NCT01254045|843324|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
352135|NCT01254045|843325|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
352136|NCT01254045|843320|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
352137|NCT01254045|843321|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
352138|NCT01254045|843322|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
352139|NCT01254045|843323|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
352140|NCT01254045|843324|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
352141|NCT01254045|843325|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
352142|NCT01254045|843320|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
352143|NCT01254045|843321|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
352144|NCT01254045|843322|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
352145|NCT01254045|843323|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
352146|NCT01254045|843324|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
352147|NCT01254045|843325|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
352148|NCT01254045|843320|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
352149|NCT01254045|843321|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
352150|NCT01254045|843322|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
352151|NCT01254045|843323|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
352152|NCT01254045|843324|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
352153|NCT01254045|843325|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
352154|NCT01254045|843320|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
352155|NCT01254045|843321|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
352156|NCT01254045|843322|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
352157|NCT01254045|843323|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
352158|NCT01254045|843324|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
352159|NCT01254045|843325|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
352160|NCT01254045|843320|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
352161|NCT01254045|843321|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
352162|NCT01254045|843322|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
352163|NCT01254045|843323|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
352164|NCT01254045|843324|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
352165|NCT01254045|843325|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
352166|NCT01254045|843320|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
352167|NCT01254045|843321|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
352168|NCT01254045|843322|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
352169|NCT01254045|843323|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
352170|NCT01254045|843324|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
352171|NCT01254045|843325|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
352172|NCT01254045|843320|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
352173|NCT01254045|843321|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
352174|NCT01254045|843322|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
352175|NCT01254045|843323|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
352176|NCT01254045|843324|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
352177|NCT01254045|843325|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
352178|NCT01254045|843320|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
352179|NCT01254045|843321|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
352180|NCT01254045|843322|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
352181|NCT01254045|843323|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
352182|NCT01254045|843324|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
352183|NCT01254045|843325|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
352184|NCT01253980|843338|P2|NOT COMPLETED|Overall Study||0
352185|NCT01253980|843339|P1|NOT COMPLETED|Overall Study||0
352186|NCT01253980|843338|P2|COMPLETED|Overall Study||39
352187|NCT01253980|843339|P1|COMPLETED|Overall Study||35
352188|NCT01253980|843338|P2|STARTED|Overall Study||39
352189|NCT01253980|843339|P1|STARTED|Overall Study||35
352190|NCT01253902|843348|P3|NOT COMPLETED|Overall Study||4
352191|NCT01253902|843349|P2|NOT COMPLETED|Overall Study||2
352192|NCT01253902|843350|P1|NOT COMPLETED|Overall Study||5
352193|NCT01253902|843348|P3|COMPLETED|Overall Study||51
352194|NCT01253902|843349|P2|COMPLETED|Overall Study||51
352195|NCT01253902|843350|P1|COMPLETED|Overall Study||51
352196|NCT01253902|843348|P3|STARTED|Overall Study||55
352197|NCT01253902|843349|P2|STARTED|Overall Study||53
352198|NCT01253902|843350|P1|STARTED|Overall Study||56
352199|NCT01253824|843366|P2|NOT COMPLETED|Overall Study||0
352200|NCT01253824|843367|P1|NOT COMPLETED|Overall Study||0
352201|NCT01253824|843366|P2|COMPLETED|Overall Study||7
352202|NCT01253824|843367|P1|COMPLETED|Overall Study||7
352203|NCT01253824|843366|P2|STARTED|Overall Study||7
352204|NCT01253824|843367|P1|STARTED|Overall Study||7
352205|NCT01253811|843379|P1|NOT COMPLETED|Overall Study||1
352206|NCT01253811|843379|P1|COMPLETED|Overall Study||5
352207|NCT01253811|843379|P1|Exposed|Overall Study||6
352208|NCT01253811|843379|P1|STARTED|Overall Study||6
352209|NCT01253577|843398|P1|NOT COMPLETED|Overall Study||3
352210|NCT01253577|843398|P1|COMPLETED|Overall Study||102
352211|NCT01253577|843398|P1|STARTED|Overall Study||105
352212|NCT01253564|843406|P1|NOT COMPLETED|Overall Study||24
352213|NCT01253564|843406|P1|COMPLETED|Overall Study||0
352214|NCT01253564|843406|P1|STARTED|Overall Study||24
352215|NCT01253525|843423|P1|NOT COMPLETED|Overall Study||0
352216|NCT01253525|843423|P1|COMPLETED|Overall Study||6
352217|NCT01253525|843423|P1|Received Any Quantity of Study Drug|Overall Study||6
352218|NCT01253525|843423|P1|STARTED|Overall Study||6
352219|NCT01253447|843450|P1|NOT COMPLETED|Overall Study||2
352220|NCT01253447|843450|P1|COMPLETED|Overall Study||17
352221|NCT01253447|843450|P1|STARTED|Overall Study||19
352222|NCT01253408|843457|P3|NOT COMPLETED|Overall Study||0
352223|NCT01253408|843458|P2|NOT COMPLETED|Overall Study||1
352224|NCT01253408|843459|P1|NOT COMPLETED|Overall Study||0
352225|NCT01253408|843457|P3|COMPLETED|Overall Study||13
352226|NCT01253408|843458|P2|COMPLETED|Overall Study||12
352227|NCT01253408|843459|P1|COMPLETED|Overall Study||10
352228|NCT01253408|843457|P3|STARTED|Overall Study||13
352229|NCT01253408|843458|P2|STARTED|Overall Study||13
352230|NCT01253408|843459|P1|STARTED|Overall Study||10
352231|NCT01253369|843482|P1|NOT COMPLETED|Overall Study||33
352232|NCT01253369|843482|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
352233|NCT01253369|843482|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
352234|NCT01253369|843482|P1|STARTED|Overall Study||33
352235|NCT01253343|843489|P2|NOT COMPLETED|Overall Study||0
352236|NCT01253343|843490|P1|NOT COMPLETED|Overall Study||0
352237|NCT01253343|843489|P2|COMPLETED|Overall Study||8
352238|NCT01253343|843490|P1|COMPLETED|Overall Study||9
352239|NCT01253343|843489|P2|STARTED|Overall Study||8
352240|NCT01253343|843490|P1|STARTED|Overall Study||9
352241|NCT01253304|843516|P4|NOT COMPLETED|Overall Study||1
352242|NCT01253304|843517|P3|NOT COMPLETED|Overall Study||0
352243|NCT01253304|843518|P2|NOT COMPLETED|Overall Study||0
352244|NCT01253304|843519|P1|NOT COMPLETED|Overall Study||0
352245|NCT01253304|843516|P4|COMPLETED|Overall Study||2
352246|NCT01253304|843517|P3|COMPLETED|Overall Study||6
352247|NCT01253304|843518|P2|COMPLETED|Overall Study||6
352248|NCT01253304|843519|P1|COMPLETED|Overall Study||11
352249|NCT01253304|843516|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
352250|NCT01253304|843517|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
352251|NCT01253304|843518|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
352252|NCT01253304|843519|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
352253|NCT01253304|843516|P4|STARTED|Overall Study||3
352254|NCT01253304|843517|P3|STARTED|Overall Study||6
352255|NCT01253304|843518|P2|STARTED|Overall Study||6
352256|NCT01253304|843519|P1|STARTED|Overall Study||11
352257|NCT01253265|843558|P5|NOT COMPLETED|Overall Study||1
352258|NCT01253265|843559|P4|NOT COMPLETED|Overall Study||0
352259|NCT01253265|843560|P3|NOT COMPLETED|Overall Study||0
352260|NCT01253265|843561|P2|NOT COMPLETED|Overall Study||0
352261|NCT01253265|843562|P1|NOT COMPLETED|Overall Study||1
352262|NCT01253265|843558|P5|COMPLETED|Overall Study||7
352263|NCT01253265|843559|P4|COMPLETED|Overall Study||6
352264|NCT01253265|843560|P3|COMPLETED|Overall Study||6
352265|NCT01253265|843561|P2|COMPLETED|Overall Study||6
352266|NCT01253265|843562|P1|COMPLETED|Overall Study||5
352267|NCT01253265|843558|P5|STARTED|Overall Study||8
352268|NCT01253265|843559|P4|STARTED|Overall Study||6
352269|NCT01253265|843560|P3|STARTED|Overall Study||6
352270|NCT01253265|843561|P2|STARTED|Overall Study||6
352271|NCT01253265|843562|P1|STARTED|Overall Study||6
352272|NCT01253187|843606|P6|NOT COMPLETED|Period 3||0
352273|NCT01253187|843607|P5|NOT COMPLETED|Period 3||1
352274|NCT01253187|843608|P4|NOT COMPLETED|Period 3||0
352275|NCT01253187|843609|P3|NOT COMPLETED|Period 3||0
352276|NCT01253187|843610|P2|NOT COMPLETED|Period 3||1
352277|NCT01253187|843611|P1|NOT COMPLETED|Period 3||1
352278|NCT01253187|843606|P6|COMPLETED|Period 3||6
352279|NCT01253187|843607|P5|COMPLETED|Period 3||7
352280|NCT01253187|843608|P4|COMPLETED|Period 3||7
352281|NCT01253187|843609|P3|COMPLETED|Period 3||7
352282|NCT01253187|843610|P2|COMPLETED|Period 3||7
352283|NCT01253187|843611|P1|COMPLETED|Period 3||6
352284|NCT01253187|843606|P6|STARTED|Period 3||6
352285|NCT01253187|843607|P5|STARTED|Period 3||8
352286|NCT01253187|843608|P4|STARTED|Period 3||7
352287|NCT01253187|843609|P3|STARTED|Period 3||7
352288|NCT01253187|843610|P2|STARTED|Period 3||8
352289|NCT01253187|843611|P1|STARTED|Period 3||7
352290|NCT01253187|843606|P6|NOT COMPLETED|Period 2||0
352291|NCT01253187|843607|P5|NOT COMPLETED|Period 2||1
352292|NCT01253187|843608|P4|NOT COMPLETED|Period 2||0
352293|NCT01253187|843609|P3|NOT COMPLETED|Period 2||0
352294|NCT01253187|843610|P2|NOT COMPLETED|Period 2||0
352295|NCT01253187|843611|P1|NOT COMPLETED|Period 2||0
352296|NCT01253187|843606|P6|COMPLETED|Period 2||6
352297|NCT01253187|843607|P5|COMPLETED|Period 2||8
352298|NCT01253187|843608|P4|COMPLETED|Period 2||7
352299|NCT01253187|843609|P3|COMPLETED|Period 2||7
352300|NCT01253187|843610|P2|COMPLETED|Period 2||8
352301|NCT01253187|843611|P1|COMPLETED|Period 2||7
352302|NCT01253187|843606|P6|STARTED|Period 2||6
352303|NCT01253187|843607|P5|STARTED|Period 2||9
352304|NCT01253187|843608|P4|STARTED|Period 2||7
352305|NCT01253187|843609|P3|STARTED|Period 2||7
352306|NCT01253187|843610|P2|STARTED|Period 2||8
352307|NCT01253187|843611|P1|STARTED|Period 2||7
352308|NCT01253187|843606|P6|NOT COMPLETED|Period 1||0
352309|NCT01253187|843607|P5|NOT COMPLETED|Period 1||0
352310|NCT01253187|843608|P4|NOT COMPLETED|Period 1||0
352311|NCT01253187|843609|P3|NOT COMPLETED|Period 1||0
352312|NCT01253187|843610|P2|NOT COMPLETED|Period 1||0
352313|NCT01253187|843611|P1|NOT COMPLETED|Period 1||0
352314|NCT01253187|843606|P6|COMPLETED|Period 1||6
352315|NCT01253187|843607|P5|COMPLETED|Period 1||9
352316|NCT01253187|843608|P4|COMPLETED|Period 1||7
352317|NCT01253187|843609|P3|COMPLETED|Period 1||7
352318|NCT01253187|843610|P2|COMPLETED|Period 1||8
352319|NCT01253187|843611|P1|COMPLETED|Period 1||7
352320|NCT01253187|843606|P6|STARTED|Period 1||6
352321|NCT01253187|843607|P5|STARTED|Period 1||9
352322|NCT01253187|843608|P4|STARTED|Period 1||7
352323|NCT01253187|843609|P3|STARTED|Period 1||7
352324|NCT01253187|843610|P2|STARTED|Period 1||8
352325|NCT01253187|843611|P1|STARTED|Period 1||7
352326|NCT01253174|843640|P6|NOT COMPLETED|Period 3||0
352327|NCT01253174|843641|P5|NOT COMPLETED|Period 3||1
352328|NCT01253174|843642|P4|NOT COMPLETED|Period 3||0
352329|NCT01253174|843643|P3|NOT COMPLETED|Period 3||1
352330|NCT01253174|843644|P2|NOT COMPLETED|Period 3||1
352331|NCT01253174|843645|P1|NOT COMPLETED|Period 3||0
352332|NCT01253174|843640|P6|COMPLETED|Period 3||7
352333|NCT01253174|843641|P5|COMPLETED|Period 3||7
352334|NCT01253174|843642|P4|COMPLETED|Period 3||7
352335|NCT01253174|843643|P3|COMPLETED|Period 3||6
352336|NCT01253174|843644|P2|COMPLETED|Period 3||8
352337|NCT01253174|843645|P1|COMPLETED|Period 3||6
352338|NCT01253174|843640|P6|STARTED|Period 3||7
352339|NCT01253174|843641|P5|STARTED|Period 3||8
352340|NCT01253174|843642|P4|STARTED|Period 3||7
352341|NCT01253174|843643|P3|STARTED|Period 3||7
352342|NCT01253174|843644|P2|STARTED|Period 3||9
352343|NCT01253174|843645|P1|STARTED|Period 3||6
352344|NCT01253174|843640|P6|NOT COMPLETED|Period 2||0
352345|NCT01253174|843641|P5|NOT COMPLETED|Period 2||0
352346|NCT01253174|843642|P4|NOT COMPLETED|Period 2||0
352347|NCT01253174|843643|P3|NOT COMPLETED|Period 2||1
352348|NCT01253174|843644|P2|NOT COMPLETED|Period 2||0
352349|NCT01253174|843645|P1|NOT COMPLETED|Period 2||0
352350|NCT01253174|843640|P6|COMPLETED|Period 2||7
352351|NCT01253174|843641|P5|COMPLETED|Period 2||8
352352|NCT01253174|843642|P4|COMPLETED|Period 2||7
352353|NCT01253174|843643|P3|COMPLETED|Period 2||7
352354|NCT01253174|843644|P2|COMPLETED|Period 2||9
352355|NCT01253174|843645|P1|COMPLETED|Period 2||6
352356|NCT01253174|843640|P6|STARTED|Period 2||7
352357|NCT01253174|843641|P5|STARTED|Period 2||8
352358|NCT01253174|843642|P4|STARTED|Period 2||7
352359|NCT01253174|843643|P3|STARTED|Period 2||8
352360|NCT01253174|843644|P2|STARTED|Period 2||9
352361|NCT01253174|843645|P1|STARTED|Period 2||6
352362|NCT01253174|843640|P6|NOT COMPLETED|Period 1||0
352363|NCT01253174|843641|P5|NOT COMPLETED|Period 1||1
352364|NCT01253174|843642|P4|NOT COMPLETED|Period 1||0
352365|NCT01253174|843643|P3|NOT COMPLETED|Period 1||1
352366|NCT01253174|843644|P2|NOT COMPLETED|Period 1||1
352367|NCT01253174|843645|P1|NOT COMPLETED|Period 1||0
352368|NCT01253174|843640|P6|COMPLETED|Period 1||7
352369|NCT01253174|843641|P5|COMPLETED|Period 1||8
352370|NCT01253174|843642|P4|COMPLETED|Period 1||7
352371|NCT01253174|843643|P3|COMPLETED|Period 1||8
352372|NCT01253174|843644|P2|COMPLETED|Period 1||9
352373|NCT01253174|843645|P1|COMPLETED|Period 1||6
352374|NCT01253174|843640|P6|STARTED|Period 1||7
352375|NCT01253174|843641|P5|STARTED|Period 1||9
352376|NCT01253174|843642|P4|STARTED|Period 1||7
352377|NCT01253174|843643|P3|STARTED|Period 1||9
352378|NCT01253174|843644|P2|STARTED|Period 1||10
352379|NCT01253174|843645|P1|STARTED|Period 1||6
352380|NCT01253148|843674|P1|NOT COMPLETED|Overall Study||0
352381|NCT01253148|843674|P1|COMPLETED|Overall Study||25
352382|NCT01253148|843674|P1|STARTED|Overall Study||25
352383|NCT01253135|843680|P1|NOT COMPLETED|Amended Protocol||1
352384|NCT01253135|843680|P1|COMPLETED|Amended Protocol||24
352385|NCT01253135|843680|P1|STARTED|Amended Protocol||25
352386|NCT01253135|843680|P1|NOT COMPLETED|Original Protocol||15
352387|NCT01253135|843680|P1|COMPLETED|Original Protocol||0
352388|NCT01253135|843680|P1|STARTED|Original Protocol||15
352389|NCT01253070|843688|P1|NOT COMPLETED|Overall Study||0
352390|NCT01253070|843688|P1|COMPLETED|Overall Study||54
352391|NCT01253070|843688|P1|STARTED|Overall Study||54
352392|NCT01253044|843699|P2|NOT COMPLETED|Overall Study||29
352393|NCT01253044|843700|P1|NOT COMPLETED|Overall Study||38
352394|NCT01253044|843699|P2|COMPLETED|Overall Study||51
352395|NCT01253044|843700|P1|COMPLETED|Overall Study||42
352396|NCT01253044|843699|P2|STARTED|Overall Study||80
352397|NCT01253044|843700|P1|STARTED|Overall Study||80
352398|NCT01253018|843710|P2|NOT COMPLETED|Overall Study||2
352399|NCT01253018|843711|P1|NOT COMPLETED|Overall Study||4
352400|NCT01253018|843710|P2|COMPLETED|Overall Study||21
352401|NCT01253018|843711|P1|COMPLETED|Overall Study||18
352402|NCT01253018|843710|P2|STARTED|Overall Study||23
352403|NCT01253018|843711|P1|STARTED|Overall Study||22
352404|NCT01252966|843725|P2|NOT COMPLETED|Overall Study||13
352405|NCT01252966|843726|P1|NOT COMPLETED|Overall Study||23
352406|NCT01252966|843725|P2|COMPLETED|Overall Study||92
352407|NCT01252966|843726|P1|COMPLETED|Overall Study||85
352408|NCT01252966|843725|P2|STARTED|Overall Study||105
352409|NCT01252966|843726|P1|STARTED|Overall Study||108
352410|NCT01252940|843742|P2|NOT COMPLETED|Extension Phase||3
352411|NCT01252940|843743|P1|NOT COMPLETED|Extension Phase||10
352412|NCT01252940|843742|P2|COMPLETED|Extension Phase||46
352413|NCT01252940|843743|P1|COMPLETED|Extension Phase||100
352414|NCT01252940|843742|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
352415|NCT01252940|843743|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
352416|NCT01252940|843742|P2|NOT COMPLETED|Main Study Phase||12
352417|NCT01252940|843743|P1|NOT COMPLETED|Main Study Phase||26
352418|NCT01252940|843742|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
352419|NCT01252940|843743|P1|COMPLETED|Main Study Phase||295
352420|NCT01252940|843742|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
352421|NCT01252940|843743|P1|Completed 24 Weeks|Main Study Phase||0
352422|NCT01252940|843742|P2|STARTED|Main Study Phase||161
352423|NCT01252940|843743|P1|STARTED|Main Study Phase||321
352424|NCT01252810|843774|P2|NOT COMPLETED|Overall Study||3
352425|NCT01252810|843775|P1|NOT COMPLETED|Overall Study||14
352426|NCT01252810|843774|P2|COMPLETED|Overall Study||139
352427|NCT01252810|843775|P1|COMPLETED|Overall Study||128
352428|NCT01252810|843774|P2|STARTED|Overall Study||142
352429|NCT01252810|843775|P1|STARTED|Overall Study||142
352430|NCT01252355|843788|P3|NOT COMPLETED|Overall Study||179
352431|NCT01252355|843789|P2|NOT COMPLETED|Overall Study||178
352432|NCT01252355|843790|P1|NOT COMPLETED|Overall Study||177
352433|NCT01252355|843788|P3|COMPLETED|Overall Study||0
352434|NCT01252355|843789|P2|COMPLETED|Overall Study||0
352435|NCT01252355|843790|P1|COMPLETED|Overall Study||0
352436|NCT01252355|843788|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
352437|NCT01252355|843789|P2|Treated|Overall Study||178
352438|NCT01252355|843790|P1|Treated|Overall Study||175
352439|NCT01252355|843788|P3|STARTED|Overall Study|Randomized.|179
352440|NCT01252355|843789|P2|STARTED|Overall Study|Randomized.|178
352441|NCT01252355|843790|P1|STARTED|Overall Study|Randomized.|177
352442|NCT01252290|843828|P1|NOT COMPLETED|Overall Study||1
352443|NCT01252290|843828|P1|COMPLETED|Overall Study||34
352444|NCT01252290|843828|P1|STARTED|Overall Study||35
352445|NCT01252277|843836|P1|NOT COMPLETED|Overall Study||2
352446|NCT01252277|843836|P1|COMPLETED|Overall Study||34
352447|NCT01252277|843836|P1|STARTED|Overall Study||36
352448|NCT01252238|843847|P3|NOT COMPLETED|Overall Study||4
352449|NCT01252238|843848|P2|NOT COMPLETED|Overall Study||4
352450|NCT01252238|843849|P1|NOT COMPLETED|Overall Study||4
352451|NCT01252238|843847|P3|COMPLETED|Overall Study|sponsor terminated study|4
352452|NCT01252238|843848|P2|COMPLETED|Overall Study|sponsor terminated study|4
352453|NCT01252238|843849|P1|COMPLETED|Overall Study|sponsor terminated study|4
352454|NCT01252238|843847|P3|STARTED|Overall Study||8
352455|NCT01252238|843848|P2|STARTED|Overall Study||8
352456|NCT01252238|843849|P1|STARTED|Overall Study||8
352457|NCT01252186|843860|P3|NOT COMPLETED|Overall Study||34
352458|NCT01252186|843861|P2|NOT COMPLETED|Overall Study||32
352459|NCT01252186|843862|P1|NOT COMPLETED|Overall Study||30
352460|NCT01252186|843860|P3|COMPLETED|Overall Study||53
352461|NCT01252186|843861|P2|COMPLETED|Overall Study||59
352462|NCT01252186|843862|P1|COMPLETED|Overall Study||57
352463|NCT01252186|843860|P3|Received Study Drug|Overall Study||80
352464|NCT01252186|843861|P2|Received Study Drug|Overall Study||89
352465|NCT01252186|843862|P1|Received Study Drug|Overall Study||83
352466|NCT01252186|843860|P3|STARTED|Overall Study||87
352467|NCT01252186|843861|P2|STARTED|Overall Study||91
352468|NCT01252186|843862|P1|STARTED|Overall Study||87
352469|NCT01252147|843930|P1|NOT COMPLETED|Overall Study||0
352470|NCT01252147|843930|P1|COMPLETED|Overall Study||68
352471|NCT01252147|843930|P1|STARTED|Overall Study||68
352472|NCT01252134|843935|P6|NOT COMPLETED|Period 3, 8 Hours||0
352473|NCT01252134|843936|P5|NOT COMPLETED|Period 3, 8 Hours||0
352474|NCT01252134|843937|P4|NOT COMPLETED|Period 3, 8 Hours||0
352475|NCT01252134|843938|P3|NOT COMPLETED|Period 3, 8 Hours||0
352476|NCT01252134|843939|P2|NOT COMPLETED|Period 3, 8 Hours||0
352477|NCT01252134|843940|P1|NOT COMPLETED|Period 3, 8 Hours||0
352478|NCT01252134|843935|P6|COMPLETED|Period 3, 8 Hours||4
352479|NCT01252134|843936|P5|COMPLETED|Period 3, 8 Hours||3
352480|NCT01252134|843937|P4|COMPLETED|Period 3, 8 Hours||5
352481|NCT01252134|843938|P3|COMPLETED|Period 3, 8 Hours||2
352482|NCT01252134|843939|P2|COMPLETED|Period 3, 8 Hours||3
352483|NCT01252134|843940|P1|COMPLETED|Period 3, 8 Hours||3
352484|NCT01252134|843935|P6|STARTED|Period 3, 8 Hours||4
352485|NCT01252134|843936|P5|STARTED|Period 3, 8 Hours||3
352486|NCT01252134|843937|P4|STARTED|Period 3, 8 Hours||5
352487|NCT01252134|843938|P3|STARTED|Period 3, 8 Hours||2
352488|NCT01252134|843939|P2|STARTED|Period 3, 8 Hours||3
352489|NCT01252134|843940|P1|STARTED|Period 3, 8 Hours||3
352490|NCT01252134|843935|P6|NOT COMPLETED|Period 2, 8 Hours||0
352491|NCT01252134|843936|P5|NOT COMPLETED|Period 2, 8 Hours||0
352492|NCT01252134|843937|P4|NOT COMPLETED|Period 2, 8 Hours||0
352493|NCT01252134|843938|P3|NOT COMPLETED|Period 2, 8 Hours||0
352494|NCT01252134|843939|P2|NOT COMPLETED|Period 2, 8 Hours||0
352495|NCT01252134|843940|P1|NOT COMPLETED|Period 2, 8 Hours||0
352496|NCT01252134|843935|P6|COMPLETED|Period 2, 8 Hours||4
352497|NCT01252134|843936|P5|COMPLETED|Period 2, 8 Hours||3
352498|NCT01252134|843937|P4|COMPLETED|Period 2, 8 Hours||5
352499|NCT01252134|843938|P3|COMPLETED|Period 2, 8 Hours||2
352500|NCT01252134|843939|P2|COMPLETED|Period 2, 8 Hours||3
352501|NCT01252134|843940|P1|COMPLETED|Period 2, 8 Hours||3
352502|NCT01252134|843935|P6|STARTED|Period 2, 8 Hours||4
352503|NCT01252134|843936|P5|STARTED|Period 2, 8 Hours||3
352504|NCT01252134|843937|P4|STARTED|Period 2, 8 Hours||5
352505|NCT01252134|843938|P3|STARTED|Period 2, 8 Hours||2
352506|NCT01252134|843939|P2|STARTED|Period 2, 8 Hours||3
352507|NCT01252134|843940|P1|STARTED|Period 2, 8 Hours||3
352508|NCT01252134|843935|P6|NOT COMPLETED|Period 1, 8 Hours||0
352509|NCT01252134|843936|P5|NOT COMPLETED|Period 1, 8 Hours||0
352510|NCT01252134|843937|P4|NOT COMPLETED|Period 1, 8 Hours||0
352511|NCT01252134|843938|P3|NOT COMPLETED|Period 1, 8 Hours||1
352512|NCT01252134|843939|P2|NOT COMPLETED|Period 1, 8 Hours||1
352513|NCT01252134|843940|P1|NOT COMPLETED|Period 1, 8 Hours||0
352514|NCT01252134|843935|P6|COMPLETED|Period 1, 8 Hours||4
352515|NCT01252134|843936|P5|COMPLETED|Period 1, 8 Hours||3
352516|NCT01252134|843937|P4|COMPLETED|Period 1, 8 Hours||5
352517|NCT01252134|843938|P3|COMPLETED|Period 1, 8 Hours||2
352518|NCT01252134|843939|P2|COMPLETED|Period 1, 8 Hours||3
352519|NCT01252134|843940|P1|COMPLETED|Period 1, 8 Hours||3
352520|NCT01252134|843935|P6|STARTED|Period 1, 8 Hours||4
352521|NCT01252134|843936|P5|STARTED|Period 1, 8 Hours||3
352522|NCT01252134|843937|P4|STARTED|Period 1, 8 Hours||5
352523|NCT01252134|843938|P3|STARTED|Period 1, 8 Hours||3
352524|NCT01252134|843939|P2|STARTED|Period 1, 8 Hours||4
352525|NCT01252134|843940|P1|STARTED|Period 1, 8 Hours||3
352526|NCT01252095|843959|P2|NOT COMPLETED|Overall Study||0
352527|NCT01252095|843960|P1|NOT COMPLETED|Overall Study||1
352528|NCT01252095|843959|P2|COMPLETED|Overall Study||1
352529|NCT01252095|843960|P1|COMPLETED|Overall Study||2
352530|NCT01252095|843959|P2|STARTED|Overall Study||1
352531|NCT01252095|843960|P1|STARTED|Overall Study||3
352532|NCT01251978|843968|P2|NOT COMPLETED|Overall Study||0
352533|NCT01251978|843969|P1|NOT COMPLETED|Overall Study||0
352534|NCT01251978|843968|P2|COMPLETED|Overall Study||3
352535|NCT01251978|843969|P1|COMPLETED|Overall Study||5
352536|NCT01251978|843968|P2|STARTED|Overall Study||3
352537|NCT01251978|843969|P1|STARTED|Overall Study||5
352538|NCT01251952|843978|P1|NOT COMPLETED|Overall Study||1
352539|NCT01251952|843978|P1|COMPLETED|Overall Study||1
352540|NCT01251952|843978|P1|STARTED|Overall Study||2
352541|NCT01251770|843984|P2|NOT COMPLETED|Overall Study||7
352542|NCT01251770|843985|P1|NOT COMPLETED|Overall Study||13
352543|NCT01251770|843984|P2|COMPLETED|Overall Study||29
352544|NCT01251770|843985|P1|COMPLETED|Overall Study||29
352545|NCT01251770|843984|P2|STARTED|Overall Study||36
352546|NCT01251770|843985|P1|STARTED|Overall Study||42
352547|NCT01251757|843996|P3|NOT COMPLETED|Overall Study||0
352548|NCT01251757|843997|P2|NOT COMPLETED|Overall Study||0
352549|NCT01251757|843998|P1|NOT COMPLETED|Overall Study||0
352550|NCT01251757|843996|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
352551|NCT01251757|843997|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
352552|NCT01251757|843998|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
352553|NCT01251757|843996|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
352640|NCT01251146|844349|P1|STARTED|Overall Study||86
352554|NCT01251757|843997|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
352555|NCT01251757|843998|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
352556|NCT01251653|844036|P9|NOT COMPLETED|Overall Study||6
352557|NCT01251653|844037|P8|NOT COMPLETED|Overall Study||12
352558|NCT01251653|844038|P7|NOT COMPLETED|Overall Study||18
352559|NCT01251653|844039|P6|NOT COMPLETED|Overall Study||18
352560|NCT01251653|844040|P5|NOT COMPLETED|Overall Study||2
352561|NCT01251653|844041|P4|NOT COMPLETED|Overall Study||6
352562|NCT01251653|844042|P3|NOT COMPLETED|Overall Study||20
352563|NCT01251653|844043|P2|NOT COMPLETED|Overall Study||8
352564|NCT01251653|844044|P1|NOT COMPLETED|Overall Study||3
352565|NCT01251653|844036|P9|COMPLETED|Overall Study||0
352566|NCT01251653|844037|P8|COMPLETED|Overall Study||0
352567|NCT01251653|844038|P7|COMPLETED|Overall Study||0
352568|NCT01251653|844039|P6|COMPLETED|Overall Study||0
352569|NCT01251653|844040|P5|COMPLETED|Overall Study||0
352570|NCT01251653|844041|P4|COMPLETED|Overall Study||0
352571|NCT01251653|844042|P3|COMPLETED|Overall Study||0
352572|NCT01251653|844043|P2|COMPLETED|Overall Study||0
352573|NCT01251653|844044|P1|COMPLETED|Overall Study||0
352574|NCT01251653|844036|P9|STARTED|Overall Study||6
352575|NCT01251653|844037|P8|STARTED|Overall Study||12
352576|NCT01251653|844038|P7|STARTED|Overall Study||18
352577|NCT01251653|844039|P6|STARTED|Overall Study||18
352578|NCT01251653|844040|P5|STARTED|Overall Study||2
352579|NCT01251653|844041|P4|STARTED|Overall Study||6
352580|NCT01251653|844042|P3|STARTED|Overall Study||20
352581|NCT01251653|844043|P2|STARTED|Overall Study||8
352582|NCT01251653|844044|P1|STARTED|Overall Study||3
352583|NCT01251614|844172|P3|NOT COMPLETED|Overall Study||8
352584|NCT01251614|844173|P2|NOT COMPLETED|Overall Study||13
352585|NCT01251614|844174|P1|NOT COMPLETED|Overall Study||3
352586|NCT01251614|844172|P3|COMPLETED|Overall Study||30
352587|NCT01251614|844173|P2|COMPLETED|Overall Study||26
352588|NCT01251614|844174|P1|COMPLETED|Overall Study||34
352589|NCT01251614|844172|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
352590|NCT01251614|844173|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
352591|NCT01251614|844174|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
352592|NCT01251614|844172|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
352593|NCT01251614|844173|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
352594|NCT01251614|844174|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
352595|NCT01251614|844172|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
352596|NCT01251614|844173|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
352597|NCT01251614|844174|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
352598|NCT01251614|844172|P3|STARTED|Overall Study||38
352599|NCT01251614|844173|P2|STARTED|Overall Study||39
352600|NCT01251614|844174|P1|STARTED|Overall Study||37
352601|NCT01251588|844248|P2|NOT COMPLETED|Overall Study||4
352602|NCT01251588|844249|P1|NOT COMPLETED|Overall Study||0
352603|NCT01251588|844248|P2|COMPLETED|Overall Study||59
352604|NCT01251588|844249|P1|COMPLETED|Overall Study||65
352605|NCT01251588|844248|P2|STARTED|Overall Study||63
352606|NCT01251588|844249|P1|STARTED|Overall Study||65
352607|NCT01251380|844281|P1|NOT COMPLETED|Overall Study||22
352608|NCT01251380|844281|P1|COMPLETED|Overall Study||194
352609|NCT01251380|844281|P1|Cycle 4|Overall Study||11
352610|NCT01251380|844281|P1|Cycle 3|Overall Study||86
352611|NCT01251380|844281|P1|Cycle 2|Overall Study||175
352612|NCT01251380|844281|P1|Cycle 1|Overall Study||207
352613|NCT01251380|844281|P1|STARTED|Overall Study|Safety population.|216
352614|NCT01251354|844305|P1|NOT COMPLETED|Overall Study||6
352615|NCT01251354|844305|P1|COMPLETED|Overall Study||0
352616|NCT01251354|844305|P1|STARTED|Overall Study||6
352617|NCT01251315|844321|P6|NOT COMPLETED|Overall Study||0
352618|NCT01251315|844322|P5|NOT COMPLETED|Overall Study||0
352619|NCT01251315|844323|P4|NOT COMPLETED|Overall Study||0
352620|NCT01251315|844324|P3|NOT COMPLETED|Overall Study||0
352621|NCT01251315|844325|P2|NOT COMPLETED|Overall Study||0
352622|NCT01251315|844326|P1|NOT COMPLETED|Overall Study||0
352623|NCT01251315|844321|P6|COMPLETED|Overall Study||4
352624|NCT01251315|844322|P5|COMPLETED|Overall Study||4
352625|NCT01251315|844323|P4|COMPLETED|Overall Study||4
352626|NCT01251315|844324|P3|COMPLETED|Overall Study||4
352627|NCT01251315|844325|P2|COMPLETED|Overall Study||4
352628|NCT01251315|844326|P1|COMPLETED|Overall Study||4
352629|NCT01251315|844321|P6|STARTED|Overall Study||4
352630|NCT01251315|844322|P5|STARTED|Overall Study||4
352631|NCT01251315|844323|P4|STARTED|Overall Study||4
352632|NCT01251315|844324|P3|STARTED|Overall Study||4
352633|NCT01251315|844325|P2|STARTED|Overall Study||4
352634|NCT01251315|844326|P1|STARTED|Overall Study||4
352635|NCT01251146|844348|P2|NOT COMPLETED|Overall Study||10
352636|NCT01251146|844349|P1|NOT COMPLETED|Overall Study||3
352637|NCT01251146|844348|P2|COMPLETED|Overall Study||81
352638|NCT01251146|844349|P1|COMPLETED|Overall Study||83
352639|NCT01251146|844348|P2|STARTED|Overall Study||91
352641|NCT01251120|844371|P2|NOT COMPLETED|Overall Study||1
352642|NCT01251120|844372|P1|NOT COMPLETED|Overall Study||0
352643|NCT01251120|844371|P2|COMPLETED|Overall Study||0
352644|NCT01251120|844372|P1|COMPLETED|Overall Study||1
352645|NCT01251120|844371|P2|STARTED|Overall Study||1
352646|NCT01251120|844372|P1|STARTED|Overall Study||1
352647|NCT01251042|844394|P2|NOT COMPLETED|Overall Study||0
352648|NCT01251042|844395|P1|NOT COMPLETED|Overall Study||0
352649|NCT01251042|844394|P2|COMPLETED|Overall Study||23
352650|NCT01251042|844395|P1|COMPLETED|Overall Study||26
352651|NCT01251042|844394|P2|STARTED|Overall Study||23
352652|NCT01251042|844395|P1|STARTED|Overall Study||26
352653|NCT01250990|844427|P2|NOT COMPLETED|Overall Study||2
352654|NCT01250990|844428|P1|NOT COMPLETED|Overall Study||4
352655|NCT01250990|844427|P2|COMPLETED|Overall Study||9
352656|NCT01250990|844428|P1|COMPLETED|Overall Study||7
352657|NCT01250990|844427|P2|STARTED|Overall Study||11
352658|NCT01250990|844428|P1|STARTED|Overall Study||11
352659|NCT01250925|844437|P3|NOT COMPLETED|Overall Study||2
352660|NCT01250925|844438|P2|NOT COMPLETED|Overall Study||3
352661|NCT01250925|844439|P1|NOT COMPLETED|Overall Study||5
352662|NCT01250925|844437|P3|COMPLETED|Overall Study||30
352663|NCT01250925|844438|P2|COMPLETED|Overall Study||28
352664|NCT01250925|844439|P1|COMPLETED|Overall Study||26
352665|NCT01250925|844437|P3|STARTED|Overall Study||32
352666|NCT01250925|844438|P2|STARTED|Overall Study||31
352667|NCT01250925|844439|P1|STARTED|Overall Study||31
352668|NCT01250899|844479|P2|NOT COMPLETED|Overall Study||0
352669|NCT01250899|844480|P1|NOT COMPLETED|Overall Study||0
352670|NCT01250899|844479|P2|COMPLETED|Overall Study||82
352671|NCT01250899|844480|P1|COMPLETED|Overall Study||40
352672|NCT01250899|844479|P2|STARTED|Overall Study||82
352673|NCT01250899|844480|P1|STARTED|Overall Study||40
352674|NCT01250834|844484|P1|NOT COMPLETED|Overall Study||0
352675|NCT01250834|844484|P1|COMPLETED|Overall Study||27
352676|NCT01250834|844484|P1|STARTED|Overall Study||27
352677|NCT01250769|844505|P4|NOT COMPLETED|Overall Study||0
352678|NCT01250769|844506|P3|NOT COMPLETED|Overall Study||2
352679|NCT01250769|844507|P2|NOT COMPLETED|Overall Study||1
352680|NCT01250769|844508|P1|NOT COMPLETED|Overall Study||0
352681|NCT01250769|844505|P4|COMPLETED|Overall Study||11
352682|NCT01250769|844506|P3|COMPLETED|Overall Study||73
352683|NCT01250769|844507|P2|COMPLETED|Overall Study||72
352684|NCT01250769|844508|P1|COMPLETED|Overall Study||11
352685|NCT01250769|844505|P4|Day 14|Overall Study||11
352686|NCT01250769|844506|P3|Day 14|Overall Study||74
352687|NCT01250769|844507|P2|Day 14|Overall Study||72
352688|NCT01250769|844508|P1|Day 14|Overall Study||11
352689|NCT01250769|844505|P4|STARTED|Overall Study||11
352690|NCT01250769|844506|P3|STARTED|Overall Study||75
352691|NCT01250769|844507|P2|STARTED|Overall Study||73
352692|NCT01250769|844508|P1|STARTED|Overall Study||11
352693|NCT01250756|844540|P2|NOT COMPLETED|After Toddler Dose||1
352694|NCT01250756|844541|P1|NOT COMPLETED|After Toddler Dose||0
352695|NCT01250756|844540|P2|COMPLETED|After Toddler Dose||147
352696|NCT01250756|844541|P1|COMPLETED|After Toddler Dose||0
352697|NCT01250756|844540|P2|STARTED|After Toddler Dose||148
352698|NCT01250756|844541|P1|STARTED|After Toddler Dose||0
352699|NCT01250756|844540|P2|NOT COMPLETED|Toddler Dose||1
352700|NCT01250756|844541|P1|NOT COMPLETED|Toddler Dose||0
352701|NCT01250756|844540|P2|COMPLETED|Toddler Dose||148
352702|NCT01250756|844541|P1|COMPLETED|Toddler Dose||122
352703|NCT01250756|844540|P2|STARTED|Toddler Dose||149
352704|NCT01250756|844541|P1|STARTED|Toddler Dose||122
352705|NCT01250756|844540|P2|NOT COMPLETED|After Infant Series||4
352706|NCT01250756|844541|P1|NOT COMPLETED|After Infant Series||11
352707|NCT01250756|844540|P2|COMPLETED|After Infant Series||149
352708|NCT01250756|844541|P1|COMPLETED|After Infant Series||122
352709|NCT01250756|844540|P2|STARTED|After Infant Series||153
352710|NCT01250756|844541|P1|STARTED|After Infant Series||133
352711|NCT01250756|844540|P2|NOT COMPLETED|Infant Series||7
352712|NCT01250756|844541|P1|NOT COMPLETED|Infant Series||28
352713|NCT01250756|844540|P2|COMPLETED|Infant Series||153
352714|NCT01250756|844541|P1|COMPLETED|Infant Series||133
352715|NCT01250756|844540|P2|Vaccinated Dose 3|Infant Series||155
352716|NCT01250756|844541|P1|Vaccinated Dose 3|Infant Series||133
352717|NCT01250756|844540|P2|Vaccinated Dose 2|Infant Series||157
352718|NCT01250756|844541|P1|Vaccinated Dose 2|Infant Series||147
352719|NCT01250756|844540|P2|Vaccinated Dose 1|Infant Series||158
352720|NCT01250756|844541|P1|Vaccinated Dose 1|Infant Series||159
352721|NCT01250756|844540|P2|STARTED|Infant Series||160
352722|NCT01250756|844541|P1|STARTED|Infant Series||161
352723|NCT01250730|844594|P3|NOT COMPLETED|Overall Study||0
352724|NCT01250730|844595|P2|NOT COMPLETED|Overall Study||0
352725|NCT01250730|844596|P1|NOT COMPLETED|Overall Study||0
352726|NCT01250730|844594|P3|COMPLETED|Overall Study||6
352727|NCT01250730|844595|P2|COMPLETED|Overall Study||6
352728|NCT01250730|844596|P1|COMPLETED|Overall Study||6
352729|NCT01250730|844594|P3|STARTED|Overall Study||6
352730|NCT01250730|844595|P2|STARTED|Overall Study||6
352731|NCT01250730|844596|P1|STARTED|Overall Study||6
352732|NCT01250717|844652|P1|NOT COMPLETED|Overall Study||0
352733|NCT01250717|844652|P1|COMPLETED|Overall Study||28
352734|NCT01250717|844652|P1|STARTED|Overall Study||28
352735|NCT01250509|844658|P2|NOT COMPLETED|Overall Study||2
352736|NCT01250509|844659|P1|NOT COMPLETED|Overall Study||5
352737|NCT01250509|844658|P2|COMPLETED|Overall Study||21
352738|NCT01250509|844659|P1|COMPLETED|Overall Study||19
352739|NCT01250509|844658|P2|STARTED|Overall Study||23
352740|NCT01250509|844659|P1|STARTED|Overall Study||24
352741|NCT01250418|844673|P2|NOT COMPLETED|Overall Study||1
352742|NCT01250418|844674|P1|NOT COMPLETED|Overall Study||1
352743|NCT01250418|844673|P2|COMPLETED|Overall Study||15
352744|NCT01250418|844674|P1|COMPLETED|Overall Study||8
352745|NCT01250418|844673|P2|STARTED|Overall Study||16
352746|NCT01250418|844674|P1|STARTED|Overall Study||9
352747|NCT01250379|844682|P2|NOT COMPLETED|Overall Study||193
352748|NCT01250379|844683|P1|NOT COMPLETED|Overall Study||202
352749|NCT01250379|844682|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
352750|NCT01250379|844683|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
352751|NCT01250379|844682|P2|STARTED|Overall Study||247
352752|NCT01250379|844683|P1|STARTED|Overall Study||247
352753|NCT01250184|844744|P3|NOT COMPLETED|Overall Study||0
352754|NCT01250184|844745|P2|NOT COMPLETED|Overall Study||0
352755|NCT01250184|844746|P1|NOT COMPLETED|Overall Study||0
352756|NCT01250184|844744|P3|COMPLETED|Overall Study||43
352757|NCT01250184|844745|P2|COMPLETED|Overall Study||41
352758|NCT01250184|844746|P1|COMPLETED|Overall Study||43
352759|NCT01250184|844744|P3|STARTED|Overall Study||43
352760|NCT01250184|844745|P2|STARTED|Overall Study||41
352761|NCT01250184|844746|P1|STARTED|Overall Study||43
352762|NCT01250171|844772|P3|NOT COMPLETED|Overall Study||0
352763|NCT01250171|844773|P2|NOT COMPLETED|Overall Study||0
352764|NCT01250171|844774|P1|NOT COMPLETED|Overall Study||1
352765|NCT01250171|844772|P3|COMPLETED|Overall Study||24
352766|NCT01250171|844773|P2|COMPLETED|Overall Study||22
352767|NCT01250171|844774|P1|COMPLETED|Overall Study||25
352768|NCT01250171|844772|P3|STARTED|Overall Study||24
352769|NCT01250171|844773|P2|STARTED|Overall Study||22
352770|NCT01250171|844774|P1|STARTED|Overall Study||26
352771|NCT01250145|844805|P2|NOT COMPLETED|Overall Study||5
352772|NCT01250145|844806|P1|NOT COMPLETED|Overall Study||2
352773|NCT01250145|844805|P2|COMPLETED|Overall Study||205
352774|NCT01250145|844806|P1|COMPLETED|Overall Study||39
352775|NCT01250145|844805|P2|STARTED|Overall Study||210
352776|NCT01250145|844806|P1|STARTED|Overall Study||41
352777|NCT01250119|844826|P2|NOT COMPLETED|Treatment Phase||41
352778|NCT01250119|844827|P1|NOT COMPLETED|Treatment Phase||0
352779|NCT01250119|844826|P2|COMPLETED|Treatment Phase||0
352780|NCT01250119|844827|P1|COMPLETED|Treatment Phase||0
352781|NCT01250119|844826|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
352782|NCT01250119|844827|P1|STARTED|Treatment Phase||0
352783|NCT01250119|844826|P2|NOT COMPLETED|Diagnostic Phase||0
352784|NCT01250119|844827|P1|NOT COMPLETED|Diagnostic Phase||113
352785|NCT01250119|844826|P2|COMPLETED|Diagnostic Phase||0
352786|NCT01250119|844827|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
352787|NCT01250119|844826|P2|STARTED|Diagnostic Phase||0
352788|NCT01250119|844827|P1|STARTED|Diagnostic Phase||688
352789|NCT01250054|844842|P2|NOT COMPLETED|Period 2, One Week of Wear||0
352790|NCT01250054|844843|P1|NOT COMPLETED|Period 2, One Week of Wear||1
352791|NCT01250054|844842|P2|COMPLETED|Period 2, One Week of Wear||8
352792|NCT01250054|844843|P1|COMPLETED|Period 2, One Week of Wear||6
352793|NCT01250054|844842|P2|STARTED|Period 2, One Week of Wear||8
352794|NCT01250054|844843|P1|STARTED|Period 2, One Week of Wear||7
352795|NCT01250054|844842|P2|NOT COMPLETED|Period 1, One Week of Wear||0
352796|NCT01250054|844843|P1|NOT COMPLETED|Period 1, One Week of Wear||0
352797|NCT01250054|844842|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
352798|NCT01250054|844843|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
352799|NCT01250054|844842|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
352800|NCT01250054|844843|P1|STARTED|Period 1, One Week of Wear||8
352801|NCT01250002|844851|P2|NOT COMPLETED|Overall Study||3
352802|NCT01250002|844852|P1|NOT COMPLETED|Overall Study||4
352803|NCT01250002|844851|P2|COMPLETED|Overall Study||32
352804|NCT01250002|844852|P1|COMPLETED|Overall Study||31
352805|NCT01250002|844851|P2|STARTED|Overall Study||35
352806|NCT01250002|844852|P1|STARTED|Overall Study||35
352807|NCT01249872|844866|P6|NOT COMPLETED|Overall Study||0
352808|NCT01249872|844867|P5|NOT COMPLETED|Overall Study||0
352809|NCT01249872|844868|P4|NOT COMPLETED|Overall Study||0
352810|NCT01249872|844869|P3|NOT COMPLETED|Overall Study||0
352811|NCT01249872|844870|P2|NOT COMPLETED|Overall Study||0
352812|NCT01249872|844871|P1|NOT COMPLETED|Overall Study||0
352813|NCT01249872|844866|P6|COMPLETED|Overall Study||16
352814|NCT01249872|844867|P5|COMPLETED|Overall Study||16
352815|NCT01249872|844868|P4|COMPLETED|Overall Study||16
352816|NCT01249872|844869|P3|COMPLETED|Overall Study||16
352817|NCT01249872|844870|P2|COMPLETED|Overall Study||16
352818|NCT01249872|844871|P1|COMPLETED|Overall Study||16
352819|NCT01249872|844866|P6|STARTED|Overall Study||16
352820|NCT01249872|844867|P5|STARTED|Overall Study||16
352821|NCT01249872|844868|P4|STARTED|Overall Study||16
352822|NCT01249872|844869|P3|STARTED|Overall Study||16
352823|NCT01249872|844870|P2|STARTED|Overall Study||16
352824|NCT01249872|844871|P1|STARTED|Overall Study||16
352825|NCT01249833|844917|P2|NOT COMPLETED|Overall Study||1
352826|NCT01249833|844918|P1|NOT COMPLETED|Overall Study||0
352827|NCT01249833|844917|P2|COMPLETED|Overall Study||62
352828|NCT01249833|844918|P1|COMPLETED|Overall Study||59
352829|NCT01249833|844917|P2|STARTED|Overall Study||63
352830|NCT01249833|844918|P1|STARTED|Overall Study||59
352831|NCT01249664|844932|P2|NOT COMPLETED|Overall Study||0
352832|NCT01249664|844933|P1|NOT COMPLETED|Overall Study||6
352833|NCT01249664|844932|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
352834|NCT01249664|844933|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
352835|NCT01249664|844932|P2|Completed 48 Weeks Treatment|Overall Study||24
352836|NCT01249664|844933|P1|Completed 48 Weeks Treatment|Overall Study||78
352837|NCT01249664|844932|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
352838|NCT01249664|844933|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
352839|NCT01249664|844932|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
352840|NCT01249664|844933|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
352841|NCT01249664|844932|P2|Participants Received Treatment|Overall Study|Safety population|31
352842|NCT01249664|844933|P1|Participants Received Treatment|Overall Study|Safety population|91
352843|NCT01249664|844932|P2|STARTED|Overall Study||31
352844|NCT01249664|844933|P1|STARTED|Overall Study||91
352845|NCT01249651|844983|P1|NOT COMPLETED|Overall Study||7
352846|NCT01249651|844983|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
352847|NCT01249651|844983|P1|STARTED|Overall Study|Enrolled|101
352848|NCT01249417|844993|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
352849|NCT01249417|844994|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
352850|NCT01249417|844995|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
352851|NCT01249417|844993|P3|COMPLETED|Treatment Phase - ITT Population||73
352852|NCT01249417|844994|P2|COMPLETED|Treatment Phase - ITT Population||75
352853|NCT01249417|844995|P1|COMPLETED|Treatment Phase - ITT Population||78
352854|NCT01249417|844993|P3|STARTED|Treatment Phase - ITT Population||77
352855|NCT01249417|844994|P2|STARTED|Treatment Phase - ITT Population||79
352856|NCT01249417|844995|P1|STARTED|Treatment Phase - ITT Population||79
352857|NCT01249417|844993|P3|NOT COMPLETED|Randomised Population||4
352858|NCT01249417|844994|P2|NOT COMPLETED|Randomised Population||1
352859|NCT01249417|844995|P1|NOT COMPLETED|Randomised Population||1
352860|NCT01249417|844993|P3|COMPLETED|Randomised Population||77
352861|NCT01249417|844994|P2|COMPLETED|Randomised Population||79
352862|NCT01249417|844995|P1|COMPLETED|Randomised Population||79
352863|NCT01249417|844993|P3|Treated|Randomised Population||79
352864|NCT01249417|844994|P2|Treated|Randomised Population||80
352865|NCT01249417|844995|P1|Treated|Randomised Population||80
352866|NCT01249417|844993|P3|STARTED|Randomised Population||81
352867|NCT01249417|844994|P2|STARTED|Randomised Population||80
352868|NCT01249417|844995|P1|STARTED|Randomised Population||80
352869|NCT01249274|845011|P2|NOT COMPLETED|Overall Study||6
352870|NCT01249274|845012|P1|NOT COMPLETED|Overall Study||4
352871|NCT01249274|845011|P2|COMPLETED|Overall Study||19
352872|NCT01249274|845012|P1|COMPLETED|Overall Study||21
352873|NCT01249274|845011|P2|Completed Post Trial Visit But Not tx|Overall Study||2
352874|NCT01249274|845012|P1|Completed Post Trial Visit But Not tx|Overall Study||1
352875|NCT01249274|845011|P2|Completed Treatment & Post Trial Visit|Overall Study||17
352876|NCT01249274|845012|P1|Completed Treatment & Post Trial Visit|Overall Study||20
352877|NCT01249274|845011|P2|Completed Treatment|Overall Study||19
352878|NCT01249274|845012|P1|Completed Treatment|Overall Study||21
352879|NCT01249274|845011|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
352880|NCT01249274|845012|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
352881|NCT01249261|845038|P2|NOT COMPLETED|Overall Study||0
352882|NCT01249261|845039|P1|NOT COMPLETED|Overall Study||1
352883|NCT01249261|845038|P2|COMPLETED|Overall Study||31
352884|NCT01249261|845039|P1|COMPLETED|Overall Study||29
352885|NCT01249261|845038|P2|STARTED|Overall Study||31
352886|NCT01249261|845039|P1|STARTED|Overall Study||30
352887|NCT01249157|845067|P1|NOT COMPLETED|Overall Study||1
352888|NCT01249157|845067|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
352889|NCT01249157|845067|P1|STARTED|Overall Study||1
352890|NCT01249131|845071|P6|NOT COMPLETED|Third Intervention||0
352891|NCT01249131|845072|P5|NOT COMPLETED|Third Intervention||0
352892|NCT01249131|845073|P4|NOT COMPLETED|Third Intervention||0
352893|NCT01249131|845074|P3|NOT COMPLETED|Third Intervention||0
352894|NCT01249131|845075|P2|NOT COMPLETED|Third Intervention||0
352895|NCT01249131|845076|P1|NOT COMPLETED|Third Intervention||0
352896|NCT01249131|845071|P6|COMPLETED|Third Intervention||4
352897|NCT01249131|845072|P5|COMPLETED|Third Intervention||2
352898|NCT01249131|845073|P4|COMPLETED|Third Intervention||3
352899|NCT01249131|845074|P3|COMPLETED|Third Intervention||4
352900|NCT01249131|845075|P2|COMPLETED|Third Intervention||3
352901|NCT01249131|845076|P1|COMPLETED|Third Intervention||3
352902|NCT01249131|845071|P6|STARTED|Third Intervention||4
352903|NCT01249131|845072|P5|STARTED|Third Intervention||2
352904|NCT01249131|845073|P4|STARTED|Third Intervention||3
352905|NCT01249131|845074|P3|STARTED|Third Intervention||4
352906|NCT01249131|845075|P2|STARTED|Third Intervention||3
352907|NCT01249131|845076|P1|STARTED|Third Intervention||3
352908|NCT01249131|845071|P6|NOT COMPLETED|Washout Period of 10 Days||0
352909|NCT01249131|845072|P5|NOT COMPLETED|Washout Period of 10 Days||0
352910|NCT01249131|845073|P4|NOT COMPLETED|Washout Period of 10 Days||0
352911|NCT01249131|845074|P3|NOT COMPLETED|Washout Period of 10 Days||0
352912|NCT01249131|845075|P2|NOT COMPLETED|Washout Period of 10 Days||0
352913|NCT01249131|845076|P1|NOT COMPLETED|Washout Period of 10 Days||0
352914|NCT01249131|845071|P6|COMPLETED|Washout Period of 10 Days||4
352915|NCT01249131|845072|P5|COMPLETED|Washout Period of 10 Days||2
352916|NCT01249131|845073|P4|COMPLETED|Washout Period of 10 Days||3
352917|NCT01249131|845074|P3|COMPLETED|Washout Period of 10 Days||4
352918|NCT01249131|845075|P2|COMPLETED|Washout Period of 10 Days||3
352919|NCT01249131|845076|P1|COMPLETED|Washout Period of 10 Days||3
352920|NCT01249131|845071|P6|STARTED|Washout Period of 10 Days||4
352921|NCT01249131|845072|P5|STARTED|Washout Period of 10 Days||2
352922|NCT01249131|845073|P4|STARTED|Washout Period of 10 Days||3
352923|NCT01249131|845074|P3|STARTED|Washout Period of 10 Days||4
352924|NCT01249131|845075|P2|STARTED|Washout Period of 10 Days||3
352925|NCT01249131|845076|P1|STARTED|Washout Period of 10 Days||3
352926|NCT01249131|845071|P6|NOT COMPLETED|Second Intervention||0
352927|NCT01249131|845072|P5|NOT COMPLETED|Second Intervention||0
352928|NCT01249131|845073|P4|NOT COMPLETED|Second Intervention||0
352929|NCT01249131|845074|P3|NOT COMPLETED|Second Intervention||0
352930|NCT01249131|845075|P2|NOT COMPLETED|Second Intervention||0
352931|NCT01249131|845076|P1|NOT COMPLETED|Second Intervention||0
352932|NCT01249131|845071|P6|COMPLETED|Second Intervention||4
352933|NCT01249131|845072|P5|COMPLETED|Second Intervention||2
352934|NCT01249131|845073|P4|COMPLETED|Second Intervention||3
352935|NCT01249131|845074|P3|COMPLETED|Second Intervention||4
352936|NCT01249131|845075|P2|COMPLETED|Second Intervention||3
352937|NCT01249131|845076|P1|COMPLETED|Second Intervention||3
352938|NCT01249131|845071|P6|STARTED|Second Intervention||4
352939|NCT01249131|845072|P5|STARTED|Second Intervention||2
352940|NCT01249131|845073|P4|STARTED|Second Intervention||3
352941|NCT01249131|845074|P3|STARTED|Second Intervention||4
352942|NCT01249131|845075|P2|STARTED|Second Intervention||3
352943|NCT01249131|845076|P1|STARTED|Second Intervention||3
352944|NCT01249131|845071|P6|NOT COMPLETED|Washout Period of 10 Days||0
352945|NCT01249131|845072|P5|NOT COMPLETED|Washout Period of 10 Days||1
352946|NCT01249131|845073|P4|NOT COMPLETED|Washout Period of 10 Days||0
352947|NCT01249131|845074|P3|NOT COMPLETED|Washout Period of 10 Days||0
352948|NCT01249131|845075|P2|NOT COMPLETED|Washout Period of 10 Days||0
352949|NCT01249131|845076|P1|NOT COMPLETED|Washout Period of 10 Days||0
352950|NCT01249131|845071|P6|COMPLETED|Washout Period of 10 Days||4
352951|NCT01249131|845072|P5|COMPLETED|Washout Period of 10 Days||2
352952|NCT01249131|845073|P4|COMPLETED|Washout Period of 10 Days||3
352953|NCT01249131|845074|P3|COMPLETED|Washout Period of 10 Days||4
352954|NCT01249131|845075|P2|COMPLETED|Washout Period of 10 Days||3
352955|NCT01249131|845076|P1|COMPLETED|Washout Period of 10 Days||3
352956|NCT01249131|845071|P6|STARTED|Washout Period of 10 Days||4
352957|NCT01249131|845072|P5|STARTED|Washout Period of 10 Days||3
352958|NCT01249131|845073|P4|STARTED|Washout Period of 10 Days||3
352959|NCT01249131|845074|P3|STARTED|Washout Period of 10 Days||4
352960|NCT01249131|845075|P2|STARTED|Washout Period of 10 Days||3
352961|NCT01249131|845076|P1|STARTED|Washout Period of 10 Days||3
352962|NCT01249131|845071|P6|NOT COMPLETED|First Intervention||0
352963|NCT01249131|845072|P5|NOT COMPLETED|First Intervention||0
352964|NCT01249131|845073|P4|NOT COMPLETED|First Intervention||0
352965|NCT01249131|845074|P3|NOT COMPLETED|First Intervention||0
352966|NCT01249131|845075|P2|NOT COMPLETED|First Intervention||0
352967|NCT01249131|845076|P1|NOT COMPLETED|First Intervention||0
352968|NCT01249131|845071|P6|COMPLETED|First Intervention||4
352969|NCT01249131|845072|P5|COMPLETED|First Intervention||3
352970|NCT01249131|845073|P4|COMPLETED|First Intervention||3
352971|NCT01249131|845074|P3|COMPLETED|First Intervention||4
352972|NCT01249131|845075|P2|COMPLETED|First Intervention||3
352973|NCT01249131|845076|P1|COMPLETED|First Intervention||3
352974|NCT01249131|845071|P6|STARTED|First Intervention||4
352975|NCT01249131|845072|P5|STARTED|First Intervention||3
352976|NCT01249131|845073|P4|STARTED|First Intervention||3
352977|NCT01249131|845074|P3|STARTED|First Intervention||4
352978|NCT01249131|845075|P2|STARTED|First Intervention||3
352979|NCT01249131|845076|P1|STARTED|First Intervention||3
352980|NCT01249118|845096|P3|NOT COMPLETED|Second Washout Period||0
352981|NCT01249118|845097|P2|NOT COMPLETED|Second Washout Period||0
352982|NCT01249118|845098|P1|NOT COMPLETED|Second Washout Period||0
352983|NCT01249118|845096|P3|COMPLETED|Second Washout Period||5
352984|NCT01249118|845097|P2|COMPLETED|Second Washout Period||5
352985|NCT01249118|845098|P1|COMPLETED|Second Washout Period||2
352986|NCT01249118|845096|P3|STARTED|Second Washout Period||5
352987|NCT01249118|845097|P2|STARTED|Second Washout Period||5
352988|NCT01249118|845098|P1|STARTED|Second Washout Period||2
352989|NCT01249118|845096|P3|NOT COMPLETED|Second Intervention Period||0
352990|NCT01249118|845097|P2|NOT COMPLETED|Second Intervention Period||0
352991|NCT01249118|845098|P1|NOT COMPLETED|Second Intervention Period||0
352992|NCT01249118|845096|P3|COMPLETED|Second Intervention Period||5
352993|NCT01249118|845097|P2|COMPLETED|Second Intervention Period||5
352994|NCT01249118|845098|P1|COMPLETED|Second Intervention Period||2
352995|NCT01249118|845096|P3|STARTED|Second Intervention Period||5
352996|NCT01249118|845097|P2|STARTED|Second Intervention Period||5
352997|NCT01249118|845098|P1|STARTED|Second Intervention Period||2
352998|NCT01249118|845096|P3|NOT COMPLETED|First Washout Period||0
352999|NCT01249118|845097|P2|NOT COMPLETED|First Washout Period||1
353000|NCT01249118|845098|P1|NOT COMPLETED|First Washout Period||0
353001|NCT01249118|845096|P3|COMPLETED|First Washout Period||5
353002|NCT01249118|845097|P2|COMPLETED|First Washout Period||5
353003|NCT01249118|845098|P1|COMPLETED|First Washout Period||2
353004|NCT01249118|845096|P3|STARTED|First Washout Period||5
353005|NCT01249118|845097|P2|STARTED|First Washout Period||6
353006|NCT01249118|845098|P1|STARTED|First Washout Period||2
353007|NCT01249118|845096|P3|NOT COMPLETED|First Intervention Period||0
353008|NCT01249118|845097|P2|NOT COMPLETED|First Intervention Period||0
353009|NCT01249118|845098|P1|NOT COMPLETED|First Intervention Period||0
353010|NCT01249118|845096|P3|COMPLETED|First Intervention Period||5
353011|NCT01249118|845097|P2|COMPLETED|First Intervention Period||6
353012|NCT01249118|845098|P1|COMPLETED|First Intervention Period||2
353013|NCT01249118|845096|P3|STARTED|First Intervention Period||5
353014|NCT01249118|845097|P2|STARTED|First Intervention Period||6
353015|NCT01249118|845098|P1|STARTED|First Intervention Period||2
353016|NCT01249092|845132|P1|NOT COMPLETED|Overall Study||2
353017|NCT01249092|845132|P1|COMPLETED|Overall Study||18
353018|NCT01249092|845132|P1|STARTED|Overall Study||20
353019|NCT01248949|845143|P5|NOT COMPLETED|Overall Study||4
353020|NCT01248949|845144|P4|NOT COMPLETED|Overall Study||10
353021|NCT01248949|845145|P3|NOT COMPLETED|Overall Study||37
353022|NCT01248949|845146|P2|NOT COMPLETED|Overall Study||13
353023|NCT01248949|845147|P1|NOT COMPLETED|Overall Study||33
353024|NCT01248949|845143|P5|COMPLETED|Overall Study||3
353025|NCT01248949|845144|P4|COMPLETED|Overall Study||3
353026|NCT01248949|845145|P3|COMPLETED|Overall Study||1
353027|NCT01248949|845146|P2|COMPLETED|Overall Study||3
353028|NCT01248949|845147|P1|COMPLETED|Overall Study||9
353029|NCT01248949|845143|P5|STARTED|Overall Study||7
353030|NCT01248949|845144|P4|STARTED|Overall Study||13
353031|NCT01248949|845145|P3|STARTED|Overall Study||38
353032|NCT01248949|845146|P2|STARTED|Overall Study||16
353033|NCT01248949|845147|P1|STARTED|Overall Study||42
353034|NCT01248936|845259|P1|NOT COMPLETED|Overall Study||374
353035|NCT01248936|845259|P1|COMPLETED|Overall Study||0
353036|NCT01248936|845259|P1|STARTED|Overall Study||374
353037|NCT01248884|845272|P3|NOT COMPLETED|Overall Study||1
353038|NCT01248884|845273|P2|NOT COMPLETED|Overall Study||3
353039|NCT01248884|845274|P1|NOT COMPLETED|Overall Study||2
353040|NCT01248884|845272|P3|COMPLETED|Overall Study||238
353041|NCT01248884|845273|P2|COMPLETED|Overall Study||239
353042|NCT01248884|845274|P1|COMPLETED|Overall Study||238
353043|NCT01248884|845272|P3|STARTED|Overall Study||239
353044|NCT01248884|845273|P2|STARTED|Overall Study||242
353045|NCT01248884|845274|P1|STARTED|Overall Study||240
353046|NCT01248793|845326|P2|NOT COMPLETED|Overall Study||6
353047|NCT01248793|845327|P1|NOT COMPLETED|Overall Study||4
353048|NCT01248793|845326|P2|COMPLETED|Overall Study||102
353049|NCT01248793|845327|P1|COMPLETED|Overall Study||101
353050|NCT01248793|845326|P2|STARTED|Overall Study||108
353051|NCT01248793|845327|P1|STARTED|Overall Study||105
353052|NCT01248780|845341|P2|NOT COMPLETED|Overall Study||15
353053|NCT01248780|845342|P1|NOT COMPLETED|Overall Study||9
353054|NCT01248780|845341|P2|COMPLETED|Overall Study||117
353055|NCT01248780|845342|P1|COMPLETED|Overall Study||123
353056|NCT01248780|845341|P2|STARTED|Overall Study||132
353057|NCT01248780|845342|P1|STARTED|Overall Study||132
353058|NCT01248728|845356|P2|NOT COMPLETED|Overall Study||2
353059|NCT01248728|845357|P1|NOT COMPLETED|Overall Study||4
353060|NCT01248728|845356|P2|COMPLETED|Overall Study||17
353061|NCT01248728|845357|P1|COMPLETED|Overall Study||15
353062|NCT01248728|845356|P2|STARTED|Overall Study||19
353063|NCT01248728|845357|P1|STARTED|Overall Study||19
353064|NCT01248468|845374|P3|NOT COMPLETED|Overall Study||4
353065|NCT01248468|845375|P2|NOT COMPLETED|Overall Study||14
353066|NCT01248468|845376|P1|NOT COMPLETED|Overall Study||15
353067|NCT01248468|845374|P3|COMPLETED|Overall Study||145
353068|NCT01248468|845375|P2|COMPLETED|Overall Study||290
353069|NCT01248468|845376|P1|COMPLETED|Overall Study||284
353070|NCT01248468|845374|P3|ITT Population|Overall Study||125
353071|NCT01248468|845375|P2|ITT Population|Overall Study||261
353072|NCT01248468|845376|P1|ITT Population|Overall Study||256
353073|NCT01248468|845374|P3|Safety Population|Overall Study||133
353074|NCT01248468|845375|P2|Safety Population|Overall Study||271
353075|NCT01248468|845376|P1|Safety Population|Overall Study||266
353076|NCT01248468|845374|P3|STARTED|Overall Study||149
353077|NCT01248468|845375|P2|STARTED|Overall Study||304
353078|NCT01248468|845376|P1|STARTED|Overall Study||299
353079|NCT01248455|845393|P1|NOT COMPLETED|Overall Study||1
353080|NCT01248455|845393|P1|COMPLETED|Overall Study||8
353081|NCT01248455|845393|P1|STARTED|Overall Study||9
353082|NCT01248364|845402|P4|NOT COMPLETED|Overall Study||0
353083|NCT01248364|845403|P3|NOT COMPLETED|Overall Study||0
353084|NCT01248364|845404|P2|NOT COMPLETED|Overall Study||1
353085|NCT01248364|845405|P1|NOT COMPLETED|Overall Study||0
353086|NCT01248364|845402|P4|COMPLETED|Overall Study||12
353087|NCT01248364|845403|P3|COMPLETED|Overall Study||13
353088|NCT01248364|845404|P2|COMPLETED|Overall Study||33
353089|NCT01248364|845405|P1|COMPLETED|Overall Study||32
353090|NCT01248364|845402|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
353091|NCT01248364|845403|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
353092|NCT01248364|845404|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
353093|NCT01248364|845405|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
353094|NCT01248364|845402|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
353095|NCT01248364|845403|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
353096|NCT01248364|845404|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
353097|NCT01248364|845405|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
353098|NCT01248364|845402|P4|STARTED|Overall Study||12
353099|NCT01248364|845403|P3|STARTED|Overall Study||13
353100|NCT01248364|845404|P2|STARTED|Overall Study||34
353101|NCT01248364|845405|P1|STARTED|Overall Study||32
353102|NCT01248221|845453|P2|NOT COMPLETED|Overall Study||0
353103|NCT01248221|845454|P1|NOT COMPLETED|Overall Study||0
353104|NCT01248221|845453|P2|COMPLETED|Overall Study||15
353105|NCT01248221|845454|P1|COMPLETED|Overall Study||15
353106|NCT01248221|845453|P2|STARTED|Overall Study||15
353107|NCT01248221|845454|P1|STARTED|Overall Study||15
353108|NCT01248130|845468|P2|NOT COMPLETED|Overall Study||0
353109|NCT01248130|845469|P1|NOT COMPLETED|Overall Study||2
353110|NCT01248130|845468|P2|COMPLETED|Overall Study||4
353111|NCT01248130|845469|P1|COMPLETED|Overall Study||1
353112|NCT01248130|845468|P2|STARTED|Overall Study||4
353113|NCT01248130|845469|P1|STARTED|Overall Study||3
353114|NCT01248065|845477|P2|NOT COMPLETED|Overall Study||22
353115|NCT01248065|845478|P1|NOT COMPLETED|Overall Study||26
353116|NCT01248065|845477|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
353210|NCT01246999|845644|P4|COMPLETED|Overall Study||15
353117|NCT01248065|845478|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
353118|NCT01248065|845477|P2|STARTED|Overall Study||201
353119|NCT01248065|845478|P1|STARTED|Overall Study||207
353120|NCT01248013|845488|P1|NOT COMPLETED|Overall Study||14
353121|NCT01248013|845488|P1|COMPLETED|Overall Study||75
353122|NCT01248013|845488|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
353123|NCT01248013|845488|P1|STARTED|Overall Study||89
353124|NCT01247974|845494|P2|NOT COMPLETED|Overall Study||19
353125|NCT01247974|845495|P1|NOT COMPLETED|Overall Study||26
353126|NCT01247974|845494|P2|COMPLETED|Overall Study||203
353127|NCT01247974|845495|P1|COMPLETED|Overall Study||191
353128|NCT01247974|845494|P2|STARTED|Overall Study||222
353129|NCT01247974|845495|P1|STARTED|Overall Study||217
353130|NCT01247922|845503|P1|NOT COMPLETED|Overall Study||4
353131|NCT01247922|845503|P1|COMPLETED|Overall Study||0
353132|NCT01247922|845503|P1|Treated|Overall Study||4
353133|NCT01247922|845503|P1|STARTED|Overall Study||4
353134|NCT01247675|845513|P4|NOT COMPLETED|Overall Study||0
353135|NCT01247675|845514|P3|NOT COMPLETED|Overall Study||0
353136|NCT01247675|845515|P2|NOT COMPLETED|Overall Study||2
353137|NCT01247675|845516|P1|NOT COMPLETED|Overall Study||2
353138|NCT01247675|845513|P4|COMPLETED|Overall Study||8
353139|NCT01247675|845514|P3|COMPLETED|Overall Study||9
353140|NCT01247675|845515|P2|COMPLETED|Overall Study||8
353141|NCT01247675|845516|P1|COMPLETED|Overall Study||8
353142|NCT01247675|845513|P4|STARTED|Overall Study||8
353143|NCT01247675|845514|P3|STARTED|Overall Study||9
353144|NCT01247675|845515|P2|STARTED|Overall Study||10
353145|NCT01247675|845516|P1|STARTED|Overall Study||10
353146|NCT01247428|845538|P1|NOT COMPLETED|Overall Study||0
353147|NCT01247428|845538|P1|COMPLETED|Overall Study||30
353148|NCT01247428|845538|P1|STARTED|Overall Study||30
353149|NCT01247285|845561|P2|NOT COMPLETED|Second Intervention||0
353150|NCT01247285|845562|P1|NOT COMPLETED|Second Intervention||0
353151|NCT01247285|845561|P2|COMPLETED|Second Intervention||13
353152|NCT01247285|845562|P1|COMPLETED|Second Intervention||13
353153|NCT01247285|845561|P2|STARTED|Second Intervention||13
353154|NCT01247285|845562|P1|STARTED|Second Intervention||13
353155|NCT01247285|845561|P2|NOT COMPLETED|Washout of 28 Days||0
353156|NCT01247285|845562|P1|NOT COMPLETED|Washout of 28 Days||0
353157|NCT01247285|845561|P2|COMPLETED|Washout of 28 Days||13
353158|NCT01247285|845562|P1|COMPLETED|Washout of 28 Days||13
353159|NCT01247285|845561|P2|STARTED|Washout of 28 Days||13
353160|NCT01247285|845562|P1|STARTED|Washout of 28 Days||13
353161|NCT01247285|845561|P2|NOT COMPLETED|First Intervention||0
353162|NCT01247285|845562|P1|NOT COMPLETED|First Intervention||0
353163|NCT01247285|845561|P2|COMPLETED|First Intervention||13
353164|NCT01247285|845562|P1|COMPLETED|First Intervention||13
353165|NCT01247285|845561|P2|STARTED|First Intervention||13
353166|NCT01247285|845562|P1|STARTED|First Intervention||13
353167|NCT01247272|845580|P2|NOT COMPLETED|Second Intervention||0
353168|NCT01247272|845581|P1|NOT COMPLETED|Second Intervention||0
353169|NCT01247272|845580|P2|COMPLETED|Second Intervention||13
353170|NCT01247272|845581|P1|COMPLETED|Second Intervention||13
353171|NCT01247272|845580|P2|STARTED|Second Intervention||13
353172|NCT01247272|845581|P1|STARTED|Second Intervention||13
353173|NCT01247272|845580|P2|NOT COMPLETED|Washout of 28 Days||0
353174|NCT01247272|845581|P1|NOT COMPLETED|Washout of 28 Days||0
353175|NCT01247272|845580|P2|COMPLETED|Washout of 28 Days||13
353176|NCT01247272|845581|P1|COMPLETED|Washout of 28 Days||13
353177|NCT01247272|845580|P2|STARTED|Washout of 28 Days||13
353178|NCT01247272|845581|P1|STARTED|Washout of 28 Days||13
353179|NCT01247272|845580|P2|NOT COMPLETED|First Intervention||0
353180|NCT01247272|845581|P1|NOT COMPLETED|First Intervention||0
353181|NCT01247272|845580|P2|COMPLETED|First Intervention||13
353182|NCT01247272|845581|P1|COMPLETED|First Intervention||13
353183|NCT01247272|845580|P2|STARTED|First Intervention||13
353184|NCT01247272|845581|P1|STARTED|First Intervention||13
353185|NCT01247220|845599|P2|NOT COMPLETED|Overall Study||0
353186|NCT01247220|845600|P1|NOT COMPLETED|Overall Study||0
353187|NCT01247220|845599|P2|COMPLETED|Overall Study||6
353188|NCT01247220|845600|P1|COMPLETED|Overall Study||6
353189|NCT01247220|845599|P2|STARTED|Overall Study||6
353190|NCT01247220|845600|P1|STARTED|Overall Study||6
353191|NCT01247090|845613|P3|NOT COMPLETED|Overall Study||0
353192|NCT01247090|845614|P2|NOT COMPLETED|Overall Study||1
353193|NCT01247090|845615|P1|NOT COMPLETED|Overall Study||1
353194|NCT01247090|845613|P3|COMPLETED|Overall Study||4
353195|NCT01247090|845614|P2|COMPLETED|Overall Study||3
353196|NCT01247090|845615|P1|COMPLETED|Overall Study||3
353197|NCT01247090|845613|P3|STARTED|Overall Study||4
353198|NCT01247090|845614|P2|STARTED|Overall Study||4
353199|NCT01247090|845615|P1|STARTED|Overall Study||4
353200|NCT01247064|845625|P2|NOT COMPLETED|Overall Study||0
353201|NCT01247064|845626|P1|NOT COMPLETED|Overall Study||0
353202|NCT01247064|845625|P2|COMPLETED|Overall Study||31
353203|NCT01247064|845626|P1|COMPLETED|Overall Study||31
353204|NCT01247064|845625|P2|STARTED|Overall Study||31
353205|NCT01247064|845626|P1|STARTED|Overall Study||31
353206|NCT01246999|845644|P4|NOT COMPLETED|Overall Study||2
353207|NCT01246999|845645|P3|NOT COMPLETED|Overall Study||0
353208|NCT01246999|845646|P2|NOT COMPLETED|Overall Study||1
353209|NCT01246999|845647|P1|NOT COMPLETED|Overall Study||0
353211|NCT01246999|845645|P3|COMPLETED|Overall Study||2
353212|NCT01246999|845646|P2|COMPLETED|Overall Study||3
353213|NCT01246999|845647|P1|COMPLETED|Overall Study||11
353214|NCT01246999|845644|P4|STARTED|Overall Study||17
353215|NCT01246999|845645|P3|STARTED|Overall Study||2
353216|NCT01246999|845646|P2|STARTED|Overall Study||4
353217|NCT01246999|845647|P1|STARTED|Overall Study||11
353218|NCT01246973|845682|P2|NOT COMPLETED|Overall Study||47
353219|NCT01246973|845683|P1|NOT COMPLETED|Overall Study||61
353220|NCT01246973|845682|P2|COMPLETED|Overall Study||295
353221|NCT01246973|845683|P1|COMPLETED|Overall Study||283
353222|NCT01246973|845682|P2|STARTED|Overall Study||342
353223|NCT01246973|845683|P1|STARTED|Overall Study||344
353224|NCT01246960|845693|P2|NOT COMPLETED|Overall Study||4
353225|NCT01246960|845694|P1|NOT COMPLETED|Overall Study||6
353226|NCT01246960|845693|P2|COMPLETED|Overall Study||80
353227|NCT01246960|845694|P1|COMPLETED|Overall Study||78
353228|NCT01246960|845693|P2|Received Any Quantity of Study Drug|Overall Study||80
353229|NCT01246960|845694|P1|Received Any Quantity of Study Drug|Overall Study||82
353230|NCT01246960|845693|P2|STARTED|Overall Study||84
353231|NCT01246960|845694|P1|STARTED|Overall Study||84
353232|NCT01246791|845712|P1|NOT COMPLETED|Overall Study||0
353233|NCT01246791|845712|P1|COMPLETED|Overall Study||12
353234|NCT01246791|845712|P1|STARTED|Overall Study||12
353235|NCT01246713|845727|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
353236|NCT01246713|845728|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
353237|NCT01246713|845727|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
353238|NCT01246713|845728|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
353239|NCT01246713|845727|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
353240|NCT01246713|845728|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
353241|NCT01246713|845727|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
353242|NCT01246713|845728|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
353243|NCT01246713|845727|P2|COMPLETED|Washout (at Least 14 Days)||9
353244|NCT01246713|845728|P1|COMPLETED|Washout (at Least 14 Days)||6
353245|NCT01246713|845727|P2|STARTED|Washout (at Least 14 Days)||9
353246|NCT01246713|845728|P1|STARTED|Washout (at Least 14 Days)||6
353247|NCT01246713|845727|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
353248|NCT01246713|845728|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
353249|NCT01246713|845727|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
353250|NCT01246713|845728|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
353251|NCT01246713|845727|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
353252|NCT01246713|845728|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
353253|NCT01246479|845734|P1|NOT COMPLETED|Overall Study||5
353254|NCT01246479|845734|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
353255|NCT01246479|845734|P1|STARTED|Overall Study||23
353256|NCT01246349|845740|P2|NOT COMPLETED|Overall Study||0
353257|NCT01246349|845741|P1|NOT COMPLETED|Overall Study||0
353258|NCT01246349|845740|P2|COMPLETED|Overall Study||20
353259|NCT01246349|845741|P1|COMPLETED|Overall Study||20
353260|NCT01246349|845740|P2|STARTED|Overall Study||20
353261|NCT01246349|845741|P1|STARTED|Overall Study||20
353262|NCT01246258|845753|P1|NOT COMPLETED|Overall Study||0
353263|NCT01246258|845753|P1|COMPLETED|Overall Study||5
353264|NCT01246258|845753|P1|STARTED|Overall Study||5
353265|NCT01246206|845758|P1|NOT COMPLETED|Overall Study||1
353266|NCT01246206|845758|P1|COMPLETED|Overall Study||20
353267|NCT01246206|845758|P1|STARTED|Overall Study||21
353268|NCT01246076|845769|P1|NOT COMPLETED|Overall Study||0
353269|NCT01246076|845769|P1|COMPLETED|Overall Study||24
353270|NCT01246076|845769|P1|STARTED|Overall Study||24
353271|NCT01246011|845781|P3|NOT COMPLETED|Overall Study||4
353272|NCT01246011|845782|P2|NOT COMPLETED|Overall Study||0
353273|NCT01246011|845783|P1|NOT COMPLETED|Overall Study||0
353274|NCT01246011|845781|P3|COMPLETED|Overall Study||5
353275|NCT01246011|845782|P2|COMPLETED|Overall Study||0
353276|NCT01246011|845783|P1|COMPLETED|Overall Study||0
353277|NCT01246011|845781|P3|STARTED|Overall Study||9
353278|NCT01246011|845782|P2|STARTED|Overall Study||0
353279|NCT01246011|845783|P1|STARTED|Overall Study||0
353280|NCT01245764|845795|P4|NOT COMPLETED|Study Phase B||0
353281|NCT01245764|845796|P3|NOT COMPLETED|Study Phase B||0
353282|NCT01245764|845797|P2|NOT COMPLETED|Study Phase B||0
353283|NCT01245764|845798|P1|NOT COMPLETED|Study Phase B||0
353284|NCT01245764|845795|P4|COMPLETED|Study Phase B||17
353285|NCT01245764|845796|P3|COMPLETED|Study Phase B||0
353286|NCT01245764|845797|P2|COMPLETED|Study Phase B||0
353287|NCT01245764|845798|P1|COMPLETED|Study Phase B||0
353288|NCT01245764|845795|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
353289|NCT01245764|845796|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
353290|NCT01245764|845797|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
353291|NCT01245764|845798|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
353292|NCT01245764|845795|P4|STARTED|Study Phase B||17
353293|NCT01245764|845796|P3|STARTED|Study Phase B||0
353294|NCT01245764|845797|P2|STARTED|Study Phase B||0
353295|NCT01245764|845798|P1|STARTED|Study Phase B||0
353296|NCT01245764|845795|P4|NOT COMPLETED|Study Phase A||3
353297|NCT01245764|845796|P3|NOT COMPLETED|Study Phase A||10
353298|NCT01245764|845797|P2|NOT COMPLETED|Study Phase A||5
353299|NCT01245764|845798|P1|NOT COMPLETED|Study Phase A||9
353300|NCT01245764|845795|P4|COMPLETED|Study Phase A||17
353301|NCT01245764|845796|P3|COMPLETED|Study Phase A||110
353302|NCT01245764|845797|P2|COMPLETED|Study Phase A||25
353303|NCT01245764|845798|P1|COMPLETED|Study Phase A||71
353304|NCT01245764|845795|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
353305|NCT01245764|845796|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
353306|NCT01245764|845797|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
353307|NCT01245764|845798|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
353308|NCT01245764|845795|P4|STARTED|Study Phase A||20
353309|NCT01245764|845796|P3|STARTED|Study Phase A||120
353310|NCT01245764|845797|P2|STARTED|Study Phase A||30
353311|NCT01245764|845798|P1|STARTED|Study Phase A||80
353312|NCT01245751|845836|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
353313|NCT01245751|845837|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
353314|NCT01245751|845838|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
353315|NCT01245751|845839|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
353316|NCT01245751|845836|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
353317|NCT01245751|845837|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
353318|NCT01245751|845838|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
353319|NCT01245751|845839|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
353320|NCT01245751|845836|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
353321|NCT01245751|845837|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
353322|NCT01245751|845838|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
353323|NCT01245751|845839|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
353324|NCT01245751|845836|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
353325|NCT01245751|845837|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
353326|NCT01245751|845838|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
353327|NCT01245751|845839|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
353328|NCT01245751|845836|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
353329|NCT01245751|845837|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
353330|NCT01245751|845838|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
353331|NCT01245751|845839|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
353332|NCT01245751|845836|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
353333|NCT01245751|845837|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
353334|NCT01245751|845838|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
353335|NCT01245751|845839|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
353336|NCT01245751|845836|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
353337|NCT01245751|845837|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
353338|NCT01245751|845838|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
353339|NCT01245751|845839|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
353340|NCT01245738|845852|P1|NOT COMPLETED|Overall Study||40
353341|NCT01245738|845852|P1|COMPLETED|Overall Study||474
353342|NCT01245738|845852|P1|STARTED|Overall Study||514
353343|NCT01245647|845871|P2|NOT COMPLETED|Overall Study||4
353344|NCT01245647|845872|P1|NOT COMPLETED|Overall Study||0
353345|NCT01245647|845871|P2|COMPLETED|Overall Study||8
353346|NCT01245647|845872|P1|COMPLETED|Overall Study||7
353347|NCT01245647|845871|P2|STARTED|Overall Study||12
353348|NCT01245647|845872|P1|STARTED|Overall Study||7
353349|NCT01245595|845888|P2|NOT COMPLETED|Overall Study||0
353350|NCT01245595|845889|P1|NOT COMPLETED|Overall Study||0
353351|NCT01245595|845888|P2|COMPLETED|Overall Study||72
353352|NCT01245595|845889|P1|COMPLETED|Overall Study||72
353353|NCT01245595|845888|P2|Completed Full Course of Study Drug|Overall Study||61
353354|NCT01245595|845889|P1|Completed Full Course of Study Drug|Overall Study||57
353355|NCT01245595|845888|P2|STARTED|Overall Study||72
353356|NCT01245595|845889|P1|STARTED|Overall Study||72
353357|NCT01245439|845895|P1|NOT COMPLETED|Overall Study||0
353358|NCT01245439|845895|P1|COMPLETED|Overall Study||65
353359|NCT01245439|845895|P1|STARTED|Overall Study||65
353360|NCT01245413|845926|P2|NOT COMPLETED|Athena First,||0
353361|NCT01245413|845927|P1|NOT COMPLETED|Athena First,||0
353362|NCT01245413|845926|P2|COMPLETED|Athena First,||16
353363|NCT01245413|845927|P1|COMPLETED|Athena First,||16
353364|NCT01245413|845926|P2|STARTED|Athena First,||16
353365|NCT01245413|845927|P1|STARTED|Athena First,||16
353366|NCT01245413|845926|P2|NOT COMPLETED|Sensura First,||0
353367|NCT01245413|845927|P1|NOT COMPLETED|Sensura First,||0
353368|NCT01245413|845926|P2|COMPLETED|Sensura First,||16
353369|NCT01245413|845927|P1|COMPLETED|Sensura First,||16
353370|NCT01245413|845926|P2|STARTED|Sensura First,||16
353371|NCT01245413|845927|P1|STARTED|Sensura First,||16
353372|NCT01245387|845933|P1|NOT COMPLETED|Overall Study||813
353373|NCT01245387|845933|P1|COMPLETED|Overall Study||188
353374|NCT01245387|845933|P1|STARTED|Overall Study||1001
353375|NCT01245374|845982|P1|NOT COMPLETED|Overall Study||4
353376|NCT01245374|845982|P1|COMPLETED|Overall Study||99
353377|NCT01245374|845982|P1|STARTED|Overall Study||103
353378|NCT01245283|846005|P3|NOT COMPLETED|Overall Study||11
353379|NCT01245283|846006|P2|NOT COMPLETED|Overall Study||11
353380|NCT01245283|846007|P1|NOT COMPLETED|Overall Study||14
353381|NCT01245283|846005|P3|COMPLETED|Overall Study||19
353382|NCT01245283|846006|P2|COMPLETED|Overall Study||17
353383|NCT01245283|846007|P1|COMPLETED|Overall Study||18
353384|NCT01245283|846005|P3|STARTED|Overall Study||30
353385|NCT01245283|846006|P2|STARTED|Overall Study||28
353386|NCT01245283|846007|P1|STARTED|Overall Study||32
353387|NCT01245270|846041|P2|NOT COMPLETED|Overall Study||0
353388|NCT01245270|846042|P1|NOT COMPLETED|Overall Study||0
353389|NCT01245270|846041|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
353390|NCT01245270|846042|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
353391|NCT01245270|846041|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
353392|NCT01245270|846042|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
353393|NCT01245140|846052|P2|NOT COMPLETED|Overall Study||10
353394|NCT01245140|846053|P1|NOT COMPLETED|Overall Study||3
353395|NCT01245140|846052|P2|COMPLETED|Overall Study||14
353396|NCT01245140|846053|P1|COMPLETED|Overall Study||6
353397|NCT01245140|846052|P2|STARTED|Overall Study||24
353398|NCT01245140|846053|P1|STARTED|Overall Study||9
353399|NCT01245101|846109|P2|NOT COMPLETED|Period 3 (Treatment)||0
353400|NCT01245101|846110|P1|NOT COMPLETED|Period 3 (Treatment)||1
353401|NCT01245101|846109|P2|COMPLETED|Period 3 (Treatment)||0
353402|NCT01245101|846110|P1|COMPLETED|Period 3 (Treatment)||11
353403|NCT01245101|846109|P2|STARTED|Period 3 (Treatment)||0
353404|NCT01245101|846110|P1|STARTED|Period 3 (Treatment)||12
353405|NCT01245101|846109|P2|NOT COMPLETED|Period 2 (Washout)||0
353406|NCT01245101|846110|P1|NOT COMPLETED|Period 2 (Washout)||1
353407|NCT01245101|846109|P2|COMPLETED|Period 2 (Washout)||0
353408|NCT01245101|846110|P1|COMPLETED|Period 2 (Washout)||12
353409|NCT01245101|846109|P2|STARTED|Period 2 (Washout)||0
353410|NCT01245101|846110|P1|STARTED|Period 2 (Washout)||13
353411|NCT01245101|846109|P2|NOT COMPLETED|Period 1 (Treatment)||0
353412|NCT01245101|846110|P1|NOT COMPLETED|Period 1 (Treatment)||2
353413|NCT01245101|846109|P2|COMPLETED|Period 1 (Treatment)||0
353414|NCT01245101|846110|P1|COMPLETED|Period 1 (Treatment)||13
353415|NCT01245101|846109|P2|STARTED|Period 1 (Treatment)||0
353416|NCT01245101|846110|P1|STARTED|Period 1 (Treatment)||15
353417|NCT01245062|846120|P3|NOT COMPLETED|Cross-over Phase||51
353418|NCT01245062|846121|P2|NOT COMPLETED|Cross-over Phase||0
353419|NCT01245062|846122|P1|NOT COMPLETED|Cross-over Phase||0
353420|NCT01245062|846120|P3|COMPLETED|Cross-over Phase||0
353421|NCT01245062|846121|P2|COMPLETED|Cross-over Phase||0
353422|NCT01245062|846122|P1|COMPLETED|Cross-over Phase||0
353423|NCT01245062|846120|P3|Ongoing|Cross-over Phase||34
353424|NCT01245062|846121|P2|Ongoing|Cross-over Phase||0
353425|NCT01245062|846122|P1|Ongoing|Cross-over Phase||0
353426|NCT01245062|846120|P3|STARTED|Cross-over Phase|51 of the 108 participants randomized to chemotherapy elected to cross-over to Trametinib.|51
353427|NCT01245062|846121|P2|STARTED|Cross-over Phase||0
353428|NCT01245062|846122|P1|STARTED|Cross-over Phase||0
353429|NCT01245062|846120|P3|NOT COMPLETED|Randomization Phase||0
353430|NCT01245062|846121|P2|NOT COMPLETED|Randomization Phase||108
353431|NCT01245062|846122|P1|NOT COMPLETED|Randomization Phase||214
353432|NCT01245062|846120|P3|COMPLETED|Randomization Phase||0
353433|NCT01245062|846121|P2|COMPLETED|Randomization Phase||0
353434|NCT01245062|846122|P1|COMPLETED|Randomization Phase||0
353435|NCT01245062|846120|P3|Ongoing|Randomization Phase||0
353436|NCT01245062|846121|P2|Ongoing|Randomization Phase||65
353437|NCT01245062|846122|P1|Ongoing|Randomization Phase||169
353438|NCT01245062|846120|P3|STARTED|Randomization Phase||0
353439|NCT01245062|846121|P2|STARTED|Randomization Phase||108
353440|NCT01245062|846122|P1|STARTED|Randomization Phase||214
353441|NCT01244984|846157|P3|NOT COMPLETED|Overall Study||4
353442|NCT01244984|846158|P2|NOT COMPLETED|Overall Study||14
353443|NCT01244984|846159|P1|NOT COMPLETED|Overall Study||5
353444|NCT01244984|846157|P3|COMPLETED|Overall Study||86
353445|NCT01244984|846158|P2|COMPLETED|Overall Study||79
353446|NCT01244984|846159|P1|COMPLETED|Overall Study||55
353447|NCT01244984|846157|P3|STARTED|Overall Study||90
353448|NCT01244984|846158|P2|STARTED|Overall Study||93
353449|NCT01244984|846159|P1|STARTED|Overall Study||60
353450|NCT01244906|846233|P1|NOT COMPLETED|Overall Study||8
353451|NCT01244906|846233|P1|COMPLETED|Overall Study||18
353452|NCT01244906|846233|P1|STARTED|Overall Study||26
353453|NCT01244893|846242|P2|NOT COMPLETED|Final Visit||0
353454|NCT01244893|846243|P1|NOT COMPLETED|Final Visit||0
353455|NCT01244893|846242|P2|COMPLETED|Final Visit||21
353456|NCT01244893|846243|P1|COMPLETED|Final Visit||21
353457|NCT01244893|846242|P2|STARTED|Final Visit||21
353458|NCT01244893|846243|P1|STARTED|Final Visit||21
353459|NCT01244893|846242|P2|NOT COMPLETED|1-Week Follow Up||0
353460|NCT01244893|846243|P1|NOT COMPLETED|1-Week Follow Up||1
353461|NCT01244893|846242|P2|COMPLETED|1-Week Follow Up||21
353462|NCT01244893|846243|P1|COMPLETED|1-Week Follow Up||21
353463|NCT01244893|846242|P2|STARTED|1-Week Follow Up||21
353464|NCT01244893|846243|P1|STARTED|1-Week Follow Up||22
353465|NCT01244893|846242|P2|NOT COMPLETED|Baseline||1
353466|NCT01244893|846243|P1|NOT COMPLETED|Baseline||0
353467|NCT01244893|846242|P2|COMPLETED|Baseline||21
353468|NCT01244893|846243|P1|COMPLETED|Baseline||22
353469|NCT01244893|846242|P2|STARTED|Baseline||22
353470|NCT01244893|846243|P1|STARTED|Baseline||22
353471|NCT01244828|846255|P1|NOT COMPLETED|Overall Study||78
353472|NCT01244828|846255|P1|COMPLETED|Overall Study||79
353473|NCT01244828|846255|P1|STARTED|Overall Study|Received study drug|157
353474|NCT01244815|846271|P4|NOT COMPLETED|Overall Study||12
353475|NCT01244815|846272|P3|NOT COMPLETED|Overall Study||11
353476|NCT01244815|846273|P2|NOT COMPLETED|Overall Study||17
353477|NCT01244815|846274|P1|NOT COMPLETED|Overall Study||14
353478|NCT01244815|846271|P4|COMPLETED|Overall Study||87
353479|NCT01244815|846272|P3|COMPLETED|Overall Study||88
353480|NCT01244815|846273|P2|COMPLETED|Overall Study||88
353481|NCT01244815|846274|P1|COMPLETED|Overall Study||87
353482|NCT01244815|846271|P4|Treated|Overall Study||99
353483|NCT01244815|846272|P3|Treated|Overall Study||99
353484|NCT01244815|846273|P2|Treated|Overall Study||104
353485|NCT01244815|846274|P1|Treated|Overall Study||101
353486|NCT01244815|846271|P4|STARTED|Overall Study|Randomized|99
353487|NCT01244815|846272|P3|STARTED|Overall Study|Randomized|99
353488|NCT01244815|846273|P2|STARTED|Overall Study|Randomized|105
353489|NCT01244815|846274|P1|STARTED|Overall Study|Randomized|101
353490|NCT01244724|846348|P1|NOT COMPLETED|Overall Study||8
353491|NCT01244724|846348|P1|COMPLETED|Overall Study||9
353492|NCT01244724|846348|P1|Week 2 Visit|Overall Study||15
353493|NCT01244724|846348|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
353494|NCT01244711|846352|P1|NOT COMPLETED|Overall Study||0
353495|NCT01244711|846352|P1|COMPLETED|Overall Study||1
353496|NCT01244711|846352|P1|STARTED|Overall Study||1
353497|NCT01244633|846356|P1|NOT COMPLETED|Overall Study||3
353498|NCT01244633|846356|P1|COMPLETED|Overall Study||15
353499|NCT01244633|846356|P1|STARTED|Overall Study||18
353500|NCT01244620|846360|P4|NOT COMPLETED|Overall Study||4
353501|NCT01244620|846361|P3|NOT COMPLETED|Overall Study||4
353502|NCT01244620|846362|P2|NOT COMPLETED|Overall Study||4
353503|NCT01244620|846363|P1|NOT COMPLETED|Overall Study||4
353504|NCT01244620|846360|P4|COMPLETED|Overall Study||0
353505|NCT01244620|846361|P3|COMPLETED|Overall Study||0
353506|NCT01244620|846362|P2|COMPLETED|Overall Study||0
353507|NCT01244620|846363|P1|COMPLETED|Overall Study||0
353508|NCT01244620|846360|P4|STARTED|Overall Study||4
353509|NCT01244620|846361|P3|STARTED|Overall Study||4
353510|NCT01244620|846362|P2|STARTED|Overall Study||4
353511|NCT01244620|846363|P1|STARTED|Overall Study||4
353512|NCT01244529|846397|P1|NOT COMPLETED|Overall Study||0
353513|NCT01244529|846397|P1|COMPLETED|Overall Study||41
353514|NCT01244529|846397|P1|STARTED|Overall Study||41
353515|NCT01244516|846422|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
353516|NCT01244516|846423|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
353517|NCT01244516|846424|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
353518|NCT01244516|846422|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
353519|NCT01244516|846423|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
353520|NCT01244516|846424|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
353521|NCT01244516|846422|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
353522|NCT01244516|846423|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
353523|NCT01244516|846424|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
353524|NCT01244516|846422|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
353525|NCT01244516|846423|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
353526|NCT01244516|846424|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
353527|NCT01244516|846422|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
353528|NCT01244516|846423|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
353529|NCT01244516|846424|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
353530|NCT01244516|846422|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
353531|NCT01244516|846423|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
353532|NCT01244516|846424|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
353533|NCT01244503|846437|P1|NOT COMPLETED|Overall Study||0
353534|NCT01244503|846437|P1|COMPLETED|Overall Study||61
353535|NCT01244503|846437|P1|STARTED|Overall Study||61
353536|NCT01244490|846445|P3|NOT COMPLETED|Overall Study||23
353537|NCT01244490|846446|P2|NOT COMPLETED|Overall Study||24
353538|NCT01244490|846447|P1|NOT COMPLETED|Overall Study||19
353539|NCT01244490|846445|P3|COMPLETED|Overall Study||89
353540|NCT01244490|846446|P2|COMPLETED|Overall Study||91
353541|NCT01244490|846447|P1|COMPLETED|Overall Study||92
353542|NCT01244490|846445|P3|STARTED|Overall Study||112
353543|NCT01244490|846446|P2|STARTED|Overall Study||115
353544|NCT01244490|846447|P1|STARTED|Overall Study||111
353545|NCT01244477|846502|P2|NOT COMPLETED|Overall Study||3
353546|NCT01244477|846503|P1|NOT COMPLETED|Overall Study||20
353547|NCT01244477|846502|P2|COMPLETED|Overall Study||20
353548|NCT01244477|846503|P1|COMPLETED|Overall Study||18
353549|NCT01244477|846502|P2|STARTED|Overall Study||23
353550|NCT01244477|846503|P1|STARTED|Overall Study||38
353551|NCT01244425|846515|P2|NOT COMPLETED|Overall Study||3
353552|NCT01244425|846516|P1|NOT COMPLETED|Overall Study||3
353553|NCT01244425|846515|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
353554|NCT01244425|846516|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
353555|NCT01244425|846515|P2|STARTED|Overall Study||35
353556|NCT01244425|846516|P1|STARTED|Overall Study||35
353557|NCT01244412|846536|P1|NOT COMPLETED|Overall Study||0
353558|NCT01244412|846536|P1|COMPLETED|Overall Study||1
353559|NCT01244412|846536|P1|STARTED|Overall Study||1
353560|NCT01244243|846540|P1|NOT COMPLETED|Overall Study||0
353561|NCT01244243|846540|P1|COMPLETED|Overall Study||41
353562|NCT01244243|846540|P1|STARTED|Overall Study||41
353563|NCT01244126|846548|P3|NOT COMPLETED|Overall Study||9
353564|NCT01244126|846549|P2|NOT COMPLETED|Overall Study||3
353565|NCT01244126|846550|P1|NOT COMPLETED|Overall Study||3
353566|NCT01244126|846548|P3|COMPLETED|Overall Study||48
353567|NCT01244126|846549|P2|COMPLETED|Overall Study||52
353568|NCT01244126|846550|P1|COMPLETED|Overall Study||56
353569|NCT01244126|846548|P3|STARTED|Overall Study||57
353570|NCT01244126|846549|P2|STARTED|Overall Study||55
353571|NCT01244126|846550|P1|STARTED|Overall Study||59
353572|NCT01244061|846563|P2|NOT COMPLETED|Overall Study||103
353573|NCT01244061|846564|P1|NOT COMPLETED|Overall Study||82
353574|NCT01244061|846563|P2|COMPLETED|Overall Study||144
353575|NCT01244061|846564|P1|COMPLETED|Overall Study||169
353576|NCT01244061|846563|P2|STARTED|Overall Study||247
353577|NCT01244061|846564|P1|STARTED|Overall Study||251
353578|NCT01243944|846578|P2|NOT COMPLETED|Overall Study||108
353579|NCT01243944|846579|P1|NOT COMPLETED|Overall Study||17
353580|NCT01243944|846578|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
353581|NCT01243944|846579|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
353582|NCT01243944|846578|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
353583|NCT01243944|846579|P1|STARTED|Overall Study||110
353584|NCT01243892|846603|P2|NOT COMPLETED|Overall Study||0
353585|NCT01243892|846604|P1|NOT COMPLETED|Overall Study||2
353586|NCT01243892|846603|P2|COMPLETED|Overall Study||3
353587|NCT01243892|846604|P1|COMPLETED|Overall Study||13
353588|NCT01243892|846603|P2|STARTED|Overall Study||3
353589|NCT01243892|846604|P1|STARTED|Overall Study||15
353590|NCT01243775|846614|P1|NOT COMPLETED|Overall Study||2
353591|NCT01243775|846614|P1|COMPLETED|Overall Study||31
353592|NCT01243775|846614|P1|STARTED|Overall Study||33
353593|NCT01243671|846621|P1|NOT COMPLETED|Overall Study||5
353594|NCT01243671|846621|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
353595|NCT01243671|846621|P1|Completed 52 Weeks of Treatment|Overall Study||17
353596|NCT01243671|846621|P1|Completed 24 Weeks of Treatment|Overall Study||18
353597|NCT01243671|846621|P1|STARTED|Overall Study||20
353598|NCT01243619|846634|P1|NOT COMPLETED|Overall Study||0
353599|NCT01243619|846634|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
353600|NCT01243619|846634|P1|STARTED|Overall Study||5
353601|NCT01243567|846640|P2|NOT COMPLETED|Overall Study||0
353602|NCT01243567|846641|P1|NOT COMPLETED|Overall Study||1
353603|NCT01243567|846640|P2|COMPLETED|Overall Study||38
353604|NCT01243567|846641|P1|COMPLETED|Overall Study||42
353605|NCT01243567|846640|P2|STARTED|Overall Study||38
353606|NCT01243567|846641|P1|STARTED|Overall Study||43
353607|NCT01243450|846658|P3|NOT COMPLETED|Overall Study||67
353608|NCT01243450|846659|P2|NOT COMPLETED|Overall Study||25
353609|NCT01243450|846660|P1|NOT COMPLETED|Overall Study||83
353610|NCT01243450|846658|P3|COMPLETED|Overall Study||337
353611|NCT01243450|846659|P2|COMPLETED|Overall Study||110
353612|NCT01243450|846660|P1|COMPLETED|Overall Study||318
353613|NCT01243450|846658|P3|STARTED|Overall Study||404
353614|NCT01243450|846659|P2|STARTED|Overall Study||135
353615|NCT01243450|846660|P1|STARTED|Overall Study||401
353616|NCT01243411|846668|P1|NOT COMPLETED|Overall Study||41
353617|NCT01243411|846668|P1|COMPLETED|Overall Study||306
353618|NCT01243411|846668|P1|STARTED|Overall Study||347
353619|NCT01243320|846680|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
353620|NCT01243320|846680|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
353621|NCT01243320|846680|P1|STARTED|32ppm Oral Silver (14 Days)||24
353622|NCT01243320|846680|P1|NOT COMPLETED|Washout (3 Days)||0
353623|NCT01243320|846680|P1|COMPLETED|Washout (3 Days)||36
353624|NCT01243320|846680|P1|STARTED|Washout (3 Days)||36
353625|NCT01243320|846680|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
353626|NCT01243320|846680|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
353627|NCT01243320|846680|P1|STARTED|10ppm Oral Silver (14 Days)||36
353628|NCT01243320|846680|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
353629|NCT01243320|846680|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
353630|NCT01243320|846680|P1|STARTED|10ppm Oral Silver (7 Days)||36
353631|NCT01243320|846680|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
353632|NCT01243320|846680|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
353633|NCT01243320|846680|P1|STARTED|10ppm Oral Silver (3 Days)||36
353634|NCT01243294|846756|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
353635|NCT01243294|846757|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
353636|NCT01243294|846756|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
353637|NCT01243294|846757|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
353638|NCT01243294|846756|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
353639|NCT01243294|846757|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
353640|NCT01243294|846756|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
353641|NCT01243294|846757|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
353642|NCT01243294|846756|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
353643|NCT01243294|846757|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
353644|NCT01243294|846756|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
353645|NCT01243294|846757|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
353646|NCT01243242|846775|P2|NOT COMPLETED|Overall Study||4
353647|NCT01243242|846776|P1|NOT COMPLETED|Overall Study||3
353648|NCT01243242|846775|P2|COMPLETED|Overall Study||56
353649|NCT01243242|846776|P1|COMPLETED|Overall Study||57
353650|NCT01243242|846775|P2|STARTED|Overall Study||60
353651|NCT01243242|846776|P1|STARTED|Overall Study||60
353652|NCT01243177|846790|P2|NOT COMPLETED|Overall Study||178
353653|NCT01243177|846791|P1|NOT COMPLETED|Overall Study||178
353654|NCT01243177|846790|P2|COMPLETED|Overall Study||264
353655|NCT01243177|846791|P1|COMPLETED|Overall Study||266
353656|NCT01243177|846790|P2|STARTED|Overall Study||442
353657|NCT01243177|846791|P1|STARTED|Overall Study||444
353658|NCT01243112|846807|P1|NOT COMPLETED|Overall Study||0
353659|NCT01243112|846807|P1|COMPLETED|Overall Study||25
353660|NCT01243112|846807|P1|STARTED|Overall Study||25
353661|NCT01242813|846812|P1|NOT COMPLETED|Overall Study||2
353662|NCT01242813|846812|P1|COMPLETED|Overall Study||18
353663|NCT01242813|846812|P1|STARTED|Overall Study||20
353664|NCT01242748|846834|P2|NOT COMPLETED|Overall Study||14
353665|NCT01242748|846835|P1|NOT COMPLETED|Overall Study||38
353666|NCT01242748|846834|P2|COMPLETED|Overall Study||80
353667|NCT01242748|846835|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
353668|NCT01242748|846834|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
353669|NCT01242748|846835|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
353670|NCT01242748|846834|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
353671|NCT01242748|846835|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
353672|NCT01242748|846834|P2|STARTED|Overall Study||94
353673|NCT01242748|846835|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
353674|NCT01242527|846859|P4|NOT COMPLETED|Overall Study||9
353675|NCT01242527|846860|P3|NOT COMPLETED|Overall Study||14
353676|NCT01242527|846861|P2|NOT COMPLETED|Overall Study||7
353677|NCT01242527|846862|P1|NOT COMPLETED|Overall Study||5
353678|NCT01242527|846859|P4|COMPLETED|Overall Study||90
353679|NCT01242527|846860|P3|COMPLETED|Overall Study||87
353680|NCT01242527|846861|P2|COMPLETED|Overall Study||93
353681|NCT01242527|846862|P1|COMPLETED|Overall Study||94
353682|NCT01242527|846859|P4|STARTED|Overall Study||99
353683|NCT01242527|846860|P3|STARTED|Overall Study||101
353684|NCT01242527|846861|P2|STARTED|Overall Study||100
353685|NCT01242527|846862|P1|STARTED|Overall Study||99
353686|NCT01242514|846875|P3|NOT COMPLETED|Overall Study||212
353687|NCT01242514|846876|P2|NOT COMPLETED|Overall Study||357
353688|NCT01242514|846877|P1|NOT COMPLETED|Overall Study||1343
353689|NCT01242514|846875|P3|COMPLETED|Overall Study|Due to project closure.|0
353690|NCT01242514|846876|P2|COMPLETED|Overall Study|Due to project closure.|0
353691|NCT01242514|846877|P1|COMPLETED|Overall Study|Due to project closure.|0
353692|NCT01242514|846875|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
353693|NCT01242514|846876|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
353694|NCT01242514|846877|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
353695|NCT01242514|846875|P3|STARTED|Overall Study|Patients who received treatment|212
353696|NCT01242514|846876|P2|STARTED|Overall Study|Patients who received treatment|357
353697|NCT01242514|846877|P1|STARTED|Overall Study|Patients who received treatment|1343
353698|NCT01242371|846896|P2|NOT COMPLETED|Overall Study||5
353699|NCT01242371|846897|P1|NOT COMPLETED|Overall Study||2
353700|NCT01242371|846896|P2|COMPLETED|Overall Study||27
353701|NCT01242371|846897|P1|COMPLETED|Overall Study||31
353702|NCT01242371|846896|P2|STARTED|Overall Study||32
353703|NCT01242371|846897|P1|STARTED|Overall Study||33
353704|NCT01242176|846903|P2|NOT COMPLETED|Second Intervention||0
353705|NCT01242176|846904|P1|NOT COMPLETED|Second Intervention||0
353706|NCT01242176|846903|P2|COMPLETED|Second Intervention||10
353707|NCT01242176|846904|P1|COMPLETED|Second Intervention||11
353708|NCT01242176|846903|P2|STARTED|Second Intervention||10
353709|NCT01242176|846904|P1|STARTED|Second Intervention||11
353710|NCT01242176|846903|P2|NOT COMPLETED|Washout Period of 7 Days||2
353711|NCT01242176|846904|P1|NOT COMPLETED|Washout Period of 7 Days||1
353712|NCT01242176|846903|P2|COMPLETED|Washout Period of 7 Days||10
353713|NCT01242176|846904|P1|COMPLETED|Washout Period of 7 Days||11
353714|NCT01242176|846903|P2|STARTED|Washout Period of 7 Days||12
353715|NCT01242176|846904|P1|STARTED|Washout Period of 7 Days||12
353716|NCT01242176|846903|P2|NOT COMPLETED|First Intervention||0
353717|NCT01242176|846904|P1|NOT COMPLETED|First Intervention||0
353718|NCT01242176|846903|P2|COMPLETED|First Intervention||12
353719|NCT01242176|846904|P1|COMPLETED|First Intervention||12
353720|NCT01242176|846903|P2|STARTED|First Intervention||12
353721|NCT01242176|846904|P1|STARTED|First Intervention||12
353722|NCT01242111|846914|P1|NOT COMPLETED|Overall Study||3
353723|NCT01242111|846914|P1|COMPLETED|Overall Study||17
353724|NCT01242111|846914|P1|STARTED|Overall Study||20
353725|NCT01242085|846926|P3|NOT COMPLETED|Overall Study||0
353726|NCT01242085|846927|P2|NOT COMPLETED|Overall Study||7
353727|NCT01242085|846928|P1|NOT COMPLETED|Overall Study||8
353728|NCT01242085|846926|P3|COMPLETED|Overall Study||1
353729|NCT01242085|846927|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
353730|NCT01242085|846928|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
353731|NCT01242085|846926|P3|STARTED|Overall Study||1
353732|NCT01242085|846927|P2|STARTED|Overall Study||33
353733|NCT01242085|846928|P1|STARTED|Overall Study||30
353734|NCT01241916|846938|P2|NOT COMPLETED|Overall Study||10
353735|NCT01241916|846939|P1|NOT COMPLETED|Overall Study||7
353736|NCT01241916|846938|P2|COMPLETED|Overall Study||21
353737|NCT01241916|846939|P1|COMPLETED|Overall Study||28
353738|NCT01241916|846938|P2|STARTED|Overall Study||31
353739|NCT01241916|846939|P1|STARTED|Overall Study||35
353740|NCT01241903|846949|P2|NOT COMPLETED|Overall Study||0
353741|NCT01241903|846950|P1|NOT COMPLETED|Overall Study||1
353742|NCT01241903|846949|P2|COMPLETED|Overall Study||27
353743|NCT01241903|846950|P1|COMPLETED|Overall Study||26
353744|NCT01241903|846949|P2|STARTED|Overall Study||27
353745|NCT01241903|846950|P1|STARTED|Overall Study||27
353746|NCT01241760|846958|P2|NOT COMPLETED|Overall Study||40
353747|NCT01241760|846959|P1|NOT COMPLETED|Overall Study||34
353748|NCT01241760|846958|P2|COMPLETED|Overall Study||329
353749|NCT01241760|846959|P1|COMPLETED|Overall Study||337
353750|NCT01241760|846958|P2|STARTED|Overall Study||369
353751|NCT01241760|846959|P1|STARTED|Overall Study||371
353752|NCT01241591|846982|P4|NOT COMPLETED|Overall Study||12
353753|NCT01241591|846983|P3|NOT COMPLETED|Overall Study||22
353754|NCT01241591|846984|P2|NOT COMPLETED|Overall Study||24
353755|NCT01241591|846985|P1|NOT COMPLETED|Overall Study||23
353756|NCT01241591|846982|P4|COMPLETED|Overall Study||95
353757|NCT01241591|846983|P3|COMPLETED|Overall Study||313
353758|NCT01241591|846984|P2|COMPLETED|Overall Study||306
353759|NCT01241591|846985|P1|COMPLETED|Overall Study||306
353760|NCT01241591|846982|P4|STARTED|Overall Study||107
353761|NCT01241591|846983|P3|STARTED|Overall Study||335
353762|NCT01241591|846984|P2|STARTED|Overall Study||330
353763|NCT01241591|846985|P1|STARTED|Overall Study||329
353764|NCT01241565|847175|P1|NOT COMPLETED|Overall Study||0
353765|NCT01241565|847175|P1|COMPLETED|Overall Study||50
353766|NCT01241565|847175|P1|STARTED|Overall Study||50
353767|NCT01241552|847188|P4|NOT COMPLETED|Overall Study||64
353768|NCT01241552|847189|P3|NOT COMPLETED|Overall Study||60
353769|NCT01241552|847190|P2|NOT COMPLETED|Overall Study||63
353770|NCT01241552|847191|P1|NOT COMPLETED|Overall Study||41
353771|NCT01241552|847188|P4|COMPLETED|Overall Study||340
353772|NCT01241552|847189|P3|COMPLETED|Overall Study||343
353773|NCT01241552|847190|P2|COMPLETED|Overall Study||340
353774|NCT01241552|847191|P1|COMPLETED|Overall Study||201
353775|NCT01241552|847188|P4|Treated|Overall Study||397
353776|NCT01241552|847189|P3|Treated|Overall Study||388
353777|NCT01241552|847190|P2|Treated|Overall Study||392
353778|NCT01241552|847191|P1|Treated|Overall Study||235
353779|NCT01241552|847188|P4|STARTED|Overall Study||404
353780|NCT01241552|847189|P3|STARTED|Overall Study||403
353781|NCT01241552|847190|P2|STARTED|Overall Study||403
353782|NCT01241552|847191|P1|STARTED|Overall Study||242
353783|NCT01241539|847257|P1|NOT COMPLETED|Period 2||0
353784|NCT01241539|847257|P1|COMPLETED|Period 2||7
353785|NCT01241539|847257|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
353786|NCT01241539|847257|P1|NOT COMPLETED|Period 1||0
353787|NCT01241539|847257|P1|COMPLETED|Period 1||7
353788|NCT01241539|847257|P1|STARTED|Period 1||7
353789|NCT01241513|847278|P2|NOT COMPLETED|Overall Study||0
353790|NCT01241513|847279|P1|NOT COMPLETED|Overall Study||0
353791|NCT01241513|847278|P2|COMPLETED|Overall Study||9
353792|NCT01241513|847279|P1|COMPLETED|Overall Study|Study has been completed|10
353793|NCT01241513|847278|P2|STARTED|Overall Study||9
353794|NCT01241513|847279|P1|STARTED|Overall Study||10
353795|NCT01241292|847286|P2|NOT COMPLETED|Overall Study||2
353796|NCT01241292|847287|P1|NOT COMPLETED|Overall Study||1
353797|NCT01241292|847286|P2|COMPLETED|Overall Study|completed=treatment on-going|1
353798|NCT01241292|847287|P1|COMPLETED|Overall Study|completed=treatment on-going|2
353799|NCT01241292|847286|P2|STARTED|Overall Study||3
353800|NCT01241292|847287|P1|STARTED|Overall Study||3
353801|NCT01241279|847311|P2|NOT COMPLETED|Overall Study||1
353802|NCT01241279|847312|P1|NOT COMPLETED|Overall Study||0
353803|NCT01241279|847311|P2|COMPLETED|Overall Study||1
353804|NCT01241279|847312|P1|COMPLETED|Overall Study||4
353805|NCT01241279|847311|P2|STARTED|Overall Study||2
353806|NCT01241279|847312|P1|STARTED|Overall Study||4
353807|NCT01241240|847322|P2|NOT COMPLETED|Overall Study||9
353808|NCT01241240|847323|P1|NOT COMPLETED|Overall Study||8
353809|NCT01241240|847322|P2|COMPLETED|Overall Study||89
353810|NCT01241240|847323|P1|COMPLETED|Overall Study||86
353811|NCT01241240|847322|P2|STARTED|Overall Study||98
353812|NCT01241240|847323|P1|STARTED|Overall Study||94
353813|NCT01240915|847341|P9|NOT COMPLETED|Overall Study||8
353814|NCT01240915|847342|P8|NOT COMPLETED|Overall Study||4
353815|NCT01240915|847343|P7|NOT COMPLETED|Overall Study||8
353816|NCT01240915|847344|P6|NOT COMPLETED|Overall Study||10
353817|NCT01240915|847345|P5|NOT COMPLETED|Overall Study||4
353818|NCT01240915|847346|P4|NOT COMPLETED|Overall Study||3
353819|NCT01240915|847347|P3|NOT COMPLETED|Overall Study||0
353820|NCT01240915|847348|P2|NOT COMPLETED|Overall Study||1
353821|NCT01240915|847349|P1|NOT COMPLETED|Overall Study||2
353822|NCT01240915|847341|P9|COMPLETED|Overall Study||13
353823|NCT01240915|847342|P8|COMPLETED|Overall Study||15
353824|NCT01240915|847343|P7|COMPLETED|Overall Study||17
353825|NCT01240915|847344|P6|COMPLETED|Overall Study||13
353826|NCT01240915|847345|P5|COMPLETED|Overall Study||2
353827|NCT01240915|847346|P4|COMPLETED|Overall Study||1
353828|NCT01240915|847347|P3|COMPLETED|Overall Study||2
353829|NCT01240915|847348|P2|COMPLETED|Overall Study||2
353830|NCT01240915|847349|P1|COMPLETED|Overall Study||0
353831|NCT01240915|847341|P9|STARTED|Overall Study||21
353832|NCT01240915|847342|P8|STARTED|Overall Study||19
353833|NCT01240915|847343|P7|STARTED|Overall Study||25
353834|NCT01240915|847344|P6|STARTED|Overall Study||23
353835|NCT01240915|847345|P5|STARTED|Overall Study||6
353836|NCT01240915|847346|P4|STARTED|Overall Study||4
353837|NCT01240915|847347|P3|STARTED|Overall Study||2
353838|NCT01240915|847348|P2|STARTED|Overall Study||3
353839|NCT01240915|847349|P1|STARTED|Overall Study||2
353840|NCT01240902|847532|P4|NOT COMPLETED|Overall Study||165
353841|NCT01240902|847533|P3|NOT COMPLETED|Overall Study||100
353842|NCT01240902|847534|P2|NOT COMPLETED|Overall Study||79
353843|NCT01240902|847535|P1|NOT COMPLETED|Overall Study||211
353844|NCT01240902|847532|P4|COMPLETED|Overall Study||237
353845|NCT01240902|847533|P3|COMPLETED|Overall Study||295
353846|NCT01240902|847534|P2|COMPLETED|Overall Study||77
353847|NCT01240902|847535|P1|COMPLETED|Overall Study||289
353848|NCT01240902|847532|P4|STARTED|Overall Study||402
353849|NCT01240902|847533|P3|STARTED|Overall Study||395
353850|NCT01240902|847534|P2|STARTED|Overall Study||156
353851|NCT01240902|847535|P1|STARTED|Overall Study||500
353852|NCT01240863|847623|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
353853|NCT01240863|847624|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
353854|NCT01240863|847625|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
353855|NCT01240863|847623|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
353856|NCT01240863|847624|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
353857|NCT01240863|847625|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
353858|NCT01240863|847623|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
353859|NCT01240863|847624|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
353860|NCT01240863|847625|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
353861|NCT01240863|847623|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
353862|NCT01240863|847624|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
353863|NCT01240863|847625|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
353864|NCT01240863|847623|P3|NOT COMPLETED|Open-label Titration Period||0
353865|NCT01240863|847624|P2|NOT COMPLETED|Open-label Titration Period||0
353866|NCT01240863|847625|P1|NOT COMPLETED|Open-label Titration Period||97
353867|NCT01240863|847623|P3|COMPLETED|Open-label Titration Period||0
353868|NCT01240863|847624|P2|COMPLETED|Open-label Titration Period||0
353869|NCT01240863|847625|P1|COMPLETED|Open-label Titration Period||294
353870|NCT01240863|847623|P3|Safety Analysis Set|Open-label Titration Period||0
353871|NCT01240863|847624|P2|Safety Analysis Set|Open-label Titration Period||0
353872|NCT01240863|847625|P1|Safety Analysis Set|Open-label Titration Period||389
353873|NCT01240863|847623|P3|STARTED|Open-label Titration Period||0
353874|NCT01240863|847624|P2|STARTED|Open-label Titration Period||0
353875|NCT01240863|847625|P1|STARTED|Open-label Titration Period||391
353876|NCT01240811|847687|P3|NOT COMPLETED|Overall Study||1
353877|NCT01240811|847688|P2|NOT COMPLETED|Overall Study||1
353878|NCT01240811|847689|P1|NOT COMPLETED|Overall Study||0
353879|NCT01240811|847687|P3|COMPLETED|Overall Study||16
353880|NCT01240811|847688|P2|COMPLETED|Overall Study||16
353881|NCT01240811|847689|P1|COMPLETED|Overall Study||8
353882|NCT01240811|847687|P3|STARTED|Overall Study||17
353883|NCT01240811|847688|P2|STARTED|Overall Study||17
353884|NCT01240811|847689|P1|STARTED|Overall Study||8
353885|NCT01240785|847699|P2|NOT COMPLETED|Overall Study||3
353886|NCT01240785|847700|P1|NOT COMPLETED|Overall Study||1
353887|NCT01240785|847699|P2|COMPLETED|Overall Study||107
353888|NCT01240785|847700|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
353889|NCT01240785|847699|P2|STARTED|Overall Study||110
353890|NCT01240785|847700|P1|STARTED|Overall Study||111
353891|NCT01240746|847731|P3|NOT COMPLETED|Overall Study||243
353892|NCT01240746|847732|P2|NOT COMPLETED|Overall Study||48
353893|NCT01240746|847733|P1|NOT COMPLETED|Overall Study||59
353894|NCT01240746|847731|P3|COMPLETED|Overall Study||2659
353895|NCT01240746|847732|P2|COMPLETED|Overall Study||677
353896|NCT01240746|847733|P1|COMPLETED|Overall Study||677
353897|NCT01240746|847731|P3|STARTED|Overall Study||2902
353898|NCT01240746|847732|P2|STARTED|Overall Study||725
353899|NCT01240746|847733|P1|STARTED|Overall Study||736
353900|NCT01240590|847788|P5|NOT COMPLETED|Phase II||1
353901|NCT01240590|847789|P4|NOT COMPLETED|Phase II||2
353902|NCT01240590|847790|P3|NOT COMPLETED|Phase II||0
353903|NCT01240590|847791|P2|NOT COMPLETED|Phase II||0
353904|NCT01240590|847792|P1|NOT COMPLETED|Phase II||0
353905|NCT01240590|847788|P5|COMPLETED|Phase II||0
353906|NCT01240590|847789|P4|COMPLETED|Phase II||15
353907|NCT01240590|847790|P3|COMPLETED|Phase II||0
353908|NCT01240590|847791|P2|COMPLETED|Phase II||0
353909|NCT01240590|847792|P1|COMPLETED|Phase II||0
353910|NCT01240590|847788|P5|STARTED|Phase II||1
353911|NCT01240590|847789|P4|STARTED|Phase II||17
353912|NCT01240590|847790|P3|STARTED|Phase II||0
353913|NCT01240590|847791|P2|STARTED|Phase II||0
353914|NCT01240590|847792|P1|STARTED|Phase II||0
353915|NCT01240590|847788|P5|NOT COMPLETED|Phase I||0
353916|NCT01240590|847789|P4|NOT COMPLETED|Phase I||0
353917|NCT01240590|847790|P3|NOT COMPLETED|Phase I||3
353918|NCT01240590|847791|P2|NOT COMPLETED|Phase I||0
353919|NCT01240590|847792|P1|NOT COMPLETED|Phase I||0
353920|NCT01240590|847788|P5|COMPLETED|Phase I||0
353921|NCT01240590|847789|P4|COMPLETED|Phase I||0
353922|NCT01240590|847790|P3|COMPLETED|Phase I||0
353923|NCT01240590|847791|P2|COMPLETED|Phase I||6
353924|NCT01240590|847792|P1|COMPLETED|Phase I||0
353925|NCT01240590|847788|P5|STARTED|Phase I||0
353926|NCT01240590|847789|P4|STARTED|Phase I||0
353927|NCT01240590|847790|P3|STARTED|Phase I||3
353928|NCT01240590|847791|P2|STARTED|Phase I||6
353929|NCT01240590|847792|P1|STARTED|Phase I||0
353930|NCT01240551|847820|P2|NOT COMPLETED|Overall Study||3
353931|NCT01240551|847821|P1|NOT COMPLETED|Overall Study||4
353932|NCT01240551|847820|P2|COMPLETED|Overall Study||27
353933|NCT01240551|847821|P1|COMPLETED|Overall Study||26
353934|NCT01240551|847820|P2|STARTED|Overall Study||30
353935|NCT01240551|847821|P1|STARTED|Overall Study||30
353936|NCT01240382|847831|P2|NOT COMPLETED|Overall Study||4
353937|NCT01240382|847832|P1|NOT COMPLETED|Overall Study||2
353938|NCT01240382|847831|P2|COMPLETED|Overall Study||139
353939|NCT01240382|847832|P1|COMPLETED|Overall Study||142
353940|NCT01240382|847831|P2|STARTED|Overall Study||143
353941|NCT01240382|847832|P1|STARTED|Overall Study||144
353942|NCT01240356|847842|P2|NOT COMPLETED|Overall Study||0
353943|NCT01240356|847843|P1|NOT COMPLETED|Overall Study||3
353944|NCT01240356|847842|P2|COMPLETED|Overall Study||20
353945|NCT01240356|847843|P1|COMPLETED|Overall Study||15
353946|NCT01240356|847842|P2|STARTED|Overall Study||20
353947|NCT01240356|847843|P1|STARTED|Overall Study||18
353948|NCT01240330|847854|P1|NOT COMPLETED|Overall Study||0
353949|NCT01240330|847854|P1|COMPLETED|Overall Study||33
353950|NCT01240330|847854|P1|STARTED|Overall Study||33
353951|NCT01240200|847862|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
353952|NCT01240200|847863|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
353953|NCT01240200|847862|P2|COMPLETED|12-week Crossover Phase - Period 2||23
353954|NCT01240200|847863|P1|COMPLETED|12-week Crossover Phase - Period 2||23
353955|NCT01240200|847862|P2|STARTED|12-week Crossover Phase - Period 2||23
353956|NCT01240200|847863|P1|STARTED|12-week Crossover Phase - Period 2||23
353957|NCT01240200|847862|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
353958|NCT01240200|847863|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
353959|NCT01240200|847862|P2|COMPLETED|12-week Crossover Phase - Period 1||23
353960|NCT01240200|847863|P1|COMPLETED|12-week Crossover Phase - Period 1||23
353961|NCT01240200|847862|P2|STARTED|12-week Crossover Phase - Period 1||24
353962|NCT01240200|847863|P1|STARTED|12-week Crossover Phase - Period 1||25
353963|NCT01240135|847871|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
353964|NCT01240135|847872|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
353965|NCT01240135|847871|P2|COMPLETED|Period Two, 14 Days of Wear||43
353966|NCT01240135|847872|P1|COMPLETED|Period Two, 14 Days of Wear||43
353967|NCT01240135|847871|P2|STARTED|Period Two, 14 Days of Wear||45
353968|NCT01240135|847872|P1|STARTED|Period Two, 14 Days of Wear||44
353969|NCT01240135|847871|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
353970|NCT01240135|847872|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
353971|NCT01240135|847871|P2|COMPLETED|Period One, 14 Days of Wear||45
353972|NCT01240135|847872|P1|COMPLETED|Period One, 14 Days of Wear||44
353973|NCT01240135|847871|P2|STARTED|Period One, 14 Days of Wear||45
353974|NCT01240135|847872|P1|STARTED|Period One, 14 Days of Wear||44
353975|NCT01240122|847880|P1|NOT COMPLETED|Overall Study||0
353976|NCT01240122|847880|P1|COMPLETED|Overall Study||29
353977|NCT01240122|847880|P1|STARTED|Overall Study||29
353978|NCT01239992|847887|P1|NOT COMPLETED|Overall Study||2
353979|NCT01239992|847887|P1|COMPLETED|Overall Study||10
353980|NCT01239992|847887|P1|STARTED|Overall Study||12
353981|NCT01239797|847896|P2|NOT COMPLETED|Treated Participants||274
353982|NCT01239797|847897|P1|NOT COMPLETED|Treated Participants||235
353983|NCT01239797|847896|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
353984|NCT01239797|847897|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
353985|NCT01239797|847896|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
353986|NCT01239797|847897|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
353987|NCT01239797|847896|P2|NOT COMPLETED|Randomized Participants||9
353988|NCT01239797|847897|P1|NOT COMPLETED|Randomized Participants||2
353989|NCT01239797|847896|P2|COMPLETED|Randomized Participants||316
353990|NCT01239797|847897|P1|COMPLETED|Randomized Participants||319
353991|NCT01239797|847896|P2|STARTED|Randomized Participants||325
353992|NCT01239797|847897|P1|STARTED|Randomized Participants||321
353993|NCT01239745|847905|P1|NOT COMPLETED|Overall Study||46
353994|NCT01239745|847905|P1|COMPLETED|Overall Study||0
353995|NCT01239745|847905|P1|STARTED|Overall Study||46
353996|NCT01239732|847916|P1|NOT COMPLETED|Overall Study||1021
353997|NCT01239732|847916|P1|COMPLETED|Overall Study||0
353998|NCT01239732|847916|P1|STARTED|Overall Study||1021
353999|NCT01239680|847929|P2|NOT COMPLETED|Overall Study||0
354000|NCT01239680|847930|P1|NOT COMPLETED|Overall Study||2
354001|NCT01239680|847929|P2|COMPLETED|Overall Study||2
354002|NCT01239680|847930|P1|COMPLETED|Overall Study||1
354003|NCT01239680|847929|P2|STARTED|Overall Study||2
354004|NCT01239680|847930|P1|STARTED|Overall Study||3
354005|NCT01239511|847940|P4|NOT COMPLETED|Overall Study||9
354006|NCT01239511|847941|P3|NOT COMPLETED|Overall Study||4
354007|NCT01239511|847942|P2|NOT COMPLETED|Overall Study||5
354008|NCT01239511|847943|P1|NOT COMPLETED|Overall Study||1
354009|NCT01239511|847940|P4|COMPLETED|Overall Study||38
354010|NCT01239511|847941|P3|COMPLETED|Overall Study||43
354011|NCT01239511|847942|P2|COMPLETED|Overall Study||40
354012|NCT01239511|847943|P1|COMPLETED|Overall Study||46
354013|NCT01239511|847940|P4|STARTED|Overall Study||47
354014|NCT01239511|847941|P3|STARTED|Overall Study||47
354015|NCT01239511|847942|P2|STARTED|Overall Study||45
354016|NCT01239511|847943|P1|STARTED|Overall Study||47
354017|NCT01239394|847953|P1|NOT COMPLETED|Overall Study||1
354018|NCT01239394|847953|P1|COMPLETED|Overall Study||41
354019|NCT01239394|847953|P1|STARTED|Overall Study||42
354020|NCT01239355|847960|P1|NOT COMPLETED|Overall Study||0
354021|NCT01239355|847960|P1|COMPLETED|Overall Study||15
354022|NCT01239355|847960|P1|STARTED|Overall Study||15
354023|NCT01239342|847968|P2|NOT COMPLETED|Overall Study||6
354024|NCT01239342|847969|P1|NOT COMPLETED|Overall Study||3
354025|NCT01239342|847968|P2|COMPLETED|Overall Study||8
354026|NCT01239342|847969|P1|COMPLETED|Overall Study||26
354027|NCT01239342|847968|P2|STARTED|Overall Study||14
354028|NCT01239342|847969|P1|STARTED|Overall Study||29
354029|NCT01239316|847985|P1|NOT COMPLETED|Overall Study||12
354030|NCT01239316|847985|P1|COMPLETED|Overall Study||0
354031|NCT01239316|847985|P1|STARTED|Overall Study||12
354032|NCT01239212|847993|P1|NOT COMPLETED|Overall Study||0
354033|NCT01239212|847993|P1|COMPLETED|Overall Study||7
354034|NCT01239212|847993|P1|STARTED|Overall Study||7
354035|NCT01239121|848000|P3|NOT COMPLETED|Overall Study||0
354036|NCT01239121|848001|P2|NOT COMPLETED|Overall Study||4
354037|NCT01239121|848002|P1|NOT COMPLETED|Overall Study||2
354038|NCT01239121|848000|P3|COMPLETED|Overall Study||15
354039|NCT01239121|848001|P2|COMPLETED|Overall Study||195
354040|NCT01239121|848002|P1|COMPLETED|Overall Study||186
354041|NCT01239121|848000|P3|STARTED|Overall Study||15
354042|NCT01239121|848001|P2|STARTED|Overall Study||199
354043|NCT01239121|848002|P1|STARTED|Overall Study||188
354044|NCT01239056|848016|P1|NOT COMPLETED|Overall Study||0
354045|NCT01239056|848016|P1|COMPLETED|Overall Study||20
354046|NCT01239056|848016|P1|STARTED|Overall Study||20
354047|NCT01239043|848024|P2|NOT COMPLETED|Overall Study||1
354048|NCT01239043|848025|P1|NOT COMPLETED|Overall Study||2
354049|NCT01239043|848024|P2|COMPLETED|Overall Study||102
354050|NCT01239043|848025|P1|COMPLETED|Overall Study||34
354051|NCT01239043|848024|P2|STARTED|Overall Study||103
354052|NCT01239043|848025|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
354053|NCT01238991|848053|P10|NOT COMPLETED|Overall Study||2
354054|NCT01238991|848054|P9|NOT COMPLETED|Overall Study||4
354055|NCT01238991|848055|P8|NOT COMPLETED|Overall Study||5
354056|NCT01238991|848056|P7|NOT COMPLETED|Overall Study||8
354057|NCT01238991|848057|P6|NOT COMPLETED|Overall Study||0
354058|NCT01238991|848058|P5|NOT COMPLETED|Overall Study||2
354059|NCT01238991|848059|P4|NOT COMPLETED|Overall Study||2
354060|NCT01238991|848060|P3|NOT COMPLETED|Overall Study||6
354061|NCT01238991|848061|P2|NOT COMPLETED|Overall Study||0
354062|NCT01238991|848062|P1|NOT COMPLETED|Overall Study||2
354063|NCT01238991|848053|P10|COMPLETED|Overall Study||0
354064|NCT01238991|848054|P9|COMPLETED|Overall Study||0
354065|NCT01238991|848055|P8|COMPLETED|Overall Study||0
354066|NCT01238991|848056|P7|COMPLETED|Overall Study||0
354067|NCT01238991|848057|P6|COMPLETED|Overall Study||2
354068|NCT01238991|848058|P5|COMPLETED|Overall Study||3
354069|NCT01238991|848059|P4|COMPLETED|Overall Study||4
354070|NCT01238991|848060|P3|COMPLETED|Overall Study||5
354071|NCT01238991|848061|P2|COMPLETED|Overall Study||3
354072|NCT01238991|848062|P1|COMPLETED|Overall Study||5
354073|NCT01238991|848053|P10|Received Treatment|Overall Study||2
354074|NCT01238991|848054|P9|Received Treatment|Overall Study||4
354075|NCT01238991|848055|P8|Received Treatment|Overall Study||5
354076|NCT01238991|848056|P7|Received Treatment|Overall Study||8
354077|NCT01238991|848057|P6|Received Treatment|Overall Study||2
354078|NCT01238991|848058|P5|Received Treatment|Overall Study||5
354079|NCT01238991|848059|P4|Received Treatment|Overall Study||6
354080|NCT01238991|848060|P3|Received Treatment|Overall Study||11
354081|NCT01238991|848061|P2|Received Treatment|Overall Study||3
354082|NCT01238991|848062|P1|Received Treatment|Overall Study||7
354083|NCT01238991|848053|P10|STARTED|Overall Study||2
354084|NCT01238991|848054|P9|STARTED|Overall Study||4
354085|NCT01238991|848055|P8|STARTED|Overall Study||5
354086|NCT01238991|848056|P7|STARTED|Overall Study||8
354087|NCT01238991|848057|P6|STARTED|Overall Study||2
354088|NCT01238991|848058|P5|STARTED|Overall Study||5
354089|NCT01238991|848059|P4|STARTED|Overall Study||6
354090|NCT01238991|848060|P3|STARTED|Overall Study||11
354091|NCT01238991|848061|P2|STARTED|Overall Study||3
354092|NCT01238991|848062|P1|STARTED|Overall Study||7
354093|NCT01238900|848149|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
354094|NCT01238900|848149|P1|COMPLETED|<12 Months Post Stent Removal||18
354095|NCT01238900|848149|P1|STARTED|<12 Months Post Stent Removal||23
354096|NCT01238900|848149|P1|NOT COMPLETED|6 Months Post Stent Placement||0
354097|NCT01238900|848149|P1|COMPLETED|6 Months Post Stent Placement||23
354098|NCT01238900|848149|P1|STARTED|6 Months Post Stent Placement||23
354099|NCT01238861|848163|P6|NOT COMPLETED|Overall Study||15
354100|NCT01238861|848164|P5|NOT COMPLETED|Overall Study||13
354101|NCT01238861|848165|P4|NOT COMPLETED|Overall Study||13
354102|NCT01238861|848166|P3|NOT COMPLETED|Overall Study||11
354103|NCT01238861|848167|P2|NOT COMPLETED|Overall Study||8
354104|NCT01238861|848168|P1|NOT COMPLETED|Overall Study||11
354105|NCT01238861|848163|P6|COMPLETED|Overall Study||125
354106|NCT01238861|848164|P5|COMPLETED|Overall Study||129
354107|NCT01238861|848165|P4|COMPLETED|Overall Study||69
354108|NCT01238861|848166|P3|COMPLETED|Overall Study||70
354109|NCT01238861|848167|P2|COMPLETED|Overall Study||73
354110|NCT01238861|848168|P1|COMPLETED|Overall Study||69
354111|NCT01238861|848163|P6|STARTED|Overall Study||140
354112|NCT01238861|848164|P5|STARTED|Overall Study||142
354113|NCT01238861|848165|P4|STARTED|Overall Study||82
354114|NCT01238861|848166|P3|STARTED|Overall Study||81
354115|NCT01238861|848167|P2|STARTED|Overall Study||81
354116|NCT01238861|848168|P1|STARTED|Overall Study||80
354117|NCT01238848|848248|P2|NOT COMPLETED|Overall Study||5
354118|NCT01238848|848249|P1|NOT COMPLETED|Overall Study||13
354119|NCT01238848|848248|P2|COMPLETED|Overall Study||45
354120|NCT01238848|848249|P1|COMPLETED|Overall Study||37
354121|NCT01238848|848248|P2|STARTED|Overall Study||50
354122|NCT01238848|848249|P1|STARTED|Overall Study||50
354123|NCT01238822|848257|P1|NOT COMPLETED|Overall Study||3
354124|NCT01238822|848257|P1|COMPLETED|Overall Study||93
354125|NCT01238822|848257|P1|Received High Dosage|Overall Study||93
354126|NCT01238822|848257|P1|Received Medium Dosage|Overall Study||93
354127|NCT01238822|848257|P1|Received Low Dosage|Overall Study||93
354128|NCT01238822|848257|P1|Received Placebo|Overall Study||93
354129|NCT01238822|848257|P1|STARTED|Overall Study||96
354130|NCT01238640|848267|P1|NOT COMPLETED|Overall Study||0
354131|NCT01238640|848267|P1|COMPLETED|Overall Study||84
354132|NCT01238640|848267|P1|STARTED|Overall Study||84
354133|NCT01238575|848286|P2|NOT COMPLETED|Overall Study||4
354134|NCT01238575|848287|P1|NOT COMPLETED|Overall Study||4
354135|NCT01238575|848286|P2|COMPLETED|Overall Study||28
354136|NCT01238575|848287|P1|COMPLETED|Overall Study||26
354137|NCT01238575|848286|P2|STARTED|Overall Study||32
354138|NCT01238575|848287|P1|STARTED|Overall Study||30
354139|NCT01238471|848325|P2|NOT COMPLETED|Overall Study||0
354140|NCT01238471|848326|P1|NOT COMPLETED|Overall Study||0
354141|NCT01238471|848325|P2|COMPLETED|Overall Study||10
354142|NCT01238471|848326|P1|COMPLETED|Overall Study||10
354143|NCT01238471|848325|P2|STARTED|Overall Study||10
354144|NCT01238471|848326|P1|STARTED|Overall Study||10
354145|NCT01238341|848332|P1|NOT COMPLETED|Overall Study||0
354146|NCT01238341|848332|P1|COMPLETED|Overall Study||7
354147|NCT01238341|848332|P1|STARTED|Overall Study||7
354148|NCT01238211|848339|P1|NOT COMPLETED|Overall Study||58
354149|NCT01238211|848339|P1|COMPLETED|Overall Study||3
354150|NCT01238211|848339|P1|STARTED|Overall Study||61
354151|NCT01237613|848343|P1|NOT COMPLETED|Overall Study||0
354152|NCT01237613|848343|P1|COMPLETED|Overall Study||4
354153|NCT01237613|848343|P1|STARTED|Overall Study||4
354154|NCT01237353|848367|P1|NOT COMPLETED|Overall Study||0
354155|NCT01237353|848367|P1|COMPLETED|Overall Study||6
354156|NCT01237353|848367|P1|STARTED|Overall Study||6
354157|NCT01237340|848372|P1|NOT COMPLETED|Overall Study||40
354158|NCT01237340|848372|P1|COMPLETED|Overall Study||19
354159|NCT01237340|848372|P1|STARTED|Overall Study||59
354160|NCT01237327|848386|P2|NOT COMPLETED|Overall Study||40
354161|NCT01237327|848387|P1|NOT COMPLETED|Overall Study||42
354162|NCT01237327|848386|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
354163|NCT01237327|848387|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
354164|NCT01237327|848386|P2|Continued Treatment in Extension Study|Overall Study||17
354165|NCT01237327|848387|P1|Continued Treatment in Extension Study|Overall Study||21
354166|NCT01237327|848386|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
354167|NCT01237327|848387|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
354168|NCT01237327|848386|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
354169|NCT01237327|848387|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
354170|NCT01237327|848386|P2|STARTED|Overall Study||41
354171|NCT01237327|848387|P1|STARTED|Overall Study||43
354172|NCT01237301|848403|P2|NOT COMPLETED|Overall Study||4
354173|NCT01237301|848404|P1|NOT COMPLETED|Overall Study||5
354174|NCT01237301|848403|P2|COMPLETED|Overall Study||55
354175|NCT01237301|848404|P1|COMPLETED|Overall Study||60
354176|NCT01237301|848403|P2|STARTED|Overall Study||59
354177|NCT01237301|848404|P1|STARTED|Overall Study||65
354178|NCT01237223|848416|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
354179|NCT01237223|848417|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
354180|NCT01237223|848418|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
354181|NCT01237223|848419|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
354182|NCT01237223|848420|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
354183|NCT01237223|848421|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
354184|NCT01237223|848416|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
354185|NCT01237223|848417|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
354186|NCT01237223|848418|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
354187|NCT01237223|848419|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
354188|NCT01237223|848420|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
354189|NCT01237223|848421|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
354190|NCT01237223|848416|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
354191|NCT01237223|848417|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
354192|NCT01237223|848418|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
354193|NCT01237223|848419|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
354194|NCT01237223|848420|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
354195|NCT01237223|848421|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
354196|NCT01237223|848416|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354197|NCT01237223|848417|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354198|NCT01237223|848418|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354199|NCT01237223|848419|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354200|NCT01237223|848420|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354201|NCT01237223|848421|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
354202|NCT01237223|848416|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354203|NCT01237223|848417|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354204|NCT01237223|848418|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354205|NCT01237223|848419|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354206|NCT01237223|848420|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
354207|NCT01237223|848421|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
354208|NCT01237223|848416|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
354209|NCT01237223|848417|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
354210|NCT01237223|848418|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
354211|NCT01237223|848419|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
354212|NCT01237223|848420|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
354213|NCT01237223|848421|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
354214|NCT01237197|848462|P2|NOT COMPLETED|Open Label Period||0
354215|NCT01237197|848463|P1|NOT COMPLETED|Open Label Period||0
354216|NCT01237197|848462|P2|COMPLETED|Open Label Period||10
354217|NCT01237197|848463|P1|COMPLETED|Open Label Period||12
354218|NCT01237197|848462|P2|STARTED|Open Label Period||10
354219|NCT01237197|848463|P1|STARTED|Open Label Period||12
354220|NCT01237197|848462|P2|NOT COMPLETED|Randomization Period||3
354221|NCT01237197|848463|P1|NOT COMPLETED|Randomization Period||1
354222|NCT01237197|848462|P2|COMPLETED|Randomization Period||10
354223|NCT01237197|848463|P1|COMPLETED|Randomization Period||12
354224|NCT01237197|848462|P2|STARTED|Randomization Period||13
354225|NCT01237197|848463|P1|STARTED|Randomization Period||13
354226|NCT01237080|848471|P2|NOT COMPLETED|Overall Study||0
354227|NCT01237080|848472|P1|NOT COMPLETED|Overall Study||0
354228|NCT01237080|848471|P2|COMPLETED|Overall Study||50
354229|NCT01237080|848472|P1|COMPLETED|Overall Study||50
354230|NCT01237080|848471|P2|STARTED|Overall Study||50
354231|NCT01237080|848472|P1|STARTED|Overall Study||50
354232|NCT01237054|848480|P1|NOT COMPLETED|Overall Study||1
354233|NCT01237054|848480|P1|COMPLETED|Overall Study||30
354234|NCT01237054|848480|P1|STARTED|Overall Study||31
354235|NCT01236573|848500|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
354236|NCT01236573|848501|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354237|NCT01236573|848502|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354238|NCT01236573|848503|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354239|NCT01236573|848504|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354240|NCT01236573|848505|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354241|NCT01236573|848506|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354242|NCT01236573|848507|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354243|NCT01236573|848508|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354244|NCT01236573|848509|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354245|NCT01236573|848510|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354246|NCT01236573|848500|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
354247|NCT01236573|848501|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354248|NCT01236573|848502|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354249|NCT01236573|848503|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354250|NCT01236573|848504|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354251|NCT01236573|848505|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354252|NCT01236573|848506|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354253|NCT01236573|848507|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354254|NCT01236573|848508|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354255|NCT01236573|848509|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354256|NCT01236573|848510|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354257|NCT01236573|848500|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
354258|NCT01236573|848501|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354259|NCT01236573|848502|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354260|NCT01236573|848503|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354261|NCT01236573|848504|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354262|NCT01236573|848505|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354263|NCT01236573|848506|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354264|NCT01236573|848507|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354265|NCT01236573|848508|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354266|NCT01236573|848509|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354267|NCT01236573|848510|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
354268|NCT01236573|848500|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354269|NCT01236573|848501|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
354270|NCT01236573|848502|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
354271|NCT01236573|848503|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354272|NCT01236573|848504|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
354273|NCT01236573|848505|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354274|NCT01236573|848506|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354275|NCT01236573|848507|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354276|NCT01236573|848508|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354277|NCT01236573|848509|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354278|NCT01236573|848510|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354279|NCT01236573|848500|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354280|NCT01236573|848501|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
354281|NCT01236573|848502|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
354282|NCT01236573|848503|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
354283|NCT01236573|848504|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
354284|NCT01236573|848505|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
354285|NCT01236573|848506|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
354286|NCT01236573|848507|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354287|NCT01236573|848508|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354288|NCT01236573|848509|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354289|NCT01236573|848510|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
354290|NCT01236573|848500|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
354291|NCT01236573|848501|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
354292|NCT01236573|848502|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
354293|NCT01236573|848503|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
354294|NCT01236573|848504|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
354295|NCT01236573|848505|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
354296|NCT01236573|848506|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
354297|NCT01236573|848507|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
354298|NCT01236573|848508|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
354299|NCT01236573|848509|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
354300|NCT01236573|848510|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
354301|NCT01236573|848500|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354302|NCT01236573|848501|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354303|NCT01236573|848502|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354304|NCT01236573|848503|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354305|NCT01236573|848504|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354306|NCT01236573|848505|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354307|NCT01236573|848506|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354308|NCT01236573|848507|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354309|NCT01236573|848508|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354310|NCT01236573|848509|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354311|NCT01236573|848510|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354312|NCT01236573|848500|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354313|NCT01236573|848501|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354314|NCT01236573|848502|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354315|NCT01236573|848503|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354316|NCT01236573|848504|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354317|NCT01236573|848505|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354318|NCT01236573|848506|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
354319|NCT01236573|848507|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
354320|NCT01236573|848508|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
354321|NCT01236573|848509|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
354322|NCT01236573|848510|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
354323|NCT01236573|848500|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354324|NCT01236573|848501|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354325|NCT01236573|848502|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354326|NCT01236573|848503|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354327|NCT01236573|848504|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354328|NCT01236573|848505|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354329|NCT01236573|848506|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
354330|NCT01236573|848507|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
354331|NCT01236573|848508|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
354332|NCT01236573|848509|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
354333|NCT01236573|848510|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
354334|NCT01236534|848548|P2|NOT COMPLETED|Overall Study||0
354335|NCT01236534|848549|P1|NOT COMPLETED|Overall Study||3
354336|NCT01236534|848548|P2|COMPLETED|Overall Study||10
354337|NCT01236534|848549|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
354338|NCT01236534|848548|P2|STARTED|Overall Study||10
354339|NCT01236534|848549|P1|STARTED|Overall Study||11
354340|NCT01236391|848557|P1|NOT COMPLETED|Overall Study||16
354341|NCT01236391|848557|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
354342|NCT01236391|848557|P1|STARTED|Overall Study|Participants who received study treatment|111
354343|NCT01236378|848565|P1|NOT COMPLETED|Overall Study||0
354344|NCT01236378|848565|P1|COMPLETED|Overall Study||24
354345|NCT01236378|848565|P1|STARTED|Overall Study||24
354346|NCT01236365|848579|P2|NOT COMPLETED|Overall Study||2
354347|NCT01236365|848580|P1|NOT COMPLETED|Overall Study||2
354348|NCT01236365|848579|P2|COMPLETED|Overall Study||19
354349|NCT01236365|848580|P1|COMPLETED|Overall Study||19
354350|NCT01236365|848579|P2|STARTED|Overall Study||21
354351|NCT01236365|848580|P1|STARTED|Overall Study||21
354352|NCT01236339|848594|P2|NOT COMPLETED|Overall Study||13
354353|NCT01236339|848595|P1|NOT COMPLETED|Overall Study||11
354354|NCT01236339|848594|P2|COMPLETED|Overall Study||0
354355|NCT01236339|848595|P1|COMPLETED|Overall Study||2
354356|NCT01236339|848594|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
354357|NCT01236339|848595|P1|LVP Crossover to TIPS|Overall Study||0
354358|NCT01236339|848594|P2|STARTED|Overall Study||13
354359|NCT01236339|848595|P1|STARTED|Overall Study||13
354360|NCT01236326|848615|P2|NOT COMPLETED|Overall Study||4
354361|NCT01236326|848616|P1|NOT COMPLETED|Overall Study||1
354362|NCT01236326|848615|P2|COMPLETED|Overall Study||51
354363|NCT01236326|848616|P1|COMPLETED|Overall Study||49
354364|NCT01236326|848615|P2|STARTED|Overall Study||55
354365|NCT01236326|848616|P1|STARTED|Overall Study||50
354366|NCT01236300|848630|P1|NOT COMPLETED|Overall Study||0
354367|NCT01236300|848630|P1|COMPLETED|Overall Study||66
354368|NCT01236300|848630|P1|STARTED|Overall Study||66
354369|NCT01236196|848640|P2|NOT COMPLETED|Overall Study||8
354370|NCT01236196|848641|P1|NOT COMPLETED|Overall Study||1
354371|NCT01236196|848640|P2|COMPLETED|Overall Study||13
354372|NCT01236196|848641|P1|COMPLETED|Overall Study||17
354373|NCT01236196|848640|P2|STARTED|Overall Study||21
354374|NCT01236196|848641|P1|STARTED|Overall Study||18
354375|NCT01236170|848653|P1|NOT COMPLETED|Overall Study||15
354376|NCT01236170|848653|P1|COMPLETED|Overall Study||482
354377|NCT01236170|848653|P1|STARTED|Overall Study||497
354378|NCT01236118|848663|P3|NOT COMPLETED|Overall Study||3
354379|NCT01236118|848664|P2|NOT COMPLETED|Overall Study||1
354380|NCT01236118|848665|P1|NOT COMPLETED|Overall Study||2
354381|NCT01236118|848663|P3|COMPLETED|Overall Study||14
354382|NCT01236118|848664|P2|COMPLETED|Overall Study||4
354383|NCT01236118|848665|P1|COMPLETED|Overall Study||4
354384|NCT01236118|848663|P3|STARTED|Overall Study||17
354385|NCT01236118|848664|P2|STARTED|Overall Study||5
354386|NCT01236118|848665|P1|STARTED|Overall Study||6
354387|NCT01236105|848673|P1|NOT COMPLETED|Overall Study||0
354388|NCT01236105|848673|P1|COMPLETED|Overall Study||21
354389|NCT01236105|848673|P1|STARTED|Overall Study||21
354390|NCT01236053|848709|P22|NOT COMPLETED|Overall Study||0
354391|NCT01236053|848710|P21|NOT COMPLETED|Overall Study||0
354392|NCT01236053|848711|P20|NOT COMPLETED|Overall Study||0
354393|NCT01236053|848712|P19|NOT COMPLETED|Overall Study||0
354394|NCT01236053|848713|P18|NOT COMPLETED|Overall Study||0
354395|NCT01236053|848714|P17|NOT COMPLETED|Overall Study||0
354396|NCT01236053|848715|P16|NOT COMPLETED|Overall Study||0
354397|NCT01236053|848716|P15|NOT COMPLETED|Overall Study||0
354398|NCT01236053|848717|P14|NOT COMPLETED|Overall Study||0
354399|NCT01236053|848718|P13|NOT COMPLETED|Overall Study||0
354400|NCT01236053|848719|P12|NOT COMPLETED|Overall Study||0
354401|NCT01236053|848720|P11|NOT COMPLETED|Overall Study||0
354402|NCT01236053|848721|P10|NOT COMPLETED|Overall Study||0
354403|NCT01236053|848722|P9|NOT COMPLETED|Overall Study||0
354404|NCT01236053|848723|P8|NOT COMPLETED|Overall Study||0
354405|NCT01236053|848724|P7|NOT COMPLETED|Overall Study||0
354406|NCT01236053|848725|P6|NOT COMPLETED|Overall Study||0
354407|NCT01236053|848726|P5|NOT COMPLETED|Overall Study||0
354408|NCT01236053|848727|P4|NOT COMPLETED|Overall Study||0
354409|NCT01236053|848728|P3|NOT COMPLETED|Overall Study||0
354410|NCT01236053|848729|P2|NOT COMPLETED|Overall Study||0
354411|NCT01236053|848730|P1|NOT COMPLETED|Overall Study||0
354412|NCT01236053|848709|P22|COMPLETED|Overall Study||12167
354413|NCT01236053|848710|P21|COMPLETED|Overall Study||1272
354414|NCT01236053|848711|P20|COMPLETED|Overall Study||20382
354415|NCT01236053|848712|P19|COMPLETED|Overall Study||2155
354416|NCT01236053|848713|P18|COMPLETED|Overall Study||380
354417|NCT01236053|848714|P17|COMPLETED|Overall Study||38
354418|NCT01236053|848715|P16|COMPLETED|Overall Study||43559
354419|NCT01236053|848716|P15|COMPLETED|Overall Study||4600
354420|NCT01236053|848717|P14|COMPLETED|Overall Study||1396
354421|NCT01236053|848718|P13|COMPLETED|Overall Study||148
354422|NCT01236053|848719|P12|COMPLETED|Overall Study||188924
354423|NCT01236053|848720|P11|COMPLETED|Overall Study||19564
354424|NCT01236053|848721|P10|COMPLETED|Overall Study||2935
354425|NCT01236053|848722|P9|COMPLETED|Overall Study||300
354426|NCT01236053|848723|P8|COMPLETED|Overall Study||102836
354427|NCT01236053|848724|P7|COMPLETED|Overall Study||10855
354428|NCT01236053|848725|P6|COMPLETED|Overall Study||2067
354429|NCT01236053|848726|P5|COMPLETED|Overall Study||212
354430|NCT01236053|848727|P4|COMPLETED|Overall Study||17853
354431|NCT01236053|848728|P3|COMPLETED|Overall Study||1877
354432|NCT01236053|848729|P2|COMPLETED|Overall Study||1710950
354433|NCT01236053|848730|P1|COMPLETED|Overall Study||179138
354434|NCT01236053|848709|P22|STARTED|Overall Study||12167
354435|NCT01236053|848710|P21|STARTED|Overall Study||1272
354436|NCT01236053|848711|P20|STARTED|Overall Study||20382
354437|NCT01236053|848712|P19|STARTED|Overall Study||2155
354438|NCT01236053|848713|P18|STARTED|Overall Study||380
354439|NCT01236053|848714|P17|STARTED|Overall Study||38
354440|NCT01236053|848715|P16|STARTED|Overall Study||43559
354441|NCT01236053|848716|P15|STARTED|Overall Study||4600
354442|NCT01236053|848717|P14|STARTED|Overall Study||1396
354443|NCT01236053|848718|P13|STARTED|Overall Study||148
354444|NCT01236053|848719|P12|STARTED|Overall Study||188924
354445|NCT01236053|848720|P11|STARTED|Overall Study||19564
354446|NCT01236053|848721|P10|STARTED|Overall Study||2935
354447|NCT01236053|848722|P9|STARTED|Overall Study||300
354448|NCT01236053|848723|P8|STARTED|Overall Study||102836
354449|NCT01236053|848724|P7|STARTED|Overall Study||10855
354450|NCT01236053|848725|P6|STARTED|Overall Study||2067
354451|NCT01236053|848726|P5|STARTED|Overall Study||212
354452|NCT01236053|848727|P4|STARTED|Overall Study||17853
354453|NCT01236053|848728|P3|STARTED|Overall Study||1877
354454|NCT01236053|848729|P2|STARTED|Overall Study||1710950
354455|NCT01236053|848730|P1|STARTED|Overall Study||179138
354456|NCT01236001|848866|P2|NOT COMPLETED|Overall Study||22
354457|NCT01236001|848867|P1|NOT COMPLETED|Overall Study||18
354458|NCT01236001|848866|P2|COMPLETED|Overall Study||65
354459|NCT01236001|848867|P1|COMPLETED|Overall Study||87
354460|NCT01236001|848866|P2|STARTED|Overall Study||87
354461|NCT01236001|848867|P1|STARTED|Overall Study||105
354462|NCT01235975|848899|P2|NOT COMPLETED|Overall Study||7
354463|NCT01235975|848900|P1|NOT COMPLETED|Overall Study||17
354464|NCT01235975|848899|P2|COMPLETED|Overall Study||88
354465|NCT01235975|848900|P1|COMPLETED|Overall Study||257
354466|NCT01235975|848899|P2|STARTED|Overall Study||95
354467|NCT01235975|848900|P1|STARTED|Overall Study||274
354468|NCT01235923|848934|P2|NOT COMPLETED|Overall Study||0
354469|NCT01235923|848935|P1|NOT COMPLETED|Overall Study||0
354470|NCT01235923|848934|P2|COMPLETED|Overall Study||10
354471|NCT01235923|848935|P1|COMPLETED|Overall Study||10
354472|NCT01235923|848934|P2|STARTED|Overall Study||10
354473|NCT01235923|848935|P1|STARTED|Overall Study||10
354474|NCT01235910|848943|P1|NOT COMPLETED|Overall Study||0
354475|NCT01235910|848943|P1|COMPLETED|Overall Study||1
354476|NCT01235910|848943|P1|STARTED|Overall Study||1
354477|NCT01235897|848947|P1|NOT COMPLETED|Overall Study||0
354478|NCT01235897|848947|P1|COMPLETED|Overall Study||16
354479|NCT01235897|848947|P1|STARTED|Overall Study||16
354480|NCT01235741|848955|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
354481|NCT01235741|848956|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
354482|NCT01235741|848957|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
354483|NCT01235741|848955|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
354484|NCT01235741|848956|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
354485|NCT01235741|848957|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
354486|NCT01235741|848955|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
354487|NCT01235741|848956|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
354488|NCT01235741|848957|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
354489|NCT01235741|848955|P3|NOT COMPLETED|Randomized to Treatment||36
354490|NCT01235741|848956|P2|NOT COMPLETED|Randomized to Treatment||36
354491|NCT01235741|848957|P1|NOT COMPLETED|Randomized to Treatment||0
354492|NCT01235741|848955|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
354493|NCT01235741|848956|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
354494|NCT01235741|848957|P1|COMPLETED|Randomized to Treatment||0
354495|NCT01235741|848955|P3|STARTED|Randomized to Treatment||36
354496|NCT01235741|848956|P2|STARTED|Randomized to Treatment||36
354497|NCT01235741|848957|P1|STARTED|Randomized to Treatment||0
354498|NCT01235741|848955|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
354499|NCT01235741|848956|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
354500|NCT01235741|848957|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
354501|NCT01235741|848955|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
354502|NCT01235741|848956|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
354503|NCT01235741|848957|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
354504|NCT01235741|848955|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
354505|NCT01235741|848956|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
354506|NCT01235741|848957|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
354507|NCT01235728|848984|P8|NOT COMPLETED|Overall Study||0
354508|NCT01235728|848985|P7|NOT COMPLETED|Overall Study||0
354509|NCT01235728|848986|P6|NOT COMPLETED|Overall Study||0
354510|NCT01235728|848987|P5|NOT COMPLETED|Overall Study||0
354511|NCT01235728|848988|P4|NOT COMPLETED|Overall Study||1
354512|NCT01235728|848989|P3|NOT COMPLETED|Overall Study||0
354513|NCT01235728|848990|P2|NOT COMPLETED|Overall Study||0
354514|NCT01235728|848991|P1|NOT COMPLETED|Overall Study||0
354515|NCT01235728|848984|P8|COMPLETED|Overall Study||3
354516|NCT01235728|848985|P7|COMPLETED|Overall Study||3
354517|NCT01235728|848986|P6|COMPLETED|Overall Study||3
354518|NCT01235728|848987|P5|COMPLETED|Overall Study||3
354519|NCT01235728|848988|P4|COMPLETED|Overall Study||2
354520|NCT01235728|848989|P3|COMPLETED|Overall Study||3
354521|NCT01235728|848990|P2|COMPLETED|Overall Study||3
354522|NCT01235728|848991|P1|COMPLETED|Overall Study||3
354523|NCT01235728|848984|P8|STARTED|Overall Study||3
354524|NCT01235728|848985|P7|STARTED|Overall Study||3
354525|NCT01235728|848986|P6|STARTED|Overall Study||3
354526|NCT01235728|848987|P5|STARTED|Overall Study||3
354527|NCT01235728|848988|P4|STARTED|Overall Study||3
354528|NCT01235728|848989|P3|STARTED|Overall Study||3
354529|NCT01235728|848990|P2|STARTED|Overall Study||3
354530|NCT01235728|848991|P1|STARTED|Overall Study||3
354531|NCT01235715|849001|P2|NOT COMPLETED|Overall Study||2
354532|NCT01235715|849002|P1|NOT COMPLETED|Overall Study||0
354533|NCT01235715|849001|P2|COMPLETED|Overall Study||100
354534|NCT01235715|849002|P1|COMPLETED|Overall Study||98
354535|NCT01235715|849001|P2|STARTED|Overall Study||102
354536|NCT01235715|849002|P1|STARTED|Overall Study||98
354537|NCT01235598|849042|P2|NOT COMPLETED|Overall Study||4
354538|NCT01235598|849043|P1|NOT COMPLETED|Overall Study||1
354539|NCT01235598|849042|P2|COMPLETED|Overall Study||24
354540|NCT01235598|849043|P1|COMPLETED|Overall Study||12
354541|NCT01235598|849042|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
354542|NCT01235598|849043|P1|STARTED|Overall Study||13
354543|NCT01235507|849086|P1|NOT COMPLETED|Overall Study||2
354544|NCT01235507|849086|P1|COMPLETED|Overall Study||69
354545|NCT01235507|849086|P1|STARTED|Overall Study||71
354546|NCT01235442|849100|P2|NOT COMPLETED|Overall Study||44
354547|NCT01235442|849101|P1|NOT COMPLETED|Overall Study||44
354548|NCT01235442|849100|P2|COMPLETED|Overall Study||251
354549|NCT01235442|849101|P1|COMPLETED|Overall Study||253
354550|NCT01235442|849100|P2|STARTED|Overall Study||295
354551|NCT01235442|849101|P1|STARTED|Overall Study||297
354552|NCT01235403|849119|P1|NOT COMPLETED|Overall Study||26
354553|NCT01235403|849119|P1|COMPLETED|Overall Study||74
354554|NCT01235403|849119|P1|STARTED|Overall Study||100
354555|NCT01235377|849127|P2|NOT COMPLETED|Overall Study||1
354556|NCT01235377|849128|P1|NOT COMPLETED|Overall Study||1
354557|NCT01235377|849127|P2|COMPLETED|Overall Study||8
354558|NCT01235377|849128|P1|COMPLETED|Overall Study||10
354559|NCT01235377|849127|P2|STARTED|Overall Study||9
354560|NCT01235377|849128|P1|STARTED|Overall Study||11
354561|NCT01235338|849136|P2|NOT COMPLETED|Overall Study||5
354562|NCT01235338|849137|P1|NOT COMPLETED|Overall Study||11
354563|NCT01235338|849136|P2|COMPLETED|Overall Study||33
354564|NCT01235338|849137|P1|COMPLETED|Overall Study||31
354565|NCT01235338|849136|P2|STARTED|Overall Study||38
354566|NCT01235338|849137|P1|STARTED|Overall Study||42
354567|NCT01235234|849182|P3|NOT COMPLETED|Overall Study||1
354568|NCT01235234|849183|P2|NOT COMPLETED|Overall Study||2
354569|NCT01235234|849184|P1|NOT COMPLETED|Overall Study||2
354570|NCT01235234|849182|P3|COMPLETED|Overall Study||80
354571|NCT01235234|849183|P2|COMPLETED|Overall Study||76
354572|NCT01235234|849184|P1|COMPLETED|Overall Study||75
354573|NCT01235234|849182|P3|STARTED|Overall Study||81
354574|NCT01235234|849183|P2|STARTED|Overall Study||78
354575|NCT01235234|849184|P1|STARTED|Overall Study||77
354576|NCT01235195|849192|P2|NOT COMPLETED|Second Intervention||0
354577|NCT01235195|849193|P1|NOT COMPLETED|Second Intervention||0
354578|NCT01235195|849192|P2|COMPLETED|Second Intervention||15
354579|NCT01235195|849193|P1|COMPLETED|Second Intervention||15
354580|NCT01235195|849192|P2|STARTED|Second Intervention||15
354581|NCT01235195|849193|P1|STARTED|Second Intervention||15
354582|NCT01235195|849192|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
354583|NCT01235195|849193|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
354584|NCT01235195|849192|P2|COMPLETED|Washout Period of At Least 8 Days||15
354585|NCT01235195|849193|P1|COMPLETED|Washout Period of At Least 8 Days||15
354586|NCT01235195|849192|P2|STARTED|Washout Period of At Least 8 Days||15
354587|NCT01235195|849193|P1|STARTED|Washout Period of At Least 8 Days||15
354588|NCT01235195|849192|P2|NOT COMPLETED|First Intervention||0
354589|NCT01235195|849193|P1|NOT COMPLETED|First Intervention||0
354590|NCT01235195|849192|P2|COMPLETED|First Intervention||15
354591|NCT01235195|849193|P1|COMPLETED|First Intervention||15
354592|NCT01235195|849192|P2|STARTED|First Intervention||15
354593|NCT01235195|849193|P1|STARTED|First Intervention||15
354594|NCT01234922|849213|P4|NOT COMPLETED|Overall Study||0
354595|NCT01234922|849214|P3|NOT COMPLETED|Overall Study||0
354596|NCT01234922|849215|P2|NOT COMPLETED|Overall Study||0
354597|NCT01234922|849216|P1|NOT COMPLETED|Overall Study||0
354598|NCT01234922|849213|P4|COMPLETED|Overall Study||2
354599|NCT01234922|849214|P3|COMPLETED|Overall Study||2
354600|NCT01234922|849215|P2|COMPLETED|Overall Study||1
354601|NCT01234922|849216|P1|COMPLETED|Overall Study||1
354602|NCT01234922|849213|P4|STARTED|Overall Study||2
354603|NCT01234922|849214|P3|STARTED|Overall Study||2
354604|NCT01234922|849215|P2|STARTED|Overall Study||1
354605|NCT01234922|849216|P1|STARTED|Overall Study||1
354606|NCT01234883|849228|P2|NOT COMPLETED|Overall Study||13
354607|NCT01234883|849229|P1|NOT COMPLETED|Overall Study||10
354608|NCT01234883|849228|P2|COMPLETED|Overall Study||36
354609|NCT01234883|849229|P1|COMPLETED|Overall Study||41
354610|NCT01234883|849228|P2|STARTED|Overall Study||49
354611|NCT01234883|849229|P1|STARTED|Overall Study||51
354612|NCT01234870|849235|P1|NOT COMPLETED|Overall Study||0
354613|NCT01234870|849235|P1|COMPLETED|Overall Study||40
354614|NCT01234870|849235|P1|STARTED|Overall Study||40
354615|NCT01234831|849242|P2|NOT COMPLETED|Overall Study||4
354616|NCT01234831|849243|P1|NOT COMPLETED|Overall Study||2
354617|NCT01234831|849242|P2|COMPLETED|Overall Study||198
354618|NCT01234831|849243|P1|COMPLETED|Overall Study||259
354619|NCT01234831|849242|P2|STARTED|Overall Study||202
354620|NCT01234831|849243|P1|STARTED|Overall Study||261
354621|NCT01234714|849254|P1|NOT COMPLETED|Overall Study||0
354622|NCT01234714|849254|P1|COMPLETED|Overall Study||84
354623|NCT01234714|849254|P1|STARTED|Overall Study||84
354624|NCT01234675|849271|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
354625|NCT01234675|849272|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
354626|NCT01234675|849271|P2|COMPLETED|Second Intervention (6 Weeks)||8
354627|NCT01234675|849272|P1|COMPLETED|Second Intervention (6 Weeks)||7
354628|NCT01234675|849271|P2|STARTED|Second Intervention (6 Weeks)||8
354629|NCT01234675|849272|P1|STARTED|Second Intervention (6 Weeks)||9
354630|NCT01234675|849271|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
354631|NCT01234675|849272|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
354632|NCT01234675|849271|P2|COMPLETED|First Intervention (6 Weeks)||8
354633|NCT01234675|849272|P1|COMPLETED|First Intervention (6 Weeks)||9
354634|NCT01234675|849271|P2|STARTED|First Intervention (6 Weeks)||9
354635|NCT01234675|849272|P1|STARTED|First Intervention (6 Weeks)||10
354636|NCT01234467|849286|P1|NOT COMPLETED|Overall Study||12
354637|NCT01234467|849286|P1|COMPLETED|Overall Study||11
354638|NCT01234467|849286|P1|STARTED|Overall Study||23
354639|NCT01234337|849297|P2|NOT COMPLETED|Overall Study||64
354640|NCT01234337|849298|P1|NOT COMPLETED|Overall Study||97
354641|NCT01234337|849297|P2|COMPLETED|Overall Study||207
354642|NCT01234337|849298|P1|COMPLETED|Overall Study||169
354643|NCT01234337|849297|P2|Participants Received Treatment|Overall Study||267
354644|NCT01234337|849298|P1|Participants Received Treatment|Overall Study||260
354645|NCT01234337|849297|P2|STARTED|Overall Study||271
354646|NCT01234337|849298|P1|STARTED|Overall Study||266
354647|NCT01234207|849326|P2|NOT COMPLETED|Second Intervention||0
354648|NCT01234207|849327|P1|NOT COMPLETED|Second Intervention||0
354649|NCT01234207|849326|P2|COMPLETED|Second Intervention||48
354650|NCT01234207|849327|P1|COMPLETED|Second Intervention||47
354651|NCT01234207|849326|P2|STARTED|Second Intervention||48
354652|NCT01234207|849327|P1|STARTED|Second Intervention||47
354653|NCT01234207|849326|P2|NOT COMPLETED|1-Week Washout Period||0
354654|NCT01234207|849327|P1|NOT COMPLETED|1-Week Washout Period||0
354655|NCT01234207|849326|P2|COMPLETED|1-Week Washout Period||48
354656|NCT01234207|849327|P1|COMPLETED|1-Week Washout Period||47
354657|NCT01234207|849326|P2|STARTED|1-Week Washout Period||48
354658|NCT01234207|849327|P1|STARTED|1-Week Washout Period||47
354659|NCT01234207|849326|P2|NOT COMPLETED|First Intervention||0
354660|NCT01234207|849327|P1|NOT COMPLETED|First Intervention||0
354661|NCT01234207|849326|P2|COMPLETED|First Intervention||48
354662|NCT01234207|849327|P1|COMPLETED|First Intervention||47
354663|NCT01234207|849326|P2|STARTED|First Intervention||48
354664|NCT01234207|849327|P1|STARTED|First Intervention||47
354665|NCT01233999|849347|P1|NOT COMPLETED|Overall Study||2
354666|NCT01233999|849347|P1|COMPLETED|Overall Study||8
354667|NCT01233999|849347|P1|STARTED|Overall Study||10
354668|NCT01233921|849353|P2|NOT COMPLETED|Overall Study||0
354669|NCT01233921|849354|P1|NOT COMPLETED|Overall Study||0
354670|NCT01233921|849353|P2|COMPLETED|Overall Study||3
354671|NCT01233921|849354|P1|COMPLETED|Overall Study||3
354672|NCT01233921|849353|P2|STARTED|Overall Study||3
354673|NCT01233921|849354|P1|STARTED|Overall Study||3
354674|NCT01233869|849366|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
354675|NCT01233869|849367|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
354676|NCT01233869|849368|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
354677|NCT01233869|849369|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
354678|NCT01233869|849366|P4|COMPLETED|Extended Treatment Period (46 Months)||18
354679|NCT01233869|849367|P3|COMPLETED|Extended Treatment Period (46 Months)||17
354680|NCT01233869|849368|P2|COMPLETED|Extended Treatment Period (46 Months)||0
354681|NCT01233869|849369|P1|COMPLETED|Extended Treatment Period (46 Months)||20
354682|NCT01233869|849366|P4|STARTED|Extended Treatment Period (46 Months)||34
354683|NCT01233869|849367|P3|STARTED|Extended Treatment Period (46 Months)||22
354684|NCT01233869|849368|P2|STARTED|Extended Treatment Period (46 Months)||3
354685|NCT01233869|849369|P1|STARTED|Extended Treatment Period (46 Months)||34
354686|NCT01233869|849366|P4|NOT COMPLETED|Washout Period 30 Days||0
354687|NCT01233869|849367|P3|NOT COMPLETED|Washout Period 30 Days||0
354688|NCT01233869|849368|P2|NOT COMPLETED|Washout Period 30 Days||0
354689|NCT01233869|849369|P1|NOT COMPLETED|Washout Period 30 Days||0
354690|NCT01233869|849366|P4|COMPLETED|Washout Period 30 Days||34
354691|NCT01233869|849367|P3|COMPLETED|Washout Period 30 Days||22
354692|NCT01233869|849368|P2|COMPLETED|Washout Period 30 Days||3
354693|NCT01233869|849369|P1|COMPLETED|Washout Period 30 Days||34
354694|NCT01233869|849366|P4|STARTED|Washout Period 30 Days||34
354695|NCT01233869|849367|P3|STARTED|Washout Period 30 Days||22
354696|NCT01233869|849368|P2|STARTED|Washout Period 30 Days||3
354697|NCT01233869|849369|P1|STARTED|Washout Period 30 Days||34
354698|NCT01233869|849366|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
354699|NCT01233869|849367|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
354700|NCT01233869|849368|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
354701|NCT01233869|849369|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
354702|NCT01233869|849366|P4|COMPLETED|Initial Treatment Period (24 Months)||34
354703|NCT01233869|849367|P3|COMPLETED|Initial Treatment Period (24 Months)||22
354704|NCT01233869|849368|P2|COMPLETED|Initial Treatment Period (24 Months)||3
354705|NCT01233869|849369|P1|COMPLETED|Initial Treatment Period (24 Months)||34
354706|NCT01233869|849366|P4|STARTED|Initial Treatment Period (24 Months)||56
354707|NCT01233869|849367|P3|STARTED|Initial Treatment Period (24 Months)||24
354708|NCT01233869|849368|P2|STARTED|Initial Treatment Period (24 Months)||31
354709|NCT01233869|849369|P1|STARTED|Initial Treatment Period (24 Months)||58
354710|NCT01233817|849455|P1|NOT COMPLETED|Overall Study||3
354711|NCT01233817|849455|P1|COMPLETED|Overall Study||9
354712|NCT01233817|849455|P1|STARTED|Overall Study||12
354713|NCT01233726|849462|P3|NOT COMPLETED|Overall Study||1
354714|NCT01233726|849463|P2|NOT COMPLETED|Overall Study||0
354715|NCT01233726|849464|P1|NOT COMPLETED|Overall Study||1
354716|NCT01233726|849462|P3|COMPLETED|Overall Study||52
354717|NCT01233726|849463|P2|COMPLETED|Overall Study||53
354718|NCT01233726|849464|P1|COMPLETED|Overall Study||52
354719|NCT01233726|849462|P3|STARTED|Overall Study||53
354720|NCT01233726|849463|P2|STARTED|Overall Study||53
354721|NCT01233726|849464|P1|STARTED|Overall Study||53
354729|NCT01232920|849512|P2|NOT COMPLETED|Overall Study||7
354730|NCT01232920|849513|P1|NOT COMPLETED|Overall Study||6
354731|NCT01232920|849512|P2|COMPLETED|Overall Study||32
354732|NCT01232920|849513|P1|COMPLETED|Overall Study||35
354733|NCT01232920|849512|P2|STARTED|Overall Study||39
354734|NCT01232920|849513|P1|STARTED|Overall Study||41
354735|NCT01232894|849527|P2|NOT COMPLETED|Overall Study||8
354736|NCT01232894|849528|P1|NOT COMPLETED|Overall Study||12
354737|NCT01232894|849527|P2|COMPLETED|Overall Study||22
354738|NCT01232894|849528|P1|COMPLETED|Overall Study||48
354739|NCT01232894|849527|P2|Received Study Drug|Overall Study||28
354740|NCT01232894|849528|P1|Received Study Drug|Overall Study||59
354741|NCT01232894|849527|P2|STARTED|Overall Study||30
354742|NCT01232894|849528|P1|STARTED|Overall Study||60
354743|NCT01232868|849536|P2|NOT COMPLETED|Overall Study||4
354744|NCT01232868|849537|P1|NOT COMPLETED|Overall Study||2
354745|NCT01232868|849536|P2|COMPLETED|Overall Study||40
354746|NCT01232868|849537|P1|COMPLETED|Overall Study||20
354747|NCT01232868|849536|P2|STARTED|Overall Study||44
354748|NCT01232868|849537|P1|STARTED|Overall Study||22
354749|NCT01232829|849545|P1|NOT COMPLETED|Overall Study||0
354750|NCT01232829|849545|P1|COMPLETED|Overall Study||18
354751|NCT01232829|849545|P1|STARTED|Overall Study||18
354752|NCT01232790|849551|P2|NOT COMPLETED|Second Crossover||2
354753|NCT01232790|849552|P1|NOT COMPLETED|Second Crossover||1
354754|NCT01232790|849551|P2|COMPLETED|Second Crossover||9
354755|NCT01232790|849552|P1|COMPLETED|Second Crossover||10
354756|NCT01232790|849551|P2|STARTED|Second Crossover||11
354757|NCT01232790|849552|P1|STARTED|Second Crossover||11
354758|NCT01232790|849551|P2|NOT COMPLETED|First Crossover||0
354759|NCT01232790|849552|P1|NOT COMPLETED|First Crossover||1
354760|NCT01232790|849551|P2|COMPLETED|First Crossover||11
354761|NCT01232790|849552|P1|COMPLETED|First Crossover||11
354762|NCT01232790|849551|P2|STARTED|First Crossover||11
354763|NCT01232790|849552|P1|STARTED|First Crossover||12
354764|NCT01232790|849551|P2|NOT COMPLETED|Initial Assessment||1
354765|NCT01232790|849552|P1|NOT COMPLETED|Initial Assessment||0
354766|NCT01232790|849551|P2|COMPLETED|Initial Assessment||11
354767|NCT01232790|849552|P1|COMPLETED|Initial Assessment||12
354768|NCT01232790|849551|P2|STARTED|Initial Assessment||12
354769|NCT01232790|849552|P1|STARTED|Initial Assessment||12
354770|NCT01232790|849551|P2|NOT COMPLETED|Randomization||2
354771|NCT01232790|849552|P1|NOT COMPLETED|Randomization||2
354772|NCT01232790|849551|P2|COMPLETED|Randomization||12
354773|NCT01232790|849552|P1|COMPLETED|Randomization||12
354774|NCT01232790|849551|P2|STARTED|Randomization||14
354775|NCT01232790|849552|P1|STARTED|Randomization||14
354776|NCT01233284|849606|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
354777|NCT01233284|849607|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
354778|NCT01233284|849608|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
354779|NCT01233284|849609|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
354780|NCT01233284|849610|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
354781|NCT01233284|849606|P5|COMPLETED|Period 4 (4 Weeks)||1
354782|NCT01233284|849607|P4|COMPLETED|Period 4 (4 Weeks)||33
354783|NCT01233284|849608|P3|COMPLETED|Period 4 (4 Weeks)||35
354784|NCT01233284|849609|P2|COMPLETED|Period 4 (4 Weeks)||36
354785|NCT01233284|849610|P1|COMPLETED|Period 4 (4 Weeks)||36
354786|NCT01233284|849606|P5|STARTED|Period 4 (4 Weeks)||1
354787|NCT01233284|849607|P4|STARTED|Period 4 (4 Weeks)||34
354788|NCT01233284|849608|P3|STARTED|Period 4 (4 Weeks)||35
354789|NCT01233284|849609|P2|STARTED|Period 4 (4 Weeks)||37
354790|NCT01233284|849610|P1|STARTED|Period 4 (4 Weeks)||36
354791|NCT01233284|849606|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
354792|NCT01233284|849607|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
354793|NCT01233284|849608|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
354794|NCT01233284|849609|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
354795|NCT01233284|849610|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
354796|NCT01233284|849606|P5|COMPLETED|Period 3 (4 Weeks)||1
354797|NCT01233284|849607|P4|COMPLETED|Period 3 (4 Weeks)||34
354798|NCT01233284|849608|P3|COMPLETED|Period 3 (4 Weeks)||35
354799|NCT01233284|849609|P2|COMPLETED|Period 3 (4 Weeks)||37
354800|NCT01233284|849610|P1|COMPLETED|Period 3 (4 Weeks)||36
354801|NCT01233284|849606|P5|STARTED|Period 3 (4 Weeks)||1
354802|NCT01233284|849607|P4|STARTED|Period 3 (4 Weeks)||35
354803|NCT01233284|849608|P3|STARTED|Period 3 (4 Weeks)||36
354804|NCT01233284|849609|P2|STARTED|Period 3 (4 Weeks)||37
354805|NCT01233284|849610|P1|STARTED|Period 3 (4 Weeks)||36
354806|NCT01233284|849606|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
354807|NCT01233284|849607|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
354808|NCT01233284|849608|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
354809|NCT01233284|849609|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
354810|NCT01233284|849610|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
354811|NCT01233284|849606|P5|COMPLETED|Period 2 (4 Weeks)||1
354812|NCT01233284|849607|P4|COMPLETED|Period 2 (4 Weeks)||35
354813|NCT01233284|849608|P3|COMPLETED|Period 2 (4 Weeks)||36
354814|NCT01233284|849609|P2|COMPLETED|Period 2 (4 Weeks)||37
354815|NCT01233284|849610|P1|COMPLETED|Period 2 (4 Weeks)||36
354816|NCT01233284|849606|P5|STARTED|Period 2 (4 Weeks)||1
354817|NCT01233284|849607|P4|STARTED|Period 2 (4 Weeks)||35
354818|NCT01233284|849608|P3|STARTED|Period 2 (4 Weeks)||37
354819|NCT01233284|849609|P2|STARTED|Period 2 (4 Weeks)||37
354820|NCT01233284|849610|P1|STARTED|Period 2 (4 Weeks)||36
354821|NCT01233284|849606|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
354822|NCT01233284|849607|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
354823|NCT01233284|849608|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
354824|NCT01233284|849609|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
354825|NCT01233284|849610|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
354826|NCT01233284|849606|P5|COMPLETED|Period 1 (4 Weeks)||1
354827|NCT01233284|849607|P4|COMPLETED|Period 1 (4 Weeks)||35
354828|NCT01233284|849608|P3|COMPLETED|Period 1 (4 Weeks)||37
354829|NCT01233284|849609|P2|COMPLETED|Period 1 (4 Weeks)||37
354830|NCT01233284|849610|P1|COMPLETED|Period 1 (4 Weeks)||36
354831|NCT01233284|849606|P5|STARTED|Period 1 (4 Weeks)||1
354832|NCT01233284|849607|P4|STARTED|Period 1 (4 Weeks)||35
354833|NCT01233284|849608|P3|STARTED|Period 1 (4 Weeks)||38
354834|NCT01233284|849609|P2|STARTED|Period 1 (4 Weeks)||38
354835|NCT01233284|849610|P1|STARTED|Period 1 (4 Weeks)||37
354836|NCT01233258|849691|P6|NOT COMPLETED|Second Intervention (6 Months)||0
354837|NCT01233258|849692|P5|NOT COMPLETED|Second Intervention (6 Months)||0
354838|NCT01233258|849693|P4|NOT COMPLETED|Second Intervention (6 Months)||0
354839|NCT01233258|849694|P3|NOT COMPLETED|Second Intervention (6 Months)||0
354840|NCT01233258|849695|P2|NOT COMPLETED|Second Intervention (6 Months)||0
354841|NCT01233258|849696|P1|NOT COMPLETED|Second Intervention (6 Months)||0
354842|NCT01233258|849691|P6|COMPLETED|Second Intervention (6 Months)||15
354843|NCT01233258|849692|P5|COMPLETED|Second Intervention (6 Months)||16
354844|NCT01233258|849693|P4|COMPLETED|Second Intervention (6 Months)||15
354845|NCT01233258|849694|P3|COMPLETED|Second Intervention (6 Months)||13
354846|NCT01233258|849695|P2|COMPLETED|Second Intervention (6 Months)||10
354847|NCT01233258|849696|P1|COMPLETED|Second Intervention (6 Months)||10
354848|NCT01233258|849691|P6|STARTED|Second Intervention (6 Months)||15
354849|NCT01233258|849692|P5|STARTED|Second Intervention (6 Months)||16
354850|NCT01233258|849693|P4|STARTED|Second Intervention (6 Months)||15
354851|NCT01233258|849694|P3|STARTED|Second Intervention (6 Months)||13
354852|NCT01233258|849695|P2|STARTED|Second Intervention (6 Months)||10
354853|NCT01233258|849696|P1|STARTED|Second Intervention (6 Months)||10
354854|NCT01233258|849691|P6|NOT COMPLETED|Washout (2-3 Days)||0
354855|NCT01233258|849692|P5|NOT COMPLETED|Washout (2-3 Days)||0
354856|NCT01233258|849693|P4|NOT COMPLETED|Washout (2-3 Days)||0
354857|NCT01233258|849694|P3|NOT COMPLETED|Washout (2-3 Days)||0
354858|NCT01233258|849695|P2|NOT COMPLETED|Washout (2-3 Days)||0
354859|NCT01233258|849696|P1|NOT COMPLETED|Washout (2-3 Days)||0
354860|NCT01233258|849691|P6|COMPLETED|Washout (2-3 Days)||15
354861|NCT01233258|849692|P5|COMPLETED|Washout (2-3 Days)||16
354862|NCT01233258|849693|P4|COMPLETED|Washout (2-3 Days)||15
354863|NCT01233258|849694|P3|COMPLETED|Washout (2-3 Days)||13
354864|NCT01233258|849695|P2|COMPLETED|Washout (2-3 Days)||10
354865|NCT01233258|849696|P1|COMPLETED|Washout (2-3 Days)||10
354866|NCT01233258|849691|P6|STARTED|Washout (2-3 Days)||15
354867|NCT01233258|849692|P5|STARTED|Washout (2-3 Days)||16
354868|NCT01233258|849693|P4|STARTED|Washout (2-3 Days)||15
354869|NCT01233258|849694|P3|STARTED|Washout (2-3 Days)||13
354870|NCT01233258|849695|P2|STARTED|Washout (2-3 Days)||10
354871|NCT01233258|849696|P1|STARTED|Washout (2-3 Days)||10
354872|NCT01233258|849691|P6|NOT COMPLETED|First Intervention (6 Months)||1
354873|NCT01233258|849692|P5|NOT COMPLETED|First Intervention (6 Months)||0
354874|NCT01233258|849693|P4|NOT COMPLETED|First Intervention (6 Months)||1
354875|NCT01233258|849694|P3|NOT COMPLETED|First Intervention (6 Months)||1
354876|NCT01233258|849695|P2|NOT COMPLETED|First Intervention (6 Months)||0
354877|NCT01233258|849696|P1|NOT COMPLETED|First Intervention (6 Months)||1
354878|NCT01233258|849691|P6|COMPLETED|First Intervention (6 Months)||15
354879|NCT01233258|849692|P5|COMPLETED|First Intervention (6 Months)||16
354880|NCT01233258|849693|P4|COMPLETED|First Intervention (6 Months)||15
354881|NCT01233258|849694|P3|COMPLETED|First Intervention (6 Months)||13
354882|NCT01233258|849695|P2|COMPLETED|First Intervention (6 Months)||10
354883|NCT01233258|849696|P1|COMPLETED|First Intervention (6 Months)||10
354884|NCT01233258|849691|P6|Participants Received Treatment|First Intervention (6 Months)||15
354885|NCT01233258|849692|P5|Participants Received Treatment|First Intervention (6 Months)||16
354886|NCT01233258|849693|P4|Participants Received Treatment|First Intervention (6 Months)||15
354887|NCT01233258|849694|P3|Participants Received Treatment|First Intervention (6 Months)||13
354888|NCT01233258|849695|P2|Participants Received Treatment|First Intervention (6 Months)||10
354889|NCT01233258|849696|P1|Participants Received Treatment|First Intervention (6 Months)||11
354890|NCT01233258|849691|P6|STARTED|First Intervention (6 Months)||16
354891|NCT01233258|849692|P5|STARTED|First Intervention (6 Months)||16
354892|NCT01233258|849693|P4|STARTED|First Intervention (6 Months)||16
354893|NCT01233258|849694|P3|STARTED|First Intervention (6 Months)||14
354894|NCT01233258|849695|P2|STARTED|First Intervention (6 Months)||10
354895|NCT01233258|849696|P1|STARTED|First Intervention (6 Months)||11
354896|NCT01233232|849716|P3|NOT COMPLETED|Overall Study||0
354897|NCT01233232|849717|P2|NOT COMPLETED|Overall Study||0
354898|NCT01233232|849718|P1|NOT COMPLETED|Overall Study||1
354899|NCT01233232|849716|P3|COMPLETED|Overall Study||28
354900|NCT01233232|849717|P2|COMPLETED|Overall Study||30
354901|NCT01233232|849718|P1|COMPLETED|Overall Study||28
354902|NCT01233232|849716|P3|STARTED|Overall Study||28
354903|NCT01233232|849717|P2|STARTED|Overall Study||30
354904|NCT01233232|849718|P1|STARTED|Overall Study||29
354905|NCT01233076|849771|P2|NOT COMPLETED|Period 2, One Week||0
354906|NCT01233076|849772|P1|NOT COMPLETED|Period 2, One Week||1
354907|NCT01233076|849771|P2|COMPLETED|Period 2, One Week||30
354908|NCT01233076|849772|P1|COMPLETED|Period 2, One Week||29
354909|NCT01233076|849771|P2|STARTED|Period 2, One Week||30
354910|NCT01233076|849772|P1|STARTED|Period 2, One Week||30
354911|NCT01233076|849771|P2|NOT COMPLETED|Period 1, One Week||0
354912|NCT01233076|849772|P1|NOT COMPLETED|Period 1, One Week||0
354913|NCT01233076|849771|P2|COMPLETED|Period 1, One Week||30
354914|NCT01233076|849772|P1|COMPLETED|Period 1, One Week||30
354915|NCT01233076|849771|P2|STARTED|Period 1, One Week||30
354916|NCT01233076|849772|P1|STARTED|Period 1, One Week||30
354917|NCT01232569|849780|P4|NOT COMPLETED|Open-label Extension Period||27
354918|NCT01232569|849781|P3|NOT COMPLETED|Open-label Extension Period||27
354919|NCT01232569|849782|P2|NOT COMPLETED|Open-label Extension Period||0
354920|NCT01232569|849783|P1|NOT COMPLETED|Open-label Extension Period||0
354921|NCT01232569|849780|P4|COMPLETED|Open-label Extension Period||200
354922|NCT01232569|849781|P3|COMPLETED|Open-label Extension Period||203
354923|NCT01232569|849782|P2|COMPLETED|Open-label Extension Period||0
354924|NCT01232569|849783|P1|COMPLETED|Open-label Extension Period||0
354925|NCT01232569|849780|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
354926|NCT01232569|849781|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
354927|NCT01232569|849782|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
354928|NCT01232569|849783|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
354929|NCT01232569|849780|P4|NOT COMPLETED|Double-blind Treatment Period||0
354930|NCT01232569|849781|P3|NOT COMPLETED|Double-blind Treatment Period||0
354931|NCT01232569|849782|P2|NOT COMPLETED|Double-blind Treatment Period||9
354932|NCT01232569|849783|P1|NOT COMPLETED|Double-blind Treatment Period||28
354933|NCT01232569|849780|P4|COMPLETED|Double-blind Treatment Period||0
354934|NCT01232569|849781|P3|COMPLETED|Double-blind Treatment Period||0
354935|NCT01232569|849782|P2|COMPLETED|Double-blind Treatment Period||209
354936|NCT01232569|849783|P1|COMPLETED|Double-blind Treatment Period||410
354937|NCT01232569|849780|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
354938|NCT01232569|849781|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
354939|NCT01232569|849782|P2|STARTED|Double-blind Treatment Period||218
354940|NCT01232569|849783|P1|STARTED|Double-blind Treatment Period||438
354941|NCT01232504|849827|P3|NOT COMPLETED|Overall Study||8
354942|NCT01232504|849828|P2|NOT COMPLETED|Overall Study||2
354943|NCT01232504|849829|P1|NOT COMPLETED|Overall Study||9
354944|NCT01232504|849827|P3|COMPLETED|Overall Study||61
354945|NCT01232504|849828|P2|COMPLETED|Overall Study||67
354946|NCT01232504|849829|P1|COMPLETED|Overall Study||59
354947|NCT01232504|849827|P3|STARTED|Overall Study||69
354948|NCT01232504|849828|P2|STARTED|Overall Study||69
354949|NCT01232504|849829|P1|STARTED|Overall Study||68
354950|NCT01232491|849863|P2|NOT COMPLETED|Overall Study||63
354951|NCT01232491|849864|P1|NOT COMPLETED|Overall Study||60
354952|NCT01232491|849863|P2|COMPLETED|Overall Study||242
354953|NCT01232491|849864|P1|COMPLETED|Overall Study||246
354954|NCT01232491|849863|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
354955|NCT01232491|849864|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
354956|NCT01232491|849863|P2|STARTED|Overall Study||305
354957|NCT01232491|849864|P1|STARTED|Overall Study||306
354958|NCT01232465|849884|P2|NOT COMPLETED|Overall Study||0
354959|NCT01232465|849885|P1|NOT COMPLETED|Overall Study||0
354960|NCT01232465|849884|P2|COMPLETED|Overall Study||402
354961|NCT01232465|849885|P1|COMPLETED|Overall Study||337
354962|NCT01232465|849884|P2|STARTED|Overall Study||402
354963|NCT01232465|849885|P1|STARTED|Overall Study||337
354964|NCT01232296|849893|P2|NOT COMPLETED|Overall Study||83
354965|NCT01232296|849894|P1|NOT COMPLETED|Overall Study||82
354966|NCT01232296|849893|P2|COMPLETED|Overall Study||0
354967|NCT01232296|849894|P1|COMPLETED|Overall Study||0
354968|NCT01232296|849893|P2|Safety Set|Overall Study||83
354969|NCT01232296|849894|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
354970|NCT01232296|849893|P2|Full Analysis Set|Overall Study||83
354971|NCT01232296|849894|P1|Full Analysis Set|Overall Study||82
354972|NCT01232296|849893|P2|STARTED|Overall Study||83
354973|NCT01232296|849894|P1|STARTED|Overall Study||82
354974|NCT01232283|849911|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
354975|NCT01232283|849912|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
354976|NCT01232283|849913|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
354977|NCT01232283|849914|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
354978|NCT01232283|849915|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354979|NCT01232283|849916|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354980|NCT01232283|849917|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354981|NCT01232283|849918|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354982|NCT01232283|849911|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
354983|NCT01232283|849912|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
354984|NCT01232283|849913|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
354985|NCT01232283|849914|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
354986|NCT01232283|849915|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354987|NCT01232283|849916|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354988|NCT01232283|849917|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354989|NCT01232283|849918|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
354990|NCT01232283|849911|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
354991|NCT01232283|849912|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
354992|NCT01232283|849913|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
354993|NCT01232283|849914|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
354994|NCT01232283|849915|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
354995|NCT01232283|849916|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
354996|NCT01232283|849917|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
354997|NCT01232283|849918|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
354998|NCT01232283|849911|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
354999|NCT01232283|849912|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
355000|NCT01232283|849913|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
355001|NCT01232283|849914|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
355002|NCT01232283|849915|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
355003|NCT01232283|849916|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
355004|NCT01232283|849917|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
355005|NCT01232283|849918|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
355006|NCT01232283|849911|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
355007|NCT01232283|849912|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
355008|NCT01232283|849913|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
355009|NCT01232283|849914|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
355010|NCT01232283|849915|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
355011|NCT01232283|849916|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
355012|NCT01232283|849917|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
355013|NCT01232283|849918|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
355014|NCT01232283|849911|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
355015|NCT01232283|849912|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
355016|NCT01232283|849913|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
355017|NCT01232283|849914|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
355018|NCT01232283|849915|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
355019|NCT01232283|849916|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
355020|NCT01232283|849917|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
355021|NCT01232283|849918|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
355022|NCT01232283|849911|P8|STARTED|Maintenance Phase (Weeks16-32)||0
355023|NCT01232283|849912|P7|STARTED|Maintenance Phase (Weeks16-32)||0
355024|NCT01232283|849913|P6|STARTED|Maintenance Phase (Weeks16-32)||0
355025|NCT01232283|849914|P5|STARTED|Maintenance Phase (Weeks16-32)||0
355026|NCT01232283|849915|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
355027|NCT01232283|849916|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
355028|NCT01232283|849917|P2|STARTED|Maintenance Phase (Weeks16-32)||0
355029|NCT01232283|849918|P1|STARTED|Maintenance Phase (Weeks16-32)||0
355030|NCT01232283|849911|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355031|NCT01232283|849912|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355032|NCT01232283|849913|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355033|NCT01232283|849914|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355034|NCT01232283|849915|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355035|NCT01232283|849916|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355036|NCT01232283|849917|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
355037|NCT01232283|849918|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
355038|NCT01232283|849911|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355039|NCT01232283|849912|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355040|NCT01232283|849913|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355041|NCT01232283|849914|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355042|NCT01232283|849915|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355043|NCT01232283|849916|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
355044|NCT01232283|849917|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
355045|NCT01232283|849918|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
355046|NCT01232283|849911|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
355047|NCT01232283|849912|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
355048|NCT01232283|849913|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
355049|NCT01232283|849914|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
355050|NCT01232283|849915|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
355051|NCT01232283|849916|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
355052|NCT01232283|849917|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
355053|NCT01232283|849918|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
355054|NCT01232283|849911|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
355055|NCT01232283|849912|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
355056|NCT01232283|849913|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
355057|NCT01232283|849914|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
355058|NCT01232283|849915|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
355059|NCT01232283|849916|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
355060|NCT01232283|849917|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
355061|NCT01232283|849918|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
355062|NCT01232205|849950|P2|NOT COMPLETED|Overall Study||3
355063|NCT01232205|849951|P1|NOT COMPLETED|Overall Study||3
355064|NCT01232205|849950|P2|COMPLETED|Overall Study||55
355065|NCT01232205|849951|P1|COMPLETED|Overall Study||49
355066|NCT01232205|849950|P2|STARTED|Overall Study||58
355067|NCT01232205|849951|P1|STARTED|Overall Study||52
355068|NCT01232127|849957|P3|NOT COMPLETED|Period 3: Days 18-24||0
355069|NCT01232127|849958|P2|NOT COMPLETED|Period 3: Days 18-24||0
355070|NCT01232127|849959|P1|NOT COMPLETED|Period 3: Days 18-24||0
355071|NCT01232127|849957|P3|COMPLETED|Period 3: Days 18-24||24
355072|NCT01232127|849958|P2|COMPLETED|Period 3: Days 18-24||0
355073|NCT01232127|849959|P1|COMPLETED|Period 3: Days 18-24||0
355074|NCT01232127|849957|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
355075|NCT01232127|849958|P2|STARTED|Period 3: Days 18-24||0
355076|NCT01232127|849959|P1|STARTED|Period 3: Days 18-24||0
355077|NCT01232127|849957|P3|NOT COMPLETED|Period 2: Days 11-17||0
355078|NCT01232127|849958|P2|NOT COMPLETED|Period 2: Days 11-17||0
355079|NCT01232127|849959|P1|NOT COMPLETED|Period 2: Days 11-17||0
355080|NCT01232127|849957|P3|COMPLETED|Period 2: Days 11-17||0
355081|NCT01232127|849958|P2|COMPLETED|Period 2: Days 11-17||24
355082|NCT01232127|849959|P1|COMPLETED|Period 2: Days 11-17||0
355083|NCT01232127|849957|P3|STARTED|Period 2: Days 11-17||0
355084|NCT01232127|849958|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
355085|NCT01232127|849959|P1|STARTED|Period 2: Days 11-17||0
355086|NCT01232127|849957|P3|NOT COMPLETED|Period 1: Days 1-10||0
355087|NCT01232127|849958|P2|NOT COMPLETED|Period 1: Days 1-10||0
355088|NCT01232127|849959|P1|NOT COMPLETED|Period 1: Days 1-10||1
355089|NCT01232127|849957|P3|COMPLETED|Period 1: Days 1-10||0
355090|NCT01232127|849958|P2|COMPLETED|Period 1: Days 1-10||0
355091|NCT01232127|849959|P1|COMPLETED|Period 1: Days 1-10||24
355092|NCT01232127|849957|P3|STARTED|Period 1: Days 1-10||0
355093|NCT01232127|849958|P2|STARTED|Period 1: Days 1-10||0
355094|NCT01232127|849959|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
355095|NCT01231984|849983|P4|NOT COMPLETED|Study Period 2||4
355096|NCT01231984|849984|P3|NOT COMPLETED|Study Period 2||0
355097|NCT01231984|849985|P2|NOT COMPLETED|Study Period 2||2
355098|NCT01231984|849986|P1|NOT COMPLETED|Study Period 2||3
355099|NCT01231984|849983|P4|COMPLETED|Study Period 2||56
355100|NCT01231984|849984|P3|COMPLETED|Study Period 2||59
355101|NCT01231984|849985|P2|COMPLETED|Study Period 2||61
355102|NCT01231984|849986|P1|COMPLETED|Study Period 2||54
355103|NCT01231984|849983|P4|STARTED|Study Period 2||60
355104|NCT01231984|849984|P3|STARTED|Study Period 2||59
355105|NCT01231984|849985|P2|STARTED|Study Period 2||63
355106|NCT01231984|849986|P1|STARTED|Study Period 2||57
355107|NCT01231984|849983|P4|NOT COMPLETED|Study Period 1||9
355108|NCT01231984|849984|P3|NOT COMPLETED|Study Period 1||7
355109|NCT01231984|849985|P2|NOT COMPLETED|Study Period 1||7
355110|NCT01231984|849986|P1|NOT COMPLETED|Study Period 1||12
355111|NCT01231984|849983|P4|COMPLETED|Study Period 1||60
355112|NCT01231984|849984|P3|COMPLETED|Study Period 1||59
355113|NCT01231984|849985|P2|COMPLETED|Study Period 1||63
355114|NCT01231984|849986|P1|COMPLETED|Study Period 1||57
355115|NCT01231984|849983|P4|STARTED|Study Period 1||69
355116|NCT01231984|849984|P3|STARTED|Study Period 1||66
355117|NCT01231984|849985|P2|STARTED|Study Period 1||70
355118|NCT01231984|849986|P1|STARTED|Study Period 1||69
355119|NCT01231841|850007|P1|NOT COMPLETED|Overall Study||0
355120|NCT01231841|850007|P1|COMPLETED|Overall Study||20
355121|NCT01231841|850007|P1|STARTED|Overall Study||20
355122|NCT01231750|850013|P2|NOT COMPLETED|Overall Study||0
355123|NCT01231750|850014|P1|NOT COMPLETED|Overall Study||0
355124|NCT01231750|850013|P2|COMPLETED|Overall Study||4
355125|NCT01231750|850014|P1|COMPLETED|Overall Study||3
355126|NCT01231750|850013|P2|STARTED|Overall Study||4
355127|NCT01231750|850014|P1|STARTED|Overall Study||3
355128|NCT01231646|850032|P2|NOT COMPLETED|Overall Study||0
355129|NCT01231646|850033|P1|NOT COMPLETED|Overall Study||0
355130|NCT01231646|850032|P2|COMPLETED|Overall Study||10
355131|NCT01231646|850033|P1|COMPLETED|Overall Study||28
355132|NCT01231646|850032|P2|STARTED|Overall Study||10
355133|NCT01231646|850033|P1|STARTED|Overall Study||28
355134|NCT01231607|850044|P5|NOT COMPLETED|Overall Study||24
355135|NCT01231607|850045|P4|NOT COMPLETED|Overall Study||38
355136|NCT01231607|850046|P3|NOT COMPLETED|Overall Study||31
355137|NCT01231607|850047|P2|NOT COMPLETED|Overall Study||34
355138|NCT01231607|850048|P1|NOT COMPLETED|Overall Study||29
355139|NCT01231607|850044|P5|COMPLETED|Overall Study||157
355140|NCT01231607|850045|P4|COMPLETED|Overall Study||141
355141|NCT01231607|850046|P3|COMPLETED|Overall Study||153
355142|NCT01231607|850047|P2|COMPLETED|Overall Study||154
355143|NCT01231607|850048|P1|COMPLETED|Overall Study||156
355144|NCT01231607|850044|P5|STARTED|Overall Study||181
355145|NCT01231607|850045|P4|STARTED|Overall Study||179
355146|NCT01231607|850046|P3|STARTED|Overall Study||184
355147|NCT01231607|850047|P2|STARTED|Overall Study||188
355148|NCT01231607|850048|P1|STARTED|Overall Study||185
355149|NCT01231581|850140|P2|NOT COMPLETED|Overall Study||80
355150|NCT01231581|850141|P1|NOT COMPLETED|Overall Study||80
355151|NCT01231581|850140|P2|COMPLETED|Overall Study||0
355152|NCT01231581|850141|P1|COMPLETED|Overall Study||0
355153|NCT01231581|850140|P2|Ongoing|Overall Study||0
355154|NCT01231581|850141|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
355155|NCT01231581|850140|P2|STARTED|Overall Study||80
355156|NCT01231581|850141|P1|STARTED|Overall Study||80
355157|NCT01231516|850161|P2|NOT COMPLETED|Open-label Phase||26
355158|NCT01231516|850162|P1|NOT COMPLETED|Open-label Phase||295
355159|NCT01231516|850161|P2|COMPLETED|Open-label Phase||1
355160|NCT01231516|850162|P1|COMPLETED|Open-label Phase||0
355161|NCT01231516|850161|P2|Ongoing at the Time of Analysis|Open-label Phase||23
355162|NCT01231516|850162|P1|Ongoing at the Time of Analysis|Open-label Phase||282
355163|NCT01231516|850161|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
355164|NCT01231516|850162|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
355165|NCT01231516|850161|P2|NOT COMPLETED|48 Week Double-blind Phase||79
355166|NCT01231516|850162|P1|NOT COMPLETED|48 Week Double-blind Phase||58
355167|NCT01231516|850161|P2|COMPLETED|48 Week Double-blind Phase||283
355168|NCT01231516|850162|P1|COMPLETED|48 Week Double-blind Phase||299
355169|NCT01231516|850161|P2|STARTED|48 Week Double-blind Phase||362
355170|NCT01231516|850162|P1|STARTED|48 Week Double-blind Phase||357
355171|NCT01231503|850192|P8|NOT COMPLETED|Overall Study||8
355172|NCT01231503|850193|P7|NOT COMPLETED|Overall Study||7
355173|NCT01231503|850194|P6|NOT COMPLETED|Overall Study||16
355174|NCT01231503|850195|P5|NOT COMPLETED|Overall Study||10
355175|NCT01231503|850196|P4|NOT COMPLETED|Overall Study||8
355176|NCT01231503|850197|P3|NOT COMPLETED|Overall Study||12
355177|NCT01231503|850198|P2|NOT COMPLETED|Overall Study||13
355178|NCT01231503|850199|P1|NOT COMPLETED|Overall Study||14
355179|NCT01231503|850192|P8|COMPLETED|Overall Study||52
355180|NCT01231503|850193|P7|COMPLETED|Overall Study||53
355181|NCT01231503|850194|P6|COMPLETED|Overall Study||44
355182|NCT01231503|850195|P5|COMPLETED|Overall Study||50
355183|NCT01231503|850196|P4|COMPLETED|Overall Study||52
355184|NCT01231503|850197|P3|COMPLETED|Overall Study||48
355185|NCT01231503|850198|P2|COMPLETED|Overall Study||46
355186|NCT01231503|850199|P1|COMPLETED|Overall Study||46
355187|NCT01231503|850192|P8|STARTED|Overall Study||60
355188|NCT01231503|850193|P7|STARTED|Overall Study||60
355189|NCT01231503|850194|P6|STARTED|Overall Study||60
355190|NCT01231503|850195|P5|STARTED|Overall Study||60
355191|NCT01231503|850196|P4|STARTED|Overall Study||60
355192|NCT01231503|850197|P3|STARTED|Overall Study||60
355193|NCT01231503|850198|P2|STARTED|Overall Study||59
355194|NCT01231503|850199|P1|STARTED|Overall Study||60
355195|NCT01231464|850415|P2|NOT COMPLETED|Overall Study||7
355196|NCT01231464|850416|P1|NOT COMPLETED|Overall Study||5
355197|NCT01231464|850415|P2|COMPLETED|Overall Study||176
355198|NCT01231464|850416|P1|COMPLETED|Overall Study||177
355199|NCT01231464|850415|P2|STARTED|Overall Study||183
355200|NCT01231464|850416|P1|STARTED|Overall Study||182
355201|NCT01231399|850426|P1|NOT COMPLETED|Overall Study||0
355202|NCT01231399|850426|P1|COMPLETED|Overall Study||6
355203|NCT01231399|850426|P1|STARTED|Overall Study||6
355204|NCT01231373|850437|P4|NOT COMPLETED|Overall Study||1
355205|NCT01231373|850438|P3|NOT COMPLETED|Overall Study||0
355206|NCT01231373|850439|P2|NOT COMPLETED|Overall Study||1
355207|NCT01231373|850440|P1|NOT COMPLETED|Overall Study||3
355208|NCT01231373|850437|P4|COMPLETED|Overall Study||57
355209|NCT01231373|850438|P3|COMPLETED|Overall Study||60
355210|NCT01231373|850439|P2|COMPLETED|Overall Study||57
355211|NCT01231373|850440|P1|COMPLETED|Overall Study||56
355212|NCT01231373|850437|P4|Patients Receiving Blinded Treatment|Overall Study||58
355213|NCT01231373|850438|P3|Patients Receiving Blinded Treatment|Overall Study||60
355214|NCT01231373|850439|P2|Patients Receiving Blinded Treatment|Overall Study||57
355215|NCT01231373|850440|P1|Patients Receiving Blinded Treatment|Overall Study||57
355216|NCT01231373|850437|P4|STARTED|Overall Study||58
355217|NCT01231373|850438|P3|STARTED|Overall Study||60
355218|NCT01231373|850439|P2|STARTED|Overall Study||58
355219|NCT01231373|850440|P1|STARTED|Overall Study||59
355220|NCT01231334|850460|P2|NOT COMPLETED|Overall Study||21
355221|NCT01231334|850461|P1|NOT COMPLETED|Overall Study||19
355222|NCT01231334|850460|P2|COMPLETED|Overall Study||120
355223|NCT01231334|850461|P1|COMPLETED|Overall Study||126
355224|NCT01231334|850460|P2|STARTED|Overall Study||141
355225|NCT01231334|850461|P1|STARTED|Overall Study||145
355226|NCT01231321|850479|P1|NOT COMPLETED|Overall Study||5
355227|NCT01231321|850479|P1|COMPLETED|Overall Study||95
355228|NCT01231321|850479|P1|STARTED|Overall Study||100
355229|NCT01231230|850490|P1|NOT COMPLETED|Overall Study||0
355230|NCT01231230|850490|P1|COMPLETED|Overall Study||14
355231|NCT01231230|850490|P1|Placebo|Overall Study||14
355232|NCT01231230|850490|P1|Fluticasone/Salmeterol|Overall Study||14
355233|NCT01231230|850490|P1|Salmeterol|Overall Study||14
355234|NCT01231230|850490|P1|Fluticasone|Overall Study||14
355235|NCT01231230|850490|P1|STARTED|Overall Study||14
355236|NCT01230892|850502|P2|NOT COMPLETED|Overall Study||1
355237|NCT01230892|850503|P1|NOT COMPLETED|Overall Study||3
355238|NCT01230892|850502|P2|COMPLETED|Overall Study||13
355239|NCT01230892|850503|P1|COMPLETED|Overall Study||12
355240|NCT01230892|850502|P2|STARTED|Overall Study||14
355241|NCT01230892|850503|P1|STARTED|Overall Study||15
355242|NCT01230827|850513|P4|NOT COMPLETED|Overall Study||78
355243|NCT01230827|850514|P3|NOT COMPLETED|Overall Study||65
355244|NCT01230827|850515|P2|NOT COMPLETED|Overall Study||11
355245|NCT01230827|850516|P1|NOT COMPLETED|Overall Study||19
355246|NCT01230827|850513|P4|COMPLETED|Overall Study||0
355247|NCT01230827|850514|P3|COMPLETED|Overall Study||0
355248|NCT01230827|850515|P2|COMPLETED|Overall Study||0
355249|NCT01230827|850516|P1|COMPLETED|Overall Study||0
355250|NCT01230827|850513|P4|STARTED|Overall Study||78
355251|NCT01230827|850514|P3|STARTED|Overall Study||65
355252|NCT01230827|850515|P2|STARTED|Overall Study||11
355253|NCT01230827|850516|P1|STARTED|Overall Study||19
355254|NCT01230814|850532|P2|NOT COMPLETED|Overall Study||4
355255|NCT01230814|850533|P1|NOT COMPLETED|Overall Study||13
355256|NCT01230814|850532|P2|COMPLETED|Overall Study||112
355257|NCT01230814|850533|P1|COMPLETED|Overall Study||105
355258|NCT01230814|850532|P2|STARTED|Overall Study||116
355259|NCT01230814|850533|P1|STARTED|Overall Study||118
355260|NCT01230788|850545|P1|NOT COMPLETED|Overall Study||1
355261|NCT01230788|850545|P1|COMPLETED|Overall Study||0
355262|NCT01230788|850545|P1|STARTED|Overall Study||1
355263|NCT01230749|850557|P4|NOT COMPLETED|Overall Study||2
355264|NCT01230749|850558|P3|NOT COMPLETED|Overall Study||2
355265|NCT01230749|850559|P2|NOT COMPLETED|Overall Study||2
355266|NCT01230749|850560|P1|NOT COMPLETED|Overall Study||0
355267|NCT01230749|850557|P4|COMPLETED|Overall Study||20
355268|NCT01230749|850558|P3|COMPLETED|Overall Study||21
355269|NCT01230749|850559|P2|COMPLETED|Overall Study||20
355270|NCT01230749|850560|P1|COMPLETED|Overall Study||22
355271|NCT01230749|850557|P4|STARTED|Overall Study||22
355272|NCT01230749|850558|P3|STARTED|Overall Study||23
355273|NCT01230749|850559|P2|STARTED|Overall Study||22
355274|NCT01230749|850560|P1|STARTED|Overall Study||22
355275|NCT01230710|850595|P1|NOT COMPLETED|Overall Study||49
355276|NCT01230710|850595|P1|COMPLETED|Overall Study||2
355277|NCT01230710|850595|P1|STARTED|Overall Study||51
355278|NCT01230502|850606|P3|NOT COMPLETED|Overall Study||0
355279|NCT01230502|850607|P2|NOT COMPLETED|Overall Study||0
355280|NCT01230502|850608|P1|NOT COMPLETED|Overall Study||0
355281|NCT01230502|850606|P3|COMPLETED|Overall Study||0
355282|NCT01230502|850607|P2|COMPLETED|Overall Study||0
355283|NCT01230502|850608|P1|COMPLETED|Overall Study||9
355284|NCT01230502|850606|P3|STARTED|Overall Study||0
355285|NCT01230502|850607|P2|STARTED|Overall Study||0
355286|NCT01230502|850608|P1|STARTED|Overall Study||9
355287|NCT01230307|850621|P2|NOT COMPLETED|Overall Study||2
355288|NCT01230307|850622|P1|NOT COMPLETED|Overall Study||0
355289|NCT01230307|850621|P2|COMPLETED|Overall Study||4
355290|NCT01230307|850622|P1|COMPLETED|Overall Study||6
355291|NCT01230307|850621|P2|STARTED|Overall Study||6
355292|NCT01230307|850622|P1|STARTED|Overall Study||6
355293|NCT01230177|850634|P1|NOT COMPLETED|Overall Study||0
355294|NCT01230177|850634|P1|COMPLETED|Overall Study||3
355295|NCT01230177|850634|P1|STARTED|Overall Study||3
355296|NCT01230060|850642|P1|NOT COMPLETED|Overall Study||1
355297|NCT01230060|850642|P1|COMPLETED|Overall Study||121
355298|NCT01230060|850642|P1|STARTED|Overall Study||122
355299|NCT01230021|850646|P1|NOT COMPLETED|Overall Study||0
355300|NCT01230021|850646|P1|COMPLETED|Overall Study||6
355301|NCT01230021|850646|P1|STARTED|Overall Study||6
355308|NCT01229891|850682|P3|NOT COMPLETED|Overall Study||0
355309|NCT01229891|850683|P2|NOT COMPLETED|Overall Study||0
355310|NCT01229891|850684|P1|NOT COMPLETED|Overall Study||0
355311|NCT01229891|850682|P3|COMPLETED|Overall Study||30
355312|NCT01229891|850683|P2|COMPLETED|Overall Study||30
355313|NCT01229891|850684|P1|COMPLETED|Overall Study||30
355314|NCT01229891|850682|P3|STARTED|Overall Study||30
355315|NCT01229891|850683|P2|STARTED|Overall Study||30
355316|NCT01229891|850684|P1|STARTED|Overall Study||30
355317|NCT01229735|850715|P2|NOT COMPLETED|Overall Study||66
355318|NCT01229735|850716|P1|NOT COMPLETED|Overall Study||66
355319|NCT01229735|850715|P2|COMPLETED|Overall Study||100
355320|NCT01229735|850716|P1|COMPLETED|Overall Study||111
355321|NCT01229735|850715|P2|STARTED|Overall Study||166
355322|NCT01229735|850716|P1|STARTED|Overall Study||177
355323|NCT01229722|850732|P2|NOT COMPLETED|Overall Study||0
355324|NCT01229722|850733|P1|NOT COMPLETED|Overall Study||4
355325|NCT01229722|850732|P2|COMPLETED|Overall Study||36
355326|NCT01229722|850733|P1|COMPLETED|Overall Study||30
355327|NCT01229722|850732|P2|STARTED|Overall Study||36
355328|NCT01229722|850733|P1|STARTED|Overall Study||34
355329|NCT01229527|850742|P3|NOT COMPLETED|Overall Study||0
355330|NCT01229527|850743|P2|NOT COMPLETED|Overall Study||0
355331|NCT01229527|850744|P1|NOT COMPLETED|Overall Study||0
355332|NCT01229527|850742|P3|COMPLETED|Overall Study||30
355333|NCT01229527|850743|P2|COMPLETED|Overall Study||30
355334|NCT01229527|850744|P1|COMPLETED|Overall Study||30
355335|NCT01229527|850742|P3|STARTED|Overall Study||30
355336|NCT01229527|850743|P2|STARTED|Overall Study||30
355337|NCT01229527|850744|P1|STARTED|Overall Study||30
355338|NCT01229462|850757|P2|NOT COMPLETED|Overall Study||9
355339|NCT01229462|850758|P1|NOT COMPLETED|Overall Study||5
355340|NCT01229462|850757|P2|COMPLETED|Overall Study||109
355341|NCT01229462|850758|P1|COMPLETED|Overall Study||115
355342|NCT01229462|850757|P2|STARTED|Overall Study||118
355343|NCT01229462|850758|P1|STARTED|Overall Study||120
355344|NCT01229436|850764|P1|NOT COMPLETED|Overall Study||5
355345|NCT01229436|850764|P1|COMPLETED|Overall Study||249
355346|NCT01229436|850764|P1|STARTED|Overall Study||254
355347|NCT01229423|850802|P1|NOT COMPLETED|Overall Study||15
355348|NCT01229423|850802|P1|COMPLETED|Overall Study||47
355349|NCT01229423|850802|P1|STARTED|Overall Study||62
355350|NCT01229410|850813|P2|NOT COMPLETED|Overall Study||3
355351|NCT01229410|850814|P1|NOT COMPLETED|Overall Study||5
355352|NCT01229410|850813|P2|COMPLETED|Overall Study||9
355353|NCT01229410|850814|P1|COMPLETED|Overall Study||7
355354|NCT01229410|850813|P2|STARTED|Overall Study||12
355355|NCT01229410|850814|P1|STARTED|Overall Study||12
355356|NCT01229397|850826|P2|NOT COMPLETED|Overall Study||9
355357|NCT01229397|850827|P1|NOT COMPLETED|Overall Study||11
355358|NCT01229397|850826|P2|COMPLETED|Overall Study||93
355359|NCT01229397|850827|P1|COMPLETED|Overall Study||92
355360|NCT01229397|850826|P2|STARTED|Overall Study||102
355361|NCT01229397|850827|P1|STARTED|Overall Study||103
355362|NCT01229371|850845|P4|NOT COMPLETED|Overall Study||0
355363|NCT01229371|850846|P3|NOT COMPLETED|Overall Study||0
355364|NCT01229371|850847|P2|NOT COMPLETED|Overall Study||1
355365|NCT01229371|850848|P1|NOT COMPLETED|Overall Study||0
355366|NCT01229371|850845|P4|COMPLETED|Overall Study||110
355367|NCT01229371|850846|P3|COMPLETED|Overall Study||110
355368|NCT01229371|850847|P2|COMPLETED|Overall Study||110
355369|NCT01229371|850848|P1|COMPLETED|Overall Study||109
355370|NCT01229371|850845|P4|STARTED|Overall Study||110
355371|NCT01229371|850846|P3|STARTED|Overall Study||110
355372|NCT01229371|850847|P2|STARTED|Overall Study||111
355373|NCT01229371|850848|P1|STARTED|Overall Study||109
355374|NCT01229228|850875|P5|NOT COMPLETED|Overall Study||1
355375|NCT01229228|850876|P4|NOT COMPLETED|Overall Study||0
355376|NCT01229228|850877|P3|NOT COMPLETED|Overall Study||1
355377|NCT01229228|850878|P2|NOT COMPLETED|Overall Study||0
355378|NCT01229228|850879|P1|NOT COMPLETED|Overall Study||1
355379|NCT01229228|850875|P5|COMPLETED|Overall Study||50
355380|NCT01229228|850876|P4|COMPLETED|Overall Study||51
355381|NCT01229228|850877|P3|COMPLETED|Overall Study||49
355382|NCT01229228|850878|P2|COMPLETED|Overall Study||51
355383|NCT01229228|850879|P1|COMPLETED|Overall Study||50
355384|NCT01229228|850875|P5|STARTED|Overall Study||51
355385|NCT01229228|850876|P4|STARTED|Overall Study||51
355386|NCT01229228|850877|P3|STARTED|Overall Study||50
355387|NCT01229228|850878|P2|STARTED|Overall Study||51
355388|NCT01229228|850879|P1|STARTED|Overall Study||51
355389|NCT01229176|850899|P8|NOT COMPLETED|Overall Study||3
355390|NCT01229176|850900|P7|NOT COMPLETED|Overall Study||0
355391|NCT01229176|850901|P6|NOT COMPLETED|Overall Study||2
355392|NCT01229176|850902|P5|NOT COMPLETED|Overall Study||2
355393|NCT01229176|850903|P4|NOT COMPLETED|Overall Study||1
355394|NCT01229176|850904|P3|NOT COMPLETED|Overall Study||0
355395|NCT01229176|850905|P2|NOT COMPLETED|Overall Study||3
355396|NCT01229176|850906|P1|NOT COMPLETED|Overall Study||0
355397|NCT01229176|850899|P8|COMPLETED|Overall Study||17
355398|NCT01229176|850900|P7|COMPLETED|Overall Study||20
355399|NCT01229176|850901|P6|COMPLETED|Overall Study||18
355400|NCT01229176|850902|P5|COMPLETED|Overall Study||18
355401|NCT01229176|850903|P4|COMPLETED|Overall Study||19
355402|NCT01229176|850904|P3|COMPLETED|Overall Study||20
355403|NCT01229176|850905|P2|COMPLETED|Overall Study||37
355404|NCT01229176|850906|P1|COMPLETED|Overall Study||40
355405|NCT01229176|850899|P8|STARTED|Overall Study||20
355406|NCT01229176|850900|P7|STARTED|Overall Study||20
355407|NCT01229176|850901|P6|STARTED|Overall Study||20
355408|NCT01229176|850902|P5|STARTED|Overall Study||20
355409|NCT01229176|850903|P4|STARTED|Overall Study||20
355410|NCT01229176|850904|P3|STARTED|Overall Study||20
355411|NCT01229176|850905|P2|STARTED|Overall Study||40
355412|NCT01229176|850906|P1|STARTED|Overall Study||40
355413|NCT01229150|850960|P4|NOT COMPLETED|Overall Study||0
355414|NCT01229150|850961|P3|NOT COMPLETED|Overall Study||0
355415|NCT01229150|850962|P2|NOT COMPLETED|Overall Study||2
355416|NCT01229150|850963|P1|NOT COMPLETED|Overall Study||2
355417|NCT01229150|850960|P4|COMPLETED|Overall Study||19
355418|NCT01229150|850961|P3|COMPLETED|Overall Study||19
355419|NCT01229150|850962|P2|COMPLETED|Overall Study||9
355420|NCT01229150|850963|P1|COMPLETED|Overall Study||28
355421|NCT01229150|850960|P4|STARTED|Overall Study||19
355422|NCT01229150|850961|P3|STARTED|Overall Study||19
355423|NCT01229150|850962|P2|STARTED|Overall Study||11
355424|NCT01229150|850963|P1|STARTED|Overall Study||30
355425|NCT01229111|851020|P1|NOT COMPLETED|Overall Study||1
355426|NCT01229111|851020|P1|COMPLETED|Overall Study||13
355427|NCT01229111|851020|P1|STARTED|Overall Study||14
355428|NCT01228968|851028|P1|NOT COMPLETED|Overall Study||0
355429|NCT01228968|851028|P1|COMPLETED|Overall Study||9
355430|NCT01228968|851028|P1|STARTED|Overall Study||9
355431|NCT01228929|851038|P3|NOT COMPLETED|High Temperature Condition||0
355432|NCT01228929|851039|P2|NOT COMPLETED|High Temperature Condition||0
355433|NCT01228929|851040|P1|NOT COMPLETED|High Temperature Condition||0
355434|NCT01228929|851038|P3|COMPLETED|High Temperature Condition||6
355435|NCT01228929|851039|P2|COMPLETED|High Temperature Condition||6
355436|NCT01228929|851040|P1|COMPLETED|High Temperature Condition||6
355437|NCT01228929|851038|P3|STARTED|High Temperature Condition||6
355438|NCT01228929|851039|P2|STARTED|High Temperature Condition||6
355439|NCT01228929|851040|P1|STARTED|High Temperature Condition||6
355440|NCT01228929|851038|P3|NOT COMPLETED|Low Humidity Condition||0
355441|NCT01228929|851039|P2|NOT COMPLETED|Low Humidity Condition||0
355442|NCT01228929|851040|P1|NOT COMPLETED|Low Humidity Condition||0
355443|NCT01228929|851038|P3|COMPLETED|Low Humidity Condition||6
355444|NCT01228929|851039|P2|COMPLETED|Low Humidity Condition||6
355445|NCT01228929|851040|P1|COMPLETED|Low Humidity Condition||6
355446|NCT01228929|851038|P3|STARTED|Low Humidity Condition||6
355447|NCT01228929|851039|P2|STARTED|Low Humidity Condition||6
355448|NCT01228929|851040|P1|STARTED|Low Humidity Condition||6
355449|NCT01228929|851038|P3|NOT COMPLETED|Nominal Condition||0
355450|NCT01228929|851039|P2|NOT COMPLETED|Nominal Condition||0
355451|NCT01228929|851040|P1|NOT COMPLETED|Nominal Condition||0
355452|NCT01228929|851038|P3|COMPLETED|Nominal Condition||6
355453|NCT01228929|851039|P2|COMPLETED|Nominal Condition||6
355454|NCT01228929|851040|P1|COMPLETED|Nominal Condition||6
355455|NCT01228929|851038|P3|STARTED|Nominal Condition||6
355456|NCT01228929|851039|P2|STARTED|Nominal Condition||6
355457|NCT01228929|851040|P1|STARTED|Nominal Condition||6
355458|NCT01228903|851050|P2|NOT COMPLETED|Overall Study||5
355459|NCT01228903|851051|P1|NOT COMPLETED|Overall Study||5
355460|NCT01228903|851050|P2|COMPLETED|Overall Study||34
355461|NCT01228903|851051|P1|COMPLETED|Overall Study||36
355462|NCT01228903|851050|P2|STARTED|Overall Study||39
355463|NCT01228903|851051|P1|STARTED|Overall Study||41
355464|NCT01228747|851069|P2|NOT COMPLETED|Overall Study||45
355465|NCT01228747|851070|P1|NOT COMPLETED|Overall Study||65
355466|NCT01228747|851069|P2|COMPLETED|Overall Study||81
355467|NCT01228747|851070|P1|COMPLETED|Overall Study||60
355468|NCT01228747|851069|P2|STARTED|Overall Study||126
355469|NCT01228747|851070|P1|STARTED|Overall Study||125
355470|NCT01228734|851086|P2|NOT COMPLETED|Overall Study||8
355471|NCT01228734|851087|P1|NOT COMPLETED|Overall Study||16
355472|NCT01228734|851086|P2|COMPLETED|Overall Study||196
355473|NCT01228734|851087|P1|COMPLETED|Overall Study||177
355474|NCT01228734|851086|P2|Modified Safety Population|Overall Study||199
355475|NCT01228734|851087|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
355476|NCT01228734|851086|P2|Modified Intent-to-treat (MITT) Populati|Overall Study||200
355477|NCT01228734|851087|P1|Modified Intent-to-treat (MITT) Populati|Overall Study||193
355478|NCT01228734|851086|P2|STARTED|Overall Study||204
355479|NCT01228734|851087|P1|STARTED|Overall Study||193
355480|NCT01228591|851101|P2|NOT COMPLETED|Final Visit||0
355481|NCT01228591|851102|P1|NOT COMPLETED|Final Visit||0
355482|NCT01228591|851101|P2|COMPLETED|Final Visit||16
355483|NCT01228591|851102|P1|COMPLETED|Final Visit||17
355484|NCT01228591|851101|P2|STARTED|Final Visit||16
355485|NCT01228591|851102|P1|STARTED|Final Visit||17
355486|NCT01228591|851101|P2|NOT COMPLETED|1-Week Follow-Up||0
355487|NCT01228591|851102|P1|NOT COMPLETED|1-Week Follow-Up||0
355488|NCT01228591|851101|P2|COMPLETED|1-Week Follow-Up||16
355489|NCT01228591|851102|P1|COMPLETED|1-Week Follow-Up||17
355490|NCT01228591|851101|P2|STARTED|1-Week Follow-Up||16
355491|NCT01228591|851102|P1|STARTED|1-Week Follow-Up||17
355492|NCT01228591|851101|P2|NOT COMPLETED|Baseline||2
355493|NCT01228591|851102|P1|NOT COMPLETED|Baseline||1
355494|NCT01228591|851101|P2|COMPLETED|Baseline||16
355495|NCT01228591|851102|P1|COMPLETED|Baseline||17
355496|NCT01228591|851101|P2|STARTED|Baseline||18
355497|NCT01228591|851102|P1|STARTED|Baseline||18
355498|NCT01228435|851120|P2|NOT COMPLETED|Overall Study||0
355499|NCT01228435|851121|P1|NOT COMPLETED|Overall Study||0
355500|NCT01228435|851120|P2|COMPLETED|Overall Study||2
355501|NCT01228435|851121|P1|COMPLETED|Overall Study||1
355502|NCT01228435|851120|P2|STARTED|Overall Study||2
355503|NCT01228435|851121|P1|STARTED|Overall Study||1
355504|NCT01228175|851129|P2|NOT COMPLETED|Overall Study||53
355505|NCT01228175|851130|P1|NOT COMPLETED|Overall Study||63
355506|NCT01228175|851129|P2|COMPLETED|Overall Study||46
355507|NCT01228175|851130|P1|COMPLETED|Overall Study||56
355508|NCT01228175|851129|P2|STARTED|Overall Study||99
355509|NCT01228175|851130|P1|STARTED|Overall Study||119
355510|NCT01228149|851138|P2|NOT COMPLETED|Overall Study||4
355511|NCT01228149|851139|P1|NOT COMPLETED|Overall Study||5
355512|NCT01228149|851138|P2|COMPLETED|Overall Study||26
355513|NCT01228149|851139|P1|COMPLETED|Overall Study||27
355514|NCT01228149|851138|P2|STARTED|Overall Study||30
355515|NCT01228149|851139|P1|STARTED|Overall Study||32
355516|NCT01228084|851145|P1|NOT COMPLETED|Overall Study||4
355517|NCT01228084|851145|P1|COMPLETED|Overall Study||16
355518|NCT01228084|851145|P1|STARTED|Overall Study||20
355519|NCT01228071|851156|P1|NOT COMPLETED|Overall Study||2
355520|NCT01228071|851156|P1|COMPLETED|Overall Study||32
355521|NCT01228071|851156|P1|STARTED|Overall Study||34
355522|NCT01228019|851162|P1|NOT COMPLETED|Overall Study||304
355523|NCT01228019|851162|P1|COMPLETED|Overall Study||862
355524|NCT01228019|851162|P1|STARTED|Overall Study||1166
355525|NCT01227993|851177|P1|NOT COMPLETED|Overall Study||0
355526|NCT01227993|851177|P1|COMPLETED|Overall Study||3
355527|NCT01227993|851177|P1|STARTED|Overall Study||3
355528|NCT01227980|851189|P2|NOT COMPLETED|Overall Study||5
355529|NCT01227980|851190|P1|NOT COMPLETED|Overall Study||2
355530|NCT01227980|851189|P2|COMPLETED|Overall Study||25
355531|NCT01227980|851190|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
355532|NCT01227980|851189|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
355533|NCT01227980|851190|P1|Measure Drug Level Concentration|Overall Study||10
355534|NCT01227980|851189|P2|Scripts Challenge Sessions|Overall Study||25
355535|NCT01227980|851190|P1|Scripts Challenge Sessions|Overall Study||26
355536|NCT01227980|851189|P2|STARTED|Overall Study||30
355537|NCT01227980|851190|P1|STARTED|Overall Study||40
355538|NCT01227928|851228|P2|NOT COMPLETED|Overall Study||17
355539|NCT01227928|851229|P1|NOT COMPLETED|Overall Study||22
355540|NCT01227928|851228|P2|COMPLETED|Overall Study||56
355541|NCT01227928|851229|P1|COMPLETED|Overall Study||50
355542|NCT01227928|851228|P2|STARTED|Overall Study||73
355543|NCT01227928|851229|P1|STARTED|Overall Study||72
355544|NCT01227902|851267|P4|NOT COMPLETED|Overall Study||10
355545|NCT01227902|851268|P3|NOT COMPLETED|Overall Study||19
355546|NCT01227902|851269|P2|NOT COMPLETED|Overall Study||13
355547|NCT01227902|851270|P1|NOT COMPLETED|Overall Study||18
355548|NCT01227902|851267|P4|COMPLETED|Overall Study||42
355549|NCT01227902|851268|P3|COMPLETED|Overall Study||25
355550|NCT01227902|851269|P2|COMPLETED|Overall Study||38
355551|NCT01227902|851270|P1|COMPLETED|Overall Study||38
355552|NCT01227902|851267|P4|STARTED|Overall Study||52
355553|NCT01227902|851268|P3|STARTED|Overall Study||44
355554|NCT01227902|851269|P2|STARTED|Overall Study||51
355555|NCT01227902|851270|P1|STARTED|Overall Study||56
355556|NCT01227889|851363|P2|NOT COMPLETED|Crossover Phase||36
355557|NCT01227889|851364|P1|NOT COMPLETED|Crossover Phase||0
355558|NCT01227889|851363|P2|COMPLETED|Crossover Phase||0
355559|NCT01227889|851364|P1|COMPLETED|Crossover Phase||0
355560|NCT01227889|851363|P2|Ongoing|Crossover Phase||4
355561|NCT01227889|851364|P1|Ongoing|Crossover Phase||0
355562|NCT01227889|851363|P2|In Follow-up|Crossover Phase||11
355563|NCT01227889|851364|P1|In Follow-up|Crossover Phase||0
355564|NCT01227889|851363|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|36
355565|NCT01227889|851364|P1|STARTED|Crossover Phase||0
355566|NCT01227889|851363|P2|NOT COMPLETED|Randomized Phase (RP)||63
355567|NCT01227889|851364|P1|NOT COMPLETED|Randomized Phase (RP)||187
355568|NCT01227889|851363|P2|COMPLETED|Randomized Phase (RP)||0
355569|NCT01227889|851364|P1|COMPLETED|Randomized Phase (RP)||0
355570|NCT01227889|851363|P2|Crossed Over|Randomized Phase (RP)||36
355571|NCT01227889|851364|P1|Crossed Over|Randomized Phase (RP)||0
355572|NCT01227889|851363|P2|Ongoing|Randomized Phase (RP)||2
355573|NCT01227889|851364|P1|Ongoing|Randomized Phase (RP)||53
355574|NCT01227889|851363|P2|In Follow-up|Randomized Phase (RP)||10
355575|NCT01227889|851364|P1|In Follow-up|Randomized Phase (RP)||49
355576|NCT01227889|851363|P2|STARTED|Randomized Phase (RP)||63
355577|NCT01227889|851364|P1|STARTED|Randomized Phase (RP)||187
355578|NCT01227824|851392|P2|NOT COMPLETED|Open-label Phase||0
355579|NCT01227824|851393|P1|NOT COMPLETED|Open-label Phase||338
355580|NCT01227824|851392|P2|COMPLETED|Open-label Phase||0
355581|NCT01227824|851393|P1|COMPLETED|Open-label Phase||0
355582|NCT01227824|851392|P2|Ongoing|Open-label Phase||0
355583|NCT01227824|851393|P1|Ongoing|Open-label Phase||337
355584|NCT01227824|851392|P2|STARTED|Open-label Phase||0
355585|NCT01227824|851393|P1|STARTED|Open-label Phase|Eleven participant completing the Double-blind Phase did not continue into the Open-label Phase.|338
355586|NCT01227824|851392|P2|NOT COMPLETED|Double-blind Phase||79
355587|NCT01227824|851393|P1|NOT COMPLETED|Double-blind Phase||62
355588|NCT01227824|851392|P2|COMPLETED|Double-blind Phase||332
355589|NCT01227824|851393|P1|COMPLETED|Double-blind Phase||349
355590|NCT01227824|851392|P2|STARTED|Double-blind Phase||411
355591|NCT01227824|851393|P1|STARTED|Double-blind Phase||411
355592|NCT01227785|851421|P1|NOT COMPLETED|Overall Study||12
355593|NCT01227785|851421|P1|COMPLETED|Overall Study||108
355594|NCT01227785|851421|P1|STARTED|Overall Study||120
355595|NCT01227707|851487|P1|NOT COMPLETED|Overall Study||24
355596|NCT01227707|851487|P1|COMPLETED|Overall Study||19
355597|NCT01227707|851487|P1|STARTED|Overall Study||43
355598|NCT01227681|851506|P3|NOT COMPLETED|Overall Study||0
355599|NCT01227681|851507|P2|NOT COMPLETED|Overall Study||0
355600|NCT01227681|851508|P1|NOT COMPLETED|Overall Study||0
355601|NCT01227681|851506|P3|COMPLETED|Overall Study||0
355602|NCT01227681|851507|P2|COMPLETED|Overall Study||0
355603|NCT01227681|851508|P1|COMPLETED|Overall Study||4
355604|NCT01227681|851506|P3|STARTED|Overall Study||0
355605|NCT01227681|851507|P2|STARTED|Overall Study||0
355606|NCT01227681|851508|P1|STARTED|Overall Study||4
355607|NCT01227668|851514|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
355608|NCT01227668|851515|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
355609|NCT01227668|851514|P2|COMPLETED|Phase 2 (Randomization Phase)||19
355610|NCT01227668|851515|P1|COMPLETED|Phase 2 (Randomization Phase)||22
355611|NCT01227668|851514|P2|Received Treatment|Phase 2 (Randomization Phase)||43
355612|NCT01227668|851515|P1|Received Treatment|Phase 2 (Randomization Phase)||39
355613|NCT01227668|851514|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
355614|NCT01227668|851515|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
355615|NCT01227668|851514|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
355616|NCT01227668|851515|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
355617|NCT01227668|851514|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
355618|NCT01227668|851515|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
355619|NCT01227668|851514|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
355620|NCT01227668|851515|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
355621|NCT01227668|851514|P2|STARTED|Phase 1 (Stabilization Phase)||0
355622|NCT01227668|851515|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
355623|NCT01227655|851532|P3|NOT COMPLETED|Overall Study||14
355624|NCT01227655|851533|P2|NOT COMPLETED|Overall Study||26
355625|NCT01227655|851534|P1|NOT COMPLETED|Overall Study||11
355626|NCT01227655|851532|P3|COMPLETED|Overall Study||130
355627|NCT01227655|851533|P2|COMPLETED|Overall Study||128
355628|NCT01227655|851534|P1|COMPLETED|Overall Study||118
355629|NCT01227655|851532|P3|Full Analysis Set|Overall Study||135
355630|NCT01227655|851533|P2|Full Analysis Set|Overall Study||147
355631|NCT01227655|851534|P1|Full Analysis Set|Overall Study||125
355632|NCT01227655|851532|P3|Safety Set|Overall Study||136
355633|NCT01227655|851533|P2|Safety Set|Overall Study||150
355634|NCT01227655|851534|P1|Safety Set|Overall Study||125
355635|NCT01227655|851532|P3|STARTED|Overall Study||144
355636|NCT01227655|851533|P2|STARTED|Overall Study||154
355637|NCT01227655|851534|P1|STARTED|Overall Study||129
355638|NCT01227629|851561|P10|NOT COMPLETED|Overall Study||2
355639|NCT01227629|851562|P9|NOT COMPLETED|Overall Study||6
355640|NCT01227629|851563|P8|NOT COMPLETED|Overall Study||6
355641|NCT01227629|851564|P7|NOT COMPLETED|Overall Study||8
355642|NCT01227629|851565|P6|NOT COMPLETED|Overall Study||1
355643|NCT01227629|851566|P5|NOT COMPLETED|Overall Study||2
355644|NCT01227629|851567|P4|NOT COMPLETED|Overall Study||8
355645|NCT01227629|851568|P3|NOT COMPLETED|Overall Study||1
355646|NCT01227629|851569|P2|NOT COMPLETED|Overall Study||2
355647|NCT01227629|851570|P1|NOT COMPLETED|Overall Study||2
355648|NCT01227629|851561|P10|COMPLETED|Overall Study||68
355649|NCT01227629|851562|P9|COMPLETED|Overall Study||24
355650|NCT01227629|851563|P8|COMPLETED|Overall Study||27
355651|NCT01227629|851564|P7|COMPLETED|Overall Study||90
355652|NCT01227629|851565|P6|COMPLETED|Overall Study||32
355653|NCT01227629|851566|P5|COMPLETED|Overall Study||32
355654|NCT01227629|851567|P4|COMPLETED|Overall Study||91
355655|NCT01227629|851568|P3|COMPLETED|Overall Study||26
355656|NCT01227629|851569|P2|COMPLETED|Overall Study||18
355657|NCT01227629|851570|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
355658|NCT01227629|851561|P10|STARTED|Overall Study||70
355659|NCT01227629|851562|P9|STARTED|Overall Study||30
355660|NCT01227629|851563|P8|STARTED|Overall Study||33
355661|NCT01227629|851564|P7|STARTED|Overall Study||98
355662|NCT01227629|851565|P6|STARTED|Overall Study||33
355663|NCT01227629|851566|P5|STARTED|Overall Study||34
355664|NCT01227629|851567|P4|STARTED|Overall Study||99
355665|NCT01227629|851568|P3|STARTED|Overall Study||27
355666|NCT01227629|851569|P2|STARTED|Overall Study||20
355667|NCT01227629|851570|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
355668|NCT01227577|851806|P1|NOT COMPLETED|Overall Study||35
355669|NCT01227577|851806|P1|COMPLETED|Overall Study||93
355670|NCT01227577|851806|P1|STARTED|Overall Study||128
355671|NCT01227564|851821|P3|NOT COMPLETED|Overall Study||6
355672|NCT01227564|851822|P2|NOT COMPLETED|Overall Study||2
355673|NCT01227564|851823|P1|NOT COMPLETED|Overall Study||4
355674|NCT01227564|851821|P3|COMPLETED|Overall Study|Completed study|15
355675|NCT01227564|851822|P2|COMPLETED|Overall Study|Completed study|18
355676|NCT01227564|851823|P1|COMPLETED|Overall Study|Completed study|18
355677|NCT01227564|851821|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
355678|NCT01227564|851822|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
355679|NCT01227564|851823|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
355680|NCT01227564|851821|P3|Treated|Overall Study||21
355681|NCT01227564|851822|P2|Treated|Overall Study||20
355682|NCT01227564|851823|P1|Treated|Overall Study||22
355683|NCT01227564|851821|P3|STARTED|Overall Study||21
355684|NCT01227564|851822|P2|STARTED|Overall Study||20
355685|NCT01227564|851823|P1|STARTED|Overall Study||22
355686|NCT01227551|851954|P1|NOT COMPLETED|Overall Study||34
355687|NCT01227551|851954|P1|COMPLETED|Overall Study||23
355688|NCT01227551|851954|P1|STARTED|Overall Study||57
355689|NCT01227512|851961|P2|NOT COMPLETED|Overall Study||10
355690|NCT01227512|851962|P1|NOT COMPLETED|Overall Study||13
355691|NCT01227512|851961|P2|COMPLETED|Overall Study||48
355692|NCT01227512|851962|P1|COMPLETED|Overall Study||53
355693|NCT01227512|851961|P2|STARTED|Overall Study||58
355694|NCT01227512|851962|P1|STARTED|Overall Study||66
355695|NCT01227434|851984|P2|NOT COMPLETED|Overall Study||0
355696|NCT01227434|851985|P1|NOT COMPLETED|Overall Study||0
355697|NCT01227434|851984|P2|COMPLETED|Overall Study||16
355698|NCT01227434|851985|P1|COMPLETED|Overall Study||6
355699|NCT01227434|851984|P2|STARTED|Overall Study||16
355700|NCT01227434|851985|P1|STARTED|Overall Study||6
355701|NCT01227421|851996|P3|NOT COMPLETED|Overall Study||10
355702|NCT01227421|851997|P2|NOT COMPLETED|Overall Study||18
355703|NCT01227421|851998|P1|NOT COMPLETED|Overall Study||11
355704|NCT01227421|851996|P3|COMPLETED|Overall Study||201
355705|NCT01227421|851997|P2|COMPLETED|Overall Study||194
355706|NCT01227421|851998|P1|COMPLETED|Overall Study||190
355707|NCT01227421|851996|P3|STARTED|Overall Study||211
355708|NCT01227421|851997|P2|STARTED|Overall Study||212
355709|NCT01227421|851998|P1|STARTED|Overall Study||201
355710|NCT01227395|852050|P2|NOT COMPLETED|Overall Study||1
355711|NCT01227395|852051|P1|NOT COMPLETED|Overall Study||0
355712|NCT01227395|852050|P2|COMPLETED|Overall Study||84
355713|NCT01227395|852051|P1|COMPLETED|Overall Study||391
355714|NCT01227395|852050|P2|STARTED|Overall Study||85
355715|NCT01227395|852051|P1|STARTED|Overall Study||391
355716|NCT01227382|852079|P1|NOT COMPLETED|Overall Study||0
355717|NCT01227382|852079|P1|COMPLETED|Overall Study||26
355718|NCT01227382|852079|P1|STARTED|Overall Study||26
355719|NCT01227278|852091|P2|NOT COMPLETED|Overall Study||8
355720|NCT01227278|852092|P1|NOT COMPLETED|Overall Study||5
355721|NCT01227278|852091|P2|COMPLETED|Overall Study||43
355722|NCT01227278|852092|P1|COMPLETED|Overall Study||45
355723|NCT01227278|852091|P2|STARTED|Overall Study||51
355724|NCT01227278|852092|P1|STARTED|Overall Study||50
355725|NCT01227265|852119|P3|NOT COMPLETED|Overall Study||14
355726|NCT01227265|852120|P2|NOT COMPLETED|Overall Study||20
355727|NCT01227265|852121|P1|NOT COMPLETED|Overall Study||19
355728|NCT01227265|852119|P3|COMPLETED|Overall Study||145
355729|NCT01227265|852120|P2|COMPLETED|Overall Study||139
355730|NCT01227265|852121|P1|COMPLETED|Overall Study||139
355731|NCT01227265|852119|P3|Treated|Overall Study||159
355732|NCT01227265|852120|P2|Treated|Overall Study||157
355733|NCT01227265|852121|P1|Treated|Overall Study||157
355734|NCT01227265|852119|P3|STARTED|Overall Study||159
355735|NCT01227265|852120|P2|STARTED|Overall Study||159
355736|NCT01227265|852121|P1|STARTED|Overall Study||158
355737|NCT01227057|852149|P2|NOT COMPLETED|Overall Study||8
355738|NCT01227057|852150|P1|NOT COMPLETED|Overall Study||6
355739|NCT01227057|852149|P2|COMPLETED|Overall Study||19
355740|NCT01227057|852150|P1|COMPLETED|Overall Study||25
355741|NCT01227057|852149|P2|STARTED|Overall Study||27
355742|NCT01227057|852150|P1|STARTED|Overall Study||31
355743|NCT01227018|852158|P1|NOT COMPLETED|Overall Study||15
355744|NCT01227018|852158|P1|COMPLETED|Overall Study||0
355745|NCT01227018|852158|P1|STARTED|Overall Study||15
355746|NCT01227005|852168|P2|NOT COMPLETED|Overall Study||1
355747|NCT01227005|852169|P1|NOT COMPLETED|Overall Study||5
355748|NCT01227005|852168|P2|COMPLETED|Overall Study||51
355749|NCT01227005|852169|P1|COMPLETED|Overall Study||50
355750|NCT01227005|852168|P2|STARTED|Overall Study||52
355751|NCT01227005|852169|P1|STARTED|Overall Study||55
355752|NCT01226745|852185|P6|NOT COMPLETED|Overall Study||5
355753|NCT01226745|852186|P5|NOT COMPLETED|Overall Study||4
355754|NCT01226745|852187|P4|NOT COMPLETED|Overall Study||5
355755|NCT01226745|852188|P3|NOT COMPLETED|Overall Study||20
355756|NCT01226745|852189|P2|NOT COMPLETED|Overall Study||16
355757|NCT01226745|852190|P1|NOT COMPLETED|Overall Study||17
355758|NCT01226745|852185|P6|COMPLETED|Overall Study||24
355759|NCT01226745|852186|P5|COMPLETED|Overall Study||22
355760|NCT01226745|852187|P4|COMPLETED|Overall Study||24
355761|NCT01226745|852188|P3|COMPLETED|Overall Study||69
355762|NCT01226745|852189|P2|COMPLETED|Overall Study||71
355763|NCT01226745|852190|P1|COMPLETED|Overall Study||63
355764|NCT01226745|852185|P6|STARTED|Overall Study||29
355765|NCT01226745|852186|P5|STARTED|Overall Study||26
355766|NCT01226745|852187|P4|STARTED|Overall Study||29
355767|NCT01226745|852188|P3|STARTED|Overall Study||89
355768|NCT01226745|852189|P2|STARTED|Overall Study||87
355769|NCT01226745|852190|P1|STARTED|Overall Study||80
355770|NCT01226732|852270|P6|NOT COMPLETED|Overall Study||6
355771|NCT01226732|852271|P5|NOT COMPLETED|Overall Study||3
355772|NCT01226732|852272|P4|NOT COMPLETED|Overall Study||5
355773|NCT01226732|852273|P3|NOT COMPLETED|Overall Study||3
355774|NCT01226732|852274|P2|NOT COMPLETED|Overall Study||3
355775|NCT01226732|852275|P1|NOT COMPLETED|Overall Study||3
355776|NCT01226732|852270|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
355777|NCT01226732|852271|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
355778|NCT01226732|852272|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
355779|NCT01226732|852273|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
355780|NCT01226732|852274|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
355781|NCT01226732|852275|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
355782|NCT01226732|852270|P6|STARTED|Overall Study||6
355783|NCT01226732|852271|P5|STARTED|Overall Study||3
355784|NCT01226732|852272|P4|STARTED|Overall Study||5
355785|NCT01226732|852273|P3|STARTED|Overall Study||3
355786|NCT01226732|852274|P2|STARTED|Overall Study||3
355787|NCT01226732|852275|P1|STARTED|Overall Study||3
355788|NCT01226719|852291|P1|NOT COMPLETED|Overall Study||13
355789|NCT01226719|852291|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
355790|NCT01226719|852291|P1|STARTED|Overall Study||15
355791|NCT01226511|852301|P2|NOT COMPLETED|Taper Period||3
355792|NCT01226511|852302|P1|NOT COMPLETED|Taper Period||5
355793|NCT01226511|852301|P2|COMPLETED|Taper Period||54
355794|NCT01226511|852302|P1|COMPLETED|Taper Period||46
355795|NCT01226511|852301|P2|STARTED|Taper Period||57
355796|NCT01226511|852302|P1|STARTED|Taper Period||51
355797|NCT01226511|852301|P2|NOT COMPLETED|Extension Treatment Period||27
355798|NCT01226511|852302|P1|NOT COMPLETED|Extension Treatment Period||27
355799|NCT01226511|852301|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
355800|NCT01226511|852302|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
355801|NCT01226511|852301|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
355802|NCT01226511|852302|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
355803|NCT01226511|852301|P2|NOT COMPLETED|Acute Treatment Period||31
355804|NCT01226511|852302|P1|NOT COMPLETED|Acute Treatment Period||32
355805|NCT01226511|852301|P2|COMPLETED|Acute Treatment Period||110
355806|NCT01226511|852302|P1|COMPLETED|Acute Treatment Period||108
355807|NCT01226511|852301|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
355808|NCT01226511|852302|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
355809|NCT01226459|852340|P2|NOT COMPLETED|Overall Study||32
355810|NCT01226459|852341|P1|NOT COMPLETED|Overall Study||21
355811|NCT01226459|852340|P2|COMPLETED|Overall Study||171
355812|NCT01226459|852341|P1|COMPLETED|Overall Study||180
355813|NCT01226459|852340|P2|STARTED|Overall Study||203
355814|NCT01226459|852341|P1|STARTED|Overall Study||201
355815|NCT01226420|852351|P1|NOT COMPLETED|Overall Study||0
355816|NCT01226420|852351|P1|COMPLETED|Overall Study||6
355817|NCT01226420|852351|P1|STARTED|Overall Study||6
355818|NCT01226121|852359|P3|NOT COMPLETED|Overall Study||1
355819|NCT01226121|852360|P2|NOT COMPLETED|Overall Study||0
355820|NCT01226121|852361|P1|NOT COMPLETED|Overall Study||2
355821|NCT01226121|852359|P3|COMPLETED|Overall Study||12
355822|NCT01226121|852360|P2|COMPLETED|Overall Study||11
355823|NCT01226121|852361|P1|COMPLETED|Overall Study||11
355824|NCT01226121|852359|P3|30 Day Evaluation|Overall Study||13
355825|NCT01226121|852360|P2|30 Day Evaluation|Overall Study||11
355826|NCT01226121|852361|P1|30 Day Evaluation|Overall Study||12
355827|NCT01226121|852359|P3|STARTED|Overall Study||13
355828|NCT01226121|852360|P2|STARTED|Overall Study||11
355829|NCT01226121|852361|P1|STARTED|Overall Study||13
355830|NCT01226095|852372|P1|NOT COMPLETED|Overall Study||1
355831|NCT01226095|852372|P1|COMPLETED|Overall Study||518
355832|NCT01226095|852372|P1|STARTED|Overall Study||519
355833|NCT01226043|852397|P4|NOT COMPLETED|30-week Observational Phase||13
355834|NCT01226043|852398|P3|NOT COMPLETED|30-week Observational Phase||6
355835|NCT01226043|852399|P2|NOT COMPLETED|30-week Observational Phase||0
355836|NCT01226043|852400|P1|NOT COMPLETED|30-week Observational Phase||0
355837|NCT01226043|852397|P4|COMPLETED|30-week Observational Phase||140
355838|NCT01226043|852398|P3|COMPLETED|30-week Observational Phase||153
355839|NCT01226043|852399|P2|COMPLETED|30-week Observational Phase||0
355840|NCT01226043|852400|P1|COMPLETED|30-week Observational Phase||0
355841|NCT01226043|852397|P4|TREATED|30-week Observational Phase||153
355842|NCT01226043|852398|P3|TREATED|30-week Observational Phase||159
355843|NCT01226043|852399|P2|TREATED|30-week Observational Phase||0
355844|NCT01226043|852400|P1|TREATED|30-week Observational Phase||0
355845|NCT01226043|852397|P4|STARTED|30-week Observational Phase||153
355846|NCT01226043|852398|P3|STARTED|30-week Observational Phase||159
355847|NCT01226043|852399|P2|STARTED|30-week Observational Phase||0
355848|NCT01226043|852400|P1|STARTED|30-week Observational Phase||0
355849|NCT01226043|852397|P4|NOT COMPLETED|6-week Re-randomization Phase||11
355850|NCT01226043|852398|P3|NOT COMPLETED|6-week Re-randomization Phase||7
355851|NCT01226043|852399|P2|NOT COMPLETED|6-week Re-randomization Phase||0
355852|NCT01226043|852400|P1|NOT COMPLETED|6-week Re-randomization Phase||0
355853|NCT01226043|852397|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
355854|NCT01226043|852398|P3|COMPLETED|6-week Re-randomization Phase||159
355855|NCT01226043|852399|P2|COMPLETED|6-week Re-randomization Phase||0
355856|NCT01226043|852400|P1|COMPLETED|6-week Re-randomization Phase||0
355857|NCT01226043|852397|P4|TREATED|6-week Re-randomization Phase||165
355858|NCT01226043|852398|P3|TREATED|6-week Re-randomization Phase||165
355859|NCT01226043|852399|P2|TREATED|6-week Re-randomization Phase||0
355860|NCT01226043|852400|P1|TREATED|6-week Re-randomization Phase||0
355861|NCT01226043|852397|P4|STARTED|6-week Re-randomization Phase||167
355862|NCT01226043|852398|P3|STARTED|6-week Re-randomization Phase||166
355863|NCT01226043|852399|P2|STARTED|6-week Re-randomization Phase||0
355864|NCT01226043|852400|P1|STARTED|6-week Re-randomization Phase||0
355865|NCT01226043|852397|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
355866|NCT01226043|852398|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
355867|NCT01226043|852399|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
355868|NCT01226043|852400|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
355869|NCT01226043|852397|P4|COMPLETED|4-week Crossover Phase - Period 2||0
355870|NCT01226043|852398|P3|COMPLETED|4-week Crossover Phase - Period 2||0
355871|NCT01226043|852399|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
355872|NCT01226043|852400|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
355873|NCT01226043|852397|P4|TREATED|4-week Crossover Phase - Period 2||0
355874|NCT01226043|852398|P3|TREATED|4-week Crossover Phase - Period 2||0
355875|NCT01226043|852399|P2|TREATED|4-week Crossover Phase - Period 2||194
355876|NCT01226043|852400|P1|TREATED|4-week Crossover Phase - Period 2||199
355877|NCT01226043|852397|P4|STARTED|4-week Crossover Phase - Period 2||0
355878|NCT01226043|852398|P3|STARTED|4-week Crossover Phase - Period 2||0
355879|NCT01226043|852399|P2|STARTED|4-week Crossover Phase - Period 2||194
355880|NCT01226043|852400|P1|STARTED|4-week Crossover Phase - Period 2||199
355881|NCT01226043|852397|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
355882|NCT01226043|852398|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
355883|NCT01226043|852399|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
355884|NCT01226043|852400|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
355885|NCT01226043|852397|P4|COMPLETED|4-week Crossover Phase - Period 1||0
355886|NCT01226043|852398|P3|COMPLETED|4-week Crossover Phase - Period 1||0
355887|NCT01226043|852399|P2|COMPLETED|4-week Crossover Phase - Period 1||194
355888|NCT01226043|852400|P1|COMPLETED|4-week Crossover Phase - Period 1||199
355889|NCT01226043|852397|P4|TREATED|4-week Crossover Phase - Period 1||0
355890|NCT01226043|852398|P3|TREATED|4-week Crossover Phase - Period 1||0
355891|NCT01226043|852399|P2|TREATED|4-week Crossover Phase - Period 1||200
355892|NCT01226043|852400|P1|TREATED|4-week Crossover Phase - Period 1||202
355893|NCT01226043|852397|P4|STARTED|4-week Crossover Phase - Period 1||0
355894|NCT01226043|852398|P3|STARTED|4-week Crossover Phase - Period 1||0
355895|NCT01226043|852399|P2|STARTED|4-week Crossover Phase - Period 1||203
355896|NCT01226043|852400|P1|STARTED|4-week Crossover Phase - Period 1||202
355897|NCT01225991|852438|P1|NOT COMPLETED|Overall Study||6
355898|NCT01225991|852438|P1|COMPLETED|Overall Study||12
355899|NCT01225991|852438|P1|STARTED|Overall Study||18
355900|NCT01225952|852445|P3|NOT COMPLETED|Overall Study||6
355901|NCT01225952|852446|P2|NOT COMPLETED|Overall Study||4
355902|NCT01225952|852447|P1|NOT COMPLETED|Overall Study||6
355903|NCT01225952|852445|P3|COMPLETED|Overall Study||25
355904|NCT01225952|852446|P2|COMPLETED|Overall Study||27
355905|NCT01225952|852447|P1|COMPLETED|Overall Study||25
355906|NCT01225952|852445|P3|STARTED|Overall Study||31
355907|NCT01225952|852446|P2|STARTED|Overall Study||31
355908|NCT01225952|852447|P1|STARTED|Overall Study||31
355909|NCT01225926|852532|P2|NOT COMPLETED|Overall Study||0
355910|NCT01225926|852533|P1|NOT COMPLETED|Overall Study||0
355911|NCT01225926|852532|P2|COMPLETED|Overall Study||12
355912|NCT01225926|852533|P1|COMPLETED|Overall Study||12
355913|NCT01225926|852532|P2|STARTED|Overall Study||12
355914|NCT01225926|852533|P1|STARTED|Overall Study||12
355915|NCT01225835|852541|P2|NOT COMPLETED|Overall Study||3
355916|NCT01225835|852542|P1|NOT COMPLETED|Overall Study||7
355917|NCT01225835|852541|P2|COMPLETED|Overall Study|hCG criterion met|59
355918|NCT01225835|852542|P1|COMPLETED|Overall Study|hCG criterion met|55
355919|NCT01225835|852541|P2|Per Protocol Population|Overall Study||58
355920|NCT01225835|852542|P1|Per Protocol Population|Overall Study||48
355921|NCT01225835|852541|P2|STARTED|Overall Study||62
355922|NCT01225835|852542|P1|STARTED|Overall Study||62
355923|NCT01225822|852590|P5|NOT COMPLETED|Overall Study||31
355924|NCT01225822|852591|P4|NOT COMPLETED|Overall Study||52
355925|NCT01225822|852592|P3|NOT COMPLETED|Overall Study||38
355926|NCT01225822|852593|P2|NOT COMPLETED|Overall Study||56
355927|NCT01225822|852594|P1|NOT COMPLETED|Overall Study||38
355928|NCT01225822|852590|P5|COMPLETED|Overall Study||361
355929|NCT01225822|852591|P4|COMPLETED|Overall Study||333
355930|NCT01225822|852592|P3|COMPLETED|Overall Study||355
355931|NCT01225822|852593|P2|COMPLETED|Overall Study||334
355932|NCT01225822|852594|P1|COMPLETED|Overall Study||351
355933|NCT01225822|852590|P5|STARTED|Overall Study||392
355934|NCT01225822|852591|P4|STARTED|Overall Study||385
355935|NCT01225822|852592|P3|STARTED|Overall Study||393
355936|NCT01225822|852593|P2|STARTED|Overall Study||390
355937|NCT01225822|852594|P1|STARTED|Overall Study||389
355938|NCT01225731|852661|P13|NOT COMPLETED|Part 3||7
355939|NCT01225731|852662|P12|NOT COMPLETED|Part 3||10
355940|NCT01225731|852663|P11|NOT COMPLETED|Part 3||6
355941|NCT01225731|852664|P10|NOT COMPLETED|Part 3||0
355942|NCT01225731|852665|P9|NOT COMPLETED|Part 3||0
355943|NCT01225731|852666|P8|NOT COMPLETED|Part 3||0
355944|NCT01225731|852667|P7|NOT COMPLETED|Part 3||0
355945|NCT01225731|852668|P6|NOT COMPLETED|Part 3||0
355946|NCT01225731|852669|P5|NOT COMPLETED|Part 3||0
355947|NCT01225731|852670|P4|NOT COMPLETED|Part 3||0
355948|NCT01225731|852671|P3|NOT COMPLETED|Part 3||0
355949|NCT01225731|852672|P2|NOT COMPLETED|Part 3||0
355950|NCT01225731|852673|P1|NOT COMPLETED|Part 3||0
355951|NCT01225731|852661|P13|COMPLETED|Part 3||60
355952|NCT01225731|852662|P12|COMPLETED|Part 3||116
355953|NCT01225731|852663|P11|COMPLETED|Part 3||80
355954|NCT01225731|852664|P10|COMPLETED|Part 3||10
355955|NCT01225731|852665|P9|COMPLETED|Part 3||0
355956|NCT01225731|852666|P8|COMPLETED|Part 3||0
355957|NCT01225731|852667|P7|COMPLETED|Part 3||0
355958|NCT01225731|852668|P6|COMPLETED|Part 3||0
355959|NCT01225731|852669|P5|COMPLETED|Part 3||0
355960|NCT01225731|852670|P4|COMPLETED|Part 3||0
355961|NCT01225731|852671|P3|COMPLETED|Part 3||0
355962|NCT01225731|852672|P2|COMPLETED|Part 3||0
355963|NCT01225731|852673|P1|COMPLETED|Part 3||0
355964|NCT01225731|852661|P13|STARTED|Part 3|Not all participants entered follow-up|67
355965|NCT01225731|852662|P12|STARTED|Part 3|Not all participants entered follow-up|126
355966|NCT01225731|852663|P11|STARTED|Part 3|Not all participants entered follow-up|86
355967|NCT01225731|852664|P10|STARTED|Part 3|Not all participants entered follow-up|10
355968|NCT01225731|852665|P9|STARTED|Part 3|Participants could enter the follow-up period|0
355969|NCT01225731|852666|P8|STARTED|Part 3|Participants could enter the follow-up period|0
355970|NCT01225731|852667|P7|STARTED|Part 3|Participants could enter the follow-up period|0
355971|NCT01225731|852668|P6|STARTED|Part 3|Participants could enter the follow-up period|0
355972|NCT01225731|852669|P5|STARTED|Part 3||0
355973|NCT01225731|852670|P4|STARTED|Part 3||0
355974|NCT01225731|852671|P3|STARTED|Part 3||0
355975|NCT01225731|852672|P2|STARTED|Part 3||0
355976|NCT01225731|852673|P1|STARTED|Part 3||0
355977|NCT01225731|852661|P13|NOT COMPLETED|Part 2||0
355978|NCT01225731|852662|P12|NOT COMPLETED|Part 2||0
355979|NCT01225731|852663|P11|NOT COMPLETED|Part 2||0
355980|NCT01225731|852664|P10|NOT COMPLETED|Part 2||0
355981|NCT01225731|852665|P9|NOT COMPLETED|Part 2||11
355982|NCT01225731|852666|P8|NOT COMPLETED|Part 2||25
355983|NCT01225731|852667|P7|NOT COMPLETED|Part 2||8
355984|NCT01225731|852668|P6|NOT COMPLETED|Part 2||3
355985|NCT01225731|852669|P5|NOT COMPLETED|Part 2||0
355986|NCT01225731|852670|P4|NOT COMPLETED|Part 2||0
355987|NCT01225731|852671|P3|NOT COMPLETED|Part 2||0
355988|NCT01225731|852672|P2|NOT COMPLETED|Part 2||0
355989|NCT01225731|852673|P1|NOT COMPLETED|Part 2||0
355990|NCT01225731|852661|P13|COMPLETED|Part 2||0
355991|NCT01225731|852662|P12|COMPLETED|Part 2||0
355992|NCT01225731|852663|P11|COMPLETED|Part 2||0
355993|NCT01225731|852664|P10|COMPLETED|Part 2||0
355994|NCT01225731|852665|P9|COMPLETED|Part 2||68
355995|NCT01225731|852666|P8|COMPLETED|Part 2||128
355996|NCT01225731|852667|P7|COMPLETED|Part 2||86
355997|NCT01225731|852668|P6|COMPLETED|Part 2||10
355998|NCT01225731|852669|P5|COMPLETED|Part 2||0
355999|NCT01225731|852670|P4|COMPLETED|Part 2||0
356000|NCT01225731|852671|P3|COMPLETED|Part 2||0
356001|NCT01225731|852672|P2|COMPLETED|Part 2||0
356002|NCT01225731|852673|P1|COMPLETED|Part 2||0
356003|NCT01225731|852661|P13|STARTED|Part 2||0
356004|NCT01225731|852662|P12|STARTED|Part 2||0
356005|NCT01225731|852663|P11|STARTED|Part 2||0
356006|NCT01225731|852664|P10|STARTED|Part 2||0
356007|NCT01225731|852665|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
356008|NCT01225731|852666|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
356009|NCT01225731|852667|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
356010|NCT01225731|852668|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
356011|NCT01225731|852669|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
356012|NCT01225731|852670|P4|STARTED|Part 2|Participants could progress into Part 2|0
356013|NCT01225731|852671|P3|STARTED|Part 2|Participants could progress into Part 2|0
356014|NCT01225731|852672|P2|STARTED|Part 2|Participants could progress into Part 2|0
356015|NCT01225731|852673|P1|STARTED|Part 2|Participants could progress into Part 2|0
356016|NCT01225731|852661|P13|NOT COMPLETED|Part 1||0
356017|NCT01225731|852662|P12|NOT COMPLETED|Part 1||0
356018|NCT01225731|852663|P11|NOT COMPLETED|Part 1||0
356019|NCT01225731|852664|P10|NOT COMPLETED|Part 1||0
356020|NCT01225731|852665|P9|NOT COMPLETED|Part 1||0
356021|NCT01225731|852666|P8|NOT COMPLETED|Part 1||0
356022|NCT01225731|852667|P7|NOT COMPLETED|Part 1||0
356023|NCT01225731|852668|P6|NOT COMPLETED|Part 1||0
356024|NCT01225731|852669|P5|NOT COMPLETED|Part 1||6
356025|NCT01225731|852670|P4|NOT COMPLETED|Part 1||2
356026|NCT01225731|852671|P3|NOT COMPLETED|Part 1||1
356027|NCT01225731|852672|P2|NOT COMPLETED|Part 1||5
356028|NCT01225731|852673|P1|NOT COMPLETED|Part 1||2
356029|NCT01225731|852661|P13|COMPLETED|Part 1||0
356030|NCT01225731|852662|P12|COMPLETED|Part 1||0
356031|NCT01225731|852663|P11|COMPLETED|Part 1||0
356032|NCT01225731|852664|P10|COMPLETED|Part 1||0
356033|NCT01225731|852665|P9|COMPLETED|Part 1||0
356034|NCT01225731|852666|P8|COMPLETED|Part 1||0
356035|NCT01225731|852667|P7|COMPLETED|Part 1||0
356036|NCT01225731|852668|P6|COMPLETED|Part 1||0
356037|NCT01225731|852669|P5|COMPLETED|Part 1||40
356038|NCT01225731|852670|P4|COMPLETED|Part 1||84
356039|NCT01225731|852671|P3|COMPLETED|Part 1||88
356040|NCT01225731|852672|P2|COMPLETED|Part 1||87
356041|NCT01225731|852673|P1|COMPLETED|Part 1||40
356042|NCT01225731|852661|P13|STARTED|Part 1||0
356043|NCT01225731|852662|P12|STARTED|Part 1||0
356044|NCT01225731|852663|P11|STARTED|Part 1||0
356045|NCT01225731|852664|P10|STARTED|Part 1||0
356046|NCT01225731|852665|P9|STARTED|Part 1||0
356047|NCT01225731|852666|P8|STARTED|Part 1||0
356048|NCT01225731|852667|P7|STARTED|Part 1||0
356049|NCT01225731|852668|P6|STARTED|Part 1||0
356050|NCT01225731|852669|P5|STARTED|Part 1||46
356051|NCT01225731|852670|P4|STARTED|Part 1||86
356052|NCT01225731|852671|P3|STARTED|Part 1||89
356053|NCT01225731|852672|P2|STARTED|Part 1||92
356054|NCT01225731|852673|P1|STARTED|Part 1||42
356055|NCT01225562|852768|P3|NOT COMPLETED|Overall Study||53
356056|NCT01225562|852769|P2|NOT COMPLETED|Overall Study||56
356057|NCT01225562|852770|P1|NOT COMPLETED|Overall Study||55
356058|NCT01225562|852768|P3|COMPLETED|Overall Study||7014
356059|NCT01225562|852769|P2|COMPLETED|Overall Study||6989
356060|NCT01225562|852770|P1|COMPLETED|Overall Study||6995
356061|NCT01225562|852768|P3|STARTED|Overall Study||7067
356062|NCT01225562|852769|P2|STARTED|Overall Study||7045
356063|NCT01225562|852770|P1|STARTED|Overall Study||7050
356064|NCT01225549|852787|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356065|NCT01225549|852788|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356066|NCT01225549|852789|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356067|NCT01225549|852790|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356068|NCT01225549|852791|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356069|NCT01225549|852792|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356070|NCT01225549|852793|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356071|NCT01225549|852794|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356072|NCT01225549|852795|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356073|NCT01225549|852796|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
356074|NCT01225549|852787|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
356075|NCT01225549|852788|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
356076|NCT01225549|852789|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
356077|NCT01225549|852790|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
356078|NCT01225549|852791|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
356079|NCT01225549|852792|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
356080|NCT01225549|852793|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
356081|NCT01225549|852794|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
356082|NCT01225549|852795|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
356083|NCT01225549|852796|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
356084|NCT01225549|852787|P10|STARTED|Period 7 - Fourth Treatment Period||1
356085|NCT01225549|852788|P9|STARTED|Period 7 - Fourth Treatment Period||4
356086|NCT01225549|852789|P8|STARTED|Period 7 - Fourth Treatment Period||1
356087|NCT01225549|852790|P7|STARTED|Period 7 - Fourth Treatment Period||3
356088|NCT01225549|852791|P6|STARTED|Period 7 - Fourth Treatment Period||1
356089|NCT01225549|852792|P5|STARTED|Period 7 - Fourth Treatment Period||1
356090|NCT01225549|852793|P4|STARTED|Period 7 - Fourth Treatment Period||0
356091|NCT01225549|852794|P3|STARTED|Period 7 - Fourth Treatment Period||3
356092|NCT01225549|852795|P2|STARTED|Period 7 - Fourth Treatment Period||3
356093|NCT01225549|852796|P1|STARTED|Period 7 - Fourth Treatment Period||1
356094|NCT01225549|852787|P10|NOT COMPLETED|Period 6 - Washout||0
356095|NCT01225549|852788|P9|NOT COMPLETED|Period 6 - Washout||0
356096|NCT01225549|852789|P8|NOT COMPLETED|Period 6 - Washout||0
356097|NCT01225549|852790|P7|NOT COMPLETED|Period 6 - Washout||0
356098|NCT01225549|852791|P6|NOT COMPLETED|Period 6 - Washout||0
356099|NCT01225549|852792|P5|NOT COMPLETED|Period 6 - Washout||0
356100|NCT01225549|852793|P4|NOT COMPLETED|Period 6 - Washout||1
356101|NCT01225549|852794|P3|NOT COMPLETED|Period 6 - Washout||0
356102|NCT01225549|852795|P2|NOT COMPLETED|Period 6 - Washout||0
356103|NCT01225549|852796|P1|NOT COMPLETED|Period 6 - Washout||0
356104|NCT01225549|852787|P10|COMPLETED|Period 6 - Washout||1
356105|NCT01225549|852788|P9|COMPLETED|Period 6 - Washout||4
356106|NCT01225549|852789|P8|COMPLETED|Period 6 - Washout||1
356107|NCT01225549|852790|P7|COMPLETED|Period 6 - Washout||3
356108|NCT01225549|852791|P6|COMPLETED|Period 6 - Washout||1
356109|NCT01225549|852792|P5|COMPLETED|Period 6 - Washout||1
356110|NCT01225549|852793|P4|COMPLETED|Period 6 - Washout||0
356111|NCT01225549|852794|P3|COMPLETED|Period 6 - Washout||3
356112|NCT01225549|852795|P2|COMPLETED|Period 6 - Washout||3
356113|NCT01225549|852796|P1|COMPLETED|Period 6 - Washout||1
356114|NCT01225549|852787|P10|STARTED|Period 6 - Washout||1
356115|NCT01225549|852788|P9|STARTED|Period 6 - Washout||4
356116|NCT01225549|852789|P8|STARTED|Period 6 - Washout||1
356117|NCT01225549|852790|P7|STARTED|Period 6 - Washout||3
356118|NCT01225549|852791|P6|STARTED|Period 6 - Washout||1
356119|NCT01225549|852792|P5|STARTED|Period 6 - Washout||1
356120|NCT01225549|852793|P4|STARTED|Period 6 - Washout||1
356121|NCT01225549|852794|P3|STARTED|Period 6 - Washout||3
356122|NCT01225549|852795|P2|STARTED|Period 6 - Washout||3
356123|NCT01225549|852796|P1|STARTED|Period 6 - Washout||1
356124|NCT01225549|852787|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
356125|NCT01225549|852788|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
356126|NCT01225549|852789|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
356127|NCT01225549|852790|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
356128|NCT01225549|852791|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
356129|NCT01225549|852792|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
356130|NCT01225549|852793|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
356131|NCT01225549|852794|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
356132|NCT01225549|852795|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
356133|NCT01225549|852796|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
356134|NCT01225549|852787|P10|COMPLETED|Period 5 - Third Treatment Period||1
356135|NCT01225549|852788|P9|COMPLETED|Period 5 - Third Treatment Period||4
356136|NCT01225549|852789|P8|COMPLETED|Period 5 - Third Treatment Period||1
356137|NCT01225549|852790|P7|COMPLETED|Period 5 - Third Treatment Period||3
356138|NCT01225549|852791|P6|COMPLETED|Period 5 - Third Treatment Period||1
356139|NCT01225549|852792|P5|COMPLETED|Period 5 - Third Treatment Period||1
356140|NCT01225549|852793|P4|COMPLETED|Period 5 - Third Treatment Period||1
356141|NCT01225549|852794|P3|COMPLETED|Period 5 - Third Treatment Period||3
356142|NCT01225549|852795|P2|COMPLETED|Period 5 - Third Treatment Period||3
356143|NCT01225549|852796|P1|COMPLETED|Period 5 - Third Treatment Period||1
356144|NCT01225549|852787|P10|STARTED|Period 5 - Third Treatment Period||1
356145|NCT01225549|852788|P9|STARTED|Period 5 - Third Treatment Period||4
356146|NCT01225549|852789|P8|STARTED|Period 5 - Third Treatment Period||1
356147|NCT01225549|852790|P7|STARTED|Period 5 - Third Treatment Period||3
356148|NCT01225549|852791|P6|STARTED|Period 5 - Third Treatment Period||1
356149|NCT01225549|852792|P5|STARTED|Period 5 - Third Treatment Period||1
356150|NCT01225549|852793|P4|STARTED|Period 5 - Third Treatment Period||1
356151|NCT01225549|852794|P3|STARTED|Period 5 - Third Treatment Period||3
356152|NCT01225549|852795|P2|STARTED|Period 5 - Third Treatment Period||3
356153|NCT01225549|852796|P1|STARTED|Period 5 - Third Treatment Period||1
356154|NCT01225549|852787|P10|NOT COMPLETED|Period 4 - Washout||0
356155|NCT01225549|852788|P9|NOT COMPLETED|Period 4 - Washout||0
356156|NCT01225549|852789|P8|NOT COMPLETED|Period 4 - Washout||0
356157|NCT01225549|852790|P7|NOT COMPLETED|Period 4 - Washout||0
356158|NCT01225549|852791|P6|NOT COMPLETED|Period 4 - Washout||0
356159|NCT01225549|852792|P5|NOT COMPLETED|Period 4 - Washout||0
356160|NCT01225549|852793|P4|NOT COMPLETED|Period 4 - Washout||0
356161|NCT01225549|852794|P3|NOT COMPLETED|Period 4 - Washout||0
356162|NCT01225549|852795|P2|NOT COMPLETED|Period 4 - Washout||1
356163|NCT01225549|852796|P1|NOT COMPLETED|Period 4 - Washout||0
356164|NCT01225549|852787|P10|COMPLETED|Period 4 - Washout||1
356165|NCT01225549|852788|P9|COMPLETED|Period 4 - Washout||4
356166|NCT01225549|852789|P8|COMPLETED|Period 4 - Washout||1
356167|NCT01225549|852790|P7|COMPLETED|Period 4 - Washout||3
356168|NCT01225549|852791|P6|COMPLETED|Period 4 - Washout||1
356169|NCT01225549|852792|P5|COMPLETED|Period 4 - Washout||1
356170|NCT01225549|852793|P4|COMPLETED|Period 4 - Washout||1
356171|NCT01225549|852794|P3|COMPLETED|Period 4 - Washout||3
356172|NCT01225549|852795|P2|COMPLETED|Period 4 - Washout||3
356173|NCT01225549|852796|P1|COMPLETED|Period 4 - Washout||1
356174|NCT01225549|852787|P10|STARTED|Period 4 - Washout||1
356175|NCT01225549|852788|P9|STARTED|Period 4 - Washout||4
356176|NCT01225549|852789|P8|STARTED|Period 4 - Washout||1
356177|NCT01225549|852790|P7|STARTED|Period 4 - Washout||3
356178|NCT01225549|852791|P6|STARTED|Period 4 - Washout||1
356179|NCT01225549|852792|P5|STARTED|Period 4 - Washout||1
356180|NCT01225549|852793|P4|STARTED|Period 4 - Washout||1
356181|NCT01225549|852794|P3|STARTED|Period 4 - Washout||3
356182|NCT01225549|852795|P2|STARTED|Period 4 - Washout||4
356183|NCT01225549|852796|P1|STARTED|Period 4 - Washout||1
356184|NCT01225549|852787|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
356185|NCT01225549|852788|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
356186|NCT01225549|852789|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
356187|NCT01225549|852790|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
356188|NCT01225549|852791|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
356189|NCT01225549|852792|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
356190|NCT01225549|852793|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
356191|NCT01225549|852794|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
356192|NCT01225549|852795|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
356193|NCT01225549|852796|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
356194|NCT01225549|852787|P10|COMPLETED|Period 3 - Second Treatment Period||1
356195|NCT01225549|852788|P9|COMPLETED|Period 3 - Second Treatment Period||4
356196|NCT01225549|852789|P8|COMPLETED|Period 3 - Second Treatment Period||1
356197|NCT01225549|852790|P7|COMPLETED|Period 3 - Second Treatment Period||3
356198|NCT01225549|852791|P6|COMPLETED|Period 3 - Second Treatment Period||1
356199|NCT01225549|852792|P5|COMPLETED|Period 3 - Second Treatment Period||1
356200|NCT01225549|852793|P4|COMPLETED|Period 3 - Second Treatment Period||1
356201|NCT01225549|852794|P3|COMPLETED|Period 3 - Second Treatment Period||3
356202|NCT01225549|852795|P2|COMPLETED|Period 3 - Second Treatment Period||4
356203|NCT01225549|852796|P1|COMPLETED|Period 3 - Second Treatment Period||1
356204|NCT01225549|852787|P10|STARTED|Period 3 - Second Treatment Period||1
356205|NCT01225549|852788|P9|STARTED|Period 3 - Second Treatment Period||4
356206|NCT01225549|852789|P8|STARTED|Period 3 - Second Treatment Period||1
356207|NCT01225549|852790|P7|STARTED|Period 3 - Second Treatment Period||3
356208|NCT01225549|852791|P6|STARTED|Period 3 - Second Treatment Period||1
356209|NCT01225549|852792|P5|STARTED|Period 3 - Second Treatment Period||1
356210|NCT01225549|852793|P4|STARTED|Period 3 - Second Treatment Period||1
356211|NCT01225549|852794|P3|STARTED|Period 3 - Second Treatment Period||3
356212|NCT01225549|852795|P2|STARTED|Period 3 - Second Treatment Period||4
356213|NCT01225549|852796|P1|STARTED|Period 3 - Second Treatment Period||1
356214|NCT01225549|852787|P10|NOT COMPLETED|Period 2 - Washout||0
356215|NCT01225549|852788|P9|NOT COMPLETED|Period 2 - Washout||0
356216|NCT01225549|852789|P8|NOT COMPLETED|Period 2 - Washout||0
356217|NCT01225549|852790|P7|NOT COMPLETED|Period 2 - Washout||0
356218|NCT01225549|852791|P6|NOT COMPLETED|Period 2 - Washout||0
356219|NCT01225549|852792|P5|NOT COMPLETED|Period 2 - Washout||0
356220|NCT01225549|852793|P4|NOT COMPLETED|Period 2 - Washout||0
356221|NCT01225549|852794|P3|NOT COMPLETED|Period 2 - Washout||0
356222|NCT01225549|852795|P2|NOT COMPLETED|Period 2 - Washout||0
356223|NCT01225549|852796|P1|NOT COMPLETED|Period 2 - Washout||0
356224|NCT01225549|852787|P10|COMPLETED|Period 2 - Washout||1
356225|NCT01225549|852788|P9|COMPLETED|Period 2 - Washout||4
356226|NCT01225549|852789|P8|COMPLETED|Period 2 - Washout||1
356227|NCT01225549|852790|P7|COMPLETED|Period 2 - Washout||3
356228|NCT01225549|852791|P6|COMPLETED|Period 2 - Washout||1
356229|NCT01225549|852792|P5|COMPLETED|Period 2 - Washout||1
356230|NCT01225549|852793|P4|COMPLETED|Period 2 - Washout||1
356231|NCT01225549|852794|P3|COMPLETED|Period 2 - Washout||3
356232|NCT01225549|852795|P2|COMPLETED|Period 2 - Washout||4
356233|NCT01225549|852796|P1|COMPLETED|Period 2 - Washout||1
356234|NCT01225549|852787|P10|STARTED|Period 2 - Washout||1
356235|NCT01225549|852788|P9|STARTED|Period 2 - Washout||4
356236|NCT01225549|852789|P8|STARTED|Period 2 - Washout||1
356237|NCT01225549|852790|P7|STARTED|Period 2 - Washout||3
356238|NCT01225549|852791|P6|STARTED|Period 2 - Washout||1
356239|NCT01225549|852792|P5|STARTED|Period 2 - Washout||1
356240|NCT01225549|852793|P4|STARTED|Period 2 - Washout||1
356241|NCT01225549|852794|P3|STARTED|Period 2 - Washout||3
356242|NCT01225549|852795|P2|STARTED|Period 2 - Washout||4
356243|NCT01225549|852796|P1|STARTED|Period 2 - Washout||1
356244|NCT01225549|852787|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
356245|NCT01225549|852788|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
356246|NCT01225549|852789|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
356247|NCT01225549|852790|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
356248|NCT01225549|852791|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
356249|NCT01225549|852792|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
356250|NCT01225549|852793|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
356251|NCT01225549|852794|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
356252|NCT01225549|852795|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
356253|NCT01225549|852796|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
356254|NCT01225549|852787|P10|COMPLETED|Period 1 - First Treatment Period||1
356255|NCT01225549|852788|P9|COMPLETED|Period 1 - First Treatment Period||4
356256|NCT01225549|852789|P8|COMPLETED|Period 1 - First Treatment Period||1
356257|NCT01225549|852790|P7|COMPLETED|Period 1 - First Treatment Period||3
356258|NCT01225549|852791|P6|COMPLETED|Period 1 - First Treatment Period||1
356259|NCT01225549|852792|P5|COMPLETED|Period 1 - First Treatment Period||1
356260|NCT01225549|852793|P4|COMPLETED|Period 1 - First Treatment Period||1
356261|NCT01225549|852794|P3|COMPLETED|Period 1 - First Treatment Period||3
356262|NCT01225549|852795|P2|COMPLETED|Period 1 - First Treatment Period||4
356263|NCT01225549|852796|P1|COMPLETED|Period 1 - First Treatment Period||1
356264|NCT01225549|852787|P10|STARTED|Period 1 - First Treatment Period||1
356265|NCT01225549|852788|P9|STARTED|Period 1 - First Treatment Period||4
356266|NCT01225549|852789|P8|STARTED|Period 1 - First Treatment Period||1
356267|NCT01225549|852790|P7|STARTED|Period 1 - First Treatment Period||3
356268|NCT01225549|852791|P6|STARTED|Period 1 - First Treatment Period||1
356269|NCT01225549|852792|P5|STARTED|Period 1 - First Treatment Period||1
356270|NCT01225549|852793|P4|STARTED|Period 1 - First Treatment Period||1
356271|NCT01225549|852794|P3|STARTED|Period 1 - First Treatment Period||3
356272|NCT01225549|852795|P2|STARTED|Period 1 - First Treatment Period||4
356273|NCT01225549|852796|P1|STARTED|Period 1 - First Treatment Period||1
356274|NCT01225354|852838|P1|NOT COMPLETED|Overall Study||1
356275|NCT01225354|852838|P1|COMPLETED|Overall Study||19
356276|NCT01225354|852838|P1|STARTED|Overall Study||20
356277|NCT01225289|852845|P2|NOT COMPLETED|Overall Study||1
356278|NCT01225289|852846|P1|NOT COMPLETED|Overall Study||0
356279|NCT01225289|852845|P2|COMPLETED|Overall Study||17
356280|NCT01225289|852846|P1|COMPLETED|Overall Study||18
356281|NCT01225289|852845|P2|STARTED|Overall Study||18
356282|NCT01225289|852846|P1|STARTED|Overall Study||18
356283|NCT01225263|852860|P2|NOT COMPLETED|Weeks 13 to 24||1
356284|NCT01225263|852861|P1|NOT COMPLETED|Weeks 13 to 24||4
356285|NCT01225263|852860|P2|COMPLETED|Weeks 13 to 24||28
356286|NCT01225263|852861|P1|COMPLETED|Weeks 13 to 24||24
356287|NCT01225263|852860|P2|STARTED|Weeks 13 to 24||29
356288|NCT01225263|852861|P1|STARTED|Weeks 13 to 24||28
356289|NCT01225263|852860|P2|NOT COMPLETED|Weeks 1 to 12||0
356290|NCT01225263|852861|P1|NOT COMPLETED|Weeks 1 to 12||0
356291|NCT01225263|852860|P2|COMPLETED|Weeks 1 to 12||29
356292|NCT01225263|852861|P1|COMPLETED|Weeks 1 to 12||28
356293|NCT01225263|852860|P2|STARTED|Weeks 1 to 12||29
356294|NCT01225263|852861|P1|STARTED|Weeks 1 to 12||28
356295|NCT01225211|852879|P10|NOT COMPLETED|Overall Study||5
356296|NCT01225211|852880|P9|NOT COMPLETED|Overall Study||1
356297|NCT01225211|852881|P8|NOT COMPLETED|Overall Study||0
356298|NCT01225211|852882|P7|NOT COMPLETED|Overall Study||1
356299|NCT01225211|852883|P6|NOT COMPLETED|Overall Study||0
356300|NCT01225211|852884|P5|NOT COMPLETED|Overall Study||0
356301|NCT01225211|852885|P4|NOT COMPLETED|Overall Study||0
356302|NCT01225211|852886|P3|NOT COMPLETED|Overall Study||1
356303|NCT01225211|852887|P2|NOT COMPLETED|Overall Study||0
356304|NCT01225211|852888|P1|NOT COMPLETED|Overall Study||0
356305|NCT01225211|852879|P10|COMPLETED|Overall Study||57
356306|NCT01225211|852880|P9|COMPLETED|Overall Study||62
356307|NCT01225211|852881|P8|COMPLETED|Overall Study||11
356308|NCT01225211|852882|P7|COMPLETED|Overall Study||41
356309|NCT01225211|852883|P6|COMPLETED|Overall Study||21
356310|NCT01225211|852884|P5|COMPLETED|Overall Study||23
356311|NCT01225211|852885|P4|COMPLETED|Overall Study||27
356312|NCT01225211|852886|P3|COMPLETED|Overall Study||20
356313|NCT01225211|852887|P2|COMPLETED|Overall Study||20
356314|NCT01225211|852888|P1|COMPLETED|Overall Study||21
356315|NCT01225211|852879|P10|STARTED|Overall Study||62
356316|NCT01225211|852880|P9|STARTED|Overall Study||63
356317|NCT01225211|852881|P8|STARTED|Overall Study||11
356318|NCT01225211|852882|P7|STARTED|Overall Study||42
356319|NCT01225211|852883|P6|STARTED|Overall Study||21
356320|NCT01225211|852884|P5|STARTED|Overall Study||23
356321|NCT01225211|852885|P4|STARTED|Overall Study||27
356322|NCT01225211|852886|P3|STARTED|Overall Study||21
356323|NCT01225211|852887|P2|STARTED|Overall Study||20
356324|NCT01225211|852888|P1|STARTED|Overall Study||21
356325|NCT01225159|852991|P2|NOT COMPLETED|Overall Study||0
356326|NCT01225159|852992|P1|NOT COMPLETED|Overall Study||1
356327|NCT01225159|852991|P2|COMPLETED|Overall Study||100
356328|NCT01225159|852992|P1|COMPLETED|Overall Study||99
356329|NCT01225159|852991|P2|STARTED|Overall Study||100
356330|NCT01225159|852992|P1|STARTED|Overall Study||100
356331|NCT01225068|853002|P2|NOT COMPLETED|Overall Study||1
356332|NCT01225068|853003|P1|NOT COMPLETED|Overall Study||4
356333|NCT01225068|853002|P2|COMPLETED|Overall Study||19
356334|NCT01225068|853003|P1|COMPLETED|Overall Study||16
356335|NCT01225068|853002|P2|STARTED|Overall Study||20
356336|NCT01225068|853003|P1|STARTED|Overall Study||20
356337|NCT01225029|853011|P2|NOT COMPLETED|Overall Study||0
356338|NCT01225029|853012|P1|NOT COMPLETED|Overall Study||0
356339|NCT01225029|853011|P2|COMPLETED|Overall Study||32
356340|NCT01225029|853012|P1|COMPLETED|Overall Study||32
356341|NCT01225029|853011|P2|STARTED|Overall Study||32
356342|NCT01225029|853012|P1|STARTED|Overall Study||32
356343|NCT01224821|853022|P1|NOT COMPLETED|Long-Term Follow-Up||11
356344|NCT01224821|853022|P1|COMPLETED|Long-Term Follow-Up||0
356345|NCT01224821|853022|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
356346|NCT01224821|853022|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
356347|NCT01224821|853022|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
356348|NCT01224821|853022|P1|STARTED|Dosimetric and Therapeutic Treatment||47
356349|NCT01224782|853041|P1|NOT COMPLETED|Overall Study||264
356350|NCT01224782|853041|P1|COMPLETED|Overall Study||730
356351|NCT01224782|853041|P1|STARTED|Overall Study||994
356352|NCT01224639|853058|P8|NOT COMPLETED|Overall Study||2
356353|NCT01224639|853059|P7|NOT COMPLETED|Overall Study||1
356354|NCT01224639|853060|P6|NOT COMPLETED|Overall Study||0
356355|NCT01224639|853061|P5|NOT COMPLETED|Overall Study||2
356356|NCT01224639|853062|P4|NOT COMPLETED|Overall Study||0
356357|NCT01224639|853063|P3|NOT COMPLETED|Overall Study||0
356358|NCT01224639|853064|P2|NOT COMPLETED|Overall Study||0
356359|NCT01224639|853065|P1|NOT COMPLETED|Overall Study||0
356360|NCT01224639|853058|P8|COMPLETED|Overall Study||3
356361|NCT01224639|853059|P7|COMPLETED|Overall Study||17
356362|NCT01224639|853060|P6|COMPLETED|Overall Study||4
356363|NCT01224639|853061|P5|COMPLETED|Overall Study||19
356364|NCT01224639|853062|P4|COMPLETED|Overall Study||3
356365|NCT01224639|853063|P3|COMPLETED|Overall Study||21
356366|NCT01224639|853064|P2|COMPLETED|Overall Study||5
356367|NCT01224639|853065|P1|COMPLETED|Overall Study||19
356368|NCT01224639|853058|P8|STARTED|Overall Study||5
356369|NCT01224639|853059|P7|STARTED|Overall Study||18
356370|NCT01224639|853060|P6|STARTED|Overall Study||4
356371|NCT01224639|853061|P5|STARTED|Overall Study||21
356372|NCT01224639|853062|P4|STARTED|Overall Study||3
356373|NCT01224639|853063|P3|STARTED|Overall Study||21
356374|NCT01224639|853064|P2|STARTED|Overall Study||5
356375|NCT01224639|853065|P1|STARTED|Overall Study||19
356376|NCT01224626|853171|P1|NOT COMPLETED|Overall Study||1
356377|NCT01224626|853171|P1|COMPLETED|Overall Study||41
356378|NCT01224626|853171|P1|STARTED|Overall Study||42
356379|NCT01224444|853177|P1|NOT COMPLETED|Overall Study||0
356380|NCT01224444|853177|P1|COMPLETED|Overall Study||269
356381|NCT01224444|853177|P1|STARTED|Overall Study||269
356382|NCT01224431|853183|P2|NOT COMPLETED|Overall Study||5
356383|NCT01224431|853184|P1|NOT COMPLETED|Overall Study||0
356384|NCT01224431|853183|P2|COMPLETED|Overall Study||25
356385|NCT01224431|853184|P1|COMPLETED|Overall Study||30
356386|NCT01224431|853183|P2|STARTED|Overall Study||30
356387|NCT01224431|853184|P1|STARTED|Overall Study||30
356388|NCT01224236|853192|P2|NOT COMPLETED|Overall Study||1
356389|NCT01224236|853193|P1|NOT COMPLETED|Overall Study||1
356390|NCT01224236|853192|P2|COMPLETED|Overall Study||73
356391|NCT01224236|853193|P1|COMPLETED|Overall Study||75
356392|NCT01224236|853192|P2|STARTED|Overall Study||74
356393|NCT01224236|853193|P1|STARTED|Overall Study||76
356394|NCT01224171|853203|P2|NOT COMPLETED|Overall Study||13
356395|NCT01224171|853204|P1|NOT COMPLETED|Overall Study||15
356396|NCT01224171|853203|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
356397|NCT01224171|853204|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
356398|NCT01224171|853203|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
356399|NCT01224171|853204|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
356400|NCT01224171|853203|P2|STARTED|Overall Study||209
356401|NCT01224171|853204|P1|STARTED|Overall Study||207
356402|NCT01224015|853227|P3|NOT COMPLETED|Overall Study||13
356403|NCT01224015|853228|P2|NOT COMPLETED|Overall Study||16
356404|NCT01224015|853229|P1|NOT COMPLETED|Overall Study||14
356405|NCT01224015|853227|P3|COMPLETED|Overall Study||83
356406|NCT01224015|853228|P2|COMPLETED|Overall Study||211
356407|NCT01224015|853229|P1|COMPLETED|Overall Study||347
356408|NCT01224015|853227|P3|STARTED|Overall Study||96
356409|NCT01224015|853228|P2|STARTED|Overall Study||227
356410|NCT01224015|853229|P1|STARTED|Overall Study||361
356411|NCT01223937|853239|P2|NOT COMPLETED|Overall Study||18
356412|NCT01223937|853240|P1|NOT COMPLETED|Overall Study||17
356413|NCT01223937|853239|P2|COMPLETED|Overall Study||119
356414|NCT01223937|853240|P1|COMPLETED|Overall Study||114
356415|NCT01223937|853239|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
356416|NCT01223937|853240|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
356417|NCT01223937|853239|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
356418|NCT01223937|853240|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
356419|NCT01223937|853239|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
356420|NCT01223937|853240|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
356421|NCT01223703|853264|P2|NOT COMPLETED|Overall Study||0
356422|NCT01223703|853265|P1|NOT COMPLETED|Overall Study||0
356423|NCT01223703|853264|P2|COMPLETED|Overall Study||66
356424|NCT01223703|853265|P1|COMPLETED|Overall Study||67
356425|NCT01223703|853264|P2|STARTED|Overall Study||66
356426|NCT01223703|853265|P1|STARTED|Overall Study||67
356427|NCT01223469|853279|P2|NOT COMPLETED|Overall Study||0
356428|NCT01223469|853280|P1|NOT COMPLETED|Overall Study||0
356429|NCT01223469|853279|P2|COMPLETED|Overall Study||43
356430|NCT01223469|853280|P1|COMPLETED|Overall Study||34
356431|NCT01223469|853279|P2|STARTED|Overall Study||43
356432|NCT01223469|853280|P1|STARTED|Overall Study||34
356433|NCT01223365|853286|P1|NOT COMPLETED|Open-label Treatment Period||102
356434|NCT01223365|853286|P1|COMPLETED|Open-label Treatment Period||189
356435|NCT01223365|853286|P1|STARTED|Open-label Treatment Period||291
356436|NCT01223365|853286|P1|NOT COMPLETED|Open-label Titration Period||39
356437|NCT01223365|853286|P1|COMPLETED|Open-label Titration Period||291
356438|NCT01223365|853286|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
356439|NCT01223365|853286|P1|Safety Analysis Set|Open-label Titration Period||329
356440|NCT01223365|853286|P1|STARTED|Open-label Titration Period||330
356441|NCT01223196|853329|P2|NOT COMPLETED|Overall Study||0
356442|NCT01223196|853330|P1|NOT COMPLETED|Overall Study||4
356443|NCT01223196|853329|P2|COMPLETED|Overall Study||11
356444|NCT01223196|853330|P1|COMPLETED|Overall Study||9
356445|NCT01223196|853329|P2|STARTED|Overall Study||11
356446|NCT01223196|853330|P1|STARTED|Overall Study||13
356447|NCT01223027|853342|P2|NOT COMPLETED|Overall Study||277
356448|NCT01223027|853343|P1|NOT COMPLETED|Overall Study||274
356449|NCT01223027|853342|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
356450|NCT01223027|853343|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
356451|NCT01223027|853342|P2|STARTED|Overall Study||286
356452|NCT01223027|853343|P1|STARTED|Overall Study||284
356453|NCT01223001|853366|P2|NOT COMPLETED|Overall Study||4
356454|NCT01223001|853367|P1|NOT COMPLETED|Overall Study||4
356455|NCT01223001|853366|P2|COMPLETED|Overall Study||0
356456|NCT01223001|853367|P1|COMPLETED|Overall Study||0
356457|NCT01223001|853366|P2|STARTED|Overall Study||4
356458|NCT01223001|853367|P1|STARTED|Overall Study||4
356459|NCT01222884|853375|P2|NOT COMPLETED|Overall Study||4
356460|NCT01222884|853376|P1|NOT COMPLETED|Overall Study||24
356461|NCT01222884|853375|P2|COMPLETED|Overall Study||113
356462|NCT01222884|853376|P1|COMPLETED|Overall Study||210
356463|NCT01222884|853375|P2|STARTED|Overall Study||117
356464|NCT01222884|853376|P1|STARTED|Overall Study||234
356465|NCT01222832|853386|P2|NOT COMPLETED|Overall Study||1
356466|NCT01222832|853387|P1|NOT COMPLETED|Overall Study||0
356467|NCT01222832|853386|P2|COMPLETED|Overall Study||112
356468|NCT01222832|853387|P1|COMPLETED|Overall Study||113
356469|NCT01222832|853386|P2|STARTED|Overall Study||113
356470|NCT01222832|853387|P1|STARTED|Overall Study||113
356471|NCT01222715|853395|P2|NOT COMPLETED|Overall Study||27
356472|NCT01222715|853396|P1|NOT COMPLETED|Overall Study||36
356473|NCT01222715|853395|P2|COMPLETED|Overall Study||16
356474|NCT01222715|853396|P1|COMPLETED|Overall Study||8
356475|NCT01222715|853395|P2|STARTED|Overall Study||43
356476|NCT01222715|853396|P1|STARTED|Overall Study||44
356477|NCT01222689|853406|P1|NOT COMPLETED|Overall Study||0
356478|NCT01222689|853406|P1|COMPLETED|Overall Study||46
356479|NCT01222689|853406|P1|STARTED|Overall Study||46
356480|NCT01222585|853419|P1|NOT COMPLETED|Overall Study||0
356481|NCT01222585|853419|P1|COMPLETED|Overall Study||24
356482|NCT01222585|853419|P1|STARTED|Overall Study||24
356483|NCT01222572|853429|P3|NOT COMPLETED|Overall Study||0
356484|NCT01222572|853430|P2|NOT COMPLETED|Overall Study||0
356485|NCT01222572|853431|P1|NOT COMPLETED|Overall Study||0
356486|NCT01222572|853429|P3|COMPLETED|Overall Study||0
356487|NCT01222572|853430|P2|COMPLETED|Overall Study||0
356488|NCT01222572|853431|P1|COMPLETED|Overall Study||1
356489|NCT01222572|853429|P3|STARTED|Overall Study||0
356490|NCT01222572|853430|P2|STARTED|Overall Study||0
356491|NCT01222572|853431|P1|STARTED|Overall Study||1
356492|NCT01222533|853435|P1|NOT COMPLETED|Overall Study||14
356493|NCT01222533|853435|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
356494|NCT01222533|853435|P1|Received Tio HH18|Overall Study||146
356495|NCT01222533|853435|P1|Received Tio R5|Overall Study||150
356496|NCT01222533|853435|P1|Received Tio R2.5|Overall Study||145
356497|NCT01222533|853435|P1|Received Tio R1.25|Overall Study||147
356498|NCT01222533|853435|P1|Received Placebo|Overall Study||147
356499|NCT01222533|853435|P1|STARTED|Overall Study|Entered and treated.|154
356500|NCT01222520|853574|P2|NOT COMPLETED|Double-blind Period||2
356501|NCT01222520|853575|P1|NOT COMPLETED|Double-blind Period||1
356502|NCT01222520|853574|P2|COMPLETED|Double-blind Period||85
356503|NCT01222520|853575|P1|COMPLETED|Double-blind Period||86
356504|NCT01222520|853574|P2|STARTED|Double-blind Period||87
356505|NCT01222520|853575|P1|STARTED|Double-blind Period||87
356506|NCT01222520|853574|P2|NOT COMPLETED|Open-label run-in Period||23
356507|NCT01222520|853575|P1|NOT COMPLETED|Open-label run-in Period||0
356508|NCT01222520|853574|P2|COMPLETED|Open-label run-in Period||174
356509|NCT01222520|853575|P1|COMPLETED|Open-label run-in Period||0
356510|NCT01222520|853574|P2|STARTED|Open-label run-in Period||197
356511|NCT01222520|853575|P1|STARTED|Open-label run-in Period||0
356512|NCT01222507|853593|P1|NOT COMPLETED|Overall Study||2
356513|NCT01222507|853593|P1|COMPLETED|Overall Study||60
356514|NCT01222507|853593|P1|STARTED|Overall Study||62
356515|NCT01222403|853599|P2|NOT COMPLETED|Overall Study||2
356516|NCT01222403|853600|P1|NOT COMPLETED|Overall Study||0
356517|NCT01222403|853599|P2|COMPLETED|Overall Study||379
356518|NCT01222403|853600|P1|COMPLETED|Overall Study||386
356519|NCT01222403|853599|P2|STARTED|Overall Study||381
356520|NCT01222403|853600|P1|STARTED|Overall Study||386
356521|NCT01222390|853610|P1|NOT COMPLETED|Overall Study||0
356522|NCT01222390|853610|P1|COMPLETED|Overall Study||12
356523|NCT01222390|853610|P1|STARTED|Overall Study||12
356524|NCT01222286|853616|P2|NOT COMPLETED|Overall Study||0
356525|NCT01222286|853617|P1|NOT COMPLETED|Overall Study||0
356526|NCT01222286|853616|P2|COMPLETED|Overall Study||14
356527|NCT01222286|853617|P1|COMPLETED|Overall Study||16
356528|NCT01222286|853616|P2|STARTED|Overall Study||14
356529|NCT01222286|853617|P1|STARTED|Overall Study||16
356530|NCT01222234|853632|P3|NOT COMPLETED|Overall Study||2
356531|NCT01222234|853633|P2|NOT COMPLETED|Overall Study||2
356532|NCT01222234|853634|P1|NOT COMPLETED|Overall Study||0
356533|NCT01222234|853632|P3|COMPLETED|Overall Study||22
356534|NCT01222234|853633|P2|COMPLETED|Overall Study||15
356535|NCT01222234|853634|P1|COMPLETED|Overall Study||15
356536|NCT01222234|853632|P3|STARTED|Overall Study||24
356537|NCT01222234|853633|P2|STARTED|Overall Study||17
356538|NCT01222234|853634|P1|STARTED|Overall Study||15
356539|NCT01222195|853643|P1|NOT COMPLETED|Overall Study||0
356540|NCT01222195|853643|P1|COMPLETED|Overall Study||1
356541|NCT01222195|853643|P1|STARTED|Overall Study||1
356542|NCT01222117|853658|P11|NOT COMPLETED|Overall Study||0
356543|NCT01222117|853659|P10|NOT COMPLETED|Overall Study||2
356544|NCT01222117|853660|P9|NOT COMPLETED|Overall Study||3
356545|NCT01222117|853661|P8|NOT COMPLETED|Overall Study||0
356546|NCT01222117|853662|P7|NOT COMPLETED|Overall Study||0
356547|NCT01222117|853663|P6|NOT COMPLETED|Overall Study||1
356548|NCT01222117|853664|P5|NOT COMPLETED|Overall Study||1
356549|NCT01222117|853665|P4|NOT COMPLETED|Overall Study||1
356550|NCT01222117|853666|P3|NOT COMPLETED|Overall Study||0
356551|NCT01222117|853667|P2|NOT COMPLETED|Overall Study||1
356552|NCT01222117|853668|P1|NOT COMPLETED|Overall Study||3
356553|NCT01222117|853658|P11|COMPLETED|Overall Study||6
356554|NCT01222117|853659|P10|COMPLETED|Overall Study||17
356555|NCT01222117|853660|P9|COMPLETED|Overall Study||20
356556|NCT01222117|853661|P8|COMPLETED|Overall Study||12
356557|NCT01222117|853662|P7|COMPLETED|Overall Study||13
356558|NCT01222117|853663|P6|COMPLETED|Overall Study||9
356559|NCT01222117|853664|P5|COMPLETED|Overall Study||8
356560|NCT01222117|853665|P4|COMPLETED|Overall Study||19
356561|NCT01222117|853666|P3|COMPLETED|Overall Study||22
356562|NCT01222117|853667|P2|COMPLETED|Overall Study||19
356563|NCT01222117|853668|P1|COMPLETED|Overall Study||17
356564|NCT01222117|853658|P11|STARTED|Overall Study||6
356565|NCT01222117|853659|P10|STARTED|Overall Study||19
356566|NCT01222117|853660|P9|STARTED|Overall Study||23
356567|NCT01222117|853661|P8|STARTED|Overall Study||12
356568|NCT01222117|853662|P7|STARTED|Overall Study||13
356569|NCT01222117|853663|P6|STARTED|Overall Study||10
356570|NCT01222117|853664|P5|STARTED|Overall Study||9
356571|NCT01222117|853665|P4|STARTED|Overall Study||20
356572|NCT01222117|853666|P3|STARTED|Overall Study||22
356573|NCT01222117|853667|P2|STARTED|Overall Study||20
356574|NCT01222117|853668|P1|STARTED|Overall Study||20
356575|NCT01222104|853703|P1|NOT COMPLETED|Overall Study||47
356576|NCT01222104|853703|P1|COMPLETED|Overall Study||587
356577|NCT01222104|853703|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
356578|NCT01222104|853703|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
356579|NCT01222104|853703|P1|Successful Deployment and Hemostasis|Overall Study||524
356580|NCT01222104|853703|P1|Successful Deployment|Overall Study||529
356581|NCT01222104|853703|P1|Angio-Seal Deployment Attempted|Overall Study||534
356582|NCT01222104|853703|P1|STARTED|Overall Study||634
356583|NCT01222078|853717|P1|NOT COMPLETED|Overall Study||1
356584|NCT01222078|853717|P1|COMPLETED|Overall Study||0
356585|NCT01222078|853717|P1|STARTED|Overall Study||1
356586|NCT01221948|853751|P1|NOT COMPLETED|Overall Study||14
356587|NCT01221948|853751|P1|COMPLETED|Overall Study||39
356588|NCT01221948|853751|P1|STARTED|Overall Study||53
356589|NCT01221753|853762|P1|NOT COMPLETED|Overall Study||1
356590|NCT01221753|853762|P1|COMPLETED|Overall Study||6
356591|NCT01221753|853762|P1|STARTED|Overall Study||7
356592|NCT01221727|853769|P2|NOT COMPLETED|Overall Study||1
356593|NCT01221727|853770|P1|NOT COMPLETED|Overall Study||3
356594|NCT01221727|853769|P2|COMPLETED|Overall Study||8
356595|NCT01221727|853770|P1|COMPLETED|Overall Study||18
356596|NCT01221727|853769|P2|Treated|Overall Study|Number of subjects received investigational product|8
356597|NCT01221727|853770|P1|Treated|Overall Study|Number of subjects received investigational product|19
356598|NCT01221727|853769|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
356599|NCT01221727|853770|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
356600|NCT01221623|853791|P2|NOT COMPLETED|Overall Study||14
356601|NCT01221623|853792|P1|NOT COMPLETED|Overall Study||38
356602|NCT01221623|853791|P2|COMPLETED|Overall Study||127
356603|NCT01221623|853792|P1|COMPLETED|Overall Study||236
356604|NCT01221623|853791|P2|STARTED|Overall Study||141
356605|NCT01221623|853792|P1|STARTED|Overall Study||274
356606|NCT01221597|853816|P2|NOT COMPLETED|Overall Study||16
356607|NCT01221597|853817|P1|NOT COMPLETED|Overall Study||36
356608|NCT01221597|853816|P2|COMPLETED|Overall Study||124
356609|NCT01221597|853817|P1|COMPLETED|Overall Study||241
356610|NCT01221597|853816|P2|STARTED|Overall Study||140
356611|NCT01221597|853817|P1|STARTED|Overall Study||277
356612|NCT01221441|853841|P2|NOT COMPLETED|Overall Study||12
356613|NCT01221441|853842|P1|NOT COMPLETED|Overall Study||22
356614|NCT01221441|853841|P2|COMPLETED|Overall Study||23
356615|NCT01221441|853842|P1|COMPLETED|Overall Study||45
356616|NCT01221441|853841|P2|STARTED|Overall Study||35
356617|NCT01221441|853842|P1|STARTED|Overall Study||67
356618|NCT01221363|853874|P2|NOT COMPLETED|Overall Study||5
356619|NCT01221363|853875|P1|NOT COMPLETED|Overall Study||12
356620|NCT01221363|853874|P2|COMPLETED|Overall Study||68
356621|NCT01221363|853875|P1|COMPLETED|Overall Study||81
356622|NCT01221363|853874|P2|STARTED|Overall Study||73
356623|NCT01221363|853875|P1|STARTED|Overall Study||93
356624|NCT01221350|853885|P2|NOT COMPLETED|Overall Study||3
356625|NCT01221350|853886|P1|NOT COMPLETED|Overall Study||5
356626|NCT01221350|853885|P2|COMPLETED|Overall Study||24
356627|NCT01221350|853886|P1|COMPLETED|Overall Study||23
356628|NCT01221350|853885|P2|Analysis Population|Overall Study||24
356629|NCT01221350|853886|P1|Analysis Population|Overall Study||23
356630|NCT01221350|853885|P2|Received Intervention|Overall Study||27
356631|NCT01221350|853886|P1|Received Intervention|Overall Study||28
356632|NCT01221350|853885|P2|STARTED|Overall Study||27
356633|NCT01221350|853886|P1|STARTED|Overall Study||28
356634|NCT01221311|853928|P2|NOT COMPLETED|Overall Study||0
356635|NCT01221311|853929|P1|NOT COMPLETED|Overall Study||0
356636|NCT01221311|853928|P2|COMPLETED|Overall Study||55
356637|NCT01221311|853929|P1|COMPLETED|Overall Study||57
356638|NCT01221311|853928|P2|STARTED|Overall Study||55
356639|NCT01221311|853929|P1|STARTED|Overall Study||57
356640|NCT01221298|853935|P1|NOT COMPLETED|Overall Study||0
356641|NCT01221298|853935|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
356642|NCT01221298|853935|P1|STARTED|Overall Study||11
356643|NCT01221285|853945|P1|NOT COMPLETED|Overall Study||1
356644|NCT01221285|853945|P1|COMPLETED|Overall Study||10
356645|NCT01221285|853945|P1|STARTED|Overall Study||11
356646|NCT01221272|853954|P2|NOT COMPLETED|Period 2||2
356647|NCT01221272|853955|P1|NOT COMPLETED|Period 2||0
356648|NCT01221272|853954|P2|COMPLETED|Period 2||37
356649|NCT01221272|853955|P1|COMPLETED|Period 2||39
356650|NCT01221272|853954|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
356651|NCT01221272|853955|P1|STARTED|Period 2||39
356652|NCT01221272|853954|P2|NOT COMPLETED|Period 1||2
356653|NCT01221272|853955|P1|NOT COMPLETED|Period 1||2
356654|NCT01221272|853954|P2|COMPLETED|Period 1||38
356655|NCT01221272|853955|P1|COMPLETED|Period 1||39
356656|NCT01221272|853954|P2|STARTED|Period 1||40
356657|NCT01221272|853955|P1|STARTED|Period 1||41
356658|NCT01221090|853974|P4|NOT COMPLETED|Overall Study||22
356659|NCT01221090|853975|P3|NOT COMPLETED|Overall Study||42
356660|NCT01221090|853976|P2|NOT COMPLETED|Overall Study||34
356661|NCT01221090|853977|P1|NOT COMPLETED|Overall Study||15
356662|NCT01221090|853974|P4|COMPLETED|Overall Study||73
356663|NCT01221090|853975|P3|COMPLETED|Overall Study||57
356664|NCT01221090|853976|P2|COMPLETED|Overall Study||47
356665|NCT01221090|853977|P1|COMPLETED|Overall Study||86
356666|NCT01221090|853974|P4|STARTED|Overall Study||95
356667|NCT01221090|853975|P3|STARTED|Overall Study||99
356668|NCT01221090|853976|P2|STARTED|Overall Study||81
356669|NCT01221090|853977|P1|STARTED|Overall Study||101
356670|NCT01220869|854003|P1|NOT COMPLETED|Overall Study||6
356671|NCT01220869|854003|P1|COMPLETED|Overall Study||104
356672|NCT01220869|854003|P1|STARTED|Overall Study||110
356673|NCT01220739|854013|P2|NOT COMPLETED|Overall Study||0
356674|NCT01220739|854014|P1|NOT COMPLETED|Overall Study||0
356675|NCT01220739|854013|P2|COMPLETED|Overall Study||5
356676|NCT01220739|854014|P1|COMPLETED|Overall Study||7
356677|NCT01220739|854013|P2|STARTED|Overall Study||5
356678|NCT01220739|854014|P1|STARTED|Overall Study||7
356679|NCT01220609|854022|P1|NOT COMPLETED|Overall Study||3
356680|NCT01220609|854022|P1|COMPLETED|Overall Study|Eligible and treated patients|23
356681|NCT01220609|854022|P1|STARTED|Overall Study||26
356682|NCT01220557|854030|P2|NOT COMPLETED|Overall Study||5
356683|NCT01220557|854031|P1|NOT COMPLETED|Overall Study||6
356684|NCT01220557|854030|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
356685|NCT01220557|854031|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
356686|NCT01220557|854030|P2|STARTED|Overall Study||79
356687|NCT01220557|854031|P1|STARTED|Overall Study||81
356688|NCT01220466|854040|P3|NOT COMPLETED|Overall Study||0
356689|NCT01220466|854041|P2|NOT COMPLETED|Overall Study||0
356690|NCT01220466|854042|P1|NOT COMPLETED|Overall Study||0
356691|NCT01220466|854040|P3|COMPLETED|Overall Study|16 eyes|10
356692|NCT01220466|854041|P2|COMPLETED|Overall Study|108 eyes|56
356693|NCT01220466|854042|P1|COMPLETED|Overall Study|19 eyes|11
356694|NCT01220466|854040|P3|STARTED|Overall Study|16 eyes|10
356695|NCT01220466|854041|P2|STARTED|Overall Study|108 eyes|56
356696|NCT01220466|854042|P1|STARTED|Overall Study|19 eyes|11
356697|NCT01220401|854062|P1|NOT COMPLETED|Overall Study||3
356698|NCT01220401|854062|P1|COMPLETED|Overall Study||18
356699|NCT01220401|854062|P1|STARTED|Overall Study||21
356700|NCT01220297|854071|P1|NOT COMPLETED|Overall Study||3
356701|NCT01220297|854071|P1|COMPLETED|Overall Study||0
356702|NCT01220297|854071|P1|STARTED|Overall Study||3
356703|NCT01220180|854088|P1|NOT COMPLETED|Overall Study||207
356704|NCT01220180|854088|P1|COMPLETED|Overall Study||3968
356705|NCT01220180|854088|P1|Treated|Overall Study||4174
356706|NCT01220180|854088|P1|STARTED|Overall Study||4175
356707|NCT01220128|854118|P7|NOT COMPLETED|Overall Study||5
356708|NCT01220128|854119|P6|NOT COMPLETED|Overall Study||0
356709|NCT01220128|854120|P5|NOT COMPLETED|Overall Study||0
356710|NCT01220128|854121|P4|NOT COMPLETED|Overall Study||0
356711|NCT01220128|854122|P3|NOT COMPLETED|Overall Study||3
356712|NCT01220128|854123|P2|NOT COMPLETED|Overall Study||1
356713|NCT01220128|854124|P1|NOT COMPLETED|Overall Study||4
356714|NCT01220128|854118|P7|COMPLETED|Overall Study||3
356715|NCT01220128|854119|P6|COMPLETED|Overall Study||4
356716|NCT01220128|854120|P5|COMPLETED|Overall Study||11
356717|NCT01220128|854121|P4|COMPLETED|Overall Study||6
356718|NCT01220128|854122|P3|COMPLETED|Overall Study||6
356719|NCT01220128|854123|P2|COMPLETED|Overall Study||6
356720|NCT01220128|854124|P1|COMPLETED|Overall Study||11
356721|NCT01220128|854118|P7|STARTED|Overall Study||8
356722|NCT01220128|854119|P6|STARTED|Overall Study||4
356723|NCT01220128|854120|P5|STARTED|Overall Study||11
356724|NCT01220128|854121|P4|STARTED|Overall Study||6
356725|NCT01220128|854122|P3|STARTED|Overall Study||9
356726|NCT01220128|854123|P2|STARTED|Overall Study||7
356727|NCT01220128|854124|P1|STARTED|Overall Study||15
356728|NCT01219985|854329|P1|NOT COMPLETED|Overall Study||20
356729|NCT01219985|854329|P1|COMPLETED|Overall Study||30
356730|NCT01219985|854329|P1|STARTED|Overall Study||50
356731|NCT01219933|854335|P1|NOT COMPLETED|Overall Study||38
356732|NCT01219933|854335|P1|COMPLETED|Overall Study||30
356733|NCT01219933|854335|P1|STARTED|Overall Study||68
356734|NCT01219881|854374|P2|NOT COMPLETED|Overall Study||5
356735|NCT01219881|854375|P1|NOT COMPLETED|Overall Study||4
356736|NCT01219881|854374|P2|COMPLETED|Overall Study||32
356737|NCT01219881|854375|P1|COMPLETED|Overall Study||34
356738|NCT01219881|854374|P2|STARTED|Overall Study||37
356739|NCT01219881|854375|P1|STARTED|Overall Study||38
356740|NCT01219855|854392|P5|NOT COMPLETED|Overall Study||1
356741|NCT01219855|854393|P4|NOT COMPLETED|Overall Study||1
356742|NCT01219855|854394|P3|NOT COMPLETED|Overall Study||1
356743|NCT01219855|854395|P2|NOT COMPLETED|Overall Study||5
356744|NCT01219855|854396|P1|NOT COMPLETED|Overall Study||1
356745|NCT01219855|854392|P5|COMPLETED|Overall Study||13
356746|NCT01219855|854393|P4|COMPLETED|Overall Study||12
356747|NCT01219855|854394|P3|COMPLETED|Overall Study||16
356748|NCT01219855|854395|P2|COMPLETED|Overall Study||12
356749|NCT01219855|854396|P1|COMPLETED|Overall Study||16
356750|NCT01219855|854392|P5|STARTED|Overall Study||14
356751|NCT01219855|854393|P4|STARTED|Overall Study||13
356752|NCT01219855|854394|P3|STARTED|Overall Study||17
356753|NCT01219855|854395|P2|STARTED|Overall Study||17
356754|NCT01219855|854396|P1|STARTED|Overall Study||17
356755|NCT01219777|854432|P1|NOT COMPLETED|Overall Study||0
356756|NCT01219777|854432|P1|COMPLETED|Overall Study||9
356757|NCT01219777|854432|P1|STARTED|Overall Study||9
356758|NCT01219738|854437|P1|NOT COMPLETED|Overall Study||0
356759|NCT01219738|854437|P1|COMPLETED|Overall Study||20
356760|NCT01219738|854437|P1|Budesonide 720- 4 Times|Overall Study||20
356761|NCT01219738|854437|P1|Budesonide 1440|Overall Study||20
356762|NCT01219738|854437|P1|Budesonide 720|Overall Study||20
356763|NCT01219738|854437|P1|Budesonide 360|Overall Study||20
356764|NCT01219738|854437|P1|STARTED|Overall Study||20
356765|NCT01219673|854458|P8|NOT COMPLETED|Overall Study||0
356766|NCT01219673|854459|P7|NOT COMPLETED|Overall Study||0
356767|NCT01219673|854460|P6|NOT COMPLETED|Overall Study||0
356768|NCT01219673|854461|P5|NOT COMPLETED|Overall Study||0
356769|NCT01219673|854462|P4|NOT COMPLETED|Overall Study||0
356770|NCT01219673|854463|P3|NOT COMPLETED|Overall Study||0
356771|NCT01219673|854464|P2|NOT COMPLETED|Overall Study||0
356772|NCT01219673|854465|P1|NOT COMPLETED|Overall Study||0
356773|NCT01219673|854458|P8|COMPLETED|Overall Study||0
356774|NCT01219673|854459|P7|COMPLETED|Overall Study||0
356775|NCT01219673|854460|P6|COMPLETED|Overall Study||0
356776|NCT01219673|854461|P5|COMPLETED|Overall Study||0
356777|NCT01219673|854462|P4|COMPLETED|Overall Study||0
356778|NCT01219673|854463|P3|COMPLETED|Overall Study||1
356779|NCT01219673|854464|P2|COMPLETED|Overall Study||0
356780|NCT01219673|854465|P1|COMPLETED|Overall Study||0
356781|NCT01219673|854458|P8|STARTED|Overall Study||0
356782|NCT01219673|854459|P7|STARTED|Overall Study||0
356783|NCT01219673|854460|P6|STARTED|Overall Study||0
356784|NCT01219673|854461|P5|STARTED|Overall Study||0
356785|NCT01219673|854462|P4|STARTED|Overall Study||0
356786|NCT01219673|854463|P3|STARTED|Overall Study||1
356787|NCT01219673|854464|P2|STARTED|Overall Study||0
356788|NCT01219673|854465|P1|STARTED|Overall Study||0
356789|NCT01218997|854485|P2|NOT COMPLETED|Overall Study||41
356790|NCT01218997|854486|P1|NOT COMPLETED|Overall Study||245
356791|NCT01218997|854485|P2|COMPLETED|Overall Study||24
356792|NCT01218997|854486|P1|COMPLETED|Overall Study||126
356793|NCT01218997|854485|P2|STARTED|Overall Study||65
356794|NCT01218997|854486|P1|STARTED|Overall Study||371
356795|NCT01218984|854495|P3|NOT COMPLETED|Overall Study||3
356796|NCT01218984|854496|P2|NOT COMPLETED|Overall Study||2
356797|NCT01218984|854497|P1|NOT COMPLETED|Overall Study||1
356798|NCT01218984|854495|P3|COMPLETED|Overall Study||7
356799|NCT01218984|854496|P2|COMPLETED|Overall Study||6
356800|NCT01218984|854497|P1|COMPLETED|Overall Study||8
356801|NCT01218984|854495|P3|STARTED|Overall Study||10
356802|NCT01218984|854496|P2|STARTED|Overall Study||8
356803|NCT01218984|854497|P1|STARTED|Overall Study||9
356804|NCT01218971|854507|P2|NOT COMPLETED|Overall Study||80
356805|NCT01218971|854508|P1|NOT COMPLETED|Overall Study||104
356806|NCT01218971|854507|P2|COMPLETED|Overall Study||77
356807|NCT01218971|854508|P1|COMPLETED|Overall Study||71
356808|NCT01218971|854507|P2|STARTED|Overall Study||157
356809|NCT01218971|854508|P1|STARTED|Overall Study||175
356810|NCT01218958|854521|P3|NOT COMPLETED|Overall Study||81
356811|NCT01218958|854522|P2|NOT COMPLETED|Overall Study||81
356812|NCT01218958|854523|P1|NOT COMPLETED|Overall Study||84
356813|NCT01218958|854521|P3|COMPLETED|Overall Study||128
356814|NCT01218958|854522|P2|COMPLETED|Overall Study||124
356815|NCT01218958|854523|P1|COMPLETED|Overall Study||126
356816|NCT01218958|854521|P3|STARTED|Overall Study||209
356817|NCT01218958|854522|P2|STARTED|Overall Study||205
356818|NCT01218958|854523|P1|STARTED|Overall Study||210
356819|NCT01218867|854545|P11|NOT COMPLETED|Overall Study||0
356820|NCT01218867|854546|P10|NOT COMPLETED|Overall Study||0
356821|NCT01218867|854547|P9|NOT COMPLETED|Overall Study||0
356822|NCT01218867|854548|P8|NOT COMPLETED|Overall Study||0
356823|NCT01218867|854549|P7|NOT COMPLETED|Overall Study||1
356824|NCT01218867|854550|P6|NOT COMPLETED|Overall Study||0
356825|NCT01218867|854551|P5|NOT COMPLETED|Overall Study||0
356826|NCT01218867|854552|P4|NOT COMPLETED|Overall Study||0
356827|NCT01218867|854553|P3|NOT COMPLETED|Overall Study||0
356828|NCT01218867|854554|P2|NOT COMPLETED|Overall Study||0
356829|NCT01218867|854555|P1|NOT COMPLETED|Overall Study||0
356830|NCT01218867|854545|P11|COMPLETED|Overall Study||2
356831|NCT01218867|854546|P10|COMPLETED|Overall Study||4
356832|NCT01218867|854547|P9|COMPLETED|Overall Study||3
356833|NCT01218867|854548|P8|COMPLETED|Overall Study||3
356834|NCT01218867|854549|P7|COMPLETED|Overall Study||3
356835|NCT01218867|854550|P6|COMPLETED|Overall Study||1
356836|NCT01218867|854551|P5|COMPLETED|Overall Study||1
356837|NCT01218867|854552|P4|COMPLETED|Overall Study||1
356838|NCT01218867|854553|P3|COMPLETED|Overall Study||3
356839|NCT01218867|854554|P2|COMPLETED|Overall Study||1
356840|NCT01218867|854555|P1|COMPLETED|Overall Study||1
356841|NCT01218867|854545|P11|STARTED|Overall Study||2
356842|NCT01218867|854546|P10|STARTED|Overall Study||4
356843|NCT01218867|854547|P9|STARTED|Overall Study||3
356844|NCT01218867|854548|P8|STARTED|Overall Study||3
356845|NCT01218867|854549|P7|STARTED|Overall Study||4
356846|NCT01218867|854550|P6|STARTED|Overall Study||1
356847|NCT01218867|854551|P5|STARTED|Overall Study||1
356848|NCT01218867|854552|P4|STARTED|Overall Study||1
356849|NCT01218867|854553|P3|STARTED|Overall Study||3
356850|NCT01218867|854554|P2|STARTED|Overall Study||1
356851|NCT01218867|854555|P1|STARTED|Overall Study||1
356852|NCT01218802|854603|P2|NOT COMPLETED|Overall Study||18
356853|NCT01218802|854604|P1|NOT COMPLETED|Overall Study||10
356854|NCT01218802|854603|P2|COMPLETED|Overall Study||57
356855|NCT01218802|854604|P1|COMPLETED|Overall Study||62
356856|NCT01218802|854603|P2|STARTED|Overall Study||75
356857|NCT01218802|854604|P1|STARTED|Overall Study||72
356858|NCT01218646|854616|P4|NOT COMPLETED|Overall Study||1
356859|NCT01218646|854617|P3|NOT COMPLETED|Overall Study||2
356860|NCT01218646|854618|P2|NOT COMPLETED|Overall Study||0
356861|NCT01218646|854619|P1|NOT COMPLETED|Overall Study||1
356862|NCT01218646|854616|P4|COMPLETED|Overall Study||63
356863|NCT01218646|854617|P3|COMPLETED|Overall Study||223
356864|NCT01218646|854618|P2|COMPLETED|Overall Study||225
356865|NCT01218646|854619|P1|COMPLETED|Overall Study||224
356866|NCT01218646|854616|P4|STARTED|Overall Study||64
356867|NCT01218646|854617|P3|STARTED|Overall Study||225
356868|NCT01218646|854618|P2|STARTED|Overall Study||225
356869|NCT01218646|854619|P1|STARTED|Overall Study||225
356870|NCT01218594|854657|P1|NOT COMPLETED|Overall Study||12
356871|NCT01218594|854657|P1|COMPLETED|Overall Study||36
356872|NCT01218594|854657|P1|STARTED|Overall Study||48
356873|NCT01218477|854665|P4|NOT COMPLETED|Overall Study||2
356874|NCT01218477|854666|P3|NOT COMPLETED|Overall Study||14
356875|NCT01218477|854667|P2|NOT COMPLETED|Overall Study||8
356876|NCT01218477|854668|P1|NOT COMPLETED|Overall Study||3
356877|NCT01218477|854665|P4|COMPLETED|Overall Study|Still receiving study drug|0
356878|NCT01218477|854666|P3|COMPLETED|Overall Study|Still receiving study drug|0
356879|NCT01218477|854667|P2|COMPLETED|Overall Study|Still receiving study drug|0
356880|NCT01218477|854668|P1|COMPLETED|Overall Study|Still receiving study drug|0
356881|NCT01218477|854665|P4|STARTED|Overall Study|Participants who received treatment|2
356882|NCT01218477|854666|P3|STARTED|Overall Study|Participants who received treatment|14
356883|NCT01218477|854667|P2|STARTED|Overall Study|Participants who received treatment|8
356884|NCT01218477|854668|P1|STARTED|Overall Study|Participants who received treatment|3
356885|NCT01218438|854685|P1|NOT COMPLETED|Epoch 4||3
356886|NCT01218438|854685|P1|COMPLETED|Epoch 4||67
356887|NCT01218438|854685|P1|STARTED|Epoch 4||70
356888|NCT01218438|854685|P1|NOT COMPLETED|Epoch 3||4
356889|NCT01218438|854685|P1|COMPLETED|Epoch 3||70
356890|NCT01218438|854685|P1|STARTED|Epoch 3||74
356891|NCT01218438|854685|P1|NOT COMPLETED|Epoch 2||0
356892|NCT01218438|854685|P1|COMPLETED|Epoch 2||45
356893|NCT01218438|854685|P1|STARTED|Epoch 2||45
356894|NCT01218438|854685|P1|NOT COMPLETED|Epoch 1||3
356895|NCT01218438|854685|P1|COMPLETED|Epoch 1||74
356896|NCT01218438|854685|P1|STARTED|Epoch 1||77
356897|NCT01218308|854840|P2|NOT COMPLETED|Overall Study||120
356898|NCT01218308|854841|P1|NOT COMPLETED|Overall Study||103
356899|NCT01218308|854840|P2|COMPLETED|Overall Study||2464
356900|NCT01218308|854841|P1|COMPLETED|Overall Study||2481
356901|NCT01218308|854840|P2|STARTED|Overall Study||2584
356902|NCT01218308|854841|P1|STARTED|Overall Study||2584
356903|NCT01218243|854885|P2|NOT COMPLETED|Overall Study||14
356904|NCT01218243|854886|P1|NOT COMPLETED|Overall Study||9
356905|NCT01218243|854885|P2|COMPLETED|Overall Study||36
356906|NCT01218243|854886|P1|COMPLETED|Overall Study||41
356907|NCT01218243|854885|P2|Treatment Completed|Overall Study||42
356908|NCT01218243|854886|P1|Treatment Completed|Overall Study||45
356909|NCT01218243|854885|P2|STARTED|Overall Study||50
356910|NCT01218243|854886|P1|STARTED|Overall Study||50
356911|NCT01218100|854904|P4|NOT COMPLETED|Overall Study||34
356912|NCT01218100|854905|P3|NOT COMPLETED|Overall Study||27
356913|NCT01218100|854906|P2|NOT COMPLETED|Overall Study||25
356914|NCT01218100|854907|P1|NOT COMPLETED|Overall Study||24
356915|NCT01218100|854904|P4|COMPLETED|Overall Study||156
356916|NCT01218100|854905|P3|COMPLETED|Overall Study||162
356917|NCT01218100|854906|P2|COMPLETED|Overall Study||165
356918|NCT01218100|854907|P1|COMPLETED|Overall Study||71
356919|NCT01218100|854904|P4|STARTED|Overall Study||190
356920|NCT01218100|854905|P3|STARTED|Overall Study||189
356921|NCT01218100|854906|P2|STARTED|Overall Study||190
356922|NCT01218100|854907|P1|STARTED|Overall Study||95
356923|NCT01218087|854923|P2|NOT COMPLETED|Overall Study||6
356924|NCT01218087|854924|P1|NOT COMPLETED|Overall Study||15
356925|NCT01218087|854923|P2|COMPLETED|Overall Study||35
356926|NCT01218087|854924|P1|COMPLETED|Overall Study||27
356927|NCT01218087|854923|P2|STARTED|Overall Study||41
356928|NCT01218087|854924|P1|STARTED|Overall Study||42
356929|NCT01218009|854934|P2|NOT COMPLETED|Overall Study||165
356930|NCT01218009|854935|P1|NOT COMPLETED|Overall Study||166
356931|NCT01218009|854934|P2|COMPLETED|Overall Study||0
356932|NCT01218009|854935|P1|COMPLETED|Overall Study||0
356933|NCT01218009|854934|P2|STARTED|Overall Study||165
356934|NCT01218009|854935|P1|STARTED|Overall Study||166
356935|NCT01217957|854958|P5|NOT COMPLETED|Phase 2||1
356936|NCT01217957|854959|P4|NOT COMPLETED|Phase 2||0
356937|NCT01217957|854960|P3|NOT COMPLETED|Phase 2||0
356938|NCT01217957|854961|P2|NOT COMPLETED|Phase 2||0
356939|NCT01217957|854962|P1|NOT COMPLETED|Phase 2||0
356940|NCT01217957|854958|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
356941|NCT01217957|854959|P4|COMPLETED|Phase 2||0
356942|NCT01217957|854960|P3|COMPLETED|Phase 2||0
356943|NCT01217957|854961|P2|COMPLETED|Phase 2||0
356944|NCT01217957|854962|P1|COMPLETED|Phase 2||0
356945|NCT01217957|854958|P5|STARTED|Phase 2||50
356946|NCT01217957|854959|P4|STARTED|Phase 2||0
356947|NCT01217957|854960|P3|STARTED|Phase 2||0
356948|NCT01217957|854961|P2|STARTED|Phase 2||0
356949|NCT01217957|854962|P1|STARTED|Phase 2||0
356950|NCT01217957|854958|P5|NOT COMPLETED|Phase 1||0
356951|NCT01217957|854959|P4|NOT COMPLETED|Phase 1||1
356952|NCT01217957|854960|P3|NOT COMPLETED|Phase 1||1
356953|NCT01217957|854961|P2|NOT COMPLETED|Phase 1||0
356954|NCT01217957|854962|P1|NOT COMPLETED|Phase 1||1
356955|NCT01217957|854958|P5|COMPLETED|Phase 1||0
356956|NCT01217957|854959|P4|COMPLETED|Phase 1||2
356957|NCT01217957|854960|P3|COMPLETED|Phase 1||5
356958|NCT01217957|854961|P2|COMPLETED|Phase 1||3
356959|NCT01217957|854962|P1|COMPLETED|Phase 1||2
356960|NCT01217957|854958|P5|STARTED|Phase 1||0
356961|NCT01217957|854959|P4|STARTED|Phase 1||3
356962|NCT01217957|854960|P3|STARTED|Phase 1||6
356963|NCT01217957|854961|P2|STARTED|Phase 1||3
356964|NCT01217957|854962|P1|STARTED|Phase 1||3
356965|NCT01217944|855021|P3|NOT COMPLETED|Overall Study||0
356966|NCT01217944|855022|P2|NOT COMPLETED|Overall Study||4
356967|NCT01217944|855023|P1|NOT COMPLETED|Overall Study||6
356968|NCT01217944|855021|P3|COMPLETED|Overall Study||55
356969|NCT01217944|855022|P2|COMPLETED|Overall Study||112
356970|NCT01217944|855023|P1|COMPLETED|Overall Study||100
356971|NCT01217944|855021|P3|Completed 6 Months|Overall Study||55
356972|NCT01217944|855022|P2|Completed 6 Months|Overall Study||116
356973|NCT01217944|855023|P1|Completed 6 Months|Overall Study||103
356974|NCT01217944|855021|P3|Completed 3 Months|Overall Study||55
356975|NCT01217944|855022|P2|Completed 3 Months|Overall Study||116
356976|NCT01217944|855023|P1|Completed 3 Months|Overall Study||105
356977|NCT01217944|855021|P3|STARTED|Overall Study||55
356978|NCT01217944|855022|P2|STARTED|Overall Study||116
356979|NCT01217944|855023|P1|STARTED|Overall Study||106
356980|NCT01217892|855066|P4|NOT COMPLETED|Overall Study||8
356981|NCT01217892|855067|P3|NOT COMPLETED|Overall Study||9
356982|NCT01217892|855068|P2|NOT COMPLETED|Overall Study||6
356983|NCT01217892|855069|P1|NOT COMPLETED|Overall Study||7
356984|NCT01217892|855066|P4|COMPLETED|Overall Study||93
356985|NCT01217892|855067|P3|COMPLETED|Overall Study||90
356986|NCT01217892|855068|P2|COMPLETED|Overall Study||94
356987|NCT01217892|855069|P1|COMPLETED|Overall Study||93
356988|NCT01217892|855066|P4|STARTED|Overall Study||101
356989|NCT01217892|855067|P3|STARTED|Overall Study||99
356990|NCT01217892|855068|P2|STARTED|Overall Study||100
356991|NCT01217892|855069|P1|STARTED|Overall Study||100
356992|NCT01217840|855097|P2|NOT COMPLETED|Overall Study||3
356993|NCT01217840|855098|P1|NOT COMPLETED|Overall Study||6
356994|NCT01217840|855097|P2|COMPLETED|Overall Study||17
356995|NCT01217840|855098|P1|COMPLETED|Overall Study||14
356996|NCT01217840|855097|P2|STARTED|Overall Study||20
356997|NCT01217840|855098|P1|STARTED|Overall Study||20
356998|NCT01217827|855106|P2|NOT COMPLETED|Overall Study||0
356999|NCT01217827|855107|P1|NOT COMPLETED|Overall Study||0
357000|NCT01217827|855106|P2|COMPLETED|Overall Study||43
357001|NCT01217827|855107|P1|COMPLETED|Overall Study||46
357002|NCT01217827|855106|P2|STARTED|Overall Study||43
357003|NCT01217827|855107|P1|STARTED|Overall Study||46
357004|NCT01217801|855115|P2|NOT COMPLETED|Period 2||0
357005|NCT01217801|855116|P1|NOT COMPLETED|Period 2||0
357006|NCT01217801|855115|P2|COMPLETED|Period 2||22
357007|NCT01217801|855116|P1|COMPLETED|Period 2||23
357008|NCT01217801|855115|P2|STARTED|Period 2||22
357009|NCT01217801|855116|P1|STARTED|Period 2||23
357010|NCT01217801|855115|P2|NOT COMPLETED|Period 1||2
357011|NCT01217801|855116|P1|NOT COMPLETED|Period 1||1
357012|NCT01217801|855115|P2|COMPLETED|Period 1||22
357013|NCT01217801|855116|P1|COMPLETED|Period 1||23
357014|NCT01217801|855115|P2|STARTED|Period 1||24
357015|NCT01217801|855116|P1|STARTED|Period 1||24
357016|NCT01217749|855125|P3|NOT COMPLETED|Overall Study||2
357017|NCT01217749|855126|P2|NOT COMPLETED|Overall Study||3
357018|NCT01217749|855127|P1|NOT COMPLETED|Overall Study||3
357019|NCT01217749|855125|P3|COMPLETED|Overall Study||22
357020|NCT01217749|855126|P2|COMPLETED|Overall Study||17
357021|NCT01217749|855127|P1|COMPLETED|Overall Study||24
357022|NCT01217749|855125|P3|STARTED|Overall Study||24
357023|NCT01217749|855126|P2|STARTED|Overall Study||20
357024|NCT01217749|855127|P1|STARTED|Overall Study||27
357025|NCT01217606|855145|P2|NOT COMPLETED|9-Month Masked Extension||11
357026|NCT01217606|855146|P1|NOT COMPLETED|9-Month Masked Extension||13
357027|NCT01217606|855145|P2|COMPLETED|9-Month Masked Extension||62
357028|NCT01217606|855146|P1|COMPLETED|9-Month Masked Extension||54
357029|NCT01217606|855145|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
357030|NCT01217606|855146|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
357031|NCT01217606|855145|P2|STARTED|9-Month Masked Extension||73
357032|NCT01217606|855146|P1|STARTED|9-Month Masked Extension||67
357033|NCT01217606|855145|P2|NOT COMPLETED|Initial Treatment Phase||12
357034|NCT01217606|855146|P1|NOT COMPLETED|Initial Treatment Phase||14
357035|NCT01217606|855145|P2|COMPLETED|Initial Treatment Phase||83
357036|NCT01217606|855146|P1|COMPLETED|Initial Treatment Phase||76
357037|NCT01217606|855145|P2|STARTED|Initial Treatment Phase||95
357038|NCT01217606|855146|P1|STARTED|Initial Treatment Phase||90
357039|NCT01217515|855159|P3|NOT COMPLETED|Overall Study||10
357040|NCT01217515|855160|P2|NOT COMPLETED|Overall Study||8
357041|NCT01217515|855161|P1|NOT COMPLETED|Overall Study||7
357042|NCT01217515|855159|P3|COMPLETED|Overall Study||145
357043|NCT01217515|855160|P2|COMPLETED|Overall Study||148
357044|NCT01217515|855161|P1|COMPLETED|Overall Study||147
357045|NCT01217515|855159|P3|STARTED|Overall Study||155
357046|NCT01217515|855160|P2|STARTED|Overall Study||156
357047|NCT01217515|855161|P1|STARTED|Overall Study||154
357048|NCT01217476|855177|P2|NOT COMPLETED|Overall Study||7
357049|NCT01217476|855178|P1|NOT COMPLETED|Overall Study||12
357050|NCT01217476|855177|P2|COMPLETED|Overall Study||95
357051|NCT01217476|855178|P1|COMPLETED|Overall Study||93
357052|NCT01217476|855177|P2|STARTED|Overall Study||102
357053|NCT01217476|855178|P1|STARTED|Overall Study||105
357054|NCT01217463|855188|P2|NOT COMPLETED|Overall Study||8
357055|NCT01217463|855189|P1|NOT COMPLETED|Overall Study||13
357056|NCT01217463|855188|P2|COMPLETED|Overall Study||94
357057|NCT01217463|855189|P1|COMPLETED|Overall Study||86
357058|NCT01217463|855188|P2|STARTED|Overall Study||102
357059|NCT01217463|855189|P1|STARTED|Overall Study||99
357060|NCT01217411|855200|P3|NOT COMPLETED|Overall Study||0
357061|NCT01217411|855201|P2|NOT COMPLETED|Overall Study||0
357062|NCT01217411|855202|P1|NOT COMPLETED|Overall Study||0
357063|NCT01217411|855200|P3|COMPLETED|Overall Study||0
357064|NCT01217411|855201|P2|COMPLETED|Overall Study||0
357065|NCT01217411|855202|P1|COMPLETED|Overall Study||5
357066|NCT01217411|855200|P3|STARTED|Overall Study||0
357067|NCT01217411|855201|P2|STARTED|Overall Study||0
357068|NCT01217411|855202|P1|STARTED|Overall Study||5
357069|NCT01217229|855207|P1|NOT COMPLETED|Overall Study||0
357070|NCT01217229|855207|P1|COMPLETED|Overall Study||20
357071|NCT01217229|855207|P1|STARTED|Overall Study||20
357072|NCT01217112|855216|P5|NOT COMPLETED|Overall Study||1
357073|NCT01217112|855217|P4|NOT COMPLETED|Overall Study||2
357074|NCT01217112|855218|P3|NOT COMPLETED|Overall Study||1
357075|NCT01217112|855219|P2|NOT COMPLETED|Overall Study||2
357076|NCT01217112|855220|P1|NOT COMPLETED|Overall Study||0
357077|NCT01217112|855216|P5|COMPLETED|Overall Study||13
357078|NCT01217112|855217|P4|COMPLETED|Overall Study||10
357079|NCT01217112|855218|P3|COMPLETED|Overall Study||12
357080|NCT01217112|855219|P2|COMPLETED|Overall Study||10
357081|NCT01217112|855220|P1|COMPLETED|Overall Study||11
357082|NCT01217112|855216|P5|STARTED|Overall Study||14
357083|NCT01217112|855217|P4|STARTED|Overall Study||12
357084|NCT01217112|855218|P3|STARTED|Overall Study||13
357085|NCT01217112|855219|P2|STARTED|Overall Study||12
357086|NCT01217112|855220|P1|STARTED|Overall Study||11
357087|NCT01217073|855453|P8|NOT COMPLETED|Extension Period||20
357088|NCT01217073|855454|P7|NOT COMPLETED|Extension Period||91
357089|NCT01217073|855455|P6|NOT COMPLETED|Extension Period||0
357090|NCT01217073|855456|P5|NOT COMPLETED|Extension Period||0
357091|NCT01217073|855457|P4|NOT COMPLETED|Extension Period||0
357092|NCT01217073|855458|P3|NOT COMPLETED|Extension Period||0
357093|NCT01217073|855459|P2|NOT COMPLETED|Extension Period||0
357094|NCT01217073|855460|P1|NOT COMPLETED|Extension Period||0
357095|NCT01217073|855453|P8|COMPLETED|Extension Period||60
357096|NCT01217073|855454|P7|COMPLETED|Extension Period||314
357097|NCT01217073|855455|P6|COMPLETED|Extension Period||0
357098|NCT01217073|855456|P5|COMPLETED|Extension Period||0
357099|NCT01217073|855457|P4|COMPLETED|Extension Period||0
357100|NCT01217073|855458|P3|COMPLETED|Extension Period||0
357101|NCT01217073|855459|P2|COMPLETED|Extension Period||0
357102|NCT01217073|855460|P1|COMPLETED|Extension Period||0
357103|NCT01217073|855453|P8|STARTED|Extension Period||80
357104|NCT01217073|855454|P7|STARTED|Extension Period||405
357105|NCT01217073|855455|P6|STARTED|Extension Period||0
357106|NCT01217073|855456|P5|STARTED|Extension Period||0
357107|NCT01217073|855457|P4|STARTED|Extension Period||0
357108|NCT01217073|855458|P3|STARTED|Extension Period||0
357109|NCT01217073|855459|P2|STARTED|Extension Period||0
357110|NCT01217073|855460|P1|STARTED|Extension Period||0
357111|NCT01217073|855453|P8|NOT COMPLETED|Base Period||0
357112|NCT01217073|855454|P7|NOT COMPLETED|Base Period||0
357113|NCT01217073|855455|P6|NOT COMPLETED|Base Period||9
357114|NCT01217073|855456|P5|NOT COMPLETED|Base Period||15
357115|NCT01217073|855457|P4|NOT COMPLETED|Base Period||2
357116|NCT01217073|855458|P3|NOT COMPLETED|Base Period||7
357117|NCT01217073|855459|P2|NOT COMPLETED|Base Period||5
357118|NCT01217073|855460|P1|NOT COMPLETED|Base Period||7
357119|NCT01217073|855453|P8|COMPLETED|Base Period||0
357120|NCT01217073|855454|P7|COMPLETED|Base Period||0
357121|NCT01217073|855455|P6|COMPLETED|Base Period||105
357122|NCT01217073|855456|P5|COMPLETED|Base Period||99
357123|NCT01217073|855457|P4|COMPLETED|Base Period||113
357124|NCT01217073|855458|P3|COMPLETED|Base Period||107
357125|NCT01217073|855459|P2|COMPLETED|Base Period||110
357126|NCT01217073|855460|P1|COMPLETED|Base Period||106
357127|NCT01217073|855453|P8|STARTED|Base Period||0
357128|NCT01217073|855454|P7|STARTED|Base Period||0
357129|NCT01217073|855455|P6|STARTED|Base Period||114
357130|NCT01217073|855456|P5|STARTED|Base Period||114
357131|NCT01217073|855457|P4|STARTED|Base Period||115
357132|NCT01217073|855458|P3|STARTED|Base Period||114
357133|NCT01217073|855459|P2|STARTED|Base Period||115
357134|NCT01217073|855460|P1|STARTED|Base Period||113
357135|NCT01216943|855528|P1|NOT COMPLETED|Overall Study||13
357136|NCT01216943|855528|P1|COMPLETED|Overall Study||113
357137|NCT01216943|855528|P1|STARTED|Overall Study||126
357138|NCT01216761|855532|P3|NOT COMPLETED|Overall Study||0
357139|NCT01216761|855533|P2|NOT COMPLETED|Overall Study||0
357140|NCT01216761|855534|P1|NOT COMPLETED|Overall Study||0
357141|NCT01216761|855532|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
357142|NCT01216761|855533|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
357143|NCT01216761|855534|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
357144|NCT01216761|855532|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
357145|NCT01216761|855533|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
357146|NCT01216761|855534|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
357147|NCT01216748|855542|P1|NOT COMPLETED|Overall Study||0
357148|NCT01216748|855542|P1|COMPLETED|Overall Study||10
357149|NCT01216748|855542|P1|Eucapnic Hyperventilation|Overall Study||10
357150|NCT01216748|855542|P1|Hypercapnic Hyperventilation|Overall Study||10
357151|NCT01216748|855542|P1|Hypocapnic Hyperventilation|Overall Study||10
357152|NCT01216748|855542|P1|Quiet Breathing|Overall Study||10
357153|NCT01216748|855542|P1|STARTED|Overall Study||10
357154|NCT01216735|855549|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
357155|NCT01216735|855550|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
357156|NCT01216735|855549|P2|COMPLETED|Second Intervention (3 Weeks)||7
357157|NCT01216735|855550|P1|COMPLETED|Second Intervention (3 Weeks)||8
357158|NCT01216735|855549|P2|STARTED|Second Intervention (3 Weeks)||7
357159|NCT01216735|855550|P1|STARTED|Second Intervention (3 Weeks)||8
357160|NCT01216735|855549|P2|NOT COMPLETED|Washout (3 Weeks)||0
357161|NCT01216735|855550|P1|NOT COMPLETED|Washout (3 Weeks)||0
357162|NCT01216735|855549|P2|COMPLETED|Washout (3 Weeks)||7
357163|NCT01216735|855550|P1|COMPLETED|Washout (3 Weeks)||8
357164|NCT01216735|855549|P2|STARTED|Washout (3 Weeks)||7
357165|NCT01216735|855550|P1|STARTED|Washout (3 Weeks)||8
357166|NCT01216735|855549|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
357167|NCT01216735|855550|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
357168|NCT01216735|855549|P2|COMPLETED|First Intervention (3 Weeks)||7
357169|NCT01216735|855550|P1|COMPLETED|First Intervention (3 Weeks)||8
357170|NCT01216735|855549|P2|STARTED|First Intervention (3 Weeks)||7
357171|NCT01216735|855550|P1|STARTED|First Intervention (3 Weeks)||8
357172|NCT01216631|855561|P3|NOT COMPLETED|Overall Study||0
357173|NCT01216631|855562|P2|NOT COMPLETED|Overall Study||0
357174|NCT01216631|855563|P1|NOT COMPLETED|Overall Study||0
357175|NCT01216631|855561|P3|COMPLETED|Overall Study||1
357176|NCT01216631|855562|P2|COMPLETED|Overall Study||0
357177|NCT01216631|855563|P1|COMPLETED|Overall Study||0
357178|NCT01216631|855561|P3|STARTED|Overall Study||1
357179|NCT01216631|855562|P2|STARTED|Overall Study||0
357180|NCT01216631|855563|P1|STARTED|Overall Study||0
357181|NCT01216410|855574|P3|NOT COMPLETED|Overall Study||3
357182|NCT01216410|855575|P2|NOT COMPLETED|Overall Study||1
357183|NCT01216410|855576|P1|NOT COMPLETED|Overall Study||2
357184|NCT01216410|855574|P3|COMPLETED|Overall Study||100
357185|NCT01216410|855575|P2|COMPLETED|Overall Study||99
357186|NCT01216410|855576|P1|COMPLETED|Overall Study||101
357187|NCT01216410|855574|P3|STARTED|Overall Study||103
357188|NCT01216410|855575|P2|STARTED|Overall Study||100
357189|NCT01216410|855576|P1|STARTED|Overall Study||103
357190|NCT01216397|855596|P2|NOT COMPLETED|Period 2||0
357191|NCT01216397|855597|P1|NOT COMPLETED|Period 2||0
357192|NCT01216397|855596|P2|COMPLETED|Period 2||20
357193|NCT01216397|855597|P1|COMPLETED|Period 2||20
357194|NCT01216397|855596|P2|STARTED|Period 2||20
357195|NCT01216397|855597|P1|STARTED|Period 2||20
357196|NCT01216397|855596|P2|NOT COMPLETED|Washout (35 Days)||0
357197|NCT01216397|855597|P1|NOT COMPLETED|Washout (35 Days)||0
357198|NCT01216397|855596|P2|COMPLETED|Washout (35 Days)||20
357199|NCT01216397|855597|P1|COMPLETED|Washout (35 Days)||20
357200|NCT01216397|855596|P2|STARTED|Washout (35 Days)||20
357201|NCT01216397|855597|P1|STARTED|Washout (35 Days)||20
357202|NCT01216397|855596|P2|NOT COMPLETED|Period 1||0
357203|NCT01216397|855597|P1|NOT COMPLETED|Period 1||0
357204|NCT01216397|855596|P2|COMPLETED|Period 1||20
357205|NCT01216397|855597|P1|COMPLETED|Period 1||20
357206|NCT01216397|855596|P2|STARTED|Period 1||20
357207|NCT01216397|855597|P1|STARTED|Period 1||20
357208|NCT01216319|855649|P1|NOT COMPLETED|Overall Study||4
357209|NCT01216319|855649|P1|COMPLETED|Overall Study||46
357210|NCT01216319|855649|P1|STARTED|Overall Study||50
357211|NCT01216241|855656|P2|NOT COMPLETED|Overall Study||0
357212|NCT01216241|855657|P1|NOT COMPLETED|Overall Study||0
357213|NCT01216241|855656|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
357214|NCT01216241|855657|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
357215|NCT01216241|855656|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
357216|NCT01216241|855657|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
357217|NCT01216163|855666|P3|NOT COMPLETED|Overall Study||0
357218|NCT01216163|855667|P2|NOT COMPLETED|Overall Study||1
357219|NCT01216163|855668|P1|NOT COMPLETED|Overall Study||1
357220|NCT01216163|855666|P3|COMPLETED|Overall Study||85
357221|NCT01216163|855667|P2|COMPLETED|Overall Study||87
357222|NCT01216163|855668|P1|COMPLETED|Overall Study||44
357223|NCT01216163|855666|P3|STARTED|Overall Study||85
357224|NCT01216163|855667|P2|STARTED|Overall Study||88
357225|NCT01216163|855668|P1|STARTED|Overall Study||45
357226|NCT01216072|855720|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
357227|NCT01216072|855721|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
357228|NCT01216072|855720|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
357229|NCT01216072|855721|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
357230|NCT01216072|855720|P2|Safety Set|Open-Label Extension Period (3 Months)||193
357231|NCT01216072|855721|P1|Safety Set|Open-Label Extension Period (3 Months)||0
357232|NCT01216072|855720|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
357233|NCT01216072|855721|P1|STARTED|Open-Label Extension Period (3 Months)||0
357234|NCT01216072|855720|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
357235|NCT01216072|855721|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
357236|NCT01216072|855720|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
357237|NCT01216072|855721|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
357238|NCT01216072|855720|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
357239|NCT01216072|855721|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
357240|NCT01216072|855720|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
357241|NCT01216072|855721|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
357242|NCT01216072|855720|P2|STARTED|Open-Label Core Period ( 6 Months)||263
357243|NCT01216072|855721|P1|STARTED|Open-Label Core Period ( 6 Months)||790
357244|NCT01215981|855749|P2|NOT COMPLETED|Overall Study||1
357245|NCT01215981|855750|P1|NOT COMPLETED|Overall Study||2
357246|NCT01215981|855749|P2|COMPLETED|Overall Study||32
357247|NCT01215981|855750|P1|COMPLETED|Overall Study||33
357248|NCT01215981|855749|P2|STARTED|Overall Study||33
357249|NCT01215981|855750|P1|STARTED|Overall Study||35
357250|NCT01215968|855760|P2|NOT COMPLETED|Overall Study||7
357251|NCT01215968|855761|P1|NOT COMPLETED|Overall Study||2
357252|NCT01215968|855760|P2|COMPLETED|Overall Study||18
357253|NCT01215968|855761|P1|COMPLETED|Overall Study||11
357254|NCT01215968|855760|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
357255|NCT01215968|855761|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
357256|NCT01215968|855760|P2|STARTED|Overall Study||25
357257|NCT01215968|855761|P1|STARTED|Overall Study||13
357258|NCT01215955|855781|P4|NOT COMPLETED|Overall Study||53
357259|NCT01215955|855782|P3|NOT COMPLETED|Overall Study||48
357260|NCT01215955|855783|P2|NOT COMPLETED|Overall Study||53
357261|NCT01215955|855784|P1|NOT COMPLETED|Overall Study||45
357262|NCT01215955|855781|P4|COMPLETED|Overall Study||241
357263|NCT01215955|855782|P3|COMPLETED|Overall Study||244
357264|NCT01215955|855783|P2|COMPLETED|Overall Study||210
357265|NCT01215955|855784|P1|COMPLETED|Overall Study||223
357266|NCT01215955|855781|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
357267|NCT01215955|855782|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
357268|NCT01215955|855783|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
357269|NCT01215955|855784|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
357270|NCT01215955|855781|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
357271|NCT01215955|855782|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
357272|NCT01215955|855783|P2|STARTED|Overall Study||263
357273|NCT01215955|855784|P1|STARTED|Overall Study||268
357274|NCT01215929|855852|P2|NOT COMPLETED|Overall Study||5
357275|NCT01215929|855853|P1|NOT COMPLETED|Overall Study||6
357276|NCT01215929|855852|P2|COMPLETED|Overall Study||12
357277|NCT01215929|855853|P1|COMPLETED|Overall Study||12
357278|NCT01215929|855852|P2|STARTED|Overall Study||17
357279|NCT01215929|855853|P1|STARTED|Overall Study||18
357280|NCT01215851|855865|P6|NOT COMPLETED|Follow up Period||1
357281|NCT01215851|855866|P5|NOT COMPLETED|Follow up Period||0
357282|NCT01215851|855867|P4|NOT COMPLETED|Follow up Period||0
357283|NCT01215851|855868|P3|NOT COMPLETED|Follow up Period||0
357284|NCT01215851|855869|P2|NOT COMPLETED|Follow up Period||0
357285|NCT01215851|855870|P1|NOT COMPLETED|Follow up Period||0
357286|NCT01215851|855865|P6|COMPLETED|Follow up Period||13
357287|NCT01215851|855866|P5|COMPLETED|Follow up Period||10
357288|NCT01215851|855867|P4|COMPLETED|Follow up Period||12
357289|NCT01215851|855868|P3|COMPLETED|Follow up Period||14
357290|NCT01215851|855869|P2|COMPLETED|Follow up Period||14
357291|NCT01215851|855870|P1|COMPLETED|Follow up Period||14
357292|NCT01215851|855865|P6|STARTED|Follow up Period||14
357293|NCT01215851|855866|P5|STARTED|Follow up Period||10
357294|NCT01215851|855867|P4|STARTED|Follow up Period||12
357295|NCT01215851|855868|P3|STARTED|Follow up Period||14
357296|NCT01215851|855869|P2|STARTED|Follow up Period||14
357297|NCT01215851|855870|P1|STARTED|Follow up Period||14
357298|NCT01215851|855865|P6|NOT COMPLETED|Treatment Period||1
357299|NCT01215851|855866|P5|NOT COMPLETED|Treatment Period||0
357300|NCT01215851|855867|P4|NOT COMPLETED|Treatment Period||3
357301|NCT01215851|855868|P3|NOT COMPLETED|Treatment Period||1
357302|NCT01215851|855869|P2|NOT COMPLETED|Treatment Period||1
357303|NCT01215851|855870|P1|NOT COMPLETED|Treatment Period||1
357304|NCT01215851|855865|P6|COMPLETED|Treatment Period||14
357305|NCT01215851|855866|P5|COMPLETED|Treatment Period||10
357306|NCT01215851|855867|P4|COMPLETED|Treatment Period||12
357307|NCT01215851|855868|P3|COMPLETED|Treatment Period||14
357308|NCT01215851|855869|P2|COMPLETED|Treatment Period||14
357309|NCT01215851|855870|P1|COMPLETED|Treatment Period||14
357310|NCT01215851|855865|P6|STARTED|Treatment Period||15
357311|NCT01215851|855866|P5|STARTED|Treatment Period||10
357312|NCT01215851|855867|P4|STARTED|Treatment Period||15
357313|NCT01215851|855868|P3|STARTED|Treatment Period||15
357314|NCT01215851|855869|P2|STARTED|Treatment Period||15
357315|NCT01215851|855870|P1|STARTED|Treatment Period||15
357316|NCT01215786|855911|P3|NOT COMPLETED|Overall Study||0
357317|NCT01215786|855912|P2|NOT COMPLETED|Overall Study||0
357318|NCT01215786|855913|P1|NOT COMPLETED|Overall Study||0
357319|NCT01215786|855911|P3|COMPLETED|Overall Study||10
357320|NCT01215786|855912|P2|COMPLETED|Overall Study||19
357321|NCT01215786|855913|P1|COMPLETED|Overall Study||21
357322|NCT01215786|855911|P3|STARTED|Overall Study||10
357323|NCT01215786|855912|P2|STARTED|Overall Study||19
357324|NCT01215786|855913|P1|STARTED|Overall Study||21
357325|NCT01215734|855929|P2|NOT COMPLETED|Overall Study||1
357326|NCT01215734|855930|P1|NOT COMPLETED|Overall Study||0
357327|NCT01215734|855929|P2|COMPLETED|Overall Study||14
357328|NCT01215734|855930|P1|COMPLETED|Overall Study||29
357329|NCT01215734|855929|P2|STARTED|Overall Study||15
357330|NCT01215734|855930|P1|STARTED|Overall Study||29
357331|NCT01215721|855938|P1|NOT COMPLETED|Overall Study||2
357332|NCT01215721|855938|P1|COMPLETED|Overall Study||38
357333|NCT01215721|855938|P1|STARTED|Overall Study||40
357334|NCT01215643|855947|P5|NOT COMPLETED|Overall Study||11
357335|NCT01215643|855948|P4|NOT COMPLETED|Overall Study||4
357336|NCT01215643|855949|P3|NOT COMPLETED|Overall Study||12
357337|NCT01215643|855950|P2|NOT COMPLETED|Overall Study||4
357338|NCT01215643|855951|P1|NOT COMPLETED|Overall Study||9
357339|NCT01215643|855947|P5|COMPLETED|Overall Study||29
357340|NCT01215643|855948|P4|COMPLETED|Overall Study||35
357341|NCT01215643|855949|P3|COMPLETED|Overall Study||82
357342|NCT01215643|855950|P2|COMPLETED|Overall Study||80
357343|NCT01215643|855951|P1|COMPLETED|Overall Study||74
357344|NCT01215643|855947|P5|STARTED|Overall Study||40
357345|NCT01215643|855948|P4|STARTED|Overall Study||39
357346|NCT01215643|855949|P3|STARTED|Overall Study||94
357347|NCT01215643|855950|P2|STARTED|Overall Study||84
357348|NCT01215643|855951|P1|STARTED|Overall Study||83
357349|NCT01215513|856053|P1|NOT COMPLETED|Overall Study||45
357350|NCT01215513|856053|P1|COMPLETED|Overall Study||112
357351|NCT01215513|856053|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
357352|NCT01215513|856053|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
357353|NCT01215513|856053|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
357448|NCT01214980|856377|P2|NOT COMPLETED|Overall Study||2
357354|NCT01215513|856053|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
357355|NCT01215435|856062|P2|NOT COMPLETED|Overall Study||16
357356|NCT01215435|856063|P1|NOT COMPLETED|Overall Study||19
357357|NCT01215435|856062|P2|COMPLETED|Overall Study||107
357358|NCT01215435|856063|P1|COMPLETED|Overall Study||103
357359|NCT01215435|856062|P2|STARTED|Overall Study||123
357360|NCT01215435|856063|P1|STARTED|Overall Study||122
357361|NCT01215422|856077|P4|NOT COMPLETED|Overall Study||8
357362|NCT01215422|856078|P3|NOT COMPLETED|Overall Study||3
357363|NCT01215422|856079|P2|NOT COMPLETED|Overall Study||0
357364|NCT01215422|856080|P1|NOT COMPLETED|Overall Study||8
357365|NCT01215422|856077|P4|COMPLETED|Overall Study||193
357366|NCT01215422|856078|P3|COMPLETED|Overall Study||193
357367|NCT01215422|856079|P2|COMPLETED|Overall Study||249
357368|NCT01215422|856080|P1|COMPLETED|Overall Study||6
357369|NCT01215422|856077|P4|STARTED|Overall Study||201
357370|NCT01215422|856078|P3|STARTED|Overall Study||196
357371|NCT01215422|856079|P2|STARTED|Overall Study||249
357372|NCT01215422|856080|P1|STARTED|Overall Study||14
357373|NCT01215357|856102|P1|NOT COMPLETED|Overall Study||12
357374|NCT01215357|856102|P1|COMPLETED|Overall Study||22
357375|NCT01215357|856102|P1|STARTED|Overall Study||34
357376|NCT01215292|856111|P5|NOT COMPLETED|Overall Study||0
357377|NCT01215292|856112|P4|NOT COMPLETED|Overall Study||0
357378|NCT01215292|856113|P3|NOT COMPLETED|Overall Study||0
357379|NCT01215292|856114|P2|NOT COMPLETED|Overall Study||0
357380|NCT01215292|856115|P1|NOT COMPLETED|Overall Study||0
357381|NCT01215292|856111|P5|COMPLETED|Overall Study||8
357382|NCT01215292|856112|P4|COMPLETED|Overall Study||8
357383|NCT01215292|856113|P3|COMPLETED|Overall Study||8
357384|NCT01215292|856114|P2|COMPLETED|Overall Study||8
357385|NCT01215292|856115|P1|COMPLETED|Overall Study||8
357386|NCT01215292|856111|P5|STARTED|Overall Study||8
357387|NCT01215292|856112|P4|STARTED|Overall Study||8
357388|NCT01215292|856113|P3|STARTED|Overall Study||8
357389|NCT01215292|856114|P2|STARTED|Overall Study||8
357390|NCT01215292|856115|P1|STARTED|Overall Study||8
357391|NCT01215279|856139|P2|NOT COMPLETED|Overall Study||0
357392|NCT01215279|856140|P1|NOT COMPLETED|Overall Study||0
357393|NCT01215279|856139|P2|COMPLETED|Overall Study||32
357394|NCT01215279|856140|P1|COMPLETED|Overall Study||31
357395|NCT01215279|856139|P2|STARTED|Overall Study||32
357396|NCT01215279|856140|P1|STARTED|Overall Study||31
357397|NCT01215227|856210|P6|NOT COMPLETED|Overall Study||58
357398|NCT01215227|856211|P5|NOT COMPLETED|Overall Study||48
357399|NCT01215227|856212|P4|NOT COMPLETED|Overall Study||49
357400|NCT01215227|856213|P3|NOT COMPLETED|Overall Study||57
357401|NCT01215227|856214|P2|NOT COMPLETED|Overall Study||119
357402|NCT01215227|856215|P1|NOT COMPLETED|Overall Study||121
357403|NCT01215227|856210|P6|COMPLETED|Overall Study||51
357404|NCT01215227|856211|P5|COMPLETED|Overall Study||45
357405|NCT01215227|856212|P4|COMPLETED|Overall Study||48
357406|NCT01215227|856213|P3|COMPLETED|Overall Study||50
357407|NCT01215227|856214|P2|COMPLETED|Overall Study||96
357408|NCT01215227|856215|P1|COMPLETED|Overall Study||97
357409|NCT01215227|856210|P6|Treated|Overall Study||108
357410|NCT01215227|856211|P5|Treated|Overall Study||93
357411|NCT01215227|856212|P4|Treated|Overall Study||96
357412|NCT01215227|856213|P3|Treated|Overall Study||106
357413|NCT01215227|856214|P2|Treated|Overall Study||215
357414|NCT01215227|856215|P1|Treated|Overall Study||218
357415|NCT01215227|856210|P6|STARTED|Overall Study||109
357416|NCT01215227|856211|P5|STARTED|Overall Study||93
357417|NCT01215227|856212|P4|STARTED|Overall Study||97
357418|NCT01215227|856213|P3|STARTED|Overall Study||107
357419|NCT01215227|856214|P2|STARTED|Overall Study||215
357420|NCT01215227|856215|P1|STARTED|Overall Study||218
357421|NCT01215123|856259|P1|NOT COMPLETED|Overall Study||0
357422|NCT01215123|856259|P1|COMPLETED|Overall Study||28
357423|NCT01215123|856259|P1|STARTED|Overall Study||28
357424|NCT01215110|856269|P5|NOT COMPLETED|Overall Study||0
357425|NCT01215110|856270|P4|NOT COMPLETED|Overall Study||1
357426|NCT01215110|856271|P3|NOT COMPLETED|Overall Study||2
357427|NCT01215110|856272|P2|NOT COMPLETED|Overall Study||0
357428|NCT01215110|856273|P1|NOT COMPLETED|Overall Study||0
357429|NCT01215110|856269|P5|COMPLETED|Overall Study||8
357430|NCT01215110|856270|P4|COMPLETED|Overall Study||14
357431|NCT01215110|856271|P3|COMPLETED|Overall Study||13
357432|NCT01215110|856272|P2|COMPLETED|Overall Study||15
357433|NCT01215110|856273|P1|COMPLETED|Overall Study||15
357434|NCT01215110|856269|P5|STARTED|Overall Study||8
357435|NCT01215110|856270|P4|STARTED|Overall Study||15
357436|NCT01215110|856271|P3|STARTED|Overall Study||15
357437|NCT01215110|856272|P2|STARTED|Overall Study||15
357438|NCT01215110|856273|P1|STARTED|Overall Study||15
357439|NCT01215097|856334|P2|NOT COMPLETED|Overall Study||14
357440|NCT01215097|856335|P1|NOT COMPLETED|Overall Study||12
357441|NCT01215097|856334|P2|COMPLETED|Overall Study||191
357442|NCT01215097|856335|P1|COMPLETED|Overall Study||88
357443|NCT01215097|856334|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
357444|NCT01215097|856335|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
357445|NCT01215032|856367|P1|NOT COMPLETED|Overall Study||20
357446|NCT01215032|856367|P1|COMPLETED|Overall Study||1
357447|NCT01215032|856367|P1|STARTED|Overall Study||21
357449|NCT01214980|856378|P1|NOT COMPLETED|Overall Study||3
357450|NCT01214980|856377|P2|COMPLETED|Overall Study||14
357451|NCT01214980|856378|P1|COMPLETED|Overall Study||13
357452|NCT01214980|856377|P2|STARTED|Overall Study||16
357453|NCT01214980|856378|P1|STARTED|Overall Study||16
357454|NCT01214915|856392|P1|NOT COMPLETED|Overall Study||11
357455|NCT01214915|856392|P1|COMPLETED|Overall Study||42
357456|NCT01214915|856392|P1|STARTED|Overall Study||53
357457|NCT01214850|856403|P3|NOT COMPLETED|Overall Study||161
357458|NCT01214850|856404|P2|NOT COMPLETED|Overall Study||144
357459|NCT01214850|856405|P1|NOT COMPLETED|Overall Study||183
357460|NCT01214850|856403|P3|COMPLETED|Overall Study||826
357461|NCT01214850|856404|P2|COMPLETED|Overall Study||844
357462|NCT01214850|856405|P1|COMPLETED|Overall Study||796
357463|NCT01214850|856403|P3|STARTED|Overall Study||987
357464|NCT01214850|856404|P2|STARTED|Overall Study||988
357465|NCT01214850|856405|P1|STARTED|Overall Study||979
357466|NCT01214837|856489|P3|NOT COMPLETED|Overall Study||62
357467|NCT01214837|856490|P2|NOT COMPLETED|Overall Study||64
357468|NCT01214837|856491|P1|NOT COMPLETED|Overall Study||54
357469|NCT01214837|856489|P3|COMPLETED|Overall Study||184
357470|NCT01214837|856490|P2|COMPLETED|Overall Study||192
357471|NCT01214837|856491|P1|COMPLETED|Overall Study||195
357472|NCT01214837|856489|P3|STARTED|Overall Study||246
357473|NCT01214837|856490|P2|STARTED|Overall Study||256
357474|NCT01214837|856491|P1|STARTED|Overall Study||249
357475|NCT01214824|856528|P1|NOT COMPLETED|Overall Study||3
357476|NCT01214824|856528|P1|COMPLETED|Overall Study||29
357477|NCT01214824|856528|P1|STARTED|Overall Study||32
357478|NCT01214811|856535|P1|NOT COMPLETED|Overall Study||3
357479|NCT01214811|856535|P1|COMPLETED|Overall Study||24
357480|NCT01214811|856535|P1|STARTED|Overall Study||27
357481|NCT01214759|856539|P1|NOT COMPLETED|Overall Study||48
357482|NCT01214759|856539|P1|COMPLETED|Overall Study||55
357483|NCT01214759|856539|P1|28 Days nPEP Completion|Overall Study||85
357484|NCT01214759|856539|P1|STARTED|Overall Study||103
357485|NCT01214720|856547|P2|NOT COMPLETED|Overall Study||68
357486|NCT01214720|856548|P1|NOT COMPLETED|Overall Study||85
357487|NCT01214720|856547|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
357488|NCT01214720|856548|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
357489|NCT01214720|856547|P2|STARTED|Overall Study||301
357490|NCT01214720|856548|P1|STARTED|Overall Study||306
357491|NCT01214616|856569|P4|NOT COMPLETED|Overall Study||6
357492|NCT01214616|856570|P3|NOT COMPLETED|Overall Study||3
357493|NCT01214616|856571|P2|NOT COMPLETED|Overall Study||5
357494|NCT01214616|856572|P1|NOT COMPLETED|Overall Study||3
357495|NCT01214616|856569|P4|COMPLETED|Overall Study||0
357496|NCT01214616|856570|P3|COMPLETED|Overall Study||0
357497|NCT01214616|856571|P2|COMPLETED|Overall Study||0
357498|NCT01214616|856572|P1|COMPLETED|Overall Study||0
357499|NCT01214616|856569|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
357500|NCT01214616|856570|P3|STARTED|Overall Study||3
357501|NCT01214616|856571|P2|STARTED|Overall Study||5
357502|NCT01214616|856572|P1|STARTED|Overall Study||3
357503|NCT01214434|856608|P2|NOT COMPLETED|Overall Study||2
357504|NCT01214434|856609|P1|NOT COMPLETED|Overall Study||4
357505|NCT01214434|856608|P2|COMPLETED|Overall Study||25
357506|NCT01214434|856609|P1|COMPLETED|Overall Study||11
357507|NCT01214434|856608|P2|STARTED|Overall Study||27
357508|NCT01214434|856609|P1|STARTED|Overall Study||15
357509|NCT01214395|856625|P1|NOT COMPLETED|Overall Study||5
357510|NCT01214395|856625|P1|COMPLETED|Overall Study||0
357511|NCT01214395|856625|P1|STARTED|Overall Study||5
357512|NCT01214330|856630|P1|NOT COMPLETED|Overall Study||48
357513|NCT01214330|856630|P1|COMPLETED|Overall Study||102
357514|NCT01214330|856630|P1|STARTED|Overall Study||150
357515|NCT01214252|856634|P1|NOT COMPLETED|Overall Study||82
357516|NCT01214252|856634|P1|COMPLETED|Overall Study||343
357517|NCT01214252|856634|P1|STARTED|Overall Study||425
357518|NCT01214239|856642|P2|NOT COMPLETED|Overall Study||18
357519|NCT01214239|856643|P1|NOT COMPLETED|Overall Study||12
357520|NCT01214239|856642|P2|COMPLETED|Overall Study||182
357521|NCT01214239|856643|P1|COMPLETED|Overall Study||87
357522|NCT01214239|856642|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
357523|NCT01214239|856643|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
357524|NCT01214187|856677|P2|NOT COMPLETED|Overall Study||6
357525|NCT01214187|856678|P1|NOT COMPLETED|Overall Study||7
357526|NCT01214187|856677|P2|COMPLETED|Overall Study||23
357527|NCT01214187|856678|P1|COMPLETED|Overall Study||22
357528|NCT01214187|856677|P2|STARTED|Overall Study||29
357529|NCT01214187|856678|P1|STARTED|Overall Study||29
357530|NCT01214174|856695|P3|NOT COMPLETED|Overall Study||1
357531|NCT01214174|856696|P2|NOT COMPLETED|Overall Study||0
357532|NCT01214174|856697|P1|NOT COMPLETED|Overall Study||0
357533|NCT01214174|856695|P3|COMPLETED|Overall Study||13
357534|NCT01214174|856696|P2|COMPLETED|Overall Study||16
357535|NCT01214174|856697|P1|COMPLETED|Overall Study||13
357536|NCT01214174|856695|P3|STARTED|Overall Study||14
357537|NCT01214174|856696|P2|STARTED|Overall Study||16
357538|NCT01214174|856697|P1|STARTED|Overall Study||13
357539|NCT01214161|856707|P2|NOT COMPLETED|Overall Study||0
357540|NCT01214161|856708|P1|NOT COMPLETED|Overall Study||0
357541|NCT01214161|856707|P2|COMPLETED|Overall Study||100
357542|NCT01214161|856708|P1|COMPLETED|Overall Study||100
357543|NCT01214161|856707|P2|STARTED|Overall Study||100
357544|NCT01214161|856708|P1|STARTED|Overall Study||100
357545|NCT01214109|856718|P4|NOT COMPLETED|Overall Study||0
357546|NCT01214109|856719|P3|NOT COMPLETED|Overall Study||0
357547|NCT01214109|856720|P2|NOT COMPLETED|Overall Study||0
357548|NCT01214109|856721|P1|NOT COMPLETED|Overall Study||0
357549|NCT01214109|856718|P4|COMPLETED|Overall Study||24
357550|NCT01214109|856719|P3|COMPLETED|Overall Study||24
357551|NCT01214109|856720|P2|COMPLETED|Overall Study||24
357552|NCT01214109|856721|P1|COMPLETED|Overall Study||24
357553|NCT01214109|856718|P4|STARTED|Overall Study||24
357554|NCT01214109|856719|P3|STARTED|Overall Study||24
357555|NCT01214109|856720|P2|STARTED|Overall Study||24
357556|NCT01214109|856721|P1|STARTED|Overall Study||24
357557|NCT01214083|856813|P3|NOT COMPLETED|Overall Study||10
357558|NCT01214083|856814|P2|NOT COMPLETED|Overall Study||10
357559|NCT01214083|856815|P1|NOT COMPLETED|Overall Study||12
357560|NCT01214083|856813|P3|COMPLETED|Overall Study||21
357561|NCT01214083|856814|P2|COMPLETED|Overall Study||23
357562|NCT01214083|856815|P1|COMPLETED|Overall Study||19
357563|NCT01214083|856813|P3|STARTED|Overall Study||31
357564|NCT01214083|856814|P2|STARTED|Overall Study||33
357565|NCT01214083|856815|P1|STARTED|Overall Study||31
357566|NCT01213966|856851|P4|NOT COMPLETED|Overall Study||1
357567|NCT01213966|856852|P3|NOT COMPLETED|Overall Study||3
357568|NCT01213966|856853|P2|NOT COMPLETED|Overall Study||0
357569|NCT01213966|856854|P1|NOT COMPLETED|Overall Study||1
357570|NCT01213966|856851|P4|COMPLETED|Overall Study||20
357571|NCT01213966|856852|P3|COMPLETED|Overall Study||17
357572|NCT01213966|856853|P2|COMPLETED|Overall Study||20
357573|NCT01213966|856854|P1|COMPLETED|Overall Study||19
357574|NCT01213966|856851|P4|STARTED|Overall Study||21
357575|NCT01213966|856852|P3|STARTED|Overall Study||20
357576|NCT01213966|856853|P2|STARTED|Overall Study||20
357577|NCT01213966|856854|P1|STARTED|Overall Study||20
357578|NCT01213836|856866|P2|NOT COMPLETED|Period 2, Second Intervention||0
357579|NCT01213836|856867|P1|NOT COMPLETED|Period 2, Second Intervention||0
357580|NCT01213836|856866|P2|COMPLETED|Period 2, Second Intervention||29
357581|NCT01213836|856867|P1|COMPLETED|Period 2, Second Intervention||31
357582|NCT01213836|856866|P2|STARTED|Period 2, Second Intervention||29
357583|NCT01213836|856867|P1|STARTED|Period 2, Second Intervention||31
357584|NCT01213836|856866|P2|NOT COMPLETED|Period 1, First Intervention||3
357585|NCT01213836|856867|P1|NOT COMPLETED|Period 1, First Intervention||3
357586|NCT01213836|856866|P2|COMPLETED|Period 1, First Intervention||29
357587|NCT01213836|856867|P1|COMPLETED|Period 1, First Intervention||31
357588|NCT01213836|856866|P2|STARTED|Period 1, First Intervention||32
357589|NCT01213836|856867|P1|STARTED|Period 1, First Intervention||34
357590|NCT01213823|856887|P2|NOT COMPLETED|Overall Study||0
357591|NCT01213823|856888|P1|NOT COMPLETED|Overall Study||0
357592|NCT01213823|856887|P2|COMPLETED|Overall Study||467
357593|NCT01213823|856888|P1|COMPLETED|Overall Study||69
357594|NCT01213823|856887|P2|STARTED|Overall Study||467
357595|NCT01213823|856888|P1|STARTED|Overall Study||69
357596|NCT01213706|856894|P1|NOT COMPLETED|WBPA||0
357597|NCT01213706|856894|P1|COMPLETED|WBPA||45
357598|NCT01213706|856894|P1|STARTED|WBPA||45
357599|NCT01213706|856894|P1|NOT COMPLETED|Washout (1 Hour)||0
357600|NCT01213706|856894|P1|COMPLETED|Washout (1 Hour)||45
357601|NCT01213706|856894|P1|STARTED|Washout (1 Hour)||45
357602|NCT01213706|856894|P1|NOT COMPLETED|Sham WBPA||0
357603|NCT01213706|856894|P1|COMPLETED|Sham WBPA||45
357604|NCT01213706|856894|P1|STARTED|Sham WBPA||45
357605|NCT01213589|856903|P3|NOT COMPLETED|Overall Study||8
357606|NCT01213589|856904|P2|NOT COMPLETED|Overall Study||5
357607|NCT01213589|856905|P1|NOT COMPLETED|Overall Study||13
357608|NCT01213589|856903|P3|COMPLETED|Overall Study||18
357609|NCT01213589|856904|P2|COMPLETED|Overall Study||19
357610|NCT01213589|856905|P1|COMPLETED|Overall Study||37
357611|NCT01213589|856903|P3|STARTED|Overall Study||26
357612|NCT01213589|856904|P2|STARTED|Overall Study||24
357613|NCT01213589|856905|P1|STARTED|Overall Study||50
357614|NCT01213576|856935|P4|NOT COMPLETED|Overall Study||4
357615|NCT01213576|856936|P3|NOT COMPLETED|Overall Study||5
357616|NCT01213576|856937|P2|NOT COMPLETED|Overall Study||4
357617|NCT01213576|856938|P1|NOT COMPLETED|Overall Study||3
357618|NCT01213576|856935|P4|COMPLETED|Overall Study||13
357619|NCT01213576|856936|P3|COMPLETED|Overall Study||13
357620|NCT01213576|856937|P2|COMPLETED|Overall Study||13
357621|NCT01213576|856938|P1|COMPLETED|Overall Study||15
357622|NCT01213576|856935|P4|STARTED|Overall Study||17
357623|NCT01213576|856936|P3|STARTED|Overall Study||18
357624|NCT01213576|856937|P2|STARTED|Overall Study||17
357625|NCT01213576|856938|P1|STARTED|Overall Study||18
357626|NCT01213329|856954|P2|NOT COMPLETED|Phase 2||0
357627|NCT01213329|856955|P1|NOT COMPLETED|Phase 2||0
357628|NCT01213329|856954|P2|COMPLETED|Phase 2||0
357629|NCT01213329|856955|P1|COMPLETED|Phase 2||0
357630|NCT01213329|856954|P2|STARTED|Phase 2||0
357631|NCT01213329|856955|P1|STARTED|Phase 2||0
357632|NCT01213329|856954|P2|NOT COMPLETED|Screening||0
357633|NCT01213329|856955|P1|NOT COMPLETED|Screening||0
357634|NCT01213329|856954|P2|COMPLETED|Screening||25
357635|NCT01213329|856955|P1|COMPLETED|Screening||25
357636|NCT01213329|856954|P2|STARTED|Screening||25
357637|NCT01213329|856955|P1|STARTED|Screening||25
357638|NCT01213316|856961|P1|NOT COMPLETED|Overall Study||0
357639|NCT01213316|856961|P1|COMPLETED|Overall Study||451
357640|NCT01213316|856961|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
357641|NCT01213316|856961|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
357642|NCT01213316|856961|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
357643|NCT01213316|856961|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
357644|NCT01213316|856961|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
357645|NCT01213264|856980|P3|NOT COMPLETED|Overall Study||6
357646|NCT01213264|856981|P2|NOT COMPLETED|Overall Study||2
357647|NCT01213264|856982|P1|NOT COMPLETED|Overall Study||2
357648|NCT01213264|856980|P3|COMPLETED|Overall Study||321
357649|NCT01213264|856981|P2|COMPLETED|Overall Study||175
357650|NCT01213264|856982|P1|COMPLETED|Overall Study||153
357651|NCT01213264|856980|P3|STARTED|Overall Study||327
357652|NCT01213264|856981|P2|STARTED|Overall Study||177
357653|NCT01213264|856982|P1|STARTED|Overall Study||155
357654|NCT01213251|857002|P3|NOT COMPLETED|Overall Study||11
357655|NCT01213251|857003|P2|NOT COMPLETED|Overall Study||4
357656|NCT01213251|857004|P1|NOT COMPLETED|Overall Study||6
357657|NCT01213251|857002|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
357658|NCT01213251|857003|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
357659|NCT01213251|857004|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
357660|NCT01213251|857002|P3|STARTED|Overall Study||45
357661|NCT01213251|857003|P2|STARTED|Overall Study||41
357662|NCT01213251|857004|P1|STARTED|Overall Study||40
357663|NCT01213199|857025|P1|NOT COMPLETED|Overall Study||4
357664|NCT01213199|857025|P1|COMPLETED|Overall Study||16
357665|NCT01213199|857025|P1|STARTED|Overall Study||20
357666|NCT01213173|857031|P2|NOT COMPLETED|Overall Study||16
357667|NCT01213173|857032|P1|NOT COMPLETED|Overall Study||12
357668|NCT01213173|857031|P2|COMPLETED|Overall Study|Patients who completed the study|110
357669|NCT01213173|857032|P1|COMPLETED|Overall Study|Patients who completed the study|113
357670|NCT01213173|857031|P2|Patients Included in PP Population|Overall Study||89
357671|NCT01213173|857032|P1|Patients Included in PP Population|Overall Study||102
357672|NCT01213173|857031|P2|Patients Included in ITT Population|Overall Study||115
357673|NCT01213173|857032|P1|Patients Included in ITT Population|Overall Study||116
357674|NCT01213173|857031|P2|Patients Included in Safety Population|Overall Study||112
357675|NCT01213173|857032|P1|Patients Included in Safety Population|Overall Study||139
357676|NCT01213173|857031|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
357677|NCT01213173|857032|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
357678|NCT01213043|857064|P2|NOT COMPLETED|Follow-up||0
357679|NCT01213043|857065|P1|NOT COMPLETED|Follow-up||0
357680|NCT01213043|857064|P2|COMPLETED|Follow-up||15
357681|NCT01213043|857065|P1|COMPLETED|Follow-up||15
357682|NCT01213043|857064|P2|STARTED|Follow-up||15
357683|NCT01213043|857065|P1|STARTED|Follow-up||15
357684|NCT01213043|857064|P2|NOT COMPLETED|Treatment Period 2||0
357685|NCT01213043|857065|P1|NOT COMPLETED|Treatment Period 2||0
357686|NCT01213043|857064|P2|COMPLETED|Treatment Period 2||15
357687|NCT01213043|857065|P1|COMPLETED|Treatment Period 2||15
357688|NCT01213043|857064|P2|STARTED|Treatment Period 2||15
357689|NCT01213043|857065|P1|STARTED|Treatment Period 2||15
357690|NCT01213043|857064|P2|NOT COMPLETED|Washout Period||0
357691|NCT01213043|857065|P1|NOT COMPLETED|Washout Period||0
357692|NCT01213043|857064|P2|COMPLETED|Washout Period||15
357693|NCT01213043|857065|P1|COMPLETED|Washout Period||15
357694|NCT01213043|857064|P2|STARTED|Washout Period||15
357695|NCT01213043|857065|P1|STARTED|Washout Period||15
357696|NCT01213043|857064|P2|NOT COMPLETED|Treatment Period 1||0
357697|NCT01213043|857065|P1|NOT COMPLETED|Treatment Period 1||0
357698|NCT01213043|857064|P2|COMPLETED|Treatment Period 1||15
357699|NCT01213043|857065|P1|COMPLETED|Treatment Period 1||15
357700|NCT01213043|857064|P2|STARTED|Treatment Period 1||15
357701|NCT01213043|857065|P1|STARTED|Treatment Period 1||15
357702|NCT01212991|857093|P2|NOT COMPLETED|Overall Study||374
357703|NCT01212991|857094|P1|NOT COMPLETED|Overall Study||613
357704|NCT01212991|857093|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
357705|NCT01212991|857094|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
357706|NCT01212991|857093|P2|STARTED|Overall Study||845
357707|NCT01212991|857094|P1|STARTED|Overall Study||872
357708|NCT01212874|857114|P2|NOT COMPLETED|Overall Study||23
357709|NCT01212874|857115|P1|NOT COMPLETED|Overall Study||22
357710|NCT01212874|857114|P2|COMPLETED|Overall Study||12
357711|NCT01212874|857115|P1|COMPLETED|Overall Study||13
357712|NCT01212874|857114|P2|Received Allocated Intervention|Overall Study||12
357713|NCT01212874|857115|P1|Received Allocated Intervention|Overall Study||13
357714|NCT01212874|857114|P2|STARTED|Overall Study||35
357715|NCT01212874|857115|P1|STARTED|Overall Study||35
357716|NCT01212770|857126|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
357717|NCT01212770|857127|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
357718|NCT01212770|857128|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
357719|NCT01212770|857129|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
357720|NCT01212770|857130|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
357721|NCT01212770|857131|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
357722|NCT01212770|857132|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
357723|NCT01212770|857126|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
357724|NCT01212770|857127|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
357725|NCT01212770|857128|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
357726|NCT01212770|857129|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
357727|NCT01212770|857130|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
357728|NCT01212770|857131|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
357729|NCT01212770|857132|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
357730|NCT01212770|857126|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
357731|NCT01212770|857127|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|47
357732|NCT01212770|857128|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
357799|NCT01212757|857328|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
357733|NCT01212770|857129|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|43
357734|NCT01212770|857130|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Seven participants who completed the placebo-controlled phase did not enter this phase|138
357735|NCT01212770|857131|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed the placebo-controlled phase did not enter this phase|139
357736|NCT01212770|857132|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
357737|NCT01212770|857126|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357738|NCT01212770|857127|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357739|NCT01212770|857128|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357740|NCT01212770|857129|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357741|NCT01212770|857130|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
357742|NCT01212770|857131|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
357743|NCT01212770|857132|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
357744|NCT01212770|857126|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357745|NCT01212770|857127|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357746|NCT01212770|857128|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357747|NCT01212770|857129|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357748|NCT01212770|857130|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
357749|NCT01212770|857131|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
357750|NCT01212770|857132|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
357751|NCT01212770|857126|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357752|NCT01212770|857127|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357753|NCT01212770|857128|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357754|NCT01212770|857129|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357755|NCT01212770|857130|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|53
357756|NCT01212770|857131|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
357757|NCT01212770|857132|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|97
357758|NCT01212770|857126|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357759|NCT01212770|857127|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357760|NCT01212770|857128|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357761|NCT01212770|857129|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357762|NCT01212770|857130|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
357763|NCT01212770|857131|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
357764|NCT01212770|857132|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
357765|NCT01212770|857126|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357766|NCT01212770|857127|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357767|NCT01212770|857128|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357768|NCT01212770|857129|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357769|NCT01212770|857130|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
357770|NCT01212770|857131|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
357771|NCT01212770|857132|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
357772|NCT01212770|857126|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357773|NCT01212770|857127|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357774|NCT01212770|857128|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357775|NCT01212770|857129|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357776|NCT01212770|857130|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
357777|NCT01212770|857131|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
357778|NCT01212770|857132|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
357779|NCT01212757|857322|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
357780|NCT01212757|857323|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
357781|NCT01212757|857324|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
357782|NCT01212757|857325|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||8
357783|NCT01212757|857326|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||20
357784|NCT01212757|857327|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
357785|NCT01212757|857328|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
357786|NCT01212757|857322|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||28
357787|NCT01212757|857323|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
357788|NCT01212757|857324|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||25
357789|NCT01212757|857325|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||35
357790|NCT01212757|857326|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||114
357791|NCT01212757|857327|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||125
357792|NCT01212757|857328|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
357793|NCT01212757|857322|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||28
357794|NCT01212757|857323|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Two participants who escaped early and completed Week 24 did not enter the active treatment phase|41
357795|NCT01212757|857324|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||27
357796|NCT01212757|857325|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)||43
357797|NCT01212757|857326|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed Week 24 did not enter the active treatment phase|134
357798|NCT01212757|857327|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Six participants who completed Week 24 did not enter the active treatment phase|137
357800|NCT01212757|857322|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357801|NCT01212757|857323|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357802|NCT01212757|857324|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357803|NCT01212757|857325|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357804|NCT01212757|857326|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
357805|NCT01212757|857327|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
357806|NCT01212757|857328|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
357807|NCT01212757|857322|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357808|NCT01212757|857323|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357809|NCT01212757|857324|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357810|NCT01212757|857325|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
357811|NCT01212757|857326|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
357812|NCT01212757|857327|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
357813|NCT01212757|857328|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
357814|NCT01212757|857322|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357815|NCT01212757|857323|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357816|NCT01212757|857324|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357817|NCT01212757|857325|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357818|NCT01212757|857326|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
357819|NCT01212757|857327|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
357820|NCT01212757|857328|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
357821|NCT01212757|857322|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357822|NCT01212757|857323|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357823|NCT01212757|857324|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357824|NCT01212757|857325|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
357825|NCT01212757|857326|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
357826|NCT01212757|857327|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
357827|NCT01212757|857328|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
357828|NCT01212757|857322|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357829|NCT01212757|857323|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357830|NCT01212757|857324|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357831|NCT01212757|857325|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
357832|NCT01212757|857326|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
357833|NCT01212757|857327|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
357834|NCT01212757|857328|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
357835|NCT01212757|857322|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357836|NCT01212757|857323|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357837|NCT01212757|857324|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357838|NCT01212757|857325|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
357839|NCT01212757|857326|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
357840|NCT01212757|857327|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
357841|NCT01212757|857328|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
357842|NCT01212627|857505|P1|NOT COMPLETED|Overall Study||0
357843|NCT01212627|857505|P1|COMPLETED|Overall Study||12
357844|NCT01212627|857505|P1|STARTED|Overall Study||12
357845|NCT01212484|857509|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
357846|NCT01212484|857510|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
357847|NCT01212484|857509|P2|COMPLETED|Second Intervention (4 Weeks)||3
357848|NCT01212484|857510|P1|COMPLETED|Second Intervention (4 Weeks)||5
357849|NCT01212484|857509|P2|STARTED|Second Intervention (4 Weeks)||4
357850|NCT01212484|857510|P1|STARTED|Second Intervention (4 Weeks)||5
357851|NCT01212484|857509|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
357852|NCT01212484|857510|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
357853|NCT01212484|857509|P2|COMPLETED|First Intervention (4 Weeks)||4
357854|NCT01212484|857510|P1|COMPLETED|First Intervention (4 Weeks)||5
357855|NCT01212484|857509|P2|STARTED|First Intervention (4 Weeks)||6
357856|NCT01212484|857510|P1|STARTED|First Intervention (4 Weeks)||5
357857|NCT01212484|857509|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
357858|NCT01212484|857510|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
357859|NCT01212484|857509|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
357860|NCT01212484|857510|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
357861|NCT01212484|857509|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
357862|NCT01212484|857510|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
357863|NCT01212445|857523|P3|NOT COMPLETED|Overall Study||0
357864|NCT01212445|857524|P2|NOT COMPLETED|Overall Study||0
357865|NCT01212445|857525|P1|NOT COMPLETED|Overall Study||0
357866|NCT01212445|857523|P3|COMPLETED|Overall Study||51
357867|NCT01212445|857524|P2|COMPLETED|Overall Study||51
357868|NCT01212445|857525|P1|COMPLETED|Overall Study||52
357869|NCT01212445|857523|P3|STARTED|Overall Study||51
357870|NCT01212445|857524|P2|STARTED|Overall Study||51
357871|NCT01212445|857525|P1|STARTED|Overall Study||52
357872|NCT01212302|857554|P1|NOT COMPLETED|Overall Study||0
357873|NCT01212302|857554|P1|COMPLETED|Overall Study||504
357874|NCT01212302|857554|P1|STARTED|Overall Study||504
357875|NCT01212185|857560|P2|NOT COMPLETED|Overall Study||1
357876|NCT01212185|857561|P1|NOT COMPLETED|Overall Study||2
357877|NCT01212185|857560|P2|COMPLETED|Overall Study||7
357878|NCT01212185|857561|P1|COMPLETED|Overall Study||4
357879|NCT01212185|857560|P2|STARTED|Overall Study||8
357880|NCT01212185|857561|P1|STARTED|Overall Study||6
357881|NCT01212172|857569|P2|NOT COMPLETED|Overall Study||1
357882|NCT01212172|857570|P1|NOT COMPLETED|Overall Study||1
357883|NCT01212172|857569|P2|COMPLETED|Overall Study||9
357884|NCT01212172|857570|P1|COMPLETED|Overall Study||9
357885|NCT01212172|857569|P2|STARTED|Overall Study||10
357886|NCT01212172|857570|P1|STARTED|Overall Study||10
357887|NCT01212159|857580|P2|NOT COMPLETED|Overall Study||12
357888|NCT01212159|857581|P1|NOT COMPLETED|Overall Study||12
357889|NCT01212159|857580|P2|COMPLETED|Overall Study||32
357890|NCT01212159|857581|P1|COMPLETED|Overall Study||14
357891|NCT01212159|857580|P2|STARTED|Overall Study||44
357892|NCT01212159|857581|P1|STARTED|Overall Study||26
357893|NCT01212094|857594|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
357894|NCT01212094|857595|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
357895|NCT01212094|857596|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
357896|NCT01212094|857594|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
357897|NCT01212094|857595|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
357898|NCT01212094|857596|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
357899|NCT01212094|857594|P3|STARTED|Years 2 & 3: Treatment Randomization||18
357900|NCT01212094|857595|P2|STARTED|Years 2 & 3: Treatment Randomization||9
357901|NCT01212094|857596|P1|STARTED|Years 2 & 3: Treatment Randomization||0
357902|NCT01212094|857594|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
357903|NCT01212094|857595|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
357904|NCT01212094|857596|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
357905|NCT01212094|857594|P3|COMPLETED|Year 1: Baseline Monitoring||0
357906|NCT01212094|857595|P2|COMPLETED|Year 1: Baseline Monitoring||0
357907|NCT01212094|857596|P1|COMPLETED|Year 1: Baseline Monitoring||27
357908|NCT01212094|857594|P3|STARTED|Year 1: Baseline Monitoring||0
357909|NCT01212094|857595|P2|STARTED|Year 1: Baseline Monitoring||0
357910|NCT01212094|857596|P1|STARTED|Year 1: Baseline Monitoring||43
357911|NCT01211873|857630|P3|NOT COMPLETED|Overall Study||2
357912|NCT01211873|857631|P2|NOT COMPLETED|Overall Study||2
357913|NCT01211873|857632|P1|NOT COMPLETED|Overall Study||5
357914|NCT01211873|857630|P3|COMPLETED|Overall Study||36
357915|NCT01211873|857631|P2|COMPLETED|Overall Study||117
357916|NCT01211873|857632|P1|COMPLETED|Overall Study||240
357917|NCT01211873|857630|P3|STARTED|Overall Study||38
357918|NCT01211873|857631|P2|STARTED|Overall Study||119
357919|NCT01211873|857632|P1|STARTED|Overall Study||245
357920|NCT01211769|857643|P4|NOT COMPLETED|Overall Study||11
357921|NCT01211769|857644|P3|NOT COMPLETED|Overall Study||8
357922|NCT01211769|857645|P2|NOT COMPLETED|Overall Study||10
357923|NCT01211769|857646|P1|NOT COMPLETED|Overall Study||9
357924|NCT01211769|857643|P4|COMPLETED|Overall Study||9
357925|NCT01211769|857644|P3|COMPLETED|Overall Study||12
357926|NCT01211769|857645|P2|COMPLETED|Overall Study||10
357927|NCT01211769|857646|P1|COMPLETED|Overall Study||11
357928|NCT01211769|857643|P4|Participants/Group|Overall Study||20
357929|NCT01211769|857644|P3|Participants/Group|Overall Study||20
357930|NCT01211769|857645|P2|Participants/Group|Overall Study||20
357931|NCT01211769|857646|P1|Participants/Group|Overall Study||20
357932|NCT01211769|857643|P4|STARTED|Overall Study||20
357933|NCT01211769|857644|P3|STARTED|Overall Study||20
357934|NCT01211769|857645|P2|STARTED|Overall Study||20
357935|NCT01211769|857646|P1|STARTED|Overall Study||20
357936|NCT01211730|857666|P2|NOT COMPLETED|Overall Study||0
357937|NCT01211730|857667|P1|NOT COMPLETED|Overall Study||0
357938|NCT01211730|857666|P2|COMPLETED|Overall Study||82
357939|NCT01211730|857667|P1|COMPLETED|Overall Study||82
357940|NCT01211730|857666|P2|STARTED|Overall Study||82
357941|NCT01211730|857667|P1|STARTED|Overall Study||82
357942|NCT01211665|857685|P2|NOT COMPLETED|Overall Study||0
357943|NCT01211665|857686|P1|NOT COMPLETED|Overall Study||2
357944|NCT01211665|857685|P2|COMPLETED|Overall Study|completed treatment with study drug|1
357945|NCT01211665|857686|P1|COMPLETED|Overall Study||0
357946|NCT01211665|857685|P2|STARTED|Overall Study||1
357947|NCT01211665|857686|P1|STARTED|Overall Study||2
357948|NCT01211613|857713|P3|NOT COMPLETED|Overall Study||2
357949|NCT01211613|857714|P2|NOT COMPLETED|Overall Study||2
357950|NCT01211613|857715|P1|NOT COMPLETED|Overall Study||3
357951|NCT01211613|857713|P3|COMPLETED|Overall Study||33
357952|NCT01211613|857714|P2|COMPLETED|Overall Study||33
357953|NCT01211613|857715|P1|COMPLETED|Overall Study||34
357954|NCT01211613|857713|P3|STARTED|Overall Study||35
357955|NCT01211613|857714|P2|STARTED|Overall Study||35
357956|NCT01211613|857715|P1|STARTED|Overall Study||37
357957|NCT01211535|857728|P2|NOT COMPLETED|Overall Study||1
357958|NCT01211535|857729|P1|NOT COMPLETED|Overall Study||0
357959|NCT01211535|857728|P2|COMPLETED|Overall Study||51
357960|NCT01211535|857729|P1|COMPLETED|Overall Study||52
357961|NCT01211535|857728|P2|STARTED|Overall Study||52
357962|NCT01211535|857729|P1|STARTED|Overall Study||52
357963|NCT01211197|857735|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
357964|NCT01211197|857736|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
357965|NCT01211197|857737|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
357966|NCT01211197|857738|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
357967|NCT01211197|857739|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
357968|NCT01211197|857740|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
357969|NCT01211197|857735|P6|COMPLETED|Treatment Period 3 (1 Day)||2
357970|NCT01211197|857736|P5|COMPLETED|Treatment Period 3 (1 Day)||2
357971|NCT01211197|857737|P4|COMPLETED|Treatment Period 3 (1 Day)||3
357972|NCT01211197|857738|P3|COMPLETED|Treatment Period 3 (1 Day)||2
357973|NCT01211197|857739|P2|COMPLETED|Treatment Period 3 (1 Day)||3
357974|NCT01211197|857740|P1|COMPLETED|Treatment Period 3 (1 Day)||2
357975|NCT01211197|857735|P6|STARTED|Treatment Period 3 (1 Day)||2
357976|NCT01211197|857736|P5|STARTED|Treatment Period 3 (1 Day)||2
357977|NCT01211197|857737|P4|STARTED|Treatment Period 3 (1 Day)||3
357978|NCT01211197|857738|P3|STARTED|Treatment Period 3 (1 Day)||2
357979|NCT01211197|857739|P2|STARTED|Treatment Period 3 (1 Day)||3
357980|NCT01211197|857740|P1|STARTED|Treatment Period 3 (1 Day)||2
357981|NCT01211197|857735|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
357982|NCT01211197|857736|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
357983|NCT01211197|857737|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
357984|NCT01211197|857738|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
357985|NCT01211197|857739|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
357986|NCT01211197|857740|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
357987|NCT01211197|857735|P6|COMPLETED|Washout Period 2 (7 Days)||2
357988|NCT01211197|857736|P5|COMPLETED|Washout Period 2 (7 Days)||2
357989|NCT01211197|857737|P4|COMPLETED|Washout Period 2 (7 Days)||3
357990|NCT01211197|857738|P3|COMPLETED|Washout Period 2 (7 Days)||2
357991|NCT01211197|857739|P2|COMPLETED|Washout Period 2 (7 Days)||3
357992|NCT01211197|857740|P1|COMPLETED|Washout Period 2 (7 Days)||2
357993|NCT01211197|857735|P6|STARTED|Washout Period 2 (7 Days)||2
357994|NCT01211197|857736|P5|STARTED|Washout Period 2 (7 Days)||2
357995|NCT01211197|857737|P4|STARTED|Washout Period 2 (7 Days)||3
357996|NCT01211197|857738|P3|STARTED|Washout Period 2 (7 Days)||2
357997|NCT01211197|857739|P2|STARTED|Washout Period 2 (7 Days)||3
357998|NCT01211197|857740|P1|STARTED|Washout Period 2 (7 Days)||3
357999|NCT01211197|857735|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
358000|NCT01211197|857736|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
358001|NCT01211197|857737|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
358002|NCT01211197|857738|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
358003|NCT01211197|857739|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
358004|NCT01211197|857740|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
358005|NCT01211197|857735|P6|COMPLETED|Treatment Period 2 (1 Day)||2
358006|NCT01211197|857736|P5|COMPLETED|Treatment Period 2 (1 Day)||2
358007|NCT01211197|857737|P4|COMPLETED|Treatment Period 2 (1 Day)||3
358008|NCT01211197|857738|P3|COMPLETED|Treatment Period 2 (1 Day)||2
358009|NCT01211197|857739|P2|COMPLETED|Treatment Period 2 (1 Day)||3
358010|NCT01211197|857740|P1|COMPLETED|Treatment Period 2 (1 Day)||3
358011|NCT01211197|857735|P6|STARTED|Treatment Period 2 (1 Day)||2
358012|NCT01211197|857736|P5|STARTED|Treatment Period 2 (1 Day)||2
358013|NCT01211197|857737|P4|STARTED|Treatment Period 2 (1 Day)||3
358014|NCT01211197|857738|P3|STARTED|Treatment Period 2 (1 Day)||2
358015|NCT01211197|857739|P2|STARTED|Treatment Period 2 (1 Day)||3
358016|NCT01211197|857740|P1|STARTED|Treatment Period 2 (1 Day)||3
358017|NCT01211197|857735|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
358018|NCT01211197|857736|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
358019|NCT01211197|857737|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
358020|NCT01211197|857738|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
358021|NCT01211197|857739|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
358022|NCT01211197|857740|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
358023|NCT01211197|857735|P6|COMPLETED|Washout Period 1 (7 Days)||2
358024|NCT01211197|857736|P5|COMPLETED|Washout Period 1 (7 Days)||2
358025|NCT01211197|857737|P4|COMPLETED|Washout Period 1 (7 Days)||3
358026|NCT01211197|857738|P3|COMPLETED|Washout Period 1 (7 Days)||2
358027|NCT01211197|857739|P2|COMPLETED|Washout Period 1 (7 Days)||3
358028|NCT01211197|857740|P1|COMPLETED|Washout Period 1 (7 Days)||3
358029|NCT01211197|857735|P6|STARTED|Washout Period 1 (7 Days)||2
358030|NCT01211197|857736|P5|STARTED|Washout Period 1 (7 Days)||2
358031|NCT01211197|857737|P4|STARTED|Washout Period 1 (7 Days)||3
358032|NCT01211197|857738|P3|STARTED|Washout Period 1 (7 Days)||3
358033|NCT01211197|857739|P2|STARTED|Washout Period 1 (7 Days)||3
358034|NCT01211197|857740|P1|STARTED|Washout Period 1 (7 Days)||3
358035|NCT01211197|857735|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
358036|NCT01211197|857736|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
358037|NCT01211197|857737|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
358038|NCT01211197|857738|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
358039|NCT01211197|857739|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
358040|NCT01211197|857740|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
358041|NCT01211197|857735|P6|COMPLETED|Treatment Period 1 (1 Day)||2
358042|NCT01211197|857736|P5|COMPLETED|Treatment Period 1 (1 Day)||2
358043|NCT01211197|857737|P4|COMPLETED|Treatment Period 1 (1 Day)||3
358044|NCT01211197|857738|P3|COMPLETED|Treatment Period 1 (1 Day)||3
358045|NCT01211197|857739|P2|COMPLETED|Treatment Period 1 (1 Day)||3
358046|NCT01211197|857740|P1|COMPLETED|Treatment Period 1 (1 Day)||3
358047|NCT01211197|857735|P6|STARTED|Treatment Period 1 (1 Day)||2
358048|NCT01211197|857736|P5|STARTED|Treatment Period 1 (1 Day)||2
358049|NCT01211197|857737|P4|STARTED|Treatment Period 1 (1 Day)||3
358050|NCT01211197|857738|P3|STARTED|Treatment Period 1 (1 Day)||3
358051|NCT01211197|857739|P2|STARTED|Treatment Period 1 (1 Day)||3
358052|NCT01211197|857740|P1|STARTED|Treatment Period 1 (1 Day)||3
358053|NCT01211184|857787|P3|NOT COMPLETED|Overall Study||1
358054|NCT01211184|857788|P2|NOT COMPLETED|Overall Study||2
358055|NCT01211184|857789|P1|NOT COMPLETED|Overall Study||0
358056|NCT01211184|857787|P3|COMPLETED|Overall Study||19
358057|NCT01211184|857788|P2|COMPLETED|Overall Study||18
358058|NCT01211184|857789|P1|COMPLETED|Overall Study||20
358059|NCT01211184|857787|P3|STARTED|Overall Study||20
358060|NCT01211184|857788|P2|STARTED|Overall Study||20
358061|NCT01211184|857789|P1|STARTED|Overall Study||20
358062|NCT01211145|857804|P4|NOT COMPLETED|Overall Study||20
358063|NCT01211145|857805|P3|NOT COMPLETED|Overall Study||13
358064|NCT01211145|857806|P2|NOT COMPLETED|Overall Study||17
358065|NCT01211145|857807|P1|NOT COMPLETED|Overall Study||26
358066|NCT01211145|857804|P4|COMPLETED|Overall Study||268
358067|NCT01211145|857805|P3|COMPLETED|Overall Study||86
358068|NCT01211145|857806|P2|COMPLETED|Overall Study||98
358069|NCT01211145|857807|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
358070|NCT01211145|857804|P4|STARTED|Overall Study||288
358071|NCT01211145|857805|P3|STARTED|Overall Study||99
358072|NCT01211145|857806|P2|STARTED|Overall Study||115
358073|NCT01211145|857807|P1|STARTED|Overall Study||296
358074|NCT01211106|857839|P2|NOT COMPLETED|Overall Study||11
358075|NCT01211106|857840|P1|NOT COMPLETED|Overall Study||13
358076|NCT01211106|857839|P2|COMPLETED|Overall Study||77
358077|NCT01211106|857840|P1|COMPLETED|Overall Study||82
358078|NCT01211106|857839|P2|STARTED|Overall Study||88
358079|NCT01211106|857840|P1|STARTED|Overall Study||95
358080|NCT01210820|857850|P2|NOT COMPLETED|Overall Study||0
358081|NCT01210820|857851|P1|NOT COMPLETED|Overall Study||0
358082|NCT01210820|857850|P2|COMPLETED|Overall Study||4
358083|NCT01210820|857851|P1|COMPLETED|Overall Study||17
358084|NCT01210820|857850|P2|STARTED|Overall Study||4
358085|NCT01210820|857851|P1|STARTED|Overall Study||17
358086|NCT01210807|857861|P2|NOT COMPLETED|Overall Study||3
358087|NCT01210807|857862|P1|NOT COMPLETED|Overall Study||3
358088|NCT01210807|857861|P2|COMPLETED|Overall Study||31
358089|NCT01210807|857862|P1|COMPLETED|Overall Study||33
358090|NCT01210807|857861|P2|STARTED|Overall Study||34
358091|NCT01210807|857862|P1|STARTED|Overall Study||36
358092|NCT01210716|857870|P2|NOT COMPLETED|Second TPE Procedure||0
358093|NCT01210716|857871|P1|NOT COMPLETED|Second TPE Procedure||3
358094|NCT01210716|857870|P2|COMPLETED|Second TPE Procedure||15
358095|NCT01210716|857871|P1|COMPLETED|Second TPE Procedure||15
358096|NCT01210716|857870|P2|STARTED|Second TPE Procedure||15
358097|NCT01210716|857871|P1|STARTED|Second TPE Procedure||18
358098|NCT01210716|857870|P2|NOT COMPLETED|First TPE Procedure||2
358099|NCT01210716|857871|P1|NOT COMPLETED|First TPE Procedure||2
358100|NCT01210716|857870|P2|COMPLETED|First TPE Procedure||15
358101|NCT01210716|857871|P1|COMPLETED|First TPE Procedure||18
358102|NCT01210716|857870|P2|STARTED|First TPE Procedure||17
358103|NCT01210716|857871|P1|STARTED|First TPE Procedure||20
358104|NCT01210690|857877|P1|NOT COMPLETED|Overall Study||26
358105|NCT01210690|857877|P1|COMPLETED|Overall Study||75
358106|NCT01210690|857877|P1|STARTED|Overall Study||101
358107|NCT01210651|857892|P2|NOT COMPLETED|Overall Study||8
358108|NCT01210651|857893|P1|NOT COMPLETED|Overall Study||5
358109|NCT01210651|857892|P2|COMPLETED|Overall Study||10
358110|NCT01210651|857893|P1|COMPLETED|Overall Study||15
358111|NCT01210651|857892|P2|Number Attending 1st Assigned Session|Overall Study||12
358112|NCT01210651|857893|P1|Number Attending 1st Assigned Session|Overall Study||18
358113|NCT01210651|857892|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
358114|NCT01210651|857893|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
358115|NCT01210495|857911|P4|NOT COMPLETED|Overall Study||68
358116|NCT01210495|857912|P3|NOT COMPLETED|Overall Study||134
358117|NCT01210495|857913|P2|NOT COMPLETED|Overall Study||7
358118|NCT01210495|857914|P1|NOT COMPLETED|Overall Study||15
358119|NCT01210495|857911|P4|COMPLETED|Overall Study||0
358120|NCT01210495|857912|P3|COMPLETED|Overall Study||0
358121|NCT01210495|857913|P2|COMPLETED|Overall Study||0
358122|NCT01210495|857914|P1|COMPLETED|Overall Study||0
358123|NCT01210495|857911|P4|STARTED|Overall Study||68
358124|NCT01210495|857912|P3|STARTED|Overall Study||134
358125|NCT01210495|857913|P2|STARTED|Overall Study||7
358126|NCT01210495|857914|P1|STARTED|Overall Study||15
358127|NCT01210443|857976|P1|NOT COMPLETED|Overall Study||2
358128|NCT01210443|857976|P1|COMPLETED|Overall Study||0
358129|NCT01210443|857976|P1|STARTED|Overall Study||2
358130|NCT01210170|857984|P1|NOT COMPLETED|Overall Study||7
358131|NCT01210170|857984|P1|COMPLETED|Overall Study||15
358132|NCT01210170|857984|P1|STARTED|Overall Study||22
358133|NCT01210144|858000|P2|NOT COMPLETED|Overall Study||0
358134|NCT01210144|858001|P1|NOT COMPLETED|Overall Study||3
358135|NCT01210144|858000|P2|COMPLETED|Overall Study||11
358136|NCT01210144|858001|P1|COMPLETED|Overall Study||10
358137|NCT01210144|858000|P2|STARTED|Overall Study||11
358138|NCT01210144|858001|P1|STARTED|Overall Study||13
358139|NCT01210118|858023|P2|NOT COMPLETED|Overall Study||5
358140|NCT01210118|858024|P1|NOT COMPLETED|Overall Study||3
358141|NCT01210118|858023|P2|COMPLETED|Overall Study||42
358142|NCT01210118|858024|P1|COMPLETED|Overall Study||42
358143|NCT01210118|858023|P2|STARTED|Overall Study||47
358144|NCT01210118|858024|P1|STARTED|Overall Study||45
358145|NCT01210079|858038|P2|NOT COMPLETED|Overall Study||0
358146|NCT01210079|858039|P1|NOT COMPLETED|Overall Study||0
358147|NCT01210079|858038|P2|COMPLETED|Overall Study||16
358148|NCT01210079|858039|P1|COMPLETED|Overall Study||10
358149|NCT01210079|858038|P2|STARTED|Overall Study||16
358150|NCT01210079|858039|P1|STARTED|Overall Study||10
358151|NCT01210001|858048|P3|NOT COMPLETED|Overall Study||12
358152|NCT01210001|858049|P2|NOT COMPLETED|Overall Study||11
358153|NCT01210001|858050|P1|NOT COMPLETED|Overall Study||19
358154|NCT01210001|858048|P3|COMPLETED|Overall Study||156
358155|NCT01210001|858049|P2|COMPLETED|Overall Study||154
358156|NCT01210001|858050|P1|COMPLETED|Overall Study||147
358157|NCT01210001|858048|P3|STARTED|Overall Study||168
358158|NCT01210001|858049|P2|STARTED|Overall Study||165
358159|NCT01210001|858050|P1|STARTED|Overall Study||166
358160|NCT01209949|858070|P1|NOT COMPLETED|Overall Study||3
358161|NCT01209949|858070|P1|COMPLETED|Overall Study||27
358162|NCT01209949|858070|P1|STARTED|Overall Study||30
358163|NCT01209780|858080|P5|NOT COMPLETED|Overall Study||5
358164|NCT01209780|858081|P4|NOT COMPLETED|Overall Study||10
358165|NCT01209780|858082|P3|NOT COMPLETED|Overall Study||4
358166|NCT01209780|858083|P2|NOT COMPLETED|Overall Study||18
358167|NCT01209780|858084|P1|NOT COMPLETED|Overall Study||26
358168|NCT01209780|858080|P5|COMPLETED|Overall Study||407
358169|NCT01209780|858081|P4|COMPLETED|Overall Study||807
358170|NCT01209780|858082|P3|COMPLETED|Overall Study||44
358171|NCT01209780|858083|P2|COMPLETED|Overall Study||467
358172|NCT01209780|858084|P1|COMPLETED|Overall Study||1016
358173|NCT01209780|858080|P5|STARTED|Overall Study||412
358174|NCT01209780|858081|P4|STARTED|Overall Study||817
358175|NCT01209780|858082|P3|STARTED|Overall Study||48
358176|NCT01209780|858083|P2|STARTED|Overall Study||485
358177|NCT01209780|858084|P1|STARTED|Overall Study||1042
358178|NCT01209767|858110|P1|NOT COMPLETED|Overall Study||4
358179|NCT01209767|858110|P1|COMPLETED|Overall Study||18
358180|NCT01209767|858110|P1|STARTED|Overall Study||22
358181|NCT01209702|858120|P4|NOT COMPLETED|Overall Study||153
358182|NCT01209702|858121|P3|NOT COMPLETED|Overall Study||51
358183|NCT01209702|858122|P2|NOT COMPLETED|Overall Study||51
358184|NCT01209702|858123|P1|NOT COMPLETED|Overall Study||51
358185|NCT01209702|858120|P4|COMPLETED|Overall Study||0
358186|NCT01209702|858121|P3|COMPLETED|Overall Study||0
358187|NCT01209702|858122|P2|COMPLETED|Overall Study||0
358188|NCT01209702|858123|P1|COMPLETED|Overall Study||0
358189|NCT01209702|858120|P4|Completed 24 Weeks Treatment|Overall Study||10
358190|NCT01209702|858121|P3|Completed 24 Weeks Treatment|Overall Study||3
358191|NCT01209702|858122|P2|Completed 24 Weeks Treatment|Overall Study||28
358192|NCT01209702|858123|P1|Completed 24 Weeks Treatment|Overall Study||19
358193|NCT01209702|858120|P4|Completed 12 Weeks Treatment|Overall Study||59
358194|NCT01209702|858121|P3|Completed 12 Weeks Treatment|Overall Study||12
358195|NCT01209702|858122|P2|Completed 12 Weeks Treatment|Overall Study||48
358196|NCT01209702|858123|P1|Completed 12 Weeks Treatment|Overall Study||50
358197|NCT01209702|858120|P4|Escape or Switched to Tocilizumab|Overall Study||0
358198|NCT01209702|858121|P3|Escape or Switched to Tocilizumab|Overall Study||6
358199|NCT01209702|858122|P2|Escape or Switched to Tocilizumab|Overall Study||0
358200|NCT01209702|858123|P1|Escape or Switched to Tocilizumab|Overall Study||51
358201|NCT01209702|858120|P4|Treated|Overall Study||152
358202|NCT01209702|858121|P3|Treated|Overall Study||51
358203|NCT01209702|858122|P2|Treated|Overall Study||51
358204|NCT01209702|858123|P1|Treated|Overall Study||51
358205|NCT01209702|858120|P4|STARTED|Overall Study||153
358206|NCT01209702|858121|P3|STARTED|Overall Study||51
358207|NCT01209702|858122|P2|STARTED|Overall Study||51
358208|NCT01209702|858123|P1|STARTED|Overall Study||51
358209|NCT01209689|858179|P2|NOT COMPLETED|Overall Study||22
358210|NCT01209689|858180|P1|NOT COMPLETED|Overall Study||91
358211|NCT01209689|858179|P2|COMPLETED|Overall Study||0
358212|NCT01209689|858180|P1|COMPLETED|Overall Study||0
358213|NCT01209689|858179|P2|STARTED|Overall Study||22
358214|NCT01209689|858180|P1|STARTED|Overall Study||91
358215|NCT01209624|858186|P1|NOT COMPLETED|Overall Study||326
358216|NCT01209624|858186|P1|COMPLETED|Overall Study||576
358217|NCT01209624|858186|P1|Per Protocol Population|Overall Study||469
358218|NCT01209624|858186|P1|STARTED|Overall Study||902
358219|NCT01209520|858217|P1|NOT COMPLETED|Overall Study||3
358220|NCT01209520|858217|P1|COMPLETED|Overall Study||3
358221|NCT01209520|858217|P1|STARTED|Overall Study||6
358222|NCT01209286|858225|P3|NOT COMPLETED|Overall Study||3
358223|NCT01209286|858226|P2|NOT COMPLETED|Overall Study||10
358224|NCT01209286|858227|P1|NOT COMPLETED|Overall Study||5
358225|NCT01209286|858225|P3|COMPLETED|Overall Study||3
358226|NCT01209286|858226|P2|COMPLETED|Overall Study||13
358227|NCT01209286|858227|P1|COMPLETED|Overall Study||2
358228|NCT01209286|858225|P3|STARTED|Overall Study||6
358229|NCT01209286|858226|P2|STARTED|Overall Study||23
358230|NCT01209286|858227|P1|STARTED|Overall Study||7
358231|NCT01209260|858280|P2|NOT COMPLETED|Overall Study||0
358232|NCT01209260|858281|P1|NOT COMPLETED|Overall Study||0
358233|NCT01209260|858280|P2|COMPLETED|Overall Study||36
358234|NCT01209260|858281|P1|COMPLETED|Overall Study||36
358235|NCT01209260|858280|P2|STARTED|Overall Study||36
358236|NCT01209260|858281|P1|STARTED|Overall Study||36
358237|NCT01209195|858295|P6|NOT COMPLETED|Overall Study||0
358238|NCT01209195|858296|P5|NOT COMPLETED|Overall Study||0
358239|NCT01209195|858297|P4|NOT COMPLETED|Overall Study||0
358240|NCT01209195|858298|P3|NOT COMPLETED|Overall Study||0
358241|NCT01209195|858299|P2|NOT COMPLETED|Overall Study||0
358242|NCT01209195|858300|P1|NOT COMPLETED|Overall Study||0
358243|NCT01209195|858295|P6|COMPLETED|Overall Study||13
358244|NCT01209195|858296|P5|COMPLETED|Overall Study||6
358245|NCT01209195|858297|P4|COMPLETED|Overall Study||6
358246|NCT01209195|858298|P3|COMPLETED|Overall Study||6
358247|NCT01209195|858299|P2|COMPLETED|Overall Study||3
358248|NCT01209195|858300|P1|COMPLETED|Overall Study||7
358249|NCT01209195|858295|P6|STARTED|Overall Study||13
358250|NCT01209195|858296|P5|STARTED|Overall Study||6
358251|NCT01209195|858297|P4|STARTED|Overall Study||6
358252|NCT01209195|858298|P3|STARTED|Overall Study||6
358253|NCT01209195|858299|P2|STARTED|Overall Study||3
358254|NCT01209195|858300|P1|STARTED|Overall Study||7
358255|NCT01208402|858336|P2|NOT COMPLETED|Overall Study||0
358256|NCT01208402|858337|P1|NOT COMPLETED|Overall Study||1
358257|NCT01208402|858336|P2|COMPLETED|Overall Study||28
358258|NCT01208402|858337|P1|COMPLETED|Overall Study||30
358259|NCT01208402|858336|P2|STARTED|Overall Study||28
358260|NCT01208402|858337|P1|STARTED|Overall Study||31
358261|NCT01208337|858353|P1|NOT COMPLETED|Overall Study||3
358262|NCT01208337|858353|P1|COMPLETED|Overall Study||20
358263|NCT01208337|858353|P1|Five-year Follow-up|Overall Study||20
358264|NCT01208337|858353|P1|One-year Follow-up|Overall Study||23
358265|NCT01208337|858353|P1|STARTED|Overall Study||23
358266|NCT01209143|858363|P2|NOT COMPLETED|Overall Study||20
358267|NCT01209143|858364|P1|NOT COMPLETED|Overall Study||19
358268|NCT01209143|858363|P2|COMPLETED|Overall Study||8
358269|NCT01209143|858364|P1|COMPLETED|Overall Study||5
358270|NCT01209143|858363|P2|STARTED|Overall Study||28
358271|NCT01209143|858364|P1|STARTED|Overall Study||24
358272|NCT01208961|858372|P2|NOT COMPLETED|High-Fat Period IV||0
358273|NCT01208961|858373|P1|NOT COMPLETED|High-Fat Period IV||0
358274|NCT01208961|858372|P2|COMPLETED|High-Fat Period IV||26
358275|NCT01208961|858373|P1|COMPLETED|High-Fat Period IV||25
358276|NCT01208961|858372|P2|STARTED|High-Fat Period IV||26
358277|NCT01208961|858373|P1|STARTED|High-Fat Period IV||25
358278|NCT01208961|858372|P2|NOT COMPLETED|High-Fat Period III||0
358279|NCT01208961|858373|P1|NOT COMPLETED|High-Fat Period III||1
358280|NCT01208961|858372|P2|COMPLETED|High-Fat Period III||26
358281|NCT01208961|858373|P1|COMPLETED|High-Fat Period III||25
358282|NCT01208961|858372|P2|STARTED|High-Fat Period III||26
358283|NCT01208961|858373|P1|STARTED|High-Fat Period III||26
358284|NCT01208961|858372|P2|NOT COMPLETED|Low-Fat Period II||0
358285|NCT01208961|858373|P1|NOT COMPLETED|Low-Fat Period II||0
358286|NCT01208961|858372|P2|COMPLETED|Low-Fat Period II||27
358287|NCT01208961|858373|P1|COMPLETED|Low-Fat Period II||26
358288|NCT01208961|858372|P2|STARTED|Low-Fat Period II||27
358289|NCT01208961|858373|P1|STARTED|Low-Fat Period II||26
358290|NCT01208961|858372|P2|NOT COMPLETED|Low-Fat Period I||0
358291|NCT01208961|858373|P1|NOT COMPLETED|Low-Fat Period I||0
358292|NCT01208961|858372|P2|COMPLETED|Low-Fat Period I||27
358293|NCT01208961|858373|P1|COMPLETED|Low-Fat Period I||27
358294|NCT01208961|858372|P2|STARTED|Low-Fat Period I||27
358295|NCT01208961|858373|P1|STARTED|Low-Fat Period I||27
358296|NCT01208233|858388|P6|NOT COMPLETED|Overall Study||21
358297|NCT01208233|858389|P5|NOT COMPLETED|Overall Study||24
358298|NCT01208233|858390|P4|NOT COMPLETED|Overall Study||1
358299|NCT01208233|858391|P3|NOT COMPLETED|Overall Study||4
358300|NCT01208233|858392|P2|NOT COMPLETED|Overall Study||3
358301|NCT01208233|858393|P1|NOT COMPLETED|Overall Study||5
358302|NCT01208233|858388|P6|COMPLETED|Overall Study||46
358303|NCT01208233|858389|P5|COMPLETED|Overall Study||46
358304|NCT01208233|858390|P4|COMPLETED|Overall Study||9
358305|NCT01208233|858391|P3|COMPLETED|Overall Study||7
358306|NCT01208233|858392|P2|COMPLETED|Overall Study||6
358307|NCT01208233|858393|P1|COMPLETED|Overall Study||6
358308|NCT01208233|858388|P6|STARTED|Overall Study||67
358309|NCT01208233|858389|P5|STARTED|Overall Study||70
358310|NCT01208233|858390|P4|STARTED|Overall Study||10
358311|NCT01208233|858391|P3|STARTED|Overall Study||11
358312|NCT01208233|858392|P2|STARTED|Overall Study||9
358313|NCT01208233|858393|P1|STARTED|Overall Study||11
358314|NCT01208220|858506|P2|NOT COMPLETED|Overall Study||0
358315|NCT01208220|858507|P1|NOT COMPLETED|Overall Study||0
358316|NCT01208220|858506|P2|COMPLETED|Overall Study||1
358317|NCT01208220|858507|P1|COMPLETED|Overall Study||1
358318|NCT01208220|858506|P2|STARTED|Overall Study||1
358319|NCT01208220|858507|P1|STARTED|Overall Study||1
358320|NCT01208207|858518|P7|NOT COMPLETED|Part II||11
358321|NCT01208207|858519|P6|NOT COMPLETED|Part II||16
358322|NCT01208207|858520|P5|NOT COMPLETED|Part II||23
358323|NCT01208207|858521|P4|NOT COMPLETED|Part II||32
358324|NCT01208207|858522|P3|NOT COMPLETED|Part II||0
358325|NCT01208207|858523|P2|NOT COMPLETED|Part II||0
358326|NCT01208207|858524|P1|NOT COMPLETED|Part II||0
358327|NCT01208207|858518|P7|COMPLETED|Part II||131
358328|NCT01208207|858519|P6|COMPLETED|Part II||129
358329|NCT01208207|858520|P5|COMPLETED|Part II||295
358330|NCT01208207|858521|P4|COMPLETED|Part II||282
358331|NCT01208207|858522|P3|COMPLETED|Part II||0
358332|NCT01208207|858523|P2|COMPLETED|Part II||0
358333|NCT01208207|858524|P1|COMPLETED|Part II||0
358334|NCT01208207|858518|P7|STARTED|Part II||142
358335|NCT01208207|858519|P6|STARTED|Part II||145
358336|NCT01208207|858520|P5|STARTED|Part II||318
358337|NCT01208207|858521|P4|STARTED|Part II||314
358338|NCT01208207|858522|P3|STARTED|Part II||0
358339|NCT01208207|858523|P2|STARTED|Part II||0
358340|NCT01208207|858524|P1|STARTED|Part II||0
358341|NCT01208207|858518|P7|NOT COMPLETED|Part I||0
358342|NCT01208207|858519|P6|NOT COMPLETED|Part I||0
358343|NCT01208207|858520|P5|NOT COMPLETED|Part I||0
358344|NCT01208207|858521|P4|NOT COMPLETED|Part I||0
358345|NCT01208207|858522|P3|NOT COMPLETED|Part I||15
358346|NCT01208207|858523|P2|NOT COMPLETED|Part I||11
358347|NCT01208207|858524|P1|NOT COMPLETED|Part I||70
358348|NCT01208207|858518|P7|COMPLETED|Part I||0
358349|NCT01208207|858519|P6|COMPLETED|Part I||0
358350|NCT01208207|858520|P5|COMPLETED|Part I||0
358351|NCT01208207|858521|P4|COMPLETED|Part I||0
358352|NCT01208207|858522|P3|COMPLETED|Part I||142
358353|NCT01208207|858523|P2|COMPLETED|Part I||145
358354|NCT01208207|858524|P1|COMPLETED|Part I||632
358355|NCT01208207|858518|P7|STARTED|Part I||0
358356|NCT01208207|858519|P6|STARTED|Part I||0
358357|NCT01208207|858520|P5|STARTED|Part I||0
358358|NCT01208207|858521|P4|STARTED|Part I||0
358359|NCT01208207|858522|P3|STARTED|Part I||157
358360|NCT01208207|858523|P2|STARTED|Part I||156
358361|NCT01208207|858524|P1|STARTED|Part I||702
358362|NCT01208181|858551|P5|NOT COMPLETED|Part 2||0
358363|NCT01208181|858552|P4|NOT COMPLETED|Part 2||20
358364|NCT01208181|858553|P3|NOT COMPLETED|Part 2||16
358365|NCT01208181|858554|P2|NOT COMPLETED|Part 2||0
358366|NCT01208181|858555|P1|NOT COMPLETED|Part 2||0
358367|NCT01208181|858551|P5|COMPLETED|Part 2||0
358368|NCT01208181|858552|P4|COMPLETED|Part 2||343
358369|NCT01208181|858553|P3|COMPLETED|Part 2||334
358370|NCT01208181|858554|P2|COMPLETED|Part 2||0
358371|NCT01208181|858555|P1|COMPLETED|Part 2||0
358372|NCT01208181|858551|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
358373|NCT01208181|858552|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
358374|NCT01208181|858553|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
358375|NCT01208181|858554|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
358376|NCT01208181|858555|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
358377|NCT01208181|858551|P5|NOT COMPLETED|Part 1||22
358378|NCT01208181|858552|P4|NOT COMPLETED|Part 1||0
358379|NCT01208181|858553|P3|NOT COMPLETED|Part 1||0
358380|NCT01208181|858554|P2|NOT COMPLETED|Part 1||55
358381|NCT01208181|858555|P1|NOT COMPLETED|Part 1||99
358382|NCT01208181|858551|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
358383|NCT01208181|858552|P4|COMPLETED|Part 1||0
358384|NCT01208181|858553|P3|COMPLETED|Part 1||0
358385|NCT01208181|858554|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
358386|NCT01208181|858555|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
358387|NCT01208181|858551|P5|STARTED|Part 1||118
358388|NCT01208181|858552|P4|STARTED|Part 1||0
358389|NCT01208181|858553|P3|STARTED|Part 1||0
358390|NCT01208181|858554|P2|STARTED|Part 1||468
358391|NCT01208181|858555|P1|STARTED|Part 1||818
358392|NCT01207934|858587|P3|NOT COMPLETED|Overall Study||0
358393|NCT01207934|858588|P2|NOT COMPLETED|Overall Study||0
358394|NCT01207934|858589|P1|NOT COMPLETED|Overall Study||0
358395|NCT01207934|858587|P3|COMPLETED|Overall Study||6
358396|NCT01207934|858588|P2|COMPLETED|Overall Study||6
358397|NCT01207934|858589|P1|COMPLETED|Overall Study||6
358398|NCT01207934|858587|P3|STARTED|Overall Study||6
358399|NCT01207934|858588|P2|STARTED|Overall Study||6
358400|NCT01207934|858589|P1|STARTED|Overall Study||6
358401|NCT01207765|858606|P1|NOT COMPLETED|Overall Study||0
358402|NCT01207765|858606|P1|COMPLETED|Overall Study||8
358403|NCT01207765|858606|P1|STARTED|Overall Study||8
358404|NCT01207648|858612|P1|NOT COMPLETED|Overall Study||0
358405|NCT01207648|858612|P1|COMPLETED|Overall Study||307
358406|NCT01207648|858612|P1|STARTED|Overall Study||307
358407|NCT01207596|858620|P1|NOT COMPLETED|Overall Study||9
358408|NCT01207596|858620|P1|COMPLETED|Overall Study||21
358409|NCT01207596|858620|P1|STARTED|Overall Study||30
358410|NCT01207583|858633|P3|NOT COMPLETED|Overall Study||1
358411|NCT01207583|858634|P2|NOT COMPLETED|Overall Study||5
358412|NCT01207583|858635|P1|NOT COMPLETED|Overall Study||1
358413|NCT01207583|858633|P3|COMPLETED|Overall Study||54
358414|NCT01207583|858634|P2|COMPLETED|Overall Study||26
358415|NCT01207583|858635|P1|COMPLETED|Overall Study||13
358416|NCT01207583|858633|P3|Dose 4|Overall Study||0
358417|NCT01207583|858634|P2|Dose 4|Overall Study||0
358418|NCT01207583|858635|P1|Dose 4|Overall Study||7
358419|NCT01207583|858633|P3|Dose 3|Overall Study||0
358420|NCT01207583|858634|P2|Dose 3|Overall Study||27
358421|NCT01207583|858635|P1|Dose 3|Overall Study||13
358422|NCT01207583|858633|P3|Dose 2|Overall Study||54
358423|NCT01207583|858634|P2|Dose 2|Overall Study||29
358424|NCT01207583|858635|P1|Dose 2|Overall Study||13
358425|NCT01207583|858633|P3|Dose 1|Overall Study||55
358426|NCT01207583|858634|P2|Dose 1|Overall Study||31
358427|NCT01207583|858635|P1|Dose 1|Overall Study||14
358428|NCT01207583|858633|P3|STARTED|Overall Study||55
358429|NCT01207583|858634|P2|STARTED|Overall Study||31
358430|NCT01207583|858635|P1|STARTED|Overall Study||14
358431|NCT01207570|858675|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
358432|NCT01207570|858676|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
358433|NCT01207570|858675|P2|COMPLETED|The Second Stage (After Crossover)||23
358434|NCT01207570|858676|P1|COMPLETED|The Second Stage (After Crossover)||31
358435|NCT01207570|858675|P2|STARTED|The Second Stage (After Crossover)||23
358436|NCT01207570|858676|P1|STARTED|The Second Stage (After Crossover)||31
358437|NCT01207570|858675|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
358438|NCT01207570|858676|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
358439|NCT01207570|858675|P2|COMPLETED|The First Stage (Before Crossover)||31
358440|NCT01207570|858676|P1|COMPLETED|The First Stage (Before Crossover)||23
358441|NCT01207570|858675|P2|STARTED|The First Stage (Before Crossover)||31
358442|NCT01207570|858676|P1|STARTED|The First Stage (Before Crossover)||23
358443|NCT01207492|858688|P1|NOT COMPLETED|Overall Study||15
358444|NCT01207492|858688|P1|COMPLETED|Overall Study||2
358445|NCT01207492|858688|P1|STARTED|Overall Study||17
358446|NCT01207466|858694|P2|NOT COMPLETED|Period 2, One Week of Wear||0
358447|NCT01207466|858695|P1|NOT COMPLETED|Period 2, One Week of Wear||0
358448|NCT01207466|858694|P2|COMPLETED|Period 2, One Week of Wear||48
358449|NCT01207466|858695|P1|COMPLETED|Period 2, One Week of Wear||45
358450|NCT01207466|858694|P2|STARTED|Period 2, One Week of Wear||48
358451|NCT01207466|858695|P1|STARTED|Period 2, One Week of Wear||45
358452|NCT01207466|858694|P2|NOT COMPLETED|Period 1, One Week of Wear||0
358453|NCT01207466|858695|P1|NOT COMPLETED|Period 1, One Week of Wear||0
358454|NCT01207466|858694|P2|COMPLETED|Period 1, One Week of Wear||48
358455|NCT01207466|858695|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
358456|NCT01207466|858694|P2|STARTED|Period 1, One Week of Wear||48
358457|NCT01207466|858695|P1|STARTED|Period 1, One Week of Wear||46
358458|NCT01207453|858703|P2|NOT COMPLETED|2nd Intervention||2
358459|NCT01207453|858704|P1|NOT COMPLETED|2nd Intervention||2
358460|NCT01207453|858703|P2|COMPLETED|2nd Intervention||15
358461|NCT01207453|858704|P1|COMPLETED|2nd Intervention||17
358462|NCT01207453|858703|P2|STARTED|2nd Intervention||17
358463|NCT01207453|858704|P1|STARTED|2nd Intervention||19
358464|NCT01207453|858703|P2|NOT COMPLETED|Washout||0
358465|NCT01207453|858704|P1|NOT COMPLETED|Washout||2
358466|NCT01207453|858703|P2|COMPLETED|Washout||17
358467|NCT01207453|858704|P1|COMPLETED|Washout||19
358468|NCT01207453|858703|P2|STARTED|Washout||17
358469|NCT01207453|858704|P1|STARTED|Washout||21
358470|NCT01207453|858703|P2|NOT COMPLETED|First Intervention||1
358471|NCT01207453|858704|P1|NOT COMPLETED|First Intervention||2
358472|NCT01207453|858703|P2|COMPLETED|First Intervention||17
358473|NCT01207453|858704|P1|COMPLETED|First Intervention||21
358474|NCT01207453|858703|P2|STARTED|First Intervention||18
358475|NCT01207453|858704|P1|STARTED|First Intervention||23
358476|NCT01207427|858726|P3|NOT COMPLETED|Run-out Placebo Period||0
358477|NCT01207427|858727|P2|NOT COMPLETED|Run-out Placebo Period||0
358478|NCT01207427|858728|P1|NOT COMPLETED|Run-out Placebo Period||0
358479|NCT01207427|858726|P3|COMPLETED|Run-out Placebo Period||41
358480|NCT01207427|858727|P2|COMPLETED|Run-out Placebo Period||43
358481|NCT01207427|858728|P1|COMPLETED|Run-out Placebo Period||40
358482|NCT01207427|858726|P3|STARTED|Run-out Placebo Period||41
358483|NCT01207427|858727|P2|STARTED|Run-out Placebo Period||43
358484|NCT01207427|858728|P1|STARTED|Run-out Placebo Period||40
358485|NCT01207427|858726|P3|NOT COMPLETED|Double-blind Treatment Period||2
358486|NCT01207427|858727|P2|NOT COMPLETED|Double-blind Treatment Period||2
358487|NCT01207427|858728|P1|NOT COMPLETED|Double-blind Treatment Period||3
358488|NCT01207427|858726|P3|COMPLETED|Double-blind Treatment Period||41
358489|NCT01207427|858727|P2|COMPLETED|Double-blind Treatment Period||43
358490|NCT01207427|858728|P1|COMPLETED|Double-blind Treatment Period||40
358491|NCT01207427|858726|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
358584|NCT01206517|858906|P3|COMPLETED|Overall Study||4
358492|NCT01207427|858727|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
358493|NCT01207427|858728|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
358494|NCT01207427|858726|P3|STARTED|Double-blind Treatment Period||43
358495|NCT01207427|858727|P2|STARTED|Double-blind Treatment Period||45
358496|NCT01207427|858728|P1|STARTED|Double-blind Treatment Period||43
358497|NCT01207427|858726|P3|NOT COMPLETED|Run-in Placebo Period||0
358498|NCT01207427|858727|P2|NOT COMPLETED|Run-in Placebo Period||0
358499|NCT01207427|858728|P1|NOT COMPLETED|Run-in Placebo Period||0
358500|NCT01207427|858726|P3|COMPLETED|Run-in Placebo Period||43
358501|NCT01207427|858727|P2|COMPLETED|Run-in Placebo Period||45
358502|NCT01207427|858728|P1|COMPLETED|Run-in Placebo Period||43
358503|NCT01207427|858726|P3|STARTED|Run-in Placebo Period||43
358504|NCT01207427|858727|P2|STARTED|Run-in Placebo Period||45
358505|NCT01207427|858728|P1|STARTED|Run-in Placebo Period||43
358506|NCT01207414|858738|P2|NOT COMPLETED|Overall Study||82
358507|NCT01207414|858739|P1|NOT COMPLETED|Overall Study||73
358508|NCT01207414|858738|P2|COMPLETED|Overall Study||178
358509|NCT01207414|858739|P1|COMPLETED|Overall Study||168
358510|NCT01207414|858738|P2|Safety Population: Received Study Drug|Overall Study||260
358511|NCT01207414|858739|P1|Safety Population: Received Study Drug|Overall Study||240
358512|NCT01207414|858738|P2|STARTED|Overall Study||260
358513|NCT01207414|858739|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
358514|NCT01207401|858757|P2|NOT COMPLETED|Overall Study||0
358515|NCT01207401|858758|P1|NOT COMPLETED|Overall Study||0
358516|NCT01207401|858757|P2|COMPLETED|Overall Study||24
358517|NCT01207401|858758|P1|COMPLETED|Overall Study||26
358518|NCT01207401|858757|P2|STARTED|Overall Study||24
358519|NCT01207401|858758|P1|STARTED|Overall Study||26
358520|NCT01207388|858764|P1|NOT COMPLETED|Overall Study||33
358521|NCT01207388|858764|P1|COMPLETED|Overall Study|Completed the core study|83
358522|NCT01207388|858764|P1|STARTED|Overall Study||116
358523|NCT01207219|858787|P3|NOT COMPLETED|Overall Study||7
358524|NCT01207219|858788|P2|NOT COMPLETED|Overall Study||11
358525|NCT01207219|858789|P1|NOT COMPLETED|Overall Study||11
358526|NCT01207219|858787|P3|COMPLETED|Overall Study||32
358527|NCT01207219|858788|P2|COMPLETED|Overall Study||29
358528|NCT01207219|858789|P1|COMPLETED|Overall Study||34
358529|NCT01207219|858787|P3|Included in ITT Analysis|Overall Study||38
358530|NCT01207219|858788|P2|Included in ITT Analysis|Overall Study||37
358531|NCT01207219|858789|P1|Included in ITT Analysis|Overall Study||40
358532|NCT01207219|858787|P3|STARTED|Overall Study||39
358533|NCT01207219|858788|P2|STARTED|Overall Study||40
358534|NCT01207219|858789|P1|STARTED|Overall Study||45
358535|NCT01207102|858809|P1|NOT COMPLETED|Overall Study||10
358536|NCT01207102|858809|P1|COMPLETED|Overall Study||0
358537|NCT01207102|858809|P1|STARTED|Overall Study||10
358538|NCT01206777|858814|P1|NOT COMPLETED|Overall Study||2
358539|NCT01206777|858814|P1|COMPLETED|Overall Study||50
358540|NCT01206777|858814|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
358541|NCT01206777|858814|P1|STARTED|Overall Study||52
358542|NCT01206738|858823|P3|NOT COMPLETED|Overall Study||19
358543|NCT01206738|858824|P2|NOT COMPLETED|Overall Study||25
358544|NCT01206738|858825|P1|NOT COMPLETED|Overall Study||23
358545|NCT01206738|858823|P3|COMPLETED|Overall Study||42
358546|NCT01206738|858824|P2|COMPLETED|Overall Study||49
358547|NCT01206738|858825|P1|COMPLETED|Overall Study||40
358548|NCT01206738|858823|P3|STARTED|Overall Study||61
358549|NCT01206738|858824|P2|STARTED|Overall Study||74
358550|NCT01206738|858825|P1|STARTED|Overall Study||63
358551|NCT01206660|858837|P2|NOT COMPLETED|Overall Study||0
358552|NCT01206660|858838|P1|NOT COMPLETED|Overall Study||0
358553|NCT01206660|858837|P2|COMPLETED|Overall Study||60
358554|NCT01206660|858838|P1|COMPLETED|Overall Study||60
358555|NCT01206660|858837|P2|STARTED|Overall Study||60
358556|NCT01206660|858838|P1|STARTED|Overall Study||60
358557|NCT01206608|858850|P2|NOT COMPLETED|Overall Study||0
358558|NCT01206608|858851|P1|NOT COMPLETED|Overall Study||0
358559|NCT01206608|858850|P2|COMPLETED|Overall Study||20
358560|NCT01206608|858851|P1|COMPLETED|Overall Study||20
358561|NCT01206608|858850|P2|STARTED|Overall Study||20
358562|NCT01206608|858851|P1|STARTED|Overall Study||20
358563|NCT01206595|858859|P2|NOT COMPLETED|Overall Study||0
358564|NCT01206595|858860|P1|NOT COMPLETED|Overall Study||0
358565|NCT01206595|858859|P2|COMPLETED|Overall Study||20
358566|NCT01206595|858860|P1|COMPLETED|Overall Study||38
358567|NCT01206595|858859|P2|STARTED|Overall Study||20
358568|NCT01206595|858860|P1|STARTED|Overall Study||38
358569|NCT01206582|858870|P2|NOT COMPLETED|Overall Study||2
358570|NCT01206582|858871|P1|NOT COMPLETED|Overall Study||2
358571|NCT01206582|858870|P2|COMPLETED|Overall Study||7
358572|NCT01206582|858871|P1|COMPLETED|Overall Study||9
358573|NCT01206582|858870|P2|STARTED|Overall Study||9
358574|NCT01206582|858871|P1|STARTED|Overall Study||11
358575|NCT01206517|858903|P6|NOT COMPLETED|Overall Study||0
358576|NCT01206517|858904|P5|NOT COMPLETED|Overall Study||1
358577|NCT01206517|858905|P4|NOT COMPLETED|Overall Study||0
358578|NCT01206517|858906|P3|NOT COMPLETED|Overall Study||2
358579|NCT01206517|858907|P2|NOT COMPLETED|Overall Study||0
358580|NCT01206517|858908|P1|NOT COMPLETED|Overall Study||0
358581|NCT01206517|858903|P6|COMPLETED|Overall Study||4
358582|NCT01206517|858904|P5|COMPLETED|Overall Study||3
358583|NCT01206517|858905|P4|COMPLETED|Overall Study||4
358585|NCT01206517|858907|P2|COMPLETED|Overall Study||6
358586|NCT01206517|858908|P1|COMPLETED|Overall Study||6
358587|NCT01206517|858903|P6|STARTED|Overall Study||4
358588|NCT01206517|858904|P5|STARTED|Overall Study||4
358589|NCT01206517|858905|P4|STARTED|Overall Study||4
358590|NCT01206517|858906|P3|STARTED|Overall Study||6
358591|NCT01206517|858907|P2|STARTED|Overall Study||6
358592|NCT01206517|858908|P1|STARTED|Overall Study||6
358593|NCT01206478|858939|P2|NOT COMPLETED|Overall Study||5
358594|NCT01206478|858940|P1|NOT COMPLETED|Overall Study||2
358595|NCT01206478|858939|P2|COMPLETED|Overall Study||7
358596|NCT01206478|858940|P1|COMPLETED|Overall Study||7
358597|NCT01206478|858939|P2|STARTED|Overall Study||12
358598|NCT01206478|858940|P1|STARTED|Overall Study||9
358599|NCT01206452|858950|P2|NOT COMPLETED|Overall Study||0
358600|NCT01206452|858951|P1|NOT COMPLETED|Overall Study||0
358601|NCT01206452|858950|P2|COMPLETED|Overall Study||30
358602|NCT01206452|858951|P1|COMPLETED|Overall Study||30
358603|NCT01206452|858950|P2|STARTED|Overall Study||30
358604|NCT01206452|858951|P1|STARTED|Overall Study||30
358605|NCT01206439|858965|P1|NOT COMPLETED|Overall Study||1
358606|NCT01206439|858965|P1|COMPLETED|Overall Study||1
358607|NCT01206439|858965|P1|STARTED|Overall Study||2
358608|NCT01206387|858971|P2|NOT COMPLETED|Overall Study||0
358609|NCT01206387|858972|P1|NOT COMPLETED|Overall Study||1
358610|NCT01206387|858971|P2|COMPLETED|Overall Study||60
358611|NCT01206387|858972|P1|COMPLETED|Overall Study||59
358612|NCT01206387|858971|P2|STARTED|Overall Study||60
358613|NCT01206387|858972|P1|STARTED|Overall Study||60
358614|NCT01206322|858988|P4|NOT COMPLETED|Overall Study||1
358615|NCT01206322|858989|P3|NOT COMPLETED|Overall Study||0
358616|NCT01206322|858990|P2|NOT COMPLETED|Overall Study||0
358617|NCT01206322|858991|P1|NOT COMPLETED|Overall Study||0
358618|NCT01206322|858988|P4|COMPLETED|Overall Study||5
358619|NCT01206322|858989|P3|COMPLETED|Overall Study||9
358620|NCT01206322|858990|P2|COMPLETED|Overall Study||11
358621|NCT01206322|858991|P1|COMPLETED|Overall Study||4
358622|NCT01206322|858988|P4|STARTED|Overall Study||6
358623|NCT01206322|858989|P3|STARTED|Overall Study||9
358624|NCT01206322|858990|P2|STARTED|Overall Study||11
358625|NCT01206322|858991|P1|STARTED|Overall Study||4
358626|NCT01206140|859007|P2|NOT COMPLETED|Overall Study||0
358627|NCT01206140|859008|P1|NOT COMPLETED|Overall Study||1
358628|NCT01206140|859007|P2|COMPLETED|Overall Study||35
358629|NCT01206140|859008|P1|COMPLETED|Overall Study||34
358630|NCT01206140|859007|P2|STARTED|Overall Study||35
358631|NCT01206140|859008|P1|STARTED|Overall Study||35
358632|NCT01206101|859020|P2|NOT COMPLETED|Overall Study||1
358633|NCT01206101|859021|P1|NOT COMPLETED|Overall Study||2
358634|NCT01206101|859020|P2|COMPLETED|Overall Study||0
358635|NCT01206101|859021|P1|COMPLETED|Overall Study||0
358636|NCT01206101|859020|P2|STARTED|Overall Study||1
358637|NCT01206101|859021|P1|STARTED|Overall Study||2
358638|NCT01205828|859037|P1|NOT COMPLETED|Overall Study||0
358639|NCT01205828|859037|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
358640|NCT01205828|859037|P1|STARTED|Overall Study||16
358641|NCT01205685|859045|P1|NOT COMPLETED|Overall Study||11
358642|NCT01205685|859045|P1|COMPLETED|Overall Study||0
358643|NCT01205685|859045|P1|STARTED|Overall Study||11
358644|NCT01205646|859052|P1|NOT COMPLETED|Overall Study||0
358645|NCT01205646|859052|P1|COMPLETED|Overall Study||11
358646|NCT01205646|859052|P1|STARTED|Overall Study||11
358647|NCT01205581|859062|P6|NOT COMPLETED|Overall Study||0
358648|NCT01205581|859063|P5|NOT COMPLETED|Overall Study||0
358649|NCT01205581|859064|P4|NOT COMPLETED|Overall Study||0
358650|NCT01205581|859065|P3|NOT COMPLETED|Overall Study||0
358651|NCT01205581|859066|P2|NOT COMPLETED|Overall Study||0
358652|NCT01205581|859067|P1|NOT COMPLETED|Overall Study||1
358653|NCT01205581|859062|P6|COMPLETED|Overall Study||20
358654|NCT01205581|859063|P5|COMPLETED|Overall Study||20
358655|NCT01205581|859064|P4|COMPLETED|Overall Study||9
358656|NCT01205581|859065|P3|COMPLETED|Overall Study||8
358657|NCT01205581|859066|P2|COMPLETED|Overall Study||13
358658|NCT01205581|859067|P1|COMPLETED|Overall Study||13
358659|NCT01205581|859062|P6|STARTED|Overall Study||20
358660|NCT01205581|859063|P5|STARTED|Overall Study||20
358661|NCT01205581|859064|P4|STARTED|Overall Study||9
358662|NCT01205581|859065|P3|STARTED|Overall Study||8
358663|NCT01205581|859066|P2|STARTED|Overall Study||13
358664|NCT01205581|859067|P1|STARTED|Overall Study||14
358665|NCT01205503|859133|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
358666|NCT01205503|859134|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
358667|NCT01205503|859133|P2|COMPLETED|Second Intervention (2nd Cycle)||16
358668|NCT01205503|859134|P1|COMPLETED|Second Intervention (2nd Cycle)||16
358669|NCT01205503|859133|P2|STARTED|Second Intervention (2nd Cycle)||16
358670|NCT01205503|859134|P1|STARTED|Second Intervention (2nd Cycle)||16
358671|NCT01205503|859133|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
358672|NCT01205503|859134|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
358673|NCT01205503|859133|P2|COMPLETED|First Intervention (1st Cycle)||16
358674|NCT01205503|859134|P1|COMPLETED|First Intervention (1st Cycle)||16
358675|NCT01205503|859133|P2|STARTED|First Intervention (1st Cycle)||16
358676|NCT01205503|859134|P1|STARTED|First Intervention (1st Cycle)||16
358677|NCT01205451|859150|P2|NOT COMPLETED|Overall Study||10
358678|NCT01205451|859151|P1|NOT COMPLETED|Overall Study||6
358679|NCT01205451|859150|P2|COMPLETED|Overall Study||46
358680|NCT01205451|859151|P1|COMPLETED|Overall Study||47
358681|NCT01205451|859150|P2|STARTED|Overall Study||56
358682|NCT01205451|859151|P1|STARTED|Overall Study||53
358683|NCT01205399|859193|P1|NOT COMPLETED|Overall Study||0
358684|NCT01205399|859193|P1|COMPLETED|Overall Study||78
358685|NCT01205399|859193|P1|STARTED|Overall Study||78
358686|NCT01205269|859199|P6|NOT COMPLETED|Period 5 - Third Intervention||0
358687|NCT01205269|859200|P5|NOT COMPLETED|Period 5 - Third Intervention||0
358688|NCT01205269|859201|P4|NOT COMPLETED|Period 5 - Third Intervention||0
358689|NCT01205269|859202|P3|NOT COMPLETED|Period 5 - Third Intervention||0
358690|NCT01205269|859203|P2|NOT COMPLETED|Period 5 - Third Intervention||0
358691|NCT01205269|859204|P1|NOT COMPLETED|Period 5 - Third Intervention||0
358692|NCT01205269|859199|P6|COMPLETED|Period 5 - Third Intervention||5
358693|NCT01205269|859200|P5|COMPLETED|Period 5 - Third Intervention||5
358694|NCT01205269|859201|P4|COMPLETED|Period 5 - Third Intervention||5
358695|NCT01205269|859202|P3|COMPLETED|Period 5 - Third Intervention||4
358696|NCT01205269|859203|P2|COMPLETED|Period 5 - Third Intervention||4
358697|NCT01205269|859204|P1|COMPLETED|Period 5 - Third Intervention||4
358698|NCT01205269|859199|P6|STARTED|Period 5 - Third Intervention||5
358699|NCT01205269|859200|P5|STARTED|Period 5 - Third Intervention||5
358700|NCT01205269|859201|P4|STARTED|Period 5 - Third Intervention||5
358701|NCT01205269|859202|P3|STARTED|Period 5 - Third Intervention||4
358702|NCT01205269|859203|P2|STARTED|Period 5 - Third Intervention||4
358703|NCT01205269|859204|P1|STARTED|Period 5 - Third Intervention||4
358704|NCT01205269|859199|P6|NOT COMPLETED|Period 4 - Washout||0
358705|NCT01205269|859200|P5|NOT COMPLETED|Period 4 - Washout||0
358706|NCT01205269|859201|P4|NOT COMPLETED|Period 4 - Washout||1
358707|NCT01205269|859202|P3|NOT COMPLETED|Period 4 - Washout||0
358708|NCT01205269|859203|P2|NOT COMPLETED|Period 4 - Washout||0
358709|NCT01205269|859204|P1|NOT COMPLETED|Period 4 - Washout||0
358710|NCT01205269|859199|P6|COMPLETED|Period 4 - Washout||5
358711|NCT01205269|859200|P5|COMPLETED|Period 4 - Washout||5
358712|NCT01205269|859201|P4|COMPLETED|Period 4 - Washout||5
358713|NCT01205269|859202|P3|COMPLETED|Period 4 - Washout||4
358714|NCT01205269|859203|P2|COMPLETED|Period 4 - Washout||4
358715|NCT01205269|859204|P1|COMPLETED|Period 4 - Washout||4
358716|NCT01205269|859199|P6|STARTED|Period 4 - Washout||5
358717|NCT01205269|859200|P5|STARTED|Period 4 - Washout||5
358718|NCT01205269|859201|P4|STARTED|Period 4 - Washout||6
358719|NCT01205269|859202|P3|STARTED|Period 4 - Washout||4
358720|NCT01205269|859203|P2|STARTED|Period 4 - Washout||4
358721|NCT01205269|859204|P1|STARTED|Period 4 - Washout||4
358722|NCT01205269|859199|P6|NOT COMPLETED|Period 3 - Second Intervention||0
358723|NCT01205269|859200|P5|NOT COMPLETED|Period 3 - Second Intervention||0
358724|NCT01205269|859201|P4|NOT COMPLETED|Period 3 - Second Intervention||0
358725|NCT01205269|859202|P3|NOT COMPLETED|Period 3 - Second Intervention||0
358726|NCT01205269|859203|P2|NOT COMPLETED|Period 3 - Second Intervention||0
358727|NCT01205269|859204|P1|NOT COMPLETED|Period 3 - Second Intervention||0
358728|NCT01205269|859199|P6|COMPLETED|Period 3 - Second Intervention||5
358729|NCT01205269|859200|P5|COMPLETED|Period 3 - Second Intervention||5
358730|NCT01205269|859201|P4|COMPLETED|Period 3 - Second Intervention||6
358731|NCT01205269|859202|P3|COMPLETED|Period 3 - Second Intervention||4
358732|NCT01205269|859203|P2|COMPLETED|Period 3 - Second Intervention||4
358733|NCT01205269|859204|P1|COMPLETED|Period 3 - Second Intervention||4
358734|NCT01205269|859199|P6|STARTED|Period 3 - Second Intervention||5
358735|NCT01205269|859200|P5|STARTED|Period 3 - Second Intervention||5
358736|NCT01205269|859201|P4|STARTED|Period 3 - Second Intervention||6
358737|NCT01205269|859202|P3|STARTED|Period 3 - Second Intervention||4
358738|NCT01205269|859203|P2|STARTED|Period 3 - Second Intervention||4
358739|NCT01205269|859204|P1|STARTED|Period 3 - Second Intervention||4
358740|NCT01205269|859199|P6|NOT COMPLETED|Period 2 - Washout||0
358741|NCT01205269|859200|P5|NOT COMPLETED|Period 2 - Washout||0
358742|NCT01205269|859201|P4|NOT COMPLETED|Period 2 - Washout||0
358743|NCT01205269|859202|P3|NOT COMPLETED|Period 2 - Washout||0
358744|NCT01205269|859203|P2|NOT COMPLETED|Period 2 - Washout||0
358745|NCT01205269|859204|P1|NOT COMPLETED|Period 2 - Washout||0
358746|NCT01205269|859199|P6|COMPLETED|Period 2 - Washout||5
358747|NCT01205269|859200|P5|COMPLETED|Period 2 - Washout||5
358748|NCT01205269|859201|P4|COMPLETED|Period 2 - Washout||6
358749|NCT01205269|859202|P3|COMPLETED|Period 2 - Washout||4
358750|NCT01205269|859203|P2|COMPLETED|Period 2 - Washout||4
358751|NCT01205269|859204|P1|COMPLETED|Period 2 - Washout||4
358752|NCT01205269|859199|P6|STARTED|Period 2 - Washout||5
358753|NCT01205269|859200|P5|STARTED|Period 2 - Washout||5
358754|NCT01205269|859201|P4|STARTED|Period 2 - Washout||6
358755|NCT01205269|859202|P3|STARTED|Period 2 - Washout||4
358756|NCT01205269|859203|P2|STARTED|Period 2 - Washout||4
358757|NCT01205269|859204|P1|STARTED|Period 2 - Washout||4
358758|NCT01205269|859199|P6|NOT COMPLETED|Period 1 - First Intervention||0
358759|NCT01205269|859200|P5|NOT COMPLETED|Period 1 - First Intervention||0
358760|NCT01205269|859201|P4|NOT COMPLETED|Period 1 - First Intervention||0
358761|NCT01205269|859202|P3|NOT COMPLETED|Period 1 - First Intervention||0
358762|NCT01205269|859203|P2|NOT COMPLETED|Period 1 - First Intervention||0
358763|NCT01205269|859204|P1|NOT COMPLETED|Period 1 - First Intervention||0
358764|NCT01205269|859199|P6|COMPLETED|Period 1 - First Intervention||5
358765|NCT01205269|859200|P5|COMPLETED|Period 1 - First Intervention||5
358766|NCT01205269|859201|P4|COMPLETED|Period 1 - First Intervention||6
358767|NCT01205269|859202|P3|COMPLETED|Period 1 - First Intervention||4
358768|NCT01205269|859203|P2|COMPLETED|Period 1 - First Intervention||4
358769|NCT01205269|859204|P1|COMPLETED|Period 1 - First Intervention||4
358770|NCT01205269|859199|P6|STARTED|Period 1 - First Intervention||5
358771|NCT01205269|859200|P5|STARTED|Period 1 - First Intervention||5
358772|NCT01205269|859201|P4|STARTED|Period 1 - First Intervention||6
358773|NCT01205269|859202|P3|STARTED|Period 1 - First Intervention||4
358774|NCT01205269|859203|P2|STARTED|Period 1 - First Intervention||4
358775|NCT01205269|859204|P1|STARTED|Period 1 - First Intervention||4
358776|NCT01205230|859244|P2|NOT COMPLETED|Overall Study||0
358777|NCT01205230|859245|P1|NOT COMPLETED|Overall Study||5
358778|NCT01205230|859244|P2|COMPLETED|Overall Study||13
358779|NCT01205230|859245|P1|COMPLETED|Overall Study||16
358780|NCT01205230|859244|P2|Combination Therapy|Overall Study||13
358781|NCT01205230|859245|P1|Combination Therapy|Overall Study||21
358782|NCT01205230|859244|P2|STARTED|Overall Study||13
358783|NCT01205230|859245|P1|STARTED|Overall Study||21
358784|NCT01205126|859290|P2|NOT COMPLETED|Maintenance Phase||40
358785|NCT01205126|859291|P1|NOT COMPLETED|Maintenance Phase||37
358786|NCT01205126|859290|P2|COMPLETED|Maintenance Phase||67
358787|NCT01205126|859291|P1|COMPLETED|Maintenance Phase||70
358788|NCT01205126|859290|P2|STARTED|Maintenance Phase||107
358789|NCT01205126|859291|P1|STARTED|Maintenance Phase||107
358790|NCT01205126|859290|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
358791|NCT01205126|859291|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
358792|NCT01205126|859290|P2|COMPLETED|Between Titration & Maintenance Phase||107
358793|NCT01205126|859291|P1|COMPLETED|Between Titration & Maintenance Phase||107
358794|NCT01205126|859290|P2|STARTED|Between Titration & Maintenance Phase||111
358795|NCT01205126|859291|P1|STARTED|Between Titration & Maintenance Phase||107
358796|NCT01205126|859290|P2|NOT COMPLETED|Titration Phase||19
358797|NCT01205126|859291|P1|NOT COMPLETED|Titration Phase||23
358798|NCT01205126|859290|P2|COMPLETED|Titration Phase||111
358799|NCT01205126|859291|P1|COMPLETED|Titration Phase||107
358800|NCT01205126|859290|P2|STARTED|Titration Phase||130
358801|NCT01205126|859291|P1|STARTED|Titration Phase||130
358802|NCT01205035|859309|P2|NOT COMPLETED|Overall Study||0
358803|NCT01205035|859310|P1|NOT COMPLETED|Overall Study||2
358804|NCT01205035|859309|P2|COMPLETED|Overall Study||3
358805|NCT01205035|859310|P1|COMPLETED|Overall Study||1
358806|NCT01205035|859309|P2|STARTED|Overall Study||3
358807|NCT01205035|859310|P1|STARTED|Overall Study||3
358808|NCT01204853|859324|P1|NOT COMPLETED|Overall Study||0
358809|NCT01204853|859324|P1|COMPLETED|Overall Study||2
358810|NCT01204853|859324|P1|STARTED|Overall Study||2
358811|NCT01204788|859336|P2|NOT COMPLETED|Overall Study||3
358812|NCT01204788|859337|P1|NOT COMPLETED|Overall Study||1
358813|NCT01204788|859336|P2|COMPLETED|Overall Study||0
358814|NCT01204788|859337|P1|COMPLETED|Overall Study||0
358815|NCT01204788|859336|P2|STARTED|Overall Study||3
358816|NCT01204788|859337|P1|STARTED|Overall Study||1
358817|NCT01204775|859345|P2|NOT COMPLETED|Overall Study||1
358818|NCT01204775|859346|P1|NOT COMPLETED|Overall Study||1
358819|NCT01204775|859345|P2|COMPLETED|Overall Study||3
358820|NCT01204775|859346|P1|COMPLETED|Overall Study||3
358821|NCT01204775|859345|P2|Double-blind Treatment Period|Overall Study||4
358822|NCT01204775|859346|P1|Double-blind Treatment Period|Overall Study||4
358823|NCT01204775|859345|P2|STARTED|Overall Study||4
358824|NCT01204775|859346|P1|STARTED|Overall Study||4
358825|NCT01204736|859356|P4|NOT COMPLETED|Overall Study||0
358826|NCT01204736|859357|P3|NOT COMPLETED|Overall Study||0
358827|NCT01204736|859358|P2|NOT COMPLETED|Overall Study||0
358828|NCT01204736|859359|P1|NOT COMPLETED|Overall Study||0
358829|NCT01204736|859356|P4|COMPLETED|Overall Study||2
358830|NCT01204736|859357|P3|COMPLETED|Overall Study||3
358831|NCT01204736|859358|P2|COMPLETED|Overall Study||5
358832|NCT01204736|859359|P1|COMPLETED|Overall Study||4
358833|NCT01204736|859356|P4|STARTED|Overall Study||2
358834|NCT01204736|859357|P3|STARTED|Overall Study||3
358835|NCT01204736|859358|P2|STARTED|Overall Study||5
358836|NCT01204736|859359|P1|STARTED|Overall Study||4
358837|NCT01204697|859371|P2|NOT COMPLETED|Overall Study||36
358838|NCT01204697|859372|P1|NOT COMPLETED|Overall Study||31
358839|NCT01204697|859371|P2|COMPLETED|Overall Study||2
358840|NCT01204697|859372|P1|COMPLETED|Overall Study||5
358841|NCT01204697|859371|P2|Treated|Overall Study||37
358842|NCT01204697|859372|P1|Treated|Overall Study||36
358843|NCT01204697|859371|P2|STARTED|Overall Study||38
358844|NCT01204697|859372|P1|STARTED|Overall Study||36
358845|NCT01204671|859393|P5|NOT COMPLETED|Overall Study||4
358846|NCT01204671|859394|P4|NOT COMPLETED|Overall Study||13
358847|NCT01204671|859395|P3|NOT COMPLETED|Overall Study||13
358848|NCT01204671|859396|P2|NOT COMPLETED|Overall Study||15
358849|NCT01204671|859397|P1|NOT COMPLETED|Overall Study||14
358850|NCT01204671|859393|P5|COMPLETED|Overall Study||606
358851|NCT01204671|859394|P4|COMPLETED|Overall Study||997
358852|NCT01204671|859395|P3|COMPLETED|Overall Study||998
358853|NCT01204671|859396|P2|COMPLETED|Overall Study||998
358854|NCT01204671|859397|P1|COMPLETED|Overall Study||998
358855|NCT01204671|859393|P5|STARTED|Overall Study||610
358856|NCT01204671|859394|P4|STARTED|Overall Study||1010
358857|NCT01204671|859395|P3|STARTED|Overall Study||1011
358858|NCT01204671|859396|P2|STARTED|Overall Study||1013
358859|NCT01204671|859397|P1|STARTED|Overall Study||1012
358860|NCT01204658|859459|P4|NOT COMPLETED|Booster Phase||0
358861|NCT01204658|859460|P3|NOT COMPLETED|Booster Phase||0
358862|NCT01204658|859461|P2|NOT COMPLETED|Booster Phase||0
358863|NCT01204658|859462|P1|NOT COMPLETED|Booster Phase||0
358864|NCT01204658|859459|P4|COMPLETED|Booster Phase||140
358865|NCT01204658|859460|P3|COMPLETED|Booster Phase||140
358866|NCT01204658|859461|P2|COMPLETED|Booster Phase||140
358867|NCT01204658|859462|P1|COMPLETED|Booster Phase||144
358868|NCT01204658|859459|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
358869|NCT01204658|859460|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
358870|NCT01204658|859461|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
358871|NCT01204658|859462|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
358872|NCT01204658|859459|P4|NOT COMPLETED|Primary Phase||0
358873|NCT01204658|859460|P3|NOT COMPLETED|Primary Phase||1
358874|NCT01204658|859461|P2|NOT COMPLETED|Primary Phase||0
358875|NCT01204658|859462|P1|NOT COMPLETED|Primary Phase||0
358876|NCT01204658|859459|P4|COMPLETED|Primary Phase||142
358877|NCT01204658|859460|P3|COMPLETED|Primary Phase||144
358878|NCT01204658|859461|P2|COMPLETED|Primary Phase||142
358879|NCT01204658|859462|P1|COMPLETED|Primary Phase||146
358880|NCT01204658|859459|P4|STARTED|Primary Phase||142
358881|NCT01204658|859460|P3|STARTED|Primary Phase||145
358882|NCT01204658|859461|P2|STARTED|Primary Phase||142
358883|NCT01204658|859462|P1|STARTED|Primary Phase||146
358884|NCT01204398|859572|P1|NOT COMPLETED|Overall Study||1
358885|NCT01204398|859572|P1|COMPLETED|Overall Study|Completed trial medication.|26
358886|NCT01204398|859572|P1|STARTED|Overall Study|Entered and treated.|27
358887|NCT01204294|859589|P7|NOT COMPLETED|Overall Study||2
358888|NCT01204294|859590|P6|NOT COMPLETED|Overall Study||5
358889|NCT01204294|859591|P5|NOT COMPLETED|Overall Study||2
358890|NCT01204294|859592|P4|NOT COMPLETED|Overall Study||11
358891|NCT01204294|859593|P3|NOT COMPLETED|Overall Study||5
358892|NCT01204294|859594|P2|NOT COMPLETED|Overall Study||8
358893|NCT01204294|859595|P1|NOT COMPLETED|Overall Study||3
358894|NCT01204294|859589|P7|COMPLETED|Overall Study||59
358895|NCT01204294|859590|P6|COMPLETED|Overall Study||58
358896|NCT01204294|859591|P5|COMPLETED|Overall Study||83
358897|NCT01204294|859592|P4|COMPLETED|Overall Study||132
358898|NCT01204294|859593|P3|COMPLETED|Overall Study||69
358899|NCT01204294|859594|P2|COMPLETED|Overall Study||58
358900|NCT01204294|859595|P1|COMPLETED|Overall Study||79
358901|NCT01204294|859589|P7|STARTED|Overall Study||61
358902|NCT01204294|859590|P6|STARTED|Overall Study||63
358903|NCT01204294|859591|P5|STARTED|Overall Study||85
358904|NCT01204294|859592|P4|STARTED|Overall Study||143
358905|NCT01204294|859593|P3|STARTED|Overall Study||74
358906|NCT01204294|859594|P2|STARTED|Overall Study||66
358907|NCT01204294|859595|P1|STARTED|Overall Study||82
358908|NCT01204255|859618|P1|NOT COMPLETED|Overall Study||1
358909|NCT01204255|859618|P1|COMPLETED|Overall Study||10
358910|NCT01204255|859618|P1|STARTED|Overall Study||11
358911|NCT01204203|859622|P1|NOT COMPLETED|Overall Study||0
358912|NCT01204203|859622|P1|COMPLETED|Overall Study||8
358913|NCT01204203|859622|P1|STARTED|Overall Study||8
358914|NCT01203956|859628|P2|NOT COMPLETED|Second Two-week Period||6
358915|NCT01203956|859629|P1|NOT COMPLETED|Second Two-week Period||5
358916|NCT01203956|859628|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
358917|NCT01203956|859629|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
358918|NCT01203956|859628|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
358919|NCT01203956|859629|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
358920|NCT01203956|859628|P2|STARTED|Second Two-week Period||13
358921|NCT01203956|859629|P1|STARTED|Second Two-week Period||15
358922|NCT01203956|859628|P2|NOT COMPLETED|First Two-week Period||0
358923|NCT01203956|859629|P1|NOT COMPLETED|First Two-week Period||0
358924|NCT01203956|859628|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
358925|NCT01203956|859629|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
358926|NCT01203956|859628|P2|STARTED|First Two-week Period||13
358927|NCT01203956|859629|P1|STARTED|First Two-week Period||15
358928|NCT01203930|859638|P2|NOT COMPLETED|Overall Study||41
358929|NCT01203930|859639|P1|NOT COMPLETED|Overall Study||21
358930|NCT01203930|859638|P2|COMPLETED|Overall Study||0
358931|NCT01203930|859639|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
358932|NCT01203930|859638|P2|STARTED|Overall Study||41
358933|NCT01203930|859639|P1|STARTED|Overall Study||64
358934|NCT01203917|859661|P1|NOT COMPLETED|Overall Study||36
358935|NCT01203917|859661|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
358936|NCT01203917|859661|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
358937|NCT01203878|859674|P3|NOT COMPLETED|Overall Study||3
358938|NCT01203878|859675|P2|NOT COMPLETED|Overall Study||0
358939|NCT01203878|859676|P1|NOT COMPLETED|Overall Study||0
358940|NCT01203878|859674|P3|COMPLETED|Overall Study||0
358941|NCT01203878|859675|P2|COMPLETED|Overall Study||9
358942|NCT01203878|859676|P1|COMPLETED|Overall Study||9
358943|NCT01203878|859674|P3|STARTED|Overall Study||3
358944|NCT01203878|859675|P2|STARTED|Overall Study||9
358945|NCT01203878|859676|P1|STARTED|Overall Study||9
358946|NCT01203852|859687|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
358947|NCT01203852|859687|P1|COMPLETED|Chlorthalidone 8 Weeks||328
358948|NCT01203852|859687|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
358949|NCT01203852|859687|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
358950|NCT01203852|859687|P1|NOT COMPLETED|Washout 2 Weeks||46
358951|NCT01203852|859687|P1|COMPLETED|Washout 2 Weeks||282
358952|NCT01203852|859687|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
358953|NCT01203852|859687|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
358954|NCT01203852|859687|P1|COMPLETED|Metoprolol 8 Weeks||369
358955|NCT01203852|859687|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
358956|NCT01203787|859696|P2|NOT COMPLETED|Overall Study||27
358957|NCT01203787|859697|P1|NOT COMPLETED|Overall Study||31
358958|NCT01203787|859696|P2|COMPLETED|Overall Study||30
358959|NCT01203787|859697|P1|COMPLETED|Overall Study||32
358960|NCT01203787|859696|P2|STARTED|Overall Study||57
358961|NCT01203787|859697|P1|STARTED|Overall Study||63
358962|NCT01203644|859717|P2|NOT COMPLETED|Overall Study||0
358963|NCT01203644|859718|P1|NOT COMPLETED|Overall Study||0
358964|NCT01203644|859717|P2|COMPLETED|Overall Study||50
358965|NCT01203644|859718|P1|COMPLETED|Overall Study||26
358966|NCT01203644|859717|P2|STARTED|Overall Study||50
358967|NCT01203644|859718|P1|STARTED|Overall Study||26
358968|NCT01203319|859730|P3|NOT COMPLETED|Overall Study||5
358969|NCT01203319|859731|P2|NOT COMPLETED|Overall Study||9
358970|NCT01203319|859732|P1|NOT COMPLETED|Overall Study||6
358971|NCT01203319|859730|P3|COMPLETED|Overall Study||217
358972|NCT01203319|859731|P2|COMPLETED|Overall Study||426
358973|NCT01203319|859732|P1|COMPLETED|Overall Study||428
358974|NCT01203319|859730|P3|STARTED|Overall Study||222
358975|NCT01203319|859731|P2|STARTED|Overall Study||435
358976|NCT01203319|859732|P1|STARTED|Overall Study||434
358977|NCT01203098|859749|P3|NOT COMPLETED|Overall Study||11
358978|NCT01203098|859750|P2|NOT COMPLETED|Overall Study||4
358979|NCT01203098|859751|P1|NOT COMPLETED|Overall Study||6
358980|NCT01203098|859749|P3|COMPLETED|Overall Study||78
358981|NCT01203098|859750|P2|COMPLETED|Overall Study||82
358982|NCT01203098|859751|P1|COMPLETED|Overall Study||83
358983|NCT01203098|859749|P3|Safety Analysis Dataset|Overall Study||87
358984|NCT01203098|859750|P2|Safety Analysis Dataset|Overall Study||85
358985|NCT01203098|859751|P1|Safety Analysis Dataset|Overall Study||89
358986|NCT01203098|859749|P3|STARTED|Overall Study||89
358987|NCT01203098|859750|P2|STARTED|Overall Study||86
358988|NCT01203098|859751|P1|STARTED|Overall Study||89
358989|NCT01203072|859767|P5|NOT COMPLETED|Overall Study||6
358990|NCT01203072|859768|P4|NOT COMPLETED|Overall Study||6
358991|NCT01203072|859769|P3|NOT COMPLETED|Overall Study||3
358992|NCT01203072|859770|P2|NOT COMPLETED|Overall Study||6
358993|NCT01203072|859771|P1|NOT COMPLETED|Overall Study||10
358994|NCT01203072|859767|P5|COMPLETED|Overall Study||96
358995|NCT01203072|859768|P4|COMPLETED|Overall Study||100
358996|NCT01203072|859769|P3|COMPLETED|Overall Study||101
358997|NCT01203072|859770|P2|COMPLETED|Overall Study||100
358998|NCT01203072|859771|P1|COMPLETED|Overall Study||95
358999|NCT01203072|859767|P5|STARTED|Overall Study||102
359000|NCT01203072|859768|P4|STARTED|Overall Study||106
359001|NCT01203072|859769|P3|STARTED|Overall Study||104
359002|NCT01203072|859770|P2|STARTED|Overall Study||106
359003|NCT01203072|859771|P1|STARTED|Overall Study||105
359004|NCT01203046|859790|P2|NOT COMPLETED|Overall Study||0
359005|NCT01203046|859791|P1|NOT COMPLETED|Overall Study||0
359006|NCT01203046|859790|P2|COMPLETED|Overall Study||28
359007|NCT01203046|859791|P1|COMPLETED|Overall Study||28
359008|NCT01203046|859790|P2|STARTED|Overall Study||28
359009|NCT01203046|859791|P1|STARTED|Overall Study||28
359010|NCT01202955|859801|P2|NOT COMPLETED|Period 3: 10 Days||0
359011|NCT01202955|859802|P1|NOT COMPLETED|Period 3: 10 Days||0
359012|NCT01202955|859801|P2|COMPLETED|Period 3: 10 Days||8
359013|NCT01202955|859802|P1|COMPLETED|Period 3: 10 Days||9
359014|NCT01202955|859801|P2|STARTED|Period 3: 10 Days||8
359015|NCT01202955|859802|P1|STARTED|Period 3: 10 Days||9
359016|NCT01202955|859801|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
359017|NCT01202955|859802|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
359018|NCT01202955|859801|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
359019|NCT01202955|859802|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
359020|NCT01202955|859801|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
359021|NCT01202955|859802|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
359022|NCT01202955|859801|P2|NOT COMPLETED|Period 1: 10 Days||2
359023|NCT01202955|859802|P1|NOT COMPLETED|Period 1: 10 Days||0
359024|NCT01202955|859801|P2|COMPLETED|Period 1: 10 Days||8
359025|NCT01202955|859802|P1|COMPLETED|Period 1: 10 Days||9
359026|NCT01202955|859801|P2|STARTED|Period 1: 10 Days||10
359027|NCT01202955|859802|P1|STARTED|Period 1: 10 Days||9
359028|NCT01202903|859814|P2|NOT COMPLETED|Overall Study||16
359029|NCT01202903|859815|P1|NOT COMPLETED|Overall Study||11
359030|NCT01202903|859814|P2|COMPLETED|Overall Study||292
359031|NCT01202903|859815|P1|COMPLETED|Overall Study||297
359032|NCT01202903|859814|P2|Safety Set*|Overall Study||299
359033|NCT01202903|859815|P1|Safety Set*|Overall Study||310
359034|NCT01202903|859814|P2|Full Analysis Set|Overall Study||302
359035|NCT01202903|859815|P1|Full Analysis Set|Overall Study||306
359036|NCT01202903|859814|P2|STARTED|Overall Study||308
359037|NCT01202903|859815|P1|STARTED|Overall Study||308
359038|NCT01202877|859842|P3|NOT COMPLETED|Overall Study||6
359039|NCT01202877|859843|P2|NOT COMPLETED|Overall Study||1
359040|NCT01202877|859844|P1|NOT COMPLETED|Overall Study||0
359041|NCT01202877|859842|P3|COMPLETED|Overall Study||34
359042|NCT01202877|859843|P2|COMPLETED|Overall Study||7
359043|NCT01202877|859844|P1|COMPLETED|Overall Study||6
359044|NCT01202877|859842|P3|STARTED|Overall Study||40
359045|NCT01202877|859843|P2|STARTED|Overall Study||8
359046|NCT01202877|859844|P1|STARTED|Overall Study||6
359047|NCT01202747|859853|P1|NOT COMPLETED|Overall Study||1
359048|NCT01202747|859853|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
359049|NCT01202747|859853|P1|STARTED|Overall Study||50
359050|NCT01202656|859859|P2|NOT COMPLETED|CrossoverCycle||0
359051|NCT01202656|859860|P1|NOT COMPLETED|CrossoverCycle||0
359052|NCT01202656|859859|P2|COMPLETED|CrossoverCycle||14
359053|NCT01202656|859860|P1|COMPLETED|CrossoverCycle||18
359054|NCT01202656|859859|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
359055|NCT01202656|859860|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
359056|NCT01202656|859859|P2|NOT COMPLETED|Cycle 1||0
359057|NCT01202656|859860|P1|NOT COMPLETED|Cycle 1||0
359058|NCT01202656|859859|P2|COMPLETED|Cycle 1||62
359059|NCT01202656|859860|P1|COMPLETED|Cycle 1||67
359060|NCT01202656|859859|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
359061|NCT01202656|859860|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
359062|NCT01202643|859870|P2|NOT COMPLETED|Crossover Cycle||0
359063|NCT01202643|859871|P1|NOT COMPLETED|Crossover Cycle||0
359064|NCT01202643|859870|P2|COMPLETED|Crossover Cycle||2
359065|NCT01202643|859871|P1|COMPLETED|Crossover Cycle||1
359066|NCT01202643|859870|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
359067|NCT01202643|859871|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
359068|NCT01202643|859870|P2|NOT COMPLETED|Period 1||0
359069|NCT01202643|859871|P1|NOT COMPLETED|Period 1||0
359070|NCT01202643|859870|P2|COMPLETED|Period 1||6
359071|NCT01202643|859871|P1|COMPLETED|Period 1||6
359072|NCT01202643|859870|P2|STARTED|Period 1||6
359073|NCT01202643|859871|P1|STARTED|Period 1||6
359074|NCT01202591|859885|P6|NOT COMPLETED|Overall Study||4
359075|NCT01202591|859886|P5|NOT COMPLETED|Overall Study||5
359076|NCT01202591|859887|P4|NOT COMPLETED|Overall Study||7
359077|NCT01202591|859888|P3|NOT COMPLETED|Overall Study||11
359078|NCT01202591|859889|P2|NOT COMPLETED|Overall Study||5
359079|NCT01202591|859890|P1|NOT COMPLETED|Overall Study||5
359080|NCT01202591|859885|P6|COMPLETED|Overall Study||0
359081|NCT01202591|859886|P5|COMPLETED|Overall Study||0
359082|NCT01202591|859887|P4|COMPLETED|Overall Study||2
359083|NCT01202591|859888|P3|COMPLETED|Overall Study||1
359084|NCT01202591|859889|P2|COMPLETED|Overall Study||0
359085|NCT01202591|859890|P1|COMPLETED|Overall Study||0
359086|NCT01202591|859885|P6|STARTED|Overall Study||4
359087|NCT01202591|859886|P5|STARTED|Overall Study||5
359088|NCT01202591|859887|P4|STARTED|Overall Study||9
359089|NCT01202591|859888|P3|STARTED|Overall Study||12
359090|NCT01202591|859889|P2|STARTED|Overall Study||5
359091|NCT01202591|859890|P1|STARTED|Overall Study||5
359092|NCT01202578|859904|P1|NOT COMPLETED|Overall Study||0
359093|NCT01202578|859904|P1|COMPLETED|Overall Study||53
359094|NCT01202578|859904|P1|STARTED|Overall Study||53
359095|NCT01202565|859911|P1|NOT COMPLETED|Overall Study||67
359096|NCT01202565|859911|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
359097|NCT01202565|859911|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
359098|NCT01202565|859911|P1|STARTED|Overall Study||506
359099|NCT01202279|859936|P2|NOT COMPLETED|Overall Study||27
359100|NCT01202279|859937|P1|NOT COMPLETED|Overall Study||37
359101|NCT01202279|859936|P2|COMPLETED|Overall Study||561
359102|NCT01202279|859937|P1|COMPLETED|Overall Study||554
359103|NCT01202279|859936|P2|STARTED|Overall Study||588
359104|NCT01202279|859937|P1|STARTED|Overall Study||591
359105|NCT01202253|859945|P1|NOT COMPLETED|Overall Study||0
359106|NCT01202253|859945|P1|COMPLETED|Overall Study||50
359107|NCT01202253|859945|P1|STARTED|Overall Study||50
359108|NCT01202227|859989|P1|NOT COMPLETED|Overall Study||19
359109|NCT01202227|859989|P1|COMPLETED|Overall Study||84
359110|NCT01202227|859989|P1|STARTED|Overall Study|Treated|103
359111|NCT01202188|860013|P5|NOT COMPLETED|Overall Study||45
359112|NCT01202188|860014|P4|NOT COMPLETED|Overall Study||42
359113|NCT01202188|860015|P3|NOT COMPLETED|Overall Study||53
359114|NCT01202188|860016|P2|NOT COMPLETED|Overall Study||56
359115|NCT01202188|860017|P1|NOT COMPLETED|Overall Study||38
359116|NCT01202188|860013|P5|COMPLETED|Overall Study||189
359117|NCT01202188|860014|P4|COMPLETED|Overall Study||441
359118|NCT01202188|860015|P3|COMPLETED|Overall Study||422
359119|NCT01202188|860016|P2|COMPLETED|Overall Study||421
359120|NCT01202188|860017|P1|COMPLETED|Overall Study||437
359121|NCT01202188|860013|P5|Safety Set; Received Study Drug|Overall Study||232
359122|NCT01202188|860014|P4|Safety Set; Received Study Drug|Overall Study||480
359123|NCT01202188|860015|P3|Safety Set; Received Study Drug|Overall Study||473
359124|NCT01202188|860016|P2|Safety Set; Received Study Drug|Overall Study||476
359125|NCT01202188|860017|P1|Safety Set; Received Study Drug|Overall Study||474
359126|NCT01202188|860013|P5|STARTED|Overall Study||234
359127|NCT01202188|860014|P4|STARTED|Overall Study||483
359128|NCT01202188|860015|P3|STARTED|Overall Study||475
359129|NCT01202188|860016|P2|STARTED|Overall Study||477
359130|NCT01202188|860017|P1|STARTED|Overall Study||475
359131|NCT01202162|860125|P2|NOT COMPLETED|Overall Study||2
359132|NCT01202162|860126|P1|NOT COMPLETED|Overall Study||3
359133|NCT01202162|860125|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
359134|NCT01202162|860126|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
359135|NCT01202162|860125|P2|STARTED|Overall Study||42
359136|NCT01202162|860126|P1|STARTED|Overall Study||43
359137|NCT01202110|860136|P2|NOT COMPLETED|Overall Study||0
359138|NCT01202110|860137|P1|NOT COMPLETED|Overall Study||0
359139|NCT01202110|860136|P2|COMPLETED|Overall Study||0
359140|NCT01202110|860137|P1|COMPLETED|Overall Study||10
359141|NCT01202110|860136|P2|STARTED|Overall Study||0
359142|NCT01202110|860137|P1|STARTED|Overall Study||10
359143|NCT01202071|860141|P4|NOT COMPLETED|Overall Study||0
359144|NCT01202071|860142|P3|NOT COMPLETED|Overall Study||0
359145|NCT01202071|860143|P2|NOT COMPLETED|Overall Study||0
359146|NCT01202071|860144|P1|NOT COMPLETED|Overall Study||0
359147|NCT01202071|860141|P4|COMPLETED|Overall Study||6
359148|NCT01202071|860142|P3|COMPLETED|Overall Study||6
359149|NCT01202071|860143|P2|COMPLETED|Overall Study||6
359150|NCT01202071|860144|P1|COMPLETED|Overall Study||6
359151|NCT01202071|860141|P4|STARTED|Overall Study||6
359152|NCT01202071|860142|P3|STARTED|Overall Study||6
359153|NCT01202071|860143|P2|STARTED|Overall Study||6
359154|NCT01202071|860144|P1|STARTED|Overall Study||6
359155|NCT01201967|860164|P2|NOT COMPLETED|Overall Study||5
359156|NCT01201967|860165|P1|NOT COMPLETED|Overall Study||6
359157|NCT01201967|860164|P2|COMPLETED|Overall Study||86
359158|NCT01201967|860165|P1|COMPLETED|Overall Study||86
359159|NCT01201967|860164|P2|STARTED|Overall Study||91
359160|NCT01201967|860165|P1|STARTED|Overall Study||92
359161|NCT01201915|860190|P3|NOT COMPLETED|Overall Study||6
359162|NCT01201915|860191|P2|NOT COMPLETED|Overall Study||11
359163|NCT01201915|860192|P1|NOT COMPLETED|Overall Study||8
359164|NCT01201915|860190|P3|COMPLETED|Overall Study||19
359165|NCT01201915|860191|P2|COMPLETED|Overall Study||14
359166|NCT01201915|860192|P1|COMPLETED|Overall Study||16
359167|NCT01201915|860190|P3|STARTED|Overall Study||25
359168|NCT01201915|860191|P2|STARTED|Overall Study||25
359169|NCT01201915|860192|P1|STARTED|Overall Study||24
359170|NCT01200810|860205|P2|NOT COMPLETED|Overall Study||5
359171|NCT01200810|860206|P1|NOT COMPLETED|Overall Study||5
359172|NCT01200810|860205|P2|COMPLETED|Overall Study||0
359173|NCT01200810|860206|P1|COMPLETED|Overall Study||0
359174|NCT01200810|860205|P2|STARTED|Overall Study||5
359175|NCT01200810|860206|P1|STARTED|Overall Study||5
359176|NCT01200797|860224|P1|NOT COMPLETED|Overall Study||19
359177|NCT01200797|860224|P1|COMPLETED|Overall Study||0
359178|NCT01200797|860224|P1|STARTED|Overall Study||19
359179|NCT01200758|860234|P4|NOT COMPLETED|Stage 2||142
359180|NCT01200758|860235|P3|NOT COMPLETED|Stage 2||141
359181|NCT01200758|860236|P2|NOT COMPLETED|Stage 2||0
359182|NCT01200758|860237|P1|NOT COMPLETED|Stage 2||0
359183|NCT01200758|860234|P4|COMPLETED|Stage 2||0
359184|NCT01200758|860235|P3|COMPLETED|Stage 2||0
359185|NCT01200758|860236|P2|COMPLETED|Stage 2||0
359186|NCT01200758|860237|P1|COMPLETED|Stage 2||0
359187|NCT01200758|860234|P4|STARTED|Stage 2||142
359188|NCT01200758|860235|P3|STARTED|Stage 2||141
359189|NCT01200758|860236|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
359190|NCT01200758|860237|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
359191|NCT01200758|860234|P4|NOT COMPLETED|Stage I||0
359192|NCT01200758|860235|P3|NOT COMPLETED|Stage I||0
359193|NCT01200758|860236|P2|NOT COMPLETED|Stage I||47
359194|NCT01200758|860237|P1|NOT COMPLETED|Stage I||47
359195|NCT01200758|860234|P4|COMPLETED|Stage I||0
359196|NCT01200758|860235|P3|COMPLETED|Stage I||0
359197|NCT01200758|860236|P2|COMPLETED|Stage I|Participants completed treatment period.|16
359198|NCT01200758|860237|P1|COMPLETED|Stage I|Participants completed treatment period.|17
359199|NCT01200758|860234|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
359200|NCT01200758|860235|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
359201|NCT01200758|860236|P2|STARTED|Stage I||63
359202|NCT01200758|860237|P1|STARTED|Stage I||64
359203|NCT01201811|860281|P1|NOT COMPLETED|Overall Study||19
359204|NCT01201811|860281|P1|COMPLETED|Overall Study||25
359205|NCT01201811|860281|P1|STARTED|Overall Study||44
359206|NCT01201798|860303|P2|NOT COMPLETED|Overall Study||15
359207|NCT01201798|860304|P1|NOT COMPLETED|Overall Study||9
359208|NCT01201798|860303|P2|COMPLETED|Overall Study||39
359209|NCT01201798|860304|P1|COMPLETED|Overall Study||47
359210|NCT01201798|860303|P2|STARTED|Overall Study||54
359211|NCT01201798|860304|P1|STARTED|Overall Study||56
359212|NCT01201785|860328|P1|NOT COMPLETED|Overall Study||16
359213|NCT01201785|860328|P1|COMPLETED|Overall Study||20
359214|NCT01201785|860328|P1|STARTED|Overall Study||36
359215|NCT01201772|860335|P3|NOT COMPLETED|Overall Study||0
359216|NCT01201772|860336|P2|NOT COMPLETED|Overall Study||0
359217|NCT01201772|860337|P1|NOT COMPLETED|Overall Study||1
359218|NCT01201772|860335|P3|COMPLETED|Overall Study||21
359219|NCT01201772|860336|P2|COMPLETED|Overall Study||21
359220|NCT01201772|860337|P1|COMPLETED|Overall Study||22
359221|NCT01201772|860335|P3|STARTED|Overall Study||21
359222|NCT01201772|860336|P2|STARTED|Overall Study||21
359223|NCT01201772|860337|P1|STARTED|Overall Study||23
359224|NCT01201759|860345|P2|NOT COMPLETED|Visit 5||0
359225|NCT01201759|860346|P1|NOT COMPLETED|Visit 5||0
359226|NCT01201759|860345|P2|COMPLETED|Visit 5||3
359227|NCT01201759|860346|P1|COMPLETED|Visit 5||7
359228|NCT01201759|860345|P2|STARTED|Visit 5||3
359229|NCT01201759|860346|P1|STARTED|Visit 5||7
359230|NCT01201759|860345|P2|NOT COMPLETED|Visit 4 Crossover||1
359231|NCT01201759|860346|P1|NOT COMPLETED|Visit 4 Crossover||0
359232|NCT01201759|860345|P2|COMPLETED|Visit 4 Crossover||3
359233|NCT01201759|860346|P1|COMPLETED|Visit 4 Crossover||7
359234|NCT01201759|860345|P2|STARTED|Visit 4 Crossover||4
359235|NCT01201759|860346|P1|STARTED|Visit 4 Crossover||7
359236|NCT01201759|860345|P2|NOT COMPLETED|Visit 3 - Washout||3
359237|NCT01201759|860346|P1|NOT COMPLETED|Visit 3 - Washout||1
359238|NCT01201759|860345|P2|COMPLETED|Visit 3 - Washout||4
359239|NCT01201759|860346|P1|COMPLETED|Visit 3 - Washout||7
359240|NCT01201759|860345|P2|STARTED|Visit 3 - Washout||7
359241|NCT01201759|860346|P1|STARTED|Visit 3 - Washout||8
359242|NCT01201759|860345|P2|NOT COMPLETED|Visit 2||0
359243|NCT01201759|860346|P1|NOT COMPLETED|Visit 2||0
359244|NCT01201759|860345|P2|COMPLETED|Visit 2||7
359245|NCT01201759|860346|P1|COMPLETED|Visit 2||8
359246|NCT01201759|860345|P2|STARTED|Visit 2||7
359247|NCT01201759|860346|P1|STARTED|Visit 2||8
359248|NCT01201759|860345|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
359249|NCT01201759|860346|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
359250|NCT01201759|860345|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
359251|NCT01201759|860346|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
359252|NCT01201759|860345|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
359253|NCT01201759|860346|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
359254|NCT01201629|860360|P2|NOT COMPLETED|Overall Study||0
359255|NCT01201629|860361|P1|NOT COMPLETED|Overall Study||0
359256|NCT01201629|860360|P2|COMPLETED|Overall Study||8
359257|NCT01201629|860361|P1|COMPLETED|Overall Study||8
359258|NCT01201629|860360|P2|STARTED|Overall Study||8
359259|NCT01201629|860361|P1|STARTED|Overall Study||8
359260|NCT01201486|860371|P1|NOT COMPLETED|Overall Study||0
359261|NCT01201486|860371|P1|COMPLETED|Overall Study||6781
359262|NCT01201486|860371|P1|STARTED|Overall Study||6781
359263|NCT01201343|860375|P1|NOT COMPLETED|Overall Study||19
359264|NCT01201343|860375|P1|COMPLETED|Overall Study||60
359265|NCT01201343|860375|P1|Treated|Overall Study||76
359266|NCT01201343|860375|P1|STARTED|Overall Study||79
359267|NCT01201317|860389|P3|NOT COMPLETED|Overall Study||8
359268|NCT01201317|860390|P2|NOT COMPLETED|Overall Study||7
359269|NCT01201317|860391|P1|NOT COMPLETED|Overall Study||9
359270|NCT01201317|860389|P3|COMPLETED|Overall Study||33
359271|NCT01201317|860390|P2|COMPLETED|Overall Study||38
359272|NCT01201317|860391|P1|COMPLETED|Overall Study||39
359273|NCT01201317|860389|P3|STARTED|Overall Study||41
359274|NCT01201317|860390|P2|STARTED|Overall Study||45
359275|NCT01201317|860391|P1|STARTED|Overall Study||48
359276|NCT01201265|860411|P1|NOT COMPLETED|Overall Study||38
359277|NCT01201265|860411|P1|COMPLETED|Overall Study||2
359278|NCT01201265|860411|P1|STARTED|Overall Study||40
359279|NCT01200992|860425|P2|NOT COMPLETED|Overall Study||41
359280|NCT01200992|860426|P1|NOT COMPLETED|Overall Study||37
359281|NCT01200992|860425|P2|COMPLETED|Overall Study||4
359282|NCT01200992|860426|P1|COMPLETED|Overall Study||2
359283|NCT01200992|860425|P2|STARTED|Overall Study||45
359284|NCT01200992|860426|P1|STARTED|Overall Study||39
359285|NCT01200875|860432|P1|NOT COMPLETED|Overall Study||0
359286|NCT01200875|860432|P1|COMPLETED|Overall Study||25
359287|NCT01200875|860432|P1|STARTED|Overall Study||25
359288|NCT01200602|860438|P2|NOT COMPLETED|Overall Study||0
359289|NCT01200602|860439|P1|NOT COMPLETED|Overall Study||0
359290|NCT01200602|860438|P2|COMPLETED|Overall Study||0
359291|NCT01200602|860439|P1|COMPLETED|Overall Study||0
359292|NCT01200602|860438|P2|STARTED|Overall Study||0
359293|NCT01200602|860439|P1|STARTED|Overall Study||0
359294|NCT01200524|860456|P3|NOT COMPLETED|Overall Study||4
359295|NCT01200524|860457|P2|NOT COMPLETED|Overall Study||1
359296|NCT01200524|860458|P1|NOT COMPLETED|Overall Study||2
359297|NCT01200524|860456|P3|COMPLETED|Overall Study||40
359298|NCT01200524|860457|P2|COMPLETED|Overall Study||47
359299|NCT01200524|860458|P1|COMPLETED|Overall Study||39
359300|NCT01200524|860456|P3|STARTED|Overall Study||44
359301|NCT01200524|860457|P2|STARTED|Overall Study||48
359302|NCT01200524|860458|P1|STARTED|Overall Study||41
359303|NCT01200511|860478|P1|NOT COMPLETED|Overall Study||5
359304|NCT01200511|860478|P1|COMPLETED|Overall Study||44
359305|NCT01200511|860478|P1|STARTED|Overall Study||49
359306|NCT01200498|860486|P1|NOT COMPLETED|Overall Study||0
359307|NCT01200498|860486|P1|COMPLETED|Overall Study||22
359308|NCT01200498|860486|P1|STARTED|Overall Study||22
359309|NCT01200433|860492|P2|NOT COMPLETED|Overall Study||0
359310|NCT01200433|860493|P1|NOT COMPLETED|Overall Study||0
359311|NCT01200433|860492|P2|COMPLETED|Overall Study||23
359312|NCT01200433|860493|P1|COMPLETED|Overall Study||21
359313|NCT01200433|860492|P2|STARTED|Overall Study||23
359314|NCT01200433|860493|P1|STARTED|Overall Study||21
359315|NCT01200368|860516|P3|NOT COMPLETED|Toddler Dose||1
359316|NCT01200368|860517|P2|NOT COMPLETED|Toddler Dose||3
359317|NCT01200368|860518|P1|NOT COMPLETED|Toddler Dose||0
359318|NCT01200368|860516|P3|COMPLETED|Toddler Dose||168
359319|NCT01200368|860517|P2|COMPLETED|Toddler Dose||159
359320|NCT01200368|860518|P1|COMPLETED|Toddler Dose||162
359321|NCT01200368|860516|P3|STARTED|Toddler Dose||169
359322|NCT01200368|860517|P2|STARTED|Toddler Dose||162
359323|NCT01200368|860518|P1|STARTED|Toddler Dose||162
359324|NCT01200368|860516|P3|NOT COMPLETED|After Infant Series||9
359325|NCT01200368|860517|P2|NOT COMPLETED|After Infant Series||16
359326|NCT01200368|860518|P1|NOT COMPLETED|After Infant Series||18
359327|NCT01200368|860516|P3|COMPLETED|After Infant Series||169
359328|NCT01200368|860517|P2|COMPLETED|After Infant Series||162
359329|NCT01200368|860518|P1|COMPLETED|After Infant Series||162
359330|NCT01200368|860516|P3|STARTED|After Infant Series||178
359331|NCT01200368|860517|P2|STARTED|After Infant Series||178
359332|NCT01200368|860518|P1|STARTED|After Infant Series||180
359333|NCT01200368|860516|P3|NOT COMPLETED|Infant Series||6
359334|NCT01200368|860517|P2|NOT COMPLETED|Infant Series||6
359335|NCT01200368|860518|P1|NOT COMPLETED|Infant Series||3
359336|NCT01200368|860516|P3|COMPLETED|Infant Series||178
359337|NCT01200368|860517|P2|COMPLETED|Infant Series||178
359338|NCT01200368|860518|P1|COMPLETED|Infant Series||180
359339|NCT01200368|860516|P3|Vaccinated Dose 3|Infant Series||182
359340|NCT01200368|860517|P2|Vaccinated Dose 3|Infant Series||178
359341|NCT01200368|860518|P1|Vaccinated Dose 3|Infant Series||181
359342|NCT01200368|860516|P3|Vaccinated Dose 2|Infant Series||183
359343|NCT01200368|860517|P2|Vaccinated Dose 2|Infant Series||182
359344|NCT01200368|860518|P1|Vaccinated Dose 2|Infant Series||183
359345|NCT01200368|860516|P3|Vaccinated Dose 1|Infant Series||183
359346|NCT01200368|860517|P2|Vaccinated Dose 1|Infant Series||183
359347|NCT01200368|860518|P1|Vaccinated Dose 1|Infant Series||183
359348|NCT01200368|860516|P3|STARTED|Infant Series||184
359349|NCT01200368|860517|P2|STARTED|Infant Series||184
359350|NCT01200368|860518|P1|STARTED|Infant Series||183
359351|NCT01200342|860582|P1|NOT COMPLETED|Overall Study||1
359352|NCT01200342|860582|P1|COMPLETED|Overall Study||6
359353|NCT01200342|860582|P1|STARTED|Overall Study||7
359354|NCT01200160|860587|P1|NOT COMPLETED|Overall Study||62
359355|NCT01200160|860587|P1|COMPLETED|Overall Study||66
359356|NCT01200160|860587|P1|STARTED|Overall Study||128
359357|NCT01200069|860593|P2|NOT COMPLETED|Overall Study||1
359358|NCT01200069|860594|P1|NOT COMPLETED|Overall Study||0
359359|NCT01200069|860593|P2|COMPLETED|Overall Study||5
359360|NCT01200069|860594|P1|COMPLETED|Overall Study||8
359361|NCT01200069|860593|P2|STARTED|Overall Study||6
359362|NCT01200069|860594|P1|STARTED|Overall Study||8
359363|NCT01199965|860648|P2|NOT COMPLETED|Overall Study||0
359364|NCT01199965|860649|P1|NOT COMPLETED|Overall Study||1
359365|NCT01199965|860648|P2|COMPLETED|Overall Study||24
359366|NCT01199965|860649|P1|COMPLETED|Overall Study||22
359367|NCT01199965|860648|P2|STARTED|Overall Study||24
359368|NCT01199965|860649|P1|STARTED|Overall Study||23
359369|NCT01199939|860663|P1|NOT COMPLETED|Overall Study||13
359370|NCT01199939|860663|P1|COMPLETED|Overall Study||41
359371|NCT01199939|860663|P1|STARTED|Overall Study|Number of enrolled participants|54
359372|NCT01199926|860682|P2|NOT COMPLETED|Overall Study||4
359373|NCT01199926|860683|P1|NOT COMPLETED|Overall Study||7
359374|NCT01199926|860682|P2|COMPLETED|Overall Study||13
359375|NCT01199926|860683|P1|COMPLETED|Overall Study||10
359376|NCT01199926|860682|P2|STARTED|Overall Study||17
359377|NCT01199926|860683|P1|STARTED|Overall Study||17
359378|NCT01199861|860695|P2|NOT COMPLETED|Overall Study||0
359379|NCT01199861|860696|P1|NOT COMPLETED|Overall Study||2
359380|NCT01199861|860695|P2|COMPLETED|Overall Study||43
359381|NCT01199861|860696|P1|COMPLETED|Overall Study||93
359382|NCT01199861|860695|P2|STARTED|Overall Study||43
359383|NCT01199861|860696|P1|STARTED|Overall Study||95
359384|NCT01199822|860717|P3|NOT COMPLETED|Overall Study||0
359385|NCT01199822|860718|P2|NOT COMPLETED|Overall Study||1
359386|NCT01199822|860719|P1|NOT COMPLETED|Overall Study||0
359387|NCT01199822|860717|P3|COMPLETED|Overall Study||6
359388|NCT01199822|860718|P2|COMPLETED|Overall Study||6
359389|NCT01199822|860719|P1|COMPLETED|Overall Study||3
359390|NCT01199822|860717|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
359391|NCT01199822|860718|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
359392|NCT01199822|860719|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
359393|NCT01199822|860717|P3|STARTED|Overall Study||6
359394|NCT01199822|860718|P2|STARTED|Overall Study||7
359395|NCT01199822|860719|P1|STARTED|Overall Study||3
359396|NCT01199744|860752|P1|NOT COMPLETED|Overall Study||0
359397|NCT01199744|860752|P1|COMPLETED|Overall Study||1575
359398|NCT01199744|860752|P1|STARTED|Overall Study||1575
359399|NCT01199705|860765|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
359400|NCT01199705|860765|P1|COMPLETED|SCIG Treatment (Efficacy)||24
359401|NCT01199705|860765|P1|STARTED|SCIG Treatment (Efficacy)||24
359402|NCT01199705|860765|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
359403|NCT01199705|860765|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
359404|NCT01199705|860765|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
359405|NCT01199705|860765|P1|NOT COMPLETED|IVIG Treatment||0
359406|NCT01199705|860765|P1|COMPLETED|IVIG Treatment||25
359407|NCT01199705|860765|P1|STARTED|IVIG Treatment||25
359408|NCT01199601|860797|P2|NOT COMPLETED|Overall Study||78
359409|NCT01199601|860798|P1|NOT COMPLETED|Overall Study||69
359410|NCT01199601|860797|P2|COMPLETED|Overall Study||344
359411|NCT01199601|860798|P1|COMPLETED|Overall Study||353
359412|NCT01199601|860797|P2|STARTED|Overall Study|Intervention Group|422
359413|NCT01199601|860798|P1|STARTED|Overall Study|Control Group|422
359414|NCT01199471|860808|P1|NOT COMPLETED|Overall Study||6
359415|NCT01199471|860808|P1|COMPLETED|Overall Study||3994
359416|NCT01199471|860808|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
359417|NCT01199237|860819|P2|NOT COMPLETED|Overall Study||0
359418|NCT01199237|860820|P1|NOT COMPLETED|Overall Study||0
359419|NCT01199237|860819|P2|COMPLETED|Overall Study||40
359420|NCT01199237|860820|P1|COMPLETED|Overall Study||41
359421|NCT01199237|860819|P2|STARTED|Overall Study||40
359422|NCT01199237|860820|P1|STARTED|Overall Study||41
359423|NCT01199042|860834|P1|NOT COMPLETED|At Home (3 Months)||1
359424|NCT01199042|860834|P1|COMPLETED|At Home (3 Months)||26
359425|NCT01199042|860834|P1|STARTED|At Home (3 Months)||27
359426|NCT01199042|860834|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
359427|NCT01199042|860834|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
359428|NCT01199042|860834|P1|STARTED|Sleep Laboratory (3 Nights)||29
359429|NCT01199016|860843|P1|NOT COMPLETED|Overall Study||77
359430|NCT01199016|860843|P1|COMPLETED|Overall Study||162
359431|NCT01199016|860843|P1|Treated|Overall Study||236
359432|NCT01199016|860843|P1|STARTED|Overall Study||239
359433|NCT01198977|860852|P2|NOT COMPLETED|Overall Study||0
359434|NCT01198977|860853|P1|NOT COMPLETED|Overall Study||1
359435|NCT01198977|860852|P2|COMPLETED|Overall Study||33
359436|NCT01198977|860853|P1|COMPLETED|Overall Study||30
359437|NCT01198977|860852|P2|STARTED|Overall Study||33
359438|NCT01198977|860853|P1|STARTED|Overall Study||31
359439|NCT01198873|860865|P2|NOT COMPLETED|Overall Study||32
359440|NCT01198873|860866|P1|NOT COMPLETED|Overall Study||37
359441|NCT01198873|860865|P2|COMPLETED|Overall Study||3
359442|NCT01198873|860866|P1|COMPLETED|Overall Study||4
359443|NCT01198873|860865|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
359444|NCT01198873|860866|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
359445|NCT01198873|860865|P2|Treated|Overall Study||35
359446|NCT01198873|860866|P1|Treated|Overall Study||41
359447|NCT01198873|860865|P2|STARTED|Overall Study||35
359448|NCT01198873|860866|P1|STARTED|Overall Study||41
359449|NCT01198795|860880|P1|NOT COMPLETED|Overall Study||82
359450|NCT01198795|860880|P1|COMPLETED|Overall Study||80
359451|NCT01198795|860880|P1|STARTED|Overall Study||162
359452|NCT01198769|860884|P1|NOT COMPLETED|Overall Study||0
359453|NCT01198769|860884|P1|COMPLETED|Overall Study||15
359454|NCT01198769|860884|P1|STARTED|Overall Study||15
359455|NCT01198756|860897|P4|NOT COMPLETED|Overall Study||26
359456|NCT01198756|860898|P3|NOT COMPLETED|Overall Study||30
359457|NCT01198756|860899|P2|NOT COMPLETED|Overall Study||40
359458|NCT01198756|860900|P1|NOT COMPLETED|Overall Study||38
359459|NCT01198756|860897|P4|COMPLETED|Overall Study||275
359460|NCT01198756|860898|P3|COMPLETED|Overall Study||902
359461|NCT01198756|860899|P2|COMPLETED|Overall Study||889
359462|NCT01198756|860900|P1|COMPLETED|Overall Study||894
359463|NCT01198756|860897|P4|STARTED|Overall Study||301
359464|NCT01198756|860898|P3|STARTED|Overall Study||932
359465|NCT01198756|860899|P2|STARTED|Overall Study||929
359466|NCT01198756|860900|P1|STARTED|Overall Study||932
359467|NCT01198691|860998|P2|NOT COMPLETED|6 Week Post-partum Survey||24
359468|NCT01198691|860999|P1|NOT COMPLETED|6 Week Post-partum Survey||29
359469|NCT01198691|860998|P2|COMPLETED|6 Week Post-partum Survey||26
359470|NCT01198691|860999|P1|COMPLETED|6 Week Post-partum Survey||21
359471|NCT01198691|860998|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
359472|NCT01198691|860999|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
359473|NCT01198691|860998|P2|NOT COMPLETED|Survey Prior to Discharge||33
359474|NCT01198691|860999|P1|NOT COMPLETED|Survey Prior to Discharge||32
359475|NCT01198691|860998|P2|COMPLETED|Survey Prior to Discharge||17
359476|NCT01198691|860999|P1|COMPLETED|Survey Prior to Discharge||18
359477|NCT01198691|860998|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
359478|NCT01198691|860999|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
359479|NCT01198691|860998|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
359480|NCT01198691|860999|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
359481|NCT01198691|860998|P2|COMPLETED|Completed VAS Score at Discharge||44
359482|NCT01198691|860999|P1|COMPLETED|Completed VAS Score at Discharge||45
359483|NCT01198691|860998|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
359484|NCT01198691|860999|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
359485|NCT01198691|860998|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
359486|NCT01198691|860999|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
359487|NCT01198691|860998|P2|COMPLETED|Completed VAS Score Postop Day 1||46
359488|NCT01198691|860999|P1|COMPLETED|Completed VAS Score Postop Day 1||47
359489|NCT01198691|860998|P2|STARTED|Completed VAS Score Postop Day 1||50
359490|NCT01198691|860999|P1|STARTED|Completed VAS Score Postop Day 1||50
359491|NCT01198691|860998|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
359492|NCT01198691|860999|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
359493|NCT01198691|860998|P2|COMPLETED|Completed Surgery -Received Intervention||50
359494|NCT01198691|860999|P1|COMPLETED|Completed Surgery -Received Intervention||50
359495|NCT01198691|860998|P2|STARTED|Completed Surgery -Received Intervention||50
359496|NCT01198691|860999|P1|STARTED|Completed Surgery -Received Intervention||50
359497|NCT01198600|861011|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
359498|NCT01198600|861012|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
359499|NCT01198600|861013|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
359500|NCT01198600|861014|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
359501|NCT01198600|861011|P4|COMPLETED|Phase 3: 43 Days of Wear||38
359502|NCT01198600|861012|P3|COMPLETED|Phase 3: 43 Days of Wear||0
359503|NCT01198600|861013|P2|COMPLETED|Phase 3: 43 Days of Wear||0
359504|NCT01198600|861014|P1|COMPLETED|Phase 3: 43 Days of Wear||0
359505|NCT01198600|861011|P4|STARTED|Phase 3: 43 Days of Wear||38
359506|NCT01198600|861012|P3|STARTED|Phase 3: 43 Days of Wear||0
359507|NCT01198600|861013|P2|STARTED|Phase 3: 43 Days of Wear||0
359508|NCT01198600|861014|P1|STARTED|Phase 3: 43 Days of Wear||0
359509|NCT01198600|861011|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
359510|NCT01198600|861012|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
359511|NCT01198600|861013|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
359512|NCT01198600|861014|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
359513|NCT01198600|861011|P4|COMPLETED|Phase 2: 56 Days of Wear||0
359514|NCT01198600|861012|P3|COMPLETED|Phase 2: 56 Days of Wear||62
359515|NCT01198600|861013|P2|COMPLETED|Phase 2: 56 Days of Wear||0
359516|NCT01198600|861014|P1|COMPLETED|Phase 2: 56 Days of Wear||0
359517|NCT01198600|861011|P4|STARTED|Phase 2: 56 Days of Wear||0
359518|NCT01198600|861012|P3|STARTED|Phase 2: 56 Days of Wear||67
359519|NCT01198600|861013|P2|STARTED|Phase 2: 56 Days of Wear||0
359520|NCT01198600|861014|P1|STARTED|Phase 2: 56 Days of Wear||0
359521|NCT01198600|861011|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
359522|NCT01198600|861012|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
359523|NCT01198600|861013|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
359524|NCT01198600|861014|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
359525|NCT01198600|861011|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
359526|NCT01198600|861012|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
359527|NCT01198600|861013|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
359528|NCT01198600|861014|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
359529|NCT01198600|861011|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
359530|NCT01198600|861012|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
359531|NCT01198600|861013|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
359532|NCT01198600|861014|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
359533|NCT01198600|861011|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
359534|NCT01198600|861012|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
359535|NCT01198600|861013|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
359536|NCT01198600|861014|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
359537|NCT01198600|861011|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
359538|NCT01198600|861012|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
359539|NCT01198600|861013|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
359540|NCT01198600|861014|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
359541|NCT01198600|861011|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
359542|NCT01198600|861012|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
359543|NCT01198600|861013|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
359544|NCT01198600|861014|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
359545|NCT01198574|861040|P4|NOT COMPLETED|Overall Study||4
359546|NCT01198574|861041|P3|NOT COMPLETED|Overall Study||1
359547|NCT01198574|861042|P2|NOT COMPLETED|Overall Study||1
359548|NCT01198574|861043|P1|NOT COMPLETED|Overall Study||4
359549|NCT01198574|861040|P4|COMPLETED|Overall Study||98
359550|NCT01198574|861041|P3|COMPLETED|Overall Study||99
359551|NCT01198574|861042|P2|COMPLETED|Overall Study||101
359552|NCT01198574|861043|P1|COMPLETED|Overall Study||94
359553|NCT01198574|861040|P4|STARTED|Overall Study||102
359554|NCT01198574|861041|P3|STARTED|Overall Study||100
359555|NCT01198574|861042|P2|STARTED|Overall Study||102
359556|NCT01198574|861043|P1|STARTED|Overall Study||98
359557|NCT01198548|861061|P1|NOT COMPLETED|Overall Study||10
359558|NCT01198548|861061|P1|COMPLETED|Overall Study||0
359559|NCT01198548|861061|P1|STARTED|Overall Study||10
359560|NCT01198509|861076|P6|NOT COMPLETED|Overall Study||0
359561|NCT01198509|861077|P5|NOT COMPLETED|Overall Study||0
359562|NCT01198509|861078|P4|NOT COMPLETED|Overall Study||0
359563|NCT01198509|861079|P3|NOT COMPLETED|Overall Study||0
359564|NCT01198509|861080|P2|NOT COMPLETED|Overall Study||0
359565|NCT01198509|861081|P1|NOT COMPLETED|Overall Study||1
359566|NCT01198509|861076|P6|COMPLETED|Overall Study||58
359567|NCT01198509|861077|P5|COMPLETED|Overall Study||20
359568|NCT01198509|861078|P4|COMPLETED|Overall Study||66
359569|NCT01198509|861079|P3|COMPLETED|Overall Study||19
359570|NCT01198509|861080|P2|COMPLETED|Overall Study||10
359571|NCT01198509|861081|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
359572|NCT01198509|861076|P6|STARTED|Overall Study||58
359573|NCT01198509|861077|P5|STARTED|Overall Study||20
359574|NCT01198509|861078|P4|STARTED|Overall Study||66
359575|NCT01198509|861079|P3|STARTED|Overall Study||19
359576|NCT01198509|861080|P2|STARTED|Overall Study||10
359577|NCT01198509|861081|P1|STARTED|Overall Study||5
359578|NCT01198366|861104|P6|NOT COMPLETED|Overall Study||13
359579|NCT01198366|861105|P5|NOT COMPLETED|Overall Study||15
359580|NCT01198366|861106|P4|NOT COMPLETED|Overall Study||5
359581|NCT01198366|861107|P3|NOT COMPLETED|Overall Study||8
359582|NCT01198366|861108|P2|NOT COMPLETED|Overall Study||7
359583|NCT01198366|861109|P1|NOT COMPLETED|Overall Study||12
359584|NCT01198366|861104|P6|COMPLETED|Overall Study||128
359585|NCT01198366|861105|P5|COMPLETED|Overall Study||125
359586|NCT01198366|861106|P4|COMPLETED|Overall Study||47
359587|NCT01198366|861107|P3|COMPLETED|Overall Study||43
359588|NCT01198366|861108|P2|COMPLETED|Overall Study||44
359589|NCT01198366|861109|P1|COMPLETED|Overall Study||40
359590|NCT01198366|861104|P6|STARTED|Overall Study||141
359591|NCT01198366|861105|P5|STARTED|Overall Study||140
359592|NCT01198366|861106|P4|STARTED|Overall Study||52
359593|NCT01198366|861107|P3|STARTED|Overall Study||51
359594|NCT01198366|861108|P2|STARTED|Overall Study||51
359595|NCT01198366|861109|P1|STARTED|Overall Study||52
359596|NCT01198327|861147|P1|NOT COMPLETED|Overall Study||10
359597|NCT01198327|861147|P1|COMPLETED|Overall Study||56
359598|NCT01198327|861147|P1|STARTED|Overall Study||66
359599|NCT01198275|861157|P2|NOT COMPLETED|Overall Study||5
359600|NCT01198275|861158|P1|NOT COMPLETED|Overall Study||6
359601|NCT01198275|861157|P2|COMPLETED|Overall Study||94
359602|NCT01198275|861158|P1|COMPLETED|Overall Study||94
359603|NCT01198275|861157|P2|STARTED|Overall Study||99
359604|NCT01198275|861158|P1|STARTED|Overall Study||100
359605|NCT01198145|861166|P2|NOT COMPLETED|Overall Study||1
359606|NCT01198145|861167|P1|NOT COMPLETED|Overall Study||1
359607|NCT01198145|861166|P2|COMPLETED|Overall Study||42
359608|NCT01198145|861167|P1|COMPLETED|Overall Study||43
359609|NCT01198145|861166|P2|STARTED|Overall Study||43
359610|NCT01198145|861167|P1|STARTED|Overall Study||44
359611|NCT01197911|861190|P3|NOT COMPLETED|Overall Study||1
359612|NCT01197911|861191|P2|NOT COMPLETED|Overall Study||0
359613|NCT01197911|861192|P1|NOT COMPLETED|Overall Study||0
359614|NCT01197911|861190|P3|COMPLETED|Overall Study||9
359615|NCT01197911|861191|P2|COMPLETED|Overall Study||10
359616|NCT01197911|861192|P1|COMPLETED|Overall Study||18
359617|NCT01197911|861190|P3|STARTED|Overall Study||10
359618|NCT01197911|861191|P2|STARTED|Overall Study||10
359619|NCT01197911|861192|P1|STARTED|Overall Study||18
359620|NCT01197898|861277|P2|NOT COMPLETED|Overall Study||0
359621|NCT01197898|861278|P1|NOT COMPLETED|Overall Study||0
359622|NCT01197898|861277|P2|COMPLETED|Overall Study||5
359623|NCT01197898|861278|P1|COMPLETED|Overall Study||5
359624|NCT01197898|861277|P2|STARTED|Overall Study||5
359625|NCT01197898|861278|P1|STARTED|Overall Study||5
359626|NCT01197833|861287|P3|NOT COMPLETED|Overall Study||0
359627|NCT01197833|861288|P2|NOT COMPLETED|Overall Study||0
359628|NCT01197833|861289|P1|NOT COMPLETED|Overall Study||0
359629|NCT01197833|861287|P3|COMPLETED|Overall Study||40
359630|NCT01197833|861288|P2|COMPLETED|Overall Study||39
359631|NCT01197833|861289|P1|COMPLETED|Overall Study||38
359632|NCT01197833|861287|P3|STARTED|Overall Study||40
359633|NCT01197833|861288|P2|STARTED|Overall Study||39
359634|NCT01197833|861289|P1|STARTED|Overall Study||38
359635|NCT01197794|861307|P7|NOT COMPLETED|Overall Study||21
359636|NCT01197794|861308|P6|NOT COMPLETED|Overall Study||19
359637|NCT01197794|861309|P5|NOT COMPLETED|Overall Study||14
359638|NCT01197794|861310|P4|NOT COMPLETED|Overall Study||12
359639|NCT01197794|861311|P3|NOT COMPLETED|Overall Study||13
359640|NCT01197794|861312|P2|NOT COMPLETED|Overall Study||15
359641|NCT01197794|861313|P1|NOT COMPLETED|Overall Study||16
359642|NCT01197794|861307|P7|COMPLETED|Overall Study||142
359643|NCT01197794|861308|P6|COMPLETED|Overall Study||144
359644|NCT01197794|861309|P5|COMPLETED|Overall Study||149
359645|NCT01197794|861310|P4|COMPLETED|Overall Study||152
359646|NCT01197794|861311|P3|COMPLETED|Overall Study||153
359647|NCT01197794|861312|P2|COMPLETED|Overall Study||146
359648|NCT01197794|861313|P1|COMPLETED|Overall Study||148
359649|NCT01197794|861307|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
359650|NCT01197794|861308|P6|STARTED|Overall Study||163
359651|NCT01197794|861309|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
359652|NCT01197794|861310|P4|STARTED|Overall Study||164
359653|NCT01197794|861311|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
359654|NCT01197794|861312|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
359655|NCT01197794|861313|P1|STARTED|Overall Study||164
359656|NCT01197755|861395|P3|NOT COMPLETED|Overall Study||54
359657|NCT01197755|861396|P2|NOT COMPLETED|Overall Study||43
359658|NCT01197755|861397|P1|NOT COMPLETED|Overall Study||38
359659|NCT01197755|861395|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
359660|NCT01197755|861396|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
359661|NCT01197755|861397|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
359662|NCT01197755|861395|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
359663|NCT01197755|861396|P2|Randomised But Did Not Receive Treatment|Overall Study||0
359664|NCT01197755|861397|P1|Randomised But Did Not Receive Treatment|Overall Study||0
359665|NCT01197755|861395|P3|STARTED|Overall Study|Patients who received treatment|109
359666|NCT01197755|861396|P2|STARTED|Overall Study|Patients who received treatment|108
359667|NCT01197755|861397|P1|STARTED|Overall Study|Patients who received treatment|105
359668|NCT01197560|861439|P2|NOT COMPLETED|Overall Study||53
359669|NCT01197560|861440|P1|NOT COMPLETED|Overall Study||46
359670|NCT01197560|861439|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
359671|NCT01197560|861440|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
359672|NCT01197560|861439|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
359673|NCT01197560|861440|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
359674|NCT01197560|861439|P2|Lenalidomide Crossover|Overall Study||29
359675|NCT01197560|861440|P1|Lenalidomide Crossover|Overall Study||0
359676|NCT01197560|861439|P2|Received ≥ One Dose Study Drug|Overall Study||55
359677|NCT01197560|861440|P1|Received ≥ One Dose Study Drug|Overall Study||54
359678|NCT01197560|861439|P2|STARTED|Overall Study|This is the intent to treat population|57
359679|NCT01197560|861440|P1|STARTED|Overall Study|This is the intent to treat population|54
359680|NCT01197547|861464|P1|NOT COMPLETED|Overall Study||22
359681|NCT01197547|861464|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
359682|NCT01197547|861464|P1|STARTED|Overall Study||1014
359683|NCT01197534|861473|P3|NOT COMPLETED|Overall Study||173
359684|NCT01197534|861474|P2|NOT COMPLETED|Overall Study||130
359685|NCT01197534|861475|P1|NOT COMPLETED|Overall Study||134
359686|NCT01197534|861473|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
359687|NCT01197534|861474|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
359688|NCT01197534|861475|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
359689|NCT01197534|861473|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
359690|NCT01197534|861474|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
359691|NCT01197534|861475|P1|Randomised But Did Not Receive Treatment|Overall Study||0
359692|NCT01197534|861473|P3|STARTED|Overall Study|Patients who received treatment|302
359693|NCT01197534|861474|P2|STARTED|Overall Study|Patients who received treatment|298
359694|NCT01197534|861475|P1|STARTED|Overall Study|Patients who received treatment|308
359695|NCT01197521|861519|P3|NOT COMPLETED|Overall Study||143
359696|NCT01197521|861520|P2|NOT COMPLETED|Overall Study||113
359697|NCT01197521|861521|P1|NOT COMPLETED|Overall Study||103
359698|NCT01197521|861519|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
359699|NCT01197521|861520|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
359700|NCT01197521|861521|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
359701|NCT01197521|861519|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
359702|NCT01197521|861520|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
359703|NCT01197521|861521|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
359704|NCT01197521|861519|P3|STARTED|Overall Study|Patients who received treatment|304
359705|NCT01197521|861520|P2|STARTED|Overall Study|Patients who received treatment|304
359706|NCT01197521|861521|P1|STARTED|Overall Study|Patients who received treatment|310
359707|NCT01197508|861566|P4|NOT COMPLETED|Overall Study||16
359708|NCT01197508|861567|P3|NOT COMPLETED|Overall Study||49
359709|NCT01197508|861568|P2|NOT COMPLETED|Overall Study||30
359710|NCT01197508|861569|P1|NOT COMPLETED|Overall Study||23
359711|NCT01197508|861566|P4|COMPLETED|Overall Study||158
359712|NCT01197508|861567|P3|COMPLETED|Overall Study||125
359713|NCT01197508|861568|P2|COMPLETED|Overall Study||144
359714|NCT01197508|861569|P1|COMPLETED|Overall Study||151
359715|NCT01197508|861566|P4|Received Treatment|Overall Study||174
359716|NCT01197508|861567|P3|Received Treatment|Overall Study||171
359717|NCT01197508|861568|P2|Received Treatment|Overall Study||174
359718|NCT01197508|861569|P1|Received Treatment|Overall Study||174
359719|NCT01197508|861566|P4|STARTED|Overall Study||174
359720|NCT01197508|861567|P3|STARTED|Overall Study||174
359721|NCT01197508|861568|P2|STARTED|Overall Study||174
359722|NCT01197508|861569|P1|STARTED|Overall Study||174
359723|NCT01197495|861665|P2|NOT COMPLETED|Overall Study||7
359724|NCT01197495|861666|P1|NOT COMPLETED|Overall Study||13
359725|NCT01197495|861665|P2|COMPLETED|Overall Study||49
359726|NCT01197495|861666|P1|COMPLETED|Overall Study||144
359727|NCT01197495|861665|P2|STARTED|Overall Study||56
359728|NCT01197495|861666|P1|STARTED|Overall Study||157
359729|NCT01197417|861679|P2|NOT COMPLETED|Overall Study||18
359730|NCT01197417|861680|P1|NOT COMPLETED|Overall Study||8
359731|NCT01197417|861679|P2|COMPLETED|Overall Study||86
359732|NCT01197417|861680|P1|COMPLETED|Overall Study||96
359733|NCT01197417|861679|P2|Received Study Drug|Overall Study||103
359734|NCT01197417|861680|P1|Received Study Drug|Overall Study||101
359735|NCT01197417|861679|P2|STARTED|Overall Study||104
359736|NCT01197417|861680|P1|STARTED|Overall Study||104
359737|NCT01197326|861700|P2|NOT COMPLETED|Overall Study||0
359738|NCT01197326|861701|P1|NOT COMPLETED|Overall Study||0
359739|NCT01197326|861700|P2|COMPLETED|Overall Study||209
359740|NCT01197326|861701|P1|COMPLETED|Overall Study||205
359741|NCT01197326|861700|P2|STARTED|Overall Study||209
359742|NCT01197326|861701|P1|STARTED|Overall Study||205
359743|NCT01196988|861713|P4|NOT COMPLETED|Overall Study||1
359744|NCT01196988|861714|P3|NOT COMPLETED|Overall Study||25
359745|NCT01196988|861715|P2|NOT COMPLETED|Overall Study||32
359746|NCT01196988|861716|P1|NOT COMPLETED|Overall Study||24
359747|NCT01196988|861713|P4|COMPLETED|Overall Study||276
359748|NCT01196988|861714|P3|COMPLETED|Overall Study||886
359749|NCT01196988|861715|P2|COMPLETED|Overall Study||880
359750|NCT01196988|861716|P1|COMPLETED|Overall Study||891
359751|NCT01196988|861713|P4|STARTED|Overall Study||277
359752|NCT01196988|861714|P3|STARTED|Overall Study||911
359753|NCT01196988|861715|P2|STARTED|Overall Study||912
359754|NCT01196988|861716|P1|STARTED|Overall Study||915
359755|NCT01196975|861810|P5|NOT COMPLETED|Overall Study||13
359756|NCT01196975|861811|P4|NOT COMPLETED|Overall Study||6
359757|NCT01196975|861812|P3|NOT COMPLETED|Overall Study||5
359758|NCT01196975|861813|P2|NOT COMPLETED|Overall Study||9
359759|NCT01196975|861814|P1|NOT COMPLETED|Overall Study||15
359760|NCT01196975|861810|P5|COMPLETED|Overall Study||205
359761|NCT01196975|861811|P4|COMPLETED|Overall Study||207
359762|NCT01196975|861812|P3|COMPLETED|Overall Study||420
359763|NCT01196975|861813|P2|COMPLETED|Overall Study||415
359764|NCT01196975|861814|P1|COMPLETED|Overall Study||408
359765|NCT01196975|861810|P5|STARTED|Overall Study||218
359766|NCT01196975|861811|P4|STARTED|Overall Study||213
359767|NCT01196975|861812|P3|STARTED|Overall Study||425
359768|NCT01196975|861813|P2|STARTED|Overall Study||424
359769|NCT01196975|861814|P1|STARTED|Overall Study||423
359770|NCT01196923|861946|P1|NOT COMPLETED|Overall Study||0
359771|NCT01196923|861946|P1|COMPLETED|Overall Study||20
359772|NCT01196923|861946|P1|STARTED|Overall Study||20
359773|NCT01196741|861952|P2|NOT COMPLETED|Overall Study||28
359774|NCT01196741|861953|P1|NOT COMPLETED|Overall Study||60
359775|NCT01196741|861952|P2|COMPLETED|Overall Study||8
359776|NCT01196741|861953|P1|COMPLETED|Overall Study||11
359777|NCT01196741|861952|P2|STARTED|Overall Study||36
359778|NCT01196741|861953|P1|STARTED|Overall Study||71
359779|NCT01196442|861967|P1|NOT COMPLETED|Overall Study||0
359780|NCT01196442|861967|P1|COMPLETED|Overall Study||39
359781|NCT01196442|861967|P1|STARTED|Overall Study||39
359782|NCT01196429|861979|P2|NOT COMPLETED|Overall Study||0
359783|NCT01196429|861980|P1|NOT COMPLETED|Overall Study||3
359784|NCT01196429|861979|P2|COMPLETED|Overall Study||45
359785|NCT01196429|861980|P1|COMPLETED|Overall Study||42
359786|NCT01196429|861979|P2|STARTED|Overall Study||45
359787|NCT01196429|861980|P1|STARTED|Overall Study||45
359788|NCT01196104|861998|P2|NOT COMPLETED|Overall Study||5
359789|NCT01196104|861999|P1|NOT COMPLETED|Overall Study||4
359790|NCT01196104|861998|P2|COMPLETED|Overall Study||15
359791|NCT01196104|861999|P1|COMPLETED|Overall Study||15
359792|NCT01196104|861998|P2|STARTED|Overall Study||20
359793|NCT01196104|861999|P1|STARTED|Overall Study||19
359794|NCT01196078|862041|P2|NOT COMPLETED|Overall Study||37
359795|NCT01196078|862042|P1|NOT COMPLETED|Overall Study||33
359796|NCT01196078|862041|P2|COMPLETED|Overall Study||20
359797|NCT01196078|862042|P1|COMPLETED|Overall Study||24
359798|NCT01196078|862041|P2|STARTED|Overall Study||57
359799|NCT01196078|862042|P1|STARTED|Overall Study||57
359800|NCT01196052|862070|P1|NOT COMPLETED|Overall Study||23
359801|NCT01196052|862070|P1|COMPLETED|Overall Study||130
359802|NCT01196052|862070|P1|Received Trastuzumab Emtansine|Overall Study||148
359803|NCT01196052|862070|P1|STARTED|Overall Study||153
359804|NCT01196026|862087|P6|NOT COMPLETED|Overall Study||0
359805|NCT01196026|862088|P5|NOT COMPLETED|Overall Study||1
359806|NCT01196026|862089|P4|NOT COMPLETED|Overall Study||0
359807|NCT01196026|862090|P3|NOT COMPLETED|Overall Study||0
359808|NCT01196026|862091|P2|NOT COMPLETED|Overall Study||8
359809|NCT01196026|862092|P1|NOT COMPLETED|Overall Study||1
359810|NCT01196026|862087|P6|COMPLETED|Overall Study||24
359811|NCT01196026|862088|P5|COMPLETED|Overall Study||42
359812|NCT01196026|862089|P4|COMPLETED|Overall Study||10
359813|NCT01196026|862090|P3|COMPLETED|Overall Study||23
359814|NCT01196026|862091|P2|COMPLETED|Overall Study||36
359815|NCT01196026|862092|P1|COMPLETED|Overall Study||9
359816|NCT01196026|862087|P6|Completed at Day 28|Overall Study||24
359817|NCT01196026|862088|P5|Completed at Day 28|Overall Study||42
359818|NCT01196026|862089|P4|Completed at Day 28|Overall Study||10
359819|NCT01196026|862090|P3|Completed at Day 28|Overall Study||23
359820|NCT01196026|862091|P2|Completed at Day 28|Overall Study||41
359821|NCT01196026|862092|P1|Completed at Day 28|Overall Study||9
359822|NCT01196026|862087|P6|STARTED|Overall Study||24
359823|NCT01196026|862088|P5|STARTED|Overall Study||43
359824|NCT01196026|862089|P4|STARTED|Overall Study||10
359825|NCT01196026|862090|P3|STARTED|Overall Study||23
359826|NCT01196026|862091|P2|STARTED|Overall Study||44
359827|NCT01196026|862092|P1|STARTED|Overall Study||10
359828|NCT01195948|862328|P3|NOT COMPLETED|Overall Study||2
359829|NCT01195948|862329|P2|NOT COMPLETED|Overall Study||1
359830|NCT01195948|862330|P1|NOT COMPLETED|Overall Study||0
359831|NCT01195948|862328|P3|COMPLETED|Overall Study||9
359832|NCT01195948|862329|P2|COMPLETED|Overall Study||9
359833|NCT01195948|862330|P1|COMPLETED|Overall Study||10
359834|NCT01195948|862328|P3|Week 24|Overall Study||10
359835|NCT01195948|862329|P2|Week 24|Overall Study||10
359836|NCT01195948|862330|P1|Week 24|Overall Study||10
359837|NCT01195948|862328|P3|STARTED|Overall Study||11
359838|NCT01195948|862329|P2|STARTED|Overall Study||10
359839|NCT01195948|862330|P1|STARTED|Overall Study||10
359840|NCT01195922|862356|P1|NOT COMPLETED|Overall Study||0
359841|NCT01195922|862356|P1|COMPLETED|Overall Study||16
359842|NCT01195922|862356|P1|STARTED|Overall Study||16
359843|NCT01195844|862362|P1|NOT COMPLETED|Overall Study||40
359844|NCT01195844|862362|P1|COMPLETED|Overall Study||190
359845|NCT01195844|862362|P1|STARTED|Overall Study||230
359846|NCT01195831|862379|P2|NOT COMPLETED|Overall Study||10
359847|NCT01195831|862380|P1|NOT COMPLETED|Overall Study||8
359848|NCT01195831|862379|P2|COMPLETED|Overall Study||114
359849|NCT01195831|862380|P1|COMPLETED|Overall Study||112
359850|NCT01195831|862379|P2|STARTED|Overall Study||124
359851|NCT01195831|862380|P1|STARTED|Overall Study||120
359852|NCT01195779|862408|P14|NOT COMPLETED|Overall Study||0
359853|NCT01195779|862409|P13|NOT COMPLETED|Overall Study||0
359854|NCT01195779|862410|P12|NOT COMPLETED|Overall Study||0
359855|NCT01195779|862411|P11|NOT COMPLETED|Overall Study||0
359856|NCT01195779|862412|P10|NOT COMPLETED|Overall Study||0
359857|NCT01195779|862413|P9|NOT COMPLETED|Overall Study||0
359858|NCT01195779|862414|P8|NOT COMPLETED|Overall Study||0
359859|NCT01195779|862415|P7|NOT COMPLETED|Overall Study||0
359860|NCT01195779|862416|P6|NOT COMPLETED|Overall Study||0
359861|NCT01195779|862417|P5|NOT COMPLETED|Overall Study||0
359862|NCT01195779|862418|P4|NOT COMPLETED|Overall Study||0
359863|NCT01195779|862419|P3|NOT COMPLETED|Overall Study||0
359864|NCT01195779|862420|P2|NOT COMPLETED|Overall Study||0
359865|NCT01195779|862421|P1|NOT COMPLETED|Overall Study||0
359866|NCT01195779|862408|P14|COMPLETED|Overall Study||1
359867|NCT01195779|862409|P13|COMPLETED|Overall Study||0
359868|NCT01195779|862410|P12|COMPLETED|Overall Study||1
359869|NCT01195779|862411|P11|COMPLETED|Overall Study||0
359870|NCT01195779|862412|P10|COMPLETED|Overall Study||0
359871|NCT01195779|862413|P9|COMPLETED|Overall Study||0
359872|NCT01195779|862414|P8|COMPLETED|Overall Study||1
359873|NCT01195779|862415|P7|COMPLETED|Overall Study||0
359874|NCT01195779|862416|P6|COMPLETED|Overall Study||0
359875|NCT01195779|862417|P5|COMPLETED|Overall Study||1
359876|NCT01195779|862418|P4|COMPLETED|Overall Study||0
359877|NCT01195779|862419|P3|COMPLETED|Overall Study||0
359878|NCT01195779|862420|P2|COMPLETED|Overall Study||0
359879|NCT01195779|862421|P1|COMPLETED|Overall Study||0
359880|NCT01195779|862408|P14|STARTED|Overall Study||1
359881|NCT01195779|862409|P13|STARTED|Overall Study||0
359882|NCT01195779|862410|P12|STARTED|Overall Study||1
359883|NCT01195779|862411|P11|STARTED|Overall Study||0
359884|NCT01195779|862412|P10|STARTED|Overall Study||0
359885|NCT01195779|862413|P9|STARTED|Overall Study||0
359886|NCT01195779|862414|P8|STARTED|Overall Study||1
359887|NCT01195779|862415|P7|STARTED|Overall Study||0
359888|NCT01195779|862416|P6|STARTED|Overall Study||0
359889|NCT01195779|862417|P5|STARTED|Overall Study||1
359890|NCT01195779|862418|P4|STARTED|Overall Study||0
359891|NCT01195779|862419|P3|STARTED|Overall Study||0
359892|NCT01195779|862420|P2|STARTED|Overall Study||0
359893|NCT01195779|862421|P1|STARTED|Overall Study||0
359894|NCT01195701|862593|P2|NOT COMPLETED|Overall Study||5
359895|NCT01195701|862594|P1|NOT COMPLETED|Overall Study||0
359896|NCT01195701|862593|P2|COMPLETED|Overall Study||20
359897|NCT01195701|862594|P1|COMPLETED|Overall Study||10
359898|NCT01195701|862593|P2|STARTED|Overall Study||25
359899|NCT01195701|862594|P1|STARTED|Overall Study||10
359900|NCT01195675|862620|P1|NOT COMPLETED|Overall Study||3
359901|NCT01195675|862620|P1|COMPLETED|Overall Study||27
359902|NCT01195675|862620|P1|Received Placebo 2|Overall Study||28
359903|NCT01195675|862620|P1|Received Placebo 1|Overall Study||29
359904|NCT01195675|862620|P1|Received Moxifloxacin|Overall Study||29
359905|NCT01195675|862620|P1|Received Empa 200mg|Overall Study||30
359906|NCT01195675|862620|P1|Received Empa 25mg|Overall Study||28
359907|NCT01195675|862620|P1|STARTED|Overall Study||30
359908|NCT01195662|862653|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
359909|NCT01195662|862654|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
359910|NCT01195662|862655|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
359911|NCT01195662|862653|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
359912|NCT01195662|862654|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
359913|NCT01195662|862655|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
359914|NCT01195662|862653|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
360002|NCT01195025|862863|P3|NOT COMPLETED|Third Intervention C||0
359915|NCT01195662|862654|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
359916|NCT01195662|862655|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
359917|NCT01195662|862653|P3|NOT COMPLETED|Double Blind Treatment Period||14
359918|NCT01195662|862654|P2|NOT COMPLETED|Double Blind Treatment Period||14
359919|NCT01195662|862655|P1|NOT COMPLETED|Double Blind Treatment Period||22
359920|NCT01195662|862653|P3|COMPLETED|Double Blind Treatment Period||119
359921|NCT01195662|862654|P2|COMPLETED|Double Blind Treatment Period||211
359922|NCT01195662|862655|P1|COMPLETED|Double Blind Treatment Period||202
359923|NCT01195662|862653|P3|STARTED|Double Blind Treatment Period||133
359924|NCT01195662|862654|P2|STARTED|Double Blind Treatment Period||225
359925|NCT01195662|862655|P1|STARTED|Double Blind Treatment Period||224
359926|NCT01195636|862685|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
359927|NCT01195636|862686|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
359928|NCT01195636|862685|P2|COMPLETED|Second Intervention (3 Weeks)||27
359929|NCT01195636|862686|P1|COMPLETED|Second Intervention (3 Weeks)||27
359930|NCT01195636|862685|P2|STARTED|Second Intervention (3 Weeks)||29
359931|NCT01195636|862686|P1|STARTED|Second Intervention (3 Weeks)||28
359932|NCT01195636|862685|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
359933|NCT01195636|862686|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
359934|NCT01195636|862685|P2|COMPLETED|Washout Period (2 Weeks)||29
359935|NCT01195636|862686|P1|COMPLETED|Washout Period (2 Weeks)||28
359936|NCT01195636|862685|P2|STARTED|Washout Period (2 Weeks)||32
359937|NCT01195636|862686|P1|STARTED|Washout Period (2 Weeks)||30
359938|NCT01195636|862685|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
359939|NCT01195636|862686|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
359940|NCT01195636|862685|P2|COMPLETED|First Intervention (3 Weeks)||32
359941|NCT01195636|862686|P1|COMPLETED|First Intervention (3 Weeks)||30
359942|NCT01195636|862685|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
359943|NCT01195636|862686|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
359944|NCT01195636|862685|P2|STARTED|First Intervention (3 Weeks)||35
359945|NCT01195636|862686|P1|STARTED|First Intervention (3 Weeks)||35
359946|NCT01195623|862712|P2|NOT COMPLETED|Overall Study||37
359947|NCT01195623|862713|P1|NOT COMPLETED|Overall Study||35
359948|NCT01195623|862712|P2|COMPLETED|Overall Study|129 legs|108
359949|NCT01195623|862713|P1|COMPLETED|Overall Study|127 legs|113
359950|NCT01195623|862712|P2|STARTED|Overall Study|177 legs total operated|145
359951|NCT01195623|862713|P1|STARTED|Overall Study|166 legs total operated|148
359952|NCT01195597|862721|P1|NOT COMPLETED|Overall Study||13
359953|NCT01195597|862721|P1|COMPLETED|Overall Study||27
359954|NCT01195597|862721|P1|STARTED|Overall Study||40
359955|NCT01195584|862729|P3|NOT COMPLETED|Overall Study||0
359956|NCT01195584|862730|P2|NOT COMPLETED|Overall Study||0
359957|NCT01195584|862731|P1|NOT COMPLETED|Overall Study||0
359958|NCT01195584|862729|P3|COMPLETED|Overall Study||27
359959|NCT01195584|862730|P2|COMPLETED|Overall Study||25
359960|NCT01195584|862731|P1|COMPLETED|Overall Study||20
359961|NCT01195584|862729|P3|STARTED|Overall Study||27
359962|NCT01195584|862730|P2|STARTED|Overall Study||25
359963|NCT01195584|862731|P1|STARTED|Overall Study||20
359964|NCT01195467|862742|P1|NOT COMPLETED|Overall Study||10
359965|NCT01195467|862742|P1|COMPLETED|Overall Study||30
359966|NCT01195467|862742|P1|STARTED|Overall Study||40
359967|NCT01195415|862747|P1|NOT COMPLETED|Overall Study||2
359968|NCT01195415|862747|P1|COMPLETED|Overall Study||23
359969|NCT01195415|862747|P1|STARTED|Overall Study||25
359970|NCT01195363|862754|P2|NOT COMPLETED|Overall Study||9
359971|NCT01195363|862755|P1|NOT COMPLETED|Overall Study||11
359972|NCT01195363|862754|P2|COMPLETED|Overall Study||4
359973|NCT01195363|862755|P1|COMPLETED|Overall Study||4
359974|NCT01195363|862754|P2|STARTED|Overall Study||13
359975|NCT01195363|862755|P1|STARTED|Overall Study||15
359976|NCT01195272|862761|P1|NOT COMPLETED|Overall Study||4
359977|NCT01195272|862761|P1|COMPLETED|Overall Study||17
359978|NCT01195272|862761|P1|STARTED|Overall Study||21
359979|NCT01195116|862780|P2|NOT COMPLETED|Overall Study||0
359980|NCT01195116|862781|P1|NOT COMPLETED|Overall Study||0
359981|NCT01195116|862780|P2|COMPLETED|Overall Study||20
359982|NCT01195116|862781|P1|COMPLETED|Overall Study||21
359983|NCT01195116|862780|P2|STARTED|Overall Study||20
359984|NCT01195116|862781|P1|STARTED|Overall Study||21
359985|NCT01195103|862790|P3|NOT COMPLETED|Overall Study||0
359986|NCT01195103|862791|P2|NOT COMPLETED|Overall Study||0
359987|NCT01195103|862792|P1|NOT COMPLETED|Overall Study||1
359988|NCT01195103|862790|P3|COMPLETED|Overall Study||5
359989|NCT01195103|862791|P2|COMPLETED|Overall Study||2
359990|NCT01195103|862792|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
359991|NCT01195103|862790|P3|STARTED|Overall Study||5
359992|NCT01195103|862791|P2|STARTED|Overall Study||2
359993|NCT01195103|862792|P1|STARTED|Overall Study||6
359994|NCT01195090|862802|P2|NOT COMPLETED|Overall Study||8
359995|NCT01195090|862803|P1|NOT COMPLETED|Overall Study||6
359996|NCT01195090|862802|P2|COMPLETED|Overall Study||52
359997|NCT01195090|862803|P1|COMPLETED|Overall Study||54
359998|NCT01195090|862802|P2|STARTED|Overall Study||60
359999|NCT01195090|862803|P1|STARTED|Overall Study||60
360000|NCT01195025|862861|P5|NOT COMPLETED|Third Intervention C||0
360001|NCT01195025|862862|P4|NOT COMPLETED|Third Intervention C||0
360003|NCT01195025|862864|P2|NOT COMPLETED|Third Intervention C||0
360004|NCT01195025|862865|P1|NOT COMPLETED|Third Intervention C||0
360005|NCT01195025|862861|P5|COMPLETED|Third Intervention C||1
360006|NCT01195025|862862|P4|COMPLETED|Third Intervention C||2
360007|NCT01195025|862863|P3|COMPLETED|Third Intervention C||2
360008|NCT01195025|862864|P2|COMPLETED|Third Intervention C||3
360009|NCT01195025|862865|P1|COMPLETED|Third Intervention C||2
360010|NCT01195025|862861|P5|STARTED|Third Intervention C||1
360011|NCT01195025|862862|P4|STARTED|Third Intervention C||2
360012|NCT01195025|862863|P3|STARTED|Third Intervention C||2
360013|NCT01195025|862864|P2|STARTED|Third Intervention C||3
360014|NCT01195025|862865|P1|STARTED|Third Intervention C||2
360015|NCT01195025|862861|P5|NOT COMPLETED|Second Intervention B||0
360016|NCT01195025|862862|P4|NOT COMPLETED|Second Intervention B||0
360017|NCT01195025|862863|P3|NOT COMPLETED|Second Intervention B||0
360018|NCT01195025|862864|P2|NOT COMPLETED|Second Intervention B||0
360019|NCT01195025|862865|P1|NOT COMPLETED|Second Intervention B||0
360020|NCT01195025|862861|P5|COMPLETED|Second Intervention B||1
360021|NCT01195025|862862|P4|COMPLETED|Second Intervention B||2
360022|NCT01195025|862863|P3|COMPLETED|Second Intervention B||2
360023|NCT01195025|862864|P2|COMPLETED|Second Intervention B||3
360024|NCT01195025|862865|P1|COMPLETED|Second Intervention B||2
360025|NCT01195025|862861|P5|STARTED|Second Intervention B||1
360026|NCT01195025|862862|P4|STARTED|Second Intervention B||2
360027|NCT01195025|862863|P3|STARTED|Second Intervention B||2
360028|NCT01195025|862864|P2|STARTED|Second Intervention B||3
360029|NCT01195025|862865|P1|STARTED|Second Intervention B||2
360030|NCT01195025|862861|P5|NOT COMPLETED|First Intervention A||0
360031|NCT01195025|862862|P4|NOT COMPLETED|First Intervention A||0
360032|NCT01195025|862863|P3|NOT COMPLETED|First Intervention A||0
360033|NCT01195025|862864|P2|NOT COMPLETED|First Intervention A||0
360034|NCT01195025|862865|P1|NOT COMPLETED|First Intervention A||0
360035|NCT01195025|862861|P5|COMPLETED|First Intervention A||1
360036|NCT01195025|862862|P4|COMPLETED|First Intervention A||2
360037|NCT01195025|862863|P3|COMPLETED|First Intervention A||2
360038|NCT01195025|862864|P2|COMPLETED|First Intervention A||3
360039|NCT01195025|862865|P1|COMPLETED|First Intervention A||2
360040|NCT01195025|862861|P5|STARTED|First Intervention A||1
360041|NCT01195025|862862|P4|STARTED|First Intervention A||2
360042|NCT01195025|862863|P3|STARTED|First Intervention A||2
360043|NCT01195025|862864|P2|STARTED|First Intervention A||3
360044|NCT01195025|862865|P1|STARTED|First Intervention A||2
360045|NCT01194999|862872|P1|NOT COMPLETED|Overall Study||17
360046|NCT01194999|862872|P1|COMPLETED|Overall Study||115
360047|NCT01194999|862872|P1|STARTED|Overall Study||132
360048|NCT01194973|862876|P1|NOT COMPLETED|26 Week Treatment Period||3
360049|NCT01194973|862876|P1|COMPLETED|26 Week Treatment Period||38
360050|NCT01194973|862876|P1|STARTED|26 Week Treatment Period||41
360051|NCT01194973|862876|P1|NOT COMPLETED|Screening Period||3
360052|NCT01194973|862876|P1|COMPLETED|Screening Period||41
360053|NCT01194973|862876|P1|STARTED|Screening Period||44
360054|NCT01194908|862891|P1|NOT COMPLETED|Overall Study||0
360055|NCT01194908|862891|P1|COMPLETED|Overall Study||5
360056|NCT01194908|862891|P1|STARTED|Overall Study||5
360057|NCT01194869|862896|P1|NOT COMPLETED|Overall Study||4
360058|NCT01194869|862896|P1|COMPLETED|Overall Study||21
360059|NCT01194869|862896|P1|STARTED|Overall Study||25
360060|NCT01194830|862904|P2|NOT COMPLETED|Overall Study||27
360061|NCT01194830|862905|P1|NOT COMPLETED|Overall Study||36
360062|NCT01194830|862904|P2|COMPLETED|Overall Study||83
360063|NCT01194830|862905|P1|COMPLETED|Overall Study||88
360064|NCT01194830|862904|P2|STARTED|Overall Study||110
360065|NCT01194830|862905|P1|STARTED|Overall Study||124
360066|NCT01194674|862927|P1|NOT COMPLETED|Overall Study||0
360067|NCT01194674|862927|P1|COMPLETED|Overall Study||2
360068|NCT01194674|862927|P1|STARTED|Overall Study||2
360069|NCT01194531|862936|P2|NOT COMPLETED|Overall Study||3
360070|NCT01194531|862937|P1|NOT COMPLETED|Overall Study||5
360071|NCT01194531|862936|P2|COMPLETED|Overall Study||27
360072|NCT01194531|862937|P1|COMPLETED|Overall Study||24
360073|NCT01194531|862936|P2|STARTED|Overall Study||30
360074|NCT01194531|862937|P1|STARTED|Overall Study||29
360075|NCT01194479|862945|P4|NOT COMPLETED|Overall Study||0
360076|NCT01194479|862946|P3|NOT COMPLETED|Overall Study||0
360077|NCT01194479|862947|P2|NOT COMPLETED|Overall Study||0
360078|NCT01194479|862948|P1|NOT COMPLETED|Overall Study||0
360079|NCT01194479|862945|P4|COMPLETED|Overall Study||5
360080|NCT01194479|862946|P3|COMPLETED|Overall Study||2
360081|NCT01194479|862947|P2|COMPLETED|Overall Study||4
360082|NCT01194479|862948|P1|COMPLETED|Overall Study||3
360083|NCT01194479|862945|P4|Cross-over at Second Visit|Overall Study||5
360084|NCT01194479|862946|P3|Cross-over at Second Visit|Overall Study||2
360085|NCT01194479|862947|P2|Cross-over at Second Visit|Overall Study||4
360086|NCT01194479|862948|P1|Cross-over at Second Visit|Overall Study||3
360087|NCT01194479|862945|P4|STARTED|Overall Study||5
360088|NCT01194479|862946|P3|STARTED|Overall Study||2
360089|NCT01194479|862947|P2|STARTED|Overall Study||4
360090|NCT01194479|862948|P1|STARTED|Overall Study||3
360091|NCT01194453|862972|P2|NOT COMPLETED|Overall Study||17
360092|NCT01194453|862973|P1|NOT COMPLETED|Overall Study||17
360093|NCT01194453|862972|P2|COMPLETED|Overall Study||127
360094|NCT01194453|862973|P1|COMPLETED|Overall Study||127
360095|NCT01194453|862972|P2|STARTED|Overall Study||144
360096|NCT01194453|862973|P1|STARTED|Overall Study||144
360097|NCT01194440|862981|P1|NOT COMPLETED|Overall Study||12
360098|NCT01194440|862981|P1|COMPLETED|Overall Study||47
360099|NCT01194440|862981|P1|STARTED|Overall Study||59
360100|NCT01194427|862985|P1|NOT COMPLETED|Overall Study||0
360101|NCT01194427|862985|P1|COMPLETED|Overall Study||2
360102|NCT01194427|862985|P1|STARTED|Overall Study||2
360103|NCT01194414|862991|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
360104|NCT01194414|862992|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
360105|NCT01194414|862993|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
360106|NCT01194414|862994|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
360107|NCT01194414|862991|P4|COMPLETED|72 Weeks Open Label Extension||160
360108|NCT01194414|862992|P3|COMPLETED|72 Weeks Open Label Extension||40
360109|NCT01194414|862993|P2|COMPLETED|72 Weeks Open Label Extension||311
360110|NCT01194414|862994|P1|COMPLETED|72 Weeks Open Label Extension||445
360111|NCT01194414|862991|P4|STARTED|72 Weeks Open Label Extension||186
360112|NCT01194414|862992|P3|STARTED|72 Weeks Open Label Extension||48
360113|NCT01194414|862993|P2|STARTED|72 Weeks Open Label Extension||377
360114|NCT01194414|862994|P1|STARTED|72 Weeks Open Label Extension||524
360115|NCT01194414|862991|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
360116|NCT01194414|862992|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
360117|NCT01194414|862993|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
360118|NCT01194414|862994|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
360119|NCT01194414|862991|P4|COMPLETED|24 Weeks Double Blind Period||0
360120|NCT01194414|862992|P3|COMPLETED|24 Weeks Double Blind Period||0
360121|NCT01194414|862993|P2|COMPLETED|24 Weeks Double Blind Period||564
360122|NCT01194414|862994|P1|COMPLETED|24 Weeks Double Blind Period||572
360123|NCT01194414|862991|P4|Per Protocol Population|24 Weeks Double Blind Period||0
360124|NCT01194414|862992|P3|Per Protocol Population|24 Weeks Double Blind Period||0
360125|NCT01194414|862993|P2|Per Protocol Population|24 Weeks Double Blind Period||537
360126|NCT01194414|862994|P1|Per Protocol Population|24 Weeks Double Blind Period||558
360127|NCT01194414|862991|P4|STARTED|24 Weeks Double Blind Period||0
360128|NCT01194414|862992|P3|STARTED|24 Weeks Double Blind Period||0
360129|NCT01194414|862993|P2|STARTED|24 Weeks Double Blind Period||631
360130|NCT01194414|862994|P1|STARTED|24 Weeks Double Blind Period||631
360131|NCT01194297|863056|P2|NOT COMPLETED|Overall Study||0
360132|NCT01194297|863057|P1|NOT COMPLETED|Overall Study||0
360133|NCT01194297|863056|P2|COMPLETED|Overall Study||1
360134|NCT01194297|863057|P1|COMPLETED|Overall Study||2
360135|NCT01194297|863056|P2|STARTED|Overall Study||1
360136|NCT01194297|863057|P1|STARTED|Overall Study||2
360137|NCT01194258|863065|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
360138|NCT01194258|863066|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
360139|NCT01194258|863067|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
360140|NCT01194258|863068|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
360141|NCT01194258|863069|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
360142|NCT01194258|863065|P5|COMPLETED|Period 2 (12 Weeks)||30
360143|NCT01194258|863066|P4|COMPLETED|Period 2 (12 Weeks)||29
360144|NCT01194258|863067|P3|COMPLETED|Period 2 (12 Weeks)||29
360145|NCT01194258|863068|P2|COMPLETED|Period 2 (12 Weeks)||27
360146|NCT01194258|863069|P1|COMPLETED|Period 2 (12 Weeks)||0
360147|NCT01194258|863065|P5|STARTED|Period 2 (12 Weeks)||32
360148|NCT01194258|863066|P4|STARTED|Period 2 (12 Weeks)||29
360149|NCT01194258|863067|P3|STARTED|Period 2 (12 Weeks)||30
360150|NCT01194258|863068|P2|STARTED|Period 2 (12 Weeks)||29
360151|NCT01194258|863069|P1|STARTED|Period 2 (12 Weeks)||0
360152|NCT01194258|863065|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
360153|NCT01194258|863066|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
360154|NCT01194258|863067|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
360155|NCT01194258|863068|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
360156|NCT01194258|863069|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
360157|NCT01194258|863065|P5|COMPLETED|Period 1 (12 Weeks)||32
360158|NCT01194258|863066|P4|COMPLETED|Period 1 (12 Weeks)||29
360159|NCT01194258|863067|P3|COMPLETED|Period 1 (12 Weeks)||30
360160|NCT01194258|863068|P2|COMPLETED|Period 1 (12 Weeks)||29
360161|NCT01194258|863069|P1|COMPLETED|Period 1 (12 Weeks)||0
360162|NCT01194258|863065|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
360163|NCT01194258|863066|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
360164|NCT01194258|863067|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
360165|NCT01194258|863068|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
360166|NCT01194258|863069|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
360167|NCT01194258|863065|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
360168|NCT01194258|863066|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
360169|NCT01194258|863067|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
360170|NCT01194258|863068|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
360171|NCT01194258|863069|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
360172|NCT01194258|863065|P5|NOT COMPLETED|Titration Period||0
360173|NCT01194258|863066|P4|NOT COMPLETED|Titration Period||0
360174|NCT01194258|863067|P3|NOT COMPLETED|Titration Period||0
360175|NCT01194258|863068|P2|NOT COMPLETED|Titration Period||0
360176|NCT01194258|863069|P1|NOT COMPLETED|Titration Period||11
360177|NCT01194258|863065|P5|COMPLETED|Titration Period||0
360178|NCT01194258|863066|P4|COMPLETED|Titration Period||0
360179|NCT01194258|863067|P3|COMPLETED|Titration Period||0
360180|NCT01194258|863068|P2|COMPLETED|Titration Period||0
360181|NCT01194258|863069|P1|COMPLETED|Titration Period||121
360182|NCT01194258|863065|P5|STARTED|Titration Period||0
360183|NCT01194258|863066|P4|STARTED|Titration Period||0
360184|NCT01194258|863067|P3|STARTED|Titration Period||0
360185|NCT01194258|863068|P2|STARTED|Titration Period||0
360186|NCT01194258|863069|P1|STARTED|Titration Period||132
360187|NCT01194245|863093|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
360188|NCT01194245|863094|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
360189|NCT01194245|863095|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
360420|NCT01193608|863370|P1|NOT COMPLETED|Overall Study||0
360190|NCT01194245|863096|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
360191|NCT01194245|863097|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
360192|NCT01194245|863093|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
360193|NCT01194245|863094|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
360194|NCT01194245|863095|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
360195|NCT01194245|863096|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
360196|NCT01194245|863097|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
360197|NCT01194245|863093|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
360198|NCT01194245|863094|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
360199|NCT01194245|863095|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
360200|NCT01194245|863096|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
360201|NCT01194245|863097|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
360202|NCT01194245|863093|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
360203|NCT01194245|863094|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
360204|NCT01194245|863095|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
360205|NCT01194245|863096|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
360206|NCT01194245|863097|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
360207|NCT01194245|863093|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
360208|NCT01194245|863094|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
360209|NCT01194245|863095|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
360210|NCT01194245|863096|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
360211|NCT01194245|863097|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
360212|NCT01194245|863093|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
360213|NCT01194245|863094|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
360214|NCT01194245|863095|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
360215|NCT01194245|863096|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
360216|NCT01194245|863097|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
360217|NCT01194245|863093|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
360218|NCT01194245|863094|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
360219|NCT01194245|863095|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
360220|NCT01194245|863096|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
360221|NCT01194245|863097|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
360222|NCT01194245|863093|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
360223|NCT01194245|863094|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
360224|NCT01194245|863095|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
360225|NCT01194245|863096|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
360226|NCT01194245|863097|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
360227|NCT01194245|863093|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
360228|NCT01194245|863094|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
360229|NCT01194245|863095|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
360230|NCT01194245|863096|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
360231|NCT01194245|863097|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
360232|NCT01194245|863093|P5|STARTED|Titration Period (4 to 6 Weeks)||0
360233|NCT01194245|863094|P4|STARTED|Titration Period (4 to 6 Weeks)||0
360234|NCT01194245|863095|P3|STARTED|Titration Period (4 to 6 Weeks)||0
360235|NCT01194245|863096|P2|STARTED|Titration Period (4 to 6 Weeks)||0
360236|NCT01194245|863097|P1|STARTED|Titration Period (4 to 6 Weeks)||135
360237|NCT01194219|863118|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||45
360238|NCT01194219|863119|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||61
360239|NCT01194219|863120|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
360240|NCT01194219|863121|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
360241|NCT01194219|863122|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360242|NCT01194219|863123|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360243|NCT01194219|863124|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360244|NCT01194219|863125|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360245|NCT01194219|863118|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
360246|NCT01194219|863119|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
360247|NCT01194219|863120|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
360248|NCT01194219|863121|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
360249|NCT01194219|863122|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360250|NCT01194219|863123|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360251|NCT01194219|863124|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360252|NCT01194219|863125|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
360253|NCT01194219|863118|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||91
360254|NCT01194219|863119|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||126
360255|NCT01194219|863120|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
360256|NCT01194219|863121|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
360257|NCT01194219|863122|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
360258|NCT01194219|863123|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
360259|NCT01194219|863124|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
360260|NCT01194219|863125|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
360261|NCT01194219|863118|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||208
360262|NCT01194219|863119|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||245
360263|NCT01194219|863120|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
360264|NCT01194219|863121|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
360265|NCT01194219|863122|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
360266|NCT01194219|863123|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
360267|NCT01194219|863124|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
360268|NCT01194219|863125|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
360269|NCT01194219|863118|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
360270|NCT01194219|863119|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
360271|NCT01194219|863120|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
360272|NCT01194219|863121|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
360273|NCT01194219|863122|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||30
360274|NCT01194219|863123|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||70
360275|NCT01194219|863124|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
360276|NCT01194219|863125|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
360277|NCT01194219|863118|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
360278|NCT01194219|863119|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
360279|NCT01194219|863120|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
360280|NCT01194219|863121|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
360281|NCT01194219|863122|P4|COMPLETED|Maintenance Phase (Weeks16-32)||215
360282|NCT01194219|863123|P3|COMPLETED|Maintenance Phase (Weeks16-32)||424
360283|NCT01194219|863124|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
360284|NCT01194219|863125|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
360285|NCT01194219|863118|P8|Received Apremilast|Maintenance Phase (Weeks16-32)||0
360286|NCT01194219|863119|P7|Received Apremilast|Maintenance Phase (Weeks16-32)||0
360287|NCT01194219|863120|P6|Received Apremilast|Maintenance Phase (Weeks16-32)||0
360288|NCT01194219|863121|P5|Received Apremilast|Maintenance Phase (Weeks16-32)||0
360289|NCT01194219|863122|P4|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|244
360290|NCT01194219|863123|P3|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|493
360291|NCT01194219|863124|P2|Received Apremilast|Maintenance Phase (Weeks16-32)||0
360292|NCT01194219|863125|P1|Received Apremilast|Maintenance Phase (Weeks16-32)||0
360293|NCT01194219|863118|P8|STARTED|Maintenance Phase (Weeks16-32)||0
360294|NCT01194219|863119|P7|STARTED|Maintenance Phase (Weeks16-32)||0
360295|NCT01194219|863120|P6|STARTED|Maintenance Phase (Weeks16-32)||0
360296|NCT01194219|863121|P5|STARTED|Maintenance Phase (Weeks16-32)||0
360297|NCT01194219|863122|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
360298|NCT01194219|863123|P3|STARTED|Maintenance Phase (Weeks16-32)|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
360299|NCT01194219|863124|P2|STARTED|Maintenance Phase (Weeks16-32)||0
360300|NCT01194219|863125|P1|STARTED|Maintenance Phase (Weeks16-32)||0
360301|NCT01194219|863118|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360302|NCT01194219|863119|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360303|NCT01194219|863120|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360304|NCT01194219|863121|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360305|NCT01194219|863122|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360306|NCT01194219|863123|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360307|NCT01194219|863124|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||33
360308|NCT01194219|863125|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||59
360309|NCT01194219|863118|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360310|NCT01194219|863119|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360311|NCT01194219|863120|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360312|NCT01194219|863121|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360313|NCT01194219|863122|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360314|NCT01194219|863123|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
360315|NCT01194219|863124|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||249
360316|NCT01194219|863125|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||503
360317|NCT01194219|863118|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
360318|NCT01194219|863119|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
360319|NCT01194219|863120|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
360320|NCT01194219|863121|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
360321|NCT01194219|863122|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
360322|NCT01194219|863123|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
360323|NCT01194219|863124|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||282
360324|NCT01194219|863125|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||560
360325|NCT01194219|863118|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
360326|NCT01194219|863119|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
360327|NCT01194219|863120|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
360328|NCT01194219|863121|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
360329|NCT01194219|863122|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
360330|NCT01194219|863123|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
360331|NCT01194219|863124|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||282
360332|NCT01194219|863125|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||562
360333|NCT01194154|863157|P2|NOT COMPLETED|Overall Study||33
360334|NCT01194154|863158|P1|NOT COMPLETED|Overall Study||49
360335|NCT01194154|863157|P2|COMPLETED|Overall Study||91
360336|NCT01194154|863158|P1|COMPLETED|Overall Study||68
360337|NCT01194154|863157|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
360338|NCT01194154|863158|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
360339|NCT01194154|863157|P2|Full Analysis Set|Overall Study||120
360340|NCT01194154|863158|P1|Full Analysis Set|Overall Study||115
360341|NCT01194154|863157|P2|STARTED|Overall Study||124
360342|NCT01194154|863158|P1|STARTED|Overall Study||117
360343|NCT01194089|863178|P2|NOT COMPLETED|Overall Study||0
360344|NCT01194089|863179|P1|NOT COMPLETED|Overall Study||0
360345|NCT01194089|863178|P2|COMPLETED|Overall Study||47
360346|NCT01194089|863179|P1|COMPLETED|Overall Study||42
360347|NCT01194089|863178|P2|STARTED|Overall Study||47
360348|NCT01194089|863179|P1|STARTED|Overall Study||42
360349|NCT01193920|863199|P10|NOT COMPLETED|Overall Study||7
360350|NCT01193920|863200|P9|NOT COMPLETED|Overall Study||5
360351|NCT01193920|863201|P8|NOT COMPLETED|Overall Study||4
360352|NCT01193920|863202|P7|NOT COMPLETED|Overall Study||6
360353|NCT01193920|863203|P6|NOT COMPLETED|Overall Study||4
360354|NCT01193920|863204|P5|NOT COMPLETED|Overall Study||6
360355|NCT01193920|863205|P4|NOT COMPLETED|Overall Study||4
360356|NCT01193920|863206|P3|NOT COMPLETED|Overall Study||6
360357|NCT01193920|863207|P2|NOT COMPLETED|Overall Study||0
360358|NCT01193920|863208|P1|NOT COMPLETED|Overall Study||3
360359|NCT01193920|863199|P10|COMPLETED|Overall Study||74
360360|NCT01193920|863200|P9|COMPLETED|Overall Study||71
360361|NCT01193920|863201|P8|COMPLETED|Overall Study||76
360362|NCT01193920|863202|P7|COMPLETED|Overall Study||74
360363|NCT01193920|863203|P6|COMPLETED|Overall Study||76
360364|NCT01193920|863204|P5|COMPLETED|Overall Study||74
360365|NCT01193920|863205|P4|COMPLETED|Overall Study||76
360366|NCT01193920|863206|P3|COMPLETED|Overall Study||74
360367|NCT01193920|863207|P2|COMPLETED|Overall Study||20
360368|NCT01193920|863208|P1|COMPLETED|Overall Study||37
360369|NCT01193920|863199|P10|STARTED|Overall Study||81
360370|NCT01193920|863200|P9|STARTED|Overall Study||76
360371|NCT01193920|863201|P8|STARTED|Overall Study||80
360372|NCT01193920|863202|P7|STARTED|Overall Study||80
360373|NCT01193920|863203|P6|STARTED|Overall Study||80
360374|NCT01193920|863204|P5|STARTED|Overall Study||80
360375|NCT01193920|863205|P4|STARTED|Overall Study||80
360376|NCT01193920|863206|P3|STARTED|Overall Study||80
360377|NCT01193920|863207|P2|STARTED|Overall Study||20
360378|NCT01193920|863208|P1|STARTED|Overall Study||40
360379|NCT01193907|863262|P4|NOT COMPLETED|Overall Study||1
360380|NCT01193907|863263|P3|NOT COMPLETED|Overall Study||0
360381|NCT01193907|863264|P2|NOT COMPLETED|Overall Study||0
360382|NCT01193907|863265|P1|NOT COMPLETED|Overall Study||1
360383|NCT01193907|863262|P4|COMPLETED|Overall Study||21
360384|NCT01193907|863263|P3|COMPLETED|Overall Study||22
360385|NCT01193907|863264|P2|COMPLETED|Overall Study||22
360386|NCT01193907|863265|P1|COMPLETED|Overall Study||21
360387|NCT01193907|863262|P4|STARTED|Overall Study||22
360388|NCT01193907|863263|P3|STARTED|Overall Study||22
360389|NCT01193907|863264|P2|STARTED|Overall Study||22
360390|NCT01193907|863265|P1|STARTED|Overall Study||22
360391|NCT01193868|863287|P1|NOT COMPLETED|Overall Study||0
360392|NCT01193868|863287|P1|COMPLETED|Overall Study||6
360393|NCT01193868|863287|P1|STARTED|Overall Study||6
360394|NCT01193686|863301|P2|NOT COMPLETED|Overall Study||1
360395|NCT01193686|863302|P1|NOT COMPLETED|Overall Study||7
360396|NCT01193686|863301|P2|COMPLETED|Overall Study||8
360397|NCT01193686|863302|P1|COMPLETED|Overall Study||8
360398|NCT01193686|863301|P2|Completed Visits and Final Assessment|Overall Study||8
360399|NCT01193686|863302|P1|Completed Visits and Final Assessment|Overall Study||8
360400|NCT01193686|863301|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
360401|NCT01193686|863302|P1|Completed Mentor Training|Overall Study||9
360402|NCT01193686|863301|P2|Completed Baseline Assessment|Overall Study||9
360403|NCT01193686|863302|P1|Completed Baseline Assessment|Overall Study||15
360404|NCT01193686|863301|P2|STARTED|Overall Study||9
360405|NCT01193686|863302|P1|STARTED|Overall Study||15
360406|NCT01193660|863319|P3|NOT COMPLETED|Overall Study||2
360407|NCT01193660|863320|P2|NOT COMPLETED|Overall Study||3
360408|NCT01193660|863321|P1|NOT COMPLETED|Overall Study||4
360409|NCT01193660|863319|P3|COMPLETED|Overall Study||32
360410|NCT01193660|863320|P2|COMPLETED|Overall Study||33
360411|NCT01193660|863321|P1|COMPLETED|Overall Study||31
360412|NCT01193660|863319|P3|STARTED|Overall Study||34
360413|NCT01193660|863320|P2|STARTED|Overall Study||36
360414|NCT01193660|863321|P1|STARTED|Overall Study||35
360415|NCT01193608|863365|P6|NOT COMPLETED|Overall Study||2
360416|NCT01193608|863366|P5|NOT COMPLETED|Overall Study||5
360417|NCT01193608|863367|P4|NOT COMPLETED|Overall Study||3
360418|NCT01193608|863368|P3|NOT COMPLETED|Overall Study||2
360419|NCT01193608|863369|P2|NOT COMPLETED|Overall Study||2
360421|NCT01193608|863365|P6|COMPLETED|Overall Study||17
360422|NCT01193608|863366|P5|COMPLETED|Overall Study||19
360423|NCT01193608|863367|P4|COMPLETED|Overall Study||14
360424|NCT01193608|863368|P3|COMPLETED|Overall Study||14
360425|NCT01193608|863369|P2|COMPLETED|Overall Study||4
360426|NCT01193608|863370|P1|COMPLETED|Overall Study||6
360427|NCT01193608|863365|P6|STARTED|Overall Study||19
360428|NCT01193608|863366|P5|STARTED|Overall Study||24
360429|NCT01193608|863367|P4|STARTED|Overall Study||17
360430|NCT01193608|863368|P3|STARTED|Overall Study||16
360431|NCT01193608|863369|P2|STARTED|Overall Study||6
360432|NCT01193608|863370|P1|STARTED|Overall Study||6
360433|NCT01193582|863607|P4|NOT COMPLETED|12 Month Follow-up||11
360434|NCT01193582|863608|P3|NOT COMPLETED|12 Month Follow-up||4
360435|NCT01193582|863609|P2|NOT COMPLETED|12 Month Follow-up||0
360436|NCT01193582|863610|P1|NOT COMPLETED|12 Month Follow-up||6
360437|NCT01193582|863607|P4|COMPLETED|12 Month Follow-up||166
360438|NCT01193582|863608|P3|COMPLETED|12 Month Follow-up||113
360439|NCT01193582|863609|P2|COMPLETED|12 Month Follow-up||88
360440|NCT01193582|863610|P1|COMPLETED|12 Month Follow-up||83
360441|NCT01193582|863607|P4|STARTED|12 Month Follow-up||177
360442|NCT01193582|863608|P3|STARTED|12 Month Follow-up||117
360443|NCT01193582|863609|P2|STARTED|12 Month Follow-up||88
360444|NCT01193582|863610|P1|STARTED|12 Month Follow-up||89
360445|NCT01193582|863607|P4|NOT COMPLETED|Vaccination Series||3
360446|NCT01193582|863608|P3|NOT COMPLETED|Vaccination Series||8
360447|NCT01193582|863609|P2|NOT COMPLETED|Vaccination Series||13
360448|NCT01193582|863610|P1|NOT COMPLETED|Vaccination Series||11
360449|NCT01193582|863607|P4|COMPLETED|Vaccination Series||177
360450|NCT01193582|863608|P3|COMPLETED|Vaccination Series||117
360451|NCT01193582|863609|P2|COMPLETED|Vaccination Series||88
360452|NCT01193582|863610|P1|COMPLETED|Vaccination Series||89
360453|NCT01193582|863607|P4|Vaccinated Dose 4|Vaccination Series||0
360454|NCT01193582|863608|P3|Vaccinated Dose 4|Vaccination Series||0
360455|NCT01193582|863609|P2|Vaccinated Dose 4|Vaccination Series||0
360456|NCT01193582|863610|P1|Vaccinated Dose 4|Vaccination Series||90
360457|NCT01193582|863607|P4|Vaccinated Dose 3|Vaccination Series||0
360458|NCT01193582|863608|P3|Vaccinated Dose 3|Vaccination Series||0
360459|NCT01193582|863609|P2|Vaccinated Dose 3|Vaccination Series||89
360460|NCT01193582|863610|P1|Vaccinated Dose 3|Vaccination Series||90
360461|NCT01193582|863607|P4|Vaccinated Dose 2|Vaccination Series||0
360462|NCT01193582|863608|P3|Vaccinated Dose 2|Vaccination Series||118
360463|NCT01193582|863609|P2|Vaccinated Dose 2|Vaccination Series||91
360464|NCT01193582|863610|P1|Vaccinated Dose 2|Vaccination Series||92
360465|NCT01193582|863607|P4|Vaccinated Dose 1|Vaccination Series||180
360466|NCT01193582|863608|P3|Vaccinated Dose 1|Vaccination Series||125
360467|NCT01193582|863609|P2|Vaccinated Dose 1|Vaccination Series||100
360468|NCT01193582|863610|P1|Vaccinated Dose 1|Vaccination Series||100
360469|NCT01193582|863607|P4|STARTED|Vaccination Series||180
360470|NCT01193582|863608|P3|STARTED|Vaccination Series||125
360471|NCT01193582|863609|P2|STARTED|Vaccination Series||101
360472|NCT01193582|863610|P1|STARTED|Vaccination Series||100
360473|NCT01193556|863640|P2|NOT COMPLETED|Overall Study||25
360474|NCT01193556|863641|P1|NOT COMPLETED|Overall Study||26
360475|NCT01193556|863640|P2|COMPLETED|Overall Study||0
360476|NCT01193556|863641|P1|COMPLETED|Overall Study||0
360477|NCT01193556|863640|P2|STARTED|Overall Study||25
360478|NCT01193556|863641|P1|STARTED|Overall Study||26
360479|NCT01193348|863649|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
360480|NCT01193348|863649|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
360481|NCT01193348|863649|P1|STARTED|Post Treatment Period (Patients Who Disc||10
360482|NCT01193348|863649|P1|NOT COMPLETED|Extension Treatment Period||1
360483|NCT01193348|863649|P1|COMPLETED|Extension Treatment Period||16
360484|NCT01193348|863649|P1|STARTED|Extension Treatment Period||17
360485|NCT01193348|863649|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
360486|NCT01193348|863649|P1|COMPLETED|Treatment Period (26 Weeks)||19
360487|NCT01193348|863649|P1|STARTED|Treatment Period (26 Weeks)||22
360488|NCT01193348|863649|P1|NOT COMPLETED|Screening Period||5
360489|NCT01193348|863649|P1|COMPLETED|Screening Period||22
360490|NCT01193348|863649|P1|STARTED|Screening Period||27
360491|NCT01193335|863669|P2|NOT COMPLETED|2-Year Follow-up||8
360492|NCT01193335|863670|P1|NOT COMPLETED|2-Year Follow-up||7
360493|NCT01193335|863669|P2|COMPLETED|2-Year Follow-up||80
360494|NCT01193335|863670|P1|COMPLETED|2-Year Follow-up||81
360495|NCT01193335|863669|P2|STARTED|2-Year Follow-up||88
360496|NCT01193335|863670|P1|STARTED|2-Year Follow-up||88
360497|NCT01193335|863669|P2|NOT COMPLETED|1-Year Follow-up||9
360498|NCT01193335|863670|P1|NOT COMPLETED|1-Year Follow-up||11
360499|NCT01193335|863669|P2|COMPLETED|1-Year Follow-up||88
360500|NCT01193335|863670|P1|COMPLETED|1-Year Follow-up||88
360501|NCT01193335|863669|P2|STARTED|1-Year Follow-up||97
360502|NCT01193335|863670|P1|STARTED|1-Year Follow-up||99
360503|NCT01193335|863669|P2|NOT COMPLETED|Toddler Dose||0
360504|NCT01193335|863670|P1|NOT COMPLETED|Toddler Dose||0
360505|NCT01193335|863669|P2|COMPLETED|Toddler Dose||97
360506|NCT01193335|863670|P1|COMPLETED|Toddler Dose||99
360507|NCT01193335|863669|P2|STARTED|Toddler Dose||97
360508|NCT01193335|863670|P1|STARTED|Toddler Dose||99
360509|NCT01193335|863669|P2|NOT COMPLETED|After Infant Series||3
360510|NCT01193335|863670|P1|NOT COMPLETED|After Infant Series||1
360511|NCT01193335|863669|P2|COMPLETED|After Infant Series||97
360512|NCT01193335|863670|P1|COMPLETED|After Infant Series||99
360513|NCT01193335|863669|P2|STARTED|After Infant Series||100
360514|NCT01193335|863670|P1|STARTED|After Infant Series||100
360515|NCT01193335|863669|P2|NOT COMPLETED|Infant Series||0
360516|NCT01193335|863670|P1|NOT COMPLETED|Infant Series||0
360517|NCT01193335|863669|P2|COMPLETED|Infant Series||100
360518|NCT01193335|863670|P1|COMPLETED|Infant Series||100
360519|NCT01193335|863669|P2|STARTED|Infant Series||100
360520|NCT01193335|863670|P1|STARTED|Infant Series||100
360521|NCT01193283|863765|P1|NOT COMPLETED|Overall Study||1
360522|NCT01193283|863765|P1|COMPLETED|Overall Study||21
360523|NCT01193283|863765|P1|STARTED|Overall Study||22
360524|NCT01193244|863771|P2|NOT COMPLETED|Overall Study||390
360525|NCT01193244|863772|P1|NOT COMPLETED|Overall Study||388
360526|NCT01193244|863771|P2|COMPLETED|Overall Study||391
360527|NCT01193244|863772|P1|COMPLETED|Overall Study||391
360528|NCT01193244|863771|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
360529|NCT01193244|863772|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
360530|NCT01193244|863771|P2|STARTED|Overall Study||781
360531|NCT01193244|863772|P1|STARTED|Overall Study||779
360532|NCT01193218|863827|P8|NOT COMPLETED|12-52 Weeks||4
360533|NCT01193218|863828|P7|NOT COMPLETED|12-52 Weeks||3
360534|NCT01193218|863829|P6|NOT COMPLETED|12-52 Weeks||5
360535|NCT01193218|863830|P5|NOT COMPLETED|12-52 Weeks||4
360536|NCT01193218|863831|P4|NOT COMPLETED|12-52 Weeks||3
360537|NCT01193218|863832|P3|NOT COMPLETED|12-52 Weeks||4
360538|NCT01193218|863833|P2|NOT COMPLETED|12-52 Weeks||0
360539|NCT01193218|863834|P1|NOT COMPLETED|12-52 Weeks||5
360540|NCT01193218|863827|P8|COMPLETED|12-52 Weeks||49
360541|NCT01193218|863828|P7|COMPLETED|12-52 Weeks||51
360542|NCT01193218|863829|P6|COMPLETED|12-52 Weeks||101
360543|NCT01193218|863830|P5|COMPLETED|12-52 Weeks||104
360544|NCT01193218|863831|P4|COMPLETED|12-52 Weeks||50
360545|NCT01193218|863832|P3|COMPLETED|12-52 Weeks||50
360546|NCT01193218|863833|P2|COMPLETED|12-52 Weeks||50
360547|NCT01193218|863834|P1|COMPLETED|12-52 Weeks||45
360548|NCT01193218|863827|P8|STARTED|12-52 Weeks||53
360549|NCT01193218|863828|P7|STARTED|12-52 Weeks||54
360550|NCT01193218|863829|P6|STARTED|12-52 Weeks||106
360551|NCT01193218|863830|P5|STARTED|12-52 Weeks||108
360552|NCT01193218|863831|P4|STARTED|12-52 Weeks||53
360553|NCT01193218|863832|P3|STARTED|12-52 Weeks||54
360554|NCT01193218|863833|P2|STARTED|12-52 Weeks||50
360555|NCT01193218|863834|P1|STARTED|12-52 Weeks||50
360556|NCT01193218|863827|P8|NOT COMPLETED|0-12 Weeks||0
360557|NCT01193218|863828|P7|NOT COMPLETED|0-12 Weeks||3
360558|NCT01193218|863829|P6|NOT COMPLETED|0-12 Weeks||3
360559|NCT01193218|863830|P5|NOT COMPLETED|0-12 Weeks||1
360560|NCT01193218|863831|P4|NOT COMPLETED|0-12 Weeks||0
360561|NCT01193218|863832|P3|NOT COMPLETED|0-12 Weeks||3
360562|NCT01193218|863833|P2|NOT COMPLETED|0-12 Weeks||0
360563|NCT01193218|863834|P1|NOT COMPLETED|0-12 Weeks||9
360564|NCT01193218|863827|P8|COMPLETED|0-12 Weeks||0
360565|NCT01193218|863828|P7|COMPLETED|0-12 Weeks||107
360566|NCT01193218|863829|P6|COMPLETED|0-12 Weeks||106
360567|NCT01193218|863830|P5|COMPLETED|0-12 Weeks||108
360568|NCT01193218|863831|P4|COMPLETED|0-12 Weeks||0
360569|NCT01193218|863832|P3|COMPLETED|0-12 Weeks||107
360570|NCT01193218|863833|P2|COMPLETED|0-12 Weeks||0
360571|NCT01193218|863834|P1|COMPLETED|0-12 Weeks||100
360572|NCT01193218|863827|P8|STARTED|0-12 Weeks|It is actually N/A|0
360573|NCT01193218|863828|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
360574|NCT01193218|863829|P6|STARTED|0-12 Weeks||109
360575|NCT01193218|863830|P5|STARTED|0-12 Weeks||109
360576|NCT01193218|863831|P4|STARTED|0-12 Weeks|It is actually N/A|0
360577|NCT01193218|863832|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
360578|NCT01193218|863833|P2|STARTED|0-12 Weeks|It is actually N/A|0
360579|NCT01193218|863834|P1|STARTED|0-12 Weeks|It is actually placebo group|109
360580|NCT01193153|863865|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
360581|NCT01193153|863866|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
360582|NCT01193153|863865|P2|COMPLETED|Double Blind Relapse Prevention Period||65
360583|NCT01193153|863866|P1|COMPLETED|Double Blind Relapse Prevention Period||100
360584|NCT01193153|863865|P2|STARTED|Double Blind Relapse Prevention Period||170
360585|NCT01193153|863866|P1|STARTED|Double Blind Relapse Prevention Period||164
360586|NCT01193153|863865|P2|NOT COMPLETED|Open-label Stabilization Period||0
360587|NCT01193153|863866|P1|NOT COMPLETED|Open-label Stabilization Period||98
360588|NCT01193153|863865|P2|COMPLETED|Open-label Stabilization Period||0
360589|NCT01193153|863866|P1|COMPLETED|Open-label Stabilization Period||334
360590|NCT01193153|863865|P2|STARTED|Open-label Stabilization Period||0
360591|NCT01193153|863866|P1|STARTED|Open-label Stabilization Period||432
360592|NCT01193153|863865|P2|NOT COMPLETED|Open-label Lead in Period||0
360593|NCT01193153|863866|P1|NOT COMPLETED|Open-label Lead in Period||235
360594|NCT01193153|863865|P2|COMPLETED|Open-label Lead in Period||0
360595|NCT01193153|863866|P1|COMPLETED|Open-label Lead in Period||432
360596|NCT01193153|863865|P2|STARTED|Open-label Lead in Period||0
360597|NCT01193153|863866|P1|STARTED|Open-label Lead in Period||667
360598|NCT01193127|863901|P4|NOT COMPLETED|Treated||1
360599|NCT01193127|863902|P3|NOT COMPLETED|Treated||0
360600|NCT01193127|863903|P2|NOT COMPLETED|Treated||0
360601|NCT01193127|863904|P1|NOT COMPLETED|Treated||0
360602|NCT01193127|863901|P4|COMPLETED|Treated||55
360603|NCT01193127|863902|P3|COMPLETED|Treated||55
360604|NCT01193127|863903|P2|COMPLETED|Treated||54
360605|NCT01193127|863904|P1|COMPLETED|Treated||57
360606|NCT01193127|863901|P4|STARTED|Treated||56
360607|NCT01193127|863902|P3|STARTED|Treated||55
360608|NCT01193127|863903|P2|STARTED|Treated||54
360609|NCT01193127|863904|P1|STARTED|Treated||57
360610|NCT01193127|863901|P4|NOT COMPLETED|Randomized||1
360611|NCT01193127|863902|P3|NOT COMPLETED|Randomized||0
360612|NCT01193127|863903|P2|NOT COMPLETED|Randomized||0
360613|NCT01193127|863904|P1|NOT COMPLETED|Randomized||0
360614|NCT01193127|863901|P4|COMPLETED|Randomized||56
360615|NCT01193127|863902|P3|COMPLETED|Randomized||55
360616|NCT01193127|863903|P2|COMPLETED|Randomized||54
360617|NCT01193127|863904|P1|COMPLETED|Randomized||57
360618|NCT01193127|863901|P4|STARTED|Randomized||57
360619|NCT01193127|863902|P3|STARTED|Randomized||55
360620|NCT01193127|863903|P2|STARTED|Randomized||54
360621|NCT01193127|863904|P1|STARTED|Randomized||57
360622|NCT01193114|864208|P2|NOT COMPLETED|Overall Study||0
360623|NCT01193114|864209|P1|NOT COMPLETED|Overall Study||0
360624|NCT01193114|864208|P2|COMPLETED|Overall Study||30
360625|NCT01193114|864209|P1|COMPLETED|Overall Study||30
360626|NCT01193114|864208|P2|STARTED|Overall Study||30
360627|NCT01193114|864209|P1|STARTED|Overall Study||30
360628|NCT01193101|864229|P4|NOT COMPLETED|Overall Study||12
360629|NCT01193101|864230|P3|NOT COMPLETED|Overall Study||3
360630|NCT01193101|864231|P2|NOT COMPLETED|Overall Study||7
360631|NCT01193101|864232|P1|NOT COMPLETED|Overall Study||5
360632|NCT01193101|864229|P4|COMPLETED|Overall Study||80
360633|NCT01193101|864230|P3|COMPLETED|Overall Study||93
360634|NCT01193101|864231|P2|COMPLETED|Overall Study||94
360635|NCT01193101|864232|P1|COMPLETED|Overall Study||95
360636|NCT01193101|864229|P4|Placebo Withdrawal Set|Overall Study||80
360637|NCT01193101|864230|P3|Placebo Withdrawal Set|Overall Study||93
360638|NCT01193101|864231|P2|Placebo Withdrawal Set|Overall Study||94
360639|NCT01193101|864232|P1|Placebo Withdrawal Set|Overall Study||95
360640|NCT01193101|864229|P4|Full Analysis Set|Overall Study||92
360641|NCT01193101|864230|P3|Full Analysis Set|Overall Study||96
360642|NCT01193101|864231|P2|Full Analysis Set|Overall Study||101
360643|NCT01193101|864232|P1|Full Analysis Set|Overall Study||100
360644|NCT01193101|864229|P4|STARTED|Overall Study||92
360645|NCT01193101|864230|P3|STARTED|Overall Study||96
360646|NCT01193101|864231|P2|STARTED|Overall Study||101
360647|NCT01193101|864232|P1|STARTED|Overall Study||100
360648|NCT01193049|864288|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
360649|NCT01193049|864289|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
360650|NCT01193049|864288|P2|COMPLETED|Period 3 : Double Blind Crossover||6
360651|NCT01193049|864289|P1|COMPLETED|Period 3 : Double Blind Crossover||5
360652|NCT01193049|864288|P2|STARTED|Period 3 : Double Blind Crossover||6
360653|NCT01193049|864289|P1|STARTED|Period 3 : Double Blind Crossover||5
360654|NCT01193049|864288|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
360655|NCT01193049|864289|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
360656|NCT01193049|864288|P2|COMPLETED|Washout 2 : 21 Day Washout||6
360657|NCT01193049|864289|P1|COMPLETED|Washout 2 : 21 Day Washout||5
360658|NCT01193049|864288|P2|STARTED|Washout 2 : 21 Day Washout||6
360659|NCT01193049|864289|P1|STARTED|Washout 2 : 21 Day Washout||5
360660|NCT01193049|864288|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
360661|NCT01193049|864289|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
360662|NCT01193049|864288|P2|COMPLETED|Period 2 : Double Blind Crossover||6
360663|NCT01193049|864289|P1|COMPLETED|Period 2 : Double Blind Crossover||5
360664|NCT01193049|864288|P2|STARTED|Period 2 : Double Blind Crossover||6
360665|NCT01193049|864289|P1|STARTED|Period 2 : Double Blind Crossover||5
360666|NCT01193049|864288|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
360667|NCT01193049|864289|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
360668|NCT01193049|864288|P2|COMPLETED|Washout 1 : 21 Day Washout||6
360669|NCT01193049|864289|P1|COMPLETED|Washout 1 : 21 Day Washout||5
360670|NCT01193049|864288|P2|STARTED|Washout 1 : 21 Day Washout||6
360671|NCT01193049|864289|P1|STARTED|Washout 1 : 21 Day Washout||5
360672|NCT01193049|864288|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
360673|NCT01193049|864289|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
360674|NCT01193049|864288|P2|COMPLETED|Period 1: Placebo Run-In||6
360675|NCT01193049|864289|P1|COMPLETED|Period 1: Placebo Run-In||5
360676|NCT01193049|864288|P2|STARTED|Period 1: Placebo Run-In||6
360677|NCT01193049|864289|P1|STARTED|Period 1: Placebo Run-In||5
360678|NCT01192542|864319|P2|NOT COMPLETED|Period 2||0
360679|NCT01192542|864320|P1|NOT COMPLETED|Period 2||0
360680|NCT01192542|864319|P2|COMPLETED|Period 2||20
360681|NCT01192542|864320|P1|COMPLETED|Period 2||18
360682|NCT01192542|864319|P2|STARTED|Period 2||20
360683|NCT01192542|864320|P1|STARTED|Period 2||18
360684|NCT01192542|864319|P2|NOT COMPLETED|Period 1||0
360685|NCT01192542|864320|P1|NOT COMPLETED|Period 1||0
360686|NCT01192542|864319|P2|COMPLETED|Period 1||20
360687|NCT01192542|864320|P1|COMPLETED|Period 1||18
360688|NCT01192542|864319|P2|STARTED|Period 1||20
360689|NCT01192542|864320|P1|STARTED|Period 1||18
360690|NCT01192516|864334|P3|NOT COMPLETED|Overall Study||8
360691|NCT01192516|864335|P2|NOT COMPLETED|Overall Study||17
360692|NCT01192516|864336|P1|NOT COMPLETED|Overall Study||20
360693|NCT01192516|864334|P3|COMPLETED|Overall Study||55
360694|NCT01192516|864335|P2|COMPLETED|Overall Study||49
360695|NCT01192516|864336|P1|COMPLETED|Overall Study||46
360696|NCT01192516|864334|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
360697|NCT01192516|864335|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
360698|NCT01192516|864336|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
360699|NCT01192412|864370|P2|NOT COMPLETED|Overall Study||2
360700|NCT01192412|864371|P1|NOT COMPLETED|Overall Study||4
360701|NCT01192412|864370|P2|COMPLETED|Overall Study||488
360702|NCT01192412|864371|P1|COMPLETED|Overall Study||493
360703|NCT01192412|864370|P2|STARTED|Overall Study||490
360704|NCT01192412|864371|P1|STARTED|Overall Study||497
360705|NCT01192347|864379|P1|NOT COMPLETED|Overall Study||12
360706|NCT01192347|864379|P1|COMPLETED|Overall Study||163
360707|NCT01192347|864379|P1|STARTED|Overall Study||175
360708|NCT01192295|864402|P2|NOT COMPLETED|Overall Study||23
360709|NCT01192295|864403|P1|NOT COMPLETED|Overall Study||10
360710|NCT01192295|864402|P2|COMPLETED|Overall Study||105
360711|NCT01192295|864403|P1|COMPLETED|Overall Study||17
360712|NCT01192295|864402|P2|STARTED|Overall Study||128
360713|NCT01192295|864403|P1|STARTED|Overall Study||27
360714|NCT01192282|864420|P1|NOT COMPLETED|Overall Study||0
360715|NCT01192282|864420|P1|COMPLETED|Overall Study||156
360716|NCT01192282|864420|P1|STARTED|Overall Study||156
360717|NCT01192204|864437|P2|NOT COMPLETED|Overall Study||0
360718|NCT01192204|864438|P1|NOT COMPLETED|Overall Study||1
360719|NCT01192204|864437|P2|COMPLETED|Overall Study||18
360720|NCT01192204|864438|P1|COMPLETED|Overall Study||22
360721|NCT01192204|864437|P2|STARTED|Overall Study||18
360722|NCT01192204|864438|P1|STARTED|Overall Study||23
360723|NCT01192191|864450|P2|NOT COMPLETED|Overall Study||21
360724|NCT01192191|864451|P1|NOT COMPLETED|Overall Study||11
360725|NCT01192191|864450|P2|COMPLETED|Overall Study||106
360726|NCT01192191|864451|P1|COMPLETED|Overall Study||49
360727|NCT01192191|864450|P2|STARTED|Overall Study||127
360728|NCT01192191|864451|P1|STARTED|Overall Study||60
360729|NCT01192178|864477|P2|NOT COMPLETED|Overall Study||23
360730|NCT01192178|864478|P1|NOT COMPLETED|Overall Study||24
360731|NCT01192178|864477|P2|COMPLETED|Overall Study||145
360732|NCT01192178|864478|P1|COMPLETED|Overall Study||147
360733|NCT01192178|864477|P2|STARTED|Overall Study||168
360734|NCT01192178|864478|P1|STARTED|Overall Study||171
360735|NCT01192152|864498|P2|NOT COMPLETED|Period 3||0
360736|NCT01192152|864499|P1|NOT COMPLETED|Period 3||1
360737|NCT01192152|864498|P2|COMPLETED|Period 3||0
360738|NCT01192152|864499|P1|COMPLETED|Period 3||14
360739|NCT01192152|864498|P2|STARTED|Period 3||0
360740|NCT01192152|864499|P1|STARTED|Period 3||15
360741|NCT01192152|864498|P2|NOT COMPLETED|Period 2||0
360742|NCT01192152|864499|P1|NOT COMPLETED|Period 2||0
360743|NCT01192152|864498|P2|COMPLETED|Period 2||14
360744|NCT01192152|864499|P1|COMPLETED|Period 2||15
360745|NCT01192152|864498|P2|STARTED|Period 2||14
360746|NCT01192152|864499|P1|STARTED|Period 2||15
360747|NCT01192152|864498|P2|NOT COMPLETED|Period 1||1
360748|NCT01192152|864499|P1|NOT COMPLETED|Period 1||0
360749|NCT01192152|864498|P2|COMPLETED|Period 1||14
360750|NCT01192152|864499|P1|COMPLETED|Period 1||15
360751|NCT01192152|864498|P2|STARTED|Period 1||15
360752|NCT01192152|864499|P1|STARTED|Period 1||15
360753|NCT01192139|864600|P6|NOT COMPLETED|Period 3||0
360754|NCT01192139|864601|P5|NOT COMPLETED|Period 3||0
360755|NCT01192139|864602|P4|NOT COMPLETED|Period 3||0
360756|NCT01192139|864603|P3|NOT COMPLETED|Period 3||0
360757|NCT01192139|864604|P2|NOT COMPLETED|Period 3||0
360758|NCT01192139|864605|P1|NOT COMPLETED|Period 3||0
360759|NCT01192139|864600|P6|COMPLETED|Period 3||5
360760|NCT01192139|864601|P5|COMPLETED|Period 3||5
360761|NCT01192139|864602|P4|COMPLETED|Period 3||5
360762|NCT01192139|864603|P3|COMPLETED|Period 3||5
360763|NCT01192139|864604|P2|COMPLETED|Period 3||5
360764|NCT01192139|864605|P1|COMPLETED|Period 3||5
360765|NCT01192139|864600|P6|STARTED|Period 3||5
360766|NCT01192139|864601|P5|STARTED|Period 3||5
360767|NCT01192139|864602|P4|STARTED|Period 3||5
360768|NCT01192139|864603|P3|STARTED|Period 3||5
360769|NCT01192139|864604|P2|STARTED|Period 3||5
360770|NCT01192139|864605|P1|STARTED|Period 3||5
360771|NCT01192139|864600|P6|NOT COMPLETED|Period 2||0
360772|NCT01192139|864601|P5|NOT COMPLETED|Period 2||0
360773|NCT01192139|864602|P4|NOT COMPLETED|Period 2||0
360774|NCT01192139|864603|P3|NOT COMPLETED|Period 2||0
360775|NCT01192139|864604|P2|NOT COMPLETED|Period 2||0
360776|NCT01192139|864605|P1|NOT COMPLETED|Period 2||0
360777|NCT01192139|864600|P6|COMPLETED|Period 2||5
360778|NCT01192139|864601|P5|COMPLETED|Period 2||5
360779|NCT01192139|864602|P4|COMPLETED|Period 2||5
360780|NCT01192139|864603|P3|COMPLETED|Period 2||5
360781|NCT01192139|864604|P2|COMPLETED|Period 2||5
360782|NCT01192139|864605|P1|COMPLETED|Period 2||5
360783|NCT01192139|864600|P6|STARTED|Period 2||5
360784|NCT01192139|864601|P5|STARTED|Period 2||5
360785|NCT01192139|864602|P4|STARTED|Period 2||5
360786|NCT01192139|864603|P3|STARTED|Period 2||5
360787|NCT01192139|864604|P2|STARTED|Period 2||5
360788|NCT01192139|864605|P1|STARTED|Period 2||5
360789|NCT01192139|864600|P6|NOT COMPLETED|Period 1||0
360790|NCT01192139|864601|P5|NOT COMPLETED|Period 1||0
360791|NCT01192139|864602|P4|NOT COMPLETED|Period 1||0
360792|NCT01192139|864603|P3|NOT COMPLETED|Period 1||0
360793|NCT01192139|864604|P2|NOT COMPLETED|Period 1||0
360794|NCT01192139|864605|P1|NOT COMPLETED|Period 1||0
360795|NCT01192139|864600|P6|COMPLETED|Period 1||5
360796|NCT01192139|864601|P5|COMPLETED|Period 1||5
360797|NCT01192139|864602|P4|COMPLETED|Period 1||5
360798|NCT01192139|864603|P3|COMPLETED|Period 1||5
360799|NCT01192139|864604|P2|COMPLETED|Period 1||5
360800|NCT01192139|864605|P1|COMPLETED|Period 1||5
360801|NCT01192139|864600|P6|STARTED|Period 1||5
360802|NCT01192139|864601|P5|STARTED|Period 1||5
360803|NCT01192139|864602|P4|STARTED|Period 1||5
360804|NCT01192139|864603|P3|STARTED|Period 1||5
360805|NCT01192139|864604|P2|STARTED|Period 1||5
360806|NCT01192139|864605|P1|STARTED|Period 1||5
360807|NCT01192126|864670|P2|NOT COMPLETED|Second Intervention (1 Week)||0
360808|NCT01192126|864671|P1|NOT COMPLETED|Second Intervention (1 Week)||0
360809|NCT01192126|864670|P2|COMPLETED|Second Intervention (1 Week)||50
360810|NCT01192126|864671|P1|COMPLETED|Second Intervention (1 Week)||49
360811|NCT01192126|864670|P2|STARTED|Second Intervention (1 Week)||50
360812|NCT01192126|864671|P1|STARTED|Second Intervention (1 Week)||49
360813|NCT01192126|864670|P2|NOT COMPLETED|First Intervention (1 Week)||1
360814|NCT01192126|864671|P1|NOT COMPLETED|First Intervention (1 Week)||2
360815|NCT01192126|864670|P2|COMPLETED|First Intervention (1 Week)||50
360816|NCT01192126|864671|P1|COMPLETED|First Intervention (1 Week)||49
360817|NCT01192126|864670|P2|STARTED|First Intervention (1 Week)||51
360818|NCT01192126|864671|P1|STARTED|First Intervention (1 Week)||51
360819|NCT01192022|864683|P5|NOT COMPLETED|Overall Study||1
360820|NCT01192022|864684|P4|NOT COMPLETED|Overall Study||2
360821|NCT01192022|864685|P3|NOT COMPLETED|Overall Study||1
360822|NCT01192022|864686|P2|NOT COMPLETED|Overall Study||11
360823|NCT01192022|864687|P1|NOT COMPLETED|Overall Study||13
360824|NCT01192022|864683|P5|COMPLETED|Overall Study||11
360825|NCT01192022|864684|P4|COMPLETED|Overall Study||7
360826|NCT01192022|864685|P3|COMPLETED|Overall Study||7
360827|NCT01192022|864686|P2|COMPLETED|Overall Study||99
360828|NCT01192022|864687|P1|COMPLETED|Overall Study||101
360829|NCT01192022|864683|P5|Safety Population-Received Treatment|Overall Study||12
360830|NCT01192022|864684|P4|Safety Population-Received Treatment|Overall Study||9
360831|NCT01192022|864685|P3|Safety Population-Received Treatment|Overall Study||8
360832|NCT01192022|864686|P2|Safety Population-Received Treatment|Overall Study||109
360833|NCT01192022|864687|P1|Safety Population-Received Treatment|Overall Study||114
360834|NCT01192022|864683|P5|STARTED|Overall Study||12
360835|NCT01192022|864684|P4|STARTED|Overall Study||9
360836|NCT01192022|864685|P3|STARTED|Overall Study||8
360837|NCT01192022|864686|P2|STARTED|Overall Study||110
360838|NCT01192022|864687|P1|STARTED|Overall Study||114
360839|NCT01191944|864710|P2|NOT COMPLETED|Overall Study||19
360840|NCT01191944|864711|P1|NOT COMPLETED|Overall Study||17
360841|NCT01191944|864710|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
360842|NCT01191944|864711|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
360843|NCT01191944|864710|P2|STARTED|Overall Study|Treated titration/maintenance|239
360844|NCT01191944|864711|P1|STARTED|Overall Study|Treated titration/maintenance|234
360845|NCT01191827|864757|P2|NOT COMPLETED|Overall Study||0
360846|NCT01191827|864758|P1|NOT COMPLETED|Overall Study||0
360847|NCT01191827|864757|P2|COMPLETED|Overall Study||20
360848|NCT01191827|864758|P1|COMPLETED|Overall Study||20
360849|NCT01191827|864757|P2|STARTED|Overall Study||20
360850|NCT01191827|864758|P1|STARTED|Overall Study||20
360851|NCT01191801|864766|P2|NOT COMPLETED|Overall Study||337
360852|NCT01191801|864767|P1|NOT COMPLETED|Overall Study||316
360853|NCT01191801|864766|P2|COMPLETED|Overall Study||18
360854|NCT01191801|864767|P1|COMPLETED|Overall Study||40
360855|NCT01191801|864766|P2|STARTED|Overall Study||355
360856|NCT01191801|864767|P1|STARTED|Overall Study||356
360857|NCT01191788|864787|P2|NOT COMPLETED|Overall Study||22
360858|NCT01191788|864788|P1|NOT COMPLETED|Overall Study||21
360859|NCT01191788|864787|P2|COMPLETED|Overall Study|Completed 3-month followup|137
360860|NCT01191788|864788|P1|COMPLETED|Overall Study|Completed 3-month followup|119
360861|NCT01191788|864787|P2|STARTED|Overall Study||159
360862|NCT01191788|864788|P1|STARTED|Overall Study||140
360863|NCT01191762|864798|P2|NOT COMPLETED|Overall Study||0
360864|NCT01191762|864799|P1|NOT COMPLETED|Overall Study||1
360865|NCT01191762|864798|P2|COMPLETED|Overall Study||15
360866|NCT01191762|864799|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
360867|NCT01191762|864798|P2|STARTED|Overall Study||15
360868|NCT01191762|864799|P1|STARTED|Overall Study||15
360869|NCT01191749|864805|P1|NOT COMPLETED|Overall Study||0
360870|NCT01191749|864805|P1|COMPLETED|Overall Study||7
360871|NCT01191749|864805|P1|STARTED|Overall Study||7
360872|NCT01191736|864816|P7|NOT COMPLETED|Overall Study||0
360873|NCT01191736|864817|P6|NOT COMPLETED|Overall Study||0
360874|NCT01191736|864818|P5|NOT COMPLETED|Overall Study||0
360875|NCT01191736|864819|P4|NOT COMPLETED|Overall Study||0
360876|NCT01191736|864820|P3|NOT COMPLETED|Overall Study||0
360877|NCT01191736|864821|P2|NOT COMPLETED|Overall Study||0
360878|NCT01191736|864822|P1|NOT COMPLETED|Overall Study||0
360879|NCT01191736|864816|P7|COMPLETED|Overall Study||45
360880|NCT01191736|864817|P6|COMPLETED|Overall Study||50
360881|NCT01191736|864818|P5|COMPLETED|Overall Study||48
360882|NCT01191736|864819|P4|COMPLETED|Overall Study||46
360883|NCT01191736|864820|P3|COMPLETED|Overall Study||49
360884|NCT01191736|864821|P2|COMPLETED|Overall Study||47
360885|NCT01191736|864822|P1|COMPLETED|Overall Study||51
360886|NCT01191736|864816|P7|STARTED|Overall Study||45
360887|NCT01191736|864817|P6|STARTED|Overall Study||50
360888|NCT01191736|864818|P5|STARTED|Overall Study||48
360889|NCT01191736|864819|P4|STARTED|Overall Study||46
360890|NCT01191736|864820|P3|STARTED|Overall Study||49
360891|NCT01191736|864821|P2|STARTED|Overall Study||47
360892|NCT01191736|864822|P1|STARTED|Overall Study||51
360893|NCT01191723|864845|P6|NOT COMPLETED|Overall Study||0
360894|NCT01191723|864846|P5|NOT COMPLETED|Overall Study||0
360895|NCT01191723|864847|P4|NOT COMPLETED|Overall Study||0
360896|NCT01191723|864848|P3|NOT COMPLETED|Overall Study||0
360897|NCT01191723|864849|P2|NOT COMPLETED|Overall Study||0
360898|NCT01191723|864850|P1|NOT COMPLETED|Overall Study||0
360899|NCT01191723|864845|P6|COMPLETED|Overall Study||9
360900|NCT01191723|864846|P5|COMPLETED|Overall Study||9
360901|NCT01191723|864847|P4|COMPLETED|Overall Study||9
360902|NCT01191723|864848|P3|COMPLETED|Overall Study||9
360903|NCT01191723|864849|P2|COMPLETED|Overall Study||9
360904|NCT01191723|864850|P1|COMPLETED|Overall Study||9
360905|NCT01191723|864845|P6|STARTED|Overall Study||9
360906|NCT01191723|864846|P5|STARTED|Overall Study||9
360907|NCT01191723|864847|P4|STARTED|Overall Study||9
360908|NCT01191723|864848|P3|STARTED|Overall Study||9
360909|NCT01191723|864849|P2|STARTED|Overall Study||9
360910|NCT01191723|864850|P1|STARTED|Overall Study||9
360911|NCT01191476|864871|P3|NOT COMPLETED|Overall Study||0
360912|NCT01191476|864872|P2|NOT COMPLETED|Overall Study||4
360913|NCT01191476|864873|P1|NOT COMPLETED|Overall Study||3
360914|NCT01191476|864871|P3|COMPLETED|Overall Study||111
360915|NCT01191476|864872|P2|COMPLETED|Overall Study||107
360916|NCT01191476|864873|P1|COMPLETED|Overall Study||109
360917|NCT01191476|864871|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
360918|NCT01191476|864872|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
360919|NCT01191476|864873|P1|STARTED|Overall Study||112
360920|NCT01191411|864896|P3|NOT COMPLETED|Overall Study||3427
360921|NCT01191411|864897|P2|NOT COMPLETED|Overall Study||361
360922|NCT01191411|864898|P1|NOT COMPLETED|Overall Study||945
360923|NCT01191411|864896|P3|COMPLETED|Overall Study||471
360924|NCT01191411|864897|P2|COMPLETED|Overall Study||118
360925|NCT01191411|864898|P1|COMPLETED|Overall Study||648
360926|NCT01191411|864896|P3|STARTED|Overall Study||3898
360927|NCT01191411|864897|P2|STARTED|Overall Study||479
360928|NCT01191411|864898|P1|STARTED|Overall Study||1593
360929|NCT01191398|864909|P3|NOT COMPLETED|Overall Study||0
360930|NCT01191398|864910|P2|NOT COMPLETED|Overall Study||0
360931|NCT01191398|864911|P1|NOT COMPLETED|Overall Study||0
360932|NCT01191398|864909|P3|COMPLETED|Overall Study||18
360933|NCT01191398|864910|P2|COMPLETED|Overall Study||17
360934|NCT01191398|864911|P1|COMPLETED|Overall Study||17
360935|NCT01191398|864909|P3|STARTED|Overall Study||18
360936|NCT01191398|864910|P2|STARTED|Overall Study||17
360937|NCT01191398|864911|P1|STARTED|Overall Study||17
360938|NCT01191320|864925|P3|NOT COMPLETED|Overall Study||7
360939|NCT01191320|864926|P2|NOT COMPLETED|Overall Study||6
360940|NCT01191320|864927|P1|NOT COMPLETED|Overall Study||7
360941|NCT01191320|864925|P3|COMPLETED|Overall Study||31
360942|NCT01191320|864926|P2|COMPLETED|Overall Study||32
360943|NCT01191320|864927|P1|COMPLETED|Overall Study||36
360944|NCT01191320|864925|P3|STARTED|Overall Study||38
360945|NCT01191320|864926|P2|STARTED|Overall Study||38
360946|NCT01191320|864927|P1|STARTED|Overall Study||43
360947|NCT01191268|864938|P3|NOT COMPLETED|Overall Study||52
360948|NCT01191268|864939|P2|NOT COMPLETED|Overall Study||55
360949|NCT01191268|864940|P1|NOT COMPLETED|Overall Study||58
360950|NCT01191268|864938|P3|COMPLETED|Overall Study||244
360951|NCT01191268|864939|P2|COMPLETED|Overall Study||238
360952|NCT01191268|864940|P1|COMPLETED|Overall Study||237
360953|NCT01191268|864938|P3|Received at Least One Dose of Study Drug|Overall Study||296
360954|NCT01191268|864939|P2|Received at Least One Dose of Study Drug|Overall Study||293
360955|NCT01191268|864940|P1|Received at Least One Dose of Study Drug|Overall Study||295
360956|NCT01191268|864938|P3|STARTED|Overall Study||296
360957|NCT01191268|864939|P2|STARTED|Overall Study||293
360958|NCT01191268|864940|P1|STARTED|Overall Study||295
360959|NCT01191255|865037|P4|NOT COMPLETED|Efficacy Assessment Period||6
360960|NCT01191255|865038|P3|NOT COMPLETED|Efficacy Assessment Period||26
360961|NCT01191255|865039|P2|NOT COMPLETED|Efficacy Assessment Period||0
360962|NCT01191255|865040|P1|NOT COMPLETED|Efficacy Assessment Period||0
360963|NCT01191255|865037|P4|COMPLETED|Efficacy Assessment Period||90
360964|NCT01191255|865038|P3|COMPLETED|Efficacy Assessment Period||70
360965|NCT01191255|865039|P2|COMPLETED|Efficacy Assessment Period||0
360966|NCT01191255|865040|P1|COMPLETED|Efficacy Assessment Period||0
360967|NCT01191255|865037|P4|STARTED|Efficacy Assessment Period||96
360968|NCT01191255|865038|P3|STARTED|Efficacy Assessment Period||96
360969|NCT01191255|865039|P2|STARTED|Efficacy Assessment Period||0
360970|NCT01191255|865040|P1|STARTED|Efficacy Assessment Period||0
360971|NCT01191255|865037|P4|NOT COMPLETED|Safety Assessment Period||0
360972|NCT01191255|865038|P3|NOT COMPLETED|Safety Assessment Period||0
360973|NCT01191255|865039|P2|NOT COMPLETED|Safety Assessment Period||99
360974|NCT01191255|865040|P1|NOT COMPLETED|Safety Assessment Period||38
360975|NCT01191255|865037|P4|COMPLETED|Safety Assessment Period||0
360976|NCT01191255|865038|P3|COMPLETED|Safety Assessment Period||0
360977|NCT01191255|865039|P2|COMPLETED|Safety Assessment Period||193
360978|NCT01191255|865040|P1|COMPLETED|Safety Assessment Period||111
360979|NCT01191255|865037|P4|Safety Population|Safety Assessment Period||0
360980|NCT01191255|865038|P3|Safety Population|Safety Assessment Period||0
360981|NCT01191255|865039|P2|Safety Population|Safety Assessment Period||289
360982|NCT01191255|865040|P1|Safety Population|Safety Assessment Period||149
360983|NCT01191255|865037|P4|STARTED|Safety Assessment Period||0
360984|NCT01191255|865038|P3|STARTED|Safety Assessment Period||0
360985|NCT01191255|865039|P2|STARTED|Safety Assessment Period||292
360986|NCT01191255|865040|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
360987|NCT01191242|865066|P1|NOT COMPLETED|Overall Study||0
360988|NCT01191242|865066|P1|COMPLETED|Overall Study||31
360989|NCT01191242|865066|P1|STARTED|Overall Study||31
360990|NCT01191190|865081|P1|NOT COMPLETED|Overall Study||1
360991|NCT01191190|865081|P1|COMPLETED|Overall Study||20
360992|NCT01191190|865081|P1|STARTED|Overall Study||21
360993|NCT01191086|865094|P1|NOT COMPLETED|Overall Study||62
360994|NCT01191086|865094|P1|COMPLETED|Overall Study||148
360995|NCT01191086|865094|P1|STARTED|Overall Study||210
360996|NCT01190891|865100|P2|NOT COMPLETED|Overall Study||0
360997|NCT01190891|865101|P1|NOT COMPLETED|Overall Study||6
360998|NCT01190891|865100|P2|COMPLETED|Overall Study||52
360999|NCT01190891|865101|P1|COMPLETED|Overall Study||46
361000|NCT01190891|865100|P2|STARTED|Overall Study||52
361001|NCT01190891|865101|P1|STARTED|Overall Study||52
361002|NCT01190878|865113|P4|NOT COMPLETED|Overall Study||20
361003|NCT01190878|865114|P3|NOT COMPLETED|Overall Study||5
361004|NCT01190878|865115|P2|NOT COMPLETED|Overall Study||3
361005|NCT01190878|865116|P1|NOT COMPLETED|Overall Study||3
361006|NCT01190878|865113|P4|COMPLETED|Overall Study||22
361007|NCT01190878|865114|P3|COMPLETED|Overall Study||37
361008|NCT01190878|865115|P2|COMPLETED|Overall Study||42
361009|NCT01190878|865116|P1|COMPLETED|Overall Study||37
361010|NCT01190878|865113|P4|STARTED|Overall Study||42
361011|NCT01190878|865114|P3|STARTED|Overall Study||42
361012|NCT01190878|865115|P2|STARTED|Overall Study||45
361013|NCT01190878|865116|P1|STARTED|Overall Study||40
361014|NCT01190865|865126|P1|NOT COMPLETED|Overall Study||3
361015|NCT01190865|865126|P1|COMPLETED|Overall Study||25
361016|NCT01190865|865126|P1|STARTED|Overall Study||28
361017|NCT01190839|865133|P2|NOT COMPLETED|Overall Study||147
361018|NCT01190839|865134|P1|NOT COMPLETED|Overall Study||150
361019|NCT01190839|865133|P2|COMPLETED|Overall Study||0
361020|NCT01190839|865134|P1|COMPLETED|Overall Study||0
361021|NCT01190839|865133|P2|Treated|Overall Study||143
361022|NCT01190839|865134|P1|Treated|Overall Study||148
361023|NCT01190839|865133|P2|STARTED|Overall Study||147
361024|NCT01190839|865134|P1|STARTED|Overall Study||150
361025|NCT01190813|865148|P2|NOT COMPLETED|Overall Study||4
361026|NCT01190813|865149|P1|NOT COMPLETED|Overall Study||4
361027|NCT01190813|865148|P2|COMPLETED|Overall Study||45
361028|NCT01190813|865149|P1|COMPLETED|Overall Study||86
361029|NCT01190813|865148|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
361030|NCT01190813|865149|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
361031|NCT01190813|865148|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
361032|NCT01190813|865149|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
361033|NCT01190813|865148|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
361034|NCT01190813|865149|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
361035|NCT01190813|865148|P2|16-week Visit|Overall Study|2 dropped|46
361036|NCT01190813|865149|P1|16-week Visit|Overall Study|1 dropped|87
361037|NCT01190813|865148|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
361038|NCT01190813|865149|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
361039|NCT01190813|865148|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
361040|NCT01190813|865149|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
361041|NCT01190813|865148|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
361042|NCT01190813|865149|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
361043|NCT01190813|865148|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
361044|NCT01190813|865149|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
361045|NCT01190813|865148|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
361046|NCT01190813|865149|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
361047|NCT01190813|865148|P2|STARTED|Overall Study||49
361048|NCT01190813|865149|P1|STARTED|Overall Study||90
361049|NCT01190566|865241|P2|NOT COMPLETED|Overall Study||0
361050|NCT01190566|865242|P1|NOT COMPLETED|Overall Study||0
361051|NCT01190566|865241|P2|COMPLETED|Overall Study||42
361052|NCT01190566|865242|P1|COMPLETED|Overall Study||6
361053|NCT01190566|865241|P2|STARTED|Overall Study||42
361054|NCT01190566|865242|P1|STARTED|Overall Study||6
361055|NCT01190527|865263|P1|NOT COMPLETED|Overall Study||0
361056|NCT01190527|865263|P1|COMPLETED|Overall Study||42
361057|NCT01190527|865263|P1|STARTED|Overall Study||42
361058|NCT01190514|865270|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
361059|NCT01190514|865271|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
361060|NCT01190514|865272|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
361061|NCT01190514|865273|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
361062|NCT01190514|865270|P4|COMPLETED|Fourth Intervention (Period 4)||10
361063|NCT01190514|865271|P3|COMPLETED|Fourth Intervention (Period 4)||10
361064|NCT01190514|865272|P2|COMPLETED|Fourth Intervention (Period 4)||10
361065|NCT01190514|865273|P1|COMPLETED|Fourth Intervention (Period 4)||9
361066|NCT01190514|865270|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
361067|NCT01190514|865271|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
361068|NCT01190514|865272|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
361069|NCT01190514|865273|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
361070|NCT01190514|865270|P4|NOT COMPLETED|Third Intervention (Period 3)||0
361071|NCT01190514|865271|P3|NOT COMPLETED|Third Intervention (Period 3)||0
361072|NCT01190514|865272|P2|NOT COMPLETED|Third Intervention (Period 3)||0
361073|NCT01190514|865273|P1|NOT COMPLETED|Third Intervention (Period 3)||1
361074|NCT01190514|865270|P4|COMPLETED|Third Intervention (Period 3)||10
361075|NCT01190514|865271|P3|COMPLETED|Third Intervention (Period 3)||10
361076|NCT01190514|865272|P2|COMPLETED|Third Intervention (Period 3)||10
361077|NCT01190514|865273|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
361078|NCT01190514|865270|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
361079|NCT01190514|865271|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
361080|NCT01190514|865272|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
361081|NCT01190514|865273|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
361082|NCT01190514|865270|P4|NOT COMPLETED|Second Intervention (Period 2)||0
361083|NCT01190514|865271|P3|NOT COMPLETED|Second Intervention (Period 2)||0
361084|NCT01190514|865272|P2|NOT COMPLETED|Second Intervention (Period 2)||0
361085|NCT01190514|865273|P1|NOT COMPLETED|Second Intervention (Period 2)||0
361086|NCT01190514|865270|P4|COMPLETED|Second Intervention (Period 2)||10
361087|NCT01190514|865271|P3|COMPLETED|Second Intervention (Period 2)||10
361088|NCT01190514|865272|P2|COMPLETED|Second Intervention (Period 2)||10
361089|NCT01190514|865273|P1|COMPLETED|Second Intervention (Period 2)||10
361090|NCT01190514|865270|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
361091|NCT01190514|865271|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
361092|NCT01190514|865272|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
361093|NCT01190514|865273|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
361094|NCT01190514|865270|P4|NOT COMPLETED|First Intervention (Period 1)||0
361095|NCT01190514|865271|P3|NOT COMPLETED|First Intervention (Period 1)||0
361096|NCT01190514|865272|P2|NOT COMPLETED|First Intervention (Period 1)||0
361097|NCT01190514|865273|P1|NOT COMPLETED|First Intervention (Period 1)||1
361098|NCT01190514|865270|P4|COMPLETED|First Intervention (Period 1)||10
361099|NCT01190514|865271|P3|COMPLETED|First Intervention (Period 1)||10
361100|NCT01190514|865272|P2|COMPLETED|First Intervention (Period 1)||10
361101|NCT01190514|865273|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
361102|NCT01190514|865270|P4|STARTED|First Intervention (Period 1)||10
361103|NCT01190514|865271|P3|STARTED|First Intervention (Period 1)||10
361104|NCT01190514|865272|P2|STARTED|First Intervention (Period 1)||10
361105|NCT01190514|865273|P1|STARTED|First Intervention (Period 1)||11
361106|NCT01190436|865303|P1|NOT COMPLETED|Overall Study||39
361107|NCT01190436|865303|P1|COMPLETED|Overall Study||86
361108|NCT01190436|865303|P1|STARTED|Overall Study||125
361109|NCT01190306|865319|P2|NOT COMPLETED|Overall Study||0
361110|NCT01190306|865320|P1|NOT COMPLETED|Overall Study||0
361111|NCT01190306|865319|P2|COMPLETED|Overall Study||66
361112|NCT01190306|865320|P1|COMPLETED|Overall Study||61
361113|NCT01190306|865319|P2|STARTED|Overall Study||66
361114|NCT01190306|865320|P1|STARTED|Overall Study||61
361115|NCT01190267|865328|P2|NOT COMPLETED|Overall Study||4
361116|NCT01190267|865329|P1|NOT COMPLETED|Overall Study||41
361117|NCT01190267|865328|P2|COMPLETED|Overall Study||4
361118|NCT01190267|865329|P1|COMPLETED|Overall Study||155
361119|NCT01190267|865328|P2|STARTED|Overall Study||8
361120|NCT01190267|865329|P1|STARTED|Overall Study||196
361121|NCT01190254|865340|P3|NOT COMPLETED|Overall Study||22
361122|NCT01190254|865341|P2|NOT COMPLETED|Overall Study||17
361123|NCT01190254|865342|P1|NOT COMPLETED|Overall Study||21
361124|NCT01190254|865340|P3|COMPLETED|Overall Study||84
361125|NCT01190254|865341|P2|COMPLETED|Overall Study||81
361126|NCT01190254|865342|P1|COMPLETED|Overall Study||81
361127|NCT01190254|865340|P3|Treated|Overall Study||106
361128|NCT01190254|865341|P2|Treated|Overall Study||98
361129|NCT01190254|865342|P1|Treated|Overall Study||102
361130|NCT01190254|865340|P3|STARTED|Overall Study||106
361131|NCT01190254|865341|P2|STARTED|Overall Study||98
361132|NCT01190254|865342|P1|STARTED|Overall Study||102
361133|NCT01190215|865406|P2|NOT COMPLETED|Up to Month 6||0
361134|NCT01190215|865407|P1|NOT COMPLETED|Up to Month 6||2
361135|NCT01190215|865406|P2|COMPLETED|Up to Month 6||39
361136|NCT01190215|865407|P1|COMPLETED|Up to Month 6||36
361137|NCT01190215|865406|P2|STARTED|Up to Month 6||39
361138|NCT01190215|865407|P1|STARTED|Up to Month 6||38
361139|NCT01190215|865406|P2|NOT COMPLETED|Up to Day 28||0
361140|NCT01190215|865407|P1|NOT COMPLETED|Up to Day 28||0
361141|NCT01190215|865406|P2|COMPLETED|Up to Day 28||39
361142|NCT01190215|865407|P1|COMPLETED|Up to Day 28||38
361143|NCT01190215|865406|P2|STARTED|Up to Day 28||39
361144|NCT01190215|865407|P1|STARTED|Up to Day 28||38
361145|NCT01190150|865477|P2|NOT COMPLETED|Second Treatment||0
361146|NCT01190150|865478|P1|NOT COMPLETED|Second Treatment||0
361147|NCT01190150|865477|P2|COMPLETED|Second Treatment||7
361148|NCT01190150|865478|P1|COMPLETED|Second Treatment||10
361149|NCT01190150|865477|P2|STARTED|Second Treatment||7
361150|NCT01190150|865478|P1|STARTED|Second Treatment||10
361151|NCT01190150|865477|P2|NOT COMPLETED|Washout||2
361152|NCT01190150|865478|P1|NOT COMPLETED|Washout||0
361153|NCT01190150|865477|P2|COMPLETED|Washout||7
361154|NCT01190150|865478|P1|COMPLETED|Washout||10
361155|NCT01190150|865477|P2|STARTED|Washout||9
361156|NCT01190150|865478|P1|STARTED|Washout||10
361157|NCT01190150|865477|P2|NOT COMPLETED|First Treatment||0
361158|NCT01190150|865478|P1|NOT COMPLETED|First Treatment||1
361159|NCT01190150|865477|P2|COMPLETED|First Treatment||9
361160|NCT01190150|865478|P1|COMPLETED|First Treatment||10
361161|NCT01190150|865477|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
361162|NCT01190150|865478|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
361163|NCT01190124|865505|P3|NOT COMPLETED|Overall Study||1
361164|NCT01190124|865506|P2|NOT COMPLETED|Overall Study||0
361165|NCT01190124|865507|P1|NOT COMPLETED|Overall Study||17
361166|NCT01190124|865505|P3|COMPLETED|Overall Study||19
361167|NCT01190124|865506|P2|COMPLETED|Overall Study||24
361168|NCT01190124|865507|P1|COMPLETED|Overall Study||90
361169|NCT01190124|865505|P3|STARTED|Overall Study||20
361170|NCT01190124|865506|P2|STARTED|Overall Study||24
361171|NCT01190124|865507|P1|STARTED|Overall Study||107
361172|NCT01190098|865545|P2|NOT COMPLETED|Overall Study||2
361173|NCT01190098|865546|P1|NOT COMPLETED|Overall Study||3
361174|NCT01190098|865545|P2|COMPLETED|Overall Study||8
361175|NCT01190098|865546|P1|COMPLETED|Overall Study||39
361176|NCT01190098|865545|P2|STARTED|Overall Study||10
361177|NCT01190098|865546|P1|STARTED|Overall Study||42
361178|NCT01190085|865569|P3|NOT COMPLETED|Overall Study||0
361179|NCT01190085|865570|P2|NOT COMPLETED|Overall Study||0
361180|NCT01190085|865571|P1|NOT COMPLETED|Overall Study||0
361181|NCT01190085|865569|P3|COMPLETED|Overall Study||18
361182|NCT01190085|865570|P2|COMPLETED|Overall Study||14
361183|NCT01190085|865571|P1|COMPLETED|Overall Study||13
361184|NCT01190085|865569|P3|STARTED|Overall Study||18
361185|NCT01190085|865570|P2|STARTED|Overall Study||14
361186|NCT01190085|865571|P1|STARTED|Overall Study||13
361187|NCT01190007|865585|P1|NOT COMPLETED|Overall Study||14
361188|NCT01190007|865585|P1|COMPLETED|Overall Study||145
361189|NCT01190007|865585|P1|STARTED|Overall Study|Treated|159
361190|NCT01189890|865602|P2|NOT COMPLETED|Overall Study||39
361191|NCT01189890|865603|P1|NOT COMPLETED|Overall Study||37
361192|NCT01189890|865602|P2|COMPLETED|Overall Study||200
361193|NCT01189890|865603|P1|COMPLETED|Overall Study||204
361194|NCT01189890|865602|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
361195|NCT01189890|865603|P1|STARTED|Overall Study||241
361196|NCT01189812|865625|P2|NOT COMPLETED|Overall Study||8
361197|NCT01189812|865626|P1|NOT COMPLETED|Overall Study||8
361198|NCT01189812|865625|P2|COMPLETED|Overall Study||32
361199|NCT01189812|865626|P1|COMPLETED|Overall Study||32
361200|NCT01189812|865625|P2|STARTED|Overall Study||40
361201|NCT01189812|865626|P1|STARTED|Overall Study||40
361202|NCT01189760|865635|P3|NOT COMPLETED|Overall Study||51
361203|NCT01189760|865636|P2|NOT COMPLETED|Overall Study||23
361204|NCT01189760|865637|P1|NOT COMPLETED|Overall Study||14
361205|NCT01189760|865635|P3|COMPLETED|Overall Study||255
361206|NCT01189760|865636|P2|COMPLETED|Overall Study||283
361207|NCT01189760|865637|P1|COMPLETED|Overall Study||291
361208|NCT01189760|865635|P3|STARTED|Overall Study||306
361209|NCT01189760|865636|P2|STARTED|Overall Study||306
361210|NCT01189760|865637|P1|STARTED|Overall Study||305
361211|NCT01189747|865671|P2|NOT COMPLETED|Overall Study||18
361212|NCT01189747|865672|P1|NOT COMPLETED|Overall Study||12
361213|NCT01189747|865671|P2|COMPLETED|Overall Study||206
361214|NCT01189747|865672|P1|COMPLETED|Overall Study||210
361215|NCT01189747|865671|P2|STARTED|Overall Study||224
361216|NCT01189747|865672|P1|STARTED|Overall Study||222
361217|NCT01189617|865696|P2|NOT COMPLETED|Overall Study||0
361218|NCT01189617|865697|P1|NOT COMPLETED|Overall Study||0
361219|NCT01189617|865696|P2|COMPLETED|Overall Study||35
361220|NCT01189617|865697|P1|COMPLETED|Overall Study||35
361221|NCT01189617|865696|P2|STARTED|Overall Study||35
361222|NCT01189617|865697|P1|STARTED|Overall Study||35
361223|NCT01189604|865710|P7|NOT COMPLETED|Overall Study||1
361224|NCT01189604|865711|P6|NOT COMPLETED|Overall Study||1
361225|NCT01189604|865712|P5|NOT COMPLETED|Overall Study||2
361226|NCT01189604|865713|P4|NOT COMPLETED|Overall Study||0
361227|NCT01189604|865714|P3|NOT COMPLETED|Overall Study||0
361228|NCT01189604|865715|P2|NOT COMPLETED|Overall Study||1
361229|NCT01189604|865716|P1|NOT COMPLETED|Overall Study||1
361230|NCT01189604|865710|P7|COMPLETED|Overall Study||9
361231|NCT01189604|865711|P6|COMPLETED|Overall Study||10
361232|NCT01189604|865712|P5|COMPLETED|Overall Study||18
361233|NCT01189604|865713|P4|COMPLETED|Overall Study||20
361234|NCT01189604|865714|P3|COMPLETED|Overall Study||20
361235|NCT01189604|865715|P2|COMPLETED|Overall Study||20
361236|NCT01189604|865716|P1|COMPLETED|Overall Study||20
361237|NCT01189604|865710|P7|Administered Study Drug|Overall Study||10
361238|NCT01189604|865711|P6|Administered Study Drug|Overall Study||10
361239|NCT01189604|865712|P5|Administered Study Drug|Overall Study||20
361240|NCT01189604|865713|P4|Administered Study Drug|Overall Study||20
361241|NCT01189604|865714|P3|Administered Study Drug|Overall Study||20
361242|NCT01189604|865715|P2|Administered Study Drug|Overall Study||20
361243|NCT01189604|865716|P1|Administered Study Drug|Overall Study||20
361244|NCT01189604|865710|P7|STARTED|Overall Study||10
361245|NCT01189604|865711|P6|STARTED|Overall Study||11
361246|NCT01189604|865712|P5|STARTED|Overall Study||20
361247|NCT01189604|865713|P4|STARTED|Overall Study||20
361248|NCT01189604|865714|P3|STARTED|Overall Study||20
361249|NCT01189604|865715|P2|STARTED|Overall Study||21
361250|NCT01189604|865716|P1|STARTED|Overall Study||21
361251|NCT01189500|865760|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
361252|NCT01189500|865760|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
361253|NCT01189500|865760|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
361254|NCT01189500|865760|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
361255|NCT01189500|865760|P1|COMPLETED|Period 1: TAMOX Alone||29
361256|NCT01189500|865760|P1|STARTED|Period 1: TAMOX Alone||30
361257|NCT01189487|865821|P1|NOT COMPLETED|Overall Study||3
361258|NCT01189487|865821|P1|COMPLETED|Overall Study||44
361259|NCT01189487|865821|P1|STARTED|Overall Study|Treated participants|47
361260|NCT01189461|865829|P1|NOT COMPLETED|Overall Study||34
361261|NCT01189461|865829|P1|COMPLETED|Overall Study||12
361262|NCT01189461|865829|P1|STARTED|Overall Study||46
361263|NCT01189435|865836|P1|NOT COMPLETED|Overall Study||2
361264|NCT01189435|865836|P1|COMPLETED|Overall Study||0
361265|NCT01189435|865836|P1|STARTED|Overall Study||2
361266|NCT01189370|865840|P3|NOT COMPLETED|Dose Level 3||6
361267|NCT01189370|865841|P2|NOT COMPLETED|Dose Level 3||0
361268|NCT01189370|865842|P1|NOT COMPLETED|Dose Level 3||0
361269|NCT01189370|865840|P3|COMPLETED|Dose Level 3||6
361270|NCT01189370|865841|P2|COMPLETED|Dose Level 3||0
361271|NCT01189370|865842|P1|COMPLETED|Dose Level 3||0
361272|NCT01189370|865840|P3|STARTED|Dose Level 3||12
361273|NCT01189370|865841|P2|STARTED|Dose Level 3||0
361274|NCT01189370|865842|P1|STARTED|Dose Level 3||0
361275|NCT01189370|865840|P3|NOT COMPLETED|Dose Level 2||0
361276|NCT01189370|865841|P2|NOT COMPLETED|Dose Level 2||4
361277|NCT01189370|865842|P1|NOT COMPLETED|Dose Level 2||0
361278|NCT01189370|865840|P3|COMPLETED|Dose Level 2||0
361279|NCT01189370|865841|P2|COMPLETED|Dose Level 2||12
361280|NCT01189370|865842|P1|COMPLETED|Dose Level 2||0
361281|NCT01189370|865840|P3|STARTED|Dose Level 2||0
361282|NCT01189370|865841|P2|STARTED|Dose Level 2||16
361283|NCT01189370|865842|P1|STARTED|Dose Level 2||0
361284|NCT01189370|865840|P3|NOT COMPLETED|Dose Level 1||0
361285|NCT01189370|865841|P2|NOT COMPLETED|Dose Level 1||0
361286|NCT01189370|865842|P1|NOT COMPLETED|Dose Level 1||9
361287|NCT01189370|865840|P3|COMPLETED|Dose Level 1||0
361288|NCT01189370|865841|P2|COMPLETED|Dose Level 1||0
361289|NCT01189370|865842|P1|COMPLETED|Dose Level 1||16
361290|NCT01189370|865840|P3|STARTED|Dose Level 1||0
361291|NCT01189370|865841|P2|STARTED|Dose Level 1||0
361292|NCT01189370|865842|P1|STARTED|Dose Level 1||25
361293|NCT01189292|865851|P2|NOT COMPLETED|Per Protocol Analysis||16
361294|NCT01189292|865852|P1|NOT COMPLETED|Per Protocol Analysis||11
361295|NCT01189292|865851|P2|COMPLETED|Per Protocol Analysis||60
361296|NCT01189292|865852|P1|COMPLETED|Per Protocol Analysis||65
361297|NCT01189292|865851|P2|STARTED|Per Protocol Analysis||76
361298|NCT01189292|865852|P1|STARTED|Per Protocol Analysis||76
361299|NCT01189292|865851|P2|NOT COMPLETED|Intention to Treat Analysis||0
361300|NCT01189292|865852|P1|NOT COMPLETED|Intention to Treat Analysis||0
361301|NCT01189292|865851|P2|COMPLETED|Intention to Treat Analysis||76
361302|NCT01189292|865852|P1|COMPLETED|Intention to Treat Analysis||76
361303|NCT01189292|865851|P2|STARTED|Intention to Treat Analysis||76
361304|NCT01189292|865852|P1|STARTED|Intention to Treat Analysis||76
361305|NCT01189279|865873|P3|NOT COMPLETED|Overall Study||1
361306|NCT01189279|865874|P2|NOT COMPLETED|Overall Study||0
361307|NCT01189279|865875|P1|NOT COMPLETED|Overall Study||1
361308|NCT01189279|865873|P3|COMPLETED|Overall Study||13
361309|NCT01189279|865874|P2|COMPLETED|Overall Study||14
361310|NCT01189279|865875|P1|COMPLETED|Overall Study||13
361311|NCT01189279|865873|P3|STARTED|Overall Study||14
361312|NCT01189279|865874|P2|STARTED|Overall Study||14
361313|NCT01189279|865875|P1|STARTED|Overall Study||14
361314|NCT01189240|865895|P3|NOT COMPLETED|Overall Study||0
361315|NCT01189240|865896|P2|NOT COMPLETED|Overall Study||0
361316|NCT01189240|865897|P1|NOT COMPLETED|Overall Study||0
361317|NCT01189240|865895|P3|COMPLETED|Overall Study||3
361318|NCT01189240|865896|P2|COMPLETED|Overall Study||6
361319|NCT01189240|865897|P1|COMPLETED|Overall Study||4
361320|NCT01189240|865895|P3|STARTED|Overall Study||3
361321|NCT01189240|865896|P2|STARTED|Overall Study||6
361322|NCT01189240|865897|P1|STARTED|Overall Study||4
361323|NCT01189227|865918|P2|NOT COMPLETED|Overall Study||3
361324|NCT01189227|865919|P1|NOT COMPLETED|Overall Study||6
361325|NCT01189227|865918|P2|COMPLETED|Overall Study||0
361326|NCT01189227|865919|P1|COMPLETED|Overall Study||0
361327|NCT01189227|865918|P2|STARTED|Overall Study||3
361328|NCT01189227|865919|P1|STARTED|Overall Study||6
361329|NCT01189201|865925|P1|NOT COMPLETED|Overall Study||1
361330|NCT01189201|865925|P1|COMPLETED|Overall Study||41
361331|NCT01189201|865925|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
361332|NCT01189201|865925|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
361333|NCT01189201|865925|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
361334|NCT01189201|865925|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
361335|NCT01189201|865925|P1|STARTED|Overall Study||42
361336|NCT01189136|865981|P2|NOT COMPLETED|Overall Study||0
361337|NCT01189136|865982|P1|NOT COMPLETED|Overall Study||0
361338|NCT01189136|865981|P2|COMPLETED|Overall Study||42
361339|NCT01189136|865982|P1|COMPLETED|Overall Study||42
361340|NCT01189136|865981|P2|STARTED|Overall Study||42
361341|NCT01189136|865982|P1|STARTED|Overall Study||42
361342|NCT01189123|865996|P2|NOT COMPLETED|Overall Study||6
361343|NCT01189123|865997|P1|NOT COMPLETED|Overall Study||2
361344|NCT01189123|865996|P2|COMPLETED|Overall Study||47
361345|NCT01189123|865997|P1|COMPLETED|Overall Study||50
361346|NCT01189123|865996|P2|STARTED|Overall Study||53
361347|NCT01189123|865997|P1|STARTED|Overall Study||52
361348|NCT01189110|866007|P2|NOT COMPLETED|Overall Study||0
361349|NCT01189110|866008|P1|NOT COMPLETED|Overall Study||0
361350|NCT01189110|866007|P2|COMPLETED|Overall Study||61
361351|NCT01189110|866008|P1|COMPLETED|Overall Study|February, 2011|64
361352|NCT01189110|866007|P2|STARTED|Overall Study||61
361353|NCT01189110|866008|P1|STARTED|Overall Study|September, 2010|64
361354|NCT01189071|866016|P2|NOT COMPLETED|Overall Study||0
361355|NCT01189071|866017|P1|NOT COMPLETED|Overall Study||0
361356|NCT01189071|866016|P2|COMPLETED|Overall Study||0
361357|NCT01189071|866017|P1|COMPLETED|Overall Study||0
361358|NCT01189071|866016|P2|STARTED|Overall Study||0
361359|NCT01189071|866017|P1|STARTED|Overall Study||0
361360|NCT01189032|866028|P3|NOT COMPLETED|Overall Study||6
361361|NCT01189032|866029|P2|NOT COMPLETED|Overall Study||7
361362|NCT01189032|866030|P1|NOT COMPLETED|Overall Study||5
361363|NCT01189032|866028|P3|COMPLETED|Overall Study||90
361364|NCT01189032|866029|P2|COMPLETED|Overall Study||89
361365|NCT01189032|866030|P1|COMPLETED|Overall Study||89
361366|NCT01189032|866028|P3|STARTED|Overall Study||96
361367|NCT01189032|866029|P2|STARTED|Overall Study||96
361368|NCT01189032|866030|P1|STARTED|Overall Study||94
361369|NCT01188967|866040|P2|NOT COMPLETED|Overall Study||4
361370|NCT01188967|866041|P1|NOT COMPLETED|Overall Study||5
361371|NCT01188967|866040|P2|COMPLETED|Overall Study||4
361372|NCT01188967|866041|P1|COMPLETED|Overall Study||5
361373|NCT01188967|866040|P2|STARTED|Overall Study||8
361374|NCT01188967|866041|P1|STARTED|Overall Study||10
361375|NCT01188928|866057|P4|NOT COMPLETED|Overall Study||18
361376|NCT01188928|866058|P3|NOT COMPLETED|Overall Study||14
361377|NCT01188928|866059|P2|NOT COMPLETED|Overall Study||62
361378|NCT01188928|866060|P1|NOT COMPLETED|Overall Study||38
361379|NCT01188928|866057|P4|COMPLETED|Overall Study||77
361380|NCT01188928|866058|P3|COMPLETED|Overall Study||82
361381|NCT01188928|866059|P2|COMPLETED|Overall Study||417
361382|NCT01188928|866060|P1|COMPLETED|Overall Study||444
361383|NCT01188928|866057|P4|STARTED|Overall Study||95
361384|NCT01188928|866058|P3|STARTED|Overall Study||96
361385|NCT01188928|866059|P2|STARTED|Overall Study||479
361386|NCT01188928|866060|P1|STARTED|Overall Study||482
361387|NCT01188811|866084|P2|NOT COMPLETED|Overall Study||2
361388|NCT01188811|866085|P1|NOT COMPLETED|Overall Study||6
361389|NCT01188811|866084|P2|COMPLETED|Overall Study||24
361390|NCT01188811|866085|P1|COMPLETED|Overall Study||22
361391|NCT01188811|866084|P2|STARTED|Overall Study||26
361392|NCT01188811|866085|P1|STARTED|Overall Study||28
361393|NCT01188798|866097|P2|NOT COMPLETED|Overall Study||3
361394|NCT01188798|866098|P1|NOT COMPLETED|Overall Study||2
361395|NCT01188798|866097|P2|COMPLETED|Overall Study||1
361396|NCT01188798|866098|P1|COMPLETED|Overall Study||0
361397|NCT01188798|866097|P2|STARTED|Overall Study||4
361398|NCT01188798|866098|P1|STARTED|Overall Study||2
361399|NCT01188772|866110|P4|NOT COMPLETED|Overall Study||1
361400|NCT01188772|866111|P3|NOT COMPLETED|Overall Study||11
361401|NCT01188772|866112|P2|NOT COMPLETED|Overall Study||3
361402|NCT01188772|866113|P1|NOT COMPLETED|Overall Study||5
361403|NCT01188772|866110|P4|COMPLETED|Overall Study||24
361404|NCT01188772|866111|P3|COMPLETED|Overall Study||15
361405|NCT01188772|866112|P2|COMPLETED|Overall Study||45
361406|NCT01188772|866113|P1|COMPLETED|Overall Study||43
361407|NCT01188772|866110|P4|Randomized and Treated|Overall Study||25
361408|NCT01188772|866111|P3|Randomized and Treated|Overall Study||26
361409|NCT01188772|866112|P2|Randomized and Treated|Overall Study||47
361410|NCT01188772|866113|P1|Randomized and Treated|Overall Study||48
361411|NCT01188772|866110|P4|STARTED|Overall Study||25
361412|NCT01188772|866111|P3|STARTED|Overall Study||26
361413|NCT01188772|866112|P2|STARTED|Overall Study||48
361414|NCT01188772|866113|P1|STARTED|Overall Study||48
361415|NCT01188694|866171|P3|NOT COMPLETED|Overall Study||1
361416|NCT01188694|866172|P2|NOT COMPLETED|Overall Study||1
361417|NCT01188694|866173|P1|NOT COMPLETED|Overall Study||5
361418|NCT01188694|866171|P3|COMPLETED|Overall Study||10
361419|NCT01188694|866172|P2|COMPLETED|Overall Study||15
361420|NCT01188694|866173|P1|COMPLETED|Overall Study||10
361421|NCT01188694|866171|P3|STARTED|Overall Study||11
361422|NCT01188694|866172|P2|STARTED|Overall Study||16
361423|NCT01188694|866173|P1|STARTED|Overall Study||15
361436|NCT01188668|866202|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
361437|NCT01188668|866202|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
361438|NCT01188668|866202|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
361439|NCT01188668|866202|P1|NOT COMPLETED|Period 1: ARIP Alone||2
361440|NCT01188668|866202|P1|COMPLETED|Period 1: ARIP Alone||36
361441|NCT01188668|866202|P1|STARTED|Period 1: ARIP Alone||38
361442|NCT01188655|866235|P1|NOT COMPLETED|Overall Study||13
361443|NCT01188655|866235|P1|COMPLETED|Overall Study||76
361444|NCT01188655|866235|P1|STARTED|Overall Study||89
361445|NCT01188603|866250|P1|NOT COMPLETED|Overall Study||0
361446|NCT01188603|866250|P1|COMPLETED|Overall Study||24
361447|NCT01188603|866250|P1|STARTED|Overall Study||24
361448|NCT01188577|866260|P2|NOT COMPLETED|Visit 2||0
361449|NCT01188577|866261|P1|NOT COMPLETED|Visit 2||0
361450|NCT01188577|866260|P2|COMPLETED|Visit 2||12
361451|NCT01188577|866261|P1|COMPLETED|Visit 2||11
361452|NCT01188577|866260|P2|STARTED|Visit 2||12
361453|NCT01188577|866261|P1|STARTED|Visit 2||11
361454|NCT01188577|866260|P2|NOT COMPLETED|3-14 Day Washout||0
361455|NCT01188577|866261|P1|NOT COMPLETED|3-14 Day Washout||0
361456|NCT01188577|866260|P2|COMPLETED|3-14 Day Washout||12
361457|NCT01188577|866261|P1|COMPLETED|3-14 Day Washout||11
361458|NCT01188577|866260|P2|STARTED|3-14 Day Washout||12
361459|NCT01188577|866261|P1|STARTED|3-14 Day Washout||11
361460|NCT01188577|866260|P2|NOT COMPLETED|Visit 1||0
361461|NCT01188577|866261|P1|NOT COMPLETED|Visit 1||0
361462|NCT01188577|866260|P2|COMPLETED|Visit 1||12
361463|NCT01188577|866261|P1|COMPLETED|Visit 1||11
361464|NCT01188577|866260|P2|STARTED|Visit 1||12
361465|NCT01188577|866261|P1|STARTED|Visit 1||11
361466|NCT01188564|866279|P2|NOT COMPLETED|Open Label Phase||0
361467|NCT01188564|866280|P1|NOT COMPLETED|Open Label Phase||0
361468|NCT01188564|866279|P2|COMPLETED|Open Label Phase||20
361469|NCT01188564|866280|P1|COMPLETED|Open Label Phase||24
361470|NCT01188564|866279|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
361471|NCT01188564|866280|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
361472|NCT01188564|866279|P2|NOT COMPLETED|Double-blind Phase||0
361473|NCT01188564|866280|P1|NOT COMPLETED|Double-blind Phase||1
361474|NCT01188564|866279|P2|COMPLETED|Double-blind Phase||31
361475|NCT01188564|866280|P1|COMPLETED|Double-blind Phase||43
361476|NCT01188564|866279|P2|STARTED|Double-blind Phase||31
361477|NCT01188564|866280|P1|STARTED|Double-blind Phase||44
361478|NCT01188551|866292|P4|NOT COMPLETED|Overall Study||0
361479|NCT01188551|866293|P3|NOT COMPLETED|Overall Study||0
361480|NCT01188551|866294|P2|NOT COMPLETED|Overall Study||0
361481|NCT01188551|866295|P1|NOT COMPLETED|Overall Study||1
361482|NCT01188551|866292|P4|COMPLETED|Overall Study||25
361483|NCT01188551|866293|P3|COMPLETED|Overall Study||25
361484|NCT01188551|866294|P2|COMPLETED|Overall Study||25
361485|NCT01188551|866295|P1|COMPLETED|Overall Study||24
361486|NCT01188551|866292|P4|STARTED|Overall Study||25
361487|NCT01188551|866293|P3|STARTED|Overall Study||25
361488|NCT01188551|866294|P2|STARTED|Overall Study||25
361489|NCT01188551|866295|P1|STARTED|Overall Study||25
361490|NCT01188538|866311|P2|NOT COMPLETED|Overall Study||1
361491|NCT01188538|866312|P1|NOT COMPLETED|Overall Study||0
361492|NCT01188538|866311|P2|COMPLETED|Overall Study||19
361493|NCT01188538|866312|P1|COMPLETED|Overall Study||20
361494|NCT01188538|866311|P2|STARTED|Overall Study||20
361495|NCT01188538|866312|P1|STARTED|Overall Study||20
361496|NCT01188499|866325|P5|NOT COMPLETED|Overall Study||0
361497|NCT01188499|866326|P4|NOT COMPLETED|Overall Study||0
361498|NCT01188499|866327|P3|NOT COMPLETED|Overall Study||0
361499|NCT01188499|866328|P2|NOT COMPLETED|Overall Study||0
361500|NCT01188499|866329|P1|NOT COMPLETED|Overall Study||0
361501|NCT01188499|866325|P5|COMPLETED|Overall Study||18
361502|NCT01188499|866326|P4|COMPLETED|Overall Study||18
361503|NCT01188499|866327|P3|COMPLETED|Overall Study||33
361504|NCT01188499|866328|P2|COMPLETED|Overall Study||83
361505|NCT01188499|866329|P1|COMPLETED|Overall Study||24
361506|NCT01188499|866325|P5|STARTED|Overall Study||18
361507|NCT01188499|866326|P4|STARTED|Overall Study||18
361508|NCT01188499|866327|P3|STARTED|Overall Study||33
361509|NCT01188499|866328|P2|STARTED|Overall Study||83
361510|NCT01188499|866329|P1|STARTED|Overall Study||24
361511|NCT01188343|866349|P3|NOT COMPLETED|Overall Study||1
361512|NCT01188343|866350|P2|NOT COMPLETED|Overall Study||26
361513|NCT01188343|866351|P1|NOT COMPLETED|Overall Study||1
361514|NCT01188343|866349|P3|COMPLETED|Overall Study||220
361515|NCT01188343|866350|P2|COMPLETED|Overall Study||193
361516|NCT01188343|866351|P1|COMPLETED|Overall Study||101
361517|NCT01188343|866349|P3|STARTED|Overall Study||221
361518|NCT01188343|866350|P2|STARTED|Overall Study||219
361519|NCT01188343|866351|P1|STARTED|Overall Study||102
361520|NCT01188226|866377|P1|NOT COMPLETED|Overall Study||4
361521|NCT01188226|866377|P1|COMPLETED|Overall Study||6
361522|NCT01188226|866377|P1|STARTED|Overall Study||10
361523|NCT01188109|866416|P1|NOT COMPLETED|Overall Study||0
361524|NCT01188109|866416|P1|COMPLETED|Overall Study||22
361525|NCT01188109|866416|P1|STARTED|Overall Study||22
361526|NCT01187953|866423|P2|NOT COMPLETED|Overall Study||21
361527|NCT01187953|866424|P1|NOT COMPLETED|Overall Study||15
361528|NCT01187953|866423|P2|COMPLETED|Overall Study||254
361529|NCT01187953|866424|P1|COMPLETED|Overall Study||253
361530|NCT01187953|866423|P2|Dosed|Overall Study||271
361531|NCT01187953|866424|P1|Dosed|Overall Study||266
361532|NCT01187953|866423|P2|STARTED|Overall Study||275
361533|NCT01187953|866424|P1|STARTED|Overall Study||268
361534|NCT01187914|866432|P1|NOT COMPLETED|Overall Study||0
361535|NCT01187914|866432|P1|COMPLETED|Overall Study||40
361536|NCT01187914|866432|P1|STARTED|Overall Study||40
361537|NCT01187901|866438|P2|NOT COMPLETED|Overall Study||10
361538|NCT01187901|866439|P1|NOT COMPLETED|Overall Study||9
361539|NCT01187901|866438|P2|COMPLETED|Overall Study||36
361540|NCT01187901|866439|P1|COMPLETED|Overall Study||37
361541|NCT01187901|866438|P2|STARTED|Overall Study||46
361542|NCT01187901|866439|P1|STARTED|Overall Study||46
361543|NCT01187550|866457|P2|NOT COMPLETED|Overall Study||1
361544|NCT01187550|866458|P1|NOT COMPLETED|Overall Study||14
361545|NCT01187550|866457|P2|COMPLETED|Overall Study||29
361546|NCT01187550|866458|P1|COMPLETED|Overall Study||169
361547|NCT01187550|866457|P2|Treated|Overall Study||30
361548|NCT01187550|866458|P1|Treated|Overall Study||175
361549|NCT01187550|866457|P2|STARTED|Overall Study||30
361550|NCT01187550|866458|P1|STARTED|Overall Study||183
361551|NCT01187511|866476|P2|NOT COMPLETED|Overall Study||1
361552|NCT01187511|866477|P1|NOT COMPLETED|Overall Study||8
361553|NCT01187511|866476|P2|COMPLETED|Overall Study||21
361554|NCT01187511|866477|P1|COMPLETED|Overall Study||14
361555|NCT01187511|866476|P2|STARTED|Overall Study||22
361556|NCT01187511|866477|P1|STARTED|Overall Study||22
361557|NCT01187498|866585|P2|NOT COMPLETED|Overall Study||10
361558|NCT01187498|866586|P1|NOT COMPLETED|Overall Study||9
361559|NCT01187498|866585|P2|COMPLETED|Overall Study||60
361560|NCT01187498|866586|P1|COMPLETED|Overall Study||64
361561|NCT01187498|866585|P2|STARTED|Overall Study||70
361562|NCT01187498|866586|P1|STARTED|Overall Study||73
361563|NCT01187433|866614|P2|NOT COMPLETED|Overall Study||4
361564|NCT01187433|866615|P1|NOT COMPLETED|Overall Study||11
361565|NCT01187433|866614|P2|COMPLETED|Overall Study||46
361566|NCT01187433|866615|P1|COMPLETED|Overall Study||89
361567|NCT01187433|866614|P2|STARTED|Overall Study||50
361568|NCT01187433|866615|P1|STARTED|Overall Study||100
361569|NCT01187355|866643|P2|NOT COMPLETED|Overall Study||20
361570|NCT01187355|866644|P1|NOT COMPLETED|Overall Study||18
361571|NCT01187355|866643|P2|COMPLETED|Overall Study||277
361572|NCT01187355|866644|P1|COMPLETED|Overall Study||276
361573|NCT01187355|866643|P2|STARTED|Overall Study||297
361574|NCT01187355|866644|P1|STARTED|Overall Study||294
361575|NCT01187043|866659|P5|NOT COMPLETED|Overall Study||2
361576|NCT01187043|866660|P4|NOT COMPLETED|Overall Study||0
361577|NCT01187043|866661|P3|NOT COMPLETED|Overall Study||4
361578|NCT01187043|866662|P2|NOT COMPLETED|Overall Study||0
361579|NCT01187043|866663|P1|NOT COMPLETED|Overall Study||1
361580|NCT01187043|866659|P5|COMPLETED|Overall Study||10
361581|NCT01187043|866660|P4|COMPLETED|Overall Study||12
361582|NCT01187043|866661|P3|COMPLETED|Overall Study||8
361583|NCT01187043|866662|P2|COMPLETED|Overall Study||10
361584|NCT01187043|866663|P1|COMPLETED|Overall Study||11
361585|NCT01187043|866659|P5|STARTED|Overall Study||12
361586|NCT01187043|866660|P4|STARTED|Overall Study||12
361587|NCT01187043|866661|P3|STARTED|Overall Study||12
361588|NCT01187043|866662|P2|STARTED|Overall Study||10
361589|NCT01187043|866663|P1|STARTED|Overall Study||12
361590|NCT01187017|866675|P1|NOT COMPLETED|Overall Study||0
361591|NCT01187017|866675|P1|COMPLETED|Overall Study||1
361592|NCT01187017|866675|P1|STARTED|Overall Study||1
361593|NCT01187004|866681|P2|NOT COMPLETED|Overall Study||0
361594|NCT01187004|866682|P1|NOT COMPLETED|Overall Study||0
361595|NCT01187004|866681|P2|COMPLETED|Overall Study||144
361596|NCT01187004|866682|P1|COMPLETED|Overall Study||20
361597|NCT01187004|866681|P2|STARTED|Overall Study||144
361598|NCT01187004|866682|P1|STARTED|Overall Study||20
361599|NCT01186939|866689|P1|NOT COMPLETED|Overall Study||40
361600|NCT01186939|866689|P1|COMPLETED|Overall Study||0
361601|NCT01186939|866689|P1|STARTED|Overall Study||40
361602|NCT01186848|866693|P1|NOT COMPLETED|Overall Study||8
361603|NCT01186848|866693|P1|COMPLETED|Overall Study||22
361604|NCT01186848|866693|P1|STARTED|Overall Study||30
361605|NCT01186796|866701|P2|NOT COMPLETED|Overall Study||2
361606|NCT01186796|866702|P1|NOT COMPLETED|Overall Study||4
361607|NCT01186796|866701|P2|COMPLETED|Overall Study||14
361608|NCT01186796|866702|P1|COMPLETED|Overall Study||10
361609|NCT01186796|866701|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
361610|NCT01186796|866702|P1|STARTED|Overall Study||14
361611|NCT01186744|866722|P6|NOT COMPLETED|Overall Study||26
361612|NCT01186744|866723|P5|NOT COMPLETED|Overall Study||6
361613|NCT01186744|866724|P4|NOT COMPLETED|Overall Study||12
361614|NCT01186744|866725|P3|NOT COMPLETED|Overall Study||6
361615|NCT01186744|866726|P2|NOT COMPLETED|Overall Study||152
361616|NCT01186744|866727|P1|NOT COMPLETED|Overall Study||208
361617|NCT01186744|866722|P6|COMPLETED|Overall Study||107
361618|NCT01186744|866723|P5|COMPLETED|Overall Study||39
361619|NCT01186744|866724|P4|COMPLETED|Overall Study||70
361620|NCT01186744|866725|P3|COMPLETED|Overall Study||25
361621|NCT01186744|866726|P2|COMPLETED|Overall Study||5
361622|NCT01186744|866727|P1|COMPLETED|Overall Study||10
361623|NCT01186744|866722|P6|STARTED|Overall Study||133
361624|NCT01186744|866723|P5|STARTED|Overall Study||45
361625|NCT01186744|866724|P4|STARTED|Overall Study||82
361626|NCT01186744|866725|P3|STARTED|Overall Study||31
361627|NCT01186744|866726|P2|STARTED|Overall Study||157
361628|NCT01186744|866727|P1|STARTED|Overall Study||218
361629|NCT01186705|867143|P1|NOT COMPLETED|Overall Study||0
361630|NCT01186705|867143|P1|COMPLETED|Overall Study||1
361631|NCT01186705|867143|P1|STARTED|Overall Study||1
361632|NCT01186692|867147|P1|NOT COMPLETED|Overall Study||32
361633|NCT01186692|867147|P1|COMPLETED|Overall Study||99
361634|NCT01186692|867147|P1|STARTED|Overall Study||131
361635|NCT01186562|867157|P2|NOT COMPLETED|Overall Study||2
361636|NCT01186562|867158|P1|NOT COMPLETED|Overall Study||4
361637|NCT01186562|867157|P2|COMPLETED|Overall Study||27
361638|NCT01186562|867158|P1|COMPLETED|Overall Study||50
361639|NCT01186562|867157|P2|STARTED|Overall Study||29
361640|NCT01186562|867158|P1|STARTED|Overall Study||54
361641|NCT01186458|867174|P1|NOT COMPLETED|Overall Study||1
361642|NCT01186458|867174|P1|COMPLETED|Overall Study||3
361643|NCT01186458|867174|P1|STARTED|Overall Study||4
361644|NCT01186419|867183|P2|NOT COMPLETED|Overall Study||9
361645|NCT01186419|867184|P1|NOT COMPLETED|Overall Study||7
361646|NCT01186419|867183|P2|COMPLETED|Overall Study||18
361647|NCT01186419|867184|P1|COMPLETED|Overall Study||17
361648|NCT01186419|867183|P2|STARTED|Overall Study||27
361649|NCT01186419|867184|P1|STARTED|Overall Study||24
361650|NCT01186406|867191|P1|NOT COMPLETED|Overall Study||0
361651|NCT01186406|867191|P1|COMPLETED|Overall Study||41
361652|NCT01186406|867191|P1|STARTED|Overall Study||41
361653|NCT01186250|867200|P2|NOT COMPLETED|Overall Study||0
361654|NCT01186250|867201|P1|NOT COMPLETED|Overall Study||1
361655|NCT01186250|867200|P2|COMPLETED|Overall Study||9
361656|NCT01186250|867201|P1|COMPLETED|Overall Study||8
361657|NCT01186250|867200|P2|STARTED|Overall Study||9
361658|NCT01186250|867201|P1|STARTED|Overall Study||9
361659|NCT01185964|867222|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
361660|NCT01185964|867223|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
361661|NCT01185964|867224|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
361662|NCT01185964|867225|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
361663|NCT01185964|867222|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
361664|NCT01185964|867223|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
361665|NCT01185964|867224|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
361666|NCT01185964|867225|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
361667|NCT01185964|867222|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
361668|NCT01185964|867223|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
361669|NCT01185964|867224|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
361670|NCT01185964|867225|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
361671|NCT01185964|867222|P4|NOT COMPLETED|Phase 1b and Phase 2||0
361672|NCT01185964|867223|P3|NOT COMPLETED|Phase 1b and Phase 2||9
361673|NCT01185964|867224|P2|NOT COMPLETED|Phase 1b and Phase 2||10
361674|NCT01185964|867225|P1|NOT COMPLETED|Phase 1b and Phase 2||2
361675|NCT01185964|867222|P4|COMPLETED|Phase 1b and Phase 2||0
361676|NCT01185964|867223|P3|COMPLETED|Phase 1b and Phase 2||58
361677|NCT01185964|867224|P2|COMPLETED|Phase 1b and Phase 2||56
361678|NCT01185964|867225|P1|COMPLETED|Phase 1b and Phase 2||13
361679|NCT01185964|867222|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
361680|NCT01185964|867223|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
361681|NCT01185964|867224|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
361682|NCT01185964|867225|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
361683|NCT01185964|867222|P4|STARTED|Phase 1b and Phase 2||0
361684|NCT01185964|867223|P3|STARTED|Phase 1b and Phase 2||67
361685|NCT01185964|867224|P2|STARTED|Phase 1b and Phase 2||66
361686|NCT01185964|867225|P1|STARTED|Phase 1b and Phase 2||15
361687|NCT01185834|867251|P1|NOT COMPLETED|Overall Study||14
361688|NCT01185834|867251|P1|COMPLETED|Overall Study||104
361689|NCT01185834|867251|P1|STARTED|Overall Study||118
361690|NCT01185782|867258|P2|NOT COMPLETED|Overall Study||11
361691|NCT01185782|867259|P1|NOT COMPLETED|Overall Study||6
361692|NCT01185782|867258|P2|COMPLETED|Overall Study||125
361693|NCT01185782|867259|P1|COMPLETED|Overall Study||123
361694|NCT01185782|867258|P2|Treated|Overall Study||132
361695|NCT01185782|867259|P1|Treated|Overall Study||129
361696|NCT01185782|867258|P2|STARTED|Overall Study||136
361697|NCT01185782|867259|P1|STARTED|Overall Study||129
361698|NCT01185704|867287|P2|NOT COMPLETED|Overall Study||8
361699|NCT01185704|867288|P1|NOT COMPLETED|Overall Study||13
361700|NCT01185704|867287|P2|COMPLETED|Overall Study||60
361701|NCT01185704|867288|P1|COMPLETED|Overall Study||55
361702|NCT01185704|867287|P2|Treated|Overall Study||65
361703|NCT01185704|867288|P1|Treated|Overall Study||65
361704|NCT01185704|867287|P2|STARTED|Overall Study||68
361705|NCT01185704|867288|P1|STARTED|Overall Study||68
361706|NCT01185600|867324|P2|NOT COMPLETED|Overall Study||45
361707|NCT01185600|867325|P1|NOT COMPLETED|Overall Study||32
361708|NCT01185600|867324|P2|COMPLETED|Overall Study||59
361709|NCT01185600|867325|P1|COMPLETED|Overall Study||41
361710|NCT01185600|867324|P2|STARTED|Overall Study||104
361711|NCT01185600|867325|P1|STARTED|Overall Study||73
361712|NCT01185561|867347|P2|NOT COMPLETED|Overall Study||12
361713|NCT01185561|867348|P1|NOT COMPLETED|Overall Study||2
361714|NCT01185561|867347|P2|COMPLETED|Overall Study||26
361715|NCT01185561|867348|P1|COMPLETED|Overall Study||34
361716|NCT01185561|867347|P2|STARTED|Overall Study||38
361717|NCT01185561|867348|P1|STARTED|Overall Study||36
361718|NCT01185522|867360|P1|NOT COMPLETED|Overall Study||108
361719|NCT01185522|867360|P1|COMPLETED|Overall Study||585
361720|NCT01185522|867360|P1|STARTED|Overall Study||693
361721|NCT01185509|867386|P2|NOT COMPLETED|Overall Study||20
361722|NCT01185509|867387|P1|NOT COMPLETED|Overall Study||11
361723|NCT01185509|867386|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
361724|NCT01185509|867387|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
361725|NCT01185509|867386|P2|STARTED|Overall Study||20
361726|NCT01185509|867387|P1|STARTED|Overall Study||11
361727|NCT01185353|867402|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
361728|NCT01185353|867403|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
361729|NCT01185353|867404|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
361730|NCT01185353|867405|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361731|NCT01185353|867406|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361732|NCT01185353|867407|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361733|NCT01185353|867408|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361734|NCT01185353|867409|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361735|NCT01185353|867410|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361736|NCT01185353|867411|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
361737|NCT01185353|867402|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
361738|NCT01185353|867403|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
361739|NCT01185353|867404|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
361740|NCT01185353|867405|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
361741|NCT01185353|867406|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
361742|NCT01185353|867407|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
361743|NCT01185353|867408|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
361744|NCT01185353|867409|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
361745|NCT01185353|867410|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
361746|NCT01185353|867411|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
361747|NCT01185353|867402|P10|STARTED|Part D (Weeks 76 Through 128)||18
361748|NCT01185353|867403|P9|STARTED|Part D (Weeks 76 Through 128)||47
361749|NCT01185353|867404|P8|STARTED|Part D (Weeks 76 Through 128)||79
361750|NCT01185353|867405|P7|STARTED|Part D (Weeks 76 Through 128)||0
361751|NCT01185353|867406|P6|STARTED|Part D (Weeks 76 Through 128)||0
361752|NCT01185353|867407|P5|STARTED|Part D (Weeks 76 Through 128)||0
361753|NCT01185353|867408|P4|STARTED|Part D (Weeks 76 Through 128)||0
361754|NCT01185353|867409|P3|STARTED|Part D (Weeks 76 Through 128)||0
361755|NCT01185353|867410|P2|STARTED|Part D (Weeks 76 Through 128)||0
361756|NCT01185353|867411|P1|STARTED|Part D (Weeks 76 Through 128)||0
361757|NCT01185353|867402|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
361758|NCT01185353|867403|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
361759|NCT01185353|867404|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
361760|NCT01185353|867405|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361761|NCT01185353|867406|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361762|NCT01185353|867407|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361763|NCT01185353|867408|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361764|NCT01185353|867409|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361765|NCT01185353|867410|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361766|NCT01185353|867411|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
361767|NCT01185353|867402|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
361768|NCT01185353|867403|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
361769|NCT01185353|867404|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
361770|NCT01185353|867405|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
361771|NCT01185353|867406|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
361772|NCT01185353|867407|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
361773|NCT01185353|867408|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
361774|NCT01185353|867409|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
361775|NCT01185353|867410|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
361776|NCT01185353|867411|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
361777|NCT01185353|867402|P10|STARTED|Part C (Weeks 24 Through 76)||32
361778|NCT01185353|867403|P9|STARTED|Part C (Weeks 24 Through 76)||61
361779|NCT01185353|867404|P8|STARTED|Part C (Weeks 24 Through 76)||108
361780|NCT01185353|867405|P7|STARTED|Part C (Weeks 24 Through 76)||0
361781|NCT01185353|867406|P6|STARTED|Part C (Weeks 24 Through 76)||0
361782|NCT01185353|867407|P5|STARTED|Part C (Weeks 24 Through 76)||0
361783|NCT01185353|867408|P4|STARTED|Part C (Weeks 24 Through 76)||0
361784|NCT01185353|867409|P3|STARTED|Part C (Weeks 24 Through 76)||0
361785|NCT01185353|867410|P2|STARTED|Part C (Weeks 24 Through 76)||0
361786|NCT01185353|867411|P1|STARTED|Part C (Weeks 24 Through 76)||0
361787|NCT01185353|867402|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
361788|NCT01185353|867403|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
361789|NCT01185353|867404|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
361790|NCT01185353|867405|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
361791|NCT01185353|867406|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
361792|NCT01185353|867407|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
361793|NCT01185353|867408|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
361794|NCT01185353|867409|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
361795|NCT01185353|867410|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
361796|NCT01185353|867411|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
361797|NCT01185353|867402|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
361798|NCT01185353|867403|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
361799|NCT01185353|867404|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
361800|NCT01185353|867405|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
361801|NCT01185353|867406|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
361802|NCT01185353|867407|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
361803|NCT01185353|867408|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
361804|NCT01185353|867409|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
361805|NCT01185353|867410|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
361806|NCT01185353|867411|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
361807|NCT01185353|867402|P10|STARTED|Part B (Weeks 12 Through 24)||0
361808|NCT01185353|867403|P9|STARTED|Part B (Weeks 12 Through 24)||0
361809|NCT01185353|867404|P8|STARTED|Part B (Weeks 12 Through 24)||0
361810|NCT01185353|867405|P7|STARTED|Part B (Weeks 12 Through 24)||63
361811|NCT01185353|867406|P6|STARTED|Part B (Weeks 12 Through 24)||63
361812|NCT01185353|867407|P5|STARTED|Part B (Weeks 12 Through 24)||0
361813|NCT01185353|867408|P4|STARTED|Part B (Weeks 12 Through 24)||49
361814|NCT01185353|867409|P3|STARTED|Part B (Weeks 12 Through 24)||50
361815|NCT01185353|867410|P2|STARTED|Part B (Weeks 12 Through 24)||51
361816|NCT01185353|867411|P1|STARTED|Part B (Weeks 12 Through 24)||0
361817|NCT01185353|867402|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
361818|NCT01185353|867403|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
361819|NCT01185353|867404|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
361820|NCT01185353|867405|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
361821|NCT01185353|867406|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
361822|NCT01185353|867407|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
361823|NCT01185353|867408|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
361824|NCT01185353|867409|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
361825|NCT01185353|867410|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
361826|NCT01185353|867411|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
361827|NCT01185353|867402|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
361828|NCT01185353|867403|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
361829|NCT01185353|867404|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
361830|NCT01185353|867405|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
361831|NCT01185353|867406|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
361832|NCT01185353|867407|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
361833|NCT01185353|867408|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
361834|NCT01185353|867409|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
361835|NCT01185353|867410|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
361836|NCT01185353|867411|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
361837|NCT01185353|867402|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
361838|NCT01185353|867403|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
361839|NCT01185353|867404|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
361840|NCT01185353|867405|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
361841|NCT01185353|867406|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
361842|NCT01185353|867407|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
361843|NCT01185353|867408|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
361844|NCT01185353|867409|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
361845|NCT01185353|867410|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
361846|NCT01185353|867411|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
361847|NCT01185353|867402|P10|STARTED|Part A (Weeks 0 Through 12)||0
361848|NCT01185353|867403|P9|STARTED|Part A (Weeks 0 Through 12)||0
361849|NCT01185353|867404|P8|STARTED|Part A (Weeks 0 Through 12)||0
361850|NCT01185353|867405|P7|STARTED|Part A (Weeks 0 Through 12)||0
361851|NCT01185353|867406|P6|STARTED|Part A (Weeks 0 Through 12)||0
361852|NCT01185353|867407|P5|STARTED|Part A (Weeks 0 Through 12)||98
361853|NCT01185353|867408|P4|STARTED|Part A (Weeks 0 Through 12)||50
361854|NCT01185353|867409|P3|STARTED|Part A (Weeks 0 Through 12)||52
361855|NCT01185353|867410|P2|STARTED|Part A (Weeks 0 Through 12)||52
361856|NCT01185353|867411|P1|STARTED|Part A (Weeks 0 Through 12)||49
361857|NCT01185301|867573|P4|NOT COMPLETED|Overall Study||9
361858|NCT01185301|867574|P3|NOT COMPLETED|Overall Study||6
361859|NCT01185301|867575|P2|NOT COMPLETED|Overall Study||7
361860|NCT01185301|867576|P1|NOT COMPLETED|Overall Study||15
361861|NCT01185301|867573|P4|COMPLETED|Overall Study||89
361862|NCT01185301|867574|P3|COMPLETED|Overall Study||93
361863|NCT01185301|867575|P2|COMPLETED|Overall Study||93
361864|NCT01185301|867576|P1|COMPLETED|Overall Study||83
361865|NCT01185301|867573|P4|STARTED|Overall Study||98
361866|NCT01185301|867574|P3|STARTED|Overall Study||99
361867|NCT01185301|867575|P2|STARTED|Overall Study||100
361868|NCT01185301|867576|P1|STARTED|Overall Study||98
361869|NCT01185288|867636|P2|NOT COMPLETED|Overall Study||16
361870|NCT01185288|867637|P1|NOT COMPLETED|Overall Study||19
361871|NCT01185288|867636|P2|COMPLETED|Overall Study||139
361872|NCT01185288|867637|P1|COMPLETED|Overall Study||135
361873|NCT01185288|867636|P2|STARTED|Overall Study||155
361874|NCT01185288|867637|P1|STARTED|Overall Study||154
361875|NCT01185249|867655|P1|NOT COMPLETED|Overall Study||42
361876|NCT01185249|867655|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
361877|NCT01185249|867655|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
361878|NCT01185080|867663|P3|NOT COMPLETED|Overall Study||1
361879|NCT01185080|867664|P2|NOT COMPLETED|Overall Study||1
361880|NCT01185080|867665|P1|NOT COMPLETED|Overall Study||1
361881|NCT01185080|867663|P3|COMPLETED|Overall Study||16
361882|NCT01185080|867664|P2|COMPLETED|Overall Study||15
361883|NCT01185080|867665|P1|COMPLETED|Overall Study||49
361884|NCT01185080|867663|P3|STARTED|Overall Study||17
361885|NCT01185080|867664|P2|STARTED|Overall Study||16
361886|NCT01185080|867665|P1|STARTED|Overall Study||50
361887|NCT01185028|867712|P1|NOT COMPLETED|Overall Study||4
361888|NCT01185028|867712|P1|COMPLETED|Overall Study||4
361889|NCT01185028|867712|P1|STARTED|Overall Study||8
361890|NCT01184989|867717|P1|NOT COMPLETED|Overall Study||12
361891|NCT01184989|867717|P1|COMPLETED|Overall Study||100
361892|NCT01184989|867717|P1|STARTED|Overall Study|Treated Patients|112
361893|NCT01184898|867723|P1|NOT COMPLETED|Overall Study||0
361894|NCT01184898|867723|P1|COMPLETED|Overall Study||36
361895|NCT01184898|867723|P1|STARTED|Overall Study||36
361896|NCT01184885|867730|P1|NOT COMPLETED|Overall Study||0
361897|NCT01184885|867730|P1|COMPLETED|Overall Study||7
361898|NCT01184885|867730|P1|STARTED|Overall Study||7
361899|NCT01184872|867737|P2|NOT COMPLETED|Overall Study||8
361900|NCT01184872|867738|P1|NOT COMPLETED|Overall Study||10
361901|NCT01184872|867737|P2|COMPLETED|Overall Study||31
361902|NCT01184872|867738|P1|COMPLETED|Overall Study||71
361903|NCT01184872|867737|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
361904|NCT01184872|867738|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
361905|NCT01184872|867737|P2|Clinical Evaluable Set (CES)|Overall Study||30
361906|NCT01184872|867738|P1|Clinical Evaluable Set (CES)|Overall Study||73
361907|NCT01184872|867737|P2|Safety Set|Overall Study||40
361908|NCT01184872|867738|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
361909|NCT01184872|867737|P2|STARTED|Overall Study||39
361910|NCT01184872|867738|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
361911|NCT01184859|867757|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
361912|NCT01184859|867758|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
361913|NCT01184859|867759|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
361914|NCT01184859|867760|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
361915|NCT01184859|867761|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
361916|NCT01184859|867757|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
361917|NCT01184859|867758|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
361918|NCT01184859|867759|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
361919|NCT01184859|867760|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
361920|NCT01184859|867761|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
361921|NCT01184859|867757|P5|STARTED|Period 2: Daily Dose for 28 Days||23
361922|NCT01184859|867758|P4|STARTED|Period 2: Daily Dose for 28 Days||22
361923|NCT01184859|867759|P3|STARTED|Period 2: Daily Dose for 28 Days||22
361924|NCT01184859|867760|P2|STARTED|Period 2: Daily Dose for 28 Days||23
361925|NCT01184859|867761|P1|STARTED|Period 2: Daily Dose for 28 Days||23
361926|NCT01184859|867757|P5|NOT COMPLETED|Washout Period||0
361927|NCT01184859|867758|P4|NOT COMPLETED|Washout Period||0
361928|NCT01184859|867759|P3|NOT COMPLETED|Washout Period||0
361929|NCT01184859|867760|P2|NOT COMPLETED|Washout Period||0
361930|NCT01184859|867761|P1|NOT COMPLETED|Washout Period||0
361931|NCT01184859|867757|P5|COMPLETED|Washout Period||23
361932|NCT01184859|867758|P4|COMPLETED|Washout Period||22
361933|NCT01184859|867759|P3|COMPLETED|Washout Period||22
361934|NCT01184859|867760|P2|COMPLETED|Washout Period||23
361935|NCT01184859|867761|P1|COMPLETED|Washout Period||23
361936|NCT01184859|867757|P5|STARTED|Washout Period||23
361937|NCT01184859|867758|P4|STARTED|Washout Period||22
361938|NCT01184859|867759|P3|STARTED|Washout Period||22
361939|NCT01184859|867760|P2|STARTED|Washout Period||23
361940|NCT01184859|867761|P1|STARTED|Washout Period||23
361941|NCT01184859|867757|P5|NOT COMPLETED|Period 1: Single Dose||1
361942|NCT01184859|867758|P4|NOT COMPLETED|Period 1: Single Dose||0
361943|NCT01184859|867759|P3|NOT COMPLETED|Period 1: Single Dose||0
361944|NCT01184859|867760|P2|NOT COMPLETED|Period 1: Single Dose||2
361945|NCT01184859|867761|P1|NOT COMPLETED|Period 1: Single Dose||0
361946|NCT01184859|867757|P5|COMPLETED|Period 1: Single Dose||23
361947|NCT01184859|867758|P4|COMPLETED|Period 1: Single Dose||22
361948|NCT01184859|867759|P3|COMPLETED|Period 1: Single Dose||22
361949|NCT01184859|867760|P2|COMPLETED|Period 1: Single Dose||23
361950|NCT01184859|867761|P1|COMPLETED|Period 1: Single Dose||23
361951|NCT01184859|867757|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
361952|NCT01184859|867758|P4|Per Protocol (PP)|Period 1: Single Dose||21
361953|NCT01184859|867759|P3|Per Protocol (PP)|Period 1: Single Dose||22
361954|NCT01184859|867760|P2|Per Protocol (PP)|Period 1: Single Dose||23
361955|NCT01184859|867761|P1|Per Protocol (PP)|Period 1: Single Dose||23
361956|NCT01184859|867757|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
361957|NCT01184859|867758|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
361958|NCT01184859|867759|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
361959|NCT01184859|867760|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
361960|NCT01184859|867761|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
361961|NCT01184859|867757|P5|STARTED|Period 1: Single Dose||24
361962|NCT01184859|867758|P4|STARTED|Period 1: Single Dose||22
361963|NCT01184859|867759|P3|STARTED|Period 1: Single Dose||22
361964|NCT01184859|867760|P2|STARTED|Period 1: Single Dose||25
361965|NCT01184859|867761|P1|STARTED|Period 1: Single Dose||23
361966|NCT01184846|867853|P1|NOT COMPLETED|Overall Study||3
361967|NCT01184846|867853|P1|COMPLETED|Overall Study||25
361968|NCT01184846|867853|P1|STARTED|Overall Study||28
361969|NCT01184755|867874|P3|NOT COMPLETED|Overall Study||6
361970|NCT01184755|867875|P2|NOT COMPLETED|Overall Study||11
361971|NCT01184755|867876|P1|NOT COMPLETED|Overall Study||25
361972|NCT01184755|867874|P3|COMPLETED|Overall Study||56
361973|NCT01184755|867875|P2|COMPLETED|Overall Study||54
361974|NCT01184755|867876|P1|COMPLETED|Overall Study||101
361975|NCT01184755|867874|P3|STARTED|Overall Study||62
361976|NCT01184755|867875|P2|STARTED|Overall Study||65
361977|NCT01184755|867876|P1|STARTED|Overall Study||126
361978|NCT01184417|867886|P2|NOT COMPLETED|Overall Study||0
361979|NCT01184417|867887|P1|NOT COMPLETED|Overall Study||0
361980|NCT01184417|867886|P2|COMPLETED|Overall Study||51
361981|NCT01184417|867887|P1|COMPLETED|Overall Study||51
361982|NCT01184417|867886|P2|STARTED|Overall Study||51
361983|NCT01184417|867887|P1|STARTED|Overall Study||51
361984|NCT01184118|867907|P1|NOT COMPLETED|Overall Study||18
361985|NCT01184118|867907|P1|COMPLETED|Overall Study||18
361986|NCT01184118|867907|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
361987|NCT01184118|867907|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
361988|NCT01184118|867907|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
361989|NCT01184118|867907|P1|STARTED|Overall Study||36
361990|NCT01184079|867915|P2|NOT COMPLETED|Overall Study||2
361991|NCT01184079|867916|P1|NOT COMPLETED|Overall Study||14
361992|NCT01184079|867915|P2|COMPLETED|Overall Study||107
361993|NCT01184079|867916|P1|COMPLETED|Overall Study||97
361994|NCT01184079|867915|P2|Final Blood Draw|Overall Study||107
361995|NCT01184079|867916|P1|Final Blood Draw|Overall Study||97
361996|NCT01184079|867915|P2|Dose 3|Overall Study||107
361997|NCT01184079|867916|P1|Dose 3|Overall Study||101
361998|NCT01184079|867915|P2|Dose 2|Overall Study||108
361999|NCT01184079|867916|P1|Dose 2|Overall Study||110
362000|NCT01184079|867915|P2|STARTED|Overall Study||109
362001|NCT01184079|867916|P1|STARTED|Overall Study||111
362002|NCT01184053|867926|P1|NOT COMPLETED|Overall Study||3
362003|NCT01184053|867926|P1|COMPLETED|Overall Study||0
362004|NCT01184053|867926|P1|STARTED|Overall Study||3
362005|NCT01184014|867935|P2|NOT COMPLETED|Overall Study||6
362006|NCT01184014|867936|P1|NOT COMPLETED|Overall Study||5
362007|NCT01184014|867935|P2|COMPLETED|Overall Study||31
362008|NCT01184014|867936|P1|COMPLETED|Overall Study||30
362009|NCT01184014|867935|P2|STARTED|Overall Study||37
362010|NCT01184014|867936|P1|STARTED|Overall Study||35
362011|NCT01183975|867942|P1|NOT COMPLETED|Overall Study||73
362012|NCT01183975|867942|P1|COMPLETED|Overall Study||444
362013|NCT01183975|867942|P1|STARTED|Overall Study||517
362014|NCT01183858|867949|P2|NOT COMPLETED|Overall Study||156
362015|NCT01183858|867950|P1|NOT COMPLETED|Overall Study||153
362016|NCT01183858|867949|P2|COMPLETED|Overall Study||3
362017|NCT01183858|867950|P1|COMPLETED|Overall Study||1
362018|NCT01183858|867949|P2|Safety Population|Overall Study||158
362019|NCT01183858|867950|P1|Safety Population|Overall Study||154
362020|NCT01183858|867949|P2|STARTED|Overall Study||159
362021|NCT01183858|867950|P1|STARTED|Overall Study||154
362022|NCT01183780|867972|P2|NOT COMPLETED|Overall Study||40
362023|NCT01183780|867973|P1|NOT COMPLETED|Overall Study||43
362024|NCT01183780|867972|P2|COMPLETED|Overall Study||496
362025|NCT01183780|867973|P1|COMPLETED|Overall Study||493
362026|NCT01183780|867972|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
362027|NCT01183780|867973|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
362028|NCT01183780|867972|P2|STARTED|Overall Study||536
362029|NCT01183780|867973|P1|STARTED|Overall Study||536
362030|NCT01183728|867990|P1|NOT COMPLETED|Overall Study||0
362031|NCT01183728|867990|P1|COMPLETED|Overall Study||12
362032|NCT01183728|867990|P1|STARTED|Overall Study||12
362033|NCT01183650|867997|P2|NOT COMPLETED|Overall Study||0
362034|NCT01183650|867998|P1|NOT COMPLETED|Overall Study||0
362035|NCT01183650|867997|P2|COMPLETED|Overall Study||12
362036|NCT01183650|867998|P1|COMPLETED|Overall Study||12
362037|NCT01183650|867997|P2|STARTED|Overall Study||12
362038|NCT01183650|867998|P1|STARTED|Overall Study||12
362039|NCT01183546|868008|P1|NOT COMPLETED|Overall Study||0
362040|NCT01183546|868008|P1|COMPLETED|Overall Study||53
362041|NCT01183546|868008|P1|STARTED|Overall Study||53
362042|NCT01183533|868015|P1|NOT COMPLETED|Overall Study||0
362043|NCT01183533|868015|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
362044|NCT01183533|868015|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
362045|NCT01183481|868021|P1|NOT COMPLETED|Overall Study||0
362046|NCT01183481|868021|P1|COMPLETED|Overall Study||19
362047|NCT01183481|868021|P1|STARTED|Overall Study||19
362048|NCT01183468|868033|P4|NOT COMPLETED|Overall Study||0
362049|NCT01183468|868034|P3|NOT COMPLETED|Overall Study||0
362050|NCT01183468|868035|P2|NOT COMPLETED|Overall Study||2
362051|NCT01183468|868036|P1|NOT COMPLETED|Overall Study||3
362052|NCT01183468|868033|P4|COMPLETED|Overall Study||0
362053|NCT01183468|868034|P3|COMPLETED|Overall Study||0
362054|NCT01183468|868035|P2|COMPLETED|Overall Study||7
362055|NCT01183468|868036|P1|COMPLETED|Overall Study||5
362056|NCT01183468|868033|P4|STARTED|Overall Study||0
362057|NCT01183468|868034|P3|STARTED|Overall Study||0
362058|NCT01183468|868035|P2|STARTED|Overall Study||9
362059|NCT01183468|868036|P1|STARTED|Overall Study||8
362060|NCT01183390|868046|P2|NOT COMPLETED|Second Intervention||0
362061|NCT01183390|868047|P1|NOT COMPLETED|Second Intervention||0
362062|NCT01183390|868046|P2|COMPLETED|Second Intervention||10
362063|NCT01183390|868047|P1|COMPLETED|Second Intervention||11
362064|NCT01183390|868046|P2|STARTED|Second Intervention||10
362065|NCT01183390|868047|P1|STARTED|Second Intervention||11
362066|NCT01183390|868046|P2|NOT COMPLETED|Washout of 21 Days||0
362067|NCT01183390|868047|P1|NOT COMPLETED|Washout of 21 Days||0
362068|NCT01183390|868046|P2|COMPLETED|Washout of 21 Days||10
362069|NCT01183390|868047|P1|COMPLETED|Washout of 21 Days||11
362070|NCT01183390|868046|P2|STARTED|Washout of 21 Days||10
362071|NCT01183390|868047|P1|STARTED|Washout of 21 Days||11
362072|NCT01183390|868046|P2|NOT COMPLETED|First Intervention||1
362073|NCT01183390|868047|P1|NOT COMPLETED|First Intervention||0
362074|NCT01183390|868046|P2|COMPLETED|First Intervention||10
362075|NCT01183390|868047|P1|COMPLETED|First Intervention||11
362076|NCT01183390|868046|P2|STARTED|First Intervention||11
362077|NCT01183390|868047|P1|STARTED|First Intervention||11
362078|NCT01183312|868057|P2|NOT COMPLETED|Second Intervention Day||0
362079|NCT01183312|868058|P1|NOT COMPLETED|Second Intervention Day||0
362080|NCT01183312|868057|P2|COMPLETED|Second Intervention Day||5
362081|NCT01183312|868058|P1|COMPLETED|Second Intervention Day||5
362082|NCT01183312|868057|P2|STARTED|Second Intervention Day||5
362083|NCT01183312|868058|P1|STARTED|Second Intervention Day||5
362084|NCT01183312|868057|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
362085|NCT01183312|868058|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
362086|NCT01183312|868057|P2|COMPLETED|Washout Period of at Least 1 Week||5
362087|NCT01183312|868058|P1|COMPLETED|Washout Period of at Least 1 Week||5
362088|NCT01183312|868057|P2|STARTED|Washout Period of at Least 1 Week||5
362089|NCT01183312|868058|P1|STARTED|Washout Period of at Least 1 Week||5
362090|NCT01183312|868057|P2|NOT COMPLETED|First Intervention Day||0
362091|NCT01183312|868058|P1|NOT COMPLETED|First Intervention Day||0
362092|NCT01183312|868057|P2|COMPLETED|First Intervention Day||5
362093|NCT01183312|868058|P1|COMPLETED|First Intervention Day||5
362094|NCT01183312|868057|P2|STARTED|First Intervention Day||5
362095|NCT01183312|868058|P1|STARTED|First Intervention Day||5
362096|NCT01183234|868078|P2|NOT COMPLETED|Second Intervention||0
362097|NCT01183234|868079|P1|NOT COMPLETED|Second Intervention||0
362098|NCT01183234|868078|P2|COMPLETED|Second Intervention||14
362099|NCT01183234|868079|P1|COMPLETED|Second Intervention||13
362100|NCT01183234|868078|P2|STARTED|Second Intervention||14
362101|NCT01183234|868079|P1|STARTED|Second Intervention||13
362102|NCT01183234|868078|P2|NOT COMPLETED|Washout||0
362103|NCT01183234|868079|P1|NOT COMPLETED|Washout||0
362104|NCT01183234|868078|P2|COMPLETED|Washout||14
362105|NCT01183234|868079|P1|COMPLETED|Washout||13
362106|NCT01183234|868078|P2|STARTED|Washout||14
362107|NCT01183234|868079|P1|STARTED|Washout||13
362108|NCT01183234|868078|P2|NOT COMPLETED|First Intervention||0
362109|NCT01183234|868079|P1|NOT COMPLETED|First Intervention||1
362110|NCT01183234|868078|P2|COMPLETED|First Intervention||14
362111|NCT01183234|868079|P1|COMPLETED|First Intervention||13
362112|NCT01183234|868078|P2|STARTED|First Intervention||14
362113|NCT01183234|868079|P1|STARTED|First Intervention||14
362114|NCT01183169|868093|P7|NOT COMPLETED|Post-switch Phase||9
362115|NCT01183169|868094|P6|NOT COMPLETED|Post-switch Phase||14
362116|NCT01183169|868095|P5|NOT COMPLETED|Post-switch Phase||0
362117|NCT01183169|868096|P4|NOT COMPLETED|Post-switch Phase||0
362118|NCT01183169|868097|P3|NOT COMPLETED|Post-switch Phase||0
362119|NCT01183169|868098|P2|NOT COMPLETED|Post-switch Phase||0
362120|NCT01183169|868099|P1|NOT COMPLETED|Post-switch Phase||0
362121|NCT01183169|868093|P7|COMPLETED|Post-switch Phase||21
362122|NCT01183169|868094|P6|COMPLETED|Post-switch Phase||21
362123|NCT01183169|868095|P5|COMPLETED|Post-switch Phase||0
362124|NCT01183169|868096|P4|COMPLETED|Post-switch Phase||0
362125|NCT01183169|868097|P3|COMPLETED|Post-switch Phase||0
362126|NCT01183169|868098|P2|COMPLETED|Post-switch Phase||0
362127|NCT01183169|868099|P1|COMPLETED|Post-switch Phase||0
362128|NCT01183169|868093|P7|Completed Treatment|Post-switch Phase||13
362129|NCT01183169|868094|P6|Completed Treatment|Post-switch Phase||12
362130|NCT01183169|868095|P5|Completed Treatment|Post-switch Phase||0
362131|NCT01183169|868096|P4|Completed Treatment|Post-switch Phase||0
362132|NCT01183169|868097|P3|Completed Treatment|Post-switch Phase||0
362133|NCT01183169|868098|P2|Completed Treatment|Post-switch Phase||0
362134|NCT01183169|868099|P1|Completed Treatment|Post-switch Phase||0
362135|NCT01183169|868093|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
362136|NCT01183169|868094|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
362137|NCT01183169|868095|P5|STARTED|Post-switch Phase|Not a post-switch group|0
362138|NCT01183169|868096|P4|STARTED|Post-switch Phase|Not a post-switch group|0
362139|NCT01183169|868097|P3|STARTED|Post-switch Phase|Not a post-switch group|0
362140|NCT01183169|868098|P2|STARTED|Post-switch Phase|Not a post-switch group|0
362141|NCT01183169|868099|P1|STARTED|Post-switch Phase|Not a post-switch group|0
362142|NCT01183169|868093|P7|NOT COMPLETED|Main Phase||0
362143|NCT01183169|868094|P6|NOT COMPLETED|Main Phase||0
362144|NCT01183169|868095|P5|NOT COMPLETED|Main Phase||26
362145|NCT01183169|868096|P4|NOT COMPLETED|Main Phase||37
362146|NCT01183169|868097|P3|NOT COMPLETED|Main Phase||41
362147|NCT01183169|868098|P2|NOT COMPLETED|Main Phase||22
362148|NCT01183169|868099|P1|NOT COMPLETED|Main Phase||27
362149|NCT01183169|868093|P7|COMPLETED|Main Phase||0
362150|NCT01183169|868094|P6|COMPLETED|Main Phase||0
362151|NCT01183169|868095|P5|COMPLETED|Main Phase||83
362152|NCT01183169|868096|P4|COMPLETED|Main Phase||18
362153|NCT01183169|868097|P3|COMPLETED|Main Phase||18
362154|NCT01183169|868098|P2|COMPLETED|Main Phase||93
362155|NCT01183169|868099|P1|COMPLETED|Main Phase||94
362156|NCT01183169|868093|P7|Switched to ALV|Main Phase||0
362157|NCT01183169|868094|P6|Switched to ALV|Main Phase||0
362158|NCT01183169|868095|P5|Switched to ALV|Main Phase||0
362159|NCT01183169|868096|P4|Switched to ALV|Main Phase||30
362160|NCT01183169|868097|P3|Switched to ALV|Main Phase||35
362161|NCT01183169|868098|P2|Switched to ALV|Main Phase||0
362162|NCT01183169|868099|P1|Switched to ALV|Main Phase||0
362163|NCT01183169|868093|P7|Completed Treatment|Main Phase||0
362164|NCT01183169|868094|P6|Completed Treatment|Main Phase||0
362165|NCT01183169|868095|P5|Completed Treatment|Main Phase||77
362166|NCT01183169|868096|P4|Completed Treatment|Main Phase||17
362167|NCT01183169|868097|P3|Completed Treatment|Main Phase||17
362168|NCT01183169|868098|P2|Completed Treatment|Main Phase||78
362169|NCT01183169|868099|P1|Completed Treatment|Main Phase||72
362170|NCT01183169|868093|P7|STARTED|Main Phase||0
362171|NCT01183169|868094|P6|STARTED|Main Phase||0
362172|NCT01183169|868095|P5|STARTED|Main Phase||109
362173|NCT01183169|868096|P4|STARTED|Main Phase||55
362174|NCT01183169|868097|P3|STARTED|Main Phase||59
362175|NCT01183169|868098|P2|STARTED|Main Phase||115
362176|NCT01183169|868099|P1|STARTED|Main Phase||121
362177|NCT01183104|868173|P2|NOT COMPLETED|Overall Study||92
362178|NCT01183104|868174|P1|NOT COMPLETED|Overall Study||77
362179|NCT01183104|868173|P2|COMPLETED|Overall Study||60
362180|NCT01183104|868174|P1|COMPLETED|Overall Study||76
362181|NCT01183104|868173|P2|Enrolled in Extension Study|Overall Study||61
362182|NCT01183104|868174|P1|Enrolled in Extension Study|Overall Study||80
362183|NCT01183104|868173|P2|Completed 52-week Treatment|Overall Study||111
362184|NCT01183104|868174|P1|Completed 52-week Treatment|Overall Study||119
362185|NCT01183104|868173|P2|Continued Treatment for 12 Weeks|Overall Study||129
362186|NCT01183104|868174|P1|Continued Treatment for 12 Weeks|Overall Study||143
362187|NCT01183104|868173|P2|Received Study Drug|Overall Study||143
362188|NCT01183104|868174|P1|Received Study Drug|Overall Study||148
362189|NCT01183104|868173|P2|STARTED|Overall Study||152
362190|NCT01183104|868174|P1|STARTED|Overall Study||153
362191|NCT01183065|868190|P1|NOT COMPLETED|Overall Study||1
362192|NCT01183065|868190|P1|COMPLETED|Overall Study||12
362193|NCT01183065|868190|P1|STARTED|Overall Study||13
362194|NCT01183013|868201|P7|NOT COMPLETED|Overall Study||37
362195|NCT01183013|868202|P6|NOT COMPLETED|Overall Study||45
362196|NCT01183013|868203|P5|NOT COMPLETED|Overall Study||36
362197|NCT01183013|868204|P4|NOT COMPLETED|Overall Study||30
362198|NCT01183013|868205|P3|NOT COMPLETED|Overall Study||41
362199|NCT01183013|868206|P2|NOT COMPLETED|Overall Study||39
362200|NCT01183013|868207|P1|NOT COMPLETED|Overall Study||45
362201|NCT01183013|868201|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
362202|NCT01183013|868202|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
362203|NCT01183013|868203|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
362204|NCT01183013|868204|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
362205|NCT01183013|868205|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
362206|NCT01183013|868206|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
362207|NCT01183013|868207|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
362208|NCT01183013|868201|P7|STARTED|Overall Study||133
362209|NCT01183013|868202|P6|STARTED|Overall Study||133
362210|NCT01183013|868203|P5|STARTED|Overall Study||126
362211|NCT01183013|868204|P4|STARTED|Overall Study||135
362212|NCT01183013|868205|P3|STARTED|Overall Study||138
362213|NCT01183013|868206|P2|STARTED|Overall Study||140
362214|NCT01183013|868207|P1|STARTED|Overall Study||131
362215|NCT01182805|868286|P1|NOT COMPLETED|Overall Study||0
362216|NCT01182805|868286|P1|COMPLETED|Overall Study||50
362217|NCT01182805|868286|P1|STARTED|Overall Study||50
362218|NCT01182727|868295|P1|NOT COMPLETED|Overall Study||0
362219|NCT01182727|868295|P1|COMPLETED|Overall Study||10
362220|NCT01182727|868295|P1|STARTED|Overall Study||10
362221|NCT01182675|868301|P2|NOT COMPLETED|Overall Study||0
362222|NCT01182675|868302|P1|NOT COMPLETED|Overall Study||0
362223|NCT01182675|868301|P2|COMPLETED|Overall Study||0
362224|NCT01182675|868302|P1|COMPLETED|Overall Study||7
362225|NCT01182675|868301|P2|STARTED|Overall Study||0
362226|NCT01182675|868302|P1|STARTED|Overall Study||7
362227|NCT01182610|868308|P1|NOT COMPLETED|Overall Study||0
362228|NCT01182610|868308|P1|COMPLETED|Overall Study||1
362229|NCT01182610|868308|P1|STARTED|Overall Study||1
362230|NCT01182493|868318|P2|NOT COMPLETED|Overall Study||7
362231|NCT01182493|868319|P1|NOT COMPLETED|Overall Study||16
362232|NCT01182493|868318|P2|COMPLETED|Overall Study||156
362233|NCT01182493|868319|P1|COMPLETED|Overall Study||152
362234|NCT01182493|868318|P2|STARTED|Overall Study||163
362235|NCT01182493|868319|P1|STARTED|Overall Study||168
362236|NCT01182480|868325|P1|NOT COMPLETED|Overall Study||0
362237|NCT01182480|868325|P1|COMPLETED|Overall Study||47
362238|NCT01182480|868325|P1|STARTED|Overall Study||47
362239|NCT01182428|868331|P2|NOT COMPLETED|Overall Study||1
362240|NCT01182428|868332|P1|NOT COMPLETED|Overall Study||11
362241|NCT01182428|868331|P2|COMPLETED|Overall Study||150
362242|NCT01182428|868332|P1|COMPLETED|Overall Study||293
362243|NCT01182428|868331|P2|STARTED|Overall Study||151
362244|NCT01182428|868332|P1|STARTED|Overall Study||304
362245|NCT01182376|868398|P2|NOT COMPLETED|Overall Study||5
362246|NCT01182376|868399|P1|NOT COMPLETED|Overall Study||11
362247|NCT01182376|868398|P2|COMPLETED|Overall Study||13
362248|NCT01182376|868399|P1|COMPLETED|Overall Study||4
362249|NCT01182376|868398|P2|STARTED|Overall Study||18
362250|NCT01182376|868399|P1|STARTED|Overall Study||15
362251|NCT01182337|868407|P2|NOT COMPLETED|Overall Study||2
362252|NCT01182337|868408|P1|NOT COMPLETED|Overall Study||3
362253|NCT01182337|868407|P2|COMPLETED|Overall Study||7
362254|NCT01182337|868408|P1|COMPLETED|Overall Study||19
362255|NCT01182337|868407|P2|STARTED|Overall Study||9
362256|NCT01182337|868408|P1|STARTED|Overall Study||22
362257|NCT01182298|868426|P1|NOT COMPLETED|Overall Study||6
362258|NCT01182298|868426|P1|COMPLETED|Overall Study||4
362259|NCT01182298|868426|P1|STARTED|Overall Study||10
362260|NCT01182285|868430|P3|NOT COMPLETED|Third Intervention Week 11-52||8
362261|NCT01182285|868431|P2|NOT COMPLETED|Third Intervention Week 11-52||0
362262|NCT01182285|868432|P1|NOT COMPLETED|Third Intervention Week 11-52||0
362263|NCT01182285|868430|P3|COMPLETED|Third Intervention Week 11-52||0
362264|NCT01182285|868431|P2|COMPLETED|Third Intervention Week 11-52||0
362265|NCT01182285|868432|P1|COMPLETED|Third Intervention Week 11-52||0
362266|NCT01182285|868430|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
362267|NCT01182285|868431|P2|STARTED|Third Intervention Week 11-52||0
362268|NCT01182285|868432|P1|STARTED|Third Intervention Week 11-52||0
362269|NCT01182285|868430|P3|NOT COMPLETED|Second Intervention Week 11-17||0
362270|NCT01182285|868431|P2|NOT COMPLETED|Second Intervention Week 11-17||0
362271|NCT01182285|868432|P1|NOT COMPLETED|Second Intervention Week 11-17||0
362272|NCT01182285|868430|P3|COMPLETED|Second Intervention Week 11-17||0
362273|NCT01182285|868431|P2|COMPLETED|Second Intervention Week 11-17||0
362274|NCT01182285|868432|P1|COMPLETED|Second Intervention Week 11-17||0
362275|NCT01182285|868430|P3|STARTED|Second Intervention Week 11-17||0
362276|NCT01182285|868431|P2|STARTED|Second Intervention Week 11-17||0
362277|NCT01182285|868432|P1|STARTED|Second Intervention Week 11-17||0
362278|NCT01182285|868430|P3|NOT COMPLETED|First Intervention Week 1-10||0
362279|NCT01182285|868431|P2|NOT COMPLETED|First Intervention Week 1-10||0
362280|NCT01182285|868432|P1|NOT COMPLETED|First Intervention Week 1-10||3
362281|NCT01182285|868430|P3|COMPLETED|First Intervention Week 1-10||0
362282|NCT01182285|868431|P2|COMPLETED|First Intervention Week 1-10||0
362283|NCT01182285|868432|P1|COMPLETED|First Intervention Week 1-10||10
362284|NCT01182285|868430|P3|STARTED|First Intervention Week 1-10||0
362285|NCT01182285|868431|P2|STARTED|First Intervention Week 1-10||0
362286|NCT01182285|868432|P1|STARTED|First Intervention Week 1-10||13
362287|NCT01182207|868442|P2|NOT COMPLETED|Second Intervention||0
362288|NCT01182207|868443|P1|NOT COMPLETED|Second Intervention||1
362289|NCT01182207|868442|P2|COMPLETED|Second Intervention||14
362290|NCT01182207|868443|P1|COMPLETED|Second Intervention||17
362291|NCT01182207|868442|P2|STARTED|Second Intervention||14
362292|NCT01182207|868443|P1|STARTED|Second Intervention||18
362293|NCT01182207|868442|P2|NOT COMPLETED|Washout of 28 Days||0
362294|NCT01182207|868443|P1|NOT COMPLETED|Washout of 28 Days||0
362295|NCT01182207|868442|P2|COMPLETED|Washout of 28 Days||14
362296|NCT01182207|868443|P1|COMPLETED|Washout of 28 Days||18
362297|NCT01182207|868442|P2|STARTED|Washout of 28 Days||14
362298|NCT01182207|868443|P1|STARTED|Washout of 28 Days||18
362299|NCT01182207|868442|P2|NOT COMPLETED|First Intervention||1
362300|NCT01182207|868443|P1|NOT COMPLETED|First Intervention||0
362301|NCT01182207|868442|P2|COMPLETED|First Intervention||14
362302|NCT01182207|868443|P1|COMPLETED|First Intervention||18
362303|NCT01182207|868442|P2|STARTED|First Intervention||15
362304|NCT01182207|868443|P1|STARTED|First Intervention||18
362305|NCT01182194|868461|P2|NOT COMPLETED|Second Intervention||0
362306|NCT01182194|868462|P1|NOT COMPLETED|Second Intervention||0
362307|NCT01182194|868461|P2|COMPLETED|Second Intervention||16
362308|NCT01182194|868462|P1|COMPLETED|Second Intervention||15
362309|NCT01182194|868461|P2|STARTED|Second Intervention||16
362310|NCT01182194|868462|P1|STARTED|Second Intervention||15
362311|NCT01182194|868461|P2|NOT COMPLETED|Washout of 28 Days||0
362312|NCT01182194|868462|P1|NOT COMPLETED|Washout of 28 Days||1
362313|NCT01182194|868461|P2|COMPLETED|Washout of 28 Days||16
362314|NCT01182194|868462|P1|COMPLETED|Washout of 28 Days||15
362315|NCT01182194|868461|P2|STARTED|Washout of 28 Days||16
362316|NCT01182194|868462|P1|STARTED|Washout of 28 Days||16
362317|NCT01182194|868461|P2|NOT COMPLETED|First Intervention||0
362318|NCT01182194|868462|P1|NOT COMPLETED|First Intervention||0
362319|NCT01182194|868461|P2|COMPLETED|First Intervention||16
362320|NCT01182194|868462|P1|COMPLETED|First Intervention||16
362321|NCT01182194|868461|P2|STARTED|First Intervention||16
362322|NCT01182194|868462|P1|STARTED|First Intervention||16
362323|NCT01182181|868480|P2|NOT COMPLETED|Second Intervention||0
362324|NCT01182181|868481|P1|NOT COMPLETED|Second Intervention||0
362325|NCT01182181|868480|P2|COMPLETED|Second Intervention||10
362326|NCT01182181|868481|P1|COMPLETED|Second Intervention||10
362327|NCT01182181|868480|P2|STARTED|Second Intervention||10
362328|NCT01182181|868481|P1|STARTED|Second Intervention||10
362329|NCT01182181|868480|P2|NOT COMPLETED|Washout of 21 Days||1
362330|NCT01182181|868481|P1|NOT COMPLETED|Washout of 21 Days||0
362331|NCT01182181|868480|P2|COMPLETED|Washout of 21 Days||10
362332|NCT01182181|868481|P1|COMPLETED|Washout of 21 Days||10
362333|NCT01182181|868480|P2|STARTED|Washout of 21 Days||11
362334|NCT01182181|868481|P1|STARTED|Washout of 21 Days||10
362335|NCT01182181|868480|P2|NOT COMPLETED|First Intervention||0
362336|NCT01182181|868481|P1|NOT COMPLETED|First Intervention||1
362337|NCT01182181|868480|P2|COMPLETED|First Intervention||11
362338|NCT01182181|868481|P1|COMPLETED|First Intervention||10
362339|NCT01182181|868480|P2|STARTED|First Intervention||11
362340|NCT01182181|868481|P1|STARTED|First Intervention||11
362341|NCT01182103|868491|P2|NOT COMPLETED|Overall Study||0
362342|NCT01182103|868492|P1|NOT COMPLETED|Overall Study||0
362343|NCT01182103|868491|P2|COMPLETED|Overall Study||62
362344|NCT01182103|868492|P1|COMPLETED|Overall Study||48
362345|NCT01182103|868491|P2|STARTED|Overall Study||62
362346|NCT01182103|868492|P1|STARTED|Overall Study||48
362347|NCT01181986|868506|P3|NOT COMPLETED|Phase 2||0
362348|NCT01181986|868507|P2|NOT COMPLETED|Phase 2||4
362349|NCT01181986|868508|P1|NOT COMPLETED|Phase 2||0
362350|NCT01181986|868506|P3|COMPLETED|Phase 2||0
362351|NCT01181986|868507|P2|COMPLETED|Phase 2||18
362352|NCT01181986|868508|P1|COMPLETED|Phase 2||18
362353|NCT01181986|868506|P3|STARTED|Phase 2|N/A for Sub-study 2|0
362354|NCT01181986|868507|P2|STARTED|Phase 2||22
362355|NCT01181986|868508|P1|STARTED|Phase 2||18
362356|NCT01181986|868506|P3|NOT COMPLETED|Phase 1||2
362357|NCT01181986|868507|P2|NOT COMPLETED|Phase 1||1
362358|NCT01181986|868508|P1|NOT COMPLETED|Phase 1||1
362359|NCT01181986|868506|P3|COMPLETED|Phase 1||32
362360|NCT01181986|868507|P2|COMPLETED|Phase 1||22
362361|NCT01181986|868508|P1|COMPLETED|Phase 1||18
362362|NCT01181986|868506|P3|Exendin-9+Exenatide|Phase 1||33
362363|NCT01181986|868507|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
362364|NCT01181986|868508|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
362365|NCT01181986|868506|P3|Saline+Placebo|Phase 1||33
362366|NCT01181986|868507|P2|Saline+Placebo|Phase 1|N/A for this arm|0
362367|NCT01181986|868508|P1|Saline+Placebo|Phase 1|N/A for this arm|0
362368|NCT01181986|868506|P3|Saline+Exenatide|Phase 1||32
362369|NCT01181986|868507|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
362370|NCT01181986|868508|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
362371|NCT01181986|868506|P3|STARTED|Phase 1||34
362372|NCT01181986|868507|P2|STARTED|Phase 1||23
362373|NCT01181986|868508|P1|STARTED|Phase 1||19
362374|NCT01181947|868524|P1|NOT COMPLETED|Overall Study||0
362375|NCT01181947|868524|P1|COMPLETED|Overall Study||100
362376|NCT01181947|868524|P1|STARTED|Overall Study||100
362377|NCT01181921|868529|P1|NOT COMPLETED|Overall Study||1
362378|NCT01181921|868529|P1|COMPLETED|Overall Study||0
362379|NCT01181921|868529|P1|STARTED|Overall Study||1
362380|NCT01181895|868536|P3|NOT COMPLETED|Overall Study||18
362381|NCT01181895|868537|P2|NOT COMPLETED|Overall Study||14
362382|NCT01181895|868538|P1|NOT COMPLETED|Overall Study||17
362383|NCT01181895|868536|P3|COMPLETED|Overall Study||98
362384|NCT01181895|868537|P2|COMPLETED|Overall Study||101
362385|NCT01181895|868538|P1|COMPLETED|Overall Study||99
362386|NCT01181895|868536|P3|STARTED|Overall Study||116
362387|NCT01181895|868537|P2|STARTED|Overall Study||115
362388|NCT01181895|868538|P1|STARTED|Overall Study||116
362389|NCT01181804|868571|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
362390|NCT01181804|868572|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
362391|NCT01181804|868573|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
362392|NCT01181804|868574|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
362393|NCT01181804|868571|P4|COMPLETED|Period 4, Fasted (Part 2)||58
362394|NCT01181804|868572|P3|COMPLETED|Period 4, Fasted (Part 2)||58
362395|NCT01181804|868573|P2|COMPLETED|Period 4, Fasted (Part 2)||0
362396|NCT01181804|868574|P1|COMPLETED|Period 4, Fasted (Part 2)||0
362397|NCT01181804|868571|P4|STARTED|Period 4, Fasted (Part 2)||58
362398|NCT01181804|868572|P3|STARTED|Period 4, Fasted (Part 2)||59
362399|NCT01181804|868573|P2|STARTED|Period 4, Fasted (Part 2)||0
362400|NCT01181804|868574|P1|STARTED|Period 4, Fasted (Part 2)||0
362401|NCT01181804|868571|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
362402|NCT01181804|868572|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
362403|NCT01181804|868573|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
362404|NCT01181804|868574|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
362405|NCT01181804|868571|P4|COMPLETED|Period 3, Fasted (Part 2)||58
362406|NCT01181804|868572|P3|COMPLETED|Period 3, Fasted (Part 2)||59
362407|NCT01181804|868573|P2|COMPLETED|Period 3, Fasted (Part 2)||0
362408|NCT01181804|868574|P1|COMPLETED|Period 3, Fasted (Part 2)||0
362409|NCT01181804|868571|P4|STARTED|Period 3, Fasted (Part 2)||58
362410|NCT01181804|868572|P3|STARTED|Period 3, Fasted (Part 2)||59
362411|NCT01181804|868573|P2|STARTED|Period 3, Fasted (Part 2)||0
362412|NCT01181804|868574|P1|STARTED|Period 3, Fasted (Part 2)||0
362413|NCT01181804|868571|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
362414|NCT01181804|868572|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
362415|NCT01181804|868573|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
362416|NCT01181804|868574|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
362417|NCT01181804|868571|P4|COMPLETED|Period 2, Fed (Part 1)||0
362418|NCT01181804|868572|P3|COMPLETED|Period 2, Fed (Part 1)||0
362419|NCT01181804|868573|P2|COMPLETED|Period 2, Fed (Part 1)||30
362420|NCT01181804|868574|P1|COMPLETED|Period 2, Fed (Part 1)||30
362421|NCT01181804|868571|P4|STARTED|Period 2, Fed (Part 1)||0
362422|NCT01181804|868572|P3|STARTED|Period 2, Fed (Part 1)||0
362423|NCT01181804|868573|P2|STARTED|Period 2, Fed (Part 1)||30
362424|NCT01181804|868574|P1|STARTED|Period 2, Fed (Part 1)||30
362425|NCT01181804|868571|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
362426|NCT01181804|868572|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
362427|NCT01181804|868573|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
362428|NCT01181804|868574|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
362429|NCT01181804|868571|P4|COMPLETED|Period 1, Fed (Part 1)||0
362430|NCT01181804|868572|P3|COMPLETED|Period 1, Fed (Part 1)||0
362431|NCT01181804|868573|P2|COMPLETED|Period 1, Fed (Part 1)||30
362432|NCT01181804|868574|P1|COMPLETED|Period 1, Fed (Part 1)||30
362433|NCT01181804|868571|P4|STARTED|Period 1, Fed (Part 1)||0
362434|NCT01181804|868572|P3|STARTED|Period 1, Fed (Part 1)||0
362435|NCT01181804|868573|P2|STARTED|Period 1, Fed (Part 1)||30
362436|NCT01181804|868574|P1|STARTED|Period 1, Fed (Part 1)||30
362437|NCT01181778|868596|P1|NOT COMPLETED|Overall Study||48
362438|NCT01181778|868596|P1|COMPLETED|Overall Study||1871
362439|NCT01181778|868596|P1|STARTED|Overall Study||1919
362440|NCT01181726|868604|P2|NOT COMPLETED|Second Intervention||0
362441|NCT01181726|868605|P1|NOT COMPLETED|Second Intervention||0
362442|NCT01181726|868604|P2|COMPLETED|Second Intervention||20
362443|NCT01181726|868605|P1|COMPLETED|Second Intervention||19
362444|NCT01181726|868604|P2|STARTED|Second Intervention||20
362445|NCT01181726|868605|P1|STARTED|Second Intervention||19
362446|NCT01181726|868604|P2|NOT COMPLETED|Washout of 28 Days||0
362447|NCT01181726|868605|P1|NOT COMPLETED|Washout of 28 Days||0
362448|NCT01181726|868604|P2|COMPLETED|Washout of 28 Days||20
362449|NCT01181726|868605|P1|COMPLETED|Washout of 28 Days||19
362450|NCT01181726|868604|P2|STARTED|Washout of 28 Days||20
362451|NCT01181726|868605|P1|STARTED|Washout of 28 Days||19
362452|NCT01181726|868604|P2|NOT COMPLETED|First Intervention||0
362453|NCT01181726|868605|P1|NOT COMPLETED|First Intervention||1
362454|NCT01181726|868604|P2|COMPLETED|First Intervention||20
362455|NCT01181726|868605|P1|COMPLETED|First Intervention||19
362456|NCT01181726|868604|P2|STARTED|First Intervention||20
362457|NCT01181726|868605|P1|STARTED|First Intervention||20
362458|NCT01181609|868651|P1|NOT COMPLETED|Overall Study||53
362459|NCT01181609|868651|P1|COMPLETED|Overall Study||1
362460|NCT01181609|868651|P1|STARTED|Overall Study||54
362461|NCT01181531|868664|P2|NOT COMPLETED|Overall Study||53
362462|NCT01181531|868665|P1|NOT COMPLETED|Overall Study||61
362463|NCT01181531|868664|P2|COMPLETED|Overall Study||102
362464|NCT01181531|868665|P1|COMPLETED|Overall Study||96
362465|NCT01181531|868664|P2|Received Investigational Product|Overall Study||153
362466|NCT01181531|868665|P1|Received Investigational Product|Overall Study||155
362467|NCT01181531|868664|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
362468|NCT01181531|868665|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
362469|NCT01181492|868678|P3|NOT COMPLETED|Overall Study||0
362470|NCT01181492|868679|P2|NOT COMPLETED|Overall Study||0
362471|NCT01181492|868680|P1|NOT COMPLETED|Overall Study||0
362472|NCT01181492|868678|P3|COMPLETED|Overall Study||7
362473|NCT01181492|868679|P2|COMPLETED|Overall Study||66
362474|NCT01181492|868680|P1|COMPLETED|Overall Study||103
362475|NCT01181492|868678|P3|STARTED|Overall Study||7
362476|NCT01181492|868679|P2|STARTED|Overall Study||66
362477|NCT01181492|868680|P1|STARTED|Overall Study||103
362478|NCT01181349|868694|P1|NOT COMPLETED|Overall Study||0
362479|NCT01181349|868694|P1|COMPLETED|Overall Study||350
362480|NCT01181349|868694|P1|STARTED|Overall Study||350
362481|NCT01181323|868710|P4|NOT COMPLETED|Overall Study||3
362482|NCT01181323|868711|P3|NOT COMPLETED|Overall Study||1
362483|NCT01181323|868712|P2|NOT COMPLETED|Overall Study||3
362484|NCT01181323|868713|P1|NOT COMPLETED|Overall Study||1
362485|NCT01181323|868710|P4|COMPLETED|Overall Study||122
362486|NCT01181323|868711|P3|COMPLETED|Overall Study||123
362487|NCT01181323|868712|P2|COMPLETED|Overall Study||121
362488|NCT01181323|868713|P1|COMPLETED|Overall Study||123
362489|NCT01181323|868710|P4|STARTED|Overall Study||125
362490|NCT01181323|868711|P3|STARTED|Overall Study||124
362491|NCT01181323|868712|P2|STARTED|Overall Study||124
362492|NCT01181323|868713|P1|STARTED|Overall Study||124
362493|NCT01181271|868788|P1|NOT COMPLETED|Allogeneic Transplant||0
362494|NCT01181271|868788|P1|COMPLETED|Allogeneic Transplant||29
362495|NCT01181271|868788|P1|STARTED|Allogeneic Transplant||29
362496|NCT01181271|868788|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
362497|NCT01181271|868788|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
362498|NCT01181271|868788|P1|STARTED|Evaluation for Allogeneic Transplant||42
362499|NCT01181271|868788|P1|NOT COMPLETED|Autologous Transplant||0
362500|NCT01181271|868788|P1|COMPLETED|Autologous Transplant||42
362501|NCT01181271|868788|P1|STARTED|Autologous Transplant||42
362502|NCT01181258|868803|P1|NOT COMPLETED|Overall Study||0
362503|NCT01181258|868803|P1|COMPLETED|Overall Study||16
362504|NCT01181258|868803|P1|STARTED|Overall Study||16
362505|NCT01181167|868812|P2|NOT COMPLETED|Overall Study||32
362506|NCT01181167|868813|P1|NOT COMPLETED|Overall Study||23
362507|NCT01181167|868812|P2|COMPLETED|Overall Study||271
362508|NCT01181167|868813|P1|COMPLETED|Overall Study||284
362509|NCT01181167|868812|P2|Efficacy Analysis Population|Overall Study||248
362510|NCT01181167|868813|P1|Efficacy Analysis Population|Overall Study||255
362511|NCT01181167|868812|P2|STARTED|Overall Study||303
362512|NCT01181167|868813|P1|STARTED|Overall Study||307
362513|NCT01181141|868823|P2|NOT COMPLETED|Overall Study||4
362514|NCT01181141|868824|P1|NOT COMPLETED|Overall Study||12
362515|NCT01181141|868823|P2|COMPLETED|Overall Study||26
362516|NCT01181141|868824|P1|COMPLETED|Overall Study||50
362517|NCT01181141|868823|P2|Safety Analysis Population|Overall Study||29
362518|NCT01181141|868824|P1|Safety Analysis Population|Overall Study||59
362519|NCT01181141|868823|P2|STARTED|Overall Study||30
362520|NCT01181141|868824|P1|STARTED|Overall Study||62
362521|NCT01181128|868833|P3|NOT COMPLETED|Overall Study||1
362522|NCT01181128|868834|P2|NOT COMPLETED|Overall Study||5
362523|NCT01181128|868835|P1|NOT COMPLETED|Overall Study||6
362524|NCT01181128|868833|P3|COMPLETED|Overall Study||22
362525|NCT01181128|868834|P2|COMPLETED|Overall Study||19
362526|NCT01181128|868835|P1|COMPLETED|Overall Study||112
362527|NCT01181128|868833|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
362528|NCT01181128|868834|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
362529|NCT01181128|868835|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
362530|NCT01181128|868833|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
362531|NCT01181128|868834|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
362532|NCT01181128|868835|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
362533|NCT01181128|868833|P3|STARTED|Overall Study||23
362534|NCT01181128|868834|P2|STARTED|Overall Study||24
362535|NCT01181128|868835|P1|STARTED|Overall Study||118
362536|NCT01181102|868923|P2|NOT COMPLETED|Overall Study||46
362537|NCT01181102|868924|P1|NOT COMPLETED|Overall Study||51
362538|NCT01181102|868923|P2|COMPLETED|Overall Study||310
362539|NCT01181102|868924|P1|COMPLETED|Overall Study||309
362540|NCT01181102|868923|P2|Efficacy Analysis Population|Overall Study||295
362541|NCT01181102|868924|P1|Efficacy Analysis Population|Overall Study||299
362542|NCT01181102|868923|P2|Safety Analysis Set|Overall Study||349
362543|NCT01181102|868924|P1|Safety Analysis Set|Overall Study||354
362544|NCT01181102|868923|P2|STARTED|Overall Study||356
362545|NCT01181102|868924|P1|STARTED|Overall Study||360
362546|NCT01181050|868934|P2|NOT COMPLETED|Overall Study||0
362547|NCT01181050|868935|P1|NOT COMPLETED|Overall Study||0
362548|NCT01181050|868934|P2|COMPLETED|Overall Study||22
362549|NCT01181050|868935|P1|COMPLETED|Overall Study||41
362550|NCT01181050|868934|P2|STARTED|Overall Study||22
362551|NCT01181050|868935|P1|STARTED|Overall Study||41
362552|NCT01181011|868945|P1|NOT COMPLETED|Overall Study||3
362553|NCT01181011|868945|P1|COMPLETED|Overall Study||25
362554|NCT01181011|868945|P1|Received Amlodipine 5mg|Overall Study||26
362555|NCT01181011|868945|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
362556|NCT01181011|868945|P1|Received Telmisartan 80mg|Overall Study||27
362557|NCT01181011|868945|P1|STARTED|Overall Study||28
362558|NCT01180998|868995|P3|NOT COMPLETED|Overall Study||10
362559|NCT01180998|868996|P2|NOT COMPLETED|Overall Study||4
362560|NCT01180998|868997|P1|NOT COMPLETED|Overall Study||4
362561|NCT01180998|868995|P3|COMPLETED|Overall Study||51
362562|NCT01180998|868996|P2|COMPLETED|Overall Study||68
362563|NCT01180998|868997|P1|COMPLETED|Overall Study||63
362564|NCT01180998|868995|P3|STARTED|Overall Study||61
362565|NCT01180998|868996|P2|STARTED|Overall Study||72
362566|NCT01180998|868997|P1|STARTED|Overall Study||67
362567|NCT01180985|869011|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
362568|NCT01180985|869012|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
362569|NCT01180985|869011|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
362570|NCT01180985|869012|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
362571|NCT01180985|869011|P2|STARTED|Period 2 (7 +/- 1 Days)||26
362572|NCT01180985|869012|P1|STARTED|Period 2 (7 +/- 1 Days)||27
362573|NCT01180985|869011|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
362574|NCT01180985|869012|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
362575|NCT01180985|869011|P2|COMPLETED|Period 1 (7 +/- Days)||26
362576|NCT01180985|869012|P1|COMPLETED|Period 1 (7 +/- Days)||27
362577|NCT01180985|869011|P2|STARTED|Period 1 (7 +/- Days)||26
362578|NCT01180985|869012|P1|STARTED|Period 1 (7 +/- Days)||27
362579|NCT01180894|869031|P2|NOT COMPLETED|Overall Study||0
362580|NCT01180894|869032|P1|NOT COMPLETED|Overall Study||0
362581|NCT01180894|869031|P2|COMPLETED|Overall Study||75
362582|NCT01180894|869032|P1|COMPLETED|Overall Study||75
362583|NCT01180894|869031|P2|STARTED|Overall Study||75
362584|NCT01180894|869032|P1|STARTED|Overall Study||75
362585|NCT01180790|869051|P7|NOT COMPLETED|Overall Study||1
362586|NCT01180790|869052|P6|NOT COMPLETED|Overall Study||7
362587|NCT01180790|869053|P5|NOT COMPLETED|Overall Study||5
362588|NCT01180790|869054|P4|NOT COMPLETED|Overall Study||9
362589|NCT01180790|869055|P3|NOT COMPLETED|Overall Study||13
362590|NCT01180790|869056|P2|NOT COMPLETED|Overall Study||5
362591|NCT01180790|869057|P1|NOT COMPLETED|Overall Study||9
362592|NCT01180790|869051|P7|COMPLETED|Overall Study||18
362593|NCT01180790|869052|P6|COMPLETED|Overall Study||13
362594|NCT01180790|869053|P5|COMPLETED|Overall Study||14
362595|NCT01180790|869054|P4|COMPLETED|Overall Study||6
362596|NCT01180790|869055|P3|COMPLETED|Overall Study||4
362597|NCT01180790|869056|P2|COMPLETED|Overall Study||11
362598|NCT01180790|869057|P1|COMPLETED|Overall Study||7
362599|NCT01180790|869051|P7|STARTED|Overall Study||19
362600|NCT01180790|869052|P6|STARTED|Overall Study||20
362601|NCT01180790|869053|P5|STARTED|Overall Study||19
362602|NCT01180790|869054|P4|STARTED|Overall Study||15
362603|NCT01180790|869055|P3|STARTED|Overall Study||17
362604|NCT01180790|869056|P2|STARTED|Overall Study||16
362605|NCT01180790|869057|P1|STARTED|Overall Study||16
362606|NCT01180777|869122|P1|NOT COMPLETED|Overall Study||12
362607|NCT01180777|869122|P1|COMPLETED|Overall Study||80
362608|NCT01180777|869122|P1|STARTED|Overall Study||92
362609|NCT01180660|869136|P2|NOT COMPLETED|Overall Study||0
362610|NCT01180660|869137|P1|NOT COMPLETED|Overall Study||1
362611|NCT01180660|869136|P2|COMPLETED|Overall Study||26
362612|NCT01180660|869137|P1|COMPLETED|Overall Study||24
362613|NCT01180660|869136|P2|STARTED|Overall Study||26
362614|NCT01180660|869137|P1|STARTED|Overall Study||25
362615|NCT01180647|869147|P2|NOT COMPLETED|Overall Study||6
362616|NCT01180647|869148|P1|NOT COMPLETED|Overall Study||5
362617|NCT01180647|869147|P2|COMPLETED|Overall Study||11
362618|NCT01180647|869148|P1|COMPLETED|Overall Study||12
362619|NCT01180647|869147|P2|STARTED|Overall Study||17
362620|NCT01180647|869148|P1|STARTED|Overall Study||17
362621|NCT01180400|869166|P2|NOT COMPLETED|Overall Study||27
362622|NCT01180400|869167|P1|NOT COMPLETED|Overall Study||25
362623|NCT01180400|869166|P2|COMPLETED|Overall Study||121
362624|NCT01180400|869167|P1|COMPLETED|Overall Study||122
362625|NCT01180400|869166|P2|Received Treatment|Overall Study||146
362626|NCT01180400|869167|P1|Received Treatment|Overall Study||147
362627|NCT01180400|869166|P2|STARTED|Overall Study||148
362628|NCT01180400|869167|P1|STARTED|Overall Study||147
362629|NCT01180296|869215|P2|NOT COMPLETED|Overall Study||2
362630|NCT01180296|869216|P1|NOT COMPLETED|Overall Study||1
362631|NCT01180296|869215|P2|COMPLETED|Overall Study||14
362632|NCT01180296|869216|P1|COMPLETED|Overall Study||19
362633|NCT01180296|869215|P2|STARTED|Overall Study||16
362634|NCT01180296|869216|P1|STARTED|Overall Study||20
362635|NCT01180244|869224|P2|NOT COMPLETED|Overall Study||8
362636|NCT01180244|869225|P1|NOT COMPLETED|Overall Study||6
362637|NCT01180244|869224|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
362638|NCT01180244|869225|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
362639|NCT01180244|869224|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
362640|NCT01180244|869225|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
362641|NCT01180244|869224|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
362642|NCT01180244|869225|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
362643|NCT01180127|869243|P4|NOT COMPLETED|Overall Study||1
362644|NCT01180127|869244|P3|NOT COMPLETED|Overall Study||1
362645|NCT01180127|869245|P2|NOT COMPLETED|Overall Study||0
362646|NCT01180127|869246|P1|NOT COMPLETED|Overall Study||2
362647|NCT01180127|869243|P4|COMPLETED|Overall Study||9
362648|NCT01180127|869244|P3|COMPLETED|Overall Study||9
362649|NCT01180127|869245|P2|COMPLETED|Overall Study||11
362650|NCT01180127|869246|P1|COMPLETED|Overall Study||8
362651|NCT01180127|869243|P4|STARTED|Overall Study||10
362652|NCT01180127|869244|P3|STARTED|Overall Study||10
362653|NCT01180127|869245|P2|STARTED|Overall Study||11
362654|NCT01180127|869246|P1|STARTED|Overall Study||10
362655|NCT01180049|869270|P2|NOT COMPLETED|Overall Study||43
362656|NCT01180049|869271|P1|NOT COMPLETED|Overall Study||47
362657|NCT01180049|869270|P2|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
362658|NCT01180049|869271|P1|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
362659|NCT01180049|869270|P2|Treated|Overall Study||42
362660|NCT01180049|869271|P1|Treated|Overall Study||47
362661|NCT01180049|869270|P2|STARTED|Overall Study||43
362662|NCT01180049|869271|P1|STARTED|Overall Study||47
362663|NCT01179984|869291|P1|NOT COMPLETED|Overall Study||18
362664|NCT01179984|869291|P1|COMPLETED|Overall Study||58
362665|NCT01179984|869291|P1|STARTED|Overall Study||76
362666|NCT01179919|869297|P1|NOT COMPLETED|Overall Study||2
362667|NCT01179919|869297|P1|COMPLETED|Overall Study||19
362668|NCT01179919|869297|P1|STARTED|Overall Study||21
362669|NCT01179737|869306|P4|NOT COMPLETED|Extension||0
362670|NCT01179737|869307|P3|NOT COMPLETED|Extension||0
362671|NCT01179737|869308|P2|NOT COMPLETED|Extension||0
362672|NCT01179737|869309|P1|NOT COMPLETED|Extension||3
362673|NCT01179737|869306|P4|COMPLETED|Extension||0
362674|NCT01179737|869307|P3|COMPLETED|Extension||0
362675|NCT01179737|869308|P2|COMPLETED|Extension||0
362676|NCT01179737|869309|P1|COMPLETED|Extension||0
362677|NCT01179737|869306|P4|STARTED|Extension||0
362678|NCT01179737|869307|P3|STARTED|Extension||0
362679|NCT01179737|869308|P2|STARTED|Extension|One patient did not enrol in the extension|0
362680|NCT01179737|869309|P1|STARTED|Extension|Two patients did not enrol in the extension|3
362681|NCT01179737|869306|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
362682|NCT01179737|869307|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
362683|NCT01179737|869308|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
362684|NCT01179737|869309|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
362685|NCT01179737|869306|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
362686|NCT01179737|869307|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
362687|NCT01179737|869308|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
362688|NCT01179737|869309|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
362689|NCT01179737|869306|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
362690|NCT01179737|869307|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
362691|NCT01179737|869308|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
362692|NCT01179737|869309|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
362693|NCT01179737|869306|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
362694|NCT01179737|869307|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
362695|NCT01179737|869308|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
362696|NCT01179737|869309|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
362697|NCT01179737|869306|P4|COMPLETED|Cohort 1 & Cohort 2||0
362698|NCT01179737|869307|P3|COMPLETED|Cohort 1 & Cohort 2||0
362699|NCT01179737|869308|P2|COMPLETED|Cohort 1 & Cohort 2||1
362700|NCT01179737|869309|P1|COMPLETED|Cohort 1 & Cohort 2||7
362701|NCT01179737|869306|P4|STARTED|Cohort 1 & Cohort 2||4
362702|NCT01179737|869307|P3|STARTED|Cohort 1 & Cohort 2||4
362703|NCT01179737|869308|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
362704|NCT01179737|869309|P1|STARTED|Cohort 1 & Cohort 2||12
362705|NCT01179672|869320|P2|NOT COMPLETED|Overall Study||26
362706|NCT01179672|869321|P1|NOT COMPLETED|Overall Study||30
362707|NCT01179672|869320|P2|COMPLETED|Overall Study||176
362708|NCT01179672|869321|P1|COMPLETED|Overall Study||173
362709|NCT01179672|869320|P2|Entered Taper|Overall Study||177
362710|NCT01179672|869321|P1|Entered Taper|Overall Study||181
362711|NCT01179672|869320|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
362712|NCT01179672|869321|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
362713|NCT01179672|869320|P2|STARTED|Overall Study||202
362714|NCT01179672|869321|P1|STARTED|Overall Study||203
362715|NCT01179568|869351|P4|NOT COMPLETED|Overall Study||20
362716|NCT01179568|869352|P3|NOT COMPLETED|Overall Study||23
362717|NCT01179568|869353|P2|NOT COMPLETED|Overall Study||38
362718|NCT01179568|869354|P1|NOT COMPLETED|Overall Study||28
362719|NCT01179568|869351|P4|COMPLETED|Overall Study||76
362720|NCT01179568|869352|P3|COMPLETED|Overall Study||76
362721|NCT01179568|869353|P2|COMPLETED|Overall Study||61
362722|NCT01179568|869354|P1|COMPLETED|Overall Study||73
362723|NCT01179568|869351|P4|Completed Week 12 Assessment|Overall Study||75
362724|NCT01179568|869352|P3|Completed Week 12 Assessment|Overall Study||76
362725|NCT01179568|869353|P2|Completed Week 12 Assessment|Overall Study||69
362726|NCT01179568|869354|P1|Completed Week 12 Assessment|Overall Study||69
362727|NCT01179568|869351|P4|STARTED|Overall Study||96
362728|NCT01179568|869352|P3|STARTED|Overall Study||99
362729|NCT01179568|869353|P2|STARTED|Overall Study||99
362730|NCT01179568|869354|P1|STARTED|Overall Study||101
362731|NCT01179516|869377|P3|NOT COMPLETED|Overall Study||31
362732|NCT01179516|869378|P2|NOT COMPLETED|Overall Study||26
362733|NCT01179516|869379|P1|NOT COMPLETED|Overall Study||27
362734|NCT01179516|869377|P3|COMPLETED|Overall Study||121
362735|NCT01179516|869378|P2|COMPLETED|Overall Study||131
362736|NCT01179516|869379|P1|COMPLETED|Overall Study||133
362737|NCT01179516|869377|P3|Treated|Overall Study||151
362738|NCT01179516|869378|P2|Treated|Overall Study||154
362739|NCT01179516|869379|P1|Treated|Overall Study||160
362740|NCT01179516|869377|P3|STARTED|Overall Study||152
362741|NCT01179516|869378|P2|STARTED|Overall Study||157
362742|NCT01179516|869379|P1|STARTED|Overall Study||160
362743|NCT01179490|869402|P1|NOT COMPLETED|Overall Study||0
362744|NCT01179490|869402|P1|COMPLETED|Overall Study||5
362745|NCT01179490|869402|P1|STARTED|Overall Study||5
362746|NCT01179399|869423|P1|NOT COMPLETED|Overall Study||32
362747|NCT01179399|869423|P1|COMPLETED|Overall Study||0
362748|NCT01179399|869423|P1|STARTED|Overall Study||32
362749|NCT01179347|869429|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
362750|NCT01179347|869430|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
362751|NCT01179347|869429|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
362752|NCT01179347|869430|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
362753|NCT01179347|869429|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
362754|NCT01179347|869430|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
362755|NCT01179347|869429|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
362756|NCT01179347|869430|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
362757|NCT01179347|869429|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
362758|NCT01179347|869430|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
362759|NCT01179347|869429|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
362760|NCT01179347|869430|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
362761|NCT01179334|869452|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
362762|NCT01179334|869453|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
362763|NCT01179334|869452|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
362764|NCT01179334|869453|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
362765|NCT01179334|869452|P2|STARTED|Long-term Extension (LTE) Period||6
362766|NCT01179334|869453|P1|STARTED|Long-term Extension (LTE) Period||11
362767|NCT01179334|869452|P2|NOT COMPLETED|Treatment Period||0
362768|NCT01179334|869453|P1|NOT COMPLETED|Treatment Period||1
362769|NCT01179334|869452|P2|COMPLETED|Treatment Period||6
362770|NCT01179334|869453|P1|COMPLETED|Treatment Period||11
362771|NCT01179334|869452|P2|Participants Received Treatment|Treatment Period||6
362772|NCT01179334|869453|P1|Participants Received Treatment|Treatment Period||12
362773|NCT01179334|869452|P2|STARTED|Treatment Period||6
362774|NCT01179334|869453|P1|STARTED|Treatment Period||12
362775|NCT01179191|869481|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
362776|NCT01179191|869481|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
362777|NCT01179191|869481|P1|STARTED|Maintenance Phase (8 Weeks)||351
362778|NCT01179191|869481|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
362779|NCT01179191|869481|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
362780|NCT01179191|869481|P1|STARTED|Titration Phase (up to 6 Weeks)||684
362781|NCT01179113|869500|P2|NOT COMPLETED|Overall Study||0
362782|NCT01179113|869501|P1|NOT COMPLETED|Overall Study||0
362783|NCT01179113|869500|P2|COMPLETED|Overall Study||16
362784|NCT01179113|869501|P1|COMPLETED|Overall Study||17
362785|NCT01179113|869500|P2|STARTED|Overall Study||16
362786|NCT01179113|869501|P1|STARTED|Overall Study||17
362787|NCT01179048|869513|P2|NOT COMPLETED|Overall Study||159
362788|NCT01179048|869514|P1|NOT COMPLETED|Overall Study||139
362789|NCT01179048|869513|P2|COMPLETED|Overall Study||4513
362790|NCT01179048|869514|P1|COMPLETED|Overall Study||4529
362791|NCT01179048|869513|P2|STARTED|Overall Study||4672
362792|NCT01179048|869514|P1|STARTED|Overall Study||4668
362793|NCT01178853|869532|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
362794|NCT01178853|869533|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
362795|NCT01178853|869532|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
362796|NCT01178853|869533|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
362797|NCT01178853|869532|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
362798|NCT01178853|869533|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
362799|NCT01178853|869532|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
362800|NCT01178853|869533|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
362801|NCT01178853|869532|P2|COMPLETED|Period 3 (Warfarin Titration)||22
362802|NCT01178853|869533|P1|COMPLETED|Period 3 (Warfarin Titration)||21
362803|NCT01178853|869532|P2|STARTED|Period 3 (Warfarin Titration)||22
362804|NCT01178853|869533|P1|STARTED|Period 3 (Warfarin Titration)||22
362805|NCT01178853|869532|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
362806|NCT01178853|869533|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
362807|NCT01178853|869532|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
362808|NCT01178853|869533|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
362809|NCT01178853|869532|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
362810|NCT01178853|869533|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
362811|NCT01178853|869532|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
362812|NCT01178853|869533|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
362813|NCT01178853|869532|P2|COMPLETED|Period 1 (Warfarin Titration)||22
362814|NCT01178853|869533|P1|COMPLETED|Period 1 (Warfarin Titration)||23
362815|NCT01178853|869532|P2|STARTED|Period 1 (Warfarin Titration)||24
362816|NCT01178853|869533|P1|STARTED|Period 1 (Warfarin Titration)||24
362817|NCT01178827|869542|P3|NOT COMPLETED|Overall Study||0
362818|NCT01178827|869543|P2|NOT COMPLETED|Overall Study||0
362819|NCT01178827|869544|P1|NOT COMPLETED|Overall Study||0
362820|NCT01178827|869542|P3|COMPLETED|Overall Study||4
362821|NCT01178827|869543|P2|COMPLETED|Overall Study||10
362822|NCT01178827|869544|P1|COMPLETED|Overall Study||6
362823|NCT01178827|869542|P3|STARTED|Overall Study||4
362824|NCT01178827|869543|P2|STARTED|Overall Study||10
362825|NCT01178827|869544|P1|STARTED|Overall Study||6
362826|NCT01178762|869573|P1|NOT COMPLETED|Overall Study||15
362827|NCT01178762|869573|P1|COMPLETED|Overall Study||27
362828|NCT01178762|869573|P1|STARTED|Overall Study||42
362829|NCT01178671|869579|P2|NOT COMPLETED|Overall Study||15
362830|NCT01178671|869580|P1|NOT COMPLETED|Overall Study||12
362831|NCT01178671|869579|P2|COMPLETED|Overall Study||3
362832|NCT01178671|869580|P1|COMPLETED|Overall Study||6
362833|NCT01178671|869579|P2|STARTED|Overall Study||18
362834|NCT01178671|869580|P1|STARTED|Overall Study||18
362835|NCT01178528|869607|P3|NOT COMPLETED|Overall Study||0
362836|NCT01178528|869608|P2|NOT COMPLETED|Overall Study||0
362837|NCT01178528|869609|P1|NOT COMPLETED|Overall Study||0
362838|NCT01178528|869607|P3|COMPLETED|Overall Study||42
362839|NCT01178528|869608|P2|COMPLETED|Overall Study||38
362840|NCT01178528|869609|P1|COMPLETED|Overall Study||41
362841|NCT01178528|869607|P3|STARTED|Overall Study||42
362842|NCT01178528|869608|P2|STARTED|Overall Study||38
362843|NCT01178528|869609|P1|STARTED|Overall Study||41
362844|NCT01178385|869628|P2|NOT COMPLETED|Overall Study||0
362845|NCT01178385|869629|P1|NOT COMPLETED|Overall Study||2
362846|NCT01178385|869628|P2|COMPLETED|Overall Study||21
362847|NCT01178385|869629|P1|COMPLETED|Overall Study||22
362848|NCT01178385|869628|P2|STARTED|Overall Study||21
362849|NCT01178385|869629|P1|STARTED|Overall Study||24
362850|NCT01178333|869642|P3|NOT COMPLETED|Overall Study||0
362851|NCT01178333|869643|P2|NOT COMPLETED|Overall Study||0
362852|NCT01178333|869644|P1|NOT COMPLETED|Overall Study||0
362853|NCT01178333|869642|P3|COMPLETED|Overall Study||87
362854|NCT01178333|869643|P2|COMPLETED|Overall Study||284
362855|NCT01178333|869644|P1|COMPLETED|Overall Study||71
362856|NCT01178333|869642|P3|STARTED|Overall Study||87
362857|NCT01178333|869643|P2|STARTED|Overall Study||284
362858|NCT01178333|869644|P1|STARTED|Overall Study||71
362859|NCT01178294|869698|P1|NOT COMPLETED|Overall Study||11
362860|NCT01178294|869698|P1|COMPLETED|Overall Study||18
362861|NCT01178294|869698|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
362862|NCT01178281|869721|P2|NOT COMPLETED|Overall Study||77
362863|NCT01178281|869722|P1|NOT COMPLETED|Overall Study||149
362864|NCT01178281|869721|P2|COMPLETED|Overall Study|Participants remain on treatment|7
362865|NCT01178281|869722|P1|COMPLETED|Overall Study|Participants remain on treatment|19
362866|NCT01178281|869721|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
362867|NCT01178281|869722|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
362868|NCT01178268|869730|P2|NOT COMPLETED|Overall Study||1
362869|NCT01178268|869731|P1|NOT COMPLETED|Overall Study||7
362870|NCT01178268|869730|P2|COMPLETED|Overall Study||120
362871|NCT01178268|869731|P1|COMPLETED|Overall Study||360
362872|NCT01178268|869730|P2|STARTED|Overall Study||121
362873|NCT01178268|869731|P1|STARTED|Overall Study||367
362874|NCT01178138|869948|P1|NOT COMPLETED|Overall Study||23
362875|NCT01178138|869948|P1|COMPLETED|Overall Study||1
362876|NCT01178138|869948|P1|Completed 3 Sessions|Overall Study||1
362877|NCT01178138|869948|P1|Completed 5 Sessions|Overall Study||1
362878|NCT01178138|869948|P1|Completed 6 Sessions|Overall Study||1
362879|NCT01178138|869948|P1|STARTED|Overall Study||24
362880|NCT01178125|869969|P1|NOT COMPLETED|Overall Study||1178
362881|NCT01178125|869969|P1|COMPLETED|Overall Study||1680
362882|NCT01178125|869969|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
362883|NCT01178125|869969|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
362884|NCT01178125|869969|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
362885|NCT01178125|869969|P1|STARTED|Overall Study|Number enrolled.|2858
362886|NCT01178099|870000|P2|NOT COMPLETED|Overall Study||1
362887|NCT01178099|870001|P1|NOT COMPLETED|Overall Study||0
362888|NCT01178099|870000|P2|COMPLETED|Overall Study||12
362889|NCT01178099|870001|P1|COMPLETED|Overall Study||13
362890|NCT01178099|870000|P2|STARTED|Overall Study||13
362891|NCT01178099|870001|P1|STARTED|Overall Study||13
362892|NCT01178073|870042|P3|NOT COMPLETED|Overall Study||46
362893|NCT01178073|870043|P2|NOT COMPLETED|Overall Study||44
362894|NCT01178073|870044|P1|NOT COMPLETED|Overall Study||62
362895|NCT01178073|870042|P3|COMPLETED|Overall Study||105
362896|NCT01178073|870043|P2|COMPLETED|Overall Study||108
362897|NCT01178073|870044|P1|COMPLETED|Overall Study||240
362898|NCT01178073|870042|P3|STARTED|Overall Study||151
362899|NCT01178073|870043|P2|STARTED|Overall Study||152
362900|NCT01178073|870044|P1|STARTED|Overall Study||302
362901|NCT01177969|870075|P2|NOT COMPLETED|Overall Study||3
362902|NCT01177969|870076|P1|NOT COMPLETED|Overall Study||3
362903|NCT01177969|870075|P2|COMPLETED|Overall Study||11
362904|NCT01177969|870076|P1|COMPLETED|Overall Study||16
362905|NCT01177969|870075|P2|STARTED|Overall Study||14
362906|NCT01177969|870076|P1|STARTED|Overall Study||19
362907|NCT01177956|870084|P1|NOT COMPLETED|Overall Study||0
362908|NCT01177956|870084|P1|COMPLETED|Overall Study||68
362909|NCT01177956|870084|P1|STARTED|Overall Study||68
362910|NCT01177943|870099|P2|NOT COMPLETED|Second Intervention||0
362911|NCT01177943|870100|P1|NOT COMPLETED|Second Intervention||0
362912|NCT01177943|870099|P2|COMPLETED|Second Intervention||21
362913|NCT01177943|870100|P1|COMPLETED|Second Intervention||19
362914|NCT01177943|870099|P2|STARTED|Second Intervention||21
362915|NCT01177943|870100|P1|STARTED|Second Intervention||19
362916|NCT01177943|870099|P2|NOT COMPLETED|First Intervention||0
362917|NCT01177943|870100|P1|NOT COMPLETED|First Intervention||2
362918|NCT01177943|870099|P2|COMPLETED|First Intervention||21
362919|NCT01177943|870100|P1|COMPLETED|First Intervention||19
362920|NCT01177943|870099|P2|STARTED|First Intervention||21
362921|NCT01177943|870100|P1|STARTED|First Intervention||21
362922|NCT01177813|870113|P5|NOT COMPLETED|Overall Study||9
362923|NCT01177813|870114|P4|NOT COMPLETED|Overall Study||17
362924|NCT01177813|870115|P3|NOT COMPLETED|Overall Study||20
362925|NCT01177813|870116|P2|NOT COMPLETED|Overall Study||18
362926|NCT01177813|870117|P1|NOT COMPLETED|Overall Study||41
362927|NCT01177813|870113|P5|COMPLETED|Overall Study||78
362928|NCT01177813|870114|P4|COMPLETED|Overall Study||206
362929|NCT01177813|870115|P3|COMPLETED|Overall Study||204
362930|NCT01177813|870116|P2|COMPLETED|Overall Study||206
362931|NCT01177813|870117|P1|COMPLETED|Overall Study||187
362932|NCT01177813|870113|P5|STARTED|Overall Study||87
362933|NCT01177813|870114|P4|STARTED|Overall Study||223
362934|NCT01177813|870115|P3|STARTED|Overall Study||224
362935|NCT01177813|870116|P2|STARTED|Overall Study||224
362936|NCT01177813|870117|P1|STARTED|Overall Study||228
362937|NCT01177800|870146|P2|NOT COMPLETED|Overall Study||5
362938|NCT01177800|870147|P1|NOT COMPLETED|Overall Study||10
362939|NCT01177800|870146|P2|COMPLETED|Overall Study||40
362940|NCT01177800|870147|P1|COMPLETED|Overall Study||74
362941|NCT01177800|870146|P2|STARTED|Overall Study||45
362942|NCT01177800|870147|P1|STARTED|Overall Study||84
362943|NCT01177735|870161|P1|NOT COMPLETED|Overall Study||71
362944|NCT01177735|870161|P1|COMPLETED|Overall Study||0
362945|NCT01177735|870161|P1|STARTED|Overall Study||71
362946|NCT01177722|870169|P4|NOT COMPLETED|Overall Study||7
362947|NCT01177722|870170|P3|NOT COMPLETED|Overall Study||9
362948|NCT01177722|870171|P2|NOT COMPLETED|Overall Study||10
362949|NCT01177722|870172|P1|NOT COMPLETED|Overall Study||13
362950|NCT01177722|870169|P4|COMPLETED|Overall Study||338
362951|NCT01177722|870170|P3|COMPLETED|Overall Study||333
362952|NCT01177722|870171|P2|COMPLETED|Overall Study||334
362953|NCT01177722|870172|P1|COMPLETED|Overall Study||331
362954|NCT01177722|870169|P4|STARTED|Overall Study||345
362955|NCT01177722|870170|P3|STARTED|Overall Study||342
362956|NCT01177722|870171|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
362957|NCT01177722|870172|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
362958|NCT01177709|870198|P1|NOT COMPLETED|Overall Study||0
362959|NCT01177709|870198|P1|COMPLETED|Overall Study||12
362960|NCT01177709|870198|P1|STARTED|Overall Study||12
362961|NCT01177670|870204|P1|NOT COMPLETED|Overall Study||169
362962|NCT01177670|870204|P1|COMPLETED|Overall Study||0
362963|NCT01177670|870204|P1|STARTED|Overall Study||169
362964|NCT01177553|870211|P2|NOT COMPLETED|Overall Study||0
362965|NCT01177553|870212|P1|NOT COMPLETED|Overall Study||1
362966|NCT01177553|870211|P2|COMPLETED|Overall Study|data as of March 2009|2
362967|NCT01177553|870212|P1|COMPLETED|Overall Study|data as of March 2009|2
362968|NCT01177553|870211|P2|STARTED|Overall Study||2
362969|NCT01177553|870212|P1|STARTED|Overall Study||3
362970|NCT01177410|870221|P3|NOT COMPLETED|Overall Study||5
362971|NCT01177410|870222|P2|NOT COMPLETED|Overall Study||7
362972|NCT01177410|870223|P1|NOT COMPLETED|Overall Study||1
362973|NCT01177410|870221|P3|COMPLETED|Overall Study||45
362974|NCT01177410|870222|P2|COMPLETED|Overall Study||40
362975|NCT01177410|870223|P1|COMPLETED|Overall Study||50
362976|NCT01177410|870221|P3|STARTED|Overall Study||50
362977|NCT01177410|870222|P2|STARTED|Overall Study||47
362978|NCT01177410|870223|P1|STARTED|Overall Study||51
362979|NCT01177384|870236|P2|NOT COMPLETED|Overall Study||26
362980|NCT01177384|870237|P1|NOT COMPLETED|Overall Study||14
362981|NCT01177384|870236|P2|COMPLETED|Overall Study||164
362982|NCT01177384|870237|P1|COMPLETED|Overall Study||177
362983|NCT01177384|870236|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
362984|NCT01177384|870237|P1|STARTED|Overall Study||191
362985|NCT01177293|870249|P2|NOT COMPLETED|Second Intervention Period||0
362986|NCT01177293|870250|P1|NOT COMPLETED|Second Intervention Period||0
362987|NCT01177293|870249|P2|COMPLETED|Second Intervention Period||6
362988|NCT01177293|870250|P1|COMPLETED|Second Intervention Period||7
362989|NCT01177293|870249|P2|STARTED|Second Intervention Period||6
362990|NCT01177293|870250|P1|STARTED|Second Intervention Period||7
362991|NCT01177293|870249|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
362992|NCT01177293|870250|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
362993|NCT01177293|870249|P2|COMPLETED|Washout Period (of 14 Days)||6
362994|NCT01177293|870250|P1|COMPLETED|Washout Period (of 14 Days)||7
362995|NCT01177293|870249|P2|STARTED|Washout Period (of 14 Days)||7
362996|NCT01177293|870250|P1|STARTED|Washout Period (of 14 Days)||7
362997|NCT01177293|870249|P2|NOT COMPLETED|First Intervention Period||0
362998|NCT01177293|870250|P1|NOT COMPLETED|First Intervention Period||0
362999|NCT01177293|870249|P2|COMPLETED|First Intervention Period||7
363000|NCT01177293|870250|P1|COMPLETED|First Intervention Period||7
363001|NCT01177293|870249|P2|STARTED|First Intervention Period||7
363002|NCT01177293|870250|P1|STARTED|First Intervention Period||7
363003|NCT01177228|870268|P4|NOT COMPLETED|Overall Study||0
363004|NCT01177228|870269|P3|NOT COMPLETED|Overall Study||0
363005|NCT01177228|870270|P2|NOT COMPLETED|Overall Study||2
363006|NCT01177228|870271|P1|NOT COMPLETED|Overall Study||1
363007|NCT01177228|870268|P4|COMPLETED|Overall Study||11
363008|NCT01177228|870269|P3|COMPLETED|Overall Study||14
363009|NCT01177228|870270|P2|COMPLETED|Overall Study||11
363010|NCT01177228|870271|P1|COMPLETED|Overall Study||8
363011|NCT01177228|870268|P4|Received Treatment|Overall Study||11
363012|NCT01177228|870269|P3|Received Treatment|Overall Study||14
363013|NCT01177228|870270|P2|Received Treatment|Overall Study||12
363014|NCT01177228|870271|P1|Received Treatment|Overall Study||9
363015|NCT01177228|870268|P4|STARTED|Overall Study||11
363016|NCT01177228|870269|P3|STARTED|Overall Study||14
363017|NCT01177228|870270|P2|STARTED|Overall Study||13
363018|NCT01177228|870271|P1|STARTED|Overall Study||9
363019|NCT01177098|870311|P2|NOT COMPLETED|Overall Study||12
363020|NCT01177098|870312|P1|NOT COMPLETED|Overall Study||9
363021|NCT01177098|870311|P2|COMPLETED|Overall Study||271
363022|NCT01177098|870312|P1|COMPLETED|Overall Study||269
363023|NCT01177098|870311|P2|STARTED|Overall Study||283
363024|NCT01177098|870312|P1|STARTED|Overall Study||278
363025|NCT01176968|870330|P2|NOT COMPLETED|Overall Study||82
363026|NCT01176968|870331|P1|NOT COMPLETED|Overall Study||84
363027|NCT01176968|870330|P2|COMPLETED|Overall Study||424
363028|NCT01176968|870331|P1|COMPLETED|Overall Study||422
363029|NCT01176968|870330|P2|Treated|Overall Study||505
363030|NCT01176968|870331|P1|Treated|Overall Study||505
363031|NCT01176968|870330|P2|STARTED|Overall Study||506
363032|NCT01176968|870331|P1|STARTED|Overall Study||506
363033|NCT01176955|870365|P2|NOT COMPLETED|Overall Study||2
363034|NCT01176955|870366|P1|NOT COMPLETED|Overall Study||3
363035|NCT01176955|870365|P2|COMPLETED|Overall Study||8
363036|NCT01176955|870366|P1|COMPLETED|Overall Study||7
363037|NCT01176955|870365|P2|STARTED|Overall Study||10
363038|NCT01176955|870366|P1|STARTED|Overall Study||10
363039|NCT01176877|870376|P1|NOT COMPLETED|Overall Study||9
363040|NCT01176877|870376|P1|COMPLETED|Overall Study||31
363041|NCT01176877|870376|P1|STARTED|Overall Study||40
363042|NCT01176773|870381|P1|NOT COMPLETED|Overall Study||3
363043|NCT01176773|870381|P1|COMPLETED|Overall Study||59
363044|NCT01176773|870381|P1|STARTED|Overall Study||62
363045|NCT01176565|870392|P2|NOT COMPLETED|Overall Study||19
363046|NCT01176565|870393|P1|NOT COMPLETED|Overall Study||20
363047|NCT01176565|870392|P2|COMPLETED|Overall Study||481
363048|NCT01176565|870393|P1|COMPLETED|Overall Study||480
363049|NCT01176565|870392|P2|STARTED|Overall Study||500
363050|NCT01176565|870393|P1|STARTED|Overall Study||500
363051|NCT01176513|870411|P1|NOT COMPLETED|Overall Study||3
363052|NCT01176513|870411|P1|COMPLETED|Overall Study||22
363053|NCT01176513|870411|P1|STARTED|Overall Study||25
363054|NCT01176448|870416|P1|NOT COMPLETED|Overall Study||0
363055|NCT01176448|870416|P1|COMPLETED|Overall Study||6
363056|NCT01176448|870416|P1|STARTED|Overall Study||6
363057|NCT01176292|870426|P2|NOT COMPLETED|Overall Study||9
363058|NCT01176292|870427|P1|NOT COMPLETED|Overall Study||5
363059|NCT01176292|870426|P2|COMPLETED|Overall Study||62
363060|NCT01176292|870427|P1|COMPLETED|Overall Study||66
363061|NCT01176292|870426|P2|STARTED|Overall Study||71
363062|NCT01176292|870427|P1|STARTED|Overall Study||71
363063|NCT01176240|870449|P2|NOT COMPLETED|Study 306B||17
363064|NCT01176240|870450|P1|NOT COMPLETED|Study 306B||26
363065|NCT01176240|870449|P2|COMPLETED|Study 306B||68
363066|NCT01176240|870450|P1|COMPLETED|Study 306B||63
363067|NCT01176240|870449|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
363068|NCT01176240|870450|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
363069|NCT01176240|870449|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
363070|NCT01176240|870450|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
363071|NCT01176240|870449|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
363072|NCT01176240|870450|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
363073|NCT01176240|870449|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
363074|NCT01176240|870450|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
363075|NCT01176240|870449|P2|STARTED|Study 306B||85
363076|NCT01176240|870450|P1|STARTED|Study 306B||89
363077|NCT01176240|870449|P2|NOT COMPLETED|Study 306A||3
363078|NCT01176240|870450|P1|NOT COMPLETED|Study 306A||3
363079|NCT01176240|870449|P2|COMPLETED|Study 306A||24
363080|NCT01176240|870450|P1|COMPLETED|Study 306A||21
363081|NCT01176240|870449|P2|STARTED|Study 306A||27
363082|NCT01176240|870450|P1|STARTED|Study 306A||24
363083|NCT01176058|870476|P2|NOT COMPLETED|Overall Study||3
363084|NCT01176058|870477|P1|NOT COMPLETED|Overall Study||4
363085|NCT01176058|870476|P2|COMPLETED|Overall Study||5
363086|NCT01176058|870477|P1|COMPLETED|Overall Study||5
363087|NCT01176058|870476|P2|STARTED|Overall Study||8
363088|NCT01176058|870477|P1|STARTED|Overall Study||9
363089|NCT01176032|870501|P2|NOT COMPLETED|Overall Study||1
363090|NCT01176032|870502|P1|NOT COMPLETED|Overall Study||6
363091|NCT01176032|870501|P2|COMPLETED|Overall Study||36
363092|NCT01176032|870502|P1|COMPLETED|Overall Study||31
363093|NCT01176032|870501|P2|Intention-to-treat (ITT) Population|Overall Study||37
363094|NCT01176032|870502|P1|Intention-to-treat (ITT) Population|Overall Study||32
363095|NCT01176032|870501|P2|STARTED|Overall Study||37
363096|NCT01176032|870502|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
363097|NCT01175902|870562|P2|NOT COMPLETED|Overall Study||0
363098|NCT01175902|870563|P1|NOT COMPLETED|Overall Study||0
363099|NCT01175902|870562|P2|COMPLETED|Overall Study||22
363100|NCT01175902|870563|P1|COMPLETED|Overall Study||22
363101|NCT01175902|870562|P2|STARTED|Overall Study||22
363102|NCT01175902|870563|P1|STARTED|Overall Study||22
363103|NCT01175850|870581|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
363104|NCT01175850|870582|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
363105|NCT01175850|870581|P2|COMPLETED|IN.PACT SFA II Phase||55
363106|NCT01175850|870582|P1|COMPLETED|IN.PACT SFA II Phase||109
363107|NCT01175850|870581|P2|STARTED|IN.PACT SFA II Phase||60
363108|NCT01175850|870582|P1|STARTED|IN.PACT SFA II Phase||121
363109|NCT01175850|870581|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
363110|NCT01175850|870582|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
363111|NCT01175850|870581|P2|COMPLETED|IN.PACT SFA I Phase||49
363112|NCT01175850|870582|P1|COMPLETED|IN.PACT SFA I Phase||88
363113|NCT01175850|870581|P2|STARTED|IN.PACT SFA I Phase||51
363114|NCT01175850|870582|P1|STARTED|IN.PACT SFA I Phase||99
363115|NCT01175824|870626|P2|NOT COMPLETED|Overall Study||22
363116|NCT01175824|870627|P1|NOT COMPLETED|Overall Study||16
363117|NCT01175824|870626|P2|COMPLETED|Overall Study||220
363118|NCT01175824|870627|P1|COMPLETED|Overall Study||220
363119|NCT01175824|870626|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
363120|NCT01175824|870627|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
363121|NCT01175824|870626|P2|STARTED|Overall Study||242
363122|NCT01175824|870627|P1|STARTED|Overall Study||236
363123|NCT01175811|870661|P2|NOT COMPLETED|Overall Study||14
363124|NCT01175811|870662|P1|NOT COMPLETED|Overall Study||16
363125|NCT01175811|870661|P2|COMPLETED|Overall Study||189
363126|NCT01175811|870662|P1|COMPLETED|Overall Study||183
363127|NCT01175811|870661|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
363128|NCT01175811|870662|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
363129|NCT01175811|870661|P2|STARTED|Overall Study||203
363130|NCT01175811|870662|P1|STARTED|Overall Study||199
363131|NCT01175798|870688|P2|NOT COMPLETED|Overall Study||21
363132|NCT01175798|870689|P1|NOT COMPLETED|Overall Study||7
363133|NCT01175798|870688|P2|COMPLETED|Overall Study||41
363134|NCT01175798|870689|P1|COMPLETED|Overall Study||27
363135|NCT01175798|870688|P2|STARTED|Overall Study||62
363136|NCT01175798|870689|P1|STARTED|Overall Study||34
363137|NCT01175707|870697|P2|NOT COMPLETED|Overall Study||6
363138|NCT01175707|870698|P1|NOT COMPLETED|Overall Study||4
363139|NCT01175707|870697|P2|COMPLETED|Overall Study||34
363140|NCT01175707|870698|P1|COMPLETED|Overall Study||36
363141|NCT01175707|870697|P2|STARTED|Overall Study||40
363142|NCT01175707|870698|P1|STARTED|Overall Study||40
363143|NCT01175668|870734|P2|NOT COMPLETED|Overall Study||0
363144|NCT01175668|870735|P1|NOT COMPLETED|Overall Study||2
363145|NCT01175668|870734|P2|COMPLETED|Overall Study||34
363146|NCT01175668|870735|P1|COMPLETED|Overall Study||32
363147|NCT01175668|870734|P2|STARTED|Overall Study||34
363148|NCT01175668|870735|P1|STARTED|Overall Study||34
363149|NCT01175590|870745|P2|NOT COMPLETED|Overall Study||10
363150|NCT01175590|870746|P1|NOT COMPLETED|Overall Study||12
363151|NCT01175590|870745|P2|COMPLETED|Overall Study||161
363152|NCT01175590|870746|P1|COMPLETED|Overall Study||335
363153|NCT01175590|870745|P2|Safety Population|Overall Study||170
363154|NCT01175590|870746|P1|Safety Population|Overall Study||344
363155|NCT01175590|870745|P2|Modified Intent to Treat Population|Overall Study||87
363156|NCT01175590|870746|P1|Modified Intent to Treat Population|Overall Study||212
363157|NCT01175590|870745|P2|STARTED|Overall Study||171
363158|NCT01175590|870746|P1|STARTED|Overall Study||347
363159|NCT01175473|870780|P2|NOT COMPLETED|Overall Study||2
363160|NCT01175473|870781|P1|NOT COMPLETED|Overall Study||2
363161|NCT01175473|870780|P2|COMPLETED|Overall Study||69
363162|NCT01175473|870781|P1|COMPLETED|Overall Study||75
363163|NCT01175473|870780|P2|Pharmacodynamic (PD) Population|Overall Study||68
363164|NCT01175473|870781|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
363165|NCT01175473|870780|P2|Safety Population|Overall Study||71
363166|NCT01175473|870781|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
363167|NCT01175473|870780|P2|STARTED|Overall Study||71
363168|NCT01175473|870781|P1|STARTED|Overall Study|Randomized and treated.|77
363169|NCT01175434|870807|P2|NOT COMPLETED|Overall Study||0
363170|NCT01175434|870808|P1|NOT COMPLETED|Overall Study||0
363171|NCT01175434|870807|P2|COMPLETED|Overall Study||51
363172|NCT01175434|870808|P1|COMPLETED|Overall Study||48
363173|NCT01175434|870807|P2|STARTED|Overall Study||51
363174|NCT01175434|870808|P1|STARTED|Overall Study||48
363175|NCT01175395|870814|P1|NOT COMPLETED|Overall Study||0
363176|NCT01175395|870814|P1|COMPLETED|Overall Study||10
363177|NCT01175395|870814|P1|STARTED|Overall Study||10
363178|NCT01175382|870822|P3|NOT COMPLETED|Overall Study||6
363179|NCT01175382|870823|P2|NOT COMPLETED|Overall Study||7
363180|NCT01175382|870824|P1|NOT COMPLETED|Overall Study||8
363181|NCT01175382|870822|P3|COMPLETED|Overall Study||59
363182|NCT01175382|870823|P2|COMPLETED|Overall Study||61
363183|NCT01175382|870824|P1|COMPLETED|Overall Study||63
363184|NCT01175382|870822|P3|STARTED|Overall Study||65
363185|NCT01175382|870823|P2|STARTED|Overall Study||68
363186|NCT01175382|870824|P1|STARTED|Overall Study||71
363187|NCT01175369|870903|P2|NOT COMPLETED|Overall Study||5
363188|NCT01175369|870904|P1|NOT COMPLETED|Overall Study||2
363189|NCT01175369|870903|P2|COMPLETED|Overall Study||260
363190|NCT01175369|870904|P1|COMPLETED|Overall Study||263
363191|NCT01175369|870903|P2|STARTED|Overall Study||265
363192|NCT01175369|870904|P1|STARTED|Overall Study||265
363193|NCT01175343|870910|P1|NOT COMPLETED|Overall Study||0
363194|NCT01175343|870910|P1|COMPLETED|Overall Study||44
363195|NCT01175343|870910|P1|STARTED|Overall Study||44
363196|NCT01175317|870922|P2|NOT COMPLETED|Overall Study||0
363197|NCT01175317|870923|P1|NOT COMPLETED|Overall Study||0
363198|NCT01175317|870922|P2|COMPLETED|Overall Study||31
363199|NCT01175317|870923|P1|COMPLETED|Overall Study||27
363200|NCT01175317|870922|P2|STARTED|Overall Study||31
363201|NCT01175317|870923|P1|STARTED|Overall Study||27
363202|NCT01175226|870933|P2|NOT COMPLETED|Overall Study||5
363203|NCT01175226|870934|P1|NOT COMPLETED|Overall Study||11
363204|NCT01175226|870933|P2|COMPLETED|Overall Study||140
363205|NCT01175226|870934|P1|COMPLETED|Overall Study||144
363206|NCT01175226|870933|P2|STARTED|Overall Study||145
363207|NCT01175226|870934|P1|STARTED|Overall Study||155
363208|NCT01175213|870944|P2|NOT COMPLETED|Safety Follow-up||0
363209|NCT01175213|870945|P1|NOT COMPLETED|Safety Follow-up||1
363210|NCT01175213|870944|P2|COMPLETED|Safety Follow-up||3
363211|NCT01175213|870945|P1|COMPLETED|Safety Follow-up||47
363212|NCT01175213|870944|P2|STARTED|Safety Follow-up||3
363213|NCT01175213|870945|P1|STARTED|Safety Follow-up||48
363214|NCT01175213|870944|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
363215|NCT01175213|870945|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
363216|NCT01175213|870944|P2|COMPLETED|IGSC, 10%/rHuPH20||3
363217|NCT01175213|870945|P1|COMPLETED|IGSC, 10%/rHuPH20||48
363218|NCT01175213|870944|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
363219|NCT01175213|870945|P1|STARTED|IGSC, 10%/rHuPH20||63
363220|NCT01175148|870992|P2|NOT COMPLETED|Overall Study||0
363221|NCT01175148|870993|P1|NOT COMPLETED|Overall Study||0
363222|NCT01175148|870992|P2|COMPLETED|Overall Study||30
363223|NCT01175148|870993|P1|COMPLETED|Overall Study||30
363224|NCT01175148|870992|P2|STARTED|Overall Study||30
363225|NCT01175148|870993|P1|STARTED|Overall Study||30
363226|NCT01175031|870998|P1|NOT COMPLETED|Overall Study||0
363227|NCT01175031|870998|P1|COMPLETED|Overall Study||45
363228|NCT01175031|870998|P1|STARTED|Overall Study||45
363229|NCT01175018|871008|P2|NOT COMPLETED|Overall Study||1
363230|NCT01175018|871009|P1|NOT COMPLETED|Overall Study||3
363231|NCT01175018|871008|P2|COMPLETED|Overall Study||14
363232|NCT01175018|871009|P1|COMPLETED|Overall Study||12
363233|NCT01175018|871008|P2|STARTED|Overall Study||15
363234|NCT01175018|871009|P1|STARTED|Overall Study||15
363235|NCT01175005|871045|P1|NOT COMPLETED|Overall Study||0
363236|NCT01175005|871045|P1|COMPLETED|Overall Study||62
363237|NCT01175005|871045|P1|STARTED|Overall Study||62
363238|NCT01174784|871050|P1|NOT COMPLETED|Overall Study||0
363239|NCT01174784|871050|P1|COMPLETED|Overall Study||88
363240|NCT01174784|871050|P1|STARTED|Overall Study||88
363241|NCT01174576|871055|P1|NOT COMPLETED|Overall Study||0
363242|NCT01174576|871055|P1|COMPLETED|Overall Study||16
363243|NCT01174576|871055|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
363244|NCT01174550|871098|P2|NOT COMPLETED|Overall Study||873
363245|NCT01174550|871099|P1|NOT COMPLETED|Overall Study||1270
363246|NCT01174550|871098|P2|COMPLETED|Overall Study||4123
363247|NCT01174550|871099|P1|COMPLETED|Overall Study||3737
363248|NCT01174550|871098|P2|STARTED|Overall Study||4996
363249|NCT01174550|871099|P1|STARTED|Overall Study||5007
363250|NCT01174459|871127|P1|NOT COMPLETED|Overall Study||5
363251|NCT01174459|871127|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
363252|NCT01174459|871127|P1|STARTED|Overall Study|Registered patients|571
363253|NCT01174446|871132|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
363254|NCT01174446|871133|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
363255|NCT01174446|871134|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
363256|NCT01174446|871135|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
363257|NCT01174446|871132|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
363258|NCT01174446|871133|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
363259|NCT01174446|871134|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
363260|NCT01174446|871135|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
363261|NCT01174446|871132|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
363262|NCT01174446|871133|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
363263|NCT01174446|871134|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
363264|NCT01174446|871135|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
363265|NCT01174446|871132|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
363266|NCT01174446|871133|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
363267|NCT01174446|871134|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
363268|NCT01174446|871135|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
363269|NCT01174446|871132|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
363270|NCT01174446|871133|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
363271|NCT01174446|871134|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
363272|NCT01174446|871135|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
363273|NCT01174446|871132|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
363274|NCT01174446|871133|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
363275|NCT01174446|871134|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
363276|NCT01174446|871135|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
363277|NCT01174446|871132|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
363278|NCT01174446|871133|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
363279|NCT01174446|871134|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
363280|NCT01174446|871135|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
363281|NCT01174446|871132|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
363282|NCT01174446|871133|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
363283|NCT01174446|871134|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
363371|NCT01173679|871470|P1|COMPLETED|Overall Study||9
363284|NCT01174446|871135|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
363285|NCT01174446|871132|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
363286|NCT01174446|871133|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
363287|NCT01174446|871134|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
363288|NCT01174446|871135|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
363289|NCT01174342|871322|P1|NOT COMPLETED|Overall Study||4
363290|NCT01174342|871322|P1|COMPLETED|Overall Study||26
363291|NCT01174342|871322|P1|STARTED|Overall Study||30
363292|NCT01174264|871329|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
363293|NCT01174264|871330|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
363294|NCT01174264|871331|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
363295|NCT01174264|871329|P3|COMPLETED|Steady-state Pharmacokinetics||27
363296|NCT01174264|871330|P2|COMPLETED|Steady-state Pharmacokinetics||0
363297|NCT01174264|871331|P1|COMPLETED|Steady-state Pharmacokinetics||25
363298|NCT01174264|871329|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
363299|NCT01174264|871330|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
363300|NCT01174264|871331|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
363301|NCT01174264|871329|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
363302|NCT01174264|871330|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
363303|NCT01174264|871331|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
363304|NCT01174264|871329|P3|COMPLETED|Single Dose Pharmacokinetics||18
363305|NCT01174264|871330|P2|COMPLETED|Single Dose Pharmacokinetics||20
363306|NCT01174264|871331|P1|COMPLETED|Single Dose Pharmacokinetics||22
363307|NCT01174264|871329|P3|STARTED|Single Dose Pharmacokinetics||20
363308|NCT01174264|871330|P2|STARTED|Single Dose Pharmacokinetics||20
363309|NCT01174264|871331|P1|STARTED|Single Dose Pharmacokinetics||23
363310|NCT01174186|871365|P2|NOT COMPLETED|Overall Study||3
363311|NCT01174186|871366|P1|NOT COMPLETED|Overall Study||0
363312|NCT01174186|871365|P2|COMPLETED|Overall Study||12
363313|NCT01174186|871366|P1|COMPLETED|Overall Study||15
363314|NCT01174186|871365|P2|STARTED|Overall Study||15
363315|NCT01174186|871366|P1|STARTED|Overall Study|Patients were included over three years|15
363316|NCT01174173|871373|P1|NOT COMPLETED|Overall Study||1
363317|NCT01174173|871373|P1|COMPLETED|Overall Study||10
363318|NCT01174173|871373|P1|STARTED|Overall Study||11
363319|NCT01174160|871383|P2|NOT COMPLETED|Overall Study||6
363320|NCT01174160|871384|P1|NOT COMPLETED|Overall Study||8
363321|NCT01174160|871383|P2|COMPLETED|Overall Study||56
363322|NCT01174160|871384|P1|COMPLETED|Overall Study||53
363323|NCT01174160|871383|P2|Discontinued Post Dose|Overall Study||0
363324|NCT01174160|871384|P1|Discontinued Post Dose|Overall Study||2
363325|NCT01174160|871383|P2|Dosed|Overall Study||56
363326|NCT01174160|871384|P1|Dosed|Overall Study||55
363327|NCT01174160|871383|P2|Discontinued Pre Dose|Overall Study||6
363328|NCT01174160|871384|P1|Discontinued Pre Dose|Overall Study||6
363329|NCT01174160|871383|P2|STARTED|Overall Study||62
363330|NCT01174160|871384|P1|STARTED|Overall Study||61
363331|NCT01174043|871390|P1|NOT COMPLETED|Overall Study||11
363332|NCT01174043|871390|P1|COMPLETED|Overall Study||0
363333|NCT01174043|871390|P1|STARTED|Overall Study||11
363334|NCT01174030|871401|P5|NOT COMPLETED|Overall Study||1
363335|NCT01174030|871402|P4|NOT COMPLETED|Overall Study||2
363336|NCT01174030|871403|P3|NOT COMPLETED|Overall Study||2
363337|NCT01174030|871404|P2|NOT COMPLETED|Overall Study||2
363338|NCT01174030|871405|P1|NOT COMPLETED|Overall Study||2
363339|NCT01174030|871401|P5|COMPLETED|Overall Study||52
363340|NCT01174030|871402|P4|COMPLETED|Overall Study||53
363341|NCT01174030|871403|P3|COMPLETED|Overall Study||52
363342|NCT01174030|871404|P2|COMPLETED|Overall Study||52
363343|NCT01174030|871405|P1|COMPLETED|Overall Study||51
363344|NCT01174030|871401|P5|STARTED|Overall Study||53
363345|NCT01174030|871402|P4|STARTED|Overall Study||55
363346|NCT01174030|871403|P3|STARTED|Overall Study||54
363347|NCT01174030|871404|P2|STARTED|Overall Study||54
363348|NCT01174030|871405|P1|STARTED|Overall Study||53
363349|NCT01174004|871429|P2|NOT COMPLETED|Overall Study||16
363350|NCT01174004|871430|P1|NOT COMPLETED|Overall Study||7
363351|NCT01174004|871429|P2|COMPLETED|Overall Study||89
363352|NCT01174004|871430|P1|COMPLETED|Overall Study||87
363353|NCT01174004|871429|P2|STARTED|Overall Study||105
363354|NCT01174004|871430|P1|STARTED|Overall Study||94
363355|NCT01173874|871440|P2|NOT COMPLETED|Overall Study||23
363356|NCT01173874|871441|P1|NOT COMPLETED|Overall Study||23
363357|NCT01173874|871440|P2|COMPLETED|Overall Study||41
363358|NCT01173874|871441|P1|COMPLETED|Overall Study||33
363359|NCT01173874|871440|P2|STARTED|Overall Study||64
363360|NCT01173874|871441|P1|STARTED|Overall Study||56
363361|NCT01173848|871455|P2|NOT COMPLETED|Overall Study||8
363362|NCT01173848|871456|P1|NOT COMPLETED|Overall Study||4
363363|NCT01173848|871455|P2|COMPLETED|Overall Study||3
363364|NCT01173848|871456|P1|COMPLETED|Overall Study||4
363365|NCT01173848|871455|P2|STARTED|Overall Study||11
363366|NCT01173848|871456|P1|STARTED|Overall Study||8
363367|NCT01173718|871461|P1|NOT COMPLETED|Overall Study||44
363368|NCT01173718|871461|P1|COMPLETED|Overall Study||94
363369|NCT01173718|871461|P1|STARTED|Overall Study||138
363370|NCT01173679|871470|P1|NOT COMPLETED|Overall Study||1
363372|NCT01173679|871470|P1|STARTED|Overall Study||10
363373|NCT01173653|871478|P2|NOT COMPLETED|Overall Study||41
363374|NCT01173653|871479|P1|NOT COMPLETED|Overall Study||53
363375|NCT01173653|871478|P2|COMPLETED|Overall Study||49
363376|NCT01173653|871479|P1|COMPLETED|Overall Study||56
363377|NCT01173653|871478|P2|STARTED|Overall Study||90
363378|NCT01173653|871479|P1|STARTED|Overall Study||109
363379|NCT01173523|871487|P2|NOT COMPLETED|Overall Study||12
363380|NCT01173523|871488|P1|NOT COMPLETED|Overall Study||13
363381|NCT01173523|871487|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
363382|NCT01173523|871488|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
363383|NCT01173523|871487|P2|STARTED|Overall Study||12
363384|NCT01173523|871488|P1|STARTED|Overall Study||13
363385|NCT01173471|871504|P4|NOT COMPLETED|Overall Study||1
363386|NCT01173471|871505|P3|NOT COMPLETED|Overall Study||3
363387|NCT01173471|871506|P2|NOT COMPLETED|Overall Study||0
363388|NCT01173471|871507|P1|NOT COMPLETED|Overall Study||2
363389|NCT01173471|871504|P4|COMPLETED|Overall Study|Completed study|18
363390|NCT01173471|871505|P3|COMPLETED|Overall Study|Completed study|15
363391|NCT01173471|871506|P2|COMPLETED|Overall Study|Completed study|7
363392|NCT01173471|871507|P1|COMPLETED|Overall Study|Completed study|4
363393|NCT01173471|871504|P4|Completed Treatment|Overall Study||18
363394|NCT01173471|871505|P3|Completed Treatment|Overall Study||15
363395|NCT01173471|871506|P2|Completed Treatment|Overall Study||7
363396|NCT01173471|871507|P1|Completed Treatment|Overall Study||4
363397|NCT01173471|871504|P4|Received Treatment|Overall Study||19
363398|NCT01173471|871505|P3|Received Treatment|Overall Study||18
363399|NCT01173471|871506|P2|Received Treatment|Overall Study||7
363400|NCT01173471|871507|P1|Received Treatment|Overall Study||6
363401|NCT01173471|871504|P4|STARTED|Overall Study|Randomized|19
363402|NCT01173471|871505|P3|STARTED|Overall Study|Randomized|18
363403|NCT01173471|871506|P2|STARTED|Overall Study|Randomized|7
363404|NCT01173471|871507|P1|STARTED|Overall Study|Randomized|6
363405|NCT01173211|871531|P6|NOT COMPLETED|Overall Study||0
363406|NCT01173211|871532|P5|NOT COMPLETED|Overall Study||0
363407|NCT01173211|871533|P4|NOT COMPLETED|Overall Study||0
363408|NCT01173211|871534|P3|NOT COMPLETED|Overall Study||2
363409|NCT01173211|871535|P2|NOT COMPLETED|Overall Study||1
363410|NCT01173211|871536|P1|NOT COMPLETED|Overall Study||2
363411|NCT01173211|871531|P6|COMPLETED|Overall Study||13
363412|NCT01173211|871532|P5|COMPLETED|Overall Study||16
363413|NCT01173211|871533|P4|COMPLETED|Overall Study||15
363414|NCT01173211|871534|P3|COMPLETED|Overall Study||44
363415|NCT01173211|871535|P2|COMPLETED|Overall Study||44
363416|NCT01173211|871536|P1|COMPLETED|Overall Study||46
363417|NCT01173211|871531|P6|STARTED|Overall Study||13
363418|NCT01173211|871532|P5|STARTED|Overall Study||16
363419|NCT01173211|871533|P4|STARTED|Overall Study||15
363420|NCT01173211|871534|P3|STARTED|Overall Study||46
363421|NCT01173211|871535|P2|STARTED|Overall Study||45
363422|NCT01173211|871536|P1|STARTED|Overall Study||48
363423|NCT01173120|871637|P1|NOT COMPLETED|Overall Study||62
363424|NCT01173120|871637|P1|COMPLETED|Overall Study||0
363425|NCT01173120|871637|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
363426|NCT01173120|871637|P1|Switched Back to Main Study|Overall Study||57
363427|NCT01173120|871637|P1|STARTED|Overall Study||62
363428|NCT01173055|871655|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
363429|NCT01173055|871656|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
363430|NCT01173055|871655|P2|COMPLETED|Period 2 - Day 64 to 112||9
363431|NCT01173055|871656|P1|COMPLETED|Period 2 - Day 64 to 112||8
363432|NCT01173055|871655|P2|STARTED|Period 2 - Day 64 to 112||10
363433|NCT01173055|871656|P1|STARTED|Period 2 - Day 64 to 112||8
363434|NCT01173055|871655|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
363435|NCT01173055|871656|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
363436|NCT01173055|871655|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
363437|NCT01173055|871656|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
363438|NCT01173055|871655|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
363439|NCT01173055|871656|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
363440|NCT01173055|871655|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
363441|NCT01173055|871656|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
363442|NCT01173055|871655|P2|COMPLETED|Period 1 - Day 1 to 49||10
363443|NCT01173055|871656|P1|COMPLETED|Period 1 - Day 1 to 49||8
363444|NCT01173055|871655|P2|STARTED|Period 1 - Day 1 to 49||12
363445|NCT01173055|871656|P1|STARTED|Period 1 - Day 1 to 49||10
363446|NCT01173029|871674|P2|NOT COMPLETED|Overall Study||0
363447|NCT01173029|871675|P1|NOT COMPLETED|Overall Study||0
363448|NCT01173029|871674|P2|COMPLETED|Overall Study||31
363449|NCT01173029|871675|P1|COMPLETED|Overall Study||61
363450|NCT01173029|871674|P2|STARTED|Overall Study||31
363451|NCT01173029|871675|P1|STARTED|Overall Study||61
363452|NCT01172938|871695|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
363453|NCT01172938|871696|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
363454|NCT01172938|871697|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||4
363455|NCT01172938|871698|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
363456|NCT01172938|871699|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
363527|NCT01172821|871920|P4|NOT COMPLETED|Overall Study||17
363457|NCT01172938|871700|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
363458|NCT01172938|871701|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
363459|NCT01172938|871695|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||22
363460|NCT01172938|871696|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
363461|NCT01172938|871697|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
363462|NCT01172938|871698|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
363463|NCT01172938|871699|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||130
363464|NCT01172938|871700|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||124
363465|NCT01172938|871701|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
363466|NCT01172938|871695|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||24
363467|NCT01172938|871696|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
363468|NCT01172938|871697|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||23
363469|NCT01172938|871698|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
363470|NCT01172938|871699|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who completed Week 24 did not enter the active treatment phase|145
363471|NCT01172938|871700|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
363472|NCT01172938|871701|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
363473|NCT01172938|871695|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363474|NCT01172938|871696|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363475|NCT01172938|871697|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363476|NCT01172938|871698|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363477|NCT01172938|871699|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
363478|NCT01172938|871700|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
363479|NCT01172938|871701|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||18
363480|NCT01172938|871695|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363481|NCT01172938|871696|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363482|NCT01172938|871697|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363483|NCT01172938|871698|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
363484|NCT01172938|871699|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||148
363485|NCT01172938|871700|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
363486|NCT01172938|871701|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|One participant who completed Week 24 did not enter the active treatment phase|150
363487|NCT01172938|871695|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363488|NCT01172938|871696|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363489|NCT01172938|871697|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363490|NCT01172938|871698|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363491|NCT01172938|871699|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||58
363492|NCT01172938|871700|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Six participants who escaped early did not complete Week 24|78
363493|NCT01172938|871701|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Five participants who escaped early did not complete Week 24|107
363494|NCT01172938|871695|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363495|NCT01172938|871696|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363496|NCT01172938|871697|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363497|NCT01172938|871698|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
363498|NCT01172938|871699|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||154
363499|NCT01172938|871700|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
363500|NCT01172938|871701|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
363501|NCT01172938|871695|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
363502|NCT01172938|871696|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
363503|NCT01172938|871697|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
363504|NCT01172938|871698|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
363505|NCT01172938|871699|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
363506|NCT01172938|871700|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
363507|NCT01172938|871701|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
363508|NCT01172938|871695|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
363509|NCT01172938|871696|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
363510|NCT01172938|871697|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
363511|NCT01172938|871698|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
363512|NCT01172938|871699|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
363513|NCT01172938|871700|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
363514|NCT01172938|871701|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
363515|NCT01172873|871880|P2|NOT COMPLETED|Overall Study||2
363516|NCT01172873|871881|P1|NOT COMPLETED|Overall Study||3
363517|NCT01172873|871880|P2|COMPLETED|Overall Study||3
363518|NCT01172873|871881|P1|COMPLETED|Overall Study||8
363519|NCT01172873|871880|P2|STARTED|Overall Study||5
363520|NCT01172873|871881|P1|STARTED|Overall Study||11
363521|NCT01172847|871891|P1|NOT COMPLETED|Overall Study||3
363522|NCT01172847|871891|P1|COMPLETED|Overall Study||21
363523|NCT01172847|871891|P1|Oseltamivir + Rimantadine|Overall Study||21
363524|NCT01172847|871891|P1|Rimantadine|Overall Study||22
363525|NCT01172847|871891|P1|Oseltamivir|Overall Study||24
363526|NCT01172847|871891|P1|STARTED|Overall Study||24
363528|NCT01172821|871921|P3|NOT COMPLETED|Overall Study||13
363529|NCT01172821|871922|P2|NOT COMPLETED|Overall Study||12
363530|NCT01172821|871923|P1|NOT COMPLETED|Overall Study||14
363531|NCT01172821|871920|P4|COMPLETED|Overall Study||249
363532|NCT01172821|871921|P3|COMPLETED|Overall Study||240
363533|NCT01172821|871922|P2|COMPLETED|Overall Study||245
363534|NCT01172821|871923|P1|COMPLETED|Overall Study||240
363535|NCT01172821|871920|P4|STARTED|Overall Study|Entered and Treated|266
363536|NCT01172821|871921|P3|STARTED|Overall Study|Entered and Treated|253
363537|NCT01172821|871922|P2|STARTED|Overall Study|Entered and Treated|257
363538|NCT01172821|871923|P1|STARTED|Overall Study|Entered and Treated|254
363539|NCT01172808|872013|P4|NOT COMPLETED|Overall Study||15
363540|NCT01172808|872014|P3|NOT COMPLETED|Overall Study||23
363541|NCT01172808|872015|P2|NOT COMPLETED|Overall Study||13
363542|NCT01172808|872016|P1|NOT COMPLETED|Overall Study||21
363543|NCT01172808|872013|P4|COMPLETED|Overall Study||260
363544|NCT01172808|872014|P3|COMPLETED|Overall Study||241
363545|NCT01172808|872015|P2|COMPLETED|Overall Study||249
363546|NCT01172808|872016|P1|COMPLETED|Overall Study||248
363547|NCT01172808|872013|P4|STARTED|Overall Study|Entered and Treated|275
363548|NCT01172808|872014|P3|STARTED|Overall Study|Entered and Treated|264
363549|NCT01172808|872015|P2|STARTED|Overall Study|Entered and Treated|262
363550|NCT01172808|872016|P1|STARTED|Overall Study|Entered and Treated|269
363551|NCT01172600|872104|P2|NOT COMPLETED|Overall Study||0
363552|NCT01172600|872105|P1|NOT COMPLETED|Overall Study||0
363553|NCT01172600|872104|P2|COMPLETED|Overall Study||39
363554|NCT01172600|872105|P1|COMPLETED|Overall Study||39
363555|NCT01172600|872104|P2|STARTED|Overall Study||39
363556|NCT01172600|872105|P1|STARTED|Overall Study||39
363557|NCT01172535|872135|P1|NOT COMPLETED|Overall Study||8
363558|NCT01172535|872135|P1|COMPLETED|Overall Study||89
363559|NCT01172535|872135|P1|STARTED|Overall Study||97
363560|NCT01172522|872152|P2|NOT COMPLETED|Overall Study||0
363561|NCT01172522|872153|P1|NOT COMPLETED|Overall Study||0
363562|NCT01172522|872152|P2|COMPLETED|Overall Study||15
363563|NCT01172522|872153|P1|COMPLETED|Overall Study||15
363564|NCT01172522|872152|P2|STARTED|Overall Study||15
363565|NCT01172522|872153|P1|STARTED|Overall Study||15
363566|NCT01172418|872160|P2|NOT COMPLETED|Overall Study||0
363567|NCT01172418|872161|P1|NOT COMPLETED|Overall Study||0
363568|NCT01172418|872160|P2|COMPLETED|Overall Study||100
363569|NCT01172418|872161|P1|COMPLETED|Overall Study||100
363570|NCT01172418|872160|P2|STARTED|Overall Study||100
363571|NCT01172418|872161|P1|STARTED|Overall Study||100
363572|NCT01172353|872169|P2|NOT COMPLETED|Overall Study||0
363573|NCT01172353|872170|P1|NOT COMPLETED|Overall Study||0
363574|NCT01172353|872169|P2|COMPLETED|Overall Study||151
363575|NCT01172353|872170|P1|COMPLETED|Overall Study||150
363576|NCT01172353|872169|P2|STARTED|Overall Study||151
363577|NCT01172353|872170|P1|STARTED|Overall Study||150
363578|NCT01172288|872180|P2|NOT COMPLETED|Overall Study||1
363579|NCT01172288|872181|P1|NOT COMPLETED|Overall Study||1
363580|NCT01172288|872180|P2|COMPLETED|Overall Study||13
363581|NCT01172288|872181|P1|COMPLETED|Overall Study||16
363582|NCT01172288|872180|P2|STARTED|Overall Study||14
363583|NCT01172288|872181|P1|STARTED|Overall Study||17
363584|NCT01172184|872195|P1|NOT COMPLETED|Overall Study||0
363585|NCT01172184|872195|P1|COMPLETED|Overall Study||111
363586|NCT01172184|872195|P1|STARTED|Overall Study||111
363587|NCT01172145|872203|P2|NOT COMPLETED|Overall Study||0
363588|NCT01172145|872204|P1|NOT COMPLETED|Overall Study||0
363589|NCT01172145|872203|P2|COMPLETED|Overall Study||11
363590|NCT01172145|872204|P1|COMPLETED|Overall Study||11
363591|NCT01172145|872203|P2|STARTED|Overall Study||11
363592|NCT01172145|872204|P1|STARTED|Overall Study||11
363593|NCT01171989|872227|P3|NOT COMPLETED|Overall Study||1
363594|NCT01171989|872228|P2|NOT COMPLETED|Overall Study||0
363595|NCT01171989|872229|P1|NOT COMPLETED|Overall Study||0
363596|NCT01171989|872227|P3|COMPLETED|Overall Study||120
363597|NCT01171989|872228|P2|COMPLETED|Overall Study||133
363598|NCT01171989|872229|P1|COMPLETED|Overall Study||137
363599|NCT01171989|872227|P3|STARTED|Overall Study||121
363600|NCT01171989|872228|P2|STARTED|Overall Study||133
363601|NCT01171989|872229|P1|STARTED|Overall Study||137
363602|NCT01171976|872303|P3|NOT COMPLETED|Overall Study||15
363603|NCT01171976|872304|P2|NOT COMPLETED|Overall Study||11
363604|NCT01171976|872305|P1|NOT COMPLETED|Overall Study||14
363605|NCT01171976|872303|P3|COMPLETED|Overall Study||108
363606|NCT01171976|872304|P2|COMPLETED|Overall Study||117
363607|NCT01171976|872305|P1|COMPLETED|Overall Study||107
363608|NCT01171976|872303|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
363609|NCT01171976|872304|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
363610|NCT01171976|872305|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
363611|NCT01171976|872303|P3|STARTED|Overall Study||123
363612|NCT01171976|872304|P2|STARTED|Overall Study||128
363613|NCT01171976|872305|P1|STARTED|Overall Study||121
363614|NCT01171963|872342|P2|NOT COMPLETED|Overall Study||168
363615|NCT01171963|872343|P1|NOT COMPLETED|Overall Study||148
363616|NCT01171963|872342|P2|COMPLETED|Overall Study||1499
363617|NCT01171963|872343|P1|COMPLETED|Overall Study||1518
363618|NCT01171963|872342|P2|STARTED|Overall Study||1667
363619|NCT01171963|872343|P1|STARTED|Overall Study||1666
363620|NCT01171924|872401|P2|NOT COMPLETED|Overall Study||23
363621|NCT01171924|872402|P1|NOT COMPLETED|Overall Study||23
363622|NCT01171924|872401|P2|COMPLETED|Overall Study||0
363623|NCT01171924|872402|P1|COMPLETED|Overall Study||0
363624|NCT01171924|872401|P2|STARTED|Overall Study||23
363625|NCT01171924|872402|P1|STARTED|Overall Study||23
363626|NCT01171820|872410|P2|NOT COMPLETED|Overall Study||6
363627|NCT01171820|872411|P1|NOT COMPLETED|Overall Study||6
363628|NCT01171820|872410|P2|COMPLETED|Overall Study||212
363629|NCT01171820|872411|P1|COMPLETED|Overall Study||100
363630|NCT01171820|872410|P2|STARTED|Overall Study||218
363631|NCT01171820|872411|P1|STARTED|Overall Study||106
363632|NCT01171794|872467|P2|NOT COMPLETED|Overall Study||0
363633|NCT01171794|872468|P1|NOT COMPLETED|Overall Study||3
363634|NCT01171794|872467|P2|COMPLETED|Overall Study||42
363635|NCT01171794|872468|P1|COMPLETED|Overall Study||44
363636|NCT01171794|872467|P2|STARTED|Overall Study||42
363637|NCT01171794|872468|P1|STARTED|Overall Study||47
363638|NCT01171690|872478|P2|NOT COMPLETED|Overall Study||0
363639|NCT01171690|872479|P1|NOT COMPLETED|Overall Study||0
363640|NCT01171690|872478|P2|COMPLETED|Overall Study||5
363641|NCT01171690|872479|P1|COMPLETED|Overall Study||5
363642|NCT01171690|872478|P2|STARTED|Overall Study||5
363643|NCT01171690|872479|P1|STARTED|Overall Study||5
363644|NCT01171677|872489|P2|NOT COMPLETED|Overall Study||3
363645|NCT01171677|872490|P1|NOT COMPLETED|Overall Study||6
363646|NCT01171677|872489|P2|COMPLETED|Overall Study||12
363647|NCT01171677|872490|P1|COMPLETED|Overall Study||11
363648|NCT01171677|872489|P2|STARTED|Overall Study||15
363649|NCT01171677|872490|P1|STARTED|Overall Study||17
363650|NCT01171612|872522|P1|NOT COMPLETED|Overall Study||51
363651|NCT01171612|872522|P1|COMPLETED|Overall Study||432
363652|NCT01171612|872522|P1|STARTED|Overall Study||483
363653|NCT01171534|872532|P2|NOT COMPLETED|Overall Study||3
363654|NCT01171534|872533|P1|NOT COMPLETED|Overall Study||0
363655|NCT01171534|872532|P2|COMPLETED|Overall Study||4
363656|NCT01171534|872533|P1|COMPLETED|Overall Study||0
363657|NCT01171534|872532|P2|STARTED|Overall Study||7
363658|NCT01171534|872533|P1|STARTED|Overall Study|retrospective arm never performed on study|0
363659|NCT01171521|872541|P1|NOT COMPLETED|Overall Study||6
363660|NCT01171521|872541|P1|COMPLETED|Overall Study||0
363661|NCT01171521|872541|P1|STARTED|Overall Study||6
363662|NCT01171183|872548|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
363663|NCT01171183|872549|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
363664|NCT01171183|872548|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
363665|NCT01171183|872549|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
363666|NCT01171183|872548|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
363667|NCT01171183|872549|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
363668|NCT01171183|872548|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
363669|NCT01171183|872549|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
363670|NCT01171183|872548|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
363671|NCT01171183|872549|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
363672|NCT01171183|872548|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
363673|NCT01171183|872549|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
363674|NCT01171118|872557|P1|NOT COMPLETED|Overall Study||0
363675|NCT01171118|872557|P1|COMPLETED|Overall Study||10
363676|NCT01171118|872557|P1|STARTED|Overall Study||10
363677|NCT01170962|872570|P3|NOT COMPLETED|Follow up Period||6
363678|NCT01170962|872571|P2|NOT COMPLETED|Follow up Period||27
363679|NCT01170962|872572|P1|NOT COMPLETED|Follow up Period||39
363680|NCT01170962|872570|P3|COMPLETED|Follow up Period||9
363681|NCT01170962|872571|P2|COMPLETED|Follow up Period||165
363682|NCT01170962|872572|P1|COMPLETED|Follow up Period||159
363683|NCT01170962|872570|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
363684|NCT01170962|872571|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
363685|NCT01170962|872572|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
363686|NCT01170962|872570|P3|NOT COMPLETED|Treatment Period||12
363687|NCT01170962|872571|P2|NOT COMPLETED|Treatment Period||111
363688|NCT01170962|872572|P1|NOT COMPLETED|Treatment Period||127
363689|NCT01170962|872570|P3|COMPLETED|Treatment Period||5
363690|NCT01170962|872571|P2|COMPLETED|Treatment Period||88
363691|NCT01170962|872572|P1|COMPLETED|Treatment Period||76
363692|NCT01170962|872570|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
363693|NCT01170962|872571|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
363694|NCT01170962|872572|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
363695|NCT01170962|872570|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
363696|NCT01170962|872571|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
363697|NCT01170962|872572|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
363698|NCT01170962|872570|P3|No PDR|Treatment Period||17
363699|NCT01170962|872571|P2|No PDR|Treatment Period||127
363700|NCT01170962|872572|P1|No PDR|Treatment Period||145
363701|NCT01170962|872570|P3|STARTED|Treatment Period||17
363702|NCT01170962|872571|P2|STARTED|Treatment Period||199
363703|NCT01170962|872572|P1|STARTED|Treatment Period||203
363704|NCT01170949|872618|P2|NOT COMPLETED|Overall Study||4
363705|NCT01170949|872619|P1|NOT COMPLETED|Overall Study||7
363706|NCT01170949|872618|P2|COMPLETED|Overall Study||22
363707|NCT01170949|872619|P1|COMPLETED|Overall Study||43
363708|NCT01170949|872618|P2|STARTED|Overall Study||26
363709|NCT01170949|872619|P1|STARTED|Overall Study||50
363710|NCT01170884|872627|P2|NOT COMPLETED|Overall Study||2
363711|NCT01170884|872628|P1|NOT COMPLETED|Overall Study||5
363712|NCT01170884|872627|P2|COMPLETED|Overall Study||60
363713|NCT01170884|872628|P1|COMPLETED|Overall Study||54
363714|NCT01170884|872627|P2|STARTED|Overall Study||62
363715|NCT01170884|872628|P1|STARTED|Overall Study||59
363716|NCT01170754|872636|P2|NOT COMPLETED|Overall Study||0
363717|NCT01170754|872637|P1|NOT COMPLETED|Overall Study||0
363718|NCT01170754|872636|P2|COMPLETED|Overall Study||70
363719|NCT01170754|872637|P1|COMPLETED|Overall Study||66
363720|NCT01170754|872636|P2|STARTED|Overall Study||70
363721|NCT01170754|872637|P1|STARTED|Overall Study||66
363722|NCT01170663|872645|P2|NOT COMPLETED|Overall Study||27
363723|NCT01170663|872646|P1|NOT COMPLETED|Overall Study||24
363724|NCT01170663|872645|P2|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|308
363725|NCT01170663|872646|P1|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|306
363726|NCT01170663|872645|P2|Received Any Treatment (Safety Pop)|Overall Study||329
363727|NCT01170663|872646|P1|Received Any Treatment (Safety Pop)|Overall Study||327
363728|NCT01170663|872645|P2|STARTED|Overall Study||335
363729|NCT01170663|872646|P1|STARTED|Overall Study||330
363730|NCT01170598|872674|P1|NOT COMPLETED|Overall Study||6
363731|NCT01170598|872674|P1|COMPLETED|Overall Study||29
363732|NCT01170598|872674|P1|STARTED|Overall Study||35
363733|NCT01170546|872693|P4|NOT COMPLETED|Overall Study||0
363734|NCT01170546|872694|P3|NOT COMPLETED|Overall Study||0
363735|NCT01170546|872695|P2|NOT COMPLETED|Overall Study||0
363736|NCT01170546|872696|P1|NOT COMPLETED|Overall Study||0
363737|NCT01170546|872693|P4|COMPLETED|Overall Study||8
363738|NCT01170546|872694|P3|COMPLETED|Overall Study||6
363739|NCT01170546|872695|P2|COMPLETED|Overall Study||7
363740|NCT01170546|872696|P1|COMPLETED|Overall Study||7
363741|NCT01170546|872693|P4|STARTED|Overall Study||8
363742|NCT01170546|872694|P3|STARTED|Overall Study||6
363743|NCT01170546|872695|P2|STARTED|Overall Study||7
363744|NCT01170546|872696|P1|STARTED|Overall Study||7
363745|NCT01170533|872706|P2|NOT COMPLETED|Pantoprazole Cross-over||0
363746|NCT01170533|872707|P1|NOT COMPLETED|Pantoprazole Cross-over||0
363747|NCT01170533|872706|P2|COMPLETED|Pantoprazole Cross-over||20
363748|NCT01170533|872707|P1|COMPLETED|Pantoprazole Cross-over||0
363749|NCT01170533|872706|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
363750|NCT01170533|872707|P1|STARTED|Pantoprazole Cross-over||0
363751|NCT01170533|872706|P2|NOT COMPLETED|Omeprazole Cross-over||0
363752|NCT01170533|872707|P1|NOT COMPLETED|Omeprazole Cross-over||0
363753|NCT01170533|872706|P2|COMPLETED|Omeprazole Cross-over||0
363754|NCT01170533|872707|P1|COMPLETED|Omeprazole Cross-over||20
363755|NCT01170533|872706|P2|STARTED|Omeprazole Cross-over||0
363756|NCT01170533|872707|P1|STARTED|Omeprazole Cross-over||20
363757|NCT01170390|872719|P3|NOT COMPLETED|Randomized Treatment||0
363758|NCT01170390|872720|P2|NOT COMPLETED|Randomized Treatment||1
363759|NCT01170390|872721|P1|NOT COMPLETED|Randomized Treatment||0
363760|NCT01170390|872719|P3|COMPLETED|Randomized Treatment||15
363761|NCT01170390|872720|P2|COMPLETED|Randomized Treatment||16
363762|NCT01170390|872721|P1|COMPLETED|Randomized Treatment||0
363763|NCT01170390|872719|P3|STARTED|Randomized Treatment||15
363764|NCT01170390|872720|P2|STARTED|Randomized Treatment||17
363765|NCT01170390|872721|P1|STARTED|Randomized Treatment||0
363766|NCT01170390|872719|P3|NOT COMPLETED|Oral Contraceptives||0
363767|NCT01170390|872720|P2|NOT COMPLETED|Oral Contraceptives||0
363768|NCT01170390|872721|P1|NOT COMPLETED|Oral Contraceptives||1
363769|NCT01170390|872719|P3|COMPLETED|Oral Contraceptives||0
363770|NCT01170390|872720|P2|COMPLETED|Oral Contraceptives||0
363771|NCT01170390|872721|P1|COMPLETED|Oral Contraceptives||31
363772|NCT01170390|872719|P3|STARTED|Oral Contraceptives||0
363773|NCT01170390|872720|P2|STARTED|Oral Contraceptives||0
363774|NCT01170390|872721|P1|STARTED|Oral Contraceptives||32
363775|NCT01170273|872737|P2|NOT COMPLETED|Overall Study||9
363776|NCT01170273|872738|P1|NOT COMPLETED|Overall Study||8
363777|NCT01170273|872737|P2|COMPLETED|Overall Study||57
363778|NCT01170273|872738|P1|COMPLETED|Overall Study||56
363779|NCT01170273|872737|P2|STARTED|Overall Study||66
363780|NCT01170273|872738|P1|STARTED|Overall Study||64
363781|NCT01170221|872746|P2|NOT COMPLETED|Overall Study||28
363782|NCT01170221|872747|P1|NOT COMPLETED|Overall Study||33
363783|NCT01170221|872746|P2|COMPLETED|Overall Study||307
363784|NCT01170221|872747|P1|COMPLETED|Overall Study||299
363785|NCT01170221|872746|P2|STARTED|Overall Study||335
363786|NCT01170221|872747|P1|STARTED|Overall Study||332
363787|NCT01170208|872770|P3|NOT COMPLETED|Overall Study||2
363788|NCT01170208|872771|P2|NOT COMPLETED|Overall Study||0
363789|NCT01170208|872772|P1|NOT COMPLETED|Overall Study||6
363790|NCT01170208|872770|P3|COMPLETED|Overall Study||4
363791|NCT01170208|872771|P2|COMPLETED|Overall Study||20
363792|NCT01170208|872772|P1|COMPLETED|Overall Study||14
363793|NCT01170208|872770|P3|STARTED|Overall Study||6
363794|NCT01170208|872771|P2|STARTED|Overall Study||20
363795|NCT01170208|872772|P1|STARTED|Overall Study||20
363796|NCT01170091|872780|P1|NOT COMPLETED|Overall Study||24
363797|NCT01170091|872780|P1|COMPLETED|Overall Study||627
363798|NCT01170091|872780|P1|STARTED|Overall Study||651
363799|NCT01170039|872789|P2|NOT COMPLETED|Overall Study||6
363800|NCT01170039|872790|P1|NOT COMPLETED|Overall Study||8
363801|NCT01170039|872789|P2|COMPLETED|Overall Study||33
363802|NCT01170039|872790|P1|COMPLETED|Overall Study||29
363803|NCT01170039|872789|P2|STARTED|Overall Study||39
363804|NCT01170039|872790|P1|STARTED|Overall Study||37
363805|NCT01169987|872802|P1|NOT COMPLETED|Overall Study||31
363806|NCT01169987|872802|P1|COMPLETED|Overall Study||160
363807|NCT01169987|872802|P1|STARTED|Overall Study||191
363808|NCT01169779|872868|P2|NOT COMPLETED|Overall Study||17
363809|NCT01169779|872869|P1|NOT COMPLETED|Overall Study||11
363810|NCT01169779|872868|P2|COMPLETED|Overall Study||179
363811|NCT01169779|872869|P1|COMPLETED|Overall Study||184
363812|NCT01169779|872868|P2|Subgroup for Standardized Meal Test|Overall Study||121
363813|NCT01169779|872869|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
363814|NCT01169779|872868|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
363815|NCT01169779|872869|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
363816|NCT01169779|872868|P2|Treated/Safety Population|Overall Study||196
363817|NCT01169779|872869|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
363818|NCT01169779|872868|P2|STARTED|Overall Study||196
363819|NCT01169779|872869|P1|STARTED|Overall Study|Randomized.|195
363820|NCT01169753|872895|P2|NOT COMPLETED|Overall Study||1
363821|NCT01169753|872896|P1|NOT COMPLETED|Overall Study||0
363822|NCT01169753|872895|P2|COMPLETED|Overall Study||0
363823|NCT01169753|872896|P1|COMPLETED|Overall Study||0
363824|NCT01169753|872895|P2|STARTED|Overall Study||1
363825|NCT01169753|872896|P1|STARTED|Overall Study||0
363826|NCT01169701|872904|P2|NOT COMPLETED|Overall Study||10
363827|NCT01169701|872905|P1|NOT COMPLETED|Overall Study||5
363828|NCT01169701|872904|P2|COMPLETED|Overall Study||25
363829|NCT01169701|872905|P1|COMPLETED|Overall Study||31
363830|NCT01169701|872904|P2|Intent to Treat (ITT) Set|Overall Study||28
363831|NCT01169701|872905|P1|Intent to Treat (ITT) Set|Overall Study||32
363832|NCT01169701|872904|P2|Safety Set|Overall Study||35
363833|NCT01169701|872905|P1|Safety Set|Overall Study||36
363834|NCT01169701|872904|P2|STARTED|Overall Study||35
363835|NCT01169701|872905|P1|STARTED|Overall Study||36
363836|NCT01169675|872942|P5|NOT COMPLETED|Overall Study||6
363837|NCT01169675|872943|P4|NOT COMPLETED|Overall Study||17
363838|NCT01169675|872944|P3|NOT COMPLETED|Overall Study||7
363839|NCT01169675|872945|P2|NOT COMPLETED|Overall Study||3
363840|NCT01169675|872946|P1|NOT COMPLETED|Overall Study||20
363841|NCT01169675|872942|P5|COMPLETED|Overall Study||0
363842|NCT01169675|872943|P4|COMPLETED|Overall Study||0
363843|NCT01169675|872944|P3|COMPLETED|Overall Study||0
363844|NCT01169675|872945|P2|COMPLETED|Overall Study||0
363845|NCT01169675|872946|P1|COMPLETED|Overall Study||0
363846|NCT01169675|872942|P5|STARTED|Overall Study||6
363847|NCT01169675|872943|P4|STARTED|Overall Study||17
363848|NCT01169675|872944|P3|STARTED|Overall Study||7
363849|NCT01169675|872945|P2|STARTED|Overall Study||3
363850|NCT01169675|872946|P1|STARTED|Overall Study||20
363851|NCT01169649|872983|P1|NOT COMPLETED|Overall Study||3
363852|NCT01169649|872983|P1|COMPLETED|Overall Study||8
363853|NCT01169649|872983|P1|STARTED|Overall Study||11
363854|NCT01169610|872987|P1|NOT COMPLETED|Overall Study||0
363855|NCT01169610|872987|P1|COMPLETED|Overall Study||1
363856|NCT01169610|872987|P1|STARTED|Overall Study||1
363857|NCT01169558|872995|P1|NOT COMPLETED|Overall Study||156
363858|NCT01169558|872995|P1|COMPLETED|Overall Study||6
363859|NCT01169558|872995|P1|STARTED|Overall Study||162
363860|NCT01169519|873002|P1|NOT COMPLETED|Overall Study||0
363861|NCT01169519|873002|P1|COMPLETED|Overall Study||21
363862|NCT01169519|873002|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
363863|NCT01169493|873020|P6|NOT COMPLETED|Period 3 (6 Months)||0
363864|NCT01169493|873021|P5|NOT COMPLETED|Period 3 (6 Months)||0
363865|NCT01169493|873022|P4|NOT COMPLETED|Period 3 (6 Months)||0
363866|NCT01169493|873023|P3|NOT COMPLETED|Period 3 (6 Months)||1
363867|NCT01169493|873024|P2|NOT COMPLETED|Period 3 (6 Months)||2
363868|NCT01169493|873025|P1|NOT COMPLETED|Period 3 (6 Months)||0
363869|NCT01169493|873020|P6|COMPLETED|Period 3 (6 Months)||2
363870|NCT01169493|873021|P5|COMPLETED|Period 3 (6 Months)||0
363871|NCT01169493|873022|P4|COMPLETED|Period 3 (6 Months)||0
363872|NCT01169493|873023|P3|COMPLETED|Period 3 (6 Months)||2
363873|NCT01169493|873024|P2|COMPLETED|Period 3 (6 Months)||1
363874|NCT01169493|873025|P1|COMPLETED|Period 3 (6 Months)||2
363875|NCT01169493|873020|P6|STARTED|Period 3 (6 Months)||2
363876|NCT01169493|873021|P5|STARTED|Period 3 (6 Months)||0
363877|NCT01169493|873022|P4|STARTED|Period 3 (6 Months)||0
363878|NCT01169493|873023|P3|STARTED|Period 3 (6 Months)||3
363879|NCT01169493|873024|P2|STARTED|Period 3 (6 Months)||3
363880|NCT01169493|873025|P1|STARTED|Period 3 (6 Months)||2
363881|NCT01169493|873020|P6|NOT COMPLETED|Period 2 (6 Months)||0
363882|NCT01169493|873021|P5|NOT COMPLETED|Period 2 (6 Months)||0
363883|NCT01169493|873022|P4|NOT COMPLETED|Period 2 (6 Months)||0
363884|NCT01169493|873023|P3|NOT COMPLETED|Period 2 (6 Months)||0
363885|NCT01169493|873024|P2|NOT COMPLETED|Period 2 (6 Months)||0
363886|NCT01169493|873025|P1|NOT COMPLETED|Period 2 (6 Months)||0
363887|NCT01169493|873020|P6|COMPLETED|Period 2 (6 Months)||2
363888|NCT01169493|873021|P5|COMPLETED|Period 2 (6 Months)||0
363889|NCT01169493|873022|P4|COMPLETED|Period 2 (6 Months)||0
363890|NCT01169493|873023|P3|COMPLETED|Period 2 (6 Months)||3
363891|NCT01169493|873024|P2|COMPLETED|Period 2 (6 Months)||3
363892|NCT01169493|873025|P1|COMPLETED|Period 2 (6 Months)||2
363893|NCT01169493|873020|P6|STARTED|Period 2 (6 Months)||2
363894|NCT01169493|873021|P5|STARTED|Period 2 (6 Months)||0
363895|NCT01169493|873022|P4|STARTED|Period 2 (6 Months)||0
363896|NCT01169493|873023|P3|STARTED|Period 2 (6 Months)||3
363897|NCT01169493|873024|P2|STARTED|Period 2 (6 Months)||3
363898|NCT01169493|873025|P1|STARTED|Period 2 (6 Months)||2
363899|NCT01169493|873020|P6|NOT COMPLETED|Period 1 (6 Months)||3
363900|NCT01169493|873021|P5|NOT COMPLETED|Period 1 (6 Months)||0
363901|NCT01169493|873022|P4|NOT COMPLETED|Period 1 (6 Months)||0
363902|NCT01169493|873023|P3|NOT COMPLETED|Period 1 (6 Months)||2
363903|NCT01169493|873024|P2|NOT COMPLETED|Period 1 (6 Months)||1
363904|NCT01169493|873025|P1|NOT COMPLETED|Period 1 (6 Months)||0
363905|NCT01169493|873020|P6|COMPLETED|Period 1 (6 Months)||2
363906|NCT01169493|873021|P5|COMPLETED|Period 1 (6 Months)||0
363907|NCT01169493|873022|P4|COMPLETED|Period 1 (6 Months)||0
363908|NCT01169493|873023|P3|COMPLETED|Period 1 (6 Months)||3
363909|NCT01169493|873024|P2|COMPLETED|Period 1 (6 Months)||3
363910|NCT01169493|873025|P1|COMPLETED|Period 1 (6 Months)||2
363911|NCT01169493|873020|P6|STARTED|Period 1 (6 Months)||5
363912|NCT01169493|873021|P5|STARTED|Period 1 (6 Months)||0
363913|NCT01169493|873022|P4|STARTED|Period 1 (6 Months)||0
363914|NCT01169493|873023|P3|STARTED|Period 1 (6 Months)||5
363915|NCT01169493|873024|P2|STARTED|Period 1 (6 Months)||4
363916|NCT01169493|873025|P1|STARTED|Period 1 (6 Months)||2
363917|NCT01169467|873056|P2|NOT COMPLETED|Overall Study||4
363918|NCT01169467|873057|P1|NOT COMPLETED|Overall Study||7
363919|NCT01169467|873056|P2|COMPLETED|Overall Study||36
363920|NCT01169467|873057|P1|COMPLETED|Overall Study||37
363921|NCT01169467|873056|P2|STARTED|Overall Study||40
363922|NCT01169467|873057|P1|STARTED|Overall Study||44
363923|NCT01169311|873071|P1|NOT COMPLETED|Overall Study||0
363924|NCT01169311|873071|P1|COMPLETED|Overall Study||27
363925|NCT01169311|873071|P1|STARTED|Overall Study||27
363926|NCT01169103|873085|P2|NOT COMPLETED|Overall Study||4
363927|NCT01169103|873086|P1|NOT COMPLETED|Overall Study||6
363928|NCT01169103|873085|P2|COMPLETED|Overall Study||7
363929|NCT01169103|873086|P1|COMPLETED|Overall Study||5
363930|NCT01169103|873085|P2|STARTED|Overall Study||11
363931|NCT01169103|873086|P1|STARTED|Overall Study||11
363932|NCT01169064|873102|P2|NOT COMPLETED|Overall Study||0
363933|NCT01169064|873103|P1|NOT COMPLETED|Overall Study||0
363934|NCT01169064|873102|P2|COMPLETED|Overall Study||236
363935|NCT01169064|873103|P1|COMPLETED|Overall Study||239
363936|NCT01169064|873102|P2|STARTED|Overall Study||236
363937|NCT01169064|873103|P1|STARTED|Overall Study||239
363938|NCT01169038|873113|P1|NOT COMPLETED|Overall Study||7
363939|NCT01169038|873113|P1|COMPLETED|Overall Study||8
363940|NCT01169038|873113|P1|STARTED|Overall Study||15
363941|NCT01168999|873121|P4|NOT COMPLETED|Overall Study||0
363942|NCT01168999|873122|P3|NOT COMPLETED|Overall Study||0
363943|NCT01168999|873123|P2|NOT COMPLETED|Overall Study||1
363944|NCT01168999|873124|P1|NOT COMPLETED|Overall Study||2
363945|NCT01168999|873121|P4|COMPLETED|Overall Study||28
363946|NCT01168999|873122|P3|COMPLETED|Overall Study||27
363947|NCT01168999|873123|P2|COMPLETED|Overall Study||26
363948|NCT01168999|873124|P1|COMPLETED|Overall Study||26
363949|NCT01168999|873121|P4|STARTED|Overall Study||28
363950|NCT01168999|873122|P3|STARTED|Overall Study||27
363951|NCT01168999|873123|P2|STARTED|Overall Study||27
363952|NCT01168999|873124|P1|STARTED|Overall Study||28
363953|NCT01168986|873169|P3|NOT COMPLETED|Overall Study||0
363954|NCT01168986|873170|P2|NOT COMPLETED|Overall Study||1
363955|NCT01168986|873171|P1|NOT COMPLETED|Overall Study||2
363956|NCT01168986|873169|P3|COMPLETED|Overall Study||21
363957|NCT01168986|873170|P2|COMPLETED|Overall Study||20
363958|NCT01168986|873171|P1|COMPLETED|Overall Study||18
363959|NCT01168986|873169|P3|STARTED|Overall Study||21
363960|NCT01168986|873170|P2|STARTED|Overall Study||21
363961|NCT01168986|873171|P1|STARTED|Overall Study||20
363962|NCT01168973|873190|P2|NOT COMPLETED|Overall Study||33
363963|NCT01168973|873191|P1|NOT COMPLETED|Overall Study||34
363964|NCT01168973|873190|P2|COMPLETED|Overall Study||592
363965|NCT01168973|873191|P1|COMPLETED|Overall Study||594
363966|NCT01168973|873190|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
363967|NCT01168973|873191|P1|Received Any Quantity of Any Study Drug|Overall Study||624
363968|NCT01168973|873190|P2|STARTED|Overall Study||625
363969|NCT01168973|873191|P1|STARTED|Overall Study||628
363970|NCT01168934|873212|P2|NOT COMPLETED|Second Intervention Period||0
363971|NCT01168934|873213|P1|NOT COMPLETED|Second Intervention Period||0
363972|NCT01168934|873212|P2|COMPLETED|Second Intervention Period||7
363973|NCT01168934|873213|P1|COMPLETED|Second Intervention Period||7
363974|NCT01168934|873212|P2|STARTED|Second Intervention Period||7
363975|NCT01168934|873213|P1|STARTED|Second Intervention Period||7
363976|NCT01168934|873212|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
363977|NCT01168934|873213|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
363978|NCT01168934|873212|P2|COMPLETED|Washout Period (at Least 14 Days)||7
363979|NCT01168934|873213|P1|COMPLETED|Washout Period (at Least 14 Days)||7
363980|NCT01168934|873212|P2|STARTED|Washout Period (at Least 14 Days)||7
363981|NCT01168934|873213|P1|STARTED|Washout Period (at Least 14 Days)||7
363982|NCT01168934|873212|P2|NOT COMPLETED|First Intervention Period||0
363983|NCT01168934|873213|P1|NOT COMPLETED|First Intervention Period||0
363984|NCT01168934|873212|P2|COMPLETED|First Intervention Period||7
363985|NCT01168934|873213|P1|COMPLETED|First Intervention Period||7
363986|NCT01168934|873212|P2|STARTED|First Intervention Period||7
363987|NCT01168934|873213|P1|STARTED|First Intervention Period||7
363988|NCT01168856|873247|P2|NOT COMPLETED|Overall Study||343
363989|NCT01168856|873248|P1|NOT COMPLETED|Overall Study||18
363990|NCT01168856|873247|P2|COMPLETED|Overall Study||215
363991|NCT01168856|873248|P1|COMPLETED|Overall Study||158
363992|NCT01168856|873247|P2|STARTED|Overall Study||558
363993|NCT01168856|873248|P1|STARTED|Overall Study||176
363994|NCT01168726|873308|P3|NOT COMPLETED|Overall Study||5
363995|NCT01168726|873309|P2|NOT COMPLETED|Overall Study||9
363996|NCT01168726|873310|P1|NOT COMPLETED|Overall Study||8
363997|NCT01168726|873308|P3|COMPLETED|Overall Study||128
363998|NCT01168726|873309|P2|COMPLETED|Overall Study||112
363999|NCT01168726|873310|P1|COMPLETED|Overall Study||103
364000|NCT01168726|873308|P3|STARTED|Overall Study||133
364001|NCT01168726|873309|P2|STARTED|Overall Study||121
364002|NCT01168726|873310|P1|STARTED|Overall Study||111
364003|NCT01168687|873329|P2|NOT COMPLETED|Overall Study||0
364004|NCT01168687|873330|P1|NOT COMPLETED|Overall Study||0
364005|NCT01168687|873329|P2|COMPLETED|Overall Study||23
364006|NCT01168687|873330|P1|COMPLETED|Overall Study||23
364007|NCT01168687|873329|P2|STARTED|Overall Study||23
364008|NCT01168687|873330|P1|STARTED|Overall Study||23
364009|NCT01168674|873336|P2|NOT COMPLETED|Overall Study||0
364010|NCT01168674|873337|P1|NOT COMPLETED|Overall Study||0
364011|NCT01168674|873336|P2|COMPLETED|Overall Study||24
364012|NCT01168674|873337|P1|COMPLETED|Overall Study||25
364013|NCT01168674|873336|P2|STARTED|Overall Study||24
364014|NCT01168674|873337|P1|STARTED|Overall Study||25
364015|NCT01168596|873346|P2|NOT COMPLETED|Overall Study||1
364016|NCT01168596|873347|P1|NOT COMPLETED|Overall Study||3
364017|NCT01168596|873346|P2|COMPLETED|Overall Study||13
364018|NCT01168596|873347|P1|COMPLETED|Overall Study||13
364019|NCT01168596|873346|P2|STARTED|Overall Study||14
364020|NCT01168596|873347|P1|STARTED|Overall Study||16
364021|NCT01168427|873391|P1|NOT COMPLETED|Overall Study||1
364022|NCT01168427|873391|P1|COMPLETED|Overall Study||65
364023|NCT01168427|873391|P1|STARTED|Overall Study||66
364024|NCT01168349|873396|P1|NOT COMPLETED|Overall Study||301
364025|NCT01168349|873396|P1|COMPLETED|Overall Study||754
364026|NCT01168349|873396|P1|STARTED|Overall Study||1055
364027|NCT01168232|873502|P1|NOT COMPLETED|Overall Study||8
364028|NCT01168232|873502|P1|COMPLETED|Overall Study|Eligible and treated patients|34
364029|NCT01168232|873502|P1|STARTED|Overall Study||42
364030|NCT01168024|873511|P2|NOT COMPLETED|Overall Study||0
364031|NCT01168024|873512|P1|NOT COMPLETED|Overall Study||0
364032|NCT01168024|873511|P2|COMPLETED|Overall Study||3
364033|NCT01168024|873512|P1|COMPLETED|Overall Study||13
364034|NCT01168024|873511|P2|STARTED|Overall Study||3
364035|NCT01168024|873512|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
364036|NCT01167881|873526|P2|NOT COMPLETED|Overall Study||191
364037|NCT01167881|873527|P1|NOT COMPLETED|Overall Study||159
364038|NCT01167881|873526|P2|COMPLETED|Overall Study||589
364039|NCT01167881|873527|P1|COMPLETED|Overall Study||610
364040|NCT01167881|873526|P2|Completed After 4 Years Treatment|Overall Study||462
364041|NCT01167881|873527|P1|Completed After 4 Years Treatment|Overall Study||515
364042|NCT01167881|873526|P2|Completed After 2 Years Treatment|Overall Study||127
364043|NCT01167881|873527|P1|Completed After 2 Years Treatment|Overall Study||95
364044|NCT01167881|873526|P2|STARTED|Overall Study||780
364045|NCT01167881|873527|P1|STARTED|Overall Study||769
364046|NCT01167829|873551|P1|NOT COMPLETED|Overall Study||0
364047|NCT01167829|873551|P1|COMPLETED|Overall Study||12
364048|NCT01167829|873551|P1|STARTED|Overall Study||12
364049|NCT01167608|873564|P1|NOT COMPLETED|Overall Study||114
364050|NCT01167608|873564|P1|COMPLETED|Overall Study||769
364051|NCT01167608|873564|P1|STARTED|Overall Study||883
364052|NCT01167582|873575|P2|NOT COMPLETED|Overall Study||1
364053|NCT01167582|873576|P1|NOT COMPLETED|Overall Study||0
364054|NCT01167582|873575|P2|COMPLETED|Overall Study||54
364055|NCT01167582|873576|P1|COMPLETED|Overall Study||55
364056|NCT01167582|873575|P2|STARTED|Overall Study||55
364057|NCT01167582|873576|P1|STARTED|Overall Study||55
364058|NCT01167504|873588|P1|NOT COMPLETED|Overall Study||3
364059|NCT01167504|873588|P1|COMPLETED|Overall Study||12
364060|NCT01167504|873588|P1|STARTED|Overall Study||15
364061|NCT01167452|873593|P1|NOT COMPLETED|Overall Study||0
364062|NCT01167452|873593|P1|COMPLETED|Overall Study||36
364063|NCT01167452|873593|P1|STARTED|Overall Study||36
364064|NCT01167426|873598|P1|NOT COMPLETED|Overall Study||10
364065|NCT01167426|873598|P1|COMPLETED|Overall Study||138
364066|NCT01167426|873598|P1|STARTED|Overall Study||148
364067|NCT01167257|873606|P2|NOT COMPLETED|Overall Study||3
364068|NCT01167257|873607|P1|NOT COMPLETED|Overall Study||3
364069|NCT01167257|873606|P2|COMPLETED|Overall Study||28
364070|NCT01167257|873607|P1|COMPLETED|Overall Study||28
364071|NCT01167257|873606|P2|STARTED|Overall Study||31
364072|NCT01167257|873607|P1|STARTED|Overall Study||31
364073|NCT01167192|873629|P1|NOT COMPLETED|Overall Study||4
364074|NCT01167192|873629|P1|COMPLETED|Overall Study||6
364075|NCT01167192|873629|P1|STARTED|Overall Study||10
364076|NCT01167153|873646|P2|NOT COMPLETED|Overall Study||33
364077|NCT01167153|873647|P1|NOT COMPLETED|Overall Study||18
364078|NCT01167153|873646|P2|COMPLETED|Overall Study||249
364079|NCT01167153|873647|P1|COMPLETED|Overall Study||264
364080|NCT01167153|873646|P2|Intention to Treat (ITT)|Overall Study||268
364081|NCT01167153|873647|P1|Intention to Treat (ITT)|Overall Study||272
364082|NCT01167153|873646|P2|STARTED|Overall Study||282
364083|NCT01167153|873647|P1|STARTED|Overall Study||282
364084|NCT01167140|873665|P1|NOT COMPLETED|Overall Study||1
364085|NCT01167140|873665|P1|COMPLETED|Overall Study||41
364086|NCT01167140|873665|P1|STARTED|Overall Study||42
364087|NCT01167023|873673|P3|NOT COMPLETED|Overall Study||2
364088|NCT01167023|873674|P2|NOT COMPLETED|Overall Study||3
364089|NCT01167023|873675|P1|NOT COMPLETED|Overall Study||0
364090|NCT01167023|873673|P3|COMPLETED|Overall Study||39
364091|NCT01167023|873674|P2|COMPLETED|Overall Study||18
364092|NCT01167023|873675|P1|COMPLETED|Overall Study||0
364093|NCT01167023|873673|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
364094|NCT01167023|873674|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
364095|NCT01167023|873675|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
364096|NCT01167023|873673|P3|STARTED|Overall Study||41
364097|NCT01167023|873674|P2|STARTED|Overall Study||21
364098|NCT01167023|873675|P1|STARTED|Overall Study||0
364099|NCT01166997|873695|P2|NOT COMPLETED|Overall Study||0
364100|NCT01166997|873696|P1|NOT COMPLETED|Overall Study||2
364101|NCT01166997|873695|P2|COMPLETED|Overall Study||30
364102|NCT01166997|873696|P1|COMPLETED|Overall Study||27
364103|NCT01166997|873695|P2|STARTED|Overall Study||30
364104|NCT01166997|873696|P1|STARTED|Overall Study||29
364105|NCT01166971|873706|P2|NOT COMPLETED|Overall Study||1
364106|NCT01166971|873707|P1|NOT COMPLETED|Overall Study||1
364107|NCT01166971|873706|P2|COMPLETED|Overall Study||30
364108|NCT01166971|873707|P1|COMPLETED|Overall Study||32
364109|NCT01166971|873706|P2|STARTED|Overall Study||31
364110|NCT01166971|873707|P1|STARTED|Overall Study||33
364111|NCT01166958|873715|P2|NOT COMPLETED|Overall Study||0
364112|NCT01166958|873716|P1|NOT COMPLETED|Overall Study||1
364113|NCT01166958|873715|P2|COMPLETED|Overall Study||13
364114|NCT01166958|873716|P1|COMPLETED|Overall Study||12
364115|NCT01166958|873715|P2|STARTED|Overall Study||13
364116|NCT01166958|873716|P1|STARTED|Overall Study||13
364117|NCT01166763|873730|P1|NOT COMPLETED|Overall Study||3
364118|NCT01166763|873730|P1|COMPLETED|Overall Study||27
364119|NCT01166763|873730|P1|STARTED|Overall Study||30
364120|NCT01166750|873738|P2|NOT COMPLETED|Overall Study||0
364121|NCT01166750|873739|P1|NOT COMPLETED|Overall Study||1
364122|NCT01166750|873738|P2|COMPLETED|Overall Study||13
364123|NCT01166750|873739|P1|COMPLETED|Overall Study||9
364124|NCT01166750|873738|P2|STARTED|Overall Study||13
364125|NCT01166750|873739|P1|STARTED|Overall Study||10
364126|NCT01166724|873747|P2|NOT COMPLETED|Overall Study||5
364127|NCT01166724|873748|P1|NOT COMPLETED|Overall Study||7
364128|NCT01166724|873747|P2|COMPLETED|Overall Study||0
364129|NCT01166724|873748|P1|COMPLETED|Overall Study||0
364130|NCT01166724|873747|P2|STARTED|Overall Study||5
364131|NCT01166724|873748|P1|STARTED|Overall Study||7
364132|NCT01166659|873756|P1|NOT COMPLETED|Overall Study||13
364133|NCT01166659|873756|P1|COMPLETED|Overall Study||35
364134|NCT01166659|873756|P1|STARTED|Overall Study||48
364135|NCT01166646|873765|P2|NOT COMPLETED|Overall Study||1
364136|NCT01166646|873766|P1|NOT COMPLETED|Overall Study||1
364137|NCT01166646|873765|P2|COMPLETED|Overall Study||21
364138|NCT01166646|873766|P1|COMPLETED|Overall Study||20
364139|NCT01166646|873765|P2|STARTED|Overall Study||22
364140|NCT01166646|873766|P1|STARTED|Overall Study||21
364141|NCT01166282|873784|P3|NOT COMPLETED|Open-label Period||17
364142|NCT01166282|873785|P2|NOT COMPLETED|Open-label Period||0
364143|NCT01166282|873786|P1|NOT COMPLETED|Open-label Period||0
364144|NCT01166282|873784|P3|COMPLETED|Open-label Period||29
364145|NCT01166282|873785|P2|COMPLETED|Open-label Period||0
364146|NCT01166282|873786|P1|COMPLETED|Open-label Period||0
364147|NCT01166282|873784|P3|STARTED|Open-label Period||46
364148|NCT01166282|873785|P2|STARTED|Open-label Period||0
364149|NCT01166282|873786|P1|STARTED|Open-label Period||0
364150|NCT01166282|873784|P3|NOT COMPLETED|Double-blind Period||0
364151|NCT01166282|873785|P2|NOT COMPLETED|Double-blind Period||0
364152|NCT01166282|873786|P1|NOT COMPLETED|Double-blind Period||0
364153|NCT01166282|873784|P3|COMPLETED|Double-blind Period||0
364154|NCT01166282|873785|P2|COMPLETED|Double-blind Period||31
364155|NCT01166282|873786|P1|COMPLETED|Double-blind Period||15
364156|NCT01166282|873784|P3|STARTED|Double-blind Period||0
364157|NCT01166282|873785|P2|STARTED|Double-blind Period||31
364158|NCT01166282|873786|P1|STARTED|Double-blind Period||15
364159|NCT01166230|873810|P2|NOT COMPLETED|Overall Study||16
364160|NCT01166230|873811|P1|NOT COMPLETED|Overall Study||19
364161|NCT01166230|873810|P2|COMPLETED|Overall Study||255
364162|NCT01166230|873811|P1|COMPLETED|Overall Study||261
364163|NCT01166230|873810|P2|STARTED|Overall Study||271
364164|NCT01166230|873811|P1|STARTED|Overall Study||280
364165|NCT01166178|873825|P2|NOT COMPLETED|Overall Study||8
364166|NCT01166178|873826|P1|NOT COMPLETED|Overall Study||21
364167|NCT01166178|873825|P2|COMPLETED|Overall Study||0
364168|NCT01166178|873826|P1|COMPLETED|Overall Study||0
364169|NCT01166178|873825|P2|STARTED|Overall Study||8
364170|NCT01166178|873826|P1|STARTED|Overall Study||21
364171|NCT01166126|873852|P1|NOT COMPLETED|Overall Study||0
364172|NCT01166126|873852|P1|COMPLETED|Overall Study||4
364173|NCT01166126|873852|P1|STARTED|Overall Study||4
364174|NCT01165996|873859|P1|NOT COMPLETED|Overall Study||2
364175|NCT01165996|873859|P1|COMPLETED|Overall Study||23
364176|NCT01165996|873859|P1|Maintenance Phase|Overall Study||23
364177|NCT01165996|873859|P1|Induction Phase|Overall Study||25
364178|NCT01165996|873859|P1|STARTED|Overall Study||25
364179|NCT01165983|873867|P2|NOT COMPLETED|Overall Study||7
364180|NCT01165983|873868|P1|NOT COMPLETED|Overall Study||5
364181|NCT01165983|873867|P2|COMPLETED|Overall Study||42
364182|NCT01165983|873868|P1|COMPLETED|Overall Study||46
364183|NCT01165983|873867|P2|STARTED|Overall Study||49
364184|NCT01165983|873868|P1|STARTED|Overall Study||51
364185|NCT01165840|873912|P1|NOT COMPLETED|Overall Study||0
364186|NCT01165840|873912|P1|COMPLETED|Overall Study||36
364187|NCT01165840|873912|P1|STARTED|Overall Study||36
364188|NCT01165775|873916|P1|NOT COMPLETED|Overall Study||2
364189|NCT01165775|873916|P1|COMPLETED|Overall Study||15
364190|NCT01165775|873916|P1|STARTED|Overall Study||17
364191|NCT01165684|873926|P2|NOT COMPLETED|Overall Study||52
364192|NCT01165684|873927|P1|NOT COMPLETED|Overall Study||28
364193|NCT01165684|873926|P2|COMPLETED|Overall Study||148
364194|NCT01165684|873927|P1|COMPLETED|Overall Study||173
364195|NCT01165684|873926|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
364196|NCT01165684|873927|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
364197|NCT01165684|873926|P2|STARTED|Overall Study||200
364198|NCT01165684|873927|P1|STARTED|Overall Study||201
364199|NCT01165554|873961|P1|NOT COMPLETED|Overall Study||23
364200|NCT01165554|873961|P1|COMPLETED|Overall Study||180
364201|NCT01165554|873961|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
364202|NCT01165541|873968|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
364203|NCT01165541|873968|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
364204|NCT01165541|873968|P1|STARTED|Quetiapine XR and Mirtazepine||16
364205|NCT01165541|873968|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
364206|NCT01165541|873968|P1|COMPLETED|Quetiapine XR Monotherapy||16
364207|NCT01165541|873968|P1|STARTED|Quetiapine XR Monotherapy||20
364208|NCT01165450|873974|P1|NOT COMPLETED|Overall Study||0
364209|NCT01165450|873974|P1|COMPLETED|Overall Study||2
364210|NCT01165450|873974|P1|STARTED|Overall Study||2
364211|NCT01165424|873984|P1|NOT COMPLETED|Overall Study||4
364212|NCT01165424|873984|P1|COMPLETED|Overall Study||76
364213|NCT01165424|873984|P1|STARTED|Overall Study||80
364214|NCT01165320|873991|P3|NOT COMPLETED|Overall Study||0
364215|NCT01165320|873992|P2|NOT COMPLETED|Overall Study||4
364216|NCT01165320|873993|P1|NOT COMPLETED|Overall Study||3
364217|NCT01165320|873991|P3|COMPLETED|Overall Study||0
364218|NCT01165320|873992|P2|COMPLETED|Overall Study||4
364219|NCT01165320|873993|P1|COMPLETED|Overall Study||9
364220|NCT01165320|873991|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
364221|NCT01165320|873992|P2|STARTED|Overall Study||8
364222|NCT01165320|873993|P1|STARTED|Overall Study||12
364223|NCT01165307|874003|P2|NOT COMPLETED|Overall Study||3
364224|NCT01165307|874004|P1|NOT COMPLETED|Overall Study||14
364225|NCT01165307|874003|P2|COMPLETED|Overall Study||31
364226|NCT01165307|874004|P1|COMPLETED|Overall Study||19
364227|NCT01165307|874003|P2|STARTED|Overall Study||34
364228|NCT01165307|874004|P1|STARTED|Overall Study||33
364229|NCT01165281|874034|P2|NOT COMPLETED|Overall Study||51
364230|NCT01165281|874035|P1|NOT COMPLETED|Overall Study||58
364231|NCT01165281|874034|P2|COMPLETED|Overall Study||121
364232|NCT01165281|874035|P1|COMPLETED|Overall Study||110
364233|NCT01165281|874034|P2|STARTED|Overall Study||172
364234|NCT01165281|874035|P1|STARTED|Overall Study||168
364235|NCT01165242|874056|P3|NOT COMPLETED|Overall Study||14
364236|NCT01165242|874057|P2|NOT COMPLETED|Overall Study||10
364237|NCT01165242|874058|P1|NOT COMPLETED|Overall Study||10
364238|NCT01165242|874056|P3|COMPLETED|Overall Study||324
364239|NCT01165242|874057|P2|COMPLETED|Overall Study||326
364240|NCT01165242|874058|P1|COMPLETED|Overall Study||327
364241|NCT01165242|874056|P3|STARTED|Overall Study||338
364242|NCT01165242|874057|P2|STARTED|Overall Study||336
364243|NCT01165242|874058|P1|STARTED|Overall Study||337
364244|NCT01165216|874092|P2|NOT COMPLETED|Overall Study||7
364245|NCT01165216|874093|P1|NOT COMPLETED|Overall Study||8
364246|NCT01165216|874092|P2|COMPLETED|Overall Study|Completed=still on study drug|0
364247|NCT01165216|874093|P1|COMPLETED|Overall Study|Completed=still on study drug|0
364248|NCT01165216|874092|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
364249|NCT01165216|874093|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
364250|NCT01165216|874092|P2|STARTED|Overall Study|Participants who received any study drug|7
364251|NCT01165216|874093|P1|STARTED|Overall Study|Participants who received any study drug|8
364252|NCT01165203|874115|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
364253|NCT01165203|874116|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
364254|NCT01165203|874115|P2|COMPLETED|Extended Safety Follow-up Phase||45
364255|NCT01165203|874116|P1|COMPLETED|Extended Safety Follow-up Phase||67
364256|NCT01165203|874115|P2|STARTED|Extended Safety Follow-up Phase||49
364257|NCT01165203|874116|P1|STARTED|Extended Safety Follow-up Phase||74
364258|NCT01165203|874115|P2|NOT COMPLETED|Active Phase||2
364259|NCT01165203|874116|P1|NOT COMPLETED|Active Phase||5
364260|NCT01165203|874115|P2|COMPLETED|Active Phase||47
364261|NCT01165203|874116|P1|COMPLETED|Active Phase||69
364262|NCT01165203|874115|P2|STARTED|Active Phase||49
364263|NCT01165203|874116|P1|STARTED|Active Phase||74
364264|NCT01165177|874206|P2|NOT COMPLETED|Overall Study||902
364265|NCT01165177|874207|P1|NOT COMPLETED|Overall Study||922
364266|NCT01165177|874206|P2|COMPLETED|Overall Study||6808
364267|NCT01165177|874207|P1|COMPLETED|Overall Study||6773
364268|NCT01165177|874206|P2|STARTED|Overall Study||7710
364269|NCT01165177|874207|P1|STARTED|Overall Study||7695
364270|NCT01165138|874332|P4|NOT COMPLETED|Overall Study||22
364271|NCT01165138|874333|P3|NOT COMPLETED|Overall Study||20
364272|NCT01165138|874334|P2|NOT COMPLETED|Overall Study||52
364273|NCT01165138|874335|P1|NOT COMPLETED|Overall Study||0
364274|NCT01165138|874332|P4|COMPLETED|Overall Study||179
364275|NCT01165138|874333|P3|COMPLETED|Overall Study||185
364276|NCT01165138|874334|P2|COMPLETED|Overall Study||151
364277|NCT01165138|874335|P1|COMPLETED|Overall Study||0
364278|NCT01165138|874332|P4|STARTED|Overall Study||201
364279|NCT01165138|874333|P3|STARTED|Overall Study||205
364280|NCT01165138|874334|P2|STARTED|Overall Study||203
364281|NCT01165138|874335|P1|STARTED|Overall Study||0
364282|NCT01165112|874394|P1|NOT COMPLETED|Overall Study||0
364283|NCT01165112|874394|P1|COMPLETED|Overall Study||48
364284|NCT01165112|874394|P1|STARTED|Overall Study||48
364285|NCT01165047|874401|P1|NOT COMPLETED|Overall Study||0
364286|NCT01165047|874401|P1|COMPLETED|Overall Study||10
364287|NCT01165047|874401|P1|STARTED|Overall Study||10
364288|NCT01165021|874405|P1|NOT COMPLETED|Overall Study||1
364289|NCT01165021|874405|P1|COMPLETED|Overall Study||18
364290|NCT01165021|874405|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
364291|NCT01165021|874405|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
364292|NCT01165021|874405|P1|≥1 Dose Chemo|Overall Study||19
364293|NCT01165021|874405|P1|STARTED|Overall Study||19
364294|NCT01164891|874413|P1|NOT COMPLETED|Overall Study||6
364295|NCT01164891|874413|P1|COMPLETED|Overall Study||1
364296|NCT01164891|874413|P1|STARTED|Overall Study||7
364297|NCT01164865|874433|P2|NOT COMPLETED|Overall Study||1
364298|NCT01164865|874434|P1|NOT COMPLETED|Overall Study||2
364299|NCT01164865|874433|P2|COMPLETED|Overall Study||38
364300|NCT01164865|874434|P1|COMPLETED|Overall Study||37
364301|NCT01164865|874433|P2|STARTED|Overall Study||39
364302|NCT01164865|874434|P1|STARTED|Overall Study||39
364303|NCT01164722|874444|P2|NOT COMPLETED|Overall Study||15
364304|NCT01164722|874445|P1|NOT COMPLETED|Overall Study||18
364305|NCT01164722|874444|P2|COMPLETED|Overall Study||45
364306|NCT01164722|874445|P1|COMPLETED|Overall Study||42
364307|NCT01164722|874444|P2|STARTED|Overall Study||60
364308|NCT01164722|874445|P1|STARTED|Overall Study||60
364309|NCT01164644|874461|P2|NOT COMPLETED|Overall Study||1
364310|NCT01164644|874462|P1|NOT COMPLETED|Overall Study||3
364311|NCT01164644|874461|P2|COMPLETED|Overall Study||13
364312|NCT01164644|874462|P1|COMPLETED|Overall Study||9
364313|NCT01164644|874461|P2|STARTED|Overall Study||14
364314|NCT01164644|874462|P1|STARTED|Overall Study||12
364315|NCT01164579|874475|P3|NOT COMPLETED|Overall Study||16
364316|NCT01164579|874476|P2|NOT COMPLETED|Overall Study||9
364317|NCT01164579|874477|P1|NOT COMPLETED|Overall Study||8
364318|NCT01164579|874475|P3|COMPLETED|Overall Study||21
364319|NCT01164579|874476|P2|COMPLETED|Overall Study||27
364320|NCT01164579|874477|P1|COMPLETED|Overall Study||28
364321|NCT01164579|874475|P3|STARTED|Overall Study||37
364322|NCT01164579|874476|P2|STARTED|Overall Study||36
364323|NCT01164579|874477|P1|STARTED|Overall Study||36
364324|NCT01164501|874557|P3|NOT COMPLETED|Overall Study||42
364325|NCT01164501|874558|P2|NOT COMPLETED|Overall Study||10
364326|NCT01164501|874559|P1|NOT COMPLETED|Overall Study||43
364327|NCT01164501|874557|P3|COMPLETED|Overall Study||280
364328|NCT01164501|874558|P2|COMPLETED|Overall Study||88
364329|NCT01164501|874559|P1|COMPLETED|Overall Study||278
364330|NCT01164501|874557|P3|STARTED|Overall Study||322
364331|NCT01164501|874558|P2|STARTED|Overall Study||98
364332|NCT01164501|874559|P1|STARTED|Overall Study||321
364333|NCT01164475|874576|P2|NOT COMPLETED|Overall Study||2
364334|NCT01164475|874577|P1|NOT COMPLETED|Overall Study||2
364335|NCT01164475|874576|P2|COMPLETED|Overall Study||29
364336|NCT01164475|874577|P1|COMPLETED|Overall Study||28
364337|NCT01164475|874576|P2|STARTED|Overall Study||31
364338|NCT01164475|874577|P1|STARTED|Overall Study||30
364339|NCT01164137|874603|P2|NOT COMPLETED|Overall Study||0
364340|NCT01164137|874604|P1|NOT COMPLETED|Overall Study||3
364341|NCT01164137|874603|P2|COMPLETED|Overall Study||76
364342|NCT01164137|874604|P1|COMPLETED|Overall Study||77
364343|NCT01164137|874603|P2|STARTED|Overall Study||76
364344|NCT01164137|874604|P1|STARTED|Overall Study||80
364345|NCT01164007|874618|P1|NOT COMPLETED|Overall Study||40
364346|NCT01164007|874618|P1|COMPLETED|Overall Study||0
364347|NCT01164007|874618|P1|Treated|Overall Study||37
364348|NCT01164007|874618|P1|STARTED|Overall Study||40
364349|NCT01163955|874634|P2|NOT COMPLETED|Overall Study||4
364350|NCT01163955|874635|P1|NOT COMPLETED|Overall Study||0
364351|NCT01163955|874634|P2|COMPLETED|Overall Study||26
364352|NCT01163955|874635|P1|COMPLETED|Overall Study||26
364353|NCT01163955|874634|P2|STARTED|Overall Study||30
364354|NCT01163955|874635|P1|STARTED|Overall Study||26
364355|NCT01163916|874644|P3|NOT COMPLETED|Overall Study||20
364356|NCT01163916|874645|P2|NOT COMPLETED|Overall Study||4
364357|NCT01163916|874646|P1|NOT COMPLETED|Overall Study||30
364358|NCT01163916|874644|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
364359|NCT01163916|874645|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
364360|NCT01163916|874646|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
364361|NCT01163916|874644|P3|Safety Population|Overall Study||91
364362|NCT01163916|874645|P2|Safety Population|Overall Study||35
364363|NCT01163916|874646|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
364364|NCT01163916|874644|P3|STARTED|Overall Study||91
364365|NCT01163916|874645|P2|STARTED|Overall Study||35
364366|NCT01163916|874646|P1|STARTED|Overall Study||126
364367|NCT01163851|874684|P2|NOT COMPLETED|Overall Study||1
364368|NCT01163851|874685|P1|NOT COMPLETED|Overall Study||1
364369|NCT01163851|874684|P2|COMPLETED|Overall Study||11
364370|NCT01163851|874685|P1|COMPLETED|Overall Study||12
364371|NCT01163851|874684|P2|TREATED|Overall Study||12
364372|NCT01163851|874685|P1|TREATED|Overall Study||12
364373|NCT01163851|874684|P2|STARTED|Overall Study||12
364374|NCT01163851|874685|P1|STARTED|Overall Study||13
364375|NCT01163760|874759|P4|NOT COMPLETED|Period 4 (Follow-up)||0
364376|NCT01163760|874760|P3|NOT COMPLETED|Period 4 (Follow-up)||0
364377|NCT01163760|874761|P2|NOT COMPLETED|Period 4 (Follow-up)||0
364378|NCT01163760|874762|P1|NOT COMPLETED|Period 4 (Follow-up)||0
364379|NCT01163760|874759|P4|COMPLETED|Period 4 (Follow-up)||12
364380|NCT01163760|874760|P3|COMPLETED|Period 4 (Follow-up)||13
364381|NCT01163760|874761|P2|COMPLETED|Period 4 (Follow-up)||13
364382|NCT01163760|874762|P1|COMPLETED|Period 4 (Follow-up)||12
364383|NCT01163760|874759|P4|STARTED|Period 4 (Follow-up)||12
364384|NCT01163760|874760|P3|STARTED|Period 4 (Follow-up)||13
364385|NCT01163760|874761|P2|STARTED|Period 4 (Follow-up)||13
364386|NCT01163760|874762|P1|STARTED|Period 4 (Follow-up)||12
364387|NCT01163760|874759|P4|NOT COMPLETED|Period 3 (Fit)||0
364388|NCT01163760|874760|P3|NOT COMPLETED|Period 3 (Fit)||0
364389|NCT01163760|874761|P2|NOT COMPLETED|Period 3 (Fit)||0
364390|NCT01163760|874762|P1|NOT COMPLETED|Period 3 (Fit)||0
364391|NCT01163760|874759|P4|COMPLETED|Period 3 (Fit)||12
364392|NCT01163760|874760|P3|COMPLETED|Period 3 (Fit)||13
364393|NCT01163760|874761|P2|COMPLETED|Period 3 (Fit)||13
364394|NCT01163760|874762|P1|COMPLETED|Period 3 (Fit)||12
364395|NCT01163760|874759|P4|STARTED|Period 3 (Fit)||12
364396|NCT01163760|874760|P3|STARTED|Period 3 (Fit)||13
364397|NCT01163760|874761|P2|STARTED|Period 3 (Fit)||13
364398|NCT01163760|874762|P1|STARTED|Period 3 (Fit)||12
364399|NCT01163760|874759|P4|NOT COMPLETED|Period 2 (Follow-up)||0
364400|NCT01163760|874760|P3|NOT COMPLETED|Period 2 (Follow-up)||0
364401|NCT01163760|874761|P2|NOT COMPLETED|Period 2 (Follow-up)||0
364402|NCT01163760|874762|P1|NOT COMPLETED|Period 2 (Follow-up)||0
364403|NCT01163760|874759|P4|COMPLETED|Period 2 (Follow-up)||12
364404|NCT01163760|874760|P3|COMPLETED|Period 2 (Follow-up)||13
364405|NCT01163760|874761|P2|COMPLETED|Period 2 (Follow-up)||13
364406|NCT01163760|874762|P1|COMPLETED|Period 2 (Follow-up)||12
364407|NCT01163760|874759|P4|STARTED|Period 2 (Follow-up)||12
364408|NCT01163760|874760|P3|STARTED|Period 2 (Follow-up)||13
364409|NCT01163760|874761|P2|STARTED|Period 2 (Follow-up)||13
364410|NCT01163760|874762|P1|STARTED|Period 2 (Follow-up)||12
364411|NCT01163760|874759|P4|NOT COMPLETED|Period 1 (Fit)||0
364412|NCT01163760|874760|P3|NOT COMPLETED|Period 1 (Fit)||0
364413|NCT01163760|874761|P2|NOT COMPLETED|Period 1 (Fit)||0
364414|NCT01163760|874762|P1|NOT COMPLETED|Period 1 (Fit)||0
364415|NCT01163760|874759|P4|COMPLETED|Period 1 (Fit)||12
364416|NCT01163760|874760|P3|COMPLETED|Period 1 (Fit)||13
364417|NCT01163760|874761|P2|COMPLETED|Period 1 (Fit)||13
364418|NCT01163760|874762|P1|COMPLETED|Period 1 (Fit)||12
364419|NCT01163760|874759|P4|STARTED|Period 1 (Fit)||12
364420|NCT01163760|874760|P3|STARTED|Period 1 (Fit)||13
364421|NCT01163760|874761|P2|STARTED|Period 1 (Fit)||13
364422|NCT01163760|874762|P1|STARTED|Period 1 (Fit)||12
364423|NCT01163747|874776|P2|NOT COMPLETED|Overall Study||11
364424|NCT01163747|874777|P1|NOT COMPLETED|Overall Study||6
364425|NCT01163747|874776|P2|COMPLETED|Overall Study||49
364426|NCT01163747|874777|P1|COMPLETED|Overall Study||25
364427|NCT01163747|874776|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
364428|NCT01163747|874777|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
364429|NCT01163747|874776|P2|STARTED|Overall Study||60
364430|NCT01163747|874777|P1|STARTED|Overall Study||31
364431|NCT01163721|874797|P2|NOT COMPLETED|Overall Study||12
364432|NCT01163721|874798|P1|NOT COMPLETED|Overall Study||8
364433|NCT01163721|874797|P2|COMPLETED|Overall Study||29
364434|NCT01163721|874798|P1|COMPLETED|Overall Study||31
364435|NCT01163721|874797|P2|STARTED|Overall Study||41
364436|NCT01163721|874798|P1|STARTED|Overall Study||39
364437|NCT01163656|874810|P2|NOT COMPLETED|Overall Study||3
364438|NCT01163656|874811|P1|NOT COMPLETED|Overall Study||3
364439|NCT01163656|874810|P2|COMPLETED|Overall Study||30
364440|NCT01163656|874811|P1|COMPLETED|Overall Study||30
364441|NCT01163656|874810|P2|STARTED|Overall Study||33
364442|NCT01163656|874811|P1|STARTED|Overall Study||33
364443|NCT01163617|874817|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364444|NCT01163617|874818|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364445|NCT01163617|874819|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364446|NCT01163617|874820|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364447|NCT01163617|874821|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364448|NCT01163617|874822|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364449|NCT01163617|874823|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364450|NCT01163617|874824|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
364451|NCT01163617|874817|P8|COMPLETED|Phase B (Injection Time), Week 4||20
364452|NCT01163617|874818|P7|COMPLETED|Phase B (Injection Time), Week 4||16
364453|NCT01163617|874819|P6|COMPLETED|Phase B (Injection Time), Week 4||27
364454|NCT01163617|874820|P5|COMPLETED|Phase B (Injection Time), Week 4||18
364455|NCT01163617|874821|P4|COMPLETED|Phase B (Injection Time), Week 4||0
364456|NCT01163617|874822|P3|COMPLETED|Phase B (Injection Time), Week 4||0
364457|NCT01163617|874823|P2|COMPLETED|Phase B (Injection Time), Week 4||0
364458|NCT01163617|874824|P1|COMPLETED|Phase B (Injection Time), Week 4||0
364459|NCT01163617|874817|P8|STARTED|Phase B (Injection Time), Week 4||20
364460|NCT01163617|874818|P7|STARTED|Phase B (Injection Time), Week 4||16
364461|NCT01163617|874819|P6|STARTED|Phase B (Injection Time), Week 4||27
364462|NCT01163617|874820|P5|STARTED|Phase B (Injection Time), Week 4||18
364463|NCT01163617|874821|P4|STARTED|Phase B (Injection Time), Week 4||0
364464|NCT01163617|874822|P3|STARTED|Phase B (Injection Time), Week 4||0
364465|NCT01163617|874823|P2|STARTED|Phase B (Injection Time), Week 4||0
364466|NCT01163617|874824|P1|STARTED|Phase B (Injection Time), Week 4||0
364467|NCT01163617|874817|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364468|NCT01163617|874818|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364469|NCT01163617|874819|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364470|NCT01163617|874820|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364471|NCT01163617|874821|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364472|NCT01163617|874822|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
364473|NCT01163617|874823|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
364474|NCT01163617|874824|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364475|NCT01163617|874817|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364476|NCT01163617|874818|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364477|NCT01163617|874819|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364478|NCT01163617|874820|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
364479|NCT01163617|874821|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
364480|NCT01163617|874822|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
364481|NCT01163617|874823|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
364482|NCT01163617|874824|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
364483|NCT01163617|874817|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
364484|NCT01163617|874818|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
364485|NCT01163617|874819|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
364486|NCT01163617|874820|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
364487|NCT01163617|874821|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
364488|NCT01163617|874822|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
364489|NCT01163617|874823|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
364490|NCT01163617|874824|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
364491|NCT01163604|874846|P2|NOT COMPLETED|Overall Study||0
364492|NCT01163604|874847|P1|NOT COMPLETED|Overall Study||0
364493|NCT01163604|874846|P2|COMPLETED|Overall Study|August 2011|56
364494|NCT01163604|874847|P1|COMPLETED|Overall Study|August 2011|58
364495|NCT01163604|874846|P2|STARTED|Overall Study|August 2010|56
364496|NCT01163604|874847|P1|STARTED|Overall Study|August 2010|58
364497|NCT01163474|874853|P1|NOT COMPLETED|Overall Study||16
364498|NCT01163474|874853|P1|COMPLETED|Overall Study||24
364499|NCT01163474|874853|P1|STARTED|Overall Study||40
364500|NCT01163461|874859|P2|NOT COMPLETED|Overall Study||0
364501|NCT01163461|874860|P1|NOT COMPLETED|Overall Study||0
364502|NCT01163461|874859|P2|COMPLETED|Overall Study||14
364503|NCT01163461|874860|P1|COMPLETED|Overall Study||14
364504|NCT01163461|874859|P2|STARTED|Overall Study||14
364505|NCT01163461|874860|P1|STARTED|Overall Study||14
364506|NCT01163318|874864|P1|NOT COMPLETED|Overall Study||268
364507|NCT01163318|874864|P1|COMPLETED|Overall Study||284
364508|NCT01163318|874864|P1|STARTED|Overall Study||552
364509|NCT01163292|874873|P2|NOT COMPLETED|Overall Study||22
364510|NCT01163292|874874|P1|NOT COMPLETED|Overall Study||41
364511|NCT01163292|874873|P2|COMPLETED|Overall Study||92
364512|NCT01163292|874874|P1|COMPLETED|Overall Study||65
364513|NCT01163292|874873|P2|STARTED|Overall Study||114
364514|NCT01163292|874874|P1|STARTED|Overall Study||106
364515|NCT01163279|874890|P2|NOT COMPLETED|Overall Study||0
364516|NCT01163279|874891|P1|NOT COMPLETED|Overall Study||2
364517|NCT01163279|874890|P2|COMPLETED|Overall Study||9
364518|NCT01163279|874891|P1|COMPLETED|Overall Study||8
364519|NCT01163279|874890|P2|STARTED|Overall Study||9
364520|NCT01163279|874891|P1|STARTED|Overall Study||10
364521|NCT01163266|874920|P3|NOT COMPLETED|Overall Study||28
364522|NCT01163266|874921|P2|NOT COMPLETED|Overall Study||31
364523|NCT01163266|874922|P1|NOT COMPLETED|Overall Study||18
364524|NCT01163266|874920|P3|COMPLETED|Overall Study||122
364525|NCT01163266|874921|P2|COMPLETED|Overall Study||124
364526|NCT01163266|874922|P1|COMPLETED|Overall Study||139
364527|NCT01163266|874920|P3|Treated|Overall Study||150
364528|NCT01163266|874921|P2|Treated|Overall Study||155
364529|NCT01163266|874922|P1|Treated|Overall Study||157
364530|NCT01163266|874920|P3|STARTED|Overall Study||150
364531|NCT01163266|874921|P2|STARTED|Overall Study||155
364532|NCT01163266|874922|P1|STARTED|Overall Study||157
364533|NCT01163214|874947|P2|NOT COMPLETED|Overall Study||0
364534|NCT01163214|874948|P1|NOT COMPLETED|Overall Study||0
364535|NCT01163214|874947|P2|COMPLETED|Overall Study||81
364536|NCT01163214|874948|P1|COMPLETED|Overall Study||79
364537|NCT01163214|874947|P2|STARTED|Overall Study||81
364538|NCT01163214|874948|P1|STARTED|Overall Study||79
364539|NCT01163162|874964|P1|NOT COMPLETED|Overall Study||0
364540|NCT01163162|874964|P1|COMPLETED|Overall Study||16
364541|NCT01163162|874964|P1|STARTED|Overall Study||16
364542|NCT01163097|874973|P3|NOT COMPLETED|Overall Study||0
364543|NCT01163097|874974|P2|NOT COMPLETED|Overall Study||0
364544|NCT01163097|874975|P1|NOT COMPLETED|Overall Study||6
364545|NCT01163097|874973|P3|COMPLETED|Overall Study||8
364546|NCT01163097|874974|P2|COMPLETED|Overall Study||16
364547|NCT01163097|874975|P1|COMPLETED|Overall Study||14
364548|NCT01163097|874973|P3|STARTED|Overall Study||8
364549|NCT01163097|874974|P2|STARTED|Overall Study||16
364550|NCT01163097|874975|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
364551|NCT01163032|875028|P3|NOT COMPLETED|Open Label Extension Phase||16
364552|NCT01163032|875029|P2|NOT COMPLETED|Open Label Extension Phase||0
364553|NCT01163032|875030|P1|NOT COMPLETED|Open Label Extension Phase||0
364554|NCT01163032|875028|P3|COMPLETED|Open Label Extension Phase||39
364555|NCT01163032|875029|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
364556|NCT01163032|875030|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
364557|NCT01163032|875028|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
364558|NCT01163032|875029|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
364559|NCT01163032|875030|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
364560|NCT01163032|875028|P3|NOT COMPLETED|Randomization Phase||0
364561|NCT01163032|875029|P2|NOT COMPLETED|Randomization Phase||12
364562|NCT01163032|875030|P1|NOT COMPLETED|Randomization Phase||10
364563|NCT01163032|875028|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
364564|NCT01163032|875029|P2|COMPLETED|Randomization Phase||30
364565|NCT01163032|875030|P1|COMPLETED|Randomization Phase||32
364566|NCT01163032|875028|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
364567|NCT01163032|875029|P2|STARTED|Randomization Phase||42
364568|NCT01163032|875030|P1|STARTED|Randomization Phase||42
364569|NCT01162863|875063|P3|NOT COMPLETED|Overall Study||0
364570|NCT01162863|875064|P2|NOT COMPLETED|Overall Study||1
364571|NCT01162863|875065|P1|NOT COMPLETED|Overall Study||1
364572|NCT01162863|875063|P3|COMPLETED|Overall Study||17
364573|NCT01162863|875064|P2|COMPLETED|Overall Study||16
364574|NCT01162863|875065|P1|COMPLETED|Overall Study||17
364575|NCT01162863|875063|P3|STARTED|Overall Study||17
364576|NCT01162863|875064|P2|STARTED|Overall Study||17
364577|NCT01162863|875065|P1|STARTED|Overall Study||18
364578|NCT01162733|875081|P2|NOT COMPLETED|Overall Study||25
364579|NCT01162733|875082|P1|NOT COMPLETED|Overall Study||27
364580|NCT01162733|875081|P2|COMPLETED|Overall Study||25
364581|NCT01162733|875082|P1|COMPLETED|Overall Study||22
364582|NCT01162733|875081|P2|STARTED|Overall Study||50
364583|NCT01162733|875082|P1|STARTED|Overall Study||49
364584|NCT01162499|875090|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
364585|NCT01162499|875091|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
364586|NCT01162499|875090|P2|COMPLETED|Intervention 2 (4 Hours)||3
364587|NCT01162499|875091|P1|COMPLETED|Intervention 2 (4 Hours)||3
364588|NCT01162499|875090|P2|STARTED|Intervention 2 (4 Hours)||3
364589|NCT01162499|875091|P1|STARTED|Intervention 2 (4 Hours)||3
364590|NCT01162499|875090|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
364591|NCT01162499|875091|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
364592|NCT01162499|875090|P2|COMPLETED|Intervention 1 (4 Hours)||3
364593|NCT01162499|875091|P1|COMPLETED|Intervention 1 (4 Hours)||3
364594|NCT01162499|875090|P2|Received Intervention|Intervention 1 (4 Hours)||3
364595|NCT01162499|875091|P1|Received Intervention|Intervention 1 (4 Hours)||3
364596|NCT01162499|875090|P2|STARTED|Intervention 1 (4 Hours)||4
364597|NCT01162499|875091|P1|STARTED|Intervention 1 (4 Hours)||3
364598|NCT01162473|875113|P2|NOT COMPLETED|Overall Study||5
364599|NCT01162473|875114|P1|NOT COMPLETED|Overall Study||2
364600|NCT01162473|875113|P2|COMPLETED|Overall Study||12
364601|NCT01162473|875114|P1|COMPLETED|Overall Study||6
364602|NCT01162473|875113|P2|STARTED|Overall Study||17
364603|NCT01162473|875114|P1|STARTED|Overall Study||8
364604|NCT01162421|875122|P2|NOT COMPLETED|Overall Study||13
364605|NCT01162421|875123|P1|NOT COMPLETED|Overall Study||8
364606|NCT01162421|875122|P2|COMPLETED|Overall Study||27
364607|NCT01162421|875123|P1|COMPLETED|Overall Study||29
364608|NCT01162421|875122|P2|STARTED|Overall Study||40
364609|NCT01162421|875123|P1|STARTED|Overall Study||37
364610|NCT01162317|875203|P2|NOT COMPLETED|Overall Study||2
364611|NCT01162317|875204|P1|NOT COMPLETED|Overall Study||3
364612|NCT01162317|875203|P2|COMPLETED|Overall Study||28
364613|NCT01162317|875204|P1|COMPLETED|Overall Study||27
364614|NCT01162317|875203|P2|STARTED|Overall Study||30
364615|NCT01162317|875204|P1|STARTED|Overall Study||30
364616|NCT01162304|875212|P1|NOT COMPLETED|Overall Study||11
364617|NCT01162304|875212|P1|COMPLETED|Overall Study||7
364618|NCT01162304|875212|P1|STARTED|Overall Study||18
364619|NCT01162135|875226|P1|NOT COMPLETED|Overall Study||3
364620|NCT01162135|875226|P1|COMPLETED|Overall Study||13
364621|NCT01162135|875226|P1|STARTED|Overall Study||16
364622|NCT01162122|875232|P2|NOT COMPLETED|Overall Study||196
364623|NCT01162122|875233|P1|NOT COMPLETED|Overall Study||191
364624|NCT01162122|875232|P2|COMPLETED|Overall Study||3356
364625|NCT01162122|875233|P1|COMPLETED|Overall Study||3361
364626|NCT01162122|875232|P2|Vaccinated|Overall Study||3541
364627|NCT01162122|875233|P1|Vaccinated|Overall Study||3541
364628|NCT01162122|875232|P2|STARTED|Overall Study||3552
364629|NCT01162122|875233|P1|STARTED|Overall Study||3552
364630|NCT01162096|875290|P1|NOT COMPLETED|Overall Study||0
364631|NCT01162096|875290|P1|COMPLETED|Overall Study||34
364632|NCT01162096|875290|P1|STARTED|Overall Study||34
364633|NCT01161771|875294|P1|NOT COMPLETED|Overall Study||0
364634|NCT01161771|875294|P1|COMPLETED|Overall Study||32
364635|NCT01161771|875294|P1|STARTED|Overall Study||32
364636|NCT01161628|875303|P1|NOT COMPLETED|Overall Study||8
364637|NCT01161628|875303|P1|COMPLETED|Overall Study||17
364638|NCT01161628|875303|P1|STARTED|Overall Study||25
364639|NCT01161563|875317|P2|NOT COMPLETED|Overall Study||6
364640|NCT01161563|875318|P1|NOT COMPLETED|Overall Study||5
364641|NCT01161563|875317|P2|COMPLETED|Overall Study||49
364642|NCT01161563|875318|P1|COMPLETED|Overall Study||58
364643|NCT01161563|875317|P2|STARTED|Overall Study||55
364644|NCT01161563|875318|P1|STARTED|Overall Study||63
364645|NCT01161537|875326|P1|NOT COMPLETED|Part B||2
364646|NCT01161537|875326|P1|COMPLETED|Part B||7
364647|NCT01161537|875326|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
364648|NCT01161537|875326|P1|NOT COMPLETED|Part A||0
364649|NCT01161537|875326|P1|COMPLETED|Part A||8
364650|NCT01161537|875326|P1|STARTED|Part A||8
364651|NCT01161498|875344|P2|NOT COMPLETED|Overall Study||1
364652|NCT01161498|875345|P1|NOT COMPLETED|Overall Study||0
364653|NCT01161498|875344|P2|COMPLETED|Overall Study||1
364654|NCT01161498|875345|P1|COMPLETED|Overall Study||3
364655|NCT01161498|875344|P2|STARTED|Overall Study||2
364656|NCT01161498|875345|P1|STARTED|Overall Study||3
364657|NCT01161472|875369|P4|NOT COMPLETED|Fourth Intervention Period||0
364658|NCT01161472|875370|P3|NOT COMPLETED|Fourth Intervention Period||0
364659|NCT01161472|875371|P2|NOT COMPLETED|Fourth Intervention Period||0
364660|NCT01161472|875372|P1|NOT COMPLETED|Fourth Intervention Period||0
364661|NCT01161472|875369|P4|COMPLETED|Fourth Intervention Period||5
364662|NCT01161472|875370|P3|COMPLETED|Fourth Intervention Period||5
364663|NCT01161472|875371|P2|COMPLETED|Fourth Intervention Period||5
364664|NCT01161472|875372|P1|COMPLETED|Fourth Intervention Period||4
364665|NCT01161472|875369|P4|STARTED|Fourth Intervention Period||5
364666|NCT01161472|875370|P3|STARTED|Fourth Intervention Period||5
364667|NCT01161472|875371|P2|STARTED|Fourth Intervention Period||5
364668|NCT01161472|875372|P1|STARTED|Fourth Intervention Period||4
364669|NCT01161472|875369|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364670|NCT01161472|875370|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364671|NCT01161472|875371|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364672|NCT01161472|875372|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364673|NCT01161472|875369|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364674|NCT01161472|875370|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364675|NCT01161472|875371|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364676|NCT01161472|875372|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
364677|NCT01161472|875369|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
364678|NCT01161472|875370|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
364679|NCT01161472|875371|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
364680|NCT01161472|875372|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
364681|NCT01161472|875369|P4|NOT COMPLETED|Third Intervention Period||0
364682|NCT01161472|875370|P3|NOT COMPLETED|Third Intervention Period||0
364683|NCT01161472|875371|P2|NOT COMPLETED|Third Intervention Period||0
364684|NCT01161472|875372|P1|NOT COMPLETED|Third Intervention Period||0
364685|NCT01161472|875369|P4|COMPLETED|Third Intervention Period||5
364686|NCT01161472|875370|P3|COMPLETED|Third Intervention Period||5
364687|NCT01161472|875371|P2|COMPLETED|Third Intervention Period||5
364688|NCT01161472|875372|P1|COMPLETED|Third Intervention Period||4
364689|NCT01161472|875369|P4|STARTED|Third Intervention Period||5
364690|NCT01161472|875370|P3|STARTED|Third Intervention Period||5
364691|NCT01161472|875371|P2|STARTED|Third Intervention Period||5
364692|NCT01161472|875372|P1|STARTED|Third Intervention Period||4
364693|NCT01161472|875369|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364694|NCT01161472|875370|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364695|NCT01161472|875371|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364696|NCT01161472|875372|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
364697|NCT01161472|875369|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364698|NCT01161472|875370|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364699|NCT01161472|875371|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364700|NCT01161472|875372|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
364701|NCT01161472|875369|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
364702|NCT01161472|875370|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
364703|NCT01161472|875371|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
364704|NCT01161472|875372|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
364705|NCT01161472|875369|P4|NOT COMPLETED|Second Intervention Period||0
364706|NCT01161472|875370|P3|NOT COMPLETED|Second Intervention Period||0
364707|NCT01161472|875371|P2|NOT COMPLETED|Second Intervention Period||0
364708|NCT01161472|875372|P1|NOT COMPLETED|Second Intervention Period||0
364709|NCT01161472|875369|P4|COMPLETED|Second Intervention Period||5
364710|NCT01161472|875370|P3|COMPLETED|Second Intervention Period||5
364711|NCT01161472|875371|P2|COMPLETED|Second Intervention Period||5
364712|NCT01161472|875372|P1|COMPLETED|Second Intervention Period||5
364713|NCT01161472|875369|P4|STARTED|Second Intervention Period||5
364714|NCT01161472|875370|P3|STARTED|Second Intervention Period||5
364715|NCT01161472|875371|P2|STARTED|Second Intervention Period||5
364716|NCT01161472|875372|P1|STARTED|Second Intervention Period||5
364717|NCT01161472|875369|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364718|NCT01161472|875370|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364719|NCT01161472|875371|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364720|NCT01161472|875372|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
364721|NCT01161472|875369|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364722|NCT01161472|875370|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364723|NCT01161472|875371|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364724|NCT01161472|875372|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
364725|NCT01161472|875369|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
364726|NCT01161472|875370|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
364727|NCT01161472|875371|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
364728|NCT01161472|875372|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
364729|NCT01161472|875369|P4|NOT COMPLETED|First Intervention Period||0
364730|NCT01161472|875370|P3|NOT COMPLETED|First Intervention Period||0
364731|NCT01161472|875371|P2|NOT COMPLETED|First Intervention Period||0
364732|NCT01161472|875372|P1|NOT COMPLETED|First Intervention Period||0
364733|NCT01161472|875369|P4|COMPLETED|First Intervention Period||5
364734|NCT01161472|875370|P3|COMPLETED|First Intervention Period||5
364735|NCT01161472|875371|P2|COMPLETED|First Intervention Period||5
364736|NCT01161472|875372|P1|COMPLETED|First Intervention Period||5
364737|NCT01161472|875369|P4|Treated|First Intervention Period||5
364738|NCT01161472|875370|P3|Treated|First Intervention Period||5
364739|NCT01161472|875371|P2|Treated|First Intervention Period||5
364740|NCT01161472|875372|P1|Treated|First Intervention Period||5
364741|NCT01161472|875369|P4|STARTED|First Intervention Period||5
364742|NCT01161472|875370|P3|STARTED|First Intervention Period||5
364743|NCT01161472|875371|P2|STARTED|First Intervention Period||5
364744|NCT01161472|875372|P1|STARTED|First Intervention Period||5
364745|NCT01161446|875428|P2|NOT COMPLETED|Overall Study||15
364746|NCT01161446|875429|P1|NOT COMPLETED|Overall Study||18
364747|NCT01161446|875428|P2|COMPLETED|Overall Study||99
364748|NCT01161446|875429|P1|COMPLETED|Overall Study||98
364749|NCT01161446|875428|P2|STARTED|Overall Study||114
364750|NCT01161446|875429|P1|STARTED|Overall Study||116
364751|NCT01161420|875441|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
364752|NCT01161420|875441|P1|COMPLETED|Withdrawal Study - Withdrawal||23
364753|NCT01161420|875441|P1|STARTED|Withdrawal Study - Withdrawal||23
364754|NCT01161420|875441|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
364755|NCT01161420|875441|P1|COMPLETED|Withdrawal Study - Maintenance||23
364756|NCT01161420|875441|P1|STARTED|Withdrawal Study - Maintenance||23
364757|NCT01161420|875441|P1|NOT COMPLETED|Inspire Therapy||2
364758|NCT01161420|875441|P1|COMPLETED|Inspire Therapy||124
364759|NCT01161420|875441|P1|STARTED|Inspire Therapy||126
364760|NCT01161407|875455|P2|NOT COMPLETED|Overall Study||1
364761|NCT01161407|875456|P1|NOT COMPLETED|Overall Study||3
364762|NCT01161407|875455|P2|COMPLETED|Overall Study||5
364763|NCT01161407|875456|P1|COMPLETED|Overall Study||3
364764|NCT01161407|875455|P2|STARTED|Overall Study||6
364765|NCT01161407|875456|P1|STARTED|Overall Study||6
364766|NCT01161329|875468|P2|NOT COMPLETED|Overall Study||10
364767|NCT01161329|875469|P1|NOT COMPLETED|Overall Study||4
364768|NCT01161329|875468|P2|COMPLETED|Overall Study||24
364769|NCT01161329|875469|P1|COMPLETED|Overall Study||29
364770|NCT01161329|875468|P2|STARTED|Overall Study||34
364771|NCT01161329|875469|P1|STARTED|Overall Study||33
364772|NCT01161225|875480|P3|NOT COMPLETED|Overall Study||2
364773|NCT01161225|875481|P2|NOT COMPLETED|Overall Study||9
364774|NCT01161225|875482|P1|NOT COMPLETED|Overall Study||14
364775|NCT01161225|875480|P3|COMPLETED|Overall Study||12
364776|NCT01161225|875481|P2|COMPLETED|Overall Study||44
364777|NCT01161225|875482|P1|COMPLETED|Overall Study||45
364778|NCT01161225|875480|P3|STARTED|Overall Study||14
364779|NCT01161225|875481|P2|STARTED|Overall Study||53
364780|NCT01161225|875482|P1|STARTED|Overall Study||59
364781|NCT01161173|875511|P1|NOT COMPLETED|Overall Study||347
364782|NCT01161173|875511|P1|COMPLETED|Overall Study||0
364783|NCT01161173|875511|P1|STARTED|Overall Study||347
364784|NCT01160848|875522|P2|NOT COMPLETED|Overall Study||0
364785|NCT01160848|875523|P1|NOT COMPLETED|Overall Study||0
364786|NCT01160848|875522|P2|COMPLETED|Overall Study||8
364787|NCT01160848|875523|P1|COMPLETED|Overall Study||12
364788|NCT01160848|875522|P2|STARTED|Overall Study||8
364789|NCT01160848|875523|P1|STARTED|Overall Study||12
364790|NCT01160822|875552|P7|NOT COMPLETED|Overall Study||9
364791|NCT01160822|875553|P6|NOT COMPLETED|Overall Study||7
364792|NCT01160822|875554|P5|NOT COMPLETED|Overall Study||9
364793|NCT01160822|875555|P4|NOT COMPLETED|Overall Study||0
364794|NCT01160822|875556|P3|NOT COMPLETED|Overall Study||0
364795|NCT01160822|875557|P2|NOT COMPLETED|Overall Study||0
364796|NCT01160822|875558|P1|NOT COMPLETED|Overall Study||0
364797|NCT01160822|875552|P7|COMPLETED|Overall Study||44
364798|NCT01160822|875553|P6|COMPLETED|Overall Study||40
364799|NCT01160822|875554|P5|COMPLETED|Overall Study||36
364800|NCT01160822|875555|P4|COMPLETED|Overall Study||5
364801|NCT01160822|875556|P3|COMPLETED|Overall Study||6
364802|NCT01160822|875557|P2|COMPLETED|Overall Study||7
364803|NCT01160822|875558|P1|COMPLETED|Overall Study||6
364804|NCT01160822|875552|P7|STARTED|Overall Study||53
364805|NCT01160822|875553|P6|STARTED|Overall Study||47
364806|NCT01160822|875554|P5|STARTED|Overall Study||45
364807|NCT01160822|875555|P4|STARTED|Overall Study||5
364808|NCT01160822|875556|P3|STARTED|Overall Study||6
364809|NCT01160822|875557|P2|STARTED|Overall Study||7
364810|NCT01160822|875558|P1|STARTED|Overall Study||6
364811|NCT01160770|875647|P1|NOT COMPLETED|Overall Study||79
364812|NCT01160770|875647|P1|COMPLETED|Overall Study||188
364813|NCT01160770|875647|P1|STARTED|Overall Study||267
364814|NCT01160744|875660|P4|NOT COMPLETED|Overall Study||22
364815|NCT01160744|875661|P3|NOT COMPLETED|Overall Study||20
364816|NCT01160744|875662|P2|NOT COMPLETED|Overall Study||25
364817|NCT01160744|875663|P1|NOT COMPLETED|Overall Study||20
364818|NCT01160744|875660|P4|COMPLETED|Overall Study||49
364819|NCT01160744|875661|P3|COMPLETED|Overall Study||49
364820|NCT01160744|875662|P2|COMPLETED|Overall Study||44
364821|NCT01160744|875663|P1|COMPLETED|Overall Study||51
364822|NCT01160744|875660|P4|Received Study Drug|Overall Study||71
364823|NCT01160744|875661|P3|Received Study Drug|Overall Study||63
364824|NCT01160744|875662|P2|Received Study Drug|Overall Study||67
364825|NCT01160744|875663|P1|Received Study Drug|Overall Study||69
364826|NCT01160744|875660|P4|STARTED|Overall Study||71
364827|NCT01160744|875661|P3|STARTED|Overall Study||69
364828|NCT01160744|875662|P2|STARTED|Overall Study||69
364829|NCT01160744|875663|P1|STARTED|Overall Study||71
364830|NCT01160640|875699|P2|NOT COMPLETED|Overall Study||6
364831|NCT01160640|875700|P1|NOT COMPLETED|Overall Study||4
364832|NCT01160640|875699|P2|COMPLETED|Overall Study||110
364833|NCT01160640|875700|P1|COMPLETED|Overall Study||113
364834|NCT01160640|875699|P2|STARTED|Overall Study||116
364835|NCT01160640|875700|P1|STARTED|Overall Study||117
364836|NCT01160614|875716|P2|NOT COMPLETED|Overall Study||2
364837|NCT01160614|875717|P1|NOT COMPLETED|Overall Study||0
364838|NCT01160614|875716|P2|COMPLETED|Overall Study||23
364839|NCT01160614|875717|P1|COMPLETED|Overall Study||5
364840|NCT01160614|875716|P2|STARTED|Overall Study||25
364841|NCT01160614|875717|P1|STARTED|Overall Study||5
364842|NCT01160484|875765|P1|NOT COMPLETED|Overall Study||18
364843|NCT01160484|875765|P1|COMPLETED|Overall Study||22
364844|NCT01160484|875765|P1|STARTED|Overall Study||40
364845|NCT01160458|875775|P1|NOT COMPLETED|Overall Study||0
364846|NCT01160458|875775|P1|COMPLETED|Overall Study||20
364847|NCT01160458|875775|P1|STARTED|Overall Study||20
364848|NCT01160445|875785|P2|NOT COMPLETED|Overall Study||0
364849|NCT01160445|875786|P1|NOT COMPLETED|Overall Study||0
364850|NCT01160445|875785|P2|COMPLETED|Overall Study||2
364851|NCT01160445|875786|P1|COMPLETED|Overall Study||7
364852|NCT01160445|875785|P2|STARTED|Overall Study||2
364853|NCT01160445|875786|P1|STARTED|Overall Study||7
364854|NCT01160380|875796|P2|NOT COMPLETED|Overall Study||5
364855|NCT01160380|875797|P1|NOT COMPLETED|Overall Study||8
364856|NCT01160380|875796|P2|COMPLETED|Overall Study||20
364857|NCT01160380|875797|P1|COMPLETED|Overall Study||17
364858|NCT01160380|875796|P2|STARTED|Overall Study||25
364859|NCT01160380|875797|P1|STARTED|Overall Study||25
364860|NCT01160237|875818|P3|NOT COMPLETED|Overall Study||0
364861|NCT01160237|875819|P2|NOT COMPLETED|Overall Study||0
364862|NCT01160237|875820|P1|NOT COMPLETED|Overall Study||0
364863|NCT01160237|875818|P3|COMPLETED|Overall Study||0
364864|NCT01160237|875819|P2|COMPLETED|Overall Study||3
364865|NCT01160237|875820|P1|COMPLETED|Overall Study||4
364866|NCT01160237|875818|P3|STARTED|Overall Study||0
364867|NCT01160237|875819|P2|STARTED|Overall Study||3
364868|NCT01160237|875820|P1|STARTED|Overall Study||4
364869|NCT01159938|875846|P5|NOT COMPLETED|Second Study Period||0
364870|NCT01159938|875847|P4|NOT COMPLETED|Second Study Period||0
364871|NCT01159938|875848|P3|NOT COMPLETED|Second Study Period||0
364872|NCT01159938|875849|P2|NOT COMPLETED|Second Study Period||0
364873|NCT01159938|875850|P1|NOT COMPLETED|Second Study Period||0
364874|NCT01159938|875846|P5|COMPLETED|Second Study Period||12
364875|NCT01159938|875847|P4|COMPLETED|Second Study Period||12
364876|NCT01159938|875848|P3|COMPLETED|Second Study Period||10
364877|NCT01159938|875849|P2|COMPLETED|Second Study Period||11
364878|NCT01159938|875850|P1|COMPLETED|Second Study Period||0
364879|NCT01159938|875846|P5|STARTED|Second Study Period||12
364880|NCT01159938|875847|P4|STARTED|Second Study Period||12
364881|NCT01159938|875848|P3|STARTED|Second Study Period||10
364882|NCT01159938|875849|P2|STARTED|Second Study Period||11
364883|NCT01159938|875850|P1|STARTED|Second Study Period||0
364884|NCT01159938|875846|P5|NOT COMPLETED|First Study Period||0
364885|NCT01159938|875847|P4|NOT COMPLETED|First Study Period||0
364886|NCT01159938|875848|P3|NOT COMPLETED|First Study Period||1
364887|NCT01159938|875849|P2|NOT COMPLETED|First Study Period||0
364888|NCT01159938|875850|P1|NOT COMPLETED|First Study Period||0
364889|NCT01159938|875846|P5|COMPLETED|First Study Period||12
364890|NCT01159938|875847|P4|COMPLETED|First Study Period||12
364891|NCT01159938|875848|P3|COMPLETED|First Study Period||10
364892|NCT01159938|875849|P2|COMPLETED|First Study Period||11
364893|NCT01159938|875850|P1|COMPLETED|First Study Period||26
364894|NCT01159938|875846|P5|Safety and Efficacy Analysis Population|First Study Period||12
364895|NCT01159938|875847|P4|Safety and Efficacy Analysis Population|First Study Period||12
364896|NCT01159938|875848|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
364897|NCT01159938|875849|P2|Safety and Efficacy Analysis Population|First Study Period||11
364898|NCT01159938|875850|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
364899|NCT01159938|875846|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
364900|NCT01159938|875847|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
364901|NCT01159938|875848|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
364902|NCT01159938|875849|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
364903|NCT01159938|875850|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
364904|NCT01159938|875846|P5|STARTED|First Study Period||12
364905|NCT01159938|875847|P4|STARTED|First Study Period||12
364906|NCT01159938|875848|P3|STARTED|First Study Period||11
364907|NCT01159938|875849|P2|STARTED|First Study Period||11
364908|NCT01159938|875850|P1|STARTED|First Study Period||26
364909|NCT01159912|875913|P3|NOT COMPLETED|Overall Study||26
364910|NCT01159912|875914|P2|NOT COMPLETED|Overall Study||22
364911|NCT01159912|875915|P1|NOT COMPLETED|Overall Study||40
364912|NCT01159912|875913|P3|COMPLETED|Overall Study||88
364913|NCT01159912|875914|P2|COMPLETED|Overall Study||92
364914|NCT01159912|875915|P1|COMPLETED|Overall Study||75
364915|NCT01159912|875913|P3|STARTED|Overall Study||114
364916|NCT01159912|875914|P2|STARTED|Overall Study||114
364917|NCT01159912|875915|P1|STARTED|Overall Study||115
364918|NCT01159769|875938|P1|NOT COMPLETED|Overall Study||1
364919|NCT01159769|875938|P1|COMPLETED|Overall Study||214
364920|NCT01159769|875938|P1|STARTED|Overall Study||215
364921|NCT01159743|875945|P2|NOT COMPLETED|Overall Study||0
364922|NCT01159743|875946|P1|NOT COMPLETED|Overall Study||0
364923|NCT01159743|875945|P2|COMPLETED|Overall Study||109
364924|NCT01159743|875946|P1|COMPLETED|Overall Study||237
364925|NCT01159743|875945|P2|STARTED|Overall Study||109
364926|NCT01159743|875946|P1|STARTED|Overall Study||237
364927|NCT01159691|875958|P1|NOT COMPLETED|Overall Study||22
364928|NCT01159691|875958|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
364929|NCT01159691|875958|P1|STARTED|Overall Study||76
364930|NCT01159665|875971|P6|NOT COMPLETED|Overall Study||0
364931|NCT01159665|875972|P5|NOT COMPLETED|Overall Study||0
364932|NCT01159665|875973|P4|NOT COMPLETED|Overall Study||0
364933|NCT01159665|875974|P3|NOT COMPLETED|Overall Study||0
364934|NCT01159665|875975|P2|NOT COMPLETED|Overall Study||1
364935|NCT01159665|875976|P1|NOT COMPLETED|Overall Study||0
364936|NCT01159665|875971|P6|COMPLETED|Overall Study||4
364937|NCT01159665|875972|P5|COMPLETED|Overall Study||4
364938|NCT01159665|875973|P4|COMPLETED|Overall Study||4
364939|NCT01159665|875974|P3|COMPLETED|Overall Study||8
364940|NCT01159665|875975|P2|COMPLETED|Overall Study||8
364941|NCT01159665|875976|P1|COMPLETED|Overall Study||9
364942|NCT01159665|875971|P6|STARTED|Overall Study||4
364943|NCT01159665|875972|P5|STARTED|Overall Study||4
364944|NCT01159665|875973|P4|STARTED|Overall Study||4
364945|NCT01159665|875974|P3|STARTED|Overall Study||8
364946|NCT01159665|875975|P2|STARTED|Overall Study||9
364947|NCT01159665|875976|P1|STARTED|Overall Study||9
364948|NCT01159600|876004|P8|NOT COMPLETED|Overall Study||18
364949|NCT01159600|876005|P7|NOT COMPLETED|Overall Study||19
364950|NCT01159600|876006|P6|NOT COMPLETED|Overall Study||18
364951|NCT01159600|876007|P5|NOT COMPLETED|Overall Study||24
364952|NCT01159600|876008|P4|NOT COMPLETED|Overall Study||11
364953|NCT01159600|876009|P3|NOT COMPLETED|Overall Study||18
364954|NCT01159600|876010|P2|NOT COMPLETED|Overall Study||8
364955|NCT01159600|876011|P1|NOT COMPLETED|Overall Study||21
364956|NCT01159600|876004|P8|COMPLETED|Overall Study||85
364957|NCT01159600|876005|P7|COMPLETED|Overall Study||199
364958|NCT01159600|876006|P6|COMPLETED|Overall Study||208
364959|NCT01159600|876007|P5|COMPLETED|Overall Study||201
364960|NCT01159600|876008|P4|COMPLETED|Overall Study||58
364961|NCT01159600|876009|P3|COMPLETED|Overall Study||196
364962|NCT01159600|876010|P2|COMPLETED|Overall Study||209
364963|NCT01159600|876011|P1|COMPLETED|Overall Study||186
364964|NCT01159600|876004|P8|STARTED|Overall Study||103
364965|NCT01159600|876005|P7|STARTED|Overall Study||218
364966|NCT01159600|876006|P6|STARTED|Overall Study||226
364967|NCT01159600|876007|P5|STARTED|Overall Study||225
364968|NCT01159600|876008|P4|STARTED|Overall Study||69
364969|NCT01159600|876009|P3|STARTED|Overall Study||214
364970|NCT01159600|876010|P2|STARTED|Overall Study||217
364971|NCT01159600|876011|P1|STARTED|Overall Study||207
364972|NCT01159574|876053|P1|NOT COMPLETED|Follow Up Phase||20
364973|NCT01159574|876053|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
364974|NCT01159574|876053|P1|STARTED|Follow Up Phase||112
364975|NCT01159574|876053|P1|NOT COMPLETED|Treatment Phase||21
364976|NCT01159574|876053|P1|COMPLETED|Treatment Phase||100
364977|NCT01159574|876053|P1|STARTED|Treatment Phase||121
364978|NCT01159535|876060|P3|NOT COMPLETED|Overall Study||31
364979|NCT01159535|876061|P2|NOT COMPLETED|Overall Study||24
364980|NCT01159535|876062|P1|NOT COMPLETED|Overall Study||24
364981|NCT01159535|876060|P3|COMPLETED|Overall Study||64
364982|NCT01159535|876061|P2|COMPLETED|Overall Study||64
364983|NCT01159535|876062|P1|COMPLETED|Overall Study||79
364984|NCT01159535|876060|P3|STARTED|Overall Study||95
364985|NCT01159535|876061|P2|STARTED|Overall Study||88
364986|NCT01159535|876062|P1|STARTED|Overall Study||103
364987|NCT01159431|876072|P2|NOT COMPLETED|Overall Study||6
364988|NCT01159431|876073|P1|NOT COMPLETED|Overall Study||2
364989|NCT01159431|876072|P2|COMPLETED|Overall Study||19
364990|NCT01159431|876073|P1|COMPLETED|Overall Study||23
364991|NCT01159431|876072|P2|STARTED|Overall Study||25
364992|NCT01159431|876073|P1|STARTED|Overall Study||25
364993|NCT01159262|876092|P3|NOT COMPLETED|Overall Study||0
364994|NCT01159262|876093|P2|NOT COMPLETED|Overall Study||0
364995|NCT01159262|876094|P1|NOT COMPLETED|Overall Study||0
364996|NCT01159262|876092|P3|COMPLETED|Overall Study||8
364997|NCT01159262|876093|P2|COMPLETED|Overall Study||14
364998|NCT01159262|876094|P1|COMPLETED|Overall Study||14
364999|NCT01159262|876092|P3|STARTED|Overall Study||8
365000|NCT01159262|876093|P2|STARTED|Overall Study||14
365001|NCT01159262|876094|P1|STARTED|Overall Study||14
365002|NCT01159171|876126|P1|NOT COMPLETED|Overall Study||50
365003|NCT01159171|876126|P1|COMPLETED|Overall Study||0
365004|NCT01159171|876126|P1|STARTED|Overall Study||50
365005|NCT01157845|876141|P1|NOT COMPLETED|Overall Study||35
365006|NCT01157845|876141|P1|COMPLETED|Overall Study||130
365007|NCT01157845|876141|P1|STARTED|Overall Study||165
365008|NCT01158924|876148|P2|NOT COMPLETED|Overall Study||3
365009|NCT01158924|876149|P1|NOT COMPLETED|Overall Study||1
365010|NCT01158924|876148|P2|COMPLETED|Overall Study||23
365011|NCT01158924|876149|P1|COMPLETED|Overall Study||13
365012|NCT01158924|876148|P2|STARTED|Overall Study||26
365013|NCT01158924|876149|P1|STARTED|Overall Study||14
365014|NCT01158716|876165|P2|NOT COMPLETED|Overall Study||1
365015|NCT01158716|876166|P1|NOT COMPLETED|Overall Study||1
365016|NCT01158716|876165|P2|COMPLETED|Overall Study||47
365017|NCT01158716|876166|P1|COMPLETED|Overall Study||47
365018|NCT01158716|876165|P2|STARTED|Overall Study||48
365019|NCT01158716|876166|P1|STARTED|Overall Study||48
365020|NCT01158703|876174|P2|NOT COMPLETED|Overall Study||0
365021|NCT01158703|876175|P1|NOT COMPLETED|Overall Study||0
365022|NCT01158703|876174|P2|COMPLETED|Overall Study||8
365023|NCT01158703|876175|P1|COMPLETED|Overall Study||12
365024|NCT01158703|876174|P2|STARTED|Overall Study||8
365025|NCT01158703|876175|P1|STARTED|Overall Study||12
365026|NCT01158534|876191|P1|NOT COMPLETED|Overall Study||3
365027|NCT01158534|876191|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
365028|NCT01158534|876191|P1|STARTED|Overall Study||17
365029|NCT01158378|876201|P2|NOT COMPLETED|Overall Study||9
365030|NCT01158378|876202|P1|NOT COMPLETED|Overall Study||10
365031|NCT01158378|876201|P2|COMPLETED|Overall Study||117
365032|NCT01158378|876202|P1|COMPLETED|Overall Study||114
365033|NCT01158378|876201|P2|STARTED|Overall Study||126
365034|NCT01158378|876202|P1|STARTED|Overall Study||124
365035|NCT01158261|876214|P1|NOT COMPLETED|Overall Study||17
365036|NCT01158261|876214|P1|COMPLETED|Overall Study||283
365037|NCT01158261|876214|P1|STARTED|Overall Study||300
365038|NCT01158118|876220|P2|NOT COMPLETED|Overall Study||3
365039|NCT01158118|876221|P1|NOT COMPLETED|Overall Study||1
365040|NCT01158118|876220|P2|COMPLETED|Overall Study||21
365041|NCT01158118|876221|P1|COMPLETED|Overall Study||23
365042|NCT01158118|876220|P2|STARTED|Overall Study||24
365043|NCT01158118|876221|P1|STARTED|Overall Study||24
365044|NCT01157533|876237|P1|NOT COMPLETED|Overall Study||0
365045|NCT01157533|876237|P1|COMPLETED|Overall Study||1
365046|NCT01157533|876237|P1|STARTED|Overall Study||1
365047|NCT01157429|876243|P2|NOT COMPLETED|Overall Study||4
365048|NCT01157429|876244|P1|NOT COMPLETED|Overall Study||4
365049|NCT01157429|876243|P2|COMPLETED|Overall Study||8
365050|NCT01157429|876244|P1|COMPLETED|Overall Study||8
365051|NCT01157429|876243|P2|STARTED|Overall Study||12
365052|NCT01157429|876244|P1|STARTED|Overall Study||12
365053|NCT01157416|876252|P2|NOT COMPLETED|Overall Study||0
365054|NCT01157416|876253|P1|NOT COMPLETED|Overall Study||2
365055|NCT01157416|876252|P2|COMPLETED|Overall Study||16
365056|NCT01157416|876253|P1|COMPLETED|Overall Study||15
365057|NCT01157416|876252|P2|STARTED|Overall Study||16
365058|NCT01157416|876253|P1|STARTED|Overall Study||17
365059|NCT01157377|876266|P7|NOT COMPLETED|Overall Study||2
365060|NCT01157377|876267|P6|NOT COMPLETED|Overall Study||3
365061|NCT01157377|876268|P5|NOT COMPLETED|Overall Study||2
365062|NCT01157377|876269|P4|NOT COMPLETED|Overall Study||1
365063|NCT01157377|876270|P3|NOT COMPLETED|Overall Study||1
365064|NCT01157377|876271|P2|NOT COMPLETED|Overall Study||3
365065|NCT01157377|876272|P1|NOT COMPLETED|Overall Study||2
365066|NCT01157377|876266|P7|COMPLETED|Overall Study||27
365067|NCT01157377|876267|P6|COMPLETED|Overall Study||16
365068|NCT01157377|876268|P5|COMPLETED|Overall Study||18
365069|NCT01157377|876269|P4|COMPLETED|Overall Study||14
365070|NCT01157377|876270|P3|COMPLETED|Overall Study||26
365071|NCT01157377|876271|P2|COMPLETED|Overall Study||20
365072|NCT01157377|876272|P1|COMPLETED|Overall Study||21
365073|NCT01157377|876266|P7|STARTED|Overall Study||29
365074|NCT01157377|876267|P6|STARTED|Overall Study||19
365075|NCT01157377|876268|P5|STARTED|Overall Study||20
365076|NCT01157377|876269|P4|STARTED|Overall Study||15
365077|NCT01157377|876270|P3|STARTED|Overall Study||27
365078|NCT01157377|876271|P2|STARTED|Overall Study||23
365079|NCT01157377|876272|P1|STARTED|Overall Study||23
365080|NCT01157351|876290|P2|NOT COMPLETED|Overall Study||132
365081|NCT01157351|876291|P1|NOT COMPLETED|Overall Study||137
365082|NCT01157351|876290|P2|COMPLETED|Overall Study||88
365083|NCT01157351|876291|P1|COMPLETED|Overall Study||93
365084|NCT01157351|876290|P2|Treated|Overall Study||218
365085|NCT01157351|876291|P1|Treated|Overall Study||226
365086|NCT01157351|876290|P2|STARTED|Overall Study||220
365087|NCT01157351|876291|P1|STARTED|Overall Study||230
365088|NCT01157234|876309|P2|NOT COMPLETED|Overall Study||0
365089|NCT01157234|876310|P1|NOT COMPLETED|Overall Study||1
365090|NCT01157234|876309|P2|COMPLETED|Overall Study||15
365091|NCT01157234|876310|P1|COMPLETED|Overall Study||14
365092|NCT01157234|876309|P2|STARTED|Overall Study||15
365093|NCT01157234|876310|P1|STARTED|Overall Study||15
365094|NCT01157182|876342|P2|NOT COMPLETED|Second Intervention||0
365095|NCT01157182|876343|P1|NOT COMPLETED|Second Intervention||0
365096|NCT01157182|876342|P2|COMPLETED|Second Intervention||18
365097|NCT01157182|876343|P1|COMPLETED|Second Intervention||16
365098|NCT01157182|876342|P2|STARTED|Second Intervention||18
365099|NCT01157182|876343|P1|STARTED|Second Intervention||16
365100|NCT01157182|876342|P2|NOT COMPLETED|Washout of 28 Days||0
365101|NCT01157182|876343|P1|NOT COMPLETED|Washout of 28 Days||2
365102|NCT01157182|876342|P2|COMPLETED|Washout of 28 Days||18
365103|NCT01157182|876343|P1|COMPLETED|Washout of 28 Days||16
365104|NCT01157182|876342|P2|STARTED|Washout of 28 Days||18
365105|NCT01157182|876343|P1|STARTED|Washout of 28 Days||18
365106|NCT01157182|876342|P2|NOT COMPLETED|First Intervention||0
365107|NCT01157182|876343|P1|NOT COMPLETED|First Intervention||0
365108|NCT01157182|876342|P2|COMPLETED|First Intervention||18
365109|NCT01157182|876343|P1|COMPLETED|First Intervention||18
365110|NCT01157182|876342|P2|STARTED|First Intervention||18
365111|NCT01157182|876343|P1|STARTED|First Intervention||18
365112|NCT01157169|876391|P2|NOT COMPLETED|Second Intervention||1
365113|NCT01157169|876392|P1|NOT COMPLETED|Second Intervention||0
365114|NCT01157169|876391|P2|COMPLETED|Second Intervention||17
365115|NCT01157169|876392|P1|COMPLETED|Second Intervention||16
365116|NCT01157169|876391|P2|STARTED|Second Intervention||18
365117|NCT01157169|876392|P1|STARTED|Second Intervention||16
365118|NCT01157169|876391|P2|NOT COMPLETED|Washout of 10 Days||0
365119|NCT01157169|876392|P1|NOT COMPLETED|Washout of 10 Days||0
365120|NCT01157169|876391|P2|COMPLETED|Washout of 10 Days||18
365121|NCT01157169|876392|P1|COMPLETED|Washout of 10 Days||16
365122|NCT01157169|876391|P2|STARTED|Washout of 10 Days||18
365123|NCT01157169|876392|P1|STARTED|Washout of 10 Days||16
365124|NCT01157169|876391|P2|NOT COMPLETED|First Intervention||2
365125|NCT01157169|876392|P1|NOT COMPLETED|First Intervention||4
365126|NCT01157169|876391|P2|COMPLETED|First Intervention||18
365127|NCT01157169|876392|P1|COMPLETED|First Intervention||16
365128|NCT01157169|876391|P2|STARTED|First Intervention||20
365129|NCT01157169|876392|P1|STARTED|First Intervention||20
365130|NCT01157117|876411|P3|NOT COMPLETED|Overall Study||15
365131|NCT01157117|876412|P2|NOT COMPLETED|Overall Study||11
365132|NCT01157117|876413|P1|NOT COMPLETED|Overall Study||9
365133|NCT01157117|876411|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
365134|NCT01157117|876412|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
365135|NCT01157117|876413|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
365136|NCT01157117|876411|P3|Completed Final Month 38 Study Visit|Overall Study||3
365137|NCT01157117|876412|P2|Completed Final Month 38 Study Visit|Overall Study||18
365138|NCT01157117|876413|P1|Completed Final Month 38 Study Visit|Overall Study||19
365139|NCT01157117|876411|P3|Completed Month 32 Tolerance OFC|Overall Study||0
365140|NCT01157117|876412|P2|Completed Month 32 Tolerance OFC|Overall Study||20
365141|NCT01157117|876413|P1|Completed Month 32 Tolerance OFC|Overall Study||24
365142|NCT01157117|876411|P3|Discontinued Milk OIT at Month 30|Overall Study||0
365143|NCT01157117|876412|P2|Discontinued Milk OIT at Month 30|Overall Study||20
365144|NCT01157117|876413|P1|Discontinued Milk OIT at Month 30|Overall Study||24
365145|NCT01157117|876411|P3|Completed Month 28 Desensitization OFC|Overall Study||0
365146|NCT01157117|876412|P2|Completed Month 28 Desensitization OFC|Overall Study||24
365147|NCT01157117|876413|P1|Completed Month 28 Desensitization OFC|Overall Study||26
365148|NCT01157117|876411|P3|Unblinded at Month 16|Overall Study||0
365149|NCT01157117|876412|P2|Unblinded at Month 16|Overall Study||26
365150|NCT01157117|876413|P1|Unblinded at Month 16|Overall Study||26
365151|NCT01157117|876411|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
365152|NCT01157117|876412|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
365153|NCT01157117|876413|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
365154|NCT01157117|876411|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
365155|NCT01157117|876412|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
365156|NCT01157117|876413|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
365157|NCT01157117|876411|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
365158|NCT01157117|876412|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
365159|NCT01157117|876413|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
365160|NCT01157117|876411|P3|STARTED|Overall Study||20
365161|NCT01157117|876412|P2|STARTED|Overall Study||29
365162|NCT01157117|876413|P1|STARTED|Overall Study||28
365163|NCT01157078|876454|P2|NOT COMPLETED|Overall Study||36
365164|NCT01157078|876455|P1|NOT COMPLETED|Overall Study||35
365165|NCT01157078|876454|P2|COMPLETED|Overall Study||124
365166|NCT01157078|876455|P1|COMPLETED|Overall Study||124
365167|NCT01157078|876454|P2|Received Treatment|Overall Study||159
365168|NCT01157078|876455|P1|Received Treatment|Overall Study||157
365169|NCT01157078|876454|P2|STARTED|Overall Study||160
365170|NCT01157078|876455|P1|STARTED|Overall Study||159
365171|NCT01157065|876505|P2|NOT COMPLETED|Overall Study||1
365172|NCT01157065|876506|P1|NOT COMPLETED|Overall Study||0
365173|NCT01157065|876505|P2|COMPLETED|Overall Study||10
365174|NCT01157065|876506|P1|COMPLETED|Overall Study||38
365175|NCT01157065|876505|P2|STARTED|Overall Study||11
365176|NCT01157065|876506|P1|STARTED|Overall Study||38
365177|NCT01156987|876516|P2|NOT COMPLETED|Overall Study||11
365178|NCT01156987|876517|P1|NOT COMPLETED|Overall Study||0
365179|NCT01156987|876516|P2|COMPLETED|Overall Study||12
365180|NCT01156987|876517|P1|COMPLETED|Overall Study||8
365181|NCT01156987|876516|P2|STARTED|Overall Study||23
365182|NCT01156987|876517|P1|STARTED|Overall Study||8
365183|NCT01156844|876527|P4|NOT COMPLETED|Overall Study||6
365184|NCT01156844|876528|P3|NOT COMPLETED|Overall Study||6
365185|NCT01156844|876529|P2|NOT COMPLETED|Overall Study||2
365186|NCT01156844|876530|P1|NOT COMPLETED|Overall Study||2
365187|NCT01156844|876527|P4|COMPLETED|Overall Study||41
365188|NCT01156844|876528|P3|COMPLETED|Overall Study||42
365189|NCT01156844|876529|P2|COMPLETED|Overall Study||46
365190|NCT01156844|876530|P1|COMPLETED|Overall Study||46
365191|NCT01156844|876527|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
365192|NCT01156844|876528|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
365193|NCT01156844|876529|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
365194|NCT01156844|876530|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
365195|NCT01156844|876527|P4|STARTED|Overall Study||47
365196|NCT01156844|876528|P3|STARTED|Overall Study||48
365197|NCT01156844|876529|P2|STARTED|Overall Study||48
365198|NCT01156844|876530|P1|STARTED|Overall Study|Randomized participants.|48
365199|NCT01156792|876549|P1|NOT COMPLETED|Overall Study||69
365200|NCT01156792|876549|P1|COMPLETED|Overall Study||93
365201|NCT01156792|876549|P1|STARTED|Overall Study||162
365202|NCT01156701|876614|P4|NOT COMPLETED|Overall Study||0
365203|NCT01156701|876615|P3|NOT COMPLETED|Overall Study||0
365204|NCT01156701|876616|P2|NOT COMPLETED|Overall Study||0
365205|NCT01156701|876617|P1|NOT COMPLETED|Overall Study||0
365206|NCT01156701|876614|P4|COMPLETED|Overall Study||6725
365207|NCT01156701|876615|P3|COMPLETED|Overall Study||163716
365208|NCT01156701|876616|P2|COMPLETED|Overall Study||1007
365209|NCT01156701|876617|P1|COMPLETED|Overall Study||257
365210|NCT01156701|876614|P4|STARTED|Overall Study||6725
365211|NCT01156701|876615|P3|STARTED|Overall Study||163716
365212|NCT01156701|876616|P2|STARTED|Overall Study||1007
365213|NCT01156701|876617|P1|STARTED|Overall Study||257
365214|NCT01156597|876653|P2|NOT COMPLETED|Overall Study||1
365215|NCT01156597|876654|P1|NOT COMPLETED|Overall Study||3
365216|NCT01156597|876653|P2|COMPLETED|Overall Study||13
365217|NCT01156597|876654|P1|COMPLETED|Overall Study||13
365218|NCT01156597|876653|P2|STARTED|Overall Study||14
365219|NCT01156597|876654|P1|STARTED|Overall Study||16
365220|NCT01156571|876666|P2|NOT COMPLETED|Overall Study||19
365221|NCT01156571|876667|P1|NOT COMPLETED|Overall Study||17
365222|NCT01156571|876666|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
365223|NCT01156571|876667|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
365224|NCT01156571|876666|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
365225|NCT01156571|876667|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
365226|NCT01156532|876677|P1|NOT COMPLETED|Overall Study||2
365227|NCT01156532|876677|P1|COMPLETED|Overall Study||28
365228|NCT01156532|876677|P1|STARTED|Overall Study||30
365229|NCT01156480|876689|P2|NOT COMPLETED|Overall Study||1
365230|NCT01156480|876690|P1|NOT COMPLETED|Overall Study||0
365231|NCT01156480|876689|P2|COMPLETED|Overall Study||1
365232|NCT01156480|876690|P1|COMPLETED|Overall Study||0
365233|NCT01156480|876689|P2|STARTED|Overall Study||2
365234|NCT01156480|876690|P1|STARTED|Overall Study||0
365235|NCT01156376|876701|P3|NOT COMPLETED|Overall Study||4
365236|NCT01156376|876702|P2|NOT COMPLETED|Overall Study||0
365237|NCT01156376|876703|P1|NOT COMPLETED|Overall Study||1
365238|NCT01156376|876701|P3|COMPLETED|Overall Study||23
365239|NCT01156376|876702|P2|COMPLETED|Overall Study||26
365240|NCT01156376|876703|P1|COMPLETED|Overall Study||26
365241|NCT01156376|876701|P3|STARTED|Overall Study||27
365242|NCT01156376|876702|P2|STARTED|Overall Study||26
365243|NCT01156376|876703|P1|STARTED|Overall Study||27
365244|NCT01156363|876924|P1|NOT COMPLETED|Overall Study||22
365245|NCT01156363|876924|P1|COMPLETED|Overall Study||64
365246|NCT01156363|876924|P1|STARTED|Overall Study||86
365247|NCT01156311|876946|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
365248|NCT01156311|876947|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
365249|NCT01156311|876948|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
365250|NCT01156311|876949|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
365251|NCT01156311|876946|P4|COMPLETED|6-month Add-on Therapy Period||37
365252|NCT01156311|876947|P3|COMPLETED|6-month Add-on Therapy Period||45
365253|NCT01156311|876948|P2|COMPLETED|6-month Add-on Therapy Period||0
365254|NCT01156311|876949|P1|COMPLETED|6-month Add-on Therapy Period||0
365255|NCT01156311|876946|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
365256|NCT01156311|876947|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
365257|NCT01156311|876948|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
365258|NCT01156311|876949|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
365259|NCT01156311|876946|P4|STARTED|6-month Add-on Therapy Period||47
365260|NCT01156311|876947|P3|STARTED|6-month Add-on Therapy Period||57
365261|NCT01156311|876948|P2|STARTED|6-month Add-on Therapy Period||0
365262|NCT01156311|876949|P1|STARTED|6-month Add-on Therapy Period||0
365263|NCT01156311|876946|P4|NOT COMPLETED|2-Month Monotherapy Period||0
365264|NCT01156311|876947|P3|NOT COMPLETED|2-Month Monotherapy Period||0
365265|NCT01156311|876948|P2|NOT COMPLETED|2-Month Monotherapy Period||2
365266|NCT01156311|876949|P1|NOT COMPLETED|2-Month Monotherapy Period||2
365267|NCT01156311|876946|P4|COMPLETED|2-Month Monotherapy Period||0
365268|NCT01156311|876947|P3|COMPLETED|2-Month Monotherapy Period||0
365269|NCT01156311|876948|P2|COMPLETED|2-Month Monotherapy Period||47
365270|NCT01156311|876949|P1|COMPLETED|2-Month Monotherapy Period||57
365271|NCT01156311|876946|P4|STARTED|2-Month Monotherapy Period||0
365272|NCT01156311|876947|P3|STARTED|2-Month Monotherapy Period||0
365273|NCT01156311|876948|P2|STARTED|2-Month Monotherapy Period||49
365274|NCT01156311|876949|P1|STARTED|2-Month Monotherapy Period||59
365275|NCT01156142|876973|P2|NOT COMPLETED|Overall Study||7
365276|NCT01156142|876974|P1|NOT COMPLETED|Overall Study||8
365277|NCT01156142|876973|P2|COMPLETED|Overall Study||71
365278|NCT01156142|876974|P1|COMPLETED|Overall Study||69
365279|NCT01156142|876973|P2|STARTED|Overall Study||78
365280|NCT01156142|876974|P1|STARTED|Overall Study||77
365281|NCT01156116|876992|P2|NOT COMPLETED|Overall Study||1
365282|NCT01156116|876993|P1|NOT COMPLETED|Overall Study||5
365283|NCT01156116|876992|P2|COMPLETED|Overall Study||12
365284|NCT01156116|876993|P1|COMPLETED|Overall Study||21
365285|NCT01156116|876992|P2|STARTED|Overall Study||13
365286|NCT01156116|876993|P1|STARTED|Overall Study||26
365287|NCT01156051|877007|P2|NOT COMPLETED|Overall Study||1
365288|NCT01156051|877008|P1|NOT COMPLETED|Overall Study||1
365289|NCT01156051|877007|P2|COMPLETED|Overall Study||16
365290|NCT01156051|877008|P1|COMPLETED|Overall Study||11
365291|NCT01156051|877007|P2|STARTED|Overall Study||17
365292|NCT01156051|877008|P1|STARTED|Overall Study||12
365293|NCT01156012|877022|P2|NOT COMPLETED|Overall Study||3
365294|NCT01156012|877023|P1|NOT COMPLETED|Overall Study||7
365295|NCT01156012|877022|P2|COMPLETED|Overall Study||186
365296|NCT01156012|877023|P1|COMPLETED|Overall Study||206
365297|NCT01156012|877022|P2|STARTED|Overall Study||189
365298|NCT01156012|877023|P1|STARTED|Overall Study||213
365299|NCT01155999|877031|P2|NOT COMPLETED|Overall Study||4
365300|NCT01155999|877032|P1|NOT COMPLETED|Overall Study||7
365301|NCT01155999|877031|P2|COMPLETED|Overall Study||136
365302|NCT01155999|877032|P1|COMPLETED|Overall Study||139
365303|NCT01155999|877031|P2|STARTED|Overall Study||140
365304|NCT01155999|877032|P1|STARTED|Overall Study||146
365305|NCT01155869|877040|P2|NOT COMPLETED|Overall Study||1
365306|NCT01155869|877041|P1|NOT COMPLETED|Overall Study||3
365307|NCT01155869|877040|P2|COMPLETED|Overall Study||3
365308|NCT01155869|877041|P1|COMPLETED|Overall Study||0
365309|NCT01155869|877040|P2|STARTED|Overall Study||4
365310|NCT01155869|877041|P1|STARTED|Overall Study||3
365311|NCT01155830|877052|P3|NOT COMPLETED|Overall Study||0
365312|NCT01155830|877053|P2|NOT COMPLETED|Overall Study||0
365313|NCT01155830|877054|P1|NOT COMPLETED|Overall Study||0
365314|NCT01155830|877052|P3|COMPLETED|Overall Study||21
365315|NCT01155830|877053|P2|COMPLETED|Overall Study||0
365316|NCT01155830|877054|P1|COMPLETED|Overall Study||0
365317|NCT01155830|877052|P3|STARTED|Overall Study||21
365318|NCT01155830|877053|P2|STARTED|Overall Study||0
365319|NCT01155830|877054|P1|STARTED|Overall Study||0
365320|NCT01155726|877065|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
365321|NCT01155726|877066|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
365322|NCT01155726|877067|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
365323|NCT01155726|877068|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
365324|NCT01155726|877065|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
365325|NCT01155726|877066|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
365326|NCT01155726|877067|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
365327|NCT01155726|877068|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
365328|NCT01155726|877065|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
365329|NCT01155726|877066|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
365330|NCT01155726|877067|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
365331|NCT01155726|877068|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
365332|NCT01155726|877065|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
365333|NCT01155726|877066|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
365334|NCT01155726|877067|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
365335|NCT01155726|877068|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
365336|NCT01155726|877065|P4|COMPLETED|Period 1, 3 Days (Masked)||25
365337|NCT01155726|877066|P3|COMPLETED|Period 1, 3 Days (Masked)||28
365338|NCT01155726|877067|P2|COMPLETED|Period 1, 3 Days (Masked)||20
365339|NCT01155726|877068|P1|COMPLETED|Period 1, 3 Days (Masked)||23
365340|NCT01155726|877065|P4|STARTED|Period 1, 3 Days (Masked)||25
365341|NCT01155726|877066|P3|STARTED|Period 1, 3 Days (Masked)||30
365342|NCT01155726|877067|P2|STARTED|Period 1, 3 Days (Masked)||20
365343|NCT01155726|877068|P1|STARTED|Period 1, 3 Days (Masked)||24
365344|NCT01155570|877090|P1|NOT COMPLETED|Overall Study||142
365345|NCT01155570|877090|P1|COMPLETED|Overall Study||592
365346|NCT01155570|877090|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
365347|NCT01155570|877090|P1|STARTED|Overall Study|Safety Analysis Population|734
365348|NCT01155531|877124|P4|NOT COMPLETED|Overall Study||1
365349|NCT01155531|877125|P3|NOT COMPLETED|Overall Study||2
365350|NCT01155531|877126|P2|NOT COMPLETED|Overall Study||0
365351|NCT01155531|877127|P1|NOT COMPLETED|Overall Study||1
365352|NCT01155531|877124|P4|COMPLETED|Overall Study||9
365353|NCT01155531|877125|P3|COMPLETED|Overall Study||8
365354|NCT01155531|877126|P2|COMPLETED|Overall Study||10
365355|NCT01155531|877127|P1|COMPLETED|Overall Study||9
365356|NCT01155531|877124|P4|STARTED|Overall Study||10
365357|NCT01155531|877125|P3|STARTED|Overall Study||10
365358|NCT01155531|877126|P2|STARTED|Overall Study||10
365359|NCT01155531|877127|P1|STARTED|Overall Study||10
365360|NCT01155479|877150|P5|NOT COMPLETED|Part II||55
365361|NCT01155479|877151|P4|NOT COMPLETED|Part II||50
365362|NCT01155479|877152|P3|NOT COMPLETED|Part II||58
365363|NCT01155479|877153|P2|NOT COMPLETED|Part II||61
365364|NCT01155479|877154|P1|NOT COMPLETED|Part II||59
365365|NCT01155479|877150|P5|COMPLETED|Part II||126
365366|NCT01155479|877151|P4|COMPLETED|Part II||127
365367|NCT01155479|877152|P3|COMPLETED|Part II||109
365368|NCT01155479|877153|P2|COMPLETED|Part II||116
365369|NCT01155479|877154|P1|COMPLETED|Part II||107
365370|NCT01155479|877150|P5|STARTED|Part II||181
365371|NCT01155479|877151|P4|STARTED|Part II||177
365372|NCT01155479|877152|P3|STARTED|Part II||167
365373|NCT01155479|877153|P2|STARTED|Part II||177
365374|NCT01155479|877154|P1|STARTED|Part II||166
365375|NCT01155479|877150|P5|NOT COMPLETED|Part I||23
365376|NCT01155479|877151|P4|NOT COMPLETED|Part I||27
365377|NCT01155479|877152|P3|NOT COMPLETED|Part I||39
365378|NCT01155479|877153|P2|NOT COMPLETED|Part I||27
365379|NCT01155479|877154|P1|NOT COMPLETED|Part I||38
365380|NCT01155479|877150|P5|COMPLETED|Part I||181
365381|NCT01155479|877151|P4|COMPLETED|Part I||177
365382|NCT01155479|877152|P3|COMPLETED|Part I||167
365383|NCT01155479|877153|P2|COMPLETED|Part I||177
365384|NCT01155479|877154|P1|COMPLETED|Part I||166
365385|NCT01155479|877150|P5|Treated|Part I||203
365386|NCT01155479|877151|P4|Treated|Part I||198
365387|NCT01155479|877152|P3|Treated|Part I||204
365388|NCT01155479|877153|P2|Treated|Part I||202
365389|NCT01155479|877154|P1|Treated|Part I||200
365390|NCT01155479|877150|P5|STARTED|Part I||204
365391|NCT01155479|877151|P4|STARTED|Part I||204
365392|NCT01155479|877152|P3|STARTED|Part I||206
365393|NCT01155479|877153|P2|STARTED|Part I||204
365394|NCT01155479|877154|P1|STARTED|Part I||204
365395|NCT01155466|877206|P5|NOT COMPLETED|Overall Study||27
365396|NCT01155466|877207|P4|NOT COMPLETED|Overall Study||21
365397|NCT01155466|877208|P3|NOT COMPLETED|Overall Study||20
365398|NCT01155466|877209|P2|NOT COMPLETED|Overall Study||25
365399|NCT01155466|877210|P1|NOT COMPLETED|Overall Study||22
365400|NCT01155466|877206|P5|COMPLETED|Overall Study|Completed treatment phase|129
365401|NCT01155466|877207|P4|COMPLETED|Overall Study|Completed treatment phase|134
365402|NCT01155466|877208|P3|COMPLETED|Overall Study|Completed treatment phase|136
365403|NCT01155466|877209|P2|COMPLETED|Overall Study|Completed treatment phase|130
365404|NCT01155466|877210|P1|COMPLETED|Overall Study|Completed treatment phase|134
365405|NCT01155466|877206|P5|Treated|Overall Study||154
365406|NCT01155466|877207|P4|Treated|Overall Study||155
365407|NCT01155466|877208|P3|Treated|Overall Study||153
365408|NCT01155466|877209|P2|Treated|Overall Study||153
365409|NCT01155466|877210|P1|Treated|Overall Study||154
365410|NCT01155466|877206|P5|STARTED|Overall Study||156
365411|NCT01155466|877207|P4|STARTED|Overall Study||155
365412|NCT01155466|877208|P3|STARTED|Overall Study||156
365413|NCT01155466|877209|P2|STARTED|Overall Study||155
365414|NCT01155466|877210|P1|STARTED|Overall Study||156
365415|NCT01155336|877264|P2|NOT COMPLETED|Overall Study||0
365416|NCT01155336|877265|P1|NOT COMPLETED|Overall Study||0
365417|NCT01155336|877264|P2|COMPLETED|Overall Study|We did not complete the study.|4
365418|NCT01155336|877265|P1|COMPLETED|Overall Study|We did not complete the study.|0
365419|NCT01155336|877264|P2|STARTED|Overall Study|We did not complete the study.|4
365420|NCT01155336|877265|P1|STARTED|Overall Study|We did not complete the study.|0
365421|NCT01155323|877271|P2|NOT COMPLETED|Second Intervention||1
365422|NCT01155323|877272|P1|NOT COMPLETED|Second Intervention||1
365423|NCT01155323|877271|P2|COMPLETED|Second Intervention||56
365424|NCT01155323|877272|P1|COMPLETED|Second Intervention||58
365425|NCT01155323|877271|P2|STARTED|Second Intervention||57
365426|NCT01155323|877272|P1|STARTED|Second Intervention||59
365427|NCT01155323|877271|P2|NOT COMPLETED|First Intervention||1
365428|NCT01155323|877272|P1|NOT COMPLETED|First Intervention||1
365429|NCT01155323|877271|P2|COMPLETED|First Intervention||57
365430|NCT01155323|877272|P1|COMPLETED|First Intervention||59
365431|NCT01155323|877271|P2|STARTED|First Intervention||58
365432|NCT01155323|877272|P1|STARTED|First Intervention||60
365433|NCT01155219|877290|P2|NOT COMPLETED|Overall Study||3
365434|NCT01155219|877291|P1|NOT COMPLETED|Overall Study||4
365435|NCT01155219|877290|P2|COMPLETED|Overall Study||70
365436|NCT01155219|877291|P1|COMPLETED|Overall Study||73
365437|NCT01155219|877290|P2|STARTED|Overall Study||73
365438|NCT01155219|877291|P1|STARTED|Overall Study||77
365439|NCT01155180|877299|P2|NOT COMPLETED|Overall Study||0
365440|NCT01155180|877300|P1|NOT COMPLETED|Overall Study||0
365441|NCT01155180|877299|P2|COMPLETED|Overall Study||6
365442|NCT01155180|877300|P1|COMPLETED|Overall Study||18
365443|NCT01155180|877299|P2|STARTED|Overall Study||6
365444|NCT01155180|877300|P1|STARTED|Overall Study||18
365445|NCT01155167|877308|P2|NOT COMPLETED|Overall Study||0
365446|NCT01155167|877309|P1|NOT COMPLETED|Overall Study||3
365447|NCT01155167|877308|P2|COMPLETED|Overall Study||43
365448|NCT01155167|877309|P1|COMPLETED|Overall Study||40
365449|NCT01155167|877308|P2|STARTED|Overall Study||43
365450|NCT01155167|877309|P1|STARTED|Overall Study||43
365451|NCT01155154|877322|P3|NOT COMPLETED|Overall Study||0
365452|NCT01155154|877323|P2|NOT COMPLETED|Overall Study||0
365453|NCT01155154|877324|P1|NOT COMPLETED|Overall Study||0
365454|NCT01155154|877322|P3|COMPLETED|Overall Study||24
365455|NCT01155154|877323|P2|COMPLETED|Overall Study||24
365456|NCT01155154|877324|P1|COMPLETED|Overall Study||25
365457|NCT01155154|877322|P3|STARTED|Overall Study||24
365458|NCT01155154|877323|P2|STARTED|Overall Study||24
365459|NCT01155154|877324|P1|STARTED|Overall Study||25
365460|NCT01155141|877332|P1|NOT COMPLETED|Overall Study||2
365461|NCT01155141|877332|P1|COMPLETED|Overall Study||14
365462|NCT01155141|877332|P1|STARTED|Overall Study||16
365463|NCT01155063|877344|P1|NOT COMPLETED|Overall Study||89
365464|NCT01155063|877344|P1|COMPLETED|Overall Study||0
365465|NCT01155063|877344|P1|STARTED|Overall Study||89
365466|NCT01155024|877354|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
365467|NCT01155024|877355|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
365468|NCT01155024|877354|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
365469|NCT01155024|877355|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
365470|NCT01155024|877354|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
365471|NCT01155024|877355|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
365472|NCT01155024|877354|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
365473|NCT01155024|877355|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
365474|NCT01155024|877354|P2|COMPLETED|Second Socket Intervention Fitting||5
365475|NCT01155024|877355|P1|COMPLETED|Second Socket Intervention Fitting||5
365476|NCT01155024|877354|P2|STARTED|Second Socket Intervention Fitting||5
365477|NCT01155024|877355|P1|STARTED|Second Socket Intervention Fitting||5
365478|NCT01155024|877354|P2|NOT COMPLETED|First Socket Intervention Fitting||0
365479|NCT01155024|877355|P1|NOT COMPLETED|First Socket Intervention Fitting||0
365480|NCT01155024|877354|P2|COMPLETED|First Socket Intervention Fitting||5
365481|NCT01155024|877355|P1|COMPLETED|First Socket Intervention Fitting||5
365482|NCT01155024|877354|P2|STARTED|First Socket Intervention Fitting||5
365483|NCT01155024|877355|P1|STARTED|First Socket Intervention Fitting||5
365484|NCT01154985|877366|P3|NOT COMPLETED|Overall Study||18
365485|NCT01154985|877367|P2|NOT COMPLETED|Overall Study||27
365486|NCT01154985|877368|P1|NOT COMPLETED|Overall Study||17
365487|NCT01154985|877366|P3|COMPLETED|Overall Study||68
365488|NCT01154985|877367|P2|COMPLETED|Overall Study||55
365489|NCT01154985|877368|P1|COMPLETED|Overall Study||58
365490|NCT01154985|877366|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
365491|NCT01154985|877367|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
365492|NCT01154985|877368|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
365493|NCT01154985|877366|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
365494|NCT01154985|877367|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
365495|NCT01154985|877368|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
365496|NCT01154985|877366|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
365497|NCT01154985|877367|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
365585|NCT01154634|877473|P1|STARTED|Period 7 - Fourth Intervention||4
365498|NCT01154985|877368|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
365499|NCT01154985|877366|P3|STARTED|Overall Study|Randomized|86
365500|NCT01154985|877367|P2|STARTED|Overall Study|Randomized|82
365501|NCT01154985|877368|P1|STARTED|Overall Study|Randomized|75
365502|NCT01154816|877394|P12|NOT COMPLETED|Overall Study||4
365503|NCT01154816|877395|P11|NOT COMPLETED|Overall Study||11
365504|NCT01154816|877396|P10|NOT COMPLETED|Overall Study||10
365505|NCT01154816|877397|P9|NOT COMPLETED|Overall Study||9
365506|NCT01154816|877398|P8|NOT COMPLETED|Overall Study||7
365507|NCT01154816|877399|P7|NOT COMPLETED|Overall Study||6
365508|NCT01154816|877400|P6|NOT COMPLETED|Overall Study||8
365509|NCT01154816|877401|P5|NOT COMPLETED|Overall Study||10
365510|NCT01154816|877402|P4|NOT COMPLETED|Overall Study||10
365511|NCT01154816|877403|P3|NOT COMPLETED|Overall Study||10
365512|NCT01154816|877404|P2|NOT COMPLETED|Overall Study||10
365513|NCT01154816|877405|P1|NOT COMPLETED|Overall Study||20
365514|NCT01154816|877394|P12|COMPLETED|Overall Study||0
365515|NCT01154816|877395|P11|COMPLETED|Overall Study||0
365516|NCT01154816|877396|P10|COMPLETED|Overall Study||0
365517|NCT01154816|877397|P9|COMPLETED|Overall Study||1
365518|NCT01154816|877398|P8|COMPLETED|Overall Study||0
365519|NCT01154816|877399|P7|COMPLETED|Overall Study||0
365520|NCT01154816|877400|P6|COMPLETED|Overall Study||0
365521|NCT01154816|877401|P5|COMPLETED|Overall Study||0
365522|NCT01154816|877402|P4|COMPLETED|Overall Study||0
365523|NCT01154816|877403|P3|COMPLETED|Overall Study||0
365524|NCT01154816|877404|P2|COMPLETED|Overall Study||2
365525|NCT01154816|877405|P1|COMPLETED|Overall Study||0
365526|NCT01154816|877394|P12|STARTED|Overall Study||4
365527|NCT01154816|877395|P11|STARTED|Overall Study||11
365528|NCT01154816|877396|P10|STARTED|Overall Study||10
365529|NCT01154816|877397|P9|STARTED|Overall Study||10
365530|NCT01154816|877398|P8|STARTED|Overall Study||7
365531|NCT01154816|877399|P7|STARTED|Overall Study||6
365532|NCT01154816|877400|P6|STARTED|Overall Study||8
365533|NCT01154816|877401|P5|STARTED|Overall Study||10
365534|NCT01154816|877402|P4|STARTED|Overall Study||10
365535|NCT01154816|877403|P3|STARTED|Overall Study||10
365536|NCT01154816|877404|P2|STARTED|Overall Study||12
365537|NCT01154816|877405|P1|STARTED|Overall Study||20
365538|NCT01154699|877440|P2|NOT COMPLETED|Second Intervention||0
365539|NCT01154699|877441|P1|NOT COMPLETED|Second Intervention||0
365540|NCT01154699|877440|P2|COMPLETED|Second Intervention||8
365541|NCT01154699|877441|P1|COMPLETED|Second Intervention||13
365542|NCT01154699|877440|P2|Subjects With Asthma + OSA|Second Intervention||2
365543|NCT01154699|877441|P1|Subjects With Asthma + OSA|Second Intervention||6
365544|NCT01154699|877440|P2|Subjects With Asthma Only|Second Intervention||6
365545|NCT01154699|877441|P1|Subjects With Asthma Only|Second Intervention||7
365546|NCT01154699|877440|P2|STARTED|Second Intervention||8
365547|NCT01154699|877441|P1|STARTED|Second Intervention||13
365548|NCT01154699|877440|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
365549|NCT01154699|877441|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
365550|NCT01154699|877440|P2|COMPLETED|Washout Period (4 Weeks)||8
365551|NCT01154699|877441|P1|COMPLETED|Washout Period (4 Weeks)||13
365552|NCT01154699|877440|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
365553|NCT01154699|877441|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
365554|NCT01154699|877440|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
365555|NCT01154699|877441|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
365556|NCT01154699|877440|P2|STARTED|Washout Period (4 Weeks)||8
365557|NCT01154699|877441|P1|STARTED|Washout Period (4 Weeks)||13
365558|NCT01154699|877440|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
365559|NCT01154699|877441|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
365560|NCT01154699|877440|P2|COMPLETED|First Intervention (4 Weeks)||8
365561|NCT01154699|877441|P1|COMPLETED|First Intervention (4 Weeks)||13
365562|NCT01154699|877440|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
365563|NCT01154699|877441|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
365564|NCT01154699|877440|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
365565|NCT01154699|877441|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
365566|NCT01154699|877440|P2|STARTED|First Intervention (4 Weeks)||8
365567|NCT01154699|877441|P1|STARTED|First Intervention (4 Weeks)||13
365568|NCT01154673|877459|P2|NOT COMPLETED|Overall Study||0
365569|NCT01154673|877460|P1|NOT COMPLETED|Overall Study||2
365570|NCT01154673|877459|P2|COMPLETED|Overall Study||16
365571|NCT01154673|877460|P1|COMPLETED|Overall Study||14
365572|NCT01154673|877459|P2|STARTED|Overall Study||16
365573|NCT01154673|877460|P1|STARTED|Overall Study||16
365574|NCT01154634|877470|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
365575|NCT01154634|877471|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
365576|NCT01154634|877472|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
365577|NCT01154634|877473|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
365578|NCT01154634|877470|P4|COMPLETED|Period 7 - Fourth Intervention||5
365579|NCT01154634|877471|P3|COMPLETED|Period 7 - Fourth Intervention||4
365580|NCT01154634|877472|P2|COMPLETED|Period 7 - Fourth Intervention||7
365581|NCT01154634|877473|P1|COMPLETED|Period 7 - Fourth Intervention||4
365582|NCT01154634|877470|P4|STARTED|Period 7 - Fourth Intervention||5
365583|NCT01154634|877471|P3|STARTED|Period 7 - Fourth Intervention||4
365584|NCT01154634|877472|P2|STARTED|Period 7 - Fourth Intervention||7
365586|NCT01154634|877470|P4|NOT COMPLETED|Period 6 - Washout||0
365587|NCT01154634|877471|P3|NOT COMPLETED|Period 6 - Washout||0
365588|NCT01154634|877472|P2|NOT COMPLETED|Period 6 - Washout||0
365589|NCT01154634|877473|P1|NOT COMPLETED|Period 6 - Washout||0
365590|NCT01154634|877470|P4|COMPLETED|Period 6 - Washout||5
365591|NCT01154634|877471|P3|COMPLETED|Period 6 - Washout||4
365592|NCT01154634|877472|P2|COMPLETED|Period 6 - Washout||7
365593|NCT01154634|877473|P1|COMPLETED|Period 6 - Washout||4
365594|NCT01154634|877470|P4|STARTED|Period 6 - Washout||5
365595|NCT01154634|877471|P3|STARTED|Period 6 - Washout||4
365596|NCT01154634|877472|P2|STARTED|Period 6 - Washout||7
365597|NCT01154634|877473|P1|STARTED|Period 6 - Washout||4
365598|NCT01154634|877470|P4|NOT COMPLETED|Period 5 - Third Intervention||0
365599|NCT01154634|877471|P3|NOT COMPLETED|Period 5 - Third Intervention||0
365600|NCT01154634|877472|P2|NOT COMPLETED|Period 5 - Third Intervention||0
365601|NCT01154634|877473|P1|NOT COMPLETED|Period 5 - Third Intervention||0
365602|NCT01154634|877470|P4|COMPLETED|Period 5 - Third Intervention||5
365603|NCT01154634|877471|P3|COMPLETED|Period 5 - Third Intervention||4
365604|NCT01154634|877472|P2|COMPLETED|Period 5 - Third Intervention||7
365605|NCT01154634|877473|P1|COMPLETED|Period 5 - Third Intervention||4
365606|NCT01154634|877470|P4|STARTED|Period 5 - Third Intervention||5
365607|NCT01154634|877471|P3|STARTED|Period 5 - Third Intervention||4
365608|NCT01154634|877472|P2|STARTED|Period 5 - Third Intervention||7
365609|NCT01154634|877473|P1|STARTED|Period 5 - Third Intervention||4
365610|NCT01154634|877470|P4|NOT COMPLETED|Period 4 - Washout||0
365611|NCT01154634|877471|P3|NOT COMPLETED|Period 4 - Washout||0
365612|NCT01154634|877472|P2|NOT COMPLETED|Period 4 - Washout||0
365613|NCT01154634|877473|P1|NOT COMPLETED|Period 4 - Washout||0
365614|NCT01154634|877470|P4|COMPLETED|Period 4 - Washout||5
365615|NCT01154634|877471|P3|COMPLETED|Period 4 - Washout||4
365616|NCT01154634|877472|P2|COMPLETED|Period 4 - Washout||7
365617|NCT01154634|877473|P1|COMPLETED|Period 4 - Washout||4
365618|NCT01154634|877470|P4|STARTED|Period 4 - Washout||5
365619|NCT01154634|877471|P3|STARTED|Period 4 - Washout||4
365620|NCT01154634|877472|P2|STARTED|Period 4 - Washout||7
365621|NCT01154634|877473|P1|STARTED|Period 4 - Washout||4
365622|NCT01154634|877470|P4|NOT COMPLETED|Period 3- Second Intervention||0
365623|NCT01154634|877471|P3|NOT COMPLETED|Period 3- Second Intervention||0
365624|NCT01154634|877472|P2|NOT COMPLETED|Period 3- Second Intervention||0
365625|NCT01154634|877473|P1|NOT COMPLETED|Period 3- Second Intervention||0
365626|NCT01154634|877470|P4|COMPLETED|Period 3- Second Intervention||5
365627|NCT01154634|877471|P3|COMPLETED|Period 3- Second Intervention||4
365628|NCT01154634|877472|P2|COMPLETED|Period 3- Second Intervention||7
365629|NCT01154634|877473|P1|COMPLETED|Period 3- Second Intervention||4
365630|NCT01154634|877470|P4|STARTED|Period 3- Second Intervention||5
365631|NCT01154634|877471|P3|STARTED|Period 3- Second Intervention||4
365632|NCT01154634|877472|P2|STARTED|Period 3- Second Intervention||7
365633|NCT01154634|877473|P1|STARTED|Period 3- Second Intervention||4
365634|NCT01154634|877470|P4|NOT COMPLETED|Period 2 - Washout||0
365635|NCT01154634|877471|P3|NOT COMPLETED|Period 2 - Washout||0
365636|NCT01154634|877472|P2|NOT COMPLETED|Period 2 - Washout||0
365637|NCT01154634|877473|P1|NOT COMPLETED|Period 2 - Washout||0
365638|NCT01154634|877470|P4|COMPLETED|Period 2 - Washout||5
365639|NCT01154634|877471|P3|COMPLETED|Period 2 - Washout||4
365640|NCT01154634|877472|P2|COMPLETED|Period 2 - Washout||7
365641|NCT01154634|877473|P1|COMPLETED|Period 2 - Washout||4
365642|NCT01154634|877470|P4|STARTED|Period 2 - Washout||5
365643|NCT01154634|877471|P3|STARTED|Period 2 - Washout||4
365644|NCT01154634|877472|P2|STARTED|Period 2 - Washout||7
365645|NCT01154634|877473|P1|STARTED|Period 2 - Washout||4
365646|NCT01154634|877470|P4|NOT COMPLETED|Period 1 - First Intervention||0
365647|NCT01154634|877471|P3|NOT COMPLETED|Period 1 - First Intervention||0
365648|NCT01154634|877472|P2|NOT COMPLETED|Period 1 - First Intervention||0
365649|NCT01154634|877473|P1|NOT COMPLETED|Period 1 - First Intervention||0
365650|NCT01154634|877470|P4|COMPLETED|Period 1 - First Intervention||5
365651|NCT01154634|877471|P3|COMPLETED|Period 1 - First Intervention||4
365652|NCT01154634|877472|P2|COMPLETED|Period 1 - First Intervention||7
365653|NCT01154634|877473|P1|COMPLETED|Period 1 - First Intervention||4
365654|NCT01154634|877470|P4|STARTED|Period 1 - First Intervention||5
365655|NCT01154634|877471|P3|STARTED|Period 1 - First Intervention||4
365656|NCT01154634|877472|P2|STARTED|Period 1 - First Intervention||7
365657|NCT01154634|877473|P1|STARTED|Period 1 - First Intervention||4
365658|NCT01154452|877515|P4|NOT COMPLETED|Phase II||6
365659|NCT01154452|877516|P3|NOT COMPLETED|Phase II||5
365660|NCT01154452|877517|P2|NOT COMPLETED|Phase II||0
365661|NCT01154452|877518|P1|NOT COMPLETED|Phase II||0
365662|NCT01154452|877515|P4|COMPLETED|Phase II||27
365663|NCT01154452|877516|P3|COMPLETED|Phase II||30
365664|NCT01154452|877517|P2|COMPLETED|Phase II||0
365665|NCT01154452|877518|P1|COMPLETED|Phase II||0
365666|NCT01154452|877515|P4|STARTED|Phase II||33
365667|NCT01154452|877516|P3|STARTED|Phase II||35
365668|NCT01154452|877517|P2|STARTED|Phase II||0
365669|NCT01154452|877518|P1|STARTED|Phase II||0
365670|NCT01154452|877515|P4|NOT COMPLETED|Phase Ib||0
365671|NCT01154452|877516|P3|NOT COMPLETED|Phase Ib||0
365672|NCT01154452|877517|P2|NOT COMPLETED|Phase Ib||1
365673|NCT01154452|877518|P1|NOT COMPLETED|Phase Ib||3
365674|NCT01154452|877515|P4|COMPLETED|Phase Ib||0
365675|NCT01154452|877516|P3|COMPLETED|Phase Ib||0
365676|NCT01154452|877517|P2|COMPLETED|Phase Ib||3
365677|NCT01154452|877518|P1|COMPLETED|Phase Ib||3
365678|NCT01154452|877515|P4|STARTED|Phase Ib||0
365679|NCT01154452|877516|P3|STARTED|Phase Ib||0
365680|NCT01154452|877517|P2|STARTED|Phase Ib||4
365681|NCT01154452|877518|P1|STARTED|Phase Ib||6
365682|NCT01154335|877532|P3|NOT COMPLETED|Overall Study||5
365683|NCT01154335|877533|P2|NOT COMPLETED|Overall Study||6
365684|NCT01154335|877534|P1|NOT COMPLETED|Overall Study||7
365685|NCT01154335|877532|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
365686|NCT01154335|877533|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
365687|NCT01154335|877534|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
365688|NCT01154335|877532|P3|STARTED|Overall Study||5
365689|NCT01154335|877533|P2|STARTED|Overall Study||6
365690|NCT01154335|877534|P1|STARTED|Overall Study||7
365691|NCT01154322|877541|P1|NOT COMPLETED|Overall Study||2
365692|NCT01154322|877541|P1|COMPLETED|Overall Study||14
365693|NCT01154322|877541|P1|STARTED|Overall Study||16
365694|NCT01154296|877548|P2|NOT COMPLETED|6-month Follow-up||328
365695|NCT01154296|877549|P1|NOT COMPLETED|6-month Follow-up||328
365696|NCT01154296|877548|P2|COMPLETED|6-month Follow-up||2179
365697|NCT01154296|877549|P1|COMPLETED|6-month Follow-up||2177
365698|NCT01154296|877548|P2|STARTED|6-month Follow-up||2507
365699|NCT01154296|877549|P1|STARTED|6-month Follow-up||2505
365700|NCT01154296|877548|P2|NOT COMPLETED|Randomization and Intervention||2
365701|NCT01154296|877549|P1|NOT COMPLETED|Randomization and Intervention||5
365702|NCT01154296|877548|P2|COMPLETED|Randomization and Intervention||2505
365703|NCT01154296|877549|P1|COMPLETED|Randomization and Intervention||2500
365704|NCT01154296|877548|P2|STARTED|Randomization and Intervention||2507
365705|NCT01154296|877549|P1|STARTED|Randomization and Intervention||2505
365706|NCT01154283|877567|P2|NOT COMPLETED|7-12 Weeks||1
365707|NCT01154283|877568|P1|NOT COMPLETED|7-12 Weeks||1
365708|NCT01154283|877567|P2|COMPLETED|7-12 Weeks||10
365709|NCT01154283|877568|P1|COMPLETED|7-12 Weeks||6
365710|NCT01154283|877567|P2|STARTED|7-12 Weeks||11
365711|NCT01154283|877568|P1|STARTED|7-12 Weeks||7
365712|NCT01154283|877567|P2|NOT COMPLETED|0-6 Weeks||3
365713|NCT01154283|877568|P1|NOT COMPLETED|0-6 Weeks||7
365714|NCT01154283|877567|P2|COMPLETED|0-6 Weeks||11
365715|NCT01154283|877568|P1|COMPLETED|0-6 Weeks||7
365716|NCT01154283|877567|P2|STARTED|0-6 Weeks||14
365717|NCT01154283|877568|P1|STARTED|0-6 Weeks||14
365718|NCT01154231|877580|P1|NOT COMPLETED|Overall Study||2
365719|NCT01154231|877580|P1|COMPLETED|Overall Study||312
365720|NCT01154231|877580|P1|STARTED|Overall Study||314
365721|NCT01154218|877586|P4|NOT COMPLETED|Fourth Intervention Period||0
365722|NCT01154218|877587|P3|NOT COMPLETED|Fourth Intervention Period||0
365723|NCT01154218|877588|P2|NOT COMPLETED|Fourth Intervention Period||0
365724|NCT01154218|877589|P1|NOT COMPLETED|Fourth Intervention Period||1
365725|NCT01154218|877586|P4|COMPLETED|Fourth Intervention Period||8
365726|NCT01154218|877587|P3|COMPLETED|Fourth Intervention Period||9
365727|NCT01154218|877588|P2|COMPLETED|Fourth Intervention Period||8
365728|NCT01154218|877589|P1|COMPLETED|Fourth Intervention Period||8
365729|NCT01154218|877586|P4|STARTED|Fourth Intervention Period||8
365730|NCT01154218|877587|P3|STARTED|Fourth Intervention Period||9
365731|NCT01154218|877588|P2|STARTED|Fourth Intervention Period||8
365732|NCT01154218|877589|P1|STARTED|Fourth Intervention Period||9
365733|NCT01154218|877586|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
365734|NCT01154218|877587|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365735|NCT01154218|877588|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365736|NCT01154218|877589|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365737|NCT01154218|877586|P4|COMPLETED|Washout Period (at Least 14 Days)||8
365738|NCT01154218|877587|P3|COMPLETED|Washout Period (at Least 14 Days)||9
365739|NCT01154218|877588|P2|COMPLETED|Washout Period (at Least 14 Days)||8
365740|NCT01154218|877589|P1|COMPLETED|Washout Period (at Least 14 Days)||9
365741|NCT01154218|877586|P4|STARTED|Washout Period (at Least 14 Days)||9
365742|NCT01154218|877587|P3|STARTED|Washout Period (at Least 14 Days)||9
365743|NCT01154218|877588|P2|STARTED|Washout Period (at Least 14 Days)||8
365744|NCT01154218|877589|P1|STARTED|Washout Period (at Least 14 Days)||9
365745|NCT01154218|877586|P4|NOT COMPLETED|Third Intervention Period||0
365746|NCT01154218|877587|P3|NOT COMPLETED|Third Intervention Period||0
365747|NCT01154218|877588|P2|NOT COMPLETED|Third Intervention Period||1
365748|NCT01154218|877589|P1|NOT COMPLETED|Third Intervention Period||0
365749|NCT01154218|877586|P4|COMPLETED|Third Intervention Period||9
365750|NCT01154218|877587|P3|COMPLETED|Third Intervention Period||9
365751|NCT01154218|877588|P2|COMPLETED|Third Intervention Period||8
365752|NCT01154218|877589|P1|COMPLETED|Third Intervention Period||9
365753|NCT01154218|877586|P4|STARTED|Third Intervention Period||9
365754|NCT01154218|877587|P3|STARTED|Third Intervention Period||9
365755|NCT01154218|877588|P2|STARTED|Third Intervention Period||9
365756|NCT01154218|877589|P1|STARTED|Third Intervention Period||9
365757|NCT01154218|877586|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365758|NCT01154218|877587|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365759|NCT01154218|877588|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365760|NCT01154218|877589|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365761|NCT01154218|877586|P4|COMPLETED|Washout Period (at Least 14 Days)||9
365762|NCT01154218|877587|P3|COMPLETED|Washout Period (at Least 14 Days)||9
365763|NCT01154218|877588|P2|COMPLETED|Washout Period (at Least 14 Days)||9
365764|NCT01154218|877589|P1|COMPLETED|Washout Period (at Least 14 Days)||9
365765|NCT01154218|877586|P4|STARTED|Washout Period (at Least 14 Days)||9
365766|NCT01154218|877587|P3|STARTED|Washout Period (at Least 14 Days)||9
365767|NCT01154218|877588|P2|STARTED|Washout Period (at Least 14 Days)||9
365768|NCT01154218|877589|P1|STARTED|Washout Period (at Least 14 Days)||9
365769|NCT01154218|877586|P4|NOT COMPLETED|Second Intervention Period||0
365770|NCT01154218|877587|P3|NOT COMPLETED|Second Intervention Period||0
365771|NCT01154218|877588|P2|NOT COMPLETED|Second Intervention Period||0
365772|NCT01154218|877589|P1|NOT COMPLETED|Second Intervention Period||0
365773|NCT01154218|877586|P4|COMPLETED|Second Intervention Period||9
365774|NCT01154218|877587|P3|COMPLETED|Second Intervention Period||9
365775|NCT01154218|877588|P2|COMPLETED|Second Intervention Period||9
365776|NCT01154218|877589|P1|COMPLETED|Second Intervention Period||9
365777|NCT01154218|877586|P4|STARTED|Second Intervention Period||9
365778|NCT01154218|877587|P3|STARTED|Second Intervention Period||9
365779|NCT01154218|877588|P2|STARTED|Second Intervention Period||9
365780|NCT01154218|877589|P1|STARTED|Second Intervention Period||9
365781|NCT01154218|877586|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365782|NCT01154218|877587|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365783|NCT01154218|877588|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365784|NCT01154218|877589|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
365785|NCT01154218|877586|P4|COMPLETED|Washout Period (at Least 14 Days)||9
365786|NCT01154218|877587|P3|COMPLETED|Washout Period (at Least 14 Days)||9
365787|NCT01154218|877588|P2|COMPLETED|Washout Period (at Least 14 Days)||9
365788|NCT01154218|877589|P1|COMPLETED|Washout Period (at Least 14 Days)||9
365789|NCT01154218|877586|P4|STARTED|Washout Period (at Least 14 Days)||9
365790|NCT01154218|877587|P3|STARTED|Washout Period (at Least 14 Days)||9
365791|NCT01154218|877588|P2|STARTED|Washout Period (at Least 14 Days)||9
365792|NCT01154218|877589|P1|STARTED|Washout Period (at Least 14 Days)||9
365793|NCT01154218|877586|P4|NOT COMPLETED|First Intervention Period||0
365794|NCT01154218|877587|P3|NOT COMPLETED|First Intervention Period||0
365795|NCT01154218|877588|P2|NOT COMPLETED|First Intervention Period||0
365796|NCT01154218|877589|P1|NOT COMPLETED|First Intervention Period||0
365797|NCT01154218|877586|P4|COMPLETED|First Intervention Period||9
365798|NCT01154218|877587|P3|COMPLETED|First Intervention Period||9
365799|NCT01154218|877588|P2|COMPLETED|First Intervention Period||9
365800|NCT01154218|877589|P1|COMPLETED|First Intervention Period||9
365801|NCT01154218|877586|P4|STARTED|First Intervention Period||9
365802|NCT01154218|877587|P3|STARTED|First Intervention Period||9
365803|NCT01154218|877588|P2|STARTED|First Intervention Period||9
365804|NCT01154218|877589|P1|STARTED|First Intervention Period||9
365805|NCT01154166|877641|P2|NOT COMPLETED|Overall Study||12
365806|NCT01154166|877642|P1|NOT COMPLETED|Overall Study||34
365807|NCT01154166|877641|P2|COMPLETED|Overall Study||163
365808|NCT01154166|877642|P1|COMPLETED|Overall Study||135
365809|NCT01154166|877641|P2|STARTED|Overall Study||175
365810|NCT01154166|877642|P1|STARTED|Overall Study||169
365811|NCT01154153|877674|P2|NOT COMPLETED|Overall Study||3
365812|NCT01154153|877675|P1|NOT COMPLETED|Overall Study||5
365813|NCT01154153|877674|P2|COMPLETED|Overall Study||66
365814|NCT01154153|877675|P1|COMPLETED|Overall Study||66
365815|NCT01154153|877674|P2|STARTED|Overall Study||69
365816|NCT01154153|877675|P1|STARTED|Overall Study||71
365817|NCT01154140|877693|P2|NOT COMPLETED|Overall Study||171
365818|NCT01154140|877694|P1|NOT COMPLETED|Overall Study||172
365819|NCT01154140|877693|P2|COMPLETED|Overall Study||0
365820|NCT01154140|877694|P1|COMPLETED|Overall Study||0
365821|NCT01154140|877693|P2|Treated|Overall Study||169
365822|NCT01154140|877694|P1|Treated|Overall Study||171
365823|NCT01154140|877693|P2|STARTED|Overall Study||171
365824|NCT01154140|877694|P1|STARTED|Overall Study||172
365825|NCT01154127|877743|P2|NOT COMPLETED|Period 2 (21 Days)||1
365826|NCT01154127|877744|P1|NOT COMPLETED|Period 2 (21 Days)||0
365827|NCT01154127|877743|P2|COMPLETED|Period 2 (21 Days)||46
365828|NCT01154127|877744|P1|COMPLETED|Period 2 (21 Days)||49
365829|NCT01154127|877743|P2|STARTED|Period 2 (21 Days)||47
365830|NCT01154127|877744|P1|STARTED|Period 2 (21 Days)||49
365831|NCT01154127|877743|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
365832|NCT01154127|877744|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
365833|NCT01154127|877743|P2|COMPLETED|Washout (14 - 28 Days)||47
365834|NCT01154127|877744|P1|COMPLETED|Washout (14 - 28 Days)||49
365835|NCT01154127|877743|P2|STARTED|Washout (14 - 28 Days)||47
365836|NCT01154127|877744|P1|STARTED|Washout (14 - 28 Days)||52
365837|NCT01154127|877743|P2|NOT COMPLETED|Period 1 (21 Days)||6
365838|NCT01154127|877744|P1|NOT COMPLETED|Period 1 (21 Days)||3
365839|NCT01154127|877743|P2|COMPLETED|Period 1 (21 Days)||47
365840|NCT01154127|877744|P1|COMPLETED|Period 1 (21 Days)||52
365841|NCT01154127|877743|P2|STARTED|Period 1 (21 Days)||53
365842|NCT01154127|877744|P1|STARTED|Period 1 (21 Days)||55
365843|NCT01154036|877769|P8|NOT COMPLETED|Phase II||6
365844|NCT01154036|877770|P7|NOT COMPLETED|Phase II||9
365845|NCT01154036|877771|P6|NOT COMPLETED|Phase II||5
365846|NCT01154036|877772|P5|NOT COMPLETED|Phase II||8
365847|NCT01154036|877773|P4|NOT COMPLETED|Phase II||1
365848|NCT01154036|877774|P3|NOT COMPLETED|Phase II||0
365849|NCT01154036|877775|P2|NOT COMPLETED|Phase II||0
365850|NCT01154036|877776|P1|NOT COMPLETED|Phase II||0
365851|NCT01154036|877769|P8|COMPLETED|Phase II||200
365852|NCT01154036|877770|P7|COMPLETED|Phase II||225
365853|NCT01154036|877771|P6|COMPLETED|Phase II||121
365854|NCT01154036|877772|P5|COMPLETED|Phase II||116
365855|NCT01154036|877773|P4|COMPLETED|Phase II||27
365856|NCT01154036|877774|P3|COMPLETED|Phase II||0
365857|NCT01154036|877775|P2|COMPLETED|Phase II||0
365858|NCT01154036|877776|P1|COMPLETED|Phase II||0
365859|NCT01154036|877769|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
365860|NCT01154036|877770|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
365861|NCT01154036|877771|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
365862|NCT01154036|877772|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
365863|NCT01154036|877773|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
365864|NCT01154036|877774|P3|STARTED|Phase II||0
365865|NCT01154036|877775|P2|STARTED|Phase II||0
365866|NCT01154036|877776|P1|STARTED|Phase II||0
365867|NCT01154036|877769|P8|NOT COMPLETED|Phase I||0
365868|NCT01154036|877770|P7|NOT COMPLETED|Phase I||0
365869|NCT01154036|877771|P6|NOT COMPLETED|Phase I||0
365870|NCT01154036|877772|P5|NOT COMPLETED|Phase I||0
365871|NCT01154036|877773|P4|NOT COMPLETED|Phase I||0
365872|NCT01154036|877774|P3|NOT COMPLETED|Phase I||56
365873|NCT01154036|877775|P2|NOT COMPLETED|Phase I||28
365874|NCT01154036|877776|P1|NOT COMPLETED|Phase I||3
365875|NCT01154036|877769|P8|COMPLETED|Phase I||0
365876|NCT01154036|877770|P7|COMPLETED|Phase I||0
365877|NCT01154036|877771|P6|COMPLETED|Phase I||0
365878|NCT01154036|877772|P5|COMPLETED|Phase I||0
365879|NCT01154036|877773|P4|COMPLETED|Phase I||0
365880|NCT01154036|877774|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
365881|NCT01154036|877775|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
365882|NCT01154036|877776|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
365883|NCT01154036|877769|P8|STARTED|Phase I||0
365884|NCT01154036|877770|P7|STARTED|Phase I||0
365885|NCT01154036|877771|P6|STARTED|Phase I||0
365886|NCT01154036|877772|P5|STARTED|Phase I||0
365887|NCT01154036|877773|P4|STARTED|Phase I||0
365888|NCT01154036|877774|P3|STARTED|Phase I||944
365889|NCT01154036|877775|P2|STARTED|Phase I||483
365890|NCT01154036|877776|P1|STARTED|Phase I||120
365891|NCT01154010|877900|P2|NOT COMPLETED|Overall Study||1
365892|NCT01154010|877901|P1|NOT COMPLETED|Overall Study||0
365893|NCT01154010|877900|P2|COMPLETED|Overall Study||8
365894|NCT01154010|877901|P1|COMPLETED|Overall Study||9
365895|NCT01154010|877900|P2|STARTED|Overall Study||9
365896|NCT01154010|877901|P1|STARTED|Overall Study||9
365897|NCT01153984|877907|P1|NOT COMPLETED|Overall Study||2
365898|NCT01153984|877907|P1|COMPLETED|Overall Study||21
365899|NCT01153984|877907|P1|STARTED|Overall Study||23
365900|NCT01153971|877918|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
365901|NCT01153971|877918|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
365902|NCT01153971|877918|P1|STARTED|Follow-up (Months 17-40 of Study)||41
365903|NCT01153971|877918|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
365904|NCT01153971|877918|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
365905|NCT01153971|877918|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
365906|NCT01153971|877918|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
365907|NCT01153971|877918|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
365908|NCT01153971|877918|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
365909|NCT01153958|877941|P2|NOT COMPLETED|Overall Study||32
365910|NCT01153958|877942|P1|NOT COMPLETED|Overall Study||36
365911|NCT01153958|877941|P2|COMPLETED|Overall Study||35
365912|NCT01153958|877942|P1|COMPLETED|Overall Study||30
365913|NCT01153958|877941|P2|STARTED|Overall Study||67
365914|NCT01153958|877942|P1|STARTED|Overall Study||66
365915|NCT01153893|877960|P2|NOT COMPLETED|Overall Study||0
365916|NCT01153893|877961|P1|NOT COMPLETED|Overall Study||1
365917|NCT01153893|877960|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
365918|NCT01153893|877961|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
365919|NCT01153893|877960|P2|STARTED|Overall Study||36
365920|NCT01153893|877961|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
365921|NCT01153841|877987|P2|NOT COMPLETED|Overall Study||0
365922|NCT01153841|877988|P1|NOT COMPLETED|Overall Study||6
365923|NCT01153841|877987|P2|COMPLETED|Overall Study||99
365924|NCT01153841|877988|P1|COMPLETED|Overall Study||193
365925|NCT01153841|877987|P2|STARTED|Overall Study||99
365926|NCT01153841|877988|P1|STARTED|Overall Study||199
365933|NCT01153763|878027|P1|NOT COMPLETED|Overall Study||59
365934|NCT01153763|878027|P1|COMPLETED|Overall Study||33
365935|NCT01153763|878027|P1|Ongoing (In Follow-up)|Overall Study||24
365936|NCT01153763|878027|P1|STARTED|Overall Study||92
365937|NCT01153724|878038|P1|NOT COMPLETED|Treatment Period 2||2
365938|NCT01153724|878038|P1|COMPLETED|Treatment Period 2||32
365939|NCT01153724|878038|P1|STARTED|Treatment Period 2||34
365940|NCT01153724|878038|P1|NOT COMPLETED|Treatment Period 1||1
365941|NCT01153724|878038|P1|COMPLETED|Treatment Period 1||34
365942|NCT01153724|878038|P1|STARTED|Treatment Period 1||35
365943|NCT01153711|878058|P1|NOT COMPLETED|Overall Study||0
365944|NCT01153711|878058|P1|COMPLETED|Overall Study||32
365945|NCT01153711|878058|P1|STARTED|Overall Study||32
365946|NCT01153698|878078|P1|NOT COMPLETED|Overall Study||29
365947|NCT01153698|878078|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
365948|NCT01153698|878078|P1|STARTED|Overall Study|Entered and treated.|168
365949|NCT01153685|878094|P2|NOT COMPLETED|Overall Study||0
365950|NCT01153685|878095|P1|NOT COMPLETED|Overall Study||0
365951|NCT01153685|878094|P2|COMPLETED|Overall Study||70
365952|NCT01153685|878095|P1|COMPLETED|Overall Study||50
365953|NCT01153685|878094|P2|STARTED|Overall Study||70
365954|NCT01153685|878095|P1|STARTED|Overall Study||50
365955|NCT01153672|878119|P1|NOT COMPLETED|Overall Study||2
365956|NCT01153672|878119|P1|COMPLETED|Overall Study||6
365957|NCT01153672|878119|P1|STARTED|Overall Study||8
365958|NCT01153633|878127|P2|NOT COMPLETED|Overall Study||4
365959|NCT01153633|878128|P1|NOT COMPLETED|Overall Study||4
365960|NCT01153633|878127|P2|COMPLETED|Overall Study||13
365961|NCT01153633|878128|P1|COMPLETED|Overall Study||13
365962|NCT01153633|878127|P2|STARTED|Overall Study||17
365963|NCT01153633|878128|P1|STARTED|Overall Study||17
365964|NCT01153620|878146|P2|NOT COMPLETED|Overall Study||0
365965|NCT01153620|878147|P1|NOT COMPLETED|Overall Study||0
365966|NCT01153620|878146|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
365967|NCT01153620|878147|P1|COMPLETED|Overall Study||30
365968|NCT01153620|878146|P2|STARTED|Overall Study|30 patients (31 wounds)|30
365969|NCT01153620|878147|P1|STARTED|Overall Study||30
365970|NCT01153581|878153|P1|NOT COMPLETED|Overall Study||0
365971|NCT01153581|878153|P1|COMPLETED|Overall Study||109
365972|NCT01153581|878153|P1|STARTED|Overall Study||109
365973|NCT01153503|878166|P3|NOT COMPLETED|Overall Study||0
365974|NCT01153503|878167|P2|NOT COMPLETED|Overall Study||1
365975|NCT01153503|878168|P1|NOT COMPLETED|Overall Study||0
365976|NCT01153503|878166|P3|COMPLETED|Overall Study||25
365977|NCT01153503|878167|P2|COMPLETED|Overall Study||24
365978|NCT01153503|878168|P1|COMPLETED|Overall Study||25
365979|NCT01153503|878166|P3|STARTED|Overall Study||25
365980|NCT01153503|878167|P2|STARTED|Overall Study||25
365981|NCT01153503|878168|P1|STARTED|Overall Study||25
365982|NCT01153347|878180|P4|NOT COMPLETED|Overall Study||32
365983|NCT01153347|878181|P3|NOT COMPLETED|Overall Study||50
365984|NCT01153347|878182|P2|NOT COMPLETED|Overall Study||44
365985|NCT01153347|878183|P1|NOT COMPLETED|Overall Study||33
365986|NCT01153347|878180|P4|COMPLETED|Overall Study||129
365987|NCT01153347|878181|P3|COMPLETED|Overall Study||110
365988|NCT01153347|878182|P2|COMPLETED|Overall Study||116
365989|NCT01153347|878183|P1|COMPLETED|Overall Study||127
365990|NCT01153347|878180|P4|Received Treatment|Overall Study||160
365991|NCT01153347|878181|P3|Received Treatment|Overall Study||158
365992|NCT01153347|878182|P2|Received Treatment|Overall Study||158
365993|NCT01153347|878183|P1|Received Treatment|Overall Study||160
365994|NCT01153347|878180|P4|STARTED|Overall Study||161
365995|NCT01153347|878181|P3|STARTED|Overall Study||160
365996|NCT01153347|878182|P2|STARTED|Overall Study||160
365997|NCT01153347|878183|P1|STARTED|Overall Study||160
365998|NCT01153321|878283|P2|NOT COMPLETED|Overall Study||3
365999|NCT01153321|878284|P1|NOT COMPLETED|Overall Study||1
366000|NCT01153321|878283|P2|COMPLETED|Overall Study||19
366001|NCT01153321|878284|P1|COMPLETED|Overall Study||21
366002|NCT01153321|878283|P2|STARTED|Overall Study||22
366003|NCT01153321|878284|P1|STARTED|Overall Study||22
366004|NCT01153269|878396|P1|NOT COMPLETED|Overall Study||2
366005|NCT01153269|878396|P1|COMPLETED|Overall Study||31
366006|NCT01153269|878396|P1|Participants Analyzed|Overall Study||33
366007|NCT01153269|878396|P1|STARTED|Overall Study||33
366008|NCT01153009|878459|P4|NOT COMPLETED|Overall Study||37
366009|NCT01153009|878460|P3|NOT COMPLETED|Overall Study||41
366010|NCT01153009|878461|P2|NOT COMPLETED|Overall Study||34
366011|NCT01153009|878462|P1|NOT COMPLETED|Overall Study||32
366012|NCT01153009|878459|P4|COMPLETED|Overall Study||115
366013|NCT01153009|878460|P3|COMPLETED|Overall Study||113
366014|NCT01153009|878461|P2|COMPLETED|Overall Study||113
366015|NCT01153009|878462|P1|COMPLETED|Overall Study||129
366016|NCT01153009|878459|P4|Treated|Overall Study||150
366017|NCT01153009|878460|P3|Treated|Overall Study||154
366018|NCT01153009|878461|P2|Treated|Overall Study||147
366019|NCT01153009|878462|P1|Treated|Overall Study||159
366020|NCT01153009|878459|P4|STARTED|Overall Study||152
366021|NCT01153009|878460|P3|STARTED|Overall Study||154
366022|NCT01153009|878461|P2|STARTED|Overall Study||147
366023|NCT01153009|878462|P1|STARTED|Overall Study||161
366024|NCT01152996|878492|P1|NOT COMPLETED|Overall Study||537
366025|NCT01152996|878492|P1|COMPLETED|Overall Study||538
366026|NCT01152996|878492|P1|Treated|Overall Study||1073
366027|NCT01152996|878492|P1|STARTED|Overall Study||1075
366028|NCT01152814|878505|P1|NOT COMPLETED|Overall Study||2
366029|NCT01152814|878505|P1|COMPLETED|Overall Study||62
366030|NCT01152814|878505|P1|STARTED|Overall Study||64
366031|NCT01152788|878514|P2|NOT COMPLETED|Overall Study||4
366032|NCT01152788|878515|P1|NOT COMPLETED|Overall Study||0
366033|NCT01152788|878514|P2|COMPLETED|Overall Study||28
366034|NCT01152788|878515|P1|COMPLETED|Overall Study||32
366035|NCT01152788|878514|P2|STARTED|Overall Study||32
366036|NCT01152788|878515|P1|STARTED|Overall Study||32
366037|NCT01152697|878527|P1|NOT COMPLETED|Overall Study||19
366038|NCT01152697|878527|P1|COMPLETED|Overall Study||11
366039|NCT01152697|878527|P1|STARTED|Overall Study||30
366040|NCT01152580|878552|P2|NOT COMPLETED|Overall Study||1
366041|NCT01152580|878553|P1|NOT COMPLETED|Overall Study||0
366042|NCT01152580|878552|P2|COMPLETED|Overall Study||13
366043|NCT01152580|878553|P1|COMPLETED|Overall Study||5
366044|NCT01152580|878552|P2|STARTED|Overall Study||14
366045|NCT01152580|878553|P1|STARTED|Overall Study||5
366046|NCT01152554|878575|P2|NOT COMPLETED|Overall Study||111
366047|NCT01152554|878576|P1|NOT COMPLETED|Overall Study||334
366048|NCT01152554|878575|P2|COMPLETED|Overall Study||92
366049|NCT01152554|878576|P1|COMPLETED|Overall Study||276
366050|NCT01152554|878575|P2|Received Treatment|Overall Study||201
366051|NCT01152554|878576|P1|Received Treatment|Overall Study||607
366052|NCT01152554|878575|P2|STARTED|Overall Study||203
366053|NCT01152554|878576|P1|STARTED|Overall Study||610
366054|NCT01152450|878598|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
366055|NCT01152450|878599|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
366056|NCT01152450|878600|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
366057|NCT01152450|878601|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
366058|NCT01152450|878602|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
366059|NCT01152450|878603|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
366060|NCT01152450|878598|P6|COMPLETED|Period 3 (4 Weeks)||12
366061|NCT01152450|878599|P5|COMPLETED|Period 3 (4 Weeks)||16
366062|NCT01152450|878600|P4|COMPLETED|Period 3 (4 Weeks)||15
366063|NCT01152450|878601|P3|COMPLETED|Period 3 (4 Weeks)||16
366064|NCT01152450|878602|P2|COMPLETED|Period 3 (4 Weeks)||15
366065|NCT01152450|878603|P1|COMPLETED|Period 3 (4 Weeks)||15
366066|NCT01152450|878598|P6|STARTED|Period 3 (4 Weeks)||12
366067|NCT01152450|878599|P5|STARTED|Period 3 (4 Weeks)||16
366068|NCT01152450|878600|P4|STARTED|Period 3 (4 Weeks)||15
366069|NCT01152450|878601|P3|STARTED|Period 3 (4 Weeks)||16
366070|NCT01152450|878602|P2|STARTED|Period 3 (4 Weeks)||15
366071|NCT01152450|878603|P1|STARTED|Period 3 (4 Weeks)||15
366072|NCT01152450|878598|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
366073|NCT01152450|878599|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
366074|NCT01152450|878600|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
366075|NCT01152450|878601|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
366076|NCT01152450|878602|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
366077|NCT01152450|878603|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
366078|NCT01152450|878598|P6|COMPLETED|Period 2 (4 Weeks)||12
366079|NCT01152450|878599|P5|COMPLETED|Period 2 (4 Weeks)||16
366080|NCT01152450|878600|P4|COMPLETED|Period 2 (4 Weeks)||15
366081|NCT01152450|878601|P3|COMPLETED|Period 2 (4 Weeks)||16
366082|NCT01152450|878602|P2|COMPLETED|Period 2 (4 Weeks)||15
366083|NCT01152450|878603|P1|COMPLETED|Period 2 (4 Weeks)||15
366084|NCT01152450|878598|P6|STARTED|Period 2 (4 Weeks)||12
366085|NCT01152450|878599|P5|STARTED|Period 2 (4 Weeks)||16
366086|NCT01152450|878600|P4|STARTED|Period 2 (4 Weeks)||15
366087|NCT01152450|878601|P3|STARTED|Period 2 (4 Weeks)||16
366088|NCT01152450|878602|P2|STARTED|Period 2 (4 Weeks)||15
366089|NCT01152450|878603|P1|STARTED|Period 2 (4 Weeks)||15
366090|NCT01152450|878598|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
366091|NCT01152450|878599|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
366092|NCT01152450|878600|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
366093|NCT01152450|878601|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
366094|NCT01152450|878602|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
366095|NCT01152450|878603|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
366096|NCT01152450|878598|P6|COMPLETED|Period 1 (4 Weeks)||12
366097|NCT01152450|878599|P5|COMPLETED|Period 1 (4 Weeks)||16
366098|NCT01152450|878600|P4|COMPLETED|Period 1 (4 Weeks)||15
366099|NCT01152450|878601|P3|COMPLETED|Period 1 (4 Weeks)||16
366100|NCT01152450|878602|P2|COMPLETED|Period 1 (4 Weeks)||15
366101|NCT01152450|878603|P1|COMPLETED|Period 1 (4 Weeks)||15
366102|NCT01152450|878598|P6|STARTED|Period 1 (4 Weeks)||13
366103|NCT01152450|878599|P5|STARTED|Period 1 (4 Weeks)||18
366104|NCT01152450|878600|P4|STARTED|Period 1 (4 Weeks)||15
366105|NCT01152450|878601|P3|STARTED|Period 1 (4 Weeks)||17
366106|NCT01152450|878602|P2|STARTED|Period 1 (4 Weeks)||16
366107|NCT01152450|878603|P1|STARTED|Period 1 (4 Weeks)||15
366108|NCT01152437|878674|P3|NOT COMPLETED|Overall Study||43
366109|NCT01152437|878675|P2|NOT COMPLETED|Overall Study||15
366110|NCT01152437|878676|P1|NOT COMPLETED|Overall Study||36
366111|NCT01152437|878674|P3|COMPLETED|Overall Study||0
366112|NCT01152437|878675|P2|COMPLETED|Overall Study||0
366113|NCT01152437|878676|P1|COMPLETED|Overall Study||0
366114|NCT01152437|878674|P3|STARTED|Overall Study|entered|43
366115|NCT01152437|878675|P2|STARTED|Overall Study|randomised|15
366116|NCT01152437|878676|P1|STARTED|Overall Study|randomised|36
366117|NCT01152385|878696|P4|NOT COMPLETED|Overall Study||5
366118|NCT01152385|878697|P3|NOT COMPLETED|Overall Study||5
366119|NCT01152385|878698|P2|NOT COMPLETED|Overall Study||6
366120|NCT01152385|878699|P1|NOT COMPLETED|Overall Study||9
366121|NCT01152385|878696|P4|COMPLETED|Overall Study||50
366122|NCT01152385|878697|P3|COMPLETED|Overall Study||51
366123|NCT01152385|878698|P2|COMPLETED|Overall Study||52
366124|NCT01152385|878699|P1|COMPLETED|Overall Study||46
366125|NCT01152385|878696|P4|STARTED|Overall Study||55
366126|NCT01152385|878697|P3|STARTED|Overall Study||56
366127|NCT01152385|878698|P2|STARTED|Overall Study||58
366128|NCT01152385|878699|P1|STARTED|Overall Study||55
366129|NCT01152359|878739|P2|NOT COMPLETED|Overall Study||22
366130|NCT01152359|878740|P1|NOT COMPLETED|Overall Study||24
366131|NCT01152359|878739|P2|COMPLETED|Overall Study||80
366132|NCT01152359|878740|P1|COMPLETED|Overall Study||81
366133|NCT01152359|878739|P2|STARTED|Overall Study||102
366134|NCT01152359|878740|P1|STARTED|Overall Study||105
366135|NCT01152307|878748|P2|NOT COMPLETED|Overall Study||0
366136|NCT01152307|878749|P1|NOT COMPLETED|Overall Study||0
366137|NCT01152307|878748|P2|COMPLETED|Overall Study||214
366138|NCT01152307|878749|P1|COMPLETED|Overall Study||191
366139|NCT01152307|878748|P2|STARTED|Overall Study||214
366140|NCT01152307|878749|P1|STARTED|Overall Study||191
366141|NCT01152294|878757|P2|NOT COMPLETED|Overall Study||0
366142|NCT01152294|878758|P1|NOT COMPLETED|Overall Study||0
366143|NCT01152294|878757|P2|COMPLETED|Overall Study||188
366144|NCT01152294|878758|P1|COMPLETED|Overall Study||213
366145|NCT01152294|878757|P2|STARTED|Overall Study||188
366146|NCT01152294|878758|P1|STARTED|Overall Study||213
366147|NCT01152190|878766|P2|NOT COMPLETED|Overall Study||8
366148|NCT01152190|878767|P1|NOT COMPLETED|Overall Study||5
366149|NCT01152190|878766|P2|COMPLETED|Overall Study||39
366150|NCT01152190|878767|P1|COMPLETED|Overall Study||45
366151|NCT01152190|878766|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
366152|NCT01152190|878767|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
366153|NCT01152190|878766|P2|STARTED|Overall Study||47
366154|NCT01152190|878767|P1|STARTED|Overall Study||50
366155|NCT01151904|878779|P1|NOT COMPLETED|Overall Study||0
366156|NCT01151904|878779|P1|COMPLETED|Overall Study||17
366157|NCT01151904|878779|P1|STARTED|Overall Study||17
366158|NCT01151852|878787|P2|NOT COMPLETED|Overall Study||0
366159|NCT01151852|878788|P1|NOT COMPLETED|Overall Study||0
366160|NCT01151852|878787|P2|COMPLETED|Overall Study||40
366161|NCT01151852|878788|P1|COMPLETED|Overall Study||41
366162|NCT01151852|878787|P2|STARTED|Overall Study||40
366163|NCT01151852|878788|P1|STARTED|Overall Study||41
366164|NCT01151761|878804|P1|NOT COMPLETED|Overall Study||0
366165|NCT01151761|878804|P1|COMPLETED|Overall Study||2
366166|NCT01151761|878804|P1|STARTED|Overall Study||2
366167|NCT01151579|878817|P2|NOT COMPLETED|Overall Study||7
366168|NCT01151579|878818|P1|NOT COMPLETED|Overall Study||12
366169|NCT01151579|878817|P2|COMPLETED|Overall Study||24
366170|NCT01151579|878818|P1|COMPLETED|Overall Study||46
366171|NCT01151579|878817|P2|STARTED|Overall Study||31
366172|NCT01151579|878818|P1|STARTED|Overall Study||58
366173|NCT01151553|878828|P1|NOT COMPLETED|Overall Study||0
366174|NCT01151553|878828|P1|COMPLETED|Overall Study||5
366175|NCT01151553|878828|P1|STARTED|Overall Study||5
366176|NCT01151449|878832|P1|NOT COMPLETED|Overall Study||0
366177|NCT01151449|878832|P1|COMPLETED|Overall Study||6
366178|NCT01151449|878832|P1|STARTED|Overall Study||6
366179|NCT01151436|878840|P1|NOT COMPLETED|Overall Study||1
366180|NCT01151436|878840|P1|COMPLETED|Overall Study||76
366181|NCT01151436|878840|P1|STARTED|Overall Study||77
366182|NCT01151410|878872|P2|NOT COMPLETED|Overall Study||15
366183|NCT01151410|878873|P1|NOT COMPLETED|Overall Study||11
366184|NCT01151410|878872|P2|COMPLETED|Overall Study||89
366185|NCT01151410|878873|P1|COMPLETED|Overall Study||93
366186|NCT01151410|878872|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
366187|NCT01151410|878873|P1|Safety Set (SAF)|Overall Study||105
366188|NCT01151410|878872|P2|STARTED|Overall Study||104
366189|NCT01151410|878873|P1|STARTED|Overall Study||104
366190|NCT01151371|878886|P3|NOT COMPLETED|Overall Study||7
366191|NCT01151371|878887|P2|NOT COMPLETED|Overall Study||1
366192|NCT01151371|878888|P1|NOT COMPLETED|Overall Study||5
366193|NCT01151371|878886|P3|COMPLETED|Overall Study||146
366194|NCT01151371|878887|P2|COMPLETED|Overall Study||149
366195|NCT01151371|878888|P1|COMPLETED|Overall Study||144
366196|NCT01151371|878886|P3|STARTED|Overall Study||153
366197|NCT01151371|878887|P2|STARTED|Overall Study||150
366198|NCT01151371|878888|P1|STARTED|Overall Study||149
366199|NCT01151345|878917|P2|NOT COMPLETED|Second Intervention Period||0
366200|NCT01151345|878918|P1|NOT COMPLETED|Second Intervention Period||0
366201|NCT01151345|878917|P2|COMPLETED|Second Intervention Period||12
366202|NCT01151345|878918|P1|COMPLETED|Second Intervention Period||13
366203|NCT01151345|878917|P2|STARTED|Second Intervention Period||12
366204|NCT01151345|878918|P1|STARTED|Second Intervention Period||13
366205|NCT01151345|878917|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
366206|NCT01151345|878918|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
366207|NCT01151345|878917|P2|COMPLETED|Wash-out Period (7 Days)||12
366208|NCT01151345|878918|P1|COMPLETED|Wash-out Period (7 Days)||13
366209|NCT01151345|878917|P2|STARTED|Wash-out Period (7 Days)||12
366210|NCT01151345|878918|P1|STARTED|Wash-out Period (7 Days)||13
366211|NCT01151345|878917|P2|NOT COMPLETED|First Intervention Period||1
366212|NCT01151345|878918|P1|NOT COMPLETED|First Intervention Period||0
366213|NCT01151345|878917|P2|COMPLETED|First Intervention Period||12
366214|NCT01151345|878918|P1|COMPLETED|First Intervention Period||13
366215|NCT01151345|878917|P2|Treated|First Intervention Period||12
366216|NCT01151345|878918|P1|Treated|First Intervention Period||13
366217|NCT01151345|878917|P2|STARTED|First Intervention Period||13
366218|NCT01151345|878918|P1|STARTED|First Intervention Period||13
366219|NCT01151280|878932|P1|NOT COMPLETED|Overall Study||4
366220|NCT01151280|878932|P1|COMPLETED|Overall Study||6
366221|NCT01151280|878932|P1|STARTED|Overall Study||10
366222|NCT01151215|878945|P3|NOT COMPLETED|Overall Study||19
366223|NCT01151215|878946|P2|NOT COMPLETED|Overall Study||23
366224|NCT01151215|878947|P1|NOT COMPLETED|Overall Study||20
366225|NCT01151215|878945|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
366226|NCT01151215|878946|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
366227|NCT01151215|878947|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
366228|NCT01151215|878945|P3|STARTED|Overall Study||121
366229|NCT01151215|878946|P2|STARTED|Overall Study||118
366230|NCT01151215|878947|P1|STARTED|Overall Study||120
366231|NCT01151189|878960|P2|NOT COMPLETED|Overall Study||10
366232|NCT01151189|878961|P1|NOT COMPLETED|Overall Study||15
366233|NCT01151189|878960|P2|COMPLETED|Overall Study||314
366234|NCT01151189|878961|P1|COMPLETED|Overall Study||311
366235|NCT01151189|878960|P2|Received Vaccine|Overall Study||324
366236|NCT01151189|878961|P1|Received Vaccine|Overall Study||325
366237|NCT01151189|878960|P2|STARTED|Overall Study||324
366238|NCT01151189|878961|P1|STARTED|Overall Study||326
366239|NCT01151137|878985|P2|NOT COMPLETED|Overall Study||28
366240|NCT01151137|878986|P1|NOT COMPLETED|Overall Study||16
366241|NCT01151137|878985|P2|COMPLETED|Overall Study||1591
366242|NCT01151137|878986|P1|COMPLETED|Overall Study||1601
366243|NCT01151137|878985|P2|Discontinued Treatment|Overall Study||342
366244|NCT01151137|878986|P1|Discontinued Treatment|Overall Study||171
366245|NCT01151137|878985|P2|Treated|Overall Study||1613
366246|NCT01151137|878986|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
366247|NCT01151137|878985|P2|STARTED|Overall Study||1619
366248|NCT01151137|878986|P1|STARTED|Overall Study||1617
366249|NCT01151098|879004|P1|NOT COMPLETED|Overall Study||117
366250|NCT01151098|879004|P1|COMPLETED|Overall Study||72
366251|NCT01151098|879004|P1|STARTED|Overall Study|Extension Safety Population|189
366252|NCT01151085|879008|P1|NOT COMPLETED|Overall Study||56
366253|NCT01151085|879008|P1|COMPLETED|Overall Study||946
366254|NCT01151085|879008|P1|STARTED|Overall Study||1002
366255|NCT01151046|879026|P2|NOT COMPLETED|Overall Study||0
366256|NCT01151046|879027|P1|NOT COMPLETED|Overall Study||3
366257|NCT01151046|879026|P2|COMPLETED|Overall Study||59
366258|NCT01151046|879027|P1|COMPLETED|Overall Study||56
366259|NCT01151046|879026|P2|STARTED|Overall Study||59
366260|NCT01151046|879027|P1|STARTED|Overall Study||59
366261|NCT01151020|879039|P1|NOT COMPLETED|Overall Study||110
366262|NCT01151020|879039|P1|COMPLETED|Overall Study||0
366263|NCT01151020|879039|P1|12-month|Overall Study||99
366264|NCT01151020|879039|P1|30-day|Overall Study||110
366265|NCT01151020|879039|P1|STARTED|Overall Study||110
366266|NCT01150981|879046|P2|NOT COMPLETED|Overall Study||2
366267|NCT01150981|879047|P1|NOT COMPLETED|Overall Study||4
366268|NCT01150981|879046|P2|COMPLETED|Overall Study||13
366269|NCT01150981|879047|P1|COMPLETED|Overall Study||16
366270|NCT01150981|879046|P2|STARTED|Overall Study||15
366271|NCT01150981|879047|P1|STARTED|Overall Study||20
366272|NCT01150903|879057|P2|NOT COMPLETED|Overall Study||0
366273|NCT01150903|879058|P1|NOT COMPLETED|Overall Study||0
366274|NCT01150903|879057|P2|COMPLETED|Overall Study||74124
366275|NCT01150903|879058|P1|COMPLETED|Overall Study||24708
366276|NCT01150903|879057|P2|STARTED|Overall Study||74124
366277|NCT01150903|879058|P1|STARTED|Overall Study||24708
366278|NCT01150760|879074|P2|NOT COMPLETED|Overall Study||0
366279|NCT01150760|879075|P1|NOT COMPLETED|Overall Study||0
366280|NCT01150760|879074|P2|COMPLETED|Overall Study||3525
366281|NCT01150760|879075|P1|COMPLETED|Overall Study||3525
366282|NCT01150760|879074|P2|STARTED|Overall Study||3525
366283|NCT01150760|879075|P1|STARTED|Overall Study||3525
366284|NCT01150500|879107|P1|NOT COMPLETED|Overall Study||65
366285|NCT01150500|879107|P1|COMPLETED|Overall Study||0
366286|NCT01150500|879107|P1|STARTED|Overall Study||65
366287|NCT01150474|879118|P2|NOT COMPLETED|Overall Study||3
366288|NCT01150474|879119|P1|NOT COMPLETED|Overall Study||10
366289|NCT01150474|879118|P2|COMPLETED|Overall Study||49
366290|NCT01150474|879119|P1|COMPLETED|Overall Study||41
366291|NCT01150474|879118|P2|STARTED|Overall Study||52
366292|NCT01150474|879119|P1|STARTED|Overall Study||51
366293|NCT01150461|879143|P2|NOT COMPLETED|Overall Study||0
366294|NCT01150461|879144|P1|NOT COMPLETED|Overall Study||0
366295|NCT01150461|879143|P2|COMPLETED|Overall Study||9
366296|NCT01150461|879144|P1|COMPLETED|Overall Study||11
366297|NCT01150461|879143|P2|STARTED|Overall Study||9
366298|NCT01150461|879144|P1|STARTED|Overall Study||11
366299|NCT01150409|879154|P2|NOT COMPLETED|Overall Study||0
366300|NCT01150409|879155|P1|NOT COMPLETED|Overall Study||0
366301|NCT01150409|879154|P2|COMPLETED|Overall Study||0
366302|NCT01150409|879155|P1|COMPLETED|Overall Study||11
366303|NCT01150409|879154|P2|STARTED|Overall Study||0
366304|NCT01150409|879155|P1|STARTED|Overall Study||11
366476|NCT01149655|879563|P3|STARTED|Period 2-Stabilization Phase||0
366305|NCT01150357|879164|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
366306|NCT01150357|879165|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
366307|NCT01150357|879166|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
366308|NCT01150357|879164|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
366309|NCT01150357|879165|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
366310|NCT01150357|879166|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
366311|NCT01150357|879164|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
366312|NCT01150357|879165|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
366313|NCT01150357|879166|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
366314|NCT01150357|879164|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
366315|NCT01150357|879165|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
366316|NCT01150357|879166|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
366317|NCT01150357|879164|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
366318|NCT01150357|879165|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
366319|NCT01150357|879166|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
366320|NCT01150357|879164|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
366321|NCT01150357|879165|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
366322|NCT01150357|879166|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
366323|NCT01150357|879164|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
366324|NCT01150357|879165|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
366325|NCT01150357|879166|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
366326|NCT01150357|879164|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
366327|NCT01150357|879165|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
366328|NCT01150357|879166|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
366329|NCT01150357|879164|P3|COMPLETED|Dose Response Phase (Phase 1)||102
366330|NCT01150357|879165|P2|COMPLETED|Dose Response Phase (Phase 1)||51
366331|NCT01150357|879166|P1|COMPLETED|Dose Response Phase (Phase 1)||107
366332|NCT01150357|879164|P3|STARTED|Dose Response Phase (Phase 1)||105
366333|NCT01150357|879165|P2|STARTED|Dose Response Phase (Phase 1)||54
366334|NCT01150357|879166|P1|STARTED|Dose Response Phase (Phase 1)||108
366335|NCT01150123|879246|P18|NOT COMPLETED|Overall Study||1
366336|NCT01150123|879247|P17|NOT COMPLETED|Overall Study||0
366337|NCT01150123|879248|P16|NOT COMPLETED|Overall Study||1
366338|NCT01150123|879249|P15|NOT COMPLETED|Overall Study||0
366339|NCT01150123|879250|P14|NOT COMPLETED|Overall Study||0
366340|NCT01150123|879251|P13|NOT COMPLETED|Overall Study||3
366341|NCT01150123|879252|P12|NOT COMPLETED|Overall Study||1
366342|NCT01150123|879253|P11|NOT COMPLETED|Overall Study||2
366343|NCT01150123|879254|P10|NOT COMPLETED|Overall Study||1
366344|NCT01150123|879255|P9|NOT COMPLETED|Overall Study||5
366345|NCT01150123|879256|P8|NOT COMPLETED|Overall Study||3
366346|NCT01150123|879257|P7|NOT COMPLETED|Overall Study||0
366347|NCT01150123|879258|P6|NOT COMPLETED|Overall Study||6
366348|NCT01150123|879259|P5|NOT COMPLETED|Overall Study||3
366349|NCT01150123|879260|P4|NOT COMPLETED|Overall Study||3
366350|NCT01150123|879261|P3|NOT COMPLETED|Overall Study||4
366351|NCT01150123|879262|P2|NOT COMPLETED|Overall Study||2
366352|NCT01150123|879263|P1|NOT COMPLETED|Overall Study||3
366353|NCT01150123|879246|P18|COMPLETED|Overall Study||19
366354|NCT01150123|879247|P17|COMPLETED|Overall Study||40
366355|NCT01150123|879248|P16|COMPLETED|Overall Study||39
366356|NCT01150123|879249|P15|COMPLETED|Overall Study||40
366357|NCT01150123|879250|P14|COMPLETED|Overall Study||40
366358|NCT01150123|879251|P13|COMPLETED|Overall Study||37
366359|NCT01150123|879252|P12|COMPLETED|Overall Study||39
366360|NCT01150123|879253|P11|COMPLETED|Overall Study||38
366361|NCT01150123|879254|P10|COMPLETED|Overall Study||39
366362|NCT01150123|879255|P9|COMPLETED|Overall Study||15
366363|NCT01150123|879256|P8|COMPLETED|Overall Study||37
366364|NCT01150123|879257|P7|COMPLETED|Overall Study||39
366365|NCT01150123|879258|P6|COMPLETED|Overall Study||34
366366|NCT01150123|879259|P5|COMPLETED|Overall Study||37
366367|NCT01150123|879260|P4|COMPLETED|Overall Study||37
366368|NCT01150123|879261|P3|COMPLETED|Overall Study||35
366369|NCT01150123|879262|P2|COMPLETED|Overall Study||38
366370|NCT01150123|879263|P1|COMPLETED|Overall Study||37
366371|NCT01150123|879246|P18|STARTED|Overall Study||20
366372|NCT01150123|879247|P17|STARTED|Overall Study||40
366373|NCT01150123|879248|P16|STARTED|Overall Study||40
366374|NCT01150123|879249|P15|STARTED|Overall Study||40
366375|NCT01150123|879250|P14|STARTED|Overall Study||40
366376|NCT01150123|879251|P13|STARTED|Overall Study||40
366377|NCT01150123|879252|P12|STARTED|Overall Study||40
366378|NCT01150123|879253|P11|STARTED|Overall Study||40
366379|NCT01150123|879254|P10|STARTED|Overall Study||40
366380|NCT01150123|879255|P9|STARTED|Overall Study||20
366381|NCT01150123|879256|P8|STARTED|Overall Study||40
366382|NCT01150123|879257|P7|STARTED|Overall Study||39
366383|NCT01150123|879258|P6|STARTED|Overall Study||40
366384|NCT01150123|879259|P5|STARTED|Overall Study||40
366385|NCT01150123|879260|P4|STARTED|Overall Study||40
366386|NCT01150123|879261|P3|STARTED|Overall Study||39
366387|NCT01150123|879262|P2|STARTED|Overall Study||40
366388|NCT01150123|879263|P1|STARTED|Overall Study||40
366389|NCT01150097|879439|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
366390|NCT01150097|879440|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
366391|NCT01150097|879441|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
366392|NCT01150097|879439|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
366393|NCT01150097|879440|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
366394|NCT01150097|879441|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
366395|NCT01150097|879439|P3|STARTED|Months 24 to 48 Post-transplantation||0
366396|NCT01150097|879440|P2|STARTED|Months 24 to 48 Post-transplantation||51
366397|NCT01150097|879441|P1|STARTED|Months 24 to 48 Post-transplantation||106
366398|NCT01150097|879439|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
366399|NCT01150097|879440|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
366400|NCT01150097|879441|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
366401|NCT01150097|879439|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
366402|NCT01150097|879440|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
366403|NCT01150097|879441|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
366404|NCT01150097|879439|P3|STARTED|Months 24 to 36 Post-transplantation||125
366405|NCT01150097|879440|P2|STARTED|Months 24 to 36 Post-transplantation||51
366406|NCT01150097|879441|P1|STARTED|Months 24 to 36 Post-transplantation||106
366407|NCT01149876|879468|P4|NOT COMPLETED|Overall Study||0
366408|NCT01149876|879469|P3|NOT COMPLETED|Overall Study||1
366409|NCT01149876|879470|P2|NOT COMPLETED|Overall Study||0
366410|NCT01149876|879471|P1|NOT COMPLETED|Overall Study||1
366411|NCT01149876|879468|P4|COMPLETED|Overall Study||18
366412|NCT01149876|879469|P3|COMPLETED|Overall Study||20
366413|NCT01149876|879470|P2|COMPLETED|Overall Study||20
366414|NCT01149876|879471|P1|COMPLETED|Overall Study||20
366415|NCT01149876|879468|P4|STARTED|Overall Study||18
366416|NCT01149876|879469|P3|STARTED|Overall Study||21
366417|NCT01149876|879470|P2|STARTED|Overall Study||20
366418|NCT01149876|879471|P1|STARTED|Overall Study||21
366419|NCT01149863|879485|P1|NOT COMPLETED|Overall Study||3
366420|NCT01149863|879485|P1|COMPLETED|Overall Study||31
366421|NCT01149863|879485|P1|STARTED|Overall Study||34
366422|NCT01149785|879490|P2|NOT COMPLETED|Second Intervention||0
366423|NCT01149785|879491|P1|NOT COMPLETED|Second Intervention||0
366424|NCT01149785|879490|P2|COMPLETED|Second Intervention||15
366425|NCT01149785|879491|P1|COMPLETED|Second Intervention||0
366426|NCT01149785|879490|P2|STARTED|Second Intervention||15
366427|NCT01149785|879491|P1|STARTED|Second Intervention||0
366428|NCT01149785|879490|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
366429|NCT01149785|879491|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
366430|NCT01149785|879490|P2|COMPLETED|Washout Period of at Least 14 Days||0
366431|NCT01149785|879491|P1|COMPLETED|Washout Period of at Least 14 Days||15
366432|NCT01149785|879490|P2|STARTED|Washout Period of at Least 14 Days||0
366433|NCT01149785|879491|P1|STARTED|Washout Period of at Least 14 Days||15
366434|NCT01149785|879490|P2|NOT COMPLETED|First Intervention||0
366435|NCT01149785|879491|P1|NOT COMPLETED|First Intervention||0
366436|NCT01149785|879490|P2|COMPLETED|First Intervention||0
366437|NCT01149785|879491|P1|COMPLETED|First Intervention||15
366438|NCT01149785|879490|P2|STARTED|First Intervention||0
366439|NCT01149785|879491|P1|STARTED|First Intervention||15
366440|NCT01149772|879525|P2|NOT COMPLETED|Overall Study||21
366441|NCT01149772|879526|P1|NOT COMPLETED|Overall Study||48
366442|NCT01149772|879525|P2|COMPLETED|Overall Study||101
366443|NCT01149772|879526|P1|COMPLETED|Overall Study||132
366444|NCT01149772|879525|P2|STARTED|Overall Study||122
366445|NCT01149772|879526|P1|STARTED|Overall Study||180
366446|NCT01149759|879542|P1|NOT COMPLETED|Overall Study||0
366447|NCT01149759|879542|P1|COMPLETED|Overall Study||9
366448|NCT01149759|879542|P1|STARTED|Overall Study||9
366449|NCT01149733|879549|P2|NOT COMPLETED|Overall Study||0
366450|NCT01149733|879550|P1|NOT COMPLETED|Overall Study||0
366451|NCT01149733|879549|P2|COMPLETED|Overall Study||16
366452|NCT01149733|879550|P1|COMPLETED|Overall Study||16
366453|NCT01149733|879549|P2|STARTED|Overall Study||16
366454|NCT01149733|879550|P1|STARTED|Overall Study||16
366455|NCT01149655|879562|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
366456|NCT01149655|879563|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
366457|NCT01149655|879564|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
366458|NCT01149655|879565|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
366459|NCT01149655|879562|P4|COMPLETED|Period 3-DB Maintenance Phase||6
366460|NCT01149655|879563|P3|COMPLETED|Period 3-DB Maintenance Phase||15
366461|NCT01149655|879564|P2|COMPLETED|Period 3-DB Maintenance Phase||0
366462|NCT01149655|879565|P1|COMPLETED|Period 3-DB Maintenance Phase||0
366463|NCT01149655|879562|P4|STARTED|Period 3-DB Maintenance Phase||48
366464|NCT01149655|879563|P3|STARTED|Period 3-DB Maintenance Phase||98
366465|NCT01149655|879564|P2|STARTED|Period 3-DB Maintenance Phase||0
366466|NCT01149655|879565|P1|STARTED|Period 3-DB Maintenance Phase||0
366467|NCT01149655|879562|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
366468|NCT01149655|879563|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
366469|NCT01149655|879564|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
366470|NCT01149655|879565|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
366471|NCT01149655|879562|P4|COMPLETED|Period 2-Stabilization Phase||0
366472|NCT01149655|879563|P3|COMPLETED|Period 2-Stabilization Phase||0
366473|NCT01149655|879564|P2|COMPLETED|Period 2-Stabilization Phase||146
366474|NCT01149655|879565|P1|COMPLETED|Period 2-Stabilization Phase||0
366475|NCT01149655|879562|P4|STARTED|Period 2-Stabilization Phase||0
366477|NCT01149655|879564|P2|STARTED|Period 2-Stabilization Phase||183
366478|NCT01149655|879565|P1|STARTED|Period 2-Stabilization Phase||0
366479|NCT01149655|879562|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
366480|NCT01149655|879563|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
366481|NCT01149655|879564|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
366482|NCT01149655|879565|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
366483|NCT01149655|879562|P4|COMPLETED|Period 1 - Conversion Phase||0
366484|NCT01149655|879563|P3|COMPLETED|Period 1 - Conversion Phase||0
366485|NCT01149655|879564|P2|COMPLETED|Period 1 - Conversion Phase||0
366486|NCT01149655|879565|P1|COMPLETED|Period 1 - Conversion Phase||168
366487|NCT01149655|879562|P4|STARTED|Period 1 - Conversion Phase||0
366488|NCT01149655|879563|P3|STARTED|Period 1 - Conversion Phase||0
366489|NCT01149655|879564|P2|STARTED|Period 1 - Conversion Phase||0
366490|NCT01149655|879565|P1|STARTED|Period 1 - Conversion Phase||186
366491|NCT01149538|879595|P2|NOT COMPLETED|Overall Study||4
366492|NCT01149538|879596|P1|NOT COMPLETED|Overall Study||5
366493|NCT01149538|879595|P2|COMPLETED|Overall Study||25
366494|NCT01149538|879596|P1|COMPLETED|Overall Study||26
366495|NCT01149538|879595|P2|STARTED|Overall Study||29
366496|NCT01149538|879596|P1|STARTED|Overall Study||31
366497|NCT01149486|879612|P2|NOT COMPLETED|Second Intervention||0
366498|NCT01149486|879613|P1|NOT COMPLETED|Second Intervention||0
366499|NCT01149486|879612|P2|COMPLETED|Second Intervention||9
366500|NCT01149486|879613|P1|COMPLETED|Second Intervention||10
366501|NCT01149486|879612|P2|STARTED|Second Intervention||9
366502|NCT01149486|879613|P1|STARTED|Second Intervention||10
366503|NCT01149486|879612|P2|NOT COMPLETED|Washout of 7 Days||0
366504|NCT01149486|879613|P1|NOT COMPLETED|Washout of 7 Days||0
366505|NCT01149486|879612|P2|COMPLETED|Washout of 7 Days||9
366506|NCT01149486|879613|P1|COMPLETED|Washout of 7 Days||10
366507|NCT01149486|879612|P2|STARTED|Washout of 7 Days||9
366508|NCT01149486|879613|P1|STARTED|Washout of 7 Days||10
366509|NCT01149486|879612|P2|NOT COMPLETED|First Intervention||1
366510|NCT01149486|879613|P1|NOT COMPLETED|First Intervention||0
366511|NCT01149486|879612|P2|COMPLETED|First Intervention||9
366512|NCT01149486|879613|P1|COMPLETED|First Intervention||10
366513|NCT01149486|879612|P2|STARTED|First Intervention||10
366514|NCT01149486|879613|P1|STARTED|First Intervention||10
366515|NCT01149473|879637|P2|NOT COMPLETED|Second Intervention||0
366516|NCT01149473|879638|P1|NOT COMPLETED|Second Intervention||0
366517|NCT01149473|879637|P2|COMPLETED|Second Intervention||38
366518|NCT01149473|879638|P1|COMPLETED|Second Intervention||38
366519|NCT01149473|879637|P2|STARTED|Second Intervention||38
366520|NCT01149473|879638|P1|STARTED|Second Intervention||38
366521|NCT01149473|879637|P2|NOT COMPLETED|Washout of 7 Days||1
366522|NCT01149473|879638|P1|NOT COMPLETED|Washout of 7 Days||1
366523|NCT01149473|879637|P2|COMPLETED|Washout of 7 Days||38
366524|NCT01149473|879638|P1|COMPLETED|Washout of 7 Days||38
366525|NCT01149473|879637|P2|STARTED|Washout of 7 Days||39
366526|NCT01149473|879638|P1|STARTED|Washout of 7 Days||39
366527|NCT01149473|879637|P2|NOT COMPLETED|First Intervention||1
366528|NCT01149473|879638|P1|NOT COMPLETED|First Intervention||1
366529|NCT01149473|879637|P2|COMPLETED|First Intervention||39
366530|NCT01149473|879638|P1|COMPLETED|First Intervention||39
366531|NCT01149473|879637|P2|STARTED|First Intervention||40
366532|NCT01149473|879638|P1|STARTED|First Intervention||40
366533|NCT01149460|879656|P2|NOT COMPLETED|Overall Study||2
366534|NCT01149460|879657|P1|NOT COMPLETED|Overall Study||0
366535|NCT01149460|879656|P2|COMPLETED|Overall Study||16
366536|NCT01149460|879657|P1|COMPLETED|Overall Study||18
366537|NCT01149460|879656|P2|STARTED|Overall Study||18
366538|NCT01149460|879657|P1|STARTED|Overall Study||18
366539|NCT01149434|879675|P2|NOT COMPLETED|Overall Study||5
366540|NCT01149434|879676|P1|NOT COMPLETED|Overall Study||0
366541|NCT01149434|879675|P2|COMPLETED|Overall Study||10
366542|NCT01149434|879676|P1|COMPLETED|Overall Study||4
366543|NCT01149434|879675|P2|STARTED|Overall Study||15
366544|NCT01149434|879676|P1|STARTED|Overall Study||4
366545|NCT01149421|879690|P3|NOT COMPLETED|Overall Study||44
366546|NCT01149421|879691|P2|NOT COMPLETED|Overall Study||29
366547|NCT01149421|879692|P1|NOT COMPLETED|Overall Study||52
366548|NCT01149421|879690|P3|COMPLETED|Overall Study||206
366549|NCT01149421|879691|P2|COMPLETED|Overall Study||225
366550|NCT01149421|879692|P1|COMPLETED|Overall Study||199
366551|NCT01149421|879690|P3|Received at Least One Dose of Study Drug|Overall Study||250
366552|NCT01149421|879691|P2|Received at Least One Dose of Study Drug|Overall Study||254
366553|NCT01149421|879692|P1|Received at Least One Dose of Study Drug|Overall Study||251
366554|NCT01149421|879690|P3|STARTED|Overall Study||250
366555|NCT01149421|879691|P2|STARTED|Overall Study||254
366556|NCT01149421|879692|P1|STARTED|Overall Study||251
366557|NCT01149148|879773|P2|NOT COMPLETED|Overall Study||2
366558|NCT01149148|879774|P1|NOT COMPLETED|Overall Study||2
366559|NCT01149148|879773|P2|COMPLETED|Overall Study||11
366560|NCT01149148|879774|P1|COMPLETED|Overall Study||10
366561|NCT01149148|879773|P2|STARTED|Overall Study||13
366562|NCT01149148|879774|P1|STARTED|Overall Study||12
366563|NCT01149057|879782|P1|NOT COMPLETED|Overall Study||57
366564|NCT01149057|879782|P1|COMPLETED|Overall Study||88
366565|NCT01149057|879782|P1|STARTED|Overall Study||145
366566|NCT01148979|879809|P2|NOT COMPLETED|Overall Study||1
366567|NCT01148979|879810|P1|NOT COMPLETED|Overall Study||0
366568|NCT01148979|879809|P2|COMPLETED|Overall Study||15
366569|NCT01148979|879810|P1|COMPLETED|Overall Study||13
366570|NCT01148979|879809|P2|STARTED|Overall Study||16
366571|NCT01148979|879810|P1|STARTED|Overall Study||13
366572|NCT01148862|879816|P2|NOT COMPLETED|Second Intervention||2
366573|NCT01148862|879817|P1|NOT COMPLETED|Second Intervention||0
366574|NCT01148862|879816|P2|COMPLETED|Second Intervention||23
366575|NCT01148862|879817|P1|COMPLETED|Second Intervention||25
366576|NCT01148862|879816|P2|STARTED|Second Intervention||25
366577|NCT01148862|879817|P1|STARTED|Second Intervention||25
366578|NCT01148862|879816|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
366579|NCT01148862|879817|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
366580|NCT01148862|879816|P2|COMPLETED|Washout Period of 2 Weeks||25
366581|NCT01148862|879817|P1|COMPLETED|Washout Period of 2 Weeks||25
366582|NCT01148862|879816|P2|STARTED|Washout Period of 2 Weeks||25
366583|NCT01148862|879817|P1|STARTED|Washout Period of 2 Weeks||25
366584|NCT01148862|879816|P2|NOT COMPLETED|First Intervention||0
366585|NCT01148862|879817|P1|NOT COMPLETED|First Intervention||0
366586|NCT01148862|879816|P2|COMPLETED|First Intervention||25
366587|NCT01148862|879817|P1|COMPLETED|First Intervention||25
366588|NCT01148862|879816|P2|STARTED|First Intervention||25
366589|NCT01148862|879817|P1|STARTED|First Intervention||25
366590|NCT01148836|879827|P2|NOT COMPLETED|Overall Study||2
366591|NCT01148836|879828|P1|NOT COMPLETED|Overall Study||1
366592|NCT01148836|879827|P2|COMPLETED|Overall Study||8
366593|NCT01148836|879828|P1|COMPLETED|Overall Study|Enrollment completed|7
366594|NCT01148836|879827|P2|STARTED|Overall Study||10
366595|NCT01148836|879828|P1|STARTED|Overall Study|Enrollment completed|8
366596|NCT01148771|879849|P2|NOT COMPLETED|Second Intervention||0
366597|NCT01148771|879850|P1|NOT COMPLETED|Second Intervention||0
366598|NCT01148771|879849|P2|COMPLETED|Second Intervention||5
366599|NCT01148771|879850|P1|COMPLETED|Second Intervention||6
366600|NCT01148771|879849|P2|STARTED|Second Intervention||5
366601|NCT01148771|879850|P1|STARTED|Second Intervention||6
366602|NCT01148771|879849|P2|NOT COMPLETED|Washout Period||1
366603|NCT01148771|879850|P1|NOT COMPLETED|Washout Period||0
366604|NCT01148771|879849|P2|COMPLETED|Washout Period||5
366605|NCT01148771|879850|P1|COMPLETED|Washout Period||6
366606|NCT01148771|879849|P2|STARTED|Washout Period||6
366607|NCT01148771|879850|P1|STARTED|Washout Period||6
366608|NCT01148771|879849|P2|NOT COMPLETED|First Intervention||0
366609|NCT01148771|879850|P1|NOT COMPLETED|First Intervention||0
366610|NCT01148771|879849|P2|COMPLETED|First Intervention||6
366611|NCT01148771|879850|P1|COMPLETED|First Intervention||6
366612|NCT01148771|879849|P2|STARTED|First Intervention||6
366613|NCT01148771|879850|P1|STARTED|First Intervention||6
366614|NCT01148745|879862|P1|NOT COMPLETED|Overall Study||0
366615|NCT01148745|879862|P1|COMPLETED|Overall Study||15
366616|NCT01148745|879862|P1|STARTED|Overall Study||15
366617|NCT01148693|879870|P2|NOT COMPLETED|Overall Study||10
366618|NCT01148693|879871|P1|NOT COMPLETED|Overall Study||13
366619|NCT01148693|879870|P2|COMPLETED|Overall Study||57
366620|NCT01148693|879871|P1|COMPLETED|Overall Study||57
366621|NCT01148693|879870|P2|STARTED|Overall Study||67
366622|NCT01148693|879871|P1|STARTED|Overall Study||70
366623|NCT01148537|879880|P3|NOT COMPLETED|Overall Study||3
366624|NCT01148537|879881|P2|NOT COMPLETED|Overall Study||0
366625|NCT01148537|879882|P1|NOT COMPLETED|Overall Study||3
366626|NCT01148537|879880|P3|COMPLETED|Overall Study||41
366627|NCT01148537|879881|P2|COMPLETED|Overall Study||44
366628|NCT01148537|879882|P1|COMPLETED|Overall Study||41
366629|NCT01148537|879880|P3|STARTED|Overall Study||44
366630|NCT01148537|879881|P2|STARTED|Overall Study||44
366631|NCT01148537|879882|P1|STARTED|Overall Study||44
366632|NCT01148524|879912|P9|NOT COMPLETED|Overall Study||0
366633|NCT01148524|879913|P8|NOT COMPLETED|Overall Study||0
366634|NCT01148524|879914|P7|NOT COMPLETED|Overall Study||0
366635|NCT01148524|879915|P6|NOT COMPLETED|Overall Study||0
366636|NCT01148524|879916|P5|NOT COMPLETED|Overall Study||0
366637|NCT01148524|879917|P4|NOT COMPLETED|Overall Study||0
366638|NCT01148524|879918|P3|NOT COMPLETED|Overall Study||0
366639|NCT01148524|879919|P2|NOT COMPLETED|Overall Study||0
366640|NCT01148524|879920|P1|NOT COMPLETED|Overall Study||0
366641|NCT01148524|879912|P9|COMPLETED|Overall Study||151
366642|NCT01148524|879913|P8|COMPLETED|Overall Study||51
366643|NCT01148524|879914|P7|COMPLETED|Overall Study||153
366644|NCT01148524|879915|P6|COMPLETED|Overall Study||106
366645|NCT01148524|879916|P5|COMPLETED|Overall Study||57
366646|NCT01148524|879917|P4|COMPLETED|Overall Study||102
366647|NCT01148524|879918|P3|COMPLETED|Overall Study||53
366648|NCT01148524|879919|P2|COMPLETED|Overall Study||95
366649|NCT01148524|879920|P1|COMPLETED|Overall Study||49
366650|NCT01148524|879912|P9|STARTED|Overall Study||151
366651|NCT01148524|879913|P8|STARTED|Overall Study||51
366652|NCT01148524|879914|P7|STARTED|Overall Study||153
366653|NCT01148524|879915|P6|STARTED|Overall Study||106
366654|NCT01148524|879916|P5|STARTED|Overall Study||57
366655|NCT01148524|879917|P4|STARTED|Overall Study||102
366656|NCT01148524|879918|P3|STARTED|Overall Study||53
366657|NCT01148524|879919|P2|STARTED|Overall Study||95
366658|NCT01148524|879920|P1|STARTED|Overall Study||49
366659|NCT01148511|879968|P3|NOT COMPLETED|Randomized||6
366660|NCT01148511|879969|P2|NOT COMPLETED|Randomized||10
366661|NCT01148511|879970|P1|NOT COMPLETED|Randomized||0
366662|NCT01148511|879968|P3|COMPLETED|Randomized||39
366663|NCT01148511|879969|P2|COMPLETED|Randomized||38
366664|NCT01148511|879970|P1|COMPLETED|Randomized||0
366665|NCT01148511|879968|P3|STARTED|Randomized||45
366666|NCT01148511|879969|P2|STARTED|Randomized||48
366667|NCT01148511|879970|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
366668|NCT01148511|879968|P3|NOT COMPLETED|Exposed to Study Drug||0
366669|NCT01148511|879969|P2|NOT COMPLETED|Exposed to Study Drug||0
366670|NCT01148511|879970|P1|NOT COMPLETED|Exposed to Study Drug||6
366671|NCT01148511|879968|P3|COMPLETED|Exposed to Study Drug||0
366672|NCT01148511|879969|P2|COMPLETED|Exposed to Study Drug||0
366673|NCT01148511|879970|P1|COMPLETED|Exposed to Study Drug||93
366674|NCT01148511|879968|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
366675|NCT01148511|879969|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
366676|NCT01148511|879970|P1|STARTED|Exposed to Study Drug||99
366677|NCT01148420|879989|P1|NOT COMPLETED|Overall Study||0
366678|NCT01148420|879989|P1|COMPLETED|Overall Study||48
366679|NCT01148420|879989|P1|STARTED|Overall Study||48
366680|NCT01148056|879995|P1|NOT COMPLETED|Overall Study||0
366681|NCT01148056|879995|P1|COMPLETED|Overall Study||2
366682|NCT01148056|879995|P1|STARTED|Overall Study||2
366683|NCT01148017|880008|P4|NOT COMPLETED|Overall Study||0
366684|NCT01148017|880009|P3|NOT COMPLETED|Overall Study||0
366685|NCT01148017|880010|P2|NOT COMPLETED|Overall Study||34
366686|NCT01148017|880011|P1|NOT COMPLETED|Overall Study||80
366687|NCT01148017|880008|P4|COMPLETED|Overall Study||45
366688|NCT01148017|880009|P3|COMPLETED|Overall Study||53
366689|NCT01148017|880010|P2|COMPLETED|Overall Study||87
366690|NCT01148017|880011|P1|COMPLETED|Overall Study||134
366691|NCT01148017|880008|P4|STARTED|Overall Study||45
366692|NCT01148017|880009|P3|STARTED|Overall Study||53
366693|NCT01148017|880010|P2|STARTED|Overall Study||121
366694|NCT01148017|880011|P1|STARTED|Overall Study||214
366695|NCT01147926|880050|P2|NOT COMPLETED|Overall Study||29
366696|NCT01147926|880051|P1|NOT COMPLETED|Overall Study||27
366697|NCT01147926|880050|P2|COMPLETED|Overall Study||158
366698|NCT01147926|880051|P1|COMPLETED|Overall Study||160
366699|NCT01147926|880050|P2|STARTED|Overall Study||187
366700|NCT01147926|880051|P1|STARTED|Overall Study||187
366701|NCT01147900|880086|P3|NOT COMPLETED|At Year 10||0
366702|NCT01147900|880087|P2|NOT COMPLETED|At Year 10||1
366703|NCT01147900|880088|P1|NOT COMPLETED|At Year 10||0
366704|NCT01147900|880086|P3|COMPLETED|At Year 10||62
366705|NCT01147900|880087|P2|COMPLETED|At Year 10||59
366706|NCT01147900|880088|P1|COMPLETED|At Year 10||55
366707|NCT01147900|880086|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
366708|NCT01147900|880087|P2|STARTED|At Year 10||60
366709|NCT01147900|880088|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
366710|NCT01147900|880086|P3|NOT COMPLETED|At Year 8.5||0
366711|NCT01147900|880087|P2|NOT COMPLETED|At Year 8.5||0
366712|NCT01147900|880088|P1|NOT COMPLETED|At Year 8.5||0
366713|NCT01147900|880086|P3|COMPLETED|At Year 8.5||66
366714|NCT01147900|880087|P2|COMPLETED|At Year 8.5||60
366715|NCT01147900|880088|P1|COMPLETED|At Year 8.5||54
366716|NCT01147900|880086|P3|STARTED|At Year 8.5||66
366717|NCT01147900|880087|P2|STARTED|At Year 8.5||60
366718|NCT01147900|880088|P1|STARTED|At Year 8.5||54
366719|NCT01147874|880147|P1|NOT COMPLETED|Overall Study||67
366720|NCT01147874|880147|P1|COMPLETED|Overall Study||946
366721|NCT01147874|880147|P1|STARTED|Overall Study||1013
366722|NCT01147848|880155|P3|NOT COMPLETED|Randomized Phase||46
366723|NCT01147848|880156|P2|NOT COMPLETED|Randomized Phase||45
366724|NCT01147848|880157|P1|NOT COMPLETED|Randomized Phase||0
366725|NCT01147848|880155|P3|COMPLETED|Randomized Phase||357
366726|NCT01147848|880156|P2|COMPLETED|Randomized Phase||358
366727|NCT01147848|880157|P1|COMPLETED|Randomized Phase||0
366728|NCT01147848|880155|P3|STARTED|Randomized Phase||403
366729|NCT01147848|880156|P2|STARTED|Randomized Phase||403
366730|NCT01147848|880157|P1|STARTED|Randomized Phase||0
366731|NCT01147848|880155|P3|NOT COMPLETED|Run-in Period||0
366732|NCT01147848|880156|P2|NOT COMPLETED|Run-in Period||0
366733|NCT01147848|880157|P1|NOT COMPLETED|Run-in Period||758
366734|NCT01147848|880155|P3|COMPLETED|Run-in Period||0
366735|NCT01147848|880156|P2|COMPLETED|Run-in Period||0
366736|NCT01147848|880157|P1|COMPLETED|Run-in Period||806
366737|NCT01147848|880155|P3|STARTED|Run-in Period||0
366738|NCT01147848|880156|P2|STARTED|Run-in Period||0
366739|NCT01147848|880157|P1|STARTED|Run-in Period||1564
366740|NCT01147822|880189|P2|NOT COMPLETED|Overall Study||179
366741|NCT01147822|880190|P1|NOT COMPLETED|Overall Study||188
366742|NCT01147822|880189|P2|COMPLETED|Overall Study||0
366743|NCT01147822|880190|P1|COMPLETED|Overall Study||0
366744|NCT01147822|880189|P2|Not Completed/Ongoing|Overall Study||102
366745|NCT01147822|880190|P1|Not Completed/Ongoing|Overall Study||111
366746|NCT01147822|880189|P2|STARTED|Overall Study||179
366747|NCT01147822|880190|P1|STARTED|Overall Study||188
366748|NCT01147809|880210|P6|NOT COMPLETED|Phase II (168 Days)||33
366749|NCT01147809|880211|P5|NOT COMPLETED|Phase II (168 Days)||16
366750|NCT01147809|880212|P4|NOT COMPLETED|Phase II (168 Days)||0
366751|NCT01147809|880213|P3|NOT COMPLETED|Phase II (168 Days)||0
366752|NCT01147809|880214|P2|NOT COMPLETED|Phase II (168 Days)||0
366753|NCT01147809|880215|P1|NOT COMPLETED|Phase II (168 Days)||0
366754|NCT01147809|880210|P6|COMPLETED|Phase II (168 Days)||19
366755|NCT01147809|880211|P5|COMPLETED|Phase II (168 Days)||7
366756|NCT01147809|880212|P4|COMPLETED|Phase II (168 Days)||0
366757|NCT01147809|880213|P3|COMPLETED|Phase II (168 Days)||0
366758|NCT01147809|880214|P2|COMPLETED|Phase II (168 Days)||0
366759|NCT01147809|880215|P1|COMPLETED|Phase II (168 Days)||0
366760|NCT01147809|880210|P6|Ongoing|Phase II (168 Days)||0
366761|NCT01147809|880211|P5|Ongoing|Phase II (168 Days)||1
366762|NCT01147809|880212|P4|Ongoing|Phase II (168 Days)||0
366763|NCT01147809|880213|P3|Ongoing|Phase II (168 Days)||0
366764|NCT01147809|880214|P2|Ongoing|Phase II (168 Days)||0
366765|NCT01147809|880215|P1|Ongoing|Phase II (168 Days)||0
366766|NCT01147809|880210|P6|STARTED|Phase II (168 Days)||52
366767|NCT01147809|880211|P5|STARTED|Phase II (168 Days)||23
366768|NCT01147809|880212|P4|STARTED|Phase II (168 Days)||0
366769|NCT01147809|880213|P3|STARTED|Phase II (168 Days)||0
366770|NCT01147809|880214|P2|STARTED|Phase II (168 Days)||0
366771|NCT01147809|880215|P1|STARTED|Phase II (168 Days)||0
366772|NCT01147809|880210|P6|NOT COMPLETED|Phase I (168 Days)||0
366773|NCT01147809|880211|P5|NOT COMPLETED|Phase I (168 Days)||0
366774|NCT01147809|880212|P4|NOT COMPLETED|Phase I (168 Days)||5
366775|NCT01147809|880213|P3|NOT COMPLETED|Phase I (168 Days)||2
366776|NCT01147809|880214|P2|NOT COMPLETED|Phase I (168 Days)||1
366777|NCT01147809|880215|P1|NOT COMPLETED|Phase I (168 Days)||1
366778|NCT01147809|880210|P6|COMPLETED|Phase I (168 Days)||0
366779|NCT01147809|880211|P5|COMPLETED|Phase I (168 Days)||0
366780|NCT01147809|880212|P4|COMPLETED|Phase I (168 Days)||5
366781|NCT01147809|880213|P3|COMPLETED|Phase I (168 Days)||2
366782|NCT01147809|880214|P2|COMPLETED|Phase I (168 Days)||8
366783|NCT01147809|880215|P1|COMPLETED|Phase I (168 Days)||2
366784|NCT01147809|880210|P6|STARTED|Phase I (168 Days)||0
366785|NCT01147809|880211|P5|STARTED|Phase I (168 Days)||0
366786|NCT01147809|880212|P4|STARTED|Phase I (168 Days)||10
366787|NCT01147809|880213|P3|STARTED|Phase I (168 Days)||4
366788|NCT01147809|880214|P2|STARTED|Phase I (168 Days)||9
366789|NCT01147809|880215|P1|STARTED|Phase I (168 Days)||3
366790|NCT01147653|880331|P2|NOT COMPLETED|Year 2||3
366791|NCT01147653|880332|P1|NOT COMPLETED|Year 2||2
366792|NCT01147653|880331|P2|COMPLETED|Year 2||28
366793|NCT01147653|880332|P1|COMPLETED|Year 2||30
366794|NCT01147653|880331|P2|STARTED|Year 2||31
366795|NCT01147653|880332|P1|STARTED|Year 2||32
366796|NCT01147653|880331|P2|NOT COMPLETED|Year 1||0
366797|NCT01147653|880332|P1|NOT COMPLETED|Year 1||0
366798|NCT01147653|880331|P2|COMPLETED|Year 1||31
366799|NCT01147653|880332|P1|COMPLETED|Year 1||32
366800|NCT01147653|880331|P2|STARTED|Year 1||31
366801|NCT01147653|880332|P1|STARTED|Year 1||32
366802|NCT01147640|880389|P2|NOT COMPLETED|Overall Study||1
366803|NCT01147640|880390|P1|NOT COMPLETED|Overall Study||5
366804|NCT01147640|880389|P2|COMPLETED|Overall Study||38
366805|NCT01147640|880390|P1|COMPLETED|Overall Study||78
366806|NCT01147640|880389|P2|STARTED|Overall Study||39
366807|NCT01147640|880390|P1|STARTED|Overall Study||83
366808|NCT01147627|880401|P3|NOT COMPLETED|Overall Study||18
366809|NCT01147627|880402|P2|NOT COMPLETED|Overall Study||24
366810|NCT01147627|880403|P1|NOT COMPLETED|Overall Study||32
366811|NCT01147627|880401|P3|COMPLETED|Overall Study||118
366812|NCT01147627|880402|P2|COMPLETED|Overall Study||114
366813|NCT01147627|880403|P1|COMPLETED|Overall Study||110
366814|NCT01147627|880401|P3|STARTED|Overall Study||136
366815|NCT01147627|880402|P2|STARTED|Overall Study||138
366816|NCT01147627|880403|P1|STARTED|Overall Study||142
366817|NCT01147497|880413|P2|NOT COMPLETED|Overall Study||0
366818|NCT01147497|880414|P1|NOT COMPLETED|Overall Study||2
366819|NCT01147497|880413|P2|COMPLETED|Overall Study||36
366820|NCT01147497|880414|P1|COMPLETED|Overall Study||35
366821|NCT01147497|880413|P2|STARTED|Overall Study||36
366822|NCT01147497|880414|P1|STARTED|Overall Study||37
366823|NCT01147471|880426|P2|NOT COMPLETED|6 Month Follow Up||2
366824|NCT01147471|880427|P1|NOT COMPLETED|6 Month Follow Up||4
366825|NCT01147471|880426|P2|COMPLETED|6 Month Follow Up||4
366826|NCT01147471|880427|P1|COMPLETED|6 Month Follow Up||8
366827|NCT01147471|880426|P2|STARTED|6 Month Follow Up||6
366828|NCT01147471|880427|P1|STARTED|6 Month Follow Up||12
366829|NCT01147471|880426|P2|NOT COMPLETED|3 Month Follow Up||2
366830|NCT01147471|880427|P1|NOT COMPLETED|3 Month Follow Up||1
366831|NCT01147471|880426|P2|COMPLETED|3 Month Follow Up||6
366832|NCT01147471|880427|P1|COMPLETED|3 Month Follow Up||12
366833|NCT01147471|880426|P2|STARTED|3 Month Follow Up||8
366834|NCT01147471|880427|P1|STARTED|3 Month Follow Up||13
366835|NCT01147471|880426|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
366836|NCT01147471|880427|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
366837|NCT01147471|880426|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
366838|NCT01147471|880427|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
366839|NCT01147471|880426|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
366840|NCT01147471|880427|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
366841|NCT01147471|880426|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
366842|NCT01147471|880427|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
366843|NCT01147471|880426|P2|COMPLETED|Through Initial Hospital Discharge||11
366844|NCT01147471|880427|P1|COMPLETED|Through Initial Hospital Discharge||13
366845|NCT01147471|880426|P2|STARTED|Through Initial Hospital Discharge||11
366846|NCT01147471|880427|P1|STARTED|Through Initial Hospital Discharge||13
366847|NCT01147458|880441|P4|NOT COMPLETED|Second Intervention||4
366848|NCT01147458|880442|P3|NOT COMPLETED|Second Intervention||8
366849|NCT01147458|880443|P2|NOT COMPLETED|Second Intervention||7
366850|NCT01147458|880444|P1|NOT COMPLETED|Second Intervention||9
366851|NCT01147458|880441|P4|COMPLETED|Second Intervention||30
366852|NCT01147458|880442|P3|COMPLETED|Second Intervention||27
366853|NCT01147458|880443|P2|COMPLETED|Second Intervention||24
366854|NCT01147458|880444|P1|COMPLETED|Second Intervention||25
366855|NCT01147458|880441|P4|STARTED|Second Intervention||34
366856|NCT01147458|880442|P3|STARTED|Second Intervention||35
366857|NCT01147458|880443|P2|STARTED|Second Intervention||31
366858|NCT01147458|880444|P1|STARTED|Second Intervention||34
366859|NCT01147458|880441|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
366860|NCT01147458|880442|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
366861|NCT01147458|880443|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
366862|NCT01147458|880444|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
366863|NCT01147458|880441|P4|COMPLETED|Washout Period of 2 Weeks||34
366864|NCT01147458|880442|P3|COMPLETED|Washout Period of 2 Weeks||35
366865|NCT01147458|880443|P2|COMPLETED|Washout Period of 2 Weeks||31
366866|NCT01147458|880444|P1|COMPLETED|Washout Period of 2 Weeks||34
366867|NCT01147458|880441|P4|STARTED|Washout Period of 2 Weeks||34
366868|NCT01147458|880442|P3|STARTED|Washout Period of 2 Weeks||35
366869|NCT01147458|880443|P2|STARTED|Washout Period of 2 Weeks||31
366870|NCT01147458|880444|P1|STARTED|Washout Period of 2 Weeks||34
366871|NCT01147458|880441|P4|NOT COMPLETED|First Intervention||14
366872|NCT01147458|880442|P3|NOT COMPLETED|First Intervention||12
366873|NCT01147458|880443|P2|NOT COMPLETED|First Intervention||16
366874|NCT01147458|880444|P1|NOT COMPLETED|First Intervention||14
366875|NCT01147458|880441|P4|COMPLETED|First Intervention||34
366876|NCT01147458|880442|P3|COMPLETED|First Intervention||35
366877|NCT01147458|880443|P2|COMPLETED|First Intervention||31
366878|NCT01147458|880444|P1|COMPLETED|First Intervention||34
366879|NCT01147458|880441|P4|STARTED|First Intervention||48
366880|NCT01147458|880442|P3|STARTED|First Intervention||47
366881|NCT01147458|880443|P2|STARTED|First Intervention||47
366882|NCT01147458|880444|P1|STARTED|First Intervention||48
366883|NCT01147406|880498|P6|NOT COMPLETED|Overall Study||0
366884|NCT01147406|880499|P5|NOT COMPLETED|Overall Study||0
366885|NCT01147406|880500|P4|NOT COMPLETED|Overall Study||0
366886|NCT01147406|880501|P3|NOT COMPLETED|Overall Study||0
366887|NCT01147406|880502|P2|NOT COMPLETED|Overall Study||0
366888|NCT01147406|880503|P1|NOT COMPLETED|Overall Study||0
366889|NCT01147406|880498|P6|COMPLETED|Overall Study||10
366890|NCT01147406|880499|P5|COMPLETED|Overall Study||6
366891|NCT01147406|880500|P4|COMPLETED|Overall Study||6
366892|NCT01147406|880501|P3|COMPLETED|Overall Study||1
366893|NCT01147406|880502|P2|COMPLETED|Overall Study||12
366894|NCT01147406|880503|P1|COMPLETED|Overall Study||6
366895|NCT01147406|880498|P6|STARTED|Overall Study||10
366896|NCT01147406|880499|P5|STARTED|Overall Study||6
366897|NCT01147406|880500|P4|STARTED|Overall Study||6
366898|NCT01147406|880501|P3|STARTED|Overall Study||1
366899|NCT01147406|880502|P2|STARTED|Overall Study||12
366900|NCT01147406|880503|P1|STARTED|Overall Study||6
366901|NCT01147393|880523|P1|NOT COMPLETED|Dose Level -1||1
366902|NCT01147393|880523|P1|COMPLETED|Dose Level -1||0
366903|NCT01147393|880523|P1|STARTED|Dose Level -1||1
366904|NCT01147393|880523|P1|NOT COMPLETED|Dose Level 1||2
366905|NCT01147393|880523|P1|COMPLETED|Dose Level 1||1
366906|NCT01147393|880523|P1|STARTED|Dose Level 1||3
366907|NCT01147380|880533|P2|NOT COMPLETED|Overall Study||0
366908|NCT01147380|880534|P1|NOT COMPLETED|Overall Study||0
366909|NCT01147380|880533|P2|COMPLETED|Overall Study||12
366910|NCT01147380|880534|P1|COMPLETED|Overall Study||6
366911|NCT01147380|880533|P2|STARTED|Overall Study||12
366912|NCT01147380|880534|P1|STARTED|Overall Study||6
366913|NCT01147341|880544|P2|NOT COMPLETED|Open Label Period||0
366914|NCT01147341|880545|P1|NOT COMPLETED|Open Label Period||4
366915|NCT01147341|880544|P2|COMPLETED|Open Label Period||8
366916|NCT01147341|880545|P1|COMPLETED|Open Label Period||22
366917|NCT01147341|880544|P2|STARTED|Open Label Period||8
366918|NCT01147341|880545|P1|STARTED|Open Label Period||26
366919|NCT01147341|880544|P2|NOT COMPLETED|Double Blind Period||2
366920|NCT01147341|880545|P1|NOT COMPLETED|Double Blind Period||1
366921|NCT01147341|880544|P2|COMPLETED|Double Blind Period||8
366922|NCT01147341|880545|P1|COMPLETED|Double Blind Period||26
366923|NCT01147341|880544|P2|STARTED|Double Blind Period||10
366924|NCT01147341|880545|P1|STARTED|Double Blind Period||27
366925|NCT01147302|880575|P2|NOT COMPLETED|Overall Study||0
366926|NCT01147302|880576|P1|NOT COMPLETED|Overall Study||0
366927|NCT01147302|880575|P2|COMPLETED|Overall Study||9
366928|NCT01147302|880576|P1|COMPLETED|Overall Study||9
366929|NCT01147302|880575|P2|STARTED|Overall Study||9
366930|NCT01147302|880576|P1|STARTED|Overall Study||9
366931|NCT01147250|880608|P2|NOT COMPLETED|Overall Study||105
366932|NCT01147250|880609|P1|NOT COMPLETED|Overall Study||110
366933|NCT01147250|880608|P2|COMPLETED|Overall Study||2929
366934|NCT01147250|880609|P1|COMPLETED|Overall Study||2924
366935|NCT01147250|880608|P2|Treated|Overall Study||3031
366936|NCT01147250|880609|P1|Treated|Overall Study||3032
366937|NCT01147250|880608|P2|STARTED|Overall Study||3034
366938|NCT01147250|880609|P1|STARTED|Overall Study||3034
366939|NCT01147172|880621|P1|NOT COMPLETED|Overall Study||4
366940|NCT01147172|880621|P1|COMPLETED|Overall Study||96
366941|NCT01147172|880621|P1|STARTED|Overall Study||100
366942|NCT01147068|880639|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
366943|NCT01147068|880640|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
366944|NCT01147068|880641|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
366945|NCT01147068|880642|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
366946|NCT01147068|880643|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
366947|NCT01147068|880644|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
366948|NCT01147068|880645|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
366949|NCT01147068|880639|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
366950|NCT01147068|880640|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
366951|NCT01147068|880641|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
366952|NCT01147068|880642|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
366953|NCT01147068|880643|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
366954|NCT01147068|880644|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
366955|NCT01147068|880645|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
366956|NCT01147068|880639|P7|STARTED|Subjects That Completed Safety Follow-up||55
366957|NCT01147068|880640|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
366958|NCT01147068|880641|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
366959|NCT01147068|880642|P4|STARTED|Subjects That Completed Safety Follow-up||56
366960|NCT01147068|880643|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
366961|NCT01147068|880644|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
366962|NCT01147068|880645|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
366963|NCT01147068|880639|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
366964|NCT01147068|880640|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
366965|NCT01147068|880641|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
366966|NCT01147068|880642|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
366967|NCT01147068|880643|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
366968|NCT01147068|880644|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
366969|NCT01147068|880645|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
366970|NCT01147068|880639|P7|COMPLETED|Subjects That Received 2nd Dose||55
366971|NCT01147068|880640|P6|COMPLETED|Subjects That Received 2nd Dose||51
366972|NCT01147068|880641|P5|COMPLETED|Subjects That Received 2nd Dose||55
366973|NCT01147068|880642|P4|COMPLETED|Subjects That Received 2nd Dose||56
366974|NCT01147068|880643|P3|COMPLETED|Subjects That Received 2nd Dose||52
366975|NCT01147068|880644|P2|COMPLETED|Subjects That Received 2nd Dose||52
366976|NCT01147068|880645|P1|COMPLETED|Subjects That Received 2nd Dose||59
366977|NCT01147068|880639|P7|STARTED|Subjects That Received 2nd Dose||55
366978|NCT01147068|880640|P6|STARTED|Subjects That Received 2nd Dose||53
366979|NCT01147068|880641|P5|STARTED|Subjects That Received 2nd Dose||56
366980|NCT01147068|880642|P4|STARTED|Subjects That Received 2nd Dose||56
366981|NCT01147068|880643|P3|STARTED|Subjects That Received 2nd Dose||55
366982|NCT01147068|880644|P2|STARTED|Subjects That Received 2nd Dose||57
366983|NCT01147068|880645|P1|STARTED|Subjects That Received 2nd Dose||60
366984|NCT01147068|880639|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
366985|NCT01147068|880640|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
366986|NCT01147068|880641|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
366987|NCT01147068|880642|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
366988|NCT01147068|880643|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
366989|NCT01147068|880644|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
366990|NCT01147068|880645|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
366991|NCT01147068|880639|P7|COMPLETED|Subjects That Received 1st Dose||55
366992|NCT01147068|880640|P6|COMPLETED|Subjects That Received 1st Dose||53
366993|NCT01147068|880641|P5|COMPLETED|Subjects That Received 1st Dose||56
366994|NCT01147068|880642|P4|COMPLETED|Subjects That Received 1st Dose||56
366995|NCT01147068|880643|P3|COMPLETED|Subjects That Received 1st Dose||55
366996|NCT01147068|880644|P2|COMPLETED|Subjects That Received 1st Dose||57
366997|NCT01147068|880645|P1|COMPLETED|Subjects That Received 1st Dose||60
366998|NCT01147068|880639|P7|STARTED|Subjects That Received 1st Dose||55
366999|NCT01147068|880640|P6|STARTED|Subjects That Received 1st Dose||53
367000|NCT01147068|880641|P5|STARTED|Subjects That Received 1st Dose||56
367001|NCT01147068|880642|P4|STARTED|Subjects That Received 1st Dose||56
367002|NCT01147068|880643|P3|STARTED|Subjects That Received 1st Dose||55
367003|NCT01147068|880644|P2|STARTED|Subjects That Received 1st Dose||57
367004|NCT01147068|880645|P1|STARTED|Subjects That Received 1st Dose||60
367005|NCT01147055|880675|P2|NOT COMPLETED|Second Intervention Period||0
367006|NCT01147055|880676|P1|NOT COMPLETED|Second Intervention Period||0
367007|NCT01147055|880675|P2|COMPLETED|Second Intervention Period||14
367008|NCT01147055|880676|P1|COMPLETED|Second Intervention Period||0
367009|NCT01147055|880675|P2|STARTED|Second Intervention Period||14
367010|NCT01147055|880676|P1|STARTED|Second Intervention Period||0
367011|NCT01147055|880675|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
367012|NCT01147055|880676|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
367013|NCT01147055|880675|P2|COMPLETED|Washout Period (at Least 14 Days)||0
367014|NCT01147055|880676|P1|COMPLETED|Washout Period (at Least 14 Days)||14
367015|NCT01147055|880675|P2|STARTED|Washout Period (at Least 14 Days)||0
367016|NCT01147055|880676|P1|STARTED|Washout Period (at Least 14 Days)||14
367017|NCT01147055|880675|P2|NOT COMPLETED|First Intervention Period||0
367018|NCT01147055|880676|P1|NOT COMPLETED|First Intervention Period||1
367019|NCT01147055|880675|P2|COMPLETED|First Intervention Period||0
367020|NCT01147055|880676|P1|COMPLETED|First Intervention Period||14
367021|NCT01147055|880675|P2|STARTED|First Intervention Period||0
367022|NCT01147055|880676|P1|STARTED|First Intervention Period||15
367023|NCT01146951|880710|P2|NOT COMPLETED|Overall Study||1
367024|NCT01146951|880711|P1|NOT COMPLETED|Overall Study||4
367025|NCT01146951|880710|P2|COMPLETED|Overall Study||29
367026|NCT01146951|880711|P1|COMPLETED|Overall Study||25
367027|NCT01146951|880710|P2|STARTED|Overall Study||30
367028|NCT01146951|880711|P1|STARTED|Overall Study||29
367029|NCT01146912|880732|P8|NOT COMPLETED|Overall Study||0
367030|NCT01146912|880733|P7|NOT COMPLETED|Overall Study||56
367031|NCT01146912|880734|P6|NOT COMPLETED|Overall Study||61
367032|NCT01146912|880735|P5|NOT COMPLETED|Overall Study||41
367033|NCT01146912|880736|P4|NOT COMPLETED|Overall Study||17
367034|NCT01146912|880737|P3|NOT COMPLETED|Overall Study||17
367035|NCT01146912|880738|P2|NOT COMPLETED|Overall Study||822
367036|NCT01146912|880739|P1|NOT COMPLETED|Overall Study||817
367037|NCT01146912|880732|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
367038|NCT01146912|880733|P7|COMPLETED|Overall Study||1764
367039|NCT01146912|880734|P6|COMPLETED|Overall Study||1760
367040|NCT01146912|880735|P5|COMPLETED|Overall Study||1780
367041|NCT01146912|880736|P4|COMPLETED|Overall Study||577
367042|NCT01146912|880737|P3|COMPLETED|Overall Study||576
367043|NCT01146912|880738|P2|COMPLETED|Overall Study||3784
367044|NCT01146912|880739|P1|COMPLETED|Overall Study||3790
367045|NCT01146912|880732|P8|STARTED|Overall Study||14675
367046|NCT01146912|880733|P7|STARTED|Overall Study||1820
367047|NCT01146912|880734|P6|STARTED|Overall Study||1821
367048|NCT01146912|880735|P5|STARTED|Overall Study||1821
367049|NCT01146912|880736|P4|STARTED|Overall Study||594
367050|NCT01146912|880737|P3|STARTED|Overall Study||593
367051|NCT01146912|880738|P2|STARTED|Overall Study||4606
367052|NCT01146912|880739|P1|STARTED|Overall Study||4607
367053|NCT01146873|880761|P2|NOT COMPLETED|Overall Study||6
367054|NCT01146873|880762|P1|NOT COMPLETED|Overall Study||0
367055|NCT01146873|880761|P2|COMPLETED|Overall Study||144
367056|NCT01146873|880762|P1|COMPLETED|Overall Study||148
367057|NCT01146873|880761|P2|STARTED|Overall Study||150
367058|NCT01146873|880762|P1|STARTED|Overall Study||148
367059|NCT01146860|880778|P2|NOT COMPLETED|Overall Study||1
367060|NCT01146860|880779|P1|NOT COMPLETED|Overall Study||0
367061|NCT01146860|880778|P2|COMPLETED|Overall Study||191
367062|NCT01146860|880779|P1|COMPLETED|Overall Study||194
367063|NCT01146860|880778|P2|STARTED|Overall Study||192
367064|NCT01146860|880779|P1|STARTED|Overall Study||194
367065|NCT01146808|880793|P1|NOT COMPLETED|Overall Study||0
367066|NCT01146808|880793|P1|COMPLETED|Overall Study||16
367067|NCT01146808|880793|P1|STARTED|Overall Study||16
367068|NCT01146782|880799|P1|NOT COMPLETED|Primary Endpoint Cohort||6
367069|NCT01146782|880799|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
367070|NCT01146782|880799|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
367071|NCT01146782|880799|P1|NOT COMPLETED|Safety Cohort||83
367072|NCT01146782|880799|P1|COMPLETED|Safety Cohort||63
367073|NCT01146782|880799|P1|STARTED|Safety Cohort||146
367074|NCT01146782|880799|P1|NOT COMPLETED|Screening Cohort||221
367075|NCT01146782|880799|P1|COMPLETED|Screening Cohort||146
367076|NCT01146782|880799|P1|STARTED|Screening Cohort||367
367077|NCT01146613|880808|P2|NOT COMPLETED|Overall Study||12
367078|NCT01146613|880809|P1|NOT COMPLETED|Overall Study||7
367079|NCT01146613|880808|P2|COMPLETED|Overall Study||89
367080|NCT01146613|880809|P1|COMPLETED|Overall Study||92
367081|NCT01146613|880808|P2|STARTED|Overall Study||101
367082|NCT01146613|880809|P1|STARTED|Overall Study||99
367083|NCT01146600|880817|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
367084|NCT01146600|880818|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
367085|NCT01146600|880817|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
367086|NCT01146600|880818|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
367087|NCT01146600|880817|P2|STARTED|Period 2 (Weeks 4 & 5)||10
367088|NCT01146600|880818|P1|STARTED|Period 2 (Weeks 4 & 5)||10
367089|NCT01146600|880817|P2|NOT COMPLETED|Washout (Week 3)||0
367090|NCT01146600|880818|P1|NOT COMPLETED|Washout (Week 3)||0
367091|NCT01146600|880817|P2|COMPLETED|Washout (Week 3)||10
367092|NCT01146600|880818|P1|COMPLETED|Washout (Week 3)||10
367093|NCT01146600|880817|P2|STARTED|Washout (Week 3)||10
367094|NCT01146600|880818|P1|STARTED|Washout (Week 3)||10
367095|NCT01146600|880817|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
367096|NCT01146600|880818|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
367097|NCT01146600|880817|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
367098|NCT01146600|880818|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
367099|NCT01146600|880817|P2|STARTED|Period 1 (Weeks 1 & 2)||10
367100|NCT01146600|880818|P1|STARTED|Period 1 (Weeks 1 & 2)||13
367101|NCT01146457|880848|P5|NOT COMPLETED|Overall Study||0
367102|NCT01146457|880849|P4|NOT COMPLETED|Overall Study||0
367103|NCT01146457|880850|P3|NOT COMPLETED|Overall Study||1
367104|NCT01146457|880851|P2|NOT COMPLETED|Overall Study||0
367105|NCT01146457|880852|P1|NOT COMPLETED|Overall Study||0
367106|NCT01146457|880848|P5|COMPLETED|Overall Study||13
367107|NCT01146457|880849|P4|COMPLETED|Overall Study||13
367108|NCT01146457|880850|P3|COMPLETED|Overall Study||20
367109|NCT01146457|880851|P2|COMPLETED|Overall Study||17
367110|NCT01146457|880852|P1|COMPLETED|Overall Study||19
367111|NCT01146457|880848|P5|STARTED|Overall Study||13
367112|NCT01146457|880849|P4|STARTED|Overall Study||13
367113|NCT01146457|880850|P3|STARTED|Overall Study||21
367114|NCT01146457|880851|P2|STARTED|Overall Study||17
367115|NCT01146457|880852|P1|STARTED|Overall Study||19
367116|NCT01146418|880866|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
367117|NCT01146418|880867|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
367118|NCT01146418|880868|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
367119|NCT01146418|880869|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
367120|NCT01146418|880866|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
367121|NCT01146418|880867|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
367122|NCT01146418|880868|P2|COMPLETED|Live-Born Infant Follow Up||0
367123|NCT01146418|880869|P1|COMPLETED|Live-Born Infant Follow Up||0
367124|NCT01146418|880866|P4|STARTED|Live-Born Infant Follow Up||56
367125|NCT01146418|880867|P3|STARTED|Live-Born Infant Follow Up||61
367126|NCT01146418|880868|P2|STARTED|Live-Born Infant Follow Up||0
367127|NCT01146418|880869|P1|STARTED|Live-Born Infant Follow Up||0
367128|NCT01146418|880866|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
367129|NCT01146418|880867|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
367130|NCT01146418|880868|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
367131|NCT01146418|880869|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
367132|NCT01146418|880866|P4|COMPLETED|Women/Expectant Mother Follow Up||0
367133|NCT01146418|880867|P3|COMPLETED|Women/Expectant Mother Follow Up||0
367134|NCT01146418|880868|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
367135|NCT01146418|880869|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
367136|NCT01146418|880866|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
367137|NCT01146418|880867|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
367138|NCT01146418|880868|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
367139|NCT01146418|880869|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
367140|NCT01146418|880866|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
367141|NCT01146418|880867|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
367142|NCT01146418|880868|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
367143|NCT01146418|880869|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
367144|NCT01146418|880866|P4|STARTED|Women/Expectant Mother Follow Up||0
367145|NCT01146418|880867|P3|STARTED|Women/Expectant Mother Follow Up||0
367146|NCT01146418|880868|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
367147|NCT01146418|880869|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
367148|NCT01146418|880866|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
367149|NCT01146418|880867|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
367150|NCT01146418|880868|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
367151|NCT01146418|880869|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
367152|NCT01146418|880866|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
367153|NCT01146418|880867|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
367154|NCT01146418|880868|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
367155|NCT01146418|880869|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
367156|NCT01146418|880866|P4|STARTED|Base Study P06029 (NCT01144416)||0
367157|NCT01146418|880867|P3|STARTED|Base Study P06029 (NCT01144416)||0
367158|NCT01146418|880868|P2|STARTED|Base Study P06029 (NCT01144416)||696
367159|NCT01146418|880869|P1|STARTED|Base Study P06029 (NCT01144416)||694
367160|NCT01146379|880885|P4|NOT COMPLETED|Overall Study||1
367161|NCT01146379|880886|P3|NOT COMPLETED|Overall Study||0
367162|NCT01146379|880887|P2|NOT COMPLETED|Overall Study||1
367163|NCT01146379|880888|P1|NOT COMPLETED|Overall Study||1
367164|NCT01146379|880885|P4|COMPLETED|Overall Study||20
367165|NCT01146379|880886|P3|COMPLETED|Overall Study||21
367166|NCT01146379|880887|P2|COMPLETED|Overall Study||21
367167|NCT01146379|880888|P1|COMPLETED|Overall Study||20
367168|NCT01146379|880885|P4|STARTED|Overall Study||21
367169|NCT01146379|880886|P3|STARTED|Overall Study||21
367170|NCT01146379|880887|P2|STARTED|Overall Study||22
367171|NCT01146379|880888|P1|STARTED|Overall Study||21
367172|NCT01146288|880900|P2|NOT COMPLETED|Second Intervention (1 Day)||0
367173|NCT01146288|880901|P1|NOT COMPLETED|Second Intervention (1 Day)||0
367174|NCT01146288|880900|P2|COMPLETED|Second Intervention (1 Day)||5
367175|NCT01146288|880901|P1|COMPLETED|Second Intervention (1 Day)||7
367176|NCT01146288|880900|P2|STARTED|Second Intervention (1 Day)||5
367177|NCT01146288|880901|P1|STARTED|Second Intervention (1 Day)||7
367178|NCT01146288|880900|P2|NOT COMPLETED|First Intervention(1 Day)||1
367179|NCT01146288|880901|P1|NOT COMPLETED|First Intervention(1 Day)||0
367180|NCT01146288|880900|P2|COMPLETED|First Intervention(1 Day)||5
367181|NCT01146288|880901|P1|COMPLETED|First Intervention(1 Day)||7
367182|NCT01146288|880900|P2|STARTED|First Intervention(1 Day)||6
367183|NCT01146288|880901|P1|STARTED|First Intervention(1 Day)||7
367184|NCT01146275|880910|P1|NOT COMPLETED|Overall Study||0
367185|NCT01146275|880910|P1|COMPLETED|Overall Study||6
367186|NCT01146275|880910|P1|STARTED|Overall Study||6
367187|NCT01146054|880915|P1|NOT COMPLETED|Overall Study||10
367188|NCT01146054|880915|P1|COMPLETED|Overall Study||49
367189|NCT01146054|880915|P1|STARTED|Overall Study||59
367190|NCT01145898|880925|P2|NOT COMPLETED|3-year Treatment||16
367191|NCT01145898|880926|P1|NOT COMPLETED|3-year Treatment||3
367192|NCT01145898|880925|P2|COMPLETED|3-year Treatment||28
367193|NCT01145898|880926|P1|COMPLETED|3-year Treatment||9
367194|NCT01145898|880925|P2|STARTED|3-year Treatment||44
367195|NCT01145898|880926|P1|STARTED|3-year Treatment||12
367196|NCT01145898|880925|P2|NOT COMPLETED|6-month Treatment||0
367197|NCT01145898|880926|P1|NOT COMPLETED|6-month Treatment||0
367198|NCT01145898|880925|P2|COMPLETED|6-month Treatment||44
367199|NCT01145898|880926|P1|COMPLETED|6-month Treatment||12
367200|NCT01145898|880925|P2|STARTED|6-month Treatment||44
367201|NCT01145898|880926|P1|STARTED|6-month Treatment||12
367202|NCT01145755|880960|P3|NOT COMPLETED|Overall Study||25
367203|NCT01145755|880961|P2|NOT COMPLETED|Overall Study||28
367204|NCT01145755|880962|P1|NOT COMPLETED|Overall Study||20
367205|NCT01145755|880960|P3|COMPLETED|Overall Study||19
367206|NCT01145755|880961|P2|COMPLETED|Overall Study||19
367207|NCT01145755|880962|P1|COMPLETED|Overall Study||20
367208|NCT01145755|880960|P3|STARTED|Overall Study||44
367209|NCT01145755|880961|P2|STARTED|Overall Study||47
367210|NCT01145755|880962|P1|STARTED|Overall Study||40
367211|NCT01145638|880978|P2|NOT COMPLETED|Overall Study||57
367212|NCT01145638|880979|P1|NOT COMPLETED|Overall Study||90
367213|NCT01145638|880978|P2|COMPLETED|Overall Study||62
367214|NCT01145638|880979|P1|COMPLETED|Overall Study||141
367215|NCT01145638|880978|P2|STARTED|Overall Study||119
367216|NCT01145638|880979|P1|STARTED|Overall Study||231
367217|NCT01145625|880989|P2|NOT COMPLETED|Overall Study||31
367218|NCT01145625|880990|P1|NOT COMPLETED|Overall Study||24
367219|NCT01145625|880989|P2|COMPLETED|Overall Study||130
367220|NCT01145625|880990|P1|COMPLETED|Overall Study||137
367221|NCT01145625|880989|P2|STARTED|Overall Study||161
367222|NCT01145625|880990|P1|STARTED|Overall Study||161
367223|NCT01145560|881003|P3|NOT COMPLETED|Overall Study||2
367224|NCT01145560|881004|P2|NOT COMPLETED|Overall Study||4
367225|NCT01145560|881005|P1|NOT COMPLETED|Overall Study||4
367226|NCT01145560|881003|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
367227|NCT01145560|881004|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
367228|NCT01145560|881005|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
367229|NCT01145560|881003|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
367230|NCT01145560|881004|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
367231|NCT01145560|881005|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
367232|NCT01145560|881003|P3|Received Treatment|Overall Study||99
367233|NCT01145560|881004|P2|Received Treatment|Overall Study||98
367234|NCT01145560|881005|P1|Received Treatment|Overall Study||99
367235|NCT01145560|881003|P3|STARTED|Overall Study||100
367236|NCT01145560|881004|P2|STARTED|Overall Study||100
367237|NCT01145560|881005|P1|STARTED|Overall Study||100
367238|NCT01145547|881022|P2|NOT COMPLETED|Overall Study||0
367239|NCT01145547|881023|P1|NOT COMPLETED|Overall Study||0
367240|NCT01145547|881022|P2|COMPLETED|Overall Study||3
367241|NCT01145547|881023|P1|COMPLETED|Overall Study||4
367242|NCT01145547|881022|P2|STARTED|Overall Study||3
367243|NCT01145547|881023|P1|STARTED|Overall Study||4
367244|NCT01145508|881031|P2|NOT COMPLETED|Overall Study||2
367245|NCT01145508|881032|P1|NOT COMPLETED|Overall Study||5
367246|NCT01145508|881031|P2|COMPLETED|Overall Study||1
367247|NCT01145508|881032|P1|COMPLETED|Overall Study||2
367248|NCT01145508|881031|P2|Treated|Overall Study||2
367249|NCT01145508|881032|P1|Treated|Overall Study||6
367250|NCT01145508|881031|P2|STARTED|Overall Study||3
367251|NCT01145508|881032|P1|STARTED|Overall Study||7
367252|NCT01145495|881038|P1|NOT COMPLETED|Overall Study||12
367253|NCT01145495|881038|P1|COMPLETED|Overall Study||51
367254|NCT01145495|881038|P1|STARTED|Overall Study||63
367255|NCT01145482|881044|P2|NOT COMPLETED|Second Intervention (1 Day)||0
367256|NCT01145482|881045|P1|NOT COMPLETED|Second Intervention (1 Day)||0
367257|NCT01145482|881044|P2|COMPLETED|Second Intervention (1 Day)||6
367258|NCT01145482|881045|P1|COMPLETED|Second Intervention (1 Day)||5
367259|NCT01145482|881044|P2|STARTED|Second Intervention (1 Day)||6
367260|NCT01145482|881045|P1|STARTED|Second Intervention (1 Day)||5
367261|NCT01145482|881044|P2|NOT COMPLETED|First Intervention (1 Day)||1
367262|NCT01145482|881045|P1|NOT COMPLETED|First Intervention (1 Day)||0
367263|NCT01145482|881044|P2|COMPLETED|First Intervention (1 Day)||5
367264|NCT01145482|881045|P1|COMPLETED|First Intervention (1 Day)||6
367265|NCT01145482|881044|P2|STARTED|First Intervention (1 Day)||6
367266|NCT01145482|881045|P1|STARTED|First Intervention (1 Day)||6
367267|NCT01145417|881055|P2|NOT COMPLETED|Overall Study||47
367268|NCT01145417|881056|P1|NOT COMPLETED|Overall Study||41
367269|NCT01145417|881055|P2|COMPLETED|Overall Study||62
367270|NCT01145417|881056|P1|COMPLETED|Overall Study||67
367271|NCT01145417|881055|P2|STARTED|Overall Study||109
367272|NCT01145417|881056|P1|STARTED|Overall Study||108
367273|NCT01145391|881080|P2|NOT COMPLETED|Overall Study||0
367274|NCT01145391|881081|P1|NOT COMPLETED|Overall Study||0
367275|NCT01145391|881080|P2|COMPLETED|Overall Study||298
367276|NCT01145391|881081|P1|COMPLETED|Overall Study||293
367277|NCT01145391|881080|P2|9 Months Post-randomization|Overall Study||298
367278|NCT01145391|881081|P1|9 Months Post-randomization|Overall Study||293
367279|NCT01145391|881080|P2|STARTED|Overall Study||298
367280|NCT01145391|881081|P1|STARTED|Overall Study||293
367281|NCT01144624|881092|P3|NOT COMPLETED|Overall Study||0
367282|NCT01144624|881093|P2|NOT COMPLETED|Overall Study||0
367283|NCT01144624|881094|P1|NOT COMPLETED|Overall Study||0
367284|NCT01144624|881092|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
367285|NCT01144624|881093|P2|COMPLETED|Overall Study||7
367286|NCT01144624|881094|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
367287|NCT01144624|881092|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
367288|NCT01144624|881093|P2|Completed Treatment|Overall Study||7
367289|NCT01144624|881094|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
367290|NCT01144624|881092|P3|Received Treatment|Overall Study||6
367291|NCT01144624|881093|P2|Received Treatment|Overall Study||7
367292|NCT01144624|881094|P1|Received Treatment|Overall Study||7
367293|NCT01144624|881092|P3|STARTED|Overall Study||6
367294|NCT01144624|881093|P2|STARTED|Overall Study||7
367295|NCT01144624|881094|P1|STARTED|Overall Study||7
367296|NCT01144598|881108|P1|NOT COMPLETED|Overall Study||0
367297|NCT01144598|881108|P1|COMPLETED|Overall Study||356
367298|NCT01144598|881108|P1|Analysis Population|Overall Study||356
367299|NCT01144598|881108|P1|STARTED|Overall Study||356
367300|NCT01145352|881126|P1|NOT COMPLETED|Overall Study||11
367301|NCT01145352|881126|P1|COMPLETED|Overall Study||102
367302|NCT01145352|881126|P1|STARTED|Overall Study||113
367303|NCT01145053|881134|P1|NOT COMPLETED|Overall Study||93
367304|NCT01145053|881134|P1|COMPLETED|Overall Study||248
367305|NCT01145053|881134|P1|STARTED|Overall Study||341
367306|NCT01145001|881148|P4|NOT COMPLETED|Overall Study||6
367307|NCT01145001|881149|P3|NOT COMPLETED|Overall Study||5
367308|NCT01145001|881150|P2|NOT COMPLETED|Overall Study||6
367309|NCT01145001|881151|P1|NOT COMPLETED|Overall Study||8
367310|NCT01145001|881148|P4|COMPLETED|Overall Study||31
367311|NCT01145001|881149|P3|COMPLETED|Overall Study||39
367312|NCT01145001|881150|P2|COMPLETED|Overall Study||31
367313|NCT01145001|881151|P1|COMPLETED|Overall Study||28
367314|NCT01145001|881148|P4|STARTED|Overall Study||37
367315|NCT01145001|881149|P3|STARTED|Overall Study||44
367316|NCT01145001|881150|P2|STARTED|Overall Study||37
367317|NCT01145001|881151|P1|STARTED|Overall Study||36
367318|NCT01144949|881167|P2|NOT COMPLETED|Overall Study||14
367319|NCT01144949|881168|P1|NOT COMPLETED|Overall Study||11
367320|NCT01144949|881167|P2|COMPLETED|Overall Study||106
367321|NCT01144949|881168|P1|COMPLETED|Overall Study||108
367322|NCT01144949|881167|P2|STARTED|Overall Study||120
367323|NCT01144949|881168|P1|STARTED|Overall Study||119
367324|NCT01144715|881186|P2|NOT COMPLETED|Overall Study||3
367325|NCT01144715|881187|P1|NOT COMPLETED|Overall Study||4
367326|NCT01144715|881186|P2|COMPLETED|Overall Study||45
367327|NCT01144715|881187|P1|COMPLETED|Overall Study||47
367328|NCT01144715|881186|P2|STARTED|Overall Study||48
367329|NCT01144715|881187|P1|STARTED|Overall Study||51
367330|NCT01144442|881199|P1|NOT COMPLETED|Overall Study||0
367331|NCT01144442|881199|P1|COMPLETED|Overall Study||10
367332|NCT01144442|881199|P1|STARTED|Overall Study||10
367333|NCT01144416|881206|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
367334|NCT01144416|881207|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
367335|NCT01144416|881206|P2|COMPLETED|Pregnancy Follow-up Period||157
367336|NCT01144416|881207|P1|COMPLETED|Pregnancy Follow-up Period||146
367337|NCT01144416|881206|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
367338|NCT01144416|881207|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
367339|NCT01144416|881206|P2|NOT COMPLETED|Intervention Period||49
367340|NCT01144416|881207|P1|NOT COMPLETED|Intervention Period||62
367341|NCT01144416|881206|P2|COMPLETED|Intervention Period||647
367342|NCT01144416|881207|P1|COMPLETED|Intervention Period||632
367343|NCT01144416|881206|P2|STARTED|Intervention Period||696
367344|NCT01144416|881207|P1|STARTED|Intervention Period||694
367345|NCT01144403|881223|P1|NOT COMPLETED|Overall Study||5
367346|NCT01144403|881223|P1|COMPLETED|Overall Study||3
367347|NCT01144403|881223|P1|STARTED|Overall Study||8
367348|NCT01144364|881232|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
367349|NCT01144364|881233|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
367350|NCT01144364|881234|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
367351|NCT01144364|881232|P3|COMPLETED|Follow-Up/Maintenance Phase||60
367352|NCT01144364|881233|P2|COMPLETED|Follow-Up/Maintenance Phase||66
367353|NCT01144364|881234|P1|COMPLETED|Follow-Up/Maintenance Phase||0
367354|NCT01144364|881232|P3|STARTED|Follow-Up/Maintenance Phase||101
367355|NCT01144364|881233|P2|STARTED|Follow-Up/Maintenance Phase||101
367356|NCT01144364|881234|P1|STARTED|Follow-Up/Maintenance Phase||0
367357|NCT01144364|881232|P3|NOT COMPLETED|Induction Phase||0
367358|NCT01144364|881233|P2|NOT COMPLETED|Induction Phase||0
367359|NCT01144364|881234|P1|NOT COMPLETED|Induction Phase||32
367360|NCT01144364|881232|P3|COMPLETED|Induction Phase||0
367361|NCT01144364|881233|P2|COMPLETED|Induction Phase||0
367362|NCT01144364|881234|P1|COMPLETED|Induction Phase||202
367363|NCT01144364|881232|P3|STARTED|Induction Phase||0
367364|NCT01144364|881233|P2|STARTED|Induction Phase||0
367365|NCT01144364|881234|P1|STARTED|Induction Phase||234
367366|NCT01144299|881260|P2|NOT COMPLETED|Overall Study||0
367367|NCT01144299|881261|P1|NOT COMPLETED|Overall Study||2
367368|NCT01144299|881260|P2|COMPLETED|Overall Study||54
367369|NCT01144299|881261|P1|COMPLETED|Overall Study||58
367370|NCT01144299|881260|P2|STARTED|Overall Study||54
367371|NCT01144299|881261|P1|STARTED|Overall Study||60
367372|NCT01144286|881287|P4|NOT COMPLETED|Overall Study||0
367373|NCT01144286|881288|P3|NOT COMPLETED|Overall Study||0
367374|NCT01144286|881289|P2|NOT COMPLETED|Overall Study||0
367375|NCT01144286|881290|P1|NOT COMPLETED|Overall Study||0
367376|NCT01144286|881287|P4|COMPLETED|Overall Study||56
367377|NCT01144286|881288|P3|COMPLETED|Overall Study||58
367378|NCT01144286|881289|P2|COMPLETED|Overall Study||58
367379|NCT01144286|881290|P1|COMPLETED|Overall Study||57
367380|NCT01144286|881287|P4|STARTED|Overall Study||56
367381|NCT01144286|881288|P3|STARTED|Overall Study||58
367382|NCT01144286|881289|P2|STARTED|Overall Study||58
367383|NCT01144286|881290|P1|STARTED|Overall Study||57
367384|NCT01144182|881306|P2|NOT COMPLETED|Overall Study||21
367385|NCT01144182|881307|P1|NOT COMPLETED|Overall Study||17
367386|NCT01144182|881306|P2|COMPLETED|Overall Study||47
367387|NCT01144182|881307|P1|COMPLETED|Overall Study||51
367388|NCT01144182|881306|P2|STARTED|Overall Study||68
367389|NCT01144182|881307|P1|STARTED|Overall Study||68
367390|NCT01144052|881339|P2|NOT COMPLETED|Overall Study||1
367391|NCT01144052|881340|P1|NOT COMPLETED|Overall Study||1
367392|NCT01144052|881339|P2|COMPLETED|Overall Study||8
367393|NCT01144052|881340|P1|COMPLETED|Overall Study||9
367394|NCT01144052|881339|P2|STARTED|Overall Study||9
367395|NCT01144052|881340|P1|STARTED|Overall Study||10
367396|NCT01144026|881362|P2|NOT COMPLETED|Overall Study||0
367397|NCT01144026|881363|P1|NOT COMPLETED|Overall Study||0
367398|NCT01144026|881362|P2|COMPLETED|Overall Study||5
367399|NCT01144026|881363|P1|COMPLETED|Overall Study||10
367400|NCT01144026|881362|P2|STARTED|Overall Study||5
367401|NCT01144026|881363|P1|STARTED|Overall Study||10
367402|NCT01143896|881371|P2|NOT COMPLETED|Overall Study||25
367403|NCT01143896|881372|P1|NOT COMPLETED|Overall Study||42
367404|NCT01143896|881371|P2|COMPLETED|Overall Study||128
367405|NCT01143896|881372|P1|COMPLETED|Overall Study||114
367406|NCT01143896|881371|P2|STARTED|Overall Study||153
367407|NCT01143896|881372|P1|STARTED|Overall Study||156
367408|NCT01143883|881390|P2|NOT COMPLETED|Overall Study||0
367409|NCT01143883|881391|P1|NOT COMPLETED|Overall Study||0
367410|NCT01143883|881390|P2|COMPLETED|Overall Study||55
367411|NCT01143883|881391|P1|COMPLETED|Overall Study||55
367412|NCT01143883|881390|P2|STARTED|Overall Study||55
367413|NCT01143883|881391|P1|STARTED|Overall Study||55
367414|NCT01143818|881397|P1|NOT COMPLETED|Overall Study||250
367415|NCT01143818|881397|P1|COMPLETED|Overall Study||799
367416|NCT01143818|881397|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
367417|NCT01143792|881407|P3|NOT COMPLETED|Overall Study||0
367418|NCT01143792|881408|P2|NOT COMPLETED|Overall Study||0
367419|NCT01143792|881409|P1|NOT COMPLETED|Overall Study||0
367420|NCT01143792|881407|P3|COMPLETED|Overall Study||91
367421|NCT01143792|881408|P2|COMPLETED|Overall Study||86
367422|NCT01143792|881409|P1|COMPLETED|Overall Study||93
367423|NCT01143792|881407|P3|STARTED|Overall Study||91
367424|NCT01143792|881408|P2|STARTED|Overall Study||86
367425|NCT01143792|881409|P1|STARTED|Overall Study||93
367426|NCT01143766|881443|P2|NOT COMPLETED|Overall Study||0
367427|NCT01143766|881444|P1|NOT COMPLETED|Overall Study||0
367428|NCT01143766|881443|P2|COMPLETED|Overall Study||31
367429|NCT01143766|881444|P1|COMPLETED|Overall Study||25
367430|NCT01143766|881443|P2|STARTED|Overall Study||31
367431|NCT01143766|881444|P1|STARTED|Overall Study||25
367432|NCT01143727|881452|P2|NOT COMPLETED|Overall Study||0
367433|NCT01143727|881453|P1|NOT COMPLETED|Overall Study||0
367434|NCT01143727|881452|P2|COMPLETED|Overall Study||8
367435|NCT01143727|881453|P1|COMPLETED|Overall Study||9
367436|NCT01143727|881452|P2|STARTED|Overall Study||8
367437|NCT01143727|881453|P1|STARTED|Overall Study||9
367438|NCT01143714|881463|P2|NOT COMPLETED|Overall Study||3
367439|NCT01143714|881464|P1|NOT COMPLETED|Overall Study||7
367440|NCT01143714|881463|P2|COMPLETED|Overall Study||25
367441|NCT01143714|881464|P1|COMPLETED|Overall Study||22
367442|NCT01143714|881463|P2|STARTED|Overall Study||28
367443|NCT01143714|881464|P1|STARTED|Overall Study||29
367444|NCT01143701|881474|P2|NOT COMPLETED|Overall Study||32
367445|NCT01143701|881475|P1|NOT COMPLETED|Overall Study||23
367446|NCT01143701|881474|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
367542|NCT01143077|881675|P1|STARTED|Overall Study||74
367447|NCT01143701|881475|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
367448|NCT01143701|881474|P2|STARTED|Overall Study||319
367449|NCT01143701|881475|P1|STARTED|Overall Study||258
367450|NCT01143688|881483|P1|NOT COMPLETED|Overall Study||0
367451|NCT01143688|881483|P1|COMPLETED|Overall Study||39
367452|NCT01143688|881483|P1|STARTED|Overall Study||39
367453|NCT01143649|881502|P6|NOT COMPLETED|Overall Study||2
367454|NCT01143649|881503|P5|NOT COMPLETED|Overall Study||1
367455|NCT01143649|881504|P4|NOT COMPLETED|Overall Study||0
367456|NCT01143649|881505|P3|NOT COMPLETED|Overall Study||0
367457|NCT01143649|881506|P2|NOT COMPLETED|Overall Study||0
367458|NCT01143649|881507|P1|NOT COMPLETED|Overall Study||0
367459|NCT01143649|881502|P6|COMPLETED|Overall Study||3
367460|NCT01143649|881503|P5|COMPLETED|Overall Study||4
367461|NCT01143649|881504|P4|COMPLETED|Overall Study||10
367462|NCT01143649|881505|P3|COMPLETED|Overall Study||10
367463|NCT01143649|881506|P2|COMPLETED|Overall Study||7
367464|NCT01143649|881507|P1|COMPLETED|Overall Study||7
367465|NCT01143649|881502|P6|STARTED|Overall Study||5
367466|NCT01143649|881503|P5|STARTED|Overall Study||5
367467|NCT01143649|881504|P4|STARTED|Overall Study||10
367468|NCT01143649|881505|P3|STARTED|Overall Study||10
367469|NCT01143649|881506|P2|STARTED|Overall Study||7
367470|NCT01143649|881507|P1|STARTED|Overall Study||7
367471|NCT01143636|881524|P4|NOT COMPLETED|Overall Study||0
367472|NCT01143636|881525|P3|NOT COMPLETED|Overall Study||0
367473|NCT01143636|881526|P2|NOT COMPLETED|Overall Study||1
367474|NCT01143636|881527|P1|NOT COMPLETED|Overall Study||1
367475|NCT01143636|881524|P4|COMPLETED|Overall Study||7
367476|NCT01143636|881525|P3|COMPLETED|Overall Study||8
367477|NCT01143636|881526|P2|COMPLETED|Overall Study||4
367478|NCT01143636|881527|P1|COMPLETED|Overall Study||5
367479|NCT01143636|881524|P4|STARTED|Overall Study||7
367480|NCT01143636|881525|P3|STARTED|Overall Study||8
367481|NCT01143636|881526|P2|STARTED|Overall Study||5
367482|NCT01143636|881527|P1|STARTED|Overall Study||6
367483|NCT01143610|881557|P2|NOT COMPLETED|Overall Study||0
367484|NCT01143610|881558|P1|NOT COMPLETED|Overall Study||0
367485|NCT01143610|881557|P2|COMPLETED|Overall Study||8
367486|NCT01143610|881558|P1|COMPLETED|Overall Study||7
367487|NCT01143610|881557|P2|STARTED|Overall Study||8
367488|NCT01143610|881558|P1|STARTED|Overall Study||7
367489|NCT01143402|881569|P3|NOT COMPLETED|Overall Study||1
367490|NCT01143402|881570|P2|NOT COMPLETED|Overall Study||1
367491|NCT01143402|881571|P1|NOT COMPLETED|Overall Study||1
367492|NCT01143402|881569|P3|COMPLETED|Overall Study||18
367493|NCT01143402|881570|P2|COMPLETED|Overall Study||49
367494|NCT01143402|881571|P1|COMPLETED|Overall Study||50
367495|NCT01143402|881569|P3|STARTED|Overall Study||19
367496|NCT01143402|881570|P2|STARTED|Overall Study||50
367497|NCT01143402|881571|P1|STARTED|Overall Study||51
367498|NCT01143337|881582|P3|NOT COMPLETED|Overall Study||12
367499|NCT01143337|881583|P2|NOT COMPLETED|Overall Study||11
367500|NCT01143337|881584|P1|NOT COMPLETED|Overall Study||10
367501|NCT01143337|881582|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
367502|NCT01143337|881583|P2|COMPLETED|Overall Study||39
367503|NCT01143337|881584|P1|COMPLETED|Overall Study||39
367504|NCT01143337|881582|P3|STARTED|Overall Study||13
367505|NCT01143337|881583|P2|STARTED|Overall Study||50
367506|NCT01143337|881584|P1|STARTED|Overall Study||49
367507|NCT01143324|881598|P1|NOT COMPLETED|Overall Study||19
367508|NCT01143324|881598|P1|COMPLETED|Overall Study||233
367509|NCT01143324|881598|P1|STARTED|Overall Study||252
367510|NCT01143272|881616|P2|NOT COMPLETED|Overall Study||0
367511|NCT01143272|881617|P1|NOT COMPLETED|Overall Study||0
367512|NCT01143272|881616|P2|COMPLETED|Overall Study||231
367513|NCT01143272|881617|P1|COMPLETED|Overall Study||246
367514|NCT01143272|881616|P2|STARTED|Overall Study||231
367515|NCT01143272|881617|P1|STARTED|Overall Study||246
367516|NCT01143259|881637|P2|NOT COMPLETED|Overall Study||20
367517|NCT01143259|881638|P1|NOT COMPLETED|Overall Study||23
367518|NCT01143259|881637|P2|COMPLETED|Overall Study||118
367519|NCT01143259|881638|P1|COMPLETED|Overall Study||113
367520|NCT01143259|881637|P2|STARTED|Overall Study||138
367521|NCT01143259|881638|P1|STARTED|Overall Study||136
367522|NCT01143207|881646|P1|NOT COMPLETED|Overall Study||2
367523|NCT01143207|881646|P1|COMPLETED|Overall Study||24
367524|NCT01143207|881646|P1|STARTED|Overall Study||26
367525|NCT01143142|881657|P2|NOT COMPLETED|Overall Study||0
367526|NCT01143142|881658|P1|NOT COMPLETED|Overall Study||0
367527|NCT01143142|881657|P2|COMPLETED|Overall Study||34
367528|NCT01143142|881658|P1|COMPLETED|Overall Study||36
367529|NCT01143142|881657|P2|STARTED|Overall Study||34
367530|NCT01143142|881658|P1|STARTED|Overall Study||36
367531|NCT01143090|881666|P1|NOT COMPLETED|Overall Study||51
367532|NCT01143090|881666|P1|COMPLETED|Overall Study||98
367533|NCT01143090|881666|P1|STARTED|Overall Study||149
367534|NCT01143077|881673|P3|NOT COMPLETED|Overall Study||15
367535|NCT01143077|881674|P2|NOT COMPLETED|Overall Study||15
367536|NCT01143077|881675|P1|NOT COMPLETED|Overall Study||16
367537|NCT01143077|881673|P3|COMPLETED|Overall Study||67
367538|NCT01143077|881674|P2|COMPLETED|Overall Study||73
367539|NCT01143077|881675|P1|COMPLETED|Overall Study||58
367540|NCT01143077|881673|P3|STARTED|Overall Study||82
367541|NCT01143077|881674|P2|STARTED|Overall Study||88
367543|NCT01143051|881692|P6|NOT COMPLETED|Visit 3||0
367544|NCT01143051|881693|P5|NOT COMPLETED|Visit 3||0
367545|NCT01143051|881694|P4|NOT COMPLETED|Visit 3||0
367546|NCT01143051|881695|P3|NOT COMPLETED|Visit 3||0
367547|NCT01143051|881696|P2|NOT COMPLETED|Visit 3||0
367548|NCT01143051|881697|P1|NOT COMPLETED|Visit 3||0
367549|NCT01143051|881692|P6|COMPLETED|Visit 3||3
367550|NCT01143051|881693|P5|COMPLETED|Visit 3||4
367551|NCT01143051|881694|P4|COMPLETED|Visit 3||4
367552|NCT01143051|881695|P3|COMPLETED|Visit 3||3
367553|NCT01143051|881696|P2|COMPLETED|Visit 3||4
367554|NCT01143051|881697|P1|COMPLETED|Visit 3||4
367555|NCT01143051|881692|P6|STARTED|Visit 3||3
367556|NCT01143051|881693|P5|STARTED|Visit 3||4
367557|NCT01143051|881694|P4|STARTED|Visit 3||4
367558|NCT01143051|881695|P3|STARTED|Visit 3||3
367559|NCT01143051|881696|P2|STARTED|Visit 3||4
367560|NCT01143051|881697|P1|STARTED|Visit 3||4
367561|NCT01143051|881692|P6|NOT COMPLETED|3-14 Day Washout||1
367562|NCT01143051|881693|P5|NOT COMPLETED|3-14 Day Washout||0
367563|NCT01143051|881694|P4|NOT COMPLETED|3-14 Day Washout||0
367564|NCT01143051|881695|P3|NOT COMPLETED|3-14 Day Washout||0
367565|NCT01143051|881696|P2|NOT COMPLETED|3-14 Day Washout||0
367566|NCT01143051|881697|P1|NOT COMPLETED|3-14 Day Washout||0
367567|NCT01143051|881692|P6|COMPLETED|3-14 Day Washout||3
367568|NCT01143051|881693|P5|COMPLETED|3-14 Day Washout||4
367569|NCT01143051|881694|P4|COMPLETED|3-14 Day Washout||4
367570|NCT01143051|881695|P3|COMPLETED|3-14 Day Washout||3
367571|NCT01143051|881696|P2|COMPLETED|3-14 Day Washout||4
367572|NCT01143051|881697|P1|COMPLETED|3-14 Day Washout||4
367573|NCT01143051|881692|P6|STARTED|3-14 Day Washout||4
367574|NCT01143051|881693|P5|STARTED|3-14 Day Washout||4
367575|NCT01143051|881694|P4|STARTED|3-14 Day Washout||4
367576|NCT01143051|881695|P3|STARTED|3-14 Day Washout||3
367577|NCT01143051|881696|P2|STARTED|3-14 Day Washout||4
367578|NCT01143051|881697|P1|STARTED|3-14 Day Washout||4
367579|NCT01143051|881692|P6|NOT COMPLETED|Visit 2||0
367580|NCT01143051|881693|P5|NOT COMPLETED|Visit 2||0
367581|NCT01143051|881694|P4|NOT COMPLETED|Visit 2||0
367582|NCT01143051|881695|P3|NOT COMPLETED|Visit 2||0
367583|NCT01143051|881696|P2|NOT COMPLETED|Visit 2||0
367584|NCT01143051|881697|P1|NOT COMPLETED|Visit 2||0
367585|NCT01143051|881692|P6|COMPLETED|Visit 2||4
367586|NCT01143051|881693|P5|COMPLETED|Visit 2||4
367587|NCT01143051|881694|P4|COMPLETED|Visit 2||4
367588|NCT01143051|881695|P3|COMPLETED|Visit 2||3
367589|NCT01143051|881696|P2|COMPLETED|Visit 2||4
367590|NCT01143051|881697|P1|COMPLETED|Visit 2||4
367591|NCT01143051|881692|P6|STARTED|Visit 2||4
367592|NCT01143051|881693|P5|STARTED|Visit 2||4
367593|NCT01143051|881694|P4|STARTED|Visit 2||4
367594|NCT01143051|881695|P3|STARTED|Visit 2||3
367595|NCT01143051|881696|P2|STARTED|Visit 2||4
367596|NCT01143051|881697|P1|STARTED|Visit 2||4
367597|NCT01143051|881692|P6|NOT COMPLETED|3-14 Day Washout||0
367598|NCT01143051|881693|P5|NOT COMPLETED|3-14 Day Washout||0
367599|NCT01143051|881694|P4|NOT COMPLETED|3-14 Day Washout||0
367600|NCT01143051|881695|P3|NOT COMPLETED|3-14 Day Washout||1
367601|NCT01143051|881696|P2|NOT COMPLETED|3-14 Day Washout||0
367602|NCT01143051|881697|P1|NOT COMPLETED|3-14 Day Washout||0
367603|NCT01143051|881692|P6|COMPLETED|3-14 Day Washout||4
367604|NCT01143051|881693|P5|COMPLETED|3-14 Day Washout||4
367605|NCT01143051|881694|P4|COMPLETED|3-14 Day Washout||4
367606|NCT01143051|881695|P3|COMPLETED|3-14 Day Washout||3
367607|NCT01143051|881696|P2|COMPLETED|3-14 Day Washout||4
367608|NCT01143051|881697|P1|COMPLETED|3-14 Day Washout||4
367609|NCT01143051|881692|P6|STARTED|3-14 Day Washout||4
367610|NCT01143051|881693|P5|STARTED|3-14 Day Washout||4
367611|NCT01143051|881694|P4|STARTED|3-14 Day Washout||4
367612|NCT01143051|881695|P3|STARTED|3-14 Day Washout||4
367613|NCT01143051|881696|P2|STARTED|3-14 Day Washout||4
367614|NCT01143051|881697|P1|STARTED|3-14 Day Washout||4
367615|NCT01143051|881692|P6|NOT COMPLETED|Visit 1||0
367616|NCT01143051|881693|P5|NOT COMPLETED|Visit 1||0
367617|NCT01143051|881694|P4|NOT COMPLETED|Visit 1||0
367618|NCT01143051|881695|P3|NOT COMPLETED|Visit 1||0
367619|NCT01143051|881696|P2|NOT COMPLETED|Visit 1||0
367620|NCT01143051|881697|P1|NOT COMPLETED|Visit 1||0
367621|NCT01143051|881692|P6|COMPLETED|Visit 1||4
367622|NCT01143051|881693|P5|COMPLETED|Visit 1||4
367623|NCT01143051|881694|P4|COMPLETED|Visit 1||4
367624|NCT01143051|881695|P3|COMPLETED|Visit 1||4
367625|NCT01143051|881696|P2|COMPLETED|Visit 1||4
367626|NCT01143051|881697|P1|COMPLETED|Visit 1||4
367627|NCT01143051|881692|P6|STARTED|Visit 1||4
367628|NCT01143051|881693|P5|STARTED|Visit 1||4
367629|NCT01143051|881694|P4|STARTED|Visit 1||4
367630|NCT01143051|881695|P3|STARTED|Visit 1||4
367631|NCT01143051|881696|P2|STARTED|Visit 1||4
367632|NCT01143051|881697|P1|STARTED|Visit 1||4
367633|NCT01143038|881720|P1|NOT COMPLETED|Overall Study||16
367634|NCT01143038|881720|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
367635|NCT01143038|881720|P1|STARTED|Overall Study||75
367636|NCT01142908|881730|P2|NOT COMPLETED|Overall Study||22
367637|NCT01142908|881731|P1|NOT COMPLETED|Overall Study||32
367638|NCT01142908|881730|P2|COMPLETED|Overall Study||191
367639|NCT01142908|881731|P1|COMPLETED|Overall Study||183
367640|NCT01142908|881730|P2|6 Month f/u|Overall Study||196
367641|NCT01142908|881731|P1|6 Month f/u|Overall Study||188
367642|NCT01142908|881730|P2|STARTED|Overall Study||213
367643|NCT01142908|881731|P1|STARTED|Overall Study||215
367644|NCT01142726|881780|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
367645|NCT01142726|881781|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
367646|NCT01142726|881782|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
367647|NCT01142726|881780|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
367648|NCT01142726|881781|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
367649|NCT01142726|881782|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
367650|NCT01142726|881780|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
367651|NCT01142726|881781|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
367652|NCT01142726|881782|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
367653|NCT01142726|881780|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
367654|NCT01142726|881781|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
367655|NCT01142726|881782|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
367656|NCT01142726|881780|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
367657|NCT01142726|881781|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
367658|NCT01142726|881782|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
367659|NCT01142726|881780|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
367660|NCT01142726|881781|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
367661|NCT01142726|881782|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
367662|NCT01142726|881780|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
367663|NCT01142726|881781|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
367664|NCT01142726|881782|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
367665|NCT01142726|881780|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
367666|NCT01142726|881781|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
367667|NCT01142726|881782|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
367668|NCT01142726|881780|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
367669|NCT01142726|881781|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
367670|NCT01142726|881782|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
367671|NCT01142661|881845|P1|NOT COMPLETED|Overall Study||4
367672|NCT01142661|881845|P1|COMPLETED|Overall Study||5
367673|NCT01142661|881845|P1|STARTED|Overall Study||9
367674|NCT01142596|881852|P2|NOT COMPLETED|Overall Study||86
367675|NCT01142596|881853|P1|NOT COMPLETED|Overall Study||29
367676|NCT01142596|881852|P2|COMPLETED|Overall Study||71
367677|NCT01142596|881853|P1|COMPLETED|Overall Study||15
367678|NCT01142596|881852|P2|STARTED|Overall Study||157
367679|NCT01142596|881853|P1|STARTED|Overall Study||44
367680|NCT01142466|881905|P2|NOT COMPLETED|Overall Study||2
367681|NCT01142466|881906|P1|NOT COMPLETED|Overall Study||3
367682|NCT01142466|881905|P2|COMPLETED|Overall Study||13
367683|NCT01142466|881906|P1|COMPLETED|Overall Study||12
367684|NCT01142466|881905|P2|STARTED|Overall Study||15
367685|NCT01142466|881906|P1|STARTED|Overall Study||15
367686|NCT01142388|881926|P2|NOT COMPLETED|Overall Study||47
367687|NCT01142388|881927|P1|NOT COMPLETED|Overall Study||47
367688|NCT01142388|881926|P2|COMPLETED|Overall Study||0
367689|NCT01142388|881927|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
367690|NCT01142388|881926|P2|Treated|Overall Study||44
367691|NCT01142388|881927|P1|Treated|Overall Study||40
367692|NCT01142388|881926|P2|Eligible|Overall Study||44
367693|NCT01142388|881927|P1|Eligible|Overall Study||43
367694|NCT01142388|881926|P2|STARTED|Overall Study||47
367695|NCT01142388|881927|P1|STARTED|Overall Study||47
367696|NCT01142323|881937|P1|NOT COMPLETED|Overall Study||0
367697|NCT01142323|881937|P1|COMPLETED|Overall Study||8
367698|NCT01142323|881937|P1|STARTED|Overall Study||8
367699|NCT01142297|881942|P1|NOT COMPLETED|Overall Study||6
367700|NCT01142297|881942|P1|COMPLETED|Overall Study||18
367701|NCT01142297|881942|P1|STARTED|Overall Study||24
367702|NCT01142193|881950|P2|NOT COMPLETED|Overall Study||11
367703|NCT01142193|881951|P1|NOT COMPLETED|Overall Study||21
367704|NCT01142193|881950|P2|COMPLETED|Overall Study||114
367705|NCT01142193|881951|P1|COMPLETED|Overall Study||103
367706|NCT01142193|881950|P2|STARTED|Overall Study||125
367707|NCT01142193|881951|P1|STARTED|Overall Study||124
367708|NCT01142128|881979|P1|NOT COMPLETED|Overall Study||4
367709|NCT01142128|881979|P1|COMPLETED|Overall Study||4
367710|NCT01142128|881979|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
367711|NCT01142128|881979|P1|Viokase 16 Plus Nexium|Overall Study||2
367712|NCT01142128|881979|P1|Placebo to Nexium, Alone|Overall Study||3
367713|NCT01142128|881979|P1|Nexium Alone|Overall Study||3
367714|NCT01142128|881979|P1|STARTED|Overall Study||8
367715|NCT01142115|881989|P2|NOT COMPLETED|Second Intervention||0
367716|NCT01142115|881990|P1|NOT COMPLETED|Second Intervention||0
367717|NCT01142115|881989|P2|COMPLETED|Second Intervention||19
367718|NCT01142115|881990|P1|COMPLETED|Second Intervention||19
367719|NCT01142115|881989|P2|STARTED|Second Intervention||19
367720|NCT01142115|881990|P1|STARTED|Second Intervention||19
367721|NCT01142115|881989|P2|NOT COMPLETED|First Intervention||1
367722|NCT01142115|881990|P1|NOT COMPLETED|First Intervention||2
367723|NCT01142115|881989|P2|COMPLETED|First Intervention||19
367724|NCT01142115|881990|P1|COMPLETED|First Intervention||19
367725|NCT01142115|881989|P2|STARTED|First Intervention||20
367726|NCT01142115|881990|P1|STARTED|First Intervention||21
367727|NCT01141712|882005|P1|NOT COMPLETED|Overall Study||3
367728|NCT01141712|882005|P1|COMPLETED|Overall Study||40
367729|NCT01141712|882005|P1|STARTED|Overall Study||43
367730|NCT01141660|882026|P2|NOT COMPLETED|Overall Study||12
367731|NCT01141660|882027|P1|NOT COMPLETED|Overall Study||0
367732|NCT01141660|882026|P2|COMPLETED|Overall Study||48
367733|NCT01141660|882027|P1|COMPLETED|Overall Study||71
367734|NCT01141660|882026|P2|STARTED|Overall Study||60
367735|NCT01141660|882027|P1|STARTED|Overall Study||71
367736|NCT01141647|882033|P1|NOT COMPLETED|Overall Study||46
367737|NCT01141647|882033|P1|COMPLETED|Overall Study||167
367738|NCT01141647|882033|P1|STARTED|Overall Study||213
367739|NCT01141595|882046|P1|NOT COMPLETED|Overall Study||2
367740|NCT01141595|882046|P1|COMPLETED|Overall Study||8
367741|NCT01141595|882046|P1|STARTED|Overall Study||10
367742|NCT01141569|882050|P1|NOT COMPLETED|Overall Study||0
367743|NCT01141569|882050|P1|COMPLETED|Overall Study||12
367744|NCT01141569|882050|P1|STARTED|Overall Study||12
367745|NCT01141491|882061|P2|NOT COMPLETED|Overall Study||47
367746|NCT01141491|882062|P1|NOT COMPLETED|Overall Study||48
367747|NCT01141491|882061|P2|COMPLETED|Overall Study||21
367748|NCT01141491|882062|P1|COMPLETED|Overall Study||20
367749|NCT01141491|882061|P2|STARTED|Overall Study||68
367750|NCT01141491|882062|P1|STARTED|Overall Study||68
367751|NCT01141374|882071|P3|NOT COMPLETED|Overall Study||0
367752|NCT01141374|882072|P2|NOT COMPLETED|Overall Study||0
367753|NCT01141374|882073|P1|NOT COMPLETED|Overall Study||0
367754|NCT01141374|882071|P3|COMPLETED|Overall Study||22
367755|NCT01141374|882072|P2|COMPLETED|Overall Study||27
367756|NCT01141374|882073|P1|COMPLETED|Overall Study||26
367757|NCT01141374|882071|P3|STARTED|Overall Study||22
367758|NCT01141374|882072|P2|STARTED|Overall Study||27
367759|NCT01141374|882073|P1|STARTED|Overall Study||26
367760|NCT01141283|882084|P1|NOT COMPLETED|Overall Study||88
367761|NCT01141283|882084|P1|COMPLETED|Overall Study||202
367762|NCT01141283|882084|P1|STARTED|Overall Study||290
367763|NCT01141205|882090|P2|NOT COMPLETED|Overall Study||2
367764|NCT01141205|882091|P1|NOT COMPLETED|Overall Study||3
367765|NCT01141205|882090|P2|COMPLETED|Overall Study||3
367766|NCT01141205|882091|P1|COMPLETED|Overall Study||15
367767|NCT01141205|882090|P2|STARTED|Overall Study||5
367768|NCT01141205|882091|P1|STARTED|Overall Study||18
367769|NCT01139879|882103|P1|NOT COMPLETED|Overall Study||0
367770|NCT01139879|882103|P1|COMPLETED|Overall Study||10
367771|NCT01139879|882103|P1|STARTED|Overall Study||10
367772|NCT01140906|882113|P4|NOT COMPLETED|Overall Study||16
367773|NCT01140906|882114|P3|NOT COMPLETED|Overall Study||26
367774|NCT01140906|882115|P2|NOT COMPLETED|Overall Study||34
367775|NCT01140906|882116|P1|NOT COMPLETED|Overall Study||25
367776|NCT01140906|882113|P4|COMPLETED|Overall Study||131
367777|NCT01140906|882114|P3|COMPLETED|Overall Study||125
367778|NCT01140906|882115|P2|COMPLETED|Overall Study||117
367779|NCT01140906|882116|P1|COMPLETED|Overall Study||133
367780|NCT01140906|882113|P4|STARTED|Overall Study||147
367781|NCT01140906|882114|P3|STARTED|Overall Study||151
367782|NCT01140906|882115|P2|STARTED|Overall Study||151
367783|NCT01140906|882116|P1|STARTED|Overall Study||158
367784|NCT01140880|882156|P2|NOT COMPLETED|Overall Study||44
367785|NCT01140880|882157|P1|NOT COMPLETED|Overall Study||14
367786|NCT01140880|882156|P2|COMPLETED|Overall Study||56
367787|NCT01140880|882157|P1|COMPLETED|Overall Study||56
367788|NCT01140880|882156|P2|STARTED|Overall Study||100
367789|NCT01140880|882157|P1|STARTED|Overall Study||70
367790|NCT01140867|882169|P1|NOT COMPLETED|Overall Study||33
367791|NCT01140867|882169|P1|COMPLETED|Overall Study||88
367792|NCT01140867|882169|P1|STARTED|Overall Study||121
367793|NCT01140815|882178|P2|NOT COMPLETED|Overall Study||0
367794|NCT01140815|882179|P1|NOT COMPLETED|Overall Study||0
367795|NCT01140815|882178|P2|COMPLETED|Overall Study||25
367796|NCT01140815|882179|P1|COMPLETED|Overall Study||25
367797|NCT01140815|882178|P2|STARTED|Overall Study||25
367798|NCT01140815|882179|P1|STARTED|Overall Study||25
367799|NCT01140646|882209|P1|NOT COMPLETED|Overall Study||9
367800|NCT01140646|882209|P1|COMPLETED|Overall Study||34
367801|NCT01140646|882209|P1|STARTED|Overall Study||43
367802|NCT01140503|882213|P1|NOT COMPLETED|Overall Study||1
367803|NCT01140503|882213|P1|COMPLETED|Overall Study||4
367804|NCT01140503|882213|P1|STARTED|Overall Study||5
367805|NCT01140477|882221|P2|NOT COMPLETED|Overall Study||6
367806|NCT01140477|882222|P1|NOT COMPLETED|Overall Study||8
367807|NCT01140477|882221|P2|COMPLETED|Overall Study||70
367808|NCT01140477|882222|P1|COMPLETED|Overall Study||145
367809|NCT01140477|882221|P2|STARTED|Overall Study||76
367810|NCT01140477|882222|P1|STARTED|Overall Study||153
367811|NCT01140347|882233|P2|NOT COMPLETED|Overall Study||14
367812|NCT01140347|882234|P1|NOT COMPLETED|Overall Study||18
367813|NCT01140347|882233|P2|COMPLETED|Overall Study||268
367814|NCT01140347|882234|P1|COMPLETED|Overall Study||265
367815|NCT01140347|882233|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
367816|NCT01140347|882234|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
367817|NCT01140347|882233|P2|STARTED|Overall Study||282
367818|NCT01140347|882234|P1|STARTED|Overall Study||283
367819|NCT01140295|882259|P2|NOT COMPLETED|Overall Study||2
367820|NCT01140295|882260|P1|NOT COMPLETED|Overall Study||1
367821|NCT01140295|882259|P2|COMPLETED|Overall Study||14
367822|NCT01140295|882260|P1|COMPLETED|Overall Study||16
367823|NCT01140295|882259|P2|STARTED|Overall Study||16
367824|NCT01140295|882260|P1|STARTED|Overall Study||17
367825|NCT01140191|882268|P1|NOT COMPLETED|Overall Study||0
367826|NCT01140191|882268|P1|COMPLETED|Overall Study||1
367827|NCT01140191|882268|P1|STARTED|Overall Study||1
367828|NCT01140061|882287|P10|NOT COMPLETED|Extension||1
367829|NCT01140061|882288|P9|NOT COMPLETED|Extension||0
367830|NCT01140061|882289|P8|NOT COMPLETED|Extension||0
367831|NCT01140061|882290|P7|NOT COMPLETED|Extension||0
367832|NCT01140061|882291|P6|NOT COMPLETED|Extension||0
367833|NCT01140061|882292|P5|NOT COMPLETED|Extension||0
367834|NCT01140061|882293|P4|NOT COMPLETED|Extension||0
367835|NCT01140061|882294|P3|NOT COMPLETED|Extension||0
367836|NCT01140061|882295|P2|NOT COMPLETED|Extension||0
367837|NCT01140061|882296|P1|NOT COMPLETED|Extension||0
367838|NCT01140061|882287|P10|COMPLETED|Extension||1
367839|NCT01140061|882288|P9|COMPLETED|Extension||7
367840|NCT01140061|882289|P8|COMPLETED|Extension||0
367841|NCT01140061|882290|P7|COMPLETED|Extension||0
367842|NCT01140061|882291|P6|COMPLETED|Extension||0
367843|NCT01140061|882292|P5|COMPLETED|Extension||0
367844|NCT01140061|882293|P4|COMPLETED|Extension||0
367845|NCT01140061|882294|P3|COMPLETED|Extension||0
367846|NCT01140061|882295|P2|COMPLETED|Extension||0
367847|NCT01140061|882296|P1|COMPLETED|Extension||0
367848|NCT01140061|882287|P10|STARTED|Extension||2
367849|NCT01140061|882288|P9|STARTED|Extension||7
367850|NCT01140061|882289|P8|STARTED|Extension||0
367851|NCT01140061|882290|P7|STARTED|Extension||0
367852|NCT01140061|882291|P6|STARTED|Extension||0
367853|NCT01140061|882292|P5|STARTED|Extension||0
367854|NCT01140061|882293|P4|STARTED|Extension||0
367855|NCT01140061|882294|P3|STARTED|Extension||0
367856|NCT01140061|882295|P2|STARTED|Extension||0
367857|NCT01140061|882296|P1|STARTED|Extension||0
367858|NCT01140061|882287|P10|NOT COMPLETED|Part III||0
367859|NCT01140061|882288|P9|NOT COMPLETED|Part III||0
367860|NCT01140061|882289|P8|NOT COMPLETED|Part III||0
367861|NCT01140061|882290|P7|NOT COMPLETED|Part III||0
367862|NCT01140061|882291|P6|NOT COMPLETED|Part III||0
367863|NCT01140061|882292|P5|NOT COMPLETED|Part III||0
367864|NCT01140061|882293|P4|NOT COMPLETED|Part III||0
367865|NCT01140061|882294|P3|NOT COMPLETED|Part III||0
367866|NCT01140061|882295|P2|NOT COMPLETED|Part III||0
367867|NCT01140061|882296|P1|NOT COMPLETED|Part III||0
367868|NCT01140061|882287|P10|COMPLETED|Part III||2
367869|NCT01140061|882288|P9|COMPLETED|Part III||7
367870|NCT01140061|882289|P8|COMPLETED|Part III||0
367871|NCT01140061|882290|P7|COMPLETED|Part III||0
367872|NCT01140061|882291|P6|COMPLETED|Part III||0
367873|NCT01140061|882292|P5|COMPLETED|Part III||0
367874|NCT01140061|882293|P4|COMPLETED|Part III||0
367875|NCT01140061|882294|P3|COMPLETED|Part III||0
367876|NCT01140061|882295|P2|COMPLETED|Part III||0
367877|NCT01140061|882296|P1|COMPLETED|Part III||0
367878|NCT01140061|882287|P10|STARTED|Part III|Includes 1 replacement participant|2
367879|NCT01140061|882288|P9|STARTED|Part III||7
367880|NCT01140061|882289|P8|STARTED|Part III||0
367881|NCT01140061|882290|P7|STARTED|Part III||0
367882|NCT01140061|882291|P6|STARTED|Part III||0
367883|NCT01140061|882292|P5|STARTED|Part III||0
367884|NCT01140061|882293|P4|STARTED|Part III||0
367885|NCT01140061|882294|P3|STARTED|Part III||0
367886|NCT01140061|882295|P2|STARTED|Part III||0
367887|NCT01140061|882296|P1|STARTED|Part III||0
367888|NCT01140061|882287|P10|NOT COMPLETED|Part II||0
367889|NCT01140061|882288|P9|NOT COMPLETED|Part II||0
367890|NCT01140061|882289|P8|NOT COMPLETED|Part II||0
367891|NCT01140061|882290|P7|NOT COMPLETED|Part II||0
367892|NCT01140061|882291|P6|NOT COMPLETED|Part II||0
367893|NCT01140061|882292|P5|NOT COMPLETED|Part II||0
367894|NCT01140061|882293|P4|NOT COMPLETED|Part II||0
367895|NCT01140061|882294|P3|NOT COMPLETED|Part II||0
367896|NCT01140061|882295|P2|NOT COMPLETED|Part II||0
367897|NCT01140061|882296|P1|NOT COMPLETED|Part II||0
367898|NCT01140061|882287|P10|COMPLETED|Part II||0
367899|NCT01140061|882288|P9|COMPLETED|Part II||0
367900|NCT01140061|882289|P8|COMPLETED|Part II||2
367901|NCT01140061|882290|P7|COMPLETED|Part II||6
367902|NCT01140061|882291|P6|COMPLETED|Part II||2
367903|NCT01140061|882292|P5|COMPLETED|Part II||6
367904|NCT01140061|882293|P4|COMPLETED|Part II||2
367905|NCT01140061|882294|P3|COMPLETED|Part II||6
367906|NCT01140061|882295|P2|COMPLETED|Part II||0
367907|NCT01140061|882296|P1|COMPLETED|Part II||0
367908|NCT01140061|882287|P10|STARTED|Part II||0
367909|NCT01140061|882288|P9|STARTED|Part II||0
367910|NCT01140061|882289|P8|STARTED|Part II||2
367911|NCT01140061|882290|P7|STARTED|Part II||6
367912|NCT01140061|882291|P6|STARTED|Part II||2
367913|NCT01140061|882292|P5|STARTED|Part II||6
367914|NCT01140061|882293|P4|STARTED|Part II||2
367915|NCT01140061|882294|P3|STARTED|Part II||6
367916|NCT01140061|882295|P2|STARTED|Part II||0
367917|NCT01140061|882296|P1|STARTED|Part II||0
367918|NCT01140061|882287|P10|NOT COMPLETED|Part I||0
367919|NCT01140061|882288|P9|NOT COMPLETED|Part I||0
367920|NCT01140061|882289|P8|NOT COMPLETED|Part I||0
367921|NCT01140061|882290|P7|NOT COMPLETED|Part I||0
367922|NCT01140061|882291|P6|NOT COMPLETED|Part I||0
367923|NCT01140061|882292|P5|NOT COMPLETED|Part I||0
367924|NCT01140061|882293|P4|NOT COMPLETED|Part I||0
367925|NCT01140061|882294|P3|NOT COMPLETED|Part I||0
367926|NCT01140061|882295|P2|NOT COMPLETED|Part I||0
367927|NCT01140061|882296|P1|NOT COMPLETED|Part I||1
367928|NCT01140061|882287|P10|COMPLETED|Part I||0
367929|NCT01140061|882288|P9|COMPLETED|Part I||0
367930|NCT01140061|882289|P8|COMPLETED|Part I||0
367931|NCT01140061|882290|P7|COMPLETED|Part I||0
367932|NCT01140061|882291|P6|COMPLETED|Part I||0
367933|NCT01140061|882292|P5|COMPLETED|Part I||0
367934|NCT01140061|882293|P4|COMPLETED|Part I||0
367935|NCT01140061|882294|P3|COMPLETED|Part I||0
367936|NCT01140061|882295|P2|COMPLETED|Part I||2
367937|NCT01140061|882296|P1|COMPLETED|Part I||6
367938|NCT01140061|882287|P10|STARTED|Part I||0
367939|NCT01140061|882288|P9|STARTED|Part I||0
367940|NCT01140061|882289|P8|STARTED|Part I||0
367941|NCT01140061|882290|P7|STARTED|Part I||0
367942|NCT01140061|882291|P6|STARTED|Part I||0
367943|NCT01140061|882292|P5|STARTED|Part I||0
367944|NCT01140061|882293|P4|STARTED|Part I||0
367945|NCT01140061|882294|P3|STARTED|Part I||0
367946|NCT01140061|882295|P2|STARTED|Part I||2
367947|NCT01140061|882296|P1|STARTED|Part I|Includes 1 replacement participant|7
367948|NCT01140048|882323|P1|NOT COMPLETED|Overall Study||45
367949|NCT01140048|882323|P1|COMPLETED|Overall Study||298
367950|NCT01140048|882323|P1|STARTED|Overall Study||343
367951|NCT01139996|882331|P2|NOT COMPLETED|Overall Study||0
367952|NCT01139996|882332|P1|NOT COMPLETED|Overall Study||0
367953|NCT01139996|882331|P2|COMPLETED|Overall Study||11
367954|NCT01139996|882332|P1|COMPLETED|Overall Study||11
367955|NCT01139996|882331|P2|STARTED|Overall Study||11
367956|NCT01139996|882332|P1|STARTED|Overall Study||11
367957|NCT01139814|882338|P1|NOT COMPLETED|Overall Study||0
367958|NCT01139814|882338|P1|COMPLETED|Overall Study||181
367959|NCT01139814|882338|P1|STARTED|Overall Study||181
367960|NCT01139762|882345|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
367961|NCT01139762|882346|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
367962|NCT01139762|882347|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
367963|NCT01139762|882345|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
367964|NCT01139762|882346|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
367965|NCT01139762|882347|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
367966|NCT01139762|882345|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
367967|NCT01139762|882346|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
367968|NCT01139762|882347|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
367969|NCT01139762|882345|P3|STARTED|Double-Blind Randomized Active Treatment||350
367970|NCT01139762|882346|P2|STARTED|Double-Blind Randomized Active Treatment||346
367971|NCT01139762|882347|P1|STARTED|Double-Blind Randomized Active Treatment||0
367972|NCT01139762|882345|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
367973|NCT01139762|882346|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
367974|NCT01139762|882347|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
367975|NCT01139762|882345|P3|COMPLETED|Washout and Placebo Lead-In Period||0
367976|NCT01139762|882346|P2|COMPLETED|Washout and Placebo Lead-In Period||0
367977|NCT01139762|882347|P1|COMPLETED|Washout and Placebo Lead-In Period||696
367978|NCT01139762|882345|P3|STARTED|Washout and Placebo Lead-In Period||0
367979|NCT01139762|882346|P2|STARTED|Washout and Placebo Lead-In Period||0
367980|NCT01139762|882347|P1|STARTED|Washout and Placebo Lead-In Period||1070
367981|NCT01139658|882382|P2|NOT COMPLETED|Overall Study||113
367982|NCT01139658|882383|P1|NOT COMPLETED|Overall Study||56
367983|NCT01139658|882382|P2|COMPLETED|Overall Study||816
367984|NCT01139658|882383|P1|COMPLETED|Overall Study||691
367985|NCT01139658|882382|P2|STARTED|Overall Study||929
367986|NCT01139658|882383|P1|STARTED|Overall Study||747
367987|NCT01139580|882421|P2|NOT COMPLETED|Overall Study||18
367988|NCT01139580|882422|P1|NOT COMPLETED|Overall Study||23
367989|NCT01139580|882421|P2|COMPLETED|Overall Study||164
367990|NCT01139580|882422|P1|COMPLETED|Overall Study||158
367991|NCT01139580|882421|P2|STARTED|Overall Study||182
367992|NCT01139580|882422|P1|STARTED|Overall Study||181
367993|NCT01139515|882438|P4|NOT COMPLETED|Fourth Intervention Period||0
367994|NCT01139515|882439|P3|NOT COMPLETED|Fourth Intervention Period||0
367995|NCT01139515|882440|P2|NOT COMPLETED|Fourth Intervention Period||0
367996|NCT01139515|882441|P1|NOT COMPLETED|Fourth Intervention Period||0
367997|NCT01139515|882438|P4|COMPLETED|Fourth Intervention Period||4
367998|NCT01139515|882439|P3|COMPLETED|Fourth Intervention Period||4
367999|NCT01139515|882440|P2|COMPLETED|Fourth Intervention Period||4
368000|NCT01139515|882441|P1|COMPLETED|Fourth Intervention Period||4
368001|NCT01139515|882438|P4|STARTED|Fourth Intervention Period||4
368002|NCT01139515|882439|P3|STARTED|Fourth Intervention Period||4
368003|NCT01139515|882440|P2|STARTED|Fourth Intervention Period||4
368004|NCT01139515|882441|P1|STARTED|Fourth Intervention Period||4
368005|NCT01139515|882438|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
368006|NCT01139515|882439|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
368007|NCT01139515|882440|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
368008|NCT01139515|882441|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
368009|NCT01139515|882438|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
368010|NCT01139515|882439|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
368011|NCT01139515|882440|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
368012|NCT01139515|882441|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
368013|NCT01139515|882438|P4|STARTED|Washout Period 3 (46 Hrs)||4
368014|NCT01139515|882439|P3|STARTED|Washout Period 3 (46 Hrs)||4
368015|NCT01139515|882440|P2|STARTED|Washout Period 3 (46 Hrs)||4
368016|NCT01139515|882441|P1|STARTED|Washout Period 3 (46 Hrs)||4
368017|NCT01139515|882438|P4|NOT COMPLETED|Third Intervention Period||0
368018|NCT01139515|882439|P3|NOT COMPLETED|Third Intervention Period||0
368019|NCT01139515|882440|P2|NOT COMPLETED|Third Intervention Period||0
368020|NCT01139515|882441|P1|NOT COMPLETED|Third Intervention Period||0
368021|NCT01139515|882438|P4|COMPLETED|Third Intervention Period||4
368022|NCT01139515|882439|P3|COMPLETED|Third Intervention Period||4
368023|NCT01139515|882440|P2|COMPLETED|Third Intervention Period||4
368024|NCT01139515|882441|P1|COMPLETED|Third Intervention Period||4
368025|NCT01139515|882438|P4|STARTED|Third Intervention Period||4
368026|NCT01139515|882439|P3|STARTED|Third Intervention Period||4
368027|NCT01139515|882440|P2|STARTED|Third Intervention Period||4
368028|NCT01139515|882441|P1|STARTED|Third Intervention Period||4
368029|NCT01139515|882438|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
368030|NCT01139515|882439|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
368031|NCT01139515|882440|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
368032|NCT01139515|882441|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
368033|NCT01139515|882438|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
368034|NCT01139515|882439|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
368035|NCT01139515|882440|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
368036|NCT01139515|882441|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
368037|NCT01139515|882438|P4|STARTED|Washout Period 2 (46 Hrs)||4
368038|NCT01139515|882439|P3|STARTED|Washout Period 2 (46 Hrs)||4
368039|NCT01139515|882440|P2|STARTED|Washout Period 2 (46 Hrs)||4
368040|NCT01139515|882441|P1|STARTED|Washout Period 2 (46 Hrs)||4
368041|NCT01139515|882438|P4|NOT COMPLETED|Second Intervention Period||0
368042|NCT01139515|882439|P3|NOT COMPLETED|Second Intervention Period||0
368043|NCT01139515|882440|P2|NOT COMPLETED|Second Intervention Period||0
368044|NCT01139515|882441|P1|NOT COMPLETED|Second Intervention Period||0
368045|NCT01139515|882438|P4|COMPLETED|Second Intervention Period||4
368046|NCT01139515|882439|P3|COMPLETED|Second Intervention Period||4
368047|NCT01139515|882440|P2|COMPLETED|Second Intervention Period||4
368048|NCT01139515|882441|P1|COMPLETED|Second Intervention Period||4
368049|NCT01139515|882438|P4|STARTED|Second Intervention Period||4
368050|NCT01139515|882439|P3|STARTED|Second Intervention Period||4
368051|NCT01139515|882440|P2|STARTED|Second Intervention Period||4
368052|NCT01139515|882441|P1|STARTED|Second Intervention Period||4
368053|NCT01139515|882438|P4|NOT COMPLETED|Washout Period I (46hrs)||0
368054|NCT01139515|882439|P3|NOT COMPLETED|Washout Period I (46hrs)||0
368055|NCT01139515|882440|P2|NOT COMPLETED|Washout Period I (46hrs)||0
368056|NCT01139515|882441|P1|NOT COMPLETED|Washout Period I (46hrs)||0
368057|NCT01139515|882438|P4|COMPLETED|Washout Period I (46hrs)||4
368058|NCT01139515|882439|P3|COMPLETED|Washout Period I (46hrs)||4
368059|NCT01139515|882440|P2|COMPLETED|Washout Period I (46hrs)||4
368060|NCT01139515|882441|P1|COMPLETED|Washout Period I (46hrs)||4
368061|NCT01139515|882438|P4|STARTED|Washout Period I (46hrs)||4
368062|NCT01139515|882439|P3|STARTED|Washout Period I (46hrs)||4
368063|NCT01139515|882440|P2|STARTED|Washout Period I (46hrs)||4
368064|NCT01139515|882441|P1|STARTED|Washout Period I (46hrs)||4
368065|NCT01139515|882438|P4|NOT COMPLETED|First Intervention Period||0
368066|NCT01139515|882439|P3|NOT COMPLETED|First Intervention Period||0
368067|NCT01139515|882440|P2|NOT COMPLETED|First Intervention Period||0
368068|NCT01139515|882441|P1|NOT COMPLETED|First Intervention Period||0
368069|NCT01139515|882438|P4|COMPLETED|First Intervention Period||4
368070|NCT01139515|882439|P3|COMPLETED|First Intervention Period||4
368071|NCT01139515|882440|P2|COMPLETED|First Intervention Period||4
368072|NCT01139515|882441|P1|COMPLETED|First Intervention Period||4
368073|NCT01139515|882438|P4|STARTED|First Intervention Period||4
368074|NCT01139515|882439|P3|STARTED|First Intervention Period||4
368075|NCT01139515|882440|P2|STARTED|First Intervention Period||4
368076|NCT01139515|882441|P1|STARTED|First Intervention Period||4
368077|NCT01139450|882470|P3|NOT COMPLETED|Overall Study||38
368078|NCT01139450|882471|P2|NOT COMPLETED|Overall Study||25
368079|NCT01139450|882472|P1|NOT COMPLETED|Overall Study||27
368080|NCT01139450|882470|P3|COMPLETED|Overall Study||262
368081|NCT01139450|882471|P2|COMPLETED|Overall Study||272
368082|NCT01139450|882472|P1|COMPLETED|Overall Study||275
368083|NCT01139450|882470|P3|STARTED|Overall Study||300
368084|NCT01139450|882471|P2|STARTED|Overall Study||297
368085|NCT01139450|882472|P1|STARTED|Overall Study||302
368086|NCT01139411|882482|P2|NOT COMPLETED|Overall Study||4
368087|NCT01139411|882483|P1|NOT COMPLETED|Overall Study||2
368088|NCT01139411|882482|P2|COMPLETED|Overall Study||19
368089|NCT01139411|882483|P1|COMPLETED|Overall Study||24
368090|NCT01139411|882482|P2|STARTED|Overall Study||23
368091|NCT01139411|882483|P1|STARTED|Overall Study||26
368092|NCT01139190|882503|P2|NOT COMPLETED|Overall Study||1
368093|NCT01139190|882504|P1|NOT COMPLETED|Overall Study||0
368094|NCT01139190|882503|P2|COMPLETED|Overall Study||38
368095|NCT01139190|882504|P1|COMPLETED|Overall Study||38
368096|NCT01139190|882503|P2|STARTED|Overall Study||39
368097|NCT01139190|882504|P1|STARTED|Overall Study||38
368098|NCT01139164|882513|P3|NOT COMPLETED|Overall Study||0
368099|NCT01139164|882514|P2|NOT COMPLETED|Overall Study||2
368100|NCT01139164|882515|P1|NOT COMPLETED|Overall Study||0
368101|NCT01139164|882513|P3|COMPLETED|Overall Study||7
368102|NCT01139164|882514|P2|COMPLETED|Overall Study||65
368103|NCT01139164|882515|P1|COMPLETED|Overall Study||4
368104|NCT01139164|882513|P3|STARTED|Overall Study||7
368105|NCT01139164|882514|P2|STARTED|Overall Study||67
368106|NCT01139164|882515|P1|STARTED|Overall Study||4
368107|NCT01139125|882529|P1|NOT COMPLETED|Overall Study||1
368108|NCT01139125|882529|P1|COMPLETED|Overall Study||2
368109|NCT01139125|882529|P1|STARTED|Overall Study||3
368110|NCT01139047|882533|P1|NOT COMPLETED|Overall Study||1
368111|NCT01139047|882533|P1|COMPLETED|Overall Study||76
368112|NCT01139047|882533|P1|STARTED|Overall Study||77
368113|NCT01139021|882548|P6|NOT COMPLETED|Overall Study||0
368114|NCT01139021|882549|P5|NOT COMPLETED|Overall Study||9
368115|NCT01139021|882550|P4|NOT COMPLETED|Overall Study||1
368116|NCT01139021|882551|P3|NOT COMPLETED|Overall Study||0
368117|NCT01139021|882552|P2|NOT COMPLETED|Overall Study||0
368118|NCT01139021|882553|P1|NOT COMPLETED|Overall Study||1
368119|NCT01139021|882548|P6|COMPLETED|Overall Study||1
368120|NCT01139021|882549|P5|COMPLETED|Overall Study||107
368121|NCT01139021|882550|P4|COMPLETED|Overall Study||18
368122|NCT01139021|882551|P3|COMPLETED|Overall Study||67
368123|NCT01139021|882552|P2|COMPLETED|Overall Study||153
368124|NCT01139021|882553|P1|COMPLETED|Overall Study||151
368125|NCT01139021|882548|P6|STARTED|Overall Study||1
368126|NCT01139021|882549|P5|STARTED|Overall Study||116
368127|NCT01139021|882550|P4|STARTED|Overall Study||19
368128|NCT01139021|882551|P3|STARTED|Overall Study||67
368129|NCT01139021|882552|P2|STARTED|Overall Study||153
368130|NCT01139021|882553|P1|STARTED|Overall Study||152
368131|NCT01139008|882589|P1|NOT COMPLETED|Overall Study||6
368132|NCT01139008|882589|P1|COMPLETED|Overall Study||74
368133|NCT01139008|882589|P1|STARTED|Overall Study||80
368134|NCT01138995|882600|P2|NOT COMPLETED|Overall Study||25
368135|NCT01138995|882601|P1|NOT COMPLETED|Overall Study||10
368136|NCT01138995|882600|P2|COMPLETED|Overall Study||74
368137|NCT01138995|882601|P1|COMPLETED|Overall Study||88
368138|NCT01138995|882600|P2|STARTED|Overall Study||99
368139|NCT01138995|882601|P1|STARTED|Overall Study||98
368140|NCT01138969|882613|P2|NOT COMPLETED|Overall Study||0
368141|NCT01138969|882614|P1|NOT COMPLETED|Overall Study||0
368142|NCT01138969|882613|P2|COMPLETED|Overall Study||82
368143|NCT01138969|882614|P1|COMPLETED|Overall Study||83
368144|NCT01138969|882613|P2|STARTED|Overall Study||82
368145|NCT01138969|882614|P1|STARTED|Overall Study||83
368146|NCT01138826|882622|P6|NOT COMPLETED|Third Intervention Period||0
368147|NCT01138826|882623|P5|NOT COMPLETED|Third Intervention Period||0
368148|NCT01138826|882624|P4|NOT COMPLETED|Third Intervention Period||0
368149|NCT01138826|882625|P3|NOT COMPLETED|Third Intervention Period||0
368150|NCT01138826|882626|P2|NOT COMPLETED|Third Intervention Period||0
368151|NCT01138826|882627|P1|NOT COMPLETED|Third Intervention Period||0
368152|NCT01138826|882622|P6|COMPLETED|Third Intervention Period||3
368153|NCT01138826|882623|P5|COMPLETED|Third Intervention Period||2
368154|NCT01138826|882624|P4|COMPLETED|Third Intervention Period||3
368155|NCT01138826|882625|P3|COMPLETED|Third Intervention Period||3
368156|NCT01138826|882626|P2|COMPLETED|Third Intervention Period||2
368157|NCT01138826|882627|P1|COMPLETED|Third Intervention Period||2
368158|NCT01138826|882622|P6|STARTED|Third Intervention Period||3
368159|NCT01138826|882623|P5|STARTED|Third Intervention Period||2
368160|NCT01138826|882624|P4|STARTED|Third Intervention Period||3
368161|NCT01138826|882625|P3|STARTED|Third Intervention Period||3
368162|NCT01138826|882626|P2|STARTED|Third Intervention Period||2
368163|NCT01138826|882627|P1|STARTED|Third Intervention Period||2
368164|NCT01138826|882622|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
368165|NCT01138826|882623|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
368166|NCT01138826|882624|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
368167|NCT01138826|882625|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
368168|NCT01138826|882626|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
368169|NCT01138826|882627|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
368170|NCT01138826|882622|P6|COMPLETED|Washout Period II (of 16 Days)||3
368171|NCT01138826|882623|P5|COMPLETED|Washout Period II (of 16 Days)||2
368172|NCT01138826|882624|P4|COMPLETED|Washout Period II (of 16 Days)||3
368173|NCT01138826|882625|P3|COMPLETED|Washout Period II (of 16 Days)||3
368174|NCT01138826|882626|P2|COMPLETED|Washout Period II (of 16 Days)||2
368175|NCT01138826|882627|P1|COMPLETED|Washout Period II (of 16 Days)||2
368176|NCT01138826|882622|P6|STARTED|Washout Period II (of 16 Days)||3
368177|NCT01138826|882623|P5|STARTED|Washout Period II (of 16 Days)||2
368178|NCT01138826|882624|P4|STARTED|Washout Period II (of 16 Days)||3
368179|NCT01138826|882625|P3|STARTED|Washout Period II (of 16 Days)||3
368180|NCT01138826|882626|P2|STARTED|Washout Period II (of 16 Days)||2
368181|NCT01138826|882627|P1|STARTED|Washout Period II (of 16 Days)||2
368182|NCT01138826|882622|P6|NOT COMPLETED|Second Intervention Period||0
368183|NCT01138826|882623|P5|NOT COMPLETED|Second Intervention Period||0
368184|NCT01138826|882624|P4|NOT COMPLETED|Second Intervention Period||0
368185|NCT01138826|882625|P3|NOT COMPLETED|Second Intervention Period||0
368186|NCT01138826|882626|P2|NOT COMPLETED|Second Intervention Period||0
368187|NCT01138826|882627|P1|NOT COMPLETED|Second Intervention Period||0
368188|NCT01138826|882622|P6|COMPLETED|Second Intervention Period||3
368189|NCT01138826|882623|P5|COMPLETED|Second Intervention Period||2
368190|NCT01138826|882624|P4|COMPLETED|Second Intervention Period||3
368191|NCT01138826|882625|P3|COMPLETED|Second Intervention Period||3
368192|NCT01138826|882626|P2|COMPLETED|Second Intervention Period||2
368193|NCT01138826|882627|P1|COMPLETED|Second Intervention Period||2
368194|NCT01138826|882622|P6|STARTED|Second Intervention Period||3
368195|NCT01138826|882623|P5|STARTED|Second Intervention Period||2
368196|NCT01138826|882624|P4|STARTED|Second Intervention Period||3
368197|NCT01138826|882625|P3|STARTED|Second Intervention Period||3
368198|NCT01138826|882626|P2|STARTED|Second Intervention Period||2
368199|NCT01138826|882627|P1|STARTED|Second Intervention Period||2
368200|NCT01138826|882622|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
368201|NCT01138826|882623|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
368202|NCT01138826|882624|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
368203|NCT01138826|882625|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
368204|NCT01138826|882626|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
368205|NCT01138826|882627|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
368206|NCT01138826|882622|P6|COMPLETED|Washout Period I (of 16 Days)||3
368207|NCT01138826|882623|P5|COMPLETED|Washout Period I (of 16 Days)||2
368208|NCT01138826|882624|P4|COMPLETED|Washout Period I (of 16 Days)||3
368209|NCT01138826|882625|P3|COMPLETED|Washout Period I (of 16 Days)||3
368210|NCT01138826|882626|P2|COMPLETED|Washout Period I (of 16 Days)||2
368211|NCT01138826|882627|P1|COMPLETED|Washout Period I (of 16 Days)||2
368212|NCT01138826|882622|P6|STARTED|Washout Period I (of 16 Days)||3
368213|NCT01138826|882623|P5|STARTED|Washout Period I (of 16 Days)||3
368214|NCT01138826|882624|P4|STARTED|Washout Period I (of 16 Days)||3
368215|NCT01138826|882625|P3|STARTED|Washout Period I (of 16 Days)||3
368216|NCT01138826|882626|P2|STARTED|Washout Period I (of 16 Days)||3
368217|NCT01138826|882627|P1|STARTED|Washout Period I (of 16 Days)||3
368218|NCT01138826|882622|P6|NOT COMPLETED|First Intervention Period||0
368219|NCT01138826|882623|P5|NOT COMPLETED|First Intervention Period||0
368220|NCT01138826|882624|P4|NOT COMPLETED|First Intervention Period||0
368221|NCT01138826|882625|P3|NOT COMPLETED|First Intervention Period||0
368222|NCT01138826|882626|P2|NOT COMPLETED|First Intervention Period||0
368223|NCT01138826|882627|P1|NOT COMPLETED|First Intervention Period||0
368224|NCT01138826|882622|P6|COMPLETED|First Intervention Period||3
368225|NCT01138826|882623|P5|COMPLETED|First Intervention Period||3
368226|NCT01138826|882624|P4|COMPLETED|First Intervention Period||3
368227|NCT01138826|882625|P3|COMPLETED|First Intervention Period||3
368228|NCT01138826|882626|P2|COMPLETED|First Intervention Period||3
368229|NCT01138826|882627|P1|COMPLETED|First Intervention Period||3
368230|NCT01138826|882622|P6|STARTED|First Intervention Period||3
368231|NCT01138826|882623|P5|STARTED|First Intervention Period||3
368232|NCT01138826|882624|P4|STARTED|First Intervention Period||3
368233|NCT01138826|882625|P3|STARTED|First Intervention Period||3
368234|NCT01138826|882626|P2|STARTED|First Intervention Period||3
368235|NCT01138826|882627|P1|STARTED|First Intervention Period||3
368236|NCT01138735|882649|P2|NOT COMPLETED|Overall Study||17
368237|NCT01138735|882650|P1|NOT COMPLETED|Overall Study||8
368238|NCT01138735|882649|P2|COMPLETED|Overall Study||126
368239|NCT01138735|882650|P1|COMPLETED|Overall Study||134
368240|NCT01138735|882649|P2|STARTED|Overall Study||143
368241|NCT01138735|882650|P1|STARTED|Overall Study||142
368242|NCT01138657|882664|P2|NOT COMPLETED|Overall Study||18
368243|NCT01138657|882665|P1|NOT COMPLETED|Overall Study||8
368244|NCT01138657|882664|P2|COMPLETED|Overall Study||101
368245|NCT01138657|882665|P1|COMPLETED|Overall Study||112
368246|NCT01138657|882664|P2|Enrolled in Japan Sub-study|Overall Study||8
368247|NCT01138657|882665|P1|Enrolled in Japan Sub-study|Overall Study||8
368248|NCT01138657|882664|P2|Enrolled in Main Study|Overall Study||111
368249|NCT01138657|882665|P1|Enrolled in Main Study|Overall Study||112
368250|NCT01138657|882664|P2|STARTED|Overall Study||119
368251|NCT01138657|882665|P1|STARTED|Overall Study||120
368252|NCT01138514|882712|P3|NOT COMPLETED|Overall Study||93
368253|NCT01138514|882713|P2|NOT COMPLETED|Overall Study||53
368254|NCT01138514|882714|P1|NOT COMPLETED|Overall Study||48
368255|NCT01138514|882712|P3|COMPLETED|Overall Study||424
368256|NCT01138514|882713|P2|COMPLETED|Overall Study||463
368257|NCT01138514|882714|P1|COMPLETED|Overall Study||474
368258|NCT01138514|882712|P3|STARTED|Overall Study||517
368259|NCT01138514|882713|P2|STARTED|Overall Study||516
368260|NCT01138514|882714|P1|STARTED|Overall Study||522
368261|NCT01138501|882728|P1|NOT COMPLETED|Overall Study||5
368262|NCT01138501|882728|P1|COMPLETED|Overall Study||60
368263|NCT01138501|882728|P1|Exposed|Overall Study||63
368264|NCT01138501|882728|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
368265|NCT01138475|882736|P3|NOT COMPLETED|Overall Study||0
368266|NCT01138475|882737|P2|NOT COMPLETED|Overall Study||0
368267|NCT01138475|882738|P1|NOT COMPLETED|Overall Study||0
368268|NCT01138475|882736|P3|COMPLETED|Overall Study||17
368269|NCT01138475|882737|P2|COMPLETED|Overall Study||16
368270|NCT01138475|882738|P1|COMPLETED|Overall Study||16
368271|NCT01138475|882736|P3|STARTED|Overall Study||17
368272|NCT01138475|882737|P2|STARTED|Overall Study||16
368273|NCT01138475|882738|P1|STARTED|Overall Study||16
368274|NCT01138150|882772|P2|NOT COMPLETED|Overall Study||1
368275|NCT01138150|882773|P1|NOT COMPLETED|Overall Study||1
368276|NCT01138150|882772|P2|COMPLETED|Overall Study||17
368277|NCT01138150|882773|P1|COMPLETED|Overall Study||17
368278|NCT01138150|882772|P2|STARTED|Overall Study||18
368279|NCT01138150|882773|P1|STARTED|Overall Study||18
368280|NCT01138124|882829|P4|NOT COMPLETED|Overall Study||0
368281|NCT01138124|882830|P3|NOT COMPLETED|Overall Study||0
368282|NCT01138124|882831|P2|NOT COMPLETED|Overall Study||0
368283|NCT01138124|882832|P1|NOT COMPLETED|Overall Study||0
368284|NCT01138124|882829|P4|COMPLETED|Overall Study||19046
368285|NCT01138124|882830|P3|COMPLETED|Overall Study||1981
368286|NCT01138124|882831|P2|COMPLETED|Overall Study||30026
368287|NCT01138124|882832|P1|COMPLETED|Overall Study||3149
368288|NCT01138124|882829|P4|STARTED|Overall Study||19046
368289|NCT01138124|882830|P3|STARTED|Overall Study||1981
368290|NCT01138124|882831|P2|STARTED|Overall Study||30026
368291|NCT01138124|882832|P1|STARTED|Overall Study||3149
368292|NCT01138111|882854|P1|NOT COMPLETED|Overall Study||9
368293|NCT01138111|882854|P1|COMPLETED|Overall Study||36
368294|NCT01138111|882854|P1|STARTED|Overall Study||45
368295|NCT01138098|882885|P2|NOT COMPLETED|Overall Study||0
368296|NCT01138098|882886|P1|NOT COMPLETED|Overall Study||0
368297|NCT01138098|882885|P2|COMPLETED|Overall Study||90
368298|NCT01138098|882886|P1|COMPLETED|Overall Study||95
368299|NCT01138098|882885|P2|STARTED|Overall Study||90
368300|NCT01138098|882886|P1|STARTED|Overall Study||95
368301|NCT01138046|882908|P1|NOT COMPLETED|Overall Study||6
368302|NCT01138046|882908|P1|COMPLETED|Overall Study||6
368303|NCT01138046|882908|P1|STARTED|Overall Study||12
368304|NCT01138007|882928|P3|NOT COMPLETED|Overall Study||48
368305|NCT01138007|882929|P2|NOT COMPLETED|Overall Study||30
368306|NCT01138007|882930|P1|NOT COMPLETED|Overall Study||22
368307|NCT01138007|882928|P3|COMPLETED|Overall Study||144
368308|NCT01138007|882929|P2|COMPLETED|Overall Study||160
368309|NCT01138007|882930|P1|COMPLETED|Overall Study||165
368310|NCT01138007|882928|P3|STARTED|Overall Study||192
368311|NCT01138007|882929|P2|STARTED|Overall Study||190
368312|NCT01138007|882930|P1|STARTED|Overall Study||187
368313|NCT01137812|882964|P2|NOT COMPLETED|Overall Study||168
368314|NCT01137812|882965|P1|NOT COMPLETED|Overall Study||123
368315|NCT01137812|882964|P2|COMPLETED|Overall Study||210
368316|NCT01137812|882965|P1|COMPLETED|Overall Study||254
368317|NCT01137812|882964|P2|STARTED|Overall Study||378
368318|NCT01137812|882965|P1|STARTED|Overall Study||377
368319|NCT01137786|882985|P2|NOT COMPLETED|Overall Study||3
368320|NCT01137786|882986|P1|NOT COMPLETED|Overall Study||1
368321|NCT01137786|882985|P2|COMPLETED|Overall Study||21
368322|NCT01137786|882986|P1|COMPLETED|Overall Study||24
368323|NCT01137786|882985|P2|STARTED|Overall Study||24
368324|NCT01137786|882986|P1|STARTED|Overall Study||25
368325|NCT01137682|882997|P3|NOT COMPLETED|Overall Study||3
368326|NCT01137682|882998|P2|NOT COMPLETED|Overall Study||8
368327|NCT01137682|882999|P1|NOT COMPLETED|Overall Study||6
368328|NCT01137682|882997|P3|COMPLETED|Overall Study||65
368329|NCT01137682|882998|P2|COMPLETED|Overall Study||57
368330|NCT01137682|882999|P1|COMPLETED|Overall Study||59
368331|NCT01137682|882997|P3|Safety Set|Overall Study|2 patients never received drug.|66
368332|NCT01137682|882998|P2|Safety Set|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
368333|NCT01137682|882999|P1|Safety Set|Overall Study|2 patients never received drug.|63
368334|NCT01137682|882997|P3|Continuing Into Extension|Overall Study||62
368335|NCT01137682|882998|P2|Continuing Into Extension|Overall Study||53
368336|NCT01137682|882999|P1|Continuing Into Extension|Overall Study||56
368337|NCT01137682|882997|P3|Not Continuing Into Extension|Overall Study||3
368338|NCT01137682|882998|P2|Not Continuing Into Extension|Overall Study||4
368339|NCT01137682|882999|P1|Not Continuing Into Extension|Overall Study||3
368340|NCT01137682|882997|P3|Completed 24-Week Core Phase|Overall Study||65
368341|NCT01137682|882998|P2|Completed 24-Week Core Phase|Overall Study||57
368342|NCT01137682|882999|P1|Completed 24-Week Core Phase|Overall Study||59
368343|NCT01137682|882997|P3|Treated|Overall Study||67
368344|NCT01137682|882998|P2|Treated|Overall Study||64
368345|NCT01137682|882999|P1|Treated|Overall Study||63
368346|NCT01137682|882997|P3|Not Treated|Overall Study||1
368347|NCT01137682|882998|P2|Not Treated|Overall Study||1
368348|NCT01137682|882999|P1|Not Treated|Overall Study||2
368349|NCT01137682|882997|P3|STARTED|Overall Study||68
368350|NCT01137682|882998|P2|STARTED|Overall Study||65
368351|NCT01137682|882999|P1|STARTED|Overall Study||65
368352|NCT01137604|883014|P4|NOT COMPLETED|Overall Study||11
368353|NCT01137604|883015|P3|NOT COMPLETED|Overall Study||13
368354|NCT01137604|883016|P2|NOT COMPLETED|Overall Study||10
368355|NCT01137604|883017|P1|NOT COMPLETED|Overall Study||2
368356|NCT01137604|883014|P4|COMPLETED|Overall Study||21
368357|NCT01137604|883015|P3|COMPLETED|Overall Study||26
368358|NCT01137604|883016|P2|COMPLETED|Overall Study||32
368359|NCT01137604|883017|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
368360|NCT01137604|883014|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
368361|NCT01137604|883015|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
368362|NCT01137604|883016|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
368363|NCT01137604|883017|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
368364|NCT01137604|883014|P4|Disease Progression|Overall Study||21
368365|NCT01137604|883015|P3|Disease Progression|Overall Study||25
368366|NCT01137604|883016|P2|Disease Progression|Overall Study||29
368367|NCT01137604|883017|P1|Disease Progression|Overall Study||34
368368|NCT01137604|883014|P4|STARTED|Overall Study||32
368369|NCT01137604|883015|P3|STARTED|Overall Study||39
368370|NCT01137604|883016|P2|STARTED|Overall Study||42
368371|NCT01137604|883017|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
368372|NCT01137578|883051|P3|NOT COMPLETED|Overall Study||6
368373|NCT01137578|883052|P2|NOT COMPLETED|Overall Study||2
368374|NCT01137578|883053|P1|NOT COMPLETED|Overall Study||16
368375|NCT01137578|883051|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
368376|NCT01137578|883052|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
368377|NCT01137578|883053|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
368378|NCT01137578|883051|P3|STARTED|Overall Study||43
368379|NCT01137578|883052|P2|STARTED|Overall Study||14
368380|NCT01137578|883053|P1|STARTED|Overall Study||77
368381|NCT01137474|883097|P4|NOT COMPLETED|Overall Study||21
368382|NCT01137474|883098|P3|NOT COMPLETED|Overall Study||7
368383|NCT01137474|883099|P2|NOT COMPLETED|Overall Study||12
368384|NCT01137474|883100|P1|NOT COMPLETED|Overall Study||24
368385|NCT01137474|883097|P4|COMPLETED|Overall Study||281
368386|NCT01137474|883098|P3|COMPLETED|Overall Study||158
368387|NCT01137474|883099|P2|COMPLETED|Overall Study||154
368388|NCT01137474|883100|P1|COMPLETED|Overall Study||287
368389|NCT01137474|883097|P4|Received Treatment|Overall Study||302
368390|NCT01137474|883098|P3|Received Treatment|Overall Study||165
368391|NCT01137474|883099|P2|Received Treatment|Overall Study||166
368392|NCT01137474|883100|P1|Received Treatment|Overall Study||311
368393|NCT01137474|883097|P4|STARTED|Overall Study||302
368394|NCT01137474|883098|P3|STARTED|Overall Study||165
368395|NCT01137474|883099|P2|STARTED|Overall Study||166
368396|NCT01137474|883100|P1|STARTED|Overall Study||311
368397|NCT01137435|883118|P1|NOT COMPLETED|Overall Study||28
368398|NCT01137435|883118|P1|COMPLETED|Overall Study||659
368399|NCT01137435|883118|P1|STARTED|Overall Study||687
368400|NCT01137396|883127|P2|NOT COMPLETED|Overall Study||2
368401|NCT01137396|883128|P1|NOT COMPLETED|Overall Study||8
368402|NCT01137396|883127|P2|COMPLETED|Overall Study||25
368403|NCT01137396|883128|P1|COMPLETED|Overall Study||22
368404|NCT01137396|883127|P2|STARTED|Overall Study||27
368405|NCT01137396|883128|P1|STARTED|Overall Study||30
368406|NCT01137370|883138|P2|NOT COMPLETED|Overall Study||0
368407|NCT01137370|883139|P1|NOT COMPLETED|Overall Study||0
368408|NCT01137370|883138|P2|COMPLETED|Overall Study||87
368409|NCT01137370|883139|P1|COMPLETED|Overall Study||116
368410|NCT01137370|883138|P2|STARTED|Overall Study||87
368411|NCT01137370|883139|P1|STARTED|Overall Study||116
368412|NCT01137292|883145|P1|NOT COMPLETED|Overall Study||54
368413|NCT01137292|883145|P1|COMPLETED|Overall Study||123
368414|NCT01137292|883145|P1|STARTED|Overall Study||177
368415|NCT01137071|883152|P1|NOT COMPLETED|Overall Study||14
368416|NCT01137071|883152|P1|COMPLETED|Overall Study|Of the eligible patients|15
368417|NCT01137071|883152|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
368418|NCT01137032|883213|P1|NOT COMPLETED|Overall Study||0
368419|NCT01137032|883213|P1|COMPLETED|Overall Study||19
368420|NCT01137032|883213|P1|STARTED|Overall Study||19
368421|NCT01136967|883221|P2|NOT COMPLETED|Overall Study||27
368422|NCT01136967|883222|P1|NOT COMPLETED|Overall Study||24
368423|NCT01136967|883221|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
368424|NCT01136967|883222|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
368425|NCT01136967|883221|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
368426|NCT01136967|883222|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
368427|NCT01136967|883221|P2|Disease Progression|Overall Study||56
368428|NCT01136967|883222|P1|Disease Progression|Overall Study||55
368429|NCT01136967|883221|P2|STARTED|Overall Study||89
368430|NCT01136967|883222|P1|STARTED|Overall Study||93
368431|NCT01136954|883240|P2|NOT COMPLETED|Overall Study||21
368432|NCT01136954|883241|P1|NOT COMPLETED|Overall Study||24
368433|NCT01136954|883240|P2|COMPLETED|Overall Study||51
368434|NCT01136954|883241|P1|COMPLETED|Overall Study||48
368435|NCT01136954|883240|P2|STARTED|Overall Study||72
368436|NCT01136954|883241|P1|STARTED|Overall Study||72
368437|NCT01136915|883255|P2|NOT COMPLETED|Overall Study||1
368438|NCT01136915|883256|P1|NOT COMPLETED|Overall Study||2
368439|NCT01136915|883255|P2|COMPLETED|Overall Study||6
368440|NCT01136915|883256|P1|COMPLETED|Overall Study||6
368441|NCT01136915|883255|P2|STARTED|Overall Study||7
368442|NCT01136915|883256|P1|STARTED|Overall Study||8
368443|NCT01136876|883266|P2|NOT COMPLETED|Overall Study||6
368444|NCT01136876|883267|P1|NOT COMPLETED|Overall Study||3
368445|NCT01136876|883266|P2|COMPLETED|Overall Study||23
368446|NCT01136876|883267|P1|COMPLETED|Overall Study||25
368447|NCT01136876|883266|P2|STARTED|Overall Study||29
368448|NCT01136876|883267|P1|STARTED|Overall Study||28
368449|NCT01136785|883277|P2|NOT COMPLETED|Overall Study||1
368450|NCT01136785|883278|P1|NOT COMPLETED|Overall Study||2
368451|NCT01136785|883277|P2|COMPLETED|Overall Study||6
368452|NCT01136785|883278|P1|COMPLETED|Overall Study||13
368453|NCT01136785|883277|P2|STARTED|Overall Study||7
368454|NCT01136785|883278|P1|STARTED|Overall Study||15
368455|NCT01136772|883293|P2|NOT COMPLETED|Overall Study||110
368456|NCT01136772|883294|P1|NOT COMPLETED|Overall Study||116
368457|NCT01136772|883293|P2|COMPLETED|Overall Study||44
368458|NCT01136772|883294|P1|COMPLETED|Overall Study||41
368459|NCT01136772|883293|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
368547|NCT01136291|883496|P2|STARTED|Overall Study||42
368460|NCT01136772|883294|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
368461|NCT01136772|883293|P2|STARTED|Overall Study||154
368462|NCT01136772|883294|P1|STARTED|Overall Study||157
368463|NCT01136746|883304|P2|NOT COMPLETED|Overall Study||3
368464|NCT01136746|883305|P1|NOT COMPLETED|Overall Study||3
368465|NCT01136746|883304|P2|COMPLETED|Overall Study||4
368466|NCT01136746|883305|P1|COMPLETED|Overall Study||6
368467|NCT01136746|883304|P2|STARTED|Overall Study||7
368468|NCT01136746|883305|P1|STARTED|Overall Study||9
368469|NCT01136655|883365|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
368470|NCT01136655|883365|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
368471|NCT01136655|883365|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
368472|NCT01136655|883365|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
368473|NCT01136655|883365|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
368474|NCT01136655|883365|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
368475|NCT01136655|883365|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
368476|NCT01136655|883365|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
368477|NCT01136655|883365|P1|STARTED|Washout After BUD 160 (7 Days)||51
368478|NCT01136655|883365|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
368479|NCT01136655|883365|P1|COMPLETED|BUD 160 (1 Dose)||51
368480|NCT01136655|883365|P1|STARTED|BUD 160 (1 Dose)||51
368481|NCT01136655|883365|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
368482|NCT01136655|883365|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
368483|NCT01136655|883365|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
368484|NCT01136655|883365|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
368485|NCT01136655|883365|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
368486|NCT01136655|883365|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
368487|NCT01136655|883365|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
368488|NCT01136655|883365|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
368489|NCT01136655|883365|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
368490|NCT01136655|883365|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
368491|NCT01136655|883365|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
368492|NCT01136655|883365|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
368493|NCT01136655|883365|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
368494|NCT01136655|883365|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
368495|NCT01136655|883365|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
368496|NCT01136655|883365|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
368497|NCT01136655|883365|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
368498|NCT01136655|883365|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
368499|NCT01136486|883391|P1|NOT COMPLETED|Overall Study||0
368500|NCT01136486|883391|P1|COMPLETED|Overall Study||56
368501|NCT01136486|883391|P1|STARTED|Overall Study||56
368502|NCT01136408|883398|P3|NOT COMPLETED|Overall Study||5
368503|NCT01136408|883399|P2|NOT COMPLETED|Overall Study||9
368504|NCT01136408|883400|P1|NOT COMPLETED|Overall Study||5
368505|NCT01136408|883398|P3|COMPLETED|Overall Study||57
368506|NCT01136408|883399|P2|COMPLETED|Overall Study||49
368507|NCT01136408|883400|P1|COMPLETED|Overall Study||41
368508|NCT01136408|883398|P3|STARTED|Overall Study||62
368509|NCT01136408|883399|P2|STARTED|Overall Study||58
368510|NCT01136408|883400|P1|STARTED|Overall Study||46
368511|NCT01136382|883457|P2|NOT COMPLETED|Overall Study||31
368512|NCT01136382|883458|P1|NOT COMPLETED|Overall Study||60
368513|NCT01136382|883457|P2|COMPLETED|Overall Study||121
368514|NCT01136382|883458|P1|COMPLETED|Overall Study||92
368515|NCT01136382|883457|P2|STARTED|Overall Study||152
368516|NCT01136382|883458|P1|STARTED|Overall Study||152
368517|NCT01136356|883484|P2|NOT COMPLETED|Second 18-day Withdrawal||1
368518|NCT01136356|883485|P1|NOT COMPLETED|Second 18-day Withdrawal||0
368519|NCT01136356|883484|P2|COMPLETED|Second 18-day Withdrawal||5
368520|NCT01136356|883485|P1|COMPLETED|Second 18-day Withdrawal||2
368521|NCT01136356|883484|P2|STARTED|Second 18-day Withdrawal||6
368522|NCT01136356|883485|P1|STARTED|Second 18-day Withdrawal||2
368523|NCT01136356|883484|P2|NOT COMPLETED|Second Intervention||0
368524|NCT01136356|883485|P1|NOT COMPLETED|Second Intervention||0
368525|NCT01136356|883484|P2|COMPLETED|Second Intervention||6
368526|NCT01136356|883485|P1|COMPLETED|Second Intervention||2
368527|NCT01136356|883484|P2|STARTED|Second Intervention||6
368528|NCT01136356|883485|P1|STARTED|Second Intervention||2
368529|NCT01136356|883484|P2|NOT COMPLETED|First 18-day Withdrawal||0
368530|NCT01136356|883485|P1|NOT COMPLETED|First 18-day Withdrawal||4
368531|NCT01136356|883484|P2|COMPLETED|First 18-day Withdrawal||6
368532|NCT01136356|883485|P1|COMPLETED|First 18-day Withdrawal||2
368533|NCT01136356|883484|P2|STARTED|First 18-day Withdrawal||6
368534|NCT01136356|883485|P1|STARTED|First 18-day Withdrawal||6
368535|NCT01136356|883484|P2|NOT COMPLETED|First Intervention||0
368536|NCT01136356|883485|P1|NOT COMPLETED|First Intervention||0
368537|NCT01136356|883484|P2|COMPLETED|First Intervention||6
368538|NCT01136356|883485|P1|COMPLETED|First Intervention||6
368539|NCT01136356|883484|P2|STARTED|First Intervention||6
368540|NCT01136356|883485|P1|STARTED|First Intervention||6
368541|NCT01136291|883496|P2|NOT COMPLETED|Overall Study||1
368542|NCT01136291|883497|P1|NOT COMPLETED|Overall Study||1
368543|NCT01136291|883496|P2|COMPLETED|Overall Study||41
368544|NCT01136291|883497|P1|COMPLETED|Overall Study||39
368545|NCT01136291|883496|P2|Follow|Overall Study||42
368546|NCT01136291|883497|P1|Follow|Overall Study||40
368548|NCT01136291|883497|P1|STARTED|Overall Study||40
368549|NCT01136226|883507|P1|NOT COMPLETED|Overall Study||13
368550|NCT01136226|883507|P1|COMPLETED|Overall Study||29
368551|NCT01136226|883507|P1|STARTED|Overall Study||42
368552|NCT01136174|883515|P4|NOT COMPLETED|Overall Study||4
368553|NCT01136174|883516|P3|NOT COMPLETED|Overall Study||0
368554|NCT01136174|883517|P2|NOT COMPLETED|Overall Study||0
368555|NCT01136174|883518|P1|NOT COMPLETED|Overall Study||0
368556|NCT01136174|883515|P4|COMPLETED|Overall Study||20
368557|NCT01136174|883516|P3|COMPLETED|Overall Study||8
368558|NCT01136174|883517|P2|COMPLETED|Overall Study||6
368559|NCT01136174|883518|P1|COMPLETED|Overall Study||12
368560|NCT01136174|883515|P4|STARTED|Overall Study||24
368561|NCT01136174|883516|P3|STARTED|Overall Study||8
368562|NCT01136174|883517|P2|STARTED|Overall Study||6
368563|NCT01136174|883518|P1|STARTED|Overall Study||12
368564|NCT01135992|883598|P1|NOT COMPLETED|Overall Study||21
368565|NCT01135992|883598|P1|COMPLETED|Overall Study||122
368566|NCT01135992|883598|P1|Full Analysis Set|Overall Study||129
368567|NCT01135992|883598|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
368568|NCT01135992|883598|P1|STARTED|Overall Study||143
368569|NCT01135914|883610|P3|NOT COMPLETED|Overall Study||22
368570|NCT01135914|883611|P2|NOT COMPLETED|Overall Study||5
368571|NCT01135914|883612|P1|NOT COMPLETED|Overall Study||4
368572|NCT01135914|883610|P3|COMPLETED|Overall Study||59
368573|NCT01135914|883611|P2|COMPLETED|Overall Study||75
368574|NCT01135914|883612|P1|COMPLETED|Overall Study||74
368575|NCT01135914|883610|P3|Safety Population|Overall Study||74
368576|NCT01135914|883611|P2|Safety Population|Overall Study||75
368577|NCT01135914|883612|P1|Safety Population|Overall Study||73
368578|NCT01135914|883610|P3|Intent to Treat (ITT) Population|Overall Study||72
368579|NCT01135914|883611|P2|Intent to Treat (ITT) Population|Overall Study||75
368580|NCT01135914|883612|P1|Intent to Treat (ITT) Population|Overall Study||73
368581|NCT01135914|883610|P3|STARTED|Overall Study||81
368582|NCT01135914|883611|P2|STARTED|Overall Study||80
368583|NCT01135914|883612|P1|STARTED|Overall Study||78
368584|NCT01135524|883641|P1|NOT COMPLETED|Overall Study||196
368585|NCT01135524|883641|P1|COMPLETED|Overall Study||0
368586|NCT01135524|883641|P1|STARTED|Overall Study||196
368587|NCT01135511|883654|P9|NOT COMPLETED|Overall Study||1
368588|NCT01135511|883655|P8|NOT COMPLETED|Overall Study||1
368589|NCT01135511|883656|P7|NOT COMPLETED|Overall Study||1
368590|NCT01135511|883657|P6|NOT COMPLETED|Overall Study||1
368591|NCT01135511|883658|P5|NOT COMPLETED|Overall Study||1
368592|NCT01135511|883659|P4|NOT COMPLETED|Overall Study||3
368593|NCT01135511|883660|P3|NOT COMPLETED|Overall Study||8
368594|NCT01135511|883661|P2|NOT COMPLETED|Overall Study||3
368595|NCT01135511|883662|P1|NOT COMPLETED|Overall Study||0
368596|NCT01135511|883654|P9|COMPLETED|Overall Study||20
368597|NCT01135511|883655|P8|COMPLETED|Overall Study||20
368598|NCT01135511|883656|P7|COMPLETED|Overall Study||18
368599|NCT01135511|883657|P6|COMPLETED|Overall Study||20
368600|NCT01135511|883658|P5|COMPLETED|Overall Study||38
368601|NCT01135511|883659|P4|COMPLETED|Overall Study||37
368602|NCT01135511|883660|P3|COMPLETED|Overall Study||33
368603|NCT01135511|883661|P2|COMPLETED|Overall Study||39
368604|NCT01135511|883662|P1|COMPLETED|Overall Study||41
368605|NCT01135511|883654|P9|STARTED|Overall Study||21
368606|NCT01135511|883655|P8|STARTED|Overall Study||21
368607|NCT01135511|883656|P7|STARTED|Overall Study||19
368608|NCT01135511|883657|P6|STARTED|Overall Study||21
368609|NCT01135511|883658|P5|STARTED|Overall Study||39
368610|NCT01135511|883659|P4|STARTED|Overall Study||40
368611|NCT01135511|883660|P3|STARTED|Overall Study||41
368612|NCT01135511|883661|P2|STARTED|Overall Study||42
368613|NCT01135511|883662|P1|STARTED|Overall Study||41
368614|NCT01135498|883944|P1|NOT COMPLETED|Overall Study||90
368615|NCT01135498|883944|P1|COMPLETED|Overall Study||0
368616|NCT01135498|883944|P1|STARTED|Overall Study||90
368617|NCT01135420|883955|P2|NOT COMPLETED|Overall Study||32
368618|NCT01135420|883956|P1|NOT COMPLETED|Overall Study||44
368619|NCT01135420|883955|P2|COMPLETED|Overall Study||175
368620|NCT01135420|883956|P1|COMPLETED|Overall Study||155
368621|NCT01135420|883955|P2|STARTED|Overall Study||207
368622|NCT01135420|883956|P1|STARTED|Overall Study||199
368623|NCT01135381|883966|P4|NOT COMPLETED|Overall Study||1
368624|NCT01135381|883967|P3|NOT COMPLETED|Overall Study||4
368625|NCT01135381|883968|P2|NOT COMPLETED|Overall Study||7
368626|NCT01135381|883969|P1|NOT COMPLETED|Overall Study||21
368627|NCT01135381|883966|P4|COMPLETED|Overall Study||67
368628|NCT01135381|883967|P3|COMPLETED|Overall Study||65
368629|NCT01135381|883968|P2|COMPLETED|Overall Study||178
368630|NCT01135381|883969|P1|COMPLETED|Overall Study||168
368631|NCT01135381|883966|P4|STARTED|Overall Study||68
368632|NCT01135381|883967|P3|STARTED|Overall Study||69
368633|NCT01135381|883968|P2|STARTED|Overall Study||185
368634|NCT01135381|883969|P1|STARTED|Overall Study||189
368635|NCT01135368|883987|P1|NOT COMPLETED|Overall Study||251
368636|NCT01135368|883987|P1|COMPLETED|Overall Study||255
368637|NCT01135368|883987|P1|STARTED|Overall Study||506
368638|NCT01135186|884103|P1|NOT COMPLETED|Overall Study||0
368639|NCT01135186|884103|P1|COMPLETED|Overall Study||9
368640|NCT01135186|884103|P1|STARTED|Overall Study||9
368641|NCT01135134|884112|P2|NOT COMPLETED|Overall Study||1
368642|NCT01135134|884113|P1|NOT COMPLETED|Overall Study||2
368643|NCT01135134|884112|P2|COMPLETED|Overall Study||112
368644|NCT01135134|884113|P1|COMPLETED|Overall Study||218
368645|NCT01135134|884112|P2|STARTED|Overall Study||113
368646|NCT01135134|884113|P1|STARTED|Overall Study||220
368647|NCT01135069|884124|P3|NOT COMPLETED|Overall Study||10
368648|NCT01135069|884125|P2|NOT COMPLETED|Overall Study||32
368649|NCT01135069|884126|P1|NOT COMPLETED|Overall Study||36
368650|NCT01135069|884124|P3|COMPLETED|Overall Study||56
368651|NCT01135069|884125|P2|COMPLETED|Overall Study||177
368652|NCT01135069|884126|P1|COMPLETED|Overall Study||169
368653|NCT01135069|884124|P3|STARTED|Overall Study||66
368654|NCT01135069|884125|P2|STARTED|Overall Study||209
368655|NCT01135069|884126|P1|STARTED|Overall Study||205
368656|NCT01135017|884136|P2|NOT COMPLETED|Overall Study||12
368657|NCT01135017|884137|P1|NOT COMPLETED|Overall Study||6
368658|NCT01135017|884136|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
368659|NCT01135017|884137|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
368660|NCT01135017|884136|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
368661|NCT01135017|884137|P1|Evaluable for Efficacy|Overall Study||55
368662|NCT01135017|884136|P2|Treated|Overall Study||57
368663|NCT01135017|884137|P1|Treated|Overall Study||55
368664|NCT01135017|884136|P2|STARTED|Overall Study||57
368665|NCT01135017|884137|P1|STARTED|Overall Study||55
368666|NCT01134952|884153|P1|NOT COMPLETED|Overall Study||0
368667|NCT01134952|884153|P1|COMPLETED|Overall Study||11
368668|NCT01134952|884153|P1|STARTED|Overall Study||11
368669|NCT01134939|884175|P8|NOT COMPLETED|Overall Study||0
368670|NCT01134939|884176|P7|NOT COMPLETED|Overall Study||9
368671|NCT01134939|884177|P6|NOT COMPLETED|Overall Study||9
368672|NCT01134939|884178|P5|NOT COMPLETED|Overall Study||10
368673|NCT01134939|884179|P4|NOT COMPLETED|Overall Study||14
368674|NCT01134939|884180|P3|NOT COMPLETED|Overall Study||10
368675|NCT01134939|884181|P2|NOT COMPLETED|Overall Study||18
368676|NCT01134939|884182|P1|NOT COMPLETED|Overall Study||17
368677|NCT01134939|884175|P8|COMPLETED|Overall Study||1
368678|NCT01134939|884176|P7|COMPLETED|Overall Study||10
368679|NCT01134939|884177|P6|COMPLETED|Overall Study||5
368680|NCT01134939|884178|P5|COMPLETED|Overall Study||23
368681|NCT01134939|884179|P4|COMPLETED|Overall Study||32
368682|NCT01134939|884180|P3|COMPLETED|Overall Study||41
368683|NCT01134939|884181|P2|COMPLETED|Overall Study||24
368684|NCT01134939|884182|P1|COMPLETED|Overall Study||42
368685|NCT01134939|884175|P8|STARTED|Overall Study||1
368686|NCT01134939|884176|P7|STARTED|Overall Study||19
368687|NCT01134939|884177|P6|STARTED|Overall Study||14
368688|NCT01134939|884178|P5|STARTED|Overall Study||33
368689|NCT01134939|884179|P4|STARTED|Overall Study||46
368690|NCT01134939|884180|P3|STARTED|Overall Study||51
368691|NCT01134939|884181|P2|STARTED|Overall Study||42
368692|NCT01134939|884182|P1|STARTED|Overall Study||59
368693|NCT01134900|884294|P2|NOT COMPLETED|Overall Study||0
368694|NCT01134900|884295|P1|NOT COMPLETED|Overall Study||0
368695|NCT01134900|884294|P2|COMPLETED|Overall Study||196
368696|NCT01134900|884295|P1|COMPLETED|Overall Study||200
368697|NCT01134900|884294|P2|STARTED|Overall Study||196
368698|NCT01134900|884295|P1|STARTED|Overall Study||200
368699|NCT01134887|884307|P4|NOT COMPLETED|Overall Study||0
368700|NCT01134887|884308|P3|NOT COMPLETED|Overall Study||0
368701|NCT01134887|884309|P2|NOT COMPLETED|Overall Study||4
368702|NCT01134887|884310|P1|NOT COMPLETED|Overall Study||0
368703|NCT01134887|884307|P4|COMPLETED|Overall Study||5
368704|NCT01134887|884308|P3|COMPLETED|Overall Study||5
368705|NCT01134887|884309|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
368706|NCT01134887|884310|P1|COMPLETED|Overall Study||9
368707|NCT01134887|884307|P4|STARTED|Overall Study||5
368708|NCT01134887|884308|P3|STARTED|Overall Study||5
368709|NCT01134887|884309|P2|STARTED|Overall Study||11
368710|NCT01134887|884310|P1|STARTED|Overall Study||9
368711|NCT01134783|884320|P2|NOT COMPLETED|Overall Study||37
368712|NCT01134783|884321|P1|NOT COMPLETED|Overall Study||36
368713|NCT01134783|884320|P2|COMPLETED|Overall Study||180
368714|NCT01134783|884321|P1|COMPLETED|Overall Study||188
368715|NCT01134783|884320|P2|STARTED|Overall Study||217
368716|NCT01134783|884321|P1|STARTED|Overall Study||224
368717|NCT01134731|884340|P3|NOT COMPLETED|Overall Study||8
368718|NCT01134731|884341|P2|NOT COMPLETED|Overall Study||11
368719|NCT01134731|884342|P1|NOT COMPLETED|Overall Study||13
368720|NCT01134731|884340|P3|COMPLETED|Overall Study||2
368721|NCT01134731|884341|P2|COMPLETED|Overall Study||10
368722|NCT01134731|884342|P1|COMPLETED|Overall Study||10
368723|NCT01134731|884340|P3|STARTED|Overall Study||10
368724|NCT01134731|884341|P2|STARTED|Overall Study||21
368725|NCT01134731|884342|P1|STARTED|Overall Study||23
368726|NCT01134705|884355|P2|NOT COMPLETED|Overall Study||22
368727|NCT01134705|884356|P1|NOT COMPLETED|Overall Study||15
368728|NCT01134705|884355|P2|COMPLETED|Overall Study||216
368729|NCT01134705|884356|P1|COMPLETED|Overall Study||221
368730|NCT01134705|884355|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
368731|NCT01134705|884356|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
368732|NCT01134705|884355|P2|STARTED|Overall Study||238
368733|NCT01134705|884356|P1|STARTED|Overall Study||236
368734|NCT01134627|884368|P2|NOT COMPLETED|Overall Study||67
368735|NCT01134627|884369|P1|NOT COMPLETED|Overall Study||69
368736|NCT01134627|884368|P2|COMPLETED|Overall Study||88
368737|NCT01134627|884369|P1|COMPLETED|Overall Study||80
368738|NCT01134627|884368|P2|STARTED|Overall Study|Number of participants treated.|155
368739|NCT01134627|884369|P1|STARTED|Overall Study|Number of participants treated.|149
368750|NCT01134549|884415|P5|NOT COMPLETED|Overall Study||0
368751|NCT01134549|884416|P4|NOT COMPLETED|Overall Study||0
368752|NCT01134549|884417|P3|NOT COMPLETED|Overall Study||0
368753|NCT01134549|884418|P2|NOT COMPLETED|Overall Study||0
368754|NCT01134549|884419|P1|NOT COMPLETED|Overall Study||0
368755|NCT01134549|884415|P5|COMPLETED|Overall Study||6
368756|NCT01134549|884416|P4|COMPLETED|Overall Study||6
368757|NCT01134549|884417|P3|COMPLETED|Overall Study||6
368758|NCT01134549|884418|P2|COMPLETED|Overall Study||6
368759|NCT01134549|884419|P1|COMPLETED|Overall Study||8
368760|NCT01134549|884415|P5|STARTED|Overall Study||6
368761|NCT01134549|884416|P4|STARTED|Overall Study||6
368762|NCT01134549|884417|P3|STARTED|Overall Study||6
368763|NCT01134549|884418|P2|STARTED|Overall Study||6
368764|NCT01134549|884419|P1|STARTED|Overall Study||8
368765|NCT01134510|884505|P2|NOT COMPLETED|Overall Study||1
368766|NCT01134510|884506|P1|NOT COMPLETED|Overall Study||0
368767|NCT01134510|884505|P2|COMPLETED|Overall Study||9
368768|NCT01134510|884506|P1|COMPLETED|Overall Study||10
368769|NCT01134510|884505|P2|Month 3|Overall Study||9
368770|NCT01134510|884506|P1|Month 3|Overall Study||10
368771|NCT01134510|884505|P2|Month 1|Overall Study||10
368772|NCT01134510|884506|P1|Month 1|Overall Study||10
368773|NCT01134510|884505|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
368774|NCT01134510|884506|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
368775|NCT01134510|884505|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
368776|NCT01134510|884506|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
368777|NCT01134510|884505|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
368778|NCT01134510|884506|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
368779|NCT01134510|884505|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
368780|NCT01134510|884506|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
368781|NCT01134510|884505|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
368782|NCT01134510|884506|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
368783|NCT01134510|884505|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
368784|NCT01134510|884506|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
368785|NCT01134510|884505|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
368786|NCT01134510|884506|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
368787|NCT01134510|884505|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
368788|NCT01134510|884506|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
368789|NCT01134393|884518|P1|NOT COMPLETED|Overall Study||52
368790|NCT01134393|884518|P1|COMPLETED|Overall Study|Completed trial medication.|449
368791|NCT01134393|884518|P1|STARTED|Overall Study|Entered and treated.|501
368792|NCT01134315|884534|P2|NOT COMPLETED|Overall Study||19
368793|NCT01134315|884535|P1|NOT COMPLETED|Overall Study||9
368794|NCT01134315|884534|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
368795|NCT01134315|884535|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
368796|NCT01134315|884534|P2|STARTED|Overall Study||40
368797|NCT01134315|884535|P1|STARTED|Overall Study||21
368798|NCT01134276|884557|P2|NOT COMPLETED|Overall Study||0
368799|NCT01134276|884558|P1|NOT COMPLETED|Overall Study||0
368800|NCT01134276|884557|P2|COMPLETED|Overall Study||107
368801|NCT01134276|884558|P1|COMPLETED|Overall Study||104
368802|NCT01134276|884557|P2|STARTED|Overall Study||107
368803|NCT01134276|884558|P1|STARTED|Overall Study||104
368804|NCT01134107|884570|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
368805|NCT01134107|884571|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
368806|NCT01134107|884570|P2|COMPLETED|Period 2-Second Treatment Intervention||61
368807|NCT01134107|884571|P1|COMPLETED|Period 2-Second Treatment Intervention||57
368808|NCT01134107|884570|P2|STARTED|Period 2-Second Treatment Intervention||61
368809|NCT01134107|884571|P1|STARTED|Period 2-Second Treatment Intervention||61
368810|NCT01134107|884570|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
368811|NCT01134107|884571|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
368812|NCT01134107|884570|P2|COMPLETED|Period 1-First Treatment Intervention||61
368813|NCT01134107|884571|P1|COMPLETED|Period 1-First Treatment Intervention||61
368814|NCT01134107|884570|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
368815|NCT01134107|884571|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
368816|NCT01134107|884570|P2|STARTED|Period 1-First Treatment Intervention||66
368817|NCT01134107|884571|P1|STARTED|Period 1-First Treatment Intervention||67
368818|NCT01134042|884606|P3|NOT COMPLETED|Overall Study||34
368819|NCT01134042|884607|P2|NOT COMPLETED|Overall Study||28
368820|NCT01134042|884608|P1|NOT COMPLETED|Overall Study||48
368821|NCT01134042|884606|P3|COMPLETED|Overall Study||161
368822|NCT01134042|884607|P2|COMPLETED|Overall Study||169
368823|NCT01134042|884608|P1|COMPLETED|Overall Study||146
368824|NCT01134042|884606|P3|STARTED|Overall Study||195
368825|NCT01134042|884607|P2|STARTED|Overall Study||197
368826|NCT01134042|884608|P1|STARTED|Overall Study||194
368827|NCT01134016|884646|P1|NOT COMPLETED|Overall Study||3
368828|NCT01134016|884646|P1|COMPLETED|Overall Study||10
368829|NCT01134016|884646|P1|STARTED|Overall Study||13
368830|NCT01133977|884684|P5|NOT COMPLETED|Overall Study||38
368831|NCT01133977|884685|P4|NOT COMPLETED|Overall Study||39
368832|NCT01133977|884686|P3|NOT COMPLETED|Overall Study||6
368833|NCT01133977|884687|P2|NOT COMPLETED|Overall Study||7
368834|NCT01133977|884688|P1|NOT COMPLETED|Overall Study||3
368835|NCT01133977|884684|P5|COMPLETED|Overall Study||1
368836|NCT01133977|884685|P4|COMPLETED|Overall Study||3
368837|NCT01133977|884686|P3|COMPLETED|Overall Study||0
368838|NCT01133977|884687|P2|COMPLETED|Overall Study||0
368839|NCT01133977|884688|P1|COMPLETED|Overall Study||0
368840|NCT01133977|884684|P5|STARTED|Overall Study|Treated|39
368841|NCT01133977|884685|P4|STARTED|Overall Study|Treated|42
368842|NCT01133977|884686|P3|STARTED|Overall Study|Treated|6
368843|NCT01133977|884687|P2|STARTED|Overall Study|Treated|7
368844|NCT01133977|884688|P1|STARTED|Overall Study|Treated|3
368845|NCT01133860|884705|P1|NOT COMPLETED|Overall Study||0
368846|NCT01133860|884705|P1|COMPLETED|Overall Study||12
368847|NCT01133860|884705|P1|STARTED|Overall Study||12
368848|NCT01133847|884715|P3|NOT COMPLETED|Follow-Up Phase||7
368849|NCT01133847|884716|P2|NOT COMPLETED|Follow-Up Phase||3
368850|NCT01133847|884717|P1|NOT COMPLETED|Follow-Up Phase||1
368851|NCT01133847|884715|P3|COMPLETED|Follow-Up Phase||60
368852|NCT01133847|884716|P2|COMPLETED|Follow-Up Phase||70
368853|NCT01133847|884717|P1|COMPLETED|Follow-Up Phase||72
368854|NCT01133847|884715|P3|STARTED|Follow-Up Phase||67
368855|NCT01133847|884716|P2|STARTED|Follow-Up Phase||73
368856|NCT01133847|884717|P1|STARTED|Follow-Up Phase||73
368857|NCT01133847|884715|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
368858|NCT01133847|884716|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
368859|NCT01133847|884717|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
368860|NCT01133847|884715|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
368861|NCT01133847|884716|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
368862|NCT01133847|884717|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
368863|NCT01133847|884715|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
368864|NCT01133847|884716|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
368865|NCT01133847|884717|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
368866|NCT01133756|884758|P3|NOT COMPLETED|Overall Study||2
368867|NCT01133756|884759|P2|NOT COMPLETED|Overall Study||3
368868|NCT01133756|884760|P1|NOT COMPLETED|Overall Study||2
368869|NCT01133756|884758|P3|COMPLETED|Overall Study||0
368870|NCT01133756|884759|P2|COMPLETED|Overall Study||0
368871|NCT01133756|884760|P1|COMPLETED|Overall Study||0
368872|NCT01133756|884758|P3|Completed 6 Cycles|Overall Study||0
368873|NCT01133756|884759|P2|Completed 6 Cycles|Overall Study||0
368874|NCT01133756|884760|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
368875|NCT01133756|884758|P3|STARTED|Overall Study||2
368876|NCT01133756|884759|P2|STARTED|Overall Study||3
368877|NCT01133756|884760|P1|STARTED|Overall Study||2
368878|NCT01133704|884776|P2|NOT COMPLETED|Overall Study||26
368879|NCT01133704|884777|P1|NOT COMPLETED|Overall Study||49
368880|NCT01133704|884776|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
368881|NCT01133704|884777|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
368882|NCT01133704|884776|P2|STARTED|Overall Study||33
368883|NCT01133704|884777|P1|STARTED|Overall Study||65
368884|NCT01133665|884785|P1|NOT COMPLETED|Overall Study||2
368885|NCT01133665|884785|P1|COMPLETED|Overall Study||40
368886|NCT01133665|884785|P1|STARTED|Overall Study||42
368887|NCT01133626|884829|P3|NOT COMPLETED|Overall Study||2
368888|NCT01133626|884830|P2|NOT COMPLETED|Overall Study||5
368889|NCT01133626|884831|P1|NOT COMPLETED|Overall Study||1
368890|NCT01133626|884829|P3|COMPLETED|Overall Study||9
368891|NCT01133626|884830|P2|COMPLETED|Overall Study||41
368892|NCT01133626|884831|P1|COMPLETED|Overall Study||49
368893|NCT01133626|884829|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
368894|NCT01133626|884830|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
368895|NCT01133626|884831|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
368896|NCT01133626|884829|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
368897|NCT01133626|884830|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
368898|NCT01133626|884831|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
368899|NCT01133626|884829|P3|STARTED|Overall Study||11
368900|NCT01133626|884830|P2|STARTED|Overall Study||46
368901|NCT01133626|884831|P1|STARTED|Overall Study||50
368902|NCT01133522|884849|P10|NOT COMPLETED|Overall Study||0
368903|NCT01133522|884850|P9|NOT COMPLETED|Overall Study||0
368904|NCT01133522|884851|P8|NOT COMPLETED|Overall Study||0
368905|NCT01133522|884852|P7|NOT COMPLETED|Overall Study||0
368906|NCT01133522|884853|P6|NOT COMPLETED|Overall Study||0
368907|NCT01133522|884854|P5|NOT COMPLETED|Overall Study||1
368908|NCT01133522|884855|P4|NOT COMPLETED|Overall Study||1
368909|NCT01133522|884856|P3|NOT COMPLETED|Overall Study||0
368910|NCT01133522|884857|P2|NOT COMPLETED|Overall Study||1
368911|NCT01133522|884858|P1|NOT COMPLETED|Overall Study||0
368912|NCT01133522|884849|P10|COMPLETED|Overall Study||4
368913|NCT01133522|884850|P9|COMPLETED|Overall Study||2
368914|NCT01133522|884851|P8|COMPLETED|Overall Study||9
368915|NCT01133522|884852|P7|COMPLETED|Overall Study||2
368916|NCT01133522|884853|P6|COMPLETED|Overall Study||6
368917|NCT01133522|884854|P5|COMPLETED|Overall Study||6
368918|NCT01133522|884855|P4|COMPLETED|Overall Study||6
368919|NCT01133522|884856|P3|COMPLETED|Overall Study||6
368920|NCT01133522|884857|P2|COMPLETED|Overall Study||6
368921|NCT01133522|884858|P1|COMPLETED|Overall Study||10
368922|NCT01133522|884849|P10|Received Treatment|Overall Study||4
368923|NCT01133522|884850|P9|Received Treatment|Overall Study||2
368924|NCT01133522|884851|P8|Received Treatment|Overall Study||9
368925|NCT01133522|884852|P7|Received Treatment|Overall Study||2
368926|NCT01133522|884853|P6|Received Treatment|Overall Study||6
368927|NCT01133522|884854|P5|Received Treatment|Overall Study||6
368928|NCT01133522|884855|P4|Received Treatment|Overall Study||6
368929|NCT01133522|884856|P3|Received Treatment|Overall Study||6
368930|NCT01133522|884857|P2|Received Treatment|Overall Study||6
368931|NCT01133522|884858|P1|Received Treatment|Overall Study||10
368932|NCT01133522|884849|P10|STARTED|Overall Study||4
368933|NCT01133522|884850|P9|STARTED|Overall Study||2
368934|NCT01133522|884851|P8|STARTED|Overall Study||9
368935|NCT01133522|884852|P7|STARTED|Overall Study||2
368936|NCT01133522|884853|P6|STARTED|Overall Study||6
368937|NCT01133522|884854|P5|STARTED|Overall Study||7
368938|NCT01133522|884855|P4|STARTED|Overall Study||7
368939|NCT01133522|884856|P3|STARTED|Overall Study||6
368940|NCT01133522|884857|P2|STARTED|Overall Study||7
368941|NCT01133522|884858|P1|STARTED|Overall Study||10
368942|NCT01133418|884926|P2|NOT COMPLETED|Overall Study||6
368943|NCT01133418|884927|P1|NOT COMPLETED|Overall Study||5
368944|NCT01133418|884926|P2|COMPLETED|Overall Study||32
368945|NCT01133418|884927|P1|COMPLETED|Overall Study||29
368946|NCT01133418|884926|P2|STARTED|Overall Study||38
368947|NCT01133418|884927|P1|STARTED|Overall Study||34
368948|NCT01133392|884941|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
368949|NCT01133392|884942|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
368950|NCT01133392|884941|P2|COMPLETED|Fourth Intervention (1 Day)||16
368951|NCT01133392|884942|P1|COMPLETED|Fourth Intervention (1 Day)||20
368952|NCT01133392|884941|P2|STARTED|Fourth Intervention (1 Day)||16
368953|NCT01133392|884942|P1|STARTED|Fourth Intervention (1 Day)||20
368954|NCT01133392|884941|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
368955|NCT01133392|884942|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
368956|NCT01133392|884941|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
368957|NCT01133392|884942|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
368958|NCT01133392|884941|P2|STARTED|Interval Between Dosing (4-7 Days)||17
368959|NCT01133392|884942|P1|STARTED|Interval Between Dosing (4-7 Days)||20
368960|NCT01133392|884941|P2|NOT COMPLETED|Third Intervention (1 Day)||0
368961|NCT01133392|884942|P1|NOT COMPLETED|Third Intervention (1 Day)||0
368962|NCT01133392|884941|P2|COMPLETED|Third Intervention (1 Day)||17
368963|NCT01133392|884942|P1|COMPLETED|Third Intervention (1 Day)||20
368964|NCT01133392|884941|P2|STARTED|Third Intervention (1 Day)||17
368965|NCT01133392|884942|P1|STARTED|Third Intervention (1 Day)||20
368966|NCT01133392|884941|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
368967|NCT01133392|884942|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
368968|NCT01133392|884941|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
368969|NCT01133392|884942|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
368970|NCT01133392|884941|P2|STARTED|Interval Between Dosing (4-7 Days)||17
368971|NCT01133392|884942|P1|STARTED|Interval Between Dosing (4-7 Days)||20
368972|NCT01133392|884941|P2|NOT COMPLETED|Second Intervention (1 Day)||0
368973|NCT01133392|884942|P1|NOT COMPLETED|Second Intervention (1 Day)||0
368974|NCT01133392|884941|P2|COMPLETED|Second Intervention (1 Day)||17
368975|NCT01133392|884942|P1|COMPLETED|Second Intervention (1 Day)||20
368976|NCT01133392|884941|P2|STARTED|Second Intervention (1 Day)||17
368977|NCT01133392|884942|P1|STARTED|Second Intervention (1 Day)||20
368978|NCT01133392|884941|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
368979|NCT01133392|884942|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
368980|NCT01133392|884941|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
368981|NCT01133392|884942|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
368982|NCT01133392|884941|P2|STARTED|Interval Between Dosing (4-7 Days)||18
368983|NCT01133392|884942|P1|STARTED|Interval Between Dosing (4-7 Days)||20
368984|NCT01133392|884941|P2|NOT COMPLETED|First Intervention (1 Day )||0
368985|NCT01133392|884942|P1|NOT COMPLETED|First Intervention (1 Day )||0
368986|NCT01133392|884941|P2|COMPLETED|First Intervention (1 Day )||18
368987|NCT01133392|884942|P1|COMPLETED|First Intervention (1 Day )||20
368988|NCT01133392|884941|P2|STARTED|First Intervention (1 Day )||18
368989|NCT01133392|884942|P1|STARTED|First Intervention (1 Day )||20
368990|NCT01133379|884959|P3|NOT COMPLETED|Overall Study||2
368991|NCT01133379|884960|P2|NOT COMPLETED|Overall Study||2
368992|NCT01133379|884961|P1|NOT COMPLETED|Overall Study||1
368993|NCT01133379|884959|P3|COMPLETED|Overall Study||56
368994|NCT01133379|884960|P2|COMPLETED|Overall Study||56
368995|NCT01133379|884961|P1|COMPLETED|Overall Study||57
368996|NCT01133379|884959|P3|STARTED|Overall Study||58
368997|NCT01133379|884960|P2|STARTED|Overall Study||58
368998|NCT01133379|884961|P1|STARTED|Overall Study||58
368999|NCT01133288|885014|P1|NOT COMPLETED|Intervention Allocation||2
369000|NCT01133288|885014|P1|COMPLETED|Intervention Allocation||0
369001|NCT01133288|885014|P1|STARTED|Intervention Allocation||2
369002|NCT01133288|885014|P1|NOT COMPLETED|Eligibility Assessment||5
369003|NCT01133288|885014|P1|COMPLETED|Eligibility Assessment||2
369004|NCT01133288|885014|P1|STARTED|Eligibility Assessment||7
369005|NCT01133275|885019|P1|NOT COMPLETED|Overall Study||2
369006|NCT01133275|885019|P1|COMPLETED|Overall Study||26
369007|NCT01133275|885019|P1|STARTED|Overall Study||28
369008|NCT01133171|885027|P3|NOT COMPLETED|Overall Study||0
369009|NCT01133171|885028|P2|NOT COMPLETED|Overall Study||2
369010|NCT01133171|885029|P1|NOT COMPLETED|Overall Study||1
369011|NCT01133171|885027|P3|COMPLETED|Overall Study||25
369012|NCT01133171|885028|P2|COMPLETED|Overall Study||25
369013|NCT01133171|885029|P1|COMPLETED|Overall Study||24
369014|NCT01133171|885027|P3|STARTED|Overall Study||25
369015|NCT01133171|885028|P2|STARTED|Overall Study||27
369016|NCT01133171|885029|P1|STARTED|Overall Study||25
369017|NCT01132846|885042|P3|NOT COMPLETED|Overall Study||11
369018|NCT01132846|885043|P2|NOT COMPLETED|Overall Study||18
369019|NCT01132846|885044|P1|NOT COMPLETED|Overall Study||16
369020|NCT01132846|885042|P3|COMPLETED|Overall Study||108
369021|NCT01132846|885043|P2|COMPLETED|Overall Study||101
369022|NCT01132846|885044|P1|COMPLETED|Overall Study||106
369023|NCT01132846|885042|P3|STARTED|Overall Study||119
369024|NCT01132846|885043|P2|STARTED|Overall Study||119
369025|NCT01132846|885044|P1|STARTED|Overall Study||122
369026|NCT01132690|885096|P2|NOT COMPLETED|Overall Study||0
369027|NCT01132690|885097|P1|NOT COMPLETED|Overall Study||0
369028|NCT01132690|885096|P2|COMPLETED|Overall Study||5
369029|NCT01132690|885097|P1|COMPLETED|Overall Study||6
369030|NCT01132690|885096|P2|STARTED|Overall Study||5
369031|NCT01132690|885097|P1|STARTED|Overall Study||6
369032|NCT01132664|885118|P5|NOT COMPLETED|BM Cohort||6
369033|NCT01132664|885119|P4|NOT COMPLETED|BM Cohort||3
369034|NCT01132664|885120|P3|NOT COMPLETED|BM Cohort||0
369035|NCT01132664|885121|P2|NOT COMPLETED|BM Cohort||0
369036|NCT01132664|885122|P1|NOT COMPLETED|BM Cohort||0
369037|NCT01132664|885118|P5|COMPLETED|BM Cohort||0
369038|NCT01132664|885119|P4|COMPLETED|BM Cohort||0
369039|NCT01132664|885120|P3|COMPLETED|BM Cohort||0
369040|NCT01132664|885121|P2|COMPLETED|BM Cohort||0
369041|NCT01132664|885122|P1|COMPLETED|BM Cohort||0
369042|NCT01132664|885118|P5|STARTED|BM Cohort||6
369043|NCT01132664|885119|P4|STARTED|BM Cohort||3
369044|NCT01132664|885120|P3|STARTED|BM Cohort||0
369045|NCT01132664|885121|P2|STARTED|BM Cohort||0
369046|NCT01132664|885122|P1|STARTED|BM Cohort||0
369047|NCT01132664|885118|P5|NOT COMPLETED|Phase ll||0
369048|NCT01132664|885119|P4|NOT COMPLETED|Phase ll||0
369049|NCT01132664|885120|P3|NOT COMPLETED|Phase ll||50
369050|NCT01132664|885121|P2|NOT COMPLETED|Phase ll||0
369051|NCT01132664|885122|P1|NOT COMPLETED|Phase ll||0
369052|NCT01132664|885118|P5|COMPLETED|Phase ll||0
369053|NCT01132664|885119|P4|COMPLETED|Phase ll||0
369054|NCT01132664|885120|P3|COMPLETED|Phase ll||0
369055|NCT01132664|885121|P2|COMPLETED|Phase ll||0
369056|NCT01132664|885122|P1|COMPLETED|Phase ll||0
369057|NCT01132664|885118|P5|STARTED|Phase ll||0
369058|NCT01132664|885119|P4|STARTED|Phase ll||0
369059|NCT01132664|885120|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
369060|NCT01132664|885121|P2|STARTED|Phase ll||0
369061|NCT01132664|885122|P1|STARTED|Phase ll||0
369062|NCT01132664|885118|P5|NOT COMPLETED|Phase lb||0
369063|NCT01132664|885119|P4|NOT COMPLETED|Phase lb||0
369064|NCT01132664|885120|P3|NOT COMPLETED|Phase lb||0
369065|NCT01132664|885121|P2|NOT COMPLETED|Phase lb||12
369066|NCT01132664|885122|P1|NOT COMPLETED|Phase lb||5
369067|NCT01132664|885118|P5|COMPLETED|Phase lb||0
369068|NCT01132664|885119|P4|COMPLETED|Phase lb||0
369069|NCT01132664|885120|P3|COMPLETED|Phase lb||0
369070|NCT01132664|885121|P2|COMPLETED|Phase lb||0
369071|NCT01132664|885122|P1|COMPLETED|Phase lb||0
369072|NCT01132664|885118|P5|STARTED|Phase lb||0
369073|NCT01132664|885119|P4|STARTED|Phase lb||0
369074|NCT01132664|885120|P3|STARTED|Phase lb||0
369075|NCT01132664|885121|P2|STARTED|Phase lb||12
369076|NCT01132664|885122|P1|STARTED|Phase lb||5
369077|NCT01132651|885156|P2|NOT COMPLETED|Overall Study||1
369078|NCT01132651|885157|P1|NOT COMPLETED|Overall Study||1
369079|NCT01132651|885156|P2|COMPLETED|Overall Study||4
369080|NCT01132651|885157|P1|COMPLETED|Overall Study||3
369081|NCT01132651|885156|P2|STARTED|Overall Study||5
369082|NCT01132651|885157|P1|STARTED|Overall Study||4
369083|NCT01132547|885167|P2|NOT COMPLETED|Overall Study||1
369084|NCT01132547|885168|P1|NOT COMPLETED|Overall Study||4
369085|NCT01132547|885167|P2|COMPLETED|Overall Study||12
369086|NCT01132547|885168|P1|COMPLETED|Overall Study||5
369087|NCT01132547|885167|P2|STARTED|Overall Study||13
369088|NCT01132547|885168|P1|STARTED|Overall Study||9
369089|NCT01132508|885178|P1|NOT COMPLETED|Overall Study||9
369090|NCT01132508|885178|P1|COMPLETED|Overall Study||24
369091|NCT01132508|885178|P1|104 Weeks|Overall Study||27
369092|NCT01132508|885178|P1|78 Weeks|Overall Study||28
369093|NCT01132508|885178|P1|52 Weeks|Overall Study||30
369094|NCT01132508|885178|P1|26 Weeks|Overall Study||33
369095|NCT01132508|885178|P1|12 Weeks|Overall Study||33
369096|NCT01132508|885178|P1|6 Weeks|Overall Study||33
369097|NCT01132508|885178|P1|Treated at Baseline|Overall Study||33
369098|NCT01132508|885178|P1|STARTED|Overall Study||33
369099|NCT01132495|885238|P4|NOT COMPLETED|Overall Study||12
369100|NCT01132495|885239|P3|NOT COMPLETED|Overall Study||20
369101|NCT01132495|885240|P2|NOT COMPLETED|Overall Study||38
369102|NCT01132495|885241|P1|NOT COMPLETED|Overall Study||40
369103|NCT01132495|885238|P4|COMPLETED|Overall Study||104
369104|NCT01132495|885239|P3|COMPLETED|Overall Study||146
369105|NCT01132495|885240|P2|COMPLETED|Overall Study||403
369106|NCT01132495|885241|P1|COMPLETED|Overall Study||407
369107|NCT01132495|885238|P4|STARTED|Overall Study||116
369108|NCT01132495|885239|P3|STARTED|Overall Study||166
369109|NCT01132495|885240|P2|STARTED|Overall Study||441
369110|NCT01132495|885241|P1|STARTED|Overall Study||447
369111|NCT01132378|885249|P1|NOT COMPLETED|Overall Study||0
369112|NCT01132378|885249|P1|COMPLETED|Overall Study||40
369113|NCT01132378|885249|P1|STARTED|Overall Study||40
369114|NCT01132326|885254|P1|NOT COMPLETED|Overall Study||218
369115|NCT01132326|885254|P1|COMPLETED|Overall Study||132
369116|NCT01132326|885254|P1|STARTED|Overall Study||350
369117|NCT01132313|885270|P12|NOT COMPLETED|Overall Study||0
369118|NCT01132313|885271|P11|NOT COMPLETED|Overall Study||1
369119|NCT01132313|885272|P10|NOT COMPLETED|Overall Study||20
369120|NCT01132313|885273|P9|NOT COMPLETED|Overall Study||21
369121|NCT01132313|885274|P8|NOT COMPLETED|Overall Study||8
369122|NCT01132313|885275|P7|NOT COMPLETED|Overall Study||30
369123|NCT01132313|885276|P6|NOT COMPLETED|Overall Study||25
369124|NCT01132313|885277|P5|NOT COMPLETED|Overall Study||45
369125|NCT01132313|885278|P4|NOT COMPLETED|Overall Study||32
369126|NCT01132313|885279|P3|NOT COMPLETED|Overall Study||20
369127|NCT01132313|885280|P2|NOT COMPLETED|Overall Study||0
369128|NCT01132313|885281|P1|NOT COMPLETED|Overall Study||3
369129|NCT01132313|885270|P12|COMPLETED|Overall Study||2
369130|NCT01132313|885271|P11|COMPLETED|Overall Study||0
369131|NCT01132313|885272|P10|COMPLETED|Overall Study||5
369132|NCT01132313|885273|P9|COMPLETED|Overall Study||5
369133|NCT01132313|885274|P8|COMPLETED|Overall Study||24
369134|NCT01132313|885275|P7|COMPLETED|Overall Study||19
369135|NCT01132313|885276|P6|COMPLETED|Overall Study||54
369136|NCT01132313|885277|P5|COMPLETED|Overall Study||34
369137|NCT01132313|885278|P4|COMPLETED|Overall Study||48
369138|NCT01132313|885279|P3|COMPLETED|Overall Study||61
369139|NCT01132313|885280|P2|COMPLETED|Overall Study||17
369140|NCT01132313|885281|P1|COMPLETED|Overall Study||14
369141|NCT01132313|885270|P12|STARTED|Overall Study||2
369142|NCT01132313|885271|P11|STARTED|Overall Study||1
369143|NCT01132313|885272|P10|STARTED|Overall Study||25
369144|NCT01132313|885273|P9|STARTED|Overall Study||26
369145|NCT01132313|885274|P8|STARTED|Overall Study||32
369146|NCT01132313|885275|P7|STARTED|Overall Study||49
369147|NCT01132313|885276|P6|STARTED|Overall Study||79
369148|NCT01132313|885277|P5|STARTED|Overall Study||79
369149|NCT01132313|885278|P4|STARTED|Overall Study||80
369150|NCT01132313|885279|P3|STARTED|Overall Study||81
369151|NCT01132313|885280|P2|STARTED|Overall Study||17
369152|NCT01132313|885281|P1|STARTED|Overall Study||17
369153|NCT01132144|885338|P2|NOT COMPLETED|Overall Study||0
369154|NCT01132144|885339|P1|NOT COMPLETED|Overall Study||0
369155|NCT01132144|885338|P2|COMPLETED|Overall Study||79
369156|NCT01132144|885339|P1|COMPLETED|Overall Study||79
369157|NCT01132144|885338|P2|STARTED|Overall Study||79
369158|NCT01132144|885339|P1|STARTED|Overall Study||79
369159|NCT01132118|885361|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
369160|NCT01132118|885362|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
369161|NCT01132118|885361|P2|COMPLETED|Second Intervention (8 Weeks)||11
369162|NCT01132118|885362|P1|COMPLETED|Second Intervention (8 Weeks)||12
369163|NCT01132118|885361|P2|STARTED|Second Intervention (8 Weeks)||12
369164|NCT01132118|885362|P1|STARTED|Second Intervention (8 Weeks)||12
369165|NCT01132118|885361|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
369166|NCT01132118|885362|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
369167|NCT01132118|885361|P2|COMPLETED|First Intervention (8 Weeks)||12
369168|NCT01132118|885362|P1|COMPLETED|First Intervention (8 Weeks)||12
369169|NCT01132118|885361|P2|STARTED|First Intervention (8 Weeks)||15
369170|NCT01132118|885362|P1|STARTED|First Intervention (8 Weeks)||15
369171|NCT01131884|885382|P2|NOT COMPLETED|Overall Study||0
369172|NCT01131884|885383|P1|NOT COMPLETED|Overall Study||0
369173|NCT01131884|885382|P2|COMPLETED|Overall Study||0
369174|NCT01131884|885383|P1|COMPLETED|Overall Study||1
369175|NCT01131884|885382|P2|STARTED|Overall Study||0
369176|NCT01131884|885383|P1|STARTED|Overall Study||1
369177|NCT01131676|885392|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
369178|NCT01131676|885393|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
369179|NCT01131676|885394|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
369180|NCT01131676|885392|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
369181|NCT01131676|885393|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
369182|NCT01131676|885394|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
369271|NCT01130844|885627|P3|COMPLETED|Overall Study||9
369183|NCT01131676|885392|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
369184|NCT01131676|885393|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
369185|NCT01131676|885394|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
369186|NCT01131676|885392|P3|STARTED|Discontinuation From Study (Treated Set)||2342
369187|NCT01131676|885393|P2|STARTED|Discontinuation From Study (Treated Set)||2345
369188|NCT01131676|885394|P1|STARTED|Discontinuation From Study (Treated Set)||2333
369189|NCT01131676|885392|P3|NOT COMPLETED|Discontinuation From Treatment||544
369190|NCT01131676|885393|P2|NOT COMPLETED|Discontinuation From Treatment||557
369191|NCT01131676|885394|P1|NOT COMPLETED|Discontinuation From Treatment||687
369192|NCT01131676|885392|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
369193|NCT01131676|885393|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
369194|NCT01131676|885394|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
369195|NCT01131676|885392|P3|STARTED|Discontinuation From Treatment|Randomised|2344
369196|NCT01131676|885393|P2|STARTED|Discontinuation From Treatment|Randomised|2347
369197|NCT01131676|885394|P1|STARTED|Discontinuation From Treatment|Randomised|2337
369198|NCT01131585|885429|P2|NOT COMPLETED|Overall Study||43
369199|NCT01131585|885430|P1|NOT COMPLETED|Overall Study||85
369200|NCT01131585|885429|P2|COMPLETED|Overall Study||0
369201|NCT01131585|885430|P1|COMPLETED|Overall Study||0
369202|NCT01131585|885429|P2|STARTED|Overall Study||43
369203|NCT01131585|885430|P1|STARTED|Overall Study||85
369204|NCT01131507|885436|P1|NOT COMPLETED|Overall Study||3
369205|NCT01131507|885436|P1|COMPLETED|Overall Study||12
369206|NCT01131507|885436|P1|STARTED|Overall Study||15
369207|NCT01131494|885441|P1|NOT COMPLETED|Overall Study||2
369208|NCT01131494|885441|P1|COMPLETED|Overall Study||15
369209|NCT01131494|885441|P1|STARTED|Overall Study||17
369210|NCT01131455|885451|P3|NOT COMPLETED|Overall Study||0
369211|NCT01131455|885452|P2|NOT COMPLETED|Overall Study||4
369212|NCT01131455|885453|P1|NOT COMPLETED|Overall Study||6
369213|NCT01131455|885451|P3|COMPLETED|Overall Study||0
369214|NCT01131455|885452|P2|COMPLETED|Overall Study||0
369215|NCT01131455|885453|P1|COMPLETED|Overall Study||0
369216|NCT01131455|885451|P3|STARTED|Overall Study||0
369217|NCT01131455|885452|P2|STARTED|Overall Study||4
369218|NCT01131455|885453|P1|STARTED|Overall Study||6
369219|NCT01131299|885461|P2|NOT COMPLETED|Overall Study||7
369220|NCT01131299|885462|P1|NOT COMPLETED|Overall Study||4
369221|NCT01131299|885461|P2|COMPLETED|Overall Study||37
369222|NCT01131299|885462|P1|COMPLETED|Overall Study||38
369223|NCT01131299|885461|P2|STARTED|Overall Study||44
369224|NCT01131299|885462|P1|STARTED|Overall Study||42
369225|NCT01131182|885475|P2|NOT COMPLETED|Overall Study||16
369226|NCT01131182|885476|P1|NOT COMPLETED|Overall Study||16
369227|NCT01131182|885475|P2|COMPLETED|Overall Study||521
369228|NCT01131182|885476|P1|COMPLETED|Overall Study||513
369229|NCT01131182|885475|P2|STARTED|Overall Study||537
369230|NCT01131182|885476|P1|STARTED|Overall Study||529
369231|NCT01131130|885484|P1|NOT COMPLETED|Period 3- Crossover||1
369232|NCT01131130|885484|P1|COMPLETED|Period 3- Crossover||116
369233|NCT01131130|885484|P1|STARTED|Period 3- Crossover||117
369234|NCT01131130|885484|P1|NOT COMPLETED|Period 2 - Crossover||0
369235|NCT01131130|885484|P1|COMPLETED|Period 2 - Crossover||117
369236|NCT01131130|885484|P1|STARTED|Period 2 - Crossover||117
369237|NCT01131130|885484|P1|NOT COMPLETED|Period 1 - Baseline||1
369238|NCT01131130|885484|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
369239|NCT01131130|885484|P1|STARTED|Period 1 - Baseline||118
369240|NCT01131078|885500|P3|NOT COMPLETED|Overall Study||102
369241|NCT01131078|885501|P2|NOT COMPLETED|Overall Study||101
369242|NCT01131078|885502|P1|NOT COMPLETED|Overall Study||101
369243|NCT01131078|885500|P3|COMPLETED|Overall Study||1
369244|NCT01131078|885501|P2|COMPLETED|Overall Study||1
369245|NCT01131078|885502|P1|COMPLETED|Overall Study||0
369246|NCT01131078|885500|P3|STARTED|Overall Study||103
369247|NCT01131078|885501|P2|STARTED|Overall Study||102
369248|NCT01131078|885502|P1|STARTED|Overall Study||101
369249|NCT01131065|885558|P1|NOT COMPLETED|Overall Study||0
369250|NCT01131065|885558|P1|COMPLETED|Overall Study||15
369251|NCT01131065|885558|P1|STARTED|Overall Study||15
369252|NCT01131052|885566|P2|NOT COMPLETED|Overall Study||0
369253|NCT01131052|885567|P1|NOT COMPLETED|Overall Study||0
369254|NCT01131052|885566|P2|COMPLETED|Overall Study||75
369255|NCT01131052|885567|P1|COMPLETED|Overall Study||75
369256|NCT01131052|885566|P2|STARTED|Overall Study||75
369257|NCT01131052|885567|P1|STARTED|Overall Study||75
369258|NCT01130974|885589|P2|NOT COMPLETED|Overall Study||13
369259|NCT01130974|885590|P1|NOT COMPLETED|Overall Study||15
369260|NCT01130974|885589|P2|COMPLETED|Overall Study||87
369261|NCT01130974|885590|P1|COMPLETED|Overall Study||85
369262|NCT01130974|885589|P2|STARTED|Overall Study||100
369263|NCT01130974|885590|P1|STARTED|Overall Study||100
369264|NCT01130883|885610|P1|NOT COMPLETED|Overall Study||10
369265|NCT01130883|885610|P1|COMPLETED|Overall Study||3120
369266|NCT01130883|885610|P1|Participants Analyzed|Overall Study||3128
369267|NCT01130883|885610|P1|STARTED|Overall Study||3130
369268|NCT01130844|885627|P3|NOT COMPLETED|Overall Study||0
369269|NCT01130844|885628|P2|NOT COMPLETED|Overall Study||0
369270|NCT01130844|885629|P1|NOT COMPLETED|Overall Study||0
369272|NCT01130844|885628|P2|COMPLETED|Overall Study||22
369273|NCT01130844|885629|P1|COMPLETED|Overall Study||21
369274|NCT01130844|885627|P3|STARTED|Overall Study||9
369275|NCT01130844|885628|P2|STARTED|Overall Study||22
369276|NCT01130844|885629|P1|STARTED|Overall Study||21
369277|NCT01130831|885667|P1|NOT COMPLETED|Overall Study||14
369278|NCT01130831|885667|P1|COMPLETED|Overall Study||52
369279|NCT01130831|885667|P1|STARTED|Overall Study||66
369280|NCT01130740|885695|P2|NOT COMPLETED|Overall Study||15
369281|NCT01130740|885696|P1|NOT COMPLETED|Overall Study||12
369282|NCT01130740|885695|P2|COMPLETED|Overall Study||136
369283|NCT01130740|885696|P1|COMPLETED|Overall Study||137
369284|NCT01130740|885695|P2|STARTED|Overall Study||151
369285|NCT01130740|885696|P1|STARTED|Overall Study||149
369286|NCT01130597|885706|P1|NOT COMPLETED|Overall Study||7
369287|NCT01130597|885706|P1|COMPLETED|Overall Study||56
369288|NCT01130597|885706|P1|STARTED|Overall Study||63
369289|NCT01130532|885731|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
369290|NCT01130532|885732|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
369291|NCT01130532|885733|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
369292|NCT01130532|885734|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
369293|NCT01130532|885731|P4|COMPLETED|Period IV (Weeks 13-16)||552
369294|NCT01130532|885732|P3|COMPLETED|Period IV (Weeks 13-16)||0
369295|NCT01130532|885733|P2|COMPLETED|Period IV (Weeks 13-16)||0
369296|NCT01130532|885734|P1|COMPLETED|Period IV (Weeks 13-16)||0
369297|NCT01130532|885731|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
369298|NCT01130532|885732|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
369299|NCT01130532|885733|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
369300|NCT01130532|885734|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
369301|NCT01130532|885731|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
369302|NCT01130532|885732|P3|STARTED|Period IV (Weeks 13-16)||0
369303|NCT01130532|885733|P2|STARTED|Period IV (Weeks 13-16)||0
369304|NCT01130532|885734|P1|STARTED|Period IV (Weeks 13-16)||0
369305|NCT01130532|885731|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
369306|NCT01130532|885732|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
369307|NCT01130532|885733|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
369308|NCT01130532|885734|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
369309|NCT01130532|885731|P4|COMPLETED|Period III (Weeks 0-12)||0
369310|NCT01130532|885732|P3|COMPLETED|Period III (Weeks 0-12)||190
369311|NCT01130532|885733|P2|COMPLETED|Period III (Weeks 0-12)||189
369312|NCT01130532|885734|P1|COMPLETED|Period III (Weeks 0-12)||186
369313|NCT01130532|885731|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
369314|NCT01130532|885732|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
369315|NCT01130532|885733|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
369316|NCT01130532|885734|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
369317|NCT01130532|885731|P4|STARTED|Period III (Weeks 0-12)||0
369318|NCT01130532|885732|P3|STARTED|Period III (Weeks 0-12)||209
369319|NCT01130532|885733|P2|STARTED|Period III (Weeks 0-12)||207
369320|NCT01130532|885734|P1|STARTED|Period III (Weeks 0-12)||207
369321|NCT01130337|885779|P1|NOT COMPLETED|Overall Study||14
369322|NCT01130337|885779|P1|COMPLETED|Overall Study||22
369323|NCT01130337|885779|P1|STARTED|Overall Study||36
369324|NCT01130168|885786|P6|NOT COMPLETED|Period 3||0
369325|NCT01130168|885787|P5|NOT COMPLETED|Period 3||0
369326|NCT01130168|885788|P4|NOT COMPLETED|Period 3||0
369327|NCT01130168|885789|P3|NOT COMPLETED|Period 3||0
369328|NCT01130168|885790|P2|NOT COMPLETED|Period 3||0
369329|NCT01130168|885791|P1|NOT COMPLETED|Period 3||0
369330|NCT01130168|885786|P6|COMPLETED|Period 3||6
369331|NCT01130168|885787|P5|COMPLETED|Period 3||5
369332|NCT01130168|885788|P4|COMPLETED|Period 3||5
369333|NCT01130168|885789|P3|COMPLETED|Period 3||5
369334|NCT01130168|885790|P2|COMPLETED|Period 3||6
369335|NCT01130168|885791|P1|COMPLETED|Period 3||6
369336|NCT01130168|885786|P6|STARTED|Period 3||6
369337|NCT01130168|885787|P5|STARTED|Period 3||5
369338|NCT01130168|885788|P4|STARTED|Period 3||5
369339|NCT01130168|885789|P3|STARTED|Period 3||5
369340|NCT01130168|885790|P2|STARTED|Period 3||6
369341|NCT01130168|885791|P1|STARTED|Period 3||6
369342|NCT01130168|885786|P6|NOT COMPLETED|Period 2||0
369343|NCT01130168|885787|P5|NOT COMPLETED|Period 2||0
369344|NCT01130168|885788|P4|NOT COMPLETED|Period 2||0
369345|NCT01130168|885789|P3|NOT COMPLETED|Period 2||0
369346|NCT01130168|885790|P2|NOT COMPLETED|Period 2||0
369347|NCT01130168|885791|P1|NOT COMPLETED|Period 2||0
369348|NCT01130168|885786|P6|COMPLETED|Period 2||6
369349|NCT01130168|885787|P5|COMPLETED|Period 2||5
369350|NCT01130168|885788|P4|COMPLETED|Period 2||5
369351|NCT01130168|885789|P3|COMPLETED|Period 2||5
369352|NCT01130168|885790|P2|COMPLETED|Period 2||6
369353|NCT01130168|885791|P1|COMPLETED|Period 2||6
369354|NCT01130168|885786|P6|STARTED|Period 2||6
369355|NCT01130168|885787|P5|STARTED|Period 2||5
369356|NCT01130168|885788|P4|STARTED|Period 2||5
369357|NCT01130168|885789|P3|STARTED|Period 2||5
369358|NCT01130168|885790|P2|STARTED|Period 2||6
369359|NCT01130168|885791|P1|STARTED|Period 2||6
369360|NCT01130168|885786|P6|NOT COMPLETED|Period 1||0
369361|NCT01130168|885787|P5|NOT COMPLETED|Period 1||0
369362|NCT01130168|885788|P4|NOT COMPLETED|Period 1||3
369363|NCT01130168|885789|P3|NOT COMPLETED|Period 1||1
369364|NCT01130168|885790|P2|NOT COMPLETED|Period 1||1
369365|NCT01130168|885791|P1|NOT COMPLETED|Period 1||0
369366|NCT01130168|885786|P6|COMPLETED|Period 1||6
369367|NCT01130168|885787|P5|COMPLETED|Period 1||5
369368|NCT01130168|885788|P4|COMPLETED|Period 1||5
369369|NCT01130168|885789|P3|COMPLETED|Period 1||5
369370|NCT01130168|885790|P2|COMPLETED|Period 1||6
369371|NCT01130168|885791|P1|COMPLETED|Period 1||6
369372|NCT01130168|885786|P6|STARTED|Period 1||6
369373|NCT01130168|885787|P5|STARTED|Period 1||5
369374|NCT01130168|885788|P4|STARTED|Period 1||8
369375|NCT01130168|885789|P3|STARTED|Period 1||6
369376|NCT01130168|885790|P2|STARTED|Period 1||7
369377|NCT01130168|885791|P1|STARTED|Period 1||6
369378|NCT01130103|885828|P2|NOT COMPLETED|Maintenance Treatment||2
369379|NCT01130103|885829|P1|NOT COMPLETED|Maintenance Treatment||2
369380|NCT01130103|885828|P2|COMPLETED|Maintenance Treatment||11
369381|NCT01130103|885829|P1|COMPLETED|Maintenance Treatment||11
369382|NCT01130103|885828|P2|STARTED|Maintenance Treatment||13
369383|NCT01130103|885829|P1|STARTED|Maintenance Treatment||13
369384|NCT01130103|885828|P2|NOT COMPLETED|Randomized Treatment||5
369385|NCT01130103|885829|P1|NOT COMPLETED|Randomized Treatment||6
369386|NCT01130103|885828|P2|COMPLETED|Randomized Treatment||13
369387|NCT01130103|885829|P1|COMPLETED|Randomized Treatment||13
369388|NCT01130103|885828|P2|STARTED|Randomized Treatment||18
369389|NCT01130103|885829|P1|STARTED|Randomized Treatment||19
369390|NCT01130051|885843|P2|NOT COMPLETED|Period 2||0
369391|NCT01130051|885844|P1|NOT COMPLETED|Period 2||0
369392|NCT01130051|885843|P2|COMPLETED|Period 2||6
369393|NCT01130051|885844|P1|COMPLETED|Period 2||7
369394|NCT01130051|885843|P2|STARTED|Period 2||6
369395|NCT01130051|885844|P1|STARTED|Period 2||7
369396|NCT01130051|885843|P2|NOT COMPLETED|Washout Period of 14 Days||2
369397|NCT01130051|885844|P1|NOT COMPLETED|Washout Period of 14 Days||1
369398|NCT01130051|885843|P2|COMPLETED|Washout Period of 14 Days||6
369399|NCT01130051|885844|P1|COMPLETED|Washout Period of 14 Days||7
369400|NCT01130051|885843|P2|STARTED|Washout Period of 14 Days||8
369401|NCT01130051|885844|P1|STARTED|Washout Period of 14 Days||8
369402|NCT01130051|885843|P2|NOT COMPLETED|Period 1||0
369403|NCT01130051|885844|P1|NOT COMPLETED|Period 1||0
369404|NCT01130051|885843|P2|COMPLETED|Period 1||8
369405|NCT01130051|885844|P1|COMPLETED|Period 1||8
369406|NCT01130051|885843|P2|STARTED|Period 1||8
369407|NCT01130051|885844|P1|STARTED|Period 1||8
369408|NCT01129960|885858|P4|NOT COMPLETED|Overall Study||13
369409|NCT01129960|885859|P3|NOT COMPLETED|Overall Study||26
369410|NCT01129960|885860|P2|NOT COMPLETED|Overall Study||22
369411|NCT01129960|885861|P1|NOT COMPLETED|Overall Study||30
369412|NCT01129960|885858|P4|COMPLETED|Overall Study||70
369413|NCT01129960|885859|P3|COMPLETED|Overall Study||56
369414|NCT01129960|885860|P2|COMPLETED|Overall Study||61
369415|NCT01129960|885861|P1|COMPLETED|Overall Study||54
369416|NCT01129960|885858|P4|Full Analysis Set (FAS|Overall Study||71
369417|NCT01129960|885859|P3|Full Analysis Set (FAS|Overall Study||68
369418|NCT01129960|885860|P2|Full Analysis Set (FAS|Overall Study||67
369419|NCT01129960|885861|P1|Full Analysis Set (FAS|Overall Study||71
369420|NCT01129960|885858|P4|Per-Protocol|Overall Study||55
369421|NCT01129960|885859|P3|Per-Protocol|Overall Study||49
369422|NCT01129960|885860|P2|Per-Protocol|Overall Study||52
369423|NCT01129960|885861|P1|Per-Protocol|Overall Study||34
369424|NCT01129960|885858|P4|Intent-to-Treat|Overall Study||83
369425|NCT01129960|885859|P3|Intent-to-Treat|Overall Study||82
369426|NCT01129960|885860|P2|Intent-to-Treat|Overall Study||83
369427|NCT01129960|885861|P1|Intent-to-Treat|Overall Study||84
369428|NCT01129960|885858|P4|Safety|Overall Study||82
369429|NCT01129960|885859|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
369430|NCT01129960|885860|P2|Safety|Overall Study||83
369431|NCT01129960|885861|P1|Safety|Overall Study||84
369432|NCT01129960|885858|P4|STARTED|Overall Study||83
369433|NCT01129960|885859|P3|STARTED|Overall Study||82
369434|NCT01129960|885860|P2|STARTED|Overall Study||83
369435|NCT01129960|885861|P1|STARTED|Overall Study||84
369436|NCT01129921|885873|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
369437|NCT01129921|885874|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
369525|NCT01129128|886074|P3|COMPLETED|Overall Study||19
369526|NCT01129128|886075|P2|COMPLETED|Overall Study||18
369438|NCT01129921|885873|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
369439|NCT01129921|885874|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
369440|NCT01129921|885873|P2|STARTED|After Sham Cross-over to Mild, One Year||20
369441|NCT01129921|885874|P1|STARTED|After Sham Cross-over to Mild, One Year||20
369442|NCT01129921|885873|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
369443|NCT01129921|885874|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
369444|NCT01129921|885873|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
369445|NCT01129921|885874|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
369446|NCT01129921|885873|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
369447|NCT01129921|885874|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
369448|NCT01129778|885884|P1|NOT COMPLETED|Overall Study||7
369449|NCT01129778|885884|P1|COMPLETED|Overall Study||15
369450|NCT01129778|885884|P1|STARTED|Overall Study||22
369451|NCT01129765|885889|P1|NOT COMPLETED|Overall Study||0
369452|NCT01129765|885889|P1|COMPLETED|Overall Study||30
369453|NCT01129765|885889|P1|STARTED|Overall Study||30
369454|NCT01129622|885898|P1|NOT COMPLETED|Overall Study||2
369455|NCT01129622|885898|P1|COMPLETED|Overall Study||14
369456|NCT01129622|885898|P1|STARTED|Overall Study||16
369457|NCT01129583|885905|P2|NOT COMPLETED|Overall Study||2
369458|NCT01129583|885906|P1|NOT COMPLETED|Overall Study||3
369459|NCT01129583|885905|P2|COMPLETED|Overall Study||7
369460|NCT01129583|885906|P1|COMPLETED|Overall Study||6
369461|NCT01129583|885905|P2|STARTED|Overall Study||9
369462|NCT01129583|885906|P1|STARTED|Overall Study||9
369463|NCT01129557|885919|P3|NOT COMPLETED|Overall Study||4
369464|NCT01129557|885920|P2|NOT COMPLETED|Overall Study||5
369465|NCT01129557|885921|P1|NOT COMPLETED|Overall Study||4
369466|NCT01129557|885919|P3|COMPLETED|Overall Study||10
369467|NCT01129557|885920|P2|COMPLETED|Overall Study||12
369468|NCT01129557|885921|P1|COMPLETED|Overall Study||11
369469|NCT01129557|885919|P3|STARTED|Overall Study||14
369470|NCT01129557|885920|P2|STARTED|Overall Study||17
369471|NCT01129557|885921|P1|STARTED|Overall Study||15
369472|NCT01129531|885992|P3|NOT COMPLETED|Treatment Cycle 2||5
369473|NCT01129531|885993|P2|NOT COMPLETED|Treatment Cycle 2||3
369474|NCT01129531|885994|P1|NOT COMPLETED|Treatment Cycle 2||6
369475|NCT01129531|885992|P3|COMPLETED|Treatment Cycle 2||74
369476|NCT01129531|885993|P2|COMPLETED|Treatment Cycle 2||92
369477|NCT01129531|885994|P1|COMPLETED|Treatment Cycle 2||88
369478|NCT01129531|885992|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
369479|NCT01129531|885993|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
369480|NCT01129531|885994|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
369481|NCT01129531|885992|P3|NOT COMPLETED|Treatment Cycle 1||16
369482|NCT01129531|885993|P2|NOT COMPLETED|Treatment Cycle 1||6
369483|NCT01129531|885994|P1|NOT COMPLETED|Treatment Cycle 1||4
369484|NCT01129531|885992|P3|COMPLETED|Treatment Cycle 1||110
369485|NCT01129531|885993|P2|COMPLETED|Treatment Cycle 1||78
369486|NCT01129531|885994|P1|COMPLETED|Treatment Cycle 1||80
369487|NCT01129531|885992|P3|STARTED|Treatment Cycle 1||126
369488|NCT01129531|885993|P2|STARTED|Treatment Cycle 1||84
369489|NCT01129531|885994|P1|STARTED|Treatment Cycle 1||84
369490|NCT01129336|886016|P2|NOT COMPLETED|Overall Study||16
369491|NCT01129336|886017|P1|NOT COMPLETED|Overall Study||12
369492|NCT01129336|886016|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
369493|NCT01129336|886017|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
369494|NCT01129336|886016|P2|Completed Treatment|Overall Study||3
369495|NCT01129336|886017|P1|Completed Treatment|Overall Study||1
369496|NCT01129336|886016|P2|STARTED|Overall Study||29
369497|NCT01129336|886017|P1|STARTED|Overall Study||15
369498|NCT01129284|886032|P3|NOT COMPLETED|Overall Study||1
369499|NCT01129284|886033|P2|NOT COMPLETED|Overall Study||0
369500|NCT01129284|886034|P1|NOT COMPLETED|Overall Study||2
369501|NCT01129284|886032|P3|COMPLETED|Overall Study||4
369502|NCT01129284|886033|P2|COMPLETED|Overall Study||5
369503|NCT01129284|886034|P1|COMPLETED|Overall Study||3
369504|NCT01129284|886032|P3|STARTED|Overall Study||5
369505|NCT01129284|886033|P2|STARTED|Overall Study||5
369506|NCT01129284|886034|P1|STARTED|Overall Study||5
369507|NCT01129245|886047|P2|NOT COMPLETED|Overall Study||0
369508|NCT01129245|886048|P1|NOT COMPLETED|Overall Study||0
369509|NCT01129245|886047|P2|COMPLETED|Overall Study||4
369510|NCT01129245|886048|P1|COMPLETED|Overall Study||7
369511|NCT01129245|886047|P2|STARTED|Overall Study||4
369512|NCT01129245|886048|P1|STARTED|Overall Study||7
369513|NCT01129206|886054|P1|NOT COMPLETED|Overall Study||0
369514|NCT01129206|886054|P1|COMPLETED|Overall Study||6
369515|NCT01129206|886054|P1|STARTED|Overall Study||6
369516|NCT01129141|886064|P2|NOT COMPLETED|Overall Study||13
369517|NCT01129141|886065|P1|NOT COMPLETED|Overall Study||15
369518|NCT01129141|886064|P2|COMPLETED|Overall Study||91
369519|NCT01129141|886065|P1|COMPLETED|Overall Study||86
369520|NCT01129141|886064|P2|STARTED|Overall Study||104
369521|NCT01129141|886065|P1|STARTED|Overall Study||101
369522|NCT01129128|886074|P3|NOT COMPLETED|Overall Study||4
369523|NCT01129128|886075|P2|NOT COMPLETED|Overall Study||4
369524|NCT01129128|886076|P1|NOT COMPLETED|Overall Study||3
369527|NCT01129128|886076|P1|COMPLETED|Overall Study||19
369528|NCT01129128|886074|P3|STARTED|Overall Study||23
369529|NCT01129128|886075|P2|STARTED|Overall Study||22
369530|NCT01129128|886076|P1|STARTED|Overall Study||22
369531|NCT01129115|886100|P4|NOT COMPLETED|Overall Study||9
369532|NCT01129115|886101|P3|NOT COMPLETED|Overall Study||6
369533|NCT01129115|886102|P2|NOT COMPLETED|Overall Study||7
369534|NCT01129115|886103|P1|NOT COMPLETED|Overall Study||2
369535|NCT01129115|886100|P4|COMPLETED|Overall Study||15
369536|NCT01129115|886101|P3|COMPLETED|Overall Study||21
369537|NCT01129115|886102|P2|COMPLETED|Overall Study||18
369538|NCT01129115|886103|P1|COMPLETED|Overall Study||23
369539|NCT01129115|886100|P4|STARTED|Overall Study||24
369540|NCT01129115|886101|P3|STARTED|Overall Study||27
369541|NCT01129115|886102|P2|STARTED|Overall Study||25
369542|NCT01129115|886103|P1|STARTED|Overall Study||25
369543|NCT01129102|886140|P3|NOT COMPLETED|Overall Study||7
369544|NCT01129102|886141|P2|NOT COMPLETED|Overall Study||6
369545|NCT01129102|886142|P1|NOT COMPLETED|Overall Study||8
369546|NCT01129102|886140|P3|COMPLETED|Overall Study||48
369547|NCT01129102|886141|P2|COMPLETED|Overall Study||44
369548|NCT01129102|886142|P1|COMPLETED|Overall Study||102
369549|NCT01129102|886140|P3|STARTED|Overall Study||55
369550|NCT01129102|886141|P2|STARTED|Overall Study||50
369551|NCT01129102|886142|P1|STARTED|Overall Study||110
369552|NCT01129011|886153|P2|NOT COMPLETED|Overall Study||57
369553|NCT01129011|886154|P1|NOT COMPLETED|Overall Study||59
369554|NCT01129011|886153|P2|COMPLETED|Overall Study||153
369555|NCT01129011|886154|P1|COMPLETED|Overall Study||151
369556|NCT01129011|886153|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
369557|NCT01129011|886154|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
369558|NCT01128972|886176|P5|NOT COMPLETED|Period V||0
369559|NCT01128972|886177|P4|NOT COMPLETED|Period V||0
369560|NCT01128972|886178|P3|NOT COMPLETED|Period V||0
369561|NCT01128972|886179|P2|NOT COMPLETED|Period V||0
369562|NCT01128972|886180|P1|NOT COMPLETED|Period V||0
369563|NCT01128972|886176|P5|COMPLETED|Period V||7
369564|NCT01128972|886177|P4|COMPLETED|Period V||7
369565|NCT01128972|886178|P3|COMPLETED|Period V||7
369566|NCT01128972|886179|P2|COMPLETED|Period V||7
369567|NCT01128972|886180|P1|COMPLETED|Period V||8
369568|NCT01128972|886176|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
369569|NCT01128972|886177|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
369570|NCT01128972|886178|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
369571|NCT01128972|886179|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
369572|NCT01128972|886180|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
369573|NCT01128972|886176|P5|NOT COMPLETED|Period IV||0
369574|NCT01128972|886177|P4|NOT COMPLETED|Period IV||0
369575|NCT01128972|886178|P3|NOT COMPLETED|Period IV||0
369576|NCT01128972|886179|P2|NOT COMPLETED|Period IV||0
369577|NCT01128972|886180|P1|NOT COMPLETED|Period IV||0
369578|NCT01128972|886176|P5|COMPLETED|Period IV||7
369579|NCT01128972|886177|P4|COMPLETED|Period IV||7
369580|NCT01128972|886178|P3|COMPLETED|Period IV||7
369581|NCT01128972|886179|P2|COMPLETED|Period IV||8
369582|NCT01128972|886180|P1|COMPLETED|Period IV||7
369583|NCT01128972|886176|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
369584|NCT01128972|886177|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
369585|NCT01128972|886178|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
369586|NCT01128972|886179|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
369587|NCT01128972|886180|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
369588|NCT01128972|886176|P5|NOT COMPLETED|Period III||0
369589|NCT01128972|886177|P4|NOT COMPLETED|Period III||0
369590|NCT01128972|886178|P3|NOT COMPLETED|Period III||0
369591|NCT01128972|886179|P2|NOT COMPLETED|Period III||0
369592|NCT01128972|886180|P1|NOT COMPLETED|Period III||0
369593|NCT01128972|886176|P5|COMPLETED|Period III||7
369594|NCT01128972|886177|P4|COMPLETED|Period III||7
369595|NCT01128972|886178|P3|COMPLETED|Period III||8
369596|NCT01128972|886179|P2|COMPLETED|Period III||7
369597|NCT01128972|886180|P1|COMPLETED|Period III||7
369598|NCT01128972|886176|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
369599|NCT01128972|886177|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
369600|NCT01128972|886178|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
369601|NCT01128972|886179|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
369602|NCT01128972|886180|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
369603|NCT01128972|886176|P5|NOT COMPLETED|Period II||0
369604|NCT01128972|886177|P4|NOT COMPLETED|Period II||0
369605|NCT01128972|886178|P3|NOT COMPLETED|Period II||0
369606|NCT01128972|886179|P2|NOT COMPLETED|Period II||0
369607|NCT01128972|886180|P1|NOT COMPLETED|Period II||0
369608|NCT01128972|886176|P5|COMPLETED|Period II||7
369609|NCT01128972|886177|P4|COMPLETED|Period II||8
369610|NCT01128972|886178|P3|COMPLETED|Period II||7
369611|NCT01128972|886179|P2|COMPLETED|Period II||7
369612|NCT01128972|886180|P1|COMPLETED|Period II||7
369613|NCT01128972|886176|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
369614|NCT01128972|886177|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
369615|NCT01128972|886178|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
369616|NCT01128972|886179|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
369617|NCT01128972|886180|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
369618|NCT01128972|886176|P5|NOT COMPLETED|Period I||0
369619|NCT01128972|886177|P4|NOT COMPLETED|Period I||0
369620|NCT01128972|886178|P3|NOT COMPLETED|Period I||0
369621|NCT01128972|886179|P2|NOT COMPLETED|Period I||0
369622|NCT01128972|886180|P1|NOT COMPLETED|Period I||0
369623|NCT01128972|886176|P5|COMPLETED|Period I||8
369624|NCT01128972|886177|P4|COMPLETED|Period I||7
369625|NCT01128972|886178|P3|COMPLETED|Period I||7
369626|NCT01128972|886179|P2|COMPLETED|Period I||7
369627|NCT01128972|886180|P1|COMPLETED|Period I||7
369628|NCT01128972|886176|P5|STARTED|Period I||8
369629|NCT01128972|886177|P4|STARTED|Period I||7
369630|NCT01128972|886178|P3|STARTED|Period I||7
369631|NCT01128972|886179|P2|STARTED|Period I||7
369632|NCT01128972|886180|P1|STARTED|Period I||7
369633|NCT01128959|886209|P1|NOT COMPLETED|Treatment Period||4
369634|NCT01128959|886209|P1|COMPLETED|Treatment Period||101
369635|NCT01128959|886209|P1|STARTED|Treatment Period||105
369636|NCT01128959|886209|P1|NOT COMPLETED|Lead in Period||3
369637|NCT01128959|886209|P1|COMPLETED|Lead in Period||105
369638|NCT01128959|886209|P1|STARTED|Lead in Period||108
369639|NCT01128946|886215|P4|NOT COMPLETED|Period IV||0
369640|NCT01128946|886216|P3|NOT COMPLETED|Period IV||0
369641|NCT01128946|886217|P2|NOT COMPLETED|Period IV||0
369642|NCT01128946|886218|P1|NOT COMPLETED|Period IV||0
369643|NCT01128946|886215|P4|COMPLETED|Period IV||19
369644|NCT01128946|886216|P3|COMPLETED|Period IV||19
369645|NCT01128946|886217|P2|COMPLETED|Period IV||20
369646|NCT01128946|886218|P1|COMPLETED|Period IV||19
369647|NCT01128946|886215|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
369648|NCT01128946|886216|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
369649|NCT01128946|886217|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
369650|NCT01128946|886218|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
369651|NCT01128946|886215|P4|NOT COMPLETED|Period III||0
369652|NCT01128946|886216|P3|NOT COMPLETED|Period III||0
369653|NCT01128946|886217|P2|NOT COMPLETED|Period III||0
369654|NCT01128946|886218|P1|NOT COMPLETED|Period III||1
369655|NCT01128946|886215|P4|COMPLETED|Period III||19
369656|NCT01128946|886216|P3|COMPLETED|Period III||20
369657|NCT01128946|886217|P2|COMPLETED|Period III||19
369658|NCT01128946|886218|P1|COMPLETED|Period III||19
369659|NCT01128946|886215|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
369660|NCT01128946|886216|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
369661|NCT01128946|886217|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
369662|NCT01128946|886218|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
369663|NCT01128946|886215|P4|NOT COMPLETED|Period II||1
369664|NCT01128946|886216|P3|NOT COMPLETED|Period II||0
369665|NCT01128946|886217|P2|NOT COMPLETED|Period II||1
369666|NCT01128946|886218|P1|NOT COMPLETED|Period II||0
369667|NCT01128946|886215|P4|COMPLETED|Period II||19
369668|NCT01128946|886216|P3|COMPLETED|Period II||20
369669|NCT01128946|886217|P2|COMPLETED|Period II||19
369670|NCT01128946|886218|P1|COMPLETED|Period II||20
369671|NCT01128946|886215|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
369672|NCT01128946|886216|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
369673|NCT01128946|886217|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
369674|NCT01128946|886218|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
369675|NCT01128946|886215|P4|NOT COMPLETED|Period I||1
369676|NCT01128946|886216|P3|NOT COMPLETED|Period I||1
369677|NCT01128946|886217|P2|NOT COMPLETED|Period I||1
369678|NCT01128946|886218|P1|NOT COMPLETED|Period I||0
369679|NCT01128946|886215|P4|COMPLETED|Period I||20
369680|NCT01128946|886216|P3|COMPLETED|Period I||20
369681|NCT01128946|886217|P2|COMPLETED|Period I||20
369682|NCT01128946|886218|P1|COMPLETED|Period I||20
369683|NCT01128946|886215|P4|STARTED|Period I||21
369684|NCT01128946|886216|P3|STARTED|Period I||21
369685|NCT01128946|886217|P2|STARTED|Period I||21
369686|NCT01128946|886218|P1|STARTED|Period I||20
369687|NCT01128894|886236|P2|NOT COMPLETED|Overall Study||68
369688|NCT01128894|886237|P1|NOT COMPLETED|Overall Study||58
369689|NCT01128894|886236|P2|COMPLETED|Overall Study||340
369690|NCT01128894|886237|P1|COMPLETED|Overall Study||346
369691|NCT01128894|886236|P2|STARTED|Overall Study||408
369692|NCT01128894|886237|P1|STARTED|Overall Study||404
369693|NCT01128829|886255|P2|NOT COMPLETED|Overall Study||0
369694|NCT01128829|886256|P1|NOT COMPLETED|Overall Study||0
369695|NCT01128829|886255|P2|COMPLETED|Overall Study||11
369696|NCT01128829|886256|P1|COMPLETED|Overall Study||6
369697|NCT01128829|886255|P2|STARTED|Overall Study||11
369698|NCT01128829|886256|P1|STARTED|Overall Study||6
369699|NCT01128738|886262|P2|NOT COMPLETED|Second TP||3
369700|NCT01128738|886263|P1|NOT COMPLETED|Second TP||0
369701|NCT01128738|886262|P2|COMPLETED|Second TP||63
369702|NCT01128738|886263|P1|COMPLETED|Second TP||34
369703|NCT01128738|886262|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
369795|NCT01128569|886419|P6|NOT COMPLETED|Treatment Period 3||0
369704|NCT01128738|886263|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
369705|NCT01128738|886262|P2|NOT COMPLETED|First Treatment Phase (TP)||1
369706|NCT01128738|886263|P1|NOT COMPLETED|First Treatment Phase (TP)||4
369707|NCT01128738|886262|P2|COMPLETED|First Treatment Phase (TP)||73
369708|NCT01128738|886263|P1|COMPLETED|First Treatment Phase (TP)||74
369709|NCT01128738|886262|P2|STARTED|First Treatment Phase (TP)||74
369710|NCT01128738|886263|P1|STARTED|First Treatment Phase (TP)||78
369711|NCT01128595|886386|P4|NOT COMPLETED|Treatment Period 4||0
369712|NCT01128595|886387|P3|NOT COMPLETED|Treatment Period 4||0
369713|NCT01128595|886388|P2|NOT COMPLETED|Treatment Period 4||0
369714|NCT01128595|886389|P1|NOT COMPLETED|Treatment Period 4||0
369715|NCT01128595|886386|P4|COMPLETED|Treatment Period 4||7
369716|NCT01128595|886387|P3|COMPLETED|Treatment Period 4||7
369717|NCT01128595|886388|P2|COMPLETED|Treatment Period 4||5
369718|NCT01128595|886389|P1|COMPLETED|Treatment Period 4||7
369719|NCT01128595|886386|P4|STARTED|Treatment Period 4||7
369720|NCT01128595|886387|P3|STARTED|Treatment Period 4||7
369721|NCT01128595|886388|P2|STARTED|Treatment Period 4||5
369722|NCT01128595|886389|P1|STARTED|Treatment Period 4||7
369723|NCT01128595|886386|P4|NOT COMPLETED|Washout Period 3||0
369724|NCT01128595|886387|P3|NOT COMPLETED|Washout Period 3||0
369725|NCT01128595|886388|P2|NOT COMPLETED|Washout Period 3||0
369726|NCT01128595|886389|P1|NOT COMPLETED|Washout Period 3||0
369727|NCT01128595|886386|P4|COMPLETED|Washout Period 3||7
369728|NCT01128595|886387|P3|COMPLETED|Washout Period 3||7
369729|NCT01128595|886388|P2|COMPLETED|Washout Period 3||5
369730|NCT01128595|886389|P1|COMPLETED|Washout Period 3||7
369731|NCT01128595|886386|P4|STARTED|Washout Period 3||7
369732|NCT01128595|886387|P3|STARTED|Washout Period 3||7
369733|NCT01128595|886388|P2|STARTED|Washout Period 3||5
369734|NCT01128595|886389|P1|STARTED|Washout Period 3||7
369735|NCT01128595|886386|P4|NOT COMPLETED|Treatment Period 3||0
369736|NCT01128595|886387|P3|NOT COMPLETED|Treatment Period 3||0
369737|NCT01128595|886388|P2|NOT COMPLETED|Treatment Period 3||1
369738|NCT01128595|886389|P1|NOT COMPLETED|Treatment Period 3||0
369739|NCT01128595|886386|P4|COMPLETED|Treatment Period 3||7
369740|NCT01128595|886387|P3|COMPLETED|Treatment Period 3||7
369741|NCT01128595|886388|P2|COMPLETED|Treatment Period 3||5
369742|NCT01128595|886389|P1|COMPLETED|Treatment Period 3||7
369743|NCT01128595|886386|P4|STARTED|Treatment Period 3||7
369744|NCT01128595|886387|P3|STARTED|Treatment Period 3||7
369745|NCT01128595|886388|P2|STARTED|Treatment Period 3||6
369746|NCT01128595|886389|P1|STARTED|Treatment Period 3||7
369747|NCT01128595|886386|P4|NOT COMPLETED|Washout Period 2||0
369748|NCT01128595|886387|P3|NOT COMPLETED|Washout Period 2||0
369749|NCT01128595|886388|P2|NOT COMPLETED|Washout Period 2||0
369750|NCT01128595|886389|P1|NOT COMPLETED|Washout Period 2||0
369751|NCT01128595|886386|P4|COMPLETED|Washout Period 2||7
369752|NCT01128595|886387|P3|COMPLETED|Washout Period 2||7
369753|NCT01128595|886388|P2|COMPLETED|Washout Period 2||6
369754|NCT01128595|886389|P1|COMPLETED|Washout Period 2||7
369755|NCT01128595|886386|P4|STARTED|Washout Period 2||7
369756|NCT01128595|886387|P3|STARTED|Washout Period 2||7
369757|NCT01128595|886388|P2|STARTED|Washout Period 2||6
369758|NCT01128595|886389|P1|STARTED|Washout Period 2||7
369759|NCT01128595|886386|P4|NOT COMPLETED|Treatment Period 2||0
369760|NCT01128595|886387|P3|NOT COMPLETED|Treatment Period 2||0
369761|NCT01128595|886388|P2|NOT COMPLETED|Treatment Period 2||0
369762|NCT01128595|886389|P1|NOT COMPLETED|Treatment Period 2||0
369763|NCT01128595|886386|P4|COMPLETED|Treatment Period 2||7
369764|NCT01128595|886387|P3|COMPLETED|Treatment Period 2||7
369765|NCT01128595|886388|P2|COMPLETED|Treatment Period 2||6
369766|NCT01128595|886389|P1|COMPLETED|Treatment Period 2||7
369767|NCT01128595|886386|P4|STARTED|Treatment Period 2||7
369768|NCT01128595|886387|P3|STARTED|Treatment Period 2||7
369769|NCT01128595|886388|P2|STARTED|Treatment Period 2||6
369770|NCT01128595|886389|P1|STARTED|Treatment Period 2||7
369771|NCT01128595|886386|P4|NOT COMPLETED|Washout Period 1||0
369772|NCT01128595|886387|P3|NOT COMPLETED|Washout Period 1||0
369773|NCT01128595|886388|P2|NOT COMPLETED|Washout Period 1||0
369774|NCT01128595|886389|P1|NOT COMPLETED|Washout Period 1||0
369775|NCT01128595|886386|P4|COMPLETED|Washout Period 1||7
369776|NCT01128595|886387|P3|COMPLETED|Washout Period 1||7
369777|NCT01128595|886388|P2|COMPLETED|Washout Period 1||6
369778|NCT01128595|886389|P1|COMPLETED|Washout Period 1||7
369779|NCT01128595|886386|P4|STARTED|Washout Period 1||7
369780|NCT01128595|886387|P3|STARTED|Washout Period 1||7
369781|NCT01128595|886388|P2|STARTED|Washout Period 1||6
369782|NCT01128595|886389|P1|STARTED|Washout Period 1||7
369783|NCT01128595|886386|P4|NOT COMPLETED|Treatment Period 1||0
369784|NCT01128595|886387|P3|NOT COMPLETED|Treatment Period 1||0
369785|NCT01128595|886388|P2|NOT COMPLETED|Treatment Period 1||0
369786|NCT01128595|886389|P1|NOT COMPLETED|Treatment Period 1||0
369787|NCT01128595|886386|P4|COMPLETED|Treatment Period 1||7
369788|NCT01128595|886387|P3|COMPLETED|Treatment Period 1||7
369789|NCT01128595|886388|P2|COMPLETED|Treatment Period 1||6
369790|NCT01128595|886389|P1|COMPLETED|Treatment Period 1||7
369791|NCT01128595|886386|P4|STARTED|Treatment Period 1||7
369792|NCT01128595|886387|P3|STARTED|Treatment Period 1||7
369793|NCT01128595|886388|P2|STARTED|Treatment Period 1||6
369794|NCT01128595|886389|P1|STARTED|Treatment Period 1||7
369796|NCT01128569|886420|P5|NOT COMPLETED|Treatment Period 3||0
369797|NCT01128569|886421|P4|NOT COMPLETED|Treatment Period 3||0
369798|NCT01128569|886422|P3|NOT COMPLETED|Treatment Period 3||0
369799|NCT01128569|886423|P2|NOT COMPLETED|Treatment Period 3||0
369800|NCT01128569|886424|P1|NOT COMPLETED|Treatment Period 3||0
369801|NCT01128569|886419|P6|COMPLETED|Treatment Period 3||9
369802|NCT01128569|886420|P5|COMPLETED|Treatment Period 3||9
369803|NCT01128569|886421|P4|COMPLETED|Treatment Period 3||8
369804|NCT01128569|886422|P3|COMPLETED|Treatment Period 3||8
369805|NCT01128569|886423|P2|COMPLETED|Treatment Period 3||7
369806|NCT01128569|886424|P1|COMPLETED|Treatment Period 3||9
369807|NCT01128569|886419|P6|STARTED|Treatment Period 3||9
369808|NCT01128569|886420|P5|STARTED|Treatment Period 3||9
369809|NCT01128569|886421|P4|STARTED|Treatment Period 3||8
369810|NCT01128569|886422|P3|STARTED|Treatment Period 3||8
369811|NCT01128569|886423|P2|STARTED|Treatment Period 3||7
369812|NCT01128569|886424|P1|STARTED|Treatment Period 3||9
369813|NCT01128569|886419|P6|NOT COMPLETED|Washout Period 2||0
369814|NCT01128569|886420|P5|NOT COMPLETED|Washout Period 2||0
369815|NCT01128569|886421|P4|NOT COMPLETED|Washout Period 2||0
369816|NCT01128569|886422|P3|NOT COMPLETED|Washout Period 2||0
369817|NCT01128569|886423|P2|NOT COMPLETED|Washout Period 2||0
369818|NCT01128569|886424|P1|NOT COMPLETED|Washout Period 2||0
369819|NCT01128569|886419|P6|COMPLETED|Washout Period 2||9
369820|NCT01128569|886420|P5|COMPLETED|Washout Period 2||9
369821|NCT01128569|886421|P4|COMPLETED|Washout Period 2||8
369822|NCT01128569|886422|P3|COMPLETED|Washout Period 2||8
369823|NCT01128569|886423|P2|COMPLETED|Washout Period 2||7
369824|NCT01128569|886424|P1|COMPLETED|Washout Period 2||9
369825|NCT01128569|886419|P6|STARTED|Washout Period 2||9
369826|NCT01128569|886420|P5|STARTED|Washout Period 2||9
369827|NCT01128569|886421|P4|STARTED|Washout Period 2||8
369828|NCT01128569|886422|P3|STARTED|Washout Period 2||8
369829|NCT01128569|886423|P2|STARTED|Washout Period 2||7
369830|NCT01128569|886424|P1|STARTED|Washout Period 2||9
369831|NCT01128569|886419|P6|NOT COMPLETED|Treatment Period 2||0
369832|NCT01128569|886420|P5|NOT COMPLETED|Treatment Period 2||0
369833|NCT01128569|886421|P4|NOT COMPLETED|Treatment Period 2||0
369834|NCT01128569|886422|P3|NOT COMPLETED|Treatment Period 2||0
369835|NCT01128569|886423|P2|NOT COMPLETED|Treatment Period 2||1
369836|NCT01128569|886424|P1|NOT COMPLETED|Treatment Period 2||0
369837|NCT01128569|886419|P6|COMPLETED|Treatment Period 2||9
369838|NCT01128569|886420|P5|COMPLETED|Treatment Period 2||9
369839|NCT01128569|886421|P4|COMPLETED|Treatment Period 2||8
369840|NCT01128569|886422|P3|COMPLETED|Treatment Period 2||8
369841|NCT01128569|886423|P2|COMPLETED|Treatment Period 2||7
369842|NCT01128569|886424|P1|COMPLETED|Treatment Period 2||9
369843|NCT01128569|886419|P6|STARTED|Treatment Period 2||9
369844|NCT01128569|886420|P5|STARTED|Treatment Period 2||9
369845|NCT01128569|886421|P4|STARTED|Treatment Period 2||8
369846|NCT01128569|886422|P3|STARTED|Treatment Period 2||8
369847|NCT01128569|886423|P2|STARTED|Treatment Period 2||8
369848|NCT01128569|886424|P1|STARTED|Treatment Period 2||9
369849|NCT01128569|886419|P6|NOT COMPLETED|Washout Period 1||0
369850|NCT01128569|886420|P5|NOT COMPLETED|Washout Period 1||0
369851|NCT01128569|886421|P4|NOT COMPLETED|Washout Period 1||0
369852|NCT01128569|886422|P3|NOT COMPLETED|Washout Period 1||1
369853|NCT01128569|886423|P2|NOT COMPLETED|Washout Period 1||0
369854|NCT01128569|886424|P1|NOT COMPLETED|Washout Period 1||0
369855|NCT01128569|886419|P6|COMPLETED|Washout Period 1||9
369856|NCT01128569|886420|P5|COMPLETED|Washout Period 1||9
369857|NCT01128569|886421|P4|COMPLETED|Washout Period 1||8
369858|NCT01128569|886422|P3|COMPLETED|Washout Period 1||8
369859|NCT01128569|886423|P2|COMPLETED|Washout Period 1||8
369860|NCT01128569|886424|P1|COMPLETED|Washout Period 1||9
369861|NCT01128569|886419|P6|STARTED|Washout Period 1||9
369862|NCT01128569|886420|P5|STARTED|Washout Period 1||9
369863|NCT01128569|886421|P4|STARTED|Washout Period 1||8
369864|NCT01128569|886422|P3|STARTED|Washout Period 1||9
369865|NCT01128569|886423|P2|STARTED|Washout Period 1||8
369866|NCT01128569|886424|P1|STARTED|Washout Period 1||9
369867|NCT01128569|886419|P6|NOT COMPLETED|Treatment Period 1||0
369868|NCT01128569|886420|P5|NOT COMPLETED|Treatment Period 1||0
369869|NCT01128569|886421|P4|NOT COMPLETED|Treatment Period 1||0
369870|NCT01128569|886422|P3|NOT COMPLETED|Treatment Period 1||0
369871|NCT01128569|886423|P2|NOT COMPLETED|Treatment Period 1||0
369872|NCT01128569|886424|P1|NOT COMPLETED|Treatment Period 1||0
369873|NCT01128569|886419|P6|COMPLETED|Treatment Period 1||9
369874|NCT01128569|886420|P5|COMPLETED|Treatment Period 1||9
369875|NCT01128569|886421|P4|COMPLETED|Treatment Period 1||8
369876|NCT01128569|886422|P3|COMPLETED|Treatment Period 1||9
369877|NCT01128569|886423|P2|COMPLETED|Treatment Period 1||8
369878|NCT01128569|886424|P1|COMPLETED|Treatment Period 1||9
369879|NCT01128569|886419|P6|STARTED|Treatment Period 1||9
369880|NCT01128569|886420|P5|STARTED|Treatment Period 1||9
369881|NCT01128569|886421|P4|STARTED|Treatment Period 1||8
369882|NCT01128569|886422|P3|STARTED|Treatment Period 1||9
369883|NCT01128569|886423|P2|STARTED|Treatment Period 1||8
369884|NCT01128569|886424|P1|STARTED|Treatment Period 1||9
369885|NCT01128543|886441|P1|NOT COMPLETED|Overall Study||4
369886|NCT01128543|886441|P1|COMPLETED|Overall Study||25
369887|NCT01128543|886441|P1|STARTED|Overall Study||29
369888|NCT01128426|886447|P1|NOT COMPLETED|Overall Study||0
369889|NCT01128426|886447|P1|COMPLETED|Overall Study||53902
369890|NCT01128426|886447|P1|STARTED|Overall Study||53902
369891|NCT01128413|886467|P2|NOT COMPLETED|Overall Study||1
369892|NCT01128413|886468|P1|NOT COMPLETED|Overall Study||4
369893|NCT01128413|886467|P2|COMPLETED|Overall Study||10
369894|NCT01128413|886468|P1|COMPLETED|Overall Study||7
369895|NCT01128413|886467|P2|STARTED|Overall Study||11
369896|NCT01128413|886468|P1|STARTED|Overall Study||11
369897|NCT01128400|886477|P3|NOT COMPLETED|Overall Study||16
369898|NCT01128400|886478|P2|NOT COMPLETED|Overall Study||0
369899|NCT01128400|886479|P1|NOT COMPLETED|Overall Study||2
369900|NCT01128400|886477|P3|COMPLETED|Overall Study||7
369901|NCT01128400|886478|P2|COMPLETED|Overall Study||9
369902|NCT01128400|886479|P1|COMPLETED|Overall Study||6
369903|NCT01128400|886477|P3|STARTED|Overall Study||23
369904|NCT01128400|886478|P2|STARTED|Overall Study||9
369905|NCT01128400|886479|P1|STARTED|Overall Study||8
369906|NCT01128361|886492|P2|NOT COMPLETED|Overall Study||3
369907|NCT01128361|886493|P1|NOT COMPLETED|Overall Study||5
369908|NCT01128361|886492|P2|COMPLETED|Overall Study||34
369909|NCT01128361|886493|P1|COMPLETED|Overall Study||34
369910|NCT01128361|886492|P2|STARTED|Overall Study||37
369911|NCT01128361|886493|P1|STARTED|Overall Study||39
369912|NCT01128270|886505|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
369913|NCT01128270|886505|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
369914|NCT01128270|886505|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
369915|NCT01128270|886505|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
369916|NCT01128270|886505|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
369917|NCT01128270|886505|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
369918|NCT01128270|886505|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
369919|NCT01128270|886505|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
369920|NCT01128270|886505|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
369921|NCT01128270|886505|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
369922|NCT01128270|886505|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
369923|NCT01128270|886505|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
369924|NCT01128244|886518|P1|NOT COMPLETED|Overall Study||3
369925|NCT01128244|886518|P1|COMPLETED|Overall Study||10
369926|NCT01128244|886518|P1|STARTED|Overall Study||13
369927|NCT01128192|886528|P3|NOT COMPLETED|Overall Study||0
369928|NCT01128192|886529|P2|NOT COMPLETED|Overall Study||0
369929|NCT01128192|886530|P1|NOT COMPLETED|Overall Study||0
369930|NCT01128192|886528|P3|COMPLETED|Overall Study||7
369931|NCT01128192|886529|P2|COMPLETED|Overall Study||19
369932|NCT01128192|886530|P1|COMPLETED|Overall Study||19
369933|NCT01128192|886528|P3|STARTED|Overall Study||7
369934|NCT01128192|886529|P2|STARTED|Overall Study||19
369935|NCT01128192|886530|P1|STARTED|Overall Study||19
369936|NCT01128179|886559|P2|NOT COMPLETED|Overall Study||0
369937|NCT01128179|886560|P1|NOT COMPLETED|Overall Study||2
369938|NCT01128179|886559|P2|COMPLETED|Overall Study||12
369939|NCT01128179|886560|P1|COMPLETED|Overall Study||21
369940|NCT01128179|886559|P2|STARTED|Overall Study||12
369941|NCT01128179|886560|P1|STARTED|Overall Study||23
369942|NCT01128153|886580|P2|NOT COMPLETED|Overall Study||15
369943|NCT01128153|886581|P1|NOT COMPLETED|Overall Study||16
369944|NCT01128153|886580|P2|COMPLETED|Overall Study|Completed 24 weeks|113
369945|NCT01128153|886581|P1|COMPLETED|Overall Study|Completed 24 weeks|113
369946|NCT01128153|886580|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
369947|NCT01128153|886581|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
369948|NCT01128153|886580|P2|STARTED|Overall Study|Randomised|128
369949|NCT01128153|886581|P1|STARTED|Overall Study|Randomised|129
369950|NCT01128114|886597|P1|NOT COMPLETED|Overall Study||8
369951|NCT01128114|886597|P1|COMPLETED|Overall Study||24
369952|NCT01128114|886597|P1|STARTED|Overall Study||32
369953|NCT01128049|886604|P3|NOT COMPLETED|Overall Study||0
369954|NCT01128049|886605|P2|NOT COMPLETED|Overall Study||0
369955|NCT01128049|886606|P1|NOT COMPLETED|Overall Study||0
369956|NCT01128049|886604|P3|COMPLETED|Overall Study||5
369957|NCT01128049|886605|P2|COMPLETED|Overall Study||5
369958|NCT01128049|886606|P1|COMPLETED|Overall Study||5
369959|NCT01128049|886604|P3|STARTED|Overall Study||5
369960|NCT01128049|886605|P2|STARTED|Overall Study||5
369961|NCT01128049|886606|P1|STARTED|Overall Study||5
369962|NCT01127763|886614|P1|NOT COMPLETED|Overall Study||5
369963|NCT01127763|886614|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
369964|NCT01127763|886614|P1|STARTED|Overall Study||25
369965|NCT01127737|886625|P2|NOT COMPLETED|Overall Study||0
369966|NCT01127737|886626|P1|NOT COMPLETED|Overall Study||0
369967|NCT01127737|886625|P2|COMPLETED|Overall Study||38
369968|NCT01127737|886626|P1|COMPLETED|Overall Study||37
369969|NCT01127737|886625|P2|STARTED|Overall Study||38
369970|NCT01127737|886626|P1|STARTED|Overall Study||37
369971|NCT01127659|886638|P6|NOT COMPLETED|Overall Study||0
369972|NCT01127659|886639|P5|NOT COMPLETED|Overall Study||0
369973|NCT01127659|886640|P4|NOT COMPLETED|Overall Study||4
369974|NCT01127659|886641|P3|NOT COMPLETED|Overall Study||2
369975|NCT01127659|886642|P2|NOT COMPLETED|Overall Study||8
369976|NCT01127659|886643|P1|NOT COMPLETED|Overall Study||2
369977|NCT01127659|886638|P6|COMPLETED|Overall Study||21
369978|NCT01127659|886639|P5|COMPLETED|Overall Study||50
369979|NCT01127659|886640|P4|COMPLETED|Overall Study||6
369980|NCT01127659|886641|P3|COMPLETED|Overall Study||10
369981|NCT01127659|886642|P2|COMPLETED|Overall Study||14
369982|NCT01127659|886643|P1|COMPLETED|Overall Study||20
369983|NCT01127659|886638|P6|STARTED|Overall Study||21
369984|NCT01127659|886639|P5|STARTED|Overall Study||50
369985|NCT01127659|886640|P4|STARTED|Overall Study||10
369986|NCT01127659|886641|P3|STARTED|Overall Study||12
369987|NCT01127659|886642|P2|STARTED|Overall Study||22
369988|NCT01127659|886643|P1|STARTED|Overall Study||22
369989|NCT01127646|886659|P2|NOT COMPLETED|Overall Study||1
369990|NCT01127646|886660|P1|NOT COMPLETED|Overall Study||1
369991|NCT01127646|886659|P2|COMPLETED|Overall Study||7
369992|NCT01127646|886660|P1|COMPLETED|Overall Study||14
369993|NCT01127646|886659|P2|STARTED|Overall Study||8
369994|NCT01127646|886660|P1|STARTED|Overall Study||15
369995|NCT01127607|886694|P2|NOT COMPLETED|Phase II (Between Subjects)||2
369996|NCT01127607|886695|P1|NOT COMPLETED|Phase II (Between Subjects)||1
369997|NCT01127607|886694|P2|COMPLETED|Phase II (Between Subjects)||11
369998|NCT01127607|886695|P1|COMPLETED|Phase II (Between Subjects)||13
369999|NCT01127607|886694|P2|STARTED|Phase II (Between Subjects)||13
370000|NCT01127607|886695|P1|STARTED|Phase II (Between Subjects)||14
370001|NCT01127607|886694|P2|NOT COMPLETED|Phase I (Within Subjects)||0
370002|NCT01127607|886695|P1|NOT COMPLETED|Phase I (Within Subjects)||0
370003|NCT01127607|886694|P2|COMPLETED|Phase I (Within Subjects)||13
370004|NCT01127607|886695|P1|COMPLETED|Phase I (Within Subjects)||14
370005|NCT01127607|886694|P2|STARTED|Phase I (Within Subjects)||13
370006|NCT01127607|886695|P1|STARTED|Phase I (Within Subjects)||14
370007|NCT01127581|886768|P2|NOT COMPLETED|Overall Study||0
370008|NCT01127581|886769|P1|NOT COMPLETED|Overall Study||0
370009|NCT01127581|886768|P2|COMPLETED|Overall Study||680
370010|NCT01127581|886769|P1|COMPLETED|Overall Study||678
370011|NCT01127581|886768|P2|STARTED|Overall Study||680
370012|NCT01127581|886769|P1|STARTED|Overall Study||678
370013|NCT01127438|886801|P6|NOT COMPLETED|Overall Study||0
370014|NCT01127438|886802|P5|NOT COMPLETED|Overall Study||0
370015|NCT01127438|886803|P4|NOT COMPLETED|Overall Study||0
370016|NCT01127438|886804|P3|NOT COMPLETED|Overall Study||0
370017|NCT01127438|886805|P2|NOT COMPLETED|Overall Study||0
370018|NCT01127438|886806|P1|NOT COMPLETED|Overall Study||0
370019|NCT01127438|886801|P6|COMPLETED|Overall Study||25
370020|NCT01127438|886802|P5|COMPLETED|Overall Study||28
370021|NCT01127438|886803|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
370022|NCT01127438|886804|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
370023|NCT01127438|886805|P2|COMPLETED|Overall Study||25
370024|NCT01127438|886806|P1|COMPLETED|Overall Study||25
370025|NCT01127438|886801|P6|STARTED|Overall Study||25
370026|NCT01127438|886802|P5|STARTED|Overall Study||28
370027|NCT01127438|886803|P4|STARTED|Overall Study||24
370028|NCT01127438|886804|P3|STARTED|Overall Study||26
370029|NCT01127438|886805|P2|STARTED|Overall Study||25
370030|NCT01127438|886806|P1|STARTED|Overall Study||25
370031|NCT01127321|886833|P5|NOT COMPLETED|Overall Study||0
370032|NCT01127321|886834|P4|NOT COMPLETED|Overall Study||0
370033|NCT01127321|886835|P3|NOT COMPLETED|Overall Study||0
370034|NCT01127321|886836|P2|NOT COMPLETED|Overall Study||0
370035|NCT01127321|886837|P1|NOT COMPLETED|Overall Study||0
370036|NCT01127321|886833|P5|COMPLETED|Overall Study||5
370037|NCT01127321|886834|P4|COMPLETED|Overall Study||7
370038|NCT01127321|886835|P3|COMPLETED|Overall Study||1
370039|NCT01127321|886836|P2|COMPLETED|Overall Study||1
370040|NCT01127321|886837|P1|COMPLETED|Overall Study||3
370041|NCT01127321|886833|P5|STARTED|Overall Study||5
370042|NCT01127321|886834|P4|STARTED|Overall Study||7
370043|NCT01127321|886835|P3|STARTED|Overall Study||1
370044|NCT01127321|886836|P2|STARTED|Overall Study||1
370045|NCT01127321|886837|P1|STARTED|Overall Study||3
370046|NCT01127256|886861|P2|NOT COMPLETED|Overall Study||39
370047|NCT01127256|886862|P1|NOT COMPLETED|Overall Study||39
370048|NCT01127256|886861|P2|COMPLETED|Overall Study||65
370049|NCT01127256|886862|P1|COMPLETED|Overall Study||57
370050|NCT01127256|886861|P2|STARTED|Overall Study||104
370051|NCT01127256|886862|P1|STARTED|Overall Study||96
370052|NCT01127165|886874|P2|NOT COMPLETED|Overall Study||19
370053|NCT01127165|886875|P1|NOT COMPLETED|Overall Study||16
370054|NCT01127165|886874|P2|COMPLETED|Overall Study||41
370055|NCT01127165|886875|P1|COMPLETED|Overall Study||49
370056|NCT01127165|886874|P2|STARTED|Overall Study||60
370057|NCT01127165|886875|P1|STARTED|Overall Study||65
370058|NCT01127139|886887|P1|NOT COMPLETED|Overall Study||57
370059|NCT01127139|886887|P1|COMPLETED|Overall Study||3771
370060|NCT01127139|886887|P1|Number of Participants Analyzed|Overall Study||3828
370061|NCT01127139|886887|P1|STARTED|Overall Study||3828
370062|NCT01127087|886904|P2|NOT COMPLETED|Overall Study||0
370063|NCT01127087|886905|P1|NOT COMPLETED|Overall Study||0
370064|NCT01127087|886904|P2|COMPLETED|Overall Study||2
370065|NCT01127087|886905|P1|COMPLETED|Overall Study||8
370066|NCT01127087|886904|P2|STARTED|Overall Study||2
370067|NCT01127087|886905|P1|STARTED|Overall Study||8
370068|NCT01126957|886913|P1|NOT COMPLETED|Overall Study||0
370069|NCT01126957|886913|P1|COMPLETED|Overall Study||103
370070|NCT01126957|886913|P1|STARTED|Overall Study||103
370071|NCT01126801|886920|P2|NOT COMPLETED|Overall Study||0
370072|NCT01126801|886921|P1|NOT COMPLETED|Overall Study||0
370073|NCT01126801|886920|P2|COMPLETED|Overall Study||1
370074|NCT01126801|886921|P1|COMPLETED|Overall Study||1
370075|NCT01126801|886920|P2|STARTED|Overall Study||1
370076|NCT01126801|886921|P1|STARTED|Overall Study||1
370077|NCT01126723|886929|P2|NOT COMPLETED|Overall Study||3
370078|NCT01126723|886930|P1|NOT COMPLETED|Overall Study||6
370079|NCT01126723|886929|P2|COMPLETED|Overall Study||28
370080|NCT01126723|886930|P1|COMPLETED|Overall Study||29
370081|NCT01126723|886929|P2|STARTED|Overall Study||31
370082|NCT01126723|886930|P1|STARTED|Overall Study||35
370083|NCT01126671|886938|P2|NOT COMPLETED|Overall Study||0
370084|NCT01126671|886939|P1|NOT COMPLETED|Overall Study||0
370085|NCT01126671|886938|P2|COMPLETED|Overall Study||29
370086|NCT01126671|886939|P1|COMPLETED|Overall Study||25
370087|NCT01126671|886938|P2|STARTED|Overall Study||29
370088|NCT01126671|886939|P1|STARTED|Overall Study||25
370089|NCT01126619|886947|P1|NOT COMPLETED|Overall Study||17
370090|NCT01126619|886947|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
370091|NCT01126619|886947|P1|STARTED|Overall Study||103
370092|NCT01126593|886962|P3|NOT COMPLETED|Overall Study||2
370093|NCT01126593|886963|P2|NOT COMPLETED|Overall Study||2
370094|NCT01126593|886964|P1|NOT COMPLETED|Overall Study||4
370095|NCT01126593|886962|P3|COMPLETED|Overall Study||32
370096|NCT01126593|886963|P2|COMPLETED|Overall Study||27
370097|NCT01126593|886964|P1|COMPLETED|Overall Study||29
370098|NCT01126593|886962|P3|STARTED|Overall Study||34
370099|NCT01126593|886963|P2|STARTED|Overall Study||29
370100|NCT01126593|886964|P1|STARTED|Overall Study||33
370101|NCT01126580|886975|P3|NOT COMPLETED|Overall Study||55
370102|NCT01126580|886976|P2|NOT COMPLETED|Overall Study||52
370103|NCT01126580|886977|P1|NOT COMPLETED|Overall Study||49
370104|NCT01126580|886975|P3|COMPLETED|Overall Study||213
370105|NCT01126580|886976|P2|COMPLETED|Overall Study||218
370106|NCT01126580|886977|P1|COMPLETED|Overall Study||220
370107|NCT01126580|886975|P3|Completed 26 Weeks|Overall Study||226
370108|NCT01126580|886976|P2|Completed 26 Weeks|Overall Study||242
370109|NCT01126580|886977|P1|Completed 26 Weeks|Overall Study||233
370110|NCT01126580|886975|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
370111|NCT01126580|886976|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
370112|NCT01126580|886977|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
370113|NCT01126580|886975|P3|STARTED|Overall Study||268
370114|NCT01126580|886976|P2|STARTED|Overall Study||270
370115|NCT01126580|886977|P1|STARTED|Overall Study||269
370116|NCT01126541|887072|P3|NOT COMPLETED|Overall Study||26
370117|NCT01126541|887073|P2|NOT COMPLETED|Overall Study||12
370118|NCT01126541|887074|P1|NOT COMPLETED|Overall Study||10
370119|NCT01126541|887072|P3|COMPLETED|Overall Study||55
370120|NCT01126541|887073|P2|COMPLETED|Overall Study||61
370121|NCT01126541|887074|P1|COMPLETED|Overall Study||60
370122|NCT01126541|887072|P3|STARTED|Overall Study||81
370123|NCT01126541|887073|P2|STARTED|Overall Study||73
370124|NCT01126541|887074|P1|STARTED|Overall Study||70
370125|NCT01126437|887158|P3|NOT COMPLETED|Overall Study||1313
370126|NCT01126437|887159|P2|NOT COMPLETED|Overall Study||1330
370127|NCT01126437|887160|P1|NOT COMPLETED|Overall Study||1341
370128|NCT01126437|887158|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
370129|NCT01126437|887159|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
370130|NCT01126437|887160|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
370131|NCT01126437|887158|P3|STARTED|Overall Study||5713
370132|NCT01126437|887159|P2|STARTED|Overall Study||5729
370133|NCT01126437|887160|P1|STARTED|Overall Study||5741
370134|NCT01126424|887198|P6|NOT COMPLETED|Overall Study||0
370135|NCT01126424|887199|P5|NOT COMPLETED|Overall Study||2
370136|NCT01126424|887200|P4|NOT COMPLETED|Overall Study||3
370137|NCT01126424|887201|P3|NOT COMPLETED|Overall Study||1
370138|NCT01126424|887202|P2|NOT COMPLETED|Overall Study||0
370139|NCT01126424|887203|P1|NOT COMPLETED|Overall Study||0
370140|NCT01126424|887198|P6|COMPLETED|Overall Study||4
370141|NCT01126424|887199|P5|COMPLETED|Overall Study||2
370142|NCT01126424|887200|P4|COMPLETED|Overall Study||3
370143|NCT01126424|887201|P3|COMPLETED|Overall Study||4
370144|NCT01126424|887202|P2|COMPLETED|Overall Study||4
370145|NCT01126424|887203|P1|COMPLETED|Overall Study||3
370146|NCT01126424|887198|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
370147|NCT01126424|887199|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
370148|NCT01126424|887200|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
370149|NCT01126424|887201|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
370150|NCT01126424|887202|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
370151|NCT01126424|887203|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
370152|NCT01126424|887198|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
370153|NCT01126424|887199|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
370154|NCT01126424|887200|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
370155|NCT01126424|887201|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
370156|NCT01126424|887202|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
370157|NCT01126424|887203|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
370158|NCT01126359|887226|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
370159|NCT01126359|887227|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
370160|NCT01126359|887226|P2|COMPLETED|Second Intervention (20-minutes)||5
370161|NCT01126359|887227|P1|COMPLETED|Second Intervention (20-minutes)||5
370162|NCT01126359|887226|P2|STARTED|Second Intervention (20-minutes)||5
370163|NCT01126359|887227|P1|STARTED|Second Intervention (20-minutes)||5
370164|NCT01126359|887226|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
370165|NCT01126359|887227|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
370166|NCT01126359|887226|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
370167|NCT01126359|887227|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
370168|NCT01126359|887226|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
370169|NCT01126359|887227|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
370170|NCT01126359|887226|P2|NOT COMPLETED|First Intervention (20-minutes)||1
370171|NCT01126359|887227|P1|NOT COMPLETED|First Intervention (20-minutes)||0
370172|NCT01126359|887226|P2|COMPLETED|First Intervention (20-minutes)||5
370173|NCT01126359|887227|P1|COMPLETED|First Intervention (20-minutes)||5
370174|NCT01126359|887226|P2|STARTED|First Intervention (20-minutes)||6
370175|NCT01126359|887227|P1|STARTED|First Intervention (20-minutes)||5
370176|NCT01126268|887239|P1|NOT COMPLETED|Overall Study||1
370177|NCT01126268|887239|P1|COMPLETED|Overall Study||37
370178|NCT01126268|887239|P1|STARTED|Overall Study||38
370179|NCT01126099|887263|P2|NOT COMPLETED|Open-label Extension||1
370180|NCT01126099|887264|P1|NOT COMPLETED|Open-label Extension||1
370181|NCT01126099|887263|P2|COMPLETED|Open-label Extension||6
370182|NCT01126099|887264|P1|COMPLETED|Open-label Extension||4
370183|NCT01126099|887263|P2|STARTED|Open-label Extension||7
370184|NCT01126099|887264|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
370185|NCT01126099|887263|P2|NOT COMPLETED|Double Blind Phase||2
370186|NCT01126099|887264|P1|NOT COMPLETED|Double Blind Phase||4
370187|NCT01126099|887263|P2|COMPLETED|Double Blind Phase||7
370188|NCT01126099|887264|P1|COMPLETED|Double Blind Phase||7
370189|NCT01126099|887263|P2|STARTED|Double Blind Phase||9
370190|NCT01126099|887264|P1|STARTED|Double Blind Phase||11
370191|NCT01126060|887278|P2|NOT COMPLETED|Overall Study||2
370192|NCT01126060|887279|P1|NOT COMPLETED|Overall Study||0
370193|NCT01126060|887278|P2|COMPLETED|Overall Study||38
370194|NCT01126060|887279|P1|COMPLETED|Overall Study||40
370195|NCT01126060|887278|P2|STARTED|Overall Study||40
370196|NCT01126060|887279|P1|STARTED|Overall Study||40
370197|NCT01125930|887287|P2|NOT COMPLETED|Overall Study||10
370198|NCT01125930|887288|P1|NOT COMPLETED|Overall Study||1
370199|NCT01125930|887287|P2|COMPLETED|Overall Study||36
370200|NCT01125930|887288|P1|COMPLETED|Overall Study||21
370201|NCT01125930|887287|P2|STARTED|Overall Study||46
370202|NCT01125930|887288|P1|STARTED|Overall Study||22
370203|NCT01125917|887442|P1|NOT COMPLETED|Overall Study||339
370204|NCT01125917|887442|P1|COMPLETED|Overall Study||15
370205|NCT01125917|887442|P1|STARTED|Overall Study||354
370206|NCT01125813|887446|P1|NOT COMPLETED|Overall Study||6
370207|NCT01125813|887446|P1|COMPLETED|Overall Study||30
370208|NCT01125813|887446|P1|STARTED|Overall Study||36
370209|NCT01125800|887456|P5|NOT COMPLETED|Phase II||11
370210|NCT01125800|887457|P4|NOT COMPLETED|Phase II||1
370211|NCT01125800|887458|P3|NOT COMPLETED|Phase II||0
370212|NCT01125800|887459|P2|NOT COMPLETED|Phase II||0
370213|NCT01125800|887460|P1|NOT COMPLETED|Phase II||0
370214|NCT01125800|887456|P5|COMPLETED|Phase II||5
370215|NCT01125800|887457|P4|COMPLETED|Phase II||0
370216|NCT01125800|887458|P3|COMPLETED|Phase II||0
370217|NCT01125800|887459|P2|COMPLETED|Phase II||0
370218|NCT01125800|887460|P1|COMPLETED|Phase II||0
370219|NCT01125800|887456|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
370220|NCT01125800|887457|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
370221|NCT01125800|887458|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
370222|NCT01125800|887459|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
370223|NCT01125800|887460|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
370224|NCT01125800|887456|P5|NOT COMPLETED|Phase I||0
370225|NCT01125800|887457|P4|NOT COMPLETED|Phase I||11
370226|NCT01125800|887458|P3|NOT COMPLETED|Phase I||4
370227|NCT01125800|887459|P2|NOT COMPLETED|Phase I||9
370228|NCT01125800|887460|P1|NOT COMPLETED|Phase I||8
370229|NCT01125800|887456|P5|COMPLETED|Phase I||0
370230|NCT01125800|887457|P4|COMPLETED|Phase I||10
370231|NCT01125800|887458|P3|COMPLETED|Phase I||7
370232|NCT01125800|887459|P2|COMPLETED|Phase I||7
370233|NCT01125800|887460|P1|COMPLETED|Phase I||3
370234|NCT01125800|887456|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
370235|NCT01125800|887457|P4|STARTED|Phase I||21
370236|NCT01125800|887458|P3|STARTED|Phase I||11
370237|NCT01125800|887459|P2|STARTED|Phase I||16
370238|NCT01125800|887460|P1|STARTED|Phase I||11
370239|NCT01125774|887499|P4|NOT COMPLETED|Overall Study||3
370240|NCT01125774|887500|P3|NOT COMPLETED|Overall Study||9
370241|NCT01125774|887501|P2|NOT COMPLETED|Overall Study||554
370242|NCT01125774|887502|P1|NOT COMPLETED|Overall Study||1125
370243|NCT01125774|887499|P4|COMPLETED|Overall Study|Completed study at least once|3
370244|NCT01125774|887500|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
370245|NCT01125774|887501|P2|COMPLETED|Overall Study||948
370246|NCT01125774|887502|P1|COMPLETED|Overall Study||1893
370247|NCT01125774|887499|P4|Treated|Overall Study||5
370248|NCT01125774|887500|P3|Treated|Overall Study|Received telcagepant|21
370249|NCT01125774|887501|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
370250|NCT01125774|887502|P1|Treated|Overall Study||2638
370251|NCT01125774|887499|P4|STARTED|Overall Study|Unique participants randomized|6
370252|NCT01125774|887500|P3|STARTED|Overall Study|Unique participants randomized|22
370253|NCT01125774|887501|P2|STARTED|Overall Study|Randomized|1502
370254|NCT01125774|887502|P1|STARTED|Overall Study|Randomized|3018
370255|NCT01125748|887526|P2|NOT COMPLETED|Overall Study||14
370256|NCT01125748|887527|P1|NOT COMPLETED|Overall Study||10
370257|NCT01125748|887526|P2|COMPLETED|Overall Study||74
370258|NCT01125748|887527|P1|COMPLETED|Overall Study||78
370259|NCT01125748|887526|P2|STARTED|Overall Study||88
370260|NCT01125748|887527|P1|STARTED|Overall Study||88
370261|NCT01125722|887537|P2|NOT COMPLETED|Overall Study||1
370262|NCT01125722|887538|P1|NOT COMPLETED|Overall Study||3
370263|NCT01125722|887537|P2|COMPLETED|Overall Study||36
370264|NCT01125722|887538|P1|COMPLETED|Overall Study||34
370265|NCT01125722|887537|P2|STARTED|Overall Study||37
370266|NCT01125722|887538|P1|STARTED|Overall Study||37
370267|NCT01125605|887552|P1|NOT COMPLETED|Overall Study||0
370268|NCT01125605|887552|P1|COMPLETED|Overall Study||325
370269|NCT01125605|887552|P1|Safety|Overall Study|1 patient was only analysed for safety|326
370270|NCT01125605|887552|P1|STARTED|Overall Study|started = had baseline values|325
370271|NCT01125566|887585|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
370272|NCT01125566|887586|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
370273|NCT01125566|887587|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
370274|NCT01125566|887585|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
370275|NCT01125566|887586|P2|COMPLETED|Patients Who Switched From AV to TV||0
370276|NCT01125566|887587|P1|COMPLETED|Patients Who Switched From AV to TV||0
370277|NCT01125566|887585|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
370278|NCT01125566|887586|P2|STARTED|Patients Who Switched From AV to TV||0
370279|NCT01125566|887587|P1|STARTED|Patients Who Switched From AV to TV||0
370280|NCT01125566|887585|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
370281|NCT01125566|887586|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
370282|NCT01125566|887587|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
370283|NCT01125566|887585|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
370284|NCT01125566|887586|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
370285|NCT01125566|887587|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
370286|NCT01125566|887585|P3|STARTED|Patients Before the Switch (26Apr2013)||0
370287|NCT01125566|887586|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
370288|NCT01125566|887587|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
370289|NCT01125514|887600|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
370290|NCT01125514|887600|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
370291|NCT01125514|887600|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
370292|NCT01125514|887600|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
370293|NCT01125514|887600|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
370294|NCT01125514|887600|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
370295|NCT01125514|887600|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
370296|NCT01125514|887600|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
370297|NCT01125514|887600|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
370298|NCT01125514|887600|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
370299|NCT01125514|887600|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
370300|NCT01125189|887675|P3|NOT COMPLETED|Follow up Period||16
370301|NCT01125189|887676|P2|NOT COMPLETED|Follow up Period||15
370302|NCT01125189|887677|P1|NOT COMPLETED|Follow up Period||20
370303|NCT01125189|887675|P3|COMPLETED|Follow up Period||58
370304|NCT01125189|887676|P2|COMPLETED|Follow up Period||138
370305|NCT01125189|887677|P1|COMPLETED|Follow up Period||132
370306|NCT01125189|887675|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
370307|NCT01125189|887676|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
370308|NCT01125189|887677|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
370309|NCT01125189|887675|P3|NOT COMPLETED|Treatment Period||41
370310|NCT01125189|887676|P2|NOT COMPLETED|Treatment Period||35
370311|NCT01125189|887677|P1|NOT COMPLETED|Treatment Period||31
370312|NCT01125189|887675|P3|COMPLETED|Treatment Period||37
370313|NCT01125189|887676|P2|COMPLETED|Treatment Period||123
370314|NCT01125189|887677|P1|COMPLETED|Treatment Period||128
370315|NCT01125189|887675|P3|STARTED|Treatment Period||78
370316|NCT01125189|887676|P2|STARTED|Treatment Period||158
370317|NCT01125189|887677|P1|STARTED|Treatment Period||159
370318|NCT01125098|887705|P2|NOT COMPLETED|Overall Study||0
370319|NCT01125098|887706|P1|NOT COMPLETED|Overall Study||3
370320|NCT01125098|887705|P2|COMPLETED|Overall Study||90
370321|NCT01125098|887706|P1|COMPLETED|Overall Study||88
370322|NCT01125098|887705|P2|STARTED|Overall Study||90
370323|NCT01125098|887706|P1|STARTED|Overall Study||91
370324|NCT01124955|887714|P2|NOT COMPLETED|Overall Study||0
370325|NCT01124955|887715|P1|NOT COMPLETED|Overall Study||0
370326|NCT01124955|887714|P2|COMPLETED|Overall Study||40
370327|NCT01124955|887715|P1|COMPLETED|Overall Study||40
370328|NCT01124955|887714|P2|STARTED|Overall Study||40
370329|NCT01124955|887715|P1|STARTED|Overall Study||40
370330|NCT01124916|887731|P2|NOT COMPLETED|Overall Study||2
370331|NCT01124916|887732|P1|NOT COMPLETED|Overall Study||3
370332|NCT01124916|887731|P2|COMPLETED|Overall Study||38
370333|NCT01124916|887732|P1|COMPLETED|Overall Study||35
370334|NCT01124916|887731|P2|STARTED|Overall Study||40
370335|NCT01124916|887732|P1|STARTED|Overall Study||38
370336|NCT01124864|887746|P6|NOT COMPLETED|Overall Study||3
370337|NCT01124864|887747|P5|NOT COMPLETED|Overall Study||30
370338|NCT01124864|887748|P4|NOT COMPLETED|Overall Study||21
370339|NCT01124864|887749|P3|NOT COMPLETED|Overall Study||34
370340|NCT01124864|887750|P2|NOT COMPLETED|Overall Study||35
370341|NCT01124864|887751|P1|NOT COMPLETED|Overall Study||28
370342|NCT01124864|887746|P6|COMPLETED|Overall Study||0
370343|NCT01124864|887747|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
370344|NCT01124864|887748|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
370345|NCT01124864|887749|P3|COMPLETED|Overall Study||0
370346|NCT01124864|887750|P2|COMPLETED|Overall Study||0
370347|NCT01124864|887751|P1|COMPLETED|Overall Study||0
370348|NCT01124864|887746|P6|STARTED|Overall Study||3
370349|NCT01124864|887747|P5|STARTED|Overall Study||31
370350|NCT01124864|887748|P4|STARTED|Overall Study||22
370351|NCT01124864|887749|P3|STARTED|Overall Study||34
370352|NCT01124864|887750|P2|STARTED|Overall Study||35
370353|NCT01124864|887751|P1|STARTED|Overall Study||28
370354|NCT01124838|887785|P2|NOT COMPLETED|Overall Study||15
370355|NCT01124838|887786|P1|NOT COMPLETED|Overall Study||18
370356|NCT01124838|887785|P2|COMPLETED|Overall Study||116
370357|NCT01124838|887786|P1|COMPLETED|Overall Study||112
370358|NCT01124838|887785|P2|Enrolled in Japan Sub-study|Overall Study||16
370359|NCT01124838|887786|P1|Enrolled in Japan Sub-study|Overall Study||16
370360|NCT01124838|887785|P2|Enrolled in Main Study|Overall Study||115
370361|NCT01124838|887786|P1|Enrolled in Main Study|Overall Study||114
370362|NCT01124838|887785|P2|STARTED|Overall Study||131
370363|NCT01124838|887786|P1|STARTED|Overall Study||130
370364|NCT01124786|887832|P2|NOT COMPLETED|Overall Study||5
370365|NCT01124786|887833|P1|NOT COMPLETED|Overall Study||4
370366|NCT01124786|887832|P2|COMPLETED|Overall Study||180
370367|NCT01124786|887833|P1|COMPLETED|Overall Study||178
370368|NCT01124786|887832|P2|Tumor Evaluable Population|Overall Study||180
370369|NCT01124786|887833|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
370370|NCT01124786|887832|P2|Safety Population|Overall Study||181
370371|NCT01124786|887833|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
370372|NCT01124786|887832|P2|Intent-to-Treat (ITT) Population|Overall Study||185
370373|NCT01124786|887833|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
370374|NCT01124786|887832|P2|STARTED|Overall Study||185
370375|NCT01124786|887833|P1|STARTED|Overall Study||182
370376|NCT01124643|887853|P1|NOT COMPLETED|Overall Study||1
370377|NCT01124643|887853|P1|COMPLETED|Overall Study||34
370378|NCT01124643|887853|P1|STARTED|Overall Study||35
370379|NCT01124617|887867|P2|NOT COMPLETED|Overall Study||6
370380|NCT01124617|887868|P1|NOT COMPLETED|Overall Study||19
370381|NCT01124617|887867|P2|COMPLETED|Overall Study||25
370382|NCT01124617|887868|P1|COMPLETED|Overall Study||41
370383|NCT01124617|887867|P2|STARTED|Overall Study||31
370384|NCT01124617|887868|P1|STARTED|Overall Study||60
370385|NCT01124604|887900|P2|NOT COMPLETED|Overall Study||2
370386|NCT01124604|887901|P1|NOT COMPLETED|Overall Study||15
370387|NCT01124604|887900|P2|COMPLETED|Overall Study||29
370388|NCT01124604|887901|P1|COMPLETED|Overall Study||45
370389|NCT01124604|887900|P2|STARTED|Overall Study||31
370390|NCT01124604|887901|P1|STARTED|Overall Study||60
370391|NCT01124448|887940|P2|NOT COMPLETED|Overall Study||3
370392|NCT01124448|887941|P1|NOT COMPLETED|Overall Study||2
370393|NCT01124448|887940|P2|COMPLETED|Overall Study||12
370394|NCT01124448|887941|P1|COMPLETED|Overall Study||23
370395|NCT01124448|887940|P2|STARTED|Overall Study||15
370396|NCT01124448|887941|P1|STARTED|Overall Study||25
370397|NCT01124422|887949|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
370398|NCT01124422|887950|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
370399|NCT01124422|887951|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
370400|NCT01124422|887949|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
370401|NCT01124422|887950|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
370402|NCT01124422|887951|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
370403|NCT01124422|887949|P3|STARTED|4-Week Double-blind Treatment Phase||124
370404|NCT01124422|887950|P2|STARTED|4-Week Double-blind Treatment Phase||131
370405|NCT01124422|887951|P1|STARTED|4-Week Double-blind Treatment Phase||0
370406|NCT01124422|887949|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
370407|NCT01124422|887950|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
370408|NCT01124422|887951|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
370409|NCT01124422|887949|P3|COMPLETED|4-Week Open-label Run-in Phase||0
370410|NCT01124422|887950|P2|COMPLETED|4-Week Open-label Run-in Phase||0
370411|NCT01124422|887951|P1|COMPLETED|4-Week Open-label Run-in Phase||255
370412|NCT01124422|887949|P3|STARTED|4-Week Open-label Run-in Phase||0
370413|NCT01124422|887950|P2|STARTED|4-Week Open-label Run-in Phase||0
370414|NCT01124422|887951|P1|STARTED|4-Week Open-label Run-in Phase||338
370415|NCT01124370|887993|P1|NOT COMPLETED|Overall Study||20
370416|NCT01124370|887993|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
370417|NCT01124370|887993|P1|3 Month Visit|Overall Study|Defines evaluable population|47
370418|NCT01124370|887993|P1|Therapy Initiated|Overall Study||48
370419|NCT01124370|887993|P1|Successfully Implanted|Overall Study||50
370420|NCT01124370|887993|P1|STARTED|Overall Study|Underwent implant attempt|57
370421|NCT01124305|888005|P2|NOT COMPLETED|Overall Study||10
370422|NCT01124305|888006|P1|NOT COMPLETED|Overall Study||8
370423|NCT01124305|888005|P2|COMPLETED|Overall Study||26
370424|NCT01124305|888006|P1|COMPLETED|Overall Study||26
370425|NCT01124305|888005|P2|STARTED|Overall Study||36
370426|NCT01124305|888006|P1|STARTED|Overall Study||34
370427|NCT01124292|888021|P3|NOT COMPLETED|Overall Study||10
370428|NCT01124292|888022|P2|NOT COMPLETED|Overall Study||15
370429|NCT01124292|888023|P1|NOT COMPLETED|Overall Study||2
370430|NCT01124292|888021|P3|COMPLETED|Overall Study||11
370431|NCT01124292|888022|P2|COMPLETED|Overall Study||9
370432|NCT01124292|888023|P1|COMPLETED|Overall Study||14
370433|NCT01124292|888021|P3|STARTED|Overall Study||21
370434|NCT01124292|888022|P2|STARTED|Overall Study||24
370435|NCT01124292|888023|P1|STARTED|Overall Study||16
370436|NCT01124188|888081|P2|NOT COMPLETED|Overall Study||6
370437|NCT01124188|888082|P1|NOT COMPLETED|Overall Study||8
370438|NCT01124188|888081|P2|COMPLETED|Overall Study||65
370439|NCT01124188|888082|P1|COMPLETED|Overall Study||60
370440|NCT01124188|888081|P2|STARTED|Overall Study||71
370441|NCT01124188|888082|P1|STARTED|Overall Study||68
370442|NCT01124175|888094|P2|NOT COMPLETED|Second Intervention||0
370443|NCT01124175|888095|P1|NOT COMPLETED|Second Intervention||0
370444|NCT01124175|888094|P2|COMPLETED|Second Intervention||38
370445|NCT01124175|888095|P1|COMPLETED|Second Intervention||40
370446|NCT01124175|888094|P2|STARTED|Second Intervention||38
370447|NCT01124175|888095|P1|STARTED|Second Intervention||40
370448|NCT01124175|888094|P2|NOT COMPLETED|Washout of 7 Days||2
370449|NCT01124175|888095|P1|NOT COMPLETED|Washout of 7 Days||0
370450|NCT01124175|888094|P2|COMPLETED|Washout of 7 Days||38
370451|NCT01124175|888095|P1|COMPLETED|Washout of 7 Days||40
370452|NCT01124175|888094|P2|STARTED|Washout of 7 Days||40
370453|NCT01124175|888095|P1|STARTED|Washout of 7 Days||40
370454|NCT01124175|888094|P2|NOT COMPLETED|First Intervention||0
370455|NCT01124175|888095|P1|NOT COMPLETED|First Intervention||0
370456|NCT01124175|888094|P2|COMPLETED|First Intervention||40
370457|NCT01124175|888095|P1|COMPLETED|First Intervention||40
370458|NCT01124175|888094|P2|STARTED|First Intervention||40
370459|NCT01124175|888095|P1|STARTED|First Intervention||40
370460|NCT01124162|888113|P2|NOT COMPLETED|Second Intervention||0
370461|NCT01124162|888114|P1|NOT COMPLETED|Second Intervention||0
370462|NCT01124162|888113|P2|COMPLETED|Second Intervention||40
370463|NCT01124162|888114|P1|COMPLETED|Second Intervention||37
370464|NCT01124162|888113|P2|STARTED|Second Intervention||40
370465|NCT01124162|888114|P1|STARTED|Second Intervention||37
370466|NCT01124162|888113|P2|NOT COMPLETED|Washout of 7 Days||0
370467|NCT01124162|888114|P1|NOT COMPLETED|Washout of 7 Days||1
370468|NCT01124162|888113|P2|COMPLETED|Washout of 7 Days||40
370469|NCT01124162|888114|P1|COMPLETED|Washout of 7 Days||37
370470|NCT01124162|888113|P2|STARTED|Washout of 7 Days||40
370471|NCT01124162|888114|P1|STARTED|Washout of 7 Days||38
370472|NCT01124162|888113|P2|NOT COMPLETED|First Intervention||0
370473|NCT01124162|888114|P1|NOT COMPLETED|First Intervention||2
370474|NCT01124162|888113|P2|COMPLETED|First Intervention||40
370475|NCT01124162|888114|P1|COMPLETED|First Intervention||38
370476|NCT01124162|888113|P2|STARTED|First Intervention||40
370477|NCT01124162|888114|P1|STARTED|First Intervention||40
370478|NCT01124149|888130|P1|NOT COMPLETED|Maintenance Phase||96
370479|NCT01124149|888130|P1|COMPLETED|Maintenance Phase||373
370480|NCT01124149|888130|P1|STARTED|Maintenance Phase||469
370481|NCT01124149|888130|P1|NOT COMPLETED|Acute Phase||83
370482|NCT01124149|888130|P1|COMPLETED|Acute Phase||639
370483|NCT01124149|888130|P1|STARTED|Acute Phase||722
370484|NCT01124097|888150|P4|NOT COMPLETED|Overall Study||14
370485|NCT01124097|888151|P3|NOT COMPLETED|Overall Study||20
370486|NCT01124097|888152|P2|NOT COMPLETED|Overall Study||22
370487|NCT01124097|888153|P1|NOT COMPLETED|Overall Study||34
370488|NCT01124097|888150|P4|COMPLETED|Overall Study||46
370489|NCT01124097|888151|P3|COMPLETED|Overall Study||40
370490|NCT01124097|888152|P2|COMPLETED|Overall Study||38
370491|NCT01124097|888153|P1|COMPLETED|Overall Study||26
370492|NCT01124097|888150|P4|Efficacy Population|Overall Study||51
370493|NCT01124097|888151|P3|Efficacy Population|Overall Study||53
370494|NCT01124097|888152|P2|Efficacy Population|Overall Study||53
370495|NCT01124097|888153|P1|Efficacy Population|Overall Study||52
370496|NCT01124097|888150|P4|Safety Population|Overall Study||60
370497|NCT01124097|888151|P3|Safety Population|Overall Study||60
370498|NCT01124097|888152|P2|Safety Population|Overall Study||60
370499|NCT01124097|888153|P1|Safety Population|Overall Study||60
370500|NCT01124097|888150|P4|STARTED|Overall Study||60
370501|NCT01124097|888151|P3|STARTED|Overall Study||60
370502|NCT01124097|888152|P2|STARTED|Overall Study||60
370503|NCT01124097|888153|P1|STARTED|Overall Study||60
370504|NCT01124045|888165|P2|NOT COMPLETED|Overall Study||3
370505|NCT01124045|888166|P1|NOT COMPLETED|Overall Study||0
370506|NCT01124045|888165|P2|COMPLETED|Overall Study||37
370507|NCT01124045|888166|P1|COMPLETED|Overall Study||39
370508|NCT01124045|888165|P2|STARTED|Overall Study||40
370509|NCT01124045|888166|P1|STARTED|Overall Study||39
370510|NCT01124006|888199|P3|NOT COMPLETED|Overall Study||2
370511|NCT01124006|888200|P2|NOT COMPLETED|Overall Study||2
370512|NCT01124006|888201|P1|NOT COMPLETED|Overall Study||3
370513|NCT01124006|888199|P3|COMPLETED|Overall Study||2
370514|NCT01124006|888200|P2|COMPLETED|Overall Study||8
370515|NCT01124006|888201|P1|COMPLETED|Overall Study||7
370516|NCT01124006|888199|P3|STARTED|Overall Study||4
370517|NCT01124006|888200|P2|STARTED|Overall Study||10
370518|NCT01124006|888201|P1|STARTED|Overall Study||10
370519|NCT01123980|888229|P2|NOT COMPLETED|Overall Study||24
370520|NCT01123980|888230|P1|NOT COMPLETED|Overall Study||19
370521|NCT01123980|888229|P2|COMPLETED|Overall Study||236
370522|NCT01123980|888230|P1|COMPLETED|Overall Study||242
370523|NCT01123980|888229|P2|STARTED|Overall Study||260
370524|NCT01123980|888230|P1|STARTED|Overall Study||261
370525|NCT01123941|888250|P2|NOT COMPLETED|Overall Study||1
370526|NCT01123941|888251|P1|NOT COMPLETED|Overall Study||2
370527|NCT01123941|888250|P2|COMPLETED|Overall Study||24
370528|NCT01123941|888251|P1|COMPLETED|Overall Study||23
370529|NCT01123941|888250|P2|STARTED|Overall Study||25
370530|NCT01123941|888251|P1|STARTED|Overall Study||25
370531|NCT01123928|888265|P2|NOT COMPLETED|Overall Study||0
370532|NCT01123928|888266|P1|NOT COMPLETED|Overall Study||0
370533|NCT01123928|888265|P2|COMPLETED|Overall Study||222
370534|NCT01123928|888266|P1|COMPLETED|Overall Study||212
370535|NCT01123928|888265|P2|STARTED|Overall Study||222
370536|NCT01123928|888266|P1|STARTED|Overall Study||212
370537|NCT01123889|888286|P2|NOT COMPLETED|Overall Study||1
370538|NCT01123889|888287|P1|NOT COMPLETED|Overall Study||3
370539|NCT01123889|888286|P2|COMPLETED|Overall Study||6
370540|NCT01123889|888287|P1|COMPLETED|Overall Study||2
370541|NCT01123889|888286|P2|STARTED|Overall Study||7
370542|NCT01123889|888287|P1|STARTED|Overall Study||5
370543|NCT01123850|888297|P1|NOT COMPLETED|Overall Study||45
370544|NCT01123850|888297|P1|COMPLETED|Overall Study||0
370545|NCT01123850|888297|P1|STARTED|Overall Study||45
370546|NCT01123642|888302|P1|NOT COMPLETED|Overall Study||68
370547|NCT01123642|888302|P1|COMPLETED|Overall Study||277
370548|NCT01123642|888302|P1|STARTED|Overall Study||345
370549|NCT01123512|888308|P2|NOT COMPLETED|Overall Study||21
370550|NCT01123512|888309|P1|NOT COMPLETED|Overall Study||26
370551|NCT01123512|888308|P2|COMPLETED|Overall Study||126
370552|NCT01123512|888309|P1|COMPLETED|Overall Study||127
370553|NCT01123512|888308|P2|STARTED|Overall Study||147
370554|NCT01123512|888309|P1|STARTED|Overall Study||153
370555|NCT01123395|888315|P2|NOT COMPLETED|Period 2||0
370556|NCT01123395|888316|P1|NOT COMPLETED|Period 2||0
370557|NCT01123395|888315|P2|COMPLETED|Period 2||7
370558|NCT01123395|888316|P1|COMPLETED|Period 2||8
370559|NCT01123395|888315|P2|STARTED|Period 2||7
370560|NCT01123395|888316|P1|STARTED|Period 2||8
370561|NCT01123395|888315|P2|NOT COMPLETED|Washout Period of 14 Days||1
370562|NCT01123395|888316|P1|NOT COMPLETED|Washout Period of 14 Days||0
370563|NCT01123395|888315|P2|COMPLETED|Washout Period of 14 Days||7
370564|NCT01123395|888316|P1|COMPLETED|Washout Period of 14 Days||8
370565|NCT01123395|888315|P2|STARTED|Washout Period of 14 Days||8
370566|NCT01123395|888316|P1|STARTED|Washout Period of 14 Days||8
370567|NCT01123395|888315|P2|NOT COMPLETED|Period 1||0
370568|NCT01123395|888316|P1|NOT COMPLETED|Period 1||0
370569|NCT01123395|888315|P2|COMPLETED|Period 1||8
370570|NCT01123395|888316|P1|COMPLETED|Period 1||8
370571|NCT01123395|888315|P2|STARTED|Period 1||8
370572|NCT01123395|888316|P1|STARTED|Period 1||8
370573|NCT01123356|888326|P1|NOT COMPLETED|Overall Study||7
370574|NCT01123356|888326|P1|COMPLETED|Overall Study||14
370575|NCT01123356|888326|P1|STARTED|Overall Study||21
370576|NCT01123200|888334|P1|NOT COMPLETED|Overall Study||1
370577|NCT01123200|888334|P1|COMPLETED|Overall Study||0
370578|NCT01123200|888334|P1|STARTED|Overall Study||1
370579|NCT01123161|888341|P2|NOT COMPLETED|Overall Study||0
370580|NCT01123161|888342|P1|NOT COMPLETED|Overall Study||2
370581|NCT01123161|888341|P2|COMPLETED|Overall Study||63
370582|NCT01123161|888342|P1|COMPLETED|Overall Study||55
370583|NCT01123161|888341|P2|STARTED|Overall Study||63
370584|NCT01123161|888342|P1|STARTED|Overall Study||57
370585|NCT01123148|888360|P1|NOT COMPLETED|Overall Study||2
370586|NCT01123148|888360|P1|COMPLETED|Overall Study||12
370587|NCT01123148|888360|P1|BCI Calibration >50% Accuracy|Overall Study||13
370588|NCT01123148|888360|P1|STARTED|Overall Study||14
370589|NCT01122927|888364|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
370590|NCT01122927|888365|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
370591|NCT01122927|888364|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
370592|NCT01122927|888365|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
370593|NCT01122927|888364|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
370594|NCT01122927|888365|P1|STARTED|Period 2- Open-label Treatment Phase||0
370595|NCT01122927|888364|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
370596|NCT01122927|888365|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
370597|NCT01122927|888364|P2|COMPLETED|Period 1 - Conversion Phase||0
370598|NCT01122927|888365|P1|COMPLETED|Period 1 - Conversion Phase||283
370599|NCT01122927|888364|P2|STARTED|Period 1 - Conversion Phase||0
370600|NCT01122927|888365|P1|STARTED|Period 1 - Conversion Phase||297
370601|NCT01122901|888398|P2|NOT COMPLETED|Overall Study||0
370602|NCT01122901|888399|P1|NOT COMPLETED|Overall Study||0
370603|NCT01122901|888398|P2|COMPLETED|Overall Study||7
370604|NCT01122901|888399|P1|COMPLETED|Overall Study||40
370605|NCT01122901|888398|P2|STARTED|Overall Study||7
370606|NCT01122901|888399|P1|STARTED|Overall Study||40
370607|NCT01122862|888417|P3|NOT COMPLETED|Period 3||0
370608|NCT01122862|888418|P2|NOT COMPLETED|Period 3||0
370609|NCT01122862|888419|P1|NOT COMPLETED|Period 3||0
370610|NCT01122862|888417|P3|COMPLETED|Period 3||8
370611|NCT01122862|888418|P2|COMPLETED|Period 3||7
370612|NCT01122862|888419|P1|COMPLETED|Period 3||6
370613|NCT01122862|888417|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
370614|NCT01122862|888418|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
370615|NCT01122862|888419|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
370616|NCT01122862|888417|P3|NOT COMPLETED|Period 2||1
370617|NCT01122862|888418|P2|NOT COMPLETED|Period 2||0
370618|NCT01122862|888419|P1|NOT COMPLETED|Period 2||0
370619|NCT01122862|888417|P3|COMPLETED|Period 2||6
370620|NCT01122862|888418|P2|COMPLETED|Period 2||7
370621|NCT01122862|888419|P1|COMPLETED|Period 2||8
370622|NCT01122862|888417|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
370623|NCT01122862|888418|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
370624|NCT01122862|888419|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
370625|NCT01122862|888417|P3|NOT COMPLETED|Period 1||0
370626|NCT01122862|888418|P2|NOT COMPLETED|Period 1||1
370627|NCT01122862|888419|P1|NOT COMPLETED|Period 1||0
370628|NCT01122862|888417|P3|COMPLETED|Period 1||7
370629|NCT01122862|888418|P2|COMPLETED|Period 1||7
370630|NCT01122862|888419|P1|COMPLETED|Period 1||8
370631|NCT01122862|888417|P3|STARTED|Period 1||7
370632|NCT01122862|888418|P2|STARTED|Period 1||8
370633|NCT01122862|888419|P1|STARTED|Period 1||8
370634|NCT01122680|888437|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
370635|NCT01122680|888438|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
370636|NCT01122680|888439|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
370637|NCT01122680|888440|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
370638|NCT01122680|888437|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
370639|NCT01122680|888438|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
370640|NCT01122680|888439|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
370641|NCT01122680|888440|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
370642|NCT01122680|888437|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
370643|NCT01122680|888438|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
370644|NCT01122680|888439|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
370645|NCT01122680|888440|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
370646|NCT01122680|888437|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
370647|NCT01122680|888438|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
370648|NCT01122680|888439|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
370649|NCT01122680|888440|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
370650|NCT01122680|888437|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
370651|NCT01122680|888438|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
370652|NCT01122680|888439|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
370653|NCT01122680|888440|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
370654|NCT01122680|888437|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
370655|NCT01122680|888438|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
370656|NCT01122680|888439|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
370657|NCT01122680|888440|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
370658|NCT01122680|888437|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
370659|NCT01122680|888438|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
370660|NCT01122680|888439|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
370661|NCT01122680|888440|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
370662|NCT01122680|888437|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
370663|NCT01122680|888438|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
370664|NCT01122680|888439|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
370665|NCT01122680|888440|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
370666|NCT01122680|888437|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
370667|NCT01122680|888438|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
370668|NCT01122680|888439|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
370669|NCT01122680|888440|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
370670|NCT01122576|888505|P3|NOT COMPLETED|Post-Cataract Surgery||2
370671|NCT01122576|888506|P2|NOT COMPLETED|Post-Cataract Surgery||0
370672|NCT01122576|888507|P1|NOT COMPLETED|Post-Cataract Surgery||0
370673|NCT01122576|888505|P3|COMPLETED|Post-Cataract Surgery||22
370674|NCT01122576|888506|P2|COMPLETED|Post-Cataract Surgery||25
370675|NCT01122576|888507|P1|COMPLETED|Post-Cataract Surgery||26
370676|NCT01122576|888505|P3|STARTED|Post-Cataract Surgery||24
370677|NCT01122576|888506|P2|STARTED|Post-Cataract Surgery||25
370678|NCT01122576|888507|P1|STARTED|Post-Cataract Surgery||26
370679|NCT01122576|888505|P3|NOT COMPLETED|Pre-Cataract Surgery||2
370680|NCT01122576|888506|P2|NOT COMPLETED|Pre-Cataract Surgery||1
370681|NCT01122576|888507|P1|NOT COMPLETED|Pre-Cataract Surgery||0
370682|NCT01122576|888505|P3|COMPLETED|Pre-Cataract Surgery||24
370683|NCT01122576|888506|P2|COMPLETED|Pre-Cataract Surgery||25
370684|NCT01122576|888507|P1|COMPLETED|Pre-Cataract Surgery||26
370685|NCT01122576|888505|P3|STARTED|Pre-Cataract Surgery||26
370686|NCT01122576|888506|P2|STARTED|Pre-Cataract Surgery||26
370687|NCT01122576|888507|P1|STARTED|Pre-Cataract Surgery||26
370688|NCT01122511|888646|P2|NOT COMPLETED|Overall Study||2
370689|NCT01122511|888647|P1|NOT COMPLETED|Overall Study||2
370690|NCT01122511|888646|P2|COMPLETED|Overall Study||0
370691|NCT01122511|888647|P1|COMPLETED|Overall Study||0
370692|NCT01122511|888646|P2|STARTED|Overall Study||2
370693|NCT01122511|888647|P1|STARTED|Overall Study||2
370694|NCT01122394|888661|P2|NOT COMPLETED|Overall Study||4
370695|NCT01122394|888662|P1|NOT COMPLETED|Overall Study||3
370696|NCT01122394|888661|P2|COMPLETED|Overall Study||70
370697|NCT01122394|888662|P1|COMPLETED|Overall Study||63
370698|NCT01122394|888661|P2|STARTED|Overall Study||74
370699|NCT01122394|888662|P1|STARTED|Overall Study||66
370700|NCT01122381|888678|P2|NOT COMPLETED|Overall Study||1
370701|NCT01122381|888679|P1|NOT COMPLETED|Overall Study||0
370702|NCT01122381|888678|P2|COMPLETED|Overall Study||0
370703|NCT01122381|888679|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
370704|NCT01122381|888678|P2|STARTED|Overall Study||1
370705|NCT01122381|888679|P1|STARTED|Overall Study||1
370706|NCT01122264|888688|P3|NOT COMPLETED|Overall Study||47
370707|NCT01122264|888689|P2|NOT COMPLETED|Overall Study||29
370708|NCT01122264|888690|P1|NOT COMPLETED|Overall Study||32
370709|NCT01122264|888688|P3|COMPLETED|Overall Study||214
370710|NCT01122264|888689|P2|COMPLETED|Overall Study||228
370711|NCT01122264|888690|P1|COMPLETED|Overall Study||220
370712|NCT01122264|888688|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
370713|NCT01122264|888689|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
370714|NCT01122264|888690|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
370715|NCT01122264|888688|P3|STARTED|Overall Study||261
370716|NCT01122264|888689|P2|STARTED|Overall Study||257
370717|NCT01122264|888690|P1|STARTED|Overall Study||252
370718|NCT01122238|888763|P16|NOT COMPLETED|Overall Study||0
370719|NCT01122238|888764|P15|NOT COMPLETED|Overall Study||0
370720|NCT01122238|888765|P14|NOT COMPLETED|Overall Study||1
370721|NCT01122238|888766|P13|NOT COMPLETED|Overall Study||2
370722|NCT01122238|888767|P12|NOT COMPLETED|Overall Study||2
370723|NCT01122238|888768|P11|NOT COMPLETED|Overall Study||0
370724|NCT01122238|888769|P10|NOT COMPLETED|Overall Study||1
370725|NCT01122238|888770|P9|NOT COMPLETED|Overall Study||1
370726|NCT01122238|888771|P8|NOT COMPLETED|Overall Study||0
370727|NCT01122238|888772|P7|NOT COMPLETED|Overall Study||1
370728|NCT01122238|888773|P6|NOT COMPLETED|Overall Study||1
370729|NCT01122238|888774|P5|NOT COMPLETED|Overall Study||0
370730|NCT01122238|888775|P4|NOT COMPLETED|Overall Study||0
370731|NCT01122238|888776|P3|NOT COMPLETED|Overall Study||5
370732|NCT01122238|888777|P2|NOT COMPLETED|Overall Study||1
370733|NCT01122238|888778|P1|NOT COMPLETED|Overall Study||2
370734|NCT01122238|888763|P16|COMPLETED|Overall Study||31
370735|NCT01122238|888764|P15|COMPLETED|Overall Study||28
370736|NCT01122238|888765|P14|COMPLETED|Overall Study||31
370737|NCT01122238|888766|P13|COMPLETED|Overall Study||28
370738|NCT01122238|888767|P12|COMPLETED|Overall Study||31
370739|NCT01122238|888768|P11|COMPLETED|Overall Study||32
370740|NCT01122238|888769|P10|COMPLETED|Overall Study||33
370741|NCT01122238|888770|P9|COMPLETED|Overall Study||31
370742|NCT01122238|888771|P8|COMPLETED|Overall Study||32
370743|NCT01122238|888772|P7|COMPLETED|Overall Study||34
370744|NCT01122238|888773|P6|COMPLETED|Overall Study||31
370745|NCT01122238|888774|P5|COMPLETED|Overall Study||33
370746|NCT01122238|888775|P4|COMPLETED|Overall Study||33
370747|NCT01122238|888776|P3|COMPLETED|Overall Study||28
370748|NCT01122238|888777|P2|COMPLETED|Overall Study||36
370749|NCT01122238|888778|P1|COMPLETED|Overall Study||28
370750|NCT01122238|888763|P16|STARTED|Overall Study||31
370751|NCT01122238|888764|P15|STARTED|Overall Study||28
370752|NCT01122238|888765|P14|STARTED|Overall Study||32
370753|NCT01122238|888766|P13|STARTED|Overall Study||30
370754|NCT01122238|888767|P12|STARTED|Overall Study||33
370755|NCT01122238|888768|P11|STARTED|Overall Study||32
370756|NCT01122238|888769|P10|STARTED|Overall Study||34
370757|NCT01122238|888770|P9|STARTED|Overall Study||32
370758|NCT01122238|888771|P8|STARTED|Overall Study||32
370759|NCT01122238|888772|P7|STARTED|Overall Study||35
370760|NCT01122238|888773|P6|STARTED|Overall Study||32
370761|NCT01122238|888774|P5|STARTED|Overall Study||33
370762|NCT01122238|888775|P4|STARTED|Overall Study||33
370763|NCT01122238|888776|P3|STARTED|Overall Study||33
370764|NCT01122238|888777|P2|STARTED|Overall Study||37
370765|NCT01122238|888778|P1|STARTED|Overall Study||30
370766|NCT01122160|888800|P2|NOT COMPLETED|Second Intervention (7 Days)||0
370767|NCT01122160|888801|P1|NOT COMPLETED|Second Intervention (7 Days)||0
370768|NCT01122160|888800|P2|COMPLETED|Second Intervention (7 Days)||5
370769|NCT01122160|888801|P1|COMPLETED|Second Intervention (7 Days)||6
370770|NCT01122160|888800|P2|STARTED|Second Intervention (7 Days)||5
370771|NCT01122160|888801|P1|STARTED|Second Intervention (7 Days)||6
370772|NCT01122160|888800|P2|NOT COMPLETED|Washout (7-14 Days)||0
370773|NCT01122160|888801|P1|NOT COMPLETED|Washout (7-14 Days)||0
370774|NCT01122160|888800|P2|COMPLETED|Washout (7-14 Days)||5
370775|NCT01122160|888801|P1|COMPLETED|Washout (7-14 Days)||6
370776|NCT01122160|888800|P2|STARTED|Washout (7-14 Days)||5
370777|NCT01122160|888801|P1|STARTED|Washout (7-14 Days)||6
370778|NCT01122160|888800|P2|NOT COMPLETED|First Intervention (7 Days)||0
370779|NCT01122160|888801|P1|NOT COMPLETED|First Intervention (7 Days)||0
370780|NCT01122160|888800|P2|COMPLETED|First Intervention (7 Days)||5
370781|NCT01122160|888801|P1|COMPLETED|First Intervention (7 Days)||6
370782|NCT01122160|888800|P2|STARTED|First Intervention (7 Days)||5
370783|NCT01122160|888801|P1|STARTED|First Intervention (7 Days)||6
370784|NCT01122108|888807|P2|NOT COMPLETED|Overall Study||0
370785|NCT01122108|888808|P1|NOT COMPLETED|Overall Study||0
370786|NCT01122108|888807|P2|COMPLETED|Overall Study||21
370787|NCT01122108|888808|P1|COMPLETED|Overall Study||21
370788|NCT01122108|888807|P2|STARTED|Overall Study||21
370789|NCT01122108|888808|P1|STARTED|Overall Study||21
370790|NCT01122030|888824|P7|NOT COMPLETED|Overall Study||0
370791|NCT01122030|888825|P6|NOT COMPLETED|Overall Study||0
370792|NCT01122030|888826|P5|NOT COMPLETED|Overall Study||0
370793|NCT01122030|888827|P4|NOT COMPLETED|Overall Study||0
370794|NCT01122030|888828|P3|NOT COMPLETED|Overall Study||0
370795|NCT01122030|888829|P2|NOT COMPLETED|Overall Study||0
370796|NCT01122030|888830|P1|NOT COMPLETED|Overall Study||0
370797|NCT01122030|888824|P7|COMPLETED|Overall Study||9
370798|NCT01122030|888825|P6|COMPLETED|Overall Study||9
370799|NCT01122030|888826|P5|COMPLETED|Overall Study||9
370800|NCT01122030|888827|P4|COMPLETED|Overall Study||9
370801|NCT01122030|888828|P3|COMPLETED|Overall Study||9
370802|NCT01122030|888829|P2|COMPLETED|Overall Study||9
370803|NCT01122030|888830|P1|COMPLETED|Overall Study||18
370804|NCT01122030|888824|P7|Received Treatment|Overall Study||9
370805|NCT01122030|888825|P6|Received Treatment|Overall Study||9
370806|NCT01122030|888826|P5|Received Treatment|Overall Study||9
370807|NCT01122030|888827|P4|Received Treatment|Overall Study||9
370808|NCT01122030|888828|P3|Received Treatment|Overall Study||9
370809|NCT01122030|888829|P2|Received Treatment|Overall Study||9
370810|NCT01122030|888830|P1|Received Treatment|Overall Study||18
370811|NCT01122030|888824|P7|STARTED|Overall Study||9
370812|NCT01122030|888825|P6|STARTED|Overall Study||9
370813|NCT01122030|888826|P5|STARTED|Overall Study||9
370814|NCT01122030|888827|P4|STARTED|Overall Study||9
370815|NCT01122030|888828|P3|STARTED|Overall Study||9
370816|NCT01122030|888829|P2|STARTED|Overall Study||9
370817|NCT01122030|888830|P1|STARTED|Overall Study||18
370818|NCT01121991|889016|P1|NOT COMPLETED|Overall Study||6
370819|NCT01121991|889016|P1|COMPLETED|Overall Study||46
370820|NCT01121991|889016|P1|STARTED|Overall Study|Number of participants treated|52
370821|NCT01121939|889027|P1|NOT COMPLETED|Overall Study||43
370822|NCT01121939|889027|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
370823|NCT01121939|889027|P1|STARTED|Overall Study||43
370824|NCT01121926|889041|P2|NOT COMPLETED|Second Intervention Period||0
370825|NCT01121926|889042|P1|NOT COMPLETED|Second Intervention Period||0
370826|NCT01121926|889041|P2|COMPLETED|Second Intervention Period||13
370827|NCT01121926|889042|P1|COMPLETED|Second Intervention Period||14
370828|NCT01121926|889041|P2|STARTED|Second Intervention Period||13
370829|NCT01121926|889042|P1|STARTED|Second Intervention Period||14
370830|NCT01121926|889041|P2|NOT COMPLETED|Washout Period||2
370831|NCT01121926|889042|P1|NOT COMPLETED|Washout Period||0
370832|NCT01121926|889041|P2|COMPLETED|Washout Period||13
370833|NCT01121926|889042|P1|COMPLETED|Washout Period||14
370834|NCT01121926|889041|P2|STARTED|Washout Period||15
370835|NCT01121926|889042|P1|STARTED|Washout Period||14
370836|NCT01121926|889041|P2|NOT COMPLETED|First Intervention Period||0
370837|NCT01121926|889042|P1|NOT COMPLETED|First Intervention Period||1
370838|NCT01121926|889041|P2|COMPLETED|First Intervention Period||15
370839|NCT01121926|889042|P1|COMPLETED|First Intervention Period||14
370840|NCT01121926|889041|P2|STARTED|First Intervention Period||15
370841|NCT01121926|889042|P1|STARTED|First Intervention Period||15
370842|NCT01121913|889060|P4|NOT COMPLETED|Fourth Intervention Period||0
370843|NCT01121913|889061|P3|NOT COMPLETED|Fourth Intervention Period||0
370844|NCT01121913|889062|P2|NOT COMPLETED|Fourth Intervention Period||0
370845|NCT01121913|889063|P1|NOT COMPLETED|Fourth Intervention Period||0
370846|NCT01121913|889060|P4|COMPLETED|Fourth Intervention Period||6
370847|NCT01121913|889061|P3|COMPLETED|Fourth Intervention Period||3
370848|NCT01121913|889062|P2|COMPLETED|Fourth Intervention Period||6
370849|NCT01121913|889063|P1|COMPLETED|Fourth Intervention Period||4
370850|NCT01121913|889060|P4|STARTED|Fourth Intervention Period||6
370851|NCT01121913|889061|P3|STARTED|Fourth Intervention Period||3
370852|NCT01121913|889062|P2|STARTED|Fourth Intervention Period||6
370853|NCT01121913|889063|P1|STARTED|Fourth Intervention Period||4
370854|NCT01121913|889060|P4|NOT COMPLETED|Third Washout Period||0
370855|NCT01121913|889061|P3|NOT COMPLETED|Third Washout Period||0
370856|NCT01121913|889062|P2|NOT COMPLETED|Third Washout Period||0
370857|NCT01121913|889063|P1|NOT COMPLETED|Third Washout Period||1
370858|NCT01121913|889060|P4|COMPLETED|Third Washout Period||6
370859|NCT01121913|889061|P3|COMPLETED|Third Washout Period||3
370860|NCT01121913|889062|P2|COMPLETED|Third Washout Period||6
370861|NCT01121913|889063|P1|COMPLETED|Third Washout Period||4
370862|NCT01121913|889060|P4|STARTED|Third Washout Period||6
370863|NCT01121913|889061|P3|STARTED|Third Washout Period||3
370864|NCT01121913|889062|P2|STARTED|Third Washout Period||6
370865|NCT01121913|889063|P1|STARTED|Third Washout Period||5
370866|NCT01121913|889060|P4|NOT COMPLETED|Third Intervention Period||0
370867|NCT01121913|889061|P3|NOT COMPLETED|Third Intervention Period||0
370868|NCT01121913|889062|P2|NOT COMPLETED|Third Intervention Period||0
370869|NCT01121913|889063|P1|NOT COMPLETED|Third Intervention Period||0
370870|NCT01121913|889060|P4|COMPLETED|Third Intervention Period||6
370871|NCT01121913|889061|P3|COMPLETED|Third Intervention Period||3
370872|NCT01121913|889062|P2|COMPLETED|Third Intervention Period||6
370873|NCT01121913|889063|P1|COMPLETED|Third Intervention Period||5
370874|NCT01121913|889060|P4|STARTED|Third Intervention Period||6
370875|NCT01121913|889061|P3|STARTED|Third Intervention Period||3
370876|NCT01121913|889062|P2|STARTED|Third Intervention Period||6
370877|NCT01121913|889063|P1|STARTED|Third Intervention Period||5
370878|NCT01121913|889060|P4|NOT COMPLETED|Second Washout Period||0
370879|NCT01121913|889061|P3|NOT COMPLETED|Second Washout Period||1
370880|NCT01121913|889062|P2|NOT COMPLETED|Second Washout Period||0
370881|NCT01121913|889063|P1|NOT COMPLETED|Second Washout Period||0
370882|NCT01121913|889060|P4|COMPLETED|Second Washout Period||6
370883|NCT01121913|889061|P3|COMPLETED|Second Washout Period||3
370884|NCT01121913|889062|P2|COMPLETED|Second Washout Period||6
370885|NCT01121913|889063|P1|COMPLETED|Second Washout Period||5
370886|NCT01121913|889060|P4|STARTED|Second Washout Period||6
370887|NCT01121913|889061|P3|STARTED|Second Washout Period||4
370888|NCT01121913|889062|P2|STARTED|Second Washout Period||6
370889|NCT01121913|889063|P1|STARTED|Second Washout Period||5
370890|NCT01121913|889060|P4|NOT COMPLETED|Second Intervention Period||0
370891|NCT01121913|889061|P3|NOT COMPLETED|Second Intervention Period||1
370892|NCT01121913|889062|P2|NOT COMPLETED|Second Intervention Period||0
370893|NCT01121913|889063|P1|NOT COMPLETED|Second Intervention Period||0
370894|NCT01121913|889060|P4|COMPLETED|Second Intervention Period||6
370895|NCT01121913|889061|P3|COMPLETED|Second Intervention Period||4
370896|NCT01121913|889062|P2|COMPLETED|Second Intervention Period||6
370897|NCT01121913|889063|P1|COMPLETED|Second Intervention Period||5
370898|NCT01121913|889060|P4|STARTED|Second Intervention Period||6
370899|NCT01121913|889061|P3|STARTED|Second Intervention Period||5
370900|NCT01121913|889062|P2|STARTED|Second Intervention Period||6
370901|NCT01121913|889063|P1|STARTED|Second Intervention Period||5
370902|NCT01121913|889060|P4|NOT COMPLETED|First Washout Period||0
370903|NCT01121913|889061|P3|NOT COMPLETED|First Washout Period||0
370904|NCT01121913|889062|P2|NOT COMPLETED|First Washout Period||0
370905|NCT01121913|889063|P1|NOT COMPLETED|First Washout Period||1
370906|NCT01121913|889060|P4|COMPLETED|First Washout Period||6
370907|NCT01121913|889061|P3|COMPLETED|First Washout Period||5
370908|NCT01121913|889062|P2|COMPLETED|First Washout Period||6
370909|NCT01121913|889063|P1|COMPLETED|First Washout Period||5
370910|NCT01121913|889060|P4|STARTED|First Washout Period||6
370911|NCT01121913|889061|P3|STARTED|First Washout Period||5
370912|NCT01121913|889062|P2|STARTED|First Washout Period||6
370913|NCT01121913|889063|P1|STARTED|First Washout Period||6
370914|NCT01121913|889060|P4|NOT COMPLETED|First Intervention Period||0
370915|NCT01121913|889061|P3|NOT COMPLETED|First Intervention Period||1
370916|NCT01121913|889062|P2|NOT COMPLETED|First Intervention Period||0
370917|NCT01121913|889063|P1|NOT COMPLETED|First Intervention Period||0
370918|NCT01121913|889060|P4|COMPLETED|First Intervention Period||6
370919|NCT01121913|889061|P3|COMPLETED|First Intervention Period||5
370920|NCT01121913|889062|P2|COMPLETED|First Intervention Period||6
370921|NCT01121913|889063|P1|COMPLETED|First Intervention Period||6
370922|NCT01121913|889060|P4|STARTED|First Intervention Period||6
370923|NCT01121913|889061|P3|STARTED|First Intervention Period||6
370924|NCT01121913|889062|P2|STARTED|First Intervention Period||6
370925|NCT01121913|889063|P1|STARTED|First Intervention Period||6
370926|NCT01121900|889093|P2|NOT COMPLETED|Second Intervention Period||0
370927|NCT01121900|889094|P1|NOT COMPLETED|Second Intervention Period||0
370928|NCT01121900|889093|P2|COMPLETED|Second Intervention Period||11
370929|NCT01121900|889094|P1|COMPLETED|Second Intervention Period||12
370930|NCT01121900|889093|P2|STARTED|Second Intervention Period||11
370931|NCT01121900|889094|P1|STARTED|Second Intervention Period||12
370932|NCT01121900|889093|P2|NOT COMPLETED|Washout Period of 7 Days||1
370933|NCT01121900|889094|P1|NOT COMPLETED|Washout Period of 7 Days||0
370934|NCT01121900|889093|P2|COMPLETED|Washout Period of 7 Days||11
370935|NCT01121900|889094|P1|COMPLETED|Washout Period of 7 Days||12
370936|NCT01121900|889093|P2|STARTED|Washout Period of 7 Days||12
370937|NCT01121900|889094|P1|STARTED|Washout Period of 7 Days||12
370938|NCT01121900|889093|P2|NOT COMPLETED|First Intervention Period||1
370939|NCT01121900|889094|P1|NOT COMPLETED|First Intervention Period||1
370940|NCT01121900|889093|P2|COMPLETED|First Intervention Period||12
370941|NCT01121900|889094|P1|COMPLETED|First Intervention Period||12
370942|NCT01121900|889093|P2|STARTED|First Intervention Period||13
370943|NCT01121900|889094|P1|STARTED|First Intervention Period||13
370944|NCT01121757|889114|P2|NOT COMPLETED|Combination||1
370945|NCT01121757|889115|P1|NOT COMPLETED|Combination||2
370946|NCT01121757|889114|P2|COMPLETED|Combination||0
370947|NCT01121757|889115|P1|COMPLETED|Combination||0
370948|NCT01121757|889114|P2|STARTED|Combination||1
370949|NCT01121757|889115|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
370950|NCT01121757|889114|P2|NOT COMPLETED|Second Drug||0
370951|NCT01121757|889115|P1|NOT COMPLETED|Second Drug||0
370952|NCT01121757|889114|P2|COMPLETED|Second Drug||1
370953|NCT01121757|889115|P1|COMPLETED|Second Drug||4
370954|NCT01121757|889114|P2|STARTED|Second Drug||1
370955|NCT01121757|889115|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
370956|NCT01121757|889114|P2|NOT COMPLETED|First Drug||2
370957|NCT01121757|889115|P1|NOT COMPLETED|First Drug||1
370958|NCT01121757|889114|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
370959|NCT01121757|889115|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
370960|NCT01121757|889114|P2|STARTED|First Drug||3
370961|NCT01121757|889115|P1|STARTED|First Drug||6
370962|NCT01121666|889131|P2|NOT COMPLETED|Overall Study||10
370963|NCT01121666|889132|P1|NOT COMPLETED|Overall Study||29
370964|NCT01121666|889131|P2|COMPLETED|Overall Study||113
370965|NCT01121666|889132|P1|COMPLETED|Overall Study||220
370966|NCT01121666|889131|P2|STARTED|Overall Study||123
370967|NCT01121666|889132|P1|STARTED|Overall Study||249
370968|NCT01121575|889188|P6|NOT COMPLETED|Overall Study||12
370969|NCT01121575|889189|P5|NOT COMPLETED|Overall Study||25
370970|NCT01121575|889190|P4|NOT COMPLETED|Overall Study||6
370971|NCT01121575|889191|P3|NOT COMPLETED|Overall Study||7
370972|NCT01121575|889192|P2|NOT COMPLETED|Overall Study||6
370973|NCT01121575|889193|P1|NOT COMPLETED|Overall Study||14
370974|NCT01121575|889188|P6|COMPLETED|Overall Study||0
370975|NCT01121575|889189|P5|COMPLETED|Overall Study||0
370976|NCT01121575|889190|P4|COMPLETED|Overall Study||0
370977|NCT01121575|889191|P3|COMPLETED|Overall Study||0
370978|NCT01121575|889192|P2|COMPLETED|Overall Study||0
370979|NCT01121575|889193|P1|COMPLETED|Overall Study||0
370980|NCT01121575|889188|P6|Treated|Overall Study||12
370981|NCT01121575|889189|P5|Treated|Overall Study||25
370982|NCT01121575|889190|P4|Treated|Overall Study||6
370983|NCT01121575|889191|P3|Treated|Overall Study||7
370984|NCT01121575|889192|P2|Treated|Overall Study||6
370985|NCT01121575|889193|P1|Treated|Overall Study||14
370986|NCT01121575|889188|P6|STARTED|Overall Study||12
370987|NCT01121575|889189|P5|STARTED|Overall Study||25
370988|NCT01121575|889190|P4|STARTED|Overall Study||6
370989|NCT01121575|889191|P3|STARTED|Overall Study||7
370990|NCT01121575|889192|P2|STARTED|Overall Study||6
370991|NCT01121575|889193|P1|STARTED|Overall Study||14
370992|NCT01121562|889317|P1|NOT COMPLETED|Overall Study||12
370993|NCT01121562|889317|P1|COMPLETED|Overall Study||0
370994|NCT01121562|889317|P1|STARTED|Overall Study||12
370995|NCT01121549|889326|P1|NOT COMPLETED|Overall Study||347
370996|NCT01121549|889326|P1|COMPLETED|Overall Study||31
370997|NCT01121549|889326|P1|STARTED|Overall Study||378
370998|NCT01121536|889337|P1|NOT COMPLETED|Overall Study||361
370999|NCT01121536|889337|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
371000|NCT01121536|889337|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
371001|NCT01121536|889337|P1|Safety Population|Overall Study|Participants treated|863
371002|NCT01121536|889337|P1|STARTED|Overall Study||867
371003|NCT01121484|889358|P2|NOT COMPLETED|Overall Study||43
371004|NCT01121484|889359|P1|NOT COMPLETED|Overall Study||33
371005|NCT01121484|889358|P2|COMPLETED|Overall Study||178
371006|NCT01121484|889359|P1|COMPLETED|Overall Study||185
371007|NCT01121484|889358|P2|Treated|Overall Study||217
371008|NCT01121484|889359|P1|Treated|Overall Study||217
371009|NCT01121484|889358|P2|STARTED|Overall Study||221
371010|NCT01121484|889359|P1|STARTED|Overall Study||218
371011|NCT01121406|889377|P2|NOT COMPLETED|Overall Study||55
371012|NCT01121406|889378|P1|NOT COMPLETED|Overall Study||55
371013|NCT01121406|889377|P2|COMPLETED|Overall Study||0
371014|NCT01121406|889378|P1|COMPLETED|Overall Study||0
371015|NCT01121406|889377|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
371016|NCT01121406|889378|P1|STARTED|Overall Study||55
371017|NCT01121393|889428|P2|NOT COMPLETED|Overall Study||84
371018|NCT01121393|889429|P1|NOT COMPLETED|Overall Study||219
371019|NCT01121393|889428|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
371020|NCT01121393|889429|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (27 December 2013)|23
371021|NCT01121393|889428|P2|STARTED|Overall Study|randomised|122
371022|NCT01121393|889429|P1|STARTED|Overall Study|randomised|242
371023|NCT01121263|889474|P2|NOT COMPLETED|Overall Study||15
371024|NCT01121263|889475|P1|NOT COMPLETED|Overall Study||25
371025|NCT01121263|889474|P2|COMPLETED|Overall Study||83
371026|NCT01121263|889475|P1|COMPLETED|Overall Study||175
371027|NCT01121263|889474|P2|STARTED|Overall Study||98
371028|NCT01121263|889475|P1|STARTED|Overall Study||200
371029|NCT01121211|889485|P2|NOT COMPLETED|Overall Study||12
371030|NCT01121211|889486|P1|NOT COMPLETED|Overall Study||11
371031|NCT01121211|889485|P2|COMPLETED|Overall Study||35
371032|NCT01121211|889486|P1|COMPLETED|Overall Study||32
371033|NCT01121211|889485|P2|STARTED|Overall Study||47
371034|NCT01121211|889486|P1|STARTED|Overall Study||43
371035|NCT01121185|889496|P2|NOT COMPLETED|Overall Study||1
371036|NCT01121185|889497|P1|NOT COMPLETED|Overall Study||1
371037|NCT01121185|889496|P2|COMPLETED|Overall Study||5
371038|NCT01121185|889497|P1|COMPLETED|Overall Study||6
371039|NCT01121185|889496|P2|Transplanted|Overall Study||5
371040|NCT01121185|889497|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
371041|NCT01121185|889496|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
371042|NCT01121185|889497|P1|Infused|Overall Study||7
371043|NCT01121185|889496|P2|STARTED|Overall Study||6
371044|NCT01121185|889497|P1|STARTED|Overall Study||7
371045|NCT01121172|889521|P2|NOT COMPLETED|Overall Study||0
371046|NCT01121172|889522|P1|NOT COMPLETED|Overall Study||0
371047|NCT01121172|889521|P2|COMPLETED|Overall Study||90
371048|NCT01121172|889522|P1|COMPLETED|Overall Study||90
371049|NCT01121172|889521|P2|STARTED|Overall Study||90
371050|NCT01121172|889522|P1|STARTED|Overall Study||90
371051|NCT01121146|889531|P2|NOT COMPLETED|Overall Study||42
371052|NCT01121146|889532|P1|NOT COMPLETED|Overall Study||26
371053|NCT01121146|889531|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
371054|NCT01121146|889532|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
371055|NCT01121146|889531|P2|STARTED|Overall Study||114
371056|NCT01121146|889532|P1|STARTED|Overall Study||116
371057|NCT01120990|889546|P1|NOT COMPLETED|Overall Study||0
371058|NCT01120990|889546|P1|COMPLETED|Overall Study||51
371059|NCT01120990|889546|P1|STARTED|Overall Study||51
371060|NCT01120899|889553|P1|NOT COMPLETED|Overall Study||3
371061|NCT01120899|889553|P1|COMPLETED|Overall Study||3
371062|NCT01120899|889553|P1|Month 18|Overall Study||3
371063|NCT01120899|889553|P1|Month 12|Overall Study||3
371064|NCT01120899|889553|P1|Month 6|Overall Study||5
371065|NCT01120899|889553|P1|STARTED|Overall Study||6
371066|NCT01120834|889573|P1|NOT COMPLETED|Overall Study||0
371067|NCT01120834|889573|P1|COMPLETED|Overall Study||18
371068|NCT01120834|889573|P1|STARTED|Overall Study||18
371069|NCT01120808|889577|P1|NOT COMPLETED|Overall Study||46
371070|NCT01120808|889577|P1|COMPLETED|Overall Study||90
371071|NCT01120808|889577|P1|STARTED|Overall Study||136
371072|NCT01120782|889581|P1|NOT COMPLETED|Overall Study||11
371073|NCT01120782|889581|P1|COMPLETED|Overall Study||34
371074|NCT01120782|889581|P1|STARTED|Overall Study||45
371075|NCT01120717|889587|P2|NOT COMPLETED|Overall Study||24
371076|NCT01120717|889588|P1|NOT COMPLETED|Overall Study||32
371077|NCT01120717|889587|P2|COMPLETED|Overall Study||89
371078|NCT01120717|889588|P1|COMPLETED|Overall Study||194
371079|NCT01120717|889587|P2|Safety Population: Received Study Drug|Overall Study||113
371080|NCT01120717|889588|P1|Safety Population: Received Study Drug|Overall Study||225
371081|NCT01120717|889587|P2|STARTED|Overall Study||113
371082|NCT01120717|889588|P1|STARTED|Overall Study||226
371083|NCT01120704|889636|P32|NOT COMPLETED|Overall Study||1
371084|NCT01120704|889637|P31|NOT COMPLETED|Overall Study||2
371085|NCT01120704|889638|P30|NOT COMPLETED|Overall Study||3
371086|NCT01120704|889639|P29|NOT COMPLETED|Overall Study||5
371087|NCT01120704|889640|P28|NOT COMPLETED|Overall Study||2
371088|NCT01120704|889641|P27|NOT COMPLETED|Overall Study||3
371089|NCT01120704|889642|P26|NOT COMPLETED|Overall Study||0
371090|NCT01120704|889643|P25|NOT COMPLETED|Overall Study||2
371091|NCT01120704|889644|P24|NOT COMPLETED|Overall Study||3
371092|NCT01120704|889645|P23|NOT COMPLETED|Overall Study||4
371093|NCT01120704|889646|P22|NOT COMPLETED|Overall Study||0
371094|NCT01120704|889647|P21|NOT COMPLETED|Overall Study||3
371095|NCT01120704|889648|P20|NOT COMPLETED|Overall Study||3
371096|NCT01120704|889649|P19|NOT COMPLETED|Overall Study||2
371097|NCT01120704|889650|P18|NOT COMPLETED|Overall Study||0
371098|NCT01120704|889651|P17|NOT COMPLETED|Overall Study||1
371099|NCT01120704|889652|P16|NOT COMPLETED|Overall Study||2
371100|NCT01120704|889653|P15|NOT COMPLETED|Overall Study||1
371101|NCT01120704|889654|P14|NOT COMPLETED|Overall Study||4
371102|NCT01120704|889655|P13|NOT COMPLETED|Overall Study||3
371103|NCT01120704|889656|P12|NOT COMPLETED|Overall Study||2
371104|NCT01120704|889657|P11|NOT COMPLETED|Overall Study||1
371105|NCT01120704|889658|P10|NOT COMPLETED|Overall Study||1
371106|NCT01120704|889659|P9|NOT COMPLETED|Overall Study||3
371107|NCT01120704|889660|P8|NOT COMPLETED|Overall Study||2
371108|NCT01120704|889661|P7|NOT COMPLETED|Overall Study||3
371109|NCT01120704|889662|P6|NOT COMPLETED|Overall Study||1
371110|NCT01120704|889663|P5|NOT COMPLETED|Overall Study||2
371111|NCT01120704|889664|P4|NOT COMPLETED|Overall Study||4
371112|NCT01120704|889665|P3|NOT COMPLETED|Overall Study||1
371113|NCT01120704|889666|P2|NOT COMPLETED|Overall Study||4
371114|NCT01120704|889667|P1|NOT COMPLETED|Overall Study||3
371115|NCT01120704|889636|P32|COMPLETED|Overall Study||17
371116|NCT01120704|889637|P31|COMPLETED|Overall Study||12
371117|NCT01120704|889638|P30|COMPLETED|Overall Study||12
371118|NCT01120704|889639|P29|COMPLETED|Overall Study||14
371119|NCT01120704|889640|P28|COMPLETED|Overall Study||16
371120|NCT01120704|889641|P27|COMPLETED|Overall Study||15
371121|NCT01120704|889642|P26|COMPLETED|Overall Study||14
371122|NCT01120704|889643|P25|COMPLETED|Overall Study||16
371123|NCT01120704|889644|P24|COMPLETED|Overall Study||13
371124|NCT01120704|889645|P23|COMPLETED|Overall Study||17
371125|NCT01120704|889646|P22|COMPLETED|Overall Study||16
371126|NCT01120704|889647|P21|COMPLETED|Overall Study||14
371127|NCT01120704|889648|P20|COMPLETED|Overall Study||15
371128|NCT01120704|889649|P19|COMPLETED|Overall Study||15
371129|NCT01120704|889650|P18|COMPLETED|Overall Study||16
371130|NCT01120704|889651|P17|COMPLETED|Overall Study||13
371131|NCT01120704|889652|P16|COMPLETED|Overall Study||16
371132|NCT01120704|889653|P15|COMPLETED|Overall Study||17
371133|NCT01120704|889654|P14|COMPLETED|Overall Study||15
371134|NCT01120704|889655|P13|COMPLETED|Overall Study||14
371135|NCT01120704|889656|P12|COMPLETED|Overall Study||14
371136|NCT01120704|889657|P11|COMPLETED|Overall Study||16
371137|NCT01120704|889658|P10|COMPLETED|Overall Study||19
371138|NCT01120704|889659|P9|COMPLETED|Overall Study||19
371139|NCT01120704|889660|P8|COMPLETED|Overall Study||13
371140|NCT01120704|889661|P7|COMPLETED|Overall Study||12
371141|NCT01120704|889662|P6|COMPLETED|Overall Study||18
371142|NCT01120704|889663|P5|COMPLETED|Overall Study||14
371143|NCT01120704|889664|P4|COMPLETED|Overall Study||15
371144|NCT01120704|889665|P3|COMPLETED|Overall Study||13
371145|NCT01120704|889666|P2|COMPLETED|Overall Study||13
371146|NCT01120704|889667|P1|COMPLETED|Overall Study||10
371147|NCT01120704|889636|P32|STARTED|Overall Study||18
371148|NCT01120704|889637|P31|STARTED|Overall Study||14
371149|NCT01120704|889638|P30|STARTED|Overall Study||15
371150|NCT01120704|889639|P29|STARTED|Overall Study||19
371151|NCT01120704|889640|P28|STARTED|Overall Study||18
371152|NCT01120704|889641|P27|STARTED|Overall Study||18
371153|NCT01120704|889642|P26|STARTED|Overall Study||14
371154|NCT01120704|889643|P25|STARTED|Overall Study||18
371155|NCT01120704|889644|P24|STARTED|Overall Study||16
371156|NCT01120704|889645|P23|STARTED|Overall Study||21
371157|NCT01120704|889646|P22|STARTED|Overall Study||16
371158|NCT01120704|889647|P21|STARTED|Overall Study||17
371159|NCT01120704|889648|P20|STARTED|Overall Study||18
371160|NCT01120704|889649|P19|STARTED|Overall Study||17
371161|NCT01120704|889650|P18|STARTED|Overall Study||16
371162|NCT01120704|889651|P17|STARTED|Overall Study||14
371163|NCT01120704|889652|P16|STARTED|Overall Study||18
371164|NCT01120704|889653|P15|STARTED|Overall Study||18
371165|NCT01120704|889654|P14|STARTED|Overall Study||19
371166|NCT01120704|889655|P13|STARTED|Overall Study||17
371167|NCT01120704|889656|P12|STARTED|Overall Study||16
371168|NCT01120704|889657|P11|STARTED|Overall Study||17
371169|NCT01120704|889658|P10|STARTED|Overall Study||20
371170|NCT01120704|889659|P9|STARTED|Overall Study||22
371171|NCT01120704|889660|P8|STARTED|Overall Study||15
371172|NCT01120704|889661|P7|STARTED|Overall Study||15
371173|NCT01120704|889662|P6|STARTED|Overall Study||19
371174|NCT01120704|889663|P5|STARTED|Overall Study||16
371175|NCT01120704|889664|P4|STARTED|Overall Study||19
371176|NCT01120704|889665|P3|STARTED|Overall Study||14
371177|NCT01120704|889666|P2|STARTED|Overall Study||17
371178|NCT01120704|889667|P1|STARTED|Overall Study||13
371179|NCT01120691|889694|P3|NOT COMPLETED|Overall Study||183
371180|NCT01120691|889695|P2|NOT COMPLETED|Overall Study||203
371181|NCT01120691|889696|P1|NOT COMPLETED|Overall Study||171
371182|NCT01120691|889694|P3|COMPLETED|Overall Study||559
371183|NCT01120691|889695|P2|COMPLETED|Overall Study||538
371184|NCT01120691|889696|P1|COMPLETED|Overall Study||570
371185|NCT01120691|889694|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
371186|NCT01120691|889695|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
371187|NCT01120691|889696|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
371188|NCT01120691|889694|P3|Modified Safety Set (mSAF)|Overall Study||737
371189|NCT01120691|889695|P2|Modified Safety Set (mSAF)|Overall Study||740
371190|NCT01120691|889696|P1|Modified Safety Set (mSAF)|Overall Study||729
371191|NCT01120691|889694|P3|Safety Set (SAF)|Overall Study||739
371192|NCT01120691|889695|P2|Safety Set (SAF)|Overall Study||740
371193|NCT01120691|889696|P1|Safety Set (SAF)|Overall Study||736
371194|NCT01120691|889694|P3|Full Analysis Set (FAS)|Overall Study||739
371195|NCT01120691|889695|P2|Full Analysis Set (FAS)|Overall Study||739
371196|NCT01120691|889696|P1|Full Analysis Set (FAS)|Overall Study||736
371197|NCT01120691|889694|P3|STARTED|Overall Study||742
371198|NCT01120691|889695|P2|STARTED|Overall Study||741
371199|NCT01120691|889696|P1|STARTED|Overall Study||741
371200|NCT01120626|889740|P2|NOT COMPLETED|Overall Study||0
371201|NCT01120626|889741|P1|NOT COMPLETED|Overall Study||1
371202|NCT01120626|889740|P2|COMPLETED|Overall Study||22
371203|NCT01120626|889741|P1|COMPLETED|Overall Study||19
371204|NCT01120626|889740|P2|STARTED|Overall Study||22
371205|NCT01120626|889741|P1|STARTED|Overall Study||20
371206|NCT01120405|889751|P2|NOT COMPLETED|Overall Study||33
371207|NCT01120405|889752|P1|NOT COMPLETED|Overall Study||27
371208|NCT01120405|889751|P2|COMPLETED|Overall Study||269
371209|NCT01120405|889752|P1|COMPLETED|Overall Study||271
371210|NCT01120405|889751|P2|STARTED|Overall Study||302
371211|NCT01120405|889752|P1|STARTED|Overall Study||298
371212|NCT01120379|889780|P1|NOT COMPLETED|Four Year Timepoint||368
371213|NCT01120379|889780|P1|COMPLETED|Four Year Timepoint||3923
371214|NCT01120379|889780|P1|STARTED|Four Year Timepoint||4291
371215|NCT01120379|889780|P1|NOT COMPLETED|Three Year Timepoint||214
371216|NCT01120379|889780|P1|COMPLETED|Three Year Timepoint||4291
371217|NCT01120379|889780|P1|STARTED|Three Year Timepoint||4505
371218|NCT01120379|889780|P1|NOT COMPLETED|Two Year Timepoint||237
371219|NCT01120379|889780|P1|COMPLETED|Two Year Timepoint||4505
371220|NCT01120379|889780|P1|STARTED|Two Year Timepoint||4742
371221|NCT01120379|889780|P1|NOT COMPLETED|One Year Timepoint||278
371222|NCT01120379|889780|P1|COMPLETED|One Year Timepoint||4742
371223|NCT01120379|889780|P1|STARTED|One Year Timepoint||5020
371224|NCT01120275|889816|P1|NOT COMPLETED|Overall Study||36
371225|NCT01120275|889816|P1|COMPLETED|Overall Study||0
371226|NCT01120275|889816|P1|Eligible and Treated|Overall Study||32
371227|NCT01120275|889816|P1|STARTED|Overall Study||36
371228|NCT01120236|889825|P2|NOT COMPLETED|Overall Study||0
371229|NCT01120236|889826|P1|NOT COMPLETED|Overall Study||0
371230|NCT01120236|889825|P2|COMPLETED|Overall Study||106
371231|NCT01120236|889826|P1|COMPLETED|Overall Study||105
371232|NCT01120236|889825|P2|STARTED|Overall Study||106
371233|NCT01120236|889826|P1|STARTED|Overall Study||105
371234|NCT01120223|889836|P1|NOT COMPLETED|Overall Study||4
371235|NCT01120223|889836|P1|COMPLETED|Overall Study||74
371236|NCT01120223|889836|P1|STARTED|Overall Study||78
371237|NCT01120210|889866|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
371238|NCT01120210|889867|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
371239|NCT01120210|889866|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
371240|NCT01120210|889867|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
371241|NCT01120210|889866|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
371242|NCT01120210|889867|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
371243|NCT01120210|889866|P2|NOT COMPLETED|MAIN INFUSION||1
371244|NCT01120210|889867|P1|NOT COMPLETED|MAIN INFUSION||1
371245|NCT01120210|889866|P2|COMPLETED|MAIN INFUSION||45
371246|NCT01120210|889867|P1|COMPLETED|MAIN INFUSION||15
371247|NCT01120210|889866|P2|STARTED|MAIN INFUSION||46
371248|NCT01120210|889867|P1|STARTED|MAIN INFUSION||16
371249|NCT01120197|889899|P2|NOT COMPLETED|Overall Study||10
371250|NCT01120197|889900|P1|NOT COMPLETED|Overall Study||9
371251|NCT01120197|889899|P2|COMPLETED|Overall Study||32
371252|NCT01120197|889900|P1|COMPLETED|Overall Study||38
371253|NCT01120197|889899|P2|STARTED|Overall Study||42
371254|NCT01120197|889900|P1|STARTED|Overall Study||47
371255|NCT01120184|889917|P3|NOT COMPLETED|Overall Study||154
371256|NCT01120184|889918|P2|NOT COMPLETED|Overall Study||154
371257|NCT01120184|889919|P1|NOT COMPLETED|Overall Study||169
371258|NCT01120184|889917|P3|COMPLETED|Overall Study|Includes 72 ongoing treatment at clinical cutoff and 137 in survival follow-up at clinical cutoff.|209
371259|NCT01120184|889918|P2|COMPLETED|Overall Study|Includes 64 ongoing treatment at clinical cutoff and 149 in survival follow-up at clinical cutoff.|213
371260|NCT01120184|889919|P1|COMPLETED|Overall Study|Includes 52 ongoing treatment at clinical cutoff and 144 in survival follow-up at clinical cutoff.|196
371261|NCT01120184|889917|P3|Treated|Overall Study||360
371262|NCT01120184|889918|P2|Treated|Overall Study||365
371263|NCT01120184|889919|P1|Treated|Overall Study||355
371264|NCT01120184|889917|P3|STARTED|Overall Study||363
371265|NCT01120184|889918|P2|STARTED|Overall Study||367
371266|NCT01120184|889919|P1|STARTED|Overall Study||365
371267|NCT01120093|890041|P5|NOT COMPLETED|Treatment Period 5||0
371268|NCT01120093|890042|P4|NOT COMPLETED|Treatment Period 5||1
371269|NCT01120093|890043|P3|NOT COMPLETED|Treatment Period 5||0
371270|NCT01120093|890044|P2|NOT COMPLETED|Treatment Period 5||1
371271|NCT01120093|890045|P1|NOT COMPLETED|Treatment Period 5||0
371272|NCT01120093|890041|P5|COMPLETED|Treatment Period 5||13
371273|NCT01120093|890042|P4|COMPLETED|Treatment Period 5||11
371274|NCT01120093|890043|P3|COMPLETED|Treatment Period 5||15
371275|NCT01120093|890044|P2|COMPLETED|Treatment Period 5||12
371276|NCT01120093|890045|P1|COMPLETED|Treatment Period 5||17
371277|NCT01120093|890041|P5|STARTED|Treatment Period 5||13
371278|NCT01120093|890042|P4|STARTED|Treatment Period 5||12
371279|NCT01120093|890043|P3|STARTED|Treatment Period 5||15
371280|NCT01120093|890044|P2|STARTED|Treatment Period 5||13
371281|NCT01120093|890045|P1|STARTED|Treatment Period 5||17
371282|NCT01120093|890041|P5|NOT COMPLETED|Treatment Period 4||0
371283|NCT01120093|890042|P4|NOT COMPLETED|Treatment Period 4||0
371284|NCT01120093|890043|P3|NOT COMPLETED|Treatment Period 4||0
371285|NCT01120093|890044|P2|NOT COMPLETED|Treatment Period 4||0
371286|NCT01120093|890045|P1|NOT COMPLETED|Treatment Period 4||1
371287|NCT01120093|890041|P5|COMPLETED|Treatment Period 4||13
371288|NCT01120093|890042|P4|COMPLETED|Treatment Period 4||12
371289|NCT01120093|890043|P3|COMPLETED|Treatment Period 4||15
371290|NCT01120093|890044|P2|COMPLETED|Treatment Period 4||13
371291|NCT01120093|890045|P1|COMPLETED|Treatment Period 4||17
371292|NCT01120093|890041|P5|STARTED|Treatment Period 4||13
371293|NCT01120093|890042|P4|STARTED|Treatment Period 4||12
371294|NCT01120093|890043|P3|STARTED|Treatment Period 4||15
371295|NCT01120093|890044|P2|STARTED|Treatment Period 4||13
371296|NCT01120093|890045|P1|STARTED|Treatment Period 4||18
371297|NCT01120093|890041|P5|NOT COMPLETED|Treatment Period 3||1
371298|NCT01120093|890042|P4|NOT COMPLETED|Treatment Period 3||1
371299|NCT01120093|890043|P3|NOT COMPLETED|Treatment Period 3||1
371300|NCT01120093|890044|P2|NOT COMPLETED|Treatment Period 3||0
371301|NCT01120093|890045|P1|NOT COMPLETED|Treatment Period 3||0
371302|NCT01120093|890041|P5|COMPLETED|Treatment Period 3||13
371303|NCT01120093|890042|P4|COMPLETED|Treatment Period 3||12
371304|NCT01120093|890043|P3|COMPLETED|Treatment Period 3||15
371305|NCT01120093|890044|P2|COMPLETED|Treatment Period 3||13
371306|NCT01120093|890045|P1|COMPLETED|Treatment Period 3||18
371307|NCT01120093|890041|P5|STARTED|Treatment Period 3||14
371308|NCT01120093|890042|P4|STARTED|Treatment Period 3||13
371309|NCT01120093|890043|P3|STARTED|Treatment Period 3||16
371310|NCT01120093|890044|P2|STARTED|Treatment Period 3||13
371311|NCT01120093|890045|P1|STARTED|Treatment Period 3||18
371312|NCT01120093|890041|P5|NOT COMPLETED|Treatment Period 2||1
371313|NCT01120093|890042|P4|NOT COMPLETED|Treatment Period 2||1
371314|NCT01120093|890043|P3|NOT COMPLETED|Treatment Period 2||0
371315|NCT01120093|890044|P2|NOT COMPLETED|Treatment Period 2||0
371316|NCT01120093|890045|P1|NOT COMPLETED|Treatment Period 2||0
371317|NCT01120093|890041|P5|COMPLETED|Treatment Period 2||14
371318|NCT01120093|890042|P4|COMPLETED|Treatment Period 2||13
371319|NCT01120093|890043|P3|COMPLETED|Treatment Period 2||16
371320|NCT01120093|890044|P2|COMPLETED|Treatment Period 2||13
371321|NCT01120093|890045|P1|COMPLETED|Treatment Period 2||18
371322|NCT01120093|890041|P5|STARTED|Treatment Period 2||15
371323|NCT01120093|890042|P4|STARTED|Treatment Period 2||14
371324|NCT01120093|890043|P3|STARTED|Treatment Period 2||16
371325|NCT01120093|890044|P2|STARTED|Treatment Period 2||13
371326|NCT01120093|890045|P1|STARTED|Treatment Period 2||18
371327|NCT01120093|890041|P5|NOT COMPLETED|Treatment Period 1||1
371328|NCT01120093|890042|P4|NOT COMPLETED|Treatment Period 1||0
371329|NCT01120093|890043|P3|NOT COMPLETED|Treatment Period 1||1
371330|NCT01120093|890044|P2|NOT COMPLETED|Treatment Period 1||1
371331|NCT01120093|890045|P1|NOT COMPLETED|Treatment Period 1||0
371332|NCT01120093|890041|P5|COMPLETED|Treatment Period 1||15
371333|NCT01120093|890042|P4|COMPLETED|Treatment Period 1||14
371334|NCT01120093|890043|P3|COMPLETED|Treatment Period 1||16
371335|NCT01120093|890044|P2|COMPLETED|Treatment Period 1||13
371336|NCT01120093|890045|P1|COMPLETED|Treatment Period 1||18
371337|NCT01120093|890041|P5|STARTED|Treatment Period 1||16
371338|NCT01120093|890042|P4|STARTED|Treatment Period 1||14
371339|NCT01120093|890043|P3|STARTED|Treatment Period 1||17
371340|NCT01120093|890044|P2|STARTED|Treatment Period 1||14
371341|NCT01120093|890045|P1|STARTED|Treatment Period 1||18
371342|NCT01120067|890074|P2|NOT COMPLETED|Overall Study||1
371343|NCT01120067|890075|P1|NOT COMPLETED|Overall Study||5
371344|NCT01120067|890074|P2|COMPLETED|Overall Study||10
371345|NCT01120067|890075|P1|COMPLETED|Overall Study||7
371346|NCT01120067|890074|P2|STARTED|Overall Study||11
371347|NCT01120067|890075|P1|STARTED|Overall Study||12
371348|NCT01119950|890081|P1|NOT COMPLETED|Overall Study||47
371349|NCT01119950|890081|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
371350|NCT01119950|890081|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
371351|NCT01119950|890081|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
371352|NCT01119950|890081|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
371353|NCT01119950|890081|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
371354|NCT01119950|890081|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
371355|NCT01119950|890081|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
371356|NCT01119950|890081|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
371357|NCT01119950|890081|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
371358|NCT01119950|890081|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
371359|NCT01119937|890328|P2|NOT COMPLETED|Overall Study||7
371360|NCT01119937|890329|P1|NOT COMPLETED|Overall Study||19
371361|NCT01119937|890328|P2|COMPLETED|Overall Study||33
371362|NCT01119937|890329|P1|COMPLETED|Overall Study||104
371363|NCT01119937|890328|P2|STARTED|Overall Study||40
371364|NCT01119937|890329|P1|STARTED|Overall Study||123
371365|NCT01119859|890357|P2|NOT COMPLETED|Overall Study||30
371366|NCT01119859|890358|P1|NOT COMPLETED|Overall Study||24
371367|NCT01119859|890357|P2|COMPLETED|Overall Study||133
371368|NCT01119859|890358|P1|COMPLETED|Overall Study||139
371369|NCT01119859|890357|P2|STARTED|Overall Study||163
371370|NCT01119859|890358|P1|STARTED|Overall Study||163
371371|NCT01119794|890374|P1|NOT COMPLETED|Overall Study||0
371372|NCT01119794|890374|P1|COMPLETED|Overall Study||10
371373|NCT01119794|890374|P1|STARTED|Overall Study||10
371374|NCT01119768|890380|P2|NOT COMPLETED|Follow-up||2
371375|NCT01119768|890381|P1|NOT COMPLETED|Follow-up||1
371376|NCT01119768|890380|P2|COMPLETED|Follow-up||122
371377|NCT01119768|890381|P1|COMPLETED|Follow-up||135
371378|NCT01119768|890380|P2|STARTED|Follow-up||124
371379|NCT01119768|890381|P1|STARTED|Follow-up||136
371380|NCT01119768|890380|P2|NOT COMPLETED|Treatment Period||25
371381|NCT01119768|890381|P1|NOT COMPLETED|Treatment Period||18
371382|NCT01119768|890380|P2|COMPLETED|Treatment Period||126
371383|NCT01119768|890381|P1|COMPLETED|Treatment Period||136
371384|NCT01119768|890380|P2|STARTED|Treatment Period||151
371385|NCT01119768|890381|P1|STARTED|Treatment Period||154
371386|NCT01119755|890403|P1|NOT COMPLETED|Overall Study||0
371387|NCT01119755|890403|P1|COMPLETED|Overall Study||80
371388|NCT01119755|890403|P1|STARTED|Overall Study||80
371389|NCT01119716|890414|P1|NOT COMPLETED|Overall Study||0
371390|NCT01119716|890414|P1|COMPLETED|Overall Study||4658
371391|NCT01119716|890414|P1|STARTED|Overall Study||4658
371392|NCT01119703|890437|P2|NOT COMPLETED|Overall Study||1
371393|NCT01119703|890438|P1|NOT COMPLETED|Overall Study||0
371394|NCT01119703|890437|P2|COMPLETED|Overall Study||143
371395|NCT01119703|890438|P1|COMPLETED|Overall Study||30
371396|NCT01119703|890437|P2|STARTED|Overall Study||144
371397|NCT01119703|890438|P1|STARTED|Overall Study||30
371398|NCT01119625|890452|P2|NOT COMPLETED|Overall Study||4
371399|NCT01119625|890453|P1|NOT COMPLETED|Overall Study||3
371400|NCT01119625|890452|P2|COMPLETED|Overall Study||116
371401|NCT01119625|890453|P1|COMPLETED|Overall Study||115
371402|NCT01119625|890452|P2|STARTED|Overall Study||120
371403|NCT01119625|890453|P1|STARTED|Overall Study||118
371404|NCT01119443|890495|P2|NOT COMPLETED|End of Study (All Patients)||0
371405|NCT01119443|890496|P1|NOT COMPLETED|End of Study (All Patients)||0
371406|NCT01119443|890495|P2|COMPLETED|End of Study (All Patients)||14
371407|NCT01119443|890496|P1|COMPLETED|End of Study (All Patients)||14
371408|NCT01119443|890495|P2|STARTED|End of Study (All Patients)||14
371409|NCT01119443|890496|P1|STARTED|End of Study (All Patients)||14
371410|NCT01119443|890495|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
371411|NCT01119443|890496|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
371412|NCT01119443|890495|P2|COMPLETED|Down-titration Period (1 Day)||13
371413|NCT01119443|890496|P1|COMPLETED|Down-titration Period (1 Day)||14
371414|NCT01119443|890495|P2|STARTED|Down-titration Period (1 Day)||13
371415|NCT01119443|890496|P1|STARTED|Down-titration Period (1 Day)||14
371416|NCT01119443|890495|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
371417|NCT01119443|890496|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
371418|NCT01119443|890495|P2|COMPLETED|Crossover Period 4 (5 Days)||13
371419|NCT01119443|890496|P1|COMPLETED|Crossover Period 4 (5 Days)||14
371420|NCT01119443|890495|P2|STARTED|Crossover Period 4 (5 Days)||13
371421|NCT01119443|890496|P1|STARTED|Crossover Period 4 (5 Days)||14
371422|NCT01119443|890495|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
371423|NCT01119443|890496|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
371424|NCT01119443|890495|P2|COMPLETED|Crossover Period 3 (5 Days)||13
371425|NCT01119443|890496|P1|COMPLETED|Crossover Period 3 (5 Days)||14
371426|NCT01119443|890495|P2|STARTED|Crossover Period 3 (5 Days)||13
371427|NCT01119443|890496|P1|STARTED|Crossover Period 3 (5 Days)||14
371428|NCT01119443|890495|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
371429|NCT01119443|890496|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
371430|NCT01119443|890495|P2|COMPLETED|Crossover Period 2 (5 Days)||13
371431|NCT01119443|890496|P1|COMPLETED|Crossover Period 2 (5 Days)||14
371432|NCT01119443|890495|P2|STARTED|Crossover Period 2 (5 Days)||13
371433|NCT01119443|890496|P1|STARTED|Crossover Period 2 (5 Days)||14
371434|NCT01119443|890495|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
371435|NCT01119443|890496|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
371436|NCT01119443|890495|P2|COMPLETED|Crossover Period 1 (5 Days)||13
371437|NCT01119443|890496|P1|COMPLETED|Crossover Period 1 (5 Days)||14
371438|NCT01119443|890495|P2|STARTED|Crossover Period 1 (5 Days)||14
371439|NCT01119443|890496|P1|STARTED|Crossover Period 1 (5 Days)||14
371440|NCT01119443|890495|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
371441|NCT01119443|890496|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
371442|NCT01119443|890495|P2|COMPLETED|Up-titration Period (10 Days)||14
371443|NCT01119443|890496|P1|COMPLETED|Up-titration Period (10 Days)||14
371444|NCT01119443|890495|P2|STARTED|Up-titration Period (10 Days)||14
371445|NCT01119443|890496|P1|STARTED|Up-titration Period (10 Days)||14
371446|NCT01119287|890539|P6|NOT COMPLETED|Overall Study||0
371447|NCT01119287|890540|P5|NOT COMPLETED|Overall Study||1
371448|NCT01119287|890541|P4|NOT COMPLETED|Overall Study||2
371449|NCT01119287|890542|P3|NOT COMPLETED|Overall Study||2
371450|NCT01119287|890543|P2|NOT COMPLETED|Overall Study||0
371451|NCT01119287|890544|P1|NOT COMPLETED|Overall Study||0
371452|NCT01119287|890539|P6|COMPLETED|Overall Study||32
371453|NCT01119287|890540|P5|COMPLETED|Overall Study||30
371454|NCT01119287|890541|P4|COMPLETED|Overall Study||29
371455|NCT01119287|890542|P3|COMPLETED|Overall Study||24
371456|NCT01119287|890543|P2|COMPLETED|Overall Study||24
371457|NCT01119287|890544|P1|COMPLETED|Overall Study||26
371458|NCT01119287|890539|P6|STARTED|Overall Study||32
371459|NCT01119287|890540|P5|STARTED|Overall Study||31
371460|NCT01119287|890541|P4|STARTED|Overall Study||31
371461|NCT01119287|890542|P3|STARTED|Overall Study||26
371462|NCT01119287|890543|P2|STARTED|Overall Study||24
371463|NCT01119287|890544|P1|STARTED|Overall Study||26
371464|NCT01119222|890557|P4|NOT COMPLETED|Overall Study||0
371465|NCT01119222|890558|P3|NOT COMPLETED|Overall Study||0
371466|NCT01119222|890559|P2|NOT COMPLETED|Overall Study||0
371467|NCT01119222|890560|P1|NOT COMPLETED|Overall Study||0
371468|NCT01119222|890557|P4|COMPLETED|Overall Study||4
371469|NCT01119222|890558|P3|COMPLETED|Overall Study||5
371470|NCT01119222|890559|P2|COMPLETED|Overall Study||5
371471|NCT01119222|890560|P1|COMPLETED|Overall Study||5
371472|NCT01119222|890557|P4|STARTED|Overall Study||4
371473|NCT01119222|890558|P3|STARTED|Overall Study||5
371474|NCT01119222|890559|P2|STARTED|Overall Study||5
371475|NCT01119222|890560|P1|STARTED|Overall Study||5
371476|NCT01119131|890601|P3|NOT COMPLETED|Overall Study||6
371477|NCT01119131|890602|P2|NOT COMPLETED|Overall Study||1
371478|NCT01119131|890603|P1|NOT COMPLETED|Overall Study||2
371479|NCT01119131|890601|P3|COMPLETED|Overall Study||24
371480|NCT01119131|890602|P2|COMPLETED|Overall Study||27
371481|NCT01119131|890603|P1|COMPLETED|Overall Study||8
371482|NCT01119131|890601|P3|STARTED|Overall Study||30
371483|NCT01119131|890602|P2|STARTED|Overall Study||28
371484|NCT01119131|890603|P1|STARTED|Overall Study||10
371485|NCT01119118|890632|P1|NOT COMPLETED|Overall Study||1
371486|NCT01119118|890632|P1|COMPLETED|Overall Study||5
371487|NCT01119118|890632|P1|STARTED|Overall Study||6
371488|NCT01119040|890640|P1|NOT COMPLETED|Overall Study||1
371489|NCT01119040|890640|P1|COMPLETED|Overall Study||0
371490|NCT01119040|890640|P1|STARTED|Overall Study||1
371491|NCT01119001|890644|P1|NOT COMPLETED|Overall Study||2
371492|NCT01119001|890644|P1|COMPLETED|Overall Study||11
371493|NCT01119001|890644|P1|STARTED|Overall Study||13
371494|NCT01118988|890653|P3|NOT COMPLETED|Overall Study||4
371495|NCT01118988|890654|P2|NOT COMPLETED|Overall Study||1
371496|NCT01118988|890655|P1|NOT COMPLETED|Overall Study||5
371497|NCT01118988|890653|P3|COMPLETED|Overall Study||3
371498|NCT01118988|890654|P2|COMPLETED|Overall Study||3
371499|NCT01118988|890655|P1|COMPLETED|Overall Study||11
371500|NCT01118988|890653|P3|STARTED|Overall Study||7
371501|NCT01118988|890654|P2|STARTED|Overall Study||4
371502|NCT01118988|890655|P1|STARTED|Overall Study||16
371503|NCT01118975|890688|P2|NOT COMPLETED|Overall Study||1
371504|NCT01118975|890689|P1|NOT COMPLETED|Overall Study||0
371505|NCT01118975|890688|P2|COMPLETED|Overall Study||2
371506|NCT01118975|890689|P1|COMPLETED|Overall Study||9
371507|NCT01118975|890688|P2|STARTED|Overall Study||3
371508|NCT01118975|890689|P1|STARTED|Overall Study||9
371509|NCT01118962|890695|P1|NOT COMPLETED|Overall Study||10
371510|NCT01118962|890695|P1|COMPLETED|Overall Study||29
371511|NCT01118962|890695|P1|STARTED|Overall Study||39
371512|NCT01118949|890700|P1|NOT COMPLETED|Overall Study||9
371513|NCT01118949|890700|P1|COMPLETED|Overall Study||40
371514|NCT01118949|890700|P1|STARTED|Overall Study||49
371515|NCT01118845|890709|P1|NOT COMPLETED|Overall Study||42
371516|NCT01118845|890709|P1|COMPLETED|Overall Study||17
371517|NCT01118845|890709|P1|STARTED|Overall Study||59
371518|NCT01118780|890730|P2|NOT COMPLETED|Overall Study||35
371519|NCT01118780|890731|P1|NOT COMPLETED|Overall Study||36
371520|NCT01118780|890730|P2|COMPLETED|Overall Study||105
371521|NCT01118780|890731|P1|COMPLETED|Overall Study||115
371522|NCT01118780|890730|P2|STARTED|Overall Study||140
371523|NCT01118780|890731|P1|STARTED|Overall Study||151
371524|NCT01118741|890780|P2|NOT COMPLETED|Overall Study||0
371525|NCT01118741|890781|P1|NOT COMPLETED|Overall Study||0
371526|NCT01118741|890780|P2|COMPLETED|Overall Study||10
371527|NCT01118741|890781|P1|COMPLETED|Overall Study||9
371528|NCT01118741|890780|P2|STARTED|Overall Study||10
371529|NCT01118741|890781|P1|STARTED|Overall Study||9
371530|NCT01118663|890789|P2|NOT COMPLETED|Overall Study||2
371531|NCT01118663|890790|P1|NOT COMPLETED|Overall Study||2
371532|NCT01118663|890789|P2|COMPLETED|Overall Study||8
371533|NCT01118663|890790|P1|COMPLETED|Overall Study||5
371534|NCT01118663|890789|P2|STARTED|Overall Study||10
371535|NCT01118663|890790|P1|STARTED|Overall Study||7
371536|NCT01118624|890804|P1|NOT COMPLETED|Overall Study||22
371537|NCT01118624|890804|P1|COMPLETED|Overall Study||0
371538|NCT01118624|890804|P1|STARTED|Overall Study||22
371539|NCT01118455|890813|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
371540|NCT01118455|890814|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
371541|NCT01118455|890813|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
371635|NCT01117870|891175|P1|NOT COMPLETED|Overall Study||1
371542|NCT01118455|890814|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
371543|NCT01118455|890813|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
371544|NCT01118455|890814|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
371545|NCT01118455|890813|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
371546|NCT01118455|890814|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
371547|NCT01118455|890813|P2|COMPLETED|Baseline [Visits 1 & 2]||69
371548|NCT01118455|890814|P1|COMPLETED|Baseline [Visits 1 & 2]||65
371549|NCT01118455|890813|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
371550|NCT01118455|890814|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
371551|NCT01118455|890813|P2|STARTED|Baseline [Visits 1 & 2]||69
371552|NCT01118455|890814|P1|STARTED|Baseline [Visits 1 & 2]||66
371553|NCT01118377|890842|P1|NOT COMPLETED|Overall Study||42
371554|NCT01118377|890842|P1|COMPLETED|Overall Study||3
371555|NCT01118377|890842|P1|STARTED|Overall Study||45
371556|NCT01118325|890851|P3|NOT COMPLETED|Overall Study||1
371557|NCT01118325|890852|P2|NOT COMPLETED|Overall Study||0
371558|NCT01118325|890853|P1|NOT COMPLETED|Overall Study||1
371559|NCT01118325|890851|P3|COMPLETED|Overall Study||45
371560|NCT01118325|890852|P2|COMPLETED|Overall Study||43
371561|NCT01118325|890853|P1|COMPLETED|Overall Study||49
371562|NCT01118325|890851|P3|STARTED|Overall Study||46
371563|NCT01118325|890852|P2|STARTED|Overall Study||43
371564|NCT01118325|890853|P1|STARTED|Overall Study||50
371565|NCT01118312|890899|P2|NOT COMPLETED|Overall Study||35
371566|NCT01118312|890900|P1|NOT COMPLETED|Overall Study||34
371567|NCT01118312|890899|P2|COMPLETED|Overall Study||164
371568|NCT01118312|890900|P1|COMPLETED|Overall Study||155
371569|NCT01118312|890899|P2|STARTED|Overall Study||199
371570|NCT01118312|890900|P1|STARTED|Overall Study||189
371571|NCT01118273|890914|P6|NOT COMPLETED|Overall Study||0
371572|NCT01118273|890915|P5|NOT COMPLETED|Overall Study||0
371573|NCT01118273|890916|P4|NOT COMPLETED|Overall Study||0
371574|NCT01118273|890917|P3|NOT COMPLETED|Overall Study||0
371575|NCT01118273|890918|P2|NOT COMPLETED|Overall Study||0
371576|NCT01118273|890919|P1|NOT COMPLETED|Overall Study||0
371577|NCT01118273|890914|P6|COMPLETED|Overall Study||27
371578|NCT01118273|890915|P5|COMPLETED|Overall Study||27
371579|NCT01118273|890916|P4|COMPLETED|Overall Study||27
371580|NCT01118273|890917|P3|COMPLETED|Overall Study||27
371581|NCT01118273|890918|P2|COMPLETED|Overall Study||27
371582|NCT01118273|890919|P1|COMPLETED|Overall Study||27
371583|NCT01118273|890914|P6|STARTED|Overall Study||27
371584|NCT01118273|890915|P5|STARTED|Overall Study||27
371585|NCT01118273|890916|P4|STARTED|Overall Study||27
371586|NCT01118273|890917|P3|STARTED|Overall Study||27
371587|NCT01118273|890918|P2|STARTED|Overall Study||27
371588|NCT01118273|890919|P1|STARTED|Overall Study||27
371589|NCT01118221|891085|P2|NOT COMPLETED|Overall Study||1
371590|NCT01118221|891086|P1|NOT COMPLETED|Overall Study||3
371591|NCT01118221|891085|P2|COMPLETED|Overall Study||10
371592|NCT01118221|891086|P1|COMPLETED|Overall Study||11
371593|NCT01118221|891085|P2|STARTED|Overall Study||11
371594|NCT01118221|891086|P1|STARTED|Overall Study||14
371595|NCT01118143|891098|P2|NOT COMPLETED|Overall Study||5
371596|NCT01118143|891099|P1|NOT COMPLETED|Overall Study||2
371597|NCT01118143|891098|P2|COMPLETED|Overall Study||64
371598|NCT01118143|891099|P1|COMPLETED|Overall Study||62
371599|NCT01118143|891098|P2|STARTED|Overall Study||69
371600|NCT01118143|891099|P1|STARTED|Overall Study||64
371601|NCT01118117|891109|P2|NOT COMPLETED|Overall Study||0
371602|NCT01118117|891110|P1|NOT COMPLETED|Overall Study||21
371603|NCT01118117|891109|P2|COMPLETED|Overall Study||15
371604|NCT01118117|891110|P1|COMPLETED|Overall Study||240
371605|NCT01118117|891109|P2|STARTED|Overall Study||15
371606|NCT01118117|891110|P1|STARTED|Overall Study||261
371607|NCT01118091|891131|P2|NOT COMPLETED|Overall Study||0
371608|NCT01118091|891132|P1|NOT COMPLETED|Overall Study||0
371609|NCT01118091|891131|P2|COMPLETED|Overall Study||5
371610|NCT01118091|891132|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
371611|NCT01118091|891131|P2|STARTED|Overall Study||5
371612|NCT01118091|891132|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
371613|NCT01118013|891142|P1|NOT COMPLETED|Overall Study||0
371614|NCT01118013|891142|P1|COMPLETED|Overall Study||6
371615|NCT01118013|891142|P1|STARTED|Overall Study||6
371616|NCT01117987|891152|P2|NOT COMPLETED|Overall Study||74
371617|NCT01117987|891153|P1|NOT COMPLETED|Overall Study||61
371618|NCT01117987|891152|P2|COMPLETED|Overall Study||4
371619|NCT01117987|891153|P1|COMPLETED|Overall Study||5
371620|NCT01117987|891152|P2|STARTED|Overall Study||78
371621|NCT01117987|891153|P1|STARTED|Overall Study||66
371622|NCT01117948|891165|P2|NOT COMPLETED|Open Label||47
371623|NCT01117948|891166|P1|NOT COMPLETED|Open Label||52
371624|NCT01117948|891165|P2|COMPLETED|Open Label||51
371625|NCT01117948|891166|P1|COMPLETED|Open Label||41
371626|NCT01117948|891165|P2|STARTED|Open Label||98
371627|NCT01117948|891166|P1|STARTED|Open Label||93
371628|NCT01117948|891165|P2|NOT COMPLETED|Double Blind||10
371629|NCT01117948|891166|P1|NOT COMPLETED|Double Blind||18
371630|NCT01117948|891165|P2|COMPLETED|Double Blind||98
371631|NCT01117948|891166|P1|COMPLETED|Double Blind||93
371632|NCT01117948|891165|P2|STARTED|Double Blind||108
371633|NCT01117948|891166|P1|STARTED|Double Blind||111
371634|NCT01117870|891174|P2|NOT COMPLETED|Overall Study||0
371636|NCT01117870|891174|P2|COMPLETED|Overall Study||16
371637|NCT01117870|891175|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
371638|NCT01117870|891174|P2|STARTED|Overall Study||16
371639|NCT01117870|891175|P1|STARTED|Overall Study||15
371640|NCT01117857|891189|P1|NOT COMPLETED|Overall Study||9
371641|NCT01117857|891189|P1|COMPLETED|Overall Study||13
371642|NCT01117857|891189|P1|STARTED|Overall Study||22
371643|NCT01117766|891197|P2|NOT COMPLETED|Second Intervention||5
371644|NCT01117766|891198|P1|NOT COMPLETED|Second Intervention||2
371645|NCT01117766|891197|P2|COMPLETED|Second Intervention||9
371646|NCT01117766|891198|P1|COMPLETED|Second Intervention||11
371647|NCT01117766|891197|P2|STARTED|Second Intervention||14
371648|NCT01117766|891198|P1|STARTED|Second Intervention||13
371649|NCT01117766|891197|P2|NOT COMPLETED|Washout Period||2
371650|NCT01117766|891198|P1|NOT COMPLETED|Washout Period||0
371651|NCT01117766|891197|P2|COMPLETED|Washout Period||14
371652|NCT01117766|891198|P1|COMPLETED|Washout Period||13
371653|NCT01117766|891197|P2|STARTED|Washout Period||16
371654|NCT01117766|891198|P1|STARTED|Washout Period||13
371655|NCT01117766|891197|P2|NOT COMPLETED|First Intervention||1
371656|NCT01117766|891198|P1|NOT COMPLETED|First Intervention||1
371657|NCT01117766|891197|P2|COMPLETED|First Intervention||16
371658|NCT01117766|891198|P1|COMPLETED|First Intervention||13
371659|NCT01117766|891197|P2|Received Treatment|First Intervention||17
371660|NCT01117766|891198|P1|Received Treatment|First Intervention||14
371661|NCT01117766|891197|P2|STARTED|First Intervention||17
371662|NCT01117766|891198|P1|STARTED|First Intervention||14
371663|NCT01117727|891222|P1|NOT COMPLETED|Overall Study||0
371664|NCT01117727|891222|P1|COMPLETED|Overall Study||1
371665|NCT01117727|891222|P1|STARTED|Overall Study||1
371666|NCT01117623|891235|P8|NOT COMPLETED|Overall Study||26
371667|NCT01117623|891236|P7|NOT COMPLETED|Overall Study||6
371668|NCT01117623|891237|P6|NOT COMPLETED|Overall Study||16
371669|NCT01117623|891238|P5|NOT COMPLETED|Overall Study||10
371670|NCT01117623|891239|P4|NOT COMPLETED|Overall Study||6
371671|NCT01117623|891240|P3|NOT COMPLETED|Overall Study||11
371672|NCT01117623|891241|P2|NOT COMPLETED|Overall Study||8
371673|NCT01117623|891242|P1|NOT COMPLETED|Overall Study||3
371674|NCT01117623|891235|P8|COMPLETED|Overall Study||0
371675|NCT01117623|891236|P7|COMPLETED|Overall Study||0
371676|NCT01117623|891237|P6|COMPLETED|Overall Study||0
371677|NCT01117623|891238|P5|COMPLETED|Overall Study||0
371678|NCT01117623|891239|P4|COMPLETED|Overall Study||0
371679|NCT01117623|891240|P3|COMPLETED|Overall Study||0
371680|NCT01117623|891241|P2|COMPLETED|Overall Study||0
371681|NCT01117623|891242|P1|COMPLETED|Overall Study||0
371682|NCT01117623|891235|P8|PK Population|Overall Study||24
371683|NCT01117623|891236|P7|PK Population|Overall Study||6
371684|NCT01117623|891237|P6|PK Population|Overall Study||14
371685|NCT01117623|891238|P5|PK Population|Overall Study||10
371686|NCT01117623|891239|P4|PK Population|Overall Study||6
371687|NCT01117623|891240|P3|PK Population|Overall Study||10
371688|NCT01117623|891241|P2|PK Population|Overall Study||8
371689|NCT01117623|891242|P1|PK Population|Overall Study||3
371690|NCT01117623|891235|P8|ITT Efficacy Analysis Population|Overall Study||22
371691|NCT01117623|891236|P7|ITT Efficacy Analysis Population|Overall Study||6
371692|NCT01117623|891237|P6|ITT Efficacy Analysis Population|Overall Study||16
371693|NCT01117623|891238|P5|ITT Efficacy Analysis Population|Overall Study||10
371694|NCT01117623|891239|P4|ITT Efficacy Analysis Population|Overall Study||5
371695|NCT01117623|891240|P3|ITT Efficacy Analysis Population|Overall Study||11
371696|NCT01117623|891241|P2|ITT Efficacy Analysis Population|Overall Study||8
371697|NCT01117623|891242|P1|ITT Efficacy Analysis Population|Overall Study||3
371698|NCT01117623|891235|P8|STARTED|Overall Study||26
371699|NCT01117623|891236|P7|STARTED|Overall Study||6
371700|NCT01117623|891237|P6|STARTED|Overall Study||16
371701|NCT01117623|891238|P5|STARTED|Overall Study||10
371702|NCT01117623|891239|P4|STARTED|Overall Study||6
371703|NCT01117623|891240|P3|STARTED|Overall Study||11
371704|NCT01117623|891241|P2|STARTED|Overall Study||8
371705|NCT01117623|891242|P1|STARTED|Overall Study||3
371706|NCT01117480|891394|P1|NOT COMPLETED|Overall Study||28
371707|NCT01117480|891394|P1|COMPLETED|Overall Study||985
371708|NCT01117480|891394|P1|STARTED|Overall Study||1013
371709|NCT01117454|891402|P2|NOT COMPLETED|Overall Study||1
371710|NCT01117454|891403|P1|NOT COMPLETED|Overall Study||0
371711|NCT01117454|891402|P2|COMPLETED|Overall Study||7
371712|NCT01117454|891403|P1|COMPLETED|Overall Study||6
371713|NCT01117454|891402|P2|STARTED|Overall Study||8
371714|NCT01117454|891403|P1|STARTED|Overall Study||6
371715|NCT01117350|891411|P2|NOT COMPLETED|Extension Period||63
371716|NCT01117350|891412|P1|NOT COMPLETED|Extension Period||0
371717|NCT01117350|891411|P2|COMPLETED|Extension Period||147
371718|NCT01117350|891412|P1|COMPLETED|Extension Period||0
371719|NCT01117350|891411|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
371720|NCT01117350|891412|P1|mITT Population (Extension)|Extension Period||0
371721|NCT01117350|891411|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
371722|NCT01117350|891412|P1|TREATED = Safety Population (Extension)|Extension Period||0
371807|NCT01116986|891583|P7|NOT COMPLETED|Overall Study||2
371723|NCT01117350|891411|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
371724|NCT01117350|891412|P1|STARTED|Extension Period||0
371725|NCT01117350|891411|P2|NOT COMPLETED|Comparative Period||75
371726|NCT01117350|891412|P1|NOT COMPLETED|Comparative Period||42
371727|NCT01117350|891411|P2|COMPLETED|Comparative Period||414
371728|NCT01117350|891412|P1|COMPLETED|Comparative Period||447
371729|NCT01117350|891411|P2|mITT Population|Comparative Period||470
371730|NCT01117350|891412|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
371731|NCT01117350|891411|P2|TREATED = Safety Population|Comparative Period||481
371732|NCT01117350|891412|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
371733|NCT01117350|891411|P2|STARTED|Comparative Period||489
371734|NCT01117350|891412|P1|STARTED|Comparative Period|STARTED: randomized|489
371735|NCT01117337|891444|P2|NOT COMPLETED|Overall Study||0
371736|NCT01117337|891445|P1|NOT COMPLETED|Overall Study||4
371737|NCT01117337|891444|P2|COMPLETED|Overall Study||52
371738|NCT01117337|891445|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
371739|NCT01117337|891444|P2|Underwent Surgery|Overall Study||52
371740|NCT01117337|891445|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
371741|NCT01117337|891444|P2|STARTED|Overall Study||52
371742|NCT01117337|891445|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
371743|NCT01117311|891455|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
371744|NCT01117311|891456|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
371745|NCT01117311|891455|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
371746|NCT01117311|891456|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
371747|NCT01117311|891455|P2|STARTED|Second Intervention - Mixed Meal 3||4
371748|NCT01117311|891456|P1|STARTED|Second Intervention - Mixed Meal 3||3
371749|NCT01117311|891455|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
371750|NCT01117311|891456|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
371751|NCT01117311|891455|P2|COMPLETED|First Intervention - Mixed Meal 2||4
371752|NCT01117311|891456|P1|COMPLETED|First Intervention - Mixed Meal 2||3
371753|NCT01117311|891455|P2|STARTED|First Intervention - Mixed Meal 2||4
371754|NCT01117311|891456|P1|STARTED|First Intervention - Mixed Meal 2||3
371755|NCT01117311|891455|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
371756|NCT01117311|891456|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
371757|NCT01117311|891455|P2|COMPLETED|Lead-in Mixed Meal 1||4
371758|NCT01117311|891456|P1|COMPLETED|Lead-in Mixed Meal 1||3
371759|NCT01117311|891455|P2|STARTED|Lead-in Mixed Meal 1||4
371760|NCT01117311|891456|P1|STARTED|Lead-in Mixed Meal 1||3
371761|NCT01117181|891466|P2|NOT COMPLETED|Overall Study||2
371762|NCT01117181|891467|P1|NOT COMPLETED|Overall Study||1
371763|NCT01117181|891466|P2|COMPLETED|Overall Study||29
371764|NCT01117181|891467|P1|COMPLETED|Overall Study||28
371765|NCT01117181|891466|P2|STARTED|Overall Study||31
371766|NCT01117181|891467|P1|STARTED|Overall Study||29
371767|NCT01117090|891485|P1|NOT COMPLETED|Overall Study||0
371768|NCT01117090|891485|P1|COMPLETED|Overall Study||47
371769|NCT01117090|891485|P1|STARTED|Overall Study||47
371770|NCT01117051|891498|P2|NOT COMPLETED|Overall Study||11
371771|NCT01117051|891499|P1|NOT COMPLETED|Overall Study||13
371772|NCT01117051|891498|P2|COMPLETED|Overall Study||77
371773|NCT01117051|891499|P1|COMPLETED|Overall Study||73
371774|NCT01117051|891498|P2|STARTED|Overall Study||88
371775|NCT01117051|891499|P1|STARTED|Overall Study||86
371776|NCT01117012|891509|P2|NOT COMPLETED|Overall Study||5
371777|NCT01117012|891510|P1|NOT COMPLETED|Overall Study||8
371778|NCT01117012|891509|P2|COMPLETED|Overall Study||98
371779|NCT01117012|891510|P1|COMPLETED|Overall Study||81
371780|NCT01117012|891509|P2|STARTED|Overall Study||103
371781|NCT01117012|891510|P1|STARTED|Overall Study||89
371782|NCT01116986|891558|P32|NOT COMPLETED|Overall Study||3
371783|NCT01116986|891559|P31|NOT COMPLETED|Overall Study||1
371784|NCT01116986|891560|P30|NOT COMPLETED|Overall Study||0
371785|NCT01116986|891561|P29|NOT COMPLETED|Overall Study||0
371786|NCT01116986|891562|P28|NOT COMPLETED|Overall Study||1
371787|NCT01116986|891563|P27|NOT COMPLETED|Overall Study||4
371788|NCT01116986|891564|P26|NOT COMPLETED|Overall Study||0
371789|NCT01116986|891565|P25|NOT COMPLETED|Overall Study||3
371790|NCT01116986|891566|P24|NOT COMPLETED|Overall Study||2
371791|NCT01116986|891567|P23|NOT COMPLETED|Overall Study||4
371792|NCT01116986|891568|P22|NOT COMPLETED|Overall Study||2
371793|NCT01116986|891569|P21|NOT COMPLETED|Overall Study||2
371794|NCT01116986|891570|P20|NOT COMPLETED|Overall Study||2
371795|NCT01116986|891571|P19|NOT COMPLETED|Overall Study||3
371796|NCT01116986|891572|P18|NOT COMPLETED|Overall Study||5
371797|NCT01116986|891573|P17|NOT COMPLETED|Overall Study||3
371798|NCT01116986|891574|P16|NOT COMPLETED|Overall Study||6
371799|NCT01116986|891575|P15|NOT COMPLETED|Overall Study||0
371800|NCT01116986|891576|P14|NOT COMPLETED|Overall Study||3
371801|NCT01116986|891577|P13|NOT COMPLETED|Overall Study||1
371802|NCT01116986|891578|P12|NOT COMPLETED|Overall Study||0
371803|NCT01116986|891579|P11|NOT COMPLETED|Overall Study||1
371804|NCT01116986|891580|P10|NOT COMPLETED|Overall Study||4
371805|NCT01116986|891581|P9|NOT COMPLETED|Overall Study||1
371806|NCT01116986|891582|P8|NOT COMPLETED|Overall Study||2
371808|NCT01116986|891584|P6|NOT COMPLETED|Overall Study||2
371809|NCT01116986|891585|P5|NOT COMPLETED|Overall Study||4
371810|NCT01116986|891586|P4|NOT COMPLETED|Overall Study||2
371811|NCT01116986|891587|P3|NOT COMPLETED|Overall Study||2
371812|NCT01116986|891588|P2|NOT COMPLETED|Overall Study||3
371813|NCT01116986|891589|P1|NOT COMPLETED|Overall Study||2
371814|NCT01116986|891558|P32|COMPLETED|Overall Study||14
371815|NCT01116986|891559|P31|COMPLETED|Overall Study||16
371816|NCT01116986|891560|P30|COMPLETED|Overall Study||17
371817|NCT01116986|891561|P29|COMPLETED|Overall Study||17
371818|NCT01116986|891562|P28|COMPLETED|Overall Study||18
371819|NCT01116986|891563|P27|COMPLETED|Overall Study||14
371820|NCT01116986|891564|P26|COMPLETED|Overall Study||19
371821|NCT01116986|891565|P25|COMPLETED|Overall Study||15
371822|NCT01116986|891566|P24|COMPLETED|Overall Study||19
371823|NCT01116986|891567|P23|COMPLETED|Overall Study||19
371824|NCT01116986|891568|P22|COMPLETED|Overall Study||18
371825|NCT01116986|891569|P21|COMPLETED|Overall Study||22
371826|NCT01116986|891570|P20|COMPLETED|Overall Study||13
371827|NCT01116986|891571|P19|COMPLETED|Overall Study||20
371828|NCT01116986|891572|P18|COMPLETED|Overall Study||19
371829|NCT01116986|891573|P17|COMPLETED|Overall Study||13
371830|NCT01116986|891574|P16|COMPLETED|Overall Study||15
371831|NCT01116986|891575|P15|COMPLETED|Overall Study||17
371832|NCT01116986|891576|P14|COMPLETED|Overall Study||16
371833|NCT01116986|891577|P13|COMPLETED|Overall Study||16
371834|NCT01116986|891578|P12|COMPLETED|Overall Study||20
371835|NCT01116986|891579|P11|COMPLETED|Overall Study||18
371836|NCT01116986|891580|P10|COMPLETED|Overall Study||19
371837|NCT01116986|891581|P9|COMPLETED|Overall Study||19
371838|NCT01116986|891582|P8|COMPLETED|Overall Study||20
371839|NCT01116986|891583|P7|COMPLETED|Overall Study||20
371840|NCT01116986|891584|P6|COMPLETED|Overall Study||20
371841|NCT01116986|891585|P5|COMPLETED|Overall Study||20
371842|NCT01116986|891586|P4|COMPLETED|Overall Study||20
371843|NCT01116986|891587|P3|COMPLETED|Overall Study||16
371844|NCT01116986|891588|P2|COMPLETED|Overall Study||16
371845|NCT01116986|891589|P1|COMPLETED|Overall Study||22
371846|NCT01116986|891558|P32|STARTED|Overall Study||17
371847|NCT01116986|891559|P31|STARTED|Overall Study||17
371848|NCT01116986|891560|P30|STARTED|Overall Study||17
371849|NCT01116986|891561|P29|STARTED|Overall Study||17
371850|NCT01116986|891562|P28|STARTED|Overall Study||19
371851|NCT01116986|891563|P27|STARTED|Overall Study||18
371852|NCT01116986|891564|P26|STARTED|Overall Study||19
371853|NCT01116986|891565|P25|STARTED|Overall Study||18
371854|NCT01116986|891566|P24|STARTED|Overall Study||21
371855|NCT01116986|891567|P23|STARTED|Overall Study||23
371856|NCT01116986|891568|P22|STARTED|Overall Study||20
371857|NCT01116986|891569|P21|STARTED|Overall Study||24
371858|NCT01116986|891570|P20|STARTED|Overall Study||15
371859|NCT01116986|891571|P19|STARTED|Overall Study||23
371860|NCT01116986|891572|P18|STARTED|Overall Study||24
371861|NCT01116986|891573|P17|STARTED|Overall Study||16
371862|NCT01116986|891574|P16|STARTED|Overall Study||21
371863|NCT01116986|891575|P15|STARTED|Overall Study||17
371864|NCT01116986|891576|P14|STARTED|Overall Study||19
371865|NCT01116986|891577|P13|STARTED|Overall Study||17
371866|NCT01116986|891578|P12|STARTED|Overall Study||20
371867|NCT01116986|891579|P11|STARTED|Overall Study||19
371868|NCT01116986|891580|P10|STARTED|Overall Study||23
371869|NCT01116986|891581|P9|STARTED|Overall Study||20
371870|NCT01116986|891582|P8|STARTED|Overall Study||22
371871|NCT01116986|891583|P7|STARTED|Overall Study||22
371872|NCT01116986|891584|P6|STARTED|Overall Study||22
371873|NCT01116986|891585|P5|STARTED|Overall Study||24
371874|NCT01116986|891586|P4|STARTED|Overall Study||22
371875|NCT01116986|891587|P3|STARTED|Overall Study||18
371876|NCT01116986|891588|P2|STARTED|Overall Study||19
371877|NCT01116986|891589|P1|STARTED|Overall Study||24
371878|NCT01116934|891623|P2|NOT COMPLETED|Overall Study||0
371879|NCT01116934|891624|P1|NOT COMPLETED|Overall Study||0
371880|NCT01116934|891623|P2|COMPLETED|Overall Study||9
371881|NCT01116934|891624|P1|COMPLETED|Overall Study||8
371882|NCT01116934|891623|P2|STARTED|Overall Study||9
371883|NCT01116934|891624|P1|STARTED|Overall Study||8
371884|NCT01116921|891632|P2|NOT COMPLETED|Overall Study||0
371885|NCT01116921|891633|P1|NOT COMPLETED|Overall Study||0
371886|NCT01116921|891632|P2|COMPLETED|Overall Study||50
371887|NCT01116921|891633|P1|COMPLETED|Overall Study||53
371888|NCT01116921|891632|P2|STARTED|Overall Study||50
371889|NCT01116921|891633|P1|STARTED|Overall Study||53
371890|NCT01116882|891651|P2|NOT COMPLETED|12-month||99
371891|NCT01116882|891652|P1|NOT COMPLETED|12-month||267
371892|NCT01116882|891651|P2|COMPLETED|12-month||787
371893|NCT01116882|891652|P1|COMPLETED|12-month||2439
371894|NCT01116882|891651|P2|STARTED|12-month||886
371895|NCT01116882|891652|P1|STARTED|12-month||2706
371896|NCT01116882|891651|P2|NOT COMPLETED|30-day||31
371897|NCT01116882|891652|P1|NOT COMPLETED|30-day||68
371898|NCT01116882|891651|P2|COMPLETED|30-day||886
371899|NCT01116882|891652|P1|COMPLETED|30-day||2706
371900|NCT01116882|891651|P2|STARTED|30-day||917
371901|NCT01116882|891652|P1|STARTED|30-day||2774
371902|NCT01116687|891690|P1|NOT COMPLETED|Overall Study||4
371903|NCT01116687|891690|P1|COMPLETED|Overall Study||33
371904|NCT01116687|891690|P1|STARTED|Overall Study||37
371905|NCT01116466|891697|P1|NOT COMPLETED|Overall Study||0
371906|NCT01116466|891697|P1|COMPLETED|Overall Study||5
371907|NCT01116466|891697|P1|STARTED|Overall Study||5
371908|NCT01116427|891707|P2|NOT COMPLETED|Extension Phase||2
371909|NCT01116427|891708|P1|NOT COMPLETED|Extension Phase||9
371910|NCT01116427|891707|P2|COMPLETED|Extension Phase||18
371911|NCT01116427|891708|P1|COMPLETED|Extension Phase||29
371912|NCT01116427|891707|P2|STARTED|Extension Phase||20
371913|NCT01116427|891708|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
371914|NCT01116427|891707|P2|NOT COMPLETED|Core Phase||1
371915|NCT01116427|891708|P1|NOT COMPLETED|Core Phase||5
371916|NCT01116427|891707|P2|COMPLETED|Core Phase||20
371917|NCT01116427|891708|P1|COMPLETED|Core Phase||39
371918|NCT01116427|891707|P2|STARTED|Core Phase||21
371919|NCT01116427|891708|P1|STARTED|Core Phase||44
371920|NCT01116232|891744|P1|NOT COMPLETED|Overall Study||1
371921|NCT01116232|891744|P1|COMPLETED|Overall Study||0
371922|NCT01116232|891744|P1|STARTED|Overall Study||1
371923|NCT01116102|891757|P8|NOT COMPLETED|Overall Study||0
371924|NCT01116102|891758|P7|NOT COMPLETED|Overall Study||0
371925|NCT01116102|891759|P6|NOT COMPLETED|Overall Study||0
371926|NCT01116102|891760|P5|NOT COMPLETED|Overall Study||0
371927|NCT01116102|891761|P4|NOT COMPLETED|Overall Study||0
371928|NCT01116102|891762|P3|NOT COMPLETED|Overall Study||0
371929|NCT01116102|891763|P2|NOT COMPLETED|Overall Study||0
371930|NCT01116102|891764|P1|NOT COMPLETED|Overall Study||0
371931|NCT01116102|891757|P8|COMPLETED|Overall Study||3
371932|NCT01116102|891758|P7|COMPLETED|Overall Study||2
371933|NCT01116102|891759|P6|COMPLETED|Overall Study||2
371934|NCT01116102|891760|P5|COMPLETED|Overall Study||2
371935|NCT01116102|891761|P4|COMPLETED|Overall Study||3
371936|NCT01116102|891762|P3|COMPLETED|Overall Study||3
371937|NCT01116102|891763|P2|COMPLETED|Overall Study||3
371938|NCT01116102|891764|P1|COMPLETED|Overall Study||2
371939|NCT01116102|891757|P8|STARTED|Overall Study||3
371940|NCT01116102|891758|P7|STARTED|Overall Study||2
371941|NCT01116102|891759|P6|STARTED|Overall Study||2
371942|NCT01116102|891760|P5|STARTED|Overall Study||2
371943|NCT01116102|891761|P4|STARTED|Overall Study||3
371944|NCT01116102|891762|P3|STARTED|Overall Study||3
371945|NCT01116102|891763|P2|STARTED|Overall Study||3
371946|NCT01116102|891764|P1|STARTED|Overall Study||2
371947|NCT01116037|891806|P1|NOT COMPLETED|Overall Study||25
371948|NCT01116037|891806|P1|COMPLETED|Overall Study||1
371949|NCT01116037|891806|P1|STARTED|Overall Study||26
371950|NCT01116024|891811|P1|NOT COMPLETED|Overall Study||52
371951|NCT01116024|891811|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
371952|NCT01116024|891811|P1|STARTED|Overall Study|Patient Enrollment start date|148
371953|NCT01115998|891852|P2|NOT COMPLETED|Overall Study||6
371954|NCT01115998|891853|P1|NOT COMPLETED|Overall Study||6
371955|NCT01115998|891852|P2|COMPLETED|Overall Study||11
371956|NCT01115998|891853|P1|COMPLETED|Overall Study||11
371957|NCT01115998|891852|P2|STARTED|Overall Study||17
371958|NCT01115998|891853|P1|STARTED|Overall Study||17
371959|NCT01115933|891863|P1|NOT COMPLETED|Overall Study||1
371960|NCT01115933|891863|P1|COMPLETED|Overall Study||64
371961|NCT01115933|891863|P1|STARTED|Overall Study||65
371962|NCT01115855|891960|P2|NOT COMPLETED|Overall Study||36
371963|NCT01115855|891961|P1|NOT COMPLETED|Overall Study||36
371964|NCT01115855|891960|P2|COMPLETED|Overall Study||74
371965|NCT01115855|891961|P1|COMPLETED|Overall Study||75
371966|NCT01115855|891960|P2|STARTED|Overall Study||110
371967|NCT01115855|891961|P1|STARTED|Overall Study||111
371968|NCT01115738|892012|P3|NOT COMPLETED|Overall Study||27
371969|NCT01115738|892013|P2|NOT COMPLETED|Overall Study||21
371970|NCT01115738|892014|P1|NOT COMPLETED|Overall Study||25
371971|NCT01115738|892012|P3|COMPLETED|Overall Study||62
371972|NCT01115738|892013|P2|COMPLETED|Overall Study||62
371973|NCT01115738|892014|P1|COMPLETED|Overall Study||85
371974|NCT01115738|892012|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
371975|NCT01115738|892013|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
371976|NCT01115738|892014|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
371977|NCT01115738|892012|P3|Received Any Treatment|Overall Study||88
371978|NCT01115738|892013|P2|Received Any Treatment|Overall Study||79
371979|NCT01115738|892014|P1|Received Any Treatment|Overall Study||109
371980|NCT01115738|892012|P3|STARTED|Overall Study||89
371981|NCT01115738|892013|P2|STARTED|Overall Study||83
371982|NCT01115738|892014|P1|STARTED|Overall Study||110
371983|NCT01115699|892048|P1|NOT COMPLETED|Overall Study||0
371984|NCT01115699|892048|P1|COMPLETED|Overall Study||2
371985|NCT01115699|892048|P1|STARTED|Overall Study||2
371986|NCT01115673|892056|P3|NOT COMPLETED|Overall Study||0
371987|NCT01115673|892057|P2|NOT COMPLETED|Overall Study||0
371988|NCT01115673|892058|P1|NOT COMPLETED|Overall Study||0
371989|NCT01115673|892056|P3|COMPLETED|Overall Study||60
371990|NCT01115673|892057|P2|COMPLETED|Overall Study||241
371991|NCT01115673|892058|P1|COMPLETED|Overall Study||239
371992|NCT01115673|892056|P3|STARTED|Overall Study||60
371993|NCT01115673|892057|P2|STARTED|Overall Study||241
371994|NCT01115673|892058|P1|STARTED|Overall Study||239
371995|NCT01115660|892194|P2|NOT COMPLETED|Overall Study||0
371996|NCT01115660|892195|P1|NOT COMPLETED|Overall Study||1
371997|NCT01115660|892194|P2|COMPLETED|Overall Study||10
371998|NCT01115660|892195|P1|COMPLETED|Overall Study||19
371999|NCT01115660|892194|P2|STARTED|Overall Study||10
372000|NCT01115660|892195|P1|STARTED|Overall Study||20
372001|NCT01115582|892203|P1|NOT COMPLETED|Overall Study||0
372002|NCT01115582|892203|P1|COMPLETED|Overall Study||16
372003|NCT01115582|892203|P1|STARTED|Overall Study||16
372004|NCT01115569|892212|P2|NOT COMPLETED|Maintenance Phase||139
372005|NCT01115569|892213|P1|NOT COMPLETED|Maintenance Phase||0
372006|NCT01115569|892212|P2|COMPLETED|Maintenance Phase||285
372007|NCT01115569|892213|P1|COMPLETED|Maintenance Phase||0
372008|NCT01115569|892212|P2|STARTED|Maintenance Phase||424
372009|NCT01115569|892213|P1|STARTED|Maintenance Phase||0
372010|NCT01115569|892212|P2|NOT COMPLETED|Conversion/Titration Phase||0
372011|NCT01115569|892213|P1|NOT COMPLETED|Conversion/Titration Phase||214
372012|NCT01115569|892212|P2|COMPLETED|Conversion/Titration Phase||0
372013|NCT01115569|892213|P1|COMPLETED|Conversion/Titration Phase||424
372014|NCT01115569|892212|P2|STARTED|Conversion/Titration Phase||0
372015|NCT01115569|892213|P1|STARTED|Conversion/Titration Phase||638
372016|NCT01115517|892220|P2|NOT COMPLETED|Overall Study||5
372017|NCT01115517|892221|P1|NOT COMPLETED|Overall Study||4
372018|NCT01115517|892220|P2|COMPLETED|Overall Study||16
372019|NCT01115517|892221|P1|COMPLETED|Overall Study||14
372020|NCT01115517|892220|P2|STARTED|Overall Study||21
372021|NCT01115517|892221|P1|STARTED|Overall Study||18
372022|NCT01115491|892231|P1|NOT COMPLETED|Overall Study||30
372023|NCT01115491|892231|P1|COMPLETED|Overall Study||2
372024|NCT01115491|892231|P1|STARTED|Overall Study||32
372025|NCT01115452|892240|P1|NOT COMPLETED|Overall Study||0
372026|NCT01115452|892240|P1|COMPLETED|Overall Study||32
372027|NCT01115452|892240|P1|STARTED|Overall Study||32
372028|NCT01115166|892290|P1|NOT COMPLETED|Overall Study||0
372029|NCT01115166|892290|P1|COMPLETED|Overall Study||10
372030|NCT01115166|892290|P1|STARTED|Overall Study||10
372031|NCT01115101|892298|P2|NOT COMPLETED|Overall Study||0
372032|NCT01115101|892299|P1|NOT COMPLETED|Overall Study||0
372033|NCT01115101|892298|P2|COMPLETED|Overall Study||126
372034|NCT01115101|892299|P1|COMPLETED|Overall Study||113
372035|NCT01115101|892298|P2|STARTED|Overall Study||126
372036|NCT01115101|892299|P1|STARTED|Overall Study||113
372037|NCT01114997|892308|P3|NOT COMPLETED|Overall Study||0
372038|NCT01114997|892309|P2|NOT COMPLETED|Overall Study||0
372039|NCT01114997|892310|P1|NOT COMPLETED|Overall Study||0
372040|NCT01114997|892308|P3|COMPLETED|Overall Study||11
372041|NCT01114997|892309|P2|COMPLETED|Overall Study||10
372042|NCT01114997|892310|P1|COMPLETED|Overall Study||11
372043|NCT01114997|892308|P3|STARTED|Overall Study||11
372044|NCT01114997|892309|P2|STARTED|Overall Study||10
372045|NCT01114997|892310|P1|STARTED|Overall Study||11
372046|NCT01114945|892340|P4|NOT COMPLETED|Overall Study||0
372047|NCT01114945|892341|P3|NOT COMPLETED|Overall Study||0
372048|NCT01114945|892342|P2|NOT COMPLETED|Overall Study||0
372049|NCT01114945|892343|P1|NOT COMPLETED|Overall Study||0
372050|NCT01114945|892340|P4|COMPLETED|Overall Study||31
372051|NCT01114945|892341|P3|COMPLETED|Overall Study||30
372052|NCT01114945|892342|P2|COMPLETED|Overall Study||30
372053|NCT01114945|892343|P1|COMPLETED|Overall Study||30
372054|NCT01114945|892340|P4|STARTED|Overall Study||31
372055|NCT01114945|892341|P3|STARTED|Overall Study||30
372056|NCT01114945|892342|P2|STARTED|Overall Study||30
372057|NCT01114945|892343|P1|STARTED|Overall Study||30
372058|NCT01114893|892370|P5|NOT COMPLETED|Overall Study||0
372059|NCT01114893|892371|P4|NOT COMPLETED|Overall Study||0
372060|NCT01114893|892372|P3|NOT COMPLETED|Overall Study||0
372061|NCT01114893|892373|P2|NOT COMPLETED|Overall Study||0
372062|NCT01114893|892374|P1|NOT COMPLETED|Overall Study||0
372063|NCT01114893|892370|P5|COMPLETED|Overall Study||12
372064|NCT01114893|892371|P4|COMPLETED|Overall Study||13
372065|NCT01114893|892372|P3|COMPLETED|Overall Study||14
372066|NCT01114893|892373|P2|COMPLETED|Overall Study||14
372067|NCT01114893|892374|P1|COMPLETED|Overall Study||14
372068|NCT01114893|892370|P5|STARTED|Overall Study||12
372069|NCT01114893|892371|P4|STARTED|Overall Study||13
372070|NCT01114893|892372|P3|STARTED|Overall Study||14
372071|NCT01114893|892373|P2|STARTED|Overall Study||14
372072|NCT01114893|892374|P1|STARTED|Overall Study||14
372073|NCT01114880|892393|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
372074|NCT01114880|892394|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
372075|NCT01114880|892393|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
372076|NCT01114880|892394|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
372077|NCT01114880|892393|P2|STARTED|Period 2 (Week 12 to Week 24)||113
372078|NCT01114880|892394|P1|STARTED|Period 2 (Week 12 to Week 24)||224
372079|NCT01114880|892393|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
372080|NCT01114880|892394|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
372081|NCT01114880|892393|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
372082|NCT01114880|892394|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
372083|NCT01114880|892393|P2|STARTED|Period 1 (Week 0 to Week 12)||115
372084|NCT01114880|892394|P1|STARTED|Period 1 (Week 0 to Week 12)||229
372085|NCT01114828|892446|P2|NOT COMPLETED|Overall Study||4
372086|NCT01114828|892447|P1|NOT COMPLETED|Overall Study||3
372087|NCT01114828|892446|P2|COMPLETED|Overall Study||17
372088|NCT01114828|892447|P1|COMPLETED|Overall Study||16
372089|NCT01114828|892446|P2|STARTED|Overall Study||21
372090|NCT01114828|892447|P1|STARTED|Overall Study||19
372091|NCT01114737|892457|P2|NOT COMPLETED|Open-Label Treatment Period||2
372092|NCT01114737|892458|P1|NOT COMPLETED|Open-Label Treatment Period||5
372093|NCT01114737|892457|P2|COMPLETED|Open-Label Treatment Period||95
372094|NCT01114737|892458|P1|COMPLETED|Open-Label Treatment Period||100
372095|NCT01114737|892457|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
372096|NCT01114737|892458|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
372097|NCT01114737|892457|P2|NOT COMPLETED|Randomized Treatment Period||1
372098|NCT01114737|892458|P1|NOT COMPLETED|Randomized Treatment Period||3
372099|NCT01114737|892457|P2|COMPLETED|Randomized Treatment Period||97
372100|NCT01114737|892458|P1|COMPLETED|Randomized Treatment Period||105
372101|NCT01114737|892457|P2|STARTED|Randomized Treatment Period||98
372102|NCT01114737|892458|P1|STARTED|Randomized Treatment Period||108
372103|NCT01114724|892506|P1|NOT COMPLETED|Overall Study||10
372104|NCT01114724|892506|P1|COMPLETED|Overall Study||40
372105|NCT01114724|892506|P1|STARTED|Overall Study||50
372106|NCT01114672|892526|P2|NOT COMPLETED|Overall Study||2
372107|NCT01114672|892527|P1|NOT COMPLETED|Overall Study||4
372108|NCT01114672|892526|P2|COMPLETED|Overall Study||23
372109|NCT01114672|892527|P1|COMPLETED|Overall Study||21
372110|NCT01114672|892526|P2|STARTED|Overall Study||25
372111|NCT01114672|892527|P1|STARTED|Overall Study||25
372112|NCT01114581|892535|P2|NOT COMPLETED|Overall Study||0
372113|NCT01114581|892536|P1|NOT COMPLETED|Overall Study||0
372114|NCT01114581|892535|P2|COMPLETED|Overall Study||19
372115|NCT01114581|892536|P1|COMPLETED|Overall Study||19
372116|NCT01114581|892535|P2|STARTED|Overall Study||19
372117|NCT01114581|892536|P1|STARTED|Overall Study||19
372118|NCT01114529|892547|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
372119|NCT01114529|892548|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
372120|NCT01114529|892549|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
372121|NCT01114529|892547|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
372122|NCT01114529|892548|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
372123|NCT01114529|892549|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
372124|NCT01114529|892547|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
372125|NCT01114529|892548|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
372126|NCT01114529|892549|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
372127|NCT01114529|892547|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
372128|NCT01114529|892548|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
372129|NCT01114529|892549|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
372130|NCT01114529|892547|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
372131|NCT01114529|892548|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
372132|NCT01114529|892549|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
372133|NCT01114529|892547|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
372134|NCT01114529|892548|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
372135|NCT01114529|892549|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
372136|NCT01114516|892568|P2|NOT COMPLETED|Overall Study||1
372137|NCT01114516|892569|P1|NOT COMPLETED|Overall Study||2
372138|NCT01114516|892568|P2|COMPLETED|Overall Study||26
372139|NCT01114516|892569|P1|COMPLETED|Overall Study||24
372140|NCT01114516|892568|P2|STARTED|Overall Study||27
372141|NCT01114516|892569|P1|STARTED|Overall Study||26
372142|NCT01114438|892583|P1|NOT COMPLETED|Overall Study||14
372143|NCT01114438|892583|P1|COMPLETED|Overall Study||31
372144|NCT01114438|892583|P1|STARTED|Overall Study||45
372145|NCT01114373|892593|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
372146|NCT01114373|892594|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
372147|NCT01114373|892593|P2|COMPLETED|Intervention 2 (4 Weeks)||18
372148|NCT01114373|892594|P1|COMPLETED|Intervention 2 (4 Weeks)||18
372149|NCT01114373|892593|P2|STARTED|Intervention 2 (4 Weeks)||19
372150|NCT01114373|892594|P1|STARTED|Intervention 2 (4 Weeks)||18
372151|NCT01114373|892593|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
372152|NCT01114373|892594|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
372153|NCT01114373|892593|P2|COMPLETED|Intervention 1 (4 Weeks)||19
372154|NCT01114373|892594|P1|COMPLETED|Intervention 1 (4 Weeks)||18
372155|NCT01114373|892593|P2|STARTED|Intervention 1 (4 Weeks)||19
372156|NCT01114373|892594|P1|STARTED|Intervention 1 (4 Weeks)||21
372157|NCT01114360|892626|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
372158|NCT01114360|892627|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
372159|NCT01114360|892626|P2|COMPLETED|Intervention 2 (4 Weeks)||18
372160|NCT01114360|892627|P1|COMPLETED|Intervention 2 (4 Weeks)||18
372161|NCT01114360|892626|P2|STARTED|Intervention 2 (4 Weeks)||18
372162|NCT01114360|892627|P1|STARTED|Intervention 2 (4 Weeks)||18
372163|NCT01114360|892626|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
372164|NCT01114360|892627|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
372165|NCT01114360|892626|P2|COMPLETED|Intervention 1 (4 Weeks)||18
372166|NCT01114360|892627|P1|COMPLETED|Intervention 1 (4 Weeks)||18
372167|NCT01114360|892626|P2|STARTED|Intervention 1 (4 Weeks)||19
372168|NCT01114360|892627|P1|STARTED|Intervention 1 (4 Weeks)||18
372169|NCT01114334|892665|P2|NOT COMPLETED|Overall Study||22
372170|NCT01114334|892666|P1|NOT COMPLETED|Overall Study||21
372171|NCT01114334|892665|P2|COMPLETED|Overall Study||58
372172|NCT01114334|892666|P1|COMPLETED|Overall Study||67
372173|NCT01114334|892665|P2|STARTED|Overall Study||80
372174|NCT01114334|892666|P1|STARTED|Overall Study||88
372175|NCT01113931|892678|P2|NOT COMPLETED|Overall Study||17
372176|NCT01113931|892679|P1|NOT COMPLETED|Overall Study||19
372177|NCT01113931|892678|P2|COMPLETED|Overall Study||231
372178|NCT01113931|892679|P1|COMPLETED|Overall Study||228
372179|NCT01113931|892678|P2|mITT Population|Overall Study||190
372180|NCT01113931|892679|P1|mITT Population|Overall Study||188
372181|NCT01113931|892678|P2|Safety Population|Overall Study||248
372182|NCT01113931|892679|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
372183|NCT01113931|892678|P2|STARTED|Overall Study||248
372184|NCT01113931|892679|P1|STARTED|Overall Study||247
372185|NCT01113749|892693|P2|NOT COMPLETED|Overall Study||2
372186|NCT01113749|892694|P1|NOT COMPLETED|Overall Study||1
372187|NCT01113749|892693|P2|COMPLETED|Overall Study||127
372188|NCT01113749|892694|P1|COMPLETED|Overall Study||126
372189|NCT01113749|892693|P2|STARTED|Overall Study||129
372190|NCT01113749|892694|P1|STARTED|Overall Study||127
372191|NCT01113723|892706|P2|NOT COMPLETED|Overall Study||0
372192|NCT01113723|892707|P1|NOT COMPLETED|Overall Study||0
372193|NCT01113723|892706|P2|COMPLETED|Overall Study||70
372194|NCT01113723|892707|P1|COMPLETED|Overall Study||70
372195|NCT01113723|892706|P2|STARTED|Overall Study||70
372196|NCT01113723|892707|P1|STARTED|Overall Study||70
372197|NCT01113710|892717|P1|NOT COMPLETED|Overall Study||269
372198|NCT01113710|892717|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
372199|NCT01113710|892717|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
372200|NCT01113632|892728|P2|NOT COMPLETED|Overall Study||25
372201|NCT01113632|892729|P1|NOT COMPLETED|Overall Study||31
372202|NCT01113632|892728|P2|COMPLETED|Overall Study||19
372203|NCT01113632|892729|P1|COMPLETED|Overall Study||2
372204|NCT01113632|892728|P2|STARTED|Overall Study||44
372205|NCT01113632|892729|P1|STARTED|Overall Study||33
372206|NCT01113580|892745|P2|NOT COMPLETED|Overall Study||0
372207|NCT01113580|892746|P1|NOT COMPLETED|Overall Study||1
372208|NCT01113580|892745|P2|COMPLETED|Overall Study||60
372209|NCT01113580|892746|P1|COMPLETED|Overall Study||59
372210|NCT01113580|892745|P2|STARTED|Overall Study||60
372211|NCT01113580|892746|P1|STARTED|Overall Study||60
372212|NCT01113541|892760|P1|NOT COMPLETED|Overall Study||13
372213|NCT01113541|892760|P1|COMPLETED|Overall Study||0
372214|NCT01113541|892760|P1|STARTED|Overall Study||13
372215|NCT01113463|892793|P1|NOT COMPLETED|Overall Study||5
372216|NCT01113463|892793|P1|COMPLETED|Overall Study||12
372217|NCT01113463|892793|P1|STARTED|Overall Study||17
372218|NCT01113398|892798|P1|NOT COMPLETED|Overall Study||0
372219|NCT01113398|892798|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
372220|NCT01113398|892798|P1|STARTED|Overall Study||36
372221|NCT01113385|892805|P1|NOT COMPLETED|Overall Study||0
372222|NCT01113385|892805|P1|COMPLETED|Overall Study||7
372223|NCT01113385|892805|P1|STARTED|Overall Study||7
372224|NCT01113008|892812|P2|NOT COMPLETED|Overall Study||0
372225|NCT01113008|892813|P1|NOT COMPLETED|Overall Study||0
372226|NCT01113008|892812|P2|COMPLETED|Overall Study||133
372227|NCT01113008|892813|P1|COMPLETED|Overall Study||133
372228|NCT01113008|892812|P2|STARTED|Overall Study||133
372229|NCT01113008|892813|P1|STARTED|Overall Study||133
372230|NCT01112917|892823|P2|NOT COMPLETED|Overall Study||15
372231|NCT01112917|892824|P1|NOT COMPLETED|Overall Study||7
372232|NCT01112917|892823|P2|COMPLETED|Overall Study||38
372233|NCT01112917|892824|P1|COMPLETED|Overall Study||89
372234|NCT01112917|892823|P2|STARTED|Overall Study||53
372235|NCT01112917|892824|P1|STARTED|Overall Study||96
372236|NCT01112865|892829|P2|NOT COMPLETED|Second Intervention||0
372237|NCT01112865|892830|P1|NOT COMPLETED|Second Intervention||0
372238|NCT01112865|892829|P2|COMPLETED|Second Intervention||61
372239|NCT01112865|892830|P1|COMPLETED|Second Intervention||59
372240|NCT01112865|892829|P2|STARTED|Second Intervention||61
372241|NCT01112865|892830|P1|STARTED|Second Intervention||59
372242|NCT01112865|892829|P2|NOT COMPLETED|First Intervention||0
372243|NCT01112865|892830|P1|NOT COMPLETED|First Intervention||0
372244|NCT01112865|892829|P2|COMPLETED|First Intervention||61
372245|NCT01112865|892830|P1|COMPLETED|First Intervention||59
372246|NCT01112865|892829|P2|STARTED|First Intervention||61
372247|NCT01112865|892830|P1|STARTED|First Intervention||59
372248|NCT01112696|892840|P1|NOT COMPLETED|Overall Study||2
372249|NCT01112696|892840|P1|COMPLETED|Overall Study||98
372250|NCT01112696|892840|P1|STARTED|Overall Study||100
372251|NCT01112683|892846|P2|NOT COMPLETED|Overall Study||1
372252|NCT01112683|892847|P1|NOT COMPLETED|Overall Study||1
372253|NCT01112683|892846|P2|COMPLETED|Overall Study||19
372254|NCT01112683|892847|P1|COMPLETED|Overall Study||18
372255|NCT01112683|892846|P2|STARTED|Overall Study||20
372256|NCT01112683|892847|P1|STARTED|Overall Study||19
372257|NCT01112670|892857|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372258|NCT01112670|892858|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372259|NCT01112670|892859|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372260|NCT01112670|892860|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372261|NCT01112670|892861|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372262|NCT01112670|892862|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372263|NCT01112670|892857|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
372264|NCT01112670|892858|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372265|NCT01112670|892859|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
372266|NCT01112670|892860|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372267|NCT01112670|892861|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
372268|NCT01112670|892862|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
372269|NCT01112670|892857|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
372270|NCT01112670|892858|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
372271|NCT01112670|892859|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
372272|NCT01112670|892860|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
372273|NCT01112670|892861|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
372274|NCT01112670|892862|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
372275|NCT01112670|892857|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
372276|NCT01112670|892858|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
372277|NCT01112670|892859|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
372278|NCT01112670|892860|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
372279|NCT01112670|892861|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
372280|NCT01112670|892862|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
372281|NCT01112670|892857|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
372282|NCT01112670|892858|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
372283|NCT01112670|892859|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
372284|NCT01112670|892860|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
372285|NCT01112670|892861|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
372286|NCT01112670|892862|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
372287|NCT01112670|892857|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
372288|NCT01112670|892858|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
372289|NCT01112670|892859|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
372290|NCT01112670|892860|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
372291|NCT01112670|892861|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
372292|NCT01112670|892862|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
372293|NCT01112579|892900|P2|NOT COMPLETED|Overall Study||3
372294|NCT01112579|892901|P1|NOT COMPLETED|Overall Study||1
372295|NCT01112579|892900|P2|COMPLETED|Overall Study||21
372296|NCT01112579|892901|P1|COMPLETED|Overall Study||41
372297|NCT01112579|892900|P2|STARTED|Overall Study||24
372298|NCT01112579|892901|P1|STARTED|Overall Study||42
372299|NCT01112514|892911|P1|NOT COMPLETED|Overall Study||1
372300|NCT01112514|892911|P1|COMPLETED|Overall Study||3
372301|NCT01112514|892911|P1|STARTED|Overall Study||4
372302|NCT01112267|892917|P2|NOT COMPLETED|Overall Study||18
372303|NCT01112267|892918|P1|NOT COMPLETED|Overall Study||34
372304|NCT01112267|892917|P2|COMPLETED|Overall Study||104
372305|NCT01112267|892918|P1|COMPLETED|Overall Study||92
372306|NCT01112267|892917|P2|Treated|Overall Study||120
372307|NCT01112267|892918|P1|Treated|Overall Study||125
372308|NCT01112267|892917|P2|STARTED|Overall Study||122
372309|NCT01112267|892918|P1|STARTED|Overall Study||126
372310|NCT01112241|892936|P1|NOT COMPLETED|Overall Study||0
372311|NCT01112241|892936|P1|COMPLETED|Overall Study||17
372312|NCT01112241|892936|P1|STARTED|Overall Study||17
372313|NCT01112059|892951|P2|NOT COMPLETED|Overall Study||0
372314|NCT01112059|892952|P1|NOT COMPLETED|Overall Study||1
372315|NCT01112059|892951|P2|COMPLETED|Overall Study||20
372316|NCT01112059|892952|P1|COMPLETED|Overall Study||19
372317|NCT01112059|892951|P2|STARTED|Overall Study||20
372318|NCT01112059|892952|P1|STARTED|Overall Study||20
372319|NCT01111851|892966|P2|NOT COMPLETED|Overall Study||0
372320|NCT01111851|892967|P1|NOT COMPLETED|Overall Study||2
372321|NCT01111851|892966|P2|COMPLETED|Overall Study||8
372322|NCT01111851|892967|P1|COMPLETED|Overall Study||6
372323|NCT01111851|892966|P2|STARTED|Overall Study||8
372324|NCT01111851|892967|P1|STARTED|Overall Study||8
372325|NCT01111838|892979|P1|NOT COMPLETED|Overall Study||7
372326|NCT01111838|892979|P1|COMPLETED|Overall Study||15
372327|NCT01111838|892979|P1|STARTED|Overall Study||22
372328|NCT01111526|892983|P3|NOT COMPLETED|Overall Study||2
372329|NCT01111526|892984|P2|NOT COMPLETED|Overall Study||1
372330|NCT01111526|892985|P1|NOT COMPLETED|Overall Study||0
372331|NCT01111526|892983|P3|COMPLETED|Overall Study||8
372332|NCT01111526|892984|P2|COMPLETED|Overall Study||7
372333|NCT01111526|892985|P1|COMPLETED|Overall Study||4
372334|NCT01111526|892983|P3|STARTED|Overall Study||10
372335|NCT01111526|892984|P2|STARTED|Overall Study||8
372336|NCT01111526|892985|P1|STARTED|Overall Study||4
372337|NCT01111461|892997|P1|NOT COMPLETED|Overall Study||51
372338|NCT01111461|892997|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
372339|NCT01111461|892997|P1|STARTED|Overall Study||133
372340|NCT01111370|893010|P1|NOT COMPLETED|Overall Study||2
372341|NCT01111370|893010|P1|COMPLETED|Overall Study||58
372342|NCT01111370|893010|P1|STARTED|Overall Study||60
372343|NCT01111331|893014|P2|NOT COMPLETED|Overall Study||0
372344|NCT01111331|893015|P1|NOT COMPLETED|Overall Study||0
372345|NCT01111331|893014|P2|COMPLETED|Overall Study||9
372346|NCT01111331|893015|P1|COMPLETED|Overall Study||9
372347|NCT01111331|893014|P2|STARTED|Overall Study||9
372348|NCT01111331|893015|P1|STARTED|Overall Study||9
372349|NCT01111318|893097|P4|NOT COMPLETED|Overall Study||0
372350|NCT01111318|893098|P3|NOT COMPLETED|Overall Study||0
372351|NCT01111318|893099|P2|NOT COMPLETED|Overall Study||0
372352|NCT01111318|893100|P1|NOT COMPLETED|Overall Study||0
372353|NCT01111318|893097|P4|COMPLETED|Overall Study||8
372354|NCT01111318|893098|P3|COMPLETED|Overall Study||8
372355|NCT01111318|893099|P2|COMPLETED|Overall Study||8
372356|NCT01111318|893100|P1|COMPLETED|Overall Study||12
372357|NCT01111318|893097|P4|STARTED|Overall Study||8
372358|NCT01111318|893098|P3|STARTED|Overall Study||8
372359|NCT01111318|893099|P2|STARTED|Overall Study||8
372360|NCT01111318|893100|P1|STARTED|Overall Study||12
372361|NCT01111305|893164|P2|NOT COMPLETED|Overall Study||0
372362|NCT01111305|893165|P1|NOT COMPLETED|Overall Study||0
372363|NCT01111305|893164|P2|COMPLETED|Overall Study||4
372364|NCT01111305|893165|P1|COMPLETED|Overall Study||4
372365|NCT01111305|893164|P2|STARTED|Overall Study||4
372366|NCT01111305|893165|P1|STARTED|Overall Study||4
372367|NCT01111292|893177|P2|NOT COMPLETED|Follow-Up||0
372368|NCT01111292|893178|P1|NOT COMPLETED|Follow-Up||0
372369|NCT01111292|893177|P2|COMPLETED|Follow-Up||1
372370|NCT01111292|893178|P1|COMPLETED|Follow-Up||2
372371|NCT01111292|893177|P2|STARTED|Follow-Up||1
372372|NCT01111292|893178|P1|STARTED|Follow-Up||2
372373|NCT01111292|893177|P2|NOT COMPLETED|Post Treatment Biopsy||0
372374|NCT01111292|893178|P1|NOT COMPLETED|Post Treatment Biopsy||0
372375|NCT01111292|893177|P2|COMPLETED|Post Treatment Biopsy||1
372376|NCT01111292|893178|P1|COMPLETED|Post Treatment Biopsy||2
372377|NCT01111292|893177|P2|STARTED|Post Treatment Biopsy||1
372378|NCT01111292|893178|P1|STARTED|Post Treatment Biopsy||2
372379|NCT01111292|893177|P2|NOT COMPLETED|Treatment||1
372380|NCT01111292|893178|P1|NOT COMPLETED|Treatment||1
372381|NCT01111292|893177|P2|COMPLETED|Treatment||1
372382|NCT01111292|893178|P1|COMPLETED|Treatment||2
372383|NCT01111292|893177|P2|STARTED|Treatment||2
372384|NCT01111292|893178|P1|STARTED|Treatment||3
372385|NCT01111292|893177|P2|NOT COMPLETED|Randomization||0
372386|NCT01111292|893178|P1|NOT COMPLETED|Randomization||0
372387|NCT01111292|893177|P2|COMPLETED|Randomization||2
372388|NCT01111292|893178|P1|COMPLETED|Randomization||3
372389|NCT01111292|893177|P2|STARTED|Randomization||2
372390|NCT01111292|893178|P1|STARTED|Randomization||3
372391|NCT01111240|893184|P1|NOT COMPLETED|Overall Study||1066
372392|NCT01111240|893184|P1|COMPLETED|Overall Study||3569
372393|NCT01111240|893184|P1|STARTED|Overall Study||4635
372394|NCT01111162|893206|P1|NOT COMPLETED|Overall Study||0
372395|NCT01111162|893206|P1|COMPLETED|Overall Study||120
372396|NCT01111162|893206|P1|STARTED|Overall Study||120
372397|NCT01111149|893214|P3|NOT COMPLETED|Overall Study||4
372398|NCT01111149|893215|P2|NOT COMPLETED|Overall Study||1
372399|NCT01111149|893216|P1|NOT COMPLETED|Overall Study||2
372400|NCT01111149|893214|P3|COMPLETED|Overall Study||5
372401|NCT01111149|893215|P2|COMPLETED|Overall Study||5
372402|NCT01111149|893216|P1|COMPLETED|Overall Study||7
372403|NCT01111149|893214|P3|STARTED|Overall Study||9
372404|NCT01111149|893215|P2|STARTED|Overall Study||6
372405|NCT01111149|893216|P1|STARTED|Overall Study||9
372406|NCT01111123|893292|P2|NOT COMPLETED|Maintenance Phase||2
372407|NCT01111123|893293|P1|NOT COMPLETED|Maintenance Phase||0
372408|NCT01111123|893292|P2|COMPLETED|Maintenance Phase||18
372409|NCT01111123|893293|P1|COMPLETED|Maintenance Phase||21
372410|NCT01111123|893292|P2|STARTED|Maintenance Phase||20
372411|NCT01111123|893293|P1|STARTED|Maintenance Phase||21
372412|NCT01111123|893292|P2|NOT COMPLETED|Open- Label Phase||0
372413|NCT01111123|893293|P1|NOT COMPLETED|Open- Label Phase||14
372414|NCT01111123|893292|P2|COMPLETED|Open- Label Phase||0
372415|NCT01111123|893293|P1|COMPLETED|Open- Label Phase||41
372416|NCT01111123|893292|P2|STARTED|Open- Label Phase||0
372417|NCT01111123|893293|P1|STARTED|Open- Label Phase||55
372418|NCT01111110|893303|P2|NOT COMPLETED|Overall Study||0
372419|NCT01111110|893304|P1|NOT COMPLETED|Overall Study||0
372420|NCT01111110|893303|P2|COMPLETED|Overall Study||4
372421|NCT01111110|893304|P1|COMPLETED|Overall Study||3
372422|NCT01111110|893303|P2|STARTED|Overall Study||4
372423|NCT01111110|893304|P1|STARTED|Overall Study||3
372424|NCT01110967|893314|P1|NOT COMPLETED|Overall Study||9
372425|NCT01110967|893314|P1|COMPLETED|Overall Study||31
372426|NCT01110967|893314|P1|12 Months Follow up|Overall Study||31
372427|NCT01110967|893314|P1|6 Months Follow up|Overall Study||24
372428|NCT01110967|893314|P1|3 Months Follow up|Overall Study||28
372429|NCT01110967|893314|P1|1 Month Follow up|Overall Study||26
372430|NCT01110967|893314|P1|Surgery|Overall Study||40
372431|NCT01110967|893314|P1|STARTED|Overall Study||40
372432|NCT01110915|893327|P2|NOT COMPLETED|Overall Study||2
372433|NCT01110915|893328|P1|NOT COMPLETED|Overall Study||10
372434|NCT01110915|893327|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
372435|NCT01110915|893328|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
372436|NCT01110915|893327|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
372437|NCT01110915|893328|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
372438|NCT01110499|893351|P8|NOT COMPLETED|Overall Study||0
372439|NCT01110499|893352|P7|NOT COMPLETED|Overall Study||0
372440|NCT01110499|893353|P6|NOT COMPLETED|Overall Study||0
372441|NCT01110499|893354|P5|NOT COMPLETED|Overall Study||0
372442|NCT01110499|893355|P4|NOT COMPLETED|Overall Study||0
372443|NCT01110499|893356|P3|NOT COMPLETED|Overall Study||0
372444|NCT01110499|893357|P2|NOT COMPLETED|Overall Study||0
372445|NCT01110499|893358|P1|NOT COMPLETED|Overall Study||0
372446|NCT01110499|893351|P8|COMPLETED|Overall Study||40
372447|NCT01110499|893352|P7|COMPLETED|Overall Study||39
372448|NCT01110499|893353|P6|COMPLETED|Overall Study||14
372449|NCT01110499|893354|P5|COMPLETED|Overall Study||14
372450|NCT01110499|893355|P4|COMPLETED|Overall Study||14
372451|NCT01110499|893356|P3|COMPLETED|Overall Study||14
372452|NCT01110499|893357|P2|COMPLETED|Overall Study||14
372453|NCT01110499|893358|P1|COMPLETED|Overall Study||14
372454|NCT01110499|893351|P8|STARTED|Overall Study||40
372455|NCT01110499|893352|P7|STARTED|Overall Study||39
372456|NCT01110499|893353|P6|STARTED|Overall Study||14
372457|NCT01110499|893354|P5|STARTED|Overall Study||14
372458|NCT01110499|893355|P4|STARTED|Overall Study||14
372459|NCT01110499|893356|P3|STARTED|Overall Study||14
372460|NCT01110499|893357|P2|STARTED|Overall Study||14
372461|NCT01110499|893358|P1|STARTED|Overall Study||14
372462|NCT01110421|893380|P2|NOT COMPLETED|Overall Study||0
372463|NCT01110421|893381|P1|NOT COMPLETED|Overall Study||0
372464|NCT01110421|893380|P2|COMPLETED|Overall Study||2
372465|NCT01110421|893381|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
372466|NCT01110421|893380|P2|STARTED|Overall Study||2
372467|NCT01110421|893381|P1|STARTED|Overall Study||5
372468|NCT01110408|893401|P2|NOT COMPLETED|Overall Study||0
372469|NCT01110408|893402|P1|NOT COMPLETED|Overall Study||1
372470|NCT01110408|893401|P2|COMPLETED|Overall Study||10
372471|NCT01110408|893402|P1|COMPLETED|Overall Study||30
372472|NCT01110408|893401|P2|STARTED|Overall Study||10
372473|NCT01110408|893402|P1|STARTED|Overall Study||31
372474|NCT01110382|893422|P2|NOT COMPLETED|Overall Study||2
372475|NCT01110382|893423|P1|NOT COMPLETED|Overall Study||0
372476|NCT01110382|893422|P2|COMPLETED|Overall Study||8
372477|NCT01110382|893423|P1|COMPLETED|Overall Study||31
372478|NCT01110382|893422|P2|STARTED|Overall Study||10
372479|NCT01110382|893423|P1|STARTED|Overall Study||31
372480|NCT01110330|893444|P3|NOT COMPLETED|Overall Study||26
372481|NCT01110330|893445|P2|NOT COMPLETED|Overall Study||23
372482|NCT01110330|893446|P1|NOT COMPLETED|Overall Study||15
372483|NCT01110330|893444|P3|COMPLETED|Overall Study||208
372484|NCT01110330|893445|P2|COMPLETED|Overall Study||207
372485|NCT01110330|893446|P1|COMPLETED|Overall Study||104
372486|NCT01110330|893444|P3|Positive Baseline Culture Set|Overall Study||114
372487|NCT01110330|893445|P2|Positive Baseline Culture Set|Overall Study||111
372488|NCT01110330|893446|P1|Positive Baseline Culture Set|Overall Study||56
372489|NCT01110330|893444|P3|STARTED|Overall Study||234
372490|NCT01110330|893445|P2|STARTED|Overall Study||230
372491|NCT01110330|893446|P1|STARTED|Overall Study||119
372492|NCT01110252|893457|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
372493|NCT01110252|893457|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
372494|NCT01110252|893457|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
372495|NCT01110252|893457|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
372496|NCT01110252|893457|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
372497|NCT01110252|893457|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
372498|NCT01110239|893474|P4|NOT COMPLETED|10 Min Ischemia||0
372499|NCT01110239|893475|P3|NOT COMPLETED|10 Min Ischemia||0
372500|NCT01110239|893476|P2|NOT COMPLETED|10 Min Ischemia||0
372501|NCT01110239|893477|P1|NOT COMPLETED|10 Min Ischemia||0
372502|NCT01110239|893474|P4|COMPLETED|10 Min Ischemia||6
372503|NCT01110239|893475|P3|COMPLETED|10 Min Ischemia||0
372504|NCT01110239|893476|P2|COMPLETED|10 Min Ischemia||0
372505|NCT01110239|893477|P1|COMPLETED|10 Min Ischemia||0
372506|NCT01110239|893474|P4|STARTED|10 Min Ischemia||6
372507|NCT01110239|893475|P3|STARTED|10 Min Ischemia||0
372508|NCT01110239|893476|P2|STARTED|10 Min Ischemia||0
372509|NCT01110239|893477|P1|STARTED|10 Min Ischemia||0
372510|NCT01110239|893474|P4|NOT COMPLETED|7.5 Min Ischemia||0
372511|NCT01110239|893475|P3|NOT COMPLETED|7.5 Min Ischemia||1
372512|NCT01110239|893476|P2|NOT COMPLETED|7.5 Min Ischemia||0
372513|NCT01110239|893477|P1|NOT COMPLETED|7.5 Min Ischemia||0
372514|NCT01110239|893474|P4|COMPLETED|7.5 Min Ischemia||0
372515|NCT01110239|893475|P3|COMPLETED|7.5 Min Ischemia||6
372516|NCT01110239|893476|P2|COMPLETED|7.5 Min Ischemia||0
372517|NCT01110239|893477|P1|COMPLETED|7.5 Min Ischemia||0
372518|NCT01110239|893474|P4|STARTED|7.5 Min Ischemia||0
372519|NCT01110239|893475|P3|STARTED|7.5 Min Ischemia||7
372520|NCT01110239|893476|P2|STARTED|7.5 Min Ischemia||0
372521|NCT01110239|893477|P1|STARTED|7.5 Min Ischemia||0
372522|NCT01110239|893474|P4|NOT COMPLETED|5 Min Ischemia||0
372523|NCT01110239|893475|P3|NOT COMPLETED|5 Min Ischemia||0
372524|NCT01110239|893476|P2|NOT COMPLETED|5 Min Ischemia||14
372525|NCT01110239|893477|P1|NOT COMPLETED|5 Min Ischemia||0
372526|NCT01110239|893474|P4|COMPLETED|5 Min Ischemia||0
372527|NCT01110239|893475|P3|COMPLETED|5 Min Ischemia||0
372528|NCT01110239|893476|P2|COMPLETED|5 Min Ischemia||0
372529|NCT01110239|893477|P1|COMPLETED|5 Min Ischemia||0
372530|NCT01110239|893474|P4|STARTED|5 Min Ischemia||0
372531|NCT01110239|893475|P3|STARTED|5 Min Ischemia||0
372532|NCT01110239|893476|P2|STARTED|5 Min Ischemia||14
372533|NCT01110239|893477|P1|STARTED|5 Min Ischemia||0
372534|NCT01110239|893474|P4|NOT COMPLETED|Sham Preconditioning||0
372535|NCT01110239|893475|P3|NOT COMPLETED|Sham Preconditioning||1
372536|NCT01110239|893476|P2|NOT COMPLETED|Sham Preconditioning||0
372537|NCT01110239|893477|P1|NOT COMPLETED|Sham Preconditioning||0
372538|NCT01110239|893474|P4|COMPLETED|Sham Preconditioning||6
372539|NCT01110239|893475|P3|COMPLETED|Sham Preconditioning||6
372540|NCT01110239|893476|P2|COMPLETED|Sham Preconditioning||14
372541|NCT01110239|893477|P1|COMPLETED|Sham Preconditioning||7
372542|NCT01110239|893474|P4|STARTED|Sham Preconditioning||6
372543|NCT01110239|893475|P3|STARTED|Sham Preconditioning||7
372544|NCT01110239|893476|P2|STARTED|Sham Preconditioning||14
372545|NCT01110239|893477|P1|STARTED|Sham Preconditioning||7
372546|NCT01110200|893493|P2|NOT COMPLETED|Overall Study||121
372547|NCT01110200|893494|P1|NOT COMPLETED|Overall Study||106
372548|NCT01110200|893493|P2|COMPLETED|Overall Study||204
372549|NCT01110200|893494|P1|COMPLETED|Overall Study||208
372550|NCT01110200|893493|P2|STARTED|Overall Study||325
372551|NCT01110200|893494|P1|STARTED|Overall Study||314
372552|NCT01110187|893510|P2|NOT COMPLETED|Overall Study||0
372553|NCT01110187|893511|P1|NOT COMPLETED|Overall Study||0
372554|NCT01110187|893510|P2|COMPLETED|Overall Study|completed 7 day treatment|4
372555|NCT01110187|893511|P1|COMPLETED|Overall Study|completed 7 day treatment|7
372556|NCT01110187|893510|P2|STARTED|Overall Study||4
372557|NCT01110187|893511|P1|STARTED|Overall Study||7
372558|NCT01110135|893519|P1|NOT COMPLETED|Overall Study||9
372559|NCT01110135|893519|P1|COMPLETED|Overall Study||34
372560|NCT01110135|893519|P1|STARTED|Overall Study||43
372561|NCT01110005|893525|P2|NOT COMPLETED|Overall Study||5
372562|NCT01110005|893526|P1|NOT COMPLETED|Overall Study||4
372563|NCT01110005|893525|P2|COMPLETED|Overall Study||156
372564|NCT01110005|893526|P1|COMPLETED|Overall Study||153
372565|NCT01110005|893525|P2|STARTED|Overall Study||161
372566|NCT01110005|893526|P1|STARTED|Overall Study||157
372567|NCT01109979|893538|P2|NOT COMPLETED|Overall Study||1
372568|NCT01109979|893539|P1|NOT COMPLETED|Overall Study||2
372569|NCT01109979|893538|P2|COMPLETED|Overall Study||11
372570|NCT01109979|893539|P1|COMPLETED|Overall Study||10
372571|NCT01109979|893538|P2|STARTED|Overall Study||12
372572|NCT01109979|893539|P1|STARTED|Overall Study||12
372573|NCT01109602|893548|P3|NOT COMPLETED|Overall Study||1
372574|NCT01109602|893549|P2|NOT COMPLETED|Overall Study||2
372575|NCT01109602|893550|P1|NOT COMPLETED|Overall Study||1
372576|NCT01109602|893548|P3|COMPLETED|Overall Study||9
372577|NCT01109602|893549|P2|COMPLETED|Overall Study||21
372578|NCT01109602|893550|P1|COMPLETED|Overall Study||13
372579|NCT01109602|893548|P3|STARTED|Overall Study||10
372580|NCT01109602|893549|P2|STARTED|Overall Study||23
372581|NCT01109602|893550|P1|STARTED|Overall Study||14
372582|NCT01109576|893561|P1|NOT COMPLETED|Overall Study||1
372583|NCT01109576|893561|P1|COMPLETED|Overall Study||12
372584|NCT01109576|893561|P1|STARTED|Overall Study||13
372585|NCT01109524|893565|P1|NOT COMPLETED|Overall Study||57
372586|NCT01109524|893565|P1|COMPLETED|Overall Study||3
372587|NCT01109524|893565|P1|STARTED|Overall Study||60
372588|NCT01109381|893575|P1|NOT COMPLETED|Overall Study||2
372589|NCT01109381|893575|P1|COMPLETED|Overall Study||31
372590|NCT01109381|893575|P1|STARTED|Overall Study||33
372591|NCT01109316|893587|P3|NOT COMPLETED|Study Period 3||1
372592|NCT01109316|893588|P2|NOT COMPLETED|Study Period 3||2
372593|NCT01109316|893589|P1|NOT COMPLETED|Study Period 3||0
372594|NCT01109316|893587|P3|COMPLETED|Study Period 3||38
372595|NCT01109316|893588|P2|COMPLETED|Study Period 3||39
372596|NCT01109316|893589|P1|COMPLETED|Study Period 3||39
372597|NCT01109316|893587|P3|STARTED|Study Period 3||39
372598|NCT01109316|893588|P2|STARTED|Study Period 3||41
372599|NCT01109316|893589|P1|STARTED|Study Period 3||39
372600|NCT01109316|893587|P3|NOT COMPLETED|Study Period 2||2
372601|NCT01109316|893588|P2|NOT COMPLETED|Study Period 2||2
372602|NCT01109316|893589|P1|NOT COMPLETED|Study Period 2||1
372603|NCT01109316|893587|P3|COMPLETED|Study Period 2||41
372604|NCT01109316|893588|P2|COMPLETED|Study Period 2||40
372605|NCT01109316|893589|P1|COMPLETED|Study Period 2||38
372606|NCT01109316|893587|P3|STARTED|Study Period 2||43
372607|NCT01109316|893588|P2|STARTED|Study Period 2||42
372608|NCT01109316|893589|P1|STARTED|Study Period 2||39
372609|NCT01109316|893587|P3|NOT COMPLETED|Study Period 1||4
372610|NCT01109316|893588|P2|NOT COMPLETED|Study Period 1||4
372611|NCT01109316|893589|P1|NOT COMPLETED|Study Period 1||0
372612|NCT01109316|893587|P3|COMPLETED|Study Period 1||40
372613|NCT01109316|893588|P2|COMPLETED|Study Period 1||40
372614|NCT01109316|893589|P1|COMPLETED|Study Period 1||44
372615|NCT01109316|893587|P3|Received at Least One Dose of Study Drug|Study Period 1||42
372616|NCT01109316|893588|P2|Received at Least One Dose of Study Drug|Study Period 1||44
372617|NCT01109316|893589|P1|Received at Least One Dose of Study Drug|Study Period 1||44
372618|NCT01109316|893587|P3|STARTED|Study Period 1||44
372619|NCT01109316|893588|P2|STARTED|Study Period 1||44
372620|NCT01109316|893589|P1|STARTED|Study Period 1||44
372621|NCT01109173|893637|P4|NOT COMPLETED|Overall Study||93
372622|NCT01109173|893638|P3|NOT COMPLETED|Overall Study||101
372623|NCT01109173|893639|P2|NOT COMPLETED|Overall Study||86
372624|NCT01109173|893640|P1|NOT COMPLETED|Overall Study||88
372625|NCT01109173|893637|P4|COMPLETED|Overall Study||120
372626|NCT01109173|893638|P3|COMPLETED|Overall Study||110
372627|NCT01109173|893639|P2|COMPLETED|Overall Study||759
372628|NCT01109173|893640|P1|COMPLETED|Overall Study||763
372629|NCT01109173|893637|P4|STARTED|Overall Study||213
372630|NCT01109173|893638|P3|STARTED|Overall Study||211
372631|NCT01109173|893639|P2|STARTED|Overall Study||845
372632|NCT01109173|893640|P1|STARTED|Overall Study||851
372633|NCT01109147|893657|P3|NOT COMPLETED|Overall Study||10
372634|NCT01109147|893658|P2|NOT COMPLETED|Overall Study||3
372635|NCT01109147|893659|P1|NOT COMPLETED|Overall Study||2
372636|NCT01109147|893657|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
372637|NCT01109147|893658|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
372638|NCT01109147|893659|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
372639|NCT01109147|893657|P3|STARTED|Overall Study||36
372640|NCT01109147|893658|P2|STARTED|Overall Study||14
372641|NCT01109147|893659|P1|STARTED|Overall Study||17
372642|NCT01109108|893669|P2|NOT COMPLETED|Overall Study||0
372643|NCT01109108|893670|P1|NOT COMPLETED|Overall Study||0
372644|NCT01109108|893669|P2|COMPLETED|Overall Study||4755
372645|NCT01109108|893670|P1|COMPLETED|Overall Study||4035
372646|NCT01109108|893669|P2|STARTED|Overall Study||4755
372647|NCT01109108|893670|P1|STARTED|Overall Study||4035
372648|NCT01109056|893678|P2|NOT COMPLETED|Overall Study||5
372649|NCT01109056|893679|P1|NOT COMPLETED|Overall Study||7
372650|NCT01109056|893678|P2|COMPLETED|Overall Study||53
372651|NCT01109056|893679|P1|COMPLETED|Overall Study||50
372652|NCT01109056|893678|P2|STARTED|Overall Study||58
372653|NCT01109056|893679|P1|STARTED|Overall Study||57
372654|NCT01108835|893691|P2|NOT COMPLETED|Overall Study||21
372655|NCT01108835|893692|P1|NOT COMPLETED|Overall Study||17
372656|NCT01108835|893691|P2|COMPLETED|Overall Study||69
372657|NCT01108835|893692|P1|COMPLETED|Overall Study||73
372658|NCT01108835|893691|P2|STARTED|Overall Study||90
372659|NCT01108835|893692|P1|STARTED|Overall Study||90
372660|NCT01108809|893706|P1|NOT COMPLETED|Overall Study||4
372661|NCT01108809|893706|P1|COMPLETED|Overall Study||291
372662|NCT01108809|893706|P1|STARTED|Overall Study||295
372663|NCT01108796|893723|P2|NOT COMPLETED|Overall Study||7
372664|NCT01108796|893724|P1|NOT COMPLETED|Overall Study||7
372665|NCT01108796|893723|P2|COMPLETED|Overall Study||1060
372666|NCT01108796|893724|P1|COMPLETED|Overall Study||767
372667|NCT01108796|893723|P2|STARTED|Overall Study||1067
372668|NCT01108796|893724|P1|STARTED|Overall Study||774
372669|NCT01108731|893758|P2|NOT COMPLETED|Overall Study||4
372670|NCT01108731|893759|P1|NOT COMPLETED|Overall Study||4
372671|NCT01108731|893758|P2|COMPLETED|Overall Study||13
372672|NCT01108731|893759|P1|COMPLETED|Overall Study||13
372673|NCT01108731|893758|P2|STARTED|Overall Study||17
372674|NCT01108731|893759|P1|STARTED|Overall Study||17
372675|NCT01108718|893771|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
372676|NCT01108718|893772|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
372677|NCT01108718|893771|P2|COMPLETED|Received Second Intervention (2 Months)||7
372678|NCT01108718|893772|P1|COMPLETED|Received Second Intervention (2 Months)||4
372679|NCT01108718|893771|P2|STARTED|Received Second Intervention (2 Months)||7
372680|NCT01108718|893772|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
372681|NCT01108718|893771|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
372682|NCT01108718|893772|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
372683|NCT01108718|893771|P2|COMPLETED|Received First Intervention (2 Months)||7
372684|NCT01108718|893772|P1|COMPLETED|Received First Intervention (2 Months)||5
372685|NCT01108718|893771|P2|STARTED|Received First Intervention (2 Months)||7
372686|NCT01108718|893772|P1|STARTED|Received First Intervention (2 Months)||5
372687|NCT01108523|893777|P1|NOT COMPLETED|Overall Study||4
372688|NCT01108523|893777|P1|COMPLETED|Overall Study||3
372689|NCT01108523|893777|P1|STARTED|Overall Study||7
372690|NCT01108510|893784|P2|NOT COMPLETED|Overall Study||268
372691|NCT01108510|893785|P1|NOT COMPLETED|Overall Study||279
372692|NCT01108510|893784|P2|COMPLETED|Overall Study||81
372693|NCT01108510|893785|P1|COMPLETED|Overall Study||70
372694|NCT01108510|893784|P2|STARTED|Overall Study||349
372695|NCT01108510|893785|P1|STARTED|Overall Study||349
372696|NCT01108458|893805|P1|NOT COMPLETED|Overall Study||1
372697|NCT01108458|893805|P1|COMPLETED|Overall Study||0
372698|NCT01108458|893805|P1|STARTED|Overall Study||1
372699|NCT01108445|893816|P2|NOT COMPLETED|Overall Study||49
372700|NCT01108445|893817|P1|NOT COMPLETED|Overall Study||56
372701|NCT01108445|893816|P2|COMPLETED|Overall Study||2
372702|NCT01108445|893817|P1|COMPLETED|Overall Study||1
372703|NCT01108445|893816|P2|STARTED|Overall Study||51
372704|NCT01108445|893817|P1|STARTED|Overall Study||57
372705|NCT01108406|893851|P1|NOT COMPLETED|Overall Study||0
372706|NCT01108406|893851|P1|COMPLETED|Overall Study||22
372707|NCT01108406|893851|P1|STARTED|Overall Study||22
372708|NCT01108341|893857|P1|NOT COMPLETED|Overall Study||5
372709|NCT01108341|893857|P1|COMPLETED|Overall Study||45
372710|NCT01108341|893857|P1|Safety Set (Enrolled and Treated)|Overall Study||49
372711|NCT01108341|893857|P1|STARTED|Overall Study||50
372712|NCT01108263|893864|P2|NOT COMPLETED|Overall Study||1
372713|NCT01108263|893865|P1|NOT COMPLETED|Overall Study||0
372714|NCT01108263|893864|P2|COMPLETED|Overall Study||2
372715|NCT01108263|893865|P1|COMPLETED|Overall Study||2
372716|NCT01108263|893864|P2|STARTED|Overall Study||3
372717|NCT01108263|893865|P1|STARTED|Overall Study||2
372718|NCT01108237|893875|P2|NOT COMPLETED|Overall Study||17
372719|NCT01108237|893876|P1|NOT COMPLETED|Overall Study||9
372720|NCT01108237|893875|P2|COMPLETED|Overall Study||84
372721|NCT01108237|893876|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
372722|NCT01108237|893875|P2|STARTED|Overall Study||101
372723|NCT01108237|893876|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
372724|NCT01108185|893882|P1|NOT COMPLETED|Overall Study||27
372725|NCT01108185|893882|P1|COMPLETED|Overall Study||3154
372726|NCT01108185|893882|P1|Per Protocol Population|Overall Study||3181
372727|NCT01108185|893882|P1|STARTED|Overall Study||3181
372728|NCT01108081|893899|P4|NOT COMPLETED|Overall Study||4
372729|NCT01108081|893900|P3|NOT COMPLETED|Overall Study||0
372730|NCT01108081|893901|P2|NOT COMPLETED|Overall Study||2
372731|NCT01108081|893902|P1|NOT COMPLETED|Overall Study||2
372732|NCT01108081|893899|P4|COMPLETED|Overall Study||39
372733|NCT01108081|893900|P3|COMPLETED|Overall Study||38
372734|NCT01108081|893901|P2|COMPLETED|Overall Study||40
372735|NCT01108081|893902|P1|COMPLETED|Overall Study||44
372736|NCT01108081|893899|P4|STARTED|Overall Study||43
372737|NCT01108081|893900|P3|STARTED|Overall Study||38
372738|NCT01108081|893901|P2|STARTED|Overall Study||42
372739|NCT01108081|893902|P1|STARTED|Overall Study||46
372740|NCT01108055|893916|P1|NOT COMPLETED|Overall Study||15
372741|NCT01108055|893916|P1|COMPLETED|Overall Study||28
372742|NCT01108055|893916|P1|Eligible and Started Treatment|Overall Study||32
372743|NCT01108055|893916|P1|STARTED|Overall Study||43
372744|NCT01108003|893926|P2|NOT COMPLETED|Overall Study||0
372745|NCT01108003|893927|P1|NOT COMPLETED|Overall Study||0
372746|NCT01108003|893926|P2|COMPLETED|Overall Study||3
372747|NCT01108003|893927|P1|COMPLETED|Overall Study||4
372748|NCT01108003|893926|P2|STARTED|Overall Study||3
372749|NCT01108003|893927|P1|STARTED|Overall Study||4
372750|NCT01107925|893939|P6|NOT COMPLETED|Period 3||0
372751|NCT01107925|893940|P5|NOT COMPLETED|Period 3||0
372752|NCT01107925|893941|P4|NOT COMPLETED|Period 3||0
372753|NCT01107925|893942|P3|NOT COMPLETED|Period 3||0
372754|NCT01107925|893943|P2|NOT COMPLETED|Period 3||0
372755|NCT01107925|893944|P1|NOT COMPLETED|Period 3||0
372756|NCT01107925|893939|P6|COMPLETED|Period 3||20
372757|NCT01107925|893940|P5|COMPLETED|Period 3||0
372758|NCT01107925|893941|P4|COMPLETED|Period 3||16
372759|NCT01107925|893942|P3|COMPLETED|Period 3||15
372760|NCT01107925|893943|P2|COMPLETED|Period 3||17
372761|NCT01107925|893944|P1|COMPLETED|Period 3||0
372762|NCT01107925|893939|P6|Took at Least 1 Dose of Study Drug|Period 3||20
372763|NCT01107925|893940|P5|Took at Least 1 Dose of Study Drug|Period 3||0
372764|NCT01107925|893941|P4|Took at Least 1 Dose of Study Drug|Period 3||16
372765|NCT01107925|893942|P3|Took at Least 1 Dose of Study Drug|Period 3||15
372766|NCT01107925|893943|P2|Took at Least 1 Dose of Study Drug|Period 3||17
372767|NCT01107925|893944|P1|Took at Least 1 Dose of Study Drug|Period 3||0
372768|NCT01107925|893939|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
372769|NCT01107925|893940|P5|STARTED|Period 3||0
372770|NCT01107925|893941|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
372771|NCT01107925|893942|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
372772|NCT01107925|893943|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
372773|NCT01107925|893944|P1|STARTED|Period 3||0
372774|NCT01107925|893939|P6|NOT COMPLETED|Period 2||1
372775|NCT01107925|893940|P5|NOT COMPLETED|Period 2||0
372776|NCT01107925|893941|P4|NOT COMPLETED|Period 2||0
372777|NCT01107925|893942|P3|NOT COMPLETED|Period 2||0
372778|NCT01107925|893943|P2|NOT COMPLETED|Period 2||1
372779|NCT01107925|893944|P1|NOT COMPLETED|Period 2||0
372780|NCT01107925|893939|P6|COMPLETED|Period 2||16
372781|NCT01107925|893940|P5|COMPLETED|Period 2||0
372782|NCT01107925|893941|P4|COMPLETED|Period 2||20
372783|NCT01107925|893942|P3|COMPLETED|Period 2||17
372784|NCT01107925|893943|P2|COMPLETED|Period 2||15
372785|NCT01107925|893944|P1|COMPLETED|Period 2||0
372786|NCT01107925|893939|P6|Took at Least 1 Dose of Study Drug|Period 2||17
372787|NCT01107925|893940|P5|Took at Least 1 Dose of Study Drug|Period 2||0
372788|NCT01107925|893941|P4|Took at Least 1 Dose of Study Drug|Period 2||20
372789|NCT01107925|893942|P3|Took at Least 1 Dose of Study Drug|Period 2||17
372790|NCT01107925|893943|P2|Took at Least 1 Dose of Study Drug|Period 2||16
372791|NCT01107925|893944|P1|Took at Least 1 Dose of Study Drug|Period 2||0
372792|NCT01107925|893939|P6|STARTED|Period 2||17
372793|NCT01107925|893940|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
372794|NCT01107925|893941|P4|STARTED|Period 2||20
372795|NCT01107925|893942|P3|STARTED|Period 2||17
372796|NCT01107925|893943|P2|STARTED|Period 2||16
372797|NCT01107925|893944|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
372798|NCT01107925|893939|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
372799|NCT01107925|893940|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
372800|NCT01107925|893941|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
372801|NCT01107925|893942|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
372802|NCT01107925|893943|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
372803|NCT01107925|893944|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
372804|NCT01107925|893939|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
372805|NCT01107925|893940|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
372806|NCT01107925|893941|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
372807|NCT01107925|893942|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
372808|NCT01107925|893943|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
372809|NCT01107925|893944|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
372810|NCT01107925|893939|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
372811|NCT01107925|893940|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
372812|NCT01107925|893941|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
372813|NCT01107925|893942|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
372814|NCT01107925|893943|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
372815|NCT01107925|893944|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
372816|NCT01107925|893939|P6|STARTED|Period 1-Randomization up Through Day 12||0
372817|NCT01107925|893940|P5|STARTED|Period 1-Randomization up Through Day 12||38
372818|NCT01107925|893941|P4|STARTED|Period 1-Randomization up Through Day 12||0
372819|NCT01107925|893942|P3|STARTED|Period 1-Randomization up Through Day 12||0
372820|NCT01107925|893943|P2|STARTED|Period 1-Randomization up Through Day 12||0
372821|NCT01107925|893944|P1|STARTED|Period 1-Randomization up Through Day 12||34
372822|NCT01107912|893982|P6|NOT COMPLETED|Period 3||0
372823|NCT01107912|893983|P5|NOT COMPLETED|Period 3||0
372824|NCT01107912|893984|P4|NOT COMPLETED|Period 3||1
372825|NCT01107912|893985|P3|NOT COMPLETED|Period 3||1
372826|NCT01107912|893986|P2|NOT COMPLETED|Period 3||1
372827|NCT01107912|893987|P1|NOT COMPLETED|Period 3||0
372828|NCT01107912|893982|P6|COMPLETED|Period 3||41
372829|NCT01107912|893983|P5|COMPLETED|Period 3||0
372830|NCT01107912|893984|P4|COMPLETED|Period 3||37
372831|NCT01107912|893985|P3|COMPLETED|Period 3||35
372832|NCT01107912|893986|P2|COMPLETED|Period 3||34
372833|NCT01107912|893987|P1|COMPLETED|Period 3||0
372834|NCT01107912|893982|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
372835|NCT01107912|893983|P5|STARTED|Period 3||0
372836|NCT01107912|893984|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
372837|NCT01107912|893985|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
372838|NCT01107912|893986|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
372839|NCT01107912|893987|P1|STARTED|Period 3||0
372840|NCT01107912|893982|P6|NOT COMPLETED|Period 2||0
372841|NCT01107912|893983|P5|NOT COMPLETED|Period 2||0
372842|NCT01107912|893984|P4|NOT COMPLETED|Period 2||0
372843|NCT01107912|893985|P3|NOT COMPLETED|Period 2||1
372844|NCT01107912|893986|P2|NOT COMPLETED|Period 2||0
372845|NCT01107912|893987|P1|NOT COMPLETED|Period 2||0
372846|NCT01107912|893982|P6|COMPLETED|Period 2||38
372847|NCT01107912|893983|P5|COMPLETED|Period 2||0
372848|NCT01107912|893984|P4|COMPLETED|Period 2||41
372849|NCT01107912|893985|P3|COMPLETED|Period 2||35
372850|NCT01107912|893986|P2|COMPLETED|Period 2||36
372851|NCT01107912|893987|P1|COMPLETED|Period 2||0
372852|NCT01107912|893982|P6|STARTED|Period 2||38
372853|NCT01107912|893983|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
372854|NCT01107912|893984|P4|STARTED|Period 2||41
372855|NCT01107912|893985|P3|STARTED|Period 2||36
372856|NCT01107912|893986|P2|STARTED|Period 2||36
372857|NCT01107912|893987|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
372858|NCT01107912|893982|P6|NOT COMPLETED|Period 1||0
372859|NCT01107912|893983|P5|NOT COMPLETED|Period 1||3
372860|NCT01107912|893984|P4|NOT COMPLETED|Period 1||0
372861|NCT01107912|893985|P3|NOT COMPLETED|Period 1||0
372862|NCT01107912|893986|P2|NOT COMPLETED|Period 1||0
372863|NCT01107912|893987|P1|NOT COMPLETED|Period 1||1
372864|NCT01107912|893982|P6|COMPLETED|Period 1||0
372865|NCT01107912|893983|P5|COMPLETED|Period 1||79
372866|NCT01107912|893984|P4|COMPLETED|Period 1||0
372867|NCT01107912|893985|P3|COMPLETED|Period 1||0
372868|NCT01107912|893986|P2|COMPLETED|Period 1||0
372869|NCT01107912|893987|P1|COMPLETED|Period 1||72
372870|NCT01107912|893982|P6|Received at Least 1 Dose of Study Drug|Period 1||0
372871|NCT01107912|893983|P5|Received at Least 1 Dose of Study Drug|Period 1||82
372872|NCT01107912|893984|P4|Received at Least 1 Dose of Study Drug|Period 1||0
372873|NCT01107912|893985|P3|Received at Least 1 Dose of Study Drug|Period 1||0
372874|NCT01107912|893986|P2|Received at Least 1 Dose of Study Drug|Period 1||0
372875|NCT01107912|893987|P1|Received at Least 1 Dose of Study Drug|Period 1||73
372876|NCT01107912|893982|P6|STARTED|Period 1||0
372877|NCT01107912|893983|P5|STARTED|Period 1||82
372878|NCT01107912|893984|P4|STARTED|Period 1||0
372879|NCT01107912|893985|P3|STARTED|Period 1||0
372880|NCT01107912|893986|P2|STARTED|Period 1||0
372881|NCT01107912|893987|P1|STARTED|Period 1||73
372882|NCT01107899|894024|P3|NOT COMPLETED|Overall Study||4
372883|NCT01107899|894025|P2|NOT COMPLETED|Overall Study||0
372884|NCT01107899|894026|P1|NOT COMPLETED|Overall Study||5
372885|NCT01107899|894024|P3|COMPLETED|Overall Study||5
372886|NCT01107899|894025|P2|COMPLETED|Overall Study||10
372887|NCT01107899|894026|P1|COMPLETED|Overall Study||5
372888|NCT01107899|894024|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
372889|NCT01107899|894025|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
372890|NCT01107899|894026|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
372891|NCT01107899|894024|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
372892|NCT01107899|894025|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
372893|NCT01107899|894026|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
372894|NCT01107899|894024|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
372984|NCT01106846|894440|P2|COMPLETED|Overall Study||9
372895|NCT01107899|894025|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
372896|NCT01107899|894026|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
372897|NCT01107899|894024|P3|Received at Least One Dose of Study Drug|Overall Study||8
372898|NCT01107899|894025|P2|Received at Least One Dose of Study Drug|Overall Study||10
372899|NCT01107899|894026|P1|Received at Least One Dose of Study Drug|Overall Study||10
372900|NCT01107899|894024|P3|STARTED|Overall Study||9
372901|NCT01107899|894025|P2|STARTED|Overall Study||10
372902|NCT01107899|894026|P1|STARTED|Overall Study||10
372903|NCT01107886|894072|P2|NOT COMPLETED|Overall Study||214
372904|NCT01107886|894073|P1|NOT COMPLETED|Overall Study||202
372905|NCT01107886|894072|P2|COMPLETED|Overall Study|Completed subjects|7998
372906|NCT01107886|894073|P1|COMPLETED|Overall Study|Completed subjects|8078
372907|NCT01107886|894072|P2|STARTED|Overall Study|Randomized subjects|8212
372908|NCT01107886|894073|P1|STARTED|Overall Study|Randomized subjects|8280
372909|NCT01107834|894085|P2|NOT COMPLETED|Overall Study||0
372910|NCT01107834|894086|P1|NOT COMPLETED|Overall Study||0
372911|NCT01107834|894085|P2|COMPLETED|Overall Study||30
372912|NCT01107834|894086|P1|COMPLETED|Overall Study||30
372913|NCT01107834|894085|P2|STARTED|Overall Study||30
372914|NCT01107834|894086|P1|STARTED|Overall Study||30
372915|NCT01107743|894102|P1|NOT COMPLETED|Overall Study||46
372916|NCT01107743|894102|P1|COMPLETED|Overall Study||1245
372917|NCT01107743|894102|P1|STARTED|Overall Study||1291
372918|NCT01107730|894191|P3|NOT COMPLETED|Overall Study||0
372919|NCT01107730|894192|P2|NOT COMPLETED|Overall Study||0
372920|NCT01107730|894193|P1|NOT COMPLETED|Overall Study||0
372921|NCT01107730|894191|P3|COMPLETED|Overall Study||11
372922|NCT01107730|894192|P2|COMPLETED|Overall Study||11
372923|NCT01107730|894193|P1|COMPLETED|Overall Study||11
372924|NCT01107730|894191|P3|STARTED|Overall Study||11
372925|NCT01107730|894192|P2|STARTED|Overall Study||11
372926|NCT01107730|894193|P1|STARTED|Overall Study||11
372927|NCT01107535|894201|P1|NOT COMPLETED|Overall Study||5
372928|NCT01107535|894201|P1|COMPLETED|Overall Study||77
372929|NCT01107535|894201|P1|Number of Participants Analyzed|Overall Study||82
372930|NCT01107535|894201|P1|STARTED|Overall Study||82
372931|NCT01107418|894213|P1|NOT COMPLETED|Overall Study||52
372932|NCT01107418|894213|P1|COMPLETED|Overall Study||0
372933|NCT01107418|894213|P1|STARTED|Overall Study||52
372934|NCT01107405|894286|P5|NOT COMPLETED|Overall Study||3
372935|NCT01107405|894287|P4|NOT COMPLETED|Overall Study||3
372936|NCT01107405|894288|P3|NOT COMPLETED|Overall Study||2
372937|NCT01107405|894289|P2|NOT COMPLETED|Overall Study||1
372938|NCT01107405|894290|P1|NOT COMPLETED|Overall Study||2
372939|NCT01107405|894286|P5|COMPLETED|Overall Study||17
372940|NCT01107405|894287|P4|COMPLETED|Overall Study||17
372941|NCT01107405|894288|P3|COMPLETED|Overall Study||18
372942|NCT01107405|894289|P2|COMPLETED|Overall Study||19
372943|NCT01107405|894290|P1|COMPLETED|Overall Study||19
372944|NCT01107405|894286|P5|STARTED|Overall Study||20
372945|NCT01107405|894287|P4|STARTED|Overall Study||20
372946|NCT01107405|894288|P3|STARTED|Overall Study||20
372947|NCT01107405|894289|P2|STARTED|Overall Study||20
372948|NCT01107405|894290|P1|STARTED|Overall Study||21
372949|NCT01107392|894329|P2|NOT COMPLETED|Overall Study||3
372950|NCT01107392|894330|P1|NOT COMPLETED|Overall Study||5
372951|NCT01107392|894329|P2|COMPLETED|Overall Study||154
372952|NCT01107392|894330|P1|COMPLETED|Overall Study||153
372953|NCT01107392|894329|P2|STARTED|Overall Study||157
372954|NCT01107392|894330|P1|STARTED|Overall Study||158
372955|NCT01107379|894342|P1|NOT COMPLETED|Overall Study||21
372956|NCT01107379|894342|P1|COMPLETED|Overall Study||182
372957|NCT01107379|894342|P1|STARTED|Overall Study||203
372958|NCT01107353|894353|P2|NOT COMPLETED|Overall Study||0
372959|NCT01107353|894354|P1|NOT COMPLETED|Overall Study||1
372960|NCT01107353|894353|P2|COMPLETED|Overall Study||20
372961|NCT01107353|894354|P1|COMPLETED|Overall Study||19
372962|NCT01107353|894353|P2|STARTED|Overall Study||20
372963|NCT01107353|894354|P1|STARTED|Overall Study||20
372964|NCT01107197|894362|P2|NOT COMPLETED|Overall Study||23
372965|NCT01107197|894363|P1|NOT COMPLETED|Overall Study||20
372966|NCT01107197|894362|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
372967|NCT01107197|894363|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
372968|NCT01107197|894362|P2|STARTED|Overall Study||101
372969|NCT01107197|894363|P1|STARTED|Overall Study||99
372970|NCT01106976|894381|P1|NOT COMPLETED|Overall Study||8
372971|NCT01106976|894381|P1|COMPLETED|Overall Study||59
372972|NCT01106976|894381|P1|STARTED|Overall Study||67
372973|NCT01106950|894385|P1|NOT COMPLETED|Overall Study||0
372974|NCT01106950|894385|P1|COMPLETED|Overall Study||15
372975|NCT01106950|894385|P1|STARTED|Overall Study||15
372976|NCT01106911|894395|P1|NOT COMPLETED|Overall Study||5
372977|NCT01106911|894395|P1|COMPLETED|Overall Study||1080
372978|NCT01106911|894395|P1|STARTED|Overall Study||1085
372979|NCT01106859|894399|P1|NOT COMPLETED|Overall Study||0
372980|NCT01106859|894399|P1|COMPLETED|Overall Study||40
372981|NCT01106859|894399|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
372982|NCT01106846|894440|P2|NOT COMPLETED|Overall Study||1
372983|NCT01106846|894441|P1|NOT COMPLETED|Overall Study||0
372985|NCT01106846|894441|P1|COMPLETED|Overall Study||12
372986|NCT01106846|894440|P2|STARTED|Overall Study||10
372987|NCT01106846|894441|P1|STARTED|Overall Study||12
372988|NCT01106690|894450|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
372989|NCT01106690|894451|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
372990|NCT01106690|894452|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
372991|NCT01106690|894450|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
372992|NCT01106690|894451|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
372993|NCT01106690|894452|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
372994|NCT01106690|894450|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
372995|NCT01106690|894451|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
372996|NCT01106690|894452|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
372997|NCT01106690|894450|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
372998|NCT01106690|894451|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
372999|NCT01106690|894452|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
373000|NCT01106690|894450|P3|COMPLETED|Core Period: Baseline to Week 26||101
373001|NCT01106690|894451|P2|COMPLETED|Core Period: Baseline to Week 26||104
373002|NCT01106690|894452|P1|COMPLETED|Core Period: Baseline to Week 26||91
373003|NCT01106690|894450|P3|STARTED|Core Period: Baseline to Week 26||114
373004|NCT01106690|894451|P2|STARTED|Core Period: Baseline to Week 26||113
373005|NCT01106690|894452|P1|STARTED|Core Period: Baseline to Week 26||115
373006|NCT01106677|894488|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
373007|NCT01106677|894489|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
373008|NCT01106677|894490|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
373009|NCT01106677|894491|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
373010|NCT01106677|894488|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
373011|NCT01106677|894489|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
373012|NCT01106677|894490|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
373013|NCT01106677|894491|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
373014|NCT01106677|894488|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
373015|NCT01106677|894489|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
373016|NCT01106677|894490|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
373017|NCT01106677|894491|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
373018|NCT01106677|894488|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
373019|NCT01106677|894489|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
373020|NCT01106677|894490|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
373021|NCT01106677|894491|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
373022|NCT01106677|894488|P4|COMPLETED|Core Period: Baseline to Week 26||319
373023|NCT01106677|894489|P3|COMPLETED|Core Period: Baseline to Week 26||323
373024|NCT01106677|894490|P2|COMPLETED|Core Period: Baseline to Week 26||322
373025|NCT01106677|894491|P1|COMPLETED|Core Period: Baseline to Week 26||155
373026|NCT01106677|894488|P4|STARTED|Core Period: Baseline to Week 26||366
373027|NCT01106677|894489|P3|STARTED|Core Period: Baseline to Week 26||367
373028|NCT01106677|894490|P2|STARTED|Core Period: Baseline to Week 26||368
373029|NCT01106677|894491|P1|STARTED|Core Period: Baseline to Week 26||183
373030|NCT01106651|894554|P3|NOT COMPLETED|Overall Study||58
373031|NCT01106651|894555|P2|NOT COMPLETED|Overall Study||57
373032|NCT01106651|894556|P1|NOT COMPLETED|Overall Study||79
373033|NCT01106651|894554|P3|COMPLETED|Overall Study||178
373034|NCT01106651|894555|P2|COMPLETED|Overall Study||184
373035|NCT01106651|894556|P1|COMPLETED|Overall Study||158
373036|NCT01106651|894554|P3|STARTED|Overall Study||236
373037|NCT01106651|894555|P2|STARTED|Overall Study||241
373038|NCT01106651|894556|P1|STARTED|Overall Study||237
373039|NCT01106625|894609|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
373040|NCT01106625|894610|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
373041|NCT01106625|894611|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
373042|NCT01106625|894609|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
373043|NCT01106625|894610|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
373044|NCT01106625|894611|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
373045|NCT01106625|894609|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
373046|NCT01106625|894610|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
373047|NCT01106625|894611|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
373048|NCT01106625|894609|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
373049|NCT01106625|894610|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
373050|NCT01106625|894611|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
373051|NCT01106625|894609|P3|COMPLETED|Core Period: Baseline to Week 26||129
373052|NCT01106625|894610|P2|COMPLETED|Core Period: Baseline to Week 26||129
373053|NCT01106625|894611|P1|COMPLETED|Core Period: Baseline to Week 26||123
373054|NCT01106625|894609|P3|STARTED|Core Period: Baseline to Week 26||156
373055|NCT01106625|894610|P2|STARTED|Core Period: Baseline to Week 26||157
373056|NCT01106625|894611|P1|STARTED|Core Period: Baseline to Week 26||156
373057|NCT01106586|894642|P2|NOT COMPLETED|Overall Study||285
373058|NCT01106586|894643|P1|NOT COMPLETED|Overall Study||285
373059|NCT01106586|894642|P2|COMPLETED|Overall Study||70
373060|NCT01106586|894643|P1|COMPLETED|Overall Study||68
373061|NCT01106586|894642|P2|STARTED|Overall Study||355
373062|NCT01106586|894643|P1|STARTED|Overall Study||353
373063|NCT01106534|894661|P1|NOT COMPLETED|Overall Study||37
373064|NCT01106534|894661|P1|COMPLETED|Overall Study||2960
373065|NCT01106534|894661|P1|STARTED|Overall Study||2997
373066|NCT01106456|894684|P2|NOT COMPLETED|Overall Study||124
373067|NCT01106456|894685|P1|NOT COMPLETED|Overall Study||103
373068|NCT01106456|894684|P2|COMPLETED|Overall Study||96
373069|NCT01106456|894685|P1|COMPLETED|Overall Study||140
373070|NCT01106456|894684|P2|STARTED|Overall Study||220
373071|NCT01106456|894685|P1|STARTED|Overall Study||243
373072|NCT01106430|894693|P2|NOT COMPLETED|Overall Study||33
373073|NCT01106430|894694|P1|NOT COMPLETED|Overall Study||33
373074|NCT01106430|894693|P2|COMPLETED|Overall Study||101
373075|NCT01106430|894694|P1|COMPLETED|Overall Study||100
373076|NCT01106430|894693|P2|STARTED|Overall Study||134
373077|NCT01106430|894694|P1|STARTED|Overall Study||133
373078|NCT01106404|894716|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
373079|NCT01106404|894717|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
373080|NCT01106404|894716|P2|COMPLETED|Period II (Second 6 Weeks)||38
373081|NCT01106404|894717|P1|COMPLETED|Period II (Second 6 Weeks)||33
373082|NCT01106404|894716|P2|STARTED|Period II (Second 6 Weeks)||38
373083|NCT01106404|894717|P1|STARTED|Period II (Second 6 Weeks)||33
373084|NCT01106404|894716|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
373085|NCT01106404|894717|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
373086|NCT01106404|894716|P2|COMPLETED|Period I (First 6 Weeks)||38
373087|NCT01106404|894717|P1|COMPLETED|Period I (First 6 Weeks)||33
373088|NCT01106404|894716|P2|STARTED|Period I (First 6 Weeks)||40
373089|NCT01106404|894717|P1|STARTED|Period I (First 6 Weeks)||36
373090|NCT01106391|894730|P1|NOT COMPLETED|Overall Study||0
373091|NCT01106391|894730|P1|COMPLETED|Overall Study||60
373092|NCT01106391|894730|P1|STARTED|Overall Study||60
373093|NCT01106352|894740|P5|NOT COMPLETED|Overall Study||8
373094|NCT01106352|894741|P4|NOT COMPLETED|Overall Study||13
373095|NCT01106352|894742|P3|NOT COMPLETED|Overall Study||2
373096|NCT01106352|894743|P2|NOT COMPLETED|Overall Study||0
373097|NCT01106352|894744|P1|NOT COMPLETED|Overall Study||1
373098|NCT01106352|894740|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
373099|NCT01106352|894741|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
373100|NCT01106352|894742|P3|COMPLETED|Overall Study||5
373101|NCT01106352|894743|P2|COMPLETED|Overall Study||3
373102|NCT01106352|894744|P1|COMPLETED|Overall Study||6
373103|NCT01106352|894740|P5|Completed Safety Cohort|Overall Study||9
373104|NCT01106352|894741|P4|Completed Safety Cohort|Overall Study||23
373105|NCT01106352|894742|P3|Completed Safety Cohort|Overall Study||0
373106|NCT01106352|894743|P2|Completed Safety Cohort|Overall Study||0
373107|NCT01106352|894744|P1|Completed Safety Cohort|Overall Study||0
373108|NCT01106352|894740|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
373109|NCT01106352|894741|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
373110|NCT01106352|894742|P3|Treated Safety Cohort|Overall Study||0
373111|NCT01106352|894743|P2|Treated Safety Cohort|Overall Study||0
373112|NCT01106352|894744|P1|Treated Safety Cohort|Overall Study||0
373113|NCT01106352|894740|P5|Started Safety Cohort|Overall Study||17
373114|NCT01106352|894741|P4|Started Safety Cohort|Overall Study||36
373115|NCT01106352|894742|P3|Started Safety Cohort|Overall Study||0
373116|NCT01106352|894743|P2|Started Safety Cohort|Overall Study||0
373117|NCT01106352|894744|P1|Started Safety Cohort|Overall Study||0
373118|NCT01106352|894740|P5|Completed Dose Escalation|Overall Study||0
373119|NCT01106352|894741|P4|Completed Dose Escalation|Overall Study||0
373120|NCT01106352|894742|P3|Completed Dose Escalation|Overall Study||5
373121|NCT01106352|894743|P2|Completed Dose Escalation|Overall Study||3
373122|NCT01106352|894744|P1|Completed Dose Escalation|Overall Study||6
373123|NCT01106352|894740|P5|Started Dose Escalation|Overall Study||0
373124|NCT01106352|894741|P4|Started Dose Escalation|Overall Study||0
373125|NCT01106352|894742|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
373126|NCT01106352|894743|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
373127|NCT01106352|894744|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
373128|NCT01106352|894740|P5|STARTED|Overall Study||17
373129|NCT01106352|894741|P4|STARTED|Overall Study||36
373130|NCT01106352|894742|P3|STARTED|Overall Study||7
373131|NCT01106352|894743|P2|STARTED|Overall Study||3
373132|NCT01106352|894744|P1|STARTED|Overall Study||7
373133|NCT01106326|894830|P1|NOT COMPLETED|Overall Study||2
373134|NCT01106326|894830|P1|COMPLETED|Overall Study||28
373135|NCT01106326|894830|P1|STARTED|Overall Study||30
373136|NCT01106287|894840|P4|NOT COMPLETED|Overall Study||0
373137|NCT01106287|894841|P3|NOT COMPLETED|Overall Study||0
373138|NCT01106287|894842|P2|NOT COMPLETED|Overall Study||0
373139|NCT01106287|894843|P1|NOT COMPLETED|Overall Study||1
373140|NCT01106287|894840|P4|COMPLETED|Overall Study||3
373141|NCT01106287|894841|P3|COMPLETED|Overall Study||3
373142|NCT01106287|894842|P2|COMPLETED|Overall Study||3
373143|NCT01106287|894843|P1|COMPLETED|Overall Study||3
373144|NCT01106287|894840|P4|STARTED|Overall Study||3
373145|NCT01106287|894841|P3|STARTED|Overall Study||3
373146|NCT01106287|894842|P2|STARTED|Overall Study||3
373147|NCT01106287|894843|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
373148|NCT01105767|894866|P3|NOT COMPLETED|Overall Study||1184
373149|NCT01105767|894867|P2|NOT COMPLETED|Overall Study||1614
373150|NCT01105767|894868|P1|NOT COMPLETED|Overall Study||1160
373151|NCT01105767|894866|P3|COMPLETED|Overall Study||8846
373152|NCT01105767|894867|P2|COMPLETED|Overall Study||9250
373153|NCT01105767|894868|P1|COMPLETED|Overall Study||8155
373154|NCT01105767|894866|P3|STARTED|Overall Study||10030
373155|NCT01105767|894867|P2|STARTED|Overall Study||10864
373156|NCT01105767|894868|P1|STARTED|Overall Study||9315
373157|NCT01106248|894879|P1|NOT COMPLETED|Overall Study||3
373158|NCT01106248|894879|P1|COMPLETED|Overall Study||23
373159|NCT01106248|894879|P1|STARTED|Overall Study||26
373160|NCT01106157|894887|P2|NOT COMPLETED|Overall Study||0
373161|NCT01106157|894888|P1|NOT COMPLETED|Overall Study||1
373162|NCT01106157|894887|P2|COMPLETED|Overall Study||8
373163|NCT01106157|894888|P1|COMPLETED|Overall Study||16
373164|NCT01106157|894887|P2|STARTED|Overall Study||8
373165|NCT01106157|894888|P1|STARTED|Overall Study||17
373166|NCT01106092|894916|P4|NOT COMPLETED|Overall Study||1
373167|NCT01106092|894917|P3|NOT COMPLETED|Overall Study||0
373168|NCT01106092|894918|P2|NOT COMPLETED|Overall Study||0
373169|NCT01106092|894919|P1|NOT COMPLETED|Overall Study||0
373170|NCT01106092|894916|P4|COMPLETED|Overall Study||77
373171|NCT01106092|894917|P3|COMPLETED|Overall Study||78
373172|NCT01106092|894918|P2|COMPLETED|Overall Study||78
373173|NCT01106092|894919|P1|COMPLETED|Overall Study||78
373174|NCT01106092|894916|P4|STARTED|Overall Study||78
373175|NCT01106092|894917|P3|STARTED|Overall Study||78
373176|NCT01106092|894918|P2|STARTED|Overall Study||78
373177|NCT01106092|894919|P1|STARTED|Overall Study||78
373178|NCT01106040|894997|P1|NOT COMPLETED|Overall Study||11
373179|NCT01106040|894997|P1|COMPLETED|Overall Study||152
373180|NCT01106040|894997|P1|STARTED|Overall Study||163
373181|NCT01106014|895004|P2|NOT COMPLETED|Overall Study||330
373182|NCT01106014|895005|P1|NOT COMPLETED|Overall Study||285
373183|NCT01106014|895004|P2|COMPLETED|Overall Study||252
373184|NCT01106014|895005|P1|COMPLETED|Overall Study||289
373185|NCT01106014|895004|P2|STARTED|Overall Study||582
373186|NCT01106014|895005|P1|STARTED|Overall Study||574
373187|NCT01105936|895015|P4|NOT COMPLETED|Period 3||0
373188|NCT01105936|895016|P3|NOT COMPLETED|Period 3||0
373189|NCT01105936|895017|P2|NOT COMPLETED|Period 3||2
373190|NCT01105936|895018|P1|NOT COMPLETED|Period 3||0
373191|NCT01105936|895015|P4|COMPLETED|Period 3||7
373192|NCT01105936|895016|P3|COMPLETED|Period 3||7
373193|NCT01105936|895017|P2|COMPLETED|Period 3||6
373194|NCT01105936|895018|P1|COMPLETED|Period 3||7
373195|NCT01105936|895015|P4|STARTED|Period 3||7
373196|NCT01105936|895016|P3|STARTED|Period 3||7
373197|NCT01105936|895017|P2|STARTED|Period 3||8
373198|NCT01105936|895018|P1|STARTED|Period 3||7
373199|NCT01105936|895015|P4|NOT COMPLETED|Wash-out Period 2||0
373200|NCT01105936|895016|P3|NOT COMPLETED|Wash-out Period 2||0
373201|NCT01105936|895017|P2|NOT COMPLETED|Wash-out Period 2||0
373202|NCT01105936|895018|P1|NOT COMPLETED|Wash-out Period 2||0
373203|NCT01105936|895015|P4|COMPLETED|Wash-out Period 2||7
373204|NCT01105936|895016|P3|COMPLETED|Wash-out Period 2||7
373205|NCT01105936|895017|P2|COMPLETED|Wash-out Period 2||8
373206|NCT01105936|895018|P1|COMPLETED|Wash-out Period 2||7
373207|NCT01105936|895015|P4|STARTED|Wash-out Period 2||7
373208|NCT01105936|895016|P3|STARTED|Wash-out Period 2||7
373209|NCT01105936|895017|P2|STARTED|Wash-out Period 2||8
373210|NCT01105936|895018|P1|STARTED|Wash-out Period 2||7
373211|NCT01105936|895015|P4|NOT COMPLETED|Period 2||0
373212|NCT01105936|895016|P3|NOT COMPLETED|Period 2||0
373213|NCT01105936|895017|P2|NOT COMPLETED|Period 2||0
373214|NCT01105936|895018|P1|NOT COMPLETED|Period 2||1
373215|NCT01105936|895015|P4|COMPLETED|Period 2||7
373216|NCT01105936|895016|P3|COMPLETED|Period 2||7
373217|NCT01105936|895017|P2|COMPLETED|Period 2||8
373218|NCT01105936|895018|P1|COMPLETED|Period 2||7
373219|NCT01105936|895015|P4|STARTED|Period 2||7
373220|NCT01105936|895016|P3|STARTED|Period 2||7
373221|NCT01105936|895017|P2|STARTED|Period 2||8
373222|NCT01105936|895018|P1|STARTED|Period 2||8
373223|NCT01105936|895015|P4|NOT COMPLETED|Wash-out Period 1||0
373224|NCT01105936|895016|P3|NOT COMPLETED|Wash-out Period 1||0
373225|NCT01105936|895017|P2|NOT COMPLETED|Wash-out Period 1||0
373226|NCT01105936|895018|P1|NOT COMPLETED|Wash-out Period 1||0
373227|NCT01105936|895015|P4|COMPLETED|Wash-out Period 1||7
373228|NCT01105936|895016|P3|COMPLETED|Wash-out Period 1||7
373229|NCT01105936|895017|P2|COMPLETED|Wash-out Period 1||8
373230|NCT01105936|895018|P1|COMPLETED|Wash-out Period 1||8
373231|NCT01105936|895015|P4|STARTED|Wash-out Period 1||7
373232|NCT01105936|895016|P3|STARTED|Wash-out Period 1||7
373233|NCT01105936|895017|P2|STARTED|Wash-out Period 1||8
373234|NCT01105936|895018|P1|STARTED|Wash-out Period 1||8
373235|NCT01105936|895015|P4|NOT COMPLETED|Period 1||1
373236|NCT01105936|895016|P3|NOT COMPLETED|Period 1||0
373237|NCT01105936|895017|P2|NOT COMPLETED|Period 1||0
373238|NCT01105936|895018|P1|NOT COMPLETED|Period 1||0
373239|NCT01105936|895015|P4|COMPLETED|Period 1||7
373240|NCT01105936|895016|P3|COMPLETED|Period 1||7
373241|NCT01105936|895017|P2|COMPLETED|Period 1||8
373242|NCT01105936|895018|P1|COMPLETED|Period 1||8
373243|NCT01105936|895015|P4|STARTED|Period 1||8
373244|NCT01105936|895016|P3|STARTED|Period 1||7
373245|NCT01105936|895017|P2|STARTED|Period 1||8
373246|NCT01105936|895018|P1|STARTED|Period 1||8
373247|NCT01105754|895046|P2|NOT COMPLETED|Overall Study||12
373248|NCT01105754|895047|P1|NOT COMPLETED|Overall Study||15
373249|NCT01105754|895046|P2|COMPLETED|Overall Study||307
373250|NCT01105754|895047|P1|COMPLETED|Overall Study||304
373251|NCT01105754|895046|P2|STARTED|Overall Study||319
373252|NCT01105754|895047|P1|STARTED|Overall Study||319
373253|NCT01105702|895055|P1|NOT COMPLETED|Overall Study||18
373254|NCT01105702|895055|P1|COMPLETED|Overall Study||10
373255|NCT01105702|895055|P1|STARTED|Overall Study||28
373256|NCT01105650|895065|P4|NOT COMPLETED|Overall Study||0
373257|NCT01105650|895066|P3|NOT COMPLETED|Overall Study||0
373258|NCT01105650|895067|P2|NOT COMPLETED|Overall Study||0
373259|NCT01105650|895068|P1|NOT COMPLETED|Overall Study||0
373260|NCT01105650|895065|P4|COMPLETED|Overall Study||0
373261|NCT01105650|895066|P3|COMPLETED|Overall Study||7
373262|NCT01105650|895067|P2|COMPLETED|Overall Study||3
373263|NCT01105650|895068|P1|COMPLETED|Overall Study||3
373264|NCT01105650|895065|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
373265|NCT01105650|895066|P3|STARTED|Overall Study||7
373266|NCT01105650|895067|P2|STARTED|Overall Study||3
373267|NCT01105650|895068|P1|STARTED|Overall Study||3
373268|NCT01105533|895085|P9|NOT COMPLETED|Overall Study||12
373269|NCT01105533|895086|P8|NOT COMPLETED|Overall Study||4
373270|NCT01105533|895087|P7|NOT COMPLETED|Overall Study||8
373271|NCT01105533|895088|P6|NOT COMPLETED|Overall Study||7
373272|NCT01105533|895089|P5|NOT COMPLETED|Overall Study||7
373273|NCT01105533|895090|P4|NOT COMPLETED|Overall Study||3
373274|NCT01105533|895091|P3|NOT COMPLETED|Overall Study||3
373275|NCT01105533|895092|P2|NOT COMPLETED|Overall Study||1
373276|NCT01105533|895093|P1|NOT COMPLETED|Overall Study||1
373277|NCT01105533|895085|P9|COMPLETED|Overall Study||0
373278|NCT01105533|895086|P8|COMPLETED|Overall Study||0
373279|NCT01105533|895087|P7|COMPLETED|Overall Study||0
373280|NCT01105533|895088|P6|COMPLETED|Overall Study||0
373281|NCT01105533|895089|P5|COMPLETED|Overall Study||0
373282|NCT01105533|895090|P4|COMPLETED|Overall Study||0
373283|NCT01105533|895091|P3|COMPLETED|Overall Study||0
373284|NCT01105533|895092|P2|COMPLETED|Overall Study||0
373285|NCT01105533|895093|P1|COMPLETED|Overall Study||0
373286|NCT01105533|895085|P9|STARTED|Overall Study||12
373287|NCT01105533|895086|P8|STARTED|Overall Study||4
373288|NCT01105533|895087|P7|STARTED|Overall Study||8
373289|NCT01105533|895088|P6|STARTED|Overall Study||7
373290|NCT01105533|895089|P5|STARTED|Overall Study||7
373291|NCT01105533|895090|P4|STARTED|Overall Study||3
373292|NCT01105533|895091|P3|STARTED|Overall Study||3
373293|NCT01105533|895092|P2|STARTED|Overall Study||1
373294|NCT01105533|895093|P1|STARTED|Overall Study||1
373295|NCT01105377|895183|P2|NOT COMPLETED|Overall Study||1
373296|NCT01105377|895184|P1|NOT COMPLETED|Overall Study||0
373297|NCT01105377|895183|P2|COMPLETED|Overall Study||22
373298|NCT01105377|895184|P1|COMPLETED|Overall Study||24
373299|NCT01105377|895183|P2|STARTED|Overall Study||23
373300|NCT01105377|895184|P1|STARTED|Overall Study||24
373301|NCT01105247|895194|P2|NOT COMPLETED|Overall Study||0
373302|NCT01105247|895195|P1|NOT COMPLETED|Overall Study||37
373303|NCT01105247|895194|P2|COMPLETED|Overall Study||16
373304|NCT01105247|895195|P1|COMPLETED|Overall Study||79
373305|NCT01105247|895194|P2|STARTED|Overall Study||16
373306|NCT01105247|895195|P1|STARTED|Overall Study||116
373307|NCT01105130|895211|P3|NOT COMPLETED|Overall Study||10
373308|NCT01105130|895212|P2|NOT COMPLETED|Overall Study||11
373309|NCT01105130|895213|P1|NOT COMPLETED|Overall Study||10
373310|NCT01105130|895211|P3|COMPLETED|Overall Study||37
373311|NCT01105130|895212|P2|COMPLETED|Overall Study||34
373312|NCT01105130|895213|P1|COMPLETED|Overall Study||38
373313|NCT01105130|895211|P3|STARTED|Overall Study||47
373314|NCT01105130|895212|P2|STARTED|Overall Study||45
373315|NCT01105130|895213|P1|STARTED|Overall Study||48
373316|NCT01105117|895232|P2|NOT COMPLETED|Overall Study||0
373317|NCT01105117|895233|P1|NOT COMPLETED|Overall Study||0
373318|NCT01105117|895232|P2|COMPLETED|Overall Study||1
373319|NCT01105117|895233|P1|COMPLETED|Overall Study||1
373320|NCT01105117|895232|P2|STARTED|Overall Study||1
373321|NCT01105117|895233|P1|STARTED|Overall Study||1
373322|NCT01105091|895243|P2|NOT COMPLETED|Overall Study||0
373323|NCT01105091|895244|P1|NOT COMPLETED|Overall Study||2
373324|NCT01105091|895243|P2|COMPLETED|Overall Study||10
373325|NCT01105091|895244|P1|COMPLETED|Overall Study||18
373326|NCT01105091|895243|P2|STARTED|Overall Study||10
373327|NCT01105091|895244|P1|STARTED|Overall Study||20
373328|NCT01105065|895268|P1|NOT COMPLETED|Overall Study||6
373329|NCT01105065|895268|P1|COMPLETED|Overall Study||17
373330|NCT01105065|895268|P1|STARTED|Overall Study||23
373331|NCT01103973|895276|P2|NOT COMPLETED|Overall Study||0
373332|NCT01103973|895277|P1|NOT COMPLETED|Overall Study||0
373333|NCT01103973|895276|P2|COMPLETED|Overall Study||46
373334|NCT01103973|895277|P1|COMPLETED|Overall Study||51
373335|NCT01103973|895276|P2|STARTED|Overall Study||46
373336|NCT01103973|895277|P1|STARTED|Overall Study||51
373337|NCT01103960|895285|P2|NOT COMPLETED|Overall Study||2
373338|NCT01103960|895286|P1|NOT COMPLETED|Overall Study||5
373339|NCT01103960|895285|P2|COMPLETED|Overall Study|Completed study medication.|158
373340|NCT01103960|895286|P1|COMPLETED|Overall Study|Completed study medication.|159
373341|NCT01103960|895285|P2|STARTED|Overall Study|Randomised and treated.|160
373342|NCT01103960|895286|P1|STARTED|Overall Study|Randomised and treated.|164
373343|NCT01103934|895312|P2|NOT COMPLETED|Overall Study||0
373344|NCT01103934|895313|P1|NOT COMPLETED|Overall Study||0
373345|NCT01103934|895312|P2|COMPLETED|Overall Study||18
373346|NCT01103934|895313|P1|COMPLETED|Overall Study||17
373347|NCT01103934|895312|P2|STARTED|Overall Study||18
373348|NCT01103934|895313|P1|STARTED|Overall Study||17
373349|NCT01102803|895323|P2|NOT COMPLETED|Post to Follow-Up||3
373350|NCT01102803|895324|P1|NOT COMPLETED|Post to Follow-Up||1
373351|NCT01102803|895323|P2|COMPLETED|Post to Follow-Up||12
373352|NCT01102803|895324|P1|COMPLETED|Post to Follow-Up||10
373353|NCT01102803|895323|P2|STARTED|Post to Follow-Up||15
373354|NCT01102803|895324|P1|STARTED|Post to Follow-Up||11
373355|NCT01102803|895323|P2|NOT COMPLETED|Baseline to Post-Treatment||0
373356|NCT01102803|895324|P1|NOT COMPLETED|Baseline to Post-Treatment||3
373357|NCT01102803|895323|P2|COMPLETED|Baseline to Post-Treatment||15
373358|NCT01102803|895324|P1|COMPLETED|Baseline to Post-Treatment||11
373359|NCT01102803|895323|P2|STARTED|Baseline to Post-Treatment||15
373360|NCT01102803|895324|P1|STARTED|Baseline to Post-Treatment||14
373361|NCT01102777|895338|P2|NOT COMPLETED|Overall Study||16
373362|NCT01102777|895339|P1|NOT COMPLETED|Overall Study||9
373363|NCT01102777|895338|P2|COMPLETED|Overall Study||139
373364|NCT01102777|895339|P1|COMPLETED|Overall Study||75
373365|NCT01102777|895338|P2|STARTED|Overall Study||155
373366|NCT01102777|895339|P1|STARTED|Overall Study||84
373367|NCT01102764|895365|P2|NOT COMPLETED|Overall Study||13
373368|NCT01102764|895366|P1|NOT COMPLETED|Overall Study||21
373369|NCT01102764|895365|P2|COMPLETED|Overall Study||55
373370|NCT01102764|895366|P1|COMPLETED|Overall Study||43
373371|NCT01102764|895365|P2|STARTED|Overall Study||68
373372|NCT01102764|895366|P1|STARTED|Overall Study||64
373373|NCT01104870|895379|P3|NOT COMPLETED|Overall Study||2
373374|NCT01104870|895380|P2|NOT COMPLETED|Overall Study||1
373375|NCT01104870|895381|P1|NOT COMPLETED|Overall Study||1
373376|NCT01104870|895379|P3|COMPLETED|Overall Study||18
373377|NCT01104870|895380|P2|COMPLETED|Overall Study||18
373378|NCT01104870|895381|P1|COMPLETED|Overall Study||10
373379|NCT01104870|895379|P3|STARTED|Overall Study||20
373380|NCT01104870|895380|P2|STARTED|Overall Study||19
373381|NCT01104870|895381|P1|STARTED|Overall Study||11
373382|NCT01104701|895414|P4|NOT COMPLETED|Overall Study||2
373383|NCT01104701|895415|P3|NOT COMPLETED|Overall Study||2
373384|NCT01104701|895416|P2|NOT COMPLETED|Overall Study||3
373385|NCT01104701|895417|P1|NOT COMPLETED|Overall Study||0
373386|NCT01104701|895414|P4|COMPLETED|Overall Study||28
373387|NCT01104701|895415|P3|COMPLETED|Overall Study||29
373388|NCT01104701|895416|P2|COMPLETED|Overall Study||27
373389|NCT01104701|895417|P1|COMPLETED|Overall Study||30
373390|NCT01104701|895414|P4|STARTED|Overall Study||30
373391|NCT01104701|895415|P3|STARTED|Overall Study||31
373392|NCT01104701|895416|P2|STARTED|Overall Study||30
373393|NCT01104701|895417|P1|STARTED|Overall Study||30
373394|NCT01104662|895479|P8|NOT COMPLETED|Overall Study||0
373395|NCT01104662|895480|P7|NOT COMPLETED|Overall Study||0
373396|NCT01104662|895481|P6|NOT COMPLETED|Overall Study||4
373397|NCT01104662|895482|P5|NOT COMPLETED|Overall Study||1
373398|NCT01104662|895483|P4|NOT COMPLETED|Overall Study||1
373399|NCT01104662|895484|P3|NOT COMPLETED|Overall Study||1
373400|NCT01104662|895485|P2|NOT COMPLETED|Overall Study||10
373401|NCT01104662|895486|P1|NOT COMPLETED|Overall Study||10
373402|NCT01104662|895479|P8|COMPLETED|Overall Study||6
373403|NCT01104662|895480|P7|COMPLETED|Overall Study||5
373404|NCT01104662|895481|P6|COMPLETED|Overall Study||12
373405|NCT01104662|895482|P5|COMPLETED|Overall Study||14
373406|NCT01104662|895483|P4|COMPLETED|Overall Study||3
373407|NCT01104662|895484|P3|COMPLETED|Overall Study||4
373408|NCT01104662|895485|P2|COMPLETED|Overall Study||11
373409|NCT01104662|895486|P1|COMPLETED|Overall Study||10
373410|NCT01104662|895479|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
373411|NCT01104662|895480|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
373504|NCT01103466|895777|P3|STARTED|Third Period (14 +/- 3 Days)||14
373412|NCT01104662|895481|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
373413|NCT01104662|895482|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
373414|NCT01104662|895483|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
373415|NCT01104662|895484|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
373416|NCT01104662|895485|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
373417|NCT01104662|895486|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
373418|NCT01104662|895479|P8|STARTED|Overall Study||6
373419|NCT01104662|895480|P7|STARTED|Overall Study||5
373420|NCT01104662|895481|P6|STARTED|Overall Study||16
373421|NCT01104662|895482|P5|STARTED|Overall Study||15
373422|NCT01104662|895483|P4|STARTED|Overall Study||4
373423|NCT01104662|895484|P3|STARTED|Overall Study||5
373424|NCT01104662|895485|P2|STARTED|Overall Study||21
373425|NCT01104662|895486|P1|STARTED|Overall Study||20
373426|NCT01104636|895512|P1|NOT COMPLETED|Overall Study||178
373427|NCT01104636|895512|P1|COMPLETED|Overall Study||999
373428|NCT01104636|895512|P1|STARTED|Overall Study||1177
373429|NCT01104584|895517|P1|NOT COMPLETED|Overall Study||23
373430|NCT01104584|895517|P1|COMPLETED|Overall Study|study course completed|437
373431|NCT01104584|895517|P1|Fulfilled Requirements of FAS Population|Overall Study||397
373432|NCT01104584|895517|P1|Received Treatment|Overall Study|treatment started|439
373433|NCT01104584|895517|P1|STARTED|Overall Study|screened and enrolled|460
373434|NCT01104558|895587|P1|NOT COMPLETED|Overall Study||17
373435|NCT01104558|895587|P1|COMPLETED|Overall Study||83
373436|NCT01104558|895587|P1|STARTED|Overall Study||100
373437|NCT01104493|895630|P2|NOT COMPLETED|Overall Study||2
373438|NCT01104493|895631|P1|NOT COMPLETED|Overall Study||0
373439|NCT01104493|895630|P2|COMPLETED|Overall Study||58
373440|NCT01104493|895631|P1|COMPLETED|Overall Study||240
373441|NCT01104493|895630|P2|STARTED|Overall Study||60
373442|NCT01104493|895631|P1|STARTED|Overall Study||240
373443|NCT01104376|895649|P1|NOT COMPLETED|Overall Study||28
373444|NCT01104376|895649|P1|COMPLETED|Overall Study||61
373445|NCT01104376|895649|P1|STARTED|Overall Study||89
373446|NCT01104311|895655|P2|NOT COMPLETED|Overall Study||12
373447|NCT01104311|895656|P1|NOT COMPLETED|Overall Study||10
373448|NCT01104311|895655|P2|COMPLETED|Overall Study||54
373449|NCT01104311|895656|P1|COMPLETED|Overall Study||56
373450|NCT01104311|895655|P2|STARTED|Overall Study||66
373451|NCT01104311|895656|P1|STARTED|Overall Study||66
373452|NCT01104285|895676|P2|NOT COMPLETED|Overall Study||0
373453|NCT01104285|895677|P1|NOT COMPLETED|Overall Study||0
373454|NCT01104285|895676|P2|COMPLETED|Overall Study||86
373455|NCT01104285|895677|P1|COMPLETED|Overall Study||112
373456|NCT01104285|895676|P2|STARTED|Overall Study||86
373457|NCT01104285|895677|P1|STARTED|Overall Study||112
373458|NCT01104246|895683|P1|NOT COMPLETED|Overall Study||5
373459|NCT01104246|895683|P1|COMPLETED|Overall Study||35
373460|NCT01104246|895683|P1|Baseline Characteristics Measured|Overall Study||35
373461|NCT01104246|895683|P1|STARTED|Overall Study||40
373462|NCT01104207|895689|P2|NOT COMPLETED|Overall Study||3
373463|NCT01104207|895690|P1|NOT COMPLETED|Overall Study||3
373464|NCT01104207|895689|P2|COMPLETED|Overall Study||32
373465|NCT01104207|895690|P1|COMPLETED|Overall Study||32
373466|NCT01104207|895689|P2|STARTED|Overall Study||35
373467|NCT01104207|895690|P1|STARTED|Overall Study||35
373468|NCT01104155|895698|P2|NOT COMPLETED|Overall Study||18
373469|NCT01104155|895699|P1|NOT COMPLETED|Overall Study||25
373470|NCT01104155|895698|P2|COMPLETED|Overall Study||42
373471|NCT01104155|895699|P1|COMPLETED|Overall Study||38
373472|NCT01104155|895698|P2|STARTED|Overall Study||60
373473|NCT01104155|895699|P1|STARTED|Overall Study||63
373474|NCT01104116|895713|P1|NOT COMPLETED|Overall Study||0
373475|NCT01104116|895713|P1|COMPLETED|Overall Study||1
373476|NCT01104116|895713|P1|STARTED|Overall Study||1
373477|NCT01104103|895720|P2|NOT COMPLETED|Overall Study||0
373478|NCT01104103|895721|P1|NOT COMPLETED|Overall Study||0
373479|NCT01104103|895720|P2|COMPLETED|Overall Study||224
373480|NCT01104103|895721|P1|COMPLETED|Overall Study||243
373481|NCT01104103|895720|P2|STARTED|Overall Study||224
373482|NCT01104103|895721|P1|STARTED|Overall Study||243
373483|NCT01103713|895729|P1|NOT COMPLETED|Overall Study||13
373484|NCT01103713|895729|P1|COMPLETED|Overall Study||155
373485|NCT01103713|895729|P1|STARTED|Overall Study||168
373486|NCT01103492|895755|P1|NOT COMPLETED|Overall Study||0
373487|NCT01103492|895755|P1|COMPLETED|Overall Study||1
373488|NCT01103492|895755|P1|STARTED|Overall Study||1
373489|NCT01103479|895762|P3|NOT COMPLETED|Overall Study||14
373490|NCT01103479|895763|P2|NOT COMPLETED|Overall Study||9
373491|NCT01103479|895764|P1|NOT COMPLETED|Overall Study||5
373492|NCT01103479|895762|P3|COMPLETED|Overall Study||174
373493|NCT01103479|895763|P2|COMPLETED|Overall Study||201
373494|NCT01103479|895764|P1|COMPLETED|Overall Study||163
373495|NCT01103479|895762|P3|STARTED|Overall Study||188
373496|NCT01103479|895763|P2|STARTED|Overall Study||210
373497|NCT01103479|895764|P1|STARTED|Overall Study||168
373498|NCT01103466|895777|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
373499|NCT01103466|895778|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
373500|NCT01103466|895779|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
373501|NCT01103466|895777|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
373502|NCT01103466|895778|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
373503|NCT01103466|895779|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
373505|NCT01103466|895778|P2|STARTED|Third Period (14 +/- 3 Days)||8
373506|NCT01103466|895779|P1|STARTED|Third Period (14 +/- 3 Days)||8
373507|NCT01103466|895777|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
373508|NCT01103466|895778|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
373509|NCT01103466|895779|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
373510|NCT01103466|895777|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
373511|NCT01103466|895778|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
373512|NCT01103466|895779|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
373513|NCT01103466|895777|P3|STARTED|Second Period (14 +/- 3 Days)||7
373514|NCT01103466|895778|P2|STARTED|Second Period (14 +/- 3 Days)||13
373515|NCT01103466|895779|P1|STARTED|Second Period (14 +/- 3 Days)||15
373516|NCT01103466|895777|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
373517|NCT01103466|895778|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
373518|NCT01103466|895779|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
373519|NCT01103466|895777|P3|COMPLETED|First Period (14 +/- 3 Days)||13
373520|NCT01103466|895778|P2|COMPLETED|First Period (14 +/- 3 Days)||12
373521|NCT01103466|895779|P1|COMPLETED|First Period (14 +/- 3 Days)||10
373522|NCT01103466|895777|P3|STARTED|First Period (14 +/- 3 Days)||13
373523|NCT01103466|895778|P2|STARTED|First Period (14 +/- 3 Days)||12
373524|NCT01103466|895779|P1|STARTED|First Period (14 +/- 3 Days)||12
373525|NCT01103414|895792|P5|NOT COMPLETED|Overall Study||15
373526|NCT01103414|895793|P4|NOT COMPLETED|Overall Study||7
373527|NCT01103414|895794|P3|NOT COMPLETED|Overall Study||15
373528|NCT01103414|895795|P2|NOT COMPLETED|Overall Study||9
373529|NCT01103414|895796|P1|NOT COMPLETED|Overall Study||13
373530|NCT01103414|895792|P5|COMPLETED|Overall Study||56
373531|NCT01103414|895793|P4|COMPLETED|Overall Study||64
373532|NCT01103414|895794|P3|COMPLETED|Overall Study||56
373533|NCT01103414|895795|P2|COMPLETED|Overall Study||62
373534|NCT01103414|895796|P1|COMPLETED|Overall Study||59
373535|NCT01103414|895792|P5|STARTED|Overall Study||71
373536|NCT01103414|895793|P4|STARTED|Overall Study||71
373537|NCT01103414|895794|P3|STARTED|Overall Study||71
373538|NCT01103414|895795|P2|STARTED|Overall Study||71
373539|NCT01103414|895796|P1|STARTED|Overall Study||72
373540|NCT01103362|895858|P1|NOT COMPLETED|Overall Study||596
373541|NCT01103362|895858|P1|COMPLETED|Overall Study||0
373542|NCT01103362|895858|P1|STARTED|Overall Study||596
373543|NCT01103323|895864|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
373544|NCT01103323|895865|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
373545|NCT01103323|895864|P2|COMPLETED|Switched From Placebo to Regorafenib||3
373546|NCT01103323|895865|P1|COMPLETED|Switched From Placebo to Regorafenib||0
373547|NCT01103323|895864|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
373548|NCT01103323|895865|P1|STARTED|Switched From Placebo to Regorafenib||0
373549|NCT01103323|895864|P2|NOT COMPLETED|Without/Before Drug Switch||18
373550|NCT01103323|895865|P1|NOT COMPLETED|Without/Before Drug Switch||76
373551|NCT01103323|895864|P2|COMPLETED|Without/Before Drug Switch||237
373552|NCT01103323|895865|P1|COMPLETED|Without/Before Drug Switch||429
373553|NCT01103323|895864|P2|Participants Received Treatment|Without/Before Drug Switch||253
373554|NCT01103323|895865|P1|Participants Received Treatment|Without/Before Drug Switch||500
373555|NCT01103323|895864|P2|STARTED|Without/Before Drug Switch||255
373556|NCT01103323|895865|P1|STARTED|Without/Before Drug Switch||505
373557|NCT01103284|895882|P2|NOT COMPLETED|Overall Study||44
373558|NCT01103284|895883|P1|NOT COMPLETED|Overall Study||42
373559|NCT01103284|895882|P2|COMPLETED|Overall Study||195
373560|NCT01103284|895883|P1|COMPLETED|Overall Study||194
373561|NCT01103284|895882|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
373562|NCT01103284|895883|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
373563|NCT01103284|895882|P2|Treated|Overall Study||238
373564|NCT01103284|895883|P1|Treated|Overall Study||236
373565|NCT01103284|895882|P2|STARTED|Overall Study||239
373566|NCT01103284|895883|P1|STARTED|Overall Study||236
373567|NCT01103271|895899|P2|NOT COMPLETED|Overall Study||4
373568|NCT01103271|895900|P1|NOT COMPLETED|Overall Study||1
373569|NCT01103271|895899|P2|COMPLETED|Overall Study||5
373570|NCT01103271|895900|P1|COMPLETED|Overall Study||10
373571|NCT01103271|895899|P2|STARTED|Overall Study||9
373572|NCT01103271|895900|P1|STARTED|Overall Study||11
373573|NCT01103232|895909|P2|NOT COMPLETED|Overall Study||2
373574|NCT01103232|895910|P1|NOT COMPLETED|Overall Study||1
373575|NCT01103232|895909|P2|COMPLETED|Overall Study||11
373576|NCT01103232|895910|P1|COMPLETED|Overall Study||12
373577|NCT01103232|895909|P2|STARTED|Overall Study||13
373578|NCT01103232|895910|P1|STARTED|Overall Study||13
373579|NCT01103141|895918|P2|NOT COMPLETED|Overall Study||2
373580|NCT01103141|895919|P1|NOT COMPLETED|Overall Study||2
373581|NCT01103141|895918|P2|COMPLETED|Overall Study||74
373582|NCT01103141|895919|P1|COMPLETED|Overall Study||65
373583|NCT01103141|895918|P2|STARTED|Overall Study||76
373584|NCT01103141|895919|P1|STARTED|Overall Study||67
373585|NCT01103063|895927|P2|NOT COMPLETED|Overall Study||421
373586|NCT01103063|895928|P1|NOT COMPLETED|Overall Study||477
373587|NCT01103063|895927|P2|COMPLETED|Overall Study||1024
373588|NCT01103063|895928|P1|COMPLETED|Overall Study||969
373589|NCT01103063|895927|P2|STARTED|Overall Study||1445
373590|NCT01103063|895928|P1|STARTED|Overall Study||1446
373591|NCT01102972|895996|P2|NOT COMPLETED|Overall Study||14
373592|NCT01102972|895997|P1|NOT COMPLETED|Overall Study||29
373593|NCT01102972|895996|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
373594|NCT01102972|895997|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
373595|NCT01102972|895996|P2|Completed Week 24|Overall Study||88
373596|NCT01102972|895997|P1|Completed Week 24|Overall Study||180
373597|NCT01102972|895996|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
373598|NCT01102972|895997|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
373599|NCT01102894|896049|P1|NOT COMPLETED|Overall Study||0
373600|NCT01102894|896049|P1|COMPLETED|Overall Study||10
373601|NCT01102894|896049|P1|STARTED|Overall Study||10
373602|NCT01102491|896061|P2|NOT COMPLETED|Overall Study||12
373603|NCT01102491|896062|P1|NOT COMPLETED|Overall Study||11
373604|NCT01102491|896061|P2|COMPLETED|Overall Study|12 patients were excluded|59
373605|NCT01102491|896062|P1|COMPLETED|Overall Study|11 patient excluded|60
373606|NCT01102491|896061|P2|STARTED|Overall Study||71
373607|NCT01102491|896062|P1|STARTED|Overall Study||71
373608|NCT01102413|896070|P2|NOT COMPLETED|Overall Study||12
373609|NCT01102413|896071|P1|NOT COMPLETED|Overall Study||25
373610|NCT01102413|896070|P2|COMPLETED|Overall Study||106
373611|NCT01102413|896071|P1|COMPLETED|Overall Study||208
373612|NCT01102413|896070|P2|STARTED|Overall Study||118
373613|NCT01102413|896071|P1|STARTED|Overall Study||233
373614|NCT01102374|896081|P2|NOT COMPLETED|Overall Study||19
373615|NCT01102374|896082|P1|NOT COMPLETED|Overall Study||16
373616|NCT01102374|896081|P2|COMPLETED|Overall Study||33
373617|NCT01102374|896082|P1|COMPLETED|Overall Study||39
373618|NCT01102374|896081|P2|STARTED|Overall Study||52
373619|NCT01102374|896082|P1|STARTED|Overall Study||55
373620|NCT01102270|896116|P2|NOT COMPLETED|Overall Study||0
373621|NCT01102270|896117|P1|NOT COMPLETED|Overall Study||0
373622|NCT01102270|896116|P2|COMPLETED|Overall Study||9
373623|NCT01102270|896117|P1|COMPLETED|Overall Study||8
373624|NCT01102270|896116|P2|STARTED|Overall Study||9
373625|NCT01102270|896117|P1|STARTED|Overall Study||8
373626|NCT01102257|896131|P2|NOT COMPLETED|Overall Study||0
373627|NCT01102257|896132|P1|NOT COMPLETED|Overall Study||2
373628|NCT01102257|896131|P2|COMPLETED|Overall Study||9
373629|NCT01102257|896132|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
373630|NCT01102257|896131|P2|STARTED|Overall Study||9
373631|NCT01102257|896132|P1|STARTED|Overall Study||9
373632|NCT01102218|896140|P2|NOT COMPLETED|Overall Study||10
373633|NCT01102218|896141|P1|NOT COMPLETED|Overall Study||11
373634|NCT01102218|896140|P2|COMPLETED|Overall Study||14
373635|NCT01102218|896141|P1|COMPLETED|Overall Study||13
373636|NCT01102218|896140|P2|STARTED|Overall Study||24
373637|NCT01102218|896141|P1|STARTED|Overall Study||24
373638|NCT01101971|896147|P1|NOT COMPLETED|Overall Study||0
373639|NCT01101971|896147|P1|COMPLETED|Overall Study||45
373640|NCT01101971|896147|P1|STARTED|Overall Study||45
373641|NCT01101958|896153|P2|NOT COMPLETED|Overall Study||5
373642|NCT01101958|896154|P1|NOT COMPLETED|Overall Study||11
373643|NCT01101958|896153|P2|COMPLETED|Overall Study||29
373644|NCT01101958|896154|P1|COMPLETED|Overall Study||51
373645|NCT01101958|896153|P2|STARTED|Overall Study||34
373646|NCT01101958|896154|P1|STARTED|Overall Study||62
373647|NCT01101867|896162|P2|NOT COMPLETED|Overall Study||4
373648|NCT01101867|896163|P1|NOT COMPLETED|Overall Study||1
373649|NCT01101867|896162|P2|COMPLETED|Overall Study||59
373650|NCT01101867|896163|P1|COMPLETED|Overall Study||62
373651|NCT01101867|896162|P2|STARTED|Overall Study||63
373652|NCT01101867|896163|P1|STARTED|Overall Study||63
373653|NCT01101841|896175|P2|NOT COMPLETED|Overall Study||67
373654|NCT01101841|896176|P1|NOT COMPLETED|Overall Study||50
373655|NCT01101841|896175|P2|COMPLETED|Overall Study||218
373656|NCT01101841|896176|P1|COMPLETED|Overall Study||235
373657|NCT01101841|896175|P2|STARTED|Overall Study||285
373658|NCT01101841|896176|P1|STARTED|Overall Study||285
373659|NCT01101542|896214|P1|NOT COMPLETED|Year 6 Surveillance Period||991
373660|NCT01101542|896214|P1|COMPLETED|Year 6 Surveillance Period||2100
373661|NCT01101542|896214|P1|STARTED|Year 6 Surveillance Period||3091
373662|NCT01101542|896214|P1|NOT COMPLETED|Year 5 Surveillance Period||141
373663|NCT01101542|896214|P1|COMPLETED|Year 5 Surveillance Period||668
373664|NCT01101542|896214|P1|STARTED|Year 5 Surveillance Period||809
373665|NCT01101542|896214|P1|NOT COMPLETED|Year 4 Surveillance Period||287
373666|NCT01101542|896214|P1|COMPLETED|Year 4 Surveillance Period||282
373667|NCT01101542|896214|P1|STARTED|Year 4 Surveillance Period||569
373668|NCT01101542|896214|P1|NOT COMPLETED|Year 3 Surveillance Period||11
373669|NCT01101542|896214|P1|COMPLETED|Year 3 Surveillance Period||94
373670|NCT01101542|896214|P1|STARTED|Year 3 Surveillance Period||105
373671|NCT01101477|896233|P3|NOT COMPLETED|Overall Study||1
373672|NCT01101477|896234|P2|NOT COMPLETED|Overall Study||3
373673|NCT01101477|896235|P1|NOT COMPLETED|Overall Study||5
373674|NCT01101477|896233|P3|COMPLETED|Overall Study||45
373675|NCT01101477|896234|P2|COMPLETED|Overall Study||46
373676|NCT01101477|896235|P1|COMPLETED|Overall Study||44
373677|NCT01101477|896233|P3|STARTED|Overall Study||46
373678|NCT01101477|896234|P2|STARTED|Overall Study||49
373679|NCT01101477|896235|P1|STARTED|Overall Study||49
373680|NCT01101464|896245|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
373681|NCT01101464|896246|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
373682|NCT01101464|896245|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
373683|NCT01101464|896246|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
373684|NCT01101464|896245|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
373685|NCT01101464|896246|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
373686|NCT01101464|896245|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
373687|NCT01101464|896246|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
373688|NCT01101464|896245|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
373689|NCT01101464|896246|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
373690|NCT01101464|896245|P2|STARTED|Day 1 Through AM Dose of Day 5||4
373691|NCT01101464|896246|P1|STARTED|Day 1 Through AM Dose of Day 5||4
373692|NCT01101321|896256|P2|NOT COMPLETED|Period 2||0
373693|NCT01101321|896257|P1|NOT COMPLETED|Period 2||0
373694|NCT01101321|896256|P2|COMPLETED|Period 2||24
373695|NCT01101321|896257|P1|COMPLETED|Period 2||26
373696|NCT01101321|896256|P2|STARTED|Period 2||24
373697|NCT01101321|896257|P1|STARTED|Period 2||26
373698|NCT01101321|896256|P2|NOT COMPLETED|Period 1||4
373699|NCT01101321|896257|P1|NOT COMPLETED|Period 1||4
373700|NCT01101321|896256|P2|COMPLETED|Period 1||24
373701|NCT01101321|896257|P1|COMPLETED|Period 1||26
373702|NCT01101321|896256|P2|STARTED|Period 1||28
373703|NCT01101321|896257|P1|STARTED|Period 1||30
373704|NCT01101308|896267|P2|NOT COMPLETED|Period 2||0
373705|NCT01101308|896268|P1|NOT COMPLETED|Period 2||0
373706|NCT01101308|896267|P2|COMPLETED|Period 2||27
373707|NCT01101308|896268|P1|COMPLETED|Period 2||24
373708|NCT01101308|896267|P2|STARTED|Period 2||27
373709|NCT01101308|896268|P1|STARTED|Period 2||24
373710|NCT01101308|896267|P2|NOT COMPLETED|Period 1||1
373711|NCT01101308|896268|P1|NOT COMPLETED|Period 1||3
373712|NCT01101308|896267|P2|COMPLETED|Period 1||27
373713|NCT01101308|896268|P1|COMPLETED|Period 1||24
373714|NCT01101308|896267|P2|STARTED|Period 1||28
373715|NCT01101308|896268|P1|STARTED|Period 1||27
373716|NCT01101191|896279|P2|NOT COMPLETED|Period 2||0
373717|NCT01101191|896280|P1|NOT COMPLETED|Period 2||0
373718|NCT01101191|896279|P2|COMPLETED|Period 2||40
373719|NCT01101191|896280|P1|COMPLETED|Period 2||40
373720|NCT01101191|896279|P2|STARTED|Period 2||40
373721|NCT01101191|896280|P1|STARTED|Period 2||40
373722|NCT01101191|896279|P2|NOT COMPLETED|Period 1||2
373723|NCT01101191|896280|P1|NOT COMPLETED|Period 1||2
373724|NCT01101191|896279|P2|COMPLETED|Period 1||40
373725|NCT01101191|896280|P1|COMPLETED|Period 1||40
373726|NCT01101191|896279|P2|STARTED|Period 1||42
373727|NCT01101191|896280|P1|STARTED|Period 1||42
373728|NCT01101178|896291|P2|NOT COMPLETED|Period 2||1
373729|NCT01101178|896292|P1|NOT COMPLETED|Period 2||0
373730|NCT01101178|896291|P2|COMPLETED|Period 2||34
373731|NCT01101178|896292|P1|COMPLETED|Period 2||36
373732|NCT01101178|896291|P2|STARTED|Period 2||35
373733|NCT01101178|896292|P1|STARTED|Period 2||36
373734|NCT01101178|896291|P2|NOT COMPLETED|Period 1||4
373735|NCT01101178|896292|P1|NOT COMPLETED|Period 1||4
373736|NCT01101178|896291|P2|COMPLETED|Period 1||35
373737|NCT01101178|896292|P1|COMPLETED|Period 1||36
373738|NCT01101178|896291|P2|STARTED|Period 1||39
373739|NCT01101178|896292|P1|STARTED|Period 1||40
373740|NCT01101165|896303|P2|NOT COMPLETED|Period 2||1
373741|NCT01101165|896304|P1|NOT COMPLETED|Period 2||4
373742|NCT01101165|896303|P2|COMPLETED|Period 2||39
373743|NCT01101165|896304|P1|COMPLETED|Period 2||41
373744|NCT01101165|896303|P2|STARTED|Period 2||40
373745|NCT01101165|896304|P1|STARTED|Period 2||45
373746|NCT01101165|896303|P2|NOT COMPLETED|Period 1||5
373747|NCT01101165|896304|P1|NOT COMPLETED|Period 1||2
373748|NCT01101165|896303|P2|COMPLETED|Period 1||40
373749|NCT01101165|896304|P1|COMPLETED|Period 1||45
373750|NCT01101165|896303|P2|STARTED|Period 1||45
373751|NCT01101165|896304|P1|STARTED|Period 1||47
373752|NCT01101022|896316|P2|NOT COMPLETED|Overall Study||27
373753|NCT01101022|896317|P1|NOT COMPLETED|Overall Study||17
373754|NCT01101022|896316|P2|COMPLETED|Overall Study||53
373755|NCT01101022|896317|P1|COMPLETED|Overall Study||62
373756|NCT01101022|896316|P2|STARTED|Overall Study||80
373757|NCT01101022|896317|P1|STARTED|Overall Study||79
373758|NCT01100944|896351|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
373759|NCT01100944|896352|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
373760|NCT01100944|896353|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
373761|NCT01100944|896351|P3|COMPLETED|Expansion Phase - Phase 2||18
373762|NCT01100944|896352|P2|COMPLETED|Expansion Phase - Phase 2||0
373763|NCT01100944|896353|P1|COMPLETED|Expansion Phase - Phase 2||0
373764|NCT01100944|896351|P3|STARTED|Expansion Phase - Phase 2||18
373765|NCT01100944|896352|P2|STARTED|Expansion Phase - Phase 2||0
373766|NCT01100944|896353|P1|STARTED|Expansion Phase - Phase 2||0
373767|NCT01100944|896351|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
373768|NCT01100944|896352|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
373769|NCT01100944|896353|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
373770|NCT01100944|896351|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
373771|NCT01100944|896352|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
373772|NCT01100944|896353|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
373773|NCT01100944|896351|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
373774|NCT01100944|896352|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
373775|NCT01100944|896353|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
373776|NCT01100944|896351|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
373777|NCT01100944|896352|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
373778|NCT01100944|896353|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
373779|NCT01100944|896351|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
373780|NCT01100944|896352|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
373781|NCT01100944|896353|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
373782|NCT01100944|896351|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
373783|NCT01100944|896352|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
373784|NCT01100944|896353|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
373785|NCT01100931|896400|P2|NOT COMPLETED|Phase II||0
373786|NCT01100931|896401|P1|NOT COMPLETED|Phase II||0
373787|NCT01100931|896400|P2|COMPLETED|Phase II||19
373788|NCT01100931|896401|P1|COMPLETED|Phase II||0
373789|NCT01100931|896400|P2|STARTED|Phase II||19
373790|NCT01100931|896401|P1|STARTED|Phase II||0
373791|NCT01100931|896400|P2|NOT COMPLETED|Phase I||0
373792|NCT01100931|896401|P1|NOT COMPLETED|Phase I||0
373793|NCT01100931|896400|P2|COMPLETED|Phase I||0
373794|NCT01100931|896401|P1|COMPLETED|Phase I||22
373795|NCT01100931|896400|P2|STARTED|Phase I||0
373796|NCT01100931|896401|P1|STARTED|Phase I||22
373797|NCT01100853|896411|P2|NOT COMPLETED|Overall Study||23
373798|NCT01100853|896412|P1|NOT COMPLETED|Overall Study||27
373799|NCT01100853|896411|P2|COMPLETED|Overall Study||26
373800|NCT01100853|896412|P1|COMPLETED|Overall Study||24
373801|NCT01100853|896411|P2|STARTED|Overall Study||49
373802|NCT01100853|896412|P1|STARTED|Overall Study||51
373803|NCT01100762|896428|P1|NOT COMPLETED|Overall Study||0
373804|NCT01100762|896428|P1|COMPLETED|Overall Study||10
373805|NCT01100762|896428|P1|STARTED|Overall Study||10
373806|NCT01100723|896449|P1|NOT COMPLETED|Overall Study||14
373807|NCT01100723|896449|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
373808|NCT01100723|896449|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
373809|NCT01100723|896449|P1|STARTED|Overall Study||92
373810|NCT01100658|896458|P1|NOT COMPLETED|Overall Study||1
373811|NCT01100658|896458|P1|COMPLETED|Overall Study||0
373812|NCT01100658|896458|P1|STARTED|Overall Study||1
373813|NCT01100606|896463|P2|NOT COMPLETED|Second Treatment Period||0
373814|NCT01100606|896464|P1|NOT COMPLETED|Second Treatment Period||0
373815|NCT01100606|896463|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
373816|NCT01100606|896464|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
373817|NCT01100606|896463|P2|STARTED|Second Treatment Period||7
373818|NCT01100606|896464|P1|STARTED|Second Treatment Period||8
373819|NCT01100606|896463|P2|NOT COMPLETED|First Treatment Period||0
373820|NCT01100606|896464|P1|NOT COMPLETED|First Treatment Period||0
373821|NCT01100606|896463|P2|COMPLETED|First Treatment Period||7
373822|NCT01100606|896464|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
373823|NCT01100606|896463|P2|STARTED|First Treatment Period||7
373824|NCT01100606|896464|P1|STARTED|First Treatment Period||8
373825|NCT01100567|896490|P2|NOT COMPLETED|Overall Study||16
373826|NCT01100567|896491|P1|NOT COMPLETED|Overall Study||12
373827|NCT01100567|896490|P2|COMPLETED|Overall Study||35
373828|NCT01100567|896491|P1|COMPLETED|Overall Study||38
373829|NCT01100567|896490|P2|STARTED|Overall Study||51
373830|NCT01100567|896491|P1|STARTED|Overall Study||50
373831|NCT01100502|896501|P2|NOT COMPLETED|Long-Term Follow-up||139
373832|NCT01100502|896502|P1|NOT COMPLETED|Long-Term Follow-up||137
373833|NCT01100502|896501|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
373834|NCT01100502|896502|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
373835|NCT01100502|896501|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
373836|NCT01100502|896502|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
373837|NCT01100502|896501|P2|NOT COMPLETED|Treatment Period||83
373838|NCT01100502|896502|P1|NOT COMPLETED|Treatment Period||87
373839|NCT01100502|896501|P2|COMPLETED|Treatment Period||81
373840|NCT01100502|896502|P1|COMPLETED|Treatment Period||78
373841|NCT01100502|896501|P2|STARTED|Treatment Period||164
373842|NCT01100502|896502|P1|STARTED|Treatment Period||165
373843|NCT01100437|896512|P3|NOT COMPLETED|Treatment 2||0
373844|NCT01100437|896513|P2|NOT COMPLETED|Treatment 2||0
373845|NCT01100437|896514|P1|NOT COMPLETED|Treatment 2||0
373846|NCT01100437|896512|P3|COMPLETED|Treatment 2||0
373847|NCT01100437|896513|P2|COMPLETED|Treatment 2||2
373848|NCT01100437|896514|P1|COMPLETED|Treatment 2||4
373849|NCT01100437|896512|P3|STARTED|Treatment 2||0
373850|NCT01100437|896513|P2|STARTED|Treatment 2||2
373851|NCT01100437|896514|P1|STARTED|Treatment 2||4
373852|NCT01100437|896512|P3|NOT COMPLETED|Washout (4 Days)||0
373853|NCT01100437|896513|P2|NOT COMPLETED|Washout (4 Days)||0
373854|NCT01100437|896514|P1|NOT COMPLETED|Washout (4 Days)||0
373855|NCT01100437|896512|P3|COMPLETED|Washout (4 Days)||0
373856|NCT01100437|896513|P2|COMPLETED|Washout (4 Days)||2
373857|NCT01100437|896514|P1|COMPLETED|Washout (4 Days)||4
373858|NCT01100437|896512|P3|STARTED|Washout (4 Days)||0
373859|NCT01100437|896513|P2|STARTED|Washout (4 Days)||2
373860|NCT01100437|896514|P1|STARTED|Washout (4 Days)||4
373861|NCT01100437|896512|P3|NOT COMPLETED|Treatment 1||0
373862|NCT01100437|896513|P2|NOT COMPLETED|Treatment 1||0
373863|NCT01100437|896514|P1|NOT COMPLETED|Treatment 1||0
373864|NCT01100437|896512|P3|COMPLETED|Treatment 1||0
373865|NCT01100437|896513|P2|COMPLETED|Treatment 1||2
373866|NCT01100437|896514|P1|COMPLETED|Treatment 1||4
373867|NCT01100437|896512|P3|STARTED|Treatment 1||0
373868|NCT01100437|896513|P2|STARTED|Treatment 1||2
373869|NCT01100437|896514|P1|STARTED|Treatment 1||4
373870|NCT01100437|896512|P3|NOT COMPLETED|Maintenance||2
373871|NCT01100437|896513|P2|NOT COMPLETED|Maintenance||0
373872|NCT01100437|896514|P1|NOT COMPLETED|Maintenance||0
373873|NCT01100437|896512|P3|COMPLETED|Maintenance||0
373874|NCT01100437|896513|P2|COMPLETED|Maintenance||2
373875|NCT01100437|896514|P1|COMPLETED|Maintenance||4
373876|NCT01100437|896512|P3|STARTED|Maintenance||2
373877|NCT01100437|896513|P2|STARTED|Maintenance||2
373878|NCT01100437|896514|P1|STARTED|Maintenance||4
373879|NCT01100437|896512|P3|NOT COMPLETED|Titration/Stabilization||6
373880|NCT01100437|896513|P2|NOT COMPLETED|Titration/Stabilization||0
373881|NCT01100437|896514|P1|NOT COMPLETED|Titration/Stabilization||0
373882|NCT01100437|896512|P3|COMPLETED|Titration/Stabilization||2
373883|NCT01100437|896513|P2|COMPLETED|Titration/Stabilization||2
373884|NCT01100437|896514|P1|COMPLETED|Titration/Stabilization||4
373885|NCT01100437|896512|P3|STARTED|Titration/Stabilization||8
373886|NCT01100437|896513|P2|STARTED|Titration/Stabilization||2
373887|NCT01100437|896514|P1|STARTED|Titration/Stabilization||4
373888|NCT01100437|896512|P3|NOT COMPLETED|Screening||0
373889|NCT01100437|896513|P2|NOT COMPLETED|Screening||0
373890|NCT01100437|896514|P1|NOT COMPLETED|Screening||0
373891|NCT01100437|896512|P3|COMPLETED|Screening||8
373892|NCT01100437|896513|P2|COMPLETED|Screening||2
373893|NCT01100437|896514|P1|COMPLETED|Screening||4
373894|NCT01100437|896512|P3|STARTED|Screening||8
373895|NCT01100437|896513|P2|STARTED|Screening||2
373896|NCT01100437|896514|P1|STARTED|Screening||4
373897|NCT01100320|896551|P2|NOT COMPLETED|Period 2||1
373898|NCT01100320|896552|P1|NOT COMPLETED|Period 2||1
373899|NCT01100320|896551|P2|COMPLETED|Period 2||37
373900|NCT01100320|896552|P1|COMPLETED|Period 2||37
373901|NCT01100320|896551|P2|STARTED|Period 2||38
373902|NCT01100320|896552|P1|STARTED|Period 2||38
373903|NCT01100320|896551|P2|NOT COMPLETED|Period 1||7
373904|NCT01100320|896552|P1|NOT COMPLETED|Period 1||5
373905|NCT01100320|896551|P2|COMPLETED|Period 1||38
373906|NCT01100320|896552|P1|COMPLETED|Period 1||38
373907|NCT01100320|896551|P2|STARTED|Period 1||45
373908|NCT01100320|896552|P1|STARTED|Period 1||43
373909|NCT01100307|896564|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
373910|NCT01100307|896565|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
373911|NCT01100307|896564|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
373912|NCT01100307|896565|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
373913|NCT01100307|896564|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
373914|NCT01100307|896565|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
373915|NCT01100307|896564|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
373916|NCT01100307|896565|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
373917|NCT01100307|896564|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
373918|NCT01100307|896565|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
373919|NCT01100307|896564|P2|STARTED|Double Masked Phase (Up to Week 24)||120
373920|NCT01100307|896565|P1|STARTED|Double Masked Phase (Up to Week 24)||123
373921|NCT01100268|896607|P1|NOT COMPLETED|Overall Study||0
373922|NCT01100268|896607|P1|COMPLETED|Overall Study||4
373923|NCT01100268|896607|P1|STARTED|Overall Study||4
373924|NCT01100255|896614|P2|NOT COMPLETED|Overall Study||0
373925|NCT01100255|896615|P1|NOT COMPLETED|Overall Study||0
373926|NCT01100255|896614|P2|COMPLETED|Overall Study||7
373927|NCT01100255|896615|P1|COMPLETED|Overall Study||8
373928|NCT01100255|896614|P2|STARTED|Overall Study||7
373929|NCT01100255|896615|P1|STARTED|Overall Study||8
373930|NCT01100242|896621|P1|NOT COMPLETED|Overall Study||0
373931|NCT01100242|896621|P1|COMPLETED|Overall Study||17
373932|NCT01100242|896621|P1|STARTED|Overall Study||17
373933|NCT01100112|896627|P1|NOT COMPLETED|Overall Study||8
373934|NCT01100112|896627|P1|COMPLETED|Overall Study||52
373935|NCT01100112|896627|P1|STARTED|Overall Study||60
373936|NCT01100086|896634|P2|NOT COMPLETED|Period 2||0
373937|NCT01100086|896635|P1|NOT COMPLETED|Period 2||0
373938|NCT01100086|896634|P2|COMPLETED|Period 2||41
373939|NCT01100086|896635|P1|COMPLETED|Period 2||42
373940|NCT01100086|896634|P2|STARTED|Period 2||41
373941|NCT01100086|896635|P1|STARTED|Period 2||42
373942|NCT01100086|896634|P2|NOT COMPLETED|Period 1||0
373943|NCT01100086|896635|P1|NOT COMPLETED|Period 1||1
373944|NCT01100086|896634|P2|COMPLETED|Period 1||41
373945|NCT01100086|896635|P1|COMPLETED|Period 1||42
373946|NCT01100086|896634|P2|STARTED|Period 1||41
373947|NCT01100086|896635|P1|STARTED|Period 1||43
373948|NCT01100073|896645|P1|NOT COMPLETED|Overall Study||100
373949|NCT01100073|896645|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
373950|NCT01100073|896645|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
373951|NCT01099917|896660|P1|NOT COMPLETED|Overall Study||27
373952|NCT01099917|896660|P1|COMPLETED|Overall Study||18
373953|NCT01099917|896660|P1|STARTED|Overall Study||45
373954|NCT01099774|896666|P2|NOT COMPLETED|Overall Study||6
373955|NCT01099774|896667|P1|NOT COMPLETED|Overall Study||6
373956|NCT01099774|896666|P2|COMPLETED|Overall Study||289
373957|NCT01099774|896667|P1|COMPLETED|Overall Study||296
373958|NCT01099774|896666|P2|STARTED|Overall Study||295
373959|NCT01099774|896667|P1|STARTED|Overall Study||302
373960|NCT01099761|896683|P4|NOT COMPLETED|Overall Study||0
373961|NCT01099761|896684|P3|NOT COMPLETED|Overall Study||0
373962|NCT01099761|896685|P2|NOT COMPLETED|Overall Study||0
373963|NCT01099761|896686|P1|NOT COMPLETED|Overall Study||0
373964|NCT01099761|896683|P4|COMPLETED|Overall Study||6
373965|NCT01099761|896684|P3|COMPLETED|Overall Study||0
373966|NCT01099761|896685|P2|COMPLETED|Overall Study||9
373967|NCT01099761|896686|P1|COMPLETED|Overall Study||9
373968|NCT01099761|896683|P4|STARTED|Overall Study||6
373969|NCT01099761|896684|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
373970|NCT01099761|896685|P2|STARTED|Overall Study||9
373971|NCT01099761|896686|P1|STARTED|Overall Study||9
373972|NCT01099709|896722|P2|NOT COMPLETED|Period 2||0
373973|NCT01099709|896723|P1|NOT COMPLETED|Period 2||0
373974|NCT01099709|896722|P2|COMPLETED|Period 2||41
373975|NCT01099709|896723|P1|COMPLETED|Period 2||41
373976|NCT01099709|896722|P2|STARTED|Period 2||41
373977|NCT01099709|896723|P1|STARTED|Period 2||41
373978|NCT01099709|896722|P2|NOT COMPLETED|Period 1||2
373979|NCT01099709|896723|P1|NOT COMPLETED|Period 1||1
373980|NCT01099709|896722|P2|COMPLETED|Period 1||41
373981|NCT01099709|896723|P1|COMPLETED|Period 1||41
373982|NCT01099709|896722|P2|STARTED|Period 1||43
373983|NCT01099709|896723|P1|STARTED|Period 1||42
373984|NCT01099618|896736|P3|NOT COMPLETED|Overall Study||0
373985|NCT01099618|896737|P2|NOT COMPLETED|Overall Study||0
373986|NCT01099618|896738|P1|NOT COMPLETED|Overall Study||0
373987|NCT01099618|896736|P3|COMPLETED|Overall Study||15
373988|NCT01099618|896737|P2|COMPLETED|Overall Study||16
373989|NCT01099618|896738|P1|COMPLETED|Overall Study||17
373990|NCT01099618|896736|P3|STARTED|Overall Study||15
373991|NCT01099618|896737|P2|STARTED|Overall Study||16
373992|NCT01099618|896738|P1|STARTED|Overall Study||17
373993|NCT01099579|896749|P3|NOT COMPLETED|Stage 2 (ATV Capsules )||15
373994|NCT01099579|896750|P2|NOT COMPLETED|Stage 2 (ATV Capsules )||14
373995|NCT01099579|896751|P1|NOT COMPLETED|Stage 2 (ATV Capsules )||16
373996|NCT01099579|896749|P3|COMPLETED|Stage 2 (ATV Capsules )||0
373997|NCT01099579|896750|P2|COMPLETED|Stage 2 (ATV Capsules )||0
373998|NCT01099579|896751|P1|COMPLETED|Stage 2 (ATV Capsules )||0
373999|NCT01099579|896749|P3|STARTED|Stage 2 (ATV Capsules )||15
374000|NCT01099579|896750|P2|STARTED|Stage 2 (ATV Capsules )||14
374001|NCT01099579|896751|P1|STARTED|Stage 2 (ATV Capsules )||16
374002|NCT01099579|896749|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
374003|NCT01099579|896750|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
374004|NCT01099579|896751|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
374005|NCT01099579|896749|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
374006|NCT01099579|896750|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
374007|NCT01099579|896751|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
374008|NCT01099579|896749|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
374009|NCT01099579|896750|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
374010|NCT01099579|896751|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
374011|NCT01099475|896807|P2|NOT COMPLETED|Overall Study||0
374012|NCT01099475|896808|P1|NOT COMPLETED|Overall Study||0
374013|NCT01099475|896807|P2|COMPLETED|Overall Study||10
374014|NCT01099475|896808|P1|COMPLETED|Overall Study||10
374015|NCT01099475|896807|P2|STARTED|Overall Study||10
374016|NCT01099475|896808|P1|STARTED|Overall Study||10
374017|NCT01099397|896820|P1|NOT COMPLETED|Overall Study||13
374018|NCT01099397|896820|P1|COMPLETED|Overall Study||26
374019|NCT01099397|896820|P1|STARTED|Overall Study||39
374020|NCT01099358|896825|P4|NOT COMPLETED|Overall Study||4
374021|NCT01099358|896826|P3|NOT COMPLETED|Overall Study||8
374022|NCT01099358|896827|P2|NOT COMPLETED|Overall Study||1
374023|NCT01099358|896828|P1|NOT COMPLETED|Overall Study||3
374024|NCT01099358|896825|P4|COMPLETED|Overall Study||12
374025|NCT01099358|896826|P3|COMPLETED|Overall Study||13
374026|NCT01099358|896827|P2|COMPLETED|Overall Study||5
374027|NCT01099358|896828|P1|COMPLETED|Overall Study||1
374028|NCT01099358|896825|P4|Received at Least One Dose of Study Drug|Overall Study||15
374029|NCT01099358|896826|P3|Received at Least One Dose of Study Drug|Overall Study||20
374030|NCT01099358|896827|P2|Received at Least One Dose of Study Drug|Overall Study||6
374031|NCT01099358|896828|P1|Received at Least One Dose of Study Drug|Overall Study||3
374032|NCT01099358|896825|P4|STARTED|Overall Study||16
374033|NCT01099358|896826|P3|STARTED|Overall Study||21
374034|NCT01099358|896827|P2|STARTED|Overall Study||6
374035|NCT01099358|896828|P1|STARTED|Overall Study||4
374036|NCT01099267|896847|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
374037|NCT01099267|896847|P1|COMPLETED|MDS-009 Extension Follow-up||54
374038|NCT01099267|896847|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
374039|NCT01099267|896847|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
374040|NCT01099267|896847|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
374041|NCT01099267|896847|P1|NOT COMPLETED|MDS-003 Study||124
374042|NCT01099267|896847|P1|COMPLETED|MDS-003 Study||24
374043|NCT01099267|896847|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
374044|NCT01099215|896857|P2|NOT COMPLETED|Overall Study||1
374045|NCT01099215|896858|P1|NOT COMPLETED|Overall Study||1
374046|NCT01099215|896857|P2|COMPLETED|Overall Study||9
374047|NCT01099215|896858|P1|COMPLETED|Overall Study||10
374048|NCT01099215|896857|P2|STARTED|Overall Study||10
374049|NCT01099215|896858|P1|STARTED|Overall Study||11
374050|NCT01099202|896896|P2|NOT COMPLETED|Overall Study||0
374051|NCT01099202|896897|P1|NOT COMPLETED|Overall Study||0
374052|NCT01099202|896896|P2|COMPLETED|Overall Study||54
374053|NCT01099202|896897|P1|COMPLETED|Overall Study||55
374054|NCT01099202|896896|P2|STARTED|Overall Study||54
374055|NCT01099202|896897|P1|STARTED|Overall Study||55
374056|NCT01099111|896910|P5|NOT COMPLETED|Overall Study||0
374057|NCT01099111|896911|P4|NOT COMPLETED|Overall Study||0
374058|NCT01099111|896912|P3|NOT COMPLETED|Overall Study||0
374059|NCT01099111|896913|P2|NOT COMPLETED|Overall Study||0
374060|NCT01099111|896914|P1|NOT COMPLETED|Overall Study||0
374061|NCT01099111|896910|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
374062|NCT01099111|896911|P4|COMPLETED|Overall Study||29
374063|NCT01099111|896912|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
374064|NCT01099111|896913|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
374065|NCT01099111|896914|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
374066|NCT01099111|896910|P5|STARTED|Overall Study||50
374067|NCT01099111|896911|P4|STARTED|Overall Study||29
374068|NCT01099111|896912|P3|STARTED|Overall Study||46
374069|NCT01099111|896913|P2|STARTED|Overall Study||50
374070|NCT01099111|896914|P1|STARTED|Overall Study||50
374071|NCT01098851|896928|P2|NOT COMPLETED|Overall Study||0
374072|NCT01098851|896929|P1|NOT COMPLETED|Overall Study||1
374073|NCT01098851|896928|P2|COMPLETED|Overall Study||10
374074|NCT01098851|896929|P1|COMPLETED|Overall Study||10
374075|NCT01098851|896928|P2|STARTED|Overall Study||10
374076|NCT01098851|896929|P1|STARTED|Overall Study||11
374077|NCT01098812|896940|P3|NOT COMPLETED|Overall Study||1
374078|NCT01098812|896941|P2|NOT COMPLETED|Overall Study||1
374079|NCT01098812|896942|P1|NOT COMPLETED|Overall Study||2
374080|NCT01098812|896940|P3|COMPLETED|Overall Study||71
374081|NCT01098812|896941|P2|COMPLETED|Overall Study||101
374082|NCT01098812|896942|P1|COMPLETED|Overall Study||93
374083|NCT01098812|896940|P3|STARTED|Overall Study||72
374084|NCT01098812|896941|P2|STARTED|Overall Study||102
374085|NCT01098812|896942|P1|STARTED|Overall Study||95
374086|NCT01098747|896956|P4|NOT COMPLETED|Overall Study||0
374087|NCT01098747|896957|P3|NOT COMPLETED|Overall Study||0
374088|NCT01098747|896958|P2|NOT COMPLETED|Overall Study||0
374089|NCT01098747|896959|P1|NOT COMPLETED|Overall Study||0
374090|NCT01098747|896956|P4|COMPLETED|Overall Study||87
374091|NCT01098747|896957|P3|COMPLETED|Overall Study||86
374092|NCT01098747|896958|P2|COMPLETED|Overall Study||95
374093|NCT01098747|896959|P1|COMPLETED|Overall Study||48
374094|NCT01098747|896956|P4|STARTED|Overall Study||87
374095|NCT01098747|896957|P3|STARTED|Overall Study||86
374096|NCT01098747|896958|P2|STARTED|Overall Study||95
374097|NCT01098747|896959|P1|STARTED|Overall Study||48
374098|NCT01098578|897009|P1|NOT COMPLETED|Overall Study||0
374099|NCT01098578|897009|P1|COMPLETED|Overall Study||20
374100|NCT01098578|897009|P1|STARTED|Overall Study||20
374101|NCT01098539|897018|P2|NOT COMPLETED|Overall Study||68
374102|NCT01098539|897019|P1|NOT COMPLETED|Overall Study||51
374103|NCT01098539|897018|P2|COMPLETED|Overall Study||178
374104|NCT01098539|897019|P1|COMPLETED|Overall Study||198
374105|NCT01098539|897018|P2|STARTED|Overall Study||246
374106|NCT01098539|897019|P1|STARTED|Overall Study||249
374107|NCT01098500|897055|P1|NOT COMPLETED|Overall Study||0
374108|NCT01098500|897055|P1|COMPLETED|Overall Study||3800
374109|NCT01098500|897055|P1|STARTED|Overall Study||3800
374110|NCT01098487|897070|P1|NOT COMPLETED|Overall Study||44
374111|NCT01098487|897070|P1|COMPLETED|Overall Study||118
374112|NCT01098487|897070|P1|STARTED|Overall Study||162
374113|NCT01098461|897086|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
374114|NCT01098461|897087|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
374115|NCT01098461|897088|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
374116|NCT01098461|897089|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
374117|NCT01098461|897086|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
374118|NCT01098461|897087|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
374119|NCT01098461|897088|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
374120|NCT01098461|897089|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
374121|NCT01098461|897086|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
374122|NCT01098461|897087|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
374123|NCT01098461|897088|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
374124|NCT01098461|897089|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
374125|NCT01098461|897086|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
374126|NCT01098461|897087|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
374127|NCT01098461|897088|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
374128|NCT01098461|897089|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
374129|NCT01098461|897086|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
374130|NCT01098461|897087|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
374131|NCT01098461|897088|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
374132|NCT01098461|897089|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
374133|NCT01098461|897086|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
374134|NCT01098461|897087|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
374135|NCT01098461|897088|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
374136|NCT01098461|897089|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
374137|NCT01098318|897122|P3|NOT COMPLETED|Overall Study||3
374138|NCT01098318|897123|P2|NOT COMPLETED|Overall Study||7
374139|NCT01098318|897124|P1|NOT COMPLETED|Overall Study||3
374140|NCT01098318|897122|P3|COMPLETED|Overall Study||15
374141|NCT01098318|897123|P2|COMPLETED|Overall Study||12
374142|NCT01098318|897124|P1|COMPLETED|Overall Study||17
374143|NCT01098318|897122|P3|STARTED|Overall Study||18
374144|NCT01098318|897123|P2|STARTED|Overall Study||19
374145|NCT01098318|897124|P1|STARTED|Overall Study||20
374146|NCT01098305|897134|P2|NOT COMPLETED|Overall Study||33
374147|NCT01098305|897135|P1|NOT COMPLETED|Overall Study||31
374148|NCT01098305|897134|P2|COMPLETED|Overall Study||85
374149|NCT01098305|897135|P1|COMPLETED|Overall Study||88
374150|NCT01098305|897134|P2|STARTED|Overall Study||118
374151|NCT01098305|897135|P1|STARTED|Overall Study||119
374152|NCT01098253|897145|P2|NOT COMPLETED|Overall Study||0
374153|NCT01098253|897146|P1|NOT COMPLETED|Overall Study||2
374154|NCT01098253|897145|P2|COMPLETED|Overall Study||88
374155|NCT01098253|897146|P1|COMPLETED|Overall Study||92
374156|NCT01098253|897145|P2|STARTED|Overall Study||88
374157|NCT01098253|897146|P1|STARTED|Overall Study||94
374158|NCT01098240|897154|P3|NOT COMPLETED|Double-Blind Phase||22
374159|NCT01098240|897155|P2|NOT COMPLETED|Double-Blind Phase||17
374160|NCT01098240|897156|P1|NOT COMPLETED|Double-Blind Phase||0
374161|NCT01098240|897154|P3|COMPLETED|Double-Blind Phase||63
374162|NCT01098240|897155|P2|COMPLETED|Double-Blind Phase||60
374163|NCT01098240|897156|P1|COMPLETED|Double-Blind Phase||0
374164|NCT01098240|897154|P3|STARTED|Double-Blind Phase||85
374165|NCT01098240|897155|P2|STARTED|Double-Blind Phase||77
374166|NCT01098240|897156|P1|STARTED|Double-Blind Phase||0
374167|NCT01098240|897154|P3|NOT COMPLETED|Open-Label Phase||0
374168|NCT01098240|897155|P2|NOT COMPLETED|Open-Label Phase||0
374169|NCT01098240|897156|P1|NOT COMPLETED|Open-Label Phase||135
374170|NCT01098240|897154|P3|COMPLETED|Open-Label Phase||0
374171|NCT01098240|897155|P2|COMPLETED|Open-Label Phase||0
374172|NCT01098240|897156|P1|COMPLETED|Open-Label Phase||162
374173|NCT01098240|897154|P3|STARTED|Open-Label Phase||0
374174|NCT01098240|897155|P2|STARTED|Open-Label Phase||0
374175|NCT01098240|897156|P1|STARTED|Open-Label Phase||297
374176|NCT01098162|897186|P1|NOT COMPLETED|Overall Study||112
374177|NCT01098162|897186|P1|COMPLETED|Overall Study||461
374178|NCT01098162|897186|P1|STARTED|Overall Study||573
374179|NCT01098110|897198|P3|NOT COMPLETED|Overall Study||94
374180|NCT01098110|897199|P2|NOT COMPLETED|Overall Study||73
374181|NCT01098110|897200|P1|NOT COMPLETED|Overall Study||62
374182|NCT01098110|897198|P3|COMPLETED|Overall Study||80
374183|NCT01098110|897199|P2|COMPLETED|Overall Study||109
374184|NCT01098110|897200|P1|COMPLETED|Overall Study||114
374185|NCT01098110|897198|P3|Treated|Overall Study|Received at least one dose of trial medication|174
374186|NCT01098110|897199|P2|Treated|Overall Study|Received at least one dose of trial medication|181
374187|NCT01098110|897200|P1|Treated|Overall Study|Received at least one dose of trial medication|175
374188|NCT01098110|897198|P3|STARTED|Overall Study|Randomized participants|174
374189|NCT01098110|897199|P2|STARTED|Overall Study|Randomized participants|182
374190|NCT01098110|897200|P1|STARTED|Overall Study|Randomized participants|176
374191|NCT01098097|897241|P1|NOT COMPLETED|Overall Study||82
374192|NCT01098097|897241|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
374193|NCT01098097|897241|P1|STARTED|Overall Study||963
374194|NCT01098071|897250|P1|NOT COMPLETED|Overall Study||15
374195|NCT01098071|897250|P1|COMPLETED|Overall Study||19
374196|NCT01098071|897250|P1|STARTED|Overall Study||34
374197|NCT01098032|897263|P2|NOT COMPLETED|Overall Study||1
374198|NCT01098032|897264|P1|NOT COMPLETED|Overall Study||1
374199|NCT01098032|897263|P2|COMPLETED|Overall Study||146
374200|NCT01098032|897264|P1|COMPLETED|Overall Study||146
374201|NCT01098032|897263|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
374202|NCT01098032|897264|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
374203|NCT01097915|897273|P3|NOT COMPLETED|Overall Study||30
374204|NCT01097915|897274|P2|NOT COMPLETED|Overall Study||42
374205|NCT01097915|897275|P1|NOT COMPLETED|Overall Study||23
374206|NCT01097915|897273|P3|COMPLETED|Overall Study||20
374207|NCT01097915|897274|P2|COMPLETED|Overall Study||28
374208|NCT01097915|897275|P1|COMPLETED|Overall Study||27
374209|NCT01097915|897273|P3|STARTED|Overall Study||50
374210|NCT01097915|897274|P2|STARTED|Overall Study||70
374211|NCT01097915|897275|P1|STARTED|Overall Study||50
374212|NCT01097863|897292|P3|NOT COMPLETED|Overall Study||2
374213|NCT01097863|897293|P2|NOT COMPLETED|Overall Study||0
374214|NCT01097863|897294|P1|NOT COMPLETED|Overall Study||1
374215|NCT01097863|897292|P3|COMPLETED|Overall Study||89
374216|NCT01097863|897293|P2|COMPLETED|Overall Study||98
374217|NCT01097863|897294|P1|COMPLETED|Overall Study||89
374218|NCT01097863|897292|P3|STARTED|Overall Study||91
374219|NCT01097863|897293|P2|STARTED|Overall Study||98
374220|NCT01097863|897294|P1|STARTED|Overall Study||90
374221|NCT01097785|897304|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
374222|NCT01097785|897305|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
374223|NCT01097785|897304|P2|COMPLETED|Cycle 3 (30 Days)||6
374224|NCT01097785|897305|P1|COMPLETED|Cycle 3 (30 Days)||6
374225|NCT01097785|897304|P2|STARTED|Cycle 3 (30 Days)||6
374226|NCT01097785|897305|P1|STARTED|Cycle 3 (30 Days)||6
374227|NCT01097785|897304|P2|NOT COMPLETED|Washout (2 Weeks)||0
374228|NCT01097785|897305|P1|NOT COMPLETED|Washout (2 Weeks)||0
374229|NCT01097785|897304|P2|COMPLETED|Washout (2 Weeks)||6
374230|NCT01097785|897305|P1|COMPLETED|Washout (2 Weeks)||6
374231|NCT01097785|897304|P2|STARTED|Washout (2 Weeks)||6
374232|NCT01097785|897305|P1|STARTED|Washout (2 Weeks)||6
374233|NCT01097785|897304|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
374234|NCT01097785|897305|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
374235|NCT01097785|897304|P2|COMPLETED|Cycle 1 (30 Days)||6
374236|NCT01097785|897305|P1|COMPLETED|Cycle 1 (30 Days)||6
374237|NCT01097785|897304|P2|STARTED|Cycle 1 (30 Days)||6
374238|NCT01097785|897305|P1|STARTED|Cycle 1 (30 Days)||6
374239|NCT01097694|897315|P2|NOT COMPLETED|Overall Study||4
374240|NCT01097694|897316|P1|NOT COMPLETED|Overall Study||8
374241|NCT01097694|897315|P2|COMPLETED|Overall Study||26
374242|NCT01097694|897316|P1|COMPLETED|Overall Study||24
374243|NCT01097694|897315|P2|STARTED|Overall Study||30
374244|NCT01097694|897316|P1|STARTED|Overall Study||32
374245|NCT01097668|897378|P2|NOT COMPLETED|Overall Study||2
374246|NCT01097668|897379|P1|NOT COMPLETED|Overall Study||2
374247|NCT01097668|897378|P2|COMPLETED|Overall Study||20
374248|NCT01097668|897379|P1|COMPLETED|Overall Study||19
374249|NCT01097668|897378|P2|Week 48|Overall Study||20
374250|NCT01097668|897379|P1|Week 48|Overall Study||19
374251|NCT01097668|897378|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
374252|NCT01097668|897379|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
374253|NCT01097668|897378|P2|STARTED|Overall Study||22
374254|NCT01097668|897379|P1|STARTED|Overall Study||21
374255|NCT01097655|897389|P1|NOT COMPLETED|Overall Study||10
374256|NCT01097655|897389|P1|COMPLETED|Overall Study|participants included for analysis|3039
374257|NCT01097655|897389|P1|STARTED|Overall Study||3049
374258|NCT01097629|897399|P8|NOT COMPLETED|DB RO Phase||1
374259|NCT01097629|897400|P7|NOT COMPLETED|DB RO Phase||3
374260|NCT01097629|897401|P6|NOT COMPLETED|DB RO Phase||1
374261|NCT01097629|897402|P5|NOT COMPLETED|DB RO Phase||0
374262|NCT01097629|897403|P4|NOT COMPLETED|DB RO Phase||1
374263|NCT01097629|897404|P3|NOT COMPLETED|DB RO Phase||0
374264|NCT01097629|897405|P2|NOT COMPLETED|DB RO Phase||0
374265|NCT01097629|897406|P1|NOT COMPLETED|DB RO Phase||0
374266|NCT01097629|897399|P8|COMPLETED|DB RO Phase||326
374267|NCT01097629|897400|P7|COMPLETED|DB RO Phase||168
374268|NCT01097629|897401|P6|COMPLETED|DB RO Phase||172
374269|NCT01097629|897402|P5|COMPLETED|DB RO Phase||108
374270|NCT01097629|897403|P4|COMPLETED|DB RO Phase||96
374271|NCT01097629|897404|P3|COMPLETED|DB RO Phase||0
374272|NCT01097629|897405|P2|COMPLETED|DB RO Phase||0
374273|NCT01097629|897406|P1|COMPLETED|DB RO Phase||0
374274|NCT01097629|897399|P8|STARTED|DB RO Phase||327
374275|NCT01097629|897400|P7|STARTED|DB RO Phase||171
374276|NCT01097629|897401|P6|STARTED|DB RO Phase||173
374277|NCT01097629|897402|P5|STARTED|DB RO Phase||108
374278|NCT01097629|897403|P4|STARTED|DB RO Phase||97
374279|NCT01097629|897404|P3|STARTED|DB RO Phase||0
374280|NCT01097629|897405|P2|STARTED|DB RO Phase||0
374281|NCT01097629|897406|P1|STARTED|DB RO Phase||0
374282|NCT01097629|897399|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374283|NCT01097629|897400|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374284|NCT01097629|897401|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374285|NCT01097629|897402|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374286|NCT01097629|897403|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374287|NCT01097629|897404|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
374288|NCT01097629|897405|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
374289|NCT01097629|897406|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
374290|NCT01097629|897399|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374291|NCT01097629|897400|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374292|NCT01097629|897401|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374293|NCT01097629|897402|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374294|NCT01097629|897403|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374295|NCT01097629|897404|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
374296|NCT01097629|897405|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
374297|NCT01097629|897406|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
374298|NCT01097629|897399|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374299|NCT01097629|897400|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374300|NCT01097629|897401|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374301|NCT01097629|897402|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374302|NCT01097629|897403|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374303|NCT01097629|897404|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
374304|NCT01097629|897405|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
374305|NCT01097629|897406|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
374306|NCT01097629|897399|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374307|NCT01097629|897400|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374308|NCT01097629|897401|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374309|NCT01097629|897402|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374310|NCT01097629|897403|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374311|NCT01097629|897404|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
374312|NCT01097629|897405|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
374313|NCT01097629|897406|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
374314|NCT01097616|897457|P8|NOT COMPLETED|DB RO Phase||1
374315|NCT01097616|897458|P7|NOT COMPLETED|DB RO Phase||1
374316|NCT01097616|897459|P6|NOT COMPLETED|DB RO Phase||2
374317|NCT01097616|897460|P5|NOT COMPLETED|DB RO Phase||1
374318|NCT01097616|897461|P4|NOT COMPLETED|DB RO Phase||1
374319|NCT01097616|897462|P3|NOT COMPLETED|DB RO Phase||0
374320|NCT01097616|897463|P2|NOT COMPLETED|DB RO Phase||0
374321|NCT01097616|897464|P1|NOT COMPLETED|DB RO Phase||0
374322|NCT01097616|897457|P8|COMPLETED|DB RO Phase||326
374323|NCT01097616|897458|P7|COMPLETED|DB RO Phase||161
374324|NCT01097616|897459|P6|COMPLETED|DB RO Phase||159
374325|NCT01097616|897460|P5|COMPLETED|DB RO Phase||111
374326|NCT01097616|897461|P4|COMPLETED|DB RO Phase||100
374327|NCT01097616|897462|P3|COMPLETED|DB RO Phase||0
374328|NCT01097616|897463|P2|COMPLETED|DB RO Phase||0
374329|NCT01097616|897464|P1|COMPLETED|DB RO Phase||0
374330|NCT01097616|897457|P8|STARTED|DB RO Phase||327
374331|NCT01097616|897458|P7|STARTED|DB RO Phase||162
374332|NCT01097616|897459|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
374333|NCT01097616|897460|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
374334|NCT01097616|897461|P4|STARTED|DB RO Phase||101
374335|NCT01097616|897462|P3|STARTED|DB RO Phase||0
374336|NCT01097616|897463|P2|STARTED|DB RO Phase||0
374337|NCT01097616|897464|P1|STARTED|DB RO Phase||0
374338|NCT01097616|897457|P8|NOT COMPLETED|Optional DB EXT Phase||0
374339|NCT01097616|897458|P7|NOT COMPLETED|Optional DB EXT Phase||0
374340|NCT01097616|897459|P6|NOT COMPLETED|Optional DB EXT Phase||0
374341|NCT01097616|897460|P5|NOT COMPLETED|Optional DB EXT Phase||0
374342|NCT01097616|897461|P4|NOT COMPLETED|Optional DB EXT Phase||0
374343|NCT01097616|897462|P3|NOT COMPLETED|Optional DB EXT Phase||10
374344|NCT01097616|897463|P2|NOT COMPLETED|Optional DB EXT Phase||21
374345|NCT01097616|897464|P1|NOT COMPLETED|Optional DB EXT Phase||15
374346|NCT01097616|897457|P8|COMPLETED|Optional DB EXT Phase||0
374347|NCT01097616|897458|P7|COMPLETED|Optional DB EXT Phase||0
374348|NCT01097616|897459|P6|COMPLETED|Optional DB EXT Phase||0
374349|NCT01097616|897460|P5|COMPLETED|Optional DB EXT Phase||0
374350|NCT01097616|897461|P4|COMPLETED|Optional DB EXT Phase||0
374351|NCT01097616|897462|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
374352|NCT01097616|897463|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
374353|NCT01097616|897464|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
374354|NCT01097616|897457|P8|STARTED|Optional DB EXT Phase||0
374355|NCT01097616|897458|P7|STARTED|Optional DB EXT Phase||0
374356|NCT01097616|897459|P6|STARTED|Optional DB EXT Phase||0
374357|NCT01097616|897460|P5|STARTED|Optional DB EXT Phase||0
374358|NCT01097616|897461|P4|STARTED|Optional DB EXT Phase||0
374359|NCT01097616|897462|P3|STARTED|Optional DB EXT Phase||151
374360|NCT01097616|897463|P2|STARTED|Optional DB EXT Phase||172
374361|NCT01097616|897464|P1|STARTED|Optional DB EXT Phase||100
374362|NCT01097616|897457|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374363|NCT01097616|897458|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374364|NCT01097616|897459|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374365|NCT01097616|897460|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374366|NCT01097616|897461|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374367|NCT01097616|897462|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
374368|NCT01097616|897463|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
374369|NCT01097616|897464|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
374370|NCT01097616|897457|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374371|NCT01097616|897458|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374372|NCT01097616|897459|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374373|NCT01097616|897460|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374374|NCT01097616|897461|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
374375|NCT01097616|897462|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
374376|NCT01097616|897463|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
374377|NCT01097616|897464|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
374378|NCT01097616|897457|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374379|NCT01097616|897458|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374380|NCT01097616|897459|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374381|NCT01097616|897460|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374382|NCT01097616|897461|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
374383|NCT01097616|897462|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
374384|NCT01097616|897463|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
374385|NCT01097616|897464|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
374386|NCT01097616|897457|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374387|NCT01097616|897458|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374388|NCT01097616|897459|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374389|NCT01097616|897460|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374390|NCT01097616|897461|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
374391|NCT01097616|897462|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
374392|NCT01097616|897463|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
374393|NCT01097616|897464|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
374394|NCT01096589|897539|P4|NOT COMPLETED|Overall Study||3
374395|NCT01096589|897540|P3|NOT COMPLETED|Overall Study||4
374396|NCT01096589|897541|P2|NOT COMPLETED|Overall Study||2
374397|NCT01096589|897542|P1|NOT COMPLETED|Overall Study||4
374398|NCT01096589|897539|P4|COMPLETED|Overall Study||15
374399|NCT01096589|897540|P3|COMPLETED|Overall Study||18
374400|NCT01096589|897541|P2|COMPLETED|Overall Study||18
374401|NCT01096589|897542|P1|COMPLETED|Overall Study||18
374402|NCT01096589|897539|P4|STARTED|Overall Study||18
374403|NCT01096589|897540|P3|STARTED|Overall Study||22
374404|NCT01096589|897541|P2|STARTED|Overall Study||20
374405|NCT01096589|897542|P1|STARTED|Overall Study||22
374406|NCT01096550|897554|P2|NOT COMPLETED|Overall Study||29
374407|NCT01096550|897555|P1|NOT COMPLETED|Overall Study||37
374408|NCT01096550|897554|P2|COMPLETED|Overall Study||146
374409|NCT01096550|897555|P1|COMPLETED|Overall Study||133
374410|NCT01096550|897554|P2|STARTED|Overall Study||175
374411|NCT01096550|897555|P1|STARTED|Overall Study||170
374412|NCT01097460|897561|P1|NOT COMPLETED|Overall Study||0
374413|NCT01097460|897561|P1|COMPLETED|Overall Study||16
374414|NCT01097460|897561|P1|STARTED|Overall Study||16
374415|NCT01097421|897565|P1|NOT COMPLETED|Overall Study||14
374416|NCT01097421|897565|P1|COMPLETED|Overall Study||314
374417|NCT01097421|897565|P1|STARTED|Overall Study||328
374418|NCT01097343|897575|P2|NOT COMPLETED|Second Intervention- 30 Days||0
374419|NCT01097343|897576|P1|NOT COMPLETED|Second Intervention- 30 Days||0
374420|NCT01097343|897575|P2|COMPLETED|Second Intervention- 30 Days||25
374421|NCT01097343|897576|P1|COMPLETED|Second Intervention- 30 Days||25
374422|NCT01097343|897575|P2|STARTED|Second Intervention- 30 Days||25
374423|NCT01097343|897576|P1|STARTED|Second Intervention- 30 Days||25
374424|NCT01097343|897575|P2|NOT COMPLETED|First Intervention- 30 Days||0
374425|NCT01097343|897576|P1|NOT COMPLETED|First Intervention- 30 Days||0
374426|NCT01097343|897575|P2|COMPLETED|First Intervention- 30 Days||25
374427|NCT01097343|897576|P1|COMPLETED|First Intervention- 30 Days||25
374428|NCT01097343|897575|P2|STARTED|First Intervention- 30 Days||25
374429|NCT01097343|897576|P1|STARTED|First Intervention- 30 Days||25
374430|NCT01097304|897582|P1|NOT COMPLETED|Overall Study||7
374431|NCT01097304|897582|P1|COMPLETED|Overall Study||29
374432|NCT01097304|897582|P1|STARTED|Overall Study||36
374433|NCT01097005|897586|P1|NOT COMPLETED|Overall Study||365
374434|NCT01097005|897586|P1|COMPLETED|Overall Study||101
374435|NCT01097005|897586|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
374436|NCT01097005|897586|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
374437|NCT01097005|897586|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
374438|NCT01097005|897586|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
374439|NCT01097005|897586|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
374440|NCT01096875|897594|P2|NOT COMPLETED|Overall Study||1
374441|NCT01096875|897595|P1|NOT COMPLETED|Overall Study||0
374442|NCT01096875|897594|P2|COMPLETED|Overall Study||29
374443|NCT01096875|897595|P1|COMPLETED|Overall Study||30
374444|NCT01096875|897594|P2|STARTED|Overall Study||30
374445|NCT01096875|897595|P1|STARTED|Overall Study||30
374446|NCT01096823|897609|P2|NOT COMPLETED|Overall Study||1
374447|NCT01096823|897610|P1|NOT COMPLETED|Overall Study||3
374448|NCT01096823|897609|P2|COMPLETED|Overall Study||15
374449|NCT01096823|897610|P1|COMPLETED|Overall Study||11
374450|NCT01096823|897609|P2|STARTED|Overall Study||16
374451|NCT01096823|897610|P1|STARTED|Overall Study||14
374452|NCT01096810|897622|P1|NOT COMPLETED|Overall Study||0
374453|NCT01096810|897622|P1|COMPLETED|Overall Study||20
374454|NCT01096810|897622|P1|STARTED|Overall Study||20
374455|NCT01096784|897630|P2|NOT COMPLETED|Overall Study||14
374456|NCT01096784|897631|P1|NOT COMPLETED|Overall Study||15
374457|NCT01096784|897630|P2|COMPLETED|Overall Study||46
374458|NCT01096784|897631|P1|COMPLETED|Overall Study||46
374459|NCT01096784|897630|P2|STARTED|Overall Study||60
374460|NCT01096784|897631|P1|STARTED|Overall Study||61
374461|NCT01096771|897665|P2|NOT COMPLETED|Overall Study||0
374462|NCT01096771|897666|P1|NOT COMPLETED|Overall Study||0
374463|NCT01096771|897665|P2|COMPLETED|Overall Study||7
374464|NCT01096771|897666|P1|COMPLETED|Overall Study||7
374465|NCT01096771|897665|P2|STARTED|Overall Study||7
374466|NCT01096771|897666|P1|STARTED|Overall Study||7
374467|NCT01096680|897695|P5|NOT COMPLETED|Overall Study||0
374468|NCT01096680|897696|P4|NOT COMPLETED|Overall Study||0
374469|NCT01096680|897697|P3|NOT COMPLETED|Overall Study||0
374470|NCT01096680|897698|P2|NOT COMPLETED|Overall Study||0
374471|NCT01096680|897699|P1|NOT COMPLETED|Overall Study||0
374472|NCT01096680|897695|P5|COMPLETED|Overall Study||27
374473|NCT01096680|897696|P4|COMPLETED|Overall Study||27
374474|NCT01096680|897697|P3|COMPLETED|Overall Study||27
374475|NCT01096680|897698|P2|COMPLETED|Overall Study||27
374476|NCT01096680|897699|P1|COMPLETED|Overall Study||27
374477|NCT01096680|897695|P5|STARTED|Overall Study||27
374478|NCT01096680|897696|P4|STARTED|Overall Study||27
374479|NCT01096680|897697|P3|STARTED|Overall Study||27
374480|NCT01096680|897698|P2|STARTED|Overall Study||27
374481|NCT01096680|897699|P1|STARTED|Overall Study||27
374482|NCT01096446|897733|P2|NOT COMPLETED|Overall Study||0
374483|NCT01096446|897734|P1|NOT COMPLETED|Overall Study||3
374484|NCT01096446|897733|P2|COMPLETED|Overall Study||10
374485|NCT01096446|897734|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
374486|NCT01096446|897733|P2|STARTED|Overall Study||10
374487|NCT01096446|897734|P1|STARTED|Overall Study||12
374488|NCT01096342|897739|P1|NOT COMPLETED|Overall Study||1
374489|NCT01096342|897739|P1|COMPLETED|Overall Study||15
374490|NCT01096342|897739|P1|STARTED|Overall Study||16
374491|NCT01096316|897747|P2|NOT COMPLETED|Overall Study||9
374492|NCT01096316|897748|P1|NOT COMPLETED|Overall Study||15
374493|NCT01096316|897747|P2|COMPLETED|Overall Study||94
374494|NCT01096316|897748|P1|COMPLETED|Overall Study||87
374495|NCT01096316|897747|P2|STARTED|Overall Study||103
374496|NCT01096316|897748|P1|STARTED|Overall Study||102
374497|NCT01096186|897758|P1|NOT COMPLETED|Overall Study||50
374498|NCT01096186|897758|P1|COMPLETED|Overall Study||567
374499|NCT01096186|897758|P1|STARTED|Overall Study||617
374500|NCT01096056|897766|P2|NOT COMPLETED|Overall Study||1
374501|NCT01096056|897767|P1|NOT COMPLETED|Overall Study||0
374502|NCT01096056|897766|P2|COMPLETED|Overall Study||19
374503|NCT01096056|897767|P1|COMPLETED|Overall Study||20
374504|NCT01096056|897766|P2|Completed at Day 42|Overall Study||20
374505|NCT01096056|897767|P1|Completed at Day 42|Overall Study||20
374506|NCT01096056|897766|P2|STARTED|Overall Study||20
374507|NCT01096056|897767|P1|STARTED|Overall Study||20
374508|NCT01096017|897799|P2|NOT COMPLETED|Treatment Period 2||1
374509|NCT01096017|897800|P1|NOT COMPLETED|Treatment Period 2||1
374510|NCT01096017|897799|P2|COMPLETED|Treatment Period 2||11
374511|NCT01096017|897800|P1|COMPLETED|Treatment Period 2||11
374512|NCT01096017|897799|P2|STARTED|Treatment Period 2||12
374513|NCT01096017|897800|P1|STARTED|Treatment Period 2||12
374514|NCT01096017|897799|P2|NOT COMPLETED|Washout 1 - 14 Days||0
374515|NCT01096017|897800|P1|NOT COMPLETED|Washout 1 - 14 Days||0
374516|NCT01096017|897799|P2|COMPLETED|Washout 1 - 14 Days||12
374517|NCT01096017|897800|P1|COMPLETED|Washout 1 - 14 Days||12
374518|NCT01096017|897799|P2|STARTED|Washout 1 - 14 Days||12
374519|NCT01096017|897800|P1|STARTED|Washout 1 - 14 Days||12
374520|NCT01096017|897799|P2|NOT COMPLETED|Treatment Period 1||0
374521|NCT01096017|897800|P1|NOT COMPLETED|Treatment Period 1||0
374522|NCT01096017|897799|P2|COMPLETED|Treatment Period 1||12
374523|NCT01096017|897800|P1|COMPLETED|Treatment Period 1||12
374524|NCT01096017|897799|P2|STARTED|Treatment Period 1||12
374525|NCT01096017|897800|P1|STARTED|Treatment Period 1||12
374526|NCT01095978|897828|P1|NOT COMPLETED|Overall Study||3
374527|NCT01095978|897828|P1|COMPLETED|Overall Study||2819
374528|NCT01095978|897828|P1|STARTED|Overall Study||2822
374529|NCT01095887|897855|P1|NOT COMPLETED|Overall Study||0
374530|NCT01095887|897855|P1|COMPLETED|Overall Study||6
374531|NCT01095887|897855|P1|STARTED|Overall Study||6
374532|NCT01095835|897862|P3|NOT COMPLETED|Overall Study||8
374533|NCT01095835|897863|P2|NOT COMPLETED|Overall Study||12
374534|NCT01095835|897864|P1|NOT COMPLETED|Overall Study||10
374535|NCT01095835|897862|P3|COMPLETED|Overall Study||17
374536|NCT01095835|897863|P2|COMPLETED|Overall Study||40
374537|NCT01095835|897864|P1|COMPLETED|Overall Study||41
374538|NCT01095835|897862|P3|STARTED|Overall Study||25
374539|NCT01095835|897863|P2|STARTED|Overall Study||52
374540|NCT01095835|897864|P1|STARTED|Overall Study||51
374541|NCT01095796|897902|P2|NOT COMPLETED|Overall Study||289
374542|NCT01095796|897903|P1|NOT COMPLETED|Overall Study||295
374543|NCT01095796|897902|P2|COMPLETED|Overall Study||65
374544|NCT01095796|897903|P1|COMPLETED|Overall Study||58
374545|NCT01095796|897902|P2|STARTED|Overall Study||354
374546|NCT01095796|897903|P1|STARTED|Overall Study||353
374547|NCT01095757|897921|P1|NOT COMPLETED|Overall Study||0
374548|NCT01095757|897921|P1|COMPLETED|Overall Study||45
374549|NCT01095757|897921|P1|STARTED|Overall Study||45
374550|NCT01095653|897933|P3|NOT COMPLETED|Overall Study||16
374551|NCT01095653|897934|P2|NOT COMPLETED|Overall Study||15
374552|NCT01095653|897935|P1|NOT COMPLETED|Overall Study||19
374553|NCT01095653|897933|P3|COMPLETED|Overall Study||117
374554|NCT01095653|897934|P2|COMPLETED|Overall Study||113
374555|NCT01095653|897935|P1|COMPLETED|Overall Study||113
374556|NCT01095653|897933|P3|STARTED|Overall Study||133
374557|NCT01095653|897934|P2|STARTED|Overall Study||128
374558|NCT01095653|897935|P1|STARTED|Overall Study||132
374559|NCT01095510|897958|P4|NOT COMPLETED|Overall Study||0
374560|NCT01095510|897959|P3|NOT COMPLETED|Overall Study||0
374561|NCT01095510|897960|P2|NOT COMPLETED|Overall Study||0
374562|NCT01095510|897961|P1|NOT COMPLETED|Overall Study||0
374563|NCT01095510|897958|P4|COMPLETED|Overall Study||3
374564|NCT01095510|897959|P3|COMPLETED|Overall Study||3
374565|NCT01095510|897960|P2|COMPLETED|Overall Study||0
374566|NCT01095510|897961|P1|COMPLETED|Overall Study||3
374567|NCT01095510|897958|P4|STARTED|Overall Study||3
374568|NCT01095510|897959|P3|STARTED|Overall Study||3
374569|NCT01095510|897960|P2|STARTED|Overall Study||0
374570|NCT01095510|897961|P1|STARTED|Overall Study||3
374571|NCT01095497|897980|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
374572|NCT01095497|897981|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
374573|NCT01095497|897980|P2|COMPLETED|Subcutaneous CINRYZE||12
374574|NCT01095497|897981|P1|COMPLETED|Subcutaneous CINRYZE||12
374575|NCT01095497|897980|P2|STARTED|Subcutaneous CINRYZE||12
374576|NCT01095497|897981|P1|STARTED|Subcutaneous CINRYZE||13
374577|NCT01095497|897980|P2|NOT COMPLETED|Intravenous CINRYZE||0
374578|NCT01095497|897981|P1|NOT COMPLETED|Intravenous CINRYZE||1
374579|NCT01095497|897980|P2|COMPLETED|Intravenous CINRYZE||12
374580|NCT01095497|897981|P1|COMPLETED|Intravenous CINRYZE||13
374581|NCT01095497|897980|P2|STARTED|Intravenous CINRYZE||12
374582|NCT01095497|897981|P1|STARTED|Intravenous CINRYZE||14
374583|NCT01095250|897993|P4|NOT COMPLETED|Overall Study||5
374584|NCT01095250|897994|P3|NOT COMPLETED|Overall Study||8
374585|NCT01095250|897995|P2|NOT COMPLETED|Overall Study||10
374586|NCT01095250|897996|P1|NOT COMPLETED|Overall Study||8
374587|NCT01095250|897993|P4|COMPLETED|Overall Study||0
374588|NCT01095250|897994|P3|COMPLETED|Overall Study||0
374589|NCT01095250|897995|P2|COMPLETED|Overall Study||0
374590|NCT01095250|897996|P1|COMPLETED|Overall Study||0
374591|NCT01095250|897993|P4|STARTED|Overall Study||5
374592|NCT01095250|897994|P3|STARTED|Overall Study||8
374593|NCT01095250|897995|P2|STARTED|Overall Study||10
374594|NCT01095250|897996|P1|STARTED|Overall Study||8
374595|NCT01095094|898026|P1|NOT COMPLETED|Overall Study||3
374596|NCT01095094|898026|P1|COMPLETED|Overall Study||16
374597|NCT01095094|898026|P1|STARTED|Overall Study||19
374598|NCT01094886|898031|P1|NOT COMPLETED|Overall Study||7
374599|NCT01094886|898031|P1|COMPLETED|Overall Study||46
374600|NCT01094886|898031|P1|STARTED|Overall Study||53
374601|NCT01094808|898041|P3|NOT COMPLETED|Overall Study||0
374602|NCT01094808|898042|P2|NOT COMPLETED|Overall Study||1
374603|NCT01094808|898043|P1|NOT COMPLETED|Overall Study||1
374604|NCT01094808|898041|P3|COMPLETED|Overall Study||21
374605|NCT01094808|898042|P2|COMPLETED|Overall Study||19
374606|NCT01094808|898043|P1|COMPLETED|Overall Study||20
374607|NCT01094808|898041|P3|STARTED|Overall Study||21
374608|NCT01094808|898042|P2|STARTED|Overall Study||20
374609|NCT01094808|898043|P1|STARTED|Overall Study||21
374610|NCT01094743|898078|P1|NOT COMPLETED|Period 2||0
374611|NCT01094743|898078|P1|COMPLETED|Period 2||50
374612|NCT01094743|898078|P1|STARTED|Period 2||50
374613|NCT01094743|898078|P1|NOT COMPLETED|Period 1||2
374614|NCT01094743|898078|P1|COMPLETED|Period 1||50
374615|NCT01094743|898078|P1|STARTED|Period 1||52
374616|NCT01094730|898095|P2|NOT COMPLETED|Period 2 (14 Days)||2
374617|NCT01094730|898096|P1|NOT COMPLETED|Period 2 (14 Days)||3
374618|NCT01094730|898095|P2|COMPLETED|Period 2 (14 Days)||84
374619|NCT01094730|898096|P1|COMPLETED|Period 2 (14 Days)||87
374620|NCT01094730|898095|P2|STARTED|Period 2 (14 Days)||86
374621|NCT01094730|898096|P1|STARTED|Period 2 (14 Days)||90
374622|NCT01094730|898095|P2|NOT COMPLETED|Period 1 (14 Days)||2
374623|NCT01094730|898096|P1|NOT COMPLETED|Period 1 (14 Days)||2
374624|NCT01094730|898095|P2|COMPLETED|Period 1 (14 Days)||86
374625|NCT01094730|898096|P1|COMPLETED|Period 1 (14 Days)||90
374626|NCT01094730|898095|P2|STARTED|Period 1 (14 Days)||88
374627|NCT01094730|898096|P1|STARTED|Period 1 (14 Days)||92
374628|NCT01094704|898109|P2|NOT COMPLETED|Overall Study||0
374629|NCT01094704|898110|P1|NOT COMPLETED|Overall Study||0
374630|NCT01094704|898109|P2|COMPLETED|Overall Study||8
374631|NCT01094704|898110|P1|COMPLETED|Overall Study||8
374632|NCT01094704|898109|P2|STARTED|Overall Study||8
374633|NCT01094704|898110|P1|STARTED|Overall Study||8
374634|NCT01094574|898122|P6|NOT COMPLETED|Overall Study||0
374635|NCT01094574|898123|P5|NOT COMPLETED|Overall Study||0
374636|NCT01094574|898124|P4|NOT COMPLETED|Overall Study||0
374637|NCT01094574|898125|P3|NOT COMPLETED|Overall Study||0
374638|NCT01094574|898126|P2|NOT COMPLETED|Overall Study||0
374639|NCT01094574|898127|P1|NOT COMPLETED|Overall Study||0
374640|NCT01094574|898122|P6|COMPLETED|Overall Study||2
374641|NCT01094574|898123|P5|COMPLETED|Overall Study||2
374642|NCT01094574|898124|P4|COMPLETED|Overall Study||2
374643|NCT01094574|898125|P3|COMPLETED|Overall Study||2
374644|NCT01094574|898126|P2|COMPLETED|Overall Study||1
374645|NCT01094574|898127|P1|COMPLETED|Overall Study||1
374646|NCT01094574|898122|P6|STARTED|Overall Study||2
374647|NCT01094574|898123|P5|STARTED|Overall Study||2
374648|NCT01094574|898124|P4|STARTED|Overall Study||2
374649|NCT01094574|898125|P3|STARTED|Overall Study||2
374650|NCT01094574|898126|P2|STARTED|Overall Study||1
374651|NCT01094574|898127|P1|STARTED|Overall Study||1
374652|NCT01094561|898174|P1|NOT COMPLETED|Overall Study||6
374653|NCT01094561|898174|P1|COMPLETED|Overall Study||17
374654|NCT01094561|898174|P1|STARTED|Overall Study||23
374655|NCT01094548|898181|P2|NOT COMPLETED|Overall Study||0
374656|NCT01094548|898182|P1|NOT COMPLETED|Overall Study||0
374657|NCT01094548|898181|P2|COMPLETED|Overall Study||17
374658|NCT01094548|898182|P1|COMPLETED|Overall Study||17
374659|NCT01094548|898181|P2|STARTED|Overall Study||17
374660|NCT01094548|898182|P1|STARTED|Overall Study||17
374661|NCT01093222|898200|P1|NOT COMPLETED|Overall Study||40
374662|NCT01093222|898200|P1|COMPLETED|Overall Study||0
374663|NCT01093222|898200|P1|Eligible and Began Protocol Therapy|Overall Study||34
374664|NCT01093222|898200|P1|STARTED|Overall Study||40
374665|NCT01094171|898207|P1|NOT COMPLETED|Overall Study||10
374666|NCT01094171|898207|P1|COMPLETED|Overall Study||390
374667|NCT01094171|898207|P1|STARTED|Overall Study||400
374668|NCT01094119|898216|P2|NOT COMPLETED|Overall Study||4
374669|NCT01094119|898217|P1|NOT COMPLETED|Overall Study||2
374670|NCT01094119|898216|P2|COMPLETED|Overall Study||32
374671|NCT01094119|898217|P1|COMPLETED|Overall Study||32
374672|NCT01094119|898216|P2|STARTED|Overall Study||36
374673|NCT01094119|898217|P1|STARTED|Overall Study||34
374674|NCT01093976|898225|P1|NOT COMPLETED|Overall Study||0
374675|NCT01093976|898225|P1|COMPLETED|Overall Study||14
374676|NCT01093976|898225|P1|STARTED|Overall Study||14
374677|NCT01093846|898232|P3|NOT COMPLETED|Overall Study||21
374678|NCT01093846|898233|P2|NOT COMPLETED|Overall Study||18
374679|NCT01093846|898234|P1|NOT COMPLETED|Overall Study||19
374680|NCT01093846|898232|P3|COMPLETED|Overall Study||1
374681|NCT01093846|898233|P2|COMPLETED|Overall Study||0
374682|NCT01093846|898234|P1|COMPLETED|Overall Study||0
374683|NCT01093846|898232|P3|STARTED|Overall Study||22
374684|NCT01093846|898233|P2|STARTED|Overall Study||18
374685|NCT01093846|898234|P1|STARTED|Overall Study||19
374686|NCT01093794|898240|P4|NOT COMPLETED|Treatment Period 4||0
374687|NCT01093794|898241|P3|NOT COMPLETED|Treatment Period 4||0
374688|NCT01093794|898242|P2|NOT COMPLETED|Treatment Period 4||0
374689|NCT01093794|898243|P1|NOT COMPLETED|Treatment Period 4||0
374690|NCT01093794|898240|P4|COMPLETED|Treatment Period 4||7
374691|NCT01093794|898241|P3|COMPLETED|Treatment Period 4||6
374692|NCT01093794|898242|P2|COMPLETED|Treatment Period 4||7
374693|NCT01093794|898243|P1|COMPLETED|Treatment Period 4||7
374694|NCT01093794|898240|P4|STARTED|Treatment Period 4||7
374695|NCT01093794|898241|P3|STARTED|Treatment Period 4||6
374696|NCT01093794|898242|P2|STARTED|Treatment Period 4||7
374697|NCT01093794|898243|P1|STARTED|Treatment Period 4||7
374698|NCT01093794|898240|P4|NOT COMPLETED|Treatment Period 3||0
374699|NCT01093794|898241|P3|NOT COMPLETED|Treatment Period 3||0
374700|NCT01093794|898242|P2|NOT COMPLETED|Treatment Period 3||0
374701|NCT01093794|898243|P1|NOT COMPLETED|Treatment Period 3||0
374702|NCT01093794|898240|P4|COMPLETED|Treatment Period 3||7
374703|NCT01093794|898241|P3|COMPLETED|Treatment Period 3||6
374704|NCT01093794|898242|P2|COMPLETED|Treatment Period 3||7
374705|NCT01093794|898243|P1|COMPLETED|Treatment Period 3||7
374706|NCT01093794|898240|P4|STARTED|Treatment Period 3||7
374707|NCT01093794|898241|P3|STARTED|Treatment Period 3||6
374708|NCT01093794|898242|P2|STARTED|Treatment Period 3||7
374709|NCT01093794|898243|P1|STARTED|Treatment Period 3||7
374710|NCT01093794|898240|P4|NOT COMPLETED|Treatment Period 2||0
374711|NCT01093794|898241|P3|NOT COMPLETED|Treatment Period 2||0
374712|NCT01093794|898242|P2|NOT COMPLETED|Treatment Period 2||0
374713|NCT01093794|898243|P1|NOT COMPLETED|Treatment Period 2||0
374714|NCT01093794|898240|P4|COMPLETED|Treatment Period 2||7
374715|NCT01093794|898241|P3|COMPLETED|Treatment Period 2||6
374716|NCT01093794|898242|P2|COMPLETED|Treatment Period 2||7
374717|NCT01093794|898243|P1|COMPLETED|Treatment Period 2||7
374718|NCT01093794|898240|P4|STARTED|Treatment Period 2||7
374719|NCT01093794|898241|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
374720|NCT01093794|898242|P2|STARTED|Treatment Period 2||7
374721|NCT01093794|898243|P1|STARTED|Treatment Period 2||7
374722|NCT01093794|898240|P4|NOT COMPLETED|Treatment Period 1||0
374723|NCT01093794|898241|P3|NOT COMPLETED|Treatment Period 1||0
374724|NCT01093794|898242|P2|NOT COMPLETED|Treatment Period 1||0
374725|NCT01093794|898243|P1|NOT COMPLETED|Treatment Period 1||0
374726|NCT01093794|898240|P4|COMPLETED|Treatment Period 1||7
374727|NCT01093794|898241|P3|COMPLETED|Treatment Period 1||7
374728|NCT01093794|898242|P2|COMPLETED|Treatment Period 1||7
374729|NCT01093794|898243|P1|COMPLETED|Treatment Period 1||7
374730|NCT01093794|898240|P4|STARTED|Treatment Period 1||7
374731|NCT01093794|898241|P3|STARTED|Treatment Period 1||7
374732|NCT01093794|898242|P2|STARTED|Treatment Period 1||7
374733|NCT01093794|898243|P1|STARTED|Treatment Period 1||7
374734|NCT01093755|898259|P2|NOT COMPLETED|Overall Study||4
374735|NCT01093755|898260|P1|NOT COMPLETED|Overall Study||3
374736|NCT01093755|898259|P2|COMPLETED|Overall Study||10
374737|NCT01093755|898260|P1|COMPLETED|Overall Study||13
374738|NCT01093755|898259|P2|STARTED|Overall Study||14
374739|NCT01093755|898260|P1|STARTED|Overall Study||16
374740|NCT01093690|898270|P2|NOT COMPLETED|Overall Study||0
374741|NCT01093690|898271|P1|NOT COMPLETED|Overall Study||0
374742|NCT01093690|898270|P2|COMPLETED|Overall Study||79
374743|NCT01093690|898271|P1|COMPLETED|Overall Study||83
374744|NCT01093690|898270|P2|STARTED|Overall Study||79
374745|NCT01093690|898271|P1|STARTED|Overall Study||83
374746|NCT01093651|898279|P2|NOT COMPLETED|Overall Study||0
374747|NCT01093651|898280|P1|NOT COMPLETED|Overall Study||0
374748|NCT01093651|898279|P2|COMPLETED|Overall Study||10
374749|NCT01093651|898280|P1|COMPLETED|Overall Study||10
374750|NCT01093651|898279|P2|STARTED|Overall Study||10
374751|NCT01093651|898280|P1|STARTED|Overall Study||10
374752|NCT01093625|898300|P2|NOT COMPLETED|1-Year Visit||3
374753|NCT01093625|898301|P1|NOT COMPLETED|1-Year Visit||5
374754|NCT01093625|898300|P2|COMPLETED|1-Year Visit||37
374755|NCT01093625|898301|P1|COMPLETED|1-Year Visit||29
374756|NCT01093625|898300|P2|STARTED|1-Year Visit||40
374757|NCT01093625|898301|P1|STARTED|1-Year Visit||34
374758|NCT01093625|898300|P2|NOT COMPLETED|6-Month Visit||9
374759|NCT01093625|898301|P1|NOT COMPLETED|6-Month Visit||8
374760|NCT01093625|898300|P2|COMPLETED|6-Month Visit||40
374761|NCT01093625|898301|P1|COMPLETED|6-Month Visit||34
374762|NCT01093625|898300|P2|STARTED|6-Month Visit||49
374763|NCT01093625|898301|P1|STARTED|6-Month Visit||42
374764|NCT01093625|898300|P2|NOT COMPLETED|3-Month Visit||0
374765|NCT01093625|898301|P1|NOT COMPLETED|3-Month Visit||2
374766|NCT01093625|898300|P2|COMPLETED|3-Month Visit||49
374767|NCT01093625|898301|P1|COMPLETED|3-Month Visit||42
374768|NCT01093625|898300|P2|STARTED|3-Month Visit||49
374769|NCT01093625|898301|P1|STARTED|3-Month Visit||44
374770|NCT01093625|898300|P2|NOT COMPLETED|1-Month Visit||0
374771|NCT01093625|898301|P1|NOT COMPLETED|1-Month Visit||2
374772|NCT01093625|898300|P2|COMPLETED|1-Month Visit||49
374773|NCT01093625|898301|P1|COMPLETED|1-Month Visit||44
374774|NCT01093625|898300|P2|STARTED|1-Month Visit||49
374775|NCT01093625|898301|P1|STARTED|1-Month Visit||46
374776|NCT01093625|898300|P2|NOT COMPLETED|2-Week Visit||0
374777|NCT01093625|898301|P1|NOT COMPLETED|2-Week Visit||1
374778|NCT01093625|898300|P2|COMPLETED|2-Week Visit||49
374779|NCT01093625|898301|P1|COMPLETED|2-Week Visit||46
374780|NCT01093625|898300|P2|STARTED|2-Week Visit||49
374781|NCT01093625|898301|P1|STARTED|2-Week Visit||47
374782|NCT01093625|898300|P2|NOT COMPLETED|Baseline and Dispensed||0
374783|NCT01093625|898301|P1|NOT COMPLETED|Baseline and Dispensed||2
374784|NCT01093625|898300|P2|COMPLETED|Baseline and Dispensed||49
374785|NCT01093625|898301|P1|COMPLETED|Baseline and Dispensed||47
374786|NCT01093625|898300|P2|STARTED|Baseline and Dispensed||49
374787|NCT01093625|898301|P1|STARTED|Baseline and Dispensed||49
374788|NCT01093599|898321|P2|NOT COMPLETED|Overall Study||46
374789|NCT01093599|898322|P1|NOT COMPLETED|Overall Study||32
374790|NCT01093599|898321|P2|COMPLETED|Overall Study||59
374791|NCT01093599|898322|P1|COMPLETED|Overall Study||59
374792|NCT01093599|898321|P2|STARTED|Overall Study||105
374793|NCT01093599|898322|P1|STARTED|Overall Study||91
374794|NCT01093534|898331|P3|NOT COMPLETED|Overall Study||9
374795|NCT01093534|898332|P2|NOT COMPLETED|Overall Study||16
374796|NCT01093534|898333|P1|NOT COMPLETED|Overall Study||10
374797|NCT01093534|898331|P3|COMPLETED|Overall Study||169
374798|NCT01093534|898332|P2|COMPLETED|Overall Study||167
374799|NCT01093534|898333|P1|COMPLETED|Overall Study||176
374800|NCT01093534|898331|P3|Received Study Treatment|Overall Study||175
374801|NCT01093534|898332|P2|Received Study Treatment|Overall Study||182
374802|NCT01093534|898333|P1|Received Study Treatment|Overall Study||186
374803|NCT01093534|898331|P3|STARTED|Overall Study||178
374804|NCT01093534|898332|P2|STARTED|Overall Study||183
374805|NCT01093534|898333|P1|STARTED|Overall Study||186
374806|NCT01093521|898438|P1|NOT COMPLETED|Overall Study||0
374807|NCT01093521|898438|P1|COMPLETED|Overall Study||20
374808|NCT01093521|898438|P1|STARTED|Overall Study||20
374809|NCT01093469|898456|P3|NOT COMPLETED|Overall Study||1
374810|NCT01093469|898457|P2|NOT COMPLETED|Overall Study||0
374811|NCT01093469|898458|P1|NOT COMPLETED|Overall Study||0
374812|NCT01093469|898456|P3|COMPLETED|Overall Study||12
374813|NCT01093469|898457|P2|COMPLETED|Overall Study||13
374814|NCT01093469|898458|P1|COMPLETED|Overall Study||13
374815|NCT01093469|898456|P3|STARTED|Overall Study||13
374816|NCT01093469|898457|P2|STARTED|Overall Study||13
374817|NCT01093469|898458|P1|STARTED|Overall Study||13
374818|NCT01093417|898468|P2|NOT COMPLETED|Overall Study||1
374819|NCT01093417|898469|P1|NOT COMPLETED|Overall Study||0
374820|NCT01093417|898468|P2|COMPLETED|Overall Study||29
374821|NCT01093417|898469|P1|COMPLETED|Overall Study||15
374822|NCT01093417|898468|P2|STARTED|Overall Study||30
374823|NCT01093417|898469|P1|STARTED|Overall Study||15
374824|NCT01093027|898479|P2|NOT COMPLETED|Visit 2||0
374825|NCT01093027|898480|P1|NOT COMPLETED|Visit 2||0
374826|NCT01093027|898479|P2|COMPLETED|Visit 2||10
374827|NCT01093027|898480|P1|COMPLETED|Visit 2||10
374828|NCT01093027|898479|P2|STARTED|Visit 2||10
374829|NCT01093027|898480|P1|STARTED|Visit 2||10
374830|NCT01093027|898479|P2|NOT COMPLETED|Visit 1||0
374831|NCT01093027|898480|P1|NOT COMPLETED|Visit 1||0
374832|NCT01093027|898479|P2|COMPLETED|Visit 1||10
374833|NCT01093027|898480|P1|COMPLETED|Visit 1||10
374834|NCT01093027|898479|P2|STARTED|Visit 1||10
374835|NCT01093027|898480|P1|STARTED|Visit 1||10
374836|NCT01093014|898491|P3|NOT COMPLETED|Overall Study||0
374837|NCT01093014|898492|P2|NOT COMPLETED|Overall Study||0
374838|NCT01093014|898493|P1|NOT COMPLETED|Overall Study||0
374839|NCT01093014|898491|P3|COMPLETED|Overall Study||12
374840|NCT01093014|898492|P2|COMPLETED|Overall Study||9
374841|NCT01093014|898493|P1|COMPLETED|Overall Study||12
374842|NCT01093014|898491|P3|STARTED|Overall Study||12
374843|NCT01093014|898492|P2|STARTED|Overall Study||9
374844|NCT01093014|898493|P1|STARTED|Overall Study||12
374845|NCT01092923|898512|P2|NOT COMPLETED|Overall Study||0
374846|NCT01092923|898513|P1|NOT COMPLETED|Overall Study||0
374847|NCT01092923|898512|P2|COMPLETED|Overall Study||10
374848|NCT01092923|898513|P1|COMPLETED|Overall Study||10
374849|NCT01092923|898512|P2|STARTED|Overall Study||10
374850|NCT01092923|898513|P1|STARTED|Overall Study||10
374851|NCT01092910|898522|P1|NOT COMPLETED|Overall Study||5
374852|NCT01092910|898522|P1|COMPLETED|Overall Study||52
374853|NCT01092910|898522|P1|10 Month Follow-up|Overall Study||52
374854|NCT01092910|898522|P1|4 Month Follow-up|Overall Study||54
374855|NCT01092910|898522|P1|STARTED|Overall Study||57
374856|NCT01092832|898534|P2|NOT COMPLETED|Overall Study||0
374857|NCT01092832|898535|P1|NOT COMPLETED|Overall Study||1
374858|NCT01092832|898534|P2|COMPLETED|Overall Study||8
374859|NCT01092832|898535|P1|COMPLETED|Overall Study||13
374860|NCT01092832|898534|P2|STARTED|Overall Study||8
374861|NCT01092832|898535|P1|STARTED|Overall Study||14
374862|NCT01092780|898547|P4|NOT COMPLETED|Treatment Period 4||0
374863|NCT01092780|898548|P3|NOT COMPLETED|Treatment Period 4||0
374864|NCT01092780|898549|P2|NOT COMPLETED|Treatment Period 4||0
374865|NCT01092780|898550|P1|NOT COMPLETED|Treatment Period 4||0
374866|NCT01092780|898547|P4|COMPLETED|Treatment Period 4||13
374867|NCT01092780|898548|P3|COMPLETED|Treatment Period 4||13
374868|NCT01092780|898549|P2|COMPLETED|Treatment Period 4||13
374869|NCT01092780|898550|P1|COMPLETED|Treatment Period 4||13
374870|NCT01092780|898547|P4|STARTED|Treatment Period 4||13
374871|NCT01092780|898548|P3|STARTED|Treatment Period 4||13
374872|NCT01092780|898549|P2|STARTED|Treatment Period 4||13
374873|NCT01092780|898550|P1|STARTED|Treatment Period 4||13
374874|NCT01092780|898547|P4|NOT COMPLETED|Washout Period 3||0
374875|NCT01092780|898548|P3|NOT COMPLETED|Washout Period 3||0
374876|NCT01092780|898549|P2|NOT COMPLETED|Washout Period 3||0
374877|NCT01092780|898550|P1|NOT COMPLETED|Washout Period 3||0
374878|NCT01092780|898547|P4|COMPLETED|Washout Period 3||13
374879|NCT01092780|898548|P3|COMPLETED|Washout Period 3||13
374880|NCT01092780|898549|P2|COMPLETED|Washout Period 3||13
374881|NCT01092780|898550|P1|COMPLETED|Washout Period 3||13
374882|NCT01092780|898547|P4|STARTED|Washout Period 3||13
374883|NCT01092780|898548|P3|STARTED|Washout Period 3||13
374884|NCT01092780|898549|P2|STARTED|Washout Period 3||13
374885|NCT01092780|898550|P1|STARTED|Washout Period 3||13
374886|NCT01092780|898547|P4|NOT COMPLETED|Treatment Period 3||0
374887|NCT01092780|898548|P3|NOT COMPLETED|Treatment Period 3||0
374888|NCT01092780|898549|P2|NOT COMPLETED|Treatment Period 3||0
374889|NCT01092780|898550|P1|NOT COMPLETED|Treatment Period 3||0
374890|NCT01092780|898547|P4|COMPLETED|Treatment Period 3||13
374891|NCT01092780|898548|P3|COMPLETED|Treatment Period 3||13
374892|NCT01092780|898549|P2|COMPLETED|Treatment Period 3||13
374893|NCT01092780|898550|P1|COMPLETED|Treatment Period 3||13
374894|NCT01092780|898547|P4|STARTED|Treatment Period 3||13
374895|NCT01092780|898548|P3|STARTED|Treatment Period 3||13
374896|NCT01092780|898549|P2|STARTED|Treatment Period 3||13
374897|NCT01092780|898550|P1|STARTED|Treatment Period 3||13
374898|NCT01092780|898547|P4|NOT COMPLETED|Washout Period 2||0
374899|NCT01092780|898548|P3|NOT COMPLETED|Washout Period 2||1
374900|NCT01092780|898549|P2|NOT COMPLETED|Washout Period 2||1
374901|NCT01092780|898550|P1|NOT COMPLETED|Washout Period 2||0
374902|NCT01092780|898547|P4|COMPLETED|Washout Period 2||13
374903|NCT01092780|898548|P3|COMPLETED|Washout Period 2||13
374904|NCT01092780|898549|P2|COMPLETED|Washout Period 2||13
374905|NCT01092780|898550|P1|COMPLETED|Washout Period 2||13
374906|NCT01092780|898547|P4|STARTED|Washout Period 2||13
374907|NCT01092780|898548|P3|STARTED|Washout Period 2||14
374908|NCT01092780|898549|P2|STARTED|Washout Period 2||14
374909|NCT01092780|898550|P1|STARTED|Washout Period 2||13
374910|NCT01092780|898547|P4|NOT COMPLETED|Treatment Period 2||0
374911|NCT01092780|898548|P3|NOT COMPLETED|Treatment Period 2||0
374912|NCT01092780|898549|P2|NOT COMPLETED|Treatment Period 2||0
374913|NCT01092780|898550|P1|NOT COMPLETED|Treatment Period 2||0
374914|NCT01092780|898547|P4|COMPLETED|Treatment Period 2||13
374915|NCT01092780|898548|P3|COMPLETED|Treatment Period 2||14
374916|NCT01092780|898549|P2|COMPLETED|Treatment Period 2||14
374917|NCT01092780|898550|P1|COMPLETED|Treatment Period 2||13
374918|NCT01092780|898547|P4|STARTED|Treatment Period 2||13
374919|NCT01092780|898548|P3|STARTED|Treatment Period 2||14
374920|NCT01092780|898549|P2|STARTED|Treatment Period 2||14
374921|NCT01092780|898550|P1|STARTED|Treatment Period 2||13
374922|NCT01092780|898547|P4|NOT COMPLETED|Washout Period 1||0
374923|NCT01092780|898548|P3|NOT COMPLETED|Washout Period 1||0
374924|NCT01092780|898549|P2|NOT COMPLETED|Washout Period 1||1
374925|NCT01092780|898550|P1|NOT COMPLETED|Washout Period 1||1
374926|NCT01092780|898547|P4|COMPLETED|Washout Period 1||13
374927|NCT01092780|898548|P3|COMPLETED|Washout Period 1||14
374928|NCT01092780|898549|P2|COMPLETED|Washout Period 1||14
374929|NCT01092780|898550|P1|COMPLETED|Washout Period 1||13
374930|NCT01092780|898547|P4|STARTED|Washout Period 1||13
374931|NCT01092780|898548|P3|STARTED|Washout Period 1||14
374932|NCT01092780|898549|P2|STARTED|Washout Period 1||15
374933|NCT01092780|898550|P1|STARTED|Washout Period 1||14
374934|NCT01092780|898547|P4|NOT COMPLETED|Treatment Period 1||0
374935|NCT01092780|898548|P3|NOT COMPLETED|Treatment Period 1||0
374936|NCT01092780|898549|P2|NOT COMPLETED|Treatment Period 1||0
374937|NCT01092780|898550|P1|NOT COMPLETED|Treatment Period 1||0
374938|NCT01092780|898547|P4|COMPLETED|Treatment Period 1||13
374939|NCT01092780|898548|P3|COMPLETED|Treatment Period 1||14
374940|NCT01092780|898549|P2|COMPLETED|Treatment Period 1||15
374941|NCT01092780|898550|P1|COMPLETED|Treatment Period 1||14
374942|NCT01092780|898547|P4|STARTED|Treatment Period 1||13
374943|NCT01092780|898548|P3|STARTED|Treatment Period 1||14
374944|NCT01092780|898549|P2|STARTED|Treatment Period 1||15
374945|NCT01092780|898550|P1|STARTED|Treatment Period 1||14
374946|NCT01092767|898580|P1|NOT COMPLETED|Overall Study||5
374947|NCT01092767|898580|P1|COMPLETED|Overall Study||45
374948|NCT01092767|898580|P1|STARTED|Overall Study||50
374949|NCT01092728|898586|P2|NOT COMPLETED|Overall Study||14
374950|NCT01092728|898587|P1|NOT COMPLETED|Overall Study||4
374951|NCT01092728|898586|P2|COMPLETED|Overall Study||0
374952|NCT01092728|898587|P1|COMPLETED|Overall Study||0
374953|NCT01092728|898586|P2|STARTED|Overall Study||14
374954|NCT01092728|898587|P1|STARTED|Overall Study||4
374955|NCT01092702|898595|P1|NOT COMPLETED|Overall Study||9
374956|NCT01092702|898595|P1|COMPLETED|Overall Study||23
374957|NCT01092702|898595|P1|STARTED|Overall Study||32
374958|NCT01092663|898601|P2|NOT COMPLETED|Overall Study||4
374959|NCT01092663|898602|P1|NOT COMPLETED|Overall Study||7
374960|NCT01092663|898601|P2|COMPLETED|Overall Study||26
374961|NCT01092663|898602|P1|COMPLETED|Overall Study||24
374962|NCT01092663|898601|P2|STARTED|Overall Study||30
374963|NCT01092663|898602|P1|STARTED|Overall Study||31
374964|NCT01092637|898650|P2|NOT COMPLETED|Overall Study||49
374965|NCT01092637|898651|P1|NOT COMPLETED|Overall Study||47
374966|NCT01092637|898650|P2|COMPLETED|Overall Study||86
374967|NCT01092637|898651|P1|COMPLETED|Overall Study||98
374968|NCT01092637|898650|P2|STARTED|Overall Study||135
374969|NCT01092637|898651|P1|STARTED|Overall Study||145
374970|NCT01092559|898661|P1|NOT COMPLETED|Overall Study||0
374971|NCT01092559|898661|P1|COMPLETED|Overall Study||10
374972|NCT01092559|898661|P1|STARTED|Overall Study||10
374973|NCT01092546|898666|P1|NOT COMPLETED|Overall Study||4
374974|NCT01092546|898666|P1|COMPLETED|Overall Study||12
374975|NCT01092546|898666|P1|STARTED|Overall Study||16
374976|NCT01092507|898673|P2|NOT COMPLETED|Overall Study||0
374977|NCT01092507|898674|P1|NOT COMPLETED|Overall Study||2
374978|NCT01092507|898673|P2|COMPLETED|Overall Study||150
374979|NCT01092507|898674|P1|COMPLETED|Overall Study||147
374980|NCT01092507|898673|P2|STARTED|Overall Study||150
374981|NCT01092507|898674|P1|STARTED|Overall Study||149
374982|NCT01092442|898694|P2|NOT COMPLETED|Overall Study||0
374983|NCT01092442|898695|P1|NOT COMPLETED|Overall Study||0
374984|NCT01092442|898694|P2|COMPLETED|Overall Study||60
374985|NCT01092442|898695|P1|COMPLETED|Overall Study||80
374986|NCT01092442|898694|P2|STARTED|Overall Study||60
374987|NCT01092442|898695|P1|STARTED|Overall Study||80
374988|NCT01092416|898709|P1|NOT COMPLETED|12-Month Follow-up||25
374989|NCT01092416|898709|P1|COMPLETED|12-Month Follow-up||413
374990|NCT01092416|898709|P1|STARTED|12-Month Follow-up||438
374991|NCT01092416|898709|P1|NOT COMPLETED|30-Day Follow-up||10
374992|NCT01092416|898709|P1|COMPLETED|30-Day Follow-up||430
374993|NCT01092416|898709|P1|STARTED|30-Day Follow-up||440
374994|NCT01092416|898709|P1|NOT COMPLETED|Enrollment||3
374995|NCT01092416|898709|P1|COMPLETED|Enrollment||440
374996|NCT01092416|898709|P1|STARTED|Enrollment||443
374997|NCT01092338|898720|P2|NOT COMPLETED|Overall Study||1
374998|NCT01092338|898721|P1|NOT COMPLETED|Overall Study||1
374999|NCT01092338|898720|P2|COMPLETED|Overall Study||21
375000|NCT01092338|898721|P1|COMPLETED|Overall Study||21
375001|NCT01092338|898720|P2|STARTED|Overall Study||22
375002|NCT01092338|898721|P1|STARTED|Overall Study||22
375003|NCT01091974|898733|P4|NOT COMPLETED|Overall Study||7
375004|NCT01091974|898734|P3|NOT COMPLETED|Overall Study||6
375005|NCT01091974|898735|P2|NOT COMPLETED|Overall Study||5
375006|NCT01091974|898736|P1|NOT COMPLETED|Overall Study||5
375007|NCT01091974|898733|P4|COMPLETED|Overall Study||17
375008|NCT01091974|898734|P3|COMPLETED|Overall Study||19
375009|NCT01091974|898735|P2|COMPLETED|Overall Study||18
375010|NCT01091974|898736|P1|COMPLETED|Overall Study||19
375011|NCT01091974|898733|P4|STARTED|Overall Study||24
375012|NCT01091974|898734|P3|STARTED|Overall Study||25
375013|NCT01091974|898735|P2|STARTED|Overall Study||23
375014|NCT01091974|898736|P1|STARTED|Overall Study||24
375015|NCT01091948|898752|P2|NOT COMPLETED|Overall Study||0
375016|NCT01091948|898753|P1|NOT COMPLETED|Overall Study||0
375017|NCT01091948|898752|P2|COMPLETED|Overall Study||38
375018|NCT01091948|898753|P1|COMPLETED|Overall Study||37
375019|NCT01091948|898752|P2|STARTED|Overall Study||38
375020|NCT01091948|898753|P1|STARTED|Overall Study||37
375021|NCT01091675|898771|P1|NOT COMPLETED|Overall Study||34
375022|NCT01091675|898771|P1|COMPLETED|Overall Study||23
375023|NCT01091675|898771|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
375024|NCT01091662|898777|P2|NOT COMPLETED|Overall Study||34
375025|NCT01091662|898778|P1|NOT COMPLETED|Overall Study||17
375026|NCT01091662|898777|P2|COMPLETED|Overall Study||80
375027|NCT01091662|898778|P1|COMPLETED|Overall Study||41
375028|NCT01091662|898777|P2|STARTED|Overall Study||114
375029|NCT01091662|898778|P1|STARTED|Overall Study||58
375030|NCT01091519|898816|P2|NOT COMPLETED|Overall Study||73
375031|NCT01091519|898817|P1|NOT COMPLETED|Overall Study||55
375032|NCT01091519|898816|P2|COMPLETED|Overall Study||362
375033|NCT01091519|898817|P1|COMPLETED|Overall Study||291
375034|NCT01091519|898816|P2|Treated|Overall Study||431
375035|NCT01091519|898817|P1|Treated|Overall Study||342
375036|NCT01091519|898816|P2|STARTED|Overall Study||435
375037|NCT01091519|898817|P1|STARTED|Overall Study||346
375038|NCT01091454|898829|P1|NOT COMPLETED|Overall Study||1
375039|NCT01091454|898829|P1|COMPLETED|Overall Study||47
375040|NCT01091454|898829|P1|STARTED|Overall Study||48
375041|NCT01091259|898838|P1|NOT COMPLETED|Overall Study||5
375042|NCT01091259|898838|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
375043|NCT01091259|898838|P1|STARTED|Overall Study||29
375044|NCT01091246|898849|P3|NOT COMPLETED|Overall Study||13
375045|NCT01091246|898850|P2|NOT COMPLETED|Overall Study||16
375046|NCT01091246|898851|P1|NOT COMPLETED|Overall Study||35
375047|NCT01091246|898849|P3|COMPLETED|Overall Study||450
375048|NCT01091246|898850|P2|COMPLETED|Overall Study||448
375049|NCT01091246|898851|P1|COMPLETED|Overall Study||1350
375050|NCT01091246|898849|P3|STARTED|Overall Study||463
375051|NCT01091246|898850|P2|STARTED|Overall Study||464
375052|NCT01091246|898851|P1|STARTED|Overall Study||1385
375053|NCT01091155|898925|P1|NOT COMPLETED|Overall Study||9
375054|NCT01091155|898925|P1|COMPLETED|Overall Study||279
375055|NCT01091155|898925|P1|STARTED|Overall Study||288
375056|NCT01091116|898934|P5|NOT COMPLETED|Overall Study||11
375057|NCT01091116|898935|P4|NOT COMPLETED|Overall Study||4
375058|NCT01091116|898936|P3|NOT COMPLETED|Overall Study||11
375059|NCT01091116|898937|P2|NOT COMPLETED|Overall Study||8
375060|NCT01091116|898938|P1|NOT COMPLETED|Overall Study||6
375061|NCT01091116|898934|P5|COMPLETED|Overall Study||73
375062|NCT01091116|898935|P4|COMPLETED|Overall Study||80
375063|NCT01091116|898936|P3|COMPLETED|Overall Study||73
375064|NCT01091116|898937|P2|COMPLETED|Overall Study||80
375065|NCT01091116|898938|P1|COMPLETED|Overall Study||77
375066|NCT01091116|898934|P5|STARTED|Overall Study||84
375067|NCT01091116|898935|P4|STARTED|Overall Study||84
375068|NCT01091116|898936|P3|STARTED|Overall Study||84
375069|NCT01091116|898937|P2|STARTED|Overall Study||88
375070|NCT01091116|898938|P1|STARTED|Overall Study||83
375071|NCT01091103|898990|P1|NOT COMPLETED|Overall Study||4
375072|NCT01091103|898990|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
375073|NCT01091103|898990|P1|STARTED|Overall Study||60
375074|NCT01090973|899010|P1|NOT COMPLETED|Overall Study||1
375075|NCT01090973|899010|P1|COMPLETED|Overall Study||0
375076|NCT01090973|899010|P1|STARTED|Overall Study||1
375077|NCT01090765|899026|P6|NOT COMPLETED|Overall Study||1
375078|NCT01090765|899027|P5|NOT COMPLETED|Overall Study||2
375079|NCT01090765|899028|P4|NOT COMPLETED|Overall Study||1
375080|NCT01090765|899029|P3|NOT COMPLETED|Overall Study||0
375081|NCT01090765|899030|P2|NOT COMPLETED|Overall Study||0
375082|NCT01090765|899031|P1|NOT COMPLETED|Overall Study||0
375083|NCT01090765|899026|P6|COMPLETED|Overall Study||3
375084|NCT01090765|899027|P5|COMPLETED|Overall Study||4
375085|NCT01090765|899028|P4|COMPLETED|Overall Study||1
375086|NCT01090765|899029|P3|COMPLETED|Overall Study||3
375087|NCT01090765|899030|P2|COMPLETED|Overall Study||3
375088|NCT01090765|899031|P1|COMPLETED|Overall Study||3
375089|NCT01090765|899026|P6|STARTED|Overall Study||4
375090|NCT01090765|899027|P5|STARTED|Overall Study||6
375091|NCT01090765|899028|P4|STARTED|Overall Study||2
375092|NCT01090765|899029|P3|STARTED|Overall Study||3
375093|NCT01090765|899030|P2|STARTED|Overall Study||3
375094|NCT01090765|899031|P1|STARTED|Overall Study||3
375095|NCT01090752|899048|P2|NOT COMPLETED|Overall Study||0
375096|NCT01090752|899049|P1|NOT COMPLETED|Overall Study||0
375097|NCT01090752|899048|P2|COMPLETED|Overall Study||8
375098|NCT01090752|899049|P1|COMPLETED|Overall Study||8
375099|NCT01090752|899048|P2|STARTED|Overall Study||8
375100|NCT01090752|899049|P1|STARTED|Overall Study||8
375101|NCT01090739|899059|P1|NOT COMPLETED|36 Month Follow-up||23
375102|NCT01090739|899059|P1|COMPLETED|36 Month Follow-up||115
375103|NCT01090739|899059|P1|STARTED|36 Month Follow-up||138
375104|NCT01090739|899059|P1|NOT COMPLETED|24 Month Follow-up||9
375105|NCT01090739|899059|P1|COMPLETED|24 Month Follow-up||138
375106|NCT01090739|899059|P1|STARTED|24 Month Follow-up||147
375107|NCT01090739|899059|P1|NOT COMPLETED|12 Month Follow-up||5
375108|NCT01090739|899059|P1|COMPLETED|12 Month Follow-up||147
375109|NCT01090739|899059|P1|STARTED|12 Month Follow-up||152
375110|NCT01090739|899059|P1|NOT COMPLETED|Enrollment||55
375111|NCT01090739|899059|P1|COMPLETED|Enrollment||152
375112|NCT01090739|899059|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
375113|NCT01090479|899078|P2|NOT COMPLETED|Overall Study||0
375114|NCT01090479|899079|P1|NOT COMPLETED|Overall Study||0
375115|NCT01090479|899078|P2|COMPLETED|Overall Study||50
375116|NCT01090479|899079|P1|COMPLETED|Overall Study||50
375117|NCT01090479|899078|P2|STARTED|Overall Study||50
375118|NCT01090479|899079|P1|STARTED|Overall Study||50
375119|NCT01090453|899087|P2|NOT COMPLETED|Overall Study||14
375120|NCT01090453|899088|P1|NOT COMPLETED|Overall Study||13
375121|NCT01090453|899087|P2|COMPLETED|Overall Study||228
375122|NCT01090453|899088|P1|COMPLETED|Overall Study||225
375123|NCT01090453|899087|P2|STARTED|Overall Study||242
375124|NCT01090453|899088|P1|STARTED|Overall Study||238
375125|NCT01090427|899135|P7|NOT COMPLETED|After Controlled Period||2
375126|NCT01090427|899136|P6|NOT COMPLETED|After Controlled Period||5
375127|NCT01090427|899137|P5|NOT COMPLETED|After Controlled Period||0
375128|NCT01090427|899138|P4|NOT COMPLETED|After Controlled Period||2
375129|NCT01090427|899139|P3|NOT COMPLETED|After Controlled Period||0
375130|NCT01090427|899140|P2|NOT COMPLETED|After Controlled Period||0
375131|NCT01090427|899141|P1|NOT COMPLETED|After Controlled Period||0
375132|NCT01090427|899135|P7|COMPLETED|After Controlled Period||34
375133|NCT01090427|899136|P6|COMPLETED|After Controlled Period||32
375134|NCT01090427|899137|P5|COMPLETED|After Controlled Period||18
375135|NCT01090427|899138|P4|COMPLETED|After Controlled Period||17
375136|NCT01090427|899139|P3|COMPLETED|After Controlled Period||0
375137|NCT01090427|899140|P2|COMPLETED|After Controlled Period||0
375138|NCT01090427|899141|P1|COMPLETED|After Controlled Period||0
375139|NCT01090427|899135|P7|STARTED|After Controlled Period||36
375140|NCT01090427|899136|P6|STARTED|After Controlled Period||37
375141|NCT01090427|899137|P5|STARTED|After Controlled Period||18
375142|NCT01090427|899138|P4|STARTED|After Controlled Period||19
375232|NCT01090050|899270|P1|STARTED|Overall Study||16
375233|NCT01090011|899290|P1|NOT COMPLETED|Overall Study||171
375143|NCT01090427|899139|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
375144|NCT01090427|899140|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
375145|NCT01090427|899141|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
375146|NCT01090427|899135|P7|NOT COMPLETED|Controlled Period||0
375147|NCT01090427|899136|P6|NOT COMPLETED|Controlled Period||0
375148|NCT01090427|899137|P5|NOT COMPLETED|Controlled Period||0
375149|NCT01090427|899138|P4|NOT COMPLETED|Controlled Period||0
375150|NCT01090427|899139|P3|NOT COMPLETED|Controlled Period||0
375151|NCT01090427|899140|P2|NOT COMPLETED|Controlled Period||0
375152|NCT01090427|899141|P1|NOT COMPLETED|Controlled Period||0
375153|NCT01090427|899135|P7|COMPLETED|Controlled Period||0
375154|NCT01090427|899136|P6|COMPLETED|Controlled Period||0
375155|NCT01090427|899137|P5|COMPLETED|Controlled Period||0
375156|NCT01090427|899138|P4|COMPLETED|Controlled Period||0
375157|NCT01090427|899139|P3|COMPLETED|Controlled Period||36
375158|NCT01090427|899140|P2|COMPLETED|Controlled Period||37
375159|NCT01090427|899141|P1|COMPLETED|Controlled Period||37
375160|NCT01090427|899135|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
375161|NCT01090427|899136|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
375162|NCT01090427|899137|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
375163|NCT01090427|899138|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
375164|NCT01090427|899139|P3|STARTED|Controlled Period||36
375165|NCT01090427|899140|P2|STARTED|Controlled Period||37
375166|NCT01090427|899141|P1|STARTED|Controlled Period||37
375167|NCT01090323|899176|P2|NOT COMPLETED|Overall Study||34
375168|NCT01090323|899177|P1|NOT COMPLETED|Overall Study||89
375169|NCT01090323|899176|P2|COMPLETED|Overall Study||19
375170|NCT01090323|899177|P1|COMPLETED|Overall Study||43
375171|NCT01090323|899176|P2|STARTED|Overall Study||53
375172|NCT01090323|899177|P1|STARTED|Overall Study||132
375173|NCT01090310|899189|P4|NOT COMPLETED|Extension Study||20
375174|NCT01090310|899190|P3|NOT COMPLETED|Extension Study||15
375175|NCT01090310|899191|P2|NOT COMPLETED|Extension Study||16
375176|NCT01090310|899192|P1|NOT COMPLETED|Extension Study||14
375177|NCT01090310|899189|P4|COMPLETED|Extension Study||1
375178|NCT01090310|899190|P3|COMPLETED|Extension Study||1
375179|NCT01090310|899191|P2|COMPLETED|Extension Study||0
375180|NCT01090310|899192|P1|COMPLETED|Extension Study||3
375181|NCT01090310|899189|P4|STARTED|Extension Study||21
375182|NCT01090310|899190|P3|STARTED|Extension Study||16
375183|NCT01090310|899191|P2|STARTED|Extension Study||16
375184|NCT01090310|899192|P1|STARTED|Extension Study||17
375185|NCT01090310|899189|P4|NOT COMPLETED|Core Study||7
375186|NCT01090310|899190|P3|NOT COMPLETED|Core Study||7
375187|NCT01090310|899191|P2|NOT COMPLETED|Core Study||11
375188|NCT01090310|899192|P1|NOT COMPLETED|Core Study||8
375189|NCT01090310|899189|P4|COMPLETED|Core Study||27
375190|NCT01090310|899190|P3|COMPLETED|Core Study||24
375191|NCT01090310|899191|P2|COMPLETED|Core Study||20
375192|NCT01090310|899192|P1|COMPLETED|Core Study||21
375193|NCT01090310|899189|P4|STARTED|Core Study||34
375194|NCT01090310|899190|P3|STARTED|Core Study||31
375195|NCT01090310|899191|P2|STARTED|Core Study||31
375196|NCT01090310|899192|P1|STARTED|Core Study||29
375197|NCT01090180|899220|P2|NOT COMPLETED|Overall Study||8
375198|NCT01090180|899221|P1|NOT COMPLETED|Overall Study||11
375199|NCT01090180|899220|P2|COMPLETED|Overall Study||21
375200|NCT01090180|899221|P1|COMPLETED|Overall Study||22
375201|NCT01090180|899220|P2|STARTED|Overall Study||29
375202|NCT01090180|899221|P1|STARTED|Overall Study||33
375203|NCT01090102|899231|P2|NOT COMPLETED|Second 12 Weeks||1
375204|NCT01090102|899232|P1|NOT COMPLETED|Second 12 Weeks||0
375205|NCT01090102|899231|P2|COMPLETED|Second 12 Weeks||15
375206|NCT01090102|899232|P1|COMPLETED|Second 12 Weeks||11
375207|NCT01090102|899231|P2|STARTED|Second 12 Weeks||16
375208|NCT01090102|899232|P1|STARTED|Second 12 Weeks||11
375209|NCT01090102|899231|P2|NOT COMPLETED|First 12 Weeks||2
375210|NCT01090102|899232|P1|NOT COMPLETED|First 12 Weeks||4
375211|NCT01090102|899231|P2|COMPLETED|First 12 Weeks||16
375212|NCT01090102|899232|P1|COMPLETED|First 12 Weeks||11
375213|NCT01090102|899231|P2|STARTED|First 12 Weeks||18
375214|NCT01090102|899232|P1|STARTED|First 12 Weeks||15
375215|NCT01090076|899242|P2|NOT COMPLETED|Overall Study||2
375216|NCT01090076|899243|P1|NOT COMPLETED|Overall Study||1
375217|NCT01090076|899242|P2|COMPLETED|Overall Study||12
375218|NCT01090076|899243|P1|COMPLETED|Overall Study||11
375219|NCT01090076|899242|P2|STARTED|Overall Study||14
375220|NCT01090076|899243|P1|STARTED|Overall Study||12
375221|NCT01090063|899253|P1|NOT COMPLETED|Treatment||4
375222|NCT01090063|899253|P1|COMPLETED|Treatment||20
375223|NCT01090063|899253|P1|STARTED|Treatment||24
375224|NCT01090063|899253|P1|NOT COMPLETED|Screen||4
375225|NCT01090063|899253|P1|COMPLETED|Screen||24
375226|NCT01090063|899253|P1|STARTED|Screen||28
375227|NCT01090050|899269|P2|NOT COMPLETED|Overall Study||7
375228|NCT01090050|899270|P1|NOT COMPLETED|Overall Study||1
375229|NCT01090050|899269|P2|COMPLETED|Overall Study||5
375230|NCT01090050|899270|P1|COMPLETED|Overall Study||15
375231|NCT01090050|899269|P2|STARTED|Overall Study||12
375234|NCT01090011|899290|P1|COMPLETED|Overall Study||0
375235|NCT01090011|899290|P1|STARTED|Overall Study||171
375236|NCT01089751|899360|P2|NOT COMPLETED|Overall Study||27
375237|NCT01089751|899361|P1|NOT COMPLETED|Overall Study||34
375238|NCT01089751|899360|P2|COMPLETED|Overall Study||132
375239|NCT01089751|899361|P1|COMPLETED|Overall Study||129
375240|NCT01089751|899360|P2|STARTED|Overall Study||159
375241|NCT01089751|899361|P1|STARTED|Overall Study||163
375242|NCT01089608|899383|P2|NOT COMPLETED|Overall Study||6
375243|NCT01089608|899384|P1|NOT COMPLETED|Overall Study||0
375244|NCT01089608|899383|P2|COMPLETED|Overall Study||44
375245|NCT01089608|899384|P1|COMPLETED|Overall Study||43
375246|NCT01089608|899383|P2|STARTED|Overall Study||50
375247|NCT01089608|899384|P1|STARTED|Overall Study||43
375248|NCT01089595|899392|P2|NOT COMPLETED|Overall Study||0
375249|NCT01089595|899393|P1|NOT COMPLETED|Overall Study||0
375250|NCT01089595|899392|P2|COMPLETED|Overall Study||3
375251|NCT01089595|899393|P1|COMPLETED|Overall Study||2
375252|NCT01089595|899392|P2|STARTED|Overall Study||3
375253|NCT01089595|899393|P1|STARTED|Overall Study||2
375254|NCT01089582|899401|P1|NOT COMPLETED|Overall Study||30
375255|NCT01089582|899401|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
375256|NCT01089582|899401|P1|STARTED|Overall Study||603
375257|NCT01089569|899414|P3|NOT COMPLETED|Overall Study||4
375258|NCT01089569|899415|P2|NOT COMPLETED|Overall Study||3
375259|NCT01089569|899416|P1|NOT COMPLETED|Overall Study||4
375260|NCT01089569|899414|P3|COMPLETED|Overall Study||16
375261|NCT01089569|899415|P2|COMPLETED|Overall Study||17
375262|NCT01089569|899416|P1|COMPLETED|Overall Study||16
375263|NCT01089569|899414|P3|STARTED|Overall Study||20
375264|NCT01089569|899415|P2|STARTED|Overall Study||20
375265|NCT01089569|899416|P1|STARTED|Overall Study||20
375266|NCT01089556|899444|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
375267|NCT01089556|899445|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
375268|NCT01089556|899446|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
375269|NCT01089556|899447|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
375270|NCT01089556|899448|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
375271|NCT01089556|899449|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
375272|NCT01089556|899444|P6|COMPLETED|Study Period III (Weeks 9-16)||92
375273|NCT01089556|899445|P5|COMPLETED|Study Period III (Weeks 9-16)||83
375274|NCT01089556|899446|P4|COMPLETED|Study Period III (Weeks 9-16)||66
375275|NCT01089556|899447|P3|COMPLETED|Study Period III (Weeks 9-16)||60
375276|NCT01089556|899448|P2|COMPLETED|Study Period III (Weeks 9-16)||0
375277|NCT01089556|899449|P1|COMPLETED|Study Period III (Weeks 9-16)||0
375278|NCT01089556|899444|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
375279|NCT01089556|899445|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
375280|NCT01089556|899446|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
375281|NCT01089556|899447|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
375282|NCT01089556|899448|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
375283|NCT01089556|899449|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
375284|NCT01089556|899444|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
375285|NCT01089556|899445|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
375286|NCT01089556|899446|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
375287|NCT01089556|899447|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
375288|NCT01089556|899448|P2|STARTED|Study Period III (Weeks 9-16)||0
375289|NCT01089556|899449|P1|STARTED|Study Period III (Weeks 9-16)||0
375290|NCT01089556|899444|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
375291|NCT01089556|899445|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
375292|NCT01089556|899446|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
375293|NCT01089556|899447|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
375294|NCT01089556|899448|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
375295|NCT01089556|899449|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
375296|NCT01089556|899444|P6|COMPLETED|Study Period II (Weeks 1-8)||0
375297|NCT01089556|899445|P5|COMPLETED|Study Period II (Weeks 1-8)||0
375298|NCT01089556|899446|P4|COMPLETED|Study Period II (Weeks 1-8)||0
375299|NCT01089556|899447|P3|COMPLETED|Study Period II (Weeks 1-8)||0
375300|NCT01089556|899448|P2|COMPLETED|Study Period II (Weeks 1-8)||333
375301|NCT01089556|899449|P1|COMPLETED|Study Period II (Weeks 1-8)||333
375302|NCT01089556|899444|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
375303|NCT01089556|899445|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
375304|NCT01089556|899446|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
375305|NCT01089556|899447|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
375306|NCT01089556|899448|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
375307|NCT01089556|899449|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
375308|NCT01089556|899444|P6|Safety Population|Study Period II (Weeks 1-8)||0
375309|NCT01089556|899445|P5|Safety Population|Study Period II (Weeks 1-8)||0
375310|NCT01089556|899446|P4|Safety Population|Study Period II (Weeks 1-8)||0
375311|NCT01089556|899447|P3|Safety Population|Study Period II (Weeks 1-8)||0
375312|NCT01089556|899448|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
375313|NCT01089556|899449|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
375314|NCT01089556|899444|P6|STARTED|Study Period II (Weeks 1-8)||0
375315|NCT01089556|899445|P5|STARTED|Study Period II (Weeks 1-8)||0
375316|NCT01089556|899446|P4|STARTED|Study Period II (Weeks 1-8)||0
375317|NCT01089556|899447|P3|STARTED|Study Period II (Weeks 1-8)||0
375318|NCT01089556|899448|P2|STARTED|Study Period II (Weeks 1-8)||407
375319|NCT01089556|899449|P1|STARTED|Study Period II (Weeks 1-8)||404
375320|NCT01089543|899523|P4|NOT COMPLETED|Overall Study||2
375321|NCT01089543|899524|P3|NOT COMPLETED|Overall Study||3
375322|NCT01089543|899525|P2|NOT COMPLETED|Overall Study||4
375323|NCT01089543|899526|P1|NOT COMPLETED|Overall Study||3
375324|NCT01089543|899523|P4|COMPLETED|Overall Study||83
375325|NCT01089543|899524|P3|COMPLETED|Overall Study||81
375326|NCT01089543|899525|P2|COMPLETED|Overall Study||81
375327|NCT01089543|899526|P1|COMPLETED|Overall Study||81
375328|NCT01089543|899523|P4|STARTED|Overall Study||85
375329|NCT01089543|899524|P3|STARTED|Overall Study||84
375330|NCT01089543|899525|P2|STARTED|Overall Study||85
375331|NCT01089543|899526|P1|STARTED|Overall Study||84
375332|NCT01089517|899543|P3|NOT COMPLETED|Overall Study||5
375333|NCT01089517|899544|P2|NOT COMPLETED|Overall Study||5
375334|NCT01089517|899545|P1|NOT COMPLETED|Overall Study||4
375335|NCT01089517|899543|P3|COMPLETED|Overall Study||147
375336|NCT01089517|899544|P2|COMPLETED|Overall Study||144
375337|NCT01089517|899545|P1|COMPLETED|Overall Study||144
375338|NCT01089517|899543|P3|STARTED|Overall Study||152
375339|NCT01089517|899544|P2|STARTED|Overall Study||149
375340|NCT01089517|899545|P1|STARTED|Overall Study||148
375341|NCT01089504|899561|P2|NOT COMPLETED|Overall Study||1
375342|NCT01089504|899562|P1|NOT COMPLETED|Overall Study||3
375343|NCT01089504|899561|P2|COMPLETED|Overall Study||4
375344|NCT01089504|899562|P1|COMPLETED|Overall Study||5
375345|NCT01089504|899561|P2|STARTED|Overall Study||5
375346|NCT01089504|899562|P1|STARTED|Overall Study||8
375347|NCT01089413|899575|P1|NOT COMPLETED|Overall Study||201
375348|NCT01089413|899575|P1|COMPLETED|Overall Study||0
375349|NCT01089413|899575|P1|Received Bevacizumab in First Line|Overall Study||199
375350|NCT01089413|899575|P1|STARTED|Overall Study||201
375351|NCT01089231|899596|P4|NOT COMPLETED|Overall Study||1
375352|NCT01089231|899597|P3|NOT COMPLETED|Overall Study||2
375353|NCT01089231|899598|P2|NOT COMPLETED|Overall Study||2
375354|NCT01089231|899599|P1|NOT COMPLETED|Overall Study||4
375355|NCT01089231|899596|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
375356|NCT01089231|899597|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
375357|NCT01089231|899598|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
375358|NCT01089231|899599|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
375359|NCT01089231|899596|P4|STARTED|Overall Study||10
375360|NCT01089231|899597|P3|STARTED|Overall Study||10
375361|NCT01089231|899598|P2|STARTED|Overall Study||10
375362|NCT01089231|899599|P1|STARTED|Overall Study||10
375363|NCT01089127|899623|P6|NOT COMPLETED|Overall Study||3
375364|NCT01089127|899624|P5|NOT COMPLETED|Overall Study||2
375365|NCT01089127|899625|P4|NOT COMPLETED|Overall Study||1
375366|NCT01089127|899626|P3|NOT COMPLETED|Overall Study||2
375367|NCT01089127|899627|P2|NOT COMPLETED|Overall Study||5
375368|NCT01089127|899628|P1|NOT COMPLETED|Overall Study||8
375369|NCT01089127|899623|P6|COMPLETED|Overall Study||88
375370|NCT01089127|899624|P5|COMPLETED|Overall Study||90
375371|NCT01089127|899625|P4|COMPLETED|Overall Study||91
375372|NCT01089127|899626|P3|COMPLETED|Overall Study||92
375373|NCT01089127|899627|P2|COMPLETED|Overall Study||86
375374|NCT01089127|899628|P1|COMPLETED|Overall Study||84
375375|NCT01089127|899623|P6|Exposed to Study Drug|Overall Study||91
375466|NCT01088997|899696|P2|STARTED|Overall Study||5
375376|NCT01089127|899624|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
375377|NCT01089127|899625|P4|Exposed to Study Drug|Overall Study||92
375378|NCT01089127|899626|P3|Exposed to Study Drug|Overall Study||94
375379|NCT01089127|899627|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
375380|NCT01089127|899628|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
375381|NCT01089127|899623|P6|STARTED|Overall Study||91
375382|NCT01089127|899624|P5|STARTED|Overall Study||92
375383|NCT01089127|899625|P4|STARTED|Overall Study||92
375384|NCT01089127|899626|P3|STARTED|Overall Study||94
375385|NCT01089127|899627|P2|STARTED|Overall Study||91
375386|NCT01089127|899628|P1|STARTED|Overall Study||92
375387|NCT01089062|899654|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
375388|NCT01089062|899655|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
375389|NCT01089062|899656|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
375390|NCT01089062|899657|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
375391|NCT01089062|899658|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
375392|NCT01089062|899659|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
375393|NCT01089062|899654|P6|COMPLETED|Follow-up Visit (Final Visit)||3
375394|NCT01089062|899655|P5|COMPLETED|Follow-up Visit (Final Visit)||3
375395|NCT01089062|899656|P4|COMPLETED|Follow-up Visit (Final Visit)||3
375396|NCT01089062|899657|P3|COMPLETED|Follow-up Visit (Final Visit)||3
375397|NCT01089062|899658|P2|COMPLETED|Follow-up Visit (Final Visit)||3
375398|NCT01089062|899659|P1|COMPLETED|Follow-up Visit (Final Visit)||3
375399|NCT01089062|899654|P6|STARTED|Follow-up Visit (Final Visit)||3
375400|NCT01089062|899655|P5|STARTED|Follow-up Visit (Final Visit)||3
375401|NCT01089062|899656|P4|STARTED|Follow-up Visit (Final Visit)||3
375402|NCT01089062|899657|P3|STARTED|Follow-up Visit (Final Visit)||3
375403|NCT01089062|899658|P2|STARTED|Follow-up Visit (Final Visit)||3
375404|NCT01089062|899659|P1|STARTED|Follow-up Visit (Final Visit)||3
375405|NCT01089062|899654|P6|NOT COMPLETED|Visit 4||0
375406|NCT01089062|899655|P5|NOT COMPLETED|Visit 4||0
375407|NCT01089062|899656|P4|NOT COMPLETED|Visit 4||0
375408|NCT01089062|899657|P3|NOT COMPLETED|Visit 4||0
375409|NCT01089062|899658|P2|NOT COMPLETED|Visit 4||0
375410|NCT01089062|899659|P1|NOT COMPLETED|Visit 4||0
375411|NCT01089062|899654|P6|COMPLETED|Visit 4||3
375412|NCT01089062|899655|P5|COMPLETED|Visit 4||3
375413|NCT01089062|899656|P4|COMPLETED|Visit 4||3
375414|NCT01089062|899657|P3|COMPLETED|Visit 4||3
375415|NCT01089062|899658|P2|COMPLETED|Visit 4||3
375416|NCT01089062|899659|P1|COMPLETED|Visit 4||3
375417|NCT01089062|899654|P6|STARTED|Visit 4||3
375418|NCT01089062|899655|P5|STARTED|Visit 4||3
375419|NCT01089062|899656|P4|STARTED|Visit 4||3
375420|NCT01089062|899657|P3|STARTED|Visit 4||3
375421|NCT01089062|899658|P2|STARTED|Visit 4||3
375422|NCT01089062|899659|P1|STARTED|Visit 4||3
375423|NCT01089062|899654|P6|NOT COMPLETED|Visit 3||0
375424|NCT01089062|899655|P5|NOT COMPLETED|Visit 3||0
375425|NCT01089062|899656|P4|NOT COMPLETED|Visit 3||1
375426|NCT01089062|899657|P3|NOT COMPLETED|Visit 3||0
375427|NCT01089062|899658|P2|NOT COMPLETED|Visit 3||0
375428|NCT01089062|899659|P1|NOT COMPLETED|Visit 3||0
375429|NCT01089062|899654|P6|COMPLETED|Visit 3||3
375430|NCT01089062|899655|P5|COMPLETED|Visit 3||3
375431|NCT01089062|899656|P4|COMPLETED|Visit 3||3
375432|NCT01089062|899657|P3|COMPLETED|Visit 3||3
375433|NCT01089062|899658|P2|COMPLETED|Visit 3||3
375434|NCT01089062|899659|P1|COMPLETED|Visit 3||3
375435|NCT01089062|899654|P6|STARTED|Visit 3||3
375436|NCT01089062|899655|P5|STARTED|Visit 3||3
375437|NCT01089062|899656|P4|STARTED|Visit 3||4
375438|NCT01089062|899657|P3|STARTED|Visit 3||3
375439|NCT01089062|899658|P2|STARTED|Visit 3||3
375440|NCT01089062|899659|P1|STARTED|Visit 3||3
375441|NCT01089062|899654|P6|NOT COMPLETED|Visit 2 (Randomization)||1
375442|NCT01089062|899655|P5|NOT COMPLETED|Visit 2 (Randomization)||1
375443|NCT01089062|899656|P4|NOT COMPLETED|Visit 2 (Randomization)||0
375444|NCT01089062|899657|P3|NOT COMPLETED|Visit 2 (Randomization)||1
375445|NCT01089062|899658|P2|NOT COMPLETED|Visit 2 (Randomization)||1
375446|NCT01089062|899659|P1|NOT COMPLETED|Visit 2 (Randomization)||1
375447|NCT01089062|899654|P6|COMPLETED|Visit 2 (Randomization)||3
375448|NCT01089062|899655|P5|COMPLETED|Visit 2 (Randomization)||3
375449|NCT01089062|899656|P4|COMPLETED|Visit 2 (Randomization)||4
375450|NCT01089062|899657|P3|COMPLETED|Visit 2 (Randomization)||3
375451|NCT01089062|899658|P2|COMPLETED|Visit 2 (Randomization)||3
375452|NCT01089062|899659|P1|COMPLETED|Visit 2 (Randomization)||3
375453|NCT01089062|899654|P6|STARTED|Visit 2 (Randomization)||4
375454|NCT01089062|899655|P5|STARTED|Visit 2 (Randomization)||4
375455|NCT01089062|899656|P4|STARTED|Visit 2 (Randomization)||4
375456|NCT01089062|899657|P3|STARTED|Visit 2 (Randomization)||4
375457|NCT01089062|899658|P2|STARTED|Visit 2 (Randomization)||4
375458|NCT01089062|899659|P1|STARTED|Visit 2 (Randomization)||4
375459|NCT01089023|899682|P1|NOT COMPLETED|Overall Study||7
375460|NCT01089023|899682|P1|COMPLETED|Overall Study||88
375461|NCT01089023|899682|P1|STARTED|Overall Study||95
375462|NCT01088997|899696|P2|NOT COMPLETED|Overall Study||3
375463|NCT01088997|899697|P1|NOT COMPLETED|Overall Study||3
375464|NCT01088997|899696|P2|COMPLETED|Overall Study||2
375465|NCT01088997|899697|P1|COMPLETED|Overall Study||4
375467|NCT01088997|899697|P1|STARTED|Overall Study||7
375468|NCT01088984|899708|P2|NOT COMPLETED|Phase 2||32
375469|NCT01088984|899709|P1|NOT COMPLETED|Phase 2||0
375470|NCT01088984|899708|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
375471|NCT01088984|899709|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
375472|NCT01088984|899708|P2|STARTED|Phase 2||32
375473|NCT01088984|899709|P1|STARTED|Phase 2||0
375474|NCT01088984|899708|P2|NOT COMPLETED|Phase 1||6
375475|NCT01088984|899709|P1|NOT COMPLETED|Phase 1||5
375476|NCT01088984|899708|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
375477|NCT01088984|899709|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
375478|NCT01088984|899708|P2|STARTED|Phase 1||6
375479|NCT01088984|899709|P1|STARTED|Phase 1||5
375480|NCT01088711|899731|P4|NOT COMPLETED|Overall Study||0
375481|NCT01088711|899732|P3|NOT COMPLETED|Overall Study||0
375482|NCT01088711|899733|P2|NOT COMPLETED|Overall Study||0
375483|NCT01088711|899734|P1|NOT COMPLETED|Overall Study||0
375484|NCT01088711|899731|P4|COMPLETED|Overall Study||2
375485|NCT01088711|899732|P3|COMPLETED|Overall Study||6
375486|NCT01088711|899733|P2|COMPLETED|Overall Study||6
375487|NCT01088711|899734|P1|COMPLETED|Overall Study||18
375488|NCT01088711|899731|P4|STARTED|Overall Study||2
375489|NCT01088711|899732|P3|STARTED|Overall Study||6
375490|NCT01088711|899733|P2|STARTED|Overall Study||6
375491|NCT01088711|899734|P1|STARTED|Overall Study||18
375492|NCT01088672|899758|P1|NOT COMPLETED|Overall Study||0
375493|NCT01088672|899758|P1|COMPLETED|Overall Study||60
375494|NCT01088672|899758|P1|STARTED|Overall Study||60
375495|NCT01088646|899764|P1|NOT COMPLETED|Overall Study||0
375496|NCT01088646|899764|P1|COMPLETED|Overall Study||25
375497|NCT01088646|899764|P1|STARTED|Overall Study||25
375498|NCT01088529|899770|P2|NOT COMPLETED|Overall Study||1
375499|NCT01088529|899771|P1|NOT COMPLETED|Overall Study||0
375500|NCT01088529|899770|P2|COMPLETED|Overall Study||21
375501|NCT01088529|899771|P1|COMPLETED|Overall Study||44
375502|NCT01088529|899770|P2|Received Treatment|Overall Study||21
375503|NCT01088529|899771|P1|Received Treatment|Overall Study||44
375504|NCT01088529|899770|P2|STARTED|Overall Study||22
375505|NCT01088529|899771|P1|STARTED|Overall Study||44
375506|NCT01088503|899784|P3|NOT COMPLETED|Overall Study||17
375507|NCT01088503|899785|P2|NOT COMPLETED|Overall Study||685
375508|NCT01088503|899786|P1|NOT COMPLETED|Overall Study||182
375509|NCT01088503|899784|P3|COMPLETED|Overall Study||241
375510|NCT01088503|899785|P2|COMPLETED|Overall Study||8161
375511|NCT01088503|899786|P1|COMPLETED|Overall Study||2941
375512|NCT01088503|899784|P3|STARTED|Overall Study||258
375513|NCT01088503|899785|P2|STARTED|Overall Study||8846
375514|NCT01088503|899786|P1|STARTED|Overall Study||3123
375515|NCT01088464|899810|P3|NOT COMPLETED|Overall Study||0
375516|NCT01088464|899811|P2|NOT COMPLETED|Overall Study||0
375517|NCT01088464|899812|P1|NOT COMPLETED|Overall Study||0
375518|NCT01088464|899810|P3|COMPLETED|Overall Study||6
375519|NCT01088464|899811|P2|COMPLETED|Overall Study||6
375520|NCT01088464|899812|P1|COMPLETED|Overall Study||3
375521|NCT01088464|899810|P3|Received Any Quantity of Study Drug|Overall Study||6
375522|NCT01088464|899811|P2|Received Any Quantity of Study Drug|Overall Study||6
375523|NCT01088464|899812|P1|Received Any Quantity of Study Drug|Overall Study||3
375524|NCT01088464|899810|P3|STARTED|Overall Study||6
375525|NCT01088464|899811|P2|STARTED|Overall Study||6
375526|NCT01088464|899812|P1|STARTED|Overall Study||3
375527|NCT01088438|899864|P2|NOT COMPLETED|Overall Study||36
375528|NCT01088438|899865|P1|NOT COMPLETED|Overall Study||29
375529|NCT01088438|899864|P2|COMPLETED|Overall Study||59
375530|NCT01088438|899865|P1|COMPLETED|Overall Study||65
375531|NCT01088438|899864|P2|STARTED|Overall Study||95
375532|NCT01088438|899865|P1|STARTED|Overall Study||94
375533|NCT01088399|899878|P3|NOT COMPLETED|Overall Study||281
375534|NCT01088399|899879|P2|NOT COMPLETED|Overall Study||1347
375535|NCT01088399|899880|P1|NOT COMPLETED|Overall Study||7121
375536|NCT01088399|899878|P3|COMPLETED|Overall Study||21
375537|NCT01088399|899879|P2|COMPLETED|Overall Study||308
375538|NCT01088399|899880|P1|COMPLETED|Overall Study||1595
375539|NCT01088399|899878|P3|STARTED|Overall Study||302
375540|NCT01088399|899879|P2|STARTED|Overall Study||1655
375541|NCT01088399|899880|P1|STARTED|Overall Study||8716
375542|NCT01088295|899903|P1|NOT COMPLETED|Overall Study||1
375543|NCT01088295|899903|P1|COMPLETED|Overall Study||35
375544|NCT01088295|899903|P1|STARTED|Overall Study||36
375545|NCT01087996|899909|P2|NOT COMPLETED|Overall Study||0
375546|NCT01087996|899910|P1|NOT COMPLETED|Overall Study||0
375547|NCT01087996|899909|P2|COMPLETED|Overall Study||15
375548|NCT01087996|899910|P1|COMPLETED|Overall Study||15
375549|NCT01087996|899909|P2|STARTED|Overall Study||15
375550|NCT01087996|899910|P1|STARTED|Overall Study||15
375551|NCT01087970|899932|P1|NOT COMPLETED|Overall Study||2
375552|NCT01087970|899932|P1|COMPLETED|Overall Study||67
375553|NCT01087970|899932|P1|Received Carboplatin|Overall Study||63
375554|NCT01087970|899932|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
375555|NCT01087970|899932|P1|Completed 6 Cycles|Overall Study||69
375556|NCT01087970|899932|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
375557|NCT01087970|899932|P1|STARTED|Overall Study||69
375558|NCT01087957|899944|P2|NOT COMPLETED|Overall Study||55
375559|NCT01087957|899945|P1|NOT COMPLETED|Overall Study||41
375560|NCT01087957|899944|P2|COMPLETED|Overall Study||187
375561|NCT01087957|899945|P1|COMPLETED|Overall Study||212
375562|NCT01087957|899944|P2|STARTED|Overall Study||242
375563|NCT01087957|899945|P1|STARTED|Overall Study||253
375564|NCT01087944|899971|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
375565|NCT01087944|899972|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
375566|NCT01087944|899971|P2|COMPLETED|Period 2 (Week 4-6)||28
375567|NCT01087944|899972|P1|COMPLETED|Period 2 (Week 4-6)||29
375568|NCT01087944|899971|P2|STARTED|Period 2 (Week 4-6)||30
375569|NCT01087944|899972|P1|STARTED|Period 2 (Week 4-6)||29
375570|NCT01087944|899971|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
375571|NCT01087944|899972|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
375572|NCT01087944|899971|P2|COMPLETED|Period 1 (Week 1-3)||30
375573|NCT01087944|899972|P1|COMPLETED|Period 1 (Week 1-3)||29
375574|NCT01087944|899971|P2|STARTED|Period 1 (Week 1-3)||30
375575|NCT01087944|899972|P1|STARTED|Period 1 (Week 1-3)||30
375576|NCT01087918|900002|P2|NOT COMPLETED|Overall Study||0
375577|NCT01087918|900003|P1|NOT COMPLETED|Overall Study||0
375578|NCT01087918|900002|P2|COMPLETED|Overall Study||4
375579|NCT01087918|900003|P1|COMPLETED|Overall Study||5
375580|NCT01087918|900002|P2|STARTED|Overall Study||4
375581|NCT01087918|900003|P1|STARTED|Overall Study||5
375582|NCT01087905|900037|P8|NOT COMPLETED|Overall Study||29
375583|NCT01087905|900038|P7|NOT COMPLETED|Overall Study||23
375584|NCT01087905|900039|P6|NOT COMPLETED|Overall Study||28
375585|NCT01087905|900040|P5|NOT COMPLETED|Overall Study||31
375586|NCT01087905|900041|P4|NOT COMPLETED|Overall Study||36
375587|NCT01087905|900042|P3|NOT COMPLETED|Overall Study||22
375588|NCT01087905|900043|P2|NOT COMPLETED|Overall Study||32
375589|NCT01087905|900044|P1|NOT COMPLETED|Overall Study||29
375590|NCT01087905|900037|P8|COMPLETED|Overall Study||98
375591|NCT01087905|900038|P7|COMPLETED|Overall Study||98
375592|NCT01087905|900039|P6|COMPLETED|Overall Study||99
375593|NCT01087905|900040|P5|COMPLETED|Overall Study||91
375594|NCT01087905|900041|P4|COMPLETED|Overall Study||86
375595|NCT01087905|900042|P3|COMPLETED|Overall Study||101
375596|NCT01087905|900043|P2|COMPLETED|Overall Study||94
375597|NCT01087905|900044|P1|COMPLETED|Overall Study||90
375598|NCT01087905|900037|P8|STARTED|Overall Study||127
375599|NCT01087905|900038|P7|STARTED|Overall Study||121
375600|NCT01087905|900039|P6|STARTED|Overall Study||127
375601|NCT01087905|900040|P5|STARTED|Overall Study||122
375602|NCT01087905|900041|P4|STARTED|Overall Study||122
375603|NCT01087905|900042|P3|STARTED|Overall Study||123
375604|NCT01087905|900043|P2|STARTED|Overall Study||126
375605|NCT01087905|900044|P1|STARTED|Overall Study||119
375606|NCT01087814|900066|P2|NOT COMPLETED|Second Intervention (5 Days)||0
375607|NCT01087814|900067|P1|NOT COMPLETED|Second Intervention (5 Days)||1
375608|NCT01087814|900066|P2|COMPLETED|Second Intervention (5 Days)||6
375609|NCT01087814|900067|P1|COMPLETED|Second Intervention (5 Days)||4
375610|NCT01087814|900066|P2|STARTED|Second Intervention (5 Days)||6
375611|NCT01087814|900067|P1|STARTED|Second Intervention (5 Days)||5
375612|NCT01087814|900066|P2|NOT COMPLETED|First Intervention (5 Days)||1
375613|NCT01087814|900067|P1|NOT COMPLETED|First Intervention (5 Days)||3
375614|NCT01087814|900066|P2|COMPLETED|First Intervention (5 Days)||6
375615|NCT01087814|900067|P1|COMPLETED|First Intervention (5 Days)||5
375616|NCT01087814|900066|P2|STARTED|First Intervention (5 Days)||7
375617|NCT01087814|900067|P1|STARTED|First Intervention (5 Days)||8
375618|NCT01087801|900075|P2|NOT COMPLETED|Overall Study||5
375619|NCT01087801|900076|P1|NOT COMPLETED|Overall Study||4
375620|NCT01087801|900075|P2|COMPLETED|Overall Study||29
375621|NCT01087801|900076|P1|COMPLETED|Overall Study||26
375622|NCT01087801|900075|P2|STARTED|Overall Study||34
375623|NCT01087801|900076|P1|STARTED|Overall Study||30
375624|NCT01087788|900085|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
375625|NCT01087788|900086|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
375626|NCT01087788|900087|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
375627|NCT01087788|900085|P3|COMPLETED|Open-Label Period (OL-P)||86
375628|NCT01087788|900086|P2|COMPLETED|Open-Label Period (OL-P)||97
375629|NCT01087788|900087|P1|COMPLETED|Open-Label Period (OL-P)||81
375630|NCT01087788|900085|P3|STARTED|Open-Label Period (OL-P)||114
375631|NCT01087788|900086|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
375632|NCT01087788|900087|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
375633|NCT01087788|900085|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
375634|NCT01087788|900086|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
375635|NCT01087788|900087|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
375636|NCT01087788|900085|P3|COMPLETED|24-weeks Dose-blind Period||114
375637|NCT01087788|900086|P2|COMPLETED|24-weeks Dose-blind Period||123
375638|NCT01087788|900087|P1|COMPLETED|24-weeks Dose-blind Period||113
375639|NCT01087788|900085|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
375640|NCT01087788|900086|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
375641|NCT01087788|900087|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
375642|NCT01087788|900085|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
375714|NCT01087528|900222|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
375643|NCT01087788|900086|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
375644|NCT01087788|900087|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
375645|NCT01087788|900085|P3|STARTED|24-weeks Dose-blind Period||120
375646|NCT01087788|900086|P2|STARTED|24-weeks Dose-blind Period||128
375647|NCT01087788|900087|P1|STARTED|24-weeks Dose-blind Period||120
375648|NCT01087788|900085|P3|NOT COMPLETED|24-weeks Double-blind Period||15
375649|NCT01087788|900086|P2|NOT COMPLETED|24-weeks Double-blind Period||10
375650|NCT01087788|900087|P1|NOT COMPLETED|24-weeks Double-blind Period||16
375651|NCT01087788|900085|P3|COMPLETED|24-weeks Double-blind Period||120
375652|NCT01087788|900086|P2|COMPLETED|24-weeks Double-blind Period||128
375653|NCT01087788|900087|P1|COMPLETED|24-weeks Double-blind Period||120
375654|NCT01087788|900085|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
375655|NCT01087788|900086|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
375656|NCT01087788|900087|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
375657|NCT01087788|900085|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
375658|NCT01087788|900086|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
375659|NCT01087788|900087|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
375660|NCT01087788|900085|P3|STARTED|24-weeks Double-blind Period||135
375661|NCT01087788|900086|P2|STARTED|24-weeks Double-blind Period||138
375662|NCT01087788|900087|P1|STARTED|24-weeks Double-blind Period||136
375663|NCT01087762|900117|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
375664|NCT01087762|900118|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
375665|NCT01087762|900119|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
375666|NCT01087762|900120|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
375667|NCT01087762|900121|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
375668|NCT01087762|900117|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
375669|NCT01087762|900118|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
375670|NCT01087762|900119|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
375671|NCT01087762|900120|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
375672|NCT01087762|900121|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
375673|NCT01087762|900117|P5|STARTED|Open-Label Period (Weeks 48-204)||157
375674|NCT01087762|900118|P4|STARTED|Open-Label Period (Weeks 48-204)||158
375675|NCT01087762|900119|P3|STARTED|Open-Label Period (Weeks 48-204)||0
375676|NCT01087762|900120|P2|STARTED|Open-Label Period (Weeks 48-204)||0
375677|NCT01087762|900121|P1|STARTED|Open-Label Period (Weeks 48-204)||0
375678|NCT01087762|900117|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
375679|NCT01087762|900118|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
375680|NCT01087762|900119|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
375681|NCT01087762|900120|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
375682|NCT01087762|900121|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
375683|NCT01087762|900117|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
375684|NCT01087762|900118|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
375685|NCT01087762|900119|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
375686|NCT01087762|900120|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
375687|NCT01087762|900121|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
375688|NCT01087762|900117|P5|STARTED|Double Blind Period (Weeks 0-24)||0
375689|NCT01087762|900118|P4|STARTED|Double Blind Period (Weeks 0-24)||0
375690|NCT01087762|900119|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
375691|NCT01087762|900120|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
375692|NCT01087762|900121|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
375693|NCT01087736|900169|P2|NOT COMPLETED|Overall Study||2
375694|NCT01087736|900170|P1|NOT COMPLETED|Overall Study||1
375695|NCT01087736|900169|P2|COMPLETED|Overall Study||14
375696|NCT01087736|900170|P1|COMPLETED|Overall Study||13
375697|NCT01087736|900169|P2|STARTED|Overall Study||16
375698|NCT01087736|900170|P1|STARTED|Overall Study||14
375699|NCT01087723|900180|P2|NOT COMPLETED|Overall Study||20
375700|NCT01087723|900181|P1|NOT COMPLETED|Overall Study||14
375701|NCT01087723|900180|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
375702|NCT01087723|900181|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
375703|NCT01087723|900180|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
375704|NCT01087723|900181|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
375705|NCT01087723|900180|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
375706|NCT01087723|900181|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
375707|NCT01087541|900205|P2|NOT COMPLETED|Overall Study||0
375708|NCT01087541|900206|P1|NOT COMPLETED|Overall Study||0
375709|NCT01087541|900205|P2|COMPLETED|Overall Study||3523
375710|NCT01087541|900206|P1|COMPLETED|Overall Study||3307
375711|NCT01087541|900205|P2|STARTED|Overall Study||3523
375712|NCT01087541|900206|P1|STARTED|Overall Study||3307
375713|NCT01087528|900222|P1|NOT COMPLETED|Overall Study||7
375715|NCT01087528|900222|P1|STARTED|Overall Study||51
375716|NCT01087502|900228|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
375717|NCT01087502|900229|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
375718|NCT01087502|900228|P2|COMPLETED|Up to Final Analysis (Week 52)||95
375719|NCT01087502|900229|P1|COMPLETED|Up to Final Analysis (Week 52)||90
375720|NCT01087502|900228|P2|STARTED|Up to Final Analysis (Week 52)||118
375721|NCT01087502|900229|P1|STARTED|Up to Final Analysis (Week 52)||123
375722|NCT01087502|900228|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
375723|NCT01087502|900229|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
375724|NCT01087502|900228|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
375725|NCT01087502|900229|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
375726|NCT01087502|900228|P2|STARTED|Up to Interim Analysis (Week 12)||118
375727|NCT01087502|900229|P1|STARTED|Up to Interim Analysis (Week 12)||123
375728|NCT01087489|900248|P2|NOT COMPLETED|Overall Study||3
375729|NCT01087489|900249|P1|NOT COMPLETED|Overall Study||0
375730|NCT01087489|900248|P2|COMPLETED|Overall Study||31
375731|NCT01087489|900249|P1|COMPLETED|Overall Study||19
375732|NCT01087489|900248|P2|STARTED|Overall Study||34
375733|NCT01087489|900249|P1|STARTED|Overall Study||19
375734|NCT01086969|900262|P3|NOT COMPLETED|Overall Study||0
375735|NCT01086969|900263|P2|NOT COMPLETED|Overall Study||2
375736|NCT01086969|900264|P1|NOT COMPLETED|Overall Study||1
375737|NCT01086969|900262|P3|COMPLETED|Overall Study||100
375738|NCT01086969|900263|P2|COMPLETED|Overall Study||98
375739|NCT01086969|900264|P1|COMPLETED|Overall Study||99
375740|NCT01086969|900262|P3|STARTED|Overall Study||100
375741|NCT01086969|900263|P2|STARTED|Overall Study||100
375742|NCT01086969|900264|P1|STARTED|Overall Study||100
375743|NCT01086852|900281|P1|NOT COMPLETED|Overall Study||0
375744|NCT01086852|900281|P1|COMPLETED|Overall Study||4
375745|NCT01086852|900281|P1|STARTED|Overall Study||4
375746|NCT01086761|900297|P6|NOT COMPLETED|Overall Study||0
375747|NCT01086761|900298|P5|NOT COMPLETED|Overall Study||0
375748|NCT01086761|900299|P4|NOT COMPLETED|Overall Study||0
375749|NCT01086761|900300|P3|NOT COMPLETED|Overall Study||0
375750|NCT01086761|900301|P2|NOT COMPLETED|Overall Study||0
375751|NCT01086761|900302|P1|NOT COMPLETED|Overall Study||0
375752|NCT01086761|900297|P6|COMPLETED|Overall Study||0
375753|NCT01086761|900298|P5|COMPLETED|Overall Study||4
375754|NCT01086761|900299|P4|COMPLETED|Overall Study||6
375755|NCT01086761|900300|P3|COMPLETED|Overall Study||6
375756|NCT01086761|900301|P2|COMPLETED|Overall Study||7
375757|NCT01086761|900302|P1|COMPLETED|Overall Study||9
375758|NCT01086761|900297|P6|STARTED|Overall Study||0
375759|NCT01086761|900298|P5|STARTED|Overall Study||4
375760|NCT01086761|900299|P4|STARTED|Overall Study||6
375761|NCT01086761|900300|P3|STARTED|Overall Study||6
375762|NCT01086761|900301|P2|STARTED|Overall Study||7
375763|NCT01086761|900302|P1|STARTED|Overall Study||9
375764|NCT01086605|900342|P2|NOT COMPLETED|Overall Study||0
375765|NCT01086605|900343|P1|NOT COMPLETED|Overall Study||0
375766|NCT01086605|900342|P2|COMPLETED|Overall Study||22
375767|NCT01086605|900343|P1|COMPLETED|Overall Study||24
375768|NCT01086605|900342|P2|STARTED|Overall Study||22
375769|NCT01086605|900343|P1|STARTED|Overall Study||24
375770|NCT01086475|900360|P2|NOT COMPLETED|Overall Study||0
375771|NCT01086475|900361|P1|NOT COMPLETED|Overall Study||0
375772|NCT01086475|900360|P2|COMPLETED|Overall Study||33
375773|NCT01086475|900361|P1|COMPLETED|Overall Study||34
375774|NCT01086475|900360|P2|STARTED|Overall Study||33
375775|NCT01086475|900361|P1|STARTED|Overall Study||34
375776|NCT01086423|900374|P3|NOT COMPLETED|Overall Study||9
375777|NCT01086423|900375|P2|NOT COMPLETED|Overall Study||3
375778|NCT01086423|900376|P1|NOT COMPLETED|Overall Study||10
375779|NCT01086423|900374|P3|COMPLETED|Overall Study||321
375780|NCT01086423|900375|P2|COMPLETED|Overall Study||321
375781|NCT01086423|900376|P1|COMPLETED|Overall Study||320
375782|NCT01086423|900374|P3|STARTED|Overall Study||330
375783|NCT01086423|900375|P2|STARTED|Overall Study||324
375784|NCT01086423|900376|P1|STARTED|Overall Study||330
375785|NCT01086410|900421|P4|NOT COMPLETED|Overall Study||2
375786|NCT01086410|900422|P3|NOT COMPLETED|Overall Study||1
375787|NCT01086410|900423|P2|NOT COMPLETED|Overall Study||2
375788|NCT01086410|900424|P1|NOT COMPLETED|Overall Study||3
375789|NCT01086410|900421|P4|COMPLETED|Overall Study||13
375790|NCT01086410|900422|P3|COMPLETED|Overall Study||55
375791|NCT01086410|900423|P2|COMPLETED|Overall Study||54
375792|NCT01086410|900424|P1|COMPLETED|Overall Study||55
375793|NCT01086410|900421|P4|STARTED|Overall Study||15
375794|NCT01086410|900422|P3|STARTED|Overall Study||56
375795|NCT01086410|900423|P2|STARTED|Overall Study||56
375796|NCT01086410|900424|P1|STARTED|Overall Study||58
375797|NCT01086384|900520|P3|NOT COMPLETED|Treatment Period||124
375798|NCT01086384|900521|P2|NOT COMPLETED|Treatment Period||148
375799|NCT01086384|900522|P1|NOT COMPLETED|Treatment Period||0
375800|NCT01086384|900520|P3|COMPLETED|Treatment Period||885
375801|NCT01086384|900521|P2|COMPLETED|Treatment Period||863
375802|NCT01086384|900522|P1|COMPLETED|Treatment Period||0
375803|NCT01086384|900520|P3|STARTED|Treatment Period||1009
375804|NCT01086384|900521|P2|STARTED|Treatment Period||1011
375805|NCT01086384|900522|P1|STARTED|Treatment Period||0
375806|NCT01086384|900520|P3|NOT COMPLETED|2-week Run-in Period||0
375807|NCT01086384|900521|P2|NOT COMPLETED|2-week Run-in Period||0
375808|NCT01086384|900522|P1|NOT COMPLETED|2-week Run-in Period||163
375809|NCT01086384|900520|P3|COMPLETED|2-week Run-in Period||0
375810|NCT01086384|900521|P2|COMPLETED|2-week Run-in Period||0
375811|NCT01086384|900522|P1|COMPLETED|2-week Run-in Period||2020
375812|NCT01086384|900520|P3|STARTED|2-week Run-in Period||0
375813|NCT01086384|900521|P2|STARTED|2-week Run-in Period||0
375814|NCT01086384|900522|P1|STARTED|2-week Run-in Period||2183
375815|NCT01086215|900536|P4|NOT COMPLETED|Overall Study||3
375816|NCT01086215|900537|P3|NOT COMPLETED|Overall Study||26
375817|NCT01086215|900538|P2|NOT COMPLETED|Overall Study||47
375818|NCT01086215|900539|P1|NOT COMPLETED|Overall Study||36
375819|NCT01086215|900536|P4|COMPLETED|Overall Study||11
375820|NCT01086215|900537|P3|COMPLETED|Overall Study||47
375821|NCT01086215|900538|P2|COMPLETED|Overall Study||154
375822|NCT01086215|900539|P1|COMPLETED|Overall Study||176
375823|NCT01086215|900536|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
375824|NCT01086215|900537|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
375825|NCT01086215|900538|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
375826|NCT01086215|900539|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
375827|NCT01086215|900536|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
375828|NCT01086215|900537|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
375829|NCT01086215|900538|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
375830|NCT01086215|900539|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
375831|NCT01086215|900536|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
375832|NCT01086215|900537|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
375833|NCT01086215|900538|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
375834|NCT01086215|900539|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
375835|NCT01086215|900536|P4|STARTED|Overall Study||14
375836|NCT01086215|900537|P3|STARTED|Overall Study||73
375837|NCT01086215|900538|P2|STARTED|Overall Study||201
375838|NCT01086215|900539|P1|STARTED|Overall Study||212
375839|NCT01086033|900557|P1|NOT COMPLETED|Overall Study||304
375840|NCT01086033|900557|P1|COMPLETED|Overall Study||262
375841|NCT01086033|900557|P1|STARTED|Overall Study||566
375842|NCT01085968|900571|P2|NOT COMPLETED|Overall Study||4
375843|NCT01085968|900572|P1|NOT COMPLETED|Overall Study||10
375844|NCT01085968|900571|P2|COMPLETED|Overall Study||21
375845|NCT01085968|900572|P1|COMPLETED|Overall Study||19
375846|NCT01085968|900571|P2|STARTED|Overall Study||25
375847|NCT01085968|900572|P1|STARTED|Overall Study||29
375848|NCT01085903|900588|P3|NOT COMPLETED|Overall Study||0
375849|NCT01085903|900589|P2|NOT COMPLETED|Overall Study||0
375850|NCT01085903|900590|P1|NOT COMPLETED|Overall Study||0
375851|NCT01085903|900588|P3|COMPLETED|Overall Study||3
375852|NCT01085903|900589|P2|COMPLETED|Overall Study||4
375853|NCT01085903|900590|P1|COMPLETED|Overall Study||21
375854|NCT01085903|900588|P3|STARTED|Overall Study||3
375855|NCT01085903|900589|P2|STARTED|Overall Study||4
375856|NCT01085903|900590|P1|STARTED|Overall Study||21
375857|NCT01085825|900616|P2|NOT COMPLETED|Overall Study||1
375858|NCT01085825|900617|P1|NOT COMPLETED|Overall Study||1
375859|NCT01085825|900616|P2|COMPLETED|Overall Study||247
375860|NCT01085825|900617|P1|COMPLETED|Overall Study||251
375861|NCT01085825|900616|P2|STARTED|Overall Study||248
375862|NCT01085825|900617|P1|STARTED|Overall Study|1st participant enrolled|252
375863|NCT01085786|900625|P2|NOT COMPLETED|Overall Study||0
375864|NCT01085786|900626|P1|NOT COMPLETED|Overall Study||0
375865|NCT01085786|900625|P2|COMPLETED|Overall Study||117
375866|NCT01085786|900626|P1|COMPLETED|Overall Study||123
375867|NCT01085786|900625|P2|STARTED|Overall Study||117
375868|NCT01085786|900626|P1|STARTED|Overall Study||123
375869|NCT01085760|900636|P4|NOT COMPLETED|Overall Study||3
375870|NCT01085760|900637|P3|NOT COMPLETED|Overall Study||2
375871|NCT01085760|900638|P2|NOT COMPLETED|Overall Study||1
375872|NCT01085760|900639|P1|NOT COMPLETED|Overall Study||1
375873|NCT01085760|900636|P4|COMPLETED|Overall Study||6
375874|NCT01085760|900637|P3|COMPLETED|Overall Study||7
375875|NCT01085760|900638|P2|COMPLETED|Overall Study||8
375876|NCT01085760|900639|P1|COMPLETED|Overall Study||7
375877|NCT01085760|900636|P4|STARTED|Overall Study||9
375878|NCT01085760|900637|P3|STARTED|Overall Study||9
375879|NCT01085760|900638|P2|STARTED|Overall Study||9
375880|NCT01085760|900639|P1|STARTED|Overall Study||8
375881|NCT01085734|900663|P2|NOT COMPLETED|Overall Study||4
375882|NCT01085734|900664|P1|NOT COMPLETED|Overall Study||1
375883|NCT01085734|900663|P2|COMPLETED|Overall Study||11
375884|NCT01085734|900664|P1|COMPLETED|Overall Study||14
375885|NCT01085734|900663|P2|STARTED|Overall Study||15
375886|NCT01085734|900664|P1|STARTED|Overall Study||15
375887|NCT01085682|900676|P2|NOT COMPLETED|Overall Study||25
375888|NCT01085682|900677|P1|NOT COMPLETED|Overall Study||25
375889|NCT01085682|900676|P2|COMPLETED|Overall Study||3
375890|NCT01085682|900677|P1|COMPLETED|Overall Study||6
375891|NCT01085682|900676|P2|STARTED|Overall Study||28
375892|NCT01085682|900677|P1|STARTED|Overall Study||31
375893|NCT01085643|900683|P1|NOT COMPLETED|Overall Study||0
375894|NCT01085643|900683|P1|COMPLETED|Overall Study||4
375895|NCT01085643|900683|P1|STARTED|Overall Study||4
375896|NCT01085591|900695|P3|NOT COMPLETED|Overall Study||7
375897|NCT01085591|900696|P2|NOT COMPLETED|Overall Study||6
375898|NCT01085591|900697|P1|NOT COMPLETED|Overall Study||3
375899|NCT01085591|900695|P3|COMPLETED|Overall Study||63
375900|NCT01085591|900696|P2|COMPLETED|Overall Study||65
375901|NCT01085591|900697|P1|COMPLETED|Overall Study||66
375902|NCT01085591|900695|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
375903|NCT01085591|900696|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
375904|NCT01085591|900697|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
375905|NCT01085591|900695|P3|STARTED|Overall Study||70
375906|NCT01085591|900696|P2|STARTED|Overall Study||71
375907|NCT01085591|900697|P1|STARTED|Overall Study||69
375908|NCT01085539|900720|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
375909|NCT01085539|900720|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
375910|NCT01085539|900720|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
375911|NCT01085539|900720|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
375912|NCT01085539|900720|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
375913|NCT01085539|900720|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
375914|NCT01085539|900720|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
375915|NCT01085539|900720|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
375916|NCT01085539|900720|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
375917|NCT01085539|900720|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
375918|NCT01085539|900720|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
375919|NCT01085539|900720|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
375920|NCT01085539|900720|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
375921|NCT01085539|900720|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
375922|NCT01085539|900720|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
375923|NCT01085513|900726|P2|NOT COMPLETED|Overall Study||0
375924|NCT01085513|900727|P1|NOT COMPLETED|Overall Study||0
375925|NCT01085513|900726|P2|COMPLETED|Overall Study||68
375926|NCT01085513|900727|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
375927|NCT01085513|900726|P2|STARTED|Overall Study||68
375928|NCT01085513|900727|P1|STARTED|Overall Study||75
375929|NCT01085500|900735|P2|NOT COMPLETED|Overall Study||0
375930|NCT01085500|900736|P1|NOT COMPLETED|Overall Study||0
375931|NCT01085500|900735|P2|COMPLETED|Overall Study||24
375932|NCT01085500|900736|P1|COMPLETED|Overall Study||26
375933|NCT01085500|900735|P2|STARTED|Overall Study||24
375934|NCT01085500|900736|P1|STARTED|Overall Study||26
375935|NCT01085357|900748|P2|NOT COMPLETED|Overall Study||6
375936|NCT01085357|900749|P1|NOT COMPLETED|Overall Study||19
375937|NCT01085357|900748|P2|COMPLETED|Overall Study||125
375938|NCT01085357|900749|P1|COMPLETED|Overall Study||355
375939|NCT01085357|900748|P2|STARTED|Overall Study||131
375940|NCT01085357|900749|P1|STARTED|Overall Study||374
375941|NCT01085331|900761|P2|NOT COMPLETED|Overall Study||0
375942|NCT01085331|900762|P1|NOT COMPLETED|Overall Study||0
375943|NCT01085331|900761|P2|COMPLETED|Overall Study||6
375944|NCT01085331|900762|P1|COMPLETED|Overall Study||10
375945|NCT01085331|900761|P2|STARTED|Overall Study||6
375946|NCT01085331|900762|P1|STARTED|Overall Study||10
375947|NCT01085318|900801|P2|NOT COMPLETED|Overall Study||0
375948|NCT01085318|900802|P1|NOT COMPLETED|Overall Study||2
375949|NCT01085318|900801|P2|COMPLETED|Overall Study||15
375950|NCT01085318|900802|P1|COMPLETED|Overall Study||21
375951|NCT01085318|900801|P2|STARTED|Overall Study||15
375952|NCT01085318|900802|P1|STARTED|Overall Study||23
375953|NCT01085214|900812|P1|NOT COMPLETED|Overall Study||1
375954|NCT01085214|900812|P1|COMPLETED|Overall Study||36
375955|NCT01085214|900812|P1|STARTED|Overall Study||37
375956|NCT01085201|900824|P5|NOT COMPLETED|Overall Study||0
375957|NCT01085201|900825|P4|NOT COMPLETED|Overall Study||0
375958|NCT01085201|900826|P3|NOT COMPLETED|Overall Study||2
375959|NCT01085201|900827|P2|NOT COMPLETED|Overall Study||1
375960|NCT01085201|900828|P1|NOT COMPLETED|Overall Study||3
375961|NCT01085201|900824|P5|COMPLETED|Overall Study||3
375962|NCT01085201|900825|P4|COMPLETED|Overall Study||6
375963|NCT01085201|900826|P3|COMPLETED|Overall Study||3
375964|NCT01085201|900827|P2|COMPLETED|Overall Study||6
375965|NCT01085201|900828|P1|COMPLETED|Overall Study||15
375966|NCT01085201|900824|P5|STARTED|Overall Study||3
375967|NCT01085201|900825|P4|STARTED|Overall Study||6
375968|NCT01085201|900826|P3|STARTED|Overall Study||5
375969|NCT01085201|900827|P2|STARTED|Overall Study||7
375970|NCT01085201|900828|P1|STARTED|Overall Study||18
375971|NCT01085136|900850|P3|NOT COMPLETED|Part B||26
375972|NCT01085136|900851|P2|NOT COMPLETED|Part B||51
375973|NCT01085136|900852|P1|NOT COMPLETED|Part B||0
375974|NCT01085136|900850|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
375975|NCT01085136|900851|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
375976|NCT01085136|900852|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
375977|NCT01085136|900850|P3|STARTED|Part B||68
375978|NCT01085136|900851|P2|STARTED|Part B||138
375979|NCT01085136|900852|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
375980|NCT01085136|900850|P3|NOT COMPLETED|Part A||0
375981|NCT01085136|900851|P2|NOT COMPLETED|Part A||0
375982|NCT01085136|900852|P1|NOT COMPLETED|Part A||323
375983|NCT01085136|900850|P3|COMPLETED|Part A||0
375984|NCT01085136|900851|P2|COMPLETED|Part A||0
375985|NCT01085136|900852|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
375986|NCT01085136|900850|P3|Randomized to Part B|Part A||0
375987|NCT01085136|900851|P2|Randomized to Part B|Part A||0
375988|NCT01085136|900852|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
375989|NCT01085136|900850|P3|STARTED|Part A||0
375990|NCT01085136|900851|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
375991|NCT01085136|900852|P1|STARTED|Part A||1154
375992|NCT01085045|900868|P1|NOT COMPLETED|Part B||15
375993|NCT01085045|900868|P1|COMPLETED|Part B||89
375994|NCT01085045|900868|P1|GP MDI 36 µg (PT001)|Part B||0
375995|NCT01085045|900868|P1|Foradil 12 µg|Part B||41
375996|NCT01085045|900868|P1|Placebo MDI|Part B||47
375997|NCT01085045|900868|P1|FF MDI 7.2 µg (PT005)|Part B||43
375998|NCT01085045|900868|P1|FF MDI 9.6 µg (PT005)|Part B||43
375999|NCT01085045|900868|P1|Spiriva 18 µg|Part B||0
376000|NCT01085045|900868|P1|GFF MDI 36/9.6 µg|Part B||0
376001|NCT01085045|900868|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
376002|NCT01085045|900868|P1|STARTED|Part B||104
376003|NCT01085045|900868|P1|NOT COMPLETED|Part A||18
376004|NCT01085045|900868|P1|COMPLETED|Part A||104
376005|NCT01085045|900868|P1|Foradil 12 µg|Part A||14
376006|NCT01085045|900868|P1|Placebo MDI|Part A||5
376007|NCT01085045|900868|P1|FF MDI 7.2 µg (PT005)|Part A||21
376008|NCT01085045|900868|P1|FF MDI 9.6 µg (PT005)|Part A||20
376009|NCT01085045|900868|P1|Spiriva 18 µg|Part A||58
376010|NCT01085045|900868|P1|GP MDI 36 µg (PT001)|Part A||40
376011|NCT01085045|900868|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
376012|NCT01085045|900868|P1|GFF MDI 72/9.6mcg|Part A||40
376013|NCT01085045|900868|P1|STARTED|Part A||122
376014|NCT01085006|900970|P2|NOT COMPLETED|Overall Study||0
376015|NCT01085006|900971|P1|NOT COMPLETED|Overall Study||0
376016|NCT01085006|900970|P2|COMPLETED|Overall Study||50
376017|NCT01085006|900971|P1|COMPLETED|Overall Study||50
376018|NCT01085006|900970|P2|STARTED|Overall Study||50
376019|NCT01085006|900971|P1|STARTED|Overall Study||50
376020|NCT01084759|900977|P1|NOT COMPLETED|Overall Study||2
376021|NCT01084759|900977|P1|COMPLETED|Overall Study||14
376022|NCT01084759|900977|P1|STARTED|Overall Study||16
376023|NCT01084707|900983|P1|NOT COMPLETED|Overall Study||6
376024|NCT01084707|900983|P1|COMPLETED|Overall Study||34
376025|NCT01084707|900983|P1|STARTED|Overall Study||40
376026|NCT01084668|901017|P1|NOT COMPLETED|Overall Study||9
376027|NCT01084668|901017|P1|COMPLETED|Overall Study||33
376028|NCT01084668|901017|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
376029|NCT01084603|901026|P1|NOT COMPLETED|Oral Nicotine 4||0
376030|NCT01084603|901026|P1|COMPLETED|Oral Nicotine 4||39
376031|NCT01084603|901026|P1|STARTED|Oral Nicotine 4||39
376032|NCT01084603|901026|P1|NOT COMPLETED|Washout Period 4||1
376033|NCT01084603|901026|P1|COMPLETED|Washout Period 4||39
376034|NCT01084603|901026|P1|STARTED|Washout Period 4||40
376035|NCT01084603|901026|P1|NOT COMPLETED|Oral Nicotine 2||0
376036|NCT01084603|901026|P1|COMPLETED|Oral Nicotine 2||40
376037|NCT01084603|901026|P1|STARTED|Oral Nicotine 2||40
376038|NCT01084603|901026|P1|NOT COMPLETED|Washout Period 3||0
376039|NCT01084603|901026|P1|COMPLETED|Washout Period 3||40
376040|NCT01084603|901026|P1|STARTED|Washout Period 3||40
376041|NCT01084603|901026|P1|NOT COMPLETED|Oral Nicotine 1||1
376042|NCT01084603|901026|P1|COMPLETED|Oral Nicotine 1||40
376043|NCT01084603|901026|P1|STARTED|Oral Nicotine 1||41
376044|NCT01084603|901026|P1|NOT COMPLETED|Washout Period 2||0
376045|NCT01084603|901026|P1|COMPLETED|Washout Period 2||41
376046|NCT01084603|901026|P1|STARTED|Washout Period 2||41
376047|NCT01084603|901026|P1|NOT COMPLETED|Nicorette® Gum||1
376048|NCT01084603|901026|P1|COMPLETED|Nicorette® Gum||41
376049|NCT01084603|901026|P1|STARTED|Nicorette® Gum||42
376050|NCT01084603|901026|P1|NOT COMPLETED|Washout Period 1||0
376051|NCT01084603|901026|P1|COMPLETED|Washout Period 1||42
376052|NCT01084603|901026|P1|STARTED|Washout Period 1||42
376053|NCT01084603|901026|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
376054|NCT01084603|901026|P1|COMPLETED|NiQuitinTM Lozenge||42
376055|NCT01084603|901026|P1|STARTED|NiQuitinTM Lozenge||43
376056|NCT01084603|901026|P1|NOT COMPLETED|Baseline||2
376057|NCT01084603|901026|P1|COMPLETED|Baseline||43
376058|NCT01084603|901026|P1|STARTED|Baseline||45
376059|NCT01084551|901062|P3|NOT COMPLETED|Overall Study||8
376060|NCT01084551|901063|P2|NOT COMPLETED|Overall Study||14
376061|NCT01084551|901064|P1|NOT COMPLETED|Overall Study||9
376062|NCT01084551|901062|P3|COMPLETED|Overall Study||86
376063|NCT01084551|901063|P2|COMPLETED|Overall Study||81
376064|NCT01084551|901064|P1|COMPLETED|Overall Study||86
376065|NCT01084551|901062|P3|STARTED|Overall Study||94
376066|NCT01084551|901063|P2|STARTED|Overall Study||95
376067|NCT01084551|901064|P1|STARTED|Overall Study||95
376068|NCT01084538|901102|P1|NOT COMPLETED|Overall Study||68
376069|NCT01084538|901102|P1|COMPLETED|Overall Study||113
376070|NCT01084538|901102|P1|STARTED|Overall Study||181
376071|NCT01084278|901114|P5|NOT COMPLETED|Overall Study||0
376072|NCT01084278|901115|P4|NOT COMPLETED|Overall Study||0
376073|NCT01084278|901116|P3|NOT COMPLETED|Overall Study||0
376074|NCT01084278|901117|P2|NOT COMPLETED|Overall Study||0
376075|NCT01084278|901118|P1|NOT COMPLETED|Overall Study||0
376076|NCT01084278|901114|P5|COMPLETED|Overall Study||8
376077|NCT01084278|901115|P4|COMPLETED|Overall Study||8
376078|NCT01084278|901116|P3|COMPLETED|Overall Study||8
376079|NCT01084278|901117|P2|COMPLETED|Overall Study||8
376080|NCT01084278|901118|P1|COMPLETED|Overall Study||8
376081|NCT01084278|901114|P5|STARTED|Overall Study||8
376082|NCT01084278|901115|P4|STARTED|Overall Study||8
376083|NCT01084278|901116|P3|STARTED|Overall Study||8
376084|NCT01084278|901117|P2|STARTED|Overall Study||8
376085|NCT01084278|901118|P1|STARTED|Overall Study||8
376086|NCT01084265|901199|P1|NOT COMPLETED|Overall Study||0
376087|NCT01084265|901199|P1|COMPLETED|Overall Study||31
376088|NCT01084265|901199|P1|STARTED|Overall Study||31
376089|NCT01084239|901213|P2|NOT COMPLETED|28-Day Follow-up||9
376090|NCT01084239|901214|P1|NOT COMPLETED|28-Day Follow-up||4
376091|NCT01084239|901213|P2|COMPLETED|28-Day Follow-up||490
376092|NCT01084239|901214|P1|COMPLETED|28-Day Follow-up||497
376093|NCT01084239|901213|P2|STARTED|28-Day Follow-up||499
376094|NCT01084239|901214|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
376095|NCT01084239|901213|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
376096|NCT01084239|901214|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
376097|NCT01084239|901213|P2|COMPLETED|Randomization - Index Hospitalization||499
376098|NCT01084239|901214|P1|COMPLETED|Randomization - Index Hospitalization||501
376099|NCT01084239|901213|P2|STARTED|Randomization - Index Hospitalization||499
376100|NCT01084239|901214|P1|STARTED|Randomization - Index Hospitalization||501
376101|NCT01084174|901232|P2|NOT COMPLETED|Overall Study||4
376102|NCT01084174|901233|P1|NOT COMPLETED|Overall Study||1
376103|NCT01084174|901232|P2|COMPLETED|Overall Study||7
376104|NCT01084174|901233|P1|COMPLETED|Overall Study||9
376105|NCT01084174|901232|P2|STARTED|Overall Study||11
376106|NCT01084174|901233|P1|STARTED|Overall Study||10
376107|NCT01084148|901253|P2|NOT COMPLETED|Overall Study||16
376108|NCT01084148|901254|P1|NOT COMPLETED|Overall Study||30
376109|NCT01084148|901253|P2|COMPLETED|Overall Study||102
376110|NCT01084148|901254|P1|COMPLETED|Overall Study||88
376111|NCT01084148|901253|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
376112|NCT01084148|901254|P1|STARTED|Overall Study||118
376113|NCT01084135|901264|P2|NOT COMPLETED|20 Week||1
376114|NCT01084135|901265|P1|NOT COMPLETED|20 Week||0
376115|NCT01084135|901264|P2|COMPLETED|20 Week||10
376116|NCT01084135|901265|P1|COMPLETED|20 Week||12
376117|NCT01084135|901264|P2|STARTED|20 Week||11
376118|NCT01084135|901265|P1|STARTED|20 Week||12
376119|NCT01084135|901264|P2|NOT COMPLETED|12 Week||0
376120|NCT01084135|901265|P1|NOT COMPLETED|12 Week||0
376121|NCT01084135|901264|P2|COMPLETED|12 Week||4
376122|NCT01084135|901265|P1|COMPLETED|12 Week||4
376123|NCT01084135|901264|P2|STARTED|12 Week||4
376124|NCT01084135|901265|P1|STARTED|12 Week||4
376125|NCT01084083|901275|P1|NOT COMPLETED|Overall Study||12
376126|NCT01084083|901275|P1|COMPLETED|Overall Study||78
376127|NCT01084083|901275|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
376128|NCT01084083|901275|P1|CR to Induction Therapy|Overall Study||56
376129|NCT01084083|901275|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
376130|NCT01084083|901275|P1|Eligible|Overall Study||81
376131|NCT01084083|901275|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
376132|NCT01084083|901275|P1|STARTED|Overall Study||90
376133|NCT01084005|901283|P2|NOT COMPLETED|Overall Study||16
376134|NCT01084005|901284|P1|NOT COMPLETED|Overall Study||5
376135|NCT01084005|901283|P2|COMPLETED|Overall Study||146
376136|NCT01084005|901284|P1|COMPLETED|Overall Study||74
376137|NCT01084005|901283|P2|STARTED|Overall Study||162
376138|NCT01084005|901284|P1|STARTED|Overall Study||79
376139|NCT01083979|901312|P1|NOT COMPLETED|Overall Study||0
376140|NCT01083979|901312|P1|COMPLETED|Overall Study||1
376141|NCT01083979|901312|P1|STARTED|Overall Study||1
376142|NCT01083901|901320|P3|NOT COMPLETED|Overall Study||2
376143|NCT01083901|901321|P2|NOT COMPLETED|Overall Study||2
376144|NCT01083901|901322|P1|NOT COMPLETED|Overall Study||1
376145|NCT01083901|901320|P3|COMPLETED|Overall Study||11
376146|NCT01083901|901321|P2|COMPLETED|Overall Study||6
376147|NCT01083901|901322|P1|COMPLETED|Overall Study||12
376148|NCT01083901|901320|P3|STARTED|Overall Study||13
376149|NCT01083901|901321|P2|STARTED|Overall Study||8
376150|NCT01083901|901322|P1|STARTED|Overall Study||13
376151|NCT01083849|901341|P2|NOT COMPLETED|Overall Study||111
376152|NCT01083849|901342|P1|NOT COMPLETED|Overall Study||60
376153|NCT01083849|901341|P2|COMPLETED|Overall Study||527
376154|NCT01083849|901342|P1|COMPLETED|Overall Study||61
376155|NCT01083849|901341|P2|STARTED|Overall Study||638
376156|NCT01083849|901342|P1|STARTED|Overall Study||121
376157|NCT01083810|901365|P3|NOT COMPLETED|Overall Study||20
376158|NCT01083810|901366|P2|NOT COMPLETED|Overall Study||45
376159|NCT01083810|901367|P1|NOT COMPLETED|Overall Study||65
376160|NCT01083810|901365|P3|COMPLETED|Overall Study||35
376161|NCT01083810|901366|P2|COMPLETED|Overall Study||47
376162|NCT01083810|901367|P1|COMPLETED|Overall Study||72
376163|NCT01083810|901365|P3|STARTED|Overall Study||55
376164|NCT01083810|901366|P2|STARTED|Overall Study||92
376165|NCT01083810|901367|P1|STARTED|Overall Study||137
376166|NCT01083771|901388|P1|NOT COMPLETED|Overall Study||5
376167|NCT01083771|901388|P1|COMPLETED|Overall Study||16
376168|NCT01083771|901388|P1|STARTED|Overall Study||21
376169|NCT01083758|901393|P1|NOT COMPLETED|Overall Study||2
376170|NCT01083758|901393|P1|COMPLETED|Overall Study||29
376171|NCT01083758|901393|P1|STARTED|Overall Study||31
376172|NCT01083732|901427|P3|NOT COMPLETED|Overall Study||0
376173|NCT01083732|901428|P2|NOT COMPLETED|Overall Study||0
376174|NCT01083732|901429|P1|NOT COMPLETED|Overall Study||0
376175|NCT01083732|901427|P3|COMPLETED|Overall Study||3
376176|NCT01083732|901428|P2|COMPLETED|Overall Study||9
376177|NCT01083732|901429|P1|COMPLETED|Overall Study||6
376178|NCT01083732|901427|P3|STARTED|Overall Study||3
376179|NCT01083732|901428|P2|STARTED|Overall Study||9
376180|NCT01083732|901429|P1|STARTED|Overall Study||6
376181|NCT01083706|901480|P1|NOT COMPLETED|Overall Study||0
376182|NCT01083706|901480|P1|COMPLETED|Overall Study||39
376183|NCT01083706|901480|P1|STARTED|Overall Study||39
376184|NCT01083693|901489|P3|NOT COMPLETED|Overall Study||7
376185|NCT01083693|901490|P2|NOT COMPLETED|Overall Study||6
376186|NCT01083693|901491|P1|NOT COMPLETED|Overall Study||20
376187|NCT01083693|901489|P3|COMPLETED|Overall Study||33
376188|NCT01083693|901490|P2|COMPLETED|Overall Study||22
376189|NCT01083693|901491|P1|COMPLETED|Overall Study||73
376190|NCT01083693|901489|P3|STARTED|Overall Study||40
376191|NCT01083693|901490|P2|STARTED|Overall Study||28
376192|NCT01083693|901491|P1|STARTED|Overall Study||93
376193|NCT01083680|901526|P1|NOT COMPLETED|Overall Study||3844
376194|NCT01083680|901526|P1|COMPLETED|Overall Study||263
376195|NCT01083680|901526|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
376196|NCT01083680|901526|P1|STARTED|Overall Study||4107
376197|NCT01083654|901537|P2|NOT COMPLETED|Overall Study||0
376198|NCT01083654|901538|P1|NOT COMPLETED|Overall Study||0
376199|NCT01083654|901537|P2|COMPLETED|Overall Study||50
376200|NCT01083654|901538|P1|COMPLETED|Overall Study||53
376201|NCT01083654|901537|P2|STARTED|Overall Study||50
376202|NCT01083654|901538|P1|STARTED|Overall Study||53
376203|NCT01083641|901544|P1|NOT COMPLETED|Overall Study||2
376204|NCT01083641|901544|P1|COMPLETED|Overall Study||15
376205|NCT01083641|901544|P1|STARTED|Overall Study||17
376206|NCT01083602|901551|P1|NOT COMPLETED|Overall Study||55
376207|NCT01083602|901551|P1|COMPLETED|Overall Study||0
376208|NCT01083602|901551|P1|STARTED|Overall Study||55
376209|NCT01083576|901562|P2|NOT COMPLETED|Overall Study||1
376210|NCT01083576|901563|P1|NOT COMPLETED|Overall Study||6
376211|NCT01083576|901562|P2|COMPLETED|Overall Study||14
376212|NCT01083576|901563|P1|COMPLETED|Overall Study||9
376213|NCT01083576|901562|P2|STARTED|Overall Study||15
376214|NCT01083576|901563|P1|STARTED|Overall Study||15
376215|NCT01083485|901593|P2|NOT COMPLETED|Overall Study||3
376216|NCT01083485|901594|P1|NOT COMPLETED|Overall Study||7
376217|NCT01083485|901593|P2|COMPLETED|Overall Study||64
376218|NCT01083485|901594|P1|COMPLETED|Overall Study||63
376219|NCT01083485|901593|P2|STARTED|Overall Study||67
376220|NCT01083485|901594|P1|STARTED|Overall Study||70
376221|NCT01083472|901604|P2|NOT COMPLETED|Overall Study||0
376222|NCT01083472|901605|P1|NOT COMPLETED|Overall Study||0
376223|NCT01083472|901604|P2|COMPLETED|Overall Study||19
376224|NCT01083472|901605|P1|COMPLETED|Overall Study||18
376225|NCT01083472|901604|P2|STARTED|Overall Study||19
376226|NCT01083472|901605|P1|STARTED|Overall Study||18
376227|NCT01083316|901611|P1|NOT COMPLETED|Overall Study||3
376228|NCT01083316|901611|P1|COMPLETED|Overall Study||32
376229|NCT01083316|901611|P1|STARTED|Overall Study||35
376230|NCT01083199|901617|P1|NOT COMPLETED|Overall Study||0
376231|NCT01083199|901617|P1|COMPLETED|Overall Study||10
376232|NCT01083199|901617|P1|STARTED|Overall Study||10
376233|NCT01083186|901622|P1|NOT COMPLETED|Overall Study||94
376234|NCT01083186|901622|P1|COMPLETED|Overall Study||406
376235|NCT01083186|901622|P1|STARTED|Overall Study||500
376236|NCT01083173|901663|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
376237|NCT01083173|901664|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
376238|NCT01083173|901663|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
376239|NCT01083173|901664|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
376240|NCT01083173|901663|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
376241|NCT01083173|901664|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
376242|NCT01083173|901663|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
376243|NCT01083173|901664|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
376244|NCT01083173|901663|P2|COMPLETED|Long-term Surveillance: Safety Group||479
376245|NCT01083173|901664|P1|COMPLETED|Long-term Surveillance: Safety Group||0
376246|NCT01083173|901663|P2|STARTED|Long-term Surveillance: Safety Group||595
376247|NCT01083173|901664|P1|STARTED|Long-term Surveillance: Safety Group||0
376248|NCT01083173|901663|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
376249|NCT01083173|901664|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
376250|NCT01083173|901663|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
376251|NCT01083173|901664|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
376252|NCT01083173|901663|P2|STARTED|Main Surveillance: Effectiveness Group||0
376253|NCT01083173|901664|P1|STARTED|Main Surveillance: Effectiveness Group||580
376254|NCT01083173|901663|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
376255|NCT01083173|901664|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
376256|NCT01083173|901663|P2|COMPLETED|Main Surveillance: Safety Group||0
376257|NCT01083173|901664|P1|COMPLETED|Main Surveillance: Safety Group||580
376258|NCT01083173|901663|P2|STARTED|Main Surveillance: Safety Group||0
376259|NCT01083173|901664|P1|STARTED|Main Surveillance: Safety Group||595
376260|NCT01083160|901682|P1|NOT COMPLETED|Overall Study||1
376261|NCT01083160|901682|P1|COMPLETED|Overall Study||81
376262|NCT01083160|901682|P1|Evaluable Population|Overall Study||71
376263|NCT01083160|901682|P1|STARTED|Overall Study||82
376264|NCT01083121|901689|P1|NOT COMPLETED|Overall Study||81
376265|NCT01083121|901689|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
376266|NCT01083121|901689|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
376267|NCT01082965|901699|P2|NOT COMPLETED|Overall Study||2
376268|NCT01082965|901700|P1|NOT COMPLETED|Overall Study||1
376269|NCT01082965|901699|P2|COMPLETED|Overall Study||6
376270|NCT01082965|901700|P1|COMPLETED|Overall Study||9
376271|NCT01082965|901699|P2|STARTED|Overall Study||8
376272|NCT01082965|901700|P1|STARTED|Overall Study||10
376273|NCT01082952|901720|P2|NOT COMPLETED|Overall Study||0
376274|NCT01082952|901721|P1|NOT COMPLETED|Overall Study||0
376275|NCT01082952|901720|P2|COMPLETED|Overall Study||6
376276|NCT01082952|901721|P1|COMPLETED|Overall Study||6
376277|NCT01082952|901720|P2|STARTED|Overall Study||6
376278|NCT01082952|901721|P1|STARTED|Overall Study||6
376279|NCT01082939|901729|P1|NOT COMPLETED|Overall Study||0
376280|NCT01082939|901729|P1|COMPLETED|Overall Study||80
376281|NCT01082939|901729|P1|STARTED|Overall Study||80
376282|NCT01082874|901737|P4|NOT COMPLETED|Overall Study||13
376283|NCT01082874|901738|P3|NOT COMPLETED|Overall Study||11
376284|NCT01082874|901739|P2|NOT COMPLETED|Overall Study||12
376285|NCT01082874|901740|P1|NOT COMPLETED|Overall Study||11
376286|NCT01082874|901737|P4|COMPLETED|Overall Study||2489
376287|NCT01082874|901738|P3|COMPLETED|Overall Study||2488
376288|NCT01082874|901739|P2|COMPLETED|Overall Study||2498
376289|NCT01082874|901740|P1|COMPLETED|Overall Study||2488
376290|NCT01082874|901737|P4|STARTED|Overall Study||2502
376291|NCT01082874|901738|P3|STARTED|Overall Study||2499
376292|NCT01082874|901739|P2|STARTED|Overall Study||2510
376293|NCT01082874|901740|P1|STARTED|Overall Study||2499
376294|NCT01082640|901753|P3|NOT COMPLETED|Overall Study||8
376295|NCT01082640|901754|P2|NOT COMPLETED|Overall Study||15
376296|NCT01082640|901755|P1|NOT COMPLETED|Overall Study||17
376297|NCT01082640|901753|P3|COMPLETED|Overall Study||24
376298|NCT01082640|901754|P2|COMPLETED|Overall Study||17
376299|NCT01082640|901755|P1|COMPLETED|Overall Study||15
376300|NCT01082640|901753|P3|STARTED|Overall Study||32
376301|NCT01082640|901754|P2|STARTED|Overall Study||32
376302|NCT01082640|901755|P1|STARTED|Overall Study||32
376303|NCT01082614|901777|P2|NOT COMPLETED|Overall Study||5
376304|NCT01082614|901778|P1|NOT COMPLETED|Overall Study||3
376305|NCT01082614|901777|P2|COMPLETED|Overall Study||18
376306|NCT01082614|901778|P1|COMPLETED|Overall Study||20
376307|NCT01082614|901777|P2|STARTED|Overall Study||23
376308|NCT01082614|901778|P1|STARTED|Overall Study||23
376309|NCT01082588|901786|P2|NOT COMPLETED|Overall Study||5
376310|NCT01082588|901787|P1|NOT COMPLETED|Overall Study||6
376311|NCT01082588|901786|P2|COMPLETED|Overall Study||25
376312|NCT01082588|901787|P1|COMPLETED|Overall Study||24
376313|NCT01082588|901786|P2|STARTED|Overall Study||30
376314|NCT01082588|901787|P1|STARTED|Overall Study||30
376315|NCT01082575|901805|P1|NOT COMPLETED|Overall Study||0
376316|NCT01082575|901805|P1|COMPLETED|Overall Study||100
376317|NCT01082575|901805|P1|STARTED|Overall Study||100
376318|NCT01082380|901810|P1|NOT COMPLETED|Overall Study||0
376319|NCT01082380|901810|P1|COMPLETED|Overall Study||6
376320|NCT01082380|901810|P1|STARTED|Overall Study||6
376321|NCT01082367|901845|P2|NOT COMPLETED|Follow-up (F-U) Period||1
376322|NCT01082367|901846|P1|NOT COMPLETED|Follow-up (F-U) Period||2
376323|NCT01082367|901845|P2|COMPLETED|Follow-up (F-U) Period||9
376324|NCT01082367|901846|P1|COMPLETED|Follow-up (F-U) Period||17
376325|NCT01082367|901845|P2|Treated in F-U|Follow-up (F-U) Period||5
376326|NCT01082367|901846|P1|Treated in F-U|Follow-up (F-U) Period||5
376327|NCT01082367|901845|P2|STARTED|Follow-up (F-U) Period||10
376328|NCT01082367|901846|P1|STARTED|Follow-up (F-U) Period||19
376329|NCT01082367|901845|P2|NOT COMPLETED|Double-blind Period||13
376330|NCT01082367|901846|P1|NOT COMPLETED|Double-blind Period||5
376331|NCT01082367|901845|P2|COMPLETED|Double-blind Period||12
376332|NCT01082367|901846|P1|COMPLETED|Double-blind Period||21
376333|NCT01082367|901845|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
376334|NCT01082367|901846|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
376335|NCT01082367|901845|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
376336|NCT01082367|901846|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
376337|NCT01082367|901845|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
376338|NCT01082367|901846|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
376339|NCT01082367|901845|P2|Entered OL TOBI|Double-blind Period||18
376340|NCT01082367|901846|P1|Entered OL TOBI|Double-blind Period||4
376341|NCT01082367|901845|P2|Stage 2:no tx|Double-blind Period||0
376342|NCT01082367|901846|P1|Stage 2:no tx|Double-blind Period||0
376343|NCT01082367|901845|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
376344|NCT01082367|901846|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
376345|NCT01082367|901845|P2|STARTED|Double-blind Period||25
376346|NCT01082367|901846|P1|STARTED|Double-blind Period||26
376347|NCT01082328|901860|P1|NOT COMPLETED|Overall Study||1
376348|NCT01082328|901860|P1|COMPLETED|Overall Study||58
376349|NCT01082328|901860|P1|STARTED|Overall Study||59
376350|NCT01082211|901869|P1|NOT COMPLETED|Overall Study||7
376351|NCT01082211|901869|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
376352|NCT01082211|901869|P1|STARTED|Overall Study||65
376353|NCT01082159|901880|P1|NOT COMPLETED|Overall Study||9
376354|NCT01082159|901880|P1|COMPLETED|Overall Study||46
376355|NCT01082159|901880|P1|STARTED|Overall Study||55
376356|NCT01082081|901889|P3|NOT COMPLETED|Overall Study||2
376357|NCT01082081|901890|P2|NOT COMPLETED|Overall Study||1
376358|NCT01082081|901891|P1|NOT COMPLETED|Overall Study||0
376359|NCT01082081|901889|P3|COMPLETED|Overall Study||58
376360|NCT01082081|901890|P2|COMPLETED|Overall Study||118
376361|NCT01082081|901891|P1|COMPLETED|Overall Study||121
376362|NCT01082081|901889|P3|STARTED|Overall Study||60
376363|NCT01082081|901890|P2|STARTED|Overall Study||119
376364|NCT01082081|901891|P1|STARTED|Overall Study||121
376365|NCT01081951|901943|P2|NOT COMPLETED|Overall Study||55
376366|NCT01081951|901944|P1|NOT COMPLETED|Overall Study||56
376367|NCT01081951|901943|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
376368|NCT01081951|901944|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
376369|NCT01081951|901943|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
376370|NCT01081951|901944|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
376371|NCT01081951|901943|P2|Entered Maintenance Phase|Overall Study||55
376372|NCT01081951|901944|P1|Entered Maintenance Phase|Overall Study||66
376373|NCT01081951|901943|P2|Received Study Treatment|Overall Study||75
376374|NCT01081951|901944|P1|Received Study Treatment|Overall Study||81
376375|NCT01081951|901943|P2|STARTED|Overall Study||81
376376|NCT01081951|901944|P1|STARTED|Overall Study||81
376377|NCT01081912|901954|P3|NOT COMPLETED|Maintenance Treatment||92
376378|NCT01081912|901955|P2|NOT COMPLETED|Maintenance Treatment||27
376379|NCT01081912|901956|P1|NOT COMPLETED|Maintenance Treatment||0
376380|NCT01081912|901954|P3|COMPLETED|Maintenance Treatment||59
376381|NCT01081912|901955|P2|COMPLETED|Maintenance Treatment||124
376382|NCT01081912|901956|P1|COMPLETED|Maintenance Treatment||0
376383|NCT01081912|901954|P3|STARTED|Maintenance Treatment||151
376384|NCT01081912|901955|P2|STARTED|Maintenance Treatment||151
376385|NCT01081912|901956|P1|STARTED|Maintenance Treatment||0
376386|NCT01081912|901954|P3|NOT COMPLETED|Conversion/Titration||0
376387|NCT01081912|901955|P2|NOT COMPLETED|Conversion/Titration||0
376388|NCT01081912|901956|P1|NOT COMPLETED|Conversion/Titration||208
376389|NCT01081912|901954|P3|COMPLETED|Conversion/Titration||0
376390|NCT01081912|901955|P2|COMPLETED|Conversion/Titration||0
376391|NCT01081912|901956|P1|COMPLETED|Conversion/Titration||302
376392|NCT01081912|901954|P3|STARTED|Conversion/Titration||0
376393|NCT01081912|901955|P2|STARTED|Conversion/Titration||0
376394|NCT01081912|901956|P1|STARTED|Conversion/Titration||510
376395|NCT01081886|901965|P2|NOT COMPLETED|Overall Study||13
376396|NCT01081886|901966|P1|NOT COMPLETED|Overall Study||11
376397|NCT01081886|901965|P2|COMPLETED|Overall Study||0
376398|NCT01081886|901966|P1|COMPLETED|Overall Study||0
376399|NCT01081886|901965|P2|STARTED|Overall Study||13
376400|NCT01081886|901966|P1|STARTED|Overall Study||11
376401|NCT01081873|901974|P1|NOT COMPLETED|Overall Study||298
376402|NCT01081873|901974|P1|COMPLETED|Overall Study||2416
376403|NCT01081873|901974|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
376404|NCT01081834|902046|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
376405|NCT01081834|902047|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
376406|NCT01081834|902048|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
376407|NCT01081834|902049|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
376408|NCT01081834|902050|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
376409|NCT01081834|902046|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
376410|NCT01081834|902047|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
376411|NCT01081834|902048|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
376412|NCT01081834|902049|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
376413|NCT01081834|902050|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
376414|NCT01081834|902046|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
376415|NCT01081834|902047|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
376416|NCT01081834|902048|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
376417|NCT01081834|902049|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
376418|NCT01081834|902050|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
376419|NCT01081834|902046|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
376420|NCT01081834|902047|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
376421|NCT01081834|902048|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
376422|NCT01081834|902049|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
376423|NCT01081834|902050|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
376424|NCT01081834|902046|P5|COMPLETED|Core Period: Baseline to Week 26||40
376425|NCT01081834|902047|P4|COMPLETED|Core Period: Baseline to Week 26||40
376426|NCT01081834|902048|P3|COMPLETED|Core Period: Baseline to Week 26||175
376427|NCT01081834|902049|P2|COMPLETED|Core Period: Baseline to Week 26||172
376428|NCT01081834|902050|P1|COMPLETED|Core Period: Baseline to Week 26||160
376429|NCT01081834|902046|P5|STARTED|Core Period: Baseline to Week 26||44
376430|NCT01081834|902047|P4|STARTED|Core Period: Baseline to Week 26||47
376431|NCT01081834|902048|P3|STARTED|Core Period: Baseline to Week 26||197
376432|NCT01081834|902049|P2|STARTED|Core Period: Baseline to Week 26||195
376433|NCT01081834|902050|P1|STARTED|Core Period: Baseline to Week 26||192
376434|NCT01081795|902111|P3|NOT COMPLETED|Overall Study||30
376435|NCT01081795|902112|P2|NOT COMPLETED|Overall Study||35
376436|NCT01081795|902113|P1|NOT COMPLETED|Overall Study||33
376437|NCT01081795|902111|P3|COMPLETED|Overall Study||97
376438|NCT01081795|902112|P2|COMPLETED|Overall Study||95
376439|NCT01081795|902113|P1|COMPLETED|Overall Study||97
376440|NCT01081795|902111|P3|STARTED|Overall Study||127
376441|NCT01081795|902112|P2|STARTED|Overall Study||130
376442|NCT01081795|902113|P1|STARTED|Overall Study||130
376443|NCT01081769|902150|P2|NOT COMPLETED|CORE Intent-To-Treat||97
376444|NCT01081769|902151|P1|NOT COMPLETED|CORE Intent-To-Treat||80
376445|NCT01081769|902150|P2|COMPLETED|CORE Intent-To-Treat||266
376446|NCT01081769|902151|P1|COMPLETED|CORE Intent-To-Treat||272
376447|NCT01081769|902150|P2|STARTED|CORE Intent-To-Treat||363
376448|NCT01081769|902151|P1|STARTED|CORE Intent-To-Treat||352
376449|NCT01081769|902150|P2|NOT COMPLETED|Whole Intent-to-Treat||25
376450|NCT01081769|902151|P1|NOT COMPLETED|Whole Intent-to-Treat||24
376451|NCT01081769|902150|P2|COMPLETED|Whole Intent-to-Treat||363
376452|NCT01081769|902151|P1|COMPLETED|Whole Intent-to-Treat||352
376453|NCT01081769|902150|P2|STARTED|Whole Intent-to-Treat||388
376454|NCT01081769|902151|P1|STARTED|Whole Intent-to-Treat||376
376455|NCT01081665|902185|P1|NOT COMPLETED|Overall Study||95
376456|NCT01081665|902185|P1|COMPLETED|Overall Study||142
376457|NCT01081665|902185|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
376458|NCT01081665|902185|P1|Full Analysis Set|Overall Study||237
376459|NCT01081665|902185|P1|STARTED|Overall Study||237
376460|NCT01081626|902197|P2|NOT COMPLETED|Overall Study||61
376461|NCT01081626|902198|P1|NOT COMPLETED|Overall Study||60
376462|NCT01081626|902197|P2|COMPLETED|Overall Study||94
376463|NCT01081626|902198|P1|COMPLETED|Overall Study||95
376464|NCT01081626|902197|P2|Assessed for Efficacy|Overall Study||125
376465|NCT01081626|902198|P1|Assessed for Efficacy|Overall Study||122
376466|NCT01081626|902197|P2|STARTED|Overall Study||155
376467|NCT01081626|902198|P1|STARTED|Overall Study||155
376468|NCT01081301|902224|P1|NOT COMPLETED|Overall Study||14
376469|NCT01081301|902224|P1|COMPLETED|Overall Study||22
376470|NCT01081301|902224|P1|STARTED|Overall Study||36
376471|NCT01081249|902262|P2|NOT COMPLETED|Overall Study||1
376472|NCT01081249|902263|P1|NOT COMPLETED|Overall Study||0
376473|NCT01081249|902262|P2|COMPLETED|Overall Study||6
376474|NCT01081249|902263|P1|COMPLETED|Overall Study||11
376475|NCT01081249|902262|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
376476|NCT01081249|902263|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
376477|NCT01081249|902262|P2|Washout (5-10 Days)|Overall Study||6
376478|NCT01081249|902263|P1|Washout (5-10 Days)|Overall Study||11
376479|NCT01081249|902262|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
376480|NCT01081249|902263|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
376481|NCT01081249|902262|P2|STARTED|Overall Study||7
376482|NCT01081249|902263|P1|STARTED|Overall Study||11
376483|NCT01081145|902269|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
376484|NCT01081145|902270|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
376485|NCT01081145|902269|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
376486|NCT01081145|902270|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
376487|NCT01081145|902269|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
376488|NCT01081145|902270|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
376489|NCT01081145|902269|P2|NOT COMPLETED|Open-Label Phase||0
376490|NCT01081145|902270|P1|NOT COMPLETED|Open-Label Phase||212
376491|NCT01081145|902269|P2|COMPLETED|Open-Label Phase||0
376492|NCT01081145|902270|P1|COMPLETED|Open-Label Phase||316
376493|NCT01081145|902269|P2|STARTED|Open-Label Phase||0
376494|NCT01081145|902270|P1|STARTED|Open-Label Phase||528
376495|NCT01081132|902298|P2|NOT COMPLETED|Overall Study||52
376496|NCT01081132|902299|P1|NOT COMPLETED|Overall Study||55
376497|NCT01081132|902298|P2|COMPLETED|Overall Study||105
376498|NCT01081132|902299|P1|COMPLETED|Overall Study||102
376499|NCT01081132|902298|P2|STARTED|Overall Study||157
376500|NCT01081132|902299|P1|STARTED|Overall Study||157
376501|NCT01081041|902340|P3|NOT COMPLETED|Overall Study||2
376502|NCT01081041|902341|P2|NOT COMPLETED|Overall Study||4
376503|NCT01081041|902342|P1|NOT COMPLETED|Overall Study||0
376504|NCT01081041|902340|P3|COMPLETED|Overall Study||71
376505|NCT01081041|902341|P2|COMPLETED|Overall Study||77
376506|NCT01081041|902342|P1|COMPLETED|Overall Study||33
376507|NCT01081041|902340|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
376508|NCT01081041|902341|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
376509|NCT01081041|902342|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
376510|NCT01081041|902340|P3|STARTED|Overall Study||73
376511|NCT01081041|902341|P2|STARTED|Overall Study||81
376512|NCT01081041|902342|P1|STARTED|Overall Study||33
376513|NCT01080807|902372|P2|NOT COMPLETED|Overall Study||23
376514|NCT01080807|902373|P1|NOT COMPLETED|Overall Study||35
376515|NCT01080807|902372|P2|COMPLETED|Overall Study||167
376516|NCT01080807|902373|P1|COMPLETED|Overall Study||158
376605|NCT01080131|902620|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
376517|NCT01080807|902372|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
376518|NCT01080807|902373|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
376519|NCT01080794|902431|P4|NOT COMPLETED|Overall Study||2
376520|NCT01080794|902432|P3|NOT COMPLETED|Overall Study||2
376521|NCT01080794|902433|P2|NOT COMPLETED|Overall Study||2
376522|NCT01080794|902434|P1|NOT COMPLETED|Overall Study||5
376523|NCT01080794|902431|P4|COMPLETED|Overall Study||13
376524|NCT01080794|902432|P3|COMPLETED|Overall Study||10
376525|NCT01080794|902433|P2|COMPLETED|Overall Study||12
376526|NCT01080794|902434|P1|COMPLETED|Overall Study||15
376527|NCT01080794|902431|P4|STARTED|Overall Study||15
376528|NCT01080794|902432|P3|STARTED|Overall Study||12
376529|NCT01080794|902433|P2|STARTED|Overall Study||14
376530|NCT01080794|902434|P1|STARTED|Overall Study||20
376531|NCT01080768|902482|P2|NOT COMPLETED|Overall Study||1
376532|NCT01080768|902483|P1|NOT COMPLETED|Overall Study||2
376533|NCT01080768|902482|P2|COMPLETED|Overall Study||16
376534|NCT01080768|902483|P1|COMPLETED|Overall Study||12
376535|NCT01080768|902482|P2|STARTED|Overall Study||17
376536|NCT01080768|902483|P1|STARTED|Overall Study||14
376537|NCT01080677|902492|P3|NOT COMPLETED|Overall Study||0
376538|NCT01080677|902493|P2|NOT COMPLETED|Overall Study||0
376539|NCT01080677|902494|P1|NOT COMPLETED|Overall Study||0
376540|NCT01080677|902492|P3|COMPLETED|Overall Study||20
376541|NCT01080677|902493|P2|COMPLETED|Overall Study||20
376542|NCT01080677|902494|P1|COMPLETED|Overall Study||20
376543|NCT01080677|902492|P3|STARTED|Overall Study||20
376544|NCT01080677|902493|P2|STARTED|Overall Study||20
376545|NCT01080677|902494|P1|STARTED|Overall Study||20
376546|NCT01080625|902514|P3|NOT COMPLETED|Overall Study||1
376547|NCT01080625|902515|P2|NOT COMPLETED|Overall Study||2
376548|NCT01080625|902516|P1|NOT COMPLETED|Overall Study||0
376549|NCT01080625|902514|P3|COMPLETED|Overall Study||31
376550|NCT01080625|902515|P2|COMPLETED|Overall Study||31
376551|NCT01080625|902516|P1|COMPLETED|Overall Study||31
376552|NCT01080625|902514|P3|STARTED|Overall Study||32
376553|NCT01080625|902515|P2|STARTED|Overall Study||33
376554|NCT01080625|902516|P1|STARTED|Overall Study||31
376555|NCT01080391|902526|P2|NOT COMPLETED|Overall Study||13
376556|NCT01080391|902527|P1|NOT COMPLETED|Overall Study||23
376557|NCT01080391|902526|P2|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|383
376558|NCT01080391|902527|P1|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|373
376559|NCT01080391|902526|P2|Treated|Overall Study||392
376560|NCT01080391|902527|P1|Treated|Overall Study||389
376561|NCT01080391|902526|P2|STARTED|Overall Study||396
376562|NCT01080391|902527|P1|STARTED|Overall Study||396
376563|NCT01080326|902545|P1|NOT COMPLETED|Overall Study||4
376564|NCT01080326|902545|P1|COMPLETED|Overall Study||3
376565|NCT01080326|902545|P1|STARTED|Overall Study||7
376566|NCT01080300|902551|P2|NOT COMPLETED|Overall Study||104
376567|NCT01080300|902552|P1|NOT COMPLETED|Overall Study||94
376568|NCT01080300|902551|P2|COMPLETED|Overall Study||191
376569|NCT01080300|902552|P1|COMPLETED|Overall Study||206
376570|NCT01080300|902551|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
376571|NCT01080300|902552|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
376572|NCT01080261|902560|P1|NOT COMPLETED|Overall Study||0
376573|NCT01080261|902560|P1|COMPLETED|Overall Study||60
376574|NCT01080261|902560|P1|STARTED|Overall Study||60
376575|NCT01080248|902575|P1|NOT COMPLETED|Overall Study||0
376576|NCT01080248|902575|P1|COMPLETED|Overall Study||2
376577|NCT01080248|902575|P1|STARTED|Overall Study||2
376578|NCT01080209|902589|P7|NOT COMPLETED|Overall Study||7
376579|NCT01080209|902590|P6|NOT COMPLETED|Overall Study||0
376580|NCT01080209|902591|P5|NOT COMPLETED|Overall Study||0
376581|NCT01080209|902592|P4|NOT COMPLETED|Overall Study||5
376582|NCT01080209|902593|P3|NOT COMPLETED|Overall Study||5
376583|NCT01080209|902594|P2|NOT COMPLETED|Overall Study||11
376584|NCT01080209|902595|P1|NOT COMPLETED|Overall Study||6
376585|NCT01080209|902589|P7|COMPLETED|Overall Study||44
376586|NCT01080209|902590|P6|COMPLETED|Overall Study||2
376587|NCT01080209|902591|P5|COMPLETED|Overall Study||6
376588|NCT01080209|902592|P4|COMPLETED|Overall Study||37
376589|NCT01080209|902593|P3|COMPLETED|Overall Study||28
376590|NCT01080209|902594|P2|COMPLETED|Overall Study||42
376591|NCT01080209|902595|P1|COMPLETED|Overall Study||22
376592|NCT01080209|902589|P7|STARTED|Overall Study||51
376593|NCT01080209|902590|P6|STARTED|Overall Study||2
376594|NCT01080209|902591|P5|STARTED|Overall Study||6
376595|NCT01080209|902592|P4|STARTED|Overall Study||42
376596|NCT01080209|902593|P3|STARTED|Overall Study||33
376597|NCT01080209|902594|P2|STARTED|Overall Study||53
376598|NCT01080209|902595|P1|STARTED|Overall Study||28
376599|NCT01080131|902620|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
376600|NCT01080131|902621|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
376601|NCT01080131|902620|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
376602|NCT01080131|902621|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
376603|NCT01080131|902620|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
376604|NCT01080131|902621|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
376606|NCT01080131|902621|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
376607|NCT01080131|902620|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
376608|NCT01080131|902621|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
376609|NCT01080131|902620|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
376610|NCT01080131|902621|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
376611|NCT01080131|902620|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
376612|NCT01080131|902621|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
376613|NCT01080131|902620|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
376614|NCT01080131|902621|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
376615|NCT01080131|902620|P2|COMPLETED|Core Study (0- 12 Weeks)||103
376616|NCT01080131|902621|P1|COMPLETED|Core Study (0- 12 Weeks)||99
376617|NCT01080131|902620|P2|STARTED|Core Study (0- 12 Weeks)||114
376618|NCT01080131|902621|P1|STARTED|Core Study (0- 12 Weeks)||112
376619|NCT01080118|902700|P4|NOT COMPLETED|Overall Study||0
376620|NCT01080118|902701|P3|NOT COMPLETED|Overall Study||0
376621|NCT01080118|902702|P2|NOT COMPLETED|Overall Study||0
376622|NCT01080118|902703|P1|NOT COMPLETED|Overall Study||0
376623|NCT01080118|902700|P4|COMPLETED|Overall Study||30
376624|NCT01080118|902701|P3|COMPLETED|Overall Study||30
376625|NCT01080118|902702|P2|COMPLETED|Overall Study||15
376626|NCT01080118|902703|P1|COMPLETED|Overall Study||15
376627|NCT01080118|902700|P4|STARTED|Overall Study||30
376628|NCT01080118|902701|P3|STARTED|Overall Study||30
376629|NCT01080118|902702|P2|STARTED|Overall Study||15
376630|NCT01080118|902703|P1|STARTED|Overall Study||15
376631|NCT01079988|902716|P5|NOT COMPLETED|Overall Study||1
376632|NCT01079988|902717|P4|NOT COMPLETED|Overall Study||3
376633|NCT01079988|902718|P3|NOT COMPLETED|Overall Study||0
376634|NCT01079988|902719|P2|NOT COMPLETED|Overall Study||0
376635|NCT01079988|902720|P1|NOT COMPLETED|Overall Study||1
376636|NCT01079988|902716|P5|COMPLETED|Overall Study||1
376637|NCT01079988|902717|P4|COMPLETED|Overall Study||17
376638|NCT01079988|902718|P3|COMPLETED|Overall Study||8
376639|NCT01079988|902719|P2|COMPLETED|Overall Study||1
376640|NCT01079988|902720|P1|COMPLETED|Overall Study||9
376641|NCT01079988|902716|P5|STARTED|Overall Study||2
376642|NCT01079988|902717|P4|STARTED|Overall Study||20
376643|NCT01079988|902718|P3|STARTED|Overall Study||8
376644|NCT01079988|902719|P2|STARTED|Overall Study||1
376645|NCT01079988|902720|P1|STARTED|Overall Study||10
376646|NCT01079962|902739|P2|NOT COMPLETED|Overall Study||15
376647|NCT01079962|902740|P1|NOT COMPLETED|Overall Study||15
376648|NCT01079962|902739|P2|COMPLETED|Overall Study||89
376649|NCT01079962|902740|P1|COMPLETED|Overall Study||90
376650|NCT01079962|902739|P2|STARTED|Overall Study||104
376651|NCT01079962|902740|P1|STARTED|Overall Study||105
376652|NCT01079949|902768|P2|NOT COMPLETED|Overall Study||13
376653|NCT01079949|902769|P1|NOT COMPLETED|Overall Study||15
376654|NCT01079949|902768|P2|COMPLETED|Overall Study||34
376655|NCT01079949|902769|P1|COMPLETED|Overall Study||31
376656|NCT01079949|902768|P2|STARTED|Overall Study||47
376657|NCT01079949|902769|P1|STARTED|Overall Study||46
376658|NCT01079936|902815|P5|NOT COMPLETED|Phase II||1
376659|NCT01079936|902816|P4|NOT COMPLETED|Phase II||0
376660|NCT01079936|902817|P3|NOT COMPLETED|Phase II||1
376661|NCT01079936|902818|P2|NOT COMPLETED|Phase II||0
376662|NCT01079936|902819|P1|NOT COMPLETED|Phase II||0
376663|NCT01079936|902815|P5|COMPLETED|Phase II||25
376664|NCT01079936|902816|P4|COMPLETED|Phase II||24
376665|NCT01079936|902817|P3|COMPLETED|Phase II||5
376666|NCT01079936|902818|P2|COMPLETED|Phase II||3
376667|NCT01079936|902819|P1|COMPLETED|Phase II||0
376668|NCT01079936|902815|P5|STARTED|Phase II||26
376669|NCT01079936|902816|P4|STARTED|Phase II||24
376670|NCT01079936|902817|P3|STARTED|Phase II||6
376671|NCT01079936|902818|P2|STARTED|Phase II||3
376672|NCT01079936|902819|P1|STARTED|Phase II||0
376673|NCT01079936|902815|P5|NOT COMPLETED|Phase I: MTD||0
376674|NCT01079936|902816|P4|NOT COMPLETED|Phase I: MTD||0
376675|NCT01079936|902817|P3|NOT COMPLETED|Phase I: MTD||0
376676|NCT01079936|902818|P2|NOT COMPLETED|Phase I: MTD||0
376677|NCT01079936|902819|P1|NOT COMPLETED|Phase I: MTD||4
376678|NCT01079936|902815|P5|COMPLETED|Phase I: MTD||0
376679|NCT01079936|902816|P4|COMPLETED|Phase I: MTD||0
376680|NCT01079936|902817|P3|COMPLETED|Phase I: MTD||0
376681|NCT01079936|902818|P2|COMPLETED|Phase I: MTD||0
376682|NCT01079936|902819|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
376683|NCT01079936|902815|P5|STARTED|Phase I: MTD||0
376684|NCT01079936|902816|P4|STARTED|Phase I: MTD||0
376685|NCT01079936|902817|P3|STARTED|Phase I: MTD||0
376686|NCT01079936|902818|P2|STARTED|Phase I: MTD||0
376687|NCT01079936|902819|P1|STARTED|Phase I: MTD||16
376688|NCT01079832|902838|P1|NOT COMPLETED|Overall Study||1
376689|NCT01079832|902838|P1|COMPLETED|Overall Study||49
376690|NCT01079832|902838|P1|STARTED|Overall Study||50
376691|NCT01079806|902848|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
376692|NCT01079806|902849|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
376693|NCT01079806|902848|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
376694|NCT01079806|902849|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
376695|NCT01079806|902848|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
376696|NCT01079806|902849|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
376697|NCT01079806|902848|P2|NOT COMPLETED|Day 1 to Week 96||4
376698|NCT01079806|902849|P1|NOT COMPLETED|Day 1 to Week 96||4
376699|NCT01079806|902848|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
376700|NCT01079806|902849|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
376701|NCT01079806|902848|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
376702|NCT01079806|902849|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
376703|NCT01079806|902848|P2|Received Treatment|Day 1 to Week 96||60
376704|NCT01079806|902849|P1|Received Treatment|Day 1 to Week 96||120
376705|NCT01079806|902848|P2|STARTED|Day 1 to Week 96|Randomized|60
376706|NCT01079806|902849|P1|STARTED|Day 1 to Week 96|Randomized|120
376707|NCT01079598|902869|P1|NOT COMPLETED|Overall Study||0
376708|NCT01079598|902869|P1|COMPLETED|Overall Study||8
376709|NCT01079598|902869|P1|STARTED|Overall Study||8
376710|NCT01079299|902878|P2|NOT COMPLETED|Overall Study||0
376711|NCT01079299|902879|P1|NOT COMPLETED|Overall Study||0
376712|NCT01079299|902878|P2|COMPLETED|Overall Study||25
376713|NCT01079299|902879|P1|COMPLETED|Overall Study||27
376714|NCT01079299|902878|P2|STARTED|Overall Study||25
376715|NCT01079299|902879|P1|STARTED|Overall Study||27
376716|NCT01079234|902888|P4|NOT COMPLETED|Extension: Week 27 to 52||16
376717|NCT01079234|902889|P3|NOT COMPLETED|Extension: Week 27 to 52||11
376718|NCT01079234|902890|P2|NOT COMPLETED|Extension: Week 27 to 52||0
376719|NCT01079234|902891|P1|NOT COMPLETED|Extension: Week 27 to 52||0
376720|NCT01079234|902888|P4|COMPLETED|Extension: Week 27 to 52||223
376721|NCT01079234|902889|P3|COMPLETED|Extension: Week 27 to 52||122
376722|NCT01079234|902890|P2|COMPLETED|Extension: Week 27 to 52||0
376723|NCT01079234|902891|P1|COMPLETED|Extension: Week 27 to 52||0
376724|NCT01079234|902888|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
376725|NCT01079234|902889|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
376726|NCT01079234|902890|P2|STARTED|Extension: Week 27 to 52||0
376727|NCT01079234|902891|P1|STARTED|Extension: Week 27 to 52||0
376728|NCT01079234|902888|P4|NOT COMPLETED|Main: Week 0 to 26||0
376729|NCT01079234|902889|P3|NOT COMPLETED|Main: Week 0 to 26||12
376730|NCT01079234|902890|P2|NOT COMPLETED|Main: Week 0 to 26||26
376731|NCT01079234|902891|P1|NOT COMPLETED|Main: Week 0 to 26||26
376732|NCT01079234|902888|P4|COMPLETED|Main: Week 0 to 26||0
376733|NCT01079234|902889|P3|COMPLETED|Main: Week 0 to 26||152
376734|NCT01079234|902890|P2|COMPLETED|Main: Week 0 to 26||139
376735|NCT01079234|902891|P1|COMPLETED|Main: Week 0 to 26||138
376736|NCT01079234|902888|P4|Exposed|Main: Week 0 to 26||0
376737|NCT01079234|902889|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
376738|NCT01079234|902890|P2|Exposed|Main: Week 0 to 26||165
376739|NCT01079234|902891|P1|Exposed|Main: Week 0 to 26||164
376740|NCT01079234|902888|P4|STARTED|Main: Week 0 to 26||0
376741|NCT01079234|902889|P3|STARTED|Main: Week 0 to 26||164
376742|NCT01079234|902890|P2|STARTED|Main: Week 0 to 26||165
376743|NCT01079234|902891|P1|STARTED|Main: Week 0 to 26||164
376744|NCT01079195|902909|P1|NOT COMPLETED|Overall Study||1431
376745|NCT01079195|902909|P1|COMPLETED|Overall Study||14442
376746|NCT01079195|902909|P1|STARTED|Overall Study||15873
376747|NCT01079182|902915|P1|NOT COMPLETED|Overall Study||2719
376748|NCT01079182|902915|P1|COMPLETED|Overall Study||1962
376749|NCT01079182|902915|P1|STARTED|Overall Study||4681
376750|NCT01079143|902946|P4|NOT COMPLETED|Overall Study||5
376751|NCT01079143|902947|P3|NOT COMPLETED|Overall Study||5
376752|NCT01079143|902948|P2|NOT COMPLETED|Overall Study||17
376753|NCT01079143|902949|P1|NOT COMPLETED|Overall Study||9
376754|NCT01079143|902946|P4|COMPLETED|Overall Study||54
376755|NCT01079143|902947|P3|COMPLETED|Overall Study||34
376756|NCT01079143|902948|P2|COMPLETED|Overall Study||43
376757|NCT01079143|902949|P1|COMPLETED|Overall Study||27
376758|NCT01079143|902946|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
376759|NCT01079143|902947|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
376760|NCT01079143|902948|P2|M3 and M12 Biopsies|Overall Study||43
376761|NCT01079143|902949|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
376762|NCT01079143|902946|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
376763|NCT01079143|902947|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
376764|NCT01079143|902948|P2|Month 12 (M12) Biopsies|Overall Study||43
376765|NCT01079143|902949|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
376766|NCT01079143|902946|P4|Month 3 (M3) Biopsies|Overall Study||59
376767|NCT01079143|902947|P3|Month 3 (M3) Biopsies|Overall Study||39
376768|NCT01079143|902948|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
376769|NCT01079143|902949|P1|Month 3 (M3) Biopsies|Overall Study||36
376770|NCT01079143|902946|P4|Exposed|Overall Study||59
376771|NCT01079143|902947|P3|Exposed|Overall Study||39
376772|NCT01079143|902948|P2|Exposed|Overall Study||60
376773|NCT01079143|902949|P1|Exposed|Overall Study||36
376774|NCT01079143|902946|P4|STARTED|Overall Study||59
376775|NCT01079143|902947|P3|STARTED|Overall Study||39
376776|NCT01079143|902948|P2|STARTED|Overall Study||60
376777|NCT01079143|902949|P1|STARTED|Overall Study||36
376778|NCT01079130|903023|P6|NOT COMPLETED|Overall Study||5
376779|NCT01079130|903024|P5|NOT COMPLETED|Overall Study||8
376780|NCT01079130|903025|P4|NOT COMPLETED|Overall Study||5
376781|NCT01079130|903026|P3|NOT COMPLETED|Overall Study||1
376782|NCT01079130|903027|P2|NOT COMPLETED|Overall Study||7
376783|NCT01079130|903028|P1|NOT COMPLETED|Overall Study||2
376784|NCT01079130|903023|P6|COMPLETED|Overall Study||80
376785|NCT01079130|903024|P5|COMPLETED|Overall Study||78
376786|NCT01079130|903025|P4|COMPLETED|Overall Study||81
376787|NCT01079130|903026|P3|COMPLETED|Overall Study||83
376788|NCT01079130|903027|P2|COMPLETED|Overall Study||78
376789|NCT01079130|903028|P1|COMPLETED|Overall Study||83
376790|NCT01079130|903023|P6|Full Analysis Set (FAS)|Overall Study||84
376791|NCT01079130|903024|P5|Full Analysis Set (FAS)|Overall Study||84
376792|NCT01079130|903025|P4|Full Analysis Set (FAS)|Overall Study||85
376793|NCT01079130|903026|P3|Full Analysis Set (FAS)|Overall Study||83
376794|NCT01079130|903027|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
376795|NCT01079130|903028|P1|Full Analysis Set (FAS)|Overall Study||84
376796|NCT01079130|903023|P6|Safety Set: Received Study Drug|Overall Study||84
376797|NCT01079130|903024|P5|Safety Set: Received Study Drug|Overall Study||84
376798|NCT01079130|903025|P4|Safety Set: Received Study Drug|Overall Study||85
376799|NCT01079130|903026|P3|Safety Set: Received Study Drug|Overall Study||84
376800|NCT01079130|903027|P2|Safety Set: Received Study Drug|Overall Study||81
376801|NCT01079130|903028|P1|Safety Set: Received Study Drug|Overall Study||84
376802|NCT01079130|903023|P6|STARTED|Overall Study||85
376803|NCT01079130|903024|P5|STARTED|Overall Study||86
376804|NCT01079130|903025|P4|STARTED|Overall Study||86
376805|NCT01079130|903026|P3|STARTED|Overall Study||84
376806|NCT01079130|903027|P2|STARTED|Overall Study||85
376807|NCT01079130|903028|P1|STARTED|Overall Study||85
376808|NCT01078974|903048|P1|NOT COMPLETED|Overall Study||3
376809|NCT01078974|903048|P1|COMPLETED|Overall Study||4
376810|NCT01078974|903048|P1|STARTED|Overall Study||7
376811|NCT01078922|903053|P1|NOT COMPLETED|Overall Study||1
376812|NCT01078922|903053|P1|COMPLETED|Overall Study||10
376813|NCT01078922|903053|P1|STARTED|Overall Study||11
376814|NCT01078909|903063|P5|NOT COMPLETED|Overall Study||2
376815|NCT01078909|903064|P4|NOT COMPLETED|Overall Study||1
376816|NCT01078909|903065|P3|NOT COMPLETED|Overall Study||1
376817|NCT01078909|903066|P2|NOT COMPLETED|Overall Study||4
376818|NCT01078909|903067|P1|NOT COMPLETED|Overall Study||2
376819|NCT01078909|903063|P5|COMPLETED|Overall Study||23
376820|NCT01078909|903064|P4|COMPLETED|Overall Study||24
376821|NCT01078909|903065|P3|COMPLETED|Overall Study||24
376822|NCT01078909|903066|P2|COMPLETED|Overall Study||21
376823|NCT01078909|903067|P1|COMPLETED|Overall Study||23
376824|NCT01078909|903063|P5|STARTED|Overall Study||25
376825|NCT01078909|903064|P4|STARTED|Overall Study||25
376826|NCT01078909|903065|P3|STARTED|Overall Study||25
376827|NCT01078909|903066|P2|STARTED|Overall Study||25
376828|NCT01078909|903067|P1|STARTED|Overall Study||25
376829|NCT01078805|903084|P1|NOT COMPLETED|Overall Study||2050
376830|NCT01078805|903084|P1|COMPLETED|Overall Study||2117
376831|NCT01078805|903084|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
376832|NCT01078805|903084|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
376833|NCT01078805|903084|P1|STARTED|Overall Study||4167
376834|NCT01078753|903098|P2|NOT COMPLETED|Treatment Period II||0
376835|NCT01078753|903099|P1|NOT COMPLETED|Treatment Period II||0
376836|NCT01078753|903098|P2|COMPLETED|Treatment Period II||44
376837|NCT01078753|903099|P1|COMPLETED|Treatment Period II||45
376838|NCT01078753|903098|P2|Full Analysis Set|Treatment Period II||44
376839|NCT01078753|903099|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
376840|NCT01078753|903098|P2|STARTED|Treatment Period II||44
376841|NCT01078753|903099|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
376842|NCT01078753|903098|P2|NOT COMPLETED|Treatment Period I||0
376843|NCT01078753|903099|P1|NOT COMPLETED|Treatment Period I||0
376844|NCT01078753|903098|P2|COMPLETED|Treatment Period I||44
376845|NCT01078753|903099|P1|COMPLETED|Treatment Period I||45
376846|NCT01078753|903098|P2|Full Analysis Set|Treatment Period I||44
376847|NCT01078753|903099|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
376848|NCT01078753|903098|P2|STARTED|Treatment Period I||44
376849|NCT01078753|903099|P1|STARTED|Treatment Period I||45
376850|NCT01078675|903111|P2|NOT COMPLETED|Overall Study||6
376851|NCT01078675|903112|P1|NOT COMPLETED|Overall Study||68
376852|NCT01078675|903111|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
376853|NCT01078675|903112|P1|COMPLETED|Overall Study||182
376854|NCT01078675|903111|P2|Patients Treated|Overall Study||0
376855|NCT01078675|903112|P1|Patients Treated|Overall Study||198
376856|NCT01078675|903111|P2|STARTED|Overall Study||65
376857|NCT01078675|903112|P1|STARTED|Overall Study||250
376858|NCT01078662|903134|P5|NOT COMPLETED|Overall Study||11
376859|NCT01078662|903135|P4|NOT COMPLETED|Overall Study||7
376860|NCT01078662|903136|P3|NOT COMPLETED|Overall Study||21
376861|NCT01078662|903137|P2|NOT COMPLETED|Overall Study||168
376862|NCT01078662|903138|P1|NOT COMPLETED|Overall Study||58
376863|NCT01078662|903134|P5|COMPLETED|Overall Study||1
376864|NCT01078662|903135|P4|COMPLETED|Overall Study||1
376865|NCT01078662|903136|P3|COMPLETED|Overall Study||2
376866|NCT01078662|903137|P2|COMPLETED|Overall Study||25
376867|NCT01078662|903138|P1|COMPLETED|Overall Study||4
376868|NCT01078662|903134|P5|STARTED|Overall Study||12
376869|NCT01078662|903135|P4|STARTED|Overall Study||8
376870|NCT01078662|903136|P3|STARTED|Overall Study||23
376871|NCT01078662|903137|P2|STARTED|Overall Study||193
376872|NCT01078662|903138|P1|STARTED|Overall Study||62
376873|NCT01078623|903177|P20|NOT COMPLETED|Treatment Period 4||0
376874|NCT01078623|903178|P19|NOT COMPLETED|Treatment Period 4||0
376875|NCT01078623|903179|P18|NOT COMPLETED|Treatment Period 4||0
376876|NCT01078623|903180|P17|NOT COMPLETED|Treatment Period 4||0
376877|NCT01078623|903181|P16|NOT COMPLETED|Treatment Period 4||1
376878|NCT01078623|903182|P15|NOT COMPLETED|Treatment Period 4||0
376879|NCT01078623|903183|P14|NOT COMPLETED|Treatment Period 4||0
376880|NCT01078623|903184|P13|NOT COMPLETED|Treatment Period 4||0
376881|NCT01078623|903185|P12|NOT COMPLETED|Treatment Period 4||0
376882|NCT01078623|903186|P11|NOT COMPLETED|Treatment Period 4||0
376883|NCT01078623|903187|P10|NOT COMPLETED|Treatment Period 4||0
376884|NCT01078623|903188|P9|NOT COMPLETED|Treatment Period 4||0
376885|NCT01078623|903189|P8|NOT COMPLETED|Treatment Period 4||0
376886|NCT01078623|903190|P7|NOT COMPLETED|Treatment Period 4||0
376887|NCT01078623|903191|P6|NOT COMPLETED|Treatment Period 4||0
376888|NCT01078623|903192|P5|NOT COMPLETED|Treatment Period 4||0
376889|NCT01078623|903193|P4|NOT COMPLETED|Treatment Period 4||0
376890|NCT01078623|903194|P3|NOT COMPLETED|Treatment Period 4||1
376891|NCT01078623|903195|P2|NOT COMPLETED|Treatment Period 4||0
376892|NCT01078623|903196|P1|NOT COMPLETED|Treatment Period 4||0
376893|NCT01078623|903177|P20|COMPLETED|Treatment Period 4||7
376894|NCT01078623|903178|P19|COMPLETED|Treatment Period 4||6
376895|NCT01078623|903179|P18|COMPLETED|Treatment Period 4||7
376896|NCT01078623|903180|P17|COMPLETED|Treatment Period 4||7
376897|NCT01078623|903181|P16|COMPLETED|Treatment Period 4||6
376898|NCT01078623|903182|P15|COMPLETED|Treatment Period 4||7
376899|NCT01078623|903183|P14|COMPLETED|Treatment Period 4||6
376900|NCT01078623|903184|P13|COMPLETED|Treatment Period 4||7
376901|NCT01078623|903185|P12|COMPLETED|Treatment Period 4||7
376902|NCT01078623|903186|P11|COMPLETED|Treatment Period 4||6
376903|NCT01078623|903187|P10|COMPLETED|Treatment Period 4||6
376904|NCT01078623|903188|P9|COMPLETED|Treatment Period 4||5
376905|NCT01078623|903189|P8|COMPLETED|Treatment Period 4||6
376906|NCT01078623|903190|P7|COMPLETED|Treatment Period 4||5
376907|NCT01078623|903191|P6|COMPLETED|Treatment Period 4||4
376908|NCT01078623|903192|P5|COMPLETED|Treatment Period 4||6
376909|NCT01078623|903193|P4|COMPLETED|Treatment Period 4||6
376910|NCT01078623|903194|P3|COMPLETED|Treatment Period 4||5
376911|NCT01078623|903195|P2|COMPLETED|Treatment Period 4||5
376912|NCT01078623|903196|P1|COMPLETED|Treatment Period 4||5
376913|NCT01078623|903177|P20|STARTED|Treatment Period 4||7
376914|NCT01078623|903178|P19|STARTED|Treatment Period 4||6
376915|NCT01078623|903179|P18|STARTED|Treatment Period 4||7
376916|NCT01078623|903180|P17|STARTED|Treatment Period 4||7
376917|NCT01078623|903181|P16|STARTED|Treatment Period 4||7
376918|NCT01078623|903182|P15|STARTED|Treatment Period 4||7
376919|NCT01078623|903183|P14|STARTED|Treatment Period 4||6
376920|NCT01078623|903184|P13|STARTED|Treatment Period 4||7
376921|NCT01078623|903185|P12|STARTED|Treatment Period 4||7
376922|NCT01078623|903186|P11|STARTED|Treatment Period 4||6
376923|NCT01078623|903187|P10|STARTED|Treatment Period 4||6
376924|NCT01078623|903188|P9|STARTED|Treatment Period 4||5
376925|NCT01078623|903189|P8|STARTED|Treatment Period 4||6
376926|NCT01078623|903190|P7|STARTED|Treatment Period 4||5
376927|NCT01078623|903191|P6|STARTED|Treatment Period 4||4
376928|NCT01078623|903192|P5|STARTED|Treatment Period 4||6
376929|NCT01078623|903193|P4|STARTED|Treatment Period 4||6
376930|NCT01078623|903194|P3|STARTED|Treatment Period 4||6
376931|NCT01078623|903195|P2|STARTED|Treatment Period 4||5
376932|NCT01078623|903196|P1|STARTED|Treatment Period 4||5
376933|NCT01078623|903177|P20|NOT COMPLETED|Treatment Period 3||0
376934|NCT01078623|903178|P19|NOT COMPLETED|Treatment Period 3||0
376935|NCT01078623|903179|P18|NOT COMPLETED|Treatment Period 3||0
376936|NCT01078623|903180|P17|NOT COMPLETED|Treatment Period 3||0
376937|NCT01078623|903181|P16|NOT COMPLETED|Treatment Period 3||0
376938|NCT01078623|903182|P15|NOT COMPLETED|Treatment Period 3||0
376939|NCT01078623|903183|P14|NOT COMPLETED|Treatment Period 3||1
376940|NCT01078623|903184|P13|NOT COMPLETED|Treatment Period 3||0
376941|NCT01078623|903185|P12|NOT COMPLETED|Treatment Period 3||0
376942|NCT01078623|903186|P11|NOT COMPLETED|Treatment Period 3||0
376943|NCT01078623|903187|P10|NOT COMPLETED|Treatment Period 3||0
376944|NCT01078623|903188|P9|NOT COMPLETED|Treatment Period 3||0
376945|NCT01078623|903189|P8|NOT COMPLETED|Treatment Period 3||0
376946|NCT01078623|903190|P7|NOT COMPLETED|Treatment Period 3||0
376947|NCT01078623|903191|P6|NOT COMPLETED|Treatment Period 3||0
376948|NCT01078623|903192|P5|NOT COMPLETED|Treatment Period 3||1
376949|NCT01078623|903193|P4|NOT COMPLETED|Treatment Period 3||0
376950|NCT01078623|903194|P3|NOT COMPLETED|Treatment Period 3||0
376951|NCT01078623|903195|P2|NOT COMPLETED|Treatment Period 3||0
376952|NCT01078623|903196|P1|NOT COMPLETED|Treatment Period 3||0
376953|NCT01078623|903177|P20|COMPLETED|Treatment Period 3||7
376954|NCT01078623|903178|P19|COMPLETED|Treatment Period 3||6
376955|NCT01078623|903179|P18|COMPLETED|Treatment Period 3||7
376956|NCT01078623|903180|P17|COMPLETED|Treatment Period 3||7
376957|NCT01078623|903181|P16|COMPLETED|Treatment Period 3||7
376958|NCT01078623|903182|P15|COMPLETED|Treatment Period 3||7
376959|NCT01078623|903183|P14|COMPLETED|Treatment Period 3||6
376960|NCT01078623|903184|P13|COMPLETED|Treatment Period 3||7
376961|NCT01078623|903185|P12|COMPLETED|Treatment Period 3||7
376962|NCT01078623|903186|P11|COMPLETED|Treatment Period 3||6
376963|NCT01078623|903187|P10|COMPLETED|Treatment Period 3||6
376964|NCT01078623|903188|P9|COMPLETED|Treatment Period 3||5
376965|NCT01078623|903189|P8|COMPLETED|Treatment Period 3||6
376966|NCT01078623|903190|P7|COMPLETED|Treatment Period 3||5
376967|NCT01078623|903191|P6|COMPLETED|Treatment Period 3||4
376968|NCT01078623|903192|P5|COMPLETED|Treatment Period 3||6
376969|NCT01078623|903193|P4|COMPLETED|Treatment Period 3||6
376970|NCT01078623|903194|P3|COMPLETED|Treatment Period 3||6
376971|NCT01078623|903195|P2|COMPLETED|Treatment Period 3||5
376972|NCT01078623|903196|P1|COMPLETED|Treatment Period 3||5
376973|NCT01078623|903177|P20|STARTED|Treatment Period 3||7
376974|NCT01078623|903178|P19|STARTED|Treatment Period 3||6
376975|NCT01078623|903179|P18|STARTED|Treatment Period 3||7
376976|NCT01078623|903180|P17|STARTED|Treatment Period 3||7
376977|NCT01078623|903181|P16|STARTED|Treatment Period 3||7
376978|NCT01078623|903182|P15|STARTED|Treatment Period 3||7
376979|NCT01078623|903183|P14|STARTED|Treatment Period 3||7
376980|NCT01078623|903184|P13|STARTED|Treatment Period 3||7
376981|NCT01078623|903185|P12|STARTED|Treatment Period 3||7
376982|NCT01078623|903186|P11|STARTED|Treatment Period 3||6
376983|NCT01078623|903187|P10|STARTED|Treatment Period 3||6
376984|NCT01078623|903188|P9|STARTED|Treatment Period 3||5
376985|NCT01078623|903189|P8|STARTED|Treatment Period 3||6
376986|NCT01078623|903190|P7|STARTED|Treatment Period 3||5
376987|NCT01078623|903191|P6|STARTED|Treatment Period 3||4
376988|NCT01078623|903192|P5|STARTED|Treatment Period 3||7
376989|NCT01078623|903193|P4|STARTED|Treatment Period 3||6
376990|NCT01078623|903194|P3|STARTED|Treatment Period 3||6
376991|NCT01078623|903195|P2|STARTED|Treatment Period 3||5
376992|NCT01078623|903196|P1|STARTED|Treatment Period 3||5
376993|NCT01078623|903177|P20|NOT COMPLETED|Treatment Period 2||0
376994|NCT01078623|903178|P19|NOT COMPLETED|Treatment Period 2||1
376995|NCT01078623|903179|P18|NOT COMPLETED|Treatment Period 2||0
376996|NCT01078623|903180|P17|NOT COMPLETED|Treatment Period 2||0
376997|NCT01078623|903181|P16|NOT COMPLETED|Treatment Period 2||0
376998|NCT01078623|903182|P15|NOT COMPLETED|Treatment Period 2||0
376999|NCT01078623|903183|P14|NOT COMPLETED|Treatment Period 2||0
377000|NCT01078623|903184|P13|NOT COMPLETED|Treatment Period 2||0
377001|NCT01078623|903185|P12|NOT COMPLETED|Treatment Period 2||0
377002|NCT01078623|903186|P11|NOT COMPLETED|Treatment Period 2||0
377003|NCT01078623|903187|P10|NOT COMPLETED|Treatment Period 2||0
377004|NCT01078623|903188|P9|NOT COMPLETED|Treatment Period 2||0
377005|NCT01078623|903189|P8|NOT COMPLETED|Treatment Period 2||0
377006|NCT01078623|903190|P7|NOT COMPLETED|Treatment Period 2||1
377007|NCT01078623|903191|P6|NOT COMPLETED|Treatment Period 2||1
377008|NCT01078623|903192|P5|NOT COMPLETED|Treatment Period 2||0
377009|NCT01078623|903193|P4|NOT COMPLETED|Treatment Period 2||0
377010|NCT01078623|903194|P3|NOT COMPLETED|Treatment Period 2||0
377011|NCT01078623|903195|P2|NOT COMPLETED|Treatment Period 2||0
377012|NCT01078623|903196|P1|NOT COMPLETED|Treatment Period 2||0
377013|NCT01078623|903177|P20|COMPLETED|Treatment Period 2||7
377014|NCT01078623|903178|P19|COMPLETED|Treatment Period 2||6
377015|NCT01078623|903179|P18|COMPLETED|Treatment Period 2||7
377016|NCT01078623|903180|P17|COMPLETED|Treatment Period 2||7
377017|NCT01078623|903181|P16|COMPLETED|Treatment Period 2||7
377018|NCT01078623|903182|P15|COMPLETED|Treatment Period 2||7
377019|NCT01078623|903183|P14|COMPLETED|Treatment Period 2||7
377020|NCT01078623|903184|P13|COMPLETED|Treatment Period 2||7
377021|NCT01078623|903185|P12|COMPLETED|Treatment Period 2||7
377022|NCT01078623|903186|P11|COMPLETED|Treatment Period 2||6
377023|NCT01078623|903187|P10|COMPLETED|Treatment Period 2||6
377024|NCT01078623|903188|P9|COMPLETED|Treatment Period 2||5
377025|NCT01078623|903189|P8|COMPLETED|Treatment Period 2||6
377026|NCT01078623|903190|P7|COMPLETED|Treatment Period 2||5
377027|NCT01078623|903191|P6|COMPLETED|Treatment Period 2||4
377028|NCT01078623|903192|P5|COMPLETED|Treatment Period 2||7
377029|NCT01078623|903193|P4|COMPLETED|Treatment Period 2||6
377030|NCT01078623|903194|P3|COMPLETED|Treatment Period 2||6
377031|NCT01078623|903195|P2|COMPLETED|Treatment Period 2||5
377032|NCT01078623|903196|P1|COMPLETED|Treatment Period 2||5
377033|NCT01078623|903177|P20|STARTED|Treatment Period 2||7
377034|NCT01078623|903178|P19|STARTED|Treatment Period 2||7
377035|NCT01078623|903179|P18|STARTED|Treatment Period 2||7
377036|NCT01078623|903180|P17|STARTED|Treatment Period 2||7
377037|NCT01078623|903181|P16|STARTED|Treatment Period 2||7
377038|NCT01078623|903182|P15|STARTED|Treatment Period 2||7
377039|NCT01078623|903183|P14|STARTED|Treatment Period 2||7
377040|NCT01078623|903184|P13|STARTED|Treatment Period 2||7
377041|NCT01078623|903185|P12|STARTED|Treatment Period 2||7
377042|NCT01078623|903186|P11|STARTED|Treatment Period 2||6
377043|NCT01078623|903187|P10|STARTED|Treatment Period 2||6
377044|NCT01078623|903188|P9|STARTED|Treatment Period 2||5
377045|NCT01078623|903189|P8|STARTED|Treatment Period 2||6
377046|NCT01078623|903190|P7|STARTED|Treatment Period 2||6
377047|NCT01078623|903191|P6|STARTED|Treatment Period 2||5
377048|NCT01078623|903192|P5|STARTED|Treatment Period 2||7
377049|NCT01078623|903193|P4|STARTED|Treatment Period 2||6
377050|NCT01078623|903194|P3|STARTED|Treatment Period 2||6
377051|NCT01078623|903195|P2|STARTED|Treatment Period 2||5
377052|NCT01078623|903196|P1|STARTED|Treatment Period 2||5
377053|NCT01078623|903177|P20|NOT COMPLETED|Treatment Period 1||0
377054|NCT01078623|903178|P19|NOT COMPLETED|Treatment Period 1||0
377055|NCT01078623|903179|P18|NOT COMPLETED|Treatment Period 1||0
377056|NCT01078623|903180|P17|NOT COMPLETED|Treatment Period 1||0
377057|NCT01078623|903181|P16|NOT COMPLETED|Treatment Period 1||0
377058|NCT01078623|903182|P15|NOT COMPLETED|Treatment Period 1||0
377059|NCT01078623|903183|P14|NOT COMPLETED|Treatment Period 1||0
377060|NCT01078623|903184|P13|NOT COMPLETED|Treatment Period 1||0
377061|NCT01078623|903185|P12|NOT COMPLETED|Treatment Period 1||0
377062|NCT01078623|903186|P11|NOT COMPLETED|Treatment Period 1||1
377063|NCT01078623|903187|P10|NOT COMPLETED|Treatment Period 1||1
377064|NCT01078623|903188|P9|NOT COMPLETED|Treatment Period 1||1
377065|NCT01078623|903189|P8|NOT COMPLETED|Treatment Period 1||1
377066|NCT01078623|903190|P7|NOT COMPLETED|Treatment Period 1||1
377067|NCT01078623|903191|P6|NOT COMPLETED|Treatment Period 1||1
377068|NCT01078623|903192|P5|NOT COMPLETED|Treatment Period 1||0
377069|NCT01078623|903193|P4|NOT COMPLETED|Treatment Period 1||0
377070|NCT01078623|903194|P3|NOT COMPLETED|Treatment Period 1||1
377071|NCT01078623|903195|P2|NOT COMPLETED|Treatment Period 1||1
377072|NCT01078623|903196|P1|NOT COMPLETED|Treatment Period 1||1
377073|NCT01078623|903177|P20|COMPLETED|Treatment Period 1||7
377074|NCT01078623|903178|P19|COMPLETED|Treatment Period 1||7
377075|NCT01078623|903179|P18|COMPLETED|Treatment Period 1||7
377076|NCT01078623|903180|P17|COMPLETED|Treatment Period 1||7
377077|NCT01078623|903181|P16|COMPLETED|Treatment Period 1||7
377078|NCT01078623|903182|P15|COMPLETED|Treatment Period 1||7
377079|NCT01078623|903183|P14|COMPLETED|Treatment Period 1||7
377080|NCT01078623|903184|P13|COMPLETED|Treatment Period 1||7
377081|NCT01078623|903185|P12|COMPLETED|Treatment Period 1||7
377082|NCT01078623|903186|P11|COMPLETED|Treatment Period 1||6
377083|NCT01078623|903187|P10|COMPLETED|Treatment Period 1||6
377084|NCT01078623|903188|P9|COMPLETED|Treatment Period 1||5
377085|NCT01078623|903189|P8|COMPLETED|Treatment Period 1||6
377086|NCT01078623|903190|P7|COMPLETED|Treatment Period 1||6
377087|NCT01078623|903191|P6|COMPLETED|Treatment Period 1||5
377088|NCT01078623|903192|P5|COMPLETED|Treatment Period 1||7
377089|NCT01078623|903193|P4|COMPLETED|Treatment Period 1||6
377090|NCT01078623|903194|P3|COMPLETED|Treatment Period 1||6
377091|NCT01078623|903195|P2|COMPLETED|Treatment Period 1||5
377092|NCT01078623|903196|P1|COMPLETED|Treatment Period 1||5
377093|NCT01078623|903177|P20|STARTED|Treatment Period 1||7
377094|NCT01078623|903178|P19|STARTED|Treatment Period 1||7
377095|NCT01078623|903179|P18|STARTED|Treatment Period 1||7
377096|NCT01078623|903180|P17|STARTED|Treatment Period 1||7
377097|NCT01078623|903181|P16|STARTED|Treatment Period 1||7
377098|NCT01078623|903182|P15|STARTED|Treatment Period 1||7
377099|NCT01078623|903183|P14|STARTED|Treatment Period 1||7
377100|NCT01078623|903184|P13|STARTED|Treatment Period 1||7
377101|NCT01078623|903185|P12|STARTED|Treatment Period 1||7
377102|NCT01078623|903186|P11|STARTED|Treatment Period 1||7
377103|NCT01078623|903187|P10|STARTED|Treatment Period 1||7
377104|NCT01078623|903188|P9|STARTED|Treatment Period 1||6
377105|NCT01078623|903189|P8|STARTED|Treatment Period 1||7
377106|NCT01078623|903190|P7|STARTED|Treatment Period 1||7
377107|NCT01078623|903191|P6|STARTED|Treatment Period 1||6
377108|NCT01078623|903192|P5|STARTED|Treatment Period 1||7
377109|NCT01078623|903193|P4|STARTED|Treatment Period 1||6
377110|NCT01078623|903194|P3|STARTED|Treatment Period 1||7
377111|NCT01078623|903195|P2|STARTED|Treatment Period 1||6
377112|NCT01078623|903196|P1|STARTED|Treatment Period 1||6
377113|NCT01078584|903218|P1|NOT COMPLETED|Overall Study||3010
377114|NCT01078584|903218|P1|COMPLETED|Overall Study||4983
377115|NCT01078584|903218|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
377116|NCT01078584|903218|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
377117|NCT01078584|903218|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
377118|NCT01078584|903218|P1|STARTED|Overall Study||7993
377119|NCT01078571|903299|P1|NOT COMPLETED|Overall Study||115
377120|NCT01078571|903299|P1|COMPLETED|Overall Study||590
377121|NCT01078571|903299|P1|Intent-to-treat (ITT) Population|Overall Study||591
377122|NCT01078571|903299|P1|Safety Population|Overall Study||675
377123|NCT01078571|903299|P1|STARTED|Overall Study||705
377124|NCT01078545|903315|P1|NOT COMPLETED|Overall Study||26
377125|NCT01078545|903315|P1|COMPLETED|Overall Study||703
377126|NCT01078545|903315|P1|Per Protocol Population|Overall Study||661
377127|NCT01078545|903315|P1|Intent-to-treat Population|Overall Study||729
377128|NCT01078545|903315|P1|STARTED|Overall Study||729
377129|NCT01078454|903325|P2|NOT COMPLETED|Overall Study||2
377130|NCT01078454|903326|P1|NOT COMPLETED|Overall Study||1
377131|NCT01078454|903325|P2|COMPLETED|Overall Study||3
377132|NCT01078454|903326|P1|COMPLETED|Overall Study||5
377133|NCT01078454|903325|P2|STARTED|Overall Study||5
377134|NCT01078454|903326|P1|STARTED|Overall Study||6
377135|NCT01078441|903332|P1|NOT COMPLETED|Overall Study||1
377136|NCT01078441|903332|P1|COMPLETED|Overall Study||1
377137|NCT01078441|903332|P1|STARTED|Overall Study||2
377138|NCT01078402|903339|P3|NOT COMPLETED|Overall Study||68
377139|NCT01078402|903340|P2|NOT COMPLETED|Overall Study||29
377140|NCT01078402|903341|P1|NOT COMPLETED|Overall Study||107
377141|NCT01078402|903339|P3|COMPLETED|Overall Study||166
377142|NCT01078402|903340|P2|COMPLETED|Overall Study||95
377143|NCT01078402|903341|P1|COMPLETED|Overall Study||324
377144|NCT01078402|903339|P3|STARTED|Overall Study||234
377145|NCT01078402|903340|P2|STARTED|Overall Study||124
377146|NCT01078402|903341|P1|STARTED|Overall Study||431
377147|NCT01078389|903372|P2|NOT COMPLETED|Overall Study||67
377148|NCT01078389|903373|P1|NOT COMPLETED|Overall Study||64
377149|NCT01078389|903372|P2|COMPLETED|Overall Study||90
377150|NCT01078389|903373|P1|COMPLETED|Overall Study||93
377151|NCT01078389|903372|P2|STARTED|Overall Study||157
377152|NCT01078389|903373|P1|STARTED|Overall Study||157
377153|NCT01078376|903391|P4|NOT COMPLETED|Overall Study||0
377154|NCT01078376|903392|P3|NOT COMPLETED|Overall Study||0
377155|NCT01078376|903393|P2|NOT COMPLETED|Overall Study||0
377156|NCT01078376|903394|P1|NOT COMPLETED|Overall Study||0
377157|NCT01078376|903391|P4|COMPLETED|Overall Study||3
377158|NCT01078376|903392|P3|COMPLETED|Overall Study||8
377159|NCT01078376|903393|P2|COMPLETED|Overall Study||9
377160|NCT01078376|903394|P1|COMPLETED|Overall Study||9
377161|NCT01078376|903391|P4|STARTED|Overall Study||3
377162|NCT01078376|903392|P3|STARTED|Overall Study||8
377163|NCT01078376|903393|P2|STARTED|Overall Study||9
377164|NCT01078376|903394|P1|STARTED|Overall Study||9
377165|NCT01078363|903515|P2|NOT COMPLETED|Overall Study||0
377166|NCT01078363|903516|P1|NOT COMPLETED|Overall Study||0
377167|NCT01078363|903515|P2|COMPLETED|Overall Study||49
377168|NCT01078363|903516|P1|COMPLETED|Overall Study||47
377169|NCT01078363|903515|P2|STARTED|Overall Study||49
377170|NCT01078363|903516|P1|STARTED|Overall Study||47
377171|NCT01078298|903534|P2|NOT COMPLETED|Overall Study||90
377172|NCT01078298|903535|P1|NOT COMPLETED|Overall Study||81
377173|NCT01078298|903534|P2|COMPLETED|Overall Study||179
377174|NCT01078298|903535|P1|COMPLETED|Overall Study||175
377175|NCT01078298|903534|P2|STARTED|Overall Study||269
377176|NCT01078298|903535|P1|STARTED|Overall Study||256
377177|NCT01078246|903568|P7|NOT COMPLETED|Overall Study||0
377178|NCT01078246|903569|P6|NOT COMPLETED|Overall Study||0
377179|NCT01078246|903570|P5|NOT COMPLETED|Overall Study||0
377180|NCT01078246|903571|P4|NOT COMPLETED|Overall Study||0
377181|NCT01078246|903572|P3|NOT COMPLETED|Overall Study||0
377182|NCT01078246|903573|P2|NOT COMPLETED|Overall Study||0
377183|NCT01078246|903574|P1|NOT COMPLETED|Overall Study||0
377184|NCT01078246|903568|P7|COMPLETED|Overall Study||22
377185|NCT01078246|903569|P6|COMPLETED|Overall Study||231
377186|NCT01078246|903570|P5|COMPLETED|Overall Study||3310
377187|NCT01078246|903571|P4|COMPLETED|Overall Study||152
377188|NCT01078246|903572|P3|COMPLETED|Overall Study||1963
377189|NCT01078246|903573|P2|COMPLETED|Overall Study||405
377190|NCT01078246|903574|P1|COMPLETED|Overall Study||1041
377191|NCT01078246|903568|P7|STARTED|Overall Study||22
377192|NCT01078246|903569|P6|STARTED|Overall Study||231
377193|NCT01078246|903570|P5|STARTED|Overall Study||3310
377194|NCT01078246|903571|P4|STARTED|Overall Study||152
377195|NCT01078246|903572|P3|STARTED|Overall Study||1963
377196|NCT01078246|903573|P2|STARTED|Overall Study||405
377197|NCT01078246|903574|P1|STARTED|Overall Study||1041
377198|NCT01078233|903606|P6|NOT COMPLETED|Overall Study||0
377199|NCT01078233|903607|P5|NOT COMPLETED|Overall Study||0
377200|NCT01078233|903608|P4|NOT COMPLETED|Overall Study||0
377201|NCT01078233|903609|P3|NOT COMPLETED|Overall Study||0
377202|NCT01078233|903610|P2|NOT COMPLETED|Overall Study||0
377203|NCT01078233|903611|P1|NOT COMPLETED|Overall Study||0
377204|NCT01078233|903606|P6|COMPLETED|Overall Study||154
377205|NCT01078233|903607|P5|COMPLETED|Overall Study||3199
377206|NCT01078233|903608|P4|COMPLETED|Overall Study||631
377207|NCT01078233|903609|P3|COMPLETED|Overall Study||1681
377208|NCT01078233|903610|P2|COMPLETED|Overall Study||296
377209|NCT01078233|903611|P1|COMPLETED|Overall Study||656
377210|NCT01078233|903606|P6|STARTED|Overall Study||154
377211|NCT01078233|903607|P5|STARTED|Overall Study||3199
377212|NCT01078233|903608|P4|STARTED|Overall Study||631
377213|NCT01078233|903609|P3|STARTED|Overall Study||1681
377214|NCT01078233|903610|P2|STARTED|Overall Study||296
377215|NCT01078233|903611|P1|STARTED|Overall Study||656
377216|NCT01078220|903628|P1|NOT COMPLETED|Overall Study||0
377217|NCT01078220|903628|P1|COMPLETED|Overall Study||189629
377218|NCT01078220|903628|P1|STARTED|Overall Study||189629
377219|NCT01078207|903638|P1|NOT COMPLETED|Overall Study||0
377220|NCT01078207|903638|P1|COMPLETED|Overall Study||100
377221|NCT01078207|903638|P1|STARTED|Overall Study||100
377222|NCT01078155|903643|P1|NOT COMPLETED|Overall Study||44
377223|NCT01078155|903643|P1|COMPLETED|Overall Study||87
377224|NCT01078155|903643|P1|STARTED|Overall Study||131
377225|NCT01078116|903659|P1|NOT COMPLETED|Overall Study||48
377226|NCT01078116|903659|P1|COMPLETED|Overall Study||76
377227|NCT01078116|903659|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
377228|NCT01078090|903667|P1|NOT COMPLETED|Overall Study||4593
377229|NCT01078090|903667|P1|COMPLETED|Overall Study||1152
377230|NCT01078090|903667|P1|STARTED|Overall Study||5745
377231|NCT01077973|903711|P3|NOT COMPLETED|Overall Study||0
377232|NCT01077973|903712|P2|NOT COMPLETED|Overall Study||0
377233|NCT01077973|903713|P1|NOT COMPLETED|Overall Study||0
377234|NCT01077973|903711|P3|COMPLETED|Overall Study||80
377235|NCT01077973|903712|P2|COMPLETED|Overall Study||79
377236|NCT01077973|903713|P1|COMPLETED|Overall Study||41
377237|NCT01077973|903711|P3|STARTED|Overall Study||80
377238|NCT01077973|903712|P2|STARTED|Overall Study||79
377239|NCT01077973|903713|P1|STARTED|Overall Study||41
377240|NCT01077960|903761|P1|NOT COMPLETED|Overall Study||16
377241|NCT01077960|903761|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
377242|NCT01077960|903761|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
377243|NCT01077921|903772|P2|NOT COMPLETED|Second Intervention||1
377244|NCT01077921|903773|P1|NOT COMPLETED|Second Intervention||0
377245|NCT01077921|903772|P2|COMPLETED|Second Intervention||9
377246|NCT01077921|903773|P1|COMPLETED|Second Intervention||13
377247|NCT01077921|903772|P2|STARTED|Second Intervention||10
377248|NCT01077921|903773|P1|STARTED|Second Intervention||13
377249|NCT01077921|903772|P2|NOT COMPLETED|Washout||2
377250|NCT01077921|903773|P1|NOT COMPLETED|Washout||0
377251|NCT01077921|903772|P2|COMPLETED|Washout||10
377252|NCT01077921|903773|P1|COMPLETED|Washout||13
377253|NCT01077921|903772|P2|STARTED|Washout||12
377254|NCT01077921|903773|P1|STARTED|Washout||13
377255|NCT01077921|903772|P2|NOT COMPLETED|First Intervention||1
377256|NCT01077921|903773|P1|NOT COMPLETED|First Intervention||1
377257|NCT01077921|903772|P2|COMPLETED|First Intervention||12
377258|NCT01077921|903773|P1|COMPLETED|First Intervention||13
377259|NCT01077921|903772|P2|STARTED|First Intervention||13
377260|NCT01077921|903773|P1|STARTED|First Intervention||14
377261|NCT01077856|903806|P3|NOT COMPLETED|Overall Study||0
377262|NCT01077856|903807|P2|NOT COMPLETED|Overall Study||0
377263|NCT01077856|903808|P1|NOT COMPLETED|Overall Study||0
377264|NCT01077856|903806|P3|COMPLETED|Overall Study||15713
377265|NCT01077856|903807|P2|COMPLETED|Overall Study||16604
377266|NCT01077856|903808|P1|COMPLETED|Overall Study||22199
377267|NCT01077856|903806|P3|STARTED|Overall Study||15713
377268|NCT01077856|903807|P2|STARTED|Overall Study||16604
377269|NCT01077856|903808|P1|STARTED|Overall Study||22199
377270|NCT01077830|903989|P2|NOT COMPLETED|Overall Study||0
377271|NCT01077830|903990|P1|NOT COMPLETED|Overall Study||0
377272|NCT01077830|903989|P2|COMPLETED|Overall Study||682
377273|NCT01077830|903990|P1|COMPLETED|Overall Study||677
377274|NCT01077830|903989|P2|STARTED|Overall Study||682
377275|NCT01077830|903990|P1|STARTED|Overall Study||677
377276|NCT01077817|904000|P1|NOT COMPLETED|Overall Study||0
377277|NCT01077817|904000|P1|COMPLETED|Overall Study||684815
377278|NCT01077817|904000|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
377279|NCT01077804|904011|P1|NOT COMPLETED|Overall Study||199
377280|NCT01077804|904011|P1|COMPLETED|Overall Study||7386
377281|NCT01077804|904011|P1|STARTED|Overall Study||7585
377282|NCT01077739|904020|P2|NOT COMPLETED|Overall Study||10
377283|NCT01077739|904021|P1|NOT COMPLETED|Overall Study||5
377284|NCT01077739|904020|P2|COMPLETED|Overall Study||40
377285|NCT01077739|904021|P1|COMPLETED|Overall Study||20
377286|NCT01077739|904020|P2|STARTED|Overall Study||50
377287|NCT01077739|904021|P1|STARTED|Overall Study||25
377288|NCT01077713|904035|P2|NOT COMPLETED|Overall Study||36
377289|NCT01077713|904036|P1|NOT COMPLETED|Overall Study||36
377290|NCT01077713|904035|P2|COMPLETED|Overall Study||6
377291|NCT01077713|904036|P1|COMPLETED|Overall Study||8
377292|NCT01077713|904035|P2|STARTED|Overall Study||42
377293|NCT01077713|904036|P1|STARTED|Overall Study||44
377294|NCT01077622|904060|P1|NOT COMPLETED|Overall Study||3
377295|NCT01077622|904060|P1|COMPLETED|Overall Study||7
377296|NCT01077622|904060|P1|STARTED|Overall Study||10
377297|NCT01077596|904118|P12|NOT COMPLETED|Overall Study||0
377298|NCT01077596|904119|P11|NOT COMPLETED|Overall Study||0
377299|NCT01077596|904120|P10|NOT COMPLETED|Overall Study||0
377300|NCT01077596|904121|P9|NOT COMPLETED|Overall Study||0
377301|NCT01077596|904122|P8|NOT COMPLETED|Overall Study||0
377302|NCT01077596|904123|P7|NOT COMPLETED|Overall Study||0
377303|NCT01077596|904124|P6|NOT COMPLETED|Overall Study||0
377304|NCT01077596|904125|P5|NOT COMPLETED|Overall Study||0
377305|NCT01077596|904126|P4|NOT COMPLETED|Overall Study||0
377306|NCT01077596|904127|P3|NOT COMPLETED|Overall Study||0
377307|NCT01077596|904128|P2|NOT COMPLETED|Overall Study||0
377308|NCT01077596|904129|P1|NOT COMPLETED|Overall Study||0
377309|NCT01077596|904118|P12|COMPLETED|Overall Study||22150
377310|NCT01077596|904119|P11|COMPLETED|Overall Study||2215
377311|NCT01077596|904120|P10|COMPLETED|Overall Study||28420
377312|NCT01077596|904121|P9|COMPLETED|Overall Study||2842
377313|NCT01077596|904122|P8|COMPLETED|Overall Study||837
377314|NCT01077596|904123|P7|COMPLETED|Overall Study||308
377315|NCT01077596|904124|P6|COMPLETED|Overall Study||882
377316|NCT01077596|904125|P5|COMPLETED|Overall Study||294
377317|NCT01077596|904126|P4|COMPLETED|Overall Study||1370
377318|NCT01077596|904127|P3|COMPLETED|Overall Study||457
377319|NCT01077596|904128|P2|COMPLETED|Overall Study||1050
377320|NCT01077596|904129|P1|COMPLETED|Overall Study||350
377321|NCT01077596|904118|P12|STARTED|Overall Study||22150
377322|NCT01077596|904119|P11|STARTED|Overall Study||2215
377323|NCT01077596|904120|P10|STARTED|Overall Study||28420
377324|NCT01077596|904121|P9|STARTED|Overall Study||2842
377325|NCT01077596|904122|P8|STARTED|Overall Study||837
377326|NCT01077596|904123|P7|STARTED|Overall Study||308
377327|NCT01077596|904124|P6|STARTED|Overall Study||882
377328|NCT01077596|904125|P5|STARTED|Overall Study||294
377329|NCT01077596|904126|P4|STARTED|Overall Study||1370
377330|NCT01077596|904127|P3|STARTED|Overall Study||457
377331|NCT01077596|904128|P2|STARTED|Overall Study||1050
377332|NCT01077596|904129|P1|STARTED|Overall Study||350
377333|NCT01077544|904180|P2|NOT COMPLETED|Overall Study||5
377334|NCT01077544|904181|P1|NOT COMPLETED|Overall Study||3
377335|NCT01077544|904180|P2|COMPLETED|Overall Study||2
377336|NCT01077544|904181|P1|COMPLETED|Overall Study||5
377337|NCT01077544|904180|P2|STARTED|Overall Study||7
377338|NCT01077544|904181|P1|STARTED|Overall Study||8
377339|NCT01077401|904209|P2|NOT COMPLETED|Overall Study||21
377340|NCT01077401|904210|P1|NOT COMPLETED|Overall Study||18
377341|NCT01077401|904209|P2|COMPLETED|Overall Study||54
377342|NCT01077401|904210|P1|COMPLETED|Overall Study||59
377343|NCT01077401|904209|P2|STARTED|Overall Study||75
377344|NCT01077401|904210|P1|STARTED|Overall Study||77
377345|NCT01077375|904222|P2|NOT COMPLETED|Overall Study||35
377346|NCT01077375|904223|P1|NOT COMPLETED|Overall Study||10
377347|NCT01077375|904222|P2|COMPLETED|Overall Study||51
377348|NCT01077375|904223|P1|COMPLETED|Overall Study||11
377349|NCT01077375|904222|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
377350|NCT01077375|904223|P1|STARTED|Overall Study||21
377351|NCT01077362|904234|P3|NOT COMPLETED|Overall Study||24
377352|NCT01077362|904235|P2|NOT COMPLETED|Overall Study||19
377353|NCT01077362|904236|P1|NOT COMPLETED|Overall Study||31
377354|NCT01077362|904234|P3|COMPLETED|Overall Study||81
377355|NCT01077362|904235|P2|COMPLETED|Overall Study||84
377356|NCT01077362|904236|P1|COMPLETED|Overall Study||73
377357|NCT01077362|904234|P3|STARTED|Overall Study||105
377358|NCT01077362|904235|P2|STARTED|Overall Study||103
377359|NCT01077362|904236|P1|STARTED|Overall Study||104
377360|NCT01077323|904272|P3|NOT COMPLETED|Overall Study||11912089
377361|NCT01077323|904273|P2|NOT COMPLETED|Overall Study||386263
377362|NCT01077323|904274|P1|NOT COMPLETED|Overall Study||11378
377363|NCT01077323|904272|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
377364|NCT01077323|904273|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
377365|NCT01077323|904274|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
377366|NCT01077323|904272|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
377367|NCT01077323|904273|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
377368|NCT01077323|904274|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
377369|NCT01077310|904293|P2|NOT COMPLETED|Overall Study||0
377370|NCT01077310|904294|P1|NOT COMPLETED|Overall Study||0
377371|NCT01077310|904293|P2|COMPLETED|Overall Study||33
377372|NCT01077310|904294|P1|COMPLETED|Overall Study||67
377373|NCT01077310|904293|P2|STARTED|Overall Study||33
377374|NCT01077310|904294|P1|STARTED|Overall Study||67
377375|NCT01077284|904317|P3|NOT COMPLETED|Overall Study||3
377376|NCT01077284|904318|P2|NOT COMPLETED|Overall Study||5
377377|NCT01077284|904319|P1|NOT COMPLETED|Overall Study||5
377378|NCT01077284|904317|P3|COMPLETED|Overall Study||30
377379|NCT01077284|904318|P2|COMPLETED|Overall Study||28
377380|NCT01077284|904319|P1|COMPLETED|Overall Study||28
377381|NCT01077284|904317|P3|STARTED|Overall Study||33
377382|NCT01077284|904318|P2|STARTED|Overall Study||33
377383|NCT01077284|904319|P1|STARTED|Overall Study||33
377384|NCT01077271|904340|P1|NOT COMPLETED|Overall Study||22
377385|NCT01077271|904340|P1|COMPLETED|Overall Study||102
377386|NCT01077271|904340|P1|Number of Participants Analyzed|Overall Study||120
377387|NCT01077271|904340|P1|Participants Treated With Palivizumab|Overall Study||120
377388|NCT01077271|904340|P1|STARTED|Overall Study||124
377389|NCT01077258|904378|P1|NOT COMPLETED|Overall Study||2568
377390|NCT01077258|904378|P1|COMPLETED|Overall Study||1640
377391|NCT01077258|904378|P1|STARTED|Overall Study||4208
377392|NCT01077193|904414|P1|NOT COMPLETED|Overall Study||44
377393|NCT01077193|904414|P1|COMPLETED|Overall Study||0
377394|NCT01077193|904414|P1|STARTED|Overall Study||44
377395|NCT01077128|904418|P1|NOT COMPLETED|Overall Study||67
377396|NCT01077128|904418|P1|COMPLETED|Overall Study||433
377397|NCT01077128|904418|P1|STARTED|Overall Study||500
377398|NCT01077076|904476|P6|NOT COMPLETED|Third Intervention||1
377399|NCT01077076|904477|P5|NOT COMPLETED|Third Intervention||0
377400|NCT01077076|904478|P4|NOT COMPLETED|Third Intervention||0
377401|NCT01077076|904479|P3|NOT COMPLETED|Third Intervention||0
377402|NCT01077076|904480|P2|NOT COMPLETED|Third Intervention||0
377403|NCT01077076|904481|P1|NOT COMPLETED|Third Intervention||0
377404|NCT01077076|904476|P6|COMPLETED|Third Intervention||4
377405|NCT01077076|904477|P5|COMPLETED|Third Intervention||5
377406|NCT01077076|904478|P4|COMPLETED|Third Intervention||5
377407|NCT01077076|904479|P3|COMPLETED|Third Intervention||5
377408|NCT01077076|904480|P2|COMPLETED|Third Intervention||5
377409|NCT01077076|904481|P1|COMPLETED|Third Intervention||4
377410|NCT01077076|904476|P6|STARTED|Third Intervention||5
377411|NCT01077076|904477|P5|STARTED|Third Intervention||5
377412|NCT01077076|904478|P4|STARTED|Third Intervention||5
377413|NCT01077076|904479|P3|STARTED|Third Intervention||5
377414|NCT01077076|904480|P2|STARTED|Third Intervention||5
377415|NCT01077076|904481|P1|STARTED|Third Intervention||4
377416|NCT01077076|904476|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
377417|NCT01077076|904477|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
377418|NCT01077076|904478|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
377419|NCT01077076|904479|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
377420|NCT01077076|904480|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
377421|NCT01077076|904481|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
377422|NCT01077076|904476|P6|COMPLETED|Washout Period of 2 Weeks||5
377423|NCT01077076|904477|P5|COMPLETED|Washout Period of 2 Weeks||5
377424|NCT01077076|904478|P4|COMPLETED|Washout Period of 2 Weeks||5
377425|NCT01077076|904479|P3|COMPLETED|Washout Period of 2 Weeks||5
377426|NCT01077076|904480|P2|COMPLETED|Washout Period of 2 Weeks||5
377427|NCT01077076|904481|P1|COMPLETED|Washout Period of 2 Weeks||4
377428|NCT01077076|904476|P6|STARTED|Washout Period of 2 Weeks||5
377429|NCT01077076|904477|P5|STARTED|Washout Period of 2 Weeks||5
377430|NCT01077076|904478|P4|STARTED|Washout Period of 2 Weeks||5
377431|NCT01077076|904479|P3|STARTED|Washout Period of 2 Weeks||5
377432|NCT01077076|904480|P2|STARTED|Washout Period of 2 Weeks||5
377433|NCT01077076|904481|P1|STARTED|Washout Period of 2 Weeks||4
377434|NCT01077076|904476|P6|NOT COMPLETED|Second Intervention||0
377435|NCT01077076|904477|P5|NOT COMPLETED|Second Intervention||0
377436|NCT01077076|904478|P4|NOT COMPLETED|Second Intervention||0
377437|NCT01077076|904479|P3|NOT COMPLETED|Second Intervention||0
377438|NCT01077076|904480|P2|NOT COMPLETED|Second Intervention||0
377439|NCT01077076|904481|P1|NOT COMPLETED|Second Intervention||0
377440|NCT01077076|904476|P6|COMPLETED|Second Intervention||5
377441|NCT01077076|904477|P5|COMPLETED|Second Intervention||5
377442|NCT01077076|904478|P4|COMPLETED|Second Intervention||5
377443|NCT01077076|904479|P3|COMPLETED|Second Intervention||5
377444|NCT01077076|904480|P2|COMPLETED|Second Intervention||5
377445|NCT01077076|904481|P1|COMPLETED|Second Intervention||4
377446|NCT01077076|904476|P6|STARTED|Second Intervention||5
377447|NCT01077076|904477|P5|STARTED|Second Intervention||5
377448|NCT01077076|904478|P4|STARTED|Second Intervention||5
377449|NCT01077076|904479|P3|STARTED|Second Intervention||5
377450|NCT01077076|904480|P2|STARTED|Second Intervention||5
377451|NCT01077076|904481|P1|STARTED|Second Intervention||4
377452|NCT01077076|904476|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
377453|NCT01077076|904477|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
377454|NCT01077076|904478|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
377455|NCT01077076|904479|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
377456|NCT01077076|904480|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
377457|NCT01077076|904481|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
377458|NCT01077076|904476|P6|COMPLETED|Washout Period of 2 Weeks||5
377459|NCT01077076|904477|P5|COMPLETED|Washout Period of 2 Weeks||5
377460|NCT01077076|904478|P4|COMPLETED|Washout Period of 2 Weeks||5
377461|NCT01077076|904479|P3|COMPLETED|Washout Period of 2 Weeks||5
377462|NCT01077076|904480|P2|COMPLETED|Washout Period of 2 Weeks||5
377463|NCT01077076|904481|P1|COMPLETED|Washout Period of 2 Weeks||4
377464|NCT01077076|904476|P6|STARTED|Washout Period of 2 Weeks||5
377465|NCT01077076|904477|P5|STARTED|Washout Period of 2 Weeks||5
377466|NCT01077076|904478|P4|STARTED|Washout Period of 2 Weeks||5
377467|NCT01077076|904479|P3|STARTED|Washout Period of 2 Weeks||5
377468|NCT01077076|904480|P2|STARTED|Washout Period of 2 Weeks||5
377469|NCT01077076|904481|P1|STARTED|Washout Period of 2 Weeks||4
377470|NCT01077076|904476|P6|NOT COMPLETED|First Intervention||0
377471|NCT01077076|904477|P5|NOT COMPLETED|First Intervention||0
377472|NCT01077076|904478|P4|NOT COMPLETED|First Intervention||0
377473|NCT01077076|904479|P3|NOT COMPLETED|First Intervention||0
377474|NCT01077076|904480|P2|NOT COMPLETED|First Intervention||0
377475|NCT01077076|904481|P1|NOT COMPLETED|First Intervention||1
377476|NCT01077076|904476|P6|COMPLETED|First Intervention||5
377477|NCT01077076|904477|P5|COMPLETED|First Intervention||5
377478|NCT01077076|904478|P4|COMPLETED|First Intervention||5
377479|NCT01077076|904479|P3|COMPLETED|First Intervention||5
377480|NCT01077076|904480|P2|COMPLETED|First Intervention||5
377481|NCT01077076|904481|P1|COMPLETED|First Intervention||4
377482|NCT01077076|904476|P6|STARTED|First Intervention||5
377483|NCT01077076|904477|P5|STARTED|First Intervention||5
377484|NCT01077076|904478|P4|STARTED|First Intervention||5
377485|NCT01077076|904479|P3|STARTED|First Intervention||5
377486|NCT01077076|904480|P2|STARTED|First Intervention||5
377487|NCT01077076|904481|P1|STARTED|First Intervention||5
377488|NCT01077063|904491|P2|NOT COMPLETED|Overall Study||3
377489|NCT01077063|904492|P1|NOT COMPLETED|Overall Study||4
377490|NCT01077063|904491|P2|COMPLETED|Overall Study||0
377491|NCT01077063|904492|P1|COMPLETED|Overall Study||0
377492|NCT01077063|904491|P2|STARTED|Overall Study||3
377493|NCT01077063|904492|P1|STARTED|Overall Study||4
377494|NCT01077050|904498|P1|NOT COMPLETED|Overall Study||9
377495|NCT01077050|904498|P1|COMPLETED|Overall Study||1942
377496|NCT01077050|904498|P1|STARTED|Overall Study||1951
377497|NCT01077024|904504|P2|NOT COMPLETED|Overall Study||28
377498|NCT01077024|904505|P1|NOT COMPLETED|Overall Study||31
377499|NCT01077024|904504|P2|COMPLETED|Overall Study||243
377500|NCT01077024|904505|P1|COMPLETED|Overall Study||236
377501|NCT01077024|904504|P2|STARTED|Overall Study||271
377502|NCT01077024|904505|P1|STARTED|Overall Study||267
377503|NCT01076985|904523|P1|NOT COMPLETED|Overall Study||0
377504|NCT01076985|904523|P1|COMPLETED|Overall Study||24
377505|NCT01076985|904523|P1|STARTED|Overall Study||24
377506|NCT01076972|904529|P1|NOT COMPLETED|Overall Study||0
377507|NCT01076972|904529|P1|COMPLETED|Overall Study||1184
377508|NCT01076972|904529|P1|STARTED|Overall Study||1184
377509|NCT01076959|904544|P1|NOT COMPLETED|Overall Study||2250
377510|NCT01076959|904544|P1|COMPLETED|Overall Study||5490
377511|NCT01076959|904544|P1|STARTED|Overall Study||7740
377512|NCT01076686|904565|P4|NOT COMPLETED|Overall Study||0
377513|NCT01076686|904566|P3|NOT COMPLETED|Overall Study||0
377514|NCT01076686|904567|P2|NOT COMPLETED|Overall Study||0
377515|NCT01076686|904568|P1|NOT COMPLETED|Overall Study||0
377516|NCT01076686|904565|P4|COMPLETED|Overall Study||31
377517|NCT01076686|904566|P3|COMPLETED|Overall Study||32
377518|NCT01076686|904567|P2|COMPLETED|Overall Study||14
377519|NCT01076686|904568|P1|COMPLETED|Overall Study||17
377520|NCT01076686|904565|P4|STARTED|Overall Study||31
377521|NCT01076686|904566|P3|STARTED|Overall Study||32
377522|NCT01076686|904567|P2|STARTED|Overall Study||14
377523|NCT01076686|904568|P1|STARTED|Overall Study||17
377524|NCT01076647|904580|P2|NOT COMPLETED|Overall Study||25
377525|NCT01076647|904581|P1|NOT COMPLETED|Overall Study||25
377526|NCT01076647|904580|P2|COMPLETED|Overall Study||209
377527|NCT01076647|904581|P1|COMPLETED|Overall Study||208
377528|NCT01076647|904580|P2|STARTED|Overall Study||234
377529|NCT01076647|904581|P1|STARTED|Overall Study||233
377530|NCT01076504|904589|P1|NOT COMPLETED|Overall Study||80
377531|NCT01076504|904589|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
377532|NCT01076504|904589|P1|STARTED|Overall Study||80
377533|NCT01076452|904599|P2|NOT COMPLETED|Overall Study||14
377534|NCT01076452|904600|P1|NOT COMPLETED|Overall Study||24
377535|NCT01076452|904599|P2|COMPLETED|Overall Study||138
377536|NCT01076452|904600|P1|COMPLETED|Overall Study||123
377537|NCT01076452|904599|P2|STARTED|Overall Study||152
377538|NCT01076452|904600|P1|STARTED|Overall Study||147
377539|NCT01076361|904612|P1|NOT COMPLETED|Overall Study||21
377540|NCT01076361|904612|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
377541|NCT01076361|904612|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
377542|NCT01076348|904616|P1|NOT COMPLETED|Overall Study||22
377543|NCT01076348|904616|P1|COMPLETED|Overall Study||51
377544|NCT01076348|904616|P1|STARTED|Overall Study||73
377545|NCT01076335|904620|P1|NOT COMPLETED|Overall Study||4
377546|NCT01076335|904620|P1|COMPLETED|Overall Study||36
377547|NCT01076335|904620|P1|STARTED|Overall Study||40
377548|NCT01076296|904624|P8|NOT COMPLETED|Overall Study||0
377549|NCT01076296|904625|P7|NOT COMPLETED|Overall Study||0
377550|NCT01076296|904626|P6|NOT COMPLETED|Overall Study||0
377551|NCT01076296|904627|P5|NOT COMPLETED|Overall Study||0
377552|NCT01076296|904628|P4|NOT COMPLETED|Overall Study||0
377553|NCT01076296|904629|P3|NOT COMPLETED|Overall Study||0
377554|NCT01076296|904630|P2|NOT COMPLETED|Overall Study||0
377555|NCT01076296|904631|P1|NOT COMPLETED|Overall Study||0
377556|NCT01076296|904624|P8|COMPLETED|Overall Study||199
377557|NCT01076296|904625|P7|COMPLETED|Overall Study||51
377558|NCT01076296|904626|P6|COMPLETED|Overall Study||191
377559|NCT01076296|904627|P5|COMPLETED|Overall Study||59
377560|NCT01076296|904628|P4|COMPLETED|Overall Study||199
377561|NCT01076296|904629|P3|COMPLETED|Overall Study||51
377562|NCT01076296|904630|P2|COMPLETED|Overall Study||196
377563|NCT01076296|904631|P1|COMPLETED|Overall Study||54
377564|NCT01076296|904624|P8|STARTED|Overall Study||199
377565|NCT01076296|904625|P7|STARTED|Overall Study||51
377566|NCT01076296|904626|P6|STARTED|Overall Study||191
377567|NCT01076296|904627|P5|STARTED|Overall Study||59
377568|NCT01076296|904628|P4|STARTED|Overall Study||199
377569|NCT01076296|904629|P3|STARTED|Overall Study||51
377570|NCT01076296|904630|P2|STARTED|Overall Study||196
377571|NCT01076296|904631|P1|STARTED|Overall Study||54
377572|NCT01076283|904651|P2|NOT COMPLETED|Overall Study||0
377573|NCT01076283|904652|P1|NOT COMPLETED|Overall Study||1
377574|NCT01076283|904651|P2|COMPLETED|Overall Study||7
377575|NCT01076283|904652|P1|COMPLETED|Overall Study||6
377576|NCT01076283|904651|P2|STARTED|Overall Study||7
377577|NCT01076283|904652|P1|STARTED|Overall Study||7
377581|NCT01076244|904665|P1|NOT COMPLETED|Overall Study||4
377582|NCT01076244|904665|P1|COMPLETED|Overall Study||42
377583|NCT01076244|904665|P1|STARTED|Overall Study||46
377584|NCT01076192|904672|P1|NOT COMPLETED|Overall Study||197
377585|NCT01076192|904672|P1|COMPLETED|Overall Study||350
377586|NCT01076192|904672|P1|STARTED|Overall Study||547
377587|NCT01076179|904687|P1|NOT COMPLETED|Overall Study||1
377588|NCT01076179|904687|P1|COMPLETED|Overall Study||501
377589|NCT01076179|904687|P1|STARTED|Overall Study||502
377590|NCT01076166|904710|P1|NOT COMPLETED|Overall Study||9
377591|NCT01076166|904710|P1|COMPLETED|Overall Study||328
377592|NCT01076166|904710|P1|STARTED|Overall Study||337
377593|NCT01076153|904717|P1|NOT COMPLETED|Overall Study||11
377594|NCT01076153|904717|P1|COMPLETED|Overall Study||749
377595|NCT01076153|904717|P1|STARTED|Overall Study||760
377596|NCT01076088|904731|P6|NOT COMPLETED|Overall Study||23
377597|NCT01076088|904732|P5|NOT COMPLETED|Overall Study||16
377598|NCT01076088|904733|P4|NOT COMPLETED|Overall Study||15
377599|NCT01076088|904734|P3|NOT COMPLETED|Overall Study||17
377600|NCT01076088|904735|P2|NOT COMPLETED|Overall Study||18
377601|NCT01076088|904736|P1|NOT COMPLETED|Overall Study||11
377602|NCT01076088|904731|P6|COMPLETED|Overall Study||104
377603|NCT01076088|904732|P5|COMPLETED|Overall Study||104
377604|NCT01076088|904733|P4|COMPLETED|Overall Study||109
377605|NCT01076088|904734|P3|COMPLETED|Overall Study||109
377606|NCT01076088|904735|P2|COMPLETED|Overall Study||107
377607|NCT01076088|904736|P1|COMPLETED|Overall Study||111
377608|NCT01076088|904731|P6|STARTED|Overall Study||127
377609|NCT01076088|904732|P5|STARTED|Overall Study||120
377610|NCT01076088|904733|P4|STARTED|Overall Study||124
377611|NCT01076088|904734|P3|STARTED|Overall Study||126
377612|NCT01076088|904735|P2|STARTED|Overall Study||125
377613|NCT01076088|904736|P1|STARTED|Overall Study||122
377614|NCT01076075|904764|P2|NOT COMPLETED|Overall Study||47
377615|NCT01076075|904765|P1|NOT COMPLETED|Overall Study||41
377616|NCT01076075|904764|P2|COMPLETED|Overall Study||167
377617|NCT01076075|904765|P1|COMPLETED|Overall Study||172
377618|NCT01076075|904764|P2|Completed Phase A|Overall Study||189
377619|NCT01076075|904765|P1|Completed Phase A|Overall Study||199
377620|NCT01076075|904764|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
377709|NCT01075282|904999|P3|COMPLETED|Overall Study||238
377710|NCT01075282|905000|P2|COMPLETED|Overall Study||243
377621|NCT01076075|904765|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
377622|NCT01076036|904779|P1|NOT COMPLETED|Overall Study||2
377623|NCT01076036|904779|P1|COMPLETED|Overall Study||8
377624|NCT01076036|904779|P1|Complete CorPath Procedures|Overall Study||8
377625|NCT01076036|904779|P1|# of Procedures|Overall Study||8
377626|NCT01076036|904779|P1|STARTED|Overall Study||10
377627|NCT01075984|904789|P5|NOT COMPLETED|Follow-up Phase||47
377628|NCT01075984|904790|P4|NOT COMPLETED|Follow-up Phase||2
377629|NCT01075984|904791|P3|NOT COMPLETED|Follow-up Phase||1
377630|NCT01075984|904792|P2|NOT COMPLETED|Follow-up Phase||0
377631|NCT01075984|904793|P1|NOT COMPLETED|Follow-up Phase||0
377632|NCT01075984|904789|P5|COMPLETED|Follow-up Phase||165
377633|NCT01075984|904790|P4|COMPLETED|Follow-up Phase||19
377634|NCT01075984|904791|P3|COMPLETED|Follow-up Phase||19
377635|NCT01075984|904792|P2|COMPLETED|Follow-up Phase||10
377636|NCT01075984|904793|P1|COMPLETED|Follow-up Phase||10
377637|NCT01075984|904789|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
377638|NCT01075984|904790|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
377639|NCT01075984|904791|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
377640|NCT01075984|904792|P2|STARTED|Follow-up Phase||10
377641|NCT01075984|904793|P1|STARTED|Follow-up Phase||10
377642|NCT01075984|904789|P5|NOT COMPLETED|Treatment Phase||60
377643|NCT01075984|904790|P4|NOT COMPLETED|Treatment Phase||7
377644|NCT01075984|904791|P3|NOT COMPLETED|Treatment Phase||7
377645|NCT01075984|904792|P2|NOT COMPLETED|Treatment Phase||1
377646|NCT01075984|904793|P1|NOT COMPLETED|Treatment Phase||0
377647|NCT01075984|904789|P5|COMPLETED|Treatment Phase||153
377648|NCT01075984|904790|P4|COMPLETED|Treatment Phase||17
377649|NCT01075984|904791|P3|COMPLETED|Treatment Phase||14
377650|NCT01075984|904792|P2|COMPLETED|Treatment Phase||10
377651|NCT01075984|904793|P1|COMPLETED|Treatment Phase||10
377652|NCT01075984|904789|P5|STARTED|Treatment Phase||213
377653|NCT01075984|904790|P4|STARTED|Treatment Phase||24
377654|NCT01075984|904791|P3|STARTED|Treatment Phase||21
377655|NCT01075984|904792|P2|STARTED|Treatment Phase||11
377656|NCT01075984|904793|P1|STARTED|Treatment Phase||10
377657|NCT01075971|904847|P1|NOT COMPLETED|Overall Study||0
377658|NCT01075971|904847|P1|COMPLETED|Overall Study||52
377659|NCT01075971|904847|P1|STARTED|Overall Study||52
377660|NCT01075958|904851|P1|NOT COMPLETED|Overall Study||44
377661|NCT01075958|904851|P1|COMPLETED|Overall Study||239
377662|NCT01075958|904851|P1|STARTED|Overall Study||283
377663|NCT01075815|904867|P2|NOT COMPLETED|Overall Study||4
377664|NCT01075815|904868|P1|NOT COMPLETED|Overall Study||10
377665|NCT01075815|904867|P2|COMPLETED|Overall Study||31
377666|NCT01075815|904868|P1|COMPLETED|Overall Study||30
377667|NCT01075815|904867|P2|STARTED|Overall Study|Number of participants treated.|35
377668|NCT01075815|904868|P1|STARTED|Overall Study|Number of participants treated.|40
377669|NCT01075763|904906|P2|NOT COMPLETED|Overall Study||4
377670|NCT01075763|904907|P1|NOT COMPLETED|Overall Study||4
377671|NCT01075763|904906|P2|COMPLETED|Overall Study||15
377672|NCT01075763|904907|P1|COMPLETED|Overall Study||19
377673|NCT01075763|904906|P2|STARTED|Overall Study||19
377674|NCT01075763|904907|P1|STARTED|Overall Study||23
377675|NCT01075685|904931|P2|NOT COMPLETED|Overall Study||226
377676|NCT01075685|904932|P1|NOT COMPLETED|Overall Study||592
377677|NCT01075685|904931|P2|COMPLETED|Overall Study||188
377678|NCT01075685|904932|P1|COMPLETED|Overall Study||151
377679|NCT01075685|904931|P2|Completed Baseline Measures|Overall Study||263
377680|NCT01075685|904932|P1|Completed Baseline Measures|Overall Study||225
377681|NCT01075685|904931|P2|Met Inclusion Criteria|Overall Study||413
377682|NCT01075685|904932|P1|Met Inclusion Criteria|Overall Study||734
377683|NCT01075685|904931|P2|STARTED|Overall Study||414
377684|NCT01075685|904932|P1|STARTED|Overall Study||743
377685|NCT01075646|904948|P4|NOT COMPLETED|Overall Study||2
377686|NCT01075646|904949|P3|NOT COMPLETED|Overall Study||1
377687|NCT01075646|904950|P2|NOT COMPLETED|Overall Study||3
377688|NCT01075646|904951|P1|NOT COMPLETED|Overall Study||4
377689|NCT01075646|904948|P4|COMPLETED|Overall Study||44
377690|NCT01075646|904949|P3|COMPLETED|Overall Study||52
377691|NCT01075646|904950|P2|COMPLETED|Overall Study||31
377692|NCT01075646|904951|P1|COMPLETED|Overall Study||29
377693|NCT01075646|904948|P4|STARTED|Overall Study||46
377694|NCT01075646|904949|P3|STARTED|Overall Study||53
377695|NCT01075646|904950|P2|STARTED|Overall Study||34
377696|NCT01075646|904951|P1|STARTED|Overall Study||33
377697|NCT01075399|904981|P1|NOT COMPLETED|Overall Study||8
377698|NCT01075399|904981|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
377699|NCT01075399|904981|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
377700|NCT01075347|904987|P2|NOT COMPLETED|Overall Study||0
377701|NCT01075347|904988|P1|NOT COMPLETED|Overall Study||0
377702|NCT01075347|904987|P2|COMPLETED|Overall Study||83
377703|NCT01075347|904988|P1|COMPLETED|Overall Study||82
377704|NCT01075347|904987|P2|STARTED|Overall Study||83
377705|NCT01075347|904988|P1|STARTED|Overall Study||82
377706|NCT01075282|904999|P3|NOT COMPLETED|Overall Study||27
377707|NCT01075282|905000|P2|NOT COMPLETED|Overall Study||29
377708|NCT01075282|905001|P1|NOT COMPLETED|Overall Study||31
377711|NCT01075282|905001|P1|COMPLETED|Overall Study||242
377712|NCT01075282|904999|P3|Received at Least One Dose of Study Drug|Overall Study||262
377713|NCT01075282|905000|P2|Received at Least One Dose of Study Drug|Overall Study||272
377714|NCT01075282|905001|P1|Received at Least One Dose of Study Drug|Overall Study||273
377715|NCT01075282|904999|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
377716|NCT01075282|905000|P2|STARTED|Overall Study||272
377717|NCT01075282|905001|P1|STARTED|Overall Study||273
377718|NCT01075256|905084|P3|NOT COMPLETED|Overall Study||0
377719|NCT01075256|905085|P2|NOT COMPLETED|Overall Study||0
377720|NCT01075256|905086|P1|NOT COMPLETED|Overall Study||1
377721|NCT01075256|905084|P3|COMPLETED|Overall Study||65
377722|NCT01075256|905085|P2|COMPLETED|Overall Study||66
377723|NCT01075256|905086|P1|COMPLETED|Overall Study||63
377724|NCT01075256|905084|P3|STARTED|Overall Study||65
377725|NCT01075256|905085|P2|STARTED|Overall Study||66
377726|NCT01075256|905086|P1|STARTED|Overall Study||64
377727|NCT01075243|905118|P3|NOT COMPLETED|Overall Study||0
377728|NCT01075243|905119|P2|NOT COMPLETED|Overall Study||3
377729|NCT01075243|905120|P1|NOT COMPLETED|Overall Study||6
377730|NCT01075243|905118|P3|COMPLETED|Overall Study||80
377731|NCT01075243|905119|P2|COMPLETED|Overall Study||155
377732|NCT01075243|905120|P1|COMPLETED|Overall Study||157
377733|NCT01075243|905118|P3|STARTED|Overall Study||80
377734|NCT01075243|905119|P2|STARTED|Overall Study||158
377735|NCT01075243|905120|P1|STARTED|Overall Study||163
377736|NCT01075217|905172|P2|NOT COMPLETED|Overall Study||1
377737|NCT01075217|905173|P1|NOT COMPLETED|Overall Study||2
377738|NCT01075217|905172|P2|COMPLETED|Overall Study||84
377739|NCT01075217|905173|P1|COMPLETED|Overall Study||82
377740|NCT01075217|905172|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
377741|NCT01075217|905173|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
377742|NCT01075204|905189|P1|NOT COMPLETED|Overall Study||0
377743|NCT01075204|905189|P1|COMPLETED|Overall Study||335
377744|NCT01075204|905189|P1|STARTED|Overall Study||335
377745|NCT01075191|905206|P1|NOT COMPLETED|Overall Study||18
377746|NCT01075191|905206|P1|COMPLETED|Overall Study||42
377747|NCT01075191|905206|P1|Discontinued Year 3|Overall Study||5
377748|NCT01075191|905206|P1|Discontinued Year 2|Overall Study||6
377749|NCT01075191|905206|P1|Discontinued Year 1|Overall Study||7
377750|NCT01075191|905206|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
377751|NCT01075178|905217|P2|NOT COMPLETED|Subject Chart Review||9
377752|NCT01075178|905218|P1|NOT COMPLETED|Subject Chart Review||9
377753|NCT01075178|905217|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
377754|NCT01075178|905218|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
377755|NCT01075178|905217|P2|STARTED|Subject Chart Review|subjects matched|1018
377756|NCT01075178|905218|P1|STARTED|Subject Chart Review|subjects matched|1018
377757|NCT01075178|905217|P2|NOT COMPLETED|Subject Matching||403
377758|NCT01075178|905218|P1|NOT COMPLETED|Subject Matching||130
377759|NCT01075178|905217|P2|COMPLETED|Subject Matching|subjects matched|1018
377760|NCT01075178|905218|P1|COMPLETED|Subject Matching|subjects matched|1018
377761|NCT01075178|905217|P2|STARTED|Subject Matching|eligible for matching|1421
377762|NCT01075178|905218|P1|STARTED|Subject Matching|eligible for matching|1148
377763|NCT01075152|905232|P2|NOT COMPLETED|Overall Study||0
377764|NCT01075152|905233|P1|NOT COMPLETED|Overall Study||1
377765|NCT01075152|905232|P2|COMPLETED|Overall Study||89
377766|NCT01075152|905233|P1|COMPLETED|Overall Study||87
377767|NCT01075152|905232|P2|STARTED|Overall Study|randomized|89
377768|NCT01075152|905233|P1|STARTED|Overall Study|randomized|88
377769|NCT01075100|905259|P2|NOT COMPLETED|Overall Study||53
377770|NCT01075100|905260|P1|NOT COMPLETED|Overall Study||49
377771|NCT01075100|905259|P2|COMPLETED|Overall Study||1
377772|NCT01075100|905260|P1|COMPLETED|Overall Study||0
377773|NCT01075100|905259|P2|STARTED|Overall Study||54
377774|NCT01075100|905260|P1|STARTED|Overall Study||49
377775|NCT01075087|905278|P2|NOT COMPLETED|Overall Study||0
377776|NCT01075087|905279|P1|NOT COMPLETED|Overall Study||0
377777|NCT01075087|905278|P2|COMPLETED|Overall Study||10
377778|NCT01075087|905279|P1|COMPLETED|Overall Study||9
377779|NCT01075087|905278|P2|STARTED|Overall Study||10
377780|NCT01075087|905279|P1|STARTED|Overall Study||9
377781|NCT01075074|905290|P3|NOT COMPLETED|Overall Study||2
377782|NCT01075074|905291|P2|NOT COMPLETED|Overall Study||2
377783|NCT01075074|905292|P1|NOT COMPLETED|Overall Study||1
377784|NCT01075074|905290|P3|COMPLETED|Overall Study||23
377785|NCT01075074|905291|P2|COMPLETED|Overall Study||23
377786|NCT01075074|905292|P1|COMPLETED|Overall Study||24
377787|NCT01075074|905290|P3|STARTED|Overall Study||25
377788|NCT01075074|905291|P2|STARTED|Overall Study||25
377789|NCT01075074|905292|P1|STARTED|Overall Study||25
377790|NCT01074944|905309|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
377791|NCT01074944|905310|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
377792|NCT01074944|905311|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
377793|NCT01074944|905312|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
377794|NCT01074944|905313|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
377795|NCT01074944|905309|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
377796|NCT01074944|905310|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
377797|NCT01074944|905311|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
377798|NCT01074944|905312|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
377799|NCT01074944|905313|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
377800|NCT01074944|905309|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
377801|NCT01074944|905310|P4|STARTED|Extended Treatment (up to 42 Months)||0
377802|NCT01074944|905311|P3|STARTED|Extended Treatment (up to 42 Months)||0
377803|NCT01074944|905312|P2|STARTED|Extended Treatment (up to 42 Months)||0
377804|NCT01074944|905313|P1|STARTED|Extended Treatment (up to 42 Months)||0
377805|NCT01074944|905309|P5|NOT COMPLETED|Long Term Treatment||0
377806|NCT01074944|905310|P4|NOT COMPLETED|Long Term Treatment||26
377807|NCT01074944|905311|P3|NOT COMPLETED|Long Term Treatment||0
377808|NCT01074944|905312|P2|NOT COMPLETED|Long Term Treatment||0
377809|NCT01074944|905313|P1|NOT COMPLETED|Long Term Treatment||0
377810|NCT01074944|905309|P5|COMPLETED|Long Term Treatment||0
377811|NCT01074944|905310|P4|COMPLETED|Long Term Treatment||95
377812|NCT01074944|905311|P3|COMPLETED|Long Term Treatment||0
377813|NCT01074944|905312|P2|COMPLETED|Long Term Treatment||0
377814|NCT01074944|905313|P1|COMPLETED|Long Term Treatment||0
377815|NCT01074944|905309|P5|STARTED|Long Term Treatment||0
377816|NCT01074944|905310|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
377817|NCT01074944|905311|P3|STARTED|Long Term Treatment||0
377818|NCT01074944|905312|P2|STARTED|Long Term Treatment||0
377819|NCT01074944|905313|P1|STARTED|Long Term Treatment||0
377820|NCT01074944|905309|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
377821|NCT01074944|905310|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
377822|NCT01074944|905311|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
377823|NCT01074944|905312|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
377824|NCT01074944|905313|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
377825|NCT01074944|905309|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
377826|NCT01074944|905310|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
377827|NCT01074944|905311|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
377828|NCT01074944|905312|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
377829|NCT01074944|905313|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
377830|NCT01074944|905309|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
377831|NCT01074944|905310|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
377832|NCT01074944|905311|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
377833|NCT01074944|905312|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
377834|NCT01074944|905313|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
377835|NCT01074944|905309|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
377836|NCT01074944|905310|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
377837|NCT01074944|905311|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
377838|NCT01074944|905312|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
377839|NCT01074944|905313|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
377840|NCT01074944|905309|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
377841|NCT01074944|905310|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
377842|NCT01074944|905311|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
377843|NCT01074944|905312|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
377844|NCT01074944|905313|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
377845|NCT01074944|905309|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
377846|NCT01074944|905310|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
377847|NCT01074944|905311|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
377848|NCT01074944|905312|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
377849|NCT01074944|905313|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
377850|NCT01074931|905367|P1|NOT COMPLETED|Overall Study||6
377851|NCT01074931|905367|P1|COMPLETED|Overall Study||92
377852|NCT01074931|905367|P1|STARTED|Overall Study||98
377853|NCT01074658|905379|P1|NOT COMPLETED|Overall Study||19
377854|NCT01074658|905379|P1|COMPLETED|Overall Study||996
377855|NCT01074658|905379|P1|Attempted Implant|Overall Study||996
377856|NCT01074658|905379|P1|STARTED|Overall Study||1015
377857|NCT01074554|905387|P2|NOT COMPLETED|Overall Study||4
377858|NCT01074554|905388|P1|NOT COMPLETED|Overall Study||3
377859|NCT01074554|905387|P2|COMPLETED|Overall Study||11
377860|NCT01074554|905388|P1|COMPLETED|Overall Study||11
377861|NCT01074554|905387|P2|STARTED|Overall Study||15
377862|NCT01074554|905388|P1|STARTED|Overall Study||14
377863|NCT01074502|905398|P1|NOT COMPLETED|Overall Study||1
377864|NCT01074502|905398|P1|COMPLETED|Overall Study||2
377865|NCT01074502|905398|P1|STARTED|Overall Study||3
377866|NCT01074463|905409|P2|NOT COMPLETED|Second Intervention||0
377867|NCT01074463|905410|P1|NOT COMPLETED|Second Intervention||0
377868|NCT01074463|905409|P2|COMPLETED|Second Intervention||12
377869|NCT01074463|905410|P1|COMPLETED|Second Intervention||12
377870|NCT01074463|905409|P2|STARTED|Second Intervention||12
377871|NCT01074463|905410|P1|STARTED|Second Intervention||12
377872|NCT01074463|905409|P2|NOT COMPLETED|Washout of 7 Days||0
377873|NCT01074463|905410|P1|NOT COMPLETED|Washout of 7 Days||0
377874|NCT01074463|905409|P2|COMPLETED|Washout of 7 Days||12
377875|NCT01074463|905410|P1|COMPLETED|Washout of 7 Days||12
377876|NCT01074463|905409|P2|STARTED|Washout of 7 Days||12
377877|NCT01074463|905410|P1|STARTED|Washout of 7 Days||12
377878|NCT01074463|905409|P2|NOT COMPLETED|First Intervention||0
377879|NCT01074463|905410|P1|NOT COMPLETED|First Intervention||0
377880|NCT01074463|905409|P2|COMPLETED|First Intervention||12
377881|NCT01074463|905410|P1|COMPLETED|First Intervention||12
377882|NCT01074463|905409|P2|STARTED|First Intervention||12
377883|NCT01074463|905410|P1|STARTED|First Intervention||12
377884|NCT01074450|905422|P2|NOT COMPLETED|Second Intervention||1
377885|NCT01074450|905423|P1|NOT COMPLETED|Second Intervention||1
377886|NCT01074450|905422|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
377887|NCT01074450|905423|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
377888|NCT01074450|905422|P2|STARTED|Second Intervention||10
377889|NCT01074450|905423|P1|STARTED|Second Intervention||12
377890|NCT01074450|905422|P2|NOT COMPLETED|Washout of 7 Days||0
377891|NCT01074450|905423|P1|NOT COMPLETED|Washout of 7 Days||0
377892|NCT01074450|905422|P2|COMPLETED|Washout of 7 Days||10
377893|NCT01074450|905423|P1|COMPLETED|Washout of 7 Days||12
377894|NCT01074450|905422|P2|STARTED|Washout of 7 Days||10
377895|NCT01074450|905423|P1|STARTED|Washout of 7 Days||12
377896|NCT01074450|905422|P2|NOT COMPLETED|First Intervention||2
377897|NCT01074450|905423|P1|NOT COMPLETED|First Intervention||0
377898|NCT01074450|905422|P2|COMPLETED|First Intervention||10
377899|NCT01074450|905423|P1|COMPLETED|First Intervention||12
377900|NCT01074450|905422|P2|STARTED|First Intervention||12
377901|NCT01074450|905423|P1|STARTED|First Intervention||12
377902|NCT01074437|905435|P2|NOT COMPLETED|Overall Study||0
377903|NCT01074437|905436|P1|NOT COMPLETED|Overall Study||0
377904|NCT01074437|905435|P2|COMPLETED|Overall Study||5
377905|NCT01074437|905436|P1|COMPLETED|Overall Study||4
377906|NCT01074437|905435|P2|STARTED|Overall Study||5
377907|NCT01074437|905436|P1|STARTED|Overall Study||4
377908|NCT01074307|905444|P2|NOT COMPLETED|Overall Study||12
377909|NCT01074307|905445|P1|NOT COMPLETED|Overall Study||22
377910|NCT01074307|905444|P2|COMPLETED|Overall Study||102
377911|NCT01074307|905445|P1|COMPLETED|Overall Study||44
377912|NCT01074307|905444|P2|STARTED|Overall Study||114
377913|NCT01074307|905445|P1|STARTED|Overall Study||66
377914|NCT01074268|905467|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
377915|NCT01074268|905468|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
377916|NCT01074268|905467|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
377917|NCT01074268|905468|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
377918|NCT01074268|905467|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
377919|NCT01074268|905468|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
377920|NCT01074268|905467|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
377921|NCT01074268|905468|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
377922|NCT01074268|905467|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
377923|NCT01074268|905468|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
377924|NCT01074268|905467|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
377925|NCT01074268|905468|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
377926|NCT01074268|905467|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
377927|NCT01074268|905468|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
377928|NCT01074268|905467|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
377929|NCT01074268|905468|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
377930|NCT01074255|905494|P1|NOT COMPLETED|Overall Study||2
377931|NCT01074255|905494|P1|COMPLETED|Overall Study||3139
377932|NCT01074255|905494|P1|Treated|Overall Study||3139
377933|NCT01074255|905494|P1|STARTED|Overall Study||3141
377934|NCT01074242|905498|P1|NOT COMPLETED|Overall Study||403
377935|NCT01074242|905498|P1|COMPLETED|Overall Study||3395
377936|NCT01074242|905498|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
377937|NCT01074242|905498|P1|STARTED|Overall Study||3798
377938|NCT01074229|905506|P3|NOT COMPLETED|Overall Study||4
377939|NCT01074229|905507|P2|NOT COMPLETED|Overall Study||3
377940|NCT01074229|905508|P1|NOT COMPLETED|Overall Study||2
377941|NCT01074229|905506|P3|COMPLETED|Overall Study||21
377942|NCT01074229|905507|P2|COMPLETED|Overall Study||22
377943|NCT01074229|905508|P1|COMPLETED|Overall Study||23
377944|NCT01074229|905506|P3|STARTED|Overall Study||25
377945|NCT01074229|905507|P2|STARTED|Overall Study||25
377946|NCT01074229|905508|P1|STARTED|Overall Study||25
377947|NCT01074216|905519|P1|NOT COMPLETED|Overall Study||13
377948|NCT01074216|905519|P1|COMPLETED|Overall Study||41
377949|NCT01074216|905519|P1|STARTED|Overall Study||54
377950|NCT01074164|905525|P2|NOT COMPLETED|Overall Study||1
377951|NCT01074164|905526|P1|NOT COMPLETED|Overall Study||3
377952|NCT01074164|905525|P2|COMPLETED|Overall Study||7
377953|NCT01074164|905526|P1|COMPLETED|Overall Study||4
377954|NCT01074164|905525|P2|STARTED|Overall Study||8
377955|NCT01074164|905526|P1|STARTED|Overall Study||7
377956|NCT01074125|905547|P3|NOT COMPLETED|Overall Study||12
377957|NCT01074125|905548|P2|NOT COMPLETED|Overall Study||5
377958|NCT01074125|905549|P1|NOT COMPLETED|Overall Study||12
377959|NCT01074125|905547|P3|COMPLETED|Overall Study||36
377960|NCT01074125|905548|P2|COMPLETED|Overall Study||47
377961|NCT01074125|905549|P1|COMPLETED|Overall Study||39
377962|NCT01074125|905547|P3|STARTED|Overall Study||48
377963|NCT01074125|905548|P2|STARTED|Overall Study||52
377964|NCT01074125|905549|P1|STARTED|Overall Study||51
377965|NCT01074099|905565|P2|NOT COMPLETED|Overall Study||0
377966|NCT01074099|905566|P1|NOT COMPLETED|Overall Study||0
377967|NCT01074099|905565|P2|COMPLETED|Overall Study||3
377968|NCT01074099|905566|P1|COMPLETED|Overall Study||2
377969|NCT01074099|905565|P2|STARTED|Overall Study||3
377970|NCT01074099|905566|P1|STARTED|Overall Study||2
377971|NCT01074047|905576|P2|NOT COMPLETED|Survival Follow-Up Phase||136
377972|NCT01074047|905577|P1|NOT COMPLETED|Survival Follow-Up Phase||124
377973|NCT01074047|905576|P2|COMPLETED|Survival Follow-Up Phase||27
377974|NCT01074047|905577|P1|COMPLETED|Survival Follow-Up Phase||16
377975|NCT01074047|905576|P2|STARTED|Survival Follow-Up Phase||163
377976|NCT01074047|905577|P1|STARTED|Survival Follow-Up Phase||140
377977|NCT01074047|905576|P2|NOT COMPLETED|Treatment Phase||247
377978|NCT01074047|905577|P1|NOT COMPLETED|Treatment Phase||241
377979|NCT01074047|905576|P2|COMPLETED|Treatment Phase||0
377980|NCT01074047|905577|P1|COMPLETED|Treatment Phase||0
377981|NCT01074047|905576|P2|Evaluable Population|Treatment Phase|Those with no major protocol violations, given 1 cycle of therapy, and had 1 efficacy assessment|191
377982|NCT01074047|905577|P1|Evaluable Population|Treatment Phase|Those with no major protocol violations, given 1 cycle of therapy, and had 1 efficacy assessment|179
377983|NCT01074047|905576|P2|Safety Population|Treatment Phase|Includes those who received one dose of study medication and had one post dose safety assessment|235
377984|NCT01074047|905577|P1|Safety Population|Treatment Phase|Includes those who received one dose of study medication and had one post dose safety assessment|236
377985|NCT01074047|905576|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
377986|NCT01074047|905577|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
377987|NCT01074047|905576|P2|STARTED|Treatment Phase||247
377988|NCT01074047|905577|P1|STARTED|Treatment Phase||241
377989|NCT01074034|905649|P1|NOT COMPLETED|Overall Study||6
377990|NCT01074034|905649|P1|COMPLETED|Overall Study||205
377991|NCT01074034|905649|P1|STARTED|Overall Study||211
377992|NCT01074008|905663|P9|NOT COMPLETED|Overall Study||4
377993|NCT01074008|905664|P8|NOT COMPLETED|Overall Study||0
377994|NCT01074008|905665|P7|NOT COMPLETED|Overall Study||1
377995|NCT01074008|905666|P6|NOT COMPLETED|Overall Study||0
377996|NCT01074008|905667|P5|NOT COMPLETED|Overall Study||2
377997|NCT01074008|905668|P4|NOT COMPLETED|Overall Study||1
377998|NCT01074008|905669|P3|NOT COMPLETED|Overall Study||2
377999|NCT01074008|905670|P2|NOT COMPLETED|Overall Study||3
378000|NCT01074008|905671|P1|NOT COMPLETED|Overall Study||1
378001|NCT01074008|905663|P9|COMPLETED|Overall Study||7
378002|NCT01074008|905664|P8|COMPLETED|Overall Study||8
378003|NCT01074008|905665|P7|COMPLETED|Overall Study||7
378004|NCT01074008|905666|P6|COMPLETED|Overall Study||7
378005|NCT01074008|905667|P5|COMPLETED|Overall Study||6
378006|NCT01074008|905668|P4|COMPLETED|Overall Study||7
378007|NCT01074008|905669|P3|COMPLETED|Overall Study||6
378008|NCT01074008|905670|P2|COMPLETED|Overall Study||5
378009|NCT01074008|905671|P1|COMPLETED|Overall Study||7
378010|NCT01074008|905663|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
378011|NCT01074008|905664|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
378012|NCT01074008|905665|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
378013|NCT01074008|905666|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
378014|NCT01074008|905667|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
378015|NCT01074008|905668|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
378016|NCT01074008|905669|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
378017|NCT01074008|905670|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
378018|NCT01074008|905671|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
378019|NCT01074008|905663|P9|STARTED|Overall Study||11
378020|NCT01074008|905664|P8|STARTED|Overall Study||8
378021|NCT01074008|905665|P7|STARTED|Overall Study||8
378022|NCT01074008|905666|P6|STARTED|Overall Study||7
378023|NCT01074008|905667|P5|STARTED|Overall Study||8
378024|NCT01074008|905668|P4|STARTED|Overall Study||8
378025|NCT01074008|905669|P3|STARTED|Overall Study||8
378026|NCT01074008|905670|P2|STARTED|Overall Study||8
378027|NCT01074008|905671|P1|STARTED|Overall Study||8
378028|NCT01073943|905781|P2|NOT COMPLETED|Overall Study||8
378029|NCT01073943|905782|P1|NOT COMPLETED|Overall Study||13
378030|NCT01073943|905781|P2|COMPLETED|Overall Study||295
378031|NCT01073943|905782|P1|COMPLETED|Overall Study||287
378032|NCT01073943|905781|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
378033|NCT01073943|905782|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
378034|NCT01073943|905781|P2|Safety Population (Treated)|Overall Study||302
378035|NCT01073943|905782|P1|Safety Population (Treated)|Overall Study||296
378036|NCT01073943|905781|P2|STARTED|Overall Study||303
378037|NCT01073943|905782|P1|STARTED|Overall Study||300
378038|NCT01073930|905808|P2|NOT COMPLETED|Overall Study||6
378039|NCT01073930|905809|P1|NOT COMPLETED|Overall Study||3
378040|NCT01073930|905808|P2|COMPLETED|Overall Study||295
378041|NCT01073930|905809|P1|COMPLETED|Overall Study||304
378042|NCT01073930|905808|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
378043|NCT01073930|905809|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
378044|NCT01073930|905808|P2|Safety Population (Treated)|Overall Study||298
378045|NCT01073930|905809|P1|Safety Population (Treated)|Overall Study||305
378046|NCT01073930|905808|P2|STARTED|Overall Study||301
378047|NCT01073930|905809|P1|STARTED|Overall Study||307
378048|NCT01073865|905833|P2|NOT COMPLETED|Overall Study||39
378049|NCT01073865|905834|P1|NOT COMPLETED|Overall Study||28
378050|NCT01073865|905833|P2|COMPLETED|Overall Study|Number of patients completed the study|74
378051|NCT01073865|905834|P1|COMPLETED|Overall Study|Number of patients completed the study|81
378052|NCT01073865|905833|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
378053|NCT01073865|905834|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
378054|NCT01073865|905833|P2|STARTED|Overall Study|Number of patients randomised|113
378055|NCT01073865|905834|P1|STARTED|Overall Study|Number of patients randomised|109
378056|NCT01073657|905846|P2|NOT COMPLETED|Overall Study||0
378057|NCT01073657|905847|P1|NOT COMPLETED|Overall Study||0
378058|NCT01073657|905846|P2|COMPLETED|Overall Study||16
378059|NCT01073657|905847|P1|COMPLETED|Overall Study||17
378060|NCT01073657|905846|P2|STARTED|Overall Study||16
378061|NCT01073657|905847|P1|STARTED|Overall Study||17
378062|NCT01073631|905853|P1|NOT COMPLETED|Overall Study||169
378063|NCT01073631|905853|P1|COMPLETED|Overall Study||374
378064|NCT01073631|905853|P1|STARTED|Overall Study||543
378065|NCT01073618|905858|P1|NOT COMPLETED|Overall Study||307
378066|NCT01073618|905858|P1|COMPLETED|Overall Study||385
378067|NCT01073618|905858|P1|STARTED|Overall Study||692
378068|NCT01073605|905866|P3|NOT COMPLETED|Overall Study||61
378069|NCT01073605|905867|P2|NOT COMPLETED|Overall Study||67
378070|NCT01073605|905868|P1|NOT COMPLETED|Overall Study||62
378071|NCT01073605|905866|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
378072|NCT01073605|905867|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
378073|NCT01073605|905868|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
378074|NCT01073605|905866|P3|Received Treatment|Overall Study||68
378075|NCT01073605|905867|P2|Received Treatment|Overall Study||70
378076|NCT01073605|905868|P1|Received Treatment|Overall Study||68
378077|NCT01073605|905866|P3|STARTED|Overall Study||69
378078|NCT01073605|905867|P2|STARTED|Overall Study||71
378079|NCT01073605|905868|P1|STARTED|Overall Study||68
378080|NCT01073566|905914|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
378081|NCT01073566|905915|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
378082|NCT01073566|905914|P2|COMPLETED|Period 2 (6 Weeks)||19
378083|NCT01073566|905915|P1|COMPLETED|Period 2 (6 Weeks)||18
378084|NCT01073566|905914|P2|STARTED|Period 2 (6 Weeks)||19
378085|NCT01073566|905915|P1|STARTED|Period 2 (6 Weeks)||19
378086|NCT01073566|905914|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
378087|NCT01073566|905915|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
378088|NCT01073566|905914|P2|COMPLETED|Period 1 (6 Weeks)||19
378089|NCT01073566|905915|P1|COMPLETED|Period 1 (6 Weeks)||19
378090|NCT01073566|905914|P2|STARTED|Period 1 (6 Weeks)||19
378091|NCT01073566|905915|P1|STARTED|Period 1 (6 Weeks)||19
378092|NCT01073462|905927|P1|NOT COMPLETED|Overall Study||41
378093|NCT01073462|905927|P1|COMPLETED|Overall Study||26
378094|NCT01073462|905927|P1|STARTED|Overall Study||67
378095|NCT01073449|905938|P1|NOT COMPLETED|Overall Study||0
378096|NCT01073449|905938|P1|COMPLETED|Overall Study||3362
378097|NCT01073449|905938|P1|STARTED|Overall Study||3362
378098|NCT01073293|905946|P2|NOT COMPLETED|Overall Study||11
378099|NCT01073293|905947|P1|NOT COMPLETED|Overall Study||5
378100|NCT01073293|905946|P2|COMPLETED|Overall Study||517
378101|NCT01073293|905947|P1|COMPLETED|Overall Study||521
378102|NCT01073293|905946|P2|STARTED|Overall Study||528
378103|NCT01073293|905947|P1|STARTED|Overall Study||526
378104|NCT01073267|905969|P1|NOT COMPLETED|Overall Study||3
378105|NCT01073267|905969|P1|COMPLETED|Overall Study||1
378106|NCT01073267|905969|P1|STARTED|Overall Study||4
378107|NCT01073163|905973|P1|NOT COMPLETED|Overall Study||3
378108|NCT01073163|905973|P1|COMPLETED|Overall Study|Patients completed study|51
378109|NCT01073163|905973|P1|Treated With >=6 Cycles|Overall Study||49
378110|NCT01073163|905973|P1|Treated With <6 Cycles|Overall Study||4
378111|NCT01073163|905973|P1|Enrolled But Not Treated|Overall Study||1
378112|NCT01073163|905973|P1|STARTED|Overall Study||54
378113|NCT01072929|905996|P3|NOT COMPLETED|Overall Study||9
378114|NCT01072929|905997|P2|NOT COMPLETED|Overall Study||51
378115|NCT01072929|905998|P1|NOT COMPLETED|Overall Study||44
378116|NCT01072929|905996|P3|COMPLETED|Overall Study||24
378117|NCT01072929|905997|P2|COMPLETED|Overall Study||150
378118|NCT01072929|905998|P1|COMPLETED|Overall Study||155
378119|NCT01072929|905996|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
378120|NCT01072929|905997|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
378121|NCT01072929|905998|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
378122|NCT01072929|905996|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
378123|NCT01072929|905997|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
378124|NCT01072929|905998|P1|Safety Population|Overall Study|Treated participants|199
378125|NCT01072929|905996|P3|STARTED|Overall Study||33
378126|NCT01072929|905997|P2|STARTED|Overall Study||201
378127|NCT01072929|905998|P1|STARTED|Overall Study||199
378128|NCT01072877|906077|P5|NOT COMPLETED|Overall Study||0
378129|NCT01072877|906078|P4|NOT COMPLETED|Overall Study||2
378130|NCT01072877|906079|P3|NOT COMPLETED|Overall Study||0
378131|NCT01072877|906080|P2|NOT COMPLETED|Overall Study||1
378132|NCT01072877|906081|P1|NOT COMPLETED|Overall Study||1
378133|NCT01072877|906077|P5|COMPLETED|Overall Study||63
378134|NCT01072877|906078|P4|COMPLETED|Overall Study||50
378135|NCT01072877|906079|P3|COMPLETED|Overall Study||51
378136|NCT01072877|906080|P2|COMPLETED|Overall Study||56
378137|NCT01072877|906081|P1|COMPLETED|Overall Study||55
378138|NCT01072877|906077|P5|STARTED|Overall Study||63
378139|NCT01072877|906078|P4|STARTED|Overall Study||52
378140|NCT01072877|906079|P3|STARTED|Overall Study||51
378141|NCT01072877|906080|P2|STARTED|Overall Study||57
378142|NCT01072877|906081|P1|STARTED|Overall Study||56
378143|NCT01072773|906103|P1|NOT COMPLETED|Overall Study||0
378144|NCT01072773|906103|P1|COMPLETED|Overall Study||2
378145|NCT01072773|906103|P1|STARTED|Overall Study||2
378146|NCT01072669|906114|P2|NOT COMPLETED|Overall Study||0
378147|NCT01072669|906115|P1|NOT COMPLETED|Overall Study||0
378148|NCT01072669|906114|P2|COMPLETED|Overall Study||5
378149|NCT01072669|906115|P1|COMPLETED|Overall Study||15
378150|NCT01072669|906114|P2|STARTED|Overall Study||5
378151|NCT01072669|906115|P1|STARTED|Overall Study||15
378152|NCT01072656|906123|P2|NOT COMPLETED|Second Intervention||0
378153|NCT01072656|906124|P1|NOT COMPLETED|Second Intervention||0
378154|NCT01072656|906123|P2|COMPLETED|Second Intervention||4
378155|NCT01072656|906124|P1|COMPLETED|Second Intervention||5
378156|NCT01072656|906123|P2|STARTED|Second Intervention||4
378157|NCT01072656|906124|P1|STARTED|Second Intervention||5
378158|NCT01072656|906123|P2|NOT COMPLETED|First Intervention||0
378159|NCT01072656|906124|P1|NOT COMPLETED|First Intervention||0
378160|NCT01072656|906123|P2|COMPLETED|First Intervention||4
378161|NCT01072656|906124|P1|COMPLETED|First Intervention||5
378162|NCT01072656|906123|P2|STARTED|First Intervention||4
378163|NCT01072656|906124|P1|STARTED|First Intervention||5
378164|NCT01072643|906134|P1|NOT COMPLETED|Overall Study||0
378165|NCT01072643|906134|P1|COMPLETED|Overall Study||4
378166|NCT01072643|906134|P1|STARTED|Overall Study||4
378167|NCT01072630|906144|P3|NOT COMPLETED|Overall Study||13
378168|NCT01072630|906145|P2|NOT COMPLETED|Overall Study||60
378169|NCT01072630|906146|P1|NOT COMPLETED|Overall Study||55
378170|NCT01072630|906144|P3|COMPLETED|Overall Study||17
378171|NCT01072630|906145|P2|COMPLETED|Overall Study||172
378172|NCT01072630|906146|P1|COMPLETED|Overall Study||175
378173|NCT01072630|906144|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
378174|NCT01072630|906145|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
378175|NCT01072630|906146|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
378176|NCT01072630|906144|P3|Safety Population|Overall Study|Treated participants.|30
378177|NCT01072630|906145|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
378178|NCT01072630|906146|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
378179|NCT01072630|906144|P3|STARTED|Overall Study||30
378180|NCT01072630|906145|P2|STARTED|Overall Study||232
378181|NCT01072630|906146|P1|STARTED|Overall Study||230
378182|NCT01072617|906220|P1|NOT COMPLETED|Overall Study||0
378183|NCT01072617|906220|P1|COMPLETED|Overall Study||8
378184|NCT01072617|906220|P1|STARTED|Overall Study||8
378185|NCT01072539|906227|P1|NOT COMPLETED|Overall Study||3
378186|NCT01072539|906227|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
378187|NCT01072539|906227|P1|STARTED|Overall Study||3172
378188|NCT01072526|906235|P2|NOT COMPLETED|Overall Study||0
378189|NCT01072526|906236|P1|NOT COMPLETED|Overall Study||0
378190|NCT01072526|906235|P2|COMPLETED|Overall Study||0
378191|NCT01072526|906236|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
378192|NCT01072526|906235|P2|STARTED|Overall Study||0
378193|NCT01072526|906236|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
378194|NCT01072500|906251|P2|NOT COMPLETED|Overall Study||14
378195|NCT01072500|906252|P1|NOT COMPLETED|Overall Study||24
378196|NCT01072500|906251|P2|COMPLETED|Overall Study||803
378197|NCT01072500|906252|P1|COMPLETED|Overall Study||794
378198|NCT01072500|906251|P2|STARTED|Overall Study||817
378199|NCT01072500|906252|P1|STARTED|Overall Study||818
378200|NCT01072448|906262|P2|NOT COMPLETED|Overall Study||30
378201|NCT01072448|906263|P1|NOT COMPLETED|Overall Study||19
378202|NCT01072448|906262|P2|COMPLETED|Overall Study||130
378203|NCT01072448|906263|P1|COMPLETED|Overall Study||144
378204|NCT01072448|906262|P2|STARTED|Overall Study||160
378205|NCT01072448|906263|P1|STARTED|Overall Study||163
378206|NCT01072409|906271|P1|NOT COMPLETED|Overall Study||7
378207|NCT01072409|906271|P1|COMPLETED|Overall Study||38
378208|NCT01072409|906271|P1|STARTED|Overall Study||45
378209|NCT01072396|906277|P2|NOT COMPLETED|Period Two||3
378210|NCT01072396|906278|P1|NOT COMPLETED|Period Two||1
378211|NCT01072396|906277|P2|COMPLETED|Period Two||57
378212|NCT01072396|906278|P1|COMPLETED|Period Two||57
378213|NCT01072396|906277|P2|STARTED|Period Two||60
378214|NCT01072396|906278|P1|STARTED|Period Two||58
378215|NCT01072396|906277|P2|NOT COMPLETED|Washout Period||1
378216|NCT01072396|906278|P1|NOT COMPLETED|Washout Period||0
378217|NCT01072396|906277|P2|COMPLETED|Washout Period||60
378218|NCT01072396|906278|P1|COMPLETED|Washout Period||58
378219|NCT01072396|906277|P2|STARTED|Washout Period||61
378220|NCT01072396|906278|P1|STARTED|Washout Period||58
378221|NCT01072396|906277|P2|NOT COMPLETED|Period One||2
378222|NCT01072396|906278|P1|NOT COMPLETED|Period One||5
378223|NCT01072396|906277|P2|COMPLETED|Period One||61
378224|NCT01072396|906278|P1|COMPLETED|Period One||58
378225|NCT01072396|906277|P2|STARTED|Period One||63
378226|NCT01072396|906278|P1|STARTED|Period One||63
378227|NCT01072357|906290|P2|NOT COMPLETED|Overall Study||1
378228|NCT01072357|906291|P1|NOT COMPLETED|Overall Study||0
378229|NCT01072357|906290|P2|COMPLETED|Overall Study||14
378230|NCT01072357|906291|P1|COMPLETED|Overall Study||15
378231|NCT01072357|906290|P2|STARTED|Overall Study||15
378232|NCT01072357|906291|P1|STARTED|Overall Study||15
378233|NCT01072331|906302|P3|NOT COMPLETED|Overall Study||0
378234|NCT01072331|906303|P2|NOT COMPLETED|Overall Study||0
378235|NCT01072331|906304|P1|NOT COMPLETED|Overall Study||0
378236|NCT01072331|906302|P3|COMPLETED|Overall Study||32
378237|NCT01072331|906303|P2|COMPLETED|Overall Study||33
378238|NCT01072331|906304|P1|COMPLETED|Overall Study||34
378239|NCT01072331|906302|P3|STARTED|Overall Study||32
378240|NCT01072331|906303|P2|STARTED|Overall Study||33
378241|NCT01072331|906304|P1|STARTED|Overall Study||34
378242|NCT01072201|906323|P2|NOT COMPLETED|Overall Study||1
378243|NCT01072201|906324|P1|NOT COMPLETED|Overall Study||0
378244|NCT01072201|906323|P2|COMPLETED|Overall Study||29
378245|NCT01072201|906324|P1|COMPLETED|Overall Study||30
378246|NCT01072201|906323|P2|STARTED|Overall Study||30
378247|NCT01072201|906324|P1|STARTED|Overall Study||30
378248|NCT01072188|906336|P2|NOT COMPLETED|Overall Study||0
378249|NCT01072188|906337|P1|NOT COMPLETED|Overall Study||0
378250|NCT01072188|906336|P2|COMPLETED|Overall Study||23
378251|NCT01072188|906337|P1|COMPLETED|Overall Study||22
378252|NCT01072188|906336|P2|STARTED|Overall Study||23
378253|NCT01072188|906337|P1|STARTED|Overall Study||22
378254|NCT01072175|906357|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
378255|NCT01072175|906358|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
378256|NCT01072175|906359|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
378257|NCT01072175|906360|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
378258|NCT01072175|906361|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
378259|NCT01072175|906362|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
378260|NCT01072175|906363|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
378261|NCT01072175|906364|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
378262|NCT01072175|906365|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
378263|NCT01072175|906366|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
378264|NCT01072175|906367|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
378265|NCT01072175|906368|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
378266|NCT01072175|906369|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
378267|NCT01072175|906357|P13|COMPLETED|Part D (HPMC Capsules)||0
378268|NCT01072175|906358|P12|COMPLETED|Part D (HPMC Capsules)||0
378269|NCT01072175|906359|P11|COMPLETED|Part D (HPMC Capsules)||0
378270|NCT01072175|906360|P10|COMPLETED|Part D (HPMC Capsules)||0
378271|NCT01072175|906361|P9|COMPLETED|Part D (HPMC Capsules)||0
378272|NCT01072175|906362|P8|COMPLETED|Part D (HPMC Capsules)||0
378273|NCT01072175|906363|P7|COMPLETED|Part D (HPMC Capsules)||0
378274|NCT01072175|906364|P6|COMPLETED|Part D (HPMC Capsules)||0
378275|NCT01072175|906365|P5|COMPLETED|Part D (HPMC Capsules)||0
378276|NCT01072175|906366|P4|COMPLETED|Part D (HPMC Capsules)||0
378277|NCT01072175|906367|P3|COMPLETED|Part D (HPMC Capsules)||0
378278|NCT01072175|906368|P2|COMPLETED|Part D (HPMC Capsules)||0
378279|NCT01072175|906369|P1|COMPLETED|Part D (HPMC Capsules)||0
378280|NCT01072175|906357|P13|Ongoing|Part D (HPMC Capsules)||34
378281|NCT01072175|906358|P12|Ongoing|Part D (HPMC Capsules)||34
378282|NCT01072175|906359|P11|Ongoing|Part D (HPMC Capsules)||12
378283|NCT01072175|906360|P10|Ongoing|Part D (HPMC Capsules)||10
378284|NCT01072175|906361|P9|Ongoing|Part D (HPMC Capsules)||0
378285|NCT01072175|906362|P8|Ongoing|Part D (HPMC Capsules)||0
378286|NCT01072175|906363|P7|Ongoing|Part D (HPMC Capsules)||0
378287|NCT01072175|906364|P6|Ongoing|Part D (HPMC Capsules)||0
378288|NCT01072175|906365|P5|Ongoing|Part D (HPMC Capsules)||0
378289|NCT01072175|906366|P4|Ongoing|Part D (HPMC Capsules)||0
378290|NCT01072175|906367|P3|Ongoing|Part D (HPMC Capsules)||0
378291|NCT01072175|906368|P2|Ongoing|Part D (HPMC Capsules)||0
378292|NCT01072175|906369|P1|Ongoing|Part D (HPMC Capsules)||0
378293|NCT01072175|906357|P13|STARTED|Part D (HPMC Capsules)||39
378294|NCT01072175|906358|P12|STARTED|Part D (HPMC Capsules)||43
378295|NCT01072175|906359|P11|STARTED|Part D (HPMC Capsules)||16
378296|NCT01072175|906360|P10|STARTED|Part D (HPMC Capsules)||12
378297|NCT01072175|906361|P9|STARTED|Part D (HPMC Capsules)||0
378298|NCT01072175|906362|P8|STARTED|Part D (HPMC Capsules)||0
378299|NCT01072175|906363|P7|STARTED|Part D (HPMC Capsules)||0
378300|NCT01072175|906364|P6|STARTED|Part D (HPMC Capsules)||0
378301|NCT01072175|906365|P5|STARTED|Part D (HPMC Capsules)||0
378302|NCT01072175|906366|P4|STARTED|Part D (HPMC Capsules)||0
378303|NCT01072175|906367|P3|STARTED|Part D (HPMC Capsules)||0
378304|NCT01072175|906368|P2|STARTED|Part D (HPMC Capsules)||0
378305|NCT01072175|906369|P1|STARTED|Part D (HPMC Capsules)||0
378306|NCT01072175|906357|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378307|NCT01072175|906358|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378308|NCT01072175|906359|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378309|NCT01072175|906360|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378310|NCT01072175|906361|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
378311|NCT01072175|906362|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378312|NCT01072175|906363|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378313|NCT01072175|906364|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378314|NCT01072175|906365|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378315|NCT01072175|906366|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378316|NCT01072175|906367|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378317|NCT01072175|906368|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378318|NCT01072175|906369|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378319|NCT01072175|906357|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378320|NCT01072175|906358|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378321|NCT01072175|906359|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378322|NCT01072175|906360|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378323|NCT01072175|906361|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378324|NCT01072175|906362|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378325|NCT01072175|906363|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378326|NCT01072175|906364|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378327|NCT01072175|906365|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378328|NCT01072175|906366|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378329|NCT01072175|906367|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378330|NCT01072175|906368|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378331|NCT01072175|906369|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
378332|NCT01072175|906357|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378333|NCT01072175|906358|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378334|NCT01072175|906359|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378335|NCT01072175|906360|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378336|NCT01072175|906361|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
378337|NCT01072175|906362|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378338|NCT01072175|906363|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378339|NCT01072175|906364|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378340|NCT01072175|906365|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378341|NCT01072175|906366|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378342|NCT01072175|906367|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378343|NCT01072175|906368|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378344|NCT01072175|906369|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
378345|NCT01072175|906357|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378346|NCT01072175|906358|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378347|NCT01072175|906359|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378348|NCT01072175|906360|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378349|NCT01072175|906361|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
378350|NCT01072175|906362|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378351|NCT01072175|906363|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378352|NCT01072175|906364|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378353|NCT01072175|906365|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378354|NCT01072175|906366|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378355|NCT01072175|906367|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378356|NCT01072175|906368|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378357|NCT01072175|906369|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
378358|NCT01072175|906357|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378359|NCT01072175|906358|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378360|NCT01072175|906359|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378361|NCT01072175|906360|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378362|NCT01072175|906361|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378363|NCT01072175|906362|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
378364|NCT01072175|906363|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
378365|NCT01072175|906364|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
378366|NCT01072175|906365|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378367|NCT01072175|906366|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378368|NCT01072175|906367|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378369|NCT01072175|906368|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378370|NCT01072175|906369|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
378371|NCT01072175|906357|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
378372|NCT01072175|906358|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
378373|NCT01072175|906359|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
378374|NCT01072175|906360|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
378375|NCT01072175|906361|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
378376|NCT01072175|906362|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
378377|NCT01072175|906363|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
378378|NCT01072175|906364|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
378379|NCT01072175|906365|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
378380|NCT01072175|906366|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
378381|NCT01072175|906367|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
378382|NCT01072175|906368|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
378383|NCT01072175|906369|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
378384|NCT01072175|906357|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
378385|NCT01072175|906358|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
378386|NCT01072175|906359|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
378387|NCT01072175|906360|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
378388|NCT01072175|906361|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
378389|NCT01072175|906362|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
378390|NCT01072175|906363|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
378391|NCT01072175|906364|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
378392|NCT01072175|906365|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
378393|NCT01072175|906366|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
378394|NCT01072175|906367|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
378395|NCT01072175|906368|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
378396|NCT01072175|906369|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
378397|NCT01072175|906357|P13|STARTED|Part C (Phase II: Randomized Phase)||0
378398|NCT01072175|906358|P12|STARTED|Part C (Phase II: Randomized Phase)||0
378399|NCT01072175|906359|P11|STARTED|Part C (Phase II: Randomized Phase)||0
378400|NCT01072175|906360|P10|STARTED|Part C (Phase II: Randomized Phase)||0
378401|NCT01072175|906361|P9|STARTED|Part C (Phase II: Randomized Phase)||0
378402|NCT01072175|906362|P8|STARTED|Part C (Phase II: Randomized Phase)||54
378403|NCT01072175|906363|P7|STARTED|Part C (Phase II: Randomized Phase)||54
378404|NCT01072175|906364|P6|STARTED|Part C (Phase II: Randomized Phase)||54
378405|NCT01072175|906365|P5|STARTED|Part C (Phase II: Randomized Phase)||0
378406|NCT01072175|906366|P4|STARTED|Part C (Phase II: Randomized Phase)||0
378407|NCT01072175|906367|P3|STARTED|Part C (Phase II: Randomized Phase)||0
378408|NCT01072175|906368|P2|STARTED|Part C (Phase II: Randomized Phase)||0
378409|NCT01072175|906369|P1|STARTED|Part C (Phase II: Randomized Phase)||0
378410|NCT01072175|906357|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378411|NCT01072175|906358|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378412|NCT01072175|906359|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378413|NCT01072175|906360|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378414|NCT01072175|906361|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378415|NCT01072175|906362|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378416|NCT01072175|906363|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378417|NCT01072175|906364|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378418|NCT01072175|906365|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
378419|NCT01072175|906366|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
378420|NCT01072175|906367|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
378421|NCT01072175|906368|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
378422|NCT01072175|906369|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
378423|NCT01072175|906357|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
378424|NCT01072175|906358|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
378425|NCT01072175|906359|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
378426|NCT01072175|906360|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
378427|NCT01072175|906361|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
378428|NCT01072175|906362|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
378429|NCT01072175|906363|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
378430|NCT01072175|906364|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
378431|NCT01072175|906365|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
378432|NCT01072175|906366|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
378433|NCT01072175|906367|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
378434|NCT01072175|906368|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
378435|NCT01072175|906369|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
378436|NCT01072175|906357|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
378437|NCT01072175|906358|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
378438|NCT01072175|906359|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
378439|NCT01072175|906360|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
378440|NCT01072175|906361|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
378441|NCT01072175|906362|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
378442|NCT01072175|906363|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
378443|NCT01072175|906364|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
378444|NCT01072175|906365|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
378445|NCT01072175|906366|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
378446|NCT01072175|906367|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
378447|NCT01072175|906368|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
378448|NCT01072175|906369|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
378449|NCT01072175|906357|P13|STARTED|Part B (Dose Escalation and Expansion)||0
378450|NCT01072175|906358|P12|STARTED|Part B (Dose Escalation and Expansion)||0
378451|NCT01072175|906359|P11|STARTED|Part B (Dose Escalation and Expansion)||0
378452|NCT01072175|906360|P10|STARTED|Part B (Dose Escalation and Expansion)||0
378453|NCT01072175|906361|P9|STARTED|Part B (Dose Escalation and Expansion)||0
378454|NCT01072175|906362|P8|STARTED|Part B (Dose Escalation and Expansion)||0
378455|NCT01072175|906363|P7|STARTED|Part B (Dose Escalation and Expansion)||0
378456|NCT01072175|906364|P6|STARTED|Part B (Dose Escalation and Expansion)||0
378457|NCT01072175|906365|P5|STARTED|Part B (Dose Escalation and Expansion)||79
378458|NCT01072175|906366|P4|STARTED|Part B (Dose Escalation and Expansion)||27
378459|NCT01072175|906367|P3|STARTED|Part B (Dose Escalation and Expansion)||23
378460|NCT01072175|906368|P2|STARTED|Part B (Dose Escalation and Expansion)||6
378461|NCT01072175|906369|P1|STARTED|Part B (Dose Escalation and Expansion)||0
378462|NCT01072175|906357|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378463|NCT01072175|906358|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378464|NCT01072175|906359|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378465|NCT01072175|906360|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378466|NCT01072175|906361|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378467|NCT01072175|906362|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378468|NCT01072175|906363|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378469|NCT01072175|906364|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378470|NCT01072175|906365|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378471|NCT01072175|906366|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378472|NCT01072175|906367|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378473|NCT01072175|906368|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
378474|NCT01072175|906369|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
378475|NCT01072175|906357|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
378476|NCT01072175|906358|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
378477|NCT01072175|906359|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
378478|NCT01072175|906360|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
378479|NCT01072175|906361|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
378480|NCT01072175|906362|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
378481|NCT01072175|906363|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
378482|NCT01072175|906364|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
378483|NCT01072175|906365|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
378484|NCT01072175|906366|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
378485|NCT01072175|906367|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
378486|NCT01072175|906368|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
378487|NCT01072175|906369|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
378488|NCT01072175|906357|P13|STARTED|Part A (Drug-Drug Interaction)||0
378489|NCT01072175|906358|P12|STARTED|Part A (Drug-Drug Interaction)||0
378490|NCT01072175|906359|P11|STARTED|Part A (Drug-Drug Interaction)||0
378491|NCT01072175|906360|P10|STARTED|Part A (Drug-Drug Interaction)||0
378492|NCT01072175|906361|P9|STARTED|Part A (Drug-Drug Interaction)||0
378493|NCT01072175|906362|P8|STARTED|Part A (Drug-Drug Interaction)||0
378494|NCT01072175|906363|P7|STARTED|Part A (Drug-Drug Interaction)||0
378495|NCT01072175|906364|P6|STARTED|Part A (Drug-Drug Interaction)||0
378496|NCT01072175|906365|P5|STARTED|Part A (Drug-Drug Interaction)||0
378497|NCT01072175|906366|P4|STARTED|Part A (Drug-Drug Interaction)||0
378498|NCT01072175|906367|P3|STARTED|Part A (Drug-Drug Interaction)||0
378499|NCT01072175|906368|P2|STARTED|Part A (Drug-Drug Interaction)||0
378500|NCT01072175|906369|P1|STARTED|Part A (Drug-Drug Interaction)||8
378501|NCT01072149|906552|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378502|NCT01072149|906553|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378503|NCT01072149|906554|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378504|NCT01072149|906555|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378505|NCT01072149|906556|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
378506|NCT01072149|906557|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378507|NCT01072149|906558|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378508|NCT01072149|906559|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378509|NCT01072149|906560|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378510|NCT01072149|906561|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378511|NCT01072149|906562|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378512|NCT01072149|906563|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378513|NCT01072149|906564|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378514|NCT01072149|906565|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378515|NCT01072149|906566|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378516|NCT01072149|906567|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
378517|NCT01072149|906568|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378518|NCT01072149|906569|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
378519|NCT01072149|906552|P18|COMPLETED|Treatment Period 3 (28 Days)||2
378520|NCT01072149|906553|P17|COMPLETED|Treatment Period 3 (28 Days)||3
378521|NCT01072149|906554|P16|COMPLETED|Treatment Period 3 (28 Days)||1
378522|NCT01072149|906555|P15|COMPLETED|Treatment Period 3 (28 Days)||3
378523|NCT01072149|906556|P14|COMPLETED|Treatment Period 3 (28 Days)||2
378524|NCT01072149|906557|P13|COMPLETED|Treatment Period 3 (28 Days)||2
378525|NCT01072149|906558|P12|COMPLETED|Treatment Period 3 (28 Days)||3
378526|NCT01072149|906559|P11|COMPLETED|Treatment Period 3 (28 Days)||2
378527|NCT01072149|906560|P10|COMPLETED|Treatment Period 3 (28 Days)||3
378528|NCT01072149|906561|P9|COMPLETED|Treatment Period 3 (28 Days)||3
378529|NCT01072149|906562|P8|COMPLETED|Treatment Period 3 (28 Days)||2
378530|NCT01072149|906563|P7|COMPLETED|Treatment Period 3 (28 Days)||3
378531|NCT01072149|906564|P6|COMPLETED|Treatment Period 3 (28 Days)||3
378532|NCT01072149|906565|P5|COMPLETED|Treatment Period 3 (28 Days)||3
378533|NCT01072149|906566|P4|COMPLETED|Treatment Period 3 (28 Days)||3
378534|NCT01072149|906567|P3|COMPLETED|Treatment Period 3 (28 Days)||0
378535|NCT01072149|906568|P2|COMPLETED|Treatment Period 3 (28 Days)||2
378536|NCT01072149|906569|P1|COMPLETED|Treatment Period 3 (28 Days)||2
378537|NCT01072149|906552|P18|STARTED|Treatment Period 3 (28 Days)||2
378538|NCT01072149|906553|P17|STARTED|Treatment Period 3 (28 Days)||3
378539|NCT01072149|906554|P16|STARTED|Treatment Period 3 (28 Days)||1
378540|NCT01072149|906555|P15|STARTED|Treatment Period 3 (28 Days)||3
378541|NCT01072149|906556|P14|STARTED|Treatment Period 3 (28 Days)||3
378542|NCT01072149|906557|P13|STARTED|Treatment Period 3 (28 Days)||2
378543|NCT01072149|906558|P12|STARTED|Treatment Period 3 (28 Days)||3
378544|NCT01072149|906559|P11|STARTED|Treatment Period 3 (28 Days)||2
378545|NCT01072149|906560|P10|STARTED|Treatment Period 3 (28 Days)||3
378546|NCT01072149|906561|P9|STARTED|Treatment Period 3 (28 Days)||3
378547|NCT01072149|906562|P8|STARTED|Treatment Period 3 (28 Days)||2
378548|NCT01072149|906563|P7|STARTED|Treatment Period 3 (28 Days)||3
378549|NCT01072149|906564|P6|STARTED|Treatment Period 3 (28 Days)||3
378550|NCT01072149|906565|P5|STARTED|Treatment Period 3 (28 Days)||3
378551|NCT01072149|906566|P4|STARTED|Treatment Period 3 (28 Days)||3
378552|NCT01072149|906567|P3|STARTED|Treatment Period 3 (28 Days)||1
378553|NCT01072149|906568|P2|STARTED|Treatment Period 3 (28 Days)||2
378554|NCT01072149|906569|P1|STARTED|Treatment Period 3 (28 Days)||2
378555|NCT01072149|906552|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
378556|NCT01072149|906553|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
378557|NCT01072149|906554|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
378558|NCT01072149|906555|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
378559|NCT01072149|906556|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
378560|NCT01072149|906557|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
378561|NCT01072149|906558|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
378562|NCT01072149|906559|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
378563|NCT01072149|906560|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
378564|NCT01072149|906561|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
378565|NCT01072149|906562|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
378566|NCT01072149|906563|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
378567|NCT01072149|906564|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
378568|NCT01072149|906565|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
378569|NCT01072149|906566|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
378570|NCT01072149|906567|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
378571|NCT01072149|906568|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
378572|NCT01072149|906569|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
378573|NCT01072149|906552|P18|COMPLETED|Washout Period 2 (14 Days)||2
378574|NCT01072149|906553|P17|COMPLETED|Washout Period 2 (14 Days)||3
378575|NCT01072149|906554|P16|COMPLETED|Washout Period 2 (14 Days)||1
378576|NCT01072149|906555|P15|COMPLETED|Washout Period 2 (14 Days)||3
378577|NCT01072149|906556|P14|COMPLETED|Washout Period 2 (14 Days)||3
378578|NCT01072149|906557|P13|COMPLETED|Washout Period 2 (14 Days)||2
378579|NCT01072149|906558|P12|COMPLETED|Washout Period 2 (14 Days)||3
378580|NCT01072149|906559|P11|COMPLETED|Washout Period 2 (14 Days)||2
378581|NCT01072149|906560|P10|COMPLETED|Washout Period 2 (14 Days)||3
378582|NCT01072149|906561|P9|COMPLETED|Washout Period 2 (14 Days)||3
378583|NCT01072149|906562|P8|COMPLETED|Washout Period 2 (14 Days)||2
378584|NCT01072149|906563|P7|COMPLETED|Washout Period 2 (14 Days)||3
378585|NCT01072149|906564|P6|COMPLETED|Washout Period 2 (14 Days)||3
378586|NCT01072149|906565|P5|COMPLETED|Washout Period 2 (14 Days)||3
378587|NCT01072149|906566|P4|COMPLETED|Washout Period 2 (14 Days)||3
378588|NCT01072149|906567|P3|COMPLETED|Washout Period 2 (14 Days)||1
378589|NCT01072149|906568|P2|COMPLETED|Washout Period 2 (14 Days)||2
378590|NCT01072149|906569|P1|COMPLETED|Washout Period 2 (14 Days)||2
378591|NCT01072149|906552|P18|STARTED|Washout Period 2 (14 Days)||2
378592|NCT01072149|906553|P17|STARTED|Washout Period 2 (14 Days)||3
378593|NCT01072149|906554|P16|STARTED|Washout Period 2 (14 Days)||3
378594|NCT01072149|906555|P15|STARTED|Washout Period 2 (14 Days)||3
378595|NCT01072149|906556|P14|STARTED|Washout Period 2 (14 Days)||3
378596|NCT01072149|906557|P13|STARTED|Washout Period 2 (14 Days)||3
378597|NCT01072149|906558|P12|STARTED|Washout Period 2 (14 Days)||3
378598|NCT01072149|906559|P11|STARTED|Washout Period 2 (14 Days)||2
378599|NCT01072149|906560|P10|STARTED|Washout Period 2 (14 Days)||3
378600|NCT01072149|906561|P9|STARTED|Washout Period 2 (14 Days)||3
378601|NCT01072149|906562|P8|STARTED|Washout Period 2 (14 Days)||2
378602|NCT01072149|906563|P7|STARTED|Washout Period 2 (14 Days)||3
378603|NCT01072149|906564|P6|STARTED|Washout Period 2 (14 Days)||3
378604|NCT01072149|906565|P5|STARTED|Washout Period 2 (14 Days)||3
378605|NCT01072149|906566|P4|STARTED|Washout Period 2 (14 Days)||3
378606|NCT01072149|906567|P3|STARTED|Washout Period 2 (14 Days)||1
378607|NCT01072149|906568|P2|STARTED|Washout Period 2 (14 Days)||2
378608|NCT01072149|906569|P1|STARTED|Washout Period 2 (14 Days)||3
378609|NCT01072149|906552|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378610|NCT01072149|906553|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378611|NCT01072149|906554|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378612|NCT01072149|906555|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378613|NCT01072149|906556|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378614|NCT01072149|906557|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378615|NCT01072149|906558|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378616|NCT01072149|906559|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378617|NCT01072149|906560|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378618|NCT01072149|906561|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378619|NCT01072149|906562|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
378620|NCT01072149|906563|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378621|NCT01072149|906564|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378622|NCT01072149|906565|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378623|NCT01072149|906566|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378624|NCT01072149|906567|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
378625|NCT01072149|906568|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
378626|NCT01072149|906569|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
378627|NCT01072149|906552|P18|COMPLETED|Treatment Period 2 (28 Days)||2
378628|NCT01072149|906553|P17|COMPLETED|Treatment Period 2 (28 Days)||3
378629|NCT01072149|906554|P16|COMPLETED|Treatment Period 2 (28 Days)||3
378630|NCT01072149|906555|P15|COMPLETED|Treatment Period 2 (28 Days)||3
378631|NCT01072149|906556|P14|COMPLETED|Treatment Period 2 (28 Days)||3
378632|NCT01072149|906557|P13|COMPLETED|Treatment Period 2 (28 Days)||3
378633|NCT01072149|906558|P12|COMPLETED|Treatment Period 2 (28 Days)||3
378634|NCT01072149|906559|P11|COMPLETED|Treatment Period 2 (28 Days)||2
378635|NCT01072149|906560|P10|COMPLETED|Treatment Period 2 (28 Days)||3
378636|NCT01072149|906561|P9|COMPLETED|Treatment Period 2 (28 Days)||3
378637|NCT01072149|906562|P8|COMPLETED|Treatment Period 2 (28 Days)||2
378638|NCT01072149|906563|P7|COMPLETED|Treatment Period 2 (28 Days)||3
378639|NCT01072149|906564|P6|COMPLETED|Treatment Period 2 (28 Days)||3
378640|NCT01072149|906565|P5|COMPLETED|Treatment Period 2 (28 Days)||3
378641|NCT01072149|906566|P4|COMPLETED|Treatment Period 2 (28 Days)||3
378642|NCT01072149|906567|P3|COMPLETED|Treatment Period 2 (28 Days)||1
378643|NCT01072149|906568|P2|COMPLETED|Treatment Period 2 (28 Days)||2
378644|NCT01072149|906569|P1|COMPLETED|Treatment Period 2 (28 Days)||3
378645|NCT01072149|906552|P18|STARTED|Treatment Period 2 (28 Days)||2
378646|NCT01072149|906553|P17|STARTED|Treatment Period 2 (28 Days)||3
378647|NCT01072149|906554|P16|STARTED|Treatment Period 2 (28 Days)||3
378648|NCT01072149|906555|P15|STARTED|Treatment Period 2 (28 Days)||3
378649|NCT01072149|906556|P14|STARTED|Treatment Period 2 (28 Days)||3
378650|NCT01072149|906557|P13|STARTED|Treatment Period 2 (28 Days)||3
378651|NCT01072149|906558|P12|STARTED|Treatment Period 2 (28 Days)||3
378652|NCT01072149|906559|P11|STARTED|Treatment Period 2 (28 Days)||2
378653|NCT01072149|906560|P10|STARTED|Treatment Period 2 (28 Days)||3
378654|NCT01072149|906561|P9|STARTED|Treatment Period 2 (28 Days)||3
378655|NCT01072149|906562|P8|STARTED|Treatment Period 2 (28 Days)||3
378656|NCT01072149|906563|P7|STARTED|Treatment Period 2 (28 Days)||3
378657|NCT01072149|906564|P6|STARTED|Treatment Period 2 (28 Days)||3
378658|NCT01072149|906565|P5|STARTED|Treatment Period 2 (28 Days)||3
378659|NCT01072149|906566|P4|STARTED|Treatment Period 2 (28 Days)||3
378660|NCT01072149|906567|P3|STARTED|Treatment Period 2 (28 Days)||2
378661|NCT01072149|906568|P2|STARTED|Treatment Period 2 (28 Days)||3
378662|NCT01072149|906569|P1|STARTED|Treatment Period 2 (28 Days)||3
378663|NCT01072149|906552|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
378664|NCT01072149|906553|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
378665|NCT01072149|906554|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
378666|NCT01072149|906555|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
378667|NCT01072149|906556|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
378668|NCT01072149|906557|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
378669|NCT01072149|906558|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
378670|NCT01072149|906559|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
378671|NCT01072149|906560|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
378672|NCT01072149|906561|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
378673|NCT01072149|906562|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
378674|NCT01072149|906563|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
378675|NCT01072149|906564|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
378676|NCT01072149|906565|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
378677|NCT01072149|906566|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
378678|NCT01072149|906567|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
378679|NCT01072149|906568|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
378680|NCT01072149|906569|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
378681|NCT01072149|906552|P18|COMPLETED|Washout Period 1 (14 Days)||2
378682|NCT01072149|906553|P17|COMPLETED|Washout Period 1 (14 Days)||3
378683|NCT01072149|906554|P16|COMPLETED|Washout Period 1 (14 Days)||3
378684|NCT01072149|906555|P15|COMPLETED|Washout Period 1 (14 Days)||3
378685|NCT01072149|906556|P14|COMPLETED|Washout Period 1 (14 Days)||3
378686|NCT01072149|906557|P13|COMPLETED|Washout Period 1 (14 Days)||3
378687|NCT01072149|906558|P12|COMPLETED|Washout Period 1 (14 Days)||3
378688|NCT01072149|906559|P11|COMPLETED|Washout Period 1 (14 Days)||2
378689|NCT01072149|906560|P10|COMPLETED|Washout Period 1 (14 Days)||3
378690|NCT01072149|906561|P9|COMPLETED|Washout Period 1 (14 Days)||3
378691|NCT01072149|906562|P8|COMPLETED|Washout Period 1 (14 Days)||3
378692|NCT01072149|906563|P7|COMPLETED|Washout Period 1 (14 Days)||3
378693|NCT01072149|906564|P6|COMPLETED|Washout Period 1 (14 Days)||3
378694|NCT01072149|906565|P5|COMPLETED|Washout Period 1 (14 Days)||3
378695|NCT01072149|906566|P4|COMPLETED|Washout Period 1 (14 Days)||3
378696|NCT01072149|906567|P3|COMPLETED|Washout Period 1 (14 Days)||2
378697|NCT01072149|906568|P2|COMPLETED|Washout Period 1 (14 Days)||3
378698|NCT01072149|906569|P1|COMPLETED|Washout Period 1 (14 Days)||3
378699|NCT01072149|906552|P18|STARTED|Washout Period 1 (14 Days)||2
378700|NCT01072149|906553|P17|STARTED|Washout Period 1 (14 Days)||3
378701|NCT01072149|906554|P16|STARTED|Washout Period 1 (14 Days)||3
378702|NCT01072149|906555|P15|STARTED|Washout Period 1 (14 Days)||3
378703|NCT01072149|906556|P14|STARTED|Washout Period 1 (14 Days)||3
378704|NCT01072149|906557|P13|STARTED|Washout Period 1 (14 Days)||3
378705|NCT01072149|906558|P12|STARTED|Washout Period 1 (14 Days)||3
378706|NCT01072149|906559|P11|STARTED|Washout Period 1 (14 Days)||2
378707|NCT01072149|906560|P10|STARTED|Washout Period 1 (14 Days)||3
378708|NCT01072149|906561|P9|STARTED|Washout Period 1 (14 Days)||3
378709|NCT01072149|906562|P8|STARTED|Washout Period 1 (14 Days)||3
378710|NCT01072149|906563|P7|STARTED|Washout Period 1 (14 Days)||3
378711|NCT01072149|906564|P6|STARTED|Washout Period 1 (14 Days)||3
378712|NCT01072149|906565|P5|STARTED|Washout Period 1 (14 Days)||3
378713|NCT01072149|906566|P4|STARTED|Washout Period 1 (14 Days)||3
378714|NCT01072149|906567|P3|STARTED|Washout Period 1 (14 Days)||2
378715|NCT01072149|906568|P2|STARTED|Washout Period 1 (14 Days)||3
378716|NCT01072149|906569|P1|STARTED|Washout Period 1 (14 Days)||3
378717|NCT01072149|906552|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
378718|NCT01072149|906553|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378719|NCT01072149|906554|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378720|NCT01072149|906555|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378721|NCT01072149|906556|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378722|NCT01072149|906557|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378723|NCT01072149|906558|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378724|NCT01072149|906559|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
378725|NCT01072149|906560|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378726|NCT01072149|906561|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378727|NCT01072149|906562|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378728|NCT01072149|906563|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378729|NCT01072149|906564|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378730|NCT01072149|906565|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378731|NCT01072149|906566|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378732|NCT01072149|906567|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
378733|NCT01072149|906568|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378734|NCT01072149|906569|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
378735|NCT01072149|906552|P18|COMPLETED|Treatment Period 1 (28 Days)||2
378736|NCT01072149|906553|P17|COMPLETED|Treatment Period 1 (28 Days)||3
378737|NCT01072149|906554|P16|COMPLETED|Treatment Period 1 (28 Days)||3
378738|NCT01072149|906555|P15|COMPLETED|Treatment Period 1 (28 Days)||3
378739|NCT01072149|906556|P14|COMPLETED|Treatment Period 1 (28 Days)||3
378740|NCT01072149|906557|P13|COMPLETED|Treatment Period 1 (28 Days)||3
378741|NCT01072149|906558|P12|COMPLETED|Treatment Period 1 (28 Days)||3
378742|NCT01072149|906559|P11|COMPLETED|Treatment Period 1 (28 Days)||2
378743|NCT01072149|906560|P10|COMPLETED|Treatment Period 1 (28 Days)||3
378744|NCT01072149|906561|P9|COMPLETED|Treatment Period 1 (28 Days)||3
378745|NCT01072149|906562|P8|COMPLETED|Treatment Period 1 (28 Days)||3
378746|NCT01072149|906563|P7|COMPLETED|Treatment Period 1 (28 Days)||3
378747|NCT01072149|906564|P6|COMPLETED|Treatment Period 1 (28 Days)||3
378748|NCT01072149|906565|P5|COMPLETED|Treatment Period 1 (28 Days)||3
378749|NCT01072149|906566|P4|COMPLETED|Treatment Period 1 (28 Days)||3
378750|NCT01072149|906567|P3|COMPLETED|Treatment Period 1 (28 Days)||2
378751|NCT01072149|906568|P2|COMPLETED|Treatment Period 1 (28 Days)||3
378752|NCT01072149|906569|P1|COMPLETED|Treatment Period 1 (28 Days)||3
378753|NCT01072149|906552|P18|STARTED|Treatment Period 1 (28 Days)||3
378754|NCT01072149|906553|P17|STARTED|Treatment Period 1 (28 Days)||3
378755|NCT01072149|906554|P16|STARTED|Treatment Period 1 (28 Days)||3
378756|NCT01072149|906555|P15|STARTED|Treatment Period 1 (28 Days)||3
378757|NCT01072149|906556|P14|STARTED|Treatment Period 1 (28 Days)||3
378758|NCT01072149|906557|P13|STARTED|Treatment Period 1 (28 Days)||3
378759|NCT01072149|906558|P12|STARTED|Treatment Period 1 (28 Days)||3
378760|NCT01072149|906559|P11|STARTED|Treatment Period 1 (28 Days)||3
378761|NCT01072149|906560|P10|STARTED|Treatment Period 1 (28 Days)||3
378762|NCT01072149|906561|P9|STARTED|Treatment Period 1 (28 Days)||3
378763|NCT01072149|906562|P8|STARTED|Treatment Period 1 (28 Days)||3
378764|NCT01072149|906563|P7|STARTED|Treatment Period 1 (28 Days)||3
378765|NCT01072149|906564|P6|STARTED|Treatment Period 1 (28 Days)||3
378766|NCT01072149|906565|P5|STARTED|Treatment Period 1 (28 Days)||3
378767|NCT01072149|906566|P4|STARTED|Treatment Period 1 (28 Days)||3
378768|NCT01072149|906567|P3|STARTED|Treatment Period 1 (28 Days)||3
378769|NCT01072149|906568|P2|STARTED|Treatment Period 1 (28 Days)||3
378770|NCT01072149|906569|P1|STARTED|Treatment Period 1 (28 Days)||3
378771|NCT01072136|906589|P2|NOT COMPLETED|Overall Study||31
378772|NCT01072136|906590|P1|NOT COMPLETED|Overall Study||23
378773|NCT01072136|906589|P2|COMPLETED|Overall Study||12
378774|NCT01072136|906590|P1|COMPLETED|Overall Study||21
378775|NCT01072136|906589|P2|Met All Enrollment Criteria|Overall Study||25
378776|NCT01072136|906590|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
378777|NCT01072136|906589|P2|STARTED|Overall Study||43
378778|NCT01072136|906590|P1|STARTED|Overall Study||44
378779|NCT01072032|906614|P2|NOT COMPLETED|Overall Study||9
378780|NCT01072032|906615|P1|NOT COMPLETED|Overall Study||8
378781|NCT01072032|906614|P2|COMPLETED|Overall Study||5
378782|NCT01072032|906615|P1|COMPLETED|Overall Study||5
378783|NCT01072032|906614|P2|STARTED|Overall Study||14
378784|NCT01072032|906615|P1|STARTED|Overall Study||13
378785|NCT01072006|906629|P4|NOT COMPLETED|Overall Study||0
378786|NCT01072006|906630|P3|NOT COMPLETED|Overall Study||0
378787|NCT01072006|906631|P2|NOT COMPLETED|Overall Study||0
378788|NCT01072006|906632|P1|NOT COMPLETED|Overall Study||0
378789|NCT01072006|906629|P4|COMPLETED|Overall Study||11
378790|NCT01072006|906630|P3|COMPLETED|Overall Study||0
378791|NCT01072006|906631|P2|COMPLETED|Overall Study||5
378792|NCT01072006|906632|P1|COMPLETED|Overall Study||14
378793|NCT01072006|906629|P4|STARTED|Overall Study||11
378794|NCT01072006|906630|P3|STARTED|Overall Study||0
378795|NCT01072006|906631|P2|STARTED|Overall Study||5
378796|NCT01072006|906632|P1|STARTED|Overall Study||14
378797|NCT01071915|906649|P1|NOT COMPLETED|Overall Study||9
378798|NCT01071915|906649|P1|COMPLETED|Overall Study||148
378799|NCT01071915|906649|P1|Safety Analysis Set|Overall Study||156
378800|NCT01071915|906649|P1|Full Analysis Set (FAS)|Overall Study||155
378801|NCT01071915|906649|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
378802|NCT01071798|906659|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
378803|NCT01071798|906659|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
378804|NCT01071798|906659|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
378805|NCT01071798|906659|P1|STARTED|Subpopulation Who Received Two Cycles||820
378806|NCT01071798|906659|P1|NOT COMPLETED|Participants Who Received One Cycle||65
378807|NCT01071798|906659|P1|COMPLETED|Participants Who Received One Cycle||1588
378808|NCT01071798|906659|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
378809|NCT01071798|906659|P1|STARTED|Participants Who Received One Cycle||1653
378810|NCT01071538|906679|P1|NOT COMPLETED|Overall Study||2
378811|NCT01071538|906679|P1|COMPLETED|Overall Study||13
378812|NCT01071538|906679|P1|STARTED|Overall Study||15
378813|NCT01071395|906691|P2|NOT COMPLETED|Overall Study||2
378814|NCT01071395|906692|P1|NOT COMPLETED|Overall Study||5
378815|NCT01071395|906691|P2|COMPLETED|Overall Study||30
378816|NCT01071395|906692|P1|COMPLETED|Overall Study||31
378817|NCT01071395|906691|P2|STARTED|Overall Study||32
378818|NCT01071395|906692|P1|STARTED|Overall Study||36
378819|NCT01071278|906698|P1|NOT COMPLETED|Overall Study||713
378820|NCT01071278|906698|P1|COMPLETED|Overall Study||1677
378821|NCT01071278|906698|P1|STARTED|Overall Study||2390
378822|NCT01071252|906709|P5|NOT COMPLETED|Overall Study||11
378823|NCT01071252|906710|P4|NOT COMPLETED|Overall Study||7
378824|NCT01071252|906711|P3|NOT COMPLETED|Overall Study||4
378825|NCT01071252|906712|P2|NOT COMPLETED|Overall Study||10
378826|NCT01071252|906713|P1|NOT COMPLETED|Overall Study||15
378827|NCT01071252|906709|P5|COMPLETED|Overall Study||11
378828|NCT01071252|906710|P4|COMPLETED|Overall Study||20
378829|NCT01071252|906711|P3|COMPLETED|Overall Study||17
378830|NCT01071252|906712|P2|COMPLETED|Overall Study||16
378831|NCT01071252|906713|P1|COMPLETED|Overall Study||14
378832|NCT01071252|906709|P5|STARTED|Overall Study||22
378833|NCT01071252|906710|P4|STARTED|Overall Study||27
378834|NCT01071252|906711|P3|STARTED|Overall Study||21
378835|NCT01071252|906712|P2|STARTED|Overall Study||26
378836|NCT01071252|906713|P1|STARTED|Overall Study||29
378837|NCT01071200|906741|P2|NOT COMPLETED|Overall Study||3
378838|NCT01071200|906742|P1|NOT COMPLETED|Overall Study||7
378839|NCT01071200|906741|P2|COMPLETED|Overall Study||63
378840|NCT01071200|906742|P1|COMPLETED|Overall Study||60
378841|NCT01071200|906741|P2|STARTED|Overall Study||66
378842|NCT01071200|906742|P1|STARTED|Overall Study||67
378843|NCT01071096|906774|P2|NOT COMPLETED|Second Intervention (90 Days)||0
378844|NCT01071096|906775|P1|NOT COMPLETED|Second Intervention (90 Days)||0
378845|NCT01071096|906774|P2|COMPLETED|Second Intervention (90 Days)||10
378846|NCT01071096|906775|P1|COMPLETED|Second Intervention (90 Days)||9
378847|NCT01071096|906774|P2|STARTED|Second Intervention (90 Days)||10
378848|NCT01071096|906775|P1|STARTED|Second Intervention (90 Days)||9
378849|NCT01071096|906774|P2|NOT COMPLETED|Washout Period (30 Days)||0
378850|NCT01071096|906775|P1|NOT COMPLETED|Washout Period (30 Days)||0
378851|NCT01071096|906774|P2|COMPLETED|Washout Period (30 Days)||10
378852|NCT01071096|906775|P1|COMPLETED|Washout Period (30 Days)||9
378853|NCT01071096|906774|P2|STARTED|Washout Period (30 Days)||10
378854|NCT01071096|906775|P1|STARTED|Washout Period (30 Days)||9
378855|NCT01071096|906774|P2|NOT COMPLETED|First Intervention (90 Days)||0
378856|NCT01071096|906775|P1|NOT COMPLETED|First Intervention (90 Days)||1
378857|NCT01071096|906774|P2|COMPLETED|First Intervention (90 Days)||10
378858|NCT01071096|906775|P1|COMPLETED|First Intervention (90 Days)||9
378859|NCT01071096|906774|P2|STARTED|First Intervention (90 Days)||10
378860|NCT01071096|906775|P1|STARTED|First Intervention (90 Days)||10
378861|NCT01071083|906799|P5|NOT COMPLETED|Overall Study||8
378862|NCT01071083|906800|P4|NOT COMPLETED|Overall Study||2
378863|NCT01071083|906801|P3|NOT COMPLETED|Overall Study||5
378864|NCT01071083|906802|P2|NOT COMPLETED|Overall Study||2
378865|NCT01071083|906803|P1|NOT COMPLETED|Overall Study||7
378866|NCT01071083|906799|P5|COMPLETED|Overall Study||46
378867|NCT01071083|906800|P4|COMPLETED|Overall Study||15
378868|NCT01071083|906801|P3|COMPLETED|Overall Study||12
378869|NCT01071083|906802|P2|COMPLETED|Overall Study||43
378870|NCT01071083|906803|P1|COMPLETED|Overall Study||35
378871|NCT01071083|906799|P5|STARTED|Overall Study||54
378872|NCT01071083|906800|P4|STARTED|Overall Study||17
378873|NCT01071083|906801|P3|STARTED|Overall Study||17
378874|NCT01071083|906802|P2|STARTED|Overall Study||45
378875|NCT01071083|906803|P1|STARTED|Overall Study||42
378876|NCT01071070|906822|P2|NOT COMPLETED|Overall Study||3
378877|NCT01071070|906823|P1|NOT COMPLETED|Overall Study||4
378878|NCT01071070|906822|P2|COMPLETED|Overall Study||105
378879|NCT01071070|906823|P1|COMPLETED|Overall Study||104
378880|NCT01071070|906822|P2|STARTED|Overall Study||108
378881|NCT01071070|906823|P1|STARTED|Overall Study||108
378882|NCT01071044|906847|P2|NOT COMPLETED|Overall Study||0
378883|NCT01071044|906848|P1|NOT COMPLETED|Overall Study||2
378884|NCT01071044|906847|P2|COMPLETED|Overall Study||11
378885|NCT01071044|906848|P1|COMPLETED|Overall Study||13
378886|NCT01071044|906847|P2|STARTED|Overall Study||11
378887|NCT01071044|906848|P1|STARTED|Overall Study||15
378888|NCT01070979|906869|P3|NOT COMPLETED|Overall Study||13
378889|NCT01070979|906870|P2|NOT COMPLETED|Overall Study||12
378890|NCT01070979|906871|P1|NOT COMPLETED|Overall Study||11
378891|NCT01070979|906869|P3|COMPLETED|Overall Study||72
378892|NCT01070979|906870|P2|COMPLETED|Overall Study||73
378893|NCT01070979|906871|P1|COMPLETED|Overall Study||68
378894|NCT01070979|906869|P3|STARTED|Overall Study||85
378895|NCT01070979|906870|P2|STARTED|Overall Study||85
378896|NCT01070979|906871|P1|STARTED|Overall Study||79
378897|NCT01070966|906897|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
378898|NCT01070966|906897|P1|COMPLETED|Participants for Efficacy Evaluation||1929
378899|NCT01070966|906897|P1|STARTED|Participants for Efficacy Evaluation||2011
378900|NCT01070966|906897|P1|NOT COMPLETED|Participants for Safety Evaluation||78
378901|NCT01070966|906897|P1|COMPLETED|Participants for Safety Evaluation||2011
378902|NCT01070966|906897|P1|STARTED|Participants for Safety Evaluation||2089
378903|NCT01070953|906908|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
378904|NCT01070953|906908|P1|COMPLETED|Participants for Efficacy Evaluation||3309
378905|NCT01070953|906908|P1|STARTED|Participants for Efficacy Evaluation||3536
378906|NCT01070953|906908|P1|NOT COMPLETED|Participants for Safety Evaluation||931
378907|NCT01070953|906908|P1|COMPLETED|Participants for Safety Evaluation||3536
378908|NCT01070953|906908|P1|STARTED|Participants for Safety Evaluation||4467
378909|NCT01070888|906921|P2|NOT COMPLETED|Second Intervention (14 Days)||0
378910|NCT01070888|906922|P1|NOT COMPLETED|Second Intervention (14 Days)||0
378911|NCT01070888|906921|P2|COMPLETED|Second Intervention (14 Days)||2
378912|NCT01070888|906922|P1|COMPLETED|Second Intervention (14 Days)||1
378913|NCT01070888|906921|P2|STARTED|Second Intervention (14 Days)||2
378914|NCT01070888|906922|P1|STARTED|Second Intervention (14 Days)||1
378915|NCT01070888|906921|P2|NOT COMPLETED|Washout (14 Days)||0
378916|NCT01070888|906922|P1|NOT COMPLETED|Washout (14 Days)||1
378917|NCT01070888|906921|P2|COMPLETED|Washout (14 Days)||2
378918|NCT01070888|906922|P1|COMPLETED|Washout (14 Days)||1
378919|NCT01070888|906921|P2|STARTED|Washout (14 Days)||2
378920|NCT01070888|906922|P1|STARTED|Washout (14 Days)||2
378921|NCT01070888|906921|P2|NOT COMPLETED|First Intervention (14 Days)||2
378922|NCT01070888|906922|P1|NOT COMPLETED|First Intervention (14 Days)||0
378923|NCT01070888|906921|P2|COMPLETED|First Intervention (14 Days)||2
378924|NCT01070888|906922|P1|COMPLETED|First Intervention (14 Days)||2
378925|NCT01070888|906921|P2|STARTED|First Intervention (14 Days)||4
378926|NCT01070888|906922|P1|STARTED|First Intervention (14 Days)||2
378927|NCT01070810|906930|P2|NOT COMPLETED|Overall Study||0
378928|NCT01070810|906931|P1|NOT COMPLETED|Overall Study||0
378929|NCT01070810|906930|P2|COMPLETED|Overall Study||43
378930|NCT01070810|906931|P1|COMPLETED|Overall Study||45
378931|NCT01070810|906930|P2|STARTED|Overall Study||43
378932|NCT01070810|906931|P1|STARTED|Overall Study||45
378933|NCT01070784|906947|P2|NOT COMPLETED|Overall Study||18
378934|NCT01070784|906948|P1|NOT COMPLETED|Overall Study||20
378935|NCT01070784|906947|P2|COMPLETED|Overall Study||112
378936|NCT01070784|906948|P1|COMPLETED|Overall Study||110
378937|NCT01070784|906947|P2|STARTED|Overall Study||130
378938|NCT01070784|906948|P1|STARTED|Overall Study||130
378939|NCT01070771|907036|P1|NOT COMPLETED|Overall Study||3
378940|NCT01070771|907036|P1|COMPLETED|Overall Study|August 2012|200
378941|NCT01070771|907036|P1|STARTED|Overall Study|September 2008|203
378942|NCT01070693|907043|P2|NOT COMPLETED|Overall Study||39
378943|NCT01070693|907044|P1|NOT COMPLETED|Overall Study||28
378944|NCT01070693|907043|P2|COMPLETED|Overall Study||110
378945|NCT01070693|907044|P1|COMPLETED|Overall Study||122
378946|NCT01070693|907043|P2|STARTED|Overall Study||149
378947|NCT01070693|907044|P1|STARTED|Overall Study||150
378948|NCT01070550|907056|P6|NOT COMPLETED|Overall Study||7
378949|NCT01070550|907057|P5|NOT COMPLETED|Overall Study||1
378950|NCT01070550|907058|P4|NOT COMPLETED|Overall Study||77
378951|NCT01070550|907059|P3|NOT COMPLETED|Overall Study||216
378952|NCT01070550|907060|P2|NOT COMPLETED|Overall Study||62
378953|NCT01070550|907061|P1|NOT COMPLETED|Overall Study||1285
378954|NCT01070550|907056|P6|COMPLETED|Overall Study||35
378955|NCT01070550|907057|P5|COMPLETED|Overall Study||20
378956|NCT01070550|907058|P4|COMPLETED|Overall Study||124
378957|NCT01070550|907059|P3|COMPLETED|Overall Study||528
378958|NCT01070550|907060|P2|COMPLETED|Overall Study||254
378959|NCT01070550|907061|P1|COMPLETED|Overall Study||2071
378960|NCT01070550|907056|P6|STARTED|Overall Study||42
378961|NCT01070550|907057|P5|STARTED|Overall Study||21
378962|NCT01070550|907058|P4|STARTED|Overall Study||201
378963|NCT01070550|907059|P3|STARTED|Overall Study||744
378964|NCT01070550|907060|P2|STARTED|Overall Study||316
378965|NCT01070550|907061|P1|STARTED|Overall Study||3356
378966|NCT01070394|907201|P1|NOT COMPLETED|Overall Study||7
378967|NCT01070394|907201|P1|COMPLETED|Overall Study||33
378968|NCT01070394|907201|P1|STARTED|Overall Study||40
378969|NCT01070381|907212|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
378970|NCT01070381|907213|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
378971|NCT01070381|907212|P2|COMPLETED|Period 2, 1 Week of Wear||106
378972|NCT01070381|907213|P1|COMPLETED|Period 2, 1 Week of Wear||108
378973|NCT01070381|907212|P2|STARTED|Period 2, 1 Week of Wear||107
378974|NCT01070381|907213|P1|STARTED|Period 2, 1 Week of Wear||109
378975|NCT01070381|907212|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
378976|NCT01070381|907213|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
378977|NCT01070381|907212|P2|COMPLETED|Period 1, 1 Week of Wear||107
378978|NCT01070381|907213|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
378979|NCT01070381|907212|P2|STARTED|Period 1, 1 Week of Wear||107
378980|NCT01070381|907213|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
378981|NCT01070329|907221|P2|NOT COMPLETED|Overall Study||49
378982|NCT01070329|907222|P1|NOT COMPLETED|Overall Study||52
378983|NCT01070329|907221|P2|COMPLETED|Overall Study||217
378984|NCT01070329|907222|P1|COMPLETED|Overall Study||209
378985|NCT01070329|907221|P2|STARTED|Overall Study||266
378986|NCT01070329|907222|P1|STARTED|Overall Study||261
378987|NCT01070316|907254|P1|NOT COMPLETED|Extension Phase||4
378988|NCT01070316|907254|P1|COMPLETED|Extension Phase||14
378989|NCT01070316|907254|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
378990|NCT01070316|907254|P1|NOT COMPLETED|Main Phase||0
378991|NCT01070316|907254|P1|COMPLETED|Main Phase||20
378992|NCT01070316|907254|P1|STARTED|Main Phase||20
378993|NCT01070303|907261|P1|NOT COMPLETED|Overall Study||89
378994|NCT01070303|907261|P1|COMPLETED|Overall Study||88
378995|NCT01070303|907261|P1|STARTED|Overall Study||177
378996|NCT01070173|907320|P3|NOT COMPLETED|Overall Study||0
378997|NCT01070173|907321|P2|NOT COMPLETED|Overall Study||0
378998|NCT01070173|907322|P1|NOT COMPLETED|Overall Study||0
378999|NCT01070173|907320|P3|COMPLETED|Overall Study||11
379000|NCT01070173|907321|P2|COMPLETED|Overall Study||8
379001|NCT01070173|907322|P1|COMPLETED|Overall Study||33
379002|NCT01070173|907320|P3|STARTED|Overall Study||11
379003|NCT01070173|907321|P2|STARTED|Overall Study||8
379004|NCT01070173|907322|P1|STARTED|Overall Study||33
379005|NCT01070043|907335|P3|NOT COMPLETED|Double-Blind Treatment||2
379006|NCT01070043|907336|P2|NOT COMPLETED|Double-Blind Treatment||0
379007|NCT01070043|907337|P1|NOT COMPLETED|Double-Blind Treatment||0
379008|NCT01070043|907335|P3|COMPLETED|Double-Blind Treatment||19
379009|NCT01070043|907336|P2|COMPLETED|Double-Blind Treatment||21
379010|NCT01070043|907337|P1|COMPLETED|Double-Blind Treatment||0
379011|NCT01070043|907335|P3|STARTED|Double-Blind Treatment||21
379012|NCT01070043|907336|P2|STARTED|Double-Blind Treatment||21
379013|NCT01070043|907337|P1|STARTED|Double-Blind Treatment||0
379014|NCT01070043|907335|P3|NOT COMPLETED|Run-In Phase||0
379015|NCT01070043|907336|P2|NOT COMPLETED|Run-In Phase||0
379016|NCT01070043|907337|P1|NOT COMPLETED|Run-In Phase||18
379017|NCT01070043|907335|P3|COMPLETED|Run-In Phase||0
379018|NCT01070043|907336|P2|COMPLETED|Run-In Phase||0
379019|NCT01070043|907337|P1|COMPLETED|Run-In Phase||42
379020|NCT01070043|907335|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
379021|NCT01070043|907336|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
379022|NCT01070043|907337|P1|STARTED|Run-In Phase||60
379023|NCT01069939|907353|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
379024|NCT01069939|907354|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
379025|NCT01069939|907353|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
379026|NCT01069939|907354|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
379027|NCT01069939|907353|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
379028|NCT01069939|907354|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
379029|NCT01069939|907353|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
379030|NCT01069939|907354|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
379031|NCT01069939|907353|P2|COMPLETED|Randomised and Included in the Analyses||137
379032|NCT01069939|907354|P1|COMPLETED|Randomised and Included in the Analyses||164
379033|NCT01069939|907353|P2|STARTED|Randomised and Included in the Analyses||214
379034|NCT01069939|907354|P1|STARTED|Randomised and Included in the Analyses||213
379035|NCT01069900|907380|P2|NOT COMPLETED|Overall Study||4
379036|NCT01069900|907381|P1|NOT COMPLETED|Overall Study||18
379037|NCT01069900|907380|P2|COMPLETED|Overall Study||149
379038|NCT01069900|907381|P1|COMPLETED|Overall Study||287
379039|NCT01069900|907380|P2|Treated|Overall Study||150
379040|NCT01069900|907381|P1|Treated|Overall Study||301
379041|NCT01069900|907380|P2|STARTED|Overall Study||153
379042|NCT01069900|907381|P1|STARTED|Overall Study||305
379043|NCT01069861|907425|P1|NOT COMPLETED|Overall Study||3
379044|NCT01069861|907425|P1|COMPLETED|Overall Study||1
379045|NCT01069861|907425|P1|STARTED|Overall Study||4
379046|NCT01069627|907438|P1|NOT COMPLETED|Overall Study||20
379047|NCT01069627|907438|P1|COMPLETED|Overall Study||0
379048|NCT01069627|907438|P1|STARTED|Overall Study||20
379049|NCT01069562|907461|P2|NOT COMPLETED|Overall Study||0
379050|NCT01069562|907462|P1|NOT COMPLETED|Overall Study||0
379051|NCT01069562|907461|P2|COMPLETED|Overall Study||20
379052|NCT01069562|907462|P1|COMPLETED|Overall Study||20
379053|NCT01069562|907461|P2|STARTED|Overall Study||20
379054|NCT01069562|907462|P1|STARTED|Overall Study||20
379055|NCT01069523|907488|P2|NOT COMPLETED|Overall Study||7
379056|NCT01069523|907489|P1|NOT COMPLETED|Overall Study||4
379057|NCT01069523|907488|P2|COMPLETED|Overall Study||9
379058|NCT01069523|907489|P1|COMPLETED|Overall Study||9
379059|NCT01069523|907488|P2|STARTED|Overall Study||16
379060|NCT01069523|907489|P1|STARTED|Overall Study||13
379061|NCT01069484|907499|P2|NOT COMPLETED|Overall Study||3
379062|NCT01069484|907500|P1|NOT COMPLETED|Overall Study||12
379063|NCT01069484|907499|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
379064|NCT01069484|907500|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
379065|NCT01069484|907499|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
379066|NCT01069484|907500|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
379067|NCT01069419|907508|P1|NOT COMPLETED|Overall Study||715
379068|NCT01069419|907508|P1|COMPLETED|Overall Study||402
379069|NCT01069419|907508|P1|Full Analysis Set|Overall Study||851
379070|NCT01069419|907508|P1|Safety Set|Overall Study||1111
379071|NCT01069419|907508|P1|STARTED|Overall Study||1117
379072|NCT01069341|907515|P1|NOT COMPLETED|Overall Study||1
379073|NCT01069341|907515|P1|COMPLETED|Overall Study||3
379074|NCT01069341|907515|P1|STARTED|Overall Study||4
379075|NCT01069289|907528|P2|NOT COMPLETED|Overall Study||56
379076|NCT01069289|907529|P1|NOT COMPLETED|Overall Study||42
379077|NCT01069289|907528|P2|COMPLETED|Overall Study||601
379078|NCT01069289|907529|P1|COMPLETED|Overall Study||594
379079|NCT01069289|907528|P2|STARTED|Overall Study||657
379080|NCT01069289|907529|P1|STARTED|Overall Study||636
379081|NCT01069172|907567|P2|NOT COMPLETED|Overall Study||0
379082|NCT01069172|907568|P1|NOT COMPLETED|Overall Study||1
379083|NCT01069172|907567|P2|COMPLETED|Overall Study|30 eyes|30
379084|NCT01069172|907568|P1|COMPLETED|Overall Study|29 eyes|29
379085|NCT01069172|907567|P2|STARTED|Overall Study|30 eyes|30
379086|NCT01069172|907568|P1|STARTED|Overall Study|30 eyes|30
379087|NCT01069120|907578|P1|NOT COMPLETED|Overall Study||27
379088|NCT01069120|907578|P1|COMPLETED|Overall Study||0
379089|NCT01069120|907578|P1|STARTED|Overall Study||27
379090|NCT01069003|907587|P3|NOT COMPLETED|Overall Study||475
379091|NCT01069003|907588|P2|NOT COMPLETED|Overall Study||54
379092|NCT01069003|907589|P1|NOT COMPLETED|Overall Study||46
379093|NCT01069003|907587|P3|COMPLETED|Overall Study||976
379094|NCT01069003|907588|P2|COMPLETED|Overall Study||358
379095|NCT01069003|907589|P1|COMPLETED|Overall Study||353
379096|NCT01069003|907587|P3|STARTED|Overall Study||1451
379097|NCT01069003|907588|P2|STARTED|Overall Study||412
379098|NCT01069003|907589|P1|STARTED|Overall Study||399
379099|NCT01068964|907605|P2|NOT COMPLETED|Overall Study||10
379100|NCT01068964|907606|P1|NOT COMPLETED|Overall Study||8
379101|NCT01068964|907605|P2|COMPLETED|Overall Study||104
379102|NCT01068964|907606|P1|COMPLETED|Overall Study||113
379103|NCT01068964|907605|P2|STARTED|Overall Study||114
379104|NCT01068964|907606|P1|STARTED|Overall Study||121
379105|NCT01068912|907615|P3|NOT COMPLETED|Overall Study||15
379106|NCT01068912|907616|P2|NOT COMPLETED|Overall Study||22
379107|NCT01068912|907617|P1|NOT COMPLETED|Overall Study||11
379108|NCT01068912|907615|P3|COMPLETED|Overall Study||186
379109|NCT01068912|907616|P2|COMPLETED|Overall Study||173
379110|NCT01068912|907617|P1|COMPLETED|Overall Study||123
379111|NCT01068912|907615|P3|STARTED|Overall Study||201
379112|NCT01068912|907616|P2|STARTED|Overall Study||195
379113|NCT01068912|907617|P1|STARTED|Overall Study||134
379114|NCT01068860|907635|P10|NOT COMPLETED|Overall Study||4
379115|NCT01068860|907636|P9|NOT COMPLETED|Overall Study||0
379116|NCT01068860|907637|P8|NOT COMPLETED|Overall Study||0
379117|NCT01068860|907638|P7|NOT COMPLETED|Overall Study||0
379118|NCT01068860|907639|P6|NOT COMPLETED|Overall Study||2
379119|NCT01068860|907640|P5|NOT COMPLETED|Overall Study||0
379120|NCT01068860|907641|P4|NOT COMPLETED|Overall Study||1
379121|NCT01068860|907642|P3|NOT COMPLETED|Overall Study||0
379122|NCT01068860|907643|P2|NOT COMPLETED|Overall Study||1
379123|NCT01068860|907644|P1|NOT COMPLETED|Overall Study||0
379124|NCT01068860|907635|P10|COMPLETED|Overall Study||23
379125|NCT01068860|907636|P9|COMPLETED|Overall Study||28
379126|NCT01068860|907637|P8|COMPLETED|Overall Study||15
379127|NCT01068860|907638|P7|COMPLETED|Overall Study||28
379128|NCT01068860|907639|P6|COMPLETED|Overall Study||14
379129|NCT01068860|907640|P5|COMPLETED|Overall Study||32
379130|NCT01068860|907641|P4|COMPLETED|Overall Study||16
379131|NCT01068860|907642|P3|COMPLETED|Overall Study||33
379132|NCT01068860|907643|P2|COMPLETED|Overall Study||16
379133|NCT01068860|907644|P1|COMPLETED|Overall Study||33
379134|NCT01068860|907635|P10|STARTED|Overall Study||27
379135|NCT01068860|907636|P9|STARTED|Overall Study||28
379136|NCT01068860|907637|P8|STARTED|Overall Study||15
379137|NCT01068860|907638|P7|STARTED|Overall Study||28
379138|NCT01068860|907639|P6|STARTED|Overall Study||16
379139|NCT01068860|907640|P5|STARTED|Overall Study||32
379140|NCT01068860|907641|P4|STARTED|Overall Study||17
379141|NCT01068860|907642|P3|STARTED|Overall Study||33
379142|NCT01068860|907643|P2|STARTED|Overall Study||17
379143|NCT01068860|907644|P1|STARTED|Overall Study||33
379144|NCT01068821|907818|P2|NOT COMPLETED|Overall Study||0
379145|NCT01068821|907819|P1|NOT COMPLETED|Overall Study||1
379146|NCT01068821|907818|P2|COMPLETED|Overall Study||29
379147|NCT01068821|907819|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
379148|NCT01068821|907818|P2|STARTED|Overall Study||29
379149|NCT01068821|907819|P1|STARTED|Overall Study||31
379150|NCT01068769|907827|P1|NOT COMPLETED|Overall Study||1
379151|NCT01068769|907827|P1|COMPLETED|Overall Study||33
379152|NCT01068769|907827|P1|STARTED|Overall Study||34
379153|NCT01068743|907832|P4|NOT COMPLETED|Period 4||0
379154|NCT01068743|907833|P3|NOT COMPLETED|Period 4||0
379155|NCT01068743|907834|P2|NOT COMPLETED|Period 4||0
379156|NCT01068743|907835|P1|NOT COMPLETED|Period 4||0
379157|NCT01068743|907832|P4|COMPLETED|Period 4||6
379158|NCT01068743|907833|P3|COMPLETED|Period 4||6
379159|NCT01068743|907834|P2|COMPLETED|Period 4||5
379160|NCT01068743|907835|P1|COMPLETED|Period 4||6
379161|NCT01068743|907832|P4|STARTED|Period 4||6
379162|NCT01068743|907833|P3|STARTED|Period 4||6
379163|NCT01068743|907834|P2|STARTED|Period 4||5
379164|NCT01068743|907835|P1|STARTED|Period 4||6
379165|NCT01068743|907832|P4|NOT COMPLETED|Period 3||0
379166|NCT01068743|907833|P3|NOT COMPLETED|Period 3||0
379167|NCT01068743|907834|P2|NOT COMPLETED|Period 3||1
379168|NCT01068743|907835|P1|NOT COMPLETED|Period 3||0
379169|NCT01068743|907832|P4|COMPLETED|Period 3||6
379170|NCT01068743|907833|P3|COMPLETED|Period 3||6
379171|NCT01068743|907834|P2|COMPLETED|Period 3||5
379172|NCT01068743|907835|P1|COMPLETED|Period 3||6
379173|NCT01068743|907832|P4|STARTED|Period 3||6
379174|NCT01068743|907833|P3|STARTED|Period 3||6
379175|NCT01068743|907834|P2|STARTED|Period 3||6
379176|NCT01068743|907835|P1|STARTED|Period 3||6
379177|NCT01068743|907832|P4|NOT COMPLETED|Period 2||0
379178|NCT01068743|907833|P3|NOT COMPLETED|Period 2||0
379179|NCT01068743|907834|P2|NOT COMPLETED|Period 2||0
379180|NCT01068743|907835|P1|NOT COMPLETED|Period 2||0
379181|NCT01068743|907832|P4|COMPLETED|Period 2||6
379182|NCT01068743|907833|P3|COMPLETED|Period 2||6
379183|NCT01068743|907834|P2|COMPLETED|Period 2||6
379184|NCT01068743|907835|P1|COMPLETED|Period 2||6
379185|NCT01068743|907832|P4|STARTED|Period 2||6
379186|NCT01068743|907833|P3|STARTED|Period 2||6
379187|NCT01068743|907834|P2|STARTED|Period 2||6
379188|NCT01068743|907835|P1|STARTED|Period 2||6
379189|NCT01068743|907832|P4|NOT COMPLETED|Period 1||0
379190|NCT01068743|907833|P3|NOT COMPLETED|Period 1||0
379191|NCT01068743|907834|P2|NOT COMPLETED|Period 1||0
379192|NCT01068743|907835|P1|NOT COMPLETED|Period 1||0
379193|NCT01068743|907832|P4|COMPLETED|Period 1||6
379194|NCT01068743|907833|P3|COMPLETED|Period 1||6
379195|NCT01068743|907834|P2|COMPLETED|Period 1||6
379196|NCT01068743|907835|P1|COMPLETED|Period 1||6
379197|NCT01068743|907832|P4|STARTED|Period 1||6
379198|NCT01068743|907833|P3|STARTED|Period 1||6
379199|NCT01068743|907834|P2|STARTED|Period 1||6
379200|NCT01068743|907835|P1|STARTED|Period 1||6
379201|NCT01068730|907909|P4|NOT COMPLETED|Period 4||0
379202|NCT01068730|907910|P3|NOT COMPLETED|Period 4||0
379203|NCT01068730|907911|P2|NOT COMPLETED|Period 4||1
379204|NCT01068730|907912|P1|NOT COMPLETED|Period 4||0
379205|NCT01068730|907909|P4|COMPLETED|Period 4||7
379206|NCT01068730|907910|P3|COMPLETED|Period 4||7
379207|NCT01068730|907911|P2|COMPLETED|Period 4||6
379208|NCT01068730|907912|P1|COMPLETED|Period 4||6
379209|NCT01068730|907909|P4|STARTED|Period 4||7
379210|NCT01068730|907910|P3|STARTED|Period 4||7
379211|NCT01068730|907911|P2|STARTED|Period 4||7
379212|NCT01068730|907912|P1|STARTED|Period 4||6
379213|NCT01068730|907909|P4|NOT COMPLETED|Period 3||0
379214|NCT01068730|907910|P3|NOT COMPLETED|Period 3||0
379215|NCT01068730|907911|P2|NOT COMPLETED|Period 3||0
379216|NCT01068730|907912|P1|NOT COMPLETED|Period 3||1
379217|NCT01068730|907909|P4|COMPLETED|Period 3||7
379218|NCT01068730|907910|P3|COMPLETED|Period 3||7
379219|NCT01068730|907911|P2|COMPLETED|Period 3||7
379220|NCT01068730|907912|P1|COMPLETED|Period 3||6
379221|NCT01068730|907909|P4|STARTED|Period 3||7
379222|NCT01068730|907910|P3|STARTED|Period 3||7
379223|NCT01068730|907911|P2|STARTED|Period 3||7
379224|NCT01068730|907912|P1|STARTED|Period 3||7
379225|NCT01068730|907909|P4|NOT COMPLETED|Period 2||0
379226|NCT01068730|907910|P3|NOT COMPLETED|Period 2||0
379227|NCT01068730|907911|P2|NOT COMPLETED|Period 2||0
379228|NCT01068730|907912|P1|NOT COMPLETED|Period 2||0
379229|NCT01068730|907909|P4|COMPLETED|Period 2||7
379230|NCT01068730|907910|P3|COMPLETED|Period 2||7
379231|NCT01068730|907911|P2|COMPLETED|Period 2||7
379232|NCT01068730|907912|P1|COMPLETED|Period 2||7
379233|NCT01068730|907909|P4|STARTED|Period 2||7
379234|NCT01068730|907910|P3|STARTED|Period 2||7
379235|NCT01068730|907911|P2|STARTED|Period 2||7
379236|NCT01068730|907912|P1|STARTED|Period 2||7
379237|NCT01068730|907909|P4|NOT COMPLETED|Period 1||0
379238|NCT01068730|907910|P3|NOT COMPLETED|Period 1||0
379239|NCT01068730|907911|P2|NOT COMPLETED|Period 1||0
379240|NCT01068730|907912|P1|NOT COMPLETED|Period 1||0
379241|NCT01068730|907909|P4|COMPLETED|Period 1||7
379242|NCT01068730|907910|P3|COMPLETED|Period 1||7
379243|NCT01068730|907911|P2|COMPLETED|Period 1||7
379244|NCT01068730|907912|P1|COMPLETED|Period 1||7
379245|NCT01068730|907909|P4|STARTED|Period 1||7
379246|NCT01068730|907910|P3|STARTED|Period 1||7
379247|NCT01068730|907911|P2|STARTED|Period 1||7
379248|NCT01068730|907912|P1|STARTED|Period 1||7
379249|NCT01068717|907966|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
379250|NCT01068717|907967|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
379251|NCT01068717|907968|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
379252|NCT01068717|907969|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
379253|NCT01068717|907966|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
379254|NCT01068717|907967|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
379255|NCT01068717|907968|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
379256|NCT01068717|907969|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
379257|NCT01068717|907966|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
379258|NCT01068717|907967|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
379259|NCT01068717|907968|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
379260|NCT01068717|907969|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
379261|NCT01068717|907966|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
379262|NCT01068717|907967|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
379263|NCT01068717|907968|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
379264|NCT01068717|907969|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
379265|NCT01068717|907966|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
379266|NCT01068717|907967|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
379267|NCT01068717|907968|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
379268|NCT01068717|907969|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
379269|NCT01068717|907966|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
379270|NCT01068717|907967|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
379271|NCT01068717|907968|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
379272|NCT01068717|907969|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
379273|NCT01068717|907966|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
379274|NCT01068717|907967|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
379275|NCT01068717|907968|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
379276|NCT01068717|907969|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
379277|NCT01068717|907966|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
379278|NCT01068717|907967|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
379279|NCT01068717|907968|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
379280|NCT01068717|907969|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
379281|NCT01068717|907966|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
379282|NCT01068717|907967|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
379283|NCT01068717|907968|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
379284|NCT01068717|907969|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
379285|NCT01068717|907966|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
379286|NCT01068717|907967|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
379287|NCT01068717|907968|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
379288|NCT01068717|907969|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
379289|NCT01068717|907966|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
379290|NCT01068717|907967|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
379291|NCT01068717|907968|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
379292|NCT01068717|907969|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
379293|NCT01068717|907966|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
379294|NCT01068717|907967|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
379295|NCT01068717|907968|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
379296|NCT01068717|907969|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
379297|NCT01068678|908025|P2|NOT COMPLETED|Overall Study||24
379298|NCT01068678|908026|P1|NOT COMPLETED|Overall Study||38
379299|NCT01068678|908025|P2|COMPLETED|Overall Study||206
379300|NCT01068678|908026|P1|COMPLETED|Overall Study||192
379301|NCT01068678|908025|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
379302|NCT01068678|908026|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
379303|NCT01068678|908025|P2|STARTED|Overall Study||230
379304|NCT01068678|908026|P1|STARTED|Overall Study||230
379305|NCT01068665|908036|P2|NOT COMPLETED|Overall Study||29
379306|NCT01068665|908037|P1|NOT COMPLETED|Overall Study||30
379307|NCT01068665|908036|P2|COMPLETED|Overall Study||201
379308|NCT01068665|908037|P1|COMPLETED|Overall Study||200
379309|NCT01068665|908036|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
379310|NCT01068665|908037|P1|Exposed|Overall Study||228
379311|NCT01068665|908036|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
379312|NCT01068665|908037|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
379313|NCT01068665|908036|P2|STARTED|Overall Study||230
379314|NCT01068665|908037|P1|STARTED|Overall Study||230
379315|NCT01068652|908047|P2|NOT COMPLETED|Overall Study||15
379316|NCT01068652|908048|P1|NOT COMPLETED|Overall Study||18
379317|NCT01068652|908047|P2|COMPLETED|Overall Study||188
379318|NCT01068652|908048|P1|COMPLETED|Overall Study||182
379319|NCT01068652|908047|P2|STARTED|Overall Study||203
379320|NCT01068652|908048|P1|STARTED|Overall Study||200
379321|NCT01068626|908088|P2|NOT COMPLETED|Overall Study||2
379322|NCT01068626|908089|P1|NOT COMPLETED|Overall Study||3
379323|NCT01068626|908088|P2|COMPLETED|Overall Study||27
379324|NCT01068626|908089|P1|COMPLETED|Overall Study||27
379325|NCT01068626|908088|P2|STARTED|Overall Study||29
379326|NCT01068626|908089|P1|STARTED|Overall Study||30
379327|NCT01068600|908107|P2|NOT COMPLETED|Overall Study||17
379328|NCT01068600|908108|P1|NOT COMPLETED|Overall Study||11
379329|NCT01068600|908107|P2|COMPLETED|Overall Study||142
379330|NCT01068600|908108|P1|COMPLETED|Overall Study||148
379331|NCT01068600|908107|P2|STARTED|Overall Study||159
379332|NCT01068600|908108|P1|STARTED|Overall Study||159
379333|NCT01068548|908118|P2|NOT COMPLETED|Overall Study||0
379334|NCT01068548|908119|P1|NOT COMPLETED|Overall Study||0
379335|NCT01068548|908118|P2|COMPLETED|Overall Study||63
379336|NCT01068548|908119|P1|COMPLETED|Overall Study||66
379337|NCT01068548|908118|P2|STARTED|Overall Study||63
379338|NCT01068548|908119|P1|STARTED|Overall Study||66
379339|NCT01068509|908128|P3|NOT COMPLETED|Overall Study||21
379340|NCT01068509|908129|P2|NOT COMPLETED|Overall Study||22
379341|NCT01068509|908130|P1|NOT COMPLETED|Overall Study||6
379342|NCT01068509|908128|P3|COMPLETED|Overall Study||6
379343|NCT01068509|908129|P2|COMPLETED|Overall Study||7
379344|NCT01068509|908130|P1|COMPLETED|Overall Study||1
379345|NCT01068509|908128|P3|STARTED|Overall Study||27
379346|NCT01068509|908129|P2|STARTED|Overall Study||29
379347|NCT01068509|908130|P1|STARTED|Overall Study||7
379348|NCT01068418|908143|P1|NOT COMPLETED|Overall Study||12
379349|NCT01068418|908143|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
379350|NCT01068418|908143|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
379351|NCT01068418|908143|P1|STARTED|Overall Study|26 participants found to be eligible|26
379352|NCT01068262|908152|P4|NOT COMPLETED|Overall Study||0
379353|NCT01068262|908153|P3|NOT COMPLETED|Overall Study||1
379354|NCT01068262|908154|P2|NOT COMPLETED|Overall Study||1
379355|NCT01068262|908155|P1|NOT COMPLETED|Overall Study||3
379356|NCT01068262|908152|P4|COMPLETED|Overall Study||2
379357|NCT01068262|908153|P3|COMPLETED|Overall Study||9
379358|NCT01068262|908154|P2|COMPLETED|Overall Study||8
379359|NCT01068262|908155|P1|COMPLETED|Overall Study||20
379360|NCT01068262|908152|P4|STARTED|Overall Study||2
379361|NCT01068262|908153|P3|STARTED|Overall Study||10
379362|NCT01068262|908154|P2|STARTED|Overall Study||9
379363|NCT01068262|908155|P1|STARTED|Overall Study||23
379364|NCT01068158|908185|P2|NOT COMPLETED|Overall Study||4
379365|NCT01068158|908186|P1|NOT COMPLETED|Overall Study||8
379366|NCT01068158|908185|P2|COMPLETED|Overall Study||198
379367|NCT01068158|908186|P1|COMPLETED|Overall Study||161
379368|NCT01068158|908185|P2|STARTED|Overall Study||202
379369|NCT01068158|908186|P1|STARTED|Overall Study||169
379370|NCT01067976|908198|P1|NOT COMPLETED|Overall Study||22
379371|NCT01067976|908198|P1|COMPLETED|Overall Study|study course completed|424
379372|NCT01067976|908198|P1|Fulfilled Requirements of FAS Population|Overall Study||390
379373|NCT01067976|908198|P1|Received Treatment|Overall Study|treatment started|426
379374|NCT01067976|908198|P1|STARTED|Overall Study|screened and enrolled|446
379375|NCT01067846|908259|P2|NOT COMPLETED|Overall Study||19
379376|NCT01067846|908260|P1|NOT COMPLETED|Overall Study||19
379377|NCT01067846|908259|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
379378|NCT01067846|908260|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
379379|NCT01067846|908259|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
379380|NCT01067846|908260|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
379381|NCT01067846|908259|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
379382|NCT01067846|908260|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
379383|NCT01067781|908272|P4|NOT COMPLETED|Up to Day 720||101
379384|NCT01067781|908273|P3|NOT COMPLETED|Up to Day 720||97
379385|NCT01067781|908274|P2|NOT COMPLETED|Up to Day 720||195
379386|NCT01067781|908275|P1|NOT COMPLETED|Up to Day 720||200
379387|NCT01067781|908272|P4|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
379388|NCT01067781|908273|P3|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
379389|NCT01067781|908274|P2|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
379390|NCT01067781|908275|P1|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
379391|NCT01067781|908272|P4|STARTED|Up to Day 720||101
379392|NCT01067781|908273|P3|STARTED|Up to Day 720||97
379393|NCT01067781|908274|P2|STARTED|Up to Day 720||199
379394|NCT01067781|908275|P1|STARTED|Up to Day 720||203
379395|NCT01067781|908272|P4|NOT COMPLETED|Up to Day 180||12
379396|NCT01067781|908273|P3|NOT COMPLETED|Up to Day 180||8
379397|NCT01067781|908274|P2|NOT COMPLETED|Up to Day 180||31
379398|NCT01067781|908275|P1|NOT COMPLETED|Up to Day 180||30
379399|NCT01067781|908272|P4|COMPLETED|Up to Day 180||89
379400|NCT01067781|908273|P3|COMPLETED|Up to Day 180||89
379401|NCT01067781|908274|P2|COMPLETED|Up to Day 180||168
379402|NCT01067781|908275|P1|COMPLETED|Up to Day 180||173
379403|NCT01067781|908272|P4|STARTED|Up to Day 180||101
379404|NCT01067781|908273|P3|STARTED|Up to Day 180||97
379405|NCT01067781|908274|P2|STARTED|Up to Day 180||199
379406|NCT01067781|908275|P1|STARTED|Up to Day 180||203
379407|NCT01067768|908285|P2|NOT COMPLETED|Overall Study||0
379408|NCT01067768|908286|P1|NOT COMPLETED|Overall Study||0
379409|NCT01067768|908285|P2|COMPLETED|Overall Study||605
379410|NCT01067768|908286|P1|COMPLETED|Overall Study||604
379411|NCT01067768|908285|P2|STARTED|Overall Study||605
379412|NCT01067768|908286|P1|STARTED|Overall Study||604
379413|NCT01067716|908297|P3|NOT COMPLETED|Overall Study||0
379414|NCT01067716|908298|P2|NOT COMPLETED|Overall Study||0
379415|NCT01067716|908299|P1|NOT COMPLETED|Overall Study||0
379416|NCT01067716|908297|P3|COMPLETED|Overall Study|15 eyes|9
379417|NCT01067716|908298|P2|COMPLETED|Overall Study|25 eyes|13
379418|NCT01067716|908299|P1|COMPLETED|Overall Study|110 eyes|57
379419|NCT01067716|908297|P3|STARTED|Overall Study|15 eyes|9
379420|NCT01067716|908298|P2|STARTED|Overall Study|25 eyes|13
379421|NCT01067716|908299|P1|STARTED|Overall Study|110 eyes|57
379422|NCT01067456|908318|P2|NOT COMPLETED|Overall Study||0
379423|NCT01067456|908319|P1|NOT COMPLETED|Overall Study||0
379424|NCT01067456|908318|P2|COMPLETED|Overall Study||29
379425|NCT01067456|908319|P1|COMPLETED|Overall Study||30
379426|NCT01067456|908318|P2|STARTED|Overall Study||29
379427|NCT01067456|908319|P1|STARTED|Overall Study||30
379428|NCT01067352|908328|P3|NOT COMPLETED|Overall Study||1
379429|NCT01067352|908329|P2|NOT COMPLETED|Overall Study||3
379430|NCT01067352|908330|P1|NOT COMPLETED|Overall Study||1
379431|NCT01067352|908328|P3|COMPLETED|Overall Study||9
379432|NCT01067352|908329|P2|COMPLETED|Overall Study||3
379433|NCT01067352|908330|P1|COMPLETED|Overall Study||8
379434|NCT01067352|908328|P3|STARTED|Overall Study||10
379435|NCT01067352|908329|P2|STARTED|Overall Study||6
379436|NCT01067352|908330|P1|STARTED|Overall Study||9
379437|NCT01067339|908346|P2|NOT COMPLETED|Overall Study||5
379438|NCT01067339|908347|P1|NOT COMPLETED|Overall Study||6
379439|NCT01067339|908346|P2|COMPLETED|Overall Study||29
379440|NCT01067339|908347|P1|COMPLETED|Overall Study||25
379441|NCT01067339|908346|P2|STARTED|Overall Study||34
379442|NCT01067339|908347|P1|STARTED|Overall Study||31
379443|NCT01067326|908357|P2|NOT COMPLETED|Overall Study||3
379444|NCT01067326|908358|P1|NOT COMPLETED|Overall Study||2
379445|NCT01067326|908357|P2|COMPLETED|Overall Study||5
379446|NCT01067326|908358|P1|COMPLETED|Overall Study||12
379447|NCT01067326|908357|P2|STARTED|Overall Study||8
379448|NCT01067326|908358|P1|STARTED|Overall Study||14
379449|NCT01067105|908370|P1|NOT COMPLETED|Overall Study||141
379450|NCT01067105|908370|P1|COMPLETED|Overall Study||683
379451|NCT01067105|908370|P1|STARTED|Overall Study||824
379452|NCT01066923|908391|P4|NOT COMPLETED|Overall Study||8
379453|NCT01066923|908392|P3|NOT COMPLETED|Overall Study||8
379454|NCT01066923|908393|P2|NOT COMPLETED|Overall Study||3
379455|NCT01066923|908394|P1|NOT COMPLETED|Overall Study||3
379456|NCT01066923|908391|P4|COMPLETED|Overall Study||23
379457|NCT01066923|908392|P3|COMPLETED|Overall Study||25
379458|NCT01066923|908393|P2|COMPLETED|Overall Study||29
379459|NCT01066923|908394|P1|COMPLETED|Overall Study||25
379460|NCT01066923|908391|P4|Retinal Imaging|Overall Study||0
379461|NCT01066923|908392|P3|Retinal Imaging|Overall Study||0
379462|NCT01066923|908393|P2|Retinal Imaging|Overall Study||0
379463|NCT01066923|908394|P1|Retinal Imaging|Overall Study||0
379464|NCT01066923|908391|P4|Activation of Coagulation|Overall Study||0
379465|NCT01066923|908392|P3|Activation of Coagulation|Overall Study||0
379466|NCT01066923|908393|P2|Activation of Coagulation|Overall Study||0
379467|NCT01066923|908394|P1|Activation of Coagulation|Overall Study||0
379468|NCT01066923|908391|P4|Vascular Function|Overall Study||13
379469|NCT01066923|908392|P3|Vascular Function|Overall Study||12
379470|NCT01066923|908393|P2|Vascular Function|Overall Study||14
379471|NCT01066923|908394|P1|Vascular Function|Overall Study||13
379472|NCT01066923|908391|P4|Platelet Closure Time|Overall Study||23
379473|NCT01066923|908392|P3|Platelet Closure Time|Overall Study||25
379474|NCT01066923|908393|P2|Platelet Closure Time|Overall Study||29
379475|NCT01066923|908394|P1|Platelet Closure Time|Overall Study||25
379476|NCT01066923|908391|P4|STARTED|Overall Study||31
379477|NCT01066923|908392|P3|STARTED|Overall Study||33
379478|NCT01066923|908393|P2|STARTED|Overall Study||32
379479|NCT01066923|908394|P1|STARTED|Overall Study||28
379480|NCT01066897|908410|P2|NOT COMPLETED|Overall Study||0
379481|NCT01066897|908411|P1|NOT COMPLETED|Overall Study||2
379482|NCT01066897|908410|P2|COMPLETED|Overall Study||9
379483|NCT01066897|908411|P1|COMPLETED|Overall Study||5
379484|NCT01066897|908410|P2|STARTED|Overall Study||9
379485|NCT01066897|908411|P1|STARTED|Overall Study||7
379486|NCT01066871|908425|P4|NOT COMPLETED|Overall Study||5
379487|NCT01066871|908426|P3|NOT COMPLETED|Overall Study||6
379488|NCT01066871|908427|P2|NOT COMPLETED|Overall Study||5
379489|NCT01066871|908428|P1|NOT COMPLETED|Overall Study||4
379490|NCT01066871|908425|P4|COMPLETED|Overall Study||13
379491|NCT01066871|908426|P3|COMPLETED|Overall Study||12
379492|NCT01066871|908427|P2|COMPLETED|Overall Study||13
379493|NCT01066871|908428|P1|COMPLETED|Overall Study||16
379494|NCT01066871|908425|P4|STARTED|Overall Study||18
379495|NCT01066871|908426|P3|STARTED|Overall Study||18
379496|NCT01066871|908427|P2|STARTED|Overall Study||18
379497|NCT01066871|908428|P1|STARTED|Overall Study||20
379498|NCT01066819|908492|P6|NOT COMPLETED|Overall Study||6
379499|NCT01066819|908493|P5|NOT COMPLETED|Overall Study||4
379500|NCT01066819|908494|P4|NOT COMPLETED|Overall Study||17
379501|NCT01066819|908495|P3|NOT COMPLETED|Overall Study||146
379502|NCT01066819|908496|P2|NOT COMPLETED|Overall Study||171
379503|NCT01066819|908497|P1|NOT COMPLETED|Overall Study||689
379504|NCT01066819|908492|P6|COMPLETED|Overall Study||7
379505|NCT01066819|908493|P5|COMPLETED|Overall Study||3
379506|NCT01066819|908494|P4|COMPLETED|Overall Study||8
379507|NCT01066819|908495|P3|COMPLETED|Overall Study||111
379508|NCT01066819|908496|P2|COMPLETED|Overall Study||177
379509|NCT01066819|908497|P1|COMPLETED|Overall Study||317
379510|NCT01066819|908492|P6|STARTED|Overall Study||13
379511|NCT01066819|908493|P5|STARTED|Overall Study||7
379512|NCT01066819|908494|P4|STARTED|Overall Study||25
379513|NCT01066819|908495|P3|STARTED|Overall Study||257
379514|NCT01066819|908496|P2|STARTED|Overall Study||348
379515|NCT01066819|908497|P1|STARTED|Overall Study||1006
379516|NCT01066793|908638|P6|NOT COMPLETED|Overall Study||1
379517|NCT01066793|908639|P5|NOT COMPLETED|Overall Study||0
379518|NCT01066793|908640|P4|NOT COMPLETED|Overall Study||49
379519|NCT01066793|908641|P3|NOT COMPLETED|Overall Study||115
379520|NCT01066793|908642|P2|NOT COMPLETED|Overall Study||77
379521|NCT01066793|908643|P1|NOT COMPLETED|Overall Study||374
379522|NCT01066793|908638|P6|COMPLETED|Overall Study||4
379523|NCT01066793|908639|P5|COMPLETED|Overall Study||11
379524|NCT01066793|908640|P4|COMPLETED|Overall Study||94
379525|NCT01066793|908641|P3|COMPLETED|Overall Study||369
379526|NCT01066793|908642|P2|COMPLETED|Overall Study||495
379527|NCT01066793|908643|P1|COMPLETED|Overall Study||754
379528|NCT01066793|908638|P6|STARTED|Overall Study||5
379529|NCT01066793|908639|P5|STARTED|Overall Study||11
379530|NCT01066793|908640|P4|STARTED|Overall Study||143
379531|NCT01066793|908641|P3|STARTED|Overall Study||484
379532|NCT01066793|908642|P2|STARTED|Overall Study||572
379533|NCT01066793|908643|P1|STARTED|Overall Study||1128
379534|NCT01066780|908783|P2|NOT COMPLETED|Overall Study||1
379535|NCT01066780|908784|P1|NOT COMPLETED|Overall Study||1
379536|NCT01066780|908783|P2|COMPLETED|Overall Study||23
379537|NCT01066780|908784|P1|COMPLETED|Overall Study||23
379538|NCT01066780|908783|P2|STARTED|Overall Study||24
379539|NCT01066780|908784|P1|STARTED|Overall Study||24
379540|NCT01066624|908791|P3|NOT COMPLETED|Overall Study||0
379541|NCT01066624|908792|P2|NOT COMPLETED|Overall Study||0
379542|NCT01066624|908793|P1|NOT COMPLETED|Overall Study||0
379543|NCT01066624|908791|P3|COMPLETED|Overall Study||39
379544|NCT01066624|908792|P2|COMPLETED|Overall Study||40
379545|NCT01066624|908793|P1|COMPLETED|Overall Study||38
379546|NCT01066624|908791|P3|STARTED|Overall Study||39
379547|NCT01066624|908792|P2|STARTED|Overall Study||40
379548|NCT01066624|908793|P1|STARTED|Overall Study||38
379549|NCT01066585|908803|P2|NOT COMPLETED|Overall Study||3
379550|NCT01066585|908804|P1|NOT COMPLETED|Overall Study||1
379551|NCT01066585|908803|P2|COMPLETED|Overall Study||196
379552|NCT01066585|908804|P1|COMPLETED|Overall Study||210
379553|NCT01066585|908803|P2|STARTED|Overall Study||199
379554|NCT01066585|908804|P1|STARTED|Overall Study||211
379555|NCT01066546|908816|P1|NOT COMPLETED|Overall Study||5
379556|NCT01066546|908816|P1|COMPLETED|Overall Study||0
379557|NCT01066546|908816|P1|STARTED|Overall Study||5
379558|NCT01066520|908830|P3|NOT COMPLETED|Overall Study||0
379559|NCT01066520|908831|P2|NOT COMPLETED|Overall Study||0
379560|NCT01066520|908832|P1|NOT COMPLETED|Overall Study||0
379561|NCT01066520|908830|P3|COMPLETED|Overall Study||137
379562|NCT01066520|908831|P2|COMPLETED|Overall Study||140
379563|NCT01066520|908832|P1|COMPLETED|Overall Study||143
379564|NCT01066520|908830|P3|STARTED|Overall Study||137
379565|NCT01066520|908831|P2|STARTED|Overall Study||140
379566|NCT01066520|908832|P1|STARTED|Overall Study||143
379567|NCT01066156|908846|P1|NOT COMPLETED|Overall Study||10
379568|NCT01066156|908846|P1|COMPLETED|Overall Study||24
379569|NCT01066156|908846|P1|STARTED|Overall Study||34
379570|NCT01066143|908850|P1|NOT COMPLETED|Overall Study||8
379571|NCT01066143|908850|P1|COMPLETED|Overall Study||0
379572|NCT01066143|908850|P1|STARTED|Overall Study||8
379573|NCT01066104|908856|P2|NOT COMPLETED|Overall Study||1
379574|NCT01066104|908857|P1|NOT COMPLETED|Overall Study||2
379575|NCT01066104|908856|P2|COMPLETED|Overall Study||12
379576|NCT01066104|908857|P1|COMPLETED|Overall Study||12
379577|NCT01066104|908856|P2|STARTED|Overall Study||13
379578|NCT01066104|908857|P1|STARTED|Overall Study||14
379579|NCT01066039|908865|P1|NOT COMPLETED|Overall Study||44
379580|NCT01066039|908865|P1|COMPLETED|Overall Study||158
379581|NCT01066039|908865|P1|Treated|Overall Study||200
379582|NCT01066039|908865|P1|STARTED|Overall Study||202
379583|NCT01066000|908878|P1|NOT COMPLETED|Overall Study||9
379584|NCT01066000|908878|P1|COMPLETED|Overall Study||24
379585|NCT01066000|908878|P1|STARTED|Overall Study||33
379586|NCT01065844|908889|P1|NOT COMPLETED|Overall Study||5
379587|NCT01065844|908889|P1|COMPLETED|Overall Study||10
379588|NCT01065844|908889|P1|STARTED|Overall Study||15
379589|NCT01065779|908893|P1|NOT COMPLETED|Overall Study||82
379590|NCT01065779|908893|P1|COMPLETED|Overall Study||798
379591|NCT01065779|908893|P1|STARTED|Overall Study||880
379592|NCT01065766|908904|P1|NOT COMPLETED|Overall Study||32
379593|NCT01065766|908904|P1|COMPLETED|Overall Study||4033
379594|NCT01065766|908904|P1|STARTED|Overall Study||4065
379595|NCT01065714|908916|P1|NOT COMPLETED|Overall Study||0
379596|NCT01065714|908916|P1|COMPLETED|Overall Study||20
379597|NCT01065714|908916|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
379598|NCT01065597|908923|P1|NOT COMPLETED|Overall Study||1
379599|NCT01065597|908923|P1|COMPLETED|Overall Study||12
379600|NCT01065597|908923|P1|STARTED|Overall Study||13
379601|NCT01065558|908930|P1|NOT COMPLETED|Overall Study||0
379602|NCT01065558|908930|P1|COMPLETED|Overall Study||5
379603|NCT01065558|908930|P1|STARTED|Overall Study||5
379604|NCT01065506|908937|P2|NOT COMPLETED|Overall Study||38
379605|NCT01065506|908938|P1|NOT COMPLETED|Overall Study||32
379606|NCT01065506|908937|P2|COMPLETED|Overall Study||34
379607|NCT01065506|908938|P1|COMPLETED|Overall Study||32
379608|NCT01065506|908937|P2|4-Month Follow-Up|Overall Study||34
379609|NCT01065506|908938|P1|4-Month Follow-Up|Overall Study||35
379610|NCT01065506|908937|P2|End of Treatment|Overall Study||37
379611|NCT01065506|908938|P1|End of Treatment|Overall Study||44
379612|NCT01065506|908937|P2|STARTED|Overall Study||72
379613|NCT01065506|908938|P1|STARTED|Overall Study||64
379614|NCT01065454|908948|P4|NOT COMPLETED|Follow up||44
379615|NCT01065454|908949|P3|NOT COMPLETED|Follow up||17
379616|NCT01065454|908950|P2|NOT COMPLETED|Follow up||24
379617|NCT01065454|908951|P1|NOT COMPLETED|Follow up||39
379618|NCT01065454|908948|P4|COMPLETED|Follow up||13
379619|NCT01065454|908949|P3|COMPLETED|Follow up||6
379620|NCT01065454|908950|P2|COMPLETED|Follow up||4
379621|NCT01065454|908951|P1|COMPLETED|Follow up||15
379622|NCT01065454|908948|P4|Entering Follow-up|Follow up||51
379623|NCT01065454|908949|P3|Entering Follow-up|Follow up||23
379624|NCT01065454|908950|P2|Entering Follow-up|Follow up||27
379625|NCT01065454|908951|P1|Entering Follow-up|Follow up||49
379626|NCT01065454|908948|P4|STARTED|Follow up||57
379627|NCT01065454|908949|P3|STARTED|Follow up||23
379628|NCT01065454|908950|P2|STARTED|Follow up||28
379629|NCT01065454|908951|P1|STARTED|Follow up||54
379630|NCT01065454|908948|P4|NOT COMPLETED|Treatment||12
379631|NCT01065454|908949|P3|NOT COMPLETED|Treatment||9
379632|NCT01065454|908950|P2|NOT COMPLETED|Treatment||5
379633|NCT01065454|908951|P1|NOT COMPLETED|Treatment||13
379634|NCT01065454|908948|P4|COMPLETED|Treatment||57
379635|NCT01065454|908949|P3|COMPLETED|Treatment||23
379636|NCT01065454|908950|P2|COMPLETED|Treatment||28
379637|NCT01065454|908951|P1|COMPLETED|Treatment||54
379638|NCT01065454|908948|P4|STARTED|Treatment||69
379639|NCT01065454|908949|P3|STARTED|Treatment||32
379640|NCT01065454|908950|P2|STARTED|Treatment||33
379641|NCT01065454|908951|P1|STARTED|Treatment||67
379642|NCT01065428|909063|P2|NOT COMPLETED|Overall Study||0
379643|NCT01065428|909064|P1|NOT COMPLETED|Overall Study||0
379644|NCT01065428|909063|P2|COMPLETED|Overall Study||35
379645|NCT01065428|909064|P1|COMPLETED|Overall Study||17
379646|NCT01065428|909063|P2|STARTED|Overall Study||35
379647|NCT01065428|909064|P1|STARTED|Overall Study||17
379648|NCT01065350|909074|P2|NOT COMPLETED|Overall Study||1
379649|NCT01065350|909075|P1|NOT COMPLETED|Overall Study||0
379650|NCT01065350|909074|P2|COMPLETED|Overall Study||41
379651|NCT01065350|909075|P1|COMPLETED|Overall Study||43
379652|NCT01065350|909074|P2|STARTED|Overall Study||42
379653|NCT01065350|909075|P1|STARTED|Overall Study||43
379654|NCT01065051|909109|P2|NOT COMPLETED|Overall Study||0
379655|NCT01065051|909110|P1|NOT COMPLETED|Overall Study||0
379656|NCT01065051|909109|P2|COMPLETED|Overall Study||0
379657|NCT01065051|909110|P1|COMPLETED|Overall Study||1
379658|NCT01065051|909109|P2|STARTED|Overall Study||0
379659|NCT01065051|909110|P1|STARTED|Overall Study||1
379660|NCT01064947|909136|P1|NOT COMPLETED|Overall Study||41
379661|NCT01064947|909136|P1|COMPLETED|Overall Study||29
379662|NCT01064947|909136|P1|STARTED|Overall Study||70
379663|NCT01064882|909147|P3|NOT COMPLETED|Overall Study||2
379664|NCT01064882|909148|P2|NOT COMPLETED|Overall Study||2
379665|NCT01064882|909149|P1|NOT COMPLETED|Overall Study||2
379666|NCT01064882|909147|P3|COMPLETED|Overall Study||32
379667|NCT01064882|909148|P2|COMPLETED|Overall Study||32
379668|NCT01064882|909149|P1|COMPLETED|Overall Study||34
379669|NCT01064882|909147|P3|STARTED|Overall Study||34
379670|NCT01064882|909148|P2|STARTED|Overall Study||34
379671|NCT01064882|909149|P1|STARTED|Overall Study||36
379672|NCT01064856|909177|P4|NOT COMPLETED|Open-label (OL) Period||20
379673|NCT01064856|909178|P3|NOT COMPLETED|Open-label (OL) Period||26
379674|NCT01064856|909179|P2|NOT COMPLETED|Open-label (OL) Period||0
379675|NCT01064856|909180|P1|NOT COMPLETED|Open-label (OL) Period||0
379676|NCT01064856|909177|P4|COMPLETED|Open-label (OL) Period||61
379677|NCT01064856|909178|P3|COMPLETED|Open-label (OL) Period||56
379678|NCT01064856|909179|P2|COMPLETED|Open-label (OL) Period||0
379679|NCT01064856|909180|P1|COMPLETED|Open-label (OL) Period||0
379680|NCT01064856|909177|P4|STARTED|Open-label (OL) Period||81
379681|NCT01064856|909178|P3|STARTED|Open-label (OL) Period||82
379682|NCT01064856|909179|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
379683|NCT01064856|909180|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
379684|NCT01064856|909177|P4|NOT COMPLETED|Double-blind (DB) Period||0
379685|NCT01064856|909178|P3|NOT COMPLETED|Double-blind (DB) Period||0
379686|NCT01064856|909179|P2|NOT COMPLETED|Double-blind (DB) Period||0
379687|NCT01064856|909180|P1|NOT COMPLETED|Double-blind (DB) Period||2
379688|NCT01064856|909177|P4|COMPLETED|Double-blind (DB) Period||0
379689|NCT01064856|909178|P3|COMPLETED|Double-blind (DB) Period||0
379690|NCT01064856|909179|P2|COMPLETED|Double-blind (DB) Period||81
379691|NCT01064856|909180|P1|COMPLETED|Double-blind (DB) Period||82
379692|NCT01064856|909177|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
379693|NCT01064856|909178|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
379694|NCT01064856|909179|P2|STARTED|Double-blind (DB) Period||81
379695|NCT01064856|909180|P1|STARTED|Double-blind (DB) Period||84
379696|NCT01064830|909213|P2|NOT COMPLETED|Overall Study||4
379697|NCT01064830|909214|P1|NOT COMPLETED|Overall Study||2
379698|NCT01064830|909213|P2|COMPLETED|Overall Study||7
379699|NCT01064830|909214|P1|COMPLETED|Overall Study||8
379700|NCT01064830|909213|P2|STARTED|Overall Study||11
379701|NCT01064830|909214|P1|STARTED|Overall Study||10
379702|NCT01064817|909224|P2|NOT COMPLETED|Study Completion||0
379703|NCT01064817|909225|P1|NOT COMPLETED|Study Completion||2
379704|NCT01064817|909224|P2|COMPLETED|Study Completion||62
379705|NCT01064817|909225|P1|COMPLETED|Study Completion||60
379706|NCT01064817|909224|P2|STARTED|Study Completion||62
379707|NCT01064817|909225|P1|STARTED|Study Completion||62
379708|NCT01064817|909224|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
379709|NCT01064817|909225|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
379710|NCT01064817|909224|P2|COMPLETED|All Study Treatment Days 1-9||62
379711|NCT01064817|909225|P1|COMPLETED|All Study Treatment Days 1-9||62
379712|NCT01064817|909224|P2|STARTED|All Study Treatment Days 1-9||62
379713|NCT01064817|909225|P1|STARTED|All Study Treatment Days 1-9||62
379714|NCT01064739|909237|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
379715|NCT01064739|909237|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
379716|NCT01064739|909237|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
379717|NCT01064739|909237|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
379718|NCT01064739|909237|P1|COMPLETED|Fixed Sodium Study Diet||14
379719|NCT01064739|909237|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
379720|NCT01064687|909297|P4|NOT COMPLETED|Overall Study||17
379721|NCT01064687|909298|P3|NOT COMPLETED|Overall Study||41
379722|NCT01064687|909299|P2|NOT COMPLETED|Overall Study||26
379723|NCT01064687|909300|P1|NOT COMPLETED|Overall Study||34
379724|NCT01064687|909297|P4|COMPLETED|Overall Study||124
379725|NCT01064687|909298|P3|COMPLETED|Overall Study||237
379726|NCT01064687|909299|P2|COMPLETED|Overall Study||254
379727|NCT01064687|909300|P1|COMPLETED|Overall Study||245
379728|NCT01064687|909297|P4|Completed 26 Weeks|Overall Study||124
379729|NCT01064687|909298|P3|Completed 26 Weeks|Overall Study||252
379730|NCT01064687|909299|P2|Completed 26 Weeks|Overall Study||263
379731|NCT01064687|909300|P1|Completed 26 Weeks|Overall Study||260
379732|NCT01064687|909297|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
379733|NCT01064687|909298|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
379734|NCT01064687|909299|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
379735|NCT01064687|909300|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
379736|NCT01064687|909297|P4|STARTED|Overall Study||141
379737|NCT01064687|909298|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
379738|NCT01064687|909299|P2|STARTED|Overall Study||280
379739|NCT01064687|909300|P1|STARTED|Overall Study||279
379740|NCT01064622|909480|P2|NOT COMPLETED|Crossover of Arm I||0
379741|NCT01064622|909481|P1|NOT COMPLETED|Crossover of Arm I||0
379742|NCT01064622|909480|P2|COMPLETED|Crossover of Arm I||0
379743|NCT01064622|909481|P1|COMPLETED|Crossover of Arm I||22
379744|NCT01064622|909480|P2|STARTED|Crossover of Arm I||0
379745|NCT01064622|909481|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
379746|NCT01064622|909480|P2|NOT COMPLETED|Randomized Phase II||3
379747|NCT01064622|909481|P1|NOT COMPLETED|Randomized Phase II||2
379748|NCT01064622|909480|P2|COMPLETED|Randomized Phase II||53
379749|NCT01064622|909481|P1|COMPLETED|Randomized Phase II||53
379750|NCT01064622|909480|P2|STARTED|Randomized Phase II||56
379751|NCT01064622|909481|P1|STARTED|Randomized Phase II||55
379752|NCT01064622|909480|P2|NOT COMPLETED|Lead-in Phase I||0
379753|NCT01064622|909481|P1|NOT COMPLETED|Lead-in Phase I||0
379754|NCT01064622|909480|P2|COMPLETED|Lead-in Phase I||7
379755|NCT01064622|909481|P1|COMPLETED|Lead-in Phase I||0
379756|NCT01064622|909480|P2|STARTED|Lead-in Phase I||7
379757|NCT01064622|909481|P1|STARTED|Lead-in Phase I||0
379758|NCT01064414|909505|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
379759|NCT01064414|909506|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
379760|NCT01064414|909507|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
379761|NCT01064414|909505|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
379762|NCT01064414|909506|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
379763|NCT01064414|909507|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
379764|NCT01064414|909505|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
379765|NCT01064414|909506|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
379766|NCT01064414|909507|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
379767|NCT01064414|909505|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
379768|NCT01064414|909506|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
379769|NCT01064414|909507|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
379770|NCT01064414|909505|P3|COMPLETED|Core Period: Baseline to Week 26||82
379771|NCT01064414|909506|P2|COMPLETED|Core Period: Baseline to Week 26||75
379772|NCT01064414|909507|P1|COMPLETED|Core Period: Baseline to Week 26||77
379773|NCT01064414|909505|P3|STARTED|Core Period: Baseline to Week 26||89
379774|NCT01064414|909506|P2|STARTED|Core Period: Baseline to Week 26||90
379775|NCT01064414|909507|P1|STARTED|Core Period: Baseline to Week 26||90
379776|NCT01064401|909526|P2|NOT COMPLETED|Overall Study||195
379777|NCT01064401|909527|P1|NOT COMPLETED|Overall Study||228
379778|NCT01064401|909526|P2|COMPLETED|Overall Study||724
379779|NCT01064401|909527|P1|COMPLETED|Overall Study||694
379780|NCT01064401|909526|P2|STARTED|Overall Study||919
379781|NCT01064401|909527|P1|STARTED|Overall Study||922
379782|NCT01064362|909543|P2|NOT COMPLETED|Overall Study||0
379783|NCT01064362|909544|P1|NOT COMPLETED|Overall Study||0
379784|NCT01064362|909543|P2|COMPLETED|Overall Study||11883
379785|NCT01064362|909544|P1|COMPLETED|Overall Study||1559
379786|NCT01064362|909543|P2|STARTED|Overall Study||11883
379787|NCT01064362|909544|P1|STARTED|Overall Study||1559
379788|NCT01064310|909554|P3|NOT COMPLETED|Open Label Pazopinib||84
379789|NCT01064310|909555|P2|NOT COMPLETED|Open Label Pazopinib||0
379790|NCT01064310|909556|P1|NOT COMPLETED|Open Label Pazopinib||0
379791|NCT01064310|909554|P3|COMPLETED|Open Label Pazopinib||0
379792|NCT01064310|909555|P2|COMPLETED|Open Label Pazopinib||0
379793|NCT01064310|909556|P1|COMPLETED|Open Label Pazopinib||0
379794|NCT01064310|909554|P3|STARTED|Open Label Pazopinib||84
379795|NCT01064310|909555|P2|STARTED|Open Label Pazopinib||0
379796|NCT01064310|909556|P1|STARTED|Open Label Pazopinib||0
379797|NCT01064310|909554|P3|NOT COMPLETED|Period 2||0
379798|NCT01064310|909555|P2|NOT COMPLETED|Period 2||6
379799|NCT01064310|909556|P1|NOT COMPLETED|Period 2||4
379800|NCT01064310|909554|P3|COMPLETED|Period 2||0
379801|NCT01064310|909555|P2|COMPLETED|Period 2||62
379802|NCT01064310|909556|P1|COMPLETED|Period 2||64
379803|NCT01064310|909554|P3|STARTED|Period 2||0
379804|NCT01064310|909555|P2|STARTED|Period 2||68
379805|NCT01064310|909556|P1|STARTED|Period 2||68
379806|NCT01064310|909554|P3|NOT COMPLETED|Period 1||0
379807|NCT01064310|909555|P2|NOT COMPLETED|Period 1||18
379808|NCT01064310|909556|P1|NOT COMPLETED|Period 1||14
379809|NCT01064310|909554|P3|COMPLETED|Period 1||0
379810|NCT01064310|909555|P2|COMPLETED|Period 1||68
379811|NCT01064310|909556|P1|COMPLETED|Period 1||68
379812|NCT01064310|909554|P3|STARTED|Period 1||0
379813|NCT01064310|909555|P2|STARTED|Period 1||86
379814|NCT01064310|909556|P1|STARTED|Period 1||82
379815|NCT01064297|909586|P3|NOT COMPLETED|Overall Study||133
379816|NCT01064297|909587|P2|NOT COMPLETED|Overall Study||48
379817|NCT01064297|909588|P1|NOT COMPLETED|Overall Study||791
379818|NCT01064297|909586|P3|COMPLETED|Overall Study||497
379819|NCT01064297|909587|P2|COMPLETED|Overall Study||171
379820|NCT01064297|909588|P1|COMPLETED|Overall Study||1776
379821|NCT01064297|909586|P3|STARTED|Overall Study||630
379822|NCT01064297|909587|P2|STARTED|Overall Study||219
379823|NCT01064297|909588|P1|STARTED|Overall Study||2567
379824|NCT01064284|909634|P2|NOT COMPLETED|Overall Study||17
379825|NCT01064284|909635|P1|NOT COMPLETED|Overall Study||18
379826|NCT01064284|909634|P2|COMPLETED|Overall Study||109
379827|NCT01064284|909635|P1|COMPLETED|Overall Study||107
379828|NCT01064284|909634|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
379829|NCT01064284|909635|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
379830|NCT01064167|909657|P2|NOT COMPLETED|Overall Study||15
379831|NCT01064167|909658|P1|NOT COMPLETED|Overall Study||14
379832|NCT01064167|909657|P2|COMPLETED|Overall Study||115
379833|NCT01064167|909658|P1|COMPLETED|Overall Study||116
379834|NCT01064167|909657|P2|STARTED|Overall Study||130
379835|NCT01064167|909658|P1|STARTED|Overall Study||130
379836|NCT01064076|909666|P1|NOT COMPLETED|Overall Study||18
379837|NCT01064076|909666|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
379927|NCT01063062|909879|P2|NOT COMPLETED|Overall Study||12
379838|NCT01064076|909666|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
379839|NCT01063907|909671|P2|NOT COMPLETED|Overall Study||0
379840|NCT01063907|909672|P1|NOT COMPLETED|Overall Study||0
379841|NCT01063907|909671|P2|COMPLETED|Overall Study||80
379842|NCT01063907|909672|P1|COMPLETED|Overall Study||15
379843|NCT01063907|909671|P2|STARTED|Overall Study||80
379844|NCT01063907|909672|P1|STARTED|Overall Study||15
379845|NCT01063881|909705|P3|NOT COMPLETED|Overall Study||1
379846|NCT01063881|909706|P2|NOT COMPLETED|Overall Study||11
379847|NCT01063881|909707|P1|NOT COMPLETED|Overall Study||55
379848|NCT01063881|909705|P3|COMPLETED|Overall Study||12
379849|NCT01063881|909706|P2|COMPLETED|Overall Study||114
379850|NCT01063881|909707|P1|COMPLETED|Overall Study||92
379851|NCT01063881|909705|P3|STARTED|Overall Study||13
379852|NCT01063881|909706|P2|STARTED|Overall Study||125
379853|NCT01063881|909707|P1|STARTED|Overall Study||147
379854|NCT01063868|909731|P2|NOT COMPLETED|Overall Study||12
379855|NCT01063868|909732|P1|NOT COMPLETED|Overall Study||35
379856|NCT01063868|909731|P2|COMPLETED|Overall Study||0
379857|NCT01063868|909732|P1|COMPLETED|Overall Study||0
379858|NCT01063868|909731|P2|STARTED|Overall Study||12
379859|NCT01063868|909732|P1|STARTED|Overall Study||35
379860|NCT01063855|909740|P2|NOT COMPLETED|Overall Study||29
379861|NCT01063855|909741|P1|NOT COMPLETED|Overall Study||37
379862|NCT01063855|909740|P2|COMPLETED|Overall Study||221
379863|NCT01063855|909741|P1|COMPLETED|Overall Study||208
379864|NCT01063855|909740|P2|STARTED|Overall Study||250
379865|NCT01063855|909741|P1|STARTED|Overall Study||245
379866|NCT01063764|909763|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
379867|NCT01063764|909763|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
379868|NCT01063764|909763|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
379869|NCT01063764|909763|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
379870|NCT01063764|909763|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
379871|NCT01063764|909763|P1|STARTED|1st Period (From Week 8 to Week 22)||73
379872|NCT01063712|909777|P1|NOT COMPLETED|Overall Study||0
379873|NCT01063712|909777|P1|COMPLETED|Overall Study||29
379874|NCT01063712|909777|P1|STARTED|Overall Study||29
379875|NCT01063595|909782|P2|NOT COMPLETED|Second Intervention||0
379876|NCT01063595|909783|P1|NOT COMPLETED|Second Intervention||0
379877|NCT01063595|909782|P2|COMPLETED|Second Intervention||24
379878|NCT01063595|909783|P1|COMPLETED|Second Intervention||29
379879|NCT01063595|909782|P2|STARTED|Second Intervention||24
379880|NCT01063595|909783|P1|STARTED|Second Intervention||29
379881|NCT01063595|909782|P2|NOT COMPLETED|First Intervention||5
379882|NCT01063595|909783|P1|NOT COMPLETED|First Intervention||2
379883|NCT01063595|909782|P2|COMPLETED|First Intervention||24
379884|NCT01063595|909783|P1|COMPLETED|First Intervention||29
379885|NCT01063595|909782|P2|STARTED|First Intervention||29
379886|NCT01063595|909783|P1|STARTED|First Intervention||31
379887|NCT01063595|909782|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
379888|NCT01063595|909783|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
379889|NCT01063595|909782|P2|COMPLETED|Enrolled in Study and Randomized||29
379890|NCT01063595|909783|P1|COMPLETED|Enrolled in Study and Randomized||31
379891|NCT01063595|909782|P2|Received Treatment|Enrolled in Study and Randomized||29
379892|NCT01063595|909783|P1|Received Treatment|Enrolled in Study and Randomized||31
379893|NCT01063595|909782|P2|STARTED|Enrolled in Study and Randomized||31
379894|NCT01063595|909783|P1|STARTED|Enrolled in Study and Randomized||32
379895|NCT01063517|909795|P2|NOT COMPLETED|Overall Study||60
379896|NCT01063517|909796|P1|NOT COMPLETED|Overall Study||58
379897|NCT01063517|909795|P2|COMPLETED|Overall Study||2
379898|NCT01063517|909796|P1|COMPLETED|Overall Study||4
379899|NCT01063517|909795|P2|Received Randomised Treatment|Overall Study||62
379900|NCT01063517|909796|P1|Received Randomised Treatment|Overall Study||61
379901|NCT01063517|909795|P2|STARTED|Overall Study||62
379902|NCT01063517|909796|P1|STARTED|Overall Study||62
379903|NCT01063348|909836|P2|NOT COMPLETED|Overall Study||10
379904|NCT01063348|909837|P1|NOT COMPLETED|Overall Study||3
379905|NCT01063348|909836|P2|COMPLETED|Overall Study||21
379906|NCT01063348|909837|P1|COMPLETED|Overall Study||32
379907|NCT01063348|909836|P2|STARTED|Overall Study||31
379908|NCT01063348|909837|P1|STARTED|Overall Study||35
379909|NCT01063153|909847|P2|NOT COMPLETED|Overall Study||12
379910|NCT01063153|909848|P1|NOT COMPLETED|Overall Study||2
379911|NCT01063153|909847|P2|COMPLETED|Overall Study||26
379912|NCT01063153|909848|P1|COMPLETED|Overall Study||31
379913|NCT01063153|909847|P2|STARTED|Overall Study||38
379914|NCT01063153|909848|P1|STARTED|Overall Study||33
379915|NCT01063075|909858|P4|NOT COMPLETED|Overall Study||1
379916|NCT01063075|909859|P3|NOT COMPLETED|Overall Study||5
379917|NCT01063075|909860|P2|NOT COMPLETED|Overall Study||2
379918|NCT01063075|909861|P1|NOT COMPLETED|Overall Study||1
379919|NCT01063075|909858|P4|COMPLETED|Overall Study||14
379920|NCT01063075|909859|P3|COMPLETED|Overall Study||9
379921|NCT01063075|909860|P2|COMPLETED|Overall Study||1
379922|NCT01063075|909861|P1|COMPLETED|Overall Study||1
379923|NCT01063075|909858|P4|STARTED|Overall Study||15
379924|NCT01063075|909859|P3|STARTED|Overall Study||14
379925|NCT01063075|909860|P2|STARTED|Overall Study||3
379926|NCT01063075|909861|P1|STARTED|Overall Study||2
379928|NCT01063062|909880|P1|NOT COMPLETED|Overall Study||8
379929|NCT01063062|909879|P2|COMPLETED|Overall Study||65
379930|NCT01063062|909880|P1|COMPLETED|Overall Study||22
379931|NCT01063062|909879|P2|Received Study Drug|Overall Study||76
379932|NCT01063062|909880|P1|Received Study Drug|Overall Study||29
379933|NCT01063062|909879|P2|STARTED|Overall Study||77
379934|NCT01063062|909880|P1|STARTED|Overall Study||30
379935|NCT01063049|909921|P3|NOT COMPLETED|Overall Study||0
379936|NCT01063049|909922|P2|NOT COMPLETED|Overall Study||0
379937|NCT01063049|909923|P1|NOT COMPLETED|Overall Study||0
379938|NCT01063049|909921|P3|COMPLETED|Overall Study||200
379939|NCT01063049|909922|P2|COMPLETED|Overall Study||200
379940|NCT01063049|909923|P1|COMPLETED|Overall Study||200
379941|NCT01063049|909921|P3|STARTED|Overall Study||200
379942|NCT01063049|909922|P2|STARTED|Overall Study||200
379943|NCT01063049|909923|P1|STARTED|Overall Study||200
379944|NCT01063036|909934|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
379945|NCT01063036|909934|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
379946|NCT01063036|909934|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
379947|NCT01063036|909934|P1|NOT COMPLETED|Participants Treated With Study Drug||6
379948|NCT01063036|909934|P1|COMPLETED|Participants Treated With Study Drug||86
379949|NCT01063036|909934|P1|STARTED|Participants Treated With Study Drug||92
379950|NCT01062841|909950|P2|NOT COMPLETED|Overall Study||53
379951|NCT01062841|909951|P1|NOT COMPLETED|Overall Study||49
379952|NCT01062841|909950|P2|COMPLETED|Overall Study||162
379953|NCT01062841|909951|P1|COMPLETED|Overall Study||154
379954|NCT01062841|909950|P2|STARTED|Overall Study||215
379955|NCT01062841|909951|P1|STARTED|Overall Study||203
379956|NCT01062763|909981|P2|NOT COMPLETED|Overall Study||4
379957|NCT01062763|909982|P1|NOT COMPLETED|Overall Study||3
379958|NCT01062763|909981|P2|COMPLETED|Overall Study||57
379959|NCT01062763|909982|P1|COMPLETED|Overall Study||55
379960|NCT01062763|909981|P2|STARTED|Overall Study||61
379961|NCT01062763|909982|P1|STARTED|Overall Study|119 randomized.|58
379962|NCT01062425|909994|P2|NOT COMPLETED|Overall Study||6
379963|NCT01062425|909995|P1|NOT COMPLETED|Overall Study||3
379964|NCT01062425|909994|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
379965|NCT01062425|909995|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
379966|NCT01062425|909994|P2|STARTED|Overall Study||103
379967|NCT01062425|909995|P1|STARTED|Overall Study||55
379968|NCT01062308|910009|P2|NOT COMPLETED|Overall Study||10
379969|NCT01062308|910010|P1|NOT COMPLETED|Overall Study||16
379970|NCT01062308|910009|P2|COMPLETED|Overall Study||72
379971|NCT01062308|910010|P1|COMPLETED|Overall Study||64
379972|NCT01062308|910009|P2|STARTED|Overall Study||82
379973|NCT01062308|910010|P1|STARTED|Overall Study||80
379974|NCT01062269|910018|P1|NOT COMPLETED|Overall Study||0
379975|NCT01062269|910018|P1|COMPLETED|Overall Study||42
379976|NCT01062269|910018|P1|STARTED|Overall Study||42
379977|NCT01062256|910032|P3|NOT COMPLETED|Overall Study||4
379978|NCT01062256|910033|P2|NOT COMPLETED|Overall Study||7
379979|NCT01062256|910034|P1|NOT COMPLETED|Overall Study||3
379980|NCT01062256|910032|P3|COMPLETED|Overall Study||103
379981|NCT01062256|910033|P2|COMPLETED|Overall Study||96
379982|NCT01062256|910034|P1|COMPLETED|Overall Study||52
379983|NCT01062256|910032|P3|STARTED|Overall Study||107
379984|NCT01062256|910033|P2|STARTED|Overall Study||103
379985|NCT01062256|910034|P1|STARTED|Overall Study||55
379986|NCT01062230|910057|P1|NOT COMPLETED|Overall Study||0
379987|NCT01062230|910057|P1|COMPLETED|Overall Study||6
379988|NCT01062230|910057|P1|STARTED|Overall Study||6
379989|NCT01062165|910061|P1|NOT COMPLETED|Overall Study||0
379990|NCT01062165|910061|P1|COMPLETED|Overall Study||18
379991|NCT01062165|910061|P1|STARTED|Overall Study||18
379992|NCT01062113|910068|P3|NOT COMPLETED|Overall Study||31
379993|NCT01062113|910069|P2|NOT COMPLETED|Overall Study||22
379994|NCT01062113|910070|P1|NOT COMPLETED|Overall Study||40
379995|NCT01062113|910068|P3|COMPLETED|Overall Study||27
379996|NCT01062113|910069|P2|COMPLETED|Overall Study||42
379997|NCT01062113|910070|P1|COMPLETED|Overall Study||93
379998|NCT01062113|910068|P3|STARTED|Overall Study||58
379999|NCT01062113|910069|P2|STARTED|Overall Study||64
380000|NCT01062113|910070|P1|STARTED|Overall Study||133
380001|NCT01062074|910083|P1|NOT COMPLETED|Overall Study||0
380002|NCT01062074|910083|P1|COMPLETED|Overall Study||3605
380003|NCT01062074|910083|P1|STARTED|Overall Study||3605
380004|NCT01062061|910088|P1|NOT COMPLETED|Overall Study||27
380005|NCT01062061|910088|P1|COMPLETED|Overall Study||727
380006|NCT01062061|910088|P1|STARTED|Overall Study||754
380007|NCT01061866|910102|P1|NOT COMPLETED|Overall Study||2
380008|NCT01061866|910102|P1|COMPLETED|Overall Study||5
380009|NCT01061866|910102|P1|STARTED|Overall Study||7
380010|NCT01061775|910106|P1|NOT COMPLETED|Overall Study||3
380011|NCT01061775|910106|P1|COMPLETED|Overall Study||16
380012|NCT01061775|910106|P1|STARTED|Overall Study||19
380013|NCT01061710|910113|P1|NOT COMPLETED|Overall Study||14
380014|NCT01061710|910113|P1|COMPLETED|Overall Study||6
380015|NCT01061710|910113|P1|STARTED|Overall Study||20
380016|NCT01061671|910123|P2|NOT COMPLETED|Overall Study||55
380017|NCT01061671|910124|P1|NOT COMPLETED|Overall Study||47
380018|NCT01061671|910123|P2|COMPLETED|Overall Study||397
380019|NCT01061671|910124|P1|COMPLETED|Overall Study||386
380020|NCT01061671|910123|P2|STARTED|Overall Study||452
380021|NCT01061671|910124|P1|STARTED|Overall Study||433
380022|NCT01061606|910136|P1|NOT COMPLETED|Overall Study||8
380023|NCT01061606|910136|P1|COMPLETED|Overall Study||0
380024|NCT01061606|910136|P1|STARTED|Overall Study||8
380025|NCT01061567|910145|P1|NOT COMPLETED|Overall Study||76
380026|NCT01061567|910145|P1|COMPLETED|Overall Study||1738
380027|NCT01061567|910145|P1|STARTED|Overall Study||1814
380028|NCT01061476|910154|P1|NOT COMPLETED|Overall Study||0
380029|NCT01061476|910154|P1|COMPLETED|Overall Study||12
380030|NCT01061476|910154|P1|STARTED|Overall Study||12
380031|NCT01061385|910160|P2|NOT COMPLETED|Overall Study||1
380032|NCT01061385|910161|P1|NOT COMPLETED|Overall Study||1
380033|NCT01061385|910160|P2|COMPLETED|Overall Study||8
380034|NCT01061385|910161|P1|COMPLETED|Overall Study||20
380035|NCT01061385|910160|P2|STARTED|Overall Study||9
380036|NCT01061385|910161|P1|STARTED|Overall Study||21
380037|NCT01061359|910169|P1|NOT COMPLETED|Overall Study||1302
380038|NCT01061359|910169|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
380039|NCT01061359|910169|P1|STARTED|Overall Study||1972
380040|NCT01061333|910175|P2|NOT COMPLETED|Period 7: Mometasone||0
380041|NCT01061333|910176|P1|NOT COMPLETED|Period 7: Mometasone||0
380042|NCT01061333|910175|P2|COMPLETED|Period 7: Mometasone||7
380043|NCT01061333|910176|P1|COMPLETED|Period 7: Mometasone||8
380044|NCT01061333|910175|P2|STARTED|Period 7: Mometasone||7
380045|NCT01061333|910176|P1|STARTED|Period 7: Mometasone||8
380046|NCT01061333|910175|P2|NOT COMPLETED|Period 6: 20-day Washout||0
380047|NCT01061333|910176|P1|NOT COMPLETED|Period 6: 20-day Washout||0
380048|NCT01061333|910175|P2|COMPLETED|Period 6: 20-day Washout||7
380049|NCT01061333|910176|P1|COMPLETED|Period 6: 20-day Washout||8
380050|NCT01061333|910175|P2|STARTED|Period 6: 20-day Washout||7
380051|NCT01061333|910176|P1|STARTED|Period 6: 20-day Washout||8
380052|NCT01061333|910175|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
380053|NCT01061333|910176|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
380054|NCT01061333|910175|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
380055|NCT01061333|910176|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
380056|NCT01061333|910175|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
380057|NCT01061333|910176|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
380058|NCT01061333|910175|P2|NOT COMPLETED|Period 4: 20-day Washout||1
380059|NCT01061333|910176|P1|NOT COMPLETED|Period 4: 20-day Washout||0
380060|NCT01061333|910175|P2|COMPLETED|Period 4: 20-day Washout||7
380061|NCT01061333|910176|P1|COMPLETED|Period 4: 20-day Washout||8
380062|NCT01061333|910175|P2|STARTED|Period 4: 20-day Washout||8
380063|NCT01061333|910176|P1|STARTED|Period 4: 20-day Washout||8
380064|NCT01061333|910175|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
380065|NCT01061333|910176|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
380066|NCT01061333|910175|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
380067|NCT01061333|910176|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
380068|NCT01061333|910175|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
380069|NCT01061333|910176|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
380070|NCT01061333|910175|P2|NOT COMPLETED|Period 2: 20-day Washout||0
380071|NCT01061333|910176|P1|NOT COMPLETED|Period 2: 20-day Washout||0
380072|NCT01061333|910175|P2|COMPLETED|Period 2: 20-day Washout||8
380073|NCT01061333|910176|P1|COMPLETED|Period 2: 20-day Washout||8
380074|NCT01061333|910175|P2|STARTED|Period 2: 20-day Washout||8
380075|NCT01061333|910176|P1|STARTED|Period 2: 20-day Washout||8
380076|NCT01061333|910175|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
380077|NCT01061333|910176|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
380078|NCT01061333|910175|P2|COMPLETED|Period 1: Placebo Run-in||8
380079|NCT01061333|910176|P1|COMPLETED|Period 1: Placebo Run-in||8
380080|NCT01061333|910175|P2|STARTED|Period 1: Placebo Run-in||8
380081|NCT01061333|910176|P1|STARTED|Period 1: Placebo Run-in||8
380082|NCT01061177|910214|P1|NOT COMPLETED|Overall Study||208
380083|NCT01061177|910214|P1|COMPLETED|Overall Study||881
380084|NCT01061177|910214|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
380085|NCT01061177|910214|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
380086|NCT01061177|910214|P1|STARTED|Overall Study||1089
380087|NCT01061034|910233|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
380088|NCT01061034|910233|P1|COMPLETED|Aspirin Plus Omeprazole||9
380089|NCT01061034|910233|P1|STARTED|Aspirin Plus Omeprazole||9
380090|NCT01061034|910233|P1|NOT COMPLETED|Aspirin||0
380091|NCT01061034|910233|P1|COMPLETED|Aspirin||9
380092|NCT01061034|910233|P1|STARTED|Aspirin||9
380093|NCT01061008|910240|P2|NOT COMPLETED|Overall Study||6
380094|NCT01061008|910241|P1|NOT COMPLETED|Overall Study||6
380095|NCT01061008|910240|P2|COMPLETED|Overall Study||9
380096|NCT01061008|910241|P1|COMPLETED|Overall Study||10
380097|NCT01061008|910240|P2|STARTED|Overall Study||15
380098|NCT01061008|910241|P1|STARTED|Overall Study||16
380099|NCT01060670|910249|P2|NOT COMPLETED|Follow up Phase||35
380100|NCT01060670|910250|P1|NOT COMPLETED|Follow up Phase||22
380101|NCT01060670|910249|P2|COMPLETED|Follow up Phase||82
380102|NCT01060670|910250|P1|COMPLETED|Follow up Phase||106
380103|NCT01060670|910249|P2|Withdrew From Follow up Phase|Follow up Phase||35
380104|NCT01060670|910250|P1|Withdrew From Follow up Phase|Follow up Phase||22
380105|NCT01060670|910249|P2|Recurrence|Follow up Phase||9
380106|NCT01060670|910250|P1|Recurrence|Follow up Phase||14
380107|NCT01060670|910249|P2|STARTED|Follow up Phase||117
380108|NCT01060670|910250|P1|STARTED|Follow up Phase||128
380109|NCT01060670|910249|P2|NOT COMPLETED|Treatment Phase||36
380110|NCT01060670|910250|P1|NOT COMPLETED|Treatment Phase||26
380111|NCT01060670|910249|P2|COMPLETED|Treatment Phase||117
380112|NCT01060670|910250|P1|COMPLETED|Treatment Phase||128
380113|NCT01060670|910249|P2|Withdrew From Treatment|Treatment Phase||36
380114|NCT01060670|910250|P1|Withdrew From Treatment|Treatment Phase||26
380115|NCT01060670|910249|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
380116|NCT01060670|910250|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
380117|NCT01060670|910249|P2|Healed at End of Treatment Phase|Treatment Phase||49
380118|NCT01060670|910250|P1|Healed at End of Treatment Phase|Treatment Phase||79
380119|NCT01060670|910249|P2|STARTED|Treatment Phase||153
380120|NCT01060670|910250|P1|STARTED|Treatment Phase||154
380121|NCT01060670|910249|P2|NOT COMPLETED|Run In||238
380122|NCT01060670|910250|P1|NOT COMPLETED|Run In||0
380123|NCT01060670|910249|P2|COMPLETED|Run In||307
380124|NCT01060670|910250|P1|COMPLETED|Run In||0
380125|NCT01060670|910249|P2|STARTED|Run In||545
380126|NCT01060670|910250|P1|STARTED|Run In||0
380127|NCT01060592|910270|P2|NOT COMPLETED|12m||18
380128|NCT01060592|910271|P1|NOT COMPLETED|12m||0
380299|NCT01059617|910696|P1|COMPLETED|Overall Study||26
380129|NCT01060592|910270|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
380130|NCT01060592|910271|P1|COMPLETED|12m||35
380131|NCT01060592|910270|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
380132|NCT01060592|910271|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
380133|NCT01060592|910270|P2|NOT COMPLETED|4-6w||10
380134|NCT01060592|910271|P1|NOT COMPLETED|4-6w||12
380135|NCT01060592|910270|P2|COMPLETED|4-6w||39
380136|NCT01060592|910271|P1|COMPLETED|4-6w||23
380137|NCT01060592|910270|P2|STARTED|4-6w||49
380138|NCT01060592|910271|P1|STARTED|4-6w||35
380139|NCT01060553|910285|P2|NOT COMPLETED|Overall Study||10
380140|NCT01060553|910286|P1|NOT COMPLETED|Overall Study||9
380141|NCT01060553|910285|P2|COMPLETED|Overall Study||5
380142|NCT01060553|910286|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
380143|NCT01060553|910285|P2|STARTED|Overall Study||15
380144|NCT01060553|910286|P1|STARTED|Overall Study||15
380145|NCT01060540|910293|P2|NOT COMPLETED|Overall Study||65
380146|NCT01060540|910294|P1|NOT COMPLETED|Overall Study||64
380147|NCT01060540|910293|P2|COMPLETED|Overall Study||233
380148|NCT01060540|910294|P1|COMPLETED|Overall Study||239
380149|NCT01060540|910293|P2|STARTED|Overall Study||298
380150|NCT01060540|910294|P1|STARTED|Overall Study||303
380151|NCT01060150|910308|P1|NOT COMPLETED|Overall Study||23
380152|NCT01060150|910308|P1|COMPLETED|Overall Study||92
380153|NCT01060150|910308|P1|Treated|Overall Study||113
380154|NCT01060150|910308|P1|STARTED|Overall Study||115
380155|NCT01060124|910323|P1|NOT COMPLETED|Overall Study||37
380156|NCT01060124|910323|P1|COMPLETED|Overall Study||66
380157|NCT01060124|910323|P1|STARTED|Overall Study||103
380158|NCT01060111|910334|P3|NOT COMPLETED|Overall Study||35
380159|NCT01060111|910335|P2|NOT COMPLETED|Overall Study||23
380160|NCT01060111|910336|P1|NOT COMPLETED|Overall Study||27
380161|NCT01060111|910334|P3|COMPLETED|Overall Study||45
380162|NCT01060111|910335|P2|COMPLETED|Overall Study||61
380163|NCT01060111|910336|P1|COMPLETED|Overall Study||54
380164|NCT01060111|910334|P3|Treated|Overall Study||79
380165|NCT01060111|910335|P2|Treated|Overall Study||83
380166|NCT01060111|910336|P1|Treated|Overall Study||81
380167|NCT01060111|910334|P3|STARTED|Overall Study||80
380168|NCT01060111|910335|P2|STARTED|Overall Study||84
380169|NCT01060111|910336|P1|STARTED|Overall Study||81
380170|NCT01060072|910355|P2|NOT COMPLETED|Overall Study||5
380171|NCT01060072|910356|P1|NOT COMPLETED|Overall Study||2
380172|NCT01060072|910355|P2|COMPLETED|Overall Study||196
380173|NCT01060072|910356|P1|COMPLETED|Overall Study||204
380174|NCT01060072|910355|P2|STARTED|Overall Study||201
380175|NCT01060072|910356|P1|STARTED|Overall Study||206
380176|NCT01060059|910372|P2|NOT COMPLETED|Overall Study||67
380177|NCT01060059|910373|P1|NOT COMPLETED|Overall Study||67
380178|NCT01060059|910372|P2|COMPLETED|Overall Study||371
380179|NCT01060059|910373|P1|COMPLETED|Overall Study||377
380180|NCT01060059|910372|P2|STARTED|Overall Study||438
380181|NCT01060059|910373|P1|STARTED|Overall Study||444
380182|NCT01060007|910423|P1|NOT COMPLETED|Overall Study||4
380183|NCT01060007|910423|P1|COMPLETED|Overall Study||76
380184|NCT01060007|910423|P1|STARTED|Overall Study||80
380185|NCT01059994|910441|P4|NOT COMPLETED|Overall Study||1
380186|NCT01059994|910442|P3|NOT COMPLETED|Overall Study||0
380187|NCT01059994|910443|P2|NOT COMPLETED|Overall Study||0
380188|NCT01059994|910444|P1|NOT COMPLETED|Overall Study||0
380189|NCT01059994|910441|P4|COMPLETED|Overall Study||3
380190|NCT01059994|910442|P3|COMPLETED|Overall Study||3
380191|NCT01059994|910443|P2|COMPLETED|Overall Study||2
380192|NCT01059994|910444|P1|COMPLETED|Overall Study||3
380193|NCT01059994|910441|P4|STARTED|Overall Study||4
380194|NCT01059994|910442|P3|STARTED|Overall Study||3
380195|NCT01059994|910443|P2|STARTED|Overall Study||2
380196|NCT01059994|910444|P1|STARTED|Overall Study||3
380197|NCT01059903|910460|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
380198|NCT01059903|910461|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
380199|NCT01059903|910460|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
380200|NCT01059903|910461|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
380201|NCT01059903|910460|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
380202|NCT01059903|910461|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
380203|NCT01059903|910460|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
380204|NCT01059903|910461|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
380205|NCT01059903|910460|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
380206|NCT01059903|910461|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
380207|NCT01059903|910460|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
380208|NCT01059903|910461|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
380209|NCT01059903|910460|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
380210|NCT01059903|910461|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
380211|NCT01059903|910460|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
380212|NCT01059903|910461|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
380213|NCT01059903|910460|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
380300|NCT01059617|910693|P4|STARTED|Overall Study||33
380214|NCT01059903|910461|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
380215|NCT01059903|910460|P2|STARTED|Period 1: First Intervention- 24 Hours||25
380216|NCT01059903|910461|P1|STARTED|Period 1: First Intervention- 24 Hours||25
380217|NCT01059864|910495|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
380218|NCT01059864|910496|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
380219|NCT01059864|910497|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
380220|NCT01059864|910495|P3|COMPLETED|Double-Blind Treatment Phase||45
380221|NCT01059864|910496|P2|COMPLETED|Double-Blind Treatment Phase||47
380222|NCT01059864|910497|P1|COMPLETED|Double-Blind Treatment Phase||0
380223|NCT01059864|910495|P3|Treated|Double-Blind Treatment Phase||47
380224|NCT01059864|910496|P2|Treated|Double-Blind Treatment Phase||50
380225|NCT01059864|910497|P1|Treated|Double-Blind Treatment Phase||0
380226|NCT01059864|910495|P3|STARTED|Double-Blind Treatment Phase||48
380227|NCT01059864|910496|P2|STARTED|Double-Blind Treatment Phase||50
380228|NCT01059864|910497|P1|STARTED|Double-Blind Treatment Phase||0
380229|NCT01059864|910495|P3|NOT COMPLETED|Open-Label Run-In Phase||0
380230|NCT01059864|910496|P2|NOT COMPLETED|Open-Label Run-In Phase||0
380231|NCT01059864|910497|P1|NOT COMPLETED|Open-Label Run-In Phase||13
380232|NCT01059864|910495|P3|COMPLETED|Open-Label Run-In Phase||0
380233|NCT01059864|910496|P2|COMPLETED|Open-Label Run-In Phase||0
380234|NCT01059864|910497|P1|COMPLETED|Open-Label Run-In Phase||98
380235|NCT01059864|910495|P3|STARTED|Open-Label Run-In Phase||0
380236|NCT01059864|910496|P2|STARTED|Open-Label Run-In Phase||0
380237|NCT01059864|910497|P1|STARTED|Open-Label Run-In Phase||111
380238|NCT01059851|910546|P6|NOT COMPLETED|Overall Study||0
380239|NCT01059851|910547|P5|NOT COMPLETED|Overall Study||0
380240|NCT01059851|910548|P4|NOT COMPLETED|Overall Study||0
380241|NCT01059851|910549|P3|NOT COMPLETED|Overall Study||0
380242|NCT01059851|910550|P2|NOT COMPLETED|Overall Study||0
380243|NCT01059851|910551|P1|NOT COMPLETED|Overall Study||0
380244|NCT01059851|910546|P6|COMPLETED|Overall Study||0
380245|NCT01059851|910547|P5|COMPLETED|Overall Study||0
380246|NCT01059851|910548|P4|COMPLETED|Overall Study||0
380247|NCT01059851|910549|P3|COMPLETED|Overall Study||0
380248|NCT01059851|910550|P2|COMPLETED|Overall Study||8
380249|NCT01059851|910551|P1|COMPLETED|Overall Study||8
380250|NCT01059851|910546|P6|STARTED|Overall Study||0
380251|NCT01059851|910547|P5|STARTED|Overall Study||0
380252|NCT01059851|910548|P4|STARTED|Overall Study||0
380253|NCT01059851|910549|P3|STARTED|Overall Study||0
380254|NCT01059851|910550|P2|STARTED|Overall Study||8
380255|NCT01059851|910551|P1|STARTED|Overall Study||8
380256|NCT01059812|910567|P2|NOT COMPLETED|Overall Study||16
380257|NCT01059812|910568|P1|NOT COMPLETED|Overall Study||37
380258|NCT01059812|910567|P2|COMPLETED|Overall Study||126
380259|NCT01059812|910568|P1|COMPLETED|Overall Study||245
380260|NCT01059812|910567|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
380261|NCT01059812|910568|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
380262|NCT01059812|910567|P2|STARTED|Overall Study||142
380263|NCT01059812|910568|P1|STARTED|Overall Study||282
380264|NCT01059799|910584|P2|NOT COMPLETED|Overall Study||10
380265|NCT01059799|910585|P1|NOT COMPLETED|Overall Study||31
380266|NCT01059799|910584|P2|COMPLETED|Overall Study||136
380267|NCT01059799|910585|P1|COMPLETED|Overall Study||258
380268|NCT01059799|910584|P2|Exposed|Overall Study||146
380269|NCT01059799|910585|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
380270|NCT01059799|910584|P2|STARTED|Overall Study||146
380271|NCT01059799|910585|P1|STARTED|Overall Study||289
380272|NCT01059773|910599|P2|NOT COMPLETED|Overall Study||24
380273|NCT01059773|910600|P1|NOT COMPLETED|Overall Study||20
380274|NCT01059773|910599|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
380275|NCT01059773|910600|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
380276|NCT01059773|910599|P2|STARTED|Overall Study||245
380277|NCT01059773|910600|P1|STARTED|Overall Study||244
380278|NCT01059630|910632|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
380279|NCT01059630|910633|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
380280|NCT01059630|910632|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
380281|NCT01059630|910633|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
380282|NCT01059630|910632|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
380283|NCT01059630|910633|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
380284|NCT01059630|910632|P2|NOT COMPLETED|Induction Period (6 Months)||38
380285|NCT01059630|910633|P1|NOT COMPLETED|Induction Period (6 Months)||73
380286|NCT01059630|910632|P2|COMPLETED|Induction Period (6 Months)||156
380287|NCT01059630|910633|P1|COMPLETED|Induction Period (6 Months)||129
380288|NCT01059630|910632|P2|Treated|Induction Period (6 Months)||194
380289|NCT01059630|910633|P1|Treated|Induction Period (6 Months)||198
380290|NCT01059630|910632|P2|STARTED|Induction Period (6 Months)||194
380291|NCT01059630|910633|P1|STARTED|Induction Period (6 Months)||202
380292|NCT01059617|910693|P4|NOT COMPLETED|Overall Study||6
380293|NCT01059617|910694|P3|NOT COMPLETED|Overall Study||8
380294|NCT01059617|910695|P2|NOT COMPLETED|Overall Study||1
380295|NCT01059617|910696|P1|NOT COMPLETED|Overall Study||7
380296|NCT01059617|910693|P4|COMPLETED|Overall Study||27
380297|NCT01059617|910694|P3|COMPLETED|Overall Study||25
380298|NCT01059617|910695|P2|COMPLETED|Overall Study||33
380301|NCT01059617|910694|P3|STARTED|Overall Study||33
380302|NCT01059617|910695|P2|STARTED|Overall Study||34
380303|NCT01059617|910696|P1|STARTED|Overall Study||33
380304|NCT01059565|910866|P2|NOT COMPLETED|24-Week Open-Label Phase||3
380305|NCT01059565|910867|P1|NOT COMPLETED|24-Week Open-Label Phase||5
380306|NCT01059565|910866|P2|COMPLETED|24-Week Open-Label Phase||42
380307|NCT01059565|910867|P1|COMPLETED|24-Week Open-Label Phase||34
380308|NCT01059565|910866|P2|STARTED|24-Week Open-Label Phase||45
380309|NCT01059565|910867|P1|STARTED|24-Week Open-Label Phase||39
380310|NCT01059565|910866|P2|NOT COMPLETED|24-Week Randomized Phase||7
380311|NCT01059565|910867|P1|NOT COMPLETED|24-Week Randomized Phase||10
380312|NCT01059565|910866|P2|COMPLETED|24-Week Randomized Phase||45
380313|NCT01059565|910867|P1|COMPLETED|24-Week Randomized Phase||39
380314|NCT01059565|910866|P2|Randomized and Treated|24-Week Randomized Phase||52
380315|NCT01059565|910867|P1|Randomized and Treated|24-Week Randomized Phase||48
380316|NCT01059565|910866|P2|STARTED|24-Week Randomized Phase||52
380317|NCT01059565|910867|P1|STARTED|24-Week Randomized Phase||49
380318|NCT01059526|910903|P2|NOT COMPLETED|Overall Study||22
380319|NCT01059526|910904|P1|NOT COMPLETED|Overall Study||30
380320|NCT01059526|910903|P2|COMPLETED|Overall Study||18
380321|NCT01059526|910904|P1|COMPLETED|Overall Study||11
380322|NCT01059526|910903|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
380323|NCT01059526|910904|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
380324|NCT01059526|910903|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
380325|NCT01059526|910904|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
380326|NCT01059344|910914|P2|NOT COMPLETED|Overall Study||46
380327|NCT01059344|910915|P1|NOT COMPLETED|Overall Study||22
380328|NCT01059344|910914|P2|COMPLETED|Overall Study||95
380329|NCT01059344|910915|P1|COMPLETED|Overall Study||118
380330|NCT01059344|910914|P2|STARTED|Overall Study||141
380331|NCT01059344|910915|P1|STARTED|Overall Study||140
380332|NCT01059305|910933|P1|NOT COMPLETED|Overall Study||0
380333|NCT01059305|910933|P1|COMPLETED|Overall Study||10
380334|NCT01059305|910933|P1|STARTED|Overall Study||10
380335|NCT01059175|910939|P2|NOT COMPLETED|Overall Study||20
380336|NCT01059175|910940|P1|NOT COMPLETED|Overall Study||21
380337|NCT01059175|910939|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
380338|NCT01059175|910940|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
380339|NCT01059175|910939|P2|STARTED|Overall Study||41
380340|NCT01059175|910940|P1|STARTED|Overall Study||43
380341|NCT01059071|910962|P4|NOT COMPLETED|Overall Study||6
380342|NCT01059071|910963|P3|NOT COMPLETED|Overall Study||2
380343|NCT01059071|910964|P2|NOT COMPLETED|Overall Study||4
380344|NCT01059071|910965|P1|NOT COMPLETED|Overall Study||2
380345|NCT01059071|910962|P4|COMPLETED|Overall Study||3
380346|NCT01059071|910963|P3|COMPLETED|Overall Study||1
380347|NCT01059071|910964|P2|COMPLETED|Overall Study||1
380348|NCT01059071|910965|P1|COMPLETED|Overall Study||2
380349|NCT01059071|910962|P4|STARTED|Overall Study||9
380350|NCT01059071|910963|P3|STARTED|Overall Study||3
380351|NCT01059071|910964|P2|STARTED|Overall Study||5
380352|NCT01059071|910965|P1|STARTED|Overall Study||4
380353|NCT01058993|910977|P1|NOT COMPLETED|Overall Study||0
380354|NCT01058993|910977|P1|COMPLETED|Overall Study||6
380355|NCT01058993|910977|P1|STARTED|Overall Study||6
380356|NCT01058941|910983|P2|NOT COMPLETED|Overall Study||11
380357|NCT01058941|910984|P1|NOT COMPLETED|Overall Study||9
380358|NCT01058941|910983|P2|COMPLETED|Overall Study||22
380359|NCT01058941|910984|P1|COMPLETED|Overall Study||25
380360|NCT01058941|910983|P2|STARTED|Overall Study||33
380361|NCT01058941|910984|P1|STARTED|Overall Study||34
380362|NCT01058863|910992|P1|NOT COMPLETED|Overall Study||4
380363|NCT01058863|910992|P1|COMPLETED|Overall Study||68
380364|NCT01058863|910992|P1|Treated With Placebo Inhaler|Overall Study||69
380365|NCT01058863|910992|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
380366|NCT01058863|910992|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
380367|NCT01058863|910992|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
380368|NCT01058863|910992|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
380369|NCT01058863|910992|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
380370|NCT01058863|910992|P1|STARTED|Overall Study||72
380371|NCT01058668|911013|P3|NOT COMPLETED|Safety Follow-up||7
380372|NCT01058668|911014|P2|NOT COMPLETED|Safety Follow-up||0
380373|NCT01058668|911015|P1|NOT COMPLETED|Safety Follow-up||5
380374|NCT01058668|911013|P3|COMPLETED|Safety Follow-up||141
380375|NCT01058668|911014|P2|COMPLETED|Safety Follow-up||146
380376|NCT01058668|911015|P1|COMPLETED|Safety Follow-up||139
380377|NCT01058668|911013|P3|STARTED|Safety Follow-up||148
380378|NCT01058668|911014|P2|STARTED|Safety Follow-up||146
380379|NCT01058668|911015|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
380380|NCT01058668|911013|P3|NOT COMPLETED|Double-blind Treatment Phase||50
380381|NCT01058668|911014|P2|NOT COMPLETED|Double-blind Treatment Phase||38
380382|NCT01058668|911015|P1|NOT COMPLETED|Double-blind Treatment Phase||39
380383|NCT01058668|911013|P3|COMPLETED|Double-blind Treatment Phase||119
380384|NCT01058668|911014|P2|COMPLETED|Double-blind Treatment Phase||129
380385|NCT01058668|911015|P1|COMPLETED|Double-blind Treatment Phase||122
380386|NCT01058668|911013|P3|STARTED|Double-blind Treatment Phase||169
380387|NCT01058668|911014|P2|STARTED|Double-blind Treatment Phase||167
380388|NCT01058668|911015|P1|STARTED|Double-blind Treatment Phase||161
380389|NCT01058655|911030|P4|NOT COMPLETED|Overall Study||42
380390|NCT01058655|911031|P3|NOT COMPLETED|Overall Study||8
380391|NCT01058655|911032|P2|NOT COMPLETED|Overall Study||3
380392|NCT01058655|911033|P1|NOT COMPLETED|Overall Study||3
380393|NCT01058655|911030|P4|COMPLETED|Overall Study||0
380394|NCT01058655|911031|P3|COMPLETED|Overall Study||0
380395|NCT01058655|911032|P2|COMPLETED|Overall Study||0
380396|NCT01058655|911033|P1|COMPLETED|Overall Study||0
380397|NCT01058655|911030|P4|Evaluable|Overall Study||40
380398|NCT01058655|911031|P3|Evaluable|Overall Study||6
380399|NCT01058655|911032|P2|Evaluable|Overall Study||3
380400|NCT01058655|911033|P1|Evaluable|Overall Study||3
380401|NCT01058655|911030|P4|STARTED|Overall Study||42
380402|NCT01058655|911031|P3|STARTED|Overall Study||8
380403|NCT01058655|911032|P2|STARTED|Overall Study||3
380404|NCT01058655|911033|P1|STARTED|Overall Study||3
380405|NCT01058642|911051|P4|NOT COMPLETED|Treatment Period 2||0
380406|NCT01058642|911052|P3|NOT COMPLETED|Treatment Period 2||0
380407|NCT01058642|911053|P2|NOT COMPLETED|Treatment Period 2||0
380408|NCT01058642|911054|P1|NOT COMPLETED|Treatment Period 2||0
380409|NCT01058642|911051|P4|COMPLETED|Treatment Period 2||7
380410|NCT01058642|911052|P3|COMPLETED|Treatment Period 2||9
380411|NCT01058642|911053|P2|COMPLETED|Treatment Period 2||11
380412|NCT01058642|911054|P1|COMPLETED|Treatment Period 2||7
380413|NCT01058642|911051|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
380414|NCT01058642|911052|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
380415|NCT01058642|911053|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
380416|NCT01058642|911054|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
380417|NCT01058642|911051|P4|STARTED|Treatment Period 2||7
380418|NCT01058642|911052|P3|STARTED|Treatment Period 2||9
380419|NCT01058642|911053|P2|STARTED|Treatment Period 2||11
380420|NCT01058642|911054|P1|STARTED|Treatment Period 2||7
380421|NCT01058642|911051|P4|NOT COMPLETED|Washout Period||0
380422|NCT01058642|911052|P3|NOT COMPLETED|Washout Period||0
380423|NCT01058642|911053|P2|NOT COMPLETED|Washout Period||0
380424|NCT01058642|911054|P1|NOT COMPLETED|Washout Period||0
380425|NCT01058642|911051|P4|COMPLETED|Washout Period||7
380426|NCT01058642|911052|P3|COMPLETED|Washout Period||9
380427|NCT01058642|911053|P2|COMPLETED|Washout Period||11
380428|NCT01058642|911054|P1|COMPLETED|Washout Period||7
380429|NCT01058642|911051|P4|STARTED|Washout Period||7
380430|NCT01058642|911052|P3|STARTED|Washout Period||9
380431|NCT01058642|911053|P2|STARTED|Washout Period||11
380432|NCT01058642|911054|P1|STARTED|Washout Period||7
380433|NCT01058642|911051|P4|NOT COMPLETED|Treatment Period 1||2
380434|NCT01058642|911052|P3|NOT COMPLETED|Treatment Period 1||2
380435|NCT01058642|911053|P2|NOT COMPLETED|Treatment Period 1||1
380436|NCT01058642|911054|P1|NOT COMPLETED|Treatment Period 1||2
380437|NCT01058642|911051|P4|COMPLETED|Treatment Period 1||7
380438|NCT01058642|911052|P3|COMPLETED|Treatment Period 1||9
380439|NCT01058642|911053|P2|COMPLETED|Treatment Period 1||11
380440|NCT01058642|911054|P1|COMPLETED|Treatment Period 1||7
380441|NCT01058642|911051|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
380442|NCT01058642|911052|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
380443|NCT01058642|911053|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
380444|NCT01058642|911054|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
380445|NCT01058642|911051|P4|STARTED|Treatment Period 1||9
380446|NCT01058642|911052|P3|STARTED|Treatment Period 1||11
380447|NCT01058642|911053|P2|STARTED|Treatment Period 1||12
380448|NCT01058642|911054|P1|STARTED|Treatment Period 1||9
380449|NCT01058421|911064|P2|NOT COMPLETED|6 Month Outcomes||26
380450|NCT01058421|911065|P1|NOT COMPLETED|6 Month Outcomes||19
380451|NCT01058421|911064|P2|COMPLETED|6 Month Outcomes||24
380452|NCT01058421|911065|P1|COMPLETED|6 Month Outcomes||27
380453|NCT01058421|911064|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
380454|NCT01058421|911065|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
380455|NCT01058421|911064|P2|NOT COMPLETED|3 Month Outcomes||26
380456|NCT01058421|911065|P1|NOT COMPLETED|3 Month Outcomes||20
380457|NCT01058421|911064|P2|COMPLETED|3 Month Outcomes||29
380458|NCT01058421|911065|P1|COMPLETED|3 Month Outcomes||29
380459|NCT01058421|911064|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
380460|NCT01058421|911065|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
380461|NCT01058421|911064|P2|NOT COMPLETED|1 Month Outcomes||42
380462|NCT01058421|911065|P1|NOT COMPLETED|1 Month Outcomes||39
380463|NCT01058421|911064|P2|COMPLETED|1 Month Outcomes||19
380464|NCT01058421|911065|P1|COMPLETED|1 Month Outcomes||20
380465|NCT01058421|911064|P2|STARTED|1 Month Outcomes||61
380466|NCT01058421|911065|P1|STARTED|1 Month Outcomes||59
380467|NCT01058356|911087|P1|NOT COMPLETED|Overall Study||42
380468|NCT01058356|911087|P1|COMPLETED|Overall Study||172
380469|NCT01058356|911087|P1|STARTED|Overall Study||214
380470|NCT01058304|911094|P2|NOT COMPLETED|Overall Study||33
380471|NCT01058304|911095|P1|NOT COMPLETED|Overall Study||27
380472|NCT01058304|911094|P2|COMPLETED|Overall Study||128
380473|NCT01058304|911095|P1|COMPLETED|Overall Study||132
380474|NCT01058304|911094|P2|STARTED|Overall Study||161
380475|NCT01058304|911095|P1|STARTED|Overall Study||159
380476|NCT01058265|911105|P2|NOT COMPLETED|Overall Study||12
380477|NCT01058265|911106|P1|NOT COMPLETED|Overall Study||11
380478|NCT01058265|911105|P2|COMPLETED|Overall Study||13
380479|NCT01058265|911106|P1|COMPLETED|Overall Study||11
380480|NCT01058265|911105|P2|STARTED|Overall Study||25
380481|NCT01058265|911106|P1|STARTED|Overall Study||22
380482|NCT01058096|911116|P2|NOT COMPLETED|Safety Follow-up||4
380483|NCT01058096|911117|P1|NOT COMPLETED|Safety Follow-up||4
380484|NCT01058096|911116|P2|COMPLETED|Safety Follow-up||130
380485|NCT01058096|911117|P1|COMPLETED|Safety Follow-up||129
380486|NCT01058096|911116|P2|STARTED|Safety Follow-up||134
380487|NCT01058096|911117|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
380488|NCT01058096|911116|P2|NOT COMPLETED|Double-blind Treatment Phase||50
380489|NCT01058096|911117|P1|NOT COMPLETED|Double-blind Treatment Phase||48
380490|NCT01058096|911116|P2|COMPLETED|Double-blind Treatment Phase||108
380491|NCT01058096|911117|P1|COMPLETED|Double-blind Treatment Phase||106
380492|NCT01058096|911116|P2|STARTED|Double-blind Treatment Phase||158
380493|NCT01058096|911117|P1|STARTED|Double-blind Treatment Phase||154
380494|NCT01058070|911125|P1|NOT COMPLETED|Overall Study||11
380495|NCT01058070|911125|P1|COMPLETED|Overall Study||33
380496|NCT01058070|911125|P1|STARTED|Overall Study||44
380497|NCT01058005|911133|P3|NOT COMPLETED|Overall Study||20
380498|NCT01058005|911134|P2|NOT COMPLETED|Overall Study||25
380499|NCT01058005|911135|P1|NOT COMPLETED|Overall Study||38
380500|NCT01058005|911133|P3|COMPLETED|Overall Study||1
380501|NCT01058005|911134|P2|COMPLETED|Overall Study||0
380502|NCT01058005|911135|P1|COMPLETED|Overall Study||0
380503|NCT01058005|911133|P3|Dosed With Study Treatment|Overall Study||17
380504|NCT01058005|911134|P2|Dosed With Study Treatment|Overall Study||22
380505|NCT01058005|911135|P1|Dosed With Study Treatment|Overall Study||36
380506|NCT01058005|911133|P3|STARTED|Overall Study||21
380507|NCT01058005|911134|P2|STARTED|Overall Study||25
380508|NCT01058005|911135|P1|STARTED|Overall Study||38
380509|NCT01057901|911145|P2|NOT COMPLETED|Overall Study||246
380510|NCT01057901|911146|P1|NOT COMPLETED|Overall Study||260
380511|NCT01057901|911145|P2|COMPLETED|Overall Study||126
380512|NCT01057901|911146|P1|COMPLETED|Overall Study||116
380513|NCT01057901|911145|P2|STARTED|Overall Study||372
380514|NCT01057901|911146|P1|STARTED|Overall Study||376
380515|NCT01057888|911157|P3|NOT COMPLETED|Overall Study||0
380516|NCT01057888|911158|P2|NOT COMPLETED|Overall Study||0
380517|NCT01057888|911159|P1|NOT COMPLETED|Overall Study||0
380518|NCT01057888|911157|P3|COMPLETED|Overall Study||2494
380519|NCT01057888|911158|P2|COMPLETED|Overall Study||2406
380520|NCT01057888|911159|P1|COMPLETED|Overall Study||2504
380521|NCT01057888|911157|P3|STARTED|Overall Study||2494
380522|NCT01057888|911158|P2|STARTED|Overall Study||2406
380523|NCT01057888|911159|P1|STARTED|Overall Study||2504
380524|NCT01057810|911170|P2|NOT COMPLETED|Overall Study||398
380525|NCT01057810|911171|P1|NOT COMPLETED|Overall Study||198
380526|NCT01057810|911170|P2|COMPLETED|Overall Study||1
380527|NCT01057810|911171|P1|COMPLETED|Overall Study||1
380528|NCT01057810|911170|P2|STARTED|Overall Study||399
380529|NCT01057810|911171|P1|STARTED|Overall Study||199
380530|NCT01057693|911187|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
380531|NCT01057693|911188|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
380532|NCT01057693|911189|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
380533|NCT01057693|911187|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
380534|NCT01057693|911188|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
380535|NCT01057693|911189|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
380536|NCT01057693|911187|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
380537|NCT01057693|911188|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
380622|NCT01057121|911298|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380538|NCT01057693|911189|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
380539|NCT01057693|911187|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
380540|NCT01057693|911188|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
380541|NCT01057693|911189|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
380542|NCT01057693|911187|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
380543|NCT01057693|911188|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
380544|NCT01057693|911189|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
380545|NCT01057693|911187|P3|COMPLETED|Between Single-Blind and Double-Blind||0
380546|NCT01057693|911188|P2|COMPLETED|Between Single-Blind and Double-Blind||0
380547|NCT01057693|911189|P1|COMPLETED|Between Single-Blind and Double-Blind||296
380548|NCT01057693|911187|P3|STARTED|Between Single-Blind and Double-Blind||0
380549|NCT01057693|911188|P2|STARTED|Between Single-Blind and Double-Blind||0
380550|NCT01057693|911189|P1|STARTED|Between Single-Blind and Double-Blind||566
380551|NCT01057693|911187|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
380552|NCT01057693|911188|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
380553|NCT01057693|911189|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
380554|NCT01057693|911187|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
380555|NCT01057693|911188|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
380556|NCT01057693|911189|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
380557|NCT01057693|911187|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
380558|NCT01057693|911188|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
380559|NCT01057693|911189|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
380560|NCT01057589|911235|P1|NOT COMPLETED|Overall Study||66
380561|NCT01057589|911235|P1|COMPLETED|Overall Study||0
380562|NCT01057589|911235|P1|STARTED|Overall Study||66
380563|NCT01057433|911244|P1|NOT COMPLETED|Overall Study||1
380564|NCT01057433|911244|P1|COMPLETED|Overall Study||23
380565|NCT01057433|911244|P1|STARTED|Overall Study||24
380566|NCT01057394|911248|P2|NOT COMPLETED|Overall Study||2
380567|NCT01057394|911249|P1|NOT COMPLETED|Overall Study||0
380568|NCT01057394|911248|P2|COMPLETED|Overall Study|19 treated participants|19
380569|NCT01057394|911249|P1|COMPLETED|Overall Study||0
380570|NCT01057394|911248|P2|STARTED|Overall Study|21 enrolled participants|21
380571|NCT01057394|911249|P1|STARTED|Overall Study||0
380572|NCT01057277|911253|P1|NOT COMPLETED|Overall Study||0
380573|NCT01057277|911253|P1|COMPLETED|Overall Study||3
380574|NCT01057277|911253|P1|STARTED|Overall Study||3
380575|NCT01057251|911259|P2|NOT COMPLETED|Overall Study||29
380576|NCT01057251|911260|P1|NOT COMPLETED|Overall Study||28
380577|NCT01057251|911259|P2|COMPLETED|Overall Study||114
380578|NCT01057251|911260|P1|COMPLETED|Overall Study||262
380579|NCT01057251|911259|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
380580|NCT01057251|911260|P1|STARTED|Overall Study||290
380581|NCT01057225|911268|P6|NOT COMPLETED|Overall Study||0
380582|NCT01057225|911269|P5|NOT COMPLETED|Overall Study||0
380583|NCT01057225|911270|P4|NOT COMPLETED|Overall Study||0
380584|NCT01057225|911271|P3|NOT COMPLETED|Overall Study||0
380585|NCT01057225|911272|P2|NOT COMPLETED|Overall Study||0
380586|NCT01057225|911273|P1|NOT COMPLETED|Overall Study||0
380587|NCT01057225|911268|P6|COMPLETED|Overall Study||23
380588|NCT01057225|911269|P5|COMPLETED|Overall Study||22
380589|NCT01057225|911270|P4|COMPLETED|Overall Study||7
380590|NCT01057225|911271|P3|COMPLETED|Overall Study||6
380591|NCT01057225|911272|P2|COMPLETED|Overall Study||3
380592|NCT01057225|911273|P1|COMPLETED|Overall Study||3
380593|NCT01057225|911268|P6|STARTED|Overall Study||23
380594|NCT01057225|911269|P5|STARTED|Overall Study||22
380595|NCT01057225|911270|P4|STARTED|Overall Study||7
380596|NCT01057225|911271|P3|STARTED|Overall Study||6
380597|NCT01057225|911272|P2|STARTED|Overall Study||3
380598|NCT01057225|911273|P1|STARTED|Overall Study||3
380599|NCT01057121|911295|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380600|NCT01057121|911296|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380601|NCT01057121|911297|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380602|NCT01057121|911298|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380603|NCT01057121|911299|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380604|NCT01057121|911295|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
380605|NCT01057121|911296|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380606|NCT01057121|911297|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380607|NCT01057121|911298|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380608|NCT01057121|911299|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
380609|NCT01057121|911295|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
380610|NCT01057121|911296|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
380611|NCT01057121|911297|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
380612|NCT01057121|911298|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
380613|NCT01057121|911299|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
380614|NCT01057121|911295|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380615|NCT01057121|911296|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380616|NCT01057121|911297|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380617|NCT01057121|911298|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380618|NCT01057121|911299|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380619|NCT01057121|911295|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380620|NCT01057121|911296|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
380621|NCT01057121|911297|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380623|NCT01057121|911299|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
380624|NCT01057121|911295|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
380625|NCT01057121|911296|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
380626|NCT01057121|911297|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
380627|NCT01057121|911298|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
380628|NCT01057121|911299|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
380629|NCT01057121|911295|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380630|NCT01057121|911296|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380631|NCT01057121|911297|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380632|NCT01057121|911298|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380633|NCT01057121|911299|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380634|NCT01057121|911295|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380635|NCT01057121|911296|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380636|NCT01057121|911297|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
380637|NCT01057121|911298|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380638|NCT01057121|911299|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
380639|NCT01057121|911295|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
380640|NCT01057121|911296|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
380641|NCT01057121|911297|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
380642|NCT01057121|911298|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
380643|NCT01057121|911299|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
380644|NCT01057121|911295|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380645|NCT01057121|911296|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380646|NCT01057121|911297|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380647|NCT01057121|911298|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380648|NCT01057121|911299|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380649|NCT01057121|911295|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380650|NCT01057121|911296|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380651|NCT01057121|911297|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380652|NCT01057121|911298|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
380653|NCT01057121|911299|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
380654|NCT01057121|911295|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
380655|NCT01057121|911296|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
380656|NCT01057121|911297|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
380657|NCT01057121|911298|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
380658|NCT01057121|911299|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
380659|NCT01057121|911295|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380660|NCT01057121|911296|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380661|NCT01057121|911297|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380662|NCT01057121|911298|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380663|NCT01057121|911299|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380664|NCT01057121|911295|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380665|NCT01057121|911296|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380666|NCT01057121|911297|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380667|NCT01057121|911298|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
380668|NCT01057121|911299|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
380669|NCT01057121|911295|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
380670|NCT01057121|911296|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
380671|NCT01057121|911297|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
380672|NCT01057121|911298|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
380673|NCT01057121|911299|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
380674|NCT01057017|911328|P1|NOT COMPLETED|Overall Study||0
380675|NCT01057017|911328|P1|COMPLETED|Overall Study||5
380676|NCT01057017|911328|P1|STARTED|Overall Study||5
380677|NCT01056913|911332|P1|NOT COMPLETED|Overall Study||0
380678|NCT01056913|911332|P1|COMPLETED|Overall Study||62
380679|NCT01056913|911332|P1|STARTED|Overall Study||62
380680|NCT01056822|911338|P2|NOT COMPLETED|Overall Study||7
380681|NCT01056822|911339|P1|NOT COMPLETED|Overall Study||8
380682|NCT01056822|911338|P2|COMPLETED|Overall Study||35
380683|NCT01056822|911339|P1|COMPLETED|Overall Study||39
380684|NCT01056822|911338|P2|Safety (SAF) Population: NO|Overall Study||2
380685|NCT01056822|911339|P1|Safety (SAF) Population: NO|Overall Study||1
380686|NCT01056822|911338|P2|Safety (SAF) Population: YES|Overall Study||40
380687|NCT01056822|911339|P1|Safety (SAF) Population: YES|Overall Study||46
380688|NCT01056822|911338|P2|Per-protocol (PP) Population: NO|Overall Study||17
380689|NCT01056822|911339|P1|Per-protocol (PP) Population: NO|Overall Study||18
380690|NCT01056822|911338|P2|Per-protocol (PP) Population: YES|Overall Study||25
380691|NCT01056822|911339|P1|Per-protocol (PP) Population: YES|Overall Study||29
380692|NCT01056822|911338|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
380693|NCT01056822|911339|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
380694|NCT01056822|911338|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
380695|NCT01056822|911339|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
380696|NCT01056822|911338|P2|STARTED|Overall Study||42
380697|NCT01056822|911339|P1|STARTED|Overall Study||47
380698|NCT01056718|911388|P1|NOT COMPLETED|Overall Study||3
380699|NCT01056718|911388|P1|COMPLETED|Overall Study||50
380700|NCT01056718|911388|P1|STARTED|Overall Study||53
380701|NCT01056653|911421|P3|NOT COMPLETED|Overall Study||2
380702|NCT01056653|911422|P2|NOT COMPLETED|Overall Study||0
380703|NCT01056653|911423|P1|NOT COMPLETED|Overall Study||0
380794|NCT01056289|911612|P4|COMPLETED|Double-blind Phase||138
380704|NCT01056653|911421|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
380705|NCT01056653|911422|P2|COMPLETED|Overall Study||23
380706|NCT01056653|911423|P1|COMPLETED|Overall Study||46
380707|NCT01056653|911421|P3|STARTED|Overall Study||44
380708|NCT01056653|911422|P2|STARTED|Overall Study||23
380709|NCT01056653|911423|P1|STARTED|Overall Study||46
380710|NCT01056640|911439|P2|NOT COMPLETED|Overall Study||12
380711|NCT01056640|911440|P1|NOT COMPLETED|Overall Study||26
380712|NCT01056640|911439|P2|COMPLETED|Overall Study||91
380713|NCT01056640|911440|P1|COMPLETED|Overall Study||76
380714|NCT01056640|911439|P2|STARTED|Overall Study||103
380715|NCT01056640|911440|P1|STARTED|Overall Study||102
380716|NCT01056601|911446|P1|NOT COMPLETED|Overall Study||0
380717|NCT01056601|911446|P1|COMPLETED|Overall Study||7
380718|NCT01056601|911446|P1|STARTED|Overall Study||7
380719|NCT01056523|911452|P7|NOT COMPLETED|Overall Study||1
380720|NCT01056523|911453|P6|NOT COMPLETED|Overall Study||0
380721|NCT01056523|911454|P5|NOT COMPLETED|Overall Study||0
380722|NCT01056523|911455|P4|NOT COMPLETED|Overall Study||3
380723|NCT01056523|911456|P3|NOT COMPLETED|Overall Study||2
380724|NCT01056523|911457|P2|NOT COMPLETED|Overall Study||0
380725|NCT01056523|911458|P1|NOT COMPLETED|Overall Study||1
380726|NCT01056523|911452|P7|COMPLETED|Overall Study||4
380727|NCT01056523|911453|P6|COMPLETED|Overall Study||3
380728|NCT01056523|911454|P5|COMPLETED|Overall Study||3
380729|NCT01056523|911455|P4|COMPLETED|Overall Study||3
380730|NCT01056523|911456|P3|COMPLETED|Overall Study||3
380731|NCT01056523|911457|P2|COMPLETED|Overall Study||3
380732|NCT01056523|911458|P1|COMPLETED|Overall Study||3
380733|NCT01056523|911452|P7|STARTED|Overall Study||5
380734|NCT01056523|911453|P6|STARTED|Overall Study||3
380735|NCT01056523|911454|P5|STARTED|Overall Study||3
380736|NCT01056523|911455|P4|STARTED|Overall Study||6
380737|NCT01056523|911456|P3|STARTED|Overall Study||5
380738|NCT01056523|911457|P2|STARTED|Overall Study||3
380739|NCT01056523|911458|P1|STARTED|Overall Study||4
380740|NCT01056510|911468|P2|NOT COMPLETED|Overall Study||64
380741|NCT01056510|911469|P1|NOT COMPLETED|Overall Study||54
380742|NCT01056510|911468|P2|COMPLETED|Overall Study||115
380743|NCT01056510|911469|P1|COMPLETED|Overall Study||124
380744|NCT01056510|911468|P2|STARTED|Overall Study||179
380745|NCT01056510|911469|P1|STARTED|Overall Study||178
380746|NCT01056484|911515|P2|NOT COMPLETED|Follow up - Non-randomized||2
380747|NCT01056484|911516|P1|NOT COMPLETED|Follow up - Non-randomized||0
380748|NCT01056484|911515|P2|COMPLETED|Follow up - Non-randomized||56
380749|NCT01056484|911516|P1|COMPLETED|Follow up - Non-randomized||57
380750|NCT01056484|911515|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
380751|NCT01056484|911516|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
380752|NCT01056484|911515|P2|NOT COMPLETED|Randomized Controlled Trial||1
380753|NCT01056484|911516|P1|NOT COMPLETED|Randomized Controlled Trial||7
380754|NCT01056484|911515|P2|COMPLETED|Randomized Controlled Trial||58
380755|NCT01056484|911516|P1|COMPLETED|Randomized Controlled Trial||57
380756|NCT01056484|911515|P2|STARTED|Randomized Controlled Trial||59
380757|NCT01056484|911516|P1|STARTED|Randomized Controlled Trial||64
380758|NCT01056341|911535|P5|NOT COMPLETED|Overall Study||14
380759|NCT01056341|911536|P4|NOT COMPLETED|Overall Study||36
380760|NCT01056341|911537|P3|NOT COMPLETED|Overall Study||15
380761|NCT01056341|911538|P2|NOT COMPLETED|Overall Study||36
380762|NCT01056341|911539|P1|NOT COMPLETED|Overall Study||36
380763|NCT01056341|911535|P5|COMPLETED|Overall Study||88
380764|NCT01056341|911536|P4|COMPLETED|Overall Study||65
380765|NCT01056341|911537|P3|COMPLETED|Overall Study||88
380766|NCT01056341|911538|P2|COMPLETED|Overall Study||63
380767|NCT01056341|911539|P1|COMPLETED|Overall Study||19
380768|NCT01056341|911535|P5|Interim Analysis|Overall Study||43
380769|NCT01056341|911536|P4|Interim Analysis|Overall Study||40
380770|NCT01056341|911537|P3|Interim Analysis|Overall Study||41
380771|NCT01056341|911538|P2|Interim Analysis|Overall Study||41
380772|NCT01056341|911539|P1|Interim Analysis|Overall Study||25
380773|NCT01056341|911535|P5|STARTED|Overall Study||102
380774|NCT01056341|911536|P4|STARTED|Overall Study||101
380775|NCT01056341|911537|P3|STARTED|Overall Study||103
380776|NCT01056341|911538|P2|STARTED|Overall Study||99
380777|NCT01056341|911539|P1|STARTED|Overall Study||55
380778|NCT01056328|911560|P2|NOT COMPLETED|Overall Study||16
380779|NCT01056328|911561|P1|NOT COMPLETED|Overall Study||17
380780|NCT01056328|911560|P2|COMPLETED|Overall Study||144
380781|NCT01056328|911561|P1|COMPLETED|Overall Study||147
380782|NCT01056328|911560|P2|STARTED|Overall Study||160
380783|NCT01056328|911561|P1|STARTED|Overall Study||164
380784|NCT01056315|911577|P2|NOT COMPLETED|Overall Study||11
380785|NCT01056315|911578|P1|NOT COMPLETED|Overall Study||14
380786|NCT01056315|911577|P2|COMPLETED|Overall Study||12
380787|NCT01056315|911578|P1|COMPLETED|Overall Study||13
380788|NCT01056315|911577|P2|STARTED|Overall Study||23
380789|NCT01056315|911578|P1|STARTED|Overall Study||27
380790|NCT01056289|911612|P4|NOT COMPLETED|Double-blind Phase||10
380791|NCT01056289|911613|P3|NOT COMPLETED|Double-blind Phase||13
380792|NCT01056289|911614|P2|NOT COMPLETED|Double-blind Phase||4
380793|NCT01056289|911615|P1|NOT COMPLETED|Double-blind Phase||0
380795|NCT01056289|911613|P3|COMPLETED|Double-blind Phase||127
380796|NCT01056289|911614|P2|COMPLETED|Double-blind Phase||69
380797|NCT01056289|911615|P1|COMPLETED|Double-blind Phase||0
380798|NCT01056289|911612|P4|STARTED|Double-blind Phase||148
380799|NCT01056289|911613|P3|STARTED|Double-blind Phase||140
380800|NCT01056289|911614|P2|STARTED|Double-blind Phase||73
380801|NCT01056289|911615|P1|STARTED|Double-blind Phase||0
380802|NCT01056289|911612|P4|NOT COMPLETED|Open-label Phase||0
380803|NCT01056289|911613|P3|NOT COMPLETED|Open-label Phase||0
380804|NCT01056289|911614|P2|NOT COMPLETED|Open-label Phase||0
380805|NCT01056289|911615|P1|NOT COMPLETED|Open-label Phase||119
380806|NCT01056289|911612|P4|COMPLETED|Open-label Phase||0
380807|NCT01056289|911613|P3|COMPLETED|Open-label Phase||0
380808|NCT01056289|911614|P2|COMPLETED|Open-label Phase||0
380809|NCT01056289|911615|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
380810|NCT01056289|911612|P4|STARTED|Open-label Phase||0
380811|NCT01056289|911613|P3|STARTED|Open-label Phase||0
380812|NCT01056289|911614|P2|STARTED|Open-label Phase||0
380813|NCT01056289|911615|P1|STARTED|Open-label Phase||480
380814|NCT01056276|911632|P2|NOT COMPLETED|Maintenance Therapy||28
380815|NCT01056276|911633|P1|NOT COMPLETED|Maintenance Therapy||0
380816|NCT01056276|911632|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
380817|NCT01056276|911633|P1|COMPLETED|Maintenance Therapy||0
380818|NCT01056276|911632|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
380819|NCT01056276|911633|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
380820|NCT01056276|911632|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
380821|NCT01056276|911633|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
380822|NCT01056276|911632|P2|COMPLETED|Treatment Period-Cycles 1-8||33
380823|NCT01056276|911633|P1|COMPLETED|Treatment Period-Cycles 1-8||5
380824|NCT01056276|911632|P2|STARTED|Treatment Period-Cycles 1-8||41
380825|NCT01056276|911633|P1|STARTED|Treatment Period-Cycles 1-8||18
380826|NCT01056263|911647|P1|NOT COMPLETED|Overall Study||52
380827|NCT01056263|911647|P1|COMPLETED|Overall Study||0
380828|NCT01056263|911647|P1|STARTED|Overall Study||52
380829|NCT01056198|911653|P2|NOT COMPLETED|Overall Study||0
380830|NCT01056198|911654|P1|NOT COMPLETED|Overall Study||0
380831|NCT01056198|911653|P2|COMPLETED|Overall Study||24
380832|NCT01056198|911654|P1|COMPLETED|Overall Study||24
380833|NCT01056198|911653|P2|STARTED|Overall Study||24
380834|NCT01056198|911654|P1|STARTED|Overall Study||24
380835|NCT01056107|911670|P4|NOT COMPLETED|Overall Study||0
380836|NCT01056107|911671|P3|NOT COMPLETED|Overall Study||3
380837|NCT01056107|911672|P2|NOT COMPLETED|Overall Study||1
380838|NCT01056107|911673|P1|NOT COMPLETED|Overall Study||0
380839|NCT01056107|911670|P4|COMPLETED|Overall Study||12
380840|NCT01056107|911671|P3|COMPLETED|Overall Study||9
380841|NCT01056107|911672|P2|COMPLETED|Overall Study||10
380842|NCT01056107|911673|P1|COMPLETED|Overall Study||11
380843|NCT01056107|911670|P4|STARTED|Overall Study||12
380844|NCT01056107|911671|P3|STARTED|Overall Study||12
380845|NCT01056107|911672|P2|STARTED|Overall Study||11
380846|NCT01056107|911673|P1|STARTED|Overall Study||11
380847|NCT01056016|911721|P2|NOT COMPLETED|Overall Study||1
380848|NCT01056016|911722|P1|NOT COMPLETED|Overall Study||2
380849|NCT01056016|911721|P2|COMPLETED|Overall Study||26
380850|NCT01056016|911722|P1|COMPLETED|Overall Study||20
380851|NCT01056016|911721|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
380852|NCT01056016|911722|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
380853|NCT01055886|911730|P2|NOT COMPLETED|Overall Study||11
380854|NCT01055886|911731|P1|NOT COMPLETED|Overall Study||5
380855|NCT01055886|911730|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
380856|NCT01055886|911731|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
380857|NCT01055886|911730|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
380858|NCT01055886|911731|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
380859|NCT01055886|911730|P2|STARTED|Overall Study||32
380860|NCT01055886|911731|P1|STARTED|Overall Study||33
380861|NCT01055834|911743|P2|NOT COMPLETED|Treatment Period III||0
380862|NCT01055834|911744|P1|NOT COMPLETED|Treatment Period III||0
380863|NCT01055834|911743|P2|COMPLETED|Treatment Period III||14
380864|NCT01055834|911744|P1|COMPLETED|Treatment Period III||0
380865|NCT01055834|911743|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
380866|NCT01055834|911744|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
380867|NCT01055834|911743|P2|NOT COMPLETED|Treatment Period II||0
380868|NCT01055834|911744|P1|NOT COMPLETED|Treatment Period II||0
380869|NCT01055834|911743|P2|COMPLETED|Treatment Period II||21
380870|NCT01055834|911744|P1|COMPLETED|Treatment Period II||20
380871|NCT01055834|911743|P2|STARTED|Treatment Period II||21
380872|NCT01055834|911744|P1|STARTED|Treatment Period II||20
380873|NCT01055834|911743|P2|NOT COMPLETED|Treatment Period I||0
380874|NCT01055834|911744|P1|NOT COMPLETED|Treatment Period I||1
380875|NCT01055834|911743|P2|COMPLETED|Treatment Period I||21
380876|NCT01055834|911744|P1|COMPLETED|Treatment Period I||20
380877|NCT01055834|911743|P2|STARTED|Treatment Period I||21
380878|NCT01055834|911744|P1|STARTED|Treatment Period I||21
380879|NCT01055782|911758|P2|NOT COMPLETED|Overall Study||0
380880|NCT01055782|911759|P1|NOT COMPLETED|Overall Study||0
380881|NCT01055782|911758|P2|COMPLETED|Overall Study||449
380882|NCT01055782|911759|P1|COMPLETED|Overall Study||555
380883|NCT01055782|911758|P2|STARTED|Overall Study||449
380884|NCT01055782|911759|P1|STARTED|Overall Study||555
380885|NCT01055769|911767|P2|NOT COMPLETED|Second Intervention||0
380886|NCT01055769|911768|P1|NOT COMPLETED|Second Intervention||0
380887|NCT01055769|911767|P2|COMPLETED|Second Intervention||10
380888|NCT01055769|911768|P1|COMPLETED|Second Intervention||10
380889|NCT01055769|911767|P2|STARTED|Second Intervention||10
380890|NCT01055769|911768|P1|STARTED|Second Intervention||10
380891|NCT01055769|911767|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
380892|NCT01055769|911768|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
380893|NCT01055769|911767|P2|COMPLETED|Washout Period of Atleast 4 Days||10
380894|NCT01055769|911768|P1|COMPLETED|Washout Period of Atleast 4 Days||10
380895|NCT01055769|911767|P2|STARTED|Washout Period of Atleast 4 Days||10
380896|NCT01055769|911768|P1|STARTED|Washout Period of Atleast 4 Days||10
380897|NCT01055769|911767|P2|NOT COMPLETED|First Intervention||0
380898|NCT01055769|911768|P1|NOT COMPLETED|First Intervention||0
380899|NCT01055769|911767|P2|COMPLETED|First Intervention||10
380900|NCT01055769|911768|P1|COMPLETED|First Intervention||10
380901|NCT01055769|911767|P2|STARTED|First Intervention||10
380902|NCT01055769|911768|P1|STARTED|First Intervention||10
380903|NCT01055704|911786|P4|NOT COMPLETED|Overall Study||0
380904|NCT01055704|911787|P3|NOT COMPLETED|Overall Study||0
380905|NCT01055704|911788|P2|NOT COMPLETED|Overall Study||0
380906|NCT01055704|911789|P1|NOT COMPLETED|Overall Study||0
380907|NCT01055704|911786|P4|COMPLETED|Overall Study||8
380908|NCT01055704|911787|P3|COMPLETED|Overall Study||16
380909|NCT01055704|911788|P2|COMPLETED|Overall Study||8
380910|NCT01055704|911789|P1|COMPLETED|Overall Study||16
380911|NCT01055704|911786|P4|STARTED|Overall Study||8
380912|NCT01055704|911787|P3|STARTED|Overall Study||16
380913|NCT01055704|911788|P2|STARTED|Overall Study||8
380914|NCT01055704|911789|P1|STARTED|Overall Study||16
380915|NCT01055639|911829|P2|NOT COMPLETED|Overall Study||29
380916|NCT01055639|911830|P1|NOT COMPLETED|Overall Study||21
380917|NCT01055639|911829|P2|COMPLETED|Overall Study||31
380918|NCT01055639|911830|P1|COMPLETED|Overall Study||45
380919|NCT01055639|911829|P2|STARTED|Overall Study||60
380920|NCT01055639|911830|P1|STARTED|Overall Study||66
380921|NCT01055613|911854|P2|NOT COMPLETED|Overall Study||4
380922|NCT01055613|911855|P1|NOT COMPLETED|Overall Study||9
380923|NCT01055613|911854|P2|COMPLETED|Overall Study||96
380924|NCT01055613|911855|P1|COMPLETED|Overall Study||191
380925|NCT01055613|911854|P2|STARTED|Overall Study||100
380926|NCT01055613|911855|P1|STARTED|Overall Study||200
380927|NCT01055457|911863|P10|NOT COMPLETED|Overall Study||1
380928|NCT01055457|911864|P9|NOT COMPLETED|Overall Study||0
380929|NCT01055457|911865|P8|NOT COMPLETED|Overall Study||1
380930|NCT01055457|911866|P7|NOT COMPLETED|Overall Study||1
380931|NCT01055457|911867|P6|NOT COMPLETED|Overall Study||3
380932|NCT01055457|911868|P5|NOT COMPLETED|Overall Study||3
380933|NCT01055457|911869|P4|NOT COMPLETED|Overall Study||3
380934|NCT01055457|911870|P3|NOT COMPLETED|Overall Study||2
380935|NCT01055457|911871|P2|NOT COMPLETED|Overall Study||1
380936|NCT01055457|911872|P1|NOT COMPLETED|Overall Study||1
380937|NCT01055457|911863|P10|COMPLETED|Overall Study||19
380938|NCT01055457|911864|P9|COMPLETED|Overall Study||20
380939|NCT01055457|911865|P8|COMPLETED|Overall Study||18
380940|NCT01055457|911866|P7|COMPLETED|Overall Study||18
380941|NCT01055457|911867|P6|COMPLETED|Overall Study||15
380942|NCT01055457|911868|P5|COMPLETED|Overall Study||38
380943|NCT01055457|911869|P4|COMPLETED|Overall Study||37
380944|NCT01055457|911870|P3|COMPLETED|Overall Study||36
380945|NCT01055457|911871|P2|COMPLETED|Overall Study||39
380946|NCT01055457|911872|P1|COMPLETED|Overall Study||39
380947|NCT01055457|911863|P10|STARTED|Overall Study||20
380948|NCT01055457|911864|P9|STARTED|Overall Study||20
380949|NCT01055457|911865|P8|STARTED|Overall Study||19
380950|NCT01055457|911866|P7|STARTED|Overall Study||19
380951|NCT01055457|911867|P6|STARTED|Overall Study||18
380952|NCT01055457|911868|P5|STARTED|Overall Study||41
380953|NCT01055457|911869|P4|STARTED|Overall Study||40
380954|NCT01055457|911870|P3|STARTED|Overall Study||38
380955|NCT01055457|911871|P2|STARTED|Overall Study||40
380956|NCT01055457|911872|P1|STARTED|Overall Study||40
380957|NCT01055262|911904|P1|NOT COMPLETED|Overall Study||9
380958|NCT01055262|911904|P1|COMPLETED|Overall Study||160
380959|NCT01055262|911904|P1|STARTED|Overall Study||169
380960|NCT01055223|911915|P1|NOT COMPLETED|Overall Study||0
380961|NCT01055223|911915|P1|COMPLETED|Overall Study||98483
380962|NCT01055223|911915|P1|STARTED|Overall Study||98483
380963|NCT01055197|911945|P2|NOT COMPLETED|Overall Study||2
380964|NCT01055197|911946|P1|NOT COMPLETED|Overall Study||9
380965|NCT01055197|911945|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
380966|NCT01055197|911946|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
380967|NCT01055197|911945|P2|STARTED|Overall Study||46
380968|NCT01055197|911946|P1|STARTED|Overall Study||51
380969|NCT01055184|911952|P1|NOT COMPLETED|Overall Study||0
380970|NCT01055184|911952|P1|COMPLETED|Overall Study||34
380971|NCT01055184|911952|P1|STARTED|Overall Study||34
380972|NCT01055171|911958|P2|NOT COMPLETED|Overall Study||7
380973|NCT01055171|911959|P1|NOT COMPLETED|Overall Study||11
380974|NCT01055171|911958|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
380975|NCT01055171|911959|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
380976|NCT01055171|911958|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
380977|NCT01055171|911959|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
380978|NCT01055171|911958|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
380979|NCT01055171|911959|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
380980|NCT01055171|911958|P2|STARTED|Overall Study|Randomized to receive placebo.|28
380981|NCT01055171|911959|P1|STARTED|Overall Study|Randomized to receive medication.|29
380982|NCT01055132|911973|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
380983|NCT01055132|911974|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
380984|NCT01055132|911973|P2|COMPLETED|Period 2 (5-9 Days)||32
380985|NCT01055132|911974|P1|COMPLETED|Period 2 (5-9 Days)||35
380986|NCT01055132|911973|P2|STARTED|Period 2 (5-9 Days)||33
380987|NCT01055132|911974|P1|STARTED|Period 2 (5-9 Days)||35
380988|NCT01055132|911973|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
380989|NCT01055132|911974|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
380990|NCT01055132|911973|P2|COMPLETED|Period 1 (5-9 Days)||33
380991|NCT01055132|911974|P1|COMPLETED|Period 1 (5-9 Days)||35
380992|NCT01055132|911973|P2|STARTED|Period 1 (5-9 Days)||33
380993|NCT01055132|911974|P1|STARTED|Period 1 (5-9 Days)||36
380994|NCT01054976|911985|P1|NOT COMPLETED|Overall Study||35
380995|NCT01054976|911985|P1|COMPLETED|Overall Study||57
380996|NCT01054976|911985|P1|STARTED|Overall Study||92
380997|NCT01054911|911993|P1|NOT COMPLETED|Overall Study||0
380998|NCT01054911|911993|P1|COMPLETED|Overall Study||5
380999|NCT01054911|911993|P1|STARTED|Overall Study||5
381000|NCT01054885|912006|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
381001|NCT01054885|912007|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
381002|NCT01054885|912008|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
381003|NCT01054885|912009|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
381004|NCT01054885|912010|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
381005|NCT01054885|912011|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
381006|NCT01054885|912012|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
381007|NCT01054885|912006|P7|COMPLETED|24-week, Double-blind Treatment Period||158
381008|NCT01054885|912007|P6|COMPLETED|24-week, Double-blind Treatment Period||144
381009|NCT01054885|912008|P5|COMPLETED|24-week, Double-blind Treatment Period||161
381010|NCT01054885|912009|P4|COMPLETED|24-week, Double-blind Treatment Period||160
381011|NCT01054885|912010|P3|COMPLETED|24-week, Double-blind Treatment Period||155
381012|NCT01054885|912011|P2|COMPLETED|24-week, Double-blind Treatment Period||146
381013|NCT01054885|912012|P1|COMPLETED|24-week, Double-blind Treatment Period||0
381014|NCT01054885|912006|P7|STARTED|24-week, Double-blind Treatment Period||205
381015|NCT01054885|912007|P6|STARTED|24-week, Double-blind Treatment Period||204
381016|NCT01054885|912008|P5|STARTED|24-week, Double-blind Treatment Period||203
381017|NCT01054885|912009|P4|STARTED|24-week, Double-blind Treatment Period||203
381018|NCT01054885|912010|P3|STARTED|24-week, Double-blind Treatment Period||204
381019|NCT01054885|912011|P2|STARTED|24-week, Double-blind Treatment Period||205
381020|NCT01054885|912012|P1|STARTED|24-week, Double-blind Treatment Period||0
381021|NCT01054885|912006|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381022|NCT01054885|912007|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381023|NCT01054885|912008|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381024|NCT01054885|912009|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381025|NCT01054885|912010|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381026|NCT01054885|912011|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381027|NCT01054885|912012|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
381028|NCT01054885|912006|P7|COMPLETED|2-week, Single-blind Run-In Period||0
381029|NCT01054885|912007|P6|COMPLETED|2-week, Single-blind Run-In Period||0
381030|NCT01054885|912008|P5|COMPLETED|2-week, Single-blind Run-In Period||0
381031|NCT01054885|912009|P4|COMPLETED|2-week, Single-blind Run-In Period||0
381032|NCT01054885|912010|P3|COMPLETED|2-week, Single-blind Run-In Period||0
381033|NCT01054885|912011|P2|COMPLETED|2-week, Single-blind Run-In Period||0
381034|NCT01054885|912012|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
381035|NCT01054885|912006|P7|STARTED|2-week, Single-blind Run-In Period||0
381036|NCT01054885|912007|P6|STARTED|2-week, Single-blind Run-In Period||0
381037|NCT01054885|912008|P5|STARTED|2-week, Single-blind Run-In Period||0
381038|NCT01054885|912009|P4|STARTED|2-week, Single-blind Run-In Period||0
381039|NCT01054885|912010|P3|STARTED|2-week, Single-blind Run-In Period||0
381040|NCT01054885|912011|P2|STARTED|2-week, Single-blind Run-In Period||0
381041|NCT01054885|912012|P1|STARTED|2-week, Single-blind Run-In Period||1577
381042|NCT01054846|912052|P2|NOT COMPLETED|Overall Study||17
381043|NCT01054846|912053|P1|NOT COMPLETED|Overall Study||76
381044|NCT01054846|912052|P2|COMPLETED|Overall Study||51
381045|NCT01054846|912053|P1|COMPLETED|Overall Study||246
381046|NCT01054846|912052|P2|STARTED|Overall Study||68
381047|NCT01054846|912053|P1|STARTED|Overall Study||322
381048|NCT01054820|912060|P1|NOT COMPLETED|Overall Study||2
381049|NCT01054820|912060|P1|COMPLETED|Overall Study||121
381050|NCT01054820|912060|P1|STARTED|Overall Study||123
381051|NCT01054742|912074|P1|NOT COMPLETED|Overall Study||0
381052|NCT01054742|912074|P1|COMPLETED|Overall Study||2
381053|NCT01054742|912074|P1|STARTED|Overall Study||2
381054|NCT01054729|912082|P4|NOT COMPLETED|Overall Study||3
381055|NCT01054729|912083|P3|NOT COMPLETED|Overall Study||6
381056|NCT01054729|912084|P2|NOT COMPLETED|Overall Study||5
381057|NCT01054729|912085|P1|NOT COMPLETED|Overall Study||4
381058|NCT01054729|912082|P4|COMPLETED|Overall Study||11
381059|NCT01054729|912083|P3|COMPLETED|Overall Study||9
381060|NCT01054729|912084|P2|COMPLETED|Overall Study||14
381061|NCT01054729|912085|P1|COMPLETED|Overall Study||12
381062|NCT01054729|912082|P4|Randomized and Treated|Overall Study||14
381063|NCT01054729|912083|P3|Randomized and Treated|Overall Study||15
381064|NCT01054729|912084|P2|Randomized and Treated|Overall Study||18
381065|NCT01054729|912085|P1|Randomized and Treated|Overall Study||16
381066|NCT01054729|912082|P4|STARTED|Overall Study||14
381067|NCT01054729|912083|P3|STARTED|Overall Study||15
381068|NCT01054729|912084|P2|STARTED|Overall Study||19
381069|NCT01054729|912085|P1|STARTED|Overall Study||16
381070|NCT01054703|912146|P1|NOT COMPLETED|Overall Study||0
381071|NCT01054703|912146|P1|COMPLETED|Overall Study||14
381072|NCT01054703|912146|P1|STARTED|Overall Study||14
381073|NCT01054625|912153|P3|NOT COMPLETED|Overall Study||1
381074|NCT01054625|912154|P2|NOT COMPLETED|Overall Study||3
381075|NCT01054625|912155|P1|NOT COMPLETED|Overall Study||2
381076|NCT01054625|912153|P3|COMPLETED|Overall Study||9
381077|NCT01054625|912154|P2|COMPLETED|Overall Study||9
381078|NCT01054625|912155|P1|COMPLETED|Overall Study||6
381079|NCT01054625|912153|P3|STARTED|Overall Study||10
381080|NCT01054625|912154|P2|STARTED|Overall Study||12
381081|NCT01054625|912155|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
381082|NCT01054586|912185|P4|NOT COMPLETED|Overall Study||0
381083|NCT01054586|912186|P3|NOT COMPLETED|Overall Study||0
381084|NCT01054586|912187|P2|NOT COMPLETED|Overall Study||0
381085|NCT01054586|912188|P1|NOT COMPLETED|Overall Study||0
381086|NCT01054586|912185|P4|COMPLETED|Overall Study||101
381087|NCT01054586|912186|P3|COMPLETED|Overall Study||8
381088|NCT01054586|912187|P2|COMPLETED|Overall Study||15
381089|NCT01054586|912188|P1|COMPLETED|Overall Study||43
381090|NCT01054586|912185|P4|STARTED|Overall Study||101
381091|NCT01054586|912186|P3|STARTED|Overall Study||8
381092|NCT01054586|912187|P2|STARTED|Overall Study||15
381093|NCT01054586|912188|P1|STARTED|Overall Study||43
381094|NCT01054573|912280|P4|NOT COMPLETED|Overall Study||2
381095|NCT01054573|912281|P3|NOT COMPLETED|Overall Study||3
381096|NCT01054573|912282|P2|NOT COMPLETED|Overall Study||4
381097|NCT01054573|912283|P1|NOT COMPLETED|Overall Study||1
381098|NCT01054573|912280|P4|COMPLETED|Overall Study||25
381099|NCT01054573|912281|P3|COMPLETED|Overall Study||19
381100|NCT01054573|912282|P2|COMPLETED|Overall Study||28
381101|NCT01054573|912283|P1|COMPLETED|Overall Study||8
381102|NCT01054573|912280|P4|STARTED|Overall Study||27
381103|NCT01054573|912281|P3|STARTED|Overall Study||22
381104|NCT01054573|912282|P2|STARTED|Overall Study||32
381105|NCT01054573|912283|P1|STARTED|Overall Study||9
381106|NCT01054560|912329|P2|NOT COMPLETED|Overall Study||28
381107|NCT01054560|912330|P1|NOT COMPLETED|Overall Study||13
381108|NCT01054560|912329|P2|COMPLETED|Overall Study||27
381109|NCT01054560|912330|P1|COMPLETED|Overall Study||45
381110|NCT01054560|912329|P2|STARTED|Overall Study||55
381111|NCT01054560|912330|P1|STARTED|Overall Study||58
381112|NCT01054404|912354|P2|NOT COMPLETED|Overall Study||0
381113|NCT01054404|912355|P1|NOT COMPLETED|Overall Study||0
381114|NCT01054404|912354|P2|COMPLETED|Overall Study||13
381115|NCT01054404|912355|P1|COMPLETED|Overall Study||10
381116|NCT01054404|912354|P2|STARTED|Overall Study||13
381117|NCT01054404|912355|P1|STARTED|Overall Study||10
381118|NCT01054339|912364|P3|NOT COMPLETED|Overall Study||0
381119|NCT01054339|912365|P2|NOT COMPLETED|Overall Study||0
381120|NCT01054339|912366|P1|NOT COMPLETED|Overall Study||0
381121|NCT01054339|912364|P3|COMPLETED|Overall Study||3
381122|NCT01054339|912365|P2|COMPLETED|Overall Study||3
381123|NCT01054339|912366|P1|COMPLETED|Overall Study||3
381124|NCT01054339|912364|P3|STARTED|Overall Study||3
381125|NCT01054339|912365|P2|STARTED|Overall Study||3
381126|NCT01054339|912366|P1|STARTED|Overall Study||3
381127|NCT01054222|912380|P1|NOT COMPLETED|Overall Study||11
381128|NCT01054222|912380|P1|COMPLETED|Overall Study||20
381129|NCT01054222|912380|P1|STARTED|Overall Study||31
381130|NCT01054183|912401|P2|NOT COMPLETED|Overall Study||0
381131|NCT01054183|912402|P1|NOT COMPLETED|Overall Study||0
381132|NCT01054183|912401|P2|COMPLETED|Overall Study||12
381133|NCT01054183|912402|P1|COMPLETED|Overall Study||10
381134|NCT01054183|912401|P2|STARTED|Overall Study||12
381135|NCT01054183|912402|P1|STARTED|Overall Study||10
381136|NCT01054170|912412|P2|NOT COMPLETED|Overall Study||6
381137|NCT01054170|912413|P1|NOT COMPLETED|Overall Study||4
381138|NCT01054170|912412|P2|COMPLETED|Overall Study||21
381139|NCT01054170|912413|P1|COMPLETED|Overall Study||21
381140|NCT01054170|912412|P2|STARTED|Overall Study||27
381141|NCT01054170|912413|P1|STARTED|Overall Study||25
381142|NCT01054079|912465|P1|NOT COMPLETED|Overall Study||0
381227|NCT01053247|912627|P3|STARTED|Overall Study||264
381143|NCT01054079|912465|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
381144|NCT01054079|912465|P1|# Recieved Proper PSA Testing|Overall Study||10
381145|NCT01054079|912465|P1|STARTED|Overall Study||20
381146|NCT01053988|912474|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
381147|NCT01053988|912475|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
381148|NCT01053988|912476|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
381149|NCT01053988|912477|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
381150|NCT01053988|912478|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
381151|NCT01053988|912479|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
381152|NCT01053988|912474|P6|COMPLETED|24-week, Double-blind Treatment Period||151
381153|NCT01053988|912475|P5|COMPLETED|24-week, Double-blind Treatment Period||147
381154|NCT01053988|912476|P4|COMPLETED|24-week, Double-blind Treatment Period||142
381155|NCT01053988|912477|P3|COMPLETED|24-week, Double-blind Treatment Period||145
381156|NCT01053988|912478|P2|COMPLETED|24-week, Double-blind Treatment Period||138
381157|NCT01053988|912479|P1|COMPLETED|24-week, Double-blind Treatment Period||0
381158|NCT01053988|912474|P6|STARTED|24-week, Double-blind Treatment Period||206
381159|NCT01053988|912475|P5|STARTED|24-week, Double-blind Treatment Period||206
381160|NCT01053988|912476|P4|STARTED|24-week, Double-blind Treatment Period||205
381161|NCT01053988|912477|P3|STARTED|24-week, Double-blind Treatment Period||206
381162|NCT01053988|912478|P2|STARTED|24-week, Double-blind Treatment Period||207
381163|NCT01053988|912479|P1|STARTED|24-week, Double-blind Treatment Period||0
381164|NCT01053988|912474|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381165|NCT01053988|912475|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381166|NCT01053988|912476|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381167|NCT01053988|912477|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381168|NCT01053988|912478|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
381169|NCT01053988|912479|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
381170|NCT01053988|912474|P6|COMPLETED|2-week, Single-blind Run-In Period||0
381171|NCT01053988|912475|P5|COMPLETED|2-week, Single-blind Run-In Period||0
381172|NCT01053988|912476|P4|COMPLETED|2-week, Single-blind Run-In Period||0
381173|NCT01053988|912477|P3|COMPLETED|2-week, Single-blind Run-In Period||0
381174|NCT01053988|912478|P2|COMPLETED|2-week, Single-blind Run-In Period||0
381175|NCT01053988|912479|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
381176|NCT01053988|912474|P6|STARTED|2-week, Single-blind Run-In Period||0
381177|NCT01053988|912475|P5|STARTED|2-week, Single-blind Run-In Period||0
381178|NCT01053988|912476|P4|STARTED|2-week, Single-blind Run-In Period||0
381179|NCT01053988|912477|P3|STARTED|2-week, Single-blind Run-In Period||0
381180|NCT01053988|912478|P2|STARTED|2-week, Single-blind Run-In Period||0
381181|NCT01053988|912479|P1|STARTED|2-week, Single-blind Run-In Period||1390
381182|NCT01053897|912511|P1|NOT COMPLETED|Overall Study||0
381183|NCT01053897|912511|P1|COMPLETED|Overall Study||5
381184|NCT01053897|912511|P1|STARTED|Overall Study||5
381185|NCT01053819|912523|P1|NOT COMPLETED|Overall Study||0
381186|NCT01053819|912523|P1|COMPLETED|Overall Study||6
381187|NCT01053819|912523|P1|STARTED|Overall Study||6
381188|NCT01053741|912529|P2|NOT COMPLETED|2nd Study Intervention||1
381189|NCT01053741|912530|P1|NOT COMPLETED|2nd Study Intervention||0
381190|NCT01053741|912529|P2|COMPLETED|2nd Study Intervention||5
381191|NCT01053741|912530|P1|COMPLETED|2nd Study Intervention||5
381192|NCT01053741|912529|P2|STARTED|2nd Study Intervention||6
381193|NCT01053741|912530|P1|STARTED|2nd Study Intervention||5
381194|NCT01053741|912529|P2|NOT COMPLETED|14 Day Washout||0
381195|NCT01053741|912530|P1|NOT COMPLETED|14 Day Washout||0
381196|NCT01053741|912529|P2|COMPLETED|14 Day Washout||6
381197|NCT01053741|912530|P1|COMPLETED|14 Day Washout||5
381198|NCT01053741|912529|P2|STARTED|14 Day Washout||6
381199|NCT01053741|912530|P1|STARTED|14 Day Washout||5
381200|NCT01053741|912529|P2|NOT COMPLETED|1st Intervention||0
381201|NCT01053741|912530|P1|NOT COMPLETED|1st Intervention||0
381202|NCT01053741|912529|P2|COMPLETED|1st Intervention||6
381203|NCT01053741|912530|P1|COMPLETED|1st Intervention||5
381204|NCT01053741|912529|P2|STARTED|1st Intervention||6
381205|NCT01053741|912530|P1|STARTED|1st Intervention||5
381206|NCT01053663|912539|P1|NOT COMPLETED|Overall Study||6
381207|NCT01053663|912539|P1|COMPLETED|Overall Study||3
381208|NCT01053663|912539|P1|STARTED|Overall Study||9
381209|NCT01053507|912582|P2|NOT COMPLETED|Overall Study||1
381210|NCT01053507|912583|P1|NOT COMPLETED|Overall Study||3
381211|NCT01053507|912582|P2|COMPLETED|Overall Study||11
381212|NCT01053507|912583|P1|COMPLETED|Overall Study||8
381213|NCT01053507|912582|P2|STARTED|Overall Study||12
381214|NCT01053507|912583|P1|STARTED|Overall Study||11
381215|NCT01053429|912597|P1|NOT COMPLETED|Overall Study||373
381216|NCT01053429|912597|P1|COMPLETED|Overall Study||3018
381217|NCT01053429|912597|P1|STARTED|Overall Study||3391
381218|NCT01053312|912606|P1|NOT COMPLETED|Overall Study||0
381219|NCT01053312|912606|P1|COMPLETED|Overall Study||7
381220|NCT01053312|912606|P1|STARTED|Overall Study||7
381221|NCT01053247|912627|P3|NOT COMPLETED|Overall Study||28
381222|NCT01053247|912628|P2|NOT COMPLETED|Overall Study||19
381223|NCT01053247|912629|P1|NOT COMPLETED|Overall Study||20
381224|NCT01053247|912627|P3|COMPLETED|Overall Study||236
381225|NCT01053247|912628|P2|COMPLETED|Overall Study||241
381226|NCT01053247|912629|P1|COMPLETED|Overall Study||249
381228|NCT01053247|912628|P2|STARTED|Overall Study||260
381229|NCT01053247|912629|P1|STARTED|Overall Study||269
381230|NCT01053156|912639|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
381231|NCT01053156|912640|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
381232|NCT01053156|912639|P2|COMPLETED|Second Intervention (Week 13-24)||22
381233|NCT01053156|912640|P1|COMPLETED|Second Intervention (Week 13-24)||26
381234|NCT01053156|912639|P2|STARTED|Second Intervention (Week 13-24)||27
381235|NCT01053156|912640|P1|STARTED|Second Intervention (Week 13-24)||28
381236|NCT01053156|912639|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
381237|NCT01053156|912640|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
381238|NCT01053156|912639|P2|COMPLETED|First Intervention (Week 1-12)||27
381239|NCT01053156|912640|P1|COMPLETED|First Intervention (Week 1-12)||28
381240|NCT01053156|912639|P2|STARTED|First Intervention (Week 1-12)||33
381241|NCT01053156|912640|P1|STARTED|First Intervention (Week 1-12)||33
381242|NCT01053078|912678|P2|NOT COMPLETED|Overall Study||3
381243|NCT01053078|912679|P1|NOT COMPLETED|Overall Study||4
381244|NCT01053078|912678|P2|COMPLETED|Overall Study||12
381245|NCT01053078|912679|P1|COMPLETED|Overall Study||10
381246|NCT01053078|912678|P2|STARTED|Overall Study||15
381247|NCT01053078|912679|P1|STARTED|Overall Study||14
381248|NCT01053000|912685|P2|NOT COMPLETED|Overall Study||0
381249|NCT01053000|912686|P1|NOT COMPLETED|Overall Study||0
381250|NCT01053000|912685|P2|COMPLETED|Overall Study||5
381251|NCT01053000|912686|P1|COMPLETED|Overall Study||5
381252|NCT01053000|912685|P2|STARTED|Overall Study||5
381253|NCT01053000|912686|P1|STARTED|Overall Study||5
381254|NCT01052948|912696|P4|NOT COMPLETED|Overall Study||0
381255|NCT01052948|912697|P3|NOT COMPLETED|Overall Study||0
381256|NCT01052948|912698|P2|NOT COMPLETED|Overall Study||0
381257|NCT01052948|912699|P1|NOT COMPLETED|Overall Study||0
381258|NCT01052948|912696|P4|COMPLETED|Overall Study||29311
381259|NCT01052948|912697|P3|COMPLETED|Overall Study||15147
381260|NCT01052948|912698|P2|COMPLETED|Overall Study||14669
381261|NCT01052948|912699|P1|COMPLETED|Overall Study||27812
381262|NCT01052948|912696|P4|STARTED|Overall Study||29311
381263|NCT01052948|912697|P3|STARTED|Overall Study||15147
381264|NCT01052948|912698|P2|STARTED|Overall Study||14669
381265|NCT01052948|912699|P1|STARTED|Overall Study||27812
381266|NCT01052844|912723|P2|NOT COMPLETED|Overall Study||1
381267|NCT01052844|912724|P1|NOT COMPLETED|Overall Study||0
381268|NCT01052844|912723|P2|COMPLETED|Overall Study||39
381269|NCT01052844|912724|P1|COMPLETED|Overall Study||40
381270|NCT01052844|912723|P2|STARTED|Overall Study||40
381271|NCT01052844|912724|P1|STARTED|Overall Study||40
381272|NCT01052831|912734|P2|NOT COMPLETED|Overall Study||1
381273|NCT01052831|912735|P1|NOT COMPLETED|Overall Study||4
381274|NCT01052831|912734|P2|COMPLETED|Overall Study||23
381275|NCT01052831|912735|P1|COMPLETED|Overall Study||22
381276|NCT01052831|912734|P2|STARTED|Overall Study||24
381277|NCT01052831|912735|P1|STARTED|Overall Study||26
381278|NCT01052701|912745|P2|NOT COMPLETED|Overall Study||0
381279|NCT01052701|912746|P1|NOT COMPLETED|Overall Study||0
381280|NCT01052701|912745|P2|COMPLETED|Overall Study||12
381281|NCT01052701|912746|P1|COMPLETED|Overall Study||14
381282|NCT01052701|912745|P2|STARTED|Overall Study||12
381283|NCT01052701|912746|P1|STARTED|Overall Study||14
381284|NCT01052662|912757|P3|NOT COMPLETED|Overall Study||22
381285|NCT01052662|912758|P2|NOT COMPLETED|Overall Study||22
381286|NCT01052662|912759|P1|NOT COMPLETED|Overall Study||22
381287|NCT01052662|912757|P3|COMPLETED|Overall Study||10
381288|NCT01052662|912758|P2|COMPLETED|Overall Study||5
381289|NCT01052662|912759|P1|COMPLETED|Overall Study||6
381290|NCT01052662|912757|P3|Discontinuation Phase|Overall Study||10
381291|NCT01052662|912758|P2|Discontinuation Phase|Overall Study||5
381292|NCT01052662|912759|P1|Discontinuation Phase|Overall Study||6
381293|NCT01052662|912757|P3|Stabilization Phase|Overall Study||26
381294|NCT01052662|912758|P2|Stabilization Phase|Overall Study||21
381295|NCT01052662|912759|P1|Stabilization Phase|Overall Study||21
381296|NCT01052662|912757|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
381297|NCT01052662|912758|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
381298|NCT01052662|912759|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
381299|NCT01052545|912775|P2|NOT COMPLETED|Overall Study||0
381300|NCT01052545|912776|P1|NOT COMPLETED|Overall Study||0
381301|NCT01052545|912775|P2|COMPLETED|Overall Study||731
381302|NCT01052545|912776|P1|COMPLETED|Overall Study||867
381303|NCT01052545|912775|P2|STARTED|Overall Study||731
381304|NCT01052545|912776|P1|STARTED|Overall Study||867
381305|NCT01052480|912790|P2|NOT COMPLETED|Overall Study||17
381306|NCT01052480|912791|P1|NOT COMPLETED|Overall Study||8
381307|NCT01052480|912790|P2|COMPLETED|Overall Study||32
381308|NCT01052480|912791|P1|COMPLETED|Overall Study||41
381309|NCT01052480|912790|P2|STARTED|Overall Study||49
381310|NCT01052480|912791|P1|STARTED|Overall Study||49
381311|NCT01052428|912841|P2|NOT COMPLETED|Overall Study||1
381312|NCT01052428|912842|P1|NOT COMPLETED|Overall Study||1
381313|NCT01052428|912841|P2|COMPLETED|Overall Study||18
381314|NCT01052428|912842|P1|COMPLETED|Overall Study||18
381315|NCT01052428|912841|P2|STARTED|Overall Study||19
381316|NCT01052428|912842|P1|STARTED|Overall Study||19
381317|NCT01052272|912864|P4|NOT COMPLETED|Overall Study||7
381318|NCT01052272|912865|P3|NOT COMPLETED|Overall Study||8
381319|NCT01052272|912866|P2|NOT COMPLETED|Overall Study||7
381320|NCT01052272|912867|P1|NOT COMPLETED|Overall Study||5
381321|NCT01052272|912864|P4|COMPLETED|Overall Study||11
381322|NCT01052272|912865|P3|COMPLETED|Overall Study||10
381323|NCT01052272|912866|P2|COMPLETED|Overall Study||11
381324|NCT01052272|912867|P1|COMPLETED|Overall Study||13
381325|NCT01052272|912864|P4|STARTED|Overall Study||18
381326|NCT01052272|912865|P3|STARTED|Overall Study||18
381327|NCT01052272|912866|P2|STARTED|Overall Study||18
381328|NCT01052272|912867|P1|STARTED|Overall Study||18
381329|NCT01052207|912903|P2|NOT COMPLETED|Overall Study||0
381330|NCT01052207|912904|P1|NOT COMPLETED|Overall Study||0
381331|NCT01052207|912903|P2|COMPLETED|Overall Study||42
381332|NCT01052207|912904|P1|COMPLETED|Overall Study||60
381333|NCT01052207|912903|P2|STARTED|Overall Study||42
381334|NCT01052207|912904|P1|STARTED|Overall Study||60
381335|NCT01052116|912912|P2|NOT COMPLETED|Overall Study||27
381336|NCT01052116|912913|P1|NOT COMPLETED|Overall Study||14
381337|NCT01052116|912912|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
381338|NCT01052116|912913|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
381339|NCT01052116|912912|P2|STARTED|Overall Study||193
381340|NCT01052116|912913|P1|STARTED|Overall Study||193
381341|NCT01052077|912921|P4|NOT COMPLETED|Phase A+||21
381342|NCT01052077|912922|P3|NOT COMPLETED|Phase A+||0
381343|NCT01052077|912923|P2|NOT COMPLETED|Phase A+||0
381344|NCT01052077|912924|P1|NOT COMPLETED|Phase A+||0
381345|NCT01052077|912921|P4|COMPLETED|Phase A+||230
381346|NCT01052077|912922|P3|COMPLETED|Phase A+||0
381347|NCT01052077|912923|P2|COMPLETED|Phase A+||0
381348|NCT01052077|912924|P1|COMPLETED|Phase A+||0
381349|NCT01052077|912921|P4|STARTED|Phase A+||251
381350|NCT01052077|912922|P3|STARTED|Phase A+||0
381351|NCT01052077|912923|P2|STARTED|Phase A+||0
381352|NCT01052077|912924|P1|STARTED|Phase A+||0
381353|NCT01052077|912921|P4|NOT COMPLETED|Phase B||0
381354|NCT01052077|912922|P3|NOT COMPLETED|Phase B||16
381355|NCT01052077|912923|P2|NOT COMPLETED|Phase B||18
381356|NCT01052077|912924|P1|NOT COMPLETED|Phase B||0
381357|NCT01052077|912921|P4|COMPLETED|Phase B||0
381358|NCT01052077|912922|P3|COMPLETED|Phase B||171
381359|NCT01052077|912923|P2|COMPLETED|Phase B||167
381360|NCT01052077|912924|P1|COMPLETED|Phase B||0
381361|NCT01052077|912921|P4|STARTED|Phase B||0
381362|NCT01052077|912922|P3|STARTED|Phase B||187
381363|NCT01052077|912923|P2|STARTED|Phase B||185
381364|NCT01052077|912924|P1|STARTED|Phase B||0
381365|NCT01052077|912921|P4|NOT COMPLETED|Phase A||0
381366|NCT01052077|912922|P3|NOT COMPLETED|Phase A||0
381367|NCT01052077|912923|P2|NOT COMPLETED|Phase A||0
381368|NCT01052077|912924|P1|NOT COMPLETED|Phase A||146
381369|NCT01052077|912921|P4|COMPLETED|Phase A||0
381370|NCT01052077|912922|P3|COMPLETED|Phase A||0
381371|NCT01052077|912923|P2|COMPLETED|Phase A||0
381372|NCT01052077|912924|P1|COMPLETED|Phase A||623
381373|NCT01052077|912921|P4|STARTED|Phase A||0
381374|NCT01052077|912922|P3|STARTED|Phase A||0
381375|NCT01052077|912923|P2|STARTED|Phase A||0
381376|NCT01052077|912924|P1|STARTED|Phase A||769
381377|NCT01052038|912951|P3|NOT COMPLETED|Overall Study||4
381378|NCT01052038|912952|P2|NOT COMPLETED|Overall Study||6
381379|NCT01052038|912953|P1|NOT COMPLETED|Overall Study||4
381380|NCT01052038|912951|P3|COMPLETED|Overall Study||36
381381|NCT01052038|912952|P2|COMPLETED|Overall Study||34
381382|NCT01052038|912953|P1|COMPLETED|Overall Study||36
381383|NCT01052038|912951|P3|STARTED|Overall Study||40
381384|NCT01052038|912952|P2|STARTED|Overall Study||40
381385|NCT01052038|912953|P1|STARTED|Overall Study||40
381386|NCT01051986|912975|P2|NOT COMPLETED|Overall Study||4
381387|NCT01051986|912976|P1|NOT COMPLETED|Overall Study||5
381388|NCT01051986|912975|P2|COMPLETED|Overall Study||108
381389|NCT01051986|912976|P1|COMPLETED|Overall Study||107
381390|NCT01051986|912975|P2|STARTED|Overall Study||112
381391|NCT01051986|912976|P1|STARTED|Overall Study||112
381392|NCT01051921|912990|P1|NOT COMPLETED|Overall Study||30
381393|NCT01051921|912990|P1|COMPLETED|Overall Study||37
381394|NCT01051921|912990|P1|STARTED|Overall Study||67
381395|NCT01051856|912997|P2|NOT COMPLETED|Overall Study||0
381396|NCT01051856|912998|P1|NOT COMPLETED|Overall Study||1
381397|NCT01051856|912997|P2|COMPLETED|Overall Study||35
381398|NCT01051856|912998|P1|COMPLETED|Overall Study||32
381399|NCT01051856|912997|P2|STARTED|Overall Study||35
381400|NCT01051856|912998|P1|STARTED|Overall Study||33
381401|NCT01051817|913008|P2|NOT COMPLETED|Overall Study||9
381402|NCT01051817|913009|P1|NOT COMPLETED|Overall Study||3
381403|NCT01051817|913008|P2|COMPLETED|Overall Study||26
381404|NCT01051817|913009|P1|COMPLETED|Overall Study||35
381405|NCT01051817|913008|P2|STARTED|Overall Study||35
381406|NCT01051817|913009|P1|STARTED|Overall Study||38
381407|NCT01051778|913021|P2|NOT COMPLETED|Overall Study||0
381408|NCT01051778|913022|P1|NOT COMPLETED|Overall Study||0
381409|NCT01051778|913021|P2|COMPLETED|Overall Study|November 2009|30
381410|NCT01051778|913022|P1|COMPLETED|Overall Study|November 2009|30
381411|NCT01051778|913021|P2|STARTED|Overall Study|June 2006|30
381412|NCT01051778|913022|P1|STARTED|Overall Study|June 2006|30
381413|NCT01051739|913030|P2|NOT COMPLETED|Overall Study||13
381414|NCT01051739|913031|P1|NOT COMPLETED|Overall Study||28
381415|NCT01051739|913030|P2|COMPLETED|Overall Study||47
381416|NCT01051739|913031|P1|COMPLETED|Overall Study||92
381417|NCT01051739|913030|P2|STARTED|Overall Study||60
381418|NCT01051739|913031|P1|STARTED|Overall Study||120
381419|NCT01051570|913037|P1|NOT COMPLETED|Overall Study||0
381420|NCT01051570|913037|P1|COMPLETED|Overall Study||26
381421|NCT01051570|913037|P1|STARTED|Overall Study||26
381422|NCT01051557|913048|P7|NOT COMPLETED|Overall Study||6
381423|NCT01051557|913049|P6|NOT COMPLETED|Overall Study||6
381424|NCT01051557|913050|P5|NOT COMPLETED|Overall Study||7
381425|NCT01051557|913051|P4|NOT COMPLETED|Overall Study||3
381426|NCT01051557|913052|P3|NOT COMPLETED|Overall Study||6
381427|NCT01051557|913053|P2|NOT COMPLETED|Overall Study||3
381428|NCT01051557|913054|P1|NOT COMPLETED|Overall Study||4
381429|NCT01051557|913048|P7|COMPLETED|Overall Study||0
381430|NCT01051557|913049|P6|COMPLETED|Overall Study||0
381431|NCT01051557|913050|P5|COMPLETED|Overall Study||1
381432|NCT01051557|913051|P4|COMPLETED|Overall Study||0
381433|NCT01051557|913052|P3|COMPLETED|Overall Study||0
381434|NCT01051557|913053|P2|COMPLETED|Overall Study||0
381435|NCT01051557|913054|P1|COMPLETED|Overall Study||0
381436|NCT01051557|913048|P7|STARTED|Overall Study||6
381437|NCT01051557|913049|P6|STARTED|Overall Study||6
381438|NCT01051557|913050|P5|STARTED|Overall Study||8
381439|NCT01051557|913051|P4|STARTED|Overall Study||3
381440|NCT01051557|913052|P3|STARTED|Overall Study||6
381441|NCT01051557|913053|P2|STARTED|Overall Study||3
381442|NCT01051557|913054|P1|STARTED|Overall Study||4
381443|NCT01051466|913066|P2|NOT COMPLETED|Overall Study||5
381444|NCT01051466|913067|P1|NOT COMPLETED|Overall Study||8
381445|NCT01051466|913066|P2|COMPLETED|Overall Study||23
381446|NCT01051466|913067|P1|COMPLETED|Overall Study||24
381447|NCT01051466|913066|P2|STARTED|Overall Study||28
381448|NCT01051466|913067|P1|STARTED|Overall Study||32
381449|NCT01051440|913101|P2|NOT COMPLETED|Overall Study||0
381450|NCT01051440|913102|P1|NOT COMPLETED|Overall Study||0
381451|NCT01051440|913101|P2|COMPLETED|Overall Study||1
381452|NCT01051440|913102|P1|COMPLETED|Overall Study||1
381453|NCT01051440|913101|P2|STARTED|Overall Study||1
381454|NCT01051440|913102|P1|STARTED|Overall Study||1
381455|NCT01051323|913114|P1|NOT COMPLETED|Overall Study||539
381456|NCT01051323|913114|P1|COMPLETED|Overall Study||1041
381457|NCT01051323|913114|P1|Received at Least One Dose|Overall Study||1547
381458|NCT01051323|913114|P1|STARTED|Overall Study||1580
381459|NCT01050998|913141|P5|NOT COMPLETED|Overall Study||14
381460|NCT01050998|913142|P4|NOT COMPLETED|Overall Study||3
381461|NCT01050998|913143|P3|NOT COMPLETED|Overall Study||3
381462|NCT01050998|913144|P2|NOT COMPLETED|Overall Study||2
381463|NCT01050998|913145|P1|NOT COMPLETED|Overall Study||4
381464|NCT01050998|913141|P5|COMPLETED|Overall Study||82
381465|NCT01050998|913142|P4|COMPLETED|Overall Study||45
381466|NCT01050998|913143|P3|COMPLETED|Overall Study||46
381467|NCT01050998|913144|P2|COMPLETED|Overall Study||47
381468|NCT01050998|913145|P1|COMPLETED|Overall Study||44
381469|NCT01050998|913141|P5|STARTED|Overall Study||96
381470|NCT01050998|913142|P4|STARTED|Overall Study||48
381471|NCT01050998|913143|P3|STARTED|Overall Study||49
381472|NCT01050998|913144|P2|STARTED|Overall Study||49
381473|NCT01050998|913145|P1|STARTED|Overall Study||48
381474|NCT01050946|913469|P1|NOT COMPLETED|Overall Study||0
381475|NCT01050946|913469|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
381476|NCT01050946|913469|P1|STARTED|Overall Study||1
381477|NCT01050816|913479|P1|NOT COMPLETED|Overall Study||4
381478|NCT01050816|913479|P1|COMPLETED|Overall Study||26
381479|NCT01050816|913479|P1|STARTED|Overall Study||30
381480|NCT01050790|913485|P1|NOT COMPLETED|Overall Study||1
381481|NCT01050790|913485|P1|COMPLETED|Overall Study||16
381482|NCT01050790|913485|P1|STARTED|Overall Study||17
381483|NCT01050764|913495|P1|NOT COMPLETED|Overall Study||3
381484|NCT01050764|913495|P1|COMPLETED|Overall Study||7
381485|NCT01050764|913495|P1|Received Infusion of T-con Cells|Overall Study||7
381486|NCT01050764|913495|P1|Received Infusion of T-reg Cells|Overall Study||7
381487|NCT01050764|913495|P1|Received HSCT Graft|Overall Study||8
381488|NCT01050764|913495|P1|STARTED|Overall Study||10
381489|NCT01050673|913506|P2|NOT COMPLETED|Overall Study||5
381490|NCT01050673|913507|P1|NOT COMPLETED|Overall Study||4
381491|NCT01050673|913506|P2|COMPLETED|Overall Study||14
381492|NCT01050673|913507|P1|COMPLETED|Overall Study||17
381493|NCT01050673|913506|P2|STARTED|Overall Study||19
381494|NCT01050673|913507|P1|STARTED|Overall Study||21
381495|NCT01050660|913531|P2|NOT COMPLETED|Overall Study||0
381496|NCT01050660|913532|P1|NOT COMPLETED|Overall Study||0
381497|NCT01050660|913531|P2|COMPLETED|Overall Study||69
381498|NCT01050660|913532|P1|COMPLETED|Overall Study||67
381499|NCT01050660|913531|P2|STARTED|Overall Study||69
381500|NCT01050660|913532|P1|STARTED|Overall Study||67
381501|NCT01050634|913556|P1|NOT COMPLETED|Overall Study||128
381502|NCT01050634|913556|P1|COMPLETED|Overall Study||852
381503|NCT01050634|913556|P1|Received Treatment|Overall Study||924
381504|NCT01050634|913556|P1|STARTED|Overall Study||980
381505|NCT01050582|913566|P2|NOT COMPLETED|Overall Study||0
381506|NCT01050582|913567|P1|NOT COMPLETED|Overall Study||0
381507|NCT01050582|913566|P2|COMPLETED|Overall Study||51
381508|NCT01050582|913567|P1|COMPLETED|Overall Study||133
381509|NCT01050582|913566|P2|STARTED|Overall Study||51
381510|NCT01050582|913567|P1|STARTED|Overall Study||133
381511|NCT01050569|913580|P3|NOT COMPLETED|Overall Study||33
381512|NCT01050569|913581|P2|NOT COMPLETED|Overall Study||24
381513|NCT01050569|913582|P1|NOT COMPLETED|Overall Study||38
381514|NCT01050569|913580|P3|COMPLETED|Overall Study||47
381515|NCT01050569|913581|P2|COMPLETED|Overall Study||52
381516|NCT01050569|913582|P1|COMPLETED|Overall Study||41
381517|NCT01050569|913580|P3|STARTED|Overall Study||80
381518|NCT01050569|913581|P2|STARTED|Overall Study||76
381519|NCT01050569|913582|P1|STARTED|Overall Study||79
381520|NCT01050543|913601|P2|NOT COMPLETED|Overall Study||4
381521|NCT01050543|913602|P1|NOT COMPLETED|Overall Study||4
381522|NCT01050543|913601|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
381523|NCT01050543|913602|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
381524|NCT01050543|913601|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
381525|NCT01050543|913602|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
381526|NCT01050530|913610|P2|NOT COMPLETED|Overall Study||10
381527|NCT01050530|913611|P1|NOT COMPLETED|Overall Study||8
381528|NCT01050530|913610|P2|COMPLETED|Overall Study||70
381529|NCT01050530|913611|P1|COMPLETED|Overall Study||74
381530|NCT01050530|913610|P2|STARTED|Overall Study||80
381531|NCT01050530|913611|P1|STARTED|Overall Study||82
381532|NCT01050257|913622|P3|NOT COMPLETED|Overall Study||7
381533|NCT01050257|913623|P2|NOT COMPLETED|Overall Study||13
381534|NCT01050257|913624|P1|NOT COMPLETED|Overall Study||11
381535|NCT01050257|913622|P3|COMPLETED|Overall Study||8
381536|NCT01050257|913623|P2|COMPLETED|Overall Study||40
381537|NCT01050257|913624|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
381538|NCT01050257|913622|P3|Switched to Oral Treatment|Overall Study||3
381539|NCT01050257|913623|P2|Switched to Oral Treatment|Overall Study||31
381540|NCT01050257|913624|P1|Switched to Oral Treatment|Overall Study||28
381541|NCT01050257|913622|P3|Intent-to-treat Infected Confirmed|Overall Study||10
381542|NCT01050257|913623|P2|Intent-to-treat Infected Confirmed|Overall Study||32
381543|NCT01050257|913624|P1|Intent-to-treat Infected Confirmed|Overall Study||30
381544|NCT01050257|913622|P3|Safety Population: Actual Dose Received|Overall Study||14
381545|NCT01050257|913623|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
381546|NCT01050257|913624|P1|Safety Population: Actual Dose Received|Overall Study||48
381547|NCT01050257|913622|P3|Received Treatment|Overall Study||14
381548|NCT01050257|913623|P2|Received Treatment|Overall Study||50
381549|NCT01050257|913624|P1|Received Treatment|Overall Study||49
381550|NCT01050257|913622|P3|STARTED|Overall Study||15
381551|NCT01050257|913623|P2|STARTED|Overall Study||53
381552|NCT01050257|913624|P1|STARTED|Overall Study||50
381553|NCT01050218|913659|P1|NOT COMPLETED|Overall Study||95
381554|NCT01050218|913659|P1|COMPLETED|Overall Study||142
381555|NCT01050218|913659|P1|STARTED|Overall Study||237
381556|NCT01050153|913665|P2|NOT COMPLETED|Overall Study||0
381557|NCT01050153|913666|P1|NOT COMPLETED|Overall Study||0
381558|NCT01050153|913665|P2|COMPLETED|Overall Study||25
381559|NCT01050153|913666|P1|COMPLETED|Overall Study||25
381560|NCT01050153|913665|P2|STARTED|Overall Study||25
381561|NCT01050153|913666|P1|STARTED|Overall Study||25
381562|NCT01050062|913692|P2|NOT COMPLETED|Overall Study||112
381563|NCT01050062|913693|P1|NOT COMPLETED|Overall Study||271
381564|NCT01050062|913692|P2|COMPLETED|Overall Study||243
381565|NCT01050062|913693|P1|COMPLETED|Overall Study||799
381566|NCT01050062|913692|P2|STARTED|Overall Study||355
381567|NCT01050062|913693|P1|STARTED|Overall Study||1070
381568|NCT01049984|913715|P2|NOT COMPLETED|Overall Study||19
381569|NCT01049984|913716|P1|NOT COMPLETED|Overall Study||19
381570|NCT01049984|913715|P2|COMPLETED|Overall Study||146
381571|NCT01049984|913716|P1|COMPLETED|Overall Study||144
381572|NCT01049984|913715|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
381573|NCT01049984|913716|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
381574|NCT01049984|913715|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
381575|NCT01049984|913716|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
381576|NCT01049984|913715|P2|STARTED|Overall Study||165
381577|NCT01049984|913716|P1|STARTED|Overall Study||163
381578|NCT01049945|913734|P6|NOT COMPLETED|Overall Study||0
381579|NCT01049945|913735|P5|NOT COMPLETED|Overall Study||0
381580|NCT01049945|913736|P4|NOT COMPLETED|Overall Study||0
381581|NCT01049945|913737|P3|NOT COMPLETED|Overall Study||0
381582|NCT01049945|913738|P2|NOT COMPLETED|Overall Study||0
381583|NCT01049945|913739|P1|NOT COMPLETED|Overall Study||0
381584|NCT01049945|913734|P6|COMPLETED|Overall Study||49
381585|NCT01049945|913735|P5|COMPLETED|Overall Study||3
381586|NCT01049945|913736|P4|COMPLETED|Overall Study||6
381587|NCT01049945|913737|P3|COMPLETED|Overall Study||3
381588|NCT01049945|913738|P2|COMPLETED|Overall Study||6
381589|NCT01049945|913739|P1|COMPLETED|Overall Study||3
381590|NCT01049945|913734|P6|STARTED|Overall Study||49
381591|NCT01049945|913735|P5|STARTED|Overall Study||3
381592|NCT01049945|913736|P4|STARTED|Overall Study||6
381593|NCT01049945|913737|P3|STARTED|Overall Study||3
381594|NCT01049945|913738|P2|STARTED|Overall Study||6
381595|NCT01049945|913739|P1|STARTED|Overall Study||3
381596|NCT01049802|913755|P2|NOT COMPLETED|Overall Study||0
381597|NCT01049802|913756|P1|NOT COMPLETED|Overall Study||0
381598|NCT01049802|913755|P2|COMPLETED|Overall Study||10
381599|NCT01049802|913756|P1|COMPLETED|Overall Study||20
381600|NCT01049802|913755|P2|STARTED|Overall Study||10
381601|NCT01049802|913756|P1|STARTED|Overall Study||20
381602|NCT01049776|913770|P1|NOT COMPLETED|Overall Study||20
381603|NCT01049776|913770|P1|COMPLETED|Overall Study||12
381604|NCT01049776|913770|P1|STARTED|Overall Study||32
381605|NCT01049581|913776|P2|NOT COMPLETED|Overall Study||1
381606|NCT01049581|913777|P1|NOT COMPLETED|Overall Study||2
381607|NCT01049581|913776|P2|COMPLETED|Overall Study||13
381608|NCT01049581|913777|P1|COMPLETED|Overall Study||11
381609|NCT01049581|913776|P2|STARTED|Overall Study||14
381610|NCT01049581|913777|P1|STARTED|Overall Study||13
381611|NCT01049503|913792|P6|NOT COMPLETED|Overall Study||8
381612|NCT01049503|913793|P5|NOT COMPLETED|Overall Study||27
381613|NCT01049503|913794|P4|NOT COMPLETED|Overall Study||26
381614|NCT01049503|913795|P3|NOT COMPLETED|Overall Study||24
381615|NCT01049503|913796|P2|NOT COMPLETED|Overall Study||12
381616|NCT01049503|913797|P1|NOT COMPLETED|Overall Study||11
381617|NCT01049503|913792|P6|COMPLETED|Overall Study||40
381618|NCT01049503|913793|P5|COMPLETED|Overall Study||29
381619|NCT01049503|913794|P4|COMPLETED|Overall Study||29
381620|NCT01049503|913795|P3|COMPLETED|Overall Study||32
381621|NCT01049503|913796|P2|COMPLETED|Overall Study||36
381622|NCT01049503|913797|P1|COMPLETED|Overall Study||41
381623|NCT01049503|913792|P6|STARTED|Overall Study||48
381624|NCT01049503|913793|P5|STARTED|Overall Study||56
381625|NCT01049503|913794|P4|STARTED|Overall Study||55
381626|NCT01049503|913795|P3|STARTED|Overall Study||56
381627|NCT01049503|913796|P2|STARTED|Overall Study||48
381628|NCT01049503|913797|P1|STARTED|Overall Study||52
381629|NCT01049373|913828|P2|NOT COMPLETED|Overall Study||44
381630|NCT01049373|913829|P1|NOT COMPLETED|Overall Study||39
381631|NCT01049373|913828|P2|COMPLETED|Overall Study||65
381632|NCT01049373|913829|P1|COMPLETED|Overall Study||73
381633|NCT01049373|913828|P2|STARTED|Overall Study||109
381634|NCT01049373|913829|P1|STARTED|Overall Study||112
381635|NCT01049360|913843|P20|NOT COMPLETED|Period 4||0
381636|NCT01049360|913844|P19|NOT COMPLETED|Period 4||0
381637|NCT01049360|913845|P18|NOT COMPLETED|Period 4||1
381638|NCT01049360|913846|P17|NOT COMPLETED|Period 4||0
381639|NCT01049360|913847|P16|NOT COMPLETED|Period 4||0
381640|NCT01049360|913848|P15|NOT COMPLETED|Period 4||0
381641|NCT01049360|913849|P14|NOT COMPLETED|Period 4||0
381642|NCT01049360|913850|P13|NOT COMPLETED|Period 4||0
381643|NCT01049360|913851|P12|NOT COMPLETED|Period 4||0
381644|NCT01049360|913852|P11|NOT COMPLETED|Period 4||0
381645|NCT01049360|913853|P10|NOT COMPLETED|Period 4||0
381646|NCT01049360|913854|P9|NOT COMPLETED|Period 4||0
381647|NCT01049360|913855|P8|NOT COMPLETED|Period 4||0
381648|NCT01049360|913856|P7|NOT COMPLETED|Period 4||0
381649|NCT01049360|913857|P6|NOT COMPLETED|Period 4||0
381650|NCT01049360|913858|P5|NOT COMPLETED|Period 4||0
381651|NCT01049360|913859|P4|NOT COMPLETED|Period 4||1
381652|NCT01049360|913860|P3|NOT COMPLETED|Period 4||0
381653|NCT01049360|913861|P2|NOT COMPLETED|Period 4||0
381654|NCT01049360|913862|P1|NOT COMPLETED|Period 4||0
381655|NCT01049360|913843|P20|COMPLETED|Period 4||5
381656|NCT01049360|913844|P19|COMPLETED|Period 4||5
381657|NCT01049360|913845|P18|COMPLETED|Period 4||5
381658|NCT01049360|913846|P17|COMPLETED|Period 4||5
381659|NCT01049360|913847|P16|COMPLETED|Period 4||6
381660|NCT01049360|913848|P15|COMPLETED|Period 4||5
381661|NCT01049360|913849|P14|COMPLETED|Period 4||6
381662|NCT01049360|913850|P13|COMPLETED|Period 4||4
381663|NCT01049360|913851|P12|COMPLETED|Period 4||6
381664|NCT01049360|913852|P11|COMPLETED|Period 4||5
381665|NCT01049360|913853|P10|COMPLETED|Period 4||6
381666|NCT01049360|913854|P9|COMPLETED|Period 4||4
381667|NCT01049360|913855|P8|COMPLETED|Period 4||4
381668|NCT01049360|913856|P7|COMPLETED|Period 4||6
381669|NCT01049360|913857|P6|COMPLETED|Period 4||5
381670|NCT01049360|913858|P5|COMPLETED|Period 4||7
381671|NCT01049360|913859|P4|COMPLETED|Period 4||3
381672|NCT01049360|913860|P3|COMPLETED|Period 4||7
381673|NCT01049360|913861|P2|COMPLETED|Period 4||4
381674|NCT01049360|913862|P1|COMPLETED|Period 4||6
381675|NCT01049360|913843|P20|STARTED|Period 4||5
381676|NCT01049360|913844|P19|STARTED|Period 4||5
381677|NCT01049360|913845|P18|STARTED|Period 4||6
381678|NCT01049360|913846|P17|STARTED|Period 4||5
381679|NCT01049360|913847|P16|STARTED|Period 4||6
381680|NCT01049360|913848|P15|STARTED|Period 4||5
381681|NCT01049360|913849|P14|STARTED|Period 4||6
381682|NCT01049360|913850|P13|STARTED|Period 4||4
381683|NCT01049360|913851|P12|STARTED|Period 4||6
381684|NCT01049360|913852|P11|STARTED|Period 4||5
381685|NCT01049360|913853|P10|STARTED|Period 4||6
381686|NCT01049360|913854|P9|STARTED|Period 4||4
381687|NCT01049360|913855|P8|STARTED|Period 4||4
381688|NCT01049360|913856|P7|STARTED|Period 4||6
381689|NCT01049360|913857|P6|STARTED|Period 4||5
381690|NCT01049360|913858|P5|STARTED|Period 4||7
381691|NCT01049360|913859|P4|STARTED|Period 4||4
381692|NCT01049360|913860|P3|STARTED|Period 4||7
381693|NCT01049360|913861|P2|STARTED|Period 4||4
381694|NCT01049360|913862|P1|STARTED|Period 4||6
381695|NCT01049360|913843|P20|NOT COMPLETED|Period 3||0
381696|NCT01049360|913844|P19|NOT COMPLETED|Period 3||0
381697|NCT01049360|913845|P18|NOT COMPLETED|Period 3||0
381698|NCT01049360|913846|P17|NOT COMPLETED|Period 3||0
381699|NCT01049360|913847|P16|NOT COMPLETED|Period 3||0
381700|NCT01049360|913848|P15|NOT COMPLETED|Period 3||0
381701|NCT01049360|913849|P14|NOT COMPLETED|Period 3||0
381702|NCT01049360|913850|P13|NOT COMPLETED|Period 3||0
381703|NCT01049360|913851|P12|NOT COMPLETED|Period 3||0
381704|NCT01049360|913852|P11|NOT COMPLETED|Period 3||0
381705|NCT01049360|913853|P10|NOT COMPLETED|Period 3||0
381706|NCT01049360|913854|P9|NOT COMPLETED|Period 3||0
381707|NCT01049360|913855|P8|NOT COMPLETED|Period 3||0
381708|NCT01049360|913856|P7|NOT COMPLETED|Period 3||0
381709|NCT01049360|913857|P6|NOT COMPLETED|Period 3||0
381710|NCT01049360|913858|P5|NOT COMPLETED|Period 3||0
381711|NCT01049360|913859|P4|NOT COMPLETED|Period 3||0
381712|NCT01049360|913860|P3|NOT COMPLETED|Period 3||0
381713|NCT01049360|913861|P2|NOT COMPLETED|Period 3||0
381714|NCT01049360|913862|P1|NOT COMPLETED|Period 3||0
381715|NCT01049360|913843|P20|COMPLETED|Period 3||5
381716|NCT01049360|913844|P19|COMPLETED|Period 3||5
381717|NCT01049360|913845|P18|COMPLETED|Period 3||6
381718|NCT01049360|913846|P17|COMPLETED|Period 3||5
381719|NCT01049360|913847|P16|COMPLETED|Period 3||6
381720|NCT01049360|913848|P15|COMPLETED|Period 3||5
381721|NCT01049360|913849|P14|COMPLETED|Period 3||6
381722|NCT01049360|913850|P13|COMPLETED|Period 3||4
381723|NCT01049360|913851|P12|COMPLETED|Period 3||6
381724|NCT01049360|913852|P11|COMPLETED|Period 3||5
381725|NCT01049360|913853|P10|COMPLETED|Period 3||6
381726|NCT01049360|913854|P9|COMPLETED|Period 3||4
381727|NCT01049360|913855|P8|COMPLETED|Period 3||4
381728|NCT01049360|913856|P7|COMPLETED|Period 3||6
381729|NCT01049360|913857|P6|COMPLETED|Period 3||5
381730|NCT01049360|913858|P5|COMPLETED|Period 3||7
381731|NCT01049360|913859|P4|COMPLETED|Period 3||4
381732|NCT01049360|913860|P3|COMPLETED|Period 3||7
381733|NCT01049360|913861|P2|COMPLETED|Period 3||4
381734|NCT01049360|913862|P1|COMPLETED|Period 3||6
381735|NCT01049360|913843|P20|STARTED|Period 3||5
381736|NCT01049360|913844|P19|STARTED|Period 3||5
381737|NCT01049360|913845|P18|STARTED|Period 3||6
381738|NCT01049360|913846|P17|STARTED|Period 3||5
381739|NCT01049360|913847|P16|STARTED|Period 3||6
381740|NCT01049360|913848|P15|STARTED|Period 3||5
381741|NCT01049360|913849|P14|STARTED|Period 3||6
381742|NCT01049360|913850|P13|STARTED|Period 3||4
381743|NCT01049360|913851|P12|STARTED|Period 3||6
381744|NCT01049360|913852|P11|STARTED|Period 3||5
381745|NCT01049360|913853|P10|STARTED|Period 3||6
381746|NCT01049360|913854|P9|STARTED|Period 3||4
381747|NCT01049360|913855|P8|STARTED|Period 3||4
381748|NCT01049360|913856|P7|STARTED|Period 3||6
381749|NCT01049360|913857|P6|STARTED|Period 3||5
381750|NCT01049360|913858|P5|STARTED|Period 3||7
381751|NCT01049360|913859|P4|STARTED|Period 3||4
381752|NCT01049360|913860|P3|STARTED|Period 3||7
381753|NCT01049360|913861|P2|STARTED|Period 3||4
381754|NCT01049360|913862|P1|STARTED|Period 3||6
381755|NCT01049360|913843|P20|NOT COMPLETED|Period 2||2
381756|NCT01049360|913844|P19|NOT COMPLETED|Period 2||0
381757|NCT01049360|913845|P18|NOT COMPLETED|Period 2||0
381758|NCT01049360|913846|P17|NOT COMPLETED|Period 2||0
381759|NCT01049360|913847|P16|NOT COMPLETED|Period 2||1
381760|NCT01049360|913848|P15|NOT COMPLETED|Period 2||2
381761|NCT01049360|913849|P14|NOT COMPLETED|Period 2||0
381762|NCT01049360|913850|P13|NOT COMPLETED|Period 2||0
381763|NCT01049360|913851|P12|NOT COMPLETED|Period 2||0
381764|NCT01049360|913852|P11|NOT COMPLETED|Period 2||0
381765|NCT01049360|913853|P10|NOT COMPLETED|Period 2||0
381766|NCT01049360|913854|P9|NOT COMPLETED|Period 2||1
381767|NCT01049360|913855|P8|NOT COMPLETED|Period 2||0
381768|NCT01049360|913856|P7|NOT COMPLETED|Period 2||0
381769|NCT01049360|913857|P6|NOT COMPLETED|Period 2||1
381770|NCT01049360|913858|P5|NOT COMPLETED|Period 2||0
381771|NCT01049360|913859|P4|NOT COMPLETED|Period 2||2
381772|NCT01049360|913860|P3|NOT COMPLETED|Period 2||0
381773|NCT01049360|913861|P2|NOT COMPLETED|Period 2||1
381774|NCT01049360|913862|P1|NOT COMPLETED|Period 2||0
381775|NCT01049360|913843|P20|COMPLETED|Period 2||5
381776|NCT01049360|913844|P19|COMPLETED|Period 2||5
381777|NCT01049360|913845|P18|COMPLETED|Period 2||6
381778|NCT01049360|913846|P17|COMPLETED|Period 2||5
381779|NCT01049360|913847|P16|COMPLETED|Period 2||6
381780|NCT01049360|913848|P15|COMPLETED|Period 2||5
381781|NCT01049360|913849|P14|COMPLETED|Period 2||6
381782|NCT01049360|913850|P13|COMPLETED|Period 2||4
381783|NCT01049360|913851|P12|COMPLETED|Period 2||6
381784|NCT01049360|913852|P11|COMPLETED|Period 2||5
381785|NCT01049360|913853|P10|COMPLETED|Period 2||6
381786|NCT01049360|913854|P9|COMPLETED|Period 2||4
381787|NCT01049360|913855|P8|COMPLETED|Period 2||4
381788|NCT01049360|913856|P7|COMPLETED|Period 2||6
381789|NCT01049360|913857|P6|COMPLETED|Period 2||5
381790|NCT01049360|913858|P5|COMPLETED|Period 2||7
381791|NCT01049360|913859|P4|COMPLETED|Period 2||4
381792|NCT01049360|913860|P3|COMPLETED|Period 2||7
381793|NCT01049360|913861|P2|COMPLETED|Period 2||4
381794|NCT01049360|913862|P1|COMPLETED|Period 2||6
381795|NCT01049360|913843|P20|STARTED|Period 2||7
381796|NCT01049360|913844|P19|STARTED|Period 2||5
381797|NCT01049360|913845|P18|STARTED|Period 2||6
381798|NCT01049360|913846|P17|STARTED|Period 2||5
381799|NCT01049360|913847|P16|STARTED|Period 2||7
381800|NCT01049360|913848|P15|STARTED|Period 2||7
381801|NCT01049360|913849|P14|STARTED|Period 2||6
381802|NCT01049360|913850|P13|STARTED|Period 2||4
381803|NCT01049360|913851|P12|STARTED|Period 2||6
381804|NCT01049360|913852|P11|STARTED|Period 2||5
381805|NCT01049360|913853|P10|STARTED|Period 2||6
381806|NCT01049360|913854|P9|STARTED|Period 2||5
381807|NCT01049360|913855|P8|STARTED|Period 2||4
381808|NCT01049360|913856|P7|STARTED|Period 2||6
381809|NCT01049360|913857|P6|STARTED|Period 2||6
381810|NCT01049360|913858|P5|STARTED|Period 2||7
381811|NCT01049360|913859|P4|STARTED|Period 2||6
381812|NCT01049360|913860|P3|STARTED|Period 2||7
381813|NCT01049360|913861|P2|STARTED|Period 2||5
381814|NCT01049360|913862|P1|STARTED|Period 2||6
381815|NCT01049360|913843|P20|NOT COMPLETED|Period 1||0
381816|NCT01049360|913844|P19|NOT COMPLETED|Period 1||1
381817|NCT01049360|913845|P18|NOT COMPLETED|Period 1||0
381818|NCT01049360|913846|P17|NOT COMPLETED|Period 1||1
381819|NCT01049360|913847|P16|NOT COMPLETED|Period 1||0
381820|NCT01049360|913848|P15|NOT COMPLETED|Period 1||0
381821|NCT01049360|913849|P14|NOT COMPLETED|Period 1||1
381822|NCT01049360|913850|P13|NOT COMPLETED|Period 1||2
381823|NCT01049360|913851|P12|NOT COMPLETED|Period 1||0
381824|NCT01049360|913852|P11|NOT COMPLETED|Period 1||1
381825|NCT01049360|913853|P10|NOT COMPLETED|Period 1||0
381826|NCT01049360|913854|P9|NOT COMPLETED|Period 1||2
381827|NCT01049360|913855|P8|NOT COMPLETED|Period 1||2
381828|NCT01049360|913856|P7|NOT COMPLETED|Period 1||0
381829|NCT01049360|913857|P6|NOT COMPLETED|Period 1||0
381830|NCT01049360|913858|P5|NOT COMPLETED|Period 1||0
381831|NCT01049360|913859|P4|NOT COMPLETED|Period 1||1
381832|NCT01049360|913860|P3|NOT COMPLETED|Period 1||0
381833|NCT01049360|913861|P2|NOT COMPLETED|Period 1||1
381834|NCT01049360|913862|P1|NOT COMPLETED|Period 1||0
381835|NCT01049360|913843|P20|COMPLETED|Period 1||7
381836|NCT01049360|913844|P19|COMPLETED|Period 1||5
381837|NCT01049360|913845|P18|COMPLETED|Period 1||6
381838|NCT01049360|913846|P17|COMPLETED|Period 1||5
381839|NCT01049360|913847|P16|COMPLETED|Period 1||7
381840|NCT01049360|913848|P15|COMPLETED|Period 1||7
381841|NCT01049360|913849|P14|COMPLETED|Period 1||6
381842|NCT01049360|913850|P13|COMPLETED|Period 1||4
381843|NCT01049360|913851|P12|COMPLETED|Period 1||6
381844|NCT01049360|913852|P11|COMPLETED|Period 1||5
381845|NCT01049360|913853|P10|COMPLETED|Period 1||6
381846|NCT01049360|913854|P9|COMPLETED|Period 1||5
381847|NCT01049360|913855|P8|COMPLETED|Period 1||4
381848|NCT01049360|913856|P7|COMPLETED|Period 1||6
381849|NCT01049360|913857|P6|COMPLETED|Period 1||6
381850|NCT01049360|913858|P5|COMPLETED|Period 1||7
381851|NCT01049360|913859|P4|COMPLETED|Period 1||6
381852|NCT01049360|913860|P3|COMPLETED|Period 1||7
381853|NCT01049360|913861|P2|COMPLETED|Period 1||5
381854|NCT01049360|913862|P1|COMPLETED|Period 1||6
381855|NCT01049360|913843|P20|STARTED|Period 1||7
381856|NCT01049360|913844|P19|STARTED|Period 1||6
381857|NCT01049360|913845|P18|STARTED|Period 1||6
381858|NCT01049360|913846|P17|STARTED|Period 1||6
381859|NCT01049360|913847|P16|STARTED|Period 1||7
381860|NCT01049360|913848|P15|STARTED|Period 1||7
381861|NCT01049360|913849|P14|STARTED|Period 1||7
381862|NCT01049360|913850|P13|STARTED|Period 1||6
381863|NCT01049360|913851|P12|STARTED|Period 1||6
381864|NCT01049360|913852|P11|STARTED|Period 1||6
381865|NCT01049360|913853|P10|STARTED|Period 1||6
381866|NCT01049360|913854|P9|STARTED|Period 1||7
381867|NCT01049360|913855|P8|STARTED|Period 1||6
381868|NCT01049360|913856|P7|STARTED|Period 1||6
381869|NCT01049360|913857|P6|STARTED|Period 1||6
381870|NCT01049360|913858|P5|STARTED|Period 1||7
381871|NCT01049360|913859|P4|STARTED|Period 1||7
381872|NCT01049360|913860|P3|STARTED|Period 1||7
381873|NCT01049360|913861|P2|STARTED|Period 1||6
381874|NCT01049360|913862|P1|STARTED|Period 1||6
381875|NCT01049308|913884|P1|NOT COMPLETED|Pill Counts||83
381876|NCT01049308|913884|P1|COMPLETED|Pill Counts||168
381877|NCT01049308|913884|P1|STARTED|Pill Counts||251
381878|NCT01049308|913884|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
381879|NCT01049308|913884|P1|COMPLETED|Evaluation of Cognitive Impairment||251
381880|NCT01049308|913884|P1|STARTED|Evaluation of Cognitive Impairment||251
381881|NCT01049243|913891|P1|NOT COMPLETED|Overall Study||2
381882|NCT01049243|913891|P1|COMPLETED|Overall Study||18
381883|NCT01049243|913891|P1|STARTED|Overall Study||20
381884|NCT01049217|913897|P2|NOT COMPLETED|Overall Study||63
381885|NCT01049217|913898|P1|NOT COMPLETED|Overall Study||56
381886|NCT01049217|913897|P2|COMPLETED|Overall Study||131
381887|NCT01049217|913898|P1|COMPLETED|Overall Study||127
381888|NCT01049217|913897|P2|Treated|Overall Study||192
381889|NCT01049217|913898|P1|Treated|Overall Study||183
381890|NCT01049217|913897|P2|STARTED|Overall Study||194
381891|NCT01049217|913898|P1|STARTED|Overall Study||183
381892|NCT01049009|913970|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
381893|NCT01049009|913971|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
381894|NCT01049009|913970|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
381895|NCT01049009|913971|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
381896|NCT01049009|913970|P2|STARTED|Treatment Period 2 (12 Weeks)||18
381897|NCT01049009|913971|P1|STARTED|Treatment Period 2 (12 Weeks)||21
381898|NCT01049009|913970|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
381899|NCT01049009|913971|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
381900|NCT01049009|913970|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
381901|NCT01049009|913971|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
381902|NCT01049009|913970|P2|STARTED|Treatment Period 1 (12 Weeks)||21
381903|NCT01049009|913971|P1|STARTED|Treatment Period 1 (12 Weeks)||23
381904|NCT01048944|913983|P4|NOT COMPLETED|Overall Study||2
381905|NCT01048944|913984|P3|NOT COMPLETED|Overall Study||10
381906|NCT01048944|913985|P2|NOT COMPLETED|Overall Study||10
381907|NCT01048944|913986|P1|NOT COMPLETED|Overall Study||8
381908|NCT01048944|913983|P4|COMPLETED|Overall Study||19
381909|NCT01048944|913984|P3|COMPLETED|Overall Study||25
381910|NCT01048944|913985|P2|COMPLETED|Overall Study||28
381911|NCT01048944|913986|P1|COMPLETED|Overall Study||24
381912|NCT01048944|913983|P4|STARTED|Overall Study||21
381913|NCT01048944|913984|P3|STARTED|Overall Study||35
381914|NCT01048944|913985|P2|STARTED|Overall Study||38
381915|NCT01048944|913986|P1|STARTED|Overall Study||32
381916|NCT01048879|914003|P3|NOT COMPLETED|Overall Study||0
381917|NCT01048879|914004|P2|NOT COMPLETED|Overall Study||0
381918|NCT01048879|914005|P1|NOT COMPLETED|Overall Study||0
381919|NCT01048879|914003|P3|COMPLETED|Overall Study||5
381920|NCT01048879|914004|P2|COMPLETED|Overall Study||9
381921|NCT01048879|914005|P1|COMPLETED|Overall Study||1
381922|NCT01048879|914003|P3|STARTED|Overall Study||5
381923|NCT01048879|914004|P2|STARTED|Overall Study||9
381924|NCT01048879|914005|P1|STARTED|Overall Study||1
381925|NCT01048788|914019|P3|NOT COMPLETED|Overall Study||2
381926|NCT01048788|914020|P2|NOT COMPLETED|Overall Study||2
381927|NCT01048788|914021|P1|NOT COMPLETED|Overall Study||5
381928|NCT01048788|914019|P3|COMPLETED|Overall Study||11
381929|NCT01048788|914020|P2|COMPLETED|Overall Study||28
381930|NCT01048788|914021|P1|COMPLETED|Overall Study||3
381931|NCT01048788|914019|P3|STARTED|Overall Study||13
381932|NCT01048788|914020|P2|STARTED|Overall Study||30
381933|NCT01048788|914021|P1|STARTED|Overall Study||8
381934|NCT01048723|914029|P1|NOT COMPLETED|Overall Study||0
381935|NCT01048723|914029|P1|COMPLETED|Overall Study||2
381936|NCT01048723|914029|P1|STARTED|Overall Study||2
381937|NCT01048697|914036|P1|NOT COMPLETED|Overall Study||0
381938|NCT01048697|914036|P1|COMPLETED|Overall Study||18
381939|NCT01048697|914036|P1|STARTED|Overall Study||18
381940|NCT01048671|914043|P3|NOT COMPLETED|Overall Study||1
381941|NCT01048671|914044|P2|NOT COMPLETED|Overall Study||1
381942|NCT01048671|914045|P1|NOT COMPLETED|Overall Study||0
381943|NCT01048671|914043|P3|COMPLETED|Overall Study||151
381944|NCT01048671|914044|P2|COMPLETED|Overall Study||263
381945|NCT01048671|914045|P1|COMPLETED|Overall Study||66
381946|NCT01048671|914043|P3|STARTED|Overall Study||152
381947|NCT01048671|914044|P2|STARTED|Overall Study||264
381948|NCT01048671|914045|P1|STARTED|Overall Study||66
381949|NCT01048606|914070|P4|NOT COMPLETED|Overall Study||5
381950|NCT01048606|914071|P3|NOT COMPLETED|Overall Study||10
381951|NCT01048606|914072|P2|NOT COMPLETED|Overall Study||7
381952|NCT01048606|914073|P1|NOT COMPLETED|Overall Study||12
381953|NCT01048606|914070|P4|COMPLETED|Overall Study||5
381954|NCT01048606|914071|P3|COMPLETED|Overall Study||16
381955|NCT01048606|914072|P2|COMPLETED|Overall Study||8
381956|NCT01048606|914073|P1|COMPLETED|Overall Study||16
381957|NCT01048606|914070|P4|STARTED|Overall Study||10
381958|NCT01048606|914071|P3|STARTED|Overall Study||26
381959|NCT01048606|914072|P2|STARTED|Overall Study||15
381960|NCT01048606|914073|P1|STARTED|Overall Study||28
381961|NCT01048593|914086|P3|NOT COMPLETED|Overall Study||0
381962|NCT01048593|914087|P2|NOT COMPLETED|Overall Study||0
381963|NCT01048593|914088|P1|NOT COMPLETED|Overall Study||0
381964|NCT01048593|914086|P3|COMPLETED|Overall Study||1
381965|NCT01048593|914087|P2|COMPLETED|Overall Study||2
381966|NCT01048593|914088|P1|COMPLETED|Overall Study||3
381967|NCT01048593|914086|P3|STARTED|Overall Study||1
381968|NCT01048593|914087|P2|STARTED|Overall Study||2
381969|NCT01048593|914088|P1|STARTED|Overall Study||3
381970|NCT01048541|914096|P2|NOT COMPLETED|Overall Study||0
381971|NCT01048541|914097|P1|NOT COMPLETED|Overall Study||1
381972|NCT01048541|914096|P2|COMPLETED|Overall Study||19
381973|NCT01048541|914097|P1|COMPLETED|Overall Study||17
381974|NCT01048541|914096|P2|STARTED|Overall Study||19
381975|NCT01048541|914097|P1|STARTED|Overall Study||18
381976|NCT01048502|914107|P4|NOT COMPLETED|Overall Study||4
381977|NCT01048502|914108|P3|NOT COMPLETED|Overall Study||5
381978|NCT01048502|914109|P2|NOT COMPLETED|Overall Study||7
381979|NCT01048502|914110|P1|NOT COMPLETED|Overall Study||4
381980|NCT01048502|914107|P4|COMPLETED|Overall Study||21
381981|NCT01048502|914108|P3|COMPLETED|Overall Study||23
381982|NCT01048502|914109|P2|COMPLETED|Overall Study||16
381983|NCT01048502|914110|P1|COMPLETED|Overall Study||20
381984|NCT01048502|914107|P4|STARTED|Overall Study||25
381985|NCT01048502|914108|P3|STARTED|Overall Study||28
381986|NCT01048502|914109|P2|STARTED|Overall Study||23
381987|NCT01048502|914110|P1|STARTED|Overall Study||24
381988|NCT01048424|914123|P2|NOT COMPLETED|Overall Study||0
381989|NCT01048424|914124|P1|NOT COMPLETED|Overall Study||2
381990|NCT01048424|914123|P2|COMPLETED|Overall Study||10
381991|NCT01048424|914124|P1|COMPLETED|Overall Study||8
381992|NCT01048424|914123|P2|STARTED|Overall Study||10
381993|NCT01048424|914124|P1|STARTED|Overall Study||10
381994|NCT01048333|914146|P6|NOT COMPLETED|Treatment Period 3||0
381995|NCT01048333|914147|P5|NOT COMPLETED|Treatment Period 3||0
381996|NCT01048333|914148|P4|NOT COMPLETED|Treatment Period 3||0
381997|NCT01048333|914149|P3|NOT COMPLETED|Treatment Period 3||0
381998|NCT01048333|914150|P2|NOT COMPLETED|Treatment Period 3||0
381999|NCT01048333|914151|P1|NOT COMPLETED|Treatment Period 3||0
382000|NCT01048333|914146|P6|COMPLETED|Treatment Period 3||18
382001|NCT01048333|914147|P5|COMPLETED|Treatment Period 3||17
382002|NCT01048333|914148|P4|COMPLETED|Treatment Period 3||18
382003|NCT01048333|914149|P3|COMPLETED|Treatment Period 3||16
382004|NCT01048333|914150|P2|COMPLETED|Treatment Period 3||18
382005|NCT01048333|914151|P1|COMPLETED|Treatment Period 3||21
382006|NCT01048333|914146|P6|STARTED|Treatment Period 3||18
382007|NCT01048333|914147|P5|STARTED|Treatment Period 3||17
382008|NCT01048333|914148|P4|STARTED|Treatment Period 3||18
382009|NCT01048333|914149|P3|STARTED|Treatment Period 3||16
382010|NCT01048333|914150|P2|STARTED|Treatment Period 3||18
382011|NCT01048333|914151|P1|STARTED|Treatment Period 3||21
382012|NCT01048333|914146|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
382013|NCT01048333|914147|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
382014|NCT01048333|914148|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
382187|NCT01047345|914354|P2|COMPLETED|Base Study||300
382015|NCT01048333|914149|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
382016|NCT01048333|914150|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
382017|NCT01048333|914151|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
382018|NCT01048333|914146|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
382019|NCT01048333|914147|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
382020|NCT01048333|914148|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
382021|NCT01048333|914149|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
382022|NCT01048333|914150|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
382023|NCT01048333|914151|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
382024|NCT01048333|914146|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
382025|NCT01048333|914147|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
382026|NCT01048333|914148|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
382027|NCT01048333|914149|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
382028|NCT01048333|914150|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
382029|NCT01048333|914151|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
382030|NCT01048333|914146|P6|NOT COMPLETED|Treatment Period 2||0
382031|NCT01048333|914147|P5|NOT COMPLETED|Treatment Period 2||0
382032|NCT01048333|914148|P4|NOT COMPLETED|Treatment Period 2||0
382033|NCT01048333|914149|P3|NOT COMPLETED|Treatment Period 2||0
382034|NCT01048333|914150|P2|NOT COMPLETED|Treatment Period 2||0
382035|NCT01048333|914151|P1|NOT COMPLETED|Treatment Period 2||0
382036|NCT01048333|914146|P6|COMPLETED|Treatment Period 2||18
382037|NCT01048333|914147|P5|COMPLETED|Treatment Period 2||17
382038|NCT01048333|914148|P4|COMPLETED|Treatment Period 2||18
382039|NCT01048333|914149|P3|COMPLETED|Treatment Period 2||16
382040|NCT01048333|914150|P2|COMPLETED|Treatment Period 2||19
382041|NCT01048333|914151|P1|COMPLETED|Treatment Period 2||21
382042|NCT01048333|914146|P6|STARTED|Treatment Period 2||18
382043|NCT01048333|914147|P5|STARTED|Treatment Period 2||17
382044|NCT01048333|914148|P4|STARTED|Treatment Period 2||18
382045|NCT01048333|914149|P3|STARTED|Treatment Period 2||16
382046|NCT01048333|914150|P2|STARTED|Treatment Period 2||19
382047|NCT01048333|914151|P1|STARTED|Treatment Period 2||21
382048|NCT01048333|914146|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
382049|NCT01048333|914147|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
382050|NCT01048333|914148|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
382051|NCT01048333|914149|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
382052|NCT01048333|914150|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
382053|NCT01048333|914151|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
382054|NCT01048333|914146|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
382055|NCT01048333|914147|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
382056|NCT01048333|914148|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
382057|NCT01048333|914149|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
382058|NCT01048333|914150|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
382059|NCT01048333|914151|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
382060|NCT01048333|914146|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
382061|NCT01048333|914147|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
382062|NCT01048333|914148|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
382063|NCT01048333|914149|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
382064|NCT01048333|914150|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
382065|NCT01048333|914151|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
382066|NCT01048333|914146|P6|NOT COMPLETED|Treatment Period 1||0
382067|NCT01048333|914147|P5|NOT COMPLETED|Treatment Period 1||0
382068|NCT01048333|914148|P4|NOT COMPLETED|Treatment Period 1||0
382069|NCT01048333|914149|P3|NOT COMPLETED|Treatment Period 1||0
382070|NCT01048333|914150|P2|NOT COMPLETED|Treatment Period 1||0
382071|NCT01048333|914151|P1|NOT COMPLETED|Treatment Period 1||0
382072|NCT01048333|914146|P6|COMPLETED|Treatment Period 1||18
382073|NCT01048333|914147|P5|COMPLETED|Treatment Period 1||17
382074|NCT01048333|914148|P4|COMPLETED|Treatment Period 1||18
382075|NCT01048333|914149|P3|COMPLETED|Treatment Period 1||16
382076|NCT01048333|914150|P2|COMPLETED|Treatment Period 1||19
382077|NCT01048333|914151|P1|COMPLETED|Treatment Period 1||21
382078|NCT01048333|914146|P6|STARTED|Treatment Period 1||18
382079|NCT01048333|914147|P5|STARTED|Treatment Period 1||17
382080|NCT01048333|914148|P4|STARTED|Treatment Period 1||18
382081|NCT01048333|914149|P3|STARTED|Treatment Period 1||16
382082|NCT01048333|914150|P2|STARTED|Treatment Period 1||19
382083|NCT01048333|914151|P1|STARTED|Treatment Period 1||21
382084|NCT01048242|914173|P2|NOT COMPLETED|Overall Study||2
382085|NCT01048242|914174|P1|NOT COMPLETED|Overall Study||4
382086|NCT01048242|914173|P2|COMPLETED|Overall Study||13
382087|NCT01048242|914174|P1|COMPLETED|Overall Study||8
382088|NCT01048242|914173|P2|STARTED|Overall Study||15
382089|NCT01048242|914174|P1|STARTED|Overall Study||12
382090|NCT01048125|914182|P2|NOT COMPLETED|Overall Study||0
382091|NCT01048125|914183|P1|NOT COMPLETED|Overall Study||0
382092|NCT01048125|914182|P2|COMPLETED|Overall Study||0
382093|NCT01048125|914183|P1|COMPLETED|Overall Study||0
382094|NCT01048125|914182|P2|STARTED|Overall Study||0
382095|NCT01048125|914183|P1|STARTED|Overall Study||0
382096|NCT01048099|914189|P1|NOT COMPLETED|Treatment Per Protocol||14
382097|NCT01048099|914189|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
382098|NCT01048099|914189|P1|STARTED|Treatment Per Protocol||14
382099|NCT01048099|914189|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
382100|NCT01048099|914189|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
382101|NCT01048099|914189|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
382102|NCT01048099|914189|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
382103|NCT01048099|914189|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
382104|NCT01048099|914189|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
382105|NCT01048099|914189|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
382106|NCT01048099|914189|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
382107|NCT01048099|914189|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
382108|NCT01047839|914200|P3|NOT COMPLETED|Overall Study||6
382109|NCT01047839|914201|P2|NOT COMPLETED|Overall Study||0
382110|NCT01047839|914202|P1|NOT COMPLETED|Overall Study||2
382111|NCT01047839|914200|P3|COMPLETED|Overall Study||53
382112|NCT01047839|914201|P2|COMPLETED|Overall Study||29
382113|NCT01047839|914202|P1|COMPLETED|Overall Study||10
382114|NCT01047839|914200|P3|STARTED|Overall Study||59
382115|NCT01047839|914201|P2|STARTED|Overall Study||29
382116|NCT01047839|914202|P1|STARTED|Overall Study||12
382117|NCT01047709|914210|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
382118|NCT01047709|914211|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
382119|NCT01047709|914210|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
382120|NCT01047709|914211|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
382121|NCT01047709|914210|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
382122|NCT01047709|914211|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
382123|NCT01047709|914210|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
382124|NCT01047709|914211|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
382125|NCT01047709|914210|P2|COMPLETED|Positional Therapy (1 Night)||9
382126|NCT01047709|914211|P1|COMPLETED|Positional Therapy (1 Night)||9
382127|NCT01047709|914210|P2|STARTED|Positional Therapy (1 Night)||9
382128|NCT01047709|914211|P1|STARTED|Positional Therapy (1 Night)||9
382129|NCT01047553|914219|P2|NOT COMPLETED|Overall Study||9
382130|NCT01047553|914220|P1|NOT COMPLETED|Overall Study||17
382131|NCT01047553|914219|P2|COMPLETED|Overall Study||117
382132|NCT01047553|914220|P1|COMPLETED|Overall Study||108
382133|NCT01047553|914219|P2|STARTED|Overall Study||126
382134|NCT01047553|914220|P1|STARTED|Overall Study||125
382135|NCT01047527|914305|P3|NOT COMPLETED|Overall Study||65
382136|NCT01047527|914306|P2|NOT COMPLETED|Overall Study||61
382137|NCT01047527|914307|P1|NOT COMPLETED|Overall Study||85
382138|NCT01047527|914305|P3|COMPLETED|Overall Study||107
382139|NCT01047527|914306|P2|COMPLETED|Overall Study||112
382140|NCT01047527|914307|P1|COMPLETED|Overall Study||95
382141|NCT01047527|914305|P3|24 Weeks|Overall Study||119
382142|NCT01047527|914306|P2|24 Weeks|Overall Study||123
382143|NCT01047527|914307|P1|24 Weeks|Overall Study||111
382144|NCT01047527|914305|P3|8 Weeks|Overall Study||138
382145|NCT01047527|914306|P2|8 Weeks|Overall Study||142
382146|NCT01047527|914307|P1|8 Weeks|Overall Study||148
382147|NCT01047527|914305|P3|STARTED|Overall Study||172
382148|NCT01047527|914306|P2|STARTED|Overall Study||173
382149|NCT01047527|914307|P1|STARTED|Overall Study||180
382150|NCT01047475|914318|P2|NOT COMPLETED|Overall Study||7
382151|NCT01047475|914319|P1|NOT COMPLETED|Overall Study||5
382152|NCT01047475|914318|P2|COMPLETED|Overall Study||31
382153|NCT01047475|914319|P1|COMPLETED|Overall Study||29
382154|NCT01047475|914318|P2|STARTED|Overall Study||38
382155|NCT01047475|914319|P1|STARTED|Overall Study||34
382156|NCT01047436|914327|P2|NOT COMPLETED|Overall Study||0
382157|NCT01047436|914328|P1|NOT COMPLETED|Overall Study||1
382158|NCT01047436|914327|P2|COMPLETED|Overall Study||15
382159|NCT01047436|914328|P1|COMPLETED|Overall Study||15
382160|NCT01047436|914327|P2|STARTED|Overall Study||15
382161|NCT01047436|914328|P1|STARTED|Overall Study||16
382162|NCT01047358|914344|P1|NOT COMPLETED|Overall Study||0
382163|NCT01047358|914344|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
382164|NCT01047358|914344|P1|STARTED|Overall Study||206
382165|NCT01047345|914353|P3|NOT COMPLETED|Extension||6
382166|NCT01047345|914354|P2|NOT COMPLETED|Extension||0
382167|NCT01047345|914355|P1|NOT COMPLETED|Extension||0
382168|NCT01047345|914353|P3|COMPLETED|Extension||96
382169|NCT01047345|914354|P2|COMPLETED|Extension||0
382170|NCT01047345|914355|P1|COMPLETED|Extension||0
382171|NCT01047345|914353|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
382172|NCT01047345|914354|P2|Vaccination 6|Extension||0
382173|NCT01047345|914355|P1|Vaccination 6|Extension||0
382174|NCT01047345|914353|P3|Vaccination 5|Extension||99
382175|NCT01047345|914354|P2|Vaccination 5|Extension||0
382176|NCT01047345|914355|P1|Vaccination 5|Extension||0
382177|NCT01047345|914353|P3|Vaccination 4|Extension||102
382178|NCT01047345|914354|P2|Vaccination 4|Extension||0
382179|NCT01047345|914355|P1|Vaccination 4|Extension||0
382180|NCT01047345|914353|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
382181|NCT01047345|914354|P2|STARTED|Extension||0
382182|NCT01047345|914355|P1|STARTED|Extension||0
382183|NCT01047345|914353|P3|NOT COMPLETED|Base Study||0
382184|NCT01047345|914354|P2|NOT COMPLETED|Base Study||6
382185|NCT01047345|914355|P1|NOT COMPLETED|Base Study||22
382186|NCT01047345|914353|P3|COMPLETED|Base Study||0
382188|NCT01047345|914355|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
382189|NCT01047345|914353|P3|Vaccination 3|Base Study||0
382190|NCT01047345|914354|P2|Vaccination 3|Base Study||300
382191|NCT01047345|914355|P1|Vaccination 3|Base Study||597
382192|NCT01047345|914353|P3|Vaccination 2|Base Study||0
382193|NCT01047345|914354|P2|Vaccination 2|Base Study||304
382194|NCT01047345|914355|P1|Vaccination 2|Base Study||604
382195|NCT01047345|914353|P3|Vaccination 1|Base Study||0
382196|NCT01047345|914354|P2|Vaccination 1|Base Study||306
382197|NCT01047345|914355|P1|Vaccination 1|Base Study||615
382198|NCT01047345|914353|P3|STARTED|Base Study||0
382199|NCT01047345|914354|P2|STARTED|Base Study||306
382200|NCT01047345|914355|P1|STARTED|Base Study||618
382201|NCT01047332|914377|P2|NOT COMPLETED|Overall Study||64
382202|NCT01047332|914378|P1|NOT COMPLETED|Overall Study||57
382203|NCT01047332|914377|P2|COMPLETED|Overall Study|Alive at final follow-up|4
382204|NCT01047332|914378|P1|COMPLETED|Overall Study|Alive at final follow-up|4
382205|NCT01047332|914377|P2|STARTED|Overall Study||68
382206|NCT01047332|914378|P1|STARTED|Overall Study||61
382207|NCT01047306|914392|P2|NOT COMPLETED|Overall Study||0
382208|NCT01047306|914393|P1|NOT COMPLETED|Overall Study||3
382209|NCT01047306|914392|P2|COMPLETED|Overall Study||6
382210|NCT01047306|914393|P1|COMPLETED|Overall Study||16
382211|NCT01047306|914392|P2|Discontinued From the Study|Overall Study||0
382212|NCT01047306|914393|P1|Discontinued From the Study|Overall Study||3
382213|NCT01047306|914392|P2|STARTED|Overall Study||6
382214|NCT01047306|914393|P1|STARTED|Overall Study||19
382215|NCT01047293|914467|P4|NOT COMPLETED|Overall Study||0
382216|NCT01047293|914468|P3|NOT COMPLETED|Overall Study||0
382217|NCT01047293|914469|P2|NOT COMPLETED|Overall Study||1
382218|NCT01047293|914470|P1|NOT COMPLETED|Overall Study||1
382219|NCT01047293|914467|P4|COMPLETED|Overall Study||26
382220|NCT01047293|914468|P3|COMPLETED|Overall Study||9
382221|NCT01047293|914469|P2|COMPLETED|Overall Study||7
382222|NCT01047293|914470|P1|COMPLETED|Overall Study||3
382223|NCT01047293|914467|P4|STARTED|Overall Study||26
382224|NCT01047293|914468|P3|STARTED|Overall Study||9
382225|NCT01047293|914469|P2|STARTED|Overall Study||8
382226|NCT01047293|914470|P1|STARTED|Overall Study||4
382227|NCT01047241|914477|P1|NOT COMPLETED|Overall Study||0
382228|NCT01047241|914477|P1|COMPLETED|Overall Study||50
382229|NCT01047241|914477|P1|STARTED|Overall Study||50
382230|NCT01047189|914488|P2|NOT COMPLETED|Overall Study||0
382231|NCT01047189|914489|P1|NOT COMPLETED|Overall Study||4
382232|NCT01047189|914488|P2|COMPLETED|Overall Study||13
382233|NCT01047189|914489|P1|COMPLETED|Overall Study||9
382234|NCT01047189|914488|P2|STARTED|Overall Study||13
382235|NCT01047189|914489|P1|STARTED|Overall Study||13
382236|NCT01046903|914497|P1|NOT COMPLETED|Overall Study||28
382237|NCT01046903|914497|P1|COMPLETED|Overall Study||475
382238|NCT01046903|914497|P1|STARTED|Overall Study||503
382239|NCT01046877|914510|P1|NOT COMPLETED|Overall Study||18
382240|NCT01046877|914510|P1|COMPLETED|Overall Study||7
382241|NCT01046877|914510|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
382242|NCT01046877|914510|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
382243|NCT01046877|914510|P1|STARTED|Overall Study||25
382244|NCT01046695|914526|P2|NOT COMPLETED|Overall Study||2
382245|NCT01046695|914527|P1|NOT COMPLETED|Overall Study||0
382246|NCT01046695|914526|P2|COMPLETED|Overall Study||20
382247|NCT01046695|914527|P1|COMPLETED|Overall Study||20
382248|NCT01046695|914526|P2|STARTED|Overall Study||22
382249|NCT01046695|914527|P1|STARTED|Overall Study||20
382250|NCT01046682|914539|P2|NOT COMPLETED|Overall Study||0
382251|NCT01046682|914540|P1|NOT COMPLETED|Overall Study||2
382252|NCT01046682|914539|P2|COMPLETED|Overall Study||20
382253|NCT01046682|914540|P1|COMPLETED|Overall Study||18
382254|NCT01046682|914539|P2|STARTED|Overall Study||20
382255|NCT01046682|914540|P1|STARTED|Overall Study||20
382256|NCT01046643|914548|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
382257|NCT01046643|914549|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
382258|NCT01046643|914550|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
382259|NCT01046643|914551|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
382260|NCT01046643|914548|P4|COMPLETED|Second Period Treatment or Placebo||7
382261|NCT01046643|914549|P3|COMPLETED|Second Period Treatment or Placebo||7
382262|NCT01046643|914550|P2|COMPLETED|Second Period Treatment or Placebo||6
382263|NCT01046643|914551|P1|COMPLETED|Second Period Treatment or Placebo||9
382264|NCT01046643|914548|P4|STARTED|Second Period Treatment or Placebo||7
382265|NCT01046643|914549|P3|STARTED|Second Period Treatment or Placebo||7
382266|NCT01046643|914550|P2|STARTED|Second Period Treatment or Placebo||6
382267|NCT01046643|914551|P1|STARTED|Second Period Treatment or Placebo||9
382268|NCT01046643|914548|P4|NOT COMPLETED|Washout Period||0
382269|NCT01046643|914549|P3|NOT COMPLETED|Washout Period||0
382270|NCT01046643|914550|P2|NOT COMPLETED|Washout Period||0
382271|NCT01046643|914551|P1|NOT COMPLETED|Washout Period||0
382272|NCT01046643|914548|P4|COMPLETED|Washout Period||7
382273|NCT01046643|914549|P3|COMPLETED|Washout Period||7
382274|NCT01046643|914550|P2|COMPLETED|Washout Period||6
382275|NCT01046643|914551|P1|COMPLETED|Washout Period||9
382276|NCT01046643|914548|P4|STARTED|Washout Period||7
382277|NCT01046643|914549|P3|STARTED|Washout Period||7
382278|NCT01046643|914550|P2|STARTED|Washout Period||6
382279|NCT01046643|914551|P1|STARTED|Washout Period||9
382280|NCT01046643|914548|P4|NOT COMPLETED|First Period Treatment or Placebo||0
382281|NCT01046643|914549|P3|NOT COMPLETED|First Period Treatment or Placebo||0
382282|NCT01046643|914550|P2|NOT COMPLETED|First Period Treatment or Placebo||1
382283|NCT01046643|914551|P1|NOT COMPLETED|First Period Treatment or Placebo||0
382284|NCT01046643|914548|P4|COMPLETED|First Period Treatment or Placebo||7
382285|NCT01046643|914549|P3|COMPLETED|First Period Treatment or Placebo||7
382286|NCT01046643|914550|P2|COMPLETED|First Period Treatment or Placebo||6
382287|NCT01046643|914551|P1|COMPLETED|First Period Treatment or Placebo||9
382288|NCT01046643|914548|P4|STARTED|First Period Treatment or Placebo||7
382289|NCT01046643|914549|P3|STARTED|First Period Treatment or Placebo||7
382290|NCT01046643|914550|P2|STARTED|First Period Treatment or Placebo||7
382291|NCT01046643|914551|P1|STARTED|First Period Treatment or Placebo||9
382292|NCT01046565|914573|P1|NOT COMPLETED|Overall Study||9
382293|NCT01046565|914573|P1|COMPLETED|Overall Study||66
382294|NCT01046565|914573|P1|STARTED|Overall Study||75
382295|NCT01046396|914582|P1|NOT COMPLETED|Overall Study||5
382296|NCT01046396|914582|P1|COMPLETED|Overall Study||64
382297|NCT01046396|914582|P1|STARTED|Overall Study||69
382298|NCT01046253|914593|P2|NOT COMPLETED|Fourth Intervention||0
382299|NCT01046253|914594|P1|NOT COMPLETED|Fourth Intervention||0
382300|NCT01046253|914593|P2|COMPLETED|Fourth Intervention||23
382301|NCT01046253|914594|P1|COMPLETED|Fourth Intervention||25
382302|NCT01046253|914593|P2|STARTED|Fourth Intervention||23
382303|NCT01046253|914594|P1|STARTED|Fourth Intervention||25
382304|NCT01046253|914593|P2|NOT COMPLETED|Third Washout of 7 Days||0
382305|NCT01046253|914594|P1|NOT COMPLETED|Third Washout of 7 Days||0
382306|NCT01046253|914593|P2|COMPLETED|Third Washout of 7 Days||23
382307|NCT01046253|914594|P1|COMPLETED|Third Washout of 7 Days||25
382308|NCT01046253|914593|P2|STARTED|Third Washout of 7 Days||23
382309|NCT01046253|914594|P1|STARTED|Third Washout of 7 Days||25
382310|NCT01046253|914593|P2|NOT COMPLETED|Third Intervention||0
382311|NCT01046253|914594|P1|NOT COMPLETED|Third Intervention||0
382312|NCT01046253|914593|P2|COMPLETED|Third Intervention||23
382313|NCT01046253|914594|P1|COMPLETED|Third Intervention||25
382314|NCT01046253|914593|P2|STARTED|Third Intervention||23
382315|NCT01046253|914594|P1|STARTED|Third Intervention||25
382316|NCT01046253|914593|P2|NOT COMPLETED|Second Washout of 7 Days||0
382317|NCT01046253|914594|P1|NOT COMPLETED|Second Washout of 7 Days||0
382318|NCT01046253|914593|P2|COMPLETED|Second Washout of 7 Days||23
382319|NCT01046253|914594|P1|COMPLETED|Second Washout of 7 Days||25
382320|NCT01046253|914593|P2|STARTED|Second Washout of 7 Days||23
382321|NCT01046253|914594|P1|STARTED|Second Washout of 7 Days||25
382322|NCT01046253|914593|P2|NOT COMPLETED|Second Intervention||2
382323|NCT01046253|914594|P1|NOT COMPLETED|Second Intervention||0
382324|NCT01046253|914593|P2|COMPLETED|Second Intervention||23
382325|NCT01046253|914594|P1|COMPLETED|Second Intervention||25
382326|NCT01046253|914593|P2|STARTED|Second Intervention||25
382327|NCT01046253|914594|P1|STARTED|Second Intervention||25
382328|NCT01046253|914593|P2|NOT COMPLETED|First Washout of 7 Days||0
382329|NCT01046253|914594|P1|NOT COMPLETED|First Washout of 7 Days||0
382330|NCT01046253|914593|P2|COMPLETED|First Washout of 7 Days||25
382331|NCT01046253|914594|P1|COMPLETED|First Washout of 7 Days||25
382332|NCT01046253|914593|P2|STARTED|First Washout of 7 Days||25
382333|NCT01046253|914594|P1|STARTED|First Washout of 7 Days||25
382334|NCT01046253|914593|P2|NOT COMPLETED|First Intervention||0
382335|NCT01046253|914594|P1|NOT COMPLETED|First Intervention||0
382336|NCT01046253|914593|P2|COMPLETED|First Intervention||25
382337|NCT01046253|914594|P1|COMPLETED|First Intervention||25
382338|NCT01046253|914593|P2|STARTED|First Intervention||25
382339|NCT01046253|914594|P1|STARTED|First Intervention||25
382340|NCT01046136|914606|P2|NOT COMPLETED|Overall Study||8
382341|NCT01046136|914607|P1|NOT COMPLETED|Overall Study||4
382342|NCT01046136|914606|P2|COMPLETED|Overall Study||182
382343|NCT01046136|914607|P1|COMPLETED|Overall Study||184
382344|NCT01046136|914606|P2|STARTED|Overall Study||190
382345|NCT01046136|914607|P1|STARTED|Overall Study||188
382346|NCT01046110|914619|P2|NOT COMPLETED|Overall Study||55
382347|NCT01046110|914620|P1|NOT COMPLETED|Overall Study||55
382348|NCT01046110|914619|P2|COMPLETED|Overall Study||174
382349|NCT01046110|914620|P1|COMPLETED|Overall Study||174
382350|NCT01046110|914619|P2|Exposed|Overall Study|1 subject was randomised in error|228
382351|NCT01046110|914620|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
382352|NCT01046110|914619|P2|STARTED|Overall Study||229
382353|NCT01046110|914620|P1|STARTED|Overall Study||229
382354|NCT01046084|914630|P2|NOT COMPLETED|Fourth Intervention||0
382355|NCT01046084|914631|P1|NOT COMPLETED|Fourth Intervention||0
382356|NCT01046084|914630|P2|COMPLETED|Fourth Intervention||25
382357|NCT01046084|914631|P1|COMPLETED|Fourth Intervention||23
382358|NCT01046084|914630|P2|STARTED|Fourth Intervention||25
382359|NCT01046084|914631|P1|STARTED|Fourth Intervention||23
382360|NCT01046084|914630|P2|NOT COMPLETED|Third Washout of 7 Days||0
382361|NCT01046084|914631|P1|NOT COMPLETED|Third Washout of 7 Days||2
382362|NCT01046084|914630|P2|COMPLETED|Third Washout of 7 Days||25
382363|NCT01046084|914631|P1|COMPLETED|Third Washout of 7 Days||23
382364|NCT01046084|914630|P2|STARTED|Third Washout of 7 Days||25
382365|NCT01046084|914631|P1|STARTED|Third Washout of 7 Days||25
382366|NCT01046084|914630|P2|NOT COMPLETED|Third Intervention||0
382367|NCT01046084|914631|P1|NOT COMPLETED|Third Intervention||0
382368|NCT01046084|914630|P2|COMPLETED|Third Intervention||25
382369|NCT01046084|914631|P1|COMPLETED|Third Intervention||25
382370|NCT01046084|914630|P2|STARTED|Third Intervention||25
382371|NCT01046084|914631|P1|STARTED|Third Intervention||25
382372|NCT01046084|914630|P2|NOT COMPLETED|Second Washout of 7 Days||0
382373|NCT01046084|914631|P1|NOT COMPLETED|Second Washout of 7 Days||0
382374|NCT01046084|914630|P2|COMPLETED|Second Washout of 7 Days||25
382375|NCT01046084|914631|P1|COMPLETED|Second Washout of 7 Days||25
382376|NCT01046084|914630|P2|STARTED|Second Washout of 7 Days||25
382377|NCT01046084|914631|P1|STARTED|Second Washout of 7 Days||25
382378|NCT01046084|914630|P2|NOT COMPLETED|Second Intervention||0
382379|NCT01046084|914631|P1|NOT COMPLETED|Second Intervention||0
382380|NCT01046084|914630|P2|COMPLETED|Second Intervention||25
382381|NCT01046084|914631|P1|COMPLETED|Second Intervention||25
382382|NCT01046084|914630|P2|STARTED|Second Intervention||25
382383|NCT01046084|914631|P1|STARTED|Second Intervention||25
382384|NCT01046084|914630|P2|NOT COMPLETED|First Washout of 7 Days||0
382385|NCT01046084|914631|P1|NOT COMPLETED|First Washout of 7 Days||0
382386|NCT01046084|914630|P2|COMPLETED|First Washout of 7 Days||25
382387|NCT01046084|914631|P1|COMPLETED|First Washout of 7 Days||25
382388|NCT01046084|914630|P2|STARTED|First Washout of 7 Days||25
382389|NCT01046084|914631|P1|STARTED|First Washout of 7 Days||25
382390|NCT01046084|914630|P2|NOT COMPLETED|First Intervention||0
382391|NCT01046084|914631|P1|NOT COMPLETED|First Intervention||0
382392|NCT01046084|914630|P2|COMPLETED|First Intervention||25
382393|NCT01046084|914631|P1|COMPLETED|First Intervention||25
382394|NCT01046084|914630|P2|STARTED|First Intervention||25
382395|NCT01046084|914631|P1|STARTED|First Intervention||25
382396|NCT01045993|914645|P4|NOT COMPLETED|Overall Study||0
382397|NCT01045993|914646|P3|NOT COMPLETED|Overall Study||0
382398|NCT01045993|914647|P2|NOT COMPLETED|Overall Study||1
382399|NCT01045993|914648|P1|NOT COMPLETED|Overall Study||0
382400|NCT01045993|914645|P4|COMPLETED|Overall Study||25
382401|NCT01045993|914646|P3|COMPLETED|Overall Study||5
382402|NCT01045993|914647|P2|COMPLETED|Overall Study||4
382403|NCT01045993|914648|P1|COMPLETED|Overall Study||26
382404|NCT01045993|914645|P4|STARTED|Overall Study||25
382405|NCT01045993|914646|P3|STARTED|Overall Study||5
382406|NCT01045993|914647|P2|STARTED|Overall Study||5
382407|NCT01045993|914648|P1|STARTED|Overall Study||26
382408|NCT01045967|914724|P2|NOT COMPLETED|Second Intervention||1
382409|NCT01045967|914725|P1|NOT COMPLETED|Second Intervention||0
382410|NCT01045967|914724|P2|COMPLETED|Second Intervention||27
382411|NCT01045967|914725|P1|COMPLETED|Second Intervention||28
382412|NCT01045967|914724|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
382413|NCT01045967|914725|P1|STARTED|Second Intervention||28
382414|NCT01045967|914724|P2|NOT COMPLETED|Washout of 7 Days||0
382415|NCT01045967|914725|P1|NOT COMPLETED|Washout of 7 Days||0
382416|NCT01045967|914724|P2|COMPLETED|Washout of 7 Days||28
382417|NCT01045967|914725|P1|COMPLETED|Washout of 7 Days||28
382418|NCT01045967|914724|P2|STARTED|Washout of 7 Days||28
382419|NCT01045967|914725|P1|STARTED|Washout of 7 Days||28
382420|NCT01045967|914724|P2|NOT COMPLETED|First Intervention||0
382421|NCT01045967|914725|P1|NOT COMPLETED|First Intervention||0
382422|NCT01045967|914724|P2|COMPLETED|First Intervention||28
382423|NCT01045967|914725|P1|COMPLETED|First Intervention||28
382424|NCT01045967|914724|P2|STARTED|First Intervention||28
382425|NCT01045967|914725|P1|STARTED|First Intervention||28
382426|NCT01045798|914737|P2|NOT COMPLETED|Overall Study||4
382427|NCT01045798|914738|P1|NOT COMPLETED|Overall Study||2
382428|NCT01045798|914737|P2|COMPLETED|Overall Study||5
382429|NCT01045798|914738|P1|COMPLETED|Overall Study||4
382430|NCT01045798|914737|P2|STARTED|Overall Study||9
382431|NCT01045798|914738|P1|STARTED|Overall Study||6
382432|NCT01045707|914746|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
382433|NCT01045707|914747|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
382434|NCT01045707|914746|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
382435|NCT01045707|914747|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
382436|NCT01045707|914746|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
382437|NCT01045707|914747|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
382438|NCT01045707|914746|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
382439|NCT01045707|914747|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
382440|NCT01045707|914746|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
382441|NCT01045707|914747|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
382442|NCT01045707|914746|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
382443|NCT01045707|914747|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
382444|NCT01045707|914746|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
382445|NCT01045707|914747|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
382446|NCT01045551|914763|P1|NOT COMPLETED|Overall Study||0
382447|NCT01045551|914763|P1|COMPLETED|Overall Study||10
382448|NCT01045551|914763|P1|STARTED|Overall Study||10
382449|NCT01045447|914773|P2|NOT COMPLETED|Overall Study||28
382450|NCT01045447|914774|P1|NOT COMPLETED|Overall Study||36
382451|NCT01045447|914773|P2|COMPLETED|Overall Study||205
382452|NCT01045447|914774|P1|COMPLETED|Overall Study||196
382453|NCT01045447|914773|P2|Exposed|Overall Study||233
382454|NCT01045447|914774|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
382455|NCT01045447|914773|P2|STARTED|Overall Study||233
382456|NCT01045447|914774|P1|STARTED|Overall Study||232
382457|NCT01045421|914788|P11|NOT COMPLETED|Phase 2||2
382458|NCT01045421|914789|P10|NOT COMPLETED|Phase 2||3
382459|NCT01045421|914790|P9|NOT COMPLETED|Phase 2||2
382460|NCT01045421|914791|P8|NOT COMPLETED|Phase 2||5
382461|NCT01045421|914792|P7|NOT COMPLETED|Phase 2||0
382462|NCT01045421|914793|P6|NOT COMPLETED|Phase 2||0
382463|NCT01045421|914794|P5|NOT COMPLETED|Phase 2||0
382464|NCT01045421|914795|P4|NOT COMPLETED|Phase 2||0
382465|NCT01045421|914796|P3|NOT COMPLETED|Phase 2||0
382466|NCT01045421|914797|P2|NOT COMPLETED|Phase 2||0
382467|NCT01045421|914798|P1|NOT COMPLETED|Phase 2||0
382468|NCT01045421|914788|P11|COMPLETED|Phase 2||58
382469|NCT01045421|914789|P10|COMPLETED|Phase 2||23
382470|NCT01045421|914790|P9|COMPLETED|Phase 2||53
382471|NCT01045421|914791|P8|COMPLETED|Phase 2||50
382472|NCT01045421|914792|P7|COMPLETED|Phase 2||53
382473|NCT01045421|914793|P6|COMPLETED|Phase 2||0
382474|NCT01045421|914794|P5|COMPLETED|Phase 2||0
382475|NCT01045421|914795|P4|COMPLETED|Phase 2||0
382476|NCT01045421|914796|P3|COMPLETED|Phase 2||0
382477|NCT01045421|914797|P2|COMPLETED|Phase 2||0
382478|NCT01045421|914798|P1|COMPLETED|Phase 2||0
382479|NCT01045421|914788|P11|STARTED|Phase 2||60
382480|NCT01045421|914789|P10|STARTED|Phase 2||26
382481|NCT01045421|914790|P9|STARTED|Phase 2||55
382482|NCT01045421|914791|P8|STARTED|Phase 2||55
382483|NCT01045421|914792|P7|STARTED|Phase 2||53
382484|NCT01045421|914793|P6|STARTED|Phase 2||0
382485|NCT01045421|914794|P5|STARTED|Phase 2||0
382486|NCT01045421|914795|P4|STARTED|Phase 2||0
382487|NCT01045421|914796|P3|STARTED|Phase 2||0
382488|NCT01045421|914797|P2|STARTED|Phase 2||0
382489|NCT01045421|914798|P1|STARTED|Phase 2||0
382490|NCT01045421|914788|P11|NOT COMPLETED|Phase 1||0
382491|NCT01045421|914789|P10|NOT COMPLETED|Phase 1||0
382492|NCT01045421|914790|P9|NOT COMPLETED|Phase 1||0
382493|NCT01045421|914791|P8|NOT COMPLETED|Phase 1||0
382494|NCT01045421|914792|P7|NOT COMPLETED|Phase 1||0
382495|NCT01045421|914793|P6|NOT COMPLETED|Phase 1||0
382496|NCT01045421|914794|P5|NOT COMPLETED|Phase 1||1
382497|NCT01045421|914795|P4|NOT COMPLETED|Phase 1||1
382498|NCT01045421|914796|P3|NOT COMPLETED|Phase 1||0
382499|NCT01045421|914797|P2|NOT COMPLETED|Phase 1||0
382500|NCT01045421|914798|P1|NOT COMPLETED|Phase 1||0
382501|NCT01045421|914788|P11|COMPLETED|Phase 1||0
382502|NCT01045421|914789|P10|COMPLETED|Phase 1||0
382503|NCT01045421|914790|P9|COMPLETED|Phase 1||0
382504|NCT01045421|914791|P8|COMPLETED|Phase 1||0
382505|NCT01045421|914792|P7|COMPLETED|Phase 1||0
382506|NCT01045421|914793|P6|COMPLETED|Phase 1||1
382507|NCT01045421|914794|P5|COMPLETED|Phase 1||2
382508|NCT01045421|914795|P4|COMPLETED|Phase 1||11
382509|NCT01045421|914796|P3|COMPLETED|Phase 1||4
382510|NCT01045421|914797|P2|COMPLETED|Phase 1||3
382511|NCT01045421|914798|P1|COMPLETED|Phase 1||1
382512|NCT01045421|914788|P11|STARTED|Phase 1||0
382513|NCT01045421|914789|P10|STARTED|Phase 1||0
382514|NCT01045421|914790|P9|STARTED|Phase 1||0
382515|NCT01045421|914791|P8|STARTED|Phase 1||0
382516|NCT01045421|914792|P7|STARTED|Phase 1||0
382517|NCT01045421|914793|P6|STARTED|Phase 1||1
382518|NCT01045421|914794|P5|STARTED|Phase 1||3
382519|NCT01045421|914795|P4|STARTED|Phase 1||12
382520|NCT01045421|914796|P3|STARTED|Phase 1||4
382521|NCT01045421|914797|P2|STARTED|Phase 1||3
382522|NCT01045421|914798|P1|STARTED|Phase 1||1
382523|NCT01045265|914878|P1|NOT COMPLETED|Overall Study||0
382524|NCT01045265|914878|P1|COMPLETED|Overall Study||16
382525|NCT01045265|914878|P1|STARTED|Overall Study||16
382526|NCT01045187|914885|P1|NOT COMPLETED|Overall Study||0
382527|NCT01045187|914885|P1|COMPLETED|Overall Study||15
382528|NCT01045187|914885|P1|STARTED|Overall Study||15
382529|NCT01045161|914892|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
382530|NCT01045161|914893|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
382531|NCT01045161|914894|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
382532|NCT01045161|914892|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
382533|NCT01045161|914893|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
382534|NCT01045161|914894|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
382535|NCT01045161|914892|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
382536|NCT01045161|914893|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
382537|NCT01045161|914894|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
382538|NCT01045161|914892|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
382539|NCT01045161|914893|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
382540|NCT01045161|914894|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
382541|NCT01045161|914892|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
382542|NCT01045161|914893|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
382543|NCT01045161|914894|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
382544|NCT01045161|914892|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
382545|NCT01045161|914893|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
382546|NCT01045161|914894|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
382547|NCT01045122|914914|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
382548|NCT01045122|914915|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
382549|NCT01045122|914914|P2|COMPLETED|Propofol Then Dexmedetomidine||6
382550|NCT01045122|914915|P1|COMPLETED|Propofol Then Dexmedetomidine||5
382551|NCT01045122|914914|P2|STARTED|Propofol Then Dexmedetomidine||6
382552|NCT01045122|914915|P1|STARTED|Propofol Then Dexmedetomidine||5
382553|NCT01045122|914914|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
382554|NCT01045122|914915|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
382555|NCT01045122|914914|P2|COMPLETED|Dexmedetomidine Then Propofol||6
382556|NCT01045122|914915|P1|COMPLETED|Dexmedetomidine Then Propofol||5
382557|NCT01045122|914914|P2|STARTED|Dexmedetomidine Then Propofol||6
382558|NCT01045122|914915|P1|STARTED|Dexmedetomidine Then Propofol||5
382559|NCT01045096|914924|P3|NOT COMPLETED|Overall Study||0
382560|NCT01045096|914925|P2|NOT COMPLETED|Overall Study||0
382561|NCT01045096|914926|P1|NOT COMPLETED|Overall Study||3
382562|NCT01045096|914924|P3|COMPLETED|Overall Study||12
382563|NCT01045096|914925|P2|COMPLETED|Overall Study||12
382564|NCT01045096|914926|P1|COMPLETED|Overall Study||9
382565|NCT01045096|914924|P3|Pharmacokinetic Set|Overall Study||11
382566|NCT01045096|914925|P2|Pharmacokinetic Set|Overall Study||11
382567|NCT01045096|914926|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
382568|NCT01045096|914924|P3|STARTED|Overall Study||12
382569|NCT01045096|914925|P2|STARTED|Overall Study||12
382570|NCT01045096|914926|P1|STARTED|Overall Study||12
382571|NCT01045057|914952|P1|NOT COMPLETED|Overall Study||0
382572|NCT01045057|914952|P1|COMPLETED|Overall Study||27
382573|NCT01045057|914952|P1|STARTED|Overall Study||27
382574|NCT01045031|914961|P2|NOT COMPLETED|Overall Study||6
382575|NCT01045031|914962|P1|NOT COMPLETED|Overall Study||9
382576|NCT01045031|914961|P2|COMPLETED|Overall Study||50
382577|NCT01045031|914962|P1|COMPLETED|Overall Study||49
382578|NCT01045031|914961|P2|STARTED|Overall Study||56
382579|NCT01045031|914962|P1|STARTED|Overall Study||58
382580|NCT01044862|914975|P3|NOT COMPLETED|Overall Study||52
382581|NCT01044862|914976|P2|NOT COMPLETED|Overall Study||49
382582|NCT01044862|914977|P1|NOT COMPLETED|Overall Study||53
382583|NCT01044862|914975|P3|COMPLETED|Overall Study||249
382584|NCT01044862|914976|P2|COMPLETED|Overall Study||251
382585|NCT01044862|914977|P1|COMPLETED|Overall Study||246
382586|NCT01044862|914975|P3|STARTED|Overall Study||301
382587|NCT01044862|914976|P2|STARTED|Overall Study||300
382588|NCT01044862|914977|P1|STARTED|Overall Study||299
382589|NCT01044771|914994|P1|NOT COMPLETED|Overall Study||0
382590|NCT01044771|914994|P1|COMPLETED|Overall Study||20
382591|NCT01044771|914994|P1|STARTED|Overall Study||20
382592|NCT01044732|915001|P2|NOT COMPLETED|Overall Study||50
382593|NCT01044732|915002|P1|NOT COMPLETED|Overall Study||49
382594|NCT01044732|915001|P2|COMPLETED|Overall Study||176
382595|NCT01044732|915002|P1|COMPLETED|Overall Study||173
382596|NCT01044732|915001|P2|STARTED|Overall Study||226
382597|NCT01044732|915002|P1|STARTED|Overall Study||222
382598|NCT01044706|915012|P2|NOT COMPLETED|Overall Study||0
382599|NCT01044706|915013|P1|NOT COMPLETED|Overall Study||0
382600|NCT01044706|915012|P2|COMPLETED|Overall Study||30
382601|NCT01044706|915013|P1|COMPLETED|Overall Study||30
382602|NCT01044706|915012|P2|STARTED|Overall Study||30
382603|NCT01044706|915013|P1|STARTED|Overall Study||30
382604|NCT01044693|915021|P16|NOT COMPLETED|Overall Study||0
382605|NCT01044693|915022|P15|NOT COMPLETED|Overall Study||0
382606|NCT01044693|915023|P14|NOT COMPLETED|Overall Study||0
382607|NCT01044693|915024|P13|NOT COMPLETED|Overall Study||0
382608|NCT01044693|915025|P12|NOT COMPLETED|Overall Study||0
382609|NCT01044693|915026|P11|NOT COMPLETED|Overall Study||0
382610|NCT01044693|915027|P10|NOT COMPLETED|Overall Study||0
382611|NCT01044693|915028|P9|NOT COMPLETED|Overall Study||0
382612|NCT01044693|915029|P8|NOT COMPLETED|Overall Study||0
382613|NCT01044693|915030|P7|NOT COMPLETED|Overall Study||0
382614|NCT01044693|915031|P6|NOT COMPLETED|Overall Study||0
382615|NCT01044693|915032|P5|NOT COMPLETED|Overall Study||0
382616|NCT01044693|915033|P4|NOT COMPLETED|Overall Study||0
382617|NCT01044693|915034|P3|NOT COMPLETED|Overall Study||0
382618|NCT01044693|915035|P2|NOT COMPLETED|Overall Study||0
382619|NCT01044693|915036|P1|NOT COMPLETED|Overall Study||0
382620|NCT01044693|915021|P16|COMPLETED|Overall Study||1
382621|NCT01044693|915022|P15|COMPLETED|Overall Study||1
382622|NCT01044693|915023|P14|COMPLETED|Overall Study||1
382623|NCT01044693|915024|P13|COMPLETED|Overall Study||2
382624|NCT01044693|915025|P12|COMPLETED|Overall Study||1
382625|NCT01044693|915026|P11|COMPLETED|Overall Study||1
382626|NCT01044693|915027|P10|COMPLETED|Overall Study||1
382627|NCT01044693|915028|P9|COMPLETED|Overall Study||1
382628|NCT01044693|915029|P8|COMPLETED|Overall Study||1
382629|NCT01044693|915030|P7|COMPLETED|Overall Study||1
382630|NCT01044693|915031|P6|COMPLETED|Overall Study||2
382631|NCT01044693|915032|P5|COMPLETED|Overall Study||1
382632|NCT01044693|915033|P4|COMPLETED|Overall Study||1
382633|NCT01044693|915034|P3|COMPLETED|Overall Study||1
382634|NCT01044693|915035|P2|COMPLETED|Overall Study||1
382635|NCT01044693|915036|P1|COMPLETED|Overall Study||3
382636|NCT01044693|915021|P16|STARTED|Overall Study||1
382637|NCT01044693|915022|P15|STARTED|Overall Study||1
382638|NCT01044693|915023|P14|STARTED|Overall Study||1
382639|NCT01044693|915024|P13|STARTED|Overall Study||2
382640|NCT01044693|915025|P12|STARTED|Overall Study||1
382641|NCT01044693|915026|P11|STARTED|Overall Study||1
382642|NCT01044693|915027|P10|STARTED|Overall Study||1
382643|NCT01044693|915028|P9|STARTED|Overall Study||1
382644|NCT01044693|915029|P8|STARTED|Overall Study||1
382645|NCT01044693|915030|P7|STARTED|Overall Study||1
382646|NCT01044693|915031|P6|STARTED|Overall Study||2
382647|NCT01044693|915032|P5|STARTED|Overall Study||1
382648|NCT01044693|915033|P4|STARTED|Overall Study||1
382649|NCT01044693|915034|P3|STARTED|Overall Study||1
382650|NCT01044693|915035|P2|STARTED|Overall Study||1
382651|NCT01044693|915036|P1|STARTED|Overall Study||3
382652|NCT01044537|915065|P7|NOT COMPLETED|Overall Study||0
382653|NCT01044537|915066|P6|NOT COMPLETED|Overall Study||0
382654|NCT01044537|915067|P5|NOT COMPLETED|Overall Study||0
382655|NCT01044537|915068|P4|NOT COMPLETED|Overall Study||0
382656|NCT01044537|915069|P3|NOT COMPLETED|Overall Study||0
382657|NCT01044537|915070|P2|NOT COMPLETED|Overall Study||0
382658|NCT01044537|915071|P1|NOT COMPLETED|Overall Study||0
382659|NCT01044537|915065|P7|COMPLETED|Overall Study||16
382660|NCT01044537|915066|P6|COMPLETED|Overall Study||5
382661|NCT01044537|915067|P5|COMPLETED|Overall Study||5
382662|NCT01044537|915068|P4|COMPLETED|Overall Study||6
382663|NCT01044537|915069|P3|COMPLETED|Overall Study||6
382664|NCT01044537|915070|P2|COMPLETED|Overall Study||6
382665|NCT01044537|915071|P1|COMPLETED|Overall Study||6
382666|NCT01044537|915065|P7|STARTED|Overall Study||16
382667|NCT01044537|915066|P6|STARTED|Overall Study||5
382668|NCT01044537|915067|P5|STARTED|Overall Study||5
382669|NCT01044537|915068|P4|STARTED|Overall Study||6
382670|NCT01044537|915069|P3|STARTED|Overall Study||6
382671|NCT01044537|915070|P2|STARTED|Overall Study||6
382672|NCT01044537|915071|P1|STARTED|Overall Study||6
382673|NCT01044498|915180|P2|NOT COMPLETED|Overall Study||2
382674|NCT01044498|915181|P1|NOT COMPLETED|Overall Study||3
382675|NCT01044498|915180|P2|COMPLETED|Overall Study||21
382676|NCT01044498|915181|P1|COMPLETED|Overall Study||20
382677|NCT01044498|915180|P2|STARTED|Overall Study||23
382678|NCT01044498|915181|P1|STARTED|Overall Study||23
382679|NCT01044459|915207|P2|NOT COMPLETED|Overall Study||131
382680|NCT01044459|915208|P1|NOT COMPLETED|Overall Study||133
382681|NCT01044459|915207|P2|COMPLETED|Overall Study||162
382682|NCT01044459|915208|P1|COMPLETED|Overall Study||179
382683|NCT01044459|915207|P2|STARTED|Overall Study||293
382684|NCT01044459|915208|P1|STARTED|Overall Study||312
382685|NCT01044303|915216|P1|NOT COMPLETED|Overall Study||2
382686|NCT01044303|915216|P1|COMPLETED|Overall Study||30
382687|NCT01044303|915216|P1|STARTED|Overall Study||32
382688|NCT01044290|915226|P3|NOT COMPLETED|Follow-Up 2||2
382689|NCT01044290|915227|P2|NOT COMPLETED|Follow-Up 2||2
382690|NCT01044290|915228|P1|NOT COMPLETED|Follow-Up 2||0
382691|NCT01044290|915226|P3|COMPLETED|Follow-Up 2||69
382692|NCT01044290|915227|P2|COMPLETED|Follow-Up 2||67
382693|NCT01044290|915228|P1|COMPLETED|Follow-Up 2||70
382694|NCT01044290|915226|P3|Completed F2 Interview|Follow-Up 2||64
382695|NCT01044290|915227|P2|Completed F2 Interview|Follow-Up 2||57
382696|NCT01044290|915228|P1|Completed F2 Interview|Follow-Up 2||64
382697|NCT01044290|915226|P3|STARTED|Follow-Up 2||71
382698|NCT01044290|915227|P2|STARTED|Follow-Up 2||69
382699|NCT01044290|915228|P1|STARTED|Follow-Up 2||70
382700|NCT01044290|915226|P3|NOT COMPLETED|Follow-up 1||1
382701|NCT01044290|915227|P2|NOT COMPLETED|Follow-up 1||5
382702|NCT01044290|915228|P1|NOT COMPLETED|Follow-up 1||5
382703|NCT01044290|915226|P3|COMPLETED|Follow-up 1||71
382704|NCT01044290|915227|P2|COMPLETED|Follow-up 1||69
382705|NCT01044290|915228|P1|COMPLETED|Follow-up 1||70
382706|NCT01044290|915226|P3|Completed F1 Interview|Follow-up 1||61
382707|NCT01044290|915227|P2|Completed F1 Interview|Follow-up 1||60
382708|NCT01044290|915228|P1|Completed F1 Interview|Follow-up 1||61
382709|NCT01044290|915226|P3|STARTED|Follow-up 1||72
382710|NCT01044290|915227|P2|STARTED|Follow-up 1||74
382711|NCT01044290|915228|P1|STARTED|Follow-up 1||75
382712|NCT01044290|915226|P3|NOT COMPLETED|Randomization||0
382713|NCT01044290|915227|P2|NOT COMPLETED|Randomization||0
382714|NCT01044290|915228|P1|NOT COMPLETED|Randomization||0
382715|NCT01044290|915226|P3|COMPLETED|Randomization||72
382716|NCT01044290|915227|P2|COMPLETED|Randomization||74
382717|NCT01044290|915228|P1|COMPLETED|Randomization||75
382718|NCT01044290|915226|P3|Randomized|Randomization||72
382719|NCT01044290|915227|P2|Randomized|Randomization||74
382720|NCT01044290|915228|P1|Randomized|Randomization||75
382721|NCT01044290|915226|P3|STARTED|Randomization||72
382722|NCT01044290|915227|P2|STARTED|Randomization||74
382723|NCT01044290|915228|P1|STARTED|Randomization||75
382724|NCT01044264|915254|P3|NOT COMPLETED|Overall Study||92
382725|NCT01044264|915255|P2|NOT COMPLETED|Overall Study||94
382726|NCT01044264|915256|P1|NOT COMPLETED|Overall Study||90
382727|NCT01044264|915254|P3|COMPLETED|Overall Study||108
382728|NCT01044264|915255|P2|COMPLETED|Overall Study||108
382729|NCT01044264|915256|P1|COMPLETED|Overall Study||110
382730|NCT01044264|915254|P3|STARTED|Overall Study||200
382731|NCT01044264|915255|P2|STARTED|Overall Study||202
382732|NCT01044264|915256|P1|STARTED|Overall Study||200
382733|NCT01044212|915266|P2|NOT COMPLETED|Overall Study||7
382734|NCT01044212|915267|P1|NOT COMPLETED|Overall Study||5
382735|NCT01044212|915266|P2|COMPLETED|Overall Study||30
382736|NCT01044212|915267|P1|COMPLETED|Overall Study||30
382737|NCT01044212|915266|P2|STARTED|Overall Study||37
382738|NCT01044212|915267|P1|STARTED|Overall Study||35
382739|NCT01044056|915280|P3|NOT COMPLETED|Overall Study||0
382740|NCT01044056|915281|P2|NOT COMPLETED|Overall Study||0
382741|NCT01044056|915282|P1|NOT COMPLETED|Overall Study||0
382742|NCT01044056|915280|P3|COMPLETED|Overall Study||8
382743|NCT01044056|915281|P2|COMPLETED|Overall Study||8
382744|NCT01044056|915282|P1|COMPLETED|Overall Study||8
382745|NCT01044056|915280|P3|STARTED|Overall Study||8
382746|NCT01044056|915281|P2|STARTED|Overall Study||8
382747|NCT01044056|915282|P1|STARTED|Overall Study||8
382748|NCT01044030|915301|P2|NOT COMPLETED|Overall Study||20
382749|NCT01044030|915302|P1|NOT COMPLETED|Overall Study||19
382750|NCT01044030|915301|P2|COMPLETED|Overall Study||146
382751|NCT01044030|915302|P1|COMPLETED|Overall Study||141
382752|NCT01044030|915301|P2|STARTED|Overall Study||166
382753|NCT01044030|915302|P1|STARTED|Overall Study||160
382754|NCT01043939|915312|P2|NOT COMPLETED|Second Intervention||0
382755|NCT01043939|915313|P1|NOT COMPLETED|Second Intervention||0
382756|NCT01043939|915312|P2|COMPLETED|Second Intervention||12
382757|NCT01043939|915313|P1|COMPLETED|Second Intervention||12
382758|NCT01043939|915312|P2|STARTED|Second Intervention||12
382759|NCT01043939|915313|P1|STARTED|Second Intervention||12
382760|NCT01043939|915312|P2|NOT COMPLETED|Washout Period||0
382761|NCT01043939|915313|P1|NOT COMPLETED|Washout Period||0
382762|NCT01043939|915312|P2|COMPLETED|Washout Period||12
382763|NCT01043939|915313|P1|COMPLETED|Washout Period||12
382764|NCT01043939|915312|P2|STARTED|Washout Period||12
382765|NCT01043939|915313|P1|STARTED|Washout Period||12
382766|NCT01043939|915312|P2|NOT COMPLETED|First Intervention||0
382767|NCT01043939|915313|P1|NOT COMPLETED|First Intervention||0
382768|NCT01043939|915312|P2|COMPLETED|First Intervention||12
382769|NCT01043939|915313|P1|COMPLETED|First Intervention||12
382770|NCT01043939|915312|P2|STARTED|First Intervention||12
382771|NCT01043939|915313|P1|STARTED|First Intervention||12
382772|NCT01043926|915327|P4|NOT COMPLETED|Overall Study||0
382773|NCT01043926|915328|P3|NOT COMPLETED|Overall Study||0
382774|NCT01043926|915329|P2|NOT COMPLETED|Overall Study||0
382775|NCT01043926|915330|P1|NOT COMPLETED|Overall Study||0
382776|NCT01043926|915327|P4|COMPLETED|Overall Study||0
382777|NCT01043926|915328|P3|COMPLETED|Overall Study||0
382778|NCT01043926|915329|P2|COMPLETED|Overall Study||8
382779|NCT01043926|915330|P1|COMPLETED|Overall Study||8
382780|NCT01043926|915327|P4|STARTED|Overall Study||0
382781|NCT01043926|915328|P3|STARTED|Overall Study||0
382782|NCT01043926|915329|P2|STARTED|Overall Study||8
382783|NCT01043926|915330|P1|STARTED|Overall Study||8
382784|NCT01043874|915344|P1|NOT COMPLETED|Overall Study||6
382785|NCT01043874|915344|P1|COMPLETED|Overall Study||39
382786|NCT01043874|915344|P1|STARTED|Overall Study||45
382787|NCT01043705|915354|P3|NOT COMPLETED|Overall Study||80
382788|NCT01043705|915355|P2|NOT COMPLETED|Overall Study||131
382789|NCT01043705|915356|P1|NOT COMPLETED|Overall Study||107
382790|NCT01043705|915354|P3|COMPLETED|Overall Study||498
382791|NCT01043705|915355|P2|COMPLETED|Overall Study||447
382792|NCT01043705|915356|P1|COMPLETED|Overall Study||352
382793|NCT01043705|915354|P3|STARTED|Overall Study||578
382794|NCT01043705|915355|P2|STARTED|Overall Study||578
382795|NCT01043705|915356|P1|STARTED|Overall Study||459
382796|NCT01043653|915366|P1|NOT COMPLETED|Overall Study||64
382797|NCT01043653|915366|P1|COMPLETED|Overall Study||186
382798|NCT01043653|915366|P1|STARTED|Overall Study||250
382799|NCT01043640|915371|P1|NOT COMPLETED|Overall Study||0
382800|NCT01043640|915371|P1|COMPLETED|Overall Study||46
382801|NCT01043640|915371|P1|STARTED|Overall Study||46
382802|NCT01043523|915386|P1|NOT COMPLETED|Overall Study||0
382803|NCT01043523|915386|P1|COMPLETED|Overall Study||52
382804|NCT01043523|915386|P1|Participants With Unenhanced Images|Overall Study||51
382805|NCT01043523|915386|P1|STARTED|Overall Study||52
382806|NCT01043432|915415|P4|NOT COMPLETED|Overall Study||0
382807|NCT01043432|915416|P3|NOT COMPLETED|Overall Study||0
382808|NCT01043432|915417|P2|NOT COMPLETED|Overall Study||0
382809|NCT01043432|915418|P1|NOT COMPLETED|Overall Study||0
382810|NCT01043432|915415|P4|COMPLETED|Overall Study||48
382811|NCT01043432|915416|P3|COMPLETED|Overall Study||12
382812|NCT01043432|915417|P2|COMPLETED|Overall Study||51
382813|NCT01043432|915418|P1|COMPLETED|Overall Study||22
382814|NCT01043432|915415|P4|STARTED|Overall Study||48
382815|NCT01043432|915416|P3|STARTED|Overall Study||12
382816|NCT01043432|915417|P2|STARTED|Overall Study||51
382817|NCT01043432|915418|P1|STARTED|Overall Study||22
382818|NCT01043393|915427|P2|NOT COMPLETED|Overall Study||0
382819|NCT01043393|915428|P1|NOT COMPLETED|Overall Study||0
382820|NCT01043393|915427|P2|COMPLETED|Overall Study||12
382821|NCT01043393|915428|P1|COMPLETED|Overall Study||12
382822|NCT01043393|915427|P2|STARTED|Overall Study||12
382823|NCT01043393|915428|P1|STARTED|Overall Study||12
382824|NCT01043185|915438|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
382825|NCT01043185|915439|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
382826|NCT01043185|915440|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
382827|NCT01043185|915441|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
382828|NCT01043185|915442|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
382829|NCT01043185|915443|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
382830|NCT01043185|915444|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
382831|NCT01043185|915445|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
382832|NCT01043185|915446|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
382833|NCT01043185|915447|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
382834|NCT01043185|915438|P10|COMPLETED|Period 7 - Fourth Intervention||3
382835|NCT01043185|915439|P9|COMPLETED|Period 7 - Fourth Intervention||2
382836|NCT01043185|915440|P8|COMPLETED|Period 7 - Fourth Intervention||3
382837|NCT01043185|915441|P7|COMPLETED|Period 7 - Fourth Intervention||3
382838|NCT01043185|915442|P6|COMPLETED|Period 7 - Fourth Intervention||3
382839|NCT01043185|915443|P5|COMPLETED|Period 7 - Fourth Intervention||2
382840|NCT01043185|915444|P4|COMPLETED|Period 7 - Fourth Intervention||2
382841|NCT01043185|915445|P3|COMPLETED|Period 7 - Fourth Intervention||3
382842|NCT01043185|915446|P2|COMPLETED|Period 7 - Fourth Intervention||2
382843|NCT01043185|915447|P1|COMPLETED|Period 7 - Fourth Intervention||3
382844|NCT01043185|915438|P10|STARTED|Period 7 - Fourth Intervention||3
382845|NCT01043185|915439|P9|STARTED|Period 7 - Fourth Intervention||2
382846|NCT01043185|915440|P8|STARTED|Period 7 - Fourth Intervention||3
382847|NCT01043185|915441|P7|STARTED|Period 7 - Fourth Intervention||3
382848|NCT01043185|915442|P6|STARTED|Period 7 - Fourth Intervention||3
382849|NCT01043185|915443|P5|STARTED|Period 7 - Fourth Intervention||2
382850|NCT01043185|915444|P4|STARTED|Period 7 - Fourth Intervention||2
382851|NCT01043185|915445|P3|STARTED|Period 7 - Fourth Intervention||3
382852|NCT01043185|915446|P2|STARTED|Period 7 - Fourth Intervention||2
382853|NCT01043185|915447|P1|STARTED|Period 7 - Fourth Intervention||3
382854|NCT01043185|915438|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
382855|NCT01043185|915439|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
382856|NCT01043185|915440|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
382857|NCT01043185|915441|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
382858|NCT01043185|915442|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
382859|NCT01043185|915443|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
382860|NCT01043185|915444|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
382861|NCT01043185|915445|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
382862|NCT01043185|915446|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
382863|NCT01043185|915447|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
382864|NCT01043185|915438|P10|COMPLETED|Period 6 - Third Washout Period||3
382865|NCT01043185|915439|P9|COMPLETED|Period 6 - Third Washout Period||2
382866|NCT01043185|915440|P8|COMPLETED|Period 6 - Third Washout Period||3
382867|NCT01043185|915441|P7|COMPLETED|Period 6 - Third Washout Period||3
382868|NCT01043185|915442|P6|COMPLETED|Period 6 - Third Washout Period||3
382869|NCT01043185|915443|P5|COMPLETED|Period 6 - Third Washout Period||2
382870|NCT01043185|915444|P4|COMPLETED|Period 6 - Third Washout Period||2
382871|NCT01043185|915445|P3|COMPLETED|Period 6 - Third Washout Period||3
382872|NCT01043185|915446|P2|COMPLETED|Period 6 - Third Washout Period||2
382873|NCT01043185|915447|P1|COMPLETED|Period 6 - Third Washout Period||3
382874|NCT01043185|915438|P10|STARTED|Period 6 - Third Washout Period||3
382875|NCT01043185|915439|P9|STARTED|Period 6 - Third Washout Period||3
382876|NCT01043185|915440|P8|STARTED|Period 6 - Third Washout Period||3
382877|NCT01043185|915441|P7|STARTED|Period 6 - Third Washout Period||3
382878|NCT01043185|915442|P6|STARTED|Period 6 - Third Washout Period||3
382879|NCT01043185|915443|P5|STARTED|Period 6 - Third Washout Period||2
382880|NCT01043185|915444|P4|STARTED|Period 6 - Third Washout Period||2
382881|NCT01043185|915445|P3|STARTED|Period 6 - Third Washout Period||3
382882|NCT01043185|915446|P2|STARTED|Period 6 - Third Washout Period||2
382883|NCT01043185|915447|P1|STARTED|Period 6 - Third Washout Period||3
382884|NCT01043185|915438|P10|NOT COMPLETED|Period 5 - Third Intervention||0
382885|NCT01043185|915439|P9|NOT COMPLETED|Period 5 - Third Intervention||0
382886|NCT01043185|915440|P8|NOT COMPLETED|Period 5 - Third Intervention||0
382887|NCT01043185|915441|P7|NOT COMPLETED|Period 5 - Third Intervention||0
382888|NCT01043185|915442|P6|NOT COMPLETED|Period 5 - Third Intervention||0
382889|NCT01043185|915443|P5|NOT COMPLETED|Period 5 - Third Intervention||0
382890|NCT01043185|915444|P4|NOT COMPLETED|Period 5 - Third Intervention||0
382891|NCT01043185|915445|P3|NOT COMPLETED|Period 5 - Third Intervention||0
382892|NCT01043185|915446|P2|NOT COMPLETED|Period 5 - Third Intervention||0
382893|NCT01043185|915447|P1|NOT COMPLETED|Period 5 - Third Intervention||0
382894|NCT01043185|915438|P10|COMPLETED|Period 5 - Third Intervention||3
382895|NCT01043185|915439|P9|COMPLETED|Period 5 - Third Intervention||3
382896|NCT01043185|915440|P8|COMPLETED|Period 5 - Third Intervention||3
382897|NCT01043185|915441|P7|COMPLETED|Period 5 - Third Intervention||3
382898|NCT01043185|915442|P6|COMPLETED|Period 5 - Third Intervention||3
382899|NCT01043185|915443|P5|COMPLETED|Period 5 - Third Intervention||2
382900|NCT01043185|915444|P4|COMPLETED|Period 5 - Third Intervention||2
382901|NCT01043185|915445|P3|COMPLETED|Period 5 - Third Intervention||3
382902|NCT01043185|915446|P2|COMPLETED|Period 5 - Third Intervention||2
382903|NCT01043185|915447|P1|COMPLETED|Period 5 - Third Intervention||3
382904|NCT01043185|915438|P10|STARTED|Period 5 - Third Intervention||3
382905|NCT01043185|915439|P9|STARTED|Period 5 - Third Intervention||3
382906|NCT01043185|915440|P8|STARTED|Period 5 - Third Intervention||3
382907|NCT01043185|915441|P7|STARTED|Period 5 - Third Intervention||3
382908|NCT01043185|915442|P6|STARTED|Period 5 - Third Intervention||3
382909|NCT01043185|915443|P5|STARTED|Period 5 - Third Intervention||2
382910|NCT01043185|915444|P4|STARTED|Period 5 - Third Intervention||2
382911|NCT01043185|915445|P3|STARTED|Period 5 - Third Intervention||3
382912|NCT01043185|915446|P2|STARTED|Period 5 - Third Intervention||2
382913|NCT01043185|915447|P1|STARTED|Period 5 - Third Intervention||3
382914|NCT01043185|915438|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
382915|NCT01043185|915439|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
382916|NCT01043185|915440|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
382917|NCT01043185|915441|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
382918|NCT01043185|915442|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
382919|NCT01043185|915443|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
382920|NCT01043185|915444|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
382921|NCT01043185|915445|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
382922|NCT01043185|915446|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
382923|NCT01043185|915447|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
382924|NCT01043185|915438|P10|COMPLETED|Period 4 - Second Washout Period||3
382925|NCT01043185|915439|P9|COMPLETED|Period 4 - Second Washout Period||3
382926|NCT01043185|915440|P8|COMPLETED|Period 4 - Second Washout Period||3
382927|NCT01043185|915441|P7|COMPLETED|Period 4 - Second Washout Period||3
382928|NCT01043185|915442|P6|COMPLETED|Period 4 - Second Washout Period||3
382929|NCT01043185|915443|P5|COMPLETED|Period 4 - Second Washout Period||2
382930|NCT01043185|915444|P4|COMPLETED|Period 4 - Second Washout Period||2
382931|NCT01043185|915445|P3|COMPLETED|Period 4 - Second Washout Period||3
382932|NCT01043185|915446|P2|COMPLETED|Period 4 - Second Washout Period||2
382933|NCT01043185|915447|P1|COMPLETED|Period 4 - Second Washout Period||3
382934|NCT01043185|915438|P10|STARTED|Period 4 - Second Washout Period||3
382935|NCT01043185|915439|P9|STARTED|Period 4 - Second Washout Period||3
382936|NCT01043185|915440|P8|STARTED|Period 4 - Second Washout Period||3
382937|NCT01043185|915441|P7|STARTED|Period 4 - Second Washout Period||3
382938|NCT01043185|915442|P6|STARTED|Period 4 - Second Washout Period||3
382939|NCT01043185|915443|P5|STARTED|Period 4 - Second Washout Period||2
382940|NCT01043185|915444|P4|STARTED|Period 4 - Second Washout Period||2
382941|NCT01043185|915445|P3|STARTED|Period 4 - Second Washout Period||3
382942|NCT01043185|915446|P2|STARTED|Period 4 - Second Washout Period||2
382943|NCT01043185|915447|P1|STARTED|Period 4 - Second Washout Period||3
382944|NCT01043185|915438|P10|NOT COMPLETED|Period 3 - Second Intervention||0
382945|NCT01043185|915439|P9|NOT COMPLETED|Period 3 - Second Intervention||0
382946|NCT01043185|915440|P8|NOT COMPLETED|Period 3 - Second Intervention||0
382947|NCT01043185|915441|P7|NOT COMPLETED|Period 3 - Second Intervention||0
382948|NCT01043185|915442|P6|NOT COMPLETED|Period 3 - Second Intervention||0
382949|NCT01043185|915443|P5|NOT COMPLETED|Period 3 - Second Intervention||0
382950|NCT01043185|915444|P4|NOT COMPLETED|Period 3 - Second Intervention||0
382951|NCT01043185|915445|P3|NOT COMPLETED|Period 3 - Second Intervention||0
382952|NCT01043185|915446|P2|NOT COMPLETED|Period 3 - Second Intervention||0
382953|NCT01043185|915447|P1|NOT COMPLETED|Period 3 - Second Intervention||0
382954|NCT01043185|915438|P10|COMPLETED|Period 3 - Second Intervention||3
382955|NCT01043185|915439|P9|COMPLETED|Period 3 - Second Intervention||3
382956|NCT01043185|915440|P8|COMPLETED|Period 3 - Second Intervention||3
382957|NCT01043185|915441|P7|COMPLETED|Period 3 - Second Intervention||3
382958|NCT01043185|915442|P6|COMPLETED|Period 3 - Second Intervention||3
382959|NCT01043185|915443|P5|COMPLETED|Period 3 - Second Intervention||2
382960|NCT01043185|915444|P4|COMPLETED|Period 3 - Second Intervention||2
382961|NCT01043185|915445|P3|COMPLETED|Period 3 - Second Intervention||3
382962|NCT01043185|915446|P2|COMPLETED|Period 3 - Second Intervention||2
382963|NCT01043185|915447|P1|COMPLETED|Period 3 - Second Intervention||3
382964|NCT01043185|915438|P10|STARTED|Period 3 - Second Intervention||3
382965|NCT01043185|915439|P9|STARTED|Period 3 - Second Intervention||3
382966|NCT01043185|915440|P8|STARTED|Period 3 - Second Intervention||3
382967|NCT01043185|915441|P7|STARTED|Period 3 - Second Intervention||3
382968|NCT01043185|915442|P6|STARTED|Period 3 - Second Intervention||3
382969|NCT01043185|915443|P5|STARTED|Period 3 - Second Intervention||2
382970|NCT01043185|915444|P4|STARTED|Period 3 - Second Intervention||2
382971|NCT01043185|915445|P3|STARTED|Period 3 - Second Intervention||3
382972|NCT01043185|915446|P2|STARTED|Period 3 - Second Intervention||2
382973|NCT01043185|915447|P1|STARTED|Period 3 - Second Intervention||3
382974|NCT01043185|915438|P10|NOT COMPLETED|Period 2 - First Washout Period||0
382975|NCT01043185|915439|P9|NOT COMPLETED|Period 2 - First Washout Period||0
382976|NCT01043185|915440|P8|NOT COMPLETED|Period 2 - First Washout Period||0
382977|NCT01043185|915441|P7|NOT COMPLETED|Period 2 - First Washout Period||0
382978|NCT01043185|915442|P6|NOT COMPLETED|Period 2 - First Washout Period||0
382979|NCT01043185|915443|P5|NOT COMPLETED|Period 2 - First Washout Period||0
382980|NCT01043185|915444|P4|NOT COMPLETED|Period 2 - First Washout Period||0
382981|NCT01043185|915445|P3|NOT COMPLETED|Period 2 - First Washout Period||0
382982|NCT01043185|915446|P2|NOT COMPLETED|Period 2 - First Washout Period||0
382983|NCT01043185|915447|P1|NOT COMPLETED|Period 2 - First Washout Period||0
382984|NCT01043185|915438|P10|COMPLETED|Period 2 - First Washout Period||3
382985|NCT01043185|915439|P9|COMPLETED|Period 2 - First Washout Period||3
382986|NCT01043185|915440|P8|COMPLETED|Period 2 - First Washout Period||3
382987|NCT01043185|915441|P7|COMPLETED|Period 2 - First Washout Period||3
382988|NCT01043185|915442|P6|COMPLETED|Period 2 - First Washout Period||3
382989|NCT01043185|915443|P5|COMPLETED|Period 2 - First Washout Period||2
382990|NCT01043185|915444|P4|COMPLETED|Period 2 - First Washout Period||2
382991|NCT01043185|915445|P3|COMPLETED|Period 2 - First Washout Period||3
382992|NCT01043185|915446|P2|COMPLETED|Period 2 - First Washout Period||2
382993|NCT01043185|915447|P1|COMPLETED|Period 2 - First Washout Period||3
382994|NCT01043185|915438|P10|STARTED|Period 2 - First Washout Period||3
382995|NCT01043185|915439|P9|STARTED|Period 2 - First Washout Period||3
382996|NCT01043185|915440|P8|STARTED|Period 2 - First Washout Period||3
382997|NCT01043185|915441|P7|STARTED|Period 2 - First Washout Period||3
382998|NCT01043185|915442|P6|STARTED|Period 2 - First Washout Period||3
382999|NCT01043185|915443|P5|STARTED|Period 2 - First Washout Period||2
383000|NCT01043185|915444|P4|STARTED|Period 2 - First Washout Period||2
383001|NCT01043185|915445|P3|STARTED|Period 2 - First Washout Period||3
383002|NCT01043185|915446|P2|STARTED|Period 2 - First Washout Period||2
383003|NCT01043185|915447|P1|STARTED|Period 2 - First Washout Period||3
383004|NCT01043185|915438|P10|NOT COMPLETED|Period 1 - First Intervention||0
383005|NCT01043185|915439|P9|NOT COMPLETED|Period 1 - First Intervention||0
383006|NCT01043185|915440|P8|NOT COMPLETED|Period 1 - First Intervention||0
383007|NCT01043185|915441|P7|NOT COMPLETED|Period 1 - First Intervention||0
383008|NCT01043185|915442|P6|NOT COMPLETED|Period 1 - First Intervention||0
383009|NCT01043185|915443|P5|NOT COMPLETED|Period 1 - First Intervention||0
383010|NCT01043185|915444|P4|NOT COMPLETED|Period 1 - First Intervention||0
383011|NCT01043185|915445|P3|NOT COMPLETED|Period 1 - First Intervention||0
383012|NCT01043185|915446|P2|NOT COMPLETED|Period 1 - First Intervention||0
383013|NCT01043185|915447|P1|NOT COMPLETED|Period 1 - First Intervention||0
383014|NCT01043185|915438|P10|COMPLETED|Period 1 - First Intervention||3
383015|NCT01043185|915439|P9|COMPLETED|Period 1 - First Intervention||3
383016|NCT01043185|915440|P8|COMPLETED|Period 1 - First Intervention||3
383017|NCT01043185|915441|P7|COMPLETED|Period 1 - First Intervention||3
383018|NCT01043185|915442|P6|COMPLETED|Period 1 - First Intervention||3
383019|NCT01043185|915443|P5|COMPLETED|Period 1 - First Intervention||2
383020|NCT01043185|915444|P4|COMPLETED|Period 1 - First Intervention||2
383021|NCT01043185|915445|P3|COMPLETED|Period 1 - First Intervention||3
383022|NCT01043185|915446|P2|COMPLETED|Period 1 - First Intervention||2
383023|NCT01043185|915447|P1|COMPLETED|Period 1 - First Intervention||3
383024|NCT01043185|915438|P10|STARTED|Period 1 - First Intervention||3
383025|NCT01043185|915439|P9|STARTED|Period 1 - First Intervention||3
383026|NCT01043185|915440|P8|STARTED|Period 1 - First Intervention||3
383027|NCT01043185|915441|P7|STARTED|Period 1 - First Intervention||3
383028|NCT01043185|915442|P6|STARTED|Period 1 - First Intervention||3
383029|NCT01043185|915443|P5|STARTED|Period 1 - First Intervention||2
383030|NCT01043185|915444|P4|STARTED|Period 1 - First Intervention||2
383031|NCT01043185|915445|P3|STARTED|Period 1 - First Intervention||3
383032|NCT01043185|915446|P2|STARTED|Period 1 - First Intervention||2
383033|NCT01043185|915447|P1|STARTED|Period 1 - First Intervention||3
383034|NCT01043146|915480|P6|NOT COMPLETED|Overall Study||0
383035|NCT01043146|915481|P5|NOT COMPLETED|Overall Study||0
383036|NCT01043146|915482|P4|NOT COMPLETED|Overall Study||0
383037|NCT01043146|915483|P3|NOT COMPLETED|Overall Study||0
383038|NCT01043146|915484|P2|NOT COMPLETED|Overall Study||0
383039|NCT01043146|915485|P1|NOT COMPLETED|Overall Study||0
383040|NCT01043146|915480|P6|COMPLETED|Overall Study||8
383041|NCT01043146|915481|P5|COMPLETED|Overall Study||8
383042|NCT01043146|915482|P4|COMPLETED|Overall Study||8
383043|NCT01043146|915483|P3|COMPLETED|Overall Study||8
383044|NCT01043146|915484|P2|COMPLETED|Overall Study||8
383045|NCT01043146|915485|P1|COMPLETED|Overall Study||10
383046|NCT01043146|915480|P6|STARTED|Overall Study||8
383047|NCT01043146|915481|P5|STARTED|Overall Study||8
383048|NCT01043146|915482|P4|STARTED|Overall Study||8
383049|NCT01043146|915483|P3|STARTED|Overall Study||8
383050|NCT01043146|915484|P2|STARTED|Overall Study||8
383051|NCT01043146|915485|P1|STARTED|Overall Study||10
383052|NCT01043133|915501|P2|NOT COMPLETED|Overall Study||2
383053|NCT01043133|915502|P1|NOT COMPLETED|Overall Study||1
383054|NCT01043133|915501|P2|COMPLETED|Overall Study||78
383055|NCT01043133|915502|P1|COMPLETED|Overall Study||74
383056|NCT01043133|915501|P2|STARTED|Overall Study||80
383057|NCT01043133|915502|P1|STARTED|Overall Study||75
383058|NCT01043094|915512|P2|NOT COMPLETED|Overall Study||0
383059|NCT01043094|915513|P1|NOT COMPLETED|Overall Study||0
383060|NCT01043094|915512|P2|COMPLETED|Overall Study||8
383061|NCT01043094|915513|P1|COMPLETED|Overall Study||8
383062|NCT01043094|915512|P2|STARTED|Overall Study||8
383063|NCT01043094|915513|P1|STARTED|Overall Study||8
383064|NCT01042977|915523|P2|NOT COMPLETED|Overall Study||55
383065|NCT01042977|915524|P1|NOT COMPLETED|Overall Study||41
383066|NCT01042977|915523|P2|COMPLETED|Overall Study||428
383067|NCT01042977|915524|P1|COMPLETED|Overall Study||441
383068|NCT01042977|915523|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
383069|NCT01042977|915524|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
383070|NCT01042938|915544|P2|NOT COMPLETED|Overall Study||2
383071|NCT01042938|915545|P1|NOT COMPLETED|Overall Study||3
383072|NCT01042938|915544|P2|COMPLETED|Overall Study||16
383073|NCT01042938|915545|P1|COMPLETED|Overall Study||14
383074|NCT01042938|915544|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
383075|NCT01042938|915545|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
383076|NCT01042678|915560|P6|NOT COMPLETED|Overall Study||0
383077|NCT01042678|915561|P5|NOT COMPLETED|Overall Study||0
383078|NCT01042678|915562|P4|NOT COMPLETED|Overall Study||0
383079|NCT01042678|915563|P3|NOT COMPLETED|Overall Study||0
383080|NCT01042678|915564|P2|NOT COMPLETED|Overall Study||0
383081|NCT01042678|915565|P1|NOT COMPLETED|Overall Study||1
383082|NCT01042678|915560|P6|COMPLETED|Overall Study||0
383083|NCT01042678|915561|P5|COMPLETED|Overall Study||0
383084|NCT01042678|915562|P4|COMPLETED|Overall Study||0
383085|NCT01042678|915563|P3|COMPLETED|Overall Study||6
383086|NCT01042678|915564|P2|COMPLETED|Overall Study||6
383087|NCT01042678|915565|P1|COMPLETED|Overall Study||5
383088|NCT01042678|915560|P6|STARTED|Overall Study||0
383089|NCT01042678|915561|P5|STARTED|Overall Study||0
383090|NCT01042678|915562|P4|STARTED|Overall Study||0
383091|NCT01042678|915563|P3|STARTED|Overall Study||6
383092|NCT01042678|915564|P2|STARTED|Overall Study||6
383093|NCT01042678|915565|P1|STARTED|Overall Study||6
383094|NCT01042613|915590|P2|NOT COMPLETED|Overall Study||0
383095|NCT01042613|915591|P1|NOT COMPLETED|Overall Study||0
383096|NCT01042613|915590|P2|COMPLETED|Overall Study||74
383097|NCT01042613|915591|P1|COMPLETED|Overall Study||72
383098|NCT01042613|915590|P2|STARTED|Overall Study||74
383099|NCT01042613|915591|P1|STARTED|Overall Study||72
383100|NCT01042600|915603|P2|NOT COMPLETED|Overall Study||0
383101|NCT01042600|915604|P1|NOT COMPLETED|Overall Study||1
383102|NCT01042600|915603|P2|COMPLETED|Overall Study||30
383103|NCT01042600|915604|P1|COMPLETED|Overall Study||30
383104|NCT01042600|915603|P2|STARTED|Overall Study||30
383105|NCT01042600|915604|P1|STARTED|Overall Study||31
383106|NCT01042535|915612|P1|NOT COMPLETED|Overall Study||8
383107|NCT01042535|915612|P1|COMPLETED|Overall Study||36
383108|NCT01042535|915612|P1|STARTED|Overall Study||44
383109|NCT01042509|915620|P1|NOT COMPLETED|Overall Study||0
383110|NCT01042509|915620|P1|COMPLETED|Overall Study||15
383111|NCT01042509|915620|P1|STARTED|Overall Study||15
383112|NCT01042496|915627|P2|NOT COMPLETED|Overall Study||0
383113|NCT01042496|915628|P1|NOT COMPLETED|Overall Study||0
383114|NCT01042496|915627|P2|COMPLETED|Overall Study||33
383115|NCT01042496|915628|P1|COMPLETED|Overall Study||29
383116|NCT01042496|915627|P2|STARTED|Overall Study||33
383117|NCT01042496|915628|P1|STARTED|Overall Study||29
383118|NCT01042392|915646|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
383119|NCT01042392|915647|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
383120|NCT01042392|915648|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
383121|NCT01042392|915649|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
383122|NCT01042392|915646|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
383123|NCT01042392|915647|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
383124|NCT01042392|915648|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
383125|NCT01042392|915649|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
383126|NCT01042392|915646|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
383127|NCT01042392|915647|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
383128|NCT01042392|915648|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
383129|NCT01042392|915649|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
383130|NCT01042392|915646|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
383131|NCT01042392|915647|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
383132|NCT01042392|915648|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
383133|NCT01042392|915649|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
383134|NCT01042392|915646|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
383135|NCT01042392|915647|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
383136|NCT01042392|915648|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
383137|NCT01042392|915649|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
383138|NCT01042392|915646|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
383139|NCT01042392|915647|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
383140|NCT01042392|915648|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
383141|NCT01042392|915649|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
383142|NCT01042392|915646|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
383143|NCT01042392|915647|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
383144|NCT01042392|915648|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
383145|NCT01042392|915649|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
383146|NCT01042392|915646|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
383147|NCT01042392|915647|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
383148|NCT01042392|915648|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
383149|NCT01042392|915649|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
383150|NCT01042288|915675|P1|NOT COMPLETED|Overall Study||69
383151|NCT01042288|915675|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
383152|NCT01042288|915675|P1|Maintenance|Overall Study||27
383153|NCT01042288|915675|P1|STARTED|Overall Study||69
383154|NCT01042236|915683|P6|NOT COMPLETED|Treatment Period 3||0
383155|NCT01042236|915684|P5|NOT COMPLETED|Treatment Period 3||0
383156|NCT01042236|915685|P4|NOT COMPLETED|Treatment Period 3||2
383157|NCT01042236|915686|P3|NOT COMPLETED|Treatment Period 3||0
383158|NCT01042236|915687|P2|NOT COMPLETED|Treatment Period 3||0
383159|NCT01042236|915688|P1|NOT COMPLETED|Treatment Period 3||0
383160|NCT01042236|915683|P6|COMPLETED|Treatment Period 3||3
383161|NCT01042236|915684|P5|COMPLETED|Treatment Period 3||3
383162|NCT01042236|915685|P4|COMPLETED|Treatment Period 3||3
383163|NCT01042236|915686|P3|COMPLETED|Treatment Period 3||3
383164|NCT01042236|915687|P2|COMPLETED|Treatment Period 3||3
383165|NCT01042236|915688|P1|COMPLETED|Treatment Period 3||3
383166|NCT01042236|915683|P6|STARTED|Treatment Period 3||3
383167|NCT01042236|915684|P5|STARTED|Treatment Period 3||3
383168|NCT01042236|915685|P4|STARTED|Treatment Period 3||5
383169|NCT01042236|915686|P3|STARTED|Treatment Period 3||3
383170|NCT01042236|915687|P2|STARTED|Treatment Period 3||3
383171|NCT01042236|915688|P1|STARTED|Treatment Period 3||3
383172|NCT01042236|915683|P6|NOT COMPLETED|Treatment Period 2||0
383173|NCT01042236|915684|P5|NOT COMPLETED|Treatment Period 2||0
383174|NCT01042236|915685|P4|NOT COMPLETED|Treatment Period 2||0
383175|NCT01042236|915686|P3|NOT COMPLETED|Treatment Period 2||0
383176|NCT01042236|915687|P2|NOT COMPLETED|Treatment Period 2||0
383177|NCT01042236|915688|P1|NOT COMPLETED|Treatment Period 2||0
383178|NCT01042236|915683|P6|COMPLETED|Treatment Period 2||3
383179|NCT01042236|915684|P5|COMPLETED|Treatment Period 2||3
383180|NCT01042236|915685|P4|COMPLETED|Treatment Period 2||5
383181|NCT01042236|915686|P3|COMPLETED|Treatment Period 2||3
383182|NCT01042236|915687|P2|COMPLETED|Treatment Period 2||3
383183|NCT01042236|915688|P1|COMPLETED|Treatment Period 2||3
383184|NCT01042236|915683|P6|STARTED|Treatment Period 2||3
383185|NCT01042236|915684|P5|STARTED|Treatment Period 2||3
383186|NCT01042236|915685|P4|STARTED|Treatment Period 2||5
383187|NCT01042236|915686|P3|STARTED|Treatment Period 2||3
383188|NCT01042236|915687|P2|STARTED|Treatment Period 2||3
383189|NCT01042236|915688|P1|STARTED|Treatment Period 2||3
383190|NCT01042236|915683|P6|NOT COMPLETED|Treatment Period 1||0
383191|NCT01042236|915684|P5|NOT COMPLETED|Treatment Period 1||1
383192|NCT01042236|915685|P4|NOT COMPLETED|Treatment Period 1||0
383193|NCT01042236|915686|P3|NOT COMPLETED|Treatment Period 1||0
383194|NCT01042236|915687|P2|NOT COMPLETED|Treatment Period 1||1
383195|NCT01042236|915688|P1|NOT COMPLETED|Treatment Period 1||0
383196|NCT01042236|915683|P6|COMPLETED|Treatment Period 1||3
383197|NCT01042236|915684|P5|COMPLETED|Treatment Period 1||3
383198|NCT01042236|915685|P4|COMPLETED|Treatment Period 1||5
383199|NCT01042236|915686|P3|COMPLETED|Treatment Period 1||3
383200|NCT01042236|915687|P2|COMPLETED|Treatment Period 1||3
383201|NCT01042236|915688|P1|COMPLETED|Treatment Period 1||3
383202|NCT01042236|915683|P6|STARTED|Treatment Period 1||3
383203|NCT01042236|915684|P5|STARTED|Treatment Period 1||4
383204|NCT01042236|915685|P4|STARTED|Treatment Period 1||5
383205|NCT01042236|915686|P3|STARTED|Treatment Period 1||3
383206|NCT01042236|915687|P2|STARTED|Treatment Period 1||4
383207|NCT01042236|915688|P1|STARTED|Treatment Period 1||3
383208|NCT01042145|915727|P2|NOT COMPLETED|Overall Study||1
383209|NCT01042145|915728|P1|NOT COMPLETED|Overall Study||1
383210|NCT01042145|915727|P2|COMPLETED|Overall Study||45
383211|NCT01042145|915728|P1|COMPLETED|Overall Study||40
383212|NCT01042145|915727|P2|STARTED|Overall Study||46
383213|NCT01042145|915728|P1|STARTED|Overall Study||41
383214|NCT01042093|915748|P4|NOT COMPLETED|Overall Study||4
383215|NCT01042093|915749|P3|NOT COMPLETED|Overall Study||2
383216|NCT01042093|915750|P2|NOT COMPLETED|Overall Study||2
383217|NCT01042093|915751|P1|NOT COMPLETED|Overall Study||2
383218|NCT01042093|915748|P4|COMPLETED|Overall Study||36
383219|NCT01042093|915749|P3|COMPLETED|Overall Study||38
383220|NCT01042093|915750|P2|COMPLETED|Overall Study||38
383221|NCT01042093|915751|P1|COMPLETED|Overall Study||38
383222|NCT01042093|915748|P4|STARTED|Overall Study||40
383223|NCT01042093|915749|P3|STARTED|Overall Study||40
383224|NCT01042093|915750|P2|STARTED|Overall Study||40
383225|NCT01042093|915751|P1|STARTED|Overall Study||40
383226|NCT01041976|915771|P2|NOT COMPLETED|Overall Study||4
383227|NCT01041976|915772|P1|NOT COMPLETED|Overall Study||5
383228|NCT01041976|915771|P2|COMPLETED|Overall Study||38
383229|NCT01041976|915772|P1|COMPLETED|Overall Study||37
383230|NCT01041976|915771|P2|18 Month Follow-up|Overall Study||38
383231|NCT01041976|915772|P1|18 Month Follow-up|Overall Study||37
383232|NCT01041976|915771|P2|12 Month Follow-up|Overall Study||38
383233|NCT01041976|915772|P1|12 Month Follow-up|Overall Study||37
383234|NCT01041976|915771|P2|6 Month Follow-up|Overall Study||41
383235|NCT01041976|915772|P1|6 Month Follow-up|Overall Study||39
383236|NCT01041976|915771|P2|STARTED|Overall Study||42
383237|NCT01041976|915772|P1|STARTED|Overall Study||42
383238|NCT01041859|915782|P3|NOT COMPLETED|Double-Blind Maintenance||45
383239|NCT01041859|915783|P2|NOT COMPLETED|Double-Blind Maintenance||46
383240|NCT01041859|915784|P1|NOT COMPLETED|Double-Blind Maintenance||0
383241|NCT01041859|915782|P3|COMPLETED|Double-Blind Maintenance||107
383242|NCT01041859|915783|P2|COMPLETED|Double-Blind Maintenance||120
383243|NCT01041859|915784|P1|COMPLETED|Double-Blind Maintenance||0
383244|NCT01041859|915782|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
383330|NCT01040832|915996|P1|COMPLETED|Overall Study||8
383331|NCT01040832|915995|P2|STARTED|Overall Study||53
383245|NCT01041859|915783|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
383246|NCT01041859|915784|P1|STARTED|Double-Blind Maintenance||0
383247|NCT01041859|915782|P3|NOT COMPLETED|Open-Label Titration||0
383248|NCT01041859|915783|P2|NOT COMPLETED|Open-Label Titration||0
383249|NCT01041859|915784|P1|NOT COMPLETED|Open-Label Titration||101
383250|NCT01041859|915782|P3|COMPLETED|Open-Label Titration||0
383251|NCT01041859|915783|P2|COMPLETED|Open-Label Titration||0
383252|NCT01041859|915784|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
383253|NCT01041859|915782|P3|STARTED|Open-Label Titration||0
383254|NCT01041859|915783|P2|STARTED|Open-Label Titration||0
383255|NCT01041859|915784|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
383256|NCT01041638|915799|P1|NOT COMPLETED|Overall Study||27
383257|NCT01041638|915799|P1|COMPLETED|Overall Study||78
383258|NCT01041638|915799|P1|STARTED|Overall Study||105
383259|NCT01041573|915807|P4|NOT COMPLETED|Overall Study||2
383260|NCT01041573|915808|P3|NOT COMPLETED|Overall Study||7
383261|NCT01041573|915809|P2|NOT COMPLETED|Overall Study||13
383262|NCT01041573|915810|P1|NOT COMPLETED|Overall Study||5
383263|NCT01041573|915807|P4|COMPLETED|Overall Study||62
383264|NCT01041573|915808|P3|COMPLETED|Overall Study||387
383265|NCT01041573|915809|P2|COMPLETED|Overall Study||858
383266|NCT01041573|915810|P1|COMPLETED|Overall Study||535
383267|NCT01041573|915807|P4|STARTED|Overall Study||64
383268|NCT01041573|915808|P3|STARTED|Overall Study||394
383269|NCT01041573|915809|P2|STARTED|Overall Study||871
383270|NCT01041573|915810|P1|STARTED|Overall Study||540
383271|NCT01041417|915822|P2|NOT COMPLETED|Overall Study||3
383272|NCT01041417|915823|P1|NOT COMPLETED|Overall Study||7
383273|NCT01041417|915822|P2|COMPLETED|Overall Study||76
383274|NCT01041417|915823|P1|COMPLETED|Overall Study||73
383275|NCT01041417|915822|P2|STARTED|Overall Study||79
383276|NCT01041417|915823|P1|STARTED|Overall Study||80
383277|NCT01041404|915861|P2|NOT COMPLETED|Overall Study||294
383278|NCT01041404|915862|P1|NOT COMPLETED|Overall Study||290
383279|NCT01041404|915861|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
383280|NCT01041404|915862|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
383281|NCT01041404|915861|P2|Alive in Follow-up|Overall Study||41
383282|NCT01041404|915862|P1|Alive in Follow-up|Overall Study||40
383283|NCT01041404|915861|P2|Lost to Follow-up|Overall Study||10
383284|NCT01041404|915862|P1|Lost to Follow-up|Overall Study||12
383285|NCT01041404|915861|P2|Died in Follow-up|Overall Study||200
383286|NCT01041404|915862|P1|Died in Follow-up|Overall Study||199
383287|NCT01041404|915861|P2|Entered Follow-Up|Overall Study||251
383288|NCT01041404|915862|P1|Entered Follow-Up|Overall Study||251
383289|NCT01041404|915861|P2|STARTED|Overall Study||294
383290|NCT01041404|915862|P1|STARTED|Overall Study||290
383291|NCT01041287|915903|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
383292|NCT01041287|915904|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
383293|NCT01041287|915903|P2|COMPLETED|Treatment Period 2 (3 Months)||14
383294|NCT01041287|915904|P1|COMPLETED|Treatment Period 2 (3 Months)||16
383295|NCT01041287|915903|P2|STARTED|Treatment Period 2 (3 Months)||19
383296|NCT01041287|915904|P1|STARTED|Treatment Period 2 (3 Months)||19
383297|NCT01041287|915903|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
383298|NCT01041287|915904|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
383299|NCT01041287|915903|P2|COMPLETED|Treatment Period 1 (3 Months)||19
383300|NCT01041287|915904|P1|COMPLETED|Treatment Period 1 (3 Months)||19
383301|NCT01041287|915903|P2|STARTED|Treatment Period 1 (3 Months)||19
383302|NCT01041287|915904|P1|STARTED|Treatment Period 1 (3 Months)||19
383303|NCT01041209|915916|P2|NOT COMPLETED|Overall Study||0
383304|NCT01041209|915917|P1|NOT COMPLETED|Overall Study||0
383305|NCT01041209|915916|P2|COMPLETED|Overall Study||60
383306|NCT01041209|915917|P1|COMPLETED|Overall Study||60
383307|NCT01041209|915916|P2|STARTED|Overall Study||60
383308|NCT01041209|915917|P1|STARTED|Overall Study||60
383309|NCT01040871|915927|P2|NOT COMPLETED|Overall Study||7
383310|NCT01040871|915928|P1|NOT COMPLETED|Overall Study||13
383311|NCT01040871|915927|P2|COMPLETED|Overall Study||73
383312|NCT01040871|915928|P1|COMPLETED|Overall Study||71
383313|NCT01040871|915927|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
383314|NCT01040871|915928|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
383315|NCT01040858|915948|P2|NOT COMPLETED|Overall Study||0
383316|NCT01040858|915949|P1|NOT COMPLETED|Overall Study||9
383317|NCT01040858|915948|P2|COMPLETED|Overall Study||69
383318|NCT01040858|915949|P1|COMPLETED|Overall Study||50
383319|NCT01040858|915948|P2|STARTED|Overall Study||69
383320|NCT01040858|915949|P1|STARTED|Overall Study||59
383321|NCT01040845|915979|P2|NOT COMPLETED|Overall Study||1
383322|NCT01040845|915980|P1|NOT COMPLETED|Overall Study||2
383323|NCT01040845|915979|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
383324|NCT01040845|915980|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
383325|NCT01040845|915979|P2|STARTED|Overall Study||15
383326|NCT01040845|915980|P1|STARTED|Overall Study||15
383327|NCT01040832|915995|P2|NOT COMPLETED|Overall Study||37
383328|NCT01040832|915996|P1|NOT COMPLETED|Overall Study||46
383329|NCT01040832|915995|P2|COMPLETED|Overall Study||16
383332|NCT01040832|915996|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
383333|NCT01040819|916012|P2|NOT COMPLETED|Overall Study||0
383334|NCT01040819|916013|P1|NOT COMPLETED|Overall Study||0
383335|NCT01040819|916012|P2|COMPLETED|Overall Study||12
383336|NCT01040819|916013|P1|COMPLETED|Overall Study||13
383337|NCT01040819|916012|P2|STARTED|Overall Study||12
383338|NCT01040819|916013|P1|STARTED|Overall Study||13
383339|NCT01040793|916019|P6|NOT COMPLETED|Overall Study||1
383340|NCT01040793|916020|P5|NOT COMPLETED|Overall Study||4
383341|NCT01040793|916021|P4|NOT COMPLETED|Overall Study||4
383342|NCT01040793|916022|P3|NOT COMPLETED|Overall Study||3
383343|NCT01040793|916023|P2|NOT COMPLETED|Overall Study||5
383344|NCT01040793|916024|P1|NOT COMPLETED|Overall Study||6
383345|NCT01040793|916019|P6|COMPLETED|Overall Study||26
383346|NCT01040793|916020|P5|COMPLETED|Overall Study||22
383347|NCT01040793|916021|P4|COMPLETED|Overall Study||22
383348|NCT01040793|916022|P3|COMPLETED|Overall Study||23
383349|NCT01040793|916023|P2|COMPLETED|Overall Study||21
383350|NCT01040793|916024|P1|COMPLETED|Overall Study||20
383351|NCT01040793|916019|P6|STARTED|Overall Study||27
383352|NCT01040793|916020|P5|STARTED|Overall Study||26
383353|NCT01040793|916021|P4|STARTED|Overall Study||26
383354|NCT01040793|916022|P3|STARTED|Overall Study||26
383355|NCT01040793|916023|P2|STARTED|Overall Study||26
383356|NCT01040793|916024|P1|STARTED|Overall Study|Entered and treated|26
383357|NCT01040780|916103|P2|NOT COMPLETED|Overall Study||3
383358|NCT01040780|916104|P1|NOT COMPLETED|Overall Study||1
383359|NCT01040780|916103|P2|COMPLETED|Overall Study||196
383360|NCT01040780|916104|P1|COMPLETED|Overall Study||199
383361|NCT01040780|916103|P2|STARTED|Overall Study||199
383362|NCT01040780|916104|P1|STARTED|Overall Study||200
383363|NCT01040728|916118|P4|NOT COMPLETED|Overall Study||6
383364|NCT01040728|916119|P3|NOT COMPLETED|Overall Study||1
383365|NCT01040728|916120|P2|NOT COMPLETED|Overall Study||11
383366|NCT01040728|916121|P1|NOT COMPLETED|Overall Study||4
383367|NCT01040728|916118|P4|COMPLETED|Overall Study||24
383368|NCT01040728|916119|P3|COMPLETED|Overall Study||30
383369|NCT01040728|916120|P2|COMPLETED|Overall Study||19
383370|NCT01040728|916121|P1|COMPLETED|Overall Study||27
383371|NCT01040728|916118|P4|STARTED|Overall Study||30
383372|NCT01040728|916119|P3|STARTED|Overall Study||31
383373|NCT01040728|916120|P2|STARTED|Overall Study||30
383374|NCT01040728|916121|P1|STARTED|Overall Study||31
383375|NCT01040689|916191|P4|NOT COMPLETED|Overall Study||4
383376|NCT01040689|916192|P3|NOT COMPLETED|Overall Study||4
383377|NCT01040689|916193|P2|NOT COMPLETED|Overall Study||2
383378|NCT01040689|916194|P1|NOT COMPLETED|Overall Study||3
383379|NCT01040689|916191|P4|COMPLETED|Overall Study||23
383380|NCT01040689|916192|P3|COMPLETED|Overall Study||23
383381|NCT01040689|916193|P2|COMPLETED|Overall Study||25
383382|NCT01040689|916194|P1|COMPLETED|Overall Study||24
383383|NCT01040689|916191|P4|STARTED|Overall Study||27
383384|NCT01040689|916192|P3|STARTED|Overall Study||27
383385|NCT01040689|916193|P2|STARTED|Overall Study||27
383386|NCT01040689|916194|P1|STARTED|Overall Study||27
383387|NCT01040624|916266|P2|NOT COMPLETED|Overall Study||0
383388|NCT01040624|916267|P1|NOT COMPLETED|Overall Study||0
383389|NCT01040624|916266|P2|COMPLETED|Overall Study||19
383390|NCT01040624|916267|P1|COMPLETED|Overall Study||58
383391|NCT01040624|916266|P2|STARTED|Overall Study||19
383392|NCT01040624|916267|P1|STARTED|Overall Study||58
383393|NCT01040403|916273|P1|NOT COMPLETED|Overall Study||20
383394|NCT01040403|916273|P1|COMPLETED|Overall Study|All treatment periods|213
383395|NCT01040403|916273|P1|Completed T+O 5/10|Overall Study||107
383396|NCT01040403|916273|P1|Completed T+O 2.5/10|Overall Study||110
383397|NCT01040403|916273|P1|Completed T+O 1.25/10|Overall Study||106
383398|NCT01040403|916273|P1|Completed Olo 10|Overall Study||109
383399|NCT01040403|916273|P1|Completed T+O 5/5|Overall Study||106
383400|NCT01040403|916273|P1|Completed T+O 2.5/5|Overall Study||111
383401|NCT01040403|916273|P1|Completed T+O 1.25/5|Overall Study||105
383402|NCT01040403|916273|P1|Completed Olo 5|Overall Study||106
383403|NCT01040403|916273|P1|STARTED|Overall Study||233
383404|NCT01040351|916461|P2|NOT COMPLETED|Overall Study||2
383405|NCT01040351|916462|P1|NOT COMPLETED|Overall Study||1
383406|NCT01040351|916461|P2|COMPLETED|Overall Study|May 2010|53
383407|NCT01040351|916462|P1|COMPLETED|Overall Study|May 2010|54
383408|NCT01040351|916461|P2|STARTED|Overall Study|October 2006|55
383409|NCT01040351|916462|P1|STARTED|Overall Study|October 2006|55
383410|NCT01040260|916472|P2|NOT COMPLETED|Overall Study||11
383411|NCT01040260|916473|P1|NOT COMPLETED|Overall Study||15
383412|NCT01040260|916472|P2|COMPLETED|Overall Study||39
383413|NCT01040260|916473|P1|COMPLETED|Overall Study||38
383414|NCT01040260|916472|P2|STARTED|Overall Study||50
383415|NCT01040260|916473|P1|STARTED|Overall Study||53
383416|NCT01040208|916482|P3|NOT COMPLETED|Overall Study||3
383417|NCT01040208|916483|P2|NOT COMPLETED|Overall Study||13
383418|NCT01040208|916484|P1|NOT COMPLETED|Overall Study||6
383419|NCT01040208|916482|P3|COMPLETED|Overall Study||35
383420|NCT01040208|916483|P2|COMPLETED|Overall Study||15
383421|NCT01040208|916484|P1|COMPLETED|Overall Study||39
383422|NCT01040208|916482|P3|STARTED|Overall Study||38
383423|NCT01040208|916483|P2|STARTED|Overall Study||28
383424|NCT01040208|916484|P1|STARTED|Overall Study||45
383425|NCT01040169|916500|P2|NOT COMPLETED|Overall Study||8
383426|NCT01040169|916501|P1|NOT COMPLETED|Overall Study||3
383427|NCT01040169|916500|P2|COMPLETED|Overall Study||36
383428|NCT01040169|916501|P1|COMPLETED|Overall Study||32
383429|NCT01040169|916500|P2|STARTED|Overall Study||44
383430|NCT01040169|916501|P1|STARTED|Overall Study||35
383431|NCT01040130|916509|P6|NOT COMPLETED|Overall Study||4
383432|NCT01040130|916510|P5|NOT COMPLETED|Overall Study||0
383433|NCT01040130|916511|P4|NOT COMPLETED|Overall Study||5
383434|NCT01040130|916512|P3|NOT COMPLETED|Overall Study||2
383435|NCT01040130|916513|P2|NOT COMPLETED|Overall Study||3
383436|NCT01040130|916514|P1|NOT COMPLETED|Overall Study||3
383437|NCT01040130|916509|P6|COMPLETED|Overall Study||22
383438|NCT01040130|916510|P5|COMPLETED|Overall Study||25
383439|NCT01040130|916511|P4|COMPLETED|Overall Study||20
383440|NCT01040130|916512|P3|COMPLETED|Overall Study||23
383441|NCT01040130|916513|P2|COMPLETED|Overall Study||22
383442|NCT01040130|916514|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
383443|NCT01040130|916509|P6|STARTED|Overall Study||26
383444|NCT01040130|916510|P5|STARTED|Overall Study||25
383445|NCT01040130|916511|P4|STARTED|Overall Study||25
383446|NCT01040130|916512|P3|STARTED|Overall Study||25
383447|NCT01040130|916513|P2|STARTED|Overall Study||25
383448|NCT01040130|916514|P1|STARTED|Overall Study|Number of patients entered and treated|25
383449|NCT01040052|916591|P1|NOT COMPLETED|Overall Study||0
383450|NCT01040052|916591|P1|COMPLETED|Overall Study||30
383451|NCT01040052|916591|P1|STARTED|Overall Study||30
383452|NCT01039792|916597|P2|NOT COMPLETED|Overall Study||1
383453|NCT01039792|916598|P1|NOT COMPLETED|Overall Study||6
383454|NCT01039792|916597|P2|COMPLETED|Overall Study||27
383455|NCT01039792|916598|P1|COMPLETED|Overall Study||23
383456|NCT01039792|916597|P2|STARTED|Overall Study||28
383457|NCT01039792|916598|P1|STARTED|Overall Study||29
383458|NCT01039675|916606|P2|NOT COMPLETED|Overall Study||7
383459|NCT01039675|916607|P1|NOT COMPLETED|Overall Study||0
383460|NCT01039675|916606|P2|COMPLETED|Overall Study||35
383461|NCT01039675|916607|P1|COMPLETED|Overall Study||9
383462|NCT01039675|916606|P2|STARTED|Overall Study||42
383463|NCT01039675|916607|P1|STARTED|Overall Study||9
383464|NCT01039584|916620|P3|NOT COMPLETED|Overall Study||57
383465|NCT01039584|916621|P2|NOT COMPLETED|Overall Study||97
383466|NCT01039584|916622|P1|NOT COMPLETED|Overall Study||103
383467|NCT01039584|916620|P3|COMPLETED|Overall Study||65
383468|NCT01039584|916621|P2|COMPLETED|Overall Study||146
383469|NCT01039584|916622|P1|COMPLETED|Overall Study||143
383470|NCT01039584|916620|P3|STARTED|Overall Study||122
383471|NCT01039584|916621|P2|STARTED|Overall Study||243
383472|NCT01039584|916622|P1|STARTED|Overall Study||246
383473|NCT01039519|916636|P1|NOT COMPLETED|Survival Follow-up||27
383474|NCT01039519|916636|P1|COMPLETED|Survival Follow-up||0
383475|NCT01039519|916636|P1|STARTED|Survival Follow-up||27
383476|NCT01039519|916636|P1|NOT COMPLETED|Treatment||27
383477|NCT01039519|916636|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
383478|NCT01039519|916636|P1|STARTED|Treatment||27
383479|NCT01039428|916647|P2|NOT COMPLETED|Overall Study||0
383480|NCT01039428|916648|P1|NOT COMPLETED|Overall Study||2
383481|NCT01039428|916647|P2|COMPLETED|Overall Study||28
383482|NCT01039428|916648|P1|COMPLETED|Overall Study||33
383483|NCT01039428|916647|P2|STARTED|Overall Study||28
383484|NCT01039428|916648|P1|STARTED|Overall Study||35
383485|NCT01039376|916672|P2|NOT COMPLETED|Overall Study||202
383486|NCT01039376|916673|P1|NOT COMPLETED|Overall Study||206
383487|NCT01039376|916672|P2|COMPLETED|Overall Study||34
383488|NCT01039376|916673|P1|COMPLETED|Overall Study||32
383489|NCT01039376|916672|P2|Ongoing|Overall Study||182
383490|NCT01039376|916673|P1|Ongoing|Overall Study||189
383491|NCT01039376|916672|P2|STARTED|Overall Study||236
383492|NCT01039376|916673|P1|STARTED|Overall Study||238
383493|NCT01035788|916733|P2|NOT COMPLETED|Overall Study||14
383494|NCT01035788|916734|P1|NOT COMPLETED|Overall Study||6
383495|NCT01035788|916733|P2|COMPLETED|Overall Study||9
383496|NCT01035788|916734|P1|COMPLETED|Overall Study||17
383497|NCT01035788|916733|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
383498|NCT01035788|916734|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
383499|NCT01035749|916744|P4|NOT COMPLETED|Overall Study||0
383500|NCT01035749|916745|P3|NOT COMPLETED|Overall Study||0
383501|NCT01035749|916746|P2|NOT COMPLETED|Overall Study||0
383502|NCT01035749|916747|P1|NOT COMPLETED|Overall Study||0
383503|NCT01035749|916744|P4|COMPLETED|Overall Study||110
383504|NCT01035749|916745|P3|COMPLETED|Overall Study||68
383505|NCT01035749|916746|P2|COMPLETED|Overall Study||66
383506|NCT01035749|916747|P1|COMPLETED|Overall Study||66
383507|NCT01035749|916744|P4|STARTED|Overall Study||110
383508|NCT01035749|916745|P3|STARTED|Overall Study||68
383509|NCT01035749|916746|P2|STARTED|Overall Study||66
383510|NCT01035749|916747|P1|STARTED|Overall Study||66
383511|NCT01035658|916869|P4|NOT COMPLETED|Overall Study||0
383512|NCT01035658|916870|P3|NOT COMPLETED|Overall Study||0
383513|NCT01035658|916871|P2|NOT COMPLETED|Overall Study||0
383514|NCT01035658|916872|P1|NOT COMPLETED|Overall Study||0
383515|NCT01035658|916869|P4|COMPLETED|Overall Study||6
383516|NCT01035658|916870|P3|COMPLETED|Overall Study||3
383517|NCT01035658|916871|P2|COMPLETED|Overall Study||8
383518|NCT01035658|916872|P1|COMPLETED|Overall Study||5
383519|NCT01035658|916869|P4|STARTED|Overall Study||6
383520|NCT01035658|916870|P3|STARTED|Overall Study||3
383521|NCT01035658|916871|P2|STARTED|Overall Study||8
383522|NCT01035658|916872|P1|STARTED|Overall Study||5
383523|NCT01038921|916897|P2|NOT COMPLETED|Overall Study||0
383524|NCT01038921|916898|P1|NOT COMPLETED|Overall Study||2
383525|NCT01038921|916897|P2|COMPLETED|Overall Study||20
383526|NCT01038921|916898|P1|COMPLETED|Overall Study|2 subjects withdrew|17
383527|NCT01038921|916897|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
383528|NCT01038921|916898|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
383529|NCT01038869|916904|P1|NOT COMPLETED|Overall Study||7
383530|NCT01038869|916904|P1|COMPLETED|Overall Study||13
383531|NCT01038869|916904|P1|STARTED|Overall Study||20
383532|NCT01038752|916914|P2|NOT COMPLETED|Overall Study||5
383533|NCT01038752|916915|P1|NOT COMPLETED|Overall Study||5
383534|NCT01038752|916914|P2|COMPLETED|Overall Study||1
383535|NCT01038752|916915|P1|COMPLETED|Overall Study||3
383536|NCT01038752|916914|P2|STARTED|Overall Study||6
383537|NCT01038752|916915|P1|STARTED|Overall Study||8
383538|NCT01038713|916938|P3|NOT COMPLETED|Overall Study||1
383539|NCT01038713|916939|P2|NOT COMPLETED|Overall Study||3
383540|NCT01038713|916940|P1|NOT COMPLETED|Overall Study||5
383541|NCT01038713|916938|P3|COMPLETED|Overall Study||16
383542|NCT01038713|916939|P2|COMPLETED|Overall Study||17
383543|NCT01038713|916940|P1|COMPLETED|Overall Study||21
383544|NCT01038713|916938|P3|STARTED|Overall Study||17
383545|NCT01038713|916939|P2|STARTED|Overall Study||20
383546|NCT01038713|916940|P1|STARTED|Overall Study||26
383547|NCT01038635|916969|P9|NOT COMPLETED|Overall Study||2
383548|NCT01038635|916970|P8|NOT COMPLETED|Overall Study||5
383549|NCT01038635|916971|P7|NOT COMPLETED|Overall Study||2
383550|NCT01038635|916972|P6|NOT COMPLETED|Overall Study||0
383551|NCT01038635|916973|P5|NOT COMPLETED|Overall Study||1
383552|NCT01038635|916974|P4|NOT COMPLETED|Overall Study||0
383553|NCT01038635|916975|P3|NOT COMPLETED|Overall Study||0
383554|NCT01038635|916976|P2|NOT COMPLETED|Overall Study||0
383555|NCT01038635|916977|P1|NOT COMPLETED|Overall Study||2
383556|NCT01038635|916969|P9|COMPLETED|Overall Study||38
383557|NCT01038635|916970|P8|COMPLETED|Overall Study||15
383558|NCT01038635|916971|P7|COMPLETED|Overall Study||5
383559|NCT01038635|916972|P6|COMPLETED|Overall Study||3
383560|NCT01038635|916973|P5|COMPLETED|Overall Study||3
383561|NCT01038635|916974|P4|COMPLETED|Overall Study||3
383562|NCT01038635|916975|P3|COMPLETED|Overall Study||3
383563|NCT01038635|916976|P2|COMPLETED|Overall Study||3
383564|NCT01038635|916977|P1|COMPLETED|Overall Study||3
383565|NCT01038635|916969|P9|STARTED|Overall Study||40
383566|NCT01038635|916970|P8|STARTED|Overall Study||20
383567|NCT01038635|916971|P7|STARTED|Overall Study||7
383568|NCT01038635|916972|P6|STARTED|Overall Study||3
383569|NCT01038635|916973|P5|STARTED|Overall Study||4
383570|NCT01038635|916974|P4|STARTED|Overall Study||3
383571|NCT01038635|916975|P3|STARTED|Overall Study||3
383572|NCT01038635|916976|P2|STARTED|Overall Study||3
383573|NCT01038635|916977|P1|STARTED|Overall Study||5
383574|NCT01038609|917003|P5|NOT COMPLETED|Overall Study||1
383575|NCT01038609|917004|P4|NOT COMPLETED|Overall Study||1
383576|NCT01038609|917005|P3|NOT COMPLETED|Overall Study||1
383577|NCT01038609|917006|P2|NOT COMPLETED|Overall Study||1
383578|NCT01038609|917007|P1|NOT COMPLETED|Overall Study||1
383579|NCT01038609|917003|P5|COMPLETED|Overall Study||50
383580|NCT01038609|917004|P4|COMPLETED|Overall Study||47
383581|NCT01038609|917005|P3|COMPLETED|Overall Study||48
383582|NCT01038609|917006|P2|COMPLETED|Overall Study||51
383583|NCT01038609|917007|P1|COMPLETED|Overall Study||49
383584|NCT01038609|917003|P5|STARTED|Overall Study||51
383585|NCT01038609|917004|P4|STARTED|Overall Study||48
383586|NCT01038609|917005|P3|STARTED|Overall Study||49
383587|NCT01038609|917006|P2|STARTED|Overall Study||52
383588|NCT01038609|917007|P1|STARTED|Overall Study||50
383589|NCT01038336|917052|P3|NOT COMPLETED|Overall Study||0
383590|NCT01038336|917053|P2|NOT COMPLETED|Overall Study||0
383591|NCT01038336|917054|P1|NOT COMPLETED|Overall Study||0
383592|NCT01038336|917052|P3|COMPLETED|Overall Study||44
383593|NCT01038336|917053|P2|COMPLETED|Overall Study||42
383594|NCT01038336|917054|P1|COMPLETED|Overall Study||43
383595|NCT01038336|917052|P3|STARTED|Overall Study||44
383596|NCT01038336|917053|P2|STARTED|Overall Study||42
383597|NCT01038336|917054|P1|STARTED|Overall Study||43
383598|NCT01038323|917086|P3|NOT COMPLETED|Overall Study||4
383599|NCT01038323|917087|P2|NOT COMPLETED|Overall Study||2
383600|NCT01038323|917088|P1|NOT COMPLETED|Overall Study||3
383601|NCT01038323|917086|P3|COMPLETED|Overall Study||15
383602|NCT01038323|917087|P2|COMPLETED|Overall Study||17
383603|NCT01038323|917088|P1|COMPLETED|Overall Study||17
383604|NCT01038323|917086|P3|STARTED|Overall Study||19
383605|NCT01038323|917087|P2|STARTED|Overall Study||19
383606|NCT01038323|917088|P1|STARTED|Overall Study||20
383607|NCT01038128|917102|P1|NOT COMPLETED|Overall Study||4
383608|NCT01038128|917102|P1|COMPLETED|Overall Study||1
383609|NCT01038128|917102|P1|Baseline Visit|Overall Study||3
383610|NCT01038128|917102|P1|STARTED|Overall Study||5
383611|NCT01037452|917114|P4|NOT COMPLETED|Overall Study||0
383612|NCT01037452|917115|P3|NOT COMPLETED|Overall Study||0
383613|NCT01037452|917116|P2|NOT COMPLETED|Overall Study||0
383614|NCT01037452|917117|P1|NOT COMPLETED|Overall Study||0
383615|NCT01037452|917114|P4|COMPLETED|Overall Study||30
383616|NCT01037452|917115|P3|COMPLETED|Overall Study||30
383617|NCT01037452|917116|P2|COMPLETED|Overall Study||30
383618|NCT01037452|917117|P1|COMPLETED|Overall Study||30
383619|NCT01037452|917114|P4|STARTED|Overall Study||30
383620|NCT01037452|917115|P3|STARTED|Overall Study||30
383621|NCT01037452|917116|P2|STARTED|Overall Study||30
383622|NCT01037452|917117|P1|STARTED|Overall Study||30
383623|NCT01035346|917141|P2|NOT COMPLETED|Overall Study||0
383624|NCT01035346|917142|P1|NOT COMPLETED|Overall Study||0
383625|NCT01035346|917141|P2|COMPLETED|Overall Study||9
383626|NCT01035346|917142|P1|COMPLETED|Overall Study||7
383627|NCT01035346|917141|P2|STARTED|Overall Study||9
383628|NCT01035346|917142|P1|STARTED|Overall Study||7
383629|NCT01035333|917160|P1|NOT COMPLETED|Overall Study||10
383630|NCT01035333|917160|P1|COMPLETED|Overall Study||9
383631|NCT01035333|917160|P1|STARTED|Overall Study||19
383632|NCT01035255|917167|P2|NOT COMPLETED|Overall Study||862
383633|NCT01035255|917168|P1|NOT COMPLETED|Overall Study||741
383634|NCT01035255|917167|P2|COMPLETED|Overall Study||3371
383635|NCT01035255|917168|P1|COMPLETED|Overall Study||3468
383636|NCT01035255|917167|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
383637|NCT01035255|917168|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
383638|NCT01035255|917167|P2|Mis-randomized|Overall Study||2
383639|NCT01035255|917168|P1|Mis-randomized|Overall Study||4
383640|NCT01035255|917167|P2|GCP Violations|Overall Study||19
383641|NCT01035255|917168|P1|GCP Violations|Overall Study||18
383642|NCT01035255|917167|P2|STARTED|Overall Study||4233
383643|NCT01035255|917168|P1|STARTED|Overall Study||4209
383644|NCT01035229|917186|P2|NOT COMPLETED|Overall Study||184
383645|NCT01035229|917187|P1|NOT COMPLETED|Overall Study||362
383646|NCT01035229|917186|P2|COMPLETED|Overall Study||0
383647|NCT01035229|917187|P1|COMPLETED|Overall Study||0
383648|NCT01035229|917186|P2|STARTED|Overall Study||184
383649|NCT01035229|917187|P1|STARTED|Overall Study||362
383650|NCT01037309|917211|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
383651|NCT01037309|917212|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
383652|NCT01037309|917213|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
383653|NCT01037309|917214|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
383654|NCT01037309|917215|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
383655|NCT01037309|917216|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
383656|NCT01037309|917217|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
383657|NCT01037309|917218|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
383658|NCT01037309|917219|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
383659|NCT01037309|917211|P9|COMPLETED|Intravenous Period 7 - 9||3
383660|NCT01037309|917212|P8|COMPLETED|Intravenous Period 7 - 9||3
383661|NCT01037309|917213|P7|COMPLETED|Intravenous Period 7 - 9||3
383662|NCT01037309|917214|P6|COMPLETED|Intravenous Period 7 - 9||0
383663|NCT01037309|917215|P5|COMPLETED|Intravenous Period 7 - 9||0
383664|NCT01037309|917216|P4|COMPLETED|Intravenous Period 7 - 9||0
383665|NCT01037309|917217|P3|COMPLETED|Intravenous Period 7 - 9||0
383666|NCT01037309|917218|P2|COMPLETED|Intravenous Period 7 - 9||0
383667|NCT01037309|917219|P1|COMPLETED|Intravenous Period 7 - 9||0
383668|NCT01037309|917211|P9|STARTED|Intravenous Period 7 - 9||3
383669|NCT01037309|917212|P8|STARTED|Intravenous Period 7 - 9||3
383670|NCT01037309|917213|P7|STARTED|Intravenous Period 7 - 9||3
383671|NCT01037309|917214|P6|STARTED|Intravenous Period 7 - 9||0
383672|NCT01037309|917215|P5|STARTED|Intravenous Period 7 - 9||0
383673|NCT01037309|917216|P4|STARTED|Intravenous Period 7 - 9||0
383674|NCT01037309|917217|P3|STARTED|Intravenous Period 7 - 9||0
383675|NCT01037309|917218|P2|STARTED|Intravenous Period 7 - 9||0
383676|NCT01037309|917219|P1|STARTED|Intravenous Period 7 - 9||0
383677|NCT01037309|917211|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383678|NCT01037309|917212|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383679|NCT01037309|917213|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383680|NCT01037309|917214|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383681|NCT01037309|917215|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383682|NCT01037309|917216|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383683|NCT01037309|917217|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383684|NCT01037309|917218|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383685|NCT01037309|917219|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
383686|NCT01037309|917211|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
383687|NCT01037309|917212|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
383688|NCT01037309|917213|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
383689|NCT01037309|917214|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
383690|NCT01037309|917215|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
383691|NCT01037309|917216|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
383692|NCT01037309|917217|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
383693|NCT01037309|917218|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
383694|NCT01037309|917219|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
383695|NCT01037309|917211|P9|STARTED|Subcutaneous Cohort 1 - 6||0
383696|NCT01037309|917212|P8|STARTED|Subcutaneous Cohort 1 - 6||0
383697|NCT01037309|917213|P7|STARTED|Subcutaneous Cohort 1 - 6||0
383698|NCT01037309|917214|P6|STARTED|Subcutaneous Cohort 1 - 6||3
383699|NCT01037309|917215|P5|STARTED|Subcutaneous Cohort 1 - 6||3
383700|NCT01037309|917216|P4|STARTED|Subcutaneous Cohort 1 - 6||3
383701|NCT01037309|917217|P3|STARTED|Subcutaneous Cohort 1 - 6||3
383702|NCT01037309|917218|P2|STARTED|Subcutaneous Cohort 1 - 6||3
383703|NCT01037309|917219|P1|STARTED|Subcutaneous Cohort 1 - 6||3
383704|NCT01037244|917252|P4|NOT COMPLETED|Overall Study||14
383705|NCT01037244|917253|P3|NOT COMPLETED|Overall Study||14
383706|NCT01037244|917254|P2|NOT COMPLETED|Overall Study||14
383707|NCT01037244|917255|P1|NOT COMPLETED|Overall Study||13
383708|NCT01037244|917252|P4|COMPLETED|Overall Study||140
383709|NCT01037244|917253|P3|COMPLETED|Overall Study||144
383710|NCT01037244|917254|P2|COMPLETED|Overall Study||138
383711|NCT01037244|917255|P1|COMPLETED|Overall Study||141
383712|NCT01037244|917252|P4|Safety Population|Overall Study||152
383713|NCT01037244|917253|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
383714|NCT01037244|917254|P2|Safety Population|Overall Study||150
383715|NCT01037244|917255|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
383716|NCT01037244|917252|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
383717|NCT01037244|917253|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
383718|NCT01037244|917254|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
383719|NCT01037244|917255|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
383720|NCT01037244|917252|P4|STARTED|Overall Study||154
383721|NCT01037244|917253|P3|STARTED|Overall Study||158
383722|NCT01037244|917254|P2|STARTED|Overall Study||152
383723|NCT01037244|917255|P1|STARTED|Overall Study||154
383724|NCT01037218|917317|P4|NOT COMPLETED|Overall Study||16
383725|NCT01037218|917318|P3|NOT COMPLETED|Overall Study||21
383726|NCT01037218|917319|P2|NOT COMPLETED|Overall Study||21
383727|NCT01037218|917320|P1|NOT COMPLETED|Overall Study||16
383728|NCT01037218|917317|P4|COMPLETED|Overall Study||134
383729|NCT01037218|917318|P3|COMPLETED|Overall Study||134
383730|NCT01037218|917319|P2|COMPLETED|Overall Study||128
383731|NCT01037218|917320|P1|COMPLETED|Overall Study||131
383732|NCT01037218|917317|P4|mITT Population|Overall Study||141
383733|NCT01037218|917318|P3|mITT Population|Overall Study||147
383734|NCT01037218|917319|P2|mITT Population|Overall Study||140
383735|NCT01037218|917320|P1|mITT Population|Overall Study||141
383736|NCT01037218|917317|P4|Safety Population|Overall Study||150
383737|NCT01037218|917318|P3|Safety Population|Overall Study||154
383738|NCT01037218|917319|P2|Safety Population|Overall Study||148
383739|NCT01037218|917320|P1|Safety Population|Overall Study||147
383740|NCT01037218|917317|P4|STARTED|Overall Study||150
383741|NCT01037218|917318|P3|STARTED|Overall Study||155
383742|NCT01037218|917319|P2|STARTED|Overall Study||149
383743|NCT01037218|917320|P1|STARTED|Overall Study||147
383744|NCT01037192|917380|P2|NOT COMPLETED|Overall Study||0
383745|NCT01037192|917381|P1|NOT COMPLETED|Overall Study||0
383746|NCT01037192|917380|P2|COMPLETED|Overall Study||1
383747|NCT01037192|917381|P1|COMPLETED|Overall Study||3
383748|NCT01037192|917380|P2|STARTED|Overall Study||1
383749|NCT01037192|917381|P1|STARTED|Overall Study||3
383750|NCT01037127|917391|P2|NOT COMPLETED|Overall Study||21
383751|NCT01037127|917392|P1|NOT COMPLETED|Overall Study||5
383752|NCT01037127|917391|P2|COMPLETED|Overall Study||36
383753|NCT01037127|917392|P1|COMPLETED|Overall Study||35
383754|NCT01037127|917391|P2|STARTED|Overall Study||57
383755|NCT01037127|917392|P1|STARTED|Overall Study||40
383756|NCT01037114|917424|P1|NOT COMPLETED|Year 20||1
383757|NCT01037114|917424|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
383758|NCT01037114|917424|P1|STARTED|Year 20||45
383759|NCT01037114|917424|P1|NOT COMPLETED|Year 19||0
383760|NCT01037114|917424|P1|COMPLETED|Year 19||45
383761|NCT01037114|917424|P1|STARTED|Year 19||45
383762|NCT01037114|917424|P1|NOT COMPLETED|Year 18||0
383763|NCT01037114|917424|P1|COMPLETED|Year 18||44
383764|NCT01037114|917424|P1|STARTED|Year 18||44
383765|NCT01037114|917424|P1|NOT COMPLETED|Year 17||0
383766|NCT01037114|917424|P1|COMPLETED|Year 17||48
383767|NCT01037114|917424|P1|STARTED|Year 17||48
383768|NCT01037114|917424|P1|NOT COMPLETED|Year 16||0
383769|NCT01037114|917424|P1|COMPLETED|Year 16||49
383770|NCT01037114|917424|P1|STARTED|Year 16||49
383771|NCT01037088|917437|P1|NOT COMPLETED|Overall Study||3
383772|NCT01037088|917437|P1|COMPLETED|Overall Study||36
383773|NCT01037088|917437|P1|Received Placebo|Overall Study||38
383774|NCT01037088|917437|P1|Received 1.29% THC|Overall Study||37
383775|NCT01037088|917437|P1|Received 3.53% THC|Overall Study||36
383776|NCT01037088|917437|P1|STARTED|Overall Study||39
383777|NCT01036802|917447|P2|NOT COMPLETED|Overall Study||0
383778|NCT01036802|917448|P1|NOT COMPLETED|Overall Study||0
383779|NCT01036802|917447|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
383780|NCT01036802|917448|P1|COMPLETED|Overall Study||2
383781|NCT01036802|917447|P2|STARTED|Overall Study||1
383782|NCT01036802|917448|P1|STARTED|Overall Study||2
383783|NCT01036763|917466|P1|NOT COMPLETED|Overall Study||93
383784|NCT01036763|917466|P1|COMPLETED|Overall Study||1171
383785|NCT01036763|917466|P1|STARTED|Overall Study||1264
383786|NCT01036724|917478|P2|NOT COMPLETED|Overall Study||8
383787|NCT01036724|917479|P1|NOT COMPLETED|Overall Study||6
383788|NCT01036724|917478|P2|COMPLETED|Overall Study||47
383789|NCT01036724|917479|P1|COMPLETED|Overall Study||46
383790|NCT01036724|917478|P2|STARTED|Overall Study||55
383791|NCT01036724|917479|P1|STARTED|Overall Study||52
383792|NCT01036529|917489|P2|NOT COMPLETED|Overall Study||15
383793|NCT01036529|917490|P1|NOT COMPLETED|Overall Study||13
383794|NCT01036529|917489|P2|COMPLETED|Overall Study||0
383795|NCT01036529|917490|P1|COMPLETED|Overall Study||0
383796|NCT01036529|917489|P2|Crossover to Other Group|Overall Study||1
383797|NCT01036529|917490|P1|Crossover to Other Group|Overall Study||1
383798|NCT01036529|917489|P2|Requested Crossover|Overall Study||2
383799|NCT01036529|917490|P1|Requested Crossover|Overall Study||1
383800|NCT01036529|917489|P2|12 Month Follow-up|Overall Study||3
383801|NCT01036529|917490|P1|12 Month Follow-up|Overall Study||4
383802|NCT01036529|917489|P2|6 Month Follow-up|Overall Study||7
383803|NCT01036529|917490|P1|6 Month Follow-up|Overall Study||6
383804|NCT01036529|917489|P2|3 Month Follow-up|Overall Study||9
383805|NCT01036529|917490|P1|3 Month Follow-up|Overall Study||7
383806|NCT01036529|917489|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
383807|NCT01036529|917490|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
383808|NCT01036529|917489|P2|Baseline Visit|Overall Study||13
383809|NCT01036529|917490|P1|Baseline Visit|Overall Study||10
383810|NCT01036529|917489|P2|STARTED|Overall Study||15
383811|NCT01036529|917490|P1|STARTED|Overall Study||13
383812|NCT01036490|917498|P2|NOT COMPLETED|Overall Study||0
383813|NCT01036490|917499|P1|NOT COMPLETED|Overall Study||4
383814|NCT01036490|917498|P2|COMPLETED|Overall Study||18
383815|NCT01036490|917499|P1|COMPLETED|Overall Study||14
383816|NCT01036490|917498|P2|STARTED|Overall Study||18
383817|NCT01036490|917499|P1|STARTED|Overall Study||18
383818|NCT01036438|917517|P2|NOT COMPLETED|Overall Study||10
383819|NCT01036438|917518|P1|NOT COMPLETED|Overall Study||10
383820|NCT01036438|917517|P2|COMPLETED|Overall Study||90
383821|NCT01036438|917518|P1|COMPLETED|Overall Study||91
383822|NCT01036438|917517|P2|STARTED|Overall Study||100
383823|NCT01036438|917518|P1|STARTED|Overall Study||101
383824|NCT01036321|917526|P2|NOT COMPLETED|Overall Study||4
383825|NCT01036321|917527|P1|NOT COMPLETED|Overall Study||5
383826|NCT01036321|917526|P2|COMPLETED|Overall Study||31
383827|NCT01036321|917527|P1|COMPLETED|Overall Study||31
383828|NCT01036321|917526|P2|STARTED|Overall Study||35
383829|NCT01036321|917527|P1|STARTED|Overall Study||36
383830|NCT01036165|917551|P1|NOT COMPLETED|Overall Study||15
383831|NCT01036165|917551|P1|COMPLETED|Overall Study||88
383832|NCT01036165|917551|P1|STARTED|Overall Study||103
383833|NCT01036009|917558|P2|NOT COMPLETED|Overall Study||0
383834|NCT01036009|917559|P1|NOT COMPLETED|Overall Study||0
383835|NCT01036009|917558|P2|COMPLETED|Overall Study||26
383836|NCT01036009|917559|P1|COMPLETED|Overall Study||17
383837|NCT01036009|917558|P2|STARTED|Overall Study||26
383838|NCT01036009|917559|P1|STARTED|Overall Study||17
383839|NCT01035944|917577|P4|NOT COMPLETED|Overall Study||0
383840|NCT01035944|917578|P3|NOT COMPLETED|Overall Study||1
383841|NCT01035944|917579|P2|NOT COMPLETED|Overall Study||1
383842|NCT01035944|917580|P1|NOT COMPLETED|Overall Study||3
383843|NCT01035944|917577|P4|COMPLETED|Overall Study||4
383844|NCT01035944|917578|P3|COMPLETED|Overall Study||4
383845|NCT01035944|917579|P2|COMPLETED|Overall Study||13
383846|NCT01035944|917580|P1|COMPLETED|Overall Study||11
383847|NCT01035944|917577|P4|STARTED|Overall Study||4
383848|NCT01035944|917578|P3|STARTED|Overall Study||5
383849|NCT01035944|917579|P2|STARTED|Overall Study||14
383850|NCT01035944|917580|P1|STARTED|Overall Study||14
383851|NCT01035905|917592|P2|NOT COMPLETED|Overall Study||1
383852|NCT01035905|917593|P1|NOT COMPLETED|Overall Study||1
383853|NCT01035905|917592|P2|COMPLETED|Overall Study||30
383854|NCT01035905|917593|P1|COMPLETED|Overall Study||31
383855|NCT01035905|917592|P2|STARTED|Overall Study||31
383856|NCT01035905|917593|P1|STARTED|Overall Study||32
383857|NCT01035138|917602|P3|NOT COMPLETED|Overall Study||47
383858|NCT01035138|917603|P2|NOT COMPLETED|Overall Study||60
383859|NCT01035138|917604|P1|NOT COMPLETED|Overall Study||73
383860|NCT01035138|917602|P3|COMPLETED|Overall Study||0
383861|NCT01035138|917603|P2|COMPLETED|Overall Study||0
383862|NCT01035138|917604|P1|COMPLETED|Overall Study||0
383863|NCT01035138|917602|P3|STARTED|Overall Study||47
383864|NCT01035138|917603|P2|STARTED|Overall Study||60
383865|NCT01035138|917604|P1|STARTED|Overall Study||73
383866|NCT01035060|917660|P2|NOT COMPLETED|Overall Study||14
383867|NCT01035060|917661|P1|NOT COMPLETED|Overall Study||24
383868|NCT01035060|917660|P2|COMPLETED|Overall Study||15
383869|NCT01035060|917661|P1|COMPLETED|Overall Study||15
383870|NCT01035060|917660|P2|STARTED|Overall Study||29
383871|NCT01035060|917661|P1|STARTED|Overall Study||39
383872|NCT01035047|917669|P2|NOT COMPLETED|Overall Study||0
383873|NCT01035047|917670|P1|NOT COMPLETED|Overall Study||0
383874|NCT01035047|917669|P2|COMPLETED|Overall Study||53
383875|NCT01035047|917670|P1|COMPLETED|Overall Study||52
383876|NCT01035047|917669|P2|STARTED|Overall Study||53
383877|NCT01035047|917670|P1|STARTED|Overall Study||52
383878|NCT01034709|917686|P2|NOT COMPLETED|Overall Study||16
383879|NCT01034709|917687|P1|NOT COMPLETED|Overall Study||9
383880|NCT01034709|917686|P2|COMPLETED|Overall Study||42
383881|NCT01034709|917687|P1|COMPLETED|Overall Study||44
383882|NCT01034709|917686|P2|STARTED|Overall Study||58
383883|NCT01034709|917687|P1|STARTED|Overall Study||53
383884|NCT01034657|917693|P3|NOT COMPLETED|Randomized Phase||1
383885|NCT01034657|917694|P2|NOT COMPLETED|Randomized Phase||6
383886|NCT01034657|917695|P1|NOT COMPLETED|Randomized Phase||5
383887|NCT01034657|917693|P3|COMPLETED|Randomized Phase||0
383888|NCT01034657|917694|P2|COMPLETED|Randomized Phase||0
383889|NCT01034657|917695|P1|COMPLETED|Randomized Phase||1
383890|NCT01034657|917693|P3|STARTED|Randomized Phase||1
383891|NCT01034657|917694|P2|STARTED|Randomized Phase||6
383892|NCT01034657|917695|P1|STARTED|Randomized Phase||6
383893|NCT01034657|917693|P3|NOT COMPLETED|Core Phase||0
383894|NCT01034657|917694|P2|NOT COMPLETED|Core Phase||0
383895|NCT01034657|917695|P1|NOT COMPLETED|Core Phase||14
383896|NCT01034657|917693|P3|COMPLETED|Core Phase||0
383897|NCT01034657|917694|P2|COMPLETED|Core Phase||0
383898|NCT01034657|917695|P1|COMPLETED|Core Phase||20
383899|NCT01034657|917693|P3|STARTED|Core Phase||0
383900|NCT01034657|917694|P2|STARTED|Core Phase||0
383901|NCT01034657|917695|P1|STARTED|Core Phase||34
383902|NCT01034631|917736|P3|NOT COMPLETED|Phase II||2
383903|NCT01034631|917737|P2|NOT COMPLETED|Phase II||1
383904|NCT01034631|917738|P1|NOT COMPLETED|Phase II||0
383905|NCT01034631|917736|P3|COMPLETED|Phase II||67
383906|NCT01034631|917737|P2|COMPLETED|Phase II||69
383907|NCT01034631|917738|P1|COMPLETED|Phase II||0
383908|NCT01034631|917736|P3|STARTED|Phase II||69
383909|NCT01034631|917737|P2|STARTED|Phase II||70
383910|NCT01034631|917738|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
383911|NCT01034631|917736|P3|NOT COMPLETED|Phase I||0
383912|NCT01034631|917737|P2|NOT COMPLETED|Phase I||0
383913|NCT01034631|917738|P1|NOT COMPLETED|Phase I||3
383914|NCT01034631|917736|P3|COMPLETED|Phase I||0
383915|NCT01034631|917737|P2|COMPLETED|Phase I||0
383916|NCT01034631|917738|P1|COMPLETED|Phase I||12
383917|NCT01034631|917736|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
383918|NCT01034631|917737|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
383919|NCT01034631|917738|P1|STARTED|Phase I||15
383920|NCT01034592|917757|P1|NOT COMPLETED|Overall Study||0
383921|NCT01034592|917757|P1|COMPLETED|Overall Study||2
383922|NCT01034592|917757|P1|STARTED|Overall Study||2
383923|NCT01034579|917769|P2|NOT COMPLETED|Overall Study||0
383924|NCT01034579|917770|P1|NOT COMPLETED|Overall Study||0
383925|NCT01034579|917769|P2|COMPLETED|Overall Study||166
383926|NCT01034579|917770|P1|COMPLETED|Overall Study||158
383927|NCT01034579|917769|P2|STARTED|Overall Study||166
383928|NCT01034579|917770|P1|STARTED|Overall Study||158
383929|NCT01034553|917784|P6|NOT COMPLETED|Overall Study||0
383930|NCT01034553|917785|P5|NOT COMPLETED|Overall Study||0
383931|NCT01034553|917786|P4|NOT COMPLETED|Overall Study||0
383932|NCT01034553|917787|P3|NOT COMPLETED|Overall Study||0
383933|NCT01034553|917788|P2|NOT COMPLETED|Overall Study||0
383934|NCT01034553|917789|P1|NOT COMPLETED|Overall Study||0
383935|NCT01034553|917784|P6|COMPLETED|Overall Study||7
383936|NCT01034553|917785|P5|COMPLETED|Overall Study||6
383937|NCT01034553|917786|P4|COMPLETED|Overall Study||3
383938|NCT01034553|917787|P3|COMPLETED|Overall Study||3
383939|NCT01034553|917788|P2|COMPLETED|Overall Study||4
383940|NCT01034553|917789|P1|COMPLETED|Overall Study||3
383941|NCT01034553|917784|P6|STARTED|Overall Study||7
383942|NCT01034553|917785|P5|STARTED|Overall Study||6
383943|NCT01034553|917786|P4|STARTED|Overall Study||3
383944|NCT01034553|917787|P3|STARTED|Overall Study||3
383945|NCT01034553|917788|P2|STARTED|Overall Study||4
383946|NCT01034553|917789|P1|STARTED|Overall Study||3
383947|NCT01034540|917805|P2|NOT COMPLETED|Overall Study||1
383948|NCT01034540|917806|P1|NOT COMPLETED|Overall Study||0
383949|NCT01034540|917805|P2|COMPLETED|Overall Study||11
383950|NCT01034540|917806|P1|COMPLETED|Overall Study||11
383951|NCT01034540|917805|P2|Completed 1st Treatment Intervention|Overall Study||11
383952|NCT01034540|917806|P1|Completed 1st Treatment Intervention|Overall Study||11
383953|NCT01034540|917805|P2|STARTED|Overall Study||12
383954|NCT01034540|917806|P1|STARTED|Overall Study||11
383955|NCT01034462|917816|P2|NOT COMPLETED|Overall Study||54
383956|NCT01034462|917817|P1|NOT COMPLETED|Overall Study||45
383957|NCT01034462|917816|P2|COMPLETED|Overall Study||163
383958|NCT01034462|917817|P1|COMPLETED|Overall Study||172
383959|NCT01034462|917816|P2|STARTED|Overall Study||217
383960|NCT01034462|917817|P1|STARTED|Overall Study||217
383961|NCT01034397|917827|P2|NOT COMPLETED|Overall Study||2
383962|NCT01034397|917828|P1|NOT COMPLETED|Overall Study||7
383963|NCT01034397|917827|P2|COMPLETED|Overall Study||17
383964|NCT01034397|917828|P1|COMPLETED|Overall Study||28
383965|NCT01034397|917827|P2|STARTED|Overall Study||19
383966|NCT01034397|917828|P1|STARTED|Overall Study||35
383967|NCT01034358|917977|P1|NOT COMPLETED|Overall Study||2
383968|NCT01034358|917977|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
383969|NCT01034358|917977|P1|STARTED|Overall Study||15
383970|NCT01034306|917983|P2|NOT COMPLETED|Overall Study||3
383971|NCT01034306|917984|P1|NOT COMPLETED|Overall Study||5
383972|NCT01034306|917983|P2|COMPLETED|Overall Study||34
383973|NCT01034306|917984|P1|COMPLETED|Overall Study||37
383974|NCT01034306|917983|P2|STARTED|Overall Study||37
383975|NCT01034306|917984|P1|STARTED|Overall Study||42
383976|NCT01034176|917992|P2|NOT COMPLETED|Overall Study||2
383977|NCT01034176|917993|P1|NOT COMPLETED|Overall Study||2
383978|NCT01034176|917992|P2|COMPLETED|Overall Study||19
383979|NCT01034176|917993|P1|COMPLETED|Overall Study||20
383980|NCT01034176|917992|P2|STARTED|Overall Study||21
383981|NCT01034176|917993|P1|STARTED|Overall Study||22
383982|NCT01034163|918003|P2|NOT COMPLETED|Overall Study||14
383983|NCT01034163|918004|P1|NOT COMPLETED|Overall Study||27
383984|NCT01034163|918003|P2|COMPLETED|Overall Study||0
383985|NCT01034163|918004|P1|COMPLETED|Overall Study||0
383986|NCT01034163|918003|P2|In Open Label Phase After Unblinding|Overall Study||0
383987|NCT01034163|918004|P1|In Open Label Phase After Unblinding|Overall Study||5
383988|NCT01034163|918003|P2|Safety Set|Overall Study||12
383989|NCT01034163|918004|P1|Safety Set|Overall Study||26
383990|NCT01034163|918003|P2|Untreated (Not in Safety Set)|Overall Study||2
383991|NCT01034163|918004|P1|Untreated (Not in Safety Set)|Overall Study||1
383992|NCT01034163|918003|P2|STARTED|Overall Study||14
383993|NCT01034163|918004|P1|STARTED|Overall Study||27
383994|NCT01034137|918013|P3|NOT COMPLETED|Overall Study||30
383995|NCT01034137|918014|P2|NOT COMPLETED|Overall Study||22
383996|NCT01034137|918015|P1|NOT COMPLETED|Overall Study||28
383997|NCT01034137|918013|P3|COMPLETED|Overall Study||78
383998|NCT01034137|918014|P2|COMPLETED|Overall Study||81
383999|NCT01034137|918015|P1|COMPLETED|Overall Study||78
384000|NCT01034137|918013|P3|STARTED|Overall Study||108
384001|NCT01034137|918014|P2|STARTED|Overall Study||103
384002|NCT01034137|918015|P1|STARTED|Overall Study||106
384003|NCT01034111|918146|P1|NOT COMPLETED|Overall Study||0
384004|NCT01034111|918146|P1|COMPLETED|Overall Study||30
384005|NCT01034111|918146|P1|STARTED|Overall Study||30
384006|NCT01033942|918154|P3|NOT COMPLETED|Overall Study||1
384007|NCT01033942|918155|P2|NOT COMPLETED|Overall Study||4
384008|NCT01033942|918156|P1|NOT COMPLETED|Overall Study||2
384009|NCT01033942|918154|P3|COMPLETED|Overall Study||18
384010|NCT01033942|918155|P2|COMPLETED|Overall Study||15
384011|NCT01033942|918156|P1|COMPLETED|Overall Study||18
384012|NCT01033942|918154|P3|STARTED|Overall Study||19
384013|NCT01033942|918155|P2|STARTED|Overall Study||19
384014|NCT01033942|918156|P1|STARTED|Overall Study||20
384015|NCT01033864|918428|P2|NOT COMPLETED|Overall Study||0
384016|NCT01033864|918429|P1|NOT COMPLETED|Overall Study||0
384017|NCT01033864|918428|P2|COMPLETED|Overall Study||11
384018|NCT01033864|918429|P1|COMPLETED|Overall Study||12
384019|NCT01033864|918428|P2|STARTED|Overall Study||11
384020|NCT01033864|918429|P1|STARTED|Overall Study||12
384021|NCT01033851|918454|P2|NOT COMPLETED|Overall Study||7
384022|NCT01033851|918455|P1|NOT COMPLETED|Overall Study||3
384023|NCT01033851|918454|P2|COMPLETED|Overall Study||34
384024|NCT01033851|918455|P1|COMPLETED|Overall Study||45
384025|NCT01033851|918454|P2|STARTED|Overall Study||41
384026|NCT01033851|918455|P1|STARTED|Overall Study||48
384027|NCT01033825|918470|P7|NOT COMPLETED|Overall Study||0
384028|NCT01033825|918471|P6|NOT COMPLETED|Overall Study||0
384029|NCT01033825|918472|P5|NOT COMPLETED|Overall Study||2
384030|NCT01033825|918473|P4|NOT COMPLETED|Overall Study||2
384031|NCT01033825|918474|P3|NOT COMPLETED|Overall Study||2
384032|NCT01033825|918475|P2|NOT COMPLETED|Overall Study||3
384033|NCT01033825|918476|P1|NOT COMPLETED|Overall Study||3
384034|NCT01033825|918470|P7|COMPLETED|Overall Study||18
384035|NCT01033825|918471|P6|COMPLETED|Overall Study||18
384036|NCT01033825|918472|P5|COMPLETED|Overall Study||56
384037|NCT01033825|918473|P4|COMPLETED|Overall Study||46
384038|NCT01033825|918474|P3|COMPLETED|Overall Study||55
384039|NCT01033825|918475|P2|COMPLETED|Overall Study||57
384040|NCT01033825|918476|P1|COMPLETED|Overall Study||48
384041|NCT01033825|918470|P7|STARTED|Overall Study||18
384042|NCT01033825|918471|P6|STARTED|Overall Study||18
384043|NCT01033825|918472|P5|STARTED|Overall Study||58
384044|NCT01033825|918473|P4|STARTED|Overall Study||48
384045|NCT01033825|918474|P3|STARTED|Overall Study||57
384046|NCT01033825|918475|P2|STARTED|Overall Study||60
384047|NCT01033825|918476|P1|STARTED|Overall Study||51
384048|NCT01033747|918697|P2|NOT COMPLETED|Overall Study||15
384049|NCT01033747|918698|P1|NOT COMPLETED|Overall Study||37
384050|NCT01033747|918697|P2|COMPLETED|Overall Study||4
384051|NCT01033747|918698|P1|COMPLETED|Overall Study||14
384052|NCT01033747|918697|P2|STARTED|Overall Study||19
384053|NCT01033747|918698|P1|STARTED|Overall Study||51
384054|NCT01033734|918706|P1|NOT COMPLETED|Overall Study||1
384055|NCT01033734|918706|P1|COMPLETED|Overall Study||7
384056|NCT01033734|918706|P1|STARTED|Overall Study||8
384057|NCT01033565|918758|P1|NOT COMPLETED|Overall Study||0
384058|NCT01033565|918758|P1|COMPLETED|Overall Study||1
384059|NCT01033565|918758|P1|STARTED|Overall Study||1
384060|NCT01033487|918762|P10|NOT COMPLETED|Fifth Intervention Period||0
384061|NCT01033487|918763|P9|NOT COMPLETED|Fifth Intervention Period||0
384062|NCT01033487|918764|P8|NOT COMPLETED|Fifth Intervention Period||0
384063|NCT01033487|918765|P7|NOT COMPLETED|Fifth Intervention Period||0
384064|NCT01033487|918766|P6|NOT COMPLETED|Fifth Intervention Period||0
384065|NCT01033487|918767|P5|NOT COMPLETED|Fifth Intervention Period||0
384066|NCT01033487|918768|P4|NOT COMPLETED|Fifth Intervention Period||0
384067|NCT01033487|918769|P3|NOT COMPLETED|Fifth Intervention Period||0
384068|NCT01033487|918770|P2|NOT COMPLETED|Fifth Intervention Period||0
384069|NCT01033487|918771|P1|NOT COMPLETED|Fifth Intervention Period||0
384070|NCT01033487|918762|P10|COMPLETED|Fifth Intervention Period||2
384071|NCT01033487|918763|P9|COMPLETED|Fifth Intervention Period||1
384072|NCT01033487|918764|P8|COMPLETED|Fifth Intervention Period||3
384073|NCT01033487|918765|P7|COMPLETED|Fifth Intervention Period||2
384074|NCT01033487|918766|P6|COMPLETED|Fifth Intervention Period||2
384075|NCT01033487|918767|P5|COMPLETED|Fifth Intervention Period||2
384076|NCT01033487|918768|P4|COMPLETED|Fifth Intervention Period||2
384077|NCT01033487|918769|P3|COMPLETED|Fifth Intervention Period||2
384078|NCT01033487|918770|P2|COMPLETED|Fifth Intervention Period||3
384079|NCT01033487|918771|P1|COMPLETED|Fifth Intervention Period||2
384080|NCT01033487|918762|P10|STARTED|Fifth Intervention Period||2
384081|NCT01033487|918763|P9|STARTED|Fifth Intervention Period||1
384082|NCT01033487|918764|P8|STARTED|Fifth Intervention Period||3
384083|NCT01033487|918765|P7|STARTED|Fifth Intervention Period||2
384084|NCT01033487|918766|P6|STARTED|Fifth Intervention Period||2
384085|NCT01033487|918767|P5|STARTED|Fifth Intervention Period||2
384086|NCT01033487|918768|P4|STARTED|Fifth Intervention Period||2
384087|NCT01033487|918769|P3|STARTED|Fifth Intervention Period||2
384088|NCT01033487|918770|P2|STARTED|Fifth Intervention Period||3
384089|NCT01033487|918771|P1|STARTED|Fifth Intervention Period||2
384090|NCT01033487|918762|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384091|NCT01033487|918763|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384092|NCT01033487|918764|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384093|NCT01033487|918765|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384094|NCT01033487|918766|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384095|NCT01033487|918767|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384096|NCT01033487|918768|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384097|NCT01033487|918769|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384098|NCT01033487|918770|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384099|NCT01033487|918771|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
384100|NCT01033487|918762|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384101|NCT01033487|918763|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
384102|NCT01033487|918764|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
384103|NCT01033487|918765|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384104|NCT01033487|918766|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384105|NCT01033487|918767|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384106|NCT01033487|918768|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384107|NCT01033487|918769|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384108|NCT01033487|918770|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
384109|NCT01033487|918771|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
384110|NCT01033487|918762|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384111|NCT01033487|918763|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
384112|NCT01033487|918764|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
384113|NCT01033487|918765|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384114|NCT01033487|918766|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384115|NCT01033487|918767|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384116|NCT01033487|918768|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384117|NCT01033487|918769|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384118|NCT01033487|918770|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
384119|NCT01033487|918771|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
384120|NCT01033487|918762|P10|NOT COMPLETED|Fourth Intervention Period||0
384121|NCT01033487|918763|P9|NOT COMPLETED|Fourth Intervention Period||1
384122|NCT01033487|918764|P8|NOT COMPLETED|Fourth Intervention Period||0
384123|NCT01033487|918765|P7|NOT COMPLETED|Fourth Intervention Period||0
384124|NCT01033487|918766|P6|NOT COMPLETED|Fourth Intervention Period||0
384125|NCT01033487|918767|P5|NOT COMPLETED|Fourth Intervention Period||0
384126|NCT01033487|918768|P4|NOT COMPLETED|Fourth Intervention Period||0
384127|NCT01033487|918769|P3|NOT COMPLETED|Fourth Intervention Period||0
384128|NCT01033487|918770|P2|NOT COMPLETED|Fourth Intervention Period||0
384129|NCT01033487|918771|P1|NOT COMPLETED|Fourth Intervention Period||0
384130|NCT01033487|918762|P10|COMPLETED|Fourth Intervention Period||2
384131|NCT01033487|918763|P9|COMPLETED|Fourth Intervention Period||1
384132|NCT01033487|918764|P8|COMPLETED|Fourth Intervention Period||3
384133|NCT01033487|918765|P7|COMPLETED|Fourth Intervention Period||2
384134|NCT01033487|918766|P6|COMPLETED|Fourth Intervention Period||2
384135|NCT01033487|918767|P5|COMPLETED|Fourth Intervention Period||2
384136|NCT01033487|918768|P4|COMPLETED|Fourth Intervention Period||2
384137|NCT01033487|918769|P3|COMPLETED|Fourth Intervention Period||2
384138|NCT01033487|918770|P2|COMPLETED|Fourth Intervention Period||3
384139|NCT01033487|918771|P1|COMPLETED|Fourth Intervention Period||2
384140|NCT01033487|918762|P10|STARTED|Fourth Intervention Period||2
384141|NCT01033487|918763|P9|STARTED|Fourth Intervention Period||2
384142|NCT01033487|918764|P8|STARTED|Fourth Intervention Period||3
384143|NCT01033487|918765|P7|STARTED|Fourth Intervention Period||2
384144|NCT01033487|918766|P6|STARTED|Fourth Intervention Period||2
384145|NCT01033487|918767|P5|STARTED|Fourth Intervention Period||2
384146|NCT01033487|918768|P4|STARTED|Fourth Intervention Period||2
384147|NCT01033487|918769|P3|STARTED|Fourth Intervention Period||2
384148|NCT01033487|918770|P2|STARTED|Fourth Intervention Period||3
384149|NCT01033487|918771|P1|STARTED|Fourth Intervention Period||2
384150|NCT01033487|918762|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384151|NCT01033487|918763|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384152|NCT01033487|918764|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384153|NCT01033487|918765|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384154|NCT01033487|918766|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384155|NCT01033487|918767|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384156|NCT01033487|918768|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384157|NCT01033487|918769|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384158|NCT01033487|918770|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384159|NCT01033487|918771|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
384160|NCT01033487|918762|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384161|NCT01033487|918763|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384162|NCT01033487|918764|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
384163|NCT01033487|918765|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384164|NCT01033487|918766|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384165|NCT01033487|918767|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384166|NCT01033487|918768|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384167|NCT01033487|918769|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384168|NCT01033487|918770|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
384169|NCT01033487|918771|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
384170|NCT01033487|918762|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384171|NCT01033487|918763|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384172|NCT01033487|918764|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
384173|NCT01033487|918765|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384174|NCT01033487|918766|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384175|NCT01033487|918767|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384176|NCT01033487|918768|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384177|NCT01033487|918769|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384178|NCT01033487|918770|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
384179|NCT01033487|918771|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
384180|NCT01033487|918762|P10|NOT COMPLETED|Third Intervention Period||0
384181|NCT01033487|918763|P9|NOT COMPLETED|Third Intervention Period||0
384182|NCT01033487|918764|P8|NOT COMPLETED|Third Intervention Period||0
384183|NCT01033487|918765|P7|NOT COMPLETED|Third Intervention Period||0
384184|NCT01033487|918766|P6|NOT COMPLETED|Third Intervention Period||0
384185|NCT01033487|918767|P5|NOT COMPLETED|Third Intervention Period||0
384186|NCT01033487|918768|P4|NOT COMPLETED|Third Intervention Period||0
384187|NCT01033487|918769|P3|NOT COMPLETED|Third Intervention Period||0
384188|NCT01033487|918770|P2|NOT COMPLETED|Third Intervention Period||0
384189|NCT01033487|918771|P1|NOT COMPLETED|Third Intervention Period||0
384190|NCT01033487|918762|P10|COMPLETED|Third Intervention Period||2
384191|NCT01033487|918763|P9|COMPLETED|Third Intervention Period||2
384192|NCT01033487|918764|P8|COMPLETED|Third Intervention Period||3
384193|NCT01033487|918765|P7|COMPLETED|Third Intervention Period||2
384194|NCT01033487|918766|P6|COMPLETED|Third Intervention Period||2
384195|NCT01033487|918767|P5|COMPLETED|Third Intervention Period||2
384196|NCT01033487|918768|P4|COMPLETED|Third Intervention Period||2
384197|NCT01033487|918769|P3|COMPLETED|Third Intervention Period||2
384198|NCT01033487|918770|P2|COMPLETED|Third Intervention Period||3
384199|NCT01033487|918771|P1|COMPLETED|Third Intervention Period||2
384200|NCT01033487|918762|P10|STARTED|Third Intervention Period||2
384201|NCT01033487|918763|P9|STARTED|Third Intervention Period||2
384202|NCT01033487|918764|P8|STARTED|Third Intervention Period||3
384203|NCT01033487|918765|P7|STARTED|Third Intervention Period||2
384204|NCT01033487|918766|P6|STARTED|Third Intervention Period||2
384205|NCT01033487|918767|P5|STARTED|Third Intervention Period||2
384206|NCT01033487|918768|P4|STARTED|Third Intervention Period||2
384207|NCT01033487|918769|P3|STARTED|Third Intervention Period||2
384208|NCT01033487|918770|P2|STARTED|Third Intervention Period||3
384209|NCT01033487|918771|P1|STARTED|Third Intervention Period||2
384210|NCT01033487|918762|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384211|NCT01033487|918763|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384212|NCT01033487|918764|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384213|NCT01033487|918765|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384214|NCT01033487|918766|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384215|NCT01033487|918767|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384216|NCT01033487|918768|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384217|NCT01033487|918769|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384218|NCT01033487|918770|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384219|NCT01033487|918771|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
384220|NCT01033487|918762|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384221|NCT01033487|918763|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384222|NCT01033487|918764|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
384223|NCT01033487|918765|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384224|NCT01033487|918766|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384225|NCT01033487|918767|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384226|NCT01033487|918768|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384227|NCT01033487|918769|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384228|NCT01033487|918770|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
384229|NCT01033487|918771|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
384230|NCT01033487|918762|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384231|NCT01033487|918763|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384232|NCT01033487|918764|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
384233|NCT01033487|918765|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384234|NCT01033487|918766|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384235|NCT01033487|918767|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384236|NCT01033487|918768|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384237|NCT01033487|918769|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384238|NCT01033487|918770|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
384239|NCT01033487|918771|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
384240|NCT01033487|918762|P10|NOT COMPLETED|Second Intervention Period||0
384241|NCT01033487|918763|P9|NOT COMPLETED|Second Intervention Period||0
384242|NCT01033487|918764|P8|NOT COMPLETED|Second Intervention Period||0
384243|NCT01033487|918765|P7|NOT COMPLETED|Second Intervention Period||0
384244|NCT01033487|918766|P6|NOT COMPLETED|Second Intervention Period||0
384245|NCT01033487|918767|P5|NOT COMPLETED|Second Intervention Period||0
384246|NCT01033487|918768|P4|NOT COMPLETED|Second Intervention Period||0
384247|NCT01033487|918769|P3|NOT COMPLETED|Second Intervention Period||0
384248|NCT01033487|918770|P2|NOT COMPLETED|Second Intervention Period||0
384249|NCT01033487|918771|P1|NOT COMPLETED|Second Intervention Period||0
384250|NCT01033487|918762|P10|COMPLETED|Second Intervention Period||2
384251|NCT01033487|918763|P9|COMPLETED|Second Intervention Period||2
384252|NCT01033487|918764|P8|COMPLETED|Second Intervention Period||3
384253|NCT01033487|918765|P7|COMPLETED|Second Intervention Period||2
384254|NCT01033487|918766|P6|COMPLETED|Second Intervention Period||2
384255|NCT01033487|918767|P5|COMPLETED|Second Intervention Period||2
384256|NCT01033487|918768|P4|COMPLETED|Second Intervention Period||2
384257|NCT01033487|918769|P3|COMPLETED|Second Intervention Period||2
384258|NCT01033487|918770|P2|COMPLETED|Second Intervention Period||3
384259|NCT01033487|918771|P1|COMPLETED|Second Intervention Period||2
384260|NCT01033487|918762|P10|STARTED|Second Intervention Period||2
384261|NCT01033487|918763|P9|STARTED|Second Intervention Period||2
384262|NCT01033487|918764|P8|STARTED|Second Intervention Period||3
384263|NCT01033487|918765|P7|STARTED|Second Intervention Period||2
384264|NCT01033487|918766|P6|STARTED|Second Intervention Period||2
384265|NCT01033487|918767|P5|STARTED|Second Intervention Period||2
384266|NCT01033487|918768|P4|STARTED|Second Intervention Period||2
384267|NCT01033487|918769|P3|STARTED|Second Intervention Period||2
384268|NCT01033487|918770|P2|STARTED|Second Intervention Period||3
384269|NCT01033487|918771|P1|STARTED|Second Intervention Period||2
384270|NCT01033487|918762|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384271|NCT01033487|918763|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384272|NCT01033487|918764|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384273|NCT01033487|918765|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384274|NCT01033487|918766|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384275|NCT01033487|918767|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384276|NCT01033487|918768|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384277|NCT01033487|918769|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384278|NCT01033487|918770|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384279|NCT01033487|918771|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
384280|NCT01033487|918762|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384281|NCT01033487|918763|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384282|NCT01033487|918764|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
384283|NCT01033487|918765|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384284|NCT01033487|918766|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384285|NCT01033487|918767|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384286|NCT01033487|918768|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384287|NCT01033487|918769|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384288|NCT01033487|918770|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
384289|NCT01033487|918771|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
384290|NCT01033487|918762|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384291|NCT01033487|918763|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384292|NCT01033487|918764|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
384293|NCT01033487|918765|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384294|NCT01033487|918766|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384295|NCT01033487|918767|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384296|NCT01033487|918768|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384297|NCT01033487|918769|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384298|NCT01033487|918770|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
384299|NCT01033487|918771|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
384300|NCT01033487|918762|P10|NOT COMPLETED|First Intervention Period||0
384301|NCT01033487|918763|P9|NOT COMPLETED|First Intervention Period||0
384302|NCT01033487|918764|P8|NOT COMPLETED|First Intervention Period||0
384303|NCT01033487|918765|P7|NOT COMPLETED|First Intervention Period||0
384304|NCT01033487|918766|P6|NOT COMPLETED|First Intervention Period||0
384305|NCT01033487|918767|P5|NOT COMPLETED|First Intervention Period||0
384306|NCT01033487|918768|P4|NOT COMPLETED|First Intervention Period||0
384307|NCT01033487|918769|P3|NOT COMPLETED|First Intervention Period||0
384308|NCT01033487|918770|P2|NOT COMPLETED|First Intervention Period||0
384309|NCT01033487|918771|P1|NOT COMPLETED|First Intervention Period||0
384310|NCT01033487|918762|P10|COMPLETED|First Intervention Period||2
384311|NCT01033487|918763|P9|COMPLETED|First Intervention Period||2
384312|NCT01033487|918764|P8|COMPLETED|First Intervention Period||3
384313|NCT01033487|918765|P7|COMPLETED|First Intervention Period||2
384314|NCT01033487|918766|P6|COMPLETED|First Intervention Period||2
384315|NCT01033487|918767|P5|COMPLETED|First Intervention Period||2
384316|NCT01033487|918768|P4|COMPLETED|First Intervention Period||2
384317|NCT01033487|918769|P3|COMPLETED|First Intervention Period||2
384318|NCT01033487|918770|P2|COMPLETED|First Intervention Period||3
384319|NCT01033487|918771|P1|COMPLETED|First Intervention Period||2
384320|NCT01033487|918762|P10|STARTED|First Intervention Period||2
384321|NCT01033487|918763|P9|STARTED|First Intervention Period||2
384322|NCT01033487|918764|P8|STARTED|First Intervention Period||3
384323|NCT01033487|918765|P7|STARTED|First Intervention Period||2
384324|NCT01033487|918766|P6|STARTED|First Intervention Period||2
384325|NCT01033487|918767|P5|STARTED|First Intervention Period||2
384326|NCT01033487|918768|P4|STARTED|First Intervention Period||2
384327|NCT01033487|918769|P3|STARTED|First Intervention Period||2
384328|NCT01033487|918770|P2|STARTED|First Intervention Period||3
384329|NCT01033487|918771|P1|STARTED|First Intervention Period||2
384330|NCT01033383|918829|P4|NOT COMPLETED|Overall Study||0
384331|NCT01033383|918830|P3|NOT COMPLETED|Overall Study||0
384332|NCT01033383|918831|P2|NOT COMPLETED|Overall Study||0
384333|NCT01033383|918832|P1|NOT COMPLETED|Overall Study||0
384334|NCT01033383|918829|P4|COMPLETED|Overall Study||20
384335|NCT01033383|918830|P3|COMPLETED|Overall Study||20
384336|NCT01033383|918831|P2|COMPLETED|Overall Study||20
384337|NCT01033383|918832|P1|COMPLETED|Overall Study||20
384338|NCT01033383|918829|P4|STARTED|Overall Study||20
384339|NCT01033383|918830|P3|STARTED|Overall Study||20
384340|NCT01033383|918831|P2|STARTED|Overall Study||20
384341|NCT01033383|918832|P1|STARTED|Overall Study||20
384342|NCT01033227|918852|P2|NOT COMPLETED|Overall Study||0
384343|NCT01033227|918853|P1|NOT COMPLETED|Overall Study||0
384344|NCT01033227|918852|P2|COMPLETED|Overall Study||2
384345|NCT01033227|918853|P1|COMPLETED|Overall Study||3
384346|NCT01033227|918852|P2|STARTED|Overall Study||2
384347|NCT01033227|918853|P1|STARTED|Overall Study||3
384348|NCT01033071|918862|P3|NOT COMPLETED|Overall Study||47
384349|NCT01033071|918863|P2|NOT COMPLETED|Overall Study||77
384350|NCT01033071|918864|P1|NOT COMPLETED|Overall Study||55
384351|NCT01033071|918862|P3|COMPLETED|Overall Study||317
384352|NCT01033071|918863|P2|COMPLETED|Overall Study||275
384353|NCT01033071|918864|P1|COMPLETED|Overall Study||300
384354|NCT01033071|918862|P3|STARTED|Overall Study||364
384355|NCT01033071|918863|P2|STARTED|Overall Study||352
384356|NCT01033071|918864|P1|STARTED|Overall Study||355
384357|NCT01033032|918923|P4|NOT COMPLETED|Phase II||0
384358|NCT01033032|918924|P3|NOT COMPLETED|Phase II||66
384359|NCT01033032|918925|P2|NOT COMPLETED|Phase II||0
384360|NCT01033032|918926|P1|NOT COMPLETED|Phase II||0
384361|NCT01033032|918923|P4|COMPLETED|Phase II||0
384362|NCT01033032|918924|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
384363|NCT01033032|918925|P2|COMPLETED|Phase II||0
384364|NCT01033032|918926|P1|COMPLETED|Phase II||0
384365|NCT01033032|918923|P4|STARTED|Phase II||0
384366|NCT01033032|918924|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
384367|NCT01033032|918925|P2|STARTED|Phase II||0
384368|NCT01033032|918926|P1|STARTED|Phase II||0
384369|NCT01033032|918923|P4|NOT COMPLETED|Phase I||6
384370|NCT01033032|918924|P3|NOT COMPLETED|Phase I||0
384371|NCT01033032|918925|P2|NOT COMPLETED|Phase I||3
384372|NCT01033032|918926|P1|NOT COMPLETED|Phase I||3
384373|NCT01033032|918923|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
384374|NCT01033032|918924|P3|COMPLETED|Phase I||3
384375|NCT01033032|918925|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
384376|NCT01033032|918926|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
384377|NCT01033032|918923|P4|STARTED|Phase I||6
384378|NCT01033032|918924|P3|STARTED|Phase I||3
384379|NCT01033032|918925|P2|STARTED|Phase I||3
384380|NCT01033032|918926|P1|STARTED|Phase I||3
384381|NCT01033019|918935|P2|NOT COMPLETED|Overall Study||0
384382|NCT01033019|918936|P1|NOT COMPLETED|Overall Study||1
384383|NCT01033019|918935|P2|COMPLETED|Overall Study||8
384384|NCT01033019|918936|P1|COMPLETED|Overall Study||15
384385|NCT01033019|918935|P2|STARTED|Overall Study||8
384386|NCT01033019|918936|P1|STARTED|Overall Study||16
384387|NCT01032993|918945|P2|NOT COMPLETED|Overall Study||0
384388|NCT01032993|918946|P1|NOT COMPLETED|Overall Study||0
384389|NCT01032993|918945|P2|COMPLETED|Overall Study||20
384390|NCT01032993|918946|P1|COMPLETED|Overall Study||19
384391|NCT01032993|918945|P2|STARTED|Overall Study||20
384392|NCT01032993|918946|P1|STARTED|Overall Study||19
384393|NCT01032928|918958|P1|NOT COMPLETED|Overall Study||0
384394|NCT01032928|918958|P1|COMPLETED|Overall Study||30
384395|NCT01032928|918958|P1|STARTED|Overall Study||30
384396|NCT01032915|918974|P4|NOT COMPLETED|Overall Study||7
384397|NCT01032915|918975|P3|NOT COMPLETED|Overall Study||7
384398|NCT01032915|918976|P2|NOT COMPLETED|Overall Study||11
384399|NCT01032915|918977|P1|NOT COMPLETED|Overall Study||8
384400|NCT01032915|918974|P4|COMPLETED|Overall Study||27
384401|NCT01032915|918975|P3|COMPLETED|Overall Study||24
384402|NCT01032915|918976|P2|COMPLETED|Overall Study||20
384403|NCT01032915|918977|P1|COMPLETED|Overall Study||21
384404|NCT01032915|918974|P4|STARTED|Overall Study||34
384405|NCT01032915|918975|P3|STARTED|Overall Study||31
384406|NCT01032915|918976|P2|STARTED|Overall Study||31
384407|NCT01032915|918977|P1|STARTED|Overall Study||29
384408|NCT01032889|919002|P3|NOT COMPLETED|Overall Study||3
384409|NCT01032889|919003|P2|NOT COMPLETED|Overall Study||15
384410|NCT01032889|919004|P1|NOT COMPLETED|Overall Study||8
384411|NCT01032889|919002|P3|COMPLETED|Overall Study||42
384412|NCT01032889|919003|P2|COMPLETED|Overall Study||28
384413|NCT01032889|919004|P1|COMPLETED|Overall Study||33
384414|NCT01032889|919002|P3|Received Treatment|Overall Study||45
384415|NCT01032889|919003|P2|Received Treatment|Overall Study||43
384416|NCT01032889|919004|P1|Received Treatment|Overall Study||41
384417|NCT01032889|919002|P3|STARTED|Overall Study||45
384418|NCT01032889|919003|P2|STARTED|Overall Study||43
384419|NCT01032889|919004|P1|STARTED|Overall Study||41
384420|NCT01032850|919024|P1|NOT COMPLETED|Overall Study||2
384421|NCT01032850|919024|P1|COMPLETED|Overall Study||13
384422|NCT01032850|919024|P1|STARTED|Overall Study||15
384423|NCT01032837|919035|P4|NOT COMPLETED|Overall Study||3
384424|NCT01032837|919036|P3|NOT COMPLETED|Overall Study||1
384425|NCT01032837|919037|P2|NOT COMPLETED|Overall Study||3
384426|NCT01032837|919038|P1|NOT COMPLETED|Overall Study||0
384427|NCT01032837|919035|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
384428|NCT01032837|919036|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
384429|NCT01032837|919037|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
384430|NCT01032837|919038|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
384431|NCT01032837|919035|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
384432|NCT01032837|919036|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
384433|NCT01032837|919037|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
384434|NCT01032837|919038|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
384435|NCT01032837|919035|P4|STARTED|Overall Study||25
384436|NCT01032837|919036|P3|STARTED|Overall Study||25
384437|NCT01032837|919037|P2|STARTED|Overall Study||26
384438|NCT01032837|919038|P1|STARTED|Overall Study||26
384439|NCT01032759|919086|P2|NOT COMPLETED|Overall Study||3
384440|NCT01032759|919087|P1|NOT COMPLETED|Overall Study||1
384441|NCT01032759|919086|P2|COMPLETED|Overall Study||28
384442|NCT01032759|919087|P1|COMPLETED|Overall Study||31
384443|NCT01032759|919086|P2|Completed 48 Hour Assessment|Overall Study||28
384444|NCT01032759|919087|P1|Completed 48 Hour Assessment|Overall Study||31
384445|NCT01032759|919086|P2|Completed 24 Hour Assessment|Overall Study||30
384446|NCT01032759|919087|P1|Completed 24 Hour Assessment|Overall Study||32
384447|NCT01032759|919086|P2|STARTED|Overall Study||31
384448|NCT01032759|919087|P1|STARTED|Overall Study||32
384449|NCT01032733|919107|P2|NOT COMPLETED|Overall Study||1
384450|NCT01032733|919108|P1|NOT COMPLETED|Overall Study||1
384451|NCT01032733|919107|P2|COMPLETED|Overall Study||16
384452|NCT01032733|919108|P1|COMPLETED|Overall Study||16
384453|NCT01032733|919107|P2|STARTED|Overall Study||17
384454|NCT01032733|919108|P1|STARTED|Overall Study||17
384455|NCT01032694|919124|P2|NOT COMPLETED|Overall Study||0
384456|NCT01032694|919125|P1|NOT COMPLETED|Overall Study||0
384457|NCT01032694|919124|P2|COMPLETED|Overall Study||10
384458|NCT01032694|919125|P1|COMPLETED|Overall Study||20
384459|NCT01032694|919124|P2|STARTED|Overall Study||10
384460|NCT01032694|919125|P1|STARTED|Overall Study||20
384461|NCT01032538|919135|P1|NOT COMPLETED|Overall Study||0
384462|NCT01032538|919135|P1|COMPLETED|Overall Study|Knees|99
384463|NCT01032538|919135|P1|STARTED|Overall Study|Knees|99
384464|NCT01032382|919143|P2|NOT COMPLETED|Overall Study||5
384465|NCT01032382|919144|P1|NOT COMPLETED|Overall Study||5
384466|NCT01032382|919143|P2|COMPLETED|Overall Study||9
384467|NCT01032382|919144|P1|COMPLETED|Overall Study||11
384468|NCT01032382|919143|P2|STARTED|Overall Study||14
384469|NCT01032382|919144|P1|STARTED|Overall Study||16
384470|NCT01032291|919173|P3|NOT COMPLETED|Proof of Concept||3
384471|NCT01032291|919174|P2|NOT COMPLETED|Proof of Concept||8
384472|NCT01032291|919175|P1|NOT COMPLETED|Proof of Concept||0
384473|NCT01032291|919173|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
384474|NCT01032291|919174|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
384475|NCT01032291|919175|P1|COMPLETED|Proof of Concept||0
384476|NCT01032291|919173|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
384477|NCT01032291|919174|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
384478|NCT01032291|919175|P1|Intent to Treat and Safety Populations|Proof of Concept||0
384479|NCT01032291|919173|P3|STARTED|Proof of Concept||21
384480|NCT01032291|919174|P2|STARTED|Proof of Concept||22
384481|NCT01032291|919175|P1|STARTED|Proof of Concept||0
384482|NCT01032291|919173|P3|NOT COMPLETED|Safety Lead-in||0
384483|NCT01032291|919174|P2|NOT COMPLETED|Safety Lead-in||0
384484|NCT01032291|919175|P1|NOT COMPLETED|Safety Lead-in||2
384485|NCT01032291|919173|P3|COMPLETED|Safety Lead-in||0
384486|NCT01032291|919174|P2|COMPLETED|Safety Lead-in||0
384487|NCT01032291|919175|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
384488|NCT01032291|919173|P3|STARTED|Safety Lead-in||0
384489|NCT01032291|919174|P2|STARTED|Safety Lead-in||0
384490|NCT01032291|919175|P1|STARTED|Safety Lead-in||8
384491|NCT01032265|919201|P2|NOT COMPLETED|Overall Study||17
384492|NCT01032265|919202|P1|NOT COMPLETED|Overall Study||13
384493|NCT01032265|919201|P2|COMPLETED|Overall Study||107
384494|NCT01032265|919202|P1|COMPLETED|Overall Study||113
384495|NCT01032265|919201|P2|STARTED|Overall Study||124
384496|NCT01032265|919202|P1|STARTED|Overall Study||126
384497|NCT01032200|919222|P2|NOT COMPLETED|Overall Study||7
384498|NCT01032200|919223|P1|NOT COMPLETED|Overall Study||4
384499|NCT01032200|919222|P2|COMPLETED|Overall Study||21
384500|NCT01032200|919223|P1|COMPLETED|Overall Study||22
384501|NCT01032200|919222|P2|STARTED|Overall Study||28
384502|NCT01032200|919223|P1|STARTED|Overall Study||26
384503|NCT01032174|919239|P2|NOT COMPLETED|Overall Study||1
384504|NCT01032174|919240|P1|NOT COMPLETED|Overall Study||0
384505|NCT01032174|919239|P2|COMPLETED|Overall Study||59
384506|NCT01032174|919240|P1|COMPLETED|Overall Study||63
384507|NCT01032174|919239|P2|STARTED|Overall Study||60
384508|NCT01032174|919240|P1|STARTED|Overall Study||63
384509|NCT01032135|919255|P7|NOT COMPLETED|8 Week Randomization||18
384510|NCT01032135|919256|P6|NOT COMPLETED|8 Week Randomization||17
384511|NCT01032135|919257|P5|NOT COMPLETED|8 Week Randomization||9
384512|NCT01032135|919258|P4|NOT COMPLETED|8 Week Randomization||11
384513|NCT01032135|919259|P3|NOT COMPLETED|8 Week Randomization||0
384514|NCT01032135|919260|P2|NOT COMPLETED|8 Week Randomization||0
384515|NCT01032135|919261|P1|NOT COMPLETED|8 Week Randomization||26
384516|NCT01032135|919255|P7|COMPLETED|8 Week Randomization||36
384517|NCT01032135|919256|P6|COMPLETED|8 Week Randomization||31
384518|NCT01032135|919257|P5|COMPLETED|8 Week Randomization||34
384519|NCT01032135|919258|P4|COMPLETED|8 Week Randomization||30
384520|NCT01032135|919259|P3|COMPLETED|8 Week Randomization||0
384521|NCT01032135|919260|P2|COMPLETED|8 Week Randomization||0
384522|NCT01032135|919261|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
384523|NCT01032135|919255|P7|12 Week Follow up|8 Week Randomization||41
384524|NCT01032135|919256|P6|12 Week Follow up|8 Week Randomization||36
384525|NCT01032135|919257|P5|12 Week Follow up|8 Week Randomization||38
384526|NCT01032135|919258|P4|12 Week Follow up|8 Week Randomization||34
384527|NCT01032135|919259|P3|12 Week Follow up|8 Week Randomization||0
384528|NCT01032135|919260|P2|12 Week Follow up|8 Week Randomization||0
384529|NCT01032135|919261|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
384530|NCT01032135|919255|P7|STARTED|8 Week Randomization||54
384531|NCT01032135|919256|P6|STARTED|8 Week Randomization||48
384532|NCT01032135|919257|P5|STARTED|8 Week Randomization||43
384533|NCT01032135|919258|P4|STARTED|8 Week Randomization||41
384534|NCT01032135|919259|P3|STARTED|8 Week Randomization||0
384535|NCT01032135|919260|P2|STARTED|8 Week Randomization||0
384536|NCT01032135|919261|P1|STARTED|8 Week Randomization||227
384537|NCT01032135|919255|P7|NOT COMPLETED|2 Week Randomization||0
384538|NCT01032135|919256|P6|NOT COMPLETED|2 Week Randomization||0
384539|NCT01032135|919257|P5|NOT COMPLETED|2 Week Randomization||0
384540|NCT01032135|919258|P4|NOT COMPLETED|2 Week Randomization||0
384541|NCT01032135|919259|P3|NOT COMPLETED|2 Week Randomization||0
384542|NCT01032135|919260|P2|NOT COMPLETED|2 Week Randomization||0
384543|NCT01032135|919261|P1|NOT COMPLETED|2 Week Randomization||0
384544|NCT01032135|919255|P7|COMPLETED|2 Week Randomization||0
384545|NCT01032135|919256|P6|COMPLETED|2 Week Randomization||0
384546|NCT01032135|919257|P5|COMPLETED|2 Week Randomization||0
384547|NCT01032135|919258|P4|COMPLETED|2 Week Randomization||0
384548|NCT01032135|919259|P3|COMPLETED|2 Week Randomization||96
384549|NCT01032135|919260|P2|COMPLETED|2 Week Randomization||93
384550|NCT01032135|919261|P1|COMPLETED|2 Week Randomization||311
384551|NCT01032135|919255|P7|STARTED|2 Week Randomization||0
384552|NCT01032135|919256|P6|STARTED|2 Week Randomization||0
384553|NCT01032135|919257|P5|STARTED|2 Week Randomization||0
384554|NCT01032135|919258|P4|STARTED|2 Week Randomization||0
384555|NCT01032135|919259|P3|STARTED|2 Week Randomization||96
384556|NCT01032135|919260|P2|STARTED|2 Week Randomization||93
384557|NCT01032135|919261|P1|STARTED|2 Week Randomization||311
384558|NCT01032070|919480|P2|NOT COMPLETED|Overall Study||12
384559|NCT01032070|919481|P1|NOT COMPLETED|Overall Study||13
384560|NCT01032070|919480|P2|COMPLETED|Overall Study||0
384561|NCT01032070|919481|P1|COMPLETED|Overall Study||0
384562|NCT01032070|919480|P2|STARTED|Overall Study||12
384563|NCT01032070|919481|P1|STARTED|Overall Study||13
384564|NCT01032044|919510|P2|NOT COMPLETED|Overall Study||20
384565|NCT01032044|919511|P1|NOT COMPLETED|Overall Study||25
384566|NCT01032044|919510|P2|COMPLETED|Overall Study||62
384567|NCT01032044|919511|P1|COMPLETED|Overall Study||57
384568|NCT01032044|919510|P2|Procedure|Overall Study||75
384569|NCT01032044|919511|P1|Procedure|Overall Study||74
384570|NCT01032044|919510|P2|STARTED|Overall Study||82
384571|NCT01032044|919511|P1|STARTED|Overall Study||82
384572|NCT01032018|919519|P2|NOT COMPLETED|Overall Study||6
384573|NCT01032018|919520|P1|NOT COMPLETED|Overall Study||6
384574|NCT01032018|919519|P2|COMPLETED|Overall Study||67
384575|NCT01032018|919520|P1|COMPLETED|Overall Study||71
384576|NCT01032018|919519|P2|STARTED|Overall Study||73
384577|NCT01032018|919520|P1|STARTED|Overall Study||77
384578|NCT01031979|919530|P2|NOT COMPLETED|Overall Study||4
384579|NCT01031979|919531|P1|NOT COMPLETED|Overall Study||5
384580|NCT01031979|919530|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
384581|NCT01031979|919531|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
384582|NCT01031979|919530|P2|Completed Primary Outcome Measure|Overall Study||12
384583|NCT01031979|919531|P1|Completed Primary Outcome Measure|Overall Study||12
384584|NCT01031979|919530|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
384585|NCT01031979|919531|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
384586|NCT01031953|919543|P1|NOT COMPLETED|Overall Study||0
384587|NCT01031953|919543|P1|COMPLETED|Overall Study||11
384588|NCT01031953|919543|P1|STARTED|Overall Study||11
384589|NCT01031914|919554|P1|NOT COMPLETED|Overall Study||0
384590|NCT01031914|919554|P1|COMPLETED|Overall Study||36
384591|NCT01031914|919554|P1|STARTED|Overall Study||36
384592|NCT01031810|919558|P1|NOT COMPLETED|Overall Study||4
384593|NCT01031810|919558|P1|COMPLETED|Overall Study||9
384594|NCT01031810|919558|P1|STARTED|Overall Study||13
384595|NCT01031706|919569|P2|NOT COMPLETED|Overall Study||1
384596|NCT01031706|919570|P1|NOT COMPLETED|Overall Study||2
384597|NCT01031706|919569|P2|COMPLETED|Overall Study||8
384598|NCT01031706|919570|P1|COMPLETED|Overall Study||12
384599|NCT01031706|919569|P2|STARTED|Overall Study||9
384600|NCT01031706|919570|P1|STARTED|Overall Study||14
384601|NCT01031680|919580|P2|NOT COMPLETED|Overall Study||58
384602|NCT01031680|919581|P1|NOT COMPLETED|Overall Study||57
384603|NCT01031680|919580|P2|COMPLETED|Overall Study||404
384604|NCT01031680|919581|P1|COMPLETED|Overall Study||403
384605|NCT01031680|919580|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
384606|NCT01031680|919581|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
384607|NCT01031628|919601|P4|NOT COMPLETED|Overall Study||0
384608|NCT01031628|919602|P3|NOT COMPLETED|Overall Study||3
384609|NCT01031628|919603|P2|NOT COMPLETED|Overall Study||1
384610|NCT01031628|919604|P1|NOT COMPLETED|Overall Study||0
384611|NCT01031628|919601|P4|COMPLETED|Overall Study||0
384612|NCT01031628|919602|P3|COMPLETED|Overall Study||0
384613|NCT01031628|919603|P2|COMPLETED|Overall Study||0
384614|NCT01031628|919604|P1|COMPLETED|Overall Study||0
384615|NCT01031628|919601|P4|STARTED|Overall Study||0
384616|NCT01031628|919602|P3|STARTED|Overall Study||3
384617|NCT01031628|919603|P2|STARTED|Overall Study||1
384618|NCT01031628|919604|P1|STARTED|Overall Study||0
384619|NCT01031550|919616|P2|NOT COMPLETED|Overall Study||0
384620|NCT01031550|919617|P1|NOT COMPLETED|Overall Study||0
384621|NCT01031550|919616|P2|COMPLETED|Overall Study||3
384622|NCT01031550|919617|P1|COMPLETED|Overall Study||5
384623|NCT01031550|919616|P2|STARTED|Overall Study||3
384624|NCT01031550|919617|P1|STARTED|Overall Study||5
384625|NCT01031498|919632|P3|NOT COMPLETED|Overall Study||2
384626|NCT01031498|919633|P2|NOT COMPLETED|Overall Study||3
384627|NCT01031498|919634|P1|NOT COMPLETED|Overall Study||2
384628|NCT01031498|919632|P3|COMPLETED|Overall Study||48
384629|NCT01031498|919633|P2|COMPLETED|Overall Study||48
384630|NCT01031498|919634|P1|COMPLETED|Overall Study||47
384631|NCT01031498|919632|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
384632|NCT01031498|919633|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
384633|NCT01031498|919634|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
384634|NCT01031446|919642|P1|NOT COMPLETED|Overall Study||55
384635|NCT01031446|919642|P1|COMPLETED|Overall Study||0
384636|NCT01031446|919642|P1|STARTED|Overall Study||55
384637|NCT01031381|919651|P1|NOT COMPLETED|Overall Study||9
384638|NCT01031381|919651|P1|COMPLETED|Overall Study||50
384639|NCT01031381|919651|P1|STARTED|Overall Study||59
384640|NCT01031134|919658|P2|NOT COMPLETED|Overall Study||10
384641|NCT01031134|919659|P1|NOT COMPLETED|Overall Study||11
384642|NCT01031134|919658|P2|COMPLETED|Overall Study||78
384643|NCT01031134|919659|P1|COMPLETED|Overall Study||103
384644|NCT01031134|919658|P2|STARTED|Overall Study||88
384645|NCT01031134|919659|P1|STARTED|Overall Study||114
384646|NCT01031095|919669|P2|NOT COMPLETED|Overall Study||0
384647|NCT01031095|919670|P1|NOT COMPLETED|Overall Study||0
384648|NCT01031095|919669|P2|COMPLETED|Overall Study||100
384649|NCT01031095|919670|P1|COMPLETED|Overall Study||100
384650|NCT01031095|919669|P2|STARTED|Overall Study||100
384651|NCT01031095|919670|P1|STARTED|Overall Study||100
384652|NCT01031043|919676|P1|NOT COMPLETED|Overall Study||1
384653|NCT01031043|919676|P1|COMPLETED|Overall Study||4
384654|NCT01031043|919676|P1|STARTED|Overall Study||5
384655|NCT01031004|919682|P2|NOT COMPLETED|Overall Study||1
384656|NCT01031004|919683|P1|NOT COMPLETED|Overall Study||1
384657|NCT01031004|919682|P2|COMPLETED|Overall Study||24
384658|NCT01031004|919683|P1|COMPLETED|Overall Study||24
384659|NCT01031004|919682|P2|STARTED|Overall Study||25
384660|NCT01031004|919683|P1|STARTED|Overall Study||25
384661|NCT01030965|919727|P4|NOT COMPLETED|Overall Study||7
384662|NCT01030965|919728|P3|NOT COMPLETED|Overall Study||4
384663|NCT01030965|919729|P2|NOT COMPLETED|Overall Study||6
384664|NCT01030965|919730|P1|NOT COMPLETED|Overall Study||4
384665|NCT01030965|919727|P4|COMPLETED|Overall Study||64
384666|NCT01030965|919728|P3|COMPLETED|Overall Study||68
384667|NCT01030965|919729|P2|COMPLETED|Overall Study||65
384668|NCT01030965|919730|P1|COMPLETED|Overall Study||67
384669|NCT01030965|919727|P4|STARTED|Overall Study||71
384670|NCT01030965|919728|P3|STARTED|Overall Study||72
384671|NCT01030965|919729|P2|STARTED|Overall Study||71
384672|NCT01030965|919730|P1|STARTED|Overall Study||71
384673|NCT01030952|919750|P2|NOT COMPLETED|Overall Study||3
384674|NCT01030952|919751|P1|NOT COMPLETED|Overall Study||2
384675|NCT01030952|919750|P2|COMPLETED|Overall Study||49
384676|NCT01030952|919751|P1|COMPLETED|Overall Study||49
384677|NCT01030952|919750|P2|STARTED|Overall Study||52
384678|NCT01030952|919751|P1|STARTED|Overall Study||51
384679|NCT01030822|919788|P3|NOT COMPLETED|Overall Study||26
384680|NCT01030822|919789|P2|NOT COMPLETED|Overall Study||24
384681|NCT01030822|919790|P1|NOT COMPLETED|Overall Study||31
384682|NCT01030822|919788|P3|COMPLETED|Overall Study||61
384683|NCT01030822|919789|P2|COMPLETED|Overall Study||71
384684|NCT01030822|919790|P1|COMPLETED|Overall Study||69
384685|NCT01030822|919788|P3|STARTED|Overall Study||87
384686|NCT01030822|919789|P2|STARTED|Overall Study||95
384687|NCT01030822|919790|P1|STARTED|Overall Study||100
384688|NCT01030757|919837|P1|NOT COMPLETED|Overall Study||0
384689|NCT01030757|919837|P1|COMPLETED|Overall Study||2
384690|NCT01030757|919837|P1|STARTED|Overall Study||2
384691|NCT01030718|919845|P3|NOT COMPLETED|Study CA180-036 Only||5
384692|NCT01030718|919846|P2|NOT COMPLETED|Study CA180-036 Only||7
384693|NCT01030718|919847|P1|NOT COMPLETED|Study CA180-036 Only||3
384694|NCT01030718|919845|P3|COMPLETED|Study CA180-036 Only||1
384695|NCT01030718|919846|P2|COMPLETED|Study CA180-036 Only||2
384696|NCT01030718|919847|P1|COMPLETED|Study CA180-036 Only||26
384697|NCT01030718|919845|P3|STARTED|Study CA180-036 Only||6
384698|NCT01030718|919846|P2|STARTED|Study CA180-036 Only||9
384699|NCT01030718|919847|P1|STARTED|Study CA180-036 Only||29
384700|NCT01030718|919845|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
384701|NCT01030718|919846|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
384702|NCT01030718|919847|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
384703|NCT01030718|919845|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
384704|NCT01030718|919846|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
384705|NCT01030718|919847|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
384706|NCT01030718|919845|P3|STARTED|Studies CA180-031 and -036 Combined||13
384707|NCT01030718|919846|P2|STARTED|Studies CA180-031 and -036 Combined||11
384708|NCT01030718|919847|P1|STARTED|Studies CA180-031 and -036 Combined||30
384709|NCT01030666|919908|P2|NOT COMPLETED|Overall Study||2
384710|NCT01030666|919909|P1|NOT COMPLETED|Overall Study||3
384711|NCT01030666|919908|P2|COMPLETED|Overall Study||31
384712|NCT01030666|919909|P1|COMPLETED|Overall Study||25
384713|NCT01030666|919908|P2|STARTED|Overall Study||33
384714|NCT01030666|919909|P1|STARTED|Overall Study||28
384715|NCT01030653|919919|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
384716|NCT01030653|919920|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
384717|NCT01030653|919919|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
384718|NCT01030653|919920|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
384719|NCT01030653|919919|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
384720|NCT01030653|919920|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
384721|NCT01030653|919919|P2|NOT COMPLETED|7-Day Washout Period||0
384722|NCT01030653|919920|P1|NOT COMPLETED|7-Day Washout Period||0
384723|NCT01030653|919919|P2|COMPLETED|7-Day Washout Period||4
384724|NCT01030653|919920|P1|COMPLETED|7-Day Washout Period||4
384725|NCT01030653|919919|P2|STARTED|7-Day Washout Period||4
384726|NCT01030653|919920|P1|STARTED|7-Day Washout Period||4
384727|NCT01030653|919919|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
384728|NCT01030653|919920|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
384729|NCT01030653|919919|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
384730|NCT01030653|919920|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
384731|NCT01030653|919919|P2|STARTED|Loading Dose & First Maintenance Regimen||4
384732|NCT01030653|919920|P1|STARTED|Loading Dose & First Maintenance Regimen||4
384733|NCT01030458|919931|P2|NOT COMPLETED|Overall Study||32
384734|NCT01030458|919932|P1|NOT COMPLETED|Overall Study||27
384735|NCT01030458|919931|P2|COMPLETED|Overall Study||57
384736|NCT01030458|919932|P1|COMPLETED|Overall Study||67
384737|NCT01030458|919931|P2|STARTED|Overall Study||89
384738|NCT01030458|919932|P1|STARTED|Overall Study||94
384739|NCT01029925|919944|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
384740|NCT01029925|919944|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
384741|NCT01029925|919944|P1|STARTED|Completion of Cycle 2 (56 Days)||3
384742|NCT01029925|919944|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
384743|NCT01029925|919944|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
384744|NCT01029925|919944|P1|STARTED|Completion of Cycle 1 (28 Days)||7
384745|NCT01029886|919950|P2|NOT COMPLETED|Overall Study||60
384746|NCT01029886|919951|P1|NOT COMPLETED|Overall Study||61
384747|NCT01029886|919950|P2|COMPLETED|Overall Study||391
384748|NCT01029886|919951|P1|COMPLETED|Overall Study||400
384749|NCT01029886|919950|P2|Intent to Treat (ITT)|Overall Study||450
384750|NCT01029886|919951|P1|Intent to Treat (ITT)|Overall Study||461
384751|NCT01029886|919950|P2|STARTED|Overall Study||451
384752|NCT01029886|919951|P1|STARTED|Overall Study||461
384753|NCT01029795|919979|P2|NOT COMPLETED|Overall Study||22
384754|NCT01029795|919980|P1|NOT COMPLETED|Overall Study||16
384755|NCT01029795|919979|P2|COMPLETED|Overall Study||0
384756|NCT01029795|919980|P1|COMPLETED|Overall Study||0
384757|NCT01029795|919979|P2|STARTED|Overall Study||22
384758|NCT01029795|919980|P1|STARTED|Overall Study||16
384759|NCT01029730|920032|P1|NOT COMPLETED|Maintenance Therapy||23
384760|NCT01029730|920032|P1|COMPLETED|Maintenance Therapy||14
384761|NCT01029730|920032|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
384762|NCT01029730|920032|P1|NOT COMPLETED|Combination Therapy||16
384763|NCT01029730|920032|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
384764|NCT01029730|920032|P1|STARTED|Combination Therapy||55
384765|NCT01029704|920044|P5|NOT COMPLETED|Overall Study||0
384766|NCT01029704|920045|P4|NOT COMPLETED|Overall Study||0
384767|NCT01029704|920046|P3|NOT COMPLETED|Overall Study||0
384768|NCT01029704|920047|P2|NOT COMPLETED|Overall Study||0
384769|NCT01029704|920048|P1|NOT COMPLETED|Overall Study||0
384770|NCT01029704|920044|P5|COMPLETED|Overall Study||26
384771|NCT01029704|920045|P4|COMPLETED|Overall Study||28
384772|NCT01029704|920046|P3|COMPLETED|Overall Study||23
384773|NCT01029704|920047|P2|COMPLETED|Overall Study||24
384774|NCT01029704|920048|P1|COMPLETED|Overall Study||28
384775|NCT01029704|920044|P5|STARTED|Overall Study||26
384776|NCT01029704|920045|P4|STARTED|Overall Study||28
384777|NCT01029704|920046|P3|STARTED|Overall Study||23
384778|NCT01029704|920047|P2|STARTED|Overall Study||24
384779|NCT01029704|920048|P1|STARTED|Overall Study||28
384780|NCT01029652|920077|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
384781|NCT01029652|920078|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
384782|NCT01029652|920077|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
384783|NCT01029652|920078|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
384784|NCT01029652|920077|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
384785|NCT01029652|920078|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
384786|NCT01029652|920077|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
384787|NCT01029652|920078|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
384788|NCT01029652|920077|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
384789|NCT01029652|920078|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
384790|NCT01029652|920077|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
384791|NCT01029652|920078|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
384792|NCT01029652|920077|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
384793|NCT01029652|920078|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
384794|NCT01029652|920077|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
384795|NCT01029652|920078|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
384796|NCT01029652|920077|P2|COMPLETED|Core Study (0-12 Weeks)||105
384797|NCT01029652|920078|P1|COMPLETED|Core Study (0-12 Weeks)||109
384798|NCT01029652|920077|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
384799|NCT01029652|920078|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
384800|NCT01029652|920077|P2|STARTED|Core Study (0-12 Weeks)||115
384801|NCT01029652|920078|P1|STARTED|Core Study (0-12 Weeks)||115
384802|NCT01029535|920156|P1|NOT COMPLETED|Overall Study||31
384803|NCT01029535|920156|P1|COMPLETED|Overall Study||72
384804|NCT01029535|920156|P1|STARTED|Overall Study||103
384805|NCT01029405|920185|P4|NOT COMPLETED|Overall Study||5
384806|NCT01029405|920186|P3|NOT COMPLETED|Overall Study||4
384807|NCT01029405|920187|P2|NOT COMPLETED|Overall Study||3
384808|NCT01029405|920188|P1|NOT COMPLETED|Overall Study||2
384809|NCT01029405|920185|P4|COMPLETED|Overall Study||32
384810|NCT01029405|920186|P3|COMPLETED|Overall Study||31
384811|NCT01029405|920187|P2|COMPLETED|Overall Study||34
384812|NCT01029405|920188|P1|COMPLETED|Overall Study||34
384813|NCT01029405|920185|P4|STARTED|Overall Study||37
384814|NCT01029405|920186|P3|STARTED|Overall Study||35
384815|NCT01029405|920187|P2|STARTED|Overall Study||37
384816|NCT01029405|920188|P1|STARTED|Overall Study||36
384817|NCT01029392|920200|P2|NOT COMPLETED|Overall Study||11
384818|NCT01029392|920201|P1|NOT COMPLETED|Overall Study||20
384819|NCT01029392|920200|P2|COMPLETED|Overall Study||27
384820|NCT01029392|920201|P1|COMPLETED|Overall Study||17
384821|NCT01029392|920200|P2|STARTED|Overall Study||38
384822|NCT01029392|920201|P1|STARTED|Overall Study||37
384823|NCT01029366|920211|P2|NOT COMPLETED|Overall Study||2
384824|NCT01029366|920212|P1|NOT COMPLETED|Overall Study||4
384825|NCT01029366|920211|P2|COMPLETED|Overall Study||6
384826|NCT01029366|920212|P1|COMPLETED|Overall Study||14
384827|NCT01029366|920211|P2|STARTED|Overall Study||8
384828|NCT01029366|920212|P1|STARTED|Overall Study||18
384829|NCT01029340|920224|P6|NOT COMPLETED|Part C Follow up Period||0
384830|NCT01029340|920225|P5|NOT COMPLETED|Part C Follow up Period||0
384831|NCT01029340|920226|P4|NOT COMPLETED|Part C Follow up Period||0
384832|NCT01029340|920227|P3|NOT COMPLETED|Part C Follow up Period||0
384833|NCT01029340|920228|P2|NOT COMPLETED|Part C Follow up Period||0
384834|NCT01029340|920229|P1|NOT COMPLETED|Part C Follow up Period||0
384835|NCT01029340|920224|P6|COMPLETED|Part C Follow up Period||0
384836|NCT01029340|920225|P5|COMPLETED|Part C Follow up Period||5
384837|NCT01029340|920226|P4|COMPLETED|Part C Follow up Period||0
384838|NCT01029340|920227|P3|COMPLETED|Part C Follow up Period||0
384839|NCT01029340|920228|P2|COMPLETED|Part C Follow up Period||0
384840|NCT01029340|920229|P1|COMPLETED|Part C Follow up Period||0
384841|NCT01029340|920224|P6|STARTED|Part C Follow up Period||0
384842|NCT01029340|920225|P5|STARTED|Part C Follow up Period||5
384843|NCT01029340|920226|P4|STARTED|Part C Follow up Period||0
384844|NCT01029340|920227|P3|STARTED|Part C Follow up Period||0
384845|NCT01029340|920228|P2|STARTED|Part C Follow up Period||0
384846|NCT01029340|920229|P1|STARTED|Part C Follow up Period||0
384847|NCT01029340|920224|P6|NOT COMPLETED|Part C Treatment Period||0
384848|NCT01029340|920225|P5|NOT COMPLETED|Part C Treatment Period||0
384849|NCT01029340|920226|P4|NOT COMPLETED|Part C Treatment Period||0
384850|NCT01029340|920227|P3|NOT COMPLETED|Part C Treatment Period||0
384851|NCT01029340|920228|P2|NOT COMPLETED|Part C Treatment Period||0
384852|NCT01029340|920229|P1|NOT COMPLETED|Part C Treatment Period||0
384853|NCT01029340|920224|P6|COMPLETED|Part C Treatment Period||0
384854|NCT01029340|920225|P5|COMPLETED|Part C Treatment Period||5
384855|NCT01029340|920226|P4|COMPLETED|Part C Treatment Period||0
384856|NCT01029340|920227|P3|COMPLETED|Part C Treatment Period||0
384857|NCT01029340|920228|P2|COMPLETED|Part C Treatment Period||0
384858|NCT01029340|920229|P1|COMPLETED|Part C Treatment Period||0
384859|NCT01029340|920224|P6|Participants Received Treatment|Part C Treatment Period||0
384860|NCT01029340|920225|P5|Participants Received Treatment|Part C Treatment Period||5
384861|NCT01029340|920226|P4|Participants Received Treatment|Part C Treatment Period||0
384862|NCT01029340|920227|P3|Participants Received Treatment|Part C Treatment Period||0
384863|NCT01029340|920228|P2|Participants Received Treatment|Part C Treatment Period||0
384864|NCT01029340|920229|P1|Participants Received Treatment|Part C Treatment Period||0
384865|NCT01029340|920224|P6|STARTED|Part C Treatment Period||0
384866|NCT01029340|920225|P5|STARTED|Part C Treatment Period||5
384867|NCT01029340|920226|P4|STARTED|Part C Treatment Period||0
384868|NCT01029340|920227|P3|STARTED|Part C Treatment Period||0
384869|NCT01029340|920228|P2|STARTED|Part C Treatment Period||0
384870|NCT01029340|920229|P1|STARTED|Part C Treatment Period||0
384871|NCT01029340|920224|P6|NOT COMPLETED|Extension Period||12
384872|NCT01029340|920225|P5|NOT COMPLETED|Extension Period||0
384873|NCT01029340|920226|P4|NOT COMPLETED|Extension Period||0
384874|NCT01029340|920227|P3|NOT COMPLETED|Extension Period||0
384875|NCT01029340|920228|P2|NOT COMPLETED|Extension Period||0
384876|NCT01029340|920229|P1|NOT COMPLETED|Extension Period||0
384877|NCT01029340|920224|P6|COMPLETED|Extension Period||43
384878|NCT01029340|920225|P5|COMPLETED|Extension Period||0
384879|NCT01029340|920226|P4|COMPLETED|Extension Period||0
384880|NCT01029340|920227|P3|COMPLETED|Extension Period||0
384881|NCT01029340|920228|P2|COMPLETED|Extension Period||0
384882|NCT01029340|920229|P1|COMPLETED|Extension Period||0
384883|NCT01029340|920224|P6|STARTED|Extension Period||55
384884|NCT01029340|920225|P5|STARTED|Extension Period||0
384885|NCT01029340|920226|P4|STARTED|Extension Period||0
384886|NCT01029340|920227|P3|STARTED|Extension Period||0
384887|NCT01029340|920228|P2|STARTED|Extension Period||0
384888|NCT01029340|920229|P1|STARTED|Extension Period||0
384889|NCT01029340|920224|P6|NOT COMPLETED|Part B Follow up Period||0
384890|NCT01029340|920225|P5|NOT COMPLETED|Part B Follow up Period||0
384891|NCT01029340|920226|P4|NOT COMPLETED|Part B Follow up Period||0
384892|NCT01029340|920227|P3|NOT COMPLETED|Part B Follow up Period||0
384893|NCT01029340|920228|P2|NOT COMPLETED|Part B Follow up Period||0
384894|NCT01029340|920229|P1|NOT COMPLETED|Part B Follow up Period||0
384895|NCT01029340|920224|P6|COMPLETED|Part B Follow up Period||0
384896|NCT01029340|920225|P5|COMPLETED|Part B Follow up Period||0
384897|NCT01029340|920226|P4|COMPLETED|Part B Follow up Period||32
384898|NCT01029340|920227|P3|COMPLETED|Part B Follow up Period||29
384899|NCT01029340|920228|P2|COMPLETED|Part B Follow up Period||0
384900|NCT01029340|920229|P1|COMPLETED|Part B Follow up Period||0
384901|NCT01029340|920224|P6|STARTED|Part B Follow up Period||0
384902|NCT01029340|920225|P5|STARTED|Part B Follow up Period||0
384903|NCT01029340|920226|P4|STARTED|Part B Follow up Period||32
384904|NCT01029340|920227|P3|STARTED|Part B Follow up Period||29
384905|NCT01029340|920228|P2|STARTED|Part B Follow up Period||0
384906|NCT01029340|920229|P1|STARTED|Part B Follow up Period||0
384907|NCT01029340|920224|P6|NOT COMPLETED|Part B Treatment Period||0
384908|NCT01029340|920225|P5|NOT COMPLETED|Part B Treatment Period||0
384909|NCT01029340|920226|P4|NOT COMPLETED|Part B Treatment Period||0
384910|NCT01029340|920227|P3|NOT COMPLETED|Part B Treatment Period||2
384911|NCT01029340|920228|P2|NOT COMPLETED|Part B Treatment Period||0
384912|NCT01029340|920229|P1|NOT COMPLETED|Part B Treatment Period||0
384913|NCT01029340|920224|P6|COMPLETED|Part B Treatment Period||0
384914|NCT01029340|920225|P5|COMPLETED|Part B Treatment Period||0
384915|NCT01029340|920226|P4|COMPLETED|Part B Treatment Period||32
384916|NCT01029340|920227|P3|COMPLETED|Part B Treatment Period||29
384917|NCT01029340|920228|P2|COMPLETED|Part B Treatment Period||0
384918|NCT01029340|920229|P1|COMPLETED|Part B Treatment Period||0
384919|NCT01029340|920224|P6|Participants Received Treatment|Part B Treatment Period||0
384920|NCT01029340|920225|P5|Participants Received Treatment|Part B Treatment Period||0
384921|NCT01029340|920226|P4|Participants Received Treatment|Part B Treatment Period||32
384922|NCT01029340|920227|P3|Participants Received Treatment|Part B Treatment Period||30
384923|NCT01029340|920228|P2|Participants Received Treatment|Part B Treatment Period||0
384924|NCT01029340|920229|P1|Participants Received Treatment|Part B Treatment Period||0
384925|NCT01029340|920224|P6|STARTED|Part B Treatment Period||0
384926|NCT01029340|920225|P5|STARTED|Part B Treatment Period||0
384927|NCT01029340|920226|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
384928|NCT01029340|920227|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
384929|NCT01029340|920228|P2|STARTED|Part B Treatment Period||0
384930|NCT01029340|920229|P1|STARTED|Part B Treatment Period||0
384931|NCT01029340|920224|P6|NOT COMPLETED|Part A Follow up Period||0
384932|NCT01029340|920225|P5|NOT COMPLETED|Part A Follow up Period||0
384933|NCT01029340|920226|P4|NOT COMPLETED|Part A Follow up Period||0
384934|NCT01029340|920227|P3|NOT COMPLETED|Part A Follow up Period||0
384935|NCT01029340|920228|P2|NOT COMPLETED|Part A Follow up Period||0
384936|NCT01029340|920229|P1|NOT COMPLETED|Part A Follow up Period||0
384937|NCT01029340|920224|P6|COMPLETED|Part A Follow up Period||0
384938|NCT01029340|920225|P5|COMPLETED|Part A Follow up Period||0
384939|NCT01029340|920226|P4|COMPLETED|Part A Follow up Period||0
384940|NCT01029340|920227|P3|COMPLETED|Part A Follow up Period||0
384941|NCT01029340|920228|P2|COMPLETED|Part A Follow up Period||14
384942|NCT01029340|920229|P1|COMPLETED|Part A Follow up Period||14
384943|NCT01029340|920224|P6|STARTED|Part A Follow up Period||0
384944|NCT01029340|920225|P5|STARTED|Part A Follow up Period||0
384945|NCT01029340|920226|P4|STARTED|Part A Follow up Period||0
384946|NCT01029340|920227|P3|STARTED|Part A Follow up Period||0
384947|NCT01029340|920228|P2|STARTED|Part A Follow up Period||14
384948|NCT01029340|920229|P1|STARTED|Part A Follow up Period||14
384949|NCT01029340|920224|P6|NOT COMPLETED|Part A Treatment Period||0
384950|NCT01029340|920225|P5|NOT COMPLETED|Part A Treatment Period||0
384951|NCT01029340|920226|P4|NOT COMPLETED|Part A Treatment Period||0
384952|NCT01029340|920227|P3|NOT COMPLETED|Part A Treatment Period||0
384953|NCT01029340|920228|P2|NOT COMPLETED|Part A Treatment Period||0
384954|NCT01029340|920229|P1|NOT COMPLETED|Part A Treatment Period||0
384955|NCT01029340|920224|P6|COMPLETED|Part A Treatment Period||0
384956|NCT01029340|920225|P5|COMPLETED|Part A Treatment Period||0
384957|NCT01029340|920226|P4|COMPLETED|Part A Treatment Period||0
384958|NCT01029340|920227|P3|COMPLETED|Part A Treatment Period||0
384959|NCT01029340|920228|P2|COMPLETED|Part A Treatment Period||14
384960|NCT01029340|920229|P1|COMPLETED|Part A Treatment Period||14
384961|NCT01029340|920224|P6|Safety Population|Part A Treatment Period||0
384962|NCT01029340|920225|P5|Safety Population|Part A Treatment Period||0
384963|NCT01029340|920226|P4|Safety Population|Part A Treatment Period||0
384964|NCT01029340|920227|P3|Safety Population|Part A Treatment Period||0
384965|NCT01029340|920228|P2|Safety Population|Part A Treatment Period||14
384966|NCT01029340|920229|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
384967|NCT01029340|920224|P6|Participants Received Treatment|Part A Treatment Period||0
384968|NCT01029340|920225|P5|Participants Received Treatment|Part A Treatment Period||0
384969|NCT01029340|920226|P4|Participants Received Treatment|Part A Treatment Period||0
384970|NCT01029340|920227|P3|Participants Received Treatment|Part A Treatment Period||0
384971|NCT01029340|920228|P2|Participants Received Treatment|Part A Treatment Period||14
384972|NCT01029340|920229|P1|Participants Received Treatment|Part A Treatment Period||14
384973|NCT01029340|920224|P6|STARTED|Part A Treatment Period||0
384974|NCT01029340|920225|P5|STARTED|Part A Treatment Period||0
384975|NCT01029340|920226|P4|STARTED|Part A Treatment Period||0
384976|NCT01029340|920227|P3|STARTED|Part A Treatment Period||0
384977|NCT01029340|920228|P2|STARTED|Part A Treatment Period||14
384978|NCT01029340|920229|P1|STARTED|Part A Treatment Period||14
384979|NCT01028131|920262|P4|NOT COMPLETED|Overall Study||4
384980|NCT01028131|920263|P3|NOT COMPLETED|Overall Study||6
384981|NCT01028131|920264|P2|NOT COMPLETED|Overall Study||3
384982|NCT01028131|920265|P1|NOT COMPLETED|Overall Study||3
384983|NCT01028131|920262|P4|COMPLETED|Overall Study||26
384984|NCT01028131|920263|P3|COMPLETED|Overall Study||22
384985|NCT01028131|920264|P2|COMPLETED|Overall Study||23
384986|NCT01028131|920265|P1|COMPLETED|Overall Study||23
384987|NCT01028131|920262|P4|Completed Intervention/Control Session|Overall Study||30
384988|NCT01028131|920263|P3|Completed Intervention/Control Session|Overall Study||28
384989|NCT01028131|920264|P2|Completed Intervention/Control Session|Overall Study||26
384990|NCT01028131|920265|P1|Completed Intervention/Control Session|Overall Study||26
384991|NCT01028131|920262|P4|STARTED|Overall Study||30
384992|NCT01028131|920263|P3|STARTED|Overall Study||28
384993|NCT01028131|920264|P2|STARTED|Overall Study||26
384994|NCT01028131|920265|P1|STARTED|Overall Study||26
384995|NCT01028053|920279|P1|NOT COMPLETED|Overall Study||133
384996|NCT01028053|920279|P1|COMPLETED|Overall Study||232
384997|NCT01028053|920279|P1|STARTED|Overall Study||365
384998|NCT01028027|920287|P2|NOT COMPLETED|Overall Study||13
384999|NCT01028027|920288|P1|NOT COMPLETED|Overall Study||16
385000|NCT01028027|920287|P2|COMPLETED|Overall Study||164
385001|NCT01028027|920288|P1|COMPLETED|Overall Study||164
385002|NCT01028027|920287|P2|STARTED|Overall Study||177
385003|NCT01028027|920288|P1|STARTED|Overall Study||180
385004|NCT01028014|920310|P6|NOT COMPLETED|Overall Study||2
385005|NCT01028014|920311|P5|NOT COMPLETED|Overall Study||1
385006|NCT01028014|920312|P4|NOT COMPLETED|Overall Study||1
385007|NCT01028014|920313|P3|NOT COMPLETED|Overall Study||0
385008|NCT01028014|920314|P2|NOT COMPLETED|Overall Study||2
385009|NCT01028014|920315|P1|NOT COMPLETED|Overall Study||1
385010|NCT01028014|920310|P6|COMPLETED|Overall Study||4
385011|NCT01028014|920311|P5|COMPLETED|Overall Study||9
385012|NCT01028014|920312|P4|COMPLETED|Overall Study||9
385013|NCT01028014|920313|P3|COMPLETED|Overall Study||10
385014|NCT01028014|920314|P2|COMPLETED|Overall Study||8
385015|NCT01028014|920315|P1|COMPLETED|Overall Study||9
385016|NCT01028014|920310|P6|STARTED|Overall Study||6
385017|NCT01028014|920311|P5|STARTED|Overall Study||10
385018|NCT01028014|920312|P4|STARTED|Overall Study||10
385019|NCT01028014|920313|P3|STARTED|Overall Study||10
385020|NCT01028014|920314|P2|STARTED|Overall Study||10
385021|NCT01028014|920315|P1|STARTED|Overall Study||10
385022|NCT01029262|920343|P2|NOT COMPLETED|Overall Study||145
385023|NCT01029262|920344|P1|NOT COMPLETED|Overall Study||78
385024|NCT01029262|920343|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
385025|NCT01029262|920344|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
385026|NCT01029262|920343|P2|STARTED|Overall Study||160
385027|NCT01029262|920344|P1|STARTED|Overall Study||79
385028|NCT01029054|920400|P3|NOT COMPLETED|Phase II||0
385029|NCT01029054|920401|P2|NOT COMPLETED|Phase II||0
385030|NCT01029054|920402|P1|NOT COMPLETED|Phase II||0
385031|NCT01029054|920400|P3|COMPLETED|Phase II||18
385032|NCT01029054|920401|P2|COMPLETED|Phase II||0
385033|NCT01029054|920402|P1|COMPLETED|Phase II||0
385034|NCT01029054|920400|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
385035|NCT01029054|920401|P2|STARTED|Phase II||0
385036|NCT01029054|920402|P1|STARTED|Phase II||0
385037|NCT01029054|920400|P3|NOT COMPLETED|Phase I||0
385038|NCT01029054|920401|P2|NOT COMPLETED|Phase I||0
385039|NCT01029054|920402|P1|NOT COMPLETED|Phase I||0
385040|NCT01029054|920400|P3|COMPLETED|Phase I||18
385041|NCT01029054|920401|P2|COMPLETED|Phase I||13
385042|NCT01029054|920402|P1|COMPLETED|Phase I||4
385043|NCT01029054|920400|P3|STARTED|Phase I||18
385044|NCT01029054|920401|P2|STARTED|Phase I||13
385045|NCT01029054|920402|P1|STARTED|Phase I||4
385046|NCT01028911|920410|P2|NOT COMPLETED|Overall Study||0
385047|NCT01028911|920411|P1|NOT COMPLETED|Overall Study||0
385048|NCT01028911|920410|P2|COMPLETED|Overall Study||2
385049|NCT01028911|920411|P1|COMPLETED|Overall Study||7
385050|NCT01028911|920410|P2|STARTED|Overall Study||2
385051|NCT01028911|920411|P1|STARTED|Overall Study||7
385052|NCT01028820|920476|P1|NOT COMPLETED|Overall Study||1
385053|NCT01028820|920476|P1|COMPLETED|Overall Study||12
385054|NCT01028820|920476|P1|STARTED|Overall Study||13
385055|NCT01028677|920485|P2|NOT COMPLETED|Overall Study||1
385056|NCT01028677|920486|P1|NOT COMPLETED|Overall Study||2
385057|NCT01028677|920485|P2|COMPLETED|Overall Study||6
385058|NCT01028677|920486|P1|COMPLETED|Overall Study||8
385059|NCT01028677|920485|P2|STARTED|Overall Study||7
385060|NCT01028677|920486|P1|STARTED|Overall Study||10
385061|NCT01028651|920502|P1|NOT COMPLETED|Overall Study||3
385062|NCT01028651|920502|P1|COMPLETED|Overall Study||10
385063|NCT01028651|920502|P1|STARTED|Overall Study||13
385064|NCT01028391|920525|P2|NOT COMPLETED|Overall Study||11
385065|NCT01028391|920526|P1|NOT COMPLETED|Overall Study||14
385066|NCT01028391|920525|P2|COMPLETED|Overall Study||142
385067|NCT01028391|920526|P1|COMPLETED|Overall Study||150
385068|NCT01028391|920525|P2|STARTED|Overall Study||153
385069|NCT01028391|920526|P1|STARTED|Overall Study||164
385070|NCT01028378|920534|P1|NOT COMPLETED|Overall Study||17
385071|NCT01028378|920534|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
385072|NCT01028378|920534|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
385073|NCT01028352|920546|P1|NOT COMPLETED|Overall Study||6
385074|NCT01028352|920546|P1|COMPLETED|Overall Study||29
385075|NCT01028352|920546|P1|STARTED|Overall Study||35
385076|NCT01028300|920551|P1|NOT COMPLETED|Overall Study||4
385077|NCT01028300|920551|P1|COMPLETED|Overall Study||0
385078|NCT01028300|920551|P1|STARTED|Overall Study||4
385079|NCT01028222|920560|P2|NOT COMPLETED|Overall Study||13
385080|NCT01028222|920561|P1|NOT COMPLETED|Overall Study||38
385081|NCT01028222|920560|P2|COMPLETED|Overall Study||0
385082|NCT01028222|920561|P1|COMPLETED|Overall Study||4
385083|NCT01028222|920560|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
385084|NCT01028222|920561|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
385085|NCT01028222|920560|P2|STARTED|Overall Study||13
385086|NCT01028222|920561|P1|STARTED|Overall Study||42
385087|NCT01027910|920584|P2|NOT COMPLETED|Overall Study||0
385088|NCT01027910|920585|P1|NOT COMPLETED|Overall Study||0
385089|NCT01027910|920584|P2|COMPLETED|Overall Study||14
385090|NCT01027910|920585|P1|COMPLETED|Overall Study||6
385091|NCT01027910|920584|P2|STARTED|Overall Study||14
385092|NCT01027910|920585|P1|STARTED|Overall Study||6
385093|NCT01027897|920597|P1|NOT COMPLETED|Overall Study||2
385094|NCT01027897|920597|P1|COMPLETED|Overall Study||28
385095|NCT01027897|920597|P1|STARTED|Overall Study||30
385096|NCT01027884|920605|P2|NOT COMPLETED|Overall Study||7
385097|NCT01027884|920606|P1|NOT COMPLETED|Overall Study||4
385098|NCT01027884|920605|P2|COMPLETED|Overall Study||25
385099|NCT01027884|920606|P1|COMPLETED|Overall Study||30
385100|NCT01027884|920605|P2|STARTED|Overall Study||32
385101|NCT01027884|920606|P1|STARTED|Overall Study||34
385102|NCT01027819|920622|P2|NOT COMPLETED|Overall Study||0
385103|NCT01027819|920623|P1|NOT COMPLETED|Overall Study||0
385104|NCT01027819|920622|P2|COMPLETED|Overall Study||40
385105|NCT01027819|920623|P1|COMPLETED|Overall Study||40
385106|NCT01027819|920622|P2|STARTED|Overall Study||40
385107|NCT01027819|920623|P1|STARTED|Overall Study||40
385108|NCT01027780|920631|P2|NOT COMPLETED|Overall Study||1
385109|NCT01027780|920632|P1|NOT COMPLETED|Overall Study||0
385110|NCT01027780|920631|P2|COMPLETED|Overall Study||102
385111|NCT01027780|920632|P1|COMPLETED|Overall Study||105
385112|NCT01027780|920631|P2|STARTED|Overall Study||103
385113|NCT01027780|920632|P1|STARTED|Overall Study||105
385114|NCT01027650|920650|P8|NOT COMPLETED|Overall Study||0
385115|NCT01027650|920651|P7|NOT COMPLETED|Overall Study||1
385116|NCT01027650|920652|P6|NOT COMPLETED|Overall Study||2
385117|NCT01027650|920653|P5|NOT COMPLETED|Overall Study||2
385118|NCT01027650|920654|P4|NOT COMPLETED|Overall Study||0
385119|NCT01027650|920655|P3|NOT COMPLETED|Overall Study||0
385120|NCT01027650|920656|P2|NOT COMPLETED|Overall Study||0
385121|NCT01027650|920657|P1|NOT COMPLETED|Overall Study||0
385122|NCT01027650|920650|P8|COMPLETED|Overall Study||24
385123|NCT01027650|920651|P7|COMPLETED|Overall Study||24
385124|NCT01027650|920652|P6|COMPLETED|Overall Study||24
385125|NCT01027650|920653|P5|COMPLETED|Overall Study||23
385126|NCT01027650|920654|P4|COMPLETED|Overall Study||3
385127|NCT01027650|920655|P3|COMPLETED|Overall Study||6
385128|NCT01027650|920656|P2|COMPLETED|Overall Study||6
385129|NCT01027650|920657|P1|COMPLETED|Overall Study||6
385130|NCT01027650|920650|P8|STARTED|Overall Study||24
385131|NCT01027650|920651|P7|STARTED|Overall Study||25
385132|NCT01027650|920652|P6|STARTED|Overall Study||26
385133|NCT01027650|920653|P5|STARTED|Overall Study||25
385134|NCT01027650|920654|P4|STARTED|Overall Study||3
385135|NCT01027650|920655|P3|STARTED|Overall Study||6
385136|NCT01027650|920656|P2|STARTED|Overall Study||6
385137|NCT01027650|920657|P1|STARTED|Overall Study||6
385138|NCT01027598|920701|P2|NOT COMPLETED|Overall Study||67
385139|NCT01027598|920702|P1|NOT COMPLETED|Overall Study||134
385140|NCT01027598|920701|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
385141|NCT01027598|920702|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
385142|NCT01027598|920701|P2|STARTED|Overall Study||67
385143|NCT01027598|920702|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
385144|NCT01027468|920712|P1|NOT COMPLETED|Overall Study||0
385145|NCT01027468|920712|P1|COMPLETED|Overall Study||160
385146|NCT01027468|920712|P1|STARTED|Overall Study||160
385147|NCT01027364|920720|P4|NOT COMPLETED|Overall Study||1
385148|NCT01027364|920721|P3|NOT COMPLETED|Overall Study||1
385149|NCT01027364|920722|P2|NOT COMPLETED|Overall Study||2
385150|NCT01027364|920723|P1|NOT COMPLETED|Overall Study||4
385151|NCT01027364|920720|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
385152|NCT01027364|920721|P3|COMPLETED|Overall Study||26
385153|NCT01027364|920722|P2|COMPLETED|Overall Study||27
385154|NCT01027364|920723|P1|COMPLETED|Overall Study||59
385155|NCT01027364|920720|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
385156|NCT01027364|920721|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
385157|NCT01027364|920722|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
385158|NCT01027364|920723|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
385159|NCT01027364|920720|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
385160|NCT01027364|920721|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
385161|NCT01027364|920722|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
385162|NCT01027364|920723|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
385163|NCT01027364|920720|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
385164|NCT01027364|920721|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
385165|NCT01027364|920722|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
385166|NCT01027364|920723|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
385167|NCT01027364|920720|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
385168|NCT01027364|920721|P3|STARTED|Overall Study||27
385169|NCT01027364|920722|P2|STARTED|Overall Study||29
385170|NCT01027364|920723|P1|STARTED|Overall Study||63
385171|NCT01027351|920818|P6|NOT COMPLETED|Overall Study||5
385172|NCT01027351|920819|P5|NOT COMPLETED|Overall Study||11
385173|NCT01027351|920820|P4|NOT COMPLETED|Overall Study||2
385174|NCT01027351|920821|P3|NOT COMPLETED|Overall Study||1
385175|NCT01027351|920822|P2|NOT COMPLETED|Overall Study||1
385176|NCT01027351|920823|P1|NOT COMPLETED|Overall Study||3
385177|NCT01027351|920818|P6|COMPLETED|Overall Study||45
385178|NCT01027351|920819|P5|COMPLETED|Overall Study||32
385179|NCT01027351|920820|P4|COMPLETED|Overall Study||6
385180|NCT01027351|920821|P3|COMPLETED|Overall Study||13
385181|NCT01027351|920822|P2|COMPLETED|Overall Study||18
385182|NCT01027351|920823|P1|COMPLETED|Overall Study||26
385183|NCT01027351|920818|P6|STARTED|Overall Study||50
385184|NCT01027351|920819|P5|STARTED|Overall Study||43
385185|NCT01027351|920820|P4|STARTED|Overall Study||8
385186|NCT01027351|920821|P3|STARTED|Overall Study||14
385187|NCT01027351|920822|P2|STARTED|Overall Study||19
385188|NCT01027351|920823|P1|STARTED|Overall Study||29
385189|NCT01027286|920907|P2|NOT COMPLETED|Overall Study||1
385190|NCT01027286|920908|P1|NOT COMPLETED|Overall Study||1
385191|NCT01027286|920907|P2|COMPLETED|Overall Study||49
385192|NCT01027286|920908|P1|COMPLETED|Overall Study||49
385193|NCT01027286|920907|P2|12 Week Postoperative|Overall Study||49
385194|NCT01027286|920908|P1|12 Week Postoperative|Overall Study||49
385195|NCT01027286|920907|P2|4 Week Postoperative|Overall Study||50
385196|NCT01027286|920908|P1|4 Week Postoperative|Overall Study||49
385197|NCT01027286|920907|P2|Day of Surgery|Overall Study||50
385198|NCT01027286|920908|P1|Day of Surgery|Overall Study||50
385199|NCT01027286|920907|P2|Preoperative|Overall Study||50
385200|NCT01027286|920908|P1|Preoperative|Overall Study||50
385201|NCT01027286|920907|P2|STARTED|Overall Study||50
385202|NCT01027286|920908|P1|STARTED|Overall Study||50
385203|NCT01027273|920928|P2|NOT COMPLETED|Overall Study||33
385204|NCT01027273|920929|P1|NOT COMPLETED|Overall Study||59
385205|NCT01027273|920928|P2|COMPLETED|Overall Study||266
385206|NCT01027273|920929|P1|COMPLETED|Overall Study||242
385207|NCT01027273|920928|P2|STARTED|Overall Study||299
385208|NCT01027273|920929|P1|STARTED|Overall Study||301
385209|NCT01027195|920947|P2|NOT COMPLETED|Overall Study||0
385210|NCT01027195|920948|P1|NOT COMPLETED|Overall Study||0
385211|NCT01027195|920947|P2|COMPLETED|Overall Study||69
385212|NCT01027195|920948|P1|COMPLETED|Overall Study||71
385213|NCT01027195|920947|P2|STARTED|Overall Study||69
385214|NCT01027195|920948|P1|STARTED|Overall Study||71
385215|NCT01027000|920968|P1|NOT COMPLETED|Overall Study||0
385216|NCT01027000|920968|P1|COMPLETED|Overall Study||68
385217|NCT01027000|920968|P1|STARTED|Overall Study||68
385218|NCT01026974|920976|P4|NOT COMPLETED|Overall Study||3
385219|NCT01026974|920977|P3|NOT COMPLETED|Overall Study||12
385220|NCT01026974|920978|P2|NOT COMPLETED|Overall Study||2
385221|NCT01026974|920979|P1|NOT COMPLETED|Overall Study||1
385222|NCT01026974|920976|P4|COMPLETED|Overall Study||46
385223|NCT01026974|920977|P3|COMPLETED|Overall Study||29
385224|NCT01026974|920978|P2|COMPLETED|Overall Study||12
385225|NCT01026974|920979|P1|COMPLETED|Overall Study||15
385226|NCT01026974|920976|P4|STARTED|Overall Study||49
385227|NCT01026974|920977|P3|STARTED|Overall Study||41
385228|NCT01026974|920978|P2|STARTED|Overall Study||14
385229|NCT01026974|920979|P1|STARTED|Overall Study||16
385230|NCT01026948|921036|P1|NOT COMPLETED|Overall Study||8
385231|NCT01026948|921036|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
385232|NCT01026948|921036|P1|STARTED|Overall Study||70
385233|NCT01026909|921043|P2|NOT COMPLETED|Overall Study||0
385234|NCT01026909|921044|P1|NOT COMPLETED|Overall Study||0
385235|NCT01026909|921043|P2|COMPLETED|Overall Study||2
385236|NCT01026909|921044|P1|COMPLETED|Overall Study||1
385237|NCT01026909|921043|P2|STARTED|Overall Study||2
385238|NCT01026909|921044|P1|STARTED|Overall Study||1
385239|NCT01026844|921054|P2|NOT COMPLETED|Overall Study||0
385240|NCT01026844|921055|P1|NOT COMPLETED|Overall Study||0
385241|NCT01026844|921054|P2|COMPLETED|Overall Study||8
385242|NCT01026844|921055|P1|COMPLETED|Overall Study||19
385243|NCT01026844|921054|P2|STARTED|Overall Study||8
385244|NCT01026844|921055|P1|STARTED|Overall Study||19
385245|NCT01026831|921069|P2|NOT COMPLETED|Overall Study||11
385246|NCT01026831|921070|P1|NOT COMPLETED|Overall Study||14
385247|NCT01026831|921069|P2|COMPLETED|Overall Study||312
385248|NCT01026831|921070|P1|COMPLETED|Overall Study||306
385249|NCT01026831|921069|P2|STARTED|Overall Study|randomized|323
385250|NCT01026831|921070|P1|STARTED|Overall Study|randomized|320
385251|NCT01026818|921081|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
385252|NCT01026818|921082|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
385253|NCT01026818|921083|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
385254|NCT01026818|921084|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
385255|NCT01026818|921081|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
385256|NCT01026818|921082|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
385257|NCT01026818|921083|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
385258|NCT01026818|921084|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
385259|NCT01026818|921081|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
385260|NCT01026818|921082|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
385261|NCT01026818|921083|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
385262|NCT01026818|921084|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
385263|NCT01026818|921081|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
385264|NCT01026818|921082|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
385265|NCT01026818|921083|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
385266|NCT01026818|921084|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
385267|NCT01026818|921081|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
385268|NCT01026818|921082|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
385269|NCT01026818|921083|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
385270|NCT01026818|921084|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
385271|NCT01026818|921081|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
385272|NCT01026818|921082|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
385273|NCT01026818|921083|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
385274|NCT01026818|921084|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
385275|NCT01026818|921081|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
385276|NCT01026818|921082|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
385277|NCT01026818|921083|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
385278|NCT01026818|921084|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
385279|NCT01026818|921081|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
385280|NCT01026818|921082|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
385281|NCT01026818|921083|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
385282|NCT01026818|921084|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
385283|NCT01026818|921081|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
385284|NCT01026818|921082|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
385285|NCT01026818|921083|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
385286|NCT01026818|921084|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
385287|NCT01026818|921081|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
385288|NCT01026818|921082|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
385289|NCT01026818|921083|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
385290|NCT01026818|921084|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
385291|NCT01026818|921081|P4|NOT COMPLETED|Screening Period||0
385292|NCT01026818|921082|P3|NOT COMPLETED|Screening Period||0
385293|NCT01026818|921083|P2|NOT COMPLETED|Screening Period||0
385294|NCT01026818|921084|P1|NOT COMPLETED|Screening Period||160
385295|NCT01026818|921081|P4|COMPLETED|Screening Period||0
385296|NCT01026818|921082|P3|COMPLETED|Screening Period||0
385297|NCT01026818|921083|P2|COMPLETED|Screening Period||0
385298|NCT01026818|921084|P1|COMPLETED|Screening Period||423
385299|NCT01026818|921081|P4|STARTED|Screening Period||0
385300|NCT01026818|921082|P3|STARTED|Screening Period||0
385301|NCT01026818|921083|P2|STARTED|Screening Period||0
385302|NCT01026818|921084|P1|STARTED|Screening Period||583
385303|NCT01026805|921162|P1|NOT COMPLETED|Overall Study||0
385304|NCT01026805|921162|P1|COMPLETED|Overall Study||11
385305|NCT01026805|921162|P1|STARTED|Overall Study||11
385306|NCT01026792|921172|P1|NOT COMPLETED|Overall Study||1
385307|NCT01026792|921172|P1|COMPLETED|Overall Study||37
385308|NCT01026792|921172|P1|STARTED|Overall Study||38
385309|NCT01026454|921178|P2|NOT COMPLETED|Second Intervention||1
385310|NCT01026454|921179|P1|NOT COMPLETED|Second Intervention||1
385311|NCT01026454|921178|P2|COMPLETED|Second Intervention||13
385312|NCT01026454|921179|P1|COMPLETED|Second Intervention||16
385313|NCT01026454|921178|P2|STARTED|Second Intervention||14
385314|NCT01026454|921179|P1|STARTED|Second Intervention||17
385315|NCT01026454|921178|P2|NOT COMPLETED|Washout||0
385316|NCT01026454|921179|P1|NOT COMPLETED|Washout||0
385317|NCT01026454|921178|P2|COMPLETED|Washout||14
385318|NCT01026454|921179|P1|COMPLETED|Washout||18
385319|NCT01026454|921178|P2|STARTED|Washout||14
385320|NCT01026454|921179|P1|STARTED|Washout||18
385321|NCT01026454|921178|P2|NOT COMPLETED|First Intervention||0
385322|NCT01026454|921179|P1|NOT COMPLETED|First Intervention||0
385323|NCT01026454|921178|P2|COMPLETED|First Intervention||14
385324|NCT01026454|921179|P1|COMPLETED|First Intervention||18
385325|NCT01026454|921178|P2|STARTED|First Intervention||14
385326|NCT01026454|921179|P1|STARTED|First Intervention||18
385327|NCT01026402|921202|P17|NOT COMPLETED|Overall Study||0
385328|NCT01026402|921203|P16|NOT COMPLETED|Overall Study||0
385329|NCT01026402|921204|P15|NOT COMPLETED|Overall Study||0
385330|NCT01026402|921205|P14|NOT COMPLETED|Overall Study||0
385331|NCT01026402|921206|P13|NOT COMPLETED|Overall Study||0
385332|NCT01026402|921207|P12|NOT COMPLETED|Overall Study||0
385333|NCT01026402|921208|P11|NOT COMPLETED|Overall Study||0
385334|NCT01026402|921209|P10|NOT COMPLETED|Overall Study||0
385335|NCT01026402|921210|P9|NOT COMPLETED|Overall Study||0
385336|NCT01026402|921211|P8|NOT COMPLETED|Overall Study||0
385337|NCT01026402|921212|P7|NOT COMPLETED|Overall Study||0
385338|NCT01026402|921213|P6|NOT COMPLETED|Overall Study||0
385339|NCT01026402|921214|P5|NOT COMPLETED|Overall Study||0
385340|NCT01026402|921215|P4|NOT COMPLETED|Overall Study||0
385341|NCT01026402|921216|P3|NOT COMPLETED|Overall Study||0
385342|NCT01026402|921217|P2|NOT COMPLETED|Overall Study||0
385343|NCT01026402|921218|P1|NOT COMPLETED|Overall Study||0
385344|NCT01026402|921202|P17|COMPLETED|Overall Study||4
385345|NCT01026402|921203|P16|COMPLETED|Overall Study||5
385346|NCT01026402|921204|P15|COMPLETED|Overall Study||3
385347|NCT01026402|921205|P14|COMPLETED|Overall Study||6
385348|NCT01026402|921206|P13|COMPLETED|Overall Study||8
385349|NCT01026402|921207|P12|COMPLETED|Overall Study||8
385350|NCT01026402|921208|P11|COMPLETED|Overall Study||7
385351|NCT01026402|921209|P10|COMPLETED|Overall Study||3
385352|NCT01026402|921210|P9|COMPLETED|Overall Study||7
385353|NCT01026402|921211|P8|COMPLETED|Overall Study||3
385354|NCT01026402|921212|P7|COMPLETED|Overall Study||8
385355|NCT01026402|921213|P6|COMPLETED|Overall Study||5
385356|NCT01026402|921214|P5|COMPLETED|Overall Study||3
385357|NCT01026402|921215|P4|COMPLETED|Overall Study||18
385358|NCT01026402|921216|P3|COMPLETED|Overall Study||33
385359|NCT01026402|921217|P2|COMPLETED|Overall Study||8
385360|NCT01026402|921218|P1|COMPLETED|Overall Study||6
385361|NCT01026402|921202|P17|STARTED|Overall Study||4
385362|NCT01026402|921203|P16|STARTED|Overall Study||5
385363|NCT01026402|921204|P15|STARTED|Overall Study||3
385364|NCT01026402|921205|P14|STARTED|Overall Study||6
385365|NCT01026402|921206|P13|STARTED|Overall Study||8
385366|NCT01026402|921207|P12|STARTED|Overall Study||8
385367|NCT01026402|921208|P11|STARTED|Overall Study||7
385368|NCT01026402|921209|P10|STARTED|Overall Study||3
385369|NCT01026402|921210|P9|STARTED|Overall Study||7
385370|NCT01026402|921211|P8|STARTED|Overall Study||3
385371|NCT01026402|921212|P7|STARTED|Overall Study||8
385372|NCT01026402|921213|P6|STARTED|Overall Study||5
385373|NCT01026402|921214|P5|STARTED|Overall Study||3
385374|NCT01026402|921215|P4|STARTED|Overall Study||18
385375|NCT01026402|921216|P3|STARTED|Overall Study||33
385376|NCT01026402|921217|P2|STARTED|Overall Study||8
385377|NCT01026402|921218|P1|STARTED|Overall Study||6
385378|NCT01026389|921528|P2|NOT COMPLETED|Overall Study||5
385379|NCT01026389|921529|P1|NOT COMPLETED|Overall Study||5
385380|NCT01026389|921528|P2|COMPLETED|Overall Study||88
385381|NCT01026389|921529|P1|COMPLETED|Overall Study||88
385382|NCT01026389|921528|P2|STARTED|Overall Study||93
385383|NCT01026389|921529|P1|STARTED|Overall Study||93
385384|NCT01026324|921544|P3|NOT COMPLETED|Follow up/Survival||0
385385|NCT01026324|921545|P2|NOT COMPLETED|Follow up/Survival||0
385386|NCT01026324|921546|P1|NOT COMPLETED|Follow up/Survival||1
385387|NCT01026324|921544|P3|COMPLETED|Follow up/Survival||4
385388|NCT01026324|921545|P2|COMPLETED|Follow up/Survival||3
385389|NCT01026324|921546|P1|COMPLETED|Follow up/Survival||4
385390|NCT01026324|921544|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
385391|NCT01026324|921545|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
385392|NCT01026324|921546|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
385393|NCT01026324|921544|P3|STARTED|Follow up/Survival||4
385394|NCT01026324|921545|P2|STARTED|Follow up/Survival||3
385395|NCT01026324|921546|P1|STARTED|Follow up/Survival||5
385396|NCT01026324|921544|P3|NOT COMPLETED|Treatment Allocation||0
385397|NCT01026324|921545|P2|NOT COMPLETED|Treatment Allocation||0
385398|NCT01026324|921546|P1|NOT COMPLETED|Treatment Allocation||0
385399|NCT01026324|921544|P3|COMPLETED|Treatment Allocation||4
385400|NCT01026324|921545|P2|COMPLETED|Treatment Allocation||3
385401|NCT01026324|921546|P1|COMPLETED|Treatment Allocation||5
385402|NCT01026324|921544|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
385403|NCT01026324|921545|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
385404|NCT01026324|921546|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
385405|NCT01026324|921544|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
385406|NCT01026324|921545|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
385407|NCT01026324|921546|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
385408|NCT01026324|921544|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
385409|NCT01026324|921545|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
385410|NCT01026324|921546|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
385411|NCT01026324|921544|P3|STARTED|Treatment Allocation||4
385412|NCT01026324|921545|P2|STARTED|Treatment Allocation||3
385413|NCT01026324|921546|P1|STARTED|Treatment Allocation||5
385414|NCT01026220|921556|P3|NOT COMPLETED|Consolidation Maintenance||14
385415|NCT01026220|921557|P2|NOT COMPLETED|Consolidation Maintenance||6
385416|NCT01026220|921558|P1|NOT COMPLETED|Consolidation Maintenance||0
385417|NCT01026220|921556|P3|COMPLETED|Consolidation Maintenance||66
385418|NCT01026220|921557|P2|COMPLETED|Consolidation Maintenance||75
385419|NCT01026220|921558|P1|COMPLETED|Consolidation Maintenance||0
385420|NCT01026220|921556|P3|STARTED|Consolidation Maintenance||80
385421|NCT01026220|921557|P2|STARTED|Consolidation Maintenance||81
385422|NCT01026220|921558|P1|STARTED|Consolidation Maintenance||0
385423|NCT01026220|921556|P3|NOT COMPLETED|Induction||0
385424|NCT01026220|921557|P2|NOT COMPLETED|Induction||0
385425|NCT01026220|921558|P1|NOT COMPLETED|Induction||25
385426|NCT01026220|921556|P3|COMPLETED|Induction||0
385427|NCT01026220|921557|P2|COMPLETED|Induction||0
385428|NCT01026220|921558|P1|COMPLETED|Induction||141
385429|NCT01026220|921556|P3|STARTED|Induction||0
385430|NCT01026220|921557|P2|STARTED|Induction||0
385431|NCT01026220|921558|P1|STARTED|Induction||166
385432|NCT01026194|921582|P2|NOT COMPLETED|Period 2：Open-label Period||10
385433|NCT01026194|921583|P1|NOT COMPLETED|Period 2：Open-label Period||7
385434|NCT01026194|921582|P2|COMPLETED|Period 2：Open-label Period||88
385435|NCT01026194|921583|P1|COMPLETED|Period 2：Open-label Period||91
385436|NCT01026194|921582|P2|STARTED|Period 2：Open-label Period||98
385437|NCT01026194|921583|P1|STARTED|Period 2：Open-label Period||98
385438|NCT01026194|921582|P2|NOT COMPLETED|Period 1：Double Blind Period||5
385439|NCT01026194|921583|P1|NOT COMPLETED|Period 1：Double Blind Period||3
385440|NCT01026194|921582|P2|COMPLETED|Period 1：Double Blind Period||98
385441|NCT01026194|921583|P1|COMPLETED|Period 1：Double Blind Period||98
385442|NCT01026194|921582|P2|STARTED|Period 1：Double Blind Period||103
385443|NCT01026194|921583|P1|STARTED|Period 1：Double Blind Period||101
385444|NCT01026142|921599|P2|NOT COMPLETED|Overall Study||121
385445|NCT01026142|921600|P1|NOT COMPLETED|Overall Study||139
385446|NCT01026142|921599|P2|COMPLETED|Overall Study||107
385447|NCT01026142|921600|P1|COMPLETED|Overall Study||79
385448|NCT01026142|921599|P2|STARTED|Overall Study||228
385449|NCT01026142|921600|P1|STARTED|Overall Study||218
385450|NCT01026103|921622|P1|NOT COMPLETED|Overall Study||2
385451|NCT01026103|921622|P1|COMPLETED|Overall Study||28
385452|NCT01026103|921622|P1|Consented|Overall Study||30
385453|NCT01026103|921622|P1|STARTED|Overall Study||30
385454|NCT01026038|921632|P3|NOT COMPLETED|Overall Study||0
385455|NCT01026038|921633|P2|NOT COMPLETED|Overall Study||1
385456|NCT01026038|921634|P1|NOT COMPLETED|Overall Study||1
385457|NCT01026038|921632|P3|COMPLETED|Overall Study||67
385458|NCT01026038|921633|P2|COMPLETED|Overall Study||64
385459|NCT01026038|921634|P1|COMPLETED|Overall Study||129
385460|NCT01026038|921632|P3|STARTED|Overall Study||67
385461|NCT01026038|921633|P2|STARTED|Overall Study||65
385462|NCT01026038|921634|P1|STARTED|Overall Study||130
385463|NCT01026012|921669|P1|NOT COMPLETED|Overall Study||0
385464|NCT01026012|921669|P1|COMPLETED|Overall Study||40
385465|NCT01026012|921669|P1|STARTED|Overall Study||40
385466|NCT01025843|921683|P10|NOT COMPLETED|Period 5||0
385467|NCT01025843|921684|P9|NOT COMPLETED|Period 5||0
385468|NCT01025843|921685|P8|NOT COMPLETED|Period 5||0
385469|NCT01025843|921686|P7|NOT COMPLETED|Period 5||0
385470|NCT01025843|921687|P6|NOT COMPLETED|Period 5||0
385471|NCT01025843|921688|P5|NOT COMPLETED|Period 5||0
385472|NCT01025843|921689|P4|NOT COMPLETED|Period 5||0
385473|NCT01025843|921690|P3|NOT COMPLETED|Period 5||0
385474|NCT01025843|921691|P2|NOT COMPLETED|Period 5||0
385475|NCT01025843|921692|P1|NOT COMPLETED|Period 5||0
385476|NCT01025843|921683|P10|COMPLETED|Period 5||2
385477|NCT01025843|921684|P9|COMPLETED|Period 5||2
385478|NCT01025843|921685|P8|COMPLETED|Period 5||2
385479|NCT01025843|921686|P7|COMPLETED|Period 5||2
385480|NCT01025843|921687|P6|COMPLETED|Period 5||2
385481|NCT01025843|921688|P5|COMPLETED|Period 5||2
385482|NCT01025843|921689|P4|COMPLETED|Period 5||1
385483|NCT01025843|921690|P3|COMPLETED|Period 5||1
385484|NCT01025843|921691|P2|COMPLETED|Period 5||2
385485|NCT01025843|921692|P1|COMPLETED|Period 5||2
385486|NCT01025843|921683|P10|STARTED|Period 5||2
385487|NCT01025843|921684|P9|STARTED|Period 5||2
385488|NCT01025843|921685|P8|STARTED|Period 5||2
385489|NCT01025843|921686|P7|STARTED|Period 5||2
385490|NCT01025843|921687|P6|STARTED|Period 5||2
385491|NCT01025843|921688|P5|STARTED|Period 5||2
385492|NCT01025843|921689|P4|STARTED|Period 5||1
385493|NCT01025843|921690|P3|STARTED|Period 5||1
385494|NCT01025843|921691|P2|STARTED|Period 5||2
385495|NCT01025843|921692|P1|STARTED|Period 5||2
385496|NCT01025843|921683|P10|NOT COMPLETED|Washout 4||0
385497|NCT01025843|921684|P9|NOT COMPLETED|Washout 4||0
385498|NCT01025843|921685|P8|NOT COMPLETED|Washout 4||0
385499|NCT01025843|921686|P7|NOT COMPLETED|Washout 4||0
385500|NCT01025843|921687|P6|NOT COMPLETED|Washout 4||0
385501|NCT01025843|921688|P5|NOT COMPLETED|Washout 4||0
385502|NCT01025843|921689|P4|NOT COMPLETED|Washout 4||1
385503|NCT01025843|921690|P3|NOT COMPLETED|Washout 4||1
385504|NCT01025843|921691|P2|NOT COMPLETED|Washout 4||0
385505|NCT01025843|921692|P1|NOT COMPLETED|Washout 4||0
385506|NCT01025843|921683|P10|COMPLETED|Washout 4||2
385507|NCT01025843|921684|P9|COMPLETED|Washout 4||2
385508|NCT01025843|921685|P8|COMPLETED|Washout 4||2
385509|NCT01025843|921686|P7|COMPLETED|Washout 4||2
385510|NCT01025843|921687|P6|COMPLETED|Washout 4||2
385511|NCT01025843|921688|P5|COMPLETED|Washout 4||2
385512|NCT01025843|921689|P4|COMPLETED|Washout 4||1
385513|NCT01025843|921690|P3|COMPLETED|Washout 4||1
385514|NCT01025843|921691|P2|COMPLETED|Washout 4||2
385515|NCT01025843|921692|P1|COMPLETED|Washout 4||2
385516|NCT01025843|921683|P10|STARTED|Washout 4||2
385517|NCT01025843|921684|P9|STARTED|Washout 4||2
385518|NCT01025843|921685|P8|STARTED|Washout 4||2
385519|NCT01025843|921686|P7|STARTED|Washout 4||2
385520|NCT01025843|921687|P6|STARTED|Washout 4||2
385521|NCT01025843|921688|P5|STARTED|Washout 4||2
385522|NCT01025843|921689|P4|STARTED|Washout 4||2
385523|NCT01025843|921690|P3|STARTED|Washout 4||2
385524|NCT01025843|921691|P2|STARTED|Washout 4||2
385525|NCT01025843|921692|P1|STARTED|Washout 4||2
385526|NCT01025843|921683|P10|NOT COMPLETED|Period 4||0
385527|NCT01025843|921684|P9|NOT COMPLETED|Period 4||0
385528|NCT01025843|921685|P8|NOT COMPLETED|Period 4||0
385529|NCT01025843|921686|P7|NOT COMPLETED|Period 4||0
385530|NCT01025843|921687|P6|NOT COMPLETED|Period 4||0
385531|NCT01025843|921688|P5|NOT COMPLETED|Period 4||0
385532|NCT01025843|921689|P4|NOT COMPLETED|Period 4||0
385533|NCT01025843|921690|P3|NOT COMPLETED|Period 4||0
385534|NCT01025843|921691|P2|NOT COMPLETED|Period 4||0
385535|NCT01025843|921692|P1|NOT COMPLETED|Period 4||0
385536|NCT01025843|921683|P10|COMPLETED|Period 4||2
385537|NCT01025843|921684|P9|COMPLETED|Period 4||2
385538|NCT01025843|921685|P8|COMPLETED|Period 4||2
385539|NCT01025843|921686|P7|COMPLETED|Period 4||2
385540|NCT01025843|921687|P6|COMPLETED|Period 4||2
385541|NCT01025843|921688|P5|COMPLETED|Period 4||2
385542|NCT01025843|921689|P4|COMPLETED|Period 4||2
385543|NCT01025843|921690|P3|COMPLETED|Period 4||2
385544|NCT01025843|921691|P2|COMPLETED|Period 4||2
385545|NCT01025843|921692|P1|COMPLETED|Period 4||2
385546|NCT01025843|921683|P10|STARTED|Period 4||2
385547|NCT01025843|921684|P9|STARTED|Period 4||2
385548|NCT01025843|921685|P8|STARTED|Period 4||2
385549|NCT01025843|921686|P7|STARTED|Period 4||2
385550|NCT01025843|921687|P6|STARTED|Period 4||2
385551|NCT01025843|921688|P5|STARTED|Period 4||2
385552|NCT01025843|921689|P4|STARTED|Period 4||2
385553|NCT01025843|921690|P3|STARTED|Period 4||2
385554|NCT01025843|921691|P2|STARTED|Period 4||2
385555|NCT01025843|921692|P1|STARTED|Period 4||2
385556|NCT01025843|921683|P10|NOT COMPLETED|Washout 3||0
385557|NCT01025843|921684|P9|NOT COMPLETED|Washout 3||0
385558|NCT01025843|921685|P8|NOT COMPLETED|Washout 3||0
385559|NCT01025843|921686|P7|NOT COMPLETED|Washout 3||0
385560|NCT01025843|921687|P6|NOT COMPLETED|Washout 3||0
385561|NCT01025843|921688|P5|NOT COMPLETED|Washout 3||0
385562|NCT01025843|921689|P4|NOT COMPLETED|Washout 3||0
385563|NCT01025843|921690|P3|NOT COMPLETED|Washout 3||0
385564|NCT01025843|921691|P2|NOT COMPLETED|Washout 3||0
385565|NCT01025843|921692|P1|NOT COMPLETED|Washout 3||0
385566|NCT01025843|921683|P10|COMPLETED|Washout 3||2
385567|NCT01025843|921684|P9|COMPLETED|Washout 3||2
385568|NCT01025843|921685|P8|COMPLETED|Washout 3||2
385569|NCT01025843|921686|P7|COMPLETED|Washout 3||2
385570|NCT01025843|921687|P6|COMPLETED|Washout 3||2
385571|NCT01025843|921688|P5|COMPLETED|Washout 3||2
385572|NCT01025843|921689|P4|COMPLETED|Washout 3||2
385573|NCT01025843|921690|P3|COMPLETED|Washout 3||2
385574|NCT01025843|921691|P2|COMPLETED|Washout 3||2
385575|NCT01025843|921692|P1|COMPLETED|Washout 3||2
385576|NCT01025843|921683|P10|STARTED|Washout 3||2
385577|NCT01025843|921684|P9|STARTED|Washout 3||2
385578|NCT01025843|921685|P8|STARTED|Washout 3||2
385579|NCT01025843|921686|P7|STARTED|Washout 3||2
385580|NCT01025843|921687|P6|STARTED|Washout 3||2
385581|NCT01025843|921688|P5|STARTED|Washout 3||2
385582|NCT01025843|921689|P4|STARTED|Washout 3||2
385583|NCT01025843|921690|P3|STARTED|Washout 3||2
385584|NCT01025843|921691|P2|STARTED|Washout 3||2
385585|NCT01025843|921692|P1|STARTED|Washout 3||2
385586|NCT01025843|921683|P10|NOT COMPLETED|Period 3||0
385587|NCT01025843|921684|P9|NOT COMPLETED|Period 3||0
385588|NCT01025843|921685|P8|NOT COMPLETED|Period 3||0
385589|NCT01025843|921686|P7|NOT COMPLETED|Period 3||0
385590|NCT01025843|921687|P6|NOT COMPLETED|Period 3||0
385591|NCT01025843|921688|P5|NOT COMPLETED|Period 3||0
385592|NCT01025843|921689|P4|NOT COMPLETED|Period 3||0
385593|NCT01025843|921690|P3|NOT COMPLETED|Period 3||0
385594|NCT01025843|921691|P2|NOT COMPLETED|Period 3||0
385595|NCT01025843|921692|P1|NOT COMPLETED|Period 3||0
385596|NCT01025843|921683|P10|COMPLETED|Period 3||2
385597|NCT01025843|921684|P9|COMPLETED|Period 3||2
385598|NCT01025843|921685|P8|COMPLETED|Period 3||2
385599|NCT01025843|921686|P7|COMPLETED|Period 3||2
385600|NCT01025843|921687|P6|COMPLETED|Period 3||2
385601|NCT01025843|921688|P5|COMPLETED|Period 3||2
385602|NCT01025843|921689|P4|COMPLETED|Period 3||2
385603|NCT01025843|921690|P3|COMPLETED|Period 3||2
385604|NCT01025843|921691|P2|COMPLETED|Period 3||2
385605|NCT01025843|921692|P1|COMPLETED|Period 3||2
385606|NCT01025843|921683|P10|STARTED|Period 3||2
385607|NCT01025843|921684|P9|STARTED|Period 3||2
385608|NCT01025843|921685|P8|STARTED|Period 3||2
385609|NCT01025843|921686|P7|STARTED|Period 3||2
385610|NCT01025843|921687|P6|STARTED|Period 3||2
385611|NCT01025843|921688|P5|STARTED|Period 3||2
385612|NCT01025843|921689|P4|STARTED|Period 3||2
385613|NCT01025843|921690|P3|STARTED|Period 3||2
385614|NCT01025843|921691|P2|STARTED|Period 3||2
385615|NCT01025843|921692|P1|STARTED|Period 3||2
385616|NCT01025843|921683|P10|NOT COMPLETED|Washout 2||0
385617|NCT01025843|921684|P9|NOT COMPLETED|Washout 2||0
385618|NCT01025843|921685|P8|NOT COMPLETED|Washout 2||0
385619|NCT01025843|921686|P7|NOT COMPLETED|Washout 2||0
385620|NCT01025843|921687|P6|NOT COMPLETED|Washout 2||0
385621|NCT01025843|921688|P5|NOT COMPLETED|Washout 2||0
385622|NCT01025843|921689|P4|NOT COMPLETED|Washout 2||0
385623|NCT01025843|921690|P3|NOT COMPLETED|Washout 2||0
385624|NCT01025843|921691|P2|NOT COMPLETED|Washout 2||0
385625|NCT01025843|921692|P1|NOT COMPLETED|Washout 2||0
385626|NCT01025843|921683|P10|COMPLETED|Washout 2||2
385627|NCT01025843|921684|P9|COMPLETED|Washout 2||2
385628|NCT01025843|921685|P8|COMPLETED|Washout 2||2
385629|NCT01025843|921686|P7|COMPLETED|Washout 2||2
385630|NCT01025843|921687|P6|COMPLETED|Washout 2||2
385631|NCT01025843|921688|P5|COMPLETED|Washout 2||2
385632|NCT01025843|921689|P4|COMPLETED|Washout 2||2
385633|NCT01025843|921690|P3|COMPLETED|Washout 2||2
385634|NCT01025843|921691|P2|COMPLETED|Washout 2||2
385635|NCT01025843|921692|P1|COMPLETED|Washout 2||2
385636|NCT01025843|921683|P10|STARTED|Washout 2||2
385637|NCT01025843|921684|P9|STARTED|Washout 2||2
385638|NCT01025843|921685|P8|STARTED|Washout 2||2
385639|NCT01025843|921686|P7|STARTED|Washout 2||2
385640|NCT01025843|921687|P6|STARTED|Washout 2||2
385641|NCT01025843|921688|P5|STARTED|Washout 2||2
385642|NCT01025843|921689|P4|STARTED|Washout 2||2
385643|NCT01025843|921690|P3|STARTED|Washout 2||2
385644|NCT01025843|921691|P2|STARTED|Washout 2||2
385645|NCT01025843|921692|P1|STARTED|Washout 2||2
385646|NCT01025843|921683|P10|NOT COMPLETED|Period 2||0
385647|NCT01025843|921684|P9|NOT COMPLETED|Period 2||0
385648|NCT01025843|921685|P8|NOT COMPLETED|Period 2||0
385649|NCT01025843|921686|P7|NOT COMPLETED|Period 2||0
385650|NCT01025843|921687|P6|NOT COMPLETED|Period 2||0
385651|NCT01025843|921688|P5|NOT COMPLETED|Period 2||0
385652|NCT01025843|921689|P4|NOT COMPLETED|Period 2||0
385653|NCT01025843|921690|P3|NOT COMPLETED|Period 2||0
385654|NCT01025843|921691|P2|NOT COMPLETED|Period 2||0
385655|NCT01025843|921692|P1|NOT COMPLETED|Period 2||0
385656|NCT01025843|921683|P10|COMPLETED|Period 2||2
385657|NCT01025843|921684|P9|COMPLETED|Period 2||2
385658|NCT01025843|921685|P8|COMPLETED|Period 2||2
385659|NCT01025843|921686|P7|COMPLETED|Period 2||2
385660|NCT01025843|921687|P6|COMPLETED|Period 2||2
385661|NCT01025843|921688|P5|COMPLETED|Period 2||2
385662|NCT01025843|921689|P4|COMPLETED|Period 2||2
385663|NCT01025843|921690|P3|COMPLETED|Period 2||2
385664|NCT01025843|921691|P2|COMPLETED|Period 2||2
385665|NCT01025843|921692|P1|COMPLETED|Period 2||2
385666|NCT01025843|921683|P10|STARTED|Period 2||2
385667|NCT01025843|921684|P9|STARTED|Period 2||2
385668|NCT01025843|921685|P8|STARTED|Period 2||2
385669|NCT01025843|921686|P7|STARTED|Period 2||2
385670|NCT01025843|921687|P6|STARTED|Period 2||2
385671|NCT01025843|921688|P5|STARTED|Period 2||2
385672|NCT01025843|921689|P4|STARTED|Period 2||2
385673|NCT01025843|921690|P3|STARTED|Period 2||2
385674|NCT01025843|921691|P2|STARTED|Period 2||2
385675|NCT01025843|921692|P1|STARTED|Period 2||2
385676|NCT01025843|921683|P10|NOT COMPLETED|Washout 1||0
385677|NCT01025843|921684|P9|NOT COMPLETED|Washout 1||0
385678|NCT01025843|921685|P8|NOT COMPLETED|Washout 1||0
385679|NCT01025843|921686|P7|NOT COMPLETED|Washout 1||0
385680|NCT01025843|921687|P6|NOT COMPLETED|Washout 1||0
385681|NCT01025843|921688|P5|NOT COMPLETED|Washout 1||0
385682|NCT01025843|921689|P4|NOT COMPLETED|Washout 1||0
385683|NCT01025843|921690|P3|NOT COMPLETED|Washout 1||0
385684|NCT01025843|921691|P2|NOT COMPLETED|Washout 1||0
385685|NCT01025843|921692|P1|NOT COMPLETED|Washout 1||0
385686|NCT01025843|921683|P10|COMPLETED|Washout 1||2
385687|NCT01025843|921684|P9|COMPLETED|Washout 1||2
385688|NCT01025843|921685|P8|COMPLETED|Washout 1||2
385689|NCT01025843|921686|P7|COMPLETED|Washout 1||2
385690|NCT01025843|921687|P6|COMPLETED|Washout 1||2
385691|NCT01025843|921688|P5|COMPLETED|Washout 1||2
385692|NCT01025843|921689|P4|COMPLETED|Washout 1||2
385693|NCT01025843|921690|P3|COMPLETED|Washout 1||2
385694|NCT01025843|921691|P2|COMPLETED|Washout 1||2
385695|NCT01025843|921692|P1|COMPLETED|Washout 1||2
385696|NCT01025843|921683|P10|STARTED|Washout 1||2
385697|NCT01025843|921684|P9|STARTED|Washout 1||2
385698|NCT01025843|921685|P8|STARTED|Washout 1||2
385699|NCT01025843|921686|P7|STARTED|Washout 1||2
385700|NCT01025843|921687|P6|STARTED|Washout 1||2
385701|NCT01025843|921688|P5|STARTED|Washout 1||2
385702|NCT01025843|921689|P4|STARTED|Washout 1||2
385703|NCT01025843|921690|P3|STARTED|Washout 1||2
385704|NCT01025843|921691|P2|STARTED|Washout 1||2
385705|NCT01025843|921692|P1|STARTED|Washout 1||2
385706|NCT01025843|921683|P10|NOT COMPLETED|Period 1||0
385707|NCT01025843|921684|P9|NOT COMPLETED|Period 1||0
385708|NCT01025843|921685|P8|NOT COMPLETED|Period 1||0
385709|NCT01025843|921686|P7|NOT COMPLETED|Period 1||0
385710|NCT01025843|921687|P6|NOT COMPLETED|Period 1||0
385711|NCT01025843|921688|P5|NOT COMPLETED|Period 1||0
385712|NCT01025843|921689|P4|NOT COMPLETED|Period 1||0
385713|NCT01025843|921690|P3|NOT COMPLETED|Period 1||0
385714|NCT01025843|921691|P2|NOT COMPLETED|Period 1||0
385715|NCT01025843|921692|P1|NOT COMPLETED|Period 1||0
385716|NCT01025843|921683|P10|COMPLETED|Period 1||2
385717|NCT01025843|921684|P9|COMPLETED|Period 1||2
385718|NCT01025843|921685|P8|COMPLETED|Period 1||2
385719|NCT01025843|921686|P7|COMPLETED|Period 1||2
385720|NCT01025843|921687|P6|COMPLETED|Period 1||2
385721|NCT01025843|921688|P5|COMPLETED|Period 1||2
385722|NCT01025843|921689|P4|COMPLETED|Period 1||2
385723|NCT01025843|921690|P3|COMPLETED|Period 1||2
385724|NCT01025843|921691|P2|COMPLETED|Period 1||2
385725|NCT01025843|921692|P1|COMPLETED|Period 1||2
385726|NCT01025843|921683|P10|STARTED|Period 1||2
385727|NCT01025843|921684|P9|STARTED|Period 1||2
385728|NCT01025843|921685|P8|STARTED|Period 1||2
385729|NCT01025843|921686|P7|STARTED|Period 1||2
385730|NCT01025843|921687|P6|STARTED|Period 1||2
385731|NCT01025843|921688|P5|STARTED|Period 1||2
385732|NCT01025843|921689|P4|STARTED|Period 1||2
385733|NCT01025843|921690|P3|STARTED|Period 1||2
385734|NCT01025843|921691|P2|STARTED|Period 1||2
385735|NCT01025843|921692|P1|STARTED|Period 1||2
385736|NCT01025830|921766|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
385737|NCT01025830|921767|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
385738|NCT01025830|921766|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
385739|NCT01025830|921767|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
385740|NCT01025830|921766|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
385741|NCT01025830|921767|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
385742|NCT01025830|921766|P2|NOT COMPLETED|Washout Period of 30 Days||0
385743|NCT01025830|921767|P1|NOT COMPLETED|Washout Period of 30 Days||0
385744|NCT01025830|921766|P2|COMPLETED|Washout Period of 30 Days||12
385745|NCT01025830|921767|P1|COMPLETED|Washout Period of 30 Days||8
385746|NCT01025830|921766|P2|STARTED|Washout Period of 30 Days||12
385747|NCT01025830|921767|P1|STARTED|Washout Period of 30 Days||8
385748|NCT01025830|921766|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
385749|NCT01025830|921767|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
385750|NCT01025830|921766|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
385751|NCT01025830|921767|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
385752|NCT01025830|921766|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
385753|NCT01025830|921767|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
385754|NCT01025817|921786|P2|NOT COMPLETED|Completed Study||22
385755|NCT01025817|921787|P1|NOT COMPLETED|Completed Study||16
385756|NCT01025817|921786|P2|COMPLETED|Completed Study|Completed study phase|282
385757|NCT01025817|921787|P1|COMPLETED|Completed Study|Completed study phase|293
385758|NCT01025817|921786|P2|STARTED|Completed Study||304
385759|NCT01025817|921787|P1|STARTED|Completed Study||309
385760|NCT01025817|921786|P2|NOT COMPLETED|Completed Study Medication||72
385761|NCT01025817|921787|P1|NOT COMPLETED|Completed Study Medication||105
385762|NCT01025817|921786|P2|COMPLETED|Completed Study Medication||232
385763|NCT01025817|921787|P1|COMPLETED|Completed Study Medication||204
385764|NCT01025817|921786|P2|STARTED|Completed Study Medication||304
385765|NCT01025817|921787|P1|STARTED|Completed Study Medication||309
385766|NCT01025635|921807|P2|NOT COMPLETED|Overall Study||25
385767|NCT01025635|921808|P1|NOT COMPLETED|Overall Study||23
385768|NCT01025635|921807|P2|COMPLETED|Overall Study||178
385769|NCT01025635|921808|P1|COMPLETED|Overall Study||175
385770|NCT01025635|921807|P2|STARTED|Overall Study||203
385771|NCT01025635|921808|P1|STARTED|Overall Study||198
385772|NCT01025492|921820|P1|NOT COMPLETED|Overall Study||0
385773|NCT01025492|921820|P1|COMPLETED|Overall Study||24
385774|NCT01025492|921820|P1|STARTED|Overall Study||24
385775|NCT01025336|921829|P5|NOT COMPLETED|Overall Study||0
385776|NCT01025336|921830|P4|NOT COMPLETED|Overall Study||2
385777|NCT01025336|921831|P3|NOT COMPLETED|Overall Study||0
385778|NCT01025336|921832|P2|NOT COMPLETED|Overall Study||0
385779|NCT01025336|921833|P1|NOT COMPLETED|Overall Study||0
385780|NCT01025336|921829|P5|COMPLETED|Overall Study||222
385781|NCT01025336|921830|P4|COMPLETED|Overall Study||219
385782|NCT01025336|921831|P3|COMPLETED|Overall Study||179
385783|NCT01025336|921832|P2|COMPLETED|Overall Study||210
385784|NCT01025336|921833|P1|COMPLETED|Overall Study||130
385785|NCT01025336|921829|P5|STARTED|Overall Study||222
385786|NCT01025336|921830|P4|STARTED|Overall Study||221
385787|NCT01025336|921831|P3|STARTED|Overall Study||179
385788|NCT01025336|921832|P2|STARTED|Overall Study||210
385789|NCT01025336|921833|P1|STARTED|Overall Study||130
385790|NCT01025271|921885|P1|NOT COMPLETED|Overall Study||0
385791|NCT01025271|921885|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
385792|NCT01025271|921885|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
385793|NCT01025232|921892|P2|NOT COMPLETED|Overall Study||6
385794|NCT01025232|921893|P1|NOT COMPLETED|Overall Study||3
385795|NCT01025232|921892|P2|COMPLETED|Overall Study||36
385796|NCT01025232|921893|P1|COMPLETED|Overall Study||43
385797|NCT01025232|921892|P2|STARTED|Overall Study||42
385798|NCT01025232|921893|P1|STARTED|Overall Study||46
385799|NCT01025193|921911|P1|NOT COMPLETED|Overall Study||4
385800|NCT01025193|921911|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
385801|NCT01025193|921911|P1|STARTED|Overall Study||8
385802|NCT01025154|921921|P1|NOT COMPLETED|Overall Study||2
385803|NCT01025154|921921|P1|COMPLETED|Overall Study||57
385804|NCT01025154|921921|P1|STARTED|Overall Study||59
385805|NCT01025076|921926|P1|NOT COMPLETED|Overall Study||0
385806|NCT01025076|921926|P1|COMPLETED|Overall Study||14
385807|NCT01025076|921926|P1|STARTED|Overall Study||14
385808|NCT01025037|921930|P1|NOT COMPLETED|Overall Study||11
385809|NCT01025037|921930|P1|COMPLETED|Overall Study||50
385810|NCT01025037|921930|P1|STARTED|Overall Study||61
385811|NCT01024972|921941|P2|NOT COMPLETED|Overall Study||0
385812|NCT01024972|921942|P1|NOT COMPLETED|Overall Study||0
385813|NCT01024972|921941|P2|COMPLETED|Overall Study||15
385814|NCT01024972|921942|P1|COMPLETED|Overall Study||16
385815|NCT01024972|921941|P2|STARTED|Overall Study||15
385816|NCT01024972|921942|P1|STARTED|Overall Study||16
385817|NCT01024959|921952|P1|NOT COMPLETED|Overall Study||41
385818|NCT01024959|921952|P1|COMPLETED|Overall Study||466
385819|NCT01024959|921952|P1|STARTED|Overall Study||507
385820|NCT01024946|921961|P1|NOT COMPLETED|Overall Study||5
385821|NCT01024946|921961|P1|COMPLETED|Overall Study||6
385822|NCT01024946|921961|P1|STARTED|Overall Study||11
385823|NCT01024855|921965|P1|NOT COMPLETED|Overall Study||1
385824|NCT01024855|921965|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
385825|NCT01024855|921965|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
385826|NCT01024751|921972|P2|NOT COMPLETED|Eligible Participants||3
385827|NCT01024751|921973|P1|NOT COMPLETED|Eligible Participants||0
385828|NCT01024751|921972|P2|COMPLETED|Eligible Participants||149
385829|NCT01024751|921973|P1|COMPLETED|Eligible Participants||153
385830|NCT01024751|921972|P2|STARTED|Eligible Participants||152
385831|NCT01024751|921973|P1|STARTED|Eligible Participants||153
385832|NCT01024751|921972|P2|NOT COMPLETED|Enrolled Participants||4
385833|NCT01024751|921973|P1|NOT COMPLETED|Enrolled Participants||3
385834|NCT01024751|921972|P2|COMPLETED|Enrolled Participants||152
385835|NCT01024751|921973|P1|COMPLETED|Enrolled Participants||153
385836|NCT01024751|921972|P2|STARTED|Enrolled Participants||156
385837|NCT01024751|921973|P1|STARTED|Enrolled Participants||156
385838|NCT01024738|921984|P3|NOT COMPLETED|Third Intervention:||0
385839|NCT01024738|921985|P2|NOT COMPLETED|Third Intervention:||0
385840|NCT01024738|921986|P1|NOT COMPLETED|Third Intervention:||0
385841|NCT01024738|921984|P3|COMPLETED|Third Intervention:||8
385842|NCT01024738|921985|P2|COMPLETED|Third Intervention:||7
385843|NCT01024738|921986|P1|COMPLETED|Third Intervention:||7
385844|NCT01024738|921984|P3|STARTED|Third Intervention:||8
385845|NCT01024738|921985|P2|STARTED|Third Intervention:||7
385846|NCT01024738|921986|P1|STARTED|Third Intervention:||7
385847|NCT01024738|921984|P3|NOT COMPLETED|Washout After 2nd Intervention||0
385848|NCT01024738|921985|P2|NOT COMPLETED|Washout After 2nd Intervention||0
385849|NCT01024738|921986|P1|NOT COMPLETED|Washout After 2nd Intervention||0
385850|NCT01024738|921984|P3|COMPLETED|Washout After 2nd Intervention||8
385851|NCT01024738|921985|P2|COMPLETED|Washout After 2nd Intervention||7
385852|NCT01024738|921986|P1|COMPLETED|Washout After 2nd Intervention||7
385853|NCT01024738|921984|P3|STARTED|Washout After 2nd Intervention||8
385854|NCT01024738|921985|P2|STARTED|Washout After 2nd Intervention||7
385855|NCT01024738|921986|P1|STARTED|Washout After 2nd Intervention||7
385856|NCT01024738|921984|P3|NOT COMPLETED|Second Intervention:||0
385857|NCT01024738|921985|P2|NOT COMPLETED|Second Intervention:||0
385858|NCT01024738|921986|P1|NOT COMPLETED|Second Intervention:||0
385859|NCT01024738|921984|P3|COMPLETED|Second Intervention:||8
385860|NCT01024738|921985|P2|COMPLETED|Second Intervention:||7
385861|NCT01024738|921986|P1|COMPLETED|Second Intervention:||7
385862|NCT01024738|921984|P3|STARTED|Second Intervention:||8
385863|NCT01024738|921985|P2|STARTED|Second Intervention:||7
385864|NCT01024738|921986|P1|STARTED|Second Intervention:||7
385865|NCT01024738|921984|P3|NOT COMPLETED|Washout After 1st Intervention||0
385866|NCT01024738|921985|P2|NOT COMPLETED|Washout After 1st Intervention||0
385867|NCT01024738|921986|P1|NOT COMPLETED|Washout After 1st Intervention||0
385868|NCT01024738|921984|P3|COMPLETED|Washout After 1st Intervention||8
385869|NCT01024738|921985|P2|COMPLETED|Washout After 1st Intervention||7
385870|NCT01024738|921986|P1|COMPLETED|Washout After 1st Intervention||7
385871|NCT01024738|921984|P3|STARTED|Washout After 1st Intervention||8
385872|NCT01024738|921985|P2|STARTED|Washout After 1st Intervention||7
385873|NCT01024738|921986|P1|STARTED|Washout After 1st Intervention||7
385874|NCT01024738|921984|P3|NOT COMPLETED|First Intervention:||0
385875|NCT01024738|921985|P2|NOT COMPLETED|First Intervention:||0
385876|NCT01024738|921986|P1|NOT COMPLETED|First Intervention:||0
385877|NCT01024738|921984|P3|COMPLETED|First Intervention:||8
385878|NCT01024738|921985|P2|COMPLETED|First Intervention:||7
385879|NCT01024738|921986|P1|COMPLETED|First Intervention:||7
385880|NCT01024738|921984|P3|STARTED|First Intervention:||8
385881|NCT01024738|921985|P2|STARTED|First Intervention:||7
385882|NCT01024738|921986|P1|STARTED|First Intervention:||7
385883|NCT01024608|921996|P2|NOT COMPLETED|Overall Study||4
385884|NCT01024608|921997|P1|NOT COMPLETED|Overall Study||4
385885|NCT01024608|921996|P2|COMPLETED|Overall Study||167
385886|NCT01024608|921997|P1|COMPLETED|Overall Study||165
385887|NCT01024608|921996|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
385888|NCT01024608|921997|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
385889|NCT01024608|921996|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
385890|NCT01024608|921997|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
385891|NCT01024608|921996|P2|STARTED|Overall Study||171
385892|NCT01024608|921997|P1|STARTED|Overall Study||169
385893|NCT01024465|922009|P1|NOT COMPLETED|Overall Study||3
385894|NCT01024465|922009|P1|COMPLETED|Overall Study||23
385895|NCT01024465|922009|P1|STARTED|Overall Study||26
385896|NCT01024335|922015|P2|NOT COMPLETED|Overall Study||26
385897|NCT01024335|922016|P1|NOT COMPLETED|Overall Study||13
385898|NCT01024335|922015|P2|COMPLETED|Overall Study||14
385899|NCT01024335|922016|P1|COMPLETED|Overall Study||7
385900|NCT01024335|922015|P2|STARTED|Overall Study||40
385901|NCT01024335|922016|P1|STARTED|Overall Study||20
385902|NCT01024309|922026|P2|NOT COMPLETED|Overall Study||4
385903|NCT01024309|922027|P1|NOT COMPLETED|Overall Study||8
385904|NCT01024309|922026|P2|COMPLETED|Overall Study||27
385905|NCT01024309|922027|P1|COMPLETED|Overall Study||27
385906|NCT01024309|922026|P2|STARTED|Overall Study||31
385907|NCT01024309|922027|P1|STARTED|Overall Study||35
385908|NCT01024244|922054|P5|NOT COMPLETED|Overall Study||14
385909|NCT01024244|922055|P4|NOT COMPLETED|Overall Study||13
385910|NCT01024244|922056|P3|NOT COMPLETED|Overall Study||14
385911|NCT01024244|922057|P2|NOT COMPLETED|Overall Study||11
385912|NCT01024244|922058|P1|NOT COMPLETED|Overall Study||17
385913|NCT01024244|922054|P5|COMPLETED|Overall Study||1
385914|NCT01024244|922055|P4|COMPLETED|Overall Study||1
385915|NCT01024244|922056|P3|COMPLETED|Overall Study||1
385916|NCT01024244|922057|P2|COMPLETED|Overall Study||1
385917|NCT01024244|922058|P1|COMPLETED|Overall Study||5
385918|NCT01024244|922054|P5|STARTED|Overall Study||15
385919|NCT01024244|922055|P4|STARTED|Overall Study||14
385920|NCT01024244|922056|P3|STARTED|Overall Study||15
385921|NCT01024244|922057|P2|STARTED|Overall Study||12
385922|NCT01024244|922058|P1|STARTED|Overall Study||22
385923|NCT01024036|922172|P2|NOT COMPLETED|Unblinded Treatment||0
385924|NCT01024036|922173|P1|NOT COMPLETED|Unblinded Treatment||3
385925|NCT01024036|922172|P2|COMPLETED|Unblinded Treatment||0
385926|NCT01024036|922173|P1|COMPLETED|Unblinded Treatment||10
385927|NCT01024036|922172|P2|STARTED|Unblinded Treatment|No participants received Placebo+BSC during unblinded treatment period|0
385928|NCT01024036|922173|P1|STARTED|Unblinded Treatment|Only 13 participants from Placebo+BSC group received siltuximab+BSC in unblinded treatment period|13
385929|NCT01024036|922172|P2|NOT COMPLETED|Blinded Treatment||20
385930|NCT01024036|922173|P1|NOT COMPLETED|Blinded Treatment||22
385931|NCT01024036|922172|P2|COMPLETED|Blinded Treatment||6
385932|NCT01024036|922173|P1|COMPLETED|Blinded Treatment||31
385933|NCT01024036|922172|P2|STARTED|Blinded Treatment||26
385934|NCT01024036|922173|P1|STARTED|Blinded Treatment||53
385935|NCT01023841|922203|P2|NOT COMPLETED|Overall Study||0
385936|NCT01023841|922204|P1|NOT COMPLETED|Overall Study||1
385937|NCT01023841|922203|P2|COMPLETED|Overall Study||23
385938|NCT01023841|922204|P1|COMPLETED|Overall Study||47
385939|NCT01023841|922203|P2|STARTED|Overall Study||23
385940|NCT01023841|922204|P1|STARTED|Overall Study||48
385941|NCT01023815|922222|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
385942|NCT01023815|922223|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
385943|NCT01023815|922224|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
385944|NCT01023815|922225|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
385945|NCT01023815|922222|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
385946|NCT01023815|922223|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
385947|NCT01023815|922224|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
385948|NCT01023815|922225|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
385949|NCT01023815|922222|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
385950|NCT01023815|922223|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
385951|NCT01023815|922224|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
385952|NCT01023815|922225|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
385953|NCT01023815|922222|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
385954|NCT01023815|922223|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
385955|NCT01023815|922224|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
385956|NCT01023815|922225|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
385957|NCT01023815|922222|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
385958|NCT01023815|922223|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
385959|NCT01023815|922224|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
385960|NCT01023815|922225|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
385961|NCT01023815|922222|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
385962|NCT01023815|922223|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
385963|NCT01023815|922224|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
385964|NCT01023815|922225|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
385965|NCT01023776|922244|P1|NOT COMPLETED|Overall Study||0
385966|NCT01023776|922244|P1|COMPLETED|Overall Study||20
385967|NCT01023776|922244|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
385968|NCT01023724|922251|P2|NOT COMPLETED|Overall Study||3
385969|NCT01023724|922252|P1|NOT COMPLETED|Overall Study||4
385970|NCT01023724|922251|P2|COMPLETED|Overall Study||22
385971|NCT01023724|922252|P1|COMPLETED|Overall Study||21
385972|NCT01023724|922251|P2|STARTED|Overall Study||25
385973|NCT01023724|922252|P1|STARTED|Overall Study||25
385974|NCT01023711|922258|P1|NOT COMPLETED|Overall Study||0
385975|NCT01023711|922258|P1|COMPLETED|Overall Study||107
385976|NCT01023711|922258|P1|STARTED|Overall Study||107
385977|NCT01023672|922263|P1|NOT COMPLETED|Overall Study||3
385978|NCT01023672|922263|P1|COMPLETED|Overall Study||17
385979|NCT01023672|922263|P1|STARTED|Overall Study||20
385980|NCT01023659|922270|P3|NOT COMPLETED|Overall Study||99
385981|NCT01023659|922271|P2|NOT COMPLETED|Overall Study||228
385982|NCT01023659|922272|P1|NOT COMPLETED|Overall Study||73
385983|NCT01023659|922270|P3|COMPLETED|Overall Study||165
385984|NCT01023659|922271|P2|COMPLETED|Overall Study||137
385985|NCT01023659|922272|P1|COMPLETED|Overall Study||185
385986|NCT01023659|922270|P3|STARTED|Overall Study||264
385987|NCT01023659|922271|P2|STARTED|Overall Study||365
385988|NCT01023659|922272|P1|STARTED|Overall Study||258
385989|NCT01023581|922288|P7|NOT COMPLETED|Overall Study||20
385990|NCT01023581|922289|P6|NOT COMPLETED|Overall Study||19
385991|NCT01023581|922290|P5|NOT COMPLETED|Overall Study||16
385992|NCT01023581|922291|P4|NOT COMPLETED|Overall Study||20
385993|NCT01023581|922292|P3|NOT COMPLETED|Overall Study||42
385994|NCT01023581|922293|P2|NOT COMPLETED|Overall Study||23
385995|NCT01023581|922294|P1|NOT COMPLETED|Overall Study||35
385996|NCT01023581|922288|P7|COMPLETED|Overall Study||94
385997|NCT01023581|922289|P6|COMPLETED|Overall Study||92
385998|NCT01023581|922290|P5|COMPLETED|Overall Study||95
385999|NCT01023581|922291|P4|COMPLETED|Overall Study||94
386000|NCT01023581|922292|P3|COMPLETED|Overall Study||71
386001|NCT01023581|922293|P2|COMPLETED|Overall Study||89
386002|NCT01023581|922294|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
386003|NCT01023581|922288|P7|Received Study Treatment|Overall Study||114
386004|NCT01023581|922289|P6|Received Study Treatment|Overall Study||106
386005|NCT01023581|922290|P5|Received Study Treatment|Overall Study||111
386006|NCT01023581|922291|P4|Received Study Treatment|Overall Study||109
386007|NCT01023581|922292|P3|Received Study Treatment|Overall Study||110
386008|NCT01023581|922293|P2|Received Study Treatment|Overall Study||112
386009|NCT01023581|922294|P1|Received Study Treatment|Overall Study||106
386010|NCT01023581|922288|P7|STARTED|Overall Study||114
386011|NCT01023581|922289|P6|STARTED|Overall Study||111
386012|NCT01023581|922290|P5|STARTED|Overall Study||111
386013|NCT01023581|922291|P4|STARTED|Overall Study||114
386014|NCT01023581|922292|P3|STARTED|Overall Study||113
386015|NCT01023581|922293|P2|STARTED|Overall Study||112
386016|NCT01023581|922294|P1|STARTED|Overall Study||109
386017|NCT01023568|922327|P3|NOT COMPLETED|Overall Study||0
386018|NCT01023568|922328|P2|NOT COMPLETED|Overall Study||0
386019|NCT01023568|922329|P1|NOT COMPLETED|Overall Study||0
386020|NCT01023568|922327|P3|COMPLETED|Overall Study||45
386021|NCT01023568|922328|P2|COMPLETED|Overall Study||44
386022|NCT01023568|922329|P1|COMPLETED|Overall Study||45
386023|NCT01023568|922327|P3|STARTED|Overall Study||45
386024|NCT01023568|922328|P2|STARTED|Overall Study||44
386025|NCT01023568|922329|P1|STARTED|Overall Study||45
386026|NCT01023516|922351|P2|NOT COMPLETED|Overall Study||18
386027|NCT01023516|922352|P1|NOT COMPLETED|Overall Study||24
386028|NCT01023516|922351|P2|COMPLETED|Overall Study||284
386029|NCT01023516|922352|P1|COMPLETED|Overall Study||289
386030|NCT01023516|922351|P2|STARTED|Overall Study||302
386031|NCT01023516|922352|P1|STARTED|Overall Study||313
386032|NCT01023308|922434|P2|NOT COMPLETED|Overall Study||279
386033|NCT01023308|922435|P1|NOT COMPLETED|Overall Study||285
386034|NCT01023308|922434|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
386035|NCT01023308|922435|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
386036|NCT01023308|922434|P2|STARTED|Overall Study||381
386037|NCT01023308|922435|P1|STARTED|Overall Study||387
386038|NCT01023256|922465|P4|NOT COMPLETED|Overall Study||5
386039|NCT01023256|922466|P3|NOT COMPLETED|Overall Study||1
386040|NCT01023256|922467|P2|NOT COMPLETED|Overall Study||3
386041|NCT01023256|922468|P1|NOT COMPLETED|Overall Study||4
386042|NCT01023256|922465|P4|COMPLETED|Overall Study||22
386043|NCT01023256|922466|P3|COMPLETED|Overall Study||23
386044|NCT01023256|922467|P2|COMPLETED|Overall Study||19
386045|NCT01023256|922468|P1|COMPLETED|Overall Study||21
386046|NCT01023256|922465|P4|STARTED|Overall Study||27
386047|NCT01023256|922466|P3|STARTED|Overall Study||24
386048|NCT01023256|922467|P2|STARTED|Overall Study||22
386049|NCT01023256|922468|P1|STARTED|Overall Study||25
386050|NCT01023217|922510|P2|NOT COMPLETED|Overall Study||0
386051|NCT01023217|922511|P1|NOT COMPLETED|Overall Study||1
386052|NCT01023217|922510|P2|COMPLETED|Overall Study||45
386053|NCT01023217|922511|P1|COMPLETED|Overall Study||44
386054|NCT01023217|922510|P2|STARTED|Overall Study||45
386055|NCT01023217|922511|P1|STARTED|Overall Study||45
386056|NCT01023178|922520|P3|NOT COMPLETED|Overall Study||3
386057|NCT01023178|922521|P2|NOT COMPLETED|Overall Study||2
386058|NCT01023178|922522|P1|NOT COMPLETED|Overall Study||2
386059|NCT01023178|922520|P3|COMPLETED|Overall Study||4
386060|NCT01023178|922521|P2|COMPLETED|Overall Study||6
386061|NCT01023178|922522|P1|COMPLETED|Overall Study||3
386062|NCT01023178|922520|P3|STARTED|Overall Study||7
386063|NCT01023178|922521|P2|STARTED|Overall Study||8
386064|NCT01023178|922522|P1|STARTED|Overall Study||5
386065|NCT01023074|922533|P3|NOT COMPLETED|Overall Study||0
386066|NCT01023074|922534|P2|NOT COMPLETED|Overall Study||0
386067|NCT01023074|922535|P1|NOT COMPLETED|Overall Study||0
386068|NCT01023074|922533|P3|COMPLETED|Overall Study||13
386069|NCT01023074|922534|P2|COMPLETED|Overall Study||13
386070|NCT01023074|922535|P1|COMPLETED|Overall Study||26
386071|NCT01023074|922533|P3|STARTED|Overall Study||13
386072|NCT01023074|922534|P2|STARTED|Overall Study||13
386073|NCT01023074|922535|P1|STARTED|Overall Study||26
386074|NCT01023061|922549|P1|NOT COMPLETED|Overall Study||2
386075|NCT01023061|922549|P1|COMPLETED|Overall Study||22
386076|NCT01023061|922549|P1|STARTED|Overall Study||24
386077|NCT01023035|922558|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
386078|NCT01023035|922559|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
386079|NCT01023035|922560|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
386080|NCT01023035|922558|P3|COMPLETED|Follow-up Period (up to Week 72)||108
386081|NCT01023035|922559|P2|COMPLETED|Follow-up Period (up to Week 72)||207
386082|NCT01023035|922560|P1|COMPLETED|Follow-up Period (up to Week 72)||210
386083|NCT01023035|922558|P3|STARTED|Follow-up Period (up to Week 72)||147
386084|NCT01023035|922559|P2|STARTED|Follow-up Period (up to Week 72)||235
386085|NCT01023035|922560|P1|STARTED|Follow-up Period (up to Week 72)||238
386086|NCT01023035|922558|P3|NOT COMPLETED|Treatment Period||118
386087|NCT01023035|922559|P2|NOT COMPLETED|Treatment Period||85
386088|NCT01023035|922560|P1|NOT COMPLETED|Treatment Period||72
386089|NCT01023035|922558|P3|COMPLETED|Treatment Period||69
386090|NCT01023035|922559|P2|COMPLETED|Treatment Period||166
386091|NCT01023035|922560|P1|COMPLETED|Treatment Period||177
386092|NCT01023035|922558|P3|STARTED|Treatment Period||187
386093|NCT01023035|922559|P2|STARTED|Treatment Period||251
386094|NCT01023035|922560|P1|STARTED|Treatment Period||249
386095|NCT01023022|922570|P1|NOT COMPLETED|Overall Study||14
386096|NCT01023022|922570|P1|COMPLETED|Overall Study||162
386097|NCT01023022|922570|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
386098|NCT01022996|922576|P1|NOT COMPLETED|Overall Study||57
386099|NCT01022996|922576|P1|COMPLETED|Overall Study||0
386100|NCT01022996|922576|P1|STARTED|Overall Study||57
386101|NCT01022762|922587|P2|NOT COMPLETED|Overall Study||28
386102|NCT01022762|922588|P1|NOT COMPLETED|Overall Study||22
386103|NCT01022762|922587|P2|COMPLETED|Overall Study||194
386104|NCT01022762|922588|P1|COMPLETED|Overall Study||196
386192|NCT01021852|922741|P2|NOT COMPLETED|Treatment Period 2||1
386105|NCT01022762|922587|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
386106|NCT01022762|922588|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
386107|NCT01022762|922587|P2|STARTED|Overall Study||222
386108|NCT01022762|922588|P1|STARTED|Overall Study||218
386109|NCT01022567|922616|P2|NOT COMPLETED|Overall Study||15
386110|NCT01022567|922617|P1|NOT COMPLETED|Overall Study||1
386111|NCT01022567|922616|P2|COMPLETED|Overall Study||242
386112|NCT01022567|922617|P1|COMPLETED|Overall Study||272
386113|NCT01022567|922616|P2|STARTED|Overall Study||257
386114|NCT01022567|922617|P1|STARTED|Overall Study||273
386115|NCT01022502|922623|P1|NOT COMPLETED|Overall Study||3
386116|NCT01022502|922623|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
386117|NCT01022502|922623|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
386118|NCT01022398|922639|P2|NOT COMPLETED|Overall Study||2
386119|NCT01022398|922640|P1|NOT COMPLETED|Overall Study||2
386120|NCT01022398|922639|P2|COMPLETED|Overall Study||0
386121|NCT01022398|922640|P1|COMPLETED|Overall Study||0
386122|NCT01022398|922639|P2|STARTED|Overall Study||2
386123|NCT01022398|922640|P1|STARTED|Overall Study||2
386124|NCT01022307|922647|P2|NOT COMPLETED|Overall Study||4
386125|NCT01022307|922648|P1|NOT COMPLETED|Overall Study||0
386126|NCT01022307|922647|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
386127|NCT01022307|922648|P1|COMPLETED|Overall Study||184
386128|NCT01022307|922647|P2|STARTED|Overall Study||28
386129|NCT01022307|922648|P1|STARTED|Overall Study||184
386130|NCT01022242|922656|P2|NOT COMPLETED|Overall Study||19
386131|NCT01022242|922657|P1|NOT COMPLETED|Overall Study||21
386132|NCT01022242|922656|P2|COMPLETED|Overall Study||46
386133|NCT01022242|922657|P1|COMPLETED|Overall Study||49
386134|NCT01022242|922656|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
386135|NCT01022242|922657|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
386136|NCT01022203|922665|P2|NOT COMPLETED|Follow-Up Assessment||2
386137|NCT01022203|922666|P1|NOT COMPLETED|Follow-Up Assessment||2
386138|NCT01022203|922665|P2|COMPLETED|Follow-Up Assessment||40
386139|NCT01022203|922666|P1|COMPLETED|Follow-Up Assessment||42
386140|NCT01022203|922665|P2|STARTED|Follow-Up Assessment||42
386141|NCT01022203|922666|P1|STARTED|Follow-Up Assessment||44
386142|NCT01022203|922665|P2|NOT COMPLETED|Post Treatment Assessment||14
386143|NCT01022203|922666|P1|NOT COMPLETED|Post Treatment Assessment||14
386144|NCT01022203|922665|P2|COMPLETED|Post Treatment Assessment||42
386145|NCT01022203|922666|P1|COMPLETED|Post Treatment Assessment||44
386146|NCT01022203|922665|P2|STARTED|Post Treatment Assessment||56
386147|NCT01022203|922666|P1|STARTED|Post Treatment Assessment||58
386148|NCT01022203|922665|P2|NOT COMPLETED|PreTreatment Assessment||0
386149|NCT01022203|922666|P1|NOT COMPLETED|PreTreatment Assessment||0
386150|NCT01022203|922665|P2|COMPLETED|PreTreatment Assessment||56
386151|NCT01022203|922666|P1|COMPLETED|PreTreatment Assessment||58
386152|NCT01022203|922665|P2|STARTED|PreTreatment Assessment||56
386153|NCT01022203|922666|P1|STARTED|PreTreatment Assessment||58
386154|NCT01022190|922676|P1|NOT COMPLETED|Overall Study||0
386155|NCT01022190|922676|P1|COMPLETED|Overall Study||42
386156|NCT01022190|922676|P1|STARTED|Overall Study||42
386157|NCT01022112|922685|P5|NOT COMPLETED|Overall Study||10
386158|NCT01022112|922686|P4|NOT COMPLETED|Overall Study||3
386159|NCT01022112|922687|P3|NOT COMPLETED|Overall Study||3
386160|NCT01022112|922688|P2|NOT COMPLETED|Overall Study||3
386161|NCT01022112|922689|P1|NOT COMPLETED|Overall Study||3
386162|NCT01022112|922685|P5|COMPLETED|Overall Study||65
386163|NCT01022112|922686|P4|COMPLETED|Overall Study||72
386164|NCT01022112|922687|P3|COMPLETED|Overall Study||74
386165|NCT01022112|922688|P2|COMPLETED|Overall Study||71
386166|NCT01022112|922689|P1|COMPLETED|Overall Study||79
386167|NCT01022112|922685|P5|STARTED|Overall Study||75
386168|NCT01022112|922686|P4|STARTED|Overall Study||75
386169|NCT01022112|922687|P3|STARTED|Overall Study||77
386170|NCT01022112|922688|P2|STARTED|Overall Study||74
386171|NCT01022112|922689|P1|STARTED|Overall Study||82
386172|NCT01022073|922703|P2|NOT COMPLETED|Overall Study||18
386173|NCT01022073|922704|P1|NOT COMPLETED|Overall Study||19
386174|NCT01022073|922703|P2|COMPLETED|Overall Study||52
386175|NCT01022073|922704|P1|COMPLETED|Overall Study||67
386176|NCT01022073|922703|P2|STARTED|Overall Study||70
386177|NCT01022073|922704|P1|STARTED|Overall Study||86
386178|NCT01021878|922712|P2|NOT COMPLETED|Overall Study||10
386179|NCT01021878|922713|P1|NOT COMPLETED|Overall Study||16
386180|NCT01021878|922712|P2|COMPLETED|Overall Study||17
386181|NCT01021878|922713|P1|COMPLETED|Overall Study||17
386182|NCT01021878|922712|P2|Completed Follow-up|Overall Study||17
386183|NCT01021878|922713|P1|Completed Follow-up|Overall Study||17
386184|NCT01021878|922712|P2|STARTED|Overall Study||27
386185|NCT01021878|922713|P1|STARTED|Overall Study||33
386186|NCT01021852|922735|P8|NOT COMPLETED|Treatment Period 2||2
386187|NCT01021852|922736|P7|NOT COMPLETED|Treatment Period 2||3
386188|NCT01021852|922737|P6|NOT COMPLETED|Treatment Period 2||1
386189|NCT01021852|922738|P5|NOT COMPLETED|Treatment Period 2||2
386190|NCT01021852|922739|P4|NOT COMPLETED|Treatment Period 2||0
386191|NCT01021852|922740|P3|NOT COMPLETED|Treatment Period 2||1
386193|NCT01021852|922742|P1|NOT COMPLETED|Treatment Period 2||0
386194|NCT01021852|922735|P8|COMPLETED|Treatment Period 2||38
386195|NCT01021852|922736|P7|COMPLETED|Treatment Period 2||37
386196|NCT01021852|922737|P6|COMPLETED|Treatment Period 2||37
386197|NCT01021852|922738|P5|COMPLETED|Treatment Period 2||37
386198|NCT01021852|922739|P4|COMPLETED|Treatment Period 2||37
386199|NCT01021852|922740|P3|COMPLETED|Treatment Period 2||38
386200|NCT01021852|922741|P2|COMPLETED|Treatment Period 2||38
386201|NCT01021852|922742|P1|COMPLETED|Treatment Period 2||37
386202|NCT01021852|922735|P8|STARTED|Treatment Period 2||40
386203|NCT01021852|922736|P7|STARTED|Treatment Period 2||40
386204|NCT01021852|922737|P6|STARTED|Treatment Period 2||38
386205|NCT01021852|922738|P5|STARTED|Treatment Period 2||39
386206|NCT01021852|922739|P4|STARTED|Treatment Period 2||37
386207|NCT01021852|922740|P3|STARTED|Treatment Period 2||39
386208|NCT01021852|922741|P2|STARTED|Treatment Period 2||39
386209|NCT01021852|922742|P1|STARTED|Treatment Period 2||37
386210|NCT01021852|922735|P8|NOT COMPLETED|Washout Period-No Drug||0
386211|NCT01021852|922736|P7|NOT COMPLETED|Washout Period-No Drug||0
386212|NCT01021852|922737|P6|NOT COMPLETED|Washout Period-No Drug||1
386213|NCT01021852|922738|P5|NOT COMPLETED|Washout Period-No Drug||0
386214|NCT01021852|922739|P4|NOT COMPLETED|Washout Period-No Drug||0
386215|NCT01021852|922740|P3|NOT COMPLETED|Washout Period-No Drug||0
386216|NCT01021852|922741|P2|NOT COMPLETED|Washout Period-No Drug||0
386217|NCT01021852|922742|P1|NOT COMPLETED|Washout Period-No Drug||1
386218|NCT01021852|922735|P8|COMPLETED|Washout Period-No Drug||40
386219|NCT01021852|922736|P7|COMPLETED|Washout Period-No Drug||40
386220|NCT01021852|922737|P6|COMPLETED|Washout Period-No Drug||38
386221|NCT01021852|922738|P5|COMPLETED|Washout Period-No Drug||39
386222|NCT01021852|922739|P4|COMPLETED|Washout Period-No Drug||37
386223|NCT01021852|922740|P3|COMPLETED|Washout Period-No Drug||39
386224|NCT01021852|922741|P2|COMPLETED|Washout Period-No Drug||39
386225|NCT01021852|922742|P1|COMPLETED|Washout Period-No Drug||37
386226|NCT01021852|922735|P8|STARTED|Washout Period-No Drug||40
386227|NCT01021852|922736|P7|STARTED|Washout Period-No Drug||40
386228|NCT01021852|922737|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
386229|NCT01021852|922738|P5|STARTED|Washout Period-No Drug||39
386230|NCT01021852|922739|P4|STARTED|Washout Period-No Drug||37
386231|NCT01021852|922740|P3|STARTED|Washout Period-No Drug||39
386232|NCT01021852|922741|P2|STARTED|Washout Period-No Drug||39
386233|NCT01021852|922742|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
386234|NCT01021852|922735|P8|NOT COMPLETED|Washout Period-Placebo||0
386235|NCT01021852|922736|P7|NOT COMPLETED|Washout Period-Placebo||1
386236|NCT01021852|922737|P6|NOT COMPLETED|Washout Period-Placebo||1
386237|NCT01021852|922738|P5|NOT COMPLETED|Washout Period-Placebo||1
386238|NCT01021852|922739|P4|NOT COMPLETED|Washout Period-Placebo||1
386239|NCT01021852|922740|P3|NOT COMPLETED|Washout Period-Placebo||0
386240|NCT01021852|922741|P2|NOT COMPLETED|Washout Period-Placebo||0
386241|NCT01021852|922742|P1|NOT COMPLETED|Washout Period-Placebo||0
386242|NCT01021852|922735|P8|COMPLETED|Washout Period-Placebo||40
386243|NCT01021852|922736|P7|COMPLETED|Washout Period-Placebo||40
386244|NCT01021852|922737|P6|COMPLETED|Washout Period-Placebo||38
386245|NCT01021852|922738|P5|COMPLETED|Washout Period-Placebo||39
386246|NCT01021852|922739|P4|COMPLETED|Washout Period-Placebo||37
386247|NCT01021852|922740|P3|COMPLETED|Washout Period-Placebo||39
386248|NCT01021852|922741|P2|COMPLETED|Washout Period-Placebo||39
386249|NCT01021852|922742|P1|COMPLETED|Washout Period-Placebo||37
386250|NCT01021852|922735|P8|STARTED|Washout Period-Placebo||40
386251|NCT01021852|922736|P7|STARTED|Washout Period-Placebo||41
386252|NCT01021852|922737|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
386253|NCT01021852|922738|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
386254|NCT01021852|922739|P4|STARTED|Washout Period-Placebo||38
386255|NCT01021852|922740|P3|STARTED|Washout Period-Placebo||39
386256|NCT01021852|922741|P2|STARTED|Washout Period-Placebo||39
386257|NCT01021852|922742|P1|STARTED|Washout Period-Placebo||37
386258|NCT01021852|922735|P8|NOT COMPLETED|Treatment Period 1||1
386259|NCT01021852|922736|P7|NOT COMPLETED|Treatment Period 1||0
386260|NCT01021852|922737|P6|NOT COMPLETED|Treatment Period 1||2
386261|NCT01021852|922738|P5|NOT COMPLETED|Treatment Period 1||3
386262|NCT01021852|922739|P4|NOT COMPLETED|Treatment Period 1||2
386263|NCT01021852|922740|P3|NOT COMPLETED|Treatment Period 1||2
386264|NCT01021852|922741|P2|NOT COMPLETED|Treatment Period 1||1
386265|NCT01021852|922742|P1|NOT COMPLETED|Treatment Period 1||3
386266|NCT01021852|922735|P8|COMPLETED|Treatment Period 1||40
386267|NCT01021852|922736|P7|COMPLETED|Treatment Period 1||41
386268|NCT01021852|922737|P6|COMPLETED|Treatment Period 1||39
386269|NCT01021852|922738|P5|COMPLETED|Treatment Period 1||39
386270|NCT01021852|922739|P4|COMPLETED|Treatment Period 1||38
386271|NCT01021852|922740|P3|COMPLETED|Treatment Period 1||39
386272|NCT01021852|922741|P2|COMPLETED|Treatment Period 1||39
386273|NCT01021852|922742|P1|COMPLETED|Treatment Period 1||37
386274|NCT01021852|922735|P8|Treated|Treatment Period 1||41
386275|NCT01021852|922736|P7|Treated|Treatment Period 1||41
386276|NCT01021852|922737|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
386277|NCT01021852|922738|P5|Treated|Treatment Period 1||42
386278|NCT01021852|922739|P4|Treated|Treatment Period 1||38
386279|NCT01021852|922740|P3|Treated|Treatment Period 1||41
386280|NCT01021852|922741|P2|Treated|Treatment Period 1||40
386281|NCT01021852|922742|P1|Treated|Treatment Period 1||40
386282|NCT01021852|922735|P8|STARTED|Treatment Period 1||41
386283|NCT01021852|922736|P7|STARTED|Treatment Period 1||41
386284|NCT01021852|922737|P6|STARTED|Treatment Period 1||41
386285|NCT01021852|922738|P5|STARTED|Treatment Period 1||42
386286|NCT01021852|922739|P4|STARTED|Treatment Period 1||40
386287|NCT01021852|922740|P3|STARTED|Treatment Period 1||41
386288|NCT01021852|922741|P2|STARTED|Treatment Period 1||40
386289|NCT01021852|922742|P1|STARTED|Treatment Period 1||40
386290|NCT01021813|922778|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
386291|NCT01021813|922779|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
386292|NCT01021813|922780|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
386293|NCT01021813|922781|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
386294|NCT01021813|922782|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
386295|NCT01021813|922778|P5|COMPLETED|DB Randomized Discontinuation Phase||157
386296|NCT01021813|922779|P4|COMPLETED|DB Randomized Discontinuation Phase||161
386297|NCT01021813|922780|P3|COMPLETED|DB Randomized Discontinuation Phase||152
386298|NCT01021813|922781|P2|COMPLETED|DB Randomized Discontinuation Phase||0
386299|NCT01021813|922782|P1|COMPLETED|DB Randomized Discontinuation Phase||0
386300|NCT01021813|922778|P5|STARTED|DB Randomized Discontinuation Phase||162
386301|NCT01021813|922779|P4|STARTED|DB Randomized Discontinuation Phase||166
386302|NCT01021813|922780|P3|STARTED|DB Randomized Discontinuation Phase||156
386303|NCT01021813|922781|P2|STARTED|DB Randomized Discontinuation Phase||0
386304|NCT01021813|922782|P1|STARTED|DB Randomized Discontinuation Phase||0
386305|NCT01021813|922778|P5|NOT COMPLETED|DB Treatment Phase||0
386306|NCT01021813|922779|P4|NOT COMPLETED|DB Treatment Phase||0
386307|NCT01021813|922780|P3|NOT COMPLETED|DB Treatment Phase||0
386308|NCT01021813|922781|P2|NOT COMPLETED|DB Treatment Phase||97
386309|NCT01021813|922782|P1|NOT COMPLETED|DB Treatment Phase||200
386310|NCT01021813|922778|P5|COMPLETED|DB Treatment Phase||0
386311|NCT01021813|922779|P4|COMPLETED|DB Treatment Phase||0
386312|NCT01021813|922780|P3|COMPLETED|DB Treatment Phase||0
386313|NCT01021813|922781|P2|COMPLETED|DB Treatment Phase||162
386314|NCT01021813|922782|P1|COMPLETED|DB Treatment Phase||322
386315|NCT01021813|922778|P5|Treated|DB Treatment Phase||0
386316|NCT01021813|922779|P4|Treated|DB Treatment Phase||0
386317|NCT01021813|922780|P3|Treated|DB Treatment Phase||0
386318|NCT01021813|922781|P2|Treated|DB Treatment Phase||258
386319|NCT01021813|922782|P1|Treated|DB Treatment Phase||521
386320|NCT01021813|922778|P5|STARTED|DB Treatment Phase||0
386321|NCT01021813|922779|P4|STARTED|DB Treatment Phase||0
386322|NCT01021813|922780|P3|STARTED|DB Treatment Phase||0
386323|NCT01021813|922781|P2|STARTED|DB Treatment Phase||259
386324|NCT01021813|922782|P1|STARTED|DB Treatment Phase||522
386325|NCT01021761|922824|P3|NOT COMPLETED|Overall Study||0
386326|NCT01021761|922825|P2|NOT COMPLETED|Overall Study||4
386327|NCT01021761|922826|P1|NOT COMPLETED|Overall Study||1
386328|NCT01021761|922824|P3|COMPLETED|Overall Study||42
386329|NCT01021761|922825|P2|COMPLETED|Overall Study||38
386330|NCT01021761|922826|P1|COMPLETED|Overall Study||41
386331|NCT01021761|922824|P3|STARTED|Overall Study||42
386332|NCT01021761|922825|P2|STARTED|Overall Study||42
386333|NCT01021761|922826|P1|STARTED|Overall Study||42
386334|NCT01021683|922834|P1|NOT COMPLETED|Overall Study||71
386335|NCT01021683|922834|P1|COMPLETED|Overall Study||132
386336|NCT01021683|922834|P1|STARTED|Overall Study||203
386337|NCT01021618|922848|P2|NOT COMPLETED|Overall Study||0
386338|NCT01021618|922849|P1|NOT COMPLETED|Overall Study||0
386339|NCT01021618|922848|P2|COMPLETED|Overall Study||96
386340|NCT01021618|922849|P1|COMPLETED|Overall Study||44
386341|NCT01021618|922848|P2|STARTED|Overall Study||96
386342|NCT01021618|922849|P1|STARTED|Overall Study||44
386343|NCT01020526|922857|P1|NOT COMPLETED|Overall Study||14
386344|NCT01020526|922857|P1|COMPLETED|Overall Study||49
386345|NCT01020526|922857|P1|STARTED|Overall Study||63
386346|NCT01021423|922863|P2|NOT COMPLETED|Overall Study||5
386347|NCT01021423|922864|P1|NOT COMPLETED|Overall Study||4
386348|NCT01021423|922863|P2|COMPLETED|Overall Study||0
386349|NCT01021423|922864|P1|COMPLETED|Overall Study||0
386350|NCT01021423|922863|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
386351|NCT01021423|922864|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
386352|NCT01021332|922880|P1|NOT COMPLETED|Overall Study||106
386353|NCT01021332|922880|P1|COMPLETED|Overall Study||960
386354|NCT01021332|922880|P1|Full Analysis Set (FAS)|Overall Study||1009
386355|NCT01021332|922880|P1|Safety Analysis Set (SAF)|Overall Study||1066
386356|NCT01021332|922880|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
386357|NCT01021306|922918|P4|NOT COMPLETED|6 Month (Follow-up)||3
386358|NCT01021306|922919|P3|NOT COMPLETED|6 Month (Follow-up)||0
386359|NCT01021306|922920|P2|NOT COMPLETED|6 Month (Follow-up)||1
386360|NCT01021306|922921|P1|NOT COMPLETED|6 Month (Follow-up)||3
386361|NCT01021306|922918|P4|COMPLETED|6 Month (Follow-up)||14
386362|NCT01021306|922919|P3|COMPLETED|6 Month (Follow-up)||14
386363|NCT01021306|922920|P2|COMPLETED|6 Month (Follow-up)||13
386364|NCT01021306|922921|P1|COMPLETED|6 Month (Follow-up)||11
386365|NCT01021306|922918|P4|STARTED|6 Month (Follow-up)||17
386366|NCT01021306|922919|P3|STARTED|6 Month (Follow-up)||14
386367|NCT01021306|922920|P2|STARTED|6 Month (Follow-up)||14
386368|NCT01021306|922921|P1|STARTED|6 Month (Follow-up)||14
386369|NCT01021306|922918|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
386370|NCT01021306|922919|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
386371|NCT01021306|922920|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
386372|NCT01021306|922921|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
386373|NCT01021306|922918|P4|COMPLETED|2 Month (Primary Outcome)||17
386374|NCT01021306|922919|P3|COMPLETED|2 Month (Primary Outcome)||14
386375|NCT01021306|922920|P2|COMPLETED|2 Month (Primary Outcome)||14
386376|NCT01021306|922921|P1|COMPLETED|2 Month (Primary Outcome)||14
386377|NCT01021306|922918|P4|STARTED|2 Month (Primary Outcome)||21
386378|NCT01021306|922919|P3|STARTED|2 Month (Primary Outcome)||19
386379|NCT01021306|922920|P2|STARTED|2 Month (Primary Outcome)||20
386380|NCT01021306|922921|P1|STARTED|2 Month (Primary Outcome)||20
386381|NCT01021293|922941|P2|NOT COMPLETED|Overall Study||24
386382|NCT01021293|922942|P1|NOT COMPLETED|Overall Study||12
386383|NCT01021293|922941|P2|COMPLETED|Overall Study||526
386384|NCT01021293|922942|P1|COMPLETED|Overall Study||538
386385|NCT01021293|922941|P2|STARTED|Overall Study||550
386386|NCT01021293|922942|P1|STARTED|Overall Study||550
386387|NCT01021215|922961|P2|NOT COMPLETED|Overall Study||0
386388|NCT01021215|922962|P1|NOT COMPLETED|Overall Study||3
386389|NCT01021215|922961|P2|COMPLETED|Overall Study||20
386390|NCT01021215|922962|P1|COMPLETED|Overall Study||57
386391|NCT01021215|922961|P2|Received Allocated Intervention|Overall Study||20
386392|NCT01021215|922962|P1|Received Allocated Intervention|Overall Study||60
386393|NCT01021215|922961|P2|STARTED|Overall Study||20
386394|NCT01021215|922962|P1|STARTED|Overall Study||60
386395|NCT01021111|922972|P1|NOT COMPLETED|Overall Study||0
386396|NCT01021111|922972|P1|COMPLETED|Overall Study||17
386397|NCT01021111|922972|P1|STARTED|Overall Study||17
386398|NCT01021020|922977|P1|NOT COMPLETED|Period III||0
386399|NCT01021020|922977|P1|COMPLETED|Period III||25
386400|NCT01021020|922977|P1|STARTED|Period III||25
386401|NCT01021020|922977|P1|NOT COMPLETED|14 Day Washout Period B||0
386402|NCT01021020|922977|P1|COMPLETED|14 Day Washout Period B||25
386403|NCT01021020|922977|P1|STARTED|14 Day Washout Period B||25
386404|NCT01021020|922977|P1|NOT COMPLETED|Period II||0
386405|NCT01021020|922977|P1|COMPLETED|Period II||25
386406|NCT01021020|922977|P1|STARTED|Period II||25
386407|NCT01021020|922977|P1|NOT COMPLETED|14 Day Washout Period A||1
386408|NCT01021020|922977|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
386409|NCT01021020|922977|P1|STARTED|14 Day Washout Period A||26
386410|NCT01021020|922977|P1|NOT COMPLETED|Period I||2
386411|NCT01021020|922977|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
386412|NCT01021020|922977|P1|STARTED|Period I||28
386413|NCT01021007|922993|P2|NOT COMPLETED|Overall Study||4
386414|NCT01021007|922994|P1|NOT COMPLETED|Overall Study||2
386415|NCT01021007|922993|P2|COMPLETED|Overall Study||33
386416|NCT01021007|922994|P1|COMPLETED|Overall Study||34
386417|NCT01021007|922993|P2|STARTED|Overall Study||37
386418|NCT01021007|922994|P1|STARTED|Overall Study||36
386419|NCT01020981|923006|P2|NOT COMPLETED|Overall Study||90
386420|NCT01020981|923007|P1|NOT COMPLETED|Overall Study||84
386421|NCT01020981|923006|P2|COMPLETED|Overall Study||60
386422|NCT01020981|923007|P1|COMPLETED|Overall Study||66
386423|NCT01020981|923006|P2|STARTED|Overall Study||150
386424|NCT01020981|923007|P1|STARTED|Overall Study||150
386425|NCT01020903|923019|P2|NOT COMPLETED|Overall Study||0
386426|NCT01020903|923020|P1|NOT COMPLETED|Overall Study||0
386427|NCT01020903|923019|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
386428|NCT01020903|923020|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
386429|NCT01020903|923019|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
386430|NCT01020903|923020|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
386431|NCT01020877|923028|P2|NOT COMPLETED|Second Intervention||0
386432|NCT01020877|923029|P1|NOT COMPLETED|Second Intervention||1
386433|NCT01020877|923028|P2|COMPLETED|Second Intervention||19
386434|NCT01020877|923029|P1|COMPLETED|Second Intervention||18
386435|NCT01020877|923028|P2|STARTED|Second Intervention||19
386436|NCT01020877|923029|P1|STARTED|Second Intervention||19
386437|NCT01020877|923028|P2|NOT COMPLETED|Washout of 7 Days||0
386438|NCT01020877|923029|P1|NOT COMPLETED|Washout of 7 Days||0
386439|NCT01020877|923028|P2|COMPLETED|Washout of 7 Days||19
386440|NCT01020877|923029|P1|COMPLETED|Washout of 7 Days||19
386441|NCT01020877|923028|P2|STARTED|Washout of 7 Days||19
386442|NCT01020877|923029|P1|STARTED|Washout of 7 Days||19
386443|NCT01020877|923028|P2|NOT COMPLETED|First Intervention||0
386444|NCT01020877|923029|P1|NOT COMPLETED|First Intervention||0
386445|NCT01020877|923028|P2|COMPLETED|First Intervention||19
386446|NCT01020877|923029|P1|COMPLETED|First Intervention||19
386447|NCT01020877|923028|P2|STARTED|First Intervention||19
386448|NCT01020877|923029|P1|STARTED|First Intervention||19
386449|NCT01020838|923039|P1|NOT COMPLETED|Overall Study||183
386450|NCT01020838|923039|P1|COMPLETED|Overall Study||35
386615|NCT01019928|923428|P1|COMPLETED|Period 2||7
386451|NCT01020838|923039|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
386452|NCT01020838|923039|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
386453|NCT01020838|923039|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
386454|NCT01020838|923039|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
386455|NCT01020838|923039|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
386456|NCT01020838|923039|P1|STARTED|Overall Study||218
386457|NCT01020812|923054|P1|NOT COMPLETED|Overall Study||3
386458|NCT01020812|923054|P1|COMPLETED|Overall Study||8
386459|NCT01020812|923054|P1|STARTED|Overall Study||11
386460|NCT01020799|923064|P3|NOT COMPLETED|Overall Study||7
386461|NCT01020799|923065|P2|NOT COMPLETED|Overall Study||14
386462|NCT01020799|923066|P1|NOT COMPLETED|Overall Study||19
386463|NCT01020799|923064|P3|COMPLETED|Overall Study||43
386464|NCT01020799|923065|P2|COMPLETED|Overall Study||85
386465|NCT01020799|923066|P1|COMPLETED|Overall Study||79
386466|NCT01020799|923064|P3|Full Analysis Set|Overall Study||49
386467|NCT01020799|923065|P2|Full Analysis Set|Overall Study||94
386468|NCT01020799|923066|P1|Full Analysis Set|Overall Study||91
386469|NCT01020799|923064|P3|Patients Received Treatment|Overall Study||50
386470|NCT01020799|923065|P2|Patients Received Treatment|Overall Study||99
386471|NCT01020799|923066|P1|Patients Received Treatment|Overall Study||96
386472|NCT01020799|923064|P3|STARTED|Overall Study||50
386473|NCT01020799|923065|P2|STARTED|Overall Study||99
386474|NCT01020799|923066|P1|STARTED|Overall Study||98
386475|NCT01020786|923089|P1|NOT COMPLETED|Maintenance Period||60
386476|NCT01020786|923089|P1|COMPLETED|Maintenance Period||0
386477|NCT01020786|923089|P1|STARTED|Maintenance Period||60
386478|NCT01020786|923089|P1|NOT COMPLETED|Induction Period||49
386479|NCT01020786|923089|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
386480|NCT01020786|923089|P1|STARTED|Induction Period||109
386481|NCT01020773|923103|P2|NOT COMPLETED|Overall Study||3
386482|NCT01020773|923104|P1|NOT COMPLETED|Overall Study||4
386483|NCT01020773|923103|P2|COMPLETED|Overall Study||29
386484|NCT01020773|923104|P1|COMPLETED|Overall Study||31
386485|NCT01020773|923103|P2|STARTED|Overall Study||32
386486|NCT01020773|923104|P1|STARTED|Overall Study||35
386487|NCT01020747|923110|P1|NOT COMPLETED|Overall Study||1
386488|NCT01020747|923110|P1|COMPLETED|Overall Study||19
386489|NCT01020747|923110|P1|STARTED|Overall Study||20
386490|NCT01020591|923117|P2|NOT COMPLETED|Overall Study||0
386491|NCT01020591|923118|P1|NOT COMPLETED|Overall Study||0
386492|NCT01020591|923117|P2|COMPLETED|Overall Study||15
386493|NCT01020591|923118|P1|COMPLETED|Overall Study||15
386494|NCT01020591|923117|P2|STARTED|Overall Study||15
386495|NCT01020591|923118|P1|STARTED|Overall Study||15
386496|NCT01020487|923129|P3|NOT COMPLETED|Part 2 Open-label Period||1
386497|NCT01020487|923130|P2|NOT COMPLETED|Part 2 Open-label Period||4
386498|NCT01020487|923131|P1|NOT COMPLETED|Part 2 Open-label Period||0
386499|NCT01020487|923129|P3|COMPLETED|Part 2 Open-label Period||12
386500|NCT01020487|923130|P2|COMPLETED|Part 2 Open-label Period||12
386501|NCT01020487|923131|P1|COMPLETED|Part 2 Open-label Period||0
386502|NCT01020487|923129|P3|STARTED|Part 2 Open-label Period||13
386503|NCT01020487|923130|P2|STARTED|Part 2 Open-label Period||16
386504|NCT01020487|923131|P1|STARTED|Part 2 Open-label Period||0
386505|NCT01020487|923129|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
386506|NCT01020487|923130|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
386507|NCT01020487|923131|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
386508|NCT01020487|923129|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
386509|NCT01020487|923130|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
386510|NCT01020487|923131|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
386511|NCT01020487|923129|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
386512|NCT01020487|923130|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
386513|NCT01020487|923131|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
386514|NCT01020487|923129|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
386515|NCT01020487|923130|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
386516|NCT01020487|923131|P1|STARTED|Part 2 Double-blind Treatment Period||0
386517|NCT01020487|923129|P3|NOT COMPLETED|Part 1||0
386518|NCT01020487|923130|P2|NOT COMPLETED|Part 1||0
386519|NCT01020487|923131|P1|NOT COMPLETED|Part 1||0
386520|NCT01020487|923129|P3|COMPLETED|Part 1||0
386521|NCT01020487|923130|P2|COMPLETED|Part 1||0
386522|NCT01020487|923131|P1|COMPLETED|Part 1||12
386523|NCT01020487|923129|P3|STARTED|Part 1||0
386524|NCT01020487|923130|P2|STARTED|Part 1||0
386525|NCT01020487|923131|P1|STARTED|Part 1||12
386526|NCT01020474|923154|P2|NOT COMPLETED|Overall Study||17
386527|NCT01020474|923155|P1|NOT COMPLETED|Overall Study||10
386528|NCT01020474|923154|P2|COMPLETED|Overall Study||36
386529|NCT01020474|923155|P1|COMPLETED|Overall Study||44
386530|NCT01020474|923154|P2|STARTED|Overall Study||53
386531|NCT01020474|923155|P1|STARTED|Overall Study||54
386532|NCT01020448|923175|P1|NOT COMPLETED|Treatment||26
386533|NCT01020448|923175|P1|COMPLETED|Treatment||299
386534|NCT01020448|923175|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
386535|NCT01020448|923175|P1|NOT COMPLETED|Pre-assignment||13
386536|NCT01020448|923175|P1|COMPLETED|Pre-assignment||326
386537|NCT01020448|923175|P1|STARTED|Pre-assignment||339
386538|NCT01020305|923184|P1|NOT COMPLETED|Overall Study||2
386539|NCT01020305|923184|P1|COMPLETED|Overall Study||3
386540|NCT01020305|923184|P1|STARTED|Overall Study||5
386541|NCT01020123|923195|P7|NOT COMPLETED|Extention Period||1
386542|NCT01020123|923196|P6|NOT COMPLETED|Extention Period||2
386543|NCT01020123|923197|P5|NOT COMPLETED|Extention Period||0
386544|NCT01020123|923198|P4|NOT COMPLETED|Extention Period||1
386545|NCT01020123|923199|P3|NOT COMPLETED|Extention Period||2
386546|NCT01020123|923200|P2|NOT COMPLETED|Extention Period||2
386547|NCT01020123|923201|P1|NOT COMPLETED|Extention Period||3
386548|NCT01020123|923195|P7|COMPLETED|Extention Period||18
386549|NCT01020123|923196|P6|COMPLETED|Extention Period||36
386550|NCT01020123|923197|P5|COMPLETED|Extention Period||31
386551|NCT01020123|923198|P4|COMPLETED|Extention Period||12
386552|NCT01020123|923199|P3|COMPLETED|Extention Period||17
386553|NCT01020123|923200|P2|COMPLETED|Extention Period||33
386554|NCT01020123|923201|P1|COMPLETED|Extention Period||37
386555|NCT01020123|923195|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
386556|NCT01020123|923196|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
386557|NCT01020123|923197|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
386558|NCT01020123|923198|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
386559|NCT01020123|923199|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
386560|NCT01020123|923200|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
386561|NCT01020123|923201|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
386562|NCT01020123|923195|P7|NOT COMPLETED|Main Period||11
386563|NCT01020123|923196|P6|NOT COMPLETED|Main Period||11
386564|NCT01020123|923197|P5|NOT COMPLETED|Main Period||11
386565|NCT01020123|923198|P4|NOT COMPLETED|Main Period||7
386566|NCT01020123|923199|P3|NOT COMPLETED|Main Period||8
386567|NCT01020123|923200|P2|NOT COMPLETED|Main Period||14
386568|NCT01020123|923201|P1|NOT COMPLETED|Main Period||17
386569|NCT01020123|923195|P7|COMPLETED|Main Period||61
386570|NCT01020123|923196|P6|COMPLETED|Main Period||83
386571|NCT01020123|923197|P5|COMPLETED|Main Period||77
386572|NCT01020123|923198|P4|COMPLETED|Main Period||33
386573|NCT01020123|923199|P3|COMPLETED|Main Period||44
386574|NCT01020123|923200|P2|COMPLETED|Main Period||77
386575|NCT01020123|923201|P1|COMPLETED|Main Period||76
386576|NCT01020123|923195|P7|STARTED|Main Period||72
386577|NCT01020123|923196|P6|STARTED|Main Period||94
386578|NCT01020123|923197|P5|STARTED|Main Period||88
386579|NCT01020123|923198|P4|STARTED|Main Period||40
386580|NCT01020123|923199|P3|STARTED|Main Period||52
386581|NCT01020123|923200|P2|STARTED|Main Period||91
386582|NCT01020123|923201|P1|STARTED|Main Period||93
386583|NCT01020019|923396|P2|NOT COMPLETED|Overall Study||29
386584|NCT01020019|923397|P1|NOT COMPLETED|Overall Study||26
386585|NCT01020019|923396|P2|COMPLETED|Overall Study||32
386586|NCT01020019|923397|P1|COMPLETED|Overall Study||35
386587|NCT01020019|923396|P2|STARTED|Overall Study||61
386588|NCT01020019|923397|P1|STARTED|Overall Study||61
386589|NCT01020006|923406|P3|NOT COMPLETED|Overall Study||16
386590|NCT01020006|923407|P2|NOT COMPLETED|Overall Study||18
386591|NCT01020006|923408|P1|NOT COMPLETED|Overall Study||8
386592|NCT01020006|923406|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
386683|NCT01018992|923670|P1|STARTED|Overall Study||63
386593|NCT01020006|923407|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
386594|NCT01020006|923408|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
386595|NCT01020006|923406|P3|STARTED|Overall Study||16
386596|NCT01020006|923407|P2|STARTED|Overall Study||18
386597|NCT01020006|923408|P1|STARTED|Overall Study||8
386598|NCT01019980|923418|P2|NOT COMPLETED|Overall Study||0
386599|NCT01019980|923419|P1|NOT COMPLETED|Overall Study||2
386600|NCT01019980|923418|P2|COMPLETED|Overall Study||0
386601|NCT01019980|923419|P1|COMPLETED|Overall Study||0
386602|NCT01019980|923418|P2|Discontinued|Overall Study||0
386603|NCT01019980|923419|P1|Discontinued|Overall Study||2
386604|NCT01019980|923418|P2|STARTED|Overall Study||0
386605|NCT01019980|923419|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
386606|NCT01019928|923427|P2|NOT COMPLETED|Period 3||0
386607|NCT01019928|923428|P1|NOT COMPLETED|Period 3||0
386608|NCT01019928|923427|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
386609|NCT01019928|923428|P1|COMPLETED|Period 3||7
386610|NCT01019928|923427|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
386611|NCT01019928|923428|P1|STARTED|Period 3||7
386612|NCT01019928|923427|P2|NOT COMPLETED|Period 2||1
386613|NCT01019928|923428|P1|NOT COMPLETED|Period 2||0
386614|NCT01019928|923427|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
386616|NCT01019928|923427|P2|STARTED|Period 2||7
386617|NCT01019928|923428|P1|STARTED|Period 2||7
386618|NCT01019928|923427|P2|NOT COMPLETED|Period 1||0
386619|NCT01019928|923428|P1|NOT COMPLETED|Period 1||0
386620|NCT01019928|923427|P2|COMPLETED|Period 1||7
386621|NCT01019928|923428|P1|COMPLETED|Period 1||7
386622|NCT01019928|923427|P2|STARTED|Period 1||7
386623|NCT01019928|923428|P1|STARTED|Period 1||7
386624|NCT01019707|923468|P2|NOT COMPLETED|Second Phase||0
386625|NCT01019707|923469|P1|NOT COMPLETED|Second Phase||0
386626|NCT01019707|923468|P2|COMPLETED|Second Phase||1
386627|NCT01019707|923469|P1|COMPLETED|Second Phase||3
386628|NCT01019707|923468|P2|STARTED|Second Phase||1
386629|NCT01019707|923469|P1|STARTED|Second Phase||3
386630|NCT01019707|923468|P2|NOT COMPLETED|Washout||2
386631|NCT01019707|923469|P1|NOT COMPLETED|Washout||0
386632|NCT01019707|923468|P2|COMPLETED|Washout||1
386633|NCT01019707|923469|P1|COMPLETED|Washout||3
386634|NCT01019707|923468|P2|STARTED|Washout||3
386635|NCT01019707|923469|P1|STARTED|Washout||3
386636|NCT01019707|923468|P2|NOT COMPLETED|First Phase||0
386637|NCT01019707|923469|P1|NOT COMPLETED|First Phase||0
386638|NCT01019707|923468|P2|COMPLETED|First Phase||3
386639|NCT01019707|923469|P1|COMPLETED|First Phase||3
386640|NCT01019707|923468|P2|STARTED|First Phase||3
386641|NCT01019707|923469|P1|STARTED|First Phase||3
386642|NCT01019694|923482|P3|NOT COMPLETED|Overall Study||47
386643|NCT01019694|923483|P2|NOT COMPLETED|Overall Study||38
386644|NCT01019694|923484|P1|NOT COMPLETED|Overall Study||24
386645|NCT01019694|923482|P3|COMPLETED|Overall Study||110
386646|NCT01019694|923483|P2|COMPLETED|Overall Study||118
386647|NCT01019694|923484|P1|COMPLETED|Overall Study||133
386648|NCT01019694|923482|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
386649|NCT01019694|923483|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
386650|NCT01019694|923484|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
386651|NCT01019486|923609|P3|NOT COMPLETED|Overall Study||1
386652|NCT01019486|923610|P2|NOT COMPLETED|Overall Study||1
386653|NCT01019486|923611|P1|NOT COMPLETED|Overall Study||1
386654|NCT01019486|923609|P3|COMPLETED|Overall Study||15
386655|NCT01019486|923610|P2|COMPLETED|Overall Study||4
386656|NCT01019486|923611|P1|COMPLETED|Overall Study||4
386657|NCT01019486|923609|P3|STARTED|Overall Study||16
386658|NCT01019486|923610|P2|STARTED|Overall Study||5
386659|NCT01019486|923611|P1|STARTED|Overall Study||5
386660|NCT01019369|923625|P2|NOT COMPLETED|Overall Study||7
386661|NCT01019369|923626|P1|NOT COMPLETED|Overall Study||10
386662|NCT01019369|923625|P2|COMPLETED|Overall Study||39
386663|NCT01019369|923626|P1|COMPLETED|Overall Study||76
386664|NCT01019369|923625|P2|STARTED|Overall Study||46
386665|NCT01019369|923626|P1|STARTED|Overall Study||86
386666|NCT01019317|923632|P1|NOT COMPLETED|Overall Study||4
386667|NCT01019317|923632|P1|COMPLETED|Overall Study||147
386668|NCT01019317|923632|P1|STARTED|Overall Study||151
386669|NCT01019135|923639|P3|NOT COMPLETED|Overall Study||31
386670|NCT01019135|923640|P2|NOT COMPLETED|Overall Study||19
386671|NCT01019135|923641|P1|NOT COMPLETED|Overall Study||20
386672|NCT01019135|923639|P3|COMPLETED|Overall Study||24
386673|NCT01019135|923640|P2|COMPLETED|Overall Study||40
386674|NCT01019135|923641|P1|COMPLETED|Overall Study||35
386675|NCT01019135|923639|P3|STARTED|Overall Study||55
386676|NCT01019135|923640|P2|STARTED|Overall Study||59
386677|NCT01019135|923641|P1|STARTED|Overall Study||55
386678|NCT01018992|923669|P2|NOT COMPLETED|Overall Study||16
386679|NCT01018992|923670|P1|NOT COMPLETED|Overall Study||16
386680|NCT01018992|923669|P2|COMPLETED|Overall Study||49
386681|NCT01018992|923670|P1|COMPLETED|Overall Study||47
386682|NCT01018992|923669|P2|STARTED|Overall Study||65
386684|NCT01018979|923684|P2|NOT COMPLETED|Overall Study||10
386685|NCT01018979|923685|P1|NOT COMPLETED|Overall Study||3
386686|NCT01018979|923684|P2|COMPLETED|Overall Study||3
386687|NCT01018979|923685|P1|COMPLETED|Overall Study||4
386688|NCT01018979|923684|P2|Received at Least One Dose|Overall Study||12
386689|NCT01018979|923685|P1|Received at Least One Dose|Overall Study||7
386690|NCT01018979|923684|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
386691|NCT01018979|923685|P1|STARTED|Overall Study||7
386692|NCT01018953|923715|P1|NOT COMPLETED|Overall Study||8
386693|NCT01018953|923715|P1|COMPLETED|Overall Study||0
386694|NCT01018953|923715|P1|BIM 23A760 4 mg|Overall Study||3
386695|NCT01018953|923715|P1|BIM 23A760 2 mg|Overall Study||2
386696|NCT01018953|923715|P1|BIM 23A760 1 mg|Overall Study||3
386697|NCT01018953|923715|P1|STARTED|Overall Study||8
386698|NCT01018862|923728|P3|NOT COMPLETED|Overall Study||16
386699|NCT01018862|923729|P2|NOT COMPLETED|Overall Study||10
386700|NCT01018862|923730|P1|NOT COMPLETED|Overall Study||13
386701|NCT01018862|923728|P3|COMPLETED|Overall Study||146
386702|NCT01018862|923729|P2|COMPLETED|Overall Study||156
386703|NCT01018862|923730|P1|COMPLETED|Overall Study||148
386704|NCT01018862|923728|P3|STARTED|Overall Study||162
386705|NCT01018862|923729|P2|STARTED|Overall Study||166
386706|NCT01018862|923730|P1|STARTED|Overall Study||161
386707|NCT01018810|923752|P5|NOT COMPLETED|Overall Study||1
386708|NCT01018810|923753|P4|NOT COMPLETED|Overall Study||1
386709|NCT01018810|923754|P3|NOT COMPLETED|Overall Study||1
386710|NCT01018810|923755|P2|NOT COMPLETED|Overall Study||1
386711|NCT01018810|923756|P1|NOT COMPLETED|Overall Study||2
386712|NCT01018810|923752|P5|COMPLETED|Overall Study||0
386713|NCT01018810|923753|P4|COMPLETED|Overall Study||0
386714|NCT01018810|923754|P3|COMPLETED|Overall Study||0
386715|NCT01018810|923755|P2|COMPLETED|Overall Study||0
386716|NCT01018810|923756|P1|COMPLETED|Overall Study||2
386717|NCT01018810|923752|P5|STARTED|Overall Study||1
386718|NCT01018810|923753|P4|STARTED|Overall Study||1
386719|NCT01018810|923754|P3|STARTED|Overall Study||1
386720|NCT01018810|923755|P2|STARTED|Overall Study||1
386721|NCT01018810|923756|P1|STARTED|Overall Study||4
386722|NCT01018732|923816|P3|NOT COMPLETED|Overall Study||4
386723|NCT01018732|923817|P2|NOT COMPLETED|Overall Study||2
386724|NCT01018732|923818|P1|NOT COMPLETED|Overall Study||1
386725|NCT01018732|923816|P3|COMPLETED|Overall Study||50
386726|NCT01018732|923817|P2|COMPLETED|Overall Study||49
386727|NCT01018732|923818|P1|COMPLETED|Overall Study||49
386728|NCT01018732|923816|P3|STARTED|Overall Study||54
386729|NCT01018732|923817|P2|STARTED|Overall Study||51
386730|NCT01018732|923818|P1|STARTED|Overall Study||50
386731|NCT01018680|923852|P2|NOT COMPLETED|Overall Study||75
386732|NCT01018680|923853|P1|NOT COMPLETED|Overall Study||61
386733|NCT01018680|923852|P2|COMPLETED|Overall Study||189
386734|NCT01018680|923853|P1|COMPLETED|Overall Study||199
386735|NCT01018680|923852|P2|STARTED|Overall Study||264
386736|NCT01018680|923853|P1|STARTED|Overall Study||260
386737|NCT01018511|923897|P4|NOT COMPLETED|Overall Study||33
386738|NCT01018511|923898|P3|NOT COMPLETED|Overall Study||40
386739|NCT01018511|923899|P2|NOT COMPLETED|Overall Study||32
386740|NCT01018511|923900|P1|NOT COMPLETED|Overall Study||26
386741|NCT01018511|923897|P4|COMPLETED|Overall Study||294
386742|NCT01018511|923898|P3|COMPLETED|Overall Study||299
386743|NCT01018511|923899|P2|COMPLETED|Overall Study||295
386744|NCT01018511|923900|P1|COMPLETED|Overall Study||315
386745|NCT01018511|923897|P4|Randomized and Treated|Overall Study||324
386746|NCT01018511|923898|P3|Randomized and Treated|Overall Study||338
386747|NCT01018511|923899|P2|Randomized and Treated|Overall Study||326
386748|NCT01018511|923900|P1|Randomized and Treated|Overall Study||341
386749|NCT01018511|923897|P4|STARTED|Overall Study||327
386750|NCT01018511|923898|P3|STARTED|Overall Study||339
386751|NCT01018511|923899|P2|STARTED|Overall Study||327
386752|NCT01018511|923900|P1|STARTED|Overall Study||341
386753|NCT01018420|924069|P2|NOT COMPLETED|Overall Study||0
386754|NCT01018420|924070|P1|NOT COMPLETED|Overall Study||0
386755|NCT01018420|924069|P2|COMPLETED|Overall Study||3
386756|NCT01018420|924070|P1|COMPLETED|Overall Study||15
386757|NCT01018420|924069|P2|STARTED|Overall Study||3
386758|NCT01018420|924070|P1|STARTED|Overall Study||15
386759|NCT01018394|924097|P2|NOT COMPLETED|Overall Study||8
386760|NCT01018394|924098|P1|NOT COMPLETED|Overall Study||9
386761|NCT01018394|924097|P2|COMPLETED|Overall Study||33
386762|NCT01018394|924098|P1|COMPLETED|Overall Study||31
386763|NCT01018394|924097|P2|STARTED|Overall Study||41
386764|NCT01018394|924098|P1|STARTED|Overall Study||40
386765|NCT01018264|924108|P2|NOT COMPLETED|Overall Study||1
386766|NCT01018264|924109|P1|NOT COMPLETED|Overall Study||1
386767|NCT01018264|924108|P2|COMPLETED|Overall Study||12
386768|NCT01018264|924109|P1|COMPLETED|Overall Study||9
386769|NCT01018264|924108|P2|STARTED|Overall Study||13
386770|NCT01018264|924109|P1|STARTED|Overall Study||10
386771|NCT01018186|924126|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
386772|NCT01018186|924127|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
386773|NCT01018186|924128|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
386774|NCT01018186|924129|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
386775|NCT01018186|924126|P4|COMPLETED|52-week Double-blind Treatment Period||71
386776|NCT01018186|924127|P3|COMPLETED|52-week Double-blind Treatment Period||161
386777|NCT01018186|924128|P2|COMPLETED|52-week Double-blind Treatment Period||161
386778|NCT01018186|924129|P1|COMPLETED|52-week Double-blind Treatment Period||0
386779|NCT01018186|924126|P4|STARTED|52-week Double-blind Treatment Period||100
386780|NCT01018186|924127|P3|STARTED|52-week Double-blind Treatment Period||202
386781|NCT01018186|924128|P2|STARTED|52-week Double-blind Treatment Period||201
386782|NCT01018186|924129|P1|STARTED|52-week Double-blind Treatment Period||0
386783|NCT01018186|924126|P4|NOT COMPLETED|2-week Run-in Period||0
386784|NCT01018186|924127|P3|NOT COMPLETED|2-week Run-in Period||0
386785|NCT01018186|924128|P2|NOT COMPLETED|2-week Run-in Period||0
386786|NCT01018186|924129|P1|NOT COMPLETED|2-week Run-in Period||114
386787|NCT01018186|924126|P4|COMPLETED|2-week Run-in Period||0
386788|NCT01018186|924127|P3|COMPLETED|2-week Run-in Period||0
386789|NCT01018186|924128|P2|COMPLETED|2-week Run-in Period||0
386790|NCT01018186|924129|P1|COMPLETED|2-week Run-in Period||503
386791|NCT01018186|924126|P4|STARTED|2-week Run-in Period||0
386792|NCT01018186|924127|P3|STARTED|2-week Run-in Period||0
386793|NCT01018186|924128|P2|STARTED|2-week Run-in Period||0
386794|NCT01018186|924129|P1|STARTED|2-week Run-in Period||617
386795|NCT01018134|924221|P6|NOT COMPLETED|Overall Study||0
386796|NCT01018134|924222|P5|NOT COMPLETED|Overall Study||0
386797|NCT01018134|924223|P4|NOT COMPLETED|Overall Study||0
386798|NCT01018134|924224|P3|NOT COMPLETED|Overall Study||1
386799|NCT01018134|924225|P2|NOT COMPLETED|Overall Study||1
386800|NCT01018134|924226|P1|NOT COMPLETED|Overall Study||0
386801|NCT01018134|924221|P6|COMPLETED|Overall Study||15
386802|NCT01018134|924222|P5|COMPLETED|Overall Study||15
386803|NCT01018134|924223|P4|COMPLETED|Overall Study||29
386804|NCT01018134|924224|P3|COMPLETED|Overall Study||29
386805|NCT01018134|924225|P2|COMPLETED|Overall Study||30
386806|NCT01018134|924226|P1|COMPLETED|Overall Study||30
386807|NCT01018134|924221|P6|STARTED|Overall Study||15
386808|NCT01018134|924222|P5|STARTED|Overall Study||15
386809|NCT01018134|924223|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
386810|NCT01018134|924224|P3|STARTED|Overall Study||30
386811|NCT01018134|924225|P2|STARTED|Overall Study||31
386812|NCT01018134|924226|P1|STARTED|Overall Study||30
386813|NCT01018095|924266|P2|NOT COMPLETED|Overall Study||62
386814|NCT01018095|924267|P1|NOT COMPLETED|Overall Study||56
386815|NCT01018095|924266|P2|COMPLETED|Overall Study||73
386816|NCT01018095|924267|P1|COMPLETED|Overall Study||79
386817|NCT01018095|924266|P2|STARTED|Overall Study||135
386818|NCT01018095|924267|P1|STARTED|Overall Study||135
386819|NCT01018056|924278|P3|NOT COMPLETED|Overall Study||1
386820|NCT01018056|924279|P2|NOT COMPLETED|Overall Study||2
386821|NCT01018056|924280|P1|NOT COMPLETED|Overall Study||3
386822|NCT01018056|924278|P3|COMPLETED|Overall Study||5
386823|NCT01018056|924279|P2|COMPLETED|Overall Study||10
386824|NCT01018056|924280|P1|COMPLETED|Overall Study||9
386825|NCT01018056|924278|P3|STARTED|Overall Study||6
386826|NCT01018056|924279|P2|STARTED|Overall Study||12
386827|NCT01018056|924280|P1|STARTED|Overall Study||12
386828|NCT01018030|924315|P3|NOT COMPLETED|Overall Study||13
386829|NCT01018030|924316|P2|NOT COMPLETED|Overall Study||11
386830|NCT01018030|924317|P1|NOT COMPLETED|Overall Study||19
386831|NCT01018030|924315|P3|COMPLETED|Overall Study||239
386832|NCT01018030|924316|P2|COMPLETED|Overall Study||232
386833|NCT01018030|924317|P1|COMPLETED|Overall Study||227
386834|NCT01018030|924315|P3|STARTED|Overall Study||252
386835|NCT01018030|924316|P2|STARTED|Overall Study||243
386836|NCT01018030|924317|P1|STARTED|Overall Study||246
386837|NCT01017952|924368|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
386838|NCT01017952|924369|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
386839|NCT01017952|924370|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
386840|NCT01017952|924371|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
386841|NCT01017952|924372|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
386842|NCT01017952|924368|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
386843|NCT01017952|924369|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
386844|NCT01017952|924370|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
386845|NCT01017952|924371|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
386846|NCT01017952|924372|P1|COMPLETED|52-week, Double-blind Treatment Period||0
386847|NCT01017952|924368|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
386848|NCT01017952|924369|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
386849|NCT01017952|924370|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
386850|NCT01017952|924371|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
386851|NCT01017952|924372|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
386852|NCT01017952|924368|P5|STARTED|52-week, Double-blind Treatment Period||409
386853|NCT01017952|924369|P4|STARTED|52-week, Double-blind Treatment Period||403
386854|NCT01017952|924370|P3|STARTED|52-week, Double-blind Treatment Period||412
386855|NCT01017952|924371|P2|STARTED|52-week, Double-blind Treatment Period||409
386856|NCT01017952|924372|P1|STARTED|52-week, Double-blind Treatment Period||0
386857|NCT01017952|924368|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
386858|NCT01017952|924369|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
386859|NCT01017952|924370|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
386860|NCT01017952|924371|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
386861|NCT01017952|924372|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
386862|NCT01017952|924368|P5|COMPLETED|4-week, Open-label Run-In Period||0
386863|NCT01017952|924369|P4|COMPLETED|4-week, Open-label Run-In Period||0
386864|NCT01017952|924370|P3|COMPLETED|4-week, Open-label Run-In Period||0
386865|NCT01017952|924371|P2|COMPLETED|4-week, Open-label Run-In Period||0
386866|NCT01017952|924372|P1|COMPLETED|4-week, Open-label Run-In Period||1633
386867|NCT01017952|924368|P5|STARTED|4-week, Open-label Run-In Period||0
386868|NCT01017952|924369|P4|STARTED|4-week, Open-label Run-In Period||0
386869|NCT01017952|924370|P3|STARTED|4-week, Open-label Run-In Period||0
386870|NCT01017952|924371|P2|STARTED|4-week, Open-label Run-In Period||0
386871|NCT01017952|924372|P1|STARTED|4-week, Open-label Run-In Period||2092
386872|NCT01017874|924396|P2|NOT COMPLETED|Overall Study||26
386873|NCT01017874|924397|P1|NOT COMPLETED|Overall Study||30
386874|NCT01017874|924396|P2|COMPLETED|Overall Study||92
386875|NCT01017874|924397|P1|COMPLETED|Overall Study||88
386876|NCT01017874|924396|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
386877|NCT01017874|924397|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
386878|NCT01017874|924396|P2|STARTED|Overall Study||118
386879|NCT01017874|924397|P1|STARTED|Overall Study||118
386880|NCT01017731|924415|P1|NOT COMPLETED|Overall Study||8
386881|NCT01017731|924415|P1|COMPLETED|Overall Study||60
386882|NCT01017731|924415|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
386883|NCT01017731|924415|P1|STARTED|Overall Study||68
386884|NCT01017653|924432|P1|NOT COMPLETED|Overall Study||0
386885|NCT01017653|924432|P1|COMPLETED|Overall Study||16
386886|NCT01017653|924432|P1|STARTED|Overall Study||16
386887|NCT01017601|924444|P2|NOT COMPLETED|Overall Study||13
386888|NCT01017601|924445|P1|NOT COMPLETED|Overall Study||12
386889|NCT01017601|924444|P2|COMPLETED|Overall Study||11
386890|NCT01017601|924445|P1|COMPLETED|Overall Study||14
386891|NCT01017601|924444|P2|STARTED|Overall Study||24
386892|NCT01017601|924445|P1|STARTED|Overall Study||26
386893|NCT01017575|924472|P5|NOT COMPLETED|Overall Study||3
386894|NCT01017575|924473|P4|NOT COMPLETED|Overall Study||1
386895|NCT01017575|924474|P3|NOT COMPLETED|Overall Study||0
386896|NCT01017575|924475|P2|NOT COMPLETED|Overall Study||2
386897|NCT01017575|924476|P1|NOT COMPLETED|Overall Study||1
386898|NCT01017575|924472|P5|COMPLETED|Overall Study||6
386899|NCT01017575|924473|P4|COMPLETED|Overall Study||7
386900|NCT01017575|924474|P3|COMPLETED|Overall Study||8
386901|NCT01017575|924475|P2|COMPLETED|Overall Study||7
386902|NCT01017575|924476|P1|COMPLETED|Overall Study||7
386903|NCT01017575|924472|P5|STARTED|Overall Study||9
386904|NCT01017575|924473|P4|STARTED|Overall Study||8
386905|NCT01017575|924474|P3|STARTED|Overall Study||8
386906|NCT01017575|924475|P2|STARTED|Overall Study||9
386907|NCT01017575|924476|P1|STARTED|Overall Study||8
386908|NCT01017549|924513|P1|NOT COMPLETED|One-year Follow-up||7
386909|NCT01017549|924513|P1|COMPLETED|One-year Follow-up||36
386910|NCT01017549|924513|P1|STARTED|One-year Follow-up||43
386911|NCT01017549|924513|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
386912|NCT01017549|924513|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
386913|NCT01017549|924513|P1|STARTED|Eligibility Through 6 Month Follow-up||44
386914|NCT01017536|924520|P2|NOT COMPLETED|Overall Study||0
386915|NCT01017536|924521|P1|NOT COMPLETED|Overall Study||0
386916|NCT01017536|924520|P2|COMPLETED|Overall Study||13
386917|NCT01017536|924521|P1|COMPLETED|Overall Study||13
386918|NCT01017536|924520|P2|STARTED|Overall Study||13
386919|NCT01017536|924521|P1|STARTED|Overall Study||13
386920|NCT01017497|924531|P1|NOT COMPLETED|Overall Study||0
386921|NCT01017497|924531|P1|COMPLETED|Overall Study||49
386922|NCT01017497|924531|P1|STARTED|Overall Study||49
386923|NCT01017263|924544|P1|NOT COMPLETED|Overall Study||12
386924|NCT01017263|924544|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
386925|NCT01017263|924544|P1|STARTED|Overall Study||14
386926|NCT01017250|924548|P1|NOT COMPLETED|Overall Study||0
386927|NCT01017250|924548|P1|COMPLETED|Overall Study||15
386928|NCT01017250|924548|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
386929|NCT01017250|924548|P1|STARTED|Overall Study||15
386930|NCT01017237|924570|P2|NOT COMPLETED|Overall Study||2
386931|NCT01017237|924571|P1|NOT COMPLETED|Overall Study||5
386932|NCT01017237|924570|P2|COMPLETED|Overall Study||6
386933|NCT01017237|924571|P1|COMPLETED|Overall Study||5
386934|NCT01017237|924570|P2|STARTED|Overall Study||8
386935|NCT01017237|924571|P1|STARTED|Overall Study||10
386936|NCT01017146|924625|P2|NOT COMPLETED|Overall Study||39
386937|NCT01017146|924626|P1|NOT COMPLETED|Overall Study||66
386938|NCT01017146|924625|P2|COMPLETED|Overall Study||333
386939|NCT01017146|924626|P1|COMPLETED|Overall Study||306
386940|NCT01017146|924625|P2|STARTED|Overall Study||372
386941|NCT01017146|924626|P1|STARTED|Overall Study||372
386942|NCT01017120|924664|P2|NOT COMPLETED|Overall Study||35
386943|NCT01017120|924665|P1|NOT COMPLETED|Overall Study||66
386944|NCT01017120|924664|P2|COMPLETED|Overall Study||334
386945|NCT01017120|924665|P1|COMPLETED|Overall Study||307
386946|NCT01017120|924664|P2|STARTED|Overall Study||369
386947|NCT01017120|924665|P1|STARTED|Overall Study||373
386948|NCT01017042|924713|P1|NOT COMPLETED|Overall Study||0
386949|NCT01017042|924713|P1|COMPLETED|Overall Study||13
386950|NCT01017042|924713|P1|STARTED|Overall Study||13
386951|NCT01017029|924726|P2|NOT COMPLETED|Overall Study||2
386952|NCT01017029|924727|P1|NOT COMPLETED|Overall Study||4
386953|NCT01017029|924726|P2|COMPLETED|Overall Study||90
386954|NCT01017029|924727|P1|COMPLETED|Overall Study||85
386955|NCT01017029|924726|P2|STARTED|Overall Study||92
386956|NCT01017029|924727|P1|STARTED|Overall Study||89
386957|NCT01017003|924743|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
386958|NCT01017003|924743|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
386959|NCT01017003|924743|P1|STARTED|Colchicine 0.6 mg Final Dose||13
386960|NCT01017003|924743|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
386961|NCT01017003|924743|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
386962|NCT01017003|924743|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
386963|NCT01017003|924743|P1|NOT COMPLETED|14 Day Washout Period||0
386964|NCT01017003|924743|P1|COMPLETED|14 Day Washout Period||13
386965|NCT01017003|924743|P1|STARTED|14 Day Washout Period||13
386966|NCT01017003|924743|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
386967|NCT01017003|924743|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
386968|NCT01017003|924743|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
386969|NCT01016977|924755|P2|NOT COMPLETED|Overall Study||2
386970|NCT01016977|924756|P1|NOT COMPLETED|Overall Study||3
386971|NCT01016977|924755|P2|COMPLETED|Overall Study||18
386972|NCT01016977|924756|P1|COMPLETED|Overall Study||17
386973|NCT01016977|924755|P2|STARTED|Overall Study||20
386974|NCT01016977|924756|P1|STARTED|Overall Study||20
386975|NCT01016964|924792|P2|NOT COMPLETED|Overall Study||3
386976|NCT01016964|924793|P1|NOT COMPLETED|Overall Study||3
386977|NCT01016964|924792|P2|COMPLETED|Overall Study||39
386978|NCT01016964|924793|P1|COMPLETED|Overall Study||18
386979|NCT01016964|924792|P2|STARTED|Overall Study||42
386980|NCT01016964|924793|P1|STARTED|Overall Study||21
386981|NCT01016938|924799|P1|NOT COMPLETED|Overall Study||9
386982|NCT01016938|924799|P1|COMPLETED|Overall Study||7
386983|NCT01016938|924799|P1|STARTED|Overall Study||16
386984|NCT01016912|924809|P5|NOT COMPLETED|Follow-up Period||0
386985|NCT01016912|924810|P4|NOT COMPLETED|Follow-up Period||1
386986|NCT01016912|924811|P3|NOT COMPLETED|Follow-up Period||1
386987|NCT01016912|924812|P2|NOT COMPLETED|Follow-up Period||0
386988|NCT01016912|924813|P1|NOT COMPLETED|Follow-up Period||0
386989|NCT01016912|924809|P5|COMPLETED|Follow-up Period||9
386990|NCT01016912|924810|P4|COMPLETED|Follow-up Period||8
386991|NCT01016912|924811|P3|COMPLETED|Follow-up Period||9
386992|NCT01016912|924812|P2|COMPLETED|Follow-up Period||9
386993|NCT01016912|924813|P1|COMPLETED|Follow-up Period||8
386994|NCT01016912|924809|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
386995|NCT01016912|924810|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
386996|NCT01016912|924811|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
386997|NCT01016912|924812|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
386998|NCT01016912|924813|P1|STARTED|Follow-up Period||8
386999|NCT01016912|924809|P5|NOT COMPLETED|End of Treatment Period||4
387000|NCT01016912|924810|P4|NOT COMPLETED|End of Treatment Period||4
387001|NCT01016912|924811|P3|NOT COMPLETED|End of Treatment Period||1
387002|NCT01016912|924812|P2|NOT COMPLETED|End of Treatment Period||3
387003|NCT01016912|924813|P1|NOT COMPLETED|End of Treatment Period||0
387004|NCT01016912|924809|P5|COMPLETED|End of Treatment Period||5
387005|NCT01016912|924810|P4|COMPLETED|End of Treatment Period||5
387006|NCT01016912|924811|P3|COMPLETED|End of Treatment Period||9
387007|NCT01016912|924812|P2|COMPLETED|End of Treatment Period||6
387008|NCT01016912|924813|P1|COMPLETED|End of Treatment Period||8
387009|NCT01016912|924809|P5|Received Treatment|End of Treatment Period||9
387010|NCT01016912|924810|P4|Received Treatment|End of Treatment Period||9
387011|NCT01016912|924811|P3|Received Treatment|End of Treatment Period||10
387012|NCT01016912|924812|P2|Received Treatment|End of Treatment Period||9
387013|NCT01016912|924813|P1|Received Treatment|End of Treatment Period||8
387014|NCT01016912|924809|P5|STARTED|End of Treatment Period||9
387015|NCT01016912|924810|P4|STARTED|End of Treatment Period||9
387016|NCT01016912|924811|P3|STARTED|End of Treatment Period||10
387017|NCT01016912|924812|P2|STARTED|End of Treatment Period||9
387018|NCT01016912|924813|P1|STARTED|End of Treatment Period||8
387019|NCT01016873|924858|P3|NOT COMPLETED|36 Months||6
387020|NCT01016873|924859|P2|NOT COMPLETED|36 Months||4
387021|NCT01016873|924860|P1|NOT COMPLETED|36 Months||11
387022|NCT01016873|924858|P3|COMPLETED|36 Months||67
387023|NCT01016873|924859|P2|COMPLETED|36 Months||64
387024|NCT01016873|924860|P1|COMPLETED|36 Months||58
387025|NCT01016873|924858|P3|STARTED|36 Months||73
387026|NCT01016873|924859|P2|STARTED|36 Months||68
387027|NCT01016873|924860|P1|STARTED|36 Months||69
387028|NCT01016873|924858|P3|NOT COMPLETED|24 Months||6
387029|NCT01016873|924859|P2|NOT COMPLETED|24 Months||4
387030|NCT01016873|924860|P1|NOT COMPLETED|24 Months||5
387031|NCT01016873|924858|P3|COMPLETED|24 Months||73
387032|NCT01016873|924859|P2|COMPLETED|24 Months||68
387033|NCT01016873|924860|P1|COMPLETED|24 Months||69
387034|NCT01016873|924858|P3|STARTED|24 Months||79
387035|NCT01016873|924859|P2|STARTED|24 Months||72
387036|NCT01016873|924860|P1|STARTED|24 Months||74
387037|NCT01016873|924858|P3|NOT COMPLETED|12 Months||1
387038|NCT01016873|924859|P2|NOT COMPLETED|12 Months||3
387039|NCT01016873|924860|P1|NOT COMPLETED|12 Months||1
387040|NCT01016873|924858|P3|COMPLETED|12 Months||79
387041|NCT01016873|924859|P2|COMPLETED|12 Months||72
387042|NCT01016873|924860|P1|COMPLETED|12 Months||74
387043|NCT01016873|924858|P3|STARTED|12 Months||80
387044|NCT01016873|924859|P2|STARTED|12 Months||75
387045|NCT01016873|924860|P1|STARTED|12 Months||75
387046|NCT01016847|924891|P2|NOT COMPLETED|Overall Study||0
387047|NCT01016847|924892|P1|NOT COMPLETED|Overall Study||0
387048|NCT01016847|924891|P2|COMPLETED|Overall Study||2
387049|NCT01016847|924892|P1|COMPLETED|Overall Study||1
387050|NCT01016847|924891|P2|STARTED|Overall Study||2
387051|NCT01016847|924892|P1|STARTED|Overall Study||1
387052|NCT01016834|924908|P1|NOT COMPLETED|Overall Study||22
387053|NCT01016834|924908|P1|COMPLETED|Overall Study||220
387054|NCT01016834|924908|P1|STARTED|Overall Study||242
387055|NCT01016691|924917|P3|NOT COMPLETED|Overall Study||0
387056|NCT01016691|924918|P2|NOT COMPLETED|Overall Study||0
387057|NCT01016691|924919|P1|NOT COMPLETED|Overall Study||0
387058|NCT01016691|924917|P3|COMPLETED|Overall Study||18
387059|NCT01016691|924918|P2|COMPLETED|Overall Study||12
387060|NCT01016691|924919|P1|COMPLETED|Overall Study||17
387061|NCT01016691|924917|P3|STARTED|Overall Study||18
387062|NCT01016691|924918|P2|STARTED|Overall Study||12
387063|NCT01016691|924919|P1|STARTED|Overall Study||17
387064|NCT01016678|924927|P5|NOT COMPLETED|Overall Study||6
387065|NCT01016678|924928|P4|NOT COMPLETED|Overall Study||0
387066|NCT01016678|924929|P3|NOT COMPLETED|Overall Study||4
387067|NCT01016678|924930|P2|NOT COMPLETED|Overall Study||3
387068|NCT01016678|924931|P1|NOT COMPLETED|Overall Study||2
387069|NCT01016678|924927|P5|COMPLETED|Overall Study||13
387070|NCT01016678|924928|P4|COMPLETED|Overall Study||19
387071|NCT01016678|924929|P3|COMPLETED|Overall Study||15
387072|NCT01016678|924930|P2|COMPLETED|Overall Study||14
387073|NCT01016678|924931|P1|COMPLETED|Overall Study||18
387074|NCT01016678|924927|P5|STARTED|Overall Study||19
387075|NCT01016678|924928|P4|STARTED|Overall Study||19
387076|NCT01016678|924929|P3|STARTED|Overall Study||19
387077|NCT01016678|924930|P2|STARTED|Overall Study||17
387078|NCT01016678|924931|P1|STARTED|Overall Study||20
387079|NCT01016652|924953|P2|NOT COMPLETED|Period 2||0
387080|NCT01016652|924954|P1|NOT COMPLETED|Period 2||0
387081|NCT01016652|924953|P2|COMPLETED|Period 2||24
387082|NCT01016652|924954|P1|COMPLETED|Period 2||25
387083|NCT01016652|924953|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
387084|NCT01016652|924954|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
387085|NCT01016652|924953|P2|NOT COMPLETED|Period 1||0
387086|NCT01016652|924954|P1|NOT COMPLETED|Period 1||0
387087|NCT01016652|924953|P2|COMPLETED|Period 1||24
387088|NCT01016652|924954|P1|COMPLETED|Period 1||25
387089|NCT01016652|924953|P2|STARTED|Period 1||24
387090|NCT01016652|924954|P1|STARTED|Period 1||25
387091|NCT01016600|924974|P4|NOT COMPLETED|Overall Study||0
387092|NCT01016600|924975|P3|NOT COMPLETED|Overall Study||0
387093|NCT01016600|924976|P2|NOT COMPLETED|Overall Study||0
387094|NCT01016600|924977|P1|NOT COMPLETED|Overall Study||1
387095|NCT01016600|924974|P4|COMPLETED|Overall Study||12
387096|NCT01016600|924975|P3|COMPLETED|Overall Study||6
387097|NCT01016600|924976|P2|COMPLETED|Overall Study||4
387098|NCT01016600|924977|P1|COMPLETED|Overall Study||8
387099|NCT01016600|924974|P4|STARTED|Overall Study||12
387100|NCT01016600|924975|P3|STARTED|Overall Study||6
387101|NCT01016600|924976|P2|STARTED|Overall Study||4
387102|NCT01016600|924977|P1|STARTED|Overall Study||9
387103|NCT01016132|925040|P1|NOT COMPLETED|Overall Study||1
387104|NCT01016132|925040|P1|COMPLETED|Overall Study||151
387105|NCT01016132|925040|P1|STARTED|Overall Study||152
387106|NCT01016106|925046|P2|NOT COMPLETED|Overall Study||0
387107|NCT01016106|925047|P1|NOT COMPLETED|Overall Study||0
387108|NCT01016106|925046|P2|COMPLETED|Overall Study||18
387109|NCT01016106|925047|P1|COMPLETED|Overall Study||17
387110|NCT01016106|925046|P2|STARTED|Overall Study||18
387111|NCT01016106|925047|P1|STARTED|Overall Study||17
387112|NCT01016067|925055|P2|NOT COMPLETED|Overall Study||4
387113|NCT01016067|925056|P1|NOT COMPLETED|Overall Study||2
387114|NCT01016067|925055|P2|COMPLETED|Overall Study||8
387115|NCT01016067|925056|P1|COMPLETED|Overall Study||9
387116|NCT01016067|925055|P2|STARTED|Overall Study||12
387117|NCT01016067|925056|P1|STARTED|Overall Study||11
387118|NCT01016015|925074|P1|NOT COMPLETED|Overall Study||19
387119|NCT01016015|925074|P1|COMPLETED|Overall Study||159
387120|NCT01016015|925074|P1|STARTED|Overall Study||178
387121|NCT01015976|925078|P2|NOT COMPLETED|Overall Study||0
387122|NCT01015976|925079|P1|NOT COMPLETED|Overall Study||0
387123|NCT01015976|925078|P2|COMPLETED|Overall Study||5
387124|NCT01015976|925079|P1|COMPLETED|Overall Study||5
387125|NCT01015976|925078|P2|STARTED|Overall Study||5
387126|NCT01015976|925079|P1|STARTED|Overall Study||5
387127|NCT01015820|925085|P2|NOT COMPLETED|Overall Study||0
387128|NCT01015820|925086|P1|NOT COMPLETED|Overall Study||1
387129|NCT01015820|925085|P2|COMPLETED|Overall Study||15
387130|NCT01015820|925086|P1|COMPLETED|Overall Study||14
387131|NCT01015820|925085|P2|STARTED|Overall Study||15
387132|NCT01015820|925086|P1|STARTED|Overall Study||15
387133|NCT01015807|925097|P3|NOT COMPLETED|Overall Study||0
387134|NCT01015807|925098|P2|NOT COMPLETED|Overall Study||0
387135|NCT01015807|925099|P1|NOT COMPLETED|Overall Study||0
387136|NCT01015807|925097|P3|COMPLETED|Overall Study||30
387137|NCT01015807|925098|P2|COMPLETED|Overall Study||30
387138|NCT01015807|925099|P1|COMPLETED|Overall Study||30
387139|NCT01015807|925097|P3|STARTED|Overall Study||30
387140|NCT01015807|925098|P2|STARTED|Overall Study||30
387141|NCT01015807|925099|P1|STARTED|Overall Study||30
387142|NCT01015781|925109|P2|NOT COMPLETED|Overall Study||29
387143|NCT01015781|925110|P1|NOT COMPLETED|Overall Study||37
387144|NCT01015781|925109|P2|COMPLETED|Overall Study||121
387145|NCT01015781|925110|P1|COMPLETED|Overall Study||113
387146|NCT01015781|925109|P2|STARTED|Overall Study||150
387147|NCT01015781|925110|P1|STARTED|Overall Study||150
387148|NCT01015703|925121|P5|NOT COMPLETED|Overall Study||0
387149|NCT01015703|925122|P4|NOT COMPLETED|Overall Study||0
387150|NCT01015703|925123|P3|NOT COMPLETED|Overall Study||0
387151|NCT01015703|925124|P2|NOT COMPLETED|Overall Study||1
387152|NCT01015703|925125|P1|NOT COMPLETED|Overall Study||2
387153|NCT01015703|925121|P5|COMPLETED|Overall Study||10
387154|NCT01015703|925122|P4|COMPLETED|Overall Study||10
387155|NCT01015703|925123|P3|COMPLETED|Overall Study||10
387156|NCT01015703|925124|P2|COMPLETED|Overall Study||9
387157|NCT01015703|925125|P1|COMPLETED|Overall Study||8
387158|NCT01015703|925121|P5|STARTED|Overall Study||10
387159|NCT01015703|925122|P4|STARTED|Overall Study||10
387160|NCT01015703|925123|P3|STARTED|Overall Study||10
387161|NCT01015703|925124|P2|STARTED|Overall Study||10
387162|NCT01015703|925125|P1|STARTED|Overall Study||10
387163|NCT01015677|925140|P3|NOT COMPLETED|Overall Study||0
387164|NCT01015677|925141|P2|NOT COMPLETED|Overall Study||4
387165|NCT01015677|925142|P1|NOT COMPLETED|Overall Study||1
387166|NCT01015677|925140|P3|COMPLETED|Overall Study||33
387167|NCT01015677|925141|P2|COMPLETED|Overall Study||28
387168|NCT01015677|925142|P1|COMPLETED|Overall Study||33
387169|NCT01015677|925140|P3|STARTED|Overall Study||33
387170|NCT01015677|925141|P2|STARTED|Overall Study||32
387171|NCT01015677|925142|P1|STARTED|Overall Study||34
387172|NCT01015638|925164|P2|NOT COMPLETED|Overall Study||0
387173|NCT01015638|925165|P1|NOT COMPLETED|Overall Study||1
387174|NCT01015638|925164|P2|COMPLETED|Overall Study||19
387175|NCT01015638|925165|P1|COMPLETED|Overall Study||16
387176|NCT01015638|925164|P2|STARTED|Overall Study||19
387177|NCT01015638|925165|P1|STARTED|Overall Study||17
387178|NCT01015560|925193|P1|NOT COMPLETED|Overall Study||3
387179|NCT01015560|925193|P1|COMPLETED|Overall Study||41
387180|NCT01015560|925193|P1|Eligible and Analyzable|Overall Study||43
387181|NCT01015560|925193|P1|STARTED|Overall Study||44
387182|NCT01015534|925199|P2|NOT COMPLETED|Overall Study||0
387183|NCT01015534|925200|P1|NOT COMPLETED|Overall Study||1
387184|NCT01015534|925199|P2|COMPLETED|Overall Study||27
387185|NCT01015534|925200|P1|COMPLETED|Overall Study||27
387186|NCT01015534|925199|P2|STARTED|Overall Study||27
387187|NCT01015534|925200|P1|STARTED|Overall Study||28
387188|NCT01015443|925214|P2|NOT COMPLETED|Overall Study||0
387189|NCT01015443|925215|P1|NOT COMPLETED|Overall Study||0
387190|NCT01015443|925214|P2|COMPLETED|Overall Study||94
387191|NCT01015443|925215|P1|COMPLETED|Overall Study||191
387192|NCT01015443|925214|P2|Treated|Overall Study||93
387193|NCT01015443|925215|P1|Treated|Overall Study||191
387194|NCT01015443|925214|P2|STARTED|Overall Study||94
387195|NCT01015443|925215|P1|STARTED|Overall Study||191
387196|NCT01015326|925233|P2|NOT COMPLETED|Overall Study||2
387197|NCT01015326|925234|P1|NOT COMPLETED|Overall Study||1
387198|NCT01015326|925233|P2|COMPLETED|Overall Study||18
387199|NCT01015326|925234|P1|COMPLETED|Overall Study||11
387200|NCT01015326|925233|P2|STARTED|Overall Study||20
387201|NCT01015326|925234|P1|STARTED|Overall Study||12
387202|NCT01015287|925242|P2|NOT COMPLETED|Overall Study||79
387203|NCT01015287|925243|P1|NOT COMPLETED|Overall Study||72
387204|NCT01015287|925242|P2|COMPLETED|Overall Study||1958
387205|NCT01015287|925243|P1|COMPLETED|Overall Study||1924
387206|NCT01015287|925242|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
387207|NCT01015287|925243|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
387208|NCT01015287|925242|P2|STARTED|Overall Study||2037
387209|NCT01015287|925243|P1|STARTED|Overall Study||1996
387210|NCT01015170|925269|P1|NOT COMPLETED|Overall Study||239
387211|NCT01015170|925269|P1|COMPLETED|Overall Study||215
387212|NCT01015170|925269|P1|STARTED|Overall Study||454
387213|NCT01015131|925275|P1|NOT COMPLETED|Overall Study||8
387214|NCT01015131|925275|P1|COMPLETED|Overall Study||36
387215|NCT01015131|925275|P1|STARTED|Overall Study||44
387216|NCT01015118|925291|P2|NOT COMPLETED|Overall Study||314
387217|NCT01015118|925292|P1|NOT COMPLETED|Overall Study||641
387218|NCT01015118|925291|P2|COMPLETED|Overall Study|Patients completed according to protocol and Patients on treatment are considered to be completed.|141
387219|NCT01015118|925292|P1|COMPLETED|Overall Study|Patients completed according to protocol and Patients on treatment are considered to be completed.|270
387220|NCT01015118|925291|P2|STARTED|Overall Study||455
387221|NCT01015118|925292|P1|STARTED|Overall Study||911
387222|NCT01014988|925316|P6|NOT COMPLETED|Overall Study||3
387223|NCT01014988|925317|P5|NOT COMPLETED|Overall Study||1
387224|NCT01014988|925318|P4|NOT COMPLETED|Overall Study||0
387225|NCT01014988|925319|P3|NOT COMPLETED|Overall Study||2
387226|NCT01014988|925320|P2|NOT COMPLETED|Overall Study||0
387227|NCT01014988|925321|P1|NOT COMPLETED|Overall Study||23
387228|NCT01014988|925316|P6|COMPLETED|Overall Study||11
387229|NCT01014988|925317|P5|COMPLETED|Overall Study||26
387230|NCT01014988|925318|P4|COMPLETED|Overall Study||12
387231|NCT01014988|925319|P3|COMPLETED|Overall Study||9
387232|NCT01014988|925320|P2|COMPLETED|Overall Study||7
387233|NCT01014988|925321|P1|COMPLETED|Overall Study||107
387234|NCT01014988|925316|P6|STARTED|Overall Study||14
387235|NCT01014988|925317|P5|STARTED|Overall Study||27
387236|NCT01014988|925318|P4|STARTED|Overall Study||12
387237|NCT01014988|925319|P3|STARTED|Overall Study||11
387238|NCT01014988|925320|P2|STARTED|Overall Study||7
387239|NCT01014988|925321|P1|STARTED|Overall Study||130
387240|NCT01014975|925493|P3|NOT COMPLETED|Overall Study||6
387241|NCT01014975|925494|P2|NOT COMPLETED|Overall Study||3
387242|NCT01014975|925495|P1|NOT COMPLETED|Overall Study||4
387243|NCT01014975|925493|P3|COMPLETED|Overall Study||10
387244|NCT01014975|925494|P2|COMPLETED|Overall Study||13
387245|NCT01014975|925495|P1|COMPLETED|Overall Study||4
387246|NCT01014975|925493|P3|STARTED|Overall Study||16
387247|NCT01014975|925494|P2|STARTED|Overall Study||16
387248|NCT01014975|925495|P1|STARTED|Overall Study||8
387249|NCT01014936|925506|P3|NOT COMPLETED|Overall Study||0
387250|NCT01014936|925507|P2|NOT COMPLETED|Overall Study||0
387251|NCT01014936|925508|P1|NOT COMPLETED|Overall Study||0
387252|NCT01014936|925506|P3|COMPLETED|Overall Study||62
387253|NCT01014936|925507|P2|COMPLETED|Overall Study||45
387254|NCT01014936|925508|P1|COMPLETED|Overall Study||42
387255|NCT01014936|925506|P3|STARTED|Overall Study||62
387256|NCT01014936|925507|P2|STARTED|Overall Study||45
387257|NCT01014936|925508|P1|STARTED|Overall Study||42
387258|NCT01014910|926000|P2|NOT COMPLETED|Overall Study||2
387259|NCT01014910|926001|P1|NOT COMPLETED|Overall Study||0
387260|NCT01014910|926000|P2|COMPLETED|Overall Study||79
387261|NCT01014910|926001|P1|COMPLETED|Overall Study||80
387262|NCT01014910|926000|P2|STARTED|Overall Study||81
387263|NCT01014910|926001|P1|STARTED|Overall Study||80
387264|NCT01014871|926009|P1|NOT COMPLETED|Overall Study||0
387265|NCT01014871|926009|P1|COMPLETED|Overall Study||30
387266|NCT01014871|926009|P1|STARTED|Overall Study||30
387267|NCT01014741|926017|P2|NOT COMPLETED|Overall Study||5
387268|NCT01014741|926018|P1|NOT COMPLETED|Overall Study||11
387269|NCT01014741|926017|P2|COMPLETED|Overall Study||90
387270|NCT01014741|926018|P1|COMPLETED|Overall Study||94
387271|NCT01014741|926017|P2|STARTED|Overall Study||95
387272|NCT01014741|926018|P1|STARTED|Overall Study||105
387273|NCT01014728|926032|P2|NOT COMPLETED|Overall Study||0
387274|NCT01014728|926033|P1|NOT COMPLETED|Overall Study||0
387275|NCT01014728|926032|P2|COMPLETED|Overall Study||15
387276|NCT01014728|926033|P1|COMPLETED|Overall Study||18
387277|NCT01014728|926032|P2|STARTED|Overall Study||15
387278|NCT01014728|926033|P1|STARTED|Overall Study||18
387279|NCT01014689|926045|P2|NOT COMPLETED|Overall Study||13
387280|NCT01014689|926046|P1|NOT COMPLETED|Overall Study||13
387281|NCT01014689|926045|P2|COMPLETED|Overall Study||174
387282|NCT01014689|926046|P1|COMPLETED|Overall Study||178
387283|NCT01014689|926045|P2|STARTED|Overall Study||187
387284|NCT01014689|926046|P1|STARTED|Overall Study||191
387285|NCT01014624|926056|P2|NOT COMPLETED|Overall Study||1
387286|NCT01014624|926057|P1|NOT COMPLETED|Overall Study||2
387287|NCT01014624|926056|P2|COMPLETED|Overall Study||26
387288|NCT01014624|926057|P1|COMPLETED|Overall Study||27
387289|NCT01014624|926056|P2|STARTED|Overall Study||27
387290|NCT01014624|926057|P1|STARTED|Overall Study||29
387291|NCT01014585|926081|P4|NOT COMPLETED|Overall Study||30
387292|NCT01014585|926082|P3|NOT COMPLETED|Overall Study||23
387293|NCT01014585|926083|P2|NOT COMPLETED|Overall Study||25
387294|NCT01014585|926084|P1|NOT COMPLETED|Overall Study||20
387295|NCT01014585|926081|P4|COMPLETED|Overall Study||99
387296|NCT01014585|926082|P3|COMPLETED|Overall Study||37
387297|NCT01014585|926083|P2|COMPLETED|Overall Study||75
387298|NCT01014585|926084|P1|COMPLETED|Overall Study||31
387299|NCT01014585|926081|P4|STARTED|Overall Study||129
387300|NCT01014585|926082|P3|STARTED|Overall Study||60
387301|NCT01014585|926083|P2|STARTED|Overall Study||100
387302|NCT01014585|926084|P1|STARTED|Overall Study||51
387303|NCT01014455|926104|P2|NOT COMPLETED|Overall Study||0
387304|NCT01014455|926105|P1|NOT COMPLETED|Overall Study||0
387305|NCT01014455|926104|P2|COMPLETED|Overall Study||87
387306|NCT01014455|926105|P1|COMPLETED|Overall Study||82
387307|NCT01014455|926104|P2|STARTED|Overall Study||87
387308|NCT01014455|926105|P1|STARTED|Overall Study||82
387309|NCT01014442|926113|P2|NOT COMPLETED|Overall Study||19
387310|NCT01014442|926114|P1|NOT COMPLETED|Overall Study||7
387311|NCT01014442|926113|P2|COMPLETED|Overall Study||16
387312|NCT01014442|926114|P1|COMPLETED|Overall Study||26
387313|NCT01014442|926113|P2|STARTED|Overall Study||35
387314|NCT01014442|926114|P1|STARTED|Overall Study||33
387315|NCT01014351|926226|P1|NOT COMPLETED|Overall Study||37
387316|NCT01014351|926226|P1|COMPLETED|Overall Study||33
387317|NCT01014351|926226|P1|STARTED|Overall Study||70
387318|NCT01014208|926234|P2|NOT COMPLETED|Overall Study||100
387319|NCT01014208|926235|P1|NOT COMPLETED|Overall Study||94
387320|NCT01014208|926234|P2|COMPLETED|Overall Study||122
387321|NCT01014208|926235|P1|COMPLETED|Overall Study||131
387322|NCT01014208|926234|P2|Intent-to-Treat Population|Overall Study||222
387323|NCT01014208|926235|P1|Intent-to-Treat Population|Overall Study||223
387324|NCT01014208|926234|P2|STARTED|Overall Study||222
387325|NCT01014208|926235|P1|STARTED|Overall Study||225
387326|NCT01014169|926263|P2|NOT COMPLETED|Overall Study||13
387327|NCT01014169|926264|P1|NOT COMPLETED|Overall Study||7
387328|NCT01014169|926263|P2|COMPLETED|Overall Study||48
387329|NCT01014169|926264|P1|COMPLETED|Overall Study||58
387330|NCT01014169|926263|P2|STARTED|Overall Study||61
387331|NCT01014169|926264|P1|STARTED|Overall Study||65
387332|NCT01014143|926277|P3|NOT COMPLETED|Third Intervention||0
387333|NCT01014143|926278|P2|NOT COMPLETED|Third Intervention||0
387334|NCT01014143|926279|P1|NOT COMPLETED|Third Intervention||0
387335|NCT01014143|926277|P3|COMPLETED|Third Intervention||9
387336|NCT01014143|926278|P2|COMPLETED|Third Intervention||9
387337|NCT01014143|926279|P1|COMPLETED|Third Intervention||8
387338|NCT01014143|926277|P3|STARTED|Third Intervention||9
387339|NCT01014143|926278|P2|STARTED|Third Intervention||9
387340|NCT01014143|926279|P1|STARTED|Third Intervention||8
387341|NCT01014143|926277|P3|NOT COMPLETED|Washout After 2nd Intervention||0
387342|NCT01014143|926278|P2|NOT COMPLETED|Washout After 2nd Intervention||0
387343|NCT01014143|926279|P1|NOT COMPLETED|Washout After 2nd Intervention||0
387344|NCT01014143|926277|P3|COMPLETED|Washout After 2nd Intervention||9
387345|NCT01014143|926278|P2|COMPLETED|Washout After 2nd Intervention||9
387346|NCT01014143|926279|P1|COMPLETED|Washout After 2nd Intervention||8
387347|NCT01014143|926277|P3|STARTED|Washout After 2nd Intervention||9
387348|NCT01014143|926278|P2|STARTED|Washout After 2nd Intervention||9
387349|NCT01014143|926279|P1|STARTED|Washout After 2nd Intervention||8
387350|NCT01014143|926277|P3|NOT COMPLETED|Second Intervention||0
387351|NCT01014143|926278|P2|NOT COMPLETED|Second Intervention||0
387352|NCT01014143|926279|P1|NOT COMPLETED|Second Intervention||2
387353|NCT01014143|926277|P3|COMPLETED|Second Intervention||9
387354|NCT01014143|926278|P2|COMPLETED|Second Intervention||9
387355|NCT01014143|926279|P1|COMPLETED|Second Intervention||8
387356|NCT01014143|926277|P3|STARTED|Second Intervention||9
387357|NCT01014143|926278|P2|STARTED|Second Intervention||9
387358|NCT01014143|926279|P1|STARTED|Second Intervention||10
387359|NCT01014143|926277|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
387360|NCT01014143|926278|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
387361|NCT01014143|926279|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
387362|NCT01014143|926277|P3|COMPLETED|Washout Period After 1st Intervention||9
387363|NCT01014143|926278|P2|COMPLETED|Washout Period After 1st Intervention||9
387364|NCT01014143|926279|P1|COMPLETED|Washout Period After 1st Intervention||10
387365|NCT01014143|926277|P3|STARTED|Washout Period After 1st Intervention||9
387366|NCT01014143|926278|P2|STARTED|Washout Period After 1st Intervention||9
387367|NCT01014143|926279|P1|STARTED|Washout Period After 1st Intervention||10
387368|NCT01014143|926277|P3|NOT COMPLETED|First Intervention||0
387369|NCT01014143|926278|P2|NOT COMPLETED|First Intervention||0
387370|NCT01014143|926279|P1|NOT COMPLETED|First Intervention||0
387371|NCT01014143|926277|P3|COMPLETED|First Intervention||9
387372|NCT01014143|926278|P2|COMPLETED|First Intervention||9
387373|NCT01014143|926279|P1|COMPLETED|First Intervention||10
387374|NCT01014143|926277|P3|STARTED|First Intervention||9
387375|NCT01014143|926278|P2|STARTED|First Intervention||9
387376|NCT01014143|926279|P1|STARTED|First Intervention||10
387377|NCT01014091|926293|P6|NOT COMPLETED|Overall Study||0
387378|NCT01014091|926294|P5|NOT COMPLETED|Overall Study||0
387379|NCT01014091|926295|P4|NOT COMPLETED|Overall Study||0
387380|NCT01014091|926296|P3|NOT COMPLETED|Overall Study||0
387381|NCT01014091|926297|P2|NOT COMPLETED|Overall Study||0
387382|NCT01014091|926298|P1|NOT COMPLETED|Overall Study||0
387383|NCT01014091|926293|P6|COMPLETED|Overall Study||12
387384|NCT01014091|926294|P5|COMPLETED|Overall Study||6
387385|NCT01014091|926295|P4|COMPLETED|Overall Study||15
387386|NCT01014091|926296|P3|COMPLETED|Overall Study||5
387387|NCT01014091|926297|P2|COMPLETED|Overall Study||13
387388|NCT01014091|926298|P1|COMPLETED|Overall Study||7
387389|NCT01014091|926293|P6|STARTED|Overall Study||12
387390|NCT01014091|926294|P5|STARTED|Overall Study||6
387391|NCT01014091|926295|P4|STARTED|Overall Study||15
387392|NCT01014091|926296|P3|STARTED|Overall Study||5
387393|NCT01014091|926297|P2|STARTED|Overall Study||13
387394|NCT01014091|926298|P1|STARTED|Overall Study||7
387395|NCT01014013|926374|P2|NOT COMPLETED|Overall Study||56
387396|NCT01014013|926375|P1|NOT COMPLETED|Overall Study||51
387397|NCT01014013|926374|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
387398|NCT01014013|926375|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
387399|NCT01014013|926374|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
387482|NCT01012973|926727|P2|STARTED|Overall Study||71
387400|NCT01014013|926375|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
387401|NCT01014013|926374|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
387402|NCT01014013|926375|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
387403|NCT01014013|926374|P2|STARTED|Overall Study||136
387404|NCT01014013|926375|P1|STARTED|Overall Study||135
387405|NCT01013961|926387|P2|NOT COMPLETED|Overall Study||3
387406|NCT01013961|926388|P1|NOT COMPLETED|Overall Study||3
387407|NCT01013961|926387|P2|COMPLETED|Overall Study||12
387408|NCT01013961|926388|P1|COMPLETED|Overall Study||13
387409|NCT01013961|926387|P2|STARTED|Overall Study||15
387410|NCT01013961|926388|P1|STARTED|Overall Study||16
387411|NCT01013883|926406|P2|NOT COMPLETED|Overall Study||2
387412|NCT01013883|926407|P1|NOT COMPLETED|Overall Study||2
387413|NCT01013883|926406|P2|COMPLETED|Overall Study||241
387414|NCT01013883|926407|P1|COMPLETED|Overall Study||268
387415|NCT01013883|926406|P2|STARTED|Overall Study||243
387416|NCT01013883|926407|P1|STARTED|Overall Study||270
387417|NCT01013870|926419|P2|NOT COMPLETED|Overall Study||3
387418|NCT01013870|926420|P1|NOT COMPLETED|Overall Study||1
387419|NCT01013870|926419|P2|COMPLETED|Overall Study||21
387420|NCT01013870|926420|P1|COMPLETED|Overall Study||27
387421|NCT01013870|926419|P2|STARTED|Overall Study||24
387422|NCT01013870|926420|P1|STARTED|Overall Study||28
387423|NCT01013844|926444|P2|NOT COMPLETED|Overall Study||0
387424|NCT01013844|926445|P1|NOT COMPLETED|Overall Study||0
387425|NCT01013844|926444|P2|COMPLETED|Overall Study||65
387426|NCT01013844|926445|P1|COMPLETED|Overall Study||65
387427|NCT01013844|926444|P2|STARTED|Overall Study||65
387428|NCT01013844|926445|P1|STARTED|Overall Study||65
387429|NCT01013792|926469|P2|NOT COMPLETED|Overall Study||5
387430|NCT01013792|926470|P1|NOT COMPLETED|Overall Study||2
387431|NCT01013792|926469|P2|COMPLETED|Overall Study||11
387432|NCT01013792|926470|P1|COMPLETED|Overall Study||12
387433|NCT01013792|926469|P2|STARTED|Overall Study||16
387434|NCT01013792|926470|P1|STARTED|Overall Study||14
387435|NCT01013753|926476|P1|NOT COMPLETED|Overall Study||16
387436|NCT01013753|926476|P1|COMPLETED|Overall Study||182
387437|NCT01013753|926476|P1|Received Form 12 mcg Bid|Overall Study||125
387438|NCT01013753|926476|P1|Received Olo 20 mcg qd|Overall Study||124
387439|NCT01013753|926476|P1|Received Olo 10 mcg qd|Overall Study||127
387440|NCT01013753|926476|P1|Received Olo 5 mcg qd|Overall Study||130
387441|NCT01013753|926476|P1|Received Olo 2 mcg qd|Overall Study||121
387442|NCT01013753|926476|P1|Received Placebo|Overall Study||125
387443|NCT01013753|926476|P1|STARTED|Overall Study|Entered and treated|198
387444|NCT01013740|926672|P2|NOT COMPLETED|Overall Study||19
387445|NCT01013740|926673|P1|NOT COMPLETED|Overall Study||11
387446|NCT01013740|926672|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
387447|NCT01013740|926673|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
387448|NCT01013740|926672|P2|Ongoing|Overall Study||0
387449|NCT01013740|926673|P1|Ongoing|Overall Study||0
387450|NCT01013740|926672|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
387451|NCT01013740|926673|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
387452|NCT01013597|926697|P1|NOT COMPLETED|Overall Study||1
387453|NCT01013597|926697|P1|COMPLETED|Overall Study||12
387454|NCT01013597|926697|P1|STARTED|Overall Study||13
387455|NCT01013207|926707|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
387456|NCT01013207|926707|P1|COMPLETED|CPAP Post Nexus (S9)||44
387457|NCT01013207|926707|P1|STARTED|CPAP Post Nexus (S9)||50
387458|NCT01013207|926707|P1|NOT COMPLETED|Nexus (S9)||0
387459|NCT01013207|926707|P1|COMPLETED|Nexus (S9)||50
387460|NCT01013207|926707|P1|STARTED|Nexus (S9)||50
387461|NCT01013207|926707|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
387462|NCT01013207|926707|P1|COMPLETED|CPAP Pre Nexus (S9)||50
387463|NCT01013207|926707|P1|STARTED|CPAP Pre Nexus (S9)||50
387464|NCT01013194|926714|P2|NOT COMPLETED|Overall Study||0
387465|NCT01013194|926715|P1|NOT COMPLETED|Overall Study||0
387466|NCT01013194|926714|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
387467|NCT01013194|926715|P1|COMPLETED|Overall Study|Consecutive patients|9
387468|NCT01013194|926714|P2|STARTED|Overall Study||16
387469|NCT01013194|926715|P1|STARTED|Overall Study||9
387470|NCT01012973|926727|P2|NOT COMPLETED|Overall Study||19
387471|NCT01012973|926728|P1|NOT COMPLETED|Overall Study||16
387472|NCT01012973|926727|P2|COMPLETED|Overall Study||52
387473|NCT01012973|926728|P1|COMPLETED|Overall Study||90
387474|NCT01012973|926727|P2|Completed Week 52, From FAS|Overall Study||52
387475|NCT01012973|926728|P1|Completed Week 52, From FAS|Overall Study||91
387476|NCT01012973|926727|P2|Completed Week 24, From FAS|Overall Study||57
387477|NCT01012973|926728|P1|Completed Week 24, From FAS|Overall Study||97
387478|NCT01012973|926727|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
387479|NCT01012973|926728|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
387480|NCT01012973|926727|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
387481|NCT01012973|926728|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
387483|NCT01012973|926728|P1|STARTED|Overall Study||106
387484|NCT01012947|926753|P5|NOT COMPLETED|Overall Study||142
387485|NCT01012947|926754|P4|NOT COMPLETED|Overall Study||118
387486|NCT01012947|926755|P3|NOT COMPLETED|Overall Study||130
387487|NCT01012947|926756|P2|NOT COMPLETED|Overall Study||135
387488|NCT01012947|926757|P1|NOT COMPLETED|Overall Study||131
387489|NCT01012947|926753|P5|COMPLETED|Overall Study||94
387490|NCT01012947|926754|P4|COMPLETED|Overall Study||93
387491|NCT01012947|926755|P3|COMPLETED|Overall Study||111
387492|NCT01012947|926756|P2|COMPLETED|Overall Study||80
387493|NCT01012947|926757|P1|COMPLETED|Overall Study||81
387494|NCT01012947|926753|P5|STARTED|Overall Study||236
387495|NCT01012947|926754|P4|STARTED|Overall Study||211
387496|NCT01012947|926755|P3|STARTED|Overall Study||241
387497|NCT01012947|926756|P2|STARTED|Overall Study||215
387498|NCT01012947|926757|P1|STARTED|Overall Study||212
387499|NCT01012765|926769|P6|NOT COMPLETED|Treatment Period 3||0
387500|NCT01012765|926770|P5|NOT COMPLETED|Treatment Period 3||0
387501|NCT01012765|926771|P4|NOT COMPLETED|Treatment Period 3||0
387502|NCT01012765|926772|P3|NOT COMPLETED|Treatment Period 3||0
387503|NCT01012765|926773|P2|NOT COMPLETED|Treatment Period 3||0
387504|NCT01012765|926774|P1|NOT COMPLETED|Treatment Period 3||0
387505|NCT01012765|926769|P6|COMPLETED|Treatment Period 3||24
387506|NCT01012765|926770|P5|COMPLETED|Treatment Period 3||18
387507|NCT01012765|926771|P4|COMPLETED|Treatment Period 3||15
387508|NCT01012765|926772|P3|COMPLETED|Treatment Period 3||18
387509|NCT01012765|926773|P2|COMPLETED|Treatment Period 3||19
387510|NCT01012765|926774|P1|COMPLETED|Treatment Period 3||16
387511|NCT01012765|926769|P6|STARTED|Treatment Period 3||24
387512|NCT01012765|926770|P5|STARTED|Treatment Period 3||18
387513|NCT01012765|926771|P4|STARTED|Treatment Period 3||15
387514|NCT01012765|926772|P3|STARTED|Treatment Period 3||18
387515|NCT01012765|926773|P2|STARTED|Treatment Period 3||19
387516|NCT01012765|926774|P1|STARTED|Treatment Period 3||16
387517|NCT01012765|926769|P6|NOT COMPLETED|Treatment Period 2||1
387518|NCT01012765|926770|P5|NOT COMPLETED|Treatment Period 2||1
387519|NCT01012765|926771|P4|NOT COMPLETED|Treatment Period 2||0
387520|NCT01012765|926772|P3|NOT COMPLETED|Treatment Period 2||3
387521|NCT01012765|926773|P2|NOT COMPLETED|Treatment Period 2||2
387522|NCT01012765|926774|P1|NOT COMPLETED|Treatment Period 2||1
387523|NCT01012765|926769|P6|COMPLETED|Treatment Period 2||24
387524|NCT01012765|926770|P5|COMPLETED|Treatment Period 2||18
387525|NCT01012765|926771|P4|COMPLETED|Treatment Period 2||15
387526|NCT01012765|926772|P3|COMPLETED|Treatment Period 2||18
387527|NCT01012765|926773|P2|COMPLETED|Treatment Period 2||19
387528|NCT01012765|926774|P1|COMPLETED|Treatment Period 2||16
387529|NCT01012765|926769|P6|STARTED|Treatment Period 2||25
387530|NCT01012765|926770|P5|STARTED|Treatment Period 2||19
387531|NCT01012765|926771|P4|STARTED|Treatment Period 2||15
387532|NCT01012765|926772|P3|STARTED|Treatment Period 2||21
387533|NCT01012765|926773|P2|STARTED|Treatment Period 2||21
387534|NCT01012765|926774|P1|STARTED|Treatment Period 2||17
387535|NCT01012765|926769|P6|NOT COMPLETED|Treatment Period 1||0
387536|NCT01012765|926770|P5|NOT COMPLETED|Treatment Period 1||3
387537|NCT01012765|926771|P4|NOT COMPLETED|Treatment Period 1||3
387538|NCT01012765|926772|P3|NOT COMPLETED|Treatment Period 1||2
387539|NCT01012765|926773|P2|NOT COMPLETED|Treatment Period 1||0
387540|NCT01012765|926774|P1|NOT COMPLETED|Treatment Period 1||3
387541|NCT01012765|926769|P6|COMPLETED|Treatment Period 1||25
387542|NCT01012765|926770|P5|COMPLETED|Treatment Period 1||19
387543|NCT01012765|926771|P4|COMPLETED|Treatment Period 1||15
387544|NCT01012765|926772|P3|COMPLETED|Treatment Period 1||21
387545|NCT01012765|926773|P2|COMPLETED|Treatment Period 1||21
387546|NCT01012765|926774|P1|COMPLETED|Treatment Period 1||17
387547|NCT01012765|926769|P6|STARTED|Treatment Period 1||25
387548|NCT01012765|926770|P5|STARTED|Treatment Period 1||22
387549|NCT01012765|926771|P4|STARTED|Treatment Period 1||18
387550|NCT01012765|926772|P3|STARTED|Treatment Period 1||23
387551|NCT01012765|926773|P2|STARTED|Treatment Period 1||21
387552|NCT01012765|926774|P1|STARTED|Treatment Period 1||20
387553|NCT01012739|926803|P4|NOT COMPLETED|Treatment Period 4||0
387554|NCT01012739|926804|P3|NOT COMPLETED|Treatment Period 4||0
387555|NCT01012739|926805|P2|NOT COMPLETED|Treatment Period 4||0
387556|NCT01012739|926806|P1|NOT COMPLETED|Treatment Period 4||0
387557|NCT01012739|926803|P4|COMPLETED|Treatment Period 4||7
387558|NCT01012739|926804|P3|COMPLETED|Treatment Period 4||9
387559|NCT01012739|926805|P2|COMPLETED|Treatment Period 4||8
387560|NCT01012739|926806|P1|COMPLETED|Treatment Period 4||9
387561|NCT01012739|926803|P4|STARTED|Treatment Period 4||7
387562|NCT01012739|926804|P3|STARTED|Treatment Period 4||9
387563|NCT01012739|926805|P2|STARTED|Treatment Period 4||8
387564|NCT01012739|926806|P1|STARTED|Treatment Period 4||9
387565|NCT01012739|926803|P4|NOT COMPLETED|Treatment Period 3||0
387566|NCT01012739|926804|P3|NOT COMPLETED|Treatment Period 3||0
387567|NCT01012739|926805|P2|NOT COMPLETED|Treatment Period 3||0
387568|NCT01012739|926806|P1|NOT COMPLETED|Treatment Period 3||0
387569|NCT01012739|926803|P4|COMPLETED|Treatment Period 3||7
387570|NCT01012739|926804|P3|COMPLETED|Treatment Period 3||9
387571|NCT01012739|926805|P2|COMPLETED|Treatment Period 3||8
387572|NCT01012739|926806|P1|COMPLETED|Treatment Period 3||9
387573|NCT01012739|926803|P4|STARTED|Treatment Period 3||7
387574|NCT01012739|926804|P3|STARTED|Treatment Period 3||9
387575|NCT01012739|926805|P2|STARTED|Treatment Period 3||8
387576|NCT01012739|926806|P1|STARTED|Treatment Period 3||9
387577|NCT01012739|926803|P4|NOT COMPLETED|Treatment Period 2||1
387578|NCT01012739|926804|P3|NOT COMPLETED|Treatment Period 2||0
387579|NCT01012739|926805|P2|NOT COMPLETED|Treatment Period 2||0
387580|NCT01012739|926806|P1|NOT COMPLETED|Treatment Period 2||0
387581|NCT01012739|926803|P4|COMPLETED|Treatment Period 2||7
387582|NCT01012739|926804|P3|COMPLETED|Treatment Period 2||9
387583|NCT01012739|926805|P2|COMPLETED|Treatment Period 2||8
387584|NCT01012739|926806|P1|COMPLETED|Treatment Period 2||9
387585|NCT01012739|926803|P4|STARTED|Treatment Period 2||8
387586|NCT01012739|926804|P3|STARTED|Treatment Period 2||9
387587|NCT01012739|926805|P2|STARTED|Treatment Period 2||8
387588|NCT01012739|926806|P1|STARTED|Treatment Period 2||9
387589|NCT01012739|926803|P4|NOT COMPLETED|Treatment Period 1||1
387590|NCT01012739|926804|P3|NOT COMPLETED|Treatment Period 1||0
387591|NCT01012739|926805|P2|NOT COMPLETED|Treatment Period 1||0
387592|NCT01012739|926806|P1|NOT COMPLETED|Treatment Period 1||0
387593|NCT01012739|926803|P4|COMPLETED|Treatment Period 1||8
387594|NCT01012739|926804|P3|COMPLETED|Treatment Period 1||9
387595|NCT01012739|926805|P2|COMPLETED|Treatment Period 1||8
387596|NCT01012739|926806|P1|COMPLETED|Treatment Period 1||9
387597|NCT01012739|926803|P4|STARTED|Treatment Period 1||9
387598|NCT01012739|926804|P3|STARTED|Treatment Period 1||9
387599|NCT01012739|926805|P2|STARTED|Treatment Period 1||8
387600|NCT01012739|926806|P1|STARTED|Treatment Period 1||9
387601|NCT01012713|926834|P1|NOT COMPLETED|Overall Study||3
387602|NCT01012713|926834|P1|COMPLETED|Overall Study||27
387603|NCT01012713|926834|P1|STARTED|Overall Study||30
387604|NCT01012674|926840|P1|NOT COMPLETED|Overall Study||24
387605|NCT01012674|926840|P1|COMPLETED|Overall Study||187
387606|NCT01012674|926840|P1|STARTED|Overall Study||211
387607|NCT01012661|926852|P1|NOT COMPLETED|Overall Study||0
387608|NCT01012661|926852|P1|COMPLETED|Overall Study||50
387609|NCT01012661|926852|P1|STARTED|Overall Study||50
387610|NCT01012622|926860|P1|NOT COMPLETED|Overall Study||31
387611|NCT01012622|926860|P1|COMPLETED|Overall Study||111
387612|NCT01012622|926860|P1|STARTED|Overall Study||142
387613|NCT01012440|926879|P1|NOT COMPLETED|Overall Study||2
387614|NCT01012440|926879|P1|COMPLETED|Overall Study||3
387615|NCT01012440|926879|P1|STARTED|Overall Study||5
387616|NCT01012414|926883|P1|NOT COMPLETED|Overall Study||10
387617|NCT01012414|926883|P1|COMPLETED|Overall Study|No subjects completed the study.|0
387618|NCT01012414|926883|P1|STARTED|Overall Study||10
387619|NCT01012388|926890|P1|NOT COMPLETED|Overall Study||0
387620|NCT01012388|926890|P1|COMPLETED|Overall Study||100
387621|NCT01012388|926890|P1|STARTED|Overall Study||100
387622|NCT01012336|926895|P1|NOT COMPLETED|Overall Study||0
387623|NCT01012336|926895|P1|COMPLETED|Overall Study||85
387624|NCT01012336|926895|P1|STARTED|Overall Study||85
387625|NCT01012323|926899|P1|NOT COMPLETED|Overall Study||1
387626|NCT01012323|926899|P1|COMPLETED|Overall Study||50
387627|NCT01012323|926899|P1|STARTED|Overall Study||51
387628|NCT01012258|926921|P1|NOT COMPLETED|Overall Study||66
387629|NCT01012258|926921|P1|COMPLETED|Overall Study||0
387630|NCT01012258|926921|P1|STARTED|Overall Study||66
387631|NCT01012245|926931|P1|NOT COMPLETED|Overall Study||2427
387632|NCT01012245|926931|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
387633|NCT01012245|926931|P1|STARTED|Overall Study||28812
387634|NCT01012219|926968|P1|NOT COMPLETED|Period 3||0
387635|NCT01012219|926968|P1|COMPLETED|Period 3||20
387636|NCT01012219|926968|P1|STARTED|Period 3|of the 36 who started Period 1|20
387637|NCT01012219|926968|P1|NOT COMPLETED|Period 2||1
387638|NCT01012219|926968|P1|COMPLETED|Period 2||34
387639|NCT01012219|926968|P1|STARTED|Period 2|Number who completed Period 1|35
387640|NCT01012219|926968|P1|NOT COMPLETED|Period 1||1
387641|NCT01012219|926968|P1|COMPLETED|Period 1||35
387642|NCT01012219|926968|P1|STARTED|Period 1|Number randomized|36
387643|NCT01012167|926978|P3|NOT COMPLETED|Overall Study||4
387644|NCT01012167|926979|P2|NOT COMPLETED|Overall Study||2
387645|NCT01012167|926980|P1|NOT COMPLETED|Overall Study||2
387646|NCT01012167|926978|P3|COMPLETED|Overall Study||17
387647|NCT01012167|926979|P2|COMPLETED|Overall Study||18
387648|NCT01012167|926980|P1|COMPLETED|Overall Study||15
387649|NCT01012167|926978|P3|Exposed to Study Drug|Overall Study||20
387650|NCT01012167|926979|P2|Exposed to Study Drug|Overall Study||20
387651|NCT01012167|926980|P1|Exposed to Study Drug|Overall Study||16
387652|NCT01012167|926978|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
387653|NCT01012167|926979|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
387654|NCT01012167|926980|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
387655|NCT01012167|926978|P3|STARTED|Overall Study||21
387656|NCT01012167|926979|P2|STARTED|Overall Study||20
387657|NCT01012167|926980|P1|STARTED|Overall Study||17
387658|NCT01012037|927237|P3|NOT COMPLETED|Overall Study||10
387659|NCT01012037|927238|P2|NOT COMPLETED|Overall Study||16
387660|NCT01012037|927239|P1|NOT COMPLETED|Overall Study||1
387661|NCT01012037|927237|P3|COMPLETED|Overall Study||214
387662|NCT01012037|927238|P2|COMPLETED|Overall Study||207
387663|NCT01012037|927239|P1|COMPLETED|Overall Study||43
387664|NCT01012037|927237|P3|STARTED|Overall Study||224
387665|NCT01012037|927238|P2|STARTED|Overall Study||223
387666|NCT01012037|927239|P1|STARTED|Overall Study||44
387667|NCT01011946|927274|P1|NOT COMPLETED|Overall Study||3
387668|NCT01011946|927274|P1|COMPLETED|Overall Study||33
387669|NCT01011946|927274|P1|STARTED|Overall Study||36
387670|NCT01011933|927278|P1|NOT COMPLETED|Overall Study||4
387671|NCT01011933|927278|P1|COMPLETED|Overall Study|total eligible and evaluable|50
387672|NCT01011933|927278|P1|STARTED|Overall Study|total enrolled|54
387673|NCT01011907|927287|P2|NOT COMPLETED|Overall Study||15
387674|NCT01011907|927288|P1|NOT COMPLETED|Overall Study||14
387675|NCT01011907|927287|P2|COMPLETED|Overall Study||18
387676|NCT01011907|927288|P1|COMPLETED|Overall Study||17
387677|NCT01011907|927287|P2|STARTED|Overall Study||33
387678|NCT01011907|927288|P1|STARTED|Overall Study||31
387679|NCT01011894|927298|P1|NOT COMPLETED|Overall Study||0
387680|NCT01011894|927298|P1|COMPLETED|Overall Study||26
387681|NCT01011894|927298|P1|STARTED|Overall Study||26
387682|NCT01011868|927305|P3|NOT COMPLETED|After Week 78 Follow-up||44
387683|NCT01011868|927306|P2|NOT COMPLETED|After Week 78 Follow-up||38
387684|NCT01011868|927307|P1|NOT COMPLETED|After Week 78 Follow-up||52
387685|NCT01011868|927305|P3|COMPLETED|After Week 78 Follow-up||111
387686|NCT01011868|927306|P2|COMPLETED|After Week 78 Follow-up||131
387687|NCT01011868|927307|P1|COMPLETED|After Week 78 Follow-up||118
387688|NCT01011868|927305|P3|STARTED|After Week 78 Follow-up||155
387689|NCT01011868|927306|P2|STARTED|After Week 78 Follow-up||169
387690|NCT01011868|927307|P1|STARTED|After Week 78 Follow-up||170
387691|NCT01011868|927305|P3|NOT COMPLETED|After Week 18 Follow-up||26
387692|NCT01011868|927306|P2|NOT COMPLETED|After Week 18 Follow-up||16
387693|NCT01011868|927307|P1|NOT COMPLETED|After Week 18 Follow-up||23
387694|NCT01011868|927305|P3|COMPLETED|After Week 18 Follow-up||129
387695|NCT01011868|927306|P2|COMPLETED|After Week 18 Follow-up||153
387696|NCT01011868|927307|P1|COMPLETED|After Week 18 Follow-up||147
387697|NCT01011868|927305|P3|STARTED|After Week 18 Follow-up||155
387698|NCT01011868|927306|P2|STARTED|After Week 18 Follow-up||169
387699|NCT01011868|927307|P1|STARTED|After Week 18 Follow-up||170
387700|NCT01011829|927344|P2|NOT COMPLETED|Overall Study||9
387701|NCT01011829|927345|P1|NOT COMPLETED|Overall Study||4
387702|NCT01011829|927344|P2|COMPLETED|Overall Study||1
387703|NCT01011829|927345|P1|COMPLETED|Overall Study||6
387704|NCT01011829|927344|P2|STARTED|Overall Study||10
387705|NCT01011829|927345|P1|STARTED|Overall Study||10
387706|NCT01011816|927355|P2|NOT COMPLETED|78-Week Extended Follow-up||28
387707|NCT01011816|927356|P1|NOT COMPLETED|78-Week Extended Follow-up||72
387708|NCT01011816|927355|P2|COMPLETED|78-Week Extended Follow-up||26
387709|NCT01011816|927356|P1|COMPLETED|78-Week Extended Follow-up||85
387710|NCT01011816|927355|P2|STARTED|78-Week Extended Follow-up||54
387711|NCT01011816|927356|P1|STARTED|78-Week Extended Follow-up||157
387712|NCT01011816|927355|P2|NOT COMPLETED|26-Week Primary Endpoint||2
387713|NCT01011816|927356|P1|NOT COMPLETED|26-Week Primary Endpoint||7
387714|NCT01011816|927355|P2|COMPLETED|26-Week Primary Endpoint||54
387715|NCT01011816|927356|P1|COMPLETED|26-Week Primary Endpoint||157
387716|NCT01011816|927355|P2|STARTED|26-Week Primary Endpoint||56
387717|NCT01011816|927356|P1|STARTED|26-Week Primary Endpoint||164
387718|NCT01011738|927369|P3|NOT COMPLETED|Overall Study||17
387719|NCT01011738|927370|P2|NOT COMPLETED|Overall Study||294
387720|NCT01011738|927371|P1|NOT COMPLETED|Overall Study||324
387721|NCT01011738|927369|P3|COMPLETED|Overall Study||36
387722|NCT01011738|927370|P2|COMPLETED|Overall Study||618
387723|NCT01011738|927371|P1|COMPLETED|Overall Study||553
387724|NCT01011738|927369|P3|STARTED|Overall Study||53
387725|NCT01011738|927370|P2|STARTED|Overall Study||912
387726|NCT01011738|927371|P1|STARTED|Overall Study||877
387727|NCT01011673|927411|P2|NOT COMPLETED|24 Hour Follow-up||3
387728|NCT01011673|927412|P1|NOT COMPLETED|24 Hour Follow-up||3
387729|NCT01011673|927411|P2|COMPLETED|24 Hour Follow-up||57
387730|NCT01011673|927412|P1|COMPLETED|24 Hour Follow-up||57
387731|NCT01011673|927411|P2|STARTED|24 Hour Follow-up||60
387732|NCT01011673|927412|P1|STARTED|24 Hour Follow-up||60
387733|NCT01011673|927411|P2|NOT COMPLETED|Emergency Department Portion||0
387734|NCT01011673|927412|P1|NOT COMPLETED|Emergency Department Portion||0
387735|NCT01011673|927411|P2|COMPLETED|Emergency Department Portion||60
387736|NCT01011673|927412|P1|COMPLETED|Emergency Department Portion||60
387737|NCT01011673|927411|P2|STARTED|Emergency Department Portion||60
387738|NCT01011673|927412|P1|STARTED|Emergency Department Portion||60
387739|NCT01011673|927411|P2|NOT COMPLETED|Randomized||1
387740|NCT01011673|927412|P1|NOT COMPLETED|Randomized||2
387741|NCT01011673|927411|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
387742|NCT01011673|927412|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
387743|NCT01011673|927411|P2|STARTED|Randomized||61
387744|NCT01011673|927412|P1|STARTED|Randomized||62
387745|NCT01011634|927422|P2|NOT COMPLETED|Overall Study||1
387746|NCT01011634|927423|P1|NOT COMPLETED|Overall Study||0
387747|NCT01011634|927422|P2|COMPLETED|Overall Study||8
387748|NCT01011634|927423|P1|COMPLETED|Overall Study||9
387749|NCT01011634|927422|P2|STARTED|Overall Study||9
387750|NCT01011634|927423|P1|STARTED|Overall Study||9
387751|NCT01011556|927435|P4|NOT COMPLETED|Overall Study||13
387752|NCT01011556|927436|P3|NOT COMPLETED|Overall Study||10
387753|NCT01011556|927437|P2|NOT COMPLETED|Overall Study||8
387754|NCT01011556|927438|P1|NOT COMPLETED|Overall Study||6
387755|NCT01011556|927435|P4|COMPLETED|Overall Study||51
387756|NCT01011556|927436|P3|COMPLETED|Overall Study||45
387757|NCT01011556|927437|P2|COMPLETED|Overall Study||48
387758|NCT01011556|927438|P1|COMPLETED|Overall Study||52
387759|NCT01011556|927435|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
387760|NCT01011556|927436|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
387761|NCT01011556|927437|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
387762|NCT01011556|927438|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
387763|NCT01011556|927435|P4|STARTED|Overall Study||64
387764|NCT01011556|927436|P3|STARTED|Overall Study||55
387765|NCT01011556|927437|P2|STARTED|Overall Study||56
387766|NCT01011556|927438|P1|STARTED|Overall Study||58
387767|NCT01011465|927516|P8|NOT COMPLETED|Overall Study||0
387768|NCT01011465|927517|P7|NOT COMPLETED|Overall Study||1
387769|NCT01011465|927518|P6|NOT COMPLETED|Overall Study||0
387770|NCT01011465|927519|P5|NOT COMPLETED|Overall Study||1
387771|NCT01011465|927520|P4|NOT COMPLETED|Overall Study||0
387772|NCT01011465|927521|P3|NOT COMPLETED|Overall Study||0
387773|NCT01011465|927522|P2|NOT COMPLETED|Overall Study||1
387774|NCT01011465|927523|P1|NOT COMPLETED|Overall Study||2
387775|NCT01011465|927516|P8|COMPLETED|Overall Study||32
387776|NCT01011465|927517|P7|COMPLETED|Overall Study||51
387777|NCT01011465|927518|P6|COMPLETED|Overall Study||29
387778|NCT01011465|927519|P5|COMPLETED|Overall Study||46
387779|NCT01011465|927520|P4|COMPLETED|Overall Study||18
387780|NCT01011465|927521|P3|COMPLETED|Overall Study||36
387781|NCT01011465|927522|P2|COMPLETED|Overall Study||19
387782|NCT01011465|927523|P1|COMPLETED|Overall Study||34
387783|NCT01011465|927516|P8|STARTED|Overall Study||32
387784|NCT01011465|927517|P7|STARTED|Overall Study||52
387785|NCT01011465|927518|P6|STARTED|Overall Study||29
387786|NCT01011465|927519|P5|STARTED|Overall Study||47
387787|NCT01011465|927520|P4|STARTED|Overall Study||18
387788|NCT01011465|927521|P3|STARTED|Overall Study||36
387789|NCT01011465|927522|P2|STARTED|Overall Study||20
387790|NCT01011465|927523|P1|STARTED|Overall Study||36
387791|NCT01011387|927551|P1|NOT COMPLETED|Overall Study||6
387792|NCT01011387|927551|P1|COMPLETED|Overall Study||10
387793|NCT01011387|927551|P1|STARTED|Overall Study||16
387794|NCT01011309|927558|P3|NOT COMPLETED|Overall Study||5
387795|NCT01011309|927559|P2|NOT COMPLETED|Overall Study||3
387796|NCT01011309|927560|P1|NOT COMPLETED|Overall Study||2
387797|NCT01011309|927558|P3|COMPLETED|Overall Study||16
387798|NCT01011309|927559|P2|COMPLETED|Overall Study||7
387799|NCT01011309|927560|P1|COMPLETED|Overall Study||12
387800|NCT01011309|927558|P3|STARTED|Overall Study||21
387801|NCT01011309|927559|P2|STARTED|Overall Study||10
387802|NCT01011309|927560|P1|STARTED|Overall Study||14
387803|NCT01011283|927576|P2|NOT COMPLETED|Overall Study||11
387804|NCT01011283|927577|P1|NOT COMPLETED|Overall Study||11
387805|NCT01011283|927576|P2|COMPLETED|Overall Study||2
387806|NCT01011283|927577|P1|COMPLETED|Overall Study||2
387807|NCT01011283|927576|P2|STARTED|Overall Study||13
387808|NCT01011283|927577|P1|STARTED|Overall Study||13
387809|NCT01011179|927587|P2|NOT COMPLETED|Overall Study||2
387810|NCT01011179|927588|P1|NOT COMPLETED|Overall Study||4
387811|NCT01011179|927587|P2|COMPLETED|Overall Study||20
387812|NCT01011179|927588|P1|COMPLETED|Overall Study||20
387813|NCT01011179|927587|P2|STARTED|Overall Study||22
387814|NCT01011179|927588|P1|STARTED|Overall Study||24
387815|NCT01011153|927597|P3|NOT COMPLETED|Overall Study||9
387816|NCT01011153|927598|P2|NOT COMPLETED|Overall Study||11
387817|NCT01011153|927599|P1|NOT COMPLETED|Overall Study||8
387818|NCT01011153|927597|P3|COMPLETED|Overall Study||45
387819|NCT01011153|927598|P2|COMPLETED|Overall Study||64
387820|NCT01011153|927599|P1|COMPLETED|Overall Study||46
387821|NCT01011153|927597|P3|STARTED|Overall Study||54
387822|NCT01011153|927598|P2|STARTED|Overall Study||75
387823|NCT01011153|927599|P1|STARTED|Overall Study||54
387824|NCT01011075|927617|P1|NOT COMPLETED|Overall Study||0
387825|NCT01011075|927617|P1|COMPLETED|Overall Study||34
387826|NCT01011075|927617|P1|STARTED|Overall Study||34
387827|NCT01011049|927628|P4|NOT COMPLETED|Overall Study||0
387828|NCT01011049|927629|P3|NOT COMPLETED|Overall Study||4
387829|NCT01011049|927630|P2|NOT COMPLETED|Overall Study||2
387830|NCT01011049|927631|P1|NOT COMPLETED|Overall Study||1
387831|NCT01011049|927628|P4|COMPLETED|Overall Study||246
387832|NCT01011049|927629|P3|COMPLETED|Overall Study||239
387833|NCT01011049|927630|P2|COMPLETED|Overall Study||250
387834|NCT01011049|927631|P1|COMPLETED|Overall Study||506
387835|NCT01011049|927628|P4|STARTED|Overall Study||246
387836|NCT01011049|927629|P3|STARTED|Overall Study||243
387837|NCT01011049|927630|P2|STARTED|Overall Study||252
387838|NCT01011049|927631|P1|STARTED|Overall Study||507
387839|NCT01010971|927656|P3|NOT COMPLETED|Overall Study||13
387840|NCT01010971|927657|P2|NOT COMPLETED|Overall Study||8
387841|NCT01010971|927658|P1|NOT COMPLETED|Overall Study||3
387842|NCT01010971|927656|P3|COMPLETED|Overall Study||207
387843|NCT01010971|927657|P2|COMPLETED|Overall Study||218
387844|NCT01010971|927658|P1|COMPLETED|Overall Study||222
387845|NCT01010971|927656|P3|STARTED|Overall Study||220
387846|NCT01010971|927657|P2|STARTED|Overall Study||226
387847|NCT01010971|927658|P1|STARTED|Overall Study||225
387848|NCT01010932|927743|P1|NOT COMPLETED|Overall Study||22
387849|NCT01010932|927743|P1|COMPLETED|Overall Study||200
387850|NCT01010932|927743|P1|STARTED|Overall Study||222
387851|NCT01010906|927761|P6|NOT COMPLETED|Overall Study||0
387852|NCT01010906|927762|P5|NOT COMPLETED|Overall Study||0
387853|NCT01010906|927763|P4|NOT COMPLETED|Overall Study||0
387854|NCT01010906|927764|P3|NOT COMPLETED|Overall Study||0
387855|NCT01010906|927765|P2|NOT COMPLETED|Overall Study||0
387856|NCT01010906|927766|P1|NOT COMPLETED|Overall Study||0
387857|NCT01010906|927761|P6|COMPLETED|Overall Study||10
387858|NCT01010906|927762|P5|COMPLETED|Overall Study||10
387859|NCT01010906|927763|P4|COMPLETED|Overall Study||10
387860|NCT01010906|927764|P3|COMPLETED|Overall Study||10
387861|NCT01010906|927765|P2|COMPLETED|Overall Study||10
387862|NCT01010906|927766|P1|COMPLETED|Overall Study||10
387863|NCT01010906|927761|P6|STARTED|Overall Study||10
387864|NCT01010906|927762|P5|STARTED|Overall Study||10
387865|NCT01010906|927763|P4|STARTED|Overall Study||10
387866|NCT01010906|927764|P3|STARTED|Overall Study||10
387867|NCT01010906|927765|P2|STARTED|Overall Study||10
387868|NCT01010906|927766|P1|STARTED|Overall Study||10
387869|NCT01010776|927786|P1|NOT COMPLETED|Extension Phase||3
387870|NCT01010776|927786|P1|COMPLETED|Extension Phase||156
387871|NCT01010776|927786|P1|STARTED|Extension Phase||159
387872|NCT01010776|927786|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
387873|NCT01010776|927786|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
387874|NCT01010776|927786|P1|STARTED|In-Between Main Phase & Extension Phase||174
387875|NCT01010776|927786|P1|NOT COMPLETED|Main Phase||49
387876|NCT01010776|927786|P1|COMPLETED|Main Phase||174
387877|NCT01010776|927786|P1|Treated|Main Phase||218
387878|NCT01010776|927786|P1|STARTED|Main Phase||223
387879|NCT01010750|927814|P6|NOT COMPLETED|Third Intervention||0
387880|NCT01010750|927815|P5|NOT COMPLETED|Third Intervention||0
387881|NCT01010750|927816|P4|NOT COMPLETED|Third Intervention||0
387882|NCT01010750|927817|P3|NOT COMPLETED|Third Intervention||0
387883|NCT01010750|927818|P2|NOT COMPLETED|Third Intervention||0
387884|NCT01010750|927819|P1|NOT COMPLETED|Third Intervention||0
387885|NCT01010750|927814|P6|COMPLETED|Third Intervention||3
387886|NCT01010750|927815|P5|COMPLETED|Third Intervention||2
387887|NCT01010750|927816|P4|COMPLETED|Third Intervention||3
387888|NCT01010750|927817|P3|COMPLETED|Third Intervention||3
387889|NCT01010750|927818|P2|COMPLETED|Third Intervention||3
387890|NCT01010750|927819|P1|COMPLETED|Third Intervention||3
387891|NCT01010750|927814|P6|STARTED|Third Intervention||3
387892|NCT01010750|927815|P5|STARTED|Third Intervention||2
387893|NCT01010750|927816|P4|STARTED|Third Intervention||3
387894|NCT01010750|927817|P3|STARTED|Third Intervention||3
387895|NCT01010750|927818|P2|STARTED|Third Intervention||3
387896|NCT01010750|927819|P1|STARTED|Third Intervention||3
387897|NCT01010750|927814|P6|NOT COMPLETED|Second Intervention||0
387898|NCT01010750|927815|P5|NOT COMPLETED|Second Intervention||0
387899|NCT01010750|927816|P4|NOT COMPLETED|Second Intervention||0
387900|NCT01010750|927817|P3|NOT COMPLETED|Second Intervention||0
387901|NCT01010750|927818|P2|NOT COMPLETED|Second Intervention||1
387902|NCT01010750|927819|P1|NOT COMPLETED|Second Intervention||0
387903|NCT01010750|927814|P6|COMPLETED|Second Intervention||3
387904|NCT01010750|927815|P5|COMPLETED|Second Intervention||2
387905|NCT01010750|927816|P4|COMPLETED|Second Intervention||3
387906|NCT01010750|927817|P3|COMPLETED|Second Intervention||3
387907|NCT01010750|927818|P2|COMPLETED|Second Intervention||3
387908|NCT01010750|927819|P1|COMPLETED|Second Intervention||3
387909|NCT01010750|927814|P6|STARTED|Second Intervention||3
387910|NCT01010750|927815|P5|STARTED|Second Intervention||2
387911|NCT01010750|927816|P4|STARTED|Second Intervention||3
387912|NCT01010750|927817|P3|STARTED|Second Intervention||3
387913|NCT01010750|927818|P2|STARTED|Second Intervention||4
387914|NCT01010750|927819|P1|STARTED|Second Intervention||3
387915|NCT01010750|927814|P6|NOT COMPLETED|First Intervention||0
387916|NCT01010750|927815|P5|NOT COMPLETED|First Intervention||0
387917|NCT01010750|927816|P4|NOT COMPLETED|First Intervention||0
387918|NCT01010750|927817|P3|NOT COMPLETED|First Intervention||0
387919|NCT01010750|927818|P2|NOT COMPLETED|First Intervention||0
387920|NCT01010750|927819|P1|NOT COMPLETED|First Intervention||0
387921|NCT01010750|927814|P6|COMPLETED|First Intervention||3
387922|NCT01010750|927815|P5|COMPLETED|First Intervention||2
387923|NCT01010750|927816|P4|COMPLETED|First Intervention||3
387924|NCT01010750|927817|P3|COMPLETED|First Intervention||3
387925|NCT01010750|927818|P2|COMPLETED|First Intervention||4
387926|NCT01010750|927819|P1|COMPLETED|First Intervention||3
387927|NCT01010750|927814|P6|STARTED|First Intervention||3
387928|NCT01010750|927815|P5|STARTED|First Intervention||2
387929|NCT01010750|927816|P4|STARTED|First Intervention||3
387930|NCT01010750|927817|P3|STARTED|First Intervention||3
387931|NCT01010750|927818|P2|STARTED|First Intervention||4
387932|NCT01010750|927819|P1|STARTED|First Intervention||3
387933|NCT01010633|927844|P2|NOT COMPLETED|Overall Study||5
387934|NCT01010633|927845|P1|NOT COMPLETED|Overall Study||4
387935|NCT01010633|927844|P2|COMPLETED|Overall Study||198
387936|NCT01010633|927845|P1|COMPLETED|Overall Study||199
387937|NCT01010633|927844|P2|STARTED|Overall Study||203
387938|NCT01010633|927845|P1|STARTED|Overall Study||203
387939|NCT01010568|927855|P1|NOT COMPLETED|Overall Study||5
387940|NCT01010568|927855|P1|COMPLETED|Overall Study||5
387941|NCT01010568|927855|P1|STARTED|Overall Study||10
387942|NCT01010555|927861|P2|NOT COMPLETED|Second Four Weeks of Wear||0
387943|NCT01010555|927862|P1|NOT COMPLETED|Second Four Weeks of Wear||0
387944|NCT01010555|927861|P2|COMPLETED|Second Four Weeks of Wear||9
387945|NCT01010555|927862|P1|COMPLETED|Second Four Weeks of Wear||10
387946|NCT01010555|927861|P2|STARTED|Second Four Weeks of Wear||9
387947|NCT01010555|927862|P1|STARTED|Second Four Weeks of Wear||10
387948|NCT01010555|927861|P2|NOT COMPLETED|First Four Weeks of Wear||0
387949|NCT01010555|927862|P1|NOT COMPLETED|First Four Weeks of Wear||0
387950|NCT01010555|927861|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
387951|NCT01010555|927862|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
387952|NCT01010555|927861|P2|STARTED|First Four Weeks of Wear||10
387953|NCT01010555|927862|P1|STARTED|First Four Weeks of Wear||11
387954|NCT01010503|927872|P1|NOT COMPLETED|Overall Study||2
387955|NCT01010503|927872|P1|COMPLETED|Overall Study||30
387956|NCT01010503|927872|P1|STARTED|Overall Study||32
387957|NCT01010477|927892|P2|NOT COMPLETED|Overall Study||3
387958|NCT01010477|927893|P1|NOT COMPLETED|Overall Study||6
387959|NCT01010477|927892|P2|COMPLETED|Overall Study||22
387960|NCT01010477|927893|P1|COMPLETED|Overall Study||21
387961|NCT01010477|927892|P2|STARTED|Overall Study||25
387962|NCT01010477|927893|P1|STARTED|Overall Study||27
387963|NCT01010399|927899|P1|NOT COMPLETED|Overall Study||5
387964|NCT01010399|927899|P1|COMPLETED|Overall Study||31
387965|NCT01010399|927899|P1|STARTED|Overall Study||36
387966|NCT01010282|927907|P3|NOT COMPLETED|Overall Study||19
387967|NCT01010282|927908|P2|NOT COMPLETED|Overall Study||7
387968|NCT01010282|927909|P1|NOT COMPLETED|Overall Study||6
387969|NCT01010282|927907|P3|COMPLETED|Overall Study||77
387970|NCT01010282|927908|P2|COMPLETED|Overall Study||88
387971|NCT01010282|927909|P1|COMPLETED|Overall Study||91
387972|NCT01010282|927907|P3|STARTED|Overall Study||96
387973|NCT01010282|927908|P2|STARTED|Overall Study||95
387974|NCT01010282|927909|P1|STARTED|Overall Study||97
387975|NCT01010230|927931|P2|NOT COMPLETED|Overall Study||7
387976|NCT01010230|927932|P1|NOT COMPLETED|Overall Study||10
387977|NCT01010230|927931|P2|COMPLETED|Overall Study||26
387978|NCT01010230|927932|P1|COMPLETED|Overall Study||22
387979|NCT01010230|927931|P2|STARTED|Overall Study||33
387980|NCT01010230|927932|P1|STARTED|Overall Study||32
387981|NCT01010204|927964|P2|NOT COMPLETED|Overall Study||9
387982|NCT01010204|927965|P1|NOT COMPLETED|Overall Study||7
387983|NCT01010204|927964|P2|COMPLETED|Overall Study||20
387984|NCT01010204|927965|P1|COMPLETED|Overall Study||24
387985|NCT01010204|927964|P2|STARTED|Overall Study||29
387986|NCT01010204|927965|P1|STARTED|Overall Study||31
387987|NCT01010061|927975|P2|NOT COMPLETED|Overall Study||95
387988|NCT01010061|927976|P1|NOT COMPLETED|Overall Study||133
387989|NCT01010061|927975|P2|COMPLETED|Overall Study||23
387990|NCT01010061|927976|P1|COMPLETED|Overall Study|Completed=Completed treatment.|105
387991|NCT01010061|927975|P2|Received Study Drug|Overall Study||116
387992|NCT01010061|927976|P1|Received Study Drug|Overall Study||236
387993|NCT01010061|927975|P2|STARTED|Overall Study||118
387994|NCT01010061|927976|P1|STARTED|Overall Study||238
387995|NCT01010009|928010|P3|NOT COMPLETED|Overall Study||0
387996|NCT01010009|928011|P2|NOT COMPLETED|Overall Study||0
387997|NCT01010009|928012|P1|NOT COMPLETED|Overall Study||0
387998|NCT01010009|928010|P3|COMPLETED|Overall Study||8
387999|NCT01010009|928011|P2|COMPLETED|Overall Study||8
388000|NCT01010009|928012|P1|COMPLETED|Overall Study||8
388001|NCT01010009|928010|P3|STARTED|Overall Study||8
388002|NCT01010009|928011|P2|STARTED|Overall Study||8
388003|NCT01010009|928012|P1|STARTED|Overall Study||8
388004|NCT01009983|928026|P1|NOT COMPLETED|Overall Study||1
388005|NCT01009983|928026|P1|COMPLETED|Overall Study||13
388006|NCT01009983|928026|P1|STARTED|Overall Study||14
388007|NCT01009931|928030|P1|NOT COMPLETED|Overall Study||1
388008|NCT01009931|928030|P1|COMPLETED|Overall Study||0
388009|NCT01009931|928030|P1|STARTED|Overall Study||1
388010|NCT01009840|928036|P1|NOT COMPLETED|Overall Study||14
388011|NCT01009840|928036|P1|COMPLETED|Overall Study||16
388012|NCT01009840|928036|P1|STARTED|Overall Study||30
388013|NCT01009762|928051|P2|NOT COMPLETED|Overall Study||0
388014|NCT01009762|928052|P1|NOT COMPLETED|Overall Study||0
388015|NCT01009762|928051|P2|COMPLETED|Overall Study|10 participants received vaccine|10
388016|NCT01009762|928052|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
388017|NCT01009762|928051|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
388018|NCT01009762|928052|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
388019|NCT01009762|928051|P2|STARTED|Overall Study||10
388020|NCT01009762|928052|P1|STARTED|Overall Study||1
388021|NCT01009645|928066|P4|NOT COMPLETED|Overall Study||5
388022|NCT01009645|928067|P3|NOT COMPLETED|Overall Study||4
388023|NCT01009645|928068|P2|NOT COMPLETED|Overall Study||8
388024|NCT01009645|928069|P1|NOT COMPLETED|Overall Study||2
388025|NCT01009645|928066|P4|COMPLETED|Overall Study||26
388026|NCT01009645|928067|P3|COMPLETED|Overall Study||28
388027|NCT01009645|928068|P2|COMPLETED|Overall Study||23
388028|NCT01009645|928069|P1|COMPLETED|Overall Study||29
388029|NCT01009645|928066|P4|STARTED|Overall Study||31
388030|NCT01009645|928067|P3|STARTED|Overall Study||32
388031|NCT01009645|928068|P2|STARTED|Overall Study||31
388032|NCT01009645|928069|P1|STARTED|Overall Study||31
388033|NCT01009619|928085|P2|NOT COMPLETED|Overall Study||0
388034|NCT01009619|928086|P1|NOT COMPLETED|Overall Study||0
388035|NCT01009619|928085|P2|COMPLETED|Overall Study||43
388036|NCT01009619|928086|P1|COMPLETED|Overall Study||40
388037|NCT01009619|928085|P2|STARTED|Overall Study||43
388038|NCT01009619|928086|P1|STARTED|Overall Study||40
388039|NCT01009580|928106|P2|NOT COMPLETED|Overall Study||35
388040|NCT01009580|928107|P1|NOT COMPLETED|Overall Study||27
388041|NCT01009580|928106|P2|COMPLETED|Overall Study||188
388042|NCT01009580|928107|P1|COMPLETED|Overall Study||197
388043|NCT01009580|928106|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
388044|NCT01009580|928107|P1|Exposed|Overall Study||224
388045|NCT01009580|928106|P2|STARTED|Overall Study||223
388046|NCT01009580|928107|P1|STARTED|Overall Study||224
388047|NCT01009554|928121|P2|NOT COMPLETED|Overall Study||7
388048|NCT01009554|928122|P1|NOT COMPLETED|Overall Study||2
388049|NCT01009554|928121|P2|COMPLETED|Overall Study||41
388050|NCT01009554|928122|P1|COMPLETED|Overall Study||46
388051|NCT01009554|928121|P2|STARTED|Overall Study||48
388052|NCT01009554|928122|P1|STARTED|Overall Study||48
388053|NCT01009515|928254|P1|NOT COMPLETED|Overall Study||3
388054|NCT01009515|928254|P1|COMPLETED|Overall Study||16
388055|NCT01009515|928254|P1|STARTED|Overall Study||19
388056|NCT01009463|928265|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
388057|NCT01009463|928266|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
388058|NCT01009463|928267|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
388059|NCT01009463|928268|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
388060|NCT01009463|928269|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
388061|NCT01009463|928265|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
388062|NCT01009463|928266|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
388063|NCT01009463|928267|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
388064|NCT01009463|928268|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
388065|NCT01009463|928269|P1|COMPLETED|52-week, Double-blind Treatment Period||0
388066|NCT01009463|928265|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
388067|NCT01009463|928266|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
388068|NCT01009463|928267|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
388069|NCT01009463|928268|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
388070|NCT01009463|928269|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
388071|NCT01009463|928265|P5|STARTED|52-week, Double-blind Treatment Period||402
388072|NCT01009463|928266|P4|STARTED|52-week, Double-blind Treatment Period||403
388073|NCT01009463|928267|P3|STARTED|52-week, Double-blind Treatment Period||408
388074|NCT01009463|928268|P2|STARTED|52-week, Double-blind Treatment Period||409
388075|NCT01009463|928269|P1|STARTED|52-week, Double-blind Treatment Period||0
388076|NCT01009463|928265|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
388077|NCT01009463|928266|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
388078|NCT01009463|928267|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
388079|NCT01009463|928268|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
388080|NCT01009463|928269|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
388081|NCT01009463|928265|P5|COMPLETED|4-week, Open-label Run-In Period||0
388082|NCT01009463|928266|P4|COMPLETED|4-week, Open-label Run-In Period||0
388083|NCT01009463|928267|P3|COMPLETED|4-week, Open-label Run-In Period||0
388084|NCT01009463|928268|P2|COMPLETED|4-week, Open-label Run-In Period||0
388085|NCT01009463|928269|P1|COMPLETED|4-week, Open-label Run-In Period||1622
388086|NCT01009463|928265|P5|STARTED|4-week, Open-label Run-In Period||0
388087|NCT01009463|928266|P4|STARTED|4-week, Open-label Run-In Period||0
388088|NCT01009463|928267|P3|STARTED|4-week, Open-label Run-In Period||0
388089|NCT01009463|928268|P2|STARTED|4-week, Open-label Run-In Period||0
388090|NCT01009463|928269|P1|STARTED|4-week, Open-label Run-In Period||2071
388091|NCT01009346|928291|P1|NOT COMPLETED|Overall Study||4
388092|NCT01009346|928291|P1|COMPLETED|Overall Study||5
388093|NCT01009346|928291|P1|Toxicity|Overall Study||8
388094|NCT01009346|928291|P1|STARTED|Overall Study||9
388095|NCT01009333|928295|P6|NOT COMPLETED|Week 3||0
388096|NCT01009333|928296|P5|NOT COMPLETED|Week 3||0
388097|NCT01009333|928297|P4|NOT COMPLETED|Week 3||0
388098|NCT01009333|928298|P3|NOT COMPLETED|Week 3||0
388099|NCT01009333|928299|P2|NOT COMPLETED|Week 3||0
388100|NCT01009333|928300|P1|NOT COMPLETED|Week 3||0
388101|NCT01009333|928295|P6|COMPLETED|Week 3||2
388102|NCT01009333|928296|P5|COMPLETED|Week 3||2
388103|NCT01009333|928297|P4|COMPLETED|Week 3||2
388104|NCT01009333|928298|P3|COMPLETED|Week 3||2
388105|NCT01009333|928299|P2|COMPLETED|Week 3||2
388106|NCT01009333|928300|P1|COMPLETED|Week 3||2
388107|NCT01009333|928295|P6|STARTED|Week 3||2
388108|NCT01009333|928296|P5|STARTED|Week 3||2
388109|NCT01009333|928297|P4|STARTED|Week 3||2
388110|NCT01009333|928298|P3|STARTED|Week 3||2
388111|NCT01009333|928299|P2|STARTED|Week 3||2
388112|NCT01009333|928300|P1|STARTED|Week 3||2
388113|NCT01009333|928295|P6|NOT COMPLETED|Week 2||0
388114|NCT01009333|928296|P5|NOT COMPLETED|Week 2||0
388115|NCT01009333|928297|P4|NOT COMPLETED|Week 2||0
388116|NCT01009333|928298|P3|NOT COMPLETED|Week 2||0
388117|NCT01009333|928299|P2|NOT COMPLETED|Week 2||0
388118|NCT01009333|928300|P1|NOT COMPLETED|Week 2||0
388119|NCT01009333|928295|P6|COMPLETED|Week 2||2
388120|NCT01009333|928296|P5|COMPLETED|Week 2||2
388121|NCT01009333|928297|P4|COMPLETED|Week 2||2
388122|NCT01009333|928298|P3|COMPLETED|Week 2||2
388123|NCT01009333|928299|P2|COMPLETED|Week 2||2
388124|NCT01009333|928300|P1|COMPLETED|Week 2||2
388125|NCT01009333|928295|P6|STARTED|Week 2||2
388126|NCT01009333|928296|P5|STARTED|Week 2||2
388127|NCT01009333|928297|P4|STARTED|Week 2||2
388128|NCT01009333|928298|P3|STARTED|Week 2||2
388129|NCT01009333|928299|P2|STARTED|Week 2||2
388130|NCT01009333|928300|P1|STARTED|Week 2||2
388131|NCT01009333|928295|P6|NOT COMPLETED|Week 1||0
388132|NCT01009333|928296|P5|NOT COMPLETED|Week 1||0
388133|NCT01009333|928297|P4|NOT COMPLETED|Week 1||0
388134|NCT01009333|928298|P3|NOT COMPLETED|Week 1||0
388135|NCT01009333|928299|P2|NOT COMPLETED|Week 1||0
388136|NCT01009333|928300|P1|NOT COMPLETED|Week 1||0
388137|NCT01009333|928295|P6|COMPLETED|Week 1||2
388138|NCT01009333|928296|P5|COMPLETED|Week 1||2
388139|NCT01009333|928297|P4|COMPLETED|Week 1||2
388140|NCT01009333|928298|P3|COMPLETED|Week 1||2
388141|NCT01009333|928299|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
388142|NCT01009333|928300|P1|COMPLETED|Week 1||2
388143|NCT01009333|928295|P6|STARTED|Week 1||2
388144|NCT01009333|928296|P5|STARTED|Week 1||2
388145|NCT01009333|928297|P4|STARTED|Week 1||2
388146|NCT01009333|928298|P3|STARTED|Week 1||2
388147|NCT01009333|928299|P2|STARTED|Week 1||3
388148|NCT01009333|928300|P1|STARTED|Week 1||2
388149|NCT01009203|928314|P1|NOT COMPLETED|Overall Study||7
388150|NCT01009203|928314|P1|COMPLETED|Overall Study||6
388151|NCT01009203|928314|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
388152|NCT01009203|928314|P1|STARTED|Overall Study||13
388153|NCT01009138|928323|P2|NOT COMPLETED|Overall Study||20
388154|NCT01009138|928324|P1|NOT COMPLETED|Overall Study||13
388155|NCT01009138|928323|P2|COMPLETED|Overall Study||88
388156|NCT01009138|928324|P1|COMPLETED|Overall Study||93
388157|NCT01009138|928323|P2|STARTED|Overall Study||108
388158|NCT01009138|928324|P1|STARTED|Overall Study||106
388159|NCT01009099|928354|P2|NOT COMPLETED|Overall Study||4
388160|NCT01009099|928355|P1|NOT COMPLETED|Overall Study||5
388161|NCT01009099|928354|P2|COMPLETED|Overall Study||57
388162|NCT01009099|928355|P1|COMPLETED|Overall Study||53
388163|NCT01009099|928354|P2|STARTED|Overall Study||61
388164|NCT01009099|928355|P1|STARTED|Overall Study||58
388165|NCT01009086|928364|P3|NOT COMPLETED|Overall Study||34
388166|NCT01009086|928365|P2|NOT COMPLETED|Overall Study||47
388167|NCT01009086|928366|P1|NOT COMPLETED|Overall Study||44
388168|NCT01009086|928364|P3|COMPLETED|Overall Study||170
388169|NCT01009086|928365|P2|COMPLETED|Overall Study||158
388170|NCT01009086|928366|P1|COMPLETED|Overall Study||162
388171|NCT01009086|928364|P3|STARTED|Overall Study||204
388172|NCT01009086|928365|P2|STARTED|Overall Study||205
388173|NCT01009086|928366|P1|STARTED|Overall Study||206
388174|NCT01009047|928401|P2|NOT COMPLETED|Overall Study||26
388175|NCT01009047|928402|P1|NOT COMPLETED|Overall Study||28
388176|NCT01009047|928401|P2|COMPLETED|Overall Study||89
388177|NCT01009047|928402|P1|COMPLETED|Overall Study||85
388178|NCT01009047|928401|P2|STARTED|Overall Study||115
388179|NCT01009047|928402|P1|STARTED|Overall Study||113
388180|NCT01009034|928424|P1|NOT COMPLETED|Overall Study||4
388181|NCT01009034|928424|P1|COMPLETED|Overall Study||10
388182|NCT01009034|928424|P1|STARTED|Overall Study||14
388183|NCT01008995|928432|P4|NOT COMPLETED|After Controlled Period||1
388184|NCT01008995|928433|P3|NOT COMPLETED|After Controlled Period||2
388185|NCT01008995|928434|P2|NOT COMPLETED|After Controlled Period||0
388186|NCT01008995|928435|P1|NOT COMPLETED|After Controlled Period||0
388187|NCT01008995|928432|P4|COMPLETED|After Controlled Period||156
388188|NCT01008995|928433|P3|COMPLETED|After Controlled Period||156
388189|NCT01008995|928434|P2|COMPLETED|After Controlled Period||0
388190|NCT01008995|928435|P1|COMPLETED|After Controlled Period||0
388191|NCT01008995|928432|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
388192|NCT01008995|928433|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
388193|NCT01008995|928434|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
388194|NCT01008995|928435|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
388195|NCT01008995|928432|P4|NOT COMPLETED|Controlled Period||0
388196|NCT01008995|928433|P3|NOT COMPLETED|Controlled Period||0
388197|NCT01008995|928434|P2|NOT COMPLETED|Controlled Period||3
388198|NCT01008995|928435|P1|NOT COMPLETED|Controlled Period||3
388199|NCT01008995|928432|P4|COMPLETED|Controlled Period||0
388200|NCT01008995|928433|P3|COMPLETED|Controlled Period||0
388201|NCT01008995|928434|P2|COMPLETED|Controlled Period||157
388202|NCT01008995|928435|P1|COMPLETED|Controlled Period||159
388203|NCT01008995|928432|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
388204|NCT01008995|928433|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
388205|NCT01008995|928434|P2|STARTED|Controlled Period||160
388206|NCT01008995|928435|P1|STARTED|Controlled Period||162
388207|NCT01008969|928447|P1|NOT COMPLETED|Overall Study||0
388208|NCT01008969|928447|P1|COMPLETED|Overall Study||10
388209|NCT01008969|928447|P1|STARTED|Overall Study||10
388210|NCT01008943|928452|P1|NOT COMPLETED|Overall Study||1
388211|NCT01008943|928452|P1|COMPLETED|Overall Study||15
388212|NCT01008943|928452|P1|STARTED|Overall Study||16
388213|NCT01008904|928459|P1|NOT COMPLETED|Overall Study||4
388214|NCT01008904|928459|P1|COMPLETED|Overall Study||25
388215|NCT01008904|928459|P1|STARTED|Overall Study||29
388216|NCT01008722|928466|P2|NOT COMPLETED|Overall Study||0
388217|NCT01008722|928467|P1|NOT COMPLETED|Overall Study||0
388218|NCT01008722|928466|P2|COMPLETED|Overall Study||71
388219|NCT01008722|928467|P1|COMPLETED|Overall Study||36
388220|NCT01008722|928466|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
388221|NCT01008722|928467|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
388222|NCT01008696|928477|P2|NOT COMPLETED|Overall Study||17
388223|NCT01008696|928478|P1|NOT COMPLETED|Overall Study||17
388224|NCT01008696|928477|P2|COMPLETED|Overall Study||92
388225|NCT01008696|928478|P1|COMPLETED|Overall Study||91
388226|NCT01008696|928477|P2|STARTED|Overall Study||109
388227|NCT01008696|928478|P1|STARTED|Overall Study||108
388228|NCT01008618|928488|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
388229|NCT01008618|928489|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
388230|NCT01008618|928490|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
388231|NCT01008618|928488|P3|COMPLETED|Period 2 (Double-Blind Period)||39
388232|NCT01008618|928489|P2|COMPLETED|Period 2 (Double-Blind Period)||37
388233|NCT01008618|928490|P1|COMPLETED|Period 2 (Double-Blind Period)||0
388234|NCT01008618|928488|P3|STARTED|Period 2 (Double-Blind Period)||77
388235|NCT01008618|928489|P2|STARTED|Period 2 (Double-Blind Period)||73
388236|NCT01008618|928490|P1|STARTED|Period 2 (Double-Blind Period)||0
388237|NCT01008618|928488|P3|NOT COMPLETED|Period 1 (Titration Period)||0
388238|NCT01008618|928489|P2|NOT COMPLETED|Period 1 (Titration Period)||0
388239|NCT01008618|928490|P1|NOT COMPLETED|Period 1 (Titration Period)||68
388240|NCT01008618|928488|P3|COMPLETED|Period 1 (Titration Period)||0
388241|NCT01008618|928489|P2|COMPLETED|Period 1 (Titration Period)||0
388242|NCT01008618|928490|P1|COMPLETED|Period 1 (Titration Period)||150
388243|NCT01008618|928488|P3|STARTED|Period 1 (Titration Period)||0
388244|NCT01008618|928489|P2|STARTED|Period 1 (Titration Period)||0
388245|NCT01008618|928490|P1|STARTED|Period 1 (Titration Period)||218
388246|NCT01008605|928515|P1|NOT COMPLETED|Overall Study||0
388247|NCT01008605|928515|P1|COMPLETED|Overall Study||48
388248|NCT01008605|928515|P1|STARTED|Overall Study||48
388249|NCT01008553|928539|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
388250|NCT01008553|928540|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
388251|NCT01008553|928541|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
388252|NCT01008553|928539|P3|COMPLETED|Period 2 (Double-Blind Period)||28
388253|NCT01008553|928540|P2|COMPLETED|Period 2 (Double-Blind Period)||47
388254|NCT01008553|928541|P1|COMPLETED|Period 2 (Double-Blind Period)||0
388255|NCT01008553|928539|P3|STARTED|Period 2 (Double-Blind Period)||79
388256|NCT01008553|928540|P2|STARTED|Period 2 (Double-Blind Period)||84
388257|NCT01008553|928541|P1|STARTED|Period 2 (Double-Blind Period)||0
388258|NCT01008553|928539|P3|NOT COMPLETED|Period 1 (Titration Period)||0
388259|NCT01008553|928540|P2|NOT COMPLETED|Period 1 (Titration Period)||0
388260|NCT01008553|928541|P1|NOT COMPLETED|Period 1 (Titration Period)||95
388261|NCT01008553|928539|P3|COMPLETED|Period 1 (Titration Period)||0
388262|NCT01008553|928540|P2|COMPLETED|Period 1 (Titration Period)||0
388263|NCT01008553|928541|P1|COMPLETED|Period 1 (Titration Period)||163
388264|NCT01008553|928539|P3|STARTED|Period 1 (Titration Period)||0
388265|NCT01008553|928540|P2|STARTED|Period 1 (Titration Period)||0
388266|NCT01008553|928541|P1|STARTED|Period 1 (Titration Period)||258
388267|NCT01008475|928573|P7|NOT COMPLETED|Overall Study||4
388268|NCT01008475|928574|P6|NOT COMPLETED|Overall Study||6
388269|NCT01008475|928575|P5|NOT COMPLETED|Overall Study||5
388270|NCT01008475|928576|P4|NOT COMPLETED|Overall Study||0
388271|NCT01008475|928577|P3|NOT COMPLETED|Overall Study||0
388272|NCT01008475|928578|P2|NOT COMPLETED|Overall Study||0
388273|NCT01008475|928579|P1|NOT COMPLETED|Overall Study||0
388274|NCT01008475|928573|P7|COMPLETED|Overall Study||67
388275|NCT01008475|928574|P6|COMPLETED|Overall Study||67
388276|NCT01008475|928575|P5|COMPLETED|Overall Study||67
388277|NCT01008475|928576|P4|COMPLETED|Overall Study||3
388278|NCT01008475|928577|P3|COMPLETED|Overall Study||7
388279|NCT01008475|928578|P2|COMPLETED|Overall Study||3
388280|NCT01008475|928579|P1|COMPLETED|Overall Study||3
388281|NCT01008475|928573|P7|Safety Analysis Set|Overall Study||69
388282|NCT01008475|928574|P6|Safety Analysis Set|Overall Study||72
388283|NCT01008475|928575|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
388284|NCT01008475|928576|P4|Safety Analysis Set|Overall Study||3
388285|NCT01008475|928577|P3|Safety Analysis Set|Overall Study||7
388286|NCT01008475|928578|P2|Safety Analysis Set|Overall Study||3
388287|NCT01008475|928579|P1|Safety Analysis Set|Overall Study||3
388288|NCT01008475|928573|P7|STARTED|Overall Study||71
388289|NCT01008475|928574|P6|STARTED|Overall Study||73
388290|NCT01008475|928575|P5|STARTED|Overall Study||72
388291|NCT01008475|928576|P4|STARTED|Overall Study||3
388292|NCT01008475|928577|P3|STARTED|Overall Study||7
388293|NCT01008475|928578|P2|STARTED|Overall Study||3
388294|NCT01008475|928579|P1|STARTED|Overall Study||3
388295|NCT01008449|928609|P2|NOT COMPLETED|Overall Study||19
388296|NCT01008449|928610|P1|NOT COMPLETED|Overall Study||29
388297|NCT01008449|928609|P2|COMPLETED|Overall Study||179
388298|NCT01008449|928610|P1|COMPLETED|Overall Study||171
388299|NCT01008449|928609|P2|STARTED|Overall Study||198
388300|NCT01008449|928610|P1|STARTED|Overall Study||200
388301|NCT01008280|928632|P2|NOT COMPLETED|Overall Study||19
388302|NCT01008280|928633|P1|NOT COMPLETED|Overall Study||21
388303|NCT01008280|928632|P2|COMPLETED|Overall Study||73
388304|NCT01008280|928633|P1|COMPLETED|Overall Study||67
388305|NCT01008280|928632|P2|STARTED|Overall Study||92
388306|NCT01008280|928633|P1|STARTED|Overall Study||88
388307|NCT01007942|928645|P2|NOT COMPLETED|Overall Study||278
388308|NCT01007942|928646|P1|NOT COMPLETED|Overall Study||281
388309|NCT01007942|928645|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
388310|NCT01007942|928646|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
388311|NCT01007942|928645|P2|STARTED|Overall Study||285
388312|NCT01007942|928646|P1|STARTED|Overall Study||284
388313|NCT01007916|928668|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
388314|NCT01007916|928669|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
388315|NCT01007916|928668|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
388316|NCT01007916|928669|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
388317|NCT01007916|928668|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
388318|NCT01007916|928669|P1|STARTED|Period 2, 4 Weeks of Wear||22
388319|NCT01007916|928668|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
388320|NCT01007916|928669|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
388321|NCT01007916|928668|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
388322|NCT01007916|928669|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
388323|NCT01007916|928668|P2|STARTED|Period 1, 4 Weeks of Wear||26
388324|NCT01007916|928669|P1|STARTED|Period 1, 4 Weeks of Wear||23
388325|NCT01007838|928679|P4|NOT COMPLETED|Overall Study||0
388326|NCT01007838|928680|P3|NOT COMPLETED|Overall Study||0
388327|NCT01007838|928681|P2|NOT COMPLETED|Overall Study||0
388328|NCT01007838|928682|P1|NOT COMPLETED|Overall Study||3
388329|NCT01007838|928679|P4|COMPLETED|Overall Study||4
388330|NCT01007838|928680|P3|COMPLETED|Overall Study||5
388331|NCT01007838|928681|P2|COMPLETED|Overall Study||11
388332|NCT01007838|928682|P1|COMPLETED|Overall Study||9
388333|NCT01007838|928679|P4|STARTED|Overall Study||4
388334|NCT01007838|928680|P3|STARTED|Overall Study||5
388335|NCT01007838|928681|P2|STARTED|Overall Study||11
388336|NCT01007838|928682|P1|STARTED|Overall Study||12
388337|NCT01007812|928692|P2|NOT COMPLETED|Period 2, One Week||0
388338|NCT01007812|928693|P1|NOT COMPLETED|Period 2, One Week||0
388339|NCT01007812|928692|P2|COMPLETED|Period 2, One Week||24
388340|NCT01007812|928693|P1|COMPLETED|Period 2, One Week||24
388341|NCT01007812|928692|P2|STARTED|Period 2, One Week||24
388342|NCT01007812|928693|P1|STARTED|Period 2, One Week||24
388343|NCT01007812|928692|P2|NOT COMPLETED|Period 1, One Week||1
388344|NCT01007812|928693|P1|NOT COMPLETED|Period 1, One Week||1
388345|NCT01007812|928692|P2|COMPLETED|Period 1, One Week||24
388346|NCT01007812|928693|P1|COMPLETED|Period 1, One Week||24
388347|NCT01007812|928692|P2|STARTED|Period 1, One Week||25
388348|NCT01007812|928693|P1|STARTED|Period 1, One Week||25
388349|NCT01007656|928699|P1|NOT COMPLETED|Overall Study||0
388350|NCT01007656|928699|P1|COMPLETED|Overall Study||31
388351|NCT01007656|928699|P1|STARTED|Overall Study||31
388352|NCT01007643|928719|P2|NOT COMPLETED|Overall Study||0
388353|NCT01007643|928720|P1|NOT COMPLETED|Overall Study||0
388354|NCT01007643|928719|P2|COMPLETED|Overall Study||14
388355|NCT01007643|928720|P1|COMPLETED|Overall Study||8
388356|NCT01007643|928719|P2|STARTED|Overall Study||14
388357|NCT01007643|928720|P1|STARTED|Overall Study||8
388358|NCT01007552|928726|P1|NOT COMPLETED|Overall Study||1
388359|NCT01007552|928726|P1|COMPLETED|Overall Study||49
388360|NCT01007552|928726|P1|STARTED|Overall Study||50
388361|NCT01007435|928740|P4|NOT COMPLETED|Overall Study||56
388362|NCT01007435|928741|P3|NOT COMPLETED|Overall Study||64
388363|NCT01007435|928742|P2|NOT COMPLETED|Overall Study||59
388364|NCT01007435|928743|P1|NOT COMPLETED|Overall Study||63
388365|NCT01007435|928740|P4|COMPLETED|Overall Study||236
388366|NCT01007435|928741|P3|COMPLETED|Overall Study||227
388367|NCT01007435|928742|P2|COMPLETED|Overall Study||231
388368|NCT01007435|928743|P1|COMPLETED|Overall Study||226
388369|NCT01007435|928740|P4|STARTED|Overall Study||292
388370|NCT01007435|928741|P3|STARTED|Overall Study||291
388371|NCT01007435|928742|P2|STARTED|Overall Study||290
388372|NCT01007435|928743|P1|STARTED|Overall Study||289
388373|NCT01007396|928785|P1|NOT COMPLETED|Overall Study||47
388374|NCT01007396|928785|P1|COMPLETED|Overall Study||275
388375|NCT01007396|928785|P1|STARTED|Overall Study||322
388376|NCT01007253|928790|P4|NOT COMPLETED|Fourth Intervention||0
388377|NCT01007253|928791|P3|NOT COMPLETED|Fourth Intervention||0
388378|NCT01007253|928792|P2|NOT COMPLETED|Fourth Intervention||0
388379|NCT01007253|928793|P1|NOT COMPLETED|Fourth Intervention||0
388380|NCT01007253|928790|P4|COMPLETED|Fourth Intervention||5
388381|NCT01007253|928791|P3|COMPLETED|Fourth Intervention||5
388382|NCT01007253|928792|P2|COMPLETED|Fourth Intervention||5
388383|NCT01007253|928793|P1|COMPLETED|Fourth Intervention||5
388384|NCT01007253|928790|P4|STARTED|Fourth Intervention||5
388385|NCT01007253|928791|P3|STARTED|Fourth Intervention||5
388386|NCT01007253|928792|P2|STARTED|Fourth Intervention||5
388387|NCT01007253|928793|P1|STARTED|Fourth Intervention||5
388388|NCT01007253|928790|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
388389|NCT01007253|928791|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
388390|NCT01007253|928792|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
388391|NCT01007253|928793|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
388392|NCT01007253|928790|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
388393|NCT01007253|928791|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
388394|NCT01007253|928792|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
388395|NCT01007253|928793|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
388396|NCT01007253|928790|P4|STARTED|Washout Period (2 Weeks) # 3||5
388397|NCT01007253|928791|P3|STARTED|Washout Period (2 Weeks) # 3||5
388398|NCT01007253|928792|P2|STARTED|Washout Period (2 Weeks) # 3||5
388399|NCT01007253|928793|P1|STARTED|Washout Period (2 Weeks) # 3||6
388400|NCT01007253|928790|P4|NOT COMPLETED|Third Intervention||0
388401|NCT01007253|928791|P3|NOT COMPLETED|Third Intervention||0
388402|NCT01007253|928792|P2|NOT COMPLETED|Third Intervention||0
388403|NCT01007253|928793|P1|NOT COMPLETED|Third Intervention||0
388404|NCT01007253|928790|P4|COMPLETED|Third Intervention||5
388405|NCT01007253|928791|P3|COMPLETED|Third Intervention||5
388406|NCT01007253|928792|P2|COMPLETED|Third Intervention||5
388407|NCT01007253|928793|P1|COMPLETED|Third Intervention||6
388408|NCT01007253|928790|P4|STARTED|Third Intervention||5
388409|NCT01007253|928791|P3|STARTED|Third Intervention||5
388410|NCT01007253|928792|P2|STARTED|Third Intervention||5
388411|NCT01007253|928793|P1|STARTED|Third Intervention||6
388412|NCT01007253|928790|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
388413|NCT01007253|928791|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
388414|NCT01007253|928792|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
388415|NCT01007253|928793|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
388416|NCT01007253|928790|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
388417|NCT01007253|928791|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
388418|NCT01007253|928792|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
388419|NCT01007253|928793|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
388420|NCT01007253|928790|P4|STARTED|Washout Period (2 Weeks) # 2||5
388421|NCT01007253|928791|P3|STARTED|Washout Period (2 Weeks) # 2||5
388422|NCT01007253|928792|P2|STARTED|Washout Period (2 Weeks) # 2||5
388423|NCT01007253|928793|P1|STARTED|Washout Period (2 Weeks) # 2||6
388424|NCT01007253|928790|P4|NOT COMPLETED|Second Intervention||0
388425|NCT01007253|928791|P3|NOT COMPLETED|Second Intervention||0
388426|NCT01007253|928792|P2|NOT COMPLETED|Second Intervention||0
388427|NCT01007253|928793|P1|NOT COMPLETED|Second Intervention||0
388428|NCT01007253|928790|P4|COMPLETED|Second Intervention||5
388429|NCT01007253|928791|P3|COMPLETED|Second Intervention||5
388430|NCT01007253|928792|P2|COMPLETED|Second Intervention||5
388431|NCT01007253|928793|P1|COMPLETED|Second Intervention||6
388432|NCT01007253|928790|P4|STARTED|Second Intervention||5
388433|NCT01007253|928791|P3|STARTED|Second Intervention||5
388434|NCT01007253|928792|P2|STARTED|Second Intervention||5
388435|NCT01007253|928793|P1|STARTED|Second Intervention||6
388436|NCT01007253|928790|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
388437|NCT01007253|928791|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
388438|NCT01007253|928792|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
388439|NCT01007253|928793|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
388440|NCT01007253|928790|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
388441|NCT01007253|928791|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
388442|NCT01007253|928792|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
388443|NCT01007253|928793|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
388444|NCT01007253|928790|P4|STARTED|Washout Period (2 Weeks) # 1||5
388445|NCT01007253|928791|P3|STARTED|Washout Period (2 Weeks) # 1||5
388446|NCT01007253|928792|P2|STARTED|Washout Period (2 Weeks) # 1||5
388447|NCT01007253|928793|P1|STARTED|Washout Period (2 Weeks) # 1||6
388448|NCT01007253|928790|P4|NOT COMPLETED|First Intervention||0
388449|NCT01007253|928791|P3|NOT COMPLETED|First Intervention||0
388450|NCT01007253|928792|P2|NOT COMPLETED|First Intervention||0
388451|NCT01007253|928793|P1|NOT COMPLETED|First Intervention||0
388452|NCT01007253|928790|P4|COMPLETED|First Intervention||5
388453|NCT01007253|928791|P3|COMPLETED|First Intervention||5
388454|NCT01007253|928792|P2|COMPLETED|First Intervention||5
388455|NCT01007253|928793|P1|COMPLETED|First Intervention||6
388456|NCT01007253|928790|P4|STARTED|First Intervention||5
388457|NCT01007253|928791|P3|STARTED|First Intervention||5
388458|NCT01007253|928792|P2|STARTED|First Intervention||5
388459|NCT01007253|928793|P1|STARTED|First Intervention||6
388460|NCT01007149|928825|P2|NOT COMPLETED|Overall Study||1
388461|NCT01007149|928826|P1|NOT COMPLETED|Overall Study||0
388462|NCT01007149|928825|P2|COMPLETED|Overall Study||20
388463|NCT01007149|928826|P1|COMPLETED|Overall Study||20
388464|NCT01007149|928825|P2|STARTED|Overall Study||21
388465|NCT01007149|928826|P1|STARTED|Overall Study||20
388466|NCT01007123|928852|P4|NOT COMPLETED|Overall Study||6
388467|NCT01007123|928853|P3|NOT COMPLETED|Overall Study||11
388468|NCT01007123|928854|P2|NOT COMPLETED|Overall Study||6
388469|NCT01007123|928855|P1|NOT COMPLETED|Overall Study||6
388470|NCT01007123|928852|P4|COMPLETED|Overall Study||41
388471|NCT01007123|928853|P3|COMPLETED|Overall Study||37
388472|NCT01007123|928854|P2|COMPLETED|Overall Study||41
388473|NCT01007123|928855|P1|COMPLETED|Overall Study||42
388474|NCT01007123|928852|P4|STARTED|Overall Study||47
388475|NCT01007123|928853|P3|STARTED|Overall Study||48
388476|NCT01007123|928854|P2|STARTED|Overall Study||47
388477|NCT01007123|928855|P1|STARTED|Overall Study||48
388478|NCT01007110|928886|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
388479|NCT01007110|928887|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
388480|NCT01007110|928886|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
388481|NCT01007110|928887|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
388482|NCT01007110|928886|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
388483|NCT01007110|928887|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
388484|NCT01007110|928886|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
388485|NCT01007110|928887|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
388486|NCT01007110|928886|P2|COMPLETED|Follow-Up at 36 Weeks||20
388487|NCT01007110|928887|P1|COMPLETED|Follow-Up at 36 Weeks||24
388488|NCT01007110|928886|P2|STARTED|Follow-Up at 36 Weeks||22
388489|NCT01007110|928887|P1|STARTED|Follow-Up at 36 Weeks||24
388490|NCT01007110|928886|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
388491|NCT01007110|928887|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
388492|NCT01007110|928886|P2|COMPLETED|Follow-Up at 32 Weeks||22
388493|NCT01007110|928887|P1|COMPLETED|Follow-Up at 32 Weeks||24
388494|NCT01007110|928886|P2|STARTED|Follow-Up at 32 Weeks||23
388495|NCT01007110|928887|P1|STARTED|Follow-Up at 32 Weeks||25
388496|NCT01007110|928886|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
388497|NCT01007110|928887|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
388498|NCT01007110|928886|P2|COMPLETED|Follow-Up at 24 Weeks||23
388499|NCT01007110|928887|P1|COMPLETED|Follow-Up at 24 Weeks||25
388500|NCT01007110|928886|P2|STARTED|Follow-Up at 24 Weeks||27
388501|NCT01007110|928887|P1|STARTED|Follow-Up at 24 Weeks||25
388502|NCT01007110|928886|P2|NOT COMPLETED|Allocation||8
388503|NCT01007110|928887|P1|NOT COMPLETED|Allocation||7
388504|NCT01007110|928886|P2|COMPLETED|Allocation||27
388505|NCT01007110|928887|P1|COMPLETED|Allocation||25
388506|NCT01007110|928886|P2|STARTED|Allocation||35
388507|NCT01007110|928887|P1|STARTED|Allocation||32
388508|NCT01006980|928903|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
388509|NCT01006980|928904|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
388510|NCT01006980|928903|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
388511|NCT01006980|928904|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
388512|NCT01006980|928903|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
388513|NCT01006980|928904|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
388514|NCT01006980|928903|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
388515|NCT01006980|928904|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
388516|NCT01006980|928903|P2|COMPLETED|Vemurafenib and Dacarbazine||0
388517|NCT01006980|928904|P1|COMPLETED|Vemurafenib and Dacarbazine||0
388518|NCT01006980|928903|P2|Treated|Vemurafenib and Dacarbazine||293
388519|NCT01006980|928904|P1|Treated|Vemurafenib and Dacarbazine||336
388520|NCT01006980|928903|P2|STARTED|Vemurafenib and Dacarbazine||338
388521|NCT01006980|928904|P1|STARTED|Vemurafenib and Dacarbazine||337
388522|NCT01006889|928924|P1|NOT COMPLETED|Overall Study||3
388523|NCT01006889|928924|P1|COMPLETED|Overall Study||17
388524|NCT01006889|928924|P1|STARTED|Overall Study||20
388525|NCT01006655|928937|P2|NOT COMPLETED|Second Intervention||0
388526|NCT01006655|928938|P1|NOT COMPLETED|Second Intervention||0
388527|NCT01006655|928937|P2|COMPLETED|Second Intervention||10
388528|NCT01006655|928938|P1|COMPLETED|Second Intervention||11
388529|NCT01006655|928937|P2|STARTED|Second Intervention||10
388530|NCT01006655|928938|P1|STARTED|Second Intervention||11
388531|NCT01006655|928937|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
388532|NCT01006655|928938|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
388533|NCT01006655|928937|P2|COMPLETED|Washout Period of 2 Weeks||10
388534|NCT01006655|928938|P1|COMPLETED|Washout Period of 2 Weeks||11
388535|NCT01006655|928937|P2|STARTED|Washout Period of 2 Weeks||10
388536|NCT01006655|928938|P1|STARTED|Washout Period of 2 Weeks||11
388537|NCT01006655|928937|P2|NOT COMPLETED|First Intervention||0
388538|NCT01006655|928938|P1|NOT COMPLETED|First Intervention||0
388539|NCT01006655|928937|P2|COMPLETED|First Intervention||10
388540|NCT01006655|928938|P1|COMPLETED|First Intervention||11
388541|NCT01006655|928937|P2|STARTED|First Intervention||10
388542|NCT01006655|928938|P1|STARTED|First Intervention||11
388543|NCT01006629|928944|P1|NOT COMPLETED|Overall Study||6
388544|NCT01006629|928944|P1|COMPLETED|Overall Study||94
388545|NCT01006629|928944|P1|STARTED|Overall Study||100
388546|NCT01006616|928959|P4|NOT COMPLETED|Period 2 (18 Months)||82
388547|NCT01006616|928960|P3|NOT COMPLETED|Period 2 (18 Months)||55
388548|NCT01006616|928961|P2|NOT COMPLETED|Period 2 (18 Months)||63
388549|NCT01006616|928962|P1|NOT COMPLETED|Period 2 (18 Months)||75
388550|NCT01006616|928959|P4|COMPLETED|Period 2 (18 Months)||0
388551|NCT01006616|928960|P3|COMPLETED|Period 2 (18 Months)||0
388552|NCT01006616|928961|P2|COMPLETED|Period 2 (18 Months)||0
388553|NCT01006616|928962|P1|COMPLETED|Period 2 (18 Months)||0
388554|NCT01006616|928959|P4|Treated|Period 2 (18 Months)||82
388555|NCT01006616|928960|P3|Treated|Period 2 (18 Months)||55
388556|NCT01006616|928961|P2|Treated|Period 2 (18 Months)||63
388557|NCT01006616|928962|P1|Treated|Period 2 (18 Months)||75
388558|NCT01006616|928959|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
388559|NCT01006616|928960|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
388560|NCT01006616|928961|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
388561|NCT01006616|928962|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
388562|NCT01006616|928959|P4|NOT COMPLETED|Period 1 (6 Months)||27
388563|NCT01006616|928960|P3|NOT COMPLETED|Period 1 (6 Months)||51
388564|NCT01006616|928961|P2|NOT COMPLETED|Period 1 (6 Months)||54
388565|NCT01006616|928962|P1|NOT COMPLETED|Period 1 (6 Months)||26
388566|NCT01006616|928959|P4|COMPLETED|Period 1 (6 Months)||128
388567|NCT01006616|928960|P3|COMPLETED|Period 1 (6 Months)||102
388568|NCT01006616|928961|P2|COMPLETED|Period 1 (6 Months)||102
388569|NCT01006616|928962|P1|COMPLETED|Period 1 (6 Months)||126
388570|NCT01006616|928959|P4|Treated|Period 1 (6 Months)||154
388571|NCT01006616|928960|P3|Treated|Period 1 (6 Months)||152
388572|NCT01006616|928961|P2|Treated|Period 1 (6 Months)||156
388573|NCT01006616|928962|P1|Treated|Period 1 (6 Months)||152
388574|NCT01006616|928959|P4|STARTED|Period 1 (6 Months)||155
388575|NCT01006616|928960|P3|STARTED|Period 1 (6 Months)||153
388576|NCT01006616|928961|P2|STARTED|Period 1 (6 Months)||156
388577|NCT01006616|928962|P1|STARTED|Period 1 (6 Months)||152
388578|NCT01006603|929098|P2|NOT COMPLETED|Overall Study||75
388579|NCT01006603|929099|P1|NOT COMPLETED|Overall Study||71
388580|NCT01006603|929098|P2|COMPLETED|Overall Study||285
388581|NCT01006603|929099|P1|COMPLETED|Overall Study||289
388582|NCT01006603|929098|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
388583|NCT01006603|929099|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
388584|NCT01006590|929119|P2|NOT COMPLETED|Overall Study||32
388585|NCT01006590|929120|P1|NOT COMPLETED|Overall Study||28
388586|NCT01006590|929119|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
388587|NCT01006590|929120|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
388588|NCT01006590|929119|P2|STARTED|Overall Study|Randomised and treated|139
388589|NCT01006590|929120|P1|STARTED|Overall Study|Randomised and treated|147
388590|NCT01006356|929136|P1|NOT COMPLETED|Overall Study||42
388591|NCT01006356|929136|P1|COMPLETED|Overall Study||99
388592|NCT01006356|929136|P1|STARTED|Overall Study||141
388593|NCT01006291|929151|P3|NOT COMPLETED|Overall Study||27
388594|NCT01006291|929152|P2|NOT COMPLETED|Overall Study||24
388595|NCT01006291|929153|P1|NOT COMPLETED|Overall Study||26
388596|NCT01006291|929151|P3|COMPLETED|Overall Study||203
388597|NCT01006291|929152|P2|COMPLETED|Overall Study||204
388598|NCT01006291|929153|P1|COMPLETED|Overall Study||203
388599|NCT01006291|929151|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
388600|NCT01006291|929152|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
388601|NCT01006291|929153|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
388602|NCT01006291|929151|P3|STARTED|Overall Study||230
388603|NCT01006291|929152|P2|STARTED|Overall Study||228
388604|NCT01006291|929153|P1|STARTED|Overall Study||229
388605|NCT01006135|929170|P1|NOT COMPLETED|Overall Study||140
388606|NCT01006135|929170|P1|COMPLETED|Overall Study||4712
388607|NCT01006135|929170|P1|STARTED|Overall Study||4852
388608|NCT01006122|929177|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
388609|NCT01006122|929178|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
388610|NCT01006122|929177|P2|COMPLETED|Second Double-blind Intervention Period||24
388611|NCT01006122|929178|P1|COMPLETED|Second Double-blind Intervention Period||29
388612|NCT01006122|929177|P2|STARTED|Second Double-blind Intervention Period||31
388613|NCT01006122|929178|P1|STARTED|Second Double-blind Intervention Period||31
388614|NCT01006122|929177|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
388615|NCT01006122|929178|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
388616|NCT01006122|929177|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
388617|NCT01006122|929178|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
388618|NCT01006122|929177|P2|STARTED|Wash-out Period (at Least 7 Days)||31
388619|NCT01006122|929178|P1|STARTED|Wash-out Period (at Least 7 Days)||31
388620|NCT01006122|929177|P2|NOT COMPLETED|First Double-blind Intervention Period||17
388621|NCT01006122|929178|P1|NOT COMPLETED|First Double-blind Intervention Period||16
388622|NCT01006122|929177|P2|COMPLETED|First Double-blind Intervention Period||31
388623|NCT01006122|929178|P1|COMPLETED|First Double-blind Intervention Period||31
388624|NCT01006122|929177|P2|STARTED|First Double-blind Intervention Period||48
388625|NCT01006122|929178|P1|STARTED|First Double-blind Intervention Period||47
388626|NCT01006018|929219|P3|NOT COMPLETED|Overall Study||0
388627|NCT01006018|929220|P2|NOT COMPLETED|Overall Study||0
388628|NCT01006018|929221|P1|NOT COMPLETED|Overall Study||0
388629|NCT01006018|929219|P3|COMPLETED|Overall Study||0
388630|NCT01006018|929220|P2|COMPLETED|Overall Study||0
388631|NCT01006018|929221|P1|COMPLETED|Overall Study||0
388632|NCT01006018|929219|P3|STARTED|Overall Study||0
388633|NCT01006018|929220|P2|STARTED|Overall Study||0
388634|NCT01006018|929221|P1|STARTED|Overall Study||0
388635|NCT01005966|929229|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
388636|NCT01005966|929230|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
388637|NCT01005966|929231|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
388638|NCT01005966|929232|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
388639|NCT01005966|929233|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
388640|NCT01005966|929229|P5|COMPLETED|Treatment Period 5 (14 Days)||10
388641|NCT01005966|929230|P4|COMPLETED|Treatment Period 5 (14 Days)||11
388642|NCT01005966|929231|P3|COMPLETED|Treatment Period 5 (14 Days)||11
388643|NCT01005966|929232|P2|COMPLETED|Treatment Period 5 (14 Days)||12
388644|NCT01005966|929233|P1|COMPLETED|Treatment Period 5 (14 Days)||9
388645|NCT01005966|929229|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
388646|NCT01005966|929230|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
388647|NCT01005966|929231|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
388648|NCT01005966|929232|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
388649|NCT01005966|929233|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
388650|NCT01005966|929229|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
388651|NCT01005966|929230|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
388652|NCT01005966|929231|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
388653|NCT01005966|929232|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
388654|NCT01005966|929233|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
388655|NCT01005966|929229|P5|COMPLETED|Washout Period 4 (4 Days)||12
388656|NCT01005966|929230|P4|COMPLETED|Washout Period 4 (4 Days)||10
388657|NCT01005966|929231|P3|COMPLETED|Washout Period 4 (4 Days)||11
388658|NCT01005966|929232|P2|COMPLETED|Washout Period 4 (4 Days)||10
388659|NCT01005966|929233|P1|COMPLETED|Washout Period 4 (4 Days)||10
388660|NCT01005966|929229|P5|STARTED|Washout Period 4 (4 Days)||12
388661|NCT01005966|929230|P4|STARTED|Washout Period 4 (4 Days)||10
388662|NCT01005966|929231|P3|STARTED|Washout Period 4 (4 Days)||11
388663|NCT01005966|929232|P2|STARTED|Washout Period 4 (4 Days)||10
388664|NCT01005966|929233|P1|STARTED|Washout Period 4 (4 Days)||10
388665|NCT01005966|929229|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
388666|NCT01005966|929230|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
388667|NCT01005966|929231|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
388668|NCT01005966|929232|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
388669|NCT01005966|929233|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
388670|NCT01005966|929229|P5|COMPLETED|Treatment Period 4 (14 Days)||12
388671|NCT01005966|929230|P4|COMPLETED|Treatment Period 4 (14 Days)||10
388672|NCT01005966|929231|P3|COMPLETED|Treatment Period 4 (14 Days)||11
388673|NCT01005966|929232|P2|COMPLETED|Treatment Period 4 (14 Days)||10
388674|NCT01005966|929233|P1|COMPLETED|Treatment Period 4 (14 Days)||10
388675|NCT01005966|929229|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
388676|NCT01005966|929230|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
388677|NCT01005966|929231|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
388678|NCT01005966|929232|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
388679|NCT01005966|929233|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
388680|NCT01005966|929229|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
388681|NCT01005966|929230|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
388682|NCT01005966|929231|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
388683|NCT01005966|929232|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
388684|NCT01005966|929233|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
388685|NCT01005966|929229|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
388686|NCT01005966|929230|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
388687|NCT01005966|929231|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
388688|NCT01005966|929232|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
388689|NCT01005966|929233|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
388690|NCT01005966|929229|P5|STARTED|Washout Period 3 ( 4 Days)||11
388691|NCT01005966|929230|P4|STARTED|Washout Period 3 ( 4 Days)||13
388692|NCT01005966|929231|P3|STARTED|Washout Period 3 ( 4 Days)||12
388693|NCT01005966|929232|P2|STARTED|Washout Period 3 ( 4 Days)||7
388694|NCT01005966|929233|P1|STARTED|Washout Period 3 ( 4 Days)||12
388695|NCT01005966|929229|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
388696|NCT01005966|929230|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
388697|NCT01005966|929231|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
388698|NCT01005966|929232|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
388699|NCT01005966|929233|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
388700|NCT01005966|929229|P5|COMPLETED|Treatment Period 3 (14 Days)||11
388701|NCT01005966|929230|P4|COMPLETED|Treatment Period 3 (14 Days)||13
388702|NCT01005966|929231|P3|COMPLETED|Treatment Period 3 (14 Days)||12
388703|NCT01005966|929232|P2|COMPLETED|Treatment Period 3 (14 Days)||7
388704|NCT01005966|929233|P1|COMPLETED|Treatment Period 3 (14 Days)||12
388780|NCT01005901|929260|P1|Safety Population|Overall Study||550
388705|NCT01005966|929229|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
388706|NCT01005966|929230|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
388707|NCT01005966|929231|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
388708|NCT01005966|929232|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
388709|NCT01005966|929233|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
388710|NCT01005966|929229|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
388711|NCT01005966|929230|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
388712|NCT01005966|929231|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
388713|NCT01005966|929232|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
388714|NCT01005966|929233|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
388715|NCT01005966|929229|P5|COMPLETED|Washout Period 2 (4 Days)||11
388716|NCT01005966|929230|P4|COMPLETED|Washout Period 2 (4 Days)||11
388717|NCT01005966|929231|P3|COMPLETED|Washout Period 2 (4 Days)||10
388718|NCT01005966|929232|P2|COMPLETED|Washout Period 2 (4 Days)||12
388719|NCT01005966|929233|P1|COMPLETED|Washout Period 2 (4 Days)||13
388720|NCT01005966|929229|P5|STARTED|Washout Period 2 (4 Days)||11
388721|NCT01005966|929230|P4|STARTED|Washout Period 2 (4 Days)||11
388722|NCT01005966|929231|P3|STARTED|Washout Period 2 (4 Days)||10
388723|NCT01005966|929232|P2|STARTED|Washout Period 2 (4 Days)||12
388724|NCT01005966|929233|P1|STARTED|Washout Period 2 (4 Days)||13
388725|NCT01005966|929229|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
388726|NCT01005966|929230|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
388727|NCT01005966|929231|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
388728|NCT01005966|929232|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
388729|NCT01005966|929233|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
388730|NCT01005966|929229|P5|COMPLETED|Treatment Period 2 (14 Days)||11
388731|NCT01005966|929230|P4|COMPLETED|Treatment Period 2 (14 Days)||11
388732|NCT01005966|929231|P3|COMPLETED|Treatment Period 2 (14 Days)||10
388733|NCT01005966|929232|P2|COMPLETED|Treatment Period 2 (14 Days)||12
388734|NCT01005966|929233|P1|COMPLETED|Treatment Period 2 (14 Days)||13
388735|NCT01005966|929229|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
388736|NCT01005966|929230|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
388737|NCT01005966|929231|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
388738|NCT01005966|929232|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
388739|NCT01005966|929233|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
388740|NCT01005966|929229|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
388741|NCT01005966|929230|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
388742|NCT01005966|929231|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
388743|NCT01005966|929232|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
388744|NCT01005966|929233|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
388745|NCT01005966|929229|P5|COMPLETED|Washout Period 1 (4 Days)||13
388746|NCT01005966|929230|P4|COMPLETED|Washout Period 1 (4 Days)||12
388747|NCT01005966|929231|P3|COMPLETED|Washout Period 1 (4 Days)||12
388748|NCT01005966|929232|P2|COMPLETED|Washout Period 1 (4 Days)||13
388749|NCT01005966|929233|P1|COMPLETED|Washout Period 1 (4 Days)||11
388750|NCT01005966|929229|P5|STARTED|Washout Period 1 (4 Days)||13
388751|NCT01005966|929230|P4|STARTED|Washout Period 1 (4 Days)||13
388752|NCT01005966|929231|P3|STARTED|Washout Period 1 (4 Days)||12
388753|NCT01005966|929232|P2|STARTED|Washout Period 1 (4 Days)||13
388754|NCT01005966|929233|P1|STARTED|Washout Period 1 (4 Days)||11
388755|NCT01005966|929229|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
388756|NCT01005966|929230|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
388757|NCT01005966|929231|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
388758|NCT01005966|929232|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
388759|NCT01005966|929233|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
388760|NCT01005966|929229|P5|COMPLETED|Treatment Period 1 (14 Days)||13
388761|NCT01005966|929230|P4|COMPLETED|Treatment Period 1 (14 Days)||13
388762|NCT01005966|929231|P3|COMPLETED|Treatment Period 1 (14 Days)||12
388763|NCT01005966|929232|P2|COMPLETED|Treatment Period 1 (14 Days)||13
388764|NCT01005966|929233|P1|COMPLETED|Treatment Period 1 (14 Days)||11
388765|NCT01005966|929229|P5|STARTED|Treatment Period 1 (14 Days)||13
388766|NCT01005966|929230|P4|STARTED|Treatment Period 1 (14 Days)||13
388767|NCT01005966|929231|P3|STARTED|Treatment Period 1 (14 Days)||13
388768|NCT01005966|929232|P2|STARTED|Treatment Period 1 (14 Days)||13
388769|NCT01005966|929233|P1|STARTED|Treatment Period 1 (14 Days)||13
388770|NCT01005914|929253|P1|NOT COMPLETED|Overall Study||10
388771|NCT01005914|929253|P1|COMPLETED|Overall Study||1
388772|NCT01005914|929253|P1|STARTED|Overall Study||11
388773|NCT01005901|929259|P2|NOT COMPLETED|Overall Study||58
388774|NCT01005901|929260|P1|NOT COMPLETED|Overall Study||102
388775|NCT01005901|929259|P2|COMPLETED|Overall Study||212
388776|NCT01005901|929260|P1|COMPLETED|Overall Study||450
388777|NCT01005901|929259|P2|Full Analysis Set|Overall Study||260
388778|NCT01005901|929260|P1|Full Analysis Set|Overall Study||534
388779|NCT01005901|929259|P2|Safety Population|Overall Study||267
388781|NCT01005901|929259|P2|STARTED|Overall Study||270
388782|NCT01005901|929260|P1|STARTED|Overall Study||552
388783|NCT01005888|929302|P2|NOT COMPLETED|Second Intervention||1
388784|NCT01005888|929303|P1|NOT COMPLETED|Second Intervention||1
388785|NCT01005888|929302|P2|COMPLETED|Second Intervention||10
388786|NCT01005888|929303|P1|COMPLETED|Second Intervention||10
388787|NCT01005888|929302|P2|STARTED|Second Intervention||11
388788|NCT01005888|929303|P1|STARTED|Second Intervention||11
388789|NCT01005888|929302|P2|NOT COMPLETED|First Intervention||1
388790|NCT01005888|929303|P1|NOT COMPLETED|First Intervention||1
388791|NCT01005888|929302|P2|COMPLETED|First Intervention||11
388792|NCT01005888|929303|P1|COMPLETED|First Intervention||11
388793|NCT01005888|929302|P2|STARTED|First Intervention||12
388794|NCT01005888|929303|P1|STARTED|First Intervention||12
388795|NCT01005875|929323|P1|NOT COMPLETED|Overall Study||3
388796|NCT01005875|929323|P1|COMPLETED|Overall Study||2
388797|NCT01005875|929323|P1|STARTED|Overall Study||5
388798|NCT01005745|929331|P1|NOT COMPLETED|Overall Study||6
388799|NCT01005745|929331|P1|COMPLETED|Overall Study||13
388800|NCT01005745|929331|P1|STARTED|Overall Study||19
388801|NCT01005732|929336|P1|NOT COMPLETED|Overall Study||11
388802|NCT01005732|929336|P1|COMPLETED|Overall Study||43
388803|NCT01005732|929336|P1|STARTED|Overall Study||54
388804|NCT01005719|929352|P6|NOT COMPLETED|Period 3||0
388805|NCT01005719|929353|P5|NOT COMPLETED|Period 3||0
388806|NCT01005719|929354|P4|NOT COMPLETED|Period 3||0
388807|NCT01005719|929355|P3|NOT COMPLETED|Period 3||0
388808|NCT01005719|929356|P2|NOT COMPLETED|Period 3||0
388809|NCT01005719|929357|P1|NOT COMPLETED|Period 3||0
388810|NCT01005719|929352|P6|COMPLETED|Period 3||9
388811|NCT01005719|929353|P5|COMPLETED|Period 3||10
388812|NCT01005719|929354|P4|COMPLETED|Period 3||10
388813|NCT01005719|929355|P3|COMPLETED|Period 3||10
388814|NCT01005719|929356|P2|COMPLETED|Period 3||10
388815|NCT01005719|929357|P1|COMPLETED|Period 3||10
388816|NCT01005719|929352|P6|STARTED|Period 3||9
388817|NCT01005719|929353|P5|STARTED|Period 3||10
388818|NCT01005719|929354|P4|STARTED|Period 3||10
388819|NCT01005719|929355|P3|STARTED|Period 3||10
388820|NCT01005719|929356|P2|STARTED|Period 3||10
388821|NCT01005719|929357|P1|STARTED|Period 3||10
388822|NCT01005719|929352|P6|NOT COMPLETED|Period 2||1
388823|NCT01005719|929353|P5|NOT COMPLETED|Period 2||1
388824|NCT01005719|929354|P4|NOT COMPLETED|Period 2||0
388825|NCT01005719|929355|P3|NOT COMPLETED|Period 2||0
388826|NCT01005719|929356|P2|NOT COMPLETED|Period 2||0
388827|NCT01005719|929357|P1|NOT COMPLETED|Period 2||0
388828|NCT01005719|929352|P6|COMPLETED|Period 2||9
388829|NCT01005719|929353|P5|COMPLETED|Period 2||10
388830|NCT01005719|929354|P4|COMPLETED|Period 2||10
388831|NCT01005719|929355|P3|COMPLETED|Period 2||10
388832|NCT01005719|929356|P2|COMPLETED|Period 2||10
388833|NCT01005719|929357|P1|COMPLETED|Period 2||10
388834|NCT01005719|929352|P6|STARTED|Period 2||10
388835|NCT01005719|929353|P5|STARTED|Period 2||11
388836|NCT01005719|929354|P4|STARTED|Period 2||10
388837|NCT01005719|929355|P3|STARTED|Period 2||10
388838|NCT01005719|929356|P2|STARTED|Period 2||10
388839|NCT01005719|929357|P1|STARTED|Period 2||10
388840|NCT01005719|929352|P6|NOT COMPLETED|Period 1||1
388841|NCT01005719|929353|P5|NOT COMPLETED|Period 1||0
388842|NCT01005719|929354|P4|NOT COMPLETED|Period 1||1
388843|NCT01005719|929355|P3|NOT COMPLETED|Period 1||0
388844|NCT01005719|929356|P2|NOT COMPLETED|Period 1||0
388845|NCT01005719|929357|P1|NOT COMPLETED|Period 1||0
388846|NCT01005719|929352|P6|COMPLETED|Period 1||10
388847|NCT01005719|929353|P5|COMPLETED|Period 1||11
388848|NCT01005719|929354|P4|COMPLETED|Period 1||10
388849|NCT01005719|929355|P3|COMPLETED|Period 1||10
388850|NCT01005719|929356|P2|COMPLETED|Period 1||10
388851|NCT01005719|929357|P1|COMPLETED|Period 1||10
388852|NCT01005719|929352|P6|STARTED|Period 1||11
388853|NCT01005719|929353|P5|STARTED|Period 1||11
388854|NCT01005719|929354|P4|STARTED|Period 1||11
388855|NCT01005719|929355|P3|STARTED|Period 1||10
388856|NCT01005719|929356|P2|STARTED|Period 1||10
388857|NCT01005719|929357|P1|STARTED|Period 1||10
388858|NCT01005706|929415|P2|NOT COMPLETED|Overall Study||0
388859|NCT01005706|929416|P1|NOT COMPLETED|Overall Study||0
388860|NCT01005706|929415|P2|COMPLETED|Overall Study||17
388861|NCT01005706|929416|P1|COMPLETED|Overall Study||23
388862|NCT01005706|929415|P2|STARTED|Overall Study||17
388863|NCT01005706|929416|P1|STARTED|Overall Study||23
388864|NCT01005680|929424|P2|NOT COMPLETED|Overall Study||11
388865|NCT01005680|929425|P1|NOT COMPLETED|Overall Study||6
388866|NCT01005680|929424|P2|COMPLETED|Overall Study||119
388867|NCT01005680|929425|P1|COMPLETED|Overall Study||120
388868|NCT01005680|929424|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
388869|NCT01005680|929425|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
388870|NCT01005680|929424|P2|STARTED|Overall Study||130
388871|NCT01005680|929425|P1|STARTED|Overall Study||126
388872|NCT01005602|929449|P2|NOT COMPLETED|Overall Study||0
388873|NCT01005602|929450|P1|NOT COMPLETED|Overall Study||1
388874|NCT01005602|929449|P2|COMPLETED|Overall Study||66
388875|NCT01005602|929450|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
388876|NCT01005602|929449|P2|STARTED|Overall Study||66
388877|NCT01005602|929450|P1|STARTED|Overall Study||66
388878|NCT01005355|929473|P3|NOT COMPLETED|Overall Study||0
388879|NCT01005355|929474|P2|NOT COMPLETED|Overall Study||0
388880|NCT01005355|929475|P1|NOT COMPLETED|Overall Study||0
388881|NCT01005355|929473|P3|COMPLETED|Overall Study||6
388882|NCT01005355|929474|P2|COMPLETED|Overall Study||6
388883|NCT01005355|929475|P1|COMPLETED|Overall Study||3
388884|NCT01005355|929473|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
388885|NCT01005355|929474|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
388886|NCT01005355|929475|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
388887|NCT01005355|929473|P3|STARTED|Overall Study||6
388888|NCT01005355|929474|P2|STARTED|Overall Study||6
388889|NCT01005355|929475|P1|STARTED|Overall Study||3
388890|NCT01005329|929510|P1|NOT COMPLETED|Overall Study||4
388891|NCT01005329|929510|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
388892|NCT01005329|929510|P1|STARTED|Overall Study||34
388893|NCT01005316|929517|P4|NOT COMPLETED|Overall Study||108
388894|NCT01005316|929518|P3|NOT COMPLETED|Overall Study||11
388895|NCT01005316|929519|P2|NOT COMPLETED|Overall Study||76
388896|NCT01005316|929520|P1|NOT COMPLETED|Overall Study||50
388897|NCT01005316|929517|P4|COMPLETED|Overall Study||19
388898|NCT01005316|929518|P3|COMPLETED|Overall Study||5
388899|NCT01005316|929519|P2|COMPLETED|Overall Study||21
388900|NCT01005316|929520|P1|COMPLETED|Overall Study||0
388901|NCT01005316|929517|P4|STARTED|Overall Study||127
388902|NCT01005316|929518|P3|STARTED|Overall Study||16
388903|NCT01005316|929519|P2|STARTED|Overall Study||97
388904|NCT01005316|929520|P1|STARTED|Overall Study||50
388905|NCT01005290|929572|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
388906|NCT01005290|929573|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
388907|NCT01005290|929574|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
388908|NCT01005290|929572|P3|COMPLETED|Period 2 (5 Weeks)||7
388909|NCT01005290|929573|P2|COMPLETED|Period 2 (5 Weeks)||13
388910|NCT01005290|929574|P1|COMPLETED|Period 2 (5 Weeks)||0
388911|NCT01005290|929572|P3|STARTED|Period 2 (5 Weeks)||9
388912|NCT01005290|929573|P2|STARTED|Period 2 (5 Weeks)||13
388913|NCT01005290|929574|P1|STARTED|Period 2 (5 Weeks)||0
388914|NCT01005290|929572|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
388915|NCT01005290|929573|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
388916|NCT01005290|929574|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
388917|NCT01005290|929572|P3|COMPLETED|Washout Period (2 Weeks)||9
388918|NCT01005290|929573|P2|COMPLETED|Washout Period (2 Weeks)||13
388919|NCT01005290|929574|P1|COMPLETED|Washout Period (2 Weeks)||0
388920|NCT01005290|929572|P3|STARTED|Washout Period (2 Weeks)||9
388921|NCT01005290|929573|P2|STARTED|Washout Period (2 Weeks)||13
388922|NCT01005290|929574|P1|STARTED|Washout Period (2 Weeks)||0
388923|NCT01005290|929572|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
388924|NCT01005290|929573|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
388925|NCT01005290|929574|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
388926|NCT01005290|929572|P3|COMPLETED|Period 1 (5 Weeks)||9
388927|NCT01005290|929573|P2|COMPLETED|Period 1 (5 Weeks)||13
388928|NCT01005290|929574|P1|COMPLETED|Period 1 (5 Weeks)||0
388929|NCT01005290|929572|P3|STARTED|Period 1 (5 Weeks)||18
388930|NCT01005290|929573|P2|STARTED|Period 1 (5 Weeks)||20
388931|NCT01005290|929574|P1|STARTED|Period 1 (5 Weeks)||0
388932|NCT01005290|929572|P3|NOT COMPLETED|Run-In||0
388933|NCT01005290|929573|P2|NOT COMPLETED|Run-In||0
388934|NCT01005290|929574|P1|NOT COMPLETED|Run-In||14
388935|NCT01005290|929572|P3|COMPLETED|Run-In||0
388936|NCT01005290|929573|P2|COMPLETED|Run-In||0
388937|NCT01005290|929574|P1|COMPLETED|Run-In||38
388938|NCT01005290|929572|P3|STARTED|Run-In||0
388939|NCT01005290|929573|P2|STARTED|Run-In||0
388940|NCT01005290|929574|P1|STARTED|Run-In||52
388941|NCT01005251|929587|P5|NOT COMPLETED|Overall Study||18
388942|NCT01005251|929588|P4|NOT COMPLETED|Overall Study||12
388943|NCT01005251|929589|P3|NOT COMPLETED|Overall Study||22
388944|NCT01005251|929590|P2|NOT COMPLETED|Overall Study||16
388945|NCT01005251|929591|P1|NOT COMPLETED|Overall Study||13
388946|NCT01005251|929587|P5|COMPLETED|Overall Study||122
388947|NCT01005251|929588|P4|COMPLETED|Overall Study||114
388948|NCT01005251|929589|P3|COMPLETED|Overall Study||114
388949|NCT01005251|929590|P2|COMPLETED|Overall Study||109
388950|NCT01005251|929591|P1|COMPLETED|Overall Study||121
388951|NCT01005251|929587|P5|STARTED|Overall Study||140
388952|NCT01005251|929588|P4|STARTED|Overall Study||126
388953|NCT01005251|929589|P3|STARTED|Overall Study||136
388954|NCT01005251|929590|P2|STARTED|Overall Study||125
388955|NCT01005251|929591|P1|STARTED|Overall Study||134
388956|NCT01004991|929608|P1|NOT COMPLETED|Overall Study||0
388957|NCT01004991|929608|P1|COMPLETED|Overall Study||12
388958|NCT01004991|929608|P1|STARTED|Overall Study||12
388959|NCT01004939|929612|P1|NOT COMPLETED|Overall Study||0
388960|NCT01004939|929612|P1|COMPLETED|Overall Study||120
388961|NCT01004939|929612|P1|STARTED|Overall Study||120
388962|NCT01004874|929653|P1|NOT COMPLETED|Overall Study||0
388963|NCT01004874|929653|P1|COMPLETED|Overall Study||80
388964|NCT01004874|929653|P1|STARTED|Overall Study||80
388965|NCT01004848|929664|P2|NOT COMPLETED|Overall Study||45
388966|NCT01004848|929665|P1|NOT COMPLETED|Overall Study||55
388967|NCT01004848|929664|P2|COMPLETED|Overall Study||147
388968|NCT01004848|929665|P1|COMPLETED|Overall Study||155
388969|NCT01004848|929664|P2|STARTED|Overall Study||192
388970|NCT01004848|929665|P1|STARTED|Overall Study||210
388971|NCT01004822|929703|P8|NOT COMPLETED|Overall Study||5
388972|NCT01004822|929704|P7|NOT COMPLETED|Overall Study||4
388973|NCT01004822|929705|P6|NOT COMPLETED|Overall Study||4
388974|NCT01004822|929706|P5|NOT COMPLETED|Overall Study||4
388975|NCT01004822|929707|P4|NOT COMPLETED|Overall Study||4
388976|NCT01004822|929708|P3|NOT COMPLETED|Overall Study||4
388977|NCT01004822|929709|P2|NOT COMPLETED|Overall Study||3
388978|NCT01004822|929710|P1|NOT COMPLETED|Overall Study||3
388979|NCT01004822|929703|P8|COMPLETED|Overall Study||0
388980|NCT01004822|929704|P7|COMPLETED|Overall Study||0
388981|NCT01004822|929705|P6|COMPLETED|Overall Study||0
388982|NCT01004822|929706|P5|COMPLETED|Overall Study||0
388983|NCT01004822|929707|P4|COMPLETED|Overall Study||0
388984|NCT01004822|929708|P3|COMPLETED|Overall Study||0
388985|NCT01004822|929709|P2|COMPLETED|Overall Study||0
388986|NCT01004822|929710|P1|COMPLETED|Overall Study||0
388987|NCT01004822|929703|P8|Treated|Overall Study||5
388988|NCT01004822|929704|P7|Treated|Overall Study||4
388989|NCT01004822|929705|P6|Treated|Overall Study||4
388990|NCT01004822|929706|P5|Treated|Overall Study||4
388991|NCT01004822|929707|P4|Treated|Overall Study||4
388992|NCT01004822|929708|P3|Treated|Overall Study||3
388993|NCT01004822|929709|P2|Treated|Overall Study||3
388994|NCT01004822|929710|P1|Treated|Overall Study||3
388995|NCT01004822|929703|P8|STARTED|Overall Study||5
388996|NCT01004822|929704|P7|STARTED|Overall Study||4
388997|NCT01004822|929705|P6|STARTED|Overall Study||4
388998|NCT01004822|929706|P5|STARTED|Overall Study||4
388999|NCT01004822|929707|P4|STARTED|Overall Study||4
389000|NCT01004822|929708|P3|STARTED|Overall Study||4
389001|NCT01004822|929709|P2|STARTED|Overall Study||3
389002|NCT01004822|929710|P1|STARTED|Overall Study||3
389003|NCT01004770|929824|P5|NOT COMPLETED|Overall Study||0
389004|NCT01004770|929825|P4|NOT COMPLETED|Overall Study||0
389005|NCT01004770|929826|P3|NOT COMPLETED|Overall Study||0
389006|NCT01004770|929827|P2|NOT COMPLETED|Overall Study||0
389007|NCT01004770|929828|P1|NOT COMPLETED|Overall Study||0
389008|NCT01004770|929824|P5|COMPLETED|Overall Study||10
389009|NCT01004770|929825|P4|COMPLETED|Overall Study||10
389010|NCT01004770|929826|P3|COMPLETED|Overall Study||10
389011|NCT01004770|929827|P2|COMPLETED|Overall Study||10
389012|NCT01004770|929828|P1|COMPLETED|Overall Study||10
389013|NCT01004770|929824|P5|STARTED|Overall Study||10
389014|NCT01004770|929825|P4|STARTED|Overall Study||10
389015|NCT01004770|929826|P3|STARTED|Overall Study||10
389016|NCT01004770|929827|P2|STARTED|Overall Study||10
389017|NCT01004770|929828|P1|STARTED|Overall Study||10
389018|NCT01004705|929860|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
389019|NCT01004705|929861|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
389020|NCT01004705|929862|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
389021|NCT01004705|929860|P3|COMPLETED|Period 2 (12 Weeks)||9
389022|NCT01004705|929861|P2|COMPLETED|Period 2 (12 Weeks)||13
389023|NCT01004705|929862|P1|COMPLETED|Period 2 (12 Weeks)||0
389024|NCT01004705|929860|P3|STARTED|Period 2 (12 Weeks)||13
389025|NCT01004705|929861|P2|STARTED|Period 2 (12 Weeks)||13
389026|NCT01004705|929862|P1|STARTED|Period 2 (12 Weeks)||0
389027|NCT01004705|929860|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
389028|NCT01004705|929861|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
389029|NCT01004705|929862|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
389030|NCT01004705|929860|P3|COMPLETED|Washout Period (6 Weeks)||13
389031|NCT01004705|929861|P2|COMPLETED|Washout Period (6 Weeks)||13
389032|NCT01004705|929862|P1|COMPLETED|Washout Period (6 Weeks)||0
389033|NCT01004705|929860|P3|STARTED|Washout Period (6 Weeks)||13
389034|NCT01004705|929861|P2|STARTED|Washout Period (6 Weeks)||13
389035|NCT01004705|929862|P1|STARTED|Washout Period (6 Weeks)||0
389036|NCT01004705|929860|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
389037|NCT01004705|929861|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
389038|NCT01004705|929862|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
389039|NCT01004705|929860|P3|COMPLETED|Period 1 (12 Weeks)||13
389040|NCT01004705|929861|P2|COMPLETED|Period 1 (12 Weeks)||13
389041|NCT01004705|929862|P1|COMPLETED|Period 1 (12 Weeks)||0
389042|NCT01004705|929860|P3|STARTED|Period 1 (12 Weeks)||18
389043|NCT01004705|929861|P2|STARTED|Period 1 (12 Weeks)||18
389044|NCT01004705|929862|P1|STARTED|Period 1 (12 Weeks)||0
389045|NCT01004705|929860|P3|NOT COMPLETED|Run-In||0
389046|NCT01004705|929861|P2|NOT COMPLETED|Run-In||0
389047|NCT01004705|929862|P1|NOT COMPLETED|Run-In||8
389048|NCT01004705|929860|P3|COMPLETED|Run-In||0
389049|NCT01004705|929861|P2|COMPLETED|Run-In||0
389050|NCT01004705|929862|P1|COMPLETED|Run-In||36
389051|NCT01004705|929860|P3|STARTED|Run-In||0
389052|NCT01004705|929861|P2|STARTED|Run-In||0
389053|NCT01004705|929862|P1|STARTED|Run-In||44
389054|NCT01004614|929875|P4|NOT COMPLETED|Second Intervention||0
389055|NCT01004614|929876|P3|NOT COMPLETED|Second Intervention||0
389056|NCT01004614|929877|P2|NOT COMPLETED|Second Intervention||0
389057|NCT01004614|929878|P1|NOT COMPLETED|Second Intervention||0
389058|NCT01004614|929875|P4|COMPLETED|Second Intervention||12
389059|NCT01004614|929876|P3|COMPLETED|Second Intervention||12
389060|NCT01004614|929877|P2|COMPLETED|Second Intervention||11
389061|NCT01004614|929878|P1|COMPLETED|Second Intervention||12
389062|NCT01004614|929875|P4|STARTED|Second Intervention||12
389063|NCT01004614|929876|P3|STARTED|Second Intervention||12
389064|NCT01004614|929877|P2|STARTED|Second Intervention||11
389065|NCT01004614|929878|P1|STARTED|Second Intervention||12
389066|NCT01004614|929875|P4|NOT COMPLETED|Washout||0
389067|NCT01004614|929876|P3|NOT COMPLETED|Washout||0
389068|NCT01004614|929877|P2|NOT COMPLETED|Washout||1
389069|NCT01004614|929878|P1|NOT COMPLETED|Washout||0
389070|NCT01004614|929875|P4|COMPLETED|Washout||12
389071|NCT01004614|929876|P3|COMPLETED|Washout||12
389072|NCT01004614|929877|P2|COMPLETED|Washout||11
389073|NCT01004614|929878|P1|COMPLETED|Washout||12
389074|NCT01004614|929875|P4|STARTED|Washout||12
389075|NCT01004614|929876|P3|STARTED|Washout||12
389076|NCT01004614|929877|P2|STARTED|Washout||12
389077|NCT01004614|929878|P1|STARTED|Washout||12
389078|NCT01004614|929875|P4|NOT COMPLETED|First Intervention||0
389079|NCT01004614|929876|P3|NOT COMPLETED|First Intervention||0
389080|NCT01004614|929877|P2|NOT COMPLETED|First Intervention||0
389081|NCT01004614|929878|P1|NOT COMPLETED|First Intervention||0
389082|NCT01004614|929875|P4|COMPLETED|First Intervention||12
389083|NCT01004614|929876|P3|COMPLETED|First Intervention||12
389084|NCT01004614|929877|P2|COMPLETED|First Intervention||12
389085|NCT01004614|929878|P1|COMPLETED|First Intervention||12
389086|NCT01004614|929875|P4|STARTED|First Intervention||12
389087|NCT01004614|929876|P3|STARTED|First Intervention||12
389088|NCT01004614|929877|P2|STARTED|First Intervention||12
389089|NCT01004614|929878|P1|STARTED|First Intervention||12
389090|NCT01004510|929912|P1|NOT COMPLETED|Overall Study||1
389091|NCT01004510|929912|P1|COMPLETED|Overall Study||2
389092|NCT01004510|929912|P1|STARTED|Overall Study||3
389093|NCT01004432|929916|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
389094|NCT01004432|929917|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
389095|NCT01004432|929918|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
389096|NCT01004432|929919|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
389097|NCT01004432|929920|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
389098|NCT01004432|929916|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
389099|NCT01004432|929917|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
389100|NCT01004432|929918|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
389101|NCT01004432|929919|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
389102|NCT01004432|929920|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
389103|NCT01004432|929916|P5|STARTED|OL Study Extension (Week 52 - 76)||212
389104|NCT01004432|929917|P4|STARTED|OL Study Extension (Week 52 - 76)||0
389105|NCT01004432|929918|P3|STARTED|OL Study Extension (Week 52 - 76)||0
389106|NCT01004432|929919|P2|STARTED|OL Study Extension (Week 52 - 76)||0
389107|NCT01004432|929920|P1|STARTED|OL Study Extension (Week 52 - 76)||0
389108|NCT01004432|929916|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
389109|NCT01004432|929917|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
389110|NCT01004432|929918|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
389111|NCT01004432|929919|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
389112|NCT01004432|929920|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
389113|NCT01004432|929916|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
389114|NCT01004432|929917|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
389115|NCT01004432|929918|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
389116|NCT01004432|929919|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
389117|NCT01004432|929920|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
389118|NCT01004432|929916|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
389119|NCT01004432|929917|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
389120|NCT01004432|929918|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
389121|NCT01004432|929919|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
389122|NCT01004432|929920|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
389123|NCT01004432|929916|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389124|NCT01004432|929917|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389125|NCT01004432|929918|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389126|NCT01004432|929919|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389127|NCT01004432|929920|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
389128|NCT01004432|929916|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389129|NCT01004432|929917|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389130|NCT01004432|929918|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389131|NCT01004432|929919|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
389132|NCT01004432|929920|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
389133|NCT01004432|929916|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
389134|NCT01004432|929917|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
389135|NCT01004432|929918|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
389136|NCT01004432|929919|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
389137|NCT01004432|929920|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
389138|NCT01004393|929940|P1|NOT COMPLETED|Overall Study||0
389139|NCT01004393|929940|P1|COMPLETED|Overall Study||12
389140|NCT01004393|929940|P1|STARTED|Overall Study||12
389141|NCT01004354|929951|P1|NOT COMPLETED|Overall Study||0
389142|NCT01004354|929951|P1|COMPLETED|Overall Study||12
389143|NCT01004354|929951|P1|STARTED|Overall Study||12
389144|NCT01004263|929955|P1|NOT COMPLETED|Overall Study||179
389145|NCT01004263|929955|P1|COMPLETED|Overall Study||427
389146|NCT01004263|929955|P1|STARTED|Overall Study|Participants who took study drug|606
389147|NCT01004250|929963|P1|NOT COMPLETED|Follow-Up (FU) Period||1
389148|NCT01004250|929963|P1|COMPLETED|Follow-Up (FU) Period||100
389149|NCT01004250|929963|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
389150|NCT01004250|929963|P1|NOT COMPLETED|Maintenance Therapy Period||26
389151|NCT01004250|929963|P1|COMPLETED|Maintenance Therapy Period||46
389152|NCT01004250|929963|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
389153|NCT01004250|929963|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
389154|NCT01004250|929963|P1|NOT COMPLETED|Induction Therapy Period||15
389155|NCT01004250|929963|P1|COMPLETED|Induction Therapy Period||94
389156|NCT01004250|929963|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
389157|NCT01004250|929963|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
389158|NCT01004250|929963|P1|STARTED|Induction Therapy Period||109
389159|NCT01004185|929975|P2|NOT COMPLETED|Overall Study||9
389160|NCT01004185|929976|P1|NOT COMPLETED|Overall Study||9
389161|NCT01004185|929975|P2|COMPLETED|Overall Study||11
389162|NCT01004185|929976|P1|COMPLETED|Overall Study||10
389163|NCT01004185|929975|P2|STARTED|Overall Study||20
389164|NCT01004185|929976|P1|STARTED|Overall Study||19
389165|NCT01004172|929984|P1|NOT COMPLETED|Overall Study||38
389166|NCT01004172|929984|P1|COMPLETED|Overall Study||0
389167|NCT01004172|929984|P1|STARTED|Overall Study||38
389168|NCT01004159|929990|P1|NOT COMPLETED|Overall Study||20
389169|NCT01004159|929990|P1|COMPLETED|Overall Study||0
389170|NCT01004159|929990|P1|STARTED|Overall Study||20
389171|NCT01004146|929997|P2|NOT COMPLETED|Overall Study||5
389172|NCT01004146|929998|P1|NOT COMPLETED|Overall Study||4
389173|NCT01004146|929997|P2|COMPLETED|Overall Study||20
389174|NCT01004146|929998|P1|COMPLETED|Overall Study||21
389175|NCT01004146|929997|P2|Have Incentive Spirometry Data|Overall Study||20
389176|NCT01004146|929998|P1|Have Incentive Spirometry Data|Overall Study||21
389177|NCT01004146|929997|P2|STARTED|Overall Study||25
389178|NCT01004146|929998|P1|STARTED|Overall Study||25
389179|NCT01004003|930013|P9|NOT COMPLETED|Overall Study||30
389180|NCT01004003|930014|P8|NOT COMPLETED|Overall Study||60
389181|NCT01004003|930015|P7|NOT COMPLETED|Overall Study||8
389182|NCT01004003|930016|P6|NOT COMPLETED|Overall Study||4
389183|NCT01004003|930017|P5|NOT COMPLETED|Overall Study||4
389184|NCT01004003|930018|P4|NOT COMPLETED|Overall Study||3
389185|NCT01004003|930019|P3|NOT COMPLETED|Overall Study||4
389186|NCT01004003|930020|P2|NOT COMPLETED|Overall Study||3
389187|NCT01004003|930021|P1|NOT COMPLETED|Overall Study||6
389188|NCT01004003|930013|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
389189|NCT01004003|930014|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
389190|NCT01004003|930015|P7|COMPLETED|Overall Study||0
389191|NCT01004003|930016|P6|COMPLETED|Overall Study||0
389192|NCT01004003|930017|P5|COMPLETED|Overall Study||0
389193|NCT01004003|930018|P4|COMPLETED|Overall Study||0
389194|NCT01004003|930019|P3|COMPLETED|Overall Study||0
389195|NCT01004003|930020|P2|COMPLETED|Overall Study||0
389196|NCT01004003|930021|P1|COMPLETED|Overall Study||0
389197|NCT01004003|930013|P9|STARTED|Overall Study||31
389198|NCT01004003|930014|P8|STARTED|Overall Study||62
389199|NCT01004003|930015|P7|STARTED|Overall Study||8
389200|NCT01004003|930016|P6|STARTED|Overall Study||4
389201|NCT01004003|930017|P5|STARTED|Overall Study||4
389202|NCT01004003|930018|P4|STARTED|Overall Study||3
389203|NCT01004003|930019|P3|STARTED|Overall Study||4
389204|NCT01004003|930020|P2|STARTED|Overall Study||3
389205|NCT01004003|930021|P1|STARTED|Overall Study||6
389206|NCT01003990|930052|P3|NOT COMPLETED|Overall Study||43
389207|NCT01003990|930053|P2|NOT COMPLETED|Overall Study||51
389208|NCT01003990|930054|P1|NOT COMPLETED|Overall Study||92
389209|NCT01003990|930052|P3|COMPLETED|Overall Study||53
389210|NCT01003990|930053|P2|COMPLETED|Overall Study||103
389211|NCT01003990|930054|P1|COMPLETED|Overall Study||367
389212|NCT01003990|930052|P3|STARTED|Overall Study||96
389213|NCT01003990|930053|P2|STARTED|Overall Study||154
389214|NCT01003990|930054|P1|STARTED|Overall Study||459
389215|NCT01003938|930062|P1|NOT COMPLETED|Overall Study||0
389216|NCT01003938|930062|P1|COMPLETED|Overall Study||6
389217|NCT01003938|930062|P1|STARTED|Overall Study||6
389218|NCT01003899|930071|P1|NOT COMPLETED|Overall Study||47
389219|NCT01003899|930071|P1|COMPLETED|Overall Study||0
389220|NCT01003899|930071|P1|STARTED|Overall Study|enrolled|47
389221|NCT01003886|930080|P1|NOT COMPLETED|Overall Study||230
389222|NCT01003886|930080|P1|COMPLETED|Overall Study||759
389223|NCT01003886|930080|P1|STARTED|Overall Study||989
389224|NCT01002742|930091|P2|NOT COMPLETED|Overall Study||1
389225|NCT01002742|930092|P1|NOT COMPLETED|Overall Study||0
389226|NCT01002742|930091|P2|COMPLETED|Overall Study||116
389227|NCT01002742|930092|P1|COMPLETED|Overall Study||119
389228|NCT01002742|930091|P2|STARTED|Overall Study||117
389229|NCT01002742|930092|P1|STARTED|Overall Study||119
389230|NCT01003301|930128|P2|NOT COMPLETED|Overall Study||0
389231|NCT01003301|930129|P1|NOT COMPLETED|Overall Study||0
389232|NCT01003301|930128|P2|COMPLETED|Overall Study||9
389233|NCT01003301|930129|P1|COMPLETED|Overall Study||10
389234|NCT01003301|930128|P2|STARTED|Overall Study||9
389235|NCT01003301|930129|P1|STARTED|Overall Study||10
389236|NCT01003288|930137|P1|NOT COMPLETED|Overall Study||0
389237|NCT01003288|930137|P1|COMPLETED|Overall Study||255
389238|NCT01003288|930137|P1|STARTED|Overall Study||255
389239|NCT01003275|930144|P2|NOT COMPLETED|Overall Study||0
389240|NCT01003275|930145|P1|NOT COMPLETED|Overall Study||1
389241|NCT01003275|930144|P2|COMPLETED|Overall Study||11
389242|NCT01003275|930145|P1|COMPLETED|Overall Study||10
389243|NCT01003275|930144|P2|STARTED|Overall Study||11
389244|NCT01003275|930145|P1|STARTED|Overall Study||11
389245|NCT01003210|930153|P2|NOT COMPLETED|Overall Study||3
389246|NCT01003210|930154|P1|NOT COMPLETED|Overall Study||1
389247|NCT01003210|930153|P2|COMPLETED|Overall Study||102
389248|NCT01003210|930154|P1|COMPLETED|Overall Study||104
389249|NCT01003210|930153|P2|STARTED|Overall Study||105
389250|NCT01003210|930154|P1|STARTED|Overall Study||105
389251|NCT01003184|930164|P2|NOT COMPLETED|Overall Study||12
389252|NCT01003184|930165|P1|NOT COMPLETED|Overall Study||19
389253|NCT01003184|930164|P2|COMPLETED|Overall Study||99
389254|NCT01003184|930165|P1|COMPLETED|Overall Study||92
389255|NCT01003184|930164|P2|Full Analysis Set (FAS)|Overall Study||105
389256|NCT01003184|930165|P1|Full Analysis Set (FAS)|Overall Study||111
389257|NCT01003184|930164|P2|STARTED|Overall Study||111
389258|NCT01003184|930165|P1|STARTED|Overall Study||111
389259|NCT01003106|930201|P8|NOT COMPLETED|Month 6-Month 36||0
389260|NCT01003106|930202|P7|NOT COMPLETED|Month 6-Month 36||1
389261|NCT01003106|930203|P6|NOT COMPLETED|Month 6-Month 36||0
389262|NCT01003106|930204|P5|NOT COMPLETED|Month 6-Month 36||0
389263|NCT01003106|930205|P4|NOT COMPLETED|Month 6-Month 36||0
389264|NCT01003106|930206|P3|NOT COMPLETED|Month 6-Month 36||1
389265|NCT01003106|930207|P2|NOT COMPLETED|Month 6-Month 36||0
389266|NCT01003106|930208|P1|NOT COMPLETED|Month 6-Month 36||0
389267|NCT01003106|930201|P8|COMPLETED|Month 6-Month 36||18
389268|NCT01003106|930202|P7|COMPLETED|Month 6-Month 36||19
389269|NCT01003106|930203|P6|COMPLETED|Month 6-Month 36||0
389270|NCT01003106|930204|P5|COMPLETED|Month 6-Month 36||0
389271|NCT01003106|930205|P4|COMPLETED|Month 6-Month 36||20
389272|NCT01003106|930206|P3|COMPLETED|Month 6-Month 36||18
389273|NCT01003106|930207|P2|COMPLETED|Month 6-Month 36||0
389274|NCT01003106|930208|P1|COMPLETED|Month 6-Month 36||0
389275|NCT01003106|930201|P8|STARTED|Month 6-Month 36||18
389276|NCT01003106|930202|P7|STARTED|Month 6-Month 36||20
389277|NCT01003106|930203|P6|STARTED|Month 6-Month 36||0
389278|NCT01003106|930204|P5|STARTED|Month 6-Month 36||0
389279|NCT01003106|930205|P4|STARTED|Month 6-Month 36||20
389280|NCT01003106|930206|P3|STARTED|Month 6-Month 36||19
389281|NCT01003106|930207|P2|STARTED|Month 6-Month 36||0
389282|NCT01003106|930208|P1|STARTED|Month 6-Month 36||0
389283|NCT01003106|930201|P8|NOT COMPLETED|Baseline to Month 6||0
389284|NCT01003106|930202|P7|NOT COMPLETED|Baseline to Month 6||0
389285|NCT01003106|930203|P6|NOT COMPLETED|Baseline to Month 6||0
389286|NCT01003106|930204|P5|NOT COMPLETED|Baseline to Month 6||0
389287|NCT01003106|930205|P4|NOT COMPLETED|Baseline to Month 6||0
389288|NCT01003106|930206|P3|NOT COMPLETED|Baseline to Month 6||0
389289|NCT01003106|930207|P2|NOT COMPLETED|Baseline to Month 6||0
389290|NCT01003106|930208|P1|NOT COMPLETED|Baseline to Month 6||0
389291|NCT01003106|930201|P8|COMPLETED|Baseline to Month 6||0
389292|NCT01003106|930202|P7|COMPLETED|Baseline to Month 6||0
389293|NCT01003106|930203|P6|COMPLETED|Baseline to Month 6||20
389294|NCT01003106|930204|P5|COMPLETED|Baseline to Month 6||19
389295|NCT01003106|930205|P4|COMPLETED|Baseline to Month 6||0
389296|NCT01003106|930206|P3|COMPLETED|Baseline to Month 6||0
389297|NCT01003106|930207|P2|COMPLETED|Baseline to Month 6||20
389298|NCT01003106|930208|P1|COMPLETED|Baseline to Month 6||22
389299|NCT01003106|930201|P8|STARTED|Baseline to Month 6||0
389300|NCT01003106|930202|P7|STARTED|Baseline to Month 6||0
389301|NCT01003106|930203|P6|STARTED|Baseline to Month 6||20
389302|NCT01003106|930204|P5|STARTED|Baseline to Month 6||19
389303|NCT01003106|930205|P4|STARTED|Baseline to Month 6||0
389304|NCT01003106|930206|P3|STARTED|Baseline to Month 6||0
389305|NCT01003106|930207|P2|STARTED|Baseline to Month 6||20
389306|NCT01003106|930208|P1|STARTED|Baseline to Month 6||22
389307|NCT01003080|930232|P2|NOT COMPLETED|Overall Study||0
389308|NCT01003080|930233|P1|NOT COMPLETED|Overall Study||0
389309|NCT01003080|930232|P2|COMPLETED|Overall Study||61
389310|NCT01003080|930233|P1|COMPLETED|Overall Study||50
389311|NCT01003080|930232|P2|STARTED|Overall Study||61
389312|NCT01003080|930233|P1|STARTED|Overall Study||50
389313|NCT01003067|930241|P2|NOT COMPLETED|Overall Study||24
389314|NCT01003067|930242|P1|NOT COMPLETED|Overall Study||33
389315|NCT01003067|930241|P2|COMPLETED|Overall Study||107
389316|NCT01003067|930242|P1|COMPLETED|Overall Study||103
389317|NCT01003067|930241|P2|STARTED|Overall Study||131
389318|NCT01003067|930242|P1|STARTED|Overall Study||136
389319|NCT01002989|930248|P1|NOT COMPLETED|Overall Study||5
389320|NCT01002989|930248|P1|COMPLETED|Overall Study||93
389321|NCT01002989|930248|P1|STARTED|Overall Study||98
389322|NCT01002573|930257|P2|NOT COMPLETED|Overall Study||7
389323|NCT01002573|930258|P1|NOT COMPLETED|Overall Study||11
389324|NCT01002573|930257|P2|COMPLETED|Overall Study||53
389325|NCT01002573|930258|P1|COMPLETED|Overall Study||47
389326|NCT01002573|930257|P2|STARTED|Overall Study||60
389327|NCT01002573|930258|P1|STARTED|Overall Study||58
389328|NCT01002482|930278|P2|NOT COMPLETED|Overall Study||21
389329|NCT01002482|930279|P1|NOT COMPLETED|Overall Study||15
389330|NCT01002482|930278|P2|COMPLETED|Overall Study||1312
389331|NCT01002482|930279|P1|COMPLETED|Overall Study||1336
389332|NCT01002482|930278|P2|STARTED|Overall Study||1333
389333|NCT01002482|930279|P1|STARTED|Overall Study||1351
389334|NCT01002456|930301|P2|NOT COMPLETED|Overall Study||0
389335|NCT01002456|930302|P1|NOT COMPLETED|Overall Study||0
389336|NCT01002456|930301|P2|COMPLETED|Overall Study||122
389337|NCT01002456|930302|P1|COMPLETED|Overall Study||98
389338|NCT01002456|930301|P2|STARTED|Overall Study||122
389339|NCT01002456|930302|P1|STARTED|Overall Study||98
389340|NCT01002339|930313|P3|NOT COMPLETED|Overall Study||5
389341|NCT01002339|930314|P2|NOT COMPLETED|Overall Study||1
389342|NCT01002339|930315|P1|NOT COMPLETED|Overall Study||0
389343|NCT01002339|930313|P3|COMPLETED|Overall Study||42
389344|NCT01002339|930314|P2|COMPLETED|Overall Study||42
389345|NCT01002339|930315|P1|COMPLETED|Overall Study||44
389346|NCT01002339|930313|P3|STARTED|Overall Study||47
389347|NCT01002339|930314|P2|STARTED|Overall Study||43
389348|NCT01002339|930315|P1|STARTED|Overall Study||44
389349|NCT01002287|930370|P2|NOT COMPLETED|Overall Study||0
389350|NCT01002287|930371|P1|NOT COMPLETED|Overall Study||0
389351|NCT01002287|930370|P2|COMPLETED|Overall Study||3
389352|NCT01002287|930371|P1|COMPLETED|Overall Study||8
389353|NCT01002287|930370|P2|STARTED|Overall Study||3
389354|NCT01002287|930371|P1|STARTED|Overall Study||8
389355|NCT01002105|930385|P2|NOT COMPLETED|Overall Study||21
389356|NCT01002105|930386|P1|NOT COMPLETED|Overall Study||19
389357|NCT01002105|930385|P2|COMPLETED|Overall Study||11
389358|NCT01002105|930386|P1|COMPLETED|Overall Study||13
389359|NCT01002105|930385|P2|STARTED|Overall Study||32
389360|NCT01002105|930386|P1|STARTED|Overall Study||32
389361|NCT01001975|930404|P2|NOT COMPLETED|Overall Study||0
389362|NCT01001975|930405|P1|NOT COMPLETED|Overall Study||0
389363|NCT01001975|930404|P2|COMPLETED|Overall Study||5
389364|NCT01001975|930405|P1|COMPLETED|Overall Study||5
389365|NCT01001975|930404|P2|STARTED|Overall Study||5
389366|NCT01001975|930405|P1|STARTED|Overall Study||5
389367|NCT01001832|930415|P2|NOT COMPLETED|Follow-up Period||21
389368|NCT01001832|930416|P1|NOT COMPLETED|Follow-up Period||18
389369|NCT01001832|930415|P2|COMPLETED|Follow-up Period||30
389370|NCT01001832|930416|P1|COMPLETED|Follow-up Period||34
389371|NCT01001832|930415|P2|STARTED|Follow-up Period||51
389372|NCT01001832|930416|P1|STARTED|Follow-up Period||52
389373|NCT01001832|930415|P2|NOT COMPLETED|Long-term Period||5
389374|NCT01001832|930416|P1|NOT COMPLETED|Long-term Period||4
389375|NCT01001832|930415|P2|COMPLETED|Long-term Period||51
389376|NCT01001832|930416|P1|COMPLETED|Long-term Period||52
389377|NCT01001832|930415|P2|STARTED|Long-term Period||56
389378|NCT01001832|930416|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
389379|NCT01001832|930415|P2|NOT COMPLETED|Short-term Period||3
389380|NCT01001832|930416|P1|NOT COMPLETED|Short-term Period||2
389381|NCT01001832|930415|P2|COMPLETED|Short-term Period||56
389382|NCT01001832|930416|P1|COMPLETED|Short-term Period||57
389383|NCT01001832|930415|P2|STARTED|Short-term Period||59
389384|NCT01001832|930416|P1|STARTED|Short-term Period||59
389385|NCT01001806|930462|P3|NOT COMPLETED|Overall Study||4
389386|NCT01001806|930463|P2|NOT COMPLETED|Overall Study||1
389387|NCT01001806|930464|P1|NOT COMPLETED|Overall Study||0
389388|NCT01001806|930462|P3|COMPLETED|Overall Study||38
389389|NCT01001806|930463|P2|COMPLETED|Overall Study||41
389390|NCT01001806|930464|P1|COMPLETED|Overall Study||42
389391|NCT01001806|930462|P3|STARTED|Overall Study||42
389392|NCT01001806|930463|P2|STARTED|Overall Study||42
389393|NCT01001806|930464|P1|STARTED|Overall Study||42
389394|NCT01001767|930474|P2|NOT COMPLETED|Overall Study||0
389395|NCT01001767|930475|P1|NOT COMPLETED|Overall Study||4
389396|NCT01001767|930474|P2|COMPLETED|Overall Study||17
389397|NCT01001767|930475|P1|COMPLETED|Overall Study||14
389398|NCT01001767|930474|P2|STARTED|Overall Study||17
389399|NCT01001767|930475|P1|STARTED|Overall Study||18
389400|NCT01001702|930481|P1|NOT COMPLETED|Overall Study||72
389401|NCT01001702|930481|P1|COMPLETED|Overall Study||13
389402|NCT01001702|930481|P1|STARTED|Overall Study||85
389403|NCT01001572|930494|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
389404|NCT01001572|930495|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
389405|NCT01001572|930496|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
389406|NCT01001572|930494|P3|COMPLETED|Double-Blind Treatment Phase||306
389407|NCT01001572|930495|P2|COMPLETED|Double-Blind Treatment Phase||319
389408|NCT01001572|930496|P1|COMPLETED|Double-Blind Treatment Phase||0
389409|NCT01001572|930494|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
389410|NCT01001572|930495|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
389411|NCT01001572|930496|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
389412|NCT01001572|930494|P3|STARTED|Double-Blind Treatment Phase||325
389413|NCT01001572|930495|P2|STARTED|Double-Blind Treatment Phase||329
389414|NCT01001572|930496|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
389415|NCT01001572|930494|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
389416|NCT01001572|930495|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
389417|NCT01001572|930496|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
389418|NCT01001572|930494|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
389419|NCT01001572|930495|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
389420|NCT01001572|930496|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
389421|NCT01001572|930494|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
389422|NCT01001572|930495|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
389423|NCT01001572|930496|P1|STARTED|Single-Blind Valsartan 160 mg||932
389424|NCT01001559|930512|P2|NOT COMPLETED|Overall Study||0
389425|NCT01001559|930513|P1|NOT COMPLETED|Overall Study||0
389426|NCT01001559|930512|P2|COMPLETED|Overall Study||147
389427|NCT01001559|930513|P1|COMPLETED|Overall Study||95
389428|NCT01001559|930512|P2|STARTED|Overall Study||147
389429|NCT01001559|930513|P1|STARTED|Overall Study||95
389430|NCT01001546|930527|P2|NOT COMPLETED|Overall Study||0
389431|NCT01001546|930528|P1|NOT COMPLETED|Overall Study||0
389432|NCT01001546|930527|P2|COMPLETED|Overall Study||207
389433|NCT01001546|930528|P1|COMPLETED|Overall Study||206
389434|NCT01001546|930527|P2|STARTED|Overall Study||207
389435|NCT01001546|930528|P1|STARTED|Overall Study||206
389436|NCT01001520|930534|P2|NOT COMPLETED|Medication Period 2||3
389437|NCT01001520|930535|P1|NOT COMPLETED|Medication Period 2||0
389438|NCT01001520|930534|P2|COMPLETED|Medication Period 2||13
389439|NCT01001520|930535|P1|COMPLETED|Medication Period 2||16
389440|NCT01001520|930534|P2|STARTED|Medication Period 2||16
389441|NCT01001520|930535|P1|STARTED|Medication Period 2||16
389442|NCT01001520|930534|P2|NOT COMPLETED|Washout Period||1
389443|NCT01001520|930535|P1|NOT COMPLETED|Washout Period||2
389444|NCT01001520|930534|P2|COMPLETED|Washout Period||16
389445|NCT01001520|930535|P1|COMPLETED|Washout Period||16
389446|NCT01001520|930534|P2|STARTED|Washout Period||17
389447|NCT01001520|930535|P1|STARTED|Washout Period||18
389448|NCT01001520|930534|P2|NOT COMPLETED|Medication Period 1||7
389449|NCT01001520|930535|P1|NOT COMPLETED|Medication Period 1||4
389450|NCT01001520|930534|P2|COMPLETED|Medication Period 1||17
389451|NCT01001520|930535|P1|COMPLETED|Medication Period 1||18
389452|NCT01001520|930534|P2|STARTED|Medication Period 1||24
389453|NCT01001520|930535|P1|STARTED|Medication Period 1||22
389454|NCT01001494|930562|P3|NOT COMPLETED|Overall Study||41
389455|NCT01001494|930563|P2|NOT COMPLETED|Overall Study||17
389456|NCT01001494|930564|P1|NOT COMPLETED|Overall Study||24
389457|NCT01001494|930562|P3|COMPLETED|Overall Study||232
389458|NCT01001494|930563|P2|COMPLETED|Overall Study||252
389459|NCT01001494|930564|P1|COMPLETED|Overall Study||253
389460|NCT01001494|930562|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
389461|NCT01001494|930563|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
389462|NCT01001494|930564|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
389463|NCT01001403|930586|P2|NOT COMPLETED|Overall Study||0
389464|NCT01001403|930587|P1|NOT COMPLETED|Overall Study||0
389465|NCT01001403|930586|P2|COMPLETED|Overall Study||31
389466|NCT01001403|930587|P1|COMPLETED|Overall Study||31
389467|NCT01001403|930586|P2|STARTED|Overall Study||31
389468|NCT01001403|930587|P1|STARTED|Overall Study||31
389469|NCT01001390|930593|P2|NOT COMPLETED|Overall Study||0
389470|NCT01001390|930594|P1|NOT COMPLETED|Overall Study||2
389471|NCT01001390|930593|P2|COMPLETED|Overall Study||0
389472|NCT01001390|930594|P1|COMPLETED|Overall Study||0
389473|NCT01001390|930593|P2|STARTED|Overall Study||0
389474|NCT01001390|930594|P1|STARTED|Overall Study||2
389475|NCT01001377|930602|P2|NOT COMPLETED|Overall Study||421
389476|NCT01001377|930603|P1|NOT COMPLETED|Overall Study||426
389477|NCT01001377|930602|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
389478|NCT01001377|930603|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
389479|NCT01001377|930602|P2|Received Treatment|Overall Study||499
389480|NCT01001377|930603|P1|Received Treatment|Overall Study||500
389481|NCT01001377|930602|P2|STARTED|Overall Study||506
389482|NCT01001377|930603|P1|STARTED|Overall Study||504
389483|NCT01001325|930633|P2|NOT COMPLETED|Overall Study||10
389484|NCT01001325|930634|P1|NOT COMPLETED|Overall Study||18
389485|NCT01001325|930633|P2|COMPLETED|Overall Study||224
389486|NCT01001325|930634|P1|COMPLETED|Overall Study||216
389487|NCT01001325|930633|P2|STARTED|Overall Study||234
389488|NCT01001325|930634|P1|STARTED|Overall Study||234
389489|NCT01001299|930640|P1|NOT COMPLETED|Overall Study||25
389490|NCT01001299|930640|P1|COMPLETED|Overall Study||0
389491|NCT01001299|930640|P1|STARTED|Overall Study||25
389492|NCT01001234|930669|P5|NOT COMPLETED|Overall Study||0
389493|NCT01001234|930670|P4|NOT COMPLETED|Overall Study||25
389494|NCT01001234|930671|P3|NOT COMPLETED|Overall Study||32
389495|NCT01001234|930672|P2|NOT COMPLETED|Overall Study||26
389496|NCT01001234|930673|P1|NOT COMPLETED|Overall Study||405
389497|NCT01001234|930669|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
389498|NCT01001234|930670|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
389499|NCT01001234|930671|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
389500|NCT01001234|930672|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
389501|NCT01001234|930673|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
389502|NCT01001234|930669|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
389503|NCT01001234|930670|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
389504|NCT01001234|930671|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
389505|NCT01001234|930672|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
389506|NCT01001234|930673|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
389507|NCT01001234|930669|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
389508|NCT01001234|930670|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
389509|NCT01001234|930671|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
389510|NCT01001234|930672|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
389511|NCT01001234|930673|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
389512|NCT01001234|930669|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
389513|NCT01001234|930670|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
389514|NCT01001234|930671|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
389515|NCT01001234|930672|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
389516|NCT01001234|930673|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
389517|NCT01001221|930689|P5|NOT COMPLETED|Overall Study||0
389518|NCT01001221|930690|P4|NOT COMPLETED|Overall Study||6
389519|NCT01001221|930691|P3|NOT COMPLETED|Overall Study||3
389520|NCT01001221|930692|P2|NOT COMPLETED|Overall Study||5
389521|NCT01001221|930693|P1|NOT COMPLETED|Overall Study||5
389522|NCT01001221|930689|P5|COMPLETED|Overall Study||0
389523|NCT01001221|930690|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
389524|NCT01001221|930691|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
389525|NCT01001221|930692|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
389526|NCT01001221|930693|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
389527|NCT01001221|930689|P5|Completed 1st Treatment Cycle|Overall Study||0
389528|NCT01001221|930690|P4|Completed 1st Treatment Cycle|Overall Study||6
389529|NCT01001221|930691|P3|Completed 1st Treatment Cycle|Overall Study||2
389530|NCT01001221|930692|P2|Completed 1st Treatment Cycle|Overall Study||5
389531|NCT01001221|930693|P1|Completed 1st Treatment Cycle|Overall Study||5
389532|NCT01001221|930689|P5|Treated|Overall Study||0
389533|NCT01001221|930690|P4|Treated|Overall Study||6
389534|NCT01001221|930691|P3|Treated|Overall Study||2
389535|NCT01001221|930692|P2|Treated|Overall Study||5
389536|NCT01001221|930693|P1|Treated|Overall Study||5
389537|NCT01001221|930689|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
389538|NCT01001221|930690|P4|STARTED|Overall Study||6
389539|NCT01001221|930691|P3|STARTED|Overall Study||3
389540|NCT01001221|930692|P2|STARTED|Overall Study||5
389541|NCT01001221|930693|P1|STARTED|Overall Study||5
389542|NCT01001208|930868|P2|NOT COMPLETED|Overall Study||33
389543|NCT01001208|930869|P1|NOT COMPLETED|Overall Study||28
389544|NCT01001208|930868|P2|COMPLETED|Overall Study||206
389545|NCT01001208|930869|P1|COMPLETED|Overall Study||211
389546|NCT01001208|930868|P2|STARTED|Overall Study||239
389547|NCT01001208|930869|P1|STARTED|Overall Study||239
389548|NCT01001195|930897|P4|NOT COMPLETED|Overall Study||0
389549|NCT01001195|930898|P3|NOT COMPLETED|Overall Study||0
389550|NCT01001195|930899|P2|NOT COMPLETED|Overall Study||2
389551|NCT01001195|930900|P1|NOT COMPLETED|Overall Study||2
389552|NCT01001195|930897|P4|COMPLETED|Overall Study||41
389553|NCT01001195|930898|P3|COMPLETED|Overall Study||44
389554|NCT01001195|930899|P2|COMPLETED|Overall Study||39
389555|NCT01001195|930900|P1|COMPLETED|Overall Study||37
389556|NCT01001195|930897|P4|STARTED|Overall Study||41
389557|NCT01001195|930898|P3|STARTED|Overall Study||44
389558|NCT01001195|930899|P2|STARTED|Overall Study||41
389559|NCT01001195|930900|P1|STARTED|Overall Study||39
389560|NCT01001169|930912|P2|NOT COMPLETED|Overall Study||1
389561|NCT01001169|930913|P1|NOT COMPLETED|Overall Study||2
389562|NCT01001169|930912|P2|COMPLETED|Overall Study||29
389563|NCT01001169|930913|P1|COMPLETED|Overall Study||28
389564|NCT01001169|930912|P2|STARTED|Overall Study||30
389565|NCT01001169|930913|P1|STARTED|Overall Study||30
389566|NCT01001104|931021|P4|NOT COMPLETED|Overall Study||3
389567|NCT01001104|931022|P3|NOT COMPLETED|Overall Study||1
389568|NCT01001104|931023|P2|NOT COMPLETED|Overall Study||1
389569|NCT01001104|931024|P1|NOT COMPLETED|Overall Study||2
389570|NCT01001104|931021|P4|COMPLETED|Overall Study||34
389571|NCT01001104|931022|P3|COMPLETED|Overall Study||35
389572|NCT01001104|931023|P2|COMPLETED|Overall Study||36
389573|NCT01001104|931024|P1|COMPLETED|Overall Study||33
389574|NCT01001104|931021|P4|STARTED|Overall Study||37
389575|NCT01001104|931022|P3|STARTED|Overall Study||36
389576|NCT01001104|931023|P2|STARTED|Overall Study||37
389577|NCT01001104|931024|P1|STARTED|Overall Study||35
389578|NCT01001078|931071|P2|NOT COMPLETED|Overall Study||0
389579|NCT01001078|931072|P1|NOT COMPLETED|Overall Study||0
389580|NCT01001078|931071|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
389581|NCT01001078|931072|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
389582|NCT01001078|931071|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
389583|NCT01001078|931072|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
389584|NCT01001078|931071|P2|Intubated|Overall Study||1
389585|NCT01001078|931072|P1|Intubated|Overall Study||2
389586|NCT01001078|931071|P2|Received Crossover|Overall Study||3
389587|NCT01001078|931072|P1|Received Crossover|Overall Study||2
389588|NCT01001078|931071|P2|Received Allocated Intervention|Overall Study||46
389589|NCT01001078|931072|P1|Received Allocated Intervention|Overall Study||46
389590|NCT01001078|931071|P2|STARTED|Overall Study||50
389591|NCT01001078|931072|P1|STARTED|Overall Study||50
389592|NCT01001052|931088|P2|NOT COMPLETED|Overall Study||0
389593|NCT01001052|931089|P1|NOT COMPLETED|Overall Study||0
389594|NCT01001052|931088|P2|COMPLETED|Overall Study||18
389595|NCT01001052|931089|P1|COMPLETED|Overall Study||20
389596|NCT01001052|931088|P2|STARTED|Overall Study||18
389597|NCT01001052|931089|P1|STARTED|Overall Study||20
389598|NCT01000974|931102|P3|NOT COMPLETED|Booster Vaccination Phase||14
389599|NCT01000974|931103|P2|NOT COMPLETED|Booster Vaccination Phase||12
389600|NCT01000974|931104|P1|NOT COMPLETED|Booster Vaccination Phase||67
389601|NCT01000974|931102|P3|COMPLETED|Booster Vaccination Phase||386
389602|NCT01000974|931103|P2|COMPLETED|Booster Vaccination Phase||423
389603|NCT01000974|931104|P1|COMPLETED|Booster Vaccination Phase||2270
389604|NCT01000974|931102|P3|STARTED|Booster Vaccination Phase||400
389605|NCT01000974|931103|P2|STARTED|Booster Vaccination Phase||435
389606|NCT01000974|931104|P1|STARTED|Booster Vaccination Phase||2337
389607|NCT01000974|931102|P3|NOT COMPLETED|Primary Vaccination Phase||63
389608|NCT01000974|931103|P2|NOT COMPLETED|Primary Vaccination Phase||50
389609|NCT01000974|931104|P1|NOT COMPLETED|Primary Vaccination Phase||338
389610|NCT01000974|931102|P3|COMPLETED|Primary Vaccination Phase||457
389611|NCT01000974|931103|P2|COMPLETED|Primary Vaccination Phase||470
389612|NCT01000974|931104|P1|COMPLETED|Primary Vaccination Phase||2625
389613|NCT01000974|931102|P3|STARTED|Primary Vaccination Phase||520
389614|NCT01000974|931103|P2|STARTED|Primary Vaccination Phase||520
389615|NCT01000974|931104|P1|STARTED|Primary Vaccination Phase||2963
389616|NCT01000961|931181|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
389617|NCT01000961|931182|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
389618|NCT01000961|931181|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
389619|NCT01000961|931182|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
389620|NCT01000961|931181|P2|STARTED|Second Intervention (3 Weeks)||20
389621|NCT01000961|931182|P1|STARTED|Second Intervention (3 Weeks)||21
389622|NCT01000961|931181|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
389623|NCT01000961|931182|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
389624|NCT01000961|931181|P2|COMPLETED|First Intervention (3 Weeks)||20
389625|NCT01000961|931182|P1|COMPLETED|First Intervention (3 Weeks)||21
389626|NCT01000961|931181|P2|STARTED|First Intervention (3 Weeks)||22
389627|NCT01000961|931182|P1|STARTED|First Intervention (3 Weeks)||21
389628|NCT01000961|931181|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
389629|NCT01000961|931182|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
389630|NCT01000961|931181|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
389631|NCT01000961|931182|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
389632|NCT01000961|931181|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
389633|NCT01000961|931182|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
389634|NCT01000818|931194|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
389635|NCT01000818|931194|P1|COMPLETED|Omeprazole + Raltegravir||18
389636|NCT01000818|931194|P1|STARTED|Omeprazole + Raltegravir||18
389637|NCT01000818|931194|P1|NOT COMPLETED|Famotidine + Raltegravir||0
389638|NCT01000818|931194|P1|COMPLETED|Famotidine + Raltegravir||18
389639|NCT01000818|931194|P1|STARTED|Famotidine + Raltegravir||18
389640|NCT01000818|931194|P1|NOT COMPLETED|Raltegravir||0
389641|NCT01000818|931194|P1|COMPLETED|Raltegravir||18
389642|NCT01000818|931194|P1|STARTED|Raltegravir||18
389643|NCT01000805|931205|P2|NOT COMPLETED|Overall Study||62
389644|NCT01000805|931206|P1|NOT COMPLETED|Overall Study||70
389645|NCT01000805|931205|P2|COMPLETED|Overall Study||204
389646|NCT01000805|931206|P1|COMPLETED|Overall Study||192
389647|NCT01000805|931205|P2|STARTED|Overall Study||266
389648|NCT01000805|931206|P1|STARTED|Overall Study||262
389649|NCT01000662|931240|P2|NOT COMPLETED|Overall Study||8
389650|NCT01000662|931241|P1|NOT COMPLETED|Overall Study||4
389651|NCT01000662|931240|P2|COMPLETED|Overall Study||198
389652|NCT01000662|931241|P1|COMPLETED|Overall Study||202
389653|NCT01000662|931240|P2|STARTED|Overall Study||206
389654|NCT01000662|931241|P1|STARTED|Overall Study||206
389655|NCT01000649|931251|P4|NOT COMPLETED|Overall Study||6
389656|NCT01000649|931252|P3|NOT COMPLETED|Overall Study||2
389657|NCT01000649|931253|P2|NOT COMPLETED|Overall Study||3
389658|NCT01000649|931254|P1|NOT COMPLETED|Overall Study||5
389659|NCT01000649|931251|P4|COMPLETED|Overall Study||15
389660|NCT01000649|931252|P3|COMPLETED|Overall Study||0
389661|NCT01000649|931253|P2|COMPLETED|Overall Study||16
389662|NCT01000649|931254|P1|COMPLETED|Overall Study||5
389663|NCT01000649|931251|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
389664|NCT01000649|931252|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
389665|NCT01000649|931253|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
389752|NCT01000025|931509|P1|COMPLETED|Overall Study||12
389666|NCT01000649|931254|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
389667|NCT01000649|931251|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
389668|NCT01000649|931252|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
389669|NCT01000649|931253|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
389670|NCT01000649|931254|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
389671|NCT01000610|931335|P1|NOT COMPLETED|Overall Study||6
389672|NCT01000610|931335|P1|COMPLETED|Overall Study||12
389673|NCT01000610|931335|P1|STARTED|Overall Study||18
389674|NCT01000506|931346|P4|NOT COMPLETED|Overall Study||23
389675|NCT01000506|931347|P3|NOT COMPLETED|Overall Study||21
389676|NCT01000506|931348|P2|NOT COMPLETED|Overall Study||24
389677|NCT01000506|931349|P1|NOT COMPLETED|Overall Study||28
389678|NCT01000506|931346|P4|COMPLETED|Overall Study||133
389679|NCT01000506|931347|P3|COMPLETED|Overall Study||131
389680|NCT01000506|931348|P2|COMPLETED|Overall Study||129
389681|NCT01000506|931349|P1|COMPLETED|Overall Study||127
389682|NCT01000506|931346|P4|STARTED|Overall Study||156
389683|NCT01000506|931347|P3|STARTED|Overall Study||152
389684|NCT01000506|931348|P2|STARTED|Overall Study||153
389685|NCT01000506|931349|P1|STARTED|Overall Study||155
389686|NCT01000480|931391|P1|NOT COMPLETED|Follow-Up Period||0
389687|NCT01000480|931391|P1|COMPLETED|Follow-Up Period||88
389779|NCT00999908|931538|P3|NOT COMPLETED|Treatment Period 1||0
389688|NCT01000480|931391|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
389689|NCT01000480|931391|P1|NOT COMPLETED|Concurrent Therapy Phase||10
389690|NCT01000480|931391|P1|COMPLETED|Concurrent Therapy Phase||65
389691|NCT01000480|931391|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
389692|NCT01000480|931391|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
389693|NCT01000480|931391|P1|NOT COMPLETED|Induction Phase||7
389694|NCT01000480|931391|P1|COMPLETED|Induction Phase||83
389695|NCT01000480|931391|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
389696|NCT01000480|931391|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
389697|NCT01000480|931391|P1|STARTED|Induction Phase||90
389698|NCT01000376|931399|P2|NOT COMPLETED|Cycle 1 Day 15||0
389699|NCT01000376|931400|P1|NOT COMPLETED|Cycle 1 Day 15||0
389700|NCT01000376|931399|P2|COMPLETED|Cycle 1 Day 15||6
389701|NCT01000376|931400|P1|COMPLETED|Cycle 1 Day 15||4
389702|NCT01000376|931399|P2|STARTED|Cycle 1 Day 15||6
389703|NCT01000376|931400|P1|STARTED|Cycle 1 Day 15||4
389704|NCT01000376|931399|P2|NOT COMPLETED|Cycle 1 Day 1||0
389705|NCT01000376|931400|P1|NOT COMPLETED|Cycle 1 Day 1||2
389706|NCT01000376|931399|P2|COMPLETED|Cycle 1 Day 1||6
389707|NCT01000376|931400|P1|COMPLETED|Cycle 1 Day 1||4
389708|NCT01000376|931399|P2|STARTED|Cycle 1 Day 1||6
389709|NCT01000376|931400|P1|STARTED|Cycle 1 Day 1||6
389710|NCT01000337|931410|P2|NOT COMPLETED|Overall Study||3
389711|NCT01000337|931411|P1|NOT COMPLETED|Overall Study||4
389712|NCT01000337|931410|P2|COMPLETED|Overall Study||30
389713|NCT01000337|931411|P1|COMPLETED|Overall Study||30
389714|NCT01000337|931410|P2|STARTED|Overall Study||33
389715|NCT01000337|931411|P1|STARTED|Overall Study||34
389716|NCT01000324|931417|P1|NOT COMPLETED|Year 20||0
389717|NCT01000324|931417|P1|COMPLETED|Year 20||28
389718|NCT01000324|931417|P1|STARTED|Year 20||28
389719|NCT01000324|931417|P1|NOT COMPLETED|Year 19||0
389720|NCT01000324|931417|P1|COMPLETED|Year 19||28
389721|NCT01000324|931417|P1|STARTED|Year 19||28
389722|NCT01000324|931417|P1|NOT COMPLETED|Year 18||0
389723|NCT01000324|931417|P1|COMPLETED|Year 18||29
389724|NCT01000324|931417|P1|STARTED|Year 18||29
389725|NCT01000324|931417|P1|NOT COMPLETED|Year 17||0
389726|NCT01000324|931417|P1|COMPLETED|Year 17||32
389727|NCT01000324|931417|P1|STARTED|Year 17||32
389728|NCT01000324|931417|P1|NOT COMPLETED|Year 16||0
389729|NCT01000324|931417|P1|COMPLETED|Year 16||40
389730|NCT01000324|931417|P1|STARTED|Year 16||40
389731|NCT01000311|931429|P2|NOT COMPLETED|Overall Study||70
389732|NCT01000311|931430|P1|NOT COMPLETED|Overall Study||45
389733|NCT01000311|931429|P2|COMPLETED|Overall Study||201
389734|NCT01000311|931430|P1|COMPLETED|Overall Study||213
389735|NCT01000311|931429|P2|STARTED|Overall Study||271
389736|NCT01000311|931430|P1|STARTED|Overall Study||258
389737|NCT01000285|931460|P1|NOT COMPLETED|Overall Study||0
389738|NCT01000285|931460|P1|COMPLETED|Overall Study||18
389739|NCT01000285|931460|P1|STARTED|Overall Study||18
389740|NCT01000155|931480|P1|NOT COMPLETED|Overall Study||2
389741|NCT01000155|931480|P1|COMPLETED|Overall Study||3
389742|NCT01000155|931480|P1|STARTED|Overall Study||5
389743|NCT01000064|931484|P2|NOT COMPLETED|Overall Study||1
389744|NCT01000064|931485|P1|NOT COMPLETED|Overall Study||1
389745|NCT01000064|931484|P2|COMPLETED|Overall Study||5
389746|NCT01000064|931485|P1|COMPLETED|Overall Study||6
389747|NCT01000064|931484|P2|STARTED|Overall Study||6
389748|NCT01000064|931485|P1|STARTED|Overall Study||7
389749|NCT01000025|931508|P2|NOT COMPLETED|Overall Study||238
389750|NCT01000025|931509|P1|NOT COMPLETED|Overall Study||468
389751|NCT01000025|931508|P2|COMPLETED|Overall Study||2
389753|NCT01000025|931508|P2|STARTED|Overall Study||240
389754|NCT01000025|931509|P1|STARTED|Overall Study||480
389755|NCT00999921|931527|P2|NOT COMPLETED|Overall Study||19
389756|NCT00999921|931528|P1|NOT COMPLETED|Overall Study||10
389757|NCT00999921|931527|P2|COMPLETED|Overall Study||110
389758|NCT00999921|931528|P1|COMPLETED|Overall Study||117
389759|NCT00999921|931527|P2|STARTED|Overall Study||129
389760|NCT00999921|931528|P1|STARTED|Overall Study||127
389761|NCT00999908|931538|P3|NOT COMPLETED|Treatment Period 3||0
389762|NCT00999908|931539|P2|NOT COMPLETED|Treatment Period 3||0
389763|NCT00999908|931540|P1|NOT COMPLETED|Treatment Period 3||0
389764|NCT00999908|931538|P3|COMPLETED|Treatment Period 3||19
389765|NCT00999908|931539|P2|COMPLETED|Treatment Period 3||16
389766|NCT00999908|931540|P1|COMPLETED|Treatment Period 3||16
389767|NCT00999908|931538|P3|STARTED|Treatment Period 3||19
389768|NCT00999908|931539|P2|STARTED|Treatment Period 3||16
389769|NCT00999908|931540|P1|STARTED|Treatment Period 3||16
389770|NCT00999908|931538|P3|NOT COMPLETED|Treatment Period 2||0
389771|NCT00999908|931539|P2|NOT COMPLETED|Treatment Period 2||0
389772|NCT00999908|931540|P1|NOT COMPLETED|Treatment Period 2||1
389773|NCT00999908|931538|P3|COMPLETED|Treatment Period 2||19
389774|NCT00999908|931539|P2|COMPLETED|Treatment Period 2||16
389775|NCT00999908|931540|P1|COMPLETED|Treatment Period 2||16
389776|NCT00999908|931538|P3|STARTED|Treatment Period 2||19
389777|NCT00999908|931539|P2|STARTED|Treatment Period 2||16
389778|NCT00999908|931540|P1|STARTED|Treatment Period 2||17
389780|NCT00999908|931539|P2|NOT COMPLETED|Treatment Period 1||0
389781|NCT00999908|931540|P1|NOT COMPLETED|Treatment Period 1||2
389782|NCT00999908|931538|P3|COMPLETED|Treatment Period 1||19
389783|NCT00999908|931539|P2|COMPLETED|Treatment Period 1||16
389784|NCT00999908|931540|P1|COMPLETED|Treatment Period 1||17
389785|NCT00999908|931538|P3|STARTED|Treatment Period 1||19
389786|NCT00999908|931539|P2|STARTED|Treatment Period 1||16
389787|NCT00999908|931540|P1|STARTED|Treatment Period 1||19
389788|NCT00999830|931556|P2|NOT COMPLETED|Overall Study||0
389789|NCT00999830|931557|P1|NOT COMPLETED|Overall Study||0
389790|NCT00999830|931556|P2|COMPLETED|Overall Study||13
389791|NCT00999830|931557|P1|COMPLETED|Overall Study||14
389792|NCT00999830|931556|P2|STARTED|Overall Study||13
389793|NCT00999830|931557|P1|STARTED|Overall Study||14
389794|NCT00999804|931569|P2|NOT COMPLETED|Overall Study||5
389795|NCT00999804|931570|P1|NOT COMPLETED|Overall Study||21
389796|NCT00999804|931569|P2|COMPLETED|Overall Study||38
389797|NCT00999804|931570|P1|COMPLETED|Overall Study||64
389798|NCT00999804|931569|P2|STARTED|Overall Study||43
389799|NCT00999804|931570|P1|STARTED|Overall Study||85
389800|NCT00999687|931582|P1|NOT COMPLETED|Second Intervention||3
389801|NCT00999687|931582|P1|COMPLETED|Second Intervention||27
389802|NCT00999687|931582|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
389803|NCT00999687|931582|P1|NOT COMPLETED|First Intervention||1
389804|NCT00999687|931582|P1|COMPLETED|First Intervention||30
389805|NCT00999687|931582|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
389806|NCT00999661|931589|P1|NOT COMPLETED|Overall Study||70
389807|NCT00999661|931589|P1|COMPLETED|Overall Study||161
389808|NCT00999661|931589|P1|STARTED|Overall Study||231
389809|NCT00999596|931595|P1|NOT COMPLETED|Overall Study||101
389810|NCT00999596|931595|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
389811|NCT00999596|931595|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
389812|NCT00999596|931595|P1|STARTED|Overall Study||107
389813|NCT00999544|931600|P1|NOT COMPLETED|Overall Study||1
389814|NCT00999544|931600|P1|COMPLETED|Overall Study||8
389815|NCT00999544|931600|P1|STARTED|Overall Study||9
389816|NCT00999466|931621|P3|NOT COMPLETED|Main Part||4
389817|NCT00999466|931622|P2|NOT COMPLETED|Main Part||4
389818|NCT00999466|931623|P1|NOT COMPLETED|Main Part||0
389819|NCT00999466|931621|P3|COMPLETED|Main Part||21
389820|NCT00999466|931622|P2|COMPLETED|Main Part||22
389821|NCT00999466|931623|P1|COMPLETED|Main Part||0
389822|NCT00999466|931621|P3|STARTED|Main Part||25
389823|NCT00999466|931622|P2|STARTED|Main Part||26
389824|NCT00999466|931623|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
389825|NCT00999466|931621|P3|NOT COMPLETED|Pilot Part||0
389826|NCT00999466|931622|P2|NOT COMPLETED|Pilot Part||0
389827|NCT00999466|931623|P1|NOT COMPLETED|Pilot Part||0
389828|NCT00999466|931621|P3|COMPLETED|Pilot Part||3
389829|NCT00999466|931622|P2|COMPLETED|Pilot Part||0
389830|NCT00999466|931623|P1|COMPLETED|Pilot Part||6
389831|NCT00999466|931621|P3|STARTED|Pilot Part||3
389832|NCT00999466|931622|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
389833|NCT00999466|931623|P1|STARTED|Pilot Part||6
389834|NCT00999167|931900|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
389835|NCT00999167|931901|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
389836|NCT00999167|931902|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
389837|NCT00999167|931900|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
389838|NCT00999167|931901|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
389839|NCT00999167|931902|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
389840|NCT00999167|931900|P3|STARTED|Part B: Randomized, Placebo Controlled||88
389841|NCT00999167|931901|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
389842|NCT00999167|931902|P1|STARTED|Part B: Randomized, Placebo Controlled||0
389843|NCT00999167|931900|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
389844|NCT00999167|931901|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
389845|NCT00999167|931902|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
389846|NCT00999167|931900|P3|COMPLETED|Part A: Open Label Safety run-in||0
389847|NCT00999167|931901|P2|COMPLETED|Part A: Open Label Safety run-in||0
389848|NCT00999167|931902|P1|COMPLETED|Part A: Open Label Safety run-in||8
389849|NCT00999167|931900|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
389850|NCT00999167|931901|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
389851|NCT00999167|931902|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
389852|NCT00999167|931900|P3|STARTED|Part A: Open Label Safety run-in||0
389853|NCT00999167|931901|P2|STARTED|Part A: Open Label Safety run-in||0
389854|NCT00999167|931902|P1|STARTED|Part A: Open Label Safety run-in||15
389855|NCT00999141|931916|P1|NOT COMPLETED|Overall Study||0
389856|NCT00999141|931916|P1|COMPLETED|Overall Study||75
389857|NCT00999141|931916|P1|STARTED|Overall Study|Randomized and treated|75
389858|NCT00999037|932000|P2|NOT COMPLETED|Overall Study||0
389859|NCT00999037|932001|P1|NOT COMPLETED|Overall Study||0
389860|NCT00999037|932000|P2|COMPLETED|Overall Study||9
389861|NCT00999037|932001|P1|COMPLETED|Overall Study||9
389862|NCT00999037|932000|P2|STARTED|Overall Study|20|9
389863|NCT00999037|932001|P1|STARTED|Overall Study||9
389864|NCT00998985|932025|P14|NOT COMPLETED|Overall Study||0
389865|NCT00998985|932026|P13|NOT COMPLETED|Overall Study||0
389866|NCT00998985|932027|P12|NOT COMPLETED|Overall Study||0
389867|NCT00998985|932028|P11|NOT COMPLETED|Overall Study||0
389868|NCT00998985|932029|P10|NOT COMPLETED|Overall Study||0
389869|NCT00998985|932030|P9|NOT COMPLETED|Overall Study||1
389870|NCT00998985|932031|P8|NOT COMPLETED|Overall Study||0
389871|NCT00998985|932032|P7|NOT COMPLETED|Overall Study||0
389872|NCT00998985|932033|P6|NOT COMPLETED|Overall Study||1
389873|NCT00998985|932034|P5|NOT COMPLETED|Overall Study||0
389874|NCT00998985|932035|P4|NOT COMPLETED|Overall Study||0
389875|NCT00998985|932036|P3|NOT COMPLETED|Overall Study||0
389876|NCT00998985|932037|P2|NOT COMPLETED|Overall Study||0
389877|NCT00998985|932038|P1|NOT COMPLETED|Overall Study||0
389878|NCT00998985|932025|P14|COMPLETED|Overall Study||15
389879|NCT00998985|932026|P13|COMPLETED|Overall Study||5
389880|NCT00998985|932027|P12|COMPLETED|Overall Study||5
389881|NCT00998985|932028|P11|COMPLETED|Overall Study||5
389882|NCT00998985|932029|P10|COMPLETED|Overall Study||5
389883|NCT00998985|932030|P9|COMPLETED|Overall Study||5
389884|NCT00998985|932031|P8|COMPLETED|Overall Study||5
389885|NCT00998985|932032|P7|COMPLETED|Overall Study||5
389886|NCT00998985|932033|P6|COMPLETED|Overall Study||4
389887|NCT00998985|932034|P5|COMPLETED|Overall Study||5
389888|NCT00998985|932035|P4|COMPLETED|Overall Study||5
389889|NCT00998985|932036|P3|COMPLETED|Overall Study||15
389890|NCT00998985|932037|P2|COMPLETED|Overall Study||5
389891|NCT00998985|932038|P1|COMPLETED|Overall Study||5
389892|NCT00998985|932025|P14|STARTED|Overall Study||15
389893|NCT00998985|932026|P13|STARTED|Overall Study||5
389894|NCT00998985|932027|P12|STARTED|Overall Study||5
389895|NCT00998985|932028|P11|STARTED|Overall Study||5
389896|NCT00998985|932029|P10|STARTED|Overall Study||5
389897|NCT00998985|932030|P9|STARTED|Overall Study||6
389898|NCT00998985|932031|P8|STARTED|Overall Study||5
389899|NCT00998985|932032|P7|STARTED|Overall Study||5
389900|NCT00998985|932033|P6|STARTED|Overall Study||5
389901|NCT00998985|932034|P5|STARTED|Overall Study||5
389902|NCT00998985|932035|P4|STARTED|Overall Study||5
389903|NCT00998985|932036|P3|STARTED|Overall Study||15
389904|NCT00998985|932037|P2|STARTED|Overall Study||5
389905|NCT00998985|932038|P1|STARTED|Overall Study||5
389906|NCT00998881|932106|P2|NOT COMPLETED|Overall Study||2
389907|NCT00998881|932107|P1|NOT COMPLETED|Overall Study||8
389908|NCT00998881|932106|P2|COMPLETED|Overall Study||97
389909|NCT00998881|932107|P1|COMPLETED|Overall Study||96
389910|NCT00998881|932106|P2|STARTED|Overall Study||99
389911|NCT00998881|932107|P1|STARTED|Overall Study||104
389912|NCT00998868|932119|P1|NOT COMPLETED|Overall Study||0
389913|NCT00998868|932119|P1|COMPLETED|Overall Study||51
389914|NCT00998868|932119|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
389915|NCT00998764|932128|P2|NOT COMPLETED|Overall Study||274
389916|NCT00998764|932129|P1|NOT COMPLETED|Overall Study||216
389917|NCT00998764|932128|P2|COMPLETED|Overall Study||2
389918|NCT00998764|932129|P1|COMPLETED|Overall Study||0
389919|NCT00998764|932128|P2|Treated|Overall Study||275
389920|NCT00998764|932129|P1|Treated|Overall Study||215
389921|NCT00998764|932128|P2|STARTED|Overall Study||276
389922|NCT00998764|932129|P1|STARTED|Overall Study||216
389923|NCT00998738|932151|P1|NOT COMPLETED|Overall Study||1
389924|NCT00998738|932151|P1|COMPLETED|Overall Study||0
389925|NCT00998738|932151|P1|STARTED|Overall Study||1
389926|NCT00998660|932166|P1|NOT COMPLETED|Overall Study||13
389927|NCT00998660|932166|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
389928|NCT00998660|932166|P1|Month 3 Visit|Overall Study||87
389929|NCT00998660|932166|P1|Implanted|Overall Study||93
389930|NCT00998660|932166|P1|STARTED|Overall Study||100
389931|NCT00998582|932172|P2|NOT COMPLETED|Overall Study||0
389932|NCT00998582|932173|P1|NOT COMPLETED|Overall Study||0
389933|NCT00998582|932172|P2|COMPLETED|Overall Study||14
389934|NCT00998582|932173|P1|COMPLETED|Overall Study||13
389935|NCT00998582|932172|P2|STARTED|Overall Study||14
389936|NCT00998582|932173|P1|STARTED|Overall Study||13
389937|NCT00998517|932184|P3|NOT COMPLETED|Overall Study||0
389938|NCT00998517|932185|P2|NOT COMPLETED|Overall Study||0
389939|NCT00998517|932186|P1|NOT COMPLETED|Overall Study||0
389940|NCT00998517|932184|P3|COMPLETED|Overall Study||918
389941|NCT00998517|932185|P2|COMPLETED|Overall Study||906
389942|NCT00998517|932186|P1|COMPLETED|Overall Study||888
389943|NCT00998517|932184|P3|STARTED|Overall Study||918
389944|NCT00998517|932185|P2|STARTED|Overall Study||906
389945|NCT00998517|932186|P1|STARTED|Overall Study||888
389946|NCT00998426|932212|P1|NOT COMPLETED|Overall Study||0
389947|NCT00998426|932212|P1|COMPLETED|Overall Study||5
389948|NCT00998426|932212|P1|Blood Glucose Monitoring|Overall Study||5
389949|NCT00998426|932212|P1|STARTED|Overall Study||5
389950|NCT00998374|932219|P2|NOT COMPLETED|Overall Study||11
389951|NCT00998374|932220|P1|NOT COMPLETED|Overall Study||12
389952|NCT00998374|932219|P2|COMPLETED|Overall Study||12
389953|NCT00998374|932220|P1|COMPLETED|Overall Study||27
389954|NCT00998374|932219|P2|STARTED|Overall Study||23
389955|NCT00998374|932220|P1|STARTED|Overall Study||39
389956|NCT00998335|932234|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
389957|NCT00998335|932235|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
389958|NCT00998335|932234|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
389959|NCT00998335|932235|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
389960|NCT00998335|932234|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
389961|NCT00998335|932235|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
389962|NCT00998335|932234|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
389963|NCT00998335|932235|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
389964|NCT00998335|932234|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
389965|NCT00998335|932235|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
389966|NCT00998335|932234|P2|STARTED|Initial Treatment (Months 0 - 3)||0
389967|NCT00998335|932235|P1|STARTED|Initial Treatment (Months 0 - 3)||30
389968|NCT00998309|932263|P1|NOT COMPLETED|Overall Study||4
389969|NCT00998309|932263|P1|COMPLETED|Overall Study||498
389970|NCT00998309|932263|P1|STARTED|Overall Study||502
389971|NCT00998296|932330|P11|NOT COMPLETED|Overall Study||7
389972|NCT00998296|932331|P10|NOT COMPLETED|Overall Study||18
389973|NCT00998296|932332|P9|NOT COMPLETED|Overall Study||2
389974|NCT00998296|932333|P8|NOT COMPLETED|Overall Study||2
389975|NCT00998296|932334|P7|NOT COMPLETED|Overall Study||1
389976|NCT00998296|932335|P6|NOT COMPLETED|Overall Study||0
389977|NCT00998296|932336|P5|NOT COMPLETED|Overall Study||2
389978|NCT00998296|932337|P4|NOT COMPLETED|Overall Study||0
389979|NCT00998296|932338|P3|NOT COMPLETED|Overall Study||0
389980|NCT00998296|932339|P2|NOT COMPLETED|Overall Study||1
389981|NCT00998296|932340|P1|NOT COMPLETED|Overall Study||0
389982|NCT00998296|932330|P11|COMPLETED|Overall Study||0
389983|NCT00998296|932331|P10|COMPLETED|Overall Study||0
389984|NCT00998296|932332|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
389985|NCT00998296|932333|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
389986|NCT00998296|932334|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
389987|NCT00998296|932335|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
389988|NCT00998296|932336|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
389989|NCT00998296|932337|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
389990|NCT00998296|932338|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
389991|NCT00998296|932339|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
389992|NCT00998296|932340|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
389993|NCT00998296|932330|P11|STARTED|Overall Study||7
389994|NCT00998296|932331|P10|STARTED|Overall Study||18
389995|NCT00998296|932332|P9|STARTED|Overall Study||6
389996|NCT00998296|932333|P8|STARTED|Overall Study||6
389997|NCT00998296|932334|P7|STARTED|Overall Study||7
389998|NCT00998296|932335|P6|STARTED|Overall Study||3
389999|NCT00998296|932336|P5|STARTED|Overall Study||8
390000|NCT00998296|932337|P4|STARTED|Overall Study||3
390001|NCT00998296|932338|P3|STARTED|Overall Study||3
390002|NCT00998296|932339|P2|STARTED|Overall Study||3
390003|NCT00998296|932340|P1|STARTED|Overall Study||6
390004|NCT00998205|932407|P1|NOT COMPLETED|Overall Study||0
390005|NCT00998205|932407|P1|COMPLETED|Overall Study||16
390006|NCT00998205|932407|P1|STARTED|Overall Study||16
390007|NCT00998049|932412|P1|NOT COMPLETED|Overall Study||0
390008|NCT00998049|932412|P1|COMPLETED|Overall Study||39
390009|NCT00998049|932412|P1|STARTED|Overall Study||39
390010|NCT00998023|932423|P2|NOT COMPLETED|Overall Study||0
390011|NCT00998023|932424|P1|NOT COMPLETED|Overall Study||0
390012|NCT00998023|932423|P2|COMPLETED|Overall Study||32
390013|NCT00998023|932424|P1|COMPLETED|Overall Study||32
390014|NCT00998023|932423|P2|STARTED|Overall Study||32
390015|NCT00998023|932424|P1|STARTED|Overall Study||32
390016|NCT00997984|932435|P3|NOT COMPLETED|Overall Study||26
390017|NCT00997984|932436|P2|NOT COMPLETED|Overall Study||34
390018|NCT00997984|932437|P1|NOT COMPLETED|Overall Study||37
390019|NCT00997984|932435|P3|COMPLETED|Overall Study||88
390020|NCT00997984|932436|P2|COMPLETED|Overall Study||79
390021|NCT00997984|932437|P1|COMPLETED|Overall Study||76
390022|NCT00997984|932435|P3|STARTED|Overall Study||114
390023|NCT00997984|932436|P2|STARTED|Overall Study||113
390024|NCT00997984|932437|P1|STARTED|Overall Study||113
390025|NCT00997932|932503|P1|NOT COMPLETED|Overall Study||2
390026|NCT00997932|932503|P1|COMPLETED|Overall Study||27
390027|NCT00997932|932503|P1|STARTED|Overall Study||29
390028|NCT00997672|932510|P2|NOT COMPLETED|Overall Study||4
390029|NCT00997672|932511|P1|NOT COMPLETED|Overall Study||4
390030|NCT00997672|932510|P2|COMPLETED|Overall Study||1
390031|NCT00997672|932511|P1|COMPLETED|Overall Study||0
390032|NCT00997672|932510|P2|STARTED|Overall Study||5
390033|NCT00997672|932511|P1|STARTED|Overall Study||4
390034|NCT00997594|932519|P2|NOT COMPLETED|Overall Study||0
390035|NCT00997594|932520|P1|NOT COMPLETED|Overall Study||0
390036|NCT00997594|932519|P2|COMPLETED|Overall Study||9
390037|NCT00997594|932520|P1|COMPLETED|Overall Study||9
390038|NCT00997594|932519|P2|Completion of Ablation Procedure|Overall Study||9
390039|NCT00997594|932520|P1|Completion of Ablation Procedure|Overall Study||9
390040|NCT00997594|932519|P2|STARTED|Overall Study||9
390041|NCT00997594|932520|P1|STARTED|Overall Study||9
390042|NCT00997555|932528|P2|NOT COMPLETED|Overall Study||0
390043|NCT00997555|932529|P1|NOT COMPLETED|Overall Study||0
390044|NCT00997555|932528|P2|COMPLETED|Overall Study||15
390045|NCT00997555|932529|P1|COMPLETED|Overall Study||13
390046|NCT00997555|932528|P2|STARTED|Overall Study||15
390047|NCT00997555|932529|P1|STARTED|Overall Study||13
390048|NCT00997516|932547|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
390049|NCT00997516|932548|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
390050|NCT00997516|932547|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
390051|NCT00997516|932548|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
390052|NCT00997516|932547|P2|STARTED|Long-term Follow-up (After 6 Months)||38
390053|NCT00997516|932548|P1|STARTED|Long-term Follow-up (After 6 Months)||37
390054|NCT00997516|932547|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
390055|NCT00997516|932548|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
390056|NCT00997516|932547|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
390057|NCT00997516|932548|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
390058|NCT00997516|932547|P2|STARTED|Short-term Follow-up (Post Operative)||38
390059|NCT00997516|932548|P1|STARTED|Short-term Follow-up (Post Operative)||37
390060|NCT00997503|932576|P1|NOT COMPLETED|Overall Study||273
390061|NCT00997503|932576|P1|COMPLETED|Overall Study||3926
390062|NCT00997503|932576|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
390063|NCT00997503|932576|P1|STARTED|Overall Study||4199
390064|NCT00997438|932619|P3|NOT COMPLETED|Overall Study||4
390065|NCT00997438|932620|P2|NOT COMPLETED|Overall Study||3
390066|NCT00997438|932621|P1|NOT COMPLETED|Overall Study||5
390067|NCT00997438|932619|P3|COMPLETED|Overall Study||20
390068|NCT00997438|932620|P2|COMPLETED|Overall Study||21
390069|NCT00997438|932621|P1|COMPLETED|Overall Study||16
390070|NCT00997438|932619|P3|STARTED|Overall Study||24
390071|NCT00997438|932620|P2|STARTED|Overall Study||24
390072|NCT00997438|932621|P1|STARTED|Overall Study||21
390073|NCT00997425|932656|P1|NOT COMPLETED|Overall Study||0
390074|NCT00997425|932656|P1|COMPLETED|Overall Study||19
390075|NCT00997425|932656|P1|STARTED|Overall Study||19
390076|NCT00997373|932663|P2|NOT COMPLETED|Overall Study||0
390077|NCT00997373|932664|P1|NOT COMPLETED|Overall Study||15
390078|NCT00997373|932663|P2|COMPLETED|Overall Study||15
390079|NCT00997373|932664|P1|COMPLETED|Overall Study||13
390080|NCT00997373|932663|P2|Completed Hysterectomy|Overall Study||15
390081|NCT00997373|932664|P1|Completed Hysterectomy|Overall Study||17
390082|NCT00997373|932663|P2|Received Letrozole|Overall Study||0
390083|NCT00997373|932664|P1|Received Letrozole|Overall Study||23
390084|NCT00997373|932663|P2|STARTED|Overall Study||15
390085|NCT00997373|932664|P1|STARTED|Overall Study||28
390086|NCT00997334|932670|P1|NOT COMPLETED|Overall Study||25
390087|NCT00997334|932670|P1|COMPLETED|Overall Study||35
390088|NCT00997334|932670|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
390089|NCT00997334|932670|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
390090|NCT00997334|932670|P1|STARTED|Overall Study||60
390091|NCT00997321|932679|P2|NOT COMPLETED|Overall Study||3
390092|NCT00997321|932680|P1|NOT COMPLETED|Overall Study||0
390093|NCT00997321|932679|P2|COMPLETED|Overall Study||47
390094|NCT00997321|932680|P1|COMPLETED|Overall Study||50
390095|NCT00997321|932679|P2|STARTED|Overall Study||50
390096|NCT00997321|932680|P1|STARTED|Overall Study||50
390097|NCT00997243|932692|P1|NOT COMPLETED|Overall Study||7
390098|NCT00997243|932692|P1|COMPLETED|Overall Study||0
390099|NCT00997243|932692|P1|STARTED|Overall Study||7
390100|NCT00997204|932704|P2|NOT COMPLETED|Self-administration Phase||1
390101|NCT00997204|932705|P1|NOT COMPLETED|Self-administration Phase||0
390102|NCT00997204|932704|P2|COMPLETED|Self-administration Phase||77
390103|NCT00997204|932705|P1|COMPLETED|Self-administration Phase||19
390104|NCT00997204|932704|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
390105|NCT00997204|932705|P1|STARTED|Self-administration Phase||19
390106|NCT00997204|932704|P2|NOT COMPLETED|Naive Treatment Phase||79
390107|NCT00997204|932705|P1|NOT COMPLETED|Naive Treatment Phase||6
390108|NCT00997204|932704|P2|COMPLETED|Naive Treatment Phase||0
390109|NCT00997204|932705|P1|COMPLETED|Naive Treatment Phase||19
390110|NCT00997204|932704|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
390111|NCT00997204|932705|P1|STARTED|Naive Treatment Phase||25
390112|NCT00997139|932716|P1|NOT COMPLETED|Overall Study||186
390113|NCT00997139|932716|P1|COMPLETED|Overall Study||30
390114|NCT00997139|932716|P1|Treated for Positive Baseline Culture|Overall Study||30
390115|NCT00997139|932716|P1|STARTED|Overall Study||216
390116|NCT00997126|932724|P2|NOT COMPLETED|Overall Study||11
390117|NCT00997126|932725|P1|NOT COMPLETED|Overall Study||7
390118|NCT00997126|932724|P2|COMPLETED|Overall Study||52
390119|NCT00997126|932725|P1|COMPLETED|Overall Study||56
390120|NCT00997126|932724|P2|STARTED|Overall Study||63
390121|NCT00997126|932725|P1|STARTED|Overall Study||63
390122|NCT00997113|932741|P2|NOT COMPLETED|Overall Study||0
390123|NCT00997113|932742|P1|NOT COMPLETED|Overall Study||0
390124|NCT00997113|932741|P2|COMPLETED|Overall Study||10
390125|NCT00997113|932742|P1|COMPLETED|Overall Study||10
390126|NCT00997113|932741|P2|STARTED|Overall Study||10
390127|NCT00997113|932742|P1|STARTED|Overall Study||10
390128|NCT00997035|932754|P2|NOT COMPLETED|3-month Follow-up Visit||6
390129|NCT00997035|932755|P1|NOT COMPLETED|3-month Follow-up Visit||12
390130|NCT00997035|932754|P2|COMPLETED|3-month Follow-up Visit||107
390131|NCT00997035|932755|P1|COMPLETED|3-month Follow-up Visit||100
390132|NCT00997035|932754|P2|STARTED|3-month Follow-up Visit||113
390133|NCT00997035|932755|P1|STARTED|3-month Follow-up Visit||112
390134|NCT00997035|932754|P2|NOT COMPLETED|3-week Followup Visit||6
390135|NCT00997035|932755|P1|NOT COMPLETED|3-week Followup Visit||9
390136|NCT00997035|932754|P2|COMPLETED|3-week Followup Visit||113
390137|NCT00997035|932755|P1|COMPLETED|3-week Followup Visit||112
390138|NCT00997035|932754|P2|STARTED|3-week Followup Visit||119
390139|NCT00997035|932755|P1|STARTED|3-week Followup Visit||121
390140|NCT00996996|932775|P1|NOT COMPLETED|Overall Study||33
390141|NCT00996996|932775|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
390142|NCT00996996|932775|P1|STARTED|Overall Study||77
390143|NCT00996944|932809|P2|NOT COMPLETED|Long-term Treatment Period||5
390144|NCT00996944|932810|P1|NOT COMPLETED|Long-term Treatment Period||12
390145|NCT00996944|932809|P2|COMPLETED|Long-term Treatment Period||0
390146|NCT00996944|932810|P1|COMPLETED|Long-term Treatment Period||0
390147|NCT00996944|932809|P2|STARTED|Long-term Treatment Period||5
390148|NCT00996944|932810|P1|STARTED|Long-term Treatment Period||12
390149|NCT00996944|932809|P2|NOT COMPLETED|Double-blind Treatment Period||7
390150|NCT00996944|932810|P1|NOT COMPLETED|Double-blind Treatment Period||10
390151|NCT00996944|932809|P2|COMPLETED|Double-blind Treatment Period||5
390152|NCT00996944|932810|P1|COMPLETED|Double-blind Treatment Period||12
390153|NCT00996944|932809|P2|STARTED|Double-blind Treatment Period||12
390154|NCT00996944|932810|P1|STARTED|Double-blind Treatment Period||22
390155|NCT00996931|932852|P1|NOT COMPLETED|Overall Study||0
390156|NCT00996931|932852|P1|COMPLETED|Overall Study||6
390157|NCT00996931|932852|P1|STARTED|Overall Study||6
390158|NCT00996918|932862|P5|NOT COMPLETED|Overall Study||4
390159|NCT00996918|932863|P4|NOT COMPLETED|Overall Study||56
390160|NCT00996918|932864|P3|NOT COMPLETED|Overall Study||37
390161|NCT00996918|932865|P2|NOT COMPLETED|Overall Study||66
390162|NCT00996918|932866|P1|NOT COMPLETED|Overall Study||39
390163|NCT00996918|932862|P5|COMPLETED|Overall Study||0
390164|NCT00996918|932863|P4|COMPLETED|Overall Study||0
390165|NCT00996918|932864|P3|COMPLETED|Overall Study||0
390166|NCT00996918|932865|P2|COMPLETED|Overall Study||0
390167|NCT00996918|932866|P1|COMPLETED|Overall Study||0
390168|NCT00996918|932862|P5|Treated|Overall Study||4
390169|NCT00996918|932863|P4|Treated|Overall Study||56
390170|NCT00996918|932864|P3|Treated|Overall Study||37
390171|NCT00996918|932865|P2|Treated|Overall Study||66
390172|NCT00996918|932866|P1|Treated|Overall Study||39
390173|NCT00996918|932862|P5|STARTED|Overall Study||4
390174|NCT00996918|932863|P4|STARTED|Overall Study||56
390175|NCT00996918|932864|P3|STARTED|Overall Study||37
390176|NCT00996918|932865|P2|STARTED|Overall Study||66
390177|NCT00996918|932866|P1|STARTED|Overall Study||39
390178|NCT00996892|932910|P20|NOT COMPLETED|Expansion Stage 2A||45
390179|NCT00996892|932911|P19|NOT COMPLETED|Expansion Stage 2A||0
390180|NCT00996892|932912|P18|NOT COMPLETED|Expansion Stage 2A||0
390181|NCT00996892|932913|P17|NOT COMPLETED|Expansion Stage 2A||0
390182|NCT00996892|932914|P16|NOT COMPLETED|Expansion Stage 2A||0
390183|NCT00996892|932915|P15|NOT COMPLETED|Expansion Stage 2A||0
390184|NCT00996892|932916|P14|NOT COMPLETED|Expansion Stage 2A||0
390185|NCT00996892|932917|P13|NOT COMPLETED|Expansion Stage 2A||0
390186|NCT00996892|932918|P12|NOT COMPLETED|Expansion Stage 2A||0
390187|NCT00996892|932919|P11|NOT COMPLETED|Expansion Stage 2A||0
390188|NCT00996892|932920|P10|NOT COMPLETED|Expansion Stage 2A||0
390189|NCT00996892|932921|P9|NOT COMPLETED|Expansion Stage 2A||0
390190|NCT00996892|932922|P8|NOT COMPLETED|Expansion Stage 2A||0
390191|NCT00996892|932923|P7|NOT COMPLETED|Expansion Stage 2A||0
390192|NCT00996892|932924|P6|NOT COMPLETED|Expansion Stage 2A||0
390193|NCT00996892|932925|P5|NOT COMPLETED|Expansion Stage 2A||0
390194|NCT00996892|932926|P4|NOT COMPLETED|Expansion Stage 2A||0
390195|NCT00996892|932927|P3|NOT COMPLETED|Expansion Stage 2A||0
390196|NCT00996892|932928|P2|NOT COMPLETED|Expansion Stage 2A||0
390197|NCT00996892|932929|P1|NOT COMPLETED|Expansion Stage 2A||0
390198|NCT00996892|932910|P20|COMPLETED|Expansion Stage 2A||0
390199|NCT00996892|932911|P19|COMPLETED|Expansion Stage 2A||0
390200|NCT00996892|932912|P18|COMPLETED|Expansion Stage 2A||0
390201|NCT00996892|932913|P17|COMPLETED|Expansion Stage 2A||0
390202|NCT00996892|932914|P16|COMPLETED|Expansion Stage 2A||0
390203|NCT00996892|932915|P15|COMPLETED|Expansion Stage 2A||0
390204|NCT00996892|932916|P14|COMPLETED|Expansion Stage 2A||0
390205|NCT00996892|932917|P13|COMPLETED|Expansion Stage 2A||0
390206|NCT00996892|932918|P12|COMPLETED|Expansion Stage 2A||0
390207|NCT00996892|932919|P11|COMPLETED|Expansion Stage 2A||0
390208|NCT00996892|932920|P10|COMPLETED|Expansion Stage 2A||0
390209|NCT00996892|932921|P9|COMPLETED|Expansion Stage 2A||0
390210|NCT00996892|932922|P8|COMPLETED|Expansion Stage 2A||0
390211|NCT00996892|932923|P7|COMPLETED|Expansion Stage 2A||0
390212|NCT00996892|932924|P6|COMPLETED|Expansion Stage 2A||0
390213|NCT00996892|932925|P5|COMPLETED|Expansion Stage 2A||0
390214|NCT00996892|932926|P4|COMPLETED|Expansion Stage 2A||0
390215|NCT00996892|932927|P3|COMPLETED|Expansion Stage 2A||0
390216|NCT00996892|932928|P2|COMPLETED|Expansion Stage 2A||0
390217|NCT00996892|932929|P1|COMPLETED|Expansion Stage 2A||0
390218|NCT00996892|932910|P20|STARTED|Expansion Stage 2A||45
390219|NCT00996892|932911|P19|STARTED|Expansion Stage 2A||0
390220|NCT00996892|932912|P18|STARTED|Expansion Stage 2A||0
390221|NCT00996892|932913|P17|STARTED|Expansion Stage 2A||0
390222|NCT00996892|932914|P16|STARTED|Expansion Stage 2A||0
390223|NCT00996892|932915|P15|STARTED|Expansion Stage 2A||0
390224|NCT00996892|932916|P14|STARTED|Expansion Stage 2A||0
390225|NCT00996892|932917|P13|STARTED|Expansion Stage 2A||0
390226|NCT00996892|932918|P12|STARTED|Expansion Stage 2A||0
390227|NCT00996892|932919|P11|STARTED|Expansion Stage 2A||0
390228|NCT00996892|932920|P10|STARTED|Expansion Stage 2A||0
390229|NCT00996892|932921|P9|STARTED|Expansion Stage 2A||0
390230|NCT00996892|932922|P8|STARTED|Expansion Stage 2A||0
390231|NCT00996892|932923|P7|STARTED|Expansion Stage 2A||0
390232|NCT00996892|932924|P6|STARTED|Expansion Stage 2A||0
390233|NCT00996892|932925|P5|STARTED|Expansion Stage 2A||0
390234|NCT00996892|932926|P4|STARTED|Expansion Stage 2A||0
390235|NCT00996892|932927|P3|STARTED|Expansion Stage 2A||0
390236|NCT00996892|932928|P2|STARTED|Expansion Stage 2A||0
390237|NCT00996892|932929|P1|STARTED|Expansion Stage 2A||0
390238|NCT00996892|932910|P20|NOT COMPLETED|Expansion Stage 2||0
390239|NCT00996892|932911|P19|NOT COMPLETED|Expansion Stage 2||35
390240|NCT00996892|932912|P18|NOT COMPLETED|Expansion Stage 2||0
390241|NCT00996892|932913|P17|NOT COMPLETED|Expansion Stage 2||0
390242|NCT00996892|932914|P16|NOT COMPLETED|Expansion Stage 2||0
390243|NCT00996892|932915|P15|NOT COMPLETED|Expansion Stage 2||0
390244|NCT00996892|932916|P14|NOT COMPLETED|Expansion Stage 2||0
390245|NCT00996892|932917|P13|NOT COMPLETED|Expansion Stage 2||0
390246|NCT00996892|932918|P12|NOT COMPLETED|Expansion Stage 2||0
390247|NCT00996892|932919|P11|NOT COMPLETED|Expansion Stage 2||0
390248|NCT00996892|932920|P10|NOT COMPLETED|Expansion Stage 2||0
390249|NCT00996892|932921|P9|NOT COMPLETED|Expansion Stage 2||0
390250|NCT00996892|932922|P8|NOT COMPLETED|Expansion Stage 2||0
390251|NCT00996892|932923|P7|NOT COMPLETED|Expansion Stage 2||0
390252|NCT00996892|932924|P6|NOT COMPLETED|Expansion Stage 2||0
390253|NCT00996892|932925|P5|NOT COMPLETED|Expansion Stage 2||0
390254|NCT00996892|932926|P4|NOT COMPLETED|Expansion Stage 2||0
390255|NCT00996892|932927|P3|NOT COMPLETED|Expansion Stage 2||0
390256|NCT00996892|932928|P2|NOT COMPLETED|Expansion Stage 2||0
390257|NCT00996892|932929|P1|NOT COMPLETED|Expansion Stage 2||0
390258|NCT00996892|932910|P20|COMPLETED|Expansion Stage 2||0
390259|NCT00996892|932911|P19|COMPLETED|Expansion Stage 2||0
390260|NCT00996892|932912|P18|COMPLETED|Expansion Stage 2||0
390261|NCT00996892|932913|P17|COMPLETED|Expansion Stage 2||0
390262|NCT00996892|932914|P16|COMPLETED|Expansion Stage 2||0
390263|NCT00996892|932915|P15|COMPLETED|Expansion Stage 2||0
390264|NCT00996892|932916|P14|COMPLETED|Expansion Stage 2||0
390265|NCT00996892|932917|P13|COMPLETED|Expansion Stage 2||0
390266|NCT00996892|932918|P12|COMPLETED|Expansion Stage 2||0
390267|NCT00996892|932919|P11|COMPLETED|Expansion Stage 2||0
390268|NCT00996892|932920|P10|COMPLETED|Expansion Stage 2||0
390269|NCT00996892|932921|P9|COMPLETED|Expansion Stage 2||0
390270|NCT00996892|932922|P8|COMPLETED|Expansion Stage 2||0
390271|NCT00996892|932923|P7|COMPLETED|Expansion Stage 2||0
390272|NCT00996892|932924|P6|COMPLETED|Expansion Stage 2||0
390273|NCT00996892|932925|P5|COMPLETED|Expansion Stage 2||0
390274|NCT00996892|932926|P4|COMPLETED|Expansion Stage 2||0
390275|NCT00996892|932927|P3|COMPLETED|Expansion Stage 2||0
390276|NCT00996892|932928|P2|COMPLETED|Expansion Stage 2||0
390277|NCT00996892|932929|P1|COMPLETED|Expansion Stage 2||0
390278|NCT00996892|932910|P20|STARTED|Expansion Stage 2||0
390279|NCT00996892|932911|P19|STARTED|Expansion Stage 2||35
390280|NCT00996892|932912|P18|STARTED|Expansion Stage 2||0
390281|NCT00996892|932913|P17|STARTED|Expansion Stage 2||0
390282|NCT00996892|932914|P16|STARTED|Expansion Stage 2||0
390283|NCT00996892|932915|P15|STARTED|Expansion Stage 2||0
390284|NCT00996892|932916|P14|STARTED|Expansion Stage 2||0
390285|NCT00996892|932917|P13|STARTED|Expansion Stage 2||0
390286|NCT00996892|932918|P12|STARTED|Expansion Stage 2||0
390287|NCT00996892|932919|P11|STARTED|Expansion Stage 2||0
390288|NCT00996892|932920|P10|STARTED|Expansion Stage 2||0
390289|NCT00996892|932921|P9|STARTED|Expansion Stage 2||0
390290|NCT00996892|932922|P8|STARTED|Expansion Stage 2||0
390291|NCT00996892|932923|P7|STARTED|Expansion Stage 2||0
390292|NCT00996892|932924|P6|STARTED|Expansion Stage 2||0
390293|NCT00996892|932925|P5|STARTED|Expansion Stage 2||0
390294|NCT00996892|932926|P4|STARTED|Expansion Stage 2||0
390295|NCT00996892|932927|P3|STARTED|Expansion Stage 2||0
390296|NCT00996892|932928|P2|STARTED|Expansion Stage 2||0
390297|NCT00996892|932929|P1|STARTED|Expansion Stage 2||0
390298|NCT00996892|932910|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
390299|NCT00996892|932911|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
390300|NCT00996892|932912|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
390301|NCT00996892|932913|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
390302|NCT00996892|932914|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
390303|NCT00996892|932915|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
390304|NCT00996892|932916|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
390305|NCT00996892|932917|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
390306|NCT00996892|932918|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
390307|NCT00996892|932919|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
390308|NCT00996892|932920|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
390309|NCT00996892|932921|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
390310|NCT00996892|932922|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
390311|NCT00996892|932923|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
390312|NCT00996892|932924|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
390313|NCT00996892|932925|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
390314|NCT00996892|932926|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
390315|NCT00996892|932927|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
390316|NCT00996892|932928|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
390317|NCT00996892|932929|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
390318|NCT00996892|932910|P20|COMPLETED|Dose-Escalation Stage 1B||0
390319|NCT00996892|932911|P19|COMPLETED|Dose-Escalation Stage 1B||0
390320|NCT00996892|932912|P18|COMPLETED|Dose-Escalation Stage 1B||0
390321|NCT00996892|932913|P17|COMPLETED|Dose-Escalation Stage 1B||0
390322|NCT00996892|932914|P16|COMPLETED|Dose-Escalation Stage 1B||0
390323|NCT00996892|932915|P15|COMPLETED|Dose-Escalation Stage 1B||0
390324|NCT00996892|932916|P14|COMPLETED|Dose-Escalation Stage 1B||0
390325|NCT00996892|932917|P13|COMPLETED|Dose-Escalation Stage 1B||0
390326|NCT00996892|932918|P12|COMPLETED|Dose-Escalation Stage 1B||0
390327|NCT00996892|932919|P11|COMPLETED|Dose-Escalation Stage 1B||0
390328|NCT00996892|932920|P10|COMPLETED|Dose-Escalation Stage 1B||0
390329|NCT00996892|932921|P9|COMPLETED|Dose-Escalation Stage 1B||0
390330|NCT00996892|932922|P8|COMPLETED|Dose-Escalation Stage 1B||0
390331|NCT00996892|932923|P7|COMPLETED|Dose-Escalation Stage 1B||0
390332|NCT00996892|932924|P6|COMPLETED|Dose-Escalation Stage 1B||0
390333|NCT00996892|932925|P5|COMPLETED|Dose-Escalation Stage 1B||0
390334|NCT00996892|932926|P4|COMPLETED|Dose-Escalation Stage 1B||0
390335|NCT00996892|932927|P3|COMPLETED|Dose-Escalation Stage 1B||0
390336|NCT00996892|932928|P2|COMPLETED|Dose-Escalation Stage 1B||0
390337|NCT00996892|932929|P1|COMPLETED|Dose-Escalation Stage 1B||0
390338|NCT00996892|932910|P20|STARTED|Dose-Escalation Stage 1B||0
390339|NCT00996892|932911|P19|STARTED|Dose-Escalation Stage 1B||0
390340|NCT00996892|932912|P18|STARTED|Dose-Escalation Stage 1B||5
390341|NCT00996892|932913|P17|STARTED|Dose-Escalation Stage 1B||3
390342|NCT00996892|932914|P16|STARTED|Dose-Escalation Stage 1B||3
390343|NCT00996892|932915|P15|STARTED|Dose-Escalation Stage 1B||4
390344|NCT00996892|932916|P14|STARTED|Dose-Escalation Stage 1B||0
390345|NCT00996892|932917|P13|STARTED|Dose-Escalation Stage 1B||0
390346|NCT00996892|932918|P12|STARTED|Dose-Escalation Stage 1B||0
390347|NCT00996892|932919|P11|STARTED|Dose-Escalation Stage 1B||0
390348|NCT00996892|932920|P10|STARTED|Dose-Escalation Stage 1B||0
390349|NCT00996892|932921|P9|STARTED|Dose-Escalation Stage 1B||0
390350|NCT00996892|932922|P8|STARTED|Dose-Escalation Stage 1B||0
390351|NCT00996892|932923|P7|STARTED|Dose-Escalation Stage 1B||0
390352|NCT00996892|932924|P6|STARTED|Dose-Escalation Stage 1B||0
390353|NCT00996892|932925|P5|STARTED|Dose-Escalation Stage 1B||0
390354|NCT00996892|932926|P4|STARTED|Dose-Escalation Stage 1B||0
390355|NCT00996892|932927|P3|STARTED|Dose-Escalation Stage 1B||0
390356|NCT00996892|932928|P2|STARTED|Dose-Escalation Stage 1B||0
390357|NCT00996892|932929|P1|STARTED|Dose-Escalation Stage 1B||0
390358|NCT00996892|932910|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
390359|NCT00996892|932911|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
390360|NCT00996892|932912|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
390361|NCT00996892|932913|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
390362|NCT00996892|932914|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
390363|NCT00996892|932915|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
390364|NCT00996892|932916|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
390365|NCT00996892|932917|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
390366|NCT00996892|932918|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
390367|NCT00996892|932919|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
390368|NCT00996892|932920|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
390369|NCT00996892|932921|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
390370|NCT00996892|932922|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
390371|NCT00996892|932923|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
390372|NCT00996892|932924|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
390373|NCT00996892|932925|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
390374|NCT00996892|932926|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
390375|NCT00996892|932927|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
390376|NCT00996892|932928|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
390377|NCT00996892|932929|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
390378|NCT00996892|932910|P20|COMPLETED|Dose-Escalation Stage 1A||0
390379|NCT00996892|932911|P19|COMPLETED|Dose-Escalation Stage 1A||0
390380|NCT00996892|932912|P18|COMPLETED|Dose-Escalation Stage 1A||0
390381|NCT00996892|932913|P17|COMPLETED|Dose-Escalation Stage 1A||0
390382|NCT00996892|932914|P16|COMPLETED|Dose-Escalation Stage 1A||0
390383|NCT00996892|932915|P15|COMPLETED|Dose-Escalation Stage 1A||0
390384|NCT00996892|932916|P14|COMPLETED|Dose-Escalation Stage 1A||0
390385|NCT00996892|932917|P13|COMPLETED|Dose-Escalation Stage 1A||0
390386|NCT00996892|932918|P12|COMPLETED|Dose-Escalation Stage 1A||0
390387|NCT00996892|932919|P11|COMPLETED|Dose-Escalation Stage 1A||0
390388|NCT00996892|932920|P10|COMPLETED|Dose-Escalation Stage 1A||0
390389|NCT00996892|932921|P9|COMPLETED|Dose-Escalation Stage 1A||0
390390|NCT00996892|932922|P8|COMPLETED|Dose-Escalation Stage 1A||0
390391|NCT00996892|932923|P7|COMPLETED|Dose-Escalation Stage 1A||0
390392|NCT00996892|932924|P6|COMPLETED|Dose-Escalation Stage 1A||0
390393|NCT00996892|932925|P5|COMPLETED|Dose-Escalation Stage 1A||0
390394|NCT00996892|932926|P4|COMPLETED|Dose-Escalation Stage 1A||0
390395|NCT00996892|932927|P3|COMPLETED|Dose-Escalation Stage 1A||0
390396|NCT00996892|932928|P2|COMPLETED|Dose-Escalation Stage 1A||0
390397|NCT00996892|932929|P1|COMPLETED|Dose-Escalation Stage 1A||0
390398|NCT00996892|932910|P20|STARTED|Dose-Escalation Stage 1A||0
390399|NCT00996892|932911|P19|STARTED|Dose-Escalation Stage 1A||0
390400|NCT00996892|932912|P18|STARTED|Dose-Escalation Stage 1A||0
390401|NCT00996892|932913|P17|STARTED|Dose-Escalation Stage 1A||0
390402|NCT00996892|932914|P16|STARTED|Dose-Escalation Stage 1A||0
390403|NCT00996892|932915|P15|STARTED|Dose-Escalation Stage 1A||0
390404|NCT00996892|932916|P14|STARTED|Dose-Escalation Stage 1A||5
390405|NCT00996892|932917|P13|STARTED|Dose-Escalation Stage 1A||8
390406|NCT00996892|932918|P12|STARTED|Dose-Escalation Stage 1A||9
390407|NCT00996892|932919|P11|STARTED|Dose-Escalation Stage 1A||7
390408|NCT00996892|932920|P10|STARTED|Dose-Escalation Stage 1A||4
390409|NCT00996892|932921|P9|STARTED|Dose-Escalation Stage 1A||3
390410|NCT00996892|932922|P8|STARTED|Dose-Escalation Stage 1A||3
390411|NCT00996892|932923|P7|STARTED|Dose-Escalation Stage 1A||0
390412|NCT00996892|932924|P6|STARTED|Dose-Escalation Stage 1A||0
390413|NCT00996892|932925|P5|STARTED|Dose-Escalation Stage 1A||0
390414|NCT00996892|932926|P4|STARTED|Dose-Escalation Stage 1A||0
390415|NCT00996892|932927|P3|STARTED|Dose-Escalation Stage 1A||0
390416|NCT00996892|932928|P2|STARTED|Dose-Escalation Stage 1A||0
390417|NCT00996892|932929|P1|STARTED|Dose-Escalation Stage 1A||0
390418|NCT00996892|932910|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
390419|NCT00996892|932911|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
390420|NCT00996892|932912|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
390421|NCT00996892|932913|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
390422|NCT00996892|932914|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
390423|NCT00996892|932915|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
390424|NCT00996892|932916|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
390425|NCT00996892|932917|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
390426|NCT00996892|932918|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
390427|NCT00996892|932919|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
390428|NCT00996892|932920|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
390429|NCT00996892|932921|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
390430|NCT00996892|932922|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
390431|NCT00996892|932923|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
390432|NCT00996892|932924|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
390433|NCT00996892|932925|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
390434|NCT00996892|932926|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
390435|NCT00996892|932927|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
390436|NCT00996892|932928|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
390437|NCT00996892|932929|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
390438|NCT00996892|932910|P20|COMPLETED|Dose-Escalation Stage 1||0
390439|NCT00996892|932911|P19|COMPLETED|Dose-Escalation Stage 1||0
390440|NCT00996892|932912|P18|COMPLETED|Dose-Escalation Stage 1||0
390441|NCT00996892|932913|P17|COMPLETED|Dose-Escalation Stage 1||0
390442|NCT00996892|932914|P16|COMPLETED|Dose-Escalation Stage 1||0
390443|NCT00996892|932915|P15|COMPLETED|Dose-Escalation Stage 1||0
390444|NCT00996892|932916|P14|COMPLETED|Dose-Escalation Stage 1||0
390445|NCT00996892|932917|P13|COMPLETED|Dose-Escalation Stage 1||0
390446|NCT00996892|932918|P12|COMPLETED|Dose-Escalation Stage 1||0
390447|NCT00996892|932919|P11|COMPLETED|Dose-Escalation Stage 1||0
390448|NCT00996892|932920|P10|COMPLETED|Dose-Escalation Stage 1||0
390449|NCT00996892|932921|P9|COMPLETED|Dose-Escalation Stage 1||0
390450|NCT00996892|932922|P8|COMPLETED|Dose-Escalation Stage 1||0
390451|NCT00996892|932923|P7|COMPLETED|Dose-Escalation Stage 1||0
390452|NCT00996892|932924|P6|COMPLETED|Dose-Escalation Stage 1||0
390453|NCT00996892|932925|P5|COMPLETED|Dose-Escalation Stage 1||0
390454|NCT00996892|932926|P4|COMPLETED|Dose-Escalation Stage 1||0
390455|NCT00996892|932927|P3|COMPLETED|Dose-Escalation Stage 1||0
390456|NCT00996892|932928|P2|COMPLETED|Dose-Escalation Stage 1||0
390457|NCT00996892|932929|P1|COMPLETED|Dose-Escalation Stage 1||0
390458|NCT00996892|932910|P20|STARTED|Dose-Escalation Stage 1||0
390459|NCT00996892|932911|P19|STARTED|Dose-Escalation Stage 1||0
390460|NCT00996892|932912|P18|STARTED|Dose-Escalation Stage 1||0
390461|NCT00996892|932913|P17|STARTED|Dose-Escalation Stage 1||0
390462|NCT00996892|932914|P16|STARTED|Dose-Escalation Stage 1||0
390463|NCT00996892|932915|P15|STARTED|Dose-Escalation Stage 1||0
390464|NCT00996892|932916|P14|STARTED|Dose-Escalation Stage 1||0
390465|NCT00996892|932917|P13|STARTED|Dose-Escalation Stage 1||0
390466|NCT00996892|932918|P12|STARTED|Dose-Escalation Stage 1||0
390467|NCT00996892|932919|P11|STARTED|Dose-Escalation Stage 1||0
390468|NCT00996892|932920|P10|STARTED|Dose-Escalation Stage 1||0
390469|NCT00996892|932921|P9|STARTED|Dose-Escalation Stage 1||0
390470|NCT00996892|932922|P8|STARTED|Dose-Escalation Stage 1||0
390471|NCT00996892|932923|P7|STARTED|Dose-Escalation Stage 1||4
390472|NCT00996892|932924|P6|STARTED|Dose-Escalation Stage 1||10
390473|NCT00996892|932925|P5|STARTED|Dose-Escalation Stage 1||11
390474|NCT00996892|932926|P4|STARTED|Dose-Escalation Stage 1||9
390475|NCT00996892|932927|P3|STARTED|Dose-Escalation Stage 1||3
390476|NCT00996892|932928|P2|STARTED|Dose-Escalation Stage 1||3
390477|NCT00996892|932929|P1|STARTED|Dose-Escalation Stage 1||4
390478|NCT00996801|933524|P6|NOT COMPLETED|Overall Study||19
390479|NCT00996801|933525|P5|NOT COMPLETED|Overall Study||88
390480|NCT00996801|933526|P4|NOT COMPLETED|Overall Study||31
390481|NCT00996801|933527|P3|NOT COMPLETED|Overall Study||23
390482|NCT00996801|933528|P2|NOT COMPLETED|Overall Study||16
390483|NCT00996801|933529|P1|NOT COMPLETED|Overall Study||20
390484|NCT00996801|933524|P6|COMPLETED|Overall Study||68
390485|NCT00996801|933525|P5|COMPLETED|Overall Study||0
390486|NCT00996801|933526|P4|COMPLETED|Overall Study||56
390487|NCT00996801|933527|P3|COMPLETED|Overall Study||65
390488|NCT00996801|933528|P2|COMPLETED|Overall Study||72
390489|NCT00996801|933529|P1|COMPLETED|Overall Study||68
390490|NCT00996801|933524|P6|STARTED|Overall Study||87
390491|NCT00996801|933525|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
390492|NCT00996801|933526|P4|STARTED|Overall Study||87
390493|NCT00996801|933527|P3|STARTED|Overall Study||88
390494|NCT00996801|933528|P2|STARTED|Overall Study||88
390495|NCT00996801|933529|P1|STARTED|Overall Study||88
390496|NCT00996775|933632|P2|NOT COMPLETED|Overall Study||14
390497|NCT00996775|933633|P1|NOT COMPLETED|Overall Study||11
390498|NCT00996775|933632|P2|COMPLETED|Overall Study||75
390499|NCT00996775|933633|P1|COMPLETED|Overall Study||67
390500|NCT00996775|933632|P2|STARTED|Overall Study||89
390501|NCT00996775|933633|P1|STARTED|Overall Study||78
390502|NCT00996736|933641|P2|NOT COMPLETED|Overall Study||18
390503|NCT00996736|933642|P1|NOT COMPLETED|Overall Study||21
390504|NCT00996736|933641|P2|COMPLETED|Overall Study||143
390505|NCT00996736|933642|P1|COMPLETED|Overall Study||141
390506|NCT00996736|933641|P2|3-month Visit|Overall Study||146
390507|NCT00996736|933642|P1|3-month Visit|Overall Study||146
390508|NCT00996736|933641|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
390509|NCT00996736|933642|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
390510|NCT00996736|933641|P2|STARTED|Overall Study||161
390511|NCT00996736|933642|P1|STARTED|Overall Study||162
390512|NCT00996658|933662|P2|NOT COMPLETED|Overall Study||21
390513|NCT00996658|933663|P1|NOT COMPLETED|Overall Study||16
390514|NCT00996658|933662|P2|COMPLETED|Overall Study||165
390515|NCT00996658|933663|P1|COMPLETED|Overall Study||76
390516|NCT00996658|933662|P2|STARTED|Overall Study||186
390517|NCT00996658|933663|P1|STARTED|Overall Study||92
390518|NCT00996632|933691|P2|NOT COMPLETED|Overall Study||0
390519|NCT00996632|933692|P1|NOT COMPLETED|Overall Study||0
390520|NCT00996632|933691|P2|COMPLETED|Overall Study||56
390521|NCT00996632|933692|P1|COMPLETED|Overall Study||38
390522|NCT00996632|933691|P2|STARTED|Overall Study||56
390523|NCT00996632|933692|P1|STARTED|Overall Study||38
390524|NCT00996606|933700|P1|NOT COMPLETED|Overall Study||8
390525|NCT00996606|933700|P1|COMPLETED|Overall Study||50
390526|NCT00996606|933700|P1|STARTED|Overall Study||58
390527|NCT00996593|933794|P1|NOT COMPLETED|Long-Term Follow-Up||3
390528|NCT00996593|933794|P1|COMPLETED|Long-Term Follow-Up||6
390529|NCT00996593|933794|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
390530|NCT00996593|933794|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
390531|NCT00996593|933794|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
390532|NCT00996593|933794|P1|STARTED|Dosimetric and Therapeutic Treatment||43
390533|NCT00996580|933822|P1|NOT COMPLETED|Overall Study||1453
390534|NCT00996580|933822|P1|COMPLETED|Overall Study||2144
390535|NCT00996580|933822|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
390536|NCT00996580|933822|P1|STARTED|Overall Study||3597
390537|NCT00996502|933850|P1|NOT COMPLETED|Overall Study||0
390538|NCT00996502|933850|P1|COMPLETED|Overall Study||4
390539|NCT00996502|933850|P1|STARTED|Overall Study||4
390540|NCT00996476|933859|P5|NOT COMPLETED|Overall Study||2
390541|NCT00996476|933860|P4|NOT COMPLETED|Overall Study||0
390542|NCT00996476|933861|P3|NOT COMPLETED|Overall Study||1
390543|NCT00996476|933862|P2|NOT COMPLETED|Overall Study||3
390544|NCT00996476|933863|P1|NOT COMPLETED|Overall Study||1
390545|NCT00996476|933859|P5|COMPLETED|Overall Study||11
390546|NCT00996476|933860|P4|COMPLETED|Overall Study||13
390547|NCT00996476|933861|P3|COMPLETED|Overall Study||12
390548|NCT00996476|933862|P2|COMPLETED|Overall Study||23
390549|NCT00996476|933863|P1|COMPLETED|Overall Study||26
390550|NCT00996476|933859|P5|STARTED|Overall Study||13
390551|NCT00996476|933860|P4|STARTED|Overall Study||13
390552|NCT00996476|933861|P3|STARTED|Overall Study||13
390553|NCT00996476|933862|P2|STARTED|Overall Study||26
390554|NCT00996476|933863|P1|STARTED|Overall Study||27
390555|NCT00996437|933931|P2|NOT COMPLETED|Overall Study||7
390556|NCT00996437|933932|P1|NOT COMPLETED|Overall Study||5
390557|NCT00996437|933931|P2|COMPLETED|Overall Study||129
390558|NCT00996437|933932|P1|COMPLETED|Overall Study||120
390559|NCT00996437|933931|P2|STARTED|Overall Study||136
390560|NCT00996437|933932|P1|STARTED|Overall Study||125
390561|NCT00996372|933954|P2|NOT COMPLETED|Overall Study||84
390562|NCT00996372|933955|P1|NOT COMPLETED|Overall Study||103
390563|NCT00996372|933954|P2|COMPLETED|Overall Study||397
390564|NCT00996372|933955|P1|COMPLETED|Overall Study||365
390565|NCT00996372|933954|P2|STARTED|Overall Study||481
390566|NCT00996372|933955|P1|STARTED|Overall Study||468
390567|NCT00996346|933968|P3|NOT COMPLETED|Overall Study||0
390568|NCT00996346|933969|P2|NOT COMPLETED|Overall Study||0
390569|NCT00996346|933970|P1|NOT COMPLETED|Overall Study||0
390570|NCT00996346|933968|P3|COMPLETED|Overall Study||3
390571|NCT00996346|933969|P2|COMPLETED|Overall Study||8
390572|NCT00996346|933970|P1|COMPLETED|Overall Study||6
390573|NCT00996346|933968|P3|STARTED|Overall Study||3
390574|NCT00996346|933969|P2|STARTED|Overall Study||8
390575|NCT00996346|933970|P1|STARTED|Overall Study||6
390576|NCT00996333|933977|P1|NOT COMPLETED|Overall Study||13
390577|NCT00996333|933977|P1|COMPLETED|Overall Study||33
390578|NCT00996333|933977|P1|STARTED|Overall Study||46
390579|NCT00996307|933987|P4|NOT COMPLETED|Overall Study||21
390580|NCT00996307|933988|P3|NOT COMPLETED|Overall Study||14
390581|NCT00996307|933989|P2|NOT COMPLETED|Overall Study||17
390582|NCT00996307|933990|P1|NOT COMPLETED|Overall Study||20
390583|NCT00996307|933987|P4|COMPLETED|Overall Study||144
390584|NCT00996307|933988|P3|COMPLETED|Overall Study||146
390585|NCT00996307|933989|P2|COMPLETED|Overall Study||148
390586|NCT00996307|933990|P1|COMPLETED|Overall Study||144
390587|NCT00996307|933987|P4|STARTED|Overall Study||165
390588|NCT00996307|933988|P3|STARTED|Overall Study||160
390589|NCT00996307|933989|P2|STARTED|Overall Study||165
390590|NCT00996307|933990|P1|STARTED|Overall Study||164
390591|NCT00996281|934050|P2|NOT COMPLETED|Overall Study||89
390592|NCT00996281|934051|P1|NOT COMPLETED|Overall Study||131
390593|NCT00996281|934050|P2|COMPLETED|Overall Study||330
390594|NCT00996281|934051|P1|COMPLETED|Overall Study||287
390595|NCT00996281|934050|P2|STARTED|Overall Study||419
390596|NCT00996281|934051|P1|STARTED|Overall Study||418
390597|NCT00996216|934059|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
390598|NCT00996216|934059|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
390599|NCT00996216|934059|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
390600|NCT00996216|934059|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
390601|NCT00996216|934059|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
390602|NCT00996216|934059|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
390603|NCT00996203|934075|P1|NOT COMPLETED|Overall Study||7
390604|NCT00996203|934075|P1|COMPLETED|Overall Study||194
390605|NCT00996203|934075|P1|STARTED|Overall Study||201
390606|NCT00996164|934096|P2|NOT COMPLETED|Overall Study||101
390607|NCT00996164|934097|P1|NOT COMPLETED|Overall Study||135
390608|NCT00996164|934096|P2|COMPLETED|Overall Study||446
390609|NCT00996164|934097|P1|COMPLETED|Overall Study||408
390610|NCT00996164|934096|P2|STARTED|Overall Study||547
390611|NCT00996164|934097|P1|STARTED|Overall Study||543
390612|NCT00996125|934107|P2|NOT COMPLETED|Overall Study||11
390613|NCT00996125|934108|P1|NOT COMPLETED|Overall Study||5
390614|NCT00996125|934107|P2|COMPLETED|Overall Study||365
390615|NCT00996125|934108|P1|COMPLETED|Overall Study||369
390616|NCT00996125|934107|P2|STARTED|Overall Study||376
390617|NCT00996125|934108|P1|STARTED|Overall Study||374
390618|NCT00996034|934128|P1|NOT COMPLETED|Overall Study||3
390619|NCT00996034|934128|P1|COMPLETED|Overall Study||11
390620|NCT00996034|934128|P1|STARTED|Overall Study||14
390621|NCT00995930|934134|P2|NOT COMPLETED|Overall Study||28
390622|NCT00995930|934135|P1|NOT COMPLETED|Overall Study||21
390623|NCT00995930|934134|P2|COMPLETED|Overall Study||67
390624|NCT00995930|934135|P1|COMPLETED|Overall Study||73
390625|NCT00995930|934134|P2|Imaging Analysis Set|Overall Study||92
390626|NCT00995930|934135|P1|Imaging Analysis Set|Overall Study||92
390627|NCT00995930|934134|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
390628|NCT00995930|934135|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
390629|NCT00995930|934134|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
390630|NCT00995930|934135|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
390631|NCT00995930|934134|P2|Safety Analysis Set|Overall Study||95
390632|NCT00995930|934135|P1|Safety Analysis Set|Overall Study||94
390633|NCT00995930|934134|P2|STARTED|Overall Study||95
390634|NCT00995930|934135|P1|STARTED|Overall Study||94
390635|NCT00995904|934164|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
390636|NCT00995904|934165|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
390637|NCT00995904|934166|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
390638|NCT00995904|934167|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
390639|NCT00995904|934168|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
390640|NCT00995904|934169|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
390641|NCT00995904|934164|P6|COMPLETED|Follow-up Visit (Final Visit)||3
390642|NCT00995904|934165|P5|COMPLETED|Follow-up Visit (Final Visit)||5
390643|NCT00995904|934166|P4|COMPLETED|Follow-up Visit (Final Visit)||5
390644|NCT00995904|934167|P3|COMPLETED|Follow-up Visit (Final Visit)||4
390645|NCT00995904|934168|P2|COMPLETED|Follow-up Visit (Final Visit)||3
390646|NCT00995904|934169|P1|COMPLETED|Follow-up Visit (Final Visit)||4
390647|NCT00995904|934164|P6|STARTED|Follow-up Visit (Final Visit)||3
390648|NCT00995904|934165|P5|STARTED|Follow-up Visit (Final Visit)||5
390649|NCT00995904|934166|P4|STARTED|Follow-up Visit (Final Visit)||5
390650|NCT00995904|934167|P3|STARTED|Follow-up Visit (Final Visit)||4
390651|NCT00995904|934168|P2|STARTED|Follow-up Visit (Final Visit)||3
390652|NCT00995904|934169|P1|STARTED|Follow-up Visit (Final Visit)||4
390653|NCT00995904|934164|P6|NOT COMPLETED|Visit 4||0
390654|NCT00995904|934165|P5|NOT COMPLETED|Visit 4||0
390655|NCT00995904|934166|P4|NOT COMPLETED|Visit 4||0
390656|NCT00995904|934167|P3|NOT COMPLETED|Visit 4||0
390657|NCT00995904|934168|P2|NOT COMPLETED|Visit 4||0
390658|NCT00995904|934169|P1|NOT COMPLETED|Visit 4||0
390659|NCT00995904|934164|P6|COMPLETED|Visit 4||3
390660|NCT00995904|934165|P5|COMPLETED|Visit 4||5
390661|NCT00995904|934166|P4|COMPLETED|Visit 4||5
390662|NCT00995904|934167|P3|COMPLETED|Visit 4||4
390663|NCT00995904|934168|P2|COMPLETED|Visit 4||3
390664|NCT00995904|934169|P1|COMPLETED|Visit 4||4
390665|NCT00995904|934164|P6|STARTED|Visit 4||3
390666|NCT00995904|934165|P5|STARTED|Visit 4||5
390667|NCT00995904|934166|P4|STARTED|Visit 4||5
390668|NCT00995904|934167|P3|STARTED|Visit 4||4
390669|NCT00995904|934168|P2|STARTED|Visit 4||3
390670|NCT00995904|934169|P1|STARTED|Visit 4||4
390671|NCT00995904|934164|P6|NOT COMPLETED|Visit 3||0
390672|NCT00995904|934165|P5|NOT COMPLETED|Visit 3||0
390673|NCT00995904|934166|P4|NOT COMPLETED|Visit 3||0
390674|NCT00995904|934167|P3|NOT COMPLETED|Visit 3||0
390675|NCT00995904|934168|P2|NOT COMPLETED|Visit 3||0
390676|NCT00995904|934169|P1|NOT COMPLETED|Visit 3||0
390677|NCT00995904|934164|P6|COMPLETED|Visit 3||3
390678|NCT00995904|934165|P5|COMPLETED|Visit 3||5
390679|NCT00995904|934166|P4|COMPLETED|Visit 3||5
390680|NCT00995904|934167|P3|COMPLETED|Visit 3||4
390681|NCT00995904|934168|P2|COMPLETED|Visit 3||3
390682|NCT00995904|934169|P1|COMPLETED|Visit 3||4
390683|NCT00995904|934164|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
390684|NCT00995904|934165|P5|STARTED|Visit 3||5
390685|NCT00995904|934166|P4|STARTED|Visit 3||5
390686|NCT00995904|934167|P3|STARTED|Visit 3||4
390687|NCT00995904|934168|P2|STARTED|Visit 3||3
390688|NCT00995904|934169|P1|STARTED|Visit 3||4
390689|NCT00995904|934164|P6|NOT COMPLETED|Visit 2 (Randomization)||0
390690|NCT00995904|934165|P5|NOT COMPLETED|Visit 2 (Randomization)||0
390691|NCT00995904|934166|P4|NOT COMPLETED|Visit 2 (Randomization)||0
390692|NCT00995904|934167|P3|NOT COMPLETED|Visit 2 (Randomization)||0
390693|NCT00995904|934168|P2|NOT COMPLETED|Visit 2 (Randomization)||0
390694|NCT00995904|934169|P1|NOT COMPLETED|Visit 2 (Randomization)||0
390695|NCT00995904|934164|P6|COMPLETED|Visit 2 (Randomization)||4
390696|NCT00995904|934165|P5|COMPLETED|Visit 2 (Randomization)||5
390697|NCT00995904|934166|P4|COMPLETED|Visit 2 (Randomization)||5
390698|NCT00995904|934167|P3|COMPLETED|Visit 2 (Randomization)||4
390699|NCT00995904|934168|P2|COMPLETED|Visit 2 (Randomization)||3
390700|NCT00995904|934169|P1|COMPLETED|Visit 2 (Randomization)||4
390701|NCT00995904|934164|P6|STARTED|Visit 2 (Randomization)||4
390702|NCT00995904|934165|P5|STARTED|Visit 2 (Randomization)||5
390703|NCT00995904|934166|P4|STARTED|Visit 2 (Randomization)||5
390704|NCT00995904|934167|P3|STARTED|Visit 2 (Randomization)||4
390705|NCT00995904|934168|P2|STARTED|Visit 2 (Randomization)||3
390706|NCT00995904|934169|P1|STARTED|Visit 2 (Randomization)||4
390707|NCT00995865|934186|P3|NOT COMPLETED|Overall Study||1
390708|NCT00995865|934187|P2|NOT COMPLETED|Overall Study||0
390709|NCT00995865|934188|P1|NOT COMPLETED|Overall Study||2
390710|NCT00995865|934186|P3|COMPLETED|Overall Study||11
390711|NCT00995865|934187|P2|COMPLETED|Overall Study||24
390712|NCT00995865|934188|P1|COMPLETED|Overall Study||22
390713|NCT00995865|934186|P3|STARTED|Overall Study||12
390714|NCT00995865|934187|P2|STARTED|Overall Study||24
390715|NCT00995865|934188|P1|STARTED|Overall Study||24
390716|NCT00995774|934210|P2|NOT COMPLETED|Training Period 2||0
390717|NCT00995774|934211|P1|NOT COMPLETED|Training Period 2||2
390718|NCT00995774|934210|P2|COMPLETED|Training Period 2||5
390719|NCT00995774|934211|P1|COMPLETED|Training Period 2||5
390720|NCT00995774|934210|P2|STARTED|Training Period 2||5
390721|NCT00995774|934211|P1|STARTED|Training Period 2||7
390722|NCT00995774|934210|P2|NOT COMPLETED|Washout Period||0
390723|NCT00995774|934211|P1|NOT COMPLETED|Washout Period||0
390724|NCT00995774|934210|P2|COMPLETED|Washout Period||5
390725|NCT00995774|934211|P1|COMPLETED|Washout Period||7
390726|NCT00995774|934210|P2|STARTED|Washout Period||5
390727|NCT00995774|934211|P1|STARTED|Washout Period||7
390728|NCT00995774|934210|P2|NOT COMPLETED|Training Period 1||0
390729|NCT00995774|934211|P1|NOT COMPLETED|Training Period 1||0
390730|NCT00995774|934210|P2|COMPLETED|Training Period 1||5
390731|NCT00995774|934211|P1|COMPLETED|Training Period 1||7
390732|NCT00995774|934210|P2|STARTED|Training Period 1||5
390733|NCT00995774|934211|P1|STARTED|Training Period 1||7
390734|NCT00995761|934219|P1|NOT COMPLETED|Overall Study||0
390735|NCT00995761|934219|P1|COMPLETED|Overall Study||48
390736|NCT00995761|934219|P1|STARTED|Overall Study||48
390737|NCT00995722|934225|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
390738|NCT00995722|934226|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
390739|NCT00995722|934225|P2|COMPLETED|Overall Study: 36 Weeks||2
390740|NCT00995722|934226|P1|COMPLETED|Overall Study: 36 Weeks||3
390741|NCT00995722|934225|P2|STARTED|Overall Study: 36 Weeks||4
390742|NCT00995722|934226|P1|STARTED|Overall Study: 36 Weeks||5
390743|NCT00995722|934225|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
390744|NCT00995722|934226|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
390745|NCT00995722|934225|P2|COMPLETED|Double Blinded: 16 Weeks||4
390746|NCT00995722|934226|P1|COMPLETED|Double Blinded: 16 Weeks||5
390747|NCT00995722|934225|P2|STARTED|Double Blinded: 16 Weeks||5
390748|NCT00995722|934226|P1|STARTED|Double Blinded: 16 Weeks||6
390749|NCT00995709|934243|P3|NOT COMPLETED|Overall Study||5
390750|NCT00995709|934244|P2|NOT COMPLETED|Overall Study||9
390751|NCT00995709|934245|P1|NOT COMPLETED|Overall Study||7
390752|NCT00995709|934243|P3|COMPLETED|Overall Study||34
390753|NCT00995709|934244|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
390754|NCT00995709|934245|P1|COMPLETED|Overall Study||32
390755|NCT00995709|934243|P3|STARTED|Overall Study||39
390756|NCT00995709|934244|P2|STARTED|Overall Study||40
390757|NCT00995709|934245|P1|STARTED|Overall Study||39
390758|NCT00995670|934271|P3|NOT COMPLETED|Overall Study||3
390759|NCT00995670|934272|P2|NOT COMPLETED|Overall Study||0
390760|NCT00995670|934273|P1|NOT COMPLETED|Overall Study||1
390761|NCT00995670|934271|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
390762|NCT00995670|934272|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
390763|NCT00995670|934273|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
390764|NCT00995670|934271|P3|STARTED|Overall Study||17
390765|NCT00995670|934272|P2|STARTED|Overall Study||16
390766|NCT00995670|934273|P1|STARTED|Overall Study||26
390767|NCT00995566|934281|P1|NOT COMPLETED|Overall Study||54
390768|NCT00995566|934281|P1|COMPLETED|Overall Study||0
390769|NCT00995566|934281|P1|STARTED|Overall Study||54
390770|NCT00995553|934295|P2|NOT COMPLETED|Overall Study||6
390771|NCT00995553|934296|P1|NOT COMPLETED|Overall Study||2
390772|NCT00995553|934295|P2|COMPLETED|Overall Study||35
390773|NCT00995553|934296|P1|COMPLETED|Overall Study||38
390774|NCT00995553|934295|P2|STARTED|Overall Study||41
390775|NCT00995553|934296|P1|STARTED|Overall Study||40
390776|NCT00995501|934312|P8|NOT COMPLETED|Overall Study||0
390777|NCT00995501|934313|P7|NOT COMPLETED|Overall Study||0
390778|NCT00995501|934314|P6|NOT COMPLETED|Overall Study||0
390779|NCT00995501|934315|P5|NOT COMPLETED|Overall Study||0
390780|NCT00995501|934316|P4|NOT COMPLETED|Overall Study||0
390781|NCT00995501|934317|P3|NOT COMPLETED|Overall Study||0
390782|NCT00995501|934318|P2|NOT COMPLETED|Overall Study||0
390783|NCT00995501|934319|P1|NOT COMPLETED|Overall Study||0
390784|NCT00995501|934312|P8|COMPLETED|Overall Study||46
390785|NCT00995501|934313|P7|COMPLETED|Overall Study||49
390786|NCT00995501|934314|P6|COMPLETED|Overall Study||44
390787|NCT00995501|934315|P5|COMPLETED|Overall Study||46
390788|NCT00995501|934316|P4|COMPLETED|Overall Study||46
390789|NCT00995501|934317|P3|COMPLETED|Overall Study||47
390790|NCT00995501|934318|P2|COMPLETED|Overall Study||51
390791|NCT00995501|934319|P1|COMPLETED|Overall Study||52
390792|NCT00995501|934312|P8|STARTED|Overall Study||46
390793|NCT00995501|934313|P7|STARTED|Overall Study||49
390794|NCT00995501|934314|P6|STARTED|Overall Study||44
390795|NCT00995501|934315|P5|STARTED|Overall Study||46
390796|NCT00995501|934316|P4|STARTED|Overall Study||46
390797|NCT00995501|934317|P3|STARTED|Overall Study||47
390798|NCT00995501|934318|P2|STARTED|Overall Study||51
390799|NCT00995501|934319|P1|STARTED|Overall Study||52
390800|NCT00995488|934345|P1|NOT COMPLETED|Overall Study||1
390801|NCT00995488|934345|P1|COMPLETED|Overall Study||15
390802|NCT00995488|934345|P1|STARTED|Overall Study||16
390803|NCT00995449|934354|P4|NOT COMPLETED|Overall Study||0
390804|NCT00995449|934355|P3|NOT COMPLETED|Overall Study||2
390805|NCT00995449|934356|P2|NOT COMPLETED|Overall Study||0
390806|NCT00995449|934357|P1|NOT COMPLETED|Overall Study||0
390807|NCT00995449|934354|P4|COMPLETED|Overall Study||2
390808|NCT00995449|934355|P3|COMPLETED|Overall Study||5
390809|NCT00995449|934356|P2|COMPLETED|Overall Study||0
390810|NCT00995449|934357|P1|COMPLETED|Overall Study||0
390811|NCT00995449|934354|P4|STARTED|Overall Study||2
390812|NCT00995449|934355|P3|STARTED|Overall Study||7
390813|NCT00995449|934356|P2|STARTED|Overall Study||0
390814|NCT00995449|934357|P1|STARTED|Overall Study||0
390815|NCT00995436|934368|P3|NOT COMPLETED|Overall Study||0
390816|NCT00995436|934369|P2|NOT COMPLETED|Overall Study||5
390817|NCT00995436|934370|P1|NOT COMPLETED|Overall Study||2
390818|NCT00995436|934368|P3|COMPLETED|Overall Study||26
390819|NCT00995436|934369|P2|COMPLETED|Overall Study||22
390820|NCT00995436|934370|P1|COMPLETED|Overall Study||23
390821|NCT00995436|934368|P3|STARTED|Overall Study||26
390822|NCT00995436|934369|P2|STARTED|Overall Study||27
390823|NCT00995436|934370|P1|STARTED|Overall Study|25|25
390824|NCT00995410|934378|P1|NOT COMPLETED|Overall Study||88
390825|NCT00995410|934378|P1|COMPLETED|Overall Study||292
390826|NCT00995410|934378|P1|Treated|Overall Study||379
390827|NCT00995410|934378|P1|STARTED|Overall Study||380
390828|NCT00995371|934385|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
390829|NCT00995371|934386|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
390830|NCT00995371|934385|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
390831|NCT00995371|934386|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
390832|NCT00995371|934385|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
390833|NCT00995371|934386|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
390834|NCT00995371|934385|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
390835|NCT00995371|934386|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
390836|NCT00995371|934385|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
390837|NCT00995371|934386|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
390838|NCT00995371|934385|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
390839|NCT00995371|934386|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
390840|NCT00995345|934404|P5|NOT COMPLETED|Overall Study||5
390841|NCT00995345|934405|P4|NOT COMPLETED|Overall Study||5
390842|NCT00995345|934406|P3|NOT COMPLETED|Overall Study||7
390843|NCT00995345|934407|P2|NOT COMPLETED|Overall Study||7
390844|NCT00995345|934408|P1|NOT COMPLETED|Overall Study||11
390845|NCT00995345|934404|P5|COMPLETED|Overall Study||75
390846|NCT00995345|934405|P4|COMPLETED|Overall Study||76
390847|NCT00995345|934406|P3|COMPLETED|Overall Study||73
390848|NCT00995345|934407|P2|COMPLETED|Overall Study||74
390849|NCT00995345|934408|P1|COMPLETED|Overall Study||70
390850|NCT00995345|934404|P5|STARTED|Overall Study||80
390851|NCT00995345|934405|P4|STARTED|Overall Study||81
390852|NCT00995345|934406|P3|STARTED|Overall Study||80
390853|NCT00995345|934407|P2|STARTED|Overall Study||81
390854|NCT00995345|934408|P1|STARTED|Overall Study||81
390855|NCT00995085|934435|P1|NOT COMPLETED|Overall Study||5
390856|NCT00995085|934435|P1|COMPLETED|Overall Study||38
390857|NCT00995085|934435|P1|STARTED|Overall Study||43
390858|NCT00995020|934441|P2|NOT COMPLETED|Overall Study||7
390859|NCT00995020|934442|P1|NOT COMPLETED|Overall Study||3
390860|NCT00995020|934441|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
390861|NCT00995020|934442|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
390862|NCT00995020|934441|P2|STARTED|Overall Study||52
390863|NCT00995020|934442|P1|STARTED|Overall Study||51
390864|NCT00995007|934452|P2|NOT COMPLETED|Overall Study||2
390865|NCT00995007|934453|P1|NOT COMPLETED|Overall Study||17
390866|NCT00995007|934452|P2|COMPLETED|Overall Study||54
390867|NCT00995007|934453|P1|COMPLETED|Overall Study||39
390868|NCT00995007|934452|P2|Crossover to Vandetanib|Overall Study||0
390869|NCT00995007|934453|P1|Crossover to Vandetanib|Overall Study||42
390870|NCT00995007|934452|P2|STARTED|Overall Study||56
390871|NCT00995007|934453|P1|STARTED|Overall Study||56
390872|NCT00994929|934469|P1|NOT COMPLETED|Overall Study||0
390873|NCT00994929|934469|P1|COMPLETED|Overall Study||9
390874|NCT00994929|934469|P1|STARTED|Overall Study||9
390875|NCT00994760|934475|P1|NOT COMPLETED|Overall Study||24
390876|NCT00994760|934475|P1|COMPLETED|Overall Study||107
390877|NCT00994760|934475|P1|STARTED|Overall Study||131
390878|NCT00994682|934516|P2|NOT COMPLETED|Pioglitazone Open Label||7
390879|NCT00994682|934517|P1|NOT COMPLETED|Pioglitazone Open Label||13
390880|NCT00994682|934516|P2|COMPLETED|Pioglitazone Open Label||34
390881|NCT00994682|934517|P1|COMPLETED|Pioglitazone Open Label||29
390882|NCT00994682|934516|P2|STARTED|Pioglitazone Open Label||41
390883|NCT00994682|934517|P1|STARTED|Pioglitazone Open Label||42
390884|NCT00994682|934516|P2|NOT COMPLETED|Double Bilnd||9
390885|NCT00994682|934517|P1|NOT COMPLETED|Double Bilnd||9
390886|NCT00994682|934516|P2|COMPLETED|Double Bilnd||41
390887|NCT00994682|934517|P1|COMPLETED|Double Bilnd||42
390888|NCT00994682|934516|P2|STARTED|Double Bilnd||50
390889|NCT00994682|934517|P1|STARTED|Double Bilnd||51
390890|NCT00994604|934561|P1|NOT COMPLETED|Overall Study||6
390891|NCT00994604|934561|P1|COMPLETED|Overall Study||45
390892|NCT00994604|934561|P1|STARTED|Overall Study||51
390893|NCT00994461|934571|P3|NOT COMPLETED|Overall Study||0
390894|NCT00994461|934572|P2|NOT COMPLETED|Overall Study||1
390895|NCT00994461|934573|P1|NOT COMPLETED|Overall Study||2
390896|NCT00994461|934571|P3|COMPLETED|Overall Study||37
390897|NCT00994461|934572|P2|COMPLETED|Overall Study||75
390898|NCT00994461|934573|P1|COMPLETED|Overall Study||74
390899|NCT00994461|934571|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
390900|NCT00994461|934572|P2|STARTED|Overall Study||76
390901|NCT00994461|934573|P1|STARTED|Overall Study||76
390902|NCT00994448|934601|P2|NOT COMPLETED|Overall Study||2
390903|NCT00994448|934602|P1|NOT COMPLETED|Overall Study||8
390904|NCT00994448|934601|P2|COMPLETED|Overall Study||5
390905|NCT00994448|934602|P1|COMPLETED|Overall Study||4
390906|NCT00994448|934601|P2|STARTED|Overall Study||7
390907|NCT00994448|934602|P1|STARTED|Overall Study||12
390908|NCT00994422|934610|P2|NOT COMPLETED|Overall Study||1
390909|NCT00994422|934611|P1|NOT COMPLETED|Overall Study||7
390910|NCT00994422|934610|P2|COMPLETED|Overall Study||54
390911|NCT00994422|934611|P1|COMPLETED|Overall Study||185
390912|NCT00994422|934610|P2|STARTED|Overall Study||55
390913|NCT00994422|934611|P1|STARTED|Overall Study||192
390914|NCT00994318|934624|P3|NOT COMPLETED|Overall Study||67
390915|NCT00994318|934625|P2|NOT COMPLETED|Overall Study||18
390916|NCT00994318|934626|P1|NOT COMPLETED|Overall Study||22
390917|NCT00994318|934624|P3|COMPLETED|Overall Study||250
390918|NCT00994318|934625|P2|COMPLETED|Overall Study||136
390919|NCT00994318|934626|P1|COMPLETED|Overall Study||133
390920|NCT00994318|934624|P3|STARTED|Overall Study||317
390921|NCT00994318|934625|P2|STARTED|Overall Study||154
390922|NCT00994318|934626|P1|STARTED|Overall Study||155
390923|NCT00994279|934636|P2|NOT COMPLETED|Overall Study||5
390924|NCT00994279|934637|P1|NOT COMPLETED|Overall Study||4
390925|NCT00994279|934636|P2|COMPLETED|Overall Study||13
390926|NCT00994279|934637|P1|COMPLETED|Overall Study||18
390927|NCT00994279|934636|P2|STARTED|Overall Study||18
390928|NCT00994279|934637|P1|STARTED|Overall Study||22
390929|NCT00994253|934647|P2|NOT COMPLETED|Overall Study||0
390930|NCT00994253|934648|P1|NOT COMPLETED|Overall Study||0
390931|NCT00994253|934647|P2|COMPLETED|Overall Study||0
390932|NCT00994253|934648|P1|COMPLETED|Overall Study||0
390933|NCT00994253|934647|P2|STARTED|Overall Study||0
390934|NCT00994253|934648|P1|STARTED|Overall Study||0
390935|NCT00994240|934656|P2|NOT COMPLETED|Overall Study||5
390936|NCT00994240|934657|P1|NOT COMPLETED|Overall Study||6
390937|NCT00994240|934656|P2|COMPLETED|Overall Study||39
390938|NCT00994240|934657|P1|COMPLETED|Overall Study||35
390939|NCT00994240|934656|P2|STARTED|Overall Study||44
390940|NCT00994240|934657|P1|STARTED|Overall Study||41
390941|NCT00994214|934667|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
390942|NCT00994214|934668|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
390943|NCT00994214|934669|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
390944|NCT00994214|934670|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
390945|NCT00994214|934667|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
390946|NCT00994214|934668|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
390947|NCT00994214|934669|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
390948|NCT00994214|934670|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
390949|NCT00994214|934667|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
390950|NCT00994214|934668|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
390951|NCT00994214|934669|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
390952|NCT00994214|934670|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
390953|NCT00994214|934667|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
390954|NCT00994214|934668|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
390955|NCT00994214|934669|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
390956|NCT00994214|934670|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
390957|NCT00994214|934667|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
390958|NCT00994214|934668|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
390959|NCT00994214|934669|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
390960|NCT00994214|934670|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
390961|NCT00994214|934667|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
390962|NCT00994214|934668|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
390963|NCT00994214|934669|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
390964|NCT00994214|934670|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
390965|NCT00994214|934667|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
390966|NCT00994214|934668|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
390967|NCT00994214|934669|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
390968|NCT00994214|934670|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
390969|NCT00994214|934667|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
390970|NCT00994214|934668|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
390971|NCT00994214|934669|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
390972|NCT00994214|934670|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
390973|NCT00994214|934667|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
390974|NCT00994214|934668|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
390975|NCT00994214|934669|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
390976|NCT00994214|934670|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
390977|NCT00994214|934667|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
390978|NCT00994214|934668|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
390979|NCT00994214|934669|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
390980|NCT00994214|934670|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
390981|NCT00994123|934717|P3|NOT COMPLETED|Overall Study||0
390982|NCT00994123|934718|P2|NOT COMPLETED|Overall Study||0
390983|NCT00994123|934719|P1|NOT COMPLETED|Overall Study||0
390984|NCT00994123|934717|P3|COMPLETED|Overall Study||44
390985|NCT00994123|934718|P2|COMPLETED|Overall Study||85
390986|NCT00994123|934719|P1|COMPLETED|Overall Study||33
390987|NCT00994123|934717|P3|STARTED|Overall Study||44
390988|NCT00994123|934718|P2|STARTED|Overall Study||85
390989|NCT00994123|934719|P1|STARTED|Overall Study||33
390990|NCT00994110|934740|P2|NOT COMPLETED|Overall Study||74
390991|NCT00994110|934741|P1|NOT COMPLETED|Overall Study||65
390992|NCT00994110|934740|P2|COMPLETED|Overall Study||148
390993|NCT00994110|934741|P1|COMPLETED|Overall Study||152
390994|NCT00994110|934740|P2|STARTED|Overall Study||222
390995|NCT00994110|934741|P1|STARTED|Overall Study||217
390996|NCT00993954|934749|P2|NOT COMPLETED|Overall Study||2
390997|NCT00993954|934750|P1|NOT COMPLETED|Overall Study||21
390998|NCT00993954|934749|P2|COMPLETED|Overall Study||121
390999|NCT00993954|934750|P1|COMPLETED|Overall Study||124
391000|NCT00993954|934749|P2|STARTED|Overall Study||123
391001|NCT00993954|934750|P1|STARTED|Overall Study||145
391002|NCT00993928|934763|P2|NOT COMPLETED|Overall Study||7
391003|NCT00993928|934764|P1|NOT COMPLETED|Overall Study||5
391004|NCT00993928|934763|P2|COMPLETED|Overall Study||38
391005|NCT00993928|934764|P1|COMPLETED|Overall Study||43
391006|NCT00993928|934763|P2|STARTED|Overall Study||45
391007|NCT00993928|934764|P1|STARTED|Overall Study||48
391008|NCT00993915|934778|P1|NOT COMPLETED|Overall Study||9
391009|NCT00993915|934778|P1|COMPLETED|Overall Study||678
391010|NCT00993915|934778|P1|STARTED|Overall Study||687
391011|NCT00993824|934789|P2|NOT COMPLETED|Overall Study||0
391012|NCT00993824|934790|P1|NOT COMPLETED|Overall Study||0
391013|NCT00993824|934789|P2|COMPLETED|Overall Study||10
391014|NCT00993824|934790|P1|COMPLETED|Overall Study||11
391015|NCT00993824|934789|P2|STARTED|Overall Study||10
391016|NCT00993824|934790|P1|STARTED|Overall Study||11
391017|NCT00993668|934804|P2|NOT COMPLETED|Open-Label Period||15
391018|NCT00993668|934805|P1|NOT COMPLETED|Open-Label Period||23
391019|NCT00993668|934804|P2|COMPLETED|Open-Label Period||91
391020|NCT00993668|934805|P1|COMPLETED|Open-Label Period||86
391021|NCT00993668|934804|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
391022|NCT00993668|934805|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
391023|NCT00993668|934804|P2|NOT COMPLETED|Single-Blind Period||3
391024|NCT00993668|934805|P1|NOT COMPLETED|Single-Blind Period||4
391025|NCT00993668|934804|P2|COMPLETED|Single-Blind Period||107
391026|NCT00993668|934805|P1|COMPLETED|Single-Blind Period||110
391027|NCT00993668|934804|P2|STARTED|Single-Blind Period||110
391028|NCT00993668|934805|P1|STARTED|Single-Blind Period||114
391029|NCT00993616|934830|P1|NOT COMPLETED|Overall Study||2
391030|NCT00993616|934830|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
391031|NCT00993616|934830|P1|STARTED|Overall Study||29
391032|NCT00993499|934840|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
391033|NCT00993499|934841|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
391034|NCT00993499|934842|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
391035|NCT00993499|934843|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
391036|NCT00993499|934844|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
391037|NCT00993499|934845|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
391038|NCT00993499|934840|P6|COMPLETED|Discontinued After Starting Course 3||0
391039|NCT00993499|934841|P5|COMPLETED|Discontinued After Starting Course 3||0
391040|NCT00993499|934842|P4|COMPLETED|Discontinued After Starting Course 3||1
391041|NCT00993499|934843|P3|COMPLETED|Discontinued After Starting Course 3||3
391042|NCT00993499|934844|P2|COMPLETED|Discontinued After Starting Course 3||4
391043|NCT00993499|934845|P1|COMPLETED|Discontinued After Starting Course 3||4
391044|NCT00993499|934840|P6|STARTED|Discontinued After Starting Course 3||3
391045|NCT00993499|934841|P5|STARTED|Discontinued After Starting Course 3||3
391046|NCT00993499|934842|P4|STARTED|Discontinued After Starting Course 3||3
391047|NCT00993499|934843|P3|STARTED|Discontinued After Starting Course 3||9
391048|NCT00993499|934844|P2|STARTED|Discontinued After Starting Course 3||9
391049|NCT00993499|934845|P1|STARTED|Discontinued After Starting Course 3||12
391050|NCT00993499|934840|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
391051|NCT00993499|934841|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
391052|NCT00993499|934842|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
391053|NCT00993499|934843|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
391054|NCT00993499|934844|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
391055|NCT00993499|934845|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
391056|NCT00993499|934840|P6|COMPLETED|Discontinued Before Starting Course 3||3
391057|NCT00993499|934841|P5|COMPLETED|Discontinued Before Starting Course 3||3
391058|NCT00993499|934842|P4|COMPLETED|Discontinued Before Starting Course 3||2
391059|NCT00993499|934843|P3|COMPLETED|Discontinued Before Starting Course 3||6
391060|NCT00993499|934844|P2|COMPLETED|Discontinued Before Starting Course 3||5
391061|NCT00993499|934845|P1|COMPLETED|Discontinued Before Starting Course 3||8
391062|NCT00993499|934840|P6|STARTED|Discontinued Before Starting Course 3||3
391063|NCT00993499|934841|P5|STARTED|Discontinued Before Starting Course 3||3
391064|NCT00993499|934842|P4|STARTED|Discontinued Before Starting Course 3||3
391065|NCT00993499|934843|P3|STARTED|Discontinued Before Starting Course 3||9
391066|NCT00993499|934844|P2|STARTED|Discontinued Before Starting Course 3||9
391067|NCT00993499|934845|P1|STARTED|Discontinued Before Starting Course 3||12
391068|NCT00993499|934840|P6|NOT COMPLETED|Run-in Period (8 Days)||0
391069|NCT00993499|934841|P5|NOT COMPLETED|Run-in Period (8 Days)||0
391070|NCT00993499|934842|P4|NOT COMPLETED|Run-in Period (8 Days)||0
391071|NCT00993499|934843|P3|NOT COMPLETED|Run-in Period (8 Days)||1
391072|NCT00993499|934844|P2|NOT COMPLETED|Run-in Period (8 Days)||3
391073|NCT00993499|934845|P1|NOT COMPLETED|Run-in Period (8 Days)||1
391074|NCT00993499|934840|P6|COMPLETED|Run-in Period (8 Days)||3
391075|NCT00993499|934841|P5|COMPLETED|Run-in Period (8 Days)||3
391076|NCT00993499|934842|P4|COMPLETED|Run-in Period (8 Days)||3
391077|NCT00993499|934843|P3|COMPLETED|Run-in Period (8 Days)||9
391078|NCT00993499|934844|P2|COMPLETED|Run-in Period (8 Days)||9
391079|NCT00993499|934845|P1|COMPLETED|Run-in Period (8 Days)||12
391080|NCT00993499|934840|P6|STARTED|Run-in Period (8 Days)||3
391081|NCT00993499|934841|P5|STARTED|Run-in Period (8 Days)||3
391082|NCT00993499|934842|P4|STARTED|Run-in Period (8 Days)||3
391083|NCT00993499|934843|P3|STARTED|Run-in Period (8 Days)||10
391084|NCT00993499|934844|P2|STARTED|Run-in Period (8 Days)||12
391085|NCT00993499|934845|P1|STARTED|Run-in Period (8 Days)||13
391086|NCT00993473|934927|P2|NOT COMPLETED|Overall Study||10
391087|NCT00993473|934928|P1|NOT COMPLETED|Overall Study||4
391088|NCT00993473|934927|P2|COMPLETED|Overall Study||54
391089|NCT00993473|934928|P1|COMPLETED|Overall Study||57
391090|NCT00993473|934927|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
391091|NCT00993473|934928|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
391092|NCT00993447|934966|P2|NOT COMPLETED|Overall Study||19
391093|NCT00993447|934967|P1|NOT COMPLETED|Overall Study||37
391094|NCT00993447|934966|P2|COMPLETED|Overall Study||180
391095|NCT00993447|934967|P1|COMPLETED|Overall Study||364
391096|NCT00993447|934966|P2|STARTED|Overall Study||199
391097|NCT00993447|934967|P1|STARTED|Overall Study||401
391098|NCT00993421|935004|P7|NOT COMPLETED|Overall Study||42
391099|NCT00993421|935005|P6|NOT COMPLETED|Overall Study||46
391100|NCT00993421|935006|P5|NOT COMPLETED|Overall Study||46
391101|NCT00993421|935007|P4|NOT COMPLETED|Overall Study||45
391102|NCT00993421|935008|P3|NOT COMPLETED|Overall Study||43
391103|NCT00993421|935009|P2|NOT COMPLETED|Overall Study||45
391104|NCT00993421|935010|P1|NOT COMPLETED|Overall Study||44
391105|NCT00993421|935004|P7|COMPLETED|Overall Study||4
391106|NCT00993421|935005|P6|COMPLETED|Overall Study||4
391107|NCT00993421|935006|P5|COMPLETED|Overall Study||6
391108|NCT00993421|935007|P4|COMPLETED|Overall Study||4
391109|NCT00993421|935008|P3|COMPLETED|Overall Study||5
391110|NCT00993421|935009|P2|COMPLETED|Overall Study||4
391111|NCT00993421|935010|P1|COMPLETED|Overall Study||5
391112|NCT00993421|935004|P7|STARTED|Overall Study||46
391113|NCT00993421|935005|P6|STARTED|Overall Study||50
391114|NCT00993421|935006|P5|STARTED|Overall Study||52
391115|NCT00993421|935007|P4|STARTED|Overall Study||49
391116|NCT00993421|935008|P3|STARTED|Overall Study||48
391117|NCT00993421|935009|P2|STARTED|Overall Study||49
391118|NCT00993421|935010|P1|STARTED|Overall Study||49
391119|NCT00993317|935161|P2|NOT COMPLETED|Overall Study||25
391120|NCT00993317|935162|P1|NOT COMPLETED|Overall Study||21
391121|NCT00993317|935161|P2|COMPLETED|Overall Study||60
391122|NCT00993317|935162|P1|COMPLETED|Overall Study||21
391123|NCT00993317|935161|P2|STARTED|Overall Study||85
391124|NCT00993317|935162|P1|STARTED|Overall Study||42
391125|NCT00993291|935180|P1|NOT COMPLETED|Overall Study||1
391126|NCT00993291|935180|P1|COMPLETED|Overall Study||19
391127|NCT00993291|935180|P1|STARTED|Overall Study||20
391128|NCT00993265|935186|P2|NOT COMPLETED|Overall Study||0
391129|NCT00993265|935187|P1|NOT COMPLETED|Overall Study||4
391130|NCT00993265|935186|P2|COMPLETED|Overall Study||19
391131|NCT00993265|935187|P1|COMPLETED|Overall Study||16
391132|NCT00993265|935186|P2|STARTED|Overall Study||19
391133|NCT00993265|935187|P1|STARTED|Overall Study||20
391134|NCT00993200|935207|P2|NOT COMPLETED|Overall Study||0
391135|NCT00993200|935208|P1|NOT COMPLETED|Overall Study||0
391136|NCT00993200|935207|P2|COMPLETED|Overall Study||13
391137|NCT00993200|935208|P1|COMPLETED|Overall Study||13
391138|NCT00993200|935207|P2|STARTED|Overall Study||13
391139|NCT00993200|935208|P1|STARTED|Overall Study||13
391140|NCT00993187|935220|P2|NOT COMPLETED|Overall Study||37
391141|NCT00993187|935221|P1|NOT COMPLETED|Overall Study||26
391142|NCT00993187|935220|P2|COMPLETED|Overall Study||108
391143|NCT00993187|935221|P1|COMPLETED|Overall Study||121
391144|NCT00993187|935220|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
391145|NCT00993187|935221|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
391146|NCT00993187|935220|P2|STARTED|Overall Study||145
391147|NCT00993187|935221|P1|STARTED|Overall Study||147
391148|NCT00993148|935239|P1|NOT COMPLETED|Overall Study||3
391149|NCT00993148|935239|P1|COMPLETED|Overall Study||22
391150|NCT00993148|935239|P1|STARTED|Overall Study||25
391151|NCT00993044|935251|P1|NOT COMPLETED|Irinotecan 50 mg||1
391152|NCT00993044|935251|P1|COMPLETED|Irinotecan 50 mg||6
391153|NCT00993044|935251|P1|STARTED|Irinotecan 50 mg||7
391154|NCT00993044|935251|P1|NOT COMPLETED|Irinotecan 30 mg||0
391155|NCT00993044|935251|P1|COMPLETED|Irinotecan 30 mg||6
391156|NCT00993044|935251|P1|STARTED|Irinotecan 30 mg||6
391157|NCT00992992|935256|P1|NOT COMPLETED|Overall Study||25
391158|NCT00992992|935256|P1|COMPLETED|Overall Study||0
391159|NCT00992992|935256|P1|STARTED|Overall Study||25
391160|NCT00992927|935278|P2|NOT COMPLETED|Overall Study||0
391161|NCT00992927|935279|P1|NOT COMPLETED|Overall Study||0
391162|NCT00992927|935278|P2|COMPLETED|Overall Study||22
391163|NCT00992927|935279|P1|COMPLETED|Overall Study||32
391164|NCT00992927|935278|P2|STARTED|Overall Study||22
391165|NCT00992927|935279|P1|STARTED|Overall Study||32
391166|NCT00992836|935287|P1|NOT COMPLETED|Overall Study||5
391167|NCT00992836|935287|P1|COMPLETED|Overall Study||150
391168|NCT00992836|935287|P1|Received Both Study Vaccinations|Overall Study||150
391169|NCT00992836|935287|P1|STARTED|Overall Study||155
391170|NCT00992784|935302|P3|NOT COMPLETED|Overall Study||1
391171|NCT00992784|935303|P2|NOT COMPLETED|Overall Study||2
391172|NCT00992784|935304|P1|NOT COMPLETED|Overall Study||3
391173|NCT00992784|935302|P3|COMPLETED|Overall Study||85
391174|NCT00992784|935303|P2|COMPLETED|Overall Study||102
391175|NCT00992784|935304|P1|COMPLETED|Overall Study||177
391176|NCT00992784|935302|P3|STARTED|Overall Study||86
391177|NCT00992784|935303|P2|STARTED|Overall Study||104
391178|NCT00992784|935304|P1|STARTED|Overall Study||180
391179|NCT00992719|935375|P3|NOT COMPLETED|Overall Study||0
391180|NCT00992719|935376|P2|NOT COMPLETED|Overall Study||1
391181|NCT00992719|935377|P1|NOT COMPLETED|Overall Study||1
391182|NCT00992719|935375|P3|COMPLETED|Overall Study||28
391183|NCT00992719|935376|P2|COMPLETED|Overall Study||27
391184|NCT00992719|935377|P1|COMPLETED|Overall Study||27
391185|NCT00992719|935375|P3|STARTED|Overall Study||28
391186|NCT00992719|935376|P2|STARTED|Overall Study||28
391187|NCT00992719|935377|P1|STARTED|Overall Study||28
391188|NCT00992589|935411|P4|NOT COMPLETED|Double-Blind Phase||10
391189|NCT00992589|935412|P3|NOT COMPLETED|Double-Blind Phase||13
391190|NCT00992589|935413|P2|NOT COMPLETED|Double-Blind Phase||13
391191|NCT00992589|935414|P1|NOT COMPLETED|Double-Blind Phase||0
391192|NCT00992589|935411|P4|COMPLETED|Double-Blind Phase||78
391193|NCT00992589|935412|P3|COMPLETED|Double-Blind Phase||77
391194|NCT00992589|935413|P2|COMPLETED|Double-Blind Phase||76
391195|NCT00992589|935414|P1|COMPLETED|Double-Blind Phase||0
391196|NCT00992589|935411|P4|STARTED|Double-Blind Phase||88
391197|NCT00992589|935412|P3|STARTED|Double-Blind Phase||90
391198|NCT00992589|935413|P2|STARTED|Double-Blind Phase||89
391199|NCT00992589|935414|P1|STARTED|Double-Blind Phase||0
391200|NCT00992589|935411|P4|NOT COMPLETED|Open-Label Phase||0
391201|NCT00992589|935412|P3|NOT COMPLETED|Open-Label Phase||0
391202|NCT00992589|935413|P2|NOT COMPLETED|Open-Label Phase||0
391203|NCT00992589|935414|P1|NOT COMPLETED|Open-Label Phase||77
391204|NCT00992589|935411|P4|COMPLETED|Open-Label Phase||0
391205|NCT00992589|935412|P3|COMPLETED|Open-Label Phase||0
391206|NCT00992589|935413|P2|COMPLETED|Open-Label Phase||0
391207|NCT00992589|935414|P1|COMPLETED|Open-Label Phase||267
391208|NCT00992589|935411|P4|STARTED|Open-Label Phase||0
391209|NCT00992589|935412|P3|STARTED|Open-Label Phase||0
391210|NCT00992589|935413|P2|STARTED|Open-Label Phase||0
391211|NCT00992589|935414|P1|STARTED|Open-Label Phase||344
391212|NCT00992459|935458|P2|NOT COMPLETED|Overall Study||1
391213|NCT00992459|935459|P1|NOT COMPLETED|Overall Study||1
391214|NCT00992459|935458|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
391215|NCT00992459|935459|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
391216|NCT00992459|935458|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
391217|NCT00992459|935459|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
391218|NCT00992446|935483|P1|NOT COMPLETED|Overall Study||8
391219|NCT00992446|935483|P1|COMPLETED|Overall Study||19
391220|NCT00992446|935483|P1|STARTED|Overall Study||27
391221|NCT00992433|935490|P2|NOT COMPLETED|Overall Study||7
391222|NCT00992433|935491|P1|NOT COMPLETED|Overall Study||4
391223|NCT00992433|935490|P2|COMPLETED|Overall Study||90
391224|NCT00992433|935491|P1|COMPLETED|Overall Study||91
391225|NCT00992433|935490|P2|STARTED|Overall Study||97
391226|NCT00992433|935491|P1|STARTED|Overall Study||95
391227|NCT00992407|935555|P2|NOT COMPLETED|Overall Study||24
391228|NCT00992407|935556|P1|NOT COMPLETED|Overall Study||31
391229|NCT00992407|935555|P2|COMPLETED|Overall Study||14
391230|NCT00992407|935556|P1|COMPLETED|Overall Study||6
391231|NCT00992407|935555|P2|Treated|Overall Study||25
391232|NCT00992407|935556|P1|Treated|Overall Study||20
391233|NCT00992407|935555|P2|STARTED|Overall Study||38
391234|NCT00992407|935556|P1|STARTED|Overall Study||37
391235|NCT00992394|935606|P2|NOT COMPLETED|Overall Study||14
391236|NCT00992394|935607|P1|NOT COMPLETED|Overall Study||24
391237|NCT00992394|935606|P2|COMPLETED|Overall Study||72
391238|NCT00992394|935607|P1|COMPLETED|Overall Study||64
391239|NCT00992394|935606|P2|mITT Population|Overall Study||84
391240|NCT00992394|935607|P1|mITT Population|Overall Study||86
391241|NCT00992394|935606|P2|Safety Population|Overall Study||84
391242|NCT00992394|935607|P1|Safety Population|Overall Study||87
391243|NCT00992394|935606|P2|STARTED|Overall Study||86
391244|NCT00992394|935607|P1|STARTED|Overall Study||88
391245|NCT00992264|935665|P16|NOT COMPLETED|Overall Study||0
391246|NCT00992264|935666|P15|NOT COMPLETED|Overall Study||0
391247|NCT00992264|935667|P14|NOT COMPLETED|Overall Study||0
391248|NCT00992264|935668|P13|NOT COMPLETED|Overall Study||0
391249|NCT00992264|935669|P12|NOT COMPLETED|Overall Study||0
391250|NCT00992264|935670|P11|NOT COMPLETED|Overall Study||0
391251|NCT00992264|935671|P10|NOT COMPLETED|Overall Study||0
391252|NCT00992264|935672|P9|NOT COMPLETED|Overall Study||0
391253|NCT00992264|935673|P8|NOT COMPLETED|Overall Study||0
391254|NCT00992264|935674|P7|NOT COMPLETED|Overall Study||0
391255|NCT00992264|935675|P6|NOT COMPLETED|Overall Study||0
391256|NCT00992264|935676|P5|NOT COMPLETED|Overall Study||0
391257|NCT00992264|935677|P4|NOT COMPLETED|Overall Study||0
391258|NCT00992264|935678|P3|NOT COMPLETED|Overall Study||0
391259|NCT00992264|935679|P2|NOT COMPLETED|Overall Study||0
391260|NCT00992264|935680|P1|NOT COMPLETED|Overall Study||0
391261|NCT00992264|935665|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391262|NCT00992264|935666|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391263|NCT00992264|935667|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391264|NCT00992264|935668|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391265|NCT00992264|935669|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391266|NCT00992264|935670|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391267|NCT00992264|935671|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391268|NCT00992264|935672|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391269|NCT00992264|935673|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391270|NCT00992264|935674|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391354|NCT00991510|935804|P1|STARTED|Period II (Days 15-28)||21
391271|NCT00992264|935675|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391272|NCT00992264|935676|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391273|NCT00992264|935677|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391274|NCT00992264|935678|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
391275|NCT00992264|935679|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391276|NCT00992264|935680|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
391277|NCT00992264|935665|P16|STARTED|Overall Study||116
391278|NCT00992264|935666|P15|STARTED|Overall Study||117
391279|NCT00992264|935667|P14|STARTED|Overall Study||117
391280|NCT00992264|935668|P13|STARTED|Overall Study||116
391281|NCT00992264|935669|P12|STARTED|Overall Study||117
391282|NCT00992264|935670|P11|STARTED|Overall Study||117
391283|NCT00992264|935671|P10|STARTED|Overall Study||116
391284|NCT00992264|935672|P9|STARTED|Overall Study||116
391285|NCT00992264|935673|P8|STARTED|Overall Study||117
391286|NCT00992264|935674|P7|STARTED|Overall Study||116
391287|NCT00992264|935675|P6|STARTED|Overall Study||117
391288|NCT00992264|935676|P5|STARTED|Overall Study||117
391289|NCT00992264|935677|P4|STARTED|Overall Study||117
391290|NCT00992264|935678|P3|STARTED|Overall Study||117
391291|NCT00992264|935679|P2|STARTED|Overall Study||116
391292|NCT00992264|935680|P1|STARTED|Overall Study||116
391293|NCT00992186|935694|P1|NOT COMPLETED|Overall Study||46
391294|NCT00992186|935694|P1|COMPLETED|Overall Study||0
391295|NCT00992186|935694|P1|STARTED|Overall Study||46
391296|NCT00992108|935713|P2|NOT COMPLETED|Overall Study||1
391297|NCT00992108|935714|P1|NOT COMPLETED|Overall Study||0
391298|NCT00992108|935713|P2|COMPLETED|Overall Study||9
391299|NCT00992108|935714|P1|COMPLETED|Overall Study||7
391300|NCT00992108|935713|P2|STARTED|Overall Study||10
391301|NCT00992108|935714|P1|STARTED|Overall Study||7
391302|NCT00992056|935728|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
391303|NCT00992056|935729|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
391304|NCT00992056|935728|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
391305|NCT00992056|935729|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
391306|NCT00992056|935728|P2|STARTED|Treatment Period 2 (6 Weeks)||10
391307|NCT00992056|935729|P1|STARTED|Treatment Period 2 (6 Weeks)||10
391308|NCT00992056|935728|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
391309|NCT00992056|935729|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
391310|NCT00992056|935728|P2|COMPLETED|Washout Period (2 Weeks)||10
391311|NCT00992056|935729|P1|COMPLETED|Washout Period (2 Weeks)||10
391312|NCT00992056|935728|P2|STARTED|Washout Period (2 Weeks)||10
391313|NCT00992056|935729|P1|STARTED|Washout Period (2 Weeks)||11
391314|NCT00992056|935728|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
391315|NCT00992056|935729|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
391316|NCT00992056|935728|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
391317|NCT00992056|935729|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
391318|NCT00992056|935728|P2|STARTED|Treatment Period 1 (6 Weeks)||12
391319|NCT00992056|935729|P1|STARTED|Treatment Period 1 (6 Weeks)||12
391320|NCT00992017|935735|P1|NOT COMPLETED|Overall Study||10
391321|NCT00992017|935735|P1|COMPLETED|Overall Study||118
391322|NCT00992017|935735|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
391323|NCT00992017|935735|P1|Received Both Study Vaccinations|Overall Study||124
391324|NCT00992017|935735|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
391325|NCT00991952|935750|P2|NOT COMPLETED|Overall Study||1
391326|NCT00991952|935751|P1|NOT COMPLETED|Overall Study||0
391327|NCT00991952|935750|P2|COMPLETED|Overall Study||5
391328|NCT00991952|935751|P1|COMPLETED|Overall Study||13
391329|NCT00991952|935750|P2|STARTED|Overall Study||6
391330|NCT00991952|935751|P1|STARTED|Overall Study||13
391331|NCT00991939|935759|P2|NOT COMPLETED|Overall Study||2
391332|NCT00991939|935760|P1|NOT COMPLETED|Overall Study||5
391333|NCT00991939|935759|P2|COMPLETED|Overall Study||1
391334|NCT00991939|935760|P1|COMPLETED|Overall Study||0
391335|NCT00991939|935759|P2|STARTED|Overall Study||3
391336|NCT00991939|935760|P1|STARTED|Overall Study||5
391337|NCT00991809|935794|P2|NOT COMPLETED|Overall Study||6
391338|NCT00991809|935795|P1|NOT COMPLETED|Overall Study||4
391339|NCT00991809|935794|P2|COMPLETED|Overall Study||4
391340|NCT00991809|935795|P1|COMPLETED|Overall Study||8
391341|NCT00991809|935794|P2|STARTED|Overall Study||10
391342|NCT00991809|935795|P1|STARTED|Overall Study||12
391343|NCT00991510|935803|P2|NOT COMPLETED|Period III (Days 29-112)||1
391344|NCT00991510|935804|P1|NOT COMPLETED|Period III (Days 29-112)||1
391345|NCT00991510|935803|P2|COMPLETED|Period III (Days 29-112)||20
391346|NCT00991510|935804|P1|COMPLETED|Period III (Days 29-112)||20
391347|NCT00991510|935803|P2|STARTED|Period III (Days 29-112)||21
391348|NCT00991510|935804|P1|STARTED|Period III (Days 29-112)||21
391349|NCT00991510|935803|P2|NOT COMPLETED|Period II (Days 15-28)||0
391350|NCT00991510|935804|P1|NOT COMPLETED|Period II (Days 15-28)||0
391351|NCT00991510|935803|P2|COMPLETED|Period II (Days 15-28)||21
391352|NCT00991510|935804|P1|COMPLETED|Period II (Days 15-28)||21
391353|NCT00991510|935803|P2|STARTED|Period II (Days 15-28)||21
391355|NCT00991510|935803|P2|NOT COMPLETED|Period I (Days 1-14)||0
391356|NCT00991510|935804|P1|NOT COMPLETED|Period I (Days 1-14)||1
391357|NCT00991510|935803|P2|COMPLETED|Period I (Days 1-14)||21
391358|NCT00991510|935804|P1|COMPLETED|Period I (Days 1-14)||21
391359|NCT00991510|935803|P2|STARTED|Period I (Days 1-14)||21
391360|NCT00991510|935804|P1|STARTED|Period I (Days 1-14)||22
391361|NCT00991458|935829|P3|NOT COMPLETED|Overall Study||25
391362|NCT00991458|935830|P2|NOT COMPLETED|Overall Study||28
391363|NCT00991458|935831|P1|NOT COMPLETED|Overall Study||20
391364|NCT00991458|935829|P3|COMPLETED|Overall Study||180
391365|NCT00991458|935830|P2|COMPLETED|Overall Study||181
391366|NCT00991458|935831|P1|COMPLETED|Overall Study||187
391367|NCT00991458|935829|P3|STARTED|Overall Study||205
391368|NCT00991458|935830|P2|STARTED|Overall Study||209
391369|NCT00991458|935831|P1|STARTED|Overall Study||207
391370|NCT00991341|935850|P2|NOT COMPLETED|Overall Study||179
391371|NCT00991341|935851|P1|NOT COMPLETED|Overall Study||204
391372|NCT00991341|935850|P2|COMPLETED|Overall Study||560
391373|NCT00991341|935851|P1|COMPLETED|Overall Study||538
391374|NCT00991341|935850|P2|STARTED|Overall Study||739
391375|NCT00991341|935851|P1|STARTED|Overall Study||742
391376|NCT00991302|935889|P2|NOT COMPLETED|Overall Study||13
391377|NCT00991302|935890|P1|NOT COMPLETED|Overall Study||14
391378|NCT00991302|935889|P2|COMPLETED|Overall Study||73
391379|NCT00991302|935890|P1|COMPLETED|Overall Study||72
391380|NCT00991302|935889|P2|STARTED|Overall Study||86
391381|NCT00991302|935890|P1|STARTED|Overall Study||86
391382|NCT00991289|935906|P1|NOT COMPLETED|Overall Study||12
391383|NCT00991289|935906|P1|COMPLETED|Overall Study|Completed study.|55
391384|NCT00991289|935906|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
391385|NCT00991289|935906|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
391386|NCT00991276|935926|P6|NOT COMPLETED|Third Intervention Period||1
391387|NCT00991276|935927|P5|NOT COMPLETED|Third Intervention Period||0
391388|NCT00991276|935928|P4|NOT COMPLETED|Third Intervention Period||1
391389|NCT00991276|935929|P3|NOT COMPLETED|Third Intervention Period||1
391390|NCT00991276|935930|P2|NOT COMPLETED|Third Intervention Period||0
391391|NCT00991276|935931|P1|NOT COMPLETED|Third Intervention Period||1
391392|NCT00991276|935926|P6|COMPLETED|Third Intervention Period||10
391393|NCT00991276|935927|P5|COMPLETED|Third Intervention Period||10
391394|NCT00991276|935928|P4|COMPLETED|Third Intervention Period||8
391395|NCT00991276|935929|P3|COMPLETED|Third Intervention Period||13
391396|NCT00991276|935930|P2|COMPLETED|Third Intervention Period||8
391397|NCT00991276|935931|P1|COMPLETED|Third Intervention Period||13
391398|NCT00991276|935926|P6|STARTED|Third Intervention Period||11
391399|NCT00991276|935927|P5|STARTED|Third Intervention Period||10
391400|NCT00991276|935928|P4|STARTED|Third Intervention Period||9
391401|NCT00991276|935929|P3|STARTED|Third Intervention Period||14
391402|NCT00991276|935930|P2|STARTED|Third Intervention Period||8
391403|NCT00991276|935931|P1|STARTED|Third Intervention Period||14
391404|NCT00991276|935926|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391405|NCT00991276|935927|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391406|NCT00991276|935928|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391407|NCT00991276|935929|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391408|NCT00991276|935930|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391409|NCT00991276|935931|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391410|NCT00991276|935926|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
391411|NCT00991276|935927|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
391412|NCT00991276|935928|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
391413|NCT00991276|935929|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
391414|NCT00991276|935930|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
391415|NCT00991276|935931|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
391416|NCT00991276|935926|P6|STARTED|Placebo Wash-out Period (7 Days)||11
391417|NCT00991276|935927|P5|STARTED|Placebo Wash-out Period (7 Days)||10
391418|NCT00991276|935928|P4|STARTED|Placebo Wash-out Period (7 Days)||9
391419|NCT00991276|935929|P3|STARTED|Placebo Wash-out Period (7 Days)||14
391420|NCT00991276|935930|P2|STARTED|Placebo Wash-out Period (7 Days)||8
391421|NCT00991276|935931|P1|STARTED|Placebo Wash-out Period (7 Days)||14
391422|NCT00991276|935926|P6|NOT COMPLETED|Second Intervention Period||1
391423|NCT00991276|935927|P5|NOT COMPLETED|Second Intervention Period||1
391424|NCT00991276|935928|P4|NOT COMPLETED|Second Intervention Period||2
391425|NCT00991276|935929|P3|NOT COMPLETED|Second Intervention Period||0
391426|NCT00991276|935930|P2|NOT COMPLETED|Second Intervention Period||2
391427|NCT00991276|935931|P1|NOT COMPLETED|Second Intervention Period||1
391428|NCT00991276|935926|P6|COMPLETED|Second Intervention Period||11
391429|NCT00991276|935927|P5|COMPLETED|Second Intervention Period||10
391430|NCT00991276|935928|P4|COMPLETED|Second Intervention Period||9
391431|NCT00991276|935929|P3|COMPLETED|Second Intervention Period||14
391432|NCT00991276|935930|P2|COMPLETED|Second Intervention Period||8
391433|NCT00991276|935931|P1|COMPLETED|Second Intervention Period||14
391434|NCT00991276|935926|P6|STARTED|Second Intervention Period||12
391435|NCT00991276|935927|P5|STARTED|Second Intervention Period||11
391436|NCT00991276|935928|P4|STARTED|Second Intervention Period||11
391437|NCT00991276|935929|P3|STARTED|Second Intervention Period||14
391438|NCT00991276|935930|P2|STARTED|Second Intervention Period||10
391439|NCT00991276|935931|P1|STARTED|Second Intervention Period||15
391440|NCT00991276|935926|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391441|NCT00991276|935927|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391442|NCT00991276|935928|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391443|NCT00991276|935929|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391444|NCT00991276|935930|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391445|NCT00991276|935931|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
391446|NCT00991276|935926|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
391447|NCT00991276|935927|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
391448|NCT00991276|935928|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
391449|NCT00991276|935929|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
391450|NCT00991276|935930|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
391451|NCT00991276|935931|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
391452|NCT00991276|935926|P6|STARTED|Placebo Wash-out Period (7 Days)||12
391453|NCT00991276|935927|P5|STARTED|Placebo Wash-out Period (7 Days)||11
391454|NCT00991276|935928|P4|STARTED|Placebo Wash-out Period (7 Days)||11
391455|NCT00991276|935929|P3|STARTED|Placebo Wash-out Period (7 Days)||14
391456|NCT00991276|935930|P2|STARTED|Placebo Wash-out Period (7 Days)||10
391457|NCT00991276|935931|P1|STARTED|Placebo Wash-out Period (7 Days)||15
391458|NCT00991276|935926|P6|NOT COMPLETED|First Intervention Period||1
391459|NCT00991276|935927|P5|NOT COMPLETED|First Intervention Period||4
391460|NCT00991276|935928|P4|NOT COMPLETED|First Intervention Period||4
391461|NCT00991276|935929|P3|NOT COMPLETED|First Intervention Period||0
391462|NCT00991276|935930|P2|NOT COMPLETED|First Intervention Period||3
391463|NCT00991276|935931|P1|NOT COMPLETED|First Intervention Period||0
391464|NCT00991276|935926|P6|COMPLETED|First Intervention Period||12
391465|NCT00991276|935927|P5|COMPLETED|First Intervention Period||11
391466|NCT00991276|935928|P4|COMPLETED|First Intervention Period||11
391467|NCT00991276|935929|P3|COMPLETED|First Intervention Period||14
391468|NCT00991276|935930|P2|COMPLETED|First Intervention Period||10
391469|NCT00991276|935931|P1|COMPLETED|First Intervention Period||15
391470|NCT00991276|935926|P6|STARTED|First Intervention Period||13
391471|NCT00991276|935927|P5|STARTED|First Intervention Period||15
391472|NCT00991276|935928|P4|STARTED|First Intervention Period||15
391473|NCT00991276|935929|P3|STARTED|First Intervention Period||14
391474|NCT00991276|935930|P2|STARTED|First Intervention Period||13
391475|NCT00991276|935931|P1|STARTED|First Intervention Period||15
391476|NCT00991185|936029|P1|NOT COMPLETED|Overall Study||0
391477|NCT00991185|936029|P1|COMPLETED|Overall Study||8
391478|NCT00991185|936029|P1|STARTED|Overall Study||8
391479|NCT00991081|936035|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
391480|NCT00991081|936036|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
391481|NCT00991081|936037|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
391482|NCT00991081|936035|P3|COMPLETED|Phase II, Randomized Control Trial||15
391483|NCT00991081|936036|P2|COMPLETED|Phase II, Randomized Control Trial||15
391484|NCT00991081|936037|P1|COMPLETED|Phase II, Randomized Control Trial||0
391485|NCT00991081|936035|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
391486|NCT00991081|936036|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
391487|NCT00991081|936037|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
391488|NCT00991081|936035|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
391489|NCT00991081|936036|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
391490|NCT00991081|936037|P1|STARTED|Phase II, Randomized Control Trial||0
391491|NCT00991081|936035|P3|NOT COMPLETED|Phase I, Formative Research||0
391492|NCT00991081|936036|P2|NOT COMPLETED|Phase I, Formative Research||0
391493|NCT00991081|936037|P1|NOT COMPLETED|Phase I, Formative Research||0
391494|NCT00991081|936035|P3|COMPLETED|Phase I, Formative Research||0
391495|NCT00991081|936036|P2|COMPLETED|Phase I, Formative Research||0
391496|NCT00991081|936037|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
391497|NCT00991081|936035|P3|STARTED|Phase I, Formative Research||0
391498|NCT00991081|936036|P2|STARTED|Phase I, Formative Research||0
391499|NCT00991081|936037|P1|STARTED|Phase I, Formative Research||20
391500|NCT00990964|936069|P1|NOT COMPLETED|Overall Study||212
391501|NCT00990964|936069|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
391502|NCT00990964|936069|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
391503|NCT00990964|936069|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
391504|NCT00990821|936088|P14|NOT COMPLETED|Overall Study||1
391505|NCT00990821|936089|P13|NOT COMPLETED|Overall Study||2
391506|NCT00990821|936090|P12|NOT COMPLETED|Overall Study||5
391507|NCT00990821|936091|P11|NOT COMPLETED|Overall Study||3
391508|NCT00990821|936092|P10|NOT COMPLETED|Overall Study||1
391509|NCT00990821|936093|P9|NOT COMPLETED|Overall Study||0
391510|NCT00990821|936094|P8|NOT COMPLETED|Overall Study||0
391511|NCT00990821|936095|P7|NOT COMPLETED|Overall Study||1
391512|NCT00990821|936096|P6|NOT COMPLETED|Overall Study||3
391513|NCT00990821|936097|P5|NOT COMPLETED|Overall Study||3
391514|NCT00990821|936098|P4|NOT COMPLETED|Overall Study||0
391515|NCT00990821|936099|P3|NOT COMPLETED|Overall Study||0
391516|NCT00990821|936100|P2|NOT COMPLETED|Overall Study||2
391517|NCT00990821|936101|P1|NOT COMPLETED|Overall Study||0
391518|NCT00990821|936088|P14|COMPLETED|Overall Study||11
391519|NCT00990821|936089|P13|COMPLETED|Overall Study||10
391520|NCT00990821|936090|P12|COMPLETED|Overall Study||9
391521|NCT00990821|936091|P11|COMPLETED|Overall Study||9
391522|NCT00990821|936092|P10|COMPLETED|Overall Study||13
391523|NCT00990821|936093|P9|COMPLETED|Overall Study||12
391524|NCT00990821|936094|P8|COMPLETED|Overall Study||14
391525|NCT00990821|936095|P7|COMPLETED|Overall Study||11
391526|NCT00990821|936096|P6|COMPLETED|Overall Study||14
391527|NCT00990821|936097|P5|COMPLETED|Overall Study||14
391528|NCT00990821|936098|P4|COMPLETED|Overall Study||8
391529|NCT00990821|936099|P3|COMPLETED|Overall Study||14
391530|NCT00990821|936100|P2|COMPLETED|Overall Study||14
391531|NCT00990821|936101|P1|COMPLETED|Overall Study||14
391532|NCT00990821|936088|P14|STARTED|Overall Study||12
391533|NCT00990821|936089|P13|STARTED|Overall Study||12
391534|NCT00990821|936090|P12|STARTED|Overall Study||14
391535|NCT00990821|936091|P11|STARTED|Overall Study||12
391536|NCT00990821|936092|P10|STARTED|Overall Study||14
391537|NCT00990821|936093|P9|STARTED|Overall Study||12
391538|NCT00990821|936094|P8|STARTED|Overall Study||14
391539|NCT00990821|936095|P7|STARTED|Overall Study||12
391540|NCT00990821|936096|P6|STARTED|Overall Study||17
391541|NCT00990821|936097|P5|STARTED|Overall Study||17
391542|NCT00990821|936098|P4|STARTED|Overall Study||8
391543|NCT00990821|936099|P3|STARTED|Overall Study||14
391544|NCT00990821|936100|P2|STARTED|Overall Study||16
391545|NCT00990821|936101|P1|STARTED|Overall Study||14
391546|NCT00990769|936120|P2|NOT COMPLETED|Overall Study||0
391547|NCT00990769|936121|P1|NOT COMPLETED|Overall Study||0
391548|NCT00990769|936120|P2|COMPLETED|Overall Study||18
391549|NCT00990769|936121|P1|COMPLETED|Overall Study||22
391550|NCT00990769|936120|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
391551|NCT00990769|936121|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
391552|NCT00990704|936133|P2|NOT COMPLETED|Overall Study||2
391553|NCT00990704|936134|P1|NOT COMPLETED|Overall Study||1
391554|NCT00990704|936133|P2|COMPLETED|Overall Study||31
391555|NCT00990704|936134|P1|COMPLETED|Overall Study||13
391556|NCT00990704|936133|P2|STARTED|Overall Study||33
391557|NCT00990704|936134|P1|STARTED|Overall Study||14
391558|NCT00990652|936154|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
391559|NCT00990652|936154|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
391560|NCT00990652|936154|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
391561|NCT00990652|936154|P1|NOT COMPLETED|Surgical Resection||0
391562|NCT00990652|936154|P1|COMPLETED|Surgical Resection||9
391563|NCT00990652|936154|P1|STARTED|Surgical Resection||9
391564|NCT00990652|936154|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
391565|NCT00990652|936154|P1|COMPLETED|Pre-surgical Bortezomib||9
391566|NCT00990652|936154|P1|STARTED|Pre-surgical Bortezomib||10
391567|NCT00990561|936164|P4|NOT COMPLETED|Period 2||2
391568|NCT00990561|936165|P3|NOT COMPLETED|Period 2||0
391569|NCT00990561|936166|P2|NOT COMPLETED|Period 2||0
391570|NCT00990561|936167|P1|NOT COMPLETED|Period 2||0
391571|NCT00990561|936164|P4|COMPLETED|Period 2||17
391572|NCT00990561|936165|P3|COMPLETED|Period 2||20
391573|NCT00990561|936166|P2|COMPLETED|Period 2||0
391574|NCT00990561|936167|P1|COMPLETED|Period 2||0
391575|NCT00990561|936164|P4|STARTED|Period 2||19
391576|NCT00990561|936165|P3|STARTED|Period 2||20
391577|NCT00990561|936166|P2|STARTED|Period 2||0
391578|NCT00990561|936167|P1|STARTED|Period 2||0
391579|NCT00990561|936164|P4|NOT COMPLETED|Period 1||0
391580|NCT00990561|936165|P3|NOT COMPLETED|Period 1||0
391581|NCT00990561|936166|P2|NOT COMPLETED|Period 1||1
391582|NCT00990561|936167|P1|NOT COMPLETED|Period 1||0
391583|NCT00990561|936164|P4|COMPLETED|Period 1||0
391584|NCT00990561|936165|P3|COMPLETED|Period 1||0
391585|NCT00990561|936166|P2|COMPLETED|Period 1||19
391586|NCT00990561|936167|P1|COMPLETED|Period 1||20
391587|NCT00990561|936164|P4|STARTED|Period 1||0
391588|NCT00990561|936165|P3|STARTED|Period 1||0
391589|NCT00990561|936166|P2|STARTED|Period 1||20
391590|NCT00990561|936167|P1|STARTED|Period 1||20
391591|NCT00990509|936175|P2|NOT COMPLETED|Overall Study||1
391592|NCT00990509|936176|P1|NOT COMPLETED|Overall Study||0
391593|NCT00990509|936175|P2|COMPLETED|Overall Study||8
391594|NCT00990509|936176|P1|COMPLETED|Overall Study||5
391595|NCT00990509|936175|P2|STARTED|Overall Study||9
391596|NCT00990509|936176|P1|STARTED|Overall Study||5
391597|NCT00990340|936188|P2|NOT COMPLETED|Second 14-day Treatment||0
391598|NCT00990340|936189|P1|NOT COMPLETED|Second 14-day Treatment||0
391599|NCT00990340|936188|P2|COMPLETED|Second 14-day Treatment||21
391600|NCT00990340|936189|P1|COMPLETED|Second 14-day Treatment||21
391601|NCT00990340|936188|P2|STARTED|Second 14-day Treatment||21
391602|NCT00990340|936189|P1|STARTED|Second 14-day Treatment||21
391603|NCT00990340|936188|P2|NOT COMPLETED|First 14-day Treatment||4
391604|NCT00990340|936189|P1|NOT COMPLETED|First 14-day Treatment||6
391605|NCT00990340|936188|P2|COMPLETED|First 14-day Treatment||21
391606|NCT00990340|936189|P1|COMPLETED|First 14-day Treatment||21
391607|NCT00990340|936188|P2|STARTED|First 14-day Treatment||25
391608|NCT00990340|936189|P1|STARTED|First 14-day Treatment||27
391609|NCT00990184|936203|P1|NOT COMPLETED|Overall Study||1
391610|NCT00990184|936203|P1|COMPLETED|Overall Study||20
391611|NCT00990184|936203|P1|STARTED|Overall Study||21
391612|NCT00990106|936211|P2|NOT COMPLETED|Overall Study||12
391613|NCT00990106|936212|P1|NOT COMPLETED|Overall Study||9
391614|NCT00990106|936211|P2|COMPLETED|Overall Study||23
391615|NCT00990106|936212|P1|COMPLETED|Overall Study||23
391616|NCT00990106|936211|P2|STARTED|Overall Study||35
391617|NCT00990106|936212|P1|STARTED|Overall Study||32
391618|NCT00990093|936222|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
391619|NCT00990093|936223|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
391620|NCT00990093|936222|P2|COMPLETED|Test Period 2 (15-28 Days)||14
391621|NCT00990093|936223|P1|COMPLETED|Test Period 2 (15-28 Days)||13
391622|NCT00990093|936222|P2|STARTED|Test Period 2 (15-28 Days)||15
391623|NCT00990093|936223|P1|STARTED|Test Period 2 (15-28 Days)||15
391624|NCT00990093|936222|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
391625|NCT00990093|936223|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
391626|NCT00990093|936222|P2|COMPLETED|Test Period 1 (1-14 Days)||15
391627|NCT00990093|936223|P1|COMPLETED|Test Period 1 (1-14 Days)||15
391628|NCT00990093|936222|P2|STARTED|Test Period 1 (1-14 Days)||17
391629|NCT00990093|936223|P1|STARTED|Test Period 1 (1-14 Days)||19
391630|NCT00989989|936232|P3|NOT COMPLETED|Overall Study||23
391631|NCT00989989|936233|P2|NOT COMPLETED|Overall Study||10
391632|NCT00989989|936234|P1|NOT COMPLETED|Overall Study||18
391633|NCT00989989|936232|P3|COMPLETED|Overall Study||108
391634|NCT00989989|936233|P2|COMPLETED|Overall Study||123
391635|NCT00989989|936234|P1|COMPLETED|Overall Study||114
391636|NCT00989989|936232|P3|STARTED|Overall Study||131
391637|NCT00989989|936233|P2|STARTED|Overall Study||133
391638|NCT00989989|936234|P1|STARTED|Overall Study||132
391639|NCT00989950|936276|P4|NOT COMPLETED|Randomized Phase||0
391640|NCT00989950|936277|P3|NOT COMPLETED|Randomized Phase||0
391641|NCT00989950|936278|P2|NOT COMPLETED|Randomized Phase||1
391642|NCT00989950|936279|P1|NOT COMPLETED|Randomized Phase||1
391643|NCT00989950|936276|P4|COMPLETED|Randomized Phase||7
391644|NCT00989950|936277|P3|COMPLETED|Randomized Phase||4
391645|NCT00989950|936278|P2|COMPLETED|Randomized Phase||8
391646|NCT00989950|936279|P1|COMPLETED|Randomized Phase||5
391647|NCT00989950|936276|P4|STARTED|Randomized Phase||7
391648|NCT00989950|936277|P3|STARTED|Randomized Phase||4
391649|NCT00989950|936278|P2|STARTED|Randomized Phase||9
391650|NCT00989950|936279|P1|STARTED|Randomized Phase||6
391651|NCT00989950|936276|P4|NOT COMPLETED|Open Label Dose Optimization||0
391652|NCT00989950|936277|P3|NOT COMPLETED|Open Label Dose Optimization||0
391653|NCT00989950|936278|P2|NOT COMPLETED|Open Label Dose Optimization||0
391654|NCT00989950|936279|P1|NOT COMPLETED|Open Label Dose Optimization||0
391655|NCT00989950|936276|P4|COMPLETED|Open Label Dose Optimization||7
391656|NCT00989950|936277|P3|COMPLETED|Open Label Dose Optimization||4
391657|NCT00989950|936278|P2|COMPLETED|Open Label Dose Optimization||9
391658|NCT00989950|936279|P1|COMPLETED|Open Label Dose Optimization||6
391659|NCT00989950|936276|P4|STARTED|Open Label Dose Optimization||7
391660|NCT00989950|936277|P3|STARTED|Open Label Dose Optimization||4
391661|NCT00989950|936278|P2|STARTED|Open Label Dose Optimization||9
391662|NCT00989950|936279|P1|STARTED|Open Label Dose Optimization||6
391663|NCT00989911|936289|P1|NOT COMPLETED|Overall Study||3
391664|NCT00989911|936289|P1|COMPLETED|Overall Study||7
391665|NCT00989911|936289|P1|STARTED|Overall Study||10
391666|NCT00989833|936296|P3|NOT COMPLETED|Overall Study||2
391667|NCT00989833|936297|P2|NOT COMPLETED|Overall Study||3
391668|NCT00989833|936298|P1|NOT COMPLETED|Overall Study||2
391669|NCT00989833|936296|P3|COMPLETED|Overall Study||21
391670|NCT00989833|936297|P2|COMPLETED|Overall Study||19
391671|NCT00989833|936298|P1|COMPLETED|Overall Study||19
391672|NCT00989833|936296|P3|STARTED|Overall Study||23
391673|NCT00989833|936297|P2|STARTED|Overall Study||22
391674|NCT00989833|936298|P1|STARTED|Overall Study||21
391675|NCT00989768|936327|P1|NOT COMPLETED|Overall Study||1
391676|NCT00989768|936327|P1|COMPLETED|Overall Study||28
391677|NCT00989768|936327|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
391678|NCT00989664|936338|P1|NOT COMPLETED|Long-Term Follow-Up||3
391679|NCT00989664|936338|P1|COMPLETED|Long-Term Follow-Up||11
391680|NCT00989664|936338|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
391681|NCT00989664|936338|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
391682|NCT00989664|936338|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
391683|NCT00989664|936338|P1|STARTED|Dosimetric and Therapeutic Treatment||61
391684|NCT00989586|936368|P2|NOT COMPLETED|Overall Study||0
391685|NCT00989586|936369|P1|NOT COMPLETED|Overall Study||0
391686|NCT00989586|936368|P2|COMPLETED|Overall Study||17
391687|NCT00989586|936369|P1|COMPLETED|Overall Study||18
391688|NCT00989586|936368|P2|STARTED|Overall Study||17
391689|NCT00989586|936369|P1|STARTED|Overall Study||18
391690|NCT00989235|936384|P2|NOT COMPLETED|Overall Study||6
391691|NCT00989235|936385|P1|NOT COMPLETED|Overall Study||3
391692|NCT00989235|936384|P2|COMPLETED|Overall Study||44
391693|NCT00989235|936385|P1|COMPLETED|Overall Study||55
391694|NCT00989235|936384|P2|Number Completing Double-Blind Treatment|Overall Study||41
391695|NCT00989235|936385|P1|Number Completing Double-Blind Treatment|Overall Study||51
391696|NCT00989235|936384|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
391697|NCT00989235|936385|P1|Number Rescued to Open-Label Treatment|Overall Study||4
391698|NCT00989235|936384|P2|STARTED|Overall Study||50
391699|NCT00989235|936385|P1|STARTED|Overall Study||58
391700|NCT00989196|936430|P2|NOT COMPLETED|Treatment Period||0
391701|NCT00989196|936431|P1|NOT COMPLETED|Treatment Period||1
391702|NCT00989196|936430|P2|COMPLETED|Treatment Period||12
391703|NCT00989196|936431|P1|COMPLETED|Treatment Period||9
391704|NCT00989196|936430|P2|STARTED|Treatment Period||12
391705|NCT00989196|936431|P1|STARTED|Treatment Period||10
391706|NCT00989196|936430|P2|NOT COMPLETED|PK Crossover Period||0
391707|NCT00989196|936431|P1|NOT COMPLETED|PK Crossover Period||0
391708|NCT00989196|936430|P2|COMPLETED|PK Crossover Period||12
391709|NCT00989196|936431|P1|COMPLETED|PK Crossover Period||10
391710|NCT00989196|936430|P2|STARTED|PK Crossover Period||12
391711|NCT00989196|936431|P1|STARTED|PK Crossover Period||10
391712|NCT00989157|936452|P2|NOT COMPLETED|Overall Study||0
391713|NCT00989157|936453|P1|NOT COMPLETED|Overall Study||0
391714|NCT00989157|936452|P2|COMPLETED|Overall Study||10
391715|NCT00989157|936453|P1|COMPLETED|Overall Study||10
391716|NCT00989157|936452|P2|STARTED|Overall Study||10
391717|NCT00989157|936453|P1|STARTED|Overall Study||10
391718|NCT00989092|936469|P2|NOT COMPLETED|Overall Study||28
391719|NCT00989092|936470|P1|NOT COMPLETED|Overall Study||90
391720|NCT00989092|936469|P2|COMPLETED|Overall Study||31
391721|NCT00989092|936470|P1|COMPLETED|Overall Study||138
391722|NCT00989092|936469|P2|Treated With Darbepoetin Alfa|Overall Study||33
391723|NCT00989092|936470|P1|Treated With Darbepoetin Alfa|Overall Study||226
391724|NCT00989092|936469|P2|STARTED|Overall Study||59
391725|NCT00989092|936470|P1|STARTED|Overall Study||228
391726|NCT00989014|936507|P4|NOT COMPLETED|Overall Study||0
391727|NCT00989014|936508|P3|NOT COMPLETED|Overall Study||0
391728|NCT00989014|936509|P2|NOT COMPLETED|Overall Study||0
391729|NCT00989014|936510|P1|NOT COMPLETED|Overall Study||0
391730|NCT00989014|936507|P4|COMPLETED|Overall Study||32
391731|NCT00989014|936508|P3|COMPLETED|Overall Study||28
391732|NCT00989014|936509|P2|COMPLETED|Overall Study||31
391733|NCT00989014|936510|P1|COMPLETED|Overall Study||31
391734|NCT00989014|936507|P4|STARTED|Overall Study||32
391735|NCT00989014|936508|P3|STARTED|Overall Study||28
391736|NCT00989014|936509|P2|STARTED|Overall Study||31
391737|NCT00989014|936510|P1|STARTED|Overall Study||31
391738|NCT00988884|936522|P2|NOT COMPLETED|Overall Study||36
391739|NCT00988884|936523|P1|NOT COMPLETED|Overall Study||35
391740|NCT00988884|936522|P2|COMPLETED|Overall Study||584
391741|NCT00988884|936523|P1|COMPLETED|Overall Study||586
391742|NCT00988884|936522|P2|STARTED|Overall Study||620
391743|NCT00988884|936523|P1|STARTED|Overall Study||621
391744|NCT00988832|936545|P1|NOT COMPLETED|Overall Study||0
391745|NCT00988832|936545|P1|COMPLETED|Overall Study||380
391746|NCT00988832|936545|P1|STARTED|Overall Study||380
391747|NCT00988637|936582|P2|NOT COMPLETED|Overall Study||3
391748|NCT00988637|936583|P1|NOT COMPLETED|Overall Study||3
391749|NCT00988637|936582|P2|COMPLETED|Overall Study||65
391750|NCT00988637|936583|P1|COMPLETED|Overall Study||67
391751|NCT00988637|936582|P2|STARTED|Overall Study||68
391752|NCT00988637|936583|P1|STARTED|Overall Study||70
391753|NCT00988533|936613|P1|NOT COMPLETED|Overall Study||3
391754|NCT00988533|936613|P1|COMPLETED|Overall Study||27
391755|NCT00988533|936613|P1|STARTED|Overall Study||30
391756|NCT00988429|936628|P3|NOT COMPLETED|Overall Study||69
391757|NCT00988429|936629|P2|NOT COMPLETED|Overall Study||43
391758|NCT00988429|936630|P1|NOT COMPLETED|Overall Study||37
391759|NCT00988429|936628|P3|COMPLETED|Overall Study||142
391760|NCT00988429|936629|P2|COMPLETED|Overall Study||173
391761|NCT00988429|936630|P1|COMPLETED|Overall Study||189
391762|NCT00988429|936628|P3|Intention-to-treat (ITT) Population|Overall Study||205
391763|NCT00988429|936629|P2|Intention-to-treat (ITT) Population|Overall Study||215
391764|NCT00988429|936630|P1|Intention-to-treat (ITT) Population|Overall Study||220
391765|NCT00988429|936628|P3|Safety Population|Overall Study||210
391766|NCT00988429|936629|P2|Safety Population|Overall Study||216
391767|NCT00988429|936630|P1|Safety Population|Overall Study||224
391768|NCT00988429|936628|P3|STARTED|Overall Study||211
391769|NCT00988429|936629|P2|STARTED|Overall Study||216
391770|NCT00988429|936630|P1|STARTED|Overall Study||226
391771|NCT00988351|936643|P2|NOT COMPLETED|Overall Study||12
391772|NCT00988351|936644|P1|NOT COMPLETED|Overall Study||19
391773|NCT00988351|936643|P2|COMPLETED|Overall Study||66
391774|NCT00988351|936644|P1|COMPLETED|Overall Study||59
391775|NCT00988351|936643|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
391776|NCT00988351|936644|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
391777|NCT00988351|936643|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
391778|NCT00988351|936644|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
391779|NCT00988351|936643|P2|PAP Setup|Overall Study|APAP treatment started|78
391780|NCT00988351|936644|P1|PAP Setup|Overall Study|CPAP treatment started|70
391781|NCT00988351|936643|P2|CPAP Titration|Overall Study|no titration needed|78
391782|NCT00988351|936644|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
391783|NCT00988351|936643|P2|STARTED|Overall Study||78
391784|NCT00988351|936644|P1|STARTED|Overall Study||78
391785|NCT00988325|936661|P3|NOT COMPLETED|Overall Study||0
391786|NCT00988325|936662|P2|NOT COMPLETED|Overall Study||0
391787|NCT00988325|936663|P1|NOT COMPLETED|Overall Study||0
391788|NCT00988325|936661|P3|COMPLETED|Overall Study||5
391789|NCT00988325|936662|P2|COMPLETED|Overall Study||20
391790|NCT00988325|936663|P1|COMPLETED|Overall Study||40
391791|NCT00988325|936661|P3|STARTED|Overall Study||5
391792|NCT00988325|936662|P2|STARTED|Overall Study||20
391793|NCT00988325|936663|P1|STARTED|Overall Study||40
391794|NCT00988247|936721|P2|NOT COMPLETED|Overall Study||26
391795|NCT00988247|936722|P1|NOT COMPLETED|Overall Study||83
391796|NCT00988247|936721|P2|COMPLETED|Overall Study||85
391797|NCT00988247|936722|P1|COMPLETED|Overall Study||335
391798|NCT00988247|936721|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
391799|NCT00988247|936722|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
391800|NCT00988247|936721|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
391801|NCT00988247|936722|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
391802|NCT00988247|936721|P2|STARTED|Overall Study||111
391803|NCT00988247|936722|P1|STARTED|Overall Study||418
391804|NCT00988221|936741|P4|NOT COMPLETED|Part III||0
391805|NCT00988221|936742|P3|NOT COMPLETED|Part III||3
391806|NCT00988221|936743|P2|NOT COMPLETED|Part III||1
391807|NCT00988221|936744|P1|NOT COMPLETED|Part III||1
391808|NCT00988221|936741|P4|COMPLETED|Part III||0
391809|NCT00988221|936742|P3|COMPLETED|Part III||103
391810|NCT00988221|936743|P2|COMPLETED|Part III||23
391811|NCT00988221|936744|P1|COMPLETED|Part III||29
391812|NCT00988221|936741|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
391813|NCT00988221|936742|P3|STARTED|Part III||106
391814|NCT00988221|936743|P2|STARTED|Part III||24
391815|NCT00988221|936744|P1|STARTED|Part III||30
391816|NCT00988221|936741|P4|NOT COMPLETED|Part II||3
391817|NCT00988221|936742|P3|NOT COMPLETED|Part II||3
391818|NCT00988221|936743|P2|NOT COMPLETED|Part II||0
391819|NCT00988221|936744|P1|NOT COMPLETED|Part II||1
391820|NCT00988221|936741|P4|COMPLETED|Part II||81
391821|NCT00988221|936742|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
391822|NCT00988221|936743|P2|COMPLETED|Part II||11
391823|NCT00988221|936744|P1|COMPLETED|Part II||15
391824|NCT00988221|936741|P4|STARTED|Part II||84
391825|NCT00988221|936742|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
391826|NCT00988221|936743|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
391827|NCT00988221|936744|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
391828|NCT00988221|936741|P4|NOT COMPLETED|Part I||0
391829|NCT00988221|936742|P3|NOT COMPLETED|Part I||8
391830|NCT00988221|936743|P2|NOT COMPLETED|Part I||10
391831|NCT00988221|936744|P1|NOT COMPLETED|Part I||4
391832|NCT00988221|936741|P4|COMPLETED|Part I||0
391833|NCT00988221|936742|P3|COMPLETED|Part I||111
391834|NCT00988221|936743|P2|COMPLETED|Part I||24
391835|NCT00988221|936744|P1|COMPLETED|Part I||31
391836|NCT00988221|936741|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
391837|NCT00988221|936742|P3|STARTED|Part I||119
391838|NCT00988221|936743|P2|STARTED|Part I||34
391839|NCT00988221|936744|P1|STARTED|Part I||35
391840|NCT00988208|936917|P2|NOT COMPLETED|Overall Study||438
391841|NCT00988208|936918|P1|NOT COMPLETED|Overall Study||431
391842|NCT00988208|936917|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
391843|NCT00988208|936918|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
391844|NCT00988208|936917|P2|Treated|Overall Study||525
391845|NCT00988208|936918|P1|Treated|Overall Study||521
391846|NCT00988208|936917|P2|STARTED|Overall Study||533
391847|NCT00988208|936918|P1|STARTED|Overall Study||526
391848|NCT00988169|936930|P1|NOT COMPLETED|Overall Study||1
391849|NCT00988169|936930|P1|COMPLETED|Overall Study||5
391850|NCT00988169|936930|P1|STARTED|Overall Study||6
391851|NCT00988156|936936|P2|NOT COMPLETED|Overall Study||20
391852|NCT00988156|936937|P1|NOT COMPLETED|Overall Study||17
391853|NCT00988156|936936|P2|COMPLETED|Overall Study||135
391854|NCT00988156|936937|P1|COMPLETED|Overall Study||132
391855|NCT00988156|936936|P2|Safety Set|Overall Study||134
391856|NCT00988156|936937|P1|Safety Set|Overall Study||129
391857|NCT00988156|936936|P2|Per Protocol Set (PP)|Overall Study||97
391858|NCT00988156|936937|P1|Per Protocol Set (PP)|Overall Study||101
391859|NCT00988156|936936|P2|Intention-to-Treat Set (ITT)|Overall Study||134
391860|NCT00988156|936937|P1|Intention-to-Treat Set (ITT)|Overall Study||129
391861|NCT00988156|936936|P2|STARTED|Overall Study||155
391862|NCT00988156|936937|P1|STARTED|Overall Study||149
391863|NCT00988143|936948|P3|NOT COMPLETED|Overall Study||0
391864|NCT00988143|936949|P2|NOT COMPLETED|Overall Study||0
391865|NCT00988143|936950|P1|NOT COMPLETED|Overall Study||0
391866|NCT00988143|936948|P3|COMPLETED|Overall Study||190
391867|NCT00988143|936949|P2|COMPLETED|Overall Study||190
391868|NCT00988143|936950|P1|COMPLETED|Overall Study||220
391869|NCT00988143|936948|P3|STARTED|Overall Study||190
391870|NCT00988143|936949|P2|STARTED|Overall Study||190
391871|NCT00988143|936950|P1|STARTED|Overall Study||220
391872|NCT00988117|936982|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
391873|NCT00988117|936982|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
391874|NCT00988117|936982|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
391875|NCT00988117|936982|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
391876|NCT00988117|936982|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
391877|NCT00988117|936982|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
391878|NCT00988091|936991|P2|NOT COMPLETED|Open-label Period||33
391879|NCT00988091|936992|P1|NOT COMPLETED|Open-label Period||21
391880|NCT00988091|936991|P2|COMPLETED|Open-label Period||192
391881|NCT00988091|936992|P1|COMPLETED|Open-label Period||208
391882|NCT00988091|936991|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
391883|NCT00988091|936992|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
391884|NCT00988091|936991|P2|NOT COMPLETED|Double-blind Period||47
391885|NCT00988091|936992|P1|NOT COMPLETED|Double-blind Period||43
391886|NCT00988091|936991|P2|COMPLETED|Double-blind Period||251
391887|NCT00988091|936992|P1|COMPLETED|Double-blind Period||255
391888|NCT00988091|936991|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
391889|NCT00988091|936992|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
391890|NCT00988091|936991|P2|STARTED|Double-blind Period||298
391891|NCT00988091|936992|P1|STARTED|Double-blind Period||298
391892|NCT00988065|937014|P3|NOT COMPLETED|Overall Study||15
391893|NCT00988065|937015|P2|NOT COMPLETED|Overall Study||23
391894|NCT00988065|937016|P1|NOT COMPLETED|Overall Study||13
391895|NCT00988065|937014|P3|COMPLETED|Overall Study||135
391896|NCT00988065|937015|P2|COMPLETED|Overall Study||127
391897|NCT00988065|937016|P1|COMPLETED|Overall Study||135
391898|NCT00988065|937014|P3|Received Third Randomized Dose|Overall Study||135
391899|NCT00988065|937015|P2|Received Third Randomized Dose|Overall Study||127
391900|NCT00988065|937016|P1|Received Third Randomized Dose|Overall Study||135
391901|NCT00988065|937014|P3|Received Second Randomized Dose|Overall Study||145
391902|NCT00988065|937015|P2|Received Second Randomized Dose|Overall Study||135
391903|NCT00988065|937016|P1|Received Second Randomized Dose|Overall Study||139
391904|NCT00988065|937014|P3|Received First Randomized Dose|Overall Study||150
391905|NCT00988065|937015|P2|Received First Randomized Dose|Overall Study||150
391906|NCT00988065|937016|P1|Received First Randomized Dose|Overall Study||148
391907|NCT00988065|937014|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
391908|NCT00988065|937015|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
391909|NCT00988065|937016|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
391910|NCT00987948|937036|P1|NOT COMPLETED|Overall Study||3
391911|NCT00987948|937036|P1|COMPLETED|Overall Study||12
391912|NCT00987948|937036|P1|STARTED|Overall Study||15
391913|NCT00987935|937050|P9|NOT COMPLETED|Overall Study||32
391914|NCT00987935|937051|P8|NOT COMPLETED|Overall Study||62
391915|NCT00987935|937052|P7|NOT COMPLETED|Overall Study||15
391916|NCT00987935|937053|P6|NOT COMPLETED|Overall Study||3
391917|NCT00987935|937054|P5|NOT COMPLETED|Overall Study||7
391918|NCT00987935|937055|P4|NOT COMPLETED|Overall Study||3
391919|NCT00987935|937056|P3|NOT COMPLETED|Overall Study||3
391920|NCT00987935|937057|P2|NOT COMPLETED|Overall Study||3
391921|NCT00987935|937058|P1|NOT COMPLETED|Overall Study||4
391922|NCT00987935|937050|P9|COMPLETED|Overall Study||0
391923|NCT00987935|937051|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
391924|NCT00987935|937052|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
391925|NCT00987935|937053|P6|COMPLETED|Overall Study||0
391926|NCT00987935|937054|P5|COMPLETED|Overall Study||0
391927|NCT00987935|937055|P4|COMPLETED|Overall Study||0
391928|NCT00987935|937056|P3|COMPLETED|Overall Study||0
391929|NCT00987935|937057|P2|COMPLETED|Overall Study||0
391930|NCT00987935|937058|P1|COMPLETED|Overall Study||0
391931|NCT00987935|937050|P9|STARTED|Overall Study||32
391932|NCT00987935|937051|P8|STARTED|Overall Study||63
391933|NCT00987935|937052|P7|STARTED|Overall Study||16
391934|NCT00987935|937053|P6|STARTED|Overall Study||3
391935|NCT00987935|937054|P5|STARTED|Overall Study||7
391936|NCT00987935|937055|P4|STARTED|Overall Study||3
391937|NCT00987935|937056|P3|STARTED|Overall Study||3
391938|NCT00987935|937057|P2|STARTED|Overall Study||3
391939|NCT00987935|937058|P1|STARTED|Overall Study||4
391940|NCT00987831|937114|P3|NOT COMPLETED|Overall Study||0
391941|NCT00987831|937115|P2|NOT COMPLETED|Overall Study||3
391942|NCT00987831|937116|P1|NOT COMPLETED|Overall Study||1
391943|NCT00987831|937114|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
391944|NCT00987831|937115|P2|COMPLETED|Overall Study|all controls returned for two visits|52
391945|NCT00987831|937116|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
391946|NCT00987831|937114|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
391947|NCT00987831|937115|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
391948|NCT00987831|937116|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
391949|NCT00987727|937127|P2|NOT COMPLETED|Overall Study||7
391950|NCT00987727|937128|P1|NOT COMPLETED|Overall Study||5
391951|NCT00987727|937127|P2|COMPLETED|Overall Study||34
391952|NCT00987727|937128|P1|COMPLETED|Overall Study||36
391953|NCT00987727|937127|P2|STARTED|Overall Study||41
391954|NCT00987727|937128|P1|STARTED|Overall Study||41
391955|NCT00987623|937138|P2|NOT COMPLETED|Overall Study||3
391956|NCT00987623|937139|P1|NOT COMPLETED|Overall Study||5
391957|NCT00987623|937138|P2|COMPLETED|Overall Study||151
391958|NCT00987623|937139|P1|COMPLETED|Overall Study||140
391959|NCT00987623|937138|P2|STARTED|Overall Study||154
391960|NCT00987623|937139|P1|STARTED|Overall Study||145
391961|NCT00987558|937145|P2|NOT COMPLETED|Overall Study||5
391962|NCT00987558|937146|P1|NOT COMPLETED|Overall Study||1
391963|NCT00987558|937145|P2|COMPLETED|Overall Study||12
391964|NCT00987558|937146|P1|COMPLETED|Overall Study||12
391965|NCT00987558|937145|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
391966|NCT00987558|937146|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
391967|NCT00987558|937145|P2|Washout|Overall Study||12
391968|NCT00987558|937146|P1|Washout|Overall Study||13
391969|NCT00987558|937145|P2|Simvastatin|Overall Study||12
391970|NCT00987558|937146|P1|Simvastatin|Overall Study||13
391971|NCT00987558|937145|P2|STARTED|Overall Study||17
391972|NCT00987558|937146|P1|STARTED|Overall Study||13
391973|NCT00987467|937159|P1|NOT COMPLETED|Overall Study||2
391974|NCT00987467|937159|P1|COMPLETED|Overall Study||10
391975|NCT00987467|937159|P1|STARTED|Overall Study||12
391976|NCT00987415|937166|P2|NOT COMPLETED|Overall Study||9
391977|NCT00987415|937167|P1|NOT COMPLETED|Overall Study||9
391978|NCT00987415|937166|P2|COMPLETED|Overall Study||116
391979|NCT00987415|937167|P1|COMPLETED|Overall Study||119
391980|NCT00987415|937166|P2|STARTED|Overall Study||125
391981|NCT00987415|937167|P1|STARTED|Overall Study||128
391982|NCT00987402|937183|P2|NOT COMPLETED|Overall Study||98
391983|NCT00987402|937184|P1|NOT COMPLETED|Overall Study||86
391984|NCT00987402|937183|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
391985|NCT00987402|937184|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
391986|NCT00987402|937183|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
391987|NCT00987402|937184|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
391988|NCT00987337|937193|P3|NOT COMPLETED|Overall Study||51
391989|NCT00987337|937194|P2|NOT COMPLETED|Overall Study||55
391990|NCT00987337|937195|P1|NOT COMPLETED|Overall Study||57
391991|NCT00987337|937193|P3|COMPLETED|Overall Study||45
391992|NCT00987337|937194|P2|COMPLETED|Overall Study||41
391993|NCT00987337|937195|P1|COMPLETED|Overall Study||39
391994|NCT00987337|937193|P3|STARTED|Overall Study||96
391995|NCT00987337|937194|P2|STARTED|Overall Study||96
391996|NCT00987337|937195|P1|STARTED|Overall Study||96
391997|NCT00986999|937239|P1|NOT COMPLETED|Overall Study||1
391998|NCT00986999|937239|P1|COMPLETED|Overall Study||6
391999|NCT00986999|937239|P1|STARTED|Overall Study||7
392000|NCT00986986|937250|P2|NOT COMPLETED|Overall Study||1
392001|NCT00986986|937251|P1|NOT COMPLETED|Overall Study||0
392002|NCT00986986|937250|P2|COMPLETED|Overall Study||9
392003|NCT00986986|937251|P1|COMPLETED|Overall Study||10
392004|NCT00986986|937250|P2|STARTED|Overall Study||10
392005|NCT00986986|937251|P1|STARTED|Overall Study||10
392006|NCT00986973|937261|P1|NOT COMPLETED|Overall Study||1
392007|NCT00986973|937261|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
392008|NCT00986973|937261|P1|STARTED|Overall Study||6
392009|NCT00986960|937273|P2|NOT COMPLETED|Overall Study||0
392010|NCT00986960|937274|P1|NOT COMPLETED|Overall Study||0
392011|NCT00986960|937273|P2|COMPLETED|Overall Study||0
392012|NCT00986960|937274|P1|COMPLETED|Overall Study||0
392013|NCT00986960|937273|P2|STARTED|Overall Study||0
392014|NCT00986960|937274|P1|STARTED|Overall Study||0
392015|NCT00986947|937280|P1|NOT COMPLETED|Overall Study||20
392016|NCT00986947|937280|P1|COMPLETED|Overall Study||0
392017|NCT00986947|937280|P1|STARTED|Overall Study||20
392018|NCT00986921|937287|P2|NOT COMPLETED|Overall Study||0
392019|NCT00986921|937288|P1|NOT COMPLETED|Overall Study||1
392020|NCT00986921|937287|P2|COMPLETED|Overall Study||25
392021|NCT00986921|937288|P1|COMPLETED|Overall Study||24
392022|NCT00986921|937287|P2|STARTED|Overall Study||25
392023|NCT00986921|937288|P1|STARTED|Overall Study||25
392024|NCT00986856|937300|P2|NOT COMPLETED|Overall Study||0
392025|NCT00986856|937301|P1|NOT COMPLETED|Overall Study||0
392026|NCT00986856|937300|P2|COMPLETED|Overall Study||16
392027|NCT00986856|937301|P1|COMPLETED|Overall Study||42
392028|NCT00986856|937300|P2|STARTED|Overall Study||16
392029|NCT00986856|937301|P1|STARTED|Overall Study||42
392030|NCT00986674|937324|P3|NOT COMPLETED|Overall Study||48
392031|NCT00986674|937325|P2|NOT COMPLETED|Overall Study||45
392032|NCT00986674|937326|P1|NOT COMPLETED|Overall Study||47
392033|NCT00986674|937324|P3|COMPLETED|Overall Study||0
392034|NCT00986674|937325|P2|COMPLETED|Overall Study||0
392035|NCT00986674|937326|P1|COMPLETED|Overall Study||0
392036|NCT00986674|937324|P3|Eligible and Treated|Overall Study||47
392037|NCT00986674|937325|P2|Eligible and Treated|Overall Study||41
392038|NCT00986674|937326|P1|Eligible and Treated|Overall Study||39
392039|NCT00986674|937324|P3|Treated|Overall Study||47
392040|NCT00986674|937325|P2|Treated|Overall Study||42
392041|NCT00986674|937326|P1|Treated|Overall Study||43
392042|NCT00986674|937324|P3|STARTED|Overall Study||48
392043|NCT00986674|937325|P2|STARTED|Overall Study||45
392044|NCT00986674|937326|P1|STARTED|Overall Study||47
392045|NCT00986583|937342|P2|NOT COMPLETED|Overall Study||0
392046|NCT00986583|937343|P1|NOT COMPLETED|Overall Study||0
392047|NCT00986583|937342|P2|COMPLETED|Overall Study||32
392048|NCT00986583|937343|P1|COMPLETED|Overall Study||38
392049|NCT00986583|937342|P2|STARTED|Overall Study||32
392050|NCT00986583|937343|P1|STARTED|Overall Study||38
392051|NCT00986570|937359|P1|NOT COMPLETED|Overall Study||7
392052|NCT00986570|937359|P1|COMPLETED|Overall Study||114
392053|NCT00986570|937359|P1|STARTED|Overall Study||121
392054|NCT00986544|937365|P2|NOT COMPLETED|Overall Study||0
392055|NCT00986544|937366|P1|NOT COMPLETED|Overall Study||0
392056|NCT00986544|937365|P2|COMPLETED|Overall Study||53
392057|NCT00986544|937366|P1|COMPLETED|Overall Study||53
392058|NCT00986544|937365|P2|STARTED|Overall Study||53
392059|NCT00986544|937366|P1|STARTED|Overall Study||53
392060|NCT00986479|937376|P2|NOT COMPLETED|Period 2||0
392061|NCT00986479|937377|P1|NOT COMPLETED|Period 2||0
392062|NCT00986479|937376|P2|COMPLETED|Period 2||10
392063|NCT00986479|937377|P1|COMPLETED|Period 2||10
392064|NCT00986479|937376|P2|STARTED|Period 2||10
392065|NCT00986479|937377|P1|STARTED|Period 2||10
392066|NCT00986479|937376|P2|NOT COMPLETED|Period 1||0
392067|NCT00986479|937377|P1|NOT COMPLETED|Period 1||2
392068|NCT00986479|937376|P2|COMPLETED|Period 1||10
392069|NCT00986479|937377|P1|COMPLETED|Period 1||10
392070|NCT00986479|937376|P2|STARTED|Period 1||10
392071|NCT00986479|937377|P1|STARTED|Period 1||12
392072|NCT00986453|937407|P1|NOT COMPLETED|Overall Study||2
392073|NCT00986453|937407|P1|COMPLETED|Overall Study||43
392074|NCT00986453|937407|P1|STARTED|Overall Study||45
392075|NCT00986427|937423|P2|NOT COMPLETED|Overall Study||0
392076|NCT00986427|937424|P1|NOT COMPLETED|Overall Study||4
392077|NCT00986427|937423|P2|COMPLETED|Overall Study||12
392078|NCT00986427|937424|P1|COMPLETED|Overall Study||8
392079|NCT00986427|937423|P2|STARTED|Overall Study||12
392080|NCT00986427|937424|P1|STARTED|Overall Study||12
392081|NCT00986401|937440|P2|NOT COMPLETED|Period 2||0
392082|NCT00986401|937441|P1|NOT COMPLETED|Period 2||0
392083|NCT00986401|937440|P2|COMPLETED|Period 2||21
392084|NCT00986401|937441|P1|COMPLETED|Period 2||22
392085|NCT00986401|937440|P2|STARTED|Period 2||21
392086|NCT00986401|937441|P1|STARTED|Period 2||22
392087|NCT00986401|937440|P2|NOT COMPLETED|Period 1||1
392088|NCT00986401|937441|P1|NOT COMPLETED|Period 1||0
392089|NCT00986401|937440|P2|COMPLETED|Period 1||21
392090|NCT00986401|937441|P1|COMPLETED|Period 1||22
392091|NCT00986401|937440|P2|STARTED|Period 1||22
392092|NCT00986401|937441|P1|STARTED|Period 1||22
392093|NCT00986362|937452|P2|NOT COMPLETED|Overall Study||1
392094|NCT00986362|937453|P1|NOT COMPLETED|Overall Study||2
392095|NCT00986362|937452|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
392096|NCT00986362|937453|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
392097|NCT00986362|937452|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
392098|NCT00986362|937453|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
392099|NCT00986349|937459|P1|NOT COMPLETED|Overall Study||7
392100|NCT00986349|937459|P1|COMPLETED|Overall Study||16
392101|NCT00986349|937459|P1|Early Explant|Overall Study||4
392102|NCT00986349|937459|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
392103|NCT00986349|937459|P1|STARTED|Overall Study|attempted implant procedures|23
392104|NCT00986258|937472|P1|NOT COMPLETED|Maintenance Period||9
392105|NCT00986258|937472|P1|COMPLETED|Maintenance Period||93
392106|NCT00986258|937472|P1|STARTED|Maintenance Period||102
392107|NCT00986258|937472|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
392108|NCT00986258|937472|P1|COMPLETED|Titration and Optimal Dose Period||102
392109|NCT00986258|937472|P1|STARTED|Titration and Optimal Dose Period||125
392110|NCT00986258|937472|P1|NOT COMPLETED|Observation Period||11
392111|NCT00986258|937472|P1|COMPLETED|Observation Period||125
392112|NCT00986258|937472|P1|STARTED|Observation Period||136
392113|NCT00986245|937500|P2|NOT COMPLETED|Second Intervention||1
392114|NCT00986245|937501|P1|NOT COMPLETED|Second Intervention||2
392115|NCT00986245|937500|P2|COMPLETED|Second Intervention||32
392116|NCT00986245|937501|P1|COMPLETED|Second Intervention||29
392117|NCT00986245|937500|P2|STARTED|Second Intervention||33
392118|NCT00986245|937501|P1|STARTED|Second Intervention||31
392119|NCT00986245|937500|P2|NOT COMPLETED|First Intervention||8
392120|NCT00986245|937501|P1|NOT COMPLETED|First Intervention||10
392121|NCT00986245|937500|P2|COMPLETED|First Intervention||33
392122|NCT00986245|937501|P1|COMPLETED|First Intervention||31
392123|NCT00986245|937500|P2|STARTED|First Intervention||41
392124|NCT00986245|937501|P1|STARTED|First Intervention||41
392125|NCT00986232|937538|P4|NOT COMPLETED|Overall Study||20
392126|NCT00986232|937539|P3|NOT COMPLETED|Overall Study||35
392127|NCT00986232|937540|P2|NOT COMPLETED|Overall Study||50
392128|NCT00986232|937541|P1|NOT COMPLETED|Overall Study||51
392129|NCT00986232|937538|P4|COMPLETED|Overall Study||370
392130|NCT00986232|937539|P3|COMPLETED|Overall Study||346
392131|NCT00986232|937540|P2|COMPLETED|Overall Study||343
392132|NCT00986232|937541|P1|COMPLETED|Overall Study||336
392133|NCT00986232|937538|P4|Vaccination Visit 2|Overall Study||0
392134|NCT00986232|937539|P3|Vaccination Visit 2|Overall Study||360
392135|NCT00986232|937540|P2|Vaccination Visit 2|Overall Study||365
392136|NCT00986232|937541|P1|Vaccination Visit 2|Overall Study||360
392137|NCT00986232|937538|P4|Vaccination Visit 1|Overall Study||390
392138|NCT00986232|937539|P3|Vaccination Visit 1|Overall Study||381
392139|NCT00986232|937540|P2|Vaccination Visit 1|Overall Study||393
392140|NCT00986232|937541|P1|Vaccination Visit 1|Overall Study||387
392141|NCT00986232|937538|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
392142|NCT00986232|937539|P3|STARTED|Overall Study||381
392143|NCT00986232|937540|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
392144|NCT00986232|937541|P1|STARTED|Overall Study||387
392145|NCT00986180|937615|P2|NOT COMPLETED|Overall Study||56
392146|NCT00986180|937616|P1|NOT COMPLETED|Overall Study||44
392147|NCT00986180|937615|P2|COMPLETED|Overall Study||268
392148|NCT00986180|937616|P1|COMPLETED|Overall Study||277
392149|NCT00986180|937615|P2|STARTED|Overall Study||324
392150|NCT00986180|937616|P1|STARTED|Overall Study||321
392151|NCT00986154|937694|P2|NOT COMPLETED|Overall Study||194
392152|NCT00986154|937695|P1|NOT COMPLETED|Overall Study||206
392153|NCT00986154|937694|P2|COMPLETED|Overall Study||3955
392154|NCT00986154|937695|P1|COMPLETED|Overall Study||3937
392155|NCT00986154|937694|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
392156|NCT00986154|937695|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
392157|NCT00986154|937694|P2|STARTED|Overall Study||4149
392158|NCT00986154|937695|P1|STARTED|Overall Study||4143
392159|NCT00986102|937709|P4|NOT COMPLETED|Overall Study||1
392160|NCT00986102|937710|P3|NOT COMPLETED|Overall Study||0
392161|NCT00986102|937711|P2|NOT COMPLETED|Overall Study||2
392162|NCT00986102|937712|P1|NOT COMPLETED|Overall Study||1
392163|NCT00986102|937709|P4|COMPLETED|Overall Study||66
392164|NCT00986102|937710|P3|COMPLETED|Overall Study||19
392165|NCT00986102|937711|P2|COMPLETED|Overall Study||75
392166|NCT00986102|937712|P1|COMPLETED|Overall Study||52
392167|NCT00986102|937709|P4|STARTED|Overall Study|Number of participants who received study medication|67
392168|NCT00986102|937710|P3|STARTED|Overall Study|Number of participants who received study medication|19
392169|NCT00986102|937711|P2|STARTED|Overall Study|Number of participants who received study medication|77
392170|NCT00986102|937712|P1|STARTED|Overall Study|Number of participants who received study medication|53
392171|NCT00985985|937762|P4|NOT COMPLETED|Overall Study||13
392172|NCT00985985|937763|P3|NOT COMPLETED|Overall Study||11
392173|NCT00985985|937764|P2|NOT COMPLETED|Overall Study||24
392174|NCT00985985|937765|P1|NOT COMPLETED|Overall Study||24
392175|NCT00985985|937762|P4|COMPLETED|Overall Study||107
392176|NCT00985985|937763|P3|COMPLETED|Overall Study||109
392177|NCT00985985|937764|P2|COMPLETED|Overall Study||218
392178|NCT00985985|937765|P1|COMPLETED|Overall Study||217
392179|NCT00985985|937762|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
392180|NCT00985985|937763|P3|Full Analysis Set (FAS) Population|Overall Study||120
392181|NCT00985985|937764|P2|Full Analysis Set (FAS) Population|Overall Study||242
392182|NCT00985985|937765|P1|Full Analysis Set (FAS) Population|Overall Study||241
392183|NCT00985985|937762|P4|Safety Population|Overall Study||118
392184|NCT00985985|937763|P3|Safety Population|Overall Study||119
392185|NCT00985985|937764|P2|Safety Population|Overall Study||242
392186|NCT00985985|937765|P1|Safety Population|Overall Study||241
392187|NCT00985985|937762|P4|STARTED|Overall Study||120
392188|NCT00985985|937763|P3|STARTED|Overall Study||120
392189|NCT00985985|937764|P2|STARTED|Overall Study||242
392190|NCT00985985|937765|P1|STARTED|Overall Study||241
392191|NCT00985959|937806|P3|NOT COMPLETED|Overall Study||59
392192|NCT00985959|937807|P2|NOT COMPLETED|Overall Study||3
392193|NCT00985959|937808|P1|NOT COMPLETED|Overall Study||3
392194|NCT00985959|937806|P3|COMPLETED|Overall Study||28
392195|NCT00985959|937807|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
392196|NCT00985959|937808|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
392197|NCT00985959|937806|P3|STARTED|Overall Study|Number of participants treated|87
392198|NCT00985959|937807|P2|STARTED|Overall Study|Number of participants treated|6
392199|NCT00985959|937808|P1|STARTED|Overall Study|Number of participants treated|6
392200|NCT00985829|937831|P1|NOT COMPLETED|Overall Study||0
392201|NCT00985829|937831|P1|COMPLETED|Overall Study||28
392202|NCT00985829|937831|P1|STARTED|Overall Study||28
392203|NCT00985790|937842|P2|NOT COMPLETED|Overall Study||8
392204|NCT00985790|937843|P1|NOT COMPLETED|Overall Study||7
392205|NCT00985790|937842|P2|COMPLETED|Overall Study||293
392206|NCT00985790|937843|P1|COMPLETED|Overall Study||291
392207|NCT00985790|937842|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
392208|NCT00985790|937843|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
392209|NCT00985738|937881|P2|NOT COMPLETED|Overall Study||8
392210|NCT00985738|937882|P1|NOT COMPLETED|Overall Study||8
392211|NCT00985738|937881|P2|COMPLETED|Overall Study||0
392212|NCT00985738|937882|P1|COMPLETED|Overall Study||0
392213|NCT00985738|937881|P2|STARTED|Overall Study||8
392214|NCT00985738|937882|P1|STARTED|Overall Study||8
392215|NCT00985725|937890|P2|NOT COMPLETED|Overall Study||13
392216|NCT00985725|937891|P1|NOT COMPLETED|Overall Study||11
392217|NCT00985725|937890|P2|COMPLETED|Overall Study||59
392218|NCT00985725|937891|P1|COMPLETED|Overall Study||60
392219|NCT00985725|937890|P2|STARTED|Overall Study||72
392220|NCT00985725|937891|P1|STARTED|Overall Study||71
392221|NCT00985712|937927|P2|NOT COMPLETED|Overall Study||7
392222|NCT00985712|937928|P1|NOT COMPLETED|Overall Study||6
392223|NCT00985712|937927|P2|COMPLETED|Overall Study||123
392224|NCT00985712|937928|P1|COMPLETED|Overall Study||127
392225|NCT00985712|937927|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
392226|NCT00985712|937928|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
392227|NCT00985712|937927|P2|Received at Least One Dose of Study Drug|Overall Study||130
392228|NCT00985712|937928|P1|Received at Least One Dose of Study Drug|Overall Study||131
392229|NCT00985712|937927|P2|STARTED|Overall Study||130
392230|NCT00985712|937928|P1|STARTED|Overall Study||133
392231|NCT00985686|937946|P4|NOT COMPLETED|Overall Study||2
392232|NCT00985686|937947|P3|NOT COMPLETED|Overall Study||0
392233|NCT00985686|937948|P2|NOT COMPLETED|Overall Study||1
392234|NCT00985686|937949|P1|NOT COMPLETED|Overall Study||1
392235|NCT00985686|937946|P4|COMPLETED|Overall Study||14
392236|NCT00985686|937947|P3|COMPLETED|Overall Study||13
392237|NCT00985686|937948|P2|COMPLETED|Overall Study||15
392238|NCT00985686|937949|P1|COMPLETED|Overall Study||17
392239|NCT00985686|937946|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
392240|NCT00985686|937947|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
392241|NCT00985686|937948|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
392242|NCT00985686|937949|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
392243|NCT00985686|937946|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
392244|NCT00985686|937947|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
392245|NCT00985686|937948|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
392246|NCT00985686|937949|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
392247|NCT00985686|937946|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
392248|NCT00985686|937947|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
392249|NCT00985686|937948|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
392250|NCT00985686|937949|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
392251|NCT00985686|937946|P4|Visit 1: Baseline Data Collection|Overall Study||16
392252|NCT00985686|937947|P3|Visit 1: Baseline Data Collection|Overall Study||13
392253|NCT00985686|937948|P2|Visit 1: Baseline Data Collection|Overall Study||15
392254|NCT00985686|937949|P1|Visit 1: Baseline Data Collection|Overall Study||18
392255|NCT00985686|937946|P4|STARTED|Overall Study||16
392256|NCT00985686|937947|P3|STARTED|Overall Study||13
392257|NCT00985686|937948|P2|STARTED|Overall Study||16
392258|NCT00985686|937949|P1|STARTED|Overall Study||18
392259|NCT00985673|937963|P6|NOT COMPLETED|Overall Study||6
392260|NCT00985673|937964|P5|NOT COMPLETED|Overall Study||8
392261|NCT00985673|937965|P4|NOT COMPLETED|Overall Study||12
392262|NCT00985673|937966|P3|NOT COMPLETED|Overall Study||12
392263|NCT00985673|937967|P2|NOT COMPLETED|Overall Study||11
392264|NCT00985673|937968|P1|NOT COMPLETED|Overall Study||7
392265|NCT00985673|937963|P6|COMPLETED|Overall Study||96
392266|NCT00985673|937964|P5|COMPLETED|Overall Study||93
392267|NCT00985673|937965|P4|COMPLETED|Overall Study||88
392268|NCT00985673|937966|P3|COMPLETED|Overall Study||90
392269|NCT00985673|937967|P2|COMPLETED|Overall Study||93
392270|NCT00985673|937968|P1|COMPLETED|Overall Study||95
392271|NCT00985673|937963|P6|STARTED|Overall Study||102
392272|NCT00985673|937964|P5|STARTED|Overall Study||101
392273|NCT00985673|937965|P4|STARTED|Overall Study||100
392274|NCT00985673|937966|P3|STARTED|Overall Study||102
392275|NCT00985673|937967|P2|STARTED|Overall Study||104
392276|NCT00985673|937968|P1|STARTED|Overall Study||102
392277|NCT00985543|938219|P1|NOT COMPLETED|Overall Study||0
392278|NCT00985543|938219|P1|COMPLETED|Overall Study||22
392279|NCT00985543|938219|P1|STARTED|Overall Study||22
392280|NCT00985504|938230|P2|NOT COMPLETED|Optimization Period||23
392281|NCT00985504|938231|P1|NOT COMPLETED|Optimization Period||26
392282|NCT00985504|938230|P2|COMPLETED|Optimization Period||204
392283|NCT00985504|938231|P1|COMPLETED|Optimization Period||203
392284|NCT00985504|938230|P2|STARTED|Optimization Period||227
392285|NCT00985504|938231|P1|STARTED|Optimization Period||229
392286|NCT00985504|938230|P2|NOT COMPLETED|Acute Treatment Period||12
392287|NCT00985504|938231|P1|NOT COMPLETED|Acute Treatment Period||15
392288|NCT00985504|938230|P2|COMPLETED|Acute Treatment Period||227
392289|NCT00985504|938231|P1|COMPLETED|Acute Treatment Period||229
392290|NCT00985504|938230|P2|STARTED|Acute Treatment Period||239
392291|NCT00985504|938231|P1|STARTED|Acute Treatment Period||244
392292|NCT00985491|938257|P1|NOT COMPLETED|Overall Study||19
392293|NCT00985491|938257|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
392294|NCT00985491|938257|P1|Received Device|Overall Study||43
392295|NCT00985491|938257|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
392296|NCT00985439|938266|P4|NOT COMPLETED|Overall Study||0
392297|NCT00985439|938267|P3|NOT COMPLETED|Overall Study||1
392298|NCT00985439|938268|P2|NOT COMPLETED|Overall Study||0
392299|NCT00985439|938269|P1|NOT COMPLETED|Overall Study||0
392300|NCT00985439|938266|P4|COMPLETED|Overall Study||51
392301|NCT00985439|938267|P3|COMPLETED|Overall Study||50
392302|NCT00985439|938268|P2|COMPLETED|Overall Study||51
392303|NCT00985439|938269|P1|COMPLETED|Overall Study||49
392304|NCT00985439|938266|P4|STARTED|Overall Study||51
392305|NCT00985439|938267|P3|STARTED|Overall Study||51
392306|NCT00985439|938268|P2|STARTED|Overall Study||51
392307|NCT00985439|938269|P1|STARTED|Overall Study||49
392308|NCT00985257|938279|P1|NOT COMPLETED|Overall Study||0
392309|NCT00985257|938279|P1|COMPLETED|Overall Study||123
392310|NCT00985257|938279|P1|STARTED|Overall Study||123
392311|NCT00985231|938285|P2|NOT COMPLETED|Overall Study||3
392312|NCT00985231|938286|P1|NOT COMPLETED|Overall Study||3
392313|NCT00985231|938285|P2|COMPLETED|Overall Study||129
392314|NCT00985231|938286|P1|COMPLETED|Overall Study||130
392315|NCT00985231|938285|P2|STARTED|Overall Study||132
392316|NCT00985231|938286|P1|STARTED|Overall Study||133
392317|NCT00985192|938294|P1|NOT COMPLETED|Overall Study||4
392318|NCT00985192|938294|P1|COMPLETED|Overall Study||45
392319|NCT00985192|938294|P1|STARTED|Overall Study||49
392320|NCT00985166|938306|P3|NOT COMPLETED|Overall Study||7
392321|NCT00985166|938307|P2|NOT COMPLETED|Overall Study||4
392322|NCT00985166|938308|P1|NOT COMPLETED|Overall Study||9
392323|NCT00985166|938306|P3|COMPLETED|Overall Study||188
392324|NCT00985166|938307|P2|COMPLETED|Overall Study||201
392325|NCT00985166|938308|P1|COMPLETED|Overall Study||392
392326|NCT00985166|938306|P3|Vaccinated at Visit 1|Overall Study||195
392327|NCT00985166|938307|P2|Vaccinated at Visit 1|Overall Study||205
392328|NCT00985166|938308|P1|Vaccinated at Visit 1|Overall Study||399
392329|NCT00985166|938306|P3|STARTED|Overall Study||195
392330|NCT00985166|938307|P2|STARTED|Overall Study||205
392331|NCT00985166|938308|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
392332|NCT00985153|938328|P4|NOT COMPLETED|Overall Study||47
392333|NCT00985153|938329|P3|NOT COMPLETED|Overall Study||44
392334|NCT00985153|938330|P2|NOT COMPLETED|Overall Study||44
392335|NCT00985153|938331|P1|NOT COMPLETED|Overall Study||35
392336|NCT00985153|938328|P4|COMPLETED|Overall Study||965
392337|NCT00985153|938329|P3|COMPLETED|Overall Study||918
392338|NCT00985153|938330|P2|COMPLETED|Overall Study||924
392339|NCT00985153|938331|P1|COMPLETED|Overall Study||950
392340|NCT00985153|938328|P4|Vaccinated at Visit 1|Overall Study||1012
392341|NCT00985153|938329|P3|Vaccinated at Visit 1|Overall Study||962
392342|NCT00985153|938330|P2|Vaccinated at Visit 1|Overall Study||968
392343|NCT00985153|938331|P1|Vaccinated at Visit 1|Overall Study||985
392344|NCT00985153|938328|P4|STARTED|Overall Study||1012
392345|NCT00985153|938329|P3|STARTED|Overall Study||962
392346|NCT00985153|938330|P2|STARTED|Overall Study||968
392347|NCT00985153|938331|P1|STARTED|Overall Study||985
392348|NCT00985140|938373|P1|NOT COMPLETED|Overall Study||0
392349|NCT00985140|938373|P1|COMPLETED|Overall Study||15
392350|NCT00985140|938373|P1|STARTED|Overall Study||15
392351|NCT00985114|938379|P2|NOT COMPLETED|Overall Study||2
392352|NCT00985114|938380|P1|NOT COMPLETED|Overall Study||1
392353|NCT00985114|938379|P2|COMPLETED|Overall Study||37
392354|NCT00985114|938380|P1|COMPLETED|Overall Study||33
392355|NCT00985114|938379|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
392356|NCT00985114|938380|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
392357|NCT00985114|938379|P2|STARTED|Overall Study||39
392358|NCT00985114|938380|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
392359|NCT00985010|938388|P2|NOT COMPLETED|Overall Study||0
392360|NCT00985010|938389|P1|NOT COMPLETED|Overall Study||0
392361|NCT00985010|938388|P2|COMPLETED|Overall Study||5
392362|NCT00985010|938389|P1|COMPLETED|Overall Study||4
392363|NCT00985010|938388|P2|STARTED|Overall Study||5
392364|NCT00985010|938389|P1|STARTED|Overall Study||4
392365|NCT00984867|938399|P2|NOT COMPLETED|Overall Study||17
392366|NCT00984867|938400|P1|NOT COMPLETED|Overall Study||23
392367|NCT00984867|938399|P2|COMPLETED|Overall Study||208
392368|NCT00984867|938400|P1|COMPLETED|Overall Study||203
392369|NCT00984867|938399|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
392370|NCT00984867|938400|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
392371|NCT00984815|938418|P1|NOT COMPLETED|Overall Study||30
392372|NCT00984815|938418|P1|COMPLETED|Overall Study||56
392373|NCT00984815|938418|P1|STARTED|Overall Study||86
392374|NCT00984698|938427|P2|NOT COMPLETED|Overall Study||8
392375|NCT00984698|938428|P1|NOT COMPLETED|Overall Study||3
392376|NCT00984698|938427|P2|COMPLETED|Overall Study||14
392377|NCT00984698|938428|P1|COMPLETED|Overall Study||18
392378|NCT00984698|938427|P2|STARTED|Overall Study||22
392379|NCT00984698|938428|P1|STARTED|Overall Study||21
392380|NCT00984659|938440|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
392381|NCT00984659|938441|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
392382|NCT00984659|938442|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
392383|NCT00984659|938443|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
392384|NCT00984659|938440|P4|COMPLETED|6-week Double-blind Treatment Period||126
392385|NCT00984659|938441|P3|COMPLETED|6-week Double-blind Treatment Period||141
392386|NCT00984659|938442|P2|COMPLETED|6-week Double-blind Treatment Period||69
392387|NCT00984659|938443|P1|COMPLETED|6-week Double-blind Treatment Period||0
392388|NCT00984659|938440|P4|STARTED|6-week Double-blind Treatment Period||139
392389|NCT00984659|938441|P3|STARTED|6-week Double-blind Treatment Period||152
392390|NCT00984659|938442|P2|STARTED|6-week Double-blind Treatment Period||75
392391|NCT00984659|938443|P1|STARTED|6-week Double-blind Treatment Period||0
392392|NCT00984659|938440|P4|NOT COMPLETED|2-week Run-in Period||0
392393|NCT00984659|938441|P3|NOT COMPLETED|2-week Run-in Period||0
392394|NCT00984659|938442|P2|NOT COMPLETED|2-week Run-in Period||0
392395|NCT00984659|938443|P1|NOT COMPLETED|2-week Run-in Period||52
392396|NCT00984659|938440|P4|COMPLETED|2-week Run-in Period||0
392397|NCT00984659|938441|P3|COMPLETED|2-week Run-in Period||0
392398|NCT00984659|938442|P2|COMPLETED|2-week Run-in Period||0
392399|NCT00984659|938443|P1|COMPLETED|2-week Run-in Period||366
392400|NCT00984659|938440|P4|STARTED|2-week Run-in Period||0
392401|NCT00984659|938441|P3|STARTED|2-week Run-in Period||0
392402|NCT00984659|938442|P2|STARTED|2-week Run-in Period||0
392403|NCT00984659|938443|P1|STARTED|2-week Run-in Period||418
392404|NCT00984620|938470|P2|NOT COMPLETED|Overall Study||12
392405|NCT00984620|938471|P1|NOT COMPLETED|Overall Study||6
392406|NCT00984620|938470|P2|COMPLETED|Overall Study||67
392407|NCT00984620|938471|P1|COMPLETED|Overall Study||75
392408|NCT00984620|938470|P2|STARTED|Overall Study||79
392409|NCT00984620|938471|P1|STARTED|Overall Study||81
392410|NCT00984594|938509|P2|NOT COMPLETED|Overall Study||1
392411|NCT00984594|938510|P1|NOT COMPLETED|Overall Study||1
392412|NCT00984594|938509|P2|COMPLETED|Overall Study||1
392413|NCT00984594|938510|P1|COMPLETED|Overall Study||1
392414|NCT00984594|938509|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
392415|NCT00984594|938510|P1|STARTED|Overall Study||2
392416|NCT00984568|938526|P2|NOT COMPLETED|Overall Study||6
392417|NCT00984568|938527|P1|NOT COMPLETED|Overall Study||8
392418|NCT00984568|938526|P2|COMPLETED|Overall Study||7
392419|NCT00984568|938527|P1|COMPLETED|Overall Study||7
392420|NCT00984568|938526|P2|STARTED|Overall Study||13
392421|NCT00984568|938527|P1|STARTED|Overall Study||15
392422|NCT00984542|938535|P1|NOT COMPLETED|Overall Study||41
392423|NCT00984542|938535|P1|COMPLETED|Overall Study||9
392424|NCT00984542|938535|P1|STARTED|Overall Study||50
392425|NCT00984490|938543|P1|NOT COMPLETED|Overall Study||0
392426|NCT00984490|938543|P1|COMPLETED|Overall Study||5
392427|NCT00984490|938543|P1|STARTED|Overall Study||5
392428|NCT00984334|938553|P5|NOT COMPLETED|Overall Study||1
392429|NCT00984334|938554|P4|NOT COMPLETED|Overall Study||1
392430|NCT00984334|938555|P3|NOT COMPLETED|Overall Study||0
392431|NCT00984334|938556|P2|NOT COMPLETED|Overall Study||1
392432|NCT00984334|938557|P1|NOT COMPLETED|Overall Study||1
392433|NCT00984334|938553|P5|COMPLETED|Overall Study||7
392434|NCT00984334|938554|P4|COMPLETED|Overall Study||7
392435|NCT00984334|938555|P3|COMPLETED|Overall Study||8
392436|NCT00984334|938556|P2|COMPLETED|Overall Study||7
392437|NCT00984334|938557|P1|COMPLETED|Overall Study||7
392438|NCT00984334|938553|P5|STARTED|Overall Study||8
392439|NCT00984334|938554|P4|STARTED|Overall Study||8
392440|NCT00984334|938555|P3|STARTED|Overall Study||8
392441|NCT00984334|938556|P2|STARTED|Overall Study||8
392442|NCT00984334|938557|P1|STARTED|Overall Study||8
392443|NCT00984308|938571|P2|NOT COMPLETED|Overall Study||6
392444|NCT00984308|938572|P1|NOT COMPLETED|Overall Study||18
392445|NCT00984308|938571|P2|COMPLETED|Overall Study||109
392446|NCT00984308|938572|P1|COMPLETED|Overall Study||92
392447|NCT00984308|938571|P2|STARTED|Overall Study||115
392448|NCT00984308|938572|P1|STARTED|Overall Study||110
392449|NCT00984295|938585|P3|NOT COMPLETED|Overall Study||37
392450|NCT00984295|938586|P2|NOT COMPLETED|Overall Study||32
392451|NCT00984295|938587|P1|NOT COMPLETED|Overall Study||65
392452|NCT00984295|938585|P3|COMPLETED|Overall Study||442
392453|NCT00984295|938586|P2|COMPLETED|Overall Study||453
392454|NCT00984295|938587|P1|COMPLETED|Overall Study||884
392455|NCT00984295|938585|P3|Visit 2|Overall Study||453
392456|NCT00984295|938586|P2|Visit 2|Overall Study||468
392457|NCT00984295|938587|P1|Visit 2|Overall Study||909
392458|NCT00984295|938585|P3|Visit 1|Overall Study||479
392459|NCT00984295|938586|P2|Visit 1|Overall Study||485
392460|NCT00984295|938587|P1|Visit 1|Overall Study||949
392461|NCT00984295|938585|P3|STARTED|Overall Study||479
392462|NCT00984295|938586|P2|STARTED|Overall Study||485
392463|NCT00984295|938587|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
392464|NCT00984282|938654|P2|NOT COMPLETED|Long Term Follow-up||117
392465|NCT00984282|938655|P1|NOT COMPLETED|Long Term Follow-up||114
392466|NCT00984282|938654|P2|COMPLETED|Long Term Follow-up||0
392467|NCT00984282|938655|P1|COMPLETED|Long Term Follow-up||0
392468|NCT00984282|938654|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|117
392553|NCT00983957|938794|P1|Treatment A|Overall Study||20
392469|NCT00984282|938655|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|114
392470|NCT00984282|938654|P2|NOT COMPLETED|Open-label Treatment||161
392471|NCT00984282|938655|P1|NOT COMPLETED|Open-label Treatment||86
392472|NCT00984282|938654|P2|COMPLETED|Open-label Treatment||0
392473|NCT00984282|938655|P1|COMPLETED|Open-label Treatment||0
392474|NCT00984282|938654|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
392475|NCT00984282|938655|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
392476|NCT00984282|938654|P2|STARTED|Open-label Treatment||161
392477|NCT00984282|938655|P1|STARTED|Open-label Treatment||86
392478|NCT00984282|938654|P2|NOT COMPLETED|Double Blind Treatment||38
392479|NCT00984282|938655|P1|NOT COMPLETED|Double Blind Treatment||104
392480|NCT00984282|938654|P2|COMPLETED|Double Blind Treatment||172
392481|NCT00984282|938655|P1|COMPLETED|Double Blind Treatment||103
392482|NCT00984282|938654|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
392483|NCT00984282|938655|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
392484|NCT00984282|938654|P2|STARTED|Double Blind Treatment||210
392485|NCT00984282|938655|P1|STARTED|Double Blind Treatment||207
392486|NCT00984256|938678|P2|NOT COMPLETED|Overall Study||1
392487|NCT00984256|938679|P1|NOT COMPLETED|Overall Study||0
392488|NCT00984256|938678|P2|COMPLETED|Overall Study||29
392489|NCT00984256|938679|P1|COMPLETED|Overall Study||6
392490|NCT00984256|938678|P2|STARTED|Overall Study||30
392491|NCT00984256|938679|P1|STARTED|Overall Study||6
392492|NCT00984204|938699|P1|NOT COMPLETED|Overall Study||15
392493|NCT00984204|938699|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
392494|NCT00984204|938699|P1|STARTED|Overall Study||188
392495|NCT00984165|938709|P4|NOT COMPLETED|Overall Study||4
392496|NCT00984165|938710|P3|NOT COMPLETED|Overall Study||0
392497|NCT00984165|938711|P2|NOT COMPLETED|Overall Study||1
392498|NCT00984165|938712|P1|NOT COMPLETED|Overall Study||7
392499|NCT00984165|938709|P4|COMPLETED|Overall Study||0
392500|NCT00984165|938710|P3|COMPLETED|Overall Study||4
392501|NCT00984165|938711|P2|COMPLETED|Overall Study||0
392502|NCT00984165|938712|P1|COMPLETED|Overall Study||2
392503|NCT00984165|938709|P4|STARTED|Overall Study||4
392504|NCT00984165|938710|P3|STARTED|Overall Study||4
392505|NCT00984165|938711|P2|STARTED|Overall Study||1
392506|NCT00984165|938712|P1|STARTED|Overall Study||9
392507|NCT00984139|938725|P1|NOT COMPLETED|Overall Study||0
392508|NCT00984139|938725|P1|COMPLETED|Overall Study||306
392509|NCT00984139|938725|P1|STARTED|Overall Study||306
392510|NCT00984061|938737|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
392511|NCT00984061|938737|P1|COMPLETED|Colchicine With Clarithromycin||23
392512|NCT00984061|938737|P1|STARTED|Colchicine With Clarithromycin||23
392513|NCT00984061|938737|P1|NOT COMPLETED|Clarithromycin Alone||1
392514|NCT00984061|938737|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
392515|NCT00984061|938737|P1|STARTED|Clarithromycin Alone||24
392516|NCT00984061|938737|P1|NOT COMPLETED|21 Day Washout Period||0
392517|NCT00984061|938737|P1|COMPLETED|21 Day Washout Period||24
392518|NCT00984061|938737|P1|STARTED|21 Day Washout Period||24
392519|NCT00984061|938737|P1|NOT COMPLETED|Colchicine Alone||0
392520|NCT00984061|938737|P1|COMPLETED|Colchicine Alone||24
392521|NCT00984061|938737|P1|STARTED|Colchicine Alone||24
392522|NCT00984022|938750|P2|NOT COMPLETED|Overall Study||14
392523|NCT00984022|938751|P1|NOT COMPLETED|Overall Study||10
392524|NCT00984022|938750|P2|COMPLETED|Overall Study||35
392525|NCT00984022|938751|P1|COMPLETED|Overall Study||33
392526|NCT00984022|938750|P2|STARTED|Overall Study||49
392527|NCT00984022|938751|P1|STARTED|Overall Study||43
392528|NCT00984009|938761|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
392529|NCT00984009|938761|P1|COMPLETED|Colchicine With Grapefruit Juice||21
392530|NCT00984009|938761|P1|STARTED|Colchicine With Grapefruit Juice||21
392531|NCT00984009|938761|P1|NOT COMPLETED|Grapefruit Juice Alone||1
392532|NCT00984009|938761|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
392533|NCT00984009|938761|P1|STARTED|Grapefruit Juice Alone||22
392534|NCT00984009|938761|P1|NOT COMPLETED|14 Day Washout Period||0
392535|NCT00984009|938761|P1|COMPLETED|14 Day Washout Period||22
392536|NCT00984009|938761|P1|STARTED|14 Day Washout Period||22
392537|NCT00984009|938761|P1|NOT COMPLETED|Colchicine Alone||0
392538|NCT00984009|938761|P1|COMPLETED|Colchicine Alone||22
392539|NCT00984009|938761|P1|STARTED|Colchicine Alone||22
392540|NCT00983983|938775|P3|NOT COMPLETED|Overall Study||1
392541|NCT00983983|938776|P2|NOT COMPLETED|Overall Study||1
392542|NCT00983983|938777|P1|NOT COMPLETED|Overall Study||2
392543|NCT00983983|938775|P3|COMPLETED|Overall Study||6
392544|NCT00983983|938776|P2|COMPLETED|Overall Study||8
392545|NCT00983983|938777|P1|COMPLETED|Overall Study||6
392546|NCT00983983|938775|P3|STARTED|Overall Study||7
392547|NCT00983983|938776|P2|STARTED|Overall Study||9
392548|NCT00983983|938777|P1|STARTED|Overall Study||8
392549|NCT00983957|938794|P1|NOT COMPLETED|Overall Study||2
392550|NCT00983957|938794|P1|COMPLETED|Overall Study||18
392551|NCT00983957|938794|P1|Treatment C|Overall Study||18
392552|NCT00983957|938794|P1|Treatment B|Overall Study||20
392554|NCT00983957|938794|P1|STARTED|Overall Study||20
392555|NCT00983931|938828|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
392556|NCT00983931|938828|P1|COMPLETED|Colchicine With Cyclosporine||23
392557|NCT00983931|938828|P1|STARTED|Colchicine With Cyclosporine||23
392558|NCT00983931|938828|P1|NOT COMPLETED|14 Day Washout Period||1
392559|NCT00983931|938828|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
392560|NCT00983931|938828|P1|STARTED|14 Day Washout Period||24
392561|NCT00983931|938828|P1|NOT COMPLETED|Colchicine Alone||0
392562|NCT00983931|938828|P1|COMPLETED|Colchicine Alone||24
392563|NCT00983931|938828|P1|STARTED|Colchicine Alone||24
392564|NCT00983918|938842|P4|NOT COMPLETED|Overall Study||2
392565|NCT00983918|938843|P3|NOT COMPLETED|Overall Study||2
392566|NCT00983918|938844|P2|NOT COMPLETED|Overall Study||2
392567|NCT00983918|938845|P1|NOT COMPLETED|Overall Study||0
392568|NCT00983918|938842|P4|COMPLETED|Overall Study||18
392569|NCT00983918|938843|P3|COMPLETED|Overall Study||18
392570|NCT00983918|938844|P2|COMPLETED|Overall Study||18
392571|NCT00983918|938845|P1|COMPLETED|Overall Study||20
392572|NCT00983918|938842|P4|STARTED|Overall Study||20
392573|NCT00983918|938843|P3|STARTED|Overall Study||20
392574|NCT00983918|938844|P2|STARTED|Overall Study||20
392575|NCT00983918|938845|P1|STARTED|Overall Study||20
392576|NCT00983905|938855|P1|NOT COMPLETED|Theophylline With Colchicine||0
392577|NCT00983905|938855|P1|COMPLETED|Theophylline With Colchicine||27
392578|NCT00983905|938855|P1|STARTED|Theophylline With Colchicine||27
392579|NCT00983905|938855|P1|NOT COMPLETED|Colchicine Alone||2
392580|NCT00983905|938855|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
392581|NCT00983905|938855|P1|STARTED|Colchicine Alone||29
392582|NCT00983905|938855|P1|NOT COMPLETED|4 Day Washout Period||0
392583|NCT00983905|938855|P1|COMPLETED|4 Day Washout Period||29
392584|NCT00983905|938855|P1|STARTED|4 Day Washout Period||29
392585|NCT00983905|938855|P1|NOT COMPLETED|Theophylline Alone||1
392586|NCT00983905|938855|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
392587|NCT00983905|938855|P1|STARTED|Theophylline Alone||30
392588|NCT00983892|938868|P2|NOT COMPLETED|Overall Study||12
392589|NCT00983892|938869|P1|NOT COMPLETED|Overall Study||10
392590|NCT00983892|938868|P2|COMPLETED|Overall Study||56
392591|NCT00983892|938869|P1|COMPLETED|Overall Study||56
392592|NCT00983892|938868|P2|STARTED|Overall Study||68
392593|NCT00983892|938869|P1|STARTED|Overall Study||66
392594|NCT00983853|938881|P6|NOT COMPLETED|Overall Study||1
392595|NCT00983853|938882|P5|NOT COMPLETED|Overall Study||3
392596|NCT00983853|938883|P4|NOT COMPLETED|Overall Study||2
392597|NCT00983853|938884|P3|NOT COMPLETED|Overall Study||3
392598|NCT00983853|938885|P2|NOT COMPLETED|Overall Study||2
392599|NCT00983853|938886|P1|NOT COMPLETED|Overall Study||1
392600|NCT00983853|938881|P6|COMPLETED|Overall Study||7
392601|NCT00983853|938882|P5|COMPLETED|Overall Study||12
392602|NCT00983853|938883|P4|COMPLETED|Overall Study||6
392603|NCT00983853|938884|P3|COMPLETED|Overall Study||14
392604|NCT00983853|938885|P2|COMPLETED|Overall Study||5
392605|NCT00983853|938886|P1|COMPLETED|Overall Study||6
392606|NCT00983853|938881|P6|STARTED|Overall Study||8
392607|NCT00983853|938882|P5|STARTED|Overall Study||15
392608|NCT00983853|938883|P4|STARTED|Overall Study||8
392609|NCT00983853|938884|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
392610|NCT00983853|938885|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
392611|NCT00983853|938886|P1|STARTED|Overall Study||7
392612|NCT00983827|938914|P1|NOT COMPLETED|Overall Study||1
392613|NCT00983827|938914|P1|COMPLETED|Overall Study||7
392614|NCT00983827|938914|P1|STARTED|Overall Study||8
392615|NCT00983801|938918|P1|NOT COMPLETED|Overall Study||0
392616|NCT00983801|938918|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
392617|NCT00983801|938918|P1|STARTED|Overall Study|Participants who received treatment.|52
392618|NCT00983749|938932|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
392619|NCT00983749|938933|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
392620|NCT00983749|938932|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
392621|NCT00983749|938933|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
392622|NCT00983749|938932|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
392623|NCT00983749|938933|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
392624|NCT00983749|938932|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
392625|NCT00983749|938933|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
392626|NCT00983749|938932|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
392627|NCT00983749|938933|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
392628|NCT00983749|938932|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
392629|NCT00983749|938933|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
392630|NCT00983645|938943|P2|NOT COMPLETED|Overall Study||0
392631|NCT00983645|938944|P1|NOT COMPLETED|Overall Study||0
392632|NCT00983645|938943|P2|COMPLETED|Overall Study||7
392633|NCT00983645|938944|P1|COMPLETED|Overall Study||8
392634|NCT00983645|938943|P2|STARTED|Overall Study||7
392635|NCT00983645|938944|P1|STARTED|Overall Study||8
392636|NCT00983541|938956|P1|NOT COMPLETED|Overall Study||0
392637|NCT00983541|938956|P1|COMPLETED|Overall Study||1
392638|NCT00983541|938956|P1|STARTED|Overall Study||1
392639|NCT00983515|938966|P1|NOT COMPLETED|Colchicine With Ritonavir||1
392724|NCT00983242|939134|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
392640|NCT00983515|938966|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
392641|NCT00983515|938966|P1|STARTED|Colchicine With Ritonavir||18
392642|NCT00983515|938966|P1|NOT COMPLETED|Ritonavir Alone||6
392643|NCT00983515|938966|P1|COMPLETED|Ritonavir Alone||18
392644|NCT00983515|938966|P1|STARTED|Ritonavir Alone||24
392645|NCT00983515|938966|P1|NOT COMPLETED|14 Day Washout Period||0
392646|NCT00983515|938966|P1|COMPLETED|14 Day Washout Period||24
392647|NCT00983515|938966|P1|STARTED|14 Day Washout Period||24
392648|NCT00983515|938966|P1|NOT COMPLETED|Colchicine Alone||0
392649|NCT00983515|938966|P1|COMPLETED|Colchicine Alone||24
392650|NCT00983515|938966|P1|STARTED|Colchicine Alone||24
392651|NCT00983489|938980|P3|NOT COMPLETED|Overall Study||312
392652|NCT00983489|938981|P2|NOT COMPLETED|Overall Study||285
392653|NCT00983489|938982|P1|NOT COMPLETED|Overall Study||185
392654|NCT00983489|938980|P3|COMPLETED|Overall Study||135
392655|NCT00983489|938981|P2|COMPLETED|Overall Study||168
392656|NCT00983489|938982|P1|COMPLETED|Overall Study||326
392657|NCT00983489|938980|P3|STARTED|Overall Study||447
392658|NCT00983489|938981|P2|STARTED|Overall Study||453
392659|NCT00983489|938982|P1|STARTED|Overall Study||511
392660|NCT00983476|938993|P3|NOT COMPLETED|Overall Study||0
392661|NCT00983476|938994|P2|NOT COMPLETED|Overall Study||22
392662|NCT00983476|938995|P1|NOT COMPLETED|Overall Study||17
392663|NCT00983476|938993|P3|COMPLETED|Overall Study||88
392664|NCT00983476|938994|P2|COMPLETED|Overall Study||71
392665|NCT00983476|938995|P1|COMPLETED|Overall Study||78
392666|NCT00983476|938993|P3|6 Month Follow up Assessment|Overall Study||74
392667|NCT00983476|938994|P2|6 Month Follow up Assessment|Overall Study||62
392668|NCT00983476|938995|P1|6 Month Follow up Assessment|Overall Study||71
392669|NCT00983476|938993|P3|STARTED|Overall Study||88
392670|NCT00983476|938994|P2|STARTED|Overall Study||93
392671|NCT00983476|938995|P1|STARTED|Overall Study||95
392672|NCT00983437|939027|P1|NOT COMPLETED|Overall Study||47
392673|NCT00983437|939027|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
392674|NCT00983437|939027|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
392675|NCT00983437|939027|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
392676|NCT00983437|939027|P1|STARTED|Overall Study||47
392677|NCT00983385|939046|P1|NOT COMPLETED|Maintenance Period||23
392678|NCT00983385|939046|P1|COMPLETED|Maintenance Period||117
392679|NCT00983385|939046|P1|STARTED|Maintenance Period||140
392680|NCT00983385|939046|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
392681|NCT00983385|939046|P1|COMPLETED|Titration and Optimal Dose Period||140
392682|NCT00983385|939046|P1|STARTED|Titration and Optimal Dose Period||176
392683|NCT00983385|939046|P1|NOT COMPLETED|Observation Period||32
392684|NCT00983385|939046|P1|COMPLETED|Observation Period||176
392685|NCT00983385|939046|P1|STARTED|Observation Period||208
392686|NCT00983372|939091|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
392687|NCT00983372|939091|P1|COMPLETED|Colchicine With Diltiazem ER||20
392688|NCT00983372|939091|P1|STARTED|Colchicine With Diltiazem ER||20
392689|NCT00983372|939091|P1|NOT COMPLETED|Diltiazem ER Alone||3
392690|NCT00983372|939091|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
392691|NCT00983372|939091|P1|STARTED|Diltiazem ER Alone||23
392692|NCT00983372|939091|P1|NOT COMPLETED|14 Day Washout Period||1
392693|NCT00983372|939091|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
392694|NCT00983372|939091|P1|STARTED|14 Day Washout Period||24
392695|NCT00983372|939091|P1|NOT COMPLETED|Colchicine Alone||0
392696|NCT00983372|939091|P1|COMPLETED|Colchicine Alone||24
392697|NCT00983372|939091|P1|STARTED|Colchicine Alone||24
392698|NCT00983359|939102|P1|NOT COMPLETED|Overall Study||1
392699|NCT00983359|939102|P1|COMPLETED|Overall Study||39
392700|NCT00983359|939102|P1|Not Eligible for Analysis|Overall Study||1
392701|NCT00983359|939102|P1|STARTED|Overall Study||40
392702|NCT00983346|939110|P1|NOT COMPLETED|Overall Study||0
392703|NCT00983346|939110|P1|COMPLETED|Overall Study||17
392704|NCT00983346|939110|P1|STARTED|Overall Study||17
392705|NCT00983294|939114|P1|NOT COMPLETED|Colchicine With Azithromycin||1
392706|NCT00983294|939114|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
392707|NCT00983294|939114|P1|STARTED|Colchicine With Azithromycin||22
392708|NCT00983294|939114|P1|NOT COMPLETED|Azithromycin Alone||0
392709|NCT00983294|939114|P1|COMPLETED|Azithromycin Alone||22
392710|NCT00983294|939114|P1|STARTED|Azithromycin Alone||22
392711|NCT00983294|939114|P1|NOT COMPLETED|14 Day Washout Period||2
392712|NCT00983294|939114|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
392713|NCT00983294|939114|P1|STARTED|14 Day Washout Period||24
392714|NCT00983294|939114|P1|NOT COMPLETED|Colchicine Alone||0
392715|NCT00983294|939114|P1|COMPLETED|Colchicine Alone||24
392716|NCT00983294|939114|P1|STARTED|Colchicine Alone||24
392717|NCT00983281|939127|P2|NOT COMPLETED|Overall Study||0
392718|NCT00983281|939128|P1|NOT COMPLETED|Overall Study||0
392719|NCT00983281|939127|P2|COMPLETED|Overall Study||909
392720|NCT00983281|939128|P1|COMPLETED|Overall Study||805
392721|NCT00983281|939127|P2|STARTED|Overall Study||909
392722|NCT00983281|939128|P1|STARTED|Overall Study||805
392723|NCT00983242|939134|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
392725|NCT00983242|939134|P1|STARTED|Colchicine With Verapamil HCl ER||24
392726|NCT00983242|939134|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
392727|NCT00983242|939134|P1|COMPLETED|Verapamil HCl ER Alone||24
392728|NCT00983242|939134|P1|STARTED|Verapamil HCl ER Alone||24
392729|NCT00983242|939134|P1|NOT COMPLETED|14 Day Washout Period||0
392730|NCT00983242|939134|P1|COMPLETED|14 Day Washout Period||24
392731|NCT00983242|939134|P1|STARTED|14 Day Washout Period||24
392732|NCT00983242|939134|P1|NOT COMPLETED|Colchicine Alone||0
392733|NCT00983242|939134|P1|COMPLETED|Colchicine Alone||24
392734|NCT00983242|939134|P1|STARTED|Colchicine Alone||24
392735|NCT00983216|939145|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
392736|NCT00983216|939145|P1|COMPLETED|Colchicine With Ketoconazole||24
392737|NCT00983216|939145|P1|STARTED|Colchicine With Ketoconazole||24
392738|NCT00983216|939145|P1|NOT COMPLETED|Ketoconazole Alone||0
392739|NCT00983216|939145|P1|COMPLETED|Ketoconazole Alone||24
392740|NCT00983216|939145|P1|STARTED|Ketoconazole Alone||24
392741|NCT00983216|939145|P1|NOT COMPLETED|14 Day Washout Period||0
392742|NCT00983216|939145|P1|COMPLETED|14 Day Washout Period||24
392743|NCT00983216|939145|P1|STARTED|14 Day Washout Period||24
392744|NCT00983216|939145|P1|NOT COMPLETED|Colchicine Alone||0
392745|NCT00983216|939145|P1|COMPLETED|Colchicine Alone||24
392746|NCT00983216|939145|P1|STARTED|Colchicine Alone||24
392747|NCT00983073|939156|P1|NOT COMPLETED|Maintenance Period||16
392748|NCT00983073|939156|P1|COMPLETED|Maintenance Period||144
392749|NCT00983073|939156|P1|STARTED|Maintenance Period||160
392750|NCT00983073|939156|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
392751|NCT00983073|939156|P1|COMPLETED|Titration and Optimal Dose Period||160
392752|NCT00983073|939156|P1|STARTED|Titration and Optimal Dose Period||200
392753|NCT00983073|939156|P1|NOT COMPLETED|Observation Period||24
392754|NCT00983073|939156|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
392755|NCT00983073|939156|P1|STARTED|Observation Period||224
392756|NCT00982995|939177|P1|NOT COMPLETED|Overall Study||0
392757|NCT00982995|939177|P1|COMPLETED|Overall Study||3
392758|NCT00982995|939177|P1|STARTED|Overall Study||3
392759|NCT00982735|939182|P1|NOT COMPLETED|Overall Study||230
392760|NCT00982735|939182|P1|COMPLETED|Overall Study||757
392761|NCT00982735|939182|P1|STARTED|Overall Study||987
392762|NCT00982657|939192|P4|NOT COMPLETED|Overall Study||9
392763|NCT00982657|939193|P3|NOT COMPLETED|Overall Study||2
392764|NCT00982657|939194|P2|NOT COMPLETED|Overall Study||0
392765|NCT00982657|939195|P1|NOT COMPLETED|Overall Study||1
392766|NCT00982657|939192|P4|COMPLETED|Overall Study||7
392767|NCT00982657|939193|P3|COMPLETED|Overall Study||1
392768|NCT00982657|939194|P2|COMPLETED|Overall Study||3
392769|NCT00982657|939195|P1|COMPLETED|Overall Study||11
392770|NCT00982657|939192|P4|STARTED|Overall Study||16
392771|NCT00982657|939193|P3|STARTED|Overall Study||3
392772|NCT00982657|939194|P2|STARTED|Overall Study||3
392773|NCT00982657|939195|P1|STARTED|Overall Study||12
392774|NCT00982644|939236|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
392775|NCT00982644|939237|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
392776|NCT00982644|939236|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
392777|NCT00982644|939237|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
392778|NCT00982644|939236|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
392779|NCT00982644|939237|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
392780|NCT00982644|939236|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
392781|NCT00982644|939237|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
392782|NCT00982644|939236|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
392783|NCT00982644|939237|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
392784|NCT00982644|939236|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
392785|NCT00982644|939237|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
392786|NCT00982644|939236|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
392787|NCT00982644|939237|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
392788|NCT00982644|939236|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
392789|NCT00982644|939237|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
392790|NCT00982592|939261|P2|NOT COMPLETED|Overall Study||33
392791|NCT00982592|939262|P1|NOT COMPLETED|Overall Study||31
392792|NCT00982592|939261|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
392793|NCT00982592|939262|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
392794|NCT00982592|939261|P2|Treatment Received|Overall Study||52
392795|NCT00982592|939262|P1|Treatment Received|Overall Study||63
392796|NCT00982592|939261|P2|STARTED|Overall Study||60
392797|NCT00982592|939262|P1|STARTED|Overall Study||64
392798|NCT00982553|939276|P1|NOT COMPLETED|Overall Study||0
392799|NCT00982553|939276|P1|COMPLETED|Overall Study||14
392800|NCT00982553|939276|P1|STARTED|Overall Study||14
392801|NCT00982488|939288|P5|NOT COMPLETED|Overall Study||1
392802|NCT00982488|939289|P4|NOT COMPLETED|Overall Study||3
392803|NCT00982488|939290|P3|NOT COMPLETED|Overall Study||34
392804|NCT00982488|939291|P2|NOT COMPLETED|Overall Study||14
392805|NCT00982488|939292|P1|NOT COMPLETED|Overall Study||185
392806|NCT00982488|939288|P5|COMPLETED|Overall Study|Still receiving treatment|0
392807|NCT00982488|939289|P4|COMPLETED|Overall Study|Still receiving treatment|0
392808|NCT00982488|939290|P3|COMPLETED|Overall Study|Still receiving treatment|0
392809|NCT00982488|939291|P2|COMPLETED|Overall Study|Still receiving treatment|0
392810|NCT00982488|939292|P1|COMPLETED|Overall Study|Still receiving treatment|0
392811|NCT00982488|939288|P5|STARTED|Overall Study|Received treatment|1
392812|NCT00982488|939289|P4|STARTED|Overall Study|Received treatment|3
392813|NCT00982488|939290|P3|STARTED|Overall Study|Received treatment|34
392814|NCT00982488|939291|P2|STARTED|Overall Study|Received treatment|14
392815|NCT00982488|939292|P1|STARTED|Overall Study|Received treatment|185
392816|NCT00982423|939306|P2|NOT COMPLETED|Overall Study||0
392817|NCT00982423|939307|P1|NOT COMPLETED|Overall Study||0
392818|NCT00982423|939306|P2|COMPLETED|Overall Study||19
392819|NCT00982423|939307|P1|COMPLETED|Overall Study||13
392820|NCT00982423|939306|P2|STARTED|Overall Study||19
392821|NCT00982423|939307|P1|STARTED|Overall Study||13
392822|NCT00982410|939325|P2|NOT COMPLETED|12-month Follow-up Assessment||9
392823|NCT00982410|939326|P1|NOT COMPLETED|12-month Follow-up Assessment||9
392824|NCT00982410|939325|P2|COMPLETED|12-month Follow-up Assessment||55
392825|NCT00982410|939326|P1|COMPLETED|12-month Follow-up Assessment||56
392826|NCT00982410|939325|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
392827|NCT00982410|939326|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
392828|NCT00982410|939325|P2|NOT COMPLETED|6-month Follow-up Assessment||11
392829|NCT00982410|939326|P1|NOT COMPLETED|6-month Follow-up Assessment||6
392830|NCT00982410|939325|P2|COMPLETED|6-month Follow-up Assessment||53
392831|NCT00982410|939326|P1|COMPLETED|6-month Follow-up Assessment||59
392832|NCT00982410|939325|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
392833|NCT00982410|939326|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
392834|NCT00982410|939325|P2|NOT COMPLETED|3-month Follow-up Assessment||13
392835|NCT00982410|939326|P1|NOT COMPLETED|3-month Follow-up Assessment||9
392836|NCT00982410|939325|P2|COMPLETED|3-month Follow-up Assessment||53
392837|NCT00982410|939326|P1|COMPLETED|3-month Follow-up Assessment||56
392838|NCT00982410|939325|P2|STARTED|3-month Follow-up Assessment||66
392839|NCT00982410|939326|P1|STARTED|3-month Follow-up Assessment||65
392840|NCT00982345|939348|P1|NOT COMPLETED|Overall Study||2
392841|NCT00982345|939348|P1|COMPLETED|Overall Study||18
392842|NCT00982345|939348|P1|STARTED|Overall Study||20
392843|NCT00982280|939352|P1|NOT COMPLETED|Maintenance Period||1
392844|NCT00982280|939352|P1|COMPLETED|Maintenance Period||54
392845|NCT00982280|939352|P1|STARTED|Maintenance Period||55
392846|NCT00982280|939352|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
392847|NCT00982280|939352|P1|COMPLETED|Titration and Optimal Dose Period||55
392848|NCT00982280|939352|P1|STARTED|Titration and Optimal Dose Period||63
392849|NCT00982280|939352|P1|NOT COMPLETED|Observation Period||19
392850|NCT00982280|939352|P1|COMPLETED|Observation Period||63
392851|NCT00982280|939352|P1|STARTED|Observation Period||82
392852|NCT00982228|939377|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
392853|NCT00982228|939378|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
392854|NCT00982228|939377|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
392855|NCT00982228|939378|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
392856|NCT00982228|939377|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
392857|NCT00982228|939378|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
392858|NCT00982228|939377|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
392859|NCT00982228|939378|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
392860|NCT00982228|939377|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
392861|NCT00982228|939378|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
392862|NCT00982228|939377|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
392863|NCT00982228|939378|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
392864|NCT00982228|939377|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
392865|NCT00982228|939378|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
392866|NCT00982228|939377|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
392867|NCT00982228|939378|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
392868|NCT00982189|939406|P4|NOT COMPLETED|Overall Study||0
392869|NCT00982189|939407|P3|NOT COMPLETED|Overall Study||0
392870|NCT00982189|939408|P2|NOT COMPLETED|Overall Study||0
392871|NCT00982189|939409|P1|NOT COMPLETED|Overall Study||0
392872|NCT00982189|939406|P4|COMPLETED|Overall Study||9
392873|NCT00982189|939407|P3|COMPLETED|Overall Study||9
392874|NCT00982189|939408|P2|COMPLETED|Overall Study||9
392875|NCT00982189|939409|P1|COMPLETED|Overall Study||10
392876|NCT00982189|939406|P4|STARTED|Overall Study||9
392877|NCT00982189|939407|P3|STARTED|Overall Study||9
392878|NCT00982189|939408|P2|STARTED|Overall Study||9
392879|NCT00982189|939409|P1|STARTED|Overall Study||10
392880|NCT00982137|939431|P4|NOT COMPLETED|Overall Study||1
392881|NCT00982137|939432|P3|NOT COMPLETED|Overall Study||0
392882|NCT00982137|939433|P2|NOT COMPLETED|Overall Study||1
392883|NCT00982137|939434|P1|NOT COMPLETED|Overall Study||0
392884|NCT00982137|939431|P4|COMPLETED|Overall Study||17
392885|NCT00982137|939432|P3|COMPLETED|Overall Study||18
392886|NCT00982137|939433|P2|COMPLETED|Overall Study||35
392887|NCT00982137|939434|P1|COMPLETED|Overall Study||36
392888|NCT00982137|939431|P4|STARTED|Overall Study||18
392889|NCT00982137|939432|P3|STARTED|Overall Study||18
392890|NCT00982137|939433|P2|STARTED|Overall Study||36
392891|NCT00982137|939434|P1|STARTED|Overall Study||36
392892|NCT00982111|939466|P2|NOT COMPLETED|Overall Study||66
392893|NCT00982111|939467|P1|NOT COMPLETED|Overall Study||75
392894|NCT00982111|939466|P2|COMPLETED|Overall Study||252
392895|NCT00982111|939467|P1|COMPLETED|Overall Study||240
392896|NCT00982111|939466|P2|On Study at Conclusion, Off Treatment|Overall Study||6
392897|NCT00982111|939467|P1|On Study at Conclusion, Off Treatment|Overall Study||4
392898|NCT00982111|939466|P2|Death Due to Any Cause|Overall Study||246
392899|NCT00982111|939467|P1|Death Due to Any Cause|Overall Study||236
392900|NCT00982111|939466|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
392901|NCT00982111|939467|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
392902|NCT00982111|939466|P2|STARTED|Overall Study||318
392903|NCT00982111|939467|P1|STARTED|Overall Study||315
392904|NCT00982033|939491|P2|NOT COMPLETED|Overall Study||0
392905|NCT00982033|939492|P1|NOT COMPLETED|Overall Study||0
392906|NCT00982033|939491|P2|COMPLETED|Overall Study||27
392907|NCT00982033|939492|P1|COMPLETED|Overall Study||25
392908|NCT00982033|939491|P2|STARTED|Overall Study||27
392909|NCT00982033|939492|P1|STARTED|Overall Study||25
392910|NCT00982020|939500|P2|NOT COMPLETED|Overall Study||64
392911|NCT00982020|939501|P1|NOT COMPLETED|Overall Study||57
392912|NCT00982020|939500|P2|COMPLETED|Overall Study||37
392913|NCT00982020|939501|P1|COMPLETED|Overall Study||45
392914|NCT00982020|939500|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
392915|NCT00982020|939501|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
392916|NCT00982020|939500|P2|STARTED|Overall Study||101
392917|NCT00982020|939501|P1|STARTED|Overall Study||102
392918|NCT00982007|939525|P4|NOT COMPLETED|Overall Study||6
392919|NCT00982007|939526|P3|NOT COMPLETED|Overall Study||0
392920|NCT00982007|939527|P2|NOT COMPLETED|Overall Study||4
392921|NCT00982007|939528|P1|NOT COMPLETED|Overall Study||4
392922|NCT00982007|939525|P4|COMPLETED|Overall Study||245
392923|NCT00982007|939526|P3|COMPLETED|Overall Study||253
392924|NCT00982007|939527|P2|COMPLETED|Overall Study||253
392925|NCT00982007|939528|P1|COMPLETED|Overall Study||246
392926|NCT00982007|939525|P4|STARTED|Overall Study||251
392927|NCT00982007|939526|P3|STARTED|Overall Study||253
392928|NCT00982007|939527|P2|STARTED|Overall Study||257
392929|NCT00982007|939528|P1|STARTED|Overall Study||250
392930|NCT00981825|939540|P2|NOT COMPLETED|Second Intervention||0
392931|NCT00981825|939541|P1|NOT COMPLETED|Second Intervention||0
392932|NCT00981825|939540|P2|COMPLETED|Second Intervention||11
392933|NCT00981825|939541|P1|COMPLETED|Second Intervention||11
392934|NCT00981825|939540|P2|STARTED|Second Intervention||11
392935|NCT00981825|939541|P1|STARTED|Second Intervention||11
392936|NCT00981825|939540|P2|NOT COMPLETED|Washout After 1st Intervention||0
392937|NCT00981825|939541|P1|NOT COMPLETED|Washout After 1st Intervention||0
392938|NCT00981825|939540|P2|COMPLETED|Washout After 1st Intervention||11
392939|NCT00981825|939541|P1|COMPLETED|Washout After 1st Intervention||11
392940|NCT00981825|939540|P2|STARTED|Washout After 1st Intervention||11
392941|NCT00981825|939541|P1|STARTED|Washout After 1st Intervention||11
392942|NCT00981825|939540|P2|NOT COMPLETED|First Intervention||0
392943|NCT00981825|939541|P1|NOT COMPLETED|First Intervention||0
392944|NCT00981825|939540|P2|COMPLETED|First Intervention||11
392945|NCT00981825|939541|P1|COMPLETED|First Intervention||11
392946|NCT00981825|939540|P2|STARTED|First Intervention||11
392947|NCT00981825|939541|P1|STARTED|First Intervention||11
392948|NCT00981812|939547|P1|NOT COMPLETED|Overall Study||0
392949|NCT00981812|939547|P1|COMPLETED|Overall Study||20
392950|NCT00981812|939547|P1|STARTED|Overall Study||20
392951|NCT00981669|939553|P2|NOT COMPLETED|Overall Study||0
392952|NCT00981669|939554|P1|NOT COMPLETED|Overall Study||1
392953|NCT00981669|939553|P2|COMPLETED|Overall Study||40
392954|NCT00981669|939554|P1|COMPLETED|Overall Study||39
392955|NCT00981669|939553|P2|STARTED|Overall Study||40
392956|NCT00981669|939554|P1|STARTED|Overall Study||40
392957|NCT00981630|939566|P4|NOT COMPLETED|Overall Study||0
392958|NCT00981630|939567|P3|NOT COMPLETED|Overall Study||0
392959|NCT00981630|939568|P2|NOT COMPLETED|Overall Study||0
392960|NCT00981630|939569|P1|NOT COMPLETED|Overall Study||0
392961|NCT00981630|939566|P4|COMPLETED|Overall Study||32
392962|NCT00981630|939567|P3|COMPLETED|Overall Study||32
392963|NCT00981630|939568|P2|COMPLETED|Overall Study||32
392964|NCT00981630|939569|P1|COMPLETED|Overall Study||32
392965|NCT00981630|939566|P4|STARTED|Overall Study||32
392966|NCT00981630|939567|P3|STARTED|Overall Study||32
392967|NCT00981630|939568|P2|STARTED|Overall Study||32
392968|NCT00981630|939569|P1|STARTED|Overall Study||32
392969|NCT00981461|939601|P2|NOT COMPLETED|Overall Study||2
392970|NCT00981461|939602|P1|NOT COMPLETED|Overall Study||5
392971|NCT00981461|939601|P2|COMPLETED|Overall Study||22
392972|NCT00981461|939602|P1|COMPLETED|Overall Study||43
392973|NCT00981461|939601|P2|STARTED|Overall Study||24
392974|NCT00981461|939602|P1|STARTED|Overall Study||48
392975|NCT00981435|939611|P3|NOT COMPLETED|Overall Study||0
392976|NCT00981435|939612|P2|NOT COMPLETED|Overall Study||0
392977|NCT00981435|939613|P1|NOT COMPLETED|Overall Study||0
392978|NCT00981435|939611|P3|COMPLETED|Overall Study||37
392979|NCT00981435|939612|P2|COMPLETED|Overall Study||29
392980|NCT00981435|939613|P1|COMPLETED|Overall Study||31
392981|NCT00981435|939611|P3|STARTED|Overall Study||37
392982|NCT00981435|939612|P2|STARTED|Overall Study||29
392983|NCT00981435|939613|P1|STARTED|Overall Study||31
392984|NCT00981409|939626|P2|NOT COMPLETED|Overall Study||1
392985|NCT00981409|939627|P1|NOT COMPLETED|Overall Study||6
392986|NCT00981409|939626|P2|COMPLETED|Overall Study||10
392987|NCT00981409|939627|P1|COMPLETED|Overall Study||24
392988|NCT00981409|939626|P2|STARTED|Overall Study||11
392989|NCT00981409|939627|P1|STARTED|Overall Study||30
392990|NCT00981370|939641|P1|NOT COMPLETED|Overall Study||0
392991|NCT00981370|939641|P1|COMPLETED|Overall Study||0
392992|NCT00981370|939641|P1|STARTED|Overall Study||0
392993|NCT00981305|939647|P2|NOT COMPLETED|Overall Study||10
392994|NCT00981305|939648|P1|NOT COMPLETED|Overall Study||19
392995|NCT00981305|939647|P2|COMPLETED|Overall Study||57
392996|NCT00981305|939648|P1|COMPLETED|Overall Study||50
392997|NCT00981305|939647|P2|STARTED|Overall Study||67
392998|NCT00981305|939648|P1|STARTED|Overall Study||69
392999|NCT00981292|939666|P6|NOT COMPLETED|Day 3||1
393000|NCT00981292|939667|P5|NOT COMPLETED|Day 3||0
393001|NCT00981292|939668|P4|NOT COMPLETED|Day 3||0
393002|NCT00981292|939669|P3|NOT COMPLETED|Day 3||0
393003|NCT00981292|939670|P2|NOT COMPLETED|Day 3||0
393004|NCT00981292|939671|P1|NOT COMPLETED|Day 3||0
393005|NCT00981292|939666|P6|COMPLETED|Day 3||4
393006|NCT00981292|939667|P5|COMPLETED|Day 3||4
393007|NCT00981292|939668|P4|COMPLETED|Day 3||4
393008|NCT00981292|939669|P3|COMPLETED|Day 3||6
393009|NCT00981292|939670|P2|COMPLETED|Day 3||4
393010|NCT00981292|939671|P1|COMPLETED|Day 3||4
393011|NCT00981292|939666|P6|STARTED|Day 3||5
393012|NCT00981292|939667|P5|STARTED|Day 3||4
393013|NCT00981292|939668|P4|STARTED|Day 3||4
393014|NCT00981292|939669|P3|STARTED|Day 3||6
393015|NCT00981292|939670|P2|STARTED|Day 3||4
393016|NCT00981292|939671|P1|STARTED|Day 3||4
393017|NCT00981292|939666|P6|NOT COMPLETED|Day 2||0
393018|NCT00981292|939667|P5|NOT COMPLETED|Day 2||0
393019|NCT00981292|939668|P4|NOT COMPLETED|Day 2||0
393020|NCT00981292|939669|P3|NOT COMPLETED|Day 2||0
393021|NCT00981292|939670|P2|NOT COMPLETED|Day 2||0
393022|NCT00981292|939671|P1|NOT COMPLETED|Day 2||2
393023|NCT00981292|939666|P6|COMPLETED|Day 2||5
393024|NCT00981292|939667|P5|COMPLETED|Day 2||4
393025|NCT00981292|939668|P4|COMPLETED|Day 2||4
393026|NCT00981292|939669|P3|COMPLETED|Day 2||6
393027|NCT00981292|939670|P2|COMPLETED|Day 2||4
393028|NCT00981292|939671|P1|COMPLETED|Day 2||4
393029|NCT00981292|939666|P6|STARTED|Day 2||5
393030|NCT00981292|939667|P5|STARTED|Day 2||4
393031|NCT00981292|939668|P4|STARTED|Day 2||4
393032|NCT00981292|939669|P3|STARTED|Day 2||6
393033|NCT00981292|939670|P2|STARTED|Day 2||4
393034|NCT00981292|939671|P1|STARTED|Day 2||6
393035|NCT00981292|939666|P6|NOT COMPLETED|Day 1||2
393036|NCT00981292|939667|P5|NOT COMPLETED|Day 1||0
393037|NCT00981292|939668|P4|NOT COMPLETED|Day 1||0
393038|NCT00981292|939669|P3|NOT COMPLETED|Day 1||0
393039|NCT00981292|939670|P2|NOT COMPLETED|Day 1||0
393040|NCT00981292|939671|P1|NOT COMPLETED|Day 1||1
393041|NCT00981292|939666|P6|COMPLETED|Day 1||5
393042|NCT00981292|939667|P5|COMPLETED|Day 1||4
393043|NCT00981292|939668|P4|COMPLETED|Day 1||4
393044|NCT00981292|939669|P3|COMPLETED|Day 1||6
393045|NCT00981292|939670|P2|COMPLETED|Day 1||4
393046|NCT00981292|939671|P1|COMPLETED|Day 1||6
393047|NCT00981292|939666|P6|STARTED|Day 1||7
393048|NCT00981292|939667|P5|STARTED|Day 1||4
393049|NCT00981292|939668|P4|STARTED|Day 1||4
393050|NCT00981292|939669|P3|STARTED|Day 1||6
393051|NCT00981292|939670|P2|STARTED|Day 1||4
393052|NCT00981292|939671|P1|STARTED|Day 1||7
393053|NCT00981227|939694|P6|NOT COMPLETED|Overall Study||18
393054|NCT00981227|939695|P5|NOT COMPLETED|Overall Study||30
393055|NCT00981227|939696|P4|NOT COMPLETED|Overall Study||21
393056|NCT00981227|939697|P3|NOT COMPLETED|Overall Study||21
393057|NCT00981227|939698|P2|NOT COMPLETED|Overall Study||19
393058|NCT00981227|939699|P1|NOT COMPLETED|Overall Study||22
393059|NCT00981227|939694|P6|COMPLETED|Overall Study||75
393060|NCT00981227|939695|P5|COMPLETED|Overall Study||60
393061|NCT00981227|939696|P4|COMPLETED|Overall Study||73
393062|NCT00981227|939697|P3|COMPLETED|Overall Study||73
393063|NCT00981227|939698|P2|COMPLETED|Overall Study||75
393064|NCT00981227|939699|P1|COMPLETED|Overall Study||80
393065|NCT00981227|939694|P6|Per–Protocol|Overall Study||70
393066|NCT00981227|939695|P5|Per–Protocol|Overall Study||50
393067|NCT00981227|939696|P4|Per–Protocol|Overall Study||68
393068|NCT00981227|939697|P3|Per–Protocol|Overall Study||67
393069|NCT00981227|939698|P2|Per–Protocol|Overall Study||72
393070|NCT00981227|939699|P1|Per–Protocol|Overall Study||69
393071|NCT00981227|939694|P6|Safety Population|Overall Study||93
393072|NCT00981227|939695|P5|Safety Population|Overall Study||90
393073|NCT00981227|939696|P4|Safety Population|Overall Study||94
393074|NCT00981227|939697|P3|Safety Population|Overall Study||94
393075|NCT00981227|939698|P2|Safety Population|Overall Study||94
393076|NCT00981227|939699|P1|Safety Population|Overall Study||102
393077|NCT00981227|939694|P6|Randomized|Overall Study||93
393078|NCT00981227|939695|P5|Randomized|Overall Study||90
393079|NCT00981227|939696|P4|Randomized|Overall Study||94
393080|NCT00981227|939697|P3|Randomized|Overall Study||94
393081|NCT00981227|939698|P2|Randomized|Overall Study||94
393082|NCT00981227|939699|P1|Randomized|Overall Study||102
393083|NCT00981227|939694|P6|STARTED|Overall Study||93
393084|NCT00981227|939695|P5|STARTED|Overall Study||90
393085|NCT00981227|939696|P4|STARTED|Overall Study||94
393086|NCT00981227|939697|P3|STARTED|Overall Study||94
393087|NCT00981227|939698|P2|STARTED|Overall Study||94
393088|NCT00981227|939699|P1|STARTED|Overall Study||102
393089|NCT00981214|939717|P1|NOT COMPLETED|Overall Study||0
393090|NCT00981214|939717|P1|COMPLETED|Overall Study||19
393091|NCT00981214|939717|P1|STARTED|Overall Study||19
393092|NCT00981175|939734|P2|NOT COMPLETED|Booster Dose Vaccination||3
393093|NCT00981175|939735|P1|NOT COMPLETED|Booster Dose Vaccination||2
393094|NCT00981175|939734|P2|COMPLETED|Booster Dose Vaccination||40
393095|NCT00981175|939735|P1|COMPLETED|Booster Dose Vaccination||53
393096|NCT00981175|939734|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
393097|NCT00981175|939735|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
393098|NCT00981175|939734|P2|NOT COMPLETED|Primary Dose Vaccination||2
393099|NCT00981175|939735|P1|NOT COMPLETED|Primary Dose Vaccination||3
393100|NCT00981175|939734|P2|COMPLETED|Primary Dose Vaccination||99
393101|NCT00981175|939735|P1|COMPLETED|Primary Dose Vaccination||98
393102|NCT00981175|939734|P2|STARTED|Primary Dose Vaccination||101
393103|NCT00981175|939735|P1|STARTED|Primary Dose Vaccination||101
393104|NCT00981084|939760|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
393105|NCT00981084|939761|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
393106|NCT00981084|939760|P2|COMPLETED|Post Intervention (Data Analysis)||16
393107|NCT00981084|939761|P1|COMPLETED|Post Intervention (Data Analysis)||14
393108|NCT00981084|939760|P2|STARTED|Post Intervention (Data Analysis)||17
393109|NCT00981084|939761|P1|STARTED|Post Intervention (Data Analysis)||16
393110|NCT00981084|939760|P2|NOT COMPLETED|Second Intervention (One Day)||0
393111|NCT00981084|939761|P1|NOT COMPLETED|Second Intervention (One Day)||0
393112|NCT00981084|939760|P2|COMPLETED|Second Intervention (One Day)||17
393113|NCT00981084|939761|P1|COMPLETED|Second Intervention (One Day)||16
393114|NCT00981084|939760|P2|STARTED|Second Intervention (One Day)||17
393115|NCT00981084|939761|P1|STARTED|Second Intervention (One Day)||16
393116|NCT00981084|939760|P2|NOT COMPLETED|Washout Period (7 Days)||0
393117|NCT00981084|939761|P1|NOT COMPLETED|Washout Period (7 Days)||0
393118|NCT00981084|939760|P2|COMPLETED|Washout Period (7 Days)||17
393119|NCT00981084|939761|P1|COMPLETED|Washout Period (7 Days)||16
393120|NCT00981084|939760|P2|STARTED|Washout Period (7 Days)||17
393121|NCT00981084|939761|P1|STARTED|Washout Period (7 Days)||16
393122|NCT00981084|939760|P2|NOT COMPLETED|First Intervention (One Day)||0
393123|NCT00981084|939761|P1|NOT COMPLETED|First Intervention (One Day)||0
393124|NCT00981084|939760|P2|COMPLETED|First Intervention (One Day)||17
393125|NCT00981084|939761|P1|COMPLETED|First Intervention (One Day)||16
393126|NCT00981084|939760|P2|STARTED|First Intervention (One Day)||17
393127|NCT00981084|939761|P1|STARTED|First Intervention (One Day)||16
393128|NCT00981058|939777|P2|NOT COMPLETED|Overall Study||97
393129|NCT00981058|939778|P1|NOT COMPLETED|Overall Study||120
393130|NCT00981058|939777|P2|COMPLETED|Overall Study||451
393131|NCT00981058|939778|P1|COMPLETED|Overall Study||425
393132|NCT00981058|939777|P2|Death Due to Any Cause|Overall Study||442
393133|NCT00981058|939778|P1|Death Due to Any Cause|Overall Study||418
393134|NCT00981058|939777|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
393135|NCT00981058|939778|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
393136|NCT00981058|939777|P2|STARTED|Overall Study||548
393137|NCT00981058|939778|P1|STARTED|Overall Study||545
393138|NCT00981045|939800|P2|NOT COMPLETED|Overall Study||9
393139|NCT00981045|939801|P1|NOT COMPLETED|Overall Study||14
393140|NCT00981045|939800|P2|COMPLETED|Overall Study||1285
393141|NCT00981045|939801|P1|COMPLETED|Overall Study||1276
393142|NCT00981045|939800|P2|STARTED|Overall Study||1294
393143|NCT00981045|939801|P1|STARTED|Overall Study||1290
393144|NCT00981019|939809|P1|NOT COMPLETED|Overall Study||477
393145|NCT00981019|939809|P1|COMPLETED|Overall Study||301
393146|NCT00981019|939809|P1|STARTED|Overall Study||778
393147|NCT00980980|939816|P3|NOT COMPLETED|Overall Study||0
393148|NCT00980980|939817|P2|NOT COMPLETED|Overall Study||1
393149|NCT00980980|939818|P1|NOT COMPLETED|Overall Study||0
393150|NCT00980980|939816|P3|COMPLETED|Overall Study||13
393151|NCT00980980|939817|P2|COMPLETED|Overall Study||13
393152|NCT00980980|939818|P1|COMPLETED|Overall Study||16
393153|NCT00980980|939816|P3|STARTED|Overall Study||13
393154|NCT00980980|939817|P2|STARTED|Overall Study||14
393155|NCT00980980|939818|P1|STARTED|Overall Study||16
393156|NCT00980798|939849|P2|NOT COMPLETED|Overall Study||55
393157|NCT00980798|939850|P1|NOT COMPLETED|Overall Study||33
393158|NCT00980798|939849|P2|COMPLETED|Overall Study||84
393159|NCT00980798|939850|P1|COMPLETED|Overall Study||116
393160|NCT00980798|939849|P2|STARTED|Overall Study||139
393161|NCT00980798|939850|P1|STARTED|Overall Study||149
393162|NCT00980746|939864|P6|NOT COMPLETED|Overall Study||18
393163|NCT00980746|939865|P5|NOT COMPLETED|Overall Study||17
393164|NCT00980746|939866|P4|NOT COMPLETED|Overall Study||36
393165|NCT00980746|939867|P3|NOT COMPLETED|Overall Study||20
393166|NCT00980746|939868|P2|NOT COMPLETED|Overall Study||22
393167|NCT00980746|939869|P1|NOT COMPLETED|Overall Study||27
393168|NCT00980746|939864|P6|COMPLETED|Overall Study||78
393169|NCT00980746|939865|P5|COMPLETED|Overall Study||75
393170|NCT00980746|939866|P4|COMPLETED|Overall Study||64
393171|NCT00980746|939867|P3|COMPLETED|Overall Study||75
393172|NCT00980746|939868|P2|COMPLETED|Overall Study||67
393173|NCT00980746|939869|P1|COMPLETED|Overall Study||58
393174|NCT00980746|939864|P6|Per-protocol|Overall Study||74
393175|NCT00980746|939865|P5|Per-protocol|Overall Study||73
393176|NCT00980746|939866|P4|Per-protocol|Overall Study||62
393177|NCT00980746|939867|P3|Per-protocol|Overall Study||73
393178|NCT00980746|939868|P2|Per-protocol|Overall Study||66
393179|NCT00980746|939869|P1|Per-protocol|Overall Study||55
393180|NCT00980746|939864|P6|Safety Population|Overall Study||96
393181|NCT00980746|939865|P5|Safety Population|Overall Study||92
393182|NCT00980746|939866|P4|Safety Population|Overall Study||100
393183|NCT00980746|939867|P3|Safety Population|Overall Study||95
393184|NCT00980746|939868|P2|Safety Population|Overall Study||89
393185|NCT00980746|939869|P1|Safety Population|Overall Study||85
393186|NCT00980746|939864|P6|Randomized|Overall Study||96
393187|NCT00980746|939865|P5|Randomized|Overall Study||92
393188|NCT00980746|939866|P4|Randomized|Overall Study||100
393189|NCT00980746|939867|P3|Randomized|Overall Study||95
393190|NCT00980746|939868|P2|Randomized|Overall Study||89
393191|NCT00980746|939869|P1|Randomized|Overall Study||85
393192|NCT00980746|939864|P6|STARTED|Overall Study||96
393193|NCT00980746|939865|P5|STARTED|Overall Study||92
393194|NCT00980746|939866|P4|STARTED|Overall Study||100
393195|NCT00980746|939867|P3|STARTED|Overall Study||95
393196|NCT00980746|939868|P2|STARTED|Overall Study||89
393197|NCT00980746|939869|P1|STARTED|Overall Study||85
393198|NCT00980681|939883|P1|NOT COMPLETED|Dotarem MRA||0
393199|NCT00980681|939883|P1|COMPLETED|Dotarem MRA||10
393200|NCT00980681|939883|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
393201|NCT00980681|939883|P1|NOT COMPLETED|TOF MRA||0
393202|NCT00980681|939883|P1|COMPLETED|TOF MRA||10
393203|NCT00980681|939883|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
393204|NCT00980655|939891|P2|NOT COMPLETED|Overall Study||51
393205|NCT00980655|939892|P1|NOT COMPLETED|Overall Study||16
393206|NCT00980655|939891|P2|COMPLETED|Overall Study||139
393207|NCT00980655|939892|P1|COMPLETED|Overall Study||45
393208|NCT00980655|939891|P2|Vaccinated 23vPS Dose|Overall Study||140
393209|NCT00980655|939892|P1|Vaccinated 23vPS Dose|Overall Study||45
393210|NCT00980655|939891|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
393211|NCT00980655|939892|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
393212|NCT00980655|939891|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
393213|NCT00980655|939892|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
393214|NCT00980655|939891|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
393215|NCT00980655|939892|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
393216|NCT00980655|939891|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
393217|NCT00980655|939892|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
393218|NCT00980655|939891|P2|STARTED|Overall Study||190
393219|NCT00980655|939892|P1|STARTED|Overall Study||61
393220|NCT00980642|939940|P2|NOT COMPLETED|Overall Study||0
393221|NCT00980642|939941|P1|NOT COMPLETED|Overall Study||0
393222|NCT00980642|939940|P2|COMPLETED|Overall Study||20
393223|NCT00980642|939941|P1|COMPLETED|Overall Study||36
393224|NCT00980642|939940|P2|STARTED|Overall Study||20
393225|NCT00980642|939941|P1|STARTED|Overall Study||36
393226|NCT00980590|939953|P2|NOT COMPLETED|Overall Study||0
393227|NCT00980590|939954|P1|NOT COMPLETED|Overall Study||0
393228|NCT00980590|939953|P2|COMPLETED|Overall Study||50
393229|NCT00980590|939954|P1|COMPLETED|Overall Study||50
393230|NCT00980590|939953|P2|STARTED|Overall Study||50
393231|NCT00980590|939954|P1|STARTED|Overall Study||50
393232|NCT00980330|939973|P7|NOT COMPLETED|Overall Study||7
393233|NCT00980330|939974|P6|NOT COMPLETED|Overall Study||4
393234|NCT00980330|939975|P5|NOT COMPLETED|Overall Study||5
393235|NCT00980330|939976|P4|NOT COMPLETED|Overall Study||5
393236|NCT00980330|939977|P3|NOT COMPLETED|Overall Study||8
393237|NCT00980330|939978|P2|NOT COMPLETED|Overall Study||5
393238|NCT00980330|939979|P1|NOT COMPLETED|Overall Study||5
393239|NCT00980330|939973|P7|COMPLETED|Overall Study||59
393240|NCT00980330|939974|P6|COMPLETED|Overall Study||61
393241|NCT00980330|939975|P5|COMPLETED|Overall Study||63
393242|NCT00980330|939976|P4|COMPLETED|Overall Study||61
393243|NCT00980330|939977|P3|COMPLETED|Overall Study||58
393244|NCT00980330|939978|P2|COMPLETED|Overall Study||60
393245|NCT00980330|939979|P1|COMPLETED|Overall Study||61
393246|NCT00980330|939973|P7|STARTED|Overall Study||66
393247|NCT00980330|939974|P6|STARTED|Overall Study||65
393248|NCT00980330|939975|P5|STARTED|Overall Study||68
393249|NCT00980330|939976|P4|STARTED|Overall Study||66
393250|NCT00980330|939977|P3|STARTED|Overall Study||66
393251|NCT00980330|939978|P2|STARTED|Overall Study||65
393252|NCT00980330|939979|P1|STARTED|Overall Study||66
393253|NCT00980278|940079|P2|NOT COMPLETED|Overall Study||0
393254|NCT00980278|940080|P1|NOT COMPLETED|Overall Study||2
393255|NCT00980278|940079|P2|COMPLETED|Overall Study||13
393256|NCT00980278|940080|P1|COMPLETED|Overall Study||11
393257|NCT00980278|940079|P2|STARTED|Overall Study||13
393258|NCT00980278|940080|P1|STARTED|Overall Study||13
393259|NCT00980200|940094|P5|NOT COMPLETED|7-day Treatment Period 5||0
393260|NCT00980200|940095|P4|NOT COMPLETED|7-day Treatment Period 5||0
393261|NCT00980200|940096|P3|NOT COMPLETED|7-day Treatment Period 5||0
393262|NCT00980200|940097|P2|NOT COMPLETED|7-day Treatment Period 5||0
393263|NCT00980200|940098|P1|NOT COMPLETED|7-day Treatment Period 5||0
393264|NCT00980200|940094|P5|COMPLETED|7-day Treatment Period 5||14
393265|NCT00980200|940095|P4|COMPLETED|7-day Treatment Period 5||16
393266|NCT00980200|940096|P3|COMPLETED|7-day Treatment Period 5||15
393267|NCT00980200|940097|P2|COMPLETED|7-day Treatment Period 5||12
393268|NCT00980200|940098|P1|COMPLETED|7-day Treatment Period 5||15
393269|NCT00980200|940094|P5|STARTED|7-day Treatment Period 5||14
393270|NCT00980200|940095|P4|STARTED|7-day Treatment Period 5||16
393271|NCT00980200|940096|P3|STARTED|7-day Treatment Period 5||15
393272|NCT00980200|940097|P2|STARTED|7-day Treatment Period 5||12
393273|NCT00980200|940098|P1|STARTED|7-day Treatment Period 5||15
393274|NCT00980200|940094|P5|NOT COMPLETED|7-day Washout Period 4||0
393275|NCT00980200|940095|P4|NOT COMPLETED|7-day Washout Period 4||0
393276|NCT00980200|940096|P3|NOT COMPLETED|7-day Washout Period 4||0
393277|NCT00980200|940097|P2|NOT COMPLETED|7-day Washout Period 4||0
393278|NCT00980200|940098|P1|NOT COMPLETED|7-day Washout Period 4||0
393279|NCT00980200|940094|P5|COMPLETED|7-day Washout Period 4||14
393280|NCT00980200|940095|P4|COMPLETED|7-day Washout Period 4||16
393281|NCT00980200|940096|P3|COMPLETED|7-day Washout Period 4||15
393282|NCT00980200|940097|P2|COMPLETED|7-day Washout Period 4||12
393283|NCT00980200|940098|P1|COMPLETED|7-day Washout Period 4||15
393284|NCT00980200|940094|P5|STARTED|7-day Washout Period 4||14
393285|NCT00980200|940095|P4|STARTED|7-day Washout Period 4||16
393286|NCT00980200|940096|P3|STARTED|7-day Washout Period 4||15
393287|NCT00980200|940097|P2|STARTED|7-day Washout Period 4||12
393288|NCT00980200|940098|P1|STARTED|7-day Washout Period 4||15
393289|NCT00980200|940094|P5|NOT COMPLETED|7-day Treatment Period 4||0
393290|NCT00980200|940095|P4|NOT COMPLETED|7-day Treatment Period 4||0
393291|NCT00980200|940096|P3|NOT COMPLETED|7-day Treatment Period 4||0
393292|NCT00980200|940097|P2|NOT COMPLETED|7-day Treatment Period 4||0
393293|NCT00980200|940098|P1|NOT COMPLETED|7-day Treatment Period 4||0
393294|NCT00980200|940094|P5|COMPLETED|7-day Treatment Period 4||14
393295|NCT00980200|940095|P4|COMPLETED|7-day Treatment Period 4||16
393296|NCT00980200|940096|P3|COMPLETED|7-day Treatment Period 4||15
393297|NCT00980200|940097|P2|COMPLETED|7-day Treatment Period 4||12
393298|NCT00980200|940098|P1|COMPLETED|7-day Treatment Period 4||15
393299|NCT00980200|940094|P5|STARTED|7-day Treatment Period 4||14
393300|NCT00980200|940095|P4|STARTED|7-day Treatment Period 4||16
393301|NCT00980200|940096|P3|STARTED|7-day Treatment Period 4||15
393302|NCT00980200|940097|P2|STARTED|7-day Treatment Period 4||12
393303|NCT00980200|940098|P1|STARTED|7-day Treatment Period 4||15
393304|NCT00980200|940094|P5|NOT COMPLETED|7-day Washout Period 3||0
393305|NCT00980200|940095|P4|NOT COMPLETED|7-day Washout Period 3||0
393306|NCT00980200|940096|P3|NOT COMPLETED|7-day Washout Period 3||0
393307|NCT00980200|940097|P2|NOT COMPLETED|7-day Washout Period 3||0
393308|NCT00980200|940098|P1|NOT COMPLETED|7-day Washout Period 3||0
393309|NCT00980200|940094|P5|COMPLETED|7-day Washout Period 3||14
393310|NCT00980200|940095|P4|COMPLETED|7-day Washout Period 3||16
393311|NCT00980200|940096|P3|COMPLETED|7-day Washout Period 3||15
393312|NCT00980200|940097|P2|COMPLETED|7-day Washout Period 3||12
393313|NCT00980200|940098|P1|COMPLETED|7-day Washout Period 3||15
393314|NCT00980200|940094|P5|STARTED|7-day Washout Period 3||14
393315|NCT00980200|940095|P4|STARTED|7-day Washout Period 3||16
393316|NCT00980200|940096|P3|STARTED|7-day Washout Period 3||15
393317|NCT00980200|940097|P2|STARTED|7-day Washout Period 3||12
393318|NCT00980200|940098|P1|STARTED|7-day Washout Period 3||15
393319|NCT00980200|940094|P5|NOT COMPLETED|7-day Treatment Period 3||1
393320|NCT00980200|940095|P4|NOT COMPLETED|7-day Treatment Period 3||0
393321|NCT00980200|940096|P3|NOT COMPLETED|7-day Treatment Period 3||0
393322|NCT00980200|940097|P2|NOT COMPLETED|7-day Treatment Period 3||1
393323|NCT00980200|940098|P1|NOT COMPLETED|7-day Treatment Period 3||0
393324|NCT00980200|940094|P5|COMPLETED|7-day Treatment Period 3||14
393325|NCT00980200|940095|P4|COMPLETED|7-day Treatment Period 3||16
393326|NCT00980200|940096|P3|COMPLETED|7-day Treatment Period 3||15
393327|NCT00980200|940097|P2|COMPLETED|7-day Treatment Period 3||12
393328|NCT00980200|940098|P1|COMPLETED|7-day Treatment Period 3||15
393329|NCT00980200|940094|P5|STARTED|7-day Treatment Period 3||15
393330|NCT00980200|940095|P4|STARTED|7-day Treatment Period 3||16
393331|NCT00980200|940096|P3|STARTED|7-day Treatment Period 3||15
393332|NCT00980200|940097|P2|STARTED|7-day Treatment Period 3||13
393333|NCT00980200|940098|P1|STARTED|7-day Treatment Period 3||15
393334|NCT00980200|940094|P5|NOT COMPLETED|7-day Washout Period 2||0
393335|NCT00980200|940095|P4|NOT COMPLETED|7-day Washout Period 2||0
393336|NCT00980200|940096|P3|NOT COMPLETED|7-day Washout Period 2||0
393337|NCT00980200|940097|P2|NOT COMPLETED|7-day Washout Period 2||0
393338|NCT00980200|940098|P1|NOT COMPLETED|7-day Washout Period 2||0
393339|NCT00980200|940094|P5|COMPLETED|7-day Washout Period 2||15
393340|NCT00980200|940095|P4|COMPLETED|7-day Washout Period 2||16
393341|NCT00980200|940096|P3|COMPLETED|7-day Washout Period 2||15
393342|NCT00980200|940097|P2|COMPLETED|7-day Washout Period 2||13
393343|NCT00980200|940098|P1|COMPLETED|7-day Washout Period 2||15
393344|NCT00980200|940094|P5|STARTED|7-day Washout Period 2||15
393345|NCT00980200|940095|P4|STARTED|7-day Washout Period 2||16
393346|NCT00980200|940096|P3|STARTED|7-day Washout Period 2||15
393347|NCT00980200|940097|P2|STARTED|7-day Washout Period 2||13
393348|NCT00980200|940098|P1|STARTED|7-day Washout Period 2||15
393349|NCT00980200|940094|P5|NOT COMPLETED|7-day Treatment Period 2||0
393350|NCT00980200|940095|P4|NOT COMPLETED|7-day Treatment Period 2||0
393351|NCT00980200|940096|P3|NOT COMPLETED|7-day Treatment Period 2||0
393352|NCT00980200|940097|P2|NOT COMPLETED|7-day Treatment Period 2||0
393353|NCT00980200|940098|P1|NOT COMPLETED|7-day Treatment Period 2||0
393354|NCT00980200|940094|P5|COMPLETED|7-day Treatment Period 2||15
393355|NCT00980200|940095|P4|COMPLETED|7-day Treatment Period 2||16
393356|NCT00980200|940096|P3|COMPLETED|7-day Treatment Period 2||15
393357|NCT00980200|940097|P2|COMPLETED|7-day Treatment Period 2||13
393358|NCT00980200|940098|P1|COMPLETED|7-day Treatment Period 2||15
393359|NCT00980200|940094|P5|STARTED|7-day Treatment Period 2||15
393360|NCT00980200|940095|P4|STARTED|7-day Treatment Period 2||16
393361|NCT00980200|940096|P3|STARTED|7-day Treatment Period 2||15
393362|NCT00980200|940097|P2|STARTED|7-day Treatment Period 2||13
393363|NCT00980200|940098|P1|STARTED|7-day Treatment Period 2||15
393364|NCT00980200|940094|P5|NOT COMPLETED|7-day Washout Period 1||0
393365|NCT00980200|940095|P4|NOT COMPLETED|7-day Washout Period 1||0
393366|NCT00980200|940096|P3|NOT COMPLETED|7-day Washout Period 1||0
393367|NCT00980200|940097|P2|NOT COMPLETED|7-day Washout Period 1||0
393368|NCT00980200|940098|P1|NOT COMPLETED|7-day Washout Period 1||0
393369|NCT00980200|940094|P5|COMPLETED|7-day Washout Period 1||15
393370|NCT00980200|940095|P4|COMPLETED|7-day Washout Period 1||16
393371|NCT00980200|940096|P3|COMPLETED|7-day Washout Period 1||15
393372|NCT00980200|940097|P2|COMPLETED|7-day Washout Period 1||13
393373|NCT00980200|940098|P1|COMPLETED|7-day Washout Period 1||15
393374|NCT00980200|940094|P5|STARTED|7-day Washout Period 1||15
393375|NCT00980200|940095|P4|STARTED|7-day Washout Period 1||16
393376|NCT00980200|940096|P3|STARTED|7-day Washout Period 1||15
393377|NCT00980200|940097|P2|STARTED|7-day Washout Period 1||13
393378|NCT00980200|940098|P1|STARTED|7-day Washout Period 1||15
393379|NCT00980200|940094|P5|NOT COMPLETED|7-day Treatment Period 1||0
393380|NCT00980200|940095|P4|NOT COMPLETED|7-day Treatment Period 1||0
393381|NCT00980200|940096|P3|NOT COMPLETED|7-day Treatment Period 1||0
393382|NCT00980200|940097|P2|NOT COMPLETED|7-day Treatment Period 1||1
393383|NCT00980200|940098|P1|NOT COMPLETED|7-day Treatment Period 1||0
393384|NCT00980200|940094|P5|COMPLETED|7-day Treatment Period 1||15
393385|NCT00980200|940095|P4|COMPLETED|7-day Treatment Period 1||16
393386|NCT00980200|940096|P3|COMPLETED|7-day Treatment Period 1||15
393387|NCT00980200|940097|P2|COMPLETED|7-day Treatment Period 1||13
393388|NCT00980200|940098|P1|COMPLETED|7-day Treatment Period 1||15
393389|NCT00980200|940094|P5|STARTED|7-day Treatment Period 1||15
393390|NCT00980200|940095|P4|STARTED|7-day Treatment Period 1||16
393391|NCT00980200|940096|P3|STARTED|7-day Treatment Period 1||15
393392|NCT00980200|940097|P2|STARTED|7-day Treatment Period 1||14
393393|NCT00980200|940098|P1|STARTED|7-day Treatment Period 1||15
393394|NCT00980174|940117|P2|NOT COMPLETED|Overall Study||10
393395|NCT00980174|940118|P1|NOT COMPLETED|Overall Study||4
393396|NCT00980174|940117|P2|COMPLETED|Overall Study||111
393397|NCT00980174|940118|P1|COMPLETED|Overall Study||117
393398|NCT00980174|940117|P2|STARTED|Overall Study||121
393399|NCT00980174|940118|P1|STARTED|Overall Study||121
393400|NCT00980148|940136|P2|NOT COMPLETED|Overall Study||128
393401|NCT00980148|940137|P1|NOT COMPLETED|Overall Study||129
393402|NCT00980148|940136|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
393403|NCT00980148|940137|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
393404|NCT00980148|940136|P2|STARTED|Overall Study||283
393405|NCT00980148|940137|P1|STARTED|Overall Study||284
393406|NCT00980044|940146|P3|NOT COMPLETED|Overall Study||5
393407|NCT00980044|940147|P2|NOT COMPLETED|Overall Study||7
393408|NCT00980044|940148|P1|NOT COMPLETED|Overall Study||5
393409|NCT00980044|940146|P3|COMPLETED|Overall Study||12
393410|NCT00980044|940147|P2|COMPLETED|Overall Study||12
393411|NCT00980044|940148|P1|COMPLETED|Overall Study||12
393412|NCT00980044|940146|P3|STARTED|Overall Study||17
393413|NCT00980044|940147|P2|STARTED|Overall Study||19
393414|NCT00980044|940148|P1|STARTED|Overall Study||17
393415|NCT00980005|940167|P2|NOT COMPLETED|Overall Study||63
393416|NCT00980005|940168|P1|NOT COMPLETED|Overall Study||47
393417|NCT00980005|940167|P2|COMPLETED|Overall Study||998
393418|NCT00980005|940168|P1|COMPLETED|Overall Study||1008
393419|NCT00980005|940167|P2|STARTED|Overall Study||1061
393420|NCT00980005|940168|P1|STARTED|Overall Study||1055
393421|NCT00979953|940212|P4|NOT COMPLETED|Overall Study||7
393422|NCT00979953|940213|P3|NOT COMPLETED|Overall Study||22
393423|NCT00979953|940214|P2|NOT COMPLETED|Overall Study||5
393424|NCT00979953|940215|P1|NOT COMPLETED|Overall Study||8
393425|NCT00979953|940212|P4|COMPLETED|Overall Study||97
393426|NCT00979953|940213|P3|COMPLETED|Overall Study||82
393427|NCT00979953|940214|P2|COMPLETED|Overall Study||94
393428|NCT00979953|940215|P1|COMPLETED|Overall Study||93
393429|NCT00979953|940212|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
393430|NCT00979953|940213|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
393431|NCT00979953|940214|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
393432|NCT00979953|940215|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
393433|NCT00979953|940212|P4|STARTED|Overall Study||104
393434|NCT00979953|940213|P3|STARTED|Overall Study||104
393435|NCT00979953|940214|P2|STARTED|Overall Study||99
393436|NCT00979953|940215|P1|STARTED|Overall Study||101
393437|NCT00979940|940227|P2|NOT COMPLETED|Overall Study||0
393438|NCT00979940|940228|P1|NOT COMPLETED|Overall Study||0
393439|NCT00979940|940227|P2|COMPLETED|Overall Study||28
393440|NCT00979940|940228|P1|COMPLETED|Overall Study||32
393441|NCT00979940|940227|P2|STARTED|Overall Study||28
393442|NCT00979940|940228|P1|STARTED|Overall Study||32
393443|NCT00979901|940238|P4|NOT COMPLETED|Overall Study||116
393444|NCT00979901|940239|P3|NOT COMPLETED|Overall Study||29
393445|NCT00979901|940240|P2|NOT COMPLETED|Overall Study||12
393446|NCT00979901|940241|P1|NOT COMPLETED|Overall Study||18
393447|NCT00979901|940238|P4|COMPLETED|Overall Study||159
393448|NCT00979901|940239|P3|COMPLETED|Overall Study||573
393449|NCT00979901|940240|P2|COMPLETED|Overall Study||336
393450|NCT00979901|940241|P1|COMPLETED|Overall Study||334
393451|NCT00979901|940238|P4|STARTED|Overall Study||275
393452|NCT00979901|940239|P3|STARTED|Overall Study||602
393453|NCT00979901|940240|P2|STARTED|Overall Study||348
393454|NCT00979901|940241|P1|STARTED|Overall Study||352
393455|NCT00979875|940265|P6|NOT COMPLETED|Intervention 3||0
393456|NCT00979875|940266|P5|NOT COMPLETED|Intervention 3||0
393457|NCT00979875|940267|P4|NOT COMPLETED|Intervention 3||0
393458|NCT00979875|940268|P3|NOT COMPLETED|Intervention 3||0
393459|NCT00979875|940269|P2|NOT COMPLETED|Intervention 3||0
393460|NCT00979875|940270|P1|NOT COMPLETED|Intervention 3||0
393461|NCT00979875|940265|P6|COMPLETED|Intervention 3||2
393462|NCT00979875|940266|P5|COMPLETED|Intervention 3||3
393463|NCT00979875|940267|P4|COMPLETED|Intervention 3||2
393464|NCT00979875|940268|P3|COMPLETED|Intervention 3||3
393465|NCT00979875|940269|P2|COMPLETED|Intervention 3||2
393466|NCT00979875|940270|P1|COMPLETED|Intervention 3||2
393467|NCT00979875|940265|P6|STARTED|Intervention 3||2
393468|NCT00979875|940266|P5|STARTED|Intervention 3||3
393469|NCT00979875|940267|P4|STARTED|Intervention 3||2
393470|NCT00979875|940268|P3|STARTED|Intervention 3||3
393471|NCT00979875|940269|P2|STARTED|Intervention 3||2
393472|NCT00979875|940270|P1|STARTED|Intervention 3||2
393473|NCT00979875|940265|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
393474|NCT00979875|940266|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
393475|NCT00979875|940267|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
393476|NCT00979875|940268|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
393477|NCT00979875|940269|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
393478|NCT00979875|940270|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
393479|NCT00979875|940265|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
393480|NCT00979875|940266|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
393481|NCT00979875|940267|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
393482|NCT00979875|940268|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
393483|NCT00979875|940269|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
393484|NCT00979875|940270|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
393485|NCT00979875|940265|P6|STARTED|Washout 2 (3 to 14 Days)||2
393486|NCT00979875|940266|P5|STARTED|Washout 2 (3 to 14 Days)||3
393487|NCT00979875|940267|P4|STARTED|Washout 2 (3 to 14 Days)||2
393488|NCT00979875|940268|P3|STARTED|Washout 2 (3 to 14 Days)||3
393489|NCT00979875|940269|P2|STARTED|Washout 2 (3 to 14 Days)||2
393490|NCT00979875|940270|P1|STARTED|Washout 2 (3 to 14 Days)||2
393491|NCT00979875|940265|P6|NOT COMPLETED|Intervention 2||0
393492|NCT00979875|940266|P5|NOT COMPLETED|Intervention 2||0
393493|NCT00979875|940267|P4|NOT COMPLETED|Intervention 2||0
393494|NCT00979875|940268|P3|NOT COMPLETED|Intervention 2||0
393495|NCT00979875|940269|P2|NOT COMPLETED|Intervention 2||0
393496|NCT00979875|940270|P1|NOT COMPLETED|Intervention 2||0
393497|NCT00979875|940265|P6|COMPLETED|Intervention 2||2
393498|NCT00979875|940266|P5|COMPLETED|Intervention 2||3
393499|NCT00979875|940267|P4|COMPLETED|Intervention 2||2
393500|NCT00979875|940268|P3|COMPLETED|Intervention 2||3
393501|NCT00979875|940269|P2|COMPLETED|Intervention 2||2
393502|NCT00979875|940270|P1|COMPLETED|Intervention 2||2
393503|NCT00979875|940265|P6|STARTED|Intervention 2||2
393504|NCT00979875|940266|P5|STARTED|Intervention 2||3
393505|NCT00979875|940267|P4|STARTED|Intervention 2||2
393506|NCT00979875|940268|P3|STARTED|Intervention 2||3
393507|NCT00979875|940269|P2|STARTED|Intervention 2||2
393508|NCT00979875|940270|P1|STARTED|Intervention 2||2
393509|NCT00979875|940265|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
393510|NCT00979875|940266|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
393511|NCT00979875|940267|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
393512|NCT00979875|940268|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
393513|NCT00979875|940269|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
393514|NCT00979875|940270|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
393515|NCT00979875|940265|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
393516|NCT00979875|940266|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
393517|NCT00979875|940267|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
393518|NCT00979875|940268|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
393519|NCT00979875|940269|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
393520|NCT00979875|940270|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
393521|NCT00979875|940265|P6|STARTED|Washout 1 (3 to 14 Days)||2
393522|NCT00979875|940266|P5|STARTED|Washout 1 (3 to 14 Days)||3
393523|NCT00979875|940267|P4|STARTED|Washout 1 (3 to 14 Days)||2
393524|NCT00979875|940268|P3|STARTED|Washout 1 (3 to 14 Days)||3
393525|NCT00979875|940269|P2|STARTED|Washout 1 (3 to 14 Days)||2
393526|NCT00979875|940270|P1|STARTED|Washout 1 (3 to 14 Days)||2
393527|NCT00979875|940265|P6|NOT COMPLETED|Intervention 1||0
393528|NCT00979875|940266|P5|NOT COMPLETED|Intervention 1||0
393529|NCT00979875|940267|P4|NOT COMPLETED|Intervention 1||0
393530|NCT00979875|940268|P3|NOT COMPLETED|Intervention 1||0
393531|NCT00979875|940269|P2|NOT COMPLETED|Intervention 1||0
393532|NCT00979875|940270|P1|NOT COMPLETED|Intervention 1||0
393533|NCT00979875|940265|P6|COMPLETED|Intervention 1||2
393534|NCT00979875|940266|P5|COMPLETED|Intervention 1||3
393535|NCT00979875|940267|P4|COMPLETED|Intervention 1||2
393536|NCT00979875|940268|P3|COMPLETED|Intervention 1||3
393537|NCT00979875|940269|P2|COMPLETED|Intervention 1||2
393538|NCT00979875|940270|P1|COMPLETED|Intervention 1||2
393539|NCT00979875|940265|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
393540|NCT00979875|940266|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
393541|NCT00979875|940267|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
393542|NCT00979875|940268|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
393543|NCT00979875|940269|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
393544|NCT00979875|940270|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
393545|NCT00979875|940265|P6|STARTED|Intervention 1||2
393546|NCT00979875|940266|P5|STARTED|Intervention 1||3
393547|NCT00979875|940267|P4|STARTED|Intervention 1||2
393548|NCT00979875|940268|P3|STARTED|Intervention 1||3
393549|NCT00979875|940269|P2|STARTED|Intervention 1||2
393550|NCT00979875|940270|P1|STARTED|Intervention 1||2
393551|NCT00979654|940314|P1|NOT COMPLETED|Overall Study||36
393552|NCT00979654|940314|P1|COMPLETED|Overall Study||67
393553|NCT00979654|940314|P1|STARTED|Overall Study||103
393554|NCT00979628|940329|P3|NOT COMPLETED|Overall Study||6
393555|NCT00979628|940330|P2|NOT COMPLETED|Overall Study||9
393556|NCT00979628|940331|P1|NOT COMPLETED|Overall Study||9
393557|NCT00979628|940329|P3|COMPLETED|Overall Study||74
393558|NCT00979628|940330|P2|COMPLETED|Overall Study||133
393559|NCT00979628|940331|P1|COMPLETED|Overall Study||144
393560|NCT00979628|940329|P3|STARTED|Overall Study||80
393561|NCT00979628|940330|P2|STARTED|Overall Study||142
393562|NCT00979628|940331|P1|STARTED|Overall Study||153
393563|NCT00979615|940341|P2|NOT COMPLETED|Overall Study||8
393564|NCT00979615|940342|P1|NOT COMPLETED|Overall Study||6
393565|NCT00979615|940341|P2|COMPLETED|Overall Study||58
393566|NCT00979615|940342|P1|COMPLETED|Overall Study||57
393567|NCT00979615|940341|P2|STARTED|Overall Study||66
393568|NCT00979615|940342|P1|STARTED|Overall Study||63
393569|NCT00979576|940359|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
393570|NCT00979576|940360|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
393571|NCT00979576|940361|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
393572|NCT00979576|940359|P3|COMPLETED|Combination Followed by Monotherapy||0
393573|NCT00979576|940360|P2|COMPLETED|Combination Followed by Monotherapy||0
393574|NCT00979576|940361|P1|COMPLETED|Combination Followed by Monotherapy||0
393575|NCT00979576|940359|P3|STARTED|Combination Followed by Monotherapy||1
393576|NCT00979576|940360|P2|STARTED|Combination Followed by Monotherapy||2
393577|NCT00979576|940361|P1|STARTED|Combination Followed by Monotherapy||0
393578|NCT00979576|940359|P3|NOT COMPLETED|Combination Treatment Phase||9
393579|NCT00979576|940360|P2|NOT COMPLETED|Combination Treatment Phase||6
393580|NCT00979576|940361|P1|NOT COMPLETED|Combination Treatment Phase||3
393581|NCT00979576|940359|P3|COMPLETED|Combination Treatment Phase||0
393582|NCT00979576|940360|P2|COMPLETED|Combination Treatment Phase||0
393583|NCT00979576|940361|P1|COMPLETED|Combination Treatment Phase||0
393584|NCT00979576|940359|P3|STARTED|Combination Treatment Phase||9
393585|NCT00979576|940360|P2|STARTED|Combination Treatment Phase||6
393586|NCT00979576|940361|P1|STARTED|Combination Treatment Phase||3
393587|NCT00979459|940392|P2|NOT COMPLETED|Second Intervention||0
393588|NCT00979459|940393|P1|NOT COMPLETED|Second Intervention||0
393589|NCT00979459|940392|P2|COMPLETED|Second Intervention||6
393590|NCT00979459|940393|P1|COMPLETED|Second Intervention||6
393591|NCT00979459|940392|P2|STARTED|Second Intervention||6
393592|NCT00979459|940393|P1|STARTED|Second Intervention||6
393593|NCT00979459|940392|P2|NOT COMPLETED|7-day Washout Period||0
393594|NCT00979459|940393|P1|NOT COMPLETED|7-day Washout Period||0
393595|NCT00979459|940392|P2|COMPLETED|7-day Washout Period||6
393596|NCT00979459|940393|P1|COMPLETED|7-day Washout Period||6
393597|NCT00979459|940392|P2|STARTED|7-day Washout Period||6
393598|NCT00979459|940393|P1|STARTED|7-day Washout Period||6
393599|NCT00979459|940392|P2|NOT COMPLETED|First Intervention||0
393600|NCT00979459|940393|P1|NOT COMPLETED|First Intervention||0
393601|NCT00979459|940392|P2|COMPLETED|First Intervention||6
393602|NCT00979459|940393|P1|COMPLETED|First Intervention||6
393603|NCT00979459|940392|P2|STARTED|First Intervention||6
393604|NCT00979459|940393|P1|STARTED|First Intervention||6
393605|NCT00979420|940409|P4|NOT COMPLETED|Overall Study||2
393606|NCT00979420|940410|P3|NOT COMPLETED|Overall Study||1
393607|NCT00979420|940411|P2|NOT COMPLETED|Overall Study||0
393608|NCT00979420|940412|P1|NOT COMPLETED|Overall Study||7
393609|NCT00979420|940409|P4|COMPLETED|Overall Study||59
393610|NCT00979420|940410|P3|COMPLETED|Overall Study||59
393611|NCT00979420|940411|P2|COMPLETED|Overall Study||57
393612|NCT00979420|940412|P1|COMPLETED|Overall Study||171
393613|NCT00979420|940409|P4|STARTED|Overall Study||61
393614|NCT00979420|940410|P3|STARTED|Overall Study||60
393615|NCT00979420|940411|P2|STARTED|Overall Study||57
393616|NCT00979420|940412|P1|STARTED|Overall Study||178
393617|NCT00979212|940482|P2|NOT COMPLETED|Overall Study||8
393618|NCT00979212|940483|P1|NOT COMPLETED|Overall Study||2
393619|NCT00979212|940482|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
393620|NCT00979212|940483|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
393621|NCT00979212|940482|P2|STARTED|Overall Study||47
393622|NCT00979212|940483|P1|STARTED|Overall Study||24
393623|NCT00979199|940501|P1|NOT COMPLETED|Overall Study||222
393624|NCT00979199|940501|P1|COMPLETED|Overall Study||475
393625|NCT00979199|940501|P1|STARTED|Overall Study||697
393626|NCT00979121|940507|P2|NOT COMPLETED|Overall Study||0
393627|NCT00979121|940508|P1|NOT COMPLETED|Overall Study||0
393628|NCT00979121|940507|P2|COMPLETED|Overall Study||366
393629|NCT00979121|940508|P1|COMPLETED|Overall Study||379
393630|NCT00979121|940507|P2|STARTED|Overall Study||366
393631|NCT00979121|940508|P1|STARTED|Overall Study||379
393632|NCT00979069|940526|P2|NOT COMPLETED|Overall Study||2
393633|NCT00979069|940527|P1|NOT COMPLETED|Overall Study||0
393634|NCT00979069|940526|P2|COMPLETED|Overall Study||8
393635|NCT00979069|940527|P1|COMPLETED|Overall Study||10
393636|NCT00979069|940526|P2|STARTED|Overall Study||10
393637|NCT00979069|940527|P1|STARTED|Overall Study||10
393638|NCT00979017|940533|P1|NOT COMPLETED|Overall Study||0
393639|NCT00979017|940533|P1|COMPLETED|Overall Study||41
393640|NCT00979017|940533|P1|STARTED|Overall Study||41
393641|NCT00978757|940543|P2|NOT COMPLETED|Overall Study||3
393642|NCT00978757|940544|P1|NOT COMPLETED|Overall Study||1
393643|NCT00978757|940543|P2|COMPLETED|Overall Study|Junio 2008|17
393644|NCT00978757|940544|P1|COMPLETED|Overall Study|Junio 2008|21
393645|NCT00978757|940543|P2|STARTED|Overall Study|Junio 2001|20
393646|NCT00978757|940544|P1|STARTED|Overall Study|Junio 2001|22
393647|NCT00978731|940554|P4|NOT COMPLETED|Overall Study||4
393648|NCT00978731|940555|P3|NOT COMPLETED|Overall Study||5
393649|NCT00978731|940556|P2|NOT COMPLETED|Overall Study||15
393650|NCT00978731|940557|P1|NOT COMPLETED|Overall Study||22
393651|NCT00978731|940554|P4|COMPLETED|Overall Study||0
393652|NCT00978731|940555|P3|COMPLETED|Overall Study||0
393653|NCT00978731|940556|P2|COMPLETED|Overall Study||0
393654|NCT00978731|940557|P1|COMPLETED|Overall Study||0
393655|NCT00978731|940554|P4|STARTED|Overall Study||4
393656|NCT00978731|940555|P3|STARTED|Overall Study||5
393657|NCT00978731|940556|P2|STARTED|Overall Study||15
393658|NCT00978731|940557|P1|STARTED|Overall Study||22
393659|NCT00978627|940597|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
393660|NCT00978627|940598|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
393661|NCT00978627|940597|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
393662|NCT00978627|940598|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
393663|NCT00978627|940597|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
393664|NCT00978627|940598|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
393665|NCT00978627|940597|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
393666|NCT00978627|940598|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
393667|NCT00978627|940597|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
393668|NCT00978627|940598|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
393669|NCT00978627|940597|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
393670|NCT00978627|940598|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
393671|NCT00978627|940597|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
393672|NCT00978627|940598|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
393673|NCT00978562|940620|P1|NOT COMPLETED|Overall Study||0
393674|NCT00978562|940620|P1|COMPLETED|Overall Study||7
393675|NCT00978562|940620|P1|STARTED|Overall Study||7
393676|NCT00978445|940625|P2|NOT COMPLETED|Overall Study||1
393677|NCT00978445|940626|P1|NOT COMPLETED|Overall Study||2
393678|NCT00978445|940625|P2|COMPLETED|Overall Study||12
393679|NCT00978445|940626|P1|COMPLETED|Overall Study||10
393680|NCT00978445|940625|P2|STARTED|Overall Study||13
393681|NCT00978445|940626|P1|STARTED|Overall Study||12
393682|NCT00978432|940636|P3|NOT COMPLETED|Overall Study||5
393683|NCT00978432|940637|P2|NOT COMPLETED|Overall Study||1
393684|NCT00978432|940638|P1|NOT COMPLETED|Overall Study||3
393685|NCT00978432|940636|P3|COMPLETED|Overall Study||13
393686|NCT00978432|940637|P2|COMPLETED|Overall Study||4
393687|NCT00978432|940638|P1|COMPLETED|Overall Study||7
393688|NCT00978432|940636|P3|STARTED|Overall Study||18
393689|NCT00978432|940637|P2|STARTED|Overall Study||5
393690|NCT00978432|940638|P1|STARTED|Overall Study||10
393691|NCT00978380|940658|P1|NOT COMPLETED|Overall Study||19
393692|NCT00978380|940658|P1|COMPLETED|Overall Study||44
393693|NCT00978380|940658|P1|STARTED|Overall Study||63
393694|NCT00978341|940664|P2|NOT COMPLETED|Second Intervention||0
393695|NCT00978341|940665|P1|NOT COMPLETED|Second Intervention||0
393696|NCT00978341|940664|P2|COMPLETED|Second Intervention||7
393697|NCT00978341|940665|P1|COMPLETED|Second Intervention||7
393698|NCT00978341|940664|P2|STARTED|Second Intervention||7
393699|NCT00978341|940665|P1|STARTED|Second Intervention||7
393700|NCT00978341|940664|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
393701|NCT00978341|940665|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
393702|NCT00978341|940664|P2|COMPLETED|Washout Period of 2 Weeks||7
393703|NCT00978341|940665|P1|COMPLETED|Washout Period of 2 Weeks||7
393704|NCT00978341|940664|P2|STARTED|Washout Period of 2 Weeks||7
393705|NCT00978341|940665|P1|STARTED|Washout Period of 2 Weeks||8
393706|NCT00978341|940664|P2|NOT COMPLETED|First Intervention||0
393707|NCT00978341|940665|P1|NOT COMPLETED|First Intervention||0
393708|NCT00978341|940664|P2|COMPLETED|First Intervention||7
393709|NCT00978341|940665|P1|COMPLETED|First Intervention||8
393710|NCT00978341|940664|P2|STARTED|First Intervention||7
393711|NCT00978341|940665|P1|STARTED|First Intervention||8
393712|NCT00978120|940687|P4|NOT COMPLETED|Overall Study||2
393713|NCT00978120|940688|P3|NOT COMPLETED|Overall Study||3
393714|NCT00978120|940689|P2|NOT COMPLETED|Overall Study||0
393715|NCT00978120|940690|P1|NOT COMPLETED|Overall Study||2
393716|NCT00978120|940687|P4|COMPLETED|Overall Study||84
393717|NCT00978120|940688|P3|COMPLETED|Overall Study||84
393718|NCT00978120|940689|P2|COMPLETED|Overall Study||107
393719|NCT00978120|940690|P1|COMPLETED|Overall Study||108
393720|NCT00978120|940687|P4|STARTED|Overall Study||86
393721|NCT00978120|940688|P3|STARTED|Overall Study||87
393722|NCT00978120|940689|P2|STARTED|Overall Study||107
393723|NCT00978120|940690|P1|STARTED|Overall Study||110
393724|NCT00978042|940742|P2|NOT COMPLETED|Received Repeat Treatment||3
393725|NCT00978042|940743|P1|NOT COMPLETED|Received Repeat Treatment||43
393726|NCT00978042|940742|P2|COMPLETED|Received Repeat Treatment||23
393727|NCT00978042|940743|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
393728|NCT00978042|940742|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
393729|NCT00978042|940743|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
393730|NCT00978042|940742|P2|NOT COMPLETED|Initial Treatment Period||15
393731|NCT00978042|940743|P1|NOT COMPLETED|Initial Treatment Period||61
393732|NCT00978042|940742|P2|COMPLETED|Initial Treatment Period||32
393733|NCT00978042|940743|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
393734|NCT00978042|940742|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
393735|NCT00978042|940743|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
393736|NCT00978042|940742|P2|STARTED|Initial Treatment Period||47
393737|NCT00978042|940743|P1|STARTED|Initial Treatment Period||235
393738|NCT00978029|940756|P3|NOT COMPLETED|Overall Study||6
393739|NCT00978029|940757|P2|NOT COMPLETED|Overall Study||3
393740|NCT00978029|940758|P1|NOT COMPLETED|Overall Study||1
393741|NCT00978029|940756|P3|COMPLETED|Overall Study||59
393742|NCT00978029|940757|P2|COMPLETED|Overall Study||63
393743|NCT00978029|940758|P1|COMPLETED|Overall Study||64
393744|NCT00978029|940756|P3|STARTED|Overall Study||65
393745|NCT00978029|940757|P2|STARTED|Overall Study||66
393746|NCT00978029|940758|P1|STARTED|Overall Study||65
393747|NCT00977938|940785|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
393748|NCT00977938|940786|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
393749|NCT00977938|940787|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
393750|NCT00977938|940788|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
393751|NCT00977938|940785|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
393752|NCT00977938|940786|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
393753|NCT00977938|940787|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
393754|NCT00977938|940788|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
393755|NCT00977938|940785|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
393756|NCT00977938|940786|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
393757|NCT00977938|940787|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
393758|NCT00977938|940788|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
393759|NCT00977938|940785|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
393760|NCT00977938|940786|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
393761|NCT00977938|940787|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
393762|NCT00977938|940788|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
393763|NCT00977938|940785|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
393764|NCT00977938|940786|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
393765|NCT00977938|940787|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
393766|NCT00977938|940788|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
393767|NCT00977938|940785|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
393768|NCT00977938|940786|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
393769|NCT00977938|940787|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
393770|NCT00977938|940788|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
393771|NCT00977808|940822|P1|NOT COMPLETED|Overall Study||1
393772|NCT00977808|940822|P1|COMPLETED|Overall Study||11
393773|NCT00977808|940822|P1|Completion of Closed-Loop Admission|Overall Study||11
393774|NCT00977808|940822|P1|Completion of Open-Loop Admission|Overall Study||12
393775|NCT00977808|940822|P1|STARTED|Overall Study||12
393776|NCT00977769|940830|P3|NOT COMPLETED|Overall Study||0
393777|NCT00977769|940831|P2|NOT COMPLETED|Overall Study||0
393778|NCT00977769|940832|P1|NOT COMPLETED|Overall Study||0
393779|NCT00977769|940830|P3|COMPLETED|Overall Study||25
393780|NCT00977769|940831|P2|COMPLETED|Overall Study||26
393781|NCT00977769|940832|P1|COMPLETED|Overall Study||25
393782|NCT00977769|940830|P3|STARTED|Overall Study||25
393783|NCT00977769|940831|P2|STARTED|Overall Study||26
393784|NCT00977769|940832|P1|STARTED|Overall Study||25
393785|NCT00977704|940846|P1|NOT COMPLETED|Overall Study||0
393786|NCT00977704|940846|P1|COMPLETED|Overall Study||20
393787|NCT00977704|940846|P1|STARTED|Overall Study||20
393788|NCT00977665|940852|P2|NOT COMPLETED|Overall Study||15
393789|NCT00977665|940853|P1|NOT COMPLETED|Overall Study||21
393790|NCT00977665|940852|P2|COMPLETED|Overall Study||75
393791|NCT00977665|940853|P1|COMPLETED|Overall Study||63
393792|NCT00977665|940852|P2|STARTED|Overall Study||90
393793|NCT00977665|940853|P1|STARTED|Overall Study||84
393794|NCT00977613|940885|P1|NOT COMPLETED|Overall Study||16
393795|NCT00977613|940885|P1|COMPLETED|Overall Study||34
393796|NCT00977613|940885|P1|STARTED|Overall Study||50
393797|NCT00977561|940891|P2|NOT COMPLETED|Overall Study||4
393798|NCT00977561|940892|P1|NOT COMPLETED|Overall Study||5
393799|NCT00977561|940891|P2|COMPLETED|Overall Study||0
393800|NCT00977561|940892|P1|COMPLETED|Overall Study||0
393801|NCT00977561|940891|P2|STARTED|Overall Study||4
393802|NCT00977561|940892|P1|STARTED|Overall Study||5
393803|NCT00977548|940919|P1|NOT COMPLETED|Overall Study||13
393804|NCT00977548|940919|P1|COMPLETED|Overall Study||26
393805|NCT00977548|940919|P1|STARTED|Overall Study||39
393806|NCT00977470|940928|P2|NOT COMPLETED|Overall Study||38
393807|NCT00977470|940929|P1|NOT COMPLETED|Overall Study||38
393808|NCT00977470|940928|P2|COMPLETED|Overall Study||0
393809|NCT00977470|940929|P1|COMPLETED|Overall Study||0
393810|NCT00977470|940928|P2|STARTED|Overall Study||38
393811|NCT00977470|940929|P1|STARTED|Overall Study||38
393812|NCT00977379|940949|P2|NOT COMPLETED|Overall Study||12
393813|NCT00977379|940950|P1|NOT COMPLETED|Overall Study||12
393814|NCT00977379|940949|P2|COMPLETED|Overall Study||0
393815|NCT00977379|940950|P1|COMPLETED|Overall Study||0
393816|NCT00977379|940949|P2|Treated|Overall Study||11
393817|NCT00977379|940950|P1|Treated|Overall Study||12
393818|NCT00977379|940949|P2|STARTED|Overall Study|Randomized|12
393819|NCT00977379|940950|P1|STARTED|Overall Study|Randomized|12
393820|NCT00977314|940986|P2|NOT COMPLETED|Overall Study||0
393821|NCT00977314|940987|P1|NOT COMPLETED|Overall Study||2
393822|NCT00977314|940986|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
393823|NCT00977314|940987|P1|COMPLETED|Overall Study||28
393824|NCT00977314|940986|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
393825|NCT00977314|940987|P1|STARTED|Overall Study||30
393826|NCT00977197|940995|P2|NOT COMPLETED|Overall Study||9
393827|NCT00977197|940996|P1|NOT COMPLETED|Overall Study||9
393828|NCT00977197|940995|P2|COMPLETED|Overall Study||35
393829|NCT00977197|940996|P1|COMPLETED|Overall Study||32
393830|NCT00977197|940995|P2|STARTED|Overall Study||44
393831|NCT00977197|940996|P1|STARTED|Overall Study||41
393832|NCT00977184|941026|P2|NOT COMPLETED|Overall Study||0
393833|NCT00977184|941027|P1|NOT COMPLETED|Overall Study||0
393834|NCT00977184|941026|P2|COMPLETED|Overall Study||13
393835|NCT00977184|941027|P1|COMPLETED|Overall Study||13
393836|NCT00977184|941026|P2|STARTED|Overall Study||13
393837|NCT00977184|941027|P1|STARTED|Overall Study||13
393838|NCT00977171|941053|P1|NOT COMPLETED|Overall Study||0
393839|NCT00977171|941053|P1|COMPLETED|Overall Study||3
393840|NCT00977171|941053|P1|STARTED|Overall Study||3
393841|NCT00977106|941059|P2|NOT COMPLETED|Overall Study||11
393842|NCT00977106|941060|P1|NOT COMPLETED|Overall Study||10
393843|NCT00977106|941059|P2|COMPLETED|Overall Study||45
393844|NCT00977106|941060|P1|COMPLETED|Overall Study||37
393845|NCT00977106|941059|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
393846|NCT00977106|941060|P1|STARTED|Overall Study||47
393847|NCT00977080|941152|P4|NOT COMPLETED|Overall Study||17
393848|NCT00977080|941153|P3|NOT COMPLETED|Overall Study||16
393849|NCT00977080|941154|P2|NOT COMPLETED|Overall Study||20
393850|NCT00977080|941155|P1|NOT COMPLETED|Overall Study||12
393851|NCT00977080|941152|P4|COMPLETED|Overall Study||53
393852|NCT00977080|941153|P3|COMPLETED|Overall Study||56
393853|NCT00977080|941154|P2|COMPLETED|Overall Study||44
393854|NCT00977080|941155|P1|COMPLETED|Overall Study||50
393855|NCT00977080|941152|P4|STARTED|Overall Study||70
393856|NCT00977080|941153|P3|STARTED|Overall Study||72
393857|NCT00977080|941154|P2|STARTED|Overall Study||64
393858|NCT00977080|941155|P1|STARTED|Overall Study||62
393859|NCT00976989|941188|P3|NOT COMPLETED|Overall Study||17
393860|NCT00976989|941189|P2|NOT COMPLETED|Overall Study||12
393861|NCT00976989|941190|P1|NOT COMPLETED|Overall Study||13
393862|NCT00976989|941188|P3|COMPLETED|Overall Study||60
393863|NCT00976989|941189|P2|COMPLETED|Overall Study||63
393864|NCT00976989|941190|P1|COMPLETED|Overall Study||60
393865|NCT00976989|941188|P3|STARTED|Overall Study||77
393866|NCT00976989|941189|P2|STARTED|Overall Study||75
393867|NCT00976989|941190|P1|STARTED|Overall Study||73
393868|NCT00976950|941231|P1|NOT COMPLETED|Overall Study||6
393869|NCT00976950|941231|P1|COMPLETED|Overall Study||36
393870|NCT00976950|941231|P1|STARTED|Overall Study||42
393871|NCT00976937|941239|P2|NOT COMPLETED|Overall Study||11
393872|NCT00976937|941240|P1|NOT COMPLETED|Overall Study||16
393873|NCT00976937|941239|P2|COMPLETED|Overall Study||150
393874|NCT00976937|941240|P1|COMPLETED|Overall Study||142
393875|NCT00976937|941239|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
393876|NCT00976937|941240|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
393877|NCT00976937|941239|P2|Treated/Safety Population|Overall Study||161
393969|NCT00976391|941664|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
393878|NCT00976937|941240|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
393879|NCT00976937|941239|P2|STARTED|Overall Study||161
393880|NCT00976937|941240|P1|STARTED|Overall Study|Randomized|158
393881|NCT00976911|941282|P2|NOT COMPLETED|Overall Study||179
393882|NCT00976911|941283|P1|NOT COMPLETED|Overall Study||182
393883|NCT00976911|941282|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
393884|NCT00976911|941283|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
393885|NCT00976911|941282|P2|STARTED|Overall Study||179
393886|NCT00976911|941283|P1|STARTED|Overall Study||182
393887|NCT00976716|941301|P1|NOT COMPLETED|Overall Study||1
393888|NCT00976716|941301|P1|COMPLETED|Overall Study||79
393889|NCT00976716|941301|P1|STARTED|Overall Study||80
393890|NCT00976703|941319|P2|NOT COMPLETED|Overall Study||3
393891|NCT00976703|941320|P1|NOT COMPLETED|Overall Study||3
393892|NCT00976703|941319|P2|COMPLETED|Overall Study||95
393893|NCT00976703|941320|P1|COMPLETED|Overall Study||96
393894|NCT00976703|941319|P2|STARTED|Overall Study||98
393895|NCT00976703|941320|P1|STARTED|Overall Study||99
393896|NCT00976677|941334|P2|NOT COMPLETED|Overall Study||5
393897|NCT00976677|941335|P1|NOT COMPLETED|Overall Study||5
393898|NCT00976677|941334|P2|COMPLETED|Overall Study||0
393899|NCT00976677|941335|P1|COMPLETED|Overall Study||0
393900|NCT00976677|941334|P2|STARTED|Overall Study||5
393901|NCT00976677|941335|P1|STARTED|Overall Study||5
393902|NCT00976664|941343|P2|NOT COMPLETED|Overall Study||1
393903|NCT00976664|941344|P1|NOT COMPLETED|Overall Study||3
393904|NCT00976664|941343|P2|COMPLETED|Overall Study||24
393905|NCT00976664|941344|P1|COMPLETED|Overall Study||22
393906|NCT00976664|941343|P2|STARTED|Overall Study||25
393907|NCT00976664|941344|P1|STARTED|Overall Study||25
393908|NCT00976599|941354|P2|NOT COMPLETED|Overall Study||0
393909|NCT00976599|941355|P1|NOT COMPLETED|Overall Study||0
393910|NCT00976599|941354|P2|COMPLETED|Overall Study||14
393911|NCT00976599|941355|P1|COMPLETED|Overall Study||15
393912|NCT00976599|941354|P2|STARTED|Overall Study||14
393913|NCT00976599|941355|P1|STARTED|Overall Study||15
393914|NCT00976573|941543|P2|NOT COMPLETED|Overall Study||3
393915|NCT00976573|941544|P1|NOT COMPLETED|Overall Study||4
393916|NCT00976573|941543|P2|COMPLETED|Overall Study||71
393917|NCT00976573|941544|P1|COMPLETED|Overall Study||71
393918|NCT00976573|941543|P2|STARTED|Overall Study||74
393919|NCT00976573|941544|P1|STARTED|Overall Study||75
393920|NCT00976521|941560|P4|NOT COMPLETED|Overall Study||19
393921|NCT00976521|941561|P3|NOT COMPLETED|Overall Study||9
393922|NCT00976521|941562|P2|NOT COMPLETED|Overall Study||12
393923|NCT00976521|941563|P1|NOT COMPLETED|Overall Study||9
393924|NCT00976521|941560|P4|COMPLETED|Overall Study||93
393925|NCT00976521|941561|P3|COMPLETED|Overall Study||102
393926|NCT00976521|941562|P2|COMPLETED|Overall Study||99
393927|NCT00976521|941563|P1|COMPLETED|Overall Study||109
393928|NCT00976521|941560|P4|STARTED|Overall Study||112
393929|NCT00976521|941561|P3|STARTED|Overall Study||111
393930|NCT00976521|941562|P2|STARTED|Overall Study||111
393931|NCT00976521|941563|P1|STARTED|Overall Study||118
393932|NCT00976508|941577|P2|NOT COMPLETED|Overall Study||6
393933|NCT00976508|941578|P1|NOT COMPLETED|Overall Study||14
393934|NCT00976508|941577|P2|COMPLETED|Overall Study||0
393935|NCT00976508|941578|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
393936|NCT00976508|941577|P2|STARTED|Overall Study||6
393937|NCT00976508|941578|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
393938|NCT00976495|941611|P3|NOT COMPLETED|Overall Study||0
393939|NCT00976495|941612|P2|NOT COMPLETED|Overall Study||1
393940|NCT00976495|941613|P1|NOT COMPLETED|Overall Study||0
393941|NCT00976495|941611|P3|COMPLETED|Overall Study||26
393942|NCT00976495|941612|P2|COMPLETED|Overall Study||23
393943|NCT00976495|941613|P1|COMPLETED|Overall Study||25
393944|NCT00976495|941611|P3|STARTED|Overall Study||26
393945|NCT00976495|941612|P2|STARTED|Overall Study||24
393946|NCT00976495|941613|P1|STARTED|Overall Study||25
393947|NCT00976482|941630|P1|NOT COMPLETED|Overall Study||259
393948|NCT00976482|941630|P1|COMPLETED|Overall Study||1486
393949|NCT00976482|941630|P1|Eligible for Last Follow up|Overall Study||1487
393950|NCT00976482|941630|P1|STARTED|Overall Study||1745
393951|NCT00976456|941636|P2|NOT COMPLETED|Overall Study||38
393952|NCT00976456|941637|P1|NOT COMPLETED|Overall Study||43
393953|NCT00976456|941636|P2|COMPLETED|Overall Study||98
393954|NCT00976456|941637|P1|COMPLETED|Overall Study||92
393955|NCT00976456|941636|P2|STARTED|Overall Study||136
393956|NCT00976456|941637|P1|STARTED|Overall Study||135
393957|NCT00976404|941647|P2|NOT COMPLETED|Overall Study||0
393958|NCT00976404|941648|P1|NOT COMPLETED|Overall Study||0
393959|NCT00976404|941647|P2|COMPLETED|Overall Study||14
393960|NCT00976404|941648|P1|COMPLETED|Overall Study||14
393961|NCT00976404|941647|P2|STARTED|Overall Study||14
393962|NCT00976404|941648|P1|STARTED|Overall Study||14
393963|NCT00976391|941664|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
393964|NCT00976391|941665|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
393965|NCT00976391|941664|P2|COMPLETED|Follow-up Period (8 Weeks)||247
393966|NCT00976391|941665|P1|COMPLETED|Follow-up Period (8 Weeks)||256
393967|NCT00976391|941664|P2|STARTED|Follow-up Period (8 Weeks)||281
393968|NCT00976391|941665|P1|STARTED|Follow-up Period (8 Weeks)||285
393970|NCT00976391|941665|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
393971|NCT00976391|941664|P2|COMPLETED|Treatment Period (52 Weeks)||242
393972|NCT00976391|941665|P1|COMPLETED|Treatment Period (52 Weeks)||243
393973|NCT00976391|941664|P2|STARTED|Treatment Period (52 Weeks)||281
393974|NCT00976391|941665|P1|STARTED|Treatment Period (52 Weeks)||285
393975|NCT00976339|941685|P1|NOT COMPLETED|Overall Study||4
393976|NCT00976339|941685|P1|COMPLETED|Overall Study||16
393977|NCT00976339|941685|P1|STARTED|Overall Study||20
393978|NCT00976274|941691|P2|NOT COMPLETED|Overall Study||8
393979|NCT00976274|941692|P1|NOT COMPLETED|Overall Study||7
393980|NCT00976274|941691|P2|COMPLETED|Overall Study||21
393981|NCT00976274|941692|P1|COMPLETED|Overall Study||24
393982|NCT00976274|941691|P2|STARTED|Overall Study||29
393983|NCT00976274|941692|P1|STARTED|Overall Study||31
393984|NCT00976248|941700|P1|NOT COMPLETED|Overall Study||0
393985|NCT00976248|941700|P1|COMPLETED|Overall Study||33
393986|NCT00976248|941700|P1|STARTED|Overall Study||33
393987|NCT00976209|941708|P2|NOT COMPLETED|Treatment Period 2||2
393988|NCT00976209|941709|P1|NOT COMPLETED|Treatment Period 2||0
393989|NCT00976209|941708|P2|COMPLETED|Treatment Period 2||161
393990|NCT00976209|941709|P1|COMPLETED|Treatment Period 2||158
393991|NCT00976209|941708|P2|STARTED|Treatment Period 2||163
393992|NCT00976209|941709|P1|STARTED|Treatment Period 2||158
393993|NCT00976209|941708|P2|NOT COMPLETED|Wash-out Period||2
393994|NCT00976209|941709|P1|NOT COMPLETED|Wash-out Period||4
393995|NCT00976209|941708|P2|COMPLETED|Wash-out Period||163
393996|NCT00976209|941709|P1|COMPLETED|Wash-out Period||158
393997|NCT00976209|941708|P2|STARTED|Wash-out Period||165
393998|NCT00976209|941709|P1|STARTED|Wash-out Period||162
393999|NCT00976209|941708|P2|NOT COMPLETED|Treatment Period 1||1
394000|NCT00976209|941709|P1|NOT COMPLETED|Treatment Period 1||3
394001|NCT00976209|941708|P2|COMPLETED|Treatment Period 1||165
394002|NCT00976209|941709|P1|COMPLETED|Treatment Period 1||162
394003|NCT00976209|941708|P2|STARTED|Treatment Period 1||166
394004|NCT00976209|941709|P1|STARTED|Treatment Period 1||165
394005|NCT00976183|941715|P1|NOT COMPLETED|Overall Study||0
394006|NCT00976183|941715|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
394007|NCT00976183|941715|P1|STARTED|Overall Study||18
394008|NCT00976027|941722|P2|NOT COMPLETED|Overall Study||215
394009|NCT00976027|941723|P1|NOT COMPLETED|Overall Study||411
394010|NCT00976027|941722|P2|COMPLETED|Overall Study||2835
394011|NCT00976027|941723|P1|COMPLETED|Overall Study||5697
394012|NCT00976027|941722|P2|STARTED|Overall Study||3050
394013|NCT00976027|941723|P1|STARTED|Overall Study||6108
394014|NCT00975975|941735|P1|NOT COMPLETED|Overall Study||6
394015|NCT00975975|941735|P1|COMPLETED|Overall Study||11
394016|NCT00975975|941735|P1|STARTED|Overall Study||17
394017|NCT00975923|941743|P2|NOT COMPLETED|Overall Study||1
394018|NCT00975923|941744|P1|NOT COMPLETED|Overall Study||0
394019|NCT00975923|941743|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
394020|NCT00975923|941744|P1|COMPLETED|Overall Study||30
394021|NCT00975923|941743|P2|STARTED|Overall Study||30
394022|NCT00975923|941744|P1|STARTED|Overall Study||30
394023|NCT00975806|941755|P3|NOT COMPLETED|Overall Study||4
394024|NCT00975806|941756|P2|NOT COMPLETED|Overall Study||7
394025|NCT00975806|941757|P1|NOT COMPLETED|Overall Study||5
394026|NCT00975806|941755|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
394027|NCT00975806|941756|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
394028|NCT00975806|941757|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
394029|NCT00975806|941755|P3|STARTED|Overall Study||4
394030|NCT00975806|941756|P2|STARTED|Overall Study||7
394031|NCT00975806|941757|P1|STARTED|Overall Study||5
394032|NCT00975780|941781|P2|NOT COMPLETED|Follow Up||157
394033|NCT00975780|941782|P1|NOT COMPLETED|Follow Up||102
394034|NCT00975780|941781|P2|COMPLETED|Follow Up||277
394035|NCT00975780|941782|P1|COMPLETED|Follow Up||298
394036|NCT00975780|941781|P2|STARTED|Follow Up||434
394037|NCT00975780|941782|P1|STARTED|Follow Up||400
394038|NCT00975780|941781|P2|NOT COMPLETED|Allocation||0
394039|NCT00975780|941782|P1|NOT COMPLETED|Allocation||0
394040|NCT00975780|941781|P2|COMPLETED|Allocation||434
394041|NCT00975780|941782|P1|COMPLETED|Allocation||400
394042|NCT00975780|941781|P2|STARTED|Allocation||434
394043|NCT00975780|941782|P1|STARTED|Allocation||400
394044|NCT00975715|941792|P2|NOT COMPLETED|Maintenance Period||1
394045|NCT00975715|941793|P1|NOT COMPLETED|Maintenance Period||2
394046|NCT00975715|941792|P2|COMPLETED|Maintenance Period||50
394047|NCT00975715|941793|P1|COMPLETED|Maintenance Period||39
394048|NCT00975715|941792|P2|STARTED|Maintenance Period||51
394049|NCT00975715|941793|P1|STARTED|Maintenance Period||41
394050|NCT00975715|941792|P2|NOT COMPLETED|Titration Period||0
394051|NCT00975715|941793|P1|NOT COMPLETED|Titration Period||7
394052|NCT00975715|941792|P2|COMPLETED|Titration Period||51
394053|NCT00975715|941793|P1|COMPLETED|Titration Period||41
394054|NCT00975715|941792|P2|STARTED|Titration Period||51
394055|NCT00975715|941793|P1|STARTED|Titration Period||48
394056|NCT00975689|941809|P2|NOT COMPLETED|Overall Study||3
394057|NCT00975689|941810|P1|NOT COMPLETED|Overall Study||2
394058|NCT00975689|941809|P2|COMPLETED|Overall Study||15
394059|NCT00975689|941810|P1|COMPLETED|Overall Study||15
394060|NCT00975689|941809|P2|STARTED|Overall Study||18
394061|NCT00975689|941810|P1|STARTED|Overall Study||17
394062|NCT00975637|941821|P5|NOT COMPLETED|Overall Study||2
394063|NCT00975637|941822|P4|NOT COMPLETED|Overall Study||6
394064|NCT00975637|941823|P3|NOT COMPLETED|Overall Study||2
394065|NCT00975637|941824|P2|NOT COMPLETED|Overall Study||1
394066|NCT00975637|941825|P1|NOT COMPLETED|Overall Study||3
394067|NCT00975637|941821|P5|COMPLETED|Overall Study||37
394068|NCT00975637|941822|P4|COMPLETED|Overall Study||32
394069|NCT00975637|941823|P3|COMPLETED|Overall Study||40
394070|NCT00975637|941824|P2|COMPLETED|Overall Study||38
394071|NCT00975637|941825|P1|COMPLETED|Overall Study||37
394072|NCT00975637|941821|P5|STARTED|Overall Study||39
394073|NCT00975637|941822|P4|STARTED|Overall Study||38
394074|NCT00975637|941823|P3|STARTED|Overall Study||42
394075|NCT00975637|941824|P2|STARTED|Overall Study||39
394076|NCT00975637|941825|P1|STARTED|Overall Study||40
394077|NCT00975611|941842|P1|NOT COMPLETED|Overall Study||17
394078|NCT00975611|941842|P1|COMPLETED|Overall Study||5
394079|NCT00975611|941842|P1|STARTED|Overall Study||22
394080|NCT00975585|941848|P2|NOT COMPLETED|Overall Study||12
394081|NCT00975585|941849|P1|NOT COMPLETED|Overall Study||7
394082|NCT00975585|941848|P2|COMPLETED|Overall Study||183
394083|NCT00975585|941849|P1|COMPLETED|Overall Study||177
394084|NCT00975585|941848|P2|STARTED|Overall Study||195
394085|NCT00975585|941849|P1|STARTED|Overall Study||184
394086|NCT00975507|941869|P2|NOT COMPLETED|Overall Study||4
394087|NCT00975507|941870|P1|NOT COMPLETED|Overall Study||20
394088|NCT00975507|941869|P2|COMPLETED|Overall Study||153
394089|NCT00975507|941870|P1|COMPLETED|Overall Study||303
394090|NCT00975507|941869|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
394091|NCT00975507|941870|P1|Vaccinated at Visit 2|Overall Study||310
394092|NCT00975507|941869|P2|Vaccinated at Visit 1|Overall Study||157
394093|NCT00975507|941870|P1|Vaccinated at Visit 1|Overall Study||323
394094|NCT00975507|941869|P2|STARTED|Overall Study||157
394095|NCT00975507|941870|P1|STARTED|Overall Study||323
394096|NCT00975481|941890|P6|NOT COMPLETED|Sixth Intervention Period||0
394097|NCT00975481|941891|P5|NOT COMPLETED|Sixth Intervention Period||0
394098|NCT00975481|941892|P4|NOT COMPLETED|Sixth Intervention Period||0
394099|NCT00975481|941893|P3|NOT COMPLETED|Sixth Intervention Period||0
394100|NCT00975481|941894|P2|NOT COMPLETED|Sixth Intervention Period||0
394101|NCT00975481|941895|P1|NOT COMPLETED|Sixth Intervention Period||0
394102|NCT00975481|941890|P6|COMPLETED|Sixth Intervention Period||6
394103|NCT00975481|941891|P5|COMPLETED|Sixth Intervention Period||5
394104|NCT00975481|941892|P4|COMPLETED|Sixth Intervention Period||5
394105|NCT00975481|941893|P3|COMPLETED|Sixth Intervention Period||4
394106|NCT00975481|941894|P2|COMPLETED|Sixth Intervention Period||5
394107|NCT00975481|941895|P1|COMPLETED|Sixth Intervention Period||4
394108|NCT00975481|941890|P6|STARTED|Sixth Intervention Period||6
394109|NCT00975481|941891|P5|STARTED|Sixth Intervention Period||5
394110|NCT00975481|941892|P4|STARTED|Sixth Intervention Period||5
394111|NCT00975481|941893|P3|STARTED|Sixth Intervention Period||4
394112|NCT00975481|941894|P2|STARTED|Sixth Intervention Period||5
394113|NCT00975481|941895|P1|STARTED|Sixth Intervention Period||4
394114|NCT00975481|941890|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394115|NCT00975481|941891|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394116|NCT00975481|941892|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394117|NCT00975481|941893|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394118|NCT00975481|941894|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394119|NCT00975481|941895|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394120|NCT00975481|941890|P6|COMPLETED|Washout Period (at Least 7 Days)||6
394121|NCT00975481|941891|P5|COMPLETED|Washout Period (at Least 7 Days)||5
394122|NCT00975481|941892|P4|COMPLETED|Washout Period (at Least 7 Days)||5
394123|NCT00975481|941893|P3|COMPLETED|Washout Period (at Least 7 Days)||4
394124|NCT00975481|941894|P2|COMPLETED|Washout Period (at Least 7 Days)||5
394125|NCT00975481|941895|P1|COMPLETED|Washout Period (at Least 7 Days)||4
394126|NCT00975481|941890|P6|STARTED|Washout Period (at Least 7 Days)||6
394127|NCT00975481|941891|P5|STARTED|Washout Period (at Least 7 Days)||5
394128|NCT00975481|941892|P4|STARTED|Washout Period (at Least 7 Days)||5
394129|NCT00975481|941893|P3|STARTED|Washout Period (at Least 7 Days)||4
394130|NCT00975481|941894|P2|STARTED|Washout Period (at Least 7 Days)||5
394131|NCT00975481|941895|P1|STARTED|Washout Period (at Least 7 Days)||4
394132|NCT00975481|941890|P6|NOT COMPLETED|Fifth Intervention Period||0
394133|NCT00975481|941891|P5|NOT COMPLETED|Fifth Intervention Period||1
394134|NCT00975481|941892|P4|NOT COMPLETED|Fifth Intervention Period||0
394135|NCT00975481|941893|P3|NOT COMPLETED|Fifth Intervention Period||0
394136|NCT00975481|941894|P2|NOT COMPLETED|Fifth Intervention Period||0
394137|NCT00975481|941895|P1|NOT COMPLETED|Fifth Intervention Period||0
394138|NCT00975481|941890|P6|COMPLETED|Fifth Intervention Period||6
394139|NCT00975481|941891|P5|COMPLETED|Fifth Intervention Period||5
394140|NCT00975481|941892|P4|COMPLETED|Fifth Intervention Period||5
394141|NCT00975481|941893|P3|COMPLETED|Fifth Intervention Period||4
394142|NCT00975481|941894|P2|COMPLETED|Fifth Intervention Period||5
394143|NCT00975481|941895|P1|COMPLETED|Fifth Intervention Period||4
394144|NCT00975481|941890|P6|STARTED|Fifth Intervention Period||6
394145|NCT00975481|941891|P5|STARTED|Fifth Intervention Period||6
394146|NCT00975481|941892|P4|STARTED|Fifth Intervention Period||5
394147|NCT00975481|941893|P3|STARTED|Fifth Intervention Period||4
394148|NCT00975481|941894|P2|STARTED|Fifth Intervention Period||5
394149|NCT00975481|941895|P1|STARTED|Fifth Intervention Period||4
394150|NCT00975481|941890|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394151|NCT00975481|941891|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394152|NCT00975481|941892|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394153|NCT00975481|941893|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394154|NCT00975481|941894|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394155|NCT00975481|941895|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394156|NCT00975481|941890|P6|COMPLETED|Washout Period (at Least 7 Days)||6
394157|NCT00975481|941891|P5|COMPLETED|Washout Period (at Least 7 Days)||6
394158|NCT00975481|941892|P4|COMPLETED|Washout Period (at Least 7 Days)||5
394159|NCT00975481|941893|P3|COMPLETED|Washout Period (at Least 7 Days)||4
394160|NCT00975481|941894|P2|COMPLETED|Washout Period (at Least 7 Days)||5
394161|NCT00975481|941895|P1|COMPLETED|Washout Period (at Least 7 Days)||4
394162|NCT00975481|941890|P6|STARTED|Washout Period (at Least 7 Days)||6
394163|NCT00975481|941891|P5|STARTED|Washout Period (at Least 7 Days)||6
394164|NCT00975481|941892|P4|STARTED|Washout Period (at Least 7 Days)||5
394165|NCT00975481|941893|P3|STARTED|Washout Period (at Least 7 Days)||4
394166|NCT00975481|941894|P2|STARTED|Washout Period (at Least 7 Days)||5
394167|NCT00975481|941895|P1|STARTED|Washout Period (at Least 7 Days)||4
394168|NCT00975481|941890|P6|NOT COMPLETED|Fourth Intervention Period||0
394169|NCT00975481|941891|P5|NOT COMPLETED|Fourth Intervention Period||0
394170|NCT00975481|941892|P4|NOT COMPLETED|Fourth Intervention Period||1
394171|NCT00975481|941893|P3|NOT COMPLETED|Fourth Intervention Period||1
394172|NCT00975481|941894|P2|NOT COMPLETED|Fourth Intervention Period||0
394173|NCT00975481|941895|P1|NOT COMPLETED|Fourth Intervention Period||0
394174|NCT00975481|941890|P6|COMPLETED|Fourth Intervention Period||6
394175|NCT00975481|941891|P5|COMPLETED|Fourth Intervention Period||6
394176|NCT00975481|941892|P4|COMPLETED|Fourth Intervention Period||5
394177|NCT00975481|941893|P3|COMPLETED|Fourth Intervention Period||4
394178|NCT00975481|941894|P2|COMPLETED|Fourth Intervention Period||5
394179|NCT00975481|941895|P1|COMPLETED|Fourth Intervention Period||4
394180|NCT00975481|941890|P6|STARTED|Fourth Intervention Period||6
394181|NCT00975481|941891|P5|STARTED|Fourth Intervention Period||6
394182|NCT00975481|941892|P4|STARTED|Fourth Intervention Period||6
394183|NCT00975481|941893|P3|STARTED|Fourth Intervention Period||5
394184|NCT00975481|941894|P2|STARTED|Fourth Intervention Period||5
394185|NCT00975481|941895|P1|STARTED|Fourth Intervention Period||4
394186|NCT00975481|941890|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394187|NCT00975481|941891|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394188|NCT00975481|941892|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394189|NCT00975481|941893|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394190|NCT00975481|941894|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394191|NCT00975481|941895|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394192|NCT00975481|941890|P6|COMPLETED|Washout Period (at Least 7 Days)||6
394193|NCT00975481|941891|P5|COMPLETED|Washout Period (at Least 7 Days)||6
394194|NCT00975481|941892|P4|COMPLETED|Washout Period (at Least 7 Days)||6
394195|NCT00975481|941893|P3|COMPLETED|Washout Period (at Least 7 Days)||5
394196|NCT00975481|941894|P2|COMPLETED|Washout Period (at Least 7 Days)||5
394197|NCT00975481|941895|P1|COMPLETED|Washout Period (at Least 7 Days)||4
394198|NCT00975481|941890|P6|STARTED|Washout Period (at Least 7 Days)||6
394199|NCT00975481|941891|P5|STARTED|Washout Period (at Least 7 Days)||6
394200|NCT00975481|941892|P4|STARTED|Washout Period (at Least 7 Days)||6
394201|NCT00975481|941893|P3|STARTED|Washout Period (at Least 7 Days)||5
394202|NCT00975481|941894|P2|STARTED|Washout Period (at Least 7 Days)||5
394203|NCT00975481|941895|P1|STARTED|Washout Period (at Least 7 Days)||4
394204|NCT00975481|941890|P6|NOT COMPLETED|Third Intervention Period||0
394205|NCT00975481|941891|P5|NOT COMPLETED|Third Intervention Period||0
394206|NCT00975481|941892|P4|NOT COMPLETED|Third Intervention Period||0
394207|NCT00975481|941893|P3|NOT COMPLETED|Third Intervention Period||0
394208|NCT00975481|941894|P2|NOT COMPLETED|Third Intervention Period||0
394209|NCT00975481|941895|P1|NOT COMPLETED|Third Intervention Period||0
394210|NCT00975481|941890|P6|COMPLETED|Third Intervention Period||6
394211|NCT00975481|941891|P5|COMPLETED|Third Intervention Period||6
394212|NCT00975481|941892|P4|COMPLETED|Third Intervention Period||6
394213|NCT00975481|941893|P3|COMPLETED|Third Intervention Period||5
394214|NCT00975481|941894|P2|COMPLETED|Third Intervention Period||5
394215|NCT00975481|941895|P1|COMPLETED|Third Intervention Period||4
394216|NCT00975481|941890|P6|STARTED|Third Intervention Period||6
394217|NCT00975481|941891|P5|STARTED|Third Intervention Period||6
394218|NCT00975481|941892|P4|STARTED|Third Intervention Period||6
394219|NCT00975481|941893|P3|STARTED|Third Intervention Period||5
394220|NCT00975481|941894|P2|STARTED|Third Intervention Period||5
394221|NCT00975481|941895|P1|STARTED|Third Intervention Period||4
394222|NCT00975481|941890|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394223|NCT00975481|941891|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394224|NCT00975481|941892|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394225|NCT00975481|941893|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394226|NCT00975481|941894|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394227|NCT00975481|941895|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394228|NCT00975481|941890|P6|COMPLETED|Washout Period (at Least 7 Days)||6
394229|NCT00975481|941891|P5|COMPLETED|Washout Period (at Least 7 Days)||6
394230|NCT00975481|941892|P4|COMPLETED|Washout Period (at Least 7 Days)||6
394231|NCT00975481|941893|P3|COMPLETED|Washout Period (at Least 7 Days)||5
394232|NCT00975481|941894|P2|COMPLETED|Washout Period (at Least 7 Days)||5
394233|NCT00975481|941895|P1|COMPLETED|Washout Period (at Least 7 Days)||4
394234|NCT00975481|941890|P6|STARTED|Washout Period (at Least 7 Days)||6
394235|NCT00975481|941891|P5|STARTED|Washout Period (at Least 7 Days)||6
394236|NCT00975481|941892|P4|STARTED|Washout Period (at Least 7 Days)||6
394237|NCT00975481|941893|P3|STARTED|Washout Period (at Least 7 Days)||5
394238|NCT00975481|941894|P2|STARTED|Washout Period (at Least 7 Days)||5
394239|NCT00975481|941895|P1|STARTED|Washout Period (at Least 7 Days)||4
394240|NCT00975481|941890|P6|NOT COMPLETED|Second Intervention Period||0
394241|NCT00975481|941891|P5|NOT COMPLETED|Second Intervention Period||0
394242|NCT00975481|941892|P4|NOT COMPLETED|Second Intervention Period||0
394243|NCT00975481|941893|P3|NOT COMPLETED|Second Intervention Period||1
394244|NCT00975481|941894|P2|NOT COMPLETED|Second Intervention Period||1
394245|NCT00975481|941895|P1|NOT COMPLETED|Second Intervention Period||2
394246|NCT00975481|941890|P6|COMPLETED|Second Intervention Period||6
394247|NCT00975481|941891|P5|COMPLETED|Second Intervention Period||6
394248|NCT00975481|941892|P4|COMPLETED|Second Intervention Period||6
394249|NCT00975481|941893|P3|COMPLETED|Second Intervention Period||5
394250|NCT00975481|941894|P2|COMPLETED|Second Intervention Period||5
394251|NCT00975481|941895|P1|COMPLETED|Second Intervention Period||4
394252|NCT00975481|941890|P6|STARTED|Second Intervention Period||6
394253|NCT00975481|941891|P5|STARTED|Second Intervention Period||6
394254|NCT00975481|941892|P4|STARTED|Second Intervention Period||6
394255|NCT00975481|941893|P3|STARTED|Second Intervention Period||6
394256|NCT00975481|941894|P2|STARTED|Second Intervention Period||6
394257|NCT00975481|941895|P1|STARTED|Second Intervention Period||6
394258|NCT00975481|941890|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394259|NCT00975481|941891|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394260|NCT00975481|941892|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394261|NCT00975481|941893|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394262|NCT00975481|941894|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394263|NCT00975481|941895|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
394264|NCT00975481|941890|P6|COMPLETED|Washout Period (at Least 7 Days)||6
394265|NCT00975481|941891|P5|COMPLETED|Washout Period (at Least 7 Days)||6
394266|NCT00975481|941892|P4|COMPLETED|Washout Period (at Least 7 Days)||6
394267|NCT00975481|941893|P3|COMPLETED|Washout Period (at Least 7 Days)||6
394268|NCT00975481|941894|P2|COMPLETED|Washout Period (at Least 7 Days)||6
394269|NCT00975481|941895|P1|COMPLETED|Washout Period (at Least 7 Days)||6
394270|NCT00975481|941890|P6|STARTED|Washout Period (at Least 7 Days)||6
394271|NCT00975481|941891|P5|STARTED|Washout Period (at Least 7 Days)||6
394272|NCT00975481|941892|P4|STARTED|Washout Period (at Least 7 Days)||6
394273|NCT00975481|941893|P3|STARTED|Washout Period (at Least 7 Days)||6
394274|NCT00975481|941894|P2|STARTED|Washout Period (at Least 7 Days)||6
394275|NCT00975481|941895|P1|STARTED|Washout Period (at Least 7 Days)||6
394276|NCT00975481|941890|P6|NOT COMPLETED|First Intervention Period||0
394277|NCT00975481|941891|P5|NOT COMPLETED|First Intervention Period||0
394278|NCT00975481|941892|P4|NOT COMPLETED|First Intervention Period||0
394279|NCT00975481|941893|P3|NOT COMPLETED|First Intervention Period||0
394280|NCT00975481|941894|P2|NOT COMPLETED|First Intervention Period||0
394281|NCT00975481|941895|P1|NOT COMPLETED|First Intervention Period||0
394282|NCT00975481|941890|P6|COMPLETED|First Intervention Period||6
394283|NCT00975481|941891|P5|COMPLETED|First Intervention Period||6
394284|NCT00975481|941892|P4|COMPLETED|First Intervention Period||6
394285|NCT00975481|941893|P3|COMPLETED|First Intervention Period||6
394286|NCT00975481|941894|P2|COMPLETED|First Intervention Period||6
394287|NCT00975481|941895|P1|COMPLETED|First Intervention Period||6
394288|NCT00975481|941890|P6|STARTED|First Intervention Period||6
394289|NCT00975481|941891|P5|STARTED|First Intervention Period||6
394290|NCT00975481|941892|P4|STARTED|First Intervention Period||6
394291|NCT00975481|941893|P3|STARTED|First Intervention Period||6
394292|NCT00975481|941894|P2|STARTED|First Intervention Period||6
394293|NCT00975481|941895|P1|STARTED|First Intervention Period||6
394294|NCT00975416|941995|P2|NOT COMPLETED|Overall Study||5
394295|NCT00975416|941996|P1|NOT COMPLETED|Overall Study||3
394296|NCT00975416|941995|P2|COMPLETED|Overall Study||11
394297|NCT00975416|941996|P1|COMPLETED|Overall Study||11
394298|NCT00975416|941995|P2|STARTED|Overall Study||16
394299|NCT00975416|941996|P1|STARTED|Overall Study||14
394300|NCT00975286|942005|P2|NOT COMPLETED|Overall Study||29
394301|NCT00975286|942006|P1|NOT COMPLETED|Overall Study||12
394302|NCT00975286|942005|P2|COMPLETED|Overall Study||194
394303|NCT00975286|942006|P1|COMPLETED|Overall Study||211
394304|NCT00975286|942005|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
394305|NCT00975286|942006|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
394306|NCT00975286|942005|P2|Safety Population|Overall Study||223
394307|NCT00975286|942006|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
394308|NCT00975286|942005|P2|STARTED|Overall Study||223
394309|NCT00975286|942006|P1|STARTED|Overall Study|Randomized.|223
394310|NCT00975221|942038|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
394311|NCT00975221|942039|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
394312|NCT00975221|942038|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
394313|NCT00975221|942039|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
394314|NCT00975221|942038|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
394315|NCT00975221|942039|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
394316|NCT00975221|942038|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
394317|NCT00975221|942039|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
394318|NCT00975221|942038|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
394319|NCT00975221|942039|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
394320|NCT00975221|942038|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
394321|NCT00975221|942039|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
394322|NCT00975221|942038|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
394323|NCT00975221|942039|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
394324|NCT00975221|942038|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
394325|NCT00975221|942039|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
394326|NCT00975221|942038|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
394327|NCT00975221|942039|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
394328|NCT00975221|942038|P2|STARTED|Titration Phase (Weeks 1-12)||33
394329|NCT00975221|942039|P1|STARTED|Titration Phase (Weeks 1-12)||34
394330|NCT00975195|942055|P2|NOT COMPLETED|Overall Study||233
394331|NCT00975195|942056|P1|NOT COMPLETED|Overall Study||228
394332|NCT00975195|942055|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
394333|NCT00975195|942056|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
394334|NCT00975195|942055|P2|STARTED|Overall Study||1244
394335|NCT00975195|942056|P1|STARTED|Overall Study||1244
394336|NCT00975156|942116|P2|NOT COMPLETED|Overall Study||1
394337|NCT00975156|942117|P1|NOT COMPLETED|Overall Study||0
394338|NCT00975156|942116|P2|COMPLETED|Overall Study||9
394339|NCT00975156|942117|P1|COMPLETED|Overall Study||11
394340|NCT00975156|942116|P2|STARTED|Overall Study||10
394341|NCT00975156|942117|P1|STARTED|Overall Study||11
394342|NCT00975143|942129|P2|NOT COMPLETED|Overall Study||60
394343|NCT00975143|942130|P1|NOT COMPLETED|Overall Study||70
394344|NCT00975143|942129|P2|COMPLETED|Overall Study||401
394345|NCT00975143|942130|P1|COMPLETED|Overall Study||394
394346|NCT00975143|942129|P2|Completed Treatment (Week 20)|Overall Study||410
394347|NCT00975143|942130|P1|Completed Treatment (Week 20)|Overall Study||403
394348|NCT00975143|942129|P2|STARTED|Overall Study||461
394349|NCT00975143|942130|P1|STARTED|Overall Study||464
394350|NCT00975130|942140|P3|NOT COMPLETED|Study Part 2||17
394351|NCT00975130|942141|P2|NOT COMPLETED|Study Part 2||38
394352|NCT00975130|942142|P1|NOT COMPLETED|Study Part 2||0
394353|NCT00975130|942140|P3|COMPLETED|Study Part 2||238
394354|NCT00975130|942141|P2|COMPLETED|Study Part 2||212
394355|NCT00975130|942142|P1|COMPLETED|Study Part 2||0
394356|NCT00975130|942140|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
394357|NCT00975130|942141|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
394358|NCT00975130|942142|P1|STARTED|Study Part 2||0
394359|NCT00975130|942140|P3|NOT COMPLETED|Study Part 1||0
394360|NCT00975130|942141|P2|NOT COMPLETED|Study Part 1||0
394361|NCT00975130|942142|P1|NOT COMPLETED|Study Part 1||280
394362|NCT00975130|942140|P3|COMPLETED|Study Part 1||0
394363|NCT00975130|942141|P2|COMPLETED|Study Part 1||0
394364|NCT00975130|942142|P1|COMPLETED|Study Part 1||3086
394365|NCT00975130|942140|P3|STARTED|Study Part 1||0
394366|NCT00975130|942141|P2|STARTED|Study Part 1||0
394367|NCT00975130|942142|P1|STARTED|Study Part 1||3366
394368|NCT00975000|942326|P2|NOT COMPLETED|Overall Study||5
394369|NCT00975000|942327|P1|NOT COMPLETED|Overall Study||5
394370|NCT00975000|942326|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
394371|NCT00975000|942327|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
394372|NCT00975000|942326|P2|Completed Maintenance Phase|Overall Study||52
394373|NCT00975000|942327|P1|Completed Maintenance Phase|Overall Study||52
394374|NCT00975000|942326|P2|Completed Efficacy Assessment Phase|Overall Study||54
394375|NCT00975000|942327|P1|Completed Efficacy Assessment Phase|Overall Study||54
394376|NCT00975000|942326|P2|Completed Titration Phase|Overall Study||55
394377|NCT00975000|942327|P1|Completed Titration Phase|Overall Study||54
394378|NCT00975000|942326|P2|STARTED|Overall Study||57
394379|NCT00975000|942327|P1|STARTED|Overall Study||57
394380|NCT00974974|942351|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
394381|NCT00974974|942352|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
394382|NCT00974974|942351|P2|COMPLETED|Maintenance - Double Blind Treatment||182
394383|NCT00974974|942352|P1|COMPLETED|Maintenance - Double Blind Treatment||186
394384|NCT00974974|942351|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
394385|NCT00974974|942352|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
394386|NCT00974974|942351|P2|NOT COMPLETED|IPX066 Dose Conversion||0
394387|NCT00974974|942352|P1|NOT COMPLETED|IPX066 Dose Conversion||57
394388|NCT00974974|942351|P2|COMPLETED|IPX066 Dose Conversion||0
394389|NCT00974974|942352|P1|COMPLETED|IPX066 Dose Conversion||393
394390|NCT00974974|942351|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
394391|NCT00974974|942352|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
394392|NCT00974974|942351|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
394393|NCT00974974|942352|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
394394|NCT00974974|942351|P2|COMPLETED|IR CD-LD Dose Adjustment||450
394395|NCT00974974|942352|P1|COMPLETED|IR CD-LD Dose Adjustment||0
394396|NCT00974974|942351|P2|STARTED|IR CD-LD Dose Adjustment||471
394397|NCT00974974|942352|P1|STARTED|IR CD-LD Dose Adjustment||0
394398|NCT00974818|942364|P2|NOT COMPLETED|Overall Study||0
394399|NCT00974818|942365|P1|NOT COMPLETED|Overall Study||0
394400|NCT00974818|942364|P2|COMPLETED|Overall Study||25
394401|NCT00974818|942365|P1|COMPLETED|Overall Study||25
394402|NCT00974818|942364|P2|STARTED|Overall Study||25
394403|NCT00974818|942365|P1|STARTED|Overall Study||25
394404|NCT00974675|942375|P4|NOT COMPLETED|Overall Study||2
394405|NCT00974675|942376|P3|NOT COMPLETED|Overall Study||2
394406|NCT00974675|942377|P2|NOT COMPLETED|Overall Study||1
394407|NCT00974675|942378|P1|NOT COMPLETED|Overall Study||2
394408|NCT00974675|942375|P4|COMPLETED|Overall Study||2
394409|NCT00974675|942376|P3|COMPLETED|Overall Study||1
394410|NCT00974675|942377|P2|COMPLETED|Overall Study||7
394411|NCT00974675|942378|P1|COMPLETED|Overall Study||6
394412|NCT00974675|942375|P4|STARTED|Overall Study||4
394413|NCT00974675|942376|P3|STARTED|Overall Study||3
394414|NCT00974675|942377|P2|STARTED|Overall Study||8
394415|NCT00974675|942378|P1|STARTED|Overall Study||8
394416|NCT00974571|942427|P3|NOT COMPLETED|Overall Study||83
394417|NCT00974571|942428|P2|NOT COMPLETED|Overall Study||16
394418|NCT00974571|942429|P1|NOT COMPLETED|Overall Study||68
394419|NCT00974571|942427|P3|COMPLETED|Overall Study||530
394420|NCT00974571|942428|P2|COMPLETED|Overall Study||106
394421|NCT00974571|942429|P1|COMPLETED|Overall Study||562
394422|NCT00974571|942427|P3|STARTED|Overall Study||613
394423|NCT00974571|942428|P2|STARTED|Overall Study||122
394424|NCT00974571|942429|P1|STARTED|Overall Study||630
394425|NCT00974480|942452|P3|NOT COMPLETED|Overall Study||10
394426|NCT00974480|942453|P2|NOT COMPLETED|Overall Study||7
394427|NCT00974480|942454|P1|NOT COMPLETED|Overall Study||11
394428|NCT00974480|942452|P3|COMPLETED|Overall Study||30
394429|NCT00974480|942453|P2|COMPLETED|Overall Study||33
394430|NCT00974480|942454|P1|COMPLETED|Overall Study||29
394431|NCT00974480|942452|P3|STARTED|Overall Study||40
394432|NCT00974480|942453|P2|STARTED|Overall Study||40
394433|NCT00974480|942454|P1|STARTED|Overall Study||40
394434|NCT00974376|942494|P2|NOT COMPLETED|Overall Study||33
394435|NCT00974376|942495|P1|NOT COMPLETED|Overall Study||34
394436|NCT00974376|942494|P2|COMPLETED|Overall Study||42
394437|NCT00974376|942495|P1|COMPLETED|Overall Study||41
394438|NCT00974376|942494|P2|STARTED|Overall Study||75
394439|NCT00974376|942495|P1|STARTED|Overall Study||75
394440|NCT00974363|942503|P2|NOT COMPLETED|Overall Study||0
394441|NCT00974363|942504|P1|NOT COMPLETED|Overall Study||0
394442|NCT00974363|942503|P2|COMPLETED|Overall Study||168
394443|NCT00974363|942504|P1|COMPLETED|Overall Study||521
394444|NCT00974363|942503|P2|STARTED|Overall Study||168
394445|NCT00974363|942504|P1|STARTED|Overall Study||521
394446|NCT00974311|942526|P2|NOT COMPLETED|Overall Study||236
394447|NCT00974311|942527|P1|NOT COMPLETED|Overall Study||546
394448|NCT00974311|942526|P2|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|163
394449|NCT00974311|942527|P1|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|254
394450|NCT00974311|942526|P2|STARTED|Overall Study||399
394451|NCT00974311|942527|P1|STARTED|Overall Study||800
394452|NCT00974246|942547|P1|NOT COMPLETED|Overall Study||0
394453|NCT00974246|942547|P1|COMPLETED|Overall Study||27
394454|NCT00974246|942547|P1|STARTED|Overall Study||27
394455|NCT00974220|942555|P2|NOT COMPLETED|Treatment Period 2||0
394456|NCT00974220|942556|P1|NOT COMPLETED|Treatment Period 2||0
394457|NCT00974220|942555|P2|COMPLETED|Treatment Period 2||5
394458|NCT00974220|942556|P1|COMPLETED|Treatment Period 2||7
394459|NCT00974220|942555|P2|STARTED|Treatment Period 2||5
394460|NCT00974220|942556|P1|STARTED|Treatment Period 2||7
394461|NCT00974220|942555|P2|NOT COMPLETED|Treatment Period 1||2
394462|NCT00974220|942556|P1|NOT COMPLETED|Treatment Period 1||2
394463|NCT00974220|942555|P2|COMPLETED|Treatment Period 1||5
394464|NCT00974220|942556|P1|COMPLETED|Treatment Period 1||7
394465|NCT00974220|942555|P2|STARTED|Treatment Period 1||7
394466|NCT00974220|942556|P1|STARTED|Treatment Period 1||9
394467|NCT00974090|942566|P2|NOT COMPLETED|Period 2: Open-label Period||10
394468|NCT00974090|942567|P1|NOT COMPLETED|Period 2: Open-label Period||8
394469|NCT00974090|942566|P2|COMPLETED|Period 2: Open-label Period||85
394470|NCT00974090|942567|P1|COMPLETED|Period 2: Open-label Period||87
394471|NCT00974090|942566|P2|STARTED|Period 2: Open-label Period||95
394472|NCT00974090|942567|P1|STARTED|Period 2: Open-label Period||95
394473|NCT00974090|942566|P2|NOT COMPLETED|Period 1: Double Blind Period||1
394474|NCT00974090|942567|P1|NOT COMPLETED|Period 1: Double Blind Period||3
394475|NCT00974090|942566|P2|COMPLETED|Period 1: Double Blind Period||95
394476|NCT00974090|942567|P1|COMPLETED|Period 1: Double Blind Period||95
394477|NCT00974090|942566|P2|STARTED|Period 1: Double Blind Period||96
394478|NCT00974090|942567|P1|STARTED|Period 1: Double Blind Period||98
394479|NCT00974051|942581|P3|NOT COMPLETED|Overall Study||0
394480|NCT00974051|942582|P2|NOT COMPLETED|Overall Study||0
394481|NCT00974051|942583|P1|NOT COMPLETED|Overall Study||0
394482|NCT00974051|942581|P3|COMPLETED|Overall Study||6
394483|NCT00974051|942582|P2|COMPLETED|Overall Study||4
394484|NCT00974051|942583|P1|COMPLETED|Overall Study||6
394485|NCT00974051|942581|P3|STARTED|Overall Study||6
394486|NCT00974051|942582|P2|STARTED|Overall Study||4
394487|NCT00974051|942583|P1|STARTED|Overall Study||6
394488|NCT00973921|942601|P1|NOT COMPLETED|Overall Study||9
394489|NCT00973921|942601|P1|COMPLETED|Overall Study||31
394490|NCT00973921|942601|P1|STARTED|Overall Study||40
394491|NCT00973765|942610|P2|NOT COMPLETED|Overall Study||14
394492|NCT00973765|942611|P1|NOT COMPLETED|Overall Study||8
394493|NCT00973765|942610|P2|COMPLETED|Overall Study|102|102
394494|NCT00973765|942611|P1|COMPLETED|Overall Study|88|88
394495|NCT00973765|942610|P2|STARTED|Overall Study|116|116
394496|NCT00973765|942611|P1|STARTED|Overall Study|96|96
394497|NCT00973752|942617|P1|NOT COMPLETED|Overall Study||0
394498|NCT00973752|942617|P1|COMPLETED|Overall Study||30
394499|NCT00973752|942617|P1|STARTED|Overall Study||30
394500|NCT00973739|942621|P1|NOT COMPLETED|Overall Study||4
394501|NCT00973739|942621|P1|COMPLETED|Overall Study||17
394502|NCT00973739|942621|P1|STARTED|Overall Study||21
394503|NCT00973700|942633|P5|NOT COMPLETED|Overall Study||10
394504|NCT00973700|942634|P4|NOT COMPLETED|Overall Study||18
394505|NCT00973700|942635|P3|NOT COMPLETED|Overall Study||10
394506|NCT00973700|942636|P2|NOT COMPLETED|Overall Study||2
394507|NCT00973700|942637|P1|NOT COMPLETED|Overall Study||7
394508|NCT00973700|942633|P5|COMPLETED|Overall Study||158
394509|NCT00973700|942634|P4|COMPLETED|Overall Study||318
394510|NCT00973700|942635|P3|COMPLETED|Overall Study||158
394511|NCT00973700|942636|P2|COMPLETED|Overall Study||54
394512|NCT00973700|942637|P1|COMPLETED|Overall Study||49
394513|NCT00973700|942633|P5|STARTED|Overall Study||168
394514|NCT00973700|942634|P4|STARTED|Overall Study||336
394515|NCT00973700|942635|P3|STARTED|Overall Study||168
394516|NCT00973700|942636|P2|STARTED|Overall Study||56
394517|NCT00973700|942637|P1|STARTED|Overall Study||56
394518|NCT00973622|942686|P2|NOT COMPLETED|Overall Study||5
394519|NCT00973622|942687|P1|NOT COMPLETED|Overall Study||31
394520|NCT00973622|942686|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
394521|NCT00973622|942687|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
394522|NCT00973622|942686|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
394523|NCT00973622|942687|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
394524|NCT00973479|942695|P2|NOT COMPLETED|Overall Study||69
394525|NCT00973479|942696|P1|NOT COMPLETED|Overall Study||37
394526|NCT00973479|942695|P2|COMPLETED|Overall Study||326
394527|NCT00973479|942696|P1|COMPLETED|Overall Study||160
394528|NCT00973479|942695|P2|STARTED|Overall Study||395
394529|NCT00973479|942696|P1|STARTED|Overall Study||197
394530|NCT00973362|942714|P2|NOT COMPLETED|3-Year Follow-up||0
394531|NCT00973362|942715|P1|NOT COMPLETED|3-Year Follow-up||17
394532|NCT00973362|942714|P2|COMPLETED|3-Year Follow-up||0
394533|NCT00973362|942715|P1|COMPLETED|3-Year Follow-up||10854
394534|NCT00973362|942714|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
394535|NCT00973362|942715|P1|STARTED|3-Year Follow-up||10871
394536|NCT00973362|942714|P2|NOT COMPLETED|Baseline Evaluation||223
394537|NCT00973362|942715|P1|NOT COMPLETED|Baseline Evaluation||773
394538|NCT00973362|942714|P2|COMPLETED|Baseline Evaluation||1029
394539|NCT00973362|942715|P1|COMPLETED|Baseline Evaluation||10871
394540|NCT00973362|942714|P2|Conclusive Disease Status|Baseline Evaluation||939
394541|NCT00973362|942715|P1|Conclusive Disease Status|Baseline Evaluation||819
394542|NCT00973362|942714|P2|Evaluable for Analysis|Baseline Evaluation||958
394543|NCT00973362|942715|P1|Evaluable for Analysis|Baseline Evaluation||10871
394544|NCT00973362|942714|P2|STARTED|Baseline Evaluation||1252
394545|NCT00973362|942715|P1|STARTED|Baseline Evaluation||11644
394546|NCT00973349|942740|P16|NOT COMPLETED|Overall Study||2
394547|NCT00973349|942741|P15|NOT COMPLETED|Overall Study||2
394548|NCT00973349|942742|P14|NOT COMPLETED|Overall Study||0
394549|NCT00973349|942743|P13|NOT COMPLETED|Overall Study||1
394550|NCT00973349|942744|P12|NOT COMPLETED|Overall Study||2
394551|NCT00973349|942745|P11|NOT COMPLETED|Overall Study||0
394552|NCT00973349|942746|P10|NOT COMPLETED|Overall Study||6
394553|NCT00973349|942747|P9|NOT COMPLETED|Overall Study||4
394554|NCT00973349|942748|P8|NOT COMPLETED|Overall Study||3
394555|NCT00973349|942749|P7|NOT COMPLETED|Overall Study||2
394556|NCT00973349|942750|P6|NOT COMPLETED|Overall Study||4
394557|NCT00973349|942751|P5|NOT COMPLETED|Overall Study||5
394558|NCT00973349|942752|P4|NOT COMPLETED|Overall Study||5
394559|NCT00973349|942753|P3|NOT COMPLETED|Overall Study||5
394560|NCT00973349|942754|P2|NOT COMPLETED|Overall Study||3
394561|NCT00973349|942755|P1|NOT COMPLETED|Overall Study||4
394562|NCT00973349|942740|P16|COMPLETED|Overall Study||165
394563|NCT00973349|942741|P15|COMPLETED|Overall Study||168
394564|NCT00973349|942742|P14|COMPLETED|Overall Study||171
394565|NCT00973349|942743|P13|COMPLETED|Overall Study||168
394566|NCT00973349|942744|P12|COMPLETED|Overall Study||167
394567|NCT00973349|942745|P11|COMPLETED|Overall Study||174
394568|NCT00973349|942746|P10|COMPLETED|Overall Study||163
394569|NCT00973349|942747|P9|COMPLETED|Overall Study||167
394570|NCT00973349|942748|P8|COMPLETED|Overall Study||166
394571|NCT00973349|942749|P7|COMPLETED|Overall Study||172
394572|NCT00973349|942750|P6|COMPLETED|Overall Study||165
394573|NCT00973349|942751|P5|COMPLETED|Overall Study||165
394574|NCT00973349|942752|P4|COMPLETED|Overall Study||163
394575|NCT00973349|942753|P3|COMPLETED|Overall Study||166
394576|NCT00973349|942754|P2|COMPLETED|Overall Study||165
394577|NCT00973349|942755|P1|COMPLETED|Overall Study||166
394578|NCT00973349|942740|P16|STARTED|Overall Study||167
394579|NCT00973349|942741|P15|STARTED|Overall Study||170
394580|NCT00973349|942742|P14|STARTED|Overall Study||171
394581|NCT00973349|942743|P13|STARTED|Overall Study||169
394582|NCT00973349|942744|P12|STARTED|Overall Study||169
394583|NCT00973349|942745|P11|STARTED|Overall Study||174
394584|NCT00973349|942746|P10|STARTED|Overall Study||169
394585|NCT00973349|942747|P9|STARTED|Overall Study||171
394586|NCT00973349|942748|P8|STARTED|Overall Study||169
394587|NCT00973349|942749|P7|STARTED|Overall Study||174
394588|NCT00973349|942750|P6|STARTED|Overall Study||169
394589|NCT00973349|942751|P5|STARTED|Overall Study||170
394590|NCT00973349|942752|P4|STARTED|Overall Study||168
394591|NCT00973349|942753|P3|STARTED|Overall Study||171
394592|NCT00973349|942754|P2|STARTED|Overall Study||168
394593|NCT00973349|942755|P1|STARTED|Overall Study||170
394594|NCT00972959|942853|P1|NOT COMPLETED|Overall Study||0
394595|NCT00972959|942853|P1|COMPLETED|Overall Study||17
394596|NCT00972959|942853|P1|STARTED|Overall Study||17
394597|NCT00972816|942876|P8|NOT COMPLETED|Overall Study||9
394598|NCT00972816|942877|P7|NOT COMPLETED|Overall Study||10
394599|NCT00972816|942878|P6|NOT COMPLETED|Overall Study||11
394600|NCT00972816|942879|P5|NOT COMPLETED|Overall Study||12
394601|NCT00972816|942880|P4|NOT COMPLETED|Overall Study||8
394602|NCT00972816|942881|P3|NOT COMPLETED|Overall Study||9
394603|NCT00972816|942882|P2|NOT COMPLETED|Overall Study||11
394604|NCT00972816|942883|P1|NOT COMPLETED|Overall Study||17
394605|NCT00972816|942876|P8|COMPLETED|Overall Study||161
394606|NCT00972816|942877|P7|COMPLETED|Overall Study||159
394607|NCT00972816|942878|P6|COMPLETED|Overall Study||158
394608|NCT00972816|942879|P5|COMPLETED|Overall Study||157
394609|NCT00972816|942880|P4|COMPLETED|Overall Study||161
394610|NCT00972816|942881|P3|COMPLETED|Overall Study||160
394611|NCT00972816|942882|P2|COMPLETED|Overall Study||158
394612|NCT00972816|942883|P1|COMPLETED|Overall Study||156
394613|NCT00972816|942876|P8|STARTED|Overall Study||170
394614|NCT00972816|942877|P7|STARTED|Overall Study||169
394615|NCT00972816|942878|P6|STARTED|Overall Study||169
394616|NCT00972816|942879|P5|STARTED|Overall Study||169
394617|NCT00972816|942880|P4|STARTED|Overall Study||169
394618|NCT00972816|942881|P3|STARTED|Overall Study||169
394619|NCT00972816|942882|P2|STARTED|Overall Study||169
394620|NCT00972816|942883|P1|STARTED|Overall Study||173
394621|NCT00972777|942967|P2|NOT COMPLETED|Overall Study||14
394622|NCT00972777|942968|P1|NOT COMPLETED|Overall Study||14
394623|NCT00972777|942967|P2|COMPLETED|Overall Study||229
394624|NCT00972777|942968|P1|COMPLETED|Overall Study||217
394625|NCT00972777|942967|P2|STARTED|Overall Study||243
394626|NCT00972777|942968|P1|STARTED|Overall Study||231
394627|NCT00972738|942983|P3|NOT COMPLETED|Overall Study||29
394628|NCT00972738|942984|P2|NOT COMPLETED|Overall Study||6
394629|NCT00972738|942985|P1|NOT COMPLETED|Overall Study||21
394630|NCT00972738|942983|P3|COMPLETED|Overall Study||492
394631|NCT00972738|942984|P2|COMPLETED|Overall Study||165
394632|NCT00972738|942985|P1|COMPLETED|Overall Study||501
394633|NCT00972738|942983|P3|STARTED|Overall Study||521
394634|NCT00972738|942984|P2|STARTED|Overall Study||171
394635|NCT00972738|942985|P1|STARTED|Overall Study||522
394636|NCT00972725|943010|P2|NOT COMPLETED|Overall Study||0
394637|NCT00972725|943011|P1|NOT COMPLETED|Overall Study||0
394638|NCT00972725|943010|P2|COMPLETED|Overall Study||15
394639|NCT00972725|943011|P1|COMPLETED|Overall Study||13
394640|NCT00972725|943010|P2|STARTED|Overall Study||15
394641|NCT00972725|943011|P1|STARTED|Overall Study||13
394642|NCT00972621|943093|P2|NOT COMPLETED|Overall Study||1
394643|NCT00972621|943094|P1|NOT COMPLETED|Overall Study||0
394644|NCT00972621|943093|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
394645|NCT00972621|943094|P1|COMPLETED|Overall Study||200
394646|NCT00972621|943093|P2|STARTED|Overall Study||200
394647|NCT00972621|943094|P1|STARTED|Overall Study||200
394648|NCT00972595|943102|P2|NOT COMPLETED|Period 2||0
394649|NCT00972595|943103|P1|NOT COMPLETED|Period 2||0
394650|NCT00972595|943102|P2|COMPLETED|Period 2||22
394651|NCT00972595|943103|P1|COMPLETED|Period 2||22
394652|NCT00972595|943102|P2|STARTED|Period 2||22
394653|NCT00972595|943103|P1|STARTED|Period 2||22
394654|NCT00972595|943102|P2|NOT COMPLETED|Period 1||0
394655|NCT00972595|943103|P1|NOT COMPLETED|Period 1||1
394656|NCT00972595|943102|P2|COMPLETED|Period 1||22
394657|NCT00972595|943103|P1|COMPLETED|Period 1||22
394658|NCT00972595|943102|P2|STARTED|Period 1||22
394659|NCT00972595|943103|P1|STARTED|Period 1||23
394660|NCT00972543|943113|P2|NOT COMPLETED|Overall Study||1
394661|NCT00972543|943114|P1|NOT COMPLETED|Overall Study||5
394662|NCT00972543|943113|P2|COMPLETED|Overall Study||0
394663|NCT00972543|943114|P1|COMPLETED|Overall Study||0
394664|NCT00972543|943113|P2|STARTED|Overall Study||1
394665|NCT00972543|943114|P1|STARTED|Overall Study||5
394666|NCT00972530|943190|P2|NOT COMPLETED|Overall Study||0
394667|NCT00972530|943191|P1|NOT COMPLETED|Overall Study||0
394668|NCT00972530|943190|P2|COMPLETED|Overall Study||46
394669|NCT00972530|943191|P1|COMPLETED|Overall Study||44
394670|NCT00972530|943190|P2|STARTED|Overall Study||46
394671|NCT00972530|943191|P1|STARTED|Overall Study||44
394672|NCT00972478|943199|P2|NOT COMPLETED|Overall Study||38
394673|NCT00972478|943200|P1|NOT COMPLETED|Overall Study||7
394674|NCT00972478|943199|P2|COMPLETED|Overall Study||34
394675|NCT00972478|943200|P1|COMPLETED|Overall Study||4
394676|NCT00972478|943199|P2|Eligible and Began Protocol Therapy|Overall Study||63
394677|NCT00972478|943200|P1|Eligible and Began Protocol Therapy|Overall Study||9
394678|NCT00972478|943199|P2|STARTED|Overall Study||72
394679|NCT00972478|943200|P1|STARTED|Overall Study||11
394680|NCT00972374|943213|P3|NOT COMPLETED|Overall Study||1
394681|NCT00972374|943214|P2|NOT COMPLETED|Overall Study||0
394682|NCT00972374|943215|P1|NOT COMPLETED|Overall Study||2
394683|NCT00972374|943213|P3|COMPLETED|Overall Study||13
394684|NCT00972374|943214|P2|COMPLETED|Overall Study||15
394685|NCT00972374|943215|P1|COMPLETED|Overall Study||13
394686|NCT00972374|943213|P3|STARTED|Overall Study||14
394687|NCT00972374|943214|P2|STARTED|Overall Study||15
394688|NCT00972374|943215|P1|STARTED|Overall Study||15
394689|NCT00972335|943229|P1|NOT COMPLETED|Overall Study||17
394690|NCT00972335|943229|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
394691|NCT00972335|943229|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
394692|NCT00972322|943236|P2|NOT COMPLETED|Overall Study||3
394693|NCT00972322|943237|P1|NOT COMPLETED|Overall Study||3
394694|NCT00972322|943236|P2|COMPLETED|Overall Study||25
394695|NCT00972322|943237|P1|COMPLETED|Overall Study||25
394696|NCT00972322|943236|P2|STARTED|Overall Study||28
394697|NCT00972322|943237|P1|STARTED|Overall Study||28
394698|NCT00972283|943249|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
394699|NCT00972283|943250|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
394700|NCT00972283|943249|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
394701|NCT00972283|943250|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
394702|NCT00972283|943249|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
394703|NCT00972283|943250|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
394704|NCT00972283|943249|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
394705|NCT00972283|943250|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
394706|NCT00972283|943249|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
394707|NCT00972283|943250|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
394708|NCT00972283|943249|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
394709|NCT00972283|943250|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
394710|NCT00972283|943249|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
394711|NCT00972283|943250|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
394712|NCT00972283|943249|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
394713|NCT00972283|943250|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
394714|NCT00972244|943277|P5|NOT COMPLETED|Overall Study||9
394715|NCT00972244|943278|P4|NOT COMPLETED|Overall Study||0
394716|NCT00972244|943279|P3|NOT COMPLETED|Overall Study||2
394717|NCT00972244|943280|P2|NOT COMPLETED|Overall Study||5
394718|NCT00972244|943281|P1|NOT COMPLETED|Overall Study||5
394719|NCT00972244|943277|P5|COMPLETED|Overall Study||45
394720|NCT00972244|943278|P4|COMPLETED|Overall Study||52
394721|NCT00972244|943279|P3|COMPLETED|Overall Study||56
394722|NCT00972244|943280|P2|COMPLETED|Overall Study||51
394723|NCT00972244|943281|P1|COMPLETED|Overall Study||54
394724|NCT00972244|943277|P5|STARTED|Overall Study||54
394725|NCT00972244|943278|P4|STARTED|Overall Study||52
394726|NCT00972244|943279|P3|STARTED|Overall Study||58
394727|NCT00972244|943280|P2|STARTED|Overall Study||56
394728|NCT00972244|943281|P1|STARTED|Overall Study||59
394729|NCT00972205|943303|P1|NOT COMPLETED|Overall Study||0
394730|NCT00972205|943303|P1|COMPLETED|Overall Study||12
394731|NCT00972205|943303|P1|STARTED|Overall Study||12
394732|NCT00972153|943313|P3|NOT COMPLETED|Overall Study||0
394733|NCT00972153|943314|P2|NOT COMPLETED|Overall Study||1
394734|NCT00972153|943315|P1|NOT COMPLETED|Overall Study||0
394735|NCT00972153|943313|P3|COMPLETED|Overall Study||12
394736|NCT00972153|943314|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
394737|NCT00972153|943315|P1|COMPLETED|Overall Study||12
394738|NCT00972153|943313|P3|STARTED|Overall Study||12
394739|NCT00972153|943314|P2|STARTED|Overall Study||12
394740|NCT00972153|943315|P1|STARTED|Overall Study||12
394741|NCT00972088|943326|P1|NOT COMPLETED|Overall Study||0
394742|NCT00972088|943326|P1|COMPLETED|Overall Study||26
394743|NCT00972088|943326|P1|STARTED|Overall Study||26
394744|NCT00972023|943330|P1|NOT COMPLETED|Overall Study||1
394745|NCT00972023|943330|P1|COMPLETED|Overall Study||0
394746|NCT00972023|943330|P1|STARTED|Overall Study||1
394747|NCT00971997|943337|P1|NOT COMPLETED|Overall Study||19
394748|NCT00971997|943337|P1|COMPLETED|Overall Study||116
394749|NCT00971997|943337|P1|STARTED|Overall Study||135
394750|NCT00971932|943355|P1|NOT COMPLETED|Overall Study||7
394751|NCT00971932|943355|P1|COMPLETED|Overall Study||26
394752|NCT00971932|943355|P1|STARTED|Overall Study|Number of participants treated.|33
394753|NCT00971841|943365|P1|NOT COMPLETED|Overall Study||0
394754|NCT00971841|943365|P1|COMPLETED|Overall Study||1
394755|NCT00971841|943365|P1|STARTED|Overall Study||1
394756|NCT00971789|943370|P1|NOT COMPLETED|Overall Study||0
394757|NCT00971789|943370|P1|COMPLETED|Overall Study||18
394758|NCT00971789|943370|P1|STARTED|Overall Study||18
394759|NCT00971750|943375|P1|NOT COMPLETED|Overall Study||0
394760|NCT00971750|943375|P1|COMPLETED|Overall Study||253
394761|NCT00971750|943375|P1|STARTED|Overall Study||253
394762|NCT00971633|943384|P6|NOT COMPLETED|Period 3||0
394763|NCT00971633|943385|P5|NOT COMPLETED|Period 3||0
394764|NCT00971633|943386|P4|NOT COMPLETED|Period 3||0
394765|NCT00971633|943387|P3|NOT COMPLETED|Period 3||0
394766|NCT00971633|943388|P2|NOT COMPLETED|Period 3||0
394767|NCT00971633|943389|P1|NOT COMPLETED|Period 3||0
394768|NCT00971633|943384|P6|COMPLETED|Period 3||2
394769|NCT00971633|943385|P5|COMPLETED|Period 3||2
394770|NCT00971633|943386|P4|COMPLETED|Period 3||2
394771|NCT00971633|943387|P3|COMPLETED|Period 3||2
394772|NCT00971633|943388|P2|COMPLETED|Period 3||2
394773|NCT00971633|943389|P1|COMPLETED|Period 3||2
394774|NCT00971633|943384|P6|STARTED|Period 3||2
394775|NCT00971633|943385|P5|STARTED|Period 3||2
394776|NCT00971633|943386|P4|STARTED|Period 3||2
394777|NCT00971633|943387|P3|STARTED|Period 3||2
394778|NCT00971633|943388|P2|STARTED|Period 3||2
394779|NCT00971633|943389|P1|STARTED|Period 3||2
394780|NCT00971633|943384|P6|NOT COMPLETED|Period 2||0
394781|NCT00971633|943385|P5|NOT COMPLETED|Period 2||0
394782|NCT00971633|943386|P4|NOT COMPLETED|Period 2||0
394783|NCT00971633|943387|P3|NOT COMPLETED|Period 2||0
394784|NCT00971633|943388|P2|NOT COMPLETED|Period 2||0
394785|NCT00971633|943389|P1|NOT COMPLETED|Period 2||0
394786|NCT00971633|943384|P6|COMPLETED|Period 2||2
394787|NCT00971633|943385|P5|COMPLETED|Period 2||2
394788|NCT00971633|943386|P4|COMPLETED|Period 2||2
394789|NCT00971633|943387|P3|COMPLETED|Period 2||2
394790|NCT00971633|943388|P2|COMPLETED|Period 2||2
394791|NCT00971633|943389|P1|COMPLETED|Period 2||2
394792|NCT00971633|943384|P6|STARTED|Period 2||2
394793|NCT00971633|943385|P5|STARTED|Period 2||2
394794|NCT00971633|943386|P4|STARTED|Period 2||2
394795|NCT00971633|943387|P3|STARTED|Period 2||2
394796|NCT00971633|943388|P2|STARTED|Period 2||2
394797|NCT00971633|943389|P1|STARTED|Period 2||2
394798|NCT00971633|943384|P6|NOT COMPLETED|Period 1||0
394799|NCT00971633|943385|P5|NOT COMPLETED|Period 1||0
394800|NCT00971633|943386|P4|NOT COMPLETED|Period 1||0
394801|NCT00971633|943387|P3|NOT COMPLETED|Period 1||0
394802|NCT00971633|943388|P2|NOT COMPLETED|Period 1||0
394803|NCT00971633|943389|P1|NOT COMPLETED|Period 1||0
394804|NCT00971633|943384|P6|COMPLETED|Period 1||2
394805|NCT00971633|943385|P5|COMPLETED|Period 1||2
394806|NCT00971633|943386|P4|COMPLETED|Period 1||2
394807|NCT00971633|943387|P3|COMPLETED|Period 1||2
394808|NCT00971633|943388|P2|COMPLETED|Period 1||2
394809|NCT00971633|943389|P1|COMPLETED|Period 1||2
394810|NCT00971633|943384|P6|STARTED|Period 1||2
394811|NCT00971633|943385|P5|STARTED|Period 1||2
394812|NCT00971633|943386|P4|STARTED|Period 1||2
394813|NCT00971633|943387|P3|STARTED|Period 1||2
394814|NCT00971633|943388|P2|STARTED|Period 1||2
394815|NCT00971633|943389|P1|STARTED|Period 1||2
394816|NCT00971620|943402|P2|NOT COMPLETED|Overall Study||0
394817|NCT00971620|943403|P1|NOT COMPLETED|Overall Study||0
394818|NCT00971620|943402|P2|COMPLETED|Overall Study||9
394819|NCT00971620|943403|P1|COMPLETED|Overall Study||9
394820|NCT00971620|943402|P2|STARTED|Overall Study||9
394821|NCT00971620|943403|P1|STARTED|Overall Study||9
394822|NCT00971425|943435|P2|NOT COMPLETED|Overall Study||2
394823|NCT00971425|943436|P1|NOT COMPLETED|Overall Study||1
394824|NCT00971425|943435|P2|COMPLETED|Overall Study||71
394825|NCT00971425|943436|P1|COMPLETED|Overall Study||71
394826|NCT00971425|943435|P2|STARTED|Overall Study||73
394827|NCT00971425|943436|P1|STARTED|Overall Study||72
394828|NCT00971295|943470|P2|NOT COMPLETED|Overall Study||1
394829|NCT00971295|943471|P1|NOT COMPLETED|Overall Study||0
394830|NCT00971295|943470|P2|COMPLETED|Overall Study||9
394831|NCT00971295|943471|P1|COMPLETED|Overall Study||10
394832|NCT00971295|943470|P2|STARTED|Overall Study||10
394833|NCT00971295|943471|P1|STARTED|Overall Study||10
394834|NCT00971282|943481|P1|NOT COMPLETED|Overall Study||0
394835|NCT00971282|943481|P1|COMPLETED|Overall Study||30
394836|NCT00971282|943481|P1|STARTED|Overall Study||30
394837|NCT00971243|943500|P5|NOT COMPLETED|Open-label Period||6
394838|NCT00971243|943501|P4|NOT COMPLETED|Open-label Period||10
394839|NCT00971243|943502|P3|NOT COMPLETED|Open-label Period||5
394840|NCT00971243|943503|P2|NOT COMPLETED|Open-label Period||10
394841|NCT00971243|943504|P1|NOT COMPLETED|Open-label Period||8
394842|NCT00971243|943500|P5|COMPLETED|Open-label Period||64
394843|NCT00971243|943501|P4|COMPLETED|Open-label Period||64
394844|NCT00971243|943502|P3|COMPLETED|Open-label Period||66
394845|NCT00971243|943503|P2|COMPLETED|Open-label Period||71
394846|NCT00971243|943504|P1|COMPLETED|Open-label Period||60
394847|NCT00971243|943500|P5|STARTED|Open-label Period||70
394848|NCT00971243|943501|P4|STARTED|Open-label Period||74
394849|NCT00971243|943502|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
394850|NCT00971243|943503|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
394851|NCT00971243|943504|P1|STARTED|Open-label Period||68
394852|NCT00971243|943500|P5|NOT COMPLETED|Double Blind Period||18
394853|NCT00971243|943501|P4|NOT COMPLETED|Double Blind Period||14
394854|NCT00971243|943502|P3|NOT COMPLETED|Double Blind Period||19
394855|NCT00971243|943503|P2|NOT COMPLETED|Double Blind Period||11
394856|NCT00971243|943504|P1|NOT COMPLETED|Double Blind Period||19
394857|NCT00971243|943500|P5|COMPLETED|Double Blind Period||70
394858|NCT00971243|943501|P4|COMPLETED|Double Blind Period||74
394859|NCT00971243|943502|P3|COMPLETED|Double Blind Period||72
394860|NCT00971243|943503|P2|COMPLETED|Double Blind Period||82
394861|NCT00971243|943504|P1|COMPLETED|Double Blind Period||68
394862|NCT00971243|943500|P5|STARTED|Double Blind Period||88
394863|NCT00971243|943501|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
394864|NCT00971243|943502|P3|STARTED|Double Blind Period||91
394865|NCT00971243|943503|P2|STARTED|Double Blind Period||93
394866|NCT00971243|943504|P1|STARTED|Double Blind Period||87
394867|NCT00971204|943521|P1|NOT COMPLETED|Overall Study||24
394868|NCT00971204|943521|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
394869|NCT00971204|943521|P1|Treated|Overall Study||86
394870|NCT00971204|943521|P1|STARTED|Overall Study|100 enrolled participants|100
394871|NCT00971048|943529|P4|NOT COMPLETED|Overall Study||2
394872|NCT00971048|943530|P3|NOT COMPLETED|Overall Study||1
394873|NCT00971048|943531|P2|NOT COMPLETED|Overall Study||2
394874|NCT00971048|943532|P1|NOT COMPLETED|Overall Study||1
394875|NCT00971048|943529|P4|COMPLETED|Overall Study||11
394876|NCT00971048|943530|P3|COMPLETED|Overall Study||11
394877|NCT00971048|943531|P2|COMPLETED|Overall Study||31
394878|NCT00971048|943532|P1|COMPLETED|Overall Study||29
394879|NCT00971048|943529|P4|STARTED|Overall Study||13
394880|NCT00971048|943530|P3|STARTED|Overall Study||12
394881|NCT00971048|943531|P2|STARTED|Overall Study||33
394882|NCT00971048|943532|P1|STARTED|Overall Study||30
394883|NCT00970944|943556|P2|NOT COMPLETED|Overall Study||2
394884|NCT00970944|943557|P1|NOT COMPLETED|Overall Study||1
394885|NCT00970944|943556|P2|COMPLETED|Overall Study||95
394886|NCT00970944|943557|P1|COMPLETED|Overall Study||86
394887|NCT00970944|943556|P2|STARTED|Overall Study||97
394888|NCT00970944|943557|P1|STARTED|Overall Study||87
394889|NCT00970853|943567|P2|NOT COMPLETED|Overall Study||0
394890|NCT00970853|943568|P1|NOT COMPLETED|Overall Study||0
394891|NCT00970853|943567|P2|COMPLETED|Overall Study||98
394892|NCT00970853|943568|P1|COMPLETED|Overall Study||89
394893|NCT00970853|943567|P2|STARTED|Overall Study||98
394894|NCT00970853|943568|P1|STARTED|Overall Study||89
394895|NCT00970814|943592|P2|NOT COMPLETED|Overall Study||14
394896|NCT00970814|943593|P1|NOT COMPLETED|Overall Study||8
394897|NCT00970814|943592|P2|COMPLETED|Overall Study||50
394898|NCT00970814|943593|P1|COMPLETED|Overall Study||58
394899|NCT00970814|943592|P2|STARTED|Overall Study||64
394900|NCT00970814|943593|P1|STARTED|Overall Study||66
394901|NCT00970736|943603|P1|NOT COMPLETED|Overall Study||2
394902|NCT00970736|943603|P1|COMPLETED|Overall Study||18
394903|NCT00970736|943603|P1|STARTED|Overall Study||20
394904|NCT00970684|943609|P1|NOT COMPLETED|Overall Study||10
394905|NCT00970684|943609|P1|COMPLETED|Overall Study||3
394906|NCT00970684|943609|P1|STARTED|Overall Study||13
394907|NCT00970632|943618|P3|NOT COMPLETED|Overall Study||18
394908|NCT00970632|943619|P2|NOT COMPLETED|Overall Study||15
394909|NCT00970632|943620|P1|NOT COMPLETED|Overall Study||24
394910|NCT00970632|943618|P3|COMPLETED|Overall Study||150
394911|NCT00970632|943619|P2|COMPLETED|Overall Study||156
394912|NCT00970632|943620|P1|COMPLETED|Overall Study||148
394913|NCT00970632|943618|P3|STARTED|Overall Study||168
394914|NCT00970632|943619|P2|STARTED|Overall Study||171
394915|NCT00970632|943620|P1|STARTED|Overall Study||172
394916|NCT00970606|943678|P2|NOT COMPLETED|Overall Study||0
394917|NCT00970606|943679|P1|NOT COMPLETED|Overall Study||0
394918|NCT00970606|943678|P2|COMPLETED|Overall Study||3
394919|NCT00970606|943679|P1|COMPLETED|Overall Study||4
394920|NCT00970606|943678|P2|STARTED|Overall Study||3
394921|NCT00970606|943679|P1|STARTED|Overall Study||4
394922|NCT00970502|943685|P1|NOT COMPLETED|Overall Study||1
394923|NCT00970502|943685|P1|COMPLETED|Overall Study||14
394924|NCT00970502|943685|P1|STARTED|Overall Study||15
394925|NCT00970489|943696|P2|NOT COMPLETED|Overall Study||41
394926|NCT00970489|943697|P1|NOT COMPLETED|Overall Study||54
394927|NCT00970489|943696|P2|COMPLETED|Overall Study||717
394928|NCT00970489|943697|P1|COMPLETED|Overall Study||704
394929|NCT00970489|943696|P2|STARTED|Overall Study||758
394930|NCT00970489|943697|P1|STARTED|Overall Study||758
394931|NCT00970359|943709|P1|NOT COMPLETED|Overall Study||4
394932|NCT00970359|943709|P1|COMPLETED|Overall Study||20
394933|NCT00970359|943709|P1|STARTED|Overall Study||24
394934|NCT00970320|943720|P5|NOT COMPLETED|Overall Study||540
394935|NCT00970320|943721|P4|NOT COMPLETED|Overall Study||14
394936|NCT00970320|943722|P3|NOT COMPLETED|Overall Study||13
394937|NCT00970320|943723|P2|NOT COMPLETED|Overall Study||11
394938|NCT00970320|943724|P1|NOT COMPLETED|Overall Study||0
394939|NCT00970320|943720|P5|COMPLETED|Overall Study||1031
394940|NCT00970320|943721|P4|COMPLETED|Overall Study||36
394941|NCT00970320|943722|P3|COMPLETED|Overall Study||35
394942|NCT00970320|943723|P2|COMPLETED|Overall Study||13
394943|NCT00970320|943724|P1|COMPLETED|Overall Study||25
394944|NCT00970320|943720|P5|STARTED|Overall Study||1571
394945|NCT00970320|943721|P4|STARTED|Overall Study||50
394946|NCT00970320|943722|P3|STARTED|Overall Study||48
394947|NCT00970320|943723|P2|STARTED|Overall Study||24
394948|NCT00970320|943724|P1|STARTED|Overall Study||25
394949|NCT00970307|943739|P3|NOT COMPLETED|Overall Study||2
394950|NCT00970307|943740|P2|NOT COMPLETED|Overall Study||3
394951|NCT00970307|943741|P1|NOT COMPLETED|Overall Study||3
394952|NCT00970307|943739|P3|COMPLETED|Overall Study||139
394953|NCT00970307|943740|P2|COMPLETED|Overall Study||136
394954|NCT00970307|943741|P1|COMPLETED|Overall Study||138
394955|NCT00970307|943739|P3|STARTED|Overall Study||141
394956|NCT00970307|943740|P2|STARTED|Overall Study||139
394957|NCT00970307|943741|P1|STARTED|Overall Study||141
394958|NCT00970294|943815|P1|NOT COMPLETED|Overall Study||5
394959|NCT00970294|943815|P1|COMPLETED|Overall Study||6
394960|NCT00970294|943815|P1|STARTED|Overall Study||11
394961|NCT00970281|943823|P2|NOT COMPLETED|Overall Study||16
394962|NCT00970281|943824|P1|NOT COMPLETED|Overall Study||2
394963|NCT00970281|943823|P2|COMPLETED|Overall Study||29
394964|NCT00970281|943824|P1|COMPLETED|Overall Study||44
394965|NCT00970281|943823|P2|Full Analysis Set|Overall Study||45
394966|NCT00970281|943824|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
394967|NCT00970281|943823|P2|STARTED|Overall Study||45
394968|NCT00970281|943824|P1|STARTED|Overall Study||46
394969|NCT00970268|943842|P2|NOT COMPLETED|Overall Study||49
394970|NCT00970268|943843|P1|NOT COMPLETED|Overall Study||43
394971|NCT00970268|943842|P2|COMPLETED|Overall Study||103
394972|NCT00970268|943843|P1|COMPLETED|Overall Study||96
394973|NCT00970268|943842|P2|STARTED|Overall Study||152
394974|NCT00970268|943843|P1|STARTED|Overall Study||139
394975|NCT00969280|943859|P2|NOT COMPLETED|Overall Study||3
394976|NCT00969280|943860|P1|NOT COMPLETED|Overall Study||2
394977|NCT00969280|943859|P2|COMPLETED|Overall Study||18
394978|NCT00969280|943860|P1|COMPLETED|Overall Study||19
394979|NCT00969280|943859|P2|STARTED|Overall Study||21
394980|NCT00969280|943860|P1|STARTED|Overall Study||21
394981|NCT00969228|943868|P2|NOT COMPLETED|Overall Study||14
394982|NCT00969228|943869|P1|NOT COMPLETED|Overall Study||43
394983|NCT00969228|943868|P2|COMPLETED|Overall Study||162
394984|NCT00969228|943869|P1|COMPLETED|Overall Study||465
394985|NCT00969228|943868|P2|STARTED|Overall Study||176
394986|NCT00969228|943869|P1|STARTED|Overall Study||508
394987|NCT00970216|943885|P1|NOT COMPLETED|Overall Study||80
394988|NCT00970216|943885|P1|COMPLETED|Overall Study||80
394989|NCT00970216|943885|P1|STARTED|Overall Study||160
394990|NCT00969878|943891|P2|NOT COMPLETED|Overall Study||26
394991|NCT00969878|943892|P1|NOT COMPLETED|Overall Study||30
394992|NCT00969878|943891|P2|COMPLETED|Overall Study||126
394993|NCT00969878|943892|P1|COMPLETED|Overall Study||118
394994|NCT00969878|943891|P2|STARTED|Overall Study||152
394995|NCT00969878|943892|P1|STARTED|Overall Study||148
394996|NCT00969709|943904|P4|NOT COMPLETED|Overall Study||63
394997|NCT00969709|943905|P3|NOT COMPLETED|Overall Study||58
394998|NCT00969709|943906|P2|NOT COMPLETED|Overall Study||48
394999|NCT00969709|943907|P1|NOT COMPLETED|Overall Study||38
395000|NCT00969709|943904|P4|COMPLETED|Overall Study||117
395001|NCT00969709|943905|P3|COMPLETED|Overall Study||121
395002|NCT00969709|943906|P2|COMPLETED|Overall Study||130
395003|NCT00969709|943907|P1|COMPLETED|Overall Study||138
395004|NCT00969709|943904|P4|STARTED|Overall Study||180
395005|NCT00969709|943905|P3|STARTED|Overall Study||179
395006|NCT00969709|943906|P2|STARTED|Overall Study||178
395007|NCT00969709|943907|P1|STARTED|Overall Study||176
395008|NCT00969618|943921|P1|NOT COMPLETED|Overall Study||78
395009|NCT00969618|943921|P1|COMPLETED|Overall Study||133
395010|NCT00969618|943921|P1|STARTED|Overall Study||211
395011|NCT00969540|943934|P2|NOT COMPLETED|Overall Study||1
395012|NCT00969540|943935|P1|NOT COMPLETED|Overall Study||1
395013|NCT00969540|943934|P2|COMPLETED|Overall Study||3
395014|NCT00969540|943935|P1|COMPLETED|Overall Study||3
395015|NCT00969540|943934|P2|STARTED|Overall Study||4
395016|NCT00969540|943935|P1|STARTED|Overall Study||4
395017|NCT00969501|943953|P1|NOT COMPLETED|Overall Study||5
395018|NCT00969501|943953|P1|COMPLETED|Overall Study||27
395019|NCT00969501|943953|P1|STARTED|Overall Study||32
395020|NCT00969150|943959|P2|NOT COMPLETED|Overall Study||40
395021|NCT00969150|943960|P1|NOT COMPLETED|Overall Study||33
395022|NCT00969150|943959|P2|COMPLETED|Overall Study||135
395023|NCT00969150|943960|P1|COMPLETED|Overall Study||149
395024|NCT00969150|943959|P2|STARTED|Overall Study||175
395025|NCT00969150|943960|P1|STARTED|Overall Study||182
395026|NCT00968981|943971|P3|NOT COMPLETED|Overall Study||22
395027|NCT00968981|943972|P2|NOT COMPLETED|Overall Study||22
395028|NCT00968981|943973|P1|NOT COMPLETED|Overall Study||22
395029|NCT00968981|943971|P3|COMPLETED|Overall Study||0
395030|NCT00968981|943972|P2|COMPLETED|Overall Study||0
395031|NCT00968981|943973|P1|COMPLETED|Overall Study||1
395032|NCT00968981|943971|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
395033|NCT00968981|943972|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
395034|NCT00968981|943973|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
395035|NCT00968981|943971|P3|STARTED|Overall Study||22
395036|NCT00968981|943972|P2|STARTED|Overall Study||22
395037|NCT00968981|943973|P1|STARTED|Overall Study||23
395038|NCT00968890|944011|P2|NOT COMPLETED|Overall Study||0
395039|NCT00968890|944012|P1|NOT COMPLETED|Overall Study||0
395040|NCT00968890|944011|P2|COMPLETED|Overall Study||84
395041|NCT00968890|944012|P1|COMPLETED|Overall Study||84
395042|NCT00968890|944011|P2|STARTED|Overall Study||84
395043|NCT00968890|944012|P1|STARTED|Overall Study||84
395044|NCT00968838|944042|P2|NOT COMPLETED|Overall Study||0
395045|NCT00968838|944043|P1|NOT COMPLETED|Overall Study||0
395046|NCT00968838|944042|P2|COMPLETED|Overall Study||58
395047|NCT00968838|944043|P1|COMPLETED|Overall Study||50
395048|NCT00968838|944042|P2|STARTED|Overall Study||58
395049|NCT00968838|944043|P1|STARTED|Overall Study||50
395050|NCT00968812|944052|P3|NOT COMPLETED|Overall Study||168
395051|NCT00968812|944053|P2|NOT COMPLETED|Overall Study||162
395052|NCT00968812|944054|P1|NOT COMPLETED|Overall Study||140
395053|NCT00968812|944052|P3|COMPLETED|Overall Study||314
395054|NCT00968812|944053|P2|COMPLETED|Overall Study||323
395055|NCT00968812|944054|P1|COMPLETED|Overall Study||343
395056|NCT00968812|944052|P3|STARTED|Overall Study||482
395057|NCT00968812|944053|P2|STARTED|Overall Study||485
395058|NCT00968812|944054|P1|STARTED|Overall Study||483
395059|NCT00968799|944074|P1|NOT COMPLETED|Overall Study||2
395060|NCT00968799|944074|P1|COMPLETED|Overall Study||4
395061|NCT00968799|944074|P1|STARTED|Overall Study||6
395062|NCT00968708|944084|P2|NOT COMPLETED|Overall Study||298
395063|NCT00968708|944085|P1|NOT COMPLETED|Overall Study||318
395064|NCT00968708|944084|P2|COMPLETED|Overall Study||2403
395065|NCT00968708|944085|P1|COMPLETED|Overall Study||2361
395066|NCT00968708|944084|P2|Treated|Overall Study||2698
395067|NCT00968708|944085|P1|Treated|Overall Study||2676
395068|NCT00968708|944084|P2|STARTED|Overall Study||2701
395069|NCT00968708|944085|P1|STARTED|Overall Study||2679
395070|NCT00968669|944097|P4|NOT COMPLETED|Overall Study||9
395071|NCT00968669|944098|P3|NOT COMPLETED|Overall Study||11
395072|NCT00968669|944099|P2|NOT COMPLETED|Overall Study||18
395073|NCT00968669|944100|P1|NOT COMPLETED|Overall Study||18
395074|NCT00968669|944097|P4|COMPLETED|Overall Study||72
395075|NCT00968669|944098|P3|COMPLETED|Overall Study||72
395076|NCT00968669|944099|P2|COMPLETED|Overall Study||63
395077|NCT00968669|944100|P1|COMPLETED|Overall Study||64
395078|NCT00968669|944097|P4|STARTED|Overall Study||81
395079|NCT00968669|944098|P3|STARTED|Overall Study||83
395080|NCT00968669|944099|P2|STARTED|Overall Study||81
395081|NCT00968669|944100|P1|STARTED|Overall Study||82
395082|NCT00968617|944190|P1|NOT COMPLETED|Overall Study||6
395083|NCT00968617|944190|P1|COMPLETED|Overall Study||1
395084|NCT00968617|944190|P1|STARTED|Overall Study||7
395085|NCT00968227|944202|P1|NOT COMPLETED|Overall Study||0
395086|NCT00968227|944202|P1|COMPLETED|Overall Study||56
395087|NCT00968227|944202|P1|STARTED|Overall Study||56
395088|NCT00968201|944209|P3|NOT COMPLETED|Extension Study - (Period III)||280
395089|NCT00968201|944210|P2|NOT COMPLETED|Extension Study - (Period III)||124
395090|NCT00968201|944211|P1|NOT COMPLETED|Extension Study - (Period III)||0
395091|NCT00968201|944209|P3|COMPLETED|Extension Study - (Period III)||84
395092|NCT00968201|944210|P2|COMPLETED|Extension Study - (Period III)||33
395093|NCT00968201|944211|P1|COMPLETED|Extension Study - (Period III)||0
395094|NCT00968201|944209|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
395095|NCT00968201|944210|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
395096|NCT00968201|944211|P1|STARTED|Extension Study - (Period III)||0
395097|NCT00968201|944209|P3|NOT COMPLETED|Base Study - (Period II)||45
395098|NCT00968201|944210|P2|NOT COMPLETED|Base Study - (Period II)||0
395099|NCT00968201|944211|P1|NOT COMPLETED|Base Study - (Period II)||26
395100|NCT00968201|944209|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
395101|NCT00968201|944210|P2|COMPLETED|Base Study - (Period II)||0
395102|NCT00968201|944211|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
395103|NCT00968201|944209|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
395104|NCT00968201|944210|P2|STARTED|Base Study - (Period II)||0
395105|NCT00968201|944211|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
395106|NCT00968149|944272|P2|NOT COMPLETED|Overall Study||6
395107|NCT00968149|944273|P1|NOT COMPLETED|Overall Study||11
395108|NCT00968149|944272|P2|COMPLETED|Overall Study||127
395109|NCT00968149|944273|P1|COMPLETED|Overall Study||269
395110|NCT00968149|944272|P2|STARTED|Overall Study||133
395111|NCT00968149|944273|P1|STARTED|Overall Study||280
395112|NCT00968071|944293|P1|NOT COMPLETED|Overall Study||0
395113|NCT00968071|944293|P1|COMPLETED|Overall Study||71
395114|NCT00968071|944293|P1|STARTED|Overall Study||71
395115|NCT00968032|944297|P1|NOT COMPLETED|Overall Study||2
395116|NCT00968032|944297|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
395117|NCT00968032|944297|P1|STARTED|Overall Study||63
395118|NCT00968019|944301|P1|NOT COMPLETED|Overall Study||15
395119|NCT00968019|944301|P1|COMPLETED|Overall Study||303
395120|NCT00968019|944301|P1|STARTED|Overall Study||318
395121|NCT00967993|944322|P1|NOT COMPLETED|Overall Study||4
395122|NCT00967993|944322|P1|COMPLETED|Overall Study||18
395123|NCT00967993|944322|P1|STARTED|Overall Study||22
395124|NCT00967694|944326|P1|NOT COMPLETED|Overall Study||6
395125|NCT00967694|944326|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
395126|NCT00967694|944326|P1|STARTED|Overall Study||26
395127|NCT00967668|944333|P3|NOT COMPLETED|Overall Study||69
395128|NCT00967668|944334|P2|NOT COMPLETED|Overall Study||56
395129|NCT00967668|944335|P1|NOT COMPLETED|Overall Study||71
395130|NCT00967668|944333|P3|COMPLETED|Overall Study||90
395131|NCT00967668|944334|P2|COMPLETED|Overall Study||104
395132|NCT00967668|944335|P1|COMPLETED|Overall Study||91
395133|NCT00967668|944333|P3|18-mo Assessment|Overall Study||92
395134|NCT00967668|944334|P2|18-mo Assessment|Overall Study||102
395135|NCT00967668|944335|P1|18-mo Assessment|Overall Study||95
395136|NCT00967668|944333|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
395137|NCT00967668|944334|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
395138|NCT00967668|944335|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
395139|NCT00967668|944333|P3|3-mo Assessment|Overall Study||115
395140|NCT00967668|944334|P2|3-mo Assessment|Overall Study||127
395141|NCT00967668|944335|P1|3-mo Assessment|Overall Study||131
395142|NCT00967668|944333|P3|STARTED|Overall Study||159
395143|NCT00967668|944334|P2|STARTED|Overall Study||160
395144|NCT00967668|944335|P1|STARTED|Overall Study||162
395145|NCT00967551|944348|P2|NOT COMPLETED|Overall Study||0
395146|NCT00967551|944349|P1|NOT COMPLETED|Overall Study||0
395147|NCT00967551|944348|P2|COMPLETED|Overall Study||75
395148|NCT00967551|944349|P1|COMPLETED|Overall Study||68
395149|NCT00967551|944348|P2|STARTED|Overall Study||75
395150|NCT00967551|944349|P1|STARTED|Overall Study||68
395151|NCT00967486|944359|P2|NOT COMPLETED|Overall Study||0
395152|NCT00967486|944360|P1|NOT COMPLETED|Overall Study||0
395153|NCT00967486|944359|P2|COMPLETED|Overall Study||102
395154|NCT00967486|944360|P1|COMPLETED|Overall Study||98
395155|NCT00967486|944359|P2|STARTED|Overall Study||102
395156|NCT00967486|944360|P1|STARTED|Overall Study||98
395157|NCT00967473|944366|P1|NOT COMPLETED|Overall Study||0
395158|NCT00967473|944366|P1|COMPLETED|Overall Study||15
395159|NCT00967473|944366|P1|STARTED|Overall Study||15
395160|NCT00967447|944372|P1|NOT COMPLETED|Overall Study||0
395161|NCT00967447|944372|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
395162|NCT00967447|944372|P1|STARTED|Overall Study|there are no collected data in CRF|2
395163|NCT00967330|944381|P2|NOT COMPLETED|Overall Study||60
395164|NCT00967330|944382|P1|NOT COMPLETED|Overall Study||122
395165|NCT00967330|944381|P2|COMPLETED|Overall Study||0
395166|NCT00967330|944382|P1|COMPLETED|Overall Study||0
395167|NCT00967330|944381|P2|STARTED|Overall Study||60
395168|NCT00967330|944382|P1|STARTED|Overall Study||122
395169|NCT00967226|944412|P2|NOT COMPLETED|Overall Study||6
395170|NCT00967226|944413|P1|NOT COMPLETED|Overall Study||2
395171|NCT00967226|944412|P2|COMPLETED|Overall Study||2
395172|NCT00967226|944413|P1|COMPLETED|Overall Study||9
395173|NCT00967226|944412|P2|STARTED|Overall Study||8
395174|NCT00967226|944413|P1|STARTED|Overall Study||11
395175|NCT00967044|944443|P1|NOT COMPLETED|Overall Study||0
395176|NCT00967044|944443|P1|COMPLETED|Overall Study||30
395177|NCT00967044|944443|P1|STARTED|Overall Study||30
395178|NCT00967018|944447|P1|NOT COMPLETED|Overall Study||21
395179|NCT00967018|944447|P1|COMPLETED|Overall Study||56
395180|NCT00967018|944447|P1|STARTED|Overall Study||77
395181|NCT00966992|944456|P2|NOT COMPLETED|Overall Study||0
395182|NCT00966992|944457|P1|NOT COMPLETED|Overall Study||0
395183|NCT00966992|944456|P2|COMPLETED|Overall Study||0
395184|NCT00966992|944457|P1|COMPLETED|Overall Study||3
395185|NCT00966992|944456|P2|STARTED|Overall Study||0
395186|NCT00966992|944457|P1|STARTED|Overall Study||3
395187|NCT00966953|944477|P4|NOT COMPLETED|4th Intervention Order||0
395188|NCT00966953|944478|P3|NOT COMPLETED|4th Intervention Order||0
395189|NCT00966953|944479|P2|NOT COMPLETED|4th Intervention Order||0
395190|NCT00966953|944480|P1|NOT COMPLETED|4th Intervention Order||0
395191|NCT00966953|944477|P4|COMPLETED|4th Intervention Order||7
395192|NCT00966953|944478|P3|COMPLETED|4th Intervention Order||6
395193|NCT00966953|944479|P2|COMPLETED|4th Intervention Order||6
395194|NCT00966953|944480|P1|COMPLETED|4th Intervention Order||6
395195|NCT00966953|944477|P4|STARTED|4th Intervention Order||7
395196|NCT00966953|944478|P3|STARTED|4th Intervention Order||6
395197|NCT00966953|944479|P2|STARTED|4th Intervention Order||6
395198|NCT00966953|944480|P1|STARTED|4th Intervention Order||6
395199|NCT00966953|944477|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
395200|NCT00966953|944478|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
395201|NCT00966953|944479|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
395202|NCT00966953|944480|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
395203|NCT00966953|944477|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
395204|NCT00966953|944478|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
395205|NCT00966953|944479|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
395206|NCT00966953|944480|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
395207|NCT00966953|944477|P4|STARTED|1 Week Washout After 3rd Intervention||7
395208|NCT00966953|944478|P3|STARTED|1 Week Washout After 3rd Intervention||6
395209|NCT00966953|944479|P2|STARTED|1 Week Washout After 3rd Intervention||6
395210|NCT00966953|944480|P1|STARTED|1 Week Washout After 3rd Intervention||6
395211|NCT00966953|944477|P4|NOT COMPLETED|3rd Intervention Order||0
395212|NCT00966953|944478|P3|NOT COMPLETED|3rd Intervention Order||0
395213|NCT00966953|944479|P2|NOT COMPLETED|3rd Intervention Order||0
395214|NCT00966953|944480|P1|NOT COMPLETED|3rd Intervention Order||0
395215|NCT00966953|944477|P4|COMPLETED|3rd Intervention Order||7
395216|NCT00966953|944478|P3|COMPLETED|3rd Intervention Order||6
395217|NCT00966953|944479|P2|COMPLETED|3rd Intervention Order||6
395218|NCT00966953|944480|P1|COMPLETED|3rd Intervention Order||6
395219|NCT00966953|944477|P4|STARTED|3rd Intervention Order||7
395220|NCT00966953|944478|P3|STARTED|3rd Intervention Order||6
395221|NCT00966953|944479|P2|STARTED|3rd Intervention Order||6
395222|NCT00966953|944480|P1|STARTED|3rd Intervention Order||6
395223|NCT00966953|944477|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
395224|NCT00966953|944478|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
395225|NCT00966953|944479|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
395226|NCT00966953|944480|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
395227|NCT00966953|944477|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
395228|NCT00966953|944478|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
395229|NCT00966953|944479|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
395230|NCT00966953|944480|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
395231|NCT00966953|944477|P4|STARTED|1 Week Washout After 2nd Intervention||7
395232|NCT00966953|944478|P3|STARTED|1 Week Washout After 2nd Intervention||6
395233|NCT00966953|944479|P2|STARTED|1 Week Washout After 2nd Intervention||6
395234|NCT00966953|944480|P1|STARTED|1 Week Washout After 2nd Intervention||6
395235|NCT00966953|944477|P4|NOT COMPLETED|2nd Intervention||0
395236|NCT00966953|944478|P3|NOT COMPLETED|2nd Intervention||0
395237|NCT00966953|944479|P2|NOT COMPLETED|2nd Intervention||0
395238|NCT00966953|944480|P1|NOT COMPLETED|2nd Intervention||0
395239|NCT00966953|944477|P4|COMPLETED|2nd Intervention||7
395240|NCT00966953|944478|P3|COMPLETED|2nd Intervention||6
395241|NCT00966953|944479|P2|COMPLETED|2nd Intervention||6
395242|NCT00966953|944480|P1|COMPLETED|2nd Intervention||6
395243|NCT00966953|944477|P4|STARTED|2nd Intervention||7
395244|NCT00966953|944478|P3|STARTED|2nd Intervention||6
395245|NCT00966953|944479|P2|STARTED|2nd Intervention||6
395246|NCT00966953|944480|P1|STARTED|2nd Intervention||6
395247|NCT00966953|944477|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
395248|NCT00966953|944478|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
395249|NCT00966953|944479|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
395250|NCT00966953|944480|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
395251|NCT00966953|944477|P4|COMPLETED|1 Week Washout After 1st Intervention||7
395252|NCT00966953|944478|P3|COMPLETED|1 Week Washout After 1st Intervention||6
395253|NCT00966953|944479|P2|COMPLETED|1 Week Washout After 1st Intervention||6
395254|NCT00966953|944480|P1|COMPLETED|1 Week Washout After 1st Intervention||6
395255|NCT00966953|944477|P4|STARTED|1 Week Washout After 1st Intervention||7
395256|NCT00966953|944478|P3|STARTED|1 Week Washout After 1st Intervention||6
395257|NCT00966953|944479|P2|STARTED|1 Week Washout After 1st Intervention||6
395258|NCT00966953|944480|P1|STARTED|1 Week Washout After 1st Intervention||6
395259|NCT00966953|944477|P4|NOT COMPLETED|1st Intervention||0
395260|NCT00966953|944478|P3|NOT COMPLETED|1st Intervention||0
395261|NCT00966953|944479|P2|NOT COMPLETED|1st Intervention||0
395262|NCT00966953|944480|P1|NOT COMPLETED|1st Intervention||0
395263|NCT00966953|944477|P4|COMPLETED|1st Intervention||7
395264|NCT00966953|944478|P3|COMPLETED|1st Intervention||6
395265|NCT00966953|944479|P2|COMPLETED|1st Intervention||6
395266|NCT00966953|944480|P1|COMPLETED|1st Intervention||6
395267|NCT00966953|944477|P4|STARTED|1st Intervention||7
395268|NCT00966953|944478|P3|STARTED|1st Intervention||6
395269|NCT00966953|944479|P2|STARTED|1st Intervention||6
395270|NCT00966953|944480|P1|STARTED|1st Intervention||6
395271|NCT00966940|944488|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
395272|NCT00966940|944489|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
395273|NCT00966940|944488|P2|COMPLETED|Period 2, Second 6 Weeks||23
395274|NCT00966940|944489|P1|COMPLETED|Period 2, Second 6 Weeks||25
395275|NCT00966940|944488|P2|STARTED|Period 2, Second 6 Weeks||23
395276|NCT00966940|944489|P1|STARTED|Period 2, Second 6 Weeks||25
395277|NCT00966940|944488|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
395278|NCT00966940|944489|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
395279|NCT00966940|944488|P2|COMPLETED|Period 1, First 6 Weeks||23
395280|NCT00966940|944489|P1|COMPLETED|Period 1, First 6 Weeks||25
395281|NCT00966940|944488|P2|STARTED|Period 1, First 6 Weeks||23
395282|NCT00966940|944489|P1|STARTED|Period 1, First 6 Weeks||28
395283|NCT00966875|944516|P9|NOT COMPLETED|Part B||18
395284|NCT00966875|944517|P8|NOT COMPLETED|Part B||19
395285|NCT00966875|944518|P7|NOT COMPLETED|Part B||22
395286|NCT00966875|944519|P6|NOT COMPLETED|Part B||6
395287|NCT00966875|944520|P5|NOT COMPLETED|Part B||7
395288|NCT00966875|944521|P4|NOT COMPLETED|Part B||3
395289|NCT00966875|944522|P3|NOT COMPLETED|Part B||6
395290|NCT00966875|944523|P2|NOT COMPLETED|Part B||3
395291|NCT00966875|944524|P1|NOT COMPLETED|Part B||5
395292|NCT00966875|944516|P9|COMPLETED|Part B||32
395293|NCT00966875|944517|P8|COMPLETED|Part B||38
395294|NCT00966875|944518|P7|COMPLETED|Part B||29
395295|NCT00966875|944519|P6|COMPLETED|Part B||26
395296|NCT00966875|944520|P5|COMPLETED|Part B||44
395297|NCT00966875|944521|P4|COMPLETED|Part B||31
395298|NCT00966875|944522|P3|COMPLETED|Part B||27
395299|NCT00966875|944523|P2|COMPLETED|Part B||33
395300|NCT00966875|944524|P1|COMPLETED|Part B||41
395301|NCT00966875|944516|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
395302|NCT00966875|944517|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
395303|NCT00966875|944518|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
395304|NCT00966875|944519|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
395305|NCT00966875|944520|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
395306|NCT00966875|944521|P4|STARTED|Part B||34
395307|NCT00966875|944522|P3|STARTED|Part B||33
395308|NCT00966875|944523|P2|STARTED|Part B||36
395309|NCT00966875|944524|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
395310|NCT00966875|944516|P9|NOT COMPLETED|Part A||8
395311|NCT00966875|944517|P8|NOT COMPLETED|Part A||7
395312|NCT00966875|944518|P7|NOT COMPLETED|Part A||12
395313|NCT00966875|944519|P6|NOT COMPLETED|Part A||4
395314|NCT00966875|944520|P5|NOT COMPLETED|Part A||5
395315|NCT00966875|944521|P4|NOT COMPLETED|Part A||3
395316|NCT00966875|944522|P3|NOT COMPLETED|Part A||2
395317|NCT00966875|944523|P2|NOT COMPLETED|Part A||4
395318|NCT00966875|944524|P1|NOT COMPLETED|Part A||6
395319|NCT00966875|944516|P9|COMPLETED|Part A||51
395320|NCT00966875|944517|P8|COMPLETED|Part A||58
395321|NCT00966875|944518|P7|COMPLETED|Part A||52
395322|NCT00966875|944519|P6|COMPLETED|Part A||33
395323|NCT00966875|944520|P5|COMPLETED|Part A||52
395324|NCT00966875|944521|P4|COMPLETED|Part A||34
395325|NCT00966875|944522|P3|COMPLETED|Part A||33
395326|NCT00966875|944523|P2|COMPLETED|Part A||36
395327|NCT00966875|944524|P1|COMPLETED|Part A||48
395328|NCT00966875|944516|P9|Received ≥1 Doses of Study Drug|Part A||59
395329|NCT00966875|944517|P8|Received ≥1 Doses of Study Drug|Part A||65
395330|NCT00966875|944518|P7|Received ≥1 Doses of Study Drug|Part A||64
395331|NCT00966875|944519|P6|Received ≥1 Doses of Study Drug|Part A||37
395332|NCT00966875|944520|P5|Received ≥1 Doses of Study Drug|Part A||57
395333|NCT00966875|944521|P4|Received ≥1 Doses of Study Drug|Part A||37
395334|NCT00966875|944522|P3|Received ≥1 Doses of Study Drug|Part A||35
395335|NCT00966875|944523|P2|Received ≥1 Doses of Study Drug|Part A||40
395336|NCT00966875|944524|P1|Received ≥1 Doses of Study Drug|Part A||54
395337|NCT00966875|944516|P9|STARTED|Part A||59
395338|NCT00966875|944517|P8|STARTED|Part A||65
395339|NCT00966875|944518|P7|STARTED|Part A||64
395340|NCT00966875|944519|P6|STARTED|Part A||37
395341|NCT00966875|944520|P5|STARTED|Part A||57
395342|NCT00966875|944521|P4|STARTED|Part A||37
395343|NCT00966875|944522|P3|STARTED|Part A||35
395344|NCT00966875|944523|P2|STARTED|Part A||40
395345|NCT00966875|944524|P1|STARTED|Part A||54
395346|NCT00966823|944843|P1|NOT COMPLETED|Overall Study||1
395347|NCT00966823|944843|P1|COMPLETED|Overall Study||2
395348|NCT00966823|944843|P1|STARTED|Overall Study||3
395349|NCT00966641|944851|P2|NOT COMPLETED|Second Intervention||0
395350|NCT00966641|944852|P1|NOT COMPLETED|Second Intervention||0
395351|NCT00966641|944851|P2|COMPLETED|Second Intervention||17
395352|NCT00966641|944852|P1|COMPLETED|Second Intervention||17
395353|NCT00966641|944851|P2|STARTED|Second Intervention||17
395354|NCT00966641|944852|P1|STARTED|Second Intervention||17
395355|NCT00966641|944851|P2|NOT COMPLETED|First Intervention||0
395356|NCT00966641|944852|P1|NOT COMPLETED|First Intervention||0
395357|NCT00966641|944851|P2|COMPLETED|First Intervention||17
395358|NCT00966641|944852|P1|COMPLETED|First Intervention||17
395359|NCT00966641|944851|P2|STARTED|First Intervention||17
395360|NCT00966641|944852|P1|STARTED|First Intervention||17
395361|NCT00966550|944860|P2|NOT COMPLETED|Overall Study||0
395362|NCT00966550|944861|P1|NOT COMPLETED|Overall Study||0
395363|NCT00966550|944860|P2|COMPLETED|Overall Study||12
395364|NCT00966550|944861|P1|COMPLETED|Overall Study||13
395365|NCT00966550|944860|P2|STARTED|Overall Study||12
395366|NCT00966550|944861|P1|STARTED|Overall Study||13
395367|NCT00966446|944870|P3|NOT COMPLETED|Overall Study||21
395368|NCT00966446|944871|P2|NOT COMPLETED|Overall Study||25
395369|NCT00966446|944872|P1|NOT COMPLETED|Overall Study||28
395370|NCT00966446|944870|P3|COMPLETED|Overall Study||52
395371|NCT00966446|944871|P2|COMPLETED|Overall Study||49
395372|NCT00966446|944872|P1|COMPLETED|Overall Study||48
395373|NCT00966446|944870|P3|STARTED|Overall Study||73
395374|NCT00966446|944871|P2|STARTED|Overall Study||74
395375|NCT00966446|944872|P1|STARTED|Overall Study||76
395376|NCT00966277|944888|P2|NOT COMPLETED|Overall Study||4
395377|NCT00966277|944889|P1|NOT COMPLETED|Overall Study||4
395378|NCT00966277|944888|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
395379|NCT00966277|944889|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
395380|NCT00966277|944888|P2|STARTED|Overall Study||37
395381|NCT00966277|944889|P1|STARTED|Overall Study||38
395382|NCT00966264|944897|P2|NOT COMPLETED|Overall Study||3
395383|NCT00966264|944898|P1|NOT COMPLETED|Overall Study||4
395384|NCT00966264|944897|P2|COMPLETED|Overall Study|5 years results|114
395385|NCT00966264|944898|P1|COMPLETED|Overall Study|5 years results|115
395386|NCT00966264|944897|P2|STARTED|Overall Study||117
395387|NCT00966264|944898|P1|STARTED|Overall Study||119
395388|NCT00966238|944910|P6|NOT COMPLETED|Overall Study||0
395389|NCT00966238|944911|P5|NOT COMPLETED|Overall Study||0
395390|NCT00966238|944912|P4|NOT COMPLETED|Overall Study||0
395391|NCT00966238|944913|P3|NOT COMPLETED|Overall Study||0
395392|NCT00966238|944914|P2|NOT COMPLETED|Overall Study||0
395393|NCT00966238|944915|P1|NOT COMPLETED|Overall Study||0
395394|NCT00966238|944910|P6|COMPLETED|Overall Study||20
395395|NCT00966238|944911|P5|COMPLETED|Overall Study||20
395396|NCT00966238|944912|P4|COMPLETED|Overall Study||20
395397|NCT00966238|944913|P3|COMPLETED|Overall Study||20
395398|NCT00966238|944914|P2|COMPLETED|Overall Study||20
395399|NCT00966238|944915|P1|COMPLETED|Overall Study||20
395400|NCT00966238|944910|P6|STARTED|Overall Study||20
395401|NCT00966238|944911|P5|STARTED|Overall Study||20
395402|NCT00966238|944912|P4|STARTED|Overall Study||20
395403|NCT00966238|944913|P3|STARTED|Overall Study||20
395404|NCT00966238|944914|P2|STARTED|Overall Study||20
395405|NCT00966238|944915|P1|STARTED|Overall Study||20
395406|NCT00966186|944937|P2|NOT COMPLETED|Overall Study||0
395407|NCT00966186|944938|P1|NOT COMPLETED|Overall Study||0
395408|NCT00966186|944937|P2|COMPLETED|Overall Study||60
395409|NCT00966186|944938|P1|COMPLETED|Overall Study||60
395410|NCT00966186|944937|P2|STARTED|Overall Study||60
395411|NCT00966186|944938|P1|STARTED|Overall Study||60
395412|NCT00965848|944944|P3|NOT COMPLETED|Overall Study||10
395413|NCT00965848|944945|P2|NOT COMPLETED|Overall Study||2
395414|NCT00965848|944946|P1|NOT COMPLETED|Overall Study||29
395415|NCT00965848|944944|P3|COMPLETED|Overall Study||117
395416|NCT00965848|944945|P2|COMPLETED|Overall Study||32
395417|NCT00965848|944946|P1|COMPLETED|Overall Study||78
395418|NCT00965848|944944|P3|STARTED|Overall Study||127
395419|NCT00965848|944945|P2|STARTED|Overall Study||34
395420|NCT00965848|944946|P1|STARTED|Overall Study||107
395421|NCT00965757|944965|P4|NOT COMPLETED|Extension Phase||24
395422|NCT00965757|944966|P3|NOT COMPLETED|Extension Phase||33
395423|NCT00965757|944967|P2|NOT COMPLETED|Extension Phase||0
395424|NCT00965757|944968|P1|NOT COMPLETED|Extension Phase||0
395425|NCT00965757|944965|P4|COMPLETED|Extension Phase||64
395426|NCT00965757|944966|P3|COMPLETED|Extension Phase||132
395427|NCT00965757|944967|P2|COMPLETED|Extension Phase||0
395428|NCT00965757|944968|P1|COMPLETED|Extension Phase||0
395429|NCT00965757|944965|P4|STARTED|Extension Phase||88
395430|NCT00965757|944966|P3|STARTED|Extension Phase||165
395431|NCT00965757|944967|P2|STARTED|Extension Phase||0
395432|NCT00965757|944968|P1|STARTED|Extension Phase||0
395433|NCT00965757|944965|P4|NOT COMPLETED|Double-blind Phase||0
395434|NCT00965757|944966|P3|NOT COMPLETED|Double-blind Phase||0
395435|NCT00965757|944967|P2|NOT COMPLETED|Double-blind Phase||18
395436|NCT00965757|944968|P1|NOT COMPLETED|Double-blind Phase||17
395437|NCT00965757|944965|P4|COMPLETED|Double-blind Phase||0
395438|NCT00965757|944966|P3|COMPLETED|Double-blind Phase||0
395439|NCT00965757|944967|P2|COMPLETED|Double-blind Phase||70
395440|NCT00965757|944968|P1|COMPLETED|Double-blind Phase||148
395441|NCT00965757|944965|P4|STARTED|Double-blind Phase||0
395442|NCT00965757|944966|P3|STARTED|Double-blind Phase||0
395443|NCT00965757|944967|P2|STARTED|Double-blind Phase||88
395444|NCT00965757|944968|P1|STARTED|Double-blind Phase||165
395445|NCT00965731|945002|P2|NOT COMPLETED|Overall Study||20
395446|NCT00965731|945003|P1|NOT COMPLETED|Overall Study||7
395447|NCT00965731|945002|P2|COMPLETED|Overall Study||0
395448|NCT00965731|945003|P1|COMPLETED|Overall Study||0
395449|NCT00965731|945002|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
395450|NCT00965731|945003|P1|STARTED|Overall Study||7
395451|NCT00965718|945067|P1|NOT COMPLETED|Overall Study||4
395452|NCT00965718|945067|P1|COMPLETED|Overall Study||16
395453|NCT00965718|945067|P1|STARTED|Overall Study||20
395454|NCT00965562|945080|P3|NOT COMPLETED|Overall Study||3
395455|NCT00965562|945081|P2|NOT COMPLETED|Overall Study||4
395456|NCT00965562|945082|P1|NOT COMPLETED|Overall Study||3
395457|NCT00965562|945080|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
395458|NCT00965562|945081|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
395459|NCT00965562|945082|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
395460|NCT00965562|945080|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
395461|NCT00965562|945081|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
395462|NCT00965562|945082|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
395463|NCT00965562|945080|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
395464|NCT00965562|945081|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
395465|NCT00965562|945082|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
395466|NCT00965562|945080|P3|STARTED|Overall Study||16
395467|NCT00965562|945081|P2|STARTED|Overall Study||17
395468|NCT00965562|945082|P1|STARTED|Overall Study||16
395469|NCT00965523|945120|P1|NOT COMPLETED|Study 224||6
395470|NCT00965523|945120|P1|COMPLETED|Study 224||0
395471|NCT00965523|945120|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
395472|NCT00965523|945120|P1|NOT COMPLETED|Study 221||7
395473|NCT00965523|945120|P1|COMPLETED|Study 221||74
395474|NCT00965523|945120|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
395475|NCT00965497|945125|P1|NOT COMPLETED|Overall Study||1
395476|NCT00965497|945125|P1|COMPLETED|Overall Study||13
395477|NCT00965497|945125|P1|STARTED|Overall Study||14
395478|NCT00965484|945130|P1|NOT COMPLETED|Overall Study||2
395479|NCT00965484|945130|P1|COMPLETED|Overall Study||134
395480|NCT00965484|945130|P1|STARTED|Overall Study||136
395481|NCT00965458|945139|P2|NOT COMPLETED|Overall Study||4
395482|NCT00965458|945140|P1|NOT COMPLETED|Overall Study||2
395483|NCT00965458|945139|P2|COMPLETED|Overall Study||12
395484|NCT00965458|945140|P1|COMPLETED|Overall Study||31
395485|NCT00965458|945139|P2|STARTED|Overall Study||16
395486|NCT00965458|945140|P1|STARTED|Overall Study||33
395487|NCT00965341|945158|P2|NOT COMPLETED|Overall Study||8
395488|NCT00965341|945159|P1|NOT COMPLETED|Overall Study||6
395489|NCT00965341|945158|P2|COMPLETED|Overall Study||16
395490|NCT00965341|945159|P1|COMPLETED|Overall Study||13
395491|NCT00965341|945158|P2|STARTED|Overall Study||24
395492|NCT00965341|945159|P1|STARTED|Overall Study||19
395493|NCT00965250|945169|P2|NOT COMPLETED|Overall Study||0
395494|NCT00965250|945170|P1|NOT COMPLETED|Overall Study||0
395495|NCT00965250|945169|P2|COMPLETED|Overall Study||12
395496|NCT00965250|945170|P1|COMPLETED|Overall Study||37
395497|NCT00965250|945169|P2|STARTED|Overall Study||12
395498|NCT00965250|945170|P1|STARTED|Overall Study||37
395499|NCT00965237|945188|P2|NOT COMPLETED|Period 2, One Week of Wear||0
395500|NCT00965237|945189|P1|NOT COMPLETED|Period 2, One Week of Wear||0
395501|NCT00965237|945188|P2|COMPLETED|Period 2, One Week of Wear||8
395502|NCT00965237|945189|P1|COMPLETED|Period 2, One Week of Wear||8
395503|NCT00965237|945188|P2|STARTED|Period 2, One Week of Wear||8
395504|NCT00965237|945189|P1|STARTED|Period 2, One Week of Wear||8
395505|NCT00965237|945188|P2|NOT COMPLETED|Period 1, One Week of Wear||0
395506|NCT00965237|945189|P1|NOT COMPLETED|Period 1, One Week of Wear||0
395507|NCT00965237|945188|P2|COMPLETED|Period 1, One Week of Wear||8
395508|NCT00965237|945189|P1|COMPLETED|Period 1, One Week of Wear||8
395509|NCT00965237|945188|P2|STARTED|Period 1, One Week of Wear||8
395510|NCT00965237|945189|P1|STARTED|Period 1, One Week of Wear||8
395511|NCT00965185|945197|P2|NOT COMPLETED|Overall Study||1
395512|NCT00965185|945198|P1|NOT COMPLETED|Overall Study||2
395513|NCT00965185|945197|P2|COMPLETED|Overall Study||20
395514|NCT00965185|945198|P1|COMPLETED|Overall Study||17
395515|NCT00965185|945197|P2|9 Month Visit|Overall Study||21
395516|NCT00965185|945198|P1|9 Month Visit|Overall Study||18
395517|NCT00965185|945197|P2|6 Month Visit|Overall Study||21
395518|NCT00965185|945198|P1|6 Month Visit|Overall Study||18
395519|NCT00965185|945197|P2|3 Month Visit|Overall Study||21
395520|NCT00965185|945198|P1|3 Month Visit|Overall Study||18
395521|NCT00965185|945197|P2|1 Month Visit|Overall Study||21
395522|NCT00965185|945198|P1|1 Month Visit|Overall Study||18
395523|NCT00965185|945197|P2|STARTED|Overall Study||21
395524|NCT00965185|945198|P1|STARTED|Overall Study||19
395525|NCT00965146|945214|P1|NOT COMPLETED|Overall Study||210
395526|NCT00965146|945214|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
395527|NCT00965146|945214|P1|STARTED|Overall Study||210
395528|NCT00965094|945220|P2|NOT COMPLETED|Overall Study||1
395529|NCT00965094|945221|P1|NOT COMPLETED|Overall Study||5
395530|NCT00965094|945220|P2|COMPLETED|Overall Study||16
395531|NCT00965094|945221|P1|COMPLETED|Overall Study||14
395532|NCT00965094|945220|P2|STARTED|Overall Study||17
395533|NCT00965094|945221|P1|STARTED|Overall Study||19
395534|NCT00965081|945237|P2|NOT COMPLETED|Overall Study||43
395535|NCT00965081|945238|P1|NOT COMPLETED|Overall Study||34
395536|NCT00965081|945237|P2|COMPLETED|Overall Study||110
395537|NCT00965081|945238|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
395538|NCT00965081|945237|P2|STARTED|Overall Study||153
395539|NCT00965081|945238|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
395540|NCT00964886|945265|P4|NOT COMPLETED|Overall Study||9
395541|NCT00964886|945266|P3|NOT COMPLETED|Overall Study||16
395542|NCT00964886|945267|P2|NOT COMPLETED|Overall Study||7
395543|NCT00964886|945268|P1|NOT COMPLETED|Overall Study||11
395544|NCT00964886|945265|P4|COMPLETED|Overall Study||24
395545|NCT00964886|945266|P3|COMPLETED|Overall Study||21
395546|NCT00964886|945267|P2|COMPLETED|Overall Study||27
395547|NCT00964886|945268|P1|COMPLETED|Overall Study||27
395548|NCT00964886|945265|P4|STARTED|Overall Study||33
395549|NCT00964886|945266|P3|STARTED|Overall Study||37
395550|NCT00964886|945267|P2|STARTED|Overall Study||34
395551|NCT00964886|945268|P1|STARTED|Overall Study||38
395552|NCT00964860|945284|P2|NOT COMPLETED|Overall Study||1
395553|NCT00964860|945285|P1|NOT COMPLETED|Overall Study||0
395554|NCT00964860|945284|P2|COMPLETED|Overall Study||29
395555|NCT00964860|945285|P1|COMPLETED|Overall Study||30
395556|NCT00964860|945284|P2|STARTED|Overall Study||30
395557|NCT00964860|945285|P1|STARTED|Overall Study||30
395558|NCT00964795|945293|P1|NOT COMPLETED|Overall Study||307
395559|NCT00964795|945293|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
395560|NCT00964795|945293|P1|Number of Participants Treated|Overall Study||320
395561|NCT00964795|945293|P1|STARTED|Overall Study|randomized|323
395562|NCT00964743|945300|P1|NOT COMPLETED|Overall Study||2
395563|NCT00964743|945300|P1|COMPLETED|Overall Study||0
395564|NCT00964743|945300|P1|STARTED|Overall Study||2
395565|NCT00964678|945308|P1|NOT COMPLETED|Overall Study||4
395566|NCT00964678|945308|P1|COMPLETED|Overall Study||6
395567|NCT00964678|945308|P1|STARTED|Overall Study||10
395568|NCT00964548|945317|P2|NOT COMPLETED|Overall Study||0
395569|NCT00964548|945318|P1|NOT COMPLETED|Overall Study||0
395570|NCT00964548|945317|P2|COMPLETED|Overall Study||5
395571|NCT00964548|945318|P1|COMPLETED|Overall Study||5
395572|NCT00964548|945317|P2|STARTED|Overall Study||5
395573|NCT00964548|945318|P1|STARTED|Overall Study||5
395574|NCT00964496|945330|P2|NOT COMPLETED|Overall Study||1
395575|NCT00964496|945331|P1|NOT COMPLETED|Overall Study||2
395576|NCT00964496|945330|P2|COMPLETED|Overall Study||26
395577|NCT00964496|945331|P1|COMPLETED|Overall Study||26
395578|NCT00964496|945330|P2|STARTED|Overall Study||27
395579|NCT00964496|945331|P1|STARTED|Overall Study||28
395580|NCT00964444|945349|P1|NOT COMPLETED|Overall Study||0
395581|NCT00964444|945349|P1|COMPLETED|Overall Study||10
395582|NCT00964444|945349|P1|STARTED|Overall Study||10
395583|NCT00964431|945357|P4|NOT COMPLETED|Overall Study||0
395584|NCT00964431|945358|P3|NOT COMPLETED|Overall Study||0
395585|NCT00964431|945359|P2|NOT COMPLETED|Overall Study||0
395586|NCT00964431|945360|P1|NOT COMPLETED|Overall Study||0
395587|NCT00964431|945357|P4|COMPLETED|Overall Study||51
395588|NCT00964431|945358|P3|COMPLETED|Overall Study||51
395589|NCT00964431|945359|P2|COMPLETED|Overall Study||51
395590|NCT00964431|945360|P1|COMPLETED|Overall Study||50
395591|NCT00964431|945357|P4|STARTED|Overall Study||51
395592|NCT00964431|945358|P3|STARTED|Overall Study||51
395593|NCT00964431|945359|P2|STARTED|Overall Study||51
395594|NCT00964431|945360|P1|STARTED|Overall Study||50
395595|NCT00964392|945372|P2|NOT COMPLETED|Overall Study||190
395596|NCT00964392|945373|P1|NOT COMPLETED|Overall Study||53
395597|NCT00964392|945372|P2|COMPLETED|Overall Study||92
395598|NCT00964392|945373|P1|COMPLETED|Overall Study||72
395599|NCT00964392|945372|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
395600|NCT00964392|945373|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
395601|NCT00964366|945383|P2|NOT COMPLETED|Overall Study||1
395602|NCT00964366|945384|P1|NOT COMPLETED|Overall Study||1
395603|NCT00964366|945383|P2|COMPLETED|Overall Study||24
395604|NCT00964366|945384|P1|COMPLETED|Overall Study||27
395605|NCT00964366|945383|P2|STARTED|Overall Study||25
395606|NCT00964366|945384|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
395607|NCT00964223|945398|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
395608|NCT00964223|945398|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
395609|NCT00964223|945398|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
395610|NCT00964223|945398|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
395611|NCT00964223|945398|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
395612|NCT00964223|945398|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
395613|NCT00964119|945463|P1|NOT COMPLETED|Overall Study||0
395614|NCT00964119|945463|P1|COMPLETED|Overall Study||15
395615|NCT00964119|945463|P1|STARTED|Overall Study||15
395616|NCT00964028|945469|P2|NOT COMPLETED|Overall Study||1
395617|NCT00964028|945470|P1|NOT COMPLETED|Overall Study||0
395618|NCT00964028|945469|P2|COMPLETED|Overall Study||24
395619|NCT00964028|945470|P1|COMPLETED|Overall Study||25
395620|NCT00964028|945469|P2|STARTED|Overall Study||25
395621|NCT00964028|945470|P1|STARTED|Overall Study||25
395622|NCT00963937|945485|P3|NOT COMPLETED|Overall Study||4
395623|NCT00963937|945486|P2|NOT COMPLETED|Overall Study||11
395624|NCT00963937|945487|P1|NOT COMPLETED|Overall Study||19
395625|NCT00963937|945485|P3|COMPLETED|Overall Study||41
395626|NCT00963937|945486|P2|COMPLETED|Overall Study||33
395627|NCT00963937|945487|P1|COMPLETED|Overall Study||70
395628|NCT00963937|945485|P3|STARTED|Overall Study||45
395629|NCT00963937|945486|P2|STARTED|Overall Study||44
395630|NCT00963937|945487|P1|STARTED|Overall Study||89
395631|NCT00963924|945525|P2|NOT COMPLETED|Overall Study||3
395632|NCT00963924|945526|P1|NOT COMPLETED|Overall Study||1
395633|NCT00963924|945525|P2|COMPLETED|Overall Study||15
395634|NCT00963924|945526|P1|COMPLETED|Overall Study||17
395635|NCT00963924|945525|P2|STARTED|Overall Study||18
395636|NCT00963924|945526|P1|STARTED|Overall Study||18
395637|NCT00963872|945544|P2|NOT COMPLETED|Overall Study||1
395638|NCT00963872|945545|P1|NOT COMPLETED|Overall Study||1
395639|NCT00963872|945544|P2|COMPLETED|Overall Study||5
395640|NCT00963872|945545|P1|COMPLETED|Overall Study||24
395641|NCT00963872|945544|P2|STARTED|Overall Study||6
395642|NCT00963872|945545|P1|STARTED|Overall Study||25
395643|NCT00963859|945589|P1|NOT COMPLETED|Overall Study||0
395644|NCT00963859|945589|P1|COMPLETED|Overall Study||11
395645|NCT00963859|945589|P1|STARTED|Overall Study||11
395646|NCT00963820|945594|P12|NOT COMPLETED|Expansion Phase||4
395647|NCT00963820|945595|P11|NOT COMPLETED|Expansion Phase||5
395648|NCT00963820|945596|P10|NOT COMPLETED|Expansion Phase||9
395649|NCT00963820|945597|P9|NOT COMPLETED|Expansion Phase||10
395650|NCT00963820|945598|P8|NOT COMPLETED|Expansion Phase||0
395651|NCT00963820|945599|P7|NOT COMPLETED|Expansion Phase||0
395652|NCT00963820|945600|P6|NOT COMPLETED|Expansion Phase||0
395653|NCT00963820|945601|P5|NOT COMPLETED|Expansion Phase||0
395654|NCT00963820|945602|P4|NOT COMPLETED|Expansion Phase||0
395655|NCT00963820|945603|P3|NOT COMPLETED|Expansion Phase||0
395656|NCT00963820|945604|P2|NOT COMPLETED|Expansion Phase||0
395657|NCT00963820|945605|P1|NOT COMPLETED|Expansion Phase||0
395658|NCT00963820|945594|P12|COMPLETED|Expansion Phase||0
395659|NCT00963820|945595|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
395660|NCT00963820|945596|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
395661|NCT00963820|945597|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
395662|NCT00963820|945598|P8|COMPLETED|Expansion Phase||0
395663|NCT00963820|945599|P7|COMPLETED|Expansion Phase||0
395664|NCT00963820|945600|P6|COMPLETED|Expansion Phase||0
395665|NCT00963820|945601|P5|COMPLETED|Expansion Phase||0
395666|NCT00963820|945602|P4|COMPLETED|Expansion Phase||0
395667|NCT00963820|945603|P3|COMPLETED|Expansion Phase||0
395668|NCT00963820|945604|P2|COMPLETED|Expansion Phase||0
395669|NCT00963820|945605|P1|COMPLETED|Expansion Phase||0
395670|NCT00963820|945594|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
395671|NCT00963820|945595|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
395672|NCT00963820|945596|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
395673|NCT00963820|945597|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
395674|NCT00963820|945598|P8|STARTED|Expansion Phase||0
395675|NCT00963820|945599|P7|STARTED|Expansion Phase||0
395676|NCT00963820|945600|P6|STARTED|Expansion Phase||0
395677|NCT00963820|945601|P5|STARTED|Expansion Phase||0
395678|NCT00963820|945602|P4|STARTED|Expansion Phase||0
395679|NCT00963820|945603|P3|STARTED|Expansion Phase||0
395680|NCT00963820|945604|P2|STARTED|Expansion Phase||0
395681|NCT00963820|945605|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
395682|NCT00963820|945594|P12|NOT COMPLETED|Dose Escalation Phase||0
395683|NCT00963820|945595|P11|NOT COMPLETED|Dose Escalation Phase||0
395684|NCT00963820|945596|P10|NOT COMPLETED|Dose Escalation Phase||0
395685|NCT00963820|945597|P9|NOT COMPLETED|Dose Escalation Phase||0
395686|NCT00963820|945598|P8|NOT COMPLETED|Dose Escalation Phase||5
395687|NCT00963820|945599|P7|NOT COMPLETED|Dose Escalation Phase||8
395688|NCT00963820|945600|P6|NOT COMPLETED|Dose Escalation Phase||3
395689|NCT00963820|945601|P5|NOT COMPLETED|Dose Escalation Phase||4
395690|NCT00963820|945602|P4|NOT COMPLETED|Dose Escalation Phase||3
395691|NCT00963820|945603|P3|NOT COMPLETED|Dose Escalation Phase||3
395692|NCT00963820|945604|P2|NOT COMPLETED|Dose Escalation Phase||3
395693|NCT00963820|945605|P1|NOT COMPLETED|Dose Escalation Phase||3
395694|NCT00963820|945594|P12|COMPLETED|Dose Escalation Phase||0
395695|NCT00963820|945595|P11|COMPLETED|Dose Escalation Phase||0
395696|NCT00963820|945596|P10|COMPLETED|Dose Escalation Phase||0
395697|NCT00963820|945597|P9|COMPLETED|Dose Escalation Phase||0
395698|NCT00963820|945598|P8|COMPLETED|Dose Escalation Phase||0
395699|NCT00963820|945599|P7|COMPLETED|Dose Escalation Phase||0
395700|NCT00963820|945600|P6|COMPLETED|Dose Escalation Phase||0
395701|NCT00963820|945601|P5|COMPLETED|Dose Escalation Phase||0
395702|NCT00963820|945602|P4|COMPLETED|Dose Escalation Phase||0
395703|NCT00963820|945603|P3|COMPLETED|Dose Escalation Phase||0
395704|NCT00963820|945604|P2|COMPLETED|Dose Escalation Phase||0
395705|NCT00963820|945605|P1|COMPLETED|Dose Escalation Phase||0
395706|NCT00963820|945594|P12|STARTED|Dose Escalation Phase||0
395707|NCT00963820|945595|P11|STARTED|Dose Escalation Phase||0
395708|NCT00963820|945596|P10|STARTED|Dose Escalation Phase||0
395709|NCT00963820|945597|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
395710|NCT00963820|945598|P8|STARTED|Dose Escalation Phase||5
395711|NCT00963820|945599|P7|STARTED|Dose Escalation Phase||8
395712|NCT00963820|945600|P6|STARTED|Dose Escalation Phase||3
395713|NCT00963820|945601|P5|STARTED|Dose Escalation Phase||4
395714|NCT00963820|945602|P4|STARTED|Dose Escalation Phase||3
395715|NCT00963820|945603|P3|STARTED|Dose Escalation Phase||3
395716|NCT00963820|945604|P2|STARTED|Dose Escalation Phase||3
395717|NCT00963820|945605|P1|STARTED|Dose Escalation Phase||3
395718|NCT00963807|945741|P1|NOT COMPLETED|Overall Study||18
395719|NCT00963807|945741|P1|COMPLETED|Overall Study||8
395720|NCT00963807|945741|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
395721|NCT00963807|945741|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
395722|NCT00963807|945741|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
395723|NCT00963807|945741|P1|Completed Baseline Imaging|Overall Study||11
395724|NCT00963807|945741|P1|STARTED|Overall Study||26
395725|NCT00963677|945752|P2|NOT COMPLETED|Overall Study||2
395726|NCT00963677|945753|P1|NOT COMPLETED|Overall Study||0
395727|NCT00963677|945752|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
395728|NCT00963677|945753|P1|COMPLETED|Overall Study||35
395729|NCT00963677|945752|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
395730|NCT00963677|945753|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
395731|NCT00963638|945763|P2|NOT COMPLETED|Overall Study||0
395732|NCT00963638|945764|P1|NOT COMPLETED|Overall Study||0
395733|NCT00963638|945763|P2|COMPLETED|Overall Study||20
395734|NCT00963638|945764|P1|COMPLETED|Overall Study||20
395735|NCT00963638|945763|P2|STARTED|Overall Study||20
395736|NCT00963638|945764|P1|STARTED|Overall Study||20
395737|NCT00963599|945774|P4|NOT COMPLETED|Overall Study||14
395738|NCT00963599|945775|P3|NOT COMPLETED|Overall Study||9
395739|NCT00963599|945776|P2|NOT COMPLETED|Overall Study||6
395740|NCT00963599|945777|P1|NOT COMPLETED|Overall Study||6
395741|NCT00963599|945774|P4|COMPLETED|Overall Study||288
395742|NCT00963599|945775|P3|COMPLETED|Overall Study||292
395743|NCT00963599|945776|P2|COMPLETED|Overall Study||149
395744|NCT00963599|945777|P1|COMPLETED|Overall Study||143
395745|NCT00963599|945774|P4|STARTED|Overall Study||302
395746|NCT00963599|945775|P3|STARTED|Overall Study||301
395747|NCT00963599|945776|P2|STARTED|Overall Study||155
395748|NCT00963599|945777|P1|STARTED|Overall Study||149
395749|NCT00963560|945834|P3|NOT COMPLETED|Overall Study||0
395750|NCT00963560|945835|P2|NOT COMPLETED|Overall Study||3
395751|NCT00963560|945836|P1|NOT COMPLETED|Overall Study||3
395752|NCT00963560|945834|P3|COMPLETED|Overall Study||41
395753|NCT00963560|945835|P2|COMPLETED|Overall Study||41
395754|NCT00963560|945836|P1|COMPLETED|Overall Study||44
395755|NCT00963560|945834|P3|STARTED|Overall Study||41
395756|NCT00963560|945835|P2|STARTED|Overall Study||44
395757|NCT00963560|945836|P1|STARTED|Overall Study||47
395758|NCT00963508|945846|P2|NOT COMPLETED|Overall Study||28
395759|NCT00963508|945847|P1|NOT COMPLETED|Overall Study||10
395760|NCT00963508|945846|P2|COMPLETED|Overall Study||169
395761|NCT00963508|945847|P1|COMPLETED|Overall Study||196
395762|NCT00963508|945846|P2|STARTED|Overall Study||197
395763|NCT00963508|945847|P1|STARTED|Overall Study||206
395764|NCT00963482|945857|P2|NOT COMPLETED|Overall Study||17
395765|NCT00963482|945858|P1|NOT COMPLETED|Overall Study||28
395766|NCT00963482|945857|P2|COMPLETED|Overall Study||33
395767|NCT00963482|945858|P1|COMPLETED|Overall Study||25
395768|NCT00963482|945857|P2|STARTED|Overall Study||50
395769|NCT00963482|945858|P1|STARTED|Overall Study||53
395770|NCT00963469|945867|P3|NOT COMPLETED|Overall Study||10
395771|NCT00963469|945868|P2|NOT COMPLETED|Overall Study||28
395772|NCT00963469|945869|P1|NOT COMPLETED|Overall Study||41
395773|NCT00963469|945867|P3|COMPLETED|Overall Study||170
395774|NCT00963469|945868|P2|COMPLETED|Overall Study||420
395775|NCT00963469|945869|P1|COMPLETED|Overall Study||410
395776|NCT00963469|945867|P3|STARTED|Overall Study||180
395777|NCT00963469|945868|P2|STARTED|Overall Study||448
395778|NCT00963469|945869|P1|STARTED|Overall Study||451
395779|NCT00963430|945897|P2|NOT COMPLETED|Overall Study||3
395780|NCT00963430|945898|P1|NOT COMPLETED|Overall Study||1
395781|NCT00963430|945897|P2|COMPLETED|Overall Study||57
395782|NCT00963430|945898|P1|COMPLETED|Overall Study||59
395783|NCT00963430|945897|P2|STARTED|Overall Study||60
395784|NCT00963430|945898|P1|STARTED|Overall Study||60
395785|NCT00963235|945936|P1|NOT COMPLETED|Overall Study||60
395786|NCT00963235|945936|P1|COMPLETED|Overall Study||271
395787|NCT00963235|945936|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
395788|NCT00963235|945936|P1|Vaccinated Dose 3|Overall Study||279
395789|NCT00963235|945936|P1|Vaccinated Dose 2|Overall Study||300
395790|NCT00963235|945936|P1|Vaccinated Dose 1|Overall Study||329
395791|NCT00963235|945936|P1|STARTED|Overall Study||331
395792|NCT00963157|945960|P5|NOT COMPLETED|Overall Study||2
395793|NCT00963157|945961|P4|NOT COMPLETED|Overall Study||7
395794|NCT00963157|945962|P3|NOT COMPLETED|Overall Study||5
395795|NCT00963157|945963|P2|NOT COMPLETED|Overall Study||4
395796|NCT00963157|945964|P1|NOT COMPLETED|Overall Study||5
395797|NCT00963157|945960|P5|COMPLETED|Overall Study||151
395798|NCT00963157|945961|P4|COMPLETED|Overall Study||150
395799|NCT00963157|945962|P3|COMPLETED|Overall Study||155
395800|NCT00963157|945963|P2|COMPLETED|Overall Study||159
395801|NCT00963157|945964|P1|COMPLETED|Overall Study||151
395802|NCT00963157|945960|P5|STARTED|Overall Study||153
395803|NCT00963157|945961|P4|STARTED|Overall Study||157
395804|NCT00963157|945962|P3|STARTED|Overall Study||160
395805|NCT00963157|945963|P2|STARTED|Overall Study||163
395806|NCT00963157|945964|P1|STARTED|Overall Study||156
395807|NCT00962871|946160|P4|NOT COMPLETED|Overall Study||0
395808|NCT00962871|946161|P3|NOT COMPLETED|Overall Study||0
395809|NCT00962871|946162|P2|NOT COMPLETED|Overall Study||0
395810|NCT00962871|946163|P1|NOT COMPLETED|Overall Study||0
395811|NCT00962871|946160|P4|COMPLETED|Overall Study||6
395812|NCT00962871|946161|P3|COMPLETED|Overall Study||12
395813|NCT00962871|946162|P2|COMPLETED|Overall Study||6
395814|NCT00962871|946163|P1|COMPLETED|Overall Study||6
395815|NCT00962871|946160|P4|STARTED|Overall Study||6
395816|NCT00962871|946161|P3|STARTED|Overall Study||12
395817|NCT00962871|946162|P2|STARTED|Overall Study||6
395818|NCT00962871|946163|P1|STARTED|Overall Study||6
395819|NCT00962780|946179|P2|NOT COMPLETED|Overall Study||14
395820|NCT00962780|946180|P1|NOT COMPLETED|Overall Study||10
395821|NCT00962780|946179|P2|COMPLETED|Overall Study||138
395822|NCT00962780|946180|P1|COMPLETED|Overall Study||141
395823|NCT00962780|946179|P2|Vaccinated 23vPS Dose|Overall Study||139
395824|NCT00962780|946180|P1|Vaccinated 23vPS Dose|Overall Study||143
395825|NCT00962780|946179|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
395826|NCT00962780|946180|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
395827|NCT00962780|946179|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
395828|NCT00962780|946180|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
395829|NCT00962780|946179|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
395830|NCT00962780|946180|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
395831|NCT00962780|946179|P2|STARTED|Overall Study||152
395832|NCT00962780|946180|P1|STARTED|Overall Study||151
395833|NCT00962754|946244|P2|NOT COMPLETED|Overall Study||0
395834|NCT00962754|946245|P1|NOT COMPLETED|Overall Study||0
395835|NCT00962754|946244|P2|COMPLETED|Overall Study||84
395836|NCT00962754|946245|P1|COMPLETED|Overall Study||86
395837|NCT00962754|946244|P2|STARTED|Overall Study||84
395838|NCT00962754|946245|P1|STARTED|Overall Study||86
395839|NCT00962741|946255|P1|NOT COMPLETED|Overall Study||8
395840|NCT00962741|946255|P1|COMPLETED|Overall Study||119
395841|NCT00962741|946255|P1|STARTED|Overall Study||127
395842|NCT00962650|946346|P1|NOT COMPLETED|Overall Study||2
395843|NCT00962650|946346|P1|COMPLETED|Overall Study||8
395844|NCT00962650|946346|P1|STARTED|Overall Study||10
395845|NCT00962598|946352|P2|NOT COMPLETED|Overall Study||6
395846|NCT00962598|946353|P1|NOT COMPLETED|Overall Study||6
395847|NCT00962598|946352|P2|COMPLETED|Overall Study||18
395848|NCT00962598|946353|P1|COMPLETED|Overall Study||21
395849|NCT00962598|946352|P2|STARTED|Overall Study||24
395850|NCT00962598|946353|P1|STARTED|Overall Study||27
395851|NCT00962585|946365|P4|NOT COMPLETED|Overall Study||0
395852|NCT00962585|946366|P3|NOT COMPLETED|Overall Study||3
395853|NCT00962585|946367|P2|NOT COMPLETED|Overall Study||2
395854|NCT00962585|946368|P1|NOT COMPLETED|Overall Study||6
395855|NCT00962585|946365|P4|COMPLETED|Overall Study||42
395856|NCT00962585|946366|P3|COMPLETED|Overall Study||39
395857|NCT00962585|946367|P2|COMPLETED|Overall Study||40
395858|NCT00962585|946368|P1|COMPLETED|Overall Study||37
395859|NCT00962585|946365|P4|STARTED|Overall Study||42
395860|NCT00962585|946366|P3|STARTED|Overall Study||42
395861|NCT00962585|946367|P2|STARTED|Overall Study||42
395862|NCT00962585|946368|P1|STARTED|Overall Study||43
395863|NCT00962390|946430|P4|NOT COMPLETED|Overall Study||1
395864|NCT00962390|946431|P3|NOT COMPLETED|Overall Study||4
395865|NCT00962390|946432|P2|NOT COMPLETED|Overall Study||3
395866|NCT00962390|946433|P1|NOT COMPLETED|Overall Study||4
395867|NCT00962390|946430|P4|COMPLETED|Overall Study||28
395868|NCT00962390|946431|P3|COMPLETED|Overall Study||25
395869|NCT00962390|946432|P2|COMPLETED|Overall Study||26
395870|NCT00962390|946433|P1|COMPLETED|Overall Study||25
395871|NCT00962390|946430|P4|STARTED|Overall Study||29
395872|NCT00962390|946431|P3|STARTED|Overall Study||29
395873|NCT00962390|946432|P2|STARTED|Overall Study||29
395874|NCT00962390|946433|P1|STARTED|Overall Study||29
395875|NCT00962208|946497|P2|NOT COMPLETED|Overall Study||10
395876|NCT00962208|946498|P1|NOT COMPLETED|Overall Study||14
395877|NCT00962208|946497|P2|COMPLETED|Overall Study||41
395878|NCT00962208|946498|P1|COMPLETED|Overall Study||37
395879|NCT00962208|946497|P2|STARTED|Overall Study||51
395880|NCT00962208|946498|P1|STARTED|Overall Study||51
395881|NCT00962104|946506|P2|NOT COMPLETED|Overall Study||25
395882|NCT00962104|946507|P1|NOT COMPLETED|Overall Study||40
395883|NCT00962104|946506|P2|COMPLETED|Overall Study||171
395884|NCT00962104|946507|P1|COMPLETED|Overall Study||155
395885|NCT00962104|946506|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
395886|NCT00962104|946507|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
395887|NCT00962104|946506|P2|STARTED|Overall Study||196
395888|NCT00962104|946507|P1|STARTED|Overall Study||195
395889|NCT00962065|946536|P3|NOT COMPLETED|Overall Study||0
395890|NCT00962065|946537|P2|NOT COMPLETED|Overall Study||0
395891|NCT00962065|946538|P1|NOT COMPLETED|Overall Study||0
395892|NCT00962065|946536|P3|COMPLETED|Overall Study||12
395893|NCT00962065|946537|P2|COMPLETED|Overall Study||12
395894|NCT00962065|946538|P1|COMPLETED|Overall Study||12
395895|NCT00962065|946536|P3|STARTED|Overall Study||12
395896|NCT00962065|946537|P2|STARTED|Overall Study||12
395897|NCT00962065|946538|P1|STARTED|Overall Study||12
395898|NCT00962013|946561|P1|NOT COMPLETED|Overall Study||68
395899|NCT00962013|946561|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
395900|NCT00962013|946561|P1|STARTED|Overall Study||120
395901|NCT00962000|946570|P2|NOT COMPLETED|Period 4 - 1 Week||0
395902|NCT00962000|946571|P1|NOT COMPLETED|Period 4 - 1 Week||0
395903|NCT00962000|946570|P2|COMPLETED|Period 4 - 1 Week||21
395904|NCT00962000|946571|P1|COMPLETED|Period 4 - 1 Week||21
395905|NCT00962000|946570|P2|STARTED|Period 4 - 1 Week||21
395906|NCT00962000|946571|P1|STARTED|Period 4 - 1 Week||21
395907|NCT00962000|946570|P2|NOT COMPLETED|Period 3 - 1 Week||0
395908|NCT00962000|946571|P1|NOT COMPLETED|Period 3 - 1 Week||0
395909|NCT00962000|946570|P2|COMPLETED|Period 3 - 1 Week||21
395910|NCT00962000|946571|P1|COMPLETED|Period 3 - 1 Week||21
395911|NCT00962000|946570|P2|STARTED|Period 3 - 1 Week||21
395912|NCT00962000|946571|P1|STARTED|Period 3 - 1 Week||21
395913|NCT00962000|946570|P2|NOT COMPLETED|Period 2 - 1 Week||0
395914|NCT00962000|946571|P1|NOT COMPLETED|Period 2 - 1 Week||0
395915|NCT00962000|946570|P2|COMPLETED|Period 2 - 1 Week||21
395916|NCT00962000|946571|P1|COMPLETED|Period 2 - 1 Week||21
395917|NCT00962000|946570|P2|STARTED|Period 2 - 1 Week||21
395918|NCT00962000|946571|P1|STARTED|Period 2 - 1 Week||21
395919|NCT00962000|946570|P2|NOT COMPLETED|Period 1 - 1 Week||0
395920|NCT00962000|946571|P1|NOT COMPLETED|Period 1 - 1 Week||0
395921|NCT00962000|946570|P2|COMPLETED|Period 1 - 1 Week||21
395922|NCT00962000|946571|P1|COMPLETED|Period 1 - 1 Week||21
395923|NCT00962000|946570|P2|STARTED|Period 1 - 1 Week||21
395924|NCT00962000|946571|P1|STARTED|Period 1 - 1 Week||21
395925|NCT00961896|946584|P3|NOT COMPLETED|Overall Study||1
395926|NCT00961896|946585|P2|NOT COMPLETED|Overall Study||0
395927|NCT00961896|946586|P1|NOT COMPLETED|Overall Study||0
395928|NCT00961896|946584|P3|COMPLETED|Overall Study||6
395929|NCT00961896|946585|P2|COMPLETED|Overall Study||3
395930|NCT00961896|946586|P1|COMPLETED|Overall Study||8
395931|NCT00961896|946584|P3|STARTED|Overall Study||7
395932|NCT00961896|946585|P2|STARTED|Overall Study||3
395933|NCT00961896|946586|P1|STARTED|Overall Study||8
395934|NCT00961805|946607|P2|NOT COMPLETED|Overall Study||0
395935|NCT00961805|946608|P1|NOT COMPLETED|Overall Study||0
395936|NCT00961805|946607|P2|COMPLETED|Overall Study||40
395937|NCT00961805|946608|P1|COMPLETED|Overall Study||40
395938|NCT00961805|946607|P2|STARTED|Overall Study||40
395939|NCT00961805|946608|P1|STARTED|Overall Study||40
395940|NCT00961662|946639|P3|NOT COMPLETED|Overall Study||19
395941|NCT00961662|946640|P2|NOT COMPLETED|Overall Study||19
395942|NCT00961662|946641|P1|NOT COMPLETED|Overall Study||22
395943|NCT00961662|946639|P3|COMPLETED|Overall Study||34
395944|NCT00961662|946640|P2|COMPLETED|Overall Study||32
395945|NCT00961662|946641|P1|COMPLETED|Overall Study||35
395946|NCT00961662|946639|P3|STARTED|Overall Study||53
395947|NCT00961662|946640|P2|STARTED|Overall Study||51
395948|NCT00961662|946641|P1|STARTED|Overall Study||57
395949|NCT00961649|946653|P4|NOT COMPLETED|Overall Study||4
395950|NCT00961649|946654|P3|NOT COMPLETED|Overall Study||5
395951|NCT00961649|946655|P2|NOT COMPLETED|Overall Study||4
395952|NCT00961649|946656|P1|NOT COMPLETED|Overall Study||9
395953|NCT00961649|946653|P4|COMPLETED|Overall Study||37
395954|NCT00961649|946654|P3|COMPLETED|Overall Study||39
395955|NCT00961649|946655|P2|COMPLETED|Overall Study||40
395956|NCT00961649|946656|P1|COMPLETED|Overall Study||32
395957|NCT00961649|946653|P4|STARTED|Overall Study||41
395958|NCT00961649|946654|P3|STARTED|Overall Study||44
395959|NCT00961649|946655|P2|STARTED|Overall Study||44
395960|NCT00961649|946656|P1|STARTED|Overall Study||41
395961|NCT00961636|946670|P3|NOT COMPLETED|Overall Study||32
395962|NCT00961636|946671|P2|NOT COMPLETED|Overall Study||131
395963|NCT00961636|946672|P1|NOT COMPLETED|Overall Study||107
395964|NCT00961636|946670|P3|COMPLETED|Overall Study||201
395965|NCT00961636|946671|P2|COMPLETED|Overall Study||325
395966|NCT00961636|946672|P1|COMPLETED|Overall Study||356
395967|NCT00961636|946670|P3|STARTED|Overall Study||233
395968|NCT00961636|946671|P2|STARTED|Overall Study||456
395969|NCT00961636|946672|P1|STARTED|Overall Study||463
395970|NCT00961571|946683|P1|NOT COMPLETED|Overall Study||39
395971|NCT00961571|946683|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
395972|NCT00961571|946683|P1|STARTED|Overall Study||50
395973|NCT00961532|946687|P1|NOT COMPLETED|Overall Study||0
395974|NCT00961532|946687|P1|COMPLETED|Overall Study||14
395975|NCT00961532|946687|P1|STARTED|Overall Study||14
395976|NCT00961441|946694|P2|NOT COMPLETED|Overall Study||0
395977|NCT00961441|946695|P1|NOT COMPLETED|Overall Study||0
395978|NCT00961441|946694|P2|COMPLETED|Overall Study||13
395979|NCT00961441|946695|P1|COMPLETED|Overall Study||12
395980|NCT00961441|946694|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
395981|NCT00961441|946695|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
395982|NCT00961441|946694|P2|STARTED|Overall Study||13
395983|NCT00961441|946695|P1|STARTED|Overall Study||12
395984|NCT00961415|946711|P3|NOT COMPLETED|Maintenance Treatment Phase||45
395985|NCT00961415|946712|P2|NOT COMPLETED|Maintenance Treatment Phase||48
395986|NCT00961415|946713|P1|NOT COMPLETED|Maintenance Treatment Phase||0
395987|NCT00961415|946711|P3|COMPLETED|Maintenance Treatment Phase||83
395988|NCT00961415|946712|P2|COMPLETED|Maintenance Treatment Phase||77
395989|NCT00961415|946713|P1|COMPLETED|Maintenance Treatment Phase||0
395990|NCT00961415|946711|P3|STARTED|Maintenance Treatment Phase||128
395991|NCT00961415|946712|P2|STARTED|Maintenance Treatment Phase||125
395992|NCT00961415|946713|P1|STARTED|Maintenance Treatment Phase||0
395993|NCT00961415|946711|P3|NOT COMPLETED|Induction Treatment Phase||0
395994|NCT00961415|946712|P2|NOT COMPLETED|Induction Treatment Phase||0
395995|NCT00961415|946713|P1|NOT COMPLETED|Induction Treatment Phase||123
395996|NCT00961415|946711|P3|COMPLETED|Induction Treatment Phase||0
395997|NCT00961415|946712|P2|COMPLETED|Induction Treatment Phase||0
395998|NCT00961415|946713|P1|COMPLETED|Induction Treatment Phase||253
395999|NCT00961415|946711|P3|STARTED|Induction Treatment Phase||0
396000|NCT00961415|946712|P2|STARTED|Induction Treatment Phase||0
396001|NCT00961415|946713|P1|STARTED|Induction Treatment Phase||376
396002|NCT00961402|946738|P2|NOT COMPLETED|Overall Study||5
396003|NCT00961402|946739|P1|NOT COMPLETED|Overall Study||1
396004|NCT00961402|946738|P2|COMPLETED|Overall Study||61
396005|NCT00961402|946739|P1|COMPLETED|Overall Study||63
396006|NCT00961402|946738|P2|Randomized|Overall Study||66
396007|NCT00961402|946739|P1|Randomized|Overall Study||64
396008|NCT00961402|946738|P2|STARTED|Overall Study||66
396009|NCT00961402|946739|P1|STARTED|Overall Study||64
396010|NCT00961350|946753|P2|NOT COMPLETED|Overall Study||67
396011|NCT00961350|946754|P1|NOT COMPLETED|Overall Study||47
396012|NCT00961350|946753|P2|COMPLETED|Overall Study||198
396013|NCT00961350|946754|P1|COMPLETED|Overall Study||218
396014|NCT00961350|946753|P2|Safety Population|Overall Study||265
396015|NCT00961350|946754|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
396016|NCT00961350|946753|P2|Intent-to-Treat Population (ITT)|Overall Study||265
396017|NCT00961350|946754|P1|Intent-to-Treat Population (ITT)|Overall Study||265
396018|NCT00961350|946753|P2|STARTED|Overall Study||265
396019|NCT00961350|946754|P1|STARTED|Overall Study||265
396020|NCT00961311|946768|P1|NOT COMPLETED|Overall Study||0
396021|NCT00961311|946768|P1|COMPLETED|Overall Study||51
396022|NCT00961311|946768|P1|STARTED|Overall Study||51
396023|NCT00961298|946775|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
396024|NCT00961298|946775|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
396025|NCT00961298|946775|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
396026|NCT00961298|946775|P1|NOT COMPLETED|Two Week Placebo Run in||1
396027|NCT00961298|946775|P1|COMPLETED|Two Week Placebo Run in||14
396028|NCT00961298|946775|P1|STARTED|Two Week Placebo Run in||15
396029|NCT00961259|946782|P3|NOT COMPLETED|Third Intervention||0
396030|NCT00961259|946783|P2|NOT COMPLETED|Third Intervention||0
396031|NCT00961259|946784|P1|NOT COMPLETED|Third Intervention||0
396032|NCT00961259|946782|P3|COMPLETED|Third Intervention||18
396033|NCT00961259|946783|P2|COMPLETED|Third Intervention||17
396034|NCT00961259|946784|P1|COMPLETED|Third Intervention||18
396035|NCT00961259|946782|P3|STARTED|Third Intervention||18
396036|NCT00961259|946783|P2|STARTED|Third Intervention||17
396037|NCT00961259|946784|P1|STARTED|Third Intervention||18
396038|NCT00961259|946782|P3|NOT COMPLETED|Washout Period of 7 Days||0
396039|NCT00961259|946783|P2|NOT COMPLETED|Washout Period of 7 Days||0
396040|NCT00961259|946784|P1|NOT COMPLETED|Washout Period of 7 Days||0
396041|NCT00961259|946782|P3|COMPLETED|Washout Period of 7 Days||18
396042|NCT00961259|946783|P2|COMPLETED|Washout Period of 7 Days||17
396043|NCT00961259|946784|P1|COMPLETED|Washout Period of 7 Days||18
396044|NCT00961259|946782|P3|STARTED|Washout Period of 7 Days||18
396045|NCT00961259|946783|P2|STARTED|Washout Period of 7 Days||17
396046|NCT00961259|946784|P1|STARTED|Washout Period of 7 Days||18
396047|NCT00961259|946782|P3|NOT COMPLETED|Second Intervention||0
396048|NCT00961259|946783|P2|NOT COMPLETED|Second Intervention||0
396049|NCT00961259|946784|P1|NOT COMPLETED|Second Intervention||0
396050|NCT00961259|946782|P3|COMPLETED|Second Intervention||18
396051|NCT00961259|946783|P2|COMPLETED|Second Intervention||17
396052|NCT00961259|946784|P1|COMPLETED|Second Intervention||18
396053|NCT00961259|946782|P3|STARTED|Second Intervention||18
396054|NCT00961259|946783|P2|STARTED|Second Intervention||17
396055|NCT00961259|946784|P1|STARTED|Second Intervention||18
396056|NCT00961259|946782|P3|NOT COMPLETED|Washout Period of 7 Days||0
396057|NCT00961259|946783|P2|NOT COMPLETED|Washout Period of 7 Days||1
396058|NCT00961259|946784|P1|NOT COMPLETED|Washout Period of 7 Days||0
396059|NCT00961259|946782|P3|COMPLETED|Washout Period of 7 Days||18
396060|NCT00961259|946783|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
396061|NCT00961259|946784|P1|COMPLETED|Washout Period of 7 Days||18
396062|NCT00961259|946782|P3|STARTED|Washout Period of 7 Days||18
396063|NCT00961259|946783|P2|STARTED|Washout Period of 7 Days||18
396064|NCT00961259|946784|P1|STARTED|Washout Period of 7 Days||18
396065|NCT00961259|946782|P3|NOT COMPLETED|First Intervention||0
396066|NCT00961259|946783|P2|NOT COMPLETED|First Intervention||0
396067|NCT00961259|946784|P1|NOT COMPLETED|First Intervention||0
396068|NCT00961259|946782|P3|COMPLETED|First Intervention||18
396069|NCT00961259|946783|P2|COMPLETED|First Intervention||18
396070|NCT00961259|946784|P1|COMPLETED|First Intervention||18
396071|NCT00961259|946782|P3|STARTED|First Intervention||18
396072|NCT00961259|946783|P2|STARTED|First Intervention||18
396073|NCT00961259|946784|P1|STARTED|First Intervention||18
396074|NCT00961233|946803|P2|NOT COMPLETED|Overall Study||1
396075|NCT00961233|946804|P1|NOT COMPLETED|Overall Study||2
396076|NCT00961233|946803|P2|COMPLETED|Overall Study||11
396077|NCT00961233|946804|P1|COMPLETED|Overall Study||11
396078|NCT00961233|946803|P2|STARTED|Overall Study||12
396079|NCT00961233|946804|P1|STARTED|Overall Study||13
396080|NCT00961220|946812|P1|NOT COMPLETED|Overall Study||7
396081|NCT00961220|946812|P1|COMPLETED|Overall Study||10
396082|NCT00961220|946812|P1|STARTED|Overall Study||17
396083|NCT00961181|946828|P1|NOT COMPLETED|Overall Study||5
396084|NCT00961181|946828|P1|COMPLETED|Overall Study||76
396085|NCT00961181|946828|P1|STARTED|Overall Study||81
396086|NCT00961116|946841|P2|NOT COMPLETED|Second Intervention||0
396087|NCT00961116|946842|P1|NOT COMPLETED|Second Intervention||0
396088|NCT00961116|946841|P2|COMPLETED|Second Intervention||24
396089|NCT00961116|946842|P1|COMPLETED|Second Intervention||25
396090|NCT00961116|946841|P2|STARTED|Second Intervention||24
396091|NCT00961116|946842|P1|STARTED|Second Intervention||25
396092|NCT00961116|946841|P2|NOT COMPLETED|Washout Period of 7 Days||3
396093|NCT00961116|946842|P1|NOT COMPLETED|Washout Period of 7 Days||2
396094|NCT00961116|946841|P2|COMPLETED|Washout Period of 7 Days||24
396095|NCT00961116|946842|P1|COMPLETED|Washout Period of 7 Days||25
396096|NCT00961116|946841|P2|STARTED|Washout Period of 7 Days||27
396097|NCT00961116|946842|P1|STARTED|Washout Period of 7 Days||27
396098|NCT00961116|946841|P2|NOT COMPLETED|First Intervention||0
396099|NCT00961116|946842|P1|NOT COMPLETED|First Intervention||0
396100|NCT00961116|946841|P2|COMPLETED|First Intervention||27
396101|NCT00961116|946842|P1|COMPLETED|First Intervention||27
396102|NCT00961116|946841|P2|STARTED|First Intervention||27
396103|NCT00961116|946842|P1|STARTED|First Intervention||27
396104|NCT00961051|946854|P2|NOT COMPLETED|Overall Study||14
396105|NCT00961051|946855|P1|NOT COMPLETED|Overall Study||12
396106|NCT00961051|946854|P2|COMPLETED|Overall Study||79
396107|NCT00961051|946855|P1|COMPLETED|Overall Study||165
396108|NCT00961051|946854|P2|STARTED|Overall Study||93
396109|NCT00961051|946855|P1|STARTED|Overall Study||177
396110|NCT00960999|946865|P2|NOT COMPLETED|Overall Study||2
396111|NCT00960999|946866|P1|NOT COMPLETED|Overall Study||8
396112|NCT00960999|946865|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
396113|NCT00960999|946866|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
396114|NCT00960999|946865|P2|STARTED|Overall Study||47
396115|NCT00960999|946866|P1|STARTED|Overall Study||47
396116|NCT00960986|946876|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
396117|NCT00960986|946877|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
396118|NCT00960986|946878|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
396119|NCT00960986|946879|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
396120|NCT00960986|946876|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
396121|NCT00960986|946877|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
396122|NCT00960986|946878|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
396123|NCT00960986|946879|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
396124|NCT00960986|946876|P4|STARTED|Period 3 (7-week Therapy Period)||61
396125|NCT00960986|946877|P3|STARTED|Period 3 (7-week Therapy Period)||59
396126|NCT00960986|946878|P2|STARTED|Period 3 (7-week Therapy Period)||59
396127|NCT00960986|946879|P1|STARTED|Period 3 (7-week Therapy Period)||56
396128|NCT00960986|946876|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
396129|NCT00960986|946877|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
396130|NCT00960986|946878|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
396131|NCT00960986|946879|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
396132|NCT00960986|946876|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
396133|NCT00960986|946877|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
396134|NCT00960986|946878|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
396135|NCT00960986|946879|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
396136|NCT00960986|946876|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
396137|NCT00960986|946877|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
396138|NCT00960986|946878|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
396139|NCT00960986|946879|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
396140|NCT00960986|946876|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
396141|NCT00960986|946877|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
396142|NCT00960986|946878|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
396143|NCT00960986|946879|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
396144|NCT00960986|946876|P4|COMPLETED|Period 1 (Screening and Washout)||61
396145|NCT00960986|946877|P3|COMPLETED|Period 1 (Screening and Washout)||59
396146|NCT00960986|946878|P2|COMPLETED|Period 1 (Screening and Washout)||59
396147|NCT00960986|946879|P1|COMPLETED|Period 1 (Screening and Washout)||56
396148|NCT00960986|946876|P4|STARTED|Period 1 (Screening and Washout)||64
396149|NCT00960986|946877|P3|STARTED|Period 1 (Screening and Washout)||63
396150|NCT00960986|946878|P2|STARTED|Period 1 (Screening and Washout)||63
396151|NCT00960986|946879|P1|STARTED|Period 1 (Screening and Washout)||59
396152|NCT00960934|946955|P6|NOT COMPLETED|Overall Study||64
396153|NCT00960934|946956|P5|NOT COMPLETED|Overall Study||64
396154|NCT00960934|946957|P4|NOT COMPLETED|Overall Study||64
396155|NCT00960934|946958|P3|NOT COMPLETED|Overall Study||64
396156|NCT00960934|946959|P2|NOT COMPLETED|Overall Study||63
396157|NCT00960934|946960|P1|NOT COMPLETED|Overall Study||64
396158|NCT00960934|946955|P6|COMPLETED|Overall Study||0
396159|NCT00960934|946956|P5|COMPLETED|Overall Study||0
396160|NCT00960934|946957|P4|COMPLETED|Overall Study||0
396161|NCT00960934|946958|P3|COMPLETED|Overall Study||0
396162|NCT00960934|946959|P2|COMPLETED|Overall Study||0
396163|NCT00960934|946960|P1|COMPLETED|Overall Study||0
396164|NCT00960934|946955|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
396165|NCT00960934|946956|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
396166|NCT00960934|946957|P4|Number Treated|Overall Study||64
396167|NCT00960934|946958|P3|Number Treated|Overall Study||64
396168|NCT00960934|946959|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
396169|NCT00960934|946960|P1|Number Treated|Overall Study||64
396170|NCT00960934|946955|P6|STARTED|Overall Study||64
396171|NCT00960934|946956|P5|STARTED|Overall Study||64
396172|NCT00960934|946957|P4|STARTED|Overall Study||64
396173|NCT00960934|946958|P3|STARTED|Overall Study||64
396174|NCT00960934|946959|P2|STARTED|Overall Study||63
396175|NCT00960934|946960|P1|STARTED|Overall Study||64
396176|NCT00960869|947072|P2|NOT COMPLETED|Overall Study||62
396177|NCT00960869|947073|P1|NOT COMPLETED|Overall Study||53
396178|NCT00960869|947072|P2|COMPLETED|Overall Study||198
396179|NCT00960869|947073|P1|COMPLETED|Overall Study||206
396180|NCT00960869|947072|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
396181|NCT00960869|947073|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
396182|NCT00960869|947072|P2|Intent-to-Treat Population (ITT)|Overall Study||260
396183|NCT00960869|947073|P1|Intent-to-Treat Population (ITT)|Overall Study||259
396184|NCT00960869|947072|P2|STARTED|Overall Study||260
396185|NCT00960869|947073|P1|STARTED|Overall Study||259
396186|NCT00960856|947087|P4|NOT COMPLETED|Period IV||0
396187|NCT00960856|947088|P3|NOT COMPLETED|Period IV||0
396188|NCT00960856|947089|P2|NOT COMPLETED|Period IV||0
396189|NCT00960856|947090|P1|NOT COMPLETED|Period IV||0
396190|NCT00960856|947087|P4|COMPLETED|Period IV||9
396191|NCT00960856|947088|P3|COMPLETED|Period IV||8
396192|NCT00960856|947089|P2|COMPLETED|Period IV||7
396193|NCT00960856|947090|P1|COMPLETED|Period IV||10
396194|NCT00960856|947087|P4|STARTED|Period IV||9
396195|NCT00960856|947088|P3|STARTED|Period IV||8
396196|NCT00960856|947089|P2|STARTED|Period IV||7
396197|NCT00960856|947090|P1|STARTED|Period IV||10
396198|NCT00960856|947087|P4|NOT COMPLETED|Washout Period of 7 Days||0
396199|NCT00960856|947088|P3|NOT COMPLETED|Washout Period of 7 Days||1
396200|NCT00960856|947089|P2|NOT COMPLETED|Washout Period of 7 Days||0
396201|NCT00960856|947090|P1|NOT COMPLETED|Washout Period of 7 Days||0
396202|NCT00960856|947087|P4|COMPLETED|Washout Period of 7 Days||9
396203|NCT00960856|947088|P3|COMPLETED|Washout Period of 7 Days||8
396204|NCT00960856|947089|P2|COMPLETED|Washout Period of 7 Days||7
396205|NCT00960856|947090|P1|COMPLETED|Washout Period of 7 Days||10
396206|NCT00960856|947087|P4|STARTED|Washout Period of 7 Days||9
396207|NCT00960856|947088|P3|STARTED|Washout Period of 7 Days||9
396208|NCT00960856|947089|P2|STARTED|Washout Period of 7 Days||7
396209|NCT00960856|947090|P1|STARTED|Washout Period of 7 Days||10
396210|NCT00960856|947087|P4|NOT COMPLETED|Period III||0
396211|NCT00960856|947088|P3|NOT COMPLETED|Period III||0
396212|NCT00960856|947089|P2|NOT COMPLETED|Period III||0
396213|NCT00960856|947090|P1|NOT COMPLETED|Period III||0
396214|NCT00960856|947087|P4|COMPLETED|Period III||9
396215|NCT00960856|947088|P3|COMPLETED|Period III||9
396216|NCT00960856|947089|P2|COMPLETED|Period III||7
396217|NCT00960856|947090|P1|COMPLETED|Period III||10
396218|NCT00960856|947087|P4|STARTED|Period III||9
396219|NCT00960856|947088|P3|STARTED|Period III||9
396220|NCT00960856|947089|P2|STARTED|Period III||7
396221|NCT00960856|947090|P1|STARTED|Period III||10
396222|NCT00960856|947087|P4|NOT COMPLETED|Washout Period of 7 Days||0
396223|NCT00960856|947088|P3|NOT COMPLETED|Washout Period of 7 Days||0
396224|NCT00960856|947089|P2|NOT COMPLETED|Washout Period of 7 Days||0
396225|NCT00960856|947090|P1|NOT COMPLETED|Washout Period of 7 Days||0
396226|NCT00960856|947087|P4|COMPLETED|Washout Period of 7 Days||9
396227|NCT00960856|947088|P3|COMPLETED|Washout Period of 7 Days||9
396228|NCT00960856|947089|P2|COMPLETED|Washout Period of 7 Days||7
396229|NCT00960856|947090|P1|COMPLETED|Washout Period of 7 Days||10
396230|NCT00960856|947087|P4|STARTED|Washout Period of 7 Days||9
396231|NCT00960856|947088|P3|STARTED|Washout Period of 7 Days||9
396232|NCT00960856|947089|P2|STARTED|Washout Period of 7 Days||7
396233|NCT00960856|947090|P1|STARTED|Washout Period of 7 Days||10
396234|NCT00960856|947087|P4|NOT COMPLETED|Period II||0
396235|NCT00960856|947088|P3|NOT COMPLETED|Period II||0
396236|NCT00960856|947089|P2|NOT COMPLETED|Period II||0
396237|NCT00960856|947090|P1|NOT COMPLETED|Period II||0
396238|NCT00960856|947087|P4|COMPLETED|Period II||9
396239|NCT00960856|947088|P3|COMPLETED|Period II||9
396240|NCT00960856|947089|P2|COMPLETED|Period II||7
396241|NCT00960856|947090|P1|COMPLETED|Period II||10
396242|NCT00960856|947087|P4|STARTED|Period II||9
396243|NCT00960856|947088|P3|STARTED|Period II||9
396244|NCT00960856|947089|P2|STARTED|Period II||7
396245|NCT00960856|947090|P1|STARTED|Period II||10
396246|NCT00960856|947087|P4|NOT COMPLETED|Washout Period of 7 Days||0
396247|NCT00960856|947088|P3|NOT COMPLETED|Washout Period of 7 Days||0
396248|NCT00960856|947089|P2|NOT COMPLETED|Washout Period of 7 Days||2
396249|NCT00960856|947090|P1|NOT COMPLETED|Washout Period of 7 Days||0
396250|NCT00960856|947087|P4|COMPLETED|Washout Period of 7 Days||9
396251|NCT00960856|947088|P3|COMPLETED|Washout Period of 7 Days||9
396252|NCT00960856|947089|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
396253|NCT00960856|947090|P1|COMPLETED|Washout Period of 7 Days||10
396254|NCT00960856|947087|P4|STARTED|Washout Period of 7 Days||9
396255|NCT00960856|947088|P3|STARTED|Washout Period of 7 Days||9
396256|NCT00960856|947089|P2|STARTED|Washout Period of 7 Days||9
396257|NCT00960856|947090|P1|STARTED|Washout Period of 7 Days||10
396258|NCT00960856|947087|P4|NOT COMPLETED|Period I||0
396259|NCT00960856|947088|P3|NOT COMPLETED|Period I||0
396260|NCT00960856|947089|P2|NOT COMPLETED|Period I||0
396261|NCT00960856|947090|P1|NOT COMPLETED|Period I||0
396262|NCT00960856|947087|P4|COMPLETED|Period I||9
396263|NCT00960856|947088|P3|COMPLETED|Period I||9
396264|NCT00960856|947089|P2|COMPLETED|Period I||9
396265|NCT00960856|947090|P1|COMPLETED|Period I||10
396266|NCT00960856|947087|P4|STARTED|Period I||9
396267|NCT00960856|947088|P3|STARTED|Period I||9
396268|NCT00960856|947089|P2|STARTED|Period I||9
396269|NCT00960856|947090|P1|STARTED|Period I||10
396270|NCT00960843|947110|P2|NOT COMPLETED|Overall Study||5
396271|NCT00960843|947111|P1|NOT COMPLETED|Overall Study||2
396272|NCT00960843|947110|P2|COMPLETED|Overall Study||21
396273|NCT00960843|947111|P1|COMPLETED|Overall Study||23
396274|NCT00960843|947110|P2|STARTED|Overall Study||26
396275|NCT00960843|947111|P1|STARTED|Overall Study||25
396276|NCT00960687|947121|P2|NOT COMPLETED|Second Intervention||0
396277|NCT00960687|947122|P1|NOT COMPLETED|Second Intervention||0
396278|NCT00960687|947121|P2|COMPLETED|Second Intervention||24
396279|NCT00960687|947122|P1|COMPLETED|Second Intervention||23
396280|NCT00960687|947121|P2|STARTED|Second Intervention||24
396281|NCT00960687|947122|P1|STARTED|Second Intervention||23
396282|NCT00960687|947121|P2|NOT COMPLETED|Washout Period of 7 Days||3
396283|NCT00960687|947122|P1|NOT COMPLETED|Washout Period of 7 Days||4
396284|NCT00960687|947121|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
396285|NCT00960687|947122|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
396286|NCT00960687|947121|P2|STARTED|Washout Period of 7 Days||27
396287|NCT00960687|947122|P1|STARTED|Washout Period of 7 Days||27
396288|NCT00960687|947121|P2|NOT COMPLETED|First Intervention||0
396289|NCT00960687|947122|P1|NOT COMPLETED|First Intervention||0
396290|NCT00960687|947121|P2|COMPLETED|First Intervention||27
396291|NCT00960687|947122|P1|COMPLETED|First Intervention||27
396292|NCT00960687|947121|P2|STARTED|First Intervention||27
396293|NCT00960687|947122|P1|STARTED|First Intervention||27
396294|NCT00960661|947134|P3|NOT COMPLETED|Interventional Phase||46
396295|NCT00960661|947135|P2|NOT COMPLETED|Interventional Phase||52
396296|NCT00960661|947136|P1|NOT COMPLETED|Interventional Phase||0
396297|NCT00960661|947134|P3|COMPLETED|Interventional Phase||275
396298|NCT00960661|947135|P2|COMPLETED|Interventional Phase||264
396299|NCT00960661|947136|P1|COMPLETED|Interventional Phase||0
396300|NCT00960661|947134|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
396301|NCT00960661|947135|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
396302|NCT00960661|947136|P1|Per Protocol Population|Interventional Phase||0
396303|NCT00960661|947134|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
396304|NCT00960661|947135|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
396305|NCT00960661|947136|P1|Intent to Treat Population|Interventional Phase||0
396306|NCT00960661|947134|P3|STARTED|Interventional Phase||321
396307|NCT00960661|947135|P2|STARTED|Interventional Phase||316
396308|NCT00960661|947136|P1|STARTED|Interventional Phase||0
396309|NCT00960661|947134|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
396310|NCT00960661|947135|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
396311|NCT00960661|947136|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
396312|NCT00960661|947134|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
396313|NCT00960661|947135|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
396314|NCT00960661|947136|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
396315|NCT00960661|947134|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
396316|NCT00960661|947135|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
396317|NCT00960661|947136|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
396318|NCT00960622|947168|P2|NOT COMPLETED|Overall Study||3
396319|NCT00960622|947169|P1|NOT COMPLETED|Overall Study||0
396320|NCT00960622|947168|P2|COMPLETED|Overall Study||7
396321|NCT00960622|947169|P1|COMPLETED|Overall Study||10
396322|NCT00960622|947168|P2|STARTED|Overall Study||10
396323|NCT00960622|947169|P1|STARTED|Overall Study||10
396324|NCT00960570|947175|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
396325|NCT00960570|947175|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
396326|NCT00960570|947175|P1|STARTED|Efavirenz and Fenofibric Acid||25
396327|NCT00960570|947175|P1|NOT COMPLETED|1 Day Period Between Dosing||3
396328|NCT00960570|947175|P1|COMPLETED|1 Day Period Between Dosing||25
396329|NCT00960570|947175|P1|STARTED|1 Day Period Between Dosing||28
396330|NCT00960570|947175|P1|NOT COMPLETED|Fenofibric Acid Alone||0
396331|NCT00960570|947175|P1|COMPLETED|Fenofibric Acid Alone||28
396332|NCT00960570|947175|P1|STARTED|Fenofibric Acid Alone||28
396333|NCT00960570|947175|P1|NOT COMPLETED|21 Day Washout Period||2
396334|NCT00960570|947175|P1|COMPLETED|21 Day Washout Period||28
396335|NCT00960570|947175|P1|STARTED|21 Day Washout Period||30
396336|NCT00960570|947175|P1|NOT COMPLETED|Efavirenz Alone||0
396337|NCT00960570|947175|P1|COMPLETED|Efavirenz Alone||30
396338|NCT00960570|947175|P1|STARTED|Efavirenz Alone||30
396339|NCT00960531|947196|P10|NOT COMPLETED|Overall Study||1
396340|NCT00960531|947197|P9|NOT COMPLETED|Overall Study||14
396341|NCT00960531|947198|P8|NOT COMPLETED|Overall Study||4
396342|NCT00960531|947199|P7|NOT COMPLETED|Overall Study||24
396343|NCT00960531|947200|P6|NOT COMPLETED|Overall Study||3
396344|NCT00960531|947201|P5|NOT COMPLETED|Overall Study||2
396345|NCT00960531|947202|P4|NOT COMPLETED|Overall Study||8
396346|NCT00960531|947203|P3|NOT COMPLETED|Overall Study||26
396347|NCT00960531|947204|P2|NOT COMPLETED|Overall Study||1
396348|NCT00960531|947205|P1|NOT COMPLETED|Overall Study||10
396349|NCT00960531|947196|P10|COMPLETED|Overall Study|Completed study|3
396350|NCT00960531|947197|P9|COMPLETED|Overall Study|Completed study|2
396351|NCT00960531|947198|P8|COMPLETED|Overall Study|Completed study|2
396352|NCT00960531|947199|P7|COMPLETED|Overall Study|Completed study|3
396353|NCT00960531|947200|P6|COMPLETED|Overall Study|Completed study|6
396354|NCT00960531|947201|P5|COMPLETED|Overall Study|Completed study|3
396355|NCT00960531|947202|P4|COMPLETED|Overall Study|Completed study|17
396356|NCT00960531|947203|P3|COMPLETED|Overall Study|Completed study|15
396357|NCT00960531|947204|P2|COMPLETED|Overall Study|Completed study|5
396358|NCT00960531|947205|P1|COMPLETED|Overall Study|Completed study|11
396359|NCT00960531|947196|P10|Completed Treatment|Overall Study||4
396360|NCT00960531|947197|P9|Completed Treatment|Overall Study||2
396361|NCT00960531|947198|P8|Completed Treatment|Overall Study||3
396362|NCT00960531|947199|P7|Completed Treatment|Overall Study||4
396363|NCT00960531|947200|P6|Completed Treatment|Overall Study||7
396364|NCT00960531|947201|P5|Completed Treatment|Overall Study||3
396365|NCT00960531|947202|P4|Completed Treatment|Overall Study||17
396366|NCT00960531|947203|P3|Completed Treatment|Overall Study||15
396367|NCT00960531|947204|P2|Completed Treatment|Overall Study||5
396368|NCT00960531|947205|P1|Completed Treatment|Overall Study||12
396369|NCT00960531|947196|P10|Treated|Overall Study||4
396370|NCT00960531|947197|P9|Treated|Overall Study||16
396371|NCT00960531|947198|P8|Treated|Overall Study||6
396372|NCT00960531|947199|P7|Treated|Overall Study||27
396373|NCT00960531|947200|P6|Treated|Overall Study||9
396374|NCT00960531|947201|P5|Treated|Overall Study||5
396375|NCT00960531|947202|P4|Treated|Overall Study||24
396376|NCT00960531|947203|P3|Treated|Overall Study||41
396377|NCT00960531|947204|P2|Treated|Overall Study||6
396378|NCT00960531|947205|P1|Treated|Overall Study||21
396379|NCT00960531|947196|P10|STARTED|Overall Study|Started=Randomized|4
396380|NCT00960531|947197|P9|STARTED|Overall Study|Started=Randomized|16
396381|NCT00960531|947198|P8|STARTED|Overall Study|Started=Randomized|6
396382|NCT00960531|947199|P7|STARTED|Overall Study|Started=Randomized|27
396383|NCT00960531|947200|P6|STARTED|Overall Study|Started=Randomized|9
396384|NCT00960531|947201|P5|STARTED|Overall Study|Started=Randomized|5
396385|NCT00960531|947202|P4|STARTED|Overall Study|Started=Randomized.|25
396386|NCT00960531|947203|P3|STARTED|Overall Study|Started=Randomized|41
396387|NCT00960531|947204|P2|STARTED|Overall Study|Started=Randomized|6
396388|NCT00960531|947205|P1|STARTED|Overall Study|Started=Randomized|21
396389|NCT00960440|947253|P4|NOT COMPLETED|Overall Study||18
396390|NCT00960440|947254|P3|NOT COMPLETED|Overall Study||13
396391|NCT00960440|947255|P2|NOT COMPLETED|Overall Study||31
396392|NCT00960440|947256|P1|NOT COMPLETED|Overall Study||26
396393|NCT00960440|947253|P4|COMPLETED|Overall Study||48
396394|NCT00960440|947254|P3|COMPLETED|Overall Study||53
396395|NCT00960440|947255|P2|COMPLETED|Overall Study||103
396396|NCT00960440|947256|P1|COMPLETED|Overall Study||107
396397|NCT00960440|947253|P4|STARTED|Overall Study||66
396398|NCT00960440|947254|P3|STARTED|Overall Study||66
396399|NCT00960440|947255|P2|STARTED|Overall Study||134
396400|NCT00960440|947256|P1|STARTED|Overall Study||133
396401|NCT00960375|947428|P2|NOT COMPLETED|Overall Study||22
396402|NCT00960375|947429|P1|NOT COMPLETED|Overall Study||20
396403|NCT00960375|947428|P2|COMPLETED|Overall Study||65
396404|NCT00960375|947429|P1|COMPLETED|Overall Study||72
396405|NCT00960375|947428|P2|STARTED|Overall Study||87
396406|NCT00960375|947429|P1|STARTED|Overall Study||92
396407|NCT00960323|947437|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
396408|NCT00960323|947437|P1|COMPLETED|Colchicine and Atorvastatin||23
396409|NCT00960323|947437|P1|STARTED|Colchicine and Atorvastatin||23
396410|NCT00960323|947437|P1|NOT COMPLETED|Atorvastatin Alone||1
396411|NCT00960323|947437|P1|COMPLETED|Atorvastatin Alone||23
396412|NCT00960323|947437|P1|STARTED|Atorvastatin Alone||24
396413|NCT00960323|947437|P1|NOT COMPLETED|14 Day Washout Period||0
396414|NCT00960323|947437|P1|COMPLETED|14 Day Washout Period||24
396415|NCT00960323|947437|P1|STARTED|14 Day Washout Period||24
396416|NCT00960323|947437|P1|NOT COMPLETED|Colchicine Alone||0
396417|NCT00960323|947437|P1|COMPLETED|Colchicine Alone||24
396418|NCT00960323|947437|P1|STARTED|Colchicine Alone||24
396419|NCT00960297|947448|P1|NOT COMPLETED|Overall Study||3
396420|NCT00960297|947448|P1|COMPLETED|Overall Study||1
396421|NCT00960297|947448|P1|STARTED|Overall Study||4
396422|NCT00960206|947455|P3|NOT COMPLETED|Overall Study||12
396423|NCT00960206|947456|P2|NOT COMPLETED|Overall Study||27
396424|NCT00960206|947457|P1|NOT COMPLETED|Overall Study||40
396425|NCT00960206|947455|P3|COMPLETED|Overall Study||77
396426|NCT00960206|947456|P2|COMPLETED|Overall Study||158
396427|NCT00960206|947457|P1|COMPLETED|Overall Study||150
396428|NCT00960206|947455|P3|STARTED|Overall Study||89
396429|NCT00960206|947456|P2|STARTED|Overall Study||185
396430|NCT00960206|947457|P1|STARTED|Overall Study||190
396431|NCT00960193|947475|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
396432|NCT00960193|947475|P1|COMPLETED|Colchicine With Seville Orange Juice||23
396433|NCT00960193|947475|P1|STARTED|Colchicine With Seville Orange Juice||23
396434|NCT00960193|947475|P1|NOT COMPLETED|Seville Orange Juice Alone||0
396435|NCT00960193|947475|P1|COMPLETED|Seville Orange Juice Alone||23
396436|NCT00960193|947475|P1|STARTED|Seville Orange Juice Alone||23
396437|NCT00960193|947475|P1|NOT COMPLETED|14 Day Washout Period||1
396438|NCT00960193|947475|P1|COMPLETED|14 Day Washout Period||23
396439|NCT00960193|947475|P1|STARTED|14 Day Washout Period||24
396440|NCT00960193|947475|P1|NOT COMPLETED|Colchicine Alone||0
396441|NCT00960193|947475|P1|COMPLETED|Colchicine Alone||24
396442|NCT00960193|947475|P1|STARTED|Colchicine Alone||24
396443|NCT00960154|947488|P2|NOT COMPLETED|Overall Study||25
396444|NCT00960154|947489|P1|NOT COMPLETED|Overall Study||25
396445|NCT00960154|947488|P2|COMPLETED|Overall Study||0
396446|NCT00960154|947489|P1|COMPLETED|Overall Study||0
396447|NCT00960154|947488|P2|STARTED|Overall Study||25
396448|NCT00960154|947489|P1|STARTED|Overall Study||25
396449|NCT00960141|947500|P3|NOT COMPLETED|Overall Study||7
396450|NCT00960141|947501|P2|NOT COMPLETED|Overall Study||17
396451|NCT00960141|947502|P1|NOT COMPLETED|Overall Study||10
396452|NCT00960141|947500|P3|COMPLETED|Overall Study||163
396453|NCT00960141|947501|P2|COMPLETED|Overall Study||309
396454|NCT00960141|947502|P1|COMPLETED|Overall Study||323
396455|NCT00960141|947500|P3|STARTED|Overall Study||170
396456|NCT00960141|947501|P2|STARTED|Overall Study||326
396457|NCT00960141|947502|P1|STARTED|Overall Study||333
396458|NCT00960115|947527|P2|NOT COMPLETED|Overall Study||15
396459|NCT00960115|947528|P1|NOT COMPLETED|Overall Study||19
396460|NCT00960115|947527|P2|COMPLETED|Overall Study||43
396461|NCT00960115|947528|P1|COMPLETED|Overall Study||95
396462|NCT00960115|947527|P2|STARTED|Overall Study||58
396463|NCT00960115|947528|P1|STARTED|Overall Study||114
396464|NCT00960076|947542|P2|NOT COMPLETED|Overall Study||25
396465|NCT00960076|947543|P1|NOT COMPLETED|Overall Study||8
396466|NCT00960076|947542|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
396467|NCT00960076|947543|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
396468|NCT00960076|947542|P2|STARTED|Overall Study|Randomized and treated|144
396469|NCT00960076|947543|P1|STARTED|Overall Study|Randomized and treated|138
396470|NCT00960063|947558|P3|NOT COMPLETED|Overall Study||3
396471|NCT00960063|947559|P2|NOT COMPLETED|Overall Study||0
396472|NCT00960063|947560|P1|NOT COMPLETED|Overall Study||1
396473|NCT00960063|947558|P3|COMPLETED|Overall Study||0
396474|NCT00960063|947559|P2|COMPLETED|Overall Study||0
396475|NCT00960063|947560|P1|COMPLETED|Overall Study||0
396476|NCT00960063|947558|P3|STARTED|Overall Study||3
396477|NCT00960063|947559|P2|STARTED|Overall Study||0
396478|NCT00960063|947560|P1|STARTED|Overall Study||1
396479|NCT00959985|947602|P4|NOT COMPLETED|Overall Study||0
396480|NCT00959985|947603|P3|NOT COMPLETED|Overall Study||0
396481|NCT00959985|947604|P2|NOT COMPLETED|Overall Study||0
396482|NCT00959985|947605|P1|NOT COMPLETED|Overall Study||0
396483|NCT00959985|947602|P4|COMPLETED|Overall Study||4
396484|NCT00959985|947603|P3|COMPLETED|Overall Study||4
396485|NCT00959985|947604|P2|COMPLETED|Overall Study||7
396486|NCT00959985|947605|P1|COMPLETED|Overall Study||8
396487|NCT00959985|947602|P4|STARTED|Overall Study||4
396488|NCT00959985|947603|P3|STARTED|Overall Study||4
396489|NCT00959985|947604|P2|STARTED|Overall Study||7
396490|NCT00959985|947605|P1|STARTED|Overall Study||8
396491|NCT00959946|947651|P8|NOT COMPLETED|Overall Study||2
396492|NCT00959946|947652|P7|NOT COMPLETED|Overall Study||2
396493|NCT00959946|947653|P6|NOT COMPLETED|Overall Study||9
396494|NCT00959946|947654|P5|NOT COMPLETED|Overall Study||4
396495|NCT00959946|947655|P4|NOT COMPLETED|Overall Study||5
396496|NCT00959946|947656|P3|NOT COMPLETED|Overall Study||4
396497|NCT00959946|947657|P2|NOT COMPLETED|Overall Study||4
396498|NCT00959946|947658|P1|NOT COMPLETED|Overall Study||2
396499|NCT00959946|947651|P8|COMPLETED|Overall Study||0
396500|NCT00959946|947652|P7|COMPLETED|Overall Study||0
396501|NCT00959946|947653|P6|COMPLETED|Overall Study||0
396502|NCT00959946|947654|P5|COMPLETED|Overall Study||0
396503|NCT00959946|947655|P4|COMPLETED|Overall Study||0
396504|NCT00959946|947656|P3|COMPLETED|Overall Study||0
396505|NCT00959946|947657|P2|COMPLETED|Overall Study||0
396506|NCT00959946|947658|P1|COMPLETED|Overall Study||0
396507|NCT00959946|947651|P8|STARTED|Overall Study||2
396508|NCT00959946|947652|P7|STARTED|Overall Study||2
396509|NCT00959946|947653|P6|STARTED|Overall Study||9
396510|NCT00959946|947654|P5|STARTED|Overall Study||4
396511|NCT00959946|947655|P4|STARTED|Overall Study||5
396512|NCT00959946|947656|P3|STARTED|Overall Study||4
396513|NCT00959946|947657|P2|STARTED|Overall Study||4
396514|NCT00959946|947658|P1|STARTED|Overall Study||2
396515|NCT00959920|947711|P2|NOT COMPLETED|Overall Study||1
396516|NCT00959920|947712|P1|NOT COMPLETED|Overall Study||0
396517|NCT00959920|947711|P2|COMPLETED|Overall Study||66
396518|NCT00959920|947712|P1|COMPLETED|Overall Study||72
396519|NCT00959920|947711|P2|STARTED|Overall Study||67
396520|NCT00959920|947712|P1|STARTED|Overall Study||72
396521|NCT00959907|947722|P2|NOT COMPLETED|Overall Study||1
396522|NCT00959907|947723|P1|NOT COMPLETED|Overall Study||3
396523|NCT00959907|947722|P2|COMPLETED|Overall Study||28
396524|NCT00959907|947723|P1|COMPLETED|Overall Study||27
396525|NCT00959907|947722|P2|STARTED|Overall Study||29
396526|NCT00959907|947723|P1|STARTED|Overall Study||30
396527|NCT00959894|947733|P1|NOT COMPLETED|Overall Study||16
396528|NCT00959894|947733|P1|COMPLETED|Overall Study||63
396529|NCT00959894|947733|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
396530|NCT00959764|947764|P3|NOT COMPLETED|Overall Study||36
396531|NCT00959764|947765|P2|NOT COMPLETED|Overall Study||57
396532|NCT00959764|947766|P1|NOT COMPLETED|Overall Study||95
396533|NCT00959764|947764|P3|COMPLETED|Overall Study||73
396534|NCT00959764|947765|P2|COMPLETED|Overall Study||128
396535|NCT00959764|947766|P1|COMPLETED|Overall Study||176
396536|NCT00959764|947764|P3|STARTED|Overall Study||109
396537|NCT00959764|947765|P2|STARTED|Overall Study||185
396538|NCT00959764|947766|P1|STARTED|Overall Study||271
396539|NCT00959751|947782|P2|NOT COMPLETED|Overall Study||12
396540|NCT00959751|947783|P1|NOT COMPLETED|Overall Study||9
396541|NCT00959751|947782|P2|COMPLETED|Overall Study||86
396542|NCT00959751|947783|P1|COMPLETED|Overall Study||88
396543|NCT00959751|947782|P2|STARTED|Overall Study||98
396544|NCT00959751|947783|P1|STARTED|Overall Study||97
396545|NCT00959699|947805|P2|NOT COMPLETED|Follow-up Period||6
396546|NCT00959699|947806|P1|NOT COMPLETED|Follow-up Period||6
396547|NCT00959699|947805|P2|COMPLETED|Follow-up Period||56
396548|NCT00959699|947806|P1|COMPLETED|Follow-up Period||27
396549|NCT00959699|947805|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
396550|NCT00959699|947806|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
396551|NCT00959699|947805|P2|NOT COMPLETED|Treatment Period||25
396552|NCT00959699|947806|P1|NOT COMPLETED|Treatment Period||23
396553|NCT00959699|947805|P2|COMPLETED|Treatment Period||40
396554|NCT00959699|947806|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
396555|NCT00959699|947805|P2|Treated|Treatment Period||64
396556|NCT00959699|947806|P1|Treated|Treatment Period||34
396557|NCT00959699|947805|P2|STARTED|Treatment Period||65
396558|NCT00959699|947806|P1|STARTED|Treatment Period||34
396559|NCT00959647|947823|P1|NOT COMPLETED|Overall Study||19
396560|NCT00959647|947823|P1|COMPLETED|Overall Study||0
396561|NCT00959647|947823|P1|STARTED|Overall Study||19
396562|NCT00959374|947828|P1|NOT COMPLETED|Overall Study||23
396563|NCT00959374|947828|P1|COMPLETED|Overall Study||218
396564|NCT00959374|947828|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
396565|NCT00959192|947842|P4|NOT COMPLETED|Overall Study||1
396566|NCT00959192|947843|P3|NOT COMPLETED|Overall Study||3
396567|NCT00959192|947844|P2|NOT COMPLETED|Overall Study||1
396568|NCT00959192|947845|P1|NOT COMPLETED|Overall Study||2
396569|NCT00959192|947842|P4|COMPLETED|Overall Study||7
396570|NCT00959192|947843|P3|COMPLETED|Overall Study||6
396571|NCT00959192|947844|P2|COMPLETED|Overall Study||8
396572|NCT00959192|947845|P1|COMPLETED|Overall Study||4
396573|NCT00959192|947842|P4|STARTED|Overall Study||8
396574|NCT00959192|947843|P3|STARTED|Overall Study||9
396575|NCT00959192|947844|P2|STARTED|Overall Study||9
396576|NCT00959192|947845|P1|STARTED|Overall Study||6
396577|NCT00959049|947893|P6|NOT COMPLETED|Overall Study||1
396578|NCT00959049|947894|P5|NOT COMPLETED|Overall Study||9
396579|NCT00959049|947895|P4|NOT COMPLETED|Overall Study||11
396580|NCT00959049|947896|P3|NOT COMPLETED|Overall Study||1
396581|NCT00959049|947897|P2|NOT COMPLETED|Overall Study||7
396582|NCT00959049|947898|P1|NOT COMPLETED|Overall Study||18
396583|NCT00959049|947893|P6|COMPLETED|Overall Study||249
396584|NCT00959049|947894|P5|COMPLETED|Overall Study||248
396585|NCT00959049|947895|P4|COMPLETED|Overall Study||217
396586|NCT00959049|947896|P3|COMPLETED|Overall Study||253
396587|NCT00959049|947897|P2|COMPLETED|Overall Study||247
396588|NCT00959049|947898|P1|COMPLETED|Overall Study||213
396589|NCT00959049|947893|P6|STARTED|Overall Study||250
396590|NCT00959049|947894|P5|STARTED|Overall Study||257
396591|NCT00959049|947895|P4|STARTED|Overall Study||228
396592|NCT00959049|947896|P3|STARTED|Overall Study||254
396593|NCT00959049|947897|P2|STARTED|Overall Study||254
396594|NCT00959049|947898|P1|STARTED|Overall Study||231
396595|NCT00958919|947948|P2|NOT COMPLETED|Second Intervention||0
396596|NCT00958919|947949|P1|NOT COMPLETED|Second Intervention||0
396597|NCT00958919|947948|P2|COMPLETED|Second Intervention||7
396598|NCT00958919|947949|P1|COMPLETED|Second Intervention||7
396599|NCT00958919|947948|P2|STARTED|Second Intervention||7
396600|NCT00958919|947949|P1|STARTED|Second Intervention||7
396601|NCT00958919|947948|P2|NOT COMPLETED|First Intervention||0
396602|NCT00958919|947949|P1|NOT COMPLETED|First Intervention||0
396603|NCT00958919|947948|P2|COMPLETED|First Intervention||7
396604|NCT00958919|947949|P1|COMPLETED|First Intervention||7
396605|NCT00958919|947948|P2|STARTED|First Intervention||7
396606|NCT00958919|947949|P1|STARTED|First Intervention||7
396607|NCT00958893|947963|P1|NOT COMPLETED|Overall Study||4
396608|NCT00958893|947963|P1|COMPLETED|Overall Study||0
396609|NCT00958893|947963|P1|STARTED|Overall Study||4
396610|NCT00958880|947969|P2|NOT COMPLETED|Overall Study||2
396611|NCT00958880|947970|P1|NOT COMPLETED|Overall Study||2
396612|NCT00958880|947969|P2|COMPLETED|Overall Study||18
396613|NCT00958880|947970|P1|COMPLETED|Overall Study||18
396614|NCT00958880|947969|P2|STARTED|Overall Study||20
396615|NCT00958880|947970|P1|STARTED|Overall Study||20
396616|NCT00958841|947978|P1|NOT COMPLETED|Overall Study||96
396617|NCT00958841|947978|P1|COMPLETED|Overall Study|Completed = Completed extension|22
396618|NCT00958841|947978|P1|Entered in Extension|Overall Study||63
396619|NCT00958841|947978|P1|Completed Month 6 (M6)|Overall Study||90
396620|NCT00958841|947978|P1|STARTED|Overall Study||118
396621|NCT00958828|947996|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
396622|NCT00958828|947997|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
396623|NCT00958828|947996|P2|COMPLETED|Period 2, 1 Week of Wear||87
396624|NCT00958828|947997|P1|COMPLETED|Period 2, 1 Week of Wear||89
396625|NCT00958828|947996|P2|STARTED|Period 2, 1 Week of Wear||88
396626|NCT00958828|947997|P1|STARTED|Period 2, 1 Week of Wear||89
396627|NCT00958828|947996|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
396628|NCT00958828|947997|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
396629|NCT00958828|947996|P2|COMPLETED|Period 1, 1 Week of Wear||88
396630|NCT00958828|947997|P1|COMPLETED|Period 1, 1 Week of Wear||89
396631|NCT00958828|947996|P2|STARTED|Period 1, 1 Week of Wear||89
396632|NCT00958828|947997|P1|STARTED|Period 1, 1 Week of Wear||89
396633|NCT00958789|948003|P1|NOT COMPLETED|Overall Study||51
396634|NCT00958789|948003|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
396635|NCT00958789|948003|P1|STARTED|Overall Study||181
396636|NCT00958776|948009|P2|NOT COMPLETED|Overall Study||29
396637|NCT00958776|948010|P1|NOT COMPLETED|Overall Study||16
396638|NCT00958776|948009|P2|COMPLETED|Overall Study||239
396639|NCT00958776|948010|P1|COMPLETED|Overall Study||121
396640|NCT00958776|948009|P2|STARTED|Overall Study||268
396641|NCT00958776|948010|P1|STARTED|Overall Study||137
396642|NCT00958568|948040|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
396643|NCT00958568|948041|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
396644|NCT00958568|948042|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
396645|NCT00958568|948043|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
396646|NCT00958568|948040|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
396647|NCT00958568|948041|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
396648|NCT00958568|948042|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
396649|NCT00958568|948043|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
396650|NCT00958568|948040|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
396651|NCT00958568|948041|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
396652|NCT00958568|948042|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
396653|NCT00958568|948043|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
396654|NCT00958568|948040|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
396655|NCT00958568|948041|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
396656|NCT00958568|948042|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
396657|NCT00958568|948043|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
396658|NCT00958568|948040|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
396659|NCT00958568|948041|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
396660|NCT00958568|948042|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
396661|NCT00958568|948043|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
396662|NCT00958568|948040|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
396663|NCT00958568|948041|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
396664|NCT00958568|948042|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
396665|NCT00958568|948043|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
396666|NCT00958568|948040|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
396667|NCT00958568|948041|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
396668|NCT00958568|948042|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
396669|NCT00958568|948043|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
396670|NCT00958568|948040|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
396671|NCT00958568|948041|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
396672|NCT00958568|948042|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
396673|NCT00958568|948043|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
396674|NCT00958568|948040|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
396675|NCT00958568|948041|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
396676|NCT00958568|948042|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
396677|NCT00958568|948043|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
396678|NCT00958438|948127|P3|NOT COMPLETED|Overall Study||6
396679|NCT00958438|948128|P2|NOT COMPLETED|Overall Study||10
396680|NCT00958438|948129|P1|NOT COMPLETED|Overall Study||10
396681|NCT00958438|948127|P3|COMPLETED|Overall Study||78
396682|NCT00958438|948128|P2|COMPLETED|Overall Study||72
396683|NCT00958438|948129|P1|COMPLETED|Overall Study||72
396684|NCT00958438|948127|P3|STARTED|Overall Study||84
396685|NCT00958438|948128|P2|STARTED|Overall Study||82
396686|NCT00958438|948129|P1|STARTED|Overall Study||82
396687|NCT00958360|948154|P2|NOT COMPLETED|Overall Study||10
396688|NCT00958360|948155|P1|NOT COMPLETED|Overall Study||11
396689|NCT00958360|948154|P2|COMPLETED|Overall Study||150
396690|NCT00958360|948155|P1|COMPLETED|Overall Study||152
396691|NCT00958360|948154|P2|STARTED|Overall Study||160
396692|NCT00958360|948155|P1|STARTED|Overall Study||163
396693|NCT00958347|948169|P1|NOT COMPLETED|Overall Study||226
396694|NCT00958347|948169|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
396695|NCT00958347|948169|P1|STARTED|Overall Study||226
396696|NCT00958334|948176|P3|NOT COMPLETED|Overall Study||13
396697|NCT00958334|948177|P2|NOT COMPLETED|Overall Study||17
396698|NCT00958334|948178|P1|NOT COMPLETED|Overall Study||14
396699|NCT00958334|948176|P3|COMPLETED|Overall Study||8
396700|NCT00958334|948177|P2|COMPLETED|Overall Study||5
396701|NCT00958334|948178|P1|COMPLETED|Overall Study||8
396702|NCT00958334|948176|P3|STARTED|Overall Study||21
396703|NCT00958334|948177|P2|STARTED|Overall Study||22
396704|NCT00958334|948178|P1|STARTED|Overall Study||22
396705|NCT00958308|948189|P3|NOT COMPLETED|Overall Study||0
396706|NCT00958308|948190|P2|NOT COMPLETED|Overall Study||0
396707|NCT00958308|948191|P1|NOT COMPLETED|Overall Study||0
396708|NCT00958308|948189|P3|COMPLETED|Overall Study||86
396709|NCT00958308|948190|P2|COMPLETED|Overall Study||85
396710|NCT00958308|948191|P1|COMPLETED|Overall Study||84
396711|NCT00958308|948189|P3|STARTED|Overall Study||86
396712|NCT00958308|948190|P2|STARTED|Overall Study||85
396713|NCT00958308|948191|P1|STARTED|Overall Study||84
396714|NCT00958282|948201|P2|NOT COMPLETED|Overall Study||6
396715|NCT00958282|948202|P1|NOT COMPLETED|Overall Study||10
396716|NCT00958282|948201|P2|COMPLETED|Overall Study||15
396717|NCT00958282|948202|P1|COMPLETED|Overall Study||12
396718|NCT00958282|948201|P2|STARTED|Overall Study||21
396719|NCT00958282|948202|P1|STARTED|Overall Study||22
396720|NCT00958256|948210|P1|NOT COMPLETED|Overall Study||3
396721|NCT00958256|948210|P1|COMPLETED|Overall Study||18
396722|NCT00958256|948210|P1|STARTED|Overall Study||21
396723|NCT00958243|948220|P6|NOT COMPLETED|Overall Study||10
396724|NCT00958243|948221|P5|NOT COMPLETED|Overall Study||9
396725|NCT00958243|948222|P4|NOT COMPLETED|Overall Study||3
396726|NCT00958243|948223|P3|NOT COMPLETED|Overall Study||14
396727|NCT00958243|948224|P2|NOT COMPLETED|Overall Study||6
396728|NCT00958243|948225|P1|NOT COMPLETED|Overall Study||2
396729|NCT00958243|948220|P6|COMPLETED|Overall Study||99
396730|NCT00958243|948221|P5|COMPLETED|Overall Study||100
396731|NCT00958243|948222|P4|COMPLETED|Overall Study||25
396732|NCT00958243|948223|P3|COMPLETED|Overall Study||82
396733|NCT00958243|948224|P2|COMPLETED|Overall Study||99
396734|NCT00958243|948225|P1|COMPLETED|Overall Study||24
396735|NCT00958243|948220|P6|STARTED|Overall Study||109
396736|NCT00958243|948221|P5|STARTED|Overall Study||109
396737|NCT00958243|948222|P4|STARTED|Overall Study||28
396738|NCT00958243|948223|P3|STARTED|Overall Study||96
396739|NCT00958243|948224|P2|STARTED|Overall Study||105
396740|NCT00958243|948225|P1|STARTED|Overall Study||26
396741|NCT00958217|948283|P2|NOT COMPLETED|Overall Study||25
396742|NCT00958217|948284|P1|NOT COMPLETED|Overall Study||24
396743|NCT00958217|948283|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
396744|NCT00958217|948284|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
396745|NCT00958217|948283|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
396746|NCT00958217|948284|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
396747|NCT00958217|948283|P2|STARTED|Overall Study||62
396748|NCT00958217|948284|P1|STARTED|Overall Study||61
396749|NCT00958191|948295|P1|NOT COMPLETED|Overall Study||112
396750|NCT00958191|948295|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|110
396751|NCT00958191|948295|P1|STARTED|Overall Study||222
396752|NCT00958165|948308|P1|NOT COMPLETED|Overall Study||14
396753|NCT00958165|948308|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
396754|NCT00958165|948308|P1|Treated|Overall Study||72
396755|NCT00958165|948308|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
396756|NCT00958126|948320|P8|NOT COMPLETED|Overall Study||0
396757|NCT00958126|948321|P7|NOT COMPLETED|Overall Study||1
396758|NCT00958126|948322|P6|NOT COMPLETED|Overall Study||1
396759|NCT00958126|948323|P5|NOT COMPLETED|Overall Study||0
396760|NCT00958126|948324|P4|NOT COMPLETED|Overall Study||11
396761|NCT00958126|948325|P3|NOT COMPLETED|Overall Study||10
396762|NCT00958126|948326|P2|NOT COMPLETED|Overall Study||9
396763|NCT00958126|948327|P1|NOT COMPLETED|Overall Study||1
396764|NCT00958126|948320|P8|COMPLETED|Overall Study||202
396765|NCT00958126|948321|P7|COMPLETED|Overall Study||199
396766|NCT00958126|948322|P6|COMPLETED|Overall Study||202
396767|NCT00958126|948323|P5|COMPLETED|Overall Study||50
396768|NCT00958126|948324|P4|COMPLETED|Overall Study||192
396769|NCT00958126|948325|P3|COMPLETED|Overall Study||191
396770|NCT00958126|948326|P2|COMPLETED|Overall Study||196
396771|NCT00958126|948327|P1|COMPLETED|Overall Study||48
396772|NCT00958126|948320|P8|STARTED|Overall Study||202
396773|NCT00958126|948321|P7|STARTED|Overall Study||200
396774|NCT00958126|948322|P6|STARTED|Overall Study||203
396775|NCT00958126|948323|P5|STARTED|Overall Study||50
396776|NCT00958126|948324|P4|STARTED|Overall Study||203
396777|NCT00958126|948325|P3|STARTED|Overall Study||201
396778|NCT00958126|948326|P2|STARTED|Overall Study||205
396779|NCT00958126|948327|P1|STARTED|Overall Study||49
396780|NCT00958074|948399|P2|NOT COMPLETED|Overall Study||1
396781|NCT00958074|948400|P1|NOT COMPLETED|Overall Study||0
396782|NCT00958074|948399|P2|COMPLETED|Overall Study||6
396783|NCT00958074|948400|P1|COMPLETED|Overall Study||4
396784|NCT00958074|948399|P2|STARTED|Overall Study||7
396785|NCT00958074|948400|P1|STARTED|Overall Study||4
396786|NCT00958035|948408|P2|NOT COMPLETED|Overall Study||4
396787|NCT00958035|948409|P1|NOT COMPLETED|Overall Study||3
396788|NCT00958035|948408|P2|COMPLETED|Overall Study||39
396789|NCT00958035|948409|P1|COMPLETED|Overall Study||43
396790|NCT00958035|948408|P2|STARTED|Overall Study||43
396791|NCT00958035|948409|P1|STARTED|Overall Study||46
396792|NCT00958009|948415|P1|NOT COMPLETED|Overall Study||2
396793|NCT00958009|948415|P1|COMPLETED|Overall Study||107
396794|NCT00958009|948415|P1|STARTED|Overall Study||109
396795|NCT00957996|948422|P2|NOT COMPLETED|Overall Study||28
396796|NCT00957996|948423|P1|NOT COMPLETED|Overall Study||26
396797|NCT00957996|948422|P2|COMPLETED|Overall Study||89
396798|NCT00957996|948423|P1|COMPLETED|Overall Study||91
396799|NCT00957996|948422|P2|STARTED|Overall Study||117
396800|NCT00957996|948423|P1|STARTED|Overall Study||117
396801|NCT00957944|948455|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
396802|NCT00957944|948456|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
396803|NCT00957944|948455|P2|COMPLETED|Second Intervention- 24 Hours||19
396804|NCT00957944|948456|P1|COMPLETED|Second Intervention- 24 Hours||20
396805|NCT00957944|948455|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
396806|NCT00957944|948456|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
396807|NCT00957944|948455|P2|STARTED|Second Intervention- 24 Hours||19
396808|NCT00957944|948456|P1|STARTED|Second Intervention- 24 Hours||20
396809|NCT00957944|948455|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
396810|NCT00957944|948456|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
396811|NCT00957944|948455|P2|COMPLETED|Washout Period of at Least 5 Days||19
396812|NCT00957944|948456|P1|COMPLETED|Washout Period of at Least 5 Days||20
396813|NCT00957944|948455|P2|STARTED|Washout Period of at Least 5 Days||19
396814|NCT00957944|948456|P1|STARTED|Washout Period of at Least 5 Days||20
396815|NCT00957944|948455|P2|NOT COMPLETED|First Intervention- 24 Hours||1
396816|NCT00957944|948456|P1|NOT COMPLETED|First Intervention- 24 Hours||0
396817|NCT00957944|948455|P2|COMPLETED|First Intervention- 24 Hours||19
396818|NCT00957944|948456|P1|COMPLETED|First Intervention- 24 Hours||20
396819|NCT00957944|948455|P2|STARTED|First Intervention- 24 Hours||20
396820|NCT00957944|948456|P1|STARTED|First Intervention- 24 Hours||20
396821|NCT00957905|948492|P2|NOT COMPLETED|Part B||4
396822|NCT00957905|948493|P1|NOT COMPLETED|Part B||0
396823|NCT00957905|948492|P2|COMPLETED|Part B||25
396824|NCT00957905|948493|P1|COMPLETED|Part B||0
396825|NCT00957905|948492|P2|STARTED|Part B||29
396826|NCT00957905|948493|P1|STARTED|Part B||0
396827|NCT00957905|948492|P2|NOT COMPLETED|Part A||0
396828|NCT00957905|948493|P1|NOT COMPLETED|Part A||0
396829|NCT00957905|948492|P2|COMPLETED|Part A||0
396830|NCT00957905|948493|P1|COMPLETED|Part A||7
396831|NCT00957905|948492|P2|STARTED|Part A||0
396832|NCT00957905|948493|P1|STARTED|Part A||7
396833|NCT00957723|948499|P1|NOT COMPLETED|Overall Study||121
396834|NCT00957723|948499|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
396835|NCT00957723|948499|P1|STARTED|Overall Study||419
396836|NCT00957684|948514|P5|NOT COMPLETED|PART II||75
396837|NCT00957684|948515|P4|NOT COMPLETED|PART II||0
396838|NCT00957684|948516|P3|NOT COMPLETED|PART II||0
396839|NCT00957684|948517|P2|NOT COMPLETED|PART II||0
396840|NCT00957684|948518|P1|NOT COMPLETED|PART II||0
396841|NCT00957684|948514|P5|COMPLETED|PART II||239
396842|NCT00957684|948515|P4|COMPLETED|PART II||0
396843|NCT00957684|948516|P3|COMPLETED|PART II||0
396844|NCT00957684|948517|P2|COMPLETED|PART II||0
396845|NCT00957684|948518|P1|COMPLETED|PART II||0
396846|NCT00957684|948514|P5|Patients Entered Part II|PART II||314
396847|NCT00957684|948515|P4|Patients Entered Part II|PART II||0
396848|NCT00957684|948516|P3|Patients Entered Part II|PART II||0
396849|NCT00957684|948517|P2|Patients Entered Part II|PART II||0
396850|NCT00957684|948518|P1|Patients Entered Part II|PART II||0
396851|NCT00957684|948514|P5|STARTED|PART II||314
396852|NCT00957684|948515|P4|STARTED|PART II||0
396853|NCT00957684|948516|P3|STARTED|PART II||0
396854|NCT00957684|948517|P2|STARTED|PART II||0
396855|NCT00957684|948518|P1|STARTED|PART II||0
396856|NCT00957684|948514|P5|NOT COMPLETED|PART I||0
396857|NCT00957684|948515|P4|NOT COMPLETED|PART I||18
396858|NCT00957684|948516|P3|NOT COMPLETED|PART I||10
396859|NCT00957684|948517|P2|NOT COMPLETED|PART I||13
396860|NCT00957684|948518|P1|NOT COMPLETED|PART I||31
396861|NCT00957684|948514|P5|COMPLETED|PART I||0
396862|NCT00957684|948515|P4|COMPLETED|PART I||84
396863|NCT00957684|948516|P3|COMPLETED|PART I||90
396864|NCT00957684|948517|P2|COMPLETED|PART I||85
396865|NCT00957684|948518|P1|COMPLETED|PART I||71
396866|NCT00957684|948514|P5|Per-protocol (PP)Population|PART I||0
396867|NCT00957684|948515|P4|Per-protocol (PP)Population|PART I||91
396868|NCT00957684|948516|P3|Per-protocol (PP)Population|PART I||94
396869|NCT00957684|948517|P2|Per-protocol (PP)Population|PART I||86
396870|NCT00957684|948518|P1|Per-protocol (PP)Population|PART I||72
396871|NCT00957684|948514|P5|Intention-to-treat (ITT) Population|PART I||0
396872|NCT00957684|948515|P4|Intention-to-treat (ITT) Population|PART I||102
396873|NCT00957684|948516|P3|Intention-to-treat (ITT) Population|PART I||99
396874|NCT00957684|948517|P2|Intention-to-treat (ITT) Population|PART I||98
396875|NCT00957684|948518|P1|Intention-to-treat (ITT) Population|PART I||98
396876|NCT00957684|948514|P5|Randomised (Safety Population)|PART I||0
396877|NCT00957684|948515|P4|Randomised (Safety Population)|PART I||102
396878|NCT00957684|948516|P3|Randomised (Safety Population)|PART I||100
396879|NCT00957684|948517|P2|Randomised (Safety Population)|PART I||98
396880|NCT00957684|948518|P1|Randomised (Safety Population)|PART I||102
396881|NCT00957684|948514|P5|STARTED|PART I||0
396882|NCT00957684|948515|P4|STARTED|PART I||102
396883|NCT00957684|948516|P3|STARTED|PART I||100
396884|NCT00957684|948517|P2|STARTED|PART I||98
396885|NCT00957684|948518|P1|STARTED|PART I||102
396886|NCT00957658|948528|P1|NOT COMPLETED|Overall Study||65
396887|NCT00957658|948528|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
396888|NCT00957658|948528|P1|STARTED|Overall Study||234
396889|NCT00957593|948543|P2|NOT COMPLETED|Overall Study||0
396890|NCT00957593|948544|P1|NOT COMPLETED|Overall Study||0
396891|NCT00957593|948543|P2|COMPLETED|Overall Study||125
396892|NCT00957593|948544|P1|COMPLETED|Overall Study||127
396893|NCT00957593|948543|P2|STARTED|Overall Study||125
396894|NCT00957593|948544|P1|STARTED|Overall Study||127
396895|NCT00957580|948553|P3|NOT COMPLETED|Overall Study||0
396896|NCT00957580|948554|P2|NOT COMPLETED|Overall Study||2
396897|NCT00957580|948555|P1|NOT COMPLETED|Overall Study||0
396898|NCT00957580|948553|P3|COMPLETED|Overall Study||15
396899|NCT00957580|948554|P2|COMPLETED|Overall Study||31
396900|NCT00957580|948555|P1|COMPLETED|Overall Study||33
396901|NCT00957580|948553|P3|Treated|Overall Study||15
396902|NCT00957580|948554|P2|Treated|Overall Study||32
396903|NCT00957580|948555|P1|Treated|Overall Study||33
396904|NCT00957580|948553|P3|STARTED|Overall Study||15
396905|NCT00957580|948554|P2|STARTED|Overall Study||33
396906|NCT00957580|948555|P1|STARTED|Overall Study||33
396907|NCT00957528|948702|P3|NOT COMPLETED|Overall Study||1
396908|NCT00957528|948703|P2|NOT COMPLETED|Overall Study||1
396909|NCT00957528|948704|P1|NOT COMPLETED|Overall Study||0
396910|NCT00957528|948702|P3|COMPLETED|Overall Study||8
396911|NCT00957528|948703|P2|COMPLETED|Overall Study||8
396912|NCT00957528|948704|P1|COMPLETED|Overall Study||8
396913|NCT00957528|948702|P3|STARTED|Overall Study||9
396914|NCT00957528|948703|P2|STARTED|Overall Study||9
396915|NCT00957528|948704|P1|STARTED|Overall Study||8
396916|NCT00957424|948727|P1|NOT COMPLETED|Overall Study||23
396917|NCT00957424|948727|P1|COMPLETED|Overall Study||44
396918|NCT00957424|948727|P1|Follow-up #2|Overall Study||50
396919|NCT00957424|948727|P1|Follow-up #1|Overall Study||59
396920|NCT00957424|948727|P1|STARTED|Overall Study||67
396921|NCT00957372|948737|P4|NOT COMPLETED|PART II||44
396922|NCT00957372|948738|P3|NOT COMPLETED|PART II||0
396923|NCT00957372|948739|P2|NOT COMPLETED|PART II||0
396924|NCT00957372|948740|P1|NOT COMPLETED|PART II||0
396925|NCT00957372|948737|P4|COMPLETED|PART II||150
396926|NCT00957372|948738|P3|COMPLETED|PART II||0
396927|NCT00957372|948739|P2|COMPLETED|PART II||0
396928|NCT00957372|948740|P1|COMPLETED|PART II||0
396929|NCT00957372|948737|P4|Per-Protocol Population|PART II||108
396930|NCT00957372|948738|P3|Per-Protocol Population|PART II||0
396931|NCT00957372|948739|P2|Per-Protocol Population|PART II||0
396932|NCT00957372|948740|P1|Per-Protocol Population|PART II||0
396933|NCT00957372|948737|P4|Intention-to-treat (ITT) Population|PART II||191
396934|NCT00957372|948738|P3|Intention-to-treat (ITT) Population|PART II||0
396935|NCT00957372|948739|P2|Intention-to-treat (ITT) Population|PART II||0
396936|NCT00957372|948740|P1|Intention-to-treat (ITT) Population|PART II||0
396937|NCT00957372|948737|P4|Safety Population|PART II||194
396938|NCT00957372|948738|P3|Safety Population|PART II||0
396939|NCT00957372|948739|P2|Safety Population|PART II||0
396940|NCT00957372|948740|P1|Safety Population|PART II||0
396941|NCT00957372|948737|P4|STARTED|PART II||194
396942|NCT00957372|948738|P3|STARTED|PART II||0
396943|NCT00957372|948739|P2|STARTED|PART II||0
396944|NCT00957372|948740|P1|STARTED|PART II||0
396945|NCT00957372|948737|P4|NOT COMPLETED|PART I||0
396946|NCT00957372|948738|P3|NOT COMPLETED|PART I||1
396947|NCT00957372|948739|P2|NOT COMPLETED|PART I||0
396948|NCT00957372|948740|P1|NOT COMPLETED|PART I||0
396949|NCT00957372|948737|P4|COMPLETED|PART I||0
396950|NCT00957372|948738|P3|COMPLETED|PART I||87
396951|NCT00957372|948739|P2|COMPLETED|PART I||85
396952|NCT00957372|948740|P1|COMPLETED|PART I||80
396953|NCT00957372|948737|P4|Randomized But Not Treated|PART I||0
396954|NCT00957372|948738|P3|Randomized But Not Treated|PART I||1
396955|NCT00957372|948739|P2|Randomized But Not Treated|PART I||0
396956|NCT00957372|948740|P1|Randomized But Not Treated|PART I||0
396957|NCT00957372|948737|P4|Per-Protocol Population|PART I||0
396958|NCT00957372|948738|P3|Per-Protocol Population|PART I||51
396959|NCT00957372|948739|P2|Per-Protocol Population|PART I||47
396960|NCT00957372|948740|P1|Per-Protocol Population|PART I||35
396961|NCT00957372|948737|P4|Intention-to-Treat Population|PART I||0
396962|NCT00957372|948738|P3|Intention-to-Treat Population|PART I||84
396963|NCT00957372|948739|P2|Intention-to-Treat Population|PART I||84
396964|NCT00957372|948740|P1|Intention-to-Treat Population|PART I||77
396965|NCT00957372|948737|P4|Safety Population|PART I||0
396966|NCT00957372|948738|P3|Safety Population|PART I||87
396967|NCT00957372|948739|P2|Safety Population|PART I||85
396968|NCT00957372|948740|P1|Safety Population|PART I||80
396969|NCT00957372|948737|P4|STARTED|PART I||0
396970|NCT00957372|948738|P3|STARTED|PART I||88
396971|NCT00957372|948739|P2|STARTED|PART I||85
396972|NCT00957372|948740|P1|STARTED|PART I||80
396973|NCT00957333|948756|P1|NOT COMPLETED|Overall Study||0
396974|NCT00957333|948756|P1|COMPLETED|Overall Study||44
396975|NCT00957333|948756|P1|STARTED|Overall Study||44
396976|NCT00957268|948765|P5|NOT COMPLETED|Overall Study||0
396977|NCT00957268|948766|P4|NOT COMPLETED|Overall Study||0
396978|NCT00957268|948767|P3|NOT COMPLETED|Overall Study||1
396979|NCT00957268|948768|P2|NOT COMPLETED|Overall Study||0
396980|NCT00957268|948769|P1|NOT COMPLETED|Overall Study||0
396981|NCT00957268|948765|P5|COMPLETED|Overall Study||22
396982|NCT00957268|948766|P4|COMPLETED|Overall Study||7
396983|NCT00957268|948767|P3|COMPLETED|Overall Study||7
396984|NCT00957268|948768|P2|COMPLETED|Overall Study||4
396985|NCT00957268|948769|P1|COMPLETED|Overall Study||5
396986|NCT00957268|948765|P5|STARTED|Overall Study||22
396987|NCT00957268|948766|P4|STARTED|Overall Study||7
396988|NCT00957268|948767|P3|STARTED|Overall Study||8
396989|NCT00957268|948768|P2|STARTED|Overall Study||4
396990|NCT00957268|948769|P1|STARTED|Overall Study||5
396991|NCT00957242|948833|P2|NOT COMPLETED|Overall Study||0
396992|NCT00957242|948834|P1|NOT COMPLETED|Overall Study||0
396993|NCT00957242|948833|P2|COMPLETED|Overall Study||72
396994|NCT00957242|948834|P1|COMPLETED|Overall Study||73
396995|NCT00957242|948833|P2|STARTED|Overall Study||72
396996|NCT00957242|948834|P1|STARTED|Overall Study||73
396997|NCT00957047|948866|P5|NOT COMPLETED|PART II||102
396998|NCT00957047|948867|P4|NOT COMPLETED|PART II||0
396999|NCT00957047|948868|P3|NOT COMPLETED|PART II||0
397000|NCT00957047|948869|P2|NOT COMPLETED|PART II||0
397001|NCT00957047|948870|P1|NOT COMPLETED|PART II||0
397002|NCT00957047|948866|P5|COMPLETED|PART II||223
397003|NCT00957047|948867|P4|COMPLETED|PART II||0
397004|NCT00957047|948868|P3|COMPLETED|PART II||0
397005|NCT00957047|948869|P2|COMPLETED|PART II||0
397006|NCT00957047|948870|P1|COMPLETED|PART II||0
397007|NCT00957047|948866|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
397008|NCT00957047|948867|P4|Terminated Prematurely|PART II||0
397009|NCT00957047|948868|P3|Terminated Prematurely|PART II||0
397010|NCT00957047|948869|P2|Terminated Prematurely|PART II||0
397011|NCT00957047|948870|P1|Terminated Prematurely|PART II||0
397012|NCT00957047|948866|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
397013|NCT00957047|948867|P4|STARTED|PART II||0
397014|NCT00957047|948868|P3|STARTED|PART II||0
397015|NCT00957047|948869|P2|STARTED|PART II||0
397016|NCT00957047|948870|P1|STARTED|PART II||0
397017|NCT00957047|948866|P5|NOT COMPLETED|PART I||0
397018|NCT00957047|948867|P4|NOT COMPLETED|PART I||30
397019|NCT00957047|948868|P3|NOT COMPLETED|PART I||21
397020|NCT00957047|948869|P2|NOT COMPLETED|PART I||13
397021|NCT00957047|948870|P1|NOT COMPLETED|PART I||6
397022|NCT00957047|948866|P5|COMPLETED|PART I||0
397023|NCT00957047|948867|P4|COMPLETED|PART I||68
397024|NCT00957047|948868|P3|COMPLETED|PART I||80
397025|NCT00957047|948869|P2|COMPLETED|PART I||83
397026|NCT00957047|948870|P1|COMPLETED|PART I||94
397027|NCT00957047|948866|P5|Per-Protocol Population|PART I||0
397028|NCT00957047|948867|P4|Per-Protocol Population|PART I||54
397029|NCT00957047|948868|P3|Per-Protocol Population|PART I||75
397030|NCT00957047|948869|P2|Per-Protocol Population|PART I||70
397031|NCT00957047|948870|P1|Per-Protocol Population|PART I||81
397032|NCT00957047|948866|P5|Intention-to-treat (ITT) Population|PART I||0
397033|NCT00957047|948867|P4|Intention-to-treat (ITT) Population|PART I||97
397034|NCT00957047|948868|P3|Intention-to-treat (ITT) Population|PART I||100
397035|NCT00957047|948869|P2|Intention-to-treat (ITT) Population|PART I||96
397036|NCT00957047|948870|P1|Intention-to-treat (ITT) Population|PART I||100
397037|NCT00957047|948866|P5|Randomized/Safety Population|PART I||0
397038|NCT00957047|948867|P4|Randomized/Safety Population|PART I||98
397039|NCT00957047|948868|P3|Randomized/Safety Population|PART I||101
397040|NCT00957047|948869|P2|Randomized/Safety Population|PART I||96
397041|NCT00957047|948870|P1|Randomized/Safety Population|PART I||100
397042|NCT00957047|948866|P5|STARTED|PART I||0
397043|NCT00957047|948867|P4|STARTED|PART I||98
397044|NCT00957047|948868|P3|STARTED|PART I||101
397045|NCT00957047|948869|P2|STARTED|PART I||96
397046|NCT00957047|948870|P1|STARTED|PART I||100
397047|NCT00957034|948891|P3|NOT COMPLETED|Overall Study||6
397048|NCT00957034|948892|P2|NOT COMPLETED|Overall Study||4
397049|NCT00957034|948893|P1|NOT COMPLETED|Overall Study||6
397050|NCT00957034|948891|P3|COMPLETED|Overall Study||1
397051|NCT00957034|948892|P2|COMPLETED|Overall Study||0
397052|NCT00957034|948893|P1|COMPLETED|Overall Study||0
397053|NCT00957034|948891|P3|STARTED|Overall Study||7
397054|NCT00957034|948892|P2|STARTED|Overall Study||4
397055|NCT00957034|948893|P1|STARTED|Overall Study||6
397056|NCT00957021|948916|P1|NOT COMPLETED|Overall Study||117
397057|NCT00957021|948916|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
397058|NCT00957021|948916|P1|STARTED|Overall Study||354
397059|NCT00957008|948929|P4|NOT COMPLETED|Overall Study||24
397060|NCT00957008|948930|P3|NOT COMPLETED|Overall Study||17
397061|NCT00957008|948931|P2|NOT COMPLETED|Overall Study||12
397062|NCT00957008|948932|P1|NOT COMPLETED|Overall Study||21
397063|NCT00957008|948929|P4|COMPLETED|Overall Study||26
397064|NCT00957008|948930|P3|COMPLETED|Overall Study||32
397065|NCT00957008|948931|P2|COMPLETED|Overall Study||37
397066|NCT00957008|948932|P1|COMPLETED|Overall Study||28
397067|NCT00957008|948929|P4|STARTED|Overall Study||50
397068|NCT00957008|948930|P3|STARTED|Overall Study||49
397069|NCT00957008|948931|P2|STARTED|Overall Study||49
397070|NCT00957008|948932|P1|STARTED|Overall Study||49
397071|NCT00956943|948948|P2|NOT COMPLETED|Overall Study||10
397072|NCT00956943|948949|P1|NOT COMPLETED|Overall Study||9
397073|NCT00956943|948948|P2|COMPLETED|Overall Study||34
397074|NCT00956943|948949|P1|COMPLETED|Overall Study||34
397075|NCT00956943|948948|P2|Baseline|Overall Study||44
397076|NCT00956943|948949|P1|Baseline|Overall Study||43
397077|NCT00956943|948948|P2|STARTED|Overall Study||44
397078|NCT00956943|948949|P1|STARTED|Overall Study||43
397079|NCT00956839|948960|P3|NOT COMPLETED|Overall Study||3
397080|NCT00956839|948961|P2|NOT COMPLETED|Overall Study||0
397081|NCT00956839|948962|P1|NOT COMPLETED|Overall Study||3
397082|NCT00956839|948960|P3|COMPLETED|Overall Study||10
397083|NCT00956839|948961|P2|COMPLETED|Overall Study||13
397084|NCT00956839|948962|P1|COMPLETED|Overall Study||11
397085|NCT00956839|948960|P3|STARTED|Overall Study||13
397086|NCT00956839|948961|P2|STARTED|Overall Study||13
397087|NCT00956839|948962|P1|STARTED|Overall Study||14
397088|NCT00956813|948975|P2|NOT COMPLETED|Continuation Phase||0
397089|NCT00956813|948976|P1|NOT COMPLETED|Continuation Phase||0
397090|NCT00956813|948975|P2|COMPLETED|Continuation Phase||0
397091|NCT00956813|948976|P1|COMPLETED|Continuation Phase||80
397092|NCT00956813|948975|P2|STARTED|Continuation Phase||0
397093|NCT00956813|948976|P1|STARTED|Continuation Phase||80
397094|NCT00956813|948975|P2|NOT COMPLETED|Flaxseed and Placebo||5
397095|NCT00956813|948976|P1|NOT COMPLETED|Flaxseed and Placebo||8
397096|NCT00956813|948975|P2|COMPLETED|Flaxseed and Placebo||100
397097|NCT00956813|948976|P1|COMPLETED|Flaxseed and Placebo||97
397098|NCT00956813|948975|P2|STARTED|Flaxseed and Placebo||105
397099|NCT00956813|948976|P1|STARTED|Flaxseed and Placebo||105
397100|NCT00956761|948991|P1|NOT COMPLETED|Overall Study||0
397101|NCT00956761|948991|P1|COMPLETED|Overall Study||63
397102|NCT00956761|948991|P1|STARTED|Overall Study||63
397103|NCT00956709|949000|P2|NOT COMPLETED|Overall Study||0
397104|NCT00956709|949001|P1|NOT COMPLETED|Overall Study||0
397105|NCT00956709|949000|P2|COMPLETED|Overall Study||19
397106|NCT00956709|949001|P1|COMPLETED|Overall Study||16
397107|NCT00956709|949000|P2|STARTED|Overall Study||19
397108|NCT00956709|949001|P1|STARTED|Overall Study||16
397109|NCT00956657|949013|P2|NOT COMPLETED|Overall Study||0
397110|NCT00956657|949014|P1|NOT COMPLETED|Overall Study||0
397111|NCT00956657|949013|P2|COMPLETED|Overall Study||13
397112|NCT00956657|949014|P1|COMPLETED|Overall Study||18
397113|NCT00956657|949013|P2|STARTED|Overall Study||13
397114|NCT00956657|949014|P1|STARTED|Overall Study||18
397115|NCT00956631|949020|P1|NOT COMPLETED|Overall Study||16
397116|NCT00956631|949020|P1|COMPLETED|Overall Study||62
397117|NCT00956631|949020|P1|STARTED|Overall Study||78
397118|NCT00956592|949028|P2|NOT COMPLETED|Overall Study||3
397119|NCT00956592|949029|P1|NOT COMPLETED|Overall Study||1
397120|NCT00956592|949028|P2|COMPLETED|Overall Study||147
397121|NCT00956592|949029|P1|COMPLETED|Overall Study||149
397122|NCT00956592|949028|P2|STARTED|Overall Study||150
397123|NCT00956592|949029|P1|STARTED|Overall Study||150
397124|NCT00956540|949039|P4|NOT COMPLETED|Overall Study||4
397125|NCT00956540|949040|P3|NOT COMPLETED|Overall Study||3
397126|NCT00956540|949041|P2|NOT COMPLETED|Overall Study||4
397127|NCT00956540|949042|P1|NOT COMPLETED|Overall Study||3
397128|NCT00956540|949039|P4|COMPLETED|Overall Study||41
397129|NCT00956540|949040|P3|COMPLETED|Overall Study||43
397130|NCT00956540|949041|P2|COMPLETED|Overall Study||46
397131|NCT00956540|949042|P1|COMPLETED|Overall Study||51
397132|NCT00956540|949039|P4|STARTED|Overall Study||45
397133|NCT00956540|949040|P3|STARTED|Overall Study||46
397134|NCT00956540|949041|P2|STARTED|Overall Study||50
397135|NCT00956540|949042|P1|STARTED|Overall Study||54
397136|NCT00956293|949054|P3|NOT COMPLETED|Follow-up Period||0
397137|NCT00956293|949055|P2|NOT COMPLETED|Follow-up Period||32
397138|NCT00956293|949056|P1|NOT COMPLETED|Follow-up Period||20
397139|NCT00956293|949054|P3|COMPLETED|Follow-up Period||0
397140|NCT00956293|949055|P2|COMPLETED|Follow-up Period||0
397141|NCT00956293|949056|P1|COMPLETED|Follow-up Period||0
397142|NCT00956293|949054|P3|STARTED|Follow-up Period||0
397143|NCT00956293|949055|P2|STARTED|Follow-up Period||32
397144|NCT00956293|949056|P1|STARTED|Follow-up Period||20
397145|NCT00956293|949054|P3|NOT COMPLETED|Main Period (Randomization)||0
397146|NCT00956293|949055|P2|NOT COMPLETED|Main Period (Randomization)||27
397147|NCT00956293|949056|P1|NOT COMPLETED|Main Period (Randomization)||1
397148|NCT00956293|949054|P3|COMPLETED|Main Period (Randomization)||0
397149|NCT00956293|949055|P2|COMPLETED|Main Period (Randomization)||26
397150|NCT00956293|949056|P1|COMPLETED|Main Period (Randomization)||23
397151|NCT00956293|949054|P3|Randomized Safety Set|Main Period (Randomization)||0
397152|NCT00956293|949055|P2|Randomized Safety Set|Main Period (Randomization)||51
397153|NCT00956293|949056|P1|Randomized Safety Set|Main Period (Randomization)||24
397154|NCT00956293|949054|P3|Full Analysis Set|Main Period (Randomization)||0
397155|NCT00956293|949055|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
397156|NCT00956293|949056|P1|Full Analysis Set|Main Period (Randomization)||24
397157|NCT00956293|949054|P3|STARTED|Main Period (Randomization)||0
397158|NCT00956293|949055|P2|STARTED|Main Period (Randomization)||53
397159|NCT00956293|949056|P1|STARTED|Main Period (Randomization)||24
397160|NCT00956293|949054|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
397161|NCT00956293|949055|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
397162|NCT00956293|949056|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
397163|NCT00956293|949054|P3|COMPLETED|Main Period (Pre-randomization)||77
397164|NCT00956293|949055|P2|COMPLETED|Main Period (Pre-randomization)||0
397165|NCT00956293|949056|P1|COMPLETED|Main Period (Pre-randomization)||0
397166|NCT00956293|949054|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
397167|NCT00956293|949055|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
397168|NCT00956293|949056|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
397169|NCT00956293|949054|P3|STARTED|Main Period (Pre-randomization)||207
397170|NCT00956293|949055|P2|STARTED|Main Period (Pre-randomization)||0
397171|NCT00956293|949056|P1|STARTED|Main Period (Pre-randomization)||0
397172|NCT00956254|949080|P1|NOT COMPLETED|Overall Study||0
397173|NCT00956254|949080|P1|COMPLETED|Overall Study||18
397174|NCT00956254|949080|P1|STARTED|Overall Study||18
397178|NCT00956020|949094|P1|NOT COMPLETED|Overall Study||0
397179|NCT00956020|949094|P1|COMPLETED|Overall Study||4
397180|NCT00956020|949094|P1|STARTED|Overall Study||4
397181|NCT00955955|949112|P3|NOT COMPLETED|Overall Study||0
397182|NCT00955955|949113|P2|NOT COMPLETED|Overall Study||0
397183|NCT00955955|949114|P1|NOT COMPLETED|Overall Study||2
397184|NCT00955955|949112|P3|COMPLETED|Overall Study||28
397185|NCT00955955|949113|P2|COMPLETED|Overall Study||28
397186|NCT00955955|949114|P1|COMPLETED|Overall Study||17
397187|NCT00955955|949112|P3|STARTED|Overall Study||28
397188|NCT00955955|949113|P2|STARTED|Overall Study||28
397189|NCT00955955|949114|P1|STARTED|Overall Study||19
397190|NCT00955916|949128|P1|NOT COMPLETED|Overall Study||0
397191|NCT00955916|949128|P1|COMPLETED|Overall Study||38
397192|NCT00955916|949128|P1|STARTED|Overall Study||38
397193|NCT00955825|949136|P2|NOT COMPLETED|Overall Study||17
397194|NCT00955825|949137|P1|NOT COMPLETED|Overall Study||26
397195|NCT00955825|949136|P2|COMPLETED|Overall Study||223
397196|NCT00955825|949137|P1|COMPLETED|Overall Study||207
397197|NCT00955825|949136|P2|STARTED|Overall Study||240
397198|NCT00955825|949137|P1|STARTED|Overall Study||233
397199|NCT00955747|949145|P2|NOT COMPLETED|Overall Study||69
397200|NCT00955747|949146|P1|NOT COMPLETED|Overall Study||69
397201|NCT00955747|949145|P2|COMPLETED|Overall Study||172
397202|NCT00955747|949146|P1|COMPLETED|Overall Study||184
397203|NCT00955747|949145|P2|STARTED|Overall Study||241
397204|NCT00955747|949146|P1|STARTED|Overall Study||253
397205|NCT00955721|949154|P2|NOT COMPLETED|Overall Study||0
397206|NCT00955721|949155|P1|NOT COMPLETED|Overall Study||3
397207|NCT00955721|949154|P2|COMPLETED|Overall Study||0
397208|NCT00955721|949155|P1|COMPLETED|Overall Study||6
397209|NCT00955721|949154|P2|STARTED|Overall Study||0
397210|NCT00955721|949155|P1|STARTED|Overall Study||9
397211|NCT00955617|949163|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
397212|NCT00955617|949164|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
397213|NCT00955617|949163|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
397214|NCT00955617|949164|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
397215|NCT00955617|949163|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
397216|NCT00955617|949164|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
397217|NCT00955617|949163|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
397218|NCT00955617|949164|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
397219|NCT00955617|949163|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
397220|NCT00955617|949164|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
397221|NCT00955617|949163|P2|STARTED|First MRA (Between Day0 and Day21)||10
397222|NCT00955617|949164|P1|STARTED|First MRA (Between Day0 and Day21)||10
397223|NCT00955513|949177|P3|NOT COMPLETED|Overall Study||3
397224|NCT00955513|949178|P2|NOT COMPLETED|Overall Study||2
397225|NCT00955513|949179|P1|NOT COMPLETED|Overall Study||1
397226|NCT00955513|949177|P3|COMPLETED|Overall Study||79
397227|NCT00955513|949178|P2|COMPLETED|Overall Study||78
397228|NCT00955513|949179|P1|COMPLETED|Overall Study||79
397229|NCT00955513|949177|P3|STARTED|Overall Study||82
397230|NCT00955513|949178|P2|STARTED|Overall Study||80
397231|NCT00955513|949179|P1|STARTED|Overall Study||80
397232|NCT00955487|949189|P6|NOT COMPLETED|Overall Study||0
397233|NCT00955487|949190|P5|NOT COMPLETED|Overall Study||0
397234|NCT00955487|949191|P4|NOT COMPLETED|Overall Study||0
397235|NCT00955487|949192|P3|NOT COMPLETED|Overall Study||0
397236|NCT00955487|949193|P2|NOT COMPLETED|Overall Study||0
397237|NCT00955487|949194|P1|NOT COMPLETED|Overall Study||0
397238|NCT00955487|949189|P6|COMPLETED|Overall Study||35
397239|NCT00955487|949190|P5|COMPLETED|Overall Study||32
397240|NCT00955487|949191|P4|COMPLETED|Overall Study||21
397241|NCT00955487|949192|P3|COMPLETED|Overall Study||17
397242|NCT00955487|949193|P2|COMPLETED|Overall Study||9
397243|NCT00955487|949194|P1|COMPLETED|Overall Study||10
397244|NCT00955487|949189|P6|STARTED|Overall Study||35
397245|NCT00955487|949190|P5|STARTED|Overall Study||32
397246|NCT00955487|949191|P4|STARTED|Overall Study||21
397247|NCT00955487|949192|P3|STARTED|Overall Study||17
397248|NCT00955487|949193|P2|STARTED|Overall Study||9
397249|NCT00955487|949194|P1|STARTED|Overall Study||10
397250|NCT00955474|949228|P2|NOT COMPLETED|Overall Study||5
397251|NCT00955474|949229|P1|NOT COMPLETED|Overall Study||7
397252|NCT00955474|949228|P2|COMPLETED|Overall Study||8
397253|NCT00955474|949229|P1|COMPLETED|Overall Study||5
397254|NCT00955474|949228|P2|STARTED|Overall Study||13
397255|NCT00955474|949229|P1|STARTED|Overall Study||12
397256|NCT00955357|949265|P2|NOT COMPLETED|Maintenance Phase||45
397257|NCT00955357|949266|P1|NOT COMPLETED|Maintenance Phase||12
397258|NCT00955357|949265|P2|COMPLETED|Maintenance Phase||249
397259|NCT00955357|949266|P1|COMPLETED|Maintenance Phase||68
397260|NCT00955357|949265|P2|STARTED|Maintenance Phase||294
397261|NCT00955357|949266|P1|STARTED|Maintenance Phase||80
397262|NCT00955357|949265|P2|NOT COMPLETED|Titration Phase||66
397263|NCT00955357|949266|P1|NOT COMPLETED|Titration Phase||16
397264|NCT00955357|949265|P2|COMPLETED|Titration Phase||294
397265|NCT00955357|949266|P1|COMPLETED|Titration Phase||80
397266|NCT00955357|949265|P2|STARTED|Titration Phase||360
397267|NCT00955357|949266|P1|STARTED|Titration Phase||96
397268|NCT00955305|949274|P2|NOT COMPLETED|Overall Study||87
397269|NCT00955305|949275|P1|NOT COMPLETED|Overall Study||88
397270|NCT00955305|949274|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
397271|NCT00955305|949275|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
397272|NCT00955305|949274|P2|Eligible and Treated|Overall Study||75
397273|NCT00955305|949275|P1|Eligible and Treated|Overall Study||78
397274|NCT00955305|949274|P2|Treated|Overall Study||82
397275|NCT00955305|949275|P1|Treated|Overall Study||83
397276|NCT00955305|949274|P2|STARTED|Overall Study||87
397277|NCT00955305|949275|P1|STARTED|Overall Study||88
397278|NCT00955279|949288|P3|NOT COMPLETED|Overall Study||8
397279|NCT00955279|949289|P2|NOT COMPLETED|Overall Study||4
397280|NCT00955279|949290|P1|NOT COMPLETED|Overall Study||3
397281|NCT00955279|949288|P3|COMPLETED|Overall Study||52
397282|NCT00955279|949289|P2|COMPLETED|Overall Study||51
397283|NCT00955279|949290|P1|COMPLETED|Overall Study||55
397284|NCT00955279|949288|P3|STARTED|Overall Study||60
397285|NCT00955279|949289|P2|STARTED|Overall Study||55
397286|NCT00955279|949290|P1|STARTED|Overall Study||58
397287|NCT00955266|949312|P2|NOT COMPLETED|Overall Study||0
397288|NCT00955266|949313|P1|NOT COMPLETED|Overall Study||0
397289|NCT00955266|949312|P2|COMPLETED|Overall Study||4
397290|NCT00955266|949313|P1|COMPLETED|Overall Study||4
397291|NCT00955266|949312|P2|STARTED|Overall Study||4
397292|NCT00955266|949313|P1|STARTED|Overall Study||4
397293|NCT00955110|949327|P1|NOT COMPLETED|Treatment Phase||6
397294|NCT00955110|949327|P1|COMPLETED|Treatment Phase||35
397295|NCT00955110|949327|P1|Oxycodone CR 60 mg|Treatment Phase||40
397296|NCT00955110|949327|P1|Oxycodone CR 30 mg|Treatment Phase||40
397297|NCT00955110|949327|P1|Oxymorphone ER 30 mg|Treatment Phase||38
397298|NCT00955110|949327|P1|Oxymorphone ER 15 mg|Treatment Phase||37
397299|NCT00955110|949327|P1|Placebo|Treatment Phase||38
397300|NCT00955110|949327|P1|STARTED|Treatment Phase||41
397301|NCT00955110|949327|P1|NOT COMPLETED|Qualification Phase||24
397302|NCT00955110|949327|P1|COMPLETED|Qualification Phase||54
397303|NCT00955110|949327|P1|STARTED|Qualification Phase||78
397304|NCT00955032|949341|P2|NOT COMPLETED|Overall Study||0
397305|NCT00955032|949342|P1|NOT COMPLETED|Overall Study||0
397306|NCT00955032|949341|P2|COMPLETED|Overall Study||8
397307|NCT00955032|949342|P1|COMPLETED|Overall Study||16
397308|NCT00955032|949341|P2|STARTED|Overall Study||8
397309|NCT00955032|949342|P1|STARTED|Overall Study||16
397310|NCT00954993|949362|P1|NOT COMPLETED|Period 2||0
397311|NCT00954993|949362|P1|COMPLETED|Period 2||3
397312|NCT00954993|949362|P1|STARTED|Period 2||3
397313|NCT00954993|949362|P1|NOT COMPLETED|Washout||0
397314|NCT00954993|949362|P1|COMPLETED|Washout||3
397315|NCT00954993|949362|P1|STARTED|Washout||3
397316|NCT00954993|949362|P1|NOT COMPLETED|Period 1||0
397317|NCT00954993|949362|P1|COMPLETED|Period 1||3
397318|NCT00954993|949362|P1|STARTED|Period 1||3
397319|NCT00954941|949374|P2|NOT COMPLETED|Overall Study||7
397320|NCT00954941|949375|P1|NOT COMPLETED|Overall Study||8
397321|NCT00954941|949374|P2|COMPLETED|Overall Study||41
397322|NCT00954941|949375|P1|COMPLETED|Overall Study||42
397323|NCT00954941|949374|P2|STARTED|Overall Study||48
397324|NCT00954941|949375|P1|STARTED|Overall Study||50
397325|NCT00954915|949383|P1|NOT COMPLETED|Overall Study||0
397326|NCT00954915|949383|P1|COMPLETED|Overall Study||1
397327|NCT00954915|949383|P1|STARTED|Overall Study||1
397328|NCT00954824|949387|P1|NOT COMPLETED|Overall Study||50
397329|NCT00954824|949387|P1|COMPLETED|Overall Study||50
397330|NCT00954824|949387|P1|STARTED|Overall Study||100
397331|NCT00954733|949391|P1|NOT COMPLETED|Overall Study||1
397332|NCT00954733|949391|P1|COMPLETED|Overall Study||39
397333|NCT00954733|949391|P1|STARTED|Overall Study||40
397334|NCT00954707|949395|P1|NOT COMPLETED|Overall Study||167
397335|NCT00954707|949395|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
397336|NCT00954707|949395|P1|STARTED|Overall Study||2509
397337|NCT00954538|949413|P6|NOT COMPLETED|Part III||0
397338|NCT00954538|949414|P5|NOT COMPLETED|Part III||1
397339|NCT00954538|949415|P4|NOT COMPLETED|Part III||0
397340|NCT00954538|949416|P3|NOT COMPLETED|Part III||0
397341|NCT00954538|949417|P2|NOT COMPLETED|Part III||0
397342|NCT00954538|949418|P1|NOT COMPLETED|Part III||0
397343|NCT00954538|949413|P6|COMPLETED|Part III||2
397344|NCT00954538|949414|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
397345|NCT00954538|949415|P4|COMPLETED|Part III||4
397346|NCT00954538|949416|P3|COMPLETED|Part III||0
397347|NCT00954538|949417|P2|COMPLETED|Part III||0
397348|NCT00954538|949418|P1|COMPLETED|Part III||0
397349|NCT00954538|949413|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
397350|NCT00954538|949414|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
397351|NCT00954538|949415|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
397352|NCT00954538|949416|P3|STARTED|Part III||0
397353|NCT00954538|949417|P2|STARTED|Part III||0
397354|NCT00954538|949418|P1|STARTED|Part III||0
397355|NCT00954538|949413|P6|NOT COMPLETED|Part II||0
397356|NCT00954538|949414|P5|NOT COMPLETED|Part II||0
397357|NCT00954538|949415|P4|NOT COMPLETED|Part II||0
397358|NCT00954538|949416|P3|NOT COMPLETED|Part II||0
397359|NCT00954538|949417|P2|NOT COMPLETED|Part II||0
397360|NCT00954538|949418|P1|NOT COMPLETED|Part II||0
397361|NCT00954538|949413|P6|COMPLETED|Part II||2
397362|NCT00954538|949414|P5|COMPLETED|Part II||0
397363|NCT00954538|949415|P4|COMPLETED|Part II||0
397364|NCT00954538|949416|P3|COMPLETED|Part II||3
397365|NCT00954538|949417|P2|COMPLETED|Part II||1
397366|NCT00954538|949418|P1|COMPLETED|Part II||0
397367|NCT00954538|949413|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
397368|NCT00954538|949414|P5|STARTED|Part II||0
397369|NCT00954538|949415|P4|STARTED|Part II||0
397370|NCT00954538|949416|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
397371|NCT00954538|949417|P2|STARTED|Part II|This subject did not participate in Part I or III|1
397372|NCT00954538|949418|P1|STARTED|Part II||0
397373|NCT00954538|949413|P6|NOT COMPLETED|Part I||0
397374|NCT00954538|949414|P5|NOT COMPLETED|Part I||0
397375|NCT00954538|949415|P4|NOT COMPLETED|Part I||0
397376|NCT00954538|949416|P3|NOT COMPLETED|Part I||0
397377|NCT00954538|949417|P2|NOT COMPLETED|Part I||0
397378|NCT00954538|949418|P1|NOT COMPLETED|Part I||0
397379|NCT00954538|949413|P6|COMPLETED|Part I||0
397380|NCT00954538|949414|P5|COMPLETED|Part I||0
397381|NCT00954538|949415|P4|COMPLETED|Part I||0
397382|NCT00954538|949416|P3|COMPLETED|Part I||0
397383|NCT00954538|949417|P2|COMPLETED|Part I||0
397384|NCT00954538|949418|P1|COMPLETED|Part I||3
397385|NCT00954538|949413|P6|STARTED|Part I||0
397386|NCT00954538|949414|P5|STARTED|Part I||0
397387|NCT00954538|949415|P4|STARTED|Part I||0
397388|NCT00954538|949416|P3|STARTED|Part I||0
397389|NCT00954538|949417|P2|STARTED|Part I||0
397390|NCT00954538|949418|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
397391|NCT00954512|949435|P6|NOT COMPLETED|Overall Study||4
397392|NCT00954512|949436|P5|NOT COMPLETED|Overall Study||4
397393|NCT00954512|949437|P4|NOT COMPLETED|Overall Study||2
397394|NCT00954512|949438|P3|NOT COMPLETED|Overall Study||0
397395|NCT00954512|949439|P2|NOT COMPLETED|Overall Study||3
397396|NCT00954512|949440|P1|NOT COMPLETED|Overall Study||2
397397|NCT00954512|949435|P6|COMPLETED|Overall Study||0
397398|NCT00954512|949436|P5|COMPLETED|Overall Study||0
397399|NCT00954512|949437|P4|COMPLETED|Overall Study||0
397400|NCT00954512|949438|P3|COMPLETED|Overall Study||0
397401|NCT00954512|949439|P2|COMPLETED|Overall Study||0
397402|NCT00954512|949440|P1|COMPLETED|Overall Study||0
397403|NCT00954512|949435|P6|STARTED|Overall Study||4
397404|NCT00954512|949436|P5|STARTED|Overall Study||4
397405|NCT00954512|949437|P4|STARTED|Overall Study||2
397406|NCT00954512|949438|P3|STARTED|Overall Study||0
397407|NCT00954512|949439|P2|STARTED|Overall Study||3
397408|NCT00954512|949440|P1|STARTED|Overall Study||2
397409|NCT00954447|949461|P2|NOT COMPLETED|Overall Study||88
397410|NCT00954447|949462|P1|NOT COMPLETED|Overall Study||110
397411|NCT00954447|949461|P2|COMPLETED|Overall Study||543
397412|NCT00954447|949462|P1|COMPLETED|Overall Study||520
397413|NCT00954447|949461|P2|STARTED|Overall Study||631
397414|NCT00954447|949462|P1|STARTED|Overall Study||630
397415|NCT00954421|949498|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
397416|NCT00954421|949498|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
397417|NCT00954421|949498|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
397418|NCT00954421|949498|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
397419|NCT00954421|949498|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
397420|NCT00954421|949498|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
397421|NCT00954421|949498|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
397422|NCT00954421|949498|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
397423|NCT00954421|949498|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
397424|NCT00954421|949498|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
397425|NCT00954421|949498|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
397426|NCT00954421|949498|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
397427|NCT00954421|949498|P1|NOT COMPLETED|6 Months of DBS||1
397428|NCT00954421|949498|P1|COMPLETED|6 Months of DBS||12
397429|NCT00954421|949498|P1|STARTED|6 Months of DBS||13
397430|NCT00954421|949498|P1|NOT COMPLETED|Baseline||0
397431|NCT00954421|949498|P1|COMPLETED|Baseline||13
397432|NCT00954421|949498|P1|STARTED|Baseline||13
397433|NCT00954421|949498|P1|NOT COMPLETED|Screening||3
397434|NCT00954421|949498|P1|COMPLETED|Screening||13
397435|NCT00954421|949498|P1|STARTED|Screening||16
397436|NCT00954356|949506|P2|NOT COMPLETED|Overall Study||0
397437|NCT00954356|949507|P1|NOT COMPLETED|Overall Study||0
397438|NCT00954356|949506|P2|COMPLETED|Overall Study||20
397439|NCT00954356|949507|P1|COMPLETED|Overall Study||41
397440|NCT00954356|949506|P2|STARTED|Overall Study||20
397441|NCT00954356|949507|P1|STARTED|Overall Study||41
397442|NCT00954187|949537|P2|NOT COMPLETED|Overall Study||0
397443|NCT00954187|949538|P1|NOT COMPLETED|Overall Study||0
397444|NCT00954187|949537|P2|COMPLETED|Overall Study||0
397445|NCT00954187|949538|P1|COMPLETED|Overall Study||0
397446|NCT00954187|949537|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
397447|NCT00954187|949538|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
397448|NCT00954122|949544|P1|NOT COMPLETED|Overall Study||7
397449|NCT00954122|949544|P1|COMPLETED|Overall Study||28
397450|NCT00954122|949544|P1|STARTED|Overall Study||35
397451|NCT00954109|949554|P1|NOT COMPLETED|Overall Study||0
397452|NCT00954109|949554|P1|COMPLETED|Overall Study||11
397453|NCT00954109|949554|P1|STARTED|Overall Study||11
397454|NCT00953927|949561|P2|NOT COMPLETED|Overall Study||95
397455|NCT00953927|949562|P1|NOT COMPLETED|Overall Study||105
397456|NCT00953927|949561|P2|COMPLETED|Overall Study||1303
397457|NCT00953927|949562|P1|COMPLETED|Overall Study||1294
397458|NCT00953927|949561|P2|STARTED|Overall Study||1398
397459|NCT00953927|949562|P1|STARTED|Overall Study||1399
397460|NCT00953862|949580|P1|NOT COMPLETED|Overall Study||6
397461|NCT00953862|949580|P1|COMPLETED|Overall Study||12
397462|NCT00953862|949580|P1|STARTED|Overall Study||18
397463|NCT00953849|949590|P4|NOT COMPLETED|Overall Study||0
397464|NCT00953849|949591|P3|NOT COMPLETED|Overall Study||0
397465|NCT00953849|949592|P2|NOT COMPLETED|Overall Study||0
397466|NCT00953849|949593|P1|NOT COMPLETED|Overall Study||0
397467|NCT00953849|949590|P4|COMPLETED|Overall Study||5
397468|NCT00953849|949591|P3|COMPLETED|Overall Study||4
397469|NCT00953849|949592|P2|COMPLETED|Overall Study||6
397470|NCT00953849|949593|P1|COMPLETED|Overall Study||6
397471|NCT00953849|949590|P4|STARTED|Overall Study||5
397472|NCT00953849|949591|P3|STARTED|Overall Study||4
397473|NCT00953849|949592|P2|STARTED|Overall Study||6
397474|NCT00953849|949593|P1|STARTED|Overall Study||6
397475|NCT00953719|949617|P2|NOT COMPLETED|Overall Study||5
397476|NCT00953719|949618|P1|NOT COMPLETED|Overall Study||19
397477|NCT00953719|949617|P2|COMPLETED|Overall Study||69
397478|NCT00953719|949618|P1|COMPLETED|Overall Study||150
397479|NCT00953719|949617|P2|STARTED|Overall Study||74
397480|NCT00953719|949618|P1|STARTED|Overall Study||169
397481|NCT00953706|949640|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
397482|NCT00953706|949641|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
397483|NCT00953706|949642|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
397484|NCT00953706|949643|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
397485|NCT00953706|949640|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
397486|NCT00953706|949641|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
397487|NCT00953706|949642|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
397488|NCT00953706|949643|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
397489|NCT00953706|949640|P4|STARTED|Part B (96-Week Open-Label Extension)||33
397490|NCT00953706|949641|P3|STARTED|Part B (96-Week Open-Label Extension)||5
397491|NCT00953706|949642|P2|STARTED|Part B (96-Week Open-Label Extension)||0
397492|NCT00953706|949643|P1|STARTED|Part B (96-Week Open-Label Extension)||0
397493|NCT00953706|949640|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
397494|NCT00953706|949641|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
397495|NCT00953706|949642|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
397496|NCT00953706|949643|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
397497|NCT00953706|949640|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
397498|NCT00953706|949641|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
397499|NCT00953706|949642|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
397500|NCT00953706|949643|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
397501|NCT00953706|949640|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
397502|NCT00953706|949641|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
397503|NCT00953706|949642|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
397504|NCT00953706|949643|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
397505|NCT00953680|949675|P2|NOT COMPLETED|Period 2||0
397506|NCT00953680|949676|P1|NOT COMPLETED|Period 2||0
397507|NCT00953680|949675|P2|COMPLETED|Period 2||38
397508|NCT00953680|949676|P1|COMPLETED|Period 2||38
397509|NCT00953680|949675|P2|STARTED|Period 2||38
397510|NCT00953680|949676|P1|STARTED|Period 2||38
397511|NCT00953680|949675|P2|NOT COMPLETED|Period 1||1
397512|NCT00953680|949676|P1|NOT COMPLETED|Period 1||0
397513|NCT00953680|949675|P2|COMPLETED|Period 1||38
397514|NCT00953680|949676|P1|COMPLETED|Period 1||38
397515|NCT00953680|949675|P2|STARTED|Period 1||39
397516|NCT00953680|949676|P1|STARTED|Period 1||38
397517|NCT00953667|949688|P1|NOT COMPLETED|Overall Study||123
397518|NCT00953667|949688|P1|COMPLETED|Overall Study||277
397519|NCT00953667|949688|P1|STARTED|Overall Study||400
397520|NCT00953654|949696|P3|NOT COMPLETED|Overall Study||0
397521|NCT00953654|949697|P2|NOT COMPLETED|Overall Study||0
397522|NCT00953654|949698|P1|NOT COMPLETED|Overall Study||0
397523|NCT00953654|949696|P3|COMPLETED|Overall Study||10
397524|NCT00953654|949697|P2|COMPLETED|Overall Study||10
397525|NCT00953654|949698|P1|COMPLETED|Overall Study||10
397526|NCT00953654|949696|P3|STARTED|Overall Study||10
397527|NCT00953654|949697|P2|STARTED|Overall Study||10
397528|NCT00953654|949698|P1|STARTED|Overall Study||10
397529|NCT00953615|949709|P1|NOT COMPLETED|Overall Study||1
397530|NCT00953615|949709|P1|COMPLETED|Overall Study||0
397531|NCT00953615|949709|P1|STARTED|Overall Study||1
397532|NCT00953524|949720|P4|NOT COMPLETED|Overall Study||8
397533|NCT00953524|949721|P3|NOT COMPLETED|Overall Study||14
397534|NCT00953524|949722|P2|NOT COMPLETED|Overall Study||15
397535|NCT00953524|949723|P1|NOT COMPLETED|Overall Study||22
397536|NCT00953524|949720|P4|COMPLETED|Overall Study||91
397537|NCT00953524|949721|P3|COMPLETED|Overall Study||233
397538|NCT00953524|949722|P2|COMPLETED|Overall Study||239
397539|NCT00953524|949723|P1|COMPLETED|Overall Study||227
397540|NCT00953524|949720|P4|STARTED|Overall Study||99
397541|NCT00953524|949721|P3|STARTED|Overall Study||247
397542|NCT00953524|949722|P2|STARTED|Overall Study||254
397543|NCT00953524|949723|P1|STARTED|Overall Study||249
397544|NCT00953407|949766|P5|NOT COMPLETED|Overall Study||1
397545|NCT00953407|949767|P4|NOT COMPLETED|Overall Study||2
397546|NCT00953407|949768|P3|NOT COMPLETED|Overall Study||1
397547|NCT00953407|949769|P2|NOT COMPLETED|Overall Study||1
397548|NCT00953407|949770|P1|NOT COMPLETED|Overall Study||1
397549|NCT00953407|949766|P5|COMPLETED|Overall Study||23
397550|NCT00953407|949767|P4|COMPLETED|Overall Study||23
397551|NCT00953407|949768|P3|COMPLETED|Overall Study||25
397552|NCT00953407|949769|P2|COMPLETED|Overall Study||24
397553|NCT00953407|949770|P1|COMPLETED|Overall Study||25
397554|NCT00953407|949766|P5|STARTED|Overall Study||24
397555|NCT00953407|949767|P4|STARTED|Overall Study||25
397556|NCT00953407|949768|P3|STARTED|Overall Study||26
397557|NCT00953407|949769|P2|STARTED|Overall Study||25
397558|NCT00953407|949770|P1|STARTED|Overall Study||26
397559|NCT00953329|949782|P1|NOT COMPLETED|Overall Study||1
397560|NCT00953329|949782|P1|COMPLETED|Overall Study||0
397561|NCT00953329|949782|P1|STARTED|Overall Study||1
397562|NCT00953290|949786|P1|NOT COMPLETED|Overall Study||0
397563|NCT00953290|949786|P1|COMPLETED|Overall Study||4
397564|NCT00953290|949786|P1|STARTED|Overall Study||4
397565|NCT00953225|949795|P2|NOT COMPLETED|Overall Study||0
397566|NCT00953225|949796|P1|NOT COMPLETED|Overall Study||2
397567|NCT00953225|949795|P2|COMPLETED|Overall Study||37
397568|NCT00953225|949796|P1|COMPLETED|Overall Study||44
397569|NCT00953225|949795|P2|STARTED|Overall Study||37
397570|NCT00953225|949796|P1|STARTED|Overall Study||46
397571|NCT00953160|949804|P1|NOT COMPLETED|Overall Study||27
397572|NCT00953160|949804|P1|COMPLETED|Overall Study||49
397573|NCT00953160|949804|P1|STARTED|Overall Study||76
397574|NCT00953147|949813|P3|NOT COMPLETED|Overall Study||42
397575|NCT00953147|949814|P2|NOT COMPLETED|Overall Study||66
397576|NCT00953147|949815|P1|NOT COMPLETED|Overall Study||37
397577|NCT00953147|949813|P3|COMPLETED|Overall Study||265
397578|NCT00953147|949814|P2|COMPLETED|Overall Study||439
397579|NCT00953147|949815|P1|COMPLETED|Overall Study||261
397580|NCT00953147|949813|P3|STARTED|Overall Study||307
397581|NCT00953147|949814|P2|STARTED|Overall Study||505
397582|NCT00953147|949815|P1|STARTED|Overall Study||298
397583|NCT00953121|949865|P3|NOT COMPLETED|Overall Study||0
397584|NCT00953121|949866|P2|NOT COMPLETED|Overall Study||0
397585|NCT00953121|949867|P1|NOT COMPLETED|Overall Study||0
397586|NCT00953121|949865|P3|COMPLETED|Overall Study||25
397587|NCT00953121|949866|P2|COMPLETED|Overall Study||39
397588|NCT00953121|949867|P1|COMPLETED|Overall Study||40
397589|NCT00953121|949865|P3|STARTED|Overall Study||25
397590|NCT00953121|949866|P2|STARTED|Overall Study||39
397591|NCT00953121|949867|P1|STARTED|Overall Study||40
397592|NCT00953056|949893|P6|NOT COMPLETED|Overall Study||4
397593|NCT00953056|949894|P5|NOT COMPLETED|Overall Study||2
397594|NCT00953056|949895|P4|NOT COMPLETED|Overall Study||0
397595|NCT00953056|949896|P3|NOT COMPLETED|Overall Study||0
397596|NCT00953056|949897|P2|NOT COMPLETED|Overall Study||0
397597|NCT00953056|949898|P1|NOT COMPLETED|Overall Study||0
397598|NCT00953056|949893|P6|COMPLETED|Overall Study||20
397599|NCT00953056|949894|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
397600|NCT00953056|949895|P4|COMPLETED|Overall Study||24
397601|NCT00953056|949896|P3|COMPLETED|Overall Study||24
397602|NCT00953056|949897|P2|COMPLETED|Overall Study||24
397603|NCT00953056|949898|P1|COMPLETED|Overall Study||24
397604|NCT00953056|949893|P6|STARTED|Overall Study||24
397605|NCT00953056|949894|P5|STARTED|Overall Study||24
397606|NCT00953056|949895|P4|STARTED|Overall Study||24
397607|NCT00953056|949896|P3|STARTED|Overall Study||24
397608|NCT00953056|949897|P2|STARTED|Overall Study||24
397609|NCT00953056|949898|P1|STARTED|Overall Study||24
397610|NCT00953043|949922|P2|NOT COMPLETED|Overall Study||2
397611|NCT00953043|949923|P1|NOT COMPLETED|Overall Study||4
397612|NCT00953043|949922|P2|COMPLETED|Overall Study||28
397613|NCT00953043|949923|P1|COMPLETED|Overall Study||26
397614|NCT00953043|949922|P2|STARTED|Overall Study||30
397615|NCT00953043|949923|P1|STARTED|Overall Study||30
397616|NCT00953017|949947|P4|NOT COMPLETED|Overall Study||5
397617|NCT00953017|949948|P3|NOT COMPLETED|Overall Study||6
397618|NCT00953017|949949|P2|NOT COMPLETED|Overall Study||6
397619|NCT00953017|949950|P1|NOT COMPLETED|Overall Study||5
397620|NCT00953017|949947|P4|COMPLETED|Overall Study||101
397621|NCT00953017|949948|P3|COMPLETED|Overall Study||100
397622|NCT00953017|949949|P2|COMPLETED|Overall Study||101
397623|NCT00953017|949950|P1|COMPLETED|Overall Study||101
397624|NCT00953017|949947|P4|STARTED|Overall Study||106
397625|NCT00953017|949948|P3|STARTED|Overall Study||106
397626|NCT00953017|949949|P2|STARTED|Overall Study||107
397627|NCT00953017|949950|P1|STARTED|Overall Study||106
397628|NCT00952848|949972|P1|NOT COMPLETED|Overall Study||4
397629|NCT00952848|949972|P1|COMPLETED|Overall Study||14
397630|NCT00952848|949972|P1|STARTED|Overall Study||18
397631|NCT00952822|949979|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
397632|NCT00952822|949980|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
397633|NCT00952822|949981|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
397634|NCT00952822|949982|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
397635|NCT00952822|949979|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
397636|NCT00952822|949980|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
397637|NCT00952822|949981|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
397638|NCT00952822|949982|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
397639|NCT00952822|949979|P4|STARTED|2nd Pharmacokinetic Evaluation||4
397640|NCT00952822|949980|P3|STARTED|2nd Pharmacokinetic Evaluation||11
397641|NCT00952822|949981|P2|STARTED|2nd Pharmacokinetic Evaluation||17
397642|NCT00952822|949982|P1|STARTED|2nd Pharmacokinetic Evaluation||9
397643|NCT00952822|949979|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
397644|NCT00952822|949980|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
397645|NCT00952822|949981|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
397646|NCT00952822|949982|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
397647|NCT00952822|949979|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
397648|NCT00952822|949980|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
397649|NCT00952822|949981|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
397650|NCT00952822|949982|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
397651|NCT00952822|949979|P4|STARTED|1st Pharmacokinetic Evaluation||4
397652|NCT00952822|949980|P3|STARTED|1st Pharmacokinetic Evaluation||11
397653|NCT00952822|949981|P2|STARTED|1st Pharmacokinetic Evaluation||18
397654|NCT00952822|949982|P1|STARTED|1st Pharmacokinetic Evaluation||9
397655|NCT00952731|950014|P2|NOT COMPLETED|Overall Study||0
397656|NCT00952731|950015|P1|NOT COMPLETED|Overall Study||1
397657|NCT00952731|950014|P2|COMPLETED|Overall Study||14
397658|NCT00952731|950015|P1|COMPLETED|Overall Study||12
397659|NCT00952731|950014|P2|Follow-up|Overall Study||14
397660|NCT00952731|950015|P1|Follow-up|Overall Study||12
397661|NCT00952731|950014|P2|Surgery|Overall Study||14
397662|NCT00952731|950015|P1|Surgery|Overall Study||12
397663|NCT00952731|950014|P2|Treatment & Pre-Surgery|Overall Study||14
397664|NCT00952731|950015|P1|Treatment & Pre-Surgery|Overall Study||12
397665|NCT00952731|950014|P2|Randomization|Overall Study||14
397666|NCT00952731|950015|P1|Randomization|Overall Study||13
397667|NCT00952731|950014|P2|STARTED|Overall Study||14
397668|NCT00952731|950015|P1|STARTED|Overall Study||13
397669|NCT00952705|950034|P3|NOT COMPLETED|Overall Study||10
397670|NCT00952705|950035|P2|NOT COMPLETED|Overall Study||10
397671|NCT00952705|950036|P1|NOT COMPLETED|Overall Study||33
397672|NCT00952705|950034|P3|COMPLETED|Overall Study||288
397673|NCT00952705|950035|P2|COMPLETED|Overall Study||290
397674|NCT00952705|950036|P1|COMPLETED|Overall Study||1169
397675|NCT00952705|950034|P3|STARTED|Overall Study||298
397676|NCT00952705|950035|P2|STARTED|Overall Study||300
397677|NCT00952705|950036|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
397678|NCT00952653|950098|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
397679|NCT00952653|950098|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
397680|NCT00952653|950098|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
397681|NCT00952653|950098|P1|NOT COMPLETED|Period 1: MDZ Alone||0
397682|NCT00952653|950098|P1|COMPLETED|Period 1: MDZ Alone||28
397683|NCT00952653|950098|P1|STARTED|Period 1: MDZ Alone||28
397684|NCT00952614|950123|P1|NOT COMPLETED|Overall Study||7
397685|NCT00952614|950123|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
397686|NCT00952614|950123|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
397687|NCT00952614|950123|P1|STARTED|Overall Study||30
397688|NCT00952588|950130|P2|NOT COMPLETED|Overall Study||24
397689|NCT00952588|950131|P1|NOT COMPLETED|Overall Study||36
397690|NCT00952588|950130|P2|COMPLETED|Overall Study||2
397691|NCT00952588|950131|P1|COMPLETED|Overall Study||12
397692|NCT00952588|950130|P2|STARTED|Overall Study||26
397693|NCT00952588|950131|P1|STARTED|Overall Study||48
397694|NCT00952523|950149|P1|NOT COMPLETED|Overall Study||7
397695|NCT00952523|950149|P1|COMPLETED|Overall Study||155
397696|NCT00952523|950149|P1|STARTED|Overall Study||162
397697|NCT00952484|950158|P3|NOT COMPLETED|Overall Study||0
397698|NCT00952484|950159|P2|NOT COMPLETED|Overall Study||1
397699|NCT00952484|950160|P1|NOT COMPLETED|Overall Study||0
397700|NCT00952484|950158|P3|COMPLETED|Overall Study||16
397701|NCT00952484|950159|P2|COMPLETED|Overall Study||6
397702|NCT00952484|950160|P1|COMPLETED|Overall Study||6
397703|NCT00952484|950158|P3|STARTED|Overall Study||16
397704|NCT00952484|950159|P2|STARTED|Overall Study||7
397705|NCT00952484|950160|P1|STARTED|Overall Study||6
397706|NCT00952419|950187|P3|NOT COMPLETED|Overall Study||0
397707|NCT00952419|950188|P2|NOT COMPLETED|Overall Study||10
397708|NCT00952419|950189|P1|NOT COMPLETED|Overall Study||6
397709|NCT00952419|950187|P3|COMPLETED|Overall Study||51
397710|NCT00952419|950188|P2|COMPLETED|Overall Study||198
397711|NCT00952419|950189|P1|COMPLETED|Overall Study||209
397712|NCT00952419|950187|P3|STARTED|Overall Study||51
397713|NCT00952419|950188|P2|STARTED|Overall Study||208
397714|NCT00952419|950189|P1|STARTED|Overall Study||215
397715|NCT00952393|950221|P1|NOT COMPLETED|Overall Study||0
397716|NCT00952393|950221|P1|COMPLETED|Overall Study||10
397717|NCT00952393|950221|P1|STARTED|Overall Study|10|10
397718|NCT00952367|950225|P1|NOT COMPLETED|Overall Study||6
397719|NCT00952367|950225|P1|COMPLETED|Overall Study||3635
397720|NCT00952367|950225|P1|STARTED|Overall Study||3641
397721|NCT00952341|950240|P2|NOT COMPLETED|Cycle 2||12
397722|NCT00952341|950241|P1|NOT COMPLETED|Cycle 2||9
397723|NCT00952341|950240|P2|COMPLETED|Cycle 2||118
397724|NCT00952341|950241|P1|COMPLETED|Cycle 2||101
397725|NCT00952341|950240|P2|STARTED|Cycle 2||130
397726|NCT00952341|950241|P1|STARTED|Cycle 2||110
397727|NCT00952341|950240|P2|NOT COMPLETED|Cycle 1||13
397728|NCT00952341|950241|P1|NOT COMPLETED|Cycle 1||20
397729|NCT00952341|950240|P2|COMPLETED|Cycle 1||199
397730|NCT00952341|950241|P1|COMPLETED|Cycle 1||189
397731|NCT00952341|950240|P2|STARTED|Cycle 1||212
397732|NCT00952341|950241|P1|STARTED|Cycle 1||209
397733|NCT00952289|950263|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
397734|NCT00952289|950264|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
397735|NCT00952289|950263|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
397736|NCT00952289|950264|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
397737|NCT00952289|950263|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
397738|NCT00952289|950264|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
397739|NCT00952289|950263|P2|NOT COMPLETED|All Participants||40
397740|NCT00952289|950264|P1|NOT COMPLETED|All Participants||21
397741|NCT00952289|950263|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
397742|NCT00952289|950264|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
397743|NCT00952289|950263|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
397744|NCT00952289|950264|P1|Safety Population|All Participants||155
397745|NCT00952289|950263|P2|STARTED|All Participants||154
397746|NCT00952289|950264|P1|STARTED|All Participants||155
397747|NCT00952276|950293|P5|NOT COMPLETED|Overall Study||0
397748|NCT00952276|950294|P4|NOT COMPLETED|Overall Study||1
397749|NCT00952276|950295|P3|NOT COMPLETED|Overall Study||0
397750|NCT00952276|950296|P2|NOT COMPLETED|Overall Study||0
397751|NCT00952276|950297|P1|NOT COMPLETED|Overall Study||1
397752|NCT00952276|950293|P5|COMPLETED|Overall Study||63
397753|NCT00952276|950294|P4|COMPLETED|Overall Study||120
397754|NCT00952276|950295|P3|COMPLETED|Overall Study||122
397755|NCT00952276|950296|P2|COMPLETED|Overall Study||115
397756|NCT00952276|950297|P1|COMPLETED|Overall Study||126
397757|NCT00952276|950293|P5|STARTED|Overall Study||63
397758|NCT00952276|950294|P4|STARTED|Overall Study||121
397759|NCT00952276|950295|P3|STARTED|Overall Study||122
397760|NCT00952276|950296|P2|STARTED|Overall Study||115
397761|NCT00952276|950297|P1|STARTED|Overall Study||127
397762|NCT00952211|950346|P2|NOT COMPLETED|Overall Study||0
397763|NCT00952211|950347|P1|NOT COMPLETED|Overall Study||0
397764|NCT00952211|950346|P2|COMPLETED|Overall Study||0
397765|NCT00952211|950347|P1|COMPLETED|Overall Study||3
397766|NCT00952211|950346|P2|STARTED|Overall Study||0
397767|NCT00952211|950347|P1|STARTED|Overall Study||3
397768|NCT00952133|950357|P2|NOT COMPLETED|Overall Study||0
397769|NCT00952133|950358|P1|NOT COMPLETED|Overall Study||0
397770|NCT00952133|950357|P2|COMPLETED|Overall Study||59
397771|NCT00952133|950358|P1|COMPLETED|Overall Study||59
397772|NCT00952133|950357|P2|STARTED|Overall Study||59
397773|NCT00952133|950358|P1|STARTED|Overall Study||59
397774|NCT00952120|950369|P3|NOT COMPLETED|Overall Study||0
397775|NCT00952120|950370|P2|NOT COMPLETED|Overall Study||0
397776|NCT00952120|950371|P1|NOT COMPLETED|Overall Study||0
397777|NCT00952120|950369|P3|COMPLETED|Overall Study||5
397778|NCT00952120|950370|P2|COMPLETED|Overall Study||47
397779|NCT00952120|950371|P1|COMPLETED|Overall Study||52
397780|NCT00952120|950369|P3|STARTED|Overall Study||5
397781|NCT00952120|950370|P2|STARTED|Overall Study||47
397782|NCT00952120|950371|P1|STARTED|Overall Study||52
397783|NCT00952081|950379|P1|NOT COMPLETED|Overall Study||0
397784|NCT00952081|950379|P1|COMPLETED|Overall Study||22
397785|NCT00952081|950379|P1|STARTED|Overall Study||22
397786|NCT00952068|950383|P1|NOT COMPLETED|Overall Study||7
397787|NCT00952068|950383|P1|COMPLETED|Overall Study||40
397788|NCT00952068|950383|P1|STARTED|Overall Study||47
397789|NCT00951912|950394|P3|NOT COMPLETED|Overall Study||2
397790|NCT00951912|950395|P2|NOT COMPLETED|Overall Study||5
397791|NCT00951912|950396|P1|NOT COMPLETED|Overall Study||7
397792|NCT00951912|950394|P3|COMPLETED|Overall Study||54
397793|NCT00951912|950395|P2|COMPLETED|Overall Study||50
397794|NCT00951912|950396|P1|COMPLETED|Overall Study||47
397795|NCT00951912|950394|P3|STARTED|Overall Study||56
397796|NCT00951912|950395|P2|STARTED|Overall Study||55
397797|NCT00951912|950396|P1|STARTED|Overall Study||54
397798|NCT00951899|950448|P2|NOT COMPLETED|Overall Study||0
397799|NCT00951899|950449|P1|NOT COMPLETED|Overall Study||0
397800|NCT00951899|950448|P2|COMPLETED|Overall Study||19
397801|NCT00951899|950449|P1|COMPLETED|Overall Study||19
397802|NCT00951899|950448|P2|STARTED|Overall Study||19
397803|NCT00951899|950449|P1|STARTED|Overall Study||19
397804|NCT00951821|950473|P2|NOT COMPLETED|Overall Study||0
397805|NCT00951821|950474|P1|NOT COMPLETED|Overall Study||0
397806|NCT00951821|950473|P2|COMPLETED|Overall Study||8
397807|NCT00951821|950474|P1|COMPLETED|Overall Study||16
397808|NCT00951821|950473|P2|STARTED|Overall Study||8
397809|NCT00951821|950474|P1|STARTED|Overall Study||16
397810|NCT00951808|950482|P3|NOT COMPLETED|Overall Study||4
397811|NCT00951808|950483|P2|NOT COMPLETED|Overall Study||0
397812|NCT00951808|950484|P1|NOT COMPLETED|Overall Study||0
397813|NCT00951808|950482|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
397814|NCT00951808|950483|P2|COMPLETED|Overall Study||6
397815|NCT00951808|950484|P1|COMPLETED|Overall Study||4
397816|NCT00951808|950482|P3|STARTED|Overall Study||227
397817|NCT00951808|950483|P2|STARTED|Overall Study||6
397818|NCT00951808|950484|P1|STARTED|Overall Study||4
397819|NCT00951665|950496|P6|NOT COMPLETED|Phase 2a||7
397820|NCT00951665|950497|P5|NOT COMPLETED|Phase 2a||12
397821|NCT00951665|950498|P4|NOT COMPLETED|Phase 2a||0
397822|NCT00951665|950499|P3|NOT COMPLETED|Phase 2a||0
397823|NCT00951665|950500|P2|NOT COMPLETED|Phase 2a||0
397824|NCT00951665|950501|P1|NOT COMPLETED|Phase 2a||0
397825|NCT00951665|950496|P6|COMPLETED|Phase 2a||15
397826|NCT00951665|950497|P5|COMPLETED|Phase 2a||10
397827|NCT00951665|950498|P4|COMPLETED|Phase 2a||0
397828|NCT00951665|950499|P3|COMPLETED|Phase 2a||0
397829|NCT00951665|950500|P2|COMPLETED|Phase 2a||0
397830|NCT00951665|950501|P1|COMPLETED|Phase 2a||0
397831|NCT00951665|950496|P6|STARTED|Phase 2a||22
397832|NCT00951665|950497|P5|STARTED|Phase 2a||22
397833|NCT00951665|950498|P4|STARTED|Phase 2a||0
397834|NCT00951665|950499|P3|STARTED|Phase 2a||0
397835|NCT00951665|950500|P2|STARTED|Phase 2a||0
397836|NCT00951665|950501|P1|STARTED|Phase 2a||0
397837|NCT00951665|950496|P6|NOT COMPLETED|Phase 1b||0
397838|NCT00951665|950497|P5|NOT COMPLETED|Phase 1b||0
397839|NCT00951665|950498|P4|NOT COMPLETED|Phase 1b||1
397840|NCT00951665|950499|P3|NOT COMPLETED|Phase 1b||17
397841|NCT00951665|950500|P2|NOT COMPLETED|Phase 1b||4
397842|NCT00951665|950501|P1|NOT COMPLETED|Phase 1b||22
397843|NCT00951665|950496|P6|COMPLETED|Phase 1b||0
397844|NCT00951665|950497|P5|COMPLETED|Phase 1b||0
397845|NCT00951665|950498|P4|COMPLETED|Phase 1b||2
397846|NCT00951665|950499|P3|COMPLETED|Phase 1b||4
397847|NCT00951665|950500|P2|COMPLETED|Phase 1b||6
397848|NCT00951665|950501|P1|COMPLETED|Phase 1b||7
397849|NCT00951665|950496|P6|Started Treatment|Phase 1b||0
397850|NCT00951665|950497|P5|Started Treatment|Phase 1b||0
397851|NCT00951665|950498|P4|Started Treatment|Phase 1b||3
397852|NCT00951665|950499|P3|Started Treatment|Phase 1b||21
397853|NCT00951665|950500|P2|Started Treatment|Phase 1b||10
397854|NCT00951665|950501|P1|Started Treatment|Phase 1b||26
397855|NCT00951665|950496|P6|STARTED|Phase 1b||0
397856|NCT00951665|950497|P5|STARTED|Phase 1b||0
397857|NCT00951665|950498|P4|STARTED|Phase 1b||3
397858|NCT00951665|950499|P3|STARTED|Phase 1b||21
397859|NCT00951665|950500|P2|STARTED|Phase 1b||10
397860|NCT00951665|950501|P1|STARTED|Phase 1b||29
397861|NCT00951561|950602|P4|NOT COMPLETED|Overall Study||1
397862|NCT00951561|950603|P3|NOT COMPLETED|Overall Study||3
397863|NCT00951561|950604|P2|NOT COMPLETED|Overall Study||0
397864|NCT00951561|950605|P1|NOT COMPLETED|Overall Study||0
397865|NCT00951561|950602|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
397866|NCT00951561|950603|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
397867|NCT00951561|950604|P2|COMPLETED|Overall Study||29
397868|NCT00951561|950605|P1|COMPLETED|Overall Study||25
397869|NCT00951561|950602|P4|STARTED|Overall Study||27
397870|NCT00951561|950603|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
397871|NCT00951561|950604|P2|STARTED|Overall Study||29
397872|NCT00951561|950605|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
397873|NCT00951509|950610|P1|NOT COMPLETED|Overall Study||2
397874|NCT00951509|950610|P1|COMPLETED|Overall Study||29
397875|NCT00951509|950610|P1|Driving Condition 5|Overall Study||30
397876|NCT00951509|950610|P1|Driving Condition 4|Overall Study||28
397877|NCT00951509|950610|P1|Driving Condition 3|Overall Study||25
397878|NCT00951509|950610|P1|Driving Condition 2|Overall Study||29
397879|NCT00951509|950610|P1|Driving Condition 1|Overall Study||29
397880|NCT00951509|950610|P1|STARTED|Overall Study||31
397881|NCT00951483|950620|P2|NOT COMPLETED|Overall Study||0
397882|NCT00951483|950621|P1|NOT COMPLETED|Overall Study||19
397883|NCT00951483|950620|P2|COMPLETED|Overall Study||44
397884|NCT00951483|950621|P1|COMPLETED|Overall Study||28
397885|NCT00951483|950620|P2|STARTED|Overall Study||44
397886|NCT00951483|950621|P1|STARTED|Overall Study||47
397887|NCT00951379|950641|P2|NOT COMPLETED|Overall Study||2
397888|NCT00951379|950642|P1|NOT COMPLETED|Overall Study||6
397889|NCT00951379|950641|P2|COMPLETED|Overall Study||23
397890|NCT00951379|950642|P1|COMPLETED|Overall Study||21
397891|NCT00951379|950641|P2|STARTED|Overall Study||25
397892|NCT00951379|950642|P1|STARTED|Overall Study||27
397893|NCT00951275|950684|P1|NOT COMPLETED|Overall Study||13
397894|NCT00951275|950684|P1|COMPLETED|Overall Study||92
397895|NCT00951275|950684|P1|STARTED|Overall Study||105
397896|NCT00951171|950716|P2|NOT COMPLETED|Overall Study||0
397897|NCT00951171|950717|P1|NOT COMPLETED|Overall Study||2
397898|NCT00951171|950716|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
397899|NCT00951171|950717|P1|COMPLETED|Overall Study||38
397900|NCT00951171|950716|P2|Pregnancy|Overall Study||7
397901|NCT00951171|950717|P1|Pregnancy|Overall Study||1
397902|NCT00951171|950716|P2|STARTED|Overall Study||55
397903|NCT00951171|950717|P1|STARTED|Overall Study||40
397904|NCT00951093|950723|P1|NOT COMPLETED|6 Months After GBP||0
397905|NCT00951093|950723|P1|COMPLETED|6 Months After GBP||53
397906|NCT00951093|950723|P1|STARTED|6 Months After GBP||53
397907|NCT00951093|950723|P1|NOT COMPLETED|Before GBP||0
397908|NCT00951093|950723|P1|COMPLETED|Before GBP||53
397909|NCT00951093|950723|P1|STARTED|Before GBP||53
397910|NCT00951015|950751|P4|NOT COMPLETED|Overall Study||18
397911|NCT00951015|950752|P3|NOT COMPLETED|Overall Study||51
397912|NCT00951015|950753|P2|NOT COMPLETED|Overall Study||51
397913|NCT00951015|950754|P1|NOT COMPLETED|Overall Study||53
397914|NCT00951015|950751|P4|COMPLETED|Overall Study||32
397915|NCT00951015|950752|P3|COMPLETED|Overall Study||0
397916|NCT00951015|950753|P2|COMPLETED|Overall Study||0
397917|NCT00951015|950754|P1|COMPLETED|Overall Study||0
397918|NCT00951015|950751|P4|Ongoing|Overall Study||8
397919|NCT00951015|950752|P3|Ongoing|Overall Study||46
397920|NCT00951015|950753|P2|Ongoing|Overall Study||45
397921|NCT00951015|950754|P1|Ongoing|Overall Study||47
397922|NCT00951015|950751|P4|STARTED|Overall Study||50
397923|NCT00951015|950752|P3|STARTED|Overall Study||51
397924|NCT00951015|950753|P2|STARTED|Overall Study||51
397925|NCT00951015|950754|P1|STARTED|Overall Study||53
397926|NCT00950963|950850|P2|NOT COMPLETED|Overall Study||24
397927|NCT00950963|950851|P1|NOT COMPLETED|Overall Study||29
397928|NCT00950963|950850|P2|COMPLETED|Overall Study||357
397929|NCT00950963|950851|P1|COMPLETED|Overall Study||352
397930|NCT00950963|950850|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
397931|NCT00950963|950851|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
397932|NCT00950937|950867|P2|NOT COMPLETED|Overall Study||0
397933|NCT00950937|950868|P1|NOT COMPLETED|Overall Study||0
397934|NCT00950937|950867|P2|COMPLETED|Overall Study||14
397935|NCT00950937|950868|P1|COMPLETED|Overall Study||14
397936|NCT00950937|950867|P2|STARTED|Overall Study||14
397937|NCT00950937|950868|P1|STARTED|Overall Study||14
397938|NCT00950911|950886|P2|NOT COMPLETED|Overall Study||15
397939|NCT00950911|950887|P1|NOT COMPLETED|Overall Study||12
397940|NCT00950911|950886|P2|COMPLETED|Overall Study||3
397941|NCT00950911|950887|P1|COMPLETED|Overall Study||5
397942|NCT00950911|950886|P2|STARTED|Overall Study||18
397943|NCT00950911|950887|P1|STARTED|Overall Study||17
397944|NCT00950872|950893|P1|NOT COMPLETED|Overall Study||3
397945|NCT00950872|950893|P1|COMPLETED|Overall Study||26
397946|NCT00950872|950893|P1|STARTED|Overall Study||29
397947|NCT00950859|950902|P2|NOT COMPLETED|Overall Study||10
397948|NCT00950859|950903|P1|NOT COMPLETED|Overall Study||16
397949|NCT00950859|950902|P2|COMPLETED|Overall Study||14
397950|NCT00950859|950903|P1|COMPLETED|Overall Study||11
397951|NCT00950859|950902|P2|STARTED|Overall Study||24
397952|NCT00950859|950903|P1|STARTED|Overall Study||27
397953|NCT00950807|950943|P10|NOT COMPLETED|Treatment Period 3||1
397954|NCT00950807|950944|P9|NOT COMPLETED|Treatment Period 3||0
397955|NCT00950807|950945|P8|NOT COMPLETED|Treatment Period 3||1
397956|NCT00950807|950946|P7|NOT COMPLETED|Treatment Period 3||1
397957|NCT00950807|950947|P6|NOT COMPLETED|Treatment Period 3||0
397958|NCT00950807|950948|P5|NOT COMPLETED|Treatment Period 3||0
397959|NCT00950807|950949|P4|NOT COMPLETED|Treatment Period 3||0
397960|NCT00950807|950950|P3|NOT COMPLETED|Treatment Period 3||0
397961|NCT00950807|950951|P2|NOT COMPLETED|Treatment Period 3||0
397962|NCT00950807|950952|P1|NOT COMPLETED|Treatment Period 3||1
397963|NCT00950807|950943|P10|COMPLETED|Treatment Period 3||10
397964|NCT00950807|950944|P9|COMPLETED|Treatment Period 3||9
397965|NCT00950807|950945|P8|COMPLETED|Treatment Period 3||9
397966|NCT00950807|950946|P7|COMPLETED|Treatment Period 3||11
397967|NCT00950807|950947|P6|COMPLETED|Treatment Period 3||9
397968|NCT00950807|950948|P5|COMPLETED|Treatment Period 3||12
397969|NCT00950807|950949|P4|COMPLETED|Treatment Period 3||11
397970|NCT00950807|950950|P3|COMPLETED|Treatment Period 3||10
397971|NCT00950807|950951|P2|COMPLETED|Treatment Period 3||9
397972|NCT00950807|950952|P1|COMPLETED|Treatment Period 3||45
397973|NCT00950807|950943|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
397974|NCT00950807|950944|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
397975|NCT00950807|950945|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
397976|NCT00950807|950946|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
397977|NCT00950807|950947|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
397978|NCT00950807|950948|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
397979|NCT00950807|950949|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
397980|NCT00950807|950950|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
397981|NCT00950807|950951|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
397982|NCT00950807|950952|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
397983|NCT00950807|950943|P10|NOT COMPLETED|Washout Period 2||0
397984|NCT00950807|950944|P9|NOT COMPLETED|Washout Period 2||0
397985|NCT00950807|950945|P8|NOT COMPLETED|Washout Period 2||1
397986|NCT00950807|950946|P7|NOT COMPLETED|Washout Period 2||1
397987|NCT00950807|950947|P6|NOT COMPLETED|Washout Period 2||0
397988|NCT00950807|950948|P5|NOT COMPLETED|Washout Period 2||1
397989|NCT00950807|950949|P4|NOT COMPLETED|Washout Period 2||1
397990|NCT00950807|950950|P3|NOT COMPLETED|Washout Period 2||0
397991|NCT00950807|950951|P2|NOT COMPLETED|Washout Period 2||1
397992|NCT00950807|950952|P1|NOT COMPLETED|Washout Period 2||4
397993|NCT00950807|950943|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
397994|NCT00950807|950944|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
397995|NCT00950807|950945|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
397996|NCT00950807|950946|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
397997|NCT00950807|950947|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
397998|NCT00950807|950948|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
397999|NCT00950807|950949|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
398000|NCT00950807|950950|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
398001|NCT00950807|950951|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
398002|NCT00950807|950952|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
398003|NCT00950807|950943|P10|STARTED|Washout Period 2||11
398004|NCT00950807|950944|P9|STARTED|Washout Period 2||11
398005|NCT00950807|950945|P8|STARTED|Washout Period 2||10
398006|NCT00950807|950946|P7|STARTED|Washout Period 2||9
398007|NCT00950807|950947|P6|STARTED|Washout Period 2||9
398008|NCT00950807|950948|P5|STARTED|Washout Period 2||13
398009|NCT00950807|950949|P4|STARTED|Washout Period 2||12
398010|NCT00950807|950950|P3|STARTED|Washout Period 2||10
398011|NCT00950807|950951|P2|STARTED|Washout Period 2||12
398012|NCT00950807|950952|P1|STARTED|Washout Period 2||51
398013|NCT00950807|950943|P10|NOT COMPLETED|Treatment Period 2||0
398014|NCT00950807|950944|P9|NOT COMPLETED|Treatment Period 2||0
398015|NCT00950807|950945|P8|NOT COMPLETED|Treatment Period 2||3
398016|NCT00950807|950946|P7|NOT COMPLETED|Treatment Period 2||1
398017|NCT00950807|950947|P6|NOT COMPLETED|Treatment Period 2||1
398018|NCT00950807|950948|P5|NOT COMPLETED|Treatment Period 2||0
398019|NCT00950807|950949|P4|NOT COMPLETED|Treatment Period 2||1
398020|NCT00950807|950950|P3|NOT COMPLETED|Treatment Period 2||0
398021|NCT00950807|950951|P2|NOT COMPLETED|Treatment Period 2||1
398022|NCT00950807|950952|P1|NOT COMPLETED|Treatment Period 2||2
398023|NCT00950807|950943|P10|COMPLETED|Treatment Period 2||11
398024|NCT00950807|950944|P9|COMPLETED|Treatment Period 2||11
398025|NCT00950807|950945|P8|COMPLETED|Treatment Period 2||10
398026|NCT00950807|950946|P7|COMPLETED|Treatment Period 2||9
398027|NCT00950807|950947|P6|COMPLETED|Treatment Period 2||9
398028|NCT00950807|950948|P5|COMPLETED|Treatment Period 2||13
398029|NCT00950807|950949|P4|COMPLETED|Treatment Period 2||12
398030|NCT00950807|950950|P3|COMPLETED|Treatment Period 2||10
398031|NCT00950807|950951|P2|COMPLETED|Treatment Period 2||12
398032|NCT00950807|950952|P1|COMPLETED|Treatment Period 2||51
398033|NCT00950807|950943|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
398034|NCT00950807|950944|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
398035|NCT00950807|950945|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
398036|NCT00950807|950946|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
398037|NCT00950807|950947|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
398038|NCT00950807|950948|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
398039|NCT00950807|950949|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
398040|NCT00950807|950950|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
398041|NCT00950807|950951|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
398042|NCT00950807|950952|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
398043|NCT00950807|950943|P10|NOT COMPLETED|Washout Period 1||0
398044|NCT00950807|950944|P9|NOT COMPLETED|Washout Period 1||1
398045|NCT00950807|950945|P8|NOT COMPLETED|Washout Period 1||1
398046|NCT00950807|950946|P7|NOT COMPLETED|Washout Period 1||2
398047|NCT00950807|950947|P6|NOT COMPLETED|Washout Period 1||0
398048|NCT00950807|950948|P5|NOT COMPLETED|Washout Period 1||1
398049|NCT00950807|950949|P4|NOT COMPLETED|Washout Period 1||1
398050|NCT00950807|950950|P3|NOT COMPLETED|Washout Period 1||0
398051|NCT00950807|950951|P2|NOT COMPLETED|Washout Period 1||0
398052|NCT00950807|950952|P1|NOT COMPLETED|Washout Period 1||5
398053|NCT00950807|950943|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
398054|NCT00950807|950944|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
398137|NCT00950664|951049|P2|STARTED|Washout Period of 4 Weeks||48
398055|NCT00950807|950945|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
398056|NCT00950807|950946|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
398057|NCT00950807|950947|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
398058|NCT00950807|950948|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
398059|NCT00950807|950949|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
398060|NCT00950807|950950|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
398061|NCT00950807|950951|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
398062|NCT00950807|950952|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
398063|NCT00950807|950943|P10|STARTED|Washout Period 1||13
398064|NCT00950807|950944|P9|STARTED|Washout Period 1||12
398065|NCT00950807|950945|P8|STARTED|Washout Period 1||14
398066|NCT00950807|950946|P7|STARTED|Washout Period 1||12
398067|NCT00950807|950947|P6|STARTED|Washout Period 1||11
398068|NCT00950807|950948|P5|STARTED|Washout Period 1||12
398069|NCT00950807|950949|P4|STARTED|Washout Period 1||12
398070|NCT00950807|950950|P3|STARTED|Washout Period 1||13
398071|NCT00950807|950951|P2|STARTED|Washout Period 1||13
398072|NCT00950807|950952|P1|STARTED|Washout Period 1||56
398073|NCT00950807|950943|P10|NOT COMPLETED|Treatment Period 1||0
398074|NCT00950807|950944|P9|NOT COMPLETED|Treatment Period 1||1
398075|NCT00950807|950945|P8|NOT COMPLETED|Treatment Period 1||0
398076|NCT00950807|950946|P7|NOT COMPLETED|Treatment Period 1||0
398077|NCT00950807|950947|P6|NOT COMPLETED|Treatment Period 1||2
398078|NCT00950807|950948|P5|NOT COMPLETED|Treatment Period 1||1
398079|NCT00950807|950949|P4|NOT COMPLETED|Treatment Period 1||0
398080|NCT00950807|950950|P3|NOT COMPLETED|Treatment Period 1||1
398081|NCT00950807|950951|P2|NOT COMPLETED|Treatment Period 1||0
398082|NCT00950807|950952|P1|NOT COMPLETED|Treatment Period 1||3
398083|NCT00950807|950943|P10|COMPLETED|Treatment Period 1||13
398084|NCT00950807|950944|P9|COMPLETED|Treatment Period 1||12
398085|NCT00950807|950945|P8|COMPLETED|Treatment Period 1||14
398086|NCT00950807|950946|P7|COMPLETED|Treatment Period 1||12
398087|NCT00950807|950947|P6|COMPLETED|Treatment Period 1||11
398088|NCT00950807|950948|P5|COMPLETED|Treatment Period 1||12
398089|NCT00950807|950949|P4|COMPLETED|Treatment Period 1||12
398090|NCT00950807|950950|P3|COMPLETED|Treatment Period 1||13
398091|NCT00950807|950951|P2|COMPLETED|Treatment Period 1||13
398092|NCT00950807|950952|P1|COMPLETED|Treatment Period 1||56
398093|NCT00950807|950943|P10|STARTED|Treatment Period 1||13
398094|NCT00950807|950944|P9|STARTED|Treatment Period 1||13
398095|NCT00950807|950945|P8|STARTED|Treatment Period 1||14
398096|NCT00950807|950946|P7|STARTED|Treatment Period 1||12
398097|NCT00950807|950947|P6|STARTED|Treatment Period 1||13
398098|NCT00950807|950948|P5|STARTED|Treatment Period 1||13
398099|NCT00950807|950949|P4|STARTED|Treatment Period 1||12
398100|NCT00950807|950950|P3|STARTED|Treatment Period 1||14
398101|NCT00950807|950951|P2|STARTED|Treatment Period 1||13
398102|NCT00950807|950952|P1|STARTED|Treatment Period 1||59
398103|NCT00950755|950994|P1|NOT COMPLETED|Long-Term Follow-Up||9
398104|NCT00950755|950994|P1|COMPLETED|Long-Term Follow-Up||9
398105|NCT00950755|950994|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
398106|NCT00950755|950994|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
398107|NCT00950755|950994|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
398108|NCT00950755|950994|P1|STARTED|Dosimetric and Therapeutic Treatment||41
398109|NCT00950742|951020|P2|NOT COMPLETED|Overall Study||2
398110|NCT00950742|951021|P1|NOT COMPLETED|Overall Study||16
398111|NCT00950742|951020|P2|COMPLETED|Overall Study||0
398112|NCT00950742|951021|P1|COMPLETED|Overall Study||0
398113|NCT00950742|951020|P2|STARTED|Overall Study|entered and treated|2
398114|NCT00950742|951021|P1|STARTED|Overall Study|entered and treated|16
398115|NCT00950729|951037|P1|NOT COMPLETED|Driving With Aircast||0
398116|NCT00950729|951037|P1|COMPLETED|Driving With Aircast||48
398117|NCT00950729|951037|P1|STARTED|Driving With Aircast||48
398118|NCT00950729|951037|P1|NOT COMPLETED|Driving With Plaster Cast||0
398119|NCT00950729|951037|P1|COMPLETED|Driving With Plaster Cast||48
398120|NCT00950729|951037|P1|STARTED|Driving With Plaster Cast||48
398121|NCT00950729|951037|P1|NOT COMPLETED|Driving With Running Shoes||0
398122|NCT00950729|951037|P1|COMPLETED|Driving With Running Shoes|June 2007|48
398123|NCT00950729|951037|P1|STARTED|Driving With Running Shoes|March 2007|48
398124|NCT00950690|951042|P1|NOT COMPLETED|Overall Study||244
398125|NCT00950690|951042|P1|COMPLETED|Overall Study||1105
398126|NCT00950690|951042|P1|STARTED|Overall Study||1349
398127|NCT00950664|951049|P2|NOT COMPLETED|Second Intervention||48
398128|NCT00950664|951050|P1|NOT COMPLETED|Second Intervention||46
398129|NCT00950664|951049|P2|COMPLETED|Second Intervention||0
398130|NCT00950664|951050|P1|COMPLETED|Second Intervention||0
398131|NCT00950664|951049|P2|STARTED|Second Intervention||48
398132|NCT00950664|951050|P1|STARTED|Second Intervention||46
398133|NCT00950664|951049|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
398134|NCT00950664|951050|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
398135|NCT00950664|951049|P2|COMPLETED|Washout Period of 4 Weeks||48
398136|NCT00950664|951050|P1|COMPLETED|Washout Period of 4 Weeks||46
398138|NCT00950664|951050|P1|STARTED|Washout Period of 4 Weeks||46
398139|NCT00950664|951049|P2|NOT COMPLETED|First Intervention||5
398140|NCT00950664|951050|P1|NOT COMPLETED|First Intervention||3
398141|NCT00950664|951049|P2|COMPLETED|First Intervention||48
398142|NCT00950664|951050|P1|COMPLETED|First Intervention||46
398143|NCT00950664|951049|P2|STARTED|First Intervention||53
398144|NCT00950664|951050|P1|STARTED|First Intervention||49
398145|NCT00950651|951070|P2|NOT COMPLETED|Overall Study||35
398146|NCT00950651|951071|P1|NOT COMPLETED|Overall Study||31
398147|NCT00950651|951070|P2|COMPLETED|Overall Study||181
398148|NCT00950651|951071|P1|COMPLETED|Overall Study||184
398149|NCT00950651|951070|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
398150|NCT00950651|951071|P1|STARTED|Overall Study||215
398151|NCT00950612|951119|P2|NOT COMPLETED|Overall Study||0
398152|NCT00950612|951120|P1|NOT COMPLETED|Overall Study||0
398153|NCT00950612|951119|P2|COMPLETED|Overall Study||20
398154|NCT00950612|951120|P1|COMPLETED|Overall Study||40
398155|NCT00950612|951119|P2|STARTED|Overall Study||20
398156|NCT00950612|951120|P1|STARTED|Overall Study||40
398157|NCT00950599|951164|P10|NOT COMPLETED|Follow-Up Period||2
398158|NCT00950599|951165|P9|NOT COMPLETED|Follow-Up Period||13
398159|NCT00950599|951166|P8|NOT COMPLETED|Follow-Up Period||0
398160|NCT00950599|951167|P7|NOT COMPLETED|Follow-Up Period||0
398161|NCT00950599|951168|P6|NOT COMPLETED|Follow-Up Period||0
398162|NCT00950599|951169|P5|NOT COMPLETED|Follow-Up Period||0
398163|NCT00950599|951170|P4|NOT COMPLETED|Follow-Up Period||0
398164|NCT00950599|951171|P3|NOT COMPLETED|Follow-Up Period||0
398165|NCT00950599|951172|P2|NOT COMPLETED|Follow-Up Period||0
398166|NCT00950599|951173|P1|NOT COMPLETED|Follow-Up Period||0
398167|NCT00950599|951164|P10|COMPLETED|Follow-Up Period||78
398168|NCT00950599|951165|P9|COMPLETED|Follow-Up Period||296
398169|NCT00950599|951166|P8|COMPLETED|Follow-Up Period||0
398170|NCT00950599|951167|P7|COMPLETED|Follow-Up Period||0
398171|NCT00950599|951168|P6|COMPLETED|Follow-Up Period||0
398172|NCT00950599|951169|P5|COMPLETED|Follow-Up Period||0
398173|NCT00950599|951170|P4|COMPLETED|Follow-Up Period||0
398174|NCT00950599|951171|P3|COMPLETED|Follow-Up Period||0
398175|NCT00950599|951172|P2|COMPLETED|Follow-Up Period||0
398176|NCT00950599|951173|P1|COMPLETED|Follow-Up Period||0
398177|NCT00950599|951164|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
398178|NCT00950599|951165|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
398179|NCT00950599|951166|P8|STARTED|Follow-Up Period||0
398180|NCT00950599|951167|P7|STARTED|Follow-Up Period||0
398181|NCT00950599|951168|P6|STARTED|Follow-Up Period||0
398182|NCT00950599|951169|P5|STARTED|Follow-Up Period||0
398183|NCT00950599|951170|P4|STARTED|Follow-Up Period||0
398184|NCT00950599|951171|P3|STARTED|Follow-Up Period||0
398185|NCT00950599|951172|P2|STARTED|Follow-Up Period||0
398186|NCT00950599|951173|P1|STARTED|Follow-Up Period||0
398187|NCT00950599|951164|P10|NOT COMPLETED|Double-Blind Treatment Period||0
398188|NCT00950599|951165|P9|NOT COMPLETED|Double-Blind Treatment Period||0
398189|NCT00950599|951166|P8|NOT COMPLETED|Double-Blind Treatment Period||6
398190|NCT00950599|951167|P7|NOT COMPLETED|Double-Blind Treatment Period||0
398191|NCT00950599|951168|P6|NOT COMPLETED|Double-Blind Treatment Period||12
398192|NCT00950599|951169|P5|NOT COMPLETED|Double-Blind Treatment Period||7
398193|NCT00950599|951170|P4|NOT COMPLETED|Double-Blind Treatment Period||11
398194|NCT00950599|951171|P3|NOT COMPLETED|Double-Blind Treatment Period||9
398195|NCT00950599|951172|P2|NOT COMPLETED|Double-Blind Treatment Period||10
398196|NCT00950599|951173|P1|NOT COMPLETED|Double-Blind Treatment Period||7
398197|NCT00950599|951164|P10|COMPLETED|Double-Blind Treatment Period||0
398198|NCT00950599|951165|P9|COMPLETED|Double-Blind Treatment Period||0
398199|NCT00950599|951166|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
398200|NCT00950599|951167|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
398201|NCT00950599|951168|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
398202|NCT00950599|951169|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
398203|NCT00950599|951170|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
398204|NCT00950599|951171|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
398205|NCT00950599|951172|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
398206|NCT00950599|951173|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
398207|NCT00950599|951164|P10|STARTED|Double-Blind Treatment Period||0
398208|NCT00950599|951165|P9|STARTED|Double-Blind Treatment Period||0
398209|NCT00950599|951166|P8|STARTED|Double-Blind Treatment Period||41
398210|NCT00950599|951167|P7|STARTED|Double-Blind Treatment Period||44
398211|NCT00950599|951168|P6|STARTED|Double-Blind Treatment Period||67
398212|NCT00950599|951169|P5|STARTED|Double-Blind Treatment Period||52
398213|NCT00950599|951170|P4|STARTED|Double-Blind Treatment Period||54
398214|NCT00950599|951171|P3|STARTED|Double-Blind Treatment Period||63
398215|NCT00950599|951172|P2|STARTED|Double-Blind Treatment Period||47
398216|NCT00950599|951173|P1|STARTED|Double-Blind Treatment Period||55
398217|NCT00950352|951737|P2|NOT COMPLETED|Overall Study||11
398218|NCT00950352|951738|P1|NOT COMPLETED|Overall Study||42
398219|NCT00950352|951737|P2|COMPLETED|Overall Study||21
398220|NCT00950352|951738|P1|COMPLETED|Overall Study||30
398221|NCT00950352|951737|P2|STARTED|Overall Study||32
398222|NCT00950352|951738|P1|STARTED|Overall Study||72
398223|NCT00950300|951746|P2|NOT COMPLETED|SFU Period||54
398224|NCT00950300|951747|P1|NOT COMPLETED|SFU Period||53
398225|NCT00950300|951746|P2|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
398226|NCT00950300|951747|P1|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
398227|NCT00950300|951746|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|76
398228|NCT00950300|951747|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|75
398229|NCT00950300|951746|P2|NOT COMPLETED|TFFU Period||252
398230|NCT00950300|951747|P1|NOT COMPLETED|TFFU Period||254
398231|NCT00950300|951746|P2|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 7 participants with missing data.|16
398232|NCT00950300|951747|P1|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 3 participants with missing data.|11
398233|NCT00950300|951746|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
398234|NCT00950300|951747|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
398235|NCT00950300|951746|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
398236|NCT00950300|951747|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
398237|NCT00950300|951746|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
398238|NCT00950300|951747|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
398239|NCT00950300|951746|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
398240|NCT00950300|951747|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
398241|NCT00950300|951746|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
398242|NCT00950300|951747|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||278
398243|NCT00950300|951746|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
398244|NCT00950300|951747|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
398245|NCT00950235|951802|P2|NOT COMPLETED|Overall Study||4
398246|NCT00950235|951803|P1|NOT COMPLETED|Overall Study||2
398247|NCT00950235|951802|P2|COMPLETED|Overall Study||54
398248|NCT00950235|951803|P1|COMPLETED|Overall Study||58
398249|NCT00950235|951802|P2|STARTED|Overall Study||58
398250|NCT00950235|951803|P1|STARTED|Overall Study||60
398251|NCT00950183|951813|P1|NOT COMPLETED|Overall Study||36
398252|NCT00950183|951813|P1|COMPLETED|Overall Study||0
398253|NCT00950183|951813|P1|STARTED|Overall Study||36
398254|NCT00949975|951825|P4|NOT COMPLETED|Overall Study||28
398255|NCT00949975|951826|P3|NOT COMPLETED|Overall Study||19
398256|NCT00949975|951827|P2|NOT COMPLETED|Overall Study||29
398257|NCT00949975|951828|P1|NOT COMPLETED|Overall Study||27
398258|NCT00949975|951825|P4|COMPLETED|Overall Study||190
398259|NCT00949975|951826|P3|COMPLETED|Overall Study||183
398260|NCT00949975|951827|P2|COMPLETED|Overall Study||177
398261|NCT00949975|951828|P1|COMPLETED|Overall Study||185
398262|NCT00949975|951825|P4|STARTED|Overall Study||218
398263|NCT00949975|951826|P3|STARTED|Overall Study||202
398264|NCT00949975|951827|P2|STARTED|Overall Study||206
398265|NCT00949975|951828|P1|STARTED|Overall Study||212
398266|NCT00949910|951946|P1|NOT COMPLETED|Overall Study||6576
398267|NCT00949910|951946|P1|COMPLETED|Overall Study||10
398268|NCT00949910|951946|P1|STARTED|Overall Study||6586
398269|NCT00949884|951959|P3|NOT COMPLETED|Overall Study||58
398270|NCT00949884|951960|P2|NOT COMPLETED|Overall Study||15
398271|NCT00949884|951961|P1|NOT COMPLETED|Overall Study||50
398272|NCT00949884|951959|P3|COMPLETED|Overall Study||411
398273|NCT00949884|951960|P2|COMPLETED|Overall Study||37
398274|NCT00949884|951961|P1|COMPLETED|Overall Study||370
398275|NCT00949884|951959|P3|STARTED|Overall Study||469
398276|NCT00949884|951960|P2|STARTED|Overall Study||52
398277|NCT00949884|951961|P1|STARTED|Overall Study||420
398278|NCT00949715|952016|P2|NOT COMPLETED|Overall Study||0
398279|NCT00949715|952017|P1|NOT COMPLETED|Overall Study||4
398280|NCT00949715|952016|P2|COMPLETED|Overall Study||33
398281|NCT00949715|952017|P1|COMPLETED|Overall Study||28
398282|NCT00949715|952016|P2|STARTED|Overall Study||33
398283|NCT00949715|952017|P1|STARTED|Overall Study||32
398284|NCT00949702|952028|P1|NOT COMPLETED|Overall Study||48
398285|NCT00949702|952028|P1|COMPLETED|Overall Study||84
398286|NCT00949702|952028|P1|STARTED|Overall Study||132
398287|NCT00949650|952045|P2|NOT COMPLETED|Overall Study||55
398288|NCT00949650|952046|P1|NOT COMPLETED|Overall Study||165
398289|NCT00949650|952045|P2|COMPLETED|Overall Study|6 courses of chemotherapy completed|60
398290|NCT00949650|952046|P1|COMPLETED|Overall Study|On-treatment at primary endpoint analysis cut-off date (09 February 2012).|65
398291|NCT00949650|952045|P2|STARTED|Overall Study|Randomized patients|115
398292|NCT00949650|952046|P1|STARTED|Overall Study|Randomized patients|230
398293|NCT00949533|952084|P2|NOT COMPLETED|Overall Study||1
398294|NCT00949533|952085|P1|NOT COMPLETED|Overall Study||0
398295|NCT00949533|952084|P2|COMPLETED|Overall Study||17
398296|NCT00949533|952085|P1|COMPLETED|Overall Study||19
398297|NCT00949533|952084|P2|STARTED|Overall Study||18
398298|NCT00949533|952085|P1|STARTED|Overall Study||19
398299|NCT00949117|952099|P2|NOT COMPLETED|Overall Study||5
398300|NCT00949117|952100|P1|NOT COMPLETED|Overall Study||3
398301|NCT00949117|952099|P2|COMPLETED|Overall Study||0
398302|NCT00949117|952100|P1|COMPLETED|Overall Study||1
398303|NCT00949117|952099|P2|STARTED|Overall Study||5
398304|NCT00949117|952100|P1|STARTED|Overall Study||4
398305|NCT00948896|952122|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
398306|NCT00948896|952123|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
398307|NCT00948896|952124|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
398308|NCT00948896|952125|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
398309|NCT00948896|952126|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
398310|NCT00948896|952127|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
398311|NCT00948896|952128|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
398312|NCT00948896|952129|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
398313|NCT00948896|952122|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
398314|NCT00948896|952123|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
398315|NCT00948896|952124|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
398316|NCT00948896|952125|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
398317|NCT00948896|952126|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
398318|NCT00948896|952127|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
398319|NCT00948896|952128|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
398320|NCT00948896|952129|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
398321|NCT00948896|952122|P8|STARTED|24 Months of Age to 36 Months of Age||45
398322|NCT00948896|952123|P7|STARTED|24 Months of Age to 36 Months of Age||43
398323|NCT00948896|952124|P6|STARTED|24 Months of Age to 36 Months of Age||42
398324|NCT00948896|952125|P5|STARTED|24 Months of Age to 36 Months of Age||44
398325|NCT00948896|952126|P4|STARTED|24 Months of Age to 36 Months of Age||87
398326|NCT00948896|952127|P3|STARTED|24 Months of Age to 36 Months of Age||90
398327|NCT00948896|952128|P2|STARTED|24 Months of Age to 36 Months of Age||85
398328|NCT00948896|952129|P1|STARTED|24 Months of Age to 36 Months of Age||90
398329|NCT00948896|952122|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
398330|NCT00948896|952123|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
398331|NCT00948896|952124|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
398332|NCT00948896|952125|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
398333|NCT00948896|952126|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
398334|NCT00948896|952127|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
398335|NCT00948896|952128|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
398336|NCT00948896|952129|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
398337|NCT00948896|952122|P8|COMPLETED|Randomization to 24 Months of Age||45
398338|NCT00948896|952123|P7|COMPLETED|Randomization to 24 Months of Age||43
398339|NCT00948896|952124|P6|COMPLETED|Randomization to 24 Months of Age||42
398340|NCT00948896|952125|P5|COMPLETED|Randomization to 24 Months of Age||44
398341|NCT00948896|952126|P4|COMPLETED|Randomization to 24 Months of Age||87
398342|NCT00948896|952127|P3|COMPLETED|Randomization to 24 Months of Age||90
398343|NCT00948896|952128|P2|COMPLETED|Randomization to 24 Months of Age||85
398344|NCT00948896|952129|P1|COMPLETED|Randomization to 24 Months of Age||90
398345|NCT00948896|952122|P8|STARTED|Randomization to 24 Months of Age||47
398346|NCT00948896|952123|P7|STARTED|Randomization to 24 Months of Age||47
398347|NCT00948896|952124|P6|STARTED|Randomization to 24 Months of Age||46
398348|NCT00948896|952125|P5|STARTED|Randomization to 24 Months of Age||46
398349|NCT00948896|952126|P4|STARTED|Randomization to 24 Months of Age||98
398350|NCT00948896|952127|P3|STARTED|Randomization to 24 Months of Age||99
398351|NCT00948896|952128|P2|STARTED|Randomization to 24 Months of Age||98
398352|NCT00948896|952129|P1|STARTED|Randomization to 24 Months of Age||98
398353|NCT00948857|952165|P2|NOT COMPLETED|Overall Study||0
398354|NCT00948857|952166|P1|NOT COMPLETED|Overall Study||1
398355|NCT00948857|952165|P2|COMPLETED|Overall Study||2
398356|NCT00948857|952166|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
398357|NCT00948857|952165|P2|STARTED|Overall Study||2
398358|NCT00948857|952166|P1|STARTED|Overall Study||3
398359|NCT00948818|952174|P2|NOT COMPLETED|Overall Study||94
398360|NCT00948818|952175|P1|NOT COMPLETED|Overall Study||62
398361|NCT00948818|952174|P2|COMPLETED|Overall Study||312
398362|NCT00948818|952175|P1|COMPLETED|Overall Study||335
398363|NCT00948818|952174|P2|STARTED|Overall Study||406
398364|NCT00948818|952175|P1|STARTED|Overall Study||397
398365|NCT00948792|952210|P1|NOT COMPLETED|Overall Study||0
398366|NCT00948792|952210|P1|COMPLETED|Overall Study||21
398367|NCT00948792|952210|P1|STARTED|Overall Study||21
398368|NCT00948766|952222|P2|NOT COMPLETED|Extension Study||0
398369|NCT00948766|952223|P1|NOT COMPLETED|Extension Study||91
398370|NCT00948766|952222|P2|COMPLETED|Extension Study||0
398371|NCT00948766|952223|P1|COMPLETED|Extension Study||306
398372|NCT00948766|952222|P2|Exposed to Study Medication|Extension Study||0
398373|NCT00948766|952223|P1|Exposed to Study Medication|Extension Study||396
398374|NCT00948766|952222|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
398375|NCT00948766|952223|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
398376|NCT00948766|952222|P2|NOT COMPLETED|Core Study||126
398377|NCT00948766|952223|P1|NOT COMPLETED|Core Study||127
398378|NCT00948766|952222|P2|COMPLETED|Core Study||234
398379|NCT00948766|952223|P1|COMPLETED|Core Study||229
398380|NCT00948766|952222|P2|Exposed to Study Medication|Core Study||359
398381|NCT00948766|952223|P1|Exposed to Study Medication|Core Study||355
398382|NCT00948766|952222|P2|STARTED|Core Study||360
398383|NCT00948766|952223|P1|STARTED|Core Study||356
398384|NCT00948688|952239|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
398385|NCT00948688|952240|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
398386|NCT00948688|952239|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
398387|NCT00948688|952240|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
398388|NCT00948688|952239|P2|STARTED|Period 2: 100 mg Vorinostat||6
398389|NCT00948688|952240|P1|STARTED|Period 2: 100 mg Vorinostat||0
398390|NCT00948688|952239|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
398391|NCT00948688|952240|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
398392|NCT00948688|952239|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
398393|NCT00948688|952240|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
398394|NCT00948688|952239|P2|STARTED|Period 1: 200 mg Vorinostat||0
398395|NCT00948688|952240|P1|STARTED|Period 1: 200 mg Vorinostat||4
398396|NCT00948675|952254|P2|NOT COMPLETED|Overall Study||4
398397|NCT00948675|952255|P1|NOT COMPLETED|Overall Study||7
398398|NCT00948675|952254|P2|COMPLETED|Overall Study||175
398399|NCT00948675|952255|P1|COMPLETED|Overall Study||175
398400|NCT00948675|952254|P2|STARTED|Overall Study||179
398401|NCT00948675|952255|P1|STARTED|Overall Study||182
398402|NCT00948506|952271|P2|NOT COMPLETED|Overall Study||1
398403|NCT00948506|952272|P1|NOT COMPLETED|Overall Study||3
398404|NCT00948506|952271|P2|COMPLETED|Overall Study||8
398405|NCT00948506|952272|P1|COMPLETED|Overall Study||8
398406|NCT00948506|952271|P2|STARTED|Overall Study||9
398407|NCT00948506|952272|P1|STARTED|Overall Study||11
398408|NCT00948441|952283|P2|NOT COMPLETED|Overall Study||4
398409|NCT00948441|952284|P1|NOT COMPLETED|Overall Study||1
398410|NCT00948441|952283|P2|COMPLETED|Overall Study||4
398411|NCT00948441|952284|P1|COMPLETED|Overall Study||7
398412|NCT00948441|952283|P2|STARTED|Overall Study||8
398413|NCT00948441|952284|P1|STARTED|Overall Study||8
398414|NCT00948389|952297|P5|NOT COMPLETED|Overall Study||1
398415|NCT00948389|952298|P4|NOT COMPLETED|Overall Study||9
398416|NCT00948389|952299|P3|NOT COMPLETED|Overall Study||7
398417|NCT00948389|952300|P2|NOT COMPLETED|Overall Study||3
398418|NCT00948389|952301|P1|NOT COMPLETED|Overall Study||6
398419|NCT00948389|952297|P5|COMPLETED|Overall Study||0
398420|NCT00948389|952298|P4|COMPLETED|Overall Study||0
398421|NCT00948389|952299|P3|COMPLETED|Overall Study||0
398422|NCT00948389|952300|P2|COMPLETED|Overall Study||0
398423|NCT00948389|952301|P1|COMPLETED|Overall Study||0
398424|NCT00948389|952297|P5|STARTED|Overall Study||1
398425|NCT00948389|952298|P4|STARTED|Overall Study||9
398426|NCT00948389|952299|P3|STARTED|Overall Study||7
398427|NCT00948389|952300|P2|STARTED|Overall Study||3
398428|NCT00948389|952301|P1|STARTED|Overall Study||6
398429|NCT00948246|952338|P1|NOT COMPLETED|Overall Study||24
398430|NCT00948246|952338|P1|COMPLETED|Overall Study||86
398431|NCT00948246|952338|P1|STARTED|Overall Study||110
398432|NCT00948155|952347|P2|NOT COMPLETED|Second Intervention 21 Days||3
398433|NCT00948155|952348|P1|NOT COMPLETED|Second Intervention 21 Days||2
398434|NCT00948155|952347|P2|COMPLETED|Second Intervention 21 Days||8
398435|NCT00948155|952348|P1|COMPLETED|Second Intervention 21 Days||9
398436|NCT00948155|952347|P2|STARTED|Second Intervention 21 Days||11
398437|NCT00948155|952348|P1|STARTED|Second Intervention 21 Days||11
398438|NCT00948155|952347|P2|NOT COMPLETED|Washout 14 Days||2
398439|NCT00948155|952348|P1|NOT COMPLETED|Washout 14 Days||1
398440|NCT00948155|952347|P2|COMPLETED|Washout 14 Days||11
398441|NCT00948155|952348|P1|COMPLETED|Washout 14 Days||11
398442|NCT00948155|952347|P2|STARTED|Washout 14 Days||13
398443|NCT00948155|952348|P1|STARTED|Washout 14 Days||12
398444|NCT00948155|952347|P2|NOT COMPLETED|First Intervention 21 Days||2
398445|NCT00948155|952348|P1|NOT COMPLETED|First Intervention 21 Days||2
398446|NCT00948155|952347|P2|COMPLETED|First Intervention 21 Days||13
398447|NCT00948155|952348|P1|COMPLETED|First Intervention 21 Days||12
398448|NCT00948155|952347|P2|STARTED|First Intervention 21 Days||15
398449|NCT00948155|952348|P1|STARTED|First Intervention 21 Days||14
398450|NCT00948090|952370|P4|NOT COMPLETED|Overall Study||11
398451|NCT00948090|952371|P3|NOT COMPLETED|Overall Study||56
398452|NCT00948090|952372|P2|NOT COMPLETED|Overall Study||1
398453|NCT00948090|952373|P1|NOT COMPLETED|Overall Study||43
398454|NCT00948090|952370|P4|COMPLETED|Overall Study||7
398455|NCT00948090|952371|P3|COMPLETED|Overall Study||67
398456|NCT00948090|952372|P2|COMPLETED|Overall Study||0
398457|NCT00948090|952373|P1|COMPLETED|Overall Study||22
398458|NCT00948090|952370|P4|STARTED|Overall Study||18
398459|NCT00948090|952371|P3|STARTED|Overall Study||123
398460|NCT00948090|952372|P2|STARTED|Overall Study||1
398461|NCT00948090|952373|P1|STARTED|Overall Study||65
398462|NCT00948064|952395|P3|NOT COMPLETED|Phase II||1
398463|NCT00948064|952396|P2|NOT COMPLETED|Phase II||1
398464|NCT00948064|952397|P1|NOT COMPLETED|Phase II||0
398465|NCT00948064|952395|P3|COMPLETED|Phase II||26
398466|NCT00948064|952396|P2|COMPLETED|Phase II||51
398467|NCT00948064|952397|P1|COMPLETED|Phase II||0
398468|NCT00948064|952395|P3|STARTED|Phase II||27
398469|NCT00948064|952396|P2|STARTED|Phase II||52
398470|NCT00948064|952397|P1|STARTED|Phase II||0
398471|NCT00948064|952395|P3|NOT COMPLETED|Phase I||0
398472|NCT00948064|952396|P2|NOT COMPLETED|Phase I||0
398473|NCT00948064|952397|P1|NOT COMPLETED|Phase I||1
398474|NCT00948064|952395|P3|COMPLETED|Phase I||0
398475|NCT00948064|952396|P2|COMPLETED|Phase I||0
398476|NCT00948064|952397|P1|COMPLETED|Phase I||30
398477|NCT00948064|952395|P3|STARTED|Phase I||0
398478|NCT00948064|952396|P2|STARTED|Phase I||0
398479|NCT00948064|952397|P1|STARTED|Phase I||31
398480|NCT00947882|952412|P4|NOT COMPLETED|Overall Study||82
398481|NCT00947882|952413|P3|NOT COMPLETED|Overall Study||79
398482|NCT00947882|952414|P2|NOT COMPLETED|Overall Study||77
398483|NCT00947882|952415|P1|NOT COMPLETED|Overall Study||74
398484|NCT00947882|952412|P4|COMPLETED|Overall Study||20
398485|NCT00947882|952413|P3|COMPLETED|Overall Study||22
398486|NCT00947882|952414|P2|COMPLETED|Overall Study||24
398487|NCT00947882|952415|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
398488|NCT00947882|952412|P4|Visit 12, Month 6|Overall Study||95
398489|NCT00947882|952413|P3|Visit 12, Month 6|Overall Study||90
398490|NCT00947882|952414|P2|Visit 12, Month 6|Overall Study||91
398491|NCT00947882|952415|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
398492|NCT00947882|952412|P4|Safety Analysis Set|Overall Study||105
398493|NCT00947882|952413|P3|Safety Analysis Set|Overall Study||100
398494|NCT00947882|952414|P2|Safety Analysis Set|Overall Study||101
398495|NCT00947882|952415|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
398496|NCT00947882|952412|P4|Actual Treatment|Overall Study||105
398497|NCT00947882|952413|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
398498|NCT00947882|952414|P2|Actual Treatment|Overall Study||101
398499|NCT00947882|952415|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
398500|NCT00947882|952412|P4|Full Analysis Set (FAS)|Overall Study||102
398501|NCT00947882|952413|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
398502|NCT00947882|952414|P2|Full Analysis Set (FAS)|Overall Study||101
398503|NCT00947882|952415|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
398504|NCT00947882|952412|P4|STARTED|Overall Study||102
398505|NCT00947882|952413|P3|STARTED|Overall Study||101
398506|NCT00947882|952414|P2|STARTED|Overall Study||101
398507|NCT00947882|952415|P1|STARTED|Overall Study|Started: Randomised.|100
398508|NCT00947856|952443|P2|NOT COMPLETED|Follow-up Period||23
398509|NCT00947856|952444|P1|NOT COMPLETED|Follow-up Period||51
398510|NCT00947856|952443|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
398511|NCT00947856|952444|P1|COMPLETED|Follow-up Period||27
398512|NCT00947856|952443|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
398513|NCT00947856|952444|P1|STARTED|Follow-up Period||78
398514|NCT00947856|952443|P2|NOT COMPLETED|Treatment Period||32
398515|NCT00947856|952444|P1|NOT COMPLETED|Treatment Period||78
398516|NCT00947856|952443|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
398517|NCT00947856|952444|P1|COMPLETED|Treatment Period||0
398518|NCT00947856|952443|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
398519|NCT00947856|952444|P1|STARTED|Treatment Period||78
398520|NCT00947791|952473|P2|NOT COMPLETED|Overall Study||0
398521|NCT00947791|952474|P1|NOT COMPLETED|Overall Study||0
398522|NCT00947791|952473|P2|COMPLETED|Overall Study||1
398523|NCT00947791|952474|P1|COMPLETED|Overall Study||0
398524|NCT00947791|952473|P2|STARTED|Overall Study||1
398525|NCT00947791|952474|P1|STARTED|Overall Study||0
398526|NCT00947765|952492|P2|NOT COMPLETED|Overall Study||0
398527|NCT00947765|952493|P1|NOT COMPLETED|Overall Study||0
398528|NCT00947765|952492|P2|COMPLETED|Overall Study||30
398529|NCT00947765|952493|P1|COMPLETED|Overall Study||30
398530|NCT00947765|952492|P2|STARTED|Overall Study||30
398531|NCT00947765|952493|P1|STARTED|Overall Study||30
398532|NCT00947752|952515|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
398533|NCT00947752|952516|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
398534|NCT00947752|952515|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
398535|NCT00947752|952516|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
398536|NCT00947752|952515|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
398537|NCT00947752|952516|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
398538|NCT00947752|952515|P2|NOT COMPLETED|1st 14-day Treatment Period||0
398539|NCT00947752|952516|P1|NOT COMPLETED|1st 14-day Treatment Period||0
398540|NCT00947752|952515|P2|COMPLETED|1st 14-day Treatment Period||71
398541|NCT00947752|952516|P1|COMPLETED|1st 14-day Treatment Period||76
398542|NCT00947752|952515|P2|STARTED|1st 14-day Treatment Period||71
398543|NCT00947752|952516|P1|STARTED|1st 14-day Treatment Period||76
398544|NCT00947752|952515|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
398545|NCT00947752|952516|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
398546|NCT00947752|952515|P2|COMPLETED|7-Day Run-in Treatment Period||0
398547|NCT00947752|952516|P1|COMPLETED|7-Day Run-in Treatment Period||147
398548|NCT00947752|952515|P2|STARTED|7-Day Run-in Treatment Period||0
398549|NCT00947752|952516|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
398550|NCT00947661|952526|P2|NOT COMPLETED|Overall Study||15
398551|NCT00947661|952527|P1|NOT COMPLETED|Overall Study||13
398552|NCT00947661|952526|P2|COMPLETED|Overall Study||274
398553|NCT00947661|952527|P1|COMPLETED|Overall Study||276
398554|NCT00947661|952526|P2|STARTED|Overall Study||289
398555|NCT00947661|952527|P1|STARTED|Overall Study||289
398556|NCT00947544|952533|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
398557|NCT00947544|952534|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
398558|NCT00947544|952533|P2|COMPLETED|Safety-Extension Period (12 Months)||6
398559|NCT00947544|952534|P1|COMPLETED|Safety-Extension Period (12 Months)||10
398560|NCT00947544|952533|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
398561|NCT00947544|952534|P1|STARTED|Safety-Extension Period (12 Months)||11
398562|NCT00947544|952533|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
398563|NCT00947544|952534|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
398564|NCT00947544|952533|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
398565|NCT00947544|952534|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
398566|NCT00947544|952533|P2|STARTED|Switch-Over Period (2 Weeks)||0
398567|NCT00947544|952534|P1|STARTED|Switch-Over Period (2 Weeks)||11
398568|NCT00947531|952560|P2|NOT COMPLETED|Overall Study||11
398569|NCT00947531|952561|P1|NOT COMPLETED|Overall Study||14
398570|NCT00947531|952560|P2|COMPLETED|Overall Study||110
398571|NCT00947531|952561|P1|COMPLETED|Overall Study||107
398572|NCT00947531|952560|P2|STARTED|Overall Study||121
398573|NCT00947531|952561|P1|STARTED|Overall Study||121
398574|NCT00947518|952570|P3|NOT COMPLETED|Overall Study||0
398575|NCT00947518|952571|P2|NOT COMPLETED|Overall Study||0
398576|NCT00947518|952572|P1|NOT COMPLETED|Overall Study||0
398577|NCT00947518|952570|P3|COMPLETED|Overall Study||20
398578|NCT00947518|952571|P2|COMPLETED|Overall Study||20
398579|NCT00947518|952572|P1|COMPLETED|Overall Study||20
398580|NCT00947518|952570|P3|STARTED|Overall Study||20
398581|NCT00947518|952571|P2|STARTED|Overall Study||20
398582|NCT00947518|952572|P1|STARTED|Overall Study||20
398583|NCT00947505|952585|P2|NOT COMPLETED|Overall Study||2
398584|NCT00947505|952586|P1|NOT COMPLETED|Overall Study||9
398585|NCT00947505|952585|P2|COMPLETED|Overall Study||14
398586|NCT00947505|952586|P1|COMPLETED|Overall Study||24
398587|NCT00947505|952585|P2|STARTED|Overall Study||16
398588|NCT00947505|952586|P1|STARTED|Overall Study||33
398589|NCT00947427|952594|P2|NOT COMPLETED|Overall Study||4
398590|NCT00947427|952595|P1|NOT COMPLETED|Overall Study||1
398591|NCT00947427|952594|P2|COMPLETED|Overall Study||45
398592|NCT00947427|952595|P1|COMPLETED|Overall Study||21
398593|NCT00947427|952594|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
398594|NCT00947427|952595|P1|STARTED|Overall Study||22
398595|NCT00947349|952605|P4|NOT COMPLETED|Overall Study Standard of Care||2
398596|NCT00947349|952606|P3|NOT COMPLETED|Overall Study Standard of Care||2
398597|NCT00947349|952607|P2|NOT COMPLETED|Overall Study Standard of Care||0
398598|NCT00947349|952608|P1|NOT COMPLETED|Overall Study Standard of Care||0
398599|NCT00947349|952605|P4|COMPLETED|Overall Study Standard of Care||4
398600|NCT00947349|952606|P3|COMPLETED|Overall Study Standard of Care||4
398601|NCT00947349|952607|P2|COMPLETED|Overall Study Standard of Care||5
398602|NCT00947349|952608|P1|COMPLETED|Overall Study Standard of Care||4
398603|NCT00947349|952605|P4|STARTED|Overall Study Standard of Care||6
398604|NCT00947349|952606|P3|STARTED|Overall Study Standard of Care||6
398605|NCT00947349|952607|P2|STARTED|Overall Study Standard of Care||5
398606|NCT00947349|952608|P1|STARTED|Overall Study Standard of Care||4
398607|NCT00947349|952605|P4|NOT COMPLETED|Triple Treatment Combination Period||0
398608|NCT00947349|952606|P3|NOT COMPLETED|Triple Treatment Combination Period||0
398609|NCT00947349|952607|P2|NOT COMPLETED|Triple Treatment Combination Period||1
398610|NCT00947349|952608|P1|NOT COMPLETED|Triple Treatment Combination Period||0
398611|NCT00947349|952605|P4|COMPLETED|Triple Treatment Combination Period||6
398612|NCT00947349|952606|P3|COMPLETED|Triple Treatment Combination Period||6
398613|NCT00947349|952607|P2|COMPLETED|Triple Treatment Combination Period||5
398614|NCT00947349|952608|P1|COMPLETED|Triple Treatment Combination Period||4
398615|NCT00947349|952605|P4|STARTED|Triple Treatment Combination Period||6
398616|NCT00947349|952606|P3|STARTED|Triple Treatment Combination Period||6
398617|NCT00947349|952607|P2|STARTED|Triple Treatment Combination Period||6
398618|NCT00947349|952608|P1|STARTED|Triple Treatment Combination Period||4
398619|NCT00947310|952743|P3|NOT COMPLETED|Overall Study||0
398620|NCT00947310|952744|P2|NOT COMPLETED|Overall Study||0
398621|NCT00947310|952745|P1|NOT COMPLETED|Overall Study||0
398622|NCT00947310|952743|P3|COMPLETED|Overall Study||486
398623|NCT00947310|952744|P2|COMPLETED|Overall Study||500
398624|NCT00947310|952745|P1|COMPLETED|Overall Study||514
398625|NCT00947310|952743|P3|STARTED|Overall Study||486
398626|NCT00947310|952744|P2|STARTED|Overall Study||500
398627|NCT00947310|952745|P1|STARTED|Overall Study||514
398628|NCT00947297|952759|P1|NOT COMPLETED|Overall Study||7
398629|NCT00947297|952759|P1|COMPLETED|Overall Study||53
398630|NCT00947297|952759|P1|STARTED|Overall Study||60
398631|NCT00947284|952766|P2|NOT COMPLETED|Overall Study||3
398632|NCT00947284|952767|P1|NOT COMPLETED|Overall Study||0
398633|NCT00947284|952766|P2|COMPLETED|Overall Study||0
398634|NCT00947284|952767|P1|COMPLETED|Overall Study||0
398635|NCT00947284|952766|P2|STARTED|Overall Study||3
398636|NCT00947284|952767|P1|STARTED|Overall Study||0
398637|NCT00947271|952775|P4|NOT COMPLETED|12 Months Post Intervention||62
398638|NCT00947271|952776|P3|NOT COMPLETED|12 Months Post Intervention||59
398639|NCT00947271|952777|P2|NOT COMPLETED|12 Months Post Intervention||60
398640|NCT00947271|952778|P1|NOT COMPLETED|12 Months Post Intervention||71
398641|NCT00947271|952775|P4|COMPLETED|12 Months Post Intervention||188
398642|NCT00947271|952776|P3|COMPLETED|12 Months Post Intervention||195
398643|NCT00947271|952777|P2|COMPLETED|12 Months Post Intervention||192
398644|NCT00947271|952778|P1|COMPLETED|12 Months Post Intervention||183
398645|NCT00947271|952775|P4|STARTED|12 Months Post Intervention||250
398646|NCT00947271|952776|P3|STARTED|12 Months Post Intervention||254
398647|NCT00947271|952777|P2|STARTED|12 Months Post Intervention||252
398648|NCT00947271|952778|P1|STARTED|12 Months Post Intervention||254
398649|NCT00947271|952775|P4|NOT COMPLETED|9 Months Post Intervention||59
398650|NCT00947271|952776|P3|NOT COMPLETED|9 Months Post Intervention||61
398651|NCT00947271|952777|P2|NOT COMPLETED|9 Months Post Intervention||60
398652|NCT00947271|952778|P1|NOT COMPLETED|9 Months Post Intervention||70
398653|NCT00947271|952775|P4|COMPLETED|9 Months Post Intervention||191
398654|NCT00947271|952776|P3|COMPLETED|9 Months Post Intervention||193
398655|NCT00947271|952777|P2|COMPLETED|9 Months Post Intervention||192
398656|NCT00947271|952778|P1|COMPLETED|9 Months Post Intervention||184
398657|NCT00947271|952775|P4|STARTED|9 Months Post Intervention||250
398658|NCT00947271|952776|P3|STARTED|9 Months Post Intervention||254
398659|NCT00947271|952777|P2|STARTED|9 Months Post Intervention||252
398660|NCT00947271|952778|P1|STARTED|9 Months Post Intervention||254
398661|NCT00947271|952775|P4|NOT COMPLETED|6 Months Post Intervention||54
398662|NCT00947271|952776|P3|NOT COMPLETED|6 Months Post Intervention||58
398663|NCT00947271|952777|P2|NOT COMPLETED|6 Months Post Intervention||53
398664|NCT00947271|952778|P1|NOT COMPLETED|6 Months Post Intervention||55
398665|NCT00947271|952775|P4|COMPLETED|6 Months Post Intervention||196
398666|NCT00947271|952776|P3|COMPLETED|6 Months Post Intervention||196
398667|NCT00947271|952777|P2|COMPLETED|6 Months Post Intervention||199
398668|NCT00947271|952778|P1|COMPLETED|6 Months Post Intervention||199
398669|NCT00947271|952775|P4|STARTED|6 Months Post Intervention||250
398670|NCT00947271|952776|P3|STARTED|6 Months Post Intervention||254
398671|NCT00947271|952777|P2|STARTED|6 Months Post Intervention||252
398672|NCT00947271|952778|P1|STARTED|6 Months Post Intervention||254
398673|NCT00947271|952775|P4|NOT COMPLETED|3 Months Post Intervention||44
398674|NCT00947271|952776|P3|NOT COMPLETED|3 Months Post Intervention||36
398675|NCT00947271|952777|P2|NOT COMPLETED|3 Months Post Intervention||48
398676|NCT00947271|952778|P1|NOT COMPLETED|3 Months Post Intervention||52
398677|NCT00947271|952775|P4|COMPLETED|3 Months Post Intervention||206
398678|NCT00947271|952776|P3|COMPLETED|3 Months Post Intervention||218
398679|NCT00947271|952777|P2|COMPLETED|3 Months Post Intervention||204
398680|NCT00947271|952778|P1|COMPLETED|3 Months Post Intervention||202
398681|NCT00947271|952775|P4|STARTED|3 Months Post Intervention||250
398682|NCT00947271|952776|P3|STARTED|3 Months Post Intervention||254
398683|NCT00947271|952777|P2|STARTED|3 Months Post Intervention||252
398684|NCT00947271|952778|P1|STARTED|3 Months Post Intervention||254
398685|NCT00947219|952807|P3|NOT COMPLETED|Overall Study||4
398686|NCT00947219|952808|P2|NOT COMPLETED|Overall Study||4
398687|NCT00947219|952809|P1|NOT COMPLETED|Overall Study||6
398688|NCT00947219|952807|P3|COMPLETED|Overall Study||22
398689|NCT00947219|952808|P2|COMPLETED|Overall Study||21
398690|NCT00947219|952809|P1|COMPLETED|Overall Study||22
398691|NCT00947219|952807|P3|STARTED|Overall Study||26
398692|NCT00947219|952808|P2|STARTED|Overall Study||25
398693|NCT00947219|952809|P1|STARTED|Overall Study||28
398694|NCT00947167|952817|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
398695|NCT00947167|952817|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
398696|NCT00947167|952817|P1|STARTED|Erlotinib Added to Pertuzumab||3
398697|NCT00947167|952817|P1|NOT COMPLETED|Pertuzumab Alone||0
398698|NCT00947167|952817|P1|COMPLETED|Pertuzumab Alone||4
398699|NCT00947167|952817|P1|STARTED|Pertuzumab Alone||4
398700|NCT00947154|952822|P1|NOT COMPLETED|Overall Study||1
398701|NCT00947154|952822|P1|COMPLETED|Overall Study||11
398702|NCT00947154|952822|P1|STARTED|Overall Study||12
398703|NCT00947115|952832|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
398704|NCT00947115|952833|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
398705|NCT00947115|952834|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
398706|NCT00947115|952832|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
398707|NCT00947115|952833|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
398708|NCT00947115|952834|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
398709|NCT00947115|952832|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
398710|NCT00947115|952833|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
398711|NCT00947115|952834|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
398712|NCT00947115|952832|P3|NOT COMPLETED|Year 10 (Month 120)||0
398713|NCT00947115|952833|P2|NOT COMPLETED|Year 10 (Month 120)||0
398714|NCT00947115|952834|P1|NOT COMPLETED|Year 10 (Month 120)||0
398715|NCT00947115|952832|P3|COMPLETED|Year 10 (Month 120)||156
398716|NCT00947115|952833|P2|COMPLETED|Year 10 (Month 120)||172
398717|NCT00947115|952834|P1|COMPLETED|Year 10 (Month 120)||142
398718|NCT00947115|952832|P3|STARTED|Year 10 (Month 120)||156
398719|NCT00947115|952833|P2|STARTED|Year 10 (Month 120)||172
398720|NCT00947115|952834|P1|STARTED|Year 10 (Month 120)||142
398721|NCT00947115|952832|P3|NOT COMPLETED|Year 9 (Month 108)||0
398722|NCT00947115|952833|P2|NOT COMPLETED|Year 9 (Month 108)||0
398723|NCT00947115|952834|P1|NOT COMPLETED|Year 9 (Month 108)||0
398724|NCT00947115|952832|P3|COMPLETED|Year 9 (Month 108)||157
398725|NCT00947115|952833|P2|COMPLETED|Year 9 (Month 108)||180
398726|NCT00947115|952834|P1|COMPLETED|Year 9 (Month 108)||146
398727|NCT00947115|952832|P3|STARTED|Year 9 (Month 108)||157
398728|NCT00947115|952833|P2|STARTED|Year 9 (Month 108)||180
398729|NCT00947115|952834|P1|STARTED|Year 9 (Month 108)||146
398730|NCT00947115|952832|P3|NOT COMPLETED|Year 8 (Month 96)||0
398731|NCT00947115|952833|P2|NOT COMPLETED|Year 8 (Month 96)||0
398732|NCT00947115|952834|P1|NOT COMPLETED|Year 8 (Month 96)||0
398733|NCT00947115|952832|P3|COMPLETED|Year 8 (Month 96)||141
398734|NCT00947115|952833|P2|COMPLETED|Year 8 (Month 96)||152
398735|NCT00947115|952834|P1|COMPLETED|Year 8 (Month 96)||137
398736|NCT00947115|952832|P3|STARTED|Year 8 (Month 96)||141
398737|NCT00947115|952833|P2|STARTED|Year 8 (Month 96)||152
398738|NCT00947115|952834|P1|STARTED|Year 8 (Month 96)||137
398739|NCT00947115|952832|P3|NOT COMPLETED|Year 7 (Month 84)||0
398740|NCT00947115|952833|P2|NOT COMPLETED|Year 7 (Month 84)||0
398741|NCT00947115|952834|P1|NOT COMPLETED|Year 7 (Month 84)||0
398742|NCT00947115|952832|P3|COMPLETED|Year 7 (Month 84)||160
398743|NCT00947115|952833|P2|COMPLETED|Year 7 (Month 84)||165
398744|NCT00947115|952834|P1|COMPLETED|Year 7 (Month 84)||149
398745|NCT00947115|952832|P3|STARTED|Year 7 (Month 84)||160
398746|NCT00947115|952833|P2|STARTED|Year 7 (Month 84)||165
398747|NCT00947115|952834|P1|STARTED|Year 7 (Month 84)||149
398748|NCT00947115|952832|P3|NOT COMPLETED|Year 6 (Month 72)||0
398749|NCT00947115|952833|P2|NOT COMPLETED|Year 6 (Month 72)||0
398750|NCT00947115|952834|P1|NOT COMPLETED|Year 6 (Month 72)||0
398751|NCT00947115|952832|P3|COMPLETED|Year 6 (Month 72)||164
398752|NCT00947115|952833|P2|COMPLETED|Year 6 (Month 72)||177
398753|NCT00947115|952834|P1|COMPLETED|Year 6 (Month 72)||147
398754|NCT00947115|952832|P3|STARTED|Year 6 (Month 72)||164
398755|NCT00947115|952833|P2|STARTED|Year 6 (Month 72)||177
398756|NCT00947115|952834|P1|STARTED|Year 6 (Month 72)||147
398757|NCT00947115|952832|P3|NOT COMPLETED|Year 5 (Month 60)||0
398758|NCT00947115|952833|P2|NOT COMPLETED|Year 5 (Month 60)||0
398759|NCT00947115|952834|P1|NOT COMPLETED|Year 5 (Month 60)||0
398760|NCT00947115|952832|P3|COMPLETED|Year 5 (Month 60)||170
398761|NCT00947115|952833|P2|COMPLETED|Year 5 (Month 60)||184
398762|NCT00947115|952834|P1|COMPLETED|Year 5 (Month 60)||153
398763|NCT00947115|952832|P3|STARTED|Year 5 (Month 60)||170
398764|NCT00947115|952833|P2|STARTED|Year 5 (Month 60)||184
398765|NCT00947115|952834|P1|STARTED|Year 5 (Month 60)||153
398766|NCT00946985|952896|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
398767|NCT00946985|952896|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
398768|NCT00946985|952896|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
398769|NCT00946985|952896|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
398770|NCT00946985|952896|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
398771|NCT00946985|952896|P1|STARTED|Stabilization Phase (25 Weeks)||162
398772|NCT00946920|952902|P2|NOT COMPLETED|Overall Study||44
398773|NCT00946920|952903|P1|NOT COMPLETED|Overall Study||110
398774|NCT00946920|952902|P2|COMPLETED|Overall Study||239
398775|NCT00946920|952903|P1|COMPLETED|Overall Study||455
398776|NCT00946920|952902|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
398777|NCT00946920|952903|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
398778|NCT00946920|952902|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
398779|NCT00946920|952903|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
398780|NCT00946530|952922|P4|NOT COMPLETED|Overall Study||4
398781|NCT00946530|952923|P3|NOT COMPLETED|Overall Study||1
398782|NCT00946530|952924|P2|NOT COMPLETED|Overall Study||4
398783|NCT00946530|952925|P1|NOT COMPLETED|Overall Study||1
398784|NCT00946530|952922|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
398785|NCT00946530|952923|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
398786|NCT00946530|952924|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
398787|NCT00946530|952925|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
398788|NCT00946530|952922|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
398789|NCT00946530|952923|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
398790|NCT00946530|952924|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
398791|NCT00946530|952925|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
398792|NCT00946478|952941|P2|NOT COMPLETED|Overall Study||0
398793|NCT00946478|952942|P1|NOT COMPLETED|Overall Study||0
398794|NCT00946478|952941|P2|COMPLETED|Overall Study||20
398795|NCT00946478|952942|P1|COMPLETED|Overall Study||20
398796|NCT00946478|952941|P2|STARTED|Overall Study||20
398797|NCT00946478|952942|P1|STARTED|Overall Study||20
398798|NCT00946348|952950|P2|NOT COMPLETED|Overall Study||0
398799|NCT00946348|952951|P1|NOT COMPLETED|Overall Study||0
398800|NCT00946348|952950|P2|COMPLETED|Overall Study||6
398801|NCT00946348|952951|P1|COMPLETED|Overall Study||6
398802|NCT00946348|952950|P2|STARTED|Overall Study||6
398803|NCT00946348|952951|P1|STARTED|Overall Study||6
398804|NCT00946322|952957|P1|NOT COMPLETED|Post-treatment||2
398805|NCT00946322|952957|P1|COMPLETED|Post-treatment||9
398806|NCT00946322|952957|P1|STARTED|Post-treatment||11
398807|NCT00946322|952957|P1|NOT COMPLETED|Pre-treatment||1
398808|NCT00946322|952957|P1|COMPLETED|Pre-treatment||11
398809|NCT00946322|952957|P1|STARTED|Pre-treatment||12
398810|NCT00946309|952970|P2|NOT COMPLETED|Overall Study||4
398811|NCT00946309|952971|P1|NOT COMPLETED|Overall Study||1
398812|NCT00946309|952970|P2|COMPLETED|Overall Study||19
398813|NCT00946309|952971|P1|COMPLETED|Overall Study||21
398814|NCT00946309|952970|P2|STARTED|Overall Study||23
398815|NCT00946309|952971|P1|STARTED|Overall Study||22
398816|NCT00946296|952989|P2|NOT COMPLETED|Overall Study||0
398817|NCT00946296|952990|P1|NOT COMPLETED|Overall Study||3
398818|NCT00946296|952989|P2|COMPLETED|Overall Study||15
398819|NCT00946296|952990|P1|COMPLETED|Overall Study||18
398820|NCT00946296|952989|P2|STARTED|Overall Study||15
398821|NCT00946296|952990|P1|STARTED|Overall Study||21
398822|NCT00946114|952998|P2|NOT COMPLETED|Overall Study||2
398823|NCT00946114|952999|P1|NOT COMPLETED|Overall Study||8
398824|NCT00946114|952998|P2|COMPLETED|Overall Study||10
398825|NCT00946114|952999|P1|COMPLETED|Overall Study||12
398826|NCT00946114|952998|P2|STARTED|Overall Study||12
398827|NCT00946114|952999|P1|STARTED|Overall Study||20
398828|NCT00946101|953007|P2|NOT COMPLETED|Overall Study||2
398829|NCT00946101|953008|P1|NOT COMPLETED|Overall Study||4
398830|NCT00946101|953007|P2|COMPLETED|Overall Study||63
398831|NCT00946101|953008|P1|COMPLETED|Overall Study||257
398832|NCT00946101|953007|P2|Day 15 Post Dose 2|Overall Study||63
398833|NCT00946101|953008|P1|Day 15 Post Dose 2|Overall Study||254
398834|NCT00946101|953007|P2|Day 15 Post Dose 1|Overall Study||64
398835|NCT00946101|953008|P1|Day 15 Post Dose 1|Overall Study||260
398836|NCT00946101|953007|P2|STARTED|Overall Study||65
398837|NCT00946101|953008|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
398838|NCT00946088|953074|P2|NOT COMPLETED|Overall Study||1
398839|NCT00946088|953075|P1|NOT COMPLETED|Overall Study||0
398840|NCT00946088|953074|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
398841|NCT00946088|953075|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
398842|NCT00946088|953074|P2|STARTED|Overall Study||3
398843|NCT00946088|953075|P1|STARTED|Overall Study||4
398844|NCT00945958|953097|P1|NOT COMPLETED|Overall Study||12
398845|NCT00945958|953097|P1|COMPLETED|Overall Study||149
398846|NCT00945958|953097|P1|STARTED|Overall Study||161
398847|NCT00945945|953104|P2|NOT COMPLETED|Overall Study||55
398848|NCT00945945|953105|P1|NOT COMPLETED|Overall Study||36
398849|NCT00945945|953104|P2|COMPLETED|Overall Study||162
398850|NCT00945945|953105|P1|COMPLETED|Overall Study||171
398851|NCT00945945|953104|P2|STARTED|Overall Study||217
398852|NCT00945945|953105|P1|STARTED|Overall Study||207
398853|NCT00945906|953131|P1|NOT COMPLETED|Overall Study||7
398854|NCT00945906|953131|P1|COMPLETED|Overall Study||54
398855|NCT00945906|953131|P1|STARTED|Overall Study||61
398856|NCT00945893|953142|P2|NOT COMPLETED|Overall Study||10
398857|NCT00945893|953143|P1|NOT COMPLETED|Overall Study||3
398858|NCT00945893|953142|P2|COMPLETED|Overall Study||230
398859|NCT00945893|953143|P1|COMPLETED|Overall Study||57
398860|NCT00945893|953142|P2|Day 15 Post Dose 2|Overall Study||226
398861|NCT00945893|953143|P1|Day 15 Post Dose 2|Overall Study||54
398862|NCT00945893|953142|P2|Day 15 Post Dose 1|Overall Study||238
398863|NCT00945893|953143|P1|Day 15 Post Dose 1|Overall Study||60
398864|NCT00945893|953142|P2|STARTED|Overall Study||240
398865|NCT00945893|953143|P1|STARTED|Overall Study||60
398866|NCT00945854|953209|P2|NOT COMPLETED|Overall Study||4
398867|NCT00945854|953210|P1|NOT COMPLETED|Overall Study||2
398868|NCT00945854|953209|P2|COMPLETED|Overall Study||26
398869|NCT00945854|953210|P1|COMPLETED|Overall Study||28
398870|NCT00945854|953209|P2|STARTED|Overall Study||30
398871|NCT00945854|953210|P1|STARTED|Overall Study||30
398872|NCT00945815|953220|P1|NOT COMPLETED|Overall Study||8
398873|NCT00945815|953220|P1|COMPLETED|Overall Study||27
398874|NCT00945815|953220|P1|Eligible and Began Protocol Therapy|Overall Study||31
398875|NCT00945815|953220|P1|Eligible|Overall Study||32
398876|NCT00945815|953220|P1|STARTED|Overall Study||35
398877|NCT00945750|953231|P6|NOT COMPLETED|Period III||0
398878|NCT00945750|953232|P5|NOT COMPLETED|Period III||0
398879|NCT00945750|953233|P4|NOT COMPLETED|Period III||0
398880|NCT00945750|953234|P3|NOT COMPLETED|Period III||0
398881|NCT00945750|953235|P2|NOT COMPLETED|Period III||0
398882|NCT00945750|953236|P1|NOT COMPLETED|Period III||0
398883|NCT00945750|953231|P6|COMPLETED|Period III||5
398884|NCT00945750|953232|P5|COMPLETED|Period III||5
398885|NCT00945750|953233|P4|COMPLETED|Period III||5
398886|NCT00945750|953234|P3|COMPLETED|Period III||5
398887|NCT00945750|953235|P2|COMPLETED|Period III||5
398888|NCT00945750|953236|P1|COMPLETED|Period III||5
398889|NCT00945750|953231|P6|STARTED|Period III||5
398890|NCT00945750|953232|P5|STARTED|Period III||5
398891|NCT00945750|953233|P4|STARTED|Period III||5
398892|NCT00945750|953234|P3|STARTED|Period III||5
398893|NCT00945750|953235|P2|STARTED|Period III||5
398894|NCT00945750|953236|P1|STARTED|Period III||5
398895|NCT00945750|953231|P6|NOT COMPLETED|Period II||0
398896|NCT00945750|953232|P5|NOT COMPLETED|Period II||0
398897|NCT00945750|953233|P4|NOT COMPLETED|Period II||0
398898|NCT00945750|953234|P3|NOT COMPLETED|Period II||0
398899|NCT00945750|953235|P2|NOT COMPLETED|Period II||0
398900|NCT00945750|953236|P1|NOT COMPLETED|Period II||0
398901|NCT00945750|953231|P6|COMPLETED|Period II||5
398902|NCT00945750|953232|P5|COMPLETED|Period II||5
398903|NCT00945750|953233|P4|COMPLETED|Period II||5
398904|NCT00945750|953234|P3|COMPLETED|Period II||5
398905|NCT00945750|953235|P2|COMPLETED|Period II||5
398906|NCT00945750|953236|P1|COMPLETED|Period II||5
398907|NCT00945750|953231|P6|STARTED|Period II||5
398908|NCT00945750|953232|P5|STARTED|Period II||5
398909|NCT00945750|953233|P4|STARTED|Period II||5
398910|NCT00945750|953234|P3|STARTED|Period II||5
398911|NCT00945750|953235|P2|STARTED|Period II||5
398912|NCT00945750|953236|P1|STARTED|Period II||5
398913|NCT00945750|953231|P6|NOT COMPLETED|Period I||0
398914|NCT00945750|953232|P5|NOT COMPLETED|Period I||0
398915|NCT00945750|953233|P4|NOT COMPLETED|Period I||0
398916|NCT00945750|953234|P3|NOT COMPLETED|Period I||0
398917|NCT00945750|953235|P2|NOT COMPLETED|Period I||0
398918|NCT00945750|953236|P1|NOT COMPLETED|Period I||0
398919|NCT00945750|953231|P6|COMPLETED|Period I||5
398920|NCT00945750|953232|P5|COMPLETED|Period I||5
398921|NCT00945750|953233|P4|COMPLETED|Period I||5
398922|NCT00945750|953234|P3|COMPLETED|Period I||5
398923|NCT00945750|953235|P2|COMPLETED|Period I||5
398924|NCT00945750|953236|P1|COMPLETED|Period I||5
398925|NCT00945750|953231|P6|STARTED|Period I||5
398926|NCT00945750|953232|P5|STARTED|Period I||5
398927|NCT00945750|953233|P4|STARTED|Period I||5
398928|NCT00945750|953234|P3|STARTED|Period I||5
398929|NCT00945750|953235|P2|STARTED|Period I||5
398930|NCT00945750|953236|P1|STARTED|Period I||5
398931|NCT00945555|953249|P1|NOT COMPLETED|Overall Study||28
398932|NCT00945555|953249|P1|COMPLETED|Overall Study||236
398933|NCT00945555|953249|P1|STARTED|Overall Study||264
398934|NCT00945477|953260|P1|NOT COMPLETED|Overall Study||6
398935|NCT00945477|953260|P1|COMPLETED|Overall Study||5
398936|NCT00945477|953260|P1|STARTED|Overall Study||11
398937|NCT00945334|953267|P2|NOT COMPLETED|Overall Study||3
398938|NCT00945334|953268|P1|NOT COMPLETED|Overall Study||3
398939|NCT00945334|953267|P2|COMPLETED|Overall Study||15
398940|NCT00945334|953268|P1|COMPLETED|Overall Study||16
398941|NCT00945334|953267|P2|STARTED|Overall Study||18
398942|NCT00945334|953268|P1|STARTED|Overall Study||19
398943|NCT00945321|953276|P6|NOT COMPLETED|Period 4||1
398944|NCT00945321|953277|P5|NOT COMPLETED|Period 4||0
398945|NCT00945321|953278|P4|NOT COMPLETED|Period 4||0
398946|NCT00945321|953279|P3|NOT COMPLETED|Period 4||0
398947|NCT00945321|953280|P2|NOT COMPLETED|Period 4||0
398948|NCT00945321|953281|P1|NOT COMPLETED|Period 4||0
398949|NCT00945321|953276|P6|COMPLETED|Period 4||6
398950|NCT00945321|953277|P5|COMPLETED|Period 4||6
398951|NCT00945321|953278|P4|COMPLETED|Period 4||7
398952|NCT00945321|953279|P3|COMPLETED|Period 4||7
398953|NCT00945321|953280|P2|COMPLETED|Period 4||7
398954|NCT00945321|953281|P1|COMPLETED|Period 4||7
398955|NCT00945321|953276|P6|STARTED|Period 4||7
398956|NCT00945321|953277|P5|STARTED|Period 4||6
398957|NCT00945321|953278|P4|STARTED|Period 4||7
398958|NCT00945321|953279|P3|STARTED|Period 4||7
398959|NCT00945321|953280|P2|STARTED|Period 4||7
398960|NCT00945321|953281|P1|STARTED|Period 4||7
398961|NCT00945321|953276|P6|NOT COMPLETED|Period 3||0
398962|NCT00945321|953277|P5|NOT COMPLETED|Period 3||0
398963|NCT00945321|953278|P4|NOT COMPLETED|Period 3||0
398964|NCT00945321|953279|P3|NOT COMPLETED|Period 3||0
398965|NCT00945321|953280|P2|NOT COMPLETED|Period 3||0
398966|NCT00945321|953281|P1|NOT COMPLETED|Period 3||0
398967|NCT00945321|953276|P6|COMPLETED|Period 3||7
398968|NCT00945321|953277|P5|COMPLETED|Period 3||6
398969|NCT00945321|953278|P4|COMPLETED|Period 3||7
398970|NCT00945321|953279|P3|COMPLETED|Period 3||7
398971|NCT00945321|953280|P2|COMPLETED|Period 3||7
398972|NCT00945321|953281|P1|COMPLETED|Period 3||7
398973|NCT00945321|953276|P6|STARTED|Period 3||7
398974|NCT00945321|953277|P5|STARTED|Period 3||6
398975|NCT00945321|953278|P4|STARTED|Period 3||7
398976|NCT00945321|953279|P3|STARTED|Period 3||7
398977|NCT00945321|953280|P2|STARTED|Period 3||7
398978|NCT00945321|953281|P1|STARTED|Period 3||7
398979|NCT00945321|953276|P6|NOT COMPLETED|Period 2||0
398980|NCT00945321|953277|P5|NOT COMPLETED|Period 2||0
398981|NCT00945321|953278|P4|NOT COMPLETED|Period 2||0
398982|NCT00945321|953279|P3|NOT COMPLETED|Period 2||0
398983|NCT00945321|953280|P2|NOT COMPLETED|Period 2||0
398984|NCT00945321|953281|P1|NOT COMPLETED|Period 2||0
398985|NCT00945321|953276|P6|COMPLETED|Period 2||7
398986|NCT00945321|953277|P5|COMPLETED|Period 2||6
398987|NCT00945321|953278|P4|COMPLETED|Period 2||7
398988|NCT00945321|953279|P3|COMPLETED|Period 2||7
398989|NCT00945321|953280|P2|COMPLETED|Period 2||7
398990|NCT00945321|953281|P1|COMPLETED|Period 2||7
398991|NCT00945321|953276|P6|STARTED|Period 2||7
398992|NCT00945321|953277|P5|STARTED|Period 2||6
398993|NCT00945321|953278|P4|STARTED|Period 2||7
398994|NCT00945321|953279|P3|STARTED|Period 2||7
398995|NCT00945321|953280|P2|STARTED|Period 2||7
398996|NCT00945321|953281|P1|STARTED|Period 2||7
398997|NCT00945321|953276|P6|NOT COMPLETED|Period 1||0
398998|NCT00945321|953277|P5|NOT COMPLETED|Period 1||1
398999|NCT00945321|953278|P4|NOT COMPLETED|Period 1||0
399000|NCT00945321|953279|P3|NOT COMPLETED|Period 1||0
399001|NCT00945321|953280|P2|NOT COMPLETED|Period 1||0
399002|NCT00945321|953281|P1|NOT COMPLETED|Period 1||0
399003|NCT00945321|953276|P6|COMPLETED|Period 1||7
399004|NCT00945321|953277|P5|COMPLETED|Period 1||6
399005|NCT00945321|953278|P4|COMPLETED|Period 1||7
399006|NCT00945321|953279|P3|COMPLETED|Period 1||7
399007|NCT00945321|953280|P2|COMPLETED|Period 1||7
399008|NCT00945321|953281|P1|COMPLETED|Period 1||7
399009|NCT00945321|953276|P6|STARTED|Period 1||7
399010|NCT00945321|953277|P5|STARTED|Period 1||7
399011|NCT00945321|953278|P4|STARTED|Period 1||7
399012|NCT00945321|953279|P3|STARTED|Period 1||7
399013|NCT00945321|953280|P2|STARTED|Period 1||7
399014|NCT00945321|953281|P1|STARTED|Period 1||7
399015|NCT00945295|953303|P2|NOT COMPLETED|Overall Study||2
399016|NCT00945295|953304|P1|NOT COMPLETED|Overall Study||0
399017|NCT00945295|953303|P2|COMPLETED|Overall Study||14
399018|NCT00945295|953304|P1|COMPLETED|Overall Study||15
399019|NCT00945295|953303|P2|STARTED|Overall Study||16
399020|NCT00945295|953304|P1|STARTED|Overall Study||15
399021|NCT00945256|953317|P5|NOT COMPLETED|Overall Study||1
399022|NCT00945256|953318|P4|NOT COMPLETED|Overall Study||9
399023|NCT00945256|953319|P3|NOT COMPLETED|Overall Study||8
399024|NCT00945256|953320|P2|NOT COMPLETED|Overall Study||2
399025|NCT00945256|953321|P1|NOT COMPLETED|Overall Study||4
399026|NCT00945256|953317|P5|COMPLETED|Overall Study||7
399027|NCT00945256|953318|P4|COMPLETED|Overall Study||7
399028|NCT00945256|953319|P3|COMPLETED|Overall Study||7
399029|NCT00945256|953320|P2|COMPLETED|Overall Study||8
399030|NCT00945256|953321|P1|COMPLETED|Overall Study||9
399031|NCT00945256|953317|P5|STARTED|Overall Study||8
399032|NCT00945256|953318|P4|STARTED|Overall Study||16
399033|NCT00945256|953319|P3|STARTED|Overall Study||15
399034|NCT00945256|953320|P2|STARTED|Overall Study||10
399035|NCT00945256|953321|P1|STARTED|Overall Study||13
399036|NCT00945243|953333|P1|NOT COMPLETED|Overall Study||3
399037|NCT00945243|953333|P1|COMPLETED|Overall Study||8
399038|NCT00945243|953333|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
399039|NCT00945139|953339|P1|NOT COMPLETED|Overall Study||0
399040|NCT00945139|953339|P1|COMPLETED|Overall Study||46
399041|NCT00945139|953339|P1|STARTED|Overall Study||46
399042|NCT00945100|953350|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
399043|NCT00945100|953351|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
399044|NCT00945100|953350|P2|COMPLETED|Post-10 Week Primary Outcome||56
399045|NCT00945100|953351|P1|COMPLETED|Post-10 Week Primary Outcome||51
399046|NCT00945100|953350|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
399047|NCT00945100|953351|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
399048|NCT00945100|953350|P2|NOT COMPLETED|10-week Primary Outcome||3
399049|NCT00945100|953351|P1|NOT COMPLETED|10-week Primary Outcome||1
399050|NCT00945100|953350|P2|COMPLETED|10-week Primary Outcome||83
399051|NCT00945100|953351|P1|COMPLETED|10-week Primary Outcome||82
399052|NCT00945100|953350|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
399053|NCT00945100|953351|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
399054|NCT00945100|953350|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
399055|NCT00945100|953351|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
399056|NCT00945100|953350|P2|STARTED|10-week Primary Outcome||86
399057|NCT00945100|953351|P1|STARTED|10-week Primary Outcome||83
399058|NCT00945035|953415|P2|NOT COMPLETED|Period 2||0
399059|NCT00945035|953416|P1|NOT COMPLETED|Period 2||0
399060|NCT00945035|953415|P2|COMPLETED|Period 2||18
399061|NCT00945035|953416|P1|COMPLETED|Period 2||18
399062|NCT00945035|953415|P2|STARTED|Period 2||18
399063|NCT00945035|953416|P1|STARTED|Period 2||18
399064|NCT00945035|953415|P2|NOT COMPLETED|Period 1||0
399065|NCT00945035|953416|P1|NOT COMPLETED|Period 1||0
399066|NCT00945035|953415|P2|COMPLETED|Period 1||18
399067|NCT00945035|953416|P1|COMPLETED|Period 1||18
399068|NCT00945035|953415|P2|STARTED|Period 1||18
399069|NCT00945035|953416|P1|STARTED|Period 1||18
399070|NCT00944749|953424|P1|NOT COMPLETED|Overall Study||1
399071|NCT00944749|953424|P1|COMPLETED|Overall Study||22
399072|NCT00944749|953424|P1|STARTED|Overall Study||23
399073|NCT00944710|953431|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
399074|NCT00944710|953432|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
399075|NCT00944710|953431|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
399076|NCT00944710|953432|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
399077|NCT00944710|953431|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
399078|NCT00944710|953432|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
399079|NCT00944710|953431|P2|STARTED|Additional Post 10-week Primary Outcome||33
399080|NCT00944710|953432|P1|STARTED|Additional Post 10-week Primary Outcome||40
399081|NCT00944710|953431|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
399082|NCT00944710|953432|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
399083|NCT00944710|953431|P2|COMPLETED|12-week Visit (Off-treatment)||33
399084|NCT00944710|953432|P1|COMPLETED|12-week Visit (Off-treatment)||40
399085|NCT00944710|953431|P2|STARTED|12-week Visit (Off-treatment)||33
399086|NCT00944710|953432|P1|STARTED|12-week Visit (Off-treatment)||40
399087|NCT00944710|953431|P2|NOT COMPLETED|10-week Primary Outcome||0
399088|NCT00944710|953432|P1|NOT COMPLETED|10-week Primary Outcome||0
399089|NCT00944710|953431|P2|COMPLETED|10-week Primary Outcome||33
399090|NCT00944710|953432|P1|COMPLETED|10-week Primary Outcome||40
399091|NCT00944710|953431|P2|STARTED|10-week Primary Outcome||33
399092|NCT00944710|953432|P1|STARTED|10-week Primary Outcome||40
399093|NCT00944697|953490|P2|NOT COMPLETED|Overall Study||5
399094|NCT00944697|953491|P1|NOT COMPLETED|Overall Study||2
399095|NCT00944697|953490|P2|COMPLETED|Overall Study||43
399096|NCT00944697|953491|P1|COMPLETED|Overall Study||48
399097|NCT00944697|953490|P2|STARTED|Overall Study||48
399098|NCT00944697|953491|P1|STARTED|Overall Study||50
399099|NCT00944671|953503|P6|NOT COMPLETED|Period III||0
399100|NCT00944671|953504|P5|NOT COMPLETED|Period III||0
399101|NCT00944671|953505|P4|NOT COMPLETED|Period III||0
399102|NCT00944671|953506|P3|NOT COMPLETED|Period III||0
399103|NCT00944671|953507|P2|NOT COMPLETED|Period III||0
399104|NCT00944671|953508|P1|NOT COMPLETED|Period III||0
399105|NCT00944671|953503|P6|COMPLETED|Period III||4
399106|NCT00944671|953504|P5|COMPLETED|Period III||4
399107|NCT00944671|953505|P4|COMPLETED|Period III||4
399108|NCT00944671|953506|P3|COMPLETED|Period III||4
399109|NCT00944671|953507|P2|COMPLETED|Period III||4
399110|NCT00944671|953508|P1|COMPLETED|Period III||4
399111|NCT00944671|953503|P6|STARTED|Period III||4
399112|NCT00944671|953504|P5|STARTED|Period III||4
399113|NCT00944671|953505|P4|STARTED|Period III||4
399114|NCT00944671|953506|P3|STARTED|Period III||4
399115|NCT00944671|953507|P2|STARTED|Period III||4
399116|NCT00944671|953508|P1|STARTED|Period III||4
399117|NCT00944671|953503|P6|NOT COMPLETED|Period II||0
399118|NCT00944671|953504|P5|NOT COMPLETED|Period II||0
399119|NCT00944671|953505|P4|NOT COMPLETED|Period II||0
399120|NCT00944671|953506|P3|NOT COMPLETED|Period II||0
399121|NCT00944671|953507|P2|NOT COMPLETED|Period II||0
399122|NCT00944671|953508|P1|NOT COMPLETED|Period II||0
399123|NCT00944671|953503|P6|COMPLETED|Period II||4
399124|NCT00944671|953504|P5|COMPLETED|Period II||4
399125|NCT00944671|953505|P4|COMPLETED|Period II||4
399126|NCT00944671|953506|P3|COMPLETED|Period II||4
399127|NCT00944671|953507|P2|COMPLETED|Period II||4
399128|NCT00944671|953508|P1|COMPLETED|Period II||4
399129|NCT00944671|953503|P6|STARTED|Period II||4
399130|NCT00944671|953504|P5|STARTED|Period II||4
399131|NCT00944671|953505|P4|STARTED|Period II||4
399132|NCT00944671|953506|P3|STARTED|Period II||4
399133|NCT00944671|953507|P2|STARTED|Period II||4
399134|NCT00944671|953508|P1|STARTED|Period II||4
399135|NCT00944671|953503|P6|NOT COMPLETED|Period I||0
399136|NCT00944671|953504|P5|NOT COMPLETED|Period I||0
399137|NCT00944671|953505|P4|NOT COMPLETED|Period I||0
399138|NCT00944671|953506|P3|NOT COMPLETED|Period I||0
399139|NCT00944671|953507|P2|NOT COMPLETED|Period I||0
399140|NCT00944671|953508|P1|NOT COMPLETED|Period I||0
399141|NCT00944671|953503|P6|COMPLETED|Period I||4
399142|NCT00944671|953504|P5|COMPLETED|Period I||4
399143|NCT00944671|953505|P4|COMPLETED|Period I||4
399144|NCT00944671|953506|P3|COMPLETED|Period I||4
399145|NCT00944671|953507|P2|COMPLETED|Period I||4
399146|NCT00944671|953508|P1|COMPLETED|Period I||4
399147|NCT00944671|953503|P6|STARTED|Period I||4
399148|NCT00944671|953504|P5|STARTED|Period I||4
399149|NCT00944671|953505|P4|STARTED|Period I||4
399150|NCT00944671|953506|P3|STARTED|Period I||4
399151|NCT00944671|953507|P2|STARTED|Period I||4
399152|NCT00944671|953508|P1|STARTED|Period I||4
399153|NCT00944645|953521|P2|NOT COMPLETED|Period 2||9
399154|NCT00944645|953522|P1|NOT COMPLETED|Period 2||8
399155|NCT00944645|953521|P2|COMPLETED|Period 2||85
399156|NCT00944645|953522|P1|COMPLETED|Period 2||86
399157|NCT00944645|953521|P2|STARTED|Period 2||94
399158|NCT00944645|953522|P1|STARTED|Period 2||94
399159|NCT00944645|953521|P2|NOT COMPLETED|Period 1||0
399160|NCT00944645|953522|P1|NOT COMPLETED|Period 1||0
399161|NCT00944645|953521|P2|COMPLETED|Period 1||94
399162|NCT00944645|953522|P1|COMPLETED|Period 1||94
399163|NCT00944645|953521|P2|STARTED|Period 1||94
399164|NCT00944645|953522|P1|STARTED|Period 1||94
399165|NCT00944450|953534|P2|NOT COMPLETED|Period 2||0
399166|NCT00944450|953535|P1|NOT COMPLETED|Period 2||0
399167|NCT00944450|953534|P2|COMPLETED|Period 2||6
399168|NCT00944450|953535|P1|COMPLETED|Period 2||6
399169|NCT00944450|953534|P2|STARTED|Period 2||6
399170|NCT00944450|953535|P1|STARTED|Period 2||6
399171|NCT00944450|953534|P2|NOT COMPLETED|Period 1||0
399172|NCT00944450|953535|P1|NOT COMPLETED|Period 1||0
399173|NCT00944450|953534|P2|COMPLETED|Period 1||6
399174|NCT00944450|953535|P1|COMPLETED|Period 1||6
399175|NCT00944450|953534|P2|STARTED|Period 1||6
399176|NCT00944450|953535|P1|STARTED|Period 1||6
399177|NCT00944229|953543|P1|NOT COMPLETED|Overall Study||25
399178|NCT00944229|953543|P1|COMPLETED|Overall Study||33
399179|NCT00944229|953543|P1|STARTED|Overall Study||58
399180|NCT00944125|953549|P2|NOT COMPLETED|6 Months to Study Completion||2
399181|NCT00944125|953550|P1|NOT COMPLETED|6 Months to Study Completion||0
399182|NCT00944125|953549|P2|COMPLETED|6 Months to Study Completion||18
399183|NCT00944125|953550|P1|COMPLETED|6 Months to Study Completion||19
399184|NCT00944125|953549|P2|STARTED|6 Months to Study Completion||20
399185|NCT00944125|953550|P1|STARTED|6 Months to Study Completion||19
399186|NCT00944125|953549|P2|NOT COMPLETED|3 to 6 Months||2
399187|NCT00944125|953550|P1|NOT COMPLETED|3 to 6 Months||0
399188|NCT00944125|953549|P2|COMPLETED|3 to 6 Months||20
399189|NCT00944125|953550|P1|COMPLETED|3 to 6 Months||19
399190|NCT00944125|953549|P2|STARTED|3 to 6 Months||22
399191|NCT00944125|953550|P1|STARTED|3 to 6 Months||19
399192|NCT00944125|953549|P2|NOT COMPLETED|Baseline to 3 Months||0
399193|NCT00944125|953550|P1|NOT COMPLETED|Baseline to 3 Months||0
399194|NCT00944125|953549|P2|COMPLETED|Baseline to 3 Months||22
399195|NCT00944125|953550|P1|COMPLETED|Baseline to 3 Months||19
399196|NCT00944125|953549|P2|STARTED|Baseline to 3 Months||22
399197|NCT00944125|953550|P1|STARTED|Baseline to 3 Months||19
399198|NCT00944073|953558|P2|NOT COMPLETED|Overall Study||4
399199|NCT00944073|953559|P1|NOT COMPLETED|Overall Study||5
399200|NCT00944073|953558|P2|COMPLETED|Overall Study||287
399201|NCT00944073|953559|P1|COMPLETED|Overall Study||287
399202|NCT00944073|953558|P2|STARTED|Overall Study||291
399203|NCT00944073|953559|P1|STARTED|Overall Study||292
399204|NCT00944034|953649|P12|NOT COMPLETED|Overall Study||4
399205|NCT00944034|953650|P11|NOT COMPLETED|Overall Study||1
399206|NCT00944034|953651|P10|NOT COMPLETED|Overall Study||10
399207|NCT00944034|953652|P9|NOT COMPLETED|Overall Study||10
399208|NCT00944034|953653|P8|NOT COMPLETED|Overall Study||5
399209|NCT00944034|953654|P7|NOT COMPLETED|Overall Study||4
399210|NCT00944034|953655|P6|NOT COMPLETED|Overall Study||20
399211|NCT00944034|953656|P5|NOT COMPLETED|Overall Study||14
399212|NCT00944034|953657|P4|NOT COMPLETED|Overall Study||4
399213|NCT00944034|953658|P3|NOT COMPLETED|Overall Study||9
399214|NCT00944034|953659|P2|NOT COMPLETED|Overall Study||7
399215|NCT00944034|953660|P1|NOT COMPLETED|Overall Study||5
399216|NCT00944034|953649|P12|COMPLETED|Overall Study||52
399217|NCT00944034|953650|P11|COMPLETED|Overall Study||50
399218|NCT00944034|953651|P10|COMPLETED|Overall Study||236
399219|NCT00944034|953652|P9|COMPLETED|Overall Study||63
399220|NCT00944034|953653|P8|COMPLETED|Overall Study||73
399221|NCT00944034|953654|P7|COMPLETED|Overall Study||102
399222|NCT00944034|953655|P6|COMPLETED|Overall Study||123
399223|NCT00944034|953656|P5|COMPLETED|Overall Study||150
399224|NCT00944034|953657|P4|COMPLETED|Overall Study||170
399225|NCT00944034|953658|P3|COMPLETED|Overall Study||143
399226|NCT00944034|953659|P2|COMPLETED|Overall Study||150
399227|NCT00944034|953660|P1|COMPLETED|Overall Study||183
399228|NCT00944034|953649|P12|STARTED|Overall Study||56
399229|NCT00944034|953650|P11|STARTED|Overall Study||51
399230|NCT00944034|953651|P10|STARTED|Overall Study||246
399231|NCT00944034|953652|P9|STARTED|Overall Study||73
399232|NCT00944034|953653|P8|STARTED|Overall Study||78
399233|NCT00944034|953654|P7|STARTED|Overall Study||106
399234|NCT00944034|953655|P6|STARTED|Overall Study||143
399235|NCT00944034|953656|P5|STARTED|Overall Study||164
399236|NCT00944034|953657|P4|STARTED|Overall Study||174
399237|NCT00944034|953658|P3|STARTED|Overall Study||152
399238|NCT00944034|953659|P2|STARTED|Overall Study||157
399239|NCT00944034|953660|P1|STARTED|Overall Study||188
399240|NCT00944021|953730|P5|NOT COMPLETED|Overall Study||0
399241|NCT00944021|953731|P4|NOT COMPLETED|Overall Study||0
399242|NCT00944021|953732|P3|NOT COMPLETED|Overall Study||0
399243|NCT00944021|953733|P2|NOT COMPLETED|Overall Study||0
399244|NCT00944021|953734|P1|NOT COMPLETED|Overall Study||1
399245|NCT00944021|953730|P5|COMPLETED|Overall Study||8
399246|NCT00944021|953731|P4|COMPLETED|Overall Study||16
399247|NCT00944021|953732|P3|COMPLETED|Overall Study||15
399248|NCT00944021|953733|P2|COMPLETED|Overall Study||15
399249|NCT00944021|953734|P1|COMPLETED|Overall Study||14
399250|NCT00944021|953730|P5|STARTED|Overall Study||8
399251|NCT00944021|953731|P4|STARTED|Overall Study||16
399252|NCT00944021|953732|P3|STARTED|Overall Study||15
399253|NCT00944021|953733|P2|STARTED|Overall Study||15
399254|NCT00944021|953734|P1|STARTED|Overall Study||15
399255|NCT00943917|953806|P15|NOT COMPLETED|Stage II Continuation||4
399256|NCT00943917|953807|P14|NOT COMPLETED|Stage II Continuation||3
399257|NCT00943917|953808|P13|NOT COMPLETED|Stage II Continuation||3
399258|NCT00943917|953809|P12|NOT COMPLETED|Stage II Continuation||2
399259|NCT00943917|953810|P11|NOT COMPLETED|Stage II Continuation||0
399260|NCT00943917|953811|P10|NOT COMPLETED|Stage II Continuation||1
399261|NCT00943917|953812|P9|NOT COMPLETED|Stage II Continuation||0
399262|NCT00943917|953813|P8|NOT COMPLETED|Stage II Continuation||0
399263|NCT00943917|953814|P7|NOT COMPLETED|Stage II Continuation||0
399264|NCT00943917|953815|P6|NOT COMPLETED|Stage II Continuation||0
399265|NCT00943917|953816|P5|NOT COMPLETED|Stage II Continuation||0
399266|NCT00943917|953817|P4|NOT COMPLETED|Stage II Continuation||0
399267|NCT00943917|953818|P3|NOT COMPLETED|Stage II Continuation||0
399268|NCT00943917|953819|P2|NOT COMPLETED|Stage II Continuation||0
399269|NCT00943917|953820|P1|NOT COMPLETED|Stage II Continuation||0
399270|NCT00943917|953806|P15|COMPLETED|Stage II Continuation||8
399271|NCT00943917|953807|P14|COMPLETED|Stage II Continuation||12
399272|NCT00943917|953808|P13|COMPLETED|Stage II Continuation||13
399273|NCT00943917|953809|P12|COMPLETED|Stage II Continuation||11
399274|NCT00943917|953810|P11|COMPLETED|Stage II Continuation||15
399275|NCT00943917|953811|P10|COMPLETED|Stage II Continuation||14
399276|NCT00943917|953812|P9|COMPLETED|Stage II Continuation||0
399277|NCT00943917|953813|P8|COMPLETED|Stage II Continuation||0
399278|NCT00943917|953814|P7|COMPLETED|Stage II Continuation||0
399279|NCT00943917|953815|P6|COMPLETED|Stage II Continuation||0
399280|NCT00943917|953816|P5|COMPLETED|Stage II Continuation||0
399281|NCT00943917|953817|P4|COMPLETED|Stage II Continuation||0
399282|NCT00943917|953818|P3|COMPLETED|Stage II Continuation||0
399283|NCT00943917|953819|P2|COMPLETED|Stage II Continuation||0
399284|NCT00943917|953820|P1|COMPLETED|Stage II Continuation||0
399285|NCT00943917|953806|P15|STARTED|Stage II Continuation||12
399286|NCT00943917|953807|P14|STARTED|Stage II Continuation||15
399287|NCT00943917|953808|P13|STARTED|Stage II Continuation||16
399288|NCT00943917|953809|P12|STARTED|Stage II Continuation||13
399289|NCT00943917|953810|P11|STARTED|Stage II Continuation||15
399290|NCT00943917|953811|P10|STARTED|Stage II Continuation||15
399291|NCT00943917|953812|P9|STARTED|Stage II Continuation||0
399292|NCT00943917|953813|P8|STARTED|Stage II Continuation||0
399293|NCT00943917|953814|P7|STARTED|Stage II Continuation||0
399294|NCT00943917|953815|P6|STARTED|Stage II Continuation||0
399295|NCT00943917|953816|P5|STARTED|Stage II Continuation||0
399296|NCT00943917|953817|P4|STARTED|Stage II Continuation||0
399297|NCT00943917|953818|P3|STARTED|Stage II Continuation||0
399298|NCT00943917|953819|P2|STARTED|Stage II Continuation||0
399299|NCT00943917|953820|P1|STARTED|Stage II Continuation||0
399300|NCT00943917|953806|P15|NOT COMPLETED|Stage II||0
399301|NCT00943917|953807|P14|NOT COMPLETED|Stage II||0
399302|NCT00943917|953808|P13|NOT COMPLETED|Stage II||0
399303|NCT00943917|953809|P12|NOT COMPLETED|Stage II||0
399304|NCT00943917|953810|P11|NOT COMPLETED|Stage II||0
399305|NCT00943917|953811|P10|NOT COMPLETED|Stage II||0
399306|NCT00943917|953812|P9|NOT COMPLETED|Stage II||1
399307|NCT00943917|953813|P8|NOT COMPLETED|Stage II||0
399308|NCT00943917|953814|P7|NOT COMPLETED|Stage II||3
399309|NCT00943917|953815|P6|NOT COMPLETED|Stage II||3
399310|NCT00943917|953816|P5|NOT COMPLETED|Stage II||0
399311|NCT00943917|953817|P4|NOT COMPLETED|Stage II||0
399312|NCT00943917|953818|P3|NOT COMPLETED|Stage II||0
399313|NCT00943917|953819|P2|NOT COMPLETED|Stage II||0
399314|NCT00943917|953820|P1|NOT COMPLETED|Stage II||0
399315|NCT00943917|953806|P15|COMPLETED|Stage II||0
399316|NCT00943917|953807|P14|COMPLETED|Stage II||0
399317|NCT00943917|953808|P13|COMPLETED|Stage II||0
399318|NCT00943917|953809|P12|COMPLETED|Stage II||0
399319|NCT00943917|953810|P11|COMPLETED|Stage II||0
399320|NCT00943917|953811|P10|COMPLETED|Stage II||0
399321|NCT00943917|953812|P9|COMPLETED|Stage II||20
399322|NCT00943917|953813|P8|COMPLETED|Stage II||23
399323|NCT00943917|953814|P7|COMPLETED|Stage II||20
399324|NCT00943917|953815|P6|COMPLETED|Stage II||20
399325|NCT00943917|953816|P5|COMPLETED|Stage II||21
399326|NCT00943917|953817|P4|COMPLETED|Stage II||20
399327|NCT00943917|953818|P3|COMPLETED|Stage II||0
399328|NCT00943917|953819|P2|COMPLETED|Stage II||0
399329|NCT00943917|953820|P1|COMPLETED|Stage II||0
399330|NCT00943917|953806|P15|STARTED|Stage II||0
399331|NCT00943917|953807|P14|STARTED|Stage II||0
399332|NCT00943917|953808|P13|STARTED|Stage II||0
399333|NCT00943917|953809|P12|STARTED|Stage II||0
399334|NCT00943917|953810|P11|STARTED|Stage II||0
399335|NCT00943917|953811|P10|STARTED|Stage II||0
399336|NCT00943917|953812|P9|STARTED|Stage II||21
399337|NCT00943917|953813|P8|STARTED|Stage II||23
399338|NCT00943917|953814|P7|STARTED|Stage II||23
399339|NCT00943917|953815|P6|STARTED|Stage II||23
399340|NCT00943917|953816|P5|STARTED|Stage II||21
399341|NCT00943917|953817|P4|STARTED|Stage II||20
399342|NCT00943917|953818|P3|STARTED|Stage II||0
399343|NCT00943917|953819|P2|STARTED|Stage II||0
399344|NCT00943917|953820|P1|STARTED|Stage II||0
399345|NCT00943917|953806|P15|NOT COMPLETED|Stage I||0
399346|NCT00943917|953807|P14|NOT COMPLETED|Stage I||0
399347|NCT00943917|953808|P13|NOT COMPLETED|Stage I||0
399348|NCT00943917|953809|P12|NOT COMPLETED|Stage I||0
399349|NCT00943917|953810|P11|NOT COMPLETED|Stage I||0
399350|NCT00943917|953811|P10|NOT COMPLETED|Stage I||0
399351|NCT00943917|953812|P9|NOT COMPLETED|Stage I||0
399352|NCT00943917|953813|P8|NOT COMPLETED|Stage I||0
399353|NCT00943917|953814|P7|NOT COMPLETED|Stage I||0
399354|NCT00943917|953815|P6|NOT COMPLETED|Stage I||0
399355|NCT00943917|953816|P5|NOT COMPLETED|Stage I||0
399356|NCT00943917|953817|P4|NOT COMPLETED|Stage I||0
399357|NCT00943917|953818|P3|NOT COMPLETED|Stage I||6
399358|NCT00943917|953819|P2|NOT COMPLETED|Stage I||3
399359|NCT00943917|953820|P1|NOT COMPLETED|Stage I||4
399360|NCT00943917|953806|P15|COMPLETED|Stage I||0
399361|NCT00943917|953807|P14|COMPLETED|Stage I||0
399362|NCT00943917|953808|P13|COMPLETED|Stage I||0
399363|NCT00943917|953809|P12|COMPLETED|Stage I||0
399364|NCT00943917|953810|P11|COMPLETED|Stage I||0
399365|NCT00943917|953811|P10|COMPLETED|Stage I||0
399366|NCT00943917|953812|P9|COMPLETED|Stage I||0
399367|NCT00943917|953813|P8|COMPLETED|Stage I||0
399368|NCT00943917|953814|P7|COMPLETED|Stage I||0
399369|NCT00943917|953815|P6|COMPLETED|Stage I||0
399370|NCT00943917|953816|P5|COMPLETED|Stage I||0
399371|NCT00943917|953817|P4|COMPLETED|Stage I||0
399372|NCT00943917|953818|P3|COMPLETED|Stage I||47
399373|NCT00943917|953819|P2|COMPLETED|Stage I||48
399374|NCT00943917|953820|P1|COMPLETED|Stage I||47
399375|NCT00943917|953806|P15|STARTED|Stage I||0
399376|NCT00943917|953807|P14|STARTED|Stage I||0
399377|NCT00943917|953808|P13|STARTED|Stage I||0
399378|NCT00943917|953809|P12|STARTED|Stage I||0
399379|NCT00943917|953810|P11|STARTED|Stage I||0
399380|NCT00943917|953811|P10|STARTED|Stage I||0
399381|NCT00943917|953812|P9|STARTED|Stage I||0
399382|NCT00943917|953813|P8|STARTED|Stage I||0
399383|NCT00943917|953814|P7|STARTED|Stage I||0
399384|NCT00943917|953815|P6|STARTED|Stage I||0
399385|NCT00943917|953816|P5|STARTED|Stage I||0
399386|NCT00943917|953817|P4|STARTED|Stage I||0
399387|NCT00943917|953818|P3|STARTED|Stage I||53
399388|NCT00943917|953819|P2|STARTED|Stage I||51
399389|NCT00943917|953820|P1|STARTED|Stage I||51
399390|NCT00943878|953871|P4|NOT COMPLETED|Overall Study||2
399391|NCT00943878|953872|P3|NOT COMPLETED|Overall Study||6
399392|NCT00943878|953873|P2|NOT COMPLETED|Overall Study||2
399393|NCT00943878|953874|P1|NOT COMPLETED|Overall Study||2
399394|NCT00943878|953871|P4|COMPLETED|Overall Study||198
399395|NCT00943878|953872|P3|COMPLETED|Overall Study||197
399396|NCT00943878|953873|P2|COMPLETED|Overall Study||198
399397|NCT00943878|953874|P1|COMPLETED|Overall Study||200
399398|NCT00943878|953871|P4|STARTED|Overall Study||200
399399|NCT00943878|953872|P3|STARTED|Overall Study||203
399400|NCT00943878|953873|P2|STARTED|Overall Study||200
399401|NCT00943878|953874|P1|STARTED|Overall Study||202
399402|NCT00943852|953996|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399403|NCT00943852|953997|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399404|NCT00943852|953998|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399405|NCT00943852|953999|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399406|NCT00943852|954000|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399407|NCT00943852|954001|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399408|NCT00943852|954002|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399409|NCT00943852|954003|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399410|NCT00943852|954004|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399411|NCT00943852|954005|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
399412|NCT00943852|953996|P10|COMPLETED|Fifth Period of Treatment Intervention||1
399413|NCT00943852|953997|P9|COMPLETED|Fifth Period of Treatment Intervention||1
399414|NCT00943852|953998|P8|COMPLETED|Fifth Period of Treatment Intervention||0
399415|NCT00943852|953999|P7|COMPLETED|Fifth Period of Treatment Intervention||0
399416|NCT00943852|954000|P6|COMPLETED|Fifth Period of Treatment Intervention||0
399417|NCT00943852|954001|P5|COMPLETED|Fifth Period of Treatment Intervention||1
399418|NCT00943852|954002|P4|COMPLETED|Fifth Period of Treatment Intervention||0
399419|NCT00943852|954003|P3|COMPLETED|Fifth Period of Treatment Intervention||0
399420|NCT00943852|954004|P2|COMPLETED|Fifth Period of Treatment Intervention||1
399421|NCT00943852|954005|P1|COMPLETED|Fifth Period of Treatment Intervention||1
399422|NCT00943852|953996|P10|STARTED|Fifth Period of Treatment Intervention||1
399423|NCT00943852|953997|P9|STARTED|Fifth Period of Treatment Intervention||1
399424|NCT00943852|953998|P8|STARTED|Fifth Period of Treatment Intervention||0
399425|NCT00943852|953999|P7|STARTED|Fifth Period of Treatment Intervention||0
399426|NCT00943852|954000|P6|STARTED|Fifth Period of Treatment Intervention||0
399427|NCT00943852|954001|P5|STARTED|Fifth Period of Treatment Intervention||1
399428|NCT00943852|954002|P4|STARTED|Fifth Period of Treatment Intervention||0
399429|NCT00943852|954003|P3|STARTED|Fifth Period of Treatment Intervention||0
399430|NCT00943852|954004|P2|STARTED|Fifth Period of Treatment Intervention||1
399431|NCT00943852|954005|P1|STARTED|Fifth Period of Treatment Intervention||1
399432|NCT00943852|953996|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
399433|NCT00943852|953997|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
399434|NCT00943852|953998|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
399435|NCT00943852|953999|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
399436|NCT00943852|954000|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
399437|NCT00943852|954001|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
399438|NCT00943852|954002|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
399439|NCT00943852|954003|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
399440|NCT00943852|954004|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
399441|NCT00943852|954005|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
399442|NCT00943852|953996|P10|COMPLETED|Washout Period After Period 4 Treatment||1
399443|NCT00943852|953997|P9|COMPLETED|Washout Period After Period 4 Treatment||1
399444|NCT00943852|953998|P8|COMPLETED|Washout Period After Period 4 Treatment||0
399445|NCT00943852|953999|P7|COMPLETED|Washout Period After Period 4 Treatment||0
399446|NCT00943852|954000|P6|COMPLETED|Washout Period After Period 4 Treatment||0
399447|NCT00943852|954001|P5|COMPLETED|Washout Period After Period 4 Treatment||1
399448|NCT00943852|954002|P4|COMPLETED|Washout Period After Period 4 Treatment||0
399449|NCT00943852|954003|P3|COMPLETED|Washout Period After Period 4 Treatment||0
399450|NCT00943852|954004|P2|COMPLETED|Washout Period After Period 4 Treatment||1
399451|NCT00943852|954005|P1|COMPLETED|Washout Period After Period 4 Treatment||1
399452|NCT00943852|953996|P10|STARTED|Washout Period After Period 4 Treatment||1
399453|NCT00943852|953997|P9|STARTED|Washout Period After Period 4 Treatment||1
399454|NCT00943852|953998|P8|STARTED|Washout Period After Period 4 Treatment||1
399455|NCT00943852|953999|P7|STARTED|Washout Period After Period 4 Treatment||1
399456|NCT00943852|954000|P6|STARTED|Washout Period After Period 4 Treatment||0
399457|NCT00943852|954001|P5|STARTED|Washout Period After Period 4 Treatment||1
399458|NCT00943852|954002|P4|STARTED|Washout Period After Period 4 Treatment||1
399459|NCT00943852|954003|P3|STARTED|Washout Period After Period 4 Treatment||1
399460|NCT00943852|954004|P2|STARTED|Washout Period After Period 4 Treatment||1
399461|NCT00943852|954005|P1|STARTED|Washout Period After Period 4 Treatment||2
399462|NCT00943852|953996|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399463|NCT00943852|953997|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399464|NCT00943852|953998|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399465|NCT00943852|953999|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399466|NCT00943852|954000|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399467|NCT00943852|954001|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399468|NCT00943852|954002|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399469|NCT00943852|954003|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399470|NCT00943852|954004|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399471|NCT00943852|954005|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
399472|NCT00943852|953996|P10|COMPLETED|Fourth Period of Treatment Intervention||1
399473|NCT00943852|953997|P9|COMPLETED|Fourth Period of Treatment Intervention||1
399474|NCT00943852|953998|P8|COMPLETED|Fourth Period of Treatment Intervention||1
399475|NCT00943852|953999|P7|COMPLETED|Fourth Period of Treatment Intervention||1
399476|NCT00943852|954000|P6|COMPLETED|Fourth Period of Treatment Intervention||0
399477|NCT00943852|954001|P5|COMPLETED|Fourth Period of Treatment Intervention||1
399478|NCT00943852|954002|P4|COMPLETED|Fourth Period of Treatment Intervention||1
399479|NCT00943852|954003|P3|COMPLETED|Fourth Period of Treatment Intervention||1
399480|NCT00943852|954004|P2|COMPLETED|Fourth Period of Treatment Intervention||1
399481|NCT00943852|954005|P1|COMPLETED|Fourth Period of Treatment Intervention||2
399482|NCT00943852|953996|P10|STARTED|Fourth Period of Treatment Intervention||1
399483|NCT00943852|953997|P9|STARTED|Fourth Period of Treatment Intervention||1
399484|NCT00943852|953998|P8|STARTED|Fourth Period of Treatment Intervention||1
399485|NCT00943852|953999|P7|STARTED|Fourth Period of Treatment Intervention||1
399486|NCT00943852|954000|P6|STARTED|Fourth Period of Treatment Intervention||0
399487|NCT00943852|954001|P5|STARTED|Fourth Period of Treatment Intervention||1
399488|NCT00943852|954002|P4|STARTED|Fourth Period of Treatment Intervention||1
399489|NCT00943852|954003|P3|STARTED|Fourth Period of Treatment Intervention||1
399490|NCT00943852|954004|P2|STARTED|Fourth Period of Treatment Intervention||1
399491|NCT00943852|954005|P1|STARTED|Fourth Period of Treatment Intervention||2
399492|NCT00943852|953996|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399493|NCT00943852|953997|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399494|NCT00943852|953998|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399495|NCT00943852|953999|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
399496|NCT00943852|954000|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399497|NCT00943852|954001|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399498|NCT00943852|954002|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399499|NCT00943852|954003|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399500|NCT00943852|954004|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399501|NCT00943852|954005|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
399502|NCT00943852|953996|P10|COMPLETED|Washout Period After Period 3 Treatment||1
399503|NCT00943852|953997|P9|COMPLETED|Washout Period After Period 3 Treatment||1
399504|NCT00943852|953998|P8|COMPLETED|Washout Period After Period 3 Treatment||1
399505|NCT00943852|953999|P7|COMPLETED|Washout Period After Period 3 Treatment||1
399506|NCT00943852|954000|P6|COMPLETED|Washout Period After Period 3 Treatment||0
399507|NCT00943852|954001|P5|COMPLETED|Washout Period After Period 3 Treatment||1
399508|NCT00943852|954002|P4|COMPLETED|Washout Period After Period 3 Treatment||1
399509|NCT00943852|954003|P3|COMPLETED|Washout Period After Period 3 Treatment||1
399510|NCT00943852|954004|P2|COMPLETED|Washout Period After Period 3 Treatment||1
399511|NCT00943852|954005|P1|COMPLETED|Washout Period After Period 3 Treatment||2
399512|NCT00943852|953996|P10|STARTED|Washout Period After Period 3 Treatment||1
399513|NCT00943852|953997|P9|STARTED|Washout Period After Period 3 Treatment||1
399514|NCT00943852|953998|P8|STARTED|Washout Period After Period 3 Treatment||1
399515|NCT00943852|953999|P7|STARTED|Washout Period After Period 3 Treatment||2
399516|NCT00943852|954000|P6|STARTED|Washout Period After Period 3 Treatment||0
399517|NCT00943852|954001|P5|STARTED|Washout Period After Period 3 Treatment||1
399518|NCT00943852|954002|P4|STARTED|Washout Period After Period 3 Treatment||1
399519|NCT00943852|954003|P3|STARTED|Washout Period After Period 3 Treatment||1
399520|NCT00943852|954004|P2|STARTED|Washout Period After Period 3 Treatment||1
399521|NCT00943852|954005|P1|STARTED|Washout Period After Period 3 Treatment||2
399522|NCT00943852|953996|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
399523|NCT00943852|953997|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
399524|NCT00943852|953998|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
399525|NCT00943852|953999|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
399526|NCT00943852|954000|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
399527|NCT00943852|954001|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
399528|NCT00943852|954002|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
399529|NCT00943852|954003|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
399530|NCT00943852|954004|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
399531|NCT00943852|954005|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
399532|NCT00943852|953996|P10|COMPLETED|Third Period of Treatment Intervention||1
399533|NCT00943852|953997|P9|COMPLETED|Third Period of Treatment Intervention||1
399534|NCT00943852|953998|P8|COMPLETED|Third Period of Treatment Intervention||1
399535|NCT00943852|953999|P7|COMPLETED|Third Period of Treatment Intervention||2
399536|NCT00943852|954000|P6|COMPLETED|Third Period of Treatment Intervention||0
399537|NCT00943852|954001|P5|COMPLETED|Third Period of Treatment Intervention||1
399538|NCT00943852|954002|P4|COMPLETED|Third Period of Treatment Intervention||1
399539|NCT00943852|954003|P3|COMPLETED|Third Period of Treatment Intervention||1
399540|NCT00943852|954004|P2|COMPLETED|Third Period of Treatment Intervention||1
399541|NCT00943852|954005|P1|COMPLETED|Third Period of Treatment Intervention||2
399542|NCT00943852|953996|P10|STARTED|Third Period of Treatment Intervention||1
399543|NCT00943852|953997|P9|STARTED|Third Period of Treatment Intervention||1
399544|NCT00943852|953998|P8|STARTED|Third Period of Treatment Intervention||1
399545|NCT00943852|953999|P7|STARTED|Third Period of Treatment Intervention||2
399546|NCT00943852|954000|P6|STARTED|Third Period of Treatment Intervention||0
399547|NCT00943852|954001|P5|STARTED|Third Period of Treatment Intervention||1
399548|NCT00943852|954002|P4|STARTED|Third Period of Treatment Intervention||1
399549|NCT00943852|954003|P3|STARTED|Third Period of Treatment Intervention||1
399550|NCT00943852|954004|P2|STARTED|Third Period of Treatment Intervention||1
399551|NCT00943852|954005|P1|STARTED|Third Period of Treatment Intervention||2
399552|NCT00943852|953996|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399553|NCT00943852|953997|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399554|NCT00943852|953998|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399555|NCT00943852|953999|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399556|NCT00943852|954000|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
399557|NCT00943852|954001|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399558|NCT00943852|954002|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399559|NCT00943852|954003|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399560|NCT00943852|954004|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399561|NCT00943852|954005|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
399562|NCT00943852|953996|P10|COMPLETED|Washout Period After Period 2 Treatment||1
399563|NCT00943852|953997|P9|COMPLETED|Washout Period After Period 2 Treatment||1
399564|NCT00943852|953998|P8|COMPLETED|Washout Period After Period 2 Treatment||1
399565|NCT00943852|953999|P7|COMPLETED|Washout Period After Period 2 Treatment||2
399566|NCT00943852|954000|P6|COMPLETED|Washout Period After Period 2 Treatment||0
399567|NCT00943852|954001|P5|COMPLETED|Washout Period After Period 2 Treatment||1
399568|NCT00943852|954002|P4|COMPLETED|Washout Period After Period 2 Treatment||1
399569|NCT00943852|954003|P3|COMPLETED|Washout Period After Period 2 Treatment||1
399570|NCT00943852|954004|P2|COMPLETED|Washout Period After Period 2 Treatment||1
399571|NCT00943852|954005|P1|COMPLETED|Washout Period After Period 2 Treatment||2
399572|NCT00943852|953996|P10|STARTED|Washout Period After Period 2 Treatment||1
399573|NCT00943852|953997|P9|STARTED|Washout Period After Period 2 Treatment||1
399574|NCT00943852|953998|P8|STARTED|Washout Period After Period 2 Treatment||1
399575|NCT00943852|953999|P7|STARTED|Washout Period After Period 2 Treatment||2
399576|NCT00943852|954000|P6|STARTED|Washout Period After Period 2 Treatment||1
399577|NCT00943852|954001|P5|STARTED|Washout Period After Period 2 Treatment||1
399578|NCT00943852|954002|P4|STARTED|Washout Period After Period 2 Treatment||1
399579|NCT00943852|954003|P3|STARTED|Washout Period After Period 2 Treatment||1
399580|NCT00943852|954004|P2|STARTED|Washout Period After Period 2 Treatment||1
399581|NCT00943852|954005|P1|STARTED|Washout Period After Period 2 Treatment||2
399582|NCT00943852|953996|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
399583|NCT00943852|953997|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
399584|NCT00943852|953998|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
399585|NCT00943852|953999|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
399586|NCT00943852|954000|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
399587|NCT00943852|954001|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
399588|NCT00943852|954002|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
399589|NCT00943852|954003|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
399590|NCT00943852|954004|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
399591|NCT00943852|954005|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
399592|NCT00943852|953996|P10|COMPLETED|Second Period of Treatment Intervention||1
399593|NCT00943852|953997|P9|COMPLETED|Second Period of Treatment Intervention||1
399594|NCT00943852|953998|P8|COMPLETED|Second Period of Treatment Intervention||1
399595|NCT00943852|953999|P7|COMPLETED|Second Period of Treatment Intervention||2
399596|NCT00943852|954000|P6|COMPLETED|Second Period of Treatment Intervention||1
399597|NCT00943852|954001|P5|COMPLETED|Second Period of Treatment Intervention||1
399598|NCT00943852|954002|P4|COMPLETED|Second Period of Treatment Intervention||1
399599|NCT00943852|954003|P3|COMPLETED|Second Period of Treatment Intervention||1
399600|NCT00943852|954004|P2|COMPLETED|Second Period of Treatment Intervention||1
399601|NCT00943852|954005|P1|COMPLETED|Second Period of Treatment Intervention||2
399602|NCT00943852|953996|P10|STARTED|Second Period of Treatment Intervention||1
399603|NCT00943852|953997|P9|STARTED|Second Period of Treatment Intervention||1
399604|NCT00943852|953998|P8|STARTED|Second Period of Treatment Intervention||1
399605|NCT00943852|953999|P7|STARTED|Second Period of Treatment Intervention||2
399606|NCT00943852|954000|P6|STARTED|Second Period of Treatment Intervention||1
399607|NCT00943852|954001|P5|STARTED|Second Period of Treatment Intervention||1
399608|NCT00943852|954002|P4|STARTED|Second Period of Treatment Intervention||1
399609|NCT00943852|954003|P3|STARTED|Second Period of Treatment Intervention||1
399610|NCT00943852|954004|P2|STARTED|Second Period of Treatment Intervention||1
399611|NCT00943852|954005|P1|STARTED|Second Period of Treatment Intervention||2
399612|NCT00943852|953996|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399613|NCT00943852|953997|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399614|NCT00943852|953998|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399615|NCT00943852|953999|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399616|NCT00943852|954000|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399617|NCT00943852|954001|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399618|NCT00943852|954002|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
399619|NCT00943852|954003|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399620|NCT00943852|954004|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399621|NCT00943852|954005|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
399622|NCT00943852|953996|P10|COMPLETED|Washout Period After Period 1 Treatment||1
399623|NCT00943852|953997|P9|COMPLETED|Washout Period After Period 1 Treatment||1
399624|NCT00943852|953998|P8|COMPLETED|Washout Period After Period 1 Treatment||1
399625|NCT00943852|953999|P7|COMPLETED|Washout Period After Period 1 Treatment||2
399626|NCT00943852|954000|P6|COMPLETED|Washout Period After Period 1 Treatment||1
399627|NCT00943852|954001|P5|COMPLETED|Washout Period After Period 1 Treatment||1
399628|NCT00943852|954002|P4|COMPLETED|Washout Period After Period 1 Treatment||1
399629|NCT00943852|954003|P3|COMPLETED|Washout Period After Period 1 Treatment||1
399630|NCT00943852|954004|P2|COMPLETED|Washout Period After Period 1 Treatment||1
399631|NCT00943852|954005|P1|COMPLETED|Washout Period After Period 1 Treatment||2
399632|NCT00943852|953996|P10|STARTED|Washout Period After Period 1 Treatment||1
399633|NCT00943852|953997|P9|STARTED|Washout Period After Period 1 Treatment||1
399634|NCT00943852|953998|P8|STARTED|Washout Period After Period 1 Treatment||1
399635|NCT00943852|953999|P7|STARTED|Washout Period After Period 1 Treatment||2
399636|NCT00943852|954000|P6|STARTED|Washout Period After Period 1 Treatment||1
399637|NCT00943852|954001|P5|STARTED|Washout Period After Period 1 Treatment||1
399638|NCT00943852|954002|P4|STARTED|Washout Period After Period 1 Treatment||2
399639|NCT00943852|954003|P3|STARTED|Washout Period After Period 1 Treatment||1
399640|NCT00943852|954004|P2|STARTED|Washout Period After Period 1 Treatment||1
399641|NCT00943852|954005|P1|STARTED|Washout Period After Period 1 Treatment||2
399642|NCT00943852|953996|P10|NOT COMPLETED|First Period of Treatment Intervention||0
399643|NCT00943852|953997|P9|NOT COMPLETED|First Period of Treatment Intervention||0
399644|NCT00943852|953998|P8|NOT COMPLETED|First Period of Treatment Intervention||0
399645|NCT00943852|953999|P7|NOT COMPLETED|First Period of Treatment Intervention||0
399646|NCT00943852|954000|P6|NOT COMPLETED|First Period of Treatment Intervention||0
399647|NCT00943852|954001|P5|NOT COMPLETED|First Period of Treatment Intervention||0
399648|NCT00943852|954002|P4|NOT COMPLETED|First Period of Treatment Intervention||0
399649|NCT00943852|954003|P3|NOT COMPLETED|First Period of Treatment Intervention||0
399650|NCT00943852|954004|P2|NOT COMPLETED|First Period of Treatment Intervention||0
399651|NCT00943852|954005|P1|NOT COMPLETED|First Period of Treatment Intervention||0
399652|NCT00943852|953996|P10|COMPLETED|First Period of Treatment Intervention||1
399653|NCT00943852|953997|P9|COMPLETED|First Period of Treatment Intervention||1
399654|NCT00943852|953998|P8|COMPLETED|First Period of Treatment Intervention||1
399655|NCT00943852|953999|P7|COMPLETED|First Period of Treatment Intervention||2
399656|NCT00943852|954000|P6|COMPLETED|First Period of Treatment Intervention||1
399657|NCT00943852|954001|P5|COMPLETED|First Period of Treatment Intervention||1
399658|NCT00943852|954002|P4|COMPLETED|First Period of Treatment Intervention||2
399659|NCT00943852|954003|P3|COMPLETED|First Period of Treatment Intervention||1
399660|NCT00943852|954004|P2|COMPLETED|First Period of Treatment Intervention||1
399661|NCT00943852|954005|P1|COMPLETED|First Period of Treatment Intervention||2
399662|NCT00943852|953996|P10|STARTED|First Period of Treatment Intervention||1
399663|NCT00943852|953997|P9|STARTED|First Period of Treatment Intervention||1
399664|NCT00943852|953998|P8|STARTED|First Period of Treatment Intervention||1
399665|NCT00943852|953999|P7|STARTED|First Period of Treatment Intervention||2
399666|NCT00943852|954000|P6|STARTED|First Period of Treatment Intervention||1
399667|NCT00943852|954001|P5|STARTED|First Period of Treatment Intervention||1
399668|NCT00943852|954002|P4|STARTED|First Period of Treatment Intervention||2
399669|NCT00943852|954003|P3|STARTED|First Period of Treatment Intervention||1
399670|NCT00943852|954004|P2|STARTED|First Period of Treatment Intervention||1
399671|NCT00943852|954005|P1|STARTED|First Period of Treatment Intervention||2
399672|NCT00943826|954018|P2|NOT COMPLETED|Monotherapy Phase||13
399673|NCT00943826|954019|P1|NOT COMPLETED|Monotherapy Phase||51
399674|NCT00943826|954018|P2|COMPLETED|Monotherapy Phase||146
399675|NCT00943826|954019|P1|COMPLETED|Monotherapy Phase||218
399676|NCT00943826|954018|P2|STARTED|Monotherapy Phase||159
399677|NCT00943826|954019|P1|STARTED|Monotherapy Phase||269
399678|NCT00943826|954018|P2|NOT COMPLETED|Maintenance Phase||41
399679|NCT00943826|954019|P1|NOT COMPLETED|Maintenance Phase||43
399680|NCT00943826|954018|P2|COMPLETED|Maintenance Phase||329
399681|NCT00943826|954019|P1|COMPLETED|Maintenance Phase||353
399682|NCT00943826|954018|P2|STARTED|Maintenance Phase||370
399683|NCT00943826|954019|P1|STARTED|Maintenance Phase||396
399684|NCT00943826|954018|P2|NOT COMPLETED|Concurrent Phase||42
399685|NCT00943826|954019|P1|NOT COMPLETED|Concurrent Phase||61
399686|NCT00943826|954018|P2|COMPLETED|Concurrent Phase||421
399687|NCT00943826|954019|P1|COMPLETED|Concurrent Phase||397
399688|NCT00943826|954018|P2|Received Randomized Treatment|Concurrent Phase||459
399689|NCT00943826|954019|P1|Received Randomized Treatment|Concurrent Phase||452
399690|NCT00943826|954018|P2|STARTED|Concurrent Phase||463
399691|NCT00943826|954019|P1|STARTED|Concurrent Phase||458
399692|NCT00943787|954033|P1|NOT COMPLETED|Overall Study||7
399693|NCT00943787|954033|P1|COMPLETED|Overall Study||34
399694|NCT00943787|954033|P1|STARTED|Overall Study||41
399695|NCT00943761|954040|P2|NOT COMPLETED|Overall Study||1
399696|NCT00943761|954041|P1|NOT COMPLETED|Overall Study||4
399697|NCT00943761|954040|P2|COMPLETED|Overall Study||23
399698|NCT00943761|954041|P1|COMPLETED|Overall Study||17
399699|NCT00943761|954040|P2|STARTED|Overall Study||24
399700|NCT00943761|954041|P1|STARTED|Overall Study||21
399701|NCT00943735|954053|P1|NOT COMPLETED|Overall Study||32
399702|NCT00943735|954053|P1|COMPLETED|Overall Study||742
399703|NCT00943735|954053|P1|Per Protocol Population|Overall Study||500
399704|NCT00943735|954053|P1|STARTED|Overall Study||774
399705|NCT00943722|954091|P5|NOT COMPLETED|Overall Study||22
399706|NCT00943722|954092|P4|NOT COMPLETED|Overall Study||22
399707|NCT00943722|954093|P3|NOT COMPLETED|Overall Study||13
399708|NCT00943722|954094|P2|NOT COMPLETED|Overall Study||22
399709|NCT00943722|954095|P1|NOT COMPLETED|Overall Study||25
399710|NCT00943722|954091|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
399711|NCT00943722|954092|P4|COMPLETED|Overall Study||647
399712|NCT00943722|954093|P3|COMPLETED|Overall Study||631
399713|NCT00943722|954094|P2|COMPLETED|Overall Study||621
399714|NCT00943722|954095|P1|COMPLETED|Overall Study||623
399715|NCT00943722|954091|P5|Vaccination 3|Overall Study||455
399716|NCT00943722|954092|P4|Vaccination 3|Overall Study||653
399717|NCT00943722|954093|P3|Vaccination 3|Overall Study||637
399718|NCT00943722|954094|P2|Vaccination 3|Overall Study||627
399719|NCT00943722|954095|P1|Vaccination 3|Overall Study||635
399720|NCT00943722|954091|P5|Vaccination 2|Overall Study||462
399721|NCT00943722|954092|P4|Vaccination 2|Overall Study||658
399722|NCT00943722|954093|P3|Vaccination 2|Overall Study||638
399723|NCT00943722|954094|P2|Vaccination 2|Overall Study||633
399724|NCT00943722|954095|P1|Vaccination 2|Overall Study||637
399725|NCT00943722|954091|P5|Vaccination 1|Overall Study||468
399726|NCT00943722|954092|P4|Vaccination 1|Overall Study||666
399727|NCT00943722|954093|P3|Vaccination 1|Overall Study||644
399728|NCT00943722|954094|P2|Vaccination 1|Overall Study||642
399729|NCT00943722|954095|P1|Vaccination 1|Overall Study||646
399730|NCT00943722|954091|P5|STARTED|Overall Study||470
399731|NCT00943722|954092|P4|STARTED|Overall Study||669
399732|NCT00943722|954093|P3|STARTED|Overall Study||644
399733|NCT00943722|954094|P2|STARTED|Overall Study||643
399734|NCT00943722|954095|P1|STARTED|Overall Study||648
399735|NCT00943683|954125|P2|NOT COMPLETED|Overall Study||6
399736|NCT00943683|954126|P1|NOT COMPLETED|Overall Study||7
399737|NCT00943683|954125|P2|COMPLETED|Overall Study||169
399738|NCT00943683|954126|P1|COMPLETED|Overall Study||74
399739|NCT00943683|954125|P2|STARTED|Overall Study||175
399740|NCT00943683|954126|P1|STARTED|Overall Study||81
399741|NCT00943670|954132|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
399742|NCT00943670|954132|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
399743|NCT00943670|954132|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
399744|NCT00943670|954132|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
399745|NCT00943670|954132|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
399746|NCT00943670|954132|P1|Treated|Single-agent Trastuzumab Emtansine||51
399747|NCT00943670|954132|P1|STARTED|Single-agent Trastuzumab Emtansine||51
399748|NCT00943631|954168|P2|NOT COMPLETED|Overall Study||2
399749|NCT00943631|954169|P1|NOT COMPLETED|Overall Study||4
399750|NCT00943631|954168|P2|COMPLETED|Overall Study||202
399751|NCT00943631|954169|P1|COMPLETED|Overall Study||198
399752|NCT00943631|954168|P2|STARTED|Overall Study||204
399753|NCT00943631|954169|P1|STARTED|Overall Study||202
399754|NCT00943605|954221|P2|NOT COMPLETED|Overall Study||30
399755|NCT00943605|954222|P1|NOT COMPLETED|Overall Study||30
399756|NCT00943605|954221|P2|COMPLETED|Overall Study||0
399757|NCT00943605|954222|P1|COMPLETED|Overall Study||0
399758|NCT00943605|954221|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
399759|NCT00943605|954222|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
399760|NCT00943592|954232|P1|NOT COMPLETED|Overall Study||3
399761|NCT00943592|954232|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
399762|NCT00943592|954232|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
399763|NCT00943592|954232|P1|STARTED|Overall Study||82
399764|NCT00943579|954245|P2|NOT COMPLETED|Overall Study||5
399765|NCT00943579|954246|P1|NOT COMPLETED|Overall Study||6
399766|NCT00943579|954245|P2|COMPLETED|Overall Study||15
399767|NCT00943579|954246|P1|COMPLETED|Overall Study||15
399768|NCT00943579|954245|P2|STARTED|Overall Study||20
399769|NCT00943579|954246|P1|STARTED|Overall Study||21
399770|NCT00943488|954260|P2|NOT COMPLETED|Overall Study||2
399771|NCT00943488|954261|P1|NOT COMPLETED|Overall Study||1
399772|NCT00943488|954260|P2|COMPLETED|Overall Study||202
399773|NCT00943488|954261|P1|COMPLETED|Overall Study||203
399774|NCT00943488|954260|P2|STARTED|Overall Study||204
399775|NCT00943488|954261|P1|STARTED|Overall Study||204
399776|NCT00943436|954317|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
399777|NCT00943436|954318|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
399778|NCT00943436|954317|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
399779|NCT00943436|954318|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
399780|NCT00943436|954317|P2|STARTED|Rest Session: 45 Minutes of Reading||10
399781|NCT00943436|954318|P1|STARTED|Rest Session: 45 Minutes of Reading||10
399782|NCT00943436|954317|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
399783|NCT00943436|954318|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
399784|NCT00943436|954317|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
399785|NCT00943436|954318|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
399786|NCT00943436|954317|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
399787|NCT00943436|954318|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
399788|NCT00943397|954340|P2|NOT COMPLETED|Overall Study||72
399789|NCT00943397|954341|P1|NOT COMPLETED|Overall Study||15
399790|NCT00943397|954340|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
399791|NCT00943397|954341|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
399792|NCT00943397|954340|P2|STARTED|Overall Study||158
399793|NCT00943397|954341|P1|STARTED|Overall Study||32
399794|NCT00943384|954347|P1|NOT COMPLETED|Overall Study||49
399795|NCT00943384|954347|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
399796|NCT00943384|954347|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
399881|NCT00942851|954763|P2|COMPLETED|Overall Study||11
399797|NCT00943384|954347|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
399798|NCT00943384|954347|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
399799|NCT00943202|954365|P4|NOT COMPLETED|Overall Study||1
399800|NCT00943202|954366|P3|NOT COMPLETED|Overall Study||0
399801|NCT00943202|954367|P2|NOT COMPLETED|Overall Study||2
399802|NCT00943202|954368|P1|NOT COMPLETED|Overall Study||1
399803|NCT00943202|954365|P4|COMPLETED|Overall Study||131
399804|NCT00943202|954366|P3|COMPLETED|Overall Study||133
399805|NCT00943202|954367|P2|COMPLETED|Overall Study||131
399806|NCT00943202|954368|P1|COMPLETED|Overall Study||132
399807|NCT00943202|954365|P4|STARTED|Overall Study||132
399808|NCT00943202|954366|P3|STARTED|Overall Study||133
399809|NCT00943202|954367|P2|STARTED|Overall Study||133
399810|NCT00943202|954368|P1|STARTED|Overall Study||133
399811|NCT00943150|954584|P2|NOT COMPLETED|Overall Study||0
399812|NCT00943150|954585|P1|NOT COMPLETED|Overall Study||0
399813|NCT00943150|954584|P2|COMPLETED|Overall Study||10
399814|NCT00943150|954585|P1|COMPLETED|Overall Study||10
399815|NCT00943150|954584|P2|STARTED|Overall Study||10
399816|NCT00943150|954585|P1|STARTED|Overall Study||10
399817|NCT00943124|954606|P2|NOT COMPLETED|Period 2||0
399818|NCT00943124|954607|P1|NOT COMPLETED|Period 2||0
399819|NCT00943124|954606|P2|COMPLETED|Period 2||108
399820|NCT00943124|954607|P1|COMPLETED|Period 2||108
399821|NCT00943124|954606|P2|STARTED|Period 2||108
399822|NCT00943124|954607|P1|STARTED|Period 2||108
399823|NCT00943124|954606|P2|NOT COMPLETED|Period 1||2
399824|NCT00943124|954607|P1|NOT COMPLETED|Period 1||2
399825|NCT00943124|954606|P2|COMPLETED|Period 1||108
399826|NCT00943124|954607|P1|COMPLETED|Period 1||108
399827|NCT00943124|954606|P2|STARTED|Period 1||110
399828|NCT00943124|954607|P1|STARTED|Period 1||110
399829|NCT00943111|954629|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
399830|NCT00943111|954630|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
399831|NCT00943111|954631|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
399832|NCT00943111|954629|P3|COMPLETED|5 Years Long-term Treatment Period||77
399833|NCT00943111|954630|P2|COMPLETED|5 Years Long-term Treatment Period||0
399834|NCT00943111|954631|P1|COMPLETED|5 Years Long-term Treatment Period||0
399835|NCT00943111|954629|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
399836|NCT00943111|954630|P2|STARTED|5 Years Long-term Treatment Period||0
399837|NCT00943111|954631|P1|STARTED|5 Years Long-term Treatment Period||0
399838|NCT00943111|954629|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
399839|NCT00943111|954630|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
399840|NCT00943111|954631|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
399841|NCT00943111|954629|P3|COMPLETED|52-Weeks Primary Analysis Period||0
399842|NCT00943111|954630|P2|COMPLETED|52-Weeks Primary Analysis Period||52
399843|NCT00943111|954631|P1|COMPLETED|52-Weeks Primary Analysis Period||104
399844|NCT00943111|954629|P3|Treated|52-Weeks Primary Analysis Period||0
399845|NCT00943111|954630|P2|Treated|52-Weeks Primary Analysis Period||53
399846|NCT00943111|954631|P1|Treated|52-Weeks Primary Analysis Period||106
399847|NCT00943111|954629|P3|STARTED|52-Weeks Primary Analysis Period||0
399848|NCT00943111|954630|P2|STARTED|52-Weeks Primary Analysis Period||54
399849|NCT00943111|954631|P1|STARTED|52-Weeks Primary Analysis Period||106
399850|NCT00943098|954664|P2|NOT COMPLETED|Overall Study||0
399851|NCT00943098|954665|P1|NOT COMPLETED|Overall Study||0
399852|NCT00943098|954664|P2|COMPLETED|Overall Study||72
399853|NCT00943098|954665|P1|COMPLETED|Overall Study||70
399854|NCT00943098|954664|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
399855|NCT00943098|954665|P1|STARTED|Overall Study||70
399856|NCT00943072|954699|P2|NOT COMPLETED|Overall Study||14
399857|NCT00943072|954700|P1|NOT COMPLETED|Overall Study||5
399858|NCT00943072|954699|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
399859|NCT00943072|954700|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
399860|NCT00943072|954699|P2|Full Analysis Set (FAS) Population|Overall Study||73
399861|NCT00943072|954700|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
399862|NCT00943072|954699|P2|Participants Received Treatment|Overall Study||74
399863|NCT00943072|954700|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
399864|NCT00943072|954699|P2|STARTED|Overall Study||74
399865|NCT00943072|954700|P1|STARTED|Overall Study||115
399866|NCT00942994|954718|P2|NOT COMPLETED|Overall Study||19
399867|NCT00942994|954719|P1|NOT COMPLETED|Overall Study||16
399868|NCT00942994|954718|P2|COMPLETED|Overall Study||190
399869|NCT00942994|954719|P1|COMPLETED|Overall Study||187
399870|NCT00942994|954718|P2|STARTED|Overall Study||209
399871|NCT00942994|954719|P1|STARTED|Overall Study||203
399872|NCT00942968|954735|P1|NOT COMPLETED|Overall Study||229
399873|NCT00942968|954735|P1|COMPLETED|Overall Study||109
399874|NCT00942968|954735|P1|Treated|Overall Study||334
399875|NCT00942968|954735|P1|STARTED|Overall Study||338
399876|NCT00942903|954756|P1|NOT COMPLETED|Overall Study||0
399877|NCT00942903|954756|P1|COMPLETED|Overall Study||20
399878|NCT00942903|954756|P1|STARTED|Overall Study||20
399879|NCT00942851|954763|P2|NOT COMPLETED|Overall Study||1
399880|NCT00942851|954764|P1|NOT COMPLETED|Overall Study||0
399882|NCT00942851|954764|P1|COMPLETED|Overall Study||12
399883|NCT00942851|954763|P2|STARTED|Overall Study||12
399884|NCT00942851|954764|P1|STARTED|Overall Study||12
399885|NCT00942825|954776|P2|NOT COMPLETED|Overall Study||0
399886|NCT00942825|954777|P1|NOT COMPLETED|Overall Study||0
399887|NCT00942825|954776|P2|COMPLETED|Overall Study||98
399888|NCT00942825|954777|P1|COMPLETED|Overall Study||97
399889|NCT00942825|954776|P2|STARTED|Overall Study||98
399890|NCT00942825|954777|P1|STARTED|Overall Study||97
399891|NCT00942786|954783|P1|NOT COMPLETED|Overall Study||0
399892|NCT00942786|954783|P1|COMPLETED|Overall Study|date of last follow-up|297
399893|NCT00942786|954783|P1|STARTED|Overall Study||297
399894|NCT00942734|954790|P1|NOT COMPLETED|Overall Study||8
399895|NCT00942734|954790|P1|COMPLETED|Overall Study||35
399896|NCT00942734|954790|P1|STARTED|Overall Study||43
399897|NCT00942604|954796|P2|NOT COMPLETED|Overall Study||4
399898|NCT00942604|954797|P1|NOT COMPLETED|Overall Study||2
399899|NCT00942604|954796|P2|COMPLETED|Overall Study||99
399900|NCT00942604|954797|P1|COMPLETED|Overall Study||98
399901|NCT00942604|954796|P2|STARTED|Overall Study||103
399902|NCT00942604|954797|P1|STARTED|Overall Study||100
399903|NCT00942448|954809|P4|NOT COMPLETED|Overall Study||0
399904|NCT00942448|954810|P3|NOT COMPLETED|Overall Study||0
399905|NCT00942448|954811|P2|NOT COMPLETED|Overall Study||0
399906|NCT00942448|954812|P1|NOT COMPLETED|Overall Study||0
399907|NCT00942448|954809|P4|COMPLETED|Overall Study||75
399908|NCT00942448|954810|P3|COMPLETED|Overall Study||78
399909|NCT00942448|954811|P2|COMPLETED|Overall Study||76
399910|NCT00942448|954812|P1|COMPLETED|Overall Study||77
399911|NCT00942448|954809|P4|STARTED|Overall Study||75
399912|NCT00942448|954810|P3|STARTED|Overall Study||78
399913|NCT00942448|954811|P2|STARTED|Overall Study||76
399914|NCT00942448|954812|P1|STARTED|Overall Study||77
399915|NCT00942422|954874|P1|NOT COMPLETED|Overall Study||3
399916|NCT00942422|954874|P1|COMPLETED|Overall Study||5
399917|NCT00942422|954874|P1|STARTED|Overall Study||8
399918|NCT00942409|954878|P1|NOT COMPLETED|Overall Study||3
399919|NCT00942409|954878|P1|COMPLETED|Overall Study||2
399920|NCT00942409|954878|P1|STARTED|Overall Study||5
399921|NCT00942266|954884|P2|NOT COMPLETED|Overall Study||15
399922|NCT00942266|954885|P1|NOT COMPLETED|Overall Study||43
399923|NCT00942266|954884|P2|COMPLETED|Overall Study||0
399924|NCT00942266|954885|P1|COMPLETED|Overall Study||0
399925|NCT00942266|954884|P2|STARTED|Overall Study||15
399926|NCT00942266|954885|P1|STARTED|Overall Study||43
399927|NCT00942175|954907|P4|NOT COMPLETED|Overall Study||2
399928|NCT00942175|954908|P3|NOT COMPLETED|Overall Study||2
399929|NCT00942175|954909|P2|NOT COMPLETED|Overall Study||4
399930|NCT00942175|954910|P1|NOT COMPLETED|Overall Study||2
399931|NCT00942175|954907|P4|COMPLETED|Overall Study||38
399932|NCT00942175|954908|P3|COMPLETED|Overall Study||38
399933|NCT00942175|954909|P2|COMPLETED|Overall Study||36
399934|NCT00942175|954910|P1|COMPLETED|Overall Study||38
399935|NCT00942175|954907|P4|STARTED|Overall Study||40
399936|NCT00942175|954908|P3|STARTED|Overall Study||40
399937|NCT00942175|954909|P2|STARTED|Overall Study||40
399938|NCT00942175|954910|P1|STARTED|Overall Study||40
399939|NCT00942149|954960|P1|NOT COMPLETED|Overall Study||0
399940|NCT00942149|954960|P1|COMPLETED|Overall Study||20
399941|NCT00942149|954960|P1|STARTED|Overall Study||20
399942|NCT00942084|954964|P1|NOT COMPLETED|Overall Study||2
399943|NCT00942084|954964|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
399944|NCT00942084|954964|P1|STARTED|Overall Study||32
399945|NCT00941993|954973|P1|NOT COMPLETED|Overall Study||0
399946|NCT00941993|954973|P1|COMPLETED|Overall Study||109
399947|NCT00941993|954973|P1|STARTED|Overall Study||109
399948|NCT00941928|954981|P1|NOT COMPLETED|Overall Study||2
399949|NCT00941928|954981|P1|COMPLETED|Overall Study||0
399950|NCT00941928|954981|P1|STARTED|Overall Study||2
399951|NCT00941889|954987|P2|NOT COMPLETED|Overall Study||12
399952|NCT00941889|954988|P1|NOT COMPLETED|Overall Study||12
399953|NCT00941889|954987|P2|COMPLETED|Overall Study||3
399954|NCT00941889|954988|P1|COMPLETED|Overall Study||5
399955|NCT00941889|954987|P2|STARTED|Overall Study||15
399956|NCT00941889|954988|P1|STARTED|Overall Study||17
399957|NCT00941863|954999|P5|NOT COMPLETED|Continued After PCD||19
399958|NCT00941863|955000|P4|NOT COMPLETED|Continued After PCD||0
399959|NCT00941863|955001|P3|NOT COMPLETED|Continued After PCD||0
399960|NCT00941863|955002|P2|NOT COMPLETED|Continued After PCD||0
399961|NCT00941863|955003|P1|NOT COMPLETED|Continued After PCD||0
399962|NCT00941863|954999|P5|COMPLETED|Continued After PCD||6
399963|NCT00941863|955000|P4|COMPLETED|Continued After PCD||0
399964|NCT00941863|955001|P3|COMPLETED|Continued After PCD||0
399965|NCT00941863|955002|P2|COMPLETED|Continued After PCD||0
399966|NCT00941863|955003|P1|COMPLETED|Continued After PCD||0
399967|NCT00941863|954999|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
399968|NCT00941863|955000|P4|STARTED|Continued After PCD||0
399969|NCT00941863|955001|P3|STARTED|Continued After PCD||0
399970|NCT00941863|955002|P2|STARTED|Continued After PCD||0
399971|NCT00941863|955003|P1|STARTED|Continued After PCD||0
399972|NCT00941863|954999|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
399973|NCT00941863|955000|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
399974|NCT00941863|955001|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
399975|NCT00941863|955002|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
399976|NCT00941863|955003|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
399977|NCT00941863|954999|P5|COMPLETED|Until Primary Completion Date (PCD)||25
399978|NCT00941863|955000|P4|COMPLETED|Until Primary Completion Date (PCD)||0
399979|NCT00941863|955001|P3|COMPLETED|Until Primary Completion Date (PCD)||0
399980|NCT00941863|955002|P2|COMPLETED|Until Primary Completion Date (PCD)||0
399981|NCT00941863|955003|P1|COMPLETED|Until Primary Completion Date (PCD)||0
399982|NCT00941863|954999|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
399983|NCT00941863|955000|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
399984|NCT00941863|955001|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
399985|NCT00941863|955002|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
399986|NCT00941863|955003|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
399987|NCT00941863|954999|P5|STARTED|Until Primary Completion Date (PCD)||119
399988|NCT00941863|955000|P4|STARTED|Until Primary Completion Date (PCD)||17
399989|NCT00941863|955001|P3|STARTED|Until Primary Completion Date (PCD)||12
399990|NCT00941863|955002|P2|STARTED|Until Primary Completion Date (PCD)||3
399991|NCT00941863|955003|P1|STARTED|Until Primary Completion Date (PCD)||7
399992|NCT00941798|955030|P2|NOT COMPLETED|Overall Study||185
399993|NCT00941798|955031|P1|NOT COMPLETED|Overall Study||194
399994|NCT00941798|955030|P2|COMPLETED|Overall Study||578
399995|NCT00941798|955031|P1|COMPLETED|Overall Study||561
399996|NCT00941798|955030|P2|Full Analysis Set|Overall Study||759
399997|NCT00941798|955031|P1|Full Analysis Set|Overall Study||749
399998|NCT00941798|955030|P2|STARTED|Overall Study||763
399999|NCT00941798|955031|P1|STARTED|Overall Study||755
400000|NCT00941733|955061|P2|NOT COMPLETED|Overall Study||28
400001|NCT00941733|955062|P1|NOT COMPLETED|Overall Study||74
400002|NCT00941733|955061|P2|COMPLETED|Overall Study|1 year follow-up|91
400003|NCT00941733|955062|P1|COMPLETED|Overall Study|1 year follow-up|165
400004|NCT00941733|955061|P2|STARTED|Overall Study||119
400005|NCT00941733|955062|P1|STARTED|Overall Study||239
400006|NCT00941720|955102|P1|NOT COMPLETED|Overall Study||14
400007|NCT00941720|955102|P1|COMPLETED|Overall Study||57
400008|NCT00941720|955102|P1|STARTED|Overall Study||71
400009|NCT00941681|955111|P3|NOT COMPLETED|Overall Study||0
400010|NCT00941681|955112|P2|NOT COMPLETED|Overall Study||1
400011|NCT00941681|955113|P1|NOT COMPLETED|Overall Study||0
400012|NCT00941681|955111|P3|COMPLETED|Overall Study||12
400013|NCT00941681|955112|P2|COMPLETED|Overall Study||10
400014|NCT00941681|955113|P1|COMPLETED|Overall Study||12
400015|NCT00941681|955111|P3|STARTED|Overall Study||12
400016|NCT00941681|955112|P2|STARTED|Overall Study||11
400017|NCT00941681|955113|P1|STARTED|Overall Study||12
400018|NCT00941668|955138|P2|NOT COMPLETED|Overall Study||25
400019|NCT00941668|955139|P1|NOT COMPLETED|Overall Study||24
400020|NCT00941668|955138|P2|COMPLETED|Overall Study||0
400021|NCT00941668|955139|P1|COMPLETED|Overall Study||0
400022|NCT00941668|955138|P2|STARTED|Overall Study||25
400023|NCT00941668|955139|P1|STARTED|Overall Study||24
400024|NCT00941655|955149|P2|NOT COMPLETED|Overall Study||7
400025|NCT00941655|955150|P1|NOT COMPLETED|Overall Study||6
400026|NCT00941655|955149|P2|COMPLETED|Overall Study||1
400027|NCT00941655|955150|P1|COMPLETED|Overall Study||2
400028|NCT00941655|955149|P2|STARTED|Overall Study||8
400029|NCT00941655|955150|P1|STARTED|Overall Study||8
400030|NCT00941603|955164|P6|NOT COMPLETED|Overall Study||3
400031|NCT00941603|955165|P5|NOT COMPLETED|Overall Study||4
400032|NCT00941603|955166|P4|NOT COMPLETED|Overall Study||4
400033|NCT00941603|955167|P3|NOT COMPLETED|Overall Study||5
400034|NCT00941603|955168|P2|NOT COMPLETED|Overall Study||16
400035|NCT00941603|955169|P1|NOT COMPLETED|Overall Study||11
400036|NCT00941603|955164|P6|COMPLETED|Overall Study||94
400037|NCT00941603|955165|P5|COMPLETED|Overall Study||101
400038|NCT00941603|955166|P4|COMPLETED|Overall Study||100
400039|NCT00941603|955167|P3|COMPLETED|Overall Study||99
400040|NCT00941603|955168|P2|COMPLETED|Overall Study||89
400041|NCT00941603|955169|P1|COMPLETED|Overall Study||93
400042|NCT00941603|955164|P6|STARTED|Overall Study||97
400043|NCT00941603|955165|P5|STARTED|Overall Study||105
400044|NCT00941603|955166|P4|STARTED|Overall Study||104
400045|NCT00941603|955167|P3|STARTED|Overall Study||104
400046|NCT00941603|955168|P2|STARTED|Overall Study||105
400047|NCT00941603|955169|P1|STARTED|Overall Study||104
400048|NCT00941330|955191|P2|NOT COMPLETED|Overall Study||2
400049|NCT00941330|955192|P1|NOT COMPLETED|Overall Study||1
400050|NCT00941330|955191|P2|COMPLETED|Overall Study||9
400051|NCT00941330|955192|P1|COMPLETED|Overall Study||14
400052|NCT00941330|955191|P2|STARTED|Overall Study||11
400053|NCT00941330|955192|P1|STARTED|Overall Study||15
400054|NCT00941304|955205|P5|NOT COMPLETED|Overall Study||0
400055|NCT00941304|955206|P4|NOT COMPLETED|Overall Study||0
400056|NCT00941304|955207|P3|NOT COMPLETED|Overall Study||0
400057|NCT00941304|955208|P2|NOT COMPLETED|Overall Study||0
400058|NCT00941304|955209|P1|NOT COMPLETED|Overall Study||1
400059|NCT00941304|955205|P5|COMPLETED|Overall Study||31
400060|NCT00941304|955206|P4|COMPLETED|Overall Study||30
400061|NCT00941304|955207|P3|COMPLETED|Overall Study||31
400062|NCT00941304|955208|P2|COMPLETED|Overall Study||30
400063|NCT00941304|955209|P1|COMPLETED|Overall Study||30
400064|NCT00941304|955205|P5|STARTED|Overall Study||31
400065|NCT00941304|955206|P4|STARTED|Overall Study||30
400066|NCT00941304|955207|P3|STARTED|Overall Study||31
400067|NCT00941304|955208|P2|STARTED|Overall Study||30
400068|NCT00941304|955209|P1|STARTED|Overall Study||31
400069|NCT00941070|955271|P1|NOT COMPLETED|Overall Study||1
400070|NCT00941070|955271|P1|COMPLETED|Overall Study||25
400071|NCT00941070|955271|P1|STARTED|Overall Study||26
400072|NCT00941031|955289|P7|NOT COMPLETED|Maintenance Period||43
400073|NCT00941031|955290|P6|NOT COMPLETED|Maintenance Period||6
400074|NCT00941031|955291|P5|NOT COMPLETED|Maintenance Period||9
400075|NCT00941031|955292|P4|NOT COMPLETED|Maintenance Period||0
400076|NCT00941031|955293|P3|NOT COMPLETED|Maintenance Period||0
400077|NCT00941031|955294|P2|NOT COMPLETED|Maintenance Period||0
400078|NCT00941031|955295|P1|NOT COMPLETED|Maintenance Period||0
400079|NCT00941031|955289|P7|COMPLETED|Maintenance Period||204
400080|NCT00941031|955290|P6|COMPLETED|Maintenance Period||61
400081|NCT00941031|955291|P5|COMPLETED|Maintenance Period||56
400082|NCT00941031|955292|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
400083|NCT00941031|955293|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
400084|NCT00941031|955294|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
400085|NCT00941031|955295|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
400086|NCT00941031|955289|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
400087|NCT00941031|955290|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
400088|NCT00941031|955291|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
400089|NCT00941031|955292|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
400090|NCT00941031|955293|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
400091|NCT00941031|955294|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
400092|NCT00941031|955295|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
400093|NCT00941031|955289|P7|NOT COMPLETED|Induction Period||0
400094|NCT00941031|955290|P6|NOT COMPLETED|Induction Period||0
400095|NCT00941031|955291|P5|NOT COMPLETED|Induction Period||0
400096|NCT00941031|955292|P4|NOT COMPLETED|Induction Period||9
400097|NCT00941031|955293|P3|NOT COMPLETED|Induction Period||6
400098|NCT00941031|955294|P2|NOT COMPLETED|Induction Period||4
400099|NCT00941031|955295|P1|NOT COMPLETED|Induction Period||5
400100|NCT00941031|955289|P7|COMPLETED|Induction Period||0
400101|NCT00941031|955290|P6|COMPLETED|Induction Period||0
400102|NCT00941031|955291|P5|COMPLETED|Induction Period||0
400103|NCT00941031|955292|P4|COMPLETED|Induction Period||58
400104|NCT00941031|955293|P3|COMPLETED|Induction Period||127
400105|NCT00941031|955294|P2|COMPLETED|Induction Period||134
400106|NCT00941031|955295|P1|COMPLETED|Induction Period||61
400107|NCT00941031|955289|P7|STARTED|Induction Period||0
400108|NCT00941031|955290|P6|STARTED|Induction Period||0
400109|NCT00941031|955291|P5|STARTED|Induction Period||0
400110|NCT00941031|955292|P4|STARTED|Induction Period||67
400111|NCT00941031|955293|P3|STARTED|Induction Period||133
400112|NCT00941031|955294|P2|STARTED|Induction Period||138
400113|NCT00941031|955295|P1|STARTED|Induction Period||66
400114|NCT00940992|955321|P3|NOT COMPLETED|Overall Study||2
400115|NCT00940992|955322|P2|NOT COMPLETED|Overall Study||2
400116|NCT00940992|955323|P1|NOT COMPLETED|Overall Study||4
400117|NCT00940992|955321|P3|COMPLETED|Overall Study||28
400118|NCT00940992|955322|P2|COMPLETED|Overall Study||28
400119|NCT00940992|955323|P1|COMPLETED|Overall Study||28
400120|NCT00940992|955321|P3|STARTED|Overall Study||30
400121|NCT00940992|955322|P2|STARTED|Overall Study||30
400122|NCT00940992|955323|P1|STARTED|Overall Study||32
400123|NCT00940927|955334|P1|NOT COMPLETED|Overall Study||0
400124|NCT00940927|955334|P1|COMPLETED|Overall Study||81
400125|NCT00940927|955334|P1|STARTED|Overall Study||81
400126|NCT00940901|955341|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
400127|NCT00940901|955342|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
400128|NCT00940901|955341|P2|COMPLETED|Week 9-16 (Phase 2)||4
400129|NCT00940901|955342|P1|COMPLETED|Week 9-16 (Phase 2)||4
400130|NCT00940901|955341|P2|STARTED|Week 9-16 (Phase 2)||7
400131|NCT00940901|955342|P1|STARTED|Week 9-16 (Phase 2)||6
400132|NCT00940901|955341|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
400133|NCT00940901|955342|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
400134|NCT00940901|955341|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
400135|NCT00940901|955342|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
400136|NCT00940901|955341|P2|STARTED|Weeks 1-8 (Phase 1)||7
400137|NCT00940901|955342|P1|STARTED|Weeks 1-8 (Phase 1)||6
400138|NCT00940875|955354|P2|NOT COMPLETED|Post-Study Treatment||3
400139|NCT00940875|955355|P1|NOT COMPLETED|Post-Study Treatment||0
400140|NCT00940875|955354|P2|COMPLETED|Post-Study Treatment||1
400141|NCT00940875|955355|P1|COMPLETED|Post-Study Treatment||0
400142|NCT00940875|955354|P2|STARTED|Post-Study Treatment||4
400143|NCT00940875|955355|P1|STARTED|Post-Study Treatment||0
400144|NCT00940875|955354|P2|NOT COMPLETED|Treatment Phase||19
400145|NCT00940875|955355|P1|NOT COMPLETED|Treatment Phase||26
400146|NCT00940875|955354|P2|COMPLETED|Treatment Phase||4
400147|NCT00940875|955355|P1|COMPLETED|Treatment Phase||5
400148|NCT00940875|955354|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
400149|NCT00940875|955355|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
400150|NCT00940576|955373|P2|NOT COMPLETED|Overall Study||0
400151|NCT00940576|955374|P1|NOT COMPLETED|Overall Study||0
400152|NCT00940576|955373|P2|COMPLETED|Overall Study||9
400153|NCT00940576|955374|P1|COMPLETED|Overall Study||8
400154|NCT00940576|955373|P2|STARTED|Overall Study||9
400155|NCT00940576|955374|P1|STARTED|Overall Study||8
400156|NCT00940537|955383|P2|NOT COMPLETED|Overall Study||0
400157|NCT00940537|955384|P1|NOT COMPLETED|Overall Study||0
400158|NCT00940537|955383|P2|COMPLETED|Overall Study||9
400159|NCT00940537|955384|P1|COMPLETED|Overall Study||5
400160|NCT00940537|955383|P2|STARTED|Overall Study||9
400161|NCT00940537|955384|P1|STARTED|Overall Study||5
400162|NCT00940485|955395|P2|NOT COMPLETED|Overall Study||7
400163|NCT00940485|955396|P1|NOT COMPLETED|Overall Study||15
400164|NCT00940485|955395|P2|COMPLETED|Overall Study||93
400165|NCT00940485|955396|P1|COMPLETED|Overall Study||82
400166|NCT00940485|955395|P2|STARTED|Overall Study||100
400167|NCT00940485|955396|P1|STARTED|Overall Study||97
400168|NCT00940290|955424|P4|NOT COMPLETED|Overall Study||0
400169|NCT00940290|955425|P3|NOT COMPLETED|Overall Study||0
400170|NCT00940290|955426|P2|NOT COMPLETED|Overall Study||0
400171|NCT00940290|955427|P1|NOT COMPLETED|Overall Study||0
400172|NCT00940290|955424|P4|COMPLETED|Overall Study||54
400173|NCT00940290|955425|P3|COMPLETED|Overall Study||55
400174|NCT00940290|955426|P2|COMPLETED|Overall Study||53
400175|NCT00940290|955427|P1|COMPLETED|Overall Study||54
400176|NCT00940290|955424|P4|STARTED|Overall Study||54
400177|NCT00940290|955425|P3|STARTED|Overall Study||55
400178|NCT00940290|955426|P2|STARTED|Overall Study||53
400179|NCT00940290|955427|P1|STARTED|Overall Study||54
400180|NCT00940108|955441|P4|NOT COMPLETED|Overall Study||5
400181|NCT00940108|955442|P3|NOT COMPLETED|Overall Study||3
400182|NCT00940108|955443|P2|NOT COMPLETED|Overall Study||9
400183|NCT00940108|955444|P1|NOT COMPLETED|Overall Study||5
400184|NCT00940108|955441|P4|COMPLETED|Overall Study||99
400185|NCT00940108|955442|P3|COMPLETED|Overall Study||100
400186|NCT00940108|955443|P2|COMPLETED|Overall Study||71
400187|NCT00940108|955444|P1|COMPLETED|Overall Study||77
400188|NCT00940108|955441|P4|STARTED|Overall Study||104
400189|NCT00940108|955442|P3|STARTED|Overall Study||103
400190|NCT00940108|955443|P2|STARTED|Overall Study||80
400191|NCT00940108|955444|P1|STARTED|Overall Study||82
400192|NCT00940017|955494|P1|NOT COMPLETED|Overall Study||4
400193|NCT00940017|955494|P1|COMPLETED|Overall Study||20
400194|NCT00940017|955494|P1|Subjects Treated|Overall Study||21
400195|NCT00940017|955494|P1|STARTED|Overall Study||24
400196|NCT00939991|955515|P2|NOT COMPLETED|Overall Study||0
400197|NCT00939991|955516|P1|NOT COMPLETED|Overall Study||0
400198|NCT00939991|955515|P2|COMPLETED|Overall Study||39
400199|NCT00939991|955516|P1|COMPLETED|Overall Study||9
400200|NCT00939991|955515|P2|STARTED|Overall Study||39
400201|NCT00939991|955516|P1|STARTED|Overall Study||9
400202|NCT00939952|955526|P1|NOT COMPLETED|Overall Study||0
400203|NCT00939952|955526|P1|COMPLETED|Overall Study||7
400204|NCT00939952|955526|P1|STARTED|Overall Study||7
400205|NCT00939900|955538|P2|NOT COMPLETED|Overall Study||7
400206|NCT00939900|955539|P1|NOT COMPLETED|Overall Study||2
400207|NCT00939900|955538|P2|COMPLETED|Overall Study||48
400208|NCT00939900|955539|P1|COMPLETED|Overall Study||53
400209|NCT00939900|955538|P2|STARTED|Overall Study||55
400210|NCT00939900|955539|P1|STARTED|Overall Study||55
400211|NCT00939874|955545|P1|NOT COMPLETED|Overall Study||20
400212|NCT00939874|955545|P1|COMPLETED|Overall Study||32
400213|NCT00939874|955545|P1|Completed Week 48|Overall Study||37
400214|NCT00939874|955545|P1|STARTED|Overall Study||52
400215|NCT00939809|955550|P1|NOT COMPLETED|Overall Study||3
400216|NCT00939809|955550|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
400217|NCT00939809|955550|P1|STARTED|Overall Study||31
400218|NCT00939796|955558|P1|NOT COMPLETED|Overall Study||0
400219|NCT00939796|955558|P1|COMPLETED|Overall Study||16
400220|NCT00939796|955558|P1|STARTED|Overall Study||16
400221|NCT00939783|955564|P1|NOT COMPLETED|Overall Study||649
400222|NCT00939783|955564|P1|COMPLETED|Overall Study||0
400223|NCT00939783|955564|P1|Treated|Overall Study||648
400224|NCT00939783|955564|P1|STARTED|Overall Study||649
400225|NCT00939731|955571|P2|NOT COMPLETED|Second Intervention Period||0
400226|NCT00939731|955572|P1|NOT COMPLETED|Second Intervention Period||0
400227|NCT00939731|955571|P2|COMPLETED|Second Intervention Period||12
400228|NCT00939731|955572|P1|COMPLETED|Second Intervention Period||12
400229|NCT00939731|955571|P2|STARTED|Second Intervention Period||12
400230|NCT00939731|955572|P1|STARTED|Second Intervention Period||12
400231|NCT00939731|955571|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
400232|NCT00939731|955572|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
400233|NCT00939731|955571|P2|COMPLETED|Washout Period (at Least 14 Days)||12
400234|NCT00939731|955572|P1|COMPLETED|Washout Period (at Least 14 Days)||12
400235|NCT00939731|955571|P2|STARTED|Washout Period (at Least 14 Days)||12
400236|NCT00939731|955572|P1|STARTED|Washout Period (at Least 14 Days)||12
400237|NCT00939731|955571|P2|NOT COMPLETED|First Intervention Period||0
400238|NCT00939731|955572|P1|NOT COMPLETED|First Intervention Period||0
400239|NCT00939731|955571|P2|COMPLETED|First Intervention Period||12
400240|NCT00939731|955572|P1|COMPLETED|First Intervention Period||12
400241|NCT00939731|955571|P2|STARTED|First Intervention Period||12
400242|NCT00939731|955572|P1|STARTED|First Intervention Period||12
400243|NCT00939705|955592|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
400244|NCT00939705|955593|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
400245|NCT00939705|955592|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
400246|NCT00939705|955593|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
400247|NCT00939705|955592|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
400248|NCT00939705|955593|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
400249|NCT00939705|955592|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
400250|NCT00939705|955593|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
400251|NCT00939705|955592|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
400252|NCT00939705|955593|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
400253|NCT00939705|955592|P2|STARTED|Period 2 - Washout Period - 21 Days||9
400254|NCT00939705|955593|P1|STARTED|Period 2 - Washout Period - 21 Days||9
400255|NCT00939705|955592|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
400256|NCT00939705|955593|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
400257|NCT00939705|955592|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
400258|NCT00939705|955593|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
400259|NCT00939705|955592|P2|STARTED|Period 1 - First Intervention - 5 Days||9
400260|NCT00939705|955593|P1|STARTED|Period 1 - First Intervention - 5 Days||9
400261|NCT00939692|955605|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
400262|NCT00939692|955606|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
400263|NCT00939692|955605|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
400264|NCT00939692|955606|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
400265|NCT00939692|955605|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
400266|NCT00939692|955606|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
400267|NCT00939692|955605|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
400268|NCT00939692|955606|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
400269|NCT00939692|955605|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
400270|NCT00939692|955606|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
400271|NCT00939692|955605|P2|STARTED|Period 1 - First Intervention - 5 Days||13
400272|NCT00939692|955606|P1|STARTED|Period 1 - First Intervention - 5 Days||13
400273|NCT00939627|955618|P3|NOT COMPLETED|Overall Study||0
400274|NCT00939627|955619|P2|NOT COMPLETED|Overall Study||28
400275|NCT00939627|955620|P1|NOT COMPLETED|Overall Study||27
400276|NCT00939627|955618|P3|COMPLETED|Overall Study||0
400277|NCT00939627|955619|P2|COMPLETED|Overall Study||0
400278|NCT00939627|955620|P1|COMPLETED|Overall Study||0
400279|NCT00939627|955618|P3|STARTED|Overall Study||0
400280|NCT00939627|955619|P2|STARTED|Overall Study||28
400281|NCT00939627|955620|P1|STARTED|Overall Study||27
400282|NCT00939562|955634|P2|NOT COMPLETED|Period 2||0
400283|NCT00939562|955635|P1|NOT COMPLETED|Period 2||0
400284|NCT00939562|955634|P2|COMPLETED|Period 2||12
400285|NCT00939562|955635|P1|COMPLETED|Period 2||12
400286|NCT00939562|955634|P2|STARTED|Period 2||12
400287|NCT00939562|955635|P1|STARTED|Period 2||12
400288|NCT00939562|955634|P2|NOT COMPLETED|Period 1||0
400289|NCT00939562|955635|P1|NOT COMPLETED|Period 1||0
400290|NCT00939562|955634|P2|COMPLETED|Period 1||12
400291|NCT00939562|955635|P1|COMPLETED|Period 1||12
400292|NCT00939562|955634|P2|STARTED|Period 1||12
400293|NCT00939562|955635|P1|STARTED|Period 1||12
400294|NCT00939536|955645|P2|NOT COMPLETED|Second Intervention||0
400295|NCT00939536|955646|P1|NOT COMPLETED|Second Intervention||0
400296|NCT00939536|955645|P2|COMPLETED|Second Intervention||12
400297|NCT00939536|955646|P1|COMPLETED|Second Intervention||12
400298|NCT00939536|955645|P2|STARTED|Second Intervention||12
400299|NCT00939536|955646|P1|STARTED|Second Intervention||12
400300|NCT00939536|955645|P2|NOT COMPLETED|First Intervention||0
400301|NCT00939536|955646|P1|NOT COMPLETED|First Intervention||0
400302|NCT00939536|955645|P2|COMPLETED|First Intervention||12
400303|NCT00939536|955646|P1|COMPLETED|First Intervention||12
400304|NCT00939536|955645|P2|STARTED|First Intervention||12
400305|NCT00939536|955646|P1|STARTED|First Intervention||12
400306|NCT00939510|955656|P1|NOT COMPLETED|Overall Study||1
400307|NCT00939510|955656|P1|COMPLETED|Overall Study||31
400308|NCT00939510|955656|P1|STARTED|Overall Study||32
400309|NCT00939484|955665|P3|NOT COMPLETED|Overall Study||3
400310|NCT00939484|955666|P2|NOT COMPLETED|Overall Study||20
400311|NCT00939484|955667|P1|NOT COMPLETED|Overall Study||8
400312|NCT00939484|955665|P3|COMPLETED|Overall Study||0
400313|NCT00939484|955666|P2|COMPLETED|Overall Study||0
400314|NCT00939484|955667|P1|COMPLETED|Overall Study||0
400315|NCT00939484|955665|P3|STARTED|Overall Study||3
400316|NCT00939484|955666|P2|STARTED|Overall Study||20
400317|NCT00939484|955667|P1|STARTED|Overall Study||8
400318|NCT00939471|955680|P1|NOT COMPLETED|Overall Study||11
400319|NCT00939471|955680|P1|COMPLETED|Overall Study||33
400320|NCT00939471|955680|P1|STARTED|Overall Study||44
400321|NCT00939393|955693|P2|NOT COMPLETED|Overall Study||0
400322|NCT00939393|955694|P1|NOT COMPLETED|Overall Study||4
400323|NCT00939393|955693|P2|COMPLETED|Overall Study||35
400324|NCT00939393|955694|P1|COMPLETED|Overall Study||33
400325|NCT00939393|955693|P2|STARTED|Overall Study||35
400326|NCT00939393|955694|P1|STARTED|Overall Study||37
400327|NCT00939367|955714|P2|NOT COMPLETED|Second Intervention||0
400328|NCT00939367|955715|P1|NOT COMPLETED|Second Intervention||0
400329|NCT00939367|955714|P2|COMPLETED|Second Intervention||15
400330|NCT00939367|955715|P1|COMPLETED|Second Intervention||15
400331|NCT00939367|955714|P2|STARTED|Second Intervention||15
400332|NCT00939367|955715|P1|STARTED|Second Intervention||15
400333|NCT00939367|955714|P2|NOT COMPLETED|First Intervention||0
400334|NCT00939367|955715|P1|NOT COMPLETED|First Intervention||0
400335|NCT00939367|955714|P2|COMPLETED|First Intervention||15
400336|NCT00939367|955715|P1|COMPLETED|First Intervention||15
400337|NCT00939367|955714|P2|STARTED|First Intervention||15
400338|NCT00939367|955715|P1|STARTED|First Intervention||15
400339|NCT00939341|955725|P1|NOT COMPLETED|Overall Study||66
400340|NCT00939341|955725|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
400341|NCT00939341|955725|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
400342|NCT00939211|955745|P1|NOT COMPLETED|Placebo||0
400343|NCT00939211|955745|P1|COMPLETED|Placebo||28
400344|NCT00939211|955745|P1|STARTED|Placebo||28
400345|NCT00939211|955745|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
400346|NCT00939211|955745|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
400347|NCT00939211|955745|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
400348|NCT00939211|955745|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
400349|NCT00939211|955745|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
400350|NCT00939211|955745|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
400351|NCT00939211|955745|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
400352|NCT00939211|955745|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
400353|NCT00939211|955745|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
400354|NCT00939211|955745|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
400355|NCT00939211|955745|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
400356|NCT00939211|955745|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
400357|NCT00939185|955807|P1|NOT COMPLETED|Overall Study||25
400358|NCT00939185|955807|P1|COMPLETED|Overall Study||375
400359|NCT00939185|955807|P1|Received Treatment|Overall Study||390
400360|NCT00939185|955807|P1|STARTED|Overall Study||400
400361|NCT00939159|955814|P1|NOT COMPLETED|Overall Study||0
400362|NCT00939159|955814|P1|COMPLETED|Overall Study||13
400363|NCT00939159|955814|P1|STARTED|Overall Study||13
400364|NCT00939120|955820|P2|NOT COMPLETED|Overall Study||5
400365|NCT00939120|955821|P1|NOT COMPLETED|Overall Study||8
400366|NCT00939120|955820|P2|COMPLETED|Overall Study||18
400367|NCT00939120|955821|P1|COMPLETED|Overall Study||15
400368|NCT00939120|955820|P2|STARTED|Overall Study||23
400369|NCT00939120|955821|P1|STARTED|Overall Study||23
400370|NCT00939107|955845|P2|NOT COMPLETED|Overall Study||12
400371|NCT00939107|955846|P1|NOT COMPLETED|Overall Study||14
400372|NCT00939107|955845|P2|COMPLETED|Overall Study||163
400373|NCT00939107|955846|P1|COMPLETED|Overall Study||161
400374|NCT00939107|955845|P2|12 Months Follow-up|Overall Study||163
400375|NCT00939107|955846|P1|12 Months Follow-up|Overall Study||161
400376|NCT00939107|955845|P2|STARTED|Overall Study||175
400377|NCT00939107|955846|P1|STARTED|Overall Study||175
400378|NCT00939094|955860|P2|NOT COMPLETED|Overall Study||10
400379|NCT00939094|955861|P1|NOT COMPLETED|Overall Study||14
400380|NCT00939094|955860|P2|COMPLETED|Overall Study||35
400381|NCT00939094|955861|P1|COMPLETED|Overall Study||28
400382|NCT00939094|955860|P2|STARTED|Overall Study||45
400383|NCT00939094|955861|P1|STARTED|Overall Study||42
400384|NCT00939055|955883|P2|NOT COMPLETED|Overall Study||0
400385|NCT00939055|955884|P1|NOT COMPLETED|Overall Study||4
400386|NCT00939055|955883|P2|COMPLETED|Overall Study||39
400387|NCT00939055|955884|P1|COMPLETED|Overall Study||69
400388|NCT00939055|955883|P2|STARTED|Overall Study||39
400389|NCT00939055|955884|P1|STARTED|Overall Study||73
400390|NCT00939029|955894|P2|NOT COMPLETED|Overall Study||12
400391|NCT00939029|955895|P1|NOT COMPLETED|Overall Study||6
400392|NCT00939029|955894|P2|COMPLETED|Overall Study||15
400393|NCT00939029|955895|P1|COMPLETED|Overall Study||19
400394|NCT00939029|955894|P2|STARTED|Overall Study||27
400395|NCT00939029|955895|P1|STARTED|Overall Study||25
400396|NCT00939003|955907|P2|NOT COMPLETED|Open-label Treatment Period||29
400397|NCT00939003|955908|P1|NOT COMPLETED|Open-label Treatment Period||29
400398|NCT00939003|955907|P2|COMPLETED|Open-label Treatment Period||62
400399|NCT00939003|955908|P1|COMPLETED|Open-label Treatment Period||66
400400|NCT00939003|955907|P2|STARTED|Open-label Treatment Period||91
400401|NCT00939003|955908|P1|STARTED|Open-label Treatment Period||95
400402|NCT00939003|955907|P2|NOT COMPLETED|Double-blind Treatment Period||4
400403|NCT00939003|955908|P1|NOT COMPLETED|Double-blind Treatment Period||2
400404|NCT00939003|955907|P2|COMPLETED|Double-blind Treatment Period||91
400405|NCT00939003|955908|P1|COMPLETED|Double-blind Treatment Period||95
400406|NCT00939003|955907|P2|STARTED|Double-blind Treatment Period||95
400407|NCT00939003|955908|P1|STARTED|Double-blind Treatment Period||97
400408|NCT00938886|955945|P2|NOT COMPLETED|Overall Study||10
400409|NCT00938886|955946|P1|NOT COMPLETED|Overall Study||7
400410|NCT00938886|955945|P2|COMPLETED|Overall Study||65
400411|NCT00938886|955946|P1|COMPLETED|Overall Study||68
400412|NCT00938886|955945|P2|Attended 1 Counseling Session|Overall Study||70
400413|NCT00938886|955946|P1|Attended 1 Counseling Session|Overall Study||70
400414|NCT00938886|955945|P2|STARTED|Overall Study||75
400415|NCT00938886|955946|P1|STARTED|Overall Study||75
400416|NCT00938860|955956|P2|NOT COMPLETED|Overall Study||17
400417|NCT00938860|955957|P1|NOT COMPLETED|Overall Study||25
400418|NCT00938860|955956|P2|COMPLETED|Overall Study||25
400419|NCT00938860|955957|P1|COMPLETED|Overall Study||25
400420|NCT00938860|955956|P2|Efficacy Population|Overall Study||41
400421|NCT00938860|955957|P1|Efficacy Population|Overall Study||40
400422|NCT00938860|955956|P2|STARTED|Overall Study||42
400423|NCT00938860|955957|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
400424|NCT00938782|955981|P2|NOT COMPLETED|Overall Study||0
400425|NCT00938782|955982|P1|NOT COMPLETED|Overall Study||0
400426|NCT00938782|955981|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
400427|NCT00938782|955982|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
400428|NCT00938782|955981|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
400429|NCT00938782|955982|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
400430|NCT00938717|955990|P2|NOT COMPLETED|Overall Study||108
400431|NCT00938717|955991|P1|NOT COMPLETED|Overall Study||98
400432|NCT00938717|955990|P2|COMPLETED|Overall Study||294
400433|NCT00938717|955991|P1|COMPLETED|Overall Study||305
400434|NCT00938717|955990|P2|STARTED|Overall Study||402
400435|NCT00938717|955991|P1|STARTED|Overall Study||403
400436|NCT00938704|956025|P2|NOT COMPLETED|Overall Study||0
400437|NCT00938704|956026|P1|NOT COMPLETED|Overall Study||0
400438|NCT00938704|956025|P2|COMPLETED|Overall Study||37
400439|NCT00938704|956026|P1|COMPLETED|Overall Study||33
400440|NCT00938704|956025|P2|STARTED|Overall Study||37
400441|NCT00938704|956026|P1|STARTED|Overall Study||33
400442|NCT00938639|956042|P2|NOT COMPLETED|Overall Study||4
400443|NCT00938639|956043|P1|NOT COMPLETED|Overall Study||3
400444|NCT00938639|956042|P2|COMPLETED|Overall Study||116
400445|NCT00938639|956043|P1|COMPLETED|Overall Study||117
400446|NCT00938639|956042|P2|STARTED|Overall Study||120
400447|NCT00938639|956043|P1|STARTED|Overall Study||120
400448|NCT00938548|956113|P2|NOT COMPLETED|Overall Study||0
400449|NCT00938548|956114|P1|NOT COMPLETED|Overall Study||0
400450|NCT00938548|956113|P2|COMPLETED|Overall Study||35
400451|NCT00938548|956114|P1|COMPLETED|Overall Study||35
400452|NCT00938548|956113|P2|STARTED|Overall Study||35
400453|NCT00938548|956114|P1|STARTED|Overall Study||35
400454|NCT00938470|956126|P2|NOT COMPLETED|Overall Study||3
400455|NCT00938470|956127|P1|NOT COMPLETED|Overall Study||7
400456|NCT00938470|956126|P2|COMPLETED|Overall Study||25
400457|NCT00938470|956127|P1|COMPLETED|Overall Study||27
400458|NCT00938470|956126|P2|STARTED|Overall Study||28
400459|NCT00938470|956127|P1|STARTED|Overall Study||34
400460|NCT00938457|956141|P1|NOT COMPLETED|Overall Study||0
400461|NCT00938457|956141|P1|COMPLETED|Overall Study||3
400462|NCT00938457|956141|P1|STARTED|Overall Study||3
400463|NCT00938431|956157|P3|NOT COMPLETED|Overall Study||8
400464|NCT00938431|956158|P2|NOT COMPLETED|Overall Study||9
400465|NCT00938431|956159|P1|NOT COMPLETED|Overall Study||6
400466|NCT00938431|956157|P3|COMPLETED|Overall Study||1
400467|NCT00938431|956158|P2|COMPLETED|Overall Study||14
400468|NCT00938431|956159|P1|COMPLETED|Overall Study||9
400469|NCT00938431|956157|P3|STARTED|Overall Study||9
400470|NCT00938431|956158|P2|STARTED|Overall Study||23
400471|NCT00938431|956159|P1|STARTED|Overall Study||15
400472|NCT00938392|956186|P2|NOT COMPLETED|Overall Study||4
400473|NCT00938392|956187|P1|NOT COMPLETED|Overall Study||2
400474|NCT00938392|956186|P2|COMPLETED|Overall Study||358
400475|NCT00938392|956187|P1|COMPLETED|Overall Study||360
400476|NCT00938392|956186|P2|STARTED|Overall Study||362
400477|NCT00938392|956187|P1|STARTED|Overall Study||362
400478|NCT00938366|956213|P2|NOT COMPLETED|Overall Study||0
400479|NCT00938366|956214|P1|NOT COMPLETED|Overall Study||1
400480|NCT00938366|956213|P2|COMPLETED|Overall Study||9
400481|NCT00938366|956214|P1|COMPLETED|Overall Study||8
400482|NCT00938366|956213|P2|STARTED|Overall Study||9
400483|NCT00938366|956214|P1|STARTED|Overall Study||9
400484|NCT00938327|956234|P1|NOT COMPLETED|Overall Study||60
400485|NCT00938327|956234|P1|COMPLETED|Overall Study||272
400486|NCT00938327|956234|P1|STARTED|Overall Study||332
400487|NCT00938314|956245|P4|NOT COMPLETED|Cohort 3||1
400488|NCT00938314|956246|P3|NOT COMPLETED|Cohort 3||4
400489|NCT00938314|956247|P2|NOT COMPLETED|Cohort 3||0
400490|NCT00938314|956248|P1|NOT COMPLETED|Cohort 3||0
400491|NCT00938314|956245|P4|COMPLETED|Cohort 3||7
400492|NCT00938314|956246|P3|COMPLETED|Cohort 3||20
400493|NCT00938314|956247|P2|COMPLETED|Cohort 3||0
400494|NCT00938314|956248|P1|COMPLETED|Cohort 3||0
400495|NCT00938314|956245|P4|STARTED|Cohort 3||8
400496|NCT00938314|956246|P3|STARTED|Cohort 3||24
400497|NCT00938314|956247|P2|STARTED|Cohort 3||0
400498|NCT00938314|956248|P1|STARTED|Cohort 3||0
400499|NCT00938314|956245|P4|NOT COMPLETED|Cohort 2||2
400500|NCT00938314|956246|P3|NOT COMPLETED|Cohort 2||0
400501|NCT00938314|956247|P2|NOT COMPLETED|Cohort 2||6
400502|NCT00938314|956248|P1|NOT COMPLETED|Cohort 2||0
400503|NCT00938314|956245|P4|COMPLETED|Cohort 2||6
400504|NCT00938314|956246|P3|COMPLETED|Cohort 2||0
400505|NCT00938314|956247|P2|COMPLETED|Cohort 2||18
400506|NCT00938314|956248|P1|COMPLETED|Cohort 2||0
400507|NCT00938314|956245|P4|STARTED|Cohort 2||8
400508|NCT00938314|956246|P3|STARTED|Cohort 2||0
400509|NCT00938314|956247|P2|STARTED|Cohort 2||24
400510|NCT00938314|956248|P1|STARTED|Cohort 2||0
400511|NCT00938314|956245|P4|NOT COMPLETED|Cohort 1||2
400512|NCT00938314|956246|P3|NOT COMPLETED|Cohort 1||0
400513|NCT00938314|956247|P2|NOT COMPLETED|Cohort 1||0
400514|NCT00938314|956248|P1|NOT COMPLETED|Cohort 1||2
400515|NCT00938314|956245|P4|COMPLETED|Cohort 1||6
400516|NCT00938314|956246|P3|COMPLETED|Cohort 1||0
400517|NCT00938314|956247|P2|COMPLETED|Cohort 1||0
400518|NCT00938314|956248|P1|COMPLETED|Cohort 1||22
400519|NCT00938314|956245|P4|STARTED|Cohort 1||8
400520|NCT00938314|956246|P3|STARTED|Cohort 1||0
400521|NCT00938314|956247|P2|STARTED|Cohort 1||0
400522|NCT00938314|956248|P1|STARTED|Cohort 1||24
400523|NCT00938041|956302|P1|NOT COMPLETED|Overall Study||27
400524|NCT00938041|956302|P1|COMPLETED|Overall Study||5
400525|NCT00938041|956302|P1|STARTED|Overall Study||32
400526|NCT00938015|956311|P1|NOT COMPLETED|Overall Study||147
400527|NCT00938015|956311|P1|COMPLETED|Overall Study||156
400528|NCT00938015|956311|P1|STARTED|Overall Study||303
400529|NCT00937950|956327|P1|NOT COMPLETED|Overall Study||216
400530|NCT00937950|956327|P1|COMPLETED|Overall Study||1787
400531|NCT00937950|956327|P1|STARTED|Overall Study||2003
400532|NCT00937937|956343|P1|NOT COMPLETED|Overall Study||72
400533|NCT00937937|956343|P1|COMPLETED|Overall Study||0
400534|NCT00937937|956343|P1|STARTED|Overall Study||72
400535|NCT00937833|956352|P2|NOT COMPLETED|Overall Study||17
400536|NCT00937833|956353|P1|NOT COMPLETED|Overall Study||15
400537|NCT00937833|956352|P2|COMPLETED|Overall Study||60
400538|NCT00937833|956353|P1|COMPLETED|Overall Study||58
400539|NCT00937833|956352|P2|STARTED|Overall Study||77
400540|NCT00937833|956353|P1|STARTED|Overall Study||73
400541|NCT00937794|956359|P1|NOT COMPLETED|Overall Study||0
400542|NCT00937794|956359|P1|COMPLETED|Overall Study||33
400543|NCT00937794|956359|P1|STARTED|Overall Study||33
400544|NCT00937768|956366|P2|NOT COMPLETED|Overall Study||8
400545|NCT00937768|956367|P1|NOT COMPLETED|Overall Study||8
400546|NCT00937768|956366|P2|COMPLETED|Overall Study||0
400547|NCT00937768|956367|P1|COMPLETED|Overall Study||0
400548|NCT00937768|956366|P2|STARTED|Overall Study||8
400549|NCT00937768|956367|P1|STARTED|Overall Study||8
400550|NCT00937560|956373|P1|NOT COMPLETED|Maintenance Treatment||18
400551|NCT00937560|956373|P1|COMPLETED|Maintenance Treatment||150
400552|NCT00937560|956373|P1|STARTED|Maintenance Treatment||168
400553|NCT00937560|956373|P1|NOT COMPLETED|Initial Treatment||21
400554|NCT00937560|956373|P1|COMPLETED|Initial Treatment||169
400555|NCT00937560|956373|P1|Received Treatment|Initial Treatment||189
400556|NCT00937560|956373|P1|STARTED|Initial Treatment||190
400557|NCT00937547|956384|P3|NOT COMPLETED|Overall Study||7
400558|NCT00937547|956385|P2|NOT COMPLETED|Overall Study||6
400559|NCT00937547|956386|P1|NOT COMPLETED|Overall Study||1
400560|NCT00937547|956384|P3|COMPLETED|Overall Study||142
400561|NCT00937547|956385|P2|COMPLETED|Overall Study||78
400562|NCT00937547|956386|P1|COMPLETED|Overall Study||95
400563|NCT00937547|956384|P3|Histological Samples|Overall Study||142
400564|NCT00937547|956385|P2|Histological Samples|Overall Study||78
400565|NCT00937547|956386|P1|Histological Samples|Overall Study||95
400566|NCT00937547|956384|P3|STARTED|Overall Study||149
400567|NCT00937547|956385|P2|STARTED|Overall Study||84
400568|NCT00937547|956386|P1|STARTED|Overall Study||96
400569|NCT00937521|956423|P8|NOT COMPLETED|Booster Phase||2
400570|NCT00937521|956424|P7|NOT COMPLETED|Booster Phase||5
400571|NCT00937521|956425|P6|NOT COMPLETED|Booster Phase||5
400572|NCT00937521|956426|P5|NOT COMPLETED|Booster Phase||5
400573|NCT00937521|956427|P4|NOT COMPLETED|Booster Phase||3
400574|NCT00937521|956428|P3|NOT COMPLETED|Booster Phase||5
400575|NCT00937521|956429|P2|NOT COMPLETED|Booster Phase||2
400576|NCT00937521|956430|P1|NOT COMPLETED|Booster Phase||3
400577|NCT00937521|956423|P8|COMPLETED|Booster Phase||159
400578|NCT00937521|956424|P7|COMPLETED|Booster Phase||160
400579|NCT00937521|956425|P6|COMPLETED|Booster Phase||160
400580|NCT00937521|956426|P5|COMPLETED|Booster Phase||163
400581|NCT00937521|956427|P4|COMPLETED|Booster Phase||167
400582|NCT00937521|956428|P3|COMPLETED|Booster Phase||164
400583|NCT00937521|956429|P2|COMPLETED|Booster Phase||161
400584|NCT00937521|956430|P1|COMPLETED|Booster Phase||152
400585|NCT00937521|956423|P8|Premature Withdrawal|Booster Phase||2
400586|NCT00937521|956424|P7|Premature Withdrawal|Booster Phase||5
400587|NCT00937521|956425|P6|Premature Withdrawal|Booster Phase||5
400588|NCT00937521|956426|P5|Premature Withdrawal|Booster Phase||5
400589|NCT00937521|956427|P4|Premature Withdrawal|Booster Phase||3
400590|NCT00937521|956428|P3|Premature Withdrawal|Booster Phase||5
400591|NCT00937521|956429|P2|Premature Withdrawal|Booster Phase||2
400592|NCT00937521|956430|P1|Premature Withdrawal|Booster Phase||3
400593|NCT00937521|956423|P8|STARTED|Booster Phase||161
400594|NCT00937521|956424|P7|STARTED|Booster Phase||165
400595|NCT00937521|956425|P6|STARTED|Booster Phase||165
400596|NCT00937521|956426|P5|STARTED|Booster Phase||168
400597|NCT00937521|956427|P4|STARTED|Booster Phase||170
400598|NCT00937521|956428|P3|STARTED|Booster Phase||169
400599|NCT00937521|956429|P2|STARTED|Booster Phase||163
400600|NCT00937521|956430|P1|STARTED|Booster Phase||155
400601|NCT00937521|956423|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
400602|NCT00937521|956424|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
400603|NCT00937521|956425|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
400604|NCT00937521|956426|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
400689|NCT00936481|956729|P2|NOT COMPLETED|Overall Study||0
400605|NCT00937521|956427|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
400606|NCT00937521|956428|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
400607|NCT00937521|956429|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
400608|NCT00937521|956430|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
400609|NCT00937521|956423|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
400610|NCT00937521|956424|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
400611|NCT00937521|956425|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
400612|NCT00937521|956426|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
400613|NCT00937521|956427|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
400614|NCT00937521|956428|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
400615|NCT00937521|956429|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
400616|NCT00937521|956430|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
400617|NCT00937521|956423|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
400618|NCT00937521|956424|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
400619|NCT00937521|956425|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
400620|NCT00937521|956426|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
400621|NCT00937521|956427|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
400622|NCT00937521|956428|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
400623|NCT00937521|956429|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
400624|NCT00937521|956430|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
400625|NCT00937521|956423|P8|STARTED|Overall Study - Prior to Booster Dose||184
400626|NCT00937521|956424|P7|STARTED|Overall Study - Prior to Booster Dose||186
400627|NCT00937521|956425|P6|STARTED|Overall Study - Prior to Booster Dose||188
400628|NCT00937521|956426|P5|STARTED|Overall Study - Prior to Booster Dose||191
400629|NCT00937521|956427|P4|STARTED|Overall Study - Prior to Booster Dose||188
400630|NCT00937521|956428|P3|STARTED|Overall Study - Prior to Booster Dose||192
400631|NCT00937521|956429|P2|STARTED|Overall Study - Prior to Booster Dose||190
400632|NCT00937521|956430|P1|STARTED|Overall Study - Prior to Booster Dose||188
400633|NCT00937495|956536|P1|NOT COMPLETED|Overall Study||2
400634|NCT00937495|956536|P1|COMPLETED|Overall Study||14
400635|NCT00937495|956536|P1|STARTED|Overall Study||16
400636|NCT00937391|956544|P1|NOT COMPLETED|Stage 2||1
400637|NCT00937391|956544|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
400638|NCT00937391|956544|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
400639|NCT00937391|956544|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
400640|NCT00937391|956544|P1|NOT COMPLETED|Stage 1||0
400641|NCT00937391|956544|P1|COMPLETED|Stage 1||20
400642|NCT00937391|956544|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
400643|NCT00937391|956544|P1|STARTED|Stage 1||20
400644|NCT00937157|956595|P1|NOT COMPLETED|Overall Study||4
400645|NCT00937157|956595|P1|COMPLETED|Overall Study||8
400646|NCT00937157|956595|P1|STARTED|Overall Study||12
400647|NCT00937118|956599|P1|NOT COMPLETED|Overall Study||0
400648|NCT00937118|956599|P1|COMPLETED|Overall Study||41
400649|NCT00937118|956599|P1|STARTED|Overall Study||41
400650|NCT00937105|956608|P2|NOT COMPLETED|Overall Study||39
400651|NCT00937105|956609|P1|NOT COMPLETED|Overall Study||40
400652|NCT00937105|956608|P2|COMPLETED|Overall Study||70
400653|NCT00937105|956609|P1|COMPLETED|Overall Study||69
400654|NCT00937105|956608|P2|STARTED|Overall Study||109
400655|NCT00937105|956609|P1|STARTED|Overall Study||109
400656|NCT00937040|956626|P2|NOT COMPLETED|Overall Study||37
400657|NCT00937040|956627|P1|NOT COMPLETED|Overall Study||41
400658|NCT00937040|956626|P2|COMPLETED|Overall Study||141
400659|NCT00937040|956627|P1|COMPLETED|Overall Study||138
400660|NCT00937040|956626|P2|STARTED|Overall Study||178
400661|NCT00937040|956627|P1|STARTED|Overall Study||179
400662|NCT00936975|956669|P1|NOT COMPLETED|Overall Study||6
400663|NCT00936975|956669|P1|COMPLETED|Overall Study||12
400664|NCT00936975|956669|P1|STARTED|Overall Study||18
400665|NCT00936897|956680|P2|NOT COMPLETED|Overall Study||60
400666|NCT00936897|956681|P1|NOT COMPLETED|Overall Study||19
400667|NCT00936897|956680|P2|COMPLETED|Overall Study||356
400668|NCT00936897|956681|P1|COMPLETED|Overall Study||398
400669|NCT00936897|956680|P2|STARTED|Overall Study|Randomized|416
400670|NCT00936897|956681|P1|STARTED|Overall Study|Randomized|417
400671|NCT00936741|956693|P1|NOT COMPLETED|Overall Study||9
400672|NCT00936741|956693|P1|COMPLETED|Overall Study||21
400673|NCT00936741|956693|P1|STARTED|Overall Study||30
400674|NCT00936715|956698|P1|NOT COMPLETED|Overall Study||6
400675|NCT00936715|956698|P1|COMPLETED|Overall Study||18
400676|NCT00936715|956698|P1|STARTED|Overall Study||24
400677|NCT00936702|956702|P1|NOT COMPLETED|Overall Study||46
400678|NCT00936702|956702|P1|COMPLETED|Overall Study||0
400679|NCT00936702|956702|P1|STARTED|Overall Study||46
400680|NCT00936598|956712|P2|NOT COMPLETED|Overall Study||0
400681|NCT00936598|956713|P1|NOT COMPLETED|Overall Study||2
400682|NCT00936598|956712|P2|COMPLETED|Overall Study||1
400683|NCT00936598|956713|P1|COMPLETED|Overall Study||2
400684|NCT00936598|956712|P2|STARTED|Overall Study||1
400685|NCT00936598|956713|P1|STARTED|Overall Study||4
400686|NCT00936585|956723|P1|NOT COMPLETED|Overall Study||0
400687|NCT00936585|956723|P1|COMPLETED|Overall Study||2
400688|NCT00936585|956723|P1|STARTED|Overall Study||2
400690|NCT00936481|956730|P1|NOT COMPLETED|Overall Study||0
400691|NCT00936481|956729|P2|COMPLETED|Overall Study||17
400692|NCT00936481|956730|P1|COMPLETED|Overall Study||17
400693|NCT00936481|956729|P2|STARTED|Overall Study||17
400694|NCT00936481|956730|P1|STARTED|Overall Study||17
400695|NCT00936455|956740|P2|NOT COMPLETED|Overall Study||0
400696|NCT00936455|956741|P1|NOT COMPLETED|Overall Study||0
400697|NCT00936455|956740|P2|COMPLETED|Overall Study||38
400698|NCT00936455|956741|P1|COMPLETED|Overall Study||37
400699|NCT00936455|956740|P2|STARTED|Overall Study||38
400700|NCT00936455|956741|P1|STARTED|Overall Study||37
400701|NCT00936377|956756|P3|NOT COMPLETED|Overall Study||0
400702|NCT00936377|956757|P2|NOT COMPLETED|Overall Study||0
400703|NCT00936377|956758|P1|NOT COMPLETED|Overall Study||0
400704|NCT00936377|956756|P3|COMPLETED|Overall Study||8
400705|NCT00936377|956757|P2|COMPLETED|Overall Study||8
400706|NCT00936377|956758|P1|COMPLETED|Overall Study||8
400707|NCT00936377|956756|P3|STARTED|Overall Study||8
400708|NCT00936377|956757|P2|STARTED|Overall Study||8
400709|NCT00936377|956758|P1|STARTED|Overall Study||8
400710|NCT00936351|956789|P2|NOT COMPLETED|Overall Study||2
400711|NCT00936351|956790|P1|NOT COMPLETED|Overall Study||3
400712|NCT00936351|956789|P2|COMPLETED|Overall Study||14
400713|NCT00936351|956790|P1|COMPLETED|Overall Study||15
400714|NCT00936351|956789|P2|STARTED|Overall Study||16
400715|NCT00936351|956790|P1|STARTED|Overall Study||18
400716|NCT00936221|956802|P2|NOT COMPLETED|Overall Study||1
400717|NCT00936221|956803|P1|NOT COMPLETED|Overall Study||1
400718|NCT00936221|956802|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
400719|NCT00936221|956803|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
400720|NCT00936221|956802|P2|Received Treatment|Overall Study||45
400721|NCT00936221|956803|P1|Received Treatment|Overall Study||44
400722|NCT00936221|956802|P2|STARTED|Overall Study||46
400723|NCT00936221|956803|P1|STARTED|Overall Study||45
400724|NCT00936208|956817|P2|NOT COMPLETED|Overall Study||22
400725|NCT00936208|956818|P1|NOT COMPLETED|Overall Study||37
400726|NCT00936208|956817|P2|COMPLETED|Overall Study||1574
400727|NCT00936208|956818|P1|COMPLETED|Overall Study||1462
400728|NCT00936208|956817|P2|STARTED|Overall Study||1596
400729|NCT00936208|956818|P1|STARTED|Overall Study||1499
400730|NCT00936117|956836|P1|NOT COMPLETED|Overall Study||10
400731|NCT00936117|956836|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
400732|NCT00936117|956836|P1|STARTED|Overall Study||20
400733|NCT00936065|956844|P3|NOT COMPLETED|Overall Study||7
400734|NCT00936065|956845|P2|NOT COMPLETED|Overall Study||4
400735|NCT00936065|956846|P1|NOT COMPLETED|Overall Study||4
400736|NCT00936065|956844|P3|COMPLETED|Overall Study||12
400737|NCT00936065|956845|P2|COMPLETED|Overall Study||16
400738|NCT00936065|956846|P1|COMPLETED|Overall Study||17
400739|NCT00936065|956844|P3|Study Assessments Performed|Overall Study||18
400740|NCT00936065|956845|P2|Study Assessments Performed|Overall Study||19
400741|NCT00936065|956846|P1|Study Assessments Performed|Overall Study||21
400742|NCT00936065|956844|P3|Received Treatment|Overall Study||18
400743|NCT00936065|956845|P2|Received Treatment|Overall Study||20
400744|NCT00936065|956846|P1|Received Treatment|Overall Study||21
400745|NCT00936065|956844|P3|STARTED|Overall Study||19
400746|NCT00936065|956845|P2|STARTED|Overall Study||20
400747|NCT00936065|956846|P1|STARTED|Overall Study||21
400748|NCT00934921|956952|P2|NOT COMPLETED|Second Intervention||0
400749|NCT00934921|956953|P1|NOT COMPLETED|Second Intervention||0
400750|NCT00934921|956952|P2|COMPLETED|Second Intervention||12
400751|NCT00934921|956953|P1|COMPLETED|Second Intervention||12
400752|NCT00934921|956952|P2|STARTED|Second Intervention||12
400753|NCT00934921|956953|P1|STARTED|Second Intervention||12
400754|NCT00934921|956952|P2|NOT COMPLETED|First Intervention||0
400755|NCT00934921|956953|P1|NOT COMPLETED|First Intervention||0
400756|NCT00934921|956952|P2|COMPLETED|First Intervention||12
400757|NCT00934921|956953|P1|COMPLETED|First Intervention||12
400758|NCT00934921|956952|P2|STARTED|First Intervention||12
400759|NCT00934921|956953|P1|STARTED|First Intervention||12
400760|NCT00935883|956963|P2|NOT COMPLETED|Follow-Up Period||0
400761|NCT00935883|956964|P1|NOT COMPLETED|Follow-Up Period||0
400762|NCT00935883|956963|P2|COMPLETED|Follow-Up Period||38
400763|NCT00935883|956964|P1|COMPLETED|Follow-Up Period||19
400764|NCT00935883|956963|P2|STARTED|Follow-Up Period||38
400765|NCT00935883|956964|P1|STARTED|Follow-Up Period||19
400766|NCT00935883|956963|P2|NOT COMPLETED|Treatment Period||2
400767|NCT00935883|956964|P1|NOT COMPLETED|Treatment Period||1
400768|NCT00935883|956963|P2|COMPLETED|Treatment Period||38
400769|NCT00935883|956964|P1|COMPLETED|Treatment Period||19
400770|NCT00935883|956963|P2|STARTED|Treatment Period||40
400771|NCT00935883|956964|P1|STARTED|Treatment Period||20
400772|NCT00935857|956978|P2|NOT COMPLETED|Overall Study||0
400773|NCT00935857|956979|P1|NOT COMPLETED|Overall Study||0
400774|NCT00935857|956978|P2|COMPLETED|Overall Study||16
400775|NCT00935857|956979|P1|COMPLETED|Overall Study||14
400776|NCT00935857|956978|P2|STARTED|Overall Study||16
400777|NCT00935857|956979|P1|STARTED|Overall Study||14
400778|NCT00935818|956991|P2|NOT COMPLETED|Overall Study||100
400779|NCT00935818|956992|P1|NOT COMPLETED|Overall Study||91
400780|NCT00935818|956991|P2|COMPLETED|Overall Study||157
400781|NCT00935818|956992|P1|COMPLETED|Overall Study||158
400782|NCT00935818|956991|P2|End of Medication Phase|Overall Study||184
400783|NCT00935818|956992|P1|End of Medication Phase|Overall Study||182
400784|NCT00935818|956991|P2|STARTED|Overall Study||257
400785|NCT00935818|956992|P1|STARTED|Overall Study||249
400786|NCT00935792|957013|P3|NOT COMPLETED|Overall Study||0
400787|NCT00935792|957014|P2|NOT COMPLETED|Overall Study||3
400788|NCT00935792|957015|P1|NOT COMPLETED|Overall Study||1
400789|NCT00935792|957013|P3|COMPLETED|Overall Study||12
400790|NCT00935792|957014|P2|COMPLETED|Overall Study||6
400791|NCT00935792|957015|P1|COMPLETED|Overall Study||6
400792|NCT00935792|957013|P3|STARTED|Overall Study||12
400793|NCT00935792|957014|P2|STARTED|Overall Study||9
400794|NCT00935792|957015|P1|STARTED|Overall Study||7
400795|NCT00935766|957032|P2|NOT COMPLETED|Overall Study||7
400796|NCT00935766|957033|P1|NOT COMPLETED|Overall Study||7
400797|NCT00935766|957032|P2|COMPLETED|Overall Study||27
400798|NCT00935766|957033|P1|COMPLETED|Overall Study||35
400799|NCT00935766|957032|P2|STARTED|Overall Study||34
400800|NCT00935766|957033|P1|STARTED|Overall Study||42
400801|NCT00935701|957043|P1|NOT COMPLETED|Overall Study||1
400802|NCT00935701|957043|P1|COMPLETED|Overall Study||9
400803|NCT00935701|957043|P1|Transition Acupressure to Acupuncture|Overall Study||9
400804|NCT00935701|957043|P1|STARTED|Overall Study||10
400805|NCT00935649|957050|P1|NOT COMPLETED|Overall Study||5
400806|NCT00935649|957050|P1|COMPLETED|Overall Study||134
400807|NCT00935649|957050|P1|STARTED|Overall Study||139
400808|NCT00935584|957060|P2|NOT COMPLETED|Overall Study||4
400809|NCT00935584|957061|P1|NOT COMPLETED|Overall Study||49
400810|NCT00935584|957060|P2|COMPLETED|Overall Study||19
400811|NCT00935584|957061|P1|COMPLETED|Overall Study||77
400812|NCT00935584|957060|P2|STARTED|Overall Study||23
400813|NCT00935584|957061|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
400814|NCT00935532|957073|P2|NOT COMPLETED|Overall Study||11
400815|NCT00935532|957074|P1|NOT COMPLETED|Overall Study||22
400816|NCT00935532|957073|P2|COMPLETED|Overall Study||201
400817|NCT00935532|957074|P1|COMPLETED|Overall Study||193
400818|NCT00935532|957073|P2|STARTED|Overall Study||212
400819|NCT00935532|957074|P1|STARTED|Overall Study||215
400820|NCT00935493|957103|P3|NOT COMPLETED|Overall Study||1
400821|NCT00935493|957104|P2|NOT COMPLETED|Overall Study||2
400822|NCT00935493|957105|P1|NOT COMPLETED|Overall Study||1
400823|NCT00935493|957103|P3|COMPLETED|Overall Study||40
400824|NCT00935493|957104|P2|COMPLETED|Overall Study||39
400825|NCT00935493|957105|P1|COMPLETED|Overall Study||40
400826|NCT00935493|957103|P3|STARTED|Overall Study||41
400827|NCT00935493|957104|P2|STARTED|Overall Study||41
400828|NCT00935493|957105|P1|STARTED|Overall Study||41
400829|NCT00935311|957122|P3|NOT COMPLETED|Overall Study||0
400830|NCT00935311|957123|P2|NOT COMPLETED|Overall Study||0
400831|NCT00935311|957124|P1|NOT COMPLETED|Overall Study||0
400832|NCT00935311|957122|P3|COMPLETED|Overall Study||40
400833|NCT00935311|957123|P2|COMPLETED|Overall Study||39
400834|NCT00935311|957124|P1|COMPLETED|Overall Study||43
400835|NCT00935311|957122|P3|STARTED|Overall Study||40
400836|NCT00935311|957123|P2|STARTED|Overall Study||39
400837|NCT00935311|957124|P1|STARTED|Overall Study||43
400838|NCT00935272|957143|P2|NOT COMPLETED|Overall Study||6
400839|NCT00935272|957144|P1|NOT COMPLETED|Overall Study||19
400840|NCT00935272|957143|P2|COMPLETED|Overall Study||39
400841|NCT00935272|957144|P1|COMPLETED|Overall Study||116
400842|NCT00935272|957143|P2|STARTED|Overall Study||45
400843|NCT00935272|957144|P1|STARTED|Overall Study||135
400844|NCT00935259|957153|P2|NOT COMPLETED|Period 2||0
400845|NCT00935259|957154|P1|NOT COMPLETED|Period 2||0
400846|NCT00935259|957153|P2|COMPLETED|Period 2||14
400847|NCT00935259|957154|P1|COMPLETED|Period 2||15
400848|NCT00935259|957153|P2|STARTED|Period 2||14
400849|NCT00935259|957154|P1|STARTED|Period 2||15
400850|NCT00935259|957153|P2|NOT COMPLETED|Period 1||1
400851|NCT00935259|957154|P1|NOT COMPLETED|Period 1||1
400852|NCT00935259|957153|P2|COMPLETED|Period 1||14
400853|NCT00935259|957154|P1|COMPLETED|Period 1||15
400854|NCT00935259|957153|P2|STARTED|Period 1||15
400855|NCT00935259|957154|P1|STARTED|Period 1||16
400856|NCT00935220|957168|P1|NOT COMPLETED|Overall Study||2
400857|NCT00935220|957168|P1|COMPLETED|Overall Study||39
400858|NCT00935220|957168|P1|STARTED|Overall Study||41
400859|NCT00935064|957182|P2|NOT COMPLETED|Overall Study||0
400860|NCT00935064|957183|P1|NOT COMPLETED|Overall Study||0
400861|NCT00935064|957182|P2|COMPLETED|Overall Study||30
400862|NCT00935064|957183|P1|COMPLETED|Overall Study||30
400863|NCT00935064|957182|P2|STARTED|Overall Study||30
400864|NCT00935064|957183|P1|STARTED|Overall Study||30
400865|NCT00934947|957199|P2|NOT COMPLETED|Overall Study||2
400866|NCT00934947|957200|P1|NOT COMPLETED|Overall Study||0
400867|NCT00934947|957199|P2|COMPLETED|Overall Study||20
400868|NCT00934947|957200|P1|COMPLETED|Overall Study||23
400869|NCT00934947|957199|P2|STARTED|Overall Study||22
400870|NCT00934947|957200|P1|STARTED|Overall Study||23
400871|NCT00934856|957212|P6|NOT COMPLETED|Extension Part||5
400872|NCT00934856|957213|P5|NOT COMPLETED|Extension Part||4
400873|NCT00934856|957214|P4|NOT COMPLETED|Extension Part||2
400874|NCT00934856|957215|P3|NOT COMPLETED|Extension Part||0
400875|NCT00934856|957216|P2|NOT COMPLETED|Extension Part||0
400876|NCT00934856|957217|P1|NOT COMPLETED|Extension Part||0
400877|NCT00934856|957212|P6|COMPLETED|Extension Part||19
400878|NCT00934856|957213|P5|COMPLETED|Extension Part||24
400879|NCT00934856|957214|P4|COMPLETED|Extension Part||2
400880|NCT00934856|957215|P3|COMPLETED|Extension Part||0
400881|NCT00934856|957216|P2|COMPLETED|Extension Part||0
400882|NCT00934856|957217|P1|COMPLETED|Extension Part||0
400883|NCT00934856|957212|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
400884|NCT00934856|957213|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
400885|NCT00934856|957214|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
400886|NCT00934856|957215|P3|STARTED|Extension Part||0
400887|NCT00934856|957216|P2|STARTED|Extension Part||0
400888|NCT00934856|957217|P1|STARTED|Extension Part||0
400889|NCT00934856|957212|P6|NOT COMPLETED|Feasibility Part||3
400890|NCT00934856|957213|P5|NOT COMPLETED|Feasibility Part||0
400891|NCT00934856|957214|P4|NOT COMPLETED|Feasibility Part||5
400892|NCT00934856|957215|P3|NOT COMPLETED|Feasibility Part||3
400893|NCT00934856|957216|P2|NOT COMPLETED|Feasibility Part||5
400894|NCT00934856|957217|P1|NOT COMPLETED|Feasibility Part||5
400895|NCT00934856|957212|P6|COMPLETED|Feasibility Part||6
400896|NCT00934856|957213|P5|COMPLETED|Feasibility Part||12
400897|NCT00934856|957214|P4|COMPLETED|Feasibility Part||1
400898|NCT00934856|957215|P3|COMPLETED|Feasibility Part||0
400899|NCT00934856|957216|P2|COMPLETED|Feasibility Part||1
400900|NCT00934856|957217|P1|COMPLETED|Feasibility Part||1
400901|NCT00934856|957212|P6|STARTED|Feasibility Part||9
400902|NCT00934856|957213|P5|STARTED|Feasibility Part||12
400903|NCT00934856|957214|P4|STARTED|Feasibility Part||6
400904|NCT00934856|957215|P3|STARTED|Feasibility Part||3
400905|NCT00934856|957216|P2|STARTED|Feasibility Part||6
400906|NCT00934856|957217|P1|STARTED|Feasibility Part||6
400907|NCT00934843|957315|P2|NOT COMPLETED|Overall Study||1
400908|NCT00934843|957316|P1|NOT COMPLETED|Overall Study||0
400909|NCT00934843|957315|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
400910|NCT00934843|957316|P1|COMPLETED|Overall Study||37
400911|NCT00934843|957315|P2|STARTED|Overall Study||40
400912|NCT00934843|957316|P1|STARTED|Overall Study||37
400913|NCT00934791|957332|P2|NOT COMPLETED|Overall Study||0
400914|NCT00934791|957333|P1|NOT COMPLETED|Overall Study||1
400915|NCT00934791|957332|P2|COMPLETED|Overall Study||0
400916|NCT00934791|957333|P1|COMPLETED|Overall Study||0
400917|NCT00934791|957332|P2|STARTED|Overall Study||0
400918|NCT00934791|957333|P1|STARTED|Overall Study||1
400919|NCT00934648|957339|P1|NOT COMPLETED|Overall Study||9
400920|NCT00934648|957339|P1|COMPLETED|Overall Study||6
400921|NCT00934648|957339|P1|STARTED|Overall Study||15
400922|NCT00934635|957355|P9|NOT COMPLETED|Overall Study||0
400923|NCT00934635|957356|P8|NOT COMPLETED|Overall Study||0
400924|NCT00934635|957357|P7|NOT COMPLETED|Overall Study||0
400925|NCT00934635|957358|P6|NOT COMPLETED|Overall Study||0
400926|NCT00934635|957359|P5|NOT COMPLETED|Overall Study||0
400927|NCT00934635|957360|P4|NOT COMPLETED|Overall Study||0
400928|NCT00934635|957361|P3|NOT COMPLETED|Overall Study||0
400929|NCT00934635|957362|P2|NOT COMPLETED|Overall Study||0
400930|NCT00934635|957363|P1|NOT COMPLETED|Overall Study||0
400931|NCT00934635|957355|P9|COMPLETED|Overall Study||1
400932|NCT00934635|957356|P8|COMPLETED|Overall Study||0
400933|NCT00934635|957357|P7|COMPLETED|Overall Study||0
400934|NCT00934635|957358|P6|COMPLETED|Overall Study||0
400935|NCT00934635|957359|P5|COMPLETED|Overall Study||0
400936|NCT00934635|957360|P4|COMPLETED|Overall Study||0
400937|NCT00934635|957361|P3|COMPLETED|Overall Study||0
400938|NCT00934635|957362|P2|COMPLETED|Overall Study||1
400939|NCT00934635|957363|P1|COMPLETED|Overall Study||0
400940|NCT00934635|957355|P9|STARTED|Overall Study||1
400941|NCT00934635|957356|P8|STARTED|Overall Study||0
400942|NCT00934635|957357|P7|STARTED|Overall Study||0
400943|NCT00934635|957358|P6|STARTED|Overall Study||0
400944|NCT00934635|957359|P5|STARTED|Overall Study||0
400945|NCT00934635|957360|P4|STARTED|Overall Study||0
400946|NCT00934635|957361|P3|STARTED|Overall Study||0
400947|NCT00934635|957362|P2|STARTED|Overall Study||1
400948|NCT00934635|957363|P1|STARTED|Overall Study||0
400949|NCT00934622|957383|P1|NOT COMPLETED|Overall Study||8
400950|NCT00934622|957383|P1|COMPLETED|Overall Study||68
400951|NCT00934622|957383|P1|STARTED|Overall Study||76
400952|NCT00934596|957390|P2|NOT COMPLETED|Overall Study||0
400953|NCT00934596|957391|P1|NOT COMPLETED|Overall Study||0
400954|NCT00934596|957390|P2|COMPLETED|Overall Study||10
400955|NCT00934596|957391|P1|COMPLETED|Overall Study||10
400956|NCT00934596|957390|P2|STARTED|Overall Study||10
400957|NCT00934596|957391|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
400958|NCT00934544|957421|P2|NOT COMPLETED|Overall Study||42
400959|NCT00934544|957422|P1|NOT COMPLETED|Overall Study||55
400960|NCT00934544|957421|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
400961|NCT00934544|957422|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
400962|NCT00934544|957421|P2|STARTED|Overall Study||73
400963|NCT00934544|957422|P1|STARTED|Overall Study||146
400964|NCT00934440|957436|P1|NOT COMPLETED|Overall Study||1
400965|NCT00934440|957436|P1|COMPLETED|Overall Study||10
400966|NCT00934440|957436|P1|STARTED|Overall Study||11
400967|NCT00934375|957443|P2|NOT COMPLETED|Overall Study||22
400968|NCT00934375|957444|P1|NOT COMPLETED|Overall Study||13
400969|NCT00934375|957443|P2|COMPLETED|Overall Study||55
400970|NCT00934375|957444|P1|COMPLETED|Overall Study||55
400971|NCT00934375|957443|P2|STARTED|Overall Study||77
400972|NCT00934375|957444|P1|STARTED|Overall Study||68
400973|NCT00934362|957452|P2|NOT COMPLETED|Overall Study||0
400974|NCT00934362|957453|P1|NOT COMPLETED|Overall Study||1
400975|NCT00934362|957452|P2|COMPLETED|Overall Study||8
400976|NCT00934362|957453|P1|COMPLETED|Overall Study||7
400977|NCT00934362|957452|P2|STARTED|Overall Study||8
400978|NCT00934362|957453|P1|STARTED|Overall Study||8
400979|NCT00934180|957463|P2|NOT COMPLETED|Second Intervention||0
400980|NCT00934180|957464|P1|NOT COMPLETED|Second Intervention||0
400981|NCT00934180|957463|P2|COMPLETED|Second Intervention||12
400982|NCT00934180|957464|P1|COMPLETED|Second Intervention||12
400983|NCT00934180|957463|P2|STARTED|Second Intervention||12
400984|NCT00934180|957464|P1|STARTED|Second Intervention||12
400985|NCT00934180|957463|P2|NOT COMPLETED|First Intervention||0
400986|NCT00934180|957464|P1|NOT COMPLETED|First Intervention||0
400987|NCT00934180|957463|P2|COMPLETED|First Intervention||12
400988|NCT00934180|957464|P1|COMPLETED|First Intervention||12
400989|NCT00934180|957463|P2|STARTED|First Intervention||12
400990|NCT00934180|957464|P1|STARTED|First Intervention||12
400991|NCT00934141|957476|P4|NOT COMPLETED|Overall Study||3
400992|NCT00934141|957477|P3|NOT COMPLETED|Overall Study||0
400993|NCT00934141|957478|P2|NOT COMPLETED|Overall Study||3
400994|NCT00934141|957479|P1|NOT COMPLETED|Overall Study||4
400995|NCT00934141|957476|P4|COMPLETED|Overall Study||51
400996|NCT00934141|957477|P3|COMPLETED|Overall Study||48
400997|NCT00934141|957478|P2|COMPLETED|Overall Study||47
400998|NCT00934141|957479|P1|COMPLETED|Overall Study||45
400999|NCT00934141|957476|P4|STARTED|Overall Study||54
401000|NCT00934141|957477|P3|STARTED|Overall Study||48
401001|NCT00934141|957478|P2|STARTED|Overall Study||50
401002|NCT00934141|957479|P1|STARTED|Overall Study||49
401003|NCT00934128|957503|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
401004|NCT00934128|957504|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
401005|NCT00934128|957503|P2|COMPLETED|Second Intervention (2 Hours)||5
401006|NCT00934128|957504|P1|COMPLETED|Second Intervention (2 Hours)||3
401007|NCT00934128|957503|P2|STARTED|Second Intervention (2 Hours)||8
401008|NCT00934128|957504|P1|STARTED|Second Intervention (2 Hours)||3
401009|NCT00934128|957503|P2|NOT COMPLETED|Washout Period (1 Hour)||5
401010|NCT00934128|957504|P1|NOT COMPLETED|Washout Period (1 Hour)||7
401011|NCT00934128|957503|P2|COMPLETED|Washout Period (1 Hour)||8
401012|NCT00934128|957504|P1|COMPLETED|Washout Period (1 Hour)||3
401013|NCT00934128|957503|P2|STARTED|Washout Period (1 Hour)||13
401014|NCT00934128|957504|P1|STARTED|Washout Period (1 Hour)||10
401015|NCT00934128|957503|P2|NOT COMPLETED|First Intervention (2 Hours)||2
401016|NCT00934128|957504|P1|NOT COMPLETED|First Intervention (2 Hours)||5
401017|NCT00934128|957503|P2|COMPLETED|First Intervention (2 Hours)||13
401018|NCT00934128|957504|P1|COMPLETED|First Intervention (2 Hours)||10
401019|NCT00934128|957503|P2|STARTED|First Intervention (2 Hours)||15
401020|NCT00934128|957504|P1|STARTED|First Intervention (2 Hours)||15
401021|NCT00934102|957512|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
401022|NCT00934102|957513|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
401023|NCT00934102|957514|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
401024|NCT00934102|957512|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
401025|NCT00934102|957513|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
401026|NCT00934102|957514|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
401027|NCT00934102|957512|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
401028|NCT00934102|957513|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
401029|NCT00934102|957514|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
401030|NCT00934102|957512|P3|NOT COMPLETED|Period 1, One Night of Wear||0
401031|NCT00934102|957513|P2|NOT COMPLETED|Period 1, One Night of Wear||0
401032|NCT00934102|957514|P1|NOT COMPLETED|Period 1, One Night of Wear||1
401033|NCT00934102|957512|P3|COMPLETED|Period 1, One Night of Wear||15
401034|NCT00934102|957513|P2|COMPLETED|Period 1, One Night of Wear||15
401035|NCT00934102|957514|P1|COMPLETED|Period 1, One Night of Wear||15
401036|NCT00934102|957512|P3|STARTED|Period 1, One Night of Wear||15
401037|NCT00934102|957513|P2|STARTED|Period 1, One Night of Wear||15
401038|NCT00934102|957514|P1|STARTED|Period 1, One Night of Wear||16
401039|NCT00934050|957528|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
401040|NCT00934050|957529|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
401041|NCT00934050|957530|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
401042|NCT00934050|957531|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
401043|NCT00934050|957532|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
401044|NCT00934050|957533|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
401045|NCT00934050|957528|P6|COMPLETED|Enrolled After 15 Dec 2009||23
401046|NCT00934050|957529|P5|COMPLETED|Enrolled After 15 Dec 2009||19
401047|NCT00934050|957530|P4|COMPLETED|Enrolled After 15 Dec 2009||0
401048|NCT00934050|957531|P3|COMPLETED|Enrolled After 15 Dec 2009||0
401049|NCT00934050|957532|P2|COMPLETED|Enrolled After 15 Dec 2009||0
401050|NCT00934050|957533|P1|COMPLETED|Enrolled After 15 Dec 2009||0
401051|NCT00934050|957528|P6|STARTED|Enrolled After 15 Dec 2009||27
401052|NCT00934050|957529|P5|STARTED|Enrolled After 15 Dec 2009||26
401053|NCT00934050|957530|P4|STARTED|Enrolled After 15 Dec 2009||0
401054|NCT00934050|957531|P3|STARTED|Enrolled After 15 Dec 2009||0
401055|NCT00934050|957532|P2|STARTED|Enrolled After 15 Dec 2009||0
401056|NCT00934050|957533|P1|STARTED|Enrolled After 15 Dec 2009||0
401057|NCT00934050|957528|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
401058|NCT00934050|957529|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
401059|NCT00934050|957530|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
401060|NCT00934050|957531|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
401061|NCT00934050|957532|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
401062|NCT00934050|957533|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
401063|NCT00934050|957528|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
401064|NCT00934050|957529|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
401065|NCT00934050|957530|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
401066|NCT00934050|957531|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
401067|NCT00934050|957532|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
401068|NCT00934050|957533|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
401069|NCT00934050|957528|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
401070|NCT00934050|957529|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
401071|NCT00934050|957530|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
401072|NCT00934050|957531|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
401073|NCT00934050|957532|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
401074|NCT00934050|957533|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
401075|NCT00933933|957548|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
401076|NCT00933933|957549|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
401077|NCT00933933|957550|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
401078|NCT00933933|957548|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
401079|NCT00933933|957549|P2|COMPLETED|Pediatric From 2 to 21 Years||64
401080|NCT00933933|957550|P1|COMPLETED|Pediatric From 2 to 21 Years||588
401081|NCT00933933|957548|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
401082|NCT00933933|957549|P2|STARTED|Pediatric From 2 to 21 Years||64
401083|NCT00933933|957550|P1|STARTED|Pediatric From 2 to 21 Years||588
401084|NCT00933933|957548|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
401085|NCT00933933|957549|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
401086|NCT00933933|957550|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
401087|NCT00933933|957548|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
401088|NCT00933933|957549|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
401089|NCT00933933|957550|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
401090|NCT00933933|957548|P3|STARTED|Pregnant Females Between 16-44 Years||203
401091|NCT00933933|957549|P2|STARTED|Pregnant Females Between 16-44 Years||67
401092|NCT00933933|957550|P1|STARTED|Pregnant Females Between 16-44 Years||448
401093|NCT00933933|957548|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
401094|NCT00933933|957549|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
401095|NCT00933933|957550|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
401096|NCT00933933|957548|P3|COMPLETED|General Population From 16 to 89 Years||1206
401097|NCT00933933|957549|P2|COMPLETED|General Population From 16 to 89 Years||1267
401098|NCT00933933|957550|P1|COMPLETED|General Population From 16 to 89 Years||6164
401099|NCT00933933|957548|P3|STARTED|General Population From 16 to 89 Years||1206
401100|NCT00933933|957549|P2|STARTED|General Population From 16 to 89 Years||1287
401101|NCT00933933|957550|P1|STARTED|General Population From 16 to 89 Years||6164
401102|NCT00933686|957568|P2|NOT COMPLETED|Overall Study||11
401103|NCT00933686|957569|P1|NOT COMPLETED|Overall Study||10
401104|NCT00933686|957568|P2|COMPLETED|Overall Study||47
401105|NCT00933686|957569|P1|COMPLETED|Overall Study||45
401106|NCT00933686|957568|P2|STARTED|Overall Study||58
401107|NCT00933686|957569|P1|STARTED|Overall Study||55
401108|NCT00933608|957589|P2|NOT COMPLETED|Overall Study||2
401109|NCT00933608|957590|P1|NOT COMPLETED|Overall Study||5
401110|NCT00933608|957589|P2|COMPLETED|Overall Study||8
401111|NCT00933608|957590|P1|COMPLETED|Overall Study||2
401112|NCT00933608|957589|P2|STARTED|Overall Study||10
401113|NCT00933608|957590|P1|STARTED|Overall Study||7
401114|NCT00933543|957598|P2|NOT COMPLETED|Overall Study||7
401115|NCT00933543|957599|P1|NOT COMPLETED|Overall Study||3
401116|NCT00933543|957598|P2|COMPLETED|Overall Study||46
401117|NCT00933543|957599|P1|COMPLETED|Overall Study||51
401118|NCT00933543|957598|P2|STARTED|Overall Study||53
401119|NCT00933543|957599|P1|STARTED|Overall Study||54
401120|NCT00933491|957657|P2|NOT COMPLETED|Overall Study||0
401121|NCT00933491|957658|P1|NOT COMPLETED|Overall Study||0
401122|NCT00933491|957657|P2|COMPLETED|Overall Study||18
401123|NCT00933491|957658|P1|COMPLETED|Overall Study||14
401124|NCT00933491|957657|P2|STARTED|Overall Study||18
401125|NCT00933491|957658|P1|STARTED|Overall Study||14
401126|NCT00933335|957668|P2|NOT COMPLETED|Overall Study||16
401127|NCT00933335|957669|P1|NOT COMPLETED|Overall Study||2
401128|NCT00933335|957668|P2|COMPLETED|Overall Study||20
401129|NCT00933335|957669|P1|COMPLETED|Overall Study||0
401130|NCT00933335|957668|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
401131|NCT00933335|957669|P1|STARTED|Overall Study||2
401132|NCT00933270|957739|P1|NOT COMPLETED|Overall Study||87
401133|NCT00933270|957739|P1|COMPLETED|Overall Study||177
401134|NCT00933270|957739|P1|STARTED|Overall Study|ITT population|264
401135|NCT00933244|957833|P3|NOT COMPLETED|Overall Study||3
401136|NCT00933244|957834|P2|NOT COMPLETED|Overall Study||1
401137|NCT00933244|957835|P1|NOT COMPLETED|Overall Study||5
401138|NCT00933244|957833|P3|COMPLETED|Overall Study||73
401139|NCT00933244|957834|P2|COMPLETED|Overall Study||74
401140|NCT00933244|957835|P1|COMPLETED|Overall Study||74
401141|NCT00933244|957833|P3|STARTED|Overall Study||76
401142|NCT00933244|957834|P2|STARTED|Overall Study||75
401143|NCT00933244|957835|P1|STARTED|Overall Study||79
401144|NCT00933166|957852|P1|NOT COMPLETED|Overall Study||18
401145|NCT00933166|957852|P1|COMPLETED|Overall Study||151
401146|NCT00933166|957852|P1|STARTED|Overall Study||169
401147|NCT00932893|957858|P2|NOT COMPLETED|Overall Study||170
401148|NCT00932893|957859|P1|NOT COMPLETED|Overall Study||133
401149|NCT00932893|957858|P2|COMPLETED|Overall Study||4
401150|NCT00932893|957859|P1|COMPLETED|Overall Study||40
401151|NCT00932893|957858|P2|Treated|Overall Study||171
401152|NCT00932893|957859|P1|Treated|Overall Study||172
401153|NCT00932893|957858|P2|STARTED|Overall Study||174
401154|NCT00932893|957859|P1|STARTED|Overall Study||173
401155|NCT00932659|957890|P1|NOT COMPLETED|Overall Study||0
401156|NCT00932659|957890|P1|COMPLETED|Overall Study||8
401157|NCT00932659|957890|P1|STARTED|Overall Study||8
401158|NCT00932646|957895|P4|NOT COMPLETED|Overall Study||1
401159|NCT00932646|957896|P3|NOT COMPLETED|Overall Study||4
401160|NCT00932646|957897|P2|NOT COMPLETED|Overall Study||3
401161|NCT00932646|957898|P1|NOT COMPLETED|Overall Study||5
401162|NCT00932646|957895|P4|COMPLETED|Overall Study||24
401163|NCT00932646|957896|P3|COMPLETED|Overall Study||21
401164|NCT00932646|957897|P2|COMPLETED|Overall Study||22
401165|NCT00932646|957898|P1|COMPLETED|Overall Study||20
401166|NCT00932646|957895|P4|STARTED|Overall Study||25
401167|NCT00932646|957896|P3|STARTED|Overall Study||25
401168|NCT00932646|957897|P2|STARTED|Overall Study||25
401169|NCT00932646|957898|P1|STARTED|Overall Study||25
401170|NCT00932620|957954|P2|NOT COMPLETED|Overall Study||0
401171|NCT00932620|957955|P1|NOT COMPLETED|Overall Study||0
401172|NCT00932620|957954|P2|COMPLETED|Overall Study||50
401173|NCT00932620|957955|P1|COMPLETED|Overall Study||50
401174|NCT00932620|957954|P2|STARTED|Overall Study||50
401175|NCT00932620|957955|P1|STARTED|Overall Study||50
401176|NCT00932477|957963|P6|NOT COMPLETED|Treatment 3||0
401177|NCT00932477|957964|P5|NOT COMPLETED|Treatment 3||0
401178|NCT00932477|957965|P4|NOT COMPLETED|Treatment 3||0
401179|NCT00932477|957966|P3|NOT COMPLETED|Treatment 3||0
401180|NCT00932477|957967|P2|NOT COMPLETED|Treatment 3||0
401181|NCT00932477|957968|P1|NOT COMPLETED|Treatment 3||0
401182|NCT00932477|957963|P6|COMPLETED|Treatment 3||8
401183|NCT00932477|957964|P5|COMPLETED|Treatment 3||8
401184|NCT00932477|957965|P4|COMPLETED|Treatment 3||7
401185|NCT00932477|957966|P3|COMPLETED|Treatment 3||9
401186|NCT00932477|957967|P2|COMPLETED|Treatment 3||8
401187|NCT00932477|957968|P1|COMPLETED|Treatment 3||7
401188|NCT00932477|957963|P6|STARTED|Treatment 3||8
401189|NCT00932477|957964|P5|STARTED|Treatment 3||8
401190|NCT00932477|957965|P4|STARTED|Treatment 3||7
401191|NCT00932477|957966|P3|STARTED|Treatment 3||9
401192|NCT00932477|957967|P2|STARTED|Treatment 3||8
401193|NCT00932477|957968|P1|STARTED|Treatment 3||7
401194|NCT00932477|957963|P6|NOT COMPLETED|Treatment 2||0
401195|NCT00932477|957964|P5|NOT COMPLETED|Treatment 2||0
401196|NCT00932477|957965|P4|NOT COMPLETED|Treatment 2||0
401197|NCT00932477|957966|P3|NOT COMPLETED|Treatment 2||0
401198|NCT00932477|957967|P2|NOT COMPLETED|Treatment 2||0
401199|NCT00932477|957968|P1|NOT COMPLETED|Treatment 2||0
401200|NCT00932477|957963|P6|COMPLETED|Treatment 2||8
401201|NCT00932477|957964|P5|COMPLETED|Treatment 2||8
401202|NCT00932477|957965|P4|COMPLETED|Treatment 2||7
401203|NCT00932477|957966|P3|COMPLETED|Treatment 2||9
401204|NCT00932477|957967|P2|COMPLETED|Treatment 2||8
401205|NCT00932477|957968|P1|COMPLETED|Treatment 2||7
401206|NCT00932477|957963|P6|STARTED|Treatment 2||8
401207|NCT00932477|957964|P5|STARTED|Treatment 2||8
401208|NCT00932477|957965|P4|STARTED|Treatment 2||7
401209|NCT00932477|957966|P3|STARTED|Treatment 2||9
401210|NCT00932477|957967|P2|STARTED|Treatment 2||8
401211|NCT00932477|957968|P1|STARTED|Treatment 2||7
401212|NCT00932477|957963|P6|NOT COMPLETED|Treatment 1||0
401213|NCT00932477|957964|P5|NOT COMPLETED|Treatment 1||0
401214|NCT00932477|957965|P4|NOT COMPLETED|Treatment 1||0
401215|NCT00932477|957966|P3|NOT COMPLETED|Treatment 1||0
401216|NCT00932477|957967|P2|NOT COMPLETED|Treatment 1||0
401217|NCT00932477|957968|P1|NOT COMPLETED|Treatment 1||0
401218|NCT00932477|957963|P6|COMPLETED|Treatment 1||8
401219|NCT00932477|957964|P5|COMPLETED|Treatment 1||8
401220|NCT00932477|957965|P4|COMPLETED|Treatment 1||7
401221|NCT00932477|957966|P3|COMPLETED|Treatment 1||9
401222|NCT00932477|957967|P2|COMPLETED|Treatment 1||8
401223|NCT00932477|957968|P1|COMPLETED|Treatment 1||7
401224|NCT00932477|957963|P6|STARTED|Treatment 1||8
401225|NCT00932477|957964|P5|STARTED|Treatment 1||8
401226|NCT00932477|957965|P4|STARTED|Treatment 1||7
401227|NCT00932477|957966|P3|STARTED|Treatment 1||9
401228|NCT00932477|957967|P2|STARTED|Treatment 1||8
401229|NCT00932477|957968|P1|STARTED|Treatment 1||7
401230|NCT00932451|957985|P1|NOT COMPLETED|Overall Study||822
401231|NCT00932451|957985|P1|COMPLETED|Overall Study||244
401232|NCT00932451|957985|P1|STARTED|Overall Study||1066
401233|NCT00932425|958009|P2|NOT COMPLETED|Overall Study||2
401234|NCT00932425|958010|P1|NOT COMPLETED|Overall Study||0
401235|NCT00932425|958009|P2|COMPLETED|Overall Study||18
401236|NCT00932425|958010|P1|COMPLETED|Overall Study||20
401237|NCT00932425|958009|P2|STARTED|Overall Study||20
401238|NCT00932425|958010|P1|STARTED|Overall Study||20
401239|NCT00932399|958025|P2|NOT COMPLETED|Overall Study||0
401240|NCT00932399|958026|P1|NOT COMPLETED|Overall Study||0
401241|NCT00932399|958025|P2|COMPLETED|Overall Study||3790
401242|NCT00932399|958026|P1|COMPLETED|Overall Study||759
401243|NCT00932399|958025|P2|STARTED|Overall Study||3790
401244|NCT00932399|958026|P1|STARTED|Overall Study||759
401245|NCT00932373|958043|P11|NOT COMPLETED|Overall Study||3
401246|NCT00932373|958044|P10|NOT COMPLETED|Overall Study||13
401247|NCT00932373|958045|P9|NOT COMPLETED|Overall Study||2
401248|NCT00932373|958046|P8|NOT COMPLETED|Overall Study||3
401249|NCT00932373|958047|P7|NOT COMPLETED|Overall Study||1
401250|NCT00932373|958048|P6|NOT COMPLETED|Overall Study||3
401251|NCT00932373|958049|P5|NOT COMPLETED|Overall Study||14
401252|NCT00932373|958050|P4|NOT COMPLETED|Overall Study||0
401253|NCT00932373|958051|P3|NOT COMPLETED|Overall Study||1
401254|NCT00932373|958052|P2|NOT COMPLETED|Overall Study||1
401255|NCT00932373|958053|P1|NOT COMPLETED|Overall Study||3
401256|NCT00932373|958043|P11|COMPLETED|Overall Study||0
401257|NCT00932373|958044|P10|COMPLETED|Overall Study||3
401258|NCT00932373|958045|P9|COMPLETED|Overall Study||1
401259|NCT00932373|958046|P8|COMPLETED|Overall Study||0
401260|NCT00932373|958047|P7|COMPLETED|Overall Study||2
401261|NCT00932373|958048|P6|COMPLETED|Overall Study||0
401262|NCT00932373|958049|P5|COMPLETED|Overall Study||1
401263|NCT00932373|958050|P4|COMPLETED|Overall Study||1
401264|NCT00932373|958051|P3|COMPLETED|Overall Study||0
401265|NCT00932373|958052|P2|COMPLETED|Overall Study||0
401266|NCT00932373|958053|P1|COMPLETED|Overall Study||0
401267|NCT00932373|958043|P11|STARTED|Overall Study||3
401268|NCT00932373|958044|P10|STARTED|Overall Study||16
401269|NCT00932373|958045|P9|STARTED|Overall Study||3
401270|NCT00932373|958046|P8|STARTED|Overall Study||3
401271|NCT00932373|958047|P7|STARTED|Overall Study||3
401272|NCT00932373|958048|P6|STARTED|Overall Study||3
401273|NCT00932373|958049|P5|STARTED|Overall Study||15
401274|NCT00932373|958050|P4|STARTED|Overall Study||1
401275|NCT00932373|958051|P3|STARTED|Overall Study||1
401276|NCT00932373|958052|P2|STARTED|Overall Study||1
401277|NCT00932373|958053|P1|STARTED|Overall Study||3
401278|NCT00932321|958155|P2|NOT COMPLETED|Overall Study||46
401279|NCT00932321|958156|P1|NOT COMPLETED|Overall Study||171
401280|NCT00932321|958155|P2|COMPLETED|Overall Study||141
401281|NCT00932321|958156|P1|COMPLETED|Overall Study||580
401282|NCT00932321|958155|P2|MITT Population|Overall Study||181
401283|NCT00932321|958156|P1|MITT Population|Overall Study||705
401284|NCT00932321|958155|P2|STARTED|Overall Study||187
401285|NCT00932321|958156|P1|STARTED|Overall Study||751
401286|NCT00932165|958164|P1|NOT COMPLETED|Overall Study||1
401287|NCT00932165|958164|P1|COMPLETED|Overall Study||450
401288|NCT00932165|958164|P1|STARTED|Overall Study||451
401289|NCT00932152|958177|P2|NOT COMPLETED|Overall Study||2
401290|NCT00932152|958178|P1|NOT COMPLETED|Overall Study||1
401291|NCT00932152|958177|P2|COMPLETED|Overall Study||0
401292|NCT00932152|958178|P1|COMPLETED|Overall Study||0
401293|NCT00932152|958177|P2|STARTED|Overall Study||2
401294|NCT00932152|958178|P1|STARTED|Overall Study||1
401295|NCT00932126|958182|P8|NOT COMPLETED|Overall Study||10
401296|NCT00932126|958183|P7|NOT COMPLETED|Overall Study||5
401297|NCT00932126|958184|P6|NOT COMPLETED|Overall Study||3
401298|NCT00932126|958185|P5|NOT COMPLETED|Overall Study||5
401299|NCT00932126|958186|P4|NOT COMPLETED|Overall Study||3
401300|NCT00932126|958187|P3|NOT COMPLETED|Overall Study||3
401301|NCT00932126|958188|P2|NOT COMPLETED|Overall Study||3
401302|NCT00932126|958189|P1|NOT COMPLETED|Overall Study||3
401303|NCT00932126|958182|P8|COMPLETED|Overall Study||0
401304|NCT00932126|958183|P7|COMPLETED|Overall Study||0
401305|NCT00932126|958184|P6|COMPLETED|Overall Study||0
401306|NCT00932126|958185|P5|COMPLETED|Overall Study||0
401307|NCT00932126|958186|P4|COMPLETED|Overall Study||0
401308|NCT00932126|958187|P3|COMPLETED|Overall Study||0
401309|NCT00932126|958188|P2|COMPLETED|Overall Study||0
401310|NCT00932126|958189|P1|COMPLETED|Overall Study||0
401311|NCT00932126|958182|P8|STARTED|Overall Study||10
401312|NCT00932126|958183|P7|STARTED|Overall Study||5
401313|NCT00932126|958184|P6|STARTED|Overall Study||3
401314|NCT00932126|958185|P5|STARTED|Overall Study||5
401315|NCT00932126|958186|P4|STARTED|Overall Study||3
401316|NCT00932126|958187|P3|STARTED|Overall Study||3
401317|NCT00932126|958188|P2|STARTED|Overall Study||3
401318|NCT00932126|958189|P1|STARTED|Overall Study||3
401319|NCT00932035|958227|P2|NOT COMPLETED|Overall Study||0
401320|NCT00932035|958228|P1|NOT COMPLETED|Overall Study||0
401321|NCT00932035|958227|P2|COMPLETED|Overall Study||21
401322|NCT00932035|958228|P1|COMPLETED|Overall Study||18
401323|NCT00932035|958227|P2|STARTED|Overall Study||21
401324|NCT00932035|958228|P1|STARTED|Overall Study||18
401325|NCT00932022|958240|P2|NOT COMPLETED|Overall Study||4
401326|NCT00932022|958241|P1|NOT COMPLETED|Overall Study||5
401327|NCT00932022|958240|P2|COMPLETED|Overall Study||59
401328|NCT00932022|958241|P1|COMPLETED|Overall Study||59
401329|NCT00932022|958240|P2|STARTED|Overall Study||63
401330|NCT00932022|958241|P1|STARTED|Overall Study||64
401331|NCT00931996|958255|P1|NOT COMPLETED|Overall Study||7
401332|NCT00931996|958255|P1|COMPLETED|Overall Study||5
401333|NCT00931996|958255|P1|STARTED|Overall Study||12
401334|NCT00931918|958261|P2|NOT COMPLETED|Overall Study||17
401335|NCT00931918|958262|P1|NOT COMPLETED|Overall Study||17
401336|NCT00931918|958261|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
401337|NCT00931918|958262|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
401338|NCT00931918|958261|P2|Safety Population: Received Study Drug|Overall Study||101
401339|NCT00931918|958262|P1|Safety Population: Received Study Drug|Overall Study||100
401340|NCT00931918|958261|P2|STARTED|Overall Study||103
401341|NCT00931918|958262|P1|STARTED|Overall Study||103
401342|NCT00931879|958288|P2|NOT COMPLETED|Overall Study||3
401343|NCT00931879|958289|P1|NOT COMPLETED|Overall Study||3
401344|NCT00931879|958288|P2|COMPLETED|Overall Study||19
401345|NCT00931879|958289|P1|COMPLETED|Overall Study||19
401346|NCT00931879|958288|P2|STARTED|Overall Study||22
401347|NCT00931879|958289|P1|STARTED|Overall Study||22
401348|NCT00931801|958314|P3|NOT COMPLETED|Overall Study||4
401349|NCT00931801|958315|P2|NOT COMPLETED|Overall Study||1
401350|NCT00931801|958316|P1|NOT COMPLETED|Overall Study||1
401351|NCT00931801|958314|P3|COMPLETED|Overall Study||10
401352|NCT00931801|958315|P2|COMPLETED|Overall Study||14
401353|NCT00931801|958316|P1|COMPLETED|Overall Study||13
401354|NCT00931801|958314|P3|STARTED|Overall Study||14
401355|NCT00931801|958315|P2|STARTED|Overall Study||15
401356|NCT00931801|958316|P1|STARTED|Overall Study||14
401357|NCT00931723|958339|P2|NOT COMPLETED|Overall Study||39
401358|NCT00931723|958340|P1|NOT COMPLETED|Overall Study||26
401359|NCT00931723|958339|P2|COMPLETED|Overall Study||144
401360|NCT00931723|958340|P1|COMPLETED|Overall Study||147
401361|NCT00931723|958339|P2|STARTED|Overall Study||183
401362|NCT00931723|958340|P1|STARTED|Overall Study||173
401363|NCT00931710|958388|P2|NOT COMPLETED|Overall Study||38
401364|NCT00931710|958389|P1|NOT COMPLETED|Overall Study||34
401365|NCT00931710|958388|P2|COMPLETED|Overall Study||209
401366|NCT00931710|958389|P1|COMPLETED|Overall Study||207
401367|NCT00931710|958388|P2|STARTED|Overall Study||247
401368|NCT00931710|958389|P1|STARTED|Overall Study||241
401369|NCT00931632|958407|P2|NOT COMPLETED|Overall Study||18
401370|NCT00931632|958408|P1|NOT COMPLETED|Overall Study||21
401371|NCT00931632|958407|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
401372|NCT00931632|958408|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
401373|NCT00931632|958407|P2|STARTED|Overall Study|Randomized|222
401374|NCT00931632|958408|P1|STARTED|Overall Study|Randomized|229
401375|NCT00931528|958416|P2|NOT COMPLETED|Overall Study||60
401376|NCT00931528|958417|P1|NOT COMPLETED|Overall Study||41
401377|NCT00931528|958416|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
401378|NCT00931528|958417|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
401379|NCT00931528|958416|P2|STARTED|Overall Study||121
401380|NCT00931528|958417|P1|STARTED|Overall Study||121
401381|NCT00931515|958425|P2|NOT COMPLETED|Overall Study||5
401382|NCT00931515|958426|P1|NOT COMPLETED|Overall Study||2
401383|NCT00931515|958425|P2|COMPLETED|Overall Study||10
401384|NCT00931515|958426|P1|COMPLETED|Overall Study||13
401385|NCT00931515|958425|P2|STARTED|Overall Study||15
401386|NCT00931515|958426|P1|STARTED|Overall Study||15
401387|NCT00931463|958434|P2|NOT COMPLETED|Overall Study||5
401388|NCT00931463|958435|P1|NOT COMPLETED|Overall Study||17
401389|NCT00931463|958434|P2|COMPLETED|Overall Study||265
401390|NCT00931463|958435|P1|COMPLETED|Overall Study||254
401391|NCT00931463|958434|P2|STARTED|Overall Study||270
401392|NCT00931463|958435|P1|STARTED|Overall Study||271
401393|NCT00931411|958451|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
401394|NCT00931411|958452|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
401395|NCT00931411|958451|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
401396|NCT00931411|958452|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
401397|NCT00931411|958451|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
401398|NCT00931411|958452|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
401399|NCT00931411|958451|P2|NOT COMPLETED|First Intervention - 42 Days||3
401400|NCT00931411|958452|P1|NOT COMPLETED|First Intervention - 42 Days||4
401401|NCT00931411|958451|P2|COMPLETED|First Intervention - 42 Days||35
401402|NCT00931411|958452|P1|COMPLETED|First Intervention - 42 Days||31
401403|NCT00931411|958451|P2|STARTED|First Intervention - 42 Days||38
401404|NCT00931411|958452|P1|STARTED|First Intervention - 42 Days||35
401405|NCT00931385|958473|P4|NOT COMPLETED|Overall Study||5
401406|NCT00931385|958474|P3|NOT COMPLETED|Overall Study||1
401407|NCT00931385|958475|P2|NOT COMPLETED|Overall Study||2
401408|NCT00931385|958476|P1|NOT COMPLETED|Overall Study||2
401409|NCT00931385|958473|P4|COMPLETED|Overall Study||21
401410|NCT00931385|958474|P3|COMPLETED|Overall Study||24
401411|NCT00931385|958475|P2|COMPLETED|Overall Study||21
401412|NCT00931385|958476|P1|COMPLETED|Overall Study||23
401413|NCT00931385|958473|P4|STARTED|Overall Study||26
401414|NCT00931385|958474|P3|STARTED|Overall Study||25
401415|NCT00931385|958475|P2|STARTED|Overall Study||23
401416|NCT00931385|958476|P1|STARTED|Overall Study||25
401417|NCT00931359|958532|P2|NOT COMPLETED|Overall Study||13
401418|NCT00931359|958533|P1|NOT COMPLETED|Overall Study||6
401419|NCT00931359|958532|P2|COMPLETED|Overall Study||68
401420|NCT00931359|958533|P1|COMPLETED|Overall Study||33
401421|NCT00931359|958532|P2|STARTED|Overall Study||81
401422|NCT00931359|958533|P1|STARTED|Overall Study||39
401423|NCT00931307|958545|P1|NOT COMPLETED|Overall Study||13
401424|NCT00931307|958545|P1|COMPLETED|Overall Study||9
401425|NCT00931307|958545|P1|STARTED|Overall Study||22
401426|NCT00931268|958549|P1|NOT COMPLETED|Overall Study||6
401427|NCT00931268|958549|P1|COMPLETED|Overall Study||4
401428|NCT00931268|958549|P1|STARTED|Overall Study||10
401429|NCT00931242|958561|P2|NOT COMPLETED|Overall Study||2
401430|NCT00931242|958562|P1|NOT COMPLETED|Overall Study||5
401431|NCT00931242|958561|P2|COMPLETED|Overall Study||0
401432|NCT00931242|958562|P1|COMPLETED|Overall Study||5
401433|NCT00931242|958561|P2|STARTED|Overall Study||2
401434|NCT00931242|958562|P1|STARTED|Overall Study||10
401435|NCT00931164|958568|P1|NOT COMPLETED|Overall Study||0
401436|NCT00931164|958568|P1|COMPLETED|Overall Study||6
401437|NCT00931164|958568|P1|STARTED|Overall Study||6
401438|NCT00930982|958574|P2|NOT COMPLETED|Overall Study||29
401439|NCT00930982|958575|P1|NOT COMPLETED|Overall Study||21
401440|NCT00930982|958574|P2|COMPLETED|Overall Study||35
401441|NCT00930982|958575|P1|COMPLETED|Overall Study||39
401442|NCT00930982|958574|P2|STARTED|Overall Study||64
401443|NCT00930982|958575|P1|STARTED|Overall Study||60
401444|NCT00930969|958609|P1|NOT COMPLETED|Overall Study||38
401445|NCT00930969|958609|P1|COMPLETED|Overall Study||137
401446|NCT00930969|958609|P1|STARTED|Overall Study||175
401447|NCT00930930|958619|P2|NOT COMPLETED|Overall Study||9
401448|NCT00930930|958620|P1|NOT COMPLETED|Overall Study||21
401449|NCT00930930|958619|P2|COMPLETED|Overall Study||40
401450|NCT00930930|958620|P1|COMPLETED|Overall Study||75
401451|NCT00930930|958619|P2|STARTED|Overall Study||49
401452|NCT00930930|958620|P1|STARTED|Overall Study||96
401453|NCT00930813|958634|P2|NOT COMPLETED|Overall Study||14
401454|NCT00930813|958635|P1|NOT COMPLETED|Overall Study||8
401455|NCT00930813|958634|P2|COMPLETED|Overall Study||38
401456|NCT00930813|958635|P1|COMPLETED|Overall Study||41
401457|NCT00930813|958634|P2|STARTED|Overall Study||52
401458|NCT00930813|958635|P1|STARTED|Overall Study||49
401459|NCT00930787|958645|P2|NOT COMPLETED|Overall Study||0
401460|NCT00930787|958646|P1|NOT COMPLETED|Overall Study||0
401461|NCT00930787|958645|P2|COMPLETED|Overall Study||9
401462|NCT00930787|958646|P1|COMPLETED|Overall Study||14
401463|NCT00930787|958645|P2|STARTED|Overall Study||9
401464|NCT00930787|958646|P1|STARTED|Overall Study||14
401465|NCT00930774|958656|P4|NOT COMPLETED|Overall Study||0
401466|NCT00930774|958657|P3|NOT COMPLETED|Overall Study||2
401467|NCT00930774|958658|P2|NOT COMPLETED|Overall Study||9
401468|NCT00930774|958659|P1|NOT COMPLETED|Overall Study||1
401469|NCT00930774|958656|P4|COMPLETED|Overall Study||25
401470|NCT00930774|958657|P3|COMPLETED|Overall Study||22
401471|NCT00930774|958658|P2|COMPLETED|Overall Study||16
401472|NCT00930774|958659|P1|COMPLETED|Overall Study||24
401473|NCT00930774|958656|P4|STARTED|Overall Study||25
401474|NCT00930774|958657|P3|STARTED|Overall Study||24
401475|NCT00930774|958658|P2|STARTED|Overall Study||25
401476|NCT00930774|958659|P1|STARTED|Overall Study||25
401477|NCT00930761|958699|P2|NOT COMPLETED|Overall Study||3
401478|NCT00930761|958700|P1|NOT COMPLETED|Overall Study||4
401479|NCT00930761|958699|P2|COMPLETED|Overall Study||48
401480|NCT00930761|958700|P1|COMPLETED|Overall Study||46
401481|NCT00930761|958699|P2|STARTED|Overall Study||51
401482|NCT00930761|958700|P1|STARTED|Overall Study||50
401483|NCT00930722|958712|P1|NOT COMPLETED|Overall Study||27
401484|NCT00930722|958712|P1|COMPLETED|Overall Study||302
401485|NCT00930722|958712|P1|STARTED|Overall Study||329
401486|NCT00930644|958727|P1|NOT COMPLETED|Overall Study||23
401487|NCT00930644|958727|P1|COMPLETED|Overall Study||65
401488|NCT00930644|958727|P1|STARTED|Overall Study||88
401489|NCT00930553|958740|P1|NOT COMPLETED|Overall Study||223
401490|NCT00930553|958740|P1|COMPLETED|Overall Study||1091
401491|NCT00930553|958740|P1|Participants Entered From CAMMS324|Overall Study||685
401492|NCT00930553|958740|P1|Participants Entered From CAMMS323|Overall Study||488
401493|NCT00930553|958740|P1|Participants Entered From CAMMS223|Overall Study||141
401494|NCT00930553|958740|P1|STARTED|Overall Study||1314
401495|NCT00930293|958808|P2|NOT COMPLETED|Overall Study||7
401496|NCT00930293|958809|P1|NOT COMPLETED|Overall Study||7
401497|NCT00930293|958808|P2|COMPLETED|Overall Study||19
401498|NCT00930293|958809|P1|COMPLETED|Overall Study||17
401499|NCT00930293|958808|P2|STARTED|Overall Study||26
401500|NCT00930293|958809|P1|STARTED|Overall Study||24
401501|NCT00930176|958817|P1|NOT COMPLETED|Overall Study||1
401502|NCT00930176|958817|P1|COMPLETED|Overall Study||15
401503|NCT00930176|958817|P1|STARTED|Overall Study||16
401504|NCT00929981|958822|P1|NOT COMPLETED|Overall Study||0
401505|NCT00929981|958822|P1|COMPLETED|Overall Study||80
401506|NCT00929981|958822|P1|STARTED|Overall Study||80
401507|NCT00929864|958834|P2|NOT COMPLETED|Overall Study||83
401508|NCT00929864|958835|P1|NOT COMPLETED|Overall Study||66
401509|NCT00929864|958834|P2|COMPLETED|Overall Study||245
401510|NCT00929864|958835|P1|COMPLETED|Overall Study||252
401511|NCT00929864|958834|P2|STARTED|Overall Study||328
401512|NCT00929864|958835|P1|STARTED|Overall Study||318
401513|NCT00929773|958855|P2|NOT COMPLETED|Overall Study||0
401514|NCT00929773|958856|P1|NOT COMPLETED|Overall Study||0
401515|NCT00929773|958855|P2|COMPLETED|Overall Study||50
401516|NCT00929773|958856|P1|COMPLETED|Overall Study||50
401517|NCT00929773|958855|P2|STARTED|Overall Study||50
401518|NCT00929773|958856|P1|STARTED|Overall Study||50
401519|NCT00929734|958874|P2|NOT COMPLETED|Overall Study||3
401520|NCT00929734|958875|P1|NOT COMPLETED|Overall Study||2
401521|NCT00929734|958874|P2|COMPLETED|Overall Study||47
401522|NCT00929734|958875|P1|COMPLETED|Overall Study||47
401523|NCT00929734|958874|P2|STARTED|Overall Study||50
401524|NCT00929734|958875|P1|STARTED|Overall Study||49
401525|NCT00929708|958892|P5|NOT COMPLETED|Overall Study||6
401526|NCT00929708|958893|P4|NOT COMPLETED|Overall Study||6
401527|NCT00929708|958894|P3|NOT COMPLETED|Overall Study||3
401528|NCT00929708|958895|P2|NOT COMPLETED|Overall Study||3
401529|NCT00929708|958896|P1|NOT COMPLETED|Overall Study||4
401530|NCT00929708|958892|P5|COMPLETED|Overall Study||57
401531|NCT00929708|958893|P4|COMPLETED|Overall Study||61
401532|NCT00929708|958894|P3|COMPLETED|Overall Study||62
401533|NCT00929708|958895|P2|COMPLETED|Overall Study||66
401534|NCT00929708|958896|P1|COMPLETED|Overall Study||61
401535|NCT00929708|958892|P5|STARTED|Overall Study||63
401536|NCT00929708|958893|P4|STARTED|Overall Study||67
401537|NCT00929708|958894|P3|STARTED|Overall Study||65
401538|NCT00929708|958895|P2|STARTED|Overall Study||69
401539|NCT00929708|958896|P1|STARTED|Overall Study||65
401540|NCT00929695|958950|P2|NOT COMPLETED|Overall Study||6
401541|NCT00929695|958951|P1|NOT COMPLETED|Overall Study||8
401542|NCT00929695|958950|P2|COMPLETED|Overall Study||77
401543|NCT00929695|958951|P1|COMPLETED|Overall Study||73
401544|NCT00929695|958950|P2|STARTED|Overall Study||83
401545|NCT00929695|958951|P1|STARTED|Overall Study||81
401546|NCT00929643|958981|P1|NOT COMPLETED|Overall Study||2
401547|NCT00929643|958981|P1|COMPLETED|Overall Study||201
401548|NCT00929643|958981|P1|STARTED|Overall Study||203
401549|NCT00929578|958990|P1|NOT COMPLETED|Overall Study||0
401550|NCT00929578|958990|P1|COMPLETED|Overall Study||15
401551|NCT00929578|958990|P1|STARTED|Overall Study||15
401552|NCT00929526|959003|P2|NOT COMPLETED|Overall Study||29
401553|NCT00929526|959004|P1|NOT COMPLETED|Overall Study||17
401554|NCT00929526|959003|P2|COMPLETED|Overall Study||348
401555|NCT00929526|959004|P1|COMPLETED|Overall Study||358
401556|NCT00929526|959003|P2|STARTED|Overall Study||377
401557|NCT00929526|959004|P1|STARTED|Overall Study||375
401558|NCT00929474|959040|P2|NOT COMPLETED|Overall Study||9
401559|NCT00929474|959041|P1|NOT COMPLETED|Overall Study||8
401560|NCT00929474|959040|P2|COMPLETED|Overall Study||0
401561|NCT00929474|959041|P1|COMPLETED|Overall Study||0
401562|NCT00929474|959040|P2|STARTED|Overall Study||9
401563|NCT00929474|959041|P1|STARTED|Overall Study||8
401564|NCT00929383|959047|P1|NOT COMPLETED|Overall Study||15
401565|NCT00929383|959047|P1|COMPLETED|Overall Study||67
401566|NCT00929383|959047|P1|STARTED|Overall Study||82
401567|NCT00929357|959057|P2|NOT COMPLETED|Overall Study||0
401568|NCT00929357|959058|P1|NOT COMPLETED|Overall Study||0
401569|NCT00929357|959057|P2|COMPLETED|Overall Study||64
401570|NCT00929357|959058|P1|COMPLETED|Overall Study||92
401571|NCT00929357|959057|P2|STARTED|Overall Study||64
401572|NCT00929357|959058|P1|STARTED|Overall Study||92
401573|NCT00929344|959081|P3|NOT COMPLETED|Overall Study||21
401574|NCT00929344|959082|P2|NOT COMPLETED|Overall Study||13
401575|NCT00929344|959083|P1|NOT COMPLETED|Overall Study||22
401576|NCT00929344|959081|P3|COMPLETED|Overall Study||29
401577|NCT00929344|959082|P2|COMPLETED|Overall Study||37
401578|NCT00929344|959083|P1|COMPLETED|Overall Study||28
401579|NCT00929344|959081|P3|STARTED|Overall Study||50
401580|NCT00929344|959082|P2|STARTED|Overall Study||50
401581|NCT00929344|959083|P1|STARTED|Overall Study||50
401582|NCT00929331|959099|P2|NOT COMPLETED|Overall Study||0
401583|NCT00929331|959100|P1|NOT COMPLETED|Overall Study||0
401584|NCT00929331|959099|P2|COMPLETED|Overall Study||55
401585|NCT00929331|959100|P1|COMPLETED|Overall Study||55
401586|NCT00929331|959099|P2|STARTED|Overall Study||55
401587|NCT00929331|959100|P1|STARTED|Overall Study||55
401588|NCT00929305|959134|P2|NOT COMPLETED|Overall Study||0
401589|NCT00929305|959135|P1|NOT COMPLETED|Overall Study||0
401590|NCT00929305|959134|P2|COMPLETED|Overall Study||43
401591|NCT00929305|959135|P1|COMPLETED|Overall Study||43
401592|NCT00929305|959134|P2|STARTED|Overall Study||43
401593|NCT00929305|959135|P1|STARTED|Overall Study||43
401594|NCT00929240|959143|P3|NOT COMPLETED|Maintenance Phase||91
401595|NCT00929240|959144|P2|NOT COMPLETED|Maintenance Phase||94
401596|NCT00929240|959145|P1|NOT COMPLETED|Maintenance Phase||0
401597|NCT00929240|959143|P3|COMPLETED|Maintenance Phase||0
401598|NCT00929240|959144|P2|COMPLETED|Maintenance Phase||0
401599|NCT00929240|959145|P1|COMPLETED|Maintenance Phase||0
401600|NCT00929240|959143|P3|STARTED|Maintenance Phase||91
401601|NCT00929240|959144|P2|STARTED|Maintenance Phase||94
401602|NCT00929240|959145|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
401603|NCT00929240|959143|P3|NOT COMPLETED|Initial Treatment Phase||0
401604|NCT00929240|959144|P2|NOT COMPLETED|Initial Treatment Phase||0
401605|NCT00929240|959145|P1|NOT COMPLETED|Initial Treatment Phase||99
401606|NCT00929240|959143|P3|COMPLETED|Initial Treatment Phase||0
401607|NCT00929240|959144|P2|COMPLETED|Initial Treatment Phase||0
401608|NCT00929240|959145|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
401609|NCT00929240|959143|P3|STARTED|Initial Treatment Phase||0
401704|NCT00928668|959375|P1|COMPLETED|Overall Study||6
401610|NCT00929240|959144|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
401611|NCT00929240|959145|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
401612|NCT00929201|959172|P2|NOT COMPLETED|Period 2||0
401613|NCT00929201|959173|P1|NOT COMPLETED|Period 2||0
401614|NCT00929201|959172|P2|COMPLETED|Period 2||30
401615|NCT00929201|959173|P1|COMPLETED|Period 2||30
401616|NCT00929201|959172|P2|STARTED|Period 2||30
401617|NCT00929201|959173|P1|STARTED|Period 2||30
401618|NCT00929201|959172|P2|NOT COMPLETED|7-day Washout||0
401619|NCT00929201|959173|P1|NOT COMPLETED|7-day Washout||0
401620|NCT00929201|959172|P2|COMPLETED|7-day Washout||30
401621|NCT00929201|959173|P1|COMPLETED|7-day Washout||30
401622|NCT00929201|959172|P2|STARTED|7-day Washout||30
401623|NCT00929201|959173|P1|STARTED|7-day Washout||30
401624|NCT00929201|959172|P2|NOT COMPLETED|Period 1||1
401625|NCT00929201|959173|P1|NOT COMPLETED|Period 1||0
401626|NCT00929201|959172|P2|COMPLETED|Period 1||30
401627|NCT00929201|959173|P1|COMPLETED|Period 1||30
401628|NCT00929201|959172|P2|STARTED|Period 1||31
401629|NCT00929201|959173|P1|STARTED|Period 1||30
401630|NCT00929162|959183|P2|NOT COMPLETED|Overall Study||42
401631|NCT00929162|959184|P1|NOT COMPLETED|Overall Study||48
401632|NCT00929162|959183|P2|COMPLETED|Overall Study||19
401633|NCT00929162|959184|P1|COMPLETED|Overall Study||11
401634|NCT00929162|959183|P2|Patients Who Received Treatment|Overall Study||58
401635|NCT00929162|959184|P1|Patients Who Received Treatment|Overall Study||58
401636|NCT00929162|959183|P2|STARTED|Overall Study||61
401637|NCT00929162|959184|P1|STARTED|Overall Study||59
401638|NCT00929110|959197|P3|NOT COMPLETED|Overall Study||62
401639|NCT00929110|959198|P2|NOT COMPLETED|Overall Study||76
401640|NCT00929110|959199|P1|NOT COMPLETED|Overall Study||118
401641|NCT00929110|959197|P3|COMPLETED|Overall Study||206
401642|NCT00929110|959198|P2|COMPLETED|Overall Study||193
401643|NCT00929110|959199|P1|COMPLETED|Overall Study||411
401644|NCT00929110|959197|P3|STARTED|Overall Study||268
401645|NCT00929110|959198|P2|STARTED|Overall Study||269
401646|NCT00929110|959199|P1|STARTED|Overall Study||529
401647|NCT00929071|959264|P1|NOT COMPLETED|Overall Study||0
401648|NCT00929071|959264|P1|COMPLETED|Overall Study||10
401649|NCT00929071|959264|P1|STARTED|Overall Study||10
401650|NCT00928954|959271|P2|NOT COMPLETED|Overall Study||0
401651|NCT00928954|959272|P1|NOT COMPLETED|Overall Study||0
401652|NCT00928954|959271|P2|COMPLETED|Overall Study||6
401653|NCT00928954|959272|P1|COMPLETED|Overall Study||4
401654|NCT00928954|959271|P2|STARTED|Overall Study||6
401655|NCT00928954|959272|P1|STARTED|Overall Study||4
401656|NCT00928889|959282|P2|NOT COMPLETED|Overall Study||2
401657|NCT00928889|959283|P1|NOT COMPLETED|Overall Study||5
401658|NCT00928889|959282|P2|COMPLETED|Overall Study||78
401659|NCT00928889|959283|P1|COMPLETED|Overall Study||75
401660|NCT00928889|959282|P2|STARTED|Overall Study||80
401661|NCT00928889|959283|P1|STARTED|Overall Study||80
401662|NCT00928772|959310|P3|NOT COMPLETED|Overall Study||0
401663|NCT00928772|959311|P2|NOT COMPLETED|Overall Study||0
401664|NCT00928772|959312|P1|NOT COMPLETED|Overall Study||0
401665|NCT00928772|959310|P3|COMPLETED|Overall Study||38
401666|NCT00928772|959311|P2|COMPLETED|Overall Study||38
401667|NCT00928772|959312|P1|COMPLETED|Overall Study||39
401668|NCT00928772|959310|P3|STARTED|Overall Study||38
401669|NCT00928772|959311|P2|STARTED|Overall Study||38
401670|NCT00928772|959312|P1|STARTED|Overall Study||39
401671|NCT00928746|959329|P1|NOT COMPLETED|Overall Study||6
401672|NCT00928746|959329|P1|COMPLETED|Overall Study||136
401673|NCT00928746|959329|P1|STARTED|Overall Study||142
401674|NCT00928720|959352|P3|NOT COMPLETED|Overall Study||3
401675|NCT00928720|959353|P2|NOT COMPLETED|Overall Study||6
401676|NCT00928720|959354|P1|NOT COMPLETED|Overall Study||2
401677|NCT00928720|959352|P3|COMPLETED|Overall Study||15
401678|NCT00928720|959353|P2|COMPLETED|Overall Study||14
401679|NCT00928720|959354|P1|COMPLETED|Overall Study||17
401680|NCT00928720|959352|P3|STARTED|Overall Study||18
401681|NCT00928720|959353|P2|STARTED|Overall Study||20
401682|NCT00928720|959354|P1|STARTED|Overall Study||19
401683|NCT00928694|959362|P2|NOT COMPLETED|Second Intervention||0
401684|NCT00928694|959363|P1|NOT COMPLETED|Second Intervention||0
401685|NCT00928694|959362|P2|COMPLETED|Second Intervention||7
401686|NCT00928694|959363|P1|COMPLETED|Second Intervention||7
401687|NCT00928694|959362|P2|STARTED|Second Intervention||7
401688|NCT00928694|959363|P1|STARTED|Second Intervention||7
401689|NCT00928694|959362|P2|NOT COMPLETED|First Intervention||0
401690|NCT00928694|959363|P1|NOT COMPLETED|First Intervention||0
401691|NCT00928694|959362|P2|COMPLETED|First Intervention||7
401692|NCT00928694|959363|P1|COMPLETED|First Intervention||7
401693|NCT00928694|959362|P2|STARTED|First Intervention||7
401694|NCT00928694|959363|P1|STARTED|First Intervention||7
401695|NCT00928668|959371|P5|NOT COMPLETED|Overall Study||1
401696|NCT00928668|959372|P4|NOT COMPLETED|Overall Study||1
401697|NCT00928668|959373|P3|NOT COMPLETED|Overall Study||1
401698|NCT00928668|959374|P2|NOT COMPLETED|Overall Study||1
401699|NCT00928668|959375|P1|NOT COMPLETED|Overall Study||1
401700|NCT00928668|959371|P5|COMPLETED|Overall Study||5
401701|NCT00928668|959372|P4|COMPLETED|Overall Study||3
401702|NCT00928668|959373|P3|COMPLETED|Overall Study||6
401703|NCT00928668|959374|P2|COMPLETED|Overall Study||6
401705|NCT00928668|959371|P5|STARTED|Overall Study||6
401706|NCT00928668|959372|P4|STARTED|Overall Study||4
401707|NCT00928668|959373|P3|STARTED|Overall Study||7
401708|NCT00928668|959374|P2|STARTED|Overall Study||7
401709|NCT00928668|959375|P1|STARTED|Overall Study||7
401710|NCT00928642|959417|P1|NOT COMPLETED|Overall Study||0
401711|NCT00928642|959417|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
401712|NCT00928642|959417|P1|STARTED|Overall Study||8
401713|NCT00928512|959431|P5|NOT COMPLETED|Overall Study||15
401714|NCT00928512|959432|P4|NOT COMPLETED|Overall Study||21
401715|NCT00928512|959433|P3|NOT COMPLETED|Overall Study||11
401716|NCT00928512|959434|P2|NOT COMPLETED|Overall Study||6
401717|NCT00928512|959435|P1|NOT COMPLETED|Overall Study||10
401718|NCT00928512|959431|P5|COMPLETED|Overall Study||35
401719|NCT00928512|959432|P4|COMPLETED|Overall Study||33
401720|NCT00928512|959433|P3|COMPLETED|Overall Study||38
401721|NCT00928512|959434|P2|COMPLETED|Overall Study||37
401722|NCT00928512|959435|P1|COMPLETED|Overall Study||31
401723|NCT00928512|959431|P5|Entered/Continued to Week 20 (All)|Overall Study||45
401724|NCT00928512|959432|P4|Entered/Continued to Week 20 (All)|Overall Study||45
401725|NCT00928512|959433|P3|Entered/Continued to Week 20 (All)|Overall Study||46
401726|NCT00928512|959434|P2|Entered/Continued to Week 20 (All)|Overall Study||43
401727|NCT00928512|959435|P1|Entered/Continued to Week 20 (All)|Overall Study||37
401728|NCT00928512|959431|P5|Completed Week 16|Overall Study||45
401729|NCT00928512|959432|P4|Completed Week 16|Overall Study||48
401730|NCT00928512|959433|P3|Completed Week 16|Overall Study||47
401731|NCT00928512|959434|P2|Completed Week 16|Overall Study||43
401732|NCT00928512|959435|P1|Completed Week 16|Overall Study||38
401733|NCT00928512|959431|P5|New Groups After Reassignment|Overall Study||0
401734|NCT00928512|959432|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
401735|NCT00928512|959433|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
401736|NCT00928512|959434|P2|New Groups After Reassignment|Overall Study||115
401737|NCT00928512|959435|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
401738|NCT00928512|959431|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
401739|NCT00928512|959432|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
401740|NCT00928512|959433|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
401741|NCT00928512|959434|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
401742|NCT00928512|959435|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
401743|NCT00928512|959431|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
401744|NCT00928512|959432|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
401745|NCT00928512|959433|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
401746|NCT00928512|959434|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
401747|NCT00928512|959435|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
401748|NCT00928512|959431|P5|Discontinued Prior to Week 16|Overall Study||5
401749|NCT00928512|959432|P4|Discontinued Prior to Week 16|Overall Study||6
401750|NCT00928512|959433|P3|Discontinued Prior to Week 16|Overall Study||2
401751|NCT00928512|959434|P2|Discontinued Prior to Week 16|Overall Study||0
401752|NCT00928512|959435|P1|Discontinued Prior to Week 16|Overall Study||3
401753|NCT00928512|959431|P5|STARTED|Overall Study||50
401754|NCT00928512|959432|P4|STARTED|Overall Study||54
401755|NCT00928512|959433|P3|STARTED|Overall Study||49
401756|NCT00928512|959434|P2|STARTED|Overall Study||43
401757|NCT00928512|959435|P1|STARTED|Overall Study||41
401758|NCT00928486|959536|P1|NOT COMPLETED|Overall Study||10
401759|NCT00928486|959536|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
401760|NCT00928486|959536|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
401761|NCT00928486|959536|P1|STARTED|Overall Study||25
401762|NCT00928434|959545|P3|NOT COMPLETED|Overall Study||44
401763|NCT00928434|959546|P2|NOT COMPLETED|Overall Study||14
401764|NCT00928434|959547|P1|NOT COMPLETED|Overall Study||44
401765|NCT00928434|959545|P3|COMPLETED|Overall Study||134
401766|NCT00928434|959546|P2|COMPLETED|Overall Study||36
401767|NCT00928434|959547|P1|COMPLETED|Overall Study||131
401768|NCT00928434|959545|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
401769|NCT00928434|959546|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
401770|NCT00928434|959547|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
401771|NCT00928434|959545|P3|STARTED|Overall Study|Full Analysis Set Patients|178
401772|NCT00928434|959546|P2|STARTED|Overall Study|Full Analysis Set Patients|50
401773|NCT00928434|959547|P1|STARTED|Overall Study|Full Analysis Set Patients|175
401774|NCT00928421|959619|P1|NOT COMPLETED|Overall Study||0
401775|NCT00928421|959619|P1|COMPLETED|Overall Study||16
401776|NCT00928421|959619|P1|Treated With Study Drug|Overall Study||16
401777|NCT00928421|959619|P1|STARTED|Overall Study||16
401778|NCT00928408|959623|P1|NOT COMPLETED|Overall Study||23
401779|NCT00928408|959623|P1|COMPLETED|Overall Study||282
401780|NCT00928408|959623|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
401781|NCT00928408|959623|P1|STARTED|Overall Study|Number Enrolled|305
401782|NCT00928395|959652|P1|NOT COMPLETED|Overall Study||21
401783|NCT00928395|959652|P1|COMPLETED|Overall Study||29
401784|NCT00928395|959652|P1|STARTED|Overall Study||50
401785|NCT00928304|959656|P2|NOT COMPLETED|Overall Study||0
401786|NCT00928304|959657|P1|NOT COMPLETED|Overall Study||0
401787|NCT00928304|959656|P2|COMPLETED|Overall Study||70
401788|NCT00928304|959657|P1|COMPLETED|Overall Study||39
401789|NCT00928304|959656|P2|STARTED|Overall Study||70
401790|NCT00928304|959657|P1|STARTED|Overall Study||39
401791|NCT00928187|959672|P3|NOT COMPLETED|Overall Study||5
401792|NCT00928187|959673|P2|NOT COMPLETED|Overall Study||6
401793|NCT00928187|959674|P1|NOT COMPLETED|Overall Study||2
401794|NCT00928187|959672|P3|COMPLETED|Overall Study||150
401795|NCT00928187|959673|P2|COMPLETED|Overall Study||141
401796|NCT00928187|959674|P1|COMPLETED|Overall Study||150
401797|NCT00928187|959672|P3|Analysed|Overall Study||154
401798|NCT00928187|959673|P2|Analysed|Overall Study||145
401799|NCT00928187|959674|P1|Analysed|Overall Study||152
401800|NCT00928187|959672|P3|STARTED|Overall Study||155
401801|NCT00928187|959673|P2|STARTED|Overall Study||147
401802|NCT00928187|959674|P1|STARTED|Overall Study||152
401803|NCT00928174|959718|P1|NOT COMPLETED|Overall Study||5
401804|NCT00928174|959718|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
401805|NCT00928174|959718|P1|STARTED|Overall Study||27
401806|NCT00928083|959725|P9|NOT COMPLETED|Overall Study||0
401807|NCT00928083|959726|P8|NOT COMPLETED|Overall Study||0
401808|NCT00928083|959727|P7|NOT COMPLETED|Overall Study||0
401809|NCT00928083|959728|P6|NOT COMPLETED|Overall Study||0
401810|NCT00928083|959729|P5|NOT COMPLETED|Overall Study||1
401811|NCT00928083|959730|P4|NOT COMPLETED|Overall Study||1
401812|NCT00928083|959731|P3|NOT COMPLETED|Overall Study||0
401813|NCT00928083|959732|P2|NOT COMPLETED|Overall Study||0
401814|NCT00928083|959733|P1|NOT COMPLETED|Overall Study||4
401815|NCT00928083|959725|P9|COMPLETED|Overall Study||6
401816|NCT00928083|959726|P8|COMPLETED|Overall Study||6
401817|NCT00928083|959727|P7|COMPLETED|Overall Study||6
401818|NCT00928083|959728|P6|COMPLETED|Overall Study||6
401819|NCT00928083|959729|P5|COMPLETED|Overall Study||6
401820|NCT00928083|959730|P4|COMPLETED|Overall Study||5
401821|NCT00928083|959731|P3|COMPLETED|Overall Study||8
401822|NCT00928083|959732|P2|COMPLETED|Overall Study||8
401823|NCT00928083|959733|P1|COMPLETED|Overall Study||6
401824|NCT00928083|959725|P9|STARTED|Overall Study||6
401825|NCT00928083|959726|P8|STARTED|Overall Study||6
401826|NCT00928083|959727|P7|STARTED|Overall Study||6
401827|NCT00928083|959728|P6|STARTED|Overall Study||6
401828|NCT00928083|959729|P5|STARTED|Overall Study||7
401829|NCT00928083|959730|P4|STARTED|Overall Study||6
401830|NCT00928083|959731|P3|STARTED|Overall Study||8
401831|NCT00928083|959732|P2|STARTED|Overall Study||8
401832|NCT00928083|959733|P1|STARTED|Overall Study||10
401833|NCT00928070|959844|P2|NOT COMPLETED|Overall Study||57
401834|NCT00928070|959845|P1|NOT COMPLETED|Overall Study||63
401835|NCT00928070|959844|P2|COMPLETED|Overall Study||226
401836|NCT00928070|959845|P1|COMPLETED|Overall Study||220
401837|NCT00928070|959844|P2|Treated|Overall Study||281
401838|NCT00928070|959845|P1|Treated|Overall Study||281
401839|NCT00928070|959844|P2|STARTED|Overall Study||283
401840|NCT00928070|959845|P1|STARTED|Overall Study||283
401841|NCT00928057|959903|P2|NOT COMPLETED|Overall Study||4
401842|NCT00928057|959904|P1|NOT COMPLETED|Overall Study||2
401843|NCT00928057|959903|P2|COMPLETED|Overall Study||85
401844|NCT00928057|959904|P1|COMPLETED|Overall Study||82
401845|NCT00928057|959903|P2|STARTED|Overall Study||89
401846|NCT00928057|959904|P1|STARTED|Overall Study||84
401847|NCT00928018|959929|P2|NOT COMPLETED|Overall Study||0
401848|NCT00928018|959930|P1|NOT COMPLETED|Overall Study||1
401849|NCT00928018|959929|P2|COMPLETED|Overall Study||73
401850|NCT00928018|959930|P1|COMPLETED|Overall Study||65
401851|NCT00928018|959929|P2|STARTED|Overall Study||73
401852|NCT00928018|959930|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
401853|NCT00927992|959948|P1|NOT COMPLETED|Overall Study||0
401854|NCT00927992|959948|P1|COMPLETED|Overall Study||11
401855|NCT00927992|959948|P1|STARTED|Overall Study||11
401856|NCT00927953|959960|P2|NOT COMPLETED|Overall Study||1
401857|NCT00927953|959961|P1|NOT COMPLETED|Overall Study||2
401858|NCT00927953|959960|P2|COMPLETED|Overall Study||6
401859|NCT00927953|959961|P1|COMPLETED|Overall Study||4
401860|NCT00927953|959960|P2|STARTED|Overall Study||7
401861|NCT00927953|959961|P1|STARTED|Overall Study||6
401862|NCT00927940|959975|P1|NOT COMPLETED|Overall Study||1
401863|NCT00927940|959975|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
401864|NCT00927940|959975|P1|STARTED|Overall Study||100
401865|NCT00927927|959995|P15|NOT COMPLETED|Overall Study||0
401866|NCT00927927|959996|P14|NOT COMPLETED|Overall Study||0
401867|NCT00927927|959997|P13|NOT COMPLETED|Overall Study||0
401868|NCT00927927|959998|P12|NOT COMPLETED|Overall Study||2
401869|NCT00927927|959999|P11|NOT COMPLETED|Overall Study||0
401870|NCT00927927|960000|P10|NOT COMPLETED|Overall Study||0
401871|NCT00927927|960001|P9|NOT COMPLETED|Overall Study||0
401872|NCT00927927|960002|P8|NOT COMPLETED|Overall Study||2
401873|NCT00927927|960003|P7|NOT COMPLETED|Overall Study||0
401874|NCT00927927|960004|P6|NOT COMPLETED|Overall Study||0
401875|NCT00927927|960005|P5|NOT COMPLETED|Overall Study||0
401876|NCT00927927|960006|P4|NOT COMPLETED|Overall Study||0
401877|NCT00927927|960007|P3|NOT COMPLETED|Overall Study||0
401878|NCT00927927|960008|P2|NOT COMPLETED|Overall Study||0
401879|NCT00927927|960009|P1|NOT COMPLETED|Overall Study||0
401880|NCT00927927|959995|P15|COMPLETED|Overall Study||9
401881|NCT00927927|959996|P14|COMPLETED|Overall Study||5
401882|NCT00927927|959997|P13|COMPLETED|Overall Study||5
401883|NCT00927927|959998|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
401884|NCT00927927|959999|P11|COMPLETED|Overall Study||5
401885|NCT00927927|960000|P10|COMPLETED|Overall Study||3
401886|NCT00927927|960001|P9|COMPLETED|Overall Study||8
401887|NCT00927927|960002|P8|COMPLETED|Overall Study||1
401888|NCT00927927|960003|P7|COMPLETED|Overall Study||3
401889|NCT00927927|960004|P6|COMPLETED|Overall Study||3
401890|NCT00927927|960005|P5|COMPLETED|Overall Study||3
401891|NCT00927927|960006|P4|COMPLETED|Overall Study||3
401892|NCT00927927|960007|P3|COMPLETED|Overall Study||3
401893|NCT00927927|960008|P2|COMPLETED|Overall Study||3
401894|NCT00927927|960009|P1|COMPLETED|Overall Study||3
401895|NCT00927927|959995|P15|Exposed|Overall Study||9
401896|NCT00927927|959996|P14|Exposed|Overall Study||5
401897|NCT00927927|959997|P13|Exposed|Overall Study||5
401898|NCT00927927|959998|P12|Exposed|Overall Study||5
401899|NCT00927927|959999|P11|Exposed|Overall Study||5
401900|NCT00927927|960000|P10|Exposed|Overall Study||3
401901|NCT00927927|960001|P9|Exposed|Overall Study||8
401902|NCT00927927|960002|P8|Exposed|Overall Study||3
401903|NCT00927927|960003|P7|Exposed|Overall Study||3
401904|NCT00927927|960004|P6|Exposed|Overall Study||3
401905|NCT00927927|960005|P5|Exposed|Overall Study||3
401906|NCT00927927|960006|P4|Exposed|Overall Study||3
401907|NCT00927927|960007|P3|Exposed|Overall Study||3
401908|NCT00927927|960008|P2|Exposed|Overall Study||3
401909|NCT00927927|960009|P1|Exposed|Overall Study||3
401910|NCT00927927|959995|P15|STARTED|Overall Study||9
401911|NCT00927927|959996|P14|STARTED|Overall Study||5
401912|NCT00927927|959997|P13|STARTED|Overall Study||5
401913|NCT00927927|959998|P12|STARTED|Overall Study||6
401914|NCT00927927|959999|P11|STARTED|Overall Study||5
401915|NCT00927927|960000|P10|STARTED|Overall Study||3
401916|NCT00927927|960001|P9|STARTED|Overall Study||8
401917|NCT00927927|960002|P8|STARTED|Overall Study||3
401918|NCT00927927|960003|P7|STARTED|Overall Study||3
401919|NCT00927927|960004|P6|STARTED|Overall Study||3
401920|NCT00927927|960005|P5|STARTED|Overall Study||3
401921|NCT00927927|960006|P4|STARTED|Overall Study||3
401922|NCT00927927|960007|P3|STARTED|Overall Study||3
401923|NCT00927927|960008|P2|STARTED|Overall Study||3
401924|NCT00927927|960009|P1|STARTED|Overall Study||3
401925|NCT00927901|960056|P4|NOT COMPLETED|Treatment Period 4||1
401926|NCT00927901|960057|P3|NOT COMPLETED|Treatment Period 4||1
401927|NCT00927901|960058|P2|NOT COMPLETED|Treatment Period 4||0
401928|NCT00927901|960059|P1|NOT COMPLETED|Treatment Period 4||0
401929|NCT00927901|960056|P4|COMPLETED|Treatment Period 4||8
401930|NCT00927901|960057|P3|COMPLETED|Treatment Period 4||5
401931|NCT00927901|960058|P2|COMPLETED|Treatment Period 4||7
401932|NCT00927901|960059|P1|COMPLETED|Treatment Period 4||7
401933|NCT00927901|960056|P4|STARTED|Treatment Period 4||9
401934|NCT00927901|960057|P3|STARTED|Treatment Period 4||6
401935|NCT00927901|960058|P2|STARTED|Treatment Period 4||7
401936|NCT00927901|960059|P1|STARTED|Treatment Period 4||7
401937|NCT00927901|960056|P4|NOT COMPLETED|Treatment Period 3||0
401938|NCT00927901|960057|P3|NOT COMPLETED|Treatment Period 3||0
401939|NCT00927901|960058|P2|NOT COMPLETED|Treatment Period 3||0
401940|NCT00927901|960059|P1|NOT COMPLETED|Treatment Period 3||0
401941|NCT00927901|960056|P4|COMPLETED|Treatment Period 3||9
401942|NCT00927901|960057|P3|COMPLETED|Treatment Period 3||6
401943|NCT00927901|960058|P2|COMPLETED|Treatment Period 3||7
401944|NCT00927901|960059|P1|COMPLETED|Treatment Period 3||7
401945|NCT00927901|960056|P4|STARTED|Treatment Period 3||9
401946|NCT00927901|960057|P3|STARTED|Treatment Period 3||6
401947|NCT00927901|960058|P2|STARTED|Treatment Period 3||7
401948|NCT00927901|960059|P1|STARTED|Treatment Period 3||7
401949|NCT00927901|960056|P4|NOT COMPLETED|Treatment Period 2||0
401950|NCT00927901|960057|P3|NOT COMPLETED|Treatment Period 2||0
401951|NCT00927901|960058|P2|NOT COMPLETED|Treatment Period 2||0
401952|NCT00927901|960059|P1|NOT COMPLETED|Treatment Period 2||0
401953|NCT00927901|960056|P4|COMPLETED|Treatment Period 2||9
401954|NCT00927901|960057|P3|COMPLETED|Treatment Period 2||6
401955|NCT00927901|960058|P2|COMPLETED|Treatment Period 2||7
401956|NCT00927901|960059|P1|COMPLETED|Treatment Period 2||7
401957|NCT00927901|960056|P4|STARTED|Treatment Period 2||9
401958|NCT00927901|960057|P3|STARTED|Treatment Period 2||6
401959|NCT00927901|960058|P2|STARTED|Treatment Period 2||7
401960|NCT00927901|960059|P1|STARTED|Treatment Period 2||7
401961|NCT00927901|960056|P4|NOT COMPLETED|Treatment Period 1||0
401962|NCT00927901|960057|P3|NOT COMPLETED|Treatment Period 1||1
401963|NCT00927901|960058|P2|NOT COMPLETED|Treatment Period 1||0
401964|NCT00927901|960059|P1|NOT COMPLETED|Treatment Period 1||0
401965|NCT00927901|960056|P4|COMPLETED|Treatment Period 1||9
401966|NCT00927901|960057|P3|COMPLETED|Treatment Period 1||6
401967|NCT00927901|960058|P2|COMPLETED|Treatment Period 1||7
401968|NCT00927901|960059|P1|COMPLETED|Treatment Period 1||7
401969|NCT00927901|960056|P4|STARTED|Treatment Period 1||9
401970|NCT00927901|960057|P3|STARTED|Treatment Period 1||7
401971|NCT00927901|960058|P2|STARTED|Treatment Period 1||7
401972|NCT00927901|960059|P1|STARTED|Treatment Period 1||7
401973|NCT00927888|960089|P2|NOT COMPLETED|Overall Study||0
401974|NCT00927888|960090|P1|NOT COMPLETED|Overall Study||0
401975|NCT00927888|960089|P2|COMPLETED|Overall Study||27
401976|NCT00927888|960090|P1|COMPLETED|Overall Study||29
401977|NCT00927888|960089|P2|STARTED|Overall Study||27
401978|NCT00927888|960090|P1|STARTED|Overall Study||29
401979|NCT00927862|960100|P2|NOT COMPLETED|Overall Study||45
401980|NCT00927862|960101|P1|NOT COMPLETED|Overall Study||27
401981|NCT00927862|960100|P2|COMPLETED|Overall Study||1866
401982|NCT00927862|960101|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
401983|NCT00927862|960100|P2|STARTED|Overall Study||1911
401984|NCT00927862|960101|P1|STARTED|Overall Study||504
401985|NCT00927849|960126|P3|NOT COMPLETED|Overall Study||0
401986|NCT00927849|960127|P2|NOT COMPLETED|Overall Study||0
401987|NCT00927849|960128|P1|NOT COMPLETED|Overall Study||0
401988|NCT00927849|960126|P3|COMPLETED|Overall Study||21
401989|NCT00927849|960127|P2|COMPLETED|Overall Study||21
401990|NCT00927849|960128|P1|COMPLETED|Overall Study||21
401991|NCT00927849|960126|P3|STARTED|Overall Study||21
401992|NCT00927849|960127|P2|STARTED|Overall Study||21
401993|NCT00927849|960128|P1|STARTED|Overall Study||21
401994|NCT00927823|960136|P4|NOT COMPLETED|Continuous Dosing Period||5
401995|NCT00927823|960137|P3|NOT COMPLETED|Continuous Dosing Period||26
401996|NCT00927823|960138|P2|NOT COMPLETED|Continuous Dosing Period||3
401997|NCT00927823|960139|P1|NOT COMPLETED|Continuous Dosing Period||3
401998|NCT00927823|960136|P4|COMPLETED|Continuous Dosing Period||0
401999|NCT00927823|960137|P3|COMPLETED|Continuous Dosing Period||0
402000|NCT00927823|960138|P2|COMPLETED|Continuous Dosing Period||0
402001|NCT00927823|960139|P1|COMPLETED|Continuous Dosing Period||0
402002|NCT00927823|960136|P4|Treated|Continuous Dosing Period||5
402003|NCT00927823|960137|P3|Treated|Continuous Dosing Period||23
402004|NCT00927823|960138|P2|Treated|Continuous Dosing Period||3
402005|NCT00927823|960139|P1|Treated|Continuous Dosing Period||3
402006|NCT00927823|960136|P4|STARTED|Continuous Dosing Period||5
402007|NCT00927823|960137|P3|STARTED|Continuous Dosing Period||26
402008|NCT00927823|960138|P2|STARTED|Continuous Dosing Period||3
402009|NCT00927823|960139|P1|STARTED|Continuous Dosing Period||3
402010|NCT00927823|960136|P4|NOT COMPLETED|Lead-In Period||0
402011|NCT00927823|960137|P3|NOT COMPLETED|Lead-In Period||0
402012|NCT00927823|960138|P2|NOT COMPLETED|Lead-In Period||0
402013|NCT00927823|960139|P1|NOT COMPLETED|Lead-In Period||0
402014|NCT00927823|960136|P4|COMPLETED|Lead-In Period||5
402015|NCT00927823|960137|P3|COMPLETED|Lead-In Period||26
402016|NCT00927823|960138|P2|COMPLETED|Lead-In Period||3
402017|NCT00927823|960139|P1|COMPLETED|Lead-In Period||3
402018|NCT00927823|960136|P4|STARTED|Lead-In Period||5
402019|NCT00927823|960137|P3|STARTED|Lead-In Period||26
402020|NCT00927823|960138|P2|STARTED|Lead-In Period||3
402021|NCT00927823|960139|P1|STARTED|Lead-In Period||3
402022|NCT00927758|960203|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
402023|NCT00927758|960204|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
402024|NCT00927758|960205|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
402025|NCT00927758|960206|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
402026|NCT00927758|960207|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
402027|NCT00927758|960208|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
402028|NCT00927758|960203|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
402029|NCT00927758|960204|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
402030|NCT00927758|960205|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
402031|NCT00927758|960206|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
402032|NCT00927758|960207|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
402033|NCT00927758|960208|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
402034|NCT00927758|960203|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
402035|NCT00927758|960204|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
402036|NCT00927758|960205|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
402037|NCT00927758|960206|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
402038|NCT00927758|960207|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
402039|NCT00927758|960208|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
402040|NCT00927758|960203|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
402041|NCT00927758|960204|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
402042|NCT00927758|960205|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
402043|NCT00927758|960206|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
402044|NCT00927758|960207|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
402045|NCT00927758|960208|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
402046|NCT00927758|960203|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
402047|NCT00927758|960204|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
402048|NCT00927758|960205|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
402049|NCT00927758|960206|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
402050|NCT00927758|960207|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
402051|NCT00927758|960208|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
402052|NCT00927758|960203|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
402053|NCT00927758|960204|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
402054|NCT00927758|960205|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
402055|NCT00927758|960206|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
402056|NCT00927758|960207|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
402057|NCT00927758|960208|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
402058|NCT00927758|960203|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
402059|NCT00927758|960204|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
402060|NCT00927758|960205|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
402061|NCT00927758|960206|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
402062|NCT00927758|960207|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
402063|NCT00927758|960208|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
402064|NCT00927758|960203|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
402065|NCT00927758|960204|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
402066|NCT00927758|960205|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
402067|NCT00927758|960206|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
402068|NCT00927758|960207|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
402069|NCT00927758|960208|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
402070|NCT00927758|960203|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
402071|NCT00927758|960204|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
402072|NCT00927758|960205|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
402073|NCT00927758|960206|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
402074|NCT00927758|960207|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
402075|NCT00927758|960208|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
402076|NCT00927758|960203|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
402077|NCT00927758|960204|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
402078|NCT00927758|960205|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
402079|NCT00927758|960206|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
402080|NCT00927758|960207|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
402081|NCT00927758|960208|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
402082|NCT00927758|960203|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
402083|NCT00927758|960204|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
402084|NCT00927758|960205|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
402085|NCT00927758|960206|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
402086|NCT00927758|960207|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
402087|NCT00927758|960208|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
402088|NCT00927589|960216|P1|NOT COMPLETED|Overall Study||16
402089|NCT00927589|960216|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
402090|NCT00927589|960216|P1|STARTED|Overall Study||59
402091|NCT00927576|960240|P2|NOT COMPLETED|Overall Study||0
402092|NCT00927576|960241|P1|NOT COMPLETED|Overall Study||0
402093|NCT00927576|960240|P2|COMPLETED|Overall Study||28
402094|NCT00927576|960241|P1|COMPLETED|Overall Study||237
402095|NCT00927576|960240|P2|Cognitive Testing|Overall Study||28
402096|NCT00927576|960241|P1|Cognitive Testing|Overall Study||237
402097|NCT00927576|960240|P2|STARTED|Overall Study||28
402098|NCT00927576|960241|P1|STARTED|Overall Study||237
402099|NCT00927563|960246|P1|NOT COMPLETED|Overall Study||2
402100|NCT00927563|960246|P1|COMPLETED|Overall Study||22
402101|NCT00927563|960246|P1|STARTED|Overall Study||24
402102|NCT00927472|960254|P2|NOT COMPLETED|Overall Study||22
402103|NCT00927472|960255|P1|NOT COMPLETED|Overall Study||11
402104|NCT00927472|960254|P2|COMPLETED|Overall Study||106
402105|NCT00927472|960255|P1|COMPLETED|Overall Study||115
402106|NCT00927472|960254|P2|STARTED|Overall Study||128
402107|NCT00927472|960255|P1|STARTED|Overall Study||126
402108|NCT00927394|960281|P2|NOT COMPLETED|Overall Study||85
402109|NCT00927394|960282|P1|NOT COMPLETED|Overall Study||77
402110|NCT00927394|960281|P2|COMPLETED|Overall Study||483
402111|NCT00927394|960282|P1|COMPLETED|Overall Study||498
402112|NCT00927394|960281|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
402113|NCT00927394|960282|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
402114|NCT00927394|960281|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
402115|NCT00927394|960282|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
402116|NCT00927394|960281|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
402117|NCT00927394|960282|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
402118|NCT00927394|960281|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
402119|NCT00927394|960282|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
402120|NCT00927394|960281|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
402121|NCT00927394|960282|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
402122|NCT00927394|960281|P2|Cohort 2 (Randomized)|Overall Study||403
402123|NCT00927394|960282|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
402124|NCT00927394|960281|P2|Cohort 1 (Randomized)|Overall Study||165
402125|NCT00927394|960282|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
402126|NCT00927394|960281|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
402127|NCT00927394|960282|P1|STARTED|Overall Study||575
402128|NCT00927368|960313|P3|NOT COMPLETED|Overall Study||5
402129|NCT00927368|960314|P2|NOT COMPLETED|Overall Study||5
402130|NCT00927368|960315|P1|NOT COMPLETED|Overall Study||6
402131|NCT00927368|960313|P3|COMPLETED|Overall Study||138
402132|NCT00927368|960314|P2|COMPLETED|Overall Study||152
402133|NCT00927368|960315|P1|COMPLETED|Overall Study||147
402134|NCT00927368|960313|P3|STARTED|Overall Study||143
402135|NCT00927368|960314|P2|STARTED|Overall Study||157
402136|NCT00927368|960315|P1|STARTED|Overall Study||153
402137|NCT00927355|960334|P2|NOT COMPLETED|Overall Study||1
402138|NCT00927355|960335|P1|NOT COMPLETED|Overall Study||1
402139|NCT00927355|960334|P2|COMPLETED|Overall Study||4
402140|NCT00927355|960335|P1|COMPLETED|Overall Study||4
402141|NCT00927355|960334|P2|STARTED|Overall Study||5
402142|NCT00927355|960335|P1|STARTED|Overall Study||5
402143|NCT00927251|960353|P1|NOT COMPLETED|Overall Study||8
402144|NCT00927251|960353|P1|COMPLETED|Overall Study||82
402145|NCT00927251|960353|P1|STARTED|Overall Study||90
402146|NCT00927186|960359|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
402147|NCT00927186|960360|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
402148|NCT00927186|960359|P2|COMPLETED|12 - 24 Months Extension Treatment||11
402149|NCT00927186|960360|P1|COMPLETED|12 - 24 Months Extension Treatment||10
402150|NCT00927186|960359|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
402151|NCT00927186|960360|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
402152|NCT00927186|960359|P2|NOT COMPLETED|12 Months Primary Study||4
402153|NCT00927186|960360|P1|NOT COMPLETED|12 Months Primary Study||7
402154|NCT00927186|960359|P2|COMPLETED|12 Months Primary Study||31
402155|NCT00927186|960360|P1|COMPLETED|12 Months Primary Study||27
402156|NCT00927186|960359|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
402157|NCT00927186|960360|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
402158|NCT00927186|960359|P2|STARTED|12 Months Primary Study||35
402159|NCT00927186|960360|P1|STARTED|12 Months Primary Study||34
402160|NCT00927160|960478|P2|NOT COMPLETED|Overall Study||0
402161|NCT00927160|960479|P1|NOT COMPLETED|Overall Study||0
402162|NCT00927160|960478|P2|COMPLETED|Overall Study||173
402163|NCT00927160|960479|P1|COMPLETED|Overall Study||173
402164|NCT00927160|960478|P2|STARTED|Overall Study||173
402165|NCT00927160|960479|P1|STARTED|Overall Study||173
402166|NCT00927095|960490|P3|NOT COMPLETED|Overall Study||2
402167|NCT00927095|960491|P2|NOT COMPLETED|Overall Study||4
402168|NCT00927095|960492|P1|NOT COMPLETED|Overall Study||6
402169|NCT00927095|960490|P3|COMPLETED|Overall Study||22
402170|NCT00927095|960491|P2|COMPLETED|Overall Study||17
402171|NCT00927095|960492|P1|COMPLETED|Overall Study||16
402172|NCT00927095|960490|P3|STARTED|Overall Study||24
402173|NCT00927095|960491|P2|STARTED|Overall Study||21
402174|NCT00927095|960492|P1|STARTED|Overall Study||22
402175|NCT00927082|960504|P4|NOT COMPLETED|Overall Study||19
402176|NCT00927082|960505|P3|NOT COMPLETED|Overall Study||22
402177|NCT00927082|960506|P2|NOT COMPLETED|Overall Study||10
402178|NCT00927082|960507|P1|NOT COMPLETED|Overall Study||12
402179|NCT00927082|960504|P4|COMPLETED|Overall Study||78
402180|NCT00927082|960505|P3|COMPLETED|Overall Study||86
402181|NCT00927082|960506|P2|COMPLETED|Overall Study||77
402182|NCT00927082|960507|P1|COMPLETED|Overall Study||79
402183|NCT00927082|960504|P4|STARTED|Overall Study||97
402184|NCT00927082|960505|P3|STARTED|Overall Study||108
402185|NCT00927082|960506|P2|STARTED|Overall Study||87
402186|NCT00927082|960507|P1|STARTED|Overall Study||91
402187|NCT00927069|960571|P4|NOT COMPLETED|Week 12 to Week 24||3
402188|NCT00927069|960572|P3|NOT COMPLETED|Week 12 to Week 24||3
402189|NCT00927069|960573|P2|NOT COMPLETED|Week 12 to Week 24||0
402190|NCT00927069|960574|P1|NOT COMPLETED|Week 12 to Week 24||2
402191|NCT00927069|960571|P4|COMPLETED|Week 12 to Week 24||20
402192|NCT00927069|960572|P3|COMPLETED|Week 12 to Week 24||28
402193|NCT00927069|960573|P2|COMPLETED|Week 12 to Week 24||11
402194|NCT00927069|960574|P1|COMPLETED|Week 12 to Week 24||16
402195|NCT00927069|960571|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
402196|NCT00927069|960572|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
402197|NCT00927069|960573|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
402198|NCT00927069|960574|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
402199|NCT00927069|960571|P4|NOT COMPLETED|Week 0 to Week 12||0
402200|NCT00927069|960572|P3|NOT COMPLETED|Week 0 to Week 12||0
402201|NCT00927069|960573|P2|NOT COMPLETED|Week 0 to Week 12||1
402202|NCT00927069|960574|P1|NOT COMPLETED|Week 0 to Week 12||1
402203|NCT00927069|960571|P4|COMPLETED|Week 0 to Week 12||0
402204|NCT00927069|960572|P3|COMPLETED|Week 0 to Week 12||0
402205|NCT00927069|960573|P2|COMPLETED|Week 0 to Week 12||34
402206|NCT00927069|960574|P1|COMPLETED|Week 0 to Week 12||49
402207|NCT00927069|960571|P4|STARTED|Week 0 to Week 12||0
402208|NCT00927069|960572|P3|STARTED|Week 0 to Week 12||0
402209|NCT00927069|960573|P2|STARTED|Week 0 to Week 12||35
402210|NCT00927069|960574|P1|STARTED|Week 0 to Week 12||50
402211|NCT00926952|960584|P1|NOT COMPLETED|Overall Study||0
402212|NCT00926952|960584|P1|COMPLETED|Overall Study||20
402213|NCT00926952|960584|P1|STARTED|Overall Study||20
402214|NCT00926887|960598|P2|NOT COMPLETED|Overall Study||0
402215|NCT00926887|960599|P1|NOT COMPLETED|Overall Study||0
402216|NCT00926887|960598|P2|COMPLETED|Overall Study||50
402217|NCT00926887|960599|P1|COMPLETED|Overall Study||54
402218|NCT00926887|960598|P2|STARTED|Overall Study||50
402219|NCT00926887|960599|P1|STARTED|Overall Study||54
402220|NCT00926796|960611|P2|NOT COMPLETED|Overall Study||106
402221|NCT00926796|960612|P1|NOT COMPLETED|Overall Study||107
402222|NCT00926796|960611|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
402223|NCT00926796|960612|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
402224|NCT00926796|960611|P2|STARTED|Overall Study|Number randomized|305
402225|NCT00926796|960612|P1|STARTED|Overall Study|Number randomized|309
402226|NCT00926783|960633|P2|NOT COMPLETED|Overall Study||3
402227|NCT00926783|960634|P1|NOT COMPLETED|Overall Study||3
402228|NCT00926783|960633|P2|COMPLETED|Overall Study||38
402229|NCT00926783|960634|P1|COMPLETED|Overall Study||39
402230|NCT00926783|960633|P2|STARTED|Overall Study||41
402231|NCT00926783|960634|P1|STARTED|Overall Study||42
402232|NCT00926588|960652|P2|NOT COMPLETED|Overall Study||4
402233|NCT00926588|960653|P1|NOT COMPLETED|Overall Study||8
402234|NCT00926588|960652|P2|COMPLETED|Overall Study||122
402235|NCT00926588|960653|P1|COMPLETED|Overall Study||116
402236|NCT00926588|960652|P2|STARTED|Overall Study||126
402237|NCT00926588|960653|P1|STARTED|Overall Study||124
402238|NCT00926575|960661|P2|NOT COMPLETED|Overall Study||17
402239|NCT00926575|960662|P1|NOT COMPLETED|Overall Study||16
402240|NCT00926575|960661|P2|COMPLETED|Overall Study||53
402241|NCT00926575|960662|P1|COMPLETED|Overall Study||54
402242|NCT00926575|960661|P2|STARTED|Overall Study||70
402243|NCT00926575|960662|P1|STARTED|Overall Study||70
402244|NCT00926536|960674|P2|NOT COMPLETED|Overall Study||2
402245|NCT00926536|960675|P1|NOT COMPLETED|Overall Study||1
402246|NCT00926536|960674|P2|COMPLETED|Overall Study||41
402247|NCT00926536|960675|P1|COMPLETED|Overall Study||43
402248|NCT00926536|960674|P2|STARTED|Overall Study||43
402249|NCT00926536|960675|P1|STARTED|Overall Study||44
402250|NCT00926497|960685|P2|NOT COMPLETED|Overall Study||0
402251|NCT00926497|960686|P1|NOT COMPLETED|Overall Study||0
402252|NCT00926497|960685|P2|COMPLETED|Overall Study||61
402253|NCT00926497|960686|P1|COMPLETED|Overall Study||60
402254|NCT00926497|960685|P2|STARTED|Overall Study||61
402255|NCT00926497|960686|P1|STARTED|Overall Study||60
402256|NCT00926393|960696|P2|NOT COMPLETED|Overall Study||3
402257|NCT00926393|960697|P1|NOT COMPLETED|Overall Study||2
402258|NCT00926393|960696|P2|COMPLETED|Overall Study||67
402259|NCT00926393|960697|P1|COMPLETED|Overall Study||67
402260|NCT00926393|960696|P2|STARTED|Overall Study||70
402261|NCT00926393|960697|P1|STARTED|Overall Study||69
402262|NCT00926367|960729|P2|NOT COMPLETED|Overall Study||3
402263|NCT00926367|960730|P1|NOT COMPLETED|Overall Study||2
402264|NCT00926367|960729|P2|COMPLETED|Overall Study||24
402265|NCT00926367|960730|P1|COMPLETED|Overall Study||23
402266|NCT00926367|960729|P2|STARTED|Overall Study||27
402267|NCT00926367|960730|P1|STARTED|Overall Study||25
402268|NCT00926328|960772|P2|NOT COMPLETED|Overall Study||14
402269|NCT00926328|960773|P1|NOT COMPLETED|Overall Study||12
402270|NCT00926328|960772|P2|COMPLETED|Overall Study||46
402271|NCT00926328|960773|P1|COMPLETED|Overall Study||48
402272|NCT00926328|960772|P2|STARTED|Overall Study||60
402273|NCT00926328|960773|P1|STARTED|Overall Study||60
402274|NCT00926289|960783|P2|NOT COMPLETED|Overall Study||36
402275|NCT00926289|960784|P1|NOT COMPLETED|Overall Study||25
402276|NCT00926289|960783|P2|COMPLETED|Overall Study||558
402277|NCT00926289|960784|P1|COMPLETED|Overall Study||269
402278|NCT00926289|960783|P2|STARTED|Overall Study|Number of treated patients|594
402279|NCT00926289|960784|P1|STARTED|Overall Study|Number of treated patients|294
402280|NCT00926263|960820|P2|NOT COMPLETED|Overall Study||0
402281|NCT00926263|960821|P1|NOT COMPLETED|Overall Study||0
402282|NCT00926263|960820|P2|COMPLETED|Overall Study||12
402283|NCT00926263|960821|P1|COMPLETED|Overall Study||16
402284|NCT00926263|960820|P2|STARTED|Overall Study||12
402285|NCT00926263|960821|P1|STARTED|Overall Study||16
402286|NCT00926211|960852|P1|NOT COMPLETED|Overall Study||1
402287|NCT00926211|960852|P1|COMPLETED|Overall Study||35
402288|NCT00926211|960852|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
402289|NCT00926185|960863|P4|NOT COMPLETED|Overall Study||10
402290|NCT00926185|960864|P3|NOT COMPLETED|Overall Study||10
402291|NCT00926185|960865|P2|NOT COMPLETED|Overall Study||6
402292|NCT00926185|960866|P1|NOT COMPLETED|Overall Study||3
402293|NCT00926185|960863|P4|COMPLETED|Overall Study||48
402294|NCT00926185|960864|P3|COMPLETED|Overall Study||48
402295|NCT00926185|960865|P2|COMPLETED|Overall Study||51
402296|NCT00926185|960866|P1|COMPLETED|Overall Study||54
402297|NCT00926185|960863|P4|STARTED|Overall Study||58
402298|NCT00926185|960864|P3|STARTED|Overall Study||58
402299|NCT00926185|960865|P2|STARTED|Overall Study||57
402300|NCT00926185|960866|P1|STARTED|Overall Study||57
402301|NCT00926029|960883|P3|NOT COMPLETED|Overall Study||1
402302|NCT00926029|960884|P2|NOT COMPLETED|Overall Study||1
402303|NCT00926029|960885|P1|NOT COMPLETED|Overall Study||2
402304|NCT00926029|960883|P3|COMPLETED|Overall Study||33
402305|NCT00926029|960884|P2|COMPLETED|Overall Study||33
402306|NCT00926029|960885|P1|COMPLETED|Overall Study||32
402307|NCT00926029|960883|P3|STARTED|Overall Study||34
402308|NCT00926029|960884|P2|STARTED|Overall Study||34
402309|NCT00926029|960885|P1|STARTED|Overall Study||34
402310|NCT00925990|960898|P2|NOT COMPLETED|Overall Study||11
402311|NCT00925990|960899|P1|NOT COMPLETED|Overall Study||5
402312|NCT00925990|960898|P2|COMPLETED|Overall Study||24
402313|NCT00925990|960899|P1|COMPLETED|Overall Study||30
402314|NCT00925990|960898|P2|STARTED|Overall Study||35
402315|NCT00925990|960899|P1|STARTED|Overall Study||35
402316|NCT00925938|960910|P3|NOT COMPLETED|Overall Study||0
402317|NCT00925938|960911|P2|NOT COMPLETED|Overall Study||0
402318|NCT00925938|960912|P1|NOT COMPLETED|Overall Study||0
402319|NCT00925938|960910|P3|COMPLETED|Overall Study||17
402320|NCT00925938|960911|P2|COMPLETED|Overall Study||25
402321|NCT00925938|960912|P1|COMPLETED|Overall Study||9
402322|NCT00925938|960910|P3|STARTED|Overall Study||17
402323|NCT00925938|960911|P2|STARTED|Overall Study||25
402324|NCT00925938|960912|P1|STARTED|Overall Study||9
402325|NCT00925899|960934|P2|NOT COMPLETED|Part 2||12
402326|NCT00925899|960935|P1|NOT COMPLETED|Part 2||6
402327|NCT00925899|960934|P2|COMPLETED|Part 2||9
402328|NCT00925899|960935|P1|COMPLETED|Part 2||9
402329|NCT00925899|960934|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
402330|NCT00925899|960935|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
402331|NCT00925899|960934|P2|NOT COMPLETED|Part 1||11
402332|NCT00925899|960935|P1|NOT COMPLETED|Part 1||11
402333|NCT00925899|960934|P2|COMPLETED|Part 1||27
402334|NCT00925899|960935|P1|COMPLETED|Part 1||23
402335|NCT00925899|960934|P2|STARTED|Part 1||38
402336|NCT00925899|960935|P1|STARTED|Part 1||34
402337|NCT00925782|960953|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
402338|NCT00925782|960954|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
402339|NCT00925782|960953|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
402340|NCT00925782|960954|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
402341|NCT00925782|960953|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
402342|NCT00925782|960954|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
402343|NCT00925782|960953|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
402344|NCT00925782|960954|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
402345|NCT00925782|960953|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
402346|NCT00925782|960954|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
402347|NCT00925782|960953|P2|STARTED|Study Period (Day -3 to Day 0)||12
402348|NCT00925782|960954|P1|STARTED|Study Period (Day -3 to Day 0)||12
402349|NCT00925782|960953|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
402350|NCT00925782|960954|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
402351|NCT00925782|960953|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
402352|NCT00925782|960954|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
402353|NCT00925782|960953|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
402354|NCT00925782|960954|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
402355|NCT00925769|960963|P6|NOT COMPLETED|Overall Study||3
402356|NCT00925769|960964|P5|NOT COMPLETED|Overall Study||3
402357|NCT00925769|960965|P4|NOT COMPLETED|Overall Study||6
402358|NCT00925769|960966|P3|NOT COMPLETED|Overall Study||6
402359|NCT00925769|960967|P2|NOT COMPLETED|Overall Study||6
402360|NCT00925769|960968|P1|NOT COMPLETED|Overall Study||6
402361|NCT00925769|960963|P6|COMPLETED|Overall Study||0
402362|NCT00925769|960964|P5|COMPLETED|Overall Study||0
402363|NCT00925769|960965|P4|COMPLETED|Overall Study||0
402364|NCT00925769|960966|P3|COMPLETED|Overall Study||0
402365|NCT00925769|960967|P2|COMPLETED|Overall Study||0
402366|NCT00925769|960968|P1|COMPLETED|Overall Study||0
402367|NCT00925769|960963|P6|STARTED|Overall Study||3
402368|NCT00925769|960964|P5|STARTED|Overall Study||3
402369|NCT00925769|960965|P4|STARTED|Overall Study||6
402370|NCT00925769|960966|P3|STARTED|Overall Study||6
402371|NCT00925769|960967|P2|STARTED|Overall Study||6
402372|NCT00925769|960968|P1|STARTED|Overall Study||6
402373|NCT00925704|961036|P6|NOT COMPLETED|Third Intervention||1
402374|NCT00925704|961037|P5|NOT COMPLETED|Third Intervention||0
402375|NCT00925704|961038|P4|NOT COMPLETED|Third Intervention||0
402376|NCT00925704|961039|P3|NOT COMPLETED|Third Intervention||0
402377|NCT00925704|961040|P2|NOT COMPLETED|Third Intervention||0
402378|NCT00925704|961041|P1|NOT COMPLETED|Third Intervention||0
402379|NCT00925704|961036|P6|COMPLETED|Third Intervention||6
402380|NCT00925704|961037|P5|COMPLETED|Third Intervention||5
402381|NCT00925704|961038|P4|COMPLETED|Third Intervention||6
402382|NCT00925704|961039|P3|COMPLETED|Third Intervention||7
402383|NCT00925704|961040|P2|COMPLETED|Third Intervention||7
402384|NCT00925704|961041|P1|COMPLETED|Third Intervention||5
402385|NCT00925704|961036|P6|STARTED|Third Intervention||7
402386|NCT00925704|961037|P5|STARTED|Third Intervention||5
402387|NCT00925704|961038|P4|STARTED|Third Intervention||6
402388|NCT00925704|961039|P3|STARTED|Third Intervention||7
402389|NCT00925704|961040|P2|STARTED|Third Intervention||7
402390|NCT00925704|961041|P1|STARTED|Third Intervention||5
402391|NCT00925704|961036|P6|NOT COMPLETED|Washout||0
402392|NCT00925704|961037|P5|NOT COMPLETED|Washout||0
402393|NCT00925704|961038|P4|NOT COMPLETED|Washout||0
402394|NCT00925704|961039|P3|NOT COMPLETED|Washout||0
402395|NCT00925704|961040|P2|NOT COMPLETED|Washout||0
402396|NCT00925704|961041|P1|NOT COMPLETED|Washout||0
402397|NCT00925704|961036|P6|COMPLETED|Washout||7
402398|NCT00925704|961037|P5|COMPLETED|Washout||5
402399|NCT00925704|961038|P4|COMPLETED|Washout||6
402400|NCT00925704|961039|P3|COMPLETED|Washout||7
402401|NCT00925704|961040|P2|COMPLETED|Washout||7
402402|NCT00925704|961041|P1|COMPLETED|Washout||5
402403|NCT00925704|961036|P6|STARTED|Washout||7
402404|NCT00925704|961037|P5|STARTED|Washout||5
402405|NCT00925704|961038|P4|STARTED|Washout||6
402406|NCT00925704|961039|P3|STARTED|Washout||7
402407|NCT00925704|961040|P2|STARTED|Washout||7
402408|NCT00925704|961041|P1|STARTED|Washout||5
402409|NCT00925704|961036|P6|NOT COMPLETED|Second Intervention||0
402410|NCT00925704|961037|P5|NOT COMPLETED|Second Intervention||1
402411|NCT00925704|961038|P4|NOT COMPLETED|Second Intervention||0
402412|NCT00925704|961039|P3|NOT COMPLETED|Second Intervention||0
402413|NCT00925704|961040|P2|NOT COMPLETED|Second Intervention||0
402414|NCT00925704|961041|P1|NOT COMPLETED|Second Intervention||1
402415|NCT00925704|961036|P6|COMPLETED|Second Intervention||7
402416|NCT00925704|961037|P5|COMPLETED|Second Intervention||5
402417|NCT00925704|961038|P4|COMPLETED|Second Intervention||6
402418|NCT00925704|961039|P3|COMPLETED|Second Intervention||7
402419|NCT00925704|961040|P2|COMPLETED|Second Intervention||7
402420|NCT00925704|961041|P1|COMPLETED|Second Intervention||5
402421|NCT00925704|961036|P6|STARTED|Second Intervention||7
402422|NCT00925704|961037|P5|STARTED|Second Intervention||6
402423|NCT00925704|961038|P4|STARTED|Second Intervention||6
402424|NCT00925704|961039|P3|STARTED|Second Intervention||7
402425|NCT00925704|961040|P2|STARTED|Second Intervention||7
402426|NCT00925704|961041|P1|STARTED|Second Intervention||6
402427|NCT00925704|961036|P6|NOT COMPLETED|Washout||0
402428|NCT00925704|961037|P5|NOT COMPLETED|Washout||0
402429|NCT00925704|961038|P4|NOT COMPLETED|Washout||0
402430|NCT00925704|961039|P3|NOT COMPLETED|Washout||0
402431|NCT00925704|961040|P2|NOT COMPLETED|Washout||0
402432|NCT00925704|961041|P1|NOT COMPLETED|Washout||0
402433|NCT00925704|961036|P6|COMPLETED|Washout||7
402434|NCT00925704|961037|P5|COMPLETED|Washout||6
402435|NCT00925704|961038|P4|COMPLETED|Washout||6
402436|NCT00925704|961039|P3|COMPLETED|Washout||7
402437|NCT00925704|961040|P2|COMPLETED|Washout||7
402438|NCT00925704|961041|P1|COMPLETED|Washout||6
402439|NCT00925704|961036|P6|STARTED|Washout||7
402440|NCT00925704|961037|P5|STARTED|Washout||6
402441|NCT00925704|961038|P4|STARTED|Washout||6
402442|NCT00925704|961039|P3|STARTED|Washout||7
402443|NCT00925704|961040|P2|STARTED|Washout||7
402444|NCT00925704|961041|P1|STARTED|Washout||6
402445|NCT00925704|961036|P6|NOT COMPLETED|First Intervention||0
402446|NCT00925704|961037|P5|NOT COMPLETED|First Intervention||1
402447|NCT00925704|961038|P4|NOT COMPLETED|First Intervention||1
402448|NCT00925704|961039|P3|NOT COMPLETED|First Intervention||0
402449|NCT00925704|961040|P2|NOT COMPLETED|First Intervention||0
402450|NCT00925704|961041|P1|NOT COMPLETED|First Intervention||0
402451|NCT00925704|961036|P6|COMPLETED|First Intervention||7
402452|NCT00925704|961037|P5|COMPLETED|First Intervention||6
402453|NCT00925704|961038|P4|COMPLETED|First Intervention||6
402454|NCT00925704|961039|P3|COMPLETED|First Intervention||7
402455|NCT00925704|961040|P2|COMPLETED|First Intervention||7
402456|NCT00925704|961041|P1|COMPLETED|First Intervention||6
402457|NCT00925704|961036|P6|STARTED|First Intervention||7
402458|NCT00925704|961037|P5|STARTED|First Intervention||7
402459|NCT00925704|961038|P4|STARTED|First Intervention||7
402460|NCT00925704|961039|P3|STARTED|First Intervention||7
402461|NCT00925704|961040|P2|STARTED|First Intervention||7
402462|NCT00925704|961041|P1|STARTED|First Intervention||6
402463|NCT00925600|961054|P2|NOT COMPLETED|Overall Study||28
402464|NCT00925600|961055|P1|NOT COMPLETED|Overall Study||32
402465|NCT00925600|961054|P2|COMPLETED|Overall Study||355
402466|NCT00925600|961055|P1|COMPLETED|Overall Study||354
402467|NCT00925600|961054|P2|Received Treatment|Overall Study||382
402468|NCT00925600|961055|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
402469|NCT00925600|961054|P2|STARTED|Overall Study||383
402470|NCT00925600|961055|P1|STARTED|Overall Study||386
402471|NCT00925587|961077|P2|NOT COMPLETED|Overall Study||25
402472|NCT00925587|961078|P1|NOT COMPLETED|Overall Study||36
402473|NCT00925587|961077|P2|COMPLETED|Overall Study||155
402474|NCT00925587|961078|P1|COMPLETED|Overall Study||142
402475|NCT00925587|961077|P2|STARTED|Overall Study||180
402476|NCT00925587|961078|P1|STARTED|Overall Study||178
402477|NCT00925548|961192|P2|NOT COMPLETED|Overall Study||5
402478|NCT00925548|961193|P1|NOT COMPLETED|Overall Study||10
402479|NCT00925548|961192|P2|COMPLETED|Overall Study||0
402480|NCT00925548|961193|P1|COMPLETED|Overall Study||1
402481|NCT00925548|961192|P2|STARTED|Overall Study||5
402482|NCT00925548|961193|P1|STARTED|Overall Study||11
402483|NCT00925522|961219|P1|NOT COMPLETED|Overall Study||0
402484|NCT00925522|961219|P1|COMPLETED|Overall Study||20
402485|NCT00925522|961219|P1|STARTED|Overall Study||20
402486|NCT00925353|961223|P1|NOT COMPLETED|Overall Study||3
402487|NCT00925353|961223|P1|COMPLETED|Overall Study||10
402488|NCT00925353|961223|P1|STARTED|Overall Study||13
402489|NCT00925288|961229|P2|NOT COMPLETED|Overall Study||7
402490|NCT00925288|961230|P1|NOT COMPLETED|Overall Study||9
402491|NCT00925288|961229|P2|COMPLETED|Overall Study||93
402492|NCT00925288|961230|P1|COMPLETED|Overall Study||91
402493|NCT00925288|961229|P2|STARTED|Overall Study||100
402494|NCT00925288|961230|P1|STARTED|Overall Study||100
402495|NCT00924950|961242|P1|NOT COMPLETED|Overall Study||2
402496|NCT00924950|961242|P1|COMPLETED|Overall Study||28
402497|NCT00924950|961242|P1|STARTED|Overall Study||30
402498|NCT00924898|961247|P1|NOT COMPLETED|Overall Study||2
402499|NCT00924898|961247|P1|COMPLETED|Overall Study||90
402500|NCT00924898|961247|P1|STARTED|Overall Study||92
402501|NCT00924833|961259|P3|NOT COMPLETED|Overall Study||0
402502|NCT00924833|961260|P2|NOT COMPLETED|Overall Study||0
402503|NCT00924833|961261|P1|NOT COMPLETED|Overall Study||0
402504|NCT00924833|961259|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
402505|NCT00924833|961260|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
402506|NCT00924833|961261|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
402507|NCT00924833|961259|P3|STARTED|Overall Study||9
402508|NCT00924833|961260|P2|STARTED|Overall Study||9
402509|NCT00924833|961261|P1|STARTED|Overall Study||9
402510|NCT00924807|961275|P1|NOT COMPLETED|Overall Study||0
402511|NCT00924807|961275|P1|COMPLETED|Overall Study||4
402512|NCT00924807|961275|P1|STARTED|Overall Study||4
402513|NCT00924781|961283|P2|NOT COMPLETED|Overall Study||10
402514|NCT00924781|961284|P1|NOT COMPLETED|Overall Study||12
402515|NCT00924781|961283|P2|COMPLETED|Overall Study||9
402516|NCT00924781|961284|P1|COMPLETED|Overall Study||8
402517|NCT00924781|961283|P2|STARTED|Overall Study||19
402518|NCT00924781|961284|P1|STARTED|Overall Study||20
402519|NCT00924729|961318|P2|NOT COMPLETED|Overall Study||0
402520|NCT00924729|961319|P1|NOT COMPLETED|Overall Study||2
402521|NCT00924729|961318|P2|COMPLETED|Overall Study||25
402522|NCT00924729|961319|P1|COMPLETED|Overall Study||23
402523|NCT00924729|961318|P2|STARTED|Overall Study||25
402524|NCT00924729|961319|P1|STARTED|Overall Study||25
402525|NCT00924638|961327|P2|NOT COMPLETED|Overall Study||13
402526|NCT00924638|961328|P1|NOT COMPLETED|Overall Study||12
402527|NCT00924638|961327|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
402528|NCT00924638|961328|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
402529|NCT00924638|961327|P2|STARTED|Overall Study|Randomized to Control Arm|220
402530|NCT00924638|961328|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
402531|NCT00924560|961350|P3|NOT COMPLETED|Overall Study||83
402532|NCT00924560|961351|P2|NOT COMPLETED|Overall Study||208
402533|NCT00924560|961352|P1|NOT COMPLETED|Overall Study||211
402534|NCT00924560|961350|P3|COMPLETED|Overall Study||372
402535|NCT00924560|961351|P2|COMPLETED|Overall Study||240
402536|NCT00924560|961352|P1|COMPLETED|Overall Study||247
402537|NCT00924560|961350|P3|Received Treatment|Overall Study||0
402538|NCT00924560|961351|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
402539|NCT00924560|961352|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
402540|NCT00924560|961350|P3|STARTED|Overall Study||455
402541|NCT00924560|961351|P2|STARTED|Overall Study||448
402542|NCT00924560|961352|P1|STARTED|Overall Study||458
402543|NCT00924508|961396|P1|NOT COMPLETED|Overall Study||3
402544|NCT00924508|961396|P1|COMPLETED|Overall Study||20
402545|NCT00924508|961396|P1|STARTED|Overall Study||23
402546|NCT00924482|961403|P1|NOT COMPLETED|Overall Study||0
402547|NCT00924482|961403|P1|COMPLETED|Overall Study||261
402548|NCT00924482|961403|P1|STARTED|Overall Study||261
402549|NCT00924469|961410|P2|NOT COMPLETED|Overall Study||2
402550|NCT00924469|961411|P1|NOT COMPLETED|Overall Study||2
402551|NCT00924469|961410|P2|COMPLETED|Overall Study||26
402552|NCT00924469|961411|P1|COMPLETED|Overall Study||28
402553|NCT00924469|961410|P2|STARTED|Overall Study||28
402554|NCT00924469|961411|P1|STARTED|Overall Study||30
402555|NCT00924443|961433|P1|NOT COMPLETED|Overall Study||3
402556|NCT00924443|961433|P1|COMPLETED|Overall Study||66
402557|NCT00924443|961433|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
402558|NCT00924443|961433|P1|STARTED|Overall Study||69
402559|NCT00924352|961441|P2|NOT COMPLETED|Overall Study||0
402560|NCT00924352|961442|P1|NOT COMPLETED|Overall Study||0
402561|NCT00924352|961441|P2|COMPLETED|Overall Study||44
402562|NCT00924352|961442|P1|COMPLETED|Overall Study||12
402563|NCT00924352|961441|P2|STARTED|Overall Study||44
402564|NCT00924352|961442|P1|STARTED|Overall Study||12
402565|NCT00924313|961455|P1|NOT COMPLETED|Overall Study||1
402566|NCT00924313|961455|P1|COMPLETED|Overall Study||39
402567|NCT00924313|961455|P1|STARTED|Overall Study||40
402568|NCT00924287|961460|P1|NOT COMPLETED|Overall Study||1
402569|NCT00924287|961460|P1|COMPLETED|Overall Study||0
402570|NCT00924287|961460|P1|STARTED|Overall Study||1
402571|NCT00924209|961466|P1|NOT COMPLETED|Overall Study||0
402572|NCT00924209|961466|P1|COMPLETED|Overall Study||7
402573|NCT00924209|961466|P1|STARTED|Overall Study||7
402574|NCT00924066|961471|P1|NOT COMPLETED|Overall Study||0
402575|NCT00924066|961471|P1|COMPLETED|Overall Study||41
402576|NCT00924066|961471|P1|STARTED|Overall Study||41
402577|NCT00924053|961480|P4|NOT COMPLETED|Overall Study||0
402578|NCT00924053|961481|P3|NOT COMPLETED|Overall Study||0
402579|NCT00924053|961482|P2|NOT COMPLETED|Overall Study||0
402580|NCT00924053|961483|P1|NOT COMPLETED|Overall Study||0
402581|NCT00924053|961480|P4|COMPLETED|Overall Study||6
402582|NCT00924053|961481|P3|COMPLETED|Overall Study||6
402583|NCT00924053|961482|P2|COMPLETED|Overall Study||6
402584|NCT00924053|961483|P1|COMPLETED|Overall Study||6
402585|NCT00924053|961480|P4|STARTED|Overall Study||6
402586|NCT00924053|961481|P3|STARTED|Overall Study||6
402587|NCT00924053|961482|P2|STARTED|Overall Study||6
402588|NCT00924053|961483|P1|STARTED|Overall Study||6
402589|NCT00924040|961529|P1|NOT COMPLETED|Overall Study||0
402590|NCT00924040|961529|P1|COMPLETED|Overall Study||1
402591|NCT00924040|961529|P1|STARTED|Overall Study||1
402592|NCT00924001|961541|P1|NOT COMPLETED|Overall Study||0
402593|NCT00924001|961541|P1|COMPLETED|Overall Study||1
402594|NCT00924001|961541|P1|STARTED|Overall Study||1
402595|NCT00923975|961547|P1|NOT COMPLETED|Overall Study||1
402596|NCT00923975|961547|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
402597|NCT00923975|961547|P1|STARTED|Overall Study||51
402598|NCT00923949|961554|P1|NOT COMPLETED|Overall Study||0
402599|NCT00923949|961554|P1|COMPLETED|Overall Study||1
402600|NCT00923949|961554|P1|STARTED|Overall Study||1
402601|NCT00923936|961566|P2|NOT COMPLETED|Overall Study||3
402602|NCT00923936|961567|P1|NOT COMPLETED|Overall Study||8
402603|NCT00923936|961566|P2|COMPLETED|Overall Study||3
402604|NCT00923936|961567|P1|COMPLETED|Overall Study||2
402605|NCT00923936|961566|P2|STARTED|Overall Study||6
402606|NCT00923936|961567|P1|STARTED|Overall Study||10
402607|NCT00923910|961583|P2|NOT COMPLETED|Period 2||0
402608|NCT00923910|961584|P1|NOT COMPLETED|Period 2||0
402609|NCT00923910|961583|P2|COMPLETED|Period 2||5
402610|NCT00923910|961584|P1|COMPLETED|Period 2||5
402611|NCT00923910|961583|P2|STARTED|Period 2||5
402612|NCT00923910|961584|P1|STARTED|Period 2||5
402613|NCT00923910|961583|P2|NOT COMPLETED|Period 1||0
402614|NCT00923910|961584|P1|NOT COMPLETED|Period 1||0
402615|NCT00923910|961583|P2|COMPLETED|Period 1||5
402616|NCT00923910|961584|P1|COMPLETED|Period 1||5
402617|NCT00923910|961583|P2|STARTED|Period 1||5
402618|NCT00923910|961584|P1|STARTED|Period 1||5
402619|NCT00923845|961596|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
402620|NCT00923845|961597|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
402621|NCT00923845|961596|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
402622|NCT00923845|961597|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
402623|NCT00923845|961596|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
402624|NCT00923845|961597|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
402625|NCT00923845|961596|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
402626|NCT00923845|961597|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
402627|NCT00923845|961596|P2|STARTED|Allogeneic Stem Cell Therapy||10
402628|NCT00923845|961597|P1|STARTED|Allogeneic Stem Cell Therapy||0
402629|NCT00923845|961596|P2|NOT COMPLETED|Induction Therapy||2
402630|NCT00923845|961597|P1|NOT COMPLETED|Induction Therapy||0
402631|NCT00923845|961596|P2|COMPLETED|Induction Therapy||10
402632|NCT00923845|961597|P1|COMPLETED|Induction Therapy||0
402633|NCT00923845|961596|P2|STARTED|Induction Therapy||12
402634|NCT00923845|961597|P1|STARTED|Induction Therapy||0
402635|NCT00923845|961596|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
402636|NCT00923845|961597|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
402637|NCT00923845|961596|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
402638|NCT00923845|961597|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
402639|NCT00923845|961596|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
402640|NCT00923845|961597|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
402641|NCT00923845|961596|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
402642|NCT00923845|961597|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
402643|NCT00923845|961596|P2|COMPLETED|Donor Lymphocyte Harvest||0
402644|NCT00923845|961597|P1|COMPLETED|Donor Lymphocyte Harvest||13
402645|NCT00923845|961596|P2|STARTED|Donor Lymphocyte Harvest||0
402646|NCT00923845|961597|P1|STARTED|Donor Lymphocyte Harvest||13
402647|NCT00923481|961604|P1|NOT COMPLETED|Overall Study||0
402648|NCT00923481|961604|P1|COMPLETED|Overall Study||37
402649|NCT00923481|961604|P1|STARTED|Overall Study||37
402650|NCT00923351|961611|P3|NOT COMPLETED|Overall Study||12
402651|NCT00923351|961612|P2|NOT COMPLETED|Overall Study||0
402652|NCT00923351|961613|P1|NOT COMPLETED|Overall Study||0
402653|NCT00923351|961611|P3|COMPLETED|Overall Study||0
402654|NCT00923351|961612|P2|COMPLETED|Overall Study||26
402655|NCT00923351|961613|P1|COMPLETED|Overall Study||6
402656|NCT00923351|961611|P3|STARTED|Overall Study||12
402657|NCT00923351|961612|P2|STARTED|Overall Study||26
402658|NCT00923351|961613|P1|STARTED|Overall Study||6
402659|NCT00923273|961626|P5|NOT COMPLETED|Phase II Treatment Period||0
402660|NCT00923273|961627|P4|NOT COMPLETED|Phase II Treatment Period||7
402661|NCT00923273|961628|P3|NOT COMPLETED|Phase II Treatment Period||0
402662|NCT00923273|961629|P2|NOT COMPLETED|Phase II Treatment Period||0
402663|NCT00923273|961630|P1|NOT COMPLETED|Phase II Treatment Period||0
402664|NCT00923273|961626|P5|COMPLETED|Phase II Treatment Period||0
402665|NCT00923273|961627|P4|COMPLETED|Phase II Treatment Period||20
402666|NCT00923273|961628|P3|COMPLETED|Phase II Treatment Period||0
402667|NCT00923273|961629|P2|COMPLETED|Phase II Treatment Period||0
402668|NCT00923273|961630|P1|COMPLETED|Phase II Treatment Period||0
402669|NCT00923273|961626|P5|STARTED|Phase II Treatment Period||0
402670|NCT00923273|961627|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
402671|NCT00923273|961628|P3|STARTED|Phase II Treatment Period||0
402672|NCT00923273|961629|P2|STARTED|Phase II Treatment Period||0
402673|NCT00923273|961630|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
402674|NCT00923273|961626|P5|NOT COMPLETED|Phase I Treatment Period||0
402675|NCT00923273|961627|P4|NOT COMPLETED|Phase I Treatment Period||0
402676|NCT00923273|961628|P3|NOT COMPLETED|Phase I Treatment Period||0
402677|NCT00923273|961629|P2|NOT COMPLETED|Phase I Treatment Period||0
402678|NCT00923273|961630|P1|NOT COMPLETED|Phase I Treatment Period||0
402679|NCT00923273|961626|P5|COMPLETED|Phase I Treatment Period||5
402680|NCT00923273|961627|P4|COMPLETED|Phase I Treatment Period||7
402681|NCT00923273|961628|P3|COMPLETED|Phase I Treatment Period||3
402682|NCT00923273|961629|P2|COMPLETED|Phase I Treatment Period||3
402683|NCT00923273|961630|P1|COMPLETED|Phase I Treatment Period||4
402684|NCT00923273|961626|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
402685|NCT00923273|961627|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
402686|NCT00923273|961628|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
402687|NCT00923273|961629|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
402688|NCT00923273|961630|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
402689|NCT00923260|961655|P2|NOT COMPLETED|Overall Study||1
402690|NCT00923260|961656|P1|NOT COMPLETED|Overall Study||1
402691|NCT00923260|961655|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
402692|NCT00923260|961656|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
402693|NCT00923260|961655|P2|STARTED|Overall Study||12
402694|NCT00923260|961656|P1|STARTED|Overall Study||12
402695|NCT00923247|961790|P2|NOT COMPLETED|Overall Study||0
402696|NCT00923247|961791|P1|NOT COMPLETED|Overall Study||0
402697|NCT00923247|961790|P2|COMPLETED|Overall Study||1
402698|NCT00923247|961791|P1|COMPLETED|Overall Study||21
402699|NCT00923247|961790|P2|STARTED|Overall Study||1
402700|NCT00923247|961791|P1|STARTED|Overall Study||21
402701|NCT00923195|961819|P2|NOT COMPLETED|Overall Study||1
402702|NCT00923195|961820|P1|NOT COMPLETED|Overall Study||0
402703|NCT00923195|961819|P2|COMPLETED|Overall Study||1
402704|NCT00923195|961820|P1|COMPLETED|Overall Study||2
402705|NCT00923195|961819|P2|STARTED|Overall Study||2
402706|NCT00923195|961820|P1|STARTED|Overall Study||2
402707|NCT00923156|961831|P3|NOT COMPLETED|Overall Study||3
402708|NCT00923156|961832|P2|NOT COMPLETED|Overall Study||4
402709|NCT00923156|961833|P1|NOT COMPLETED|Overall Study||0
402710|NCT00923156|961831|P3|COMPLETED|Overall Study||38
402711|NCT00923156|961832|P2|COMPLETED|Overall Study||38
402712|NCT00923156|961833|P1|COMPLETED|Overall Study||40
402713|NCT00923156|961831|P3|STARTED|Overall Study||41
402714|NCT00923156|961832|P2|STARTED|Overall Study||42
402715|NCT00923156|961833|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
402716|NCT00923117|961861|P2|NOT COMPLETED|Overall Study||0
402717|NCT00923117|961862|P1|NOT COMPLETED|Overall Study||0
402718|NCT00923117|961861|P2|COMPLETED|Overall Study||43
402719|NCT00923117|961862|P1|COMPLETED|Overall Study||44
402720|NCT00923117|961861|P2|STARTED|Overall Study||43
402721|NCT00923117|961862|P1|STARTED|Overall Study||44
402722|NCT00923091|961878|P13|NOT COMPLETED|Period VI (Open-Label)||0
402723|NCT00923091|961879|P12|NOT COMPLETED|Period VI (Open-Label)||0
402724|NCT00923091|961880|P11|NOT COMPLETED|Period VI (Open-Label)||0
402725|NCT00923091|961881|P10|NOT COMPLETED|Period VI (Open-Label)||0
402726|NCT00923091|961882|P9|NOT COMPLETED|Period VI (Open-Label)||0
402727|NCT00923091|961883|P8|NOT COMPLETED|Period VI (Open-Label)||0
402728|NCT00923091|961884|P7|NOT COMPLETED|Period VI (Open-Label)||0
402729|NCT00923091|961885|P6|NOT COMPLETED|Period VI (Open-Label)||0
402730|NCT00923091|961886|P5|NOT COMPLETED|Period VI (Open-Label)||7
402731|NCT00923091|961887|P4|NOT COMPLETED|Period VI (Open-Label)||3
402732|NCT00923091|961888|P3|NOT COMPLETED|Period VI (Open-Label)||13
402733|NCT00923091|961889|P2|NOT COMPLETED|Period VI (Open-Label)||8
402734|NCT00923091|961890|P1|NOT COMPLETED|Period VI (Open-Label)||39
402735|NCT00923091|961878|P13|COMPLETED|Period VI (Open-Label)||0
402736|NCT00923091|961879|P12|COMPLETED|Period VI (Open-Label)||0
402737|NCT00923091|961880|P11|COMPLETED|Period VI (Open-Label)||0
402738|NCT00923091|961881|P10|COMPLETED|Period VI (Open-Label)||0
402739|NCT00923091|961882|P9|COMPLETED|Period VI (Open-Label)||0
402740|NCT00923091|961883|P8|COMPLETED|Period VI (Open-Label)||0
402741|NCT00923091|961884|P7|COMPLETED|Period VI (Open-Label)||0
402742|NCT00923091|961885|P6|COMPLETED|Period VI (Open-Label)||0
402743|NCT00923091|961886|P5|COMPLETED|Period VI (Open-Label)||157
402744|NCT00923091|961887|P4|COMPLETED|Period VI (Open-Label)||143
402745|NCT00923091|961888|P3|COMPLETED|Period VI (Open-Label)||467
402746|NCT00923091|961889|P2|COMPLETED|Period VI (Open-Label)||264
402747|NCT00923091|961890|P1|COMPLETED|Period VI (Open-Label)||1408
402748|NCT00923091|961878|P13|STARTED|Period VI (Open-Label)||0
402749|NCT00923091|961879|P12|STARTED|Period VI (Open-Label)||0
402750|NCT00923091|961880|P11|STARTED|Period VI (Open-Label)||0
402751|NCT00923091|961881|P10|STARTED|Period VI (Open-Label)||0
402752|NCT00923091|961882|P9|STARTED|Period VI (Open-Label)||0
402753|NCT00923091|961883|P8|STARTED|Period VI (Open-Label)||0
402754|NCT00923091|961884|P7|STARTED|Period VI (Open-Label)||0
402755|NCT00923091|961885|P6|STARTED|Period VI (Open-Label)||0
402756|NCT00923091|961886|P5|STARTED|Period VI (Open-Label)||164
402757|NCT00923091|961887|P4|STARTED|Period VI (Open-Label)||146
402758|NCT00923091|961888|P3|STARTED|Period VI (Open-Label)||480
402759|NCT00923091|961889|P2|STARTED|Period VI (Open-Label)||272
402760|NCT00923091|961890|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
402761|NCT00923091|961878|P13|NOT COMPLETED|Period V (Double -Blind)||2
402762|NCT00923091|961879|P12|NOT COMPLETED|Period V (Double -Blind)||0
402763|NCT00923091|961880|P11|NOT COMPLETED|Period V (Double -Blind)||1
402764|NCT00923091|961881|P10|NOT COMPLETED|Period V (Double -Blind)||0
402765|NCT00923091|961882|P9|NOT COMPLETED|Period V (Double -Blind)||1
402766|NCT00923091|961883|P8|NOT COMPLETED|Period V (Double -Blind)||0
402767|NCT00923091|961884|P7|NOT COMPLETED|Period V (Double -Blind)||0
402768|NCT00923091|961885|P6|NOT COMPLETED|Period V (Double -Blind)||0
402769|NCT00923091|961886|P5|NOT COMPLETED|Period V (Double -Blind)||0
402770|NCT00923091|961887|P4|NOT COMPLETED|Period V (Double -Blind)||0
402771|NCT00923091|961888|P3|NOT COMPLETED|Period V (Double -Blind)||0
402772|NCT00923091|961889|P2|NOT COMPLETED|Period V (Double -Blind)||0
402773|NCT00923091|961890|P1|NOT COMPLETED|Period V (Double -Blind)||0
402774|NCT00923091|961878|P13|COMPLETED|Period V (Double -Blind)||73
402775|NCT00923091|961879|P12|COMPLETED|Period V (Double -Blind)||151
402776|NCT00923091|961880|P11|COMPLETED|Period V (Double -Blind)||193
402777|NCT00923091|961881|P10|COMPLETED|Period V (Double -Blind)||119
402778|NCT00923091|961882|P9|COMPLETED|Period V (Double -Blind)||134
402779|NCT00923091|961883|P8|COMPLETED|Period V (Double -Blind)||0
402780|NCT00923091|961884|P7|COMPLETED|Period V (Double -Blind)||0
402781|NCT00923091|961885|P6|COMPLETED|Period V (Double -Blind)||0
402782|NCT00923091|961886|P5|COMPLETED|Period V (Double -Blind)||0
402783|NCT00923091|961887|P4|COMPLETED|Period V (Double -Blind)||0
402784|NCT00923091|961888|P3|COMPLETED|Period V (Double -Blind)||0
402785|NCT00923091|961889|P2|COMPLETED|Period V (Double -Blind)||0
402786|NCT00923091|961890|P1|COMPLETED|Period V (Double -Blind)||0
402787|NCT00923091|961878|P13|STARTED|Period V (Double -Blind)||75
402788|NCT00923091|961879|P12|STARTED|Period V (Double -Blind)||151
402789|NCT00923091|961880|P11|STARTED|Period V (Double -Blind)||194
402790|NCT00923091|961881|P10|STARTED|Period V (Double -Blind)||119
402791|NCT00923091|961882|P9|STARTED|Period V (Double -Blind)||135
402792|NCT00923091|961883|P8|STARTED|Period V (Double -Blind)||0
402793|NCT00923091|961884|P7|STARTED|Period V (Double -Blind)||0
402794|NCT00923091|961885|P6|STARTED|Period V (Double -Blind)||0
402795|NCT00923091|961886|P5|STARTED|Period V (Double -Blind)||0
402796|NCT00923091|961887|P4|STARTED|Period V (Double -Blind)||0
402797|NCT00923091|961888|P3|STARTED|Period V (Double -Blind)||0
402798|NCT00923091|961889|P2|STARTED|Period V (Double -Blind)||0
402799|NCT00923091|961890|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
402800|NCT00923091|961878|P13|NOT COMPLETED|Period IV (Double-Blind)||0
402801|NCT00923091|961879|P12|NOT COMPLETED|Period IV (Double-Blind)||0
402802|NCT00923091|961880|P11|NOT COMPLETED|Period IV (Double-Blind)||0
402803|NCT00923091|961881|P10|NOT COMPLETED|Period IV (Double-Blind)||0
402804|NCT00923091|961882|P9|NOT COMPLETED|Period IV (Double-Blind)||0
402805|NCT00923091|961883|P8|NOT COMPLETED|Period IV (Double-Blind)||0
402806|NCT00923091|961884|P7|NOT COMPLETED|Period IV (Double-Blind)||0
402807|NCT00923091|961885|P6|NOT COMPLETED|Period IV (Double-Blind)||0
402808|NCT00923091|961886|P5|NOT COMPLETED|Period IV (Double-Blind)||0
402809|NCT00923091|961887|P4|NOT COMPLETED|Period IV (Double-Blind)||0
402810|NCT00923091|961888|P3|NOT COMPLETED|Period IV (Double-Blind)||0
402811|NCT00923091|961889|P2|NOT COMPLETED|Period IV (Double-Blind)||2
402812|NCT00923091|961890|P1|NOT COMPLETED|Period IV (Double-Blind)||2
402813|NCT00923091|961878|P13|COMPLETED|Period IV (Double-Blind)||0
402814|NCT00923091|961879|P12|COMPLETED|Period IV (Double-Blind)||0
402815|NCT00923091|961880|P11|COMPLETED|Period IV (Double-Blind)||0
402816|NCT00923091|961881|P10|COMPLETED|Period IV (Double-Blind)||0
402817|NCT00923091|961882|P9|COMPLETED|Period IV (Double-Blind)||0
402818|NCT00923091|961883|P8|COMPLETED|Period IV (Double-Blind)||0
402819|NCT00923091|961884|P7|COMPLETED|Period IV (Double-Blind)||0
402820|NCT00923091|961885|P6|COMPLETED|Period IV (Double-Blind)||0
402821|NCT00923091|961886|P5|COMPLETED|Period IV (Double-Blind)||0
402822|NCT00923091|961887|P4|COMPLETED|Period IV (Double-Blind)||0
402823|NCT00923091|961888|P3|COMPLETED|Period IV (Double-Blind)||0
402824|NCT00923091|961889|P2|COMPLETED|Period IV (Double-Blind)||451
402825|NCT00923091|961890|P1|COMPLETED|Period IV (Double-Blind)||226
402826|NCT00923091|961878|P13|STARTED|Period IV (Double-Blind)||0
402827|NCT00923091|961879|P12|STARTED|Period IV (Double-Blind)||0
402828|NCT00923091|961880|P11|STARTED|Period IV (Double-Blind)||0
402829|NCT00923091|961881|P10|STARTED|Period IV (Double-Blind)||0
402830|NCT00923091|961882|P9|STARTED|Period IV (Double-Blind)||0
402831|NCT00923091|961883|P8|STARTED|Period IV (Double-Blind)||0
402832|NCT00923091|961884|P7|STARTED|Period IV (Double-Blind)||0
402833|NCT00923091|961885|P6|STARTED|Period IV (Double-Blind)||0
402834|NCT00923091|961886|P5|STARTED|Period IV (Double-Blind)||0
402835|NCT00923091|961887|P4|STARTED|Period IV (Double-Blind)||0
402836|NCT00923091|961888|P3|STARTED|Period IV (Double-Blind)||0
402837|NCT00923091|961889|P2|STARTED|Period IV (Double-Blind)||453
402838|NCT00923091|961890|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
402839|NCT00923091|961878|P13|NOT COMPLETED|Period III (Single-Blind)||0
402840|NCT00923091|961879|P12|NOT COMPLETED|Period III (Single-Blind)||0
402841|NCT00923091|961880|P11|NOT COMPLETED|Period III (Single-Blind)||0
402842|NCT00923091|961881|P10|NOT COMPLETED|Period III (Single-Blind)||0
402843|NCT00923091|961882|P9|NOT COMPLETED|Period III (Single-Blind)||0
402844|NCT00923091|961883|P8|NOT COMPLETED|Period III (Single-Blind)||0
402845|NCT00923091|961884|P7|NOT COMPLETED|Period III (Single-Blind)||0
402846|NCT00923091|961885|P6|NOT COMPLETED|Period III (Single-Blind)||0
402847|NCT00923091|961886|P5|NOT COMPLETED|Period III (Single-Blind)||0
402848|NCT00923091|961887|P4|NOT COMPLETED|Period III (Single-Blind)||0
402849|NCT00923091|961888|P3|NOT COMPLETED|Period III (Single-Blind)||0
402850|NCT00923091|961889|P2|NOT COMPLETED|Period III (Single-Blind)||0
402851|NCT00923091|961890|P1|NOT COMPLETED|Period III (Single-Blind)||20
402852|NCT00923091|961878|P13|COMPLETED|Period III (Single-Blind)||0
402853|NCT00923091|961879|P12|COMPLETED|Period III (Single-Blind)||0
402854|NCT00923091|961880|P11|COMPLETED|Period III (Single-Blind)||0
402855|NCT00923091|961881|P10|COMPLETED|Period III (Single-Blind)||0
402856|NCT00923091|961882|P9|COMPLETED|Period III (Single-Blind)||0
402857|NCT00923091|961883|P8|COMPLETED|Period III (Single-Blind)||0
402858|NCT00923091|961884|P7|COMPLETED|Period III (Single-Blind)||0
402859|NCT00923091|961885|P6|COMPLETED|Period III (Single-Blind)||0
402860|NCT00923091|961886|P5|COMPLETED|Period III (Single-Blind)||0
402861|NCT00923091|961887|P4|COMPLETED|Period III (Single-Blind)||0
402862|NCT00923091|961888|P3|COMPLETED|Period III (Single-Blind)||0
402863|NCT00923091|961889|P2|COMPLETED|Period III (Single-Blind)||0
402864|NCT00923091|961890|P1|COMPLETED|Period III (Single-Blind)||2520
402865|NCT00923091|961878|P13|STARTED|Period III (Single-Blind)||0
402866|NCT00923091|961879|P12|STARTED|Period III (Single-Blind)||0
402867|NCT00923091|961880|P11|STARTED|Period III (Single-Blind)||0
402868|NCT00923091|961881|P10|STARTED|Period III (Single-Blind)||0
402869|NCT00923091|961882|P9|STARTED|Period III (Single-Blind)||0
402870|NCT00923091|961883|P8|STARTED|Period III (Single-Blind)||0
402871|NCT00923091|961884|P7|STARTED|Period III (Single-Blind)||0
402872|NCT00923091|961885|P6|STARTED|Period III (Single-Blind)||0
402873|NCT00923091|961886|P5|STARTED|Period III (Single-Blind)||0
402874|NCT00923091|961887|P4|STARTED|Period III (Single-Blind)||0
402875|NCT00923091|961888|P3|STARTED|Period III (Single-Blind)||0
402876|NCT00923091|961889|P2|STARTED|Period III (Single-Blind)||0
402877|NCT00923091|961890|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
402878|NCT00923091|961878|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402879|NCT00923091|961879|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402880|NCT00923091|961880|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402881|NCT00923091|961881|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402882|NCT00923091|961882|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402883|NCT00923091|961883|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
402884|NCT00923091|961884|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
402885|NCT00923091|961885|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
402886|NCT00923091|961886|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
402887|NCT00923091|961887|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
402888|NCT00923091|961888|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
402889|NCT00923091|961889|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
402890|NCT00923091|961890|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
402891|NCT00923091|961878|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402892|NCT00923091|961879|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402893|NCT00923091|961880|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402894|NCT00923091|961881|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402895|NCT00923091|961882|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
402896|NCT00923091|961883|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
402897|NCT00923091|961884|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
402898|NCT00923091|961885|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
402899|NCT00923091|961886|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
402900|NCT00923091|961887|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
402901|NCT00923091|961888|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
402902|NCT00923091|961889|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
402903|NCT00923091|961890|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
402904|NCT00923091|961878|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
402905|NCT00923091|961879|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
402906|NCT00923091|961880|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
402907|NCT00923091|961881|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
402908|NCT00923091|961882|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
402909|NCT00923091|961883|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
402910|NCT00923091|961884|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
402911|NCT00923091|961885|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
402912|NCT00923091|961886|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
402913|NCT00923091|961887|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
402914|NCT00923091|961888|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
402915|NCT00923091|961889|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
402916|NCT00923091|961890|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
402917|NCT00922987|961937|P1|NOT COMPLETED|Overall Study||4
402918|NCT00922987|961937|P1|COMPLETED|Overall Study||277
402919|NCT00922987|961937|P1|STARTED|Overall Study||281
402920|NCT00922935|961952|P3|NOT COMPLETED|Overall Study||0
402921|NCT00922935|961953|P2|NOT COMPLETED|Overall Study||5
402922|NCT00922935|961954|P1|NOT COMPLETED|Overall Study||1
402923|NCT00922935|961952|P3|COMPLETED|Overall Study||10
402924|NCT00922935|961953|P2|COMPLETED|Overall Study||11
402925|NCT00922935|961954|P1|COMPLETED|Overall Study||9
402926|NCT00922935|961952|P3|STARTED|Overall Study||10
402927|NCT00922935|961953|P2|STARTED|Overall Study||16
402928|NCT00922935|961954|P1|STARTED|Overall Study||10
402929|NCT00922779|961962|P1|NOT COMPLETED|Overall Study||2327
402930|NCT00922779|961962|P1|COMPLETED|Overall Study||4334
402931|NCT00922779|961962|P1|STARTED|Overall Study||6661
402932|NCT00922766|961969|P1|NOT COMPLETED|Overall Study||7
402933|NCT00922766|961969|P1|COMPLETED|Overall Study||610
402934|NCT00922766|961969|P1|STARTED|Overall Study||617
402935|NCT00922701|961978|P1|NOT COMPLETED|Overall Study||0
402936|NCT00922701|961978|P1|COMPLETED|Overall Study||4
402937|NCT00922701|961978|P1|STARTED|Overall Study||4
402938|NCT00922636|961987|P5|NOT COMPLETED|Overall Study||16
402939|NCT00922636|961988|P4|NOT COMPLETED|Overall Study||17
402940|NCT00922636|961989|P3|NOT COMPLETED|Overall Study||20
402941|NCT00922636|961990|P2|NOT COMPLETED|Overall Study||16
402942|NCT00922636|961991|P1|NOT COMPLETED|Overall Study||7
402943|NCT00922636|961987|P5|COMPLETED|Overall Study||59
402944|NCT00922636|961988|P4|COMPLETED|Overall Study||58
402945|NCT00922636|961989|P3|COMPLETED|Overall Study||56
402946|NCT00922636|961990|P2|COMPLETED|Overall Study||62
402947|NCT00922636|961991|P1|COMPLETED|Overall Study||29
402948|NCT00922636|961987|P5|Entered Optional Taper Phase|Overall Study||12
402949|NCT00922636|961988|P4|Entered Optional Taper Phase|Overall Study||7
402950|NCT00922636|961989|P3|Entered Optional Taper Phase|Overall Study||15
402951|NCT00922636|961990|P2|Entered Optional Taper Phase|Overall Study||10
402952|NCT00922636|961991|P1|Entered Optional Taper Phase|Overall Study||4
402953|NCT00922636|961987|P5|STARTED|Overall Study||75
402954|NCT00922636|961988|P4|STARTED|Overall Study||75
402955|NCT00922636|961989|P3|STARTED|Overall Study||76
402956|NCT00922636|961990|P2|STARTED|Overall Study||78
402957|NCT00922636|961991|P1|STARTED|Overall Study||36
402958|NCT00922623|962138|P1|NOT COMPLETED|Overall Study||5
402959|NCT00922623|962138|P1|COMPLETED|Overall Study||88
402960|NCT00922623|962138|P1|STARTED|Overall Study||93
402961|NCT00922428|962144|P1|NOT COMPLETED|Overall Study||15
402962|NCT00922428|962144|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
402963|NCT00922428|962144|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
402964|NCT00922272|962173|P2|NOT COMPLETED|Double-blind Phase||6
402965|NCT00922272|962174|P1|NOT COMPLETED|Double-blind Phase||7
402966|NCT00922272|962173|P2|COMPLETED|Double-blind Phase||29
402967|NCT00922272|962174|P1|COMPLETED|Double-blind Phase||27
402968|NCT00922272|962173|P2|STARTED|Double-blind Phase||35
402969|NCT00922272|962174|P1|STARTED|Double-blind Phase||34
402970|NCT00922272|962173|P2|NOT COMPLETED|Open-label Phase||0
402971|NCT00922272|962174|P1|NOT COMPLETED|Open-label Phase||23
402972|NCT00922272|962173|P2|COMPLETED|Open-label Phase||0
402973|NCT00922272|962174|P1|COMPLETED|Open-label Phase||69
402974|NCT00922272|962173|P2|STARTED|Open-label Phase||0
402975|NCT00922272|962174|P1|STARTED|Open-label Phase||92
402976|NCT00922233|962230|P1|NOT COMPLETED|Overall Study||4
402977|NCT00922233|962230|P1|COMPLETED|Overall Study||68
402978|NCT00922233|962230|P1|STARTED|Overall Study||72
402979|NCT00922207|962239|P3|NOT COMPLETED|Overall Study||4
402980|NCT00922207|962240|P2|NOT COMPLETED|Overall Study||7
402981|NCT00922207|962241|P1|NOT COMPLETED|Overall Study||6
402982|NCT00922207|962239|P3|COMPLETED|Overall Study||90
402983|NCT00922207|962240|P2|COMPLETED|Overall Study||88
402984|NCT00922207|962241|P1|COMPLETED|Overall Study||85
402985|NCT00922207|962239|P3|STARTED|Overall Study||94
402986|NCT00922207|962240|P2|STARTED|Overall Study||95
402987|NCT00922207|962241|P1|STARTED|Overall Study||91
402988|NCT00922194|962267|P1|NOT COMPLETED|Metformin for 12 Months or More||0
402989|NCT00922194|962267|P1|COMPLETED|Metformin for 12 Months or More||102
402990|NCT00922194|962267|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
402991|NCT00922194|962267|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
402992|NCT00922194|962267|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
402993|NCT00922194|962267|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
402994|NCT00922116|962277|P1|NOT COMPLETED|Overall Study||15
402995|NCT00922116|962277|P1|COMPLETED|Overall Study||176
402996|NCT00922116|962277|P1|STARTED|Overall Study||191
402997|NCT00921947|962288|P2|NOT COMPLETED|Day 28||0
402998|NCT00921947|962289|P1|NOT COMPLETED|Day 28||0
402999|NCT00921947|962288|P2|COMPLETED|Day 28||30
403000|NCT00921947|962289|P1|COMPLETED|Day 28||28
403001|NCT00921947|962288|P2|STARTED|Day 28||30
403002|NCT00921947|962289|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
403003|NCT00921947|962288|P2|NOT COMPLETED|Day 0||0
403004|NCT00921947|962289|P1|NOT COMPLETED|Day 0||0
403005|NCT00921947|962288|P2|COMPLETED|Day 0||30
403006|NCT00921947|962289|P1|COMPLETED|Day 0||30
403007|NCT00921947|962288|P2|STARTED|Day 0||30
403008|NCT00921947|962289|P1|STARTED|Day 0||30
403009|NCT00921934|962299|P1|NOT COMPLETED|Overall Study||0
403010|NCT00921934|962299|P1|COMPLETED|Overall Study||68
403011|NCT00921934|962299|P1|STARTED|Overall Study||68
403012|NCT00921895|962303|P1|NOT COMPLETED|Overall Study||0
403013|NCT00921895|962303|P1|COMPLETED|Overall Study||128
403014|NCT00921895|962303|P1|STARTED|Overall Study||128
403015|NCT00921687|962310|P2|NOT COMPLETED|Overall Study||0
403016|NCT00921687|962311|P1|NOT COMPLETED|Overall Study||0
403017|NCT00921687|962310|P2|COMPLETED|Overall Study||363
403018|NCT00921687|962311|P1|COMPLETED|Overall Study||418
403019|NCT00921687|962310|P2|STARTED|Overall Study||363
403020|NCT00921687|962311|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
403021|NCT00921557|962322|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
403022|NCT00921557|962323|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
403023|NCT00921557|962324|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
403024|NCT00921557|962322|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
403025|NCT00921557|962323|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
403026|NCT00921557|962324|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
403027|NCT00921557|962322|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
403028|NCT00921557|962323|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
403029|NCT00921557|962324|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
403030|NCT00921557|962322|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
403031|NCT00921557|962323|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
403032|NCT00921557|962324|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
403033|NCT00921557|962322|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
403034|NCT00921557|962323|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
403035|NCT00921557|962324|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
403036|NCT00921557|962322|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
403037|NCT00921557|962323|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
403038|NCT00921557|962324|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
403039|NCT00921557|962322|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
403040|NCT00921557|962323|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
403041|NCT00921557|962324|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
403042|NCT00921557|962322|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
403043|NCT00921557|962323|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
403044|NCT00921557|962324|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
403045|NCT00921557|962322|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
403046|NCT00921557|962323|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
403047|NCT00921557|962324|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
403048|NCT00921518|962384|P2|NOT COMPLETED|Overall Study||0
403049|NCT00921518|962385|P1|NOT COMPLETED|Overall Study||0
403050|NCT00921518|962384|P2|COMPLETED|Overall Study||44
403051|NCT00921518|962385|P1|COMPLETED|Overall Study||48
403052|NCT00921518|962384|P2|STARTED|Overall Study||44
403053|NCT00921518|962385|P1|STARTED|Overall Study||48
403054|NCT00921310|962393|P3|NOT COMPLETED|Overall Study||0
403055|NCT00921310|962394|P2|NOT COMPLETED|Overall Study||0
403056|NCT00921310|962395|P1|NOT COMPLETED|Overall Study||0
403057|NCT00921310|962393|P3|COMPLETED|Overall Study||4
403058|NCT00921310|962394|P2|COMPLETED|Overall Study||6
403059|NCT00921310|962395|P1|COMPLETED|Overall Study||2
403060|NCT00921310|962393|P3|STARTED|Overall Study||4
403061|NCT00921310|962394|P2|STARTED|Overall Study||6
403062|NCT00921310|962395|P1|STARTED|Overall Study||2
403063|NCT00921115|962420|P1|NOT COMPLETED|Overall Study||0
403064|NCT00921115|962420|P1|COMPLETED|Overall Study||42
403065|NCT00921115|962420|P1|STARTED|Overall Study||42
403066|NCT00921024|962426|P2|NOT COMPLETED|Overall Study||3
403067|NCT00921024|962427|P1|NOT COMPLETED|Overall Study||4
403068|NCT00921024|962426|P2|COMPLETED|Overall Study||39
403069|NCT00921024|962427|P1|COMPLETED|Overall Study||81
403070|NCT00921024|962426|P2|STARTED|Overall Study||42
403071|NCT00921024|962427|P1|STARTED|Overall Study||85
403072|NCT00920907|962437|P2|NOT COMPLETED|Maintenance Period||13
403073|NCT00920907|962438|P1|NOT COMPLETED|Maintenance Period||12
403074|NCT00920907|962437|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
403075|NCT00920907|962438|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
403076|NCT00920907|962437|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
403077|NCT00920907|962438|P1|STARTED|Maintenance Period||15
403078|NCT00920907|962437|P2|NOT COMPLETED|Induction Period||22
403079|NCT00920907|962438|P1|NOT COMPLETED|Induction Period||22
403080|NCT00920907|962437|P2|COMPLETED|Induction Period||16
403081|NCT00920907|962438|P1|COMPLETED|Induction Period||15
403082|NCT00920907|962437|P2|STARTED|Induction Period||38
403083|NCT00920907|962438|P1|STARTED|Induction Period||37
403084|NCT00920855|962479|P3|NOT COMPLETED|Overall Study||22
403085|NCT00920855|962480|P2|NOT COMPLETED|Overall Study||3
403086|NCT00920855|962481|P1|NOT COMPLETED|Overall Study||5
403087|NCT00920855|962479|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
403182|NCT00920140|962694|P2|STARTED|Phase 1 (Dose Escalation)||9
403088|NCT00920855|962480|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
403089|NCT00920855|962481|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
403090|NCT00920855|962479|P3|Safety and Efficacy Populations|Overall Study||31
403091|NCT00920855|962480|P2|Safety and Efficacy Populations|Overall Study||4
403092|NCT00920855|962481|P1|Safety and Efficacy Populations|Overall Study||5
403093|NCT00920855|962479|P3|STARTED|Overall Study||31
403094|NCT00920855|962480|P2|STARTED|Overall Study||4
403095|NCT00920855|962481|P1|STARTED|Overall Study||5
403096|NCT00920816|962507|P4|NOT COMPLETED|Overall Study||69
403097|NCT00920816|962508|P3|NOT COMPLETED|Overall Study||135
403098|NCT00920816|962509|P2|NOT COMPLETED|Overall Study||96
403099|NCT00920816|962510|P1|NOT COMPLETED|Overall Study||192
403100|NCT00920816|962507|P4|COMPLETED|Overall Study||0
403101|NCT00920816|962508|P3|COMPLETED|Overall Study||0
403102|NCT00920816|962509|P2|COMPLETED|Overall Study||0
403103|NCT00920816|962510|P1|COMPLETED|Overall Study||0
403104|NCT00920816|962507|P4|Treated|Overall Study||69
403105|NCT00920816|962508|P3|Treated|Overall Study||135
403106|NCT00920816|962509|P2|Treated|Overall Study||96
403107|NCT00920816|962510|P1|Treated|Overall Study||189
403108|NCT00920816|962507|P4|STARTED|Overall Study||69
403109|NCT00920816|962508|P3|STARTED|Overall Study||135
403110|NCT00920816|962509|P2|STARTED|Overall Study||96
403111|NCT00920816|962510|P1|STARTED|Overall Study||192
403112|NCT00920790|962548|P1|NOT COMPLETED|Overall Study||14
403113|NCT00920790|962548|P1|COMPLETED|Overall Study||13
403114|NCT00920790|962548|P1|STARTED|Overall Study||27
403115|NCT00920686|962560|P3|NOT COMPLETED|Overall Study||13
403116|NCT00920686|962561|P2|NOT COMPLETED|Overall Study||22
403117|NCT00920686|962562|P1|NOT COMPLETED|Overall Study||19
403118|NCT00920686|962560|P3|COMPLETED|Overall Study||62
403119|NCT00920686|962561|P2|COMPLETED|Overall Study||60
403120|NCT00920686|962562|P1|COMPLETED|Overall Study||63
403121|NCT00920686|962560|P3|STARTED|Overall Study||75
403122|NCT00920686|962561|P2|STARTED|Overall Study||82
403123|NCT00920686|962562|P1|STARTED|Overall Study||82
403124|NCT00920647|962586|P4|NOT COMPLETED|Overall Study||0
403125|NCT00920647|962587|P3|NOT COMPLETED|Overall Study||0
403126|NCT00920647|962588|P2|NOT COMPLETED|Overall Study||0
403127|NCT00920647|962589|P1|NOT COMPLETED|Overall Study||0
403128|NCT00920647|962586|P4|COMPLETED|Overall Study||4
403129|NCT00920647|962587|P3|COMPLETED|Overall Study||4
403130|NCT00920647|962588|P2|COMPLETED|Overall Study||4
403131|NCT00920647|962589|P1|COMPLETED|Overall Study||4
403132|NCT00920647|962586|P4|STARTED|Overall Study||4
403133|NCT00920647|962587|P3|STARTED|Overall Study||4
403134|NCT00920647|962588|P2|STARTED|Overall Study||4
403135|NCT00920647|962589|P1|STARTED|Overall Study||4
403136|NCT00920374|962639|P2|NOT COMPLETED|Overall Study||0
403137|NCT00920374|962640|P1|NOT COMPLETED|Overall Study||0
403138|NCT00920374|962639|P2|COMPLETED|Overall Study||57
403139|NCT00920374|962640|P1|COMPLETED|Overall Study||61
403140|NCT00920374|962639|P2|STARTED|Overall Study||57
403141|NCT00920374|962640|P1|STARTED|Overall Study||61
403142|NCT00920309|962666|P2|NOT COMPLETED|Overall Study||0
403143|NCT00920309|962667|P1|NOT COMPLETED|Overall Study||0
403144|NCT00920309|962666|P2|COMPLETED|Overall Study||7
403145|NCT00920309|962667|P1|COMPLETED|Overall Study||14
403146|NCT00920309|962666|P2|STARTED|Overall Study||7
403147|NCT00920309|962667|P1|STARTED|Overall Study||14
403148|NCT00920231|962677|P2|NOT COMPLETED|Overall Study||0
403149|NCT00920231|962678|P1|NOT COMPLETED|Overall Study||0
403150|NCT00920231|962677|P2|COMPLETED|Overall Study||8
403151|NCT00920231|962678|P1|COMPLETED|Overall Study||8
403152|NCT00920231|962677|P2|STARTED|Overall Study||8
403153|NCT00920231|962678|P1|STARTED|Overall Study||8
403154|NCT00920140|962691|P5|NOT COMPLETED|Phase 2||11
403155|NCT00920140|962692|P4|NOT COMPLETED|Phase 2||22
403156|NCT00920140|962693|P3|NOT COMPLETED|Phase 2||50
403157|NCT00920140|962694|P2|NOT COMPLETED|Phase 2||0
403158|NCT00920140|962695|P1|NOT COMPLETED|Phase 2||0
403159|NCT00920140|962691|P5|COMPLETED|Phase 2||0
403160|NCT00920140|962692|P4|COMPLETED|Phase 2||0
403161|NCT00920140|962693|P3|COMPLETED|Phase 2||0
403162|NCT00920140|962694|P2|COMPLETED|Phase 2||0
403163|NCT00920140|962695|P1|COMPLETED|Phase 2||0
403164|NCT00920140|962691|P5|STARTED|Phase 2||11
403165|NCT00920140|962692|P4|STARTED|Phase 2||22
403166|NCT00920140|962693|P3|STARTED|Phase 2||50
403167|NCT00920140|962694|P2|STARTED|Phase 2||0
403168|NCT00920140|962695|P1|STARTED|Phase 2||0
403169|NCT00920140|962691|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
403170|NCT00920140|962692|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
403171|NCT00920140|962693|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
403172|NCT00920140|962694|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
403173|NCT00920140|962695|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
403174|NCT00920140|962691|P5|COMPLETED|Phase 1 (Dose Escalation)||0
403175|NCT00920140|962692|P4|COMPLETED|Phase 1 (Dose Escalation)||0
403176|NCT00920140|962693|P3|COMPLETED|Phase 1 (Dose Escalation)||0
403177|NCT00920140|962694|P2|COMPLETED|Phase 1 (Dose Escalation)||0
403178|NCT00920140|962695|P1|COMPLETED|Phase 1 (Dose Escalation)||0
403179|NCT00920140|962691|P5|STARTED|Phase 1 (Dose Escalation)||0
403180|NCT00920140|962692|P4|STARTED|Phase 1 (Dose Escalation)||0
403181|NCT00920140|962693|P3|STARTED|Phase 1 (Dose Escalation)||0
403183|NCT00920140|962695|P1|STARTED|Phase 1 (Dose Escalation)||5
403184|NCT00920075|962733|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
403185|NCT00920075|962733|P1|COMPLETED|Post Study, 11 Pts Responded||11
403186|NCT00920075|962733|P1|STARTED|Post Study, 11 Pts Responded||11
403187|NCT00920075|962733|P1|NOT COMPLETED|Last Study,25 Pts Invited,11 Responded||0
403188|NCT00920075|962733|P1|COMPLETED|Last Study,25 Pts Invited,11 Responded||11
403189|NCT00920075|962733|P1|STARTED|Last Study,25 Pts Invited,11 Responded||11
403190|NCT00919932|962741|P2|NOT COMPLETED|Overall Study||0
403191|NCT00919932|962742|P1|NOT COMPLETED|Overall Study||0
403192|NCT00919932|962741|P2|COMPLETED|Overall Study||5
403193|NCT00919932|962742|P1|COMPLETED|Overall Study||4
403194|NCT00919932|962741|P2|STARTED|Overall Study||5
403195|NCT00919932|962742|P1|STARTED|Overall Study||4
403196|NCT00919893|962752|P2|NOT COMPLETED|Overall Study||9
403197|NCT00919893|962753|P1|NOT COMPLETED|Overall Study||19
403198|NCT00919893|962752|P2|COMPLETED|Overall Study||60
403199|NCT00919893|962753|P1|COMPLETED|Overall Study||51
403200|NCT00919893|962752|P2|STARTED|Overall Study||69
403201|NCT00919893|962753|P1|STARTED|Overall Study||70
403202|NCT00919867|962765|P6|NOT COMPLETED|Third Intervention||0
403203|NCT00919867|962766|P5|NOT COMPLETED|Third Intervention||0
403204|NCT00919867|962767|P4|NOT COMPLETED|Third Intervention||0
403205|NCT00919867|962768|P3|NOT COMPLETED|Third Intervention||0
403206|NCT00919867|962769|P2|NOT COMPLETED|Third Intervention||0
403207|NCT00919867|962770|P1|NOT COMPLETED|Third Intervention||0
403208|NCT00919867|962765|P6|COMPLETED|Third Intervention||6
403209|NCT00919867|962766|P5|COMPLETED|Third Intervention||7
403210|NCT00919867|962767|P4|COMPLETED|Third Intervention||7
403211|NCT00919867|962768|P3|COMPLETED|Third Intervention||6
403212|NCT00919867|962769|P2|COMPLETED|Third Intervention||7
403213|NCT00919867|962770|P1|COMPLETED|Third Intervention||7
403214|NCT00919867|962765|P6|STARTED|Third Intervention||6
403215|NCT00919867|962766|P5|STARTED|Third Intervention||7
403216|NCT00919867|962767|P4|STARTED|Third Intervention||7
403217|NCT00919867|962768|P3|STARTED|Third Intervention||6
403218|NCT00919867|962769|P2|STARTED|Third Intervention||7
403219|NCT00919867|962770|P1|STARTED|Third Intervention||7
403220|NCT00919867|962765|P6|NOT COMPLETED|Washout||0
403221|NCT00919867|962766|P5|NOT COMPLETED|Washout||0
403222|NCT00919867|962767|P4|NOT COMPLETED|Washout||0
403223|NCT00919867|962768|P3|NOT COMPLETED|Washout||0
403224|NCT00919867|962769|P2|NOT COMPLETED|Washout||0
403225|NCT00919867|962770|P1|NOT COMPLETED|Washout||0
403226|NCT00919867|962765|P6|COMPLETED|Washout||6
403227|NCT00919867|962766|P5|COMPLETED|Washout||7
403228|NCT00919867|962767|P4|COMPLETED|Washout||7
403229|NCT00919867|962768|P3|COMPLETED|Washout||6
403230|NCT00919867|962769|P2|COMPLETED|Washout||7
403231|NCT00919867|962770|P1|COMPLETED|Washout||7
403232|NCT00919867|962765|P6|STARTED|Washout||6
403233|NCT00919867|962766|P5|STARTED|Washout||7
403234|NCT00919867|962767|P4|STARTED|Washout||7
403235|NCT00919867|962768|P3|STARTED|Washout||6
403236|NCT00919867|962769|P2|STARTED|Washout||7
403237|NCT00919867|962770|P1|STARTED|Washout||7
403238|NCT00919867|962765|P6|NOT COMPLETED|Second Intervention||0
403239|NCT00919867|962766|P5|NOT COMPLETED|Second Intervention||0
403240|NCT00919867|962767|P4|NOT COMPLETED|Second Intervention||0
403241|NCT00919867|962768|P3|NOT COMPLETED|Second Intervention||0
403242|NCT00919867|962769|P2|NOT COMPLETED|Second Intervention||0
403243|NCT00919867|962770|P1|NOT COMPLETED|Second Intervention||0
403244|NCT00919867|962765|P6|COMPLETED|Second Intervention||6
403245|NCT00919867|962766|P5|COMPLETED|Second Intervention||7
403246|NCT00919867|962767|P4|COMPLETED|Second Intervention||7
403247|NCT00919867|962768|P3|COMPLETED|Second Intervention||6
403248|NCT00919867|962769|P2|COMPLETED|Second Intervention||7
403249|NCT00919867|962770|P1|COMPLETED|Second Intervention||7
403250|NCT00919867|962765|P6|STARTED|Second Intervention||6
403251|NCT00919867|962766|P5|STARTED|Second Intervention||7
403252|NCT00919867|962767|P4|STARTED|Second Intervention||7
403253|NCT00919867|962768|P3|STARTED|Second Intervention||6
403254|NCT00919867|962769|P2|STARTED|Second Intervention||7
403255|NCT00919867|962770|P1|STARTED|Second Intervention||7
403256|NCT00919867|962765|P6|NOT COMPLETED|Washout||0
403257|NCT00919867|962766|P5|NOT COMPLETED|Washout||0
403258|NCT00919867|962767|P4|NOT COMPLETED|Washout||0
403259|NCT00919867|962768|P3|NOT COMPLETED|Washout||0
403260|NCT00919867|962769|P2|NOT COMPLETED|Washout||0
403261|NCT00919867|962770|P1|NOT COMPLETED|Washout||0
403262|NCT00919867|962765|P6|COMPLETED|Washout||6
403263|NCT00919867|962766|P5|COMPLETED|Washout||7
403264|NCT00919867|962767|P4|COMPLETED|Washout||7
403265|NCT00919867|962768|P3|COMPLETED|Washout||6
403266|NCT00919867|962769|P2|COMPLETED|Washout||7
403267|NCT00919867|962770|P1|COMPLETED|Washout||7
403268|NCT00919867|962765|P6|STARTED|Washout||6
403269|NCT00919867|962766|P5|STARTED|Washout||7
403270|NCT00919867|962767|P4|STARTED|Washout||7
403271|NCT00919867|962768|P3|STARTED|Washout||6
403272|NCT00919867|962769|P2|STARTED|Washout||7
403273|NCT00919867|962770|P1|STARTED|Washout||7
403274|NCT00919867|962765|P6|NOT COMPLETED|First Intervention||1
403275|NCT00919867|962766|P5|NOT COMPLETED|First Intervention||0
403276|NCT00919867|962767|P4|NOT COMPLETED|First Intervention||0
403277|NCT00919867|962768|P3|NOT COMPLETED|First Intervention||1
403278|NCT00919867|962769|P2|NOT COMPLETED|First Intervention||0
403279|NCT00919867|962770|P1|NOT COMPLETED|First Intervention||0
403280|NCT00919867|962765|P6|COMPLETED|First Intervention||6
403281|NCT00919867|962766|P5|COMPLETED|First Intervention||7
403282|NCT00919867|962767|P4|COMPLETED|First Intervention||7
403283|NCT00919867|962768|P3|COMPLETED|First Intervention||6
403284|NCT00919867|962769|P2|COMPLETED|First Intervention||7
403285|NCT00919867|962770|P1|COMPLETED|First Intervention||7
403286|NCT00919867|962765|P6|STARTED|First Intervention||7
403287|NCT00919867|962766|P5|STARTED|First Intervention||7
403288|NCT00919867|962767|P4|STARTED|First Intervention||7
403289|NCT00919867|962768|P3|STARTED|First Intervention||7
403290|NCT00919867|962769|P2|STARTED|First Intervention||7
403291|NCT00919867|962770|P1|STARTED|First Intervention||7
403292|NCT00919854|962791|P1|NOT COMPLETED|Overall Study||1
403293|NCT00919854|962791|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
403294|NCT00919854|962791|P1|STARTED|Overall Study||21
403295|NCT00919802|962800|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
403296|NCT00919802|962801|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
403297|NCT00919802|962800|P2|COMPLETED|Second Intervention - (24 Hours)||13
403298|NCT00919802|962801|P1|COMPLETED|Second Intervention - (24 Hours)||12
403299|NCT00919802|962800|P2|STARTED|Second Intervention - (24 Hours)||13
403300|NCT00919802|962801|P1|STARTED|Second Intervention - (24 Hours)||12
403301|NCT00919802|962800|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
403302|NCT00919802|962801|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
403303|NCT00919802|962800|P2|COMPLETED|First Intervention - (24 Hours)||13
403304|NCT00919802|962801|P1|COMPLETED|First Intervention - (24 Hours)||12
403305|NCT00919802|962800|P2|STARTED|First Intervention - (24 Hours)||13
403306|NCT00919802|962801|P1|STARTED|First Intervention - (24 Hours)||12
403307|NCT00919763|962811|P2|NOT COMPLETED|Overall Study||4
403308|NCT00919763|962812|P1|NOT COMPLETED|Overall Study||12
403309|NCT00919763|962811|P2|COMPLETED|Overall Study||45
403310|NCT00919763|962812|P1|COMPLETED|Overall Study||41
403311|NCT00919763|962811|P2|STARTED|Overall Study||49
403312|NCT00919763|962812|P1|STARTED|Overall Study||53
403313|NCT00919724|962820|P2|NOT COMPLETED|Overall Study||0
403314|NCT00919724|962821|P1|NOT COMPLETED|Overall Study||0
403315|NCT00919724|962820|P2|COMPLETED|Overall Study||44
403316|NCT00919724|962821|P1|COMPLETED|Overall Study||45
403317|NCT00919724|962820|P2|STARTED|Overall Study||44
403318|NCT00919724|962821|P1|STARTED|Overall Study||45
403319|NCT00919711|962829|P2|NOT COMPLETED|Overall Study||13
403320|NCT00919711|962830|P1|NOT COMPLETED|Overall Study||33
403321|NCT00919711|962829|P2|COMPLETED|Overall Study||422
403322|NCT00919711|962830|P1|COMPLETED|Overall Study||402
403323|NCT00919711|962829|P2|STARTED|Overall Study||435
403324|NCT00919711|962830|P1|STARTED|Overall Study||435
403325|NCT00916643|962842|P1|NOT COMPLETED|Overall Study||0
403326|NCT00916643|962842|P1|COMPLETED|Overall Study||113
403327|NCT00916643|962842|P1|STARTED|Overall Study||113
403328|NCT00916617|962853|P4|NOT COMPLETED|Overall Study||7
403329|NCT00916617|962854|P3|NOT COMPLETED|Overall Study||10
403330|NCT00916617|962855|P2|NOT COMPLETED|Overall Study||21
403331|NCT00916617|962856|P1|NOT COMPLETED|Overall Study||23
403332|NCT00916617|962853|P4|COMPLETED|Overall Study||0
403333|NCT00916617|962854|P3|COMPLETED|Overall Study||0
403334|NCT00916617|962855|P2|COMPLETED|Overall Study||0
403335|NCT00916617|962856|P1|COMPLETED|Overall Study||1
403336|NCT00916617|962853|P4|STARTED|Overall Study||7
403337|NCT00916617|962854|P3|STARTED|Overall Study||10
403338|NCT00916617|962855|P2|STARTED|Overall Study||21
403339|NCT00916617|962856|P1|STARTED|Overall Study||24
403340|NCT00916539|962872|P2|NOT COMPLETED|Overall Study||0
403341|NCT00916539|962873|P1|NOT COMPLETED|Overall Study||0
403342|NCT00916539|962872|P2|COMPLETED|Overall Study||31
403343|NCT00916539|962873|P1|COMPLETED|Overall Study||31
403344|NCT00916539|962872|P2|STARTED|Overall Study||31
403345|NCT00916539|962873|P1|STARTED|Overall Study||31
403346|NCT00919633|962899|P4|NOT COMPLETED|Overall Study||21
403347|NCT00919633|962900|P3|NOT COMPLETED|Overall Study||23
403348|NCT00919633|962901|P2|NOT COMPLETED|Overall Study||15
403349|NCT00919633|962902|P1|NOT COMPLETED|Overall Study||22
403350|NCT00919633|962899|P4|COMPLETED|Overall Study||5
403351|NCT00919633|962900|P3|COMPLETED|Overall Study||4
403352|NCT00919633|962901|P2|COMPLETED|Overall Study||10
403353|NCT00919633|962902|P1|COMPLETED|Overall Study||6
403354|NCT00919633|962899|P4|STARTED|Overall Study||26
403355|NCT00919633|962900|P3|STARTED|Overall Study||27
403356|NCT00919633|962901|P2|STARTED|Overall Study||25
403357|NCT00919633|962902|P1|STARTED|Overall Study||28
403358|NCT00919191|962920|P1|NOT COMPLETED|Overall Study||0
403359|NCT00919191|962920|P1|COMPLETED|Overall Study||26
403360|NCT00919191|962920|P1|STARTED|Overall Study||26
403361|NCT00919126|962930|P3|NOT COMPLETED|Overall Study||1
403362|NCT00919126|962931|P2|NOT COMPLETED|Overall Study||5
403363|NCT00919126|962932|P1|NOT COMPLETED|Overall Study||1
403364|NCT00919126|962930|P3|COMPLETED|Overall Study||32
403365|NCT00919126|962931|P2|COMPLETED|Overall Study||32
403366|NCT00919126|962932|P1|COMPLETED|Overall Study||31
403367|NCT00919126|962930|P3|STARTED|Overall Study||33
403368|NCT00919126|962931|P2|STARTED|Overall Study||37
403369|NCT00919126|962932|P1|STARTED|Overall Study||32
403370|NCT00919113|962978|P2|NOT COMPLETED|Overall Study||8
403371|NCT00919113|962979|P1|NOT COMPLETED|Overall Study||9
403372|NCT00919113|962978|P2|COMPLETED|Overall Study||40
403373|NCT00919113|962979|P1|COMPLETED|Overall Study||41
403374|NCT00919113|962978|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
403375|NCT00919113|962979|P1|Received Placebo|Overall Study||0
403376|NCT00919113|962978|P2|Received Uracyst|Overall Study||0
403377|NCT00919113|962979|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
403378|NCT00919113|962978|P2|STARTED|Overall Study||48
403379|NCT00919113|962979|P1|STARTED|Overall Study||50
403380|NCT00919061|962987|P1|NOT COMPLETED|Overall Study||2
403381|NCT00919061|962987|P1|COMPLETED|Overall Study||37
403382|NCT00919061|962987|P1|STARTED|Overall Study||39
403383|NCT00919035|962992|P1|NOT COMPLETED|Overall Study||0
403384|NCT00919035|962992|P1|COMPLETED|Overall Study||21
403385|NCT00919035|962992|P1|STARTED|Overall Study||21
403386|NCT00918957|963000|P2|NOT COMPLETED|Overall Study||0
403387|NCT00918957|963001|P1|NOT COMPLETED|Overall Study||3
403388|NCT00918957|963000|P2|COMPLETED|Overall Study||30
403389|NCT00918957|963001|P1|COMPLETED|Overall Study||29
403390|NCT00918957|963000|P2|STARTED|Overall Study||30
403391|NCT00918957|963001|P1|STARTED|Overall Study||32
403392|NCT00918931|963028|P1|NOT COMPLETED|Overall Study||0
403393|NCT00918931|963028|P1|COMPLETED|Overall Study||3
403394|NCT00918931|963028|P1|STARTED|Overall Study||3
403395|NCT00918879|963034|P2|NOT COMPLETED|Overall Study||6
403396|NCT00918879|963035|P1|NOT COMPLETED|Overall Study||6
403397|NCT00918879|963034|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
403398|NCT00918879|963035|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
403399|NCT00918879|963034|P2|STARTED|Overall Study|Randomized and treated|106
403400|NCT00918879|963035|P1|STARTED|Overall Study|Randomized and treated|107
403401|NCT00918866|963049|P2|NOT COMPLETED|Overall Study||0
403402|NCT00918866|963050|P1|NOT COMPLETED|Overall Study||0
403403|NCT00918866|963049|P2|COMPLETED|Overall Study||16
403404|NCT00918866|963050|P1|COMPLETED|Overall Study||16
403405|NCT00918866|963049|P2|STARTED|Overall Study||16
403406|NCT00918866|963050|P1|STARTED|Overall Study||16
403407|NCT00918749|963067|P3|NOT COMPLETED|Overall Study||7
403408|NCT00918749|963068|P2|NOT COMPLETED|Overall Study||3
403409|NCT00918749|963069|P1|NOT COMPLETED|Overall Study||7
403410|NCT00918749|963067|P3|COMPLETED|Overall Study||62
403411|NCT00918749|963068|P2|COMPLETED|Overall Study||63
403412|NCT00918749|963069|P1|COMPLETED|Overall Study||63
403413|NCT00918749|963067|P3|ITT (Intent to Treat) Population|Overall Study||69
403414|NCT00918749|963068|P2|ITT (Intent to Treat) Population|Overall Study||66
403415|NCT00918749|963069|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
403416|NCT00918749|963067|P3|STARTED|Overall Study||69
403417|NCT00918749|963068|P2|STARTED|Overall Study||66
403418|NCT00918749|963069|P1|STARTED|Overall Study||70
403419|NCT00918736|963101|P1|NOT COMPLETED|Overall Study||4
403420|NCT00918736|963101|P1|COMPLETED|Overall Study|October, 2008|46
403421|NCT00918736|963101|P1|STARTED|Overall Study|October, 2007|50
403422|NCT00918684|963105|P1|NOT COMPLETED|Treatment Phase||25
403423|NCT00918684|963105|P1|COMPLETED|Treatment Phase||65
403424|NCT00918684|963105|P1|STARTED|Treatment Phase||90
403425|NCT00918684|963105|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
403426|NCT00918684|963105|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
403427|NCT00918684|963105|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
403428|NCT00918671|963111|P1|NOT COMPLETED|Overall Study||0
403429|NCT00918671|963111|P1|COMPLETED|Overall Study||60
403430|NCT00918671|963111|P1|STARTED|Overall Study||60
403431|NCT00918580|963116|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
403432|NCT00918580|963116|P1|COMPLETED|After 6-month FU to 1-year FU||87
403433|NCT00918580|963116|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
403434|NCT00918580|963116|P1|STARTED|After 6-month FU to 1-year FU||147
403435|NCT00918580|963116|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
403436|NCT00918580|963116|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
403437|NCT00918580|963116|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
403438|NCT00918580|963116|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
403439|NCT00918580|963116|P1|STARTED|Up to 6-month Follow-up(FU)||158
403440|NCT00918385|963136|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
403441|NCT00918385|963137|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
403442|NCT00918385|963136|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
403443|NCT00918385|963137|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
403444|NCT00918385|963136|P2|STARTED|Combination Nilutamide and Dasatinib||11
403445|NCT00918385|963137|P1|STARTED|Combination Nilutamide and Dasatinib||12
403446|NCT00918385|963136|P2|NOT COMPLETED|Monotherapy||6
403447|NCT00918385|963137|P1|NOT COMPLETED|Monotherapy||2
403448|NCT00918385|963136|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
403449|NCT00918385|963137|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
403450|NCT00918385|963136|P2|STARTED|Monotherapy||17
403451|NCT00918385|963137|P1|STARTED|Monotherapy||14
403452|NCT00918346|963146|P2|NOT COMPLETED|Post Study Period||0
403453|NCT00918346|963147|P1|NOT COMPLETED|Post Study Period||0
403454|NCT00918346|963146|P2|COMPLETED|Post Study Period||21
403455|NCT00918346|963147|P1|COMPLETED|Post Study Period||21
403456|NCT00918346|963146|P2|STARTED|Post Study Period||21
403457|NCT00918346|963147|P1|STARTED|Post Study Period||21
403458|NCT00918346|963146|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
403459|NCT00918346|963147|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
403460|NCT00918346|963146|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
403461|NCT00918346|963147|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
403462|NCT00918346|963146|P2|STARTED|Second Treatment Period (4 Weeks)||21
403463|NCT00918346|963147|P1|STARTED|Second Treatment Period (4 Weeks)||21
403464|NCT00918346|963146|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
403465|NCT00918346|963147|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
403466|NCT00918346|963146|P2|COMPLETED|Washout (at Least 4 Weeks)||21
403467|NCT00918346|963147|P1|COMPLETED|Washout (at Least 4 Weeks)||21
403468|NCT00918346|963146|P2|STARTED|Washout (at Least 4 Weeks)||21
403469|NCT00918346|963147|P1|STARTED|Washout (at Least 4 Weeks)||21
403470|NCT00918346|963146|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
403471|NCT00918346|963147|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
403472|NCT00918346|963146|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
403473|NCT00918346|963147|P1|COMPLETED|First Treatment Period (4 Weeks)||21
403474|NCT00918346|963146|P2|STARTED|First Treatment Period (4 Weeks)||22
403475|NCT00918346|963147|P1|STARTED|First Treatment Period (4 Weeks)||21
403476|NCT00918281|963161|P1|NOT COMPLETED|Overall Study||29
403477|NCT00918281|963161|P1|COMPLETED|Overall Study||41
403478|NCT00918281|963161|P1|STARTED|Overall Study||70
403479|NCT00918255|963171|P3|NOT COMPLETED|Overall Study||5
403480|NCT00918255|963172|P2|NOT COMPLETED|Overall Study||0
403481|NCT00918255|963173|P1|NOT COMPLETED|Overall Study||6
403482|NCT00918255|963171|P3|COMPLETED|Overall Study||46
403483|NCT00918255|963172|P2|COMPLETED|Overall Study||52
403484|NCT00918255|963173|P1|COMPLETED|Overall Study||45
403485|NCT00918255|963171|P3|STARTED|Overall Study||51
403486|NCT00918255|963172|P2|STARTED|Overall Study||52
403487|NCT00918255|963173|P1|STARTED|Overall Study||51
403488|NCT00918203|963201|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||3
403489|NCT00918203|963202|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
403490|NCT00918203|963203|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
403491|NCT00918203|963201|P3|COMPLETED|Crossover to Olaratumab Monotherapy||14
403492|NCT00918203|963202|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
403493|NCT00918203|963203|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
403494|NCT00918203|963201|P3|STARTED|Crossover to Olaratumab Monotherapy|16 participants crossed over to olaratumab after PD and 1 participant of symptomatic deterioration.|17
403495|NCT00918203|963202|P2|STARTED|Crossover to Olaratumab Monotherapy||0
403496|NCT00918203|963203|P1|STARTED|Crossover to Olaratumab Monotherapy||0
403497|NCT00918203|963201|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
403498|NCT00918203|963202|P2|NOT COMPLETED|Treatment With or Without Olaratumab||14
403499|NCT00918203|963203|P1|NOT COMPLETED|Treatment With or Without Olaratumab||7
403500|NCT00918203|963201|P3|COMPLETED|Treatment With or Without Olaratumab||0
403501|NCT00918203|963202|P2|COMPLETED|Treatment With or Without Olaratumab||53
403502|NCT00918203|963203|P1|COMPLETED|Treatment With or Without Olaratumab||63
403503|NCT00918203|963201|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
403504|NCT00918203|963202|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
403505|NCT00918203|963203|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
403506|NCT00918203|963201|P3|STARTED|Treatment With or Without Olaratumab||0
403507|NCT00918203|963202|P2|STARTED|Treatment With or Without Olaratumab||67
403508|NCT00918203|963203|P1|STARTED|Treatment With or Without Olaratumab||70
403509|NCT00918138|963234|P2|NOT COMPLETED|Overall Study||1
403510|NCT00918138|963235|P1|NOT COMPLETED|Overall Study||2
403511|NCT00918138|963234|P2|COMPLETED|Overall Study||46
403512|NCT00918138|963235|P1|COMPLETED|Overall Study||44
403513|NCT00918138|963234|P2|STARTED|Overall Study||47
403514|NCT00918138|963235|P1|STARTED|Overall Study||46
403515|NCT00918125|963251|P2|NOT COMPLETED|Overall Study||0
403516|NCT00918125|963252|P1|NOT COMPLETED|Overall Study||0
403517|NCT00918125|963251|P2|COMPLETED|Overall Study||39
403518|NCT00918125|963252|P1|COMPLETED|Overall Study||20
403519|NCT00918125|963251|P2|STARTED|Overall Study||39
403520|NCT00918125|963252|P1|STARTED|Overall Study||20
403521|NCT00917865|963263|P1|NOT COMPLETED|Overall Study||0
403522|NCT00917865|963263|P1|COMPLETED|Overall Study||11
403523|NCT00917865|963263|P1|STARTED|Overall Study||11
403524|NCT00917852|963274|P1|NOT COMPLETED|Overall Study||6
403525|NCT00917852|963274|P1|COMPLETED|Overall Study||45
403526|NCT00917852|963274|P1|STARTED|Overall Study||51
403527|NCT00917735|963280|P2|NOT COMPLETED|Overall Study||63
403528|NCT00917735|963281|P1|NOT COMPLETED|Overall Study||75
403529|NCT00917735|963280|P2|COMPLETED|Overall Study||474
403530|NCT00917735|963281|P1|COMPLETED|Overall Study||463
403531|NCT00917735|963280|P2|STARTED|Overall Study||537
403532|NCT00917735|963281|P1|STARTED|Overall Study||538
403533|NCT00917644|963291|P2|NOT COMPLETED|Period 2: Second Intervention||0
403534|NCT00917644|963292|P1|NOT COMPLETED|Period 2: Second Intervention||1
403535|NCT00917644|963291|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
403536|NCT00917644|963292|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
403537|NCT00917644|963291|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
403538|NCT00917644|963292|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
403539|NCT00917644|963291|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
403540|NCT00917644|963292|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
403541|NCT00917644|963291|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
403542|NCT00917644|963292|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
403543|NCT00917644|963291|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
403544|NCT00917644|963292|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
403545|NCT00917644|963291|P2|NOT COMPLETED|Period 1: First Intervention||0
403546|NCT00917644|963292|P1|NOT COMPLETED|Period 1: First Intervention||0
403547|NCT00917644|963291|P2|COMPLETED|Period 1: First Intervention||37
403548|NCT00917644|963292|P1|COMPLETED|Period 1: First Intervention||39
403549|NCT00917644|963291|P2|STARTED|Period 1: First Intervention||37
403550|NCT00917644|963292|P1|STARTED|Period 1: First Intervention||39
403551|NCT00917579|963306|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
403552|NCT00917579|963307|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
403553|NCT00917579|963306|P2|COMPLETED|Period 2: 2nd Intervention||37
403554|NCT00917579|963307|P1|COMPLETED|Period 2: 2nd Intervention||37
403555|NCT00917579|963306|P2|STARTED|Period 2: 2nd Intervention||37
403556|NCT00917579|963307|P1|STARTED|Period 2: 2nd Intervention||37
403557|NCT00917579|963306|P2|NOT COMPLETED|Washout >= 2 Weeks||0
403558|NCT00917579|963307|P1|NOT COMPLETED|Washout >= 2 Weeks||2
403559|NCT00917579|963306|P2|COMPLETED|Washout >= 2 Weeks||37
403560|NCT00917579|963307|P1|COMPLETED|Washout >= 2 Weeks||37
403561|NCT00917579|963306|P2|STARTED|Washout >= 2 Weeks||37
403562|NCT00917579|963307|P1|STARTED|Washout >= 2 Weeks||39
403563|NCT00917579|963306|P2|NOT COMPLETED|Period 1: 1st Intervention||0
403564|NCT00917579|963307|P1|NOT COMPLETED|Period 1: 1st Intervention||0
403565|NCT00917579|963306|P2|COMPLETED|Period 1: 1st Intervention||37
403566|NCT00917579|963307|P1|COMPLETED|Period 1: 1st Intervention||39
403567|NCT00917579|963306|P2|STARTED|Period 1: 1st Intervention||37
403568|NCT00917579|963307|P1|STARTED|Period 1: 1st Intervention||39
403569|NCT00917501|963323|P2|NOT COMPLETED|Overall Study||5
403570|NCT00917501|963324|P1|NOT COMPLETED|Overall Study||8
403571|NCT00917501|963323|P2|COMPLETED|Overall Study||21
403572|NCT00917501|963324|P1|COMPLETED|Overall Study||21
403573|NCT00917501|963323|P2|STARTED|Overall Study||26
403574|NCT00917501|963324|P1|STARTED|Overall Study||29
403575|NCT00917384|963332|P2|NOT COMPLETED|Overall Study||4
403576|NCT00917384|963333|P1|NOT COMPLETED|Overall Study||14
403577|NCT00917384|963332|P2|COMPLETED|Overall Study||113
403578|NCT00917384|963333|P1|COMPLETED|Overall Study||224
403579|NCT00917384|963332|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
403580|NCT00917384|963333|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
403581|NCT00917384|963332|P2|STARTED|Overall Study||117
403582|NCT00917384|963333|P1|STARTED|Overall Study||238
403583|NCT00917267|963357|P2|NOT COMPLETED|Overall Study||79
403584|NCT00917267|963358|P1|NOT COMPLETED|Overall Study||39
403585|NCT00917267|963357|P2|COMPLETED|Overall Study||266
403586|NCT00917267|963358|P1|COMPLETED|Overall Study||307
403587|NCT00917267|963357|P2|Intent to Treat (ITT)|Overall Study||338
403588|NCT00917267|963358|P1|Intent to Treat (ITT)|Overall Study||340
403589|NCT00917267|963357|P2|STARTED|Overall Study||345
403590|NCT00917267|963358|P1|STARTED|Overall Study||346
403591|NCT00917124|963386|P2|NOT COMPLETED|Overall Study||6
403592|NCT00917124|963387|P1|NOT COMPLETED|Overall Study||4
403593|NCT00917124|963386|P2|COMPLETED|Overall Study||94
403594|NCT00917124|963387|P1|COMPLETED|Overall Study||96
403595|NCT00917124|963386|P2|STARTED|Overall Study||100
403596|NCT00917124|963387|P1|STARTED|Overall Study||100
403597|NCT00916929|963397|P2|NOT COMPLETED|Overall Study||29
403598|NCT00916929|963398|P1|NOT COMPLETED|Overall Study||10
403599|NCT00916929|963397|P2|COMPLETED|Overall Study||53
403600|NCT00916929|963398|P1|COMPLETED|Overall Study||70
403601|NCT00916929|963397|P2|STARTED|Overall Study||82
403602|NCT00916929|963398|P1|STARTED|Overall Study||80
403603|NCT00916721|963408|P2|NOT COMPLETED|Overall Study||10
403604|NCT00916721|963409|P1|NOT COMPLETED|Overall Study||10
403605|NCT00916721|963408|P2|COMPLETED|Overall Study||29
403606|NCT00916721|963409|P1|COMPLETED|Overall Study||25
403607|NCT00916721|963408|P2|STARTED|Overall Study||39
403608|NCT00916721|963409|P1|STARTED|Overall Study||35
403609|NCT00916383|963421|P1|NOT COMPLETED|Overall Study||3
403610|NCT00916383|963421|P1|COMPLETED|Overall Study||46
403611|NCT00916383|963421|P1|STARTED|Overall Study||49
403612|NCT00916370|963449|P2|NOT COMPLETED|Overall Study||2
403613|NCT00916370|963450|P1|NOT COMPLETED|Overall Study||5
403614|NCT00916370|963449|P2|COMPLETED|Overall Study||102
403615|NCT00916370|963450|P1|COMPLETED|Overall Study||396
403616|NCT00916370|963449|P2|STARTED|Overall Study||104
403617|NCT00916370|963450|P1|STARTED|Overall Study||401
403618|NCT00916357|963624|P6|NOT COMPLETED|Period 3||0
403619|NCT00916357|963625|P5|NOT COMPLETED|Period 3||0
403620|NCT00916357|963626|P4|NOT COMPLETED|Period 3||0
403621|NCT00916357|963627|P3|NOT COMPLETED|Period 3||0
403622|NCT00916357|963628|P2|NOT COMPLETED|Period 3||0
403623|NCT00916357|963629|P1|NOT COMPLETED|Period 3||0
403624|NCT00916357|963624|P6|COMPLETED|Period 3||4
403625|NCT00916357|963625|P5|COMPLETED|Period 3||3
403626|NCT00916357|963626|P4|COMPLETED|Period 3||3
403627|NCT00916357|963627|P3|COMPLETED|Period 3||4
403628|NCT00916357|963628|P2|COMPLETED|Period 3||4
403629|NCT00916357|963629|P1|COMPLETED|Period 3||3
403630|NCT00916357|963624|P6|STARTED|Period 3||4
403631|NCT00916357|963625|P5|STARTED|Period 3||3
403632|NCT00916357|963626|P4|STARTED|Period 3||3
403633|NCT00916357|963627|P3|STARTED|Period 3||4
403634|NCT00916357|963628|P2|STARTED|Period 3||4
403635|NCT00916357|963629|P1|STARTED|Period 3||3
403636|NCT00916357|963624|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
403637|NCT00916357|963625|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
403638|NCT00916357|963626|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
403639|NCT00916357|963627|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
403640|NCT00916357|963628|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
403641|NCT00916357|963629|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
403642|NCT00916357|963624|P6|COMPLETED|Washout (3 to 14 Days)||4
403643|NCT00916357|963625|P5|COMPLETED|Washout (3 to 14 Days)||3
403644|NCT00916357|963626|P4|COMPLETED|Washout (3 to 14 Days)||3
403645|NCT00916357|963627|P3|COMPLETED|Washout (3 to 14 Days)||4
403646|NCT00916357|963628|P2|COMPLETED|Washout (3 to 14 Days)||4
403647|NCT00916357|963629|P1|COMPLETED|Washout (3 to 14 Days)||3
403648|NCT00916357|963624|P6|STARTED|Washout (3 to 14 Days)||4
403649|NCT00916357|963625|P5|STARTED|Washout (3 to 14 Days)||3
403650|NCT00916357|963626|P4|STARTED|Washout (3 to 14 Days)||3
403651|NCT00916357|963627|P3|STARTED|Washout (3 to 14 Days)||4
403652|NCT00916357|963628|P2|STARTED|Washout (3 to 14 Days)||4
403653|NCT00916357|963629|P1|STARTED|Washout (3 to 14 Days)||3
403654|NCT00916357|963624|P6|NOT COMPLETED|Period 2||0
403655|NCT00916357|963625|P5|NOT COMPLETED|Period 2||0
403656|NCT00916357|963626|P4|NOT COMPLETED|Period 2||1
403657|NCT00916357|963627|P3|NOT COMPLETED|Period 2||0
403658|NCT00916357|963628|P2|NOT COMPLETED|Period 2||0
403659|NCT00916357|963629|P1|NOT COMPLETED|Period 2||0
403660|NCT00916357|963624|P6|COMPLETED|Period 2||4
403661|NCT00916357|963625|P5|COMPLETED|Period 2||3
403662|NCT00916357|963626|P4|COMPLETED|Period 2||3
403663|NCT00916357|963627|P3|COMPLETED|Period 2||4
403664|NCT00916357|963628|P2|COMPLETED|Period 2||4
403665|NCT00916357|963629|P1|COMPLETED|Period 2||3
403666|NCT00916357|963624|P6|STARTED|Period 2||4
403667|NCT00916357|963625|P5|STARTED|Period 2||3
403668|NCT00916357|963626|P4|STARTED|Period 2||4
403669|NCT00916357|963627|P3|STARTED|Period 2||4
403670|NCT00916357|963628|P2|STARTED|Period 2||4
403671|NCT00916357|963629|P1|STARTED|Period 2||3
403672|NCT00916357|963624|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
403673|NCT00916357|963625|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
403674|NCT00916357|963626|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
403675|NCT00916357|963627|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
403676|NCT00916357|963628|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
403677|NCT00916357|963629|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
403678|NCT00916357|963624|P6|COMPLETED|Washout (3 to 14 Days)||4
403679|NCT00916357|963625|P5|COMPLETED|Washout (3 to 14 Days)||3
403680|NCT00916357|963626|P4|COMPLETED|Washout (3 to 14 Days)||4
403681|NCT00916357|963627|P3|COMPLETED|Washout (3 to 14 Days)||4
403682|NCT00916357|963628|P2|COMPLETED|Washout (3 to 14 Days)||4
403683|NCT00916357|963629|P1|COMPLETED|Washout (3 to 14 Days)||3
403684|NCT00916357|963624|P6|STARTED|Washout (3 to 14 Days)||4
403685|NCT00916357|963625|P5|STARTED|Washout (3 to 14 Days)||3
403686|NCT00916357|963626|P4|STARTED|Washout (3 to 14 Days)||4
403687|NCT00916357|963627|P3|STARTED|Washout (3 to 14 Days)||4
403688|NCT00916357|963628|P2|STARTED|Washout (3 to 14 Days)||4
403689|NCT00916357|963629|P1|STARTED|Washout (3 to 14 Days)||3
403690|NCT00916357|963624|P6|NOT COMPLETED|Period 1||0
403691|NCT00916357|963625|P5|NOT COMPLETED|Period 1||0
403692|NCT00916357|963626|P4|NOT COMPLETED|Period 1||0
403693|NCT00916357|963627|P3|NOT COMPLETED|Period 1||0
403694|NCT00916357|963628|P2|NOT COMPLETED|Period 1||0
403695|NCT00916357|963629|P1|NOT COMPLETED|Period 1||1
403696|NCT00916357|963624|P6|COMPLETED|Period 1||4
403697|NCT00916357|963625|P5|COMPLETED|Period 1||3
403698|NCT00916357|963626|P4|COMPLETED|Period 1||4
403699|NCT00916357|963627|P3|COMPLETED|Period 1||4
403700|NCT00916357|963628|P2|COMPLETED|Period 1||4
403701|NCT00916357|963629|P1|COMPLETED|Period 1||3
403702|NCT00916357|963624|P6|Received at Least 1 Dose of Study Drug|Period 1||4
403703|NCT00916357|963625|P5|Received at Least 1 Dose of Study Drug|Period 1||3
403704|NCT00916357|963626|P4|Received at Least 1 Dose of Study Drug|Period 1||4
403705|NCT00916357|963627|P3|Received at Least 1 Dose of Study Drug|Period 1||4
403706|NCT00916357|963628|P2|Received at Least 1 Dose of Study Drug|Period 1||4
403707|NCT00916357|963629|P1|Received at Least 1 Dose of Study Drug|Period 1||4
403708|NCT00916357|963624|P6|STARTED|Period 1||4
403709|NCT00916357|963625|P5|STARTED|Period 1||3
403710|NCT00916357|963626|P4|STARTED|Period 1||4
403711|NCT00916357|963627|P3|STARTED|Period 1||4
403712|NCT00916357|963628|P2|STARTED|Period 1||4
403713|NCT00916357|963629|P1|STARTED|Period 1||4
403714|NCT00916344|963667|P1|NOT COMPLETED|Overall Study||8
403715|NCT00916344|963667|P1|COMPLETED|Overall Study||167
403716|NCT00916344|963667|P1|STARTED|Overall Study||175
403717|NCT00916305|963674|P2|NOT COMPLETED|Overall Study||28
403718|NCT00916305|963675|P1|NOT COMPLETED|Overall Study||21
403719|NCT00916305|963674|P2|COMPLETED|Overall Study||9
403720|NCT00916305|963675|P1|COMPLETED|Overall Study||7
403721|NCT00916305|963674|P2|STARTED|Overall Study||37
403722|NCT00916305|963675|P1|STARTED|Overall Study||28
403723|NCT00916279|963683|P1|NOT COMPLETED|Overall Study||4
403724|NCT00916279|963683|P1|COMPLETED|Overall Study||37
403725|NCT00916279|963683|P1|24 Months|Overall Study||37
403726|NCT00916279|963683|P1|6 Months|Overall Study||41
403727|NCT00916279|963683|P1|30 Days|Overall Study||41
403728|NCT00916279|963683|P1|STARTED|Overall Study||41
403729|NCT00916136|963693|P2|NOT COMPLETED|Overall Study||0
403730|NCT00916136|963694|P1|NOT COMPLETED|Overall Study||0
403731|NCT00916136|963693|P2|COMPLETED|Overall Study||29
403732|NCT00916136|963694|P1|COMPLETED|Overall Study||37
403733|NCT00916136|963693|P2|STARTED|Overall Study||29
403734|NCT00916136|963694|P1|STARTED|Overall Study||37
403735|NCT00916032|963702|P2|NOT COMPLETED|Overall Study||0
403736|NCT00916032|963703|P1|NOT COMPLETED|Overall Study||0
403737|NCT00916032|963702|P2|COMPLETED|Overall Study||11
403738|NCT00916032|963703|P1|COMPLETED|Overall Study||12
403739|NCT00916032|963702|P2|STARTED|Overall Study||11
403740|NCT00916032|963703|P1|STARTED|Overall Study||12
403741|NCT00916006|963745|P2|NOT COMPLETED|Overall Study||7
403742|NCT00916006|963746|P1|NOT COMPLETED|Overall Study||3
403743|NCT00916006|963745|P2|COMPLETED|Overall Study||127
403744|NCT00916006|963746|P1|COMPLETED|Overall Study||132
403745|NCT00916006|963745|P2|STARTED|Overall Study||134
403746|NCT00916006|963746|P1|STARTED|Overall Study||135
403747|NCT00915902|963756|P2|NOT COMPLETED|2nd Treatment Period||1
403748|NCT00915902|963757|P1|NOT COMPLETED|2nd Treatment Period||0
403749|NCT00915902|963756|P2|COMPLETED|2nd Treatment Period||20
403750|NCT00915902|963757|P1|COMPLETED|2nd Treatment Period||19
403751|NCT00915902|963756|P2|STARTED|2nd Treatment Period||21
403752|NCT00915902|963757|P1|STARTED|2nd Treatment Period||19
403753|NCT00915902|963756|P2|NOT COMPLETED|Washout (4 Weeks)||1
403754|NCT00915902|963757|P1|NOT COMPLETED|Washout (4 Weeks)||0
403755|NCT00915902|963756|P2|COMPLETED|Washout (4 Weeks)||21
403756|NCT00915902|963757|P1|COMPLETED|Washout (4 Weeks)||19
403757|NCT00915902|963756|P2|STARTED|Washout (4 Weeks)||22
403758|NCT00915902|963757|P1|STARTED|Washout (4 Weeks)||19
403759|NCT00915902|963756|P2|NOT COMPLETED|1st Treatment Period||0
403760|NCT00915902|963757|P1|NOT COMPLETED|1st Treatment Period||1
403761|NCT00915902|963756|P2|COMPLETED|1st Treatment Period||22
403762|NCT00915902|963757|P1|COMPLETED|1st Treatment Period||19
403763|NCT00915902|963756|P2|STARTED|1st Treatment Period||22
403764|NCT00915902|963757|P1|STARTED|1st Treatment Period||20
403765|NCT00915876|963767|P2|NOT COMPLETED|Overall Study||1
403766|NCT00915876|963768|P1|NOT COMPLETED|Overall Study||0
403767|NCT00915876|963767|P2|COMPLETED|Overall Study||20
403768|NCT00915876|963768|P1|COMPLETED|Overall Study||20
403769|NCT00915876|963767|P2|Moving Beyond First Dose|Overall Study||20
403770|NCT00915876|963768|P1|Moving Beyond First Dose|Overall Study||20
403771|NCT00915876|963767|P2|STARTED|Overall Study||21
403772|NCT00915876|963768|P1|STARTED|Overall Study||20
403773|NCT00915798|963778|P4|NOT COMPLETED|Overall Study||0
403774|NCT00915798|963779|P3|NOT COMPLETED|Overall Study||0
403775|NCT00915798|963780|P2|NOT COMPLETED|Overall Study||0
403776|NCT00915798|963781|P1|NOT COMPLETED|Overall Study||0
403777|NCT00915798|963778|P4|COMPLETED|Overall Study||26
403778|NCT00915798|963779|P3|COMPLETED|Overall Study||23
403779|NCT00915798|963780|P2|COMPLETED|Overall Study||21
403780|NCT00915798|963781|P1|COMPLETED|Overall Study||19
403781|NCT00915798|963778|P4|STARTED|Overall Study||26
403782|NCT00915798|963779|P3|STARTED|Overall Study||23
403783|NCT00915798|963780|P2|STARTED|Overall Study||21
403784|NCT00915798|963781|P1|STARTED|Overall Study||19
403785|NCT00915772|963804|P3|NOT COMPLETED|Overall Study||29
403786|NCT00915772|963805|P2|NOT COMPLETED|Overall Study||46
403787|NCT00915772|963806|P1|NOT COMPLETED|Overall Study||36
403788|NCT00915772|963804|P3|COMPLETED|Overall Study||142
403789|NCT00915772|963805|P2|COMPLETED|Overall Study||179
403790|NCT00915772|963806|P1|COMPLETED|Overall Study||134
403791|NCT00915772|963804|P3|STARTED|Overall Study||171
403792|NCT00915772|963805|P2|STARTED|Overall Study||225
403793|NCT00915772|963806|P1|STARTED|Overall Study||170
403794|NCT00915759|963851|P1|NOT COMPLETED|Overall Study||0
403795|NCT00915759|963851|P1|COMPLETED|Overall Study|number of participants|40
403796|NCT00915759|963851|P1|STARTED|Overall Study|number of participants|40
403797|NCT00915655|963861|P1|NOT COMPLETED|Overall Study||0
403798|NCT00915655|963861|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
403799|NCT00915655|963861|P1|STARTED|Overall Study||12
403800|NCT00915603|963868|P2|NOT COMPLETED|Overall Study||55
403801|NCT00915603|963869|P1|NOT COMPLETED|Overall Study||56
403802|NCT00915603|963868|P2|COMPLETED|Overall Study||0
403803|NCT00915603|963869|P1|COMPLETED|Overall Study||0
403804|NCT00915603|963868|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
403805|NCT00915603|963869|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
403806|NCT00915590|963885|P2|NOT COMPLETED|Overall Study||1
403807|NCT00915590|963886|P1|NOT COMPLETED|Overall Study||2
403808|NCT00915590|963885|P2|COMPLETED|Overall Study||4
403809|NCT00915590|963886|P1|COMPLETED|Overall Study||3
403810|NCT00915590|963885|P2|STARTED|Overall Study||5
403811|NCT00915590|963886|P1|STARTED|Overall Study||5
403812|NCT00915551|963905|P2|NOT COMPLETED|Overall Study||1
403813|NCT00915551|963906|P1|NOT COMPLETED|Overall Study||0
403814|NCT00915551|963905|P2|COMPLETED|Overall Study||135
403815|NCT00915551|963906|P1|COMPLETED|Overall Study||142
403816|NCT00915551|963905|P2|STARTED|Overall Study||136
403817|NCT00915551|963906|P1|STARTED|Overall Study||142
403818|NCT00915525|963916|P2|NOT COMPLETED|Overall Study||135
403819|NCT00915525|963917|P1|NOT COMPLETED|Overall Study||265
403820|NCT00915525|963916|P2|COMPLETED|Overall Study||151
403821|NCT00915525|963917|P1|COMPLETED|Overall Study||278
403822|NCT00915525|963916|P2|STARTED|Overall Study||286
403823|NCT00915525|963917|P1|STARTED|Overall Study||543
403824|NCT00915499|964020|P2|NOT COMPLETED|Overall Study||2
403825|NCT00915499|964021|P1|NOT COMPLETED|Overall Study||4
403826|NCT00915499|964020|P2|COMPLETED|Overall Study||31
403827|NCT00915499|964021|P1|COMPLETED|Overall Study||29
403828|NCT00915499|964020|P2|STARTED|Overall Study||33
403829|NCT00915499|964021|P1|STARTED|Overall Study||33
403830|NCT00915473|964031|P2|NOT COMPLETED|4-week Follow Up||5
403831|NCT00915473|964032|P1|NOT COMPLETED|4-week Follow Up||1
403832|NCT00915473|964031|P2|COMPLETED|4-week Follow Up||30
403833|NCT00915473|964032|P1|COMPLETED|4-week Follow Up||33
403834|NCT00915473|964031|P2|STARTED|4-week Follow Up||35
403835|NCT00915473|964032|P1|STARTED|4-week Follow Up||34
403836|NCT00915473|964031|P2|NOT COMPLETED|Injection||0
403837|NCT00915473|964032|P1|NOT COMPLETED|Injection||0
403838|NCT00915473|964031|P2|COMPLETED|Injection||35
403839|NCT00915473|964032|P1|COMPLETED|Injection||34
403840|NCT00915473|964031|P2|STARTED|Injection||35
403841|NCT00915473|964032|P1|STARTED|Injection||34
403842|NCT00915473|964031|P2|NOT COMPLETED|Screening||0
403843|NCT00915473|964032|P1|NOT COMPLETED|Screening||1
403844|NCT00915473|964031|P2|COMPLETED|Screening||35
403845|NCT00915473|964032|P1|COMPLETED|Screening||34
403846|NCT00915473|964031|P2|STARTED|Screening||35
403847|NCT00915473|964032|P1|STARTED|Screening||35
403848|NCT00915356|964049|P5|NOT COMPLETED|Overall Study||0
403849|NCT00915356|964050|P4|NOT COMPLETED|Overall Study||0
403850|NCT00915356|964051|P3|NOT COMPLETED|Overall Study||0
403851|NCT00915356|964052|P2|NOT COMPLETED|Overall Study||0
403852|NCT00915356|964053|P1|NOT COMPLETED|Overall Study||1
403853|NCT00915356|964049|P5|COMPLETED|Overall Study||43
403854|NCT00915356|964050|P4|COMPLETED|Overall Study||12
403855|NCT00915356|964051|P3|COMPLETED|Overall Study||45
403856|NCT00915356|964052|P2|COMPLETED|Overall Study||45
403857|NCT00915356|964053|P1|COMPLETED|Overall Study||25
403858|NCT00915356|964049|P5|STARTED|Overall Study||43
403859|NCT00915356|964050|P4|STARTED|Overall Study||12
403860|NCT00915356|964051|P3|STARTED|Overall Study||45
403861|NCT00915356|964052|P2|STARTED|Overall Study||45
403862|NCT00915356|964053|P1|STARTED|Overall Study||26
403863|NCT00915343|964115|P3|NOT COMPLETED|Part B - Open Label Period||2
403864|NCT00915343|964116|P2|NOT COMPLETED|Part B - Open Label Period||0
403865|NCT00915343|964117|P1|NOT COMPLETED|Part B - Open Label Period||0
403866|NCT00915343|964115|P3|COMPLETED|Part B - Open Label Period||57
403867|NCT00915343|964116|P2|COMPLETED|Part B - Open Label Period||0
403868|NCT00915343|964117|P1|COMPLETED|Part B - Open Label Period||0
403869|NCT00915343|964115|P3|STARTED|Part B - Open Label Period||59
403870|NCT00915343|964116|P2|STARTED|Part B - Open Label Period||0
403871|NCT00915343|964117|P1|STARTED|Part B - Open Label Period||0
403872|NCT00915343|964115|P3|NOT COMPLETED|Part A - Second Intervention Period||0
403873|NCT00915343|964116|P2|NOT COMPLETED|Part A - Second Intervention Period||0
403874|NCT00915343|964117|P1|NOT COMPLETED|Part A - Second Intervention Period||0
403875|NCT00915343|964115|P3|COMPLETED|Part A - Second Intervention Period||0
403876|NCT00915343|964116|P2|COMPLETED|Part A - Second Intervention Period||32
403877|NCT00915343|964117|P1|COMPLETED|Part A - Second Intervention Period||32
403878|NCT00915343|964115|P3|STARTED|Part A - Second Intervention Period||0
403879|NCT00915343|964116|P2|STARTED|Part A - Second Intervention Period||32
403880|NCT00915343|964117|P1|STARTED|Part A - Second Intervention Period||32
403881|NCT00915343|964115|P3|NOT COMPLETED|Part A - First Intervention Period||0
403882|NCT00915343|964116|P2|NOT COMPLETED|Part A - First Intervention Period||0
403883|NCT00915343|964117|P1|NOT COMPLETED|Part A - First Intervention Period||0
403884|NCT00915343|964115|P3|COMPLETED|Part A - First Intervention Period||0
403885|NCT00915343|964116|P2|COMPLETED|Part A - First Intervention Period||32
403886|NCT00915343|964117|P1|COMPLETED|Part A - First Intervention Period||32
403887|NCT00915343|964115|P3|STARTED|Part A - First Intervention Period||0
403888|NCT00915343|964116|P2|STARTED|Part A - First Intervention Period||32
403889|NCT00915343|964117|P1|STARTED|Part A - First Intervention Period||32
403890|NCT00915278|964202|P6|NOT COMPLETED|Overall Study||8
403891|NCT00915278|964203|P5|NOT COMPLETED|Overall Study||2
403892|NCT00915278|964204|P4|NOT COMPLETED|Overall Study||3
403893|NCT00915278|964205|P3|NOT COMPLETED|Overall Study||1
403894|NCT00915278|964206|P2|NOT COMPLETED|Overall Study||3
403895|NCT00915278|964207|P1|NOT COMPLETED|Overall Study||5
403896|NCT00915278|964202|P6|COMPLETED|Overall Study||1
403897|NCT00915278|964203|P5|COMPLETED|Overall Study||1
403898|NCT00915278|964204|P4|COMPLETED|Overall Study||2
403899|NCT00915278|964205|P3|COMPLETED|Overall Study||2
403900|NCT00915278|964206|P2|COMPLETED|Overall Study||2
403901|NCT00915278|964207|P1|COMPLETED|Overall Study||3
403902|NCT00915278|964202|P6|STARTED|Overall Study||9
403903|NCT00915278|964203|P5|STARTED|Overall Study||3
403904|NCT00915278|964204|P4|STARTED|Overall Study||5
403905|NCT00915278|964205|P3|STARTED|Overall Study||3
403906|NCT00915278|964206|P2|STARTED|Overall Study||5
403907|NCT00915278|964207|P1|STARTED|Overall Study||8
403908|NCT00915148|964353|P1|NOT COMPLETED|Overall Study||0
403909|NCT00915148|964353|P1|COMPLETED|Overall Study|August 2010|110
403910|NCT00915148|964353|P1|STARTED|Overall Study|October 2009|110
403911|NCT00914966|964358|P1|NOT COMPLETED|Step 3: 2500 Units||0
403912|NCT00914966|964358|P1|COMPLETED|Step 3: 2500 Units||12
403913|NCT00914966|964358|P1|STARTED|Step 3: 2500 Units||12
403914|NCT00914966|964358|P1|NOT COMPLETED|Step 2: 2000 Units||1
403915|NCT00914966|964358|P1|COMPLETED|Step 2: 2000 Units||12
403916|NCT00914966|964358|P1|STARTED|Step 2: 2000 Units||13
403917|NCT00914966|964358|P1|NOT COMPLETED|Step 1: 1500 Units||2
403918|NCT00914966|964358|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
403919|NCT00914966|964358|P1|STARTED|Step 1: 1500 Units||20
403920|NCT00914862|964375|P5|NOT COMPLETED|Overall Study||0
403921|NCT00914862|964376|P4|NOT COMPLETED|Overall Study||0
403922|NCT00914862|964377|P3|NOT COMPLETED|Overall Study||0
403923|NCT00914862|964378|P2|NOT COMPLETED|Overall Study||0
403924|NCT00914862|964379|P1|NOT COMPLETED|Overall Study||0
403925|NCT00914862|964375|P5|COMPLETED|Overall Study||28
403926|NCT00914862|964376|P4|COMPLETED|Overall Study||8
403927|NCT00914862|964377|P3|COMPLETED|Overall Study||8
403928|NCT00914862|964378|P2|COMPLETED|Overall Study||6
403929|NCT00914862|964379|P1|COMPLETED|Overall Study||6
403930|NCT00914862|964375|P5|STARTED|Overall Study||28
403931|NCT00914862|964376|P4|STARTED|Overall Study||8
403932|NCT00914862|964377|P3|STARTED|Overall Study||8
403933|NCT00914862|964378|P2|STARTED|Overall Study||6
403934|NCT00914862|964379|P1|STARTED|Overall Study||6
403935|NCT00914849|964453|P2|NOT COMPLETED|Overall Study||1
403936|NCT00914849|964454|P1|NOT COMPLETED|Overall Study||1
403937|NCT00914849|964453|P2|COMPLETED|Overall Study||33
403938|NCT00914849|964454|P1|COMPLETED|Overall Study||33
403939|NCT00914849|964453|P2|STARTED|Overall Study||34
403940|NCT00914849|964454|P1|STARTED|Overall Study||34
403941|NCT00914810|964488|P2|NOT COMPLETED|Overall Study||1
403942|NCT00914810|964489|P1|NOT COMPLETED|Overall Study||2
403943|NCT00914810|964488|P2|COMPLETED|Overall Study||18
403944|NCT00914810|964489|P1|COMPLETED|Overall Study||18
403945|NCT00914810|964488|P2|STARTED|Overall Study||19
403946|NCT00914810|964489|P1|STARTED|Overall Study||20
403947|NCT00914589|964500|P3|NOT COMPLETED|Overall Study||12
403948|NCT00914589|964501|P2|NOT COMPLETED|Overall Study||16
403949|NCT00914589|964502|P1|NOT COMPLETED|Overall Study||25
403950|NCT00914589|964500|P3|COMPLETED|Overall Study||126
403951|NCT00914589|964501|P2|COMPLETED|Overall Study||127
403952|NCT00914589|964502|P1|COMPLETED|Overall Study||103
403953|NCT00914589|964500|P3|STARTED|Overall Study||138
403954|NCT00914589|964501|P2|STARTED|Overall Study||143
403955|NCT00914589|964502|P1|STARTED|Overall Study||128
403956|NCT00914485|964522|P1|NOT COMPLETED|Overall Study||0
403957|NCT00914485|964522|P1|COMPLETED|Overall Study||369
403958|NCT00914485|964522|P1|STARTED|Overall Study||369
403959|NCT00914459|964528|P2|NOT COMPLETED|Overall Study||1
403960|NCT00914459|964529|P1|NOT COMPLETED|Overall Study||1
403961|NCT00914459|964528|P2|COMPLETED|Overall Study||18
403962|NCT00914459|964529|P1|COMPLETED|Overall Study||17
403963|NCT00914459|964528|P2|STARTED|Overall Study||19
403964|NCT00914459|964529|P1|STARTED|Overall Study||18
403965|NCT00914186|964559|P4|NOT COMPLETED|Overall Study||10
403966|NCT00914186|964560|P3|NOT COMPLETED|Overall Study||2
403967|NCT00914186|964561|P2|NOT COMPLETED|Overall Study||2
403968|NCT00914186|964562|P1|NOT COMPLETED|Overall Study||3
403969|NCT00914186|964559|P4|COMPLETED|Overall Study||20
403970|NCT00914186|964560|P3|COMPLETED|Overall Study||29
403971|NCT00914186|964561|P2|COMPLETED|Overall Study||28
403972|NCT00914186|964562|P1|COMPLETED|Overall Study||28
403973|NCT00914186|964559|P4|STARTED|Overall Study||30
403974|NCT00914186|964560|P3|STARTED|Overall Study||31
403975|NCT00914186|964561|P2|STARTED|Overall Study||30
403976|NCT00914186|964562|P1|STARTED|Overall Study||31
403977|NCT00914069|964596|P2|NOT COMPLETED|Overall Study||0
403978|NCT00914069|964597|P1|NOT COMPLETED|Overall Study||0
403979|NCT00914069|964596|P2|COMPLETED|Overall Study||88
403980|NCT00914069|964597|P1|COMPLETED|Overall Study||84
403981|NCT00914069|964596|P2|STARTED|Overall Study||88
403982|NCT00914069|964597|P1|STARTED|Overall Study||84
403983|NCT00913913|964611|P1|NOT COMPLETED|Overall Study||8
403984|NCT00913913|964611|P1|COMPLETED|Overall Study||0
403985|NCT00913913|964611|P1|STARTED|Overall Study||8
403986|NCT00913835|964620|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
403987|NCT00913835|964621|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
403988|NCT00913835|964620|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
403989|NCT00913835|964621|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
403990|NCT00913835|964620|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
403991|NCT00913835|964621|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
403992|NCT00913835|964620|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
403993|NCT00913835|964621|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
403994|NCT00913835|964620|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
403995|NCT00913835|964621|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
403996|NCT00913835|964620|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
403997|NCT00913835|964621|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
403998|NCT00913835|964620|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
403999|NCT00913835|964621|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
404000|NCT00913835|964620|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
404001|NCT00913835|964621|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
404002|NCT00913770|964660|P3|NOT COMPLETED|Overall Study||21
404003|NCT00913770|964661|P2|NOT COMPLETED|Overall Study||29
404004|NCT00913770|964662|P1|NOT COMPLETED|Overall Study||35
404005|NCT00913770|964660|P3|COMPLETED|Overall Study||93
404006|NCT00913770|964661|P2|COMPLETED|Overall Study||82
404007|NCT00913770|964662|P1|COMPLETED|Overall Study||69
404008|NCT00913770|964660|P3|STARTED|Overall Study||114
404009|NCT00913770|964661|P2|STARTED|Overall Study||111
404010|NCT00913770|964662|P1|STARTED|Overall Study||104
404011|NCT00913744|964675|P2|NOT COMPLETED|Overall Study||1
404012|NCT00913744|964676|P1|NOT COMPLETED|Overall Study||5
404013|NCT00913744|964675|P2|COMPLETED|Overall Study||24
404014|NCT00913744|964676|P1|COMPLETED|Overall Study||70
404015|NCT00913744|964675|P2|STARTED|Overall Study||25
404016|NCT00913744|964676|P1|STARTED|Overall Study||75
404017|NCT00913692|964682|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
404018|NCT00913692|964682|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
404019|NCT00913692|964682|P1|STARTED|Treatment Phase 2 (5 Months)||1
404020|NCT00913692|964682|P1|NOT COMPLETED|Washout (2 Weeks)||0
404021|NCT00913692|964682|P1|COMPLETED|Washout (2 Weeks)||1
404022|NCT00913692|964682|P1|STARTED|Washout (2 Weeks)||1
404023|NCT00913692|964682|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
404024|NCT00913692|964682|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
404025|NCT00913692|964682|P1|STARTED|Treatment Phase 1 (5 Months)||2
404026|NCT00913692|964682|P1|NOT COMPLETED|Screening (4 Months)||9
404027|NCT00913692|964682|P1|COMPLETED|Screening (4 Months)||2
404028|NCT00913692|964682|P1|STARTED|Screening (4 Months)||11
404029|NCT00913523|964695|P3|NOT COMPLETED|Overall Study||14
404030|NCT00913523|964696|P2|NOT COMPLETED|Overall Study||16
404031|NCT00913523|964697|P1|NOT COMPLETED|Overall Study||18
404032|NCT00913523|964695|P3|COMPLETED|Overall Study||147
404033|NCT00913523|964696|P2|COMPLETED|Overall Study||143
404034|NCT00913523|964697|P1|COMPLETED|Overall Study||144
404035|NCT00913523|964695|P3|STARTED|Overall Study||161
404036|NCT00913523|964696|P2|STARTED|Overall Study||159
404037|NCT00913523|964697|P1|STARTED|Overall Study||162
404038|NCT00913510|964722|P2|NOT COMPLETED|Overall Study||4
404039|NCT00913510|964723|P1|NOT COMPLETED|Overall Study||8
404040|NCT00913510|964722|P2|COMPLETED|Overall Study||3
404041|NCT00913510|964723|P1|COMPLETED|Overall Study||5
404042|NCT00913510|964722|P2|STARTED|Overall Study||7
404043|NCT00913510|964723|P1|STARTED|Overall Study||13
404044|NCT00913458|964729|P7|NOT COMPLETED|Phase 3||8
404045|NCT00913458|964730|P6|NOT COMPLETED|Phase 3||18
404046|NCT00913458|964731|P5|NOT COMPLETED|Phase 3||22
404047|NCT00913458|964732|P4|NOT COMPLETED|Phase 3||0
404048|NCT00913458|964733|P3|NOT COMPLETED|Phase 3||0
404049|NCT00913458|964734|P2|NOT COMPLETED|Phase 3||0
404050|NCT00913458|964735|P1|NOT COMPLETED|Phase 3||0
404051|NCT00913458|964729|P7|COMPLETED|Phase 3||24
404052|NCT00913458|964730|P6|COMPLETED|Phase 3||28
404053|NCT00913458|964731|P5|COMPLETED|Phase 3||31
404054|NCT00913458|964732|P4|COMPLETED|Phase 3||0
404055|NCT00913458|964733|P3|COMPLETED|Phase 3||0
404056|NCT00913458|964734|P2|COMPLETED|Phase 3||0
404057|NCT00913458|964735|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
404058|NCT00913458|964729|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
404059|NCT00913458|964730|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
404060|NCT00913458|964731|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
404061|NCT00913458|964732|P4|STARTED|Phase 3||0
404062|NCT00913458|964733|P3|STARTED|Phase 3||0
404063|NCT00913458|964734|P2|STARTED|Phase 3||0
404064|NCT00913458|964735|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
404065|NCT00913458|964729|P7|NOT COMPLETED|Phase 2||0
404066|NCT00913458|964730|P6|NOT COMPLETED|Phase 2||0
404067|NCT00913458|964731|P5|NOT COMPLETED|Phase 2||0
404068|NCT00913458|964732|P4|NOT COMPLETED|Phase 2||33
404069|NCT00913458|964733|P3|NOT COMPLETED|Phase 2||19
404070|NCT00913458|964734|P2|NOT COMPLETED|Phase 2||10
404071|NCT00913458|964735|P1|NOT COMPLETED|Phase 2||0
404072|NCT00913458|964729|P7|COMPLETED|Phase 2||0
404073|NCT00913458|964730|P6|COMPLETED|Phase 2||0
404074|NCT00913458|964731|P5|COMPLETED|Phase 2||0
404075|NCT00913458|964732|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
404076|NCT00913458|964733|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
404077|NCT00913458|964734|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
404078|NCT00913458|964735|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
404079|NCT00913458|964729|P7|STARTED|Phase 2||0
404080|NCT00913458|964730|P6|STARTED|Phase 2||0
404081|NCT00913458|964731|P5|STARTED|Phase 2||0
404082|NCT00913458|964732|P4|STARTED|Phase 2||65
404083|NCT00913458|964733|P3|STARTED|Phase 2||65
404084|NCT00913458|964734|P2|STARTED|Phase 2||63
404085|NCT00913458|964735|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
404086|NCT00913458|964729|P7|NOT COMPLETED|Phase 1||0
404087|NCT00913458|964730|P6|NOT COMPLETED|Phase 1||0
404088|NCT00913458|964731|P5|NOT COMPLETED|Phase 1||0
404089|NCT00913458|964732|P4|NOT COMPLETED|Phase 1||0
404090|NCT00913458|964733|P3|NOT COMPLETED|Phase 1||0
404091|NCT00913458|964734|P2|NOT COMPLETED|Phase 1||0
404092|NCT00913458|964735|P1|NOT COMPLETED|Phase 1||112
404093|NCT00913458|964729|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
404094|NCT00913458|964730|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
404095|NCT00913458|964731|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
404096|NCT00913458|964732|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
404097|NCT00913458|964733|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
404098|NCT00913458|964734|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
404099|NCT00913458|964735|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
404100|NCT00913458|964729|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
404101|NCT00913458|964730|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
404102|NCT00913458|964731|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
404103|NCT00913458|964732|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
404104|NCT00913458|964733|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
404105|NCT00913458|964734|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
404106|NCT00913458|964735|P1|STARTED|Phase 1||306
404107|NCT00913380|964828|P2|NOT COMPLETED|Clinical Outcomes||6
404108|NCT00913380|964829|P1|NOT COMPLETED|Clinical Outcomes||6
404109|NCT00913380|964828|P2|COMPLETED|Clinical Outcomes||441
404110|NCT00913380|964829|P1|COMPLETED|Clinical Outcomes||438
404111|NCT00913380|964828|P2|STARTED|Clinical Outcomes||447
404112|NCT00913380|964829|P1|STARTED|Clinical Outcomes||444
404113|NCT00913380|964828|P2|NOT COMPLETED|CT Examination||0
404114|NCT00913380|964829|P1|NOT COMPLETED|CT Examination||0
404115|NCT00913380|964828|P2|COMPLETED|CT Examination||447
404116|NCT00913380|964829|P1|COMPLETED|CT Examination||444
404117|NCT00913380|964828|P2|STARTED|CT Examination||447
404118|NCT00913380|964829|P1|STARTED|CT Examination||444
404119|NCT00913263|964855|P1|NOT COMPLETED|Overall Study||0
404120|NCT00913263|964855|P1|COMPLETED|Overall Study||24
404121|NCT00913263|964855|P1|STARTED|Overall Study||24
404122|NCT00913133|964864|P1|NOT COMPLETED|Overall Study||0
404123|NCT00913133|964864|P1|COMPLETED|Overall Study||516
404124|NCT00913133|964864|P1|STARTED|Overall Study||516
404125|NCT00913081|964869|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
404126|NCT00913081|964869|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
404127|NCT00913081|964869|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
404128|NCT00913081|964869|P1|NOT COMPLETED|Washout #3 (7days)||0
404129|NCT00913081|964869|P1|COMPLETED|Washout #3 (7days)||17
404130|NCT00913081|964869|P1|STARTED|Washout #3 (7days)||17
404131|NCT00913081|964869|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
404132|NCT00913081|964869|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
404133|NCT00913081|964869|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
404134|NCT00913081|964869|P1|NOT COMPLETED|Washout #2 (7 Days)||0
404135|NCT00913081|964869|P1|COMPLETED|Washout #2 (7 Days)||17
404136|NCT00913081|964869|P1|STARTED|Washout #2 (7 Days)||17
404137|NCT00913081|964869|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
404138|NCT00913081|964869|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
404139|NCT00913081|964869|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
404140|NCT00913081|964869|P1|NOT COMPLETED|Washout #1 (7 Days)||0
404141|NCT00913081|964869|P1|COMPLETED|Washout #1 (7 Days)||17
404142|NCT00913081|964869|P1|STARTED|Washout #1 (7 Days)||17
404143|NCT00913081|964869|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
404144|NCT00913081|964869|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
404145|NCT00913081|964869|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
404146|NCT00913003|964881|P2|NOT COMPLETED|Overall Study||0
404147|NCT00913003|964882|P1|NOT COMPLETED|Overall Study||0
404148|NCT00913003|964881|P2|COMPLETED|Overall Study||11
404149|NCT00913003|964882|P1|COMPLETED|Overall Study||11
404150|NCT00913003|964881|P2|STARTED|Overall Study||11
404151|NCT00913003|964882|P1|STARTED|Overall Study||11
404152|NCT00912964|964895|P3|NOT COMPLETED|Overall Study||54
404153|NCT00912964|964896|P2|NOT COMPLETED|Overall Study||46
404154|NCT00912964|964897|P1|NOT COMPLETED|Overall Study||66
404155|NCT00912964|964895|P3|COMPLETED|Overall Study||386
404156|NCT00912964|964896|P2|COMPLETED|Overall Study||387
404157|NCT00912964|964897|P1|COMPLETED|Overall Study||367
404158|NCT00912964|964895|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
404159|NCT00912964|964896|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
404160|NCT00912964|964897|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
404161|NCT00912964|964895|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
404162|NCT00912964|964896|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
404163|NCT00912964|964897|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
404164|NCT00912964|964895|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
404165|NCT00912964|964896|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
404166|NCT00912964|964897|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
404167|NCT00912964|964895|P3|STARTED|Overall Study||440
404168|NCT00912964|964896|P2|STARTED|Overall Study||433
404169|NCT00912964|964897|P1|STARTED|Overall Study||433
404170|NCT00912925|965021|P2|NOT COMPLETED|Overall Study||0
404171|NCT00912925|965022|P1|NOT COMPLETED|Overall Study||0
404172|NCT00912925|965021|P2|COMPLETED|Overall Study||22
404173|NCT00912925|965022|P1|COMPLETED|Overall Study||23
404174|NCT00912925|965021|P2|STARTED|Overall Study||22
404175|NCT00912925|965022|P1|STARTED|Overall Study||23
404176|NCT00912912|965040|P1|NOT COMPLETED|Overall Study||4
404177|NCT00912912|965040|P1|COMPLETED|Overall Study||1
404178|NCT00912912|965040|P1|STARTED|Overall Study||5
404179|NCT00912808|965046|P2|NOT COMPLETED|Overall Study||1
404180|NCT00912808|965047|P1|NOT COMPLETED|Overall Study||3
404181|NCT00912808|965046|P2|COMPLETED|Overall Study||11
404182|NCT00912808|965047|P1|COMPLETED|Overall Study||8
404183|NCT00912808|965046|P2|STARTED|Overall Study||12
404184|NCT00912808|965047|P1|STARTED|Overall Study||11
404185|NCT00912795|965057|P2|NOT COMPLETED|Overall Study||58
404186|NCT00912795|965058|P1|NOT COMPLETED|Overall Study||47
404187|NCT00912795|965057|P2|COMPLETED|Overall Study||17
404188|NCT00912795|965058|P1|COMPLETED|Overall Study||29
404189|NCT00912795|965057|P2|STARTED|Overall Study||75
404190|NCT00912795|965058|P1|STARTED|Overall Study||76
404191|NCT00912782|965072|P2|NOT COMPLETED|Overall Study||5
404192|NCT00912782|965073|P1|NOT COMPLETED|Overall Study||3
404193|NCT00912782|965072|P2|COMPLETED|Overall Study||20
404194|NCT00912782|965073|P1|COMPLETED|Overall Study||24
404195|NCT00912782|965072|P2|STARTED|Overall Study||25
404196|NCT00912782|965073|P1|STARTED|Overall Study||27
404197|NCT00912743|965083|P2|NOT COMPLETED|Overall Study||20
404198|NCT00912743|965084|P1|NOT COMPLETED|Overall Study||13
404199|NCT00912743|965083|P2|COMPLETED|Overall Study||0
404200|NCT00912743|965084|P1|COMPLETED|Overall Study||0
404201|NCT00912743|965083|P2|STARTED|Overall Study||20
404202|NCT00912743|965084|P1|STARTED|Overall Study||13
404203|NCT00912509|965096|P2|NOT COMPLETED|Overall Study||3
404204|NCT00912509|965097|P1|NOT COMPLETED|Overall Study||5
404205|NCT00912509|965096|P2|COMPLETED|Overall Study||7
404206|NCT00912509|965097|P1|COMPLETED|Overall Study||15
404207|NCT00912509|965096|P2|STARTED|Overall Study||10
404208|NCT00912509|965097|P1|STARTED|Overall Study||20
404209|NCT00912405|965103|P1|NOT COMPLETED|Overall Study||5
404210|NCT00912405|965103|P1|COMPLETED|Overall Study||45
404211|NCT00912405|965103|P1|STARTED|Overall Study||50
404212|NCT00912301|965113|P3|NOT COMPLETED|Overall Study||0
404213|NCT00912301|965114|P2|NOT COMPLETED|Overall Study||0
404214|NCT00912301|965115|P1|NOT COMPLETED|Overall Study||0
404215|NCT00912301|965113|P3|COMPLETED|Overall Study||13
404216|NCT00912301|965114|P2|COMPLETED|Overall Study||12
404217|NCT00912301|965115|P1|COMPLETED|Overall Study||11
404218|NCT00912301|965113|P3|STARTED|Overall Study||13
404219|NCT00912301|965114|P2|STARTED|Overall Study||12
404220|NCT00912301|965115|P1|STARTED|Overall Study||11
404221|NCT00912288|965137|P2|NOT COMPLETED|Overall Study||40
404222|NCT00912288|965138|P1|NOT COMPLETED|Overall Study||41
404223|NCT00912288|965137|P2|COMPLETED|Overall Study||2
404224|NCT00912288|965138|P1|COMPLETED|Overall Study||3
404225|NCT00912288|965137|P2|STARTED|Overall Study||42
404226|NCT00912288|965138|P1|STARTED|Overall Study||44
404227|NCT00912223|965160|P1|NOT COMPLETED|Overall Study||3
404228|NCT00912223|965160|P1|COMPLETED|Overall Study||62
404229|NCT00912223|965160|P1|STARTED|Overall Study||65
404230|NCT00912158|965179|P3|NOT COMPLETED|Overall Study||0
404231|NCT00912158|965180|P2|NOT COMPLETED|Overall Study||0
404232|NCT00912158|965181|P1|NOT COMPLETED|Overall Study||0
404233|NCT00912158|965179|P3|COMPLETED|Overall Study||41
404234|NCT00912158|965180|P2|COMPLETED|Overall Study||44
404235|NCT00912158|965181|P1|COMPLETED|Overall Study||44
404236|NCT00912158|965179|P3|STARTED|Overall Study||41
404237|NCT00912158|965180|P2|STARTED|Overall Study||44
404238|NCT00912158|965181|P1|STARTED|Overall Study||44
404239|NCT00912093|965191|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
404240|NCT00912093|965192|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
404241|NCT00912093|965193|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
404242|NCT00912093|965194|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
404243|NCT00912093|965195|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
404244|NCT00912093|965191|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
404245|NCT00912093|965192|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
404246|NCT00912093|965193|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
404247|NCT00912093|965194|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
404248|NCT00912093|965195|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
404249|NCT00912093|965191|P5|STARTED|The Open Label Extension (OLE) Phase||4
404250|NCT00912093|965192|P4|STARTED|The Open Label Extension (OLE) Phase||2
404251|NCT00912093|965193|P3|STARTED|The Open Label Extension (OLE) Phase||3
404252|NCT00912093|965194|P2|STARTED|The Open Label Extension (OLE) Phase||35
404253|NCT00912093|965195|P1|STARTED|The Open Label Extension (OLE) Phase||38
404254|NCT00912093|965191|P5|NOT COMPLETED|The Controlled Phase||1
404255|NCT00912093|965192|P4|NOT COMPLETED|The Controlled Phase||0
404256|NCT00912093|965193|P3|NOT COMPLETED|The Controlled Phase||0
404257|NCT00912093|965194|P2|NOT COMPLETED|The Controlled Phase||2
404258|NCT00912093|965195|P1|NOT COMPLETED|The Controlled Phase||0
404259|NCT00912093|965191|P5|COMPLETED|The Controlled Phase||4
404260|NCT00912093|965192|P4|COMPLETED|The Controlled Phase||2
404261|NCT00912093|965193|P3|COMPLETED|The Controlled Phase||3
404262|NCT00912093|965194|P2|COMPLETED|The Controlled Phase||43
404263|NCT00912093|965195|P1|COMPLETED|The Controlled Phase||43
404264|NCT00912093|965191|P5|STARTED|The Controlled Phase||5
404265|NCT00912093|965192|P4|STARTED|The Controlled Phase||2
404266|NCT00912093|965193|P3|STARTED|The Controlled Phase||3
404267|NCT00912093|965194|P2|STARTED|The Controlled Phase||45
404268|NCT00912093|965195|P1|STARTED|The Controlled Phase||43
404269|NCT00912028|965214|P5|NOT COMPLETED|Overall Study||3
404270|NCT00912028|965215|P4|NOT COMPLETED|Overall Study||1
404271|NCT00912028|965216|P3|NOT COMPLETED|Overall Study||0
404272|NCT00912028|965217|P2|NOT COMPLETED|Overall Study||3
404273|NCT00912028|965218|P1|NOT COMPLETED|Overall Study||5
404274|NCT00912028|965214|P5|COMPLETED|Overall Study||0
404275|NCT00912028|965215|P4|COMPLETED|Overall Study||16
404276|NCT00912028|965216|P3|COMPLETED|Overall Study||13
404277|NCT00912028|965217|P2|COMPLETED|Overall Study||0
404278|NCT00912028|965218|P1|COMPLETED|Overall Study||30
404279|NCT00912028|965214|P5|STARTED|Overall Study||3
404280|NCT00912028|965215|P4|STARTED|Overall Study||17
404281|NCT00912028|965216|P3|STARTED|Overall Study||13
404282|NCT00912028|965217|P2|STARTED|Overall Study||3
404283|NCT00912028|965218|P1|STARTED|Overall Study||35
404284|NCT00912015|965247|P4|NOT COMPLETED|Overall Study||2
404285|NCT00912015|965248|P3|NOT COMPLETED|Overall Study||3
404286|NCT00912015|965249|P2|NOT COMPLETED|Overall Study||8
404287|NCT00912015|965250|P1|NOT COMPLETED|Overall Study||16
404288|NCT00912015|965247|P4|COMPLETED|Overall Study||0
404289|NCT00912015|965248|P3|COMPLETED|Overall Study||22
404290|NCT00912015|965249|P2|COMPLETED|Overall Study||62
404291|NCT00912015|965250|P1|COMPLETED|Overall Study||125
404292|NCT00912015|965247|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
404293|NCT00912015|965248|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
404294|NCT00912015|965249|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
404295|NCT00912015|965250|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
404296|NCT00912002|965260|P1|NOT COMPLETED|Overall Study||0
404297|NCT00912002|965260|P1|COMPLETED|Overall Study||6
404298|NCT00912002|965260|P1|STARTED|Overall Study||6
404299|NCT00911989|965266|P1|NOT COMPLETED|Overall Study||1
404300|NCT00911989|965266|P1|COMPLETED|Overall Study||3
404301|NCT00911989|965266|P1|STARTED|Overall Study||4
404302|NCT00911937|965272|P2|NOT COMPLETED|Overall Study||95
404303|NCT00911937|965273|P1|NOT COMPLETED|Overall Study||87
404304|NCT00911937|965272|P2|COMPLETED|Overall Study||381
404305|NCT00911937|965273|P1|COMPLETED|Overall Study||400
404306|NCT00911937|965272|P2|Treated|Overall Study||463
404307|NCT00911937|965273|P1|Treated|Overall Study||474
404308|NCT00911937|965272|P2|STARTED|Overall Study||476
404309|NCT00911937|965273|P1|STARTED|Overall Study||487
404310|NCT00911898|965333|P1|NOT COMPLETED|Overall Study||0
404311|NCT00911898|965333|P1|COMPLETED|Overall Study||20
404312|NCT00911898|965333|P1|STARTED|Overall Study||20
404313|NCT00911859|965340|P3|NOT COMPLETED|Follow-up Period||41
404314|NCT00911859|965341|P2|NOT COMPLETED|Follow-up Period||46
404315|NCT00911859|965342|P1|NOT COMPLETED|Follow-up Period||11
404316|NCT00911859|965340|P3|COMPLETED|Follow-up Period||11
404317|NCT00911859|965341|P2|COMPLETED|Follow-up Period||7
404318|NCT00911859|965342|P1|COMPLETED|Follow-up Period||1
404319|NCT00911859|965340|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
404320|NCT00911859|965341|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
404321|NCT00911859|965342|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
404322|NCT00911859|965340|P3|NOT COMPLETED|Maintainance Period||21
404323|NCT00911859|965341|P2|NOT COMPLETED|Maintainance Period||0
404324|NCT00911859|965342|P1|NOT COMPLETED|Maintainance Period||0
404325|NCT00911859|965340|P3|COMPLETED|Maintainance Period||0
404326|NCT00911859|965341|P2|COMPLETED|Maintainance Period||0
404327|NCT00911859|965342|P1|COMPLETED|Maintainance Period||0
404328|NCT00911859|965340|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
404329|NCT00911859|965341|P2|STARTED|Maintainance Period||0
404330|NCT00911859|965342|P1|STARTED|Maintainance Period||0
404331|NCT00911859|965340|P3|NOT COMPLETED|Treatment Period||25
404332|NCT00911859|965341|P2|NOT COMPLETED|Treatment Period||21
404333|NCT00911859|965342|P1|NOT COMPLETED|Treatment Period||8
404334|NCT00911859|965340|P3|COMPLETED|Treatment Period||27
404335|NCT00911859|965341|P2|COMPLETED|Treatment Period||33
404336|NCT00911859|965342|P1|COMPLETED|Treatment Period||4
404337|NCT00911859|965340|P3|Received Treatment|Treatment Period||52
404338|NCT00911859|965341|P2|Received Treatment|Treatment Period||53
404339|NCT00911859|965342|P1|Received Treatment|Treatment Period||12
404340|NCT00911859|965340|P3|STARTED|Treatment Period||52
404341|NCT00911859|965341|P2|STARTED|Treatment Period||54
404342|NCT00911859|965342|P1|STARTED|Treatment Period||12
404343|NCT00911807|965369|P3|NOT COMPLETED|Overall Study||23
404344|NCT00911807|965370|P2|NOT COMPLETED|Overall Study||18
404345|NCT00911807|965371|P1|NOT COMPLETED|Overall Study||17
404346|NCT00911807|965369|P3|COMPLETED|Overall Study||52
404347|NCT00911807|965370|P2|COMPLETED|Overall Study||52
404348|NCT00911807|965371|P1|COMPLETED|Overall Study||55
404349|NCT00911807|965369|P3|STARTED|Overall Study||75
404350|NCT00911807|965370|P2|STARTED|Overall Study||70
404351|NCT00911807|965371|P1|STARTED|Overall Study||72
404352|NCT00911768|965381|P2|NOT COMPLETED|Overall Study||4
404353|NCT00911768|965382|P1|NOT COMPLETED|Overall Study||6
404354|NCT00911768|965381|P2|COMPLETED|Overall Study||46
404355|NCT00911768|965382|P1|COMPLETED|Overall Study||44
404356|NCT00911768|965381|P2|STARTED|Overall Study||50
404357|NCT00911768|965382|P1|STARTED|Overall Study||50
404358|NCT00911742|965394|P2|NOT COMPLETED|Treatment Phase II||0
404359|NCT00911742|965395|P1|NOT COMPLETED|Treatment Phase II||0
404360|NCT00911742|965394|P2|COMPLETED|Treatment Phase II||13
404361|NCT00911742|965395|P1|COMPLETED|Treatment Phase II||13
404362|NCT00911742|965394|P2|STARTED|Treatment Phase II||13
404363|NCT00911742|965395|P1|STARTED|Treatment Phase II||13
404364|NCT00911742|965394|P2|NOT COMPLETED|Treatment Phase I||0
404365|NCT00911742|965395|P1|NOT COMPLETED|Treatment Phase I||0
404366|NCT00911742|965394|P2|COMPLETED|Treatment Phase I||13
404367|NCT00911742|965395|P1|COMPLETED|Treatment Phase I||13
404368|NCT00911742|965394|P2|STARTED|Treatment Phase I||13
404369|NCT00911742|965395|P1|STARTED|Treatment Phase I||13
404370|NCT00911625|965411|P2|NOT COMPLETED|Overall Study||0
404371|NCT00911625|965412|P1|NOT COMPLETED|Overall Study||7
404372|NCT00911625|965411|P2|COMPLETED|Overall Study||57
404373|NCT00911625|965412|P1|COMPLETED|Overall Study||50
404374|NCT00911625|965411|P2|STARTED|Overall Study||57
404375|NCT00911625|965412|P1|STARTED|Overall Study||57
404376|NCT00911612|965422|P2|NOT COMPLETED|Overall Study||0
404377|NCT00911612|965423|P1|NOT COMPLETED|Overall Study||0
404378|NCT00911612|965422|P2|COMPLETED|Overall Study||12
404379|NCT00911612|965423|P1|COMPLETED|Overall Study||12
404380|NCT00911612|965422|P2|STARTED|Overall Study||12
404381|NCT00911612|965423|P1|STARTED|Overall Study||12
404382|NCT00911547|965441|P4|NOT COMPLETED|Overall Study||16
404383|NCT00911547|965442|P3|NOT COMPLETED|Overall Study||22
404384|NCT00911547|965443|P2|NOT COMPLETED|Overall Study||42
404385|NCT00911547|965444|P1|NOT COMPLETED|Overall Study||11
404386|NCT00911547|965441|P4|COMPLETED|Overall Study||177
404387|NCT00911547|965442|P3|COMPLETED|Overall Study||178
404388|NCT00911547|965443|P2|COMPLETED|Overall Study||159
404389|NCT00911547|965444|P1|COMPLETED|Overall Study||37
404390|NCT00911547|965441|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
404391|NCT00911547|965442|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
404392|NCT00911547|965443|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
404393|NCT00911547|965444|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
404394|NCT00911534|965472|P2|NOT COMPLETED|Overall Study||16
404395|NCT00911534|965473|P1|NOT COMPLETED|Overall Study||15
404396|NCT00911534|965472|P2|COMPLETED|Overall Study||137
404397|NCT00911534|965473|P1|COMPLETED|Overall Study||132
404398|NCT00911534|965472|P2|STARTED|Overall Study|Randomized (treated)|153
404399|NCT00911534|965473|P1|STARTED|Overall Study|Randomized (treated)|147
404400|NCT00911495|965485|P1|NOT COMPLETED|Overall Study||1
404401|NCT00911495|965485|P1|COMPLETED|Overall Study||14
404402|NCT00911495|965485|P1|STARTED|Overall Study||15
404403|NCT00911443|965498|P5|NOT COMPLETED|Overall Study||0
404404|NCT00911443|965499|P4|NOT COMPLETED|Overall Study||0
404405|NCT00911443|965500|P3|NOT COMPLETED|Overall Study||0
404406|NCT00911443|965501|P2|NOT COMPLETED|Overall Study||0
404407|NCT00911443|965502|P1|NOT COMPLETED|Overall Study||0
404408|NCT00911443|965498|P5|COMPLETED|Overall Study||97
404409|NCT00911443|965499|P4|COMPLETED|Overall Study||99
404410|NCT00911443|965500|P3|COMPLETED|Overall Study||98
404411|NCT00911443|965501|P2|COMPLETED|Overall Study||97
404412|NCT00911443|965502|P1|COMPLETED|Overall Study||97
404413|NCT00911443|965498|P5|STARTED|Overall Study||97
404414|NCT00911443|965499|P4|STARTED|Overall Study||99
404415|NCT00911443|965500|P3|STARTED|Overall Study||98
404416|NCT00911443|965501|P2|STARTED|Overall Study||97
404417|NCT00911443|965502|P1|STARTED|Overall Study||97
404418|NCT00911326|965519|P1|NOT COMPLETED|Overall Study||16
404419|NCT00911326|965519|P1|COMPLETED|Overall Study||85
404420|NCT00911326|965519|P1|STARTED|Overall Study||101
404421|NCT00911300|965528|P2|NOT COMPLETED|Overall Study||43
404422|NCT00911300|965529|P1|NOT COMPLETED|Overall Study||35
404423|NCT00911300|965528|P2|COMPLETED|Overall Study||131
404424|NCT00911300|965529|P1|COMPLETED|Overall Study||140
404425|NCT00911300|965528|P2|STARTED|Overall Study||174
404426|NCT00911300|965529|P1|STARTED|Overall Study||175
404427|NCT00911274|965555|P2|NOT COMPLETED|Period 2||0
404428|NCT00911274|965556|P1|NOT COMPLETED|Period 2||0
404429|NCT00911274|965555|P2|COMPLETED|Period 2||26
404430|NCT00911274|965556|P1|COMPLETED|Period 2||27
404431|NCT00911274|965555|P2|STARTED|Period 2||26
404432|NCT00911274|965556|P1|STARTED|Period 2||27
404433|NCT00911274|965555|P2|NOT COMPLETED|Period 1||0
404434|NCT00911274|965556|P1|NOT COMPLETED|Period 1||0
404435|NCT00911274|965555|P2|COMPLETED|Period 1||26
404436|NCT00911274|965556|P1|COMPLETED|Period 1||27
404437|NCT00911274|965555|P2|STARTED|Period 1||26
404438|NCT00911274|965556|P1|STARTED|Period 1||27
404439|NCT00911170|965566|P2|NOT COMPLETED|Long Term Follow-Up||422
404440|NCT00911170|965567|P1|NOT COMPLETED|Long Term Follow-Up||423
404441|NCT00911170|965566|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
404442|NCT00911170|965567|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
404443|NCT00911170|965566|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
404444|NCT00911170|965567|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
404445|NCT00911170|965566|P2|NOT COMPLETED|Treatment Period||37
404446|NCT00911170|965567|P1|NOT COMPLETED|Treatment Period||27
404447|NCT00911170|965566|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
404448|NCT00911170|965567|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
404449|NCT00911170|965566|P2|Received Investigational Product|Treatment Period||419
404450|NCT00911170|965567|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
404451|NCT00911170|965566|P2|Received Bevacizumab|Treatment Period||420
404452|NCT00911170|965567|P1|Received Bevacizumab|Treatment Period||423
404453|NCT00911170|965566|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
404454|NCT00911170|965567|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
404455|NCT00911170|965566|P2|STARTED|Treatment Period||423
404456|NCT00911170|965567|P1|STARTED|Treatment Period||424
404457|NCT00911157|965591|P2|NOT COMPLETED|Overall Study||2
404458|NCT00911157|965592|P1|NOT COMPLETED|Overall Study||7
404459|NCT00911157|965591|P2|COMPLETED|Overall Study||8
404460|NCT00911157|965592|P1|COMPLETED|Overall Study||22
404461|NCT00911157|965591|P2|STARTED|Overall Study||10
404462|NCT00911157|965592|P1|STARTED|Overall Study||29
404463|NCT00911144|965608|P2|NOT COMPLETED|Overall Study||5
404464|NCT00911144|965609|P1|NOT COMPLETED|Overall Study||16
404465|NCT00911144|965608|P2|COMPLETED|Overall Study||108
404466|NCT00911144|965609|P1|COMPLETED|Overall Study||319
404467|NCT00911144|965608|P2|STARTED|Overall Study||113
404468|NCT00911144|965609|P1|STARTED|Overall Study||335
404469|NCT00910988|965637|P4|NOT COMPLETED|Overall Study||0
404470|NCT00910988|965638|P3|NOT COMPLETED|Overall Study||3
404471|NCT00910988|965639|P2|NOT COMPLETED|Overall Study||4
404472|NCT00910988|965640|P1|NOT COMPLETED|Overall Study||2
404473|NCT00910988|965637|P4|COMPLETED|Overall Study||6
404474|NCT00910988|965638|P3|COMPLETED|Overall Study||5
404475|NCT00910988|965639|P2|COMPLETED|Overall Study||12
404476|NCT00910988|965640|P1|COMPLETED|Overall Study||14
404477|NCT00910988|965637|P4|STARTED|Overall Study||6
404478|NCT00910988|965638|P3|STARTED|Overall Study||8
404479|NCT00910988|965639|P2|STARTED|Overall Study||16
404480|NCT00910988|965640|P1|STARTED|Overall Study||16
404481|NCT00910910|965684|P2|NOT COMPLETED|Overall Study||224
404482|NCT00910910|965685|P1|NOT COMPLETED|Overall Study||225
404483|NCT00910910|965684|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
404484|NCT00910910|965685|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
404485|NCT00910910|965684|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
404486|NCT00910910|965685|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
404487|NCT00910910|965684|P2|STARTED|Overall Study||225
404488|NCT00910910|965685|P1|STARTED|Overall Study||225
404489|NCT00910871|965719|P1|NOT COMPLETED|Overall Study||54
404490|NCT00910871|965719|P1|COMPLETED|Overall Study||179
404491|NCT00910871|965719|P1|STARTED|Overall Study||233
404492|NCT00910858|965727|P3|NOT COMPLETED|Combined Treatment Phase||4
404493|NCT00910858|965728|P2|NOT COMPLETED|Combined Treatment Phase||10
404494|NCT00910858|965729|P1|NOT COMPLETED|Combined Treatment Phase||9
404495|NCT00910858|965727|P3|COMPLETED|Combined Treatment Phase||0
404496|NCT00910858|965728|P2|COMPLETED|Combined Treatment Phase||0
404497|NCT00910858|965729|P1|COMPLETED|Combined Treatment Phase||0
404498|NCT00910858|965727|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
404499|NCT00910858|965728|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
404500|NCT00910858|965729|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
404501|NCT00910858|965727|P3|NOT COMPLETED|Monotherapy Phase||7
404502|NCT00910858|965728|P2|NOT COMPLETED|Monotherapy Phase||15
404503|NCT00910858|965729|P1|NOT COMPLETED|Monotherapy Phase||17
404504|NCT00910858|965727|P3|COMPLETED|Monotherapy Phase||0
404505|NCT00910858|965728|P2|COMPLETED|Monotherapy Phase||0
404506|NCT00910858|965729|P1|COMPLETED|Monotherapy Phase||0
404507|NCT00910858|965727|P3|Pharmacokinetic Population|Monotherapy Phase||7
404508|NCT00910858|965728|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
404509|NCT00910858|965729|P1|Pharmacokinetic Population|Monotherapy Phase||17
404510|NCT00910858|965727|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
404511|NCT00910858|965728|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
404512|NCT00910858|965729|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
404513|NCT00910858|965727|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
404514|NCT00910858|965728|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
404515|NCT00910858|965729|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
404516|NCT00910858|965727|P3|NOT COMPLETED|Pharmacokinetic Phase||0
404517|NCT00910858|965728|P2|NOT COMPLETED|Pharmacokinetic Phase||0
404518|NCT00910858|965729|P1|NOT COMPLETED|Pharmacokinetic Phase||1
404519|NCT00910858|965727|P3|COMPLETED|Pharmacokinetic Phase||3
404520|NCT00910858|965728|P2|COMPLETED|Pharmacokinetic Phase||0
404521|NCT00910858|965729|P1|COMPLETED|Pharmacokinetic Phase||8
404522|NCT00910858|965727|P3|STARTED|Pharmacokinetic Phase||3
404523|NCT00910858|965728|P2|STARTED|Pharmacokinetic Phase||0
404524|NCT00910858|965729|P1|STARTED|Pharmacokinetic Phase||9
404525|NCT00910845|965754|P2|NOT COMPLETED|Treatment Cycle 2||9
404526|NCT00910845|965755|P1|NOT COMPLETED|Treatment Cycle 2||5
404527|NCT00910845|965754|P2|COMPLETED|Treatment Cycle 2||203
404528|NCT00910845|965755|P1|COMPLETED|Treatment Cycle 2||136
404529|NCT00910845|965754|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
404530|NCT00910845|965755|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
404531|NCT00910845|965754|P2|NOT COMPLETED|Treatment Cycle 1||34
404532|NCT00910845|965755|P1|NOT COMPLETED|Treatment Cycle 1||31
404533|NCT00910845|965754|P2|COMPLETED|Treatment Cycle 1||243
404534|NCT00910845|965755|P1|COMPLETED|Treatment Cycle 1||249
404535|NCT00910845|965754|P2|STARTED|Treatment Cycle 1||277
404536|NCT00910845|965755|P1|STARTED|Treatment Cycle 1||280
404537|NCT00910728|965774|P9|NOT COMPLETED|Overall Study||3
404538|NCT00910728|965775|P8|NOT COMPLETED|Overall Study||3
404539|NCT00910728|965776|P7|NOT COMPLETED|Overall Study||6
404540|NCT00910728|965777|P6|NOT COMPLETED|Overall Study||1
404541|NCT00910728|965778|P5|NOT COMPLETED|Overall Study||5
404542|NCT00910728|965779|P4|NOT COMPLETED|Overall Study||3
404543|NCT00910728|965780|P3|NOT COMPLETED|Overall Study||3
404544|NCT00910728|965781|P2|NOT COMPLETED|Overall Study||3
404545|NCT00910728|965782|P1|NOT COMPLETED|Overall Study||6
404546|NCT00910728|965774|P9|COMPLETED|Overall Study||0
404547|NCT00910728|965775|P8|COMPLETED|Overall Study||1
404548|NCT00910728|965776|P7|COMPLETED|Overall Study||0
404549|NCT00910728|965777|P6|COMPLETED|Overall Study||0
404550|NCT00910728|965778|P5|COMPLETED|Overall Study||1
404551|NCT00910728|965779|P4|COMPLETED|Overall Study||0
404552|NCT00910728|965780|P3|COMPLETED|Overall Study||0
404553|NCT00910728|965781|P2|COMPLETED|Overall Study||0
404554|NCT00910728|965782|P1|COMPLETED|Overall Study||0
404555|NCT00910728|965774|P9|STARTED|Overall Study||3
404556|NCT00910728|965775|P8|STARTED|Overall Study||4
404557|NCT00910728|965776|P7|STARTED|Overall Study||6
404558|NCT00910728|965777|P6|STARTED|Overall Study||1
404559|NCT00910728|965778|P5|STARTED|Overall Study||6
404560|NCT00910728|965779|P4|STARTED|Overall Study||3
404561|NCT00910728|965780|P3|STARTED|Overall Study||3
404562|NCT00910728|965781|P2|STARTED|Overall Study||3
404563|NCT00910728|965782|P1|STARTED|Overall Study||6
404564|NCT00910715|965904|P3|NOT COMPLETED|Overall Study||0
404565|NCT00910715|965905|P2|NOT COMPLETED|Overall Study||26
404566|NCT00910715|965906|P1|NOT COMPLETED|Overall Study||22
404567|NCT00910715|965904|P3|COMPLETED|Overall Study||81
404568|NCT00910715|965905|P2|COMPLETED|Overall Study||91
404569|NCT00910715|965906|P1|COMPLETED|Overall Study||86
404570|NCT00910715|965904|P3|STARTED|Overall Study||81
404571|NCT00910715|965905|P2|STARTED|Overall Study||117
404572|NCT00910715|965906|P1|STARTED|Overall Study||108
404573|NCT00910689|965920|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
404574|NCT00910689|965921|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
404575|NCT00910689|965922|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
404576|NCT00910689|965923|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
404577|NCT00910689|965920|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
404578|NCT00910689|965921|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
404579|NCT00910689|965922|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
404580|NCT00910689|965923|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
404581|NCT00910689|965920|P4|STARTED|Months 11- 16: Evaluation Period II||41
404582|NCT00910689|965921|P3|STARTED|Months 11- 16: Evaluation Period II||35
404583|NCT00910689|965922|P2|STARTED|Months 11- 16: Evaluation Period II||35
404584|NCT00910689|965923|P1|STARTED|Months 11- 16: Evaluation Period II||40
404585|NCT00910689|965920|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
404586|NCT00910689|965921|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
404587|NCT00910689|965922|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
404588|NCT00910689|965923|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
404589|NCT00910689|965920|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
404590|NCT00910689|965921|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
404591|NCT00910689|965922|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
404592|NCT00910689|965923|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
404593|NCT00910689|965920|P4|STARTED|Months 5 - 10: Evaluation Period I||48
404594|NCT00910689|965921|P3|STARTED|Months 5 - 10: Evaluation Period I||42
404595|NCT00910689|965922|P2|STARTED|Months 5 - 10: Evaluation Period I||42
404596|NCT00910689|965923|P1|STARTED|Months 5 - 10: Evaluation Period I||44
404597|NCT00910689|965920|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
404598|NCT00910689|965921|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
404599|NCT00910689|965922|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
404600|NCT00910689|965923|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
404601|NCT00910689|965920|P4|COMPLETED|Month 2- 4: Treatment Period||48
404602|NCT00910689|965921|P3|COMPLETED|Month 2- 4: Treatment Period||42
404603|NCT00910689|965922|P2|COMPLETED|Month 2- 4: Treatment Period||42
404604|NCT00910689|965923|P1|COMPLETED|Month 2- 4: Treatment Period||44
404605|NCT00910689|965920|P4|STARTED|Month 2- 4: Treatment Period||59
404606|NCT00910689|965921|P3|STARTED|Month 2- 4: Treatment Period||50
404607|NCT00910689|965922|P2|STARTED|Month 2- 4: Treatment Period||52
404608|NCT00910689|965923|P1|STARTED|Month 2- 4: Treatment Period||53
404609|NCT00910689|965920|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
404610|NCT00910689|965921|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
404611|NCT00910689|965922|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
404612|NCT00910689|965923|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
404613|NCT00910689|965920|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
404614|NCT00910689|965921|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
404615|NCT00910689|965922|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
404616|NCT00910689|965923|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
404617|NCT00910689|965920|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
404618|NCT00910689|965921|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
404619|NCT00910689|965922|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
404620|NCT00910689|965923|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
404621|NCT00910663|965955|P2|NOT COMPLETED|Period 2||0
404622|NCT00910663|965956|P1|NOT COMPLETED|Period 2||0
404623|NCT00910663|965955|P2|COMPLETED|Period 2||29
404624|NCT00910663|965956|P1|COMPLETED|Period 2||30
404625|NCT00910663|965955|P2|STARTED|Period 2||29
404626|NCT00910663|965956|P1|STARTED|Period 2||30
404627|NCT00910663|965955|P2|NOT COMPLETED|Period 1||1
404628|NCT00910663|965956|P1|NOT COMPLETED|Period 1||0
404629|NCT00910663|965955|P2|COMPLETED|Period 1||29
404630|NCT00910663|965956|P1|COMPLETED|Period 1||30
404631|NCT00910663|965955|P2|STARTED|Period 1||30
404632|NCT00910663|965956|P1|STARTED|Period 1||30
404633|NCT00910624|965970|P4|NOT COMPLETED|Follow-Up Phase||0
404634|NCT00910624|965971|P3|NOT COMPLETED|Follow-Up Phase||4
404635|NCT00910624|965972|P2|NOT COMPLETED|Follow-Up Phase||4
404636|NCT00910624|965973|P1|NOT COMPLETED|Follow-Up Phase||6
404637|NCT00910624|965970|P4|COMPLETED|Follow-Up Phase||2
404638|NCT00910624|965971|P3|COMPLETED|Follow-Up Phase||25
404639|NCT00910624|965972|P2|COMPLETED|Follow-Up Phase||76
404640|NCT00910624|965973|P1|COMPLETED|Follow-Up Phase||42
404641|NCT00910624|965970|P4|STARTED|Follow-Up Phase||2
404642|NCT00910624|965971|P3|STARTED|Follow-Up Phase||29
404643|NCT00910624|965972|P2|STARTED|Follow-Up Phase||80
404644|NCT00910624|965973|P1|STARTED|Follow-Up Phase||48
404645|NCT00910624|965970|P4|NOT COMPLETED|Treatment Phase||0
404646|NCT00910624|965971|P3|NOT COMPLETED|Treatment Phase||9
404647|NCT00910624|965972|P2|NOT COMPLETED|Treatment Phase||21
404648|NCT00910624|965973|P1|NOT COMPLETED|Treatment Phase||30
404649|NCT00910624|965970|P4|COMPLETED|Treatment Phase||2
404650|NCT00910624|965971|P3|COMPLETED|Treatment Phase||20
404651|NCT00910624|965972|P2|COMPLETED|Treatment Phase||64
404652|NCT00910624|965973|P1|COMPLETED|Treatment Phase||22
404653|NCT00910624|965970|P4|STARTED|Treatment Phase||2
404654|NCT00910624|965971|P3|STARTED|Treatment Phase||29
404655|NCT00910624|965972|P2|STARTED|Treatment Phase||85
404656|NCT00910624|965973|P1|STARTED|Treatment Phase||52
404657|NCT00910520|965987|P2|NOT COMPLETED|Treatment Cycle 2||8
404658|NCT00910520|965988|P1|NOT COMPLETED|Treatment Cycle 2||7
404659|NCT00910520|965987|P2|COMPLETED|Treatment Cycle 2||215
404660|NCT00910520|965988|P1|COMPLETED|Treatment Cycle 2||156
404661|NCT00910520|965987|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
404662|NCT00910520|965988|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
404663|NCT00910520|965987|P2|NOT COMPLETED|Treatment Cycle 1||24
404664|NCT00910520|965988|P1|NOT COMPLETED|Treatment Cycle 1||20
404665|NCT00910520|965987|P2|COMPLETED|Treatment Cycle 1||247
404666|NCT00910520|965988|P1|COMPLETED|Treatment Cycle 1||257
404667|NCT00910520|965987|P2|STARTED|Treatment Cycle 1||271
404668|NCT00910520|965988|P1|STARTED|Treatment Cycle 1||277
404669|NCT00910299|966000|P2|NOT COMPLETED|Overall Study||74
404670|NCT00910299|966001|P1|NOT COMPLETED|Overall Study||76
404671|NCT00910299|966000|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
404672|NCT00910299|966001|P1|COMPLETED|Overall Study||136
404673|NCT00910299|966000|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
404674|NCT00910299|966001|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
404675|NCT00910299|966000|P2|STARTED|Overall Study||211
404676|NCT00910299|966001|P1|STARTED|Overall Study||212
404677|NCT00910273|966013|P2|NOT COMPLETED|Overall Study||13
404678|NCT00910273|966014|P1|NOT COMPLETED|Overall Study||18
404679|NCT00910273|966013|P2|COMPLETED|Overall Study||3
404680|NCT00910273|966014|P1|COMPLETED|Overall Study||0
404681|NCT00910273|966013|P2|STARTED|Overall Study||16
404682|NCT00910273|966014|P1|STARTED|Overall Study||18
404683|NCT00910091|966066|P2|NOT COMPLETED|Treatment and Survival||4
404684|NCT00910091|966067|P1|NOT COMPLETED|Treatment and Survival||4
404685|NCT00910091|966066|P2|COMPLETED|Treatment and Survival||31
404686|NCT00910091|966067|P1|COMPLETED|Treatment and Survival||32
404687|NCT00910091|966066|P2|STARTED|Treatment and Survival||35
404688|NCT00910091|966067|P1|STARTED|Treatment and Survival||36
404689|NCT00910091|966066|P2|NOT COMPLETED|Pre-assignment||2
404690|NCT00910091|966067|P1|NOT COMPLETED|Pre-assignment||0
404691|NCT00910091|966066|P2|COMPLETED|Pre-assignment||35
404692|NCT00910091|966067|P1|COMPLETED|Pre-assignment||36
404693|NCT00910091|966066|P2|STARTED|Pre-assignment||37
404694|NCT00910091|966067|P1|STARTED|Pre-assignment||36
404695|NCT00910039|966095|P1|NOT COMPLETED|Overall Study||1
404696|NCT00910039|966095|P1|COMPLETED|Overall Study||13
404697|NCT00910039|966095|P1|STARTED|Overall Study||14
404698|NCT00910000|966112|P6|NOT COMPLETED|Overall Study||1
404699|NCT00910000|966113|P5|NOT COMPLETED|Overall Study||1
404700|NCT00910000|966114|P4|NOT COMPLETED|Overall Study||2
404701|NCT00910000|966115|P3|NOT COMPLETED|Overall Study||3
404702|NCT00910000|966116|P2|NOT COMPLETED|Overall Study||3
404703|NCT00910000|966117|P1|NOT COMPLETED|Overall Study||0
404704|NCT00910000|966112|P6|COMPLETED|Overall Study||0
404705|NCT00910000|966113|P5|COMPLETED|Overall Study||2
404706|NCT00910000|966114|P4|COMPLETED|Overall Study||0
404707|NCT00910000|966115|P3|COMPLETED|Overall Study||0
404708|NCT00910000|966116|P2|COMPLETED|Overall Study||0
404709|NCT00910000|966117|P1|COMPLETED|Overall Study||3
404710|NCT00910000|966112|P6|STARTED|Overall Study||1
404711|NCT00910000|966113|P5|STARTED|Overall Study||3
404712|NCT00910000|966114|P4|STARTED|Overall Study||2
404713|NCT00910000|966115|P3|STARTED|Overall Study||3
404714|NCT00910000|966116|P2|STARTED|Overall Study||3
404715|NCT00910000|966117|P1|STARTED|Overall Study||3
404716|NCT00909870|966135|P2|NOT COMPLETED|Overall Study||27
404717|NCT00909870|966136|P1|NOT COMPLETED|Overall Study||23
404718|NCT00909870|966135|P2|COMPLETED|Overall Study||236
404719|NCT00909870|966136|P1|COMPLETED|Overall Study||251
404720|NCT00909870|966135|P2|STARTED|Overall Study||263
404721|NCT00909870|966136|P1|STARTED|Overall Study||274
404722|NCT00909857|966148|P2|NOT COMPLETED|Overall Study||45
404723|NCT00909857|966149|P1|NOT COMPLETED|Overall Study||36
404724|NCT00909857|966148|P2|COMPLETED|Overall Study||209
404725|NCT00909857|966149|P1|COMPLETED|Overall Study||217
404726|NCT00909857|966148|P2|Treated|Overall Study||230
404727|NCT00909857|966149|P1|Treated|Overall Study||234
404728|NCT00909857|966148|P2|STARTED|Overall Study||254
404729|NCT00909857|966149|P1|STARTED|Overall Study||253
404730|NCT00909844|966289|P1|NOT COMPLETED|Overall Study||4
404731|NCT00909844|966289|P1|COMPLETED|Overall Study||31
404732|NCT00909844|966289|P1|STARTED|Overall Study||35
404733|NCT00909792|966307|P2|NOT COMPLETED|Period 2||1
404734|NCT00909792|966308|P1|NOT COMPLETED|Period 2||1
404735|NCT00909792|966307|P2|COMPLETED|Period 2||124
404736|NCT00909792|966308|P1|COMPLETED|Period 2||128
404737|NCT00909792|966307|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
404738|NCT00909792|966308|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
404739|NCT00909792|966307|P2|NOT COMPLETED|Period 1||1
404740|NCT00909792|966308|P1|NOT COMPLETED|Period 1||0
404741|NCT00909792|966307|P2|COMPLETED|Period 1||127
404742|NCT00909792|966308|P1|COMPLETED|Period 1||130
404743|NCT00909792|966307|P2|STARTED|Period 1||128
404744|NCT00909792|966308|P1|STARTED|Period 1||130
404745|NCT00909779|966316|P2|NOT COMPLETED|Overall Study||165
404746|NCT00909779|966317|P1|NOT COMPLETED|Overall Study||210
404747|NCT00909779|966316|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
404748|NCT00909779|966317|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
404749|NCT00909779|966316|P2|STARTED|Overall Study||420
404750|NCT00909779|966317|P1|STARTED|Overall Study||421
404751|NCT00909753|966341|P2|NOT COMPLETED|Period: Second Intervention||0
404752|NCT00909753|966342|P1|NOT COMPLETED|Period: Second Intervention||1
404753|NCT00909753|966341|P2|COMPLETED|Period: Second Intervention||43
404754|NCT00909753|966342|P1|COMPLETED|Period: Second Intervention||43
404755|NCT00909753|966341|P2|STARTED|Period: Second Intervention||43
404756|NCT00909753|966342|P1|STARTED|Period: Second Intervention||44
404757|NCT00909753|966341|P2|NOT COMPLETED|Period: Washout of 28 Days||3
404758|NCT00909753|966342|P1|NOT COMPLETED|Period: Washout of 28 Days||2
404759|NCT00909753|966341|P2|COMPLETED|Period: Washout of 28 Days||43
404760|NCT00909753|966342|P1|COMPLETED|Period: Washout of 28 Days||44
404761|NCT00909753|966341|P2|STARTED|Period: Washout of 28 Days||46
404762|NCT00909753|966342|P1|STARTED|Period: Washout of 28 Days||46
404763|NCT00909753|966341|P2|NOT COMPLETED|Period: First Intervention||0
404764|NCT00909753|966342|P1|NOT COMPLETED|Period: First Intervention||0
404765|NCT00909753|966341|P2|COMPLETED|Period: First Intervention||46
404766|NCT00909753|966342|P1|COMPLETED|Period: First Intervention||46
404767|NCT00909753|966341|P2|STARTED|Period: First Intervention||46
404768|NCT00909753|966342|P1|STARTED|Period: First Intervention||46
404769|NCT00909727|966362|P2|NOT COMPLETED|Overall Study||0
404770|NCT00909727|966363|P1|NOT COMPLETED|Overall Study||4
404771|NCT00909727|966362|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
404772|NCT00909727|966363|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
404773|NCT00909727|966362|P2|Completed Treatment Period, Week 24|Overall Study||26
404774|NCT00909727|966363|P1|Completed Treatment Period, Week 24|Overall Study||23
404775|NCT00909727|966362|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
404776|NCT00909727|966363|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
404777|NCT00909649|966379|P2|NOT COMPLETED|Overall Study||0
404778|NCT00909649|966380|P1|NOT COMPLETED|Overall Study||0
404779|NCT00909649|966379|P2|COMPLETED|Overall Study||25
404780|NCT00909649|966380|P1|COMPLETED|Overall Study||25
404781|NCT00909649|966379|P2|STARTED|Overall Study||25
404782|NCT00909649|966380|P1|STARTED|Overall Study||25
404783|NCT00909610|966386|P2|NOT COMPLETED|Period: Second Intervention||0
404784|NCT00909610|966387|P1|NOT COMPLETED|Period: Second Intervention||1
404785|NCT00909610|966386|P2|COMPLETED|Period: Second Intervention||33
404786|NCT00909610|966387|P1|COMPLETED|Period: Second Intervention||36
404787|NCT00909610|966386|P2|STARTED|Period: Second Intervention||33
404788|NCT00909610|966387|P1|STARTED|Period: Second Intervention||37
404789|NCT00909610|966386|P2|NOT COMPLETED|Period: Washout of 28 Days||6
404790|NCT00909610|966387|P1|NOT COMPLETED|Period: Washout of 28 Days||3
404791|NCT00909610|966386|P2|COMPLETED|Period: Washout of 28 Days||33
404792|NCT00909610|966387|P1|COMPLETED|Period: Washout of 28 Days||37
404793|NCT00909610|966386|P2|STARTED|Period: Washout of 28 Days||39
404794|NCT00909610|966387|P1|STARTED|Period: Washout of 28 Days||40
404795|NCT00909610|966386|P2|NOT COMPLETED|Period: First Intervention||1
404796|NCT00909610|966387|P1|NOT COMPLETED|Period: First Intervention||0
404797|NCT00909610|966386|P2|COMPLETED|Period: First Intervention||39
404798|NCT00909610|966387|P1|COMPLETED|Period: First Intervention||40
404799|NCT00909610|966386|P2|STARTED|Period: First Intervention||40
404800|NCT00909610|966387|P1|STARTED|Period: First Intervention||40
404801|NCT00909545|966409|P4|NOT COMPLETED|Overall Study||5
404802|NCT00909545|966410|P3|NOT COMPLETED|Overall Study||1
404803|NCT00909545|966411|P2|NOT COMPLETED|Overall Study||1
404804|NCT00909545|966412|P1|NOT COMPLETED|Overall Study||1
404805|NCT00909545|966409|P4|COMPLETED|Overall Study||19
404806|NCT00909545|966410|P3|COMPLETED|Overall Study||25
404807|NCT00909545|966411|P2|COMPLETED|Overall Study||22
404808|NCT00909545|966412|P1|COMPLETED|Overall Study||25
404809|NCT00909545|966409|P4|STARTED|Overall Study||24
404810|NCT00909545|966410|P3|STARTED|Overall Study||26
404811|NCT00909545|966411|P2|STARTED|Overall Study||23
404812|NCT00909545|966412|P1|STARTED|Overall Study||26
404813|NCT00909532|966548|P2|NOT COMPLETED|Overall Study||6
404814|NCT00909532|966549|P1|NOT COMPLETED|Overall Study||10
404815|NCT00909532|966548|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
404816|NCT00909532|966549|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
404817|NCT00909532|966548|P2|Completed Treatment Period, Week 24|Overall Study||80
404818|NCT00909532|966549|P1|Completed Treatment Period, Week 24|Overall Study||71
404819|NCT00909532|966548|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
404820|NCT00909532|966549|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
404821|NCT00909480|966567|P2|NOT COMPLETED|Overall Study||41
404822|NCT00909480|966568|P1|NOT COMPLETED|Overall Study||38
404823|NCT00909480|966567|P2|COMPLETED|Overall Study||188
404824|NCT00909480|966568|P1|COMPLETED|Overall Study||190
404825|NCT00909480|966567|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
404922|NCT00908648|966755|P1|STARTED|Overall Study||108
404826|NCT00909480|966568|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
404827|NCT00909480|966567|P2|STARTED|Overall Study||229
404828|NCT00909480|966568|P1|STARTED|Overall Study||228
404829|NCT00909428|966603|P3|NOT COMPLETED|Overall Study||9
404830|NCT00909428|966604|P2|NOT COMPLETED|Overall Study||10
404831|NCT00909428|966605|P1|NOT COMPLETED|Overall Study||13
404832|NCT00909428|966603|P3|COMPLETED|Overall Study||0
404833|NCT00909428|966604|P2|COMPLETED|Overall Study||5
404834|NCT00909428|966605|P1|COMPLETED|Overall Study||5
404835|NCT00909428|966603|P3|STARTED|Overall Study||9
404836|NCT00909428|966604|P2|STARTED|Overall Study||15
404837|NCT00909428|966605|P1|STARTED|Overall Study||18
404838|NCT00909389|966612|P1|NOT COMPLETED|Overall Study||133
404839|NCT00909389|966612|P1|COMPLETED|Overall Study||4615
404840|NCT00909389|966612|P1|STARTED|Overall Study||4748
404841|NCT00909324|966618|P2|NOT COMPLETED|Overall Study||0
404842|NCT00909324|966619|P1|NOT COMPLETED|Overall Study||0
404843|NCT00909324|966618|P2|COMPLETED|Overall Study||90
404844|NCT00909324|966619|P1|COMPLETED|Overall Study||72
404845|NCT00909324|966618|P2|STARTED|Overall Study||90
404846|NCT00909324|966619|P1|STARTED|Overall Study||72
404847|NCT00909181|966632|P3|NOT COMPLETED|Overall Study||33
404848|NCT00909181|966633|P2|NOT COMPLETED|Overall Study||18
404849|NCT00909181|966634|P1|NOT COMPLETED|Overall Study||39
404850|NCT00909181|966632|P3|COMPLETED|Overall Study||169
404851|NCT00909181|966633|P2|COMPLETED|Overall Study||196
404852|NCT00909181|966634|P1|COMPLETED|Overall Study||171
404853|NCT00909181|966632|P3|STARTED|Overall Study||202
404854|NCT00909181|966633|P2|STARTED|Overall Study||214
404855|NCT00909181|966634|P1|STARTED|Overall Study||210
404856|NCT00909155|966645|P3|NOT COMPLETED|Overall Study||7
404857|NCT00909155|966646|P2|NOT COMPLETED|Overall Study||5
404858|NCT00909155|966647|P1|NOT COMPLETED|Overall Study||3
404859|NCT00909155|966645|P3|COMPLETED|Overall Study||14
404860|NCT00909155|966646|P2|COMPLETED|Overall Study||9
404861|NCT00909155|966647|P1|COMPLETED|Overall Study||12
404862|NCT00909155|966645|P3|STARTED|Overall Study||21
404863|NCT00909155|966646|P2|STARTED|Overall Study||14
404864|NCT00909155|966647|P1|STARTED|Overall Study||15
404865|NCT00909064|966655|P1|NOT COMPLETED|Overall Study||0
404866|NCT00909064|966655|P1|COMPLETED|Overall Study||114
404867|NCT00909064|966655|P1|STARTED|Overall Study||114
404868|NCT00909038|966661|P1|NOT COMPLETED|Overall Study||417
404869|NCT00909038|966661|P1|COMPLETED|Overall Study||1994
404870|NCT00909038|966661|P1|STARTED|Overall Study||2411
404871|NCT00908960|966673|P3|NOT COMPLETED|Overall Study||2
404872|NCT00908960|966674|P2|NOT COMPLETED|Overall Study||1
404873|NCT00908960|966675|P1|NOT COMPLETED|Overall Study||1
404874|NCT00908960|966673|P3|COMPLETED|Overall Study||32
404875|NCT00908960|966674|P2|COMPLETED|Overall Study||11
404876|NCT00908960|966675|P1|COMPLETED|Overall Study||23
404877|NCT00908960|966673|P3|STARTED|Overall Study||34
404878|NCT00908960|966674|P2|STARTED|Overall Study||12
404879|NCT00908960|966675|P1|STARTED|Overall Study||24
404880|NCT00908908|966683|P1|NOT COMPLETED|Overall Study||0
404881|NCT00908908|966683|P1|COMPLETED|Overall Study||6
404882|NCT00908908|966683|P1|Physician Decision|Overall Study||0
404883|NCT00908908|966683|P1|Administrative/Other|Overall Study||0
404884|NCT00908908|966683|P1|Withdrawl by Subject|Overall Study||0
404885|NCT00908908|966683|P1|Adverse Event|Overall Study||0
404886|NCT00908908|966683|P1|STARTED|Overall Study||6
404887|NCT00908895|966691|P2|NOT COMPLETED|Overall Study||6
404888|NCT00908895|966692|P1|NOT COMPLETED|Overall Study||4
404889|NCT00908895|966691|P2|COMPLETED|Overall Study||57
404890|NCT00908895|966692|P1|COMPLETED|Overall Study||53
404891|NCT00908895|966691|P2|STARTED|Overall Study||63
404892|NCT00908895|966692|P1|STARTED|Overall Study||57
404893|NCT00908882|966702|P2|NOT COMPLETED|Overall Study||30
404894|NCT00908882|966703|P1|NOT COMPLETED|Overall Study||28
404895|NCT00908882|966702|P2|COMPLETED|Overall Study||59
404896|NCT00908882|966703|P1|COMPLETED|Overall Study||61
404897|NCT00908882|966702|P2|STARTED|Overall Study||89
404898|NCT00908882|966703|P1|STARTED|Overall Study||89
404899|NCT00908687|966733|P6|NOT COMPLETED|Overall Study||6
404900|NCT00908687|966734|P5|NOT COMPLETED|Overall Study||4
404901|NCT00908687|966735|P4|NOT COMPLETED|Overall Study||3
404902|NCT00908687|966736|P3|NOT COMPLETED|Overall Study||3
404903|NCT00908687|966737|P2|NOT COMPLETED|Overall Study||1
404904|NCT00908687|966738|P1|NOT COMPLETED|Overall Study||1
404905|NCT00908687|966733|P6|COMPLETED|Overall Study||94
404906|NCT00908687|966734|P5|COMPLETED|Overall Study||94
404907|NCT00908687|966735|P4|COMPLETED|Overall Study||47
404908|NCT00908687|966736|P3|COMPLETED|Overall Study||99
404909|NCT00908687|966737|P2|COMPLETED|Overall Study||99
404910|NCT00908687|966738|P1|COMPLETED|Overall Study||49
404911|NCT00908687|966733|P6|STARTED|Overall Study||100
404912|NCT00908687|966734|P5|STARTED|Overall Study||98
404913|NCT00908687|966735|P4|STARTED|Overall Study||50
404914|NCT00908687|966736|P3|STARTED|Overall Study||102
404915|NCT00908687|966737|P2|STARTED|Overall Study||100
404916|NCT00908687|966738|P1|STARTED|Overall Study||50
404917|NCT00908648|966754|P2|NOT COMPLETED|Overall Study||0
404918|NCT00908648|966755|P1|NOT COMPLETED|Overall Study||0
404919|NCT00908648|966754|P2|COMPLETED|Overall Study||103
404920|NCT00908648|966755|P1|COMPLETED|Overall Study||108
404921|NCT00908648|966754|P2|STARTED|Overall Study||103
404923|NCT00908596|966765|P4|NOT COMPLETED|Overall Study||37
404924|NCT00908596|966766|P3|NOT COMPLETED|Overall Study||74
404925|NCT00908596|966767|P2|NOT COMPLETED|Overall Study||13
404926|NCT00908596|966768|P1|NOT COMPLETED|Overall Study||47
404927|NCT00908596|966765|P4|COMPLETED|Overall Study||48
404928|NCT00908596|966766|P3|COMPLETED|Overall Study||119
404929|NCT00908596|966767|P2|COMPLETED|Overall Study||19
404930|NCT00908596|966768|P1|COMPLETED|Overall Study||0
404931|NCT00908596|966765|P4|STARTED|Overall Study||85
404932|NCT00908596|966766|P3|STARTED|Overall Study||193
404933|NCT00908596|966767|P2|STARTED|Overall Study||32
404934|NCT00908596|966768|P1|STARTED|Overall Study||47
404935|NCT00908583|966798|P1|NOT COMPLETED|Phase 5||3
404936|NCT00908583|966798|P1|COMPLETED|Phase 5||2
404937|NCT00908583|966798|P1|STARTED|Phase 5||5
404938|NCT00908583|966798|P1|NOT COMPLETED|Phase 4||2
404939|NCT00908583|966798|P1|COMPLETED|Phase 4||3
404940|NCT00908583|966798|P1|STARTED|Phase 4||5
404941|NCT00908583|966798|P1|NOT COMPLETED|Phase 3||2
404942|NCT00908583|966798|P1|COMPLETED|Phase 3||8
404943|NCT00908583|966798|P1|STARTED|Phase 3||10
404944|NCT00908583|966798|P1|NOT COMPLETED|Phase 2||2
404945|NCT00908583|966798|P1|COMPLETED|Phase 2||10
404946|NCT00908583|966798|P1|STARTED|Phase 2||12
404947|NCT00908583|966798|P1|NOT COMPLETED|Phase 1||5
404948|NCT00908583|966798|P1|COMPLETED|Phase 1||15
404949|NCT00908583|966798|P1|STARTED|Phase 1||20
404950|NCT00908388|966816|P1|NOT COMPLETED|Overall Study||10
404951|NCT00908388|966816|P1|COMPLETED|Overall Study||40
404952|NCT00908388|966816|P1|STARTED|Overall Study||50
404953|NCT00908375|966826|P2|NOT COMPLETED|Overall Study||10
404954|NCT00908375|966827|P1|NOT COMPLETED|Overall Study||10
404955|NCT00908375|966826|P2|COMPLETED|Overall Study||9
404956|NCT00908375|966827|P1|COMPLETED|Overall Study||10
404957|NCT00908375|966826|P2|STARTED|Overall Study||19
404958|NCT00908375|966827|P1|STARTED|Overall Study||20
404959|NCT00908349|966837|P1|NOT COMPLETED|Overall Study||35
404960|NCT00908349|966837|P1|COMPLETED|Overall Study||179
404961|NCT00908349|966837|P1|STARTED|Overall Study||214
404962|NCT00908310|966841|P1|NOT COMPLETED|Overall Study||60
404963|NCT00908310|966841|P1|COMPLETED|Overall Study||153
404964|NCT00908310|966841|P1|STARTED|Overall Study||213
404965|NCT00908232|966845|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
404966|NCT00908232|966846|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
404967|NCT00908232|966847|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
404968|NCT00908232|966848|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
404969|NCT00908232|966845|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
404970|NCT00908232|966846|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
404971|NCT00908232|966847|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
404972|NCT00908232|966848|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
404973|NCT00908232|966845|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
404974|NCT00908232|966846|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
404975|NCT00908232|966847|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
404976|NCT00908232|966848|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
404977|NCT00908232|966845|P4|NOT COMPLETED|Cycle 1 to 4||0
404978|NCT00908232|966846|P3|NOT COMPLETED|Cycle 1 to 4||0
404979|NCT00908232|966847|P2|NOT COMPLETED|Cycle 1 to 4||0
404980|NCT00908232|966848|P1|NOT COMPLETED|Cycle 1 to 4||28
404981|NCT00908232|966845|P4|COMPLETED|Cycle 1 to 4||0
404982|NCT00908232|966846|P3|COMPLETED|Cycle 1 to 4||0
404983|NCT00908232|966847|P2|COMPLETED|Cycle 1 to 4||0
404984|NCT00908232|966848|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
404985|NCT00908232|966845|P4|STARTED|Cycle 1 to 4||0
404986|NCT00908232|966846|P3|STARTED|Cycle 1 to 4||0
404987|NCT00908232|966847|P2|STARTED|Cycle 1 to 4||0
404988|NCT00908232|966848|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
404989|NCT00908141|966866|P2|NOT COMPLETED|Overall Study||1
404990|NCT00908141|966867|P1|NOT COMPLETED|Overall Study||0
404991|NCT00908141|966866|P2|COMPLETED|Overall Study||8
404992|NCT00908141|966867|P1|COMPLETED|Overall Study||8
404993|NCT00908141|966866|P2|STARTED|Overall Study||9
404994|NCT00908141|966867|P1|STARTED|Overall Study||8
404995|NCT00908128|966875|P2|NOT COMPLETED|Period 4||0
404996|NCT00908128|966876|P1|NOT COMPLETED|Period 4||0
404997|NCT00908128|966875|P2|COMPLETED|Period 4||19
404998|NCT00908128|966876|P1|COMPLETED|Period 4||20
404999|NCT00908128|966875|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
405000|NCT00908128|966876|P1|STARTED|Period 4||20
405001|NCT00908128|966875|P2|NOT COMPLETED|Period 3||0
405002|NCT00908128|966876|P1|NOT COMPLETED|Period 3||0
405003|NCT00908128|966875|P2|COMPLETED|Period 3||20
405004|NCT00908128|966876|P1|COMPLETED|Period 3||20
405005|NCT00908128|966875|P2|STARTED|Period 3||20
405006|NCT00908128|966876|P1|STARTED|Period 3||20
405007|NCT00908128|966875|P2|NOT COMPLETED|Period 2||0
405008|NCT00908128|966876|P1|NOT COMPLETED|Period 2||0
405009|NCT00908128|966875|P2|COMPLETED|Period 2||20
405010|NCT00908128|966876|P1|COMPLETED|Period 2||20
405011|NCT00908128|966875|P2|STARTED|Period 2||20
405012|NCT00908128|966876|P1|STARTED|Period 2||20
405013|NCT00908128|966875|P2|NOT COMPLETED|Period 1||0
405014|NCT00908128|966876|P1|NOT COMPLETED|Period 1||0
405015|NCT00908128|966875|P2|COMPLETED|Period 1||20
405016|NCT00908128|966876|P1|COMPLETED|Period 1||20
405017|NCT00908128|966875|P2|STARTED|Period 1||20
405018|NCT00908128|966876|P1|STARTED|Period 1||20
405019|NCT00908115|966884|P1|NOT COMPLETED|Overall Study||14
405020|NCT00908115|966884|P1|COMPLETED|Overall Study||1244
405021|NCT00908115|966884|P1|STARTED|Overall Study||1258
405022|NCT00908076|966892|P2|NOT COMPLETED|Overall Study||1
405023|NCT00908076|966893|P1|NOT COMPLETED|Overall Study||1
405024|NCT00908076|966892|P2|COMPLETED|Overall Study||26
405025|NCT00908076|966893|P1|COMPLETED|Overall Study||26
405026|NCT00908076|966892|P2|STARTED|Overall Study||27
405027|NCT00908076|966893|P1|STARTED|Overall Study||27
405028|NCT00908037|966906|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
405029|NCT00908037|966907|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
405030|NCT00908037|966908|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
405031|NCT00908037|966909|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405032|NCT00908037|966910|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405033|NCT00908037|966911|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405034|NCT00908037|966912|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405035|NCT00908037|966913|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405036|NCT00908037|966914|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405037|NCT00908037|966915|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405202|NCT00907621|967178|P1|COMPLETED|Overall Study||38
405038|NCT00908037|966916|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405039|NCT00908037|966917|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405040|NCT00908037|966906|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
405041|NCT00908037|966907|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
405042|NCT00908037|966908|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
405043|NCT00908037|966909|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405044|NCT00908037|966910|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405045|NCT00908037|966911|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405046|NCT00908037|966912|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405047|NCT00908037|966913|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405048|NCT00908037|966914|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405049|NCT00908037|966915|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405050|NCT00908037|966916|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405051|NCT00908037|966917|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
405052|NCT00908037|966906|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
405053|NCT00908037|966907|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
405054|NCT00908037|966908|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
405055|NCT00908037|966909|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405056|NCT00908037|966910|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405057|NCT00908037|966911|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405058|NCT00908037|966912|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405059|NCT00908037|966913|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405060|NCT00908037|966914|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405061|NCT00908037|966915|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405062|NCT00908037|966916|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405063|NCT00908037|966917|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
405064|NCT00908037|966906|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405065|NCT00908037|966907|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405066|NCT00908037|966908|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405067|NCT00908037|966909|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
405068|NCT00908037|966910|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405069|NCT00908037|966911|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
405070|NCT00908037|966912|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405071|NCT00908037|966913|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
405072|NCT00908037|966914|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
405073|NCT00908037|966915|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405074|NCT00908037|966916|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405075|NCT00908037|966917|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
405076|NCT00908037|966906|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
405077|NCT00908037|966907|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
405078|NCT00908037|966908|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
405079|NCT00908037|966909|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
405080|NCT00908037|966910|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
405081|NCT00908037|966911|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
405082|NCT00908037|966912|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
405083|NCT00908037|966913|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
405084|NCT00908037|966914|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
405085|NCT00908037|966915|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
405086|NCT00908037|966916|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
405087|NCT00908037|966917|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
405088|NCT00908037|966906|P12|STARTED|Part 2 (7 Week Randomized Period)||0
405089|NCT00908037|966907|P11|STARTED|Part 2 (7 Week Randomized Period)||0
405090|NCT00908037|966908|P10|STARTED|Part 2 (7 Week Randomized Period)||0
405091|NCT00908037|966909|P9|STARTED|Part 2 (7 Week Randomized Period)||10
405092|NCT00908037|966910|P8|STARTED|Part 2 (7 Week Randomized Period)||5
405093|NCT00908037|966911|P7|STARTED|Part 2 (7 Week Randomized Period)||19
405094|NCT00908037|966912|P6|STARTED|Part 2 (7 Week Randomized Period)||9
405095|NCT00908037|966913|P5|STARTED|Part 2 (7 Week Randomized Period)||16
405096|NCT00908037|966914|P4|STARTED|Part 2 (7 Week Randomized Period)||8
405097|NCT00908037|966915|P3|STARTED|Part 2 (7 Week Randomized Period)||0
405098|NCT00908037|966916|P2|STARTED|Part 2 (7 Week Randomized Period)||0
405099|NCT00908037|966917|P1|STARTED|Part 2 (7 Week Randomized Period)||0
405100|NCT00908037|966906|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405101|NCT00908037|966907|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405102|NCT00908037|966908|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405103|NCT00908037|966909|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405104|NCT00908037|966910|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405105|NCT00908037|966911|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405106|NCT00908037|966912|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405107|NCT00908037|966913|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405108|NCT00908037|966914|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405109|NCT00908037|966915|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405110|NCT00908037|966916|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405111|NCT00908037|966917|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405112|NCT00908037|966906|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405113|NCT00908037|966907|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405114|NCT00908037|966908|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405115|NCT00908037|966909|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405116|NCT00908037|966910|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405117|NCT00908037|966911|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405118|NCT00908037|966912|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405119|NCT00908037|966913|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405120|NCT00908037|966914|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
405121|NCT00908037|966915|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
405122|NCT00908037|966916|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
405123|NCT00908037|966917|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
405124|NCT00908037|966906|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
405125|NCT00908037|966907|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
405126|NCT00908037|966908|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
405127|NCT00908037|966909|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
405128|NCT00908037|966910|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
405129|NCT00908037|966911|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
405130|NCT00908037|966912|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
405131|NCT00908037|966913|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
405132|NCT00908037|966914|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
405133|NCT00908037|966915|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
405134|NCT00908037|966916|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
405135|NCT00908037|966917|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
405136|NCT00908011|967066|P2|NOT COMPLETED|Overall Study||2
405137|NCT00908011|967067|P1|NOT COMPLETED|Overall Study||2
405138|NCT00908011|967066|P2|COMPLETED|Overall Study||18
405139|NCT00908011|967067|P1|COMPLETED|Overall Study||21
405140|NCT00908011|967066|P2|STARTED|Overall Study||20
405141|NCT00908011|967067|P1|STARTED|Overall Study||23
405142|NCT00907907|967075|P2|NOT COMPLETED|Period 4||0
405143|NCT00907907|967076|P1|NOT COMPLETED|Period 4||0
405144|NCT00907907|967075|P2|COMPLETED|Period 4||18
405145|NCT00907907|967076|P1|COMPLETED|Period 4||19
405146|NCT00907907|967075|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
405147|NCT00907907|967076|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
405148|NCT00907907|967075|P2|NOT COMPLETED|Period 3||0
405149|NCT00907907|967076|P1|NOT COMPLETED|Period 3||0
405150|NCT00907907|967075|P2|COMPLETED|Period 3||20
405151|NCT00907907|967076|P1|COMPLETED|Period 3||20
405152|NCT00907907|967075|P2|STARTED|Period 3||20
405153|NCT00907907|967076|P1|STARTED|Period 3||20
405154|NCT00907907|967075|P2|NOT COMPLETED|Period 2||0
405155|NCT00907907|967076|P1|NOT COMPLETED|Period 2||0
405156|NCT00907907|967075|P2|COMPLETED|Period 2||20
405157|NCT00907907|967076|P1|COMPLETED|Period 2||20
405158|NCT00907907|967075|P2|STARTED|Period 2||20
405159|NCT00907907|967076|P1|STARTED|Period 2||20
405160|NCT00907907|967075|P2|NOT COMPLETED|Period 1||0
405161|NCT00907907|967076|P1|NOT COMPLETED|Period 1||0
405162|NCT00907907|967075|P2|COMPLETED|Period 1||20
405163|NCT00907907|967076|P1|COMPLETED|Period 1||20
405164|NCT00907907|967075|P2|STARTED|Period 1||20
405165|NCT00907907|967076|P1|STARTED|Period 1||20
405166|NCT00907881|967084|P1|NOT COMPLETED|Overall Study||85
405167|NCT00907881|967084|P1|COMPLETED|Overall Study||984
405168|NCT00907881|967084|P1|STARTED|Overall Study||1069
405169|NCT00907803|967094|P3|NOT COMPLETED|Overall Study||0
405170|NCT00907803|967095|P2|NOT COMPLETED|Overall Study||3
405171|NCT00907803|967096|P1|NOT COMPLETED|Overall Study||3
405172|NCT00907803|967094|P3|COMPLETED|Overall Study||16
405173|NCT00907803|967095|P2|COMPLETED|Overall Study||43
405174|NCT00907803|967096|P1|COMPLETED|Overall Study||42
405175|NCT00907803|967094|P3|STARTED|Overall Study||16
405176|NCT00907803|967095|P2|STARTED|Overall Study||46
405177|NCT00907803|967096|P1|STARTED|Overall Study||45
405178|NCT00907777|967127|P2|NOT COMPLETED|Overall Study||1
405179|NCT00907777|967128|P1|NOT COMPLETED|Overall Study||0
405180|NCT00907777|967127|P2|COMPLETED|Overall Study||26
405181|NCT00907777|967128|P1|COMPLETED|Overall Study||25
405182|NCT00907777|967127|P2|STARTED|Overall Study||27
405183|NCT00907777|967128|P1|STARTED|Overall Study||25
405184|NCT00907738|967155|P5|NOT COMPLETED|Overall Study||2
405185|NCT00907738|967156|P4|NOT COMPLETED|Overall Study||4
405186|NCT00907738|967157|P3|NOT COMPLETED|Overall Study||7
405187|NCT00907738|967158|P2|NOT COMPLETED|Overall Study||1
405188|NCT00907738|967159|P1|NOT COMPLETED|Overall Study||13
405189|NCT00907738|967155|P5|COMPLETED|Overall Study||0
405190|NCT00907738|967156|P4|COMPLETED|Overall Study||0
405191|NCT00907738|967157|P3|COMPLETED|Overall Study||0
405192|NCT00907738|967158|P2|COMPLETED|Overall Study||0
405193|NCT00907738|967159|P1|COMPLETED|Overall Study||0
405194|NCT00907738|967155|P5|STARTED|Overall Study||2
405195|NCT00907738|967156|P4|STARTED|Overall Study||4
405196|NCT00907738|967157|P3|STARTED|Overall Study||7
405197|NCT00907738|967158|P2|STARTED|Overall Study||1
405198|NCT00907738|967159|P1|STARTED|Overall Study||13
405199|NCT00907621|967177|P2|NOT COMPLETED|Overall Study||4
405200|NCT00907621|967178|P1|NOT COMPLETED|Overall Study||7
405201|NCT00907621|967177|P2|COMPLETED|Overall Study||41
405203|NCT00907621|967177|P2|STARTED|Overall Study||45
405204|NCT00907621|967178|P1|STARTED|Overall Study||45
405205|NCT00907517|967191|P5|NOT COMPLETED|Overall Study||5
405206|NCT00907517|967192|P4|NOT COMPLETED|Overall Study||4
405207|NCT00907517|967193|P3|NOT COMPLETED|Overall Study||4
405208|NCT00907517|967194|P2|NOT COMPLETED|Overall Study||3
405209|NCT00907517|967195|P1|NOT COMPLETED|Overall Study||3
405210|NCT00907517|967191|P5|COMPLETED|Overall Study||1
405211|NCT00907517|967192|P4|COMPLETED|Overall Study||2
405212|NCT00907517|967193|P3|COMPLETED|Overall Study||2
405213|NCT00907517|967194|P2|COMPLETED|Overall Study||0
405214|NCT00907517|967195|P1|COMPLETED|Overall Study||0
405215|NCT00907517|967191|P5|STARTED|Overall Study||6
405216|NCT00907517|967192|P4|STARTED|Overall Study||6
405217|NCT00907517|967193|P3|STARTED|Overall Study||6
405218|NCT00907517|967194|P2|STARTED|Overall Study||3
405219|NCT00907517|967195|P1|STARTED|Overall Study||3
405220|NCT00907478|967220|P3|NOT COMPLETED|Overall Study||22
405221|NCT00907478|967221|P2|NOT COMPLETED|Overall Study||17
405222|NCT00907478|967222|P1|NOT COMPLETED|Overall Study||27
405223|NCT00907478|967220|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
405224|NCT00907478|967221|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
405225|NCT00907478|967222|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
405226|NCT00907478|967220|P3|STARTED|Overall Study||69
405227|NCT00907478|967221|P2|STARTED|Overall Study||50
405228|NCT00907478|967222|P1|STARTED|Overall Study||50
405229|NCT00907426|967253|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
405230|NCT00907426|967254|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
405231|NCT00907426|967255|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
405232|NCT00907426|967253|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
405233|NCT00907426|967254|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
405234|NCT00907426|967255|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
405235|NCT00907426|967253|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
405236|NCT00907426|967254|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
405237|NCT00907426|967255|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
405238|NCT00907426|967253|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
405239|NCT00907426|967254|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
405240|NCT00907426|967255|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
405241|NCT00907426|967253|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
405242|NCT00907426|967254|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
405243|NCT00907426|967255|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
405244|NCT00907426|967253|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
405245|NCT00907426|967254|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
405246|NCT00907426|967255|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
405247|NCT00907374|967272|P2|NOT COMPLETED|Overall Study||2
405248|NCT00907374|967273|P1|NOT COMPLETED|Overall Study||2
405249|NCT00907374|967272|P2|COMPLETED|Overall Study||11
405250|NCT00907374|967273|P1|COMPLETED|Overall Study||12
405251|NCT00907374|967272|P2|STARTED|Overall Study||13
405252|NCT00907374|967273|P1|STARTED|Overall Study||14
405253|NCT00907335|967287|P2|NOT COMPLETED|Overall Study||1
405254|NCT00907335|967288|P1|NOT COMPLETED|Overall Study||8
405255|NCT00907335|967287|P2|COMPLETED|Overall Study||54
405256|NCT00907335|967288|P1|COMPLETED|Overall Study||47
405257|NCT00907335|967287|P2|STARTED|Overall Study||55
405258|NCT00907335|967288|P1|STARTED|Overall Study||55
405259|NCT00907257|967306|P2|NOT COMPLETED|Overall Study||12
405260|NCT00907257|967307|P1|NOT COMPLETED|Overall Study||13
405261|NCT00907257|967306|P2|COMPLETED|Overall Study||112
405262|NCT00907257|967307|P1|COMPLETED|Overall Study||110
405263|NCT00907257|967306|P2|STARTED|Overall Study||124
405264|NCT00907257|967307|P1|STARTED|Overall Study||123
405265|NCT00907218|967317|P1|NOT COMPLETED|Overall Study||0
405266|NCT00907218|967317|P1|COMPLETED|Overall Study||2
405267|NCT00907218|967317|P1|STARTED|Overall Study||2
405268|NCT00907101|967321|P1|NOT COMPLETED|Overall Study||0
405269|NCT00907101|967321|P1|COMPLETED|Overall Study||30
405270|NCT00907101|967321|P1|STARTED|Overall Study||30
405271|NCT00907088|967331|P2|NOT COMPLETED|Overall Study||30
405272|NCT00907088|967332|P1|NOT COMPLETED|Overall Study||20
405273|NCT00907088|967331|P2|COMPLETED|Overall Study||99
405274|NCT00907088|967332|P1|COMPLETED|Overall Study||102
405275|NCT00907088|967331|P2|STARTED|Overall Study||129
405276|NCT00907088|967332|P1|STARTED|Overall Study||122
405277|NCT00906971|967340|P2|NOT COMPLETED|Overall Study||3
405278|NCT00906971|967341|P1|NOT COMPLETED|Overall Study||8
405279|NCT00906971|967340|P2|COMPLETED|Overall Study||33
405280|NCT00906971|967341|P1|COMPLETED|Overall Study||28
405281|NCT00906971|967340|P2|STARTED|Overall Study||36
405282|NCT00906971|967341|P1|STARTED|Overall Study||36
405283|NCT00906945|967354|P6|NOT COMPLETED|Overall Study||2
405284|NCT00906945|967355|P5|NOT COMPLETED|Overall Study||1
405285|NCT00906945|967356|P4|NOT COMPLETED|Overall Study||1
405286|NCT00906945|967357|P3|NOT COMPLETED|Overall Study||0
405287|NCT00906945|967358|P2|NOT COMPLETED|Overall Study||0
405288|NCT00906945|967359|P1|NOT COMPLETED|Overall Study||0
405289|NCT00906945|967354|P6|COMPLETED|Overall Study||14
405290|NCT00906945|967355|P5|COMPLETED|Overall Study||6
405291|NCT00906945|967356|P4|COMPLETED|Overall Study||6
405292|NCT00906945|967357|P3|COMPLETED|Overall Study||3
405293|NCT00906945|967358|P2|COMPLETED|Overall Study||3
405294|NCT00906945|967359|P1|COMPLETED|Overall Study||3
405295|NCT00906945|967354|P6|STARTED|Overall Study||16
405296|NCT00906945|967355|P5|STARTED|Overall Study||7
405297|NCT00906945|967356|P4|STARTED|Overall Study||7
405298|NCT00906945|967357|P3|STARTED|Overall Study||3
405299|NCT00906945|967358|P2|STARTED|Overall Study||3
405300|NCT00906945|967359|P1|STARTED|Overall Study||3
405301|NCT00906789|967386|P1|NOT COMPLETED|Overall Study||0
405302|NCT00906789|967386|P1|COMPLETED|Overall Study||15
405303|NCT00906789|967386|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
405304|NCT00906776|967396|P2|NOT COMPLETED|Overall Study||0
405305|NCT00906776|967397|P1|NOT COMPLETED|Overall Study||0
405306|NCT00906776|967396|P2|COMPLETED|Overall Study||8
405307|NCT00906776|967397|P1|COMPLETED|Overall Study||11
405308|NCT00906776|967396|P2|STARTED|Overall Study||8
405309|NCT00906776|967397|P1|STARTED|Overall Study||11
405310|NCT00906698|967419|P6|NOT COMPLETED|Overall Study||5
405311|NCT00906698|967420|P5|NOT COMPLETED|Overall Study||18
405312|NCT00906698|967421|P4|NOT COMPLETED|Overall Study||4
405313|NCT00906698|967422|P3|NOT COMPLETED|Overall Study||6
405314|NCT00906698|967423|P2|NOT COMPLETED|Overall Study||19
405315|NCT00906698|967424|P1|NOT COMPLETED|Overall Study||3
405316|NCT00906698|967419|P6|COMPLETED|Overall Study||0
405317|NCT00906698|967420|P5|COMPLETED|Overall Study||0
405318|NCT00906698|967421|P4|COMPLETED|Overall Study||0
405319|NCT00906698|967422|P3|COMPLETED|Overall Study||0
405320|NCT00906698|967423|P2|COMPLETED|Overall Study||0
405321|NCT00906698|967424|P1|COMPLETED|Overall Study||0
405322|NCT00906698|967419|P6|STARTED|Overall Study||5
405323|NCT00906698|967420|P5|STARTED|Overall Study||18
405324|NCT00906698|967421|P4|STARTED|Overall Study||4
405325|NCT00906698|967422|P3|STARTED|Overall Study||6
405326|NCT00906698|967423|P2|STARTED|Overall Study||19
405327|NCT00906698|967424|P1|STARTED|Overall Study||3
405328|NCT00906503|967506|P1|NOT COMPLETED|Overall Study||0
405329|NCT00906503|967506|P1|COMPLETED|Overall Study||9
405330|NCT00906503|967506|P1|STARTED|Overall Study||9
405331|NCT00906425|967512|P2|NOT COMPLETED|Overall Study||72
405332|NCT00906425|967513|P1|NOT COMPLETED|Overall Study||73
405333|NCT00906425|967512|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
405334|NCT00906425|967513|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
405335|NCT00906425|967512|P2|2 Year|Overall Study|ITT population|58
405336|NCT00906425|967513|P1|2 Year|Overall Study|ITT population|62
405337|NCT00906425|967512|P2|1 Year|Overall Study|ITT population|60
405338|NCT00906425|967513|P1|1 Year|Overall Study|ITT population|67
405339|NCT00906425|967512|P2|6 Months|Overall Study|ITT population|64
405340|NCT00906425|967513|P1|6 Months|Overall Study|ITT population|69
405341|NCT00906425|967512|P2|STARTED|Overall Study||72
405342|NCT00906425|967513|P1|STARTED|Overall Study||73
405343|NCT00906399|967526|P7|NOT COMPLETED|Year 2||29
405344|NCT00906399|967527|P6|NOT COMPLETED|Year 2||47
405345|NCT00906399|967528|P5|NOT COMPLETED|Year 2||35
405346|NCT00906399|967529|P4|NOT COMPLETED|Year 2||30
405347|NCT00906399|967530|P3|NOT COMPLETED|Year 2||0
405348|NCT00906399|967531|P2|NOT COMPLETED|Year 2||0
405349|NCT00906399|967532|P1|NOT COMPLETED|Year 2||0
405350|NCT00906399|967526|P7|COMPLETED|Year 2||409
405351|NCT00906399|967527|P6|COMPLETED|Year 2||391
405352|NCT00906399|967528|P5|COMPLETED|Year 2||193
405353|NCT00906399|967529|P4|COMPLETED|Year 2||198
405354|NCT00906399|967530|P3|COMPLETED|Year 2||0
405355|NCT00906399|967531|P2|COMPLETED|Year 2||0
405356|NCT00906399|967532|P1|COMPLETED|Year 2||0
405357|NCT00906399|967526|P7|Completed Year 2 Study Treatment|Year 2||411
405358|NCT00906399|967527|P6|Completed Year 2 Study Treatment|Year 2||391
405359|NCT00906399|967528|P5|Completed Year 2 Study Treatment|Year 2||196
405360|NCT00906399|967529|P4|Completed Year 2 Study Treatment|Year 2||200
405361|NCT00906399|967530|P3|Completed Year 2 Study Treatment|Year 2||0
405362|NCT00906399|967531|P2|Completed Year 2 Study Treatment|Year 2||0
405363|NCT00906399|967532|P1|Completed Year 2 Study Treatment|Year 2||0
405364|NCT00906399|967526|P7|STARTED|Year 2||438
405365|NCT00906399|967527|P6|STARTED|Year 2||438
405366|NCT00906399|967528|P5|STARTED|Year 2||228
405367|NCT00906399|967529|P4|STARTED|Year 2||228
405368|NCT00906399|967530|P3|STARTED|Year 2||0
405369|NCT00906399|967531|P2|STARTED|Year 2||0
405370|NCT00906399|967532|P1|STARTED|Year 2||0
405371|NCT00906399|967526|P7|NOT COMPLETED|Year 1||0
405372|NCT00906399|967527|P6|NOT COMPLETED|Year 1||0
405373|NCT00906399|967528|P5|NOT COMPLETED|Year 1||0
405374|NCT00906399|967529|P4|NOT COMPLETED|Year 1||0
405375|NCT00906399|967530|P3|NOT COMPLETED|Year 1||76
405376|NCT00906399|967531|P2|NOT COMPLETED|Year 1||63
405377|NCT00906399|967532|P1|NOT COMPLETED|Year 1||44
405378|NCT00906399|967526|P7|COMPLETED|Year 1||0
405379|NCT00906399|967527|P6|COMPLETED|Year 1||0
405380|NCT00906399|967528|P5|COMPLETED|Year 1||0
405381|NCT00906399|967529|P4|COMPLETED|Year 1||0
405382|NCT00906399|967530|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
405383|NCT00906399|967531|P2|COMPLETED|Year 1||438
405384|NCT00906399|967532|P1|COMPLETED|Year 1||456
405385|NCT00906399|967526|P7|Completed Year 1 Study Treatment|Year 1||0
405386|NCT00906399|967527|P6|Completed Year 1 Study Treatment|Year 1||0
405387|NCT00906399|967528|P5|Completed Year 1 Study Treatment|Year 1||0
405388|NCT00906399|967529|P4|Completed Year 1 Study Treatment|Year 1||0
405389|NCT00906399|967530|P3|Completed Year 1 Study Treatment|Year 1||438
405390|NCT00906399|967531|P2|Completed Year 1 Study Treatment|Year 1||438
405391|NCT00906399|967532|P1|Completed Year 1 Study Treatment|Year 1||456
405392|NCT00906399|967526|P7|STARTED|Year 1||0
405393|NCT00906399|967527|P6|STARTED|Year 1||0
405394|NCT00906399|967528|P5|STARTED|Year 1||0
405395|NCT00906399|967529|P4|STARTED|Year 1||0
405396|NCT00906399|967530|P3|STARTED|Year 1||515
405397|NCT00906399|967531|P2|STARTED|Year 1||501
405398|NCT00906399|967532|P1|STARTED|Year 1||500
405399|NCT00906347|967555|P2|NOT COMPLETED|Received Study Drug||31
405400|NCT00906347|967556|P1|NOT COMPLETED|Received Study Drug||40
405401|NCT00906347|967555|P2|COMPLETED|Received Study Drug||143
405402|NCT00906347|967556|P1|COMPLETED|Received Study Drug||136
405403|NCT00906347|967555|P2|STARTED|Received Study Drug||174
405404|NCT00906347|967556|P1|STARTED|Received Study Drug||176
405405|NCT00906347|967555|P2|NOT COMPLETED|Randomized||0
405406|NCT00906347|967556|P1|NOT COMPLETED|Randomized||0
405407|NCT00906347|967555|P2|COMPLETED|Randomized||174
405408|NCT00906347|967556|P1|COMPLETED|Randomized||176
405409|NCT00906347|967555|P2|STARTED|Randomized||174
405410|NCT00906347|967556|P1|STARTED|Randomized||176
405411|NCT00906282|967576|P1|NOT COMPLETED|Surgical Resection||0
405412|NCT00906282|967576|P1|COMPLETED|Surgical Resection||27
405413|NCT00906282|967576|P1|STARTED|Surgical Resection||27
405414|NCT00906282|967576|P1|NOT COMPLETED|Preoperative Chemotherapy||19
405415|NCT00906282|967576|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
405416|NCT00906282|967576|P1|STARTED|Preoperative Chemotherapy||46
405417|NCT00906243|967584|P1|NOT COMPLETED|Overall Study||0
405418|NCT00906243|967584|P1|COMPLETED|Overall Study||6
405419|NCT00906243|967584|P1|STARTED|Overall Study||6
405420|NCT00906204|967590|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
405421|NCT00906204|967591|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
405422|NCT00906204|967590|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
405423|NCT00906204|967591|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
405424|NCT00906204|967590|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
405425|NCT00906204|967591|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
405426|NCT00906204|967590|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
405427|NCT00906204|967591|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
405428|NCT00906204|967590|P2|COMPLETED|Primary Endpoint (Early Safety)||51
405429|NCT00906204|967591|P1|COMPLETED|Primary Endpoint (Early Safety)||43
405430|NCT00906204|967590|P2|STARTED|Primary Endpoint (Early Safety)||52
405431|NCT00906204|967591|P1|STARTED|Primary Endpoint (Early Safety)||45
405432|NCT00906178|967609|P2|NOT COMPLETED|Overall Study||16
405433|NCT00906178|967610|P1|NOT COMPLETED|Overall Study||15
405434|NCT00906178|967609|P2|COMPLETED|Overall Study||167
405435|NCT00906178|967610|P1|COMPLETED|Overall Study||168
405436|NCT00906178|967609|P2|STARTED|Overall Study||183
405437|NCT00906178|967610|P1|STARTED|Overall Study||183
405438|NCT00906087|967622|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
405439|NCT00906087|967622|P1|COMPLETED|Final Washout Period 4 Weeks||12
405440|NCT00906087|967622|P1|STARTED|Final Washout Period 4 Weeks||12
405441|NCT00906087|967622|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
405442|NCT00906087|967622|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
405443|NCT00906087|967622|P1|STARTED|Cosopt Treatment 6 Weeks||12
405444|NCT00906087|967622|P1|NOT COMPLETED|Initial Washout||2
405445|NCT00906087|967622|P1|COMPLETED|Initial Washout||12
405446|NCT00906087|967622|P1|Completed Washout and Continue Protocol|Initial Washout||12
405447|NCT00906087|967622|P1|Begin Washout|Initial Washout||13
405448|NCT00906087|967622|P1|Completed Screening|Initial Washout||14
405449|NCT00906087|967622|P1|STARTED|Initial Washout||14
405450|NCT00906074|967631|P2|NOT COMPLETED|Overall Study||0
405451|NCT00906074|967632|P1|NOT COMPLETED|Overall Study||0
405452|NCT00906074|967631|P2|COMPLETED|Overall Study||90
405453|NCT00906074|967632|P1|COMPLETED|Overall Study||90
405454|NCT00906074|967631|P2|STARTED|Overall Study||90
405455|NCT00906074|967632|P1|STARTED|Overall Study||90
405456|NCT00905164|967658|P2|NOT COMPLETED|Period 2||0
405457|NCT00905164|967659|P1|NOT COMPLETED|Period 2||0
405458|NCT00905164|967658|P2|COMPLETED|Period 2||11
405459|NCT00905164|967659|P1|COMPLETED|Period 2||12
405460|NCT00905164|967658|P2|STARTED|Period 2||11
405461|NCT00905164|967659|P1|STARTED|Period 2||12
405462|NCT00905164|967658|P2|NOT COMPLETED|Period 1||1
405463|NCT00905164|967659|P1|NOT COMPLETED|Period 1||0
405464|NCT00905164|967658|P2|COMPLETED|Period 1||11
405465|NCT00905164|967659|P1|COMPLETED|Period 1||12
405466|NCT00905164|967658|P2|STARTED|Period 1||12
405467|NCT00905164|967659|P1|STARTED|Period 1||12
405468|NCT00905151|967667|P1|NOT COMPLETED|Overall Study||6
405469|NCT00905151|967667|P1|COMPLETED|Overall Study||200
405470|NCT00905151|967667|P1|STARTED|Overall Study||206
405471|NCT00905125|967673|P2|NOT COMPLETED|Overall Study||3
405472|NCT00905125|967674|P1|NOT COMPLETED|Overall Study||4
405473|NCT00905125|967673|P2|COMPLETED|Overall Study||53
405474|NCT00905125|967674|P1|COMPLETED|Overall Study||42
405475|NCT00905125|967673|P2|STARTED|Overall Study||56
405476|NCT00905125|967674|P1|STARTED|Overall Study||46
405477|NCT00905034|967706|P1|NOT COMPLETED|Overall Study||1
405478|NCT00905034|967706|P1|COMPLETED|Overall Study||36
405479|NCT00905034|967706|P1|STARTED|Overall Study||37
405480|NCT00905021|967710|P1|NOT COMPLETED|Overall Study||2
405481|NCT00905021|967710|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
405482|NCT00905021|967710|P1|STARTED|Overall Study||4
405483|NCT00904995|967717|P2|NOT COMPLETED|Overall Study||0
405484|NCT00904995|967718|P1|NOT COMPLETED|Overall Study||0
405485|NCT00904995|967717|P2|COMPLETED|Overall Study||11
405486|NCT00904995|967718|P1|COMPLETED|Overall Study||10
405487|NCT00904995|967717|P2|STARTED|Overall Study||11
405488|NCT00904995|967718|P1|STARTED|Overall Study||10
405489|NCT00904982|967728|P4|NOT COMPLETED|Overall Study||0
405490|NCT00904982|967729|P3|NOT COMPLETED|Overall Study||0
405491|NCT00904982|967730|P2|NOT COMPLETED|Overall Study||0
405492|NCT00904982|967731|P1|NOT COMPLETED|Overall Study||2
405493|NCT00904982|967728|P4|COMPLETED|Overall Study||68
405494|NCT00904982|967729|P3|COMPLETED|Overall Study||67
405495|NCT00904982|967730|P2|COMPLETED|Overall Study||67
405496|NCT00904982|967731|P1|COMPLETED|Overall Study||66
405497|NCT00904982|967728|P4|STARTED|Overall Study||68
405498|NCT00904982|967729|P3|STARTED|Overall Study||67
405499|NCT00904982|967730|P2|STARTED|Overall Study||67
405500|NCT00904982|967731|P1|STARTED|Overall Study||68
405501|NCT00905840|967741|P1|NOT COMPLETED|Overall Study||16
405502|NCT00905840|967741|P1|COMPLETED|Overall Study||75
405503|NCT00905840|967741|P1|STARTED|Overall Study||91
405504|NCT00905827|967753|P3|NOT COMPLETED|Overall Study||0
405505|NCT00905827|967754|P2|NOT COMPLETED|Overall Study||0
405506|NCT00905827|967755|P1|NOT COMPLETED|Overall Study||0
405507|NCT00905827|967753|P3|COMPLETED|Overall Study||73
405508|NCT00905827|967754|P2|COMPLETED|Overall Study||69
405509|NCT00905827|967755|P1|COMPLETED|Overall Study||70
405510|NCT00905827|967753|P3|STARTED|Overall Study||73
405511|NCT00905827|967754|P2|STARTED|Overall Study||69
405512|NCT00905827|967755|P1|STARTED|Overall Study||70
405513|NCT00905632|967772|P7|NOT COMPLETED|Overall Study||4
405514|NCT00905632|967773|P6|NOT COMPLETED|Overall Study||1
405515|NCT00905632|967774|P5|NOT COMPLETED|Overall Study||0
405516|NCT00905632|967775|P4|NOT COMPLETED|Overall Study||0
405517|NCT00905632|967776|P3|NOT COMPLETED|Overall Study||0
405518|NCT00905632|967777|P2|NOT COMPLETED|Overall Study||0
405519|NCT00905632|967778|P1|NOT COMPLETED|Overall Study||0
405520|NCT00905632|967772|P7|COMPLETED|Overall Study||7
405521|NCT00905632|967773|P6|COMPLETED|Overall Study||8
405522|NCT00905632|967774|P5|COMPLETED|Overall Study||10
405523|NCT00905632|967775|P4|COMPLETED|Overall Study||6
405524|NCT00905632|967776|P3|COMPLETED|Overall Study||7
405525|NCT00905632|967777|P2|COMPLETED|Overall Study||6
405526|NCT00905632|967778|P1|COMPLETED|Overall Study||8
405527|NCT00905632|967772|P7|STARTED|Overall Study||11
405528|NCT00905632|967773|P6|STARTED|Overall Study||9
405529|NCT00905632|967774|P5|STARTED|Overall Study||10
405530|NCT00905632|967775|P4|STARTED|Overall Study||6
405531|NCT00905632|967776|P3|STARTED|Overall Study||7
405532|NCT00905632|967777|P2|STARTED|Overall Study||6
405533|NCT00905632|967778|P1|STARTED|Overall Study||8
405534|NCT00905606|967916|P2|NOT COMPLETED|Period 2||0
405535|NCT00905606|967917|P1|NOT COMPLETED|Period 2||0
405536|NCT00905606|967916|P2|COMPLETED|Period 2||14
405537|NCT00905606|967917|P1|COMPLETED|Period 2||14
405538|NCT00905606|967916|P2|STARTED|Period 2||14
405539|NCT00905606|967917|P1|STARTED|Period 2||14
405540|NCT00905606|967916|P2|NOT COMPLETED|Washout||0
405541|NCT00905606|967917|P1|NOT COMPLETED|Washout||1
405542|NCT00905606|967916|P2|COMPLETED|Washout||14
405543|NCT00905606|967917|P1|COMPLETED|Washout||14
405544|NCT00905606|967916|P2|STARTED|Washout||14
405545|NCT00905606|967917|P1|STARTED|Washout||15
405546|NCT00905606|967916|P2|NOT COMPLETED|Period 1||1
405547|NCT00905606|967917|P1|NOT COMPLETED|Period 1||0
405548|NCT00905606|967916|P2|COMPLETED|Period 1||14
405549|NCT00905606|967917|P1|COMPLETED|Period 1||15
405550|NCT00905606|967916|P2|STARTED|Period 1||15
405551|NCT00905606|967917|P1|STARTED|Period 1||15
405552|NCT00905580|967927|P2|NOT COMPLETED|Overall Study||3
405553|NCT00905580|967928|P1|NOT COMPLETED|Overall Study||2
405554|NCT00905580|967927|P2|COMPLETED|Overall Study||47
405555|NCT00905580|967928|P1|COMPLETED|Overall Study||47
405556|NCT00905580|967927|P2|STARTED|Overall Study||50
405557|NCT00905580|967928|P1|STARTED|Overall Study||49
405558|NCT00905567|967942|P2|NOT COMPLETED|Period 2||0
405559|NCT00905567|967943|P1|NOT COMPLETED|Period 2||0
405560|NCT00905567|967942|P2|COMPLETED|Period 2||11
405561|NCT00905567|967943|P1|COMPLETED|Period 2||12
405562|NCT00905567|967942|P2|STARTED|Period 2||11
405563|NCT00905567|967943|P1|STARTED|Period 2||12
405564|NCT00905567|967942|P2|NOT COMPLETED|Washout||1
405565|NCT00905567|967943|P1|NOT COMPLETED|Washout||0
405566|NCT00905567|967942|P2|COMPLETED|Washout||11
405567|NCT00905567|967943|P1|COMPLETED|Washout||12
405568|NCT00905567|967942|P2|STARTED|Washout||12
405569|NCT00905567|967943|P1|STARTED|Washout||12
405570|NCT00905567|967942|P2|NOT COMPLETED|Period 1||0
405571|NCT00905567|967943|P1|NOT COMPLETED|Period 1||0
405572|NCT00905567|967942|P2|COMPLETED|Period 1||12
405573|NCT00905567|967943|P1|COMPLETED|Period 1||12
405574|NCT00905567|967942|P2|STARTED|Period 1||12
405575|NCT00905567|967943|P1|STARTED|Period 1||12
405576|NCT00905554|967953|P2|NOT COMPLETED|Overall Study||0
405577|NCT00905554|967954|P1|NOT COMPLETED|Overall Study||0
405578|NCT00905554|967953|P2|COMPLETED|Overall Study||114
405579|NCT00905554|967954|P1|COMPLETED|Overall Study||116
405580|NCT00905554|967953|P2|STARTED|Overall Study||114
405581|NCT00905554|967954|P1|STARTED|Overall Study||116
405582|NCT00905515|967965|P3|NOT COMPLETED|Overall Study||2
405583|NCT00905515|967966|P2|NOT COMPLETED|Overall Study||0
405584|NCT00905515|967967|P1|NOT COMPLETED|Overall Study||2
405585|NCT00905515|967965|P3|COMPLETED|Overall Study||20
405586|NCT00905515|967966|P2|COMPLETED|Overall Study||20
405587|NCT00905515|967967|P1|COMPLETED|Overall Study||19
405588|NCT00905515|967965|P3|STARTED|Overall Study||22
405589|NCT00905515|967966|P2|STARTED|Overall Study||20
405590|NCT00905515|967967|P1|STARTED|Overall Study||21
405591|NCT00905489|967975|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
405592|NCT00905489|967975|P1|COMPLETED|Optional Extension Phase (OEP)||39
405593|NCT00905489|967975|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
405594|NCT00905489|967975|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
405595|NCT00905489|967975|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
405596|NCT00905489|967975|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
405597|NCT00905437|968024|P2|NOT COMPLETED|Overall Study||10
405598|NCT00905437|968025|P1|NOT COMPLETED|Overall Study||8
405599|NCT00905437|968024|P2|COMPLETED|Overall Study||27
405600|NCT00905437|968025|P1|COMPLETED|Overall Study||27
405601|NCT00905437|968024|P2|STARTED|Overall Study||37
405602|NCT00905437|968025|P1|STARTED|Overall Study||35
405603|NCT00905424|968045|P2|NOT COMPLETED|Overall Study||9
405604|NCT00905424|968046|P1|NOT COMPLETED|Overall Study||11
405605|NCT00905424|968045|P2|COMPLETED|Overall Study||79
405606|NCT00905424|968046|P1|COMPLETED|Overall Study||78
405607|NCT00905424|968045|P2|STARTED|Overall Study||88
405608|NCT00905424|968046|P1|STARTED|Overall Study||89
405609|NCT00905359|968088|P2|NOT COMPLETED|Overall Study||16
405610|NCT00905359|968089|P1|NOT COMPLETED|Overall Study||24
405611|NCT00905359|968088|P2|COMPLETED|Overall Study||65
405612|NCT00905359|968089|P1|COMPLETED|Overall Study||58
405613|NCT00905359|968088|P2|24 Months Follow up|Overall Study||65
405614|NCT00905359|968089|P1|24 Months Follow up|Overall Study||58
405615|NCT00905359|968088|P2|12 Months Follow up|Overall Study||72
405616|NCT00905359|968089|P1|12 Months Follow up|Overall Study||68
405617|NCT00905359|968088|P2|STARTED|Overall Study||81
405618|NCT00905359|968089|P1|STARTED|Overall Study||82
405619|NCT00905346|968125|P2|NOT COMPLETED|Period 2||0
405620|NCT00905346|968126|P1|NOT COMPLETED|Period 2||0
405621|NCT00905346|968125|P2|COMPLETED|Period 2||11
405622|NCT00905346|968126|P1|COMPLETED|Period 2||10
405623|NCT00905346|968125|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
405624|NCT00905346|968126|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
405625|NCT00905346|968125|P2|NOT COMPLETED|Period 1||0
405626|NCT00905346|968126|P1|NOT COMPLETED|Period 1||1
405627|NCT00905346|968125|P2|COMPLETED|Period 1||12
405628|NCT00905346|968126|P1|COMPLETED|Period 1||11
405629|NCT00905346|968125|P2|STARTED|Period 1||12
405630|NCT00905346|968126|P1|STARTED|Period 1||12
405631|NCT00905307|968140|P6|NOT COMPLETED|Overall Study||42
405632|NCT00905307|968141|P5|NOT COMPLETED|Overall Study||16
405633|NCT00905307|968142|P4|NOT COMPLETED|Overall Study||37
405634|NCT00905307|968143|P3|NOT COMPLETED|Overall Study||37
405635|NCT00905307|968144|P2|NOT COMPLETED|Overall Study||37
405636|NCT00905307|968145|P1|NOT COMPLETED|Overall Study||22
405637|NCT00905307|968140|P6|COMPLETED|Overall Study||53
405638|NCT00905307|968141|P5|COMPLETED|Overall Study||34
405639|NCT00905307|968142|P4|COMPLETED|Overall Study||56
405640|NCT00905307|968143|P3|COMPLETED|Overall Study||53
405641|NCT00905307|968144|P2|COMPLETED|Overall Study||52
405642|NCT00905307|968145|P1|COMPLETED|Overall Study||20
405643|NCT00905307|968140|P6|STARTED|Overall Study||95
405644|NCT00905307|968141|P5|STARTED|Overall Study||50
405645|NCT00905307|968142|P4|STARTED|Overall Study||93
405646|NCT00905307|968143|P3|STARTED|Overall Study||90
405647|NCT00905307|968144|P2|STARTED|Overall Study||89
405648|NCT00905307|968145|P1|STARTED|Overall Study||42
405649|NCT00905268|968205|P4|NOT COMPLETED|Overall Study||2
405650|NCT00905268|968206|P3|NOT COMPLETED|Overall Study||0
405651|NCT00905268|968207|P2|NOT COMPLETED|Overall Study||1
405652|NCT00905268|968208|P1|NOT COMPLETED|Overall Study||4
405653|NCT00905268|968205|P4|COMPLETED|Overall Study||57
405654|NCT00905268|968206|P3|COMPLETED|Overall Study||59
405655|NCT00905268|968207|P2|COMPLETED|Overall Study||56
405656|NCT00905268|968208|P1|COMPLETED|Overall Study||53
405657|NCT00905268|968205|P4|STARTED|Overall Study||59
405658|NCT00905268|968206|P3|STARTED|Overall Study||59
405659|NCT00905268|968207|P2|STARTED|Overall Study||57
405660|NCT00905268|968208|P1|STARTED|Overall Study||57
405661|NCT00905255|968240|P2|NOT COMPLETED|Overall Study||9
405662|NCT00905255|968241|P1|NOT COMPLETED|Overall Study||13
405663|NCT00905255|968240|P2|COMPLETED|Overall Study||27
405664|NCT00905255|968241|P1|COMPLETED|Overall Study||20
405665|NCT00905255|968240|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
405755|NCT00904423|968405|P1|NOT COMPLETED|Overall Study||0
405666|NCT00905255|968241|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
405667|NCT00905255|968240|P2|Safety Population|Overall Study||36
405668|NCT00905255|968241|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
405669|NCT00905255|968240|P2|STARTED|Overall Study||36
405670|NCT00905255|968241|P1|STARTED|Overall Study|Randomized.|33
405671|NCT00904943|968259|P2|NOT COMPLETED|Period 2||0
405672|NCT00904943|968260|P1|NOT COMPLETED|Period 2||0
405673|NCT00904943|968259|P2|COMPLETED|Period 2||8
405674|NCT00904943|968260|P1|COMPLETED|Period 2||9
405675|NCT00904943|968259|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
405676|NCT00904943|968260|P1|STARTED|Period 2||9
405677|NCT00904943|968259|P2|NOT COMPLETED|Period 1||0
405678|NCT00904943|968260|P1|NOT COMPLETED|Period 1||0
405679|NCT00904943|968259|P2|COMPLETED|Period 1||9
405680|NCT00904943|968260|P1|COMPLETED|Period 1||9
405681|NCT00904943|968259|P2|STARTED|Period 1||9
405682|NCT00904943|968260|P1|STARTED|Period 1||9
405683|NCT00904917|968272|P4|NOT COMPLETED|Overall Study||2
405684|NCT00904917|968273|P3|NOT COMPLETED|Overall Study||2
405685|NCT00904917|968274|P2|NOT COMPLETED|Overall Study||2
405686|NCT00904917|968275|P1|NOT COMPLETED|Overall Study||2
405687|NCT00904917|968272|P4|COMPLETED|Overall Study||6
405688|NCT00904917|968273|P3|COMPLETED|Overall Study||6
405689|NCT00904917|968274|P2|COMPLETED|Overall Study||9
405690|NCT00904917|968275|P1|COMPLETED|Overall Study||5
405691|NCT00904917|968272|P4|STARTED|Overall Study||8
405692|NCT00904917|968273|P3|STARTED|Overall Study||8
405693|NCT00904917|968274|P2|STARTED|Overall Study||11
405694|NCT00904917|968275|P1|STARTED|Overall Study||7
405695|NCT00904839|968293|P3|NOT COMPLETED|Overall Study||15
405696|NCT00904839|968294|P2|NOT COMPLETED|Overall Study||18
405697|NCT00904839|968295|P1|NOT COMPLETED|Overall Study||1
405698|NCT00904839|968293|P3|COMPLETED|Overall Study||27
405699|NCT00904839|968294|P2|COMPLETED|Overall Study||64
405700|NCT00904839|968295|P1|COMPLETED|Overall Study||3
405701|NCT00904839|968293|P3|STARTED|Overall Study|Randomised|42
405702|NCT00904839|968294|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
405703|NCT00904839|968295|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
405704|NCT00904826|968329|P1|NOT COMPLETED|Overall Study||0
405705|NCT00904826|968329|P1|COMPLETED|Overall Study||14
405706|NCT00904826|968329|P1|STARTED|Overall Study||14
405707|NCT00904748|968341|P6|NOT COMPLETED|Overall Study||0
405708|NCT00904748|968342|P5|NOT COMPLETED|Overall Study||1
405709|NCT00904748|968343|P4|NOT COMPLETED|Overall Study||2
405710|NCT00904748|968344|P3|NOT COMPLETED|Overall Study||1
405711|NCT00904748|968345|P2|NOT COMPLETED|Overall Study||1
405712|NCT00904748|968346|P1|NOT COMPLETED|Overall Study||1
405713|NCT00904748|968341|P6|COMPLETED|Overall Study||8
405714|NCT00904748|968342|P5|COMPLETED|Overall Study||7
405715|NCT00904748|968343|P4|COMPLETED|Overall Study||6
405716|NCT00904748|968344|P3|COMPLETED|Overall Study||7
405717|NCT00904748|968345|P2|COMPLETED|Overall Study||7
405718|NCT00904748|968346|P1|COMPLETED|Overall Study||7
405719|NCT00904748|968341|P6|Received Treatment|Overall Study||8
405720|NCT00904748|968342|P5|Received Treatment|Overall Study||7
405721|NCT00904748|968343|P4|Received Treatment|Overall Study||8
405722|NCT00904748|968344|P3|Received Treatment|Overall Study||8
405723|NCT00904748|968345|P2|Received Treatment|Overall Study||8
405724|NCT00904748|968346|P1|Received Treatment|Overall Study||8
405725|NCT00904748|968341|P6|STARTED|Overall Study||8
405726|NCT00904748|968342|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
405727|NCT00904748|968343|P4|STARTED|Overall Study||8
405728|NCT00904748|968344|P3|STARTED|Overall Study||8
405729|NCT00904748|968345|P2|STARTED|Overall Study||8
405730|NCT00904748|968346|P1|STARTED|Overall Study||8
405731|NCT00904722|968370|P1|NOT COMPLETED|Overall Study||1
405732|NCT00904722|968370|P1|COMPLETED|Overall Study||29
405733|NCT00904722|968370|P1|STARTED|Overall Study||30
405734|NCT00904670|968375|P2|NOT COMPLETED|Second Intervention Period||0
405735|NCT00904670|968376|P1|NOT COMPLETED|Second Intervention Period||0
405736|NCT00904670|968375|P2|COMPLETED|Second Intervention Period||22
405737|NCT00904670|968376|P1|COMPLETED|Second Intervention Period||17
405738|NCT00904670|968375|P2|STARTED|Second Intervention Period||22
405739|NCT00904670|968376|P1|STARTED|Second Intervention Period||17
405740|NCT00904670|968375|P2|NOT COMPLETED|First Intervention Period||0
405741|NCT00904670|968376|P1|NOT COMPLETED|First Intervention Period||0
405742|NCT00904670|968375|P2|COMPLETED|First Intervention Period||22
405743|NCT00904670|968376|P1|COMPLETED|First Intervention Period||17
405744|NCT00904670|968375|P2|STARTED|First Intervention Period||22
405745|NCT00904670|968376|P1|STARTED|First Intervention Period||17
405746|NCT00904670|968375|P2|NOT COMPLETED|Open Label Phase||0
405747|NCT00904670|968376|P1|NOT COMPLETED|Open Label Phase||6
405748|NCT00904670|968375|P2|COMPLETED|Open Label Phase||22
405749|NCT00904670|968376|P1|COMPLETED|Open Label Phase||17
405750|NCT00904670|968375|P2|STARTED|Open Label Phase||22
405751|NCT00904670|968376|P1|STARTED|Open Label Phase||23
405752|NCT00904618|968397|P1|NOT COMPLETED|Overall Study||0
405753|NCT00904618|968397|P1|COMPLETED|Overall Study||48
405754|NCT00904618|968397|P1|STARTED|Overall Study||48
405756|NCT00904423|968405|P1|COMPLETED|Overall Study||8
405757|NCT00904423|968405|P1|STARTED|Overall Study||8
405758|NCT00904371|968413|P1|NOT COMPLETED|Overall Study||9
405759|NCT00904371|968413|P1|COMPLETED|Overall Study||202
405760|NCT00904371|968413|P1|STARTED|Overall Study||211
405761|NCT00904215|968427|P1|NOT COMPLETED|Overall Study||135
405762|NCT00904215|968427|P1|COMPLETED|Overall Study||960
405763|NCT00904215|968427|P1|STARTED|Overall Study||1095
405764|NCT00904189|968434|P1|NOT COMPLETED|Overall Study||0
405765|NCT00904189|968434|P1|COMPLETED|Overall Study||2
405766|NCT00904189|968434|P1|STARTED|Overall Study||2
405767|NCT00904150|968441|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
405768|NCT00904150|968442|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
405769|NCT00904150|968441|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
405770|NCT00904150|968442|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
405771|NCT00904150|968441|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
405772|NCT00904150|968442|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
405773|NCT00904150|968441|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
405774|NCT00904150|968442|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
405775|NCT00904150|968441|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
405776|NCT00904150|968442|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
405777|NCT00904150|968441|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
405778|NCT00904150|968442|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
405779|NCT00904150|968441|P2|NOT COMPLETED|Saliva Samples (DNA)||145
405780|NCT00904150|968442|P1|NOT COMPLETED|Saliva Samples (DNA)||3
405781|NCT00904150|968441|P2|COMPLETED|Saliva Samples (DNA)||155
405782|NCT00904150|968442|P1|COMPLETED|Saliva Samples (DNA)||282
405783|NCT00904150|968441|P2|STARTED|Saliva Samples (DNA)||300
405784|NCT00904150|968442|P1|STARTED|Saliva Samples (DNA)||285
405785|NCT00904007|968462|P2|NOT COMPLETED|Overall Study||0
405786|NCT00904007|968463|P1|NOT COMPLETED|Overall Study||0
405787|NCT00904007|968462|P2|COMPLETED|Overall Study||56
405788|NCT00904007|968463|P1|COMPLETED|Overall Study||55
405789|NCT00904007|968462|P2|STARTED|Overall Study||56
405790|NCT00904007|968463|P1|STARTED|Overall Study||55
405791|NCT00903929|968469|P4|NOT COMPLETED|Overall Study||3
405792|NCT00903929|968470|P3|NOT COMPLETED|Overall Study||1
405793|NCT00903929|968471|P2|NOT COMPLETED|Overall Study||0
405794|NCT00903929|968472|P1|NOT COMPLETED|Overall Study||0
405795|NCT00903929|968469|P4|COMPLETED|Overall Study||6
405796|NCT00903929|968470|P3|COMPLETED|Overall Study||3
405797|NCT00903929|968471|P2|COMPLETED|Overall Study||3
405798|NCT00903929|968472|P1|COMPLETED|Overall Study||3
405799|NCT00903929|968469|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
405800|NCT00903929|968470|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
405801|NCT00903929|968471|P2|STARTED|Overall Study||3
405802|NCT00903929|968472|P1|STARTED|Overall Study||3
405803|NCT00902850|968480|P2|NOT COMPLETED|Overall Study||2
405804|NCT00902850|968481|P1|NOT COMPLETED|Overall Study||2
405805|NCT00902850|968480|P2|COMPLETED|Overall Study||12
405806|NCT00902850|968481|P1|COMPLETED|Overall Study||12
405807|NCT00902850|968480|P2|STARTED|Overall Study||14
405808|NCT00902850|968481|P1|STARTED|Overall Study||14
405809|NCT00903695|968489|P2|NOT COMPLETED|Overall Study||0
405810|NCT00903695|968490|P1|NOT COMPLETED|Overall Study||2
405811|NCT00903695|968489|P2|COMPLETED|Overall Study||2
405812|NCT00903695|968490|P1|COMPLETED|Overall Study||6
405813|NCT00903695|968489|P2|STARTED|Overall Study||2
405814|NCT00903695|968490|P1|STARTED|Overall Study||8
405815|NCT00903682|968512|P2|NOT COMPLETED|Overall Study||15
405816|NCT00903682|968513|P1|NOT COMPLETED|Overall Study||16
405817|NCT00903682|968512|P2|COMPLETED|Overall Study||63
405818|NCT00903682|968513|P1|COMPLETED|Overall Study||63
405819|NCT00903682|968512|P2|STARTED|Overall Study||78
405820|NCT00903682|968513|P1|STARTED|Overall Study||79
405821|NCT00903630|968534|P3|NOT COMPLETED|Phase 2||1
405822|NCT00903630|968535|P2|NOT COMPLETED|Phase 2||0
405823|NCT00903630|968536|P1|NOT COMPLETED|Phase 2||0
405824|NCT00903630|968534|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
405825|NCT00903630|968535|P2|COMPLETED|Phase 2||0
405826|NCT00903630|968536|P1|COMPLETED|Phase 2||6
405827|NCT00903630|968534|P3|STARTED|Phase 2||4
405828|NCT00903630|968535|P2|STARTED|Phase 2||0
405829|NCT00903630|968536|P1|STARTED|Phase 2||6
405830|NCT00903630|968534|P3|NOT COMPLETED|Phase l||0
405831|NCT00903630|968535|P2|NOT COMPLETED|Phase l||0
405832|NCT00903630|968536|P1|NOT COMPLETED|Phase l||0
405833|NCT00903630|968534|P3|COMPLETED|Phase l||0
405834|NCT00903630|968535|P2|COMPLETED|Phase l||5
405835|NCT00903630|968536|P1|COMPLETED|Phase l||6
405836|NCT00903630|968534|P3|STARTED|Phase l||0
405837|NCT00903630|968535|P2|STARTED|Phase l||5
405838|NCT00903630|968536|P1|STARTED|Phase l||6
405839|NCT00903448|968550|P2|NOT COMPLETED|Period 3: 5 Days||0
405840|NCT00903448|968551|P1|NOT COMPLETED|Period 3: 5 Days||0
405841|NCT00903448|968550|P2|COMPLETED|Period 3: 5 Days||20
405842|NCT00903448|968551|P1|COMPLETED|Period 3: 5 Days||20
405843|NCT00903448|968550|P2|STARTED|Period 3: 5 Days||20
405844|NCT00903448|968551|P1|STARTED|Period 3: 5 Days||20
405845|NCT00903448|968550|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
405846|NCT00903448|968551|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
405847|NCT00903448|968550|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
405848|NCT00903448|968551|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
405849|NCT00903448|968550|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
405850|NCT00903448|968551|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
405851|NCT00903448|968550|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
405852|NCT00903448|968551|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
405853|NCT00903448|968550|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
405854|NCT00903448|968551|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
405855|NCT00903448|968550|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
405856|NCT00903448|968551|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
405857|NCT00903409|968559|P2|NOT COMPLETED|Overall Study||27
405858|NCT00903409|968560|P1|NOT COMPLETED|Overall Study||26
405859|NCT00903409|968559|P2|COMPLETED|Overall Study||73
405860|NCT00903409|968560|P1|COMPLETED|Overall Study||62
405861|NCT00903409|968559|P2|STARTED|Overall Study||100
405862|NCT00903409|968560|P1|STARTED|Overall Study||88
405863|NCT00903396|968578|P4|NOT COMPLETED|Overall Study||0
405864|NCT00903396|968579|P3|NOT COMPLETED|Overall Study||0
405865|NCT00903396|968580|P2|NOT COMPLETED|Overall Study||0
405866|NCT00903396|968581|P1|NOT COMPLETED|Overall Study||0
405867|NCT00903396|968578|P4|COMPLETED|Overall Study||1
405868|NCT00903396|968579|P3|COMPLETED|Overall Study||3
405869|NCT00903396|968580|P2|COMPLETED|Overall Study||1
405870|NCT00903396|968581|P1|COMPLETED|Overall Study||2
405871|NCT00903396|968578|P4|STARTED|Overall Study||1
405872|NCT00903396|968579|P3|STARTED|Overall Study||3
405873|NCT00903396|968580|P2|STARTED|Overall Study||1
405874|NCT00903396|968581|P1|STARTED|Overall Study||2
405875|NCT00903383|968611|P4|NOT COMPLETED|Overall Study||5
405876|NCT00903383|968612|P3|NOT COMPLETED|Overall Study||3
405877|NCT00903383|968613|P2|NOT COMPLETED|Overall Study||6
405878|NCT00903383|968614|P1|NOT COMPLETED|Overall Study||7
405879|NCT00903383|968611|P4|COMPLETED|Overall Study||44
405880|NCT00903383|968612|P3|COMPLETED|Overall Study||47
405881|NCT00903383|968613|P2|COMPLETED|Overall Study||48
405882|NCT00903383|968614|P1|COMPLETED|Overall Study||48
405883|NCT00903383|968611|P4|STARTED|Overall Study||49
405884|NCT00903383|968612|P3|STARTED|Overall Study||50
405885|NCT00903383|968613|P2|STARTED|Overall Study||54
405886|NCT00903383|968614|P1|STARTED|Overall Study||55
405887|NCT00903370|968646|P2|NOT COMPLETED|Overall Study||24
405888|NCT00903370|968647|P1|NOT COMPLETED|Overall Study||28
405889|NCT00903370|968646|P2|COMPLETED|Overall Study||109
405890|NCT00903370|968647|P1|COMPLETED|Overall Study||99
405891|NCT00903370|968646|P2|STARTED|Overall Study||133
405892|NCT00903370|968647|P1|STARTED|Overall Study||127
405893|NCT00903357|968655|P2|NOT COMPLETED|Second Intervention||0
405894|NCT00903357|968656|P1|NOT COMPLETED|Second Intervention||1
405895|NCT00903357|968655|P2|COMPLETED|Second Intervention||22
405896|NCT00903357|968656|P1|COMPLETED|Second Intervention||21
405897|NCT00903357|968655|P2|STARTED|Second Intervention||22
405898|NCT00903357|968656|P1|STARTED|Second Intervention||22
405899|NCT00903357|968655|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
405900|NCT00903357|968656|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
405901|NCT00903357|968655|P2|COMPLETED|Wash Out Period of 2 Weeks||22
405902|NCT00903357|968656|P1|COMPLETED|Wash Out Period of 2 Weeks||22
405903|NCT00903357|968655|P2|STARTED|Wash Out Period of 2 Weeks||23
405904|NCT00903357|968656|P1|STARTED|Wash Out Period of 2 Weeks||22
405905|NCT00903357|968655|P2|NOT COMPLETED|First Intervention||4
405906|NCT00903357|968656|P1|NOT COMPLETED|First Intervention||5
405907|NCT00903357|968655|P2|COMPLETED|First Intervention||23
405908|NCT00903357|968656|P1|COMPLETED|First Intervention||22
405909|NCT00903357|968655|P2|STARTED|First Intervention||27
405910|NCT00903357|968656|P1|STARTED|First Intervention||27
405911|NCT00903344|968668|P2|NOT COMPLETED|Overall Study||3
405912|NCT00903344|968669|P1|NOT COMPLETED|Overall Study||5
405913|NCT00903344|968668|P2|COMPLETED|Overall Study||7
405914|NCT00903344|968669|P1|COMPLETED|Overall Study||7
405915|NCT00903344|968668|P2|6 Month Visit|Overall Study||10
405916|NCT00903344|968669|P1|6 Month Visit|Overall Study||9
405917|NCT00903344|968668|P2|3 Month Visit|Overall Study||10
405918|NCT00903344|968669|P1|3 Month Visit|Overall Study||10
405919|NCT00903344|968668|P2|STARTED|Overall Study||10
405920|NCT00903344|968669|P1|STARTED|Overall Study||12
405921|NCT00903331|968687|P2|NOT COMPLETED|Overall Study||18
405922|NCT00903331|968688|P1|NOT COMPLETED|Overall Study||5
405923|NCT00903331|968687|P2|COMPLETED|Overall Study||101
405924|NCT00903331|968688|P1|COMPLETED|Overall Study||54
405925|NCT00903331|968687|P2|STARTED|Overall Study||119
405926|NCT00903331|968688|P1|STARTED|Overall Study||59
405927|NCT00903175|968698|P2|NOT COMPLETED|Period 2 - Second Line||36
405928|NCT00903175|968699|P1|NOT COMPLETED|Period 2 - Second Line||49
405929|NCT00903175|968698|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
405930|NCT00903175|968699|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
405931|NCT00903175|968698|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
405932|NCT00903175|968699|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
405933|NCT00903175|968698|P2|NOT COMPLETED|Period 1 - First Line||89
405934|NCT00903175|968699|P1|NOT COMPLETED|Period 1 - First Line||77
405935|NCT00903175|968698|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
405936|NCT00903175|968699|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
405937|NCT00903175|968698|P2|STARTED|Period 1 - First Line||231
405938|NCT00903175|968699|P1|STARTED|Period 1 - First Line||238
405939|NCT00903162|968729|P1|NOT COMPLETED|Overall Study||4
405940|NCT00903162|968729|P1|COMPLETED|Overall Study||12
405941|NCT00903162|968729|P1|STARTED|Overall Study||16
405942|NCT00903032|968737|P2|NOT COMPLETED|Overall Study||5
405943|NCT00903032|968738|P1|NOT COMPLETED|Overall Study||7
405944|NCT00903032|968737|P2|COMPLETED|Overall Study||119
405945|NCT00903032|968738|P1|COMPLETED|Overall Study||122
405946|NCT00903032|968737|P2|STARTED|Overall Study||124
405947|NCT00903032|968738|P1|STARTED|Overall Study||129
405948|NCT00903006|968748|P4|NOT COMPLETED|Overall Study||0
405949|NCT00903006|968749|P3|NOT COMPLETED|Overall Study||1
405950|NCT00903006|968750|P2|NOT COMPLETED|Overall Study||3
405951|NCT00903006|968751|P1|NOT COMPLETED|Overall Study||2
405952|NCT00903006|968748|P4|COMPLETED|Overall Study||0
405953|NCT00903006|968749|P3|COMPLETED|Overall Study||0
405954|NCT00903006|968750|P2|COMPLETED|Overall Study||0
405955|NCT00903006|968751|P1|COMPLETED|Overall Study||0
405956|NCT00903006|968748|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
405957|NCT00903006|968749|P3|STARTED|Overall Study||1
405958|NCT00903006|968750|P2|STARTED|Overall Study||3
405959|NCT00903006|968751|P1|STARTED|Overall Study||2
405960|NCT00902746|968761|P1|NOT COMPLETED|Overall Study||36
405961|NCT00902746|968761|P1|COMPLETED|Overall Study||113
405962|NCT00902746|968761|P1|Transfer to Step 2|Overall Study||133
405963|NCT00902746|968761|P1|Initiation of Study Drug Administration|Overall Study||148
405964|NCT00902746|968761|P1|STARTED|Overall Study||149
405965|NCT00902668|968766|P1|NOT COMPLETED|Overall Study||3
405966|NCT00902668|968766|P1|COMPLETED|Overall Study||0
405967|NCT00902668|968766|P1|STARTED|Overall Study||3
405968|NCT00902564|968770|P1|NOT COMPLETED|Overall Study||2
405969|NCT00902564|968770|P1|COMPLETED|Overall Study||28
405970|NCT00902564|968770|P1|STARTED|Overall Study||30
405971|NCT00902538|968785|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
405972|NCT00902538|968786|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
405973|NCT00902538|968787|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
405974|NCT00902538|968788|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
405975|NCT00902538|968789|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
405976|NCT00902538|968790|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
405977|NCT00902538|968785|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
405978|NCT00902538|968786|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
405979|NCT00902538|968787|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
405980|NCT00902538|968788|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
405981|NCT00902538|968789|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
405982|NCT00902538|968790|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
405983|NCT00902538|968785|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
405984|NCT00902538|968786|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
405985|NCT00902538|968787|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
405986|NCT00902538|968788|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
405987|NCT00902538|968789|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
405988|NCT00902538|968790|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
405989|NCT00902538|968785|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
405990|NCT00902538|968786|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
405991|NCT00902538|968787|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
405992|NCT00902538|968788|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
405993|NCT00902538|968789|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
405994|NCT00902538|968790|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
405995|NCT00902538|968785|P6|COMPLETED|3-Single-blind, Single Treatment||0
405996|NCT00902538|968786|P5|COMPLETED|3-Single-blind, Single Treatment||0
405997|NCT00902538|968787|P4|COMPLETED|3-Single-blind, Single Treatment||0
405998|NCT00902538|968788|P3|COMPLETED|3-Single-blind, Single Treatment||0
405999|NCT00902538|968789|P2|COMPLETED|3-Single-blind, Single Treatment||767
406000|NCT00902538|968790|P1|COMPLETED|3-Single-blind, Single Treatment||0
406001|NCT00902538|968785|P6|STARTED|3-Single-blind, Single Treatment||0
406002|NCT00902538|968786|P5|STARTED|3-Single-blind, Single Treatment||0
406003|NCT00902538|968787|P4|STARTED|3-Single-blind, Single Treatment||0
406004|NCT00902538|968788|P3|STARTED|3-Single-blind, Single Treatment||0
406005|NCT00902538|968789|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
406006|NCT00902538|968790|P1|STARTED|3-Single-blind, Single Treatment||0
406007|NCT00902538|968785|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
406008|NCT00902538|968786|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
406009|NCT00902538|968787|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
406010|NCT00902538|968788|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
406011|NCT00902538|968789|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
406012|NCT00902538|968790|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
406013|NCT00902538|968785|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
406014|NCT00902538|968786|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
406015|NCT00902538|968787|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
406016|NCT00902538|968788|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
406017|NCT00902538|968789|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
406018|NCT00902538|968790|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
406019|NCT00902538|968785|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
406020|NCT00902538|968786|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
406021|NCT00902538|968787|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
406022|NCT00902538|968788|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
406023|NCT00902538|968789|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
406024|NCT00902538|968790|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
406025|NCT00902538|968785|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406026|NCT00902538|968786|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406027|NCT00902538|968787|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406028|NCT00902538|968788|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406029|NCT00902538|968789|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406030|NCT00902538|968790|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
406031|NCT00902538|968785|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406032|NCT00902538|968786|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406033|NCT00902538|968787|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406034|NCT00902538|968788|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406035|NCT00902538|968789|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
406036|NCT00902538|968790|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
406037|NCT00902538|968785|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
406038|NCT00902538|968786|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
406039|NCT00902538|968787|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
406040|NCT00902538|968788|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
406041|NCT00902538|968789|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
406042|NCT00902538|968790|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
406043|NCT00902330|968822|P2|NOT COMPLETED|Overall Study||5
406044|NCT00902330|968823|P1|NOT COMPLETED|Overall Study||4
406045|NCT00902330|968822|P2|COMPLETED|Overall Study||75
406046|NCT00902330|968823|P1|COMPLETED|Overall Study||77
406047|NCT00902330|968822|P2|STARTED|Overall Study||80
406048|NCT00902330|968823|P1|STARTED|Overall Study||81
406049|NCT00902304|968860|P3|NOT COMPLETED|Overall Study||110
406050|NCT00902304|968861|P2|NOT COMPLETED|Overall Study||71
406051|NCT00902304|968862|P1|NOT COMPLETED|Overall Study||58
406052|NCT00902304|968860|P3|COMPLETED|Overall Study||568
406053|NCT00902304|968861|P2|COMPLETED|Overall Study||289
406054|NCT00902304|968862|P1|COMPLETED|Overall Study||466
406055|NCT00902304|968860|P3|STARTED|Overall Study||678
406056|NCT00902304|968861|P2|STARTED|Overall Study||360
406057|NCT00902304|968862|P1|STARTED|Overall Study||524
406058|NCT00902265|968907|P1|NOT COMPLETED|Overall Study||6
406059|NCT00902265|968907|P1|COMPLETED|Overall Study||132
406060|NCT00902265|968907|P1|Participants Who Received Treatment|Overall Study||137
406061|NCT00902265|968907|P1|STARTED|Overall Study||138
406062|NCT00902226|968919|P1|NOT COMPLETED|Overall Study||0
406063|NCT00902226|968919|P1|COMPLETED|Overall Study||30
406064|NCT00902226|968919|P1|STARTED|Overall Study||30
406065|NCT00902174|968931|P2|NOT COMPLETED|Overall Study||18
406066|NCT00902174|968932|P1|NOT COMPLETED|Overall Study||34
406067|NCT00902174|968931|P2|COMPLETED|Overall Study||81
406068|NCT00902174|968932|P1|COMPLETED|Overall Study||69
406069|NCT00902174|968931|P2|STARTED|Overall Study||99
406070|NCT00902174|968932|P1|STARTED|Overall Study||103
406071|NCT00902161|968970|P3|NOT COMPLETED|Period 2||0
406072|NCT00902161|968971|P2|NOT COMPLETED|Period 2||0
406073|NCT00902161|968972|P1|NOT COMPLETED|Period 2||0
406074|NCT00902161|968970|P3|COMPLETED|Period 2||0
406075|NCT00902161|968971|P2|COMPLETED|Period 2||9
406076|NCT00902161|968972|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
406077|NCT00902161|968970|P3|STARTED|Period 2||0
406078|NCT00902161|968971|P2|STARTED|Period 2||9
406079|NCT00902161|968972|P1|STARTED|Period 2||8
406080|NCT00902161|968970|P3|NOT COMPLETED|Post-clamp Washout||0
406081|NCT00902161|968971|P2|NOT COMPLETED|Post-clamp Washout||0
406082|NCT00902161|968972|P1|NOT COMPLETED|Post-clamp Washout||0
406083|NCT00902161|968970|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
406084|NCT00902161|968971|P2|COMPLETED|Post-clamp Washout||0
406085|NCT00902161|968972|P1|COMPLETED|Post-clamp Washout||0
406086|NCT00902161|968970|P3|STARTED|Post-clamp Washout||22
406087|NCT00902161|968971|P2|STARTED|Post-clamp Washout||0
406088|NCT00902161|968972|P1|STARTED|Post-clamp Washout||0
406089|NCT00902161|968970|P3|NOT COMPLETED|Period 1||0
406090|NCT00902161|968971|P2|NOT COMPLETED|Period 1||0
406091|NCT00902161|968972|P1|NOT COMPLETED|Period 1||0
406092|NCT00902161|968970|P3|COMPLETED|Period 1||0
406093|NCT00902161|968971|P2|COMPLETED|Period 1||10
406094|NCT00902161|968972|P1|COMPLETED|Period 1||12
406095|NCT00902161|968970|P3|STARTED|Period 1||0
406096|NCT00902161|968971|P2|STARTED|Period 1||10
406097|NCT00902161|968972|P1|STARTED|Period 1||12
406098|NCT00902161|968970|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
406099|NCT00902161|968971|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
406100|NCT00902161|968972|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
406101|NCT00902161|968970|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
406102|NCT00902161|968971|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
406103|NCT00902161|968972|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
406104|NCT00902161|968970|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
406105|NCT00902161|968971|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
406106|NCT00902161|968972|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
406107|NCT00901901|968989|P2|NOT COMPLETED|Follow-up Period||259
406108|NCT00901901|968990|P1|NOT COMPLETED|Follow-up Period||246
406109|NCT00901901|968989|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
406110|NCT00901901|968990|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
406111|NCT00901901|968989|P2|STARTED|Follow-up Period||324
406112|NCT00901901|968990|P1|STARTED|Follow-up Period||322
406113|NCT00901901|968989|P2|NOT COMPLETED|Treatment Period||168
406114|NCT00901901|968990|P1|NOT COMPLETED|Treatment Period||157
406115|NCT00901901|968989|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
406116|NCT00901901|968990|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
406117|NCT00901901|968989|P2|Participants Received Treatment|Treatment Period||355
406118|NCT00901901|968990|P1|Participants Received Treatment|Treatment Period||362
406119|NCT00901901|968989|P2|STARTED|Treatment Period||358
406120|NCT00901901|968990|P1|STARTED|Treatment Period||362
406121|NCT00899574|969010|P1|NOT COMPLETED|Overall Study||0
406122|NCT00899574|969010|P1|COMPLETED|Overall Study||10
406123|NCT00899574|969010|P1|STARTED|Overall Study||10
406124|NCT00899470|969015|P4|NOT COMPLETED|Fourth Therapy||0
406125|NCT00899470|969016|P3|NOT COMPLETED|Fourth Therapy||0
406126|NCT00899470|969017|P2|NOT COMPLETED|Fourth Therapy||0
406127|NCT00899470|969018|P1|NOT COMPLETED|Fourth Therapy||0
406128|NCT00899470|969015|P4|COMPLETED|Fourth Therapy||6
406129|NCT00899470|969016|P3|COMPLETED|Fourth Therapy||6
406130|NCT00899470|969017|P2|COMPLETED|Fourth Therapy||6
406131|NCT00899470|969018|P1|COMPLETED|Fourth Therapy||6
406132|NCT00899470|969015|P4|STARTED|Fourth Therapy||6
406133|NCT00899470|969016|P3|STARTED|Fourth Therapy||6
406134|NCT00899470|969017|P2|STARTED|Fourth Therapy||6
406135|NCT00899470|969018|P1|STARTED|Fourth Therapy||6
406136|NCT00899470|969015|P4|NOT COMPLETED|Third Washout||0
406137|NCT00899470|969016|P3|NOT COMPLETED|Third Washout||0
406138|NCT00899470|969017|P2|NOT COMPLETED|Third Washout||0
406139|NCT00899470|969018|P1|NOT COMPLETED|Third Washout||0
406140|NCT00899470|969015|P4|COMPLETED|Third Washout||6
406141|NCT00899470|969016|P3|COMPLETED|Third Washout||6
406142|NCT00899470|969017|P2|COMPLETED|Third Washout||6
406143|NCT00899470|969018|P1|COMPLETED|Third Washout||6
406144|NCT00899470|969015|P4|STARTED|Third Washout||6
406145|NCT00899470|969016|P3|STARTED|Third Washout||6
406146|NCT00899470|969017|P2|STARTED|Third Washout||6
406147|NCT00899470|969018|P1|STARTED|Third Washout||6
406148|NCT00899470|969015|P4|NOT COMPLETED|Third Therapy||0
406149|NCT00899470|969016|P3|NOT COMPLETED|Third Therapy||0
406150|NCT00899470|969017|P2|NOT COMPLETED|Third Therapy||0
406151|NCT00899470|969018|P1|NOT COMPLETED|Third Therapy||0
406152|NCT00899470|969015|P4|COMPLETED|Third Therapy||6
406153|NCT00899470|969016|P3|COMPLETED|Third Therapy||6
406154|NCT00899470|969017|P2|COMPLETED|Third Therapy||6
406155|NCT00899470|969018|P1|COMPLETED|Third Therapy||6
406156|NCT00899470|969015|P4|STARTED|Third Therapy||6
406157|NCT00899470|969016|P3|STARTED|Third Therapy||6
406158|NCT00899470|969017|P2|STARTED|Third Therapy||6
406159|NCT00899470|969018|P1|STARTED|Third Therapy||6
406160|NCT00899470|969015|P4|NOT COMPLETED|Second Washout||0
406161|NCT00899470|969016|P3|NOT COMPLETED|Second Washout||0
406162|NCT00899470|969017|P2|NOT COMPLETED|Second Washout||0
406163|NCT00899470|969018|P1|NOT COMPLETED|Second Washout||0
406164|NCT00899470|969015|P4|COMPLETED|Second Washout||6
406165|NCT00899470|969016|P3|COMPLETED|Second Washout||6
406166|NCT00899470|969017|P2|COMPLETED|Second Washout||6
406167|NCT00899470|969018|P1|COMPLETED|Second Washout||6
406168|NCT00899470|969015|P4|STARTED|Second Washout||6
406169|NCT00899470|969016|P3|STARTED|Second Washout||6
406170|NCT00899470|969017|P2|STARTED|Second Washout||6
406171|NCT00899470|969018|P1|STARTED|Second Washout||6
406172|NCT00899470|969015|P4|NOT COMPLETED|Second Therapy||0
406173|NCT00899470|969016|P3|NOT COMPLETED|Second Therapy||0
406174|NCT00899470|969017|P2|NOT COMPLETED|Second Therapy||0
406175|NCT00899470|969018|P1|NOT COMPLETED|Second Therapy||0
406176|NCT00899470|969015|P4|COMPLETED|Second Therapy||6
406177|NCT00899470|969016|P3|COMPLETED|Second Therapy||6
406178|NCT00899470|969017|P2|COMPLETED|Second Therapy||6
406179|NCT00899470|969018|P1|COMPLETED|Second Therapy||6
406180|NCT00899470|969015|P4|STARTED|Second Therapy||6
406181|NCT00899470|969016|P3|STARTED|Second Therapy||6
406182|NCT00899470|969017|P2|STARTED|Second Therapy||6
406183|NCT00899470|969018|P1|STARTED|Second Therapy||6
406184|NCT00899470|969015|P4|NOT COMPLETED|First Washout Period||0
406185|NCT00899470|969016|P3|NOT COMPLETED|First Washout Period||0
406186|NCT00899470|969017|P2|NOT COMPLETED|First Washout Period||0
406187|NCT00899470|969018|P1|NOT COMPLETED|First Washout Period||0
406188|NCT00899470|969015|P4|COMPLETED|First Washout Period||6
406189|NCT00899470|969016|P3|COMPLETED|First Washout Period||6
406190|NCT00899470|969017|P2|COMPLETED|First Washout Period||6
406191|NCT00899470|969018|P1|COMPLETED|First Washout Period||6
406192|NCT00899470|969015|P4|STARTED|First Washout Period||6
406193|NCT00899470|969016|P3|STARTED|First Washout Period||6
406194|NCT00899470|969017|P2|STARTED|First Washout Period||6
406195|NCT00899470|969018|P1|STARTED|First Washout Period||6
406196|NCT00899470|969015|P4|NOT COMPLETED|First Therapy||0
406197|NCT00899470|969016|P3|NOT COMPLETED|First Therapy||0
406198|NCT00899470|969017|P2|NOT COMPLETED|First Therapy||0
406199|NCT00899470|969018|P1|NOT COMPLETED|First Therapy||0
406200|NCT00899470|969015|P4|COMPLETED|First Therapy||6
406201|NCT00899470|969016|P3|COMPLETED|First Therapy||6
406202|NCT00899470|969017|P2|COMPLETED|First Therapy||6
406203|NCT00899470|969018|P1|COMPLETED|First Therapy||6
406204|NCT00899470|969015|P4|STARTED|First Therapy||6
406205|NCT00899470|969016|P3|STARTED|First Therapy||6
406206|NCT00899470|969017|P2|STARTED|First Therapy||6
406207|NCT00899470|969018|P1|STARTED|First Therapy||6
406208|NCT00901628|969096|P2|NOT COMPLETED|Overall Study||10
406209|NCT00901628|969097|P1|NOT COMPLETED|Overall Study||4
406210|NCT00901628|969096|P2|COMPLETED|Overall Study||42
406211|NCT00901628|969097|P1|COMPLETED|Overall Study||45
406212|NCT00901628|969096|P2|STARTED|Overall Study||52
406213|NCT00901628|969097|P1|STARTED|Overall Study||49
406214|NCT00901576|969119|P6|NOT COMPLETED|Third Intervention||0
406215|NCT00901576|969120|P5|NOT COMPLETED|Third Intervention||0
406216|NCT00901576|969121|P4|NOT COMPLETED|Third Intervention||0
406217|NCT00901576|969122|P3|NOT COMPLETED|Third Intervention||0
406218|NCT00901576|969123|P2|NOT COMPLETED|Third Intervention||0
406219|NCT00901576|969124|P1|NOT COMPLETED|Third Intervention||0
406220|NCT00901576|969119|P6|COMPLETED|Third Intervention||5
406221|NCT00901576|969120|P5|COMPLETED|Third Intervention||6
406222|NCT00901576|969121|P4|COMPLETED|Third Intervention||5
406223|NCT00901576|969122|P3|COMPLETED|Third Intervention||7
406224|NCT00901576|969123|P2|COMPLETED|Third Intervention||7
406225|NCT00901576|969124|P1|COMPLETED|Third Intervention||5
406226|NCT00901576|969119|P6|STARTED|Third Intervention||5
406227|NCT00901576|969120|P5|STARTED|Third Intervention||6
406228|NCT00901576|969121|P4|STARTED|Third Intervention||5
406229|NCT00901576|969122|P3|STARTED|Third Intervention||7
406230|NCT00901576|969123|P2|STARTED|Third Intervention||7
406231|NCT00901576|969124|P1|STARTED|Third Intervention||5
406232|NCT00901576|969119|P6|NOT COMPLETED|Washout||0
406233|NCT00901576|969120|P5|NOT COMPLETED|Washout||0
406234|NCT00901576|969121|P4|NOT COMPLETED|Washout||0
406235|NCT00901576|969122|P3|NOT COMPLETED|Washout||0
406236|NCT00901576|969123|P2|NOT COMPLETED|Washout||0
406237|NCT00901576|969124|P1|NOT COMPLETED|Washout||0
406238|NCT00901576|969119|P6|COMPLETED|Washout||5
406239|NCT00901576|969120|P5|COMPLETED|Washout||6
406240|NCT00901576|969121|P4|COMPLETED|Washout||5
406241|NCT00901576|969122|P3|COMPLETED|Washout||7
406242|NCT00901576|969123|P2|COMPLETED|Washout||7
406243|NCT00901576|969124|P1|COMPLETED|Washout||5
406244|NCT00901576|969119|P6|STARTED|Washout||5
406245|NCT00901576|969120|P5|STARTED|Washout||6
406246|NCT00901576|969121|P4|STARTED|Washout||5
406247|NCT00901576|969122|P3|STARTED|Washout||7
406248|NCT00901576|969123|P2|STARTED|Washout||7
406249|NCT00901576|969124|P1|STARTED|Washout||5
406250|NCT00901576|969119|P6|NOT COMPLETED|Second Intervention||1
406251|NCT00901576|969120|P5|NOT COMPLETED|Second Intervention||0
406252|NCT00901576|969121|P4|NOT COMPLETED|Second Intervention||1
406253|NCT00901576|969122|P3|NOT COMPLETED|Second Intervention||0
406254|NCT00901576|969123|P2|NOT COMPLETED|Second Intervention||0
406255|NCT00901576|969124|P1|NOT COMPLETED|Second Intervention||1
406256|NCT00901576|969119|P6|COMPLETED|Second Intervention||5
406257|NCT00901576|969120|P5|COMPLETED|Second Intervention||6
406258|NCT00901576|969121|P4|COMPLETED|Second Intervention||5
406259|NCT00901576|969122|P3|COMPLETED|Second Intervention||7
406260|NCT00901576|969123|P2|COMPLETED|Second Intervention||7
406261|NCT00901576|969124|P1|COMPLETED|Second Intervention||5
406262|NCT00901576|969119|P6|STARTED|Second Intervention||6
406263|NCT00901576|969120|P5|STARTED|Second Intervention||6
406264|NCT00901576|969121|P4|STARTED|Second Intervention||6
406265|NCT00901576|969122|P3|STARTED|Second Intervention||7
406266|NCT00901576|969123|P2|STARTED|Second Intervention||7
406267|NCT00901576|969124|P1|STARTED|Second Intervention||6
406268|NCT00901576|969119|P6|NOT COMPLETED|Washout||0
406269|NCT00901576|969120|P5|NOT COMPLETED|Washout||0
406270|NCT00901576|969121|P4|NOT COMPLETED|Washout||0
406271|NCT00901576|969122|P3|NOT COMPLETED|Washout||0
406272|NCT00901576|969123|P2|NOT COMPLETED|Washout||0
406273|NCT00901576|969124|P1|NOT COMPLETED|Washout||0
406274|NCT00901576|969119|P6|COMPLETED|Washout||6
406275|NCT00901576|969120|P5|COMPLETED|Washout||6
406276|NCT00901576|969121|P4|COMPLETED|Washout||6
406277|NCT00901576|969122|P3|COMPLETED|Washout||7
406278|NCT00901576|969123|P2|COMPLETED|Washout||7
406279|NCT00901576|969124|P1|COMPLETED|Washout||6
406280|NCT00901576|969119|P6|STARTED|Washout||6
406281|NCT00901576|969120|P5|STARTED|Washout||6
406282|NCT00901576|969121|P4|STARTED|Washout||6
406283|NCT00901576|969122|P3|STARTED|Washout||7
406284|NCT00901576|969123|P2|STARTED|Washout||7
406285|NCT00901576|969124|P1|STARTED|Washout||6
406286|NCT00901576|969119|P6|NOT COMPLETED|First Intervention||0
406287|NCT00901576|969120|P5|NOT COMPLETED|First Intervention||0
406288|NCT00901576|969121|P4|NOT COMPLETED|First Intervention||0
406289|NCT00901576|969122|P3|NOT COMPLETED|First Intervention||0
406290|NCT00901576|969123|P2|NOT COMPLETED|First Intervention||0
406291|NCT00901576|969124|P1|NOT COMPLETED|First Intervention||0
406292|NCT00901576|969119|P6|COMPLETED|First Intervention||6
406293|NCT00901576|969120|P5|COMPLETED|First Intervention||6
406294|NCT00901576|969121|P4|COMPLETED|First Intervention||6
406295|NCT00901576|969122|P3|COMPLETED|First Intervention||7
406296|NCT00901576|969123|P2|COMPLETED|First Intervention||7
406297|NCT00901576|969124|P1|COMPLETED|First Intervention||6
406298|NCT00901576|969119|P6|STARTED|First Intervention||6
406299|NCT00901576|969120|P5|STARTED|First Intervention||6
406300|NCT00901576|969121|P4|STARTED|First Intervention||6
406301|NCT00901576|969122|P3|STARTED|First Intervention||7
406302|NCT00901576|969123|P2|STARTED|First Intervention||7
406303|NCT00901576|969124|P1|STARTED|First Intervention||6
406304|NCT00901459|969145|P1|NOT COMPLETED|Overall Study||6
406305|NCT00901459|969145|P1|COMPLETED|Overall Study||15
406306|NCT00901459|969145|P1|STARTED|Overall Study||21
406307|NCT00901342|969156|P1|NOT COMPLETED|Overall Study||15
406308|NCT00901342|969156|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
406309|NCT00901342|969156|P1|Received at Least 1 Infusion|Overall Study||98
406310|NCT00901342|969156|P1|STARTED|Overall Study||104
406311|NCT00901316|969162|P2|NOT COMPLETED|Overall Study||0
406312|NCT00901316|969163|P1|NOT COMPLETED|Overall Study||0
406313|NCT00901316|969162|P2|COMPLETED|Overall Study||495
406314|NCT00901316|969163|P1|COMPLETED|Overall Study||492
406315|NCT00901316|969162|P2|STARTED|Overall Study||495
406316|NCT00901316|969163|P1|STARTED|Overall Study||492
406317|NCT00901225|969169|P1|NOT COMPLETED|Overall Study||1
406318|NCT00901225|969169|P1|COMPLETED|Overall Study||20
406319|NCT00901225|969169|P1|STARTED|Overall Study||21
406320|NCT00901186|969180|P2|NOT COMPLETED|Overall Study||11
406321|NCT00901186|969181|P1|NOT COMPLETED|Overall Study||9
406322|NCT00901186|969180|P2|COMPLETED|Overall Study||32
406323|NCT00901186|969181|P1|COMPLETED|Overall Study||31
406324|NCT00901186|969180|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
406325|NCT00901186|969181|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
406326|NCT00901186|969180|P2|Safety Set|Overall Study||43
406327|NCT00901186|969181|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
406328|NCT00901186|969180|P2|STARTED|Overall Study||43
406329|NCT00901186|969181|P1|STARTED|Overall Study||40
406330|NCT00901017|969197|P1|NOT COMPLETED|Overall Study||0
406331|NCT00901017|969197|P1|COMPLETED|Overall Study||14
406332|NCT00901017|969197|P1|STARTED|Overall Study||14
406333|NCT00900822|969211|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
406334|NCT00900822|969211|P1|COMPLETED|12 Months Clinical Evaluation||11
406335|NCT00900822|969211|P1|STARTED|12 Months Clinical Evaluation||11
406336|NCT00900822|969211|P1|NOT COMPLETED|9 Months Histological Evaluation||0
406337|NCT00900822|969211|P1|COMPLETED|9 Months Histological Evaluation||11
406338|NCT00900822|969211|P1|STARTED|9 Months Histological Evaluation||11
406339|NCT00900796|969221|P1|NOT COMPLETED|Phase 2||5
406340|NCT00900796|969221|P1|COMPLETED|Phase 2||6
406341|NCT00900796|969221|P1|STARTED|Phase 2||11
406342|NCT00900796|969221|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
406343|NCT00900796|969221|P1|COMPLETED|Between Phase 1 and Phase 2||11
406344|NCT00900796|969221|P1|STARTED|Between Phase 1 and Phase 2||121
406345|NCT00900796|969221|P1|NOT COMPLETED|Phase 1||11
406346|NCT00900796|969221|P1|COMPLETED|Phase 1||121
406347|NCT00900796|969221|P1|STARTED|Phase 1||132
406348|NCT00900757|969231|P1|NOT COMPLETED|Overall Study||19
406349|NCT00900757|969231|P1|COMPLETED|Overall Study||38
406350|NCT00900757|969231|P1|STARTED|Overall Study||57
406351|NCT00900731|969241|P2|NOT COMPLETED|Overall Study||61
406352|NCT00900731|969242|P1|NOT COMPLETED|Overall Study||60
406353|NCT00900731|969241|P2|COMPLETED|Overall Study||740
406354|NCT00900731|969242|P1|COMPLETED|Overall Study||737
406355|NCT00900731|969241|P2|Safety Set: Received Study Drug|Overall Study||799
406356|NCT00900731|969242|P1|Safety Set: Received Study Drug|Overall Study||794
406357|NCT00900731|969241|P2|STARTED|Overall Study||801
406358|NCT00900731|969242|P1|STARTED|Overall Study|Randomized participants|797
406359|NCT00899392|969264|P2|NOT COMPLETED|Overall Study||24
406360|NCT00899392|969265|P1|NOT COMPLETED|Overall Study||21
406361|NCT00899392|969264|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
406362|NCT00899392|969265|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
406363|NCT00899392|969264|P2|STARTED|Overall Study||74
406364|NCT00899392|969265|P1|STARTED|Overall Study||68
406365|NCT00899379|969282|P5|NOT COMPLETED|Overall Study||31
406366|NCT00899379|969283|P4|NOT COMPLETED|Overall Study||37
406367|NCT00899379|969284|P3|NOT COMPLETED|Overall Study||29
406368|NCT00899379|969285|P2|NOT COMPLETED|Overall Study||29
406369|NCT00899379|969286|P1|NOT COMPLETED|Overall Study||34
406370|NCT00899379|969282|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
406371|NCT00899379|969283|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
406372|NCT00899379|969284|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
406373|NCT00899379|969285|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
406374|NCT00899379|969286|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
406375|NCT00899379|969282|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
406376|NCT00899379|969283|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
406377|NCT00899379|969284|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
406378|NCT00899379|969285|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
406379|NCT00899379|969286|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
406380|NCT00899379|969282|P5|Patients Treated|Overall Study|Patients who took study drug|81
406381|NCT00899379|969283|P4|Patients Treated|Overall Study|Patients who took study drug|77
406382|NCT00899379|969284|P3|Patients Treated|Overall Study|Patients who took study drug|84
406383|NCT00899379|969285|P2|Patients Treated|Overall Study|Patients who took study drug|82
406384|NCT00899379|969286|P1|Patients Treated|Overall Study|Patients who took study drug|83
406385|NCT00899379|969282|P5|STARTED|Overall Study|Patients who were allocated study drug|94
406386|NCT00899379|969283|P4|STARTED|Overall Study|Patients who were allocated study drug|94
406387|NCT00899379|969284|P3|STARTED|Overall Study|Patients who were allocated study drug|95
406388|NCT00899379|969285|P2|STARTED|Overall Study|Patients who were allocated study drug|95
406389|NCT00899379|969286|P1|STARTED|Overall Study|Patients who were allocated study drug|95
406390|NCT00900666|969300|P2|NOT COMPLETED|Overall Study||0
406391|NCT00900666|969301|P1|NOT COMPLETED|Overall Study||0
406392|NCT00900666|969300|P2|COMPLETED|Overall Study||9
406393|NCT00900666|969301|P1|COMPLETED|Overall Study||10
406394|NCT00900666|969300|P2|STARTED|Overall Study||9
406395|NCT00900666|969301|P1|STARTED|Overall Study||10
406396|NCT00900627|969315|P6|NOT COMPLETED|Overall Study||26
406397|NCT00900627|969316|P5|NOT COMPLETED|Overall Study||29
406398|NCT00900627|969317|P4|NOT COMPLETED|Overall Study||6
406399|NCT00900627|969318|P3|NOT COMPLETED|Overall Study||6
406400|NCT00900627|969319|P2|NOT COMPLETED|Overall Study||2
406401|NCT00900627|969320|P1|NOT COMPLETED|Overall Study||6
406402|NCT00900627|969315|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
406403|NCT00900627|969316|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
406404|NCT00900627|969317|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
406405|NCT00900627|969318|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
406406|NCT00900627|969319|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
406407|NCT00900627|969320|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
406408|NCT00900627|969315|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
406409|NCT00900627|969316|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
406410|NCT00900627|969317|P4|STARTED|Overall Study||6
406411|NCT00900627|969318|P3|STARTED|Overall Study||6
406412|NCT00900627|969319|P2|STARTED|Overall Study||2
406413|NCT00900627|969320|P1|STARTED|Overall Study||6
406414|NCT00900237|969340|P2|NOT COMPLETED|Overall Study||0
406415|NCT00900237|969341|P1|NOT COMPLETED|Overall Study||0
406416|NCT00900237|969340|P2|COMPLETED|Overall Study||7
406417|NCT00900237|969341|P1|COMPLETED|Overall Study||7
406418|NCT00900237|969340|P2|STARTED|Overall Study||7
406419|NCT00900237|969341|P1|STARTED|Overall Study||7
406420|NCT00900146|969354|P5|NOT COMPLETED|Intermediate: Period III||167
406421|NCT00900146|969355|P4|NOT COMPLETED|Intermediate: Period III||90
406422|NCT00900146|969356|P3|NOT COMPLETED|Intermediate: Period III||84
406423|NCT00900146|969357|P2|NOT COMPLETED|Intermediate: Period III||93
406424|NCT00900146|969358|P1|NOT COMPLETED|Intermediate: Period III||87
406425|NCT00900146|969354|P5|COMPLETED|Intermediate: Period III||0
406426|NCT00900146|969355|P4|COMPLETED|Intermediate: Period III||0
406427|NCT00900146|969356|P3|COMPLETED|Intermediate: Period III||0
406428|NCT00900146|969357|P2|COMPLETED|Intermediate: Period III||0
406429|NCT00900146|969358|P1|COMPLETED|Intermediate: Period III||0
406430|NCT00900146|969354|P5|Safety Set|Intermediate: Period III||166
406431|NCT00900146|969355|P4|Safety Set|Intermediate: Period III||90
406432|NCT00900146|969356|P3|Safety Set|Intermediate: Period III||84
406433|NCT00900146|969357|P2|Safety Set|Intermediate: Period III||92
406434|NCT00900146|969358|P1|Safety Set|Intermediate: Period III||86
406435|NCT00900146|969354|P5|STARTED|Intermediate: Period III||167
406436|NCT00900146|969355|P4|STARTED|Intermediate: Period III||90
406437|NCT00900146|969356|P3|STARTED|Intermediate: Period III||84
406438|NCT00900146|969357|P2|STARTED|Intermediate: Period III||93
406439|NCT00900146|969358|P1|STARTED|Intermediate: Period III||87
406440|NCT00900146|969354|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
406441|NCT00900146|969355|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
406442|NCT00900146|969356|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
406443|NCT00900146|969357|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
406444|NCT00900146|969358|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
406445|NCT00900146|969354|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
406446|NCT00900146|969355|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
406447|NCT00900146|969356|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
406448|NCT00900146|969357|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
406449|NCT00900146|969358|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
406450|NCT00900146|969354|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
406451|NCT00900146|969355|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
406452|NCT00900146|969356|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
406453|NCT00900146|969357|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
406454|NCT00900146|969358|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
406455|NCT00900146|969354|P5|STARTED|Dose Finding: Period II (4 Months)||179
406456|NCT00900146|969355|P4|STARTED|Dose Finding: Period II (4 Months)||92
406457|NCT00900146|969356|P3|STARTED|Dose Finding: Period II (4 Months)||92
406458|NCT00900146|969357|P2|STARTED|Dose Finding: Period II (4 Months)||95
406459|NCT00900146|969358|P1|STARTED|Dose Finding: Period II (4 Months)||93
406460|NCT00900029|969475|P5|NOT COMPLETED|Overall Study||6
406461|NCT00900029|969476|P4|NOT COMPLETED|Overall Study||7
406462|NCT00900029|969477|P3|NOT COMPLETED|Overall Study||3
406463|NCT00900029|969478|P2|NOT COMPLETED|Overall Study||4
406464|NCT00900029|969479|P1|NOT COMPLETED|Overall Study||3
406465|NCT00900029|969475|P5|COMPLETED|Overall Study||38
406466|NCT00900029|969476|P4|COMPLETED|Overall Study||35
406467|NCT00900029|969477|P3|COMPLETED|Overall Study||38
406468|NCT00900029|969478|P2|COMPLETED|Overall Study||37
406469|NCT00900029|969479|P1|COMPLETED|Overall Study||35
406470|NCT00900029|969475|P5|STARTED|Overall Study||44
406471|NCT00900029|969476|P4|STARTED|Overall Study||42
406472|NCT00900029|969477|P3|STARTED|Overall Study||41
406473|NCT00900029|969478|P2|STARTED|Overall Study||41
406474|NCT00900029|969479|P1|STARTED|Overall Study||38
406475|NCT00899717|969498|P2|NOT COMPLETED|Overall Study||0
406476|NCT00899717|969499|P1|NOT COMPLETED|Overall Study||0
406477|NCT00899717|969498|P2|COMPLETED|Overall Study||11
406478|NCT00899717|969499|P1|COMPLETED|Overall Study||10
406479|NCT00899717|969498|P2|STARTED|Overall Study||11
406480|NCT00899717|969499|P1|STARTED|Overall Study||10
406481|NCT00899678|969516|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
406482|NCT00899678|969517|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
406483|NCT00899678|969518|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
406484|NCT00899678|969516|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
406485|NCT00899678|969517|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
406486|NCT00899678|969518|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
406487|NCT00899678|969516|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
406488|NCT00899678|969517|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
406489|NCT00899678|969518|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
406490|NCT00899678|969516|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
406491|NCT00899678|969517|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
406492|NCT00899678|969518|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
406493|NCT00899678|969516|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
406494|NCT00899678|969517|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
406495|NCT00899678|969518|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
406496|NCT00899678|969516|P3|STARTED|Induction Period (Weeks 0 to 6)||35
406497|NCT00899678|969517|P2|STARTED|Induction Period (Weeks 0 to 6)||37
406498|NCT00899678|969518|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
406499|NCT00899600|969548|P2|NOT COMPLETED|Overall Study||0
406500|NCT00899600|969549|P1|NOT COMPLETED|Overall Study||0
406501|NCT00899600|969548|P2|COMPLETED|Overall Study||52
406502|NCT00899600|969549|P1|COMPLETED|Overall Study||50
406503|NCT00899600|969548|P2|STARTED|Overall Study||52
406504|NCT00899600|969549|P1|STARTED|Overall Study||50
406505|NCT00899353|969555|P1|NOT COMPLETED|Overall Study||5
406506|NCT00899353|969555|P1|COMPLETED|Overall Study||11
406507|NCT00899353|969555|P1|STARTED|Overall Study||16
406508|NCT00898807|969578|P2|NOT COMPLETED|Overall Study||9
406509|NCT00898807|969579|P1|NOT COMPLETED|Overall Study||8
406510|NCT00898807|969578|P2|COMPLETED|Overall Study||83
406511|NCT00898807|969579|P1|COMPLETED|Overall Study||86
406512|NCT00898807|969578|P2|STARTED|Overall Study||92
406513|NCT00898807|969579|P1|STARTED|Overall Study||94
406514|NCT00898677|969595|P4|NOT COMPLETED|Overall Study||19
406515|NCT00898677|969596|P3|NOT COMPLETED|Overall Study||72
406516|NCT00898677|969597|P2|NOT COMPLETED|Overall Study||69
406517|NCT00898677|969598|P1|NOT COMPLETED|Overall Study||17
406518|NCT00898677|969595|P4|COMPLETED|Overall Study||159
406519|NCT00898677|969596|P3|COMPLETED|Overall Study||383
406520|NCT00898677|969597|P2|COMPLETED|Overall Study||386
406521|NCT00898677|969598|P1|COMPLETED|Overall Study||163
406522|NCT00898677|969595|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
406523|NCT00898677|969596|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
406524|NCT00898677|969597|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
406525|NCT00898677|969598|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
406526|NCT00898677|969595|P4|STARTED|Overall Study||178
406527|NCT00898677|969596|P3|STARTED|Overall Study||455
406528|NCT00898677|969597|P2|STARTED|Overall Study||455
406529|NCT00898677|969598|P1|STARTED|Overall Study||180
406530|NCT00898560|969624|P1|NOT COMPLETED|Overall Study||1
406531|NCT00898560|969624|P1|COMPLETED|Overall Study||19
406532|NCT00898560|969624|P1|STARTED|Overall Study||20
406533|NCT00898443|969636|P2|NOT COMPLETED|Overall Study||0
406534|NCT00898443|969637|P1|NOT COMPLETED|Overall Study||1
406535|NCT00898443|969636|P2|COMPLETED|Overall Study||8
406536|NCT00898443|969637|P1|COMPLETED|Overall Study||9
406537|NCT00898443|969636|P2|STARTED|Overall Study||8
406538|NCT00898443|969637|P1|STARTED|Overall Study||10
406539|NCT00898222|969645|P1|NOT COMPLETED|Overall Study||0
406540|NCT00898222|969645|P1|COMPLETED|Overall Study||4
406541|NCT00898222|969645|P1|STARTED|Overall Study||4
406542|NCT00897949|969652|P3|NOT COMPLETED|Overall Study||69
406543|NCT00897949|969653|P2|NOT COMPLETED|Overall Study||103
406544|NCT00897949|969654|P1|NOT COMPLETED|Overall Study||104
406545|NCT00897949|969652|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
406546|NCT00897949|969653|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
406547|NCT00897949|969654|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
406548|NCT00897949|969652|P3|Patients Treated|Overall Study|Patients who took study drug|304
406549|NCT00897949|969653|P2|Patients Treated|Overall Study|Patients who took study drug|456
406550|NCT00897949|969654|P1|Patients Treated|Overall Study|Patients who took study drug|458
406551|NCT00897949|969652|P3|STARTED|Overall Study|Patients who were allocated study drug|370
406552|NCT00897949|969653|P2|STARTED|Overall Study|Patients who were allocated study drug|549
406553|NCT00897949|969654|P1|STARTED|Overall Study|Patients who were allocated study drug|554
406554|NCT00897910|969677|P1|NOT COMPLETED|Overall Study||0
406555|NCT00897910|969677|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
406556|NCT00897910|969677|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
406557|NCT00897897|969681|P1|NOT COMPLETED|Overall Study||0
406558|NCT00897897|969681|P1|COMPLETED|Overall Study||33
406559|NCT00897897|969681|P1|STARTED|Overall Study||33
406560|NCT00897715|969688|P2|NOT COMPLETED|Overall Study||1
406561|NCT00897715|969689|P1|NOT COMPLETED|Overall Study||2
406562|NCT00897715|969688|P2|COMPLETED|Overall Study||6
406563|NCT00897715|969689|P1|COMPLETED|Overall Study||6
406564|NCT00897715|969688|P2|STARTED|Overall Study||7
406565|NCT00897715|969689|P1|STARTED|Overall Study||8
406566|NCT00897390|969697|P1|NOT COMPLETED|Overall Study||6
406567|NCT00897390|969697|P1|COMPLETED|Overall Study||18
406568|NCT00897390|969697|P1|STARTED|Overall Study||24
406569|NCT00897104|969787|P3|NOT COMPLETED|Overall Study||8
406570|NCT00897104|969788|P2|NOT COMPLETED|Overall Study||71
406571|NCT00897104|969789|P1|NOT COMPLETED|Overall Study||64
406572|NCT00897104|969787|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
406573|NCT00897104|969788|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
406574|NCT00897104|969789|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
406575|NCT00897104|969787|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
406576|NCT00897104|969788|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
406577|NCT00897104|969789|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
406578|NCT00897104|969787|P3|Participants Treated|Overall Study|Participants who took study drug|80
406579|NCT00897104|969788|P2|Participants Treated|Overall Study|Participants who took study drug|357
406580|NCT00897104|969789|P1|Participants Treated|Overall Study|Participants who took study drug|355
406581|NCT00897104|969787|P3|STARTED|Overall Study|Participants who were allocated study drug|87
406582|NCT00897104|969788|P2|STARTED|Overall Study|Participants who were allocated study drug|428
406583|NCT00897104|969789|P1|STARTED|Overall Study|Participants who were allocated study drug|418
406584|NCT00896779|969817|P2|NOT COMPLETED|Overall Study||1
406585|NCT00896779|969818|P1|NOT COMPLETED|Overall Study||0
406586|NCT00896779|969817|P2|COMPLETED|Overall Study||11
406587|NCT00896779|969818|P1|COMPLETED|Overall Study||8
406588|NCT00896779|969817|P2|STARTED|Overall Study||12
406589|NCT00896779|969818|P1|STARTED|Overall Study||8
406590|NCT00896649|969824|P1|NOT COMPLETED|Overall Study||5
406591|NCT00896649|969824|P1|COMPLETED|Overall Study||188
406592|NCT00896649|969824|P1|STARTED|Overall Study||193
406593|NCT00896454|969829|P1|NOT COMPLETED|Overall Study||33
406594|NCT00896454|969829|P1|COMPLETED|Overall Study||0
406595|NCT00896454|969829|P1|STARTED|Overall Study||33
406596|NCT00896337|969841|P1|NOT COMPLETED|Overall Study||25
406597|NCT00896337|969841|P1|COMPLETED|Overall Study||100
406598|NCT00896337|969841|P1|STARTED|Overall Study||125
406599|NCT00896233|969908|P1|NOT COMPLETED|Overall Study||1
406600|NCT00896233|969908|P1|COMPLETED|Overall Study||9
406601|NCT00896233|969908|P1|STARTED|Overall Study||10
406602|NCT00896168|969921|P2|NOT COMPLETED|Overall Study||19
406603|NCT00896168|969922|P1|NOT COMPLETED|Overall Study||14
406604|NCT00896168|969921|P2|COMPLETED|Overall Study||111
406605|NCT00896168|969922|P1|COMPLETED|Overall Study||90
406606|NCT00896168|969921|P2|STARTED|Overall Study||130
406607|NCT00896168|969922|P1|STARTED|Overall Study||104
406608|NCT00896051|969952|P2|NOT COMPLETED|Overall Study||9
406609|NCT00896051|969953|P1|NOT COMPLETED|Overall Study||10
406610|NCT00896051|969952|P2|COMPLETED|Overall Study||16
406611|NCT00896051|969953|P1|COMPLETED|Overall Study||15
406612|NCT00896051|969952|P2|STARTED|Overall Study||25
406613|NCT00896051|969953|P1|STARTED|Overall Study||25
406614|NCT00896038|969995|P2|NOT COMPLETED|Overall Study||1
406615|NCT00896038|969996|P1|NOT COMPLETED|Overall Study||4
406616|NCT00896038|969995|P2|COMPLETED|Overall Study||27
406617|NCT00896038|969996|P1|COMPLETED|Overall Study||26
406618|NCT00896038|969995|P2|STARTED|Overall Study||28
406619|NCT00896038|969996|P1|STARTED|Overall Study||30
406620|NCT00896025|970034|P1|NOT COMPLETED|Overall Study||0
406621|NCT00896025|970034|P1|COMPLETED|Overall Study||8
406622|NCT00896025|970034|P1|STARTED|Overall Study||8
406623|NCT00895947|970040|P2|NOT COMPLETED|Overall Study||10
406624|NCT00895947|970041|P1|NOT COMPLETED|Overall Study||12
406625|NCT00895947|970040|P2|COMPLETED|Overall Study||90
406626|NCT00895947|970041|P1|COMPLETED|Overall Study||88
406627|NCT00895947|970040|P2|STARTED|Overall Study||100
406628|NCT00895947|970041|P1|STARTED|Overall Study||100
406629|NCT00895934|970059|P2|NOT COMPLETED|Overall Study||25
406630|NCT00895934|970060|P1|NOT COMPLETED|Overall Study||6
406631|NCT00895934|970059|P2|COMPLETED|Overall Study||18
406632|NCT00895934|970060|P1|COMPLETED|Overall Study||4
406633|NCT00895934|970059|P2|STARTED|Overall Study||43
406634|NCT00895934|970060|P1|STARTED|Overall Study||10
406635|NCT00895895|970071|P5|NOT COMPLETED|Period 2||49
406636|NCT00895895|970072|P4|NOT COMPLETED|Period 2||54
406637|NCT00895895|970073|P3|NOT COMPLETED|Period 2||49
406638|NCT00895895|970074|P2|NOT COMPLETED|Period 2||53
406639|NCT00895895|970075|P1|NOT COMPLETED|Period 2||56
406640|NCT00895895|970071|P5|COMPLETED|Period 2||35
406641|NCT00895895|970072|P4|COMPLETED|Period 2||37
406642|NCT00895895|970073|P3|COMPLETED|Period 2||33
406643|NCT00895895|970074|P2|COMPLETED|Period 2||31
406644|NCT00895895|970075|P1|COMPLETED|Period 2||30
406645|NCT00895895|970071|P5|STARTED|Period 2||84
406646|NCT00895895|970072|P4|STARTED|Period 2||91
406647|NCT00895895|970073|P3|STARTED|Period 2||82
406648|NCT00895895|970074|P2|STARTED|Period 2||84
406649|NCT00895895|970075|P1|STARTED|Period 2||86
406650|NCT00895895|970071|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
406651|NCT00895895|970072|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
406652|NCT00895895|970073|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
406653|NCT00895895|970074|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
406654|NCT00895895|970075|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
406655|NCT00895895|970071|P5|COMPLETED|After Period 1, Prior to Period 2||84
406656|NCT00895895|970072|P4|COMPLETED|After Period 1, Prior to Period 2||91
406657|NCT00895895|970073|P3|COMPLETED|After Period 1, Prior to Period 2||82
406658|NCT00895895|970074|P2|COMPLETED|After Period 1, Prior to Period 2||84
406659|NCT00895895|970075|P1|COMPLETED|After Period 1, Prior to Period 2||86
406660|NCT00895895|970071|P5|STARTED|After Period 1, Prior to Period 2||86
406661|NCT00895895|970072|P4|STARTED|After Period 1, Prior to Period 2||91
406662|NCT00895895|970073|P3|STARTED|After Period 1, Prior to Period 2||84
406663|NCT00895895|970074|P2|STARTED|After Period 1, Prior to Period 2||84
406664|NCT00895895|970075|P1|STARTED|After Period 1, Prior to Period 2||86
406665|NCT00895895|970071|P5|NOT COMPLETED|Period 1||20
406666|NCT00895895|970072|P4|NOT COMPLETED|Period 1||13
406667|NCT00895895|970073|P3|NOT COMPLETED|Period 1||20
406668|NCT00895895|970074|P2|NOT COMPLETED|Period 1||21
406669|NCT00895895|970075|P1|NOT COMPLETED|Period 1||21
406670|NCT00895895|970071|P5|COMPLETED|Period 1||86
406671|NCT00895895|970072|P4|COMPLETED|Period 1||91
406672|NCT00895895|970073|P3|COMPLETED|Period 1||84
406673|NCT00895895|970074|P2|COMPLETED|Period 1||84
406674|NCT00895895|970075|P1|COMPLETED|Period 1||86
406675|NCT00895895|970071|P5|Randomized But Not Treated|Period 1||2
406676|NCT00895895|970072|P4|Randomized But Not Treated|Period 1||1
406677|NCT00895895|970073|P3|Randomized But Not Treated|Period 1||1
406678|NCT00895895|970074|P2|Randomized But Not Treated|Period 1||3
406679|NCT00895895|970075|P1|Randomized But Not Treated|Period 1||1
406680|NCT00895895|970071|P5|STARTED|Period 1||106
406681|NCT00895895|970072|P4|STARTED|Period 1||104
406682|NCT00895895|970073|P3|STARTED|Period 1||104
406683|NCT00895895|970074|P2|STARTED|Period 1||105
406684|NCT00895895|970075|P1|STARTED|Period 1||107
406685|NCT00895843|970189|P2|NOT COMPLETED|Overall Study||12
406686|NCT00895843|970190|P1|NOT COMPLETED|Overall Study||12
406687|NCT00895843|970189|P2|COMPLETED|Overall Study||50
406688|NCT00895843|970190|P1|COMPLETED|Overall Study||48
406689|NCT00895843|970189|P2|STARTED|Overall Study||62
406690|NCT00895843|970190|P1|STARTED|Overall Study||60
406691|NCT00895830|970201|P5|NOT COMPLETED|Overall Study||0
406692|NCT00895830|970202|P4|NOT COMPLETED|Overall Study||0
406693|NCT00895830|970203|P3|NOT COMPLETED|Overall Study||0
406694|NCT00895830|970204|P2|NOT COMPLETED|Overall Study||0
406695|NCT00895830|970205|P1|NOT COMPLETED|Overall Study||0
406696|NCT00895830|970201|P5|COMPLETED|Overall Study||55
406697|NCT00895830|970202|P4|COMPLETED|Overall Study||52
406698|NCT00895830|970203|P3|COMPLETED|Overall Study||49
406699|NCT00895830|970204|P2|COMPLETED|Overall Study||50
406700|NCT00895830|970205|P1|COMPLETED|Overall Study||51
406701|NCT00895830|970201|P5|STARTED|Overall Study||55
406702|NCT00895830|970202|P4|STARTED|Overall Study||52
406703|NCT00895830|970203|P3|STARTED|Overall Study||49
406704|NCT00895830|970204|P2|STARTED|Overall Study||50
406705|NCT00895830|970205|P1|STARTED|Overall Study||51
406706|NCT00895817|970219|P2|NOT COMPLETED|Overall Study||0
406707|NCT00895817|970220|P1|NOT COMPLETED|Overall Study||0
406708|NCT00895817|970219|P2|COMPLETED|Overall Study||21
406709|NCT00895817|970220|P1|COMPLETED|Overall Study||21
406710|NCT00895817|970219|P2|STARTED|Overall Study||21
406711|NCT00895817|970220|P1|STARTED|Overall Study||21
406712|NCT00895752|970226|P1|NOT COMPLETED|Overall Study||0
406713|NCT00895752|970226|P1|COMPLETED|Overall Study||6
406714|NCT00895752|970226|P1|STARTED|Overall Study||6
406715|NCT00895661|970237|P1|NOT COMPLETED|Overall Study||3
406716|NCT00895661|970237|P1|COMPLETED|Overall Study||37
406717|NCT00895661|970237|P1|STARTED|Overall Study||40
406718|NCT00895583|970246|P2|NOT COMPLETED|Overall Study||12
406719|NCT00895583|970247|P1|NOT COMPLETED|Overall Study||44
406720|NCT00895583|970246|P2|COMPLETED|Overall Study||111
406721|NCT00895583|970247|P1|COMPLETED|Overall Study||87
406722|NCT00895583|970246|P2|STARTED|Overall Study||123
406723|NCT00895583|970247|P1|STARTED|Overall Study||131
406724|NCT00895453|970328|P3|NOT COMPLETED|Overall Study||23
406725|NCT00895453|970329|P2|NOT COMPLETED|Overall Study||25
406726|NCT00895453|970330|P1|NOT COMPLETED|Overall Study||25
406727|NCT00895453|970328|P3|COMPLETED|Overall Study||23
406728|NCT00895453|970329|P2|COMPLETED|Overall Study||25
406729|NCT00895453|970330|P1|COMPLETED|Overall Study||23
406730|NCT00895453|970328|P3|STARTED|Overall Study||46
406731|NCT00895453|970329|P2|STARTED|Overall Study||50
406732|NCT00895453|970330|P1|STARTED|Overall Study||48
406733|NCT00895310|970338|P1|NOT COMPLETED|Overall Study||1
406734|NCT00895310|970338|P1|COMPLETED|Overall Study||29
406735|NCT00895310|970338|P1|STARTED|Overall Study||30
406736|NCT00895284|970347|P2|NOT COMPLETED|Overall Study||0
406737|NCT00895284|970348|P1|NOT COMPLETED|Overall Study||0
406738|NCT00895284|970347|P2|COMPLETED|Overall Study||0
406739|NCT00895284|970348|P1|COMPLETED|Overall Study||3
406740|NCT00895284|970347|P2|STARTED|Overall Study||0
406741|NCT00895284|970348|P1|STARTED|Overall Study||3
406742|NCT00895245|970354|P1|NOT COMPLETED|Overall Study||6
406743|NCT00895245|970354|P1|COMPLETED|Overall Study||0
406744|NCT00895245|970354|P1|STARTED|Overall Study||6
406745|NCT00895232|970364|P3|NOT COMPLETED|Overall Study||5
406746|NCT00895232|970365|P2|NOT COMPLETED|Overall Study||4
406747|NCT00895232|970366|P1|NOT COMPLETED|Overall Study||3
406748|NCT00895232|970364|P3|COMPLETED|Overall Study||3
406749|NCT00895232|970365|P2|COMPLETED|Overall Study||2
406750|NCT00895232|970366|P1|COMPLETED|Overall Study||4
406751|NCT00895232|970364|P3|STARTED|Overall Study||8
406752|NCT00895232|970365|P2|STARTED|Overall Study||6
406753|NCT00895232|970366|P1|STARTED|Overall Study||7
406754|NCT00895193|970384|P4|NOT COMPLETED|Overall Study||0
406755|NCT00895193|970385|P3|NOT COMPLETED|Overall Study||0
406756|NCT00895193|970386|P2|NOT COMPLETED|Overall Study||0
406757|NCT00895193|970387|P1|NOT COMPLETED|Overall Study||0
406758|NCT00895193|970384|P4|COMPLETED|Overall Study||25
406759|NCT00895193|970385|P3|COMPLETED|Overall Study||25
406760|NCT00895193|970386|P2|COMPLETED|Overall Study||25
406761|NCT00895193|970387|P1|COMPLETED|Overall Study||25
406762|NCT00895193|970384|P4|STARTED|Overall Study||25
406763|NCT00895193|970385|P3|STARTED|Overall Study||25
406764|NCT00895193|970386|P2|STARTED|Overall Study||25
406765|NCT00895193|970387|P1|STARTED|Overall Study||25
406766|NCT00895180|970411|P2|NOT COMPLETED|Overall Study||0
406767|NCT00895180|970412|P1|NOT COMPLETED|Overall Study||0
406768|NCT00895180|970411|P2|COMPLETED|Overall Study||40
406769|NCT00895180|970412|P1|COMPLETED|Overall Study||40
406770|NCT00895180|970411|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
406771|NCT00895180|970412|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
406772|NCT00895180|970411|P2|STARTED|Overall Study||40
406773|NCT00895180|970412|P1|STARTED|Overall Study||40
406774|NCT00895011|970433|P3|NOT COMPLETED|Overall Study||8
406775|NCT00895011|970434|P2|NOT COMPLETED|Overall Study||14
406776|NCT00895011|970435|P1|NOT COMPLETED|Overall Study||24
406777|NCT00895011|970433|P3|COMPLETED|Overall Study||91
406778|NCT00895011|970434|P2|COMPLETED|Overall Study||85
406779|NCT00895011|970435|P1|COMPLETED|Overall Study||76
406780|NCT00895011|970433|P3|STARTED|Overall Study||99
406781|NCT00895011|970434|P2|STARTED|Overall Study||99
406782|NCT00895011|970435|P1|STARTED|Overall Study||100
406783|NCT00894933|970449|P1|NOT COMPLETED|Overall Study||4
406784|NCT00894933|970449|P1|COMPLETED|Overall Study||29
406785|NCT00894933|970449|P1|STARTED|Overall Study||33
406786|NCT00894803|970467|P2|NOT COMPLETED|Overall Study||5
406787|NCT00894803|970468|P1|NOT COMPLETED|Overall Study||20
406788|NCT00894803|970467|P2|COMPLETED|Overall Study||20
406789|NCT00894803|970468|P1|COMPLETED|Overall Study||81
406790|NCT00894803|970467|P2|STARTED|Overall Study||25
406791|NCT00894803|970468|P1|STARTED|Overall Study||101
406792|NCT00894790|970504|P2|NOT COMPLETED|Overall Study||2
406793|NCT00894790|970505|P1|NOT COMPLETED|Overall Study||1
406794|NCT00894790|970504|P2|COMPLETED|Overall Study||2
406795|NCT00894790|970505|P1|COMPLETED|Overall Study||3
406796|NCT00894790|970504|P2|STARTED|Overall Study||4
406797|NCT00894790|970505|P1|STARTED|Overall Study||4
406798|NCT00894699|970529|P2|NOT COMPLETED|Overall Study||0
406799|NCT00894699|970530|P1|NOT COMPLETED|Overall Study||0
406800|NCT00894699|970529|P2|COMPLETED|Overall Study||19
406801|NCT00894699|970530|P1|COMPLETED|Overall Study||21
406802|NCT00894699|970529|P2|STARTED|Overall Study||19
406803|NCT00894699|970530|P1|STARTED|Overall Study||21
406804|NCT00894647|970538|P2|NOT COMPLETED|Overall Study||14
406805|NCT00894647|970539|P1|NOT COMPLETED|Overall Study||10
406806|NCT00894647|970538|P2|COMPLETED|Overall Study||112
406807|NCT00894647|970539|P1|COMPLETED|Overall Study||111
406808|NCT00894647|970538|P2|STARTED|Overall Study||126
406809|NCT00894647|970539|P1|STARTED|Overall Study||121
406810|NCT00894556|970552|P4|NOT COMPLETED|Treatment Phase||0
406811|NCT00894556|970553|P3|NOT COMPLETED|Treatment Phase||1
406812|NCT00894556|970554|P2|NOT COMPLETED|Treatment Phase||4
406813|NCT00894556|970555|P1|NOT COMPLETED|Treatment Phase||4
406814|NCT00894556|970552|P4|COMPLETED|Treatment Phase||0
406815|NCT00894556|970553|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
406816|NCT00894556|970554|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
406817|NCT00894556|970555|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
406818|NCT00894556|970552|P4|STARTED|Treatment Phase||0
406819|NCT00894556|970553|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
406820|NCT00894556|970554|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
406821|NCT00894556|970555|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
406822|NCT00894556|970552|P4|NOT COMPLETED|Baseline Phase||85
406823|NCT00894556|970553|P3|NOT COMPLETED|Baseline Phase||0
406824|NCT00894556|970554|P2|NOT COMPLETED|Baseline Phase||0
406825|NCT00894556|970555|P1|NOT COMPLETED|Baseline Phase||0
406826|NCT00894556|970552|P4|COMPLETED|Baseline Phase||109
406827|NCT00894556|970553|P3|COMPLETED|Baseline Phase||0
406828|NCT00894556|970554|P2|COMPLETED|Baseline Phase||0
406829|NCT00894556|970555|P1|COMPLETED|Baseline Phase||0
406830|NCT00894556|970552|P4|STARTED|Baseline Phase||194
406831|NCT00894556|970553|P3|STARTED|Baseline Phase||0
406832|NCT00894556|970554|P2|STARTED|Baseline Phase||0
406833|NCT00894556|970555|P1|STARTED|Baseline Phase||0
406834|NCT00894543|970566|P2|NOT COMPLETED|Week 4 to Week 8||2
406835|NCT00894543|970567|P1|NOT COMPLETED|Week 4 to Week 8||4
406836|NCT00894543|970566|P2|COMPLETED|Week 4 to Week 8||97
406837|NCT00894543|970567|P1|COMPLETED|Week 4 to Week 8||97
406838|NCT00894543|970566|P2|STARTED|Week 4 to Week 8||99
406839|NCT00894543|970567|P1|STARTED|Week 4 to Week 8||101
406840|NCT00894543|970566|P2|NOT COMPLETED|Baseline to Week 4||2
406841|NCT00894543|970567|P1|NOT COMPLETED|Baseline to Week 4||3
406842|NCT00894543|970566|P2|COMPLETED|Baseline to Week 4||99
406843|NCT00894543|970567|P1|COMPLETED|Baseline to Week 4||101
406844|NCT00894543|970566|P2|STARTED|Baseline to Week 4||101
406845|NCT00894543|970567|P1|STARTED|Baseline to Week 4||104
406846|NCT00894543|970566|P2|NOT COMPLETED|Baseline||0
406847|NCT00894543|970567|P1|NOT COMPLETED|Baseline||0
406848|NCT00894543|970566|P2|COMPLETED|Baseline||101
406849|NCT00894543|970567|P1|COMPLETED|Baseline||104
406850|NCT00894543|970566|P2|STARTED|Baseline||101
406851|NCT00894543|970567|P1|STARTED|Baseline||104
406852|NCT00894517|970591|P2|NOT COMPLETED|Overall Study||5
406853|NCT00894517|970592|P1|NOT COMPLETED|Overall Study||2
406854|NCT00894517|970591|P2|COMPLETED|Overall Study||26
406855|NCT00894517|970592|P1|COMPLETED|Overall Study||28
406856|NCT00894517|970591|P2|STARTED|Overall Study||31
406857|NCT00894517|970592|P1|STARTED|Overall Study||30
406858|NCT00894504|970606|P1|NOT COMPLETED|Overall Study||71
406859|NCT00894504|970606|P1|COMPLETED|Overall Study||0
406860|NCT00894504|970606|P1|STARTED|Overall Study||71
406861|NCT00894465|970622|P2|NOT COMPLETED|Overall Study||0
406862|NCT00894465|970623|P1|NOT COMPLETED|Overall Study||0
406863|NCT00894465|970622|P2|COMPLETED|Overall Study||22
406864|NCT00894465|970623|P1|COMPLETED|Overall Study||22
406865|NCT00894465|970622|P2|STARTED|Overall Study||22
406866|NCT00894465|970623|P1|STARTED|Overall Study||22
406867|NCT00894387|970633|P2|NOT COMPLETED|Overall Study||175
406868|NCT00894387|970634|P1|NOT COMPLETED|Overall Study||175
406869|NCT00894387|970633|P2|COMPLETED|Overall Study||643
406870|NCT00894387|970634|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
406871|NCT00894387|970633|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
406872|NCT00894387|970634|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
406873|NCT00894387|970633|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
406874|NCT00894387|970634|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
406875|NCT00894387|970633|P2|Full Analysis Set|Overall Study||807
406876|NCT00894387|970634|P1|Full Analysis Set|Overall Study||808
406877|NCT00894387|970633|P2|Safety Set|Overall Study||810
406878|NCT00894387|970634|P1|Safety Set|Overall Study||808
406879|NCT00894387|970633|P2|STARTED|Overall Study||818
406880|NCT00894387|970634|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
406881|NCT00894361|970654|P2|NOT COMPLETED|Overall Study||64
406882|NCT00894361|970655|P1|NOT COMPLETED|Overall Study||24
406883|NCT00894361|970654|P2|COMPLETED|Overall Study||136
406884|NCT00894361|970655|P1|COMPLETED|Overall Study||176
406885|NCT00894361|970654|P2|STARTED|Overall Study||200
406886|NCT00894361|970655|P1|STARTED|Overall Study||200
406887|NCT00894322|970664|P3|NOT COMPLETED|Overall Study||0
406888|NCT00894322|970665|P2|NOT COMPLETED|Overall Study||0
406889|NCT00894322|970666|P1|NOT COMPLETED|Overall Study||1
406890|NCT00894322|970664|P3|COMPLETED|Overall Study||12
406891|NCT00894322|970665|P2|COMPLETED|Overall Study||23
406892|NCT00894322|970666|P1|COMPLETED|Overall Study||29
406893|NCT00894322|970664|P3|STARTED|Overall Study||12
406894|NCT00894322|970665|P2|STARTED|Overall Study||23
406895|NCT00894322|970666|P1|STARTED|Overall Study||30
406896|NCT00894244|970705|P1|NOT COMPLETED|Overall Study||1
406897|NCT00894244|970705|P1|COMPLETED|Overall Study||24
406898|NCT00894244|970705|P1|STARTED|Overall Study||25
406899|NCT00894166|970717|P8|NOT COMPLETED|Overall Study||34
406900|NCT00894166|970718|P7|NOT COMPLETED|Overall Study||16
406901|NCT00894166|970719|P6|NOT COMPLETED|Overall Study||16
406902|NCT00894166|970720|P5|NOT COMPLETED|Overall Study||24
406903|NCT00894166|970721|P4|NOT COMPLETED|Overall Study||69
406904|NCT00894166|970722|P3|NOT COMPLETED|Overall Study||62
406905|NCT00894166|970723|P2|NOT COMPLETED|Overall Study||63
406906|NCT00894166|970724|P1|NOT COMPLETED|Overall Study||61
406907|NCT00894166|970717|P8|COMPLETED|Overall Study||0
406908|NCT00894166|970718|P7|COMPLETED|Overall Study||19
406909|NCT00894166|970719|P6|COMPLETED|Overall Study||20
406910|NCT00894166|970720|P5|COMPLETED|Overall Study||10
406911|NCT00894166|970721|P4|COMPLETED|Overall Study||45
406912|NCT00894166|970722|P3|COMPLETED|Overall Study||50
406913|NCT00894166|970723|P2|COMPLETED|Overall Study||46
406914|NCT00894166|970724|P1|COMPLETED|Overall Study||71
406915|NCT00894166|970717|P8|STARTED|Overall Study||34
406916|NCT00894166|970718|P7|STARTED|Overall Study||35
406917|NCT00894166|970719|P6|STARTED|Overall Study||36
406918|NCT00894166|970720|P5|STARTED|Overall Study||34
406919|NCT00894166|970721|P4|STARTED|Overall Study||114
406920|NCT00894166|970722|P3|STARTED|Overall Study||112
406921|NCT00894166|970723|P2|STARTED|Overall Study||109
406922|NCT00894166|970724|P1|STARTED|Overall Study||132
406923|NCT00894127|970754|P1|NOT COMPLETED|Overall Study||0
406924|NCT00894127|970754|P1|COMPLETED|Overall Study||128
406925|NCT00894127|970754|P1|STARTED|Overall Study||128
406926|NCT00893997|970758|P1|NOT COMPLETED|Overall Study||0
406927|NCT00893997|970758|P1|COMPLETED|Overall Study||10
406928|NCT00893997|970758|P1|STARTED|Overall Study||10
406929|NCT00893971|970763|P1|NOT COMPLETED|Overall Study||3
406930|NCT00893971|970763|P1|COMPLETED|Overall Study||13
406931|NCT00893971|970763|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
406932|NCT00893971|970763|P1|Placebo + FF MDI (PT005)|Overall Study||13
406933|NCT00893971|970763|P1|Placebo + GFF MDI (PT003)|Overall Study||15
406934|NCT00893971|970763|P1|Placebo + GP MDI (PT001)|Overall Study||15
406935|NCT00893971|970763|P1|STARTED|Overall Study||16
406936|NCT00893789|970881|P4|NOT COMPLETED|Overall Study||13
406937|NCT00893789|970882|P3|NOT COMPLETED|Overall Study||7
406938|NCT00893789|970883|P2|NOT COMPLETED|Overall Study||4
406939|NCT00893789|970884|P1|NOT COMPLETED|Overall Study||6
406940|NCT00893789|970881|P4|COMPLETED|Overall Study||16
406941|NCT00893789|970882|P3|COMPLETED|Overall Study||22
406942|NCT00893789|970883|P2|COMPLETED|Overall Study||26
406943|NCT00893789|970884|P1|COMPLETED|Overall Study||23
406944|NCT00893789|970881|P4|Full Analysis Set (FAS)|Overall Study||27
406945|NCT00893789|970882|P3|Full Analysis Set (FAS)|Overall Study||28
406946|NCT00893789|970883|P2|Full Analysis Set (FAS)|Overall Study||29
406947|NCT00893789|970884|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
406948|NCT00893789|970881|P4|Safety Analysis Set (SAS)|Overall Study||29
406949|NCT00893789|970882|P3|Safety Analysis Set (SAS)|Overall Study||29
406950|NCT00893789|970883|P2|Safety Analysis Set (SAS)|Overall Study||30
406951|NCT00893789|970884|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
406952|NCT00893789|970881|P4|STARTED|Overall Study||29
406953|NCT00893789|970882|P3|STARTED|Overall Study||29
406954|NCT00893789|970883|P2|STARTED|Overall Study||30
406955|NCT00893789|970884|P1|STARTED|Overall Study||29
406956|NCT00893763|970968|P2|NOT COMPLETED|Overall Study||110
406957|NCT00893763|970969|P1|NOT COMPLETED|Overall Study||110
406958|NCT00893763|970968|P2|COMPLETED|Overall Study||47
406959|NCT00893763|970969|P1|COMPLETED|Overall Study||47
406960|NCT00893763|970968|P2|STARTED|Overall Study||157
406961|NCT00893763|970969|P1|STARTED|Overall Study||157
406962|NCT00893737|970977|P1|NOT COMPLETED|Overall Study||12
406963|NCT00893737|970977|P1|COMPLETED|Overall Study||135
406964|NCT00893737|970977|P1|STARTED|Overall Study||147
406965|NCT00893464|970991|P8|NOT COMPLETED|Overall Study||2
406966|NCT00893464|970992|P7|NOT COMPLETED|Overall Study||2
406967|NCT00893464|970993|P6|NOT COMPLETED|Overall Study||0
406968|NCT00893464|970994|P5|NOT COMPLETED|Overall Study||0
406969|NCT00893464|970995|P4|NOT COMPLETED|Overall Study||0
406970|NCT00893464|970996|P3|NOT COMPLETED|Overall Study||0
406971|NCT00893464|970997|P2|NOT COMPLETED|Overall Study||0
406972|NCT00893464|970998|P1|NOT COMPLETED|Overall Study||0
406973|NCT00893464|970991|P8|COMPLETED|Overall Study||3
406974|NCT00893464|970992|P7|COMPLETED|Overall Study||8
406975|NCT00893464|970993|P6|COMPLETED|Overall Study||7
406976|NCT00893464|970994|P5|COMPLETED|Overall Study||4
406977|NCT00893464|970995|P4|COMPLETED|Overall Study||1
406978|NCT00893464|970996|P3|COMPLETED|Overall Study||1
406979|NCT00893464|970997|P2|COMPLETED|Overall Study||1
406980|NCT00893464|970998|P1|COMPLETED|Overall Study||1
406981|NCT00893464|970991|P8|STARTED|Overall Study||5
406982|NCT00893464|970992|P7|STARTED|Overall Study||10
406983|NCT00893464|970993|P6|STARTED|Overall Study||7
406984|NCT00893464|970994|P5|STARTED|Overall Study||4
406985|NCT00893464|970995|P4|STARTED|Overall Study||1
406986|NCT00893464|970996|P3|STARTED|Overall Study||1
406987|NCT00893464|970997|P2|STARTED|Overall Study||1
406988|NCT00893464|970998|P1|STARTED|Overall Study||1
406989|NCT00893152|971116|P2|NOT COMPLETED|Overall Study||0
406990|NCT00893152|971117|P1|NOT COMPLETED|Overall Study||0
406991|NCT00893152|971116|P2|COMPLETED|Overall Study||36
406992|NCT00893152|971117|P1|COMPLETED|Overall Study||47
406993|NCT00893152|971116|P2|STARTED|Overall Study||36
406994|NCT00893152|971117|P1|STARTED|Overall Study||47
406995|NCT00893113|971125|P2|NOT COMPLETED|Overall Study||16
406996|NCT00893113|971126|P1|NOT COMPLETED|Overall Study||13
406997|NCT00893113|971125|P2|COMPLETED|Overall Study||22
406998|NCT00893113|971126|P1|COMPLETED|Overall Study||23
406999|NCT00893113|971125|P2|STARTED|Overall Study||38
407000|NCT00893113|971126|P1|STARTED|Overall Study||36
407001|NCT00892957|971138|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
407002|NCT00892957|971139|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
407003|NCT00892957|971138|P2|COMPLETED|Postoperative Day 30 Assessment||66
407004|NCT00892957|971139|P1|COMPLETED|Postoperative Day 30 Assessment||70
407005|NCT00892957|971138|P2|STARTED|Postoperative Day 30 Assessment||66
407006|NCT00892957|971139|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
407007|NCT00892957|971138|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
407008|NCT00892957|971139|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
407009|NCT00892957|971138|P2|COMPLETED|Postoperative Day 14 Assessment||66
407010|NCT00892957|971139|P1|COMPLETED|Postoperative Day 14 Assessment||68
407011|NCT00892957|971138|P2|STARTED|Postoperative Day 14 Assessment||66
407012|NCT00892957|971139|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
407013|NCT00892957|971138|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
407014|NCT00892957|971139|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
407015|NCT00892957|971138|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
407016|NCT00892957|971139|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
407017|NCT00892957|971138|P2|STARTED|Between Postoperative Day 1 and Day 14||70
407018|NCT00892957|971139|P1|STARTED|Between Postoperative Day 1 and Day 14||70
407019|NCT00892957|971138|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
407020|NCT00892957|971139|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
407021|NCT00892957|971138|P2|COMPLETED|Postoperative Day 1 Assessment||70
407022|NCT00892957|971139|P1|COMPLETED|Postoperative Day 1 Assessment||70
407023|NCT00892957|971138|P2|STARTED|Postoperative Day 1 Assessment||70
407024|NCT00892957|971139|P1|STARTED|Postoperative Day 1 Assessment||70
407025|NCT00892957|971138|P2|NOT COMPLETED|Intraoperative Day 0||0
407026|NCT00892957|971139|P1|NOT COMPLETED|Intraoperative Day 0||0
407027|NCT00892957|971138|P2|COMPLETED|Intraoperative Day 0||70
407028|NCT00892957|971139|P1|COMPLETED|Intraoperative Day 0||70
407029|NCT00892957|971138|P2|STARTED|Intraoperative Day 0||70
407030|NCT00892957|971139|P1|STARTED|Intraoperative Day 0||70
407031|NCT00892723|971228|P3|NOT COMPLETED|Overall Study||2
407032|NCT00892723|971229|P2|NOT COMPLETED|Overall Study||4
407033|NCT00892723|971230|P1|NOT COMPLETED|Overall Study||2
407034|NCT00892723|971228|P3|COMPLETED|Overall Study||17
407035|NCT00892723|971229|P2|COMPLETED|Overall Study||15
407036|NCT00892723|971230|P1|COMPLETED|Overall Study||19
407037|NCT00892723|971228|P3|STARTED|Overall Study||19
407038|NCT00892723|971229|P2|STARTED|Overall Study||19
407039|NCT00892723|971230|P1|STARTED|Overall Study||21
407040|NCT00892710|971274|P3|NOT COMPLETED|Overall Study||55
407041|NCT00892710|971275|P2|NOT COMPLETED|Overall Study||59
407042|NCT00892710|971276|P1|NOT COMPLETED|Overall Study||48
407043|NCT00892710|971274|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
407044|NCT00892710|971275|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
407045|NCT00892710|971276|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
407046|NCT00892710|971274|P3|STARTED|Overall Study||55
407047|NCT00892710|971275|P2|STARTED|Overall Study||59
407048|NCT00892710|971276|P1|STARTED|Overall Study||48
407049|NCT00892697|971299|P1|NOT COMPLETED|Overall Study||0
407050|NCT00892697|971299|P1|COMPLETED|Overall Study||15
407051|NCT00892697|971299|P1|STARTED|Overall Study||15
407052|NCT00892606|971306|P2|NOT COMPLETED|Overall Study||4
407053|NCT00892606|971307|P1|NOT COMPLETED|Overall Study||5
407054|NCT00892606|971306|P2|COMPLETED|Overall Study||33
407055|NCT00892606|971307|P1|COMPLETED|Overall Study||33
407056|NCT00892606|971306|P2|STARTED|Overall Study||37
407057|NCT00892606|971307|P1|STARTED|Overall Study||38
407058|NCT00892437|971319|P2|NOT COMPLETED|Open-Label Extension Phase||4
407059|NCT00892437|971320|P1|NOT COMPLETED|Open-Label Extension Phase||12
407060|NCT00892437|971319|P2|COMPLETED|Open-Label Extension Phase||15
407061|NCT00892437|971320|P1|COMPLETED|Open-Label Extension Phase||32
407062|NCT00892437|971319|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
407063|NCT00892437|971320|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
407064|NCT00892437|971319|P2|NOT COMPLETED|Randomized Phase||5
407065|NCT00892437|971320|P1|NOT COMPLETED|Randomized Phase||11
407066|NCT00892437|971319|P2|COMPLETED|Randomized Phase||24
407067|NCT00892437|971320|P1|COMPLETED|Randomized Phase||45
407068|NCT00892437|971319|P2|Randomized and Treated|Randomized Phase||29
407069|NCT00892437|971320|P1|Randomized and Treated|Randomized Phase||50
407070|NCT00892437|971319|P2|STARTED|Randomized Phase||29
407071|NCT00892437|971320|P1|STARTED|Randomized Phase||56
407072|NCT00892281|971339|P2|NOT COMPLETED|Overall Study||37
407073|NCT00892281|971340|P1|NOT COMPLETED|Overall Study||267
407074|NCT00892281|971339|P2|COMPLETED|Overall Study||187
407075|NCT00892281|971340|P1|COMPLETED|Overall Study||930
407076|NCT00892281|971339|P2|STARTED|Overall Study||224
407077|NCT00892281|971340|P1|STARTED|Overall Study||1197
407078|NCT00892151|971350|P1|NOT COMPLETED|Overall Study||1
407079|NCT00892151|971350|P1|COMPLETED|Overall Study||50
407080|NCT00892151|971350|P1|STARTED|Overall Study||51
407081|NCT00892099|971359|P3|NOT COMPLETED|Overall Study||7
407082|NCT00892099|971360|P2|NOT COMPLETED|Overall Study||1
407083|NCT00892099|971361|P1|NOT COMPLETED|Overall Study||5
407084|NCT00892099|971359|P3|COMPLETED|Overall Study||29
407085|NCT00892099|971360|P2|COMPLETED|Overall Study||32
407086|NCT00892099|971361|P1|COMPLETED|Overall Study||31
407087|NCT00892099|971359|P3|STARTED|Overall Study||36
407088|NCT00892099|971360|P2|STARTED|Overall Study||33
407089|NCT00892099|971361|P1|STARTED|Overall Study||36
407090|NCT00892047|971371|P2|NOT COMPLETED|Overall Study||7
407091|NCT00892047|971372|P1|NOT COMPLETED|Overall Study||4
407092|NCT00892047|971371|P2|COMPLETED|Overall Study||83
407093|NCT00892047|971372|P1|COMPLETED|Overall Study||87
407094|NCT00892047|971371|P2|STARTED|Overall Study||90
407095|NCT00892047|971372|P1|STARTED|Overall Study||91
407096|NCT00892008|971388|P1|NOT COMPLETED|Overall Study||565
407097|NCT00892008|971388|P1|COMPLETED|Overall Study||1713
407098|NCT00892008|971388|P1|STARTED|Overall Study||2278
407099|NCT00891995|971404|P2|NOT COMPLETED|Overall Study||0
407100|NCT00891995|971405|P1|NOT COMPLETED|Overall Study||0
407101|NCT00891995|971404|P2|COMPLETED|Overall Study||21
407102|NCT00891995|971405|P1|COMPLETED|Overall Study||50
407103|NCT00891995|971404|P2|STARTED|Overall Study||21
407104|NCT00891995|971405|P1|STARTED|Overall Study||50
407105|NCT00891982|971429|P2|NOT COMPLETED|Overall Study||1
407106|NCT00891982|971430|P1|NOT COMPLETED|Overall Study||2
407107|NCT00891982|971429|P2|COMPLETED|Overall Study||30
407108|NCT00891982|971430|P1|COMPLETED|Overall Study||28
407109|NCT00891982|971429|P2|STARTED|Overall Study||31
407110|NCT00891982|971430|P1|STARTED|Overall Study||30
407111|NCT00891930|971474|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
407112|NCT00891930|971474|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
407113|NCT00891930|971474|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
407114|NCT00891930|971474|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
407115|NCT00891930|971474|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
407116|NCT00891930|971474|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
407117|NCT00891930|971474|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
407118|NCT00891904|971495|P1|NOT COMPLETED|Overall Study||2
407119|NCT00891904|971495|P1|COMPLETED|Overall Study||0
407120|NCT00891904|971495|P1|STARTED|Overall Study||2
407121|NCT00891839|971502|P1|NOT COMPLETED|Overall Study||7
407122|NCT00891839|971502|P1|COMPLETED|Overall Study|completed treatment|38
407123|NCT00891839|971502|P1|STARTED|Overall Study||45
407124|NCT00891813|971511|P1|NOT COMPLETED|Overall Study||12
407125|NCT00891813|971511|P1|COMPLETED|Overall Study||88
407126|NCT00891813|971511|P1|STARTED|Overall Study||100
407127|NCT00891774|971517|P1|NOT COMPLETED|Overall Study||14
407128|NCT00891774|971517|P1|COMPLETED|Overall Study||158
407129|NCT00891774|971517|P1|STARTED|Overall Study||172
407130|NCT00891735|971525|P4|NOT COMPLETED|Overall Study||15
407131|NCT00891735|971526|P3|NOT COMPLETED|Overall Study||12
407132|NCT00891735|971527|P2|NOT COMPLETED|Overall Study||16
407133|NCT00891735|971528|P1|NOT COMPLETED|Overall Study||17
407134|NCT00891735|971525|P4|COMPLETED|Overall Study||258
407135|NCT00891735|971526|P3|COMPLETED|Overall Study||263
407136|NCT00891735|971527|P2|COMPLETED|Overall Study||258
407137|NCT00891735|971528|P1|COMPLETED|Overall Study||258
407138|NCT00891735|971525|P4|STARTED|Overall Study||273
407139|NCT00891735|971526|P3|STARTED|Overall Study||275
407140|NCT00891735|971527|P2|STARTED|Overall Study||274
407141|NCT00891735|971528|P1|STARTED|Overall Study||275
407142|NCT00891657|971568|P2|NOT COMPLETED|Overall Study||1
407143|NCT00891657|971569|P1|NOT COMPLETED|Overall Study||1
407144|NCT00891657|971568|P2|COMPLETED|Overall Study||5
407145|NCT00891657|971569|P1|COMPLETED|Overall Study||8
407146|NCT00891657|971568|P2|STARTED|Overall Study||6
407147|NCT00891657|971569|P1|STARTED|Overall Study||9
407148|NCT00891618|971581|P1|NOT COMPLETED|Overall Study||1
407149|NCT00891618|971581|P1|COMPLETED|Overall Study||20
407150|NCT00891618|971581|P1|STARTED|Overall Study||21
407151|NCT00891527|971585|P1|NOT COMPLETED|Overall Study||2
407152|NCT00891527|971585|P1|COMPLETED|Overall Study||48
407153|NCT00891527|971585|P1|STARTED|Overall Study||50
407154|NCT00891462|971594|P3|NOT COMPLETED|Overall Study||24
407155|NCT00891462|971595|P2|NOT COMPLETED|Overall Study||33
407156|NCT00891462|971596|P1|NOT COMPLETED|Overall Study||37
407157|NCT00891462|971594|P3|COMPLETED|Overall Study||166
407158|NCT00891462|971595|P2|COMPLETED|Overall Study||152
407159|NCT00891462|971596|P1|COMPLETED|Overall Study||149
407160|NCT00891462|971594|P3|STARTED|Overall Study||190
407161|NCT00891462|971595|P2|STARTED|Overall Study||185
407162|NCT00891462|971596|P1|STARTED|Overall Study||186
407163|NCT00891436|971609|P2|NOT COMPLETED|Overall Study||0
407164|NCT00891436|971610|P1|NOT COMPLETED|Overall Study||0
407165|NCT00891436|971609|P2|COMPLETED|Overall Study||10
407166|NCT00891436|971610|P1|COMPLETED|Overall Study||10
407167|NCT00891436|971609|P2|STARTED|Overall Study||10
407168|NCT00891436|971610|P1|STARTED|Overall Study||10
407169|NCT00891371|971618|P1|NOT COMPLETED|Treatment||9
407170|NCT00891371|971618|P1|COMPLETED|Treatment||27
407171|NCT00891371|971618|P1|STARTED|Treatment||36
407172|NCT00891371|971618|P1|NOT COMPLETED|Pre-assignment||6
407173|NCT00891371|971618|P1|COMPLETED|Pre-assignment||36
407174|NCT00891371|971618|P1|STARTED|Pre-assignment||42
407175|NCT00891293|971627|P1|NOT COMPLETED|Overall Study||84
407176|NCT00891293|971627|P1|COMPLETED|Overall Study||9
407177|NCT00891293|971627|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
407178|NCT00891202|971641|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
407179|NCT00891202|971642|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
407180|NCT00891202|971643|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
407181|NCT00891202|971644|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
407182|NCT00891202|971641|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
407183|NCT00891202|971642|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
407184|NCT00891202|971643|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
407185|NCT00891202|971644|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
407186|NCT00891202|971641|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
407187|NCT00891202|971642|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
407188|NCT00891202|971643|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
407189|NCT00891202|971644|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
407190|NCT00891202|971641|P4|NOT COMPLETED|PAP (Up To Week 39)||0
407191|NCT00891202|971642|P3|NOT COMPLETED|PAP (Up To Week 39)||0
407192|NCT00891202|971643|P2|NOT COMPLETED|PAP (Up To Week 39)||0
407193|NCT00891202|971644|P1|NOT COMPLETED|PAP (Up To Week 39)||1
407194|NCT00891202|971641|P4|COMPLETED|PAP (Up To Week 39)||0
407195|NCT00891202|971642|P3|COMPLETED|PAP (Up To Week 39)||0
407196|NCT00891202|971643|P2|COMPLETED|PAP (Up To Week 39)||20
407197|NCT00891202|971644|P1|COMPLETED|PAP (Up To Week 39)||19
407198|NCT00891202|971641|P4|STARTED|PAP (Up To Week 39)||0
407199|NCT00891202|971642|P3|STARTED|PAP (Up To Week 39)||0
407200|NCT00891202|971643|P2|STARTED|PAP (Up To Week 39)||20
407201|NCT00891202|971644|P1|STARTED|PAP (Up To Week 39)||20
407202|NCT00891176|971670|P4|NOT COMPLETED|At 6 Years of Age||0
407203|NCT00891176|971671|P3|NOT COMPLETED|At 6 Years of Age||0
407204|NCT00891176|971672|P2|NOT COMPLETED|At 6 Years of Age||0
407205|NCT00891176|971673|P1|NOT COMPLETED|At 6 Years of Age||0
407206|NCT00891176|971670|P4|COMPLETED|At 6 Years of Age||135
407207|NCT00891176|971671|P3|COMPLETED|At 6 Years of Age||135
407208|NCT00891176|971672|P2|COMPLETED|At 6 Years of Age||138
407209|NCT00891176|971673|P1|COMPLETED|At 6 Years of Age||131
407210|NCT00891176|971670|P4|STARTED|At 6 Years of Age||135
407211|NCT00891176|971671|P3|STARTED|At 6 Years of Age||135
407212|NCT00891176|971672|P2|STARTED|At 6 Years of Age||138
407213|NCT00891176|971673|P1|STARTED|At 6 Years of Age||131
407214|NCT00891176|971670|P4|NOT COMPLETED|At 4 Years of Age||0
407215|NCT00891176|971671|P3|NOT COMPLETED|At 4 Years of Age||0
407216|NCT00891176|971672|P2|NOT COMPLETED|At 4 Years of Age||0
407217|NCT00891176|971673|P1|NOT COMPLETED|At 4 Years of Age||0
407218|NCT00891176|971670|P4|COMPLETED|At 4 Years of Age||137
407219|NCT00891176|971671|P3|COMPLETED|At 4 Years of Age||142
407220|NCT00891176|971672|P2|COMPLETED|At 4 Years of Age||142
407221|NCT00891176|971673|P1|COMPLETED|At 4 Years of Age||140
407222|NCT00891176|971670|P4|STARTED|At 4 Years of Age||137
407223|NCT00891176|971671|P3|STARTED|At 4 Years of Age||142
407224|NCT00891176|971672|P2|STARTED|At 4 Years of Age||142
407225|NCT00891176|971673|P1|STARTED|At 4 Years of Age||140
407226|NCT00891176|971670|P4|NOT COMPLETED|At 3 Years of Age||0
407227|NCT00891176|971671|P3|NOT COMPLETED|At 3 Years of Age||0
407228|NCT00891176|971672|P2|NOT COMPLETED|At 3 Years of Age||0
407229|NCT00891176|971673|P1|NOT COMPLETED|At 3 Years of Age||0
407230|NCT00891176|971670|P4|COMPLETED|At 3 Years of Age||141
407231|NCT00891176|971671|P3|COMPLETED|At 3 Years of Age||149
407232|NCT00891176|971672|P2|COMPLETED|At 3 Years of Age||147
407233|NCT00891176|971673|P1|COMPLETED|At 3 Years of Age||144
407234|NCT00891176|971670|P4|STARTED|At 3 Years of Age||141
407235|NCT00891176|971671|P3|STARTED|At 3 Years of Age||149
407236|NCT00891176|971672|P2|STARTED|At 3 Years of Age||147
407237|NCT00891176|971673|P1|STARTED|At 3 Years of Age||144
407238|NCT00891046|971804|P5|NOT COMPLETED|Overall Study||39
407239|NCT00891046|971805|P4|NOT COMPLETED|Overall Study||3
407240|NCT00891046|971806|P3|NOT COMPLETED|Overall Study||23
407241|NCT00891046|971807|P2|NOT COMPLETED|Overall Study||9
407242|NCT00891046|971808|P1|NOT COMPLETED|Overall Study||12
407243|NCT00891046|971804|P5|COMPLETED|Overall Study||84
407244|NCT00891046|971805|P4|COMPLETED|Overall Study||8
407245|NCT00891046|971806|P3|COMPLETED|Overall Study||17
407246|NCT00891046|971807|P2|COMPLETED|Overall Study||54
407247|NCT00891046|971808|P1|COMPLETED|Overall Study||21
407248|NCT00891046|971804|P5|STARTED|Overall Study||123
407249|NCT00891046|971805|P4|STARTED|Overall Study||11
407250|NCT00891046|971806|P3|STARTED|Overall Study||40
407251|NCT00891046|971807|P2|STARTED|Overall Study||63
407252|NCT00891046|971808|P1|STARTED|Overall Study||33
407253|NCT00891020|971884|P3|NOT COMPLETED|Long-term Extension Period||23
407254|NCT00891020|971885|P2|NOT COMPLETED|Long-term Extension Period||24
407255|NCT00891020|971886|P1|NOT COMPLETED|Long-term Extension Period||6
407256|NCT00891020|971884|P3|COMPLETED|Long-term Extension Period||170
407257|NCT00891020|971885|P2|COMPLETED|Long-term Extension Period||172
407258|NCT00891020|971886|P1|COMPLETED|Long-term Extension Period||49
407259|NCT00891020|971884|P3|STARTED|Long-term Extension Period||193
407260|NCT00891020|971885|P2|STARTED|Long-term Extension Period||196
407261|NCT00891020|971886|P1|STARTED|Long-term Extension Period||55
407262|NCT00891020|971884|P3|NOT COMPLETED|24 Week Treatment Period||58
407263|NCT00891020|971885|P2|NOT COMPLETED|24 Week Treatment Period||60
407264|NCT00891020|971886|P1|NOT COMPLETED|24 Week Treatment Period||37
407265|NCT00891020|971884|P3|COMPLETED|24 Week Treatment Period||302
407266|NCT00891020|971885|P2|COMPLETED|24 Week Treatment Period||303
407267|NCT00891020|971886|P1|COMPLETED|24 Week Treatment Period||126
407268|NCT00891020|971884|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
407269|NCT00891020|971885|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
407270|NCT00891020|971886|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
407271|NCT00891020|971884|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
407272|NCT00891020|971885|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
407273|NCT00891020|971886|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
407274|NCT00891020|971884|P3|STARTED|24 Week Treatment Period||360
407275|NCT00891020|971885|P2|STARTED|24 Week Treatment Period||363
407276|NCT00891020|971886|P1|STARTED|24 Week Treatment Period||163
407277|NCT00890981|971919|P2|NOT COMPLETED|Overall Study||0
407278|NCT00890981|971920|P1|NOT COMPLETED|Overall Study||0
407279|NCT00890981|971919|P2|COMPLETED|Overall Study||40
407280|NCT00890981|971920|P1|COMPLETED|Overall Study||39
407281|NCT00890981|971919|P2|STARTED|Overall Study||40
407282|NCT00890981|971920|P1|STARTED|Overall Study||39
407283|NCT00890929|971950|P1|NOT COMPLETED|Overall Study||6
407284|NCT00890929|971950|P1|COMPLETED|Overall Study||39
407285|NCT00890929|971950|P1|Initiated Treatment|Overall Study||43
407286|NCT00890929|971950|P1|Consented & Enrolled|Overall Study||45
407287|NCT00890929|971950|P1|STARTED|Overall Study||45
407288|NCT00890916|971962|P1|NOT COMPLETED|"Rehab - NP OFF"||0
407289|NCT00890916|971962|P1|COMPLETED|"Rehab - NP OFF"||10
407290|NCT00890916|971962|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP OFF"||10
407291|NCT00890916|971962|P1|STARTED|"Rehab - NP OFF"||10
407292|NCT00890916|971962|P1|NOT COMPLETED|"Rehab - NP ON"||0
407293|NCT00890916|971962|P1|COMPLETED|"Rehab - NP ON"||10
407294|NCT00890916|971962|P1|"Grasp Release Pre-Test ON"|"Rehab - NP ON"||10
407295|NCT00890916|971962|P1|STARTED|"Rehab - NP ON"|First IST-12 Implant.|10
407296|NCT00890721|971968|P2|NOT COMPLETED|Overall Study||1
407297|NCT00890721|971969|P1|NOT COMPLETED|Overall Study||1
407298|NCT00890721|971968|P2|COMPLETED|Overall Study||93
407299|NCT00890721|971969|P1|COMPLETED|Overall Study||94
407300|NCT00890721|971968|P2|STARTED|Overall Study||94
407301|NCT00890721|971969|P1|STARTED|Overall Study||95
407302|NCT00890695|971977|P2|NOT COMPLETED|Overall Study||0
407303|NCT00890695|971978|P1|NOT COMPLETED|Overall Study||1
407304|NCT00890695|971977|P2|COMPLETED|Overall Study||33
407305|NCT00890695|971978|P1|COMPLETED|Overall Study||31
407306|NCT00890695|971977|P2|STARTED|Overall Study||33
407307|NCT00890695|971978|P1|STARTED|Overall Study||32
407308|NCT00890682|971996|P2|NOT COMPLETED|Overall Study||2
407309|NCT00890682|971997|P1|NOT COMPLETED|Overall Study||4
407310|NCT00890682|971996|P2|COMPLETED|Overall Study||94
407311|NCT00890682|971997|P1|COMPLETED|Overall Study||93
407312|NCT00890682|971996|P2|STARTED|Overall Study||96
407313|NCT00890682|971997|P1|STARTED|Overall Study||97
407314|NCT00890656|972003|P1|NOT COMPLETED|Overall Study||0
407315|NCT00890656|972003|P1|COMPLETED|Overall Study||90
407316|NCT00890656|972003|P1|STARTED|Overall Study||90
407317|NCT00890591|972007|P1|NOT COMPLETED|Overall Study||20
407318|NCT00890591|972007|P1|COMPLETED|Overall Study||124
407319|NCT00890591|972007|P1|STARTED|Overall Study||144
407320|NCT00890552|972013|P1|NOT COMPLETED|On-treatment||10
407321|NCT00890552|972013|P1|COMPLETED|On-treatment||14
407322|NCT00890552|972013|P1|STARTED|On-treatment||24
407323|NCT00890552|972013|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
407324|NCT00890552|972013|P1|COMPLETED|Enrollment and Pre-treatment||24
407325|NCT00890552|972013|P1|STARTED|Enrollment and Pre-treatment||25
407326|NCT00890409|972022|P2|NOT COMPLETED|Overall Study||21
407327|NCT00890409|972023|P1|NOT COMPLETED|Overall Study||20
407328|NCT00890409|972022|P2|COMPLETED|Overall Study||119
407329|NCT00890409|972023|P1|COMPLETED|Overall Study||96
407330|NCT00890409|972022|P2|STARTED|Overall Study||140
407331|NCT00890409|972023|P1|STARTED|Overall Study||116
407332|NCT00890201|972033|P2|NOT COMPLETED|Overall Study||56
407333|NCT00890201|972034|P1|NOT COMPLETED|Overall Study||5
407334|NCT00890201|972033|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
407335|NCT00890201|972034|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
407336|NCT00890201|972033|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
407337|NCT00890201|972034|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
407338|NCT00890097|972043|P3|NOT COMPLETED|Overall Study||77
407339|NCT00890097|972044|P2|NOT COMPLETED|Overall Study||86
407340|NCT00890097|972045|P1|NOT COMPLETED|Overall Study||68
407341|NCT00890097|972043|P3|COMPLETED|Overall Study||184
407342|NCT00890097|972044|P2|COMPLETED|Overall Study||173
407343|NCT00890097|972045|P1|COMPLETED|Overall Study||184
407344|NCT00890097|972043|P3|STARTED|Overall Study||261
407345|NCT00890097|972044|P2|STARTED|Overall Study||259
407346|NCT00890097|972045|P1|STARTED|Overall Study||252
407347|NCT00890084|972053|P1|NOT COMPLETED|Overall Study||142
407348|NCT00890084|972053|P1|COMPLETED|Overall Study||2771
407349|NCT00890084|972053|P1|STARTED|Overall Study||2913
407350|NCT00889928|972064|P1|NOT COMPLETED|Overall Study||0
407351|NCT00889928|972064|P1|COMPLETED|Overall Study||7
407352|NCT00889928|972064|P1|STARTED|Overall Study||7
407353|NCT00889915|972072|P4|NOT COMPLETED|Overall Study||8
407354|NCT00889915|972073|P3|NOT COMPLETED|Overall Study||13
407355|NCT00889915|972074|P2|NOT COMPLETED|Overall Study||5
407356|NCT00889915|972075|P1|NOT COMPLETED|Overall Study||2
407357|NCT00889915|972072|P4|COMPLETED|Overall Study||40
407358|NCT00889915|972073|P3|COMPLETED|Overall Study||54
407359|NCT00889915|972074|P2|COMPLETED|Overall Study||71
407360|NCT00889915|972075|P1|COMPLETED|Overall Study||35
407361|NCT00889915|972072|P4|STARTED|Overall Study||48
407362|NCT00889915|972073|P3|STARTED|Overall Study||67
407363|NCT00889915|972074|P2|STARTED|Overall Study||76
407364|NCT00889915|972075|P1|STARTED|Overall Study||37
407365|NCT00889863|972093|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
407366|NCT00889863|972094|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
407367|NCT00889863|972093|P2|COMPLETED|Part II: Randomized Double Blind||24
407368|NCT00889863|972094|P1|COMPLETED|Part II: Randomized Double Blind||39
407369|NCT00889863|972093|P2|STARTED|Part II: Randomized Double Blind||50
407370|NCT00889863|972094|P1|STARTED|Part II: Randomized Double Blind||50
407371|NCT00889863|972093|P2|NOT COMPLETED|Part I: Open Label||0
407372|NCT00889863|972094|P1|NOT COMPLETED|Part I: Open Label||77
407373|NCT00889863|972093|P2|COMPLETED|Part I: Open Label||0
407374|NCT00889863|972094|P1|COMPLETED|Part I: Open Label||100
407375|NCT00889863|972093|P2|Entered Part 1d|Part I: Open Label||0
407376|NCT00889863|972094|P1|Entered Part 1d|Part I: Open Label||103
407377|NCT00889863|972093|P2|Entered Part Ic|Part I: Open Label||0
407378|NCT00889863|972094|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
407379|NCT00889863|972093|P2|Entered Part Ib|Part I: Open Label||0
407380|NCT00889863|972094|P1|Entered Part Ib|Part I: Open Label||142
407381|NCT00889863|972093|P2|Entered Part Ia|Part I: Open Label||0
407382|NCT00889863|972094|P1|Entered Part Ia|Part I: Open Label||145
407383|NCT00889863|972093|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
407384|NCT00889863|972094|P1|STARTED|Part I: Open Label||177
407385|NCT00889824|972116|P1|NOT COMPLETED|Overall Study||0
407386|NCT00889824|972116|P1|COMPLETED|Overall Study||5
407387|NCT00889824|972116|P1|STARTED|Overall Study||5
407388|NCT00888940|972122|P2|NOT COMPLETED|Overall Study||21
407389|NCT00888940|972123|P1|NOT COMPLETED|Overall Study||28
407390|NCT00888940|972122|P2|COMPLETED|Overall Study||101
407391|NCT00888940|972123|P1|COMPLETED|Overall Study||92
407392|NCT00888940|972122|P2|Completed Therapy|Overall Study||106
407393|NCT00888940|972123|P1|Completed Therapy|Overall Study||107
407394|NCT00888940|972122|P2|STARTED|Overall Study||122
407395|NCT00888940|972123|P1|STARTED|Overall Study||120
407396|NCT00888849|972133|P2|NOT COMPLETED|Overall Study||9
407397|NCT00888849|972134|P1|NOT COMPLETED|Overall Study||5
407398|NCT00888849|972133|P2|COMPLETED|Overall Study||129
407399|NCT00888849|972134|P1|COMPLETED|Overall Study||137
407400|NCT00888849|972133|P2|STARTED|Overall Study||138
407401|NCT00888849|972134|P1|STARTED|Overall Study||142
407402|NCT00889720|972144|P1|NOT COMPLETED|Overall Study||8
407403|NCT00889720|972144|P1|COMPLETED|Overall Study||8
407404|NCT00889720|972144|P1|Surgical Population|Overall Study||12
407405|NCT00889720|972144|P1|STARTED|Overall Study||16
407406|NCT00889707|972171|P2|NOT COMPLETED|Overall Study||10
407407|NCT00889707|972172|P1|NOT COMPLETED|Overall Study||7
407408|NCT00889707|972171|P2|COMPLETED|Overall Study||21
407409|NCT00889707|972172|P1|COMPLETED|Overall Study||54
407410|NCT00889707|972171|P2|STARTED|Overall Study||31
407411|NCT00889707|972172|P1|STARTED|Overall Study||61
407412|NCT00889681|972180|P1|NOT COMPLETED|Overall Study||3
407413|NCT00889681|972180|P1|COMPLETED|Overall Study||78
407414|NCT00889681|972180|P1|Received Treatment|Overall Study||78
407415|NCT00889681|972180|P1|STARTED|Overall Study||81
407416|NCT00889603|972187|P1|NOT COMPLETED|Overall Study||37
407417|NCT00889603|972187|P1|COMPLETED|Overall Study||333
407418|NCT00889603|972187|P1|STARTED|Overall Study||370
407419|NCT00889512|972202|P2|NOT COMPLETED|Overall Study||0
407420|NCT00889512|972203|P1|NOT COMPLETED|Overall Study||0
407421|NCT00889512|972202|P2|COMPLETED|Overall Study||9
407422|NCT00889512|972203|P1|COMPLETED|Overall Study||5
407423|NCT00889512|972202|P2|STARTED|Overall Study||9
407424|NCT00889512|972203|P1|STARTED|Overall Study||5
407425|NCT00889421|972209|P1|NOT COMPLETED|Overall Study||3
407426|NCT00889421|972209|P1|COMPLETED|Overall Study||0
407427|NCT00889421|972209|P1|STARTED|Overall Study||3
407428|NCT00889330|972219|P2|NOT COMPLETED|Overall Study||0
407429|NCT00889330|972220|P1|NOT COMPLETED|Overall Study||0
407430|NCT00889330|972219|P2|COMPLETED|Overall Study||30
407431|NCT00889330|972220|P1|COMPLETED|Overall Study||30
407432|NCT00889330|972219|P2|STARTED|Overall Study||30
407433|NCT00889330|972220|P1|STARTED|Overall Study||30
407434|NCT00889265|972250|P1|NOT COMPLETED|Overall Study||7
407435|NCT00889265|972250|P1|COMPLETED|Overall Study||44
407436|NCT00889265|972250|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
407437|NCT00889252|972257|P2|NOT COMPLETED|Overall Study||4
407438|NCT00889252|972258|P1|NOT COMPLETED|Overall Study||7
407439|NCT00889252|972257|P2|COMPLETED|Overall Study||78
407440|NCT00889252|972258|P1|COMPLETED|Overall Study||161
407441|NCT00889252|972257|P2|STARTED|Overall Study||82
407442|NCT00889252|972258|P1|STARTED|Overall Study||168
407443|NCT00889200|972300|P1|NOT COMPLETED|Overall Study||0
407444|NCT00889200|972300|P1|COMPLETED|Overall Study||12
407445|NCT00889200|972300|P1|STARTED|Overall Study||12
407446|NCT00888979|972304|P1|NOT COMPLETED|Overall Study||4
407447|NCT00888979|972304|P1|COMPLETED|Overall Study||6
407448|NCT00888979|972304|P1|Received the Inhaler/Counseling|Overall Study||8
407449|NCT00888979|972304|P1|STARTED|Overall Study||10
407450|NCT00888654|972310|P1|NOT COMPLETED|Overall Study||10
407451|NCT00888654|972310|P1|COMPLETED|Overall Study||31
407452|NCT00888654|972310|P1|STARTED|Overall Study||41
407453|NCT00888628|972314|P1|NOT COMPLETED|Overall Study||3
407454|NCT00888628|972314|P1|COMPLETED|Overall Study||4
407455|NCT00888628|972314|P1|Transplanted|Overall Study||4
407456|NCT00888628|972314|P1|Withdrawn|Overall Study||1
407457|NCT00888628|972314|P1|Screen Failure|Overall Study||2
407458|NCT00888628|972314|P1|Enrolled|Overall Study||7
407459|NCT00888628|972314|P1|STARTED|Overall Study||7
407460|NCT00888459|972322|P2|NOT COMPLETED|Overall Study||0
407461|NCT00888459|972323|P1|NOT COMPLETED|Overall Study||0
407462|NCT00888459|972322|P2|COMPLETED|Overall Study||30
407463|NCT00888459|972323|P1|COMPLETED|Overall Study||30
407464|NCT00888459|972322|P2|STARTED|Overall Study||30
407465|NCT00888459|972323|P1|STARTED|Overall Study||30
407466|NCT00888433|972331|P2|NOT COMPLETED|Overall Study||3
407467|NCT00888433|972332|P1|NOT COMPLETED|Overall Study||3
407468|NCT00888433|972331|P2|COMPLETED|Overall Study||51
407469|NCT00888433|972332|P1|COMPLETED|Overall Study||49
407470|NCT00888433|972331|P2|STARTED|Overall Study||54
407471|NCT00888433|972332|P1|STARTED|Overall Study||52
407472|NCT00888381|972340|P2|NOT COMPLETED|Overall Study||1
407473|NCT00888381|972341|P1|NOT COMPLETED|Overall Study||0
407474|NCT00888381|972340|P2|COMPLETED|Overall Study||59
407475|NCT00888381|972341|P1|COMPLETED|Overall Study||60
407476|NCT00888381|972340|P2|STARTED|Overall Study||60
407477|NCT00888381|972341|P1|STARTED|Overall Study||60
407478|NCT00888355|972361|P4|NOT COMPLETED|Overall Study||10
407479|NCT00888355|972362|P3|NOT COMPLETED|Overall Study||12
407480|NCT00888355|972363|P2|NOT COMPLETED|Overall Study||9
407481|NCT00888355|972364|P1|NOT COMPLETED|Overall Study||22
407482|NCT00888355|972361|P4|COMPLETED|Overall Study||96
407483|NCT00888355|972362|P3|COMPLETED|Overall Study||94
407484|NCT00888355|972363|P2|COMPLETED|Overall Study||99
407485|NCT00888355|972364|P1|COMPLETED|Overall Study||86
407486|NCT00888355|972361|P4|STARTED|Overall Study||106
407487|NCT00888355|972362|P3|STARTED|Overall Study||106
407488|NCT00888355|972363|P2|STARTED|Overall Study||108
407489|NCT00888355|972364|P1|STARTED|Overall Study||108
407490|NCT00888329|972420|P2|NOT COMPLETED|Overall Study||9
407491|NCT00888329|972421|P1|NOT COMPLETED|Overall Study||6
407492|NCT00888329|972420|P2|COMPLETED|Overall Study||122
407493|NCT00888329|972421|P1|COMPLETED|Overall Study||119
407494|NCT00888329|972420|P2|STARTED|Overall Study||131
407495|NCT00888329|972421|P1|STARTED|Overall Study||125
407496|NCT00888238|972427|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
407497|NCT00888238|972428|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
407498|NCT00888238|972429|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
407499|NCT00888238|972427|P3|COMPLETED|Third Period of Treatment Intervention||3
407500|NCT00888238|972428|P2|COMPLETED|Third Period of Treatment Intervention||4
407501|NCT00888238|972429|P1|COMPLETED|Third Period of Treatment Intervention||4
407502|NCT00888238|972427|P3|STARTED|Third Period of Treatment Intervention||3
407503|NCT00888238|972428|P2|STARTED|Third Period of Treatment Intervention||4
407504|NCT00888238|972429|P1|STARTED|Third Period of Treatment Intervention||4
407505|NCT00888238|972427|P3|NOT COMPLETED|Washout Period After Period 2||1
407506|NCT00888238|972428|P2|NOT COMPLETED|Washout Period After Period 2||0
407507|NCT00888238|972429|P1|NOT COMPLETED|Washout Period After Period 2||0
407508|NCT00888238|972427|P3|COMPLETED|Washout Period After Period 2||3
407509|NCT00888238|972428|P2|COMPLETED|Washout Period After Period 2||4
407510|NCT00888238|972429|P1|COMPLETED|Washout Period After Period 2||4
407511|NCT00888238|972427|P3|STARTED|Washout Period After Period 2||4
407512|NCT00888238|972428|P2|STARTED|Washout Period After Period 2||4
407513|NCT00888238|972429|P1|STARTED|Washout Period After Period 2||4
407514|NCT00888238|972427|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
407515|NCT00888238|972428|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
407516|NCT00888238|972429|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
407517|NCT00888238|972427|P3|COMPLETED|Second Period of Treatment Intervention||4
407518|NCT00888238|972428|P2|COMPLETED|Second Period of Treatment Intervention||4
407519|NCT00888238|972429|P1|COMPLETED|Second Period of Treatment Intervention||4
407520|NCT00888238|972427|P3|STARTED|Second Period of Treatment Intervention||4
407521|NCT00888238|972428|P2|STARTED|Second Period of Treatment Intervention||4
407522|NCT00888238|972429|P1|STARTED|Second Period of Treatment Intervention||4
407523|NCT00888238|972427|P3|NOT COMPLETED|Washout Period After Period 1||0
407524|NCT00888238|972428|P2|NOT COMPLETED|Washout Period After Period 1||0
407525|NCT00888238|972429|P1|NOT COMPLETED|Washout Period After Period 1||0
407526|NCT00888238|972427|P3|COMPLETED|Washout Period After Period 1||4
407527|NCT00888238|972428|P2|COMPLETED|Washout Period After Period 1||4
407528|NCT00888238|972429|P1|COMPLETED|Washout Period After Period 1||4
407529|NCT00888238|972427|P3|STARTED|Washout Period After Period 1||4
407530|NCT00888238|972428|P2|STARTED|Washout Period After Period 1||4
407531|NCT00888238|972429|P1|STARTED|Washout Period After Period 1||4
407532|NCT00888238|972427|P3|NOT COMPLETED|First Period of Treatment Intervention||0
407533|NCT00888238|972428|P2|NOT COMPLETED|First Period of Treatment Intervention||0
407534|NCT00888238|972429|P1|NOT COMPLETED|First Period of Treatment Intervention||0
407535|NCT00888238|972427|P3|COMPLETED|First Period of Treatment Intervention||4
407536|NCT00888238|972428|P2|COMPLETED|First Period of Treatment Intervention||4
407537|NCT00888238|972429|P1|COMPLETED|First Period of Treatment Intervention||4
407538|NCT00888238|972427|P3|STARTED|First Period of Treatment Intervention||4
407539|NCT00888238|972428|P2|STARTED|First Period of Treatment Intervention||4
407540|NCT00888238|972429|P1|STARTED|First Period of Treatment Intervention||4
407541|NCT00888134|972437|P1|NOT COMPLETED|Follow-up||1
407542|NCT00888134|972437|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
407543|NCT00888134|972437|P1|STARTED|Follow-up||27
407544|NCT00888134|972437|P1|NOT COMPLETED|Treatment With Study Drug||1
407545|NCT00888134|972437|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
407546|NCT00888134|972437|P1|STARTED|Treatment With Study Drug||28
407547|NCT00887978|972447|P2|NOT COMPLETED|Overall Study||15
407548|NCT00887978|972448|P1|NOT COMPLETED|Overall Study||25
407549|NCT00887978|972447|P2|COMPLETED|Overall Study||138
407550|NCT00887978|972448|P1|COMPLETED|Overall Study||132
407551|NCT00887978|972447|P2|STARTED|Overall Study||153
407552|NCT00887978|972448|P1|STARTED|Overall Study||157
407553|NCT00887965|972484|P1|NOT COMPLETED|Overall Study||0
407554|NCT00887965|972484|P1|COMPLETED|Overall Study||15
407555|NCT00887965|972484|P1|STARTED|Overall Study||15
407556|NCT00887913|972514|P1|NOT COMPLETED|Overall Study||6
407557|NCT00887913|972514|P1|COMPLETED|Overall Study||63
407558|NCT00887913|972514|P1|STARTED|Overall Study||69
407559|NCT00887822|972522|P2|NOT COMPLETED|Overall Study||102
407560|NCT00887822|972523|P1|NOT COMPLETED|Overall Study||97
407561|NCT00887822|972522|P2|COMPLETED|Overall Study||0
407562|NCT00887822|972523|P1|COMPLETED|Overall Study||3
407563|NCT00887822|972522|P2|Treated (Safety Population)|Overall Study||101
407564|NCT00887822|972523|P1|Treated (Safety Population)|Overall Study||100
407565|NCT00887822|972522|P2|STARTED|Overall Study||102
407566|NCT00887822|972523|P1|STARTED|Overall Study||100
407567|NCT00887809|972555|P2|NOT COMPLETED|Overall Study||0
407568|NCT00887809|972556|P1|NOT COMPLETED|Overall Study||4
407569|NCT00887809|972555|P2|COMPLETED|Overall Study||10
407570|NCT00887809|972556|P1|COMPLETED|Overall Study||33
407571|NCT00887809|972555|P2|STARTED|Overall Study||10
407572|NCT00887809|972556|P1|STARTED|Overall Study||37
407573|NCT00887744|972562|P1|NOT COMPLETED|Overall Study||34
407574|NCT00887744|972562|P1|COMPLETED|Overall Study||128
407575|NCT00887744|972562|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
407576|NCT00887679|972571|P1|NOT COMPLETED|Overall Study||10
407663|NCT00887471|972767|P2|STARTED|Overall Study||15
407577|NCT00887679|972571|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
407578|NCT00887679|972571|P1|STARTED|Overall Study||30
407579|NCT00887653|972580|P1|NOT COMPLETED|Overall Study||0
407580|NCT00887653|972580|P1|COMPLETED|Overall Study||20
407581|NCT00887653|972580|P1|STARTED|Overall Study||20
407582|NCT00887640|972586|P1|NOT COMPLETED|Overall Study||0
407583|NCT00887640|972586|P1|COMPLETED|Overall Study||11
407584|NCT00887640|972586|P1|STARTED|Overall Study||11
407585|NCT00887588|972601|P2|NOT COMPLETED|Extension Period||5
407586|NCT00887588|972602|P1|NOT COMPLETED|Extension Period||6
407587|NCT00887588|972601|P2|COMPLETED|Extension Period||120
407588|NCT00887588|972602|P1|COMPLETED|Extension Period||121
407589|NCT00887588|972601|P2|Arterial Stiffness Set|Extension Period||94
407590|NCT00887588|972602|P1|Arterial Stiffness Set|Extension Period||86
407591|NCT00887588|972601|P2|STARTED|Extension Period||125
407592|NCT00887588|972602|P1|STARTED|Extension Period||127
407593|NCT00887588|972601|P2|NOT COMPLETED|Core Period||21
407594|NCT00887588|972602|P1|NOT COMPLETED|Core Period||19
407595|NCT00887588|972601|P2|COMPLETED|Core Period||131
407596|NCT00887588|972602|P1|COMPLETED|Core Period||130
407597|NCT00887588|972601|P2|Arterial Stiffness Set|Core Period||94
407598|NCT00887588|972602|P1|Arterial Stiffness Set|Core Period||86
407599|NCT00887588|972601|P2|Full Analysis Set|Core Period||146
407600|NCT00887588|972602|P1|Full Analysis Set|Core Period||148
407601|NCT00887588|972601|P2|Extension Efficacy Set|Core Period||125
407602|NCT00887588|972602|P1|Extension Efficacy Set|Core Period||127
407603|NCT00887588|972601|P2|STARTED|Core Period||152
407604|NCT00887588|972602|P1|STARTED|Core Period||149
407605|NCT00887575|972654|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
407606|NCT00887575|972655|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
407607|NCT00887575|972656|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
407608|NCT00887575|972654|P3|COMPLETED|Phase II - Maintenance Therapy||0
407609|NCT00887575|972655|P2|COMPLETED|Phase II - Maintenance Therapy||0
407610|NCT00887575|972656|P1|COMPLETED|Phase II - Maintenance Therapy||6
407611|NCT00887575|972654|P3|STARTED|Phase II - Maintenance Therapy||0
407612|NCT00887575|972655|P2|STARTED|Phase II - Maintenance Therapy||0
407613|NCT00887575|972656|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
407614|NCT00887575|972654|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
407615|NCT00887575|972655|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
407616|NCT00887575|972656|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
407617|NCT00887575|972654|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
407618|NCT00887575|972655|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
407619|NCT00887575|972656|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
407620|NCT00887575|972654|P3|STARTED|Phase II - Neoadjuvant Therapy||0
407621|NCT00887575|972655|P2|STARTED|Phase II - Neoadjuvant Therapy||0
407622|NCT00887575|972656|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
407623|NCT00887575|972654|P3|NOT COMPLETED|Phase I||3
407624|NCT00887575|972655|P2|NOT COMPLETED|Phase I||6
407625|NCT00887575|972656|P1|NOT COMPLETED|Phase I||0
407626|NCT00887575|972654|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
407627|NCT00887575|972655|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
407628|NCT00887575|972656|P1|COMPLETED|Phase I||6
407629|NCT00887575|972654|P3|STARTED|Phase I||3
407630|NCT00887575|972655|P2|STARTED|Phase I||6
407631|NCT00887575|972656|P1|STARTED|Phase I||6
407632|NCT00887562|972667|P3|NOT COMPLETED|Overall Study||1
407633|NCT00887562|972668|P2|NOT COMPLETED|Overall Study||2
407634|NCT00887562|972669|P1|NOT COMPLETED|Overall Study||3
407635|NCT00887562|972667|P3|COMPLETED|Overall Study||7
407636|NCT00887562|972668|P2|COMPLETED|Overall Study||7
407637|NCT00887562|972669|P1|COMPLETED|Overall Study||7
407638|NCT00887562|972667|P3|STARTED|Overall Study||8
407639|NCT00887562|972668|P2|STARTED|Overall Study||9
407640|NCT00887562|972669|P1|STARTED|Overall Study||10
407641|NCT00887549|972683|P1|NOT COMPLETED|Maintenance Therapy||43
407642|NCT00887549|972683|P1|COMPLETED|Maintenance Therapy||0
407643|NCT00887549|972683|P1|STARTED|Maintenance Therapy||43
407644|NCT00887549|972683|P1|NOT COMPLETED|Induction Therapy||27
407645|NCT00887549|972683|P1|COMPLETED|Induction Therapy||43
407646|NCT00887549|972683|P1|STARTED|Induction Therapy||70
407647|NCT00887510|972692|P2|NOT COMPLETED|Overall Study||0
407648|NCT00887510|972693|P1|NOT COMPLETED|Overall Study||0
407649|NCT00887510|972692|P2|COMPLETED|Overall Study||12
407650|NCT00887510|972693|P1|COMPLETED|Overall Study||12
407651|NCT00887510|972692|P2|STARTED|Overall Study||12
407652|NCT00887510|972693|P1|STARTED|Overall Study||12
407653|NCT00887484|972701|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
407654|NCT00887484|972701|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
407655|NCT00887484|972701|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
407656|NCT00887484|972701|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
407657|NCT00887484|972701|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
407658|NCT00887484|972701|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
407659|NCT00887471|972767|P2|NOT COMPLETED|Overall Study||0
407660|NCT00887471|972768|P1|NOT COMPLETED|Overall Study||0
407661|NCT00887471|972767|P2|COMPLETED|Overall Study||15
407662|NCT00887471|972768|P1|COMPLETED|Overall Study||15
407664|NCT00887471|972768|P1|STARTED|Overall Study||15
407665|NCT00887458|972778|P2|NOT COMPLETED|Overall Study||4
407666|NCT00887458|972779|P1|NOT COMPLETED|Overall Study||0
407667|NCT00887458|972778|P2|COMPLETED|Overall Study||25
407668|NCT00887458|972779|P1|COMPLETED|Overall Study||17
407669|NCT00887458|972778|P2|STARTED|Overall Study||29
407670|NCT00887458|972779|P1|STARTED|Overall Study||17
407671|NCT00887354|972787|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
407672|NCT00887354|972788|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
407673|NCT00887354|972787|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
407674|NCT00887354|972788|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
407675|NCT00887354|972787|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
407676|NCT00887354|972788|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
407677|NCT00887354|972787|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
407678|NCT00887354|972788|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
407679|NCT00887354|972787|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
407680|NCT00887354|972788|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
407681|NCT00887354|972787|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
407682|NCT00887354|972788|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
407683|NCT00887354|972787|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
407684|NCT00887354|972788|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
407685|NCT00887354|972787|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
407686|NCT00887354|972788|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
407687|NCT00887341|972808|P2|NOT COMPLETED|Overall Study||3
407688|NCT00887341|972809|P1|NOT COMPLETED|Overall Study||2
407689|NCT00887341|972808|P2|COMPLETED|Overall Study||36
407690|NCT00887341|972809|P1|COMPLETED|Overall Study||35
407691|NCT00887341|972808|P2|STARTED|Overall Study||39
407692|NCT00887341|972809|P1|STARTED|Overall Study||37
407693|NCT00887315|972845|P2|NOT COMPLETED|Overall Study||4
407694|NCT00887315|972846|P1|NOT COMPLETED|Overall Study||7
407695|NCT00887315|972845|P2|COMPLETED|Overall Study||0
407696|NCT00887315|972846|P1|COMPLETED|Overall Study||0
407697|NCT00887315|972845|P2|STARTED|Overall Study||4
407698|NCT00887315|972846|P1|STARTED|Overall Study||7
407699|NCT00887289|972854|P1|NOT COMPLETED|Overall Study||95
407700|NCT00887289|972854|P1|COMPLETED|Overall Study||1409
407701|NCT00887289|972854|P1|STARTED|Overall Study||1504
407702|NCT00887250|972866|P3|NOT COMPLETED|Overall Study||13
407703|NCT00887250|972867|P2|NOT COMPLETED|Overall Study||12
407704|NCT00887250|972868|P1|NOT COMPLETED|Overall Study||18
407705|NCT00887250|972866|P3|COMPLETED|Overall Study||110
407706|NCT00887250|972867|P2|COMPLETED|Overall Study||115
407707|NCT00887250|972868|P1|COMPLETED|Overall Study||98
407708|NCT00887250|972866|P3|STARTED|Overall Study||123
407709|NCT00887250|972867|P2|STARTED|Overall Study||127
407710|NCT00887250|972868|P1|STARTED|Overall Study||116
407711|NCT00887224|972891|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
407712|NCT00887224|972892|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
407713|NCT00887224|972893|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
407714|NCT00887224|972891|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
407715|NCT00887224|972892|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
407716|NCT00887224|972893|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
407717|NCT00887224|972891|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
407718|NCT00887224|972892|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
407719|NCT00887224|972893|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
407720|NCT00887224|972891|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
407721|NCT00887224|972892|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
407722|NCT00887224|972893|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
407723|NCT00887224|972891|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
407724|NCT00887224|972892|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
407725|NCT00887224|972893|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
407726|NCT00887224|972891|P3|NOT COMPLETED|Double-blind (DB) Phase||62
407727|NCT00887224|972892|P2|NOT COMPLETED|Double-blind (DB) Phase||100
407728|NCT00887224|972893|P1|NOT COMPLETED|Double-blind (DB) Phase||0
407729|NCT00887224|972891|P3|COMPLETED|Double-blind (DB) Phase||210
407730|NCT00887224|972892|P2|COMPLETED|Double-blind (DB) Phase||176
407731|NCT00887224|972893|P1|COMPLETED|Double-blind (DB) Phase||0
407732|NCT00887224|972891|P3|STARTED|Double-blind (DB) Phase||272
407733|NCT00887224|972892|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
407734|NCT00887224|972893|P1|STARTED|Double-blind (DB) Phase||0
407735|NCT00887224|972891|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
407736|NCT00887224|972892|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
407737|NCT00887224|972893|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
407738|NCT00887224|972891|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
407739|NCT00887224|972892|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
407740|NCT00887224|972893|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
407741|NCT00887224|972891|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
407742|NCT00887224|972892|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
407825|NCT00886821|973012|P8|NOT COMPLETED|Stage 2||0
407743|NCT00887224|972893|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
407744|NCT00887224|972891|P3|STARTED|OL Taper Phase / OL Follow Up||0
407745|NCT00887224|972892|P2|STARTED|OL Taper Phase / OL Follow Up||0
407746|NCT00887224|972893|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
407747|NCT00887224|972891|P3|NOT COMPLETED|Between OLS and DB Phases||0
407748|NCT00887224|972892|P2|NOT COMPLETED|Between OLS and DB Phases||0
407749|NCT00887224|972893|P1|NOT COMPLETED|Between OLS and DB Phases||28
407750|NCT00887224|972891|P3|COMPLETED|Between OLS and DB Phases||0
407751|NCT00887224|972892|P2|COMPLETED|Between OLS and DB Phases||0
407752|NCT00887224|972893|P1|COMPLETED|Between OLS and DB Phases||548
407753|NCT00887224|972891|P3|STARTED|Between OLS and DB Phases||0
407754|NCT00887224|972892|P2|STARTED|Between OLS and DB Phases||0
407755|NCT00887224|972893|P1|STARTED|Between OLS and DB Phases||576
407756|NCT00887224|972891|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
407757|NCT00887224|972892|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
407758|NCT00887224|972893|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
407759|NCT00887224|972891|P3|COMPLETED|Open-label Stability (OLS) Phase||0
407760|NCT00887224|972892|P2|COMPLETED|Open-label Stability (OLS) Phase||0
407761|NCT00887224|972893|P1|COMPLETED|Open-label Stability (OLS) Phase||576
407762|NCT00887224|972891|P3|STARTED|Open-label Stability (OLS) Phase||0
407763|NCT00887224|972892|P2|STARTED|Open-label Stability (OLS) Phase||0
407764|NCT00887224|972893|P1|STARTED|Open-label Stability (OLS) Phase||659
407765|NCT00887224|972891|P3|NOT COMPLETED|Between OLR and OLS Phases||0
407766|NCT00887224|972892|P2|NOT COMPLETED|Between OLR and OLS Phases||0
407767|NCT00887224|972893|P1|NOT COMPLETED|Between OLR and OLS Phases||93
407768|NCT00887224|972891|P3|COMPLETED|Between OLR and OLS Phases||0
407769|NCT00887224|972892|P2|COMPLETED|Between OLR and OLS Phases||0
407770|NCT00887224|972893|P1|COMPLETED|Between OLR and OLS Phases||659
407771|NCT00887224|972891|P3|STARTED|Between OLR and OLS Phases||0
407772|NCT00887224|972892|P2|STARTED|Between OLR and OLS Phases||0
407773|NCT00887224|972893|P1|STARTED|Between OLR and OLS Phases||752
407774|NCT00887224|972891|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
407775|NCT00887224|972892|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
407776|NCT00887224|972893|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
407777|NCT00887224|972891|P3|COMPLETED|Open-label Response (OLR) Phase||0
407778|NCT00887224|972892|P2|COMPLETED|Open-label Response (OLR) Phase||0
407779|NCT00887224|972893|P1|COMPLETED|Open-label Response (OLR) Phase||752
407780|NCT00887224|972891|P3|STARTED|Open-label Response (OLR) Phase||0
407781|NCT00887224|972892|P2|STARTED|Open-label Response (OLR) Phase||0
407782|NCT00887224|972893|P1|STARTED|Open-label Response (OLR) Phase||874
407783|NCT00887198|972920|P2|NOT COMPLETED|Overall Study||431
407784|NCT00887198|972921|P1|NOT COMPLETED|Overall Study||384
407785|NCT00887198|972920|P2|COMPLETED|Overall Study||111
407786|NCT00887198|972921|P1|COMPLETED|Overall Study||162
407787|NCT00887198|972920|P2|STARTED|Overall Study||542
407788|NCT00887198|972921|P1|STARTED|Overall Study||546
407789|NCT00887159|972952|P3|NOT COMPLETED|Overall Study||56
407790|NCT00887159|972953|P2|NOT COMPLETED|Overall Study||56
407791|NCT00887159|972954|P1|NOT COMPLETED|Overall Study||29
407792|NCT00887159|972952|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
407793|NCT00887159|972953|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
407794|NCT00887159|972954|P1|COMPLETED|Overall Study||27
407795|NCT00887159|972952|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
407796|NCT00887159|972953|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
407797|NCT00887159|972954|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
407798|NCT00887159|972952|P3|Eligible and Treated Patients|Overall Study||52
407799|NCT00887159|972953|P2|Eligible and Treated Patients|Overall Study||52
407800|NCT00887159|972954|P1|Eligible and Treated Patients|Overall Study||48
407801|NCT00887159|972952|P3|Patients Who Started Assigned Treatment|Overall Study||52
407802|NCT00887159|972953|P2|Patients Who Started Assigned Treatment|Overall Study||53
407803|NCT00887159|972954|P1|Patients Who Started Assigned Treatment|Overall Study||53
407804|NCT00887159|972952|P3|STARTED|Overall Study||56
407805|NCT00887159|972953|P2|STARTED|Overall Study||56
407806|NCT00887159|972954|P1|STARTED|Overall Study||56
407807|NCT00886938|972970|P1|NOT COMPLETED|Overall Study||2
407808|NCT00886938|972970|P1|COMPLETED|Overall Study||10
407809|NCT00886938|972970|P1|STARTED|Overall Study||12
407810|NCT00886899|972974|P1|NOT COMPLETED|Overall Study||0
407811|NCT00886899|972974|P1|COMPLETED|Overall Study||147
407812|NCT00886899|972974|P1|STARTED|Overall Study||147
407813|NCT00886834|972983|P2|NOT COMPLETED|Overall Study||3
407814|NCT00886834|972984|P1|NOT COMPLETED|Overall Study||0
407815|NCT00886834|972983|P2|COMPLETED|Overall Study||51
407816|NCT00886834|972984|P1|COMPLETED|Overall Study||54
407817|NCT00886834|972983|P2|STARTED|Overall Study||54
407818|NCT00886834|972984|P1|STARTED|Overall Study||54
407819|NCT00886821|973006|P14|NOT COMPLETED|Stage 2||1
407820|NCT00886821|973007|P13|NOT COMPLETED|Stage 2||5
407821|NCT00886821|973008|P12|NOT COMPLETED|Stage 2||1
407822|NCT00886821|973009|P11|NOT COMPLETED|Stage 2||0
407823|NCT00886821|973010|P10|NOT COMPLETED|Stage 2||0
407824|NCT00886821|973011|P9|NOT COMPLETED|Stage 2||0
407826|NCT00886821|973013|P7|NOT COMPLETED|Stage 2||0
407827|NCT00886821|973014|P6|NOT COMPLETED|Stage 2||0
407828|NCT00886821|973015|P5|NOT COMPLETED|Stage 2||0
407829|NCT00886821|973016|P4|NOT COMPLETED|Stage 2||0
407830|NCT00886821|973017|P3|NOT COMPLETED|Stage 2||0
407831|NCT00886821|973018|P2|NOT COMPLETED|Stage 2||0
407832|NCT00886821|973019|P1|NOT COMPLETED|Stage 2||0
407833|NCT00886821|973006|P14|COMPLETED|Stage 2||8
407834|NCT00886821|973007|P13|COMPLETED|Stage 2||8
407835|NCT00886821|973008|P12|COMPLETED|Stage 2||8
407836|NCT00886821|973009|P11|COMPLETED|Stage 2||9
407837|NCT00886821|973010|P10|COMPLETED|Stage 2||0
407838|NCT00886821|973011|P9|COMPLETED|Stage 2||0
407839|NCT00886821|973012|P8|COMPLETED|Stage 2||0
407840|NCT00886821|973013|P7|COMPLETED|Stage 2||0
407841|NCT00886821|973014|P6|COMPLETED|Stage 2||0
407842|NCT00886821|973015|P5|COMPLETED|Stage 2||0
407843|NCT00886821|973016|P4|COMPLETED|Stage 2||0
407844|NCT00886821|973017|P3|COMPLETED|Stage 2||0
407845|NCT00886821|973018|P2|COMPLETED|Stage 2||0
407846|NCT00886821|973019|P1|COMPLETED|Stage 2||0
407847|NCT00886821|973006|P14|STARTED|Stage 2||9
407848|NCT00886821|973007|P13|STARTED|Stage 2||13
407849|NCT00886821|973008|P12|STARTED|Stage 2||9
407850|NCT00886821|973009|P11|STARTED|Stage 2||9
407851|NCT00886821|973010|P10|STARTED|Stage 2||0
407852|NCT00886821|973011|P9|STARTED|Stage 2||0
407853|NCT00886821|973012|P8|STARTED|Stage 2||0
407854|NCT00886821|973013|P7|STARTED|Stage 2||0
407855|NCT00886821|973014|P6|STARTED|Stage 2||0
407856|NCT00886821|973015|P5|STARTED|Stage 2||0
407857|NCT00886821|973016|P4|STARTED|Stage 2||0
407858|NCT00886821|973017|P3|STARTED|Stage 2||0
407859|NCT00886821|973018|P2|STARTED|Stage 2||0
407860|NCT00886821|973019|P1|STARTED|Stage 2||0
407861|NCT00886821|973006|P14|NOT COMPLETED|Stage 1||0
407862|NCT00886821|973007|P13|NOT COMPLETED|Stage 1||0
407863|NCT00886821|973008|P12|NOT COMPLETED|Stage 1||0
407864|NCT00886821|973009|P11|NOT COMPLETED|Stage 1||0
407865|NCT00886821|973010|P10|NOT COMPLETED|Stage 1||0
407866|NCT00886821|973011|P9|NOT COMPLETED|Stage 1||0
407867|NCT00886821|973012|P8|NOT COMPLETED|Stage 1||0
407868|NCT00886821|973013|P7|NOT COMPLETED|Stage 1||0
407869|NCT00886821|973014|P6|NOT COMPLETED|Stage 1||0
407870|NCT00886821|973015|P5|NOT COMPLETED|Stage 1||0
407871|NCT00886821|973016|P4|NOT COMPLETED|Stage 1||0
407872|NCT00886821|973017|P3|NOT COMPLETED|Stage 1||0
407873|NCT00886821|973018|P2|NOT COMPLETED|Stage 1||0
407874|NCT00886821|973019|P1|NOT COMPLETED|Stage 1||0
407875|NCT00886821|973006|P14|COMPLETED|Stage 1||0
407876|NCT00886821|973007|P13|COMPLETED|Stage 1||0
407877|NCT00886821|973008|P12|COMPLETED|Stage 1||0
407878|NCT00886821|973009|P11|COMPLETED|Stage 1||0
407879|NCT00886821|973010|P10|COMPLETED|Stage 1||18
407880|NCT00886821|973011|P9|COMPLETED|Stage 1||6
407881|NCT00886821|973012|P8|COMPLETED|Stage 1||6
407882|NCT00886821|973013|P7|COMPLETED|Stage 1||6
407883|NCT00886821|973014|P6|COMPLETED|Stage 1||6
407884|NCT00886821|973015|P5|COMPLETED|Stage 1||6
407885|NCT00886821|973016|P4|COMPLETED|Stage 1||7
407886|NCT00886821|973017|P3|COMPLETED|Stage 1||6
407887|NCT00886821|973018|P2|COMPLETED|Stage 1||6
407888|NCT00886821|973019|P1|COMPLETED|Stage 1||7
407889|NCT00886821|973006|P14|STARTED|Stage 1||0
407890|NCT00886821|973007|P13|STARTED|Stage 1||0
407891|NCT00886821|973008|P12|STARTED|Stage 1||0
407892|NCT00886821|973009|P11|STARTED|Stage 1||0
407893|NCT00886821|973010|P10|STARTED|Stage 1||18
407894|NCT00886821|973011|P9|STARTED|Stage 1||6
407895|NCT00886821|973012|P8|STARTED|Stage 1||6
407896|NCT00886821|973013|P7|STARTED|Stage 1||6
407897|NCT00886821|973014|P6|STARTED|Stage 1||6
407898|NCT00886821|973015|P5|STARTED|Stage 1||6
407899|NCT00886821|973016|P4|STARTED|Stage 1||7
407900|NCT00886821|973017|P3|STARTED|Stage 1||6
407901|NCT00886821|973018|P2|STARTED|Stage 1||6
407902|NCT00886821|973019|P1|STARTED|Stage 1||7
407903|NCT00886795|973244|P1|NOT COMPLETED|Overall Study||1
407904|NCT00886795|973244|P1|COMPLETED|Overall Study||3
407905|NCT00886795|973244|P1|STARTED|Overall Study||4
407906|NCT00886769|973251|P2|NOT COMPLETED|Overall Study||37
407907|NCT00886769|973252|P1|NOT COMPLETED|Overall Study||6
407908|NCT00886769|973251|P2|COMPLETED|Overall Study||4
407909|NCT00886769|973252|P1|COMPLETED|Overall Study||37
407910|NCT00886769|973251|P2|STARTED|Overall Study||41
407911|NCT00886769|973252|P1|STARTED|Overall Study||43
407912|NCT00886743|973276|P1|NOT COMPLETED|Overall Study||4
407913|NCT00886743|973276|P1|COMPLETED|Overall Study||15
407914|NCT00886743|973276|P1|STARTED|Overall Study|Received treatment|19
407915|NCT00886704|973286|P2|NOT COMPLETED|Overall Study||0
407916|NCT00886704|973287|P1|NOT COMPLETED|Overall Study||0
407917|NCT00886704|973286|P2|COMPLETED|Overall Study||10
407918|NCT00886704|973287|P1|COMPLETED|Overall Study||40
407919|NCT00886704|973286|P2|STARTED|Overall Study||10
407920|NCT00886704|973287|P1|STARTED|Overall Study||40
407921|NCT00886639|973295|P1|NOT COMPLETED|Overall Study||16
407922|NCT00886639|973295|P1|COMPLETED|Overall Study||111
407923|NCT00886639|973295|P1|STARTED|Overall Study||127
407924|NCT00886626|973299|P2|NOT COMPLETED|Period 2 (90 Days)||0
407925|NCT00886626|973300|P1|NOT COMPLETED|Period 2 (90 Days)||0
407926|NCT00886626|973299|P2|COMPLETED|Period 2 (90 Days)||6
407927|NCT00886626|973300|P1|COMPLETED|Period 2 (90 Days)||5
407928|NCT00886626|973299|P2|STARTED|Period 2 (90 Days)||6
407929|NCT00886626|973300|P1|STARTED|Period 2 (90 Days)||5
407930|NCT00886626|973299|P2|NOT COMPLETED|Period 1 (90 Days)||0
407931|NCT00886626|973300|P1|NOT COMPLETED|Period 1 (90 Days)||1
407932|NCT00886626|973299|P2|COMPLETED|Period 1 (90 Days)||6
407933|NCT00886626|973300|P1|COMPLETED|Period 1 (90 Days)||5
407934|NCT00886626|973299|P2|STARTED|Period 1 (90 Days)||6
407935|NCT00886626|973300|P1|STARTED|Period 1 (90 Days)||6
407936|NCT00886613|973309|P3|NOT COMPLETED|Overall Study||3
407937|NCT00886613|973310|P2|NOT COMPLETED|Overall Study||0
407938|NCT00886613|973311|P1|NOT COMPLETED|Overall Study||2
407939|NCT00886613|973309|P3|COMPLETED|Overall Study||37
407940|NCT00886613|973310|P2|COMPLETED|Overall Study||39
407941|NCT00886613|973311|P1|COMPLETED|Overall Study||39
407942|NCT00886613|973309|P3|STARTED|Overall Study||40
407943|NCT00886613|973310|P2|STARTED|Overall Study||39
407944|NCT00886613|973311|P1|STARTED|Overall Study||41
407945|NCT00886600|973333|P4|NOT COMPLETED|Combination Therapy Period||0
407946|NCT00886600|973334|P3|NOT COMPLETED|Combination Therapy Period||2
407947|NCT00886600|973335|P2|NOT COMPLETED|Combination Therapy Period||0
407948|NCT00886600|973336|P1|NOT COMPLETED|Combination Therapy Period||0
407949|NCT00886600|973333|P4|COMPLETED|Combination Therapy Period||23
407950|NCT00886600|973334|P3|COMPLETED|Combination Therapy Period||19
407951|NCT00886600|973335|P2|COMPLETED|Combination Therapy Period||21
407952|NCT00886600|973336|P1|COMPLETED|Combination Therapy Period||28
407953|NCT00886600|973333|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
407954|NCT00886600|973334|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
407955|NCT00886600|973335|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
407956|NCT00886600|973336|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
407957|NCT00886600|973333|P4|NOT COMPLETED|Double-blind Monotherapy||2
407958|NCT00886600|973334|P3|NOT COMPLETED|Double-blind Monotherapy||1
407959|NCT00886600|973335|P2|NOT COMPLETED|Double-blind Monotherapy||1
407960|NCT00886600|973336|P1|NOT COMPLETED|Double-blind Monotherapy||2
407961|NCT00886600|973333|P4|COMPLETED|Double-blind Monotherapy||29
407962|NCT00886600|973334|P3|COMPLETED|Double-blind Monotherapy||29
407963|NCT00886600|973335|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
407964|NCT00886600|973336|P1|COMPLETED|Double-blind Monotherapy||30
407965|NCT00886600|973333|P4|STARTED|Double-blind Monotherapy||31
407966|NCT00886600|973334|P3|STARTED|Double-blind Monotherapy||30
407967|NCT00886600|973335|P2|STARTED|Double-blind Monotherapy||29
407968|NCT00886600|973336|P1|STARTED|Double-blind Monotherapy||32
407969|NCT00886587|973360|P2|NOT COMPLETED|Overall Study||2
407970|NCT00886587|973361|P1|NOT COMPLETED|Overall Study||4
407971|NCT00886587|973360|P2|COMPLETED|Overall Study||39
407972|NCT00886587|973361|P1|COMPLETED|Overall Study||37
407973|NCT00886587|973360|P2|STARTED|Overall Study||41
407974|NCT00886587|973361|P1|STARTED|Overall Study||41
407975|NCT00886483|973375|P2|NOT COMPLETED|Overall Study||3
407976|NCT00886483|973376|P1|NOT COMPLETED|Overall Study||2
407977|NCT00886483|973375|P2|COMPLETED|Overall Study||10
407978|NCT00886483|973376|P1|COMPLETED|Overall Study||24
407979|NCT00886483|973375|P2|Completed 20 Treatments|Overall Study||11
407980|NCT00886483|973376|P1|Completed 20 Treatments|Overall Study||25
407981|NCT00886483|973375|P2|STARTED|Overall Study||13
407982|NCT00886483|973376|P1|STARTED|Overall Study||26
407983|NCT00886340|973394|P2|NOT COMPLETED|Overall Study||7
407984|NCT00886340|973395|P1|NOT COMPLETED|Overall Study||0
407985|NCT00886340|973394|P2|COMPLETED|Overall Study||24
407986|NCT00886340|973395|P1|COMPLETED|Overall Study||27
407987|NCT00886340|973394|P2|STARTED|Overall Study||31
407988|NCT00886340|973395|P1|STARTED|Overall Study||27
407989|NCT00886288|973403|P2|NOT COMPLETED|Overall Study||227
407990|NCT00886288|973404|P1|NOT COMPLETED|Overall Study||743
407991|NCT00886288|973403|P2|COMPLETED|Overall Study||457
407992|NCT00886288|973404|P1|COMPLETED|Overall Study||1284
407993|NCT00886288|973403|P2|STARTED|Overall Study|Baseline Population|684
407994|NCT00886288|973404|P1|STARTED|Overall Study|Baseline Population|2027
407995|NCT00886145|973420|P1|NOT COMPLETED|Overall Study||0
407996|NCT00886145|973420|P1|COMPLETED|Overall Study||1
407997|NCT00886145|973420|P1|STARTED|Overall Study||1
407998|NCT00886119|973426|P2|NOT COMPLETED|Period 2||0
407999|NCT00886119|973427|P1|NOT COMPLETED|Period 2||0
408000|NCT00886119|973426|P2|COMPLETED|Period 2||22
408001|NCT00886119|973427|P1|COMPLETED|Period 2||23
408002|NCT00886119|973426|P2|STARTED|Period 2||22
408003|NCT00886119|973427|P1|STARTED|Period 2||23
408004|NCT00886119|973426|P2|NOT COMPLETED|Period 1||0
408005|NCT00886119|973427|P1|NOT COMPLETED|Period 1||1
408006|NCT00886119|973426|P2|COMPLETED|Period 1||22
408007|NCT00886119|973427|P1|COMPLETED|Period 1||23
408008|NCT00886119|973426|P2|STARTED|Period 1||22
408009|NCT00886119|973427|P1|STARTED|Period 1||24
408010|NCT00886015|973435|P2|NOT COMPLETED|Overall Study||2
408011|NCT00886015|973436|P1|NOT COMPLETED|Overall Study||0
408012|NCT00886015|973435|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
408013|NCT00886015|973436|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
408098|NCT00885170|973621|P1|NOT COMPLETED|Overall Study||38
408014|NCT00886015|973435|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
408015|NCT00886015|973436|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
408016|NCT00885846|973455|P3|NOT COMPLETED|Overall Study||2
408017|NCT00885846|973456|P2|NOT COMPLETED|Overall Study||5
408018|NCT00885846|973457|P1|NOT COMPLETED|Overall Study||2
408019|NCT00885846|973455|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
408020|NCT00885846|973456|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
408021|NCT00885846|973457|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
408022|NCT00885846|973455|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
408023|NCT00885846|973456|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
408024|NCT00885846|973457|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
408025|NCT00885768|973465|P1|NOT COMPLETED|Overall Study||0
408026|NCT00885768|973465|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
408027|NCT00885768|973465|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
408028|NCT00885755|973472|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
408029|NCT00885755|973473|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
408030|NCT00885755|973474|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
408031|NCT00885755|973472|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
408032|NCT00885755|973473|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
408033|NCT00885755|973474|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
408034|NCT00885755|973472|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
408035|NCT00885755|973473|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
408036|NCT00885755|973474|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
408037|NCT00885755|973472|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
408038|NCT00885755|973473|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
408039|NCT00885755|973474|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
408040|NCT00885755|973472|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
408041|NCT00885755|973473|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
408042|NCT00885755|973474|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
408043|NCT00885755|973472|P3|STARTED|Part I: Trastuzumab+Taxane||1
408044|NCT00885755|973473|P2|STARTED|Part I: Trastuzumab+Taxane||1
408045|NCT00885755|973474|P1|STARTED|Part I: Trastuzumab+Taxane||31
408046|NCT00885742|973499|P1|NOT COMPLETED|Overall Study||0
408047|NCT00885742|973499|P1|COMPLETED|Overall Study||41
408048|NCT00885742|973499|P1|STARTED|Overall Study||41
408049|NCT00885677|973512|P2|NOT COMPLETED|Overall Study||178
408050|NCT00885677|973513|P1|NOT COMPLETED|Overall Study||183
408051|NCT00885677|973512|P2|COMPLETED|Overall Study||277
408052|NCT00885677|973513|P1|COMPLETED|Overall Study||279
408053|NCT00885677|973512|P2|Intention To Treat|Overall Study||428
408054|NCT00885677|973513|P1|Intention To Treat|Overall Study||437
408055|NCT00885677|973512|P2|STARTED|Overall Study||455
408056|NCT00885677|973513|P1|STARTED|Overall Study||462
408057|NCT00885638|973521|P2|NOT COMPLETED|Overall Study||0
408058|NCT00885638|973522|P1|NOT COMPLETED|Overall Study||0
408059|NCT00885638|973521|P2|COMPLETED|Overall Study||6
408060|NCT00885638|973522|P1|COMPLETED|Overall Study||6
408061|NCT00885638|973521|P2|STARTED|Overall Study||6
408062|NCT00885638|973522|P1|STARTED|Overall Study||6
408063|NCT00885534|973529|P1|NOT COMPLETED|Overall Study||1
408064|NCT00885534|973529|P1|COMPLETED|Overall Study||6
408065|NCT00885534|973529|P1|STARTED|Overall Study||7
408066|NCT00885482|973533|P1|NOT COMPLETED|Overall Study||4
408067|NCT00885482|973533|P1|COMPLETED|Overall Study||36
408068|NCT00885482|973533|P1|STARTED|Overall Study||40
408069|NCT00885378|973539|P2|NOT COMPLETED|Overall Study||8
408070|NCT00885378|973540|P1|NOT COMPLETED|Overall Study||8
408071|NCT00885378|973539|P2|COMPLETED|Overall Study||78
408072|NCT00885378|973540|P1|COMPLETED|Overall Study||66
408073|NCT00885378|973539|P2|STARTED|Overall Study|Number randomized.|86
408074|NCT00885378|973540|P1|STARTED|Overall Study|Number randomized.|74
408075|NCT00885365|973570|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
408076|NCT00885365|973571|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
408077|NCT00885365|973570|P2|COMPLETED|4 Weeks OFF Treatment||159
408078|NCT00885365|973571|P1|COMPLETED|4 Weeks OFF Treatment||155
408079|NCT00885365|973570|P2|STARTED|4 Weeks OFF Treatment||159
408080|NCT00885365|973571|P1|STARTED|4 Weeks OFF Treatment||155
408081|NCT00885365|973570|P2|NOT COMPLETED|4 Weeks ON Treatment||6
408082|NCT00885365|973571|P1|NOT COMPLETED|4 Weeks ON Treatment||4
408083|NCT00885365|973570|P2|COMPLETED|4 Weeks ON Treatment||159
408084|NCT00885365|973571|P1|COMPLETED|4 Weeks ON Treatment||155
408085|NCT00885365|973570|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
408086|NCT00885365|973571|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
408087|NCT00885365|973570|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
408088|NCT00885365|973571|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
408089|NCT00885365|973570|P2|STARTED|4 Weeks ON Treatment||165
408090|NCT00885365|973571|P1|STARTED|4 Weeks ON Treatment||159
408091|NCT00885352|973607|P2|NOT COMPLETED|Overall Study||20
408092|NCT00885352|973608|P1|NOT COMPLETED|Overall Study||8
408093|NCT00885352|973607|P2|COMPLETED|Overall Study||136
408094|NCT00885352|973608|P1|COMPLETED|Overall Study||149
408095|NCT00885352|973607|P2|STARTED|Overall Study||156
408096|NCT00885352|973608|P1|STARTED|Overall Study||157
408097|NCT00885170|973620|P2|NOT COMPLETED|Overall Study||23
408099|NCT00885170|973620|P2|COMPLETED|Overall Study||99
408100|NCT00885170|973621|P1|COMPLETED|Overall Study||86
408101|NCT00885170|973620|P2|Treated|Overall Study||121
408102|NCT00885170|973621|P1|Treated|Overall Study||122
408103|NCT00885170|973620|P2|STARTED|Overall Study||122
408104|NCT00885170|973621|P1|STARTED|Overall Study||124
408105|NCT00885118|973680|P5|NOT COMPLETED|Overall Study||1
408106|NCT00885118|973681|P4|NOT COMPLETED|Overall Study||0
408107|NCT00885118|973682|P3|NOT COMPLETED|Overall Study||1
408108|NCT00885118|973683|P2|NOT COMPLETED|Overall Study||0
408109|NCT00885118|973684|P1|NOT COMPLETED|Overall Study||1
408110|NCT00885118|973680|P5|COMPLETED|Overall Study||18
408111|NCT00885118|973681|P4|COMPLETED|Overall Study||20
408112|NCT00885118|973682|P3|COMPLETED|Overall Study||20
408113|NCT00885118|973683|P2|COMPLETED|Overall Study||19
408114|NCT00885118|973684|P1|COMPLETED|Overall Study||20
408115|NCT00885118|973680|P5|STARTED|Overall Study||19
408116|NCT00885118|973681|P4|STARTED|Overall Study||20
408117|NCT00885118|973682|P3|STARTED|Overall Study||21
408118|NCT00885118|973683|P2|STARTED|Overall Study||19
408119|NCT00885118|973684|P1|STARTED|Overall Study||21
408120|NCT00885105|973823|P2|NOT COMPLETED|Overall Study||10
408121|NCT00885105|973824|P1|NOT COMPLETED|Overall Study||1
408122|NCT00885105|973823|P2|COMPLETED|Overall Study||120
408123|NCT00885105|973824|P1|COMPLETED|Overall Study||111
408124|NCT00885105|973823|P2|STARTED|Overall Study||130
408125|NCT00885105|973824|P1|STARTED|Overall Study||112
408126|NCT00885092|973842|P2|NOT COMPLETED|Period 2, 7 Days||0
408127|NCT00885092|973843|P1|NOT COMPLETED|Period 2, 7 Days||0
408128|NCT00885092|973842|P2|COMPLETED|Period 2, 7 Days||20
408129|NCT00885092|973843|P1|COMPLETED|Period 2, 7 Days||20
408130|NCT00885092|973842|P2|STARTED|Period 2, 7 Days||20
408131|NCT00885092|973843|P1|STARTED|Period 2, 7 Days||20
408132|NCT00885092|973842|P2|NOT COMPLETED|Period 1, 7 Days||0
408133|NCT00885092|973843|P1|NOT COMPLETED|Period 1, 7 Days||0
408134|NCT00885092|973842|P2|COMPLETED|Period 1, 7 Days||20
408135|NCT00885092|973843|P1|COMPLETED|Period 1, 7 Days||20
408136|NCT00885092|973842|P2|STARTED|Period 1, 7 Days||20
408137|NCT00885092|973843|P1|STARTED|Period 1, 7 Days||20
408138|NCT00885079|973855|P2|NOT COMPLETED|Overall Study||4
408139|NCT00885079|973856|P1|NOT COMPLETED|Overall Study||2
408140|NCT00885079|973855|P2|COMPLETED|Overall Study||91
408141|NCT00885079|973856|P1|COMPLETED|Overall Study||91
408142|NCT00885079|973855|P2|STARTED|Overall Study||95
408143|NCT00885079|973856|P1|STARTED|Overall Study||93
408144|NCT00884949|973864|P1|NOT COMPLETED|Continuation Period||0
408145|NCT00884949|973864|P1|COMPLETED|Continuation Period||18
408146|NCT00884949|973864|P1|STARTED|Continuation Period||18
408147|NCT00884949|973864|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
408148|NCT00884949|973864|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
408149|NCT00884949|973864|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
408150|NCT00884949|973864|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
408151|NCT00884949|973864|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
408152|NCT00884949|973864|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
408153|NCT00884949|973864|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
408154|NCT00884949|973864|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
408155|NCT00884949|973864|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
408156|NCT00884910|973881|P1|NOT COMPLETED|Overall Study||1
408157|NCT00884910|973881|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
408158|NCT00884910|973881|P1|STARTED|Overall Study||33
408159|NCT00884897|973888|P2|NOT COMPLETED|Overall Study||0
408160|NCT00884897|973889|P1|NOT COMPLETED|Overall Study||0
408161|NCT00884897|973888|P2|COMPLETED|Overall Study||15
408162|NCT00884897|973889|P1|COMPLETED|Overall Study||13
408163|NCT00884897|973888|P2|STARTED|Overall Study||15
408164|NCT00884897|973889|P1|STARTED|Overall Study||13
408165|NCT00884832|973899|P2|NOT COMPLETED|Overall Study||1
408166|NCT00884832|973900|P1|NOT COMPLETED|Overall Study||0
408167|NCT00884832|973899|P2|COMPLETED|Overall Study||21
408168|NCT00884832|973900|P1|COMPLETED|Overall Study||22
408169|NCT00884832|973899|P2|STARTED|Overall Study||22
408170|NCT00884832|973900|P1|STARTED|Overall Study||22
408171|NCT00884806|973930|P1|NOT COMPLETED|Overall Study||0
408172|NCT00884806|973930|P1|COMPLETED|Overall Study||110
408173|NCT00884806|973930|P1|STARTED|Overall Study||110
408174|NCT00884793|973935|P1|NOT COMPLETED|Overall Study||1
408175|NCT00884793|973935|P1|COMPLETED|Overall Study||7
408176|NCT00884793|973935|P1|STARTED|Overall Study||8
408177|NCT00884754|973944|P2|NOT COMPLETED|Overall Study||0
408178|NCT00884754|973945|P1|NOT COMPLETED|Overall Study||0
408179|NCT00884754|973944|P2|COMPLETED|Overall Study||30
408180|NCT00884754|973945|P1|COMPLETED|Overall Study||30
408181|NCT00884754|973944|P2|STARTED|Overall Study||30
408182|NCT00884754|973945|P1|STARTED|Overall Study||30
408183|NCT00884741|973954|P4|NOT COMPLETED|Randomization||8
408184|NCT00884741|973955|P3|NOT COMPLETED|Randomization||8
408185|NCT00884741|973956|P2|NOT COMPLETED|Randomization||0
408186|NCT00884741|973957|P1|NOT COMPLETED|Randomization||0
408187|NCT00884741|973954|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
408188|NCT00884741|973955|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
408189|NCT00884741|973956|P2|COMPLETED|Randomization||0
408190|NCT00884741|973957|P1|COMPLETED|Randomization||0
408191|NCT00884741|973954|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
408192|NCT00884741|973955|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
408193|NCT00884741|973956|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
408194|NCT00884741|973957|P1|STARTED|Randomization||0
408195|NCT00884741|973954|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
408196|NCT00884741|973955|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
408197|NCT00884741|973956|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
408198|NCT00884741|973957|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
408199|NCT00884741|973954|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
408200|NCT00884741|973955|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
408201|NCT00884741|973956|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
408202|NCT00884741|973957|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
408203|NCT00884741|973954|P4|STARTED|Step 2 Registration: Tissue Analysis||0
408204|NCT00884741|973955|P3|STARTED|Step 2 Registration: Tissue Analysis||0
408205|NCT00884741|973956|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
408206|NCT00884741|973957|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
408207|NCT00884741|973954|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
408208|NCT00884741|973955|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
408209|NCT00884741|973956|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
408210|NCT00884741|973957|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
408211|NCT00884741|973954|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
408212|NCT00884741|973955|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
408213|NCT00884741|973956|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
408214|NCT00884741|973957|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
408215|NCT00884741|973954|P4|STARTED|Step 1 Registration: Tissue Screening||0
408216|NCT00884741|973955|P3|STARTED|Step 1 Registration: Tissue Screening||0
408217|NCT00884741|973956|P2|STARTED|Step 1 Registration: Tissue Screening||0
408218|NCT00884741|973957|P1|STARTED|Step 1 Registration: Tissue Screening||978
408219|NCT00884585|973970|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
408220|NCT00884585|973971|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
408221|NCT00884585|973970|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
408222|NCT00884585|973971|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
408223|NCT00884585|973970|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
408224|NCT00884585|973971|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
408225|NCT00884585|973970|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
408226|NCT00884585|973971|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
408227|NCT00884585|973970|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
408228|NCT00884585|973971|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
408229|NCT00884585|973970|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
408230|NCT00884585|973971|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
408231|NCT00884585|973970|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
408232|NCT00884585|973971|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
408233|NCT00884585|973970|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
408234|NCT00884585|973971|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
408235|NCT00884585|973970|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
408236|NCT00884585|973971|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
408237|NCT00884390|973985|P2|NOT COMPLETED|Overall Study||8
408238|NCT00884390|973986|P1|NOT COMPLETED|Overall Study||23
408239|NCT00884390|973985|P2|COMPLETED|Overall Study||54
408240|NCT00884390|973986|P1|COMPLETED|Overall Study||123
408241|NCT00884390|973985|P2|STARTED|Overall Study||62
408242|NCT00884390|973986|P1|STARTED|Overall Study||146
408243|NCT00884325|974004|P2|NOT COMPLETED|Overall Study||4
408244|NCT00884325|974005|P1|NOT COMPLETED|Overall Study||3
408245|NCT00884325|974004|P2|COMPLETED|Overall Study||16
408246|NCT00884325|974005|P1|COMPLETED|Overall Study||17
408247|NCT00884325|974004|P2|STARTED|Overall Study||20
408248|NCT00884325|974005|P1|STARTED|Overall Study||20
408249|NCT00884273|974015|P2|NOT COMPLETED|Overall Study||5
408250|NCT00884273|974016|P1|NOT COMPLETED|Overall Study||2
408251|NCT00884273|974015|P2|COMPLETED|Overall Study||93
408252|NCT00884273|974016|P1|COMPLETED|Overall Study||82
408253|NCT00884273|974015|P2|Safety Analysis Set|Overall Study||98
408254|NCT00884273|974016|P1|Safety Analysis Set|Overall Study||84
408255|NCT00884273|974015|P2|Per Protocol (PP) Analysis Set|Overall Study||92
408256|NCT00884273|974016|P1|Per Protocol (PP) Analysis Set|Overall Study||81
408257|NCT00884273|974015|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
408258|NCT00884273|974016|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
408259|NCT00884273|974015|P2|STARTED|Overall Study|ITT population.|98
408260|NCT00884273|974016|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
408261|NCT00884221|974042|P2|NOT COMPLETED|Overall Study||32
408262|NCT00884221|974043|P1|NOT COMPLETED|Overall Study||34
408263|NCT00884221|974042|P2|COMPLETED|Overall Study||343
408264|NCT00884221|974043|P1|COMPLETED|Overall Study||340
408265|NCT00884221|974042|P2|STARTED|Overall Study||375
408266|NCT00884221|974043|P1|STARTED|Overall Study||374
408267|NCT00884117|974079|P1|NOT COMPLETED|Overall Study||249
408268|NCT00884117|974079|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
408269|NCT00884117|974079|P1|STARTED|Overall Study||4561
408270|NCT00884065|974123|P2|NOT COMPLETED|Overall Study||0
408271|NCT00884065|974124|P1|NOT COMPLETED|Overall Study||0
408272|NCT00884065|974123|P2|COMPLETED|Overall Study||25
408273|NCT00884065|974124|P1|COMPLETED|Overall Study||25
408274|NCT00884065|974123|P2|STARTED|Overall Study||25
408275|NCT00884065|974124|P1|STARTED|Overall Study||25
408276|NCT00884039|974142|P2|NOT COMPLETED|Overall Study||1
408277|NCT00884039|974143|P1|NOT COMPLETED|Overall Study||2
408278|NCT00884039|974142|P2|COMPLETED|Overall Study||1
408279|NCT00884039|974143|P1|COMPLETED|Overall Study||3
408280|NCT00884039|974142|P2|STARTED|Overall Study||2
408281|NCT00884039|974143|P1|STARTED|Overall Study||5
408282|NCT00883779|974151|P2|NOT COMPLETED|Off-study Phase||202
408283|NCT00883779|974152|P1|NOT COMPLETED|Off-study Phase||209
408284|NCT00883779|974151|P2|COMPLETED|Off-study Phase||0
408285|NCT00883779|974152|P1|COMPLETED|Off-study Phase||0
408286|NCT00883779|974151|P2|STARTED|Off-study Phase||202
408287|NCT00883779|974152|P1|STARTED|Off-study Phase||209
408288|NCT00883779|974151|P2|NOT COMPLETED|Post-Study Treatment Phase||135
408289|NCT00883779|974152|P1|NOT COMPLETED|Post-Study Treatment Phase||112
408290|NCT00883779|974151|P2|COMPLETED|Post-Study Treatment Phase||0
408291|NCT00883779|974152|P1|COMPLETED|Post-Study Treatment Phase||0
408292|NCT00883779|974151|P2|STARTED|Post-Study Treatment Phase||135
408293|NCT00883779|974152|P1|STARTED|Post-Study Treatment Phase||112
408294|NCT00883779|974151|P2|NOT COMPLETED|Primary Study Treatment Phase||86
408295|NCT00883779|974152|P1|NOT COMPLETED|Primary Study Treatment Phase||105
408296|NCT00883779|974151|P2|COMPLETED|Primary Study Treatment Phase||140
408297|NCT00883779|974152|P1|COMPLETED|Primary Study Treatment Phase||120
408298|NCT00883779|974151|P2|STARTED|Primary Study Treatment Phase||226
408299|NCT00883779|974152|P1|STARTED|Primary Study Treatment Phase||225
408300|NCT00883753|974188|P1|NOT COMPLETED|Overall Study||107
408301|NCT00883753|974188|P1|COMPLETED|Overall Study||827
408302|NCT00883753|974188|P1|STARTED|Overall Study||934
408303|NCT00883740|974228|P2|NOT COMPLETED|Second Intervention||1
408304|NCT00883740|974229|P1|NOT COMPLETED|Second Intervention||1
408305|NCT00883740|974228|P2|COMPLETED|Second Intervention||50
408306|NCT00883740|974229|P1|COMPLETED|Second Intervention||52
408307|NCT00883740|974228|P2|STARTED|Second Intervention||51
408308|NCT00883740|974229|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
408309|NCT00883740|974228|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
408310|NCT00883740|974229|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
408311|NCT00883740|974228|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
408312|NCT00883740|974229|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
408313|NCT00883740|974228|P2|STARTED|Taper and Washout Period (2 Weeks)||51
408314|NCT00883740|974229|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
408315|NCT00883740|974228|P2|NOT COMPLETED|First Intervention||8
408316|NCT00883740|974229|P1|NOT COMPLETED|First Intervention||7
408317|NCT00883740|974228|P2|COMPLETED|First Intervention||51
408318|NCT00883740|974229|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
408319|NCT00883740|974228|P2|STARTED|First Intervention||59
408320|NCT00883740|974229|P1|STARTED|First Intervention||60
408321|NCT00883675|974269|P1|NOT COMPLETED|Overall Study||0
408322|NCT00883675|974269|P1|COMPLETED|Overall Study||133
408323|NCT00883675|974269|P1|STARTED|Overall Study||133
408324|NCT00883558|974273|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
408325|NCT00883558|974274|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
408326|NCT00883558|974275|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
408327|NCT00883558|974273|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
408328|NCT00883558|974274|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
408329|NCT00883558|974275|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
408330|NCT00883558|974273|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
408331|NCT00883558|974274|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
408332|NCT00883558|974275|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
408333|NCT00883558|974273|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
408334|NCT00883558|974274|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
408335|NCT00883558|974275|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
408336|NCT00883558|974273|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
408337|NCT00883558|974274|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
408338|NCT00883558|974275|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
408339|NCT00883558|974273|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
408340|NCT00883558|974274|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
408341|NCT00883558|974275|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
408342|NCT00883558|974273|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
408343|NCT00883558|974274|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
408344|NCT00883558|974275|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
408345|NCT00883558|974273|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
408346|NCT00883558|974274|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
408347|NCT00883558|974275|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
408348|NCT00883558|974273|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
408349|NCT00883558|974274|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
408350|NCT00883558|974275|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
408351|NCT00883558|974273|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
408352|NCT00883558|974274|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
408353|NCT00883558|974275|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
408354|NCT00883558|974273|P3|STARTED|Titration Period (Weeks 0 to 4)||0
408355|NCT00883558|974274|P2|STARTED|Titration Period (Weeks 0 to 4)||0
408356|NCT00883558|974275|P1|STARTED|Titration Period (Weeks 0 to 4)||48
408357|NCT00883493|974287|P2|NOT COMPLETED|Overall Study||50
408358|NCT00883493|974288|P1|NOT COMPLETED|Overall Study||46
408359|NCT00883493|974287|P2|COMPLETED|Overall Study||159
408360|NCT00883493|974288|P1|COMPLETED|Overall Study||166
408361|NCT00883493|974287|P2|Per Protocol Analysis Population|Overall Study||155
408362|NCT00883493|974288|P1|Per Protocol Analysis Population|Overall Study||162
408363|NCT00883493|974287|P2|Intention To Treat Analysis Population|Overall Study||195
408364|NCT00883493|974288|P1|Intention To Treat Analysis Population|Overall Study||204
408365|NCT00883493|974287|P2|STARTED|Overall Study||209
408366|NCT00883493|974288|P1|STARTED|Overall Study||212
408367|NCT00883389|974312|P1|NOT COMPLETED|Overall Study||0
408368|NCT00883389|974312|P1|COMPLETED|Overall Study||26
408369|NCT00883389|974312|P1|STARTED|Overall Study||26
408370|NCT00883337|974319|P3|NOT COMPLETED|Extension Treatment Period||19
408371|NCT00883337|974320|P2|NOT COMPLETED|Extension Treatment Period||23
408372|NCT00883337|974321|P1|NOT COMPLETED|Extension Treatment Period||28
408373|NCT00883337|974319|P3|COMPLETED|Extension Treatment Period||40
408374|NCT00883337|974320|P2|COMPLETED|Extension Treatment Period||66
408375|NCT00883337|974321|P1|COMPLETED|Extension Treatment Period||61
408376|NCT00883337|974319|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
408377|NCT00883337|974320|P2|STARTED|Extension Treatment Period||89
408378|NCT00883337|974321|P1|STARTED|Extension Treatment Period||89
408379|NCT00883337|974319|P3|NOT COMPLETED|Core Treatment Period||33
408380|NCT00883337|974320|P2|NOT COMPLETED|Core Treatment Period||22
408381|NCT00883337|974321|P1|NOT COMPLETED|Core Treatment Period||20
408382|NCT00883337|974319|P3|COMPLETED|Core Treatment Period||71
408383|NCT00883337|974320|P2|COMPLETED|Core Treatment Period||89
408384|NCT00883337|974321|P1|COMPLETED|Core Treatment Period||89
408385|NCT00883337|974319|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
408386|NCT00883337|974320|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
408387|NCT00883337|974321|P1|Treated|Core Treatment Period||109
408388|NCT00883337|974319|P3|STARTED|Core Treatment Period||104
408389|NCT00883337|974320|P2|STARTED|Core Treatment Period||111
408390|NCT00883337|974321|P1|STARTED|Core Treatment Period||109
408391|NCT00883246|974353|P1|NOT COMPLETED|Overall Study||173
408392|NCT00883246|974353|P1|COMPLETED|Overall Study||626
408393|NCT00883246|974353|P1|STARTED|Overall Study||799
408394|NCT00883233|974375|P4|NOT COMPLETED|Overall Study||5
408395|NCT00883233|974376|P3|NOT COMPLETED|Overall Study||4
408396|NCT00883233|974377|P2|NOT COMPLETED|Overall Study||4
408397|NCT00883233|974378|P1|NOT COMPLETED|Overall Study||5
408398|NCT00883233|974375|P4|COMPLETED|Overall Study||25
408399|NCT00883233|974376|P3|COMPLETED|Overall Study||25
408400|NCT00883233|974377|P2|COMPLETED|Overall Study||28
408401|NCT00883233|974378|P1|COMPLETED|Overall Study||27
408402|NCT00883233|974375|P4|STARTED|Overall Study||30
408403|NCT00883233|974376|P3|STARTED|Overall Study||29
408404|NCT00883233|974377|P2|STARTED|Overall Study||32
408405|NCT00883233|974378|P1|STARTED|Overall Study||32
408406|NCT00883181|974388|P1|NOT COMPLETED|Overall Study||278
408407|NCT00883181|974388|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
408408|NCT00883181|974388|P1|STARTED|Overall Study|Full analysis set|1347
408409|NCT00883168|974601|P4|NOT COMPLETED|Overall Study||15
408410|NCT00883168|974602|P3|NOT COMPLETED|Overall Study||19
408411|NCT00883168|974603|P2|NOT COMPLETED|Overall Study||15
408412|NCT00883168|974604|P1|NOT COMPLETED|Overall Study||14
408413|NCT00883168|974601|P4|COMPLETED|Overall Study||433
408414|NCT00883168|974602|P3|COMPLETED|Overall Study||431
408415|NCT00883168|974603|P2|COMPLETED|Overall Study||430
408416|NCT00883168|974604|P1|COMPLETED|Overall Study||434
408417|NCT00883168|974601|P4|STARTED|Overall Study||448
408418|NCT00883168|974602|P3|STARTED|Overall Study||450
408419|NCT00883168|974603|P2|STARTED|Overall Study||445
408420|NCT00883168|974604|P1|STARTED|Overall Study||448
408421|NCT00883129|974624|P2|NOT COMPLETED|Overall Study||36
408422|NCT00883129|974625|P1|NOT COMPLETED|Overall Study||20
408423|NCT00883129|974624|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
408424|NCT00883129|974625|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
408425|NCT00883129|974624|P2|STARTED|Overall Study||73
408426|NCT00883129|974625|P1|STARTED|Overall Study||69
408427|NCT00883116|974649|P2|NOT COMPLETED|Overall Study||219
408428|NCT00883116|974650|P1|NOT COMPLETED|Overall Study||209
408429|NCT00883116|974649|P2|COMPLETED|Overall Study||29
408430|NCT00883116|974650|P1|COMPLETED|Overall Study||39
408431|NCT00883116|974649|P2|Received Treatment|Overall Study||239
408432|NCT00883116|974650|P1|Received Treatment|Overall Study||248
408433|NCT00883116|974649|P2|STARTED|Overall Study||248
408434|NCT00883116|974650|P1|STARTED|Overall Study||248
408435|NCT00883103|974665|P2|NOT COMPLETED|Overall Study||0
408436|NCT00883103|974666|P1|NOT COMPLETED|Overall Study||0
408437|NCT00883103|974665|P2|COMPLETED|Overall Study||68
408438|NCT00883103|974666|P1|COMPLETED|Overall Study||69
408439|NCT00883103|974665|P2|STARTED|Overall Study||68
408440|NCT00883103|974666|P1|STARTED|Overall Study||69
408441|NCT00883090|974672|P1|NOT COMPLETED|Overall Study||2
408442|NCT00883090|974672|P1|COMPLETED|Overall Study||13
408443|NCT00883090|974672|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
408444|NCT00882921|974687|P1|NOT COMPLETED|Overall Study||11
408445|NCT00882921|974687|P1|COMPLETED|Overall Study||15
408446|NCT00882921|974687|P1|STARTED|Overall Study||26
408447|NCT00882908|974697|P5|NOT COMPLETED|Overall Study||6
408448|NCT00882908|974698|P4|NOT COMPLETED|Overall Study||7
408449|NCT00882908|974699|P3|NOT COMPLETED|Overall Study||7
408450|NCT00882908|974700|P2|NOT COMPLETED|Overall Study||6
408451|NCT00882908|974701|P1|NOT COMPLETED|Overall Study||3
408452|NCT00882908|974697|P5|COMPLETED|Overall Study||71
408453|NCT00882908|974698|P4|COMPLETED|Overall Study||72
408454|NCT00882908|974699|P3|COMPLETED|Overall Study||70
408455|NCT00882908|974700|P2|COMPLETED|Overall Study||69
408456|NCT00882908|974701|P1|COMPLETED|Overall Study||75
408457|NCT00882908|974697|P5|STARTED|Overall Study||77
408458|NCT00882908|974698|P4|STARTED|Overall Study||79
408459|NCT00882908|974699|P3|STARTED|Overall Study||77
408460|NCT00882908|974700|P2|STARTED|Overall Study||75
408461|NCT00882908|974701|P1|STARTED|Overall Study||78
408462|NCT00882778|974776|P1|NOT COMPLETED|Overall Study||0
408463|NCT00882778|974776|P1|COMPLETED|Overall Study||86
408464|NCT00882778|974776|P1|STARTED|Overall Study||86
408465|NCT00882713|974807|P1|NOT COMPLETED|Overall Study||22
408466|NCT00882713|974807|P1|COMPLETED|Overall Study||172
408467|NCT00882713|974807|P1|STARTED|Overall Study||194
408468|NCT00882687|974833|P4|NOT COMPLETED|Overall Study||2
408469|NCT00882687|974834|P3|NOT COMPLETED|Overall Study||3
408470|NCT00882687|974835|P2|NOT COMPLETED|Overall Study||2
408471|NCT00882687|974836|P1|NOT COMPLETED|Overall Study||2
408472|NCT00882687|974833|P4|COMPLETED|Overall Study||13
408473|NCT00882687|974834|P3|COMPLETED|Overall Study||12
408474|NCT00882687|974835|P2|COMPLETED|Overall Study||13
408475|NCT00882687|974836|P1|COMPLETED|Overall Study||13
408476|NCT00882687|974833|P4|STARTED|Overall Study||15
408477|NCT00882687|974834|P3|STARTED|Overall Study||15
408478|NCT00882687|974835|P2|STARTED|Overall Study||15
408479|NCT00882687|974836|P1|STARTED|Overall Study||15
408480|NCT00882661|974869|P2|NOT COMPLETED|Treatment||26
408481|NCT00882661|974870|P1|NOT COMPLETED|Treatment||10
408482|NCT00882661|974869|P2|COMPLETED|Treatment||114
408483|NCT00882661|974870|P1|COMPLETED|Treatment||141
408484|NCT00882661|974869|P2|STARTED|Treatment||140
408485|NCT00882661|974870|P1|STARTED|Treatment||151
408486|NCT00882661|974869|P2|NOT COMPLETED|Investigational Training||0
408487|NCT00882661|974870|P1|NOT COMPLETED|Investigational Training||10
408488|NCT00882661|974869|P2|COMPLETED|Investigational Training||0
408489|NCT00882661|974870|P1|COMPLETED|Investigational Training||79
408490|NCT00882661|974869|P2|STARTED|Investigational Training||0
408491|NCT00882661|974870|P1|STARTED|Investigational Training||89
408492|NCT00882583|974900|P2|NOT COMPLETED|Overall Study||1
408493|NCT00882583|974901|P1|NOT COMPLETED|Overall Study||1
408494|NCT00882583|974900|P2|COMPLETED|Overall Study||11
408495|NCT00882583|974901|P1|COMPLETED|Overall Study||6
408496|NCT00882583|974900|P2|STARTED|Overall Study||12
408497|NCT00882583|974901|P1|STARTED|Overall Study||7
408498|NCT00882557|974909|P2|NOT COMPLETED|Overall Study||1
408499|NCT00882557|974910|P1|NOT COMPLETED|Overall Study||2
408500|NCT00882557|974909|P2|COMPLETED|Overall Study||7
408501|NCT00882557|974910|P1|COMPLETED|Overall Study||6
408502|NCT00882557|974909|P2|Completed Dose 2|Overall Study||7
408503|NCT00882557|974910|P1|Completed Dose 2|Overall Study||6
408504|NCT00882557|974909|P2|Completed Dose 1|Overall Study||7
408505|NCT00882557|974910|P1|Completed Dose 1|Overall Study||8
408506|NCT00882557|974909|P2|STARTED|Overall Study||8
408507|NCT00882557|974910|P1|STARTED|Overall Study||8
408508|NCT00882518|974930|P2|NOT COMPLETED|Overall Study||44
408509|NCT00882518|974931|P1|NOT COMPLETED|Overall Study||38
408510|NCT00882518|974930|P2|COMPLETED|Overall Study||148
408511|NCT00882518|974931|P1|COMPLETED|Overall Study||158
408512|NCT00882518|974930|P2|STARTED|Overall Study||192
408513|NCT00882518|974931|P1|STARTED|Overall Study||196
408514|NCT00882440|974960|P7|NOT COMPLETED|Overall Study||4
408515|NCT00882440|974961|P6|NOT COMPLETED|Overall Study||7
408516|NCT00882440|974962|P5|NOT COMPLETED|Overall Study||10
408517|NCT00882440|974963|P4|NOT COMPLETED|Overall Study||3
408518|NCT00882440|974964|P3|NOT COMPLETED|Overall Study||7
408519|NCT00882440|974965|P2|NOT COMPLETED|Overall Study||8
408520|NCT00882440|974966|P1|NOT COMPLETED|Overall Study||11
408521|NCT00882440|974960|P7|COMPLETED|Overall Study||79
408522|NCT00882440|974961|P6|COMPLETED|Overall Study||77
408523|NCT00882440|974962|P5|COMPLETED|Overall Study||80
408524|NCT00882440|974963|P4|COMPLETED|Overall Study||76
408525|NCT00882440|974964|P3|COMPLETED|Overall Study||75
408526|NCT00882440|974965|P2|COMPLETED|Overall Study||72
408527|NCT00882440|974966|P1|COMPLETED|Overall Study||67
408528|NCT00882440|974960|P7|STARTED|Overall Study||83
408529|NCT00882440|974961|P6|STARTED|Overall Study||84
408530|NCT00882440|974962|P5|STARTED|Overall Study||90
408531|NCT00882440|974963|P4|STARTED|Overall Study||79
408532|NCT00882440|974964|P3|STARTED|Overall Study||82
408533|NCT00882440|974965|P2|STARTED|Overall Study||80
408534|NCT00882440|974966|P1|STARTED|Overall Study||78
408535|NCT00882362|974991|P2|NOT COMPLETED|Overall Study||23
408536|NCT00882362|974992|P1|NOT COMPLETED|Overall Study||49
408537|NCT00882362|974991|P2|COMPLETED|Overall Study||10
408538|NCT00882362|974992|P1|COMPLETED|Overall Study||73
408539|NCT00882362|974991|P2|STARTED|Overall Study||33
408540|NCT00882362|974992|P1|STARTED|Overall Study||122
408541|NCT00882310|974998|P1|NOT COMPLETED|Overall Study||22
408542|NCT00882310|974998|P1|COMPLETED|Overall Study||15
408543|NCT00882310|974998|P1|STARTED|Overall Study||37
408544|NCT00882206|975004|P1|NOT COMPLETED|Overall Study||0
408545|NCT00882206|975004|P1|COMPLETED|Overall Study||13
408546|NCT00882206|975004|P1|STARTED|Overall Study||13
408547|NCT00882102|975011|P1|NOT COMPLETED|Overall Study||0
408548|NCT00882102|975011|P1|COMPLETED|Overall Study||40
408549|NCT00882102|975011|P1|STARTED|Overall Study||40
408550|NCT00881959|975017|P2|NOT COMPLETED|Overall Study||4
408551|NCT00881959|975018|P1|NOT COMPLETED|Overall Study||2
408552|NCT00881959|975017|P2|COMPLETED|Overall Study||38
408553|NCT00881959|975018|P1|COMPLETED|Overall Study||36
408554|NCT00881959|975017|P2|STARTED|Overall Study||42
408555|NCT00881959|975018|P1|STARTED|Overall Study||38
408556|NCT00881894|975026|P2|NOT COMPLETED|Overall Study||3
408557|NCT00881894|975027|P1|NOT COMPLETED|Overall Study||1
408558|NCT00881894|975026|P2|COMPLETED|Overall Study||23
408559|NCT00881894|975027|P1|COMPLETED|Overall Study||25
408560|NCT00881894|975026|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
408561|NCT00881894|975027|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
408562|NCT00881894|975026|P2|STARTED|Overall Study||26
408563|NCT00881894|975027|P1|STARTED|Overall Study||26
408564|NCT00881868|975059|P2|NOT COMPLETED|Overall Study||2
408565|NCT00881868|975060|P1|NOT COMPLETED|Overall Study||8
408566|NCT00881868|975059|P2|COMPLETED|Overall Study||38
408567|NCT00881868|975060|P1|COMPLETED|Overall Study||33
408568|NCT00881868|975059|P2|STARTED|Overall Study||40
408569|NCT00881868|975060|P1|STARTED|Overall Study||41
408570|NCT00881712|975075|P3|NOT COMPLETED|Overall Study||0
408571|NCT00881712|975076|P2|NOT COMPLETED|Overall Study||0
408572|NCT00881712|975077|P1|NOT COMPLETED|Overall Study||2
408573|NCT00881712|975075|P3|COMPLETED|Overall Study||0
408574|NCT00881712|975076|P2|COMPLETED|Overall Study||0
408575|NCT00881712|975077|P1|COMPLETED|Overall Study||13
408576|NCT00881712|975075|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
408577|NCT00881712|975076|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
408578|NCT00881712|975077|P1|STARTED|Overall Study||15
408579|NCT00881647|975099|P2|NOT COMPLETED|Overall Study||1
408580|NCT00881647|975100|P1|NOT COMPLETED|Overall Study||2
408581|NCT00881647|975099|P2|COMPLETED|Overall Study||15
408582|NCT00881647|975100|P1|COMPLETED|Overall Study||27
408583|NCT00881647|975099|P2|STARTED|Overall Study||16
408584|NCT00881647|975100|P1|STARTED|Overall Study||29
408585|NCT00881621|975110|P1|NOT COMPLETED|Overall Study||34
408586|NCT00881621|975110|P1|COMPLETED|Overall Study||17
408587|NCT00881621|975110|P1|STARTED|Overall Study||51
408588|NCT00881608|975122|P1|NOT COMPLETED|Overall Study||11
408589|NCT00881608|975122|P1|COMPLETED|Overall Study||0
408590|NCT00881608|975122|P1|STARTED|Overall Study||11
408591|NCT00881530|975145|P6|NOT COMPLETED|Overall Study||5
408592|NCT00881530|975146|P5|NOT COMPLETED|Overall Study||14
408593|NCT00881530|975147|P4|NOT COMPLETED|Overall Study||9
408594|NCT00881530|975148|P3|NOT COMPLETED|Overall Study||5
408595|NCT00881530|975149|P2|NOT COMPLETED|Overall Study||5
408596|NCT00881530|975150|P1|NOT COMPLETED|Overall Study||14
408597|NCT00881530|975145|P6|COMPLETED|Overall Study||51
408598|NCT00881530|975146|P5|COMPLETED|Overall Study||152
408599|NCT00881530|975147|P4|COMPLETED|Overall Study||157
408600|NCT00881530|975148|P3|COMPLETED|Overall Study||51
408601|NCT00881530|975149|P2|COMPLETED|Overall Study||104
408602|NCT00881530|975150|P1|COMPLETED|Overall Study||92
408603|NCT00881530|975145|P6|STARTED|Overall Study||56
408604|NCT00881530|975146|P5|STARTED|Overall Study||166
408605|NCT00881530|975147|P4|STARTED|Overall Study||166
408606|NCT00881530|975148|P3|STARTED|Overall Study||56
408607|NCT00881530|975149|P2|STARTED|Overall Study||109
408608|NCT00881530|975150|P1|STARTED|Overall Study||106
408609|NCT00881504|975206|P1|NOT COMPLETED|Overall Study||1
408610|NCT00881504|975206|P1|COMPLETED|Overall Study||8
408611|NCT00881504|975206|P1|STARTED|Overall Study||9
408612|NCT00881465|975213|P2|NOT COMPLETED|Overall Study||0
408613|NCT00881465|975214|P1|NOT COMPLETED|Overall Study||2
408614|NCT00881465|975213|P2|COMPLETED|Overall Study||15
408615|NCT00881465|975214|P1|COMPLETED|Overall Study||14
408616|NCT00881465|975213|P2|STARTED|Overall Study||15
408617|NCT00881465|975214|P1|STARTED|Overall Study||16
408618|NCT00881335|975226|P2|NOT COMPLETED|Overall Study||2
408619|NCT00881335|975227|P1|NOT COMPLETED|Overall Study||3
408620|NCT00881335|975226|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
408621|NCT00881335|975227|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
408622|NCT00881335|975226|P2|STARTED|Overall Study||30
408623|NCT00881335|975227|P1|STARTED|Overall Study||30
408624|NCT00881205|975247|P2|NOT COMPLETED|Overall Study||7
408625|NCT00881205|975248|P1|NOT COMPLETED|Overall Study||11
408626|NCT00881205|975247|P2|COMPLETED|Overall Study||34
408627|NCT00881205|975248|P1|COMPLETED|Overall Study||34
408628|NCT00881205|975247|P2|STARTED|Overall Study||41
408629|NCT00881205|975248|P1|STARTED|Overall Study||45
408630|NCT00880919|975258|P3|NOT COMPLETED|Overall Study||6
408631|NCT00880919|975259|P2|NOT COMPLETED|Overall Study||14
408632|NCT00880919|975260|P1|NOT COMPLETED|Overall Study||15
408633|NCT00880919|975258|P3|COMPLETED|Overall Study||23
408634|NCT00880919|975259|P2|COMPLETED|Overall Study||19
408635|NCT00880919|975260|P1|COMPLETED|Overall Study||18
408636|NCT00880919|975258|P3|STARTED|Overall Study||29
408637|NCT00880919|975259|P2|STARTED|Overall Study||33
408638|NCT00880919|975260|P1|STARTED|Overall Study||33
408639|NCT00880906|975294|P2|NOT COMPLETED|Overall Study||7
408640|NCT00880906|975295|P1|NOT COMPLETED|Overall Study||12
408641|NCT00880906|975294|P2|COMPLETED|Overall Study||14
408642|NCT00880906|975295|P1|COMPLETED|Overall Study||17
408643|NCT00880906|975294|P2|STARTED|Overall Study||21
408644|NCT00880906|975295|P1|STARTED|Overall Study||29
408645|NCT00880763|975305|P4|NOT COMPLETED|Extension Period (Part 2)||3
408646|NCT00880763|975306|P3|NOT COMPLETED|Extension Period (Part 2)||3
408647|NCT00880763|975307|P2|NOT COMPLETED|Extension Period (Part 2)||3
408648|NCT00880763|975308|P1|NOT COMPLETED|Extension Period (Part 2)||0
408649|NCT00880763|975305|P4|COMPLETED|Extension Period (Part 2)||19
408650|NCT00880763|975306|P3|COMPLETED|Extension Period (Part 2)||20
408651|NCT00880763|975307|P2|COMPLETED|Extension Period (Part 2)||19
408652|NCT00880763|975308|P1|COMPLETED|Extension Period (Part 2)||23
408653|NCT00880763|975305|P4|STARTED|Extension Period (Part 2)||22
408654|NCT00880763|975306|P3|STARTED|Extension Period (Part 2)||23
408655|NCT00880763|975307|P2|STARTED|Extension Period (Part 2)||22
408656|NCT00880763|975308|P1|STARTED|Extension Period (Part 2)||23
408657|NCT00880763|975305|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
408658|NCT00880763|975306|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
408659|NCT00880763|975307|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
408660|NCT00880763|975308|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
408661|NCT00880763|975305|P4|COMPLETED|Initial Treatment Period (Part 1)||22
408662|NCT00880763|975306|P3|COMPLETED|Initial Treatment Period (Part 1)||23
408663|NCT00880763|975307|P2|COMPLETED|Initial Treatment Period (Part 1)||22
408664|NCT00880763|975308|P1|COMPLETED|Initial Treatment Period (Part 1)||23
408665|NCT00880763|975305|P4|STARTED|Initial Treatment Period (Part 1)||22
408666|NCT00880763|975306|P3|STARTED|Initial Treatment Period (Part 1)||23
408667|NCT00880763|975307|P2|STARTED|Initial Treatment Period (Part 1)||22
408668|NCT00880763|975308|P1|STARTED|Initial Treatment Period (Part 1)||23
408669|NCT00880750|975340|P2|NOT COMPLETED|Second Intervention||2
408670|NCT00880750|975341|P1|NOT COMPLETED|Second Intervention||4
408671|NCT00880750|975340|P2|COMPLETED|Second Intervention||30
408672|NCT00880750|975341|P1|COMPLETED|Second Intervention||26
408673|NCT00880750|975340|P2|STARTED|Second Intervention||32
408674|NCT00880750|975341|P1|STARTED|Second Intervention||30
408675|NCT00880750|975340|P2|NOT COMPLETED|Washout Period||0
408676|NCT00880750|975341|P1|NOT COMPLETED|Washout Period||0
408677|NCT00880750|975340|P2|COMPLETED|Washout Period||32
408678|NCT00880750|975341|P1|COMPLETED|Washout Period||30
408679|NCT00880750|975340|P2|STARTED|Washout Period||32
408680|NCT00880750|975341|P1|STARTED|Washout Period||30
408681|NCT00880750|975340|P2|NOT COMPLETED|First Intervention||1
408682|NCT00880750|975341|P1|NOT COMPLETED|First Intervention||9
408683|NCT00880750|975340|P2|COMPLETED|First Intervention||32
408684|NCT00880750|975341|P1|COMPLETED|First Intervention||30
408685|NCT00880750|975340|P2|STARTED|First Intervention||33
408686|NCT00880750|975341|P1|STARTED|First Intervention||39
408687|NCT00880698|975359|P4|NOT COMPLETED|Overall Study||3
408688|NCT00880698|975360|P3|NOT COMPLETED|Overall Study||1
408689|NCT00880698|975361|P2|NOT COMPLETED|Overall Study||3
408690|NCT00880698|975362|P1|NOT COMPLETED|Overall Study||1
408691|NCT00880698|975359|P4|COMPLETED|Overall Study||36
408692|NCT00880698|975360|P3|COMPLETED|Overall Study||36
408693|NCT00880698|975361|P2|COMPLETED|Overall Study||61
408694|NCT00880698|975362|P1|COMPLETED|Overall Study||61
408695|NCT00880698|975359|P4|STARTED|Overall Study||39
408696|NCT00880698|975360|P3|STARTED|Overall Study||37
408697|NCT00880698|975361|P2|STARTED|Overall Study||64
408698|NCT00880698|975362|P1|STARTED|Overall Study||62
408699|NCT00880685|975388|P1|NOT COMPLETED|Memantine 30mg||0
408700|NCT00880685|975388|P1|COMPLETED|Memantine 30mg||9
408701|NCT00880685|975388|P1|STARTED|Memantine 30mg||9
408702|NCT00880685|975388|P1|NOT COMPLETED|Memantine 20mg||1
408703|NCT00880685|975388|P1|COMPLETED|Memantine 20mg||9
408704|NCT00880685|975388|P1|STARTED|Memantine 20mg||10
408705|NCT00880685|975388|P1|NOT COMPLETED|Memantine 10mg||2
408706|NCT00880685|975388|P1|COMPLETED|Memantine 10mg||10
408707|NCT00880685|975388|P1|STARTED|Memantine 10mg||12
408708|NCT00880620|975400|P4|NOT COMPLETED|Overall Study||24
408709|NCT00880620|975401|P3|NOT COMPLETED|Overall Study||21
408710|NCT00880620|975402|P2|NOT COMPLETED|Overall Study||15
408711|NCT00880620|975403|P1|NOT COMPLETED|Overall Study||21
408712|NCT00880620|975400|P4|COMPLETED|Overall Study||74
408713|NCT00880620|975401|P3|COMPLETED|Overall Study||83
408714|NCT00880620|975402|P2|COMPLETED|Overall Study||72
408715|NCT00880620|975403|P1|COMPLETED|Overall Study||71
408716|NCT00880620|975400|P4|STARTED|Overall Study||98
408717|NCT00880620|975401|P3|STARTED|Overall Study||104
408718|NCT00880620|975402|P2|STARTED|Overall Study||87
408719|NCT00880620|975403|P1|STARTED|Overall Study||92
408720|NCT00880581|975413|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
408721|NCT00880581|975413|P1|COMPLETED|Cycle 2 Re-treatment||24
408722|NCT00880581|975413|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
408723|NCT00880581|975413|P1|NOT COMPLETED|Cycle 1||0
408724|NCT00880581|975413|P1|COMPLETED|Cycle 1||30
408725|NCT00880581|975413|P1|STARTED|Cycle 1||30
408726|NCT00880568|975427|P9|NOT COMPLETED|Overall Study||3
408727|NCT00880568|975428|P8|NOT COMPLETED|Overall Study||2
408728|NCT00880568|975429|P7|NOT COMPLETED|Overall Study||6
408729|NCT00880568|975430|P6|NOT COMPLETED|Overall Study||3
408730|NCT00880568|975431|P5|NOT COMPLETED|Overall Study||3
408731|NCT00880568|975432|P4|NOT COMPLETED|Overall Study||1
408732|NCT00880568|975433|P3|NOT COMPLETED|Overall Study||3
408733|NCT00880568|975434|P2|NOT COMPLETED|Overall Study||3
408734|NCT00880568|975435|P1|NOT COMPLETED|Overall Study||3
408735|NCT00880568|975427|P9|COMPLETED|Overall Study||0
408736|NCT00880568|975428|P8|COMPLETED|Overall Study||0
408737|NCT00880568|975429|P7|COMPLETED|Overall Study||0
408738|NCT00880568|975430|P6|COMPLETED|Overall Study||0
408739|NCT00880568|975431|P5|COMPLETED|Overall Study||0
408740|NCT00880568|975432|P4|COMPLETED|Overall Study||0
408741|NCT00880568|975433|P3|COMPLETED|Overall Study||0
408742|NCT00880568|975434|P2|COMPLETED|Overall Study||0
408743|NCT00880568|975435|P1|COMPLETED|Overall Study||0
408744|NCT00880568|975427|P9|STARTED|Overall Study||3
408745|NCT00880568|975428|P8|STARTED|Overall Study||2
408746|NCT00880568|975429|P7|STARTED|Overall Study||6
408747|NCT00880568|975430|P6|STARTED|Overall Study||3
408748|NCT00880568|975431|P5|STARTED|Overall Study||3
408749|NCT00880568|975432|P4|STARTED|Overall Study||1
408750|NCT00880568|975433|P3|STARTED|Overall Study||3
408751|NCT00880568|975434|P2|STARTED|Overall Study||3
408752|NCT00880568|975435|P1|STARTED|Overall Study||3
408753|NCT00880555|975481|P6|NOT COMPLETED|Overall Study||1
408754|NCT00880555|975482|P5|NOT COMPLETED|Overall Study||1
408755|NCT00880555|975483|P4|NOT COMPLETED|Overall Study||2
408756|NCT00880555|975484|P3|NOT COMPLETED|Overall Study||5
408757|NCT00880555|975485|P2|NOT COMPLETED|Overall Study||17
408758|NCT00880555|975486|P1|NOT COMPLETED|Overall Study||10
408759|NCT00880555|975481|P6|COMPLETED|Overall Study||0
408760|NCT00880555|975482|P5|COMPLETED|Overall Study||0
408761|NCT00880555|975483|P4|COMPLETED|Overall Study||0
408762|NCT00880555|975484|P3|COMPLETED|Overall Study||6
408763|NCT00880555|975485|P2|COMPLETED|Overall Study||23
408764|NCT00880555|975486|P1|COMPLETED|Overall Study||13
408765|NCT00880555|975481|P6|STARTED|Overall Study||1
408766|NCT00880555|975482|P5|STARTED|Overall Study||1
408767|NCT00880555|975483|P4|STARTED|Overall Study||2
408768|NCT00880555|975484|P3|STARTED|Overall Study||11
408769|NCT00880555|975485|P2|STARTED|Overall Study||40
408770|NCT00880555|975486|P1|STARTED|Overall Study||23
408771|NCT00880542|975497|P1|NOT COMPLETED|Follow-up Period||0
408772|NCT00880542|975497|P1|COMPLETED|Follow-up Period||7
408773|NCT00880542|975497|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
408774|NCT00880542|975497|P1|NOT COMPLETED|Continued Treatment Period||0
408775|NCT00880542|975497|P1|COMPLETED|Continued Treatment Period||0
408776|NCT00880542|975497|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
408777|NCT00880542|975497|P1|NOT COMPLETED|Post Surgical Evaluation||0
408778|NCT00880542|975497|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
408779|NCT00880542|975497|P1|STARTED|Post Surgical Evaluation||3
408780|NCT00880542|975497|P1|NOT COMPLETED|REP: Surgical Resection||1
408781|NCT00880542|975497|P1|COMPLETED|REP: Surgical Resection||3
408782|NCT00880542|975497|P1|STARTED|REP: Surgical Resection||4
408783|NCT00880542|975497|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
408784|NCT00880542|975497|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
408785|NCT00880542|975497|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
408786|NCT00880542|975497|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
408787|NCT00880542|975497|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
408788|NCT00880542|975497|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
408789|NCT00880425|975502|P2|NOT COMPLETED|Overall Study||0
408790|NCT00880425|975503|P1|NOT COMPLETED|Overall Study||0
408791|NCT00880425|975502|P2|COMPLETED|Overall Study||27
408792|NCT00880425|975503|P1|COMPLETED|Overall Study||18
408793|NCT00880425|975502|P2|STARTED|Overall Study||27
408794|NCT00880425|975503|P1|STARTED|Overall Study||18
408795|NCT00880360|975511|P1|NOT COMPLETED|Overall Study||0
408796|NCT00880360|975511|P1|COMPLETED|Overall Study||19
408797|NCT00880360|975511|P1|STARTED|Overall Study||19
408798|NCT00880334|975517|P2|NOT COMPLETED|Overall Study||3
408799|NCT00880334|975518|P1|NOT COMPLETED|Overall Study||4
408800|NCT00880334|975517|P2|COMPLETED|Overall Study||72
408801|NCT00880334|975518|P1|COMPLETED|Overall Study||70
408802|NCT00880334|975517|P2|Eligible & Treated|Overall Study||72
408803|NCT00880334|975518|P1|Eligible & Treated|Overall Study||70
408804|NCT00880334|975517|P2|STARTED|Overall Study||75
408805|NCT00880334|975518|P1|STARTED|Overall Study||74
408806|NCT00880269|975534|P2|NOT COMPLETED|Overall Study||27
408807|NCT00880269|975535|P1|NOT COMPLETED|Overall Study||32
408808|NCT00880269|975534|P2|COMPLETED|Overall Study||0
408809|NCT00880269|975535|P1|COMPLETED|Overall Study||0
408810|NCT00880269|975534|P2|Discontinued Treatment|Overall Study||27
408811|NCT00880269|975535|P1|Discontinued Treatment|Overall Study||32
408812|NCT00880269|975534|P2|STARTED|Overall Study||27
408813|NCT00880269|975535|P1|STARTED|Overall Study||32
408814|NCT00880256|975551|P1|NOT COMPLETED|Overall Study||28
408815|NCT00880256|975551|P1|COMPLETED|Overall Study||65
408816|NCT00880256|975551|P1|STARTED|Overall Study||93
408817|NCT00880230|975556|P1|NOT COMPLETED|Overall Study||7
408818|NCT00880230|975556|P1|COMPLETED|Overall Study||134
408819|NCT00880230|975556|P1|STARTED|Overall Study||141
408820|NCT00880191|975578|P2|NOT COMPLETED|Overall Study||8
408821|NCT00880191|975579|P1|NOT COMPLETED|Overall Study||13
408822|NCT00880191|975578|P2|COMPLETED|Overall Study||198
408823|NCT00880191|975579|P1|COMPLETED|Overall Study||194
408824|NCT00880191|975578|P2|Available for Primary Endpoint Analysis|Overall Study||206
408825|NCT00880191|975579|P1|Available for Primary Endpoint Analysis|Overall Study||207
408826|NCT00880191|975578|P2|STARTED|Overall Study||206
408827|NCT00880191|975579|P1|STARTED|Overall Study||207
408828|NCT00880165|975599|P2|NOT COMPLETED|Overall Study||50
408829|NCT00880165|975600|P1|NOT COMPLETED|Overall Study||62
408830|NCT00880165|975599|P2|COMPLETED|Overall Study||98
408831|NCT00880165|975600|P1|COMPLETED|Overall Study||86
408832|NCT00880165|975599|P2|STARTED|Overall Study||148
408833|NCT00880165|975600|P1|STARTED|Overall Study||148
408834|NCT00880100|975610|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
408835|NCT00880100|975610|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
408836|NCT00880100|975610|P1|STARTED|Treatment Phase With Ultrase® MT12||48
408837|NCT00880100|975610|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
408838|NCT00880100|975610|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
408839|NCT00880100|975610|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
408840|NCT00880022|975623|P2|NOT COMPLETED|Overall Study||3
408841|NCT00880022|975624|P1|NOT COMPLETED|Overall Study||2
408842|NCT00880022|975623|P2|COMPLETED|Overall Study||21
408843|NCT00880022|975624|P1|COMPLETED|Overall Study||21
408844|NCT00880022|975623|P2|STARTED|Overall Study||24
408845|NCT00880022|975624|P1|STARTED|Overall Study||23
408846|NCT00880009|975630|P1|NOT COMPLETED|Overall Study||16
408847|NCT00880009|975630|P1|COMPLETED|Overall Study||0
408848|NCT00880009|975630|P1|STARTED|Overall Study||16
408849|NCT00879996|975654|P2|NOT COMPLETED|Overall Study||13
408850|NCT00879996|975655|P1|NOT COMPLETED|Overall Study||15
408851|NCT00879996|975654|P2|COMPLETED|Overall Study||13
408852|NCT00879996|975655|P1|COMPLETED|Overall Study||13
408853|NCT00879996|975654|P2|STARTED|Overall Study||26
408854|NCT00879996|975655|P1|STARTED|Overall Study||28
408855|NCT00879970|975670|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
408856|NCT00879970|975671|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
408857|NCT00879970|975672|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
408858|NCT00879970|975673|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
408859|NCT00879970|975674|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
408860|NCT00879970|975670|P5|COMPLETED|Period 2 Vitamin D Randomization||600
408861|NCT00879970|975671|P4|COMPLETED|Period 2 Vitamin D Randomization||610
408862|NCT00879970|975672|P3|COMPLETED|Period 2 Vitamin D Randomization||0
408863|NCT00879970|975673|P2|COMPLETED|Period 2 Vitamin D Randomization||0
408864|NCT00879970|975674|P1|COMPLETED|Period 2 Vitamin D Randomization||0
408865|NCT00879970|975670|P5|STARTED|Period 2 Vitamin D Randomization||607
408866|NCT00879970|975671|P4|STARTED|Period 2 Vitamin D Randomization||614
408867|NCT00879970|975672|P3|STARTED|Period 2 Vitamin D Randomization||0
408868|NCT00879970|975673|P2|STARTED|Period 2 Vitamin D Randomization||0
408869|NCT00879970|975674|P1|STARTED|Period 2 Vitamin D Randomization||0
408870|NCT00879970|975670|P5|NOT COMPLETED|Period 1 TZD Randomization||0
408871|NCT00879970|975671|P4|NOT COMPLETED|Period 1 TZD Randomization||0
408872|NCT00879970|975672|P3|NOT COMPLETED|Period 1 TZD Randomization||6
408873|NCT00879970|975673|P2|NOT COMPLETED|Period 1 TZD Randomization||4
408874|NCT00879970|975674|P1|NOT COMPLETED|Period 1 TZD Randomization||8
408875|NCT00879970|975670|P5|COMPLETED|Period 1 TZD Randomization||0
408876|NCT00879970|975671|P4|COMPLETED|Period 1 TZD Randomization||0
408877|NCT00879970|975672|P3|COMPLETED|Period 1 TZD Randomization||393
408878|NCT00879970|975673|P2|COMPLETED|Period 1 TZD Randomization||388
408879|NCT00879970|975674|P1|COMPLETED|Period 1 TZD Randomization||533
408880|NCT00879970|975670|P5|STARTED|Period 1 TZD Randomization||0
408881|NCT00879970|975671|P4|STARTED|Period 1 TZD Randomization||0
408882|NCT00879970|975672|P3|STARTED|Period 1 TZD Randomization||399
408883|NCT00879970|975673|P2|STARTED|Period 1 TZD Randomization||392
408884|NCT00879970|975674|P1|STARTED|Period 1 TZD Randomization||541
408885|NCT00879879|975756|P1|NOT COMPLETED|Overall Study||3
408886|NCT00879879|975756|P1|COMPLETED|Overall Study||17
408887|NCT00879879|975756|P1|STARTED|Overall Study||20
408888|NCT00879814|975764|P4|NOT COMPLETED|Overall Study||5
408889|NCT00879814|975765|P3|NOT COMPLETED|Overall Study||3
408890|NCT00879814|975766|P2|NOT COMPLETED|Overall Study||2
408891|NCT00879814|975767|P1|NOT COMPLETED|Overall Study||4
408892|NCT00879814|975764|P4|COMPLETED|Overall Study||7
408893|NCT00879814|975765|P3|COMPLETED|Overall Study||9
408894|NCT00879814|975766|P2|COMPLETED|Overall Study||10
408895|NCT00879814|975767|P1|COMPLETED|Overall Study||8
408896|NCT00879814|975764|P4|STARTED|Overall Study||12
408897|NCT00879814|975765|P3|STARTED|Overall Study||12
408898|NCT00879814|975766|P2|STARTED|Overall Study||12
408899|NCT00879814|975767|P1|STARTED|Overall Study||12
408900|NCT00879775|975875|P2|NOT COMPLETED|Overall Study||1
408901|NCT00879775|975876|P1|NOT COMPLETED|Overall Study||2
408902|NCT00879775|975875|P2|COMPLETED|Overall Study||20
408903|NCT00879775|975876|P1|COMPLETED|Overall Study||18
408904|NCT00879775|975875|P2|STARTED|Overall Study||21
408905|NCT00879775|975876|P1|STARTED|Overall Study||20
408906|NCT00879710|975892|P4|NOT COMPLETED|Phase 2 6 Weeks||0
408907|NCT00879710|975893|P3|NOT COMPLETED|Phase 2 6 Weeks||0
408908|NCT00879710|975894|P2|NOT COMPLETED|Phase 2 6 Weeks||0
408909|NCT00879710|975895|P1|NOT COMPLETED|Phase 2 6 Weeks||0
408910|NCT00879710|975892|P4|COMPLETED|Phase 2 6 Weeks||13
408911|NCT00879710|975893|P3|COMPLETED|Phase 2 6 Weeks||10
408912|NCT00879710|975894|P2|COMPLETED|Phase 2 6 Weeks||14
408913|NCT00879710|975895|P1|COMPLETED|Phase 2 6 Weeks||10
408914|NCT00879710|975892|P4|STARTED|Phase 2 6 Weeks||13
408915|NCT00879710|975893|P3|STARTED|Phase 2 6 Weeks||10
408916|NCT00879710|975894|P2|STARTED|Phase 2 6 Weeks||14
408917|NCT00879710|975895|P1|STARTED|Phase 2 6 Weeks||10
408918|NCT00879710|975892|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
408919|NCT00879710|975893|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
408920|NCT00879710|975894|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
408921|NCT00879710|975895|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
408922|NCT00879710|975892|P4|COMPLETED|Wash Out Period of 4 Weeks||13
408923|NCT00879710|975893|P3|COMPLETED|Wash Out Period of 4 Weeks||10
408924|NCT00879710|975894|P2|COMPLETED|Wash Out Period of 4 Weeks||14
408925|NCT00879710|975895|P1|COMPLETED|Wash Out Period of 4 Weeks||10
408926|NCT00879710|975892|P4|STARTED|Wash Out Period of 4 Weeks||13
408927|NCT00879710|975893|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
408928|NCT00879710|975894|P2|STARTED|Wash Out Period of 4 Weeks||14
408929|NCT00879710|975895|P1|STARTED|Wash Out Period of 4 Weeks||10
408930|NCT00879710|975892|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
408931|NCT00879710|975893|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
408932|NCT00879710|975894|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
408933|NCT00879710|975895|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
408934|NCT00879710|975892|P4|COMPLETED|Phase 1 - 6 Weeks||13
408935|NCT00879710|975893|P3|COMPLETED|Phase 1 - 6 Weeks||9
408936|NCT00879710|975894|P2|COMPLETED|Phase 1 - 6 Weeks||14
408937|NCT00879710|975895|P1|COMPLETED|Phase 1 - 6 Weeks||10
408938|NCT00879710|975892|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
408939|NCT00879710|975893|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
408940|NCT00879710|975894|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
408941|NCT00879710|975895|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
408942|NCT00879697|975905|P2|NOT COMPLETED|Overall Study||2
408943|NCT00879697|975906|P1|NOT COMPLETED|Overall Study||2
408944|NCT00879697|975905|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
408945|NCT00879697|975906|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
408946|NCT00879697|975905|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
408947|NCT00879697|975906|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
408948|NCT00879684|975912|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
408949|NCT00879684|975913|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
408950|NCT00879684|975914|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
408951|NCT00879684|975915|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
408952|NCT00879684|975916|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
408953|NCT00879684|975917|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
408954|NCT00879684|975918|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
408955|NCT00879684|975912|P7|COMPLETED|Stage 2: Expanded Cohort||0
408956|NCT00879684|975913|P6|COMPLETED|Stage 2: Expanded Cohort||0
408957|NCT00879684|975914|P5|COMPLETED|Stage 2: Expanded Cohort||0
408958|NCT00879684|975915|P4|COMPLETED|Stage 2: Expanded Cohort||0
408959|NCT00879684|975916|P3|COMPLETED|Stage 2: Expanded Cohort||0
408960|NCT00879684|975917|P2|COMPLETED|Stage 2: Expanded Cohort||0
408961|NCT00879684|975918|P1|COMPLETED|Stage 2: Expanded Cohort||0
408962|NCT00879684|975912|P7|STARTED|Stage 2: Expanded Cohort||13
408963|NCT00879684|975913|P6|STARTED|Stage 2: Expanded Cohort||0
408964|NCT00879684|975914|P5|STARTED|Stage 2: Expanded Cohort||0
408965|NCT00879684|975915|P4|STARTED|Stage 2: Expanded Cohort||0
408966|NCT00879684|975916|P3|STARTED|Stage 2: Expanded Cohort||0
408967|NCT00879684|975917|P2|STARTED|Stage 2: Expanded Cohort||0
408968|NCT00879684|975918|P1|STARTED|Stage 2: Expanded Cohort||0
408969|NCT00879684|975912|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
408970|NCT00879684|975913|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
408971|NCT00879684|975914|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
408972|NCT00879684|975915|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
408973|NCT00879684|975916|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
408974|NCT00879684|975917|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
408975|NCT00879684|975918|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
408976|NCT00879684|975912|P7|COMPLETED|Stage 1: Dose Escalation||0
408977|NCT00879684|975913|P6|COMPLETED|Stage 1: Dose Escalation||0
408978|NCT00879684|975914|P5|COMPLETED|Stage 1: Dose Escalation||0
408979|NCT00879684|975915|P4|COMPLETED|Stage 1: Dose Escalation||0
408980|NCT00879684|975916|P3|COMPLETED|Stage 1: Dose Escalation||0
408981|NCT00879684|975917|P2|COMPLETED|Stage 1: Dose Escalation||0
408982|NCT00879684|975918|P1|COMPLETED|Stage 1: Dose Escalation||0
408983|NCT00879684|975912|P7|STARTED|Stage 1: Dose Escalation||0
408984|NCT00879684|975913|P6|STARTED|Stage 1: Dose Escalation||3
408985|NCT00879684|975914|P5|STARTED|Stage 1: Dose Escalation||3
408986|NCT00879684|975915|P4|STARTED|Stage 1: Dose Escalation||6
408987|NCT00879684|975916|P3|STARTED|Stage 1: Dose Escalation||3
408988|NCT00879684|975917|P2|STARTED|Stage 1: Dose Escalation||3
408989|NCT00879684|975918|P1|STARTED|Stage 1: Dose Escalation||3
408990|NCT00879645|975984|P4|NOT COMPLETED|Overall Study||0
408991|NCT00879645|975985|P3|NOT COMPLETED|Overall Study||0
408992|NCT00879645|975986|P2|NOT COMPLETED|Overall Study||0
408993|NCT00879645|975987|P1|NOT COMPLETED|Overall Study||1
408994|NCT00879645|975984|P4|COMPLETED|Overall Study||7
408995|NCT00879645|975985|P3|COMPLETED|Overall Study||6
408996|NCT00879645|975986|P2|COMPLETED|Overall Study||6
408997|NCT00879645|975987|P1|COMPLETED|Overall Study||8
408998|NCT00879645|975984|P4|STARTED|Overall Study||7
408999|NCT00879645|975985|P3|STARTED|Overall Study||6
409000|NCT00879645|975986|P2|STARTED|Overall Study||6
409001|NCT00879645|975987|P1|STARTED|Overall Study||9
409002|NCT00879619|976005|P1|NOT COMPLETED|Overall Study||0
409003|NCT00879619|976005|P1|COMPLETED|Overall Study||4
409004|NCT00879619|976005|P1|STARTED|Overall Study||4
409005|NCT00879411|976014|P1|NOT COMPLETED|Overall Study||162
409006|NCT00879411|976014|P1|COMPLETED|Overall Study||539
409007|NCT00879411|976014|P1|STARTED|Overall Study||701
409008|NCT00879398|976020|P1|NOT COMPLETED|Overall Study||675
409009|NCT00879398|976020|P1|COMPLETED|Overall Study||2434
409010|NCT00879398|976020|P1|STARTED|Overall Study||3109
409011|NCT00879359|976030|P1|NOT COMPLETED|Overall Study||0
409012|NCT00879359|976030|P1|COMPLETED|Overall Study||15
409013|NCT00879359|976030|P1|STARTED|Overall Study||15
409014|NCT00879333|976038|P2|NOT COMPLETED|Overall Study||217
409015|NCT00879333|976039|P1|NOT COMPLETED|Overall Study||428
409016|NCT00879333|976038|P2|COMPLETED|Overall Study||0
409017|NCT00879333|976039|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
409018|NCT00879333|976038|P2|Discontinued Study Treatment|Overall Study||217
409019|NCT00879333|976039|P1|Discontinued Study Treatment|Overall Study||428
409020|NCT00879333|976038|P2|STARTED|Overall Study||217
409021|NCT00879333|976039|P1|STARTED|Overall Study||439
409022|NCT00879255|976059|P2|NOT COMPLETED|Overall Study||19
409023|NCT00879255|976060|P1|NOT COMPLETED|Overall Study||16
409024|NCT00879255|976059|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
409025|NCT00879255|976060|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
409026|NCT00879255|976059|P2|Completed 3-mo Follow-up|Overall Study||49
409027|NCT00879255|976060|P1|Completed 3-mo Follow-up|Overall Study||48
409028|NCT00879255|976059|P2|Completed Posttreatment Follow-up|Overall Study||55
409029|NCT00879255|976060|P1|Completed Posttreatment Follow-up|Overall Study||50
409030|NCT00879255|976059|P2|Received Allocated Intervention:|Overall Study||56
409031|NCT00879255|976060|P1|Received Allocated Intervention:|Overall Study||51
409032|NCT00879255|976059|P2|STARTED|Overall Study||64
409033|NCT00879255|976060|P1|STARTED|Overall Study||61
409034|NCT00879229|976072|P2|NOT COMPLETED|Overall Study||14
409035|NCT00879229|976073|P1|NOT COMPLETED|Overall Study||22
409036|NCT00879229|976072|P2|COMPLETED|Overall Study||1
409037|NCT00879229|976073|P1|COMPLETED|Overall Study||3
409038|NCT00879229|976072|P2|STARTED|Overall Study||15
409039|NCT00879229|976073|P1|STARTED|Overall Study||25
409040|NCT00879190|976099|P2|NOT COMPLETED|Overall Study||0
409041|NCT00879190|976100|P1|NOT COMPLETED|Overall Study||0
409042|NCT00879190|976099|P2|COMPLETED|Overall Study||49
409043|NCT00879190|976100|P1|COMPLETED|Overall Study||43
409044|NCT00879190|976099|P2|STARTED|Overall Study||49
409045|NCT00879190|976100|P1|STARTED|Overall Study||43
409046|NCT00878969|976113|P3|NOT COMPLETED|Overall Study||11
409047|NCT00878969|976114|P2|NOT COMPLETED|Overall Study||15
409048|NCT00878969|976115|P1|NOT COMPLETED|Overall Study||15
409049|NCT00878969|976113|P3|COMPLETED|Overall Study||15
409050|NCT00878969|976114|P2|COMPLETED|Overall Study||12
409051|NCT00878969|976115|P1|COMPLETED|Overall Study||10
409052|NCT00878969|976113|P3|STARTED|Overall Study||26
409053|NCT00878969|976114|P2|STARTED|Overall Study||27
409054|NCT00878969|976115|P1|STARTED|Overall Study||25
409055|NCT00878878|976125|P2|NOT COMPLETED|Overall Study||0
409056|NCT00878878|976126|P1|NOT COMPLETED|Overall Study||0
409057|NCT00878878|976125|P2|COMPLETED|Overall Study||15
409058|NCT00878878|976126|P1|COMPLETED|Overall Study||15
409059|NCT00878878|976125|P2|STARTED|Overall Study||15
409060|NCT00878878|976126|P1|STARTED|Overall Study||15
409061|NCT00878826|976139|P3|NOT COMPLETED|Overall Study||0
409062|NCT00878826|976140|P2|NOT COMPLETED|Overall Study||0
409063|NCT00878826|976141|P1|NOT COMPLETED|Overall Study||0
409064|NCT00878826|976139|P3|COMPLETED|Overall Study||2
409065|NCT00878826|976140|P2|COMPLETED|Overall Study||6
409066|NCT00878826|976141|P1|COMPLETED|Overall Study||3
409067|NCT00878826|976139|P3|STARTED|Overall Study||2
409068|NCT00878826|976140|P2|STARTED|Overall Study||6
409069|NCT00878826|976141|P1|STARTED|Overall Study||3
409070|NCT00878800|976163|P5|NOT COMPLETED|Overall Study||16
409071|NCT00878800|976164|P4|NOT COMPLETED|Overall Study||6
409072|NCT00878800|976165|P3|NOT COMPLETED|Overall Study||9
409073|NCT00878800|976166|P2|NOT COMPLETED|Overall Study||7
409074|NCT00878800|976167|P1|NOT COMPLETED|Overall Study||3
409075|NCT00878800|976163|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
409076|NCT00878800|976164|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
409077|NCT00878800|976165|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
409078|NCT00878800|976166|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
409079|NCT00878800|976167|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
409080|NCT00878800|976163|P5|STARTED|Overall Study||16
409081|NCT00878800|976164|P4|STARTED|Overall Study||6
409082|NCT00878800|976165|P3|STARTED|Overall Study||9
409083|NCT00878800|976166|P2|STARTED|Overall Study||7
409084|NCT00878800|976167|P1|STARTED|Overall Study||3
409085|NCT00878722|976202|P8|NOT COMPLETED|Overall Study||7
409086|NCT00878722|976203|P7|NOT COMPLETED|Overall Study||6
409087|NCT00878722|976204|P6|NOT COMPLETED|Overall Study||2
409088|NCT00878722|976205|P5|NOT COMPLETED|Overall Study||7
409089|NCT00878722|976206|P4|NOT COMPLETED|Overall Study||9
409090|NCT00878722|976207|P3|NOT COMPLETED|Overall Study||3
409091|NCT00878722|976208|P2|NOT COMPLETED|Overall Study||3
409092|NCT00878722|976209|P1|NOT COMPLETED|Overall Study||3
409093|NCT00878722|976202|P8|COMPLETED|Overall Study||0
409094|NCT00878722|976203|P7|COMPLETED|Overall Study||0
409095|NCT00878722|976204|P6|COMPLETED|Overall Study||1
409096|NCT00878722|976205|P5|COMPLETED|Overall Study||0
409097|NCT00878722|976206|P4|COMPLETED|Overall Study||0
409098|NCT00878722|976207|P3|COMPLETED|Overall Study||0
409099|NCT00878722|976208|P2|COMPLETED|Overall Study||0
409100|NCT00878722|976209|P1|COMPLETED|Overall Study||0
409101|NCT00878722|976202|P8|STARTED|Overall Study||7
409102|NCT00878722|976203|P7|STARTED|Overall Study||6
409103|NCT00878722|976204|P6|STARTED|Overall Study||3
409104|NCT00878722|976205|P5|STARTED|Overall Study||7
409105|NCT00878722|976206|P4|STARTED|Overall Study||9
409106|NCT00878722|976207|P3|STARTED|Overall Study||3
409107|NCT00878722|976208|P2|STARTED|Overall Study||3
409108|NCT00878722|976209|P1|STARTED|Overall Study||3
409109|NCT00878605|976296|P4|NOT COMPLETED|Overall Study||3
409110|NCT00878605|976297|P3|NOT COMPLETED|Overall Study||1
409111|NCT00878605|976298|P2|NOT COMPLETED|Overall Study||3
409112|NCT00878605|976299|P1|NOT COMPLETED|Overall Study||3
409113|NCT00878605|976296|P4|COMPLETED|Overall Study||6
409114|NCT00878605|976297|P3|COMPLETED|Overall Study||8
409115|NCT00878605|976298|P2|COMPLETED|Overall Study||7
409116|NCT00878605|976299|P1|COMPLETED|Overall Study||7
409117|NCT00878605|976296|P4|STARTED|Overall Study||9
409118|NCT00878605|976297|P3|STARTED|Overall Study||9
409119|NCT00878605|976298|P2|STARTED|Overall Study||10
409120|NCT00878605|976299|P1|STARTED|Overall Study||10
409121|NCT00878553|976313|P5|NOT COMPLETED|PK Study||0
409122|NCT00878553|976314|P4|NOT COMPLETED|PK Study||1
409123|NCT00878553|976315|P3|NOT COMPLETED|PK Study||0
409124|NCT00878553|976316|P2|NOT COMPLETED|PK Study||0
409125|NCT00878553|976317|P1|NOT COMPLETED|PK Study||0
409126|NCT00878553|976313|P5|COMPLETED|PK Study||15
409127|NCT00878553|976314|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
409128|NCT00878553|976315|P3|COMPLETED|PK Study||17
409129|NCT00878553|976316|P2|COMPLETED|PK Study||16
409130|NCT00878553|976317|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
409131|NCT00878553|976313|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
409132|NCT00878553|976314|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
409133|NCT00878553|976315|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
409134|NCT00878553|976316|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
409135|NCT00878553|976317|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
409136|NCT00878553|976313|P5|NOT COMPLETED|Sleep Study||0
409137|NCT00878553|976314|P4|NOT COMPLETED|Sleep Study||0
409138|NCT00878553|976315|P3|NOT COMPLETED|Sleep Study||0
409139|NCT00878553|976316|P2|NOT COMPLETED|Sleep Study||0
409140|NCT00878553|976317|P1|NOT COMPLETED|Sleep Study||5
409141|NCT00878553|976313|P5|COMPLETED|Sleep Study||0
409142|NCT00878553|976314|P4|COMPLETED|Sleep Study||0
409143|NCT00878553|976315|P3|COMPLETED|Sleep Study||0
409144|NCT00878553|976316|P2|COMPLETED|Sleep Study||0
409145|NCT00878553|976317|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
409146|NCT00878553|976313|P5|Number of Patients Receiving 20mg|Sleep Study||0
409147|NCT00878553|976314|P4|Number of Patients Receiving 20mg|Sleep Study||0
409148|NCT00878553|976315|P3|Number of Patients Receiving 20mg|Sleep Study||0
409149|NCT00878553|976316|P2|Number of Patients Receiving 20mg|Sleep Study||0
409150|NCT00878553|976317|P1|Number of Patients Receiving 20mg|Sleep Study||65
409151|NCT00878553|976313|P5|Number of Patients Receiving 15mg|Sleep Study||0
409152|NCT00878553|976314|P4|Number of Patients Receiving 15mg|Sleep Study||0
409153|NCT00878553|976315|P3|Number of Patients Receiving 15mg|Sleep Study||0
409154|NCT00878553|976316|P2|Number of Patients Receiving 15mg|Sleep Study||0
409155|NCT00878553|976317|P1|Number of Patients Receiving 15mg|Sleep Study||65
409156|NCT00878553|976313|P5|Number of Patients Receiving 10mg|Sleep Study||0
409157|NCT00878553|976314|P4|Number of Patients Receiving 10mg|Sleep Study||0
409158|NCT00878553|976315|P3|Number of Patients Receiving 10mg|Sleep Study||0
409159|NCT00878553|976316|P2|Number of Patients Receiving 10mg|Sleep Study||0
409160|NCT00878553|976317|P1|Number of Patients Receiving 10mg|Sleep Study||65
409161|NCT00878553|976313|P5|Number of Patients Receiving Placebo|Sleep Study||0
409162|NCT00878553|976314|P4|Number of Patients Receiving Placebo|Sleep Study||0
409163|NCT00878553|976315|P3|Number of Patients Receiving Placebo|Sleep Study||0
409164|NCT00878553|976316|P2|Number of Patients Receiving Placebo|Sleep Study||0
409165|NCT00878553|976317|P1|Number of Patients Receiving Placebo|Sleep Study||66
409166|NCT00878553|976313|P5|STARTED|Sleep Study||0
409167|NCT00878553|976314|P4|STARTED|Sleep Study||0
409168|NCT00878553|976315|P3|STARTED|Sleep Study||0
409169|NCT00878553|976316|P2|STARTED|Sleep Study||0
409170|NCT00878553|976317|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
409171|NCT00878501|976376|P3|NOT COMPLETED|Overall Study||8
409172|NCT00878501|976377|P2|NOT COMPLETED|Overall Study||7
409173|NCT00878501|976378|P1|NOT COMPLETED|Overall Study||17
409174|NCT00878501|976376|P3|COMPLETED|Overall Study||85
409175|NCT00878501|976377|P2|COMPLETED|Overall Study||37
409176|NCT00878501|976378|P1|COMPLETED|Overall Study||87
409177|NCT00878501|976376|P3|Interim Analysis|Overall Study||81
409178|NCT00878501|976377|P2|Interim Analysis|Overall Study||37
409179|NCT00878501|976378|P1|Interim Analysis|Overall Study||83
409180|NCT00878501|976376|P3|STARTED|Overall Study||93
409181|NCT00878501|976377|P2|STARTED|Overall Study||44
409182|NCT00878501|976378|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
409183|NCT00878228|976397|P2|NOT COMPLETED|Overall Study||12
409184|NCT00878228|976398|P1|NOT COMPLETED|Overall Study||10
409185|NCT00878228|976397|P2|COMPLETED|Overall Study||37
409186|NCT00878228|976398|P1|COMPLETED|Overall Study||39
409187|NCT00878228|976397|P2|STARTED|Overall Study||49
409188|NCT00878228|976398|P1|STARTED|Overall Study||49
409189|NCT00877929|976410|P2|NOT COMPLETED|Overall Study||35
409190|NCT00877929|976411|P1|NOT COMPLETED|Overall Study||20
409191|NCT00877929|976410|P2|COMPLETED|Overall Study||319
409192|NCT00877929|976411|P1|COMPLETED|Overall Study||332
409193|NCT00877929|976410|P2|STARTED|Overall Study||354
409194|NCT00877929|976411|P1|STARTED|Overall Study||352
409195|NCT00877890|976499|P2|NOT COMPLETED|Overall Study||30
409196|NCT00877890|976500|P1|NOT COMPLETED|Overall Study||20
409197|NCT00877890|976499|P2|COMPLETED|Overall Study||95
409198|NCT00877890|976500|P1|COMPLETED|Overall Study||109
409199|NCT00877890|976499|P2|Intent to Treat (ITT)|Overall Study||123
409200|NCT00877890|976500|P1|Intent to Treat (ITT)|Overall Study||129
409201|NCT00877890|976499|P2|STARTED|Overall Study||125
409202|NCT00877890|976500|P1|STARTED|Overall Study||129
409203|NCT00877877|976534|P1|NOT COMPLETED|Year 10||0
409204|NCT00877877|976534|P1|COMPLETED|Year 10||495
409205|NCT00877877|976534|P1|STARTED|Year 10||495
409206|NCT00877877|976534|P1|NOT COMPLETED|Year 9||0
409207|NCT00877877|976534|P1|COMPLETED|Year 9||507
409208|NCT00877877|976534|P1|STARTED|Year 9||507
409209|NCT00877877|976534|P1|NOT COMPLETED|Year 8||0
409210|NCT00877877|976534|P1|COMPLETED|Year 8||522
409211|NCT00877877|976534|P1|STARTED|Year 8||522
409212|NCT00877877|976534|P1|NOT COMPLETED|Year 7||0
409213|NCT00877877|976534|P1|COMPLETED|Year 7||523
409214|NCT00877877|976534|P1|STARTED|Year 7||523
409215|NCT00877877|976534|P1|NOT COMPLETED|Year 6||0
409216|NCT00877877|976534|P1|COMPLETED|Year 6||529
409217|NCT00877877|976534|P1|STARTED|Year 6||529
409218|NCT00877877|976534|P1|NOT COMPLETED|Year 5||0
409219|NCT00877877|976534|P1|COMPLETED|Year 5||397
409220|NCT00877877|976534|P1|STARTED|Year 5||397
409221|NCT00877799|976565|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
409222|NCT00877799|976566|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
409223|NCT00877799|976567|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
409224|NCT00877799|976568|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
409225|NCT00877799|976569|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
409226|NCT00877799|976565|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
409227|NCT00877799|976566|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
409228|NCT00877799|976567|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
409229|NCT00877799|976568|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
409230|NCT00877799|976569|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
409231|NCT00877799|976565|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
409232|NCT00877799|976566|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
409233|NCT00877799|976567|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
409234|NCT00877799|976568|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
409235|NCT00877799|976569|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
409236|NCT00877799|976565|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
409237|NCT00877799|976566|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
409238|NCT00877799|976567|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
409239|NCT00877799|976568|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
409240|NCT00877799|976569|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
409241|NCT00877799|976565|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
409242|NCT00877799|976566|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
409243|NCT00877799|976567|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
409244|NCT00877799|976568|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
409245|NCT00877799|976569|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
409246|NCT00877799|976565|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
409247|NCT00877799|976566|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
409248|NCT00877799|976567|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
409249|NCT00877799|976568|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
409250|NCT00877799|976569|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
409251|NCT00877773|976584|P1|NOT COMPLETED|Overall Study||44
409252|NCT00877773|976584|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
409253|NCT00877773|976584|P1|STARTED|Overall Study||44
409254|NCT00877604|976590|P2|NOT COMPLETED|Overall Study||3
409255|NCT00877604|976591|P1|NOT COMPLETED|Overall Study||2
409256|NCT00877604|976590|P2|COMPLETED|Overall Study||14
409257|NCT00877604|976591|P1|COMPLETED|Overall Study||15
409258|NCT00877604|976590|P2|STARTED|Overall Study||17
409259|NCT00877604|976591|P1|STARTED|Overall Study||17
409260|NCT00877487|976597|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
409261|NCT00877487|976598|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
409262|NCT00877487|976597|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
409263|NCT00877487|976598|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
409264|NCT00877487|976597|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
409265|NCT00877487|976598|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
409266|NCT00877487|976597|P2|NOT COMPLETED|Open-label Treatment Phase||0
409267|NCT00877487|976598|P1|NOT COMPLETED|Open-label Treatment Phase||7
409268|NCT00877487|976597|P2|COMPLETED|Open-label Treatment Phase||0
409269|NCT00877487|976598|P1|COMPLETED|Open-label Treatment Phase||116
409270|NCT00877487|976597|P2|STARTED|Open-label Treatment Phase||0
409271|NCT00877487|976598|P1|STARTED|Open-label Treatment Phase||123
409272|NCT00877448|976615|P7|NOT COMPLETED|Overall Study||0
409273|NCT00877448|976616|P6|NOT COMPLETED|Overall Study||1
409274|NCT00877448|976617|P5|NOT COMPLETED|Overall Study||0
409275|NCT00877448|976618|P4|NOT COMPLETED|Overall Study||1
409276|NCT00877448|976619|P3|NOT COMPLETED|Overall Study||0
409277|NCT00877448|976620|P2|NOT COMPLETED|Overall Study||1
409278|NCT00877448|976621|P1|NOT COMPLETED|Overall Study||0
409279|NCT00877448|976615|P7|COMPLETED|Overall Study||3
409280|NCT00877448|976616|P6|COMPLETED|Overall Study||9
409281|NCT00877448|976617|P5|COMPLETED|Overall Study||10
409282|NCT00877448|976618|P4|COMPLETED|Overall Study||9
409283|NCT00877448|976619|P3|COMPLETED|Overall Study||10
409284|NCT00877448|976620|P2|COMPLETED|Overall Study||9
409285|NCT00877448|976621|P1|COMPLETED|Overall Study||10
409286|NCT00877448|976615|P7|STARTED|Overall Study||3
409287|NCT00877448|976616|P6|STARTED|Overall Study||10
409288|NCT00877448|976617|P5|STARTED|Overall Study||10
409289|NCT00877448|976618|P4|STARTED|Overall Study||10
409290|NCT00877448|976619|P3|STARTED|Overall Study||10
409291|NCT00877448|976620|P2|STARTED|Overall Study||10
409292|NCT00877448|976621|P1|STARTED|Overall Study||10
409293|NCT00877383|976646|P2|NOT COMPLETED|Overall Study||37
409294|NCT00877383|976647|P1|NOT COMPLETED|Overall Study||29
409295|NCT00877383|976646|P2|COMPLETED|Overall Study||533
409296|NCT00877383|976647|P1|COMPLETED|Overall Study||543
409297|NCT00877383|976646|P2|STARTED|Overall Study||570
409298|NCT00877383|976647|P1|STARTED|Overall Study||572
409299|NCT00877370|976663|P1|NOT COMPLETED|Overall Study||0
409300|NCT00877370|976663|P1|COMPLETED|Overall Study||8
409301|NCT00877370|976663|P1|STARTED|Overall Study||8
409302|NCT00877071|976667|P1|NOT COMPLETED|Overall Study||2
409303|NCT00877071|976667|P1|COMPLETED|Overall Study||0
409304|NCT00877071|976667|P1|STARTED|Overall Study||2
409305|NCT00877058|976677|P3|NOT COMPLETED|Overall Study||39
409306|NCT00877058|976678|P2|NOT COMPLETED|Overall Study||40
409307|NCT00877058|976679|P1|NOT COMPLETED|Overall Study||37
409308|NCT00877058|976677|P3|COMPLETED|Overall Study||75
409309|NCT00877058|976678|P2|COMPLETED|Overall Study||131
409310|NCT00877058|976679|P1|COMPLETED|Overall Study||137
409311|NCT00877058|976677|P3|STARTED|Overall Study||114
409312|NCT00877058|976678|P2|STARTED|Overall Study||171
409313|NCT00877058|976679|P1|STARTED|Overall Study||174
409314|NCT00877032|976700|P7|NOT COMPLETED|Overall Study||2
409315|NCT00877032|976701|P6|NOT COMPLETED|Overall Study||0
409316|NCT00877032|976702|P5|NOT COMPLETED|Overall Study||0
409317|NCT00877032|976703|P4|NOT COMPLETED|Overall Study||1
409318|NCT00877032|976704|P3|NOT COMPLETED|Overall Study||0
409319|NCT00877032|976705|P2|NOT COMPLETED|Overall Study||0
409320|NCT00877032|976706|P1|NOT COMPLETED|Overall Study||0
409321|NCT00877032|976700|P7|COMPLETED|Overall Study||18
409322|NCT00877032|976701|P6|COMPLETED|Overall Study||6
409323|NCT00877032|976702|P5|COMPLETED|Overall Study||6
409324|NCT00877032|976703|P4|COMPLETED|Overall Study||6
409325|NCT00877032|976704|P3|COMPLETED|Overall Study||6
409326|NCT00877032|976705|P2|COMPLETED|Overall Study||6
409327|NCT00877032|976706|P1|COMPLETED|Overall Study||6
409328|NCT00877032|976700|P7|Treated|Overall Study||18
409329|NCT00877032|976701|P6|Treated|Overall Study||6
409330|NCT00877032|976702|P5|Treated|Overall Study||6
409331|NCT00877032|976703|P4|Treated|Overall Study||6
409332|NCT00877032|976704|P3|Treated|Overall Study||6
409333|NCT00877032|976705|P2|Treated|Overall Study||6
409334|NCT00877032|976706|P1|Treated|Overall Study||6
409335|NCT00877032|976700|P7|STARTED|Overall Study||20
409336|NCT00877032|976701|P6|STARTED|Overall Study||6
409337|NCT00877032|976702|P5|STARTED|Overall Study||6
409338|NCT00877032|976703|P4|STARTED|Overall Study||7
409339|NCT00877032|976704|P3|STARTED|Overall Study||6
409340|NCT00877032|976705|P2|STARTED|Overall Study||6
409341|NCT00877032|976706|P1|STARTED|Overall Study||6
409342|NCT00877006|976807|P2|NOT COMPLETED|Long-Term Follow-up Period||210
409343|NCT00877006|976808|P1|NOT COMPLETED|Long-Term Follow-up Period||210
409344|NCT00877006|976807|P2|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
409345|NCT00877006|976808|P1|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
409346|NCT00877006|976807|P2|STARTED|Long-Term Follow-up Period||210
409347|NCT00877006|976808|P1|STARTED|Long-Term Follow-up Period||210
409348|NCT00877006|976807|P2|NOT COMPLETED|Treatment Period||27
409349|NCT00877006|976808|P1|NOT COMPLETED|Treatment Period||21
409350|NCT00877006|976807|P2|COMPLETED|Treatment Period||196
409351|NCT00877006|976808|P1|COMPLETED|Treatment Period|treated for >=6 cycles|203
409352|NCT00877006|976807|P2|STARTED|Treatment Period||223
409353|NCT00877006|976808|P1|STARTED|Treatment Period||224
409354|NCT00876928|976836|P2|NOT COMPLETED|Overall Study||5
409355|NCT00876928|976837|P1|NOT COMPLETED|Overall Study||3
409356|NCT00876928|976836|P2|COMPLETED|Overall Study||56
409357|NCT00876928|976837|P1|COMPLETED|Overall Study||53
409358|NCT00876928|976836|P2|STARTED|Overall Study||61
409359|NCT00876928|976837|P1|STARTED|Overall Study||56
409360|NCT00876915|976848|P3|NOT COMPLETED|Overall Study||0
409361|NCT00876915|976849|P2|NOT COMPLETED|Overall Study||14
409362|NCT00876915|976850|P1|NOT COMPLETED|Overall Study||19
409363|NCT00876915|976848|P3|COMPLETED|Overall Study||101
409364|NCT00876915|976849|P2|COMPLETED|Overall Study||34
409365|NCT00876915|976850|P1|COMPLETED|Overall Study||31
409366|NCT00876915|976848|P3|Week 8|Overall Study||0
409367|NCT00876915|976849|P2|Week 8|Overall Study||36
409368|NCT00876915|976850|P1|Week 8|Overall Study||33
409369|NCT00876915|976848|P3|Week 4|Overall Study||0
409370|NCT00876915|976849|P2|Week 4|Overall Study||45
409371|NCT00876915|976850|P1|Week 4|Overall Study||38
409372|NCT00876915|976848|P3|STARTED|Overall Study||101
409373|NCT00876915|976849|P2|STARTED|Overall Study||48
409374|NCT00876915|976850|P1|STARTED|Overall Study||50
409375|NCT00876733|976874|P4|NOT COMPLETED|Overall Study||7
409376|NCT00876733|976875|P3|NOT COMPLETED|Overall Study||30
409377|NCT00876733|976876|P2|NOT COMPLETED|Overall Study||42
409378|NCT00876733|976877|P1|NOT COMPLETED|Overall Study||91
409379|NCT00876733|976874|P4|COMPLETED|Overall Study||14
409380|NCT00876733|976875|P3|COMPLETED|Overall Study||63
409381|NCT00876733|976876|P2|COMPLETED|Overall Study||161
409382|NCT00876733|976877|P1|COMPLETED|Overall Study||197
409383|NCT00876733|976874|P4|STARTED|Overall Study||21
409384|NCT00876733|976875|P3|STARTED|Overall Study||93
409385|NCT00876733|976876|P2|STARTED|Overall Study||203
409386|NCT00876733|976877|P1|STARTED|Overall Study||288
409387|NCT00876694|976985|P2|NOT COMPLETED|Overall Study||12
409388|NCT00876694|976986|P1|NOT COMPLETED|Overall Study||21
409389|NCT00876694|976985|P2|COMPLETED|Overall Study||49
409390|NCT00876694|976986|P1|COMPLETED|Overall Study||104
409391|NCT00876694|976985|P2|STARTED|Overall Study||61
409392|NCT00876694|976986|P1|STARTED|Overall Study||125
409393|NCT00876460|977012|P8|NOT COMPLETED|Mono Therapy Phase||3
409394|NCT00876460|977013|P7|NOT COMPLETED|Mono Therapy Phase||1
409395|NCT00876460|977014|P6|NOT COMPLETED|Mono Therapy Phase||0
409396|NCT00876460|977015|P5|NOT COMPLETED|Mono Therapy Phase||2
409397|NCT00876460|977016|P4|NOT COMPLETED|Mono Therapy Phase||1
409398|NCT00876460|977017|P3|NOT COMPLETED|Mono Therapy Phase||0
409399|NCT00876460|977018|P2|NOT COMPLETED|Mono Therapy Phase||1
409400|NCT00876460|977019|P1|NOT COMPLETED|Mono Therapy Phase||0
409401|NCT00876460|977012|P8|COMPLETED|Mono Therapy Phase||0
409402|NCT00876460|977013|P7|COMPLETED|Mono Therapy Phase||0
409403|NCT00876460|977014|P6|COMPLETED|Mono Therapy Phase||0
409404|NCT00876460|977015|P5|COMPLETED|Mono Therapy Phase||0
409405|NCT00876460|977016|P4|COMPLETED|Mono Therapy Phase||0
409406|NCT00876460|977017|P3|COMPLETED|Mono Therapy Phase||0
409407|NCT00876460|977018|P2|COMPLETED|Mono Therapy Phase||0
409408|NCT00876460|977019|P1|COMPLETED|Mono Therapy Phase||0
409409|NCT00876460|977012|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
409410|NCT00876460|977013|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
409411|NCT00876460|977014|P6|STARTED|Mono Therapy Phase||0
409412|NCT00876460|977015|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
409413|NCT00876460|977016|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
409414|NCT00876460|977017|P3|STARTED|Mono Therapy Phase||0
409415|NCT00876460|977018|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
409416|NCT00876460|977019|P1|STARTED|Mono Therapy Phase||0
409417|NCT00876460|977012|P8|NOT COMPLETED|Combination Therapy Phase||6
409418|NCT00876460|977013|P7|NOT COMPLETED|Combination Therapy Phase||8
409419|NCT00876460|977014|P6|NOT COMPLETED|Combination Therapy Phase||3
409420|NCT00876460|977015|P5|NOT COMPLETED|Combination Therapy Phase||7
409421|NCT00876460|977016|P4|NOT COMPLETED|Combination Therapy Phase||6
409422|NCT00876460|977017|P3|NOT COMPLETED|Combination Therapy Phase||3
409423|NCT00876460|977018|P2|NOT COMPLETED|Combination Therapy Phase||7
409424|NCT00876460|977019|P1|NOT COMPLETED|Combination Therapy Phase||3
409425|NCT00876460|977012|P8|COMPLETED|Combination Therapy Phase||0
409426|NCT00876460|977013|P7|COMPLETED|Combination Therapy Phase||0
409427|NCT00876460|977014|P6|COMPLETED|Combination Therapy Phase||0
409428|NCT00876460|977015|P5|COMPLETED|Combination Therapy Phase||0
409429|NCT00876460|977016|P4|COMPLETED|Combination Therapy Phase||0
409430|NCT00876460|977017|P3|COMPLETED|Combination Therapy Phase||0
409431|NCT00876460|977018|P2|COMPLETED|Combination Therapy Phase||0
409432|NCT00876460|977019|P1|COMPLETED|Combination Therapy Phase||0
409433|NCT00876460|977012|P8|STARTED|Combination Therapy Phase||6
409434|NCT00876460|977013|P7|STARTED|Combination Therapy Phase||8
409435|NCT00876460|977014|P6|STARTED|Combination Therapy Phase||3
409436|NCT00876460|977015|P5|STARTED|Combination Therapy Phase||7
409437|NCT00876460|977016|P4|STARTED|Combination Therapy Phase||6
409438|NCT00876460|977017|P3|STARTED|Combination Therapy Phase||3
409439|NCT00876460|977018|P2|STARTED|Combination Therapy Phase||7
409440|NCT00876460|977019|P1|STARTED|Combination Therapy Phase||3
409441|NCT00876447|977091|P2|NOT COMPLETED|Overall Study||81
409442|NCT00876447|977092|P1|NOT COMPLETED|Overall Study||80
409443|NCT00876447|977091|P2|COMPLETED|Overall Study||122
409444|NCT00876447|977092|P1|COMPLETED|Overall Study||105
409445|NCT00876447|977091|P2|STARTED|Overall Study||203
409446|NCT00876447|977092|P1|STARTED|Overall Study||185
409447|NCT00876343|977153|P3|NOT COMPLETED|Overall Study||12
409448|NCT00876343|977154|P2|NOT COMPLETED|Overall Study||17
409449|NCT00876343|977155|P1|NOT COMPLETED|Overall Study||17
409450|NCT00876343|977153|P3|COMPLETED|Overall Study||183
409451|NCT00876343|977154|P2|COMPLETED|Overall Study||180
409452|NCT00876343|977155|P1|COMPLETED|Overall Study||177
409453|NCT00876343|977153|P3|STARTED|Overall Study||195
409454|NCT00876343|977154|P2|STARTED|Overall Study||197
409455|NCT00876343|977155|P1|STARTED|Overall Study||194
409456|NCT00876265|977169|P1|NOT COMPLETED|Overall Study||12
409457|NCT00876265|977169|P1|COMPLETED|Overall Study||106
409458|NCT00876265|977169|P1|STARTED|Overall Study||118
409459|NCT00875979|977177|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
409460|NCT00875979|977178|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
409461|NCT00875979|977177|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
409462|NCT00875979|977178|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
409463|NCT00875979|977177|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
409464|NCT00875979|977178|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
409465|NCT00875979|977177|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
409466|NCT00875979|977178|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
409467|NCT00875979|977177|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
409468|NCT00875979|977178|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
409469|NCT00875979|977177|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
409470|NCT00875979|977178|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
409471|NCT00875979|977177|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
409472|NCT00875979|977178|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
409473|NCT00875979|977177|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
409474|NCT00875979|977178|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
409475|NCT00875979|977177|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
409476|NCT00875979|977178|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
409477|NCT00875836|977190|P2|NOT COMPLETED|Overall Study||40
409478|NCT00875836|977191|P1|NOT COMPLETED|Overall Study||43
409479|NCT00875836|977190|P2|COMPLETED|Overall Study||47
409480|NCT00875836|977191|P1|COMPLETED|Overall Study||45
409481|NCT00875836|977190|P2|STARTED|Overall Study||87
409482|NCT00875836|977191|P1|STARTED|Overall Study||88
409483|NCT00875810|977201|P1|NOT COMPLETED|Overall Study||46
409484|NCT00875810|977201|P1|COMPLETED|Overall Study||148
409485|NCT00875810|977201|P1|24 Months Follow up|Overall Study||148
409486|NCT00875810|977201|P1|12 Months Follow up|Overall Study||112
409487|NCT00875810|977201|P1|6 Months Follow up|Overall Study||80
409488|NCT00875810|977201|P1|3 Months Follow up|Overall Study||175
409489|NCT00875810|977201|P1|Discharged|Overall Study||177
409490|NCT00875810|977201|P1|Implanted|Overall Study||190
409491|NCT00875810|977201|P1|STARTED|Overall Study||194
409492|NCT00875797|977210|P2|NOT COMPLETED|Overall Study||3
409493|NCT00875797|977211|P1|NOT COMPLETED|Overall Study||6
409494|NCT00875797|977210|P2|COMPLETED|Overall Study||42
409495|NCT00875797|977211|P1|COMPLETED|Overall Study||39
409496|NCT00875797|977210|P2|STARTED|Overall Study||45
409497|NCT00875797|977211|P1|STARTED|Overall Study||45
409498|NCT00875706|977224|P3|NOT COMPLETED|Overall Study||0
409499|NCT00875706|977225|P2|NOT COMPLETED|Overall Study||0
409500|NCT00875706|977226|P1|NOT COMPLETED|Overall Study||1
409501|NCT00875706|977224|P3|COMPLETED|Overall Study||13
409502|NCT00875706|977225|P2|COMPLETED|Overall Study||24
409503|NCT00875706|977226|P1|COMPLETED|Overall Study||7
409504|NCT00875706|977224|P3|STARTED|Overall Study||13
409505|NCT00875706|977225|P2|STARTED|Overall Study||24
409506|NCT00875706|977226|P1|STARTED|Overall Study||8
409507|NCT00875615|977243|P1|NOT COMPLETED|Overall Study||1
409508|NCT00875615|977243|P1|COMPLETED|Overall Study||10
409509|NCT00875615|977243|P1|STARTED|Overall Study||11
409510|NCT00875589|977250|P2|NOT COMPLETED|Overall Study||0
409511|NCT00875589|977251|P1|NOT COMPLETED|Overall Study||0
409512|NCT00875589|977250|P2|COMPLETED|Overall Study||11
409513|NCT00875589|977251|P1|COMPLETED|Overall Study||15
409514|NCT00875589|977250|P2|STARTED|Overall Study||11
409515|NCT00875589|977251|P1|STARTED|Overall Study||15
409516|NCT00875563|977257|P1|NOT COMPLETED|Overall Study||24
409517|NCT00875563|977257|P1|COMPLETED|Overall Study||18
409518|NCT00875563|977257|P1|STARTED|Overall Study||42
409519|NCT00875550|977263|P2|NOT COMPLETED|Overall Study||10
409520|NCT00875550|977264|P1|NOT COMPLETED|Overall Study||12
409521|NCT00875550|977263|P2|COMPLETED|Overall Study||76
409522|NCT00875550|977264|P1|COMPLETED|Overall Study||77
409523|NCT00875550|977263|P2|STARTED|Overall Study||86
409524|NCT00875550|977264|P1|STARTED|Overall Study||89
409525|NCT00875485|977282|P2|NOT COMPLETED|Challenge Dose Epoch||0
409526|NCT00875485|977283|P1|NOT COMPLETED|Challenge Dose Epoch||1
409527|NCT00875485|977282|P2|COMPLETED|Challenge Dose Epoch||11
409528|NCT00875485|977283|P1|COMPLETED|Challenge Dose Epoch||7
409529|NCT00875485|977282|P2|STARTED|Challenge Dose Epoch||11
409530|NCT00875485|977283|P1|STARTED|Challenge Dose Epoch||8
409531|NCT00875485|977282|P2|NOT COMPLETED|Year 15||0
409532|NCT00875485|977283|P1|NOT COMPLETED|Year 15||0
409533|NCT00875485|977282|P2|COMPLETED|Year 15||111
409534|NCT00875485|977283|P1|COMPLETED|Year 15||98
409535|NCT00875485|977282|P2|STARTED|Year 15||111
409536|NCT00875485|977283|P1|STARTED|Year 15||98
409537|NCT00875485|977282|P2|NOT COMPLETED|Year 14||0
409538|NCT00875485|977283|P1|NOT COMPLETED|Year 14||0
409539|NCT00875485|977282|P2|COMPLETED|Year 14||113
409540|NCT00875485|977283|P1|COMPLETED|Year 14||100
409541|NCT00875485|977282|P2|STARTED|Year 14||113
409542|NCT00875485|977283|P1|STARTED|Year 14||100
409543|NCT00875485|977282|P2|NOT COMPLETED|Year 13||0
409544|NCT00875485|977283|P1|NOT COMPLETED|Year 13||0
409545|NCT00875485|977282|P2|COMPLETED|Year 13||113
409546|NCT00875485|977283|P1|COMPLETED|Year 13||102
409547|NCT00875485|977282|P2|STARTED|Year 13||113
409548|NCT00875485|977283|P1|STARTED|Year 13||102
409549|NCT00875485|977282|P2|NOT COMPLETED|Year 12||0
409550|NCT00875485|977283|P1|NOT COMPLETED|Year 12||0
409551|NCT00875485|977282|P2|COMPLETED|Year 12||109
409552|NCT00875485|977283|P1|COMPLETED|Year 12||101
409553|NCT00875485|977282|P2|STARTED|Year 12||109
409554|NCT00875485|977283|P1|STARTED|Year 12||101
409555|NCT00875485|977282|P2|NOT COMPLETED|Year 11||0
409556|NCT00875485|977283|P1|NOT COMPLETED|Year 11||0
409557|NCT00875485|977282|P2|COMPLETED|Year 11||111
409558|NCT00875485|977283|P1|COMPLETED|Year 11||99
409559|NCT00875485|977282|P2|STARTED|Year 11||111
409560|NCT00875485|977283|P1|STARTED|Year 11||99
409561|NCT00875433|977323|P1|NOT COMPLETED|Overall Study||60
409562|NCT00875433|977323|P1|COMPLETED|Overall Study||0
409563|NCT00875433|977323|P1|STARTED|Overall Study|Treated|60
409564|NCT00875420|977353|P5|NOT COMPLETED|Overall Study||2
409565|NCT00875420|977354|P4|NOT COMPLETED|Overall Study||2
409566|NCT00875420|977355|P3|NOT COMPLETED|Overall Study||3
409567|NCT00875420|977356|P2|NOT COMPLETED|Overall Study||2
409568|NCT00875420|977357|P1|NOT COMPLETED|Overall Study||2
409569|NCT00875420|977353|P5|COMPLETED|Overall Study||17
409570|NCT00875420|977354|P4|COMPLETED|Overall Study||16
409571|NCT00875420|977355|P3|COMPLETED|Overall Study||18
409572|NCT00875420|977356|P2|COMPLETED|Overall Study||18
409573|NCT00875420|977357|P1|COMPLETED|Overall Study||20
409574|NCT00875420|977353|P5|STARTED|Overall Study||19
409575|NCT00875420|977354|P4|STARTED|Overall Study||18
409576|NCT00875420|977355|P3|STARTED|Overall Study||21
409577|NCT00875420|977356|P2|STARTED|Overall Study||20
409578|NCT00875420|977357|P1|STARTED|Overall Study||22
409579|NCT00875394|977387|P3|NOT COMPLETED|Overall Study||0
409580|NCT00875394|977388|P2|NOT COMPLETED|Overall Study||0
409581|NCT00875394|977389|P1|NOT COMPLETED|Overall Study||0
409582|NCT00875394|977387|P3|COMPLETED|Overall Study||9
409583|NCT00875394|977388|P2|COMPLETED|Overall Study||23
409584|NCT00875394|977389|P1|COMPLETED|Overall Study||36
409585|NCT00875394|977387|P3|STARTED|Overall Study||9
409586|NCT00875394|977388|P2|STARTED|Overall Study||23
409587|NCT00875394|977389|P1|STARTED|Overall Study||36
409588|NCT00875329|977397|P1|NOT COMPLETED|Overall Study||0
409589|NCT00875329|977397|P1|COMPLETED|Overall Study||97
409590|NCT00875329|977397|P1|STARTED|Overall Study||97
409591|NCT00875212|977401|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
409592|NCT00875212|977401|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
409593|NCT00875212|977401|P1|STARTED|CaGP and Fluoride Dentifrice||12
409594|NCT00875212|977401|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
409595|NCT00875212|977401|P1|COMPLETED|Fluoride Only Dentifrice||12
409596|NCT00875212|977401|P1|STARTED|Fluoride Only Dentifrice||12
409597|NCT00875212|977401|P1|NOT COMPLETED|CaGP Only Dentifrice||0
409598|NCT00875212|977401|P1|COMPLETED|CaGP Only Dentifrice||12
409599|NCT00875212|977401|P1|STARTED|CaGP Only Dentifrice||12
409600|NCT00875212|977401|P1|NOT COMPLETED|Placebo Dentifrice||0
409601|NCT00875212|977401|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
409602|NCT00875212|977401|P1|STARTED|Placebo Dentifrice||12
409603|NCT00875017|977418|P6|NOT COMPLETED|Fourth Intervention||1
409604|NCT00875017|977419|P5|NOT COMPLETED|Fourth Intervention||0
409605|NCT00875017|977420|P4|NOT COMPLETED|Fourth Intervention||0
409606|NCT00875017|977421|P3|NOT COMPLETED|Fourth Intervention||0
409607|NCT00875017|977422|P2|NOT COMPLETED|Fourth Intervention||0
409608|NCT00875017|977423|P1|NOT COMPLETED|Fourth Intervention||0
409609|NCT00875017|977418|P6|COMPLETED|Fourth Intervention||4
409610|NCT00875017|977419|P5|COMPLETED|Fourth Intervention||3
409611|NCT00875017|977420|P4|COMPLETED|Fourth Intervention||4
409612|NCT00875017|977421|P3|COMPLETED|Fourth Intervention||2
409613|NCT00875017|977422|P2|COMPLETED|Fourth Intervention||3
409614|NCT00875017|977423|P1|COMPLETED|Fourth Intervention||3
409615|NCT00875017|977418|P6|STARTED|Fourth Intervention||5
409616|NCT00875017|977419|P5|STARTED|Fourth Intervention||3
409617|NCT00875017|977420|P4|STARTED|Fourth Intervention||4
409618|NCT00875017|977421|P3|STARTED|Fourth Intervention||2
409619|NCT00875017|977422|P2|STARTED|Fourth Intervention||3
409620|NCT00875017|977423|P1|STARTED|Fourth Intervention||3
409621|NCT00875017|977418|P6|NOT COMPLETED|Washout||0
409622|NCT00875017|977419|P5|NOT COMPLETED|Washout||1
409623|NCT00875017|977420|P4|NOT COMPLETED|Washout||0
409624|NCT00875017|977421|P3|NOT COMPLETED|Washout||0
409625|NCT00875017|977422|P2|NOT COMPLETED|Washout||0
409626|NCT00875017|977423|P1|NOT COMPLETED|Washout||0
409627|NCT00875017|977418|P6|COMPLETED|Washout||5
409628|NCT00875017|977419|P5|COMPLETED|Washout||3
409629|NCT00875017|977420|P4|COMPLETED|Washout||4
409630|NCT00875017|977421|P3|COMPLETED|Washout||2
409631|NCT00875017|977422|P2|COMPLETED|Washout||3
409632|NCT00875017|977423|P1|COMPLETED|Washout||3
409633|NCT00875017|977418|P6|STARTED|Washout||5
409634|NCT00875017|977419|P5|STARTED|Washout||4
409635|NCT00875017|977420|P4|STARTED|Washout||4
409636|NCT00875017|977421|P3|STARTED|Washout||2
409637|NCT00875017|977422|P2|STARTED|Washout||3
409638|NCT00875017|977423|P1|STARTED|Washout||3
409639|NCT00875017|977418|P6|NOT COMPLETED|Third Intervention||0
409640|NCT00875017|977419|P5|NOT COMPLETED|Third Intervention||0
409641|NCT00875017|977420|P4|NOT COMPLETED|Third Intervention||0
409642|NCT00875017|977421|P3|NOT COMPLETED|Third Intervention||1
409643|NCT00875017|977422|P2|NOT COMPLETED|Third Intervention||1
409644|NCT00875017|977423|P1|NOT COMPLETED|Third Intervention||0
409645|NCT00875017|977418|P6|COMPLETED|Third Intervention||5
409646|NCT00875017|977419|P5|COMPLETED|Third Intervention||4
409647|NCT00875017|977420|P4|COMPLETED|Third Intervention||4
409648|NCT00875017|977421|P3|COMPLETED|Third Intervention||2
409649|NCT00875017|977422|P2|COMPLETED|Third Intervention||3
409650|NCT00875017|977423|P1|COMPLETED|Third Intervention||3
409651|NCT00875017|977418|P6|STARTED|Third Intervention||5
409652|NCT00875017|977419|P5|STARTED|Third Intervention||4
409653|NCT00875017|977420|P4|STARTED|Third Intervention||4
409654|NCT00875017|977421|P3|STARTED|Third Intervention||3
409655|NCT00875017|977422|P2|STARTED|Third Intervention||4
409656|NCT00875017|977423|P1|STARTED|Third Intervention||3
409657|NCT00875017|977418|P6|NOT COMPLETED|Washout||0
409658|NCT00875017|977419|P5|NOT COMPLETED|Washout||0
409659|NCT00875017|977420|P4|NOT COMPLETED|Washout||0
409660|NCT00875017|977421|P3|NOT COMPLETED|Washout||0
409661|NCT00875017|977422|P2|NOT COMPLETED|Washout||1
409662|NCT00875017|977423|P1|NOT COMPLETED|Washout||0
409663|NCT00875017|977418|P6|COMPLETED|Washout||5
409664|NCT00875017|977419|P5|COMPLETED|Washout||4
409665|NCT00875017|977420|P4|COMPLETED|Washout||4
409666|NCT00875017|977421|P3|COMPLETED|Washout||3
409667|NCT00875017|977422|P2|COMPLETED|Washout||4
409668|NCT00875017|977423|P1|COMPLETED|Washout||3
409669|NCT00875017|977418|P6|STARTED|Washout||5
409670|NCT00875017|977419|P5|STARTED|Washout||4
409671|NCT00875017|977420|P4|STARTED|Washout||4
409672|NCT00875017|977421|P3|STARTED|Washout||3
409673|NCT00875017|977422|P2|STARTED|Washout||5
409674|NCT00875017|977423|P1|STARTED|Washout||3
409675|NCT00875017|977418|P6|NOT COMPLETED|Second Intervention||0
409676|NCT00875017|977419|P5|NOT COMPLETED|Second Intervention||0
409677|NCT00875017|977420|P4|NOT COMPLETED|Second Intervention||1
409678|NCT00875017|977421|P3|NOT COMPLETED|Second Intervention||0
409679|NCT00875017|977422|P2|NOT COMPLETED|Second Intervention||0
409680|NCT00875017|977423|P1|NOT COMPLETED|Second Intervention||0
409681|NCT00875017|977418|P6|COMPLETED|Second Intervention||5
409682|NCT00875017|977419|P5|COMPLETED|Second Intervention||4
409683|NCT00875017|977420|P4|COMPLETED|Second Intervention||4
409684|NCT00875017|977421|P3|COMPLETED|Second Intervention||3
409685|NCT00875017|977422|P2|COMPLETED|Second Intervention||5
409686|NCT00875017|977423|P1|COMPLETED|Second Intervention||3
409687|NCT00875017|977418|P6|STARTED|Second Intervention||5
409688|NCT00875017|977419|P5|STARTED|Second Intervention||4
409689|NCT00875017|977420|P4|STARTED|Second Intervention||5
409690|NCT00875017|977421|P3|STARTED|Second Intervention||3
409691|NCT00875017|977422|P2|STARTED|Second Intervention||5
409692|NCT00875017|977423|P1|STARTED|Second Intervention||3
409693|NCT00875017|977418|P6|NOT COMPLETED|Washout||0
409694|NCT00875017|977419|P5|NOT COMPLETED|Washout||0
409695|NCT00875017|977420|P4|NOT COMPLETED|Washout||0
409696|NCT00875017|977421|P3|NOT COMPLETED|Washout||1
409697|NCT00875017|977422|P2|NOT COMPLETED|Washout||0
409698|NCT00875017|977423|P1|NOT COMPLETED|Washout||0
409699|NCT00875017|977418|P6|COMPLETED|Washout||5
409700|NCT00875017|977419|P5|COMPLETED|Washout||4
409701|NCT00875017|977420|P4|COMPLETED|Washout||5
409702|NCT00875017|977421|P3|COMPLETED|Washout||3
409703|NCT00875017|977422|P2|COMPLETED|Washout||5
409704|NCT00875017|977423|P1|COMPLETED|Washout||3
409705|NCT00875017|977418|P6|STARTED|Washout||5
409706|NCT00875017|977419|P5|STARTED|Washout||4
409707|NCT00875017|977420|P4|STARTED|Washout||5
409708|NCT00875017|977421|P3|STARTED|Washout||4
409709|NCT00875017|977422|P2|STARTED|Washout||5
409710|NCT00875017|977423|P1|STARTED|Washout||3
409711|NCT00875017|977418|P6|NOT COMPLETED|First Intervention||0
409712|NCT00875017|977419|P5|NOT COMPLETED|First Intervention||1
409713|NCT00875017|977420|P4|NOT COMPLETED|First Intervention||1
409714|NCT00875017|977421|P3|NOT COMPLETED|First Intervention||1
409715|NCT00875017|977422|P2|NOT COMPLETED|First Intervention||0
409716|NCT00875017|977423|P1|NOT COMPLETED|First Intervention||2
409717|NCT00875017|977418|P6|COMPLETED|First Intervention||5
409718|NCT00875017|977419|P5|COMPLETED|First Intervention||4
409719|NCT00875017|977420|P4|COMPLETED|First Intervention||5
409720|NCT00875017|977421|P3|COMPLETED|First Intervention||4
409721|NCT00875017|977422|P2|COMPLETED|First Intervention||5
409722|NCT00875017|977423|P1|COMPLETED|First Intervention||3
409723|NCT00875017|977418|P6|STARTED|First Intervention||5
409724|NCT00875017|977419|P5|STARTED|First Intervention||5
409725|NCT00875017|977420|P4|STARTED|First Intervention||6
409726|NCT00875017|977421|P3|STARTED|First Intervention||5
409727|NCT00875017|977422|P2|STARTED|First Intervention||5
409728|NCT00875017|977423|P1|STARTED|First Intervention||5
409729|NCT00874939|977437|P1|NOT COMPLETED|Overall Study||4
409730|NCT00874939|977437|P1|COMPLETED|Overall Study||0
409731|NCT00874939|977437|P1|Treated|Overall Study||0
409732|NCT00874939|977437|P1|STARTED|Overall Study||4
409733|NCT00874887|977453|P2|NOT COMPLETED|Overall Study||0
409734|NCT00874887|977454|P1|NOT COMPLETED|Overall Study||0
409735|NCT00874887|977453|P2|COMPLETED|Overall Study||34
409736|NCT00874887|977454|P1|COMPLETED|Overall Study||32
409737|NCT00874887|977453|P2|STARTED|Overall Study||34
409738|NCT00874887|977454|P1|STARTED|Overall Study||32
409739|NCT00874848|977470|P2|NOT COMPLETED|Overall Study||28
409740|NCT00874848|977471|P1|NOT COMPLETED|Overall Study||59
409741|NCT00874848|977470|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
409742|NCT00874848|977471|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
409743|NCT00874848|977470|P2|Discontinued|Overall Study||28
409744|NCT00874848|977471|P1|Discontinued|Overall Study||59
409745|NCT00874848|977470|P2|STARTED|Overall Study||29
409746|NCT00874848|977471|P1|STARTED|Overall Study||59
409747|NCT00874822|977487|P1|NOT COMPLETED|Overall Study||8
409748|NCT00874822|977487|P1|COMPLETED|Overall Study||208
409749|NCT00874822|977487|P1|STARTED|Overall Study||216
409750|NCT00874770|977495|P4|NOT COMPLETED|Overall Study||5
409751|NCT00874770|977496|P3|NOT COMPLETED|Overall Study||4
409752|NCT00874770|977497|P2|NOT COMPLETED|Overall Study||1
409753|NCT00874770|977498|P1|NOT COMPLETED|Overall Study||5
409754|NCT00874770|977495|P4|COMPLETED|Overall Study||7
409755|NCT00874770|977496|P3|COMPLETED|Overall Study||8
409756|NCT00874770|977497|P2|COMPLETED|Overall Study||11
409757|NCT00874770|977498|P1|COMPLETED|Overall Study||7
409758|NCT00874770|977495|P4|STARTED|Overall Study||12
409759|NCT00874770|977496|P3|STARTED|Overall Study||12
409760|NCT00874770|977497|P2|STARTED|Overall Study||12
409761|NCT00874770|977498|P1|STARTED|Overall Study||12
409762|NCT00874549|977536|P4|NOT COMPLETED|Overall Study||2
409763|NCT00874549|977537|P3|NOT COMPLETED|Overall Study||4
409764|NCT00874549|977538|P2|NOT COMPLETED|Overall Study||1
409765|NCT00874549|977539|P1|NOT COMPLETED|Overall Study||1
409766|NCT00874549|977536|P4|COMPLETED|Overall Study||56
409767|NCT00874549|977537|P3|COMPLETED|Overall Study||47
409768|NCT00874549|977538|P2|COMPLETED|Overall Study||55
409769|NCT00874549|977539|P1|COMPLETED|Overall Study||50
409770|NCT00874549|977536|P4|STARTED|Overall Study||58
409771|NCT00874549|977537|P3|STARTED|Overall Study||51
409772|NCT00874549|977538|P2|STARTED|Overall Study||56
409773|NCT00874549|977539|P1|STARTED|Overall Study||51
409774|NCT00874510|977607|P2|NOT COMPLETED|Year 2||0
409775|NCT00874510|977608|P1|NOT COMPLETED|Year 2||0
409776|NCT00874510|977607|P2|COMPLETED|Year 2||87
409777|NCT00874510|977608|P1|COMPLETED|Year 2||92
409778|NCT00874510|977607|P2|STARTED|Year 2||87
409779|NCT00874510|977608|P1|STARTED|Year 2||92
409780|NCT00874510|977607|P2|NOT COMPLETED|Year 1||0
409781|NCT00874510|977608|P1|NOT COMPLETED|Year 1||0
409782|NCT00874510|977607|P2|COMPLETED|Year 1||85
409783|NCT00874510|977608|P1|COMPLETED|Year 1||88
409784|NCT00874510|977607|P2|STARTED|Year 1||85
409785|NCT00874510|977608|P1|STARTED|Year 1||88
409786|NCT00874497|977616|P2|NOT COMPLETED|Overall Study||18
409787|NCT00874497|977617|P1|NOT COMPLETED|Overall Study||28
409788|NCT00874497|977616|P2|COMPLETED|Overall Study||15
409789|NCT00874497|977617|P1|COMPLETED|Overall Study||23
409790|NCT00874497|977616|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
409791|NCT00874497|977617|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
409792|NCT00874276|977657|P2|NOT COMPLETED|Overall Study||1
409793|NCT00874276|977658|P1|NOT COMPLETED|Overall Study||1
409794|NCT00874276|977657|P2|COMPLETED|Overall Study||7
409795|NCT00874276|977658|P1|COMPLETED|Overall Study||5
409796|NCT00874276|977657|P2|STARTED|Overall Study||8
409797|NCT00874276|977658|P1|STARTED|Overall Study||6
409798|NCT00874250|977666|P1|NOT COMPLETED|Overall Study||51
409799|NCT00874250|977666|P1|COMPLETED|Overall Study||0
409800|NCT00874250|977666|P1|STARTED|Overall Study||51
409801|NCT00874120|977678|P2|NOT COMPLETED|Second Intervention||0
409802|NCT00874120|977679|P1|NOT COMPLETED|Second Intervention||2
409803|NCT00874120|977678|P2|COMPLETED|Second Intervention||56
409804|NCT00874120|977679|P1|COMPLETED|Second Intervention||50
409805|NCT00874120|977678|P2|STARTED|Second Intervention||56
409806|NCT00874120|977679|P1|STARTED|Second Intervention||52
409807|NCT00874120|977678|P2|NOT COMPLETED|Wash-out Period||0
409808|NCT00874120|977679|P1|NOT COMPLETED|Wash-out Period||0
409809|NCT00874120|977678|P2|COMPLETED|Wash-out Period||56
409810|NCT00874120|977679|P1|COMPLETED|Wash-out Period||52
409811|NCT00874120|977678|P2|STARTED|Wash-out Period||56
409812|NCT00874120|977679|P1|STARTED|Wash-out Period||52
409813|NCT00874120|977678|P2|NOT COMPLETED|First Intervention||2
409814|NCT00874120|977679|P1|NOT COMPLETED|First Intervention||6
409815|NCT00874120|977678|P2|COMPLETED|First Intervention||56
409816|NCT00874120|977679|P1|COMPLETED|First Intervention||52
409817|NCT00874120|977678|P2|STARTED|First Intervention||58
409818|NCT00874120|977679|P1|STARTED|First Intervention||58
409819|NCT00874094|977685|P1|NOT COMPLETED|Overall Study||0
409820|NCT00874094|977685|P1|COMPLETED|Overall Study||15
409821|NCT00874094|977685|P1|STARTED|Overall Study||15
409822|NCT00874029|977692|P1|NOT COMPLETED|Overall Study||21
409823|NCT00874029|977692|P1|COMPLETED|Overall Study||116
409824|NCT00874029|977692|P1|STARTED|Overall Study||137
409825|NCT00873912|977708|P2|NOT COMPLETED|Overall Study||0
409826|NCT00873912|977709|P1|NOT COMPLETED|Overall Study||3
409827|NCT00873912|977708|P2|COMPLETED|Overall Study||60
409828|NCT00873912|977709|P1|COMPLETED|Overall Study||237
409829|NCT00873912|977708|P2|STARTED|Overall Study||60
409830|NCT00873912|977709|P1|STARTED|Overall Study||240
409831|NCT00873873|977727|P4|NOT COMPLETED|Overall Study||0
409832|NCT00873873|977728|P3|NOT COMPLETED|Overall Study||0
409833|NCT00873873|977729|P2|NOT COMPLETED|Overall Study||0
409834|NCT00873873|977730|P1|NOT COMPLETED|Overall Study||0
409835|NCT00873873|977727|P4|COMPLETED|Overall Study||18
409836|NCT00873873|977728|P3|COMPLETED|Overall Study||9
409837|NCT00873873|977729|P2|COMPLETED|Overall Study||8
409838|NCT00873873|977730|P1|COMPLETED|Overall Study||20
409839|NCT00873873|977727|P4|STARTED|Overall Study||18
409840|NCT00873873|977728|P3|STARTED|Overall Study||9
409841|NCT00873873|977729|P2|STARTED|Overall Study||8
409842|NCT00873873|977730|P1|STARTED|Overall Study||20
409843|NCT00873860|977748|P4|NOT COMPLETED|Overall Study||1
409844|NCT00873860|977749|P3|NOT COMPLETED|Overall Study||3
409845|NCT00873860|977750|P2|NOT COMPLETED|Overall Study||0
409846|NCT00873860|977751|P1|NOT COMPLETED|Overall Study||4
409847|NCT00873860|977748|P4|COMPLETED|Overall Study||47
409848|NCT00873860|977749|P3|COMPLETED|Overall Study||48
409849|NCT00873860|977750|P2|COMPLETED|Overall Study||47
409850|NCT00873860|977751|P1|COMPLETED|Overall Study||44
409851|NCT00873860|977748|P4|Treated|Overall Study||48
409852|NCT00873860|977749|P3|Treated|Overall Study||51
409853|NCT00873860|977750|P2|Treated|Overall Study||47
409854|NCT00873860|977751|P1|Treated|Overall Study||47
409855|NCT00873860|977748|P4|STARTED|Overall Study||48
409856|NCT00873860|977749|P3|STARTED|Overall Study||51
409857|NCT00873860|977750|P2|STARTED|Overall Study||47
409858|NCT00873860|977751|P1|STARTED|Overall Study||48
409859|NCT00873821|977822|P2|NOT COMPLETED|Overall Study||0
409860|NCT00873821|977823|P1|NOT COMPLETED|Overall Study||0
409861|NCT00873821|977822|P2|COMPLETED|Overall Study||22
409862|NCT00873821|977823|P1|COMPLETED|Overall Study||22
409863|NCT00873821|977822|P2|STARTED|Overall Study||22
409864|NCT00873821|977823|P1|STARTED|Overall Study||22
409865|NCT00873782|977833|P1|NOT COMPLETED|Overall Study||0
409866|NCT00873782|977833|P1|COMPLETED|Overall Study||16
409867|NCT00873782|977833|P1|STARTED|Overall Study||16
409868|NCT00873730|977839|P2|NOT COMPLETED|Overall Study||5
409869|NCT00873730|977840|P1|NOT COMPLETED|Overall Study||6
409870|NCT00873730|977839|P2|COMPLETED|Overall Study||49
409871|NCT00873730|977840|P1|COMPLETED|Overall Study||48
409872|NCT00873730|977839|P2|STARTED|Overall Study||54
409873|NCT00873730|977840|P1|STARTED|Overall Study||54
409874|NCT00873457|977876|P1|NOT COMPLETED|Overall Study||0
409875|NCT00873457|977876|P1|COMPLETED|Overall Study||16
409876|NCT00873457|977876|P1|STARTED|Overall Study||16
409877|NCT00873327|977883|P1|NOT COMPLETED|Overall Study||0
409878|NCT00873327|977883|P1|COMPLETED|Overall Study||32
409879|NCT00873327|977883|P1|STARTED|Overall Study||32
409880|NCT00873119|977889|P2|NOT COMPLETED|Overall Study||26
409881|NCT00873119|977890|P1|NOT COMPLETED|Overall Study||44
409882|NCT00873119|977889|P2|COMPLETED|Overall Study||19
409883|NCT00873119|977890|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
409884|NCT00873119|977889|P2|STARTED|Overall Study||45
409885|NCT00873119|977890|P1|STARTED|Overall Study||44
409886|NCT00873093|977911|P5|NOT COMPLETED|Overall Study||2
409887|NCT00873093|977912|P4|NOT COMPLETED|Overall Study||11
409888|NCT00873093|977913|P3|NOT COMPLETED|Overall Study||16
409889|NCT00873093|977914|P2|NOT COMPLETED|Overall Study||27
409890|NCT00873093|977915|P1|NOT COMPLETED|Overall Study||1
409891|NCT00873093|977911|P5|COMPLETED|Overall Study||8
409892|NCT00873093|977912|P4|COMPLETED|Overall Study||12
409893|NCT00873093|977913|P3|COMPLETED|Overall Study||33
409894|NCT00873093|977914|P2|COMPLETED|Overall Study||35
409895|NCT00873093|977915|P1|COMPLETED|Overall Study||3
409896|NCT00873093|977911|P5|STARTED|Overall Study||10
409897|NCT00873093|977912|P4|STARTED|Overall Study||23
409898|NCT00873093|977913|P3|STARTED|Overall Study||49
409899|NCT00873093|977914|P2|STARTED|Overall Study||62
409900|NCT00873093|977915|P1|STARTED|Overall Study||4
409901|NCT00873041|977972|P3|NOT COMPLETED|Extension Study||2
409902|NCT00873041|977973|P2|NOT COMPLETED|Extension Study||0
409903|NCT00873041|977974|P1|NOT COMPLETED|Extension Study||1
409904|NCT00873041|977972|P3|COMPLETED|Extension Study||46
409905|NCT00873041|977973|P2|COMPLETED|Extension Study||44
409906|NCT00873041|977974|P1|COMPLETED|Extension Study||40
409907|NCT00873041|977972|P3|STARTED|Extension Study||48
409908|NCT00873041|977973|P2|STARTED|Extension Study||44
409909|NCT00873041|977974|P1|STARTED|Extension Study||41
409910|NCT00873041|977972|P3|NOT COMPLETED|Core Study||5
409911|NCT00873041|977973|P2|NOT COMPLETED|Core Study||6
409912|NCT00873041|977974|P1|NOT COMPLETED|Core Study||7
409913|NCT00873041|977972|P3|COMPLETED|Core Study||51
409914|NCT00873041|977973|P2|COMPLETED|Core Study||49
409915|NCT00873041|977974|P1|COMPLETED|Core Study||48
409916|NCT00873041|977972|P3|STARTED|Core Study||56
409917|NCT00873041|977973|P2|STARTED|Core Study||55
409918|NCT00873041|977974|P1|STARTED|Core Study||55
409919|NCT00873015|978032|P4|NOT COMPLETED|Overall Study||0
409920|NCT00873015|978033|P3|NOT COMPLETED|Overall Study||0
409921|NCT00873015|978034|P2|NOT COMPLETED|Overall Study||1
409922|NCT00873015|978035|P1|NOT COMPLETED|Overall Study||0
409923|NCT00873015|978032|P4|COMPLETED|Overall Study||3
409924|NCT00873015|978033|P3|COMPLETED|Overall Study||3
409925|NCT00873015|978034|P2|COMPLETED|Overall Study||3
409926|NCT00873015|978035|P1|COMPLETED|Overall Study||9
409927|NCT00873015|978032|P4|STARTED|Overall Study||3
409928|NCT00873015|978033|P3|STARTED|Overall Study||3
409929|NCT00873015|978034|P2|STARTED|Overall Study||4
409930|NCT00873015|978035|P1|STARTED|Overall Study||9
409931|NCT00872989|978044|P2|NOT COMPLETED|Overall Study||63
409932|NCT00872989|978045|P1|NOT COMPLETED|Overall Study||65
409933|NCT00872989|978044|P2|COMPLETED|Overall Study||0
409934|NCT00872989|978045|P1|COMPLETED|Overall Study||1
409935|NCT00872989|978044|P2|STARTED|Overall Study||63
409936|NCT00872989|978045|P1|STARTED|Overall Study||66
409937|NCT00872898|978064|P2|NOT COMPLETED|Part Two - Double Blind||6
409938|NCT00872898|978065|P1|NOT COMPLETED|Part Two - Double Blind||11
409939|NCT00872898|978064|P2|COMPLETED|Part Two - Double Blind||54
409940|NCT00872898|978065|P1|COMPLETED|Part Two - Double Blind||50
409941|NCT00872898|978064|P2|STARTED|Part Two - Double Blind||60
409942|NCT00872898|978065|P1|STARTED|Part Two - Double Blind||61
409943|NCT00872898|978064|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
409944|NCT00872898|978065|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
409945|NCT00872898|978064|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
409946|NCT00872898|978065|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
409947|NCT00872898|978064|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
409948|NCT00872898|978065|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
409949|NCT00872833|978099|P2|NOT COMPLETED|Overall Study||0
409950|NCT00872833|978100|P1|NOT COMPLETED|Overall Study||0
409951|NCT00872833|978099|P2|COMPLETED|Overall Study||17
409952|NCT00872833|978100|P1|COMPLETED|Overall Study||15
409953|NCT00872833|978099|P2|STARTED|Overall Study||17
409954|NCT00872833|978100|P1|STARTED|Overall Study||15
409955|NCT00872729|978109|P1|NOT COMPLETED|Overall Study||0
409956|NCT00872729|978109|P1|COMPLETED|Overall Study||9
409957|NCT00872729|978109|P1|STARTED|Overall Study||9
409958|NCT00872599|978139|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
409959|NCT00872599|978140|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
409960|NCT00872599|978139|P2|COMPLETED|Second Drug During High Salt Intake||16
409961|NCT00872599|978140|P1|COMPLETED|Second Drug During High Salt Intake||15
409962|NCT00872599|978139|P2|STARTED|Second Drug During High Salt Intake||16
409963|NCT00872599|978140|P1|STARTED|Second Drug During High Salt Intake||15
409964|NCT00872599|978139|P2|NOT COMPLETED|Second Washout Period||1
409965|NCT00872599|978140|P1|NOT COMPLETED|Second Washout Period||1
409966|NCT00872599|978139|P2|COMPLETED|Second Washout Period||16
409967|NCT00872599|978140|P1|COMPLETED|Second Washout Period||15
409968|NCT00872599|978139|P2|STARTED|Second Washout Period||17
409969|NCT00872599|978140|P1|STARTED|Second Washout Period||16
409970|NCT00872599|978139|P2|NOT COMPLETED|First Drug During High Salt Intake||0
409971|NCT00872599|978140|P1|NOT COMPLETED|First Drug During High Salt Intake||0
409972|NCT00872599|978139|P2|COMPLETED|First Drug During High Salt Intake||17
409973|NCT00872599|978140|P1|COMPLETED|First Drug During High Salt Intake||16
409974|NCT00872599|978139|P2|STARTED|First Drug During High Salt Intake||17
409975|NCT00872599|978140|P1|STARTED|First Drug During High Salt Intake||16
409976|NCT00872599|978139|P2|NOT COMPLETED|First Washout Period After Low Salt||0
409977|NCT00872599|978140|P1|NOT COMPLETED|First Washout Period After Low Salt||0
409978|NCT00872599|978139|P2|COMPLETED|First Washout Period After Low Salt||17
409979|NCT00872599|978140|P1|COMPLETED|First Washout Period After Low Salt||16
409980|NCT00872599|978139|P2|STARTED|First Washout Period After Low Salt||17
409981|NCT00872599|978140|P1|STARTED|First Washout Period After Low Salt||16
409982|NCT00872534|978150|P2|NOT COMPLETED|Overall Study||3
409983|NCT00872534|978151|P1|NOT COMPLETED|Overall Study||3
409984|NCT00872534|978150|P2|COMPLETED|Overall Study||101
409985|NCT00872534|978151|P1|COMPLETED|Overall Study||97
409986|NCT00872534|978150|P2|STARTED|Overall Study||104
409987|NCT00872534|978151|P1|STARTED|Overall Study||100
409988|NCT00872521|978160|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
409989|NCT00872521|978161|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
409990|NCT00872521|978162|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
409991|NCT00872521|978160|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
409992|NCT00872521|978161|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
409993|NCT00872521|978162|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
409994|NCT00872521|978160|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
409995|NCT00872521|978161|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
409996|NCT00872521|978162|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
409997|NCT00872521|978160|P3|NOT COMPLETED|Completed 3-month Follow up||0
409998|NCT00872521|978161|P2|NOT COMPLETED|Completed 3-month Follow up||3
409999|NCT00872521|978162|P1|NOT COMPLETED|Completed 3-month Follow up||0
410000|NCT00872521|978160|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
410001|NCT00872521|978161|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
410002|NCT00872521|978162|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
410003|NCT00872521|978160|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
410004|NCT00872521|978161|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
410005|NCT00872521|978162|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
410006|NCT00872521|978160|P3|NOT COMPLETED|Primary Endpoint Analysis||1
410007|NCT00872521|978161|P2|NOT COMPLETED|Primary Endpoint Analysis||5
410008|NCT00872521|978162|P1|NOT COMPLETED|Primary Endpoint Analysis||1
410009|NCT00872521|978160|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
410010|NCT00872521|978161|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
410011|NCT00872521|978162|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
410012|NCT00872521|978160|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
410013|NCT00872521|978161|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
410014|NCT00872521|978162|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
410015|NCT00872521|978160|P3|NOT COMPLETED|Completed PAD Induction||0
410016|NCT00872521|978161|P2|NOT COMPLETED|Completed PAD Induction||4
410017|NCT00872521|978162|P1|NOT COMPLETED|Completed PAD Induction||5
410018|NCT00872521|978160|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
410019|NCT00872521|978161|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
410020|NCT00872521|978162|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
410021|NCT00872521|978160|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
410022|NCT00872521|978161|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
410023|NCT00872521|978162|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
410024|NCT00872430|978210|P2|NOT COMPLETED|Second Intervention||0
410025|NCT00872430|978211|P1|NOT COMPLETED|Second Intervention||0
410026|NCT00872430|978210|P2|COMPLETED|Second Intervention||10
410027|NCT00872430|978211|P1|COMPLETED|Second Intervention||10
410028|NCT00872430|978210|P2|STARTED|Second Intervention||10
410029|NCT00872430|978211|P1|STARTED|Second Intervention||10
410030|NCT00872430|978210|P2|NOT COMPLETED|Washout Period||0
410031|NCT00872430|978211|P1|NOT COMPLETED|Washout Period||0
410032|NCT00872430|978210|P2|COMPLETED|Washout Period||10
410033|NCT00872430|978211|P1|COMPLETED|Washout Period||10
410034|NCT00872430|978210|P2|STARTED|Washout Period||10
410035|NCT00872430|978211|P1|STARTED|Washout Period||10
410036|NCT00872430|978210|P2|NOT COMPLETED|First Intervention||0
410037|NCT00872430|978211|P1|NOT COMPLETED|First Intervention||0
410038|NCT00872430|978210|P2|COMPLETED|First Intervention||10
410039|NCT00872430|978211|P1|COMPLETED|First Intervention||10
410040|NCT00872430|978210|P2|STARTED|First Intervention||10
410041|NCT00872430|978211|P1|STARTED|First Intervention||10
410042|NCT00872339|978220|P3|NOT COMPLETED|Overall Study||0
410043|NCT00872339|978221|P2|NOT COMPLETED|Overall Study||0
410044|NCT00872339|978222|P1|NOT COMPLETED|Overall Study||0
410045|NCT00872339|978220|P3|COMPLETED|Overall Study||37
410046|NCT00872339|978221|P2|COMPLETED|Overall Study||14
410047|NCT00872339|978222|P1|COMPLETED|Overall Study||201
410048|NCT00872339|978220|P3|STARTED|Overall Study||37
410049|NCT00872339|978221|P2|STARTED|Overall Study||14
410050|NCT00872339|978222|P1|STARTED|Overall Study||201
410051|NCT00872170|978233|P2|NOT COMPLETED|Overall Study||0
410052|NCT00872170|978234|P1|NOT COMPLETED|Overall Study||1
410053|NCT00872170|978233|P2|COMPLETED|Overall Study||13
410054|NCT00872170|978234|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
410055|NCT00872170|978233|P2|STARTED|Overall Study||13
410056|NCT00872170|978234|P1|STARTED|Overall Study||14
410057|NCT00872079|978249|P1|NOT COMPLETED|Overall Study||0
410058|NCT00872079|978249|P1|COMPLETED|Overall Study||175
410059|NCT00872079|978249|P1|STARTED|Overall Study||175
410060|NCT00872027|978255|P2|NOT COMPLETED|Overall Study||0
410061|NCT00872027|978256|P1|NOT COMPLETED|Overall Study||0
410062|NCT00872027|978255|P2|COMPLETED|Overall Study||8
410063|NCT00872027|978256|P1|COMPLETED|Overall Study||7
410064|NCT00872027|978255|P2|STARTED|Overall Study||8
410065|NCT00872027|978256|P1|STARTED|Overall Study||7
410066|NCT00872001|978264|P2|NOT COMPLETED|Overall Study||131
410067|NCT00872001|978265|P1|NOT COMPLETED|Overall Study||136
410068|NCT00872001|978264|P2|COMPLETED|Overall Study||1413
410069|NCT00872001|978265|P1|COMPLETED|Overall Study||1400
410070|NCT00872001|978264|P2|STARTED|Overall Study||1544
410071|NCT00872001|978265|P1|STARTED|Overall Study||1536
410072|NCT00871975|978273|P1|NOT COMPLETED|Overall Study||22
410073|NCT00871975|978273|P1|COMPLETED|Overall Study||133
410074|NCT00871975|978273|P1|STARTED|Overall Study||155
410075|NCT00871871|978279|P4|NOT COMPLETED|Part II||4
410076|NCT00871871|978280|P3|NOT COMPLETED|Part II||4
410077|NCT00871871|978281|P2|NOT COMPLETED|Part II||0
410078|NCT00871871|978282|P1|NOT COMPLETED|Part II||0
410079|NCT00871871|978279|P4|COMPLETED|Part II||11
410080|NCT00871871|978280|P3|COMPLETED|Part II||9
410081|NCT00871871|978281|P2|COMPLETED|Part II||0
410082|NCT00871871|978282|P1|COMPLETED|Part II||0
410083|NCT00871871|978279|P4|STARTED|Part II||15
410084|NCT00871871|978280|P3|STARTED|Part II||13
410085|NCT00871871|978281|P2|STARTED|Part II||0
410086|NCT00871871|978282|P1|STARTED|Part II||0
410087|NCT00871871|978279|P4|NOT COMPLETED|Part I||0
410088|NCT00871871|978280|P3|NOT COMPLETED|Part I||0
410089|NCT00871871|978281|P2|NOT COMPLETED|Part I||3
410090|NCT00871871|978282|P1|NOT COMPLETED|Part I||3
410091|NCT00871871|978279|P4|COMPLETED|Part I||0
410092|NCT00871871|978280|P3|COMPLETED|Part I||0
410093|NCT00871871|978281|P2|COMPLETED|Part I||15
410094|NCT00871871|978282|P1|COMPLETED|Part I||15
410095|NCT00871871|978279|P4|STARTED|Part I||0
410096|NCT00871871|978280|P3|STARTED|Part I||0
410097|NCT00871871|978281|P2|STARTED|Part I||18
410098|NCT00871871|978282|P1|STARTED|Part I||18
410099|NCT00871819|978302|P1|NOT COMPLETED|Overall Study||0
410100|NCT00871819|978302|P1|COMPLETED|Overall Study||20
410101|NCT00871819|978302|P1|STARTED|Overall Study||20
410102|NCT00871780|978306|P1|NOT COMPLETED|Overall Study||27
410103|NCT00871780|978306|P1|COMPLETED|Overall Study||197
410104|NCT00871780|978306|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
410105|NCT00871780|978306|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
410106|NCT00871780|978306|P1|STARTED|Overall Study|number enrolled|224
410107|NCT00871741|978326|P2|NOT COMPLETED|Overall Study||7
410108|NCT00871741|978327|P1|NOT COMPLETED|Overall Study||9
410109|NCT00871741|978326|P2|COMPLETED|Overall Study||0
410110|NCT00871741|978327|P1|COMPLETED|Overall Study||0
410111|NCT00871741|978326|P2|STARTED|Overall Study||7
410112|NCT00871741|978327|P1|STARTED|Overall Study||9
410113|NCT00871728|978341|P1|NOT COMPLETED|Overall Study||20
410114|NCT00871728|978341|P1|COMPLETED|Overall Study||112
410115|NCT00871728|978341|P1|Treated|Overall Study||130
410116|NCT00871728|978341|P1|STARTED|Overall Study||132
410117|NCT00871715|978354|P3|NOT COMPLETED|Overall Study||26
410118|NCT00871715|978355|P2|NOT COMPLETED|Overall Study||16
410119|NCT00871715|978356|P1|NOT COMPLETED|Overall Study||15
410120|NCT00871715|978354|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
410121|NCT00871715|978355|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
410122|NCT00871715|978356|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
410123|NCT00871715|978354|P3|6-mo Follow-up|Overall Study||112
410124|NCT00871715|978355|P2|6-mo Follow-up|Overall Study||113
410125|NCT00871715|978356|P1|6-mo Follow-up|Overall Study||110
410126|NCT00871715|978354|P3|Post-Intervention|Overall Study||115
410127|NCT00871715|978355|P2|Post-Intervention|Overall Study||115
410128|NCT00871715|978356|P1|Post-Intervention|Overall Study||112
410129|NCT00871715|978354|P3|STARTED|Overall Study||122
410130|NCT00871715|978355|P2|STARTED|Overall Study||120
410131|NCT00871715|978356|P1|STARTED|Overall Study||119
410132|NCT00871689|978374|P1|NOT COMPLETED|Overall Study||0
410133|NCT00871689|978374|P1|COMPLETED|Overall Study||2
410134|NCT00871689|978374|P1|STARTED|Overall Study||2
410135|NCT00871624|978387|P2|NOT COMPLETED|Overall Study||1
410136|NCT00871624|978388|P1|NOT COMPLETED|Overall Study||2
410137|NCT00871624|978387|P2|COMPLETED|Overall Study||17
410138|NCT00871624|978388|P1|COMPLETED|Overall Study||16
410139|NCT00871624|978387|P2|STARTED|Overall Study||18
410140|NCT00871624|978388|P1|STARTED|Overall Study||18
410141|NCT00871494|978394|P1|NOT COMPLETED|Overall Study||14
410142|NCT00871494|978394|P1|COMPLETED|Overall Study||62
410143|NCT00871494|978394|P1|STARTED|Overall Study||76
410144|NCT00871429|978401|P1|NOT COMPLETED|Overall Study||24
410145|NCT00871429|978401|P1|COMPLETED|Overall Study||75
410146|NCT00871429|978401|P1|STARTED|Overall Study||99
410147|NCT00871403|978412|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
410148|NCT00871403|978413|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
410149|NCT00871403|978414|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
410150|NCT00871403|978412|P3|COMPLETED|Monotherapy Treatment Phase||0
410151|NCT00871403|978413|P2|COMPLETED|Monotherapy Treatment Phase||0
410152|NCT00871403|978414|P1|COMPLETED|Monotherapy Treatment Phase||0
410153|NCT00871403|978412|P3|STARTED|Monotherapy Treatment Phase||1
410154|NCT00871403|978413|P2|STARTED|Monotherapy Treatment Phase||13
410155|NCT00871403|978414|P1|STARTED|Monotherapy Treatment Phase||0
410156|NCT00871403|978412|P3|NOT COMPLETED|Combination Treatment Phase||12
410157|NCT00871403|978413|P2|NOT COMPLETED|Combination Treatment Phase||49
410158|NCT00871403|978414|P1|NOT COMPLETED|Combination Treatment Phase||9
410159|NCT00871403|978412|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
410160|NCT00871403|978413|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
410161|NCT00871403|978414|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
410162|NCT00871403|978412|P3|STARTED|Combination Treatment Phase||35
410163|NCT00871403|978413|P2|STARTED|Combination Treatment Phase||62
410164|NCT00871403|978414|P1|STARTED|Combination Treatment Phase||9
410165|NCT00871377|978427|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
410166|NCT00871377|978428|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
410167|NCT00871377|978429|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
410168|NCT00871377|978430|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
410169|NCT00871377|978431|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
410170|NCT00871377|978432|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
410171|NCT00871377|978427|P6|COMPLETED|Third Intervention (10 Weeks)||3
410172|NCT00871377|978428|P5|COMPLETED|Third Intervention (10 Weeks)||4
410173|NCT00871377|978429|P4|COMPLETED|Third Intervention (10 Weeks)||3
410174|NCT00871377|978430|P3|COMPLETED|Third Intervention (10 Weeks)||3
410175|NCT00871377|978431|P2|COMPLETED|Third Intervention (10 Weeks)||4
410176|NCT00871377|978432|P1|COMPLETED|Third Intervention (10 Weeks)||2
410177|NCT00871377|978427|P6|STARTED|Third Intervention (10 Weeks)||3
410178|NCT00871377|978428|P5|STARTED|Third Intervention (10 Weeks)||4
410179|NCT00871377|978429|P4|STARTED|Third Intervention (10 Weeks)||4
410180|NCT00871377|978430|P3|STARTED|Third Intervention (10 Weeks)||3
410181|NCT00871377|978431|P2|STARTED|Third Intervention (10 Weeks)||4
410182|NCT00871377|978432|P1|STARTED|Third Intervention (10 Weeks)||2
410183|NCT00871377|978427|P6|NOT COMPLETED|Washout (6 Weeks)||1
410184|NCT00871377|978428|P5|NOT COMPLETED|Washout (6 Weeks)||0
410185|NCT00871377|978429|P4|NOT COMPLETED|Washout (6 Weeks)||0
410186|NCT00871377|978430|P3|NOT COMPLETED|Washout (6 Weeks)||0
410187|NCT00871377|978431|P2|NOT COMPLETED|Washout (6 Weeks)||0
410188|NCT00871377|978432|P1|NOT COMPLETED|Washout (6 Weeks)||0
410189|NCT00871377|978427|P6|COMPLETED|Washout (6 Weeks)||3
410190|NCT00871377|978428|P5|COMPLETED|Washout (6 Weeks)||4
410191|NCT00871377|978429|P4|COMPLETED|Washout (6 Weeks)||4
410192|NCT00871377|978430|P3|COMPLETED|Washout (6 Weeks)||3
410193|NCT00871377|978431|P2|COMPLETED|Washout (6 Weeks)||4
410194|NCT00871377|978432|P1|COMPLETED|Washout (6 Weeks)||2
410195|NCT00871377|978427|P6|STARTED|Washout (6 Weeks)||4
410196|NCT00871377|978428|P5|STARTED|Washout (6 Weeks)||4
410197|NCT00871377|978429|P4|STARTED|Washout (6 Weeks)||4
410198|NCT00871377|978430|P3|STARTED|Washout (6 Weeks)||3
410199|NCT00871377|978431|P2|STARTED|Washout (6 Weeks)||4
410200|NCT00871377|978432|P1|STARTED|Washout (6 Weeks)||2
410201|NCT00871377|978427|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
410202|NCT00871377|978428|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
410203|NCT00871377|978429|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
410204|NCT00871377|978430|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
410205|NCT00871377|978431|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
410206|NCT00871377|978432|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
410207|NCT00871377|978427|P6|COMPLETED|Second Intervention (10 Weeks)||4
410208|NCT00871377|978428|P5|COMPLETED|Second Intervention (10 Weeks)||4
410209|NCT00871377|978429|P4|COMPLETED|Second Intervention (10 Weeks)||4
410210|NCT00871377|978430|P3|COMPLETED|Second Intervention (10 Weeks)||3
410211|NCT00871377|978431|P2|COMPLETED|Second Intervention (10 Weeks)||4
410212|NCT00871377|978432|P1|COMPLETED|Second Intervention (10 Weeks)||2
410213|NCT00871377|978427|P6|STARTED|Second Intervention (10 Weeks)||4
410214|NCT00871377|978428|P5|STARTED|Second Intervention (10 Weeks)||4
410215|NCT00871377|978429|P4|STARTED|Second Intervention (10 Weeks)||4
410216|NCT00871377|978430|P3|STARTED|Second Intervention (10 Weeks)||3
410217|NCT00871377|978431|P2|STARTED|Second Intervention (10 Weeks)||4
410218|NCT00871377|978432|P1|STARTED|Second Intervention (10 Weeks)||2
410219|NCT00871377|978427|P6|NOT COMPLETED|Washout (6 Weeks)||0
410220|NCT00871377|978428|P5|NOT COMPLETED|Washout (6 Weeks)||0
410221|NCT00871377|978429|P4|NOT COMPLETED|Washout (6 Weeks)||0
410222|NCT00871377|978430|P3|NOT COMPLETED|Washout (6 Weeks)||0
410223|NCT00871377|978431|P2|NOT COMPLETED|Washout (6 Weeks)||0
410224|NCT00871377|978432|P1|NOT COMPLETED|Washout (6 Weeks)||1
410225|NCT00871377|978427|P6|COMPLETED|Washout (6 Weeks)||4
410226|NCT00871377|978428|P5|COMPLETED|Washout (6 Weeks)||4
410227|NCT00871377|978429|P4|COMPLETED|Washout (6 Weeks)||4
410228|NCT00871377|978430|P3|COMPLETED|Washout (6 Weeks)||3
410229|NCT00871377|978431|P2|COMPLETED|Washout (6 Weeks)||4
410230|NCT00871377|978432|P1|COMPLETED|Washout (6 Weeks)||2
410231|NCT00871377|978427|P6|STARTED|Washout (6 Weeks)||4
410232|NCT00871377|978428|P5|STARTED|Washout (6 Weeks)||4
410233|NCT00871377|978429|P4|STARTED|Washout (6 Weeks)||4
410234|NCT00871377|978430|P3|STARTED|Washout (6 Weeks)||3
410235|NCT00871377|978431|P2|STARTED|Washout (6 Weeks)||4
410236|NCT00871377|978432|P1|STARTED|Washout (6 Weeks)||3
410237|NCT00871377|978427|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
410238|NCT00871377|978428|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
410239|NCT00871377|978429|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
410240|NCT00871377|978430|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
410241|NCT00871377|978431|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
410242|NCT00871377|978432|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
410243|NCT00871377|978427|P6|COMPLETED|First Intervention (10 Weeks)||4
410244|NCT00871377|978428|P5|COMPLETED|First Intervention (10 Weeks)||4
410245|NCT00871377|978429|P4|COMPLETED|First Intervention (10 Weeks)||4
410246|NCT00871377|978430|P3|COMPLETED|First Intervention (10 Weeks)||3
410247|NCT00871377|978431|P2|COMPLETED|First Intervention (10 Weeks)||4
410248|NCT00871377|978432|P1|COMPLETED|First Intervention (10 Weeks)||3
410249|NCT00871377|978427|P6|STARTED|First Intervention (10 Weeks)||5
410250|NCT00871377|978428|P5|STARTED|First Intervention (10 Weeks)||4
410251|NCT00871377|978429|P4|STARTED|First Intervention (10 Weeks)||4
410252|NCT00871377|978430|P3|STARTED|First Intervention (10 Weeks)||4
410253|NCT00871377|978431|P2|STARTED|First Intervention (10 Weeks)||4
410254|NCT00871377|978432|P1|STARTED|First Intervention (10 Weeks)||3
410255|NCT00871351|978443|P3|NOT COMPLETED|Overall Study||0
410256|NCT00871351|978444|P2|NOT COMPLETED|Overall Study||1
410257|NCT00871351|978445|P1|NOT COMPLETED|Overall Study||4
410258|NCT00871351|978443|P3|COMPLETED|Overall Study||32
410259|NCT00871351|978444|P2|COMPLETED|Overall Study||45
410260|NCT00871351|978445|P1|COMPLETED|Overall Study||43
410261|NCT00871351|978443|P3|STARTED|Overall Study||32
410262|NCT00871351|978444|P2|STARTED|Overall Study||46
410263|NCT00871351|978445|P1|STARTED|Overall Study||47
410264|NCT00871338|978467|P2|NOT COMPLETED|After Booster||0
410265|NCT00871338|978468|P1|NOT COMPLETED|After Booster||0
410266|NCT00871338|978467|P2|COMPLETED|After Booster||135
410267|NCT00871338|978468|P1|COMPLETED|After Booster||139
410268|NCT00871338|978467|P2|STARTED|After Booster||135
410269|NCT00871338|978468|P1|STARTED|After Booster||139
410270|NCT00871338|978467|P2|NOT COMPLETED|Prior to Booster||3
410271|NCT00871338|978468|P1|NOT COMPLETED|Prior to Booster||2
410272|NCT00871338|978467|P2|COMPLETED|Prior to Booster||139
410273|NCT00871338|978468|P1|COMPLETED|Prior to Booster||140
410274|NCT00871338|978467|P2|STARTED|Prior to Booster||142
410275|NCT00871338|978468|P1|STARTED|Prior to Booster||142
410276|NCT00871286|978548|P2|NOT COMPLETED|Overall Study||6
410277|NCT00871286|978549|P1|NOT COMPLETED|Overall Study||0
410278|NCT00871286|978548|P2|COMPLETED|Overall Study||14
410279|NCT00871286|978549|P1|COMPLETED|Overall Study||20
410280|NCT00871286|978548|P2|STARTED|Overall Study||20
410281|NCT00871286|978549|P1|STARTED|Overall Study||20
410282|NCT00871234|978557|P1|NOT COMPLETED|Overall Study||5
410283|NCT00871234|978557|P1|COMPLETED|Overall Study||23
410284|NCT00871234|978557|P1|STARTED|Overall Study||28
410285|NCT00871169|978561|P1|NOT COMPLETED|Overall Study||3
410286|NCT00871169|978561|P1|COMPLETED|Overall Study||58
410287|NCT00871169|978561|P1|STARTED|Overall Study||61
410288|NCT00871143|978568|P2|NOT COMPLETED|Overall Study||0
410289|NCT00871143|978569|P1|NOT COMPLETED|Overall Study||0
410290|NCT00871143|978568|P2|COMPLETED|Overall Study||25
410291|NCT00871143|978569|P1|COMPLETED|Overall Study||21
410292|NCT00871143|978568|P2|STARTED|Overall Study||25
410293|NCT00871143|978569|P1|STARTED|Overall Study||21
410294|NCT00871117|978589|P2|NOT COMPLETED|Overall Study||10
410295|NCT00871117|978590|P1|NOT COMPLETED|Overall Study||5
410296|NCT00871117|978589|P2|COMPLETED|Overall Study||227
410297|NCT00871117|978590|P1|COMPLETED|Overall Study||234
410298|NCT00871117|978589|P2|STARTED|Overall Study||237
410299|NCT00871117|978590|P1|STARTED|Overall Study||239
410300|NCT00871000|978622|P2|NOT COMPLETED|Overall Study||0
410301|NCT00871000|978623|P1|NOT COMPLETED|Overall Study||1
410302|NCT00871000|978622|P2|COMPLETED|Overall Study||152
410303|NCT00871000|978623|P1|COMPLETED|Overall Study||150
410304|NCT00871000|978622|P2|STARTED|Overall Study||152
410305|NCT00871000|978623|P1|STARTED|Overall Study||151
410306|NCT00870896|978665|P1|NOT COMPLETED|Overall Study||0
410307|NCT00870896|978665|P1|COMPLETED|Overall Study||5
410308|NCT00870896|978665|P1|STARTED|Overall Study||5
410309|NCT00870740|978677|P6|NOT COMPLETED|Overall Study||17
410310|NCT00870740|978678|P5|NOT COMPLETED|Overall Study||11
410311|NCT00870740|978679|P4|NOT COMPLETED|Overall Study||12
410312|NCT00870740|978680|P3|NOT COMPLETED|Overall Study||10
410313|NCT00870740|978681|P2|NOT COMPLETED|Overall Study||9
410314|NCT00870740|978682|P1|NOT COMPLETED|Overall Study||12
410315|NCT00870740|978677|P6|COMPLETED|Overall Study||70
410316|NCT00870740|978678|P5|COMPLETED|Overall Study||77
410317|NCT00870740|978679|P4|COMPLETED|Overall Study||74
410318|NCT00870740|978680|P3|COMPLETED|Overall Study||76
410319|NCT00870740|978681|P2|COMPLETED|Overall Study||75
410320|NCT00870740|978682|P1|COMPLETED|Overall Study||74
410321|NCT00870740|978677|P6|STARTED|Overall Study|number randomized and dosed|87
410322|NCT00870740|978678|P5|STARTED|Overall Study|number randomized and dosed|88
410323|NCT00870740|978679|P4|STARTED|Overall Study|number randomized and dosed|86
410324|NCT00870740|978680|P3|STARTED|Overall Study|number randomized and dosed|86
410325|NCT00870740|978681|P2|STARTED|Overall Study|number randomized and dosed|84
410326|NCT00870740|978682|P1|STARTED|Overall Study|number randomized and dosed|86
410327|NCT00870688|978756|P1|NOT COMPLETED|Overall Study||4
410328|NCT00870688|978756|P1|COMPLETED|Overall Study||78
410329|NCT00870688|978756|P1|STARTED|Overall Study||82
410330|NCT00870584|978761|P2|NOT COMPLETED|Overall Study||13
410331|NCT00870584|978762|P1|NOT COMPLETED|Overall Study||16
410332|NCT00870584|978761|P2|COMPLETED|Overall Study||122
410333|NCT00870584|978762|P1|COMPLETED|Overall Study||120
410334|NCT00870584|978761|P2|STARTED|Overall Study||135
410335|NCT00870584|978762|P1|STARTED|Overall Study||136
410336|NCT00870545|978770|P1|NOT COMPLETED|Overall Study||17
410337|NCT00870545|978770|P1|COMPLETED|Overall Study||69
410338|NCT00870545|978770|P1|STARTED|Overall Study||86
410339|NCT00870467|978781|P6|NOT COMPLETED|Open-label||3
410340|NCT00870467|978782|P5|NOT COMPLETED|Open-label||5
410341|NCT00870467|978783|P4|NOT COMPLETED|Open-label||7
410342|NCT00870467|978784|P3|NOT COMPLETED|Open-label||13
410343|NCT00870467|978785|P2|NOT COMPLETED|Open-label||0
410344|NCT00870467|978786|P1|NOT COMPLETED|Open-label||0
410345|NCT00870467|978781|P6|COMPLETED|Open-label||21
410346|NCT00870467|978782|P5|COMPLETED|Open-label||5
410347|NCT00870467|978783|P4|COMPLETED|Open-label||120
410348|NCT00870467|978784|P3|COMPLETED|Open-label||132
410349|NCT00870467|978785|P2|COMPLETED|Open-label||0
410350|NCT00870467|978786|P1|COMPLETED|Open-label||0
410351|NCT00870467|978781|P6|STARTED|Open-label||24
410352|NCT00870467|978782|P5|STARTED|Open-label||10
410353|NCT00870467|978783|P4|STARTED|Open-label||127
410354|NCT00870467|978784|P3|STARTED|Open-label||145
410355|NCT00870467|978785|P2|STARTED|Open-label||0
410356|NCT00870467|978786|P1|STARTED|Open-label||0
410357|NCT00870467|978781|P6|NOT COMPLETED|Double-blind||0
410358|NCT00870467|978782|P5|NOT COMPLETED|Double-blind||0
410359|NCT00870467|978783|P4|NOT COMPLETED|Double-blind||0
410360|NCT00870467|978784|P3|NOT COMPLETED|Double-blind||0
410361|NCT00870467|978785|P2|NOT COMPLETED|Double-blind||12
410362|NCT00870467|978786|P1|NOT COMPLETED|Double-blind||16
410363|NCT00870467|978781|P6|COMPLETED|Double-blind||0
410364|NCT00870467|978782|P5|COMPLETED|Double-blind||0
410365|NCT00870467|978783|P4|COMPLETED|Double-blind||0
410366|NCT00870467|978784|P3|COMPLETED|Double-blind||0
410367|NCT00870467|978785|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
410368|NCT00870467|978786|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
410369|NCT00870467|978781|P6|STARTED|Double-blind||0
410370|NCT00870467|978782|P5|STARTED|Double-blind||0
410371|NCT00870467|978783|P4|STARTED|Double-blind||0
410372|NCT00870467|978784|P3|STARTED|Double-blind||0
410373|NCT00870467|978785|P2|STARTED|Double-blind||163
410374|NCT00870467|978786|P1|STARTED|Double-blind||171
410375|NCT00870363|978834|P4|NOT COMPLETED|Overall Study||0
410376|NCT00870363|978835|P3|NOT COMPLETED|Overall Study||3
410377|NCT00870363|978836|P2|NOT COMPLETED|Overall Study||3
410378|NCT00870363|978837|P1|NOT COMPLETED|Overall Study||0
410379|NCT00870363|978834|P4|COMPLETED|Overall Study||12
410380|NCT00870363|978835|P3|COMPLETED|Overall Study||8
410381|NCT00870363|978836|P2|COMPLETED|Overall Study||8
410382|NCT00870363|978837|P1|COMPLETED|Overall Study||10
410383|NCT00870363|978834|P4|STARTED|Overall Study||12
410384|NCT00870363|978835|P3|STARTED|Overall Study||11
410385|NCT00870363|978836|P2|STARTED|Overall Study||11
410386|NCT00870363|978837|P1|STARTED|Overall Study||10
410387|NCT00870194|978873|P2|NOT COMPLETED|Overall Study||14
410388|NCT00870194|978874|P1|NOT COMPLETED|Overall Study||26
410389|NCT00870194|978873|P2|COMPLETED|Overall Study||114
410390|NCT00870194|978874|P1|COMPLETED|Overall Study||101
410391|NCT00870194|978873|P2|Per Protocol Set|Overall Study||111
410392|NCT00870194|978874|P1|Per Protocol Set|Overall Study||97
410393|NCT00870194|978873|P2|STARTED|Overall Study||128
410394|NCT00870194|978874|P1|STARTED|Overall Study||127
410395|NCT00870103|978912|P1|NOT COMPLETED|Overall Study||4
410396|NCT00870103|978912|P1|COMPLETED|Overall Study||60
410397|NCT00870103|978912|P1|STARTED|Overall Study||64
410398|NCT00869999|978917|P1|NOT COMPLETED|Overall Study||2
410399|NCT00869999|978917|P1|COMPLETED|Overall Study||24
410400|NCT00869999|978917|P1|STARTED|Overall Study||26
410401|NCT00869960|978923|P1|NOT COMPLETED|Overall Study||2
410402|NCT00869960|978923|P1|COMPLETED|Overall Study||22
410403|NCT00869960|978923|P1|STARTED|Overall Study||24
410404|NCT00869947|978936|P2|NOT COMPLETED|Overall Study||0
410405|NCT00869947|978937|P1|NOT COMPLETED|Overall Study||0
410406|NCT00869947|978936|P2|COMPLETED|Overall Study||8
410407|NCT00869947|978937|P1|COMPLETED|Overall Study||8
410408|NCT00869947|978936|P2|STARTED|Overall Study||8
410409|NCT00869947|978937|P1|STARTED|Overall Study||8
410410|NCT00869791|978950|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
410411|NCT00869791|978951|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
410412|NCT00869791|978950|P2|COMPLETED|Period 2 Treatment for 7 Days||13
410413|NCT00869791|978951|P1|COMPLETED|Period 2 Treatment for 7 Days||14
410414|NCT00869791|978950|P2|STARTED|Period 2 Treatment for 7 Days||13
410415|NCT00869791|978951|P1|STARTED|Period 2 Treatment for 7 Days||14
410416|NCT00869791|978950|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
410417|NCT00869791|978951|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
410418|NCT00869791|978950|P2|COMPLETED|Period 1 Treatment for 7 Days||13
410419|NCT00869791|978951|P1|COMPLETED|Period 1 Treatment for 7 Days||14
410420|NCT00869791|978950|P2|STARTED|Period 1 Treatment for 7 Days||13
410421|NCT00869791|978951|P1|STARTED|Period 1 Treatment for 7 Days||14
410422|NCT00869778|978972|P3|NOT COMPLETED|Overall Study||10
410423|NCT00869778|978973|P2|NOT COMPLETED|Overall Study||7
410424|NCT00869778|978974|P1|NOT COMPLETED|Overall Study||12
410425|NCT00869778|978972|P3|COMPLETED|Overall Study||110
410426|NCT00869778|978973|P2|COMPLETED|Overall Study||113
410427|NCT00869778|978974|P1|COMPLETED|Overall Study||108
410428|NCT00869778|978972|P3|STARTED|Overall Study||120
410429|NCT00869778|978973|P2|STARTED|Overall Study||120
410430|NCT00869778|978974|P1|STARTED|Overall Study||120
410431|NCT00869622|979011|P2|NOT COMPLETED|Overall Study||14
410432|NCT00869622|979012|P1|NOT COMPLETED|Overall Study||13
410433|NCT00869622|979011|P2|COMPLETED|Overall Study||26
410434|NCT00869622|979012|P1|COMPLETED|Overall Study||27
410435|NCT00869622|979011|P2|STARTED|Overall Study||40
410436|NCT00869622|979012|P1|STARTED|Overall Study||40
410437|NCT00869609|979022|P2|NOT COMPLETED|Overall Study||3
410438|NCT00869609|979023|P1|NOT COMPLETED|Overall Study||6
410439|NCT00869609|979022|P2|COMPLETED|Overall Study||26
410440|NCT00869609|979023|P1|COMPLETED|Overall Study||25
410441|NCT00869609|979022|P2|STARTED|Overall Study||29
410442|NCT00869609|979023|P1|STARTED|Overall Study||31
410443|NCT00869557|979049|P2|NOT COMPLETED|Extension Phase||3
410444|NCT00869557|979050|P1|NOT COMPLETED|Extension Phase||10
410445|NCT00869557|979049|P2|COMPLETED|Extension Phase||11
410446|NCT00869557|979050|P1|COMPLETED|Extension Phase||35
410447|NCT00869557|979049|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
410448|NCT00869557|979050|P1|STARTED|Extension Phase||45
410449|NCT00869557|979049|P2|NOT COMPLETED|Randomized Phase||2
410450|NCT00869557|979050|P1|NOT COMPLETED|Randomized Phase||3
410451|NCT00869557|979049|P2|COMPLETED|Randomized Phase||21
410452|NCT00869557|979050|P1|COMPLETED|Randomized Phase||45
410453|NCT00869557|979049|P2|STARTED|Randomized Phase||23
410454|NCT00869557|979050|P1|STARTED|Randomized Phase||48
410455|NCT00869518|979069|P2|NOT COMPLETED|Overall Study||1
410456|NCT00869518|979070|P1|NOT COMPLETED|Overall Study||1
410457|NCT00869518|979069|P2|COMPLETED|Overall Study||5
410458|NCT00869518|979070|P1|COMPLETED|Overall Study||5
410459|NCT00869518|979069|P2|STARTED|Overall Study||6
410460|NCT00869518|979070|P1|STARTED|Overall Study||6
410461|NCT00869401|979085|P5|NOT COMPLETED|Overall Study||3
410462|NCT00869401|979086|P4|NOT COMPLETED|Overall Study||5
410463|NCT00869401|979087|P3|NOT COMPLETED|Overall Study||0
410464|NCT00869401|979088|P2|NOT COMPLETED|Overall Study||0
410465|NCT00869401|979089|P1|NOT COMPLETED|Overall Study||0
410466|NCT00869401|979085|P5|COMPLETED|Overall Study||63
410467|NCT00869401|979086|P4|COMPLETED|Overall Study||133
410468|NCT00869401|979087|P3|COMPLETED|Overall Study||7
410469|NCT00869401|979088|P2|COMPLETED|Overall Study||3
410470|NCT00869401|979089|P1|COMPLETED|Overall Study||3
410471|NCT00869401|979085|P5|STARTED|Overall Study||66
410472|NCT00869401|979086|P4|STARTED|Overall Study||138
410473|NCT00869401|979087|P3|STARTED|Overall Study||7
410474|NCT00869401|979088|P2|STARTED|Overall Study||3
410475|NCT00869401|979089|P1|STARTED|Overall Study||3
410476|NCT00869375|979107|P2|NOT COMPLETED|Overall Study||0
410477|NCT00869375|979108|P1|NOT COMPLETED|Overall Study||0
410478|NCT00869375|979107|P2|COMPLETED|Overall Study||3
410479|NCT00869375|979108|P1|COMPLETED|Overall Study||3
410480|NCT00869375|979107|P2|STARTED|Overall Study||3
410481|NCT00869375|979108|P1|STARTED|Overall Study||3
410482|NCT00869362|979118|P2|NOT COMPLETED|Overall Study||5
410483|NCT00869362|979119|P1|NOT COMPLETED|Overall Study||1
410484|NCT00869362|979118|P2|COMPLETED|Overall Study||11
410485|NCT00869362|979119|P1|COMPLETED|Overall Study||14
410486|NCT00869362|979118|P2|STARTED|Overall Study||16
410487|NCT00869362|979119|P1|STARTED|Overall Study||15
410488|NCT00869349|979129|P2|NOT COMPLETED|Overall Study||4
410489|NCT00869349|979130|P1|NOT COMPLETED|Overall Study||7
410490|NCT00869349|979129|P2|COMPLETED|Overall Study||36
410491|NCT00869349|979130|P1|COMPLETED|Overall Study||32
410492|NCT00869349|979129|P2|STARTED|Overall Study||40
410493|NCT00869349|979130|P1|STARTED|Overall Study||39
410494|NCT00869323|979140|P1|NOT COMPLETED|Maintenance Therapy||1
410495|NCT00869323|979140|P1|COMPLETED|Maintenance Therapy||1
410496|NCT00869323|979140|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
410497|NCT00869323|979140|P1|NOT COMPLETED|Induction Therapy||0
410498|NCT00869323|979140|P1|COMPLETED|Induction Therapy||3
410499|NCT00869323|979140|P1|STARTED|Induction Therapy||3
410500|NCT00869258|979148|P1|NOT COMPLETED|Overall Study||1
410501|NCT00869258|979148|P1|COMPLETED|Overall Study||31
410502|NCT00869258|979148|P1|STARTED|Overall Study||32
410503|NCT00869167|979154|P2|NOT COMPLETED|Overall Study||1
410504|NCT00869167|979155|P1|NOT COMPLETED|Overall Study||0
410505|NCT00869167|979154|P2|COMPLETED|Overall Study||0
410506|NCT00869167|979155|P1|COMPLETED|Overall Study||2
410507|NCT00869167|979154|P2|STARTED|Overall Study||1
410508|NCT00869167|979155|P1|STARTED|Overall Study||2
410509|NCT00869141|979171|P2|NOT COMPLETED|Overall Study||0
410510|NCT00869141|979172|P1|NOT COMPLETED|Overall Study||0
410511|NCT00869141|979171|P2|COMPLETED|Overall Study||26
410512|NCT00869141|979172|P1|COMPLETED|Overall Study||26
410513|NCT00869141|979171|P2|STARTED|Overall Study||26
410514|NCT00869141|979172|P1|STARTED|Overall Study||26
410515|NCT00869128|979182|P2|NOT COMPLETED|Overall Study||6
410516|NCT00869128|979183|P1|NOT COMPLETED|Overall Study||6
410517|NCT00869128|979182|P2|COMPLETED|Overall Study||12
410518|NCT00869128|979183|P1|COMPLETED|Overall Study||12
410519|NCT00869128|979182|P2|STARTED|Overall Study||18
410520|NCT00869128|979183|P1|STARTED|Overall Study||18
410521|NCT00869089|979187|P1|NOT COMPLETED|Overall Study||3
410522|NCT00869089|979187|P1|COMPLETED|Overall Study||2
410523|NCT00869089|979187|P1|STARTED|Overall Study||5
410524|NCT00869050|979191|P1|NOT COMPLETED|Overall Study||3
410525|NCT00869050|979191|P1|COMPLETED|Overall Study||38
410526|NCT00869050|979191|P1|STARTED|Overall Study||41
410527|NCT00868998|979196|P1|NOT COMPLETED|Overall Study||5
410528|NCT00868998|979196|P1|COMPLETED|Overall Study||0
410529|NCT00868998|979196|P1|STARTED|Overall Study||5
410530|NCT00868959|979201|P1|NOT COMPLETED|Overall Study||258
410531|NCT00868959|979201|P1|COMPLETED|Overall Study||559
410532|NCT00868959|979201|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
410533|NCT00868790|979207|P14|NOT COMPLETED|Post-study||0
410534|NCT00868790|979208|P13|NOT COMPLETED|Post-study||0
410535|NCT00868790|979209|P12|NOT COMPLETED|Post-study||0
410536|NCT00868790|979210|P11|NOT COMPLETED|Post-study||0
410537|NCT00868790|979211|P10|NOT COMPLETED|Post-study||1
410538|NCT00868790|979212|P9|NOT COMPLETED|Post-study||0
410539|NCT00868790|979213|P8|NOT COMPLETED|Post-study||2
410540|NCT00868790|979214|P7|NOT COMPLETED|Post-study||0
410541|NCT00868790|979215|P6|NOT COMPLETED|Post-study||0
410542|NCT00868790|979216|P5|NOT COMPLETED|Post-study||1
410543|NCT00868790|979217|P4|NOT COMPLETED|Post-study||0
410544|NCT00868790|979218|P3|NOT COMPLETED|Post-study||0
410545|NCT00868790|979219|P2|NOT COMPLETED|Post-study||0
410546|NCT00868790|979220|P1|NOT COMPLETED|Post-study||0
410547|NCT00868790|979207|P14|COMPLETED|Post-study||7
410548|NCT00868790|979208|P13|COMPLETED|Post-study||6
410549|NCT00868790|979209|P12|COMPLETED|Post-study||3
410550|NCT00868790|979210|P11|COMPLETED|Post-study||5
410551|NCT00868790|979211|P10|COMPLETED|Post-study||1
410552|NCT00868790|979212|P9|COMPLETED|Post-study||6
410553|NCT00868790|979213|P8|COMPLETED|Post-study||12
410554|NCT00868790|979214|P7|COMPLETED|Post-study||4
410555|NCT00868790|979215|P6|COMPLETED|Post-study||1
410556|NCT00868790|979216|P5|COMPLETED|Post-study||17
410557|NCT00868790|979217|P4|COMPLETED|Post-study||3
410558|NCT00868790|979218|P3|COMPLETED|Post-study||3
410559|NCT00868790|979219|P2|COMPLETED|Post-study||6
410560|NCT00868790|979220|P1|COMPLETED|Post-study||7
410561|NCT00868790|979207|P14|STARTED|Post-study||7
410562|NCT00868790|979208|P13|STARTED|Post-study||6
410563|NCT00868790|979209|P12|STARTED|Post-study||3
410564|NCT00868790|979210|P11|STARTED|Post-study||5
410565|NCT00868790|979211|P10|STARTED|Post-study||2
410566|NCT00868790|979212|P9|STARTED|Post-study||6
410567|NCT00868790|979213|P8|STARTED|Post-study||14
410568|NCT00868790|979214|P7|STARTED|Post-study||4
410569|NCT00868790|979215|P6|STARTED|Post-study||1
410570|NCT00868790|979216|P5|STARTED|Post-study||18
410571|NCT00868790|979217|P4|STARTED|Post-study||3
410572|NCT00868790|979218|P3|STARTED|Post-study||3
410573|NCT00868790|979219|P2|STARTED|Post-study||6
410574|NCT00868790|979220|P1|STARTED|Post-study||7
410575|NCT00868790|979207|P14|NOT COMPLETED|Period 4||1
410576|NCT00868790|979208|P13|NOT COMPLETED|Period 4||1
410577|NCT00868790|979209|P12|NOT COMPLETED|Period 4||1
410578|NCT00868790|979210|P11|NOT COMPLETED|Period 4||3
410579|NCT00868790|979211|P10|NOT COMPLETED|Period 4||0
410580|NCT00868790|979212|P9|NOT COMPLETED|Period 4||2
410581|NCT00868790|979213|P8|NOT COMPLETED|Period 4||3
410582|NCT00868790|979214|P7|NOT COMPLETED|Period 4||0
410583|NCT00868790|979215|P6|NOT COMPLETED|Period 4||0
410584|NCT00868790|979216|P5|NOT COMPLETED|Period 4||0
410585|NCT00868790|979217|P4|NOT COMPLETED|Period 4||0
410586|NCT00868790|979218|P3|NOT COMPLETED|Period 4||1
410587|NCT00868790|979219|P2|NOT COMPLETED|Period 4||0
410588|NCT00868790|979220|P1|NOT COMPLETED|Period 4||2
410589|NCT00868790|979207|P14|COMPLETED|Period 4||7
410590|NCT00868790|979208|P13|COMPLETED|Period 4||6
410591|NCT00868790|979209|P12|COMPLETED|Period 4||3
410592|NCT00868790|979210|P11|COMPLETED|Period 4||5
410593|NCT00868790|979211|P10|COMPLETED|Period 4||2
410594|NCT00868790|979212|P9|COMPLETED|Period 4||6
410595|NCT00868790|979213|P8|COMPLETED|Period 4||14
410596|NCT00868790|979214|P7|COMPLETED|Period 4||4
410597|NCT00868790|979215|P6|COMPLETED|Period 4||1
410598|NCT00868790|979216|P5|COMPLETED|Period 4||18
410599|NCT00868790|979217|P4|COMPLETED|Period 4||3
410600|NCT00868790|979218|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
410601|NCT00868790|979219|P2|COMPLETED|Period 4||6
410602|NCT00868790|979220|P1|COMPLETED|Period 4||7
410603|NCT00868790|979207|P14|STARTED|Period 4||8
410604|NCT00868790|979208|P13|STARTED|Period 4||7
410605|NCT00868790|979209|P12|STARTED|Period 4||4
410606|NCT00868790|979210|P11|STARTED|Period 4||8
410607|NCT00868790|979211|P10|STARTED|Period 4||2
410608|NCT00868790|979212|P9|STARTED|Period 4||8
410609|NCT00868790|979213|P8|STARTED|Period 4||17
410610|NCT00868790|979214|P7|STARTED|Period 4||4
410611|NCT00868790|979215|P6|STARTED|Period 4||1
410612|NCT00868790|979216|P5|STARTED|Period 4||18
410613|NCT00868790|979217|P4|STARTED|Period 4||3
410614|NCT00868790|979218|P3|STARTED|Period 4||4
410615|NCT00868790|979219|P2|STARTED|Period 4||6
410616|NCT00868790|979220|P1|STARTED|Period 4||9
410617|NCT00868790|979207|P14|NOT COMPLETED|Period 3||0
410618|NCT00868790|979208|P13|NOT COMPLETED|Period 3||0
410619|NCT00868790|979209|P12|NOT COMPLETED|Period 3||0
410620|NCT00868790|979210|P11|NOT COMPLETED|Period 3||1
410621|NCT00868790|979211|P10|NOT COMPLETED|Period 3||1
410622|NCT00868790|979212|P9|NOT COMPLETED|Period 3||0
410623|NCT00868790|979213|P8|NOT COMPLETED|Period 3||0
410624|NCT00868790|979214|P7|NOT COMPLETED|Period 3||0
410625|NCT00868790|979215|P6|NOT COMPLETED|Period 3||0
410626|NCT00868790|979216|P5|NOT COMPLETED|Period 3||0
410627|NCT00868790|979217|P4|NOT COMPLETED|Period 3||1
410628|NCT00868790|979218|P3|NOT COMPLETED|Period 3||0
410629|NCT00868790|979219|P2|NOT COMPLETED|Period 3||0
410630|NCT00868790|979220|P1|NOT COMPLETED|Period 3||0
410631|NCT00868790|979207|P14|COMPLETED|Period 3||8
410632|NCT00868790|979208|P13|COMPLETED|Period 3||7
410633|NCT00868790|979209|P12|COMPLETED|Period 3||4
410634|NCT00868790|979210|P11|COMPLETED|Period 3||8
410635|NCT00868790|979211|P10|COMPLETED|Period 3||2
410636|NCT00868790|979212|P9|COMPLETED|Period 3||8
410637|NCT00868790|979213|P8|COMPLETED|Period 3||17
410638|NCT00868790|979214|P7|COMPLETED|Period 3||4
410639|NCT00868790|979215|P6|COMPLETED|Period 3||1
410640|NCT00868790|979216|P5|COMPLETED|Period 3||18
410641|NCT00868790|979217|P4|COMPLETED|Period 3||3
410642|NCT00868790|979218|P3|COMPLETED|Period 3||4
410643|NCT00868790|979219|P2|COMPLETED|Period 3||6
410644|NCT00868790|979220|P1|COMPLETED|Period 3||9
410645|NCT00868790|979207|P14|STARTED|Period 3||8
410646|NCT00868790|979208|P13|STARTED|Period 3||7
410647|NCT00868790|979209|P12|STARTED|Period 3||4
410648|NCT00868790|979210|P11|STARTED|Period 3||9
410649|NCT00868790|979211|P10|STARTED|Period 3||3
410650|NCT00868790|979212|P9|STARTED|Period 3||8
410651|NCT00868790|979213|P8|STARTED|Period 3||17
410652|NCT00868790|979214|P7|STARTED|Period 3||4
410653|NCT00868790|979215|P6|STARTED|Period 3||1
410654|NCT00868790|979216|P5|STARTED|Period 3||18
410655|NCT00868790|979217|P4|STARTED|Period 3||4
410656|NCT00868790|979218|P3|STARTED|Period 3||4
410657|NCT00868790|979219|P2|STARTED|Period 3||6
410658|NCT00868790|979220|P1|STARTED|Period 3||9
410659|NCT00868790|979207|P14|NOT COMPLETED|Period 2||1
410660|NCT00868790|979208|P13|NOT COMPLETED|Period 2||0
410661|NCT00868790|979209|P12|NOT COMPLETED|Period 2||0
410662|NCT00868790|979210|P11|NOT COMPLETED|Period 2||0
410663|NCT00868790|979211|P10|NOT COMPLETED|Period 2||0
410664|NCT00868790|979212|P9|NOT COMPLETED|Period 2||2
410665|NCT00868790|979213|P8|NOT COMPLETED|Period 2||0
410666|NCT00868790|979214|P7|NOT COMPLETED|Period 2||0
410667|NCT00868790|979215|P6|NOT COMPLETED|Period 2||1
410668|NCT00868790|979216|P5|NOT COMPLETED|Period 2||0
410669|NCT00868790|979217|P4|NOT COMPLETED|Period 2||0
410670|NCT00868790|979218|P3|NOT COMPLETED|Period 2||0
410671|NCT00868790|979219|P2|NOT COMPLETED|Period 2||1
410672|NCT00868790|979220|P1|NOT COMPLETED|Period 2||0
410673|NCT00868790|979207|P14|COMPLETED|Period 2||8
410674|NCT00868790|979208|P13|COMPLETED|Period 2||7
410675|NCT00868790|979209|P12|COMPLETED|Period 2||4
410676|NCT00868790|979210|P11|COMPLETED|Period 2||9
410677|NCT00868790|979211|P10|COMPLETED|Period 2||3
410678|NCT00868790|979212|P9|COMPLETED|Period 2||8
410679|NCT00868790|979213|P8|COMPLETED|Period 2||17
410680|NCT00868790|979214|P7|COMPLETED|Period 2||4
410681|NCT00868790|979215|P6|COMPLETED|Period 2||1
410682|NCT00868790|979216|P5|COMPLETED|Period 2||18
410683|NCT00868790|979217|P4|COMPLETED|Period 2||4
410684|NCT00868790|979218|P3|COMPLETED|Period 2||4
410685|NCT00868790|979219|P2|COMPLETED|Period 2||6
410686|NCT00868790|979220|P1|COMPLETED|Period 2||9
410687|NCT00868790|979207|P14|STARTED|Period 2||9
410688|NCT00868790|979208|P13|STARTED|Period 2||7
410689|NCT00868790|979209|P12|STARTED|Period 2||4
410690|NCT00868790|979210|P11|STARTED|Period 2||9
410691|NCT00868790|979211|P10|STARTED|Period 2||3
410692|NCT00868790|979212|P9|STARTED|Period 2||10
410693|NCT00868790|979213|P8|STARTED|Period 2||17
410694|NCT00868790|979214|P7|STARTED|Period 2||4
410695|NCT00868790|979215|P6|STARTED|Period 2||2
410696|NCT00868790|979216|P5|STARTED|Period 2||18
410697|NCT00868790|979217|P4|STARTED|Period 2||4
410698|NCT00868790|979218|P3|STARTED|Period 2||4
410699|NCT00868790|979219|P2|STARTED|Period 2||7
410700|NCT00868790|979220|P1|STARTED|Period 2||9
410701|NCT00868790|979207|P14|NOT COMPLETED|Period 1||2
410702|NCT00868790|979208|P13|NOT COMPLETED|Period 1||0
410703|NCT00868790|979209|P12|NOT COMPLETED|Period 1||0
410704|NCT00868790|979210|P11|NOT COMPLETED|Period 1||0
410705|NCT00868790|979211|P10|NOT COMPLETED|Period 1||0
410706|NCT00868790|979212|P9|NOT COMPLETED|Period 1||1
410707|NCT00868790|979213|P8|NOT COMPLETED|Period 1||3
410708|NCT00868790|979214|P7|NOT COMPLETED|Period 1||0
410709|NCT00868790|979215|P6|NOT COMPLETED|Period 1||1
410710|NCT00868790|979216|P5|NOT COMPLETED|Period 1||1
410711|NCT00868790|979217|P4|NOT COMPLETED|Period 1||0
410712|NCT00868790|979218|P3|NOT COMPLETED|Period 1||0
410713|NCT00868790|979219|P2|NOT COMPLETED|Period 1||1
410714|NCT00868790|979220|P1|NOT COMPLETED|Period 1||2
410715|NCT00868790|979207|P14|COMPLETED|Period 1||9
410716|NCT00868790|979208|P13|COMPLETED|Period 1||7
410717|NCT00868790|979209|P12|COMPLETED|Period 1||4
410718|NCT00868790|979210|P11|COMPLETED|Period 1||9
410719|NCT00868790|979211|P10|COMPLETED|Period 1||3
410720|NCT00868790|979212|P9|COMPLETED|Period 1||10
410721|NCT00868790|979213|P8|COMPLETED|Period 1||17
410722|NCT00868790|979214|P7|COMPLETED|Period 1||4
410723|NCT00868790|979215|P6|COMPLETED|Period 1||2
410724|NCT00868790|979216|P5|COMPLETED|Period 1||18
410725|NCT00868790|979217|P4|COMPLETED|Period 1||4
410726|NCT00868790|979218|P3|COMPLETED|Period 1||4
410727|NCT00868790|979219|P2|COMPLETED|Period 1||7
410728|NCT00868790|979220|P1|COMPLETED|Period 1||9
410729|NCT00868790|979207|P14|STARTED|Period 1||11
410730|NCT00868790|979208|P13|STARTED|Period 1||7
410731|NCT00868790|979209|P12|STARTED|Period 1||4
410732|NCT00868790|979210|P11|STARTED|Period 1||9
410733|NCT00868790|979211|P10|STARTED|Period 1||3
410734|NCT00868790|979212|P9|STARTED|Period 1||11
410735|NCT00868790|979213|P8|STARTED|Period 1||20
410736|NCT00868790|979214|P7|STARTED|Period 1||4
410737|NCT00868790|979215|P6|STARTED|Period 1||3
410738|NCT00868790|979216|P5|STARTED|Period 1||19
410739|NCT00868790|979217|P4|STARTED|Period 1||4
410740|NCT00868790|979218|P3|STARTED|Period 1||4
410741|NCT00868790|979219|P2|STARTED|Period 1||8
410742|NCT00868790|979220|P1|STARTED|Period 1||11
410743|NCT00868751|979257|P1|NOT COMPLETED|Overall Study||1
410744|NCT00868751|979257|P1|COMPLETED|Overall Study||0
410745|NCT00868751|979257|P1|STARTED|Overall Study||1
410746|NCT00868712|979268|P3|NOT COMPLETED|Overall Study||0
410747|NCT00868712|979269|P2|NOT COMPLETED|Overall Study||0
410748|NCT00868712|979270|P1|NOT COMPLETED|Overall Study||0
410749|NCT00868712|979268|P3|COMPLETED|Overall Study||28
410750|NCT00868712|979269|P2|COMPLETED|Overall Study||11
410751|NCT00868712|979270|P1|COMPLETED|Overall Study||31
410752|NCT00868712|979268|P3|STARTED|Overall Study||28
410753|NCT00868712|979269|P2|STARTED|Overall Study||11
410754|NCT00868712|979270|P1|STARTED|Overall Study||31
410755|NCT00868699|979284|P3|NOT COMPLETED|Overall Study||43
410756|NCT00868699|979285|P2|NOT COMPLETED|Overall Study||45
410757|NCT00868699|979286|P1|NOT COMPLETED|Overall Study||43
410758|NCT00868699|979284|P3|COMPLETED|Overall Study||123
410759|NCT00868699|979285|P2|COMPLETED|Overall Study||124
410760|NCT00868699|979286|P1|COMPLETED|Overall Study||127
410761|NCT00868699|979284|P3|Safety Population|Overall Study||164
410762|NCT00868699|979285|P2|Safety Population|Overall Study||167
410763|NCT00868699|979286|P1|Safety Population|Overall Study||168
410764|NCT00868699|979284|P3|Intent-to-Treat Population|Overall Study||161
410765|NCT00868699|979285|P2|Intent-to-Treat Population|Overall Study||162
410766|NCT00868699|979286|P1|Intent-to-Treat Population|Overall Study||162
410767|NCT00868699|979284|P3|STARTED|Overall Study||166
410768|NCT00868699|979285|P2|STARTED|Overall Study||169
410769|NCT00868699|979286|P1|STARTED|Overall Study||170
410770|NCT00868530|979300|P1|NOT COMPLETED|Overall Study||4
410771|NCT00868530|979300|P1|COMPLETED|Overall Study||49
410772|NCT00868530|979300|P1|STARTED|Overall Study||53
410773|NCT00868517|979315|P3|NOT COMPLETED|Overall Study||2
410774|NCT00868517|979316|P2|NOT COMPLETED|Overall Study||4
410775|NCT00868517|979317|P1|NOT COMPLETED|Overall Study||4
410776|NCT00868517|979315|P3|COMPLETED|Overall Study||9
410777|NCT00868517|979316|P2|COMPLETED|Overall Study||8
410778|NCT00868517|979317|P1|COMPLETED|Overall Study||8
410779|NCT00868517|979315|P3|STARTED|Overall Study||11
410780|NCT00868517|979316|P2|STARTED|Overall Study||12
410781|NCT00868517|979317|P1|STARTED|Overall Study||12
410782|NCT00868452|979342|P2|NOT COMPLETED|Overall Study||29
410783|NCT00868452|979343|P1|NOT COMPLETED|Overall Study||40
410784|NCT00868452|979342|P2|COMPLETED|Overall Study||136
410785|NCT00868452|979343|P1|COMPLETED|Overall Study||143
410786|NCT00868452|979342|P2|STARTED|Overall Study||165
410787|NCT00868452|979343|P1|STARTED|Overall Study||183
410788|NCT00868439|979355|P2|NOT COMPLETED|Overall Study||9
410789|NCT00868439|979356|P1|NOT COMPLETED|Overall Study||8
410790|NCT00868439|979355|P2|COMPLETED|Overall Study||40
410791|NCT00868439|979356|P1|COMPLETED|Overall Study||48
410792|NCT00868439|979355|P2|STARTED|Overall Study||49
410793|NCT00868439|979356|P1|STARTED|Overall Study||56
410794|NCT00868374|979374|P2|NOT COMPLETED|Overall Study||7
410795|NCT00868374|979375|P1|NOT COMPLETED|Overall Study||7
410796|NCT00868374|979374|P2|COMPLETED|Overall Study||4
410797|NCT00868374|979375|P1|COMPLETED|Overall Study||5
410798|NCT00868374|979374|P2|STARTED|Overall Study||11
410799|NCT00868374|979375|P1|STARTED|Overall Study||12
410800|NCT00868348|979383|P2|NOT COMPLETED|Overall Study||0
410801|NCT00868348|979384|P1|NOT COMPLETED|Overall Study||0
410802|NCT00868348|979383|P2|COMPLETED|Overall Study||30
410803|NCT00868348|979384|P1|COMPLETED|Overall Study||30
410804|NCT00868348|979383|P2|STARTED|Overall Study||30
410805|NCT00868348|979384|P1|STARTED|Overall Study||30
410806|NCT00868309|979402|P2|NOT COMPLETED|Overall Study||0
410807|NCT00868309|979403|P1|NOT COMPLETED|Overall Study||0
410808|NCT00868309|979402|P2|COMPLETED|Overall Study||6
410809|NCT00868309|979403|P1|COMPLETED|Overall Study||6
410810|NCT00868309|979402|P2|STARTED|Overall Study||6
410811|NCT00868309|979403|P1|STARTED|Overall Study||6
410812|NCT00868296|979413|P2|NOT COMPLETED|Overall Study||3
410813|NCT00868296|979414|P1|NOT COMPLETED|Overall Study||0
410814|NCT00868296|979413|P2|COMPLETED|Overall Study||43
410815|NCT00868296|979414|P1|COMPLETED|Overall Study||12
410816|NCT00868296|979413|P2|STARTED|Overall Study||46
410817|NCT00868296|979414|P1|STARTED|Overall Study||12
410818|NCT00868231|979422|P6|NOT COMPLETED|Treatment Period 3||0
410819|NCT00868231|979423|P5|NOT COMPLETED|Treatment Period 3||0
410820|NCT00868231|979424|P4|NOT COMPLETED|Treatment Period 3||0
410821|NCT00868231|979425|P3|NOT COMPLETED|Treatment Period 3||1
410822|NCT00868231|979426|P2|NOT COMPLETED|Treatment Period 3||0
410823|NCT00868231|979427|P1|NOT COMPLETED|Treatment Period 3||0
410824|NCT00868231|979422|P6|COMPLETED|Treatment Period 3||5
410825|NCT00868231|979423|P5|COMPLETED|Treatment Period 3||4
410826|NCT00868231|979424|P4|COMPLETED|Treatment Period 3||5
410827|NCT00868231|979425|P3|COMPLETED|Treatment Period 3||4
410828|NCT00868231|979426|P2|COMPLETED|Treatment Period 3||5
410829|NCT00868231|979427|P1|COMPLETED|Treatment Period 3||4
410830|NCT00868231|979422|P6|STARTED|Treatment Period 3||5
410831|NCT00868231|979423|P5|STARTED|Treatment Period 3||4
410832|NCT00868231|979424|P4|STARTED|Treatment Period 3||5
410833|NCT00868231|979425|P3|STARTED|Treatment Period 3||5
410834|NCT00868231|979426|P2|STARTED|Treatment Period 3||5
410835|NCT00868231|979427|P1|STARTED|Treatment Period 3||4
410836|NCT00868231|979422|P6|NOT COMPLETED|Treatment Period 2||0
410837|NCT00868231|979423|P5|NOT COMPLETED|Treatment Period 2||0
410838|NCT00868231|979424|P4|NOT COMPLETED|Treatment Period 2||0
410839|NCT00868231|979425|P3|NOT COMPLETED|Treatment Period 2||0
410840|NCT00868231|979426|P2|NOT COMPLETED|Treatment Period 2||0
410841|NCT00868231|979427|P1|NOT COMPLETED|Treatment Period 2||1
410842|NCT00868231|979422|P6|COMPLETED|Treatment Period 2||5
410843|NCT00868231|979423|P5|COMPLETED|Treatment Period 2||4
410844|NCT00868231|979424|P4|COMPLETED|Treatment Period 2||5
410845|NCT00868231|979425|P3|COMPLETED|Treatment Period 2||5
410846|NCT00868231|979426|P2|COMPLETED|Treatment Period 2||5
410847|NCT00868231|979427|P1|COMPLETED|Treatment Period 2||4
410848|NCT00868231|979422|P6|STARTED|Treatment Period 2||5
410849|NCT00868231|979423|P5|STARTED|Treatment Period 2||4
410850|NCT00868231|979424|P4|STARTED|Treatment Period 2||5
410851|NCT00868231|979425|P3|STARTED|Treatment Period 2||5
410852|NCT00868231|979426|P2|STARTED|Treatment Period 2||5
410853|NCT00868231|979427|P1|STARTED|Treatment Period 2||5
410854|NCT00868231|979422|P6|NOT COMPLETED|Treatment Period 1||0
410855|NCT00868231|979423|P5|NOT COMPLETED|Treatment Period 1||1
410856|NCT00868231|979424|P4|NOT COMPLETED|Treatment Period 1||0
410857|NCT00868231|979425|P3|NOT COMPLETED|Treatment Period 1||0
410858|NCT00868231|979426|P2|NOT COMPLETED|Treatment Period 1||0
410859|NCT00868231|979427|P1|NOT COMPLETED|Treatment Period 1||0
410860|NCT00868231|979422|P6|COMPLETED|Treatment Period 1||5
410861|NCT00868231|979423|P5|COMPLETED|Treatment Period 1||4
410862|NCT00868231|979424|P4|COMPLETED|Treatment Period 1||5
410863|NCT00868231|979425|P3|COMPLETED|Treatment Period 1||5
410864|NCT00868231|979426|P2|COMPLETED|Treatment Period 1||5
410865|NCT00868231|979427|P1|COMPLETED|Treatment Period 1||5
410866|NCT00868231|979422|P6|STARTED|Treatment Period 1||5
410867|NCT00868231|979423|P5|STARTED|Treatment Period 1||5
410868|NCT00868231|979424|P4|STARTED|Treatment Period 1||5
410869|NCT00868231|979425|P3|STARTED|Treatment Period 1||5
410870|NCT00868231|979426|P2|STARTED|Treatment Period 1||5
410871|NCT00868231|979427|P1|STARTED|Treatment Period 1||5
410872|NCT00868218|979472|P4|NOT COMPLETED|Overall Study||0
410873|NCT00868218|979473|P3|NOT COMPLETED|Overall Study||0
410874|NCT00868218|979474|P2|NOT COMPLETED|Overall Study||0
410875|NCT00868218|979475|P1|NOT COMPLETED|Overall Study||0
410876|NCT00868218|979472|P4|COMPLETED|Overall Study||15
410877|NCT00868218|979473|P3|COMPLETED|Overall Study||15
410878|NCT00868218|979474|P2|COMPLETED|Overall Study||15
410879|NCT00868218|979475|P1|COMPLETED|Overall Study||15
410880|NCT00868218|979472|P4|STARTED|Overall Study||15
410881|NCT00868218|979473|P3|STARTED|Overall Study||15
410882|NCT00868218|979474|P2|STARTED|Overall Study||15
410883|NCT00868218|979475|P1|STARTED|Overall Study||15
410884|NCT00868192|979493|P1|NOT COMPLETED|Overall Study||4
410885|NCT00868192|979493|P1|COMPLETED|Overall Study||34
410886|NCT00868192|979493|P1|STARTED|Overall Study||38
410887|NCT00868140|979510|P2|NOT COMPLETED|Overall Study||0
410888|NCT00868140|979511|P1|NOT COMPLETED|Overall Study||0
410889|NCT00868140|979510|P2|COMPLETED|Overall Study||25
410890|NCT00868140|979511|P1|COMPLETED|Overall Study||26
410891|NCT00868140|979510|P2|STARTED|Overall Study||25
410892|NCT00868140|979511|P1|STARTED|Overall Study||26
410893|NCT00868101|979529|P2|NOT COMPLETED|Overall Study||0
410894|NCT00868101|979530|P1|NOT COMPLETED|Overall Study||0
410895|NCT00868101|979529|P2|COMPLETED|Overall Study||10
410896|NCT00868101|979530|P1|COMPLETED|Overall Study||12
410897|NCT00868101|979529|P2|STARTED|Overall Study||10
410898|NCT00868101|979530|P1|STARTED|Overall Study||12
410899|NCT00867659|979542|P1|NOT COMPLETED|Overall Study||0
410900|NCT00867659|979542|P1|COMPLETED|Overall Study|January 2010|20
410901|NCT00867659|979542|P1|STARTED|Overall Study|October 2009|20
410902|NCT00867568|979547|P1|NOT COMPLETED|Overall Study||15
410903|NCT00867568|979547|P1|COMPLETED|Overall Study||3
410904|NCT00867568|979547|P1|STARTED|Overall Study||18
410905|NCT00867529|979556|P1|NOT COMPLETED|Overall Study||0
410906|NCT00867529|979556|P1|COMPLETED|Overall Study||63
410907|NCT00867529|979556|P1|STARTED|Overall Study||63
410908|NCT00867503|979561|P1|NOT COMPLETED|Overall Study||1
410909|NCT00867503|979561|P1|COMPLETED|Overall Study||9
410910|NCT00867503|979561|P1|STARTED|Overall Study||10
410911|NCT00867490|979567|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
410912|NCT00867490|979567|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
410913|NCT00867490|979567|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
410914|NCT00867490|979567|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
410915|NCT00867490|979567|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
410916|NCT00867490|979567|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
410917|NCT00867490|979567|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
410918|NCT00867490|979567|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
410919|NCT00867490|979567|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
410920|NCT00867451|979586|P2|NOT COMPLETED|Overall Study||0
410921|NCT00867451|979587|P1|NOT COMPLETED|Overall Study||0
410922|NCT00867451|979586|P2|COMPLETED|Overall Study||4
410923|NCT00867451|979587|P1|COMPLETED|Overall Study||4
410924|NCT00867451|979586|P2|STARTED|Overall Study||4
410925|NCT00867451|979587|P1|STARTED|Overall Study||4
410926|NCT00867360|979609|P2|NOT COMPLETED|Overall Study||1
410927|NCT00867360|979610|P1|NOT COMPLETED|Overall Study||1
410928|NCT00867360|979609|P2|COMPLETED|Overall Study||5
410929|NCT00867360|979610|P1|COMPLETED|Overall Study||3
410930|NCT00867360|979609|P2|STARTED|Overall Study||6
410931|NCT00867360|979610|P1|STARTED|Overall Study||4
410932|NCT00866177|979620|P1|NOT COMPLETED|Overall Study||152
410933|NCT00866177|979620|P1|COMPLETED|Overall Study||15
410934|NCT00866177|979620|P1|STARTED|Overall Study||167
410935|NCT00867165|979626|P2|NOT COMPLETED|Overall Study||0
410936|NCT00867165|979627|P1|NOT COMPLETED|Overall Study||4
410937|NCT00867165|979626|P2|COMPLETED|Overall Study||45
410938|NCT00867165|979627|P1|COMPLETED|Overall Study||89
410939|NCT00867165|979626|P2|STARTED|Overall Study||45
410940|NCT00867165|979627|P1|STARTED|Overall Study||93
410941|NCT00867139|979732|P3|NOT COMPLETED|Overall Study||1
410942|NCT00867139|979733|P2|NOT COMPLETED|Overall Study||0
410943|NCT00867139|979734|P1|NOT COMPLETED|Overall Study||0
410944|NCT00867139|979732|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
410945|NCT00867139|979733|P2|COMPLETED|Overall Study||1
410946|NCT00867139|979734|P1|COMPLETED|Overall Study||2
410947|NCT00867139|979732|P3|STARTED|Overall Study||4
410948|NCT00867139|979733|P2|STARTED|Overall Study||1
410949|NCT00867139|979734|P1|STARTED|Overall Study||2
410950|NCT00867035|979777|P2|NOT COMPLETED|Baseline to 1 Week||0
410951|NCT00867035|979778|P1|NOT COMPLETED|Baseline to 1 Week||1
410952|NCT00867035|979777|P2|COMPLETED|Baseline to 1 Week||8
410953|NCT00867035|979778|P1|COMPLETED|Baseline to 1 Week||11
410954|NCT00867035|979777|P2|STARTED|Baseline to 1 Week||8
410955|NCT00867035|979778|P1|STARTED|Baseline to 1 Week||12
410956|NCT00867035|979777|P2|NOT COMPLETED|Baseline to 4 Hours||0
410957|NCT00867035|979778|P1|NOT COMPLETED|Baseline to 4 Hours||0
410958|NCT00867035|979777|P2|COMPLETED|Baseline to 4 Hours||8
410959|NCT00867035|979778|P1|COMPLETED|Baseline to 4 Hours||12
410960|NCT00867035|979777|P2|STARTED|Baseline to 4 Hours||8
410961|NCT00867035|979778|P1|STARTED|Baseline to 4 Hours||12
410962|NCT00867035|979777|P2|NOT COMPLETED|Baseline to 2 Hours||0
410963|NCT00867035|979778|P1|NOT COMPLETED|Baseline to 2 Hours||0
410964|NCT00867035|979777|P2|COMPLETED|Baseline to 2 Hours||8
410965|NCT00867035|979778|P1|COMPLETED|Baseline to 2 Hours||12
410966|NCT00867035|979777|P2|STARTED|Baseline to 2 Hours||8
410967|NCT00867035|979778|P1|STARTED|Baseline to 2 Hours||12
410968|NCT00867035|979777|P2|NOT COMPLETED|Baseline to 1 Hour||1
410969|NCT00867035|979778|P1|NOT COMPLETED|Baseline to 1 Hour||1
410970|NCT00867035|979777|P2|COMPLETED|Baseline to 1 Hour||8
410971|NCT00867035|979778|P1|COMPLETED|Baseline to 1 Hour||12
410972|NCT00867035|979777|P2|STARTED|Baseline to 1 Hour||9
410973|NCT00867035|979778|P1|STARTED|Baseline to 1 Hour||13
410974|NCT00867009|979804|P1|NOT COMPLETED|Maintenance Period||4
410975|NCT00867009|979804|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
410976|NCT00867009|979804|P1|STARTED|Maintenance Period||51
410977|NCT00867009|979804|P1|NOT COMPLETED|Induction Period||62
410978|NCT00867009|979804|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
410979|NCT00867009|979804|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
410980|NCT00867009|979804|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
410981|NCT00867009|979804|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
410982|NCT00866918|979813|P2|NOT COMPLETED|Overall Study||12
410983|NCT00866918|979814|P1|NOT COMPLETED|Overall Study||16
410984|NCT00866918|979813|P2|COMPLETED|Overall Study||27
410985|NCT00866918|979814|P1|COMPLETED|Overall Study||53
410986|NCT00866918|979813|P2|STARTED|Overall Study||39
410987|NCT00866918|979814|P1|STARTED|Overall Study||69
410988|NCT00866905|979826|P1|NOT COMPLETED|Overall Study||33
410989|NCT00866905|979826|P1|COMPLETED|Overall Study||135
410990|NCT00866905|979826|P1|STARTED|Overall Study||168
410991|NCT00866814|979831|P1|NOT COMPLETED|Overall Study||20
410992|NCT00866814|979831|P1|COMPLETED|Overall Study||99
410993|NCT00866814|979831|P1|STARTED|Overall Study||119
410994|NCT00866788|979844|P4|NOT COMPLETED|Overall Study||5
410995|NCT00866788|979845|P3|NOT COMPLETED|Overall Study||2
410996|NCT00866788|979846|P2|NOT COMPLETED|Overall Study||6
410997|NCT00866788|979847|P1|NOT COMPLETED|Overall Study||6
410998|NCT00866788|979844|P4|COMPLETED|Overall Study||16
410999|NCT00866788|979845|P3|COMPLETED|Overall Study||23
411000|NCT00866788|979846|P2|COMPLETED|Overall Study||17
411001|NCT00866788|979847|P1|COMPLETED|Overall Study||15
411002|NCT00866788|979844|P4|STARTED|Overall Study||21
411003|NCT00866788|979845|P3|STARTED|Overall Study||25
411004|NCT00866788|979846|P2|STARTED|Overall Study||23
411005|NCT00866788|979847|P1|STARTED|Overall Study||21
411006|NCT00866775|979895|P2|NOT COMPLETED|Overall Study||52
411007|NCT00866775|979896|P1|NOT COMPLETED|Overall Study||36
411008|NCT00866775|979895|P2|COMPLETED|Overall Study||76
411009|NCT00866775|979896|P1|COMPLETED|Overall Study||29
411010|NCT00866775|979895|P2|STARTED|Overall Study||128
411011|NCT00866775|979896|P1|STARTED|Overall Study||65
411012|NCT00866723|979932|P1|NOT COMPLETED|Overall Study||5
411013|NCT00866723|979932|P1|COMPLETED|Overall Study||0
411014|NCT00866723|979932|P1|STARTED|Overall Study||5
411015|NCT00866697|979939|P2|NOT COMPLETED|Overall Study||377
411016|NCT00866697|979940|P1|NOT COMPLETED|Overall Study||373
411017|NCT00866697|979939|P2|COMPLETED|Overall Study||95
411018|NCT00866697|979940|P1|COMPLETED|Overall Study||95
411019|NCT00866697|979939|P2|Ongoing|Overall Study||312
411020|NCT00866697|979940|P1|Ongoing|Overall Study||335
411021|NCT00866697|979939|P2|STARTED|Overall Study||472
411022|NCT00866697|979940|P1|STARTED|Overall Study||468
411023|NCT00866658|979984|P2|NOT COMPLETED|Overall Study||21
411024|NCT00866658|979985|P1|NOT COMPLETED|Overall Study||13
411025|NCT00866658|979984|P2|COMPLETED|Overall Study||133
411026|NCT00866658|979985|P1|COMPLETED|Overall Study||144
411027|NCT00866658|979984|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
411028|NCT00866658|979985|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
411029|NCT00866658|979984|P2|Safety Population|Overall Study||154
411030|NCT00866658|979985|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
411031|NCT00866658|979984|P2|STARTED|Overall Study||154
411032|NCT00866658|979985|P1|STARTED|Overall Study|Randomized.|157
411033|NCT00866606|980013|P1|NOT COMPLETED|Overall Study||4
411034|NCT00866606|980013|P1|COMPLETED|Overall Study||31
411035|NCT00866606|980013|P1|STARTED|Overall Study||35
411036|NCT00866359|980027|P4|NOT COMPLETED|Observational Follow-Up Phase||0
411037|NCT00866359|980028|P3|NOT COMPLETED|Observational Follow-Up Phase||0
411038|NCT00866359|980029|P2|NOT COMPLETED|Observational Follow-Up Phase||0
411039|NCT00866359|980030|P1|NOT COMPLETED|Observational Follow-Up Phase||0
411040|NCT00866359|980027|P4|COMPLETED|Observational Follow-Up Phase||54
411041|NCT00866359|980028|P3|COMPLETED|Observational Follow-Up Phase||54
411042|NCT00866359|980029|P2|COMPLETED|Observational Follow-Up Phase||0
411043|NCT00866359|980030|P1|COMPLETED|Observational Follow-Up Phase||0
411044|NCT00866359|980027|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
411045|NCT00866359|980028|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
411046|NCT00866359|980029|P2|STARTED|Observational Follow-Up Phase||0
411047|NCT00866359|980030|P1|STARTED|Observational Follow-Up Phase||0
411048|NCT00866359|980027|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
411049|NCT00866359|980028|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
411050|NCT00866359|980029|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
411051|NCT00866359|980030|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
411052|NCT00866359|980027|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
411053|NCT00866359|980028|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
411054|NCT00866359|980029|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
411055|NCT00866359|980030|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
411056|NCT00866359|980027|P4|STARTED|Extension Phase (Day 86 to 169)||50
411057|NCT00866359|980028|P3|STARTED|Extension Phase (Day 86 to 169)||45
411058|NCT00866359|980029|P2|STARTED|Extension Phase (Day 86 to 169)||0
411059|NCT00866359|980030|P1|STARTED|Extension Phase (Day 86 to 169)||0
411060|NCT00866359|980027|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
411061|NCT00866359|980028|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
411062|NCT00866359|980029|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
411063|NCT00866359|980030|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
411064|NCT00866359|980027|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
411065|NCT00866359|980028|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
411066|NCT00866359|980029|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
411067|NCT00866359|980030|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
411068|NCT00866359|980027|P4|STARTED|Treatment Phase (Days 1 to 85)||0
411069|NCT00866359|980028|P3|STARTED|Treatment Phase (Days 1 to 85)||0
411070|NCT00866359|980029|P2|STARTED|Treatment Phase (Days 1 to 85)||55
411071|NCT00866359|980030|P1|STARTED|Treatment Phase (Days 1 to 85)||56
411072|NCT00866320|980083|P1|NOT COMPLETED|Overall Study||6
411073|NCT00866320|980083|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
411074|NCT00866320|980083|P1|STARTED|Overall Study||49
411075|NCT00866307|980090|P3|NOT COMPLETED|Consolidation/Maintenance||16
411076|NCT00866307|980091|P2|NOT COMPLETED|Consolidation/Maintenance||9
411077|NCT00866307|980092|P1|NOT COMPLETED|Consolidation/Maintenance||0
411078|NCT00866307|980090|P3|COMPLETED|Consolidation/Maintenance||14
411079|NCT00866307|980091|P2|COMPLETED|Consolidation/Maintenance||45
411080|NCT00866307|980092|P1|COMPLETED|Consolidation/Maintenance||0
411081|NCT00866307|980090|P3|STARTED|Consolidation/Maintenance||30
411082|NCT00866307|980091|P2|STARTED|Consolidation/Maintenance||54
411083|NCT00866307|980092|P1|STARTED|Consolidation/Maintenance||0
411084|NCT00866307|980090|P3|NOT COMPLETED|Induction||0
411085|NCT00866307|980091|P2|NOT COMPLETED|Induction||0
411086|NCT00866307|980092|P1|NOT COMPLETED|Induction||20
411087|NCT00866307|980090|P3|COMPLETED|Induction||0
411088|NCT00866307|980091|P2|COMPLETED|Induction||0
411089|NCT00866307|980092|P1|COMPLETED|Induction||84
411090|NCT00866307|980090|P3|STARTED|Induction||0
411091|NCT00866307|980091|P2|STARTED|Induction||0
411092|NCT00866307|980092|P1|STARTED|Induction||104
411093|NCT00866294|980102|P3|NOT COMPLETED|Overall Study||11
411094|NCT00866294|980103|P2|NOT COMPLETED|Overall Study||20
411095|NCT00866294|980104|P1|NOT COMPLETED|Overall Study||33
411096|NCT00866294|980102|P3|COMPLETED|Overall Study||72
411097|NCT00866294|980103|P2|COMPLETED|Overall Study||141
411098|NCT00866294|980104|P1|COMPLETED|Overall Study||139
411099|NCT00866294|980102|P3|STARTED|Overall Study||83
411100|NCT00866294|980103|P2|STARTED|Overall Study||161
411101|NCT00866294|980104|P1|STARTED|Overall Study||172
411102|NCT00866281|980133|P2|NOT COMPLETED|Overall Study||15
411103|NCT00866281|980134|P1|NOT COMPLETED|Overall Study||7
411104|NCT00866281|980133|P2|COMPLETED|Overall Study||0
411105|NCT00866281|980134|P1|COMPLETED|Overall Study||0
411106|NCT00866281|980133|P2|STARTED|Overall Study||15
411107|NCT00866281|980134|P1|STARTED|Overall Study||7
411108|NCT00866047|980150|P1|NOT COMPLETED|Follow-up Period||5
411109|NCT00866047|980150|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
411110|NCT00866047|980150|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
411111|NCT00866047|980150|P1|NOT COMPLETED|Treatment Period||48
411112|NCT00866047|980150|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
411113|NCT00866047|980150|P1|STARTED|Treatment Period||58
411114|NCT00866034|980168|P2|NOT COMPLETED|Overall Study||8
411115|NCT00866034|980169|P1|NOT COMPLETED|Overall Study||16
411116|NCT00866034|980168|P2|COMPLETED|Overall Study||301
411117|NCT00866034|980169|P1|COMPLETED|Overall Study||292
411118|NCT00866034|980168|P2|STARTED|Overall Study||309
411119|NCT00866034|980169|P1|STARTED|Overall Study||308
411120|NCT00865904|980182|P5|NOT COMPLETED|Overall Study||1
411121|NCT00865904|980183|P4|NOT COMPLETED|Overall Study||1
411122|NCT00865904|980184|P3|NOT COMPLETED|Overall Study||0
411123|NCT00865904|980185|P2|NOT COMPLETED|Overall Study||0
411124|NCT00865904|980186|P1|NOT COMPLETED|Overall Study||2
411125|NCT00865904|980182|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
411126|NCT00865904|980183|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
411127|NCT00865904|980184|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
411128|NCT00865904|980185|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
411129|NCT00865904|980186|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
411130|NCT00865904|980182|P5|STARTED|Overall Study|Randomized.|20
411131|NCT00865904|980183|P4|STARTED|Overall Study|Randomized.|18
411132|NCT00865904|980184|P3|STARTED|Overall Study|Randomized.|18
411133|NCT00865904|980185|P2|STARTED|Overall Study|Randomized.|18
411134|NCT00865904|980186|P1|STARTED|Overall Study|Randomized.|19
411135|NCT00865709|980243|P2|NOT COMPLETED|Long Term Follow-up||49
411136|NCT00865709|980244|P1|NOT COMPLETED|Long Term Follow-up||46
411137|NCT00865709|980243|P2|COMPLETED|Long Term Follow-up||33
411138|NCT00865709|980244|P1|COMPLETED|Long Term Follow-up||24
411139|NCT00865709|980243|P2|STARTED|Long Term Follow-up||82
411140|NCT00865709|980244|P1|STARTED|Long Term Follow-up||70
411141|NCT00865709|980243|P2|NOT COMPLETED|Active Follow-up||1
411142|NCT00865709|980244|P1|NOT COMPLETED|Active Follow-up||8
411143|NCT00865709|980243|P2|COMPLETED|Active Follow-up||15
411144|NCT00865709|980244|P1|COMPLETED|Active Follow-up||17
411145|NCT00865709|980243|P2|STARTED|Active Follow-up||16
411146|NCT00865709|980244|P1|STARTED|Active Follow-up||25
411147|NCT00865709|980243|P2|NOT COMPLETED|Treatment||18
411148|NCT00865709|980244|P1|NOT COMPLETED|Treatment||30
411149|NCT00865709|980243|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
411150|NCT00865709|980244|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
411151|NCT00865709|980243|P2|Received Treatment|Treatment|Safety population|101
411152|NCT00865709|980244|P1|Received Treatment|Treatment|Safety population|97
411153|NCT00865709|980243|P2|STARTED|Treatment||101
411154|NCT00865709|980244|P1|STARTED|Treatment||97
411155|NCT00865514|980260|P1|NOT COMPLETED|Overall Study||2
411156|NCT00865514|980260|P1|COMPLETED|Overall Study||0
411157|NCT00865514|980260|P1|STARTED|Overall Study||2
411158|NCT00865345|980265|P1|NOT COMPLETED|Overall Study||2
411159|NCT00865345|980265|P1|COMPLETED|Overall Study||61
411160|NCT00865345|980265|P1|STARTED|Overall Study||63
411161|NCT00865306|980272|P2|NOT COMPLETED|One-Year Follow-Up||0
411162|NCT00865306|980273|P1|NOT COMPLETED|One-Year Follow-Up||0
411163|NCT00865306|980272|P2|COMPLETED|One-Year Follow-Up||15
411164|NCT00865306|980273|P1|COMPLETED|One-Year Follow-Up||29
411165|NCT00865306|980272|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
411166|NCT00865306|980273|P1|STARTED|One-Year Follow-Up||29
411167|NCT00865306|980272|P2|NOT COMPLETED|Controlled Trial||2
411168|NCT00865306|980273|P1|NOT COMPLETED|Controlled Trial||5
411169|NCT00865306|980272|P2|COMPLETED|Controlled Trial||28
411170|NCT00865306|980273|P1|COMPLETED|Controlled Trial||29
411171|NCT00865306|980272|P2|STARTED|Controlled Trial||30
411261|NCT00864383|980473|P2|STARTED|Modified Intent to Treat||655
411172|NCT00865306|980273|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
411173|NCT00865202|980285|P2|NOT COMPLETED|Overall Study||0
411174|NCT00865202|980286|P1|NOT COMPLETED|Overall Study||0
411175|NCT00865202|980285|P2|COMPLETED|Overall Study||149
411176|NCT00865202|980286|P1|COMPLETED|Overall Study||152
411177|NCT00865202|980285|P2|STARTED|Overall Study||149
411178|NCT00865202|980286|P1|STARTED|Overall Study||152
411179|NCT00865124|980303|P3|NOT COMPLETED|Overall Study||0
411180|NCT00865124|980304|P2|NOT COMPLETED|Overall Study||1
411181|NCT00865124|980305|P1|NOT COMPLETED|Overall Study||4
411182|NCT00865124|980303|P3|COMPLETED|Overall Study||17
411183|NCT00865124|980304|P2|COMPLETED|Overall Study||24
411184|NCT00865124|980305|P1|COMPLETED|Overall Study||23
411185|NCT00865124|980303|P3|STARTED|Overall Study||17
411186|NCT00865124|980304|P2|STARTED|Overall Study||25
411187|NCT00865124|980305|P1|STARTED|Overall Study||27
411188|NCT00865098|980322|P1|NOT COMPLETED|Overall Study||1
411189|NCT00865098|980322|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
411190|NCT00865098|980322|P1|STARTED|Overall Study||22
411191|NCT00865046|980334|P3|NOT COMPLETED|Overall Study||1
411192|NCT00865046|980335|P2|NOT COMPLETED|Overall Study||5
411193|NCT00865046|980336|P1|NOT COMPLETED|Overall Study||6
411194|NCT00865046|980334|P3|COMPLETED|Overall Study||62
411195|NCT00865046|980335|P2|COMPLETED|Overall Study||59
411196|NCT00865046|980336|P1|COMPLETED|Overall Study||57
411197|NCT00865046|980334|P3|STARTED|Overall Study||63
411198|NCT00865046|980335|P2|STARTED|Overall Study||64
411199|NCT00865046|980336|P1|STARTED|Overall Study||63
411200|NCT00865020|980346|P2|NOT COMPLETED|Overall Study||51
411201|NCT00865020|980347|P1|NOT COMPLETED|Overall Study||49
411202|NCT00865020|980346|P2|COMPLETED|Overall Study||357
411203|NCT00865020|980347|P1|COMPLETED|Overall Study||365
411204|NCT00865020|980346|P2|STARTED|Overall Study||408
411205|NCT00865020|980347|P1|STARTED|Overall Study||414
411206|NCT00864916|980363|P2|NOT COMPLETED|Overall Study||4
411207|NCT00864916|980364|P1|NOT COMPLETED|Overall Study||6
411208|NCT00864916|980363|P2|COMPLETED|Overall Study||5
411209|NCT00864916|980364|P1|COMPLETED|Overall Study||4
411210|NCT00864916|980363|P2|STARTED|Overall Study||9
411211|NCT00864916|980364|P1|STARTED|Overall Study||10
411212|NCT00864851|980373|P3|NOT COMPLETED|Overall Study||0
411213|NCT00864851|980374|P2|NOT COMPLETED|Overall Study||1
411214|NCT00864851|980375|P1|NOT COMPLETED|Overall Study||3
411215|NCT00864851|980373|P3|COMPLETED|Overall Study||5
411216|NCT00864851|980374|P2|COMPLETED|Overall Study||18
411217|NCT00864851|980375|P1|COMPLETED|Overall Study||17
411218|NCT00864851|980373|P3|STARTED|Overall Study||5
411219|NCT00864851|980374|P2|STARTED|Overall Study||19
411220|NCT00864851|980375|P1|STARTED|Overall Study||20
411221|NCT00864708|980409|P1|NOT COMPLETED|Overall Study||0
411222|NCT00864708|980409|P1|COMPLETED|Overall Study||1
411223|NCT00864708|980409|P1|STARTED|Overall Study||1
411224|NCT00864682|980421|P3|NOT COMPLETED|Overall Study||2
411225|NCT00864682|980422|P2|NOT COMPLETED|Overall Study||1
411226|NCT00864682|980423|P1|NOT COMPLETED|Overall Study||2
411227|NCT00864682|980421|P3|COMPLETED|Overall Study||51
411228|NCT00864682|980422|P2|COMPLETED|Overall Study||50
411229|NCT00864682|980423|P1|COMPLETED|Overall Study||50
411230|NCT00864682|980421|P3|STARTED|Overall Study||53
411231|NCT00864682|980422|P2|STARTED|Overall Study||51
411232|NCT00864682|980423|P1|STARTED|Overall Study||52
411233|NCT00864539|980443|P6|NOT COMPLETED|Overall Study||14
411234|NCT00864539|980444|P5|NOT COMPLETED|Overall Study||22
411235|NCT00864539|980445|P4|NOT COMPLETED|Overall Study||7
411236|NCT00864539|980446|P3|NOT COMPLETED|Overall Study||10
411237|NCT00864539|980447|P2|NOT COMPLETED|Overall Study||23
411238|NCT00864539|980448|P1|NOT COMPLETED|Overall Study||9
411239|NCT00864539|980443|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
411240|NCT00864539|980444|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
411241|NCT00864539|980445|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
411242|NCT00864539|980446|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
411243|NCT00864539|980447|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
411244|NCT00864539|980448|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
411245|NCT00864539|980443|P6|STARTED|Overall Study||85
411246|NCT00864539|980444|P5|STARTED|Overall Study||103
411247|NCT00864539|980445|P4|STARTED|Overall Study||96
411248|NCT00864539|980446|P3|STARTED|Overall Study||102
411249|NCT00864539|980447|P2|STARTED|Overall Study||95
411250|NCT00864539|980448|P1|STARTED|Overall Study||104
411251|NCT00864513|980462|P1|NOT COMPLETED|Overall Study||3
411252|NCT00864513|980462|P1|COMPLETED|Overall Study||12
411253|NCT00864513|980462|P1|STARTED|Overall Study||15
411254|NCT00864383|980472|P3|NOT COMPLETED|Modified Intent to Treat||85
411255|NCT00864383|980473|P2|NOT COMPLETED|Modified Intent to Treat||87
411256|NCT00864383|980474|P1|NOT COMPLETED|Modified Intent to Treat||85
411257|NCT00864383|980472|P3|COMPLETED|Modified Intent to Treat||551
411258|NCT00864383|980473|P2|COMPLETED|Modified Intent to Treat||568
411259|NCT00864383|980474|P1|COMPLETED|Modified Intent to Treat||555
411260|NCT00864383|980472|P3|STARTED|Modified Intent to Treat||636
411262|NCT00864383|980474|P1|STARTED|Modified Intent to Treat||640
411263|NCT00864383|980472|P3|NOT COMPLETED|Per- Protocol||112
411264|NCT00864383|980473|P2|NOT COMPLETED|Per- Protocol||141
411265|NCT00864383|980474|P1|NOT COMPLETED|Per- Protocol||130
411266|NCT00864383|980472|P3|COMPLETED|Per- Protocol||524
411267|NCT00864383|980473|P2|COMPLETED|Per- Protocol||514
411268|NCT00864383|980474|P1|COMPLETED|Per- Protocol||510
411269|NCT00864383|980472|P3|STARTED|Per- Protocol||636
411270|NCT00864383|980473|P2|STARTED|Per- Protocol||655
411271|NCT00864383|980474|P1|STARTED|Per- Protocol||640
411272|NCT00864253|980508|P2|NOT COMPLETED|Overall Study||58
411273|NCT00864253|980509|P1|NOT COMPLETED|Overall Study||99
411274|NCT00864253|980508|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
411275|NCT00864253|980509|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
411276|NCT00864253|980508|P2|Treated|Overall Study||258
411277|NCT00864253|980509|P1|Treated|Overall Study||257
411278|NCT00864253|980508|P2|STARTED|Overall Study||265
411279|NCT00864253|980509|P1|STARTED|Overall Study||264
411280|NCT00864227|980539|P1|NOT COMPLETED|Overall Study||4
411281|NCT00864227|980539|P1|COMPLETED|Overall Study||50
411282|NCT00864227|980539|P1|STARTED|Overall Study||54
411283|NCT00864123|980556|P2|NOT COMPLETED|Overall Study||0
411284|NCT00864123|980557|P1|NOT COMPLETED|Overall Study||0
411285|NCT00864123|980556|P2|COMPLETED|Overall Study||15
411286|NCT00864123|980557|P1|COMPLETED|Overall Study||15
411287|NCT00864123|980556|P2|STARTED|Overall Study||15
411288|NCT00864123|980557|P1|STARTED|Overall Study||15
411289|NCT00864084|980567|P1|NOT COMPLETED|Overall Study||3
411290|NCT00864084|980567|P1|COMPLETED|Overall Study||11
411291|NCT00864084|980567|P1|STARTED|Overall Study||14
411292|NCT00864032|980590|P3|NOT COMPLETED|Overall Study||0
411293|NCT00864032|980591|P2|NOT COMPLETED|Overall Study||0
411294|NCT00864032|980592|P1|NOT COMPLETED|Overall Study||0
411295|NCT00864032|980590|P3|COMPLETED|Overall Study||0
411296|NCT00864032|980591|P2|COMPLETED|Overall Study||5
411297|NCT00864032|980592|P1|COMPLETED|Overall Study||3
411298|NCT00864032|980590|P3|STARTED|Overall Study||0
411299|NCT00864032|980591|P2|STARTED|Overall Study||5
411300|NCT00864032|980592|P1|STARTED|Overall Study||3
411301|NCT00863798|980601|P3|NOT COMPLETED|Overall Study||25
411302|NCT00863798|980602|P2|NOT COMPLETED|Overall Study||30
411303|NCT00863798|980603|P1|NOT COMPLETED|Overall Study||32
411304|NCT00863798|980601|P3|COMPLETED|Overall Study||202
411305|NCT00863798|980602|P2|COMPLETED|Overall Study||198
411306|NCT00863798|980603|P1|COMPLETED|Overall Study||195
411307|NCT00863798|980601|P3|Treated|Overall Study||224
411308|NCT00863798|980602|P2|Treated|Overall Study||226
411309|NCT00863798|980603|P1|Treated|Overall Study||223
411310|NCT00863798|980601|P3|STARTED|Overall Study||227
411311|NCT00863798|980602|P2|STARTED|Overall Study||228
411312|NCT00863798|980603|P1|STARTED|Overall Study||227
411313|NCT00863746|980655|P2|NOT COMPLETED|Survival Follow up||280
411314|NCT00863746|980656|P1|NOT COMPLETED|Survival Follow up||253
411315|NCT00863746|980655|P2|COMPLETED|Survival Follow up||51
411316|NCT00863746|980656|P1|COMPLETED|Survival Follow up||45
411317|NCT00863746|980655|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
411318|NCT00863746|980656|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
411319|NCT00863746|980655|P2|NOT COMPLETED|Treatment||35
411320|NCT00863746|980656|P1|NOT COMPLETED|Treatment||71
411321|NCT00863746|980655|P2|COMPLETED|Treatment||318
411322|NCT00863746|980656|P1|COMPLETED|Treatment||279
411323|NCT00863746|980655|P2|Participants Received Treatment|Treatment|Safety population|351
411324|NCT00863746|980656|P1|Participants Received Treatment|Treatment|Safety population|346
411325|NCT00863746|980655|P2|STARTED|Treatment||353
411326|NCT00863746|980656|P1|STARTED|Treatment||350
411327|NCT00863707|980682|P2|NOT COMPLETED|Overall Study||3
411328|NCT00863707|980683|P1|NOT COMPLETED|Overall Study||4
411329|NCT00863707|980682|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
411330|NCT00863707|980683|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
411331|NCT00863707|980682|P2|STARTED|Overall Study||337
411332|NCT00863707|980683|P1|STARTED|Overall Study||174
411333|NCT00863655|980691|P2|NOT COMPLETED|Overall Study||239
411334|NCT00863655|980692|P1|NOT COMPLETED|Overall Study||485
411335|NCT00863655|980691|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
411336|NCT00863655|980692|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
411337|NCT00863655|980691|P2|STARTED|Overall Study||239
411338|NCT00863655|980692|P1|STARTED|Overall Study||485
411339|NCT00863551|980719|P1|NOT COMPLETED|Overall Study||0
411340|NCT00863551|980719|P1|COMPLETED|Overall Study||12
411341|NCT00863551|980719|P1|STARTED|Overall Study||12
411342|NCT00863512|980729|P2|NOT COMPLETED|Overall Study||0
411343|NCT00863512|980730|P1|NOT COMPLETED|Overall Study||14
411344|NCT00863512|980729|P2|COMPLETED|Overall Study||17
411345|NCT00863512|980730|P1|COMPLETED|Overall Study||3
411346|NCT00863512|980729|P2|STARTED|Overall Study||17
411347|NCT00863512|980730|P1|STARTED|Overall Study||17
411348|NCT00863434|980736|P1|NOT COMPLETED|Overall Study||0
411349|NCT00863434|980736|P1|COMPLETED|Overall Study||2
411350|NCT00863434|980736|P1|STARTED|Overall Study||2
411351|NCT00863356|980742|P1|NOT COMPLETED|Overall Study||0
411352|NCT00863356|980742|P1|COMPLETED|Overall Study||20
411353|NCT00863356|980742|P1|STARTED|Overall Study||20
411354|NCT00863343|980748|P2|NOT COMPLETED|Overall Study||0
411355|NCT00863343|980749|P1|NOT COMPLETED|Overall Study||0
411356|NCT00863343|980748|P2|COMPLETED|Overall Study||374
411357|NCT00863343|980749|P1|COMPLETED|Overall Study||17
411358|NCT00863343|980748|P2|STARTED|Overall Study||374
411359|NCT00863343|980749|P1|STARTED|Overall Study||17
411360|NCT00863330|980761|P1|NOT COMPLETED|Overall Study||6
411361|NCT00863330|980761|P1|COMPLETED|Overall Study||0
411362|NCT00863330|980761|P1|STARTED|Overall Study||6
411363|NCT00863317|980767|P2|NOT COMPLETED|Overall Study||9
411364|NCT00863317|980768|P1|NOT COMPLETED|Overall Study||8
411365|NCT00863317|980767|P2|COMPLETED|Overall Study||64
411366|NCT00863317|980768|P1|COMPLETED|Overall Study||60
411367|NCT00863317|980767|P2|STARTED|Overall Study||73
411368|NCT00863317|980768|P1|STARTED|Overall Study||68
411369|NCT00863109|980774|P1|NOT COMPLETED|Follow-up Period||11
411370|NCT00863109|980774|P1|COMPLETED|Follow-up Period||48
411371|NCT00863109|980774|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
411372|NCT00863109|980774|P1|NOT COMPLETED|Treatment Period||77
411373|NCT00863109|980774|P1|COMPLETED|Treatment Period||53
411374|NCT00863109|980774|P1|STARTED|Treatment Period||130
411375|NCT00863057|980791|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
411376|NCT00863057|980792|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
411377|NCT00863057|980793|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
411378|NCT00863057|980794|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
411379|NCT00863057|980791|P4|COMPLETED|Period 4 (Weeks 16-20)||2
411380|NCT00863057|980792|P3|COMPLETED|Period 4 (Weeks 16-20)||2
411381|NCT00863057|980793|P2|COMPLETED|Period 4 (Weeks 16-20)||1
411382|NCT00863057|980794|P1|COMPLETED|Period 4 (Weeks 16-20)||3
411383|NCT00863057|980791|P4|STARTED|Period 4 (Weeks 16-20)||2
411384|NCT00863057|980792|P3|STARTED|Period 4 (Weeks 16-20)||2
411385|NCT00863057|980793|P2|STARTED|Period 4 (Weeks 16-20)||1
411386|NCT00863057|980794|P1|STARTED|Period 4 (Weeks 16-20)||3
411387|NCT00863057|980791|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
411388|NCT00863057|980792|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
411389|NCT00863057|980793|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
411390|NCT00863057|980794|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
411391|NCT00863057|980791|P4|COMPLETED|Period 3 (Weeks 11-15)||2
411392|NCT00863057|980792|P3|COMPLETED|Period 3 (Weeks 11-15)||2
411393|NCT00863057|980793|P2|COMPLETED|Period 3 (Weeks 11-15)||1
411394|NCT00863057|980794|P1|COMPLETED|Period 3 (Weeks 11-15)||3
411395|NCT00863057|980791|P4|STARTED|Period 3 (Weeks 11-15)||2
411396|NCT00863057|980792|P3|STARTED|Period 3 (Weeks 11-15)||2
411397|NCT00863057|980793|P2|STARTED|Period 3 (Weeks 11-15)||1
411398|NCT00863057|980794|P1|STARTED|Period 3 (Weeks 11-15)||3
411399|NCT00863057|980791|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
411400|NCT00863057|980792|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
411401|NCT00863057|980793|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
411402|NCT00863057|980794|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
411403|NCT00863057|980791|P4|COMPLETED|Period 2 (Weeks 6-10)||2
411404|NCT00863057|980792|P3|COMPLETED|Period 2 (Weeks 6-10)||2
411405|NCT00863057|980793|P2|COMPLETED|Period 2 (Weeks 6-10)||1
411406|NCT00863057|980794|P1|COMPLETED|Period 2 (Weeks 6-10)||3
411407|NCT00863057|980791|P4|STARTED|Period 2 (Weeks 6-10)||3
411408|NCT00863057|980792|P3|STARTED|Period 2 (Weeks 6-10)||3
411409|NCT00863057|980793|P2|STARTED|Period 2 (Weeks 6-10)||2
411410|NCT00863057|980794|P1|STARTED|Period 2 (Weeks 6-10)||3
411411|NCT00863057|980791|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
411412|NCT00863057|980792|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
411413|NCT00863057|980793|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
411414|NCT00863057|980794|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
411415|NCT00863057|980791|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
411416|NCT00863057|980792|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
411417|NCT00863057|980793|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
411418|NCT00863057|980794|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
411419|NCT00863057|980791|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
411420|NCT00863057|980792|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
411421|NCT00863057|980793|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
411422|NCT00863057|980794|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
411423|NCT00862940|980836|P2|NOT COMPLETED|Overall Study||30
411424|NCT00862940|980837|P1|NOT COMPLETED|Overall Study||30
411425|NCT00862940|980836|P2|COMPLETED|Overall Study||114
411426|NCT00862940|980837|P1|COMPLETED|Overall Study||103
411427|NCT00862940|980836|P2|STARTED|Overall Study||144
411428|NCT00862940|980837|P1|STARTED|Overall Study||133
411429|NCT00862849|980849|P6|NOT COMPLETED|Intervention 6||0
411430|NCT00862849|980850|P5|NOT COMPLETED|Intervention 6||0
411431|NCT00862849|980851|P4|NOT COMPLETED|Intervention 6||0
411432|NCT00862849|980852|P3|NOT COMPLETED|Intervention 6||0
411433|NCT00862849|980853|P2|NOT COMPLETED|Intervention 6||0
411434|NCT00862849|980854|P1|NOT COMPLETED|Intervention 6||0
411435|NCT00862849|980849|P6|COMPLETED|Intervention 6||3
411436|NCT00862849|980850|P5|COMPLETED|Intervention 6||4
411437|NCT00862849|980851|P4|COMPLETED|Intervention 6||4
411438|NCT00862849|980852|P3|COMPLETED|Intervention 6||3
411439|NCT00862849|980853|P2|COMPLETED|Intervention 6||3
411440|NCT00862849|980854|P1|COMPLETED|Intervention 6||3
411441|NCT00862849|980849|P6|STARTED|Intervention 6||3
411442|NCT00862849|980850|P5|STARTED|Intervention 6||4
411443|NCT00862849|980851|P4|STARTED|Intervention 6||4
411444|NCT00862849|980852|P3|STARTED|Intervention 6||3
411445|NCT00862849|980853|P2|STARTED|Intervention 6||3
411446|NCT00862849|980854|P1|STARTED|Intervention 6||3
411447|NCT00862849|980849|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
411448|NCT00862849|980850|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
411449|NCT00862849|980851|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
411450|NCT00862849|980852|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
411451|NCT00862849|980853|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
411452|NCT00862849|980854|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
411453|NCT00862849|980849|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
411454|NCT00862849|980850|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
411455|NCT00862849|980851|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
411456|NCT00862849|980852|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
411457|NCT00862849|980853|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
411458|NCT00862849|980854|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
411459|NCT00862849|980849|P6|STARTED|Washout 5 (3 to 14 Days)||3
411460|NCT00862849|980850|P5|STARTED|Washout 5 (3 to 14 Days)||4
411461|NCT00862849|980851|P4|STARTED|Washout 5 (3 to 14 Days)||4
411462|NCT00862849|980852|P3|STARTED|Washout 5 (3 to 14 Days)||3
411463|NCT00862849|980853|P2|STARTED|Washout 5 (3 to 14 Days)||3
411464|NCT00862849|980854|P1|STARTED|Washout 5 (3 to 14 Days)||3
411465|NCT00862849|980849|P6|NOT COMPLETED|Intervention 5||0
411466|NCT00862849|980850|P5|NOT COMPLETED|Intervention 5||0
411467|NCT00862849|980851|P4|NOT COMPLETED|Intervention 5||0
411468|NCT00862849|980852|P3|NOT COMPLETED|Intervention 5||0
411469|NCT00862849|980853|P2|NOT COMPLETED|Intervention 5||0
411470|NCT00862849|980854|P1|NOT COMPLETED|Intervention 5||0
411471|NCT00862849|980849|P6|COMPLETED|Intervention 5||3
411472|NCT00862849|980850|P5|COMPLETED|Intervention 5||4
411473|NCT00862849|980851|P4|COMPLETED|Intervention 5||4
411474|NCT00862849|980852|P3|COMPLETED|Intervention 5||3
411475|NCT00862849|980853|P2|COMPLETED|Intervention 5||3
411476|NCT00862849|980854|P1|COMPLETED|Intervention 5||3
411477|NCT00862849|980849|P6|STARTED|Intervention 5||3
411478|NCT00862849|980850|P5|STARTED|Intervention 5||4
411479|NCT00862849|980851|P4|STARTED|Intervention 5||4
411480|NCT00862849|980852|P3|STARTED|Intervention 5||3
411481|NCT00862849|980853|P2|STARTED|Intervention 5||3
411482|NCT00862849|980854|P1|STARTED|Intervention 5||3
411483|NCT00862849|980849|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
411484|NCT00862849|980850|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
411485|NCT00862849|980851|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
411486|NCT00862849|980852|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
411487|NCT00862849|980853|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
411488|NCT00862849|980854|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
411489|NCT00862849|980849|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
411490|NCT00862849|980850|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
411491|NCT00862849|980851|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
411492|NCT00862849|980852|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
411493|NCT00862849|980853|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
411494|NCT00862849|980854|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
411495|NCT00862849|980849|P6|STARTED|Washout 4 (3 to 14 Days)||3
411496|NCT00862849|980850|P5|STARTED|Washout 4 (3 to 14 Days)||4
411497|NCT00862849|980851|P4|STARTED|Washout 4 (3 to 14 Days)||4
411498|NCT00862849|980852|P3|STARTED|Washout 4 (3 to 14 Days)||3
411499|NCT00862849|980853|P2|STARTED|Washout 4 (3 to 14 Days)||3
411500|NCT00862849|980854|P1|STARTED|Washout 4 (3 to 14 Days)||3
411501|NCT00862849|980849|P6|NOT COMPLETED|Intervention 4||0
411502|NCT00862849|980850|P5|NOT COMPLETED|Intervention 4||0
411503|NCT00862849|980851|P4|NOT COMPLETED|Intervention 4||0
411504|NCT00862849|980852|P3|NOT COMPLETED|Intervention 4||0
411505|NCT00862849|980853|P2|NOT COMPLETED|Intervention 4||0
411506|NCT00862849|980854|P1|NOT COMPLETED|Intervention 4||0
411507|NCT00862849|980849|P6|COMPLETED|Intervention 4||3
411508|NCT00862849|980850|P5|COMPLETED|Intervention 4||4
411509|NCT00862849|980851|P4|COMPLETED|Intervention 4||4
411510|NCT00862849|980852|P3|COMPLETED|Intervention 4||3
411511|NCT00862849|980853|P2|COMPLETED|Intervention 4||3
411512|NCT00862849|980854|P1|COMPLETED|Intervention 4||3
411513|NCT00862849|980849|P6|STARTED|Intervention 4||3
411514|NCT00862849|980850|P5|STARTED|Intervention 4||4
411515|NCT00862849|980851|P4|STARTED|Intervention 4||4
411516|NCT00862849|980852|P3|STARTED|Intervention 4||3
411517|NCT00862849|980853|P2|STARTED|Intervention 4||3
411518|NCT00862849|980854|P1|STARTED|Intervention 4||3
411519|NCT00862849|980849|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
411520|NCT00862849|980850|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
411521|NCT00862849|980851|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
411522|NCT00862849|980852|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
411523|NCT00862849|980853|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
411524|NCT00862849|980854|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
411525|NCT00862849|980849|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
411526|NCT00862849|980850|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
411527|NCT00862849|980851|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
411528|NCT00862849|980852|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
411529|NCT00862849|980853|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
411530|NCT00862849|980854|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
411531|NCT00862849|980849|P6|STARTED|Washout 3 (3 to 14 Days)||3
411532|NCT00862849|980850|P5|STARTED|Washout 3 (3 to 14 Days)||4
411533|NCT00862849|980851|P4|STARTED|Washout 3 (3 to 14 Days)||4
411534|NCT00862849|980852|P3|STARTED|Washout 3 (3 to 14 Days)||3
411535|NCT00862849|980853|P2|STARTED|Washout 3 (3 to 14 Days)||3
411536|NCT00862849|980854|P1|STARTED|Washout 3 (3 to 14 Days)||3
411537|NCT00862849|980849|P6|NOT COMPLETED|Intervention 3||0
411538|NCT00862849|980850|P5|NOT COMPLETED|Intervention 3||0
411539|NCT00862849|980851|P4|NOT COMPLETED|Intervention 3||0
411540|NCT00862849|980852|P3|NOT COMPLETED|Intervention 3||0
411541|NCT00862849|980853|P2|NOT COMPLETED|Intervention 3||0
411542|NCT00862849|980854|P1|NOT COMPLETED|Intervention 3||0
411543|NCT00862849|980849|P6|COMPLETED|Intervention 3||3
411544|NCT00862849|980850|P5|COMPLETED|Intervention 3||4
411545|NCT00862849|980851|P4|COMPLETED|Intervention 3||4
411546|NCT00862849|980852|P3|COMPLETED|Intervention 3||3
411547|NCT00862849|980853|P2|COMPLETED|Intervention 3||3
411548|NCT00862849|980854|P1|COMPLETED|Intervention 3||3
411549|NCT00862849|980849|P6|STARTED|Intervention 3||3
411550|NCT00862849|980850|P5|STARTED|Intervention 3||4
411551|NCT00862849|980851|P4|STARTED|Intervention 3||4
411552|NCT00862849|980852|P3|STARTED|Intervention 3||3
411553|NCT00862849|980853|P2|STARTED|Intervention 3||3
411554|NCT00862849|980854|P1|STARTED|Intervention 3||3
411555|NCT00862849|980849|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
411556|NCT00862849|980850|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
411557|NCT00862849|980851|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
411558|NCT00862849|980852|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
411559|NCT00862849|980853|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
411560|NCT00862849|980854|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
411561|NCT00862849|980849|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
411562|NCT00862849|980850|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
411563|NCT00862849|980851|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
411564|NCT00862849|980852|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
411565|NCT00862849|980853|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
411566|NCT00862849|980854|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
411567|NCT00862849|980849|P6|STARTED|Washout 2 (3 to 14 Days)||3
411568|NCT00862849|980850|P5|STARTED|Washout 2 (3 to 14 Days)||4
411569|NCT00862849|980851|P4|STARTED|Washout 2 (3 to 14 Days)||4
411570|NCT00862849|980852|P3|STARTED|Washout 2 (3 to 14 Days)||3
411571|NCT00862849|980853|P2|STARTED|Washout 2 (3 to 14 Days)||4
411572|NCT00862849|980854|P1|STARTED|Washout 2 (3 to 14 Days)||3
411573|NCT00862849|980849|P6|NOT COMPLETED|Intervention 2||0
411574|NCT00862849|980850|P5|NOT COMPLETED|Intervention 2||0
411575|NCT00862849|980851|P4|NOT COMPLETED|Intervention 2||0
411576|NCT00862849|980852|P3|NOT COMPLETED|Intervention 2||0
411577|NCT00862849|980853|P2|NOT COMPLETED|Intervention 2||0
411578|NCT00862849|980854|P1|NOT COMPLETED|Intervention 2||0
411579|NCT00862849|980849|P6|COMPLETED|Intervention 2||3
411580|NCT00862849|980850|P5|COMPLETED|Intervention 2||4
411581|NCT00862849|980851|P4|COMPLETED|Intervention 2||4
411582|NCT00862849|980852|P3|COMPLETED|Intervention 2||3
411583|NCT00862849|980853|P2|COMPLETED|Intervention 2||4
411584|NCT00862849|980854|P1|COMPLETED|Intervention 2||3
411585|NCT00862849|980849|P6|STARTED|Intervention 2||3
411586|NCT00862849|980850|P5|STARTED|Intervention 2||4
411587|NCT00862849|980851|P4|STARTED|Intervention 2||4
411588|NCT00862849|980852|P3|STARTED|Intervention 2||3
411589|NCT00862849|980853|P2|STARTED|Intervention 2||4
411590|NCT00862849|980854|P1|STARTED|Intervention 2||3
411591|NCT00862849|980849|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
411592|NCT00862849|980850|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
411593|NCT00862849|980851|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
411594|NCT00862849|980852|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
411595|NCT00862849|980853|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
411596|NCT00862849|980854|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
411597|NCT00862849|980849|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
411598|NCT00862849|980850|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
411599|NCT00862849|980851|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
411600|NCT00862849|980852|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
411601|NCT00862849|980853|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
411602|NCT00862849|980854|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
411603|NCT00862849|980849|P6|STARTED|Washout 1 (3 to 14 Days)||3
411604|NCT00862849|980850|P5|STARTED|Washout 1 (3 to 14 Days)||4
411605|NCT00862849|980851|P4|STARTED|Washout 1 (3 to 14 Days)||4
411606|NCT00862849|980852|P3|STARTED|Washout 1 (3 to 14 Days)||3
411607|NCT00862849|980853|P2|STARTED|Washout 1 (3 to 14 Days)||5
411608|NCT00862849|980854|P1|STARTED|Washout 1 (3 to 14 Days)||3
411609|NCT00862849|980849|P6|NOT COMPLETED|Intervention 1||0
411610|NCT00862849|980850|P5|NOT COMPLETED|Intervention 1||0
411611|NCT00862849|980851|P4|NOT COMPLETED|Intervention 1||0
411612|NCT00862849|980852|P3|NOT COMPLETED|Intervention 1||0
411613|NCT00862849|980853|P2|NOT COMPLETED|Intervention 1||0
411614|NCT00862849|980854|P1|NOT COMPLETED|Intervention 1||0
411615|NCT00862849|980849|P6|COMPLETED|Intervention 1||3
411616|NCT00862849|980850|P5|COMPLETED|Intervention 1||4
411617|NCT00862849|980851|P4|COMPLETED|Intervention 1||4
411618|NCT00862849|980852|P3|COMPLETED|Intervention 1||3
411619|NCT00862849|980853|P2|COMPLETED|Intervention 1||5
411620|NCT00862849|980854|P1|COMPLETED|Intervention 1||3
411621|NCT00862849|980849|P6|Received at Least One Dose of Study Drug|Intervention 1||3
411622|NCT00862849|980850|P5|Received at Least One Dose of Study Drug|Intervention 1||4
411623|NCT00862849|980851|P4|Received at Least One Dose of Study Drug|Intervention 1||4
411624|NCT00862849|980852|P3|Received at Least One Dose of Study Drug|Intervention 1||3
411625|NCT00862849|980853|P2|Received at Least One Dose of Study Drug|Intervention 1||5
411626|NCT00862849|980854|P1|Received at Least One Dose of Study Drug|Intervention 1||3
411627|NCT00862849|980849|P6|STARTED|Intervention 1||3
411628|NCT00862849|980850|P5|STARTED|Intervention 1||4
411629|NCT00862849|980851|P4|STARTED|Intervention 1||4
411630|NCT00862849|980852|P3|STARTED|Intervention 1||3
411631|NCT00862849|980853|P2|STARTED|Intervention 1||5
411632|NCT00862849|980854|P1|STARTED|Intervention 1||3
411633|NCT00862836|980877|P1|NOT COMPLETED|Overall Study||1
411634|NCT00862836|980877|P1|COMPLETED|Overall Study||14
411635|NCT00862836|980877|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
411636|NCT00862836|980877|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
411637|NCT00862836|980877|P1|STARTED|Overall Study||15
411638|NCT00862823|980888|P2|NOT COMPLETED|Second Intervention||0
411639|NCT00862823|980889|P1|NOT COMPLETED|Second Intervention||0
411640|NCT00862823|980888|P2|COMPLETED|Second Intervention||9
411641|NCT00862823|980889|P1|COMPLETED|Second Intervention||5
411642|NCT00862823|980888|P2|STARTED|Second Intervention||9
411643|NCT00862823|980889|P1|STARTED|Second Intervention||5
411644|NCT00862823|980888|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
411645|NCT00862823|980889|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
411646|NCT00862823|980888|P2|COMPLETED|Washout Period of 2 Weeks||9
411647|NCT00862823|980889|P1|COMPLETED|Washout Period of 2 Weeks||5
411648|NCT00862823|980888|P2|STARTED|Washout Period of 2 Weeks||9
411649|NCT00862823|980889|P1|STARTED|Washout Period of 2 Weeks||5
411650|NCT00862823|980888|P2|NOT COMPLETED|First Intervention||1
411651|NCT00862823|980889|P1|NOT COMPLETED|First Intervention||1
411652|NCT00862823|980888|P2|COMPLETED|First Intervention||9
411653|NCT00862823|980889|P1|COMPLETED|First Intervention||5
411654|NCT00862823|980888|P2|STARTED|First Intervention||10
411655|NCT00862823|980889|P1|STARTED|First Intervention||6
411656|NCT00862810|980898|P2|NOT COMPLETED|Overall Study||4
411657|NCT00862810|980899|P1|NOT COMPLETED|Overall Study||4
411658|NCT00862810|980898|P2|COMPLETED|Overall Study||35
411659|NCT00862810|980899|P1|COMPLETED|Overall Study||29
411660|NCT00862810|980898|P2|STARTED|Overall Study||39
411661|NCT00862810|980899|P1|STARTED|Overall Study||33
411662|NCT00862784|980905|P1|NOT COMPLETED|Overall Study||0
411663|NCT00862784|980905|P1|COMPLETED|Overall Study||48
411664|NCT00862784|980905|P1|Received Any Amount of Study Drug|Overall Study||48
411665|NCT00862784|980905|P1|STARTED|Overall Study||48
411666|NCT00862745|980927|P2|NOT COMPLETED|Open-label Follow-up||49
411667|NCT00862745|980928|P1|NOT COMPLETED|Open-label Follow-up||39
411668|NCT00862745|980927|P2|COMPLETED|Open-label Follow-up||225
411669|NCT00862745|980928|P1|COMPLETED|Open-label Follow-up||229
411670|NCT00862745|980927|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
411671|NCT00862745|980928|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
411672|NCT00862745|980927|P2|NOT COMPLETED|Randomized Control Trial||39
411673|NCT00862745|980928|P1|NOT COMPLETED|Randomized Control Trial||38
411674|NCT00862745|980927|P2|COMPLETED|Randomized Control Trial||284
411675|NCT00862745|980928|P1|COMPLETED|Randomized Control Trial||284
411676|NCT00862745|980927|P2|STARTED|Randomized Control Trial||323
411677|NCT00862745|980928|P1|STARTED|Randomized Control Trial||322
411678|NCT00862719|980938|P4|NOT COMPLETED|Overall Study||1
411679|NCT00862719|980939|P3|NOT COMPLETED|Overall Study||4
411680|NCT00862719|980940|P2|NOT COMPLETED|Overall Study||6
411681|NCT00862719|980941|P1|NOT COMPLETED|Overall Study||10
411682|NCT00862719|980938|P4|COMPLETED|Overall Study||0
411683|NCT00862719|980939|P3|COMPLETED|Overall Study||0
411684|NCT00862719|980940|P2|COMPLETED|Overall Study||1
411685|NCT00862719|980941|P1|COMPLETED|Overall Study||7
411686|NCT00862719|980938|P4|STARTED|Overall Study||1
411687|NCT00862719|980939|P3|STARTED|Overall Study||4
411688|NCT00862719|980940|P2|STARTED|Overall Study||7
411689|NCT00862719|980941|P1|STARTED|Overall Study||17
411690|NCT00862654|980964|P4|NOT COMPLETED|Overall Study||6
411691|NCT00862654|980965|P3|NOT COMPLETED|Overall Study||6
411692|NCT00862654|980966|P2|NOT COMPLETED|Overall Study||8
411693|NCT00862654|980967|P1|NOT COMPLETED|Overall Study||6
411694|NCT00862654|980964|P4|COMPLETED|Overall Study||74
411695|NCT00862654|980965|P3|COMPLETED|Overall Study||76
411696|NCT00862654|980966|P2|COMPLETED|Overall Study||74
411697|NCT00862654|980967|P1|COMPLETED|Overall Study||76
411698|NCT00862654|980964|P4|STARTED|Overall Study||80
411699|NCT00862654|980965|P3|STARTED|Overall Study||82
411700|NCT00862654|980966|P2|STARTED|Overall Study||82
411701|NCT00862654|980967|P1|STARTED|Overall Study||82
411702|NCT00862641|980981|P4|NOT COMPLETED|Overall Study||4
411703|NCT00862641|980982|P3|NOT COMPLETED|Overall Study||1
411704|NCT00862641|980983|P2|NOT COMPLETED|Overall Study||4
411705|NCT00862641|980984|P1|NOT COMPLETED|Overall Study||1
411791|NCT00861757|981393|P4|COMPLETED|Overall Study||143
411706|NCT00862641|980981|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
411707|NCT00862641|980982|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
411708|NCT00862641|980983|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
411709|NCT00862641|980984|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
411710|NCT00862641|980981|P4|STARTED|Overall Study||320
411711|NCT00862641|980982|P3|STARTED|Overall Study||152
411712|NCT00862641|980983|P2|STARTED|Overall Study||360
411713|NCT00862641|980984|P1|STARTED|Overall Study||177
411714|NCT00862563|981030|P4|NOT COMPLETED|Overall Study||5
411715|NCT00862563|981031|P3|NOT COMPLETED|Overall Study||6
411716|NCT00862563|981032|P2|NOT COMPLETED|Overall Study||4
411717|NCT00862563|981033|P1|NOT COMPLETED|Overall Study||4
411718|NCT00862563|981030|P4|COMPLETED|Overall Study||19
411719|NCT00862563|981031|P3|COMPLETED|Overall Study||15
411720|NCT00862563|981032|P2|COMPLETED|Overall Study||17
411721|NCT00862563|981033|P1|COMPLETED|Overall Study||15
411722|NCT00862563|981030|P4|STARTED|Overall Study||24
411723|NCT00862563|981031|P3|STARTED|Overall Study||21
411724|NCT00862563|981032|P2|STARTED|Overall Study||21
411725|NCT00862563|981033|P1|STARTED|Overall Study||19
411726|NCT00862537|981071|P1|NOT COMPLETED|Overall Study||7
411727|NCT00862537|981071|P1|COMPLETED|Overall Study||11
411728|NCT00862537|981071|P1|STARTED|Overall Study||18
411729|NCT00862459|981078|P3|NOT COMPLETED|Overall Study||6
411730|NCT00862459|981079|P2|NOT COMPLETED|Overall Study||8
411731|NCT00862459|981080|P1|NOT COMPLETED|Overall Study||6
411732|NCT00862459|981078|P3|COMPLETED|Overall Study||66
411733|NCT00862459|981079|P2|COMPLETED|Overall Study||85
411734|NCT00862459|981080|P1|COMPLETED|Overall Study||66
411735|NCT00862459|981078|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
411736|NCT00862459|981079|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
411737|NCT00862459|981080|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
411738|NCT00862459|981078|P3|STARTED|Overall Study||72
411739|NCT00862459|981079|P2|STARTED|Overall Study||93
411740|NCT00862459|981080|P1|STARTED|Overall Study||72
411741|NCT00862277|981227|P3|NOT COMPLETED|Overall Study||5
411742|NCT00862277|981228|P2|NOT COMPLETED|Overall Study||2
411743|NCT00862277|981229|P1|NOT COMPLETED|Overall Study||1
411744|NCT00862277|981227|P3|COMPLETED|Overall Study||100
411745|NCT00862277|981228|P2|COMPLETED|Overall Study||94
411746|NCT00862277|981229|P1|COMPLETED|Overall Study||560
411747|NCT00862277|981227|P3|STARTED|Overall Study||105
411748|NCT00862277|981228|P2|STARTED|Overall Study||96
411749|NCT00862277|981229|P1|STARTED|Overall Study||561
411750|NCT00862251|981243|P3|NOT COMPLETED|Overall Study||9
411751|NCT00862251|981244|P2|NOT COMPLETED|Overall Study||5
411752|NCT00862251|981245|P1|NOT COMPLETED|Overall Study||19
411753|NCT00862251|981243|P3|COMPLETED|Overall Study||315
411754|NCT00862251|981244|P2|COMPLETED|Overall Study||157
411755|NCT00862251|981245|P1|COMPLETED|Overall Study||303
411756|NCT00862251|981243|P3|STARTED|Overall Study||324
411757|NCT00862251|981244|P2|STARTED|Overall Study||162
411758|NCT00862251|981245|P1|STARTED|Overall Study||322
411759|NCT00862186|981298|P1|NOT COMPLETED|Overall Study||0
411760|NCT00862186|981298|P1|COMPLETED|Overall Study||15
411761|NCT00862186|981298|P1|STARTED|Overall Study||15
411762|NCT00862134|981305|P2|NOT COMPLETED|Overall Study||12
411763|NCT00862134|981306|P1|NOT COMPLETED|Overall Study||11
411764|NCT00862134|981305|P2|COMPLETED|Overall Study||11
411765|NCT00862134|981306|P1|COMPLETED|Overall Study||8
411766|NCT00862134|981305|P2|STARTED|Overall Study||23
411767|NCT00862134|981306|P1|STARTED|Overall Study||19
411768|NCT00862121|981318|P2|NOT COMPLETED|Overall Study||8
411769|NCT00862121|981319|P1|NOT COMPLETED|Overall Study||1
411770|NCT00862121|981318|P2|COMPLETED|Overall Study||4
411771|NCT00862121|981319|P1|COMPLETED|Overall Study||7
411772|NCT00862121|981318|P2|Safety Analysis Set|Overall Study||11
411866|NCT00860847|981798|P2|NOT COMPLETED|Overall Study||5
411773|NCT00862121|981319|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
411774|NCT00862121|981318|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
411775|NCT00862121|981319|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
411776|NCT00862121|981318|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
411777|NCT00862121|981319|P1|STARTED|Overall Study||8
411778|NCT00862082|981337|P2|NOT COMPLETED|Overall Study||1
411779|NCT00862082|981338|P1|NOT COMPLETED|Overall Study||5
411780|NCT00862082|981337|P2|COMPLETED|Overall Study||5
411781|NCT00862082|981338|P1|COMPLETED|Overall Study||3
411782|NCT00862082|981337|P2|STARTED|Overall Study||6
411783|NCT00862082|981338|P1|STARTED|Overall Study||8
411784|NCT00861913|981381|P1|NOT COMPLETED|Overall Study||0
411785|NCT00861913|981381|P1|COMPLETED|Overall Study||13
411786|NCT00861913|981381|P1|STARTED|Overall Study||13
411787|NCT00861757|981393|P4|NOT COMPLETED|Overall Study||9
411788|NCT00861757|981394|P3|NOT COMPLETED|Overall Study||18
411789|NCT00861757|981395|P2|NOT COMPLETED|Overall Study||15
411790|NCT00861757|981396|P1|NOT COMPLETED|Overall Study||9
411792|NCT00861757|981394|P3|COMPLETED|Overall Study||137
411793|NCT00861757|981395|P2|COMPLETED|Overall Study||136
411794|NCT00861757|981396|P1|COMPLETED|Overall Study||145
411795|NCT00861757|981393|P4|STARTED|Overall Study||152
411796|NCT00861757|981394|P3|STARTED|Overall Study||155
411797|NCT00861757|981395|P2|STARTED|Overall Study||151
411798|NCT00861757|981396|P1|STARTED|Overall Study||154
411799|NCT00861744|981454|P4|NOT COMPLETED|Overall Study||33
411800|NCT00861744|981455|P3|NOT COMPLETED|Overall Study||24
411801|NCT00861744|981456|P2|NOT COMPLETED|Overall Study||29
411802|NCT00861744|981457|P1|NOT COMPLETED|Overall Study||17
411803|NCT00861744|981454|P4|COMPLETED|Overall Study||275
411804|NCT00861744|981455|P3|COMPLETED|Overall Study||280
411805|NCT00861744|981456|P2|COMPLETED|Overall Study||275
411806|NCT00861744|981457|P1|COMPLETED|Overall Study||287
411807|NCT00861744|981454|P4|STARTED|Overall Study||308
411808|NCT00861744|981455|P3|STARTED|Overall Study||304
411809|NCT00861744|981456|P2|STARTED|Overall Study||304
411810|NCT00861744|981457|P1|STARTED|Overall Study||304
411811|NCT00861705|981639|P4|NOT COMPLETED|Overall Study||1
411812|NCT00861705|981640|P3|NOT COMPLETED|Overall Study||0
411813|NCT00861705|981641|P2|NOT COMPLETED|Overall Study||3
411814|NCT00861705|981642|P1|NOT COMPLETED|Overall Study||7
411815|NCT00861705|981639|P4|COMPLETED|Overall Study||112
411816|NCT00861705|981640|P3|COMPLETED|Overall Study||113
411817|NCT00861705|981641|P2|COMPLETED|Overall Study||110
411818|NCT00861705|981642|P1|COMPLETED|Overall Study||108
411819|NCT00861705|981639|P4|STARTED|Overall Study||113
411820|NCT00861705|981640|P3|STARTED|Overall Study||113
411821|NCT00861705|981641|P2|STARTED|Overall Study||113
411822|NCT00861705|981642|P1|STARTED|Overall Study||115
411823|NCT00861692|981658|P1|NOT COMPLETED|Overall Study||6
411824|NCT00861692|981658|P1|COMPLETED|Overall Study||14
411825|NCT00861692|981658|P1|STARTED|Overall Study||20
411826|NCT00861614|981670|P2|NOT COMPLETED|Overall Study||368
411827|NCT00861614|981671|P1|NOT COMPLETED|Overall Study||371
411828|NCT00861614|981670|P2|COMPLETED|Overall Study||28
411829|NCT00861614|981671|P1|COMPLETED|Overall Study||22
411830|NCT00861614|981670|P2|STARTED|Overall Study||396
411831|NCT00861614|981671|P1|STARTED|Overall Study||393
411832|NCT00861601|981704|P3|NOT COMPLETED|Overall Study||0
411833|NCT00861601|981705|P2|NOT COMPLETED|Overall Study||0
411834|NCT00861601|981706|P1|NOT COMPLETED|Overall Study||0
411835|NCT00861601|981704|P3|COMPLETED|Overall Study||12
411836|NCT00861601|981705|P2|COMPLETED|Overall Study||14
411837|NCT00861601|981706|P1|COMPLETED|Overall Study||12
411838|NCT00861601|981704|P3|STARTED|Overall Study||12
411839|NCT00861601|981705|P2|STARTED|Overall Study||14
411840|NCT00861601|981706|P1|STARTED|Overall Study||12
411841|NCT00861471|981756|P1|NOT COMPLETED|Overall Study||9
411842|NCT00861471|981756|P1|COMPLETED|Overall Study||3
411843|NCT00861471|981756|P1|STARTED|Overall Study||12
411844|NCT00861341|981764|P1|NOT COMPLETED|Overall Study||2
411845|NCT00861341|981764|P1|COMPLETED|Overall Study||38
411846|NCT00861341|981764|P1|STARTED|Overall Study||40
411847|NCT00861263|981769|P1|NOT COMPLETED|Overall Study||0
411848|NCT00861263|981769|P1|COMPLETED|Overall Study||193
411849|NCT00861263|981769|P1|STARTED|Overall Study||193
411850|NCT00861198|981773|P1|NOT COMPLETED|Overall Study||5
411851|NCT00861198|981773|P1|COMPLETED|Overall Study||70
411852|NCT00861198|981773|P1|STARTED|Overall Study||75
411853|NCT00861146|981779|P2|NOT COMPLETED|Overall Study||8
411854|NCT00861146|981780|P1|NOT COMPLETED|Overall Study||20
411855|NCT00861146|981779|P2|COMPLETED|Overall Study||38
411856|NCT00861146|981780|P1|COMPLETED|Overall Study||85
411857|NCT00861146|981779|P2|Week 13 Assessment|Overall Study||38
411858|NCT00861146|981780|P1|Week 13 Assessment|Overall Study||85
411859|NCT00861146|981779|P2|Week 2 Assessment|Overall Study||45
411860|NCT00861146|981780|P1|Week 2 Assessment|Overall Study||97
411861|NCT00861146|981779|P2|STARTED|Overall Study||46
411862|NCT00861146|981780|P1|STARTED|Overall Study||105
411863|NCT00860951|981790|P1|NOT COMPLETED|Overall Study||7
411864|NCT00860951|981790|P1|COMPLETED|Overall Study||22
411865|NCT00860951|981790|P1|STARTED|Overall Study||29
411867|NCT00860847|981799|P1|NOT COMPLETED|Overall Study||4
411868|NCT00860847|981798|P2|COMPLETED|Overall Study||28
411869|NCT00860847|981799|P1|COMPLETED|Overall Study||28
411870|NCT00860847|981798|P2|STARTED|Overall Study||33
411871|NCT00860847|981799|P1|STARTED|Overall Study||32
411872|NCT00860795|981807|P2|NOT COMPLETED|Overall Study||0
411873|NCT00860795|981808|P1|NOT COMPLETED|Overall Study||0
411874|NCT00860795|981807|P2|COMPLETED|Overall Study||10
411875|NCT00860795|981808|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
411876|NCT00860795|981807|P2|Number to Complete Study Medication|Overall Study||10
411877|NCT00860795|981808|P1|Number to Complete Study Medication|Overall Study||9
411878|NCT00860795|981807|P2|STARTED|Overall Study||10
411879|NCT00860795|981808|P1|STARTED|Overall Study||10
411880|NCT00860743|981832|P2|NOT COMPLETED|Overall Study||0
411881|NCT00860743|981833|P1|NOT COMPLETED|Overall Study||3
411882|NCT00860743|981832|P2|COMPLETED|Overall Study||23
411883|NCT00860743|981833|P1|COMPLETED|Overall Study||37
411884|NCT00860743|981832|P2|STARTED|Overall Study||23
411885|NCT00860743|981833|P1|STARTED|Overall Study||40
411886|NCT00860535|981839|P1|NOT COMPLETED|Overall Study||1
411887|NCT00860535|981839|P1|COMPLETED|Overall Study||8
411888|NCT00860535|981839|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
411889|NCT00860535|981839|P1|STARTED|Overall Study||9
411890|NCT00860470|981846|P2|NOT COMPLETED|Overall Study||59
411891|NCT00860470|981847|P1|NOT COMPLETED|Overall Study||48
411892|NCT00860470|981846|P2|COMPLETED|Overall Study||22346
411893|NCT00860470|981847|P1|COMPLETED|Overall Study||22114
411894|NCT00860470|981846|P2|STARTED|Overall Study||22405
411895|NCT00860470|981847|P1|STARTED|Overall Study||22162
411896|NCT00860457|981871|P1|NOT COMPLETED|Overall Study||11
411897|NCT00860457|981871|P1|COMPLETED|Overall Study||11
411898|NCT00860457|981871|P1|STARTED|Overall Study||22
411899|NCT00860405|981877|P2|NOT COMPLETED|Overall Study||4
411900|NCT00860405|981878|P1|NOT COMPLETED|Overall Study||5
411901|NCT00860405|981877|P2|COMPLETED|Overall Study||26
411902|NCT00860405|981878|P1|COMPLETED|Overall Study|completed overall study|26
411903|NCT00860405|981877|P2|Day 28 Follow-up Performed|Overall Study||29
411904|NCT00860405|981878|P1|Day 28 Follow-up Performed|Overall Study||31
411905|NCT00860405|981877|P2|Completed Treatment|Overall Study||29
411906|NCT00860405|981878|P1|Completed Treatment|Overall Study||31
411907|NCT00860405|981877|P2|STARTED|Overall Study||30
411908|NCT00860405|981878|P1|STARTED|Overall Study||31
411909|NCT00860314|981902|P2|NOT COMPLETED|Overall Study||0
411910|NCT00860314|981903|P1|NOT COMPLETED|Overall Study||0
411911|NCT00860314|981902|P2|COMPLETED|Overall Study||48
411912|NCT00860314|981903|P1|COMPLETED|Overall Study||48
411913|NCT00860314|981902|P2|STARTED|Overall Study||48
411914|NCT00860314|981903|P1|STARTED|Overall Study||48
411915|NCT00860262|981918|P3|NOT COMPLETED|Overall Study||18
411916|NCT00860262|981919|P2|NOT COMPLETED|Overall Study||22
411917|NCT00860262|981920|P1|NOT COMPLETED|Overall Study||20
411918|NCT00860262|981918|P3|COMPLETED|Overall Study||202
411919|NCT00860262|981919|P2|COMPLETED|Overall Study||195
411920|NCT00860262|981920|P1|COMPLETED|Overall Study||401
411921|NCT00860262|981918|P3|STARTED|Overall Study||220
411922|NCT00860262|981919|P2|STARTED|Overall Study||217
411923|NCT00860262|981920|P1|STARTED|Overall Study||421
411924|NCT00860249|982033|P3|NOT COMPLETED|Overall Study||21
411925|NCT00860249|982034|P2|NOT COMPLETED|Overall Study||18
411926|NCT00860249|982035|P1|NOT COMPLETED|Overall Study||21
411927|NCT00860249|982033|P3|COMPLETED|Overall Study||0
411928|NCT00860249|982034|P2|COMPLETED|Overall Study||0
411929|NCT00860249|982035|P1|COMPLETED|Overall Study||0
411930|NCT00860249|982033|P3|STARTED|Overall Study||21
411931|NCT00860249|982034|P2|STARTED|Overall Study||18
411932|NCT00860249|982035|P1|STARTED|Overall Study||21
411933|NCT00860158|982046|P1|NOT COMPLETED|Overall Study||1
411934|NCT00860158|982046|P1|COMPLETED|Overall Study||0
411935|NCT00860158|982046|P1|STARTED|Overall Study||1
411936|NCT00860067|982057|P3|NOT COMPLETED|Overall Study||9
411937|NCT00860067|982058|P2|NOT COMPLETED|Overall Study||9
411938|NCT00860067|982059|P1|NOT COMPLETED|Overall Study||51
411939|NCT00860067|982057|P3|COMPLETED|Overall Study||292
411940|NCT00860067|982058|P2|COMPLETED|Overall Study||290
411941|NCT00860067|982059|P1|COMPLETED|Overall Study||1149
411942|NCT00860067|982057|P3|STARTED|Overall Study||301
411943|NCT00860067|982058|P2|STARTED|Overall Study||299
411944|NCT00860067|982059|P1|STARTED|Overall Study||1200
411945|NCT00860028|982119|P2|NOT COMPLETED|Smoking Cessation Phase||2
411946|NCT00860028|982120|P1|NOT COMPLETED|Smoking Cessation Phase||0
411947|NCT00860028|982119|P2|COMPLETED|Smoking Cessation Phase||12
411948|NCT00860028|982120|P1|COMPLETED|Smoking Cessation Phase||13
411949|NCT00860028|982119|P2|STARTED|Smoking Cessation Phase||14
411950|NCT00860028|982120|P1|STARTED|Smoking Cessation Phase||13
411951|NCT00860028|982119|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
411952|NCT00860028|982120|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
411953|NCT00860028|982119|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
411954|NCT00860028|982120|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
411955|NCT00860028|982119|P2|STARTED|Placebo Controlled Pretreatment Period||15
411956|NCT00860028|982120|P1|STARTED|Placebo Controlled Pretreatment Period||15
411957|NCT00859950|982132|P2|NOT COMPLETED|Overall Study||0
411958|NCT00859950|982133|P1|NOT COMPLETED|Overall Study||0
411959|NCT00859950|982132|P2|COMPLETED|Overall Study||21
411960|NCT00859950|982133|P1|COMPLETED|Overall Study||49
411961|NCT00859950|982132|P2|STARTED|Overall Study||21
411962|NCT00859950|982133|P1|STARTED|Overall Study||49
411963|NCT00859937|982141|P2|NOT COMPLETED|Overall Study||0
411964|NCT00859937|982142|P1|NOT COMPLETED|Overall Study||1
411965|NCT00859937|982141|P2|COMPLETED|Overall Study||14
411966|NCT00859937|982142|P1|COMPLETED|Overall Study||40
411967|NCT00859937|982141|P2|STARTED|Overall Study||14
411968|NCT00859937|982142|P1|STARTED|Overall Study||41
411969|NCT00859898|982157|P3|NOT COMPLETED|Overall Study||27
411970|NCT00859898|982158|P2|NOT COMPLETED|Overall Study||31
411971|NCT00859898|982159|P1|NOT COMPLETED|Overall Study||28
411972|NCT00859898|982157|P3|COMPLETED|Overall Study||181
411973|NCT00859898|982158|P2|COMPLETED|Overall Study||188
411974|NCT00859898|982159|P1|COMPLETED|Overall Study||183
411975|NCT00859898|982157|P3|STARTED|Overall Study||208
411976|NCT00859898|982158|P2|STARTED|Overall Study||219
411977|NCT00859898|982159|P1|STARTED|Overall Study||211
411978|NCT00859833|982200|P1|NOT COMPLETED|Overall Study||0
411979|NCT00859833|982200|P1|COMPLETED|Overall Study||30
411980|NCT00859833|982200|P1|STARTED|Overall Study||30
411981|NCT00859638|982207|P2|NOT COMPLETED|Overall Study||4
411982|NCT00859638|982208|P1|NOT COMPLETED|Overall Study||10
411983|NCT00859638|982207|P2|COMPLETED|Overall Study||55
411984|NCT00859638|982208|P1|COMPLETED|Overall Study||55
411985|NCT00859638|982207|P2|STARTED|Overall Study||59
411986|NCT00859638|982208|P1|STARTED|Overall Study||65
411987|NCT00859586|982214|P1|NOT COMPLETED|Overall Study||4
411988|NCT00859586|982214|P1|COMPLETED|Overall Study||4
411989|NCT00859586|982214|P1|STARTED|Overall Study||8
411990|NCT00859573|982220|P2|NOT COMPLETED|Overall Study||2
411991|NCT00859573|982221|P1|NOT COMPLETED|Overall Study||5
411992|NCT00859573|982220|P2|COMPLETED|Overall Study||1
411993|NCT00859573|982221|P1|COMPLETED|Overall Study||1
411994|NCT00859573|982220|P2|STARTED|Overall Study||3
411995|NCT00859573|982221|P1|STARTED|Overall Study||6
411996|NCT00859547|982227|P1|NOT COMPLETED|Overall Study||2
411997|NCT00859547|982227|P1|COMPLETED|Overall Study||28
411998|NCT00859547|982227|P1|STARTED|Overall Study||30
411999|NCT00859521|982240|P2|NOT COMPLETED|Second Intervention||0
412000|NCT00859521|982241|P1|NOT COMPLETED|Second Intervention||0
412001|NCT00859521|982240|P2|COMPLETED|Second Intervention||14
412002|NCT00859521|982241|P1|COMPLETED|Second Intervention||15
412003|NCT00859521|982240|P2|STARTED|Second Intervention||14
412004|NCT00859521|982241|P1|STARTED|Second Intervention||15
412005|NCT00859521|982240|P2|NOT COMPLETED|Washout||1
412006|NCT00859521|982241|P1|NOT COMPLETED|Washout||0
412007|NCT00859521|982240|P2|COMPLETED|Washout||14
412008|NCT00859521|982241|P1|COMPLETED|Washout||15
412009|NCT00859521|982240|P2|STARTED|Washout||15
412010|NCT00859521|982241|P1|STARTED|Washout||15
412011|NCT00859521|982240|P2|NOT COMPLETED|First Intervention||0
412012|NCT00859521|982241|P1|NOT COMPLETED|First Intervention||0
412013|NCT00859521|982240|P2|COMPLETED|First Intervention||15
412014|NCT00859521|982241|P1|COMPLETED|First Intervention||15
412015|NCT00859521|982240|P2|STARTED|First Intervention||15
412016|NCT00859521|982241|P1|STARTED|First Intervention||15
412017|NCT00859508|982251|P2|NOT COMPLETED|Overall Study||0
412018|NCT00859508|982252|P1|NOT COMPLETED|Overall Study||6
412019|NCT00859508|982251|P2|COMPLETED|Overall Study||37
412020|NCT00859508|982252|P1|COMPLETED|Overall Study||62
412021|NCT00859508|982251|P2|STARTED|Overall Study||37
412022|NCT00859508|982252|P1|STARTED|Overall Study||68
412023|NCT00859469|982258|P1|NOT COMPLETED|Overall Study||28
412024|NCT00859469|982258|P1|COMPLETED|Overall Study||1
412025|NCT00859469|982258|P1|6 Cycles|Overall Study||16
412026|NCT00859469|982258|P1|STARTED|Overall Study||29
412027|NCT00859430|982266|P2|NOT COMPLETED|Second Intervention||0
412028|NCT00859430|982267|P1|NOT COMPLETED|Second Intervention||0
412029|NCT00859430|982266|P2|COMPLETED|Second Intervention||10
412030|NCT00859430|982267|P1|COMPLETED|Second Intervention||11
412031|NCT00859430|982266|P2|STARTED|Second Intervention||10
412032|NCT00859430|982267|P1|STARTED|Second Intervention||11
412033|NCT00859430|982266|P2|NOT COMPLETED|First Intervention||1
412034|NCT00859430|982267|P1|NOT COMPLETED|First Intervention||0
412035|NCT00859430|982266|P2|COMPLETED|First Intervention||10
412036|NCT00859430|982267|P1|COMPLETED|First Intervention||11
412037|NCT00859430|982266|P2|STARTED|First Intervention||11
412038|NCT00859430|982267|P1|STARTED|First Intervention||11
412039|NCT00859339|982275|P1|NOT COMPLETED|Overall Study||0
412040|NCT00859339|982275|P1|COMPLETED|Overall Study||9
412041|NCT00859339|982275|P1|STARTED|Overall Study||9
412042|NCT00859313|982283|P1|NOT COMPLETED|Overall Study||4
412043|NCT00859313|982283|P1|COMPLETED|Overall Study||26
412044|NCT00859313|982283|P1|STARTED|Overall Study||30
412045|NCT00859222|982290|P5|NOT COMPLETED|Overall Study||15
412046|NCT00859222|982291|P4|NOT COMPLETED|Overall Study||24
412047|NCT00859222|982292|P3|NOT COMPLETED|Overall Study||6
412048|NCT00859222|982293|P2|NOT COMPLETED|Overall Study||3
412049|NCT00859222|982294|P1|NOT COMPLETED|Overall Study||3
412050|NCT00859222|982290|P5|COMPLETED|Overall Study||0
412051|NCT00859222|982291|P4|COMPLETED|Overall Study||0
412052|NCT00859222|982292|P3|COMPLETED|Overall Study||0
412053|NCT00859222|982293|P2|COMPLETED|Overall Study||0
412054|NCT00859222|982294|P1|COMPLETED|Overall Study||0
412055|NCT00859222|982290|P5|STARTED|Overall Study||15
412056|NCT00859222|982291|P4|STARTED|Overall Study||24
412057|NCT00859222|982292|P3|STARTED|Overall Study||6
412058|NCT00859222|982293|P2|STARTED|Overall Study||3
412059|NCT00859222|982294|P1|STARTED|Overall Study||3
412060|NCT00859131|982321|P2|NOT COMPLETED|Overall Study||0
412061|NCT00859131|982322|P1|NOT COMPLETED|Overall Study||0
412062|NCT00859131|982321|P2|COMPLETED|Overall Study||98
412063|NCT00859131|982322|P1|COMPLETED|Overall Study||102
412064|NCT00859131|982321|P2|STARTED|Overall Study||98
412065|NCT00859131|982322|P1|STARTED|Overall Study||102
412066|NCT00859053|982344|P4|NOT COMPLETED|Overall Study||0
412067|NCT00859053|982345|P3|NOT COMPLETED|Overall Study||0
412068|NCT00859053|982346|P2|NOT COMPLETED|Overall Study||0
412069|NCT00859053|982347|P1|NOT COMPLETED|Overall Study||0
412070|NCT00859053|982344|P4|COMPLETED|Overall Study||12
412071|NCT00859053|982345|P3|COMPLETED|Overall Study||6
412072|NCT00859053|982346|P2|COMPLETED|Overall Study||6
412073|NCT00859053|982347|P1|COMPLETED|Overall Study||6
412074|NCT00859053|982344|P4|STARTED|Overall Study||12
412075|NCT00859053|982345|P3|STARTED|Overall Study||6
412076|NCT00859053|982346|P2|STARTED|Overall Study||6
412077|NCT00859053|982347|P1|STARTED|Overall Study||6
412078|NCT00859040|982391|P2|NOT COMPLETED|Overall Study||0
412079|NCT00859040|982392|P1|NOT COMPLETED|Overall Study||0
412080|NCT00859040|982391|P2|COMPLETED|Overall Study||16
412081|NCT00859040|982392|P1|COMPLETED|Overall Study||18
412082|NCT00859040|982391|P2|STARTED|Overall Study||16
412083|NCT00859040|982392|P1|STARTED|Overall Study||18
412084|NCT00859027|982406|P2|NOT COMPLETED|Overall Study||5
412085|NCT00859027|982407|P1|NOT COMPLETED|Overall Study||5
412086|NCT00859027|982406|P2|COMPLETED|Overall Study||20
412087|NCT00859027|982407|P1|COMPLETED|Overall Study||20
412088|NCT00859027|982406|P2|STARTED|Overall Study||25
412089|NCT00859027|982407|P1|STARTED|Overall Study||25
412090|NCT00859014|982413|P1|NOT COMPLETED|Overall Study||5
412091|NCT00859014|982413|P1|COMPLETED|Overall Study||20
412092|NCT00859014|982413|P1|STARTED|Overall Study||25
412093|NCT00858962|982418|P1|NOT COMPLETED|Overall Study||0
412094|NCT00858962|982418|P1|COMPLETED|Overall Study||12
412095|NCT00858962|982418|P1|STARTED|Overall Study||12
412096|NCT00858858|982422|P1|NOT COMPLETED|Overall Study||18
412097|NCT00858858|982422|P1|COMPLETED|Overall Study||42
412098|NCT00858858|982422|P1|STARTED|Overall Study||60
412099|NCT00858845|982426|P1|NOT COMPLETED|Overall Study||1
412100|NCT00858845|982426|P1|COMPLETED|Overall Study||10
412101|NCT00858845|982426|P1|STARTED|Overall Study||11
412102|NCT00858832|982432|P2|NOT COMPLETED|Overall Study||1
412103|NCT00858832|982433|P1|NOT COMPLETED|Overall Study||1
412104|NCT00858832|982432|P2|COMPLETED|Overall Study||22
412105|NCT00858832|982433|P1|COMPLETED|Overall Study||20
412106|NCT00858832|982432|P2|STARTED|Overall Study||23
412107|NCT00858832|982433|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
412108|NCT00858780|982439|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
412109|NCT00858780|982440|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412110|NCT00858780|982441|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412111|NCT00858780|982442|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412112|NCT00858780|982443|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412113|NCT00858780|982439|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
412114|NCT00858780|982440|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412115|NCT00858780|982441|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412116|NCT00858780|982442|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412117|NCT00858780|982443|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
412118|NCT00858780|982439|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
412119|NCT00858780|982440|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
412120|NCT00858780|982441|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
412121|NCT00858780|982442|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
412122|NCT00858780|982443|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
412123|NCT00858780|982439|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
412124|NCT00858780|982440|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
412125|NCT00858780|982441|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
412126|NCT00858780|982442|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
412127|NCT00858780|982443|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
412128|NCT00858780|982439|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
412129|NCT00858780|982440|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
412130|NCT00858780|982441|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
412131|NCT00858780|982442|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
412132|NCT00858780|982443|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
412133|NCT00858780|982439|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
412134|NCT00858780|982440|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
412135|NCT00858780|982441|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
412136|NCT00858780|982442|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
412137|NCT00858780|982443|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
412138|NCT00858780|982439|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412139|NCT00858780|982440|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412140|NCT00858780|982441|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412141|NCT00858780|982442|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412142|NCT00858780|982443|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
412143|NCT00858780|982439|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412144|NCT00858780|982440|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412145|NCT00858780|982441|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412146|NCT00858780|982442|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412147|NCT00858780|982443|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
412148|NCT00858780|982439|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412149|NCT00858780|982440|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412150|NCT00858780|982441|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412151|NCT00858780|982442|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
412152|NCT00858780|982443|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
412153|NCT00858702|982518|P2|NOT COMPLETED|Overall Study||2
412154|NCT00858702|982519|P1|NOT COMPLETED|Overall Study||5
412155|NCT00858702|982518|P2|COMPLETED|Overall Study||50
412156|NCT00858702|982519|P1|COMPLETED|Overall Study||48
412157|NCT00858702|982518|P2|STARTED|Overall Study||52
412158|NCT00858702|982519|P1|STARTED|Overall Study||53
412159|NCT00858689|982529|P1|NOT COMPLETED|Overall Study||1
412160|NCT00858689|982529|P1|COMPLETED|Overall Study||19
412161|NCT00858689|982529|P1|STARTED|Overall Study||20
412162|NCT00858637|982536|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
412163|NCT00858637|982537|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
412164|NCT00858637|982538|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
412165|NCT00858637|982539|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
412166|NCT00858637|982540|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
412167|NCT00858637|982541|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
412168|NCT00858637|982536|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
412169|NCT00858637|982537|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
412170|NCT00858637|982538|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
412171|NCT00858637|982539|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
412172|NCT00858637|982540|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
412173|NCT00858637|982541|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
412174|NCT00858637|982536|P6|STARTED|Placebo-controlled Withdrawal Phase||59
412175|NCT00858637|982537|P5|STARTED|Placebo-controlled Withdrawal Phase||56
412176|NCT00858637|982538|P4|STARTED|Placebo-controlled Withdrawal Phase||0
412177|NCT00858637|982539|P3|STARTED|Placebo-controlled Withdrawal Phase||54
412178|NCT00858637|982540|P2|STARTED|Placebo-controlled Withdrawal Phase||49
412179|NCT00858637|982541|P1|STARTED|Placebo-controlled Withdrawal Phase||0
412180|NCT00858637|982536|P6|NOT COMPLETED|Active Comparison Phase||0
412181|NCT00858637|982537|P5|NOT COMPLETED|Active Comparison Phase||0
412182|NCT00858637|982538|P4|NOT COMPLETED|Active Comparison Phase||18
412183|NCT00858637|982539|P3|NOT COMPLETED|Active Comparison Phase||0
412184|NCT00858637|982540|P2|NOT COMPLETED|Active Comparison Phase||0
412185|NCT00858637|982541|P1|NOT COMPLETED|Active Comparison Phase||24
412186|NCT00858637|982536|P6|COMPLETED|Active Comparison Phase||0
412187|NCT00858637|982537|P5|COMPLETED|Active Comparison Phase||0
412188|NCT00858637|982538|P4|COMPLETED|Active Comparison Phase||115
412189|NCT00858637|982539|P3|COMPLETED|Active Comparison Phase||0
412190|NCT00858637|982540|P2|COMPLETED|Active Comparison Phase||0
412191|NCT00858637|982541|P1|COMPLETED|Active Comparison Phase||103
412192|NCT00858637|982536|P6|STARTED|Active Comparison Phase||0
412193|NCT00858637|982537|P5|STARTED|Active Comparison Phase||0
412194|NCT00858637|982538|P4|STARTED|Active Comparison Phase||133
412195|NCT00858637|982539|P3|STARTED|Active Comparison Phase||0
412196|NCT00858637|982540|P2|STARTED|Active Comparison Phase||0
412197|NCT00858637|982541|P1|STARTED|Active Comparison Phase||127
412198|NCT00858507|982553|P2|NOT COMPLETED|Overall Study||15
412199|NCT00858507|982554|P1|NOT COMPLETED|Overall Study||22
412200|NCT00858507|982553|P2|COMPLETED|Overall Study||101
412201|NCT00858507|982554|P1|COMPLETED|Overall Study||83
412202|NCT00858507|982553|P2|STARTED|Overall Study||116
412203|NCT00858507|982554|P1|STARTED|Overall Study||105
412204|NCT00858494|982560|P1|NOT COMPLETED|Overall Study||4
412205|NCT00858494|982560|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
412206|NCT00858494|982560|P1|STARTED|Overall Study||49
412207|NCT00858468|982567|P2|NOT COMPLETED|Overall Study||0
412208|NCT00858468|982568|P1|NOT COMPLETED|Overall Study||0
412209|NCT00858468|982567|P2|COMPLETED|Overall Study||192
412210|NCT00858468|982568|P1|COMPLETED|Overall Study||201
412211|NCT00858468|982567|P2|STARTED|Overall Study||192
412212|NCT00858468|982568|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
412213|NCT00858442|982582|P2|NOT COMPLETED|Compression:Start to Finish||3
412214|NCT00858442|982583|P1|NOT COMPLETED|Compression:Start to Finish||1
412215|NCT00858442|982582|P2|COMPLETED|Compression:Start to Finish||20
412216|NCT00858442|982583|P1|COMPLETED|Compression:Start to Finish||20
412217|NCT00858442|982582|P2|STARTED|Compression:Start to Finish||23
412218|NCT00858442|982583|P1|STARTED|Compression:Start to Finish||21
412219|NCT00858442|982582|P2|NOT COMPLETED|From Surgery to Start Compression;||0
412220|NCT00858442|982583|P1|NOT COMPLETED|From Surgery to Start Compression;||0
412221|NCT00858442|982582|P2|COMPLETED|From Surgery to Start Compression;||23
412222|NCT00858442|982583|P1|COMPLETED|From Surgery to Start Compression;||21
412223|NCT00858442|982582|P2|STARTED|From Surgery to Start Compression;||23
412224|NCT00858442|982583|P1|STARTED|From Surgery to Start Compression;||21
412225|NCT00858403|982593|P1|NOT COMPLETED|Overall Study||5
412226|NCT00858403|982593|P1|COMPLETED|Overall Study||2
412227|NCT00858403|982593|P1|STARTED|Overall Study||7
412228|NCT00858390|982605|P2|NOT COMPLETED|Overall Study||0
412229|NCT00858390|982606|P1|NOT COMPLETED|Overall Study||0
412230|NCT00858390|982605|P2|COMPLETED|Overall Study||18
412231|NCT00858390|982606|P1|COMPLETED|Overall Study||18
412232|NCT00858390|982605|P2|STARTED|Overall Study||18
412233|NCT00858390|982606|P1|STARTED|Overall Study||18
412234|NCT00858247|982614|P2|NOT COMPLETED|Week 12 Follow-up||1
412235|NCT00858247|982615|P1|NOT COMPLETED|Week 12 Follow-up||0
412236|NCT00858247|982614|P2|COMPLETED|Week 12 Follow-up||23
412237|NCT00858247|982615|P1|COMPLETED|Week 12 Follow-up||23
412238|NCT00858247|982614|P2|STARTED|Week 12 Follow-up||24
412239|NCT00858247|982615|P1|STARTED|Week 12 Follow-up||23
412240|NCT00858247|982614|P2|NOT COMPLETED|Baseline Assessment||2
412241|NCT00858247|982615|P1|NOT COMPLETED|Baseline Assessment||2
412242|NCT00858247|982614|P2|COMPLETED|Baseline Assessment||24
412243|NCT00858247|982615|P1|COMPLETED|Baseline Assessment||23
412244|NCT00858247|982614|P2|STARTED|Baseline Assessment||26
412245|NCT00858247|982615|P1|STARTED|Baseline Assessment||25
412246|NCT00858208|982631|P1|NOT COMPLETED|Overall Study||79
412247|NCT00858208|982631|P1|COMPLETED|Overall Study||6
412248|NCT00858208|982631|P1|STARTED|Overall Study||85
412249|NCT00858143|982648|P1|NOT COMPLETED|Overall Study||50
412250|NCT00858143|982648|P1|COMPLETED|Overall Study||261
412251|NCT00858143|982648|P1|STARTED|Overall Study|Baseline|311
412252|NCT00858013|982699|P2|NOT COMPLETED|Overall Study||19
412253|NCT00858013|982700|P1|NOT COMPLETED|Overall Study||22
412254|NCT00858013|982699|P2|COMPLETED|Overall Study||23
412255|NCT00858013|982700|P1|COMPLETED|Overall Study||24
412256|NCT00858013|982699|P2|STARTED|Overall Study||42
412257|NCT00858013|982700|P1|STARTED|Overall Study||46
412258|NCT00857961|982714|P1|NOT COMPLETED|Overall Study||0
412259|NCT00857961|982714|P1|COMPLETED|Overall Study||21
412260|NCT00857961|982714|P1|STARTED|Overall Study||21
412261|NCT00857948|982752|P4|NOT COMPLETED|Overall Study||0
412262|NCT00857948|982753|P3|NOT COMPLETED|Overall Study||1
412263|NCT00857948|982754|P2|NOT COMPLETED|Overall Study||0
412264|NCT00857948|982755|P1|NOT COMPLETED|Overall Study||3
412265|NCT00857948|982752|P4|COMPLETED|Overall Study||23
412266|NCT00857948|982753|P3|COMPLETED|Overall Study||18
412267|NCT00857948|982754|P2|COMPLETED|Overall Study||18
412268|NCT00857948|982755|P1|COMPLETED|Overall Study||15
412269|NCT00857948|982752|P4|STARTED|Overall Study||23
412270|NCT00857948|982753|P3|STARTED|Overall Study||19
412271|NCT00857948|982754|P2|STARTED|Overall Study||18
412272|NCT00857948|982755|P1|STARTED|Overall Study||18
412273|NCT00857896|982777|P1|NOT COMPLETED|Week 5 to Week 8||0
412274|NCT00857896|982777|P1|COMPLETED|Week 5 to Week 8||20
412275|NCT00857896|982777|P1|STARTED|Week 5 to Week 8||20
412276|NCT00857896|982777|P1|NOT COMPLETED|Baseline to Week 4||1
412277|NCT00857896|982777|P1|COMPLETED|Baseline to Week 4||20
412278|NCT00857896|982777|P1|STARTED|Baseline to Week 4||21
412279|NCT00857818|982791|P2|NOT COMPLETED|Overall Study||8
412280|NCT00857818|982792|P1|NOT COMPLETED|Overall Study||11
412281|NCT00857818|982791|P2|COMPLETED|Overall Study||6
412282|NCT00857818|982792|P1|COMPLETED|Overall Study||3
412283|NCT00857818|982791|P2|Received Treatment|Overall Study||12
412284|NCT00857818|982792|P1|Received Treatment|Overall Study||14
412285|NCT00857818|982791|P2|STARTED|Overall Study||14
412286|NCT00857818|982792|P1|STARTED|Overall Study||14
412287|NCT00857792|982820|P1|NOT COMPLETED|Overall Study||12
412288|NCT00857792|982820|P1|COMPLETED|Overall Study||108
412289|NCT00857792|982820|P1|STARTED|Overall Study||120
412290|NCT00857766|982826|P2|NOT COMPLETED|Overall Study||30
412291|NCT00857766|982827|P1|NOT COMPLETED|Overall Study||31
412292|NCT00857766|982826|P2|COMPLETED|Overall Study||96
412293|NCT00857766|982827|P1|COMPLETED|Overall Study||92
412294|NCT00857766|982826|P2|STARTED|Overall Study||126
412295|NCT00857766|982827|P1|STARTED|Overall Study||123
412296|NCT00857714|982837|P1|NOT COMPLETED|Overall Study||0
412297|NCT00857714|982837|P1|COMPLETED|Overall Study||1
412298|NCT00857714|982837|P1|STARTED|Overall Study||1
412299|NCT00857649|982844|P2|NOT COMPLETED|Overall Study||32
412300|NCT00857649|982845|P1|NOT COMPLETED|Overall Study||31
412301|NCT00857649|982844|P2|COMPLETED|Overall Study||155
412302|NCT00857649|982845|P1|COMPLETED|Overall Study||151
412303|NCT00857649|982844|P2|STARTED|Overall Study||187
412304|NCT00857649|982845|P1|STARTED|Overall Study||182
412305|NCT00857623|982861|P2|NOT COMPLETED|Overall Study||10
412306|NCT00857623|982862|P1|NOT COMPLETED|Overall Study||14
412307|NCT00857623|982861|P2|COMPLETED|Overall Study||55
412308|NCT00857623|982862|P1|COMPLETED|Overall Study||48
412309|NCT00857623|982861|P2|STARTED|Overall Study||65
412310|NCT00857623|982862|P1|STARTED|Overall Study||62
412311|NCT00857584|982886|P2|NOT COMPLETED|Overall Study||5
412312|NCT00857584|982887|P1|NOT COMPLETED|Overall Study||4
412313|NCT00857584|982886|P2|COMPLETED|Overall Study||8
412314|NCT00857584|982887|P1|COMPLETED|Overall Study||10
412315|NCT00857584|982886|P2|Week 8|Overall Study||8
412316|NCT00857584|982887|P1|Week 8|Overall Study||10
412317|NCT00857584|982886|P2|Week 4|Overall Study||9
412318|NCT00857584|982887|P1|Week 4|Overall Study||11
412319|NCT00857584|982886|P2|Week 2|Overall Study||11
412320|NCT00857584|982887|P1|Week 2|Overall Study||14
412321|NCT00857584|982886|P2|Week 1|Overall Study||13
412322|NCT00857584|982887|P1|Week 1|Overall Study||14
412323|NCT00857584|982886|P2|STARTED|Overall Study||13
412324|NCT00857584|982887|P1|STARTED|Overall Study||14
412325|NCT00857532|982927|P1|NOT COMPLETED|Overall Study||0
412326|NCT00857532|982927|P1|COMPLETED|Overall Study||31
412327|NCT00857532|982927|P1|STARTED|Overall Study||31
412328|NCT00857506|982938|P3|NOT COMPLETED|Overall Study||18
412329|NCT00857506|982939|P2|NOT COMPLETED|Overall Study||15
412330|NCT00857506|982940|P1|NOT COMPLETED|Overall Study||15
412331|NCT00857506|982938|P3|COMPLETED|Overall Study||51
412332|NCT00857506|982939|P2|COMPLETED|Overall Study||37
412333|NCT00857506|982940|P1|COMPLETED|Overall Study||16
412334|NCT00857506|982938|P3|STARTED|Overall Study||69
412335|NCT00857506|982939|P2|STARTED|Overall Study||52
412336|NCT00857506|982940|P1|STARTED|Overall Study||31
412337|NCT00857454|982966|P1|NOT COMPLETED|Overall Study||20
412338|NCT00857454|982966|P1|COMPLETED|Overall Study||51
412339|NCT00857454|982966|P1|STARTED|Overall Study||71
412340|NCT00857415|982979|P2|NOT COMPLETED|Overall Study||0
412341|NCT00857415|982980|P1|NOT COMPLETED|Overall Study||117
412342|NCT00857415|982979|P2|COMPLETED|Overall Study||74
412343|NCT00857415|982980|P1|COMPLETED|Overall Study||35
412344|NCT00857415|982979|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
412345|NCT00857415|982980|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
412346|NCT00857415|982979|P2|STARTED|Overall Study||74
412347|NCT00857415|982980|P1|STARTED|Overall Study||152
412348|NCT00857311|982991|P4|NOT COMPLETED|Overall Study||0
412349|NCT00857311|982992|P3|NOT COMPLETED|Overall Study||0
412350|NCT00857311|982993|P2|NOT COMPLETED|Overall Study||0
412351|NCT00857311|982994|P1|NOT COMPLETED|Overall Study||1
412352|NCT00857311|982991|P4|COMPLETED|Overall Study||0
412353|NCT00857311|982992|P3|COMPLETED|Overall Study||8
412354|NCT00857311|982993|P2|COMPLETED|Overall Study||0
412355|NCT00857311|982994|P1|COMPLETED|Overall Study||8
412356|NCT00857311|982991|P4|STARTED|Overall Study||0
412357|NCT00857311|982992|P3|STARTED|Overall Study||8
412358|NCT00857311|982993|P2|STARTED|Overall Study||0
412359|NCT00857311|982994|P1|STARTED|Overall Study||9
412360|NCT00857285|983006|P2|NOT COMPLETED|Overall Study||6
412361|NCT00857285|983007|P1|NOT COMPLETED|Overall Study||12
412362|NCT00857285|983006|P2|COMPLETED|Overall Study||59
412363|NCT00857285|983007|P1|COMPLETED|Overall Study||53
412364|NCT00857285|983006|P2|STARTED|Overall Study||65
412365|NCT00857285|983007|P1|STARTED|Overall Study||65
412366|NCT00857272|983013|P2|NOT COMPLETED|Overall Study||9
412367|NCT00857272|983014|P1|NOT COMPLETED|Overall Study||9
412368|NCT00857272|983013|P2|COMPLETED|Overall Study||145
412369|NCT00857272|983014|P1|COMPLETED|Overall Study||145
412370|NCT00857272|983013|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
412371|NCT00857272|983014|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
412372|NCT00857259|983023|P3|NOT COMPLETED|Overall Study||1
412373|NCT00857259|983024|P2|NOT COMPLETED|Overall Study||0
412374|NCT00857259|983025|P1|NOT COMPLETED|Overall Study||1
412375|NCT00857259|983023|P3|COMPLETED|Overall Study||6
412376|NCT00857259|983024|P2|COMPLETED|Overall Study||1
412377|NCT00857259|983025|P1|COMPLETED|Overall Study||7
412378|NCT00857259|983023|P3|STARTED|Overall Study||7
412379|NCT00857259|983024|P2|STARTED|Overall Study||1
412380|NCT00857259|983025|P1|STARTED|Overall Study||8
412381|NCT00857246|983035|P1|NOT COMPLETED|ChemoRT||3
412382|NCT00857246|983035|P1|COMPLETED|ChemoRT||12
412383|NCT00857246|983035|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
412384|NCT00857246|983035|P1|NOT COMPLETED|Surgery (Curative)||6
412385|NCT00857246|983035|P1|COMPLETED|Surgery (Curative)||21
412386|NCT00857246|983035|P1|STARTED|Surgery (Curative)||27
412387|NCT00857246|983035|P1|NOT COMPLETED|Induction Regimen||3
412388|NCT00857246|983035|P1|COMPLETED|Induction Regimen||27
412389|NCT00857246|983035|P1|STARTED|Induction Regimen||30
412390|NCT00857233|983045|P1|NOT COMPLETED|Overall Study||55
412391|NCT00857233|983045|P1|COMPLETED|Overall Study||242
412392|NCT00857233|983045|P1|STARTED|Overall Study||297
412393|NCT00857220|983054|P1|NOT COMPLETED|Overall Study||183
412394|NCT00857220|983054|P1|COMPLETED|Overall Study||121
412395|NCT00857220|983054|P1|STARTED|Overall Study||304
412396|NCT00856986|983076|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
412397|NCT00856986|983077|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
412398|NCT00856986|983078|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
412399|NCT00856986|983079|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
412400|NCT00856986|983080|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
412401|NCT00856986|983076|P5|COMPLETED|Extension Period, Weeks 26-52||0
412402|NCT00856986|983077|P4|COMPLETED|Extension Period, Weeks 26-52||0
412403|NCT00856986|983078|P3|COMPLETED|Extension Period, Weeks 26-52||432
412404|NCT00856986|983079|P2|COMPLETED|Extension Period, Weeks 26-52||130
412405|NCT00856986|983080|P1|COMPLETED|Extension Period, Weeks 26-52||108
412406|NCT00856986|983076|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
412407|NCT00856986|983077|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
412408|NCT00856986|983078|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
412409|NCT00856986|983079|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
412410|NCT00856986|983080|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
412411|NCT00856986|983076|P5|STARTED|Extension Period, Weeks 26-52||0
412412|NCT00856986|983077|P4|STARTED|Extension Period, Weeks 26-52||0
412413|NCT00856986|983078|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
412414|NCT00856986|983079|P2|STARTED|Extension Period, Weeks 26-52||144
412415|NCT00856986|983080|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
412416|NCT00856986|983076|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
412417|NCT00856986|983077|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
412418|NCT00856986|983078|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
412419|NCT00856986|983079|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
412420|NCT00856986|983080|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
412421|NCT00856986|983076|P5|COMPLETED|Main Period, Weeks 0-26||0
412422|NCT00856986|983077|P4|COMPLETED|Main Period, Weeks 0-26||0
412423|NCT00856986|983078|P3|COMPLETED|Main Period, Weeks 0-26||470
412424|NCT00856986|983079|P2|COMPLETED|Main Period, Weeks 0-26||144
412425|NCT00856986|983080|P1|COMPLETED|Main Period, Weeks 0-26||127
412426|NCT00856986|983076|P5|STARTED|Main Period, Weeks 0-26||0
412427|NCT00856986|983077|P4|STARTED|Main Period, Weeks 0-26||0
412428|NCT00856986|983078|P3|STARTED|Main Period, Weeks 0-26||498
412429|NCT00856986|983079|P2|STARTED|Main Period, Weeks 0-26||162
412430|NCT00856986|983080|P1|STARTED|Main Period, Weeks 0-26||161
412431|NCT00856986|983076|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
412432|NCT00856986|983077|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
412433|NCT00856986|983078|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
412434|NCT00856986|983079|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
412435|NCT00856986|983080|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
412436|NCT00856986|983076|P5|COMPLETED|Run-in Period, Weeks -12-0||0
412437|NCT00856986|983077|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
412438|NCT00856986|983078|P3|COMPLETED|Run-in Period, Weeks -12-0||498
412439|NCT00856986|983079|P2|COMPLETED|Run-in Period, Weeks -12-0||162
412440|NCT00856986|983080|P1|COMPLETED|Run-in Period, Weeks -12-0||161
412441|NCT00856986|983076|P5|STARTED|Run-in Period, Weeks -12-0||0
412442|NCT00856986|983077|P4|STARTED|Run-in Period, Weeks -12-0||167
412443|NCT00856986|983078|P3|STARTED|Run-in Period, Weeks -12-0||498
412444|NCT00856986|983079|P2|STARTED|Run-in Period, Weeks -12-0||162
412445|NCT00856986|983080|P1|STARTED|Run-in Period, Weeks -12-0||161
412446|NCT00856973|983250|P3|NOT COMPLETED|Overall Study||38
412447|NCT00856973|983251|P2|NOT COMPLETED|Overall Study||41
412448|NCT00856973|983252|P1|NOT COMPLETED|Overall Study||36
412449|NCT00856973|983250|P3|COMPLETED|Overall Study||123
412450|NCT00856973|983251|P2|COMPLETED|Overall Study||122
412451|NCT00856973|983252|P1|COMPLETED|Overall Study||126
412452|NCT00856973|983250|P3|STARTED|Overall Study||161
412453|NCT00856973|983251|P2|STARTED|Overall Study||163
412454|NCT00856973|983252|P1|STARTED|Overall Study||162
412455|NCT00856934|983320|P3|NOT COMPLETED|Overall Study||0
412456|NCT00856934|983321|P2|NOT COMPLETED|Overall Study||0
412457|NCT00856934|983322|P1|NOT COMPLETED|Overall Study||0
412458|NCT00856934|983320|P3|COMPLETED|Overall Study||15
412459|NCT00856934|983321|P2|COMPLETED|Overall Study||15
412460|NCT00856934|983322|P1|COMPLETED|Overall Study||15
412461|NCT00856934|983320|P3|STARTED|Overall Study||15
412462|NCT00856934|983321|P2|STARTED|Overall Study||15
412463|NCT00856934|983322|P1|STARTED|Overall Study||15
412464|NCT00856908|983332|P2|NOT COMPLETED|Overall Study||0
412465|NCT00856908|983333|P1|NOT COMPLETED|Overall Study||1
412466|NCT00856908|983332|P2|COMPLETED|Overall Study||5
412467|NCT00856908|983333|P1|COMPLETED|Overall Study||14
412468|NCT00856908|983332|P2|STARTED|Overall Study||5
412469|NCT00856908|983333|P1|STARTED|Overall Study||15
412470|NCT00856843|983360|P2|NOT COMPLETED|Overall Study||5
412471|NCT00856843|983361|P1|NOT COMPLETED|Overall Study||2
412472|NCT00856843|983360|P2|COMPLETED|Overall Study||63
412473|NCT00856843|983361|P1|COMPLETED|Overall Study||66
412474|NCT00856843|983360|P2|STARTED|Overall Study||68
412475|NCT00856843|983361|P1|STARTED|Overall Study||68
412476|NCT00856791|983393|P1|NOT COMPLETED|Overall Study||0
412477|NCT00856791|983393|P1|COMPLETED|Overall Study||1
412478|NCT00856791|983393|P1|STARTED|Overall Study||1
412479|NCT00856778|983398|P1|NOT COMPLETED|Overall Study||24
412480|NCT00856778|983398|P1|COMPLETED|Overall Study||74
412481|NCT00856778|983398|P1|STARTED|Overall Study||98
412482|NCT00856739|983417|P3|NOT COMPLETED|Overall Study||0
412483|NCT00856739|983418|P2|NOT COMPLETED|Overall Study||0
412484|NCT00856739|983419|P1|NOT COMPLETED|Overall Study||0
412485|NCT00856739|983417|P3|COMPLETED|Overall Study||55
412486|NCT00856739|983418|P2|COMPLETED|Overall Study||52
412487|NCT00856739|983419|P1|COMPLETED|Overall Study||70
412488|NCT00856739|983417|P3|STARTED|Overall Study||55
412489|NCT00856739|983418|P2|STARTED|Overall Study||52
412490|NCT00856739|983419|P1|STARTED|Overall Study||70
412491|NCT00856661|983432|P2|NOT COMPLETED|Overall Study||29
412492|NCT00856661|983433|P1|NOT COMPLETED|Overall Study||27
412493|NCT00856661|983432|P2|COMPLETED|Overall Study||106
412494|NCT00856661|983433|P1|COMPLETED|Overall Study||108
412495|NCT00856661|983432|P2|Randomized Not Treated|Overall Study||4
412496|NCT00856661|983433|P1|Randomized Not Treated|Overall Study||9
412497|NCT00856661|983432|P2|Treated|Overall Study||131
412498|NCT00856661|983433|P1|Treated|Overall Study||126
412499|NCT00856661|983432|P2|STARTED|Overall Study|Randomised|135
412500|NCT00856661|983433|P1|STARTED|Overall Study|Randomised|135
412501|NCT00856635|983447|P2|NOT COMPLETED|Overall Study||8
412502|NCT00856635|983448|P1|NOT COMPLETED|Overall Study||10
412503|NCT00856635|983447|P2|COMPLETED|Overall Study||14
412504|NCT00856635|983448|P1|COMPLETED|Overall Study||12
412505|NCT00856635|983447|P2|Received Study Drug|Overall Study||20
412506|NCT00856635|983448|P1|Received Study Drug|Overall Study||20
412507|NCT00856635|983447|P2|STARTED|Overall Study||22
412508|NCT00856635|983448|P1|STARTED|Overall Study||22
412509|NCT00856583|983456|P2|NOT COMPLETED|Overall Study||2597
412510|NCT00856583|983457|P1|NOT COMPLETED|Overall Study||3137
412511|NCT00856583|983456|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
412512|NCT00856583|983457|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
412513|NCT00856583|983456|P2|STARTED|Overall Study|Patients treated|4904
412514|NCT00856583|983457|P1|STARTED|Overall Study|Patients treated|4905
412515|NCT00856557|983487|P2|NOT COMPLETED|Overall Study||16
412516|NCT00856557|983488|P1|NOT COMPLETED|Overall Study||12
412517|NCT00856557|983487|P2|COMPLETED|Overall Study||60
412518|NCT00856557|983488|P1|COMPLETED|Overall Study||50
412519|NCT00856557|983487|P2|With Patients With Contextual Flags|Overall Study||60
412520|NCT00856557|983488|P1|With Patients With Contextual Flags|Overall Study||50
412521|NCT00856557|983487|P2|Tested With Standardized Patients|Overall Study||76
412522|NCT00856557|983488|P1|Tested With Standardized Patients|Overall Study||62
412523|NCT00856557|983487|P2|Received Intervention/Control|Overall Study||76
412524|NCT00856557|983488|P1|Received Intervention/Control|Overall Study||62
412525|NCT00856557|983487|P2|STARTED|Overall Study||76
412526|NCT00856557|983488|P1|STARTED|Overall Study||62
412527|NCT00856544|983502|P4|NOT COMPLETED|Overall Study||13
412528|NCT00856544|983503|P3|NOT COMPLETED|Overall Study||8
412529|NCT00856544|983504|P2|NOT COMPLETED|Overall Study||66
412530|NCT00856544|983505|P1|NOT COMPLETED|Overall Study||57
412531|NCT00856544|983502|P4|COMPLETED|Overall Study||67
412532|NCT00856544|983503|P3|COMPLETED|Overall Study||71
412533|NCT00856544|983504|P2|COMPLETED|Overall Study||252
412534|NCT00856544|983505|P1|COMPLETED|Overall Study||261
412535|NCT00856544|983502|P4|Treated|Overall Study||80
412536|NCT00856544|983503|P3|Treated|Overall Study||79
412537|NCT00856544|983504|P2|Treated|Overall Study||318
412538|NCT00856544|983505|P1|Treated|Overall Study||315
412539|NCT00856544|983502|P4|STARTED|Overall Study||80
412540|NCT00856544|983503|P3|STARTED|Overall Study||79
412541|NCT00856544|983504|P2|STARTED|Overall Study||318
412542|NCT00856544|983505|P1|STARTED|Overall Study||318
412543|NCT00856518|983684|P2|NOT COMPLETED|Overall Study||2
412544|NCT00856518|983685|P1|NOT COMPLETED|Overall Study||4
412545|NCT00856518|983684|P2|COMPLETED|Overall Study||16
412546|NCT00856518|983685|P1|COMPLETED|Overall Study||20
412547|NCT00856518|983684|P2|STARTED|Overall Study||18
412548|NCT00856518|983685|P1|STARTED|Overall Study||24
412549|NCT00856414|983695|P1|NOT COMPLETED|Overall Study||0
412550|NCT00856414|983695|P1|COMPLETED|Overall Study||45
412551|NCT00856414|983695|P1|STARTED|Overall Study||45
412552|NCT00856388|983703|P1|NOT COMPLETED|Overall Study||1
412553|NCT00856388|983703|P1|COMPLETED|Overall Study||61
412554|NCT00856388|983703|P1|STARTED|Overall Study||62
412555|NCT00856349|983714|P1|NOT COMPLETED|Overall Study||1021
412556|NCT00856349|983714|P1|COMPLETED|Overall Study||3111
412557|NCT00856349|983714|P1|24 Month Follow-up|Overall Study||1698
412558|NCT00856349|983714|P1|18 Month Follow-up|Overall Study||2467
412559|NCT00856349|983714|P1|12 Month Follow-up|Overall Study||3228
412560|NCT00856349|983714|P1|STARTED|Overall Study||4132
412561|NCT00856323|983723|P1|NOT COMPLETED|Overall Study||2
412562|NCT00856323|983723|P1|COMPLETED|Overall Study||51
412563|NCT00856323|983723|P1|STARTED|Overall Study||53
412564|NCT00856297|983735|P5|NOT COMPLETED|Overall Study||0
412565|NCT00856297|983736|P4|NOT COMPLETED|Overall Study||0
412566|NCT00856297|983737|P3|NOT COMPLETED|Overall Study||0
412567|NCT00856297|983738|P2|NOT COMPLETED|Overall Study||0
412568|NCT00856297|983739|P1|NOT COMPLETED|Overall Study||2
412569|NCT00856297|983735|P5|COMPLETED|Overall Study||31
412570|NCT00856297|983736|P4|COMPLETED|Overall Study||44
412571|NCT00856297|983737|P3|COMPLETED|Overall Study||107
412572|NCT00856297|983738|P2|COMPLETED|Overall Study||76
412573|NCT00856297|983739|P1|COMPLETED|Overall Study||129
412574|NCT00856297|983735|P5|STARTED|Overall Study||31
412575|NCT00856297|983736|P4|STARTED|Overall Study||44
412576|NCT00856297|983737|P3|STARTED|Overall Study||107
412577|NCT00856297|983738|P2|STARTED|Overall Study||76
412578|NCT00856297|983739|P1|STARTED|Overall Study||131
412579|NCT00856284|983772|P3|NOT COMPLETED|Overall Study||447
412580|NCT00856284|983773|P2|NOT COMPLETED|Overall Study||392
412581|NCT00856284|983774|P1|NOT COMPLETED|Overall Study||408
412582|NCT00856284|983772|P3|COMPLETED|Overall Study||427
412583|NCT00856284|983773|P2|COMPLETED|Overall Study||493
412584|NCT00856284|983774|P1|COMPLETED|Overall Study||472
412585|NCT00856284|983772|P3|Received Study Drug|Overall Study||869
412586|NCT00856284|983773|P2|Received Study Drug|Overall Study||878
412587|NCT00856284|983774|P1|Received Study Drug|Overall Study||873
412588|NCT00856284|983772|P3|STARTED|Overall Study||874
412589|NCT00856284|983773|P2|STARTED|Overall Study||885
412590|NCT00856284|983774|P1|STARTED|Overall Study||880
412591|NCT00856245|983800|P1|NOT COMPLETED|Overall Study||5
412592|NCT00856245|983800|P1|COMPLETED|Overall Study||14
412593|NCT00856245|983800|P1|STARTED|Overall Study||19
412594|NCT00856232|983808|P3|NOT COMPLETED|Overall Study||0
412595|NCT00856232|983809|P2|NOT COMPLETED|Overall Study||0
412596|NCT00856232|983810|P1|NOT COMPLETED|Overall Study||0
412597|NCT00856232|983808|P3|COMPLETED|Overall Study||36
412598|NCT00856232|983809|P2|COMPLETED|Overall Study||29
412599|NCT00856232|983810|P1|COMPLETED|Overall Study||26
412600|NCT00856232|983808|P3|STARTED|Overall Study||36
412601|NCT00856232|983809|P2|STARTED|Overall Study||29
412602|NCT00856232|983810|P1|STARTED|Overall Study||26
412603|NCT00856206|983823|P2|NOT COMPLETED|Overall Study||161
412604|NCT00856206|983824|P1|NOT COMPLETED|Overall Study||54
412605|NCT00856206|983823|P2|COMPLETED|Overall Study||824
412606|NCT00856206|983824|P1|COMPLETED|Overall Study||276
412607|NCT00856206|983823|P2|STARTED|Overall Study||985
412608|NCT00856206|983824|P1|STARTED|Overall Study||330
412609|NCT00856193|983838|P2|NOT COMPLETED|Period 2||2
412610|NCT00856193|983839|P1|NOT COMPLETED|Period 2||0
412611|NCT00856193|983838|P2|COMPLETED|Period 2||15
412612|NCT00856193|983839|P1|COMPLETED|Period 2||16
412613|NCT00856193|983838|P2|STARTED|Period 2||17
412614|NCT00856193|983839|P1|STARTED|Period 2||16
412615|NCT00856193|983838|P2|NOT COMPLETED|Period 1||0
412616|NCT00856193|983839|P1|NOT COMPLETED|Period 1||0
412617|NCT00856193|983838|P2|COMPLETED|Period 1||17
412618|NCT00856193|983839|P1|COMPLETED|Period 1||16
412619|NCT00856193|983838|P2|STARTED|Period 1||17
412620|NCT00856193|983839|P1|STARTED|Period 1||16
412621|NCT00856180|983851|P1|NOT COMPLETED|Overall Study||20
412622|NCT00856180|983851|P1|COMPLETED|Overall Study||0
412623|NCT00856180|983851|P1|STARTED|Overall Study||20
412624|NCT00856050|983860|P1|NOT COMPLETED|Overall Study||0
412625|NCT00856050|983860|P1|COMPLETED|Overall Study||26
412626|NCT00856050|983860|P1|STARTED|Overall Study||26
412627|NCT00856024|983864|P1|NOT COMPLETED|Overall Study||0
412628|NCT00856024|983864|P1|COMPLETED|Overall Study||902
412629|NCT00856024|983864|P1|STARTED|Overall Study||902
412630|NCT00855959|983876|P1|NOT COMPLETED|Overall Study||9
412631|NCT00855959|983876|P1|COMPLETED|Overall Study||99
412632|NCT00855959|983876|P1|Patients Who Received Pulmicort Respules|Overall Study||105
412633|NCT00855959|983876|P1|STARTED|Overall Study||108
412634|NCT00855933|983893|P2|NOT COMPLETED|Overall Study||1
412635|NCT00855933|983894|P1|NOT COMPLETED|Overall Study||0
412636|NCT00855933|983893|P2|COMPLETED|Overall Study||29
412637|NCT00855933|983894|P1|COMPLETED|Overall Study||30
412638|NCT00855933|983893|P2|STARTED|Overall Study||30
412639|NCT00855933|983894|P1|STARTED|Overall Study||30
412640|NCT00855920|983903|P3|NOT COMPLETED|Overall Study||11
412641|NCT00855920|983904|P2|NOT COMPLETED|Overall Study||9
412642|NCT00855920|983905|P1|NOT COMPLETED|Overall Study||8
412643|NCT00855920|983903|P3|COMPLETED|Overall Study||64
412644|NCT00855920|983904|P2|COMPLETED|Overall Study||65
412645|NCT00855920|983905|P1|COMPLETED|Overall Study||68
412646|NCT00855920|983903|P3|Safety Population|Overall Study||75
412647|NCT00855920|983904|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
412648|NCT00855920|983905|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
412649|NCT00855920|983903|P3|STARTED|Overall Study||75
412650|NCT00855920|983904|P2|STARTED|Overall Study||74
412651|NCT00855920|983905|P1|STARTED|Overall Study||76
412652|NCT00855894|983922|P1|NOT COMPLETED|Overall Study||33
412653|NCT00855894|983922|P1|COMPLETED|Overall Study||8
412654|NCT00855894|983922|P1|STARTED|Overall Study||41
412655|NCT00855868|983932|P2|NOT COMPLETED|Overall Study||1
412656|NCT00855868|983933|P1|NOT COMPLETED|Overall Study||1
412657|NCT00855868|983932|P2|COMPLETED|Overall Study||14
412658|NCT00855868|983933|P1|COMPLETED|Overall Study||12
412659|NCT00855868|983932|P2|STARTED|Overall Study||15
412660|NCT00855868|983933|P1|STARTED|Overall Study||13
412661|NCT00855842|983939|P1|NOT COMPLETED|Overall Study||0
412662|NCT00855842|983939|P1|COMPLETED|Overall Study||4
412663|NCT00855842|983939|P1|STARTED|Overall Study||4
412664|NCT00855816|983945|P2|NOT COMPLETED|Overall Study||21
412665|NCT00855816|983946|P1|NOT COMPLETED|Overall Study||26
412666|NCT00855816|983945|P2|COMPLETED|Overall Study||12
412667|NCT00855816|983946|P1|COMPLETED|Overall Study||21
412668|NCT00855816|983945|P2|STARTED|Overall Study||33
412669|NCT00855816|983946|P1|STARTED|Overall Study||47
412670|NCT00855738|983952|P1|NOT COMPLETED|Overall Study||5
412671|NCT00855738|983952|P1|COMPLETED|Overall Study||106
412672|NCT00855738|983952|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
412673|NCT00855738|983952|P1|STARTED|Overall Study||111
412674|NCT00855595|983980|P2|NOT COMPLETED|Overall Study||7
412675|NCT00855595|983981|P1|NOT COMPLETED|Overall Study||6
412676|NCT00855595|983980|P2|COMPLETED|Overall Study||94
412677|NCT00855595|983981|P1|COMPLETED|Overall Study||100
412678|NCT00855595|983980|P2|STARTED|Overall Study||101
412679|NCT00855595|983981|P1|STARTED|Overall Study||106
412680|NCT00855582|984020|P3|NOT COMPLETED|Overall Study||30
412681|NCT00855582|984021|P2|NOT COMPLETED|Overall Study||24
412682|NCT00855582|984022|P1|NOT COMPLETED|Overall Study||26
412683|NCT00855582|984020|P3|COMPLETED|Overall Study||170
412684|NCT00855582|984021|P2|COMPLETED|Overall Study||184
412685|NCT00855582|984022|P1|COMPLETED|Overall Study||172
412686|NCT00855582|984020|P3|STARTED|Overall Study||200
412687|NCT00855582|984021|P2|STARTED|Overall Study||208
412688|NCT00855582|984022|P1|STARTED|Overall Study||198
412689|NCT00855465|984111|P2|NOT COMPLETED|Follow-up Period (FUP)||2
412690|NCT00855465|984112|P1|NOT COMPLETED|Follow-up Period (FUP)||8
412691|NCT00855465|984111|P2|COMPLETED|Follow-up Period (FUP)||2
412692|NCT00855465|984112|P1|COMPLETED|Follow-up Period (FUP)||9
412693|NCT00855465|984111|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
412694|NCT00855465|984112|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
412695|NCT00855465|984111|P2|NOT COMPLETED|Treatment Period||5
412696|NCT00855465|984112|P1|NOT COMPLETED|Treatment Period||14
412697|NCT00855465|984111|P2|COMPLETED|Treatment Period||83
412698|NCT00855465|984112|P1|COMPLETED|Treatment Period||160
412699|NCT00855465|984111|P2|Participants Received Treatment|Treatment Period||88
412700|NCT00855465|984112|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
412701|NCT00855465|984111|P2|STARTED|Treatment Period||88
412702|NCT00855465|984112|P1|STARTED|Treatment Period||174
412703|NCT00855439|984202|P2|NOT COMPLETED|Overall Study||0
412704|NCT00855439|984203|P1|NOT COMPLETED|Overall Study||3
412705|NCT00855439|984202|P2|COMPLETED|Overall Study||24
412706|NCT00855439|984203|P1|COMPLETED|Overall Study||19
412707|NCT00855439|984202|P2|STARTED|Overall Study||24
412708|NCT00855439|984203|P1|STARTED|Overall Study||22
412709|NCT00855309|984217|P2|NOT COMPLETED|Overall Study||0
412710|NCT00855309|984218|P1|NOT COMPLETED|Overall Study||1
412711|NCT00855309|984217|P2|COMPLETED|Overall Study||55
412712|NCT00855309|984218|P1|COMPLETED|Overall Study||56
412713|NCT00855309|984217|P2|STARTED|Overall Study||55
412714|NCT00855309|984218|P1|STARTED|Overall Study||57
412715|NCT00855218|984226|P2|NOT COMPLETED|Overall Study||153
412716|NCT00855218|984227|P1|NOT COMPLETED|Overall Study||154
412717|NCT00855218|984226|P2|COMPLETED|Overall Study||0
412718|NCT00855218|984227|P1|COMPLETED|Overall Study||0
412719|NCT00855218|984226|P2|Participants Received Treatment|Overall Study||151
412720|NCT00855218|984227|P1|Participants Received Treatment|Overall Study||153
412721|NCT00855218|984226|P2|STARTED|Overall Study||153
412722|NCT00855218|984227|P1|STARTED|Overall Study||154
412723|NCT00855166|984245|P2|NOT COMPLETED|Overall Study||8
412724|NCT00855166|984246|P1|NOT COMPLETED|Overall Study||5
412725|NCT00855166|984245|P2|COMPLETED|Overall Study||83
412726|NCT00855166|984246|P1|COMPLETED|Overall Study||86
412727|NCT00855166|984245|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
412728|NCT00855166|984246|P1|STARTED|Overall Study||91
412729|NCT00855062|984266|P2|NOT COMPLETED|Step2||6
412730|NCT00855062|984267|P1|NOT COMPLETED|Step2||6
412731|NCT00855062|984266|P2|COMPLETED|Step2||15
412732|NCT00855062|984267|P1|COMPLETED|Step2||13
412733|NCT00855062|984266|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
412734|NCT00855062|984267|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
412735|NCT00855062|984266|P2|NOT COMPLETED|Step1||11
412736|NCT00855062|984267|P1|NOT COMPLETED|Step1||10
412737|NCT00855062|984266|P2|COMPLETED|Step1||26
412738|NCT00855062|984267|P1|COMPLETED|Step1||26
412739|NCT00855062|984266|P2|STARTED|Step1||37
412740|NCT00855062|984267|P1|STARTED|Step1||36
412741|NCT00854906|984291|P1|NOT COMPLETED|Overall Study||1
412742|NCT00854906|984291|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
412743|NCT00854906|984291|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
412744|NCT00854724|984300|P2|NOT COMPLETED|Second Intervention||1
412745|NCT00854724|984301|P1|NOT COMPLETED|Second Intervention||1
412746|NCT00854724|984300|P2|COMPLETED|Second Intervention||5
412747|NCT00854724|984301|P1|COMPLETED|Second Intervention||5
412748|NCT00854724|984300|P2|STARTED|Second Intervention||6
412749|NCT00854724|984301|P1|STARTED|Second Intervention||6
412750|NCT00854724|984300|P2|NOT COMPLETED|Washout||1
412751|NCT00854724|984301|P1|NOT COMPLETED|Washout||1
412752|NCT00854724|984300|P2|COMPLETED|Washout||6
412753|NCT00854724|984301|P1|COMPLETED|Washout||6
412754|NCT00854724|984300|P2|STARTED|Washout||7
412755|NCT00854724|984301|P1|STARTED|Washout||7
412756|NCT00854724|984300|P2|NOT COMPLETED|First Intervention||1
412757|NCT00854724|984301|P1|NOT COMPLETED|First Intervention||1
412758|NCT00854724|984300|P2|COMPLETED|First Intervention||7
412759|NCT00854724|984301|P1|COMPLETED|First Intervention||7
412760|NCT00854724|984300|P2|STARTED|First Intervention||8
412761|NCT00854724|984301|P1|STARTED|First Intervention||8
412762|NCT00854620|984307|P1|NOT COMPLETED|Overall Study||1
412763|NCT00854620|984307|P1|COMPLETED|Overall Study||8
412764|NCT00854620|984307|P1|STARTED|Overall Study||9
412765|NCT00854607|984311|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
412766|NCT00854607|984311|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
412767|NCT00854607|984311|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
412768|NCT00854607|984311|P1|NOT COMPLETED|Enrollment||0
412769|NCT00854607|984311|P1|COMPLETED|Enrollment||116
412770|NCT00854607|984311|P1|STARTED|Enrollment||116
412771|NCT00854594|984346|P2|NOT COMPLETED|Overall Study||0
412772|NCT00854594|984347|P1|NOT COMPLETED|Overall Study||0
412773|NCT00854594|984346|P2|COMPLETED|Overall Study||69
412774|NCT00854594|984347|P1|COMPLETED|Overall Study||48
412775|NCT00854594|984346|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
412776|NCT00854594|984347|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
412777|NCT00854581|984359|P1|NOT COMPLETED|Overall Study||2
412778|NCT00854581|984359|P1|COMPLETED|Overall Study||11
412779|NCT00854581|984359|P1|STARTED|Overall Study||13
412780|NCT00854373|984366|P2|NOT COMPLETED|Overall Study||4
412781|NCT00854373|984367|P1|NOT COMPLETED|Overall Study||2
412782|NCT00854373|984366|P2|COMPLETED|Overall Study||89
412783|NCT00854373|984367|P1|COMPLETED|Overall Study||93
412784|NCT00854373|984366|P2|STARTED|Overall Study||93
412785|NCT00854373|984367|P1|STARTED|Overall Study||95
412786|NCT00854360|984381|P4|NOT COMPLETED|Overall Study||10
412787|NCT00854360|984382|P3|NOT COMPLETED|Overall Study||2
412788|NCT00854360|984383|P2|NOT COMPLETED|Overall Study||3
412789|NCT00854360|984384|P1|NOT COMPLETED|Overall Study||2
412790|NCT00854360|984381|P4|COMPLETED|Overall Study||114
412791|NCT00854360|984382|P3|COMPLETED|Overall Study||120
412792|NCT00854360|984383|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
412793|NCT00854360|984384|P1|COMPLETED|Overall Study||116
412794|NCT00854360|984381|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
412795|NCT00854360|984382|P3|Intent to Treat / Safety Population|Overall Study||122
412796|NCT00854360|984383|P2|Intent to Treat / Safety Population|Overall Study||123
412797|NCT00854360|984384|P1|Intent to Treat / Safety Population|Overall Study||118
412798|NCT00854360|984381|P4|STARTED|Overall Study||124
412799|NCT00854360|984382|P3|STARTED|Overall Study||122
412800|NCT00854360|984383|P2|STARTED|Overall Study||123
412801|NCT00854360|984384|P1|STARTED|Overall Study||118
412802|NCT00854308|984416|P2|NOT COMPLETED|Overall Study||67
412803|NCT00854308|984417|P1|NOT COMPLETED|Overall Study||62
412804|NCT00854308|984416|P2|COMPLETED|Overall Study||1
412805|NCT00854308|984417|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
412806|NCT00854308|984416|P2|Received Study Drug|Overall Study||67
412807|NCT00854308|984417|P1|Received Study Drug|Overall Study||69
412808|NCT00854308|984416|P2|STARTED|Overall Study||68
412809|NCT00854308|984417|P1|STARTED|Overall Study||69
412810|NCT00854113|984442|P11|NOT COMPLETED|Overall Study||0
412811|NCT00854113|984443|P10|NOT COMPLETED|Overall Study||0
412812|NCT00854113|984444|P9|NOT COMPLETED|Overall Study||1
412813|NCT00854113|984445|P8|NOT COMPLETED|Overall Study||3
412814|NCT00854113|984446|P7|NOT COMPLETED|Overall Study||0
412815|NCT00854113|984447|P6|NOT COMPLETED|Overall Study||0
412816|NCT00854113|984448|P5|NOT COMPLETED|Overall Study||0
412817|NCT00854113|984449|P4|NOT COMPLETED|Overall Study||0
412818|NCT00854113|984450|P3|NOT COMPLETED|Overall Study||0
412819|NCT00854113|984451|P2|NOT COMPLETED|Overall Study||0
412820|NCT00854113|984452|P1|NOT COMPLETED|Overall Study||0
412821|NCT00854113|984442|P11|COMPLETED|Overall Study||6
412822|NCT00854113|984443|P10|COMPLETED|Overall Study||8
412823|NCT00854113|984444|P9|COMPLETED|Overall Study||7
412824|NCT00854113|984445|P8|COMPLETED|Overall Study||5
412825|NCT00854113|984446|P7|COMPLETED|Overall Study||12
412826|NCT00854113|984447|P6|COMPLETED|Overall Study||6
412827|NCT00854113|984448|P5|COMPLETED|Overall Study||6
412828|NCT00854113|984449|P4|COMPLETED|Overall Study||6
412829|NCT00854113|984450|P3|COMPLETED|Overall Study||6
412830|NCT00854113|984451|P2|COMPLETED|Overall Study||6
412831|NCT00854113|984452|P1|COMPLETED|Overall Study||6
412832|NCT00854113|984442|P11|STARTED|Overall Study||6
412833|NCT00854113|984443|P10|STARTED|Overall Study||8
412834|NCT00854113|984444|P9|STARTED|Overall Study||8
412835|NCT00854113|984445|P8|STARTED|Overall Study||8
412836|NCT00854113|984446|P7|STARTED|Overall Study||12
412837|NCT00854113|984447|P6|STARTED|Overall Study||6
412838|NCT00854113|984448|P5|STARTED|Overall Study||6
412839|NCT00854113|984449|P4|STARTED|Overall Study||6
412840|NCT00854113|984450|P3|STARTED|Overall Study||6
412841|NCT00854113|984451|P2|STARTED|Overall Study||6
412842|NCT00854113|984452|P1|STARTED|Overall Study||6
412843|NCT00854087|984555|P2|NOT COMPLETED|Overall Study||19
412844|NCT00854087|984556|P1|NOT COMPLETED|Overall Study||19
412845|NCT00854087|984555|P2|COMPLETED|Overall Study||40
412846|NCT00854087|984556|P1|COMPLETED|Overall Study||40
412847|NCT00854087|984555|P2|STARTED|Overall Study||59
412848|NCT00854087|984556|P1|STARTED|Overall Study||59
412849|NCT00853996|984562|P1|NOT COMPLETED|Overall Study||0
412850|NCT00853996|984562|P1|COMPLETED|Overall Study||25
412851|NCT00853996|984562|P1|STARTED|Overall Study||25
412852|NCT00853970|984569|P2|NOT COMPLETED|Overall Study||3
412853|NCT00853970|984570|P1|NOT COMPLETED|Overall Study||6
412854|NCT00853970|984569|P2|COMPLETED|Overall Study||144
412855|NCT00853970|984570|P1|COMPLETED|Overall Study||146
412856|NCT00853970|984569|P2|STARTED|Overall Study||147
412857|NCT00853970|984570|P1|STARTED|Overall Study||152
412858|NCT00853957|984580|P2|NOT COMPLETED|Overall Study||19
412859|NCT00853957|984581|P1|NOT COMPLETED|Overall Study||14
412860|NCT00853957|984580|P2|COMPLETED|Overall Study||204
412861|NCT00853957|984581|P1|COMPLETED|Overall Study||206
412862|NCT00853957|984580|P2|STARTED|Overall Study||223
412863|NCT00853957|984581|P1|STARTED|Overall Study||220
412864|NCT00853905|984599|P2|NOT COMPLETED|Overall Study||4
412865|NCT00853905|984600|P1|NOT COMPLETED|Overall Study||2
412866|NCT00853905|984599|P2|COMPLETED|Overall Study||36
412867|NCT00853905|984600|P1|COMPLETED|Overall Study||35
412868|NCT00853905|984599|P2|STARTED|Overall Study||40
412869|NCT00853905|984600|P1|STARTED|Overall Study||37
412870|NCT00853840|984606|P2|NOT COMPLETED|Period 2||0
412871|NCT00853840|984607|P1|NOT COMPLETED|Period 2||0
412872|NCT00853840|984606|P2|COMPLETED|Period 2||9
412873|NCT00853840|984607|P1|COMPLETED|Period 2||9
412874|NCT00853840|984606|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
412875|NCT00853840|984607|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
412876|NCT00853840|984606|P2|Maraviroc (Days 1 - 3)|Period 2||9
412877|NCT00853840|984607|P1|Maraviroc (Days 1 - 3)|Period 2||9
412878|NCT00853840|984606|P2|STARTED|Period 2||9
412879|NCT00853840|984607|P1|STARTED|Period 2||9
412880|NCT00853840|984606|P2|NOT COMPLETED|Period 1||0
412881|NCT00853840|984607|P1|NOT COMPLETED|Period 1||0
412882|NCT00853840|984606|P2|COMPLETED|Period 1||9
412883|NCT00853840|984607|P1|COMPLETED|Period 1||9
412884|NCT00853840|984606|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
412885|NCT00853840|984607|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
412886|NCT00853840|984606|P2|Maraviroc (Days 1 - 4)|Period 1||9
412887|NCT00853840|984607|P1|Maraviroc (Days 1 - 4)|Period 1||9
412888|NCT00853840|984606|P2|STARTED|Period 1||9
412889|NCT00853840|984607|P1|STARTED|Period 1||9
412890|NCT00853827|984624|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
412891|NCT00853827|984625|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
412892|NCT00853827|984624|P2|COMPLETED|Double Blind Period (103 Weeks)||199
412893|NCT00853827|984625|P1|COMPLETED|Double Blind Period (103 Weeks)||201
412894|NCT00853827|984624|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
412895|NCT00853827|984625|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
412896|NCT00853827|984624|P2|STARTED|Double Blind Period (103 Weeks)||308
412897|NCT00853827|984625|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
412898|NCT00853827|984624|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
412899|NCT00853827|984625|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
412900|NCT00853827|984624|P2|COMPLETED|Single Blind Period (1 Week)||0
412901|NCT00853827|984625|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
412902|NCT00853827|984624|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
412903|NCT00853827|984625|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
412904|NCT00853762|984641|P4|NOT COMPLETED|Overall Study||22
412905|NCT00853762|984642|P3|NOT COMPLETED|Overall Study||17
412906|NCT00853762|984643|P2|NOT COMPLETED|Overall Study||19
412907|NCT00853762|984644|P1|NOT COMPLETED|Overall Study||16
412908|NCT00853762|984641|P4|COMPLETED|Overall Study||0
412909|NCT00853762|984642|P3|COMPLETED|Overall Study||0
412910|NCT00853762|984643|P2|COMPLETED|Overall Study||0
412911|NCT00853762|984644|P1|COMPLETED|Overall Study||0
412912|NCT00853762|984641|P4|STARTED|Overall Study||22
412913|NCT00853762|984642|P3|STARTED|Overall Study||17
412914|NCT00853762|984643|P2|STARTED|Overall Study||19
412915|NCT00853762|984644|P1|STARTED|Overall Study||16
412916|NCT00853749|984712|P2|NOT COMPLETED|Overall Study||1
412917|NCT00853749|984713|P1|NOT COMPLETED|Overall Study||0
412918|NCT00853749|984712|P2|COMPLETED|Overall Study||38
412919|NCT00853749|984713|P1|COMPLETED|Overall Study||50
412920|NCT00853749|984712|P2|Vaccinated|Overall Study||39
412921|NCT00853749|984713|P1|Vaccinated|Overall Study||50
412922|NCT00853749|984712|P2|STARTED|Overall Study||39
412923|NCT00853749|984713|P1|STARTED|Overall Study||50
412924|NCT00853723|984734|P3|NOT COMPLETED|Overall Study||2
412925|NCT00853723|984735|P2|NOT COMPLETED|Overall Study||7
412926|NCT00853723|984736|P1|NOT COMPLETED|Overall Study||6
412927|NCT00853723|984734|P3|COMPLETED|Overall Study||33
412928|NCT00853723|984735|P2|COMPLETED|Overall Study||28
412929|NCT00853723|984736|P1|COMPLETED|Overall Study||29
412930|NCT00853723|984734|P3|STARTED|Overall Study||35
412931|NCT00853723|984735|P2|STARTED|Overall Study||35
412932|NCT00853723|984736|P1|STARTED|Overall Study||35
412933|NCT00853658|984783|P3|NOT COMPLETED|Overall Study||815
412934|NCT00853658|984784|P2|NOT COMPLETED|Overall Study||832
412935|NCT00853658|984785|P1|NOT COMPLETED|Overall Study||787
412936|NCT00853658|984783|P3|COMPLETED|Overall Study||1539
412937|NCT00853658|984784|P2|COMPLETED|Overall Study||1524
412938|NCT00853658|984785|P1|COMPLETED|Overall Study||1567
412939|NCT00853658|984783|P3|Safety Set|Overall Study||2345
412940|NCT00853658|984784|P2|Safety Set|Overall Study||2348
412941|NCT00853658|984785|P1|Safety Set|Overall Study||2347
412942|NCT00853658|984783|P3|Full Analysis Set (FAS)|Overall Study||2336
412943|NCT00853658|984784|P2|Full Analysis Set (FAS)|Overall Study||2340
412944|NCT00853658|984785|P1|Full Analysis Set (FAS)|Overall Study||2340
412945|NCT00853658|984783|P3|STARTED|Overall Study||2354
412946|NCT00853658|984784|P2|STARTED|Overall Study||2356
412947|NCT00853658|984785|P1|STARTED|Overall Study||2354
412948|NCT00853606|984799|P1|NOT COMPLETED|Overall Study||220
412949|NCT00853606|984799|P1|COMPLETED|Overall Study||492
412950|NCT00853606|984799|P1|STARTED|Overall Study||712
412951|NCT00853593|984805|P1|NOT COMPLETED|Overall Study||45
412952|NCT00853593|984805|P1|COMPLETED|Overall Study||152
412953|NCT00853593|984805|P1|Model 4396 Lead Attempted|Overall Study||164
412954|NCT00853593|984805|P1|Implant Attempted|Overall Study||193
412955|NCT00853593|984805|P1|STARTED|Overall Study||197
412956|NCT00853567|984833|P1|NOT COMPLETED|Overall Study||71
412957|NCT00853567|984833|P1|COMPLETED|Overall Study||0
412958|NCT00853567|984833|P1|STARTED|Overall Study||71
412959|NCT00853385|984846|P5|NOT COMPLETED|Overall Study||42
412960|NCT00853385|984847|P4|NOT COMPLETED|Overall Study||13
412961|NCT00853385|984848|P3|NOT COMPLETED|Overall Study||9
412962|NCT00853385|984849|P2|NOT COMPLETED|Overall Study||43
412963|NCT00853385|984850|P1|NOT COMPLETED|Overall Study||54
412964|NCT00853385|984846|P5|COMPLETED|Overall Study||162
412965|NCT00853385|984847|P4|COMPLETED|Overall Study||39
412966|NCT00853385|984848|P3|COMPLETED|Overall Study||47
412967|NCT00853385|984849|P2|COMPLETED|Overall Study||158
412968|NCT00853385|984850|P1|COMPLETED|Overall Study||150
412969|NCT00853385|984846|P5|STARTED|Overall Study||204
412970|NCT00853385|984847|P4|STARTED|Overall Study||52
412971|NCT00853385|984848|P3|STARTED|Overall Study||56
412972|NCT00853385|984849|P2|STARTED|Overall Study||201
412973|NCT00853385|984850|P1|STARTED|Overall Study||204
412974|NCT00853333|985066|P3|NOT COMPLETED|Overall Study||0
412975|NCT00853333|985067|P2|NOT COMPLETED|Overall Study||0
412976|NCT00853333|985068|P1|NOT COMPLETED|Overall Study||0
412977|NCT00853333|985066|P3|COMPLETED|Overall Study||31
412978|NCT00853333|985067|P2|COMPLETED|Overall Study||27
412979|NCT00853333|985068|P1|COMPLETED|Overall Study||28
412980|NCT00853333|985066|P3|STARTED|Overall Study||31
412981|NCT00853333|985067|P2|STARTED|Overall Study||27
412982|NCT00853333|985068|P1|STARTED|Overall Study||28
412983|NCT00853242|985083|P7|NOT COMPLETED|Overall Study||5
412984|NCT00853242|985084|P6|NOT COMPLETED|Overall Study||2
412985|NCT00853242|985085|P5|NOT COMPLETED|Overall Study||4
412986|NCT00853242|985086|P4|NOT COMPLETED|Overall Study||4
412987|NCT00853242|985087|P3|NOT COMPLETED|Overall Study||3
412988|NCT00853242|985088|P2|NOT COMPLETED|Overall Study||3
412989|NCT00853242|985089|P1|NOT COMPLETED|Overall Study||3
412990|NCT00853242|985083|P7|COMPLETED|Overall Study||44
412991|NCT00853242|985084|P6|COMPLETED|Overall Study||49
412992|NCT00853242|985085|P5|COMPLETED|Overall Study||46
412993|NCT00853242|985086|P4|COMPLETED|Overall Study||46
412994|NCT00853242|985087|P3|COMPLETED|Overall Study||46
412995|NCT00853242|985088|P2|COMPLETED|Overall Study||47
412996|NCT00853242|985089|P1|COMPLETED|Overall Study||47
412997|NCT00853242|985083|P7|Treated|Overall Study||48
412998|NCT00853242|985084|P6|Treated|Overall Study||51
412999|NCT00853242|985085|P5|Treated|Overall Study||50
413000|NCT00853242|985086|P4|Treated|Overall Study||50
413001|NCT00853242|985087|P3|Treated|Overall Study||48
413002|NCT00853242|985088|P2|Treated|Overall Study||49
413003|NCT00853242|985089|P1|Treated|Overall Study||50
413004|NCT00853242|985083|P7|STARTED|Overall Study||49
413005|NCT00853242|985084|P6|STARTED|Overall Study||51
413006|NCT00853242|985085|P5|STARTED|Overall Study||50
413007|NCT00853242|985086|P4|STARTED|Overall Study||50
413008|NCT00853242|985087|P3|STARTED|Overall Study||49
413009|NCT00853242|985088|P2|STARTED|Overall Study||50
413010|NCT00853242|985089|P1|STARTED|Overall Study||50
413011|NCT00853229|985131|P2|NOT COMPLETED|Phase 2: Cross Over||0
413012|NCT00853229|985132|P1|NOT COMPLETED|Phase 2: Cross Over||0
413013|NCT00853229|985131|P2|COMPLETED|Phase 2: Cross Over||0
413014|NCT00853229|985132|P1|COMPLETED|Phase 2: Cross Over||0
413015|NCT00853229|985131|P2|STARTED|Phase 2: Cross Over||0
413016|NCT00853229|985132|P1|STARTED|Phase 2: Cross Over||0
413017|NCT00853229|985131|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
413018|NCT00853229|985132|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
413019|NCT00853229|985131|P2|COMPLETED|Phase 1: Initial Intervention||0
413020|NCT00853229|985132|P1|COMPLETED|Phase 1: Initial Intervention||0
413021|NCT00853229|985131|P2|STARTED|Phase 1: Initial Intervention||8
413022|NCT00853229|985132|P1|STARTED|Phase 1: Initial Intervention||8
413023|NCT00853151|985142|P4|NOT COMPLETED|Overall Study||3
413024|NCT00853151|985143|P3|NOT COMPLETED|Overall Study||8
413025|NCT00853151|985144|P2|NOT COMPLETED|Overall Study||13
413026|NCT00853151|985145|P1|NOT COMPLETED|Overall Study||10
413027|NCT00853151|985142|P4|COMPLETED|Overall Study||15
413028|NCT00853151|985143|P3|COMPLETED|Overall Study||30
413029|NCT00853151|985144|P2|COMPLETED|Overall Study||24
413030|NCT00853151|985145|P1|COMPLETED|Overall Study||28
413031|NCT00853151|985142|P4|STARTED|Overall Study||18
413032|NCT00853151|985143|P3|STARTED|Overall Study||38
413033|NCT00853151|985144|P2|STARTED|Overall Study||37
413034|NCT00853151|985145|P1|STARTED|Overall Study||38
413035|NCT00853099|985290|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
413036|NCT00853099|985291|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
413037|NCT00853099|985292|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
413038|NCT00853099|985293|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
413039|NCT00853099|985290|P4|COMPLETED|Double-blind + Open-label Periods||119
413040|NCT00853099|985291|P3|COMPLETED|Double-blind + Open-label Periods||0
413041|NCT00853099|985292|P2|COMPLETED|Double-blind + Open-label Periods||0
413042|NCT00853099|985293|P1|COMPLETED|Double-blind + Open-label Periods||0
413043|NCT00853099|985290|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
413044|NCT00853099|985291|P3|STARTED|Double-blind + Open-label Periods||0
413045|NCT00853099|985292|P2|STARTED|Double-blind + Open-label Periods||0
413046|NCT00853099|985293|P1|STARTED|Double-blind + Open-label Periods||0
413047|NCT00853099|985290|P4|NOT COMPLETED|Double-blind Period||0
413048|NCT00853099|985291|P3|NOT COMPLETED|Double-blind Period||31
413049|NCT00853099|985292|P2|NOT COMPLETED|Double-blind Period||29
413050|NCT00853099|985293|P1|NOT COMPLETED|Double-blind Period||23
413051|NCT00853099|985290|P4|COMPLETED|Double-blind Period||0
413052|NCT00853099|985291|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
413053|NCT00853099|985292|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
413054|NCT00853099|985293|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
413055|NCT00853099|985290|P4|Completed Week 8|Double-blind Period||0
413056|NCT00853099|985291|P3|Completed Week 8|Double-blind Period||86
413057|NCT00853099|985292|P2|Completed Week 8|Double-blind Period||85
413058|NCT00853099|985293|P1|Completed Week 8|Double-blind Period||92
413059|NCT00853099|985290|P4|Treated|Double-blind Period||0
413060|NCT00853099|985291|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
413061|NCT00853099|985292|P2|Treated|Double-blind Period||87
413062|NCT00853099|985293|P1|Treated|Double-blind Period||96
413063|NCT00853099|985290|P4|STARTED|Double-blind Period||0
413064|NCT00853099|985291|P3|STARTED|Double-blind Period||91
413065|NCT00853099|985292|P2|STARTED|Double-blind Period||87
413066|NCT00853099|985293|P1|STARTED|Double-blind Period||96
413067|NCT00853073|985335|P2|NOT COMPLETED|Overall Study||2
413068|NCT00853073|985336|P1|NOT COMPLETED|Overall Study||3
413069|NCT00853073|985335|P2|COMPLETED|Overall Study||29
413070|NCT00853073|985336|P1|COMPLETED|Overall Study||29
413071|NCT00853073|985335|P2|STARTED|Overall Study||31
413072|NCT00853073|985336|P1|STARTED|Overall Study||32
413073|NCT00853021|985342|P1|NOT COMPLETED|Overall Study||5
413074|NCT00853021|985342|P1|COMPLETED|Overall Study||21
413075|NCT00853021|985342|P1|STARTED|Overall Study||26
413076|NCT00852995|985354|P5|NOT COMPLETED|Overall Study||4
413077|NCT00852995|985355|P4|NOT COMPLETED|Overall Study||5
413078|NCT00852995|985356|P3|NOT COMPLETED|Overall Study||5
413079|NCT00852995|985357|P2|NOT COMPLETED|Overall Study||1
413080|NCT00852995|985358|P1|NOT COMPLETED|Overall Study||8
413081|NCT00852995|985354|P5|COMPLETED|Overall Study||46
413082|NCT00852995|985355|P4|COMPLETED|Overall Study||40
413083|NCT00852995|985356|P3|COMPLETED|Overall Study||39
413084|NCT00852995|985357|P2|COMPLETED|Overall Study||42
413085|NCT00852995|985358|P1|COMPLETED|Overall Study||38
413086|NCT00852995|985354|P5|STARTED|Overall Study||50
413087|NCT00852995|985355|P4|STARTED|Overall Study||45
413088|NCT00852995|985356|P3|STARTED|Overall Study||44
413089|NCT00852995|985357|P2|STARTED|Overall Study||43
413090|NCT00852995|985358|P1|STARTED|Overall Study||46
413091|NCT00852969|985402|P2|NOT COMPLETED|Overall Study||2
413092|NCT00852969|985403|P1|NOT COMPLETED|Overall Study||0
413093|NCT00852969|985402|P2|COMPLETED|Overall Study||13
413094|NCT00852969|985403|P1|COMPLETED|Overall Study||15
413095|NCT00852969|985402|P2|STARTED|Overall Study||15
413096|NCT00852969|985403|P1|STARTED|Overall Study||15
413097|NCT00852930|985414|P3|NOT COMPLETED|Overall Study||2
413098|NCT00852930|985415|P2|NOT COMPLETED|Overall Study||1
413099|NCT00852930|985416|P1|NOT COMPLETED|Overall Study||1
413100|NCT00852930|985414|P3|COMPLETED|Overall Study||15
413101|NCT00852930|985415|P2|COMPLETED|Overall Study||16
413102|NCT00852930|985416|P1|COMPLETED|Overall Study||15
413103|NCT00852930|985414|P3|STARTED|Overall Study||17
413104|NCT00852930|985415|P2|STARTED|Overall Study||17
413105|NCT00852930|985416|P1|STARTED|Overall Study||16
413106|NCT00852917|985437|P4|NOT COMPLETED|Overall Study||93
413107|NCT00852917|985438|P3|NOT COMPLETED|Overall Study||58
413108|NCT00852917|985439|P2|NOT COMPLETED|Overall Study||46
413109|NCT00852917|985440|P1|NOT COMPLETED|Overall Study||44
413110|NCT00852917|985437|P4|COMPLETED|Overall Study||134
413111|NCT00852917|985438|P3|COMPLETED|Overall Study||50
413112|NCT00852917|985439|P2|COMPLETED|Overall Study||65
413113|NCT00852917|985440|P1|COMPLETED|Overall Study||62
413114|NCT00852917|985437|P4|STARTED|Overall Study||227
413115|NCT00852917|985438|P3|STARTED|Overall Study||108
413116|NCT00852917|985439|P2|STARTED|Overall Study||111
413117|NCT00852917|985440|P1|STARTED|Overall Study||106
413118|NCT00852761|985480|P2|NOT COMPLETED|Overall Study||0
413119|NCT00852761|985481|P1|NOT COMPLETED|Overall Study||0
413120|NCT00852761|985480|P2|COMPLETED|Overall Study||17
413121|NCT00852761|985481|P1|COMPLETED|Overall Study||17
413122|NCT00852761|985480|P2|STARTED|Overall Study||17
413123|NCT00852761|985481|P1|STARTED|Overall Study||17
413124|NCT00852631|985523|P1|NOT COMPLETED|Overall Study||11
413125|NCT00852631|985523|P1|COMPLETED|Overall Study||17
413126|NCT00852631|985523|P1|STARTED|Overall Study||28
413127|NCT00852592|985531|P2|NOT COMPLETED|Overall Study||4
413128|NCT00852592|985532|P1|NOT COMPLETED|Overall Study||3
413129|NCT00852592|985531|P2|COMPLETED|Overall Study||19
413130|NCT00852592|985532|P1|COMPLETED|Overall Study||20
413131|NCT00852592|985531|P2|STARTED|Overall Study||23
413132|NCT00852592|985532|P1|STARTED|Overall Study||23
413133|NCT00852540|985542|P2|NOT COMPLETED|Overall Study||18
413134|NCT00852540|985543|P1|NOT COMPLETED|Overall Study||36
413135|NCT00852540|985542|P2|COMPLETED|Overall Study||122
413136|NCT00852540|985543|P1|COMPLETED|Overall Study||234
413137|NCT00852540|985542|P2|STARTED|Overall Study||140
413138|NCT00852540|985543|P1|STARTED|Overall Study||270
413139|NCT00852527|985569|P2|NOT COMPLETED|Overall Study||0
413140|NCT00852527|985570|P1|NOT COMPLETED|Overall Study||0
413141|NCT00852527|985569|P2|COMPLETED|Overall Study||242
413142|NCT00852527|985570|P1|COMPLETED|Overall Study||196
413143|NCT00852527|985569|P2|STARTED|Overall Study||242
413144|NCT00852527|985570|P1|STARTED|Overall Study||196
413145|NCT00852475|985577|P2|NOT COMPLETED|Overall Study||4
413146|NCT00852475|985578|P1|NOT COMPLETED|Overall Study||3
413147|NCT00852475|985577|P2|COMPLETED|Overall Study||16
413148|NCT00852475|985578|P1|COMPLETED|Overall Study||23
413149|NCT00852475|985577|P2|STARTED|Overall Study||20
413150|NCT00852475|985578|P1|STARTED|Overall Study||26
413151|NCT00852397|985589|P3|NOT COMPLETED|Overall Study||14
413152|NCT00852397|985590|P2|NOT COMPLETED|Overall Study||8
413153|NCT00852397|985591|P1|NOT COMPLETED|Overall Study||11
413154|NCT00852397|985589|P3|COMPLETED|Overall Study||36
413155|NCT00852397|985590|P2|COMPLETED|Overall Study||41
413156|NCT00852397|985591|P1|COMPLETED|Overall Study||41
413157|NCT00852397|985589|P3|Treated Participants|Overall Study||49
413158|NCT00852397|985590|P2|Treated Participants|Overall Study||49
413159|NCT00852397|985591|P1|Treated Participants|Overall Study||51
413160|NCT00852397|985589|P3|STARTED|Overall Study||50
413161|NCT00852397|985590|P2|STARTED|Overall Study||49
413162|NCT00852397|985591|P1|STARTED|Overall Study||52
413163|NCT00852137|985622|P2|NOT COMPLETED|Overall Study||0
413164|NCT00852137|985623|P1|NOT COMPLETED|Overall Study||0
413165|NCT00852137|985622|P2|COMPLETED|Overall Study||3
413166|NCT00852137|985623|P1|COMPLETED|Overall Study||13
413167|NCT00852137|985622|P2|STARTED|Overall Study||3
413168|NCT00852137|985623|P1|STARTED|Overall Study||13
413169|NCT00852124|985645|P2|NOT COMPLETED|Overall Study||0
413170|NCT00852124|985646|P1|NOT COMPLETED|Overall Study||0
413171|NCT00852124|985645|P2|COMPLETED|Overall Study||0
413172|NCT00852124|985646|P1|COMPLETED|Overall Study||3
413173|NCT00852124|985645|P2|STARTED|Overall Study||0
413174|NCT00852124|985646|P1|STARTED|Overall Study||3
413175|NCT00851903|985651|P1|NOT COMPLETED|Overall Study||2
413176|NCT00851903|985651|P1|COMPLETED|Overall Study||110
413177|NCT00851903|985651|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
413178|NCT00851903|985651|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
413179|NCT00851903|985651|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
413180|NCT00851903|985651|P1|STARTED|Overall Study||112
413181|NCT00851890|985665|P4|NOT COMPLETED|Overall Study||1
413182|NCT00851890|985666|P3|NOT COMPLETED|Overall Study||0
413183|NCT00851890|985667|P2|NOT COMPLETED|Overall Study||1
413184|NCT00851890|985668|P1|NOT COMPLETED|Overall Study||0
413185|NCT00851890|985665|P4|COMPLETED|Overall Study||5
413186|NCT00851890|985666|P3|COMPLETED|Overall Study||8
413187|NCT00851890|985667|P2|COMPLETED|Overall Study||7
413188|NCT00851890|985668|P1|COMPLETED|Overall Study||8
413189|NCT00851890|985665|P4|STARTED|Overall Study||6
413190|NCT00851890|985666|P3|STARTED|Overall Study||8
413191|NCT00851890|985667|P2|STARTED|Overall Study||8
413192|NCT00851890|985668|P1|STARTED|Overall Study||8
413193|NCT00851799|985728|P3|NOT COMPLETED|Overall Study||24
413194|NCT00851799|985729|P2|NOT COMPLETED|Overall Study||13
413195|NCT00851799|985730|P1|NOT COMPLETED|Overall Study||16
413196|NCT00851799|985728|P3|COMPLETED|Overall Study||89
413197|NCT00851799|985729|P2|COMPLETED|Overall Study||93
413198|NCT00851799|985730|P1|COMPLETED|Overall Study||93
413199|NCT00851799|985728|P3|STARTED|Overall Study||113
413200|NCT00851799|985729|P2|STARTED|Overall Study||106
413201|NCT00851799|985730|P1|STARTED|Overall Study||109
413202|NCT00851786|985818|P2|NOT COMPLETED|Overall Study||2
413203|NCT00851786|985819|P1|NOT COMPLETED|Overall Study||5
413204|NCT00851786|985818|P2|COMPLETED|Overall Study||97
413205|NCT00851786|985819|P1|COMPLETED|Overall Study||291
413206|NCT00851786|985818|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
413207|NCT00851786|985819|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
413208|NCT00851721|985829|P2|NOT COMPLETED|Overall Study||1
413209|NCT00851721|985830|P1|NOT COMPLETED|Overall Study||2
413210|NCT00851721|985829|P2|COMPLETED|Overall Study||16
413211|NCT00851721|985830|P1|COMPLETED|Overall Study||17
413212|NCT00851721|985829|P2|STARTED|Overall Study||17
413213|NCT00851721|985830|P1|STARTED|Overall Study||19
413214|NCT00851682|985920|P2|NOT COMPLETED|Overall Study||0
413215|NCT00851682|985921|P1|NOT COMPLETED|Overall Study||5
413216|NCT00851682|985920|P2|COMPLETED|Overall Study||5
413217|NCT00851682|985921|P1|COMPLETED|Overall Study||55
413218|NCT00851682|985920|P2|STARTED|Overall Study||5
413219|NCT00851682|985921|P1|STARTED|Overall Study||60
413220|NCT00851643|985935|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
413221|NCT00851643|985936|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
413222|NCT00851643|985937|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
413223|NCT00851643|985938|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
413224|NCT00851643|985939|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
413225|NCT00851643|985940|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
413226|NCT00851643|985935|P6|COMPLETED|Extension Study (Up to 36 Months)||14
413227|NCT00851643|985936|P5|COMPLETED|Extension Study (Up to 36 Months)||19
413228|NCT00851643|985937|P4|COMPLETED|Extension Study (Up to 36 Months)||5
413229|NCT00851643|985938|P3|COMPLETED|Extension Study (Up to 36 Months)||14
413230|NCT00851643|985939|P2|COMPLETED|Extension Study (Up to 36 Months)||15
413231|NCT00851643|985940|P1|COMPLETED|Extension Study (Up to 36 Months)||6
413232|NCT00851643|985935|P6|STARTED|Extension Study (Up to 36 Months)||15
413233|NCT00851643|985936|P5|STARTED|Extension Study (Up to 36 Months)||21
413234|NCT00851643|985937|P4|STARTED|Extension Study (Up to 36 Months)||7
413235|NCT00851643|985938|P3|STARTED|Extension Study (Up to 36 Months)||19
413236|NCT00851643|985939|P2|STARTED|Extension Study (Up to 36 Months)||19
413237|NCT00851643|985940|P1|STARTED|Extension Study (Up to 36 Months)||10
413238|NCT00851643|985935|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
413239|NCT00851643|985936|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
413240|NCT00851643|985937|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
413241|NCT00851643|985938|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
413242|NCT00851643|985939|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
413243|NCT00851643|985940|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
413244|NCT00851643|985935|P6|COMPLETED|Base Study (Up to 12 Months)||29
413245|NCT00851643|985936|P5|COMPLETED|Base Study (Up to 12 Months)||30
413246|NCT00851643|985937|P4|COMPLETED|Base Study (Up to 12 Months)||15
413247|NCT00851643|985938|P3|COMPLETED|Base Study (Up to 12 Months)||30
413248|NCT00851643|985939|P2|COMPLETED|Base Study (Up to 12 Months)||30
413249|NCT00851643|985940|P1|COMPLETED|Base Study (Up to 12 Months)||14
413250|NCT00851643|985935|P6|STARTED|Base Study (Up to 12 Months)||30
413251|NCT00851643|985936|P5|STARTED|Base Study (Up to 12 Months)||30
413252|NCT00851643|985937|P4|STARTED|Base Study (Up to 12 Months)||15
413253|NCT00851643|985938|P3|STARTED|Base Study (Up to 12 Months)||30
413254|NCT00851643|985939|P2|STARTED|Base Study (Up to 12 Months)||30
413255|NCT00851643|985940|P1|STARTED|Base Study (Up to 12 Months)||15
413256|NCT00851630|985961|P2|NOT COMPLETED|Overall Study||2
413257|NCT00851630|985962|P1|NOT COMPLETED|Overall Study||2
413258|NCT00851630|985961|P2|COMPLETED|Overall Study||33
413259|NCT00851630|985962|P1|COMPLETED|Overall Study||33
413260|NCT00851630|985961|P2|STARTED|Overall Study||35
413261|NCT00851630|985962|P1|STARTED|Overall Study||35
413262|NCT00851591|985976|P2|NOT COMPLETED|Overall Study||0
413263|NCT00851591|985977|P1|NOT COMPLETED|Overall Study||2
413264|NCT00851591|985976|P2|COMPLETED|Overall Study||1
413265|NCT00851591|985977|P1|COMPLETED|Overall Study||0
413266|NCT00851591|985976|P2|STARTED|Overall Study|One received treatment.|1
413267|NCT00851591|985977|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
413268|NCT00851552|985983|P1|NOT COMPLETED|Overall Study||7
413269|NCT00851552|985983|P1|COMPLETED|Overall Study||2
413270|NCT00851552|985983|P1|STARTED|Overall Study||9
413271|NCT00851409|985988|P1|NOT COMPLETED|Overall Study||0
413272|NCT00851409|985988|P1|COMPLETED|Overall Study||25
413273|NCT00851409|985988|P1|STARTED|Overall Study||25
413274|NCT00851318|985997|P4|NOT COMPLETED|Overall Study||19
413275|NCT00851318|985998|P3|NOT COMPLETED|Overall Study||21
413276|NCT00851318|985999|P2|NOT COMPLETED|Overall Study||5
413277|NCT00851318|986000|P1|NOT COMPLETED|Overall Study||30
413278|NCT00851318|985997|P4|COMPLETED|Overall Study||73
413279|NCT00851318|985998|P3|COMPLETED|Overall Study||72
413280|NCT00851318|985999|P2|COMPLETED|Overall Study||14
413281|NCT00851318|986000|P1|COMPLETED|Overall Study||51
413282|NCT00851318|985997|P4|Completed Week 52|Overall Study||85
413283|NCT00851318|985998|P3|Completed Week 52|Overall Study||87
413284|NCT00851318|985999|P2|Completed Week 52|Overall Study||16
413285|NCT00851318|986000|P1|Completed Week 52|Overall Study||64
413286|NCT00851318|985997|P4|Completed Week 24|Overall Study||87
413287|NCT00851318|985998|P3|Completed Week 24|Overall Study||90
413288|NCT00851318|985999|P2|Completed Week 24|Overall Study||17
413289|NCT00851318|986000|P1|Completed Week 24|Overall Study||69
413290|NCT00851318|985997|P4|STARTED|Overall Study||92
413291|NCT00851318|985998|P3|STARTED|Overall Study||93
413292|NCT00851318|985999|P2|STARTED|Overall Study||19
413293|NCT00851318|986000|P1|STARTED|Overall Study||81
413294|NCT00851279|986030|P1|NOT COMPLETED|Overall Study||0
413295|NCT00851279|986030|P1|COMPLETED|Overall Study||53
413296|NCT00851279|986030|P1|STARTED|Overall Study||53
413297|NCT00851084|986036|P2|NOT COMPLETED|Overall Study||119
413298|NCT00851084|986037|P1|NOT COMPLETED|Overall Study||117
413299|NCT00851084|986036|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
413300|NCT00851084|986037|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
413301|NCT00851084|986036|P2|STARTED|Overall Study||119
413302|NCT00851084|986037|P1|STARTED|Overall Study||117
413303|NCT00851006|986053|P2|NOT COMPLETED|Overall Study||0
413304|NCT00851006|986054|P1|NOT COMPLETED|Overall Study||0
413305|NCT00851006|986053|P2|COMPLETED|Overall Study||6
413306|NCT00851006|986054|P1|COMPLETED|Overall Study||7
413307|NCT00851006|986053|P2|STARTED|Overall Study||6
413308|NCT00851006|986054|P1|STARTED|Overall Study||7
413309|NCT00850993|986065|P4|NOT COMPLETED|Overall Study||0
413310|NCT00850993|986066|P3|NOT COMPLETED|Overall Study||0
413311|NCT00850993|986067|P2|NOT COMPLETED|Overall Study||1
413312|NCT00850993|986068|P1|NOT COMPLETED|Overall Study||0
413313|NCT00850993|986065|P4|COMPLETED|Overall Study||8
413314|NCT00850993|986066|P3|COMPLETED|Overall Study||18
413315|NCT00850993|986067|P2|COMPLETED|Overall Study||16
413316|NCT00850993|986068|P1|COMPLETED|Overall Study||15
413317|NCT00850993|986065|P4|STARTED|Overall Study||8
413318|NCT00850993|986066|P3|STARTED|Overall Study||18
413319|NCT00850993|986067|P2|STARTED|Overall Study||17
413320|NCT00850993|986068|P1|STARTED|Overall Study||15
413321|NCT00850889|986082|P1|NOT COMPLETED|Overall Study||0
413322|NCT00850889|986082|P1|COMPLETED|Overall Study||32
413323|NCT00850889|986082|P1|STARTED|Overall Study||32
413324|NCT00850759|986097|P4|NOT COMPLETED|Overall Study||3
413325|NCT00850759|986098|P3|NOT COMPLETED|Overall Study||5
413326|NCT00850759|986099|P2|NOT COMPLETED|Overall Study||5
413327|NCT00850759|986100|P1|NOT COMPLETED|Overall Study||7
413328|NCT00850759|986097|P4|COMPLETED|Overall Study||55
413329|NCT00850759|986098|P3|COMPLETED|Overall Study||52
413330|NCT00850759|986099|P2|COMPLETED|Overall Study||52
413331|NCT00850759|986100|P1|COMPLETED|Overall Study||52
413332|NCT00850759|986097|P4|STARTED|Overall Study||58
413333|NCT00850759|986098|P3|STARTED|Overall Study||57
413334|NCT00850759|986099|P2|STARTED|Overall Study||57
413335|NCT00850759|986100|P1|STARTED|Overall Study||59
413336|NCT00850720|986110|P1|NOT COMPLETED|Overall Study||0
413337|NCT00850720|986110|P1|COMPLETED|Overall Study||0
413338|NCT00850720|986110|P1|STARTED|Overall Study||0
413339|NCT00850603|986119|P5|NOT COMPLETED|Overall Study||0
413340|NCT00850603|986120|P4|NOT COMPLETED|Overall Study||0
413341|NCT00850603|986121|P3|NOT COMPLETED|Overall Study||0
413342|NCT00850603|986122|P2|NOT COMPLETED|Overall Study||0
413343|NCT00850603|986123|P1|NOT COMPLETED|Overall Study||0
413344|NCT00850603|986119|P5|COMPLETED|Overall Study||34
413345|NCT00850603|986120|P4|COMPLETED|Overall Study||34
413346|NCT00850603|986121|P3|COMPLETED|Overall Study||34
413347|NCT00850603|986122|P2|COMPLETED|Overall Study||34
413348|NCT00850603|986123|P1|COMPLETED|Overall Study||34
413349|NCT00850603|986119|P5|STARTED|Overall Study||34
413350|NCT00850603|986120|P4|STARTED|Overall Study||34
413351|NCT00850603|986121|P3|STARTED|Overall Study||34
413352|NCT00850603|986122|P2|STARTED|Overall Study||34
413353|NCT00850603|986123|P1|STARTED|Overall Study||34
413354|NCT00850564|986145|P1|NOT COMPLETED|Overall Study||2
413355|NCT00850564|986145|P1|COMPLETED|Overall Study||13
413356|NCT00850564|986145|P1|STARTED|Overall Study||15
413357|NCT00850538|986150|P1|NOT COMPLETED|Overall Study||41
413358|NCT00850538|986150|P1|COMPLETED|Overall Study||60
413359|NCT00850538|986150|P1|STARTED|Overall Study||101
413360|NCT00850499|986156|P2|NOT COMPLETED|Overall Study||2
413361|NCT00850499|986157|P1|NOT COMPLETED|Overall Study||3
413362|NCT00850499|986156|P2|COMPLETED|Overall Study||6
413363|NCT00850499|986157|P1|COMPLETED|Overall Study||1
413364|NCT00850499|986156|P2|STARTED|Overall Study||8
413365|NCT00850499|986157|P1|STARTED|Overall Study||4
413366|NCT00850460|986167|P2|NOT COMPLETED|Overall Study||4
413367|NCT00850460|986168|P1|NOT COMPLETED|Overall Study||4
413368|NCT00850460|986167|P2|COMPLETED|Overall Study||3
413369|NCT00850460|986168|P1|COMPLETED|Overall Study||3
413370|NCT00850460|986167|P2|Completion - Week 8|Overall Study||3
413371|NCT00850460|986168|P1|Completion - Week 8|Overall Study||3
413372|NCT00850460|986167|P2|Started - Week 0|Overall Study||7
413373|NCT00850460|986168|P1|Started - Week 0|Overall Study||7
413374|NCT00850460|986167|P2|STARTED|Overall Study||7
413375|NCT00850460|986168|P1|STARTED|Overall Study||7
413376|NCT00850421|986176|P1|NOT COMPLETED|Overall Study||17
413377|NCT00850421|986176|P1|COMPLETED|Overall Study||18
413378|NCT00850421|986176|P1|STARTED|Overall Study||35
413379|NCT00850395|986180|P1|NOT COMPLETED|Overall Study||10
413380|NCT00850395|986180|P1|COMPLETED|Overall Study||69
413381|NCT00850395|986180|P1|STARTED|Overall Study||79
413382|NCT00850343|986200|P4|NOT COMPLETED|Overall Study||13
413383|NCT00850343|986201|P3|NOT COMPLETED|Overall Study||14
413384|NCT00850343|986202|P2|NOT COMPLETED|Overall Study||3
413385|NCT00850343|986203|P1|NOT COMPLETED|Overall Study||46
413386|NCT00850343|986200|P4|COMPLETED|Overall Study||30
413387|NCT00850343|986201|P3|COMPLETED|Overall Study||29
413388|NCT00850343|986202|P2|COMPLETED|Overall Study||9
413389|NCT00850343|986203|P1|COMPLETED|Overall Study||64
413390|NCT00850343|986200|P4|Completed Week 52|Overall Study||37
413391|NCT00850343|986201|P3|Completed Week 52|Overall Study||37
413392|NCT00850343|986202|P2|Completed Week 52|Overall Study||11
413393|NCT00850343|986203|P1|Completed Week 52|Overall Study||88
413394|NCT00850343|986200|P4|Completed Week 24|Overall Study||39
413395|NCT00850343|986201|P3|Completed Week 24|Overall Study||39
413396|NCT00850343|986202|P2|Completed Week 24|Overall Study||12
413397|NCT00850343|986203|P1|Completed Week 24|Overall Study||94
413398|NCT00850343|986200|P4|STARTED|Overall Study||43
413399|NCT00850343|986201|P3|STARTED|Overall Study||43
413400|NCT00850343|986202|P2|STARTED|Overall Study||12
413401|NCT00850343|986203|P1|STARTED|Overall Study||110
413402|NCT00850200|986233|P1|NOT COMPLETED|Overall Study||1
413403|NCT00850200|986233|P1|COMPLETED|Overall Study||19
413404|NCT00850200|986233|P1|STARTED|Overall Study||20
413405|NCT00850174|986241|P2|NOT COMPLETED|Second Intervention||0
413406|NCT00850174|986242|P1|NOT COMPLETED|Second Intervention||1
413407|NCT00850174|986241|P2|COMPLETED|Second Intervention||28
413408|NCT00850174|986242|P1|COMPLETED|Second Intervention||29
413409|NCT00850174|986241|P2|STARTED|Second Intervention||28
413410|NCT00850174|986242|P1|STARTED|Second Intervention||30
413411|NCT00850174|986241|P2|NOT COMPLETED|Washout: One Week||2
413412|NCT00850174|986242|P1|NOT COMPLETED|Washout: One Week||0
413413|NCT00850174|986241|P2|COMPLETED|Washout: One Week||28
413414|NCT00850174|986242|P1|COMPLETED|Washout: One Week||30
413415|NCT00850174|986241|P2|STARTED|Washout: One Week||30
413416|NCT00850174|986242|P1|STARTED|Washout: One Week||30
413417|NCT00850174|986241|P2|NOT COMPLETED|First Intervention||0
413418|NCT00850174|986242|P1|NOT COMPLETED|First Intervention||0
413419|NCT00850174|986241|P2|COMPLETED|First Intervention||30
413420|NCT00850174|986242|P1|COMPLETED|First Intervention||30
413421|NCT00850174|986241|P2|STARTED|First Intervention||30
413422|NCT00850174|986242|P1|STARTED|First Intervention||30
413423|NCT00850135|986256|P1|NOT COMPLETED|Overall Study||1
413424|NCT00850135|986256|P1|COMPLETED|Overall Study||56
413425|NCT00850135|986256|P1|STARTED|Overall Study||57
413426|NCT00850096|986264|P2|NOT COMPLETED|Overall Study||2
413427|NCT00850096|986265|P1|NOT COMPLETED|Overall Study||3
413428|NCT00850096|986264|P2|COMPLETED|Overall Study||45
413429|NCT00850096|986265|P1|COMPLETED|Overall Study||44
413430|NCT00850096|986264|P2|STARTED|Overall Study||47
413431|NCT00850096|986265|P1|STARTED|Overall Study||47
413432|NCT00850070|986275|P2|NOT COMPLETED|Overall Study||1
413433|NCT00850070|986276|P1|NOT COMPLETED|Overall Study||3
413434|NCT00850070|986275|P2|COMPLETED|Overall Study||22
413435|NCT00850070|986276|P1|COMPLETED|Overall Study||20
413436|NCT00850070|986275|P2|STARTED|Overall Study||23
413437|NCT00850070|986276|P1|STARTED|Overall Study||23
413438|NCT00850031|986292|P1|NOT COMPLETED|Overall Study||17
413439|NCT00850031|986292|P1|COMPLETED|Overall Study||101
413440|NCT00850031|986292|P1|STARTED|Overall Study||118
413441|NCT00849940|986297|P1|NOT COMPLETED|Overall Study||4
413442|NCT00849940|986297|P1|COMPLETED|Overall Study||68
413443|NCT00849940|986297|P1|STARTED|Overall Study||72
413444|NCT00849901|986308|P3|NOT COMPLETED|Extension Phase||17
413445|NCT00849901|986309|P2|NOT COMPLETED|Extension Phase||26
413446|NCT00849901|986310|P1|NOT COMPLETED|Extension Phase||27
413447|NCT00849901|986308|P3|COMPLETED|Extension Phase||69
413448|NCT00849901|986309|P2|COMPLETED|Extension Phase||65
413449|NCT00849901|986310|P1|COMPLETED|Extension Phase||56
413450|NCT00849901|986308|P3|STARTED|Extension Phase||86
413451|NCT00849901|986309|P2|STARTED|Extension Phase||91
413452|NCT00849901|986310|P1|STARTED|Extension Phase||83
413453|NCT00849901|986308|P3|NOT COMPLETED|Acute Treatment Phase||16
413454|NCT00849901|986309|P2|NOT COMPLETED|Acute Treatment Phase||26
413455|NCT00849901|986310|P1|NOT COMPLETED|Acute Treatment Phase||30
413456|NCT00849901|986308|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
413457|NCT00849901|986309|P2|COMPLETED|Acute Treatment Phase||91
413458|NCT00849901|986310|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
413459|NCT00849901|986308|P3|STARTED|Acute Treatment Phase||103
413460|NCT00849901|986309|P2|STARTED|Acute Treatment Phase||117
413461|NCT00849901|986310|P1|STARTED|Acute Treatment Phase||117
413462|NCT00849875|986357|P1|NOT COMPLETED|Overall Study||47
413463|NCT00849875|986357|P1|COMPLETED|Overall Study||1
413464|NCT00849875|986357|P1|STARTED|Overall Study||48
413465|NCT00849862|986439|P2|NOT COMPLETED|Second Intervention||0
413466|NCT00849862|986440|P1|NOT COMPLETED|Second Intervention||0
413467|NCT00849862|986439|P2|COMPLETED|Second Intervention||11
413468|NCT00849862|986440|P1|COMPLETED|Second Intervention||11
413469|NCT00849862|986439|P2|STARTED|Second Intervention||11
413470|NCT00849862|986440|P1|STARTED|Second Intervention||11
413471|NCT00849862|986439|P2|NOT COMPLETED|Washout: 7 Days||0
413472|NCT00849862|986440|P1|NOT COMPLETED|Washout: 7 Days||0
413473|NCT00849862|986439|P2|COMPLETED|Washout: 7 Days||11
413474|NCT00849862|986440|P1|COMPLETED|Washout: 7 Days||11
413475|NCT00849862|986439|P2|STARTED|Washout: 7 Days||11
413476|NCT00849862|986440|P1|STARTED|Washout: 7 Days||11
413477|NCT00849862|986439|P2|NOT COMPLETED|First Intervention||0
413478|NCT00849862|986440|P1|NOT COMPLETED|First Intervention||0
413479|NCT00849862|986439|P2|COMPLETED|First Intervention||11
413480|NCT00849862|986440|P1|COMPLETED|First Intervention||11
413481|NCT00849862|986439|P2|STARTED|First Intervention||11
413482|NCT00849862|986440|P1|STARTED|First Intervention||11
413483|NCT00849810|986448|P1|NOT COMPLETED|Overall Study||0
413484|NCT00849810|986448|P1|COMPLETED|Overall Study||1
413485|NCT00849810|986448|P1|STARTED|Overall Study||1
413486|NCT00849797|986454|P2|NOT COMPLETED|Second Intervention||0
413487|NCT00849797|986455|P1|NOT COMPLETED|Second Intervention||0
413488|NCT00849797|986454|P2|COMPLETED|Second Intervention||57
413489|NCT00849797|986455|P1|COMPLETED|Second Intervention||59
413490|NCT00849797|986454|P2|STARTED|Second Intervention||57
413491|NCT00849797|986455|P1|STARTED|Second Intervention||59
413492|NCT00849797|986454|P2|NOT COMPLETED|Washout: One Week||2
413493|NCT00849797|986455|P1|NOT COMPLETED|Washout: One Week||0
413494|NCT00849797|986454|P2|COMPLETED|Washout: One Week||57
413495|NCT00849797|986455|P1|COMPLETED|Washout: One Week||59
413496|NCT00849797|986454|P2|STARTED|Washout: One Week||59
413497|NCT00849797|986455|P1|STARTED|Washout: One Week||59
413498|NCT00849797|986454|P2|NOT COMPLETED|First Intervention||1
413499|NCT00849797|986455|P1|NOT COMPLETED|First Intervention||1
413500|NCT00849797|986454|P2|COMPLETED|First Intervention||59
413501|NCT00849797|986455|P1|COMPLETED|First Intervention||59
413502|NCT00849797|986454|P2|STARTED|First Intervention||60
413503|NCT00849797|986455|P1|STARTED|First Intervention||60
413504|NCT00849693|986473|P4|NOT COMPLETED|Extension Phase||38
413505|NCT00849693|986474|P3|NOT COMPLETED|Extension Phase||35
413506|NCT00849693|986475|P2|NOT COMPLETED|Extension Phase||30
413507|NCT00849693|986476|P1|NOT COMPLETED|Extension Phase||30
413508|NCT00849693|986473|P4|COMPLETED|Extension Phase||44
413509|NCT00849693|986474|P3|COMPLETED|Extension Phase||49
413510|NCT00849693|986475|P2|COMPLETED|Extension Phase||50
413511|NCT00849693|986476|P1|COMPLETED|Extension Phase||43
413512|NCT00849693|986473|P4|STARTED|Extension Phase||82
413513|NCT00849693|986474|P3|STARTED|Extension Phase||84
413514|NCT00849693|986475|P2|STARTED|Extension Phase||80
413515|NCT00849693|986476|P1|STARTED|Extension Phase||73
413516|NCT00849693|986473|P4|NOT COMPLETED|Acute Treatment Phase||37
413517|NCT00849693|986474|P3|NOT COMPLETED|Acute Treatment Phase||33
413518|NCT00849693|986475|P2|NOT COMPLETED|Acute Treatment Phase||35
413519|NCT00849693|986476|P1|NOT COMPLETED|Acute Treatment Phase||33
413520|NCT00849693|986473|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
413521|NCT00849693|986474|P3|COMPLETED|Acute Treatment Phase||84
413522|NCT00849693|986475|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
413523|NCT00849693|986476|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
413524|NCT00849693|986473|P4|STARTED|Acute Treatment Phase||122
413525|NCT00849693|986474|P3|STARTED|Acute Treatment Phase||117
413526|NCT00849693|986475|P2|STARTED|Acute Treatment Phase||116
413527|NCT00849693|986476|P1|STARTED|Acute Treatment Phase||108
413528|NCT00849680|986543|P8|NOT COMPLETED|Overall Study||8
413529|NCT00849680|986544|P7|NOT COMPLETED|Overall Study||17
413530|NCT00849680|986545|P6|NOT COMPLETED|Overall Study||15
413531|NCT00849680|986546|P5|NOT COMPLETED|Overall Study||10
413532|NCT00849680|986547|P4|NOT COMPLETED|Overall Study||14
413533|NCT00849680|986548|P3|NOT COMPLETED|Overall Study||15
413534|NCT00849680|986549|P2|NOT COMPLETED|Overall Study||3
413535|NCT00849680|986550|P1|NOT COMPLETED|Overall Study||11
413536|NCT00849680|986543|P8|COMPLETED|Overall Study||23
413537|NCT00849680|986544|P7|COMPLETED|Overall Study||61
413538|NCT00849680|986545|P6|COMPLETED|Overall Study||27
413539|NCT00849680|986546|P5|COMPLETED|Overall Study||32
413540|NCT00849680|986547|P4|COMPLETED|Overall Study||28
413541|NCT00849680|986548|P3|COMPLETED|Overall Study||27
413542|NCT00849680|986549|P2|COMPLETED|Overall Study||10
413543|NCT00849680|986550|P1|COMPLETED|Overall Study||16
413544|NCT00849680|986543|P8|STARTED|Overall Study||31
413545|NCT00849680|986544|P7|STARTED|Overall Study||78
413546|NCT00849680|986545|P6|STARTED|Overall Study||42
413547|NCT00849680|986546|P5|STARTED|Overall Study||42
413548|NCT00849680|986547|P4|STARTED|Overall Study||42
413549|NCT00849680|986548|P3|STARTED|Overall Study||42
413550|NCT00849680|986549|P2|STARTED|Overall Study||13
413551|NCT00849680|986550|P1|STARTED|Overall Study||27
413552|NCT00849524|986592|P1|NOT COMPLETED|Overall Study||3
413553|NCT00849524|986592|P1|COMPLETED|Overall Study||3
413554|NCT00849524|986592|P1|STARTED|Overall Study||6
413555|NCT00849485|986600|P2|NOT COMPLETED|Second Intervention||0
413556|NCT00849485|986601|P1|NOT COMPLETED|Second Intervention||0
413557|NCT00849485|986600|P2|COMPLETED|Second Intervention||11
413558|NCT00849485|986601|P1|COMPLETED|Second Intervention||11
413559|NCT00849485|986600|P2|STARTED|Second Intervention||11
413560|NCT00849485|986601|P1|STARTED|Second Intervention||11
413561|NCT00849485|986600|P2|NOT COMPLETED|Washout: 7 Days||0
413562|NCT00849485|986601|P1|NOT COMPLETED|Washout: 7 Days||0
413563|NCT00849485|986600|P2|COMPLETED|Washout: 7 Days||11
413564|NCT00849485|986601|P1|COMPLETED|Washout: 7 Days||11
413565|NCT00849485|986600|P2|STARTED|Washout: 7 Days||11
413566|NCT00849485|986601|P1|STARTED|Washout: 7 Days||11
413567|NCT00849485|986600|P2|NOT COMPLETED|First Intervention||0
413568|NCT00849485|986601|P1|NOT COMPLETED|First Intervention||0
413569|NCT00849485|986600|P2|COMPLETED|First Intervention||11
413570|NCT00849485|986601|P1|COMPLETED|First Intervention||11
413571|NCT00849485|986600|P2|STARTED|First Intervention||11
413572|NCT00849485|986601|P1|STARTED|First Intervention||11
413573|NCT00849472|986609|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
413574|NCT00849472|986609|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
413575|NCT00849472|986609|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
413576|NCT00849472|986609|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
413577|NCT00849472|986609|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
413578|NCT00849472|986609|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
413579|NCT00849472|986609|P1|NOT COMPLETED|Weekly Paclitaxel||16
413580|NCT00849472|986609|P1|COMPLETED|Weekly Paclitaxel||78
413581|NCT00849472|986609|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
413582|NCT00849472|986609|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
413583|NCT00849472|986609|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
413584|NCT00849472|986609|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
413585|NCT00849381|986623|P1|NOT COMPLETED|Overall Study||145
413586|NCT00849381|986623|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
413587|NCT00849381|986623|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
413588|NCT00849290|986629|P1|NOT COMPLETED|Overall Study||55
413589|NCT00849290|986629|P1|COMPLETED|Overall Study||58
413590|NCT00849290|986629|P1|STARTED|Overall Study||113
413591|NCT00849212|986633|P1|NOT COMPLETED|Overall Study||7
413592|NCT00849212|986633|P1|COMPLETED|Overall Study||23
413593|NCT00849212|986633|P1|STARTED|Overall Study||30
413594|NCT00849186|986638|P1|NOT COMPLETED|Overall Study||10
413595|NCT00849186|986638|P1|COMPLETED|Overall Study||16
413596|NCT00849186|986638|P1|STARTED|Overall Study||26
413597|NCT00849147|986644|P1|NOT COMPLETED|Overall Study||5
413598|NCT00849147|986644|P1|COMPLETED|Overall Study||50
413599|NCT00849147|986644|P1|STARTED|Overall Study||55
413600|NCT00849121|986661|P2|NOT COMPLETED|Overall Study||0
413601|NCT00849121|986662|P1|NOT COMPLETED|Overall Study||0
413602|NCT00849121|986661|P2|COMPLETED|Overall Study||9
413603|NCT00849121|986662|P1|COMPLETED|Overall Study||8
413604|NCT00849121|986661|P2|STARTED|Overall Study||9
413605|NCT00849121|986662|P1|STARTED|Overall Study||8
413606|NCT00849108|986677|P2|NOT COMPLETED|Cohort 2 Efficacy||10
413607|NCT00849108|986678|P1|NOT COMPLETED|Cohort 2 Efficacy||0
413608|NCT00849108|986677|P2|COMPLETED|Cohort 2 Efficacy||133
413609|NCT00849108|986678|P1|COMPLETED|Cohort 2 Efficacy||0
413610|NCT00849108|986677|P2|STARTED|Cohort 2 Efficacy||143
413611|NCT00849108|986678|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
413612|NCT00849108|986677|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
413613|NCT00849108|986678|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
413614|NCT00849108|986677|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
413615|NCT00849108|986678|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
413616|NCT00849108|986677|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
413617|NCT00849108|986678|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
413618|NCT00849056|986688|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
413619|NCT00849056|986689|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
413620|NCT00849056|986688|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
413621|NCT00849056|986689|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
413622|NCT00849056|986688|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
413623|NCT00849056|986689|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
413624|NCT00849056|986688|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
413625|NCT00849056|986689|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
413626|NCT00849056|986688|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
413627|NCT00849056|986689|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
413628|NCT00849056|986688|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
413629|NCT00849056|986689|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
413630|NCT00849017|986714|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
413631|NCT00849017|986715|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
413632|NCT00849017|986716|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
413633|NCT00849017|986714|P3|COMPLETED|Follow-up Period (8 Weeks)||74
413634|NCT00849017|986715|P2|COMPLETED|Follow-up Period (8 Weeks)||83
413635|NCT00849017|986716|P1|COMPLETED|Follow-up Period (8 Weeks)||76
413636|NCT00849017|986714|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
413637|NCT00849017|986715|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
413638|NCT00849017|986716|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
413639|NCT00849017|986714|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
413640|NCT00849017|986715|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
413641|NCT00849017|986716|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
413642|NCT00849017|986714|P3|COMPLETED|Treatment Period (156 Weeks)||57
413643|NCT00849017|986715|P2|COMPLETED|Treatment Period (156 Weeks)||68
413644|NCT00849017|986716|P1|COMPLETED|Treatment Period (156 Weeks)||58
413645|NCT00849017|986714|P3|STARTED|Treatment Period (156 Weeks)||99
413646|NCT00849017|986715|P2|STARTED|Treatment Period (156 Weeks)||101
413647|NCT00849017|986716|P1|STARTED|Treatment Period (156 Weeks)||101
413648|NCT00848965|986759|P1|NOT COMPLETED|Overall Study||2
413649|NCT00848965|986759|P1|COMPLETED|Overall Study||57
413650|NCT00848965|986759|P1|STARTED|Overall Study||59
413651|NCT00848926|986801|P1|NOT COMPLETED|Follow-up Period||12
413652|NCT00848926|986801|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
413653|NCT00848926|986801|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
413654|NCT00848926|986801|P1|NOT COMPLETED|Treatment Period||84
413655|NCT00848926|986801|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
413656|NCT00848926|986801|P1|STARTED|Treatment Period||102
413657|NCT00848783|986820|P3|NOT COMPLETED|Overall Study||0
413658|NCT00848783|986821|P2|NOT COMPLETED|Overall Study||2
413659|NCT00848783|986822|P1|NOT COMPLETED|Overall Study||3
413660|NCT00848783|986820|P3|COMPLETED|Overall Study||1
413661|NCT00848783|986821|P2|COMPLETED|Overall Study||1
413662|NCT00848783|986822|P1|COMPLETED|Overall Study||1
413663|NCT00848783|986820|P3|STARTED|Overall Study||1
413664|NCT00848783|986821|P2|STARTED|Overall Study||3
413665|NCT00848783|986822|P1|STARTED|Overall Study||4
413666|NCT00848744|986828|P1|NOT COMPLETED|Overall Study||0
413667|NCT00848744|986828|P1|COMPLETED|Overall Study||10
413668|NCT00848744|986828|P1|STARTED|Overall Study||10
413669|NCT00848549|986835|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
413670|NCT00848549|986836|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
413671|NCT00848549|986835|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
413672|NCT00848549|986836|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
413673|NCT00848549|986835|P2|STARTED|E2090-E044-314 (Extension Study)||158
413674|NCT00848549|986836|P1|STARTED|E2090-E044-314 (Extension Study)||137
413675|NCT00848549|986835|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
413676|NCT00848549|986836|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
413677|NCT00848549|986835|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
413678|NCT00848549|986836|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
413679|NCT00848549|986835|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
413680|NCT00848549|986836|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
413681|NCT00848549|986835|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
413682|NCT00848549|986836|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
413683|NCT00848549|986835|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
413684|NCT00848549|986836|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
413685|NCT00848549|986835|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
413686|NCT00848549|986836|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
413687|NCT00848536|986854|P2|NOT COMPLETED|Overall Study||7
413688|NCT00848536|986855|P1|NOT COMPLETED|Overall Study||4
413689|NCT00848536|986854|P2|COMPLETED|Overall Study||179
413690|NCT00848536|986855|P1|COMPLETED|Overall Study||181
413691|NCT00848536|986854|P2|STARTED|Overall Study||186
413692|NCT00848536|986855|P1|STARTED|Overall Study||185
413693|NCT00848510|986869|P4|NOT COMPLETED|Overall Study||0
413694|NCT00848510|986870|P3|NOT COMPLETED|Overall Study||0
413695|NCT00848510|986871|P2|NOT COMPLETED|Overall Study||0
413696|NCT00848510|986872|P1|NOT COMPLETED|Overall Study||0
413697|NCT00848510|986869|P4|COMPLETED|Overall Study||10
413698|NCT00848510|986870|P3|COMPLETED|Overall Study||8
413699|NCT00848510|986871|P2|COMPLETED|Overall Study||13
413700|NCT00848510|986872|P1|COMPLETED|Overall Study||10
413701|NCT00848510|986869|P4|STARTED|Overall Study||10
413702|NCT00848510|986870|P3|STARTED|Overall Study||8
413703|NCT00848510|986871|P2|STARTED|Overall Study||13
413704|NCT00848510|986872|P1|STARTED|Overall Study||10
413705|NCT00848497|986920|P2|NOT COMPLETED|Overall Study||1
413706|NCT00848497|986921|P1|NOT COMPLETED|Overall Study||2
413707|NCT00848497|986920|P2|COMPLETED|Overall Study||0
413708|NCT00848497|986921|P1|COMPLETED|Overall Study||0
413709|NCT00848497|986920|P2|STARTED|Overall Study|Completed Visit 4|1
413710|NCT00848497|986921|P1|STARTED|Overall Study||2
413711|NCT00848484|986935|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
413712|NCT00848484|986936|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
413713|NCT00848484|986935|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
413714|NCT00848484|986936|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
413715|NCT00848484|986935|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
413716|NCT00848484|986936|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
413717|NCT00848484|986935|P2|STARTED|Second Intervention (Treatment Period 2)||21
413718|NCT00848484|986936|P1|STARTED|Second Intervention (Treatment Period 2)||25
413719|NCT00848484|986935|P2|NOT COMPLETED|Washout Period of Two Weeks||3
413720|NCT00848484|986936|P1|NOT COMPLETED|Washout Period of Two Weeks||0
413721|NCT00848484|986935|P2|COMPLETED|Washout Period of Two Weeks||21
413722|NCT00848484|986936|P1|COMPLETED|Washout Period of Two Weeks||25
413723|NCT00848484|986935|P2|STARTED|Washout Period of Two Weeks||24
413724|NCT00848484|986936|P1|STARTED|Washout Period of Two Weeks||25
413725|NCT00848484|986935|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
413726|NCT00848484|986936|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
413727|NCT00848484|986935|P2|COMPLETED|First Intervention (Treatment Period 1)||24
413728|NCT00848484|986936|P1|COMPLETED|First Intervention (Treatment Period 1)||25
413729|NCT00848484|986935|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
413730|NCT00848484|986936|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
413731|NCT00848484|986935|P2|STARTED|First Intervention (Treatment Period 1)||27
413732|NCT00848484|986936|P1|STARTED|First Intervention (Treatment Period 1)||27
413733|NCT00848367|986954|P2|NOT COMPLETED|Overall Study||9
413734|NCT00848367|986955|P1|NOT COMPLETED|Overall Study||9
413735|NCT00848367|986954|P2|COMPLETED|Overall Study||41
413736|NCT00848367|986955|P1|COMPLETED|Overall Study||43
413737|NCT00848367|986954|P2|STARTED|Overall Study||50
413738|NCT00848367|986955|P1|STARTED|Overall Study||52
413739|NCT00848354|986965|P2|NOT COMPLETED|Phase 2 Year 2||7
413740|NCT00848354|986966|P1|NOT COMPLETED|Phase 2 Year 2||23
413741|NCT00848354|986965|P2|COMPLETED|Phase 2 Year 2||113
413742|NCT00848354|986966|P1|COMPLETED|Phase 2 Year 2||218
413833|NCT00848042|987256|P2|Day 15|Overall Study||5
413743|NCT00848354|986965|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
413744|NCT00848354|986966|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
413745|NCT00848354|986965|P2|NOT COMPLETED|Phase 2 Year 1||6
413746|NCT00848354|986966|P1|NOT COMPLETED|Phase 2 Year 1||18
413747|NCT00848354|986965|P2|COMPLETED|Phase 2 Year 1||120
413748|NCT00848354|986966|P1|COMPLETED|Phase 2 Year 1||242
413749|NCT00848354|986965|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
413750|NCT00848354|986966|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
413751|NCT00848354|986965|P2|NOT COMPLETED|Phase 1||14
413752|NCT00848354|986966|P1|NOT COMPLETED|Phase 1||12
413753|NCT00848354|986965|P2|COMPLETED|Phase 1||129
413754|NCT00848354|986966|P1|COMPLETED|Phase 1||269
413755|NCT00848354|986965|P2|STARTED|Phase 1||143
413756|NCT00848354|986966|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
413757|NCT00848237|987116|P1|NOT COMPLETED|Overall Study||539
413758|NCT00848237|987116|P1|COMPLETED|Overall Study||4982
413759|NCT00848237|987116|P1|STARTED|Overall Study||5521
413760|NCT00848211|987129|P4|NOT COMPLETED|Overall Study||0
413761|NCT00848211|987130|P3|NOT COMPLETED|Overall Study||1
413762|NCT00848211|987131|P2|NOT COMPLETED|Overall Study||1
413763|NCT00848211|987132|P1|NOT COMPLETED|Overall Study||0
413764|NCT00848211|987129|P4|COMPLETED|Overall Study||5
413765|NCT00848211|987130|P3|COMPLETED|Overall Study||5
413766|NCT00848211|987131|P2|COMPLETED|Overall Study||6
413767|NCT00848211|987132|P1|COMPLETED|Overall Study||6
413768|NCT00848211|987129|P4|STARTED|Overall Study||5
413769|NCT00848211|987130|P3|STARTED|Overall Study||6
413770|NCT00848211|987131|P2|STARTED|Overall Study||7
413771|NCT00848211|987132|P1|STARTED|Overall Study||6
413772|NCT00848198|987150|P1|NOT COMPLETED|Overall Study||15
413773|NCT00848198|987150|P1|COMPLETED|Overall Study||299
413774|NCT00848198|987150|P1|STARTED|Overall Study||314
413775|NCT00848185|987191|P3|NOT COMPLETED|Overall Study||0
413776|NCT00848185|987192|P2|NOT COMPLETED|Overall Study||0
413777|NCT00848185|987193|P1|NOT COMPLETED|Overall Study||0
413778|NCT00848185|987191|P3|COMPLETED|Overall Study||32
413779|NCT00848185|987192|P2|COMPLETED|Overall Study||32
413780|NCT00848185|987193|P1|COMPLETED|Overall Study||32
413781|NCT00848185|987191|P3|STARTED|Overall Study||32
413782|NCT00848185|987192|P2|STARTED|Overall Study||32
413783|NCT00848185|987193|P1|STARTED|Overall Study||32
413784|NCT00848172|987203|P2|NOT COMPLETED|Visit 3 - Follow Up||0
413785|NCT00848172|987204|P1|NOT COMPLETED|Visit 3 - Follow Up||0
413786|NCT00848172|987203|P2|COMPLETED|Visit 3 - Follow Up||8
413787|NCT00848172|987204|P1|COMPLETED|Visit 3 - Follow Up||10
413788|NCT00848172|987203|P2|STARTED|Visit 3 - Follow Up||8
413789|NCT00848172|987204|P1|STARTED|Visit 3 - Follow Up||10
413790|NCT00848172|987203|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
413791|NCT00848172|987204|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
413792|NCT00848172|987203|P2|COMPLETED|Visit 2 - Drug Administration||8
413793|NCT00848172|987204|P1|COMPLETED|Visit 2 - Drug Administration||10
413794|NCT00848172|987203|P2|STARTED|Visit 2 - Drug Administration||9
413795|NCT00848172|987204|P1|STARTED|Visit 2 - Drug Administration||10
413796|NCT00848120|987215|P1|NOT COMPLETED|Overall Study||1
413797|NCT00848120|987215|P1|COMPLETED|Overall Study||28
413798|NCT00848120|987215|P1|STARTED|Overall Study||29
413799|NCT00848107|987227|P1|NOT COMPLETED|Overall Study||21
413800|NCT00848107|987227|P1|COMPLETED|Overall Study||94
413801|NCT00848107|987227|P1|STARTED|Overall Study||115
413802|NCT00848081|987237|P2|NOT COMPLETED|Overall Study||18
413803|NCT00848081|987238|P1|NOT COMPLETED|Overall Study||20
413804|NCT00848081|987237|P2|COMPLETED|Overall Study||140
413805|NCT00848081|987238|P1|COMPLETED|Overall Study||140
413806|NCT00848081|987237|P2|STARTED|Overall Study||158
413807|NCT00848081|987238|P1|STARTED|Overall Study||160
413808|NCT00848042|987255|P3|NOT COMPLETED|Overall Study||0
413809|NCT00848042|987256|P2|NOT COMPLETED|Overall Study||2
413810|NCT00848042|987257|P1|NOT COMPLETED|Overall Study||4
413811|NCT00848042|987255|P3|COMPLETED|Overall Study||1
413812|NCT00848042|987256|P2|COMPLETED|Overall Study||3
413813|NCT00848042|987257|P1|COMPLETED|Overall Study||1
413814|NCT00848042|987255|P3|Month 6|Overall Study||1
413815|NCT00848042|987256|P2|Month 6|Overall Study||3
413816|NCT00848042|987257|P1|Month 6|Overall Study||1
413817|NCT00848042|987255|P3|Month 5|Overall Study||1
413818|NCT00848042|987256|P2|Month 5|Overall Study||3
413819|NCT00848042|987257|P1|Month 5|Overall Study||1
413820|NCT00848042|987255|P3|Month 4|Overall Study||1
413821|NCT00848042|987256|P2|Month 4|Overall Study||4
413822|NCT00848042|987257|P1|Month 4|Overall Study||1
413823|NCT00848042|987255|P3|Month 3|Overall Study||1
413824|NCT00848042|987256|P2|Month 3|Overall Study||4
413825|NCT00848042|987257|P1|Month 3|Overall Study||1
413826|NCT00848042|987255|P3|Month 2|Overall Study||1
413827|NCT00848042|987256|P2|Month 2|Overall Study||5
413828|NCT00848042|987257|P1|Month 2|Overall Study||1
413829|NCT00848042|987255|P3|Month 1|Overall Study||1
413830|NCT00848042|987256|P2|Month 1|Overall Study||5
413831|NCT00848042|987257|P1|Month 1|Overall Study||4
413832|NCT00848042|987255|P3|Day 15|Overall Study||1
413834|NCT00848042|987257|P1|Day 15|Overall Study||4
413835|NCT00848042|987255|P3|Day 8|Overall Study||1
413836|NCT00848042|987256|P2|Day 8|Overall Study||5
413837|NCT00848042|987257|P1|Day 8|Overall Study||5
413838|NCT00848042|987255|P3|Day 3|Overall Study||1
413839|NCT00848042|987256|P2|Day 3|Overall Study||5
413840|NCT00848042|987257|P1|Day 3|Overall Study||5
413841|NCT00848042|987255|P3|Day 2|Overall Study||1
413842|NCT00848042|987256|P2|Day 2|Overall Study||5
413843|NCT00848042|987257|P1|Day 2|Overall Study||5
413844|NCT00848042|987255|P3|Day 1|Overall Study||1
413845|NCT00848042|987256|P2|Day 1|Overall Study||5
413846|NCT00848042|987257|P1|Day 1|Overall Study||5
413847|NCT00848042|987255|P3|STARTED|Overall Study||1
413848|NCT00848042|987256|P2|STARTED|Overall Study||5
413849|NCT00848042|987257|P1|STARTED|Overall Study||5
413850|NCT00848016|987268|P1|NOT COMPLETED|Overall Study||0
413851|NCT00848016|987268|P1|COMPLETED|Overall Study||29
413852|NCT00848016|987268|P1|STARTED|Overall Study||29
413853|NCT00847912|987276|P2|NOT COMPLETED|Overall Study||13
413854|NCT00847912|987277|P1|NOT COMPLETED|Overall Study||9
413855|NCT00847912|987276|P2|COMPLETED|Overall Study||464
413856|NCT00847912|987277|P1|COMPLETED|Overall Study||468
413857|NCT00847912|987276|P2|STARTED|Overall Study||477
413858|NCT00847912|987277|P1|STARTED|Overall Study||477
413859|NCT00847886|987287|P2|NOT COMPLETED|Overall Study||1
413860|NCT00847886|987288|P1|NOT COMPLETED|Overall Study||0
413861|NCT00847886|987287|P2|COMPLETED|Overall Study||3
413862|NCT00847886|987288|P1|COMPLETED|Overall Study||12
413863|NCT00847886|987287|P2|STARTED|Overall Study||4
413864|NCT00847886|987288|P1|STARTED|Overall Study||12
413865|NCT00847808|987314|P1|NOT COMPLETED|Overall Study||15
413866|NCT00847808|987314|P1|COMPLETED|Overall Study||163
413867|NCT00847808|987314|P1|STARTED|Overall Study||178
413868|NCT00847704|987331|P1|NOT COMPLETED|Overall Study||1
413869|NCT00847704|987331|P1|COMPLETED|Overall Study||2
413870|NCT00847704|987331|P1|STARTED|Overall Study||3
413871|NCT00847665|987342|P2|NOT COMPLETED|Overall Study||0
413872|NCT00847665|987343|P1|NOT COMPLETED|Overall Study||1
413873|NCT00847665|987342|P2|COMPLETED|Overall Study||165
413874|NCT00847665|987343|P1|COMPLETED|Overall Study||164
413875|NCT00847665|987342|P2|STARTED|Overall Study||165
413876|NCT00847665|987343|P1|STARTED|Overall Study||165
413877|NCT00847626|987366|P11|NOT COMPLETED|Overall Study||20
413878|NCT00847626|987367|P10|NOT COMPLETED|Overall Study||14
413879|NCT00847626|987368|P9|NOT COMPLETED|Overall Study||14
413880|NCT00847626|987369|P8|NOT COMPLETED|Overall Study||19
413881|NCT00847626|987370|P7|NOT COMPLETED|Overall Study||22
413882|NCT00847626|987371|P6|NOT COMPLETED|Overall Study||37
413883|NCT00847626|987372|P5|NOT COMPLETED|Overall Study||28
413884|NCT00847626|987373|P4|NOT COMPLETED|Overall Study||31
413885|NCT00847626|987374|P3|NOT COMPLETED|Overall Study||16
413886|NCT00847626|987375|P2|NOT COMPLETED|Overall Study||23
413887|NCT00847626|987376|P1|NOT COMPLETED|Overall Study||21
413888|NCT00847626|987366|P11|COMPLETED|Overall Study||142
413889|NCT00847626|987367|P10|COMPLETED|Overall Study||139
413890|NCT00847626|987368|P9|COMPLETED|Overall Study||141
413891|NCT00847626|987369|P8|COMPLETED|Overall Study||141
413892|NCT00847626|987370|P7|COMPLETED|Overall Study||135
413893|NCT00847626|987371|P6|COMPLETED|Overall Study||125
413894|NCT00847626|987372|P5|COMPLETED|Overall Study||125
413895|NCT00847626|987373|P4|COMPLETED|Overall Study||125
413896|NCT00847626|987374|P3|COMPLETED|Overall Study||131
413897|NCT00847626|987375|P2|COMPLETED|Overall Study||131
413898|NCT00847626|987376|P1|COMPLETED|Overall Study||135
413899|NCT00847626|987366|P11|STARTED|Overall Study||162
413900|NCT00847626|987367|P10|STARTED|Overall Study||153
413901|NCT00847626|987368|P9|STARTED|Overall Study||155
413902|NCT00847626|987369|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
413903|NCT00847626|987370|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
413904|NCT00847626|987371|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
413905|NCT00847626|987372|P5|STARTED|Overall Study||153
413906|NCT00847626|987373|P4|STARTED|Overall Study||156
413907|NCT00847626|987374|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
413908|NCT00847626|987375|P2|STARTED|Overall Study||154
413909|NCT00847626|987376|P1|STARTED|Overall Study||156
413910|NCT00847613|987575|P4|NOT COMPLETED|Overall Study||79
413911|NCT00847613|987576|P3|NOT COMPLETED|Overall Study||81
413912|NCT00847613|987577|P2|NOT COMPLETED|Overall Study||319
413913|NCT00847613|987578|P1|NOT COMPLETED|Overall Study||321
413914|NCT00847613|987575|P4|COMPLETED|Overall Study||0
413915|NCT00847613|987576|P3|COMPLETED|Overall Study||0
413916|NCT00847613|987577|P2|COMPLETED|Overall Study||0
413917|NCT00847613|987578|P1|COMPLETED|Overall Study||0
413918|NCT00847613|987575|P4|Treated|Overall Study||79
413919|NCT00847613|987576|P3|Treated|Overall Study||81
413920|NCT00847613|987577|P2|Treated|Overall Study||316
413921|NCT00847613|987578|P1|Treated|Overall Study||321
413922|NCT00847613|987575|P4|STARTED|Overall Study||79
413923|NCT00847613|987576|P3|STARTED|Overall Study||81
413924|NCT00847613|987577|P2|STARTED|Overall Study||319
413925|NCT00847613|987578|P1|STARTED|Overall Study||321
413926|NCT00847587|987818|P2|NOT COMPLETED|Overall Study||0
413927|NCT00847587|987819|P1|NOT COMPLETED|Overall Study||1
413928|NCT00847587|987818|P2|COMPLETED|Overall Study||34
413929|NCT00847587|987819|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
413930|NCT00847587|987818|P2|STARTED|Overall Study||34
413931|NCT00847587|987819|P1|STARTED|Overall Study||35
413932|NCT00847561|987829|P2|NOT COMPLETED|Overall Study||4
413933|NCT00847561|987830|P1|NOT COMPLETED|Overall Study||13
413934|NCT00847561|987829|P2|COMPLETED|Overall Study||62
413935|NCT00847561|987830|P1|COMPLETED|Overall Study||57
413936|NCT00847561|987829|P2|STARTED|Overall Study||66
413937|NCT00847561|987830|P1|STARTED|Overall Study||70
413938|NCT00847535|987836|P3|NOT COMPLETED|Overall Study||1
413939|NCT00847535|987837|P2|NOT COMPLETED|Overall Study||2
413940|NCT00847535|987838|P1|NOT COMPLETED|Overall Study||2
413941|NCT00847535|987836|P3|COMPLETED|Overall Study||15
413942|NCT00847535|987837|P2|COMPLETED|Overall Study||22
413943|NCT00847535|987838|P1|COMPLETED|Overall Study||22
413944|NCT00847535|987836|P3|200 Million AMDC|Overall Study||8
413945|NCT00847535|987837|P2|200 Million AMDC|Overall Study||0
413946|NCT00847535|987838|P1|200 Million AMDC|Overall Study||0
413947|NCT00847535|987836|P3|100 Million AMDC|Overall Study||8
413948|NCT00847535|987837|P2|100 Million AMDC|Overall Study||8
413949|NCT00847535|987838|P1|100 Million AMDC|Overall Study||8
413950|NCT00847535|987836|P3|50 Million AMDC|Overall Study||0
413951|NCT00847535|987837|P2|50 Million AMDC|Overall Study||8
413952|NCT00847535|987838|P1|50 Million AMDC|Overall Study||8
413953|NCT00847535|987836|P3|10 Million AMDC|Overall Study||0
413954|NCT00847535|987837|P2|10 Million AMDC|Overall Study||8
413955|NCT00847535|987838|P1|10 Million AMDC|Overall Study||8
413956|NCT00847535|987836|P3|STARTED|Overall Study||16
413957|NCT00847535|987837|P2|STARTED|Overall Study||24
413958|NCT00847535|987838|P1|STARTED|Overall Study||24
413959|NCT00847509|987846|P1|NOT COMPLETED|Overall Study||11
413960|NCT00847509|987846|P1|COMPLETED|Overall Study||38
413961|NCT00847509|987846|P1|STARTED|Overall Study||49
413962|NCT00847405|987852|P2|NOT COMPLETED|Second Intervention||0
413963|NCT00847405|987853|P1|NOT COMPLETED|Second Intervention||0
413964|NCT00847405|987852|P2|COMPLETED|Second Intervention||13
413965|NCT00847405|987853|P1|COMPLETED|Second Intervention||13
413966|NCT00847405|987852|P2|STARTED|Second Intervention||13
413967|NCT00847405|987853|P1|STARTED|Second Intervention||13
413968|NCT00847405|987852|P2|NOT COMPLETED|Washout of 7 Days||0
413969|NCT00847405|987853|P1|NOT COMPLETED|Washout of 7 Days||1
413970|NCT00847405|987852|P2|COMPLETED|Washout of 7 Days||13
413971|NCT00847405|987853|P1|COMPLETED|Washout of 7 Days||13
413972|NCT00847405|987852|P2|STARTED|Washout of 7 Days||13
413973|NCT00847405|987853|P1|STARTED|Washout of 7 Days||14
413974|NCT00847405|987852|P2|NOT COMPLETED|First Intervention||1
413975|NCT00847405|987853|P1|NOT COMPLETED|First Intervention||0
413976|NCT00847405|987852|P2|COMPLETED|First Intervention||13
413977|NCT00847405|987853|P1|COMPLETED|First Intervention||14
413978|NCT00847405|987852|P2|STARTED|First Intervention||14
413979|NCT00847405|987853|P1|STARTED|First Intervention||14
413980|NCT00847301|987861|P1|NOT COMPLETED|Overall Study||54
413981|NCT00847301|987861|P1|COMPLETED|Overall Study||374
413982|NCT00847301|987861|P1|STARTED|Overall Study||428
413983|NCT00847288|987871|P2|NOT COMPLETED|Overall Study||47
413984|NCT00847288|987872|P1|NOT COMPLETED|Overall Study||30
413985|NCT00847288|987871|P2|COMPLETED|Overall Study||780
413986|NCT00847288|987872|P1|COMPLETED|Overall Study||811
413987|NCT00847288|987871|P2|STARTED|Overall Study||827
413988|NCT00847288|987872|P1|STARTED|Overall Study||841
413989|NCT00847210|987886|P2|NOT COMPLETED|Overall Study||0
413990|NCT00847210|987887|P1|NOT COMPLETED|Overall Study||0
413991|NCT00847210|987886|P2|COMPLETED|Overall Study||18
413992|NCT00847210|987887|P1|COMPLETED|Overall Study||18
413993|NCT00847210|987886|P2|STARTED|Overall Study||18
413994|NCT00847210|987887|P1|STARTED|Overall Study||18
413995|NCT00847197|987909|P2|NOT COMPLETED|Overall Study||5
413996|NCT00847197|987910|P1|NOT COMPLETED|Overall Study||24
413997|NCT00847197|987909|P2|COMPLETED|Overall Study||70
413998|NCT00847197|987910|P1|COMPLETED|Overall Study||92
413999|NCT00847197|987909|P2|STARTED|Overall Study||75
414000|NCT00847197|987910|P1|STARTED|Overall Study||116
414001|NCT00847145|987928|P8|NOT COMPLETED|Overall Study||4
414002|NCT00847145|987929|P7|NOT COMPLETED|Overall Study||9
414003|NCT00847145|987930|P6|NOT COMPLETED|Overall Study||4
414004|NCT00847145|987931|P5|NOT COMPLETED|Overall Study||6
414005|NCT00847145|987932|P4|NOT COMPLETED|Overall Study||1
414006|NCT00847145|987933|P3|NOT COMPLETED|Overall Study||11
414007|NCT00847145|987934|P2|NOT COMPLETED|Overall Study||6
414008|NCT00847145|987935|P1|NOT COMPLETED|Overall Study||6
414009|NCT00847145|987928|P8|COMPLETED|Overall Study||136
414010|NCT00847145|987929|P7|COMPLETED|Overall Study||143
414011|NCT00847145|987930|P6|COMPLETED|Overall Study||152
414012|NCT00847145|987931|P5|COMPLETED|Overall Study||131
414013|NCT00847145|987932|P4|COMPLETED|Overall Study||116
414014|NCT00847145|987933|P3|COMPLETED|Overall Study||274
414015|NCT00847145|987934|P2|COMPLETED|Overall Study||627
414016|NCT00847145|987935|P1|COMPLETED|Overall Study||623
414017|NCT00847145|987928|P8|STARTED|Overall Study||140
414018|NCT00847145|987929|P7|STARTED|Overall Study||152
414019|NCT00847145|987930|P6|STARTED|Overall Study||156
414020|NCT00847145|987931|P5|STARTED|Overall Study||137
414021|NCT00847145|987932|P4|STARTED|Overall Study||117
414022|NCT00847145|987933|P3|STARTED|Overall Study||285
414023|NCT00847145|987934|P2|STARTED|Overall Study||633
414024|NCT00847145|987935|P1|STARTED|Overall Study||629
414025|NCT00847132|987985|P2|NOT COMPLETED|Overall Study||1
414026|NCT00847132|987986|P1|NOT COMPLETED|Overall Study||1
414027|NCT00847132|987985|P2|COMPLETED|Overall Study||84
414028|NCT00847132|987986|P1|COMPLETED|Overall Study||89
414029|NCT00847132|987985|P2|STARTED|Overall Study||85
414030|NCT00847132|987986|P1|STARTED|Overall Study||90
414031|NCT00847015|987994|P1|NOT COMPLETED|Overall Study||3
414032|NCT00847015|987994|P1|COMPLETED|Overall Study||15
414033|NCT00847015|987994|P1|STARTED|Overall Study||18
414034|NCT00847002|988002|P2|NOT COMPLETED|Overall Study||0
414035|NCT00847002|988003|P1|NOT COMPLETED|Overall Study||0
414036|NCT00847002|988002|P2|COMPLETED|Overall Study||4
414037|NCT00847002|988003|P1|COMPLETED|Overall Study||4
414038|NCT00847002|988002|P2|STARTED|Overall Study||4
414039|NCT00847002|988003|P1|STARTED|Overall Study||4
414040|NCT00846885|988013|P2|NOT COMPLETED|Second Intervention||0
414041|NCT00846885|988014|P1|NOT COMPLETED|Second Intervention||0
414042|NCT00846885|988013|P2|COMPLETED|Second Intervention||14
414043|NCT00846885|988014|P1|COMPLETED|Second Intervention||14
414044|NCT00846885|988013|P2|STARTED|Second Intervention||14
414045|NCT00846885|988014|P1|STARTED|Second Intervention||14
414046|NCT00846885|988013|P2|NOT COMPLETED|Washout of 7 Days||0
414047|NCT00846885|988014|P1|NOT COMPLETED|Washout of 7 Days||0
414048|NCT00846885|988013|P2|COMPLETED|Washout of 7 Days||14
414049|NCT00846885|988014|P1|COMPLETED|Washout of 7 Days||14
414050|NCT00846885|988013|P2|STARTED|Washout of 7 Days||14
414051|NCT00846885|988014|P1|STARTED|Washout of 7 Days||14
414052|NCT00846885|988013|P2|NOT COMPLETED|First Intervention||0
414053|NCT00846885|988014|P1|NOT COMPLETED|First Intervention||0
414054|NCT00846885|988013|P2|COMPLETED|First Intervention||14
414055|NCT00846885|988014|P1|COMPLETED|First Intervention||14
414056|NCT00846885|988013|P2|STARTED|First Intervention||14
414057|NCT00846885|988014|P1|STARTED|First Intervention||14
414058|NCT00846846|988022|P1|NOT COMPLETED|Overall Study||75
414059|NCT00846846|988022|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
414060|NCT00846846|988022|P1|STARTED|Overall Study||1018
414061|NCT00846066|988029|P2|NOT COMPLETED|Overall Study||0
414062|NCT00846066|988030|P1|NOT COMPLETED|Overall Study||0
414063|NCT00846066|988029|P2|COMPLETED|Overall Study||29
414064|NCT00846066|988030|P1|COMPLETED|Overall Study||27
414065|NCT00846066|988029|P2|STARTED|Overall Study||29
414066|NCT00846066|988030|P1|STARTED|Overall Study||27
414067|NCT00846027|988042|P1|NOT COMPLETED|Overall Study||90
414068|NCT00846027|988042|P1|COMPLETED|Overall Study||0
414069|NCT00846027|988042|P1|Received Treatment|Overall Study||83
414070|NCT00846027|988042|P1|STARTED|Overall Study||90
414071|NCT00845975|988051|P2|NOT COMPLETED|Overall Study||0
414072|NCT00845975|988052|P1|NOT COMPLETED|Overall Study||0
414073|NCT00845975|988051|P2|COMPLETED|Overall Study||9
414074|NCT00845975|988052|P1|COMPLETED|Overall Study||9
414075|NCT00845975|988051|P2|STARTED|Overall Study||9
414076|NCT00845975|988052|P1|STARTED|Overall Study||9
414077|NCT00846807|988062|P1|NOT COMPLETED|Overall Study||632
414078|NCT00846807|988062|P1|COMPLETED|Overall Study|Completed treatment.|4660
414079|NCT00846807|988062|P1|STARTED|Overall Study|Entered and treated.|5292
414080|NCT00846768|988070|P4|NOT COMPLETED|Overall Study||0
414081|NCT00846768|988071|P3|NOT COMPLETED|Overall Study||0
414082|NCT00846768|988072|P2|NOT COMPLETED|Overall Study||1
414083|NCT00846768|988073|P1|NOT COMPLETED|Overall Study||0
414084|NCT00846768|988070|P4|COMPLETED|Overall Study||12
414085|NCT00846768|988071|P3|COMPLETED|Overall Study||12
414086|NCT00846768|988072|P2|COMPLETED|Overall Study||11
414087|NCT00846768|988073|P1|COMPLETED|Overall Study||11
414088|NCT00846768|988070|P4|STARTED|Overall Study||12
414089|NCT00846768|988071|P3|STARTED|Overall Study||12
414090|NCT00846768|988072|P2|STARTED|Overall Study||12
414091|NCT00846768|988073|P1|STARTED|Overall Study||11
414092|NCT00846651|988145|P2|NOT COMPLETED|Overall Study||4
414093|NCT00846651|988146|P1|NOT COMPLETED|Overall Study||4
414094|NCT00846651|988145|P2|COMPLETED|Overall Study||37
414095|NCT00846651|988146|P1|COMPLETED|Overall Study||37
414096|NCT00846651|988145|P2|STARTED|Overall Study||41
414097|NCT00846651|988146|P1|STARTED|Overall Study||41
414098|NCT00846586|988162|P2|NOT COMPLETED|Overall Study||35
414099|NCT00846586|988163|P1|NOT COMPLETED|Overall Study||39
414100|NCT00846586|988162|P2|COMPLETED|Overall Study||529
414101|NCT00846586|988163|P1|COMPLETED|Overall Study||531
414102|NCT00846586|988162|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
414103|NCT00846586|988163|P1|Received Study Drug|Overall Study||570
414104|NCT00846586|988162|P2|STARTED|Overall Study||564
414105|NCT00846586|988163|P1|STARTED|Overall Study||570
414106|NCT00846573|988182|P4|NOT COMPLETED|Overall Study||0
414107|NCT00846573|988183|P3|NOT COMPLETED|Overall Study||0
414108|NCT00846573|988184|P2|NOT COMPLETED|Overall Study||0
414109|NCT00846573|988185|P1|NOT COMPLETED|Overall Study||0
414110|NCT00846573|988182|P4|COMPLETED|Overall Study||0
414111|NCT00846573|988183|P3|COMPLETED|Overall Study||7
414112|NCT00846573|988184|P2|COMPLETED|Overall Study||2
414113|NCT00846573|988185|P1|COMPLETED|Overall Study||5
414114|NCT00846573|988182|P4|STARTED|Overall Study||0
414115|NCT00846573|988183|P3|STARTED|Overall Study||7
414116|NCT00846573|988184|P2|STARTED|Overall Study||2
414117|NCT00846573|988185|P1|STARTED|Overall Study||5
414118|NCT00846547|988193|P1|NOT COMPLETED|Overall Study||7
414119|NCT00846547|988193|P1|COMPLETED|Overall Study||25
414120|NCT00846547|988193|P1|STARTED|Overall Study||32
414121|NCT00846521|988197|P1|NOT COMPLETED|Overall Study||11
414122|NCT00846521|988197|P1|COMPLETED|Overall Study||12
414123|NCT00846521|988197|P1|STARTED|Overall Study||23
414124|NCT00846495|988204|P2|NOT COMPLETED|Overall Study||3
414125|NCT00846495|988205|P1|NOT COMPLETED|Overall Study||8
414126|NCT00846495|988204|P2|COMPLETED|Overall Study||24
414127|NCT00846495|988205|P1|COMPLETED|Overall Study||20
414128|NCT00846495|988204|P2|STARTED|Overall Study||27
414129|NCT00846495|988205|P1|STARTED|Overall Study||28
414130|NCT00846391|988228|P3|NOT COMPLETED|Overall Study||3
414131|NCT00846391|988229|P2|NOT COMPLETED|Overall Study||2
414132|NCT00846391|988230|P1|NOT COMPLETED|Overall Study||1
414133|NCT00846391|988228|P3|COMPLETED|Overall Study||3
414134|NCT00846391|988229|P2|COMPLETED|Overall Study||2
414135|NCT00846391|988230|P1|COMPLETED|Overall Study||3
414136|NCT00846391|988228|P3|STARTED|Overall Study||6
414137|NCT00846391|988229|P2|STARTED|Overall Study||4
414138|NCT00846391|988230|P1|STARTED|Overall Study||4
414139|NCT00846365|988241|P3|NOT COMPLETED|Overall Study||33
414140|NCT00846365|988242|P2|NOT COMPLETED|Overall Study||49
414141|NCT00846365|988243|P1|NOT COMPLETED|Overall Study||55
414142|NCT00846365|988241|P3|COMPLETED|Overall Study||323
414143|NCT00846365|988242|P2|COMPLETED|Overall Study||308
414144|NCT00846365|988243|P1|COMPLETED|Overall Study||317
414145|NCT00846365|988241|P3|STARTED|Overall Study||356
414146|NCT00846365|988242|P2|STARTED|Overall Study||357
414147|NCT00846365|988243|P1|STARTED|Overall Study||372
414148|NCT00846287|988298|P2|NOT COMPLETED|Overall Study||5
414149|NCT00846287|988299|P1|NOT COMPLETED|Overall Study||10
414150|NCT00846287|988298|P2|COMPLETED|Overall Study||10
414151|NCT00846287|988299|P1|COMPLETED|Overall Study||6
414152|NCT00846287|988298|P2|STARTED|Overall Study||15
414153|NCT00846287|988299|P1|STARTED|Overall Study||16
414154|NCT00845897|988310|P3|NOT COMPLETED|Overall Study||3
414155|NCT00845897|988311|P2|NOT COMPLETED|Overall Study||5
414156|NCT00845897|988312|P1|NOT COMPLETED|Overall Study||2
414157|NCT00845897|988310|P3|COMPLETED|Overall Study||2
414158|NCT00845897|988311|P2|COMPLETED|Overall Study||2
414159|NCT00845897|988312|P1|COMPLETED|Overall Study||3
414160|NCT00845897|988310|P3|STARTED|Overall Study||5
414161|NCT00845897|988311|P2|STARTED|Overall Study||7
414162|NCT00845897|988312|P1|STARTED|Overall Study||5
414163|NCT00845858|988326|P3|NOT COMPLETED|Overall Study||8
414164|NCT00845858|988327|P2|NOT COMPLETED|Overall Study||12
414165|NCT00845858|988328|P1|NOT COMPLETED|Overall Study||8
414166|NCT00845858|988326|P3|COMPLETED|Overall Study||87
414167|NCT00845858|988327|P2|COMPLETED|Overall Study||84
414168|NCT00845858|988328|P1|COMPLETED|Overall Study||88
414169|NCT00845858|988326|P3|STARTED|Overall Study||95
414170|NCT00845858|988327|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
414171|NCT00845858|988328|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
414172|NCT00845845|988341|P2|NOT COMPLETED|Overall Study||4
414173|NCT00845845|988342|P1|NOT COMPLETED|Overall Study||0
414174|NCT00845845|988341|P2|COMPLETED|Overall Study||2
414175|NCT00845845|988342|P1|COMPLETED|Overall Study||3
414176|NCT00845845|988341|P2|STARTED|Overall Study||6
414177|NCT00845845|988342|P1|STARTED|Overall Study||3
414178|NCT00845832|988353|P3|NOT COMPLETED|Extended Safety Follow-Up||7
414179|NCT00845832|988354|P2|NOT COMPLETED|Extended Safety Follow-Up||0
414180|NCT00845832|988355|P1|NOT COMPLETED|Extended Safety Follow-Up||0
414181|NCT00845832|988353|P3|COMPLETED|Extended Safety Follow-Up||0
414182|NCT00845832|988354|P2|COMPLETED|Extended Safety Follow-Up||5
414183|NCT00845832|988355|P1|COMPLETED|Extended Safety Follow-Up||2
414184|NCT00845832|988353|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
414185|NCT00845832|988354|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
414186|NCT00845832|988355|P1|STARTED|Extended Safety Follow-Up||2
414187|NCT00845832|988353|P3|NOT COMPLETED|Safety Follow-Up||0
414188|NCT00845832|988354|P2|NOT COMPLETED|Safety Follow-Up||0
414189|NCT00845832|988355|P1|NOT COMPLETED|Safety Follow-Up||1
414190|NCT00845832|988353|P3|COMPLETED|Safety Follow-Up||12
414191|NCT00845832|988354|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
414192|NCT00845832|988355|P1|COMPLETED|Safety Follow-Up||2
414193|NCT00845832|988353|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
414194|NCT00845832|988354|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
414195|NCT00845832|988355|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
414196|NCT00845832|988353|P3|NOT COMPLETED|Treatment Period||0
414197|NCT00845832|988354|P2|NOT COMPLETED|Treatment Period||3
414198|NCT00845832|988355|P1|NOT COMPLETED|Treatment Period||1
414199|NCT00845832|988353|P3|COMPLETED|Treatment Period||10
414200|NCT00845832|988354|P2|COMPLETED|Treatment Period||7
414201|NCT00845832|988355|P1|COMPLETED|Treatment Period||3
414202|NCT00845832|988353|P3|STARTED|Treatment Period||10
414203|NCT00845832|988354|P2|STARTED|Treatment Period||10
414204|NCT00845832|988355|P1|STARTED|Treatment Period||4
414205|NCT00845728|988401|P2|NOT COMPLETED|Overall Study||342
414206|NCT00845728|988402|P1|NOT COMPLETED|Overall Study||386
414207|NCT00845728|988401|P2|COMPLETED|Overall Study||1379
414208|NCT00845728|988402|P1|COMPLETED|Overall Study||1337
414209|NCT00845728|988401|P2|Exposed|Overall Study||1718
414210|NCT00845728|988402|P1|Exposed|Overall Study||1721
414211|NCT00845728|988401|P2|STARTED|Overall Study||1721
414212|NCT00845728|988402|P1|STARTED|Overall Study||1723
414213|NCT00845702|988410|P1|NOT COMPLETED|Dotarem MRA||0
414214|NCT00845702|988410|P1|COMPLETED|Dotarem MRA||32
414215|NCT00845702|988410|P1|STARTED|Dotarem MRA||32
414216|NCT00845702|988410|P1|NOT COMPLETED|TOF MRA||1
414217|NCT00845702|988410|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
414218|NCT00845702|988410|P1|STARTED|TOF MRA||33
414219|NCT00845676|988416|P1|NOT COMPLETED|Overall Study||2
414220|NCT00845676|988416|P1|COMPLETED|Overall Study||19
414221|NCT00845676|988416|P1|STARTED|Overall Study||21
414222|NCT00845663|988422|P2|NOT COMPLETED|Overall Study||0
414223|NCT00845663|988423|P1|NOT COMPLETED|Overall Study||0
414224|NCT00845663|988422|P2|COMPLETED|Overall Study||49
414225|NCT00845663|988423|P1|COMPLETED|Overall Study||49
414226|NCT00845663|988422|P2|STARTED|Overall Study||49
414227|NCT00845663|988423|P1|STARTED|Overall Study||49
414228|NCT00845481|988471|P1|NOT COMPLETED|Overall Study||0
414229|NCT00845481|988471|P1|COMPLETED|Overall Study||24
414230|NCT00845481|988471|P1|STARTED|Overall Study||24
414231|NCT00845429|988483|P3|NOT COMPLETED|Overall Study||20
414232|NCT00845429|988484|P2|NOT COMPLETED|Overall Study||15
414233|NCT00845429|988485|P1|NOT COMPLETED|Overall Study||14
414234|NCT00845429|988483|P3|COMPLETED|Overall Study||224
414235|NCT00845429|988484|P2|COMPLETED|Overall Study||226
414236|NCT00845429|988485|P1|COMPLETED|Overall Study||230
414237|NCT00845429|988483|P3|STARTED|Overall Study||244
414238|NCT00845429|988484|P2|STARTED|Overall Study||241
414239|NCT00845429|988485|P1|STARTED|Overall Study||244
414240|NCT00845195|988504|P2|NOT COMPLETED|Overall Study||0
414241|NCT00845195|988505|P1|NOT COMPLETED|Overall Study||0
414242|NCT00845195|988504|P2|COMPLETED|Overall Study||75
414243|NCT00845195|988505|P1|COMPLETED|Overall Study||75
414244|NCT00845195|988504|P2|STARTED|Overall Study||75
414245|NCT00845195|988505|P1|STARTED|Overall Study||75
414246|NCT00845182|988520|P3|NOT COMPLETED|Overall Study||6
414247|NCT00845182|988521|P2|NOT COMPLETED|Overall Study||4
414248|NCT00845182|988522|P1|NOT COMPLETED|Overall Study||3
414249|NCT00845182|988520|P3|COMPLETED|Overall Study||9
414250|NCT00845182|988521|P2|COMPLETED|Overall Study||11
414251|NCT00845182|988522|P1|COMPLETED|Overall Study||10
414252|NCT00845182|988520|P3|STARTED|Overall Study||15
414253|NCT00845182|988521|P2|STARTED|Overall Study||15
414254|NCT00845182|988522|P1|STARTED|Overall Study||13
414255|NCT00845130|988535|P2|NOT COMPLETED|Overall Study||3
414256|NCT00845130|988536|P1|NOT COMPLETED|Overall Study||4
414257|NCT00845130|988535|P2|COMPLETED|Overall Study||19
414258|NCT00845130|988536|P1|COMPLETED|Overall Study||16
414259|NCT00845130|988535|P2|STARTED|Overall Study||22
414260|NCT00845130|988536|P1|STARTED|Overall Study||20
414261|NCT00845065|988546|P2|NOT COMPLETED|Overall Study||55
414262|NCT00845065|988547|P1|NOT COMPLETED|Overall Study||47
414263|NCT00845065|988546|P2|COMPLETED|Overall Study||79
414264|NCT00845065|988547|P1|COMPLETED|Overall Study||20
414265|NCT00845065|988546|P2|STARTED|Overall Study||134
414266|NCT00845065|988547|P1|STARTED|Overall Study||67
414267|NCT00845000|988567|P6|NOT COMPLETED|Period 3||0
414268|NCT00845000|988568|P5|NOT COMPLETED|Period 3||0
414269|NCT00845000|988569|P4|NOT COMPLETED|Period 3||0
414270|NCT00845000|988570|P3|NOT COMPLETED|Period 3||0
414271|NCT00845000|988571|P2|NOT COMPLETED|Period 3||0
414272|NCT00845000|988572|P1|NOT COMPLETED|Period 3||0
414273|NCT00845000|988567|P6|COMPLETED|Period 3||2
414274|NCT00845000|988568|P5|COMPLETED|Period 3||2
414275|NCT00845000|988569|P4|COMPLETED|Period 3||2
414276|NCT00845000|988570|P3|COMPLETED|Period 3||2
414277|NCT00845000|988571|P2|COMPLETED|Period 3||2
414278|NCT00845000|988572|P1|COMPLETED|Period 3||2
414279|NCT00845000|988567|P6|STARTED|Period 3||2
414280|NCT00845000|988568|P5|STARTED|Period 3||2
414281|NCT00845000|988569|P4|STARTED|Period 3||2
414282|NCT00845000|988570|P3|STARTED|Period 3||2
414283|NCT00845000|988571|P2|STARTED|Period 3||2
414284|NCT00845000|988572|P1|STARTED|Period 3||2
414285|NCT00845000|988567|P6|NOT COMPLETED|Period 2||0
414286|NCT00845000|988568|P5|NOT COMPLETED|Period 2||0
414287|NCT00845000|988569|P4|NOT COMPLETED|Period 2||0
414288|NCT00845000|988570|P3|NOT COMPLETED|Period 2||0
414289|NCT00845000|988571|P2|NOT COMPLETED|Period 2||0
414290|NCT00845000|988572|P1|NOT COMPLETED|Period 2||0
414291|NCT00845000|988567|P6|COMPLETED|Period 2||2
414292|NCT00845000|988568|P5|COMPLETED|Period 2||2
414293|NCT00845000|988569|P4|COMPLETED|Period 2||2
414294|NCT00845000|988570|P3|COMPLETED|Period 2||2
414295|NCT00845000|988571|P2|COMPLETED|Period 2||2
414296|NCT00845000|988572|P1|COMPLETED|Period 2||2
414297|NCT00845000|988567|P6|STARTED|Period 2||2
414298|NCT00845000|988568|P5|STARTED|Period 2||2
414299|NCT00845000|988569|P4|STARTED|Period 2||2
414300|NCT00845000|988570|P3|STARTED|Period 2||2
414301|NCT00845000|988571|P2|STARTED|Period 2||2
414302|NCT00845000|988572|P1|STARTED|Period 2||2
414303|NCT00845000|988567|P6|NOT COMPLETED|Period 1||0
414304|NCT00845000|988568|P5|NOT COMPLETED|Period 1||0
414305|NCT00845000|988569|P4|NOT COMPLETED|Period 1||0
414306|NCT00845000|988570|P3|NOT COMPLETED|Period 1||0
414307|NCT00845000|988571|P2|NOT COMPLETED|Period 1||0
414308|NCT00845000|988572|P1|NOT COMPLETED|Period 1||0
414309|NCT00845000|988567|P6|COMPLETED|Period 1||2
414310|NCT00845000|988568|P5|COMPLETED|Period 1||2
414311|NCT00845000|988569|P4|COMPLETED|Period 1||2
414312|NCT00845000|988570|P3|COMPLETED|Period 1||2
414313|NCT00845000|988571|P2|COMPLETED|Period 1||2
414314|NCT00845000|988572|P1|COMPLETED|Period 1||2
414315|NCT00845000|988567|P6|STARTED|Period 1||2
414316|NCT00845000|988568|P5|STARTED|Period 1||2
414317|NCT00845000|988569|P4|STARTED|Period 1||2
414318|NCT00845000|988570|P3|STARTED|Period 1||2
414319|NCT00845000|988571|P2|STARTED|Period 1||2
414320|NCT00845000|988572|P1|STARTED|Period 1||2
414321|NCT00844896|988591|P2|NOT COMPLETED|Overall Study||17
414322|NCT00844896|988592|P1|NOT COMPLETED|Overall Study||12
414323|NCT00844896|988591|P2|COMPLETED|Overall Study||11
414324|NCT00844896|988592|P1|COMPLETED|Overall Study||17
414325|NCT00844896|988591|P2|STARTED|Overall Study||28
414326|NCT00844896|988592|P1|STARTED|Overall Study||29
414327|NCT00844857|988616|P2|NOT COMPLETED|Overall Study||37
414328|NCT00844857|988617|P1|NOT COMPLETED|Overall Study||78
414329|NCT00844857|988616|P2|COMPLETED|Overall Study||60
414330|NCT00844857|988617|P1|COMPLETED|Overall Study||116
414331|NCT00844857|988616|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
414332|NCT00844857|988617|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
414333|NCT00844857|988616|P2|STARTED|Overall Study||97
414334|NCT00844857|988617|P1|STARTED|Overall Study||194
414335|NCT00844844|988661|P1|NOT COMPLETED|Post Treatment Period||1
414336|NCT00844844|988661|P1|COMPLETED|Post Treatment Period||5
414337|NCT00844844|988661|P1|STARTED|Post Treatment Period||6
414338|NCT00844844|988661|P1|NOT COMPLETED|Extension Treatment Period||2
414339|NCT00844844|988661|P1|COMPLETED|Extension Treatment Period||11
414340|NCT00844844|988661|P1|STARTED|Extension Treatment Period||13
414341|NCT00844844|988661|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
414342|NCT00844844|988661|P1|COMPLETED|Treatment Period (26 Weeks)||15
414343|NCT00844844|988661|P1|STARTED|Treatment Period (26 Weeks)||17
414344|NCT00844844|988661|P1|NOT COMPLETED|Screening Period||0
414345|NCT00844844|988661|P1|COMPLETED|Screening Period||17
414346|NCT00844844|988661|P1|STARTED|Screening Period||17
414347|NCT00844805|988677|P4|NOT COMPLETED|Follow-Up Phase||9
414348|NCT00844805|988678|P3|NOT COMPLETED|Follow-Up Phase||9
414349|NCT00844805|988679|P2|NOT COMPLETED|Follow-Up Phase||0
414350|NCT00844805|988680|P1|NOT COMPLETED|Follow-Up Phase||0
414351|NCT00844805|988677|P4|COMPLETED|Follow-Up Phase||32
414352|NCT00844805|988678|P3|COMPLETED|Follow-Up Phase||32
414353|NCT00844805|988679|P2|COMPLETED|Follow-Up Phase||0
414354|NCT00844805|988680|P1|COMPLETED|Follow-Up Phase||0
414355|NCT00844805|988677|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
414356|NCT00844805|988678|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
414357|NCT00844805|988679|P2|STARTED|Follow-Up Phase||0
414358|NCT00844805|988680|P1|STARTED|Follow-Up Phase||0
414359|NCT00844805|988677|P4|NOT COMPLETED|Treatment Phase||0
414360|NCT00844805|988678|P3|NOT COMPLETED|Treatment Phase||0
414361|NCT00844805|988679|P2|NOT COMPLETED|Treatment Phase||7
414362|NCT00844805|988680|P1|NOT COMPLETED|Treatment Phase||10
414363|NCT00844805|988677|P4|COMPLETED|Treatment Phase||0
414364|NCT00844805|988678|P3|COMPLETED|Treatment Phase||0
414365|NCT00844805|988679|P2|COMPLETED|Treatment Phase||45
414366|NCT00844805|988680|P1|COMPLETED|Treatment Phase||96
414367|NCT00844805|988677|P4|STARTED|Treatment Phase||0
414368|NCT00844805|988678|P3|STARTED|Treatment Phase||0
414369|NCT00844805|988679|P2|STARTED|Treatment Phase||52
414370|NCT00844805|988680|P1|STARTED|Treatment Phase||106
414371|NCT00844753|988724|P4|NOT COMPLETED|Overall Study||11
414372|NCT00844753|988725|P3|NOT COMPLETED|Overall Study||7
414373|NCT00844753|988726|P2|NOT COMPLETED|Overall Study||3
414374|NCT00844753|988727|P1|NOT COMPLETED|Overall Study||8
414375|NCT00844753|988724|P4|COMPLETED|Overall Study||21
414376|NCT00844753|988725|P3|COMPLETED|Overall Study||25
414377|NCT00844753|988726|P2|COMPLETED|Overall Study||29
414378|NCT00844753|988727|P1|COMPLETED|Overall Study||24
414379|NCT00844753|988724|P4|STARTED|Overall Study||32
414380|NCT00844753|988725|P3|STARTED|Overall Study||32
414381|NCT00844753|988726|P2|STARTED|Overall Study||32
414382|NCT00844753|988727|P1|STARTED|Overall Study||32
414383|NCT00844714|988739|P1|NOT COMPLETED|Overall Study||0
414384|NCT00844714|988739|P1|COMPLETED|Overall Study||20
414385|NCT00844714|988739|P1|STARTED|Overall Study||20
414386|NCT00844649|988745|P2|NOT COMPLETED|Overall Study||418
414387|NCT00844649|988746|P1|NOT COMPLETED|Overall Study||405
414388|NCT00844649|988745|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
414389|NCT00844649|988746|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
414565|NCT00843492|989356|P2|STARTED|Overall Study||621
414390|NCT00844649|988745|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
414391|NCT00844649|988746|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
414392|NCT00844649|988745|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
414393|NCT00844649|988746|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
414394|NCT00844597|988770|P6|NOT COMPLETED|Overall Study||0
414395|NCT00844597|988771|P5|NOT COMPLETED|Overall Study||0
414396|NCT00844597|988772|P4|NOT COMPLETED|Overall Study||1
414397|NCT00844597|988773|P3|NOT COMPLETED|Overall Study||0
414398|NCT00844597|988774|P2|NOT COMPLETED|Overall Study||0
414399|NCT00844597|988775|P1|NOT COMPLETED|Overall Study||0
414400|NCT00844597|988770|P6|COMPLETED|Overall Study||4
414401|NCT00844597|988771|P5|COMPLETED|Overall Study||4
414402|NCT00844597|988772|P4|COMPLETED|Overall Study||2
414403|NCT00844597|988773|P3|COMPLETED|Overall Study||2
414404|NCT00844597|988774|P2|COMPLETED|Overall Study||2
414405|NCT00844597|988775|P1|COMPLETED|Overall Study||4
414406|NCT00844597|988770|P6|STARTED|Overall Study||4
414407|NCT00844597|988771|P5|STARTED|Overall Study||4
414408|NCT00844597|988772|P4|STARTED|Overall Study||3
414409|NCT00844597|988773|P3|STARTED|Overall Study||2
414410|NCT00844597|988774|P2|STARTED|Overall Study||2
414411|NCT00844597|988775|P1|STARTED|Overall Study||4
414412|NCT00844558|988795|P2|NOT COMPLETED|Overall Study||4
414413|NCT00844558|988796|P1|NOT COMPLETED|Overall Study||12
414414|NCT00844558|988795|P2|COMPLETED|Overall Study||18
414415|NCT00844558|988796|P1|COMPLETED|Overall Study||24
414416|NCT00844558|988795|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
414417|NCT00844558|988796|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
414418|NCT00844558|988795|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
414419|NCT00844558|988796|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
414420|NCT00844558|988795|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
414421|NCT00844558|988796|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
414422|NCT00844558|988795|P2|Received Allocated Intervention|Overall Study||21
414423|NCT00844558|988796|P1|Received Allocated Intervention|Overall Study||33
414424|NCT00844558|988795|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
414425|NCT00844558|988796|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
414426|NCT00844545|988812|P1|NOT COMPLETED|Post Treatment Period||1
414427|NCT00844545|988812|P1|COMPLETED|Post Treatment Period||5
414428|NCT00844545|988812|P1|STARTED|Post Treatment Period||6
414429|NCT00844545|988812|P1|NOT COMPLETED|Extension Treatment Period||2
414430|NCT00844545|988812|P1|COMPLETED|Extension Treatment Period||11
414431|NCT00844545|988812|P1|STARTED|Extension Treatment Period||13
414432|NCT00844545|988812|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
414433|NCT00844545|988812|P1|COMPLETED|Treatment Period (26 Weeks)||15
414434|NCT00844545|988812|P1|STARTED|Treatment Period (26 Weeks)||17
414435|NCT00844545|988812|P1|NOT COMPLETED|Screening Period||0
414436|NCT00844545|988812|P1|COMPLETED|Screening Period||17
414437|NCT00844545|988812|P1|STARTED|Screening Period||17
414438|NCT00844532|988826|P1|NOT COMPLETED|Overall Study||39
414439|NCT00844532|988826|P1|COMPLETED|Overall Study||112
414440|NCT00844532|988826|P1|STARTED|Overall Study||151
414441|NCT00844519|988912|P2|NOT COMPLETED|Overall Study||1
414442|NCT00844519|988913|P1|NOT COMPLETED|Overall Study||2
414443|NCT00844519|988912|P2|COMPLETED|Overall Study||25
414444|NCT00844519|988913|P1|COMPLETED|Overall Study||24
414445|NCT00844519|988912|P2|STARTED|Overall Study||26
414446|NCT00844519|988913|P1|STARTED|Overall Study||26
414447|NCT00844480|988921|P2|NOT COMPLETED|Overall Study||3
414448|NCT00844480|988922|P1|NOT COMPLETED|Overall Study||2
414449|NCT00844480|988921|P2|COMPLETED|Overall Study||6
414450|NCT00844480|988922|P1|COMPLETED|Overall Study||6
414451|NCT00844480|988921|P2|STARTED|Overall Study||9
414452|NCT00844480|988922|P1|STARTED|Overall Study||8
414453|NCT00844428|988930|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
414454|NCT00844428|988930|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
414455|NCT00844428|988930|P1|STARTED|Post Treatment Period (Patients Who Disc||5
414456|NCT00844428|988930|P1|NOT COMPLETED|Extension Treatment Period||1
414457|NCT00844428|988930|P1|COMPLETED|Extension Treatment Period||18
414458|NCT00844428|988930|P1|STARTED|Extension Treatment Period||19
414459|NCT00844428|988930|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
414460|NCT00844428|988930|P1|COMPLETED|Treatment Period (26 Weeks)||20
414461|NCT00844428|988930|P1|STARTED|Treatment Period (26 Weeks)||20
414462|NCT00844428|988930|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
414463|NCT00844428|988930|P1|COMPLETED|Observation Period (8 Weeks)||20
414464|NCT00844428|988930|P1|STARTED|Observation Period (8 Weeks)||20
414465|NCT00844428|988930|P1|NOT COMPLETED|Screening Period||3
414466|NCT00844428|988930|P1|COMPLETED|Screening Period||20
414467|NCT00844428|988930|P1|STARTED|Screening Period||23
414468|NCT00844415|988946|P1|NOT COMPLETED|Overall Study||1
414469|NCT00844415|988946|P1|COMPLETED|Overall Study|Completed.|8
414470|NCT00844415|988946|P1|Pat. Received Single Dose 75mg|Overall Study||1
414471|NCT00844415|988946|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
414472|NCT00844415|988946|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
414473|NCT00844415|988946|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
414474|NCT00844415|988946|P1|STARTED|Overall Study|Entered and treated.|9
414475|NCT00844376|988960|P2|NOT COMPLETED|Period 2: Second Intervention||0
414476|NCT00844376|988961|P1|NOT COMPLETED|Period 2: Second Intervention||0
414477|NCT00844376|988960|P2|COMPLETED|Period 2: Second Intervention||6
414478|NCT00844376|988961|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
414479|NCT00844376|988960|P2|STARTED|Period 2: Second Intervention||6
414480|NCT00844376|988961|P1|STARTED|Period 2: Second Intervention||5
414481|NCT00844376|988960|P2|NOT COMPLETED|Period 1: First Intervention||0
414482|NCT00844376|988961|P1|NOT COMPLETED|Period 1: First Intervention||1
414483|NCT00844376|988960|P2|COMPLETED|Period 1: First Intervention||6
414484|NCT00844376|988961|P1|COMPLETED|Period 1: First Intervention||5
414485|NCT00844376|988960|P2|STARTED|Period 1: First Intervention||6
414486|NCT00844376|988961|P1|STARTED|Period 1: First Intervention||6
414487|NCT00844298|988979|P1|NOT COMPLETED|Overall Study||0
414488|NCT00844298|988979|P1|COMPLETED|Overall Study||91
414489|NCT00844298|988979|P1|STARTED|Overall Study||91
414490|NCT00844194|988985|P2|NOT COMPLETED|Overall Study||8
414491|NCT00844194|988986|P1|NOT COMPLETED|Overall Study||25
414492|NCT00844194|988985|P2|COMPLETED|Overall Study||22
414493|NCT00844194|988986|P1|COMPLETED|Overall Study||53
414494|NCT00844194|988985|P2|STARTED|Overall Study||30
414495|NCT00844194|988986|P1|STARTED|Overall Study||78
414496|NCT00844090|989192|P2|NOT COMPLETED|Overall Study||8
414497|NCT00844090|989193|P1|NOT COMPLETED|Overall Study||6
414498|NCT00844090|989192|P2|COMPLETED|Overall Study||46
414499|NCT00844090|989193|P1|COMPLETED|Overall Study||46
414500|NCT00844090|989192|P2|STARTED|Overall Study||54
414501|NCT00844090|989193|P1|STARTED|Overall Study||52
414502|NCT00844051|989201|P2|NOT COMPLETED|Overall Study||0
414503|NCT00844051|989202|P1|NOT COMPLETED|Overall Study||0
414504|NCT00844051|989201|P2|COMPLETED|Overall Study||2368
414505|NCT00844051|989202|P1|COMPLETED|Overall Study||2087
414506|NCT00844051|989201|P2|STARTED|Overall Study||2368
414507|NCT00844051|989202|P1|STARTED|Overall Study||2087
414508|NCT00843986|989212|P2|NOT COMPLETED|Overall Study||1
414509|NCT00843986|989213|P1|NOT COMPLETED|Overall Study||1
414510|NCT00843986|989212|P2|COMPLETED|Overall Study||5
414511|NCT00843986|989213|P1|COMPLETED|Overall Study||2
414512|NCT00843986|989212|P2|Completed Treatment (Infusion)|Overall Study||6
414513|NCT00843986|989213|P1|Completed Treatment (Infusion)|Overall Study||2
414514|NCT00843986|989212|P2|STARTED|Overall Study||6
414515|NCT00843986|989213|P1|STARTED|Overall Study||3
414516|NCT00843843|989241|P2|NOT COMPLETED|Overall Study||2
414517|NCT00843843|989242|P1|NOT COMPLETED|Overall Study||2
414518|NCT00843843|989241|P2|COMPLETED|Overall Study||6
414519|NCT00843843|989242|P1|COMPLETED|Overall Study||6
414520|NCT00843843|989241|P2|STARTED|Overall Study||8
414521|NCT00843843|989242|P1|STARTED|Overall Study||8
414522|NCT00843830|989250|P1|NOT COMPLETED|Overall Study||0
414523|NCT00843830|989250|P1|COMPLETED|Overall Study||4
414524|NCT00843830|989250|P1|STARTED|Overall Study||4
414525|NCT00843778|989255|P1|NOT COMPLETED|Overall Study||35
414526|NCT00843778|989255|P1|COMPLETED|Overall Study||96
414527|NCT00843778|989255|P1|STARTED|Overall Study||131
414528|NCT00842608|989292|P4|NOT COMPLETED|Overall Study||0
414529|NCT00842608|989293|P3|NOT COMPLETED|Overall Study||0
414530|NCT00842608|989294|P2|NOT COMPLETED|Overall Study||0
414531|NCT00842608|989295|P1|NOT COMPLETED|Overall Study||0
414532|NCT00842608|989292|P4|COMPLETED|Overall Study||100
414533|NCT00842608|989293|P3|COMPLETED|Overall Study||99
414534|NCT00842608|989294|P2|COMPLETED|Overall Study||176
414535|NCT00842608|989295|P1|COMPLETED|Overall Study||170
414536|NCT00842608|989292|P4|STARTED|Overall Study||100
414537|NCT00842608|989293|P3|STARTED|Overall Study||99
414538|NCT00842608|989294|P2|STARTED|Overall Study||176
414539|NCT00842608|989295|P1|STARTED|Overall Study||170
414540|NCT00843713|989315|P2|NOT COMPLETED|Overall Study||0
414541|NCT00843713|989316|P1|NOT COMPLETED|Overall Study||0
414542|NCT00843713|989315|P2|COMPLETED|Overall Study||26
414543|NCT00843713|989316|P1|COMPLETED|Overall Study||30
414544|NCT00843713|989315|P2|STARTED|Overall Study||26
414545|NCT00843713|989316|P1|STARTED|Overall Study||30
414546|NCT00843635|989325|P3|NOT COMPLETED|Overall Study||0
414547|NCT00843635|989326|P2|NOT COMPLETED|Overall Study||2
414548|NCT00843635|989327|P1|NOT COMPLETED|Overall Study||2
414549|NCT00843635|989325|P3|COMPLETED|Overall Study||5
414550|NCT00843635|989326|P2|COMPLETED|Overall Study||13
414551|NCT00843635|989327|P1|COMPLETED|Overall Study||13
414552|NCT00843635|989325|P3|STARTED|Overall Study||5
414553|NCT00843635|989326|P2|STARTED|Overall Study||15
414554|NCT00843635|989327|P1|STARTED|Overall Study||15
414555|NCT00843622|989347|P2|NOT COMPLETED|Overall Study||55
414556|NCT00843622|989348|P1|NOT COMPLETED|Overall Study||43
414557|NCT00843622|989347|P2|COMPLETED|Overall Study||70
414558|NCT00843622|989348|P1|COMPLETED|Overall Study||82
414559|NCT00843622|989347|P2|STARTED|Overall Study||125
414560|NCT00843622|989348|P1|STARTED|Overall Study||125
414561|NCT00843492|989356|P2|NOT COMPLETED|Overall Study||14
414562|NCT00843492|989357|P1|NOT COMPLETED|Overall Study||8
414563|NCT00843492|989356|P2|COMPLETED|Overall Study||607
414564|NCT00843492|989357|P1|COMPLETED|Overall Study||614
414566|NCT00843492|989357|P1|STARTED|Overall Study||622
414567|NCT00843479|989377|P2|NOT COMPLETED|Overall Study||0
414568|NCT00843479|989378|P1|NOT COMPLETED|Overall Study||0
414569|NCT00843479|989377|P2|COMPLETED|Overall Study||12
414570|NCT00843479|989378|P1|COMPLETED|Overall Study||12
414571|NCT00843479|989377|P2|STARTED|Overall Study||12
414572|NCT00843479|989378|P1|STARTED|Overall Study||12
414573|NCT00843466|989396|P2|NOT COMPLETED|Overall Study||0
414574|NCT00843466|989397|P1|NOT COMPLETED|Overall Study||0
414575|NCT00843466|989396|P2|COMPLETED|Overall Study||18
414576|NCT00843466|989397|P1|COMPLETED|Overall Study||24
414577|NCT00843466|989396|P2|STARTED|Overall Study||18
414578|NCT00843466|989397|P1|STARTED|Overall Study||24
414579|NCT00843349|989407|P4|NOT COMPLETED|Overall Study||1
414580|NCT00843349|989408|P3|NOT COMPLETED|Overall Study||0
414581|NCT00843349|989409|P2|NOT COMPLETED|Overall Study||0
414582|NCT00843349|989410|P1|NOT COMPLETED|Overall Study||3
414583|NCT00843349|989407|P4|COMPLETED|Overall Study||10
414584|NCT00843349|989408|P3|COMPLETED|Overall Study||10
414585|NCT00843349|989409|P2|COMPLETED|Overall Study||11
414586|NCT00843349|989410|P1|COMPLETED|Overall Study||8
414587|NCT00843349|989407|P4|STARTED|Overall Study||11
414588|NCT00843349|989408|P3|STARTED|Overall Study||10
414589|NCT00843349|989409|P2|STARTED|Overall Study||11
414590|NCT00843349|989410|P1|STARTED|Overall Study||11
414591|NCT00843310|989424|P1|NOT COMPLETED|Overall Study||7
414592|NCT00843310|989424|P1|COMPLETED|Overall Study||1
414593|NCT00843310|989424|P1|STARTED|Overall Study||8
414594|NCT00843284|989431|P1|NOT COMPLETED|Overall Study||72
414595|NCT00843284|989431|P1|COMPLETED|Overall Study||619
414596|NCT00843284|989431|P1|STARTED|Overall Study||691
414597|NCT00843180|989441|P2|NOT COMPLETED|Overall Study||0
414598|NCT00843180|989442|P1|NOT COMPLETED|Overall Study||0
414599|NCT00843180|989441|P2|COMPLETED|Overall Study||7
414600|NCT00843180|989442|P1|COMPLETED|Overall Study||16
414601|NCT00843180|989441|P2|STARTED|Overall Study||7
414602|NCT00843180|989442|P1|STARTED|Overall Study||16
414603|NCT00843167|989456|P2|NOT COMPLETED|Follow-up||0
414604|NCT00843167|989457|P1|NOT COMPLETED|Follow-up||0
414605|NCT00843167|989456|P2|COMPLETED|Follow-up||24
414606|NCT00843167|989457|P1|COMPLETED|Follow-up||24
414607|NCT00843167|989456|P2|Completed Final Visit|Follow-up||24
414608|NCT00843167|989457|P1|Completed Final Visit|Follow-up||24
414609|NCT00843167|989456|P2|STARTED|Follow-up||24
414610|NCT00843167|989457|P1|STARTED|Follow-up||24
414611|NCT00843167|989456|P2|NOT COMPLETED|Treatment Period||8
414612|NCT00843167|989457|P1|NOT COMPLETED|Treatment Period||3
414613|NCT00843167|989456|P2|COMPLETED|Treatment Period||19
414614|NCT00843167|989457|P1|COMPLETED|Treatment Period||24
414615|NCT00843167|989456|P2|STARTED|Treatment Period||27
414616|NCT00843167|989457|P1|STARTED|Treatment Period||27
414617|NCT00843115|989470|P1|NOT COMPLETED|Overall Study||66
414618|NCT00843115|989470|P1|COMPLETED|Overall Study||304
414619|NCT00843115|989470|P1|STARTED|Overall Study||370
414620|NCT00843050|989516|P1|NOT COMPLETED|Overall Study||13
414621|NCT00843050|989516|P1|COMPLETED|Overall Study||0
414622|NCT00843050|989516|P1|STARTED|Overall Study||13
414623|NCT00843024|989526|P6|NOT COMPLETED|Double-blind Treatment Phase||25
414624|NCT00843024|989527|P5|NOT COMPLETED|Double-blind Treatment Phase||20
414625|NCT00843024|989528|P4|NOT COMPLETED|Double-blind Treatment Phase||23
414626|NCT00843024|989529|P3|NOT COMPLETED|Double-blind Treatment Phase||31
414627|NCT00843024|989530|P2|NOT COMPLETED|Double-blind Treatment Phase||0
414628|NCT00843024|989531|P1|NOT COMPLETED|Double-blind Treatment Phase||0
414629|NCT00843024|989526|P6|COMPLETED|Double-blind Treatment Phase||152
414630|NCT00843024|989527|P5|COMPLETED|Double-blind Treatment Phase||97
414631|NCT00843024|989528|P4|COMPLETED|Double-blind Treatment Phase||96
414632|NCT00843024|989529|P3|COMPLETED|Double-blind Treatment Phase||145
414633|NCT00843024|989530|P2|COMPLETED|Double-blind Treatment Phase||0
414634|NCT00843024|989531|P1|COMPLETED|Double-blind Treatment Phase||0
414635|NCT00843024|989526|P6|STARTED|Double-blind Treatment Phase||177
414636|NCT00843024|989527|P5|STARTED|Double-blind Treatment Phase||117
414637|NCT00843024|989528|P4|STARTED|Double-blind Treatment Phase||119
414638|NCT00843024|989529|P3|STARTED|Double-blind Treatment Phase||176
414639|NCT00843024|989530|P2|STARTED|Double-blind Treatment Phase||0
414640|NCT00843024|989531|P1|STARTED|Double-blind Treatment Phase||0
414641|NCT00843024|989526|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
414642|NCT00843024|989527|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
414643|NCT00843024|989528|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
414644|NCT00843024|989529|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
414645|NCT00843024|989530|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
414646|NCT00843024|989531|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
414647|NCT00843024|989526|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
414648|NCT00843024|989527|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
414649|NCT00843024|989528|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
414650|NCT00843024|989529|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
414651|NCT00843024|989530|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
414652|NCT00843024|989531|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
414653|NCT00843024|989526|P6|STARTED|Single-blind Placebo Run-In Phase||0
414654|NCT00843024|989527|P5|STARTED|Single-blind Placebo Run-In Phase||0
414655|NCT00843024|989528|P4|STARTED|Single-blind Placebo Run-In Phase||0
414656|NCT00843024|989529|P3|STARTED|Single-blind Placebo Run-In Phase||0
414657|NCT00843024|989530|P2|STARTED|Single-blind Placebo Run-In Phase||457
414658|NCT00843024|989531|P1|STARTED|Single-blind Placebo Run-In Phase||408
414659|NCT00842985|989596|P1|NOT COMPLETED|Fourth Intervention||0
414660|NCT00842985|989596|P1|COMPLETED|Fourth Intervention||15
414661|NCT00842985|989596|P1|STARTED|Fourth Intervention||15
414662|NCT00842985|989596|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
414663|NCT00842985|989596|P1|COMPLETED|Washout Period of GE 4 Days||15
414664|NCT00842985|989596|P1|STARTED|Washout Period of GE 4 Days||15
414665|NCT00842985|989596|P1|NOT COMPLETED|Third Intervention||0
414666|NCT00842985|989596|P1|COMPLETED|Third Intervention||15
414667|NCT00842985|989596|P1|STARTED|Third Intervention||15
414668|NCT00842985|989596|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
414669|NCT00842985|989596|P1|COMPLETED|Washout Period of GE 4 Days||15
414670|NCT00842985|989596|P1|STARTED|Washout Period of GE 4 Days||17
414671|NCT00842985|989596|P1|NOT COMPLETED|Second Intervention||1
414672|NCT00842985|989596|P1|COMPLETED|Second Intervention||17
414673|NCT00842985|989596|P1|STARTED|Second Intervention||18
414674|NCT00842985|989596|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
414675|NCT00842985|989596|P1|COMPLETED|Washout Period of GE 4 Days||18
414676|NCT00842985|989596|P1|STARTED|Washout Period of GE 4 Days||20
414677|NCT00842985|989596|P1|NOT COMPLETED|First Intervention||6
414678|NCT00842985|989596|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
414679|NCT00842985|989596|P1|STARTED|First Intervention|Signed Consent|26
414680|NCT00842985|989596|P1|NOT COMPLETED|Screening||27
414681|NCT00842985|989596|P1|COMPLETED|Screening||26
414682|NCT00842985|989596|P1|STARTED|Screening||53
414683|NCT00842946|989605|P2|NOT COMPLETED|Overall Study||5
414684|NCT00842946|989606|P1|NOT COMPLETED|Overall Study||5
414685|NCT00842946|989605|P2|COMPLETED|Overall Study||19
414686|NCT00842946|989606|P1|COMPLETED|Overall Study||16
414687|NCT00842946|989605|P2|STARTED|Overall Study||24
414688|NCT00842946|989606|P1|STARTED|Overall Study||21
414689|NCT00842829|989614|P3|NOT COMPLETED|Continuation Period||61
414690|NCT00842829|989615|P2|NOT COMPLETED|Continuation Period||0
414691|NCT00842829|989616|P1|NOT COMPLETED|Continuation Period||0
414692|NCT00842829|989614|P3|COMPLETED|Continuation Period||27
414693|NCT00842829|989615|P2|COMPLETED|Continuation Period||0
414694|NCT00842829|989616|P1|COMPLETED|Continuation Period||0
414695|NCT00842829|989614|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
414696|NCT00842829|989615|P2|Continuation Safety Analysis Set|Continuation Period||0
414697|NCT00842829|989616|P1|Continuation Safety Analysis Set|Continuation Period||0
414698|NCT00842829|989614|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
414699|NCT00842829|989615|P2|STARTED|Continuation Period||0
414700|NCT00842829|989616|P1|STARTED|Continuation Period||0
414701|NCT00842829|989614|P3|NOT COMPLETED|Treatment Period||63
414702|NCT00842829|989615|P2|NOT COMPLETED|Treatment Period||0
414703|NCT00842829|989616|P1|NOT COMPLETED|Treatment Period||0
414704|NCT00842829|989614|P3|COMPLETED|Treatment Period||218
414705|NCT00842829|989615|P2|COMPLETED|Treatment Period||0
414706|NCT00842829|989616|P1|COMPLETED|Treatment Period||0
414707|NCT00842829|989614|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
414708|NCT00842829|989615|P2|Safety Analysis Set|Treatment Period||0
414709|NCT00842829|989616|P1|Safety Analysis Set|Treatment Period||0
414710|NCT00842829|989614|P3|STARTED|Treatment Period||281
414711|NCT00842829|989615|P2|STARTED|Treatment Period||0
414712|NCT00842829|989616|P1|STARTED|Treatment Period||0
414713|NCT00842829|989614|P3|NOT COMPLETED|Dose Titration Period||0
414714|NCT00842829|989615|P2|NOT COMPLETED|Dose Titration Period||23
414715|NCT00842829|989616|P1|NOT COMPLETED|Dose Titration Period||26
414716|NCT00842829|989614|P3|COMPLETED|Dose Titration Period||0
414717|NCT00842829|989615|P2|COMPLETED|Dose Titration Period||151
414718|NCT00842829|989616|P1|COMPLETED|Dose Titration Period||130
414719|NCT00842829|989614|P3|Titration Safety Analysis Set|Dose Titration Period||0
414720|NCT00842829|989615|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
414721|NCT00842829|989616|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
414722|NCT00842829|989614|P3|STARTED|Dose Titration Period||0
414723|NCT00842829|989615|P2|STARTED|Dose Titration Period||174
414724|NCT00842829|989616|P1|STARTED|Dose Titration Period||156
414725|NCT00842751|989650|P1|NOT COMPLETED|Overall Study||0
414726|NCT00842751|989650|P1|COMPLETED|Overall Study||11
414727|NCT00842751|989650|P1|STARTED|Overall Study||11
414728|NCT00842712|989671|P7|NOT COMPLETED|Randomized Part||6
414729|NCT00842712|989672|P6|NOT COMPLETED|Randomized Part||1
414730|NCT00842712|989673|P5|NOT COMPLETED|Randomized Part||0
414731|NCT00842712|989674|P4|NOT COMPLETED|Randomized Part||0
414732|NCT00842712|989675|P3|NOT COMPLETED|Randomized Part||0
414733|NCT00842712|989676|P2|NOT COMPLETED|Randomized Part||0
414734|NCT00842712|989677|P1|NOT COMPLETED|Randomized Part||0
414735|NCT00842712|989671|P7|COMPLETED|Randomized Part||78
414736|NCT00842712|989672|P6|COMPLETED|Randomized Part||50
414737|NCT00842712|989673|P5|COMPLETED|Randomized Part||85
414738|NCT00842712|989674|P4|COMPLETED|Randomized Part||0
414739|NCT00842712|989675|P3|COMPLETED|Randomized Part||0
414740|NCT00842712|989676|P2|COMPLETED|Randomized Part||0
414741|NCT00842712|989677|P1|COMPLETED|Randomized Part||0
414742|NCT00842712|989671|P7|Treated|Randomized Part||80
414743|NCT00842712|989672|P6|Treated|Randomized Part||50
414744|NCT00842712|989673|P5|Treated|Randomized Part||85
414745|NCT00842712|989674|P4|Treated|Randomized Part||0
414746|NCT00842712|989675|P3|Treated|Randomized Part||0
414747|NCT00842712|989676|P2|Treated|Randomized Part||0
414748|NCT00842712|989677|P1|Treated|Randomized Part||0
414749|NCT00842712|989671|P7|STARTED|Randomized Part||84
414750|NCT00842712|989672|P6|STARTED|Randomized Part||51
414751|NCT00842712|989673|P5|STARTED|Randomized Part||85
414752|NCT00842712|989674|P4|STARTED|Randomized Part||0
414753|NCT00842712|989675|P3|STARTED|Randomized Part||0
414754|NCT00842712|989676|P2|STARTED|Randomized Part||0
414755|NCT00842712|989677|P1|STARTED|Randomized Part||0
414756|NCT00842712|989671|P7|NOT COMPLETED|Safety Run-in Part||0
414757|NCT00842712|989672|P6|NOT COMPLETED|Safety Run-in Part||0
414758|NCT00842712|989673|P5|NOT COMPLETED|Safety Run-in Part||0
414759|NCT00842712|989674|P4|NOT COMPLETED|Safety Run-in Part||1
414760|NCT00842712|989675|P3|NOT COMPLETED|Safety Run-in Part||0
414761|NCT00842712|989676|P2|NOT COMPLETED|Safety Run-in Part||2
414762|NCT00842712|989677|P1|NOT COMPLETED|Safety Run-in Part||3
414763|NCT00842712|989671|P7|COMPLETED|Safety Run-in Part||0
414764|NCT00842712|989672|P6|COMPLETED|Safety Run-in Part||0
414765|NCT00842712|989673|P5|COMPLETED|Safety Run-in Part||0
414766|NCT00842712|989674|P4|COMPLETED|Safety Run-in Part||2
414767|NCT00842712|989675|P3|COMPLETED|Safety Run-in Part||3
414768|NCT00842712|989676|P2|COMPLETED|Safety Run-in Part||1
414769|NCT00842712|989677|P1|COMPLETED|Safety Run-in Part||0
414770|NCT00842712|989671|P7|STARTED|Safety Run-in Part||0
414771|NCT00842712|989672|P6|STARTED|Safety Run-in Part||0
414772|NCT00842712|989673|P5|STARTED|Safety Run-in Part||0
414773|NCT00842712|989674|P4|STARTED|Safety Run-in Part||3
414774|NCT00842712|989675|P3|STARTED|Safety Run-in Part||3
414775|NCT00842712|989676|P2|STARTED|Safety Run-in Part||3
414776|NCT00842712|989677|P1|STARTED|Safety Run-in Part||3
414777|NCT00842543|989709|P4|NOT COMPLETED|Overall Study||4
414778|NCT00842543|989710|P3|NOT COMPLETED|Overall Study||3
414779|NCT00842543|989711|P2|NOT COMPLETED|Overall Study||0
414780|NCT00842543|989712|P1|NOT COMPLETED|Overall Study||2
414781|NCT00842543|989709|P4|COMPLETED|Overall Study||4
414782|NCT00842543|989710|P3|COMPLETED|Overall Study||10
414783|NCT00842543|989711|P2|COMPLETED|Overall Study||5
414784|NCT00842543|989712|P1|COMPLETED|Overall Study||11
414785|NCT00842543|989709|P4|STARTED|Overall Study||8
414786|NCT00842543|989710|P3|STARTED|Overall Study||13
414787|NCT00842543|989711|P2|STARTED|Overall Study||5
414788|NCT00842543|989712|P1|STARTED|Overall Study||13
414789|NCT00842361|989726|P2|NOT COMPLETED|Overall Study||2
414790|NCT00842361|989727|P1|NOT COMPLETED|Overall Study||1
414791|NCT00842361|989726|P2|COMPLETED|Overall Study||31
414792|NCT00842361|989727|P1|COMPLETED|Overall Study||32
414793|NCT00842361|989726|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
414794|NCT00842361|989727|P1|Exposed|Overall Study||33
414795|NCT00842361|989726|P2|STARTED|Overall Study||33
414796|NCT00842361|989727|P1|STARTED|Overall Study||33
414797|NCT00842348|989747|P2|NOT COMPLETED|Study 729||38
414798|NCT00842348|989748|P1|NOT COMPLETED|Study 729||26
414799|NCT00842348|989747|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
414800|NCT00842348|989748|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
414801|NCT00842348|989747|P2|STARTED|Study 729||47
414802|NCT00842348|989748|P1|STARTED|Study 729||42
414803|NCT00842348|989747|P2|NOT COMPLETED|Patients Randomised in Study 726||56
414804|NCT00842348|989748|P1|NOT COMPLETED|Patients Randomised in Study 726||59
414805|NCT00842348|989747|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
414806|NCT00842348|989748|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
414807|NCT00842348|989747|P2|STARTED|Patients Randomised in Study 726||103
414808|NCT00842348|989748|P1|STARTED|Patients Randomised in Study 726||101
414809|NCT00842335|989758|P1|NOT COMPLETED|Overall Study||0
414810|NCT00842335|989758|P1|COMPLETED|Overall Study||18
414811|NCT00842335|989758|P1|STARTED|Overall Study||18
414812|NCT00842257|989765|P1|NOT COMPLETED|Overall Study||1
414813|NCT00842257|989765|P1|COMPLETED|Overall Study||19
414814|NCT00842257|989765|P1|STARTED|Overall Study||20
414815|NCT00842244|989772|P1|NOT COMPLETED|Overall Study||21
414816|NCT00842244|989772|P1|COMPLETED|Overall Study||1
414817|NCT00842244|989772|P1|STARTED|Overall Study||22
414818|NCT00842231|989791|P1|NOT COMPLETED|Overall Study||0
414819|NCT00842231|989791|P1|COMPLETED|Overall Study||40
414820|NCT00842231|989791|P1|STARTED|Overall Study||40
414821|NCT00842153|989799|P2|NOT COMPLETED|Overall Study||3
414822|NCT00842153|989800|P1|NOT COMPLETED|Overall Study||1
414823|NCT00842153|989799|P2|COMPLETED|Overall Study||27
414824|NCT00842153|989800|P1|COMPLETED|Overall Study||27
414825|NCT00842153|989799|P2|STARTED|Overall Study||30
414826|NCT00842153|989800|P1|STARTED|Overall Study||28
414827|NCT00842075|989840|P2|NOT COMPLETED|Overall Study||0
414828|NCT00842075|989841|P1|NOT COMPLETED|Overall Study||0
414829|NCT00842075|989840|P2|COMPLETED|Overall Study||5
414830|NCT00842075|989841|P1|COMPLETED|Overall Study||5
414831|NCT00842075|989840|P2|STARTED|Overall Study||5
414832|NCT00842075|989841|P1|STARTED|Overall Study||5
414833|NCT00842023|989851|P2|NOT COMPLETED|Overall Study||0
414834|NCT00842023|989852|P1|NOT COMPLETED|Overall Study||0
414835|NCT00842023|989851|P2|COMPLETED|Overall Study||44
414836|NCT00842023|989852|P1|COMPLETED|Overall Study||45
414837|NCT00842023|989851|P2|STARTED|Overall Study||44
414838|NCT00842023|989852|P1|STARTED|Overall Study||45
414839|NCT00841971|989864|P2|NOT COMPLETED|Overall Study||1
414840|NCT00841971|989865|P1|NOT COMPLETED|Overall Study||2
414841|NCT00841971|989864|P2|COMPLETED|Overall Study||99
414842|NCT00841971|989865|P1|COMPLETED|Overall Study||98
414843|NCT00841971|989864|P2|STARTED|Overall Study||100
414844|NCT00841971|989865|P1|STARTED|Overall Study||100
414845|NCT00841906|989875|P2|NOT COMPLETED|Overall Study||0
414846|NCT00841906|989876|P1|NOT COMPLETED|Overall Study||2
414847|NCT00841906|989875|P2|COMPLETED|Overall Study||15
414848|NCT00841906|989876|P1|COMPLETED|Overall Study||15
414849|NCT00841906|989875|P2|STARTED|Overall Study||15
414850|NCT00841906|989876|P1|STARTED|Overall Study||17
414851|NCT00841815|989890|P2|NOT COMPLETED|Period 2||0
414852|NCT00841815|989891|P1|NOT COMPLETED|Period 2||0
414853|NCT00841815|989890|P2|COMPLETED|Period 2||13
414854|NCT00841815|989891|P1|COMPLETED|Period 2||14
414855|NCT00841815|989890|P2|STARTED|Period 2||13
414856|NCT00841815|989891|P1|STARTED|Period 2||14
414857|NCT00841815|989890|P2|NOT COMPLETED|Washout||1
414858|NCT00841815|989891|P1|NOT COMPLETED|Washout||0
414859|NCT00841815|989890|P2|COMPLETED|Washout||13
414860|NCT00841815|989891|P1|COMPLETED|Washout||14
414861|NCT00841815|989890|P2|STARTED|Washout||14
414862|NCT00841815|989891|P1|STARTED|Washout||14
414863|NCT00841815|989890|P2|NOT COMPLETED|Period 1||0
414864|NCT00841815|989891|P1|NOT COMPLETED|Period 1||0
414865|NCT00841815|989890|P2|COMPLETED|Period 1||14
414866|NCT00841815|989891|P1|COMPLETED|Period 1||14
414867|NCT00841815|989890|P2|STARTED|Period 1||14
414868|NCT00841815|989891|P1|STARTED|Period 1||14
414869|NCT00841776|989901|P2|NOT COMPLETED|Overall Study||3
414870|NCT00841776|989902|P1|NOT COMPLETED|Overall Study||2
414871|NCT00841776|989901|P2|COMPLETED|Overall Study||24
414872|NCT00841776|989902|P1|COMPLETED|Overall Study||25
414873|NCT00841776|989901|P2|STARTED|Overall Study||27
414874|NCT00841776|989902|P1|STARTED|Overall Study||27
414875|NCT00841763|989920|P4|NOT COMPLETED|Overall Study||3
414876|NCT00841763|989921|P3|NOT COMPLETED|Overall Study||8
414877|NCT00841763|989922|P2|NOT COMPLETED|Overall Study||57
414878|NCT00841763|989923|P1|NOT COMPLETED|Overall Study||162
414879|NCT00841763|989920|P4|COMPLETED|Overall Study||53
414880|NCT00841763|989921|P3|COMPLETED|Overall Study||211
414881|NCT00841763|989922|P2|COMPLETED|Overall Study||624
414882|NCT00841763|989923|P1|COMPLETED|Overall Study||2529
414883|NCT00841763|989920|P4|STARTED|Overall Study||56
414884|NCT00841763|989921|P3|STARTED|Overall Study||219
414885|NCT00841763|989922|P2|STARTED|Overall Study||681
414886|NCT00841763|989923|P1|STARTED|Overall Study||2691
414887|NCT00841698|989985|P2|NOT COMPLETED|Second Intervention||0
414888|NCT00841698|989986|P1|NOT COMPLETED|Second Intervention||0
414889|NCT00841698|989985|P2|COMPLETED|Second Intervention||25
414890|NCT00841698|989986|P1|COMPLETED|Second Intervention||24
414891|NCT00841698|989985|P2|STARTED|Second Intervention||25
414892|NCT00841698|989986|P1|STARTED|Second Intervention||24
414893|NCT00841698|989985|P2|NOT COMPLETED|Washout: 2 Weeks||0
414894|NCT00841698|989986|P1|NOT COMPLETED|Washout: 2 Weeks||0
414895|NCT00841698|989985|P2|COMPLETED|Washout: 2 Weeks||25
414896|NCT00841698|989986|P1|COMPLETED|Washout: 2 Weeks||24
414897|NCT00841698|989985|P2|STARTED|Washout: 2 Weeks||25
414898|NCT00841698|989986|P1|STARTED|Washout: 2 Weeks||24
414899|NCT00841698|989985|P2|NOT COMPLETED|First Intervention||0
414900|NCT00841698|989986|P1|NOT COMPLETED|First Intervention||1
414901|NCT00841698|989985|P2|COMPLETED|First Intervention||25
414902|NCT00841698|989986|P1|COMPLETED|First Intervention||24
414903|NCT00841698|989985|P2|STARTED|First Intervention||25
414904|NCT00841698|989986|P1|STARTED|First Intervention||25
414905|NCT00841672|989996|P2|NOT COMPLETED|Overall Study||32
414906|NCT00841672|989997|P1|NOT COMPLETED|Overall Study||20
414907|NCT00841672|989996|P2|COMPLETED|Overall Study||209
414908|NCT00841672|989997|P1|COMPLETED|Overall Study||224
414909|NCT00841672|989996|P2|STARTED|Overall Study||241
414910|NCT00841672|989997|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
414911|NCT00841659|990013|P2|NOT COMPLETED|Second Intervention||0
414912|NCT00841659|990014|P1|NOT COMPLETED|Second Intervention||0
414913|NCT00841659|990013|P2|COMPLETED|Second Intervention||12
414914|NCT00841659|990014|P1|COMPLETED|Second Intervention||11
414915|NCT00841659|990013|P2|STARTED|Second Intervention||12
414916|NCT00841659|990014|P1|STARTED|Second Intervention||11
414917|NCT00841659|990013|P2|NOT COMPLETED|Washout: 2 Weeks||0
414918|NCT00841659|990014|P1|NOT COMPLETED|Washout: 2 Weeks||1
414919|NCT00841659|990013|P2|COMPLETED|Washout: 2 Weeks||12
414920|NCT00841659|990014|P1|COMPLETED|Washout: 2 Weeks||11
414921|NCT00841659|990013|P2|STARTED|Washout: 2 Weeks||12
414922|NCT00841659|990014|P1|STARTED|Washout: 2 Weeks||12
414923|NCT00841659|990013|P2|NOT COMPLETED|First Intervention||0
414924|NCT00841659|990014|P1|NOT COMPLETED|First Intervention||0
414925|NCT00841659|990013|P2|COMPLETED|First Intervention||12
414926|NCT00841659|990014|P1|COMPLETED|First Intervention||12
414927|NCT00841659|990013|P2|STARTED|First Intervention||12
414928|NCT00841659|990014|P1|STARTED|First Intervention||12
414929|NCT00841555|990025|P3|NOT COMPLETED|Overall Study||0
414930|NCT00841555|990026|P2|NOT COMPLETED|Overall Study||0
414931|NCT00841555|990027|P1|NOT COMPLETED|Overall Study||0
414932|NCT00841555|990025|P3|COMPLETED|Overall Study||3
414933|NCT00841555|990026|P2|COMPLETED|Overall Study||3
414934|NCT00841555|990027|P1|COMPLETED|Overall Study||3
414935|NCT00841555|990025|P3|STARTED|Overall Study||3
414936|NCT00841555|990026|P2|STARTED|Overall Study||3
414937|NCT00841555|990027|P1|STARTED|Overall Study||3
414938|NCT00841542|990037|P2|NOT COMPLETED|Period 2||0
414939|NCT00841542|990038|P1|NOT COMPLETED|Period 2||0
414940|NCT00841542|990037|P2|COMPLETED|Period 2||14
414941|NCT00841542|990038|P1|COMPLETED|Period 2||13
414942|NCT00841542|990037|P2|STARTED|Period 2||14
414943|NCT00841542|990038|P1|STARTED|Period 2||13
414944|NCT00841542|990037|P2|NOT COMPLETED|Period 1||0
414945|NCT00841542|990038|P1|NOT COMPLETED|Period 1||1
414946|NCT00841542|990037|P2|COMPLETED|Period 1||14
414947|NCT00841542|990038|P1|COMPLETED|Period 1||13
414948|NCT00841542|990037|P2|STARTED|Period 1||14
414949|NCT00841542|990038|P1|STARTED|Period 1||14
414950|NCT00841412|990046|P2|NOT COMPLETED|Overall Study||30
414951|NCT00841412|990047|P1|NOT COMPLETED|Overall Study||40
414952|NCT00841412|990046|P2|COMPLETED|Overall Study||50
414953|NCT00841412|990047|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
414954|NCT00841412|990046|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
414955|NCT00841412|990047|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
414956|NCT00841321|990053|P2|NOT COMPLETED|Overall Study||3
414957|NCT00841321|990054|P1|NOT COMPLETED|Overall Study||1
414958|NCT00841321|990053|P2|COMPLETED|Overall Study||58
414959|NCT00841321|990054|P1|COMPLETED|Overall Study||58
414960|NCT00841321|990053|P2|STARTED|Overall Study||61
414961|NCT00841321|990054|P1|STARTED|Overall Study||59
414962|NCT00841269|990066|P1|NOT COMPLETED|Overall Study||2
414963|NCT00841269|990066|P1|COMPLETED|Overall Study||5
414964|NCT00841269|990066|P1|STARTED|Overall Study||7
414965|NCT00841204|990072|P2|NOT COMPLETED|Overall Study||0
414966|NCT00841204|990073|P1|NOT COMPLETED|Overall Study||0
414967|NCT00841204|990072|P2|COMPLETED|Overall Study||25
414968|NCT00841204|990073|P1|COMPLETED|Overall Study||25
414969|NCT00841204|990072|P2|STARTED|Overall Study||25
414970|NCT00841204|990073|P1|STARTED|Overall Study||25
414971|NCT00841087|990085|P2|NOT COMPLETED|Overall Study||0
414972|NCT00841087|990086|P1|NOT COMPLETED|Overall Study||0
414973|NCT00841087|990085|P2|COMPLETED|Overall Study||32
414974|NCT00841087|990086|P1|COMPLETED|Overall Study||33
414975|NCT00841087|990085|P2|STARTED|Overall Study||32
414976|NCT00841087|990086|P1|STARTED|Overall Study||33
414977|NCT00841035|990104|P1|NOT COMPLETED|Phase 2 of Overall Study||0
414978|NCT00841035|990104|P1|COMPLETED|Phase 2 of Overall Study||6
414979|NCT00841035|990104|P1|STARTED|Phase 2 of Overall Study||6
414980|NCT00841035|990104|P1|NOT COMPLETED|Phase 1 Overall Study||13
414981|NCT00841035|990104|P1|COMPLETED|Phase 1 Overall Study||6
414982|NCT00841035|990104|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
414983|NCT00840996|990111|P2|NOT COMPLETED|Overall Study||0
414984|NCT00840996|990112|P1|NOT COMPLETED|Overall Study||1
414985|NCT00840996|990111|P2|COMPLETED|Overall Study||58
414986|NCT00840996|990112|P1|COMPLETED|Overall Study||57
414987|NCT00840996|990111|P2|STARTED|Overall Study||58
414988|NCT00840996|990112|P1|STARTED|Overall Study||58
414989|NCT00840879|990132|P2|NOT COMPLETED|Second Intervention||0
414990|NCT00840879|990133|P1|NOT COMPLETED|Second Intervention||1
414991|NCT00840879|990132|P2|COMPLETED|Second Intervention||14
414992|NCT00840879|990133|P1|COMPLETED|Second Intervention||13
414993|NCT00840879|990132|P2|STARTED|Second Intervention||14
414994|NCT00840879|990133|P1|STARTED|Second Intervention||14
414995|NCT00840879|990132|P2|NOT COMPLETED|Washout: 14 Days||0
414996|NCT00840879|990133|P1|NOT COMPLETED|Washout: 14 Days||0
414997|NCT00840879|990132|P2|COMPLETED|Washout: 14 Days||14
414998|NCT00840879|990133|P1|COMPLETED|Washout: 14 Days||14
414999|NCT00840879|990132|P2|STARTED|Washout: 14 Days||14
415000|NCT00840879|990133|P1|STARTED|Washout: 14 Days||14
415001|NCT00840879|990132|P2|NOT COMPLETED|First Intervention||0
415002|NCT00840879|990133|P1|NOT COMPLETED|First Intervention||0
415003|NCT00840879|990132|P2|COMPLETED|First Intervention||14
415004|NCT00840879|990133|P1|COMPLETED|First Intervention||14
415005|NCT00840879|990132|P2|STARTED|First Intervention||14
415006|NCT00840879|990133|P1|STARTED|First Intervention||14
415007|NCT00840866|990143|P2|NOT COMPLETED|Second Intervention||0
415008|NCT00840866|990144|P1|NOT COMPLETED|Second Intervention||0
415009|NCT00840866|990143|P2|COMPLETED|Second Intervention||19
415010|NCT00840866|990144|P1|COMPLETED|Second Intervention||20
415011|NCT00840866|990143|P2|STARTED|Second Intervention||19
415012|NCT00840866|990144|P1|STARTED|Second Intervention||20
415013|NCT00840866|990143|P2|NOT COMPLETED|Washout of 7 Days||0
415014|NCT00840866|990144|P1|NOT COMPLETED|Washout of 7 Days||0
415015|NCT00840866|990143|P2|COMPLETED|Washout of 7 Days||19
415016|NCT00840866|990144|P1|COMPLETED|Washout of 7 Days||20
415017|NCT00840866|990143|P2|STARTED|Washout of 7 Days||19
415018|NCT00840866|990144|P1|STARTED|Washout of 7 Days||20
415019|NCT00840866|990143|P2|NOT COMPLETED|First Intervention||0
415020|NCT00840866|990144|P1|NOT COMPLETED|First Intervention||0
415021|NCT00840866|990143|P2|COMPLETED|First Intervention||19
415022|NCT00840866|990144|P1|COMPLETED|First Intervention||20
415023|NCT00840866|990143|P2|STARTED|First Intervention||19
415024|NCT00840866|990144|P1|STARTED|First Intervention||20
415025|NCT00840840|990154|P2|NOT COMPLETED|Period 2||0
415026|NCT00840840|990155|P1|NOT COMPLETED|Period 2||0
415027|NCT00840840|990154|P2|COMPLETED|Period 2||24
415028|NCT00840840|990155|P1|COMPLETED|Period 2||23
415029|NCT00840840|990154|P2|STARTED|Period 2||24
415030|NCT00840840|990155|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
415031|NCT00840840|990154|P2|NOT COMPLETED|Period 1||0
415032|NCT00840840|990155|P1|NOT COMPLETED|Period 1||0
415033|NCT00840840|990154|P2|COMPLETED|Period 1||24
415034|NCT00840840|990155|P1|COMPLETED|Period 1||24
415035|NCT00840840|990154|P2|STARTED|Period 1||24
415036|NCT00840840|990155|P1|STARTED|Period 1||24
415037|NCT00840658|990173|P4|NOT COMPLETED|Overall Study||4
415038|NCT00840658|990174|P3|NOT COMPLETED|Overall Study||5
415039|NCT00840658|990175|P2|NOT COMPLETED|Overall Study||3
415040|NCT00840658|990176|P1|NOT COMPLETED|Overall Study||5
415041|NCT00840658|990173|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
415042|NCT00840658|990174|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
415043|NCT00840658|990175|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
415044|NCT00840658|990176|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
415045|NCT00840658|990173|P4|STARTED|Overall Study||146
415046|NCT00840658|990174|P3|STARTED|Overall Study||148
415047|NCT00840658|990175|P2|STARTED|Overall Study||146
415048|NCT00840658|990176|P1|STARTED|Overall Study||144
415049|NCT00840632|990188|P2|NOT COMPLETED|Second Intervention||0
415050|NCT00840632|990189|P1|NOT COMPLETED|Second Intervention||0
415051|NCT00840632|990188|P2|COMPLETED|Second Intervention||18
415052|NCT00840632|990189|P1|COMPLETED|Second Intervention||19
415053|NCT00840632|990188|P2|STARTED|Second Intervention||18
415054|NCT00840632|990189|P1|STARTED|Second Intervention||19
415055|NCT00840632|990188|P2|NOT COMPLETED|Washout||1
415056|NCT00840632|990189|P1|NOT COMPLETED|Washout||1
415057|NCT00840632|990188|P2|COMPLETED|Washout||18
415058|NCT00840632|990189|P1|COMPLETED|Washout||19
415059|NCT00840632|990188|P2|STARTED|Washout||19
415060|NCT00840632|990189|P1|STARTED|Washout||20
415061|NCT00840632|990188|P2|NOT COMPLETED|First Intervention||1
415062|NCT00840632|990189|P1|NOT COMPLETED|First Intervention||0
415063|NCT00840632|990188|P2|COMPLETED|First Intervention||19
415064|NCT00840632|990189|P1|COMPLETED|First Intervention||20
415065|NCT00840632|990188|P2|STARTED|First Intervention||20
415066|NCT00840632|990189|P1|STARTED|First Intervention||20
415067|NCT00840476|990205|P2|NOT COMPLETED|Second Intervention||0
415068|NCT00840476|990206|P1|NOT COMPLETED|Second Intervention||0
415069|NCT00840476|990205|P2|COMPLETED|Second Intervention||14
415070|NCT00840476|990206|P1|COMPLETED|Second Intervention||14
415071|NCT00840476|990205|P2|STARTED|Second Intervention||14
415072|NCT00840476|990206|P1|STARTED|Second Intervention||14
415073|NCT00840476|990205|P2|NOT COMPLETED|Washout: 14 Days||0
415074|NCT00840476|990206|P1|NOT COMPLETED|Washout: 14 Days||0
415075|NCT00840476|990205|P2|COMPLETED|Washout: 14 Days||14
415076|NCT00840476|990206|P1|COMPLETED|Washout: 14 Days||14
415077|NCT00840476|990205|P2|STARTED|Washout: 14 Days||14
415078|NCT00840476|990206|P1|STARTED|Washout: 14 Days||14
415079|NCT00840476|990205|P2|NOT COMPLETED|First Intervention||0
415080|NCT00840476|990206|P1|NOT COMPLETED|First Intervention||0
415081|NCT00840476|990205|P2|COMPLETED|First Intervention||14
415082|NCT00840476|990206|P1|COMPLETED|First Intervention||14
415083|NCT00840476|990205|P2|STARTED|First Intervention||14
415084|NCT00840476|990206|P1|STARTED|First Intervention||14
415085|NCT00840450|990214|P1|NOT COMPLETED|Overall Study||3
415086|NCT00840450|990214|P1|COMPLETED|Overall Study||9
415087|NCT00840450|990214|P1|STARTED|Overall Study||12
415088|NCT00840411|990222|P2|NOT COMPLETED|Second Intervention||0
415089|NCT00840411|990223|P1|NOT COMPLETED|Second Intervention||0
415090|NCT00840411|990222|P2|COMPLETED|Second Intervention||33
415091|NCT00840411|990223|P1|COMPLETED|Second Intervention||31
415092|NCT00840411|990222|P2|STARTED|Second Intervention||33
415093|NCT00840411|990223|P1|STARTED|Second Intervention||31
415094|NCT00840411|990222|P2|NOT COMPLETED|Washout||0
415095|NCT00840411|990223|P1|NOT COMPLETED|Washout||1
415096|NCT00840411|990222|P2|COMPLETED|Washout||33
415097|NCT00840411|990223|P1|COMPLETED|Washout||31
415098|NCT00840411|990222|P2|STARTED|Washout||33
415099|NCT00840411|990223|P1|STARTED|Washout||32
415100|NCT00840411|990222|P2|NOT COMPLETED|First Intervention||0
415101|NCT00840411|990223|P1|NOT COMPLETED|First Intervention||1
415102|NCT00840411|990222|P2|COMPLETED|First Intervention||33
415103|NCT00840411|990223|P1|COMPLETED|First Intervention||32
415104|NCT00840411|990222|P2|STARTED|First Intervention||33
415105|NCT00840411|990223|P1|STARTED|First Intervention||33
415106|NCT00840294|990233|P2|NOT COMPLETED|Overall Study||5
415107|NCT00840294|990234|P1|NOT COMPLETED|Overall Study||3
415108|NCT00840294|990233|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
415109|NCT00840294|990234|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
415110|NCT00840294|990233|P2|STARTED|Overall Study||43
415111|NCT00840294|990234|P1|STARTED|Overall Study||42
415112|NCT00840281|990244|P2|NOT COMPLETED|Second Intervention||0
415113|NCT00840281|990245|P1|NOT COMPLETED|Second Intervention||0
415114|NCT00840281|990244|P2|COMPLETED|Second Intervention||19
415115|NCT00840281|990245|P1|COMPLETED|Second Intervention||19
415116|NCT00840281|990244|P2|STARTED|Second Intervention||19
415117|NCT00840281|990245|P1|STARTED|Second Intervention||19
415118|NCT00840281|990244|P2|NOT COMPLETED|Washout of 7 Days||0
415119|NCT00840281|990245|P1|NOT COMPLETED|Washout of 7 Days||0
415120|NCT00840281|990244|P2|COMPLETED|Washout of 7 Days||19
415121|NCT00840281|990245|P1|COMPLETED|Washout of 7 Days||19
415122|NCT00840281|990244|P2|STARTED|Washout of 7 Days||19
415123|NCT00840281|990245|P1|STARTED|Washout of 7 Days||19
415124|NCT00840281|990244|P2|NOT COMPLETED|First Intervention||0
415125|NCT00840281|990245|P1|NOT COMPLETED|First Intervention||0
415126|NCT00840281|990244|P2|COMPLETED|First Intervention||19
415127|NCT00840281|990245|P1|COMPLETED|First Intervention||19
415128|NCT00840281|990244|P2|STARTED|First Intervention||19
415129|NCT00840281|990245|P1|STARTED|First Intervention||19
415130|NCT00840216|990255|P2|NOT COMPLETED|Second Intervention||0
415131|NCT00840216|990256|P1|NOT COMPLETED|Second Intervention||0
415132|NCT00840216|990255|P2|COMPLETED|Second Intervention||11
415133|NCT00840216|990256|P1|COMPLETED|Second Intervention||10
415134|NCT00840216|990255|P2|STARTED|Second Intervention||11
415135|NCT00840216|990256|P1|STARTED|Second Intervention||10
415136|NCT00840216|990255|P2|NOT COMPLETED|Washout: 7 Days||0
415137|NCT00840216|990256|P1|NOT COMPLETED|Washout: 7 Days||1
415138|NCT00840216|990255|P2|COMPLETED|Washout: 7 Days||11
415139|NCT00840216|990256|P1|COMPLETED|Washout: 7 Days||10
415140|NCT00840216|990255|P2|STARTED|Washout: 7 Days||11
415141|NCT00840216|990256|P1|STARTED|Washout: 7 Days||11
415142|NCT00840216|990255|P2|NOT COMPLETED|First Intervention||0
415143|NCT00840216|990256|P1|NOT COMPLETED|First Intervention||0
415144|NCT00840216|990255|P2|COMPLETED|First Intervention||11
415145|NCT00840216|990256|P1|COMPLETED|First Intervention||11
415146|NCT00840216|990255|P2|STARTED|First Intervention||11
415147|NCT00840216|990256|P1|STARTED|First Intervention||11
415148|NCT00840203|990266|P2|NOT COMPLETED|Second Intervention||0
415149|NCT00840203|990267|P1|NOT COMPLETED|Second Intervention||0
415150|NCT00840203|990266|P2|COMPLETED|Second Intervention||34
415151|NCT00840203|990267|P1|COMPLETED|Second Intervention||35
415152|NCT00840203|990266|P2|STARTED|Second Intervention||34
415153|NCT00840203|990267|P1|STARTED|Second Intervention||35
415154|NCT00840203|990266|P2|NOT COMPLETED|Washout||0
415155|NCT00840203|990267|P1|NOT COMPLETED|Washout||1
415156|NCT00840203|990266|P2|COMPLETED|Washout||34
415157|NCT00840203|990267|P1|COMPLETED|Washout||35
415158|NCT00840203|990266|P2|STARTED|Washout||34
415159|NCT00840203|990267|P1|STARTED|Washout||36
415160|NCT00840203|990266|P2|NOT COMPLETED|First Intervention||1
415161|NCT00840203|990267|P1|NOT COMPLETED|First Intervention||1
415162|NCT00840203|990266|P2|COMPLETED|First Intervention||34
415163|NCT00840203|990267|P1|COMPLETED|First Intervention||36
415164|NCT00840203|990266|P2|STARTED|First Intervention||35
415165|NCT00840203|990267|P1|STARTED|First Intervention||37
415166|NCT00840099|990283|P2|NOT COMPLETED|Period 2||0
415167|NCT00840099|990284|P1|NOT COMPLETED|Period 2||0
415168|NCT00840099|990283|P2|COMPLETED|Period 2||24
415169|NCT00840099|990284|P1|COMPLETED|Period 2||21
415170|NCT00840099|990283|P2|STARTED|Period 2||24
415171|NCT00840099|990284|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
415172|NCT00840099|990283|P2|NOT COMPLETED|Period 1||0
415173|NCT00840099|990284|P1|NOT COMPLETED|Period 1||0
415174|NCT00840099|990283|P2|COMPLETED|Period 1||24
415175|NCT00840099|990284|P1|COMPLETED|Period 1||24
415176|NCT00840099|990283|P2|STARTED|Period 1||24
415177|NCT00840099|990284|P1|STARTED|Period 1||24
415178|NCT00840086|990298|P1|NOT COMPLETED|Overall Study||4
415179|NCT00840086|990298|P1|COMPLETED|Overall Study||146
415180|NCT00840086|990298|P1|STARTED|Overall Study||150
415181|NCT00840073|990307|P2|NOT COMPLETED|Second Intervention||1
415182|NCT00840073|990308|P1|NOT COMPLETED|Second Intervention||1
415183|NCT00840073|990307|P2|COMPLETED|Second Intervention||24
415184|NCT00840073|990308|P1|COMPLETED|Second Intervention||24
415185|NCT00840073|990307|P2|STARTED|Second Intervention||25
415186|NCT00840073|990308|P1|STARTED|Second Intervention||25
415187|NCT00840073|990307|P2|NOT COMPLETED|First Intervention||0
415188|NCT00840073|990308|P1|NOT COMPLETED|First Intervention||0
415189|NCT00840073|990307|P2|COMPLETED|First Intervention||25
415190|NCT00840073|990308|P1|COMPLETED|First Intervention||25
415191|NCT00840073|990307|P2|STARTED|First Intervention||25
415192|NCT00840073|990308|P1|STARTED|First Intervention||25
415193|NCT00840060|990322|P2|NOT COMPLETED|Overall Study||1
415194|NCT00840060|990323|P1|NOT COMPLETED|Overall Study||1
415195|NCT00840060|990322|P2|COMPLETED|Overall Study||19
415196|NCT00840060|990323|P1|COMPLETED|Overall Study||19
415197|NCT00840060|990322|P2|STARTED|Overall Study||20
415198|NCT00840060|990323|P1|STARTED|Overall Study||20
415199|NCT00839956|990331|P1|NOT COMPLETED|Overall Study||12
415200|NCT00839956|990331|P1|COMPLETED|Overall Study||19
415201|NCT00839956|990331|P1|STARTED|Overall Study||31
415202|NCT00839930|990340|P2|NOT COMPLETED|Second Intervention||0
415203|NCT00839930|990341|P1|NOT COMPLETED|Second Intervention||0
415204|NCT00839930|990340|P2|COMPLETED|Second Intervention||15
415205|NCT00839930|990341|P1|COMPLETED|Second Intervention||15
415206|NCT00839930|990340|P2|STARTED|Second Intervention||15
415207|NCT00839930|990341|P1|STARTED|Second Intervention||15
415208|NCT00839930|990340|P2|NOT COMPLETED|Washout: 7 Days||0
415209|NCT00839930|990341|P1|NOT COMPLETED|Washout: 7 Days||0
415210|NCT00839930|990340|P2|COMPLETED|Washout: 7 Days||15
415211|NCT00839930|990341|P1|COMPLETED|Washout: 7 Days||15
415212|NCT00839930|990340|P2|STARTED|Washout: 7 Days||15
415213|NCT00839930|990341|P1|STARTED|Washout: 7 Days||15
415214|NCT00839930|990340|P2|NOT COMPLETED|First Intervention||0
415215|NCT00839930|990341|P1|NOT COMPLETED|First Intervention||0
415216|NCT00839930|990340|P2|COMPLETED|First Intervention||15
415217|NCT00839930|990341|P1|COMPLETED|First Intervention||15
415218|NCT00839930|990340|P2|STARTED|First Intervention||15
415219|NCT00839930|990341|P1|STARTED|First Intervention||15
415220|NCT00839917|990351|P2|NOT COMPLETED|Overall Study||1
415221|NCT00839917|990352|P1|NOT COMPLETED|Overall Study||1
415306|NCT00839241|990579|P1|STARTED|Overall Study||20
415222|NCT00839917|990351|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
415223|NCT00839917|990352|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
415224|NCT00839917|990351|P2|STARTED|Overall Study||17
415225|NCT00839917|990352|P1|STARTED|Overall Study||13
415226|NCT00839800|990390|P2|NOT COMPLETED|Overall Study||110
415227|NCT00839800|990391|P1|NOT COMPLETED|Overall Study||93
415228|NCT00839800|990390|P2|COMPLETED|Overall Study||932
415229|NCT00839800|990391|P1|COMPLETED|Overall Study||956
415230|NCT00839800|990390|P2|STARTED|Overall Study||1042
415231|NCT00839800|990391|P1|STARTED|Overall Study||1049
415232|NCT00839540|990424|P3|NOT COMPLETED|Overall Study||0
415233|NCT00839540|990425|P2|NOT COMPLETED|Overall Study||0
415234|NCT00839540|990426|P1|NOT COMPLETED|Overall Study||0
415235|NCT00839540|990424|P3|COMPLETED|Overall Study||5
415236|NCT00839540|990425|P2|COMPLETED|Overall Study||8
415237|NCT00839540|990426|P1|COMPLETED|Overall Study||8
415238|NCT00839540|990424|P3|STARTED|Overall Study||5
415239|NCT00839540|990425|P2|STARTED|Overall Study||8
415240|NCT00839540|990426|P1|STARTED|Overall Study||8
415241|NCT00839527|990437|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
415242|NCT00839527|990438|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
415243|NCT00839527|990439|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
415244|NCT00839527|990437|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
415245|NCT00839527|990438|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
415246|NCT00839527|990439|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
415247|NCT00839527|990437|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
415248|NCT00839527|990438|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
415249|NCT00839527|990439|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
415250|NCT00839527|990437|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
415251|NCT00839527|990438|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
415252|NCT00839527|990439|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
415253|NCT00839527|990437|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
415254|NCT00839527|990438|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
415255|NCT00839527|990439|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
415256|NCT00839527|990437|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
415257|NCT00839527|990438|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
415258|NCT00839527|990439|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
415259|NCT00839436|990474|P3|NOT COMPLETED|Overall Study||1
415260|NCT00839436|990475|P2|NOT COMPLETED|Overall Study||1
415261|NCT00839436|990476|P1|NOT COMPLETED|Overall Study||1
415262|NCT00839436|990474|P3|COMPLETED|Overall Study||0
415263|NCT00839436|990475|P2|COMPLETED|Overall Study||4
415264|NCT00839436|990476|P1|COMPLETED|Overall Study||2
415265|NCT00839436|990474|P3|STARTED|Overall Study||1
415266|NCT00839436|990475|P2|STARTED|Overall Study||5
415267|NCT00839436|990476|P1|STARTED|Overall Study||3
415268|NCT00839423|990488|P4|NOT COMPLETED|Overall Study||20
415269|NCT00839423|990489|P3|NOT COMPLETED|Overall Study||18
415270|NCT00839423|990490|P2|NOT COMPLETED|Overall Study||10
415271|NCT00839423|990491|P1|NOT COMPLETED|Overall Study||18
415272|NCT00839423|990488|P4|COMPLETED|Overall Study||93
415273|NCT00839423|990489|P3|COMPLETED|Overall Study||82
415274|NCT00839423|990490|P2|COMPLETED|Overall Study||98
415275|NCT00839423|990491|P1|COMPLETED|Overall Study||87
415276|NCT00839423|990488|P4|STARTED|Overall Study||113
415277|NCT00839423|990489|P3|STARTED|Overall Study||100
415278|NCT00839423|990490|P2|STARTED|Overall Study||108
415279|NCT00839423|990491|P1|STARTED|Overall Study||105
415280|NCT00839319|990534|P5|NOT COMPLETED|Overall Study||0
415281|NCT00839319|990535|P4|NOT COMPLETED|Overall Study||3
415282|NCT00839319|990536|P3|NOT COMPLETED|Overall Study||3
415283|NCT00839319|990537|P2|NOT COMPLETED|Overall Study||1
415284|NCT00839319|990538|P1|NOT COMPLETED|Overall Study||2
415285|NCT00839319|990534|P5|COMPLETED|Overall Study||8
415286|NCT00839319|990535|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
415287|NCT00839319|990536|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
415288|NCT00839319|990537|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
415289|NCT00839319|990538|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
415290|NCT00839319|990534|P5|STARTED|Overall Study||8
415291|NCT00839319|990535|P4|STARTED|Overall Study||8
415292|NCT00839319|990536|P3|STARTED|Overall Study||8
415293|NCT00839319|990537|P2|STARTED|Overall Study||8
415294|NCT00839319|990538|P1|STARTED|Overall Study||8
415295|NCT00839306|990567|P2|NOT COMPLETED|Overall Study||43
415296|NCT00839306|990568|P1|NOT COMPLETED|Overall Study||25
415297|NCT00839306|990567|P2|COMPLETED|Overall Study||134
415298|NCT00839306|990568|P1|COMPLETED|Overall Study||35
415299|NCT00839306|990567|P2|STARTED|Overall Study|Treated|177
415300|NCT00839306|990568|P1|STARTED|Overall Study|Treated|60
415301|NCT00839241|990578|P2|NOT COMPLETED|Overall Study||17
415302|NCT00839241|990579|P1|NOT COMPLETED|Overall Study||5
415303|NCT00839241|990578|P2|COMPLETED|Overall Study||8
415304|NCT00839241|990579|P1|COMPLETED|Overall Study||15
415305|NCT00839241|990578|P2|STARTED|Overall Study||25
415307|NCT00839098|990666|P3|NOT COMPLETED|Overall Study||7
415308|NCT00839098|990667|P2|NOT COMPLETED|Overall Study||1
415309|NCT00839098|990668|P1|NOT COMPLETED|Overall Study||2
415310|NCT00839098|990666|P3|COMPLETED|Overall Study||6
415311|NCT00839098|990667|P2|COMPLETED|Overall Study||11
415312|NCT00839098|990668|P1|COMPLETED|Overall Study||1
415313|NCT00839098|990666|P3|STARTED|Overall Study||13
415314|NCT00839098|990667|P2|STARTED|Overall Study||12
415315|NCT00839098|990668|P1|STARTED|Overall Study||3
415316|NCT00839072|990694|P2|NOT COMPLETED|Second Intervention Period||0
415317|NCT00839072|990695|P1|NOT COMPLETED|Second Intervention Period||1
415318|NCT00839072|990694|P2|COMPLETED|Second Intervention Period||11
415319|NCT00839072|990695|P1|COMPLETED|Second Intervention Period||9
415320|NCT00839072|990694|P2|STARTED|Second Intervention Period||11
415321|NCT00839072|990695|P1|STARTED|Second Intervention Period||10
415322|NCT00839072|990694|P2|NOT COMPLETED|Washout Period of 7 Days||0
415323|NCT00839072|990695|P1|NOT COMPLETED|Washout Period of 7 Days||0
415324|NCT00839072|990694|P2|COMPLETED|Washout Period of 7 Days||11
415325|NCT00839072|990695|P1|COMPLETED|Washout Period of 7 Days||10
415326|NCT00839072|990694|P2|STARTED|Washout Period of 7 Days||11
415327|NCT00839072|990695|P1|STARTED|Washout Period of 7 Days||10
415328|NCT00839072|990694|P2|NOT COMPLETED|First Intervention Period||1
415329|NCT00839072|990695|P1|NOT COMPLETED|First Intervention Period||2
415330|NCT00839072|990694|P2|COMPLETED|First Intervention Period||11
415331|NCT00839072|990695|P1|COMPLETED|First Intervention Period||10
415332|NCT00839072|990694|P2|STARTED|First Intervention Period||12
415333|NCT00839072|990695|P1|STARTED|First Intervention Period||12
415334|NCT00838929|990714|P3|NOT COMPLETED|Overall Study||1
415335|NCT00838929|990715|P2|NOT COMPLETED|Overall Study||3
415336|NCT00838929|990716|P1|NOT COMPLETED|Overall Study||0
415337|NCT00838929|990714|P3|COMPLETED|Overall Study||5
415338|NCT00838929|990715|P2|COMPLETED|Overall Study||5
415339|NCT00838929|990716|P1|COMPLETED|Overall Study||3
415340|NCT00838929|990714|P3|STARTED|Overall Study||6
415341|NCT00838929|990715|P2|STARTED|Overall Study||8
415342|NCT00838929|990716|P1|STARTED|Overall Study||3
415343|NCT00838916|990724|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
415344|NCT00838916|990725|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
415345|NCT00838916|990724|P2|COMPLETED|Follow-up Period (8 Weeks)||190
415346|NCT00838916|990725|P1|COMPLETED|Follow-up Period (8 Weeks)||408
415347|NCT00838916|990724|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
415348|NCT00838916|990725|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
415349|NCT00838916|990724|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
415350|NCT00838916|990725|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
415351|NCT00838916|990724|P2|COMPLETED|Treatment Period (156 Weeks)||164
415352|NCT00838916|990725|P1|COMPLETED|Treatment Period (156 Weeks)||308
415353|NCT00838916|990724|P2|STARTED|Treatment Period (156 Weeks)||241
415354|NCT00838916|990725|P1|STARTED|Treatment Period (156 Weeks)||504
415355|NCT00838903|990754|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
415356|NCT00838903|990755|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
415357|NCT00838903|990756|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
415358|NCT00838903|990757|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
415359|NCT00838903|990754|P4|COMPLETED|Follow-up Period (8 Weeks)||244
415360|NCT00838903|990755|P3|COMPLETED|Follow-up Period (8 Weeks)||243
415361|NCT00838903|990756|P2|COMPLETED|Follow-up Period (8 Weeks)||237
415362|NCT00838903|990757|P1|COMPLETED|Follow-up Period (8 Weeks)||75
415363|NCT00838903|990754|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
415364|NCT00838903|990755|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
415365|NCT00838903|990756|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
415366|NCT00838903|990757|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
415367|NCT00838903|990754|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
415368|NCT00838903|990755|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
415369|NCT00838903|990756|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
415370|NCT00838903|990757|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
415371|NCT00838903|990754|P4|COMPLETED|Treatment Period (156 Weeks)||192
415372|NCT00838903|990755|P3|COMPLETED|Treatment Period (156 Weeks)||191
415373|NCT00838903|990756|P2|COMPLETED|Treatment Period (156 Weeks)||190
415374|NCT00838903|990757|P1|COMPLETED|Treatment Period (156 Weeks)||55
415375|NCT00838903|990754|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
415376|NCT00838903|990755|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
415377|NCT00838903|990756|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
415378|NCT00838903|990757|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
415379|NCT00838903|990754|P4|STARTED|Treatment Period (156 Weeks)||302
415380|NCT00838903|990755|P3|STARTED|Treatment Period (156 Weeks)||307
415381|NCT00838903|990756|P2|STARTED|Treatment Period (156 Weeks)||302
415382|NCT00838903|990757|P1|STARTED|Treatment Period (156 Weeks)||101
415383|NCT00838682|990801|P2|NOT COMPLETED|Overall Study||19
415384|NCT00838682|990802|P1|NOT COMPLETED|Overall Study||25
415385|NCT00838682|990801|P2|COMPLETED|Overall Study||33
415386|NCT00838682|990802|P1|COMPLETED|Overall Study||29
415387|NCT00838682|990801|P2|STARTED|Overall Study||52
415388|NCT00838682|990802|P1|STARTED|Overall Study||54
415389|NCT00838630|990820|P2|NOT COMPLETED|Second Intervention||0
415390|NCT00838630|990821|P1|NOT COMPLETED|Second Intervention||0
415391|NCT00838630|990820|P2|COMPLETED|Second Intervention||18
415392|NCT00838630|990821|P1|COMPLETED|Second Intervention||16
415393|NCT00838630|990820|P2|STARTED|Second Intervention||18
415394|NCT00838630|990821|P1|STARTED|Second Intervention||16
415395|NCT00838630|990820|P2|NOT COMPLETED|Washout: 7 Days||0
415396|NCT00838630|990821|P1|NOT COMPLETED|Washout: 7 Days||1
415397|NCT00838630|990820|P2|COMPLETED|Washout: 7 Days||18
415398|NCT00838630|990821|P1|COMPLETED|Washout: 7 Days||16
415399|NCT00838630|990820|P2|STARTED|Washout: 7 Days||18
415400|NCT00838630|990821|P1|STARTED|Washout: 7 Days||17
415401|NCT00838630|990820|P2|NOT COMPLETED|First Intervention||0
415402|NCT00838630|990821|P1|NOT COMPLETED|First Intervention||1
415403|NCT00838630|990820|P2|COMPLETED|First Intervention||18
415404|NCT00838630|990821|P1|COMPLETED|First Intervention||17
415405|NCT00838630|990820|P2|STARTED|First Intervention||18
415406|NCT00838630|990821|P1|STARTED|First Intervention||18
415407|NCT00838578|990829|P1|NOT COMPLETED|Overall Study||2
415408|NCT00838578|990829|P1|COMPLETED|Overall Study||63
415409|NCT00838578|990829|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
415410|NCT00838526|990839|P2|NOT COMPLETED|Overall Study||39
415411|NCT00838526|990840|P1|NOT COMPLETED|Overall Study||24
415412|NCT00838526|990839|P2|COMPLETED|Overall Study||137
415413|NCT00838526|990840|P1|COMPLETED|Overall Study||35
415414|NCT00838526|990839|P2|STARTED|Overall Study|Treated|176
415415|NCT00838526|990840|P1|STARTED|Overall Study|Treated|59
415416|NCT00838513|990848|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
415417|NCT00838513|990848|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
415418|NCT00838513|990848|P1|STARTED|Post Treatment Period (Patients Who Disc||5
415419|NCT00838513|990848|P1|NOT COMPLETED|Extension Treatment Period||1
415420|NCT00838513|990848|P1|COMPLETED|Extension Treatment Period||18
415421|NCT00838513|990848|P1|STARTED|Extension Treatment Period||19
415422|NCT00838513|990848|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
415423|NCT00838513|990848|P1|COMPLETED|Treatment Period (26 Weeks)||20
415424|NCT00838513|990848|P1|STARTED|Treatment Period (26 Weeks)||20
415425|NCT00838513|990848|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
415426|NCT00838513|990848|P1|COMPLETED|Observation Period (8 Weeks)||20
415427|NCT00838513|990848|P1|STARTED|Observation Period (8 Weeks)||20
415428|NCT00838513|990848|P1|NOT COMPLETED|Screening Period||3
415429|NCT00838513|990848|P1|COMPLETED|Screening Period||20
415430|NCT00838513|990848|P1|STARTED|Screening Period||23
415431|NCT00838331|990864|P1|NOT COMPLETED|Aged Blood Transfusion||9
415432|NCT00838331|990864|P1|COMPLETED|Aged Blood Transfusion||8
415433|NCT00838331|990864|P1|STARTED|Aged Blood Transfusion||17
415434|NCT00838331|990864|P1|NOT COMPLETED|Fresh Blood Transfusion||0
415435|NCT00838331|990864|P1|COMPLETED|Fresh Blood Transfusion||17
415436|NCT00838331|990864|P1|STARTED|Fresh Blood Transfusion||17
415437|NCT00838279|990870|P2|NOT COMPLETED|Second Intervention||0
415438|NCT00838279|990871|P1|NOT COMPLETED|Second Intervention||0
415439|NCT00838279|990870|P2|COMPLETED|Second Intervention||15
415440|NCT00838279|990871|P1|COMPLETED|Second Intervention||15
415441|NCT00838279|990870|P2|STARTED|Second Intervention||15
415442|NCT00838279|990871|P1|STARTED|Second Intervention||15
415443|NCT00838279|990870|P2|NOT COMPLETED|Washout||1
415444|NCT00838279|990871|P1|NOT COMPLETED|Washout||1
415445|NCT00838279|990870|P2|COMPLETED|Washout||15
415446|NCT00838279|990871|P1|COMPLETED|Washout||15
415447|NCT00838279|990870|P2|STARTED|Washout||16
415448|NCT00838279|990871|P1|STARTED|Washout||16
415449|NCT00838279|990870|P2|NOT COMPLETED|First Intervention||0
415450|NCT00838279|990871|P1|NOT COMPLETED|First Intervention||0
415451|NCT00838279|990870|P2|COMPLETED|First Intervention||16
415452|NCT00838279|990871|P1|COMPLETED|First Intervention||16
415453|NCT00838279|990870|P2|STARTED|First Intervention||16
415454|NCT00838279|990871|P1|STARTED|First Intervention||16
415455|NCT00838201|990881|P2|NOT COMPLETED|Overall Study||53
415456|NCT00838201|990882|P1|NOT COMPLETED|Overall Study||42
415457|NCT00838201|990881|P2|COMPLETED|Overall Study||145
415458|NCT00838201|990882|P1|COMPLETED|Overall Study||144
415459|NCT00838201|990881|P2|STARTED|Overall Study||198
415460|NCT00838201|990882|P1|STARTED|Overall Study||186
415461|NCT00838162|990892|P4|NOT COMPLETED|Overall Study||0
415462|NCT00838162|990893|P3|NOT COMPLETED|Overall Study||0
415463|NCT00838162|990894|P2|NOT COMPLETED|Overall Study||0
415464|NCT00838162|990895|P1|NOT COMPLETED|Overall Study||0
415465|NCT00838162|990892|P4|COMPLETED|Overall Study||8
415466|NCT00838162|990893|P3|COMPLETED|Overall Study||8
415467|NCT00838162|990894|P2|COMPLETED|Overall Study||8
415468|NCT00838162|990895|P1|COMPLETED|Overall Study||9
415469|NCT00838162|990892|P4|STARTED|Overall Study||8
415470|NCT00838162|990893|P3|STARTED|Overall Study||8
415471|NCT00838162|990894|P2|STARTED|Overall Study||8
415472|NCT00838162|990895|P1|STARTED|Overall Study||9
415473|NCT00838136|990939|P2|NOT COMPLETED|Second Intervention||1
415474|NCT00838136|990940|P1|NOT COMPLETED|Second Intervention||0
415475|NCT00838136|990939|P2|COMPLETED|Second Intervention||15
415476|NCT00838136|990940|P1|COMPLETED|Second Intervention||16
415477|NCT00838136|990939|P2|STARTED|Second Intervention||16
415478|NCT00838136|990940|P1|STARTED|Second Intervention||16
415479|NCT00838136|990939|P2|NOT COMPLETED|First Intervention||0
415480|NCT00838136|990940|P1|NOT COMPLETED|First Intervention||0
415481|NCT00838136|990939|P2|COMPLETED|First Intervention||16
415482|NCT00838136|990940|P1|COMPLETED|First Intervention||16
415483|NCT00838136|990939|P2|STARTED|First Intervention||16
415484|NCT00838136|990940|P1|STARTED|First Intervention||16
415485|NCT00838110|990950|P4|NOT COMPLETED|Overall Study||18
415486|NCT00838110|990951|P3|NOT COMPLETED|Overall Study||17
415487|NCT00838110|990952|P2|NOT COMPLETED|Overall Study||22
415488|NCT00838110|990953|P1|NOT COMPLETED|Overall Study||22
415489|NCT00838110|990950|P4|COMPLETED|Overall Study||226
415490|NCT00838110|990951|P3|COMPLETED|Overall Study||226
415491|NCT00838110|990952|P2|COMPLETED|Overall Study||106
415492|NCT00838110|990953|P1|COMPLETED|Overall Study||105
415493|NCT00838110|990950|P4|Treated|Overall Study||244
415494|NCT00838110|990951|P3|Treated|Overall Study||243
415495|NCT00838110|990952|P2|Treated|Overall Study||127
415496|NCT00838110|990953|P1|Treated|Overall Study||127
415497|NCT00838110|990950|P4|STARTED|Overall Study||244
415498|NCT00838110|990951|P3|STARTED|Overall Study||243
415499|NCT00838110|990952|P2|STARTED|Overall Study||128
415500|NCT00838110|990953|P1|STARTED|Overall Study||127
415501|NCT00838097|990973|P1|NOT COMPLETED|Overall Study||176
415502|NCT00838097|990973|P1|COMPLETED|Overall Study||145
415503|NCT00838097|990973|P1|Received Darbepoetin Alfa|Overall Study||319
415504|NCT00838097|990973|P1|STARTED|Overall Study||321
415505|NCT00837967|990981|P2|NOT COMPLETED|Second Intervention||0
415506|NCT00837967|990982|P1|NOT COMPLETED|Second Intervention||0
415507|NCT00837967|990981|P2|COMPLETED|Second Intervention||12
415508|NCT00837967|990982|P1|COMPLETED|Second Intervention||11
415509|NCT00837967|990981|P2|STARTED|Second Intervention||12
415510|NCT00837967|990982|P1|STARTED|Second Intervention||11
415511|NCT00837967|990981|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
415512|NCT00837967|990982|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
415513|NCT00837967|990981|P2|COMPLETED|Washout Period of 7 - 14 Days||12
415514|NCT00837967|990982|P1|COMPLETED|Washout Period of 7 - 14 Days||11
415515|NCT00837967|990981|P2|STARTED|Washout Period of 7 - 14 Days||12
415516|NCT00837967|990982|P1|STARTED|Washout Period of 7 - 14 Days||13
415517|NCT00837967|990981|P2|NOT COMPLETED|First Intervention||0
415518|NCT00837967|990982|P1|NOT COMPLETED|First Intervention||0
415519|NCT00837967|990981|P2|COMPLETED|First Intervention||12
415520|NCT00837967|990982|P1|COMPLETED|First Intervention||13
415521|NCT00837967|990981|P2|STARTED|First Intervention||12
415522|NCT00837967|990982|P1|STARTED|First Intervention||13
415523|NCT00837876|990998|P1|NOT COMPLETED|Overall Study||37
415524|NCT00837876|990998|P1|COMPLETED|Overall Study||0
415525|NCT00837876|990998|P1|STARTED|Overall Study||37
415526|NCT00837824|991007|P2|NOT COMPLETED|Overall Study||0
415527|NCT00837824|991008|P1|NOT COMPLETED|Overall Study||0
415528|NCT00837824|991007|P2|COMPLETED|Overall Study||9
415529|NCT00837824|991008|P1|COMPLETED|Overall Study||11
415530|NCT00837824|991007|P2|STARTED|Overall Study||9
415531|NCT00837824|991008|P1|STARTED|Overall Study||11
415532|NCT00837759|991017|P1|NOT COMPLETED|Overall Study||4
415533|NCT00837759|991017|P1|COMPLETED|Overall Study||3
415534|NCT00837759|991017|P1|STARTED|Overall Study||7
415535|NCT00837616|991028|P2|NOT COMPLETED|Overall Study||1
415536|NCT00837616|991029|P1|NOT COMPLETED|Overall Study||0
415537|NCT00837616|991028|P2|COMPLETED|Overall Study||20
415538|NCT00837616|991029|P1|COMPLETED|Overall Study||20
415539|NCT00837616|991028|P2|STARTED|Overall Study||21
415540|NCT00837616|991029|P1|STARTED|Overall Study||20
415541|NCT00837577|991055|P2|NOT COMPLETED|Open-label Period||9
415542|NCT00837577|991056|P1|NOT COMPLETED|Open-label Period||8
415543|NCT00837577|991055|P2|COMPLETED|Open-label Period||54
415544|NCT00837577|991056|P1|COMPLETED|Open-label Period||60
415545|NCT00837577|991055|P2|STARTED|Open-label Period||63
415546|NCT00837577|991056|P1|STARTED|Open-label Period||68
415547|NCT00837577|991055|P2|NOT COMPLETED|Double-blind Period||0
415548|NCT00837577|991056|P1|NOT COMPLETED|Double-blind Period||2
415549|NCT00837577|991055|P2|COMPLETED|Double-blind Period||63
415550|NCT00837577|991056|P1|COMPLETED|Double-blind Period||68
415551|NCT00837577|991055|P2|STARTED|Double-blind Period||63
415552|NCT00837577|991056|P1|STARTED|Double-blind Period||70
415553|NCT00837512|991067|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
415554|NCT00837512|991068|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
415555|NCT00837512|991067|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
415556|NCT00837512|991068|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
415557|NCT00837512|991067|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
415558|NCT00837512|991068|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
415559|NCT00837512|991067|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
415560|NCT00837512|991068|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
415561|NCT00837512|991067|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
415562|NCT00837512|991068|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
415563|NCT00837512|991067|P2|STARTED|Both Arms: Washout (7-28 Days)||8
415564|NCT00837512|991068|P1|STARTED|Both Arms: Washout (7-28 Days)||8
415565|NCT00837512|991067|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
415566|NCT00837512|991068|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
415567|NCT00837512|991067|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
415568|NCT00837512|991068|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
415569|NCT00837512|991067|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
415570|NCT00837512|991068|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
415571|NCT00837486|991076|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
415572|NCT00837486|991077|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
415573|NCT00837486|991076|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
415574|NCT00837486|991077|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
415575|NCT00837486|991076|P2|STARTED|Long-term Follow-up Phase - Open Label||0
415576|NCT00837486|991077|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
415577|NCT00837486|991076|P2|NOT COMPLETED|Blinded-treatment Phase||0
415578|NCT00837486|991077|P1|NOT COMPLETED|Blinded-treatment Phase||1
415579|NCT00837486|991076|P2|COMPLETED|Blinded-treatment Phase||14
415580|NCT00837486|991077|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
415581|NCT00837486|991076|P2|STARTED|Blinded-treatment Phase||14
415582|NCT00837486|991077|P1|STARTED|Blinded-treatment Phase||16
415583|NCT00837447|991089|P1|NOT COMPLETED|Overall Study||0
415584|NCT00837447|991089|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
415585|NCT00837447|991089|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
415586|NCT00837434|991096|P2|NOT COMPLETED|Overall Study||1
415587|NCT00837434|991097|P1|NOT COMPLETED|Overall Study||9
415588|NCT00837434|991096|P2|COMPLETED|Overall Study||19
415589|NCT00837434|991097|P1|COMPLETED|Overall Study||34
415590|NCT00837434|991096|P2|STARTED|Overall Study||20
415591|NCT00837434|991097|P1|STARTED|Overall Study||43
415592|NCT00837330|991117|P2|NOT COMPLETED|Overall Study||3
415593|NCT00837330|991118|P1|NOT COMPLETED|Overall Study||1
415594|NCT00837330|991117|P2|COMPLETED|Overall Study||7
415595|NCT00837330|991118|P1|COMPLETED|Overall Study||9
415596|NCT00837330|991117|P2|STARTED|Overall Study||10
415597|NCT00837330|991118|P1|STARTED|Overall Study||10
415598|NCT00837252|991124|P1|NOT COMPLETED|Overall Study||0
415599|NCT00837252|991124|P1|COMPLETED|Overall Study||5
415600|NCT00837252|991124|P1|STARTED|Overall Study||5
415601|NCT00837213|991141|P2|NOT COMPLETED|Overall Study||5
415602|NCT00837213|991142|P1|NOT COMPLETED|Overall Study||6
415603|NCT00837213|991141|P2|COMPLETED|Overall Study||12
415604|NCT00837213|991142|P1|COMPLETED|Overall Study||10
415605|NCT00837213|991141|P2|STARTED|Overall Study||17
415606|NCT00837213|991142|P1|STARTED|Overall Study||16
415607|NCT00837200|991162|P1|NOT COMPLETED|Overall Study||0
415608|NCT00837200|991162|P1|COMPLETED|Overall Study||13
415609|NCT00837200|991162|P1|STARTED|Overall Study||13
415610|NCT00837161|991168|P1|NOT COMPLETED|Overall Study||2
415611|NCT00837161|991168|P1|COMPLETED|Overall Study||9
415612|NCT00837161|991168|P1|STARTED|Overall Study||11
415613|NCT00837148|991176|P1|NOT COMPLETED|Overall Study||2
415614|NCT00837148|991176|P1|COMPLETED|Overall Study||35
415615|NCT00837148|991176|P1|STARTED|Overall Study||37
415616|NCT00837031|991180|P1|NOT COMPLETED|Overall Study||0
415617|NCT00837031|991180|P1|COMPLETED|Overall Study||72
415618|NCT00837031|991180|P1|STARTED|Overall Study||72
415619|NCT00836953|991186|P1|NOT COMPLETED|Overall Study||2
415620|NCT00836953|991186|P1|COMPLETED|Overall Study||31
415621|NCT00836953|991186|P1|STARTED|Overall Study||33
415622|NCT00836901|991194|P2|NOT COMPLETED|Second Intervention||0
415623|NCT00836901|991195|P1|NOT COMPLETED|Second Intervention||0
415624|NCT00836901|991194|P2|COMPLETED|Second Intervention||28
415625|NCT00836901|991195|P1|COMPLETED|Second Intervention||23
415626|NCT00836901|991194|P2|STARTED|Second Intervention||28
415627|NCT00836901|991195|P1|STARTED|Second Intervention||23
415628|NCT00836901|991194|P2|NOT COMPLETED|First Intervention||0
415629|NCT00836901|991195|P1|NOT COMPLETED|First Intervention||1
415630|NCT00836901|991194|P2|COMPLETED|First Intervention||28
415631|NCT00836901|991195|P1|COMPLETED|First Intervention||23
415632|NCT00836901|991194|P2|STARTED|First Intervention||28
415633|NCT00836901|991195|P1|STARTED|First Intervention||24
415634|NCT00836875|991211|P2|NOT COMPLETED|Overall Study||3
415635|NCT00836875|991212|P1|NOT COMPLETED|Overall Study||3
415636|NCT00836875|991211|P2|COMPLETED|Overall Study||17
415637|NCT00836875|991212|P1|COMPLETED|Overall Study||8
415638|NCT00836875|991211|P2|STARTED|Overall Study||20
415639|NCT00836875|991212|P1|STARTED|Overall Study||11
415640|NCT00836745|991226|P1|NOT COMPLETED|Overall Study||21
415641|NCT00836745|991226|P1|COMPLETED|Overall Study||15
415642|NCT00836745|991226|P1|STARTED|Overall Study||36
415643|NCT00836719|991233|P1|NOT COMPLETED|Overall Study||0
415644|NCT00836719|991233|P1|COMPLETED|Overall Study||10
415645|NCT00836719|991233|P1|STARTED|Overall Study||10
415646|NCT00836706|991240|P2|NOT COMPLETED|Second Intervention||0
415647|NCT00836706|991241|P1|NOT COMPLETED|Second Intervention||0
415648|NCT00836706|991240|P2|COMPLETED|Second Intervention||11
415649|NCT00836706|991241|P1|COMPLETED|Second Intervention||11
415650|NCT00836706|991240|P2|STARTED|Second Intervention||11
415651|NCT00836706|991241|P1|STARTED|Second Intervention||11
415652|NCT00836706|991240|P2|NOT COMPLETED|Washout: 7 Days||1
415653|NCT00836706|991241|P1|NOT COMPLETED|Washout: 7 Days||0
415654|NCT00836706|991240|P2|COMPLETED|Washout: 7 Days||11
415655|NCT00836706|991241|P1|COMPLETED|Washout: 7 Days||11
415656|NCT00836706|991240|P2|STARTED|Washout: 7 Days||12
415657|NCT00836706|991241|P1|STARTED|Washout: 7 Days||11
415658|NCT00836706|991240|P2|NOT COMPLETED|First Intervention||0
415659|NCT00836706|991241|P1|NOT COMPLETED|First Intervention||0
415660|NCT00836706|991240|P2|COMPLETED|First Intervention||12
415661|NCT00836706|991241|P1|COMPLETED|First Intervention||11
415662|NCT00836706|991240|P2|STARTED|First Intervention||12
415663|NCT00836706|991241|P1|STARTED|First Intervention||11
415664|NCT00836693|991251|P2|NOT COMPLETED|Overall Study||6
415665|NCT00836693|991252|P1|NOT COMPLETED|Overall Study||17
415666|NCT00836693|991251|P2|COMPLETED|Overall Study||64
415667|NCT00836693|991252|P1|COMPLETED|Overall Study||130
415668|NCT00836693|991251|P2|STARTED|Overall Study||70
415669|NCT00836693|991252|P1|STARTED|Overall Study||147
415670|NCT00836641|991294|P2|NOT COMPLETED|Overall Study||0
415671|NCT00836641|991295|P1|NOT COMPLETED|Overall Study||0
415672|NCT00836641|991294|P2|COMPLETED|Overall Study||34
415673|NCT00836641|991295|P1|COMPLETED|Overall Study||36
415674|NCT00836641|991294|P2|STARTED|Overall Study||34
415675|NCT00836641|991295|P1|STARTED|Overall Study||36
415676|NCT00836498|991304|P2|NOT COMPLETED|Overall Study||1
415677|NCT00836498|991305|P1|NOT COMPLETED|Overall Study||4
415678|NCT00836498|991304|P2|COMPLETED|Overall Study||21
415679|NCT00836498|991305|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
415680|NCT00836498|991304|P2|STARTED|Overall Study||22
415681|NCT00836498|991305|P1|STARTED|Overall Study||44
415682|NCT00836472|991337|P2|NOT COMPLETED|Second Intervention||0
415683|NCT00836472|991338|P1|NOT COMPLETED|Second Intervention||0
415684|NCT00836472|991337|P2|COMPLETED|Second Intervention||27
415685|NCT00836472|991338|P1|COMPLETED|Second Intervention||28
415686|NCT00836472|991337|P2|STARTED|Second Intervention||27
415687|NCT00836472|991338|P1|STARTED|Second Intervention||28
415688|NCT00836472|991337|P2|NOT COMPLETED|Washout||3
415689|NCT00836472|991338|P1|NOT COMPLETED|Washout||2
415690|NCT00836472|991337|P2|COMPLETED|Washout||27
415691|NCT00836472|991338|P1|COMPLETED|Washout||28
415692|NCT00836472|991337|P2|STARTED|Washout||30
415693|NCT00836472|991338|P1|STARTED|Washout||30
415694|NCT00836472|991337|P2|NOT COMPLETED|First Intervention||0
415695|NCT00836472|991338|P1|NOT COMPLETED|First Intervention||0
415696|NCT00836472|991337|P2|COMPLETED|First Intervention||30
415697|NCT00836472|991338|P1|COMPLETED|First Intervention||30
415698|NCT00836472|991337|P2|STARTED|First Intervention||30
415699|NCT00836472|991338|P1|STARTED|First Intervention||30
415700|NCT00836433|991354|P2|NOT COMPLETED|Overall Study||7
415701|NCT00836433|991355|P1|NOT COMPLETED|Overall Study||12
415702|NCT00836433|991354|P2|COMPLETED|Overall Study||321
415703|NCT00836433|991355|P1|COMPLETED|Overall Study||349
415704|NCT00836433|991354|P2|STARTED|Overall Study||328
415705|NCT00836433|991355|P1|STARTED|Overall Study||361
415706|NCT00836407|991365|P2|NOT COMPLETED|Overall Study||8
415707|NCT00836407|991366|P1|NOT COMPLETED|Overall Study||11
415708|NCT00836407|991365|P2|COMPLETED|Overall Study||7
415709|NCT00836407|991366|P1|COMPLETED|Overall Study||4
415710|NCT00836407|991365|P2|STARTED|Overall Study||15
415711|NCT00836407|991366|P1|STARTED|Overall Study||15
415712|NCT00836355|991378|P4|NOT COMPLETED|Overall Study||0
415713|NCT00836355|991379|P3|NOT COMPLETED|Overall Study||0
415714|NCT00836355|991380|P2|NOT COMPLETED|Overall Study||0
415715|NCT00836355|991381|P1|NOT COMPLETED|Overall Study||0
415716|NCT00836355|991378|P4|COMPLETED|Overall Study||2
415717|NCT00836355|991379|P3|COMPLETED|Overall Study||0
415718|NCT00836355|991380|P2|COMPLETED|Overall Study||4
415719|NCT00836355|991381|P1|COMPLETED|Overall Study||0
415720|NCT00836355|991378|P4|STARTED|Overall Study||2
415721|NCT00836355|991379|P3|STARTED|Overall Study||0
415722|NCT00836355|991380|P2|STARTED|Overall Study||4
415723|NCT00836355|991381|P1|STARTED|Overall Study||0
415724|NCT00836342|991402|P3|NOT COMPLETED|Overall Study||0
415725|NCT00836342|991403|P2|NOT COMPLETED|Overall Study||0
415726|NCT00836342|991404|P1|NOT COMPLETED|Overall Study||0
415727|NCT00836342|991402|P3|COMPLETED|Overall Study||36
415728|NCT00836342|991403|P2|COMPLETED|Overall Study||23
415729|NCT00836342|991404|P1|COMPLETED|Overall Study||22
415730|NCT00836342|991402|P3|STARTED|Overall Study||36
415731|NCT00836342|991403|P2|STARTED|Overall Study||23
415732|NCT00836342|991404|P1|STARTED|Overall Study||22
415733|NCT00836277|991415|P1|NOT COMPLETED|Overall Study||6
415734|NCT00836277|991415|P1|COMPLETED|Overall Study||18
415735|NCT00836277|991415|P1|STARTED|Overall Study||24
415736|NCT00836095|991425|P2|NOT COMPLETED|Overall Study||3
415737|NCT00836095|991426|P1|NOT COMPLETED|Overall Study||0
415738|NCT00836095|991425|P2|COMPLETED|Overall Study||27
415739|NCT00836095|991426|P1|COMPLETED|Overall Study||22
415740|NCT00836095|991425|P2|STARTED|Overall Study||30
415741|NCT00836095|991426|P1|STARTED|Overall Study||22
415742|NCT00836056|991436|P2|NOT COMPLETED|Second Intervention||0
415743|NCT00836056|991437|P1|NOT COMPLETED|Second Intervention||0
415744|NCT00836056|991436|P2|COMPLETED|Second Intervention||12
415745|NCT00836056|991437|P1|COMPLETED|Second Intervention||11
415746|NCT00836056|991436|P2|STARTED|Second Intervention||12
415747|NCT00836056|991437|P1|STARTED|Second Intervention||11
415748|NCT00836056|991436|P2|NOT COMPLETED|Washout: 7 Days||0
415749|NCT00836056|991437|P1|NOT COMPLETED|Washout: 7 Days||0
415750|NCT00836056|991436|P2|COMPLETED|Washout: 7 Days||12
415751|NCT00836056|991437|P1|COMPLETED|Washout: 7 Days||11
415752|NCT00836056|991436|P2|STARTED|Washout: 7 Days||12
415753|NCT00836056|991437|P1|STARTED|Washout: 7 Days||11
415754|NCT00836056|991436|P2|NOT COMPLETED|First Intervention||0
415755|NCT00836056|991437|P1|NOT COMPLETED|First Intervention||1
415756|NCT00836056|991436|P2|COMPLETED|First Intervention||12
415757|NCT00836056|991437|P1|COMPLETED|First Intervention||11
415758|NCT00836056|991436|P2|STARTED|First Intervention||12
415759|NCT00836056|991437|P1|STARTED|First Intervention||12
415760|NCT00836017|991445|P1|NOT COMPLETED|Overall Study||544
415761|NCT00836017|991445|P1|COMPLETED|Overall Study||502
415762|NCT00836017|991445|P1|STARTED|Overall Study||1046
415763|NCT00836004|991455|P2|NOT COMPLETED|Second Intervention||0
415764|NCT00836004|991456|P1|NOT COMPLETED|Second Intervention||0
415765|NCT00836004|991455|P2|COMPLETED|Second Intervention||12
415766|NCT00836004|991456|P1|COMPLETED|Second Intervention||12
415767|NCT00836004|991455|P2|STARTED|Second Intervention||12
415768|NCT00836004|991456|P1|STARTED|Second Intervention||12
415769|NCT00836004|991455|P2|NOT COMPLETED|Washout: 7 Days||0
415770|NCT00836004|991456|P1|NOT COMPLETED|Washout: 7 Days||0
415771|NCT00836004|991455|P2|COMPLETED|Washout: 7 Days||12
415772|NCT00836004|991456|P1|COMPLETED|Washout: 7 Days||12
415773|NCT00836004|991455|P2|STARTED|Washout: 7 Days||12
415774|NCT00836004|991456|P1|STARTED|Washout: 7 Days||12
415775|NCT00836004|991455|P2|NOT COMPLETED|First Intervention||0
415776|NCT00836004|991456|P1|NOT COMPLETED|First Intervention||0
415777|NCT00836004|991455|P2|COMPLETED|First Intervention||12
415778|NCT00836004|991456|P1|COMPLETED|First Intervention||12
415779|NCT00836004|991455|P2|STARTED|First Intervention||12
415780|NCT00836004|991456|P1|STARTED|First Intervention||12
415781|NCT00835991|991466|P2|NOT COMPLETED|Second Intervention||0
415782|NCT00835991|991467|P1|NOT COMPLETED|Second Intervention||0
415783|NCT00835991|991466|P2|COMPLETED|Second Intervention||26
415784|NCT00835991|991467|P1|COMPLETED|Second Intervention||27
415785|NCT00835991|991466|P2|STARTED|Second Intervention||26
415786|NCT00835991|991467|P1|STARTED|Second Intervention||27
415787|NCT00835991|991466|P2|NOT COMPLETED|Washout||3
415788|NCT00835991|991467|P1|NOT COMPLETED|Washout||3
415789|NCT00835991|991466|P2|COMPLETED|Washout||26
415790|NCT00835991|991467|P1|COMPLETED|Washout||27
415791|NCT00835991|991466|P2|STARTED|Washout||29
415792|NCT00835991|991467|P1|STARTED|Washout||30
415793|NCT00835991|991466|P2|NOT COMPLETED|First Intervention||1
415794|NCT00835991|991467|P1|NOT COMPLETED|First Intervention||0
415795|NCT00835991|991466|P2|COMPLETED|First Intervention||29
415796|NCT00835991|991467|P1|COMPLETED|First Intervention||30
415797|NCT00835991|991466|P2|STARTED|First Intervention||30
415798|NCT00835991|991467|P1|STARTED|First Intervention||30
415799|NCT00835978|991485|P4|NOT COMPLETED|Overall Study||10
415800|NCT00835978|991486|P3|NOT COMPLETED|Overall Study||91
415801|NCT00835978|991487|P2|NOT COMPLETED|Overall Study||56
415802|NCT00835978|991488|P1|NOT COMPLETED|Overall Study||56
415803|NCT00835978|991485|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
415804|NCT00835978|991486|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
415805|NCT00835978|991487|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
415806|NCT00835978|991488|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
415807|NCT00835978|991485|P4|Treated|Overall Study||10
415808|NCT00835978|991486|P3|Treated|Overall Study||91
415809|NCT00835978|991487|P2|Treated|Overall Study||56
415810|NCT00835978|991488|P1|Treated|Overall Study||56
415811|NCT00835978|991485|P4|STARTED|Overall Study||10
415812|NCT00835978|991486|P3|STARTED|Overall Study||91
415813|NCT00835978|991487|P2|STARTED|Overall Study||56
415814|NCT00835978|991488|P1|STARTED|Overall Study||56
415815|NCT00835926|991548|P2|NOT COMPLETED|Overall Study||0
415816|NCT00835926|991549|P1|NOT COMPLETED|Overall Study||0
415817|NCT00835926|991548|P2|COMPLETED|Overall Study||60
415818|NCT00835926|991549|P1|COMPLETED|Overall Study||61
415819|NCT00835926|991548|P2|STARTED|Overall Study||60
415820|NCT00835926|991549|P1|STARTED|Overall Study||61
415821|NCT00835900|991563|P2|NOT COMPLETED|Overall Study||6
415822|NCT00835900|991564|P1|NOT COMPLETED|Overall Study||5
415823|NCT00835900|991563|P2|COMPLETED|Overall Study||22
415824|NCT00835900|991564|P1|COMPLETED|Overall Study||27
415825|NCT00835900|991563|P2|STARTED|Overall Study||28
415826|NCT00835900|991564|P1|STARTED|Overall Study||32
415827|NCT00835861|991574|P2|NOT COMPLETED|Overall Study||2
415828|NCT00835861|991575|P1|NOT COMPLETED|Overall Study||1
415829|NCT00835861|991574|P2|COMPLETED|Overall Study||14
415830|NCT00835861|991575|P1|COMPLETED|Overall Study||14
415831|NCT00835861|991574|P2|STARTED|Overall Study||16
415832|NCT00835861|991575|P1|STARTED|Overall Study||15
415833|NCT00835796|991599|P2|NOT COMPLETED|Second Intervention||0
415834|NCT00835796|991600|P1|NOT COMPLETED|Second Intervention||0
415835|NCT00835796|991599|P2|COMPLETED|Second Intervention||9
415836|NCT00835796|991600|P1|COMPLETED|Second Intervention||10
415837|NCT00835796|991599|P2|STARTED|Second Intervention||9
415838|NCT00835796|991600|P1|STARTED|Second Intervention||10
415839|NCT00835796|991599|P2|NOT COMPLETED|Washout||0
415840|NCT00835796|991600|P1|NOT COMPLETED|Washout||0
415841|NCT00835796|991599|P2|COMPLETED|Washout||9
415842|NCT00835796|991600|P1|COMPLETED|Washout||10
415843|NCT00835796|991599|P2|STARTED|Washout||9
415844|NCT00835796|991600|P1|STARTED|Washout||10
415845|NCT00835796|991599|P2|NOT COMPLETED|First Intervention||1
415846|NCT00835796|991600|P1|NOT COMPLETED|First Intervention||0
415847|NCT00835796|991599|P2|COMPLETED|First Intervention||9
415848|NCT00835796|991600|P1|COMPLETED|First Intervention||10
415849|NCT00835796|991599|P2|STARTED|First Intervention||10
415850|NCT00835796|991600|P1|STARTED|First Intervention||10
415851|NCT00835731|991610|P2|NOT COMPLETED|Overall Study||1
415852|NCT00835731|991611|P1|NOT COMPLETED|Overall Study||2
415853|NCT00835731|991610|P2|COMPLETED|Overall Study||60
415854|NCT00835731|991611|P1|COMPLETED|Overall Study||62
415855|NCT00835731|991610|P2|STARTED|Overall Study||61
415856|NCT00835731|991611|P1|STARTED|Overall Study||64
415857|NCT00835705|991627|P2|NOT COMPLETED|Second Intervention||0
415858|NCT00835705|991628|P1|NOT COMPLETED|Second Intervention||1
415859|NCT00835705|991627|P2|COMPLETED|Second Intervention||28
415860|NCT00835705|991628|P1|COMPLETED|Second Intervention||22
415861|NCT00835705|991627|P2|STARTED|Second Intervention||28
415862|NCT00835705|991628|P1|STARTED|Second Intervention||23
415863|NCT00835705|991627|P2|NOT COMPLETED|First Intervention||0
415864|NCT00835705|991628|P1|NOT COMPLETED|First Intervention||1
415865|NCT00835705|991627|P2|COMPLETED|First Intervention||28
415866|NCT00835705|991628|P1|COMPLETED|First Intervention||23
415867|NCT00835705|991627|P2|STARTED|First Intervention||28
415868|NCT00835705|991628|P1|STARTED|First Intervention||24
415869|NCT00835692|991644|P2|NOT COMPLETED|Second Intervention||0
415870|NCT00835692|991645|P1|NOT COMPLETED|Second Intervention||0
415871|NCT00835692|991644|P2|COMPLETED|Second Intervention||28
415872|NCT00835692|991645|P1|COMPLETED|Second Intervention||27
415873|NCT00835692|991644|P2|STARTED|Second Intervention||28
415874|NCT00835692|991645|P1|STARTED|Second Intervention||27
415875|NCT00835692|991644|P2|NOT COMPLETED|Washout||0
415876|NCT00835692|991645|P1|NOT COMPLETED|Washout||0
415877|NCT00835692|991644|P2|COMPLETED|Washout||28
415878|NCT00835692|991645|P1|COMPLETED|Washout||27
415879|NCT00835692|991644|P2|STARTED|Washout||28
415880|NCT00835692|991645|P1|STARTED|Washout||27
415881|NCT00835692|991644|P2|NOT COMPLETED|First Intervention||0
415882|NCT00835692|991645|P1|NOT COMPLETED|First Intervention||1
415883|NCT00835692|991644|P2|COMPLETED|First Intervention||28
415884|NCT00835692|991645|P1|COMPLETED|First Intervention||27
415885|NCT00835692|991644|P2|STARTED|First Intervention||28
415886|NCT00835692|991645|P1|STARTED|First Intervention||28
415887|NCT00835679|991657|P4|NOT COMPLETED|Overall Study||0
415888|NCT00835679|991658|P3|NOT COMPLETED|Overall Study||0
415889|NCT00835679|991659|P2|NOT COMPLETED|Overall Study||0
415890|NCT00835679|991660|P1|NOT COMPLETED|Overall Study||1
415891|NCT00835679|991657|P4|COMPLETED|Overall Study||0
415892|NCT00835679|991658|P3|COMPLETED|Overall Study||0
415893|NCT00835679|991659|P2|COMPLETED|Overall Study||0
415894|NCT00835679|991660|P1|COMPLETED|Overall Study||8
415895|NCT00835679|991657|P4|STARTED|Overall Study||0
415896|NCT00835679|991658|P3|STARTED|Overall Study||0
415897|NCT00835679|991659|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
415898|NCT00835679|991660|P1|STARTED|Overall Study||9
415899|NCT00835666|991684|P2|NOT COMPLETED|Second Intervention||0
415900|NCT00835666|991685|P1|NOT COMPLETED|Second Intervention||0
415901|NCT00835666|991684|P2|COMPLETED|Second Intervention||16
415902|NCT00835666|991685|P1|COMPLETED|Second Intervention||14
415903|NCT00835666|991684|P2|STARTED|Second Intervention||16
415904|NCT00835666|991685|P1|STARTED|Second Intervention||14
415905|NCT00835666|991684|P2|NOT COMPLETED|Washout||0
415906|NCT00835666|991685|P1|NOT COMPLETED|Washout||2
415907|NCT00835666|991684|P2|COMPLETED|Washout||16
415908|NCT00835666|991685|P1|COMPLETED|Washout||14
415909|NCT00835666|991684|P2|STARTED|Washout||16
415910|NCT00835666|991685|P1|STARTED|Washout||16
415911|NCT00835666|991684|P2|NOT COMPLETED|First Intervention||0
415912|NCT00835666|991685|P1|NOT COMPLETED|First Intervention||0
415913|NCT00835666|991684|P2|COMPLETED|First Intervention||16
415914|NCT00835666|991685|P1|COMPLETED|First Intervention||16
415915|NCT00835666|991684|P2|STARTED|First Intervention||16
415916|NCT00835666|991685|P1|STARTED|First Intervention||16
415917|NCT00835640|991695|P2|NOT COMPLETED|Second Intervention||0
415918|NCT00835640|991696|P1|NOT COMPLETED|Second Intervention||1
415919|NCT00835640|991695|P2|COMPLETED|Second Intervention||12
415920|NCT00835640|991696|P1|COMPLETED|Second Intervention||11
415921|NCT00835640|991695|P2|STARTED|Second Intervention||12
415922|NCT00835640|991696|P1|STARTED|Second Intervention||12
415923|NCT00835640|991695|P2|NOT COMPLETED|Washout of 7 Days||0
415924|NCT00835640|991696|P1|NOT COMPLETED|Washout of 7 Days||0
415925|NCT00835640|991695|P2|COMPLETED|Washout of 7 Days||12
415926|NCT00835640|991696|P1|COMPLETED|Washout of 7 Days||12
415927|NCT00835640|991695|P2|STARTED|Washout of 7 Days||12
415928|NCT00835640|991696|P1|STARTED|Washout of 7 Days||12
415929|NCT00835640|991695|P2|NOT COMPLETED|First Intervention||0
415930|NCT00835640|991696|P1|NOT COMPLETED|First Intervention||0
415931|NCT00835640|991695|P2|COMPLETED|First Intervention||12
415932|NCT00835640|991696|P1|COMPLETED|First Intervention||12
415933|NCT00835640|991695|P2|STARTED|First Intervention||12
415934|NCT00835640|991696|P1|STARTED|First Intervention||12
415935|NCT00835614|991706|P2|NOT COMPLETED|Second Intervention||0
415936|NCT00835614|991707|P1|NOT COMPLETED|Second Intervention||0
415937|NCT00835614|991706|P2|COMPLETED|Second Intervention||13
415938|NCT00835614|991707|P1|COMPLETED|Second Intervention||13
415939|NCT00835614|991706|P2|STARTED|Second Intervention||13
415940|NCT00835614|991707|P1|STARTED|Second Intervention||13
415941|NCT00835614|991706|P2|NOT COMPLETED|Washout of 7 Days||0
415942|NCT00835614|991707|P1|NOT COMPLETED|Washout of 7 Days||0
415943|NCT00835614|991706|P2|COMPLETED|Washout of 7 Days||13
415944|NCT00835614|991707|P1|COMPLETED|Washout of 7 Days||13
415945|NCT00835614|991706|P2|STARTED|Washout of 7 Days||13
415946|NCT00835614|991707|P1|STARTED|Washout of 7 Days||13
415947|NCT00835614|991706|P2|NOT COMPLETED|First Intervention||0
415948|NCT00835614|991707|P1|NOT COMPLETED|First Intervention||0
415949|NCT00835614|991706|P2|COMPLETED|First Intervention||13
415950|NCT00835614|991707|P1|COMPLETED|First Intervention||13
415951|NCT00835614|991706|P2|STARTED|First Intervention||13
415952|NCT00835614|991707|P1|STARTED|First Intervention||13
415953|NCT00835588|991717|P2|NOT COMPLETED|Second Intervention||0
415954|NCT00835588|991718|P1|NOT COMPLETED|Second Intervention||0
415955|NCT00835588|991717|P2|COMPLETED|Second Intervention||50
415956|NCT00835588|991718|P1|COMPLETED|Second Intervention||50
415957|NCT00835588|991717|P2|STARTED|Second Intervention||50
415958|NCT00835588|991718|P1|STARTED|Second Intervention||50
415959|NCT00835588|991717|P2|NOT COMPLETED|Washout: 5 Days||0
415960|NCT00835588|991718|P1|NOT COMPLETED|Washout: 5 Days||0
415961|NCT00835588|991717|P2|COMPLETED|Washout: 5 Days||50
415962|NCT00835588|991718|P1|COMPLETED|Washout: 5 Days||50
415963|NCT00835588|991717|P2|STARTED|Washout: 5 Days||50
415964|NCT00835588|991718|P1|STARTED|Washout: 5 Days||50
415965|NCT00835588|991717|P2|NOT COMPLETED|First Intervention||0
415966|NCT00835588|991718|P1|NOT COMPLETED|First Intervention||0
415967|NCT00835588|991717|P2|COMPLETED|First Intervention||50
415968|NCT00835588|991718|P1|COMPLETED|First Intervention||50
415969|NCT00835588|991717|P2|STARTED|First Intervention||50
415970|NCT00835588|991718|P1|STARTED|First Intervention||50
415971|NCT00835575|991728|P2|NOT COMPLETED|Second Intervention||0
415972|NCT00835575|991729|P1|NOT COMPLETED|Second Intervention||0
415973|NCT00835575|991728|P2|COMPLETED|Second Intervention||16
415974|NCT00835575|991729|P1|COMPLETED|Second Intervention||15
415975|NCT00835575|991728|P2|STARTED|Second Intervention||16
415976|NCT00835575|991729|P1|STARTED|Second Intervention||15
415977|NCT00835575|991728|P2|NOT COMPLETED|Washout of 14 Days||0
415978|NCT00835575|991729|P1|NOT COMPLETED|Washout of 14 Days||1
415979|NCT00835575|991728|P2|COMPLETED|Washout of 14 Days||16
415980|NCT00835575|991729|P1|COMPLETED|Washout of 14 Days||15
415981|NCT00835575|991728|P2|STARTED|Washout of 14 Days||16
415982|NCT00835575|991729|P1|STARTED|Washout of 14 Days||16
415983|NCT00835575|991728|P2|NOT COMPLETED|First Intervention||0
415984|NCT00835575|991729|P1|NOT COMPLETED|First Intervention||0
415985|NCT00835575|991728|P2|COMPLETED|First Intervention||16
415986|NCT00835575|991729|P1|COMPLETED|First Intervention||16
415987|NCT00835575|991728|P2|STARTED|First Intervention||16
415988|NCT00835575|991729|P1|STARTED|First Intervention||16
415989|NCT00835549|991739|P2|NOT COMPLETED|Second Intervention||0
415990|NCT00835549|991740|P1|NOT COMPLETED|Second Intervention||0
415991|NCT00835549|991739|P2|COMPLETED|Second Intervention||16
415992|NCT00835549|991740|P1|COMPLETED|Second Intervention||14
415993|NCT00835549|991739|P2|STARTED|Second Intervention||16
415994|NCT00835549|991740|P1|STARTED|Second Intervention||14
415995|NCT00835549|991739|P2|NOT COMPLETED|Washout of 7 Days||0
415996|NCT00835549|991740|P1|NOT COMPLETED|Washout of 7 Days||2
415997|NCT00835549|991739|P2|COMPLETED|Washout of 7 Days||16
415998|NCT00835549|991740|P1|COMPLETED|Washout of 7 Days||14
415999|NCT00835549|991739|P2|STARTED|Washout of 7 Days||16
416000|NCT00835549|991740|P1|STARTED|Washout of 7 Days||16
416001|NCT00835549|991739|P2|NOT COMPLETED|First Intervention||0
416002|NCT00835549|991740|P1|NOT COMPLETED|First Intervention||0
416003|NCT00835549|991739|P2|COMPLETED|First Intervention||16
416004|NCT00835549|991740|P1|COMPLETED|First Intervention||16
416005|NCT00835549|991739|P2|STARTED|First Intervention||16
416006|NCT00835549|991740|P1|STARTED|First Intervention||16
416007|NCT00835536|991750|P2|NOT COMPLETED|Second Intervention||0
416008|NCT00835536|991751|P1|NOT COMPLETED|Second Intervention||0
416009|NCT00835536|991750|P2|COMPLETED|Second Intervention||14
416010|NCT00835536|991751|P1|COMPLETED|Second Intervention||12
416011|NCT00835536|991750|P2|STARTED|Second Intervention||14
416012|NCT00835536|991751|P1|STARTED|Second Intervention||12
416013|NCT00835536|991750|P2|NOT COMPLETED|Washout of 5 Weeks||0
416014|NCT00835536|991751|P1|NOT COMPLETED|Washout of 5 Weeks||1
416015|NCT00835536|991750|P2|COMPLETED|Washout of 5 Weeks||14
416016|NCT00835536|991751|P1|COMPLETED|Washout of 5 Weeks||12
416017|NCT00835536|991750|P2|STARTED|Washout of 5 Weeks||14
416018|NCT00835536|991751|P1|STARTED|Washout of 5 Weeks||13
416019|NCT00835536|991750|P2|NOT COMPLETED|First Intervention||0
416020|NCT00835536|991751|P1|NOT COMPLETED|First Intervention||0
416021|NCT00835536|991750|P2|COMPLETED|First Intervention||14
416022|NCT00835536|991751|P1|COMPLETED|First Intervention||13
416023|NCT00835536|991750|P2|STARTED|First Intervention||14
416024|NCT00835536|991751|P1|STARTED|First Intervention||13
416025|NCT00835510|991760|P3|NOT COMPLETED|Overall Study||38
416026|NCT00835510|991761|P2|NOT COMPLETED|Overall Study||69
416027|NCT00835510|991762|P1|NOT COMPLETED|Overall Study||76
416028|NCT00835510|991760|P3|COMPLETED|Overall Study||70
416029|NCT00835510|991761|P2|COMPLETED|Overall Study||152
416030|NCT00835510|991762|P1|COMPLETED|Overall Study||143
416031|NCT00835510|991760|P3|Positive Fungal Culture|Overall Study||71
416032|NCT00835510|991761|P2|Positive Fungal Culture|Overall Study||155
416033|NCT00835510|991762|P1|Positive Fungal Culture|Overall Study||149
416034|NCT00835510|991760|P3|STARTED|Overall Study||108
416035|NCT00835510|991761|P2|STARTED|Overall Study||221
416036|NCT00835510|991762|P1|STARTED|Overall Study||219
416037|NCT00835497|991784|P2|NOT COMPLETED|Second Intervention||0
416038|NCT00835497|991785|P1|NOT COMPLETED|Second Intervention||0
416039|NCT00835497|991784|P2|COMPLETED|Second Intervention||20
416040|NCT00835497|991785|P1|COMPLETED|Second Intervention||20
416041|NCT00835497|991784|P2|STARTED|Second Intervention||20
416042|NCT00835497|991785|P1|STARTED|Second Intervention||20
416043|NCT00835497|991784|P2|NOT COMPLETED|Washout: 7 Days||0
416044|NCT00835497|991785|P1|NOT COMPLETED|Washout: 7 Days||0
416045|NCT00835497|991784|P2|COMPLETED|Washout: 7 Days||20
416046|NCT00835497|991785|P1|COMPLETED|Washout: 7 Days||20
416047|NCT00835497|991784|P2|STARTED|Washout: 7 Days||20
416048|NCT00835497|991785|P1|STARTED|Washout: 7 Days||20
416049|NCT00835497|991784|P2|NOT COMPLETED|First Intervention||0
416050|NCT00835497|991785|P1|NOT COMPLETED|First Intervention||0
416051|NCT00835497|991784|P2|COMPLETED|First Intervention||20
416052|NCT00835497|991785|P1|COMPLETED|First Intervention||20
416053|NCT00835497|991784|P2|STARTED|First Intervention||20
416054|NCT00835497|991785|P1|STARTED|First Intervention||20
416055|NCT00835484|991801|P2|NOT COMPLETED|Second Intervention||0
416056|NCT00835484|991802|P1|NOT COMPLETED|Second Intervention||0
416057|NCT00835484|991801|P2|COMPLETED|Second Intervention||16
416058|NCT00835484|991802|P1|COMPLETED|Second Intervention||16
416059|NCT00835484|991801|P2|STARTED|Second Intervention||16
416060|NCT00835484|991802|P1|STARTED|Second Intervention||16
416061|NCT00835484|991801|P2|NOT COMPLETED|Washout of 7 Days||0
416062|NCT00835484|991802|P1|NOT COMPLETED|Washout of 7 Days||0
416063|NCT00835484|991801|P2|COMPLETED|Washout of 7 Days||16
416064|NCT00835484|991802|P1|COMPLETED|Washout of 7 Days||16
416065|NCT00835484|991801|P2|STARTED|Washout of 7 Days||16
416066|NCT00835484|991802|P1|STARTED|Washout of 7 Days||16
416067|NCT00835484|991801|P2|NOT COMPLETED|First Intervention||0
416068|NCT00835484|991802|P1|NOT COMPLETED|First Intervention||0
416069|NCT00835484|991801|P2|COMPLETED|First Intervention||16
416070|NCT00835484|991802|P1|COMPLETED|First Intervention||16
416071|NCT00835484|991801|P2|STARTED|First Intervention||16
416072|NCT00835484|991802|P1|STARTED|First Intervention||16
416073|NCT00835406|991812|P2|NOT COMPLETED|Period: Second Intervention||0
416074|NCT00835406|991813|P1|NOT COMPLETED|Period: Second Intervention||0
416075|NCT00835406|991812|P2|COMPLETED|Period: Second Intervention||67
416076|NCT00835406|991813|P1|COMPLETED|Period: Second Intervention||68
416077|NCT00835406|991812|P2|STARTED|Period: Second Intervention||67
416078|NCT00835406|991813|P1|STARTED|Period: Second Intervention||68
416079|NCT00835406|991812|P2|NOT COMPLETED|Period: Washout of 7 Days||2
416080|NCT00835406|991813|P1|NOT COMPLETED|Period: Washout of 7 Days||0
416081|NCT00835406|991812|P2|COMPLETED|Period: Washout of 7 Days||67
416082|NCT00835406|991813|P1|COMPLETED|Period: Washout of 7 Days||68
416083|NCT00835406|991812|P2|STARTED|Period: Washout of 7 Days||69
416084|NCT00835406|991813|P1|STARTED|Period: Washout of 7 Days||68
416085|NCT00835406|991812|P2|NOT COMPLETED|Period: First Intervention||1
416086|NCT00835406|991813|P1|NOT COMPLETED|Period: First Intervention||2
416087|NCT00835406|991812|P2|COMPLETED|Period: First Intervention||69
416088|NCT00835406|991813|P1|COMPLETED|Period: First Intervention||68
416089|NCT00835406|991812|P2|STARTED|Period: First Intervention||70
416090|NCT00835406|991813|P1|STARTED|Period: First Intervention||70
416091|NCT00835380|991819|P1|NOT COMPLETED|Overall Study||2
416092|NCT00835380|991819|P1|COMPLETED|Overall Study||78
416093|NCT00835380|991819|P1|STARTED|Overall Study||80
416094|NCT00835367|991826|P2|NOT COMPLETED|Second Intervention||1
416095|NCT00835367|991827|P1|NOT COMPLETED|Second Intervention||1
416096|NCT00835367|991826|P2|COMPLETED|Second Intervention||33
416097|NCT00835367|991827|P1|COMPLETED|Second Intervention||30
416098|NCT00835367|991826|P2|STARTED|Second Intervention||34
416099|NCT00835367|991827|P1|STARTED|Second Intervention||31
416100|NCT00835367|991826|P2|NOT COMPLETED|Washout||0
416101|NCT00835367|991827|P1|NOT COMPLETED|Washout||3
416102|NCT00835367|991826|P2|COMPLETED|Washout||34
416103|NCT00835367|991827|P1|COMPLETED|Washout||31
416104|NCT00835367|991826|P2|STARTED|Washout||34
416105|NCT00835367|991827|P1|STARTED|Washout||34
416106|NCT00835367|991826|P2|NOT COMPLETED|First Intervention||0
416107|NCT00835367|991827|P1|NOT COMPLETED|First Intervention||0
416108|NCT00835367|991826|P2|COMPLETED|First Intervention||34
416109|NCT00835367|991827|P1|COMPLETED|First Intervention||34
416110|NCT00835367|991826|P2|STARTED|First Intervention||34
416111|NCT00835367|991827|P1|STARTED|First Intervention||34
416112|NCT00835354|991849|P2|NOT COMPLETED|Second Intervention||0
416113|NCT00835354|991850|P1|NOT COMPLETED|Second Intervention||0
416114|NCT00835354|991849|P2|COMPLETED|Second Intervention||12
416115|NCT00835354|991850|P1|COMPLETED|Second Intervention||13
416116|NCT00835354|991849|P2|STARTED|Second Intervention||12
416117|NCT00835354|991850|P1|STARTED|Second Intervention||13
416118|NCT00835354|991849|P2|NOT COMPLETED|Washout of 7 Days||0
416119|NCT00835354|991850|P1|NOT COMPLETED|Washout of 7 Days||0
416120|NCT00835354|991849|P2|COMPLETED|Washout of 7 Days||12
416121|NCT00835354|991850|P1|COMPLETED|Washout of 7 Days||13
416122|NCT00835354|991849|P2|STARTED|Washout of 7 Days||12
416123|NCT00835354|991850|P1|STARTED|Washout of 7 Days||13
416124|NCT00835354|991849|P2|NOT COMPLETED|First Intervention||1
416125|NCT00835354|991850|P1|NOT COMPLETED|First Intervention||0
416126|NCT00835354|991849|P2|COMPLETED|First Intervention||12
416127|NCT00835354|991850|P1|COMPLETED|First Intervention||13
416128|NCT00835354|991849|P2|STARTED|First Intervention||13
416129|NCT00835354|991850|P1|STARTED|First Intervention||13
416130|NCT00835341|991860|P2|NOT COMPLETED|Overall Study||12
416131|NCT00835341|991861|P1|NOT COMPLETED|Overall Study||3
416132|NCT00835341|991860|P2|COMPLETED|Overall Study||46
416133|NCT00835341|991861|P1|COMPLETED|Overall Study||32
416134|NCT00835341|991860|P2|STARTED|Overall Study||58
416135|NCT00835341|991861|P1|STARTED|Overall Study||35
416136|NCT00835276|991869|P2|NOT COMPLETED|Second Intervention||0
416137|NCT00835276|991870|P1|NOT COMPLETED|Second Intervention||0
416138|NCT00835276|991869|P2|COMPLETED|Second Intervention||24
416139|NCT00835276|991870|P1|COMPLETED|Second Intervention||24
416140|NCT00835276|991869|P2|STARTED|Second Intervention||24
416141|NCT00835276|991870|P1|STARTED|Second Intervention||24
416142|NCT00835276|991869|P2|NOT COMPLETED|Washout of 7 Days||0
416143|NCT00835276|991870|P1|NOT COMPLETED|Washout of 7 Days||0
416144|NCT00835276|991869|P2|COMPLETED|Washout of 7 Days||24
416145|NCT00835276|991870|P1|COMPLETED|Washout of 7 Days||24
416146|NCT00835276|991869|P2|STARTED|Washout of 7 Days||24
416147|NCT00835276|991870|P1|STARTED|Washout of 7 Days||24
416148|NCT00835276|991869|P2|NOT COMPLETED|First Intervention||0
416149|NCT00835276|991870|P1|NOT COMPLETED|First Intervention||0
416150|NCT00835276|991869|P2|COMPLETED|First Intervention||24
416151|NCT00835276|991870|P1|COMPLETED|First Intervention||24
416152|NCT00835276|991869|P2|STARTED|First Intervention||24
416153|NCT00835276|991870|P1|STARTED|First Intervention||24
416154|NCT00835263|991880|P2|NOT COMPLETED|Second Intervention||0
416155|NCT00835263|991881|P1|NOT COMPLETED|Second Intervention||1
416156|NCT00835263|991880|P2|COMPLETED|Second Intervention||16
416157|NCT00835263|991881|P1|COMPLETED|Second Intervention||15
416158|NCT00835263|991880|P2|STARTED|Second Intervention||16
416159|NCT00835263|991881|P1|STARTED|Second Intervention||16
416160|NCT00835263|991880|P2|NOT COMPLETED|First Intervention||0
416161|NCT00835263|991881|P1|NOT COMPLETED|First Intervention||0
416162|NCT00835263|991880|P2|COMPLETED|First Intervention||16
416163|NCT00835263|991881|P1|COMPLETED|First Intervention||16
416164|NCT00835263|991880|P2|STARTED|First Intervention||16
416165|NCT00835263|991881|P1|STARTED|First Intervention||16
416166|NCT00835237|991891|P2|NOT COMPLETED|Overall Study||0
416167|NCT00835237|991892|P1|NOT COMPLETED|Overall Study||6
416168|NCT00835237|991891|P2|COMPLETED|Overall Study||445
416169|NCT00835237|991892|P1|COMPLETED|Overall Study||881
416170|NCT00835237|991891|P2|STARTED|Overall Study||445
416171|NCT00835237|991892|P1|STARTED|Overall Study||887
416172|NCT00835224|991916|P1|NOT COMPLETED|Overall Study||10
416173|NCT00835224|991916|P1|COMPLETED|Overall Study||24
416174|NCT00835224|991916|P1|STARTED|Overall Study||34
416175|NCT00835211|991932|P2|NOT COMPLETED|Second Intervention||0
416176|NCT00835211|991933|P1|NOT COMPLETED|Second Intervention||0
416177|NCT00835211|991932|P2|COMPLETED|Second Intervention||22
416178|NCT00835211|991933|P1|COMPLETED|Second Intervention||21
416179|NCT00835211|991932|P2|STARTED|Second Intervention||22
416180|NCT00835211|991933|P1|STARTED|Second Intervention||21
416181|NCT00835211|991932|P2|NOT COMPLETED|Washout: 7 Days||1
416182|NCT00835211|991933|P1|NOT COMPLETED|Washout: 7 Days||3
416183|NCT00835211|991932|P2|COMPLETED|Washout: 7 Days||22
416184|NCT00835211|991933|P1|COMPLETED|Washout: 7 Days||21
416185|NCT00835211|991932|P2|STARTED|Washout: 7 Days||23
416186|NCT00835211|991933|P1|STARTED|Washout: 7 Days||24
416187|NCT00835211|991932|P2|NOT COMPLETED|First Intervention||1
416188|NCT00835211|991933|P1|NOT COMPLETED|First Intervention||0
416189|NCT00835211|991932|P2|COMPLETED|First Intervention||23
416190|NCT00835211|991933|P1|COMPLETED|First Intervention||24
416191|NCT00835211|991932|P2|STARTED|First Intervention||24
416192|NCT00835211|991933|P1|STARTED|First Intervention||24
416193|NCT00835198|991943|P2|NOT COMPLETED|Overall Study||7
416194|NCT00835198|991944|P1|NOT COMPLETED|Overall Study||8
416195|NCT00835198|991943|P2|COMPLETED|Overall Study||74
416196|NCT00835198|991944|P1|COMPLETED|Overall Study||74
416197|NCT00835198|991943|P2|STARTED|Overall Study||81
416198|NCT00835198|991944|P1|STARTED|Overall Study||82
416199|NCT00835185|991956|P1|NOT COMPLETED|Overall Study||0
416200|NCT00835185|991956|P1|COMPLETED|Overall Study||44
416201|NCT00835185|991956|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
416202|NCT00835185|991956|P1|STARTED|Overall Study||44
416203|NCT00835172|991979|P2|NOT COMPLETED|Second Intervention||0
416204|NCT00835172|991980|P1|NOT COMPLETED|Second Intervention||0
416205|NCT00835172|991979|P2|COMPLETED|Second Intervention||15
416206|NCT00835172|991980|P1|COMPLETED|Second Intervention||16
416207|NCT00835172|991979|P2|STARTED|Second Intervention||15
416208|NCT00835172|991980|P1|STARTED|Second Intervention||16
416209|NCT00835172|991979|P2|NOT COMPLETED|Washout||1
416210|NCT00835172|991980|P1|NOT COMPLETED|Washout||0
416211|NCT00835172|991979|P2|COMPLETED|Washout||15
416212|NCT00835172|991980|P1|COMPLETED|Washout||16
416213|NCT00835172|991979|P2|STARTED|Washout||16
416214|NCT00835172|991980|P1|STARTED|Washout||16
416215|NCT00835172|991979|P2|NOT COMPLETED|First Intervention||0
416216|NCT00835172|991980|P1|NOT COMPLETED|First Intervention||0
416217|NCT00835172|991979|P2|COMPLETED|First Intervention||16
416218|NCT00835172|991980|P1|COMPLETED|First Intervention||16
416219|NCT00835172|991979|P2|STARTED|First Intervention||16
416220|NCT00835172|991980|P1|STARTED|First Intervention||16
416221|NCT00835159|991990|P2|NOT COMPLETED|Overall Study||0
416222|NCT00835159|991991|P1|NOT COMPLETED|Overall Study||0
416223|NCT00835159|991990|P2|COMPLETED|Overall Study||17
416224|NCT00835159|991991|P1|COMPLETED|Overall Study||11
416225|NCT00835159|991990|P2|STARTED|Overall Study||17
416226|NCT00835159|991991|P1|STARTED|Overall Study||11
416227|NCT00835146|991999|P2|NOT COMPLETED|Second Intervention||0
416228|NCT00835146|992000|P1|NOT COMPLETED|Second Intervention||0
416229|NCT00835146|991999|P2|COMPLETED|Second Intervention||14
416230|NCT00835146|992000|P1|COMPLETED|Second Intervention||14
416231|NCT00835146|991999|P2|STARTED|Second Intervention||14
416232|NCT00835146|992000|P1|STARTED|Second Intervention||14
416233|NCT00835146|991999|P2|NOT COMPLETED|Washout of 5 Weeks||0
416234|NCT00835146|992000|P1|NOT COMPLETED|Washout of 5 Weeks||0
416235|NCT00835146|991999|P2|COMPLETED|Washout of 5 Weeks||14
416236|NCT00835146|992000|P1|COMPLETED|Washout of 5 Weeks||14
416237|NCT00835146|991999|P2|STARTED|Washout of 5 Weeks||14
416238|NCT00835146|992000|P1|STARTED|Washout of 5 Weeks||14
416239|NCT00835146|991999|P2|NOT COMPLETED|First Intervention||0
416240|NCT00835146|992000|P1|NOT COMPLETED|First Intervention||0
416241|NCT00835146|991999|P2|COMPLETED|First Intervention||14
416242|NCT00835146|992000|P1|COMPLETED|First Intervention||14
416243|NCT00835146|991999|P2|STARTED|First Intervention||14
416244|NCT00835146|992000|P1|STARTED|First Intervention||14
416245|NCT00835120|992006|P1|NOT COMPLETED|Overall Study||8
416246|NCT00835120|992006|P1|COMPLETED|Overall Study||26
416247|NCT00835120|992006|P1|STARTED|Overall Study||34
416248|NCT00835081|992016|P2|NOT COMPLETED|Second Intervention||0
416249|NCT00835081|992017|P1|NOT COMPLETED|Second Intervention||0
416250|NCT00835081|992016|P2|COMPLETED|Second Intervention||13
416251|NCT00835081|992017|P1|COMPLETED|Second Intervention||12
416252|NCT00835081|992016|P2|STARTED|Second Intervention||13
416253|NCT00835081|992017|P1|STARTED|Second Intervention||12
416254|NCT00835081|992016|P2|NOT COMPLETED|Washout of 7 Days||0
416255|NCT00835081|992017|P1|NOT COMPLETED|Washout of 7 Days||1
416256|NCT00835081|992016|P2|COMPLETED|Washout of 7 Days||13
416257|NCT00835081|992017|P1|COMPLETED|Washout of 7 Days||12
416258|NCT00835081|992016|P2|STARTED|Washout of 7 Days||13
416259|NCT00835081|992017|P1|STARTED|Washout of 7 Days||13
416260|NCT00835081|992016|P2|NOT COMPLETED|First Intervention||0
416261|NCT00835081|992017|P1|NOT COMPLETED|First Intervention||0
416262|NCT00835081|992016|P2|COMPLETED|First Intervention||13
416263|NCT00835081|992017|P1|COMPLETED|First Intervention||13
416264|NCT00835081|992016|P2|STARTED|First Intervention||13
416265|NCT00835081|992017|P1|STARTED|First Intervention||13
416266|NCT00835068|992027|P2|NOT COMPLETED|Overall Study||1
416267|NCT00835068|992028|P1|NOT COMPLETED|Overall Study||10
416268|NCT00835068|992027|P2|COMPLETED|Overall Study||0
416269|NCT00835068|992028|P1|COMPLETED|Overall Study||47
416270|NCT00835068|992027|P2|STARTED|Overall Study||1
416271|NCT00835068|992028|P1|STARTED|Overall Study||57
416272|NCT00835042|992048|P2|NOT COMPLETED|Second Intervention||0
416273|NCT00835042|992049|P1|NOT COMPLETED|Second Intervention||0
416274|NCT00835042|992048|P2|COMPLETED|Second Intervention||24
416275|NCT00835042|992049|P1|COMPLETED|Second Intervention||26
416276|NCT00835042|992048|P2|STARTED|Second Intervention||24
416277|NCT00835042|992049|P1|STARTED|Second Intervention||26
416278|NCT00835042|992048|P2|NOT COMPLETED|Washout of 21 Days||2
416279|NCT00835042|992049|P1|NOT COMPLETED|Washout of 21 Days||0
416280|NCT00835042|992048|P2|COMPLETED|Washout of 21 Days||24
416281|NCT00835042|992049|P1|COMPLETED|Washout of 21 Days||26
416282|NCT00835042|992048|P2|STARTED|Washout of 21 Days||26
416283|NCT00835042|992049|P1|STARTED|Washout of 21 Days||26
416284|NCT00835042|992048|P2|NOT COMPLETED|First Intervention||2
416285|NCT00835042|992049|P1|NOT COMPLETED|First Intervention||4
416286|NCT00835042|992048|P2|COMPLETED|First Intervention||26
416287|NCT00835042|992049|P1|COMPLETED|First Intervention||26
416288|NCT00835042|992048|P2|STARTED|First Intervention||28
416289|NCT00835042|992049|P1|STARTED|First Intervention||30
416290|NCT00835003|992071|P2|NOT COMPLETED|Overall Study||0
416291|NCT00835003|992072|P1|NOT COMPLETED|Overall Study||0
416292|NCT00835003|992071|P2|COMPLETED|Overall Study||638
416293|NCT00835003|992072|P1|COMPLETED|Overall Study||636
416294|NCT00835003|992071|P2|STARTED|Overall Study||638
416295|NCT00835003|992072|P1|STARTED|Overall Study||636
416296|NCT00834990|992080|P2|NOT COMPLETED|Second Intervention||0
416297|NCT00834990|992081|P1|NOT COMPLETED|Second Intervention||0
416298|NCT00834990|992080|P2|COMPLETED|Second Intervention||11
416299|NCT00834990|992081|P1|COMPLETED|Second Intervention||12
416300|NCT00834990|992080|P2|STARTED|Second Intervention||11
416301|NCT00834990|992081|P1|STARTED|Second Intervention||12
416302|NCT00834990|992080|P2|NOT COMPLETED|Washout of 7 Days||0
416303|NCT00834990|992081|P1|NOT COMPLETED|Washout of 7 Days||0
416304|NCT00834990|992080|P2|COMPLETED|Washout of 7 Days||11
416305|NCT00834990|992081|P1|COMPLETED|Washout of 7 Days||12
416306|NCT00834990|992080|P2|STARTED|Washout of 7 Days||11
416307|NCT00834990|992081|P1|STARTED|Washout of 7 Days||12
416308|NCT00834990|992080|P2|NOT COMPLETED|First Intervention||0
416309|NCT00834990|992081|P1|NOT COMPLETED|First Intervention||0
416310|NCT00834990|992080|P2|COMPLETED|First Intervention||11
416311|NCT00834990|992081|P1|COMPLETED|First Intervention||12
416312|NCT00834990|992080|P2|STARTED|First Intervention||11
416313|NCT00834990|992081|P1|STARTED|First Intervention||12
416314|NCT00834977|992091|P2|NOT COMPLETED|Second Intervention||0
416315|NCT00834977|992092|P1|NOT COMPLETED|Second Intervention||0
416316|NCT00834977|992091|P2|COMPLETED|Second Intervention||24
416317|NCT00834977|992092|P1|COMPLETED|Second Intervention||24
416318|NCT00834977|992091|P2|STARTED|Second Intervention||24
416319|NCT00834977|992092|P1|STARTED|Second Intervention||24
416320|NCT00834977|992091|P2|NOT COMPLETED|First Intervention||0
416321|NCT00834977|992092|P1|NOT COMPLETED|First Intervention||0
416322|NCT00834977|992091|P2|COMPLETED|First Intervention||24
416323|NCT00834977|992092|P1|COMPLETED|First Intervention||24
416324|NCT00834977|992091|P2|STARTED|First Intervention||24
416325|NCT00834977|992092|P1|STARTED|First Intervention||24
416326|NCT00834964|992114|P2|NOT COMPLETED|Second Intervention||0
416327|NCT00834964|992115|P1|NOT COMPLETED|Second Intervention||0
416328|NCT00834964|992114|P2|COMPLETED|Second Intervention||15
416329|NCT00834964|992115|P1|COMPLETED|Second Intervention||15
416330|NCT00834964|992114|P2|STARTED|Second Intervention||15
416331|NCT00834964|992115|P1|STARTED|Second Intervention||15
416332|NCT00834964|992114|P2|NOT COMPLETED|Washout: 7 Days||0
416333|NCT00834964|992115|P1|NOT COMPLETED|Washout: 7 Days||0
416334|NCT00834964|992114|P2|COMPLETED|Washout: 7 Days||15
416335|NCT00834964|992115|P1|COMPLETED|Washout: 7 Days||15
416336|NCT00834964|992114|P2|STARTED|Washout: 7 Days||15
416337|NCT00834964|992115|P1|STARTED|Washout: 7 Days||15
416338|NCT00834964|992114|P2|NOT COMPLETED|First Intervention||0
416339|NCT00834964|992115|P1|NOT COMPLETED|First Intervention||0
416340|NCT00834964|992114|P2|COMPLETED|First Intervention||15
416341|NCT00834964|992115|P1|COMPLETED|First Intervention||15
416342|NCT00834964|992114|P2|STARTED|First Intervention||15
416343|NCT00834964|992115|P1|STARTED|First Intervention||15
416344|NCT00834912|992135|P6|NOT COMPLETED|Treatment Period 3||0
416345|NCT00834912|992136|P5|NOT COMPLETED|Treatment Period 3||0
416346|NCT00834912|992137|P4|NOT COMPLETED|Treatment Period 3||0
416347|NCT00834912|992138|P3|NOT COMPLETED|Treatment Period 3||0
416348|NCT00834912|992139|P2|NOT COMPLETED|Treatment Period 3||0
416349|NCT00834912|992140|P1|NOT COMPLETED|Treatment Period 3||0
416350|NCT00834912|992135|P6|COMPLETED|Treatment Period 3||6
416351|NCT00834912|992136|P5|COMPLETED|Treatment Period 3||5
416352|NCT00834912|992137|P4|COMPLETED|Treatment Period 3||5
416353|NCT00834912|992138|P3|COMPLETED|Treatment Period 3||5
416354|NCT00834912|992139|P2|COMPLETED|Treatment Period 3||5
416355|NCT00834912|992140|P1|COMPLETED|Treatment Period 3||6
416356|NCT00834912|992135|P6|STARTED|Treatment Period 3||6
416357|NCT00834912|992136|P5|STARTED|Treatment Period 3||5
416358|NCT00834912|992137|P4|STARTED|Treatment Period 3||5
416359|NCT00834912|992138|P3|STARTED|Treatment Period 3||5
416360|NCT00834912|992139|P2|STARTED|Treatment Period 3||5
416361|NCT00834912|992140|P1|STARTED|Treatment Period 3||6
416362|NCT00834912|992135|P6|NOT COMPLETED|Treatment Period 2||0
416363|NCT00834912|992136|P5|NOT COMPLETED|Treatment Period 2||1
416364|NCT00834912|992137|P4|NOT COMPLETED|Treatment Period 2||0
416365|NCT00834912|992138|P3|NOT COMPLETED|Treatment Period 2||1
416366|NCT00834912|992139|P2|NOT COMPLETED|Treatment Period 2||0
416367|NCT00834912|992140|P1|NOT COMPLETED|Treatment Period 2||0
416368|NCT00834912|992135|P6|COMPLETED|Treatment Period 2||6
416369|NCT00834912|992136|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
416370|NCT00834912|992137|P4|COMPLETED|Treatment Period 2||5
416371|NCT00834912|992138|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
416372|NCT00834912|992139|P2|COMPLETED|Treatment Period 2||5
416373|NCT00834912|992140|P1|COMPLETED|Treatment Period 2||6
416374|NCT00834912|992135|P6|STARTED|Treatment Period 2||6
416375|NCT00834912|992136|P5|STARTED|Treatment Period 2||6
416376|NCT00834912|992137|P4|STARTED|Treatment Period 2||5
416377|NCT00834912|992138|P3|STARTED|Treatment Period 2||6
416378|NCT00834912|992139|P2|STARTED|Treatment Period 2||5
416379|NCT00834912|992140|P1|STARTED|Treatment Period 2||6
416380|NCT00834912|992135|P6|NOT COMPLETED|Treatment Period 1||0
416381|NCT00834912|992136|P5|NOT COMPLETED|Treatment Period 1||0
416382|NCT00834912|992137|P4|NOT COMPLETED|Treatment Period 1||1
416383|NCT00834912|992138|P3|NOT COMPLETED|Treatment Period 1||0
416384|NCT00834912|992139|P2|NOT COMPLETED|Treatment Period 1||1
416385|NCT00834912|992140|P1|NOT COMPLETED|Treatment Period 1||0
416386|NCT00834912|992135|P6|COMPLETED|Treatment Period 1||6
416387|NCT00834912|992136|P5|COMPLETED|Treatment Period 1||6
416388|NCT00834912|992137|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
416389|NCT00834912|992138|P3|COMPLETED|Treatment Period 1||6
416390|NCT00834912|992139|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
416391|NCT00834912|992140|P1|COMPLETED|Treatment Period 1||6
416392|NCT00834912|992135|P6|STARTED|Treatment Period 1||6
416393|NCT00834912|992136|P5|STARTED|Treatment Period 1||6
416394|NCT00834912|992137|P4|STARTED|Treatment Period 1||6
416395|NCT00834912|992138|P3|STARTED|Treatment Period 1||6
416396|NCT00834912|992139|P2|STARTED|Treatment Period 1||6
416397|NCT00834912|992140|P1|STARTED|Treatment Period 1||6
416398|NCT00834899|992162|P2|NOT COMPLETED|Overall Study||1
416399|NCT00834899|992163|P1|NOT COMPLETED|Overall Study||1
416400|NCT00834899|992162|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
416401|NCT00834899|992163|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
416402|NCT00834899|992162|P2|STARTED|Overall Study||4
416403|NCT00834899|992163|P1|STARTED|Overall Study||9
416404|NCT00834886|992179|P4|NOT COMPLETED|Overall Study||0
416405|NCT00834886|992180|P3|NOT COMPLETED|Overall Study||1
416406|NCT00834886|992181|P2|NOT COMPLETED|Overall Study||1
416407|NCT00834886|992182|P1|NOT COMPLETED|Overall Study||0
416408|NCT00834886|992179|P4|COMPLETED|Overall Study||10
416409|NCT00834886|992180|P3|COMPLETED|Overall Study||9
416410|NCT00834886|992181|P2|COMPLETED|Overall Study||9
416411|NCT00834886|992182|P1|COMPLETED|Overall Study||10
416412|NCT00834886|992179|P4|STARTED|Overall Study||10
416413|NCT00834886|992180|P3|STARTED|Overall Study||10
416414|NCT00834886|992181|P2|STARTED|Overall Study||10
416415|NCT00834886|992182|P1|STARTED|Overall Study||10
416416|NCT00834873|992202|P2|NOT COMPLETED|Second Intervention||0
416417|NCT00834873|992203|P1|NOT COMPLETED|Second Intervention||0
416418|NCT00834873|992202|P2|COMPLETED|Second Intervention||11
416419|NCT00834873|992203|P1|COMPLETED|Second Intervention||12
416420|NCT00834873|992202|P2|STARTED|Second Intervention||11
416421|NCT00834873|992203|P1|STARTED|Second Intervention||12
416422|NCT00834873|992202|P2|NOT COMPLETED|Washout: 7 Days||0
416423|NCT00834873|992203|P1|NOT COMPLETED|Washout: 7 Days||0
416424|NCT00834873|992202|P2|COMPLETED|Washout: 7 Days||11
416425|NCT00834873|992203|P1|COMPLETED|Washout: 7 Days||12
416426|NCT00834873|992202|P2|STARTED|Washout: 7 Days||11
416427|NCT00834873|992203|P1|STARTED|Washout: 7 Days||12
416428|NCT00834873|992202|P2|NOT COMPLETED|First Intervention||1
416429|NCT00834873|992203|P1|NOT COMPLETED|First Intervention||0
416430|NCT00834873|992202|P2|COMPLETED|First Intervention||11
416431|NCT00834873|992203|P1|COMPLETED|First Intervention||12
416432|NCT00834873|992202|P2|STARTED|First Intervention||12
416433|NCT00834873|992203|P1|STARTED|First Intervention||12
416434|NCT00834808|992214|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
416435|NCT00834808|992215|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
416436|NCT00834808|992216|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
416437|NCT00834808|992214|P3|COMPLETED|Treatment Period 3 (Day 15)||9
416438|NCT00834808|992215|P2|COMPLETED|Treatment Period 3 (Day 15)||9
416439|NCT00834808|992216|P1|COMPLETED|Treatment Period 3 (Day 15)||9
416440|NCT00834808|992214|P3|STARTED|Treatment Period 3 (Day 15)||9
416441|NCT00834808|992215|P2|STARTED|Treatment Period 3 (Day 15)||9
416442|NCT00834808|992216|P1|STARTED|Treatment Period 3 (Day 15)||9
416443|NCT00834808|992214|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
416444|NCT00834808|992215|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
416445|NCT00834808|992216|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
416446|NCT00834808|992214|P3|COMPLETED|Treatment Period 2 (Day 8)||9
416447|NCT00834808|992215|P2|COMPLETED|Treatment Period 2 (Day 8)||9
416448|NCT00834808|992216|P1|COMPLETED|Treatment Period 2 (Day 8)||9
416449|NCT00834808|992214|P3|STARTED|Treatment Period 2 (Day 8)||9
416450|NCT00834808|992215|P2|STARTED|Treatment Period 2 (Day 8)||9
416451|NCT00834808|992216|P1|STARTED|Treatment Period 2 (Day 8)||9
416452|NCT00834808|992214|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
416453|NCT00834808|992215|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
416454|NCT00834808|992216|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
416455|NCT00834808|992214|P3|COMPLETED|Treatment Period 1 (Day 1)||9
416456|NCT00834808|992215|P2|COMPLETED|Treatment Period 1 (Day 1)||9
416457|NCT00834808|992216|P1|COMPLETED|Treatment Period 1 (Day 1)||9
416458|NCT00834808|992214|P3|STARTED|Treatment Period 1 (Day 1)||9
416459|NCT00834808|992215|P2|STARTED|Treatment Period 1 (Day 1)||9
416460|NCT00834808|992216|P1|STARTED|Treatment Period 1 (Day 1)||9
416461|NCT00834795|992238|P2|NOT COMPLETED|Second Intervention||0
416462|NCT00834795|992239|P1|NOT COMPLETED|Second Intervention||1
416463|NCT00834795|992238|P2|COMPLETED|Second Intervention||17
416464|NCT00834795|992239|P1|COMPLETED|Second Intervention||17
416465|NCT00834795|992238|P2|STARTED|Second Intervention||17
416466|NCT00834795|992239|P1|STARTED|Second Intervention||18
416467|NCT00834795|992238|P2|NOT COMPLETED|Washout: 7 Days||1
416468|NCT00834795|992239|P1|NOT COMPLETED|Washout: 7 Days||0
416469|NCT00834795|992238|P2|COMPLETED|Washout: 7 Days||17
416470|NCT00834795|992239|P1|COMPLETED|Washout: 7 Days||18
416471|NCT00834795|992238|P2|STARTED|Washout: 7 Days||18
416472|NCT00834795|992239|P1|STARTED|Washout: 7 Days||18
416473|NCT00834795|992238|P2|NOT COMPLETED|First Intervention||0
416474|NCT00834795|992239|P1|NOT COMPLETED|First Intervention||0
416475|NCT00834795|992238|P2|COMPLETED|First Intervention||18
416476|NCT00834795|992239|P1|COMPLETED|First Intervention||18
416477|NCT00834795|992238|P2|STARTED|First Intervention||18
416478|NCT00834795|992239|P1|STARTED|First Intervention||18
416479|NCT00833794|992249|P2|NOT COMPLETED|Double-blind Phase||49
416480|NCT00833794|992250|P1|NOT COMPLETED|Double-blind Phase||106
416481|NCT00833794|992249|P2|COMPLETED|Double-blind Phase||165
416482|NCT00833794|992250|P1|COMPLETED|Double-blind Phase||326
416483|NCT00833794|992249|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
416484|NCT00833794|992250|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
416485|NCT00833794|992249|P2|NOT COMPLETED|Open-label Phase||0
416486|NCT00833794|992250|P1|NOT COMPLETED|Open-label Phase||382
416487|NCT00833794|992249|P2|COMPLETED|Open-label Phase||0
416488|NCT00833794|992250|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
416489|NCT00833794|992249|P2|Received Open-Label Treatment|Open-label Phase||0
416490|NCT00833794|992250|P1|Received Open-Label Treatment|Open-label Phase||1023
416491|NCT00833794|992249|P2|Entered run-in Period|Open-label Phase||0
416492|NCT00833794|992250|P1|Entered run-in Period|Open-label Phase||1027
416493|NCT00833794|992249|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
416494|NCT00833794|992250|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
416495|NCT00833781|992278|P2|NOT COMPLETED|Overall Study||0
416496|NCT00833781|992279|P1|NOT COMPLETED|Overall Study||0
416497|NCT00833781|992278|P2|COMPLETED|Overall Study||5
416498|NCT00833781|992279|P1|COMPLETED|Overall Study||10
416499|NCT00833781|992278|P2|STARTED|Overall Study||5
416500|NCT00833781|992279|P1|STARTED|Overall Study||10
416501|NCT00833755|992294|P4|NOT COMPLETED|Overall Study||6
416502|NCT00833755|992295|P3|NOT COMPLETED|Overall Study||2
416503|NCT00833755|992296|P2|NOT COMPLETED|Overall Study||5
416504|NCT00833755|992297|P1|NOT COMPLETED|Overall Study||4
416505|NCT00833755|992294|P4|COMPLETED|Overall Study||17
416506|NCT00833755|992295|P3|COMPLETED|Overall Study||20
416507|NCT00833755|992296|P2|COMPLETED|Overall Study||13
416508|NCT00833755|992297|P1|COMPLETED|Overall Study||12
416509|NCT00833755|992294|P4|STARTED|Overall Study||23
416510|NCT00833755|992295|P3|STARTED|Overall Study||22
416511|NCT00833755|992296|P2|STARTED|Overall Study||18
416512|NCT00833755|992297|P1|STARTED|Overall Study||16
416513|NCT00833703|992317|P2|NOT COMPLETED|Overall Study||1
416514|NCT00833703|992318|P1|NOT COMPLETED|Overall Study||0
416515|NCT00833703|992317|P2|COMPLETED|Overall Study|Completed follow-up|25
416516|NCT00833703|992318|P1|COMPLETED|Overall Study|Completed follow-up|23
416517|NCT00833703|992317|P2|Completed Treatment|Overall Study||24
416518|NCT00833703|992318|P1|Completed Treatment|Overall Study||22
416519|NCT00833703|992317|P2|Treated|Overall Study||26
416520|NCT00833703|992318|P1|Treated|Overall Study||23
416521|NCT00833703|992317|P2|STARTED|Overall Study|Included|26
416522|NCT00833703|992318|P1|STARTED|Overall Study|Included|23
416523|NCT00833690|992331|P3|NOT COMPLETED|Overall Study||0
416524|NCT00833690|992332|P2|NOT COMPLETED|Overall Study||2
416525|NCT00833690|992333|P1|NOT COMPLETED|Overall Study||4
416526|NCT00833690|992331|P3|COMPLETED|Overall Study||26
416527|NCT00833690|992332|P2|COMPLETED|Overall Study||22
416528|NCT00833690|992333|P1|COMPLETED|Overall Study||21
416529|NCT00833690|992331|P3|STARTED|Overall Study||26
416530|NCT00833690|992332|P2|STARTED|Overall Study||24
416531|NCT00833690|992333|P1|STARTED|Overall Study||25
416532|NCT00834756|992457|P2|NOT COMPLETED|Second Intervention||0
416533|NCT00834756|992458|P1|NOT COMPLETED|Second Intervention||0
416534|NCT00834756|992457|P2|COMPLETED|Second Intervention||18
416535|NCT00834756|992458|P1|COMPLETED|Second Intervention||16
416536|NCT00834756|992457|P2|STARTED|Second Intervention||18
416537|NCT00834756|992458|P1|STARTED|Second Intervention||16
416538|NCT00834756|992457|P2|NOT COMPLETED|Washout: 21 Days||0
416539|NCT00834756|992458|P1|NOT COMPLETED|Washout: 21 Days||1
416540|NCT00834756|992457|P2|COMPLETED|Washout: 21 Days||18
416541|NCT00834756|992458|P1|COMPLETED|Washout: 21 Days||16
416542|NCT00834756|992457|P2|STARTED|Washout: 21 Days||18
416543|NCT00834756|992458|P1|STARTED|Washout: 21 Days||17
416544|NCT00834756|992457|P2|NOT COMPLETED|First Intervention||0
416545|NCT00834756|992458|P1|NOT COMPLETED|First Intervention||1
416546|NCT00834756|992457|P2|COMPLETED|First Intervention||18
416547|NCT00834756|992458|P1|COMPLETED|First Intervention||17
416548|NCT00834756|992457|P2|STARTED|First Intervention||18
416549|NCT00834756|992458|P1|STARTED|First Intervention||18
416550|NCT00834743|992468|P2|NOT COMPLETED|Second Intervention||0
416551|NCT00834743|992469|P1|NOT COMPLETED|Second Intervention||1
416552|NCT00834743|992468|P2|COMPLETED|Second Intervention||16
416553|NCT00834743|992469|P1|COMPLETED|Second Intervention||15
416554|NCT00834743|992468|P2|STARTED|Second Intervention||16
416555|NCT00834743|992469|P1|STARTED|Second Intervention||16
416556|NCT00834743|992468|P2|NOT COMPLETED|Washout of 7 Days||0
416557|NCT00834743|992469|P1|NOT COMPLETED|Washout of 7 Days||0
416558|NCT00834743|992468|P2|COMPLETED|Washout of 7 Days||16
416559|NCT00834743|992469|P1|COMPLETED|Washout of 7 Days||16
416560|NCT00834743|992468|P2|STARTED|Washout of 7 Days||16
416561|NCT00834743|992469|P1|STARTED|Washout of 7 Days||16
416562|NCT00834743|992468|P2|NOT COMPLETED|First Intervention||0
416563|NCT00834743|992469|P1|NOT COMPLETED|First Intervention||0
416564|NCT00834743|992468|P2|COMPLETED|First Intervention||16
416565|NCT00834743|992469|P1|COMPLETED|First Intervention||16
416566|NCT00834743|992468|P2|STARTED|First Intervention||16
416567|NCT00834743|992469|P1|STARTED|First Intervention||16
416568|NCT00834717|992479|P2|NOT COMPLETED|Second Intervention||0
416569|NCT00834717|992480|P1|NOT COMPLETED|Second Intervention||0
416570|NCT00834717|992479|P2|COMPLETED|Second Intervention||19
416571|NCT00834717|992480|P1|COMPLETED|Second Intervention||19
416572|NCT00834717|992479|P2|STARTED|Second Intervention||19
416573|NCT00834717|992480|P1|STARTED|Second Intervention||19
416574|NCT00834717|992479|P2|NOT COMPLETED|First Intervention||1
416575|NCT00834717|992480|P1|NOT COMPLETED|First Intervention||1
416576|NCT00834717|992479|P2|COMPLETED|First Intervention||19
416577|NCT00834717|992480|P1|COMPLETED|First Intervention||19
416578|NCT00834717|992479|P2|STARTED|First Intervention||20
416579|NCT00834717|992480|P1|STARTED|First Intervention||20
416580|NCT00834678|992488|P1|NOT COMPLETED|Overall Study||0
416581|NCT00834678|992488|P1|COMPLETED|Overall Study||11
416582|NCT00834678|992488|P1|STARTED|Overall Study||11
416583|NCT00834639|992501|P2|NOT COMPLETED|Second Intervention||2
416584|NCT00834639|992502|P1|NOT COMPLETED|Second Intervention||0
416585|NCT00834639|992501|P2|COMPLETED|Second Intervention||10
416586|NCT00834639|992502|P1|COMPLETED|Second Intervention||12
416587|NCT00834639|992501|P2|STARTED|Second Intervention||12
416588|NCT00834639|992502|P1|STARTED|Second Intervention||12
416589|NCT00834639|992501|P2|NOT COMPLETED|Washout of 7 Days||0
416590|NCT00834639|992502|P1|NOT COMPLETED|Washout of 7 Days||0
416591|NCT00834639|992501|P2|COMPLETED|Washout of 7 Days||12
416592|NCT00834639|992502|P1|COMPLETED|Washout of 7 Days||12
416593|NCT00834639|992501|P2|STARTED|Washout of 7 Days||12
416594|NCT00834639|992502|P1|STARTED|Washout of 7 Days||12
416595|NCT00834639|992501|P2|NOT COMPLETED|First Intervention||0
416596|NCT00834639|992502|P1|NOT COMPLETED|First Intervention||0
416597|NCT00834639|992501|P2|COMPLETED|First Intervention||12
416598|NCT00834639|992502|P1|COMPLETED|First Intervention||12
416599|NCT00834639|992501|P2|STARTED|First Intervention||12
416600|NCT00834639|992502|P1|STARTED|First Intervention||12
416601|NCT00834626|992510|P1|NOT COMPLETED|Overall Study||0
416602|NCT00834626|992510|P1|COMPLETED|Overall Study||30
416603|NCT00834626|992510|P1|1 Year Follow-up|Overall Study||30
416604|NCT00834626|992510|P1|STARTED|Overall Study||30
416605|NCT00834613|992519|P2|NOT COMPLETED|Second Intervention||0
416606|NCT00834613|992520|P1|NOT COMPLETED|Second Intervention||0
416607|NCT00834613|992519|P2|COMPLETED|Second Intervention||16
416608|NCT00834613|992520|P1|COMPLETED|Second Intervention||15
416609|NCT00834613|992519|P2|STARTED|Second Intervention||16
416610|NCT00834613|992520|P1|STARTED|Second Intervention||15
416611|NCT00834613|992519|P2|NOT COMPLETED|Washout of 7 Days||0
416612|NCT00834613|992520|P1|NOT COMPLETED|Washout of 7 Days||0
416613|NCT00834613|992519|P2|COMPLETED|Washout of 7 Days||16
416614|NCT00834613|992520|P1|COMPLETED|Washout of 7 Days||15
416615|NCT00834613|992519|P2|STARTED|Washout of 7 Days||16
416616|NCT00834613|992520|P1|STARTED|Washout of 7 Days||15
416617|NCT00834613|992519|P2|NOT COMPLETED|First Intervention||0
416618|NCT00834613|992520|P1|NOT COMPLETED|First Intervention||1
416619|NCT00834613|992519|P2|COMPLETED|First Intervention||16
416620|NCT00834613|992520|P1|COMPLETED|First Intervention||15
416621|NCT00834613|992519|P2|STARTED|First Intervention||16
416622|NCT00834613|992520|P1|STARTED|First Intervention||16
416623|NCT00834587|992530|P2|NOT COMPLETED|Second Intervention||0
416624|NCT00834587|992531|P1|NOT COMPLETED|Second Intervention||0
416625|NCT00834587|992530|P2|COMPLETED|Second Intervention||20
416626|NCT00834587|992531|P1|COMPLETED|Second Intervention||19
416627|NCT00834587|992530|P2|STARTED|Second Intervention||20
416628|NCT00834587|992531|P1|STARTED|Second Intervention||19
416629|NCT00834587|992530|P2|NOT COMPLETED|Washout: 7 Days||0
416630|NCT00834587|992531|P1|NOT COMPLETED|Washout: 7 Days||1
416631|NCT00834587|992530|P2|COMPLETED|Washout: 7 Days||20
416632|NCT00834587|992531|P1|COMPLETED|Washout: 7 Days||19
416633|NCT00834587|992530|P2|STARTED|Washout: 7 Days||20
416634|NCT00834587|992531|P1|STARTED|Washout: 7 Days||20
416635|NCT00834587|992530|P2|NOT COMPLETED|First Intervention||0
416636|NCT00834587|992531|P1|NOT COMPLETED|First Intervention||0
416637|NCT00834587|992530|P2|COMPLETED|First Intervention||20
416638|NCT00834587|992531|P1|COMPLETED|First Intervention||20
416639|NCT00834587|992530|P2|STARTED|First Intervention||20
416640|NCT00834587|992531|P1|STARTED|First Intervention||20
416641|NCT00834574|992547|P2|NOT COMPLETED|Second Intervention||0
416642|NCT00834574|992548|P1|NOT COMPLETED|Second Intervention||0
416643|NCT00834574|992547|P2|COMPLETED|Second Intervention||16
416644|NCT00834574|992548|P1|COMPLETED|Second Intervention||16
416645|NCT00834574|992547|P2|STARTED|Second Intervention||16
416646|NCT00834574|992548|P1|STARTED|Second Intervention||16
416647|NCT00834574|992547|P2|NOT COMPLETED|Washout of 7 Days||0
416648|NCT00834574|992548|P1|NOT COMPLETED|Washout of 7 Days||0
416649|NCT00834574|992547|P2|COMPLETED|Washout of 7 Days||16
416650|NCT00834574|992548|P1|COMPLETED|Washout of 7 Days||16
416651|NCT00834574|992547|P2|STARTED|Washout of 7 Days||16
416652|NCT00834574|992548|P1|STARTED|Washout of 7 Days||16
416653|NCT00834574|992547|P2|NOT COMPLETED|First Intervention||0
416654|NCT00834574|992548|P1|NOT COMPLETED|First Intervention||0
416655|NCT00834574|992547|P2|COMPLETED|First Intervention||16
416656|NCT00834574|992548|P1|COMPLETED|First Intervention||16
416657|NCT00834574|992547|P2|STARTED|First Intervention||16
416658|NCT00834574|992548|P1|STARTED|First Intervention||16
416659|NCT00834561|992558|P2|NOT COMPLETED|Second Intervention||0
416660|NCT00834561|992559|P1|NOT COMPLETED|Second Intervention||0
416661|NCT00834561|992558|P2|COMPLETED|Second Intervention||16
416662|NCT00834561|992559|P1|COMPLETED|Second Intervention||16
416663|NCT00834561|992558|P2|STARTED|Second Intervention||16
416664|NCT00834561|992559|P1|STARTED|Second Intervention||16
416665|NCT00834561|992558|P2|NOT COMPLETED|First Intervention||0
416666|NCT00834561|992559|P1|NOT COMPLETED|First Intervention||0
416667|NCT00834561|992558|P2|COMPLETED|First Intervention||16
416668|NCT00834561|992559|P1|COMPLETED|First Intervention||16
416669|NCT00834561|992558|P2|STARTED|First Intervention||16
416670|NCT00834561|992559|P1|STARTED|First Intervention||16
416671|NCT00834535|992569|P2|NOT COMPLETED|Second Intervention||0
416672|NCT00834535|992570|P1|NOT COMPLETED|Second Intervention||0
416673|NCT00834535|992569|P2|COMPLETED|Second Intervention||16
416674|NCT00834535|992570|P1|COMPLETED|Second Intervention||16
416675|NCT00834535|992569|P2|STARTED|Second Intervention||16
416676|NCT00834535|992570|P1|STARTED|Second Intervention||16
416677|NCT00834535|992569|P2|NOT COMPLETED|Washout of 7 Days||0
416678|NCT00834535|992570|P1|NOT COMPLETED|Washout of 7 Days||0
416679|NCT00834535|992569|P2|COMPLETED|Washout of 7 Days||16
416680|NCT00834535|992570|P1|COMPLETED|Washout of 7 Days||16
416681|NCT00834535|992569|P2|STARTED|Washout of 7 Days||16
416682|NCT00834535|992570|P1|STARTED|Washout of 7 Days||16
416683|NCT00834535|992569|P2|NOT COMPLETED|First Intervention||0
416684|NCT00834535|992570|P1|NOT COMPLETED|First Intervention||0
416685|NCT00834535|992569|P2|COMPLETED|First Intervention||16
416686|NCT00834535|992570|P1|COMPLETED|First Intervention||16
416687|NCT00834535|992569|P2|STARTED|First Intervention||16
416688|NCT00834535|992570|P1|STARTED|First Intervention||16
416689|NCT00834522|992580|P2|NOT COMPLETED|Second Intervention||0
416690|NCT00834522|992581|P1|NOT COMPLETED|Second Intervention||0
416691|NCT00834522|992580|P2|COMPLETED|Second Intervention||39
416692|NCT00834522|992581|P1|COMPLETED|Second Intervention||37
416693|NCT00834522|992580|P2|STARTED|Second Intervention||39
416694|NCT00834522|992581|P1|STARTED|Second Intervention||37
416695|NCT00834522|992580|P2|NOT COMPLETED|Washout||1
416696|NCT00834522|992581|P1|NOT COMPLETED|Washout||3
416697|NCT00834522|992580|P2|COMPLETED|Washout||39
416698|NCT00834522|992581|P1|COMPLETED|Washout||37
416699|NCT00834522|992580|P2|STARTED|Washout||40
416700|NCT00834522|992581|P1|STARTED|Washout||40
416701|NCT00834522|992580|P2|NOT COMPLETED|First Intervention||0
416702|NCT00834522|992581|P1|NOT COMPLETED|First Intervention||0
416703|NCT00834522|992580|P2|COMPLETED|First Intervention||40
416704|NCT00834522|992581|P1|COMPLETED|First Intervention||40
416705|NCT00834522|992580|P2|STARTED|First Intervention||40
416706|NCT00834522|992581|P1|STARTED|First Intervention||40
416707|NCT00834483|992591|P2|NOT COMPLETED|Overall Study||0
416708|NCT00834483|992592|P1|NOT COMPLETED|Overall Study||0
416709|NCT00834483|992591|P2|COMPLETED|Overall Study||29
416710|NCT00834483|992592|P1|COMPLETED|Overall Study||31
416711|NCT00834483|992591|P2|STARTED|Overall Study||29
416712|NCT00834483|992592|P1|STARTED|Overall Study||31
416713|NCT00834444|992604|P2|NOT COMPLETED|Second Intervention||0
416714|NCT00834444|992605|P1|NOT COMPLETED|Second Intervention||1
416715|NCT00834444|992604|P2|COMPLETED|Second Intervention||16
416716|NCT00834444|992605|P1|COMPLETED|Second Intervention||16
416717|NCT00834444|992604|P2|STARTED|Second Intervention||16
416718|NCT00834444|992605|P1|STARTED|Second Intervention||17
416719|NCT00834444|992604|P2|NOT COMPLETED|Washout of 7 Days||1
416720|NCT00834444|992605|P1|NOT COMPLETED|Washout of 7 Days||0
416721|NCT00834444|992604|P2|COMPLETED|Washout of 7 Days||16
416722|NCT00834444|992605|P1|COMPLETED|Washout of 7 Days||17
416723|NCT00834444|992604|P2|STARTED|Washout of 7 Days||17
416724|NCT00834444|992605|P1|STARTED|Washout of 7 Days||17
416725|NCT00834444|992604|P2|NOT COMPLETED|First Intervention||1
416726|NCT00834444|992605|P1|NOT COMPLETED|First Intervention||1
416727|NCT00834444|992604|P2|COMPLETED|First Intervention||17
416728|NCT00834444|992605|P1|COMPLETED|First Intervention||17
416729|NCT00834444|992604|P2|STARTED|First Intervention||18
416730|NCT00834444|992605|P1|STARTED|First Intervention||18
416731|NCT00834431|992615|P2|NOT COMPLETED|Second Intervention||0
416732|NCT00834431|992616|P1|NOT COMPLETED|Second Intervention||0
416733|NCT00834431|992615|P2|COMPLETED|Second Intervention||16
416734|NCT00834431|992616|P1|COMPLETED|Second Intervention||18
416735|NCT00834431|992615|P2|STARTED|Second Intervention||16
416736|NCT00834431|992616|P1|STARTED|Second Intervention||18
416737|NCT00834431|992615|P2|NOT COMPLETED|Washout of 7 Days||1
416738|NCT00834431|992616|P1|NOT COMPLETED|Washout of 7 Days||0
416739|NCT00834431|992615|P2|COMPLETED|Washout of 7 Days||16
416740|NCT00834431|992616|P1|COMPLETED|Washout of 7 Days||18
416741|NCT00834431|992615|P2|STARTED|Washout of 7 Days||17
416742|NCT00834431|992616|P1|STARTED|Washout of 7 Days||18
416743|NCT00834431|992615|P2|NOT COMPLETED|First Intervention||1
416744|NCT00834431|992616|P1|NOT COMPLETED|First Intervention||0
416745|NCT00834431|992615|P2|COMPLETED|First Intervention||17
416746|NCT00834431|992616|P1|COMPLETED|First Intervention||18
416747|NCT00834431|992615|P2|STARTED|First Intervention||18
416748|NCT00834431|992616|P1|STARTED|First Intervention||18
416749|NCT00834418|992626|P2|NOT COMPLETED|Overall Study||2
416750|NCT00834418|992627|P1|NOT COMPLETED|Overall Study||0
416751|NCT00834418|992626|P2|COMPLETED|Overall Study||40
416752|NCT00834418|992627|P1|COMPLETED|Overall Study||42
416753|NCT00834418|992626|P2|STARTED|Overall Study||42
416754|NCT00834418|992627|P1|STARTED|Overall Study||42
416755|NCT00834405|992635|P2|NOT COMPLETED|Overall Study||0
416756|NCT00834405|992636|P1|NOT COMPLETED|Overall Study||0
416757|NCT00834405|992635|P2|COMPLETED|Overall Study||17
416758|NCT00834405|992636|P1|COMPLETED|Overall Study||20
416759|NCT00834405|992635|P2|STARTED|Overall Study||17
416760|NCT00834405|992636|P1|STARTED|Overall Study||20
416761|NCT00834366|992644|P2|NOT COMPLETED|Treatment Period 2||0
416762|NCT00834366|992645|P1|NOT COMPLETED|Treatment Period 2||0
416763|NCT00834366|992644|P2|COMPLETED|Treatment Period 2||12
416764|NCT00834366|992645|P1|COMPLETED|Treatment Period 2||12
416765|NCT00834366|992644|P2|STARTED|Treatment Period 2||12
416766|NCT00834366|992645|P1|STARTED|Treatment Period 2||12
416767|NCT00834366|992644|P2|NOT COMPLETED|Treatment Period 1||1
416768|NCT00834366|992645|P1|NOT COMPLETED|Treatment Period 1||1
416769|NCT00834366|992644|P2|COMPLETED|Treatment Period 1||12
416770|NCT00834366|992645|P1|COMPLETED|Treatment Period 1||12
416771|NCT00834366|992644|P2|STARTED|Treatment Period 1||13
416772|NCT00834366|992645|P1|STARTED|Treatment Period 1||13
416773|NCT00834340|992661|P2|NOT COMPLETED|Second Intervention||0
416774|NCT00834340|992662|P1|NOT COMPLETED|Second Intervention||0
416775|NCT00834340|992661|P2|COMPLETED|Second Intervention||16
416776|NCT00834340|992662|P1|COMPLETED|Second Intervention||14
416777|NCT00834340|992661|P2|STARTED|Second Intervention||16
416778|NCT00834340|992662|P1|STARTED|Second Intervention||14
416779|NCT00834340|992661|P2|NOT COMPLETED|Washout||0
416780|NCT00834340|992662|P1|NOT COMPLETED|Washout||2
416781|NCT00834340|992661|P2|COMPLETED|Washout||16
416782|NCT00834340|992662|P1|COMPLETED|Washout||14
416783|NCT00834340|992661|P2|STARTED|Washout||16
416784|NCT00834340|992662|P1|STARTED|Washout||16
416785|NCT00834340|992661|P2|NOT COMPLETED|First Intervention||0
416786|NCT00834340|992662|P1|NOT COMPLETED|First Intervention||0
416787|NCT00834340|992661|P2|COMPLETED|First Intervention||16
416788|NCT00834340|992662|P1|COMPLETED|First Intervention||16
416789|NCT00834340|992661|P2|STARTED|First Intervention||16
416790|NCT00834340|992662|P1|STARTED|First Intervention||16
416791|NCT00834288|992672|P2|NOT COMPLETED|Treatment Phase II||0
416792|NCT00834288|992673|P1|NOT COMPLETED|Treatment Phase II||0
416793|NCT00834288|992672|P2|COMPLETED|Treatment Phase II||13
416794|NCT00834288|992673|P1|COMPLETED|Treatment Phase II||13
416795|NCT00834288|992672|P2|STARTED|Treatment Phase II||13
416796|NCT00834288|992673|P1|STARTED|Treatment Phase II||13
416797|NCT00834288|992672|P2|NOT COMPLETED|Treatment Phase I||0
416798|NCT00834288|992673|P1|NOT COMPLETED|Treatment Phase I||0
416799|NCT00834288|992672|P2|COMPLETED|Treatment Phase I||13
416800|NCT00834288|992673|P1|COMPLETED|Treatment Phase I||13
416801|NCT00834288|992672|P2|STARTED|Treatment Phase I||13
416802|NCT00834288|992673|P1|STARTED|Treatment Phase I||13
416803|NCT00834275|992695|P2|NOT COMPLETED|Second Intervention||0
416804|NCT00834275|992696|P1|NOT COMPLETED|Second Intervention||0
416805|NCT00834275|992695|P2|COMPLETED|Second Intervention||13
416806|NCT00834275|992696|P1|COMPLETED|Second Intervention||13
416807|NCT00834275|992695|P2|STARTED|Second Intervention||13
416808|NCT00834275|992696|P1|STARTED|Second Intervention||13
416809|NCT00834275|992695|P2|NOT COMPLETED|Washout of 7 Days||0
416810|NCT00834275|992696|P1|NOT COMPLETED|Washout of 7 Days||0
416811|NCT00834275|992695|P2|COMPLETED|Washout of 7 Days||13
416812|NCT00834275|992696|P1|COMPLETED|Washout of 7 Days||13
416813|NCT00834275|992695|P2|STARTED|Washout of 7 Days||13
416814|NCT00834275|992696|P1|STARTED|Washout of 7 Days||13
416815|NCT00834275|992695|P2|NOT COMPLETED|First Intervention||0
416816|NCT00834275|992696|P1|NOT COMPLETED|First Intervention||0
416817|NCT00834275|992695|P2|COMPLETED|First Intervention||13
416818|NCT00834275|992696|P1|COMPLETED|First Intervention||13
416819|NCT00834275|992695|P2|STARTED|First Intervention||13
416820|NCT00834275|992696|P1|STARTED|First Intervention||13
416821|NCT00834249|992706|P2|NOT COMPLETED|Second Intervention||0
416822|NCT00834249|992707|P1|NOT COMPLETED|Second Intervention||1
416823|NCT00834249|992706|P2|COMPLETED|Second Intervention||8
416824|NCT00834249|992707|P1|COMPLETED|Second Intervention||7
416825|NCT00834249|992706|P2|STARTED|Second Intervention||8
416826|NCT00834249|992707|P1|STARTED|Second Intervention||8
416827|NCT00834249|992706|P2|NOT COMPLETED|Washout: 7 Days||1
416828|NCT00834249|992707|P1|NOT COMPLETED|Washout: 7 Days||1
416829|NCT00834249|992706|P2|COMPLETED|Washout: 7 Days||8
416830|NCT00834249|992707|P1|COMPLETED|Washout: 7 Days||8
416831|NCT00834249|992706|P2|STARTED|Washout: 7 Days||9
416832|NCT00834249|992707|P1|STARTED|Washout: 7 Days||9
416833|NCT00834249|992706|P2|NOT COMPLETED|First Intervention||0
416834|NCT00834249|992707|P1|NOT COMPLETED|First Intervention||0
416835|NCT00834249|992706|P2|COMPLETED|First Intervention||9
416836|NCT00834249|992707|P1|COMPLETED|First Intervention||9
416837|NCT00834249|992706|P2|STARTED|First Intervention||9
416838|NCT00834249|992707|P1|STARTED|First Intervention||9
416839|NCT00834236|992723|P2|NOT COMPLETED|Overall Study||0
416840|NCT00834236|992724|P1|NOT COMPLETED|Overall Study||0
416841|NCT00834236|992723|P2|COMPLETED|Overall Study||47
416842|NCT00834236|992724|P1|COMPLETED|Overall Study||29
416843|NCT00834236|992723|P2|STARTED|Overall Study||47
416844|NCT00834236|992724|P1|STARTED|Overall Study||29
416845|NCT00834210|992732|P2|NOT COMPLETED|Overall Study||8
416846|NCT00834210|992733|P1|NOT COMPLETED|Overall Study||3
416847|NCT00834210|992732|P2|COMPLETED|Overall Study||77
416848|NCT00834210|992733|P1|COMPLETED|Overall Study||83
416849|NCT00834210|992732|P2|STARTED|Overall Study||85
416850|NCT00834210|992733|P1|STARTED|Overall Study||86
416851|NCT00834197|992747|P2|NOT COMPLETED|Second Intervention||0
416852|NCT00834197|992748|P1|NOT COMPLETED|Second Intervention||0
416853|NCT00834197|992747|P2|COMPLETED|Second Intervention||16
416854|NCT00834197|992748|P1|COMPLETED|Second Intervention||16
416855|NCT00834197|992747|P2|STARTED|Second Intervention||16
416856|NCT00834197|992748|P1|STARTED|Second Intervention||16
416857|NCT00834197|992747|P2|NOT COMPLETED|Washout of 14 Days||0
416858|NCT00834197|992748|P1|NOT COMPLETED|Washout of 14 Days||0
416859|NCT00834197|992747|P2|COMPLETED|Washout of 14 Days||16
416860|NCT00834197|992748|P1|COMPLETED|Washout of 14 Days||16
416861|NCT00834197|992747|P2|STARTED|Washout of 14 Days||16
416862|NCT00834197|992748|P1|STARTED|Washout of 14 Days||16
416863|NCT00834197|992747|P2|NOT COMPLETED|First Intervention||0
416864|NCT00834197|992748|P1|NOT COMPLETED|First Intervention||0
416865|NCT00834197|992747|P2|COMPLETED|First Intervention||16
416866|NCT00834197|992748|P1|COMPLETED|First Intervention||16
416867|NCT00834197|992747|P2|STARTED|First Intervention||16
416868|NCT00834197|992748|P1|STARTED|First Intervention||16
416869|NCT00834171|992758|P2|NOT COMPLETED|Overall Study||0
416870|NCT00834171|992759|P1|NOT COMPLETED|Overall Study||0
416871|NCT00834171|992758|P2|COMPLETED|Overall Study||7
416872|NCT00834171|992759|P1|COMPLETED|Overall Study||43
416873|NCT00834171|992758|P2|STARTED|Overall Study||7
416874|NCT00834171|992759|P1|STARTED|Overall Study||43
416875|NCT00834132|992767|P2|NOT COMPLETED|Second Intervention||0
416876|NCT00834132|992768|P1|NOT COMPLETED|Second Intervention||0
416877|NCT00834132|992767|P2|COMPLETED|Second Intervention||12
416878|NCT00834132|992768|P1|COMPLETED|Second Intervention||12
416879|NCT00834132|992767|P2|STARTED|Second Intervention||12
416880|NCT00834132|992768|P1|STARTED|Second Intervention||12
416881|NCT00834132|992767|P2|NOT COMPLETED|Washout: 21 Days||0
416882|NCT00834132|992768|P1|NOT COMPLETED|Washout: 21 Days||0
416883|NCT00834132|992767|P2|COMPLETED|Washout: 21 Days||12
416884|NCT00834132|992768|P1|COMPLETED|Washout: 21 Days||12
416885|NCT00834132|992767|P2|STARTED|Washout: 21 Days||12
416886|NCT00834132|992768|P1|STARTED|Washout: 21 Days||12
416887|NCT00834132|992767|P2|NOT COMPLETED|First Intervention||0
416888|NCT00834132|992768|P1|NOT COMPLETED|First Intervention||0
416889|NCT00834132|992767|P2|COMPLETED|First Intervention||12
416890|NCT00834132|992768|P1|COMPLETED|First Intervention||12
416891|NCT00834132|992767|P2|STARTED|First Intervention||12
416892|NCT00834132|992768|P1|STARTED|First Intervention||12
416893|NCT00834080|992776|P1|NOT COMPLETED|Overall Study||23
416894|NCT00834080|992776|P1|COMPLETED|Overall Study||15
416895|NCT00834080|992776|P1|STARTED|Overall Study||38
416896|NCT00834067|992782|P2|NOT COMPLETED|Second Intervention||0
416897|NCT00834067|992783|P1|NOT COMPLETED|Second Intervention||0
416898|NCT00834067|992782|P2|COMPLETED|Second Intervention||29
416899|NCT00834067|992783|P1|COMPLETED|Second Intervention||30
416900|NCT00834067|992782|P2|STARTED|Second Intervention||29
416901|NCT00834067|992783|P1|STARTED|Second Intervention||30
416902|NCT00834067|992782|P2|NOT COMPLETED|Washout of 21 Days||1
416903|NCT00834067|992783|P1|NOT COMPLETED|Washout of 21 Days||0
416904|NCT00834067|992782|P2|COMPLETED|Washout of 21 Days||29
416905|NCT00834067|992783|P1|COMPLETED|Washout of 21 Days||30
416906|NCT00834067|992782|P2|STARTED|Washout of 21 Days||30
416907|NCT00834067|992783|P1|STARTED|Washout of 21 Days||30
416908|NCT00834067|992782|P2|NOT COMPLETED|First Intervention||0
416909|NCT00834067|992783|P1|NOT COMPLETED|First Intervention||0
416910|NCT00834067|992782|P2|COMPLETED|First Intervention||30
416911|NCT00834067|992783|P1|COMPLETED|First Intervention||30
416912|NCT00834067|992782|P2|STARTED|First Intervention||30
416913|NCT00834067|992783|P1|STARTED|First Intervention||30
416914|NCT00834041|992805|P2|NOT COMPLETED|Overall Study||1
416915|NCT00834041|992806|P1|NOT COMPLETED|Overall Study||1
416916|NCT00834041|992805|P2|COMPLETED|Overall Study||19
416917|NCT00834041|992806|P1|COMPLETED|Overall Study||18
416918|NCT00834041|992805|P2|STARTED|Overall Study||20
416919|NCT00834041|992806|P1|STARTED|Overall Study||19
416920|NCT00833976|992820|P1|NOT COMPLETED|Overall Study||51
416921|NCT00833976|992820|P1|COMPLETED|Overall Study||14
416922|NCT00833976|992820|P1|STARTED|Overall Study||65
416923|NCT00833937|992828|P2|NOT COMPLETED|Second Intervention||0
416924|NCT00833937|992829|P1|NOT COMPLETED|Second Intervention||0
416925|NCT00833937|992828|P2|COMPLETED|Second Intervention||12
416926|NCT00833937|992829|P1|COMPLETED|Second Intervention||11
416927|NCT00833937|992828|P2|STARTED|Second Intervention||12
416928|NCT00833937|992829|P1|STARTED|Second Intervention||11
416929|NCT00833937|992828|P2|NOT COMPLETED|Washout||0
416930|NCT00833937|992829|P1|NOT COMPLETED|Washout||1
416931|NCT00833937|992828|P2|COMPLETED|Washout||12
416932|NCT00833937|992829|P1|COMPLETED|Washout||11
416933|NCT00833937|992828|P2|STARTED|Washout||12
416934|NCT00833937|992829|P1|STARTED|Washout||12
416935|NCT00833937|992828|P2|NOT COMPLETED|First Intervention||0
416936|NCT00833937|992829|P1|NOT COMPLETED|First Intervention||0
416937|NCT00833937|992828|P2|COMPLETED|First Intervention||12
416938|NCT00833937|992829|P1|COMPLETED|First Intervention||12
416939|NCT00833937|992828|P2|STARTED|First Intervention||12
416940|NCT00833937|992829|P1|STARTED|First Intervention||12
416941|NCT00833924|992837|P1|NOT COMPLETED|Overall Study||109
416942|NCT00833924|992837|P1|COMPLETED|Overall Study||11
416943|NCT00833924|992837|P1|12-month|Overall Study||113
416944|NCT00833924|992837|P1|30-day|Overall Study||120
416945|NCT00833924|992837|P1|STARTED|Overall Study||120
416946|NCT00833911|992842|P1|NOT COMPLETED|Maintenance Phase II||10
416947|NCT00833911|992842|P1|COMPLETED|Maintenance Phase II||166
416948|NCT00833911|992842|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
416949|NCT00833911|992842|P1|NOT COMPLETED|Maintenance Phase I||98
416950|NCT00833911|992842|P1|COMPLETED|Maintenance Phase I||273
416951|NCT00833911|992842|P1|STARTED|Maintenance Phase I||371
416952|NCT00833911|992842|P1|NOT COMPLETED|Titration||21
416953|NCT00833911|992842|P1|COMPLETED|Titration||371
416954|NCT00833911|992842|P1|STARTED|Titration||392
416955|NCT00833898|992852|P2|NOT COMPLETED|Overall Study||36
416956|NCT00833898|992853|P1|NOT COMPLETED|Overall Study||40
416957|NCT00833898|992852|P2|COMPLETED|Overall Study||38
416958|NCT00833898|992853|P1|COMPLETED|Overall Study||34
416959|NCT00833898|992852|P2|Month 12 (Post Transplantation)|Overall Study||50
416960|NCT00833898|992853|P1|Month 12 (Post Transplantation)|Overall Study||50
416961|NCT00833898|992852|P2|Month 6 (Post Transplantation)|Overall Study||54
416962|NCT00833898|992853|P1|Month 6 (Post Transplantation)|Overall Study||59
416963|NCT00833898|992852|P2|Month 3 (Post Transplantation)|Overall Study||64
416964|NCT00833898|992853|P1|Month 3 (Post Transplantation)|Overall Study||66
416965|NCT00833898|992852|P2|Month 1 (Post Transplantation)|Overall Study||74
416966|NCT00833898|992853|P1|Month 1 (Post Transplantation)|Overall Study||72
416967|NCT00833898|992852|P2|STARTED|Overall Study||74
416968|NCT00833898|992853|P1|STARTED|Overall Study||74
416969|NCT00833859|992899|P1|NOT COMPLETED|Overall Study||0
416970|NCT00833859|992899|P1|COMPLETED|Overall Study||2
416971|NCT00833859|992899|P1|STARTED|Overall Study||2
416972|NCT00833833|992909|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
416973|NCT00833833|992910|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
416974|NCT00833833|992911|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
416975|NCT00833833|992912|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
416976|NCT00833833|992913|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
416977|NCT00833833|992914|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
416978|NCT00833833|992909|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
416979|NCT00833833|992910|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
416980|NCT00833833|992911|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
416981|NCT00833833|992912|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
416982|NCT00833833|992913|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
416983|NCT00833833|992914|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
416984|NCT00833833|992909|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
416985|NCT00833833|992910|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
416986|NCT00833833|992911|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
416987|NCT00833833|992912|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
416988|NCT00833833|992913|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
416989|NCT00833833|992914|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
416990|NCT00833833|992909|P6|STARTED|Phase 2 (as of 01 April 2011)||108
416991|NCT00833833|992910|P5|STARTED|Phase 2 (as of 01 April 2011)||113
416992|NCT00833833|992911|P4|STARTED|Phase 2 (as of 01 April 2011)||0
416993|NCT00833833|992912|P3|STARTED|Phase 2 (as of 01 April 2011)||0
416994|NCT00833833|992913|P2|STARTED|Phase 2 (as of 01 April 2011)||0
416995|NCT00833833|992914|P1|STARTED|Phase 2 (as of 01 April 2011)||0
416996|NCT00833833|992909|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
416997|NCT00833833|992910|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
416998|NCT00833833|992911|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
416999|NCT00833833|992912|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
417000|NCT00833833|992913|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
417001|NCT00833833|992914|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
417002|NCT00833833|992909|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
417003|NCT00833833|992910|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
417004|NCT00833833|992911|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
417005|NCT00833833|992912|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
417006|NCT00833833|992913|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
417007|NCT00833833|992914|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
417008|NCT00833833|992909|P6|STARTED|Phase 1 (as of 01 April 2011)||0
417009|NCT00833833|992910|P5|STARTED|Phase 1 (as of 01 April 2011)||0
417010|NCT00833833|992911|P4|STARTED|Phase 1 (as of 01 April 2011)||10
417011|NCT00833833|992912|P3|STARTED|Phase 1 (as of 01 April 2011)||14
417012|NCT00833833|992913|P2|STARTED|Phase 1 (as of 01 April 2011)||8
417013|NCT00833833|992914|P1|STARTED|Phase 1 (as of 01 April 2011)||6
417014|NCT00833664|992954|P2|NOT COMPLETED|Second Intervention||0
417015|NCT00833664|992955|P1|NOT COMPLETED|Second Intervention||0
417016|NCT00833664|992954|P2|COMPLETED|Second Intervention||11
417017|NCT00833664|992955|P1|COMPLETED|Second Intervention||10
417018|NCT00833664|992954|P2|STARTED|Second Intervention||11
417019|NCT00833664|992955|P1|STARTED|Second Intervention||10
417020|NCT00833664|992954|P2|NOT COMPLETED|Washout: 14 Days||0
417021|NCT00833664|992955|P1|NOT COMPLETED|Washout: 14 Days||1
417022|NCT00833664|992954|P2|COMPLETED|Washout: 14 Days||11
417023|NCT00833664|992955|P1|COMPLETED|Washout: 14 Days||10
417024|NCT00833664|992954|P2|STARTED|Washout: 14 Days||11
417025|NCT00833664|992955|P1|STARTED|Washout: 14 Days||11
417026|NCT00833664|992954|P2|NOT COMPLETED|First Intervention||0
417027|NCT00833664|992955|P1|NOT COMPLETED|First Intervention||0
417028|NCT00833664|992954|P2|COMPLETED|First Intervention||11
417029|NCT00833664|992955|P1|COMPLETED|First Intervention||11
417030|NCT00833664|992954|P2|STARTED|First Intervention||11
417031|NCT00833664|992955|P1|STARTED|First Intervention||11
417032|NCT00833638|992966|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
417033|NCT00833638|992967|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
417034|NCT00833638|992968|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
417035|NCT00833638|992966|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
417036|NCT00833638|992967|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
417037|NCT00833638|992968|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
417038|NCT00833638|992966|P3|STARTED|Phase 3: Open-label Extension Phase||124
417039|NCT00833638|992967|P2|STARTED|Phase 3: Open-label Extension Phase||108
417040|NCT00833638|992968|P1|STARTED|Phase 3: Open-label Extension Phase||111
417041|NCT00833638|992966|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
417042|NCT00833638|992967|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
417043|NCT00833638|992968|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
417044|NCT00833638|992966|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
417045|NCT00833638|992967|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
417046|NCT00833638|992968|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
417047|NCT00833638|992966|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
417048|NCT00833638|992967|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
417049|NCT00833638|992968|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
417050|NCT00833586|993010|P2|NOT COMPLETED|Second Intervention||0
417051|NCT00833586|993011|P1|NOT COMPLETED|Second Intervention||0
417052|NCT00833586|993010|P2|COMPLETED|Second Intervention||14
417053|NCT00833586|993011|P1|COMPLETED|Second Intervention||14
417054|NCT00833586|993010|P2|STARTED|Second Intervention||14
417055|NCT00833586|993011|P1|STARTED|Second Intervention||14
417056|NCT00833586|993010|P2|NOT COMPLETED|Washout: 14 Days||0
417057|NCT00833586|993011|P1|NOT COMPLETED|Washout: 14 Days||0
417058|NCT00833586|993010|P2|COMPLETED|Washout: 14 Days||14
417059|NCT00833586|993011|P1|COMPLETED|Washout: 14 Days||14
417060|NCT00833586|993010|P2|STARTED|Washout: 14 Days||14
417061|NCT00833586|993011|P1|STARTED|Washout: 14 Days||14
417062|NCT00833586|993010|P2|NOT COMPLETED|First Intervention||0
417063|NCT00833586|993011|P1|NOT COMPLETED|First Intervention||0
417064|NCT00833586|993010|P2|COMPLETED|First Intervention||14
417065|NCT00833586|993011|P1|COMPLETED|First Intervention||14
417066|NCT00833586|993010|P2|STARTED|First Intervention||14
417067|NCT00833586|993011|P1|STARTED|First Intervention||14
417068|NCT00833560|993019|P1|NOT COMPLETED|Overall Study||42
417069|NCT00833560|993019|P1|COMPLETED|Overall Study||353
417070|NCT00833560|993019|P1|STARTED|Overall Study||395
417071|NCT00833547|993028|P2|NOT COMPLETED|Overall Study||2
417072|NCT00833547|993029|P1|NOT COMPLETED|Overall Study||2
417073|NCT00833547|993028|P2|COMPLETED|Overall Study||10
417074|NCT00833547|993029|P1|COMPLETED|Overall Study||11
417075|NCT00833547|993028|P2|STARTED|Overall Study||12
417076|NCT00833547|993029|P1|STARTED|Overall Study||13
417077|NCT00833521|993039|P2|NOT COMPLETED|Second Intervention||0
417078|NCT00833521|993040|P1|NOT COMPLETED|Second Intervention||0
417079|NCT00833521|993039|P2|COMPLETED|Second Intervention||19
417080|NCT00833521|993040|P1|COMPLETED|Second Intervention||19
417081|NCT00833521|993039|P2|STARTED|Second Intervention||19
417082|NCT00833521|993040|P1|STARTED|Second Intervention||19
417083|NCT00833521|993039|P2|NOT COMPLETED|First Intervention||0
417084|NCT00833521|993040|P1|NOT COMPLETED|First Intervention||0
417085|NCT00833521|993039|P2|COMPLETED|First Intervention||19
417086|NCT00833521|993040|P1|COMPLETED|First Intervention||19
417087|NCT00833521|993039|P2|STARTED|First Intervention||19
417088|NCT00833521|993040|P1|STARTED|First Intervention||19
417089|NCT00833482|993050|P6|NOT COMPLETED|Days 21-30||0
417090|NCT00833482|993051|P5|NOT COMPLETED|Days 21-30||1
417091|NCT00833482|993052|P4|NOT COMPLETED|Days 21-30||0
417092|NCT00833482|993053|P3|NOT COMPLETED|Days 21-30||1
417093|NCT00833482|993054|P2|NOT COMPLETED|Days 21-30||0
417094|NCT00833482|993055|P1|NOT COMPLETED|Days 21-30||0
417095|NCT00833482|993050|P6|COMPLETED|Days 21-30||0
417096|NCT00833482|993051|P5|COMPLETED|Days 21-30||7
417097|NCT00833482|993052|P4|COMPLETED|Days 21-30||0
417098|NCT00833482|993053|P3|COMPLETED|Days 21-30||20
417099|NCT00833482|993054|P2|COMPLETED|Days 21-30||0
417100|NCT00833482|993055|P1|COMPLETED|Days 21-30||0
417101|NCT00833482|993050|P6|STARTED|Days 21-30||0
417102|NCT00833482|993051|P5|STARTED|Days 21-30||8
417103|NCT00833482|993052|P4|STARTED|Days 21-30||0
417104|NCT00833482|993053|P3|STARTED|Days 21-30||21
417105|NCT00833482|993054|P2|STARTED|Days 21-30||0
417106|NCT00833482|993055|P1|STARTED|Days 21-30||0
417107|NCT00833482|993050|P6|NOT COMPLETED|Days 11-20||0
417108|NCT00833482|993051|P5|NOT COMPLETED|Days 11-20||0
417109|NCT00833482|993052|P4|NOT COMPLETED|Days 11-20||0
417110|NCT00833482|993053|P3|NOT COMPLETED|Days 11-20||0
417111|NCT00833482|993054|P2|NOT COMPLETED|Days 11-20||3
417112|NCT00833482|993055|P1|NOT COMPLETED|Days 11-20||0
417113|NCT00833482|993050|P6|COMPLETED|Days 11-20||8
417114|NCT00833482|993051|P5|COMPLETED|Days 11-20||0
417115|NCT00833482|993052|P4|COMPLETED|Days 11-20||0
417116|NCT00833482|993053|P3|COMPLETED|Days 11-20||0
417117|NCT00833482|993054|P2|COMPLETED|Days 11-20||21
417118|NCT00833482|993055|P1|COMPLETED|Days 11-20||0
417119|NCT00833482|993050|P6|STARTED|Days 11-20|Participants who received treatment.|8
417120|NCT00833482|993051|P5|STARTED|Days 11-20||0
417121|NCT00833482|993052|P4|STARTED|Days 11-20||0
417122|NCT00833482|993053|P3|STARTED|Days 11-20||0
417123|NCT00833482|993054|P2|STARTED|Days 11-20|Participants who received treatment.|24
417124|NCT00833482|993055|P1|STARTED|Days 11-20||0
417125|NCT00833482|993050|P6|NOT COMPLETED|Days 1-3||0
417126|NCT00833482|993051|P5|NOT COMPLETED|Days 1-3||0
417127|NCT00833482|993052|P4|NOT COMPLETED|Days 1-3||0
417128|NCT00833482|993053|P3|NOT COMPLETED|Days 1-3||0
417129|NCT00833482|993054|P2|NOT COMPLETED|Days 1-3||0
417130|NCT00833482|993055|P1|NOT COMPLETED|Days 1-3||0
417131|NCT00833482|993050|P6|COMPLETED|Days 1-3||0
417132|NCT00833482|993051|P5|COMPLETED|Days 1-3||0
417133|NCT00833482|993052|P4|COMPLETED|Days 1-3||8
417134|NCT00833482|993053|P3|COMPLETED|Days 1-3||0
417135|NCT00833482|993054|P2|COMPLETED|Days 1-3||0
417136|NCT00833482|993055|P1|COMPLETED|Days 1-3||24
417137|NCT00833482|993050|P6|STARTED|Days 1-3||0
417138|NCT00833482|993051|P5|STARTED|Days 1-3||0
417139|NCT00833482|993052|P4|STARTED|Days 1-3||8
417140|NCT00833482|993053|P3|STARTED|Days 1-3||0
417141|NCT00833482|993054|P2|STARTED|Days 1-3|Participants who received treatment|0
417142|NCT00833482|993055|P1|STARTED|Days 1-3|Participants who received treatment|24
417143|NCT00833469|993111|P1|NOT COMPLETED|Overall Study||2
417144|NCT00833469|993111|P1|COMPLETED|Overall Study||3
417145|NCT00833469|993111|P1|STARTED|Overall Study||5
417146|NCT00833443|993119|P2|NOT COMPLETED|Overall Study||28
417147|NCT00833443|993120|P1|NOT COMPLETED|Overall Study||20
417148|NCT00833443|993119|P2|COMPLETED|Overall Study||15
417149|NCT00833443|993120|P1|COMPLETED|Overall Study||21
417150|NCT00833443|993119|P2|STARTED|Overall Study||43
417151|NCT00833443|993120|P1|STARTED|Overall Study||41
417152|NCT00833417|993134|P2|NOT COMPLETED|Overall Study||71
417153|NCT00833417|993135|P1|NOT COMPLETED|Overall Study||33
417154|NCT00833417|993134|P2|COMPLETED|Overall Study||0
417155|NCT00833417|993135|P1|COMPLETED|Overall Study||0
417156|NCT00833417|993134|P2|STARTED|Overall Study||71
417157|NCT00833417|993135|P1|STARTED|Overall Study||33
417158|NCT00833365|993150|P2|NOT COMPLETED|Overall Study||0
417159|NCT00833365|993151|P1|NOT COMPLETED|Overall Study||0
417160|NCT00833365|993150|P2|COMPLETED|Overall Study||6
417161|NCT00833365|993151|P1|COMPLETED|Overall Study||9
417162|NCT00833365|993150|P2|STARTED|Overall Study||6
417163|NCT00833365|993151|P1|STARTED|Overall Study||9
417164|NCT00833248|993161|P2|NOT COMPLETED|Overall Study||3
417165|NCT00833248|993162|P1|NOT COMPLETED|Overall Study||4
417166|NCT00833248|993161|P2|COMPLETED|Overall Study||62
417167|NCT00833248|993162|P1|COMPLETED|Overall Study||177
417168|NCT00833248|993161|P2|Safety Analysis Set|Overall Study||64
417169|NCT00833248|993162|P1|Safety Analysis Set|Overall Study||181
417170|NCT00833248|993161|P2|Per Protocol (PP) Analysis Set|Overall Study||57
417171|NCT00833248|993162|P1|Per Protocol (PP) Analysis Set|Overall Study||164
417172|NCT00833248|993161|P2|Full Analysis Set (FAS)|Overall Study||64
417173|NCT00833248|993162|P1|Full Analysis Set (FAS)|Overall Study||180
417174|NCT00833248|993161|P2|STARTED|Overall Study||65
417175|NCT00833248|993162|P1|STARTED|Overall Study||181
417176|NCT00833092|993186|P2|NOT COMPLETED|Overall Study||7
417177|NCT00833092|993187|P1|NOT COMPLETED|Overall Study||4
417178|NCT00833092|993186|P2|COMPLETED|Overall Study||50
417179|NCT00833092|993187|P1|COMPLETED|Overall Study||50
417180|NCT00833092|993186|P2|STARTED|Overall Study||57
417181|NCT00833092|993187|P1|STARTED|Overall Study||54
417182|NCT00833053|993195|P2|NOT COMPLETED|Overall Study||3
417183|NCT00833053|993196|P1|NOT COMPLETED|Overall Study||9
417184|NCT00833053|993195|P2|COMPLETED|Overall Study||17
417185|NCT00833053|993196|P1|COMPLETED|Overall Study||10
417186|NCT00833053|993195|P2|STARTED|Overall Study||20
417187|NCT00833053|993196|P1|STARTED|Overall Study||19
417188|NCT00833040|993214|P6|NOT COMPLETED|Overall Study||1
417189|NCT00833040|993215|P5|NOT COMPLETED|Overall Study||0
417190|NCT00833040|993216|P4|NOT COMPLETED|Overall Study||0
417191|NCT00833040|993217|P3|NOT COMPLETED|Overall Study||0
417192|NCT00833040|993218|P2|NOT COMPLETED|Overall Study||0
417193|NCT00833040|993219|P1|NOT COMPLETED|Overall Study||0
417194|NCT00833040|993214|P6|COMPLETED|Overall Study||4
417195|NCT00833040|993215|P5|COMPLETED|Overall Study||5
417196|NCT00833040|993216|P4|COMPLETED|Overall Study||6
417197|NCT00833040|993217|P3|COMPLETED|Overall Study||6
417198|NCT00833040|993218|P2|COMPLETED|Overall Study||6
417199|NCT00833040|993219|P1|COMPLETED|Overall Study||6
417200|NCT00833040|993214|P6|STARTED|Overall Study||5
417201|NCT00833040|993215|P5|STARTED|Overall Study||5
417202|NCT00833040|993216|P4|STARTED|Overall Study||6
417203|NCT00833040|993217|P3|STARTED|Overall Study||6
417204|NCT00833040|993218|P2|STARTED|Overall Study||6
417205|NCT00833040|993219|P1|STARTED|Overall Study||6
417206|NCT00833027|993224|P1|NOT COMPLETED|Overall Study||211
417207|NCT00833027|993224|P1|COMPLETED|Overall Study||397
417208|NCT00833027|993224|P1|STARTED|Overall Study||608
417209|NCT00832975|993229|P1|NOT COMPLETED|Overall Study||39
417210|NCT00832975|993229|P1|COMPLETED|Overall Study||118
417211|NCT00832975|993229|P1|STARTED|Overall Study||157
417212|NCT00832871|993234|P1|NOT COMPLETED|Overall Study||0
417213|NCT00832871|993234|P1|COMPLETED|Overall Study||4
417214|NCT00832871|993234|P1|STARTED|Overall Study||4
417215|NCT00832819|993243|P3|NOT COMPLETED|Overall Study||1
417216|NCT00832819|993244|P2|NOT COMPLETED|Overall Study||1
417217|NCT00832819|993245|P1|NOT COMPLETED|Overall Study||0
417218|NCT00832819|993243|P3|COMPLETED|Overall Study||15
417219|NCT00832819|993244|P2|COMPLETED|Overall Study||5
417220|NCT00832819|993245|P1|COMPLETED|Overall Study||6
417221|NCT00832819|993243|P3|STARTED|Overall Study||16
417222|NCT00832819|993244|P2|STARTED|Overall Study||6
417223|NCT00832819|993245|P1|STARTED|Overall Study||6
417224|NCT00832650|993254|P3|NOT COMPLETED|Overall Study||1
417225|NCT00832650|993255|P2|NOT COMPLETED|Overall Study||0
417226|NCT00832650|993256|P1|NOT COMPLETED|Overall Study||0
417227|NCT00832650|993254|P3|COMPLETED|Overall Study||22
417228|NCT00832650|993255|P2|COMPLETED|Overall Study||12
417229|NCT00832650|993256|P1|COMPLETED|Overall Study||25
417230|NCT00832650|993254|P3|Treated|Overall Study||22
417231|NCT00832650|993255|P2|Treated|Overall Study||12
417232|NCT00832650|993256|P1|Treated|Overall Study||25
417233|NCT00832650|993254|P3|STARTED|Overall Study||23
417234|NCT00832650|993255|P2|STARTED|Overall Study||12
417235|NCT00832650|993256|P1|STARTED|Overall Study||25
417236|NCT00832637|993288|P1|NOT COMPLETED|Overall Study||0
417237|NCT00832637|993288|P1|COMPLETED|Overall Study||33
417238|NCT00832637|993288|P1|STARTED|Overall Study||33
417239|NCT00832624|993296|P1|NOT COMPLETED|Overall Study||10
417240|NCT00832624|993296|P1|COMPLETED|Overall Study||0
417241|NCT00832624|993296|P1|STARTED|Overall Study||10
417242|NCT00832585|993300|P1|NOT COMPLETED|Overall Study||2
417243|NCT00832585|993300|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
417244|NCT00832585|993300|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
417245|NCT00832572|993307|P2|NOT COMPLETED|Period 2||0
417246|NCT00832572|993308|P1|NOT COMPLETED|Period 2||0
417247|NCT00832572|993307|P2|COMPLETED|Period 2||2
417248|NCT00832572|993308|P1|COMPLETED|Period 2||3
417249|NCT00832572|993307|P2|STARTED|Period 2||2
417250|NCT00832572|993308|P1|STARTED|Period 2||3
417251|NCT00832572|993307|P2|NOT COMPLETED|Period 1||0
417252|NCT00832572|993308|P1|NOT COMPLETED|Period 1||0
417253|NCT00832572|993307|P2|COMPLETED|Period 1||2
417254|NCT00832572|993308|P1|COMPLETED|Period 1||3
417255|NCT00832572|993307|P2|STARTED|Period 1||2
417256|NCT00832572|993308|P1|STARTED|Period 1||3
417257|NCT00832520|993320|P1|NOT COMPLETED|Overall Study||0
417258|NCT00832520|993320|P1|COMPLETED|Overall Study||13
417259|NCT00832520|993320|P1|STARTED|Overall Study||13
417260|NCT00832455|993324|P1|NOT COMPLETED|Overall Study||72
417261|NCT00832455|993324|P1|COMPLETED|Overall Study||373
417262|NCT00832455|993324|P1|Week 12|Overall Study||373
417263|NCT00832455|993324|P1|Week 8 (Optional)|Overall Study||247
417264|NCT00832455|993324|P1|Week 4|Overall Study||411
417265|NCT00832455|993324|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
417266|NCT00832455|993324|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
417267|NCT00832416|993348|P4|NOT COMPLETED|Overall Study||83
417268|NCT00832416|993349|P3|NOT COMPLETED|Overall Study||61
417269|NCT00832416|993350|P2|NOT COMPLETED|Overall Study||53
417270|NCT00832416|993351|P1|NOT COMPLETED|Overall Study||46
417271|NCT00832416|993348|P4|COMPLETED|Overall Study||144
417272|NCT00832416|993349|P3|COMPLETED|Overall Study||54
417273|NCT00832416|993350|P2|COMPLETED|Overall Study||60
417274|NCT00832416|993351|P1|COMPLETED|Overall Study||64
417275|NCT00832416|993348|P4|STARTED|Overall Study||227
417276|NCT00832416|993349|P3|STARTED|Overall Study||115
417277|NCT00832416|993350|P2|STARTED|Overall Study||113
417278|NCT00832416|993351|P1|STARTED|Overall Study||110
417279|NCT00832390|993392|P3|NOT COMPLETED|Overall Study||0
417280|NCT00832390|993393|P2|NOT COMPLETED|Overall Study||0
417281|NCT00832390|993394|P1|NOT COMPLETED|Overall Study||0
417282|NCT00832390|993392|P3|COMPLETED|Overall Study||1
417283|NCT00832390|993393|P2|COMPLETED|Overall Study||16
417284|NCT00832390|993394|P1|COMPLETED|Overall Study||12
417285|NCT00832390|993392|P3|STARTED|Overall Study||1
417286|NCT00832390|993393|P2|STARTED|Overall Study||16
417287|NCT00832390|993394|P1|STARTED|Overall Study||12
417288|NCT00832377|993402|P1|NOT COMPLETED|Overall Study||1
417289|NCT00832377|993402|P1|COMPLETED|Overall Study||36
417290|NCT00832377|993402|P1|STARTED|Overall Study||37
417291|NCT00832338|993409|P1|NOT COMPLETED|Overall Study||0
417292|NCT00832338|993409|P1|COMPLETED|Overall Study||23
417293|NCT00832338|993409|P1|STARTED|Overall Study||23
417294|NCT00832299|993413|P1|NOT COMPLETED|Overall Study||0
417295|NCT00832299|993413|P1|COMPLETED|Overall Study||2
417296|NCT00832299|993413|P1|STARTED|Overall Study||2
417297|NCT00832260|993417|P1|NOT COMPLETED|Overall Study||0
417298|NCT00832260|993417|P1|COMPLETED|Overall Study||70
417299|NCT00832260|993417|P1|STARTED|Overall Study||70
417300|NCT00832130|993424|P2|NOT COMPLETED|Overall Study||0
417301|NCT00832130|993425|P1|NOT COMPLETED|Overall Study||0
417302|NCT00832130|993424|P2|COMPLETED|Overall Study||70
417303|NCT00832130|993425|P1|COMPLETED|Overall Study||69
417304|NCT00832130|993424|P2|STARTED|Overall Study||70
417305|NCT00832130|993425|P1|STARTED|Overall Study||69
417306|NCT00832117|993447|P1|NOT COMPLETED|Overall Study||12
417307|NCT00832117|993447|P1|COMPLETED|Overall Study||17
417308|NCT00832117|993447|P1|STARTED|Overall Study||29
417309|NCT00832091|993466|P2|NOT COMPLETED|Overall Study||2
417310|NCT00832091|993467|P1|NOT COMPLETED|Overall Study||5
417311|NCT00832091|993466|P2|COMPLETED|Overall Study||53
417312|NCT00832091|993467|P1|COMPLETED|Overall Study||12
417313|NCT00832091|993466|P2|STARTED|Overall Study||55
417314|NCT00832091|993467|P1|STARTED|Overall Study||17
417315|NCT00832078|993475|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
417316|NCT00832078|993476|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
417317|NCT00832078|993475|P2|COMPLETED|Test Day 2 - 2 Period||10
417318|NCT00832078|993476|P1|COMPLETED|Test Day 2 - 2 Period||12
417319|NCT00832078|993475|P2|STARTED|Test Day 2 - 2 Period||10
417320|NCT00832078|993476|P1|STARTED|Test Day 2 - 2 Period||13
417321|NCT00832078|993475|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
417322|NCT00832078|993476|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
417323|NCT00832078|993475|P2|COMPLETED|Test Day 2 - 1 Period||10
417324|NCT00832078|993476|P1|COMPLETED|Test Day 2 - 1 Period||13
417325|NCT00832078|993475|P2|STARTED|Test Day 2 - 1 Period||10
417326|NCT00832078|993476|P1|STARTED|Test Day 2 - 1 Period||13
417327|NCT00832078|993475|P2|NOT COMPLETED|Test Day 1-2 Period||2
417328|NCT00832078|993476|P1|NOT COMPLETED|Test Day 1-2 Period||0
417329|NCT00832078|993475|P2|COMPLETED|Test Day 1-2 Period||10
417330|NCT00832078|993476|P1|COMPLETED|Test Day 1-2 Period||13
417331|NCT00832078|993475|P2|STARTED|Test Day 1-2 Period||12
417332|NCT00832078|993476|P1|STARTED|Test Day 1-2 Period||13
417333|NCT00832078|993475|P2|NOT COMPLETED|Test Day 1- 1 Period||0
417334|NCT00832078|993476|P1|NOT COMPLETED|Test Day 1- 1 Period||0
417335|NCT00832078|993475|P2|COMPLETED|Test Day 1- 1 Period||12
417336|NCT00832078|993476|P1|COMPLETED|Test Day 1- 1 Period||13
417337|NCT00832078|993475|P2|STARTED|Test Day 1- 1 Period||12
417338|NCT00832078|993476|P1|STARTED|Test Day 1- 1 Period||13
417339|NCT00832000|993482|P2|NOT COMPLETED|Overall Study||1
417340|NCT00832000|993483|P1|NOT COMPLETED|Overall Study||6
417341|NCT00832000|993482|P2|COMPLETED|Overall Study||29
417342|NCT00832000|993483|P1|COMPLETED|Overall Study||23
417343|NCT00832000|993482|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
417344|NCT00832000|993483|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
417345|NCT00832000|993482|P2|STARTED|Overall Study|Placebo|30
417346|NCT00832000|993483|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
417347|NCT00831987|993521|P2|NOT COMPLETED|Overall Study||0
417348|NCT00831987|993522|P1|NOT COMPLETED|Overall Study||0
417349|NCT00831987|993521|P2|COMPLETED|Overall Study||60
417350|NCT00831987|993522|P1|COMPLETED|Overall Study||60
417351|NCT00831987|993521|P2|STARTED|Overall Study||60
417352|NCT00831987|993522|P1|STARTED|Overall Study||60
417353|NCT00831844|993544|P10|NOT COMPLETED|Overall Study||0
417354|NCT00831844|993545|P9|NOT COMPLETED|Overall Study||9
417355|NCT00831844|993546|P8|NOT COMPLETED|Overall Study||10
417356|NCT00831844|993547|P7|NOT COMPLETED|Overall Study||10
417357|NCT00831844|993548|P6|NOT COMPLETED|Overall Study||19
417358|NCT00831844|993549|P5|NOT COMPLETED|Overall Study||14
417359|NCT00831844|993550|P4|NOT COMPLETED|Overall Study||10
417360|NCT00831844|993551|P3|NOT COMPLETED|Overall Study||20
417361|NCT00831844|993552|P2|NOT COMPLETED|Overall Study||12
417362|NCT00831844|993553|P1|NOT COMPLETED|Overall Study||10
417363|NCT00831844|993544|P10|COMPLETED|Overall Study||0
417364|NCT00831844|993545|P9|COMPLETED|Overall Study||0
417365|NCT00831844|993546|P8|COMPLETED|Overall Study||0
417366|NCT00831844|993547|P7|COMPLETED|Overall Study||0
417367|NCT00831844|993548|P6|COMPLETED|Overall Study||1
417368|NCT00831844|993549|P5|COMPLETED|Overall Study||0
417369|NCT00831844|993550|P4|COMPLETED|Overall Study||0
417370|NCT00831844|993551|P3|COMPLETED|Overall Study||1
417371|NCT00831844|993552|P2|COMPLETED|Overall Study||0
417372|NCT00831844|993553|P1|COMPLETED|Overall Study||0
417373|NCT00831844|993544|P10|STARTED|Overall Study||0
417374|NCT00831844|993545|P9|STARTED|Overall Study||9
417375|NCT00831844|993546|P8|STARTED|Overall Study||10
417376|NCT00831844|993547|P7|STARTED|Overall Study||10
417377|NCT00831844|993548|P6|STARTED|Overall Study||20
417378|NCT00831844|993549|P5|STARTED|Overall Study||14
417379|NCT00831844|993550|P4|STARTED|Overall Study||10
417380|NCT00831844|993551|P3|STARTED|Overall Study||21
417381|NCT00831844|993552|P2|STARTED|Overall Study||12
417382|NCT00831844|993553|P1|STARTED|Overall Study||10
417383|NCT00831779|993577|P2|NOT COMPLETED|Overall Study||1
417384|NCT00831779|993578|P1|NOT COMPLETED|Overall Study||1
417385|NCT00831779|993577|P2|COMPLETED|Overall Study||22
417386|NCT00831779|993578|P1|COMPLETED|Overall Study||20
417387|NCT00831779|993577|P2|STARTED|Overall Study||23
417388|NCT00831779|993578|P1|STARTED|Overall Study||21
417389|NCT00831766|993588|P2|NOT COMPLETED|Overall Study||0
417390|NCT00831766|993589|P1|NOT COMPLETED|Overall Study||0
417391|NCT00831766|993588|P2|COMPLETED|Overall Study||28
417392|NCT00831766|993589|P1|COMPLETED|Overall Study||23
417393|NCT00831766|993588|P2|STARTED|Overall Study||28
417394|NCT00831766|993589|P1|STARTED|Overall Study||23
417395|NCT00831753|993597|P2|NOT COMPLETED|Overall Study||0
417396|NCT00831753|993598|P1|NOT COMPLETED|Overall Study||0
417397|NCT00831753|993597|P2|COMPLETED|Overall Study||131
417398|NCT00831753|993598|P1|COMPLETED|Overall Study||132
417399|NCT00831753|993597|P2|STARTED|Overall Study||131
417400|NCT00831753|993598|P1|STARTED|Overall Study||132
417401|NCT00831701|993612|P2|NOT COMPLETED|Overall Study||5
417402|NCT00831701|993613|P1|NOT COMPLETED|Overall Study||5
417403|NCT00831701|993612|P2|COMPLETED|Overall Study||45
417404|NCT00831701|993613|P1|COMPLETED|Overall Study||45
417405|NCT00831701|993612|P2|STARTED|Overall Study||50
417406|NCT00831701|993613|P1|STARTED|Overall Study||50
417407|NCT00831675|993629|P2|NOT COMPLETED|Overall Study||0
417408|NCT00831675|993630|P1|NOT COMPLETED|Overall Study||0
417409|NCT00831675|993629|P2|COMPLETED|Overall Study||18
417410|NCT00831675|993630|P1|COMPLETED|Overall Study||12
417411|NCT00831675|993629|P2|STARTED|Overall Study||18
417412|NCT00831675|993630|P1|STARTED|Overall Study||12
417413|NCT00831493|993642|P1|NOT COMPLETED|Overall Study||1
417414|NCT00831493|993642|P1|COMPLETED|Overall Study||2
417415|NCT00831493|993642|P1|STARTED|Overall Study||3
417416|NCT00831480|993646|P1|NOT COMPLETED|Overall Study||2
417417|NCT00831480|993646|P1|COMPLETED|Overall Study||7
417418|NCT00831480|993646|P1|STARTED|Overall Study||9
417419|NCT00831441|993652|P2|NOT COMPLETED|Follow Up (30 Days)||174
417420|NCT00831441|993653|P1|NOT COMPLETED|Follow Up (30 Days)||133
417421|NCT00831441|993652|P2|COMPLETED|Follow Up (30 Days)||3355
417422|NCT00831441|993653|P1|COMPLETED|Follow Up (30 Days)||3375
417423|NCT00831441|993652|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
417424|NCT00831441|993653|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
417425|NCT00831441|993652|P2|NOT COMPLETED|Randomized||3705
417426|NCT00831441|993653|P1|NOT COMPLETED|Randomized||3687
417427|NCT00831441|993652|P2|COMPLETED|Randomized||0
417428|NCT00831441|993653|P1|COMPLETED|Randomized||0
417429|NCT00831441|993652|P2|Treated|Randomized||3672
417430|NCT00831441|993653|P1|Treated|Randomized||3643
417431|NCT00831441|993652|P2|STARTED|Randomized||3705
417432|NCT00831441|993653|P1|STARTED|Randomized||3687
417433|NCT00831428|993681|P1|NOT COMPLETED|Overall Study||0
417434|NCT00831428|993681|P1|COMPLETED|Overall Study||97
417435|NCT00831428|993681|P1|STARTED|Overall Study||97
417436|NCT00831415|993685|P1|NOT COMPLETED|Overall Study||75
417437|NCT00831415|993685|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
417438|NCT00831415|993685|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
417439|NCT00831415|993685|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
417440|NCT00831415|993685|P1|STARTED|Overall Study||304
417441|NCT00831389|993692|P1|NOT COMPLETED|Overall Study||1
417442|NCT00831389|993692|P1|COMPLETED|Overall Study||12
417443|NCT00831389|993692|P1|STARTED|Overall Study||13
417444|NCT00831311|993718|P2|NOT COMPLETED|Overall Study||8
417445|NCT00831311|993719|P1|NOT COMPLETED|Overall Study||12
417446|NCT00831311|993718|P2|COMPLETED|Overall Study||304
417447|NCT00831311|993719|P1|COMPLETED|Overall Study||300
417448|NCT00831311|993718|P2|STARTED|Overall Study||312
417449|NCT00831311|993719|P1|STARTED|Overall Study||312
417450|NCT00831272|993741|P4|NOT COMPLETED|Overall Study||10
417451|NCT00831272|993742|P3|NOT COMPLETED|Overall Study||10
417452|NCT00831272|993743|P2|NOT COMPLETED|Overall Study||7
417453|NCT00831272|993744|P1|NOT COMPLETED|Overall Study||8
417454|NCT00831272|993741|P4|COMPLETED|Overall Study||56
417455|NCT00831272|993742|P3|COMPLETED|Overall Study||63
417456|NCT00831272|993743|P2|COMPLETED|Overall Study||37
417457|NCT00831272|993744|P1|COMPLETED|Overall Study||30
417458|NCT00831272|993741|P4|STARTED|Overall Study||66
417459|NCT00831272|993742|P3|STARTED|Overall Study||73
417460|NCT00831272|993743|P2|STARTED|Overall Study||44
417461|NCT00831272|993744|P1|STARTED|Overall Study||38
417462|NCT00831233|993756|P2|NOT COMPLETED|Overall Study||1
417463|NCT00831233|993757|P1|NOT COMPLETED|Overall Study||3
417464|NCT00831233|993756|P2|COMPLETED|Overall Study||12
417465|NCT00831233|993757|P1|COMPLETED|Overall Study||26
417466|NCT00831233|993756|P2|Per Protocol (PP) Analysis Set|Overall Study||11
417467|NCT00831233|993757|P1|Per Protocol (PP) Analysis Set|Overall Study||26
417468|NCT00831233|993756|P2|Full Analysis Set (FAS)|Overall Study||13
417469|NCT00831233|993757|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
417470|NCT00831233|993756|P2|STARTED|Overall Study|ITT population.|13
417471|NCT00831233|993757|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
417472|NCT00831129|993783|P2|NOT COMPLETED|Overall Study||10
417473|NCT00831129|993784|P1|NOT COMPLETED|Overall Study||0
417474|NCT00831129|993783|P2|COMPLETED|Overall Study||23
417475|NCT00831129|993784|P1|COMPLETED|Overall Study||20
417476|NCT00831129|993783|P2|STARTED|Overall Study||33
417477|NCT00831129|993784|P1|STARTED|Overall Study||20
417478|NCT00830960|993826|P6|NOT COMPLETED|Overall Study||37
417479|NCT00830960|993827|P5|NOT COMPLETED|Overall Study||32
417480|NCT00830960|993828|P4|NOT COMPLETED|Overall Study||32
417481|NCT00830960|993829|P3|NOT COMPLETED|Overall Study||29
417482|NCT00830960|993830|P2|NOT COMPLETED|Overall Study||28
417483|NCT00830960|993831|P1|NOT COMPLETED|Overall Study||33
417484|NCT00830960|993826|P6|COMPLETED|Overall Study||63
417485|NCT00830960|993827|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
417486|NCT00830960|993828|P4|COMPLETED|Overall Study||106
417487|NCT00830960|993829|P3|COMPLETED|Overall Study||108
417488|NCT00830960|993830|P2|COMPLETED|Overall Study||96
417489|NCT00830960|993831|P1|COMPLETED|Overall Study||91
417490|NCT00830960|993826|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
417491|NCT00830960|993827|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
417492|NCT00830960|993828|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
417493|NCT00830960|993829|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
417494|NCT00830960|993830|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
417495|NCT00830960|993831|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
417496|NCT00830960|993826|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
417497|NCT00830960|993827|P5|STARTED|Overall Study||96
417498|NCT00830960|993828|P4|STARTED|Overall Study||138
417499|NCT00830960|993829|P3|STARTED|Overall Study||137
417500|NCT00830960|993830|P2|STARTED|Overall Study||124
417501|NCT00830960|993831|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
417502|NCT00830947|993947|P2|NOT COMPLETED|Overall Study||4
417503|NCT00830947|993948|P1|NOT COMPLETED|Overall Study||4
417504|NCT00830947|993947|P2|COMPLETED|Overall Study||18
417505|NCT00830947|993948|P1|COMPLETED|Overall Study||19
417506|NCT00830947|993947|P2|STARTED|Overall Study||22
417507|NCT00830947|993948|P1|STARTED|Overall Study||23
417508|NCT00830804|993954|P1|NOT COMPLETED|Overall Study||15
417509|NCT00830804|993954|P1|COMPLETED|Overall Study||97
417510|NCT00830804|993954|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
417511|NCT00830791|993980|P6|NOT COMPLETED|Overall Study||0
417512|NCT00830791|993981|P5|NOT COMPLETED|Overall Study||0
417513|NCT00830791|993982|P4|NOT COMPLETED|Overall Study||0
417514|NCT00830791|993983|P3|NOT COMPLETED|Overall Study||0
417515|NCT00830791|993984|P2|NOT COMPLETED|Overall Study||0
417516|NCT00830791|993985|P1|NOT COMPLETED|Overall Study||0
417517|NCT00830791|993980|P6|COMPLETED|Overall Study||0
417518|NCT00830791|993981|P5|COMPLETED|Overall Study||0
417519|NCT00830791|993982|P4|COMPLETED|Overall Study||8
417520|NCT00830791|993983|P3|COMPLETED|Overall Study||8
417521|NCT00830791|993984|P2|COMPLETED|Overall Study||8
417522|NCT00830791|993985|P1|COMPLETED|Overall Study||8
417523|NCT00830791|993980|P6|STARTED|Overall Study||0
417524|NCT00830791|993981|P5|STARTED|Overall Study||0
417525|NCT00830791|993982|P4|STARTED|Overall Study||8
417526|NCT00830791|993983|P3|STARTED|Overall Study||8
417527|NCT00830791|993984|P2|STARTED|Overall Study||8
417528|NCT00830791|993985|P1|STARTED|Overall Study||8
417529|NCT00830765|994034|P2|NOT COMPLETED|Overall Study||2
417530|NCT00830765|994035|P1|NOT COMPLETED|Overall Study||3
417531|NCT00830765|994034|P2|COMPLETED|Overall Study||69
417532|NCT00830765|994035|P1|COMPLETED|Overall Study||70
417533|NCT00830765|994034|P2|STARTED|Overall Study||71
417534|NCT00830765|994035|P1|STARTED|Overall Study||73
417535|NCT00830440|994043|P2|NOT COMPLETED|Overall Study||0
417536|NCT00830440|994044|P1|NOT COMPLETED|Overall Study||8
417537|NCT00830440|994043|P2|COMPLETED|Overall Study||11
417538|NCT00830440|994044|P1|COMPLETED|Overall Study||24
417539|NCT00830440|994043|P2|Completed 24 Week Follow up|Overall Study||0
417540|NCT00830440|994044|P1|Completed 24 Week Follow up|Overall Study||3
417541|NCT00830440|994043|P2|Completed 16 Week Follow up|Overall Study||0
417542|NCT00830440|994044|P1|Completed 16 Week Follow up|Overall Study||4
417543|NCT00830440|994043|P2|Completed 12 Week Follow up|Overall Study||11
417544|NCT00830440|994044|P1|Completed 12 Week Follow up|Overall Study||24
417545|NCT00830440|994043|P2|Received Device|Overall Study||0
417546|NCT00830440|994044|P1|Received Device|Overall Study||26
417547|NCT00830440|994043|P2|STARTED|Overall Study||11
417548|NCT00830440|994044|P1|STARTED|Overall Study||32
417549|NCT00830388|994054|P1|NOT COMPLETED|Overall Study||0
417550|NCT00830388|994054|P1|COMPLETED|Overall Study||11
417551|NCT00830388|994054|P1|STARTED|Overall Study||11
417552|NCT00830375|994059|P1|NOT COMPLETED|Overall Study||1
417553|NCT00830375|994059|P1|COMPLETED|Overall Study||9
417554|NCT00830375|994059|P1|STARTED|Overall Study||10
417555|NCT00830362|994065|P2|NOT COMPLETED|Overall Study||4
417556|NCT00830362|994066|P1|NOT COMPLETED|Overall Study||4
417557|NCT00830362|994065|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
417558|NCT00830362|994066|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
417559|NCT00830362|994065|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
417560|NCT00830362|994066|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
417651|NCT00830167|994144|P2|STARTED|Overall Study|Treated|250
417561|NCT00830362|994065|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
417562|NCT00830362|994066|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
417563|NCT00830336|994074|P2|NOT COMPLETED|Second Intervention||0
417564|NCT00830336|994075|P1|NOT COMPLETED|Second Intervention||0
417565|NCT00830336|994074|P2|COMPLETED|Second Intervention||40
417566|NCT00830336|994075|P1|COMPLETED|Second Intervention||39
417567|NCT00830336|994074|P2|STARTED|Second Intervention||40
417568|NCT00830336|994075|P1|STARTED|Second Intervention||39
417569|NCT00830336|994074|P2|NOT COMPLETED|Washout: 21 Days||0
417570|NCT00830336|994075|P1|NOT COMPLETED|Washout: 21 Days||1
417571|NCT00830336|994074|P2|COMPLETED|Washout: 21 Days||40
417572|NCT00830336|994075|P1|COMPLETED|Washout: 21 Days||39
417573|NCT00830336|994074|P2|STARTED|Washout: 21 Days||40
417574|NCT00830336|994075|P1|STARTED|Washout: 21 Days||40
417575|NCT00830336|994074|P2|NOT COMPLETED|First Intervention||0
417576|NCT00830336|994075|P1|NOT COMPLETED|First Intervention||0
417577|NCT00830336|994074|P2|COMPLETED|First Intervention||40
417578|NCT00830336|994075|P1|COMPLETED|First Intervention||40
417579|NCT00830336|994074|P2|STARTED|First Intervention||40
417580|NCT00830336|994075|P1|STARTED|First Intervention||40
417581|NCT00830310|994083|P1|NOT COMPLETED|Overall Study||13
417582|NCT00830310|994083|P1|COMPLETED|Overall Study||30
417583|NCT00830310|994083|P1|STARTED|Overall Study||43
417584|NCT00830284|994095|P1|NOT COMPLETED|Overall Study||2
417585|NCT00830284|994095|P1|COMPLETED|Overall Study||10
417586|NCT00830284|994095|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
417587|NCT00830258|994102|P2|NOT COMPLETED|Second Intervention||0
417588|NCT00830258|994103|P1|NOT COMPLETED|Second Intervention||0
417589|NCT00830258|994102|P2|COMPLETED|Second Intervention||30
417590|NCT00830258|994103|P1|COMPLETED|Second Intervention||28
417591|NCT00830258|994102|P2|STARTED|Second Intervention||30
417592|NCT00830258|994103|P1|STARTED|Second Intervention||28
417593|NCT00830258|994102|P2|NOT COMPLETED|Washout: 7 Days||0
417594|NCT00830258|994103|P1|NOT COMPLETED|Washout: 7 Days||1
417595|NCT00830258|994102|P2|COMPLETED|Washout: 7 Days||30
417596|NCT00830258|994103|P1|COMPLETED|Washout: 7 Days||28
417597|NCT00830258|994102|P2|STARTED|Washout: 7 Days||30
417598|NCT00830258|994103|P1|STARTED|Washout: 7 Days||29
417599|NCT00830258|994102|P2|NOT COMPLETED|First Intervention||0
417600|NCT00830258|994103|P1|NOT COMPLETED|First Intervention||1
417601|NCT00830258|994102|P2|COMPLETED|First Intervention||30
417602|NCT00830258|994103|P1|COMPLETED|First Intervention||29
417603|NCT00830258|994102|P2|STARTED|First Intervention||30
417604|NCT00830258|994103|P1|STARTED|First Intervention||30
417605|NCT00830232|994113|P2|NOT COMPLETED|Overall Study||0
417606|NCT00830232|994114|P1|NOT COMPLETED|Overall Study||0
417607|NCT00830232|994113|P2|COMPLETED|Overall Study||20
417608|NCT00830232|994114|P1|COMPLETED|Overall Study||20
417609|NCT00830232|994113|P2|STARTED|Overall Study||20
417610|NCT00830232|994114|P1|STARTED|Overall Study||20
417611|NCT00830219|994122|P2|NOT COMPLETED|Second Intervention||0
417612|NCT00830219|994123|P1|NOT COMPLETED|Second Intervention||0
417613|NCT00830219|994122|P2|COMPLETED|Second Intervention||22
417614|NCT00830219|994123|P1|COMPLETED|Second Intervention||22
417615|NCT00830219|994122|P2|STARTED|Second Intervention||22
417616|NCT00830219|994123|P1|STARTED|Second Intervention||22
417617|NCT00830219|994122|P2|NOT COMPLETED|Washout of 7 Days||1
417618|NCT00830219|994123|P1|NOT COMPLETED|Washout of 7 Days||1
417619|NCT00830219|994122|P2|COMPLETED|Washout of 7 Days||22
417620|NCT00830219|994123|P1|COMPLETED|Washout of 7 Days||22
417621|NCT00830219|994122|P2|STARTED|Washout of 7 Days||23
417622|NCT00830219|994123|P1|STARTED|Washout of 7 Days||23
417623|NCT00830219|994122|P2|NOT COMPLETED|First Intervention||0
417624|NCT00830219|994123|P1|NOT COMPLETED|First Intervention||0
417625|NCT00830219|994122|P2|COMPLETED|First Intervention||23
417626|NCT00830219|994123|P1|COMPLETED|First Intervention||23
417627|NCT00830219|994122|P2|STARTED|First Intervention||23
417628|NCT00830219|994123|P1|STARTED|First Intervention||23
417629|NCT00830206|994133|P2|NOT COMPLETED|Second Intervention||0
417630|NCT00830206|994134|P1|NOT COMPLETED|Second Intervention||0
417631|NCT00830206|994133|P2|COMPLETED|Second Intervention||39
417632|NCT00830206|994134|P1|COMPLETED|Second Intervention||39
417633|NCT00830206|994133|P2|STARTED|Second Intervention||39
417634|NCT00830206|994134|P1|STARTED|Second Intervention||39
417635|NCT00830206|994133|P2|NOT COMPLETED|Washout: 21 Days||1
417636|NCT00830206|994134|P1|NOT COMPLETED|Washout: 21 Days||1
417637|NCT00830206|994133|P2|COMPLETED|Washout: 21 Days||39
417638|NCT00830206|994134|P1|COMPLETED|Washout: 21 Days||39
417639|NCT00830206|994133|P2|STARTED|Washout: 21 Days||40
417640|NCT00830206|994134|P1|STARTED|Washout: 21 Days||40
417641|NCT00830206|994133|P2|NOT COMPLETED|First Intervention||0
417642|NCT00830206|994134|P1|NOT COMPLETED|First Intervention||0
417643|NCT00830206|994133|P2|COMPLETED|First Intervention||40
417644|NCT00830206|994134|P1|COMPLETED|First Intervention||40
417645|NCT00830206|994133|P2|STARTED|First Intervention||40
417646|NCT00830206|994134|P1|STARTED|First Intervention||40
417647|NCT00830167|994144|P2|NOT COMPLETED|Overall Study||43
417648|NCT00830167|994145|P1|NOT COMPLETED|Overall Study||40
417649|NCT00830167|994144|P2|COMPLETED|Overall Study||207
417650|NCT00830167|994145|P1|COMPLETED|Overall Study||208
417652|NCT00830167|994145|P1|STARTED|Overall Study|Treated|248
417653|NCT00830128|994215|P1|NOT COMPLETED|Overall Study||19
417654|NCT00830128|994215|P1|COMPLETED|Overall Study||87
417655|NCT00830128|994215|P1|STARTED|Overall Study||106
417656|NCT00830115|994230|P1|NOT COMPLETED|Overall Study||3
417657|NCT00830115|994230|P1|COMPLETED|Overall Study||1042
417658|NCT00830115|994230|P1|STARTED|Overall Study||1045
417659|NCT00830076|994246|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
417660|NCT00830076|994246|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
417661|NCT00830076|994246|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
417662|NCT00830076|994246|P1|NOT COMPLETED|7-day Washout||0
417663|NCT00830076|994246|P1|COMPLETED|7-day Washout||18
417664|NCT00830076|994246|P1|STARTED|7-day Washout||18
417665|NCT00830076|994246|P1|NOT COMPLETED|Sitagliptin + Metformin||0
417666|NCT00830076|994246|P1|COMPLETED|Sitagliptin + Metformin||18
417667|NCT00830076|994246|P1|STARTED|Sitagliptin + Metformin||18
417668|NCT00830076|994246|P1|NOT COMPLETED|7-day Washout||0
417669|NCT00830076|994246|P1|COMPLETED|7-day Washout||18
417670|NCT00830076|994246|P1|STARTED|7-day Washout||18
417671|NCT00830076|994246|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
417672|NCT00830076|994246|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
417673|NCT00830076|994246|P1|STARTED|Metformin + Placebo Sitagliptin||18
417674|NCT00830076|994246|P1|NOT COMPLETED|7-day Washout||0
417675|NCT00830076|994246|P1|COMPLETED|7-day Washout||18
417676|NCT00830076|994246|P1|STARTED|7-day Washout||18
417677|NCT00830076|994246|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
417678|NCT00830076|994246|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
417679|NCT00830076|994246|P1|STARTED|Sitagliptin + Placebo Metformin||18
417680|NCT00830037|994257|P2|NOT COMPLETED|Overall Study||19
417681|NCT00830037|994258|P1|NOT COMPLETED|Overall Study||18
417682|NCT00830037|994257|P2|COMPLETED|Overall Study||50
417683|NCT00830037|994258|P1|COMPLETED|Overall Study||49
417684|NCT00830037|994257|P2|STARTED|Overall Study||69
417685|NCT00830037|994258|P1|STARTED|Overall Study||67
417686|NCT00830024|994268|P2|NOT COMPLETED|Second Intervention||0
417687|NCT00830024|994269|P1|NOT COMPLETED|Second Intervention||0
417688|NCT00830024|994268|P2|COMPLETED|Second Intervention||18
417689|NCT00830024|994269|P1|COMPLETED|Second Intervention||17
417690|NCT00830024|994268|P2|STARTED|Second Intervention||18
417691|NCT00830024|994269|P1|STARTED|Second Intervention||17
417692|NCT00830024|994268|P2|NOT COMPLETED|Washout: 7 Days||0
417693|NCT00830024|994269|P1|NOT COMPLETED|Washout: 7 Days||1
417694|NCT00830024|994268|P2|COMPLETED|Washout: 7 Days||18
417695|NCT00830024|994269|P1|COMPLETED|Washout: 7 Days||17
417696|NCT00830024|994268|P2|STARTED|Washout: 7 Days||18
417697|NCT00830024|994269|P1|STARTED|Washout: 7 Days||18
417698|NCT00830024|994268|P2|NOT COMPLETED|First Intervention||0
417699|NCT00830024|994269|P1|NOT COMPLETED|First Intervention||0
417700|NCT00830024|994268|P2|COMPLETED|First Intervention||18
417701|NCT00830024|994269|P1|COMPLETED|First Intervention||18
417702|NCT00830024|994268|P2|STARTED|First Intervention||18
417703|NCT00830024|994269|P1|STARTED|First Intervention||18
417704|NCT00829998|994279|P2|NOT COMPLETED|Second Intervention||0
417705|NCT00829998|994280|P1|NOT COMPLETED|Second Intervention||0
417706|NCT00829998|994279|P2|COMPLETED|Second Intervention||19
417707|NCT00829998|994280|P1|COMPLETED|Second Intervention||21
417708|NCT00829998|994279|P2|STARTED|Second Intervention||19
417709|NCT00829998|994280|P1|STARTED|Second Intervention||21
417710|NCT00829998|994279|P2|NOT COMPLETED|Washout||1
417711|NCT00829998|994280|P1|NOT COMPLETED|Washout||0
417712|NCT00829998|994279|P2|COMPLETED|Washout||19
417713|NCT00829998|994280|P1|COMPLETED|Washout||21
417714|NCT00829998|994279|P2|STARTED|Washout||20
417715|NCT00829998|994280|P1|STARTED|Washout||21
417716|NCT00829998|994279|P2|NOT COMPLETED|First Intervention||0
417717|NCT00829998|994280|P1|NOT COMPLETED|First Intervention||0
417718|NCT00829998|994279|P2|COMPLETED|First Intervention||20
417719|NCT00829998|994280|P1|COMPLETED|First Intervention||21
417720|NCT00829998|994279|P2|STARTED|First Intervention||20
417721|NCT00829998|994280|P1|STARTED|First Intervention||21
417722|NCT00829985|994290|P2|NOT COMPLETED|Overall Study||4
417723|NCT00829985|994291|P1|NOT COMPLETED|Overall Study||9
417724|NCT00829985|994290|P2|COMPLETED|Overall Study||22
417725|NCT00829985|994291|P1|COMPLETED|Overall Study||19
417726|NCT00829985|994290|P2|STARTED|Overall Study||26
417727|NCT00829985|994291|P1|STARTED|Overall Study||28
417728|NCT00829933|994309|P4|NOT COMPLETED|Overall Study||14
417729|NCT00829933|994310|P3|NOT COMPLETED|Overall Study||13
417730|NCT00829933|994311|P2|NOT COMPLETED|Overall Study||13
417731|NCT00829933|994312|P1|NOT COMPLETED|Overall Study||14
417732|NCT00829933|994309|P4|COMPLETED|Overall Study||120
417733|NCT00829933|994310|P3|COMPLETED|Overall Study||119
417734|NCT00829933|994311|P2|COMPLETED|Overall Study||122
417735|NCT00829933|994312|P1|COMPLETED|Overall Study||121
417736|NCT00829933|994309|P4|Baseline Analysis Population|Overall Study||129
417737|NCT00829933|994310|P3|Baseline Analysis Population|Overall Study||131
417738|NCT00829933|994311|P2|Baseline Analysis Population|Overall Study||134
417739|NCT00829933|994312|P1|Baseline Analysis Population|Overall Study||131
417740|NCT00829933|994309|P4|STARTED|Overall Study||134
417741|NCT00829933|994310|P3|STARTED|Overall Study||132
417742|NCT00829933|994311|P2|STARTED|Overall Study||135
417743|NCT00829933|994312|P1|STARTED|Overall Study||135
417744|NCT00829868|994324|P2|NOT COMPLETED|Second Intervention||0
417745|NCT00829868|994325|P1|NOT COMPLETED|Second Intervention||0
417746|NCT00829868|994324|P2|COMPLETED|Second Intervention||21
417747|NCT00829868|994325|P1|COMPLETED|Second Intervention||20
417748|NCT00829868|994324|P2|STARTED|Second Intervention||21
417749|NCT00829868|994325|P1|STARTED|Second Intervention||20
417750|NCT00829868|994324|P2|NOT COMPLETED|Washout||0
417751|NCT00829868|994325|P1|NOT COMPLETED|Washout||1
417752|NCT00829868|994324|P2|COMPLETED|Washout||21
417753|NCT00829868|994325|P1|COMPLETED|Washout||20
417754|NCT00829868|994324|P2|STARTED|Washout||21
417755|NCT00829868|994325|P1|STARTED|Washout||21
417756|NCT00829868|994324|P2|NOT COMPLETED|First Intervention||0
417757|NCT00829868|994325|P1|NOT COMPLETED|First Intervention||0
417758|NCT00829868|994324|P2|COMPLETED|First Intervention||21
417759|NCT00829868|994325|P1|COMPLETED|First Intervention||21
417760|NCT00829868|994324|P2|STARTED|First Intervention||21
417761|NCT00829868|994325|P1|STARTED|First Intervention||21
417762|NCT00829829|994336|P3|NOT COMPLETED|Overall Study||11
417763|NCT00829829|994337|P2|NOT COMPLETED|Overall Study||16
417764|NCT00829829|994338|P1|NOT COMPLETED|Overall Study||22
417765|NCT00829829|994336|P3|COMPLETED|Overall Study||70
417766|NCT00829829|994337|P2|COMPLETED|Overall Study||64
417767|NCT00829829|994338|P1|COMPLETED|Overall Study||58
417768|NCT00829829|994336|P3|Treated|Overall Study||81
417769|NCT00829829|994337|P2|Treated|Overall Study||80
417770|NCT00829829|994338|P1|Treated|Overall Study||79
417771|NCT00829829|994336|P3|STARTED|Overall Study||81
417772|NCT00829829|994337|P2|STARTED|Overall Study||80
417773|NCT00829829|994338|P1|STARTED|Overall Study||80
417774|NCT00829790|994363|P2|NOT COMPLETED|Second Intervention||0
417775|NCT00829790|994364|P1|NOT COMPLETED|Second Intervention||0
417776|NCT00829790|994363|P2|COMPLETED|Second Intervention||14
417777|NCT00829790|994364|P1|COMPLETED|Second Intervention||15
417778|NCT00829790|994363|P2|STARTED|Second Intervention||14
417779|NCT00829790|994364|P1|STARTED|Second Intervention||15
417780|NCT00829790|994363|P2|NOT COMPLETED|Washout of 14 Days||1
417781|NCT00829790|994364|P1|NOT COMPLETED|Washout of 14 Days||0
417782|NCT00829790|994363|P2|COMPLETED|Washout of 14 Days||14
417783|NCT00829790|994364|P1|COMPLETED|Washout of 14 Days||15
417784|NCT00829790|994363|P2|STARTED|Washout of 14 Days||15
417785|NCT00829790|994364|P1|STARTED|Washout of 14 Days||15
417786|NCT00829790|994363|P2|NOT COMPLETED|First Intervention||0
417787|NCT00829790|994364|P1|NOT COMPLETED|First Intervention||0
417788|NCT00829790|994363|P2|COMPLETED|First Intervention||15
417789|NCT00829790|994364|P1|COMPLETED|First Intervention||15
417790|NCT00829790|994363|P2|STARTED|First Intervention||15
417791|NCT00829790|994364|P1|STARTED|First Intervention||15
417792|NCT00829764|994374|P2|NOT COMPLETED|Second Intervention||0
417793|NCT00829764|994375|P1|NOT COMPLETED|Second Intervention||0
417794|NCT00829764|994374|P2|COMPLETED|Second Intervention||14
417795|NCT00829764|994375|P1|COMPLETED|Second Intervention||13
417796|NCT00829764|994374|P2|STARTED|Second Intervention||14
417797|NCT00829764|994375|P1|STARTED|Second Intervention||13
417798|NCT00829764|994374|P2|NOT COMPLETED|Washout of 14 Days||0
417799|NCT00829764|994375|P1|NOT COMPLETED|Washout of 14 Days||0
417800|NCT00829764|994374|P2|COMPLETED|Washout of 14 Days||14
417801|NCT00829764|994375|P1|COMPLETED|Washout of 14 Days||13
417802|NCT00829764|994374|P2|STARTED|Washout of 14 Days||14
417803|NCT00829764|994375|P1|STARTED|Washout of 14 Days||13
417804|NCT00829764|994374|P2|NOT COMPLETED|First Intervention||1
417805|NCT00829764|994375|P1|NOT COMPLETED|First Intervention||2
417806|NCT00829764|994374|P2|COMPLETED|First Intervention||14
417807|NCT00829764|994375|P1|COMPLETED|First Intervention||13
417808|NCT00829764|994374|P2|STARTED|First Intervention||15
417809|NCT00829764|994375|P1|STARTED|First Intervention||15
417810|NCT00829738|994383|P1|NOT COMPLETED|Overall Study||8
417811|NCT00829738|994383|P1|COMPLETED|Overall Study||4180
417812|NCT00829738|994383|P1|STARTED|Overall Study||4188
417813|NCT00829712|994401|P2|NOT COMPLETED|Second Intervention||0
417814|NCT00829712|994402|P1|NOT COMPLETED|Second Intervention||0
417815|NCT00829712|994401|P2|COMPLETED|Second Intervention||11
417816|NCT00829712|994402|P1|COMPLETED|Second Intervention||12
417817|NCT00829712|994401|P2|STARTED|Second Intervention||11
417818|NCT00829712|994402|P1|STARTED|Second Intervention||12
417819|NCT00829712|994401|P2|NOT COMPLETED|Washout of 7 Days||1
417820|NCT00829712|994402|P1|NOT COMPLETED|Washout of 7 Days||0
417821|NCT00829712|994401|P2|COMPLETED|Washout of 7 Days||11
417822|NCT00829712|994402|P1|COMPLETED|Washout of 7 Days||12
417823|NCT00829712|994401|P2|STARTED|Washout of 7 Days||12
417824|NCT00829712|994402|P1|STARTED|Washout of 7 Days||12
417825|NCT00829712|994401|P2|NOT COMPLETED|First Intervention||0
417826|NCT00829712|994402|P1|NOT COMPLETED|First Intervention||0
417827|NCT00829712|994401|P2|COMPLETED|First Intervention||12
417828|NCT00829712|994402|P1|COMPLETED|First Intervention||12
417829|NCT00829712|994401|P2|STARTED|First Intervention||12
417830|NCT00829712|994402|P1|STARTED|First Intervention||12
417831|NCT00829686|994412|P2|NOT COMPLETED|Overall Study||0
417832|NCT00829686|994413|P1|NOT COMPLETED|Overall Study||0
417833|NCT00829686|994412|P2|COMPLETED|Overall Study||18
417834|NCT00829686|994413|P1|COMPLETED|Overall Study||13
417835|NCT00829686|994412|P2|STARTED|Overall Study||18
417836|NCT00829686|994413|P1|STARTED|Overall Study||13
417837|NCT00829673|994421|P2|NOT COMPLETED|Second Intervention||0
417838|NCT00829673|994422|P1|NOT COMPLETED|Second Intervention||0
417839|NCT00829673|994421|P2|COMPLETED|Second Intervention||12
417840|NCT00829673|994422|P1|COMPLETED|Second Intervention||11
417841|NCT00829673|994421|P2|STARTED|Second Intervention||12
417842|NCT00829673|994422|P1|STARTED|Second Intervention||11
417843|NCT00829673|994421|P2|NOT COMPLETED|Washout of 7 Days||0
417844|NCT00829673|994422|P1|NOT COMPLETED|Washout of 7 Days||1
417845|NCT00829673|994421|P2|COMPLETED|Washout of 7 Days||12
417846|NCT00829673|994422|P1|COMPLETED|Washout of 7 Days||11
417847|NCT00829673|994421|P2|STARTED|Washout of 7 Days||12
417848|NCT00829673|994422|P1|STARTED|Washout of 7 Days||12
417849|NCT00829673|994421|P2|NOT COMPLETED|First Intervention||0
417850|NCT00829673|994422|P1|NOT COMPLETED|First Intervention||0
417851|NCT00829673|994421|P2|COMPLETED|First Intervention||12
417852|NCT00829673|994422|P1|COMPLETED|First Intervention||12
417853|NCT00829673|994421|P2|STARTED|First Intervention||12
417854|NCT00829673|994422|P1|STARTED|First Intervention||12
417855|NCT00829621|994432|P2|NOT COMPLETED|Overall Study||4
417856|NCT00829621|994433|P1|NOT COMPLETED|Overall Study||4
417857|NCT00829621|994432|P2|COMPLETED|Overall Study||8
417858|NCT00829621|994433|P1|COMPLETED|Overall Study||4
417859|NCT00829621|994432|P2|STARTED|Overall Study||12
417860|NCT00829621|994433|P1|STARTED|Overall Study||8
417861|NCT00829530|994441|P2|NOT COMPLETED|Second Intervention||0
417862|NCT00829530|994442|P1|NOT COMPLETED|Second Intervention||1
417863|NCT00829530|994441|P2|COMPLETED|Second Intervention||18
417864|NCT00829530|994442|P1|COMPLETED|Second Intervention||19
417865|NCT00829530|994441|P2|STARTED|Second Intervention||18
417866|NCT00829530|994442|P1|STARTED|Second Intervention||20
417867|NCT00829530|994441|P2|NOT COMPLETED|Washout of 42 Days||0
417868|NCT00829530|994442|P1|NOT COMPLETED|Washout of 42 Days||0
417869|NCT00829530|994441|P2|COMPLETED|Washout of 42 Days||18
417870|NCT00829530|994442|P1|COMPLETED|Washout of 42 Days||20
417871|NCT00829530|994441|P2|STARTED|Washout of 42 Days||18
417872|NCT00829530|994442|P1|STARTED|Washout of 42 Days||20
417873|NCT00829530|994441|P2|NOT COMPLETED|First Intervention||2
417874|NCT00829530|994442|P1|NOT COMPLETED|First Intervention||0
417875|NCT00829530|994441|P2|COMPLETED|First Intervention||18
417876|NCT00829530|994442|P1|COMPLETED|First Intervention||20
417877|NCT00829530|994441|P2|STARTED|First Intervention||20
417878|NCT00829530|994442|P1|STARTED|First Intervention||20
417879|NCT00829504|994456|P2|NOT COMPLETED|Second Intervention||0
417880|NCT00829504|994457|P1|NOT COMPLETED|Second Intervention||1
417881|NCT00829504|994456|P2|COMPLETED|Second Intervention||22
417882|NCT00829504|994457|P1|COMPLETED|Second Intervention||19
417883|NCT00829504|994456|P2|STARTED|Second Intervention||22
417884|NCT00829504|994457|P1|STARTED|Second Intervention||20
417885|NCT00829504|994456|P2|NOT COMPLETED|Washout of 7 Days||0
417886|NCT00829504|994457|P1|NOT COMPLETED|Washout of 7 Days||1
417887|NCT00829504|994456|P2|COMPLETED|Washout of 7 Days||22
417888|NCT00829504|994457|P1|COMPLETED|Washout of 7 Days||20
417889|NCT00829504|994456|P2|STARTED|Washout of 7 Days||22
417890|NCT00829504|994457|P1|STARTED|Washout of 7 Days||21
417891|NCT00829504|994456|P2|NOT COMPLETED|First Intervention||0
417892|NCT00829504|994457|P1|NOT COMPLETED|First Intervention||1
417893|NCT00829504|994456|P2|COMPLETED|First Intervention||22
417894|NCT00829504|994457|P1|COMPLETED|First Intervention||21
417895|NCT00829504|994456|P2|STARTED|First Intervention||22
417896|NCT00829504|994457|P1|STARTED|First Intervention||22
417897|NCT00829452|994467|P2|NOT COMPLETED|Second Intervention||1
417898|NCT00829452|994468|P1|NOT COMPLETED|Second Intervention||0
417899|NCT00829452|994467|P2|COMPLETED|Second Intervention||17
417900|NCT00829452|994468|P1|COMPLETED|Second Intervention||20
417901|NCT00829452|994467|P2|STARTED|Second Intervention||18
417902|NCT00829452|994468|P1|STARTED|Second Intervention||20
417903|NCT00829452|994467|P2|NOT COMPLETED|Washout of 42 Days||1
417904|NCT00829452|994468|P1|NOT COMPLETED|Washout of 42 Days||0
417905|NCT00829452|994467|P2|COMPLETED|Washout of 42 Days||18
417906|NCT00829452|994468|P1|COMPLETED|Washout of 42 Days||20
417907|NCT00829452|994467|P2|STARTED|Washout of 42 Days||19
417908|NCT00829452|994468|P1|STARTED|Washout of 42 Days||20
417909|NCT00829452|994467|P2|NOT COMPLETED|First Intervention||1
417910|NCT00829452|994468|P1|NOT COMPLETED|First Intervention||0
417911|NCT00829452|994467|P2|COMPLETED|First Intervention||19
417912|NCT00829452|994468|P1|COMPLETED|First Intervention||20
417913|NCT00829452|994467|P2|STARTED|First Intervention||20
417914|NCT00829452|994468|P1|STARTED|First Intervention||20
417915|NCT00829439|994480|P4|NOT COMPLETED|Overall Study||0
417916|NCT00829439|994481|P3|NOT COMPLETED|Overall Study||1
417917|NCT00829439|994482|P2|NOT COMPLETED|Overall Study||0
417918|NCT00829439|994483|P1|NOT COMPLETED|Overall Study||0
417919|NCT00829439|994480|P4|COMPLETED|Overall Study||4
417920|NCT00829439|994481|P3|COMPLETED|Overall Study||5
417921|NCT00829439|994482|P2|COMPLETED|Overall Study||3
417922|NCT00829439|994483|P1|COMPLETED|Overall Study||3
417923|NCT00829439|994480|P4|STARTED|Overall Study||4
417924|NCT00829439|994481|P3|STARTED|Overall Study||6
417925|NCT00829439|994482|P2|STARTED|Overall Study||3
417926|NCT00829439|994483|P1|STARTED|Overall Study||3
417927|NCT00829426|994489|P2|NOT COMPLETED|Second Intervention||0
417928|NCT00829426|994490|P1|NOT COMPLETED|Second Intervention||0
417929|NCT00829426|994489|P2|COMPLETED|Second Intervention||16
417930|NCT00829426|994490|P1|COMPLETED|Second Intervention||15
417931|NCT00829426|994489|P2|STARTED|Second Intervention||16
417932|NCT00829426|994490|P1|STARTED|Second Intervention||15
417933|NCT00829426|994489|P2|NOT COMPLETED|Washout: 7 Days||0
417934|NCT00829426|994490|P1|NOT COMPLETED|Washout: 7 Days||1
417935|NCT00829426|994489|P2|COMPLETED|Washout: 7 Days||16
417936|NCT00829426|994490|P1|COMPLETED|Washout: 7 Days||15
417937|NCT00829426|994489|P2|STARTED|Washout: 7 Days||16
417938|NCT00829426|994490|P1|STARTED|Washout: 7 Days||16
417939|NCT00829426|994489|P2|NOT COMPLETED|First Intervention||0
417940|NCT00829426|994490|P1|NOT COMPLETED|First Intervention||0
417941|NCT00829426|994489|P2|COMPLETED|First Intervention||16
417942|NCT00829426|994490|P1|COMPLETED|First Intervention||16
417943|NCT00829426|994489|P2|STARTED|First Intervention||16
417944|NCT00829426|994490|P1|STARTED|First Intervention||16
417945|NCT00829387|994500|P2|NOT COMPLETED|Overall Study||3
417946|NCT00829387|994501|P1|NOT COMPLETED|Overall Study||3
417947|NCT00829387|994500|P2|COMPLETED|Overall Study||21
417948|NCT00829387|994501|P1|COMPLETED|Overall Study||20
417949|NCT00829387|994500|P2|STARTED|Overall Study||24
417950|NCT00829387|994501|P1|STARTED|Overall Study||23
417951|NCT00829309|994519|P2|NOT COMPLETED|Second Intervention||0
417952|NCT00829309|994520|P1|NOT COMPLETED|Second Intervention||0
417953|NCT00829309|994519|P2|COMPLETED|Second Intervention||8
417954|NCT00829309|994520|P1|COMPLETED|Second Intervention||7
417955|NCT00829309|994519|P2|STARTED|Second Intervention||8
417956|NCT00829309|994520|P1|STARTED|Second Intervention||7
417957|NCT00829309|994519|P2|NOT COMPLETED|Washout: 7 Days||0
417958|NCT00829309|994520|P1|NOT COMPLETED|Washout: 7 Days||1
417959|NCT00829309|994519|P2|COMPLETED|Washout: 7 Days||8
417960|NCT00829309|994520|P1|COMPLETED|Washout: 7 Days||7
417961|NCT00829309|994519|P2|STARTED|Washout: 7 Days||8
417962|NCT00829309|994520|P1|STARTED|Washout: 7 Days||8
417963|NCT00829309|994519|P2|NOT COMPLETED|First Intervention||0
417964|NCT00829309|994520|P1|NOT COMPLETED|First Intervention||0
417965|NCT00829309|994519|P2|COMPLETED|First Intervention||8
417966|NCT00829309|994520|P1|COMPLETED|First Intervention||8
417967|NCT00829309|994519|P2|STARTED|First Intervention||8
417968|NCT00829309|994520|P1|STARTED|First Intervention||8
417969|NCT00829296|994530|P2|NOT COMPLETED|Overall Study||4
417970|NCT00829296|994531|P1|NOT COMPLETED|Overall Study||5
417971|NCT00829296|994530|P2|COMPLETED|Overall Study||32
417972|NCT00829296|994531|P1|COMPLETED|Overall Study||29
417973|NCT00829296|994530|P2|STARTED|Overall Study||36
417974|NCT00829296|994531|P1|STARTED|Overall Study||34
417975|NCT00829283|994545|P2|NOT COMPLETED|Overall Study||25
417976|NCT00829283|994546|P1|NOT COMPLETED|Overall Study||7
417977|NCT00829283|994545|P2|COMPLETED|Overall Study||127
417978|NCT00829283|994546|P1|COMPLETED|Overall Study||32
417979|NCT00829283|994545|P2|STARTED|Overall Study||152
417980|NCT00829283|994546|P1|STARTED|Overall Study||39
417981|NCT00829244|994556|P2|NOT COMPLETED|Overall Study||21
417982|NCT00829244|994557|P1|NOT COMPLETED|Overall Study||14
417983|NCT00829244|994556|P2|COMPLETED|Overall Study||83
417984|NCT00829244|994557|P1|COMPLETED|Overall Study||82
417985|NCT00829244|994556|P2|STARTED|Overall Study||104
417986|NCT00829244|994557|P1|STARTED|Overall Study||96
417987|NCT00829179|994587|P1|NOT COMPLETED|Overall Study||1
417988|NCT00829179|994587|P1|COMPLETED|Overall Study||19
417989|NCT00829179|994587|P1|STARTED|Overall Study||20
417990|NCT00829166|994593|P2|NOT COMPLETED|Overall Study||496
417991|NCT00829166|994594|P1|NOT COMPLETED|Overall Study||495
417992|NCT00829166|994593|P2|COMPLETED|Overall Study||0
417993|NCT00829166|994594|P1|COMPLETED|Overall Study||0
417994|NCT00829166|994593|P2|Treated|Overall Study||488
417995|NCT00829166|994594|P1|Treated|Overall Study||490
417996|NCT00829166|994593|P2|STARTED|Overall Study||496
417997|NCT00829166|994594|P1|STARTED|Overall Study||495
417998|NCT00829049|994635|P2|NOT COMPLETED|Overall Study||20
417999|NCT00829049|994636|P1|NOT COMPLETED|Overall Study||17
418000|NCT00829049|994635|P2|COMPLETED|Overall Study||68
418001|NCT00829049|994636|P1|COMPLETED|Overall Study||60
418002|NCT00829049|994635|P2|STARTED|Overall Study||88
418003|NCT00829049|994636|P1|STARTED|Overall Study||77
418004|NCT00829036|994648|P1|NOT COMPLETED|Overall Study||0
418005|NCT00829036|994648|P1|COMPLETED|Overall Study||24
418006|NCT00829036|994648|P1|STARTED|Overall Study||24
418007|NCT00829010|994657|P5|NOT COMPLETED|Overall Study||2
418008|NCT00829010|994658|P4|NOT COMPLETED|Overall Study||8
418009|NCT00829010|994659|P3|NOT COMPLETED|Overall Study||3
418010|NCT00829010|994660|P2|NOT COMPLETED|Overall Study||9
418011|NCT00829010|994661|P1|NOT COMPLETED|Overall Study||10
418012|NCT00829010|994657|P5|COMPLETED|Overall Study||98
418013|NCT00829010|994658|P4|COMPLETED|Overall Study||92
418014|NCT00829010|994659|P3|COMPLETED|Overall Study||97
418015|NCT00829010|994660|P2|COMPLETED|Overall Study||92
418016|NCT00829010|994661|P1|COMPLETED|Overall Study||73
418017|NCT00829010|994657|P5|STARTED|Overall Study||100
418018|NCT00829010|994658|P4|STARTED|Overall Study||100
418019|NCT00829010|994659|P3|STARTED|Overall Study||100
418020|NCT00829010|994660|P2|STARTED|Overall Study||101
418021|NCT00829010|994661|P1|STARTED|Overall Study||83
418022|NCT00828984|994826|P3|NOT COMPLETED|Overall Study||9
418023|NCT00828984|994827|P2|NOT COMPLETED|Overall Study||16
418024|NCT00828984|994828|P1|NOT COMPLETED|Overall Study||14
418025|NCT00828984|994826|P3|COMPLETED|Overall Study||19
418026|NCT00828984|994827|P2|COMPLETED|Overall Study||15
418027|NCT00828984|994828|P1|COMPLETED|Overall Study||14
418028|NCT00828984|994826|P3|Post Intervention Follow-Up|Overall Study||19
418029|NCT00828984|994827|P2|Post Intervention Follow-Up|Overall Study||16
418030|NCT00828984|994828|P1|Post Intervention Follow-Up|Overall Study||15
418031|NCT00828984|994826|P3|Flexible Sigmoidoscopy|Overall Study||19
418032|NCT00828984|994827|P2|Flexible Sigmoidoscopy|Overall Study||19
418033|NCT00828984|994828|P1|Flexible Sigmoidoscopy|Overall Study||20
418034|NCT00828984|994826|P3|Treatment|Overall Study||24
418035|NCT00828984|994827|P2|Treatment|Overall Study||26
418036|NCT00828984|994828|P1|Treatment|Overall Study||24
418037|NCT00828984|994826|P3|Randomization|Overall Study||28
418038|NCT00828984|994827|P2|Randomization|Overall Study||31
418039|NCT00828984|994828|P1|Randomization|Overall Study||28
418040|NCT00828984|994826|P3|STARTED|Overall Study||28
418041|NCT00828984|994827|P2|STARTED|Overall Study||31
418042|NCT00828984|994828|P1|STARTED|Overall Study||28
418043|NCT00828945|994851|P1|NOT COMPLETED|Overall Study||41
418044|NCT00828945|994851|P1|COMPLETED|Overall Study||216
418045|NCT00828945|994851|P1|STARTED|Overall Study||257
418046|NCT00828841|994868|P3|NOT COMPLETED|Overall Study||4
418047|NCT00828841|994869|P2|NOT COMPLETED|Overall Study||4
418048|NCT00828841|994870|P1|NOT COMPLETED|Overall Study||4
418049|NCT00828841|994868|P3|COMPLETED|Overall Study||126
418050|NCT00828841|994869|P2|COMPLETED|Overall Study||232
418051|NCT00828841|994870|P1|COMPLETED|Overall Study||231
418052|NCT00828841|994868|P3|STARTED|Overall Study||130
418053|NCT00828841|994869|P2|STARTED|Overall Study||236
418054|NCT00828841|994870|P1|STARTED|Overall Study||235
418055|NCT00828750|994883|P1|NOT COMPLETED|Overall Study||4
418056|NCT00828750|994883|P1|COMPLETED|Overall Study||15
418057|NCT00828750|994883|P1|STARTED|Overall Study||19
418058|NCT00828711|994897|P3|NOT COMPLETED|Overall Study||0
418059|NCT00828711|994898|P2|NOT COMPLETED|Overall Study||0
418060|NCT00828711|994899|P1|NOT COMPLETED|Overall Study||1
418061|NCT00828711|994897|P3|COMPLETED|Overall Study||131
418062|NCT00828711|994898|P2|COMPLETED|Overall Study||125
418063|NCT00828711|994899|P1|COMPLETED|Overall Study||117
418064|NCT00828711|994897|P3|STARTED|Overall Study||131
418065|NCT00828711|994898|P2|STARTED|Overall Study||125
418066|NCT00828711|994899|P1|STARTED|Overall Study||118
418067|NCT00828568|994931|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
418068|NCT00828568|994932|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
418069|NCT00828568|994933|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
418070|NCT00828568|994931|P3|COMPLETED|Treated - Received at Least One Dose||55
418071|NCT00828568|994932|P2|COMPLETED|Treated - Received at Least One Dose||150
418072|NCT00828568|994933|P1|COMPLETED|Treated - Received at Least One Dose||153
418073|NCT00828568|994931|P3|STARTED|Treated - Received at Least One Dose||60
418074|NCT00828568|994932|P2|STARTED|Treated - Received at Least One Dose||179
418075|NCT00828568|994933|P1|STARTED|Treated - Received at Least One Dose||183
418076|NCT00828568|994931|P3|NOT COMPLETED|Randomized||2
418077|NCT00828568|994932|P2|NOT COMPLETED|Randomized||0
418078|NCT00828568|994933|P1|NOT COMPLETED|Randomized||1
418079|NCT00828568|994931|P3|COMPLETED|Randomized||60
418080|NCT00828568|994932|P2|COMPLETED|Randomized||179
418081|NCT00828568|994933|P1|COMPLETED|Randomized||183
418082|NCT00828568|994931|P3|STARTED|Randomized||62
418083|NCT00828568|994932|P2|STARTED|Randomized||179
418084|NCT00828568|994933|P1|STARTED|Randomized||184
418085|NCT00828542|994948|P2|NOT COMPLETED|Overall Study||3
418086|NCT00828542|994949|P1|NOT COMPLETED|Overall Study||3
418087|NCT00828542|994948|P2|COMPLETED|Overall Study||20
418088|NCT00828542|994949|P1|COMPLETED|Overall Study||20
418089|NCT00828542|994948|P2|STARTED|Overall Study||23
418090|NCT00828542|994949|P1|STARTED|Overall Study||23
418091|NCT00828516|994955|P1|NOT COMPLETED|Clinical Phase: Series 2||0
418092|NCT00828516|994955|P1|COMPLETED|Clinical Phase: Series 2||30
418093|NCT00828516|994955|P1|STARTED|Clinical Phase: Series 2||30
418094|NCT00828516|994955|P1|NOT COMPLETED|Clinical Phase: Series 1||2
418095|NCT00828516|994955|P1|COMPLETED|Clinical Phase: Series 1||33
418096|NCT00828516|994955|P1|STARTED|Clinical Phase: Series 1||35
418097|NCT00828464|994960|P1|NOT COMPLETED|Overall Study||1
418098|NCT00828464|994960|P1|COMPLETED|Overall Study||29
418099|NCT00828464|994960|P1|STARTED|Overall Study||30
418100|NCT00828412|994979|P2|NOT COMPLETED|Overall Study||2
418101|NCT00828412|994980|P1|NOT COMPLETED|Overall Study||9
418102|NCT00828412|994979|P2|COMPLETED|Overall Study||48
418103|NCT00828412|994980|P1|COMPLETED|Overall Study||41
418104|NCT00828412|994979|P2|STARTED|Overall Study||50
418105|NCT00828412|994980|P1|STARTED|Overall Study||50
418106|NCT00828347|994988|P2|NOT COMPLETED|Overall Study||0
418107|NCT00828347|994989|P1|NOT COMPLETED|Overall Study||0
418108|NCT00828347|994988|P2|COMPLETED|Overall Study||11
418109|NCT00828347|994989|P1|COMPLETED|Overall Study||12
418110|NCT00828347|994988|P2|STARTED|Overall Study||11
418111|NCT00828347|994989|P1|STARTED|Overall Study||12
418112|NCT00828321|994997|P2|NOT COMPLETED|Second Intervention||1
418113|NCT00828321|994998|P1|NOT COMPLETED|Second Intervention||0
418114|NCT00828321|994997|P2|COMPLETED|Second Intervention||19
418115|NCT00828321|994998|P1|COMPLETED|Second Intervention||18
418116|NCT00828321|994997|P2|STARTED|Second Intervention||20
418117|NCT00828321|994998|P1|STARTED|Second Intervention||18
418118|NCT00828321|994997|P2|NOT COMPLETED|Washout of 42 Days||0
418119|NCT00828321|994998|P1|NOT COMPLETED|Washout of 42 Days||2
418120|NCT00828321|994997|P2|COMPLETED|Washout of 42 Days||20
418121|NCT00828321|994998|P1|COMPLETED|Washout of 42 Days||18
418122|NCT00828321|994997|P2|STARTED|Washout of 42 Days||20
418123|NCT00828321|994998|P1|STARTED|Washout of 42 Days||20
418124|NCT00828321|994997|P2|NOT COMPLETED|First Intervention||0
418125|NCT00828321|994998|P1|NOT COMPLETED|First Intervention||0
418126|NCT00828321|994997|P2|COMPLETED|First Intervention||20
418127|NCT00828321|994998|P1|COMPLETED|First Intervention||20
418128|NCT00828321|994997|P2|STARTED|First Intervention||20
418129|NCT00828321|994998|P1|STARTED|First Intervention||20
418130|NCT00828308|995010|P1|NOT COMPLETED|Overall Study||0
418131|NCT00828308|995010|P1|COMPLETED|Overall Study||16
418132|NCT00828308|995010|P1|STARTED|Overall Study||16
418133|NCT00828295|995016|P2|NOT COMPLETED|Overall Study||0
418134|NCT00828295|995017|P1|NOT COMPLETED|Overall Study||0
418135|NCT00828295|995016|P2|COMPLETED|Overall Study||75
418136|NCT00828295|995017|P1|COMPLETED|Overall Study||75
418137|NCT00828295|995016|P2|STARTED|Overall Study||75
418138|NCT00828295|995017|P1|STARTED|Overall Study||75
418139|NCT00828204|995027|P2|NOT COMPLETED|Extension Study||3
418140|NCT00828204|995028|P1|NOT COMPLETED|Extension Study||0
418141|NCT00828204|995027|P2|COMPLETED|Extension Study||61
418142|NCT00828204|995028|P1|COMPLETED|Extension Study||0
418143|NCT00828204|995027|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
418144|NCT00828204|995028|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
418145|NCT00828204|995027|P2|NOT COMPLETED|Main Study: After Study Restart||3
418146|NCT00828204|995028|P1|NOT COMPLETED|Main Study: After Study Restart||0
418147|NCT00828204|995027|P2|COMPLETED|Main Study: After Study Restart||71
418148|NCT00828204|995028|P1|COMPLETED|Main Study: After Study Restart||0
418149|NCT00828204|995027|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
418150|NCT00828204|995028|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
418151|NCT00828204|995027|P2|Completed Manual Injection|Main Study: After Study Restart||74
418152|NCT00828204|995028|P1|Completed Manual Injection|Main Study: After Study Restart||0
418153|NCT00828204|995027|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
418154|NCT00828204|995028|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
418155|NCT00828204|995027|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
418156|NCT00828204|995028|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
418157|NCT00828204|995027|P2|COMPLETED|Main Study: Prior to Study Suspension||0
418158|NCT00828204|995028|P1|COMPLETED|Main Study: Prior to Study Suspension||7
418159|NCT00828204|995027|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
418160|NCT00828204|995028|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
418161|NCT00828204|995027|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
418162|NCT00828204|995028|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
418163|NCT00828204|995027|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
418164|NCT00828204|995028|P1|STARTED|Main Study: Prior to Study Suspension||21
418165|NCT00828191|995047|P2|NOT COMPLETED|Overall Study||10
418166|NCT00828191|995048|P1|NOT COMPLETED|Overall Study||8
418167|NCT00828191|995047|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
418168|NCT00828191|995048|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
418169|NCT00828191|995047|P2|STARTED|Overall Study|Randomized patients|400
418170|NCT00828191|995048|P1|STARTED|Overall Study|Randomized patients|400
418171|NCT00828178|995060|P2|NOT COMPLETED|Overall Study||2
418172|NCT00828178|995061|P1|NOT COMPLETED|Overall Study||0
418173|NCT00828178|995060|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
418174|NCT00828178|995061|P1|COMPLETED|Overall Study||42
418175|NCT00828178|995060|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
418176|NCT00828178|995061|P1|STARTED|Overall Study||42
418177|NCT00828139|995075|P4|NOT COMPLETED|Overall Study||51
418178|NCT00828139|995076|P3|NOT COMPLETED|Overall Study||55
418179|NCT00828139|995077|P2|NOT COMPLETED|Overall Study||41
418180|NCT00828139|995078|P1|NOT COMPLETED|Overall Study||41
418181|NCT00828139|995075|P4|COMPLETED|Overall Study||0
418182|NCT00828139|995076|P3|COMPLETED|Overall Study||0
418183|NCT00828139|995077|P2|COMPLETED|Overall Study||0
418184|NCT00828139|995078|P1|COMPLETED|Overall Study||1
418185|NCT00828139|995075|P4|STARTED|Overall Study||51
418186|NCT00828139|995076|P3|STARTED|Overall Study||55
418187|NCT00828139|995077|P2|STARTED|Overall Study||41
418188|NCT00828139|995078|P1|STARTED|Overall Study||42
418189|NCT00828113|995098|P2|NOT COMPLETED|Overall Study||31
418190|NCT00828113|995099|P1|NOT COMPLETED|Overall Study||30
418191|NCT00828113|995098|P2|COMPLETED|Overall Study||20
418192|NCT00828113|995099|P1|COMPLETED|Overall Study||20
418193|NCT00828113|995098|P2|STARTED|Overall Study||51
418194|NCT00828113|995099|P1|STARTED|Overall Study||50
418195|NCT00828074|995107|P3|NOT COMPLETED|Overall Study||0
418196|NCT00828074|995108|P2|NOT COMPLETED|Overall Study||0
418197|NCT00828074|995109|P1|NOT COMPLETED|Overall Study||0
418198|NCT00828074|995107|P3|COMPLETED|Overall Study||35
418199|NCT00828074|995108|P2|COMPLETED|Overall Study||5
418200|NCT00828074|995109|P1|COMPLETED|Overall Study||6
418201|NCT00828074|995107|P3|STARTED|Overall Study||35
418202|NCT00828074|995108|P2|STARTED|Overall Study||5
418203|NCT00828074|995109|P1|STARTED|Overall Study||6
418204|NCT00828061|995121|P6|NOT COMPLETED|Period 3||0
418205|NCT00828061|995122|P5|NOT COMPLETED|Period 3||0
418206|NCT00828061|995123|P4|NOT COMPLETED|Period 3||0
418207|NCT00828061|995124|P3|NOT COMPLETED|Period 3||0
418208|NCT00828061|995125|P2|NOT COMPLETED|Period 3||0
418209|NCT00828061|995126|P1|NOT COMPLETED|Period 3||0
418210|NCT00828061|995121|P6|COMPLETED|Period 3||3
418211|NCT00828061|995122|P5|COMPLETED|Period 3||3
418212|NCT00828061|995123|P4|COMPLETED|Period 3||3
418213|NCT00828061|995124|P3|COMPLETED|Period 3||3
418214|NCT00828061|995125|P2|COMPLETED|Period 3||3
418215|NCT00828061|995126|P1|COMPLETED|Period 3||4
418216|NCT00828061|995121|P6|STARTED|Period 3||3
418217|NCT00828061|995122|P5|STARTED|Period 3||3
418218|NCT00828061|995123|P4|STARTED|Period 3||3
418219|NCT00828061|995124|P3|STARTED|Period 3||3
418220|NCT00828061|995125|P2|STARTED|Period 3||3
418221|NCT00828061|995126|P1|STARTED|Period 3||4
418222|NCT00828061|995121|P6|NOT COMPLETED|Period 2||0
418223|NCT00828061|995122|P5|NOT COMPLETED|Period 2||0
418224|NCT00828061|995123|P4|NOT COMPLETED|Period 2||0
418225|NCT00828061|995124|P3|NOT COMPLETED|Period 2||0
418226|NCT00828061|995125|P2|NOT COMPLETED|Period 2||0
418227|NCT00828061|995126|P1|NOT COMPLETED|Period 2||0
418228|NCT00828061|995121|P6|COMPLETED|Period 2||3
418229|NCT00828061|995122|P5|COMPLETED|Period 2||3
418230|NCT00828061|995123|P4|COMPLETED|Period 2||3
418231|NCT00828061|995124|P3|COMPLETED|Period 2||3
418232|NCT00828061|995125|P2|COMPLETED|Period 2||3
418233|NCT00828061|995126|P1|COMPLETED|Period 2||4
418234|NCT00828061|995121|P6|STARTED|Period 2||3
418235|NCT00828061|995122|P5|STARTED|Period 2||3
418236|NCT00828061|995123|P4|STARTED|Period 2||3
418237|NCT00828061|995124|P3|STARTED|Period 2||3
418238|NCT00828061|995125|P2|STARTED|Period 2||3
418239|NCT00828061|995126|P1|STARTED|Period 2||4
418240|NCT00828061|995121|P6|NOT COMPLETED|Period 1||0
418241|NCT00828061|995122|P5|NOT COMPLETED|Period 1||0
418242|NCT00828061|995123|P4|NOT COMPLETED|Period 1||0
418243|NCT00828061|995124|P3|NOT COMPLETED|Period 1||0
418244|NCT00828061|995125|P2|NOT COMPLETED|Period 1||0
418245|NCT00828061|995126|P1|NOT COMPLETED|Period 1||0
418246|NCT00828061|995121|P6|COMPLETED|Period 1||3
418247|NCT00828061|995122|P5|COMPLETED|Period 1||3
418248|NCT00828061|995123|P4|COMPLETED|Period 1||3
418249|NCT00828061|995124|P3|COMPLETED|Period 1||3
418250|NCT00828061|995125|P2|COMPLETED|Period 1||3
418251|NCT00828061|995126|P1|COMPLETED|Period 1||4
418252|NCT00828061|995121|P6|STARTED|Period 1||3
418253|NCT00828061|995122|P5|STARTED|Period 1||3
418254|NCT00828061|995123|P4|STARTED|Period 1||3
418255|NCT00828061|995124|P3|STARTED|Period 1||3
418256|NCT00828061|995125|P2|STARTED|Period 1||3
418257|NCT00828061|995126|P1|STARTED|Period 1||4
418258|NCT00827983|995139|P2|NOT COMPLETED|Overall Study||16
418259|NCT00827983|995140|P1|NOT COMPLETED|Overall Study||18
418260|NCT00827983|995139|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
418261|NCT00827983|995140|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
418262|NCT00827983|995139|P2|STARTED|Overall Study|all randomised patients|344
418263|NCT00827983|995140|P1|STARTED|Overall Study|All randomised patients|339
418264|NCT00827944|995152|P2|NOT COMPLETED|Overall Study||59
418265|NCT00827944|995153|P1|NOT COMPLETED|Overall Study||63
418266|NCT00827944|995152|P2|COMPLETED|Overall Study||240
418267|NCT00827944|995153|P1|COMPLETED|Overall Study||241
418268|NCT00827944|995152|P2|STARTED|Overall Study||299
418269|NCT00827944|995153|P1|STARTED|Overall Study||304
418270|NCT00827931|995173|P2|NOT COMPLETED|Overall Study||6
418271|NCT00827931|995174|P1|NOT COMPLETED|Overall Study||6
418272|NCT00827931|995173|P2|COMPLETED|Overall Study||39
418273|NCT00827931|995174|P1|COMPLETED|Overall Study||43
418274|NCT00827931|995173|P2|STARTED|Overall Study||45
418275|NCT00827931|995174|P1|STARTED|Overall Study||49
418276|NCT00827918|995195|P3|NOT COMPLETED|Overall Study||21
418277|NCT00827918|995196|P2|NOT COMPLETED|Overall Study||9
418278|NCT00827918|995197|P1|NOT COMPLETED|Overall Study||28
418279|NCT00827918|995195|P3|COMPLETED|Overall Study||62
418280|NCT00827918|995196|P2|COMPLETED|Overall Study||38
418281|NCT00827918|995197|P1|COMPLETED|Overall Study||58
418282|NCT00827918|995195|P3|STARTED|Overall Study||83
418283|NCT00827918|995196|P2|STARTED|Overall Study||47
418284|NCT00827918|995197|P1|STARTED|Overall Study||86
418285|NCT00827827|995225|P2|NOT COMPLETED|Overall Study||0
418286|NCT00827827|995226|P1|NOT COMPLETED|Overall Study||8
418287|NCT00827827|995225|P2|COMPLETED|Overall Study||16
418288|NCT00827827|995226|P1|COMPLETED|Overall Study||14
418289|NCT00827827|995225|P2|STARTED|Overall Study||16
418290|NCT00827827|995226|P1|STARTED|Overall Study||22
418291|NCT00827632|995270|P2|NOT COMPLETED|Overall Study||23
418292|NCT00827632|995271|P1|NOT COMPLETED|Overall Study||22
418293|NCT00827632|995270|P2|COMPLETED|Overall Study||75
418294|NCT00827632|995271|P1|COMPLETED|Overall Study||106
418295|NCT00827632|995270|P2|STARTED|Overall Study||98
418296|NCT00827632|995271|P1|STARTED|Overall Study||128
418297|NCT00827606|995279|P2|NOT COMPLETED|Overall Study||38
418298|NCT00827606|995280|P1|NOT COMPLETED|Overall Study||27
418299|NCT00827606|995279|P2|COMPLETED|Overall Study||94
418300|NCT00827606|995280|P1|COMPLETED|Overall Study||112
418301|NCT00827606|995279|P2|STARTED|Overall Study||132
418302|NCT00827606|995280|P1|STARTED|Overall Study||139
418303|NCT00827567|995341|P1|NOT COMPLETED|Overall Study||4
418304|NCT00827567|995341|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
418305|NCT00827567|995341|P1|STARTED|Overall Study||4
418306|NCT00827541|995347|P2|NOT COMPLETED|Overall Study||11
418307|NCT00827541|995348|P1|NOT COMPLETED|Overall Study||4
418308|NCT00827541|995347|P2|COMPLETED|Overall Study||85
418309|NCT00827541|995348|P1|COMPLETED|Overall Study||15
418310|NCT00827541|995347|P2|STARTED|Overall Study||96
418311|NCT00827541|995348|P1|STARTED|Overall Study||19
418312|NCT00827502|995360|P1|NOT COMPLETED|Overall Study||21
418313|NCT00827502|995360|P1|COMPLETED|Overall Study||400
418314|NCT00827502|995360|P1|Received Treatment (Number Treated)|Overall Study||410
418315|NCT00827502|995360|P1|STARTED|Overall Study||421
418316|NCT00827372|995366|P1|NOT COMPLETED|Overall Study||8
418317|NCT00827372|995366|P1|COMPLETED|Overall Study||2
418318|NCT00827372|995366|P1|STARTED|Overall Study||10
418319|NCT00827255|995374|P1|NOT COMPLETED|Overall Study||0
418320|NCT00827255|995374|P1|COMPLETED|Overall Study||35
418321|NCT00827255|995374|P1|STARTED|Overall Study||35
418322|NCT00827242|995381|P2|NOT COMPLETED|Overall Study||12
418323|NCT00827242|995382|P1|NOT COMPLETED|Overall Study||13
418324|NCT00827242|995381|P2|COMPLETED|Overall Study||152
418325|NCT00827242|995382|P1|COMPLETED|Overall Study||148
418326|NCT00827242|995381|P2|STARTED|Overall Study||164
418327|NCT00827242|995382|P1|STARTED|Overall Study||161
418328|NCT00827112|995420|P2|NOT COMPLETED|Overall Study||12
418329|NCT00827112|995421|P1|NOT COMPLETED|Overall Study||15
418330|NCT00827112|995420|P2|COMPLETED|Overall Study||52
418331|NCT00827112|995421|P1|COMPLETED|Overall Study||50
418332|NCT00827112|995420|P2|Treated|Overall Study||61
418333|NCT00827112|995421|P1|Treated|Overall Study||60
418334|NCT00827112|995420|P2|STARTED|Overall Study||64
418335|NCT00827112|995421|P1|STARTED|Overall Study||65
418336|NCT00827099|995454|P1|NOT COMPLETED|Overall Study||0
418337|NCT00827099|995454|P1|COMPLETED|Overall Study||5
418338|NCT00827099|995454|P1|STARTED|Overall Study||5
418339|NCT00827073|995465|P2|NOT COMPLETED|Overall Study||0
418340|NCT00827073|995466|P1|NOT COMPLETED|Overall Study||0
418341|NCT00827073|995465|P2|COMPLETED|Overall Study||20
418342|NCT00827073|995466|P1|COMPLETED|Overall Study||20
418343|NCT00827073|995465|P2|STARTED|Overall Study||20
418344|NCT00827073|995466|P1|STARTED|Overall Study||20
418345|NCT00826943|995474|P6|NOT COMPLETED|Overall Study||0
418346|NCT00826943|995475|P5|NOT COMPLETED|Overall Study||1
418347|NCT00826943|995476|P4|NOT COMPLETED|Overall Study||0
418348|NCT00826943|995477|P3|NOT COMPLETED|Overall Study||0
418349|NCT00826943|995478|P2|NOT COMPLETED|Overall Study||0
418350|NCT00826943|995479|P1|NOT COMPLETED|Overall Study||0
418351|NCT00826943|995474|P6|COMPLETED|Overall Study||2
418352|NCT00826943|995475|P5|COMPLETED|Overall Study||6
418353|NCT00826943|995476|P4|COMPLETED|Overall Study||5
418354|NCT00826943|995477|P3|COMPLETED|Overall Study||4
418355|NCT00826943|995478|P2|COMPLETED|Overall Study||6
418356|NCT00826943|995479|P1|COMPLETED|Overall Study||6
418357|NCT00826943|995474|P6|STARTED|Overall Study||2
418358|NCT00826943|995475|P5|STARTED|Overall Study||7
418359|NCT00826943|995476|P4|STARTED|Overall Study||5
418360|NCT00826943|995477|P3|STARTED|Overall Study||4
418361|NCT00826943|995478|P2|STARTED|Overall Study||6
418362|NCT00826943|995479|P1|STARTED|Overall Study||6
418363|NCT00826800|995493|P1|NOT COMPLETED|Overall Study||0
418364|NCT00826800|995493|P1|COMPLETED|Overall Study||2
418365|NCT00826800|995493|P1|STARTED|Overall Study||2
418366|NCT00826618|995497|P1|NOT COMPLETED|Overall Study||1
418367|NCT00826618|995497|P1|COMPLETED|Overall Study||5
418368|NCT00826618|995497|P1|STARTED|Overall Study||6
418369|NCT00826540|995501|P1|NOT COMPLETED|Overall Study||4
418370|NCT00826540|995501|P1|COMPLETED|Overall Study||79
418371|NCT00826540|995501|P1|STARTED|Overall Study||83
418372|NCT00826449|995507|P1|NOT COMPLETED|Overall Study||5
418373|NCT00826449|995507|P1|COMPLETED|Overall Study||42
418374|NCT00826449|995507|P1|Phase II|Overall Study||35
418375|NCT00826449|995507|P1|Phase I|Overall Study||12
418376|NCT00826449|995507|P1|STARTED|Overall Study||47
418377|NCT00826280|995516|P3|NOT COMPLETED|Overall Study||46
418378|NCT00826280|995517|P2|NOT COMPLETED|Overall Study||46
418379|NCT00826280|995518|P1|NOT COMPLETED|Overall Study||48
418380|NCT00826280|995516|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
418381|NCT00826280|995517|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
418382|NCT00826280|995518|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
418383|NCT00826280|995516|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
418384|NCT00826280|995517|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
418469|NCT00825825|995687|P3|COMPLETED|Second Washout Period (14 Days)||2
418385|NCT00826280|995518|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
418386|NCT00826280|995516|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
418387|NCT00826280|995517|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
418388|NCT00826280|995518|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
418389|NCT00826280|995516|P3|STARTED|Overall Study||117
418390|NCT00826280|995517|P2|STARTED|Overall Study||116
418391|NCT00826280|995518|P1|STARTED|Overall Study||114
418392|NCT00826267|995547|P3|NOT COMPLETED|Overall Study||0
418393|NCT00826267|995548|P2|NOT COMPLETED|Overall Study||0
418394|NCT00826267|995549|P1|NOT COMPLETED|Overall Study||1
418395|NCT00826267|995547|P3|COMPLETED|Overall Study||11
418396|NCT00826267|995548|P2|COMPLETED|Overall Study||8
418397|NCT00826267|995549|P1|COMPLETED|Overall Study||9
418398|NCT00826267|995547|P3|STARTED|Overall Study||11
418399|NCT00826267|995548|P2|STARTED|Overall Study||8
418400|NCT00826267|995549|P1|STARTED|Overall Study||10
418401|NCT00826228|995567|P1|NOT COMPLETED|Overall Study||1
418402|NCT00826228|995567|P1|COMPLETED|Overall Study||11
418403|NCT00826228|995567|P1|STARTED|Overall Study||12
418404|NCT00826202|995574|P2|NOT COMPLETED|Overall Study||13
418405|NCT00826202|995575|P1|NOT COMPLETED|Overall Study||10
418406|NCT00826202|995574|P2|COMPLETED|Overall Study||11
418407|NCT00826202|995575|P1|COMPLETED|Overall Study||10
418408|NCT00826202|995574|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
418409|NCT00826202|995575|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
418410|NCT00826202|995574|P2|STARTED|Overall Study||24
418411|NCT00826202|995575|P1|STARTED|Overall Study||20
418412|NCT00826176|995589|P2|NOT COMPLETED|Overall Study||0
418413|NCT00826176|995590|P1|NOT COMPLETED|Overall Study||13
418414|NCT00826176|995589|P2|COMPLETED|Overall Study|treated and completed|36
418415|NCT00826176|995590|P1|COMPLETED|Overall Study|treated and completed|115
418416|NCT00826176|995589|P2|STARTED|Overall Study|enrolled|36
418417|NCT00826176|995590|P1|STARTED|Overall Study|enrolled|128
418418|NCT00826111|995602|P2|NOT COMPLETED|Overall Study||2
418419|NCT00826111|995603|P1|NOT COMPLETED|Overall Study||7
418420|NCT00826111|995602|P2|COMPLETED|Overall Study||3
418421|NCT00826111|995603|P1|COMPLETED|Overall Study||7
418422|NCT00826111|995602|P2|STARTED|Overall Study||5
418423|NCT00826111|995603|P1|STARTED|Overall Study||14
418424|NCT00826007|995627|P2|NOT COMPLETED|Overall Study||0
418425|NCT00826007|995628|P1|NOT COMPLETED|Overall Study||0
418426|NCT00826007|995627|P2|COMPLETED|Overall Study||279
418427|NCT00826007|995628|P1|COMPLETED|Overall Study|Retrospective review|308
418428|NCT00826007|995627|P2|STARTED|Overall Study||279
418429|NCT00826007|995628|P1|STARTED|Overall Study|Retrospective review|308
418430|NCT00825994|995633|P1|NOT COMPLETED|Overall Study||5
418431|NCT00825994|995633|P1|COMPLETED|Overall Study||19
418432|NCT00825994|995633|P1|STARTED|Overall Study||24
418433|NCT00825916|995641|P3|NOT COMPLETED|Overall Study||1
418434|NCT00825916|995642|P2|NOT COMPLETED|Overall Study||2
418435|NCT00825916|995643|P1|NOT COMPLETED|Overall Study||4
418436|NCT00825916|995641|P3|COMPLETED|Overall Study||19
418437|NCT00825916|995642|P2|COMPLETED|Overall Study||18
418438|NCT00825916|995643|P1|COMPLETED|Overall Study||15
418439|NCT00825916|995641|P3|STARTED|Overall Study||20
418440|NCT00825916|995642|P2|STARTED|Overall Study||20
418441|NCT00825916|995643|P1|STARTED|Overall Study||19
418442|NCT00825825|995684|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
418443|NCT00825825|995685|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
418444|NCT00825825|995686|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
418445|NCT00825825|995687|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
418446|NCT00825825|995688|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
418447|NCT00825825|995689|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
418448|NCT00825825|995684|P6|COMPLETED|Third Medication Period (14 Days)||1
418449|NCT00825825|995685|P5|COMPLETED|Third Medication Period (14 Days)||3
418450|NCT00825825|995686|P4|COMPLETED|Third Medication Period (14 Days)||3
418451|NCT00825825|995687|P3|COMPLETED|Third Medication Period (14 Days)||2
418452|NCT00825825|995688|P2|COMPLETED|Third Medication Period (14 Days)||2
418453|NCT00825825|995689|P1|COMPLETED|Third Medication Period (14 Days)||1
418454|NCT00825825|995684|P6|STARTED|Third Medication Period (14 Days)||3
418455|NCT00825825|995685|P5|STARTED|Third Medication Period (14 Days)||3
418456|NCT00825825|995686|P4|STARTED|Third Medication Period (14 Days)||3
418457|NCT00825825|995687|P3|STARTED|Third Medication Period (14 Days)||2
418458|NCT00825825|995688|P2|STARTED|Third Medication Period (14 Days)||4
418459|NCT00825825|995689|P1|STARTED|Third Medication Period (14 Days)||1
418460|NCT00825825|995684|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
418461|NCT00825825|995685|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
418462|NCT00825825|995686|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
418463|NCT00825825|995687|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
418464|NCT00825825|995688|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
418465|NCT00825825|995689|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
418466|NCT00825825|995684|P6|COMPLETED|Second Washout Period (14 Days)||3
418467|NCT00825825|995685|P5|COMPLETED|Second Washout Period (14 Days)||3
418468|NCT00825825|995686|P4|COMPLETED|Second Washout Period (14 Days)||3
418470|NCT00825825|995688|P2|COMPLETED|Second Washout Period (14 Days)||4
418471|NCT00825825|995689|P1|COMPLETED|Second Washout Period (14 Days)||1
418472|NCT00825825|995684|P6|STARTED|Second Washout Period (14 Days)||3
418473|NCT00825825|995685|P5|STARTED|Second Washout Period (14 Days)||3
418474|NCT00825825|995686|P4|STARTED|Second Washout Period (14 Days)||3
418475|NCT00825825|995687|P3|STARTED|Second Washout Period (14 Days)||2
418476|NCT00825825|995688|P2|STARTED|Second Washout Period (14 Days)||4
418477|NCT00825825|995689|P1|STARTED|Second Washout Period (14 Days)||1
418478|NCT00825825|995684|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
418479|NCT00825825|995685|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
418480|NCT00825825|995686|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
418481|NCT00825825|995687|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
418482|NCT00825825|995688|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
418483|NCT00825825|995689|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
418484|NCT00825825|995684|P6|COMPLETED|Second Medication Period (14 Days)||3
418485|NCT00825825|995685|P5|COMPLETED|Second Medication Period (14 Days)||3
418486|NCT00825825|995686|P4|COMPLETED|Second Medication Period (14 Days)||3
418487|NCT00825825|995687|P3|COMPLETED|Second Medication Period (14 Days)||2
418488|NCT00825825|995688|P2|COMPLETED|Second Medication Period (14 Days)||4
418489|NCT00825825|995689|P1|COMPLETED|Second Medication Period (14 Days)||1
418490|NCT00825825|995684|P6|STARTED|Second Medication Period (14 Days)||3
418491|NCT00825825|995685|P5|STARTED|Second Medication Period (14 Days)||4
418492|NCT00825825|995686|P4|STARTED|Second Medication Period (14 Days)||5
418493|NCT00825825|995687|P3|STARTED|Second Medication Period (14 Days)||2
418494|NCT00825825|995688|P2|STARTED|Second Medication Period (14 Days)||4
418495|NCT00825825|995689|P1|STARTED|Second Medication Period (14 Days)||3
418496|NCT00825825|995684|P6|NOT COMPLETED|First Washout Period (14 Days)||0
418497|NCT00825825|995685|P5|NOT COMPLETED|First Washout Period (14 Days)||0
418498|NCT00825825|995686|P4|NOT COMPLETED|First Washout Period (14 Days)||0
418499|NCT00825825|995687|P3|NOT COMPLETED|First Washout Period (14 Days)||0
418500|NCT00825825|995688|P2|NOT COMPLETED|First Washout Period (14 Days)||0
418501|NCT00825825|995689|P1|NOT COMPLETED|First Washout Period (14 Days)||0
418502|NCT00825825|995684|P6|COMPLETED|First Washout Period (14 Days)||3
418503|NCT00825825|995685|P5|COMPLETED|First Washout Period (14 Days)||4
418504|NCT00825825|995686|P4|COMPLETED|First Washout Period (14 Days)||5
418505|NCT00825825|995687|P3|COMPLETED|First Washout Period (14 Days)||2
418506|NCT00825825|995688|P2|COMPLETED|First Washout Period (14 Days)||4
418507|NCT00825825|995689|P1|COMPLETED|First Washout Period (14 Days)||3
418508|NCT00825825|995684|P6|STARTED|First Washout Period (14 Days)||3
418509|NCT00825825|995685|P5|STARTED|First Washout Period (14 Days)||4
418510|NCT00825825|995686|P4|STARTED|First Washout Period (14 Days)||5
418511|NCT00825825|995687|P3|STARTED|First Washout Period (14 Days)||2
418512|NCT00825825|995688|P2|STARTED|First Washout Period (14 Days)||4
418513|NCT00825825|995689|P1|STARTED|First Washout Period (14 Days)||3
418514|NCT00825825|995684|P6|NOT COMPLETED|First Medication Period (14 Days)||2
418515|NCT00825825|995685|P5|NOT COMPLETED|First Medication Period (14 Days)||0
418516|NCT00825825|995686|P4|NOT COMPLETED|First Medication Period (14 Days)||0
418517|NCT00825825|995687|P3|NOT COMPLETED|First Medication Period (14 Days)||1
418518|NCT00825825|995688|P2|NOT COMPLETED|First Medication Period (14 Days)||0
418519|NCT00825825|995689|P1|NOT COMPLETED|First Medication Period (14 Days)||3
418520|NCT00825825|995684|P6|COMPLETED|First Medication Period (14 Days)||3
418521|NCT00825825|995685|P5|COMPLETED|First Medication Period (14 Days)||4
418522|NCT00825825|995686|P4|COMPLETED|First Medication Period (14 Days)||5
418523|NCT00825825|995687|P3|COMPLETED|First Medication Period (14 Days)||2
418524|NCT00825825|995688|P2|COMPLETED|First Medication Period (14 Days)||4
418525|NCT00825825|995689|P1|COMPLETED|First Medication Period (14 Days)||3
418526|NCT00825825|995684|P6|STARTED|First Medication Period (14 Days)||5
418527|NCT00825825|995685|P5|STARTED|First Medication Period (14 Days)||4
418528|NCT00825825|995686|P4|STARTED|First Medication Period (14 Days)||5
418529|NCT00825825|995687|P3|STARTED|First Medication Period (14 Days)||3
418530|NCT00825825|995688|P2|STARTED|First Medication Period (14 Days)||4
418531|NCT00825825|995689|P1|STARTED|First Medication Period (14 Days)||6
418532|NCT00825812|995705|P4|NOT COMPLETED|Overall Study||10
418533|NCT00825812|995706|P3|NOT COMPLETED|Overall Study||6
418534|NCT00825812|995707|P2|NOT COMPLETED|Overall Study||1
418535|NCT00825812|995708|P1|NOT COMPLETED|Overall Study||0
418536|NCT00825812|995705|P4|COMPLETED|Overall Study||111
418537|NCT00825812|995706|P3|COMPLETED|Overall Study||120
418538|NCT00825812|995707|P2|COMPLETED|Overall Study||31
418539|NCT00825812|995708|P1|COMPLETED|Overall Study||29
418540|NCT00825812|995705|P4|TREATED|Overall Study||111
418541|NCT00825812|995706|P3|TREATED|Overall Study||120
418542|NCT00825812|995707|P2|TREATED|Overall Study||31
418543|NCT00825812|995708|P1|TREATED|Overall Study||29
418544|NCT00825812|995705|P4|STARTED|Overall Study||121
418545|NCT00825812|995706|P3|STARTED|Overall Study||126
418546|NCT00825812|995707|P2|STARTED|Overall Study||32
418547|NCT00825812|995708|P1|STARTED|Overall Study||29
418548|NCT00825786|995724|P2|NOT COMPLETED|Overall Study||0
418549|NCT00825786|995725|P1|NOT COMPLETED|Overall Study||0
418550|NCT00825786|995724|P2|COMPLETED|Overall Study||51
418551|NCT00825786|995725|P1|COMPLETED|Overall Study||52
418552|NCT00825786|995724|P2|STARTED|Overall Study||51
418553|NCT00825786|995725|P1|STARTED|Overall Study||52
418554|NCT00825734|995743|P3|NOT COMPLETED|Phase II||76
418555|NCT00825734|995744|P2|NOT COMPLETED|Phase II||0
418556|NCT00825734|995745|P1|NOT COMPLETED|Phase II||0
418557|NCT00825734|995743|P3|COMPLETED|Phase II||0
418558|NCT00825734|995744|P2|COMPLETED|Phase II||0
418559|NCT00825734|995745|P1|COMPLETED|Phase II||0
418560|NCT00825734|995743|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
418561|NCT00825734|995744|P2|STARTED|Phase II||0
418562|NCT00825734|995745|P1|STARTED|Phase II||0
418563|NCT00825734|995743|P3|NOT COMPLETED|Phase I||0
418564|NCT00825734|995744|P2|NOT COMPLETED|Phase I||3
418565|NCT00825734|995745|P1|NOT COMPLETED|Phase I||4
418566|NCT00825734|995743|P3|COMPLETED|Phase I||3
418567|NCT00825734|995744|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
418568|NCT00825734|995745|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
418569|NCT00825734|995743|P3|STARTED|Phase I||3
418570|NCT00825734|995744|P2|STARTED|Phase I||3
418571|NCT00825734|995745|P1|STARTED|Phase I||4
418572|NCT00825682|995755|P2|NOT COMPLETED|Overall Study||5
418573|NCT00825682|995756|P1|NOT COMPLETED|Overall Study||13
418574|NCT00825682|995755|P2|COMPLETED|Overall Study||20
418575|NCT00825682|995756|P1|COMPLETED|Overall Study||34
418576|NCT00825682|995755|P2|STARTED|Overall Study||25
418577|NCT00825682|995756|P1|STARTED|Overall Study||47
418578|NCT00825630|995770|P4|NOT COMPLETED|Overall Study||0
418579|NCT00825630|995771|P3|NOT COMPLETED|Overall Study||0
418580|NCT00825630|995772|P2|NOT COMPLETED|Overall Study||0
418581|NCT00825630|995773|P1|NOT COMPLETED|Overall Study||0
418582|NCT00825630|995770|P4|COMPLETED|Overall Study||13
418583|NCT00825630|995771|P3|COMPLETED|Overall Study||19
418584|NCT00825630|995772|P2|COMPLETED|Overall Study||62
418585|NCT00825630|995773|P1|COMPLETED|Overall Study||29
418586|NCT00825630|995770|P4|STARTED|Overall Study||13
418587|NCT00825630|995771|P3|STARTED|Overall Study||19
418588|NCT00825630|995772|P2|STARTED|Overall Study||62
418589|NCT00825630|995773|P1|STARTED|Overall Study||29
418590|NCT00825565|995783|P1|NOT COMPLETED|Overall Study||0
418591|NCT00825565|995783|P1|COMPLETED|Overall Study||8
418592|NCT00825565|995783|P1|STARTED|Overall Study||8
418593|NCT00825500|995791|P3|NOT COMPLETED|Overall Study||0
418594|NCT00825500|995792|P2|NOT COMPLETED|Overall Study||0
418595|NCT00825500|995793|P1|NOT COMPLETED|Overall Study||0
418596|NCT00825500|995791|P3|COMPLETED|Overall Study||120
418597|NCT00825500|995792|P2|COMPLETED|Overall Study||121
418598|NCT00825500|995793|P1|COMPLETED|Overall Study||125
418599|NCT00825500|995791|P3|STARTED|Overall Study||120
418600|NCT00825500|995792|P2|STARTED|Overall Study||121
418601|NCT00825500|995793|P1|STARTED|Overall Study||125
418602|NCT00825344|995806|P2|NOT COMPLETED|Overall Study||1
418603|NCT00825344|995807|P1|NOT COMPLETED|Overall Study||1
418604|NCT00825344|995806|P2|COMPLETED|Overall Study||42
418605|NCT00825344|995807|P1|COMPLETED|Overall Study||33
418606|NCT00825344|995806|P2|STARTED|Overall Study||43
418607|NCT00825344|995807|P1|STARTED|Overall Study||34
418608|NCT00825318|995817|P1|NOT COMPLETED|Overall Study||1
418609|NCT00825318|995817|P1|COMPLETED|Overall Study||12
418610|NCT00825318|995817|P1|STARTED|Overall Study||13
418611|NCT00825305|995827|P2|NOT COMPLETED|Overall Study||23
418612|NCT00825305|995828|P1|NOT COMPLETED|Overall Study||17
418613|NCT00825305|995827|P2|COMPLETED|Overall Study||252
418614|NCT00825305|995828|P1|COMPLETED|Overall Study||533
418615|NCT00825305|995827|P2|STARTED|Overall Study||275
418616|NCT00825305|995828|P1|STARTED|Overall Study||550
418617|NCT00825266|995842|P2|NOT COMPLETED|Overall Study||0
418618|NCT00825266|995843|P1|NOT COMPLETED|Overall Study||0
418619|NCT00825266|995842|P2|COMPLETED|Overall Study||1
418620|NCT00825266|995843|P1|COMPLETED|Overall Study||1
418621|NCT00825266|995842|P2|STARTED|Overall Study||1
418622|NCT00825266|995843|P1|STARTED|Overall Study||1
418623|NCT00825227|995855|P2|NOT COMPLETED|Overall Study||0
418624|NCT00825227|995856|P1|NOT COMPLETED|Overall Study||0
418625|NCT00825227|995855|P2|COMPLETED|Overall Study||4
418626|NCT00825227|995856|P1|COMPLETED|Overall Study||6
418627|NCT00825227|995855|P2|STARTED|Overall Study||4
418628|NCT00825227|995856|P1|STARTED|Overall Study||6
418629|NCT00825175|995864|P2|NOT COMPLETED|Overall Study||5
418630|NCT00825175|995865|P1|NOT COMPLETED|Overall Study||0
418631|NCT00825175|995864|P2|COMPLETED|Overall Study||7
418632|NCT00825175|995865|P1|COMPLETED|Overall Study||10
418633|NCT00825175|995864|P2|STARTED|Overall Study||12
418634|NCT00825175|995865|P1|STARTED|Overall Study||10
418635|NCT00825162|995874|P3|NOT COMPLETED|Overall Study||6
418636|NCT00825162|995875|P2|NOT COMPLETED|Overall Study||21
418637|NCT00825162|995876|P1|NOT COMPLETED|Overall Study||28
418638|NCT00825162|995874|P3|COMPLETED|Overall Study||396
418639|NCT00825162|995875|P2|COMPLETED|Overall Study||859
418640|NCT00825162|995876|P1|COMPLETED|Overall Study||682
418641|NCT00825162|995874|P3|STARTED|Overall Study||402
418642|NCT00825162|995875|P2|STARTED|Overall Study||880
418643|NCT00825162|995876|P1|STARTED|Overall Study||710
418644|NCT00824850|995902|P2|NOT COMPLETED|Overall Study||1
418645|NCT00824850|995903|P1|NOT COMPLETED|Overall Study||0
418646|NCT00824850|995902|P2|COMPLETED|Overall Study||36
418647|NCT00824850|995903|P1|COMPLETED|Overall Study||38
418648|NCT00824850|995902|P2|Received Vaccination 13vPnC|Overall Study||36
418649|NCT00824850|995903|P1|Received Vaccination 13vPnC|Overall Study||38
418650|NCT00824850|995902|P2|STARTED|Overall Study||37
418651|NCT00824850|995903|P1|STARTED|Overall Study||38
418652|NCT00824824|995949|P2|NOT COMPLETED|Overall Study||0
418653|NCT00824824|995950|P1|NOT COMPLETED|Overall Study||0
418654|NCT00824824|995949|P2|COMPLETED|Overall Study||3
418655|NCT00824824|995950|P1|COMPLETED|Overall Study||4
418656|NCT00824824|995949|P2|STARTED|Overall Study||3
418657|NCT00824824|995950|P1|STARTED|Overall Study||4
418658|NCT00824772|995956|P1|NOT COMPLETED|Overall Study||8
418659|NCT00824772|995956|P1|COMPLETED|Overall Study||196
418660|NCT00824772|995956|P1|STARTED|Overall Study||204
418661|NCT00824746|995961|P1|NOT COMPLETED|Overall Study||0
418662|NCT00824746|995961|P1|COMPLETED|Overall Study||23
418663|NCT00824746|995961|P1|STARTED|Overall Study||23
418664|NCT00824733|995967|P1|NOT COMPLETED|Overall Study||0
418665|NCT00824733|995967|P1|COMPLETED|Overall Study||6
418666|NCT00824733|995967|P1|STARTED|Overall Study||6
418667|NCT00824720|995976|P3|NOT COMPLETED|Overall Study||1
418668|NCT00824720|995977|P2|NOT COMPLETED|Overall Study||1
418669|NCT00824720|995978|P1|NOT COMPLETED|Overall Study||3
418670|NCT00824720|995976|P3|COMPLETED|Overall Study||19
418671|NCT00824720|995977|P2|COMPLETED|Overall Study||15
418672|NCT00824720|995978|P1|COMPLETED|Overall Study||16
418673|NCT00824720|995976|P3|STARTED|Overall Study||20
418674|NCT00824720|995977|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
418675|NCT00824720|995978|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
418676|NCT00824655|995994|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
418677|NCT00824655|995995|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
418678|NCT00824655|995994|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
418679|NCT00824655|995995|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
418680|NCT00824655|995994|P2|STARTED|Toddler Dose (12 Months of Age)||116
418681|NCT00824655|995995|P1|STARTED|Toddler Dose (12 Months of Age)||118
418682|NCT00824655|995994|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
418683|NCT00824655|995995|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
418684|NCT00824655|995994|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
418685|NCT00824655|995995|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
418686|NCT00824655|995994|P2|STARTED|After Infant Dose (6 Months of Age)||0
418687|NCT00824655|995995|P1|STARTED|After Infant Dose (6 Months of Age)||118
418688|NCT00824655|995994|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
418689|NCT00824655|995995|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
418690|NCT00824655|995994|P2|COMPLETED|Infant Series (5 Months of Age)||0
418691|NCT00824655|995995|P1|COMPLETED|Infant Series (5 Months of Age)||118
418692|NCT00824655|995994|P2|STARTED|Infant Series (5 Months of Age)||0
418693|NCT00824655|995995|P1|STARTED|Infant Series (5 Months of Age)||118
418694|NCT00824616|996015|P2|NOT COMPLETED|Overall Study||7
418695|NCT00824616|996016|P1|NOT COMPLETED|Overall Study||6
418696|NCT00824616|996015|P2|COMPLETED|Overall Study||27
418697|NCT00824616|996016|P1|COMPLETED|Overall Study||28
418698|NCT00824616|996015|P2|STARTED|Overall Study||34
418699|NCT00824616|996016|P1|STARTED|Overall Study||34
418700|NCT00824564|996026|P2|NOT COMPLETED|Overall Study||10
418701|NCT00824564|996027|P1|NOT COMPLETED|Overall Study||8
418702|NCT00824564|996026|P2|COMPLETED|Overall Study||30
418703|NCT00824564|996027|P1|COMPLETED|Overall Study||34
418704|NCT00824564|996026|P2|Treated|Overall Study||40
418705|NCT00824564|996027|P1|Treated|Overall Study||41
418706|NCT00824564|996026|P2|STARTED|Overall Study||40
418707|NCT00824564|996027|P1|STARTED|Overall Study||42
418708|NCT00824538|996045|P1|NOT COMPLETED|Overall Study||2
418709|NCT00824538|996045|P1|COMPLETED|Overall Study||11
418710|NCT00824538|996045|P1|STARTED|Overall Study|13 patients entered the study|13
418711|NCT00824512|996053|P2|NOT COMPLETED|Overall Study||0
418712|NCT00824512|996054|P1|NOT COMPLETED|Overall Study||0
418713|NCT00824512|996053|P2|COMPLETED|Overall Study||11
418714|NCT00824512|996054|P1|COMPLETED|Overall Study||11
418715|NCT00824512|996053|P2|STARTED|Overall Study||11
418716|NCT00824512|996054|P1|STARTED|Overall Study||11
418717|NCT00824473|996104|P2|NOT COMPLETED|Overall Study||13
418718|NCT00824473|996105|P1|NOT COMPLETED|Overall Study||15
418719|NCT00824473|996104|P2|COMPLETED|Overall Study||238
418720|NCT00824473|996105|P1|COMPLETED|Overall Study||240
418721|NCT00824473|996104|P2|STARTED|Overall Study||251
418722|NCT00824473|996105|P1|STARTED|Overall Study|1 subject was randomized in error|255
418723|NCT00824460|996127|P6|NOT COMPLETED|Overall Study||8
418724|NCT00824460|996128|P5|NOT COMPLETED|Overall Study||9
418725|NCT00824460|996129|P4|NOT COMPLETED|Overall Study||12
418726|NCT00824460|996130|P3|NOT COMPLETED|Overall Study||5
418727|NCT00824460|996131|P2|NOT COMPLETED|Overall Study||9
418728|NCT00824460|996132|P1|NOT COMPLETED|Overall Study||8
418729|NCT00824460|996127|P6|COMPLETED|Overall Study||18
418730|NCT00824460|996128|P5|COMPLETED|Overall Study||15
418731|NCT00824460|996129|P4|COMPLETED|Overall Study||15
418732|NCT00824460|996130|P3|COMPLETED|Overall Study||20
418733|NCT00824460|996131|P2|COMPLETED|Overall Study||17
418734|NCT00824460|996132|P1|COMPLETED|Overall Study||18
418735|NCT00824460|996127|P6|STARTED|Overall Study||26
418736|NCT00824460|996128|P5|STARTED|Overall Study||24
418737|NCT00824460|996129|P4|STARTED|Overall Study||27
418738|NCT00824460|996130|P3|STARTED|Overall Study||25
418739|NCT00824460|996131|P2|STARTED|Overall Study||26
418740|NCT00824460|996132|P1|STARTED|Overall Study||26
418741|NCT00824434|996164|P1|NOT COMPLETED|Overall Study||0
418742|NCT00824434|996164|P1|COMPLETED|Overall Study||100
418743|NCT00824434|996164|P1|STARTED|Overall Study||100
418744|NCT00824421|996186|P3|NOT COMPLETED|Overall Study||14
418745|NCT00824421|996187|P2|NOT COMPLETED|Overall Study||22
418746|NCT00824421|996188|P1|NOT COMPLETED|Overall Study||17
418747|NCT00824421|996186|P3|COMPLETED|Overall Study||49
418748|NCT00824421|996187|P2|COMPLETED|Overall Study||44
418749|NCT00824421|996188|P1|COMPLETED|Overall Study||49
418750|NCT00824421|996186|P3|Treated|Overall Study||63
418751|NCT00824421|996187|P2|Treated|Overall Study||65
418752|NCT00824421|996188|P1|Treated|Overall Study||65
418753|NCT00824421|996186|P3|STARTED|Overall Study||63
418754|NCT00824421|996187|P2|STARTED|Overall Study||66
418755|NCT00824421|996188|P1|STARTED|Overall Study||66
418756|NCT00824408|996239|P5|NOT COMPLETED|Randomized Phase||46
418757|NCT00824408|996240|P4|NOT COMPLETED|Randomized Phase||46
418758|NCT00824408|996241|P3|NOT COMPLETED|Randomized Phase||36
418759|NCT00824408|996242|P2|NOT COMPLETED|Randomized Phase||0
418760|NCT00824408|996243|P1|NOT COMPLETED|Randomized Phase||0
418761|NCT00824408|996239|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
418762|NCT00824408|996240|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
418763|NCT00824408|996241|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
418764|NCT00824408|996242|P2|COMPLETED|Randomized Phase||0
418765|NCT00824408|996243|P1|COMPLETED|Randomized Phase||0
418766|NCT00824408|996239|P5|STARTED|Randomized Phase||47
418767|NCT00824408|996240|P4|STARTED|Randomized Phase||47
418768|NCT00824408|996241|P3|STARTED|Randomized Phase||37
418769|NCT00824408|996242|P2|STARTED|Randomized Phase||0
418770|NCT00824408|996243|P1|STARTED|Randomized Phase||0
418771|NCT00824408|996239|P5|NOT COMPLETED|Run-in Phase||0
418772|NCT00824408|996240|P4|NOT COMPLETED|Run-in Phase||0
418773|NCT00824408|996241|P3|NOT COMPLETED|Run-in Phase||0
418774|NCT00824408|996242|P2|NOT COMPLETED|Run-in Phase||6
418775|NCT00824408|996243|P1|NOT COMPLETED|Run-in Phase||6
418776|NCT00824408|996239|P5|COMPLETED|Run-in Phase||0
418777|NCT00824408|996240|P4|COMPLETED|Run-in Phase||0
418778|NCT00824408|996241|P3|COMPLETED|Run-in Phase||0
418779|NCT00824408|996242|P2|COMPLETED|Run-in Phase||0
418780|NCT00824408|996243|P1|COMPLETED|Run-in Phase||0
418781|NCT00824408|996239|P5|STARTED|Run-in Phase||0
418782|NCT00824408|996240|P4|STARTED|Run-in Phase||0
418783|NCT00824408|996241|P3|STARTED|Run-in Phase||0
418784|NCT00824408|996242|P2|STARTED|Run-in Phase||6
418785|NCT00824408|996243|P1|STARTED|Run-in Phase||6
418786|NCT00824382|996295|P4|NOT COMPLETED|Overall Study||5
418787|NCT00824382|996296|P3|NOT COMPLETED|Overall Study||3
418788|NCT00824382|996297|P2|NOT COMPLETED|Overall Study||2
418789|NCT00824382|996298|P1|NOT COMPLETED|Overall Study||5
418790|NCT00824382|996295|P4|COMPLETED|Overall Study||81
418791|NCT00824382|996296|P3|COMPLETED|Overall Study||76
418792|NCT00824382|996297|P2|COMPLETED|Overall Study||82
418793|NCT00824382|996298|P1|COMPLETED|Overall Study||74
418794|NCT00824382|996295|P4|STARTED|Overall Study||86
418795|NCT00824382|996296|P3|STARTED|Overall Study||79
418796|NCT00824382|996297|P2|STARTED|Overall Study||84
418797|NCT00824382|996298|P1|STARTED|Overall Study||79
418798|NCT00824369|996374|P6|NOT COMPLETED|Overall Study||1
418799|NCT00824369|996375|P5|NOT COMPLETED|Overall Study||1
418800|NCT00824369|996376|P4|NOT COMPLETED|Overall Study||2
418801|NCT00824369|996377|P3|NOT COMPLETED|Overall Study||1
418802|NCT00824369|996378|P2|NOT COMPLETED|Overall Study||0
418803|NCT00824369|996379|P1|NOT COMPLETED|Overall Study||1
418804|NCT00824369|996374|P6|COMPLETED|Overall Study||16
418805|NCT00824369|996375|P5|COMPLETED|Overall Study||11
418806|NCT00824369|996376|P4|COMPLETED|Overall Study||9
418807|NCT00824369|996377|P3|COMPLETED|Overall Study||2
418808|NCT00824369|996378|P2|COMPLETED|Overall Study||4
418809|NCT00824369|996379|P1|COMPLETED|Overall Study||4
418810|NCT00824369|996374|P6|STARTED|Overall Study||17
418811|NCT00824369|996375|P5|STARTED|Overall Study||12
418812|NCT00824369|996376|P4|STARTED|Overall Study||11
418813|NCT00824369|996377|P3|STARTED|Overall Study||3
418814|NCT00824369|996378|P2|STARTED|Overall Study||4
418815|NCT00824369|996379|P1|STARTED|Overall Study||5
418816|NCT00824291|996419|P2|NOT COMPLETED|Overall Study||35
418817|NCT00824291|996420|P1|NOT COMPLETED|Overall Study||54
418818|NCT00824291|996419|P2|COMPLETED|Overall Study||107
418819|NCT00824291|996420|P1|COMPLETED|Overall Study||231
418820|NCT00824291|996419|P2|STARTED|Overall Study||142
418821|NCT00824291|996420|P1|STARTED|Overall Study||285
418822|NCT00824265|996442|P2|NOT COMPLETED|Overall Study||80
418823|NCT00824265|996443|P1|NOT COMPLETED|Overall Study||64
418824|NCT00824265|996442|P2|COMPLETED|Overall Study||102
418825|NCT00824265|996443|P1|COMPLETED|Overall Study||119
418826|NCT00824265|996442|P2|STARTED|Overall Study||182
418827|NCT00824265|996443|P1|STARTED|Overall Study||183
418828|NCT00824161|996502|P1|NOT COMPLETED|Overall Study||2
418829|NCT00824161|996502|P1|COMPLETED|Overall Study||26
418830|NCT00824161|996502|P1|STARTED|Overall Study||28
418831|NCT00824070|996511|P3|NOT COMPLETED|Overall Study||0
418832|NCT00824070|996512|P2|NOT COMPLETED|Overall Study||0
418833|NCT00824070|996513|P1|NOT COMPLETED|Overall Study||0
418834|NCT00824070|996511|P3|COMPLETED|Overall Study||36
418835|NCT00824070|996512|P2|COMPLETED|Overall Study||35
418836|NCT00824070|996513|P1|COMPLETED|Overall Study||34
418837|NCT00824070|996511|P3|STARTED|Overall Study||36
418838|NCT00824070|996512|P2|STARTED|Overall Study||35
418839|NCT00824070|996513|P1|STARTED|Overall Study||34
418840|NCT00824044|996523|P2|NOT COMPLETED|Overall Study||6
418841|NCT00824044|996524|P1|NOT COMPLETED|Overall Study||9
418842|NCT00824044|996523|P2|COMPLETED|Overall Study||10
418843|NCT00824044|996524|P1|COMPLETED|Overall Study||14
418844|NCT00824044|996523|P2|STARTED|Overall Study||16
418845|NCT00824044|996524|P1|STARTED|Overall Study||23
418846|NCT00823264|996532|P2|NOT COMPLETED|Overall Study||0
418847|NCT00823264|996533|P1|NOT COMPLETED|Overall Study||2
418848|NCT00823264|996532|P2|COMPLETED|Overall Study||7
418849|NCT00823264|996533|P1|COMPLETED|Overall Study||8
418850|NCT00823264|996532|P2|STARTED|Overall Study||7
418851|NCT00823264|996533|P1|STARTED|Overall Study||10
418852|NCT00823212|996541|P2|NOT COMPLETED|Overall Study||33
418853|NCT00823212|996542|P1|NOT COMPLETED|Overall Study||35
418854|NCT00823212|996541|P2|COMPLETED|Overall Study|12-month follow-up|735
418855|NCT00823212|996542|P1|COMPLETED|Overall Study|12-month follow-up|727
418856|NCT00823212|996541|P2|STARTED|Overall Study||768
418857|NCT00823212|996542|P1|STARTED|Overall Study||762
418858|NCT00823199|996624|P1|NOT COMPLETED|Overall Study||2
418859|NCT00823199|996624|P1|COMPLETED|Overall Study||8
418860|NCT00823199|996624|P1|STARTED|Overall Study||10
418861|NCT00824005|996632|P2|NOT COMPLETED|Overall Study||2
418862|NCT00824005|996633|P1|NOT COMPLETED|Overall Study||0
418863|NCT00824005|996632|P2|COMPLETED|Overall Study||59
418864|NCT00824005|996633|P1|COMPLETED|Overall Study||31
418865|NCT00824005|996632|P2|STARTED|Overall Study||61
418866|NCT00824005|996633|P1|STARTED|Overall Study||31
418867|NCT00823979|996668|P3|NOT COMPLETED|Overall Study||24
418868|NCT00823979|996669|P2|NOT COMPLETED|Overall Study||32
418869|NCT00823979|996670|P1|NOT COMPLETED|Overall Study||29
418870|NCT00823979|996668|P3|COMPLETED|Overall Study||11
418871|NCT00823979|996669|P2|COMPLETED|Overall Study||3
418872|NCT00823979|996670|P1|COMPLETED|Overall Study||6
418873|NCT00823979|996668|P3|Treated|Overall Study||34
418874|NCT00823979|996669|P2|Treated|Overall Study||32
418875|NCT00823979|996670|P1|Treated|Overall Study||31
418876|NCT00823979|996668|P3|STARTED|Overall Study||35
418877|NCT00823979|996669|P2|STARTED|Overall Study||35
418878|NCT00823979|996670|P1|STARTED|Overall Study||35
418879|NCT00823966|996708|P1|NOT COMPLETED|Overall Study||0
418880|NCT00823966|996708|P1|COMPLETED|Overall Study||3
418881|NCT00823966|996708|P1|STARTED|Overall Study||3
418882|NCT00823901|996715|P2|NOT COMPLETED|Overall Study||2
418883|NCT00823901|996716|P1|NOT COMPLETED|Overall Study||4
418884|NCT00823901|996715|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
418885|NCT00823901|996716|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
418886|NCT00823901|996715|P2|STARTED|Overall Study|Randomized to placebo gel|40
418887|NCT00823901|996716|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
418888|NCT00823836|996724|P2|NOT COMPLETED|Long-term Phase||5
418889|NCT00823836|996725|P1|NOT COMPLETED|Long-term Phase||5
418890|NCT00823836|996724|P2|COMPLETED|Long-term Phase||79
418891|NCT00823836|996725|P1|COMPLETED|Long-term Phase||68
418892|NCT00823836|996724|P2|STARTED|Long-term Phase||84
418893|NCT00823836|996725|P1|STARTED|Long-term Phase||73
418894|NCT00823836|996724|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
418895|NCT00823836|996725|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
418896|NCT00823836|996724|P2|COMPLETED|NV and PR/XR Switching Phases||117
418897|NCT00823836|996725|P1|COMPLETED|NV and PR/XR Switching Phases||124
418898|NCT00823836|996724|P2|STARTED|NV and PR/XR Switching Phases||146
418899|NCT00823836|996725|P1|STARTED|NV and PR/XR Switching Phases||156
418900|NCT00823823|996831|P2|NOT COMPLETED|Overall Study||6
418901|NCT00823823|996832|P1|NOT COMPLETED|Overall Study||8
418902|NCT00823823|996831|P2|COMPLETED|Overall Study||101
418903|NCT00823823|996832|P1|COMPLETED|Overall Study||101
418904|NCT00823823|996831|P2|STARTED|Overall Study||107
418905|NCT00823823|996832|P1|STARTED|Overall Study||109
418906|NCT00823797|996842|P2|NOT COMPLETED|Overall Study||0
418907|NCT00823797|996843|P1|NOT COMPLETED|Overall Study||0
418908|NCT00823797|996842|P2|COMPLETED|Overall Study||16
418909|NCT00823797|996843|P1|COMPLETED|Overall Study||29
418910|NCT00823797|996842|P2|STARTED|Overall Study||16
418911|NCT00823797|996843|P1|STARTED|Overall Study||29
418912|NCT00823719|996856|P2|NOT COMPLETED|Overall Study||11
418913|NCT00823719|996857|P1|NOT COMPLETED|Overall Study||6
418914|NCT00823719|996856|P2|COMPLETED|Overall Study||24
418915|NCT00823719|996857|P1|COMPLETED|Overall Study||20
418916|NCT00823719|996856|P2|STARTED|Overall Study||35
418917|NCT00823719|996857|P1|STARTED|Overall Study||26
418918|NCT00823615|996910|P2|NOT COMPLETED|Period 2||2
418919|NCT00823615|996911|P1|NOT COMPLETED|Period 2||3
418920|NCT00823615|996910|P2|COMPLETED|Period 2||17
418921|NCT00823615|996911|P1|COMPLETED|Period 2||16
418922|NCT00823615|996910|P2|STARTED|Period 2||19
418923|NCT00823615|996911|P1|STARTED|Period 2||19
418924|NCT00823615|996910|P2|NOT COMPLETED|Period 1||0
418925|NCT00823615|996911|P1|NOT COMPLETED|Period 1||0
418926|NCT00823615|996910|P2|COMPLETED|Period 1||19
418927|NCT00823615|996911|P1|COMPLETED|Period 1||19
418928|NCT00823615|996910|P2|STARTED|Period 1||19
418929|NCT00823615|996911|P1|STARTED|Period 1||19
418930|NCT00823472|996921|P2|NOT COMPLETED|Overall Study||28
418931|NCT00823472|996922|P1|NOT COMPLETED|Overall Study||24
418932|NCT00823472|996921|P2|COMPLETED|Overall Study||39
418933|NCT00823472|996922|P1|COMPLETED|Overall Study||56
418934|NCT00823472|996921|P2|STARTED|Overall Study||67
418935|NCT00823472|996922|P1|STARTED|Overall Study||80
418936|NCT00823303|996932|P2|NOT COMPLETED|Overall Study||11
418937|NCT00823303|996933|P1|NOT COMPLETED|Overall Study||9
418938|NCT00823303|996932|P2|COMPLETED|Overall Study||45
418939|NCT00823303|996933|P1|COMPLETED|Overall Study||45
418940|NCT00823303|996932|P2|STARTED|Overall Study||56
418941|NCT00823303|996933|P1|STARTED|Overall Study||54
418942|NCT00823095|996939|P1|NOT COMPLETED|Overall Study||0
418943|NCT00823095|996939|P1|COMPLETED|Overall Study||7
418944|NCT00823095|996939|P1|STARTED|Overall Study||7
418945|NCT00823082|996946|P2|NOT COMPLETED|Overall Study||1
418946|NCT00823082|996947|P1|NOT COMPLETED|Overall Study||0
418947|NCT00823082|996946|P2|COMPLETED|Overall Study||99
418948|NCT00823082|996947|P1|COMPLETED|Overall Study||100
418949|NCT00823082|996946|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
418950|NCT00823082|996947|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
418951|NCT00823082|996946|P2|Safety Population|Overall Study||99
418952|NCT00823082|996947|P1|Safety Population|Overall Study||100
418953|NCT00823082|996946|P2|STARTED|Overall Study||100
418954|NCT00823082|996947|P1|STARTED|Overall Study||100
418955|NCT00823069|996981|P1|NOT COMPLETED|Overall Study||0
418956|NCT00823069|996981|P1|COMPLETED|Overall Study||60
418957|NCT00823069|996981|P1|STARTED|Overall Study||60
418958|NCT00823043|996988|P2|NOT COMPLETED|Overall Study||0
418959|NCT00823043|996989|P1|NOT COMPLETED|Overall Study||0
418960|NCT00823043|996988|P2|COMPLETED|Overall Study||39
418961|NCT00823043|996989|P1|COMPLETED|Overall Study||64
418962|NCT00823043|996988|P2|STARTED|Overall Study||39
418963|NCT00823043|996989|P1|STARTED|Overall Study||64
418964|NCT00822900|997002|P2|NOT COMPLETED|Overall Study||93
418965|NCT00822900|997003|P1|NOT COMPLETED|Overall Study||108
418966|NCT00822900|997002|P2|COMPLETED|Overall Study||347
418967|NCT00822900|997003|P1|COMPLETED|Overall Study||334
418968|NCT00822900|997002|P2|STARTED|Overall Study||440
418969|NCT00822900|997003|P1|STARTED|Overall Study||442
418970|NCT00822770|997031|P1|NOT COMPLETED|Overall Study||0
418971|NCT00822770|997031|P1|COMPLETED|Overall Study||47
418972|NCT00822770|997031|P1|STARTED|Overall Study||47
418973|NCT00822757|997037|P2|NOT COMPLETED|Overall Study||0
418974|NCT00822757|997038|P1|NOT COMPLETED|Overall Study||0
418975|NCT00822757|997037|P2|COMPLETED|Overall Study||10
418976|NCT00822757|997038|P1|COMPLETED|Overall Study||41
418977|NCT00822757|997037|P2|STARTED|Overall Study||10
418978|NCT00822757|997038|P1|STARTED|Overall Study||41
418979|NCT00822692|997050|P2|NOT COMPLETED|Overall Study||25
418980|NCT00822692|997051|P1|NOT COMPLETED|Overall Study||17
418981|NCT00822692|997050|P2|COMPLETED|Overall Study|June 1 , 2009|51
418982|NCT00822692|997051|P1|COMPLETED|Overall Study|June 1, 2009|46
418983|NCT00822692|997050|P2|STARTED|Overall Study|July 1, 2008|76
418984|NCT00822692|997051|P1|STARTED|Overall Study|July 1, 2008|63
418985|NCT00822679|997059|P2|NOT COMPLETED|Overall Study||0
418986|NCT00822679|997060|P1|NOT COMPLETED|Overall Study||0
418987|NCT00822679|997059|P2|COMPLETED|Overall Study||0
418988|NCT00822679|997060|P1|COMPLETED|Overall Study||0
418989|NCT00822679|997059|P2|STARTED|Overall Study||0
418990|NCT00822679|997060|P1|STARTED|Overall Study||0
418991|NCT00822588|997068|P2|NOT COMPLETED|Overall Study||4
418992|NCT00822588|997069|P1|NOT COMPLETED|Overall Study||7
418993|NCT00822588|997068|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
418994|NCT00822588|997069|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
418995|NCT00822588|997068|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
418996|NCT00822588|997069|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
418997|NCT00822523|997078|P3|NOT COMPLETED|Overall Study||0
418998|NCT00822523|997079|P2|NOT COMPLETED|Overall Study||0
418999|NCT00822523|997080|P1|NOT COMPLETED|Overall Study||0
419000|NCT00822523|997078|P3|COMPLETED|Overall Study||4
419001|NCT00822523|997079|P2|COMPLETED|Overall Study||4
419002|NCT00822523|997080|P1|COMPLETED|Overall Study||5
419003|NCT00822523|997078|P3|STARTED|Overall Study||4
419004|NCT00822523|997079|P2|STARTED|Overall Study||4
419005|NCT00822523|997080|P1|STARTED|Overall Study||5
419006|NCT00822510|997126|P2|NOT COMPLETED|Overall Study||5
419007|NCT00822510|997127|P1|NOT COMPLETED|Overall Study||3
419008|NCT00822510|997126|P2|COMPLETED|Overall Study||36
419009|NCT00822510|997127|P1|COMPLETED|Overall Study||35
419010|NCT00822510|997126|P2|STARTED|Overall Study||41
419011|NCT00822510|997127|P1|STARTED|Overall Study||38
419012|NCT00822354|997147|P2|NOT COMPLETED|Second Intervention (28 Days)||0
419013|NCT00822354|997148|P1|NOT COMPLETED|Second Intervention (28 Days)||1
419014|NCT00822354|997147|P2|COMPLETED|Second Intervention (28 Days)||5
419015|NCT00822354|997148|P1|COMPLETED|Second Intervention (28 Days)||3
419016|NCT00822354|997147|P2|STARTED|Second Intervention (28 Days)||5
419017|NCT00822354|997148|P1|STARTED|Second Intervention (28 Days)||4
419018|NCT00822354|997147|P2|NOT COMPLETED|Washout (7 Days)||0
419019|NCT00822354|997148|P1|NOT COMPLETED|Washout (7 Days)||0
419020|NCT00822354|997147|P2|COMPLETED|Washout (7 Days)||5
419021|NCT00822354|997148|P1|COMPLETED|Washout (7 Days)||4
419022|NCT00822354|997147|P2|STARTED|Washout (7 Days)||5
419023|NCT00822354|997148|P1|STARTED|Washout (7 Days)||4
419024|NCT00822354|997147|P2|NOT COMPLETED|First Intervention (28 Days)||0
419025|NCT00822354|997148|P1|NOT COMPLETED|First Intervention (28 Days)||1
419026|NCT00822354|997147|P2|COMPLETED|First Intervention (28 Days)||5
419027|NCT00822354|997148|P1|COMPLETED|First Intervention (28 Days)||4
419028|NCT00822354|997147|P2|STARTED|First Intervention (28 Days)||5
419029|NCT00822354|997148|P1|STARTED|First Intervention (28 Days)||5
419030|NCT00822328|997178|P2|NOT COMPLETED|Overall Study||0
419031|NCT00822328|997179|P1|NOT COMPLETED|Overall Study||0
419032|NCT00822328|997178|P2|COMPLETED|Overall Study||12
419033|NCT00822328|997179|P1|COMPLETED|Overall Study||12
419034|NCT00822328|997178|P2|STARTED|Overall Study||12
419035|NCT00822328|997179|P1|STARTED|Overall Study||12
419036|NCT00822237|997189|P2|NOT COMPLETED|Dose 2 Vaccination||11
419037|NCT00822237|997190|P1|NOT COMPLETED|Dose 2 Vaccination||4
419038|NCT00822237|997189|P2|COMPLETED|Dose 2 Vaccination||262
419039|NCT00822237|997190|P1|COMPLETED|Dose 2 Vaccination||270
419040|NCT00822237|997189|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
419041|NCT00822237|997190|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
419042|NCT00822237|997189|P2|NOT COMPLETED|Dose 1 Vaccination||26
419043|NCT00822237|997190|P1|NOT COMPLETED|Dose 1 Vaccination||25
419044|NCT00822237|997189|P2|COMPLETED|Dose 1 Vaccination||273
419045|NCT00822237|997190|P1|COMPLETED|Dose 1 Vaccination||274
419046|NCT00822237|997189|P2|STARTED|Dose 1 Vaccination|Number randomized|299
419047|NCT00822237|997190|P1|STARTED|Dose 1 Vaccination|Number randomized|299
419048|NCT00822185|997200|P5|NOT COMPLETED|Overall Study||0
419049|NCT00822185|997201|P4|NOT COMPLETED|Overall Study||0
419050|NCT00822185|997202|P3|NOT COMPLETED|Overall Study||0
419051|NCT00822185|997203|P2|NOT COMPLETED|Overall Study||0
419052|NCT00822185|997204|P1|NOT COMPLETED|Overall Study||0
419053|NCT00822185|997200|P5|COMPLETED|Overall Study||8
419054|NCT00822185|997201|P4|COMPLETED|Overall Study||6
419055|NCT00822185|997202|P3|COMPLETED|Overall Study||6
419056|NCT00822185|997203|P2|COMPLETED|Overall Study||6
419057|NCT00822185|997204|P1|COMPLETED|Overall Study||6
419058|NCT00822185|997200|P5|STARTED|Overall Study||8
419059|NCT00822185|997201|P4|STARTED|Overall Study||6
419060|NCT00822185|997202|P3|STARTED|Overall Study||6
419061|NCT00822185|997203|P2|STARTED|Overall Study||6
419062|NCT00822185|997204|P1|STARTED|Overall Study||6
419063|NCT00822172|997271|P2|NOT COMPLETED|Overall Study||19
419064|NCT00822172|997272|P1|NOT COMPLETED|Overall Study||15
419065|NCT00822172|997271|P2|COMPLETED|Overall Study||64
419066|NCT00822172|997272|P1|COMPLETED|Overall Study||65
419067|NCT00822172|997271|P2|STARTED|Overall Study||83
419068|NCT00822172|997272|P1|STARTED|Overall Study||80
419069|NCT00821951|997278|P1|NOT COMPLETED|Overall Study||5
419070|NCT00821951|997278|P1|COMPLETED|Overall Study||12
419071|NCT00821951|997278|P1|STARTED|Overall Study||17
419072|NCT00821886|997282|P1|NOT COMPLETED|Overall Study||9
419073|NCT00821886|997282|P1|COMPLETED|Overall Study||49
419074|NCT00821886|997282|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
419075|NCT00821873|997289|P1|NOT COMPLETED|Overall Study||4
419076|NCT00821873|997289|P1|COMPLETED|Overall Study||5
419077|NCT00821873|997289|P1|STARTED|Overall Study||9
419078|NCT00821821|997296|P3|NOT COMPLETED|Overall Study||0
419079|NCT00821821|997297|P2|NOT COMPLETED|Overall Study||0
419080|NCT00821821|997298|P1|NOT COMPLETED|Overall Study||0
419081|NCT00821821|997296|P3|COMPLETED|Overall Study||11
419082|NCT00821821|997297|P2|COMPLETED|Overall Study||13
419083|NCT00821821|997298|P1|COMPLETED|Overall Study||12
419084|NCT00821821|997296|P3|STARTED|Overall Study||11
419085|NCT00821821|997297|P2|STARTED|Overall Study||13
419086|NCT00821821|997298|P1|STARTED|Overall Study||12
419087|NCT00821678|997310|P2|NOT COMPLETED|Overall Study||14
419088|NCT00821678|997311|P1|NOT COMPLETED|Overall Study||21
419089|NCT00821678|997310|P2|COMPLETED|Overall Study||118
419090|NCT00821678|997311|P1|COMPLETED|Overall Study||112
419091|NCT00821678|997310|P2|STARTED|Overall Study||132
419092|NCT00821678|997311|P1|STARTED|Overall Study||133
419093|NCT00821587|997329|P2|NOT COMPLETED|Overall Study||1
419094|NCT00821587|997330|P1|NOT COMPLETED|Overall Study||0
419095|NCT00821587|997329|P2|COMPLETED|Overall Study||18
419096|NCT00821587|997330|P1|COMPLETED|Overall Study||20
419097|NCT00821587|997329|P2|STARTED|Overall Study||19
419098|NCT00821587|997330|P1|STARTED|Overall Study||20
419099|NCT00821509|997339|P3|NOT COMPLETED|Overall Study||34
419100|NCT00821509|997340|P2|NOT COMPLETED|Overall Study||11
419101|NCT00821509|997341|P1|NOT COMPLETED|Overall Study||12
419102|NCT00821509|997339|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
419103|NCT00821509|997340|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
419104|NCT00821509|997341|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
419105|NCT00821509|997339|P3|STARTED|Overall Study||224
419106|NCT00821509|997340|P2|STARTED|Overall Study||202
419107|NCT00821509|997341|P1|STARTED|Overall Study||257
419108|NCT00821431|997354|P2|NOT COMPLETED|Overall Study||5
419109|NCT00821431|997355|P1|NOT COMPLETED|Overall Study||15
419110|NCT00821431|997354|P2|COMPLETED|Overall Study||47
419111|NCT00821431|997355|P1|COMPLETED|Overall Study||23
419112|NCT00821431|997354|P2|STARTED|Overall Study||52
419113|NCT00821431|997355|P1|STARTED|Overall Study||38
419114|NCT00821327|997363|P1|NOT COMPLETED|Overall Study||35
419115|NCT00821327|997363|P1|COMPLETED|Overall Study||1
419116|NCT00821327|997363|P1|STARTED|Overall Study||36
419117|NCT00821236|997372|P1|NOT COMPLETED|Overall Study||3
419118|NCT00821236|997372|P1|COMPLETED|Overall Study||37
419119|NCT00821236|997372|P1|STARTED|Overall Study||40
419120|NCT00821184|997388|P2|NOT COMPLETED|Overall Study||0
419121|NCT00821184|997389|P1|NOT COMPLETED|Overall Study||0
419122|NCT00821184|997388|P2|COMPLETED|Overall Study||6
419123|NCT00821184|997389|P1|COMPLETED|Overall Study||6
419124|NCT00821184|997388|P2|STARTED|Overall Study||6
419125|NCT00821184|997389|P1|STARTED|Overall Study||6
419126|NCT00821119|997397|P2|NOT COMPLETED|Overall Study||0
419127|NCT00821119|997398|P1|NOT COMPLETED|Overall Study||0
419128|NCT00821119|997397|P2|COMPLETED|Overall Study||100
419129|NCT00821119|997398|P1|COMPLETED|Overall Study||100
419130|NCT00821119|997397|P2|STARTED|Overall Study||100
419131|NCT00821119|997398|P1|STARTED|Overall Study||100
419132|NCT00821093|997410|P2|NOT COMPLETED|Overall Study||40
419133|NCT00821093|997411|P1|NOT COMPLETED|Overall Study||49
419134|NCT00821093|997410|P2|COMPLETED|Overall Study||523
419135|NCT00821093|997411|P1|COMPLETED|Overall Study||511
419136|NCT00821093|997410|P2|Exposed to Drug|Overall Study||562
419137|NCT00821093|997411|P1|Exposed to Drug|Overall Study||559
419138|NCT00821093|997410|P2|STARTED|Overall Study||563
419139|NCT00821093|997411|P1|STARTED|Overall Study||560
419140|NCT00821041|997421|P2|NOT COMPLETED|Overall Study||0
419141|NCT00821041|997422|P1|NOT COMPLETED|Overall Study||0
419142|NCT00821041|997421|P2|COMPLETED|Overall Study||59
419143|NCT00821041|997422|P1|COMPLETED|Overall Study||59
419144|NCT00821041|997421|P2|STARTED|Overall Study||59
419145|NCT00821041|997422|P1|STARTED|Overall Study||59
419146|NCT00820872|997430|P1|NOT COMPLETED|Overall Study||0
419147|NCT00820872|997430|P1|COMPLETED|Overall Study||30
419148|NCT00820872|997430|P1|STARTED|Overall Study||30
419149|NCT00820755|997434|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
419150|NCT00820755|997435|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
419151|NCT00820755|997436|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
419152|NCT00820755|997434|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
419153|NCT00820755|997435|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
419154|NCT00820755|997436|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
419155|NCT00820755|997434|P3|STARTED|Period 2: Maintenance Therapy Phase||154
419156|NCT00820755|997435|P2|STARTED|Period 2: Maintenance Therapy Phase||157
419157|NCT00820755|997436|P1|STARTED|Period 2: Maintenance Therapy Phase||0
419158|NCT00820755|997434|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
419159|NCT00820755|997435|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
419160|NCT00820755|997436|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
419161|NCT00820755|997434|P3|COMPLETED|Period 1: Combination Therapy Phase||0
419162|NCT00820755|997435|P2|COMPLETED|Period 1: Combination Therapy Phase||0
419163|NCT00820755|997436|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
419164|NCT00820755|997434|P3|STARTED|Period 1: Combination Therapy Phase||0
419165|NCT00820755|997435|P2|STARTED|Period 1: Combination Therapy Phase||0
419166|NCT00820755|997436|P1|STARTED|Period 1: Combination Therapy Phase||583
419167|NCT00820664|997460|P3|NOT COMPLETED|Overall Study||0
419168|NCT00820664|997461|P2|NOT COMPLETED|Overall Study||0
419169|NCT00820664|997462|P1|NOT COMPLETED|Overall Study||0
419170|NCT00820664|997460|P3|COMPLETED|Overall Study||9
419171|NCT00820664|997461|P2|COMPLETED|Overall Study||11
419172|NCT00820664|997462|P1|COMPLETED|Overall Study||9
419173|NCT00820664|997460|P3|STARTED|Overall Study||9
419174|NCT00820664|997461|P2|STARTED|Overall Study||11
419175|NCT00820664|997462|P1|STARTED|Overall Study||9
419176|NCT00820612|997472|P2|NOT COMPLETED|Overall Study||0
419177|NCT00820612|997473|P1|NOT COMPLETED|Overall Study||0
419178|NCT00820612|997472|P2|COMPLETED|Overall Study||295
419179|NCT00820612|997473|P1|COMPLETED|Overall Study||307
419180|NCT00820612|997472|P2|STARTED|Overall Study||295
419181|NCT00820612|997473|P1|STARTED|Overall Study||307
419182|NCT00820573|997483|P4|NOT COMPLETED|Overall Study||0
419183|NCT00820573|997484|P3|NOT COMPLETED|Overall Study||0
419184|NCT00820573|997485|P2|NOT COMPLETED|Overall Study||0
419185|NCT00820573|997486|P1|NOT COMPLETED|Overall Study||0
419186|NCT00820573|997483|P4|COMPLETED|Overall Study||4
419187|NCT00820573|997484|P3|COMPLETED|Overall Study||4
419188|NCT00820573|997485|P2|COMPLETED|Overall Study||4
419189|NCT00820573|997486|P1|COMPLETED|Overall Study||4
419190|NCT00820573|997483|P4|STARTED|Overall Study||4
419191|NCT00820573|997484|P3|STARTED|Overall Study||4
419192|NCT00820573|997485|P2|STARTED|Overall Study||4
419193|NCT00820573|997486|P1|STARTED|Overall Study||4
419194|NCT00820534|997510|P2|NOT COMPLETED|Overall Study||0
419195|NCT00820534|997511|P1|NOT COMPLETED|Overall Study||0
419196|NCT00820534|997510|P2|COMPLETED|Overall Study||62
419197|NCT00820534|997511|P1|COMPLETED|Overall Study||64
419198|NCT00820534|997510|P2|STARTED|Overall Study||62
419199|NCT00820534|997511|P1|STARTED|Overall Study||64
419200|NCT00820443|997519|P1|NOT COMPLETED|24 Month||43
419201|NCT00820443|997519|P1|COMPLETED|24 Month||202
419202|NCT00820443|997519|P1|STARTED|24 Month||245
419203|NCT00820443|997519|P1|NOT COMPLETED|12 Month||24
419204|NCT00820443|997519|P1|COMPLETED|12 Month||226
419205|NCT00820443|997519|P1|STARTED|12 Month||250
419206|NCT00820443|997519|P1|NOT COMPLETED|6 Month||20
419207|NCT00820443|997519|P1|COMPLETED|6 Month||233
419208|NCT00820443|997519|P1|STARTED|6 Month||253
419209|NCT00820443|997519|P1|NOT COMPLETED|3 Month||9
419210|NCT00820443|997519|P1|COMPLETED|3 Month||244
419211|NCT00820443|997519|P1|STARTED|3 Month||253
419212|NCT00820443|997519|P1|NOT COMPLETED|Immediately||5
419213|NCT00820443|997519|P1|COMPLETED|Immediately||248
419214|NCT00820443|997519|P1|STARTED|Immediately||253
419215|NCT00820443|997519|P1|NOT COMPLETED|Op||0
419216|NCT00820443|997519|P1|COMPLETED|Op||253
419217|NCT00820443|997519|P1|STARTED|Op||253
419218|NCT00820443|997519|P1|NOT COMPLETED|Pre-Op||0
419219|NCT00820443|997519|P1|COMPLETED|Pre-Op||253
419220|NCT00820443|997519|P1|STARTED|Pre-Op||253
419221|NCT00820222|997529|P2|NOT COMPLETED|Overall Study||211
419222|NCT00820222|997530|P1|NOT COMPLETED|Overall Study||201
419223|NCT00820222|997529|P2|COMPLETED|Overall Study||58
419224|NCT00820222|997530|P1|COMPLETED|Overall Study||70
419225|NCT00820222|997529|P2|Ongoing|Overall Study||191
419226|NCT00820222|997530|P1|Ongoing|Overall Study||185
419227|NCT00820222|997529|P2|STARTED|Overall Study||269
419228|NCT00820222|997530|P1|STARTED|Overall Study||271
419229|NCT00819182|997559|P3|NOT COMPLETED|Overall Study||1
419230|NCT00819182|997560|P2|NOT COMPLETED|Overall Study||8
419231|NCT00819182|997561|P1|NOT COMPLETED|Overall Study||13
419232|NCT00819182|997559|P3|COMPLETED|Overall Study||43
419233|NCT00819182|997560|P2|COMPLETED|Overall Study||78
419234|NCT00819182|997561|P1|COMPLETED|Overall Study||75
419235|NCT00819182|997559|P3|Week 16 Visit|Overall Study||43
419236|NCT00819182|997560|P2|Week 16 Visit|Overall Study||78
419237|NCT00819182|997561|P1|Week 16 Visit|Overall Study||75
419238|NCT00819182|997559|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
419239|NCT00819182|997560|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
419240|NCT00819182|997561|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
419241|NCT00819156|997597|P6|NOT COMPLETED|Overall Study||8
419242|NCT00819156|997598|P5|NOT COMPLETED|Overall Study||6
419243|NCT00819156|997599|P4|NOT COMPLETED|Overall Study||2
419244|NCT00819156|997600|P3|NOT COMPLETED|Overall Study||6
419245|NCT00819156|997601|P2|NOT COMPLETED|Overall Study||10
419246|NCT00819156|997602|P1|NOT COMPLETED|Overall Study||10
419247|NCT00819156|997597|P6|COMPLETED|Overall Study||23
419248|NCT00819156|997598|P5|COMPLETED|Overall Study||27
419249|NCT00819156|997599|P4|COMPLETED|Overall Study||28
419250|NCT00819156|997600|P3|COMPLETED|Overall Study||26
419251|NCT00819156|997601|P2|COMPLETED|Overall Study||23
419252|NCT00819156|997602|P1|COMPLETED|Overall Study||20
419253|NCT00819156|997597|P6|Randomised and Treated (ITT Population)|Overall Study||30
419254|NCT00819156|997598|P5|Randomised and Treated (ITT Population)|Overall Study||33
419255|NCT00819156|997599|P4|Randomised and Treated (ITT Population)|Overall Study||30
419256|NCT00819156|997600|P3|Randomised and Treated (ITT Population)|Overall Study||32
419257|NCT00819156|997601|P2|Randomised and Treated (ITT Population)|Overall Study||32
419258|NCT00819156|997602|P1|Randomised and Treated (ITT Population)|Overall Study||30
419259|NCT00819156|997597|P6|STARTED|Overall Study||31
419260|NCT00819156|997598|P5|STARTED|Overall Study||33
419261|NCT00819156|997599|P4|STARTED|Overall Study||30
419262|NCT00819156|997600|P3|STARTED|Overall Study||32
419263|NCT00819156|997601|P2|STARTED|Overall Study||33
419264|NCT00819156|997602|P1|STARTED|Overall Study||30
419265|NCT00817596|997690|P1|NOT COMPLETED|Overall Study||48
419266|NCT00817596|997690|P1|COMPLETED|Overall Study||62
419267|NCT00817596|997690|P1|STARTED|Overall Study||110
419268|NCT00819910|997698|P4|NOT COMPLETED|Overall Study||1
419269|NCT00819910|997699|P3|NOT COMPLETED|Overall Study||3
419270|NCT00819910|997700|P2|NOT COMPLETED|Overall Study||1
419271|NCT00819910|997701|P1|NOT COMPLETED|Overall Study||2
419272|NCT00819910|997698|P4|COMPLETED|Overall Study||10
419273|NCT00819910|997699|P3|COMPLETED|Overall Study||7
419274|NCT00819910|997700|P2|COMPLETED|Overall Study||9
419275|NCT00819910|997701|P1|COMPLETED|Overall Study||8
419276|NCT00819910|997698|P4|STARTED|Overall Study||11
419277|NCT00819910|997699|P3|STARTED|Overall Study||10
419278|NCT00819910|997700|P2|STARTED|Overall Study||10
419279|NCT00819910|997701|P1|STARTED|Overall Study||10
419280|NCT00819832|997733|P6|NOT COMPLETED|Overall Study||0
419281|NCT00819832|997734|P5|NOT COMPLETED|Overall Study||0
419282|NCT00819832|997735|P4|NOT COMPLETED|Overall Study||0
419283|NCT00819832|997736|P3|NOT COMPLETED|Overall Study||0
419284|NCT00819832|997737|P2|NOT COMPLETED|Overall Study||0
419285|NCT00819832|997738|P1|NOT COMPLETED|Overall Study||3
419286|NCT00819832|997733|P6|COMPLETED|Overall Study||0
419287|NCT00819832|997734|P5|COMPLETED|Overall Study||0
419288|NCT00819832|997735|P4|COMPLETED|Overall Study||0
419289|NCT00819832|997736|P3|COMPLETED|Overall Study||0
419290|NCT00819832|997737|P2|COMPLETED|Overall Study||0
419291|NCT00819832|997738|P1|COMPLETED|Overall Study||0
419292|NCT00819832|997733|P6|STARTED|Overall Study||0
419293|NCT00819832|997734|P5|STARTED|Overall Study||0
419294|NCT00819832|997735|P4|STARTED|Overall Study||0
419295|NCT00819832|997736|P3|STARTED|Overall Study||0
419296|NCT00819832|997737|P2|STARTED|Overall Study||0
419297|NCT00819832|997738|P1|STARTED|Overall Study|No patient data analysis.|3
419298|NCT00819780|997754|P2|NOT COMPLETED|Overall Study||21
419299|NCT00819780|997755|P1|NOT COMPLETED|Overall Study||28
419300|NCT00819780|997754|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
419301|NCT00819780|997755|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
419302|NCT00819780|997754|P2|Received Study Treatment|Overall Study||139
419303|NCT00819780|997755|P1|Received Study Treatment|Overall Study||139
419304|NCT00819780|997754|P2|STARTED|Overall Study||143
419305|NCT00819780|997755|P1|STARTED|Overall Study||142
419306|NCT00819767|997789|P2|NOT COMPLETED|Overall Study||2
419307|NCT00819767|997790|P1|NOT COMPLETED|Overall Study||1
419308|NCT00819767|997789|P2|COMPLETED|Overall Study||33
419309|NCT00819767|997790|P1|COMPLETED|Overall Study||32
419310|NCT00819767|997789|P2|STARTED|Overall Study||35
419311|NCT00819767|997790|P1|STARTED|Overall Study||33
419312|NCT00819741|997802|P2|NOT COMPLETED|Overall Study||14
419313|NCT00819741|997803|P1|NOT COMPLETED|Overall Study||22
419314|NCT00819741|997802|P2|COMPLETED|Overall Study||201
419315|NCT00819741|997803|P1|COMPLETED|Overall Study||196
419316|NCT00819741|997802|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
419317|NCT00819741|997803|P1|Exposed to Drug|Overall Study||218
419318|NCT00819741|997802|P2|STARTED|Overall Study||215
419319|NCT00819741|997803|P1|STARTED|Overall Study||218
419320|NCT00819637|997840|P3|NOT COMPLETED|Overall Study||0
419321|NCT00819637|997841|P2|NOT COMPLETED|Overall Study||0
419322|NCT00819637|997842|P1|NOT COMPLETED|Overall Study||0
419323|NCT00819637|997840|P3|COMPLETED|Overall Study||0
419324|NCT00819637|997841|P2|COMPLETED|Overall Study||0
419325|NCT00819637|997842|P1|COMPLETED|Overall Study||2
419326|NCT00819637|997840|P3|STARTED|Overall Study||0
419327|NCT00819637|997841|P2|STARTED|Overall Study||0
419328|NCT00819637|997842|P1|STARTED|Overall Study||2
419329|NCT00819585|997857|P7|NOT COMPLETED|Overall Study||13
419330|NCT00819585|997858|P6|NOT COMPLETED|Overall Study||2
419331|NCT00819585|997859|P5|NOT COMPLETED|Overall Study||3
419332|NCT00819585|997860|P4|NOT COMPLETED|Overall Study||5
419333|NCT00819585|997861|P3|NOT COMPLETED|Overall Study||6
419334|NCT00819585|997862|P2|NOT COMPLETED|Overall Study||6
419335|NCT00819585|997863|P1|NOT COMPLETED|Overall Study||6
419336|NCT00819585|997857|P7|COMPLETED|Overall Study||95
419337|NCT00819585|997858|P6|COMPLETED|Overall Study||52
419338|NCT00819585|997859|P5|COMPLETED|Overall Study||50
419339|NCT00819585|997860|P4|COMPLETED|Overall Study||49
419340|NCT00819585|997861|P3|COMPLETED|Overall Study||48
419341|NCT00819585|997862|P2|COMPLETED|Overall Study||48
419342|NCT00819585|997863|P1|COMPLETED|Overall Study||49
419343|NCT00819585|997857|P7|Safety Population|Overall Study||108
419344|NCT00819585|997858|P6|Safety Population|Overall Study|A pt. who was randomized to repeated dose regimen, found as HIV +ve, didn't take any study drug.|53
419345|NCT00819585|997859|P5|Safety Population|Overall Study||53
419346|NCT00819585|997860|P4|Safety Population|Overall Study||54
419347|NCT00819585|997861|P3|Safety Population|Overall Study||54
419348|NCT00819585|997862|P2|Safety Population|Overall Study||54
419349|NCT00819585|997863|P1|Safety Population|Overall Study||55
419350|NCT00819585|997857|P7|STARTED|Overall Study||108
419351|NCT00819585|997858|P6|STARTED|Overall Study||54
419352|NCT00819585|997859|P5|STARTED|Overall Study||53
419353|NCT00819585|997860|P4|STARTED|Overall Study||54
419354|NCT00819585|997861|P3|STARTED|Overall Study||54
419355|NCT00819585|997862|P2|STARTED|Overall Study||54
419356|NCT00819585|997863|P1|STARTED|Overall Study|"Started indicates randomized as well as full analysis set."|55
419357|NCT00819403|997922|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
419358|NCT00819403|997923|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
419359|NCT00819403|997922|P2|COMPLETED|Second Intervention (6 Weeks)||8
419360|NCT00819403|997923|P1|COMPLETED|Second Intervention (6 Weeks)||7
419361|NCT00819403|997922|P2|STARTED|Second Intervention (6 Weeks)||8
419362|NCT00819403|997923|P1|STARTED|Second Intervention (6 Weeks)||7
419363|NCT00819403|997922|P2|NOT COMPLETED|Washout (14 Days)||0
419364|NCT00819403|997923|P1|NOT COMPLETED|Washout (14 Days)||0
419365|NCT00819403|997922|P2|COMPLETED|Washout (14 Days)||8
419366|NCT00819403|997923|P1|COMPLETED|Washout (14 Days)||7
419367|NCT00819403|997922|P2|STARTED|Washout (14 Days)||8
419368|NCT00819403|997923|P1|STARTED|Washout (14 Days)||7
419369|NCT00819403|997922|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
419370|NCT00819403|997923|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
419371|NCT00819403|997922|P2|COMPLETED|First Intervention (6 Weeks)||8
419372|NCT00819403|997923|P1|COMPLETED|First Intervention (6 Weeks)||7
419373|NCT00819403|997922|P2|STARTED|First Intervention (6 Weeks)||8
419374|NCT00819403|997923|P1|STARTED|First Intervention (6 Weeks)||7
419375|NCT00819390|997935|P4|NOT COMPLETED|Overall Study||0
419376|NCT00819390|997936|P3|NOT COMPLETED|Overall Study||1
419377|NCT00819390|997937|P2|NOT COMPLETED|Overall Study||1
419378|NCT00819390|997938|P1|NOT COMPLETED|Overall Study||3
419379|NCT00819390|997935|P4|COMPLETED|Overall Study||19
419380|NCT00819390|997936|P3|COMPLETED|Overall Study||17
419381|NCT00819390|997937|P2|COMPLETED|Overall Study||16
419382|NCT00819390|997938|P1|COMPLETED|Overall Study||13
419383|NCT00819390|997935|P4|STARTED|Overall Study||19
419384|NCT00819390|997936|P3|STARTED|Overall Study||18
419385|NCT00819390|997937|P2|STARTED|Overall Study||17
419386|NCT00819390|997938|P1|STARTED|Overall Study||16
419387|NCT00819286|998050|P2|NOT COMPLETED|Overall Study||25
419388|NCT00819286|998051|P1|NOT COMPLETED|Overall Study||14
419389|NCT00819286|998050|P2|COMPLETED|Overall Study||45
419390|NCT00819286|998051|P1|COMPLETED|Overall Study||56
419391|NCT00819286|998050|P2|STARTED|Overall Study||70
419392|NCT00819286|998051|P1|STARTED|Overall Study||70
419393|NCT00819260|998059|P1|NOT COMPLETED|Overall Study||0
419394|NCT00819260|998059|P1|COMPLETED|Overall Study||31
419395|NCT00819260|998059|P1|STARTED|Overall Study||31
419396|NCT00819247|998074|P3|NOT COMPLETED|Overall Study||14
419397|NCT00819247|998075|P2|NOT COMPLETED|Overall Study||16
419398|NCT00819247|998076|P1|NOT COMPLETED|Overall Study||11
419399|NCT00819247|998074|P3|COMPLETED|Overall Study||26
419400|NCT00819247|998075|P2|COMPLETED|Overall Study||30
419401|NCT00819247|998076|P1|COMPLETED|Overall Study||32
419402|NCT00819247|998074|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
419403|NCT00819247|998075|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
419404|NCT00819247|998076|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
419405|NCT00819247|998074|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
419406|NCT00819247|998075|P2|Intent-to-treat Population|Overall Study||46
419407|NCT00819247|998076|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
419408|NCT00819247|998074|P3|Randomized|Overall Study||40
419409|NCT00819247|998075|P2|Randomized|Overall Study||46
419410|NCT00819247|998076|P1|Randomized|Overall Study||43
419411|NCT00819247|998074|P3|STARTED|Overall Study||40
419412|NCT00819247|998075|P2|STARTED|Overall Study||46
419413|NCT00819247|998076|P1|STARTED|Overall Study||43
419414|NCT00819234|998102|P10|NOT COMPLETED|Overall Study||7
419415|NCT00819234|998103|P9|NOT COMPLETED|Overall Study||6
419416|NCT00819234|998104|P8|NOT COMPLETED|Overall Study||9
419417|NCT00819234|998105|P7|NOT COMPLETED|Overall Study||5
419418|NCT00819234|998106|P6|NOT COMPLETED|Overall Study||7
419419|NCT00819234|998107|P5|NOT COMPLETED|Overall Study||1
419420|NCT00819234|998108|P4|NOT COMPLETED|Overall Study||6
419421|NCT00819234|998109|P3|NOT COMPLETED|Overall Study||8
419422|NCT00819234|998110|P2|NOT COMPLETED|Overall Study||15
419423|NCT00819234|998111|P1|NOT COMPLETED|Overall Study||10
419424|NCT00819234|998102|P10|COMPLETED|Overall Study||30
419425|NCT00819234|998103|P9|COMPLETED|Overall Study||31
419426|NCT00819234|998104|P8|COMPLETED|Overall Study||20
419427|NCT00819234|998105|P7|COMPLETED|Overall Study||8
419428|NCT00819234|998106|P6|COMPLETED|Overall Study||7
419429|NCT00819234|998107|P5|COMPLETED|Overall Study||12
419430|NCT00819234|998108|P4|COMPLETED|Overall Study||22
419431|NCT00819234|998109|P3|COMPLETED|Overall Study||28
419432|NCT00819234|998110|P2|COMPLETED|Overall Study||20
419433|NCT00819234|998111|P1|COMPLETED|Overall Study||21
419434|NCT00819234|998102|P10|STARTED|Overall Study||37
419435|NCT00819234|998103|P9|STARTED|Overall Study||37
419436|NCT00819234|998104|P8|STARTED|Overall Study||29
419437|NCT00819234|998105|P7|STARTED|Overall Study||13
419438|NCT00819234|998106|P6|STARTED|Overall Study||14
419439|NCT00819234|998107|P5|STARTED|Overall Study||13
419440|NCT00819234|998108|P4|STARTED|Overall Study||28
419441|NCT00819234|998109|P3|STARTED|Overall Study||36
419442|NCT00819234|998110|P2|STARTED|Overall Study||35
419443|NCT00819234|998111|P1|STARTED|Overall Study||31
419444|NCT00819091|998271|P2|NOT COMPLETED|Overall Study||10
419445|NCT00819091|998272|P1|NOT COMPLETED|Overall Study||7
419446|NCT00819091|998271|P2|COMPLETED|Overall Study||151
419447|NCT00819091|998272|P1|COMPLETED|Overall Study||77
419448|NCT00819091|998271|P2|STARTED|Overall Study||161
419449|NCT00819091|998272|P1|STARTED|Overall Study||84
419450|NCT00819052|998298|P2|NOT COMPLETED|Overall Study||14
419451|NCT00819052|998299|P1|NOT COMPLETED|Overall Study||6
419452|NCT00819052|998298|P2|COMPLETED|Overall Study||281
419453|NCT00819052|998299|P1|COMPLETED|Overall Study||142
419454|NCT00819052|998298|P2|STARTED|Overall Study||295
419455|NCT00819052|998299|P1|STARTED|Overall Study||148
419456|NCT00819039|998414|P3|NOT COMPLETED|Overall Study||1
419457|NCT00819039|998415|P2|NOT COMPLETED|Overall Study||0
419458|NCT00819039|998416|P1|NOT COMPLETED|Overall Study||2
419459|NCT00819039|998414|P3|COMPLETED|Overall Study||24
419460|NCT00819039|998415|P2|COMPLETED|Overall Study||27
419461|NCT00819039|998416|P1|COMPLETED|Overall Study||44
419462|NCT00819039|998414|P3|STARTED|Overall Study||25
419463|NCT00819039|998415|P2|STARTED|Overall Study||27
419464|NCT00819039|998416|P1|STARTED|Overall Study||46
419465|NCT00819013|998446|P4|NOT COMPLETED|Overall Study||4
419466|NCT00819013|998447|P3|NOT COMPLETED|Overall Study||5
419467|NCT00819013|998448|P2|NOT COMPLETED|Overall Study||1
419468|NCT00819013|998449|P1|NOT COMPLETED|Overall Study||3
419469|NCT00819013|998446|P4|COMPLETED|Overall Study||17
419470|NCT00819013|998447|P3|COMPLETED|Overall Study||16
419471|NCT00819013|998448|P2|COMPLETED|Overall Study||22
419472|NCT00819013|998449|P1|COMPLETED|Overall Study||19
419473|NCT00819013|998446|P4|STARTED|Overall Study||21
419474|NCT00819013|998447|P3|STARTED|Overall Study||21
419475|NCT00819013|998448|P2|STARTED|Overall Study||23
419476|NCT00819013|998449|P1|STARTED|Overall Study||22
419477|NCT00818961|998499|P1|NOT COMPLETED|Overall Study||0
419478|NCT00818961|998499|P1|COMPLETED|Overall Study||36
419479|NCT00818961|998499|P1|STARTED|Overall Study||36
419480|NCT00818883|998515|P2|NOT COMPLETED|Overall Study||46
419481|NCT00818883|998516|P1|NOT COMPLETED|Overall Study||51
419482|NCT00818883|998515|P2|COMPLETED|Overall Study||260
419483|NCT00818883|998516|P1|COMPLETED|Overall Study||252
419484|NCT00818883|998515|P2|STARTED|Overall Study||306
419485|NCT00818883|998516|P1|STARTED|Overall Study||303
419486|NCT00818805|998550|P2|NOT COMPLETED|Second Intervention||0
419487|NCT00818805|998551|P1|NOT COMPLETED|Second Intervention||0
419488|NCT00818805|998550|P2|COMPLETED|Second Intervention||25
419489|NCT00818805|998551|P1|COMPLETED|Second Intervention||25
419490|NCT00818805|998550|P2|STARTED|Second Intervention||25
419491|NCT00818805|998551|P1|STARTED|Second Intervention||25
419492|NCT00818805|998550|P2|NOT COMPLETED|First Intervention||0
419493|NCT00818805|998551|P1|NOT COMPLETED|First Intervention||0
419494|NCT00818805|998550|P2|COMPLETED|First Intervention||25
419495|NCT00818805|998551|P1|COMPLETED|First Intervention||25
419496|NCT00818805|998550|P2|STARTED|First Intervention||25
419497|NCT00818805|998551|P1|STARTED|First Intervention||25
419498|NCT00818779|998563|P2|NOT COMPLETED|Overall Study||1
419499|NCT00818779|998564|P1|NOT COMPLETED|Overall Study||6
419500|NCT00818779|998563|P2|COMPLETED|Overall Study||15
419501|NCT00818779|998564|P1|COMPLETED|Overall Study||16
419502|NCT00818779|998563|P2|STARTED|Overall Study||16
419503|NCT00818779|998564|P1|STARTED|Overall Study||22
419504|NCT00818766|998572|P2|NOT COMPLETED|Overall Study||10
419505|NCT00818766|998573|P1|NOT COMPLETED|Overall Study||15
419506|NCT00818766|998572|P2|COMPLETED|Overall Study||116
419507|NCT00818766|998573|P1|COMPLETED|Overall Study||110
419508|NCT00818766|998572|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
419509|NCT00818766|998573|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
419510|NCT00818766|998572|P2|Received Allocated Intervention|Overall Study||126
419511|NCT00818766|998573|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
419512|NCT00818766|998572|P2|STARTED|Overall Study||126
419513|NCT00818766|998573|P1|STARTED|Overall Study||125
419514|NCT00818753|998602|P3|NOT COMPLETED|Overall Study||1
419515|NCT00818753|998603|P2|NOT COMPLETED|Overall Study||0
419516|NCT00818753|998604|P1|NOT COMPLETED|Overall Study||3
419517|NCT00818753|998602|P3|COMPLETED|Overall Study||9
419518|NCT00818753|998603|P2|COMPLETED|Overall Study||21
419519|NCT00818753|998604|P1|COMPLETED|Overall Study||19
419520|NCT00818753|998602|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
419521|NCT00818753|998603|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
419522|NCT00818753|998604|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
419523|NCT00818662|998628|P4|NOT COMPLETED|Overall Study||16
419524|NCT00818662|998629|P3|NOT COMPLETED|Overall Study||9
419525|NCT00818662|998630|P2|NOT COMPLETED|Overall Study||33
419526|NCT00818662|998631|P1|NOT COMPLETED|Overall Study||23
419527|NCT00818662|998628|P4|COMPLETED|Overall Study||47
419528|NCT00818662|998629|P3|COMPLETED|Overall Study||49
419529|NCT00818662|998630|P2|COMPLETED|Overall Study||102
419530|NCT00818662|998631|P1|COMPLETED|Overall Study||104
419531|NCT00818662|998628|P4|STARTED|Overall Study||63
419532|NCT00818662|998629|P3|STARTED|Overall Study||58
419533|NCT00818662|998630|P2|STARTED|Overall Study||135
419534|NCT00818662|998631|P1|STARTED|Overall Study||127
419535|NCT00818649|998717|P1|NOT COMPLETED|Overall Study||4
419536|NCT00818649|998717|P1|COMPLETED|Overall Study||12
419537|NCT00818649|998717|P1|STARTED|Overall Study||16
419538|NCT00818623|998731|P8|NOT COMPLETED|Overall Study||1
419539|NCT00818623|998732|P7|NOT COMPLETED|Overall Study||4
419540|NCT00818623|998733|P6|NOT COMPLETED|Overall Study||3
419541|NCT00818623|998734|P5|NOT COMPLETED|Overall Study||4
419542|NCT00818623|998735|P4|NOT COMPLETED|Overall Study||5
419543|NCT00818623|998736|P3|NOT COMPLETED|Overall Study||4
419544|NCT00818623|998737|P2|NOT COMPLETED|Overall Study||4
419545|NCT00818623|998738|P1|NOT COMPLETED|Overall Study||2
419546|NCT00818623|998731|P8|COMPLETED|Overall Study||26
419547|NCT00818623|998732|P7|COMPLETED|Overall Study||23
419548|NCT00818623|998733|P6|COMPLETED|Overall Study||21
419549|NCT00818623|998734|P5|COMPLETED|Overall Study||23
419550|NCT00818623|998735|P4|COMPLETED|Overall Study||19
419551|NCT00818623|998736|P3|COMPLETED|Overall Study||9
419552|NCT00818623|998737|P2|COMPLETED|Overall Study||8
419553|NCT00818623|998738|P1|COMPLETED|Overall Study||24
419554|NCT00818623|998731|P8|Intent-to-treat (ITT) Population|Overall Study||27
419555|NCT00818623|998732|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
419556|NCT00818623|998733|P6|Intent-to-treat (ITT) Population|Overall Study||24
419557|NCT00818623|998734|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
419558|NCT00818623|998735|P4|Intent-to-treat (ITT) Population|Overall Study||24
419559|NCT00818623|998736|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
419560|NCT00818623|998737|P2|Intent-to-treat (ITT) Population|Overall Study||12
419561|NCT00818623|998738|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
419562|NCT00818623|998731|P8|STARTED|Overall Study||27
419563|NCT00818623|998732|P7|STARTED|Overall Study||27
419564|NCT00818623|998733|P6|STARTED|Overall Study||24
419565|NCT00818623|998734|P5|STARTED|Overall Study||27
419566|NCT00818623|998735|P4|STARTED|Overall Study||24
419567|NCT00818623|998736|P3|STARTED|Overall Study||13
419568|NCT00818623|998737|P2|STARTED|Overall Study||12
419569|NCT00818623|998738|P1|STARTED|Overall Study||26
419570|NCT00818519|998814|P2|NOT COMPLETED|Overall Study||19
419571|NCT00818519|998815|P1|NOT COMPLETED|Overall Study||14
419572|NCT00818519|998814|P2|COMPLETED|Overall Study||71
419573|NCT00818519|998815|P1|COMPLETED|Overall Study||75
419574|NCT00818519|998814|P2|Participants Received Treatment|Overall Study|= Baseline|86
419575|NCT00818519|998815|P1|Participants Received Treatment|Overall Study|= Baseline|87
419576|NCT00818519|998814|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
419577|NCT00818519|998815|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
419578|NCT00818454|998845|P4|NOT COMPLETED|Treatment Period 3||1
419579|NCT00818454|998846|P3|NOT COMPLETED|Treatment Period 3||0
419580|NCT00818454|998847|P2|NOT COMPLETED|Treatment Period 3||0
419581|NCT00818454|998848|P1|NOT COMPLETED|Treatment Period 3||0
419582|NCT00818454|998845|P4|COMPLETED|Treatment Period 3||138
419583|NCT00818454|998846|P3|COMPLETED|Treatment Period 3||26
419584|NCT00818454|998847|P2|COMPLETED|Treatment Period 3||0
419585|NCT00818454|998848|P1|COMPLETED|Treatment Period 3||0
419586|NCT00818454|998845|P4|STARTED|Treatment Period 3||139
419587|NCT00818454|998846|P3|STARTED|Treatment Period 3||26
419588|NCT00818454|998847|P2|STARTED|Treatment Period 3||0
419589|NCT00818454|998848|P1|STARTED|Treatment Period 3||0
419590|NCT00818454|998845|P4|NOT COMPLETED|Treatment Period 2||0
419591|NCT00818454|998846|P3|NOT COMPLETED|Treatment Period 2||0
419592|NCT00818454|998847|P2|NOT COMPLETED|Treatment Period 2||1
419593|NCT00818454|998848|P1|NOT COMPLETED|Treatment Period 2||2
419594|NCT00818454|998845|P4|COMPLETED|Treatment Period 2||0
419595|NCT00818454|998846|P3|COMPLETED|Treatment Period 2||0
419596|NCT00818454|998847|P2|COMPLETED|Treatment Period 2||106
419597|NCT00818454|998848|P1|COMPLETED|Treatment Period 2||106
419598|NCT00818454|998845|P4|STARTED|Treatment Period 2||0
419599|NCT00818454|998846|P3|STARTED|Treatment Period 2||0
419600|NCT00818454|998847|P2|STARTED|Treatment Period 2||107
419601|NCT00818454|998848|P1|STARTED|Treatment Period 2||108
419602|NCT00818454|998845|P4|NOT COMPLETED|Washout Period of 1 Week||0
419603|NCT00818454|998846|P3|NOT COMPLETED|Washout Period of 1 Week||0
419604|NCT00818454|998847|P2|NOT COMPLETED|Washout Period of 1 Week||3
419605|NCT00818454|998848|P1|NOT COMPLETED|Washout Period of 1 Week||4
419606|NCT00818454|998845|P4|COMPLETED|Washout Period of 1 Week||0
419607|NCT00818454|998846|P3|COMPLETED|Washout Period of 1 Week||0
419608|NCT00818454|998847|P2|COMPLETED|Washout Period of 1 Week||107
419609|NCT00818454|998848|P1|COMPLETED|Washout Period of 1 Week||108
419610|NCT00818454|998845|P4|STARTED|Washout Period of 1 Week||0
419611|NCT00818454|998846|P3|STARTED|Washout Period of 1 Week||0
419612|NCT00818454|998847|P2|STARTED|Washout Period of 1 Week||110
419613|NCT00818454|998848|P1|STARTED|Washout Period of 1 Week||112
419614|NCT00818454|998845|P4|NOT COMPLETED|Treatment Period 1||0
419615|NCT00818454|998846|P3|NOT COMPLETED|Treatment Period 1||0
419616|NCT00818454|998847|P2|NOT COMPLETED|Treatment Period 1||1
419617|NCT00818454|998848|P1|NOT COMPLETED|Treatment Period 1||3
419618|NCT00818454|998845|P4|COMPLETED|Treatment Period 1||0
419619|NCT00818454|998846|P3|COMPLETED|Treatment Period 1||0
419620|NCT00818454|998847|P2|COMPLETED|Treatment Period 1||110
419621|NCT00818454|998848|P1|COMPLETED|Treatment Period 1||112
419622|NCT00818454|998845|P4|STARTED|Treatment Period 1||0
419623|NCT00818454|998846|P3|STARTED|Treatment Period 1||0
419624|NCT00818454|998847|P2|STARTED|Treatment Period 1||111
419625|NCT00818454|998848|P1|STARTED|Treatment Period 1||115
419626|NCT00818441|998876|P2|NOT COMPLETED|Overall Study||30
419627|NCT00818441|998877|P1|NOT COMPLETED|Overall Study||89
419628|NCT00818441|998876|P2|COMPLETED|Overall Study||0
419629|NCT00818441|998877|P1|COMPLETED|Overall Study||0
419630|NCT00818441|998876|P2|STARTED|Overall Study||30
419631|NCT00818441|998877|P1|STARTED|Overall Study||89
419632|NCT00818389|998899|P2|NOT COMPLETED|Overall Study||6
419633|NCT00818389|998900|P1|NOT COMPLETED|Overall Study||4
419634|NCT00818389|998899|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
419635|NCT00818389|998900|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
419636|NCT00818389|998899|P2|STARTED|Overall Study||44
419637|NCT00818389|998900|P1|STARTED|Overall Study||40
419638|NCT00818337|998910|P1|NOT COMPLETED|Overall Study||0
419639|NCT00818337|998910|P1|COMPLETED|Overall Study||36
419640|NCT00818337|998910|P1|STARTED|Overall Study||36
419641|NCT00818324|998915|P1|NOT COMPLETED|Overall Study||27
419642|NCT00818324|998915|P1|COMPLETED|Overall Study||127
419643|NCT00818324|998915|P1|STARTED|Overall Study||154
419644|NCT00818272|998920|P1|NOT COMPLETED|Overall Study||74
419645|NCT00818272|998920|P1|COMPLETED|Overall Study||74
419646|NCT00818272|998920|P1|STARTED|Overall Study||148
419647|NCT00818259|998935|P9|NOT COMPLETED|Part V||0
419648|NCT00818259|998936|P8|NOT COMPLETED|Part V||1
419649|NCT00818259|998937|P7|NOT COMPLETED|Part V||0
419650|NCT00818259|998938|P6|NOT COMPLETED|Part V||0
419651|NCT00818259|998939|P5|NOT COMPLETED|Part V||0
419652|NCT00818259|998940|P4|NOT COMPLETED|Part V||0
419653|NCT00818259|998941|P3|NOT COMPLETED|Part V||0
419654|NCT00818259|998942|P2|NOT COMPLETED|Part V||0
419655|NCT00818259|998943|P1|NOT COMPLETED|Part V||0
419656|NCT00818259|998935|P9|COMPLETED|Part V||6
419657|NCT00818259|998936|P8|COMPLETED|Part V||16
419658|NCT00818259|998937|P7|COMPLETED|Part V||0
419659|NCT00818259|998938|P6|COMPLETED|Part V||0
419660|NCT00818259|998939|P5|COMPLETED|Part V||0
419661|NCT00818259|998940|P4|COMPLETED|Part V||0
419662|NCT00818259|998941|P3|COMPLETED|Part V||0
419663|NCT00818259|998942|P2|COMPLETED|Part V||0
419664|NCT00818259|998943|P1|COMPLETED|Part V||0
419665|NCT00818259|998935|P9|STARTED|Part V|Newly enrolled participants|6
419666|NCT00818259|998936|P8|STARTED|Part V|Participants continuing from Part IV|17
419667|NCT00818259|998937|P7|STARTED|Part V||0
419668|NCT00818259|998938|P6|STARTED|Part V||0
419669|NCT00818259|998939|P5|STARTED|Part V||0
419670|NCT00818259|998940|P4|STARTED|Part V||0
419671|NCT00818259|998941|P3|STARTED|Part V||0
419672|NCT00818259|998942|P2|STARTED|Part V||0
419673|NCT00818259|998943|P1|STARTED|Part V||0
419674|NCT00818259|998935|P9|NOT COMPLETED|Part IV||0
419675|NCT00818259|998936|P8|NOT COMPLETED|Part IV||0
419676|NCT00818259|998937|P7|NOT COMPLETED|Part IV||0
419677|NCT00818259|998938|P6|NOT COMPLETED|Part IV||1
419678|NCT00818259|998939|P5|NOT COMPLETED|Part IV||0
419679|NCT00818259|998940|P4|NOT COMPLETED|Part IV||0
419680|NCT00818259|998941|P3|NOT COMPLETED|Part IV||0
419681|NCT00818259|998942|P2|NOT COMPLETED|Part IV||0
419682|NCT00818259|998943|P1|NOT COMPLETED|Part IV||0
419683|NCT00818259|998935|P9|COMPLETED|Part IV||0
419684|NCT00818259|998936|P8|COMPLETED|Part IV||0
419685|NCT00818259|998937|P7|COMPLETED|Part IV||5
419686|NCT00818259|998938|P6|COMPLETED|Part IV||14
419687|NCT00818259|998939|P5|COMPLETED|Part IV||0
419688|NCT00818259|998940|P4|COMPLETED|Part IV||0
419689|NCT00818259|998941|P3|COMPLETED|Part IV||0
419690|NCT00818259|998942|P2|COMPLETED|Part IV||0
419691|NCT00818259|998943|P1|COMPLETED|Part IV||0
419692|NCT00818259|998935|P9|STARTED|Part IV||0
419693|NCT00818259|998936|P8|STARTED|Part IV||0
419694|NCT00818259|998937|P7|STARTED|Part IV|Newly enrolled participants|5
419695|NCT00818259|998938|P6|STARTED|Part IV|Participants continuing from Part III|15
419696|NCT00818259|998939|P5|STARTED|Part IV||0
419697|NCT00818259|998940|P4|STARTED|Part IV||0
419698|NCT00818259|998941|P3|STARTED|Part IV||0
419699|NCT00818259|998942|P2|STARTED|Part IV||0
419700|NCT00818259|998943|P1|STARTED|Part IV||0
419701|NCT00818259|998935|P9|NOT COMPLETED|Part III||0
419702|NCT00818259|998936|P8|NOT COMPLETED|Part III||0
419703|NCT00818259|998937|P7|NOT COMPLETED|Part III||0
419704|NCT00818259|998938|P6|NOT COMPLETED|Part III||0
419705|NCT00818259|998939|P5|NOT COMPLETED|Part III||0
419706|NCT00818259|998940|P4|NOT COMPLETED|Part III||0
419707|NCT00818259|998941|P3|NOT COMPLETED|Part III||0
419708|NCT00818259|998942|P2|NOT COMPLETED|Part III||0
419709|NCT00818259|998943|P1|NOT COMPLETED|Part III||0
419710|NCT00818259|998935|P9|COMPLETED|Part III||0
419711|NCT00818259|998936|P8|COMPLETED|Part III||0
419712|NCT00818259|998937|P7|COMPLETED|Part III||0
419713|NCT00818259|998938|P6|COMPLETED|Part III||0
419714|NCT00818259|998939|P5|COMPLETED|Part III||19
419715|NCT00818259|998940|P4|COMPLETED|Part III||0
419716|NCT00818259|998941|P3|COMPLETED|Part III||0
419717|NCT00818259|998942|P2|COMPLETED|Part III||0
419718|NCT00818259|998943|P1|COMPLETED|Part III||0
419719|NCT00818259|998935|P9|STARTED|Part III||0
419720|NCT00818259|998936|P8|STARTED|Part III||0
419721|NCT00818259|998937|P7|STARTED|Part III||0
419722|NCT00818259|998938|P6|STARTED|Part III||0
419723|NCT00818259|998939|P5|STARTED|Part III|Newly enrolled participants|19
419724|NCT00818259|998940|P4|STARTED|Part III||0
419725|NCT00818259|998941|P3|STARTED|Part III||0
419726|NCT00818259|998942|P2|STARTED|Part III||0
419727|NCT00818259|998943|P1|STARTED|Part III||0
419728|NCT00818259|998935|P9|NOT COMPLETED|Part II||0
419729|NCT00818259|998936|P8|NOT COMPLETED|Part II||0
419730|NCT00818259|998937|P7|NOT COMPLETED|Part II||0
419731|NCT00818259|998938|P6|NOT COMPLETED|Part II||0
419732|NCT00818259|998939|P5|NOT COMPLETED|Part II||0
419733|NCT00818259|998940|P4|NOT COMPLETED|Part II||2
419734|NCT00818259|998941|P3|NOT COMPLETED|Part II||1
419735|NCT00818259|998942|P2|NOT COMPLETED|Part II||0
419736|NCT00818259|998943|P1|NOT COMPLETED|Part II||0
419737|NCT00818259|998935|P9|COMPLETED|Part II||0
419738|NCT00818259|998936|P8|COMPLETED|Part II||0
419739|NCT00818259|998937|P7|COMPLETED|Part II||0
419740|NCT00818259|998938|P6|COMPLETED|Part II||0
419741|NCT00818259|998939|P5|COMPLETED|Part II||0
419742|NCT00818259|998940|P4|COMPLETED|Part II||18
419743|NCT00818259|998941|P3|COMPLETED|Part II||18
419744|NCT00818259|998942|P2|COMPLETED|Part II||0
419745|NCT00818259|998943|P1|COMPLETED|Part II||0
419746|NCT00818259|998935|P9|Treated|Part II||0
419747|NCT00818259|998936|P8|Treated|Part II||0
419748|NCT00818259|998937|P7|Treated|Part II||0
419749|NCT00818259|998938|P6|Treated|Part II||0
419750|NCT00818259|998939|P5|Treated|Part II||0
419751|NCT00818259|998940|P4|Treated|Part II||19
419752|NCT00818259|998941|P3|Treated|Part II||19
419753|NCT00818259|998942|P2|Treated|Part II||0
419754|NCT00818259|998943|P1|Treated|Part II||0
419755|NCT00818259|998935|P9|STARTED|Part II||0
419756|NCT00818259|998936|P8|STARTED|Part II||0
419757|NCT00818259|998937|P7|STARTED|Part II||0
419758|NCT00818259|998938|P6|STARTED|Part II||0
419759|NCT00818259|998939|P5|STARTED|Part II||0
419760|NCT00818259|998940|P4|STARTED|Part II|Newly enrolled participants|20
419761|NCT00818259|998941|P3|STARTED|Part II|Newly enrolled participants|19
419762|NCT00818259|998942|P2|STARTED|Part II||0
419763|NCT00818259|998943|P1|STARTED|Part II||0
419764|NCT00818259|998935|P9|NOT COMPLETED|Part I||0
419765|NCT00818259|998936|P8|NOT COMPLETED|Part I||0
419766|NCT00818259|998937|P7|NOT COMPLETED|Part I||0
419767|NCT00818259|998938|P6|NOT COMPLETED|Part I||0
419768|NCT00818259|998939|P5|NOT COMPLETED|Part I||0
419769|NCT00818259|998940|P4|NOT COMPLETED|Part I||0
419770|NCT00818259|998941|P3|NOT COMPLETED|Part I||0
419771|NCT00818259|998942|P2|NOT COMPLETED|Part I||0
419772|NCT00818259|998943|P1|NOT COMPLETED|Part I||1
419773|NCT00818259|998935|P9|COMPLETED|Part I||0
419774|NCT00818259|998936|P8|COMPLETED|Part I||0
419775|NCT00818259|998937|P7|COMPLETED|Part I||0
419776|NCT00818259|998938|P6|COMPLETED|Part I||0
419777|NCT00818259|998939|P5|COMPLETED|Part I||0
419778|NCT00818259|998940|P4|COMPLETED|Part I||0
419779|NCT00818259|998941|P3|COMPLETED|Part I||0
419780|NCT00818259|998942|P2|COMPLETED|Part I||11
419781|NCT00818259|998943|P1|COMPLETED|Part I||11
419782|NCT00818259|998935|P9|STARTED|Part I||0
419783|NCT00818259|998936|P8|STARTED|Part I||0
419784|NCT00818259|998937|P7|STARTED|Part I||0
419785|NCT00818259|998938|P6|STARTED|Part I||0
419786|NCT00818259|998939|P5|STARTED|Part I||0
419787|NCT00818259|998940|P4|STARTED|Part I||0
419788|NCT00818259|998941|P3|STARTED|Part I||0
419789|NCT00818259|998942|P2|STARTED|Part I|Newly enrolled participants|11
419790|NCT00818259|998943|P1|STARTED|Part I|Newly enrolled participants|12
419791|NCT00818259|998935|P9|NOT COMPLETED|Randomization||0
419792|NCT00818259|998936|P8|NOT COMPLETED|Randomization||0
419793|NCT00818259|998937|P7|NOT COMPLETED|Randomization||0
419794|NCT00818259|998938|P6|NOT COMPLETED|Randomization||0
419795|NCT00818259|998939|P5|NOT COMPLETED|Randomization||0
419796|NCT00818259|998940|P4|NOT COMPLETED|Randomization||0
419797|NCT00818259|998941|P3|NOT COMPLETED|Randomization||0
419798|NCT00818259|998942|P2|NOT COMPLETED|Randomization||0
419799|NCT00818259|998943|P1|NOT COMPLETED|Randomization||0
419800|NCT00818259|998935|P9|COMPLETED|Randomization||6
419801|NCT00818259|998936|P8|COMPLETED|Randomization||0
419802|NCT00818259|998937|P7|COMPLETED|Randomization||5
419803|NCT00818259|998938|P6|COMPLETED|Randomization||0
419804|NCT00818259|998939|P5|COMPLETED|Randomization||19
419805|NCT00818259|998940|P4|COMPLETED|Randomization||20
419806|NCT00818259|998941|P3|COMPLETED|Randomization||19
419807|NCT00818259|998942|P2|COMPLETED|Randomization||11
419808|NCT00818259|998943|P1|COMPLETED|Randomization||12
419809|NCT00818259|998935|P9|STARTED|Randomization||6
419810|NCT00818259|998936|P8|STARTED|Randomization||0
419811|NCT00818259|998937|P7|STARTED|Randomization||5
419812|NCT00818259|998938|P6|STARTED|Randomization||0
419813|NCT00818259|998939|P5|STARTED|Randomization||19
419814|NCT00818259|998940|P4|STARTED|Randomization||20
419815|NCT00818259|998941|P3|STARTED|Randomization||19
419816|NCT00818259|998942|P2|STARTED|Randomization||11
419817|NCT00818259|998943|P1|STARTED|Randomization||12
419818|NCT00818246|999015|P1|NOT COMPLETED|Overall Study||5
419819|NCT00818246|999015|P1|COMPLETED|Overall Study|split-face study|35
419820|NCT00818246|999015|P1|STARTED|Overall Study||40
419821|NCT00818207|999024|P2|NOT COMPLETED|Overall Study||267
419822|NCT00818207|999025|P1|NOT COMPLETED|Overall Study||222
419823|NCT00818207|999024|P2|COMPLETED|Overall Study||417
419824|NCT00818207|999025|P1|COMPLETED|Overall Study||474
419825|NCT00818207|999024|P2|STARTED|Overall Study||684
419826|NCT00818207|999025|P1|STARTED|Overall Study||696
419827|NCT00818168|999039|P1|NOT COMPLETED|Overall Study||70
419828|NCT00818168|999039|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
419829|NCT00818168|999039|P1|STARTED|Overall Study||320
419830|NCT00818116|999047|P1|NOT COMPLETED|Overall Study||0
419831|NCT00818116|999047|P1|COMPLETED|Overall Study||34
419832|NCT00818116|999047|P1|STARTED|Overall Study||34
419833|NCT00817999|999053|P2|NOT COMPLETED|No Grapefruit Juice||0
419834|NCT00817999|999054|P1|NOT COMPLETED|No Grapefruit Juice||0
419835|NCT00817999|999053|P2|COMPLETED|No Grapefruit Juice||17
419836|NCT00817999|999054|P1|COMPLETED|No Grapefruit Juice||15
419837|NCT00817999|999053|P2|STARTED|No Grapefruit Juice||17
419838|NCT00817999|999054|P1|STARTED|No Grapefruit Juice||15
419839|NCT00817999|999053|P2|NOT COMPLETED|Grapefruit Juice||0
419840|NCT00817999|999054|P1|NOT COMPLETED|Grapefruit Juice||0
419841|NCT00817999|999053|P2|COMPLETED|Grapefruit Juice||17
419842|NCT00817999|999054|P1|COMPLETED|Grapefruit Juice||15
419843|NCT00817999|999053|P2|STARTED|Grapefruit Juice||17
419844|NCT00817999|999054|P1|STARTED|Grapefruit Juice||15
419845|NCT00817843|999062|P2|NOT COMPLETED|Second Period (6 Weeks)||1
419846|NCT00817843|999063|P1|NOT COMPLETED|Second Period (6 Weeks)||0
419847|NCT00817843|999062|P2|COMPLETED|Second Period (6 Weeks)||44
419848|NCT00817843|999063|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
419849|NCT00817843|999062|P2|STARTED|Second Period (6 Weeks)||45
419850|NCT00817843|999063|P1|STARTED|Second Period (6 Weeks)||41
419851|NCT00817843|999062|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
419852|NCT00817843|999063|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
419853|NCT00817843|999062|P2|COMPLETED|Washout Period (6 Weeks)||45
419854|NCT00817843|999063|P1|COMPLETED|Washout Period (6 Weeks)||41
419855|NCT00817843|999062|P2|STARTED|Washout Period (6 Weeks)||46
419856|NCT00817843|999063|P1|STARTED|Washout Period (6 Weeks)||42
419857|NCT00817843|999062|P2|NOT COMPLETED|First Period (6 Weeks)||4
419858|NCT00817843|999063|P1|NOT COMPLETED|First Period (6 Weeks)||8
419859|NCT00817843|999062|P2|COMPLETED|First Period (6 Weeks)||46
419860|NCT00817843|999063|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
419861|NCT00817843|999062|P2|STARTED|First Period (6 Weeks)||50
419862|NCT00817843|999063|P1|STARTED|First Period (6 Weeks)||50
419863|NCT00817804|999070|P2|NOT COMPLETED|Overall Study||0
419864|NCT00817804|999071|P1|NOT COMPLETED|Overall Study||0
419865|NCT00817804|999070|P2|COMPLETED|Overall Study||2
419866|NCT00817804|999071|P1|COMPLETED|Overall Study||1
419867|NCT00817804|999070|P2|STARTED|Overall Study||2
419868|NCT00817804|999071|P1|STARTED|Overall Study||1
419869|NCT00817778|999079|P2|NOT COMPLETED|Overall Study||3
419870|NCT00817778|999080|P1|NOT COMPLETED|Overall Study||3
419871|NCT00817778|999079|P2|COMPLETED|Overall Study||5
419872|NCT00817778|999080|P1|COMPLETED|Overall Study||16
419873|NCT00817778|999079|P2|STARTED|Overall Study||8
419874|NCT00817778|999080|P1|STARTED|Overall Study||19
419875|NCT00817531|999105|P1|NOT COMPLETED|Overall Study||2
419876|NCT00817531|999105|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
419877|NCT00817531|999105|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
419878|NCT00817479|999111|P2|NOT COMPLETED|Overall Study||1
419879|NCT00817479|999112|P1|NOT COMPLETED|Overall Study||1
419880|NCT00817479|999111|P2|COMPLETED|Overall Study||13
419881|NCT00817479|999112|P1|COMPLETED|Overall Study||5
419882|NCT00817479|999111|P2|STARTED|Overall Study||14
419883|NCT00817479|999112|P1|STARTED|Overall Study||6
419884|NCT00817219|999120|P1|NOT COMPLETED|Overall Study||0
419885|NCT00817219|999120|P1|COMPLETED|Overall Study||33
419886|NCT00817219|999120|P1|STARTED|Overall Study||33
419887|NCT00817206|999135|P2|NOT COMPLETED|Overall Study||9
419888|NCT00817206|999136|P1|NOT COMPLETED|Overall Study||21
419889|NCT00817206|999135|P2|COMPLETED|Overall Study||154
419890|NCT00817206|999136|P1|COMPLETED|Overall Study||142
419891|NCT00817206|999135|P2|STARTED|Overall Study||163
419892|NCT00817206|999136|P1|STARTED|Overall Study||163
419893|NCT00816907|999144|P2|NOT COMPLETED|Overall Study||17
419894|NCT00816907|999145|P1|NOT COMPLETED|Overall Study||13
419895|NCT00816907|999144|P2|COMPLETED|Overall Study||58
419896|NCT00816907|999145|P1|COMPLETED|Overall Study||58
419897|NCT00816907|999144|P2|STARTED|Overall Study||75
419898|NCT00816907|999145|P1|STARTED|Overall Study||71
419899|NCT00816829|999167|P2|NOT COMPLETED|Overall Study||0
419900|NCT00816829|999168|P1|NOT COMPLETED|Overall Study||0
419901|NCT00816829|999167|P2|COMPLETED|Overall Study||18
419902|NCT00816829|999168|P1|COMPLETED|Overall Study||16
419903|NCT00816829|999167|P2|STARTED|Overall Study||18
419904|NCT00816829|999168|P1|STARTED|Overall Study||16
419905|NCT00816777|999194|P2|NOT COMPLETED|Overall Study||0
419906|NCT00816777|999195|P1|NOT COMPLETED|Overall Study||0
419907|NCT00816777|999194|P2|COMPLETED|Overall Study||2
419908|NCT00816777|999195|P1|COMPLETED|Overall Study||2
419909|NCT00816777|999194|P2|STARTED|Overall Study||2
419910|NCT00816777|999195|P1|STARTED|Overall Study||2
419911|NCT00816595|999203|P2|NOT COMPLETED|Overall Study||0
419912|NCT00816595|999204|P1|NOT COMPLETED|Overall Study||2
419913|NCT00816595|999203|P2|COMPLETED|Overall Study||33
419914|NCT00816595|999204|P1|COMPLETED|Overall Study||33
419915|NCT00816595|999203|P2|STARTED|Overall Study||33
419916|NCT00816595|999204|P1|STARTED|Overall Study||35
419917|NCT00816556|999217|P3|NOT COMPLETED|Overall Study||3
419918|NCT00816556|999218|P2|NOT COMPLETED|Overall Study||2
419919|NCT00816556|999219|P1|NOT COMPLETED|Overall Study||2
419920|NCT00816556|999217|P3|COMPLETED|Overall Study||19
419921|NCT00816556|999218|P2|COMPLETED|Overall Study||19
419922|NCT00816556|999219|P1|COMPLETED|Overall Study||18
419923|NCT00816556|999217|P3|STARTED|Overall Study||22
419924|NCT00816556|999218|P2|STARTED|Overall Study||21
419925|NCT00816556|999219|P1|STARTED|Overall Study||20
419926|NCT00816400|999242|P9|NOT COMPLETED|Overall Study||6
419927|NCT00816400|999243|P8|NOT COMPLETED|Overall Study||5
419928|NCT00816400|999244|P7|NOT COMPLETED|Overall Study||2
419929|NCT00816400|999245|P6|NOT COMPLETED|Overall Study||3
419930|NCT00816400|999246|P5|NOT COMPLETED|Overall Study||2
419931|NCT00816400|999247|P4|NOT COMPLETED|Overall Study||3
419932|NCT00816400|999248|P3|NOT COMPLETED|Overall Study||5
419933|NCT00816400|999249|P2|NOT COMPLETED|Overall Study||3
419934|NCT00816400|999250|P1|NOT COMPLETED|Overall Study||2
419935|NCT00816400|999242|P9|COMPLETED|Overall Study||0
419936|NCT00816400|999243|P8|COMPLETED|Overall Study||1
419937|NCT00816400|999244|P7|COMPLETED|Overall Study||1
419938|NCT00816400|999245|P6|COMPLETED|Overall Study||0
419939|NCT00816400|999246|P5|COMPLETED|Overall Study||1
419940|NCT00816400|999247|P4|COMPLETED|Overall Study||0
419941|NCT00816400|999248|P3|COMPLETED|Overall Study||0
419942|NCT00816400|999249|P2|COMPLETED|Overall Study||0
419943|NCT00816400|999250|P1|COMPLETED|Overall Study||1
419944|NCT00816400|999242|P9|STARTED|Overall Study||6
419945|NCT00816400|999243|P8|STARTED|Overall Study||6
419946|NCT00816400|999244|P7|STARTED|Overall Study||3
419947|NCT00816400|999245|P6|STARTED|Overall Study||3
419948|NCT00816400|999246|P5|STARTED|Overall Study||3
419949|NCT00816400|999247|P4|STARTED|Overall Study||3
419950|NCT00816400|999248|P3|STARTED|Overall Study||5
419951|NCT00816400|999249|P2|STARTED|Overall Study||3
419952|NCT00816400|999250|P1|STARTED|Overall Study||3
419953|NCT00816348|999434|P1|NOT COMPLETED|Overall Study||0
419954|NCT00816348|999434|P1|COMPLETED|Overall Study||15
419955|NCT00816348|999434|P1|STARTED|Overall Study||15
419956|NCT00816166|999440|P2|NOT COMPLETED|Overall Study||12
419957|NCT00816166|999441|P1|NOT COMPLETED|Overall Study||10
419958|NCT00816166|999440|P2|COMPLETED|Overall Study||41
419959|NCT00816166|999441|P1|COMPLETED|Overall Study||49
419960|NCT00816166|999440|P2|ITT Population (Met Eligibility)|Overall Study||53
419961|NCT00816166|999441|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
419962|NCT00816166|999440|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
419963|NCT00816166|999441|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
419964|NCT00816101|999450|P3|NOT COMPLETED|Overall Study||0
419965|NCT00816101|999451|P2|NOT COMPLETED|Overall Study||0
419966|NCT00816101|999452|P1|NOT COMPLETED|Overall Study||0
419967|NCT00816101|999450|P3|COMPLETED|Overall Study||5
419968|NCT00816101|999451|P2|COMPLETED|Overall Study||8
419969|NCT00816101|999452|P1|COMPLETED|Overall Study||13
419970|NCT00816101|999450|P3|STARTED|Overall Study||5
419971|NCT00816101|999451|P2|STARTED|Overall Study||8
419972|NCT00816101|999452|P1|STARTED|Overall Study||13
419973|NCT00816036|999468|P2|NOT COMPLETED|Overall Study||108
419974|NCT00816036|999469|P1|NOT COMPLETED|Overall Study||176
419975|NCT00816036|999468|P2|COMPLETED|Overall Study||287
419976|NCT00816036|999469|P1|COMPLETED|Overall Study||327
419977|NCT00816036|999468|P2|STARTED|Overall Study||395
419978|NCT00816036|999469|P1|STARTED|Overall Study||503
419979|NCT00816023|999483|P4|NOT COMPLETED|Overall Study||12
419980|NCT00816023|999484|P3|NOT COMPLETED|Overall Study||9
419981|NCT00816023|999485|P2|NOT COMPLETED|Overall Study||6
419982|NCT00816023|999486|P1|NOT COMPLETED|Overall Study||9
419983|NCT00816023|999483|P4|COMPLETED|Overall Study||62
419984|NCT00816023|999484|P3|COMPLETED|Overall Study||60
419985|NCT00816023|999485|P2|COMPLETED|Overall Study||56
419986|NCT00816023|999486|P1|COMPLETED|Overall Study||62
419987|NCT00816023|999483|P4|Completed Therapy|Overall Study||63
419988|NCT00816023|999484|P3|Completed Therapy|Overall Study||61
419989|NCT00816023|999485|P2|Completed Therapy|Overall Study||59
419990|NCT00816023|999486|P1|Completed Therapy|Overall Study||65
419991|NCT00816023|999483|P4|STARTED|Overall Study||74
419992|NCT00816023|999484|P3|STARTED|Overall Study||69
419993|NCT00816023|999485|P2|STARTED|Overall Study||62
419994|NCT00816023|999486|P1|STARTED|Overall Study||71
419995|NCT00815919|999500|P1|NOT COMPLETED|Overall Study||4
419996|NCT00815919|999500|P1|COMPLETED|Overall Study||18
419997|NCT00815919|999500|P1|STARTED|Overall Study||22
419998|NCT00815776|999511|P3|NOT COMPLETED|Overall Study||6
419999|NCT00815776|999512|P2|NOT COMPLETED|Overall Study||8
420000|NCT00815776|999513|P1|NOT COMPLETED|Overall Study||8
420001|NCT00815776|999511|P3|COMPLETED|Overall Study||22
420002|NCT00815776|999512|P2|COMPLETED|Overall Study||56
420003|NCT00815776|999513|P1|COMPLETED|Overall Study||52
420004|NCT00815776|999511|P3|STARTED|Overall Study||28
420005|NCT00815776|999512|P2|STARTED|Overall Study||64
420006|NCT00815776|999513|P1|STARTED|Overall Study||60
420007|NCT00815698|999529|P2|NOT COMPLETED|Overall Study||0
420008|NCT00815698|999530|P1|NOT COMPLETED|Overall Study||0
420009|NCT00815698|999529|P2|COMPLETED|Overall Study||171
420010|NCT00815698|999530|P1|COMPLETED|Overall Study||163
420011|NCT00815698|999529|P2|STARTED|Overall Study||171
420012|NCT00815698|999530|P1|STARTED|Overall Study||163
420013|NCT00815685|999538|P1|NOT COMPLETED|Overall Study||22
420014|NCT00815685|999538|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
420015|NCT00815685|999538|P1|STARTED|Overall Study||36
420016|NCT00815659|999543|P1|NOT COMPLETED|Overall Study||23
420017|NCT00815659|999543|P1|COMPLETED|Overall Study||74
420018|NCT00815659|999543|P1|STARTED|Overall Study||97
420019|NCT00815516|999588|P2|NOT COMPLETED|Overall Study||1
420020|NCT00815516|999589|P1|NOT COMPLETED|Overall Study||4
420021|NCT00815516|999588|P2|COMPLETED|Overall Study||9
420022|NCT00815516|999589|P1|COMPLETED|Overall Study||16
420023|NCT00815516|999588|P2|STARTED|Overall Study||10
420024|NCT00815516|999589|P1|STARTED|Overall Study||20
420025|NCT00815490|999620|P2|NOT COMPLETED|Overall Study||0
420026|NCT00815490|999621|P1|NOT COMPLETED|Overall Study||0
420027|NCT00815490|999620|P2|COMPLETED|Overall Study||9
420028|NCT00815490|999621|P1|COMPLETED|Overall Study||9
420029|NCT00815490|999620|P2|STARTED|Overall Study||9
420030|NCT00815490|999621|P1|STARTED|Overall Study||9
420031|NCT00815360|999629|P2|NOT COMPLETED|Overall Study||0
420032|NCT00815360|999630|P1|NOT COMPLETED|Overall Study||0
420033|NCT00815360|999629|P2|COMPLETED|Overall Study||11
420034|NCT00815360|999630|P1|COMPLETED|Overall Study||11
420035|NCT00815360|999629|P2|STARTED|Overall Study||11
420036|NCT00815360|999630|P1|STARTED|Overall Study||11
420037|NCT00815347|999638|P1|NOT COMPLETED|Overall Study||4
420038|NCT00815347|999638|P1|COMPLETED|Overall Study||7
420039|NCT00815347|999638|P1|STARTED|Overall Study||11
420040|NCT00815308|999654|P1|NOT COMPLETED|Overall Study||10
420041|NCT00815308|999654|P1|COMPLETED|Overall Study||45
420042|NCT00815308|999654|P1|STARTED|Overall Study||55
420043|NCT00815295|999663|P3|NOT COMPLETED|Overall Study||3
420044|NCT00815295|999664|P2|NOT COMPLETED|Overall Study||1
420045|NCT00815295|999665|P1|NOT COMPLETED|Overall Study||0
420046|NCT00815295|999663|P3|COMPLETED|Overall Study||9
420047|NCT00815295|999664|P2|COMPLETED|Overall Study||7
420048|NCT00815295|999665|P1|COMPLETED|Overall Study||8
420049|NCT00815295|999663|P3|STARTED|Overall Study||12
420050|NCT00815295|999664|P2|STARTED|Overall Study||8
420051|NCT00815295|999665|P1|STARTED|Overall Study||8
420052|NCT00815191|999677|P2|NOT COMPLETED|Overall Study||1
420053|NCT00815191|999678|P1|NOT COMPLETED|Overall Study||1
420054|NCT00815191|999677|P2|COMPLETED|Overall Study||34
420055|NCT00815191|999678|P1|COMPLETED|Overall Study||37
420056|NCT00815191|999677|P2|STARTED|Overall Study||35
420057|NCT00815191|999678|P1|STARTED|Overall Study||38
420058|NCT00815087|999686|P2|NOT COMPLETED|Overall Study||0
420059|NCT00815087|999687|P1|NOT COMPLETED|Overall Study||0
420060|NCT00815087|999686|P2|COMPLETED|Overall Study||10
420061|NCT00815087|999687|P1|COMPLETED|Overall Study||10
420062|NCT00815087|999686|P2|STARTED|Overall Study||10
420063|NCT00815087|999687|P1|STARTED|Overall Study||10
420064|NCT00815035|999695|P3|NOT COMPLETED|Open Label Extension Phase||6
420065|NCT00815035|999696|P2|NOT COMPLETED|Open Label Extension Phase||0
420066|NCT00815035|999697|P1|NOT COMPLETED|Open Label Extension Phase||0
420067|NCT00815035|999695|P3|COMPLETED|Open Label Extension Phase||9
420068|NCT00815035|999696|P2|COMPLETED|Open Label Extension Phase||0
420069|NCT00815035|999697|P1|COMPLETED|Open Label Extension Phase||0
420070|NCT00815035|999695|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
420071|NCT00815035|999696|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
420072|NCT00815035|999697|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
420073|NCT00815035|999695|P3|NOT COMPLETED|Blinded Phase||0
420074|NCT00815035|999696|P2|NOT COMPLETED|Blinded Phase||0
420075|NCT00815035|999697|P1|NOT COMPLETED|Blinded Phase||1
420076|NCT00815035|999695|P3|COMPLETED|Blinded Phase||0
420077|NCT00815035|999696|P2|COMPLETED|Blinded Phase||6
420078|NCT00815035|999697|P1|COMPLETED|Blinded Phase||9
420079|NCT00815035|999695|P3|STARTED|Blinded Phase||0
420080|NCT00815035|999696|P2|STARTED|Blinded Phase||6
420081|NCT00815035|999697|P1|STARTED|Blinded Phase||10
420082|NCT00814983|999715|P2|NOT COMPLETED|Overall Study||0
420083|NCT00814983|999716|P1|NOT COMPLETED|Overall Study||3
420084|NCT00814983|999715|P2|COMPLETED|Overall Study||0
420085|NCT00814983|999716|P1|COMPLETED|Overall Study||12
420086|NCT00814983|999715|P2|STARTED|Overall Study||0
420087|NCT00814983|999716|P1|STARTED|Overall Study||15
420088|NCT00814970|999726|P1|NOT COMPLETED|Overall Study||50
420089|NCT00814970|999726|P1|COMPLETED|Overall Study||146
420090|NCT00814970|999726|P1|STARTED|Overall Study||196
420091|NCT00814892|999747|P1|NOT COMPLETED|Overall Study||2
420092|NCT00814892|999747|P1|COMPLETED|Overall Study||0
420093|NCT00814892|999747|P1|STARTED|Overall Study||2
420094|NCT00814879|999759|P2|NOT COMPLETED|By Week 48||3
420095|NCT00814879|999760|P1|NOT COMPLETED|By Week 48||2
420096|NCT00814879|999759|P2|COMPLETED|By Week 48||26
420097|NCT00814879|999760|P1|COMPLETED|By Week 48||25
420098|NCT00814879|999759|P2|STARTED|By Week 48||29
420099|NCT00814879|999760|P1|STARTED|By Week 48||27
420100|NCT00814879|999759|P2|NOT COMPLETED|By Week 24||1
420101|NCT00814879|999760|P1|NOT COMPLETED|By Week 24||1
420102|NCT00814879|999759|P2|COMPLETED|By Week 24||29
420103|NCT00814879|999760|P1|COMPLETED|By Week 24||27
420104|NCT00814879|999759|P2|STARTED|By Week 24||30
420105|NCT00814879|999760|P1|STARTED|By Week 24||28
420106|NCT00814801|999779|P3|NOT COMPLETED|Overall Study||43
420107|NCT00814801|999780|P2|NOT COMPLETED|Overall Study||38
420108|NCT00814801|999781|P1|NOT COMPLETED|Overall Study||34
420109|NCT00814801|999779|P3|COMPLETED|Overall Study||151
420110|NCT00814801|999780|P2|COMPLETED|Overall Study||154
420111|NCT00814801|999781|P1|COMPLETED|Overall Study||160
420112|NCT00814801|999779|P3|STARTED|Overall Study||194
420113|NCT00814801|999780|P2|STARTED|Overall Study||192
420114|NCT00814801|999781|P1|STARTED|Overall Study||194
420115|NCT00814788|999801|P1|NOT COMPLETED|Overall Study||0
420116|NCT00814788|999801|P1|COMPLETED|Overall Study||24
420117|NCT00814788|999801|P1|STARTED|Overall Study||24
420118|NCT00814775|999809|P2|NOT COMPLETED|Overall Study||0
420119|NCT00814775|999810|P1|NOT COMPLETED|Overall Study||0
420120|NCT00814775|999809|P2|COMPLETED|Overall Study||20
420121|NCT00814775|999810|P1|COMPLETED|Overall Study||23
420122|NCT00814775|999809|P2|STARTED|Overall Study||20
420123|NCT00814775|999810|P1|STARTED|Overall Study||23
420124|NCT00814710|999820|P2|NOT COMPLETED|Overall Study||3
420125|NCT00814710|999821|P1|NOT COMPLETED|Overall Study||8
420126|NCT00814710|999820|P2|COMPLETED|Overall Study||117
420127|NCT00814710|999821|P1|COMPLETED|Overall Study||232
420128|NCT00814710|999820|P2|STARTED|Overall Study||120
420129|NCT00814710|999821|P1|STARTED|Overall Study||240
420130|NCT00814697|999859|P1|NOT COMPLETED|Overall Study||0
420131|NCT00814697|999859|P1|COMPLETED|Overall Study||12
420132|NCT00814697|999859|P1|STARTED|Overall Study||12
420133|NCT00814671|999866|P3|NOT COMPLETED|Overall Study||2
420134|NCT00814671|999867|P2|NOT COMPLETED|Overall Study||4
420135|NCT00814671|999868|P1|NOT COMPLETED|Overall Study||7
420136|NCT00814671|999866|P3|COMPLETED|Overall Study||49
420137|NCT00814671|999867|P2|COMPLETED|Overall Study||44
420138|NCT00814671|999868|P1|COMPLETED|Overall Study||47
420139|NCT00814671|999866|P3|STARTED|Overall Study||51
420140|NCT00814671|999867|P2|STARTED|Overall Study||48
420141|NCT00814671|999868|P1|STARTED|Overall Study||54
420142|NCT00814658|999881|P2|NOT COMPLETED|Overall Study||4
420143|NCT00814658|999882|P1|NOT COMPLETED|Overall Study||4
420144|NCT00814658|999881|P2|COMPLETED|Overall Study||8
420145|NCT00814658|999882|P1|COMPLETED|Overall Study||5
420146|NCT00814658|999881|P2|STARTED|Overall Study||12
420147|NCT00814658|999882|P1|STARTED|Overall Study||9
420148|NCT00814632|999948|P1|NOT COMPLETED|Overall Study||2
420149|NCT00814632|999948|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
420150|NCT00814632|999948|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
420151|NCT00814580|999954|P2|NOT COMPLETED|Overall Study||47
420152|NCT00814580|999955|P1|NOT COMPLETED|Overall Study||31
420153|NCT00814580|999954|P2|COMPLETED|Overall Study||141
420154|NCT00814580|999955|P1|COMPLETED|Overall Study||163
420155|NCT00814580|999954|P2|STARTED|Overall Study||188
420156|NCT00814580|999955|P1|STARTED|Overall Study||194
420157|NCT00814502|1000085|P2|NOT COMPLETED|Overall Study||2
420158|NCT00814502|1000086|P1|NOT COMPLETED|Overall Study||1
420159|NCT00814502|1000085|P2|COMPLETED|Overall Study||7
420160|NCT00814502|1000086|P1|COMPLETED|Overall Study||7
420161|NCT00814502|1000085|P2|STARTED|Overall Study||9
420162|NCT00814502|1000086|P1|STARTED|Overall Study||8
420163|NCT00814489|1000099|P3|NOT COMPLETED|Overall Study||1
420164|NCT00814489|1000100|P2|NOT COMPLETED|Overall Study||0
420165|NCT00814489|1000101|P1|NOT COMPLETED|Overall Study||2
420166|NCT00814489|1000099|P3|COMPLETED|Overall Study||7
420167|NCT00814489|1000100|P2|COMPLETED|Overall Study||17
420168|NCT00814489|1000101|P1|COMPLETED|Overall Study||13
420169|NCT00814489|1000099|P3|STARTED|Overall Study||8
420170|NCT00814489|1000100|P2|STARTED|Overall Study||17
420171|NCT00814489|1000101|P1|STARTED|Overall Study||15
420172|NCT00814463|1000133|P1|NOT COMPLETED|Overall Study||1
420173|NCT00814463|1000133|P1|COMPLETED|Overall Study||0
420174|NCT00814463|1000133|P1|STARTED|Overall Study||1
420175|NCT00814346|1000139|P2|NOT COMPLETED|Open Phase (17 Months)||0
420176|NCT00814346|1000140|P1|NOT COMPLETED|Open Phase (17 Months)||10
420177|NCT00814346|1000139|P2|COMPLETED|Open Phase (17 Months)||0
420178|NCT00814346|1000140|P1|COMPLETED|Open Phase (17 Months)||31
420179|NCT00814346|1000139|P2|AD|Open Phase (17 Months)||0
420180|NCT00814346|1000140|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
420181|NCT00814346|1000139|P2|MC|Open Phase (17 Months)||0
420182|NCT00814346|1000140|P1|MC|Open Phase (17 Months)||20
420183|NCT00814346|1000139|P2|CNE|Open Phase (17 Months)||0
420184|NCT00814346|1000140|P1|CNE|Open Phase (17 Months)||21
420185|NCT00814346|1000139|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
420186|NCT00814346|1000140|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
420187|NCT00814346|1000139|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
420188|NCT00814346|1000140|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
420189|NCT00814346|1000139|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
420190|NCT00814346|1000140|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
420191|NCT00814346|1000139|P2|AD|Double-blind Phase (4 Weeks)||2
420192|NCT00814346|1000140|P1|AD|Double-blind Phase (4 Weeks)||3
420193|NCT00814346|1000139|P2|MC|Double-blind Phase (4 Weeks)||11
420194|NCT00814346|1000140|P1|MC|Double-blind Phase (4 Weeks)||10
420195|NCT00814346|1000139|P2|CNE|Double-blind Phase (4 Weeks)||13
420196|NCT00814346|1000140|P1|CNE|Double-blind Phase (4 Weeks)||10
420197|NCT00814346|1000139|P2|STARTED|Double-blind Phase (4 Weeks)||26
420198|NCT00814346|1000140|P1|STARTED|Double-blind Phase (4 Weeks)||23
420199|NCT00814333|1000206|P2|NOT COMPLETED|Treatment Period||0
420200|NCT00814333|1000207|P1|NOT COMPLETED|Treatment Period||0
420201|NCT00814333|1000206|P2|COMPLETED|Treatment Period||0
420202|NCT00814333|1000207|P1|COMPLETED|Treatment Period||0
420203|NCT00814333|1000206|P2|STARTED|Treatment Period||0
420204|NCT00814333|1000207|P1|STARTED|Treatment Period||0
420205|NCT00814333|1000206|P2|NOT COMPLETED|Enrollment||0
420206|NCT00814333|1000207|P1|NOT COMPLETED|Enrollment||1
420207|NCT00814333|1000206|P2|COMPLETED|Enrollment||0
420208|NCT00814333|1000207|P1|COMPLETED|Enrollment||0
420209|NCT00814333|1000206|P2|STARTED|Enrollment||0
420210|NCT00814333|1000207|P1|STARTED|Enrollment||1
420211|NCT00814320|1000215|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
420212|NCT00814320|1000216|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
420213|NCT00814320|1000215|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
420214|NCT00814320|1000216|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
420215|NCT00814320|1000215|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
420216|NCT00814320|1000216|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
420217|NCT00814320|1000215|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
420218|NCT00814320|1000216|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
420219|NCT00814320|1000215|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
420220|NCT00814320|1000216|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
420221|NCT00814320|1000215|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
420222|NCT00814320|1000216|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
420223|NCT00814320|1000215|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
420224|NCT00814320|1000216|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
420225|NCT00814320|1000215|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
420226|NCT00814320|1000216|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
420227|NCT00814320|1000215|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
420228|NCT00814320|1000216|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
420229|NCT00814320|1000215|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
420230|NCT00814320|1000216|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
420231|NCT00814320|1000215|P2|COMPLETED|Epoch 1 (IV Treatment)||71
420232|NCT00814320|1000216|P1|COMPLETED|Epoch 1 (IV Treatment)||13
420233|NCT00814320|1000215|P2|STARTED|Epoch 1 (IV Treatment)||73
420234|NCT00814320|1000216|P1|STARTED|Epoch 1 (IV Treatment)||14
420235|NCT00814307|1000348|P4|NOT COMPLETED|Overall Study||10
420236|NCT00814307|1000349|P3|NOT COMPLETED|Overall Study||7
420237|NCT00814307|1000350|P2|NOT COMPLETED|Overall Study||27
420238|NCT00814307|1000351|P1|NOT COMPLETED|Overall Study||12
420239|NCT00814307|1000348|P4|COMPLETED|Overall Study||51
420240|NCT00814307|1000349|P3|COMPLETED|Overall Study||54
420241|NCT00814307|1000350|P2|COMPLETED|Overall Study||218
420242|NCT00814307|1000351|P1|COMPLETED|Overall Study||232
420243|NCT00814307|1000348|P4|Treated|Overall Study||61
420244|NCT00814307|1000349|P3|Treated|Overall Study||61
420245|NCT00814307|1000350|P2|Treated|Overall Study||245
420246|NCT00814307|1000351|P1|Treated|Overall Study||243
420247|NCT00814307|1000348|P4|STARTED|Overall Study||61
420248|NCT00814307|1000349|P3|STARTED|Overall Study||61
420249|NCT00814307|1000350|P2|STARTED|Overall Study||245
420250|NCT00814307|1000351|P1|STARTED|Overall Study||244
420251|NCT00814255|1000516|P3|NOT COMPLETED|Overall Study||1
420252|NCT00814255|1000517|P2|NOT COMPLETED|Overall Study||0
420253|NCT00814255|1000518|P1|NOT COMPLETED|Overall Study||1
420254|NCT00814255|1000516|P3|COMPLETED|Overall Study||7
420255|NCT00814255|1000517|P2|COMPLETED|Overall Study||7
420256|NCT00814255|1000518|P1|COMPLETED|Overall Study||7
420257|NCT00814255|1000516|P3|STARTED|Overall Study||8
420258|NCT00814255|1000517|P2|STARTED|Overall Study||7
420259|NCT00814255|1000518|P1|STARTED|Overall Study||8
420260|NCT00814177|1000540|P2|NOT COMPLETED|Overall Study||0
420261|NCT00814177|1000541|P1|NOT COMPLETED|Overall Study||0
420262|NCT00814177|1000540|P2|COMPLETED|Overall Study||80
420263|NCT00814177|1000541|P1|COMPLETED|Overall Study||80
420264|NCT00814177|1000540|P2|STARTED|Overall Study||80
420265|NCT00814177|1000541|P1|STARTED|Overall Study||80
420266|NCT00814164|1000547|P1|NOT COMPLETED|Overall Study||19
420267|NCT00814164|1000547|P1|COMPLETED|Overall Study||2
420268|NCT00814164|1000547|P1|STARTED|Overall Study||21
420269|NCT00814138|1000560|P2|NOT COMPLETED|Overall Study||7
420270|NCT00814138|1000561|P1|NOT COMPLETED|Overall Study||1
420271|NCT00814138|1000560|P2|COMPLETED|Overall Study||18
420272|NCT00814138|1000561|P1|COMPLETED|Overall Study||24
420273|NCT00814138|1000560|P2|STARTED|Overall Study||25
420274|NCT00814138|1000561|P1|STARTED|Overall Study||25
420275|NCT00813995|1000581|P2|NOT COMPLETED|Overall Study||16
420276|NCT00813995|1000582|P1|NOT COMPLETED|Overall Study||23
420277|NCT00813995|1000581|P2|COMPLETED|Overall Study||182
420278|NCT00813995|1000582|P1|COMPLETED|Overall Study||174
420279|NCT00813995|1000581|P2|STARTED|Overall Study||198
420280|NCT00813995|1000582|P1|STARTED|Overall Study||197
420281|NCT00813982|1000596|P1|NOT COMPLETED|Overall Study||0
420282|NCT00813982|1000596|P1|COMPLETED|Overall Study||59
420283|NCT00813982|1000596|P1|STARTED|Overall Study||59
420284|NCT00813943|1000605|P3|NOT COMPLETED|Overall Study||3
420285|NCT00813943|1000606|P2|NOT COMPLETED|Overall Study||5
420286|NCT00813943|1000607|P1|NOT COMPLETED|Overall Study||5
420287|NCT00813943|1000605|P3|COMPLETED|Overall Study||86
420288|NCT00813943|1000606|P2|COMPLETED|Overall Study||83
420289|NCT00813943|1000607|P1|COMPLETED|Overall Study||83
420290|NCT00813943|1000605|P3|STARTED|Overall Study||89
420291|NCT00813943|1000606|P2|STARTED|Overall Study||88
420292|NCT00813943|1000607|P1|STARTED|Overall Study||88
420293|NCT00813917|1000637|P2|NOT COMPLETED|Overall Study||6
420294|NCT00813917|1000638|P1|NOT COMPLETED|Overall Study||6
420295|NCT00813917|1000637|P2|COMPLETED|Overall Study||32
420296|NCT00813917|1000638|P1|COMPLETED|Overall Study||32
420297|NCT00813917|1000637|P2|STARTED|Overall Study||38
420298|NCT00813917|1000638|P1|STARTED|Overall Study||38
420299|NCT00813904|1000644|P1|NOT COMPLETED|Overall Study||1
420300|NCT00813904|1000644|P1|COMPLETED|Overall Study||30
420301|NCT00813904|1000644|P1|STARTED|Overall Study||31
420302|NCT00813813|1000652|P2|NOT COMPLETED|Overall Study||9
420303|NCT00813813|1000653|P1|NOT COMPLETED|Overall Study||3
420304|NCT00813813|1000652|P2|COMPLETED|Overall Study||16
420305|NCT00813813|1000653|P1|COMPLETED|Overall Study||4
420306|NCT00813813|1000652|P2|STARTED|Overall Study||25
420307|NCT00813813|1000653|P1|STARTED|Overall Study||7
420308|NCT00813800|1000669|P1|NOT COMPLETED|Overall Study||6
420309|NCT00813800|1000669|P1|COMPLETED|Overall Study||5
420310|NCT00813800|1000669|P1|STARTED|Overall Study||11
420311|NCT00813761|1000677|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
420312|NCT00813761|1000678|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
420313|NCT00813761|1000679|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
420314|NCT00813761|1000680|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
420315|NCT00813761|1000677|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
420316|NCT00813761|1000678|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
420317|NCT00813761|1000679|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
420318|NCT00813761|1000680|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
420319|NCT00813761|1000677|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
420320|NCT00813761|1000678|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
420321|NCT00813761|1000679|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
420322|NCT00813761|1000680|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
420323|NCT00813761|1000677|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
420324|NCT00813761|1000678|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
420325|NCT00813761|1000679|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
420326|NCT00813761|1000680|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
420327|NCT00813761|1000677|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
420328|NCT00813761|1000678|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
420329|NCT00813761|1000679|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
420330|NCT00813761|1000680|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
420331|NCT00813761|1000677|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
420332|NCT00813761|1000678|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
420333|NCT00813761|1000679|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
420334|NCT00813761|1000680|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
420335|NCT00813748|1000730|P2|NOT COMPLETED|Skin Test Substudy||1
420336|NCT00813748|1000731|P1|NOT COMPLETED|Skin Test Substudy||0
420337|NCT00813748|1000730|P2|COMPLETED|Skin Test Substudy||7
420338|NCT00813748|1000731|P1|COMPLETED|Skin Test Substudy||3
420339|NCT00813748|1000730|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
420340|NCT00813748|1000731|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
420341|NCT00813748|1000730|P2|NOT COMPLETED|Main Observational Study||0
420342|NCT00813748|1000731|P1|NOT COMPLETED|Main Observational Study||0
420343|NCT00813748|1000730|P2|COMPLETED|Main Observational Study||88
420344|NCT00813748|1000731|P1|COMPLETED|Main Observational Study||30
420345|NCT00813748|1000730|P2|STARTED|Main Observational Study||88
420346|NCT00813748|1000731|P1|STARTED|Main Observational Study||30
420347|NCT00813709|1000760|P6|NOT COMPLETED|Open Label Period||11
420348|NCT00813709|1000761|P5|NOT COMPLETED|Open Label Period||10
420349|NCT00813709|1000762|P4|NOT COMPLETED|Open Label Period||20
420350|NCT00813709|1000763|P3|NOT COMPLETED|Open Label Period||0
420351|NCT00813709|1000764|P2|NOT COMPLETED|Open Label Period||0
420352|NCT00813709|1000765|P1|NOT COMPLETED|Open Label Period||0
420353|NCT00813709|1000760|P6|COMPLETED|Open Label Period||35
420354|NCT00813709|1000761|P5|COMPLETED|Open Label Period||41
420355|NCT00813709|1000762|P4|COMPLETED|Open Label Period||38
420356|NCT00813709|1000763|P3|COMPLETED|Open Label Period||0
420357|NCT00813709|1000764|P2|COMPLETED|Open Label Period||0
420358|NCT00813709|1000765|P1|COMPLETED|Open Label Period||0
420359|NCT00813709|1000760|P6|Treated|Open Label Period||45
420360|NCT00813709|1000761|P5|Treated|Open Label Period||51
420361|NCT00813709|1000762|P4|Treated|Open Label Period||57
420362|NCT00813709|1000763|P3|Treated|Open Label Period||0
420363|NCT00813709|1000764|P2|Treated|Open Label Period||0
420364|NCT00813709|1000765|P1|Treated|Open Label Period||0
420365|NCT00813709|1000760|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
420537|NCT00812487|1001301|P2|STARTED|Overall Study||42
420366|NCT00813709|1000761|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
420367|NCT00813709|1000762|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
420368|NCT00813709|1000763|P3|STARTED|Open Label Period||0
420369|NCT00813709|1000764|P2|STARTED|Open Label Period||0
420370|NCT00813709|1000765|P1|STARTED|Open Label Period||0
420371|NCT00813709|1000760|P6|NOT COMPLETED|Double Blind Period||0
420372|NCT00813709|1000761|P5|NOT COMPLETED|Double Blind Period||0
420373|NCT00813709|1000762|P4|NOT COMPLETED|Double Blind Period||0
420374|NCT00813709|1000763|P3|NOT COMPLETED|Double Blind Period||31
420375|NCT00813709|1000764|P2|NOT COMPLETED|Double Blind Period||41
420376|NCT00813709|1000765|P1|NOT COMPLETED|Double Blind Period||31
420377|NCT00813709|1000760|P6|COMPLETED|Double Blind Period||0
420378|NCT00813709|1000761|P5|COMPLETED|Double Blind Period||0
420379|NCT00813709|1000762|P4|COMPLETED|Double Blind Period||0
420380|NCT00813709|1000763|P3|COMPLETED|Double Blind Period||68
420381|NCT00813709|1000764|P2|COMPLETED|Double Blind Period||76
420382|NCT00813709|1000765|P1|COMPLETED|Double Blind Period||53
420383|NCT00813709|1000760|P6|Treated|Double Blind Period||0
420384|NCT00813709|1000761|P5|Treated|Double Blind Period||0
420385|NCT00813709|1000762|P4|Treated|Double Blind Period||0
420386|NCT00813709|1000763|P3|Treated|Double Blind Period||98
420387|NCT00813709|1000764|P2|Treated|Double Blind Period||114
420388|NCT00813709|1000765|P1|Treated|Double Blind Period||83
420389|NCT00813709|1000760|P6|STARTED|Double Blind Period||0
420390|NCT00813709|1000761|P5|STARTED|Double Blind Period||0
420391|NCT00813709|1000762|P4|STARTED|Double Blind Period||0
420392|NCT00813709|1000763|P3|STARTED|Double Blind Period||99
420393|NCT00813709|1000764|P2|STARTED|Double Blind Period||117
420394|NCT00813709|1000765|P1|STARTED|Double Blind Period||84
420395|NCT00813592|1000845|P1|NOT COMPLETED|Overall Study||2
420396|NCT00813592|1000845|P1|COMPLETED|Overall Study||0
420397|NCT00813592|1000845|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
420398|NCT00813592|1000845|P1|Treated|Overall Study|Two patients were treated.|2
420399|NCT00813592|1000845|P1|STARTED|Overall Study||2
420400|NCT00813488|1000854|P2|NOT COMPLETED|Open-label Extension||7
420401|NCT00813488|1000855|P1|NOT COMPLETED|Open-label Extension||12
420402|NCT00813488|1000854|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
420403|NCT00813488|1000855|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
420404|NCT00813488|1000854|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
420405|NCT00813488|1000855|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
420406|NCT00813488|1000854|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
420407|NCT00813488|1000855|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
420408|NCT00813488|1000854|P2|COMPLETED|Double-blind Treatment Period 2||65
420409|NCT00813488|1000855|P1|COMPLETED|Double-blind Treatment Period 2||66
420410|NCT00813488|1000854|P2|STARTED|Double-blind Treatment Period 2||66
420411|NCT00813488|1000855|P1|STARTED|Double-blind Treatment Period 2||71
420412|NCT00813488|1000854|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
420413|NCT00813488|1000855|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
420414|NCT00813488|1000854|P2|COMPLETED|Double-blind Treatment Period 1||66
420415|NCT00813488|1000855|P1|COMPLETED|Double-blind Treatment Period 1||71
420416|NCT00813488|1000854|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
420417|NCT00813488|1000855|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
420418|NCT00813488|1000854|P2|NOT COMPLETED|Titration Period 2||10
420419|NCT00813488|1000855|P1|NOT COMPLETED|Titration Period 2||16
420420|NCT00813488|1000854|P2|COMPLETED|Titration Period 2||79
420421|NCT00813488|1000855|P1|COMPLETED|Titration Period 2||64
420422|NCT00813488|1000854|P2|STARTED|Titration Period 2||89
420423|NCT00813488|1000855|P1|STARTED|Titration Period 2||80
420424|NCT00813488|1000854|P2|NOT COMPLETED|Titration Period 1||17
420425|NCT00813488|1000855|P1|NOT COMPLETED|Titration Period 1||27
420426|NCT00813488|1000854|P2|COMPLETED|Titration Period 1||89
420427|NCT00813488|1000855|P1|COMPLETED|Titration Period 1||80
420428|NCT00813488|1000854|P2|STARTED|Titration Period 1||106
420429|NCT00813488|1000855|P1|STARTED|Titration Period 1||107
420430|NCT00813319|1000953|P2|NOT COMPLETED|Overall Study||0
420431|NCT00813319|1000954|P1|NOT COMPLETED|Overall Study||0
420432|NCT00813319|1000953|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
420433|NCT00813319|1000954|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
420434|NCT00813319|1000953|P2|STARTED|Overall Study||108
420435|NCT00813319|1000954|P1|STARTED|Overall Study||108
420436|NCT00813150|1000966|P2|NOT COMPLETED|Long Term Follow-up||31
420437|NCT00813150|1000967|P1|NOT COMPLETED|Long Term Follow-up||24
420438|NCT00813150|1000966|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
420439|NCT00813150|1000967|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
420440|NCT00813150|1000966|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
420441|NCT00813150|1000967|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
420442|NCT00813150|1000966|P2|NOT COMPLETED|Treatment Period||32
420443|NCT00813150|1000967|P1|NOT COMPLETED|Treatment Period||32
420444|NCT00813150|1000966|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
420445|NCT00813150|1000967|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
420446|NCT00813150|1000966|P2|Intent-to-treat Participants|Treatment Period||47
420447|NCT00813150|1000967|P1|Intent-to-treat Participants|Treatment Period||43
420448|NCT00813150|1000966|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
420449|NCT00813150|1000967|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
420450|NCT00813111|1000981|P2|NOT COMPLETED|Overall Study||0
420451|NCT00813111|1000982|P1|NOT COMPLETED|Overall Study||2
420452|NCT00813111|1000981|P2|COMPLETED|Overall Study||70
420453|NCT00813111|1000982|P1|COMPLETED|Overall Study||64
420454|NCT00813111|1000981|P2|STARTED|Overall Study||70
420455|NCT00813111|1000982|P1|STARTED|Overall Study||66
420456|NCT00813098|1000991|P3|NOT COMPLETED|Overall Study||2
420457|NCT00813098|1000992|P2|NOT COMPLETED|Overall Study||8
420458|NCT00813098|1000993|P1|NOT COMPLETED|Overall Study||3
420459|NCT00813098|1000991|P3|COMPLETED|Overall Study||50
420460|NCT00813098|1000992|P2|COMPLETED|Overall Study||46
420461|NCT00813098|1000993|P1|COMPLETED|Overall Study||46
420462|NCT00813098|1000991|P3|STARTED|Overall Study||52
420463|NCT00813098|1000992|P2|STARTED|Overall Study||54
420464|NCT00813098|1000993|P1|STARTED|Overall Study||49
420465|NCT00812981|1001018|P2|NOT COMPLETED|Overall Study||1
420466|NCT00812981|1001019|P1|NOT COMPLETED|Overall Study||0
420467|NCT00812981|1001018|P2|COMPLETED|Overall Study||159
420468|NCT00812981|1001019|P1|COMPLETED|Overall Study||160
420469|NCT00812981|1001018|P2|STARTED|Overall Study||160
420470|NCT00812981|1001019|P1|STARTED|Overall Study||160
420471|NCT00812968|1001057|P1|NOT COMPLETED|Overall Study||11
420472|NCT00812968|1001057|P1|COMPLETED|Overall Study||0
420473|NCT00812968|1001057|P1|STARTED|Overall Study||11
420474|NCT00812955|1001092|P4|NOT COMPLETED|Overall Study||8
420475|NCT00812955|1001093|P3|NOT COMPLETED|Overall Study||6
420476|NCT00812955|1001094|P2|NOT COMPLETED|Overall Study||7
420477|NCT00812955|1001095|P1|NOT COMPLETED|Overall Study||10
420478|NCT00812955|1001092|P4|COMPLETED|Overall Study||110
420479|NCT00812955|1001093|P3|COMPLETED|Overall Study||113
420480|NCT00812955|1001094|P2|COMPLETED|Overall Study||111
420481|NCT00812955|1001095|P1|COMPLETED|Overall Study||109
420482|NCT00812955|1001092|P4|STARTED|Overall Study||118
420483|NCT00812955|1001093|P3|STARTED|Overall Study||119
420484|NCT00812955|1001094|P2|STARTED|Overall Study||118
420485|NCT00812955|1001095|P1|STARTED|Overall Study||119
420486|NCT00812916|1001115|P1|NOT COMPLETED|Overall Study||3
420487|NCT00812916|1001115|P1|COMPLETED|Overall Study||203
420488|NCT00812916|1001115|P1|CFAE - Guided Ablation|Overall Study||203
420489|NCT00812916|1001115|P1|Data Available|Overall Study||205
420490|NCT00812916|1001115|P1|STARTED|Overall Study|206 enrolled (consented)|206
420491|NCT00812877|1001126|P2|NOT COMPLETED|Overall Study||51
420492|NCT00812877|1001127|P1|NOT COMPLETED|Overall Study||37
420493|NCT00812877|1001126|P2|COMPLETED|Overall Study||130
420494|NCT00812877|1001127|P1|COMPLETED|Overall Study||158
420495|NCT00812877|1001126|P2|STARTED|Overall Study||181
420496|NCT00812877|1001127|P1|STARTED|Overall Study||195
420497|NCT00812812|1001137|P2|NOT COMPLETED|Overall Study||4
420498|NCT00812812|1001138|P1|NOT COMPLETED|Overall Study||3
420499|NCT00812812|1001137|P2|COMPLETED|Overall Study||25
420500|NCT00812812|1001138|P1|COMPLETED|Overall Study||24
420501|NCT00812812|1001137|P2|STARTED|Overall Study||29
420502|NCT00812812|1001138|P1|STARTED|Overall Study||27
420503|NCT00812604|1001153|P2|NOT COMPLETED|Overall Study||5
420504|NCT00812604|1001154|P1|NOT COMPLETED|Overall Study||5
420505|NCT00812604|1001153|P2|COMPLETED|Overall Study||22
420506|NCT00812604|1001154|P1|COMPLETED|Overall Study||23
420507|NCT00812604|1001153|P2|STARTED|Overall Study||27
420508|NCT00812604|1001154|P1|STARTED|Overall Study||28
420509|NCT00812565|1001170|P8|NOT COMPLETED|Overall Study||1
420510|NCT00812565|1001171|P7|NOT COMPLETED|Overall Study||0
420511|NCT00812565|1001172|P6|NOT COMPLETED|Overall Study||1
420512|NCT00812565|1001173|P5|NOT COMPLETED|Overall Study||1
420513|NCT00812565|1001174|P4|NOT COMPLETED|Overall Study||2
420514|NCT00812565|1001175|P3|NOT COMPLETED|Overall Study||0
420515|NCT00812565|1001176|P2|NOT COMPLETED|Overall Study||1
420516|NCT00812565|1001177|P1|NOT COMPLETED|Overall Study||3
420517|NCT00812565|1001170|P8|COMPLETED|Overall Study||6
420518|NCT00812565|1001171|P7|COMPLETED|Overall Study||8
420519|NCT00812565|1001172|P6|COMPLETED|Overall Study||6
420520|NCT00812565|1001173|P5|COMPLETED|Overall Study||6
420521|NCT00812565|1001174|P4|COMPLETED|Overall Study||5
420522|NCT00812565|1001175|P3|COMPLETED|Overall Study||7
420523|NCT00812565|1001176|P2|COMPLETED|Overall Study||6
420524|NCT00812565|1001177|P1|COMPLETED|Overall Study||5
420525|NCT00812565|1001170|P8|STARTED|Overall Study||7
420526|NCT00812565|1001171|P7|STARTED|Overall Study||8
420527|NCT00812565|1001172|P6|STARTED|Overall Study||7
420528|NCT00812565|1001173|P5|STARTED|Overall Study||7
420529|NCT00812565|1001174|P4|STARTED|Overall Study||7
420530|NCT00812565|1001175|P3|STARTED|Overall Study||7
420531|NCT00812565|1001176|P2|STARTED|Overall Study||7
420532|NCT00812565|1001177|P1|STARTED|Overall Study||8
420533|NCT00812487|1001301|P2|NOT COMPLETED|Overall Study||3
420534|NCT00812487|1001302|P1|NOT COMPLETED|Overall Study||6
420535|NCT00812487|1001301|P2|COMPLETED|Overall Study||39
420536|NCT00812487|1001302|P1|COMPLETED|Overall Study||26
420538|NCT00812487|1001302|P1|STARTED|Overall Study||32
420539|NCT00812461|1001328|P2|NOT COMPLETED|All Treated Patients||147
420540|NCT00812461|1001329|P1|NOT COMPLETED|All Treated Patients||132
420541|NCT00812461|1001328|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
420542|NCT00812461|1001329|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
420543|NCT00812461|1001328|P2|STARTED|All Treated Patients||341
420544|NCT00812461|1001329|P1|STARTED|All Treated Patients||337
420545|NCT00812461|1001328|P2|NOT COMPLETED|All Randomised Patients||17
420546|NCT00812461|1001329|P1|NOT COMPLETED|All Randomised Patients||23
420547|NCT00812461|1001328|P2|COMPLETED|All Randomised Patients||341
420548|NCT00812461|1001329|P1|COMPLETED|All Randomised Patients||337
420549|NCT00812461|1001328|P2|STARTED|All Randomised Patients||358
420550|NCT00812461|1001329|P1|STARTED|All Randomised Patients||360
420551|NCT00812331|1001352|P5|NOT COMPLETED|Overall Study||0
420552|NCT00812331|1001353|P4|NOT COMPLETED|Overall Study||0
420553|NCT00812331|1001354|P3|NOT COMPLETED|Overall Study||0
420554|NCT00812331|1001355|P2|NOT COMPLETED|Overall Study||0
420555|NCT00812331|1001356|P1|NOT COMPLETED|Overall Study||1
420556|NCT00812331|1001352|P5|COMPLETED|Overall Study||8
420557|NCT00812331|1001353|P4|COMPLETED|Overall Study||7
420558|NCT00812331|1001354|P3|COMPLETED|Overall Study||8
420559|NCT00812331|1001355|P2|COMPLETED|Overall Study||8
420560|NCT00812331|1001356|P1|COMPLETED|Overall Study||5
420561|NCT00812331|1001352|P5|STARTED|Overall Study||8
420562|NCT00812331|1001353|P4|STARTED|Overall Study||7
420563|NCT00812331|1001354|P3|STARTED|Overall Study||8
420564|NCT00812331|1001355|P2|STARTED|Overall Study||8
420565|NCT00812331|1001356|P1|STARTED|Overall Study||6
420566|NCT00812253|1001431|P2|NOT COMPLETED|Overall Study||3
420567|NCT00812253|1001432|P1|NOT COMPLETED|Overall Study||6
420568|NCT00812253|1001431|P2|COMPLETED|Overall Study||39
420569|NCT00812253|1001432|P1|COMPLETED|Overall Study||26
420570|NCT00812253|1001431|P2|STARTED|Overall Study||42
420571|NCT00812253|1001432|P1|STARTED|Overall Study||32
420572|NCT00812110|1001442|P1|NOT COMPLETED|Overall Study||0
420573|NCT00812110|1001442|P1|COMPLETED|Overall Study||292
420574|NCT00812110|1001442|P1|STARTED|Overall Study||292
420575|NCT00812097|1001451|P4|NOT COMPLETED|Overall Study||35
420576|NCT00812097|1001452|P3|NOT COMPLETED|Overall Study||57
420577|NCT00812097|1001453|P2|NOT COMPLETED|Overall Study||89
420578|NCT00812097|1001454|P1|NOT COMPLETED|Overall Study||245
420579|NCT00812097|1001451|P4|COMPLETED|Overall Study||34
420580|NCT00812097|1001452|P3|COMPLETED|Overall Study||67
420581|NCT00812097|1001453|P2|COMPLETED|Overall Study||101
420582|NCT00812097|1001454|P1|COMPLETED|Overall Study||327
420583|NCT00812097|1001451|P4|STARTED|Overall Study||69
420584|NCT00812097|1001452|P3|STARTED|Overall Study||124
420585|NCT00812097|1001453|P2|STARTED|Overall Study||190
420586|NCT00812097|1001454|P1|STARTED|Overall Study||572
420587|NCT00812006|1001483|P3|NOT COMPLETED|Overall Study||6
420588|NCT00812006|1001484|P2|NOT COMPLETED|Overall Study||3
420589|NCT00812006|1001485|P1|NOT COMPLETED|Overall Study||6
420590|NCT00812006|1001483|P3|COMPLETED|Overall Study||30
420591|NCT00812006|1001484|P2|COMPLETED|Overall Study||33
420592|NCT00812006|1001485|P1|COMPLETED|Overall Study||30
420593|NCT00812006|1001483|P3|STARTED|Overall Study||36
420594|NCT00812006|1001484|P2|STARTED|Overall Study||36
420595|NCT00812006|1001485|P1|STARTED|Overall Study||36
420596|NCT00811954|1001502|P3|NOT COMPLETED|Overall Study||101
420597|NCT00811954|1001503|P2|NOT COMPLETED|Overall Study||72
420598|NCT00811954|1001504|P1|NOT COMPLETED|Overall Study||89
420599|NCT00811954|1001502|P3|COMPLETED|Overall Study||500
420600|NCT00811954|1001503|P2|COMPLETED|Overall Study||531
420601|NCT00811954|1001504|P1|COMPLETED|Overall Study||516
420602|NCT00811954|1001502|P3|STARTED|Overall Study||601
420603|NCT00811954|1001503|P2|STARTED|Overall Study||603
420604|NCT00811954|1001504|P1|STARTED|Overall Study||605
420605|NCT00811941|1001568|P2|NOT COMPLETED|All Treated Patients||191
420606|NCT00811941|1001569|P1|NOT COMPLETED|All Treated Patients||52
420607|NCT00811941|1001568|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
420608|NCT00811941|1001569|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
420609|NCT00811941|1001568|P2|STARTED|All Treated Patients||501
420610|NCT00811941|1001569|P1|STARTED|All Treated Patients||164
420611|NCT00811941|1001568|P2|NOT COMPLETED|All Randomised Patients||8
420612|NCT00811941|1001569|P1|NOT COMPLETED|All Randomised Patients||2
420613|NCT00811941|1001568|P2|COMPLETED|All Randomised Patients||501
420614|NCT00811941|1001569|P1|COMPLETED|All Randomised Patients||164
420615|NCT00811941|1001568|P2|STARTED|All Randomised Patients||509
420616|NCT00811941|1001569|P1|STARTED|All Randomised Patients||166
420617|NCT00811928|1001607|P2|NOT COMPLETED|Overall Study||33
420618|NCT00811928|1001608|P1|NOT COMPLETED|Overall Study||39
420619|NCT00811928|1001607|P2|COMPLETED|Overall Study||90
420620|NCT00811928|1001608|P1|COMPLETED|Overall Study||90
420621|NCT00811928|1001607|P2|STARTED|Overall Study||123
420622|NCT00811928|1001608|P1|STARTED|Overall Study||129
420623|NCT00811850|1001626|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
420624|NCT00811850|1001626|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
420625|NCT00811850|1001626|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
420626|NCT00811850|1001626|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
420627|NCT00811850|1001626|P1|COMPLETED|Treatment Period 2: Wash Out||15
420628|NCT00811850|1001626|P1|STARTED|Treatment Period 2: Wash Out||15
420629|NCT00811850|1001626|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
420630|NCT00811850|1001626|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
420631|NCT00811850|1001626|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
420632|NCT00811798|1001646|P1|NOT COMPLETED|Overall Study||0
420633|NCT00811798|1001646|P1|COMPLETED|Overall Study||92
420634|NCT00811798|1001646|P1|STARTED|Overall Study||92
420635|NCT00811733|1001652|P2|NOT COMPLETED|Overall Study||10
420636|NCT00811733|1001653|P1|NOT COMPLETED|Overall Study||11
420637|NCT00811733|1001652|P2|COMPLETED|Overall Study||12
420638|NCT00811733|1001653|P1|COMPLETED|Overall Study||4
420639|NCT00811733|1001652|P2|STARTED|Overall Study||22
420640|NCT00811733|1001653|P1|STARTED|Overall Study||15
420641|NCT00811720|1001701|P2|NOT COMPLETED|All Treated Patients||164
420642|NCT00811720|1001702|P1|NOT COMPLETED|All Treated Patients||96
420643|NCT00811720|1001701|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
420644|NCT00811720|1001702|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
420645|NCT00811720|1001701|P2|STARTED|All Treated Patients||302
420646|NCT00811720|1001702|P1|STARTED|All Treated Patients||296
420647|NCT00811720|1001701|P2|NOT COMPLETED|All Randomised Patients||4
420648|NCT00811720|1001702|P1|NOT COMPLETED|All Randomised Patients||2
420649|NCT00811720|1001701|P2|COMPLETED|All Randomised Patients||302
420650|NCT00811720|1001702|P1|COMPLETED|All Randomised Patients||296
420651|NCT00811720|1001701|P2|STARTED|All Randomised Patients||306
420652|NCT00811720|1001702|P1|STARTED|All Randomised Patients||298
420653|NCT00811655|1001720|P1|NOT COMPLETED|Overall Study||1
420654|NCT00811655|1001720|P1|COMPLETED|Overall Study||5
420655|NCT00811655|1001720|P1|STARTED|Overall Study||6
420656|NCT00811642|1001732|P1|NOT COMPLETED|Overall Study||15
420657|NCT00811642|1001732|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
420658|NCT00811642|1001732|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
420659|NCT00811590|1001742|P1|NOT COMPLETED|Overall Study||0
420660|NCT00811590|1001742|P1|COMPLETED|Overall Study||3
420661|NCT00811590|1001742|P1|STARTED|Overall Study||3
420662|NCT00811577|1001748|P2|NOT COMPLETED|Overall Study||1
420663|NCT00811577|1001749|P1|NOT COMPLETED|Overall Study||10
420664|NCT00811577|1001748|P2|COMPLETED|Overall Study||23
420665|NCT00811577|1001749|P1|COMPLETED|Overall Study||116
420666|NCT00811577|1001748|P2|STARTED|Overall Study||24
420667|NCT00811577|1001749|P1|STARTED|Overall Study||126
420668|NCT00811564|1001800|P2|NOT COMPLETED|Overall Study||2
420669|NCT00811564|1001801|P1|NOT COMPLETED|Overall Study||9
420670|NCT00811564|1001800|P2|COMPLETED|Overall Study||73
420671|NCT00811564|1001801|P1|COMPLETED|Overall Study||64
420672|NCT00811564|1001800|P2|STARTED|Overall Study||75
420673|NCT00811564|1001801|P1|STARTED|Overall Study||73
420674|NCT00811473|1001809|P2|NOT COMPLETED|Overall Study||26
420675|NCT00811473|1001810|P1|NOT COMPLETED|Overall Study||23
420676|NCT00811473|1001809|P2|COMPLETED|Overall Study||74
420677|NCT00811473|1001810|P1|COMPLETED|Overall Study||70
420678|NCT00811473|1001809|P2|STARTED|Overall Study||100
420679|NCT00811473|1001810|P1|STARTED|Overall Study||93
420680|NCT00811434|1001826|P2|NOT COMPLETED|Second Intervention||0
420681|NCT00811434|1001827|P1|NOT COMPLETED|Second Intervention||0
420682|NCT00811434|1001826|P2|COMPLETED|Second Intervention||5
420683|NCT00811434|1001827|P1|COMPLETED|Second Intervention||4
420684|NCT00811434|1001826|P2|STARTED|Second Intervention||5
420685|NCT00811434|1001827|P1|STARTED|Second Intervention||4
420686|NCT00811434|1001826|P2|NOT COMPLETED|Washout (1 Month)||0
420687|NCT00811434|1001827|P1|NOT COMPLETED|Washout (1 Month)||0
420688|NCT00811434|1001826|P2|COMPLETED|Washout (1 Month)||5
420689|NCT00811434|1001827|P1|COMPLETED|Washout (1 Month)||4
420690|NCT00811434|1001826|P2|STARTED|Washout (1 Month)||5
420691|NCT00811434|1001827|P1|STARTED|Washout (1 Month)||4
420692|NCT00811434|1001826|P2|NOT COMPLETED|First Intervention||0
420693|NCT00811434|1001827|P1|NOT COMPLETED|First Intervention||3
420694|NCT00811434|1001826|P2|COMPLETED|First Intervention||5
420695|NCT00811434|1001827|P1|COMPLETED|First Intervention||4
420696|NCT00811434|1001826|P2|STARTED|First Intervention||5
420697|NCT00811434|1001827|P1|STARTED|First Intervention||7
420698|NCT00811395|1001841|P6|NOT COMPLETED|Extension Treatment||2
420699|NCT00811395|1001842|P5|NOT COMPLETED|Extension Treatment||0
420700|NCT00811395|1001843|P4|NOT COMPLETED|Extension Treatment||3
420701|NCT00811395|1001844|P3|NOT COMPLETED|Extension Treatment||3
420702|NCT00811395|1001845|P2|NOT COMPLETED|Extension Treatment||6
420703|NCT00811395|1001846|P1|NOT COMPLETED|Extension Treatment||2
420704|NCT00811395|1001841|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
420705|NCT00811395|1001842|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
420706|NCT00811395|1001843|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
420707|NCT00811395|1001844|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
420708|NCT00811395|1001845|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
420709|NCT00811395|1001846|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
420710|NCT00811395|1001841|P6|STARTED|Extension Treatment|continued initial treatment|29
420711|NCT00811395|1001842|P5|STARTED|Extension Treatment|continued initial treatment|30
420712|NCT00811395|1001843|P4|STARTED|Extension Treatment|continued initial treatment|37
420713|NCT00811395|1001844|P3|STARTED|Extension Treatment|continued initial treatment|27
420714|NCT00811395|1001845|P2|STARTED|Extension Treatment|continued initial treatment|28
420715|NCT00811395|1001846|P1|STARTED|Extension Treatment|continued initial treatment|31
420716|NCT00811395|1001841|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
420717|NCT00811395|1001842|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
420718|NCT00811395|1001843|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
420719|NCT00811395|1001844|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
420720|NCT00811395|1001845|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
420721|NCT00811395|1001846|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
420722|NCT00811395|1001841|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
420723|NCT00811395|1001842|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
420724|NCT00811395|1001843|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
420725|NCT00811395|1001844|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
420813|NCT00810693|1002129|P3|NOT COMPLETED|Treatment Period||16
420726|NCT00811395|1001845|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
420727|NCT00811395|1001846|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
420728|NCT00811395|1001841|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
420729|NCT00811395|1001842|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
420730|NCT00811395|1001843|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
420731|NCT00811395|1001844|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
420732|NCT00811395|1001845|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
420733|NCT00811395|1001846|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
420734|NCT00811382|1001910|P2|NOT COMPLETED|Overall Study||0
420735|NCT00811382|1001911|P1|NOT COMPLETED|Overall Study||0
420736|NCT00811382|1001910|P2|COMPLETED|Overall Study||75
420737|NCT00811382|1001911|P1|COMPLETED|Overall Study||88
420738|NCT00811382|1001910|P2|STARTED|Overall Study||75
420739|NCT00811382|1001911|P1|STARTED|Overall Study||88
420740|NCT00811252|1001926|P3|NOT COMPLETED|Overall Study||23
420741|NCT00811252|1001927|P2|NOT COMPLETED|Overall Study||20
420742|NCT00811252|1001928|P1|NOT COMPLETED|Overall Study||17
420743|NCT00811252|1001926|P3|COMPLETED|Overall Study||128
420744|NCT00811252|1001927|P2|COMPLETED|Overall Study||136
420745|NCT00811252|1001928|P1|COMPLETED|Overall Study||128
420746|NCT00811252|1001926|P3|STARTED|Overall Study||151
420747|NCT00811252|1001927|P2|STARTED|Overall Study||156
420748|NCT00811252|1001928|P1|STARTED|Overall Study||145
420749|NCT00811135|1001972|P1|NOT COMPLETED|Overall Study||88
420750|NCT00811135|1001972|P1|COMPLETED|Overall Study||0
420751|NCT00811135|1001972|P1|STARTED|Overall Study||88
420752|NCT00811070|1001990|P6|NOT COMPLETED|Overall Study||1
420753|NCT00811070|1001991|P5|NOT COMPLETED|Overall Study||5
420754|NCT00811070|1001992|P4|NOT COMPLETED|Overall Study||2
420755|NCT00811070|1001993|P3|NOT COMPLETED|Overall Study||0
420756|NCT00811070|1001994|P2|NOT COMPLETED|Overall Study||1
420757|NCT00811070|1001995|P1|NOT COMPLETED|Overall Study||1
420758|NCT00811070|1001990|P6|COMPLETED|Overall Study||10
420759|NCT00811070|1001991|P5|COMPLETED|Overall Study||2
420760|NCT00811070|1001992|P4|COMPLETED|Overall Study||26
420761|NCT00811070|1001993|P3|COMPLETED|Overall Study||3
420762|NCT00811070|1001994|P2|COMPLETED|Overall Study||6
420763|NCT00811070|1001995|P1|COMPLETED|Overall Study||6
420764|NCT00811070|1001990|P6|STARTED|Overall Study||11
420765|NCT00811070|1001991|P5|STARTED|Overall Study||7
420766|NCT00811070|1001992|P4|STARTED|Overall Study||28
420767|NCT00811070|1001993|P3|STARTED|Overall Study||3
420768|NCT00811070|1001994|P2|STARTED|Overall Study||7
420769|NCT00811070|1001995|P1|STARTED|Overall Study||7
420770|NCT00811057|1002055|P3|NOT COMPLETED|Overall Study||10
420771|NCT00811057|1002056|P2|NOT COMPLETED|Overall Study||10
420772|NCT00811057|1002057|P1|NOT COMPLETED|Overall Study||5
420773|NCT00811057|1002055|P3|COMPLETED|Overall Study||87
420774|NCT00811057|1002056|P2|COMPLETED|Overall Study||104
420775|NCT00811057|1002057|P1|COMPLETED|Overall Study||85
420776|NCT00811057|1002055|P3|STARTED|Overall Study||97
420777|NCT00811057|1002056|P2|STARTED|Overall Study||114
420778|NCT00811057|1002057|P1|STARTED|Overall Study||90
420779|NCT00811018|1002068|P1|NOT COMPLETED|Overall Study||968
420780|NCT00811018|1002068|P1|COMPLETED|Overall Study||224
420781|NCT00811018|1002068|P1|STARTED|Overall Study||1192
420782|NCT00810901|1002086|P2|NOT COMPLETED|Overall Study||58
420783|NCT00810901|1002087|P1|NOT COMPLETED|Overall Study||88
420784|NCT00810901|1002086|P2|COMPLETED|Overall Study||118
420785|NCT00810901|1002087|P1|COMPLETED|Overall Study||165
420786|NCT00810901|1002086|P2|6-month Follow-up|Overall Study||122
420787|NCT00810901|1002087|P1|6-month Follow-up|Overall Study||181
420788|NCT00810901|1002086|P2|1-month Follow up|Overall Study||146
420789|NCT00810901|1002087|P1|1-month Follow up|Overall Study||242
420790|NCT00810901|1002086|P2|STARTED|Overall Study||176
420791|NCT00810901|1002087|P1|STARTED|Overall Study||253
420792|NCT00810771|1002098|P3|NOT COMPLETED|Overall Study||0
420793|NCT00810771|1002099|P2|NOT COMPLETED|Overall Study||0
420794|NCT00810771|1002100|P1|NOT COMPLETED|Overall Study||0
420795|NCT00810771|1002098|P3|COMPLETED|Overall Study||84
420796|NCT00810771|1002099|P2|COMPLETED|Overall Study||234
420797|NCT00810771|1002100|P1|COMPLETED|Overall Study||232
420798|NCT00810771|1002098|P3|STARTED|Overall Study||84
420799|NCT00810771|1002099|P2|STARTED|Overall Study||234
420800|NCT00810771|1002100|P1|STARTED|Overall Study||232
420801|NCT00810719|1002120|P1|NOT COMPLETED|Overall Study||0
420802|NCT00810719|1002120|P1|COMPLETED|Overall Study||30
420803|NCT00810719|1002120|P1|STARTED|Overall Study||30
420804|NCT00810693|1002129|P3|NOT COMPLETED|Follow-up Period (FUP)||4
420805|NCT00810693|1002130|P2|NOT COMPLETED|Follow-up Period (FUP)||3
420806|NCT00810693|1002131|P1|NOT COMPLETED|Follow-up Period (FUP)||8
420807|NCT00810693|1002129|P3|COMPLETED|Follow-up Period (FUP)||12
420808|NCT00810693|1002130|P2|COMPLETED|Follow-up Period (FUP)||4
420809|NCT00810693|1002131|P1|COMPLETED|Follow-up Period (FUP)||15
420810|NCT00810693|1002129|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
420811|NCT00810693|1002130|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
420812|NCT00810693|1002131|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
420814|NCT00810693|1002130|P2|NOT COMPLETED|Treatment Period||7
420815|NCT00810693|1002131|P1|NOT COMPLETED|Treatment Period||17
420816|NCT00810693|1002129|P3|COMPLETED|Treatment Period||111
420817|NCT00810693|1002130|P2|COMPLETED|Treatment Period||57
420818|NCT00810693|1002131|P1|COMPLETED|Treatment Period||237
420819|NCT00810693|1002129|P3|Participants Received Treatment|Treatment Period||126
420820|NCT00810693|1002130|P2|Participants Received Treatment|Treatment Period||63
420821|NCT00810693|1002131|P1|Participants Received Treatment|Treatment Period||254
420822|NCT00810693|1002129|P3|STARTED|Treatment Period|1 randomized but not treated|127
420823|NCT00810693|1002130|P2|STARTED|Treatment Period|1 randomized but not treated|64
420824|NCT00810693|1002131|P1|STARTED|Treatment Period||254
420825|NCT00810641|1002163|P3|NOT COMPLETED|Overall Study||2
420826|NCT00810641|1002164|P2|NOT COMPLETED|Overall Study||1
420827|NCT00810641|1002165|P1|NOT COMPLETED|Overall Study||0
420828|NCT00810641|1002163|P3|COMPLETED|Overall Study||49
420829|NCT00810641|1002164|P2|COMPLETED|Overall Study||53
420830|NCT00810641|1002165|P1|COMPLETED|Overall Study||52
420831|NCT00810641|1002163|P3|STARTED|Overall Study||51
420832|NCT00810641|1002164|P2|STARTED|Overall Study||54
420833|NCT00810641|1002165|P1|STARTED|Overall Study||52
420834|NCT00810602|1002173|P2|NOT COMPLETED|Overall Study||3
420835|NCT00810602|1002174|P1|NOT COMPLETED|Overall Study||8
420836|NCT00810602|1002173|P2|COMPLETED|Overall Study||31
420837|NCT00810602|1002174|P1|COMPLETED|Overall Study||19
420838|NCT00810602|1002173|P2|STARTED|Overall Study||34
420839|NCT00810602|1002174|P1|STARTED|Overall Study||27
420840|NCT00810576|1002181|P1|NOT COMPLETED|Overall Study||0
420841|NCT00810576|1002181|P1|COMPLETED|Overall Study||1
420842|NCT00810576|1002181|P1|STARTED|Overall Study||1
420843|NCT00810511|1002187|P2|NOT COMPLETED|Overall Study||4
420844|NCT00810511|1002188|P1|NOT COMPLETED|Overall Study||10
420845|NCT00810511|1002187|P2|COMPLETED|Overall Study||102
420846|NCT00810511|1002188|P1|COMPLETED|Overall Study||97
420847|NCT00810511|1002187|P2|STARTED|Overall Study||106
420848|NCT00810511|1002188|P1|STARTED|Overall Study||107
420849|NCT00810394|1002194|P1|NOT COMPLETED|Overall Study||3
420850|NCT00810394|1002194|P1|COMPLETED|Overall Study||47
420851|NCT00810394|1002194|P1|Cycle 3 400mg Twice Daily|Overall Study||5
420852|NCT00810394|1002194|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
420853|NCT00810394|1002194|P1|Cycle 2 400mg Once Daily|Overall Study||22
420854|NCT00810394|1002194|P1|Cycle 2 600mg Twice Daily|Overall Study||13
420855|NCT00810394|1002194|P1|STARTED|Overall Study||50
420856|NCT00810368|1002202|P2|NOT COMPLETED|Overall Study||2
420857|NCT00810368|1002203|P1|NOT COMPLETED|Overall Study||6
420858|NCT00810368|1002202|P2|COMPLETED|Overall Study||13
420859|NCT00810368|1002203|P1|COMPLETED|Overall Study||12
420860|NCT00810368|1002202|P2|STARTED|Overall Study||15
420861|NCT00810368|1002203|P1|STARTED|Overall Study||18
420862|NCT00810355|1002224|P3|NOT COMPLETED|Overall Study||11
420863|NCT00810355|1002225|P2|NOT COMPLETED|Overall Study||17
420864|NCT00810355|1002226|P1|NOT COMPLETED|Overall Study||14
420865|NCT00810355|1002224|P3|COMPLETED|Overall Study||14
420866|NCT00810355|1002225|P2|COMPLETED|Overall Study||8
420867|NCT00810355|1002226|P1|COMPLETED|Overall Study||11
420868|NCT00810355|1002224|P3|STARTED|Overall Study||25
420869|NCT00810355|1002225|P2|STARTED|Overall Study||25
420870|NCT00810355|1002226|P1|STARTED|Overall Study||25
420871|NCT00810342|1002242|P2|NOT COMPLETED|12-month Followup||11
420872|NCT00810342|1002243|P1|NOT COMPLETED|12-month Followup||12
420873|NCT00810342|1002242|P2|COMPLETED|12-month Followup||136
420874|NCT00810342|1002243|P1|COMPLETED|12-month Followup||113
420875|NCT00810342|1002242|P2|STARTED|12-month Followup||147
420876|NCT00810342|1002243|P1|STARTED|12-month Followup||125
420877|NCT00810342|1002242|P2|NOT COMPLETED|6-month Follow-up||8
420878|NCT00810342|1002243|P1|NOT COMPLETED|6-month Follow-up||24
420879|NCT00810342|1002242|P2|COMPLETED|6-month Follow-up||147
420880|NCT00810342|1002243|P1|COMPLETED|6-month Follow-up||125
420881|NCT00810342|1002242|P2|STARTED|6-month Follow-up||155
420882|NCT00810342|1002243|P1|STARTED|6-month Follow-up||149
420883|NCT00810342|1002242|P2|NOT COMPLETED|Month 1 Follow-up||2
420884|NCT00810342|1002243|P1|NOT COMPLETED|Month 1 Follow-up||5
420885|NCT00810342|1002242|P2|COMPLETED|Month 1 Follow-up||155
420886|NCT00810342|1002243|P1|COMPLETED|Month 1 Follow-up||149
420887|NCT00810342|1002242|P2|STARTED|Month 1 Follow-up||157
420888|NCT00810342|1002243|P1|STARTED|Month 1 Follow-up||154
420889|NCT00810303|1002251|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
420890|NCT00810303|1002251|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
420891|NCT00810303|1002251|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
420892|NCT00810303|1002251|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
420893|NCT00810303|1002251|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
420894|NCT00810303|1002251|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
420895|NCT00810303|1002251|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
420896|NCT00810303|1002251|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
420897|NCT00810303|1002251|P1|STARTED|Ezetimibe Alone - Day 6-15||12
420898|NCT00810303|1002251|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
420899|NCT00810303|1002251|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
420900|NCT00810303|1002251|P1|STARTED|Efavirenz Alone - Day 1-5||12
420901|NCT00810277|1002276|P1|NOT COMPLETED|Overall Study||1
420902|NCT00810277|1002276|P1|COMPLETED|Overall Study||13
420903|NCT00810277|1002276|P1|STARTED|Overall Study||14
420904|NCT00810199|1002291|P2|NOT COMPLETED|Overall Study||82
420905|NCT00810199|1002292|P1|NOT COMPLETED|Overall Study||59
420906|NCT00810199|1002291|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
420907|NCT00810199|1002292|P1|COMPLETED|Overall Study||220
420908|NCT00810199|1002291|P2|Completed Week 104|Overall Study||201
420909|NCT00810199|1002292|P1|Completed Week 104|Overall Study||222
420910|NCT00810199|1002291|P2|Completed Week 52|Overall Study||229
420911|NCT00810199|1002292|P1|Completed Week 52|Overall Study||243
420912|NCT00810199|1002291|P2|Completed Week 24|Overall Study||250
420913|NCT00810199|1002292|P1|Completed Week 24|Overall Study||259
420914|NCT00810199|1002291|P2|Received Study Drug|Overall Study||276
420915|NCT00810199|1002292|P1|Received Study Drug|Overall Study||277
420916|NCT00810199|1002291|P2|STARTED|Overall Study||277
420917|NCT00810199|1002292|P1|STARTED|Overall Study||279
420918|NCT00810108|1002370|P2|NOT COMPLETED|Overall Study||0
420919|NCT00810108|1002371|P1|NOT COMPLETED|Overall Study||1
420920|NCT00810108|1002370|P2|COMPLETED|Overall Study||7
420921|NCT00810108|1002371|P1|COMPLETED|Overall Study||5
420922|NCT00810108|1002370|P2|STARTED|Overall Study||7
420923|NCT00810108|1002371|P1|STARTED|Overall Study||6
420924|NCT00810095|1002376|P1|NOT COMPLETED|Overall Study||0
420925|NCT00810095|1002376|P1|COMPLETED|Overall Study||40
420926|NCT00810095|1002376|P1|STARTED|Overall Study||40
420927|NCT00810082|1002385|P2|NOT COMPLETED|Overall Study||4
420928|NCT00810082|1002386|P1|NOT COMPLETED|Overall Study||0
420929|NCT00810082|1002385|P2|COMPLETED|Overall Study||27
420930|NCT00810082|1002386|P1|COMPLETED|Overall Study||34
420931|NCT00810082|1002385|P2|STARTED|Overall Study||31
420932|NCT00810082|1002386|P1|STARTED|Overall Study||34
420933|NCT00810069|1002394|P3|NOT COMPLETED|Double-Blind Period II||72
420934|NCT00810069|1002395|P2|NOT COMPLETED|Double-Blind Period II||56
420935|NCT00810069|1002396|P1|NOT COMPLETED|Double-Blind Period II||0
420936|NCT00810069|1002394|P3|COMPLETED|Double-Blind Period II||212
420937|NCT00810069|1002395|P2|COMPLETED|Double-Blind Period II||226
420938|NCT00810069|1002396|P1|COMPLETED|Double-Blind Period II||0
420939|NCT00810069|1002394|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
420940|NCT00810069|1002395|P2|STARTED|Double-Blind Period II||282
420941|NCT00810069|1002396|P1|STARTED|Double-Blind Period II||0
420942|NCT00810069|1002394|P3|NOT COMPLETED|Lead-in Period I||0
420943|NCT00810069|1002395|P2|NOT COMPLETED|Lead-in Period I||0
420944|NCT00810069|1002396|P1|NOT COMPLETED|Lead-in Period I||274
420945|NCT00810069|1002394|P3|COMPLETED|Lead-in Period I||0
420946|NCT00810069|1002395|P2|COMPLETED|Lead-in Period I||0
420947|NCT00810069|1002396|P1|COMPLETED|Lead-in Period I||566
420948|NCT00810069|1002394|P3|STARTED|Lead-in Period I||0
420949|NCT00810069|1002395|P2|STARTED|Lead-in Period I||0
420950|NCT00810069|1002396|P1|STARTED|Lead-in Period I||840
420951|NCT00810043|1002441|P3|NOT COMPLETED|Overall Study||8
420952|NCT00810043|1002442|P2|NOT COMPLETED|Overall Study||1
420953|NCT00810043|1002443|P1|NOT COMPLETED|Overall Study||4
420954|NCT00810043|1002441|P3|COMPLETED|Overall Study||0
420955|NCT00810043|1002442|P2|COMPLETED|Overall Study||54
420956|NCT00810043|1002443|P1|COMPLETED|Overall Study||53
420957|NCT00810043|1002441|P3|STARTED|Overall Study||8
420958|NCT00810043|1002442|P2|STARTED|Overall Study||55
420959|NCT00810043|1002443|P1|STARTED|Overall Study||57
420960|NCT00809965|1002465|P3|NOT COMPLETED|Overall Study||844
420961|NCT00809965|1002466|P2|NOT COMPLETED|Overall Study||775
420962|NCT00809965|1002467|P1|NOT COMPLETED|Overall Study||783
420963|NCT00809965|1002465|P3|COMPLETED|Overall Study||4332
420964|NCT00809965|1002466|P2|COMPLETED|Overall Study||4399
420965|NCT00809965|1002467|P1|COMPLETED|Overall Study||4393
420966|NCT00809965|1002465|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
420967|NCT00809965|1002466|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
420968|NCT00809965|1002467|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
420969|NCT00809965|1002465|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
421062|NCT00809445|1002743|P1|STARTED|6 Month Follow-up||429
420970|NCT00809965|1002466|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
420971|NCT00809965|1002467|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
420972|NCT00809965|1002465|P3|STARTED|Overall Study||5176
420973|NCT00809965|1002466|P2|STARTED|Overall Study||5174
420974|NCT00809965|1002467|P1|STARTED|Overall Study||5176
420975|NCT00809926|1002489|P2|NOT COMPLETED|Overall Study||23
420976|NCT00809926|1002490|P1|NOT COMPLETED|Overall Study||31
420977|NCT00809926|1002489|P2|COMPLETED|Overall Study||196
420978|NCT00809926|1002490|P1|COMPLETED|Overall Study||201
420979|NCT00809926|1002489|P2|STARTED|Overall Study||219
420980|NCT00809926|1002490|P1|STARTED|Overall Study||232
420981|NCT00809848|1002519|P5|NOT COMPLETED|Overall Study||3
420982|NCT00809848|1002520|P4|NOT COMPLETED|Overall Study||1
420983|NCT00809848|1002521|P3|NOT COMPLETED|Overall Study||0
420984|NCT00809848|1002522|P2|NOT COMPLETED|Overall Study||0
420985|NCT00809848|1002523|P1|NOT COMPLETED|Overall Study||0
420986|NCT00809848|1002519|P5|COMPLETED|Overall Study||34
420987|NCT00809848|1002520|P4|COMPLETED|Overall Study||30
420988|NCT00809848|1002521|P3|COMPLETED|Overall Study||34
420989|NCT00809848|1002522|P2|COMPLETED|Overall Study||34
420990|NCT00809848|1002523|P1|COMPLETED|Overall Study||36
420991|NCT00809848|1002519|P5|STARTED|Overall Study||37
420992|NCT00809848|1002520|P4|STARTED|Overall Study||31
420993|NCT00809848|1002521|P3|STARTED|Overall Study||34
420994|NCT00809848|1002522|P2|STARTED|Overall Study||34
420995|NCT00809848|1002523|P1|STARTED|Overall Study||36
420996|NCT00809835|1002544|P4|NOT COMPLETED|Overall Study||2
420997|NCT00809835|1002545|P3|NOT COMPLETED|Overall Study||11
420998|NCT00809835|1002546|P2|NOT COMPLETED|Overall Study||7
420999|NCT00809835|1002547|P1|NOT COMPLETED|Overall Study||8
421000|NCT00809835|1002544|P4|COMPLETED|Overall Study||25
421001|NCT00809835|1002545|P3|COMPLETED|Overall Study||27
421002|NCT00809835|1002546|P2|COMPLETED|Overall Study||20
421003|NCT00809835|1002547|P1|COMPLETED|Overall Study||20
421004|NCT00809835|1002544|P4|STARTED|Overall Study||27
421005|NCT00809835|1002545|P3|STARTED|Overall Study||38
421006|NCT00809835|1002546|P2|STARTED|Overall Study||27
421007|NCT00809835|1002547|P1|STARTED|Overall Study||28
421008|NCT00809809|1002567|P2|NOT COMPLETED|Overall Study||2
421009|NCT00809809|1002568|P1|NOT COMPLETED|Overall Study||3
421010|NCT00809809|1002567|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
421011|NCT00809809|1002568|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
421012|NCT00809809|1002567|P2|STARTED|Overall Study||79
421013|NCT00809809|1002568|P1|STARTED|Overall Study||78
421014|NCT00809757|1002577|P3|NOT COMPLETED|Overall Study||11
421015|NCT00809757|1002578|P2|NOT COMPLETED|Overall Study||5
421016|NCT00809757|1002579|P1|NOT COMPLETED|Overall Study||6
421017|NCT00809757|1002577|P3|COMPLETED|Overall Study||53
421018|NCT00809757|1002578|P2|COMPLETED|Overall Study||60
421019|NCT00809757|1002579|P1|COMPLETED|Overall Study||62
421020|NCT00809757|1002577|P3|STARTED|Overall Study||64
421021|NCT00809757|1002578|P2|STARTED|Overall Study||65
421022|NCT00809757|1002579|P1|STARTED|Overall Study||68
421023|NCT00809614|1002664|P2|NOT COMPLETED|Overall Study||4
421024|NCT00809614|1002665|P1|NOT COMPLETED|Overall Study||3
421025|NCT00809614|1002664|P2|COMPLETED|Overall Study||10
421026|NCT00809614|1002665|P1|COMPLETED|Overall Study||25
421027|NCT00809614|1002664|P2|Pharmacodynamic (PD) Set|Overall Study||13
421028|NCT00809614|1002665|P1|Pharmacodynamic (PD) Set|Overall Study||24
421029|NCT00809614|1002664|P2|Pharmacokinetic Safety Set|Overall Study||14
421030|NCT00809614|1002665|P1|Pharmacokinetic Safety Set|Overall Study||27
421031|NCT00809614|1002664|P2|STARTED|Overall Study||14
421032|NCT00809614|1002665|P1|STARTED|Overall Study||28
421033|NCT00809523|1002695|P2|NOT COMPLETED|Overall Study||4
421034|NCT00809523|1002696|P1|NOT COMPLETED|Overall Study||7
421035|NCT00809523|1002695|P2|COMPLETED|Overall Study||48
421036|NCT00809523|1002696|P1|COMPLETED|Overall Study||47
421037|NCT00809523|1002695|P2|STARTED|Overall Study||52
421038|NCT00809523|1002696|P1|STARTED|Overall Study||54
421039|NCT00809471|1002709|P3|NOT COMPLETED|Overall Study||17
421040|NCT00809471|1002710|P2|NOT COMPLETED|Overall Study||20
421041|NCT00809471|1002711|P1|NOT COMPLETED|Overall Study||20
421042|NCT00809471|1002709|P3|COMPLETED|Overall Study||114
421043|NCT00809471|1002710|P2|COMPLETED|Overall Study||109
421044|NCT00809471|1002711|P1|COMPLETED|Overall Study||110
421045|NCT00809471|1002709|P3|STARTED|Overall Study||131
421046|NCT00809471|1002710|P2|STARTED|Overall Study||129
421047|NCT00809471|1002711|P1|STARTED|Overall Study||130
421048|NCT00809458|1002727|P2|NOT COMPLETED|Overall Study||1
421049|NCT00809458|1002728|P1|NOT COMPLETED|Overall Study||1
421050|NCT00809458|1002727|P2|COMPLETED|Overall Study||5
421051|NCT00809458|1002728|P1|COMPLETED|Overall Study||8
421052|NCT00809458|1002727|P2|STARTED|Overall Study||6
421053|NCT00809458|1002728|P1|STARTED|Overall Study||9
421054|NCT00809445|1002741|P3|NOT COMPLETED|6 Month Follow-up||24
421055|NCT00809445|1002742|P2|NOT COMPLETED|6 Month Follow-up||23
421056|NCT00809445|1002743|P1|NOT COMPLETED|6 Month Follow-up||24
421057|NCT00809445|1002741|P3|COMPLETED|6 Month Follow-up||395
421058|NCT00809445|1002742|P2|COMPLETED|6 Month Follow-up||410
421059|NCT00809445|1002743|P1|COMPLETED|6 Month Follow-up||405
421060|NCT00809445|1002741|P3|STARTED|6 Month Follow-up||419
421061|NCT00809445|1002742|P2|STARTED|6 Month Follow-up||433
421063|NCT00809445|1002741|P3|NOT COMPLETED|1 Month Follow-up||4
421064|NCT00809445|1002742|P2|NOT COMPLETED|1 Month Follow-up||4
421065|NCT00809445|1002743|P1|NOT COMPLETED|1 Month Follow-up||2
421066|NCT00809445|1002741|P3|COMPLETED|1 Month Follow-up||415
421067|NCT00809445|1002742|P2|COMPLETED|1 Month Follow-up||429
421068|NCT00809445|1002743|P1|COMPLETED|1 Month Follow-up||427
421069|NCT00809445|1002741|P3|STARTED|1 Month Follow-up||419
421070|NCT00809445|1002742|P2|STARTED|1 Month Follow-up||433
421071|NCT00809445|1002743|P1|STARTED|1 Month Follow-up||429
421072|NCT00809328|1002760|P1|NOT COMPLETED|Overall Study||29
421073|NCT00809328|1002760|P1|COMPLETED|Overall Study||73
421074|NCT00809328|1002760|P1|STARTED|Overall Study||102
421075|NCT00809276|1002768|P1|NOT COMPLETED|Overall Study||0
421076|NCT00809276|1002768|P1|COMPLETED|Overall Study||92
421077|NCT00809276|1002768|P1|STARTED|Overall Study||92
421078|NCT00809185|1002772|P1|NOT COMPLETED|Overall Study||0
421079|NCT00809185|1002772|P1|COMPLETED|Overall Study||7
421080|NCT00809185|1002772|P1|STARTED|Overall Study||7
421081|NCT00809159|1002780|P6|NOT COMPLETED|Part 1 and 2||3
421082|NCT00809159|1002781|P5|NOT COMPLETED|Part 1 and 2||6
421083|NCT00809159|1002782|P4|NOT COMPLETED|Part 1 and 2||5
421084|NCT00809159|1002783|P3|NOT COMPLETED|Part 1 and 2||10
421085|NCT00809159|1002784|P2|NOT COMPLETED|Part 1 and 2||0
421086|NCT00809159|1002785|P1|NOT COMPLETED|Part 1 and 2||0
421087|NCT00809159|1002780|P6|COMPLETED|Part 1 and 2||3
421088|NCT00809159|1002781|P5|COMPLETED|Part 1 and 2||6
421089|NCT00809159|1002782|P4|COMPLETED|Part 1 and 2||7
421090|NCT00809159|1002783|P3|COMPLETED|Part 1 and 2||20
421091|NCT00809159|1002784|P2|COMPLETED|Part 1 and 2||0
421092|NCT00809159|1002785|P1|COMPLETED|Part 1 and 2||0
421093|NCT00809159|1002780|P6|PD Analysis Set|Part 1 and 2||6
421094|NCT00809159|1002781|P5|PD Analysis Set|Part 1 and 2||12
421095|NCT00809159|1002782|P4|PD Analysis Set|Part 1 and 2||12
421096|NCT00809159|1002783|P3|PD Analysis Set|Part 1 and 2||28
421097|NCT00809159|1002784|P2|PD Analysis Set|Part 1 and 2||0
421098|NCT00809159|1002785|P1|PD Analysis Set|Part 1 and 2||0
421099|NCT00809159|1002780|P6|PK Analysis Set|Part 1 and 2||6
421100|NCT00809159|1002781|P5|PK Analysis Set|Part 1 and 2||12
421101|NCT00809159|1002782|P4|PK Analysis Set|Part 1 and 2||12
421102|NCT00809159|1002783|P3|PK Analysis Set|Part 1 and 2||30
421103|NCT00809159|1002784|P2|PK Analysis Set|Part 1 and 2||0
421104|NCT00809159|1002785|P1|PK Analysis Set|Part 1 and 2||0
421105|NCT00809159|1002780|P6|STARTED|Part 1 and 2||6
421106|NCT00809159|1002781|P5|STARTED|Part 1 and 2||12
421107|NCT00809159|1002782|P4|STARTED|Part 1 and 2||12
421108|NCT00809159|1002783|P3|STARTED|Part 1 and 2||30
421109|NCT00809159|1002784|P2|STARTED|Part 1 and 2||0
421110|NCT00809159|1002785|P1|STARTED|Part 1 and 2||0
421111|NCT00809159|1002780|P6|NOT COMPLETED|Part 1||0
421112|NCT00809159|1002781|P5|NOT COMPLETED|Part 1||0
421113|NCT00809159|1002782|P4|NOT COMPLETED|Part 1||0
421114|NCT00809159|1002783|P3|NOT COMPLETED|Part 1||0
421115|NCT00809159|1002784|P2|NOT COMPLETED|Part 1||3
421116|NCT00809159|1002785|P1|NOT COMPLETED|Part 1||8
421117|NCT00809159|1002780|P6|COMPLETED|Part 1||0
421118|NCT00809159|1002781|P5|COMPLETED|Part 1||0
421119|NCT00809159|1002782|P4|COMPLETED|Part 1||0
421120|NCT00809159|1002783|P3|COMPLETED|Part 1||0
421121|NCT00809159|1002784|P2|COMPLETED|Part 1||3
421122|NCT00809159|1002785|P1|COMPLETED|Part 1||16
421123|NCT00809159|1002780|P6|PD Analysis Set|Part 1||0
421124|NCT00809159|1002781|P5|PD Analysis Set|Part 1||0
421125|NCT00809159|1002782|P4|PD Analysis Set|Part 1||0
421126|NCT00809159|1002783|P3|PD Analysis Set|Part 1||0
421127|NCT00809159|1002784|P2|PD Analysis Set|Part 1||6
421128|NCT00809159|1002785|P1|PD Analysis Set|Part 1||23
421129|NCT00809159|1002780|P6|PK Analysis Set|Part 1||0
421130|NCT00809159|1002781|P5|PK Analysis Set|Part 1||0
421131|NCT00809159|1002782|P4|PK Analysis Set|Part 1||0
421132|NCT00809159|1002783|P3|PK Analysis Set|Part 1||0
421133|NCT00809159|1002784|P2|PK Analysis Set|Part 1||6
421134|NCT00809159|1002785|P1|PK Analysis Set|Part 1||24
421135|NCT00809159|1002780|P6|STARTED|Part 1||0
421136|NCT00809159|1002781|P5|STARTED|Part 1||0
421137|NCT00809159|1002782|P4|STARTED|Part 1||0
421138|NCT00809159|1002783|P3|STARTED|Part 1||0
421139|NCT00809159|1002784|P2|STARTED|Part 1||6
421140|NCT00809159|1002785|P1|STARTED|Part 1||24
421141|NCT00809146|1002851|P2|NOT COMPLETED|Overall Study||0
421142|NCT00809146|1002852|P1|NOT COMPLETED|Overall Study||0
421143|NCT00809146|1002851|P2|COMPLETED|Overall Study||445
421144|NCT00809146|1002852|P1|COMPLETED|Overall Study||448
421145|NCT00809146|1002851|P2|STARTED|Overall Study||445
421146|NCT00809146|1002852|P1|STARTED|Overall Study||448
421147|NCT00809133|1002890|P14|NOT COMPLETED|Overall Study||7
421148|NCT00809133|1002891|P13|NOT COMPLETED|Overall Study||5
421149|NCT00809133|1002892|P12|NOT COMPLETED|Overall Study||8
421150|NCT00809133|1002893|P11|NOT COMPLETED|Overall Study||6
421151|NCT00809133|1002894|P10|NOT COMPLETED|Overall Study||9
421152|NCT00809133|1002895|P9|NOT COMPLETED|Overall Study||3
421153|NCT00809133|1002896|P8|NOT COMPLETED|Overall Study||8
421154|NCT00809133|1002897|P7|NOT COMPLETED|Overall Study||6
421155|NCT00809133|1002898|P6|NOT COMPLETED|Overall Study||7
421156|NCT00809133|1002899|P5|NOT COMPLETED|Overall Study||5
421157|NCT00809133|1002900|P4|NOT COMPLETED|Overall Study||3
421158|NCT00809133|1002901|P3|NOT COMPLETED|Overall Study||6
421159|NCT00809133|1002902|P2|NOT COMPLETED|Overall Study||7
421160|NCT00809133|1002903|P1|NOT COMPLETED|Overall Study||3
421161|NCT00809133|1002890|P14|COMPLETED|Overall Study||0
421162|NCT00809133|1002891|P13|COMPLETED|Overall Study||0
421163|NCT00809133|1002892|P12|COMPLETED|Overall Study||0
421164|NCT00809133|1002893|P11|COMPLETED|Overall Study||0
421165|NCT00809133|1002894|P10|COMPLETED|Overall Study||0
421166|NCT00809133|1002895|P9|COMPLETED|Overall Study||0
421167|NCT00809133|1002896|P8|COMPLETED|Overall Study||0
421168|NCT00809133|1002897|P7|COMPLETED|Overall Study||0
421169|NCT00809133|1002898|P6|COMPLETED|Overall Study||0
421170|NCT00809133|1002899|P5|COMPLETED|Overall Study||0
421171|NCT00809133|1002900|P4|COMPLETED|Overall Study||0
421172|NCT00809133|1002901|P3|COMPLETED|Overall Study||0
421173|NCT00809133|1002902|P2|COMPLETED|Overall Study||0
421174|NCT00809133|1002903|P1|COMPLETED|Overall Study||0
421175|NCT00809133|1002890|P14|STARTED|Overall Study||7
421176|NCT00809133|1002891|P13|STARTED|Overall Study||5
421177|NCT00809133|1002892|P12|STARTED|Overall Study||8
421178|NCT00809133|1002893|P11|STARTED|Overall Study||6
421179|NCT00809133|1002894|P10|STARTED|Overall Study||9
421180|NCT00809133|1002895|P9|STARTED|Overall Study||3
421181|NCT00809133|1002896|P8|STARTED|Overall Study||8
421182|NCT00809133|1002897|P7|STARTED|Overall Study||6
421183|NCT00809133|1002898|P6|STARTED|Overall Study||7
421184|NCT00809133|1002899|P5|STARTED|Overall Study||5
421185|NCT00809133|1002900|P4|STARTED|Overall Study||3
421186|NCT00809133|1002901|P3|STARTED|Overall Study||6
421187|NCT00809133|1002902|P2|STARTED|Overall Study||7
421188|NCT00809133|1002903|P1|STARTED|Overall Study||3
421189|NCT00809094|1003057|P2|NOT COMPLETED|Overall Study||1
421190|NCT00809094|1003058|P1|NOT COMPLETED|Overall Study||0
421191|NCT00809094|1003057|P2|COMPLETED|Overall Study||33
421192|NCT00809094|1003058|P1|COMPLETED|Overall Study||36
421193|NCT00809094|1003057|P2|STARTED|Overall Study||34
421194|NCT00809094|1003058|P1|STARTED|Overall Study||36
421195|NCT00809055|1003078|P2|NOT COMPLETED|Overall Study||7
421196|NCT00809055|1003079|P1|NOT COMPLETED|Overall Study||9
421197|NCT00809055|1003078|P2|COMPLETED|Overall Study||30
421198|NCT00809055|1003079|P1|COMPLETED|Overall Study||28
421199|NCT00809055|1003078|P2|STARTED|Overall Study||37
421200|NCT00809055|1003079|P1|STARTED|Overall Study||37
421201|NCT00808899|1003103|P1|NOT COMPLETED|Overall Study||4
421202|NCT00808899|1003103|P1|COMPLETED|Overall Study||0
421203|NCT00808899|1003103|P1|STARTED|Overall Study||4
421204|NCT00808834|1003107|P2|NOT COMPLETED|Period 2||0
421205|NCT00808834|1003108|P1|NOT COMPLETED|Period 2||0
421206|NCT00808834|1003107|P2|COMPLETED|Period 2||99
421207|NCT00808834|1003108|P1|COMPLETED|Period 2||97
421208|NCT00808834|1003107|P2|STARTED|Period 2||99
421209|NCT00808834|1003108|P1|STARTED|Period 2||97
421210|NCT00808834|1003107|P2|NOT COMPLETED|Period 1||0
421211|NCT00808834|1003108|P1|NOT COMPLETED|Period 1||0
421212|NCT00808834|1003107|P2|COMPLETED|Period 1||99
421213|NCT00808834|1003108|P1|COMPLETED|Period 1||97
421214|NCT00808834|1003107|P2|STARTED|Period 1||99
421215|NCT00808834|1003108|P1|STARTED|Period 1||97
421216|NCT00808808|1003117|P3|NOT COMPLETED|Overall Study||2557
421217|NCT00808808|1003118|P2|NOT COMPLETED|Overall Study||2437
421218|NCT00808808|1003119|P1|NOT COMPLETED|Overall Study||2817
421219|NCT00808808|1003117|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
421220|NCT00808808|1003118|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
421221|NCT00808808|1003119|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
421222|NCT00808808|1003117|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
421223|NCT00808808|1003118|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
421224|NCT00808808|1003119|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
421225|NCT00808808|1003117|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
421226|NCT00808808|1003118|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
421227|NCT00808808|1003119|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
421228|NCT00808769|1003145|P2|NOT COMPLETED|Second Intervention||0
421229|NCT00808769|1003146|P1|NOT COMPLETED|Second Intervention||0
421230|NCT00808769|1003145|P2|COMPLETED|Second Intervention||15
421231|NCT00808769|1003146|P1|COMPLETED|Second Intervention||15
421232|NCT00808769|1003145|P2|STARTED|Second Intervention||15
421233|NCT00808769|1003146|P1|STARTED|Second Intervention||15
421234|NCT00808769|1003145|P2|NOT COMPLETED|First Intervention||0
421235|NCT00808769|1003146|P1|NOT COMPLETED|First Intervention||0
421236|NCT00808769|1003145|P2|COMPLETED|First Intervention||15
421237|NCT00808769|1003146|P1|COMPLETED|First Intervention||15
421238|NCT00808769|1003145|P2|STARTED|First Intervention||15
421239|NCT00808769|1003146|P1|STARTED|First Intervention||15
421240|NCT00808639|1003152|P1|NOT COMPLETED|Overall Study||1
421241|NCT00808639|1003152|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
421242|NCT00808639|1003152|P1|STARTED|Overall Study||39
421243|NCT00808509|1003160|P2|NOT COMPLETED|Observation Phase||0
421244|NCT00808509|1003161|P1|NOT COMPLETED|Observation Phase||0
421245|NCT00808509|1003160|P2|COMPLETED|Observation Phase||15
421246|NCT00808509|1003161|P1|COMPLETED|Observation Phase||16
421247|NCT00808509|1003160|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
421248|NCT00808509|1003161|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
421249|NCT00808509|1003160|P2|NOT COMPLETED|Randomized Phase||5
421250|NCT00808509|1003161|P1|NOT COMPLETED|Randomized Phase||2
421251|NCT00808509|1003160|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
421252|NCT00808509|1003161|P1|COMPLETED|Randomized Phase||15
421253|NCT00808509|1003160|P2|Received Rescue Therapy|Randomized Phase||9
421254|NCT00808509|1003161|P1|Received Rescue Therapy|Randomized Phase||0
421255|NCT00808509|1003160|P2|STARTED|Randomized Phase||16
421256|NCT00808509|1003161|P1|STARTED|Randomized Phase||17
421257|NCT00808483|1003259|P2|NOT COMPLETED|From 5 Months to 12 Months||0
421258|NCT00808483|1003260|P1|NOT COMPLETED|From 5 Months to 12 Months||1
421259|NCT00808483|1003259|P2|COMPLETED|From 5 Months to 12 Months||32
421260|NCT00808483|1003260|P1|COMPLETED|From 5 Months to 12 Months||32
421261|NCT00808483|1003259|P2|STARTED|From 5 Months to 12 Months||32
421262|NCT00808483|1003260|P1|STARTED|From 5 Months to 12 Months||33
421263|NCT00808483|1003259|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
421264|NCT00808483|1003260|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
421265|NCT00808483|1003259|P2|COMPLETED|From 3 to 5 Months After Surgery||32
421266|NCT00808483|1003260|P1|COMPLETED|From 3 to 5 Months After Surgery||33
421267|NCT00808483|1003259|P2|STARTED|From 3 to 5 Months After Surgery||33
421268|NCT00808483|1003260|P1|STARTED|From 3 to 5 Months After Surgery||35
421269|NCT00808470|1003282|P2|NOT COMPLETED|Overall Study||0
421270|NCT00808470|1003283|P1|NOT COMPLETED|Overall Study||2
421271|NCT00808470|1003282|P2|COMPLETED|Overall Study||35
421272|NCT00808470|1003283|P1|COMPLETED|Overall Study||35
421273|NCT00808470|1003282|P2|STARTED|Overall Study||35
421274|NCT00808470|1003283|P1|STARTED|Overall Study||37
421275|NCT00808444|1003297|P2|NOT COMPLETED|Overall Study||1
421276|NCT00808444|1003298|P1|NOT COMPLETED|Overall Study||1
421277|NCT00808444|1003297|P2|COMPLETED|Overall Study||232
421278|NCT00808444|1003298|P1|COMPLETED|Overall Study||232
421279|NCT00808444|1003297|P2|STARTED|Overall Study||233
421280|NCT00808444|1003298|P1|STARTED|Overall Study||233
421281|NCT00808405|1003338|P2|NOT COMPLETED|Overall Study||0
421282|NCT00808405|1003339|P1|NOT COMPLETED|Overall Study||0
421283|NCT00808405|1003338|P2|COMPLETED|Overall Study||27
421284|NCT00808405|1003339|P1|COMPLETED|Overall Study||61
421285|NCT00808405|1003338|P2|STARTED|Overall Study||27
421286|NCT00808405|1003339|P1|STARTED|Overall Study||61
421287|NCT00808340|1003347|P6|NOT COMPLETED|Third Intervention||0
421288|NCT00808340|1003348|P5|NOT COMPLETED|Third Intervention||0
421289|NCT00808340|1003349|P4|NOT COMPLETED|Third Intervention||0
421290|NCT00808340|1003350|P3|NOT COMPLETED|Third Intervention||0
421291|NCT00808340|1003351|P2|NOT COMPLETED|Third Intervention||0
421292|NCT00808340|1003352|P1|NOT COMPLETED|Third Intervention||0
421293|NCT00808340|1003347|P6|COMPLETED|Third Intervention||6
421294|NCT00808340|1003348|P5|COMPLETED|Third Intervention||5
421295|NCT00808340|1003349|P4|COMPLETED|Third Intervention||3
421296|NCT00808340|1003350|P3|COMPLETED|Third Intervention||7
421297|NCT00808340|1003351|P2|COMPLETED|Third Intervention||9
421298|NCT00808340|1003352|P1|COMPLETED|Third Intervention||4
421299|NCT00808340|1003347|P6|STARTED|Third Intervention||6
421300|NCT00808340|1003348|P5|STARTED|Third Intervention||5
421301|NCT00808340|1003349|P4|STARTED|Third Intervention||3
421302|NCT00808340|1003350|P3|STARTED|Third Intervention||7
421303|NCT00808340|1003351|P2|STARTED|Third Intervention||9
421304|NCT00808340|1003352|P1|STARTED|Third Intervention||4
421305|NCT00808340|1003347|P6|NOT COMPLETED|Second Intervention||0
421306|NCT00808340|1003348|P5|NOT COMPLETED|Second Intervention||0
421307|NCT00808340|1003349|P4|NOT COMPLETED|Second Intervention||0
421308|NCT00808340|1003350|P3|NOT COMPLETED|Second Intervention||0
421309|NCT00808340|1003351|P2|NOT COMPLETED|Second Intervention||0
421310|NCT00808340|1003352|P1|NOT COMPLETED|Second Intervention||0
421311|NCT00808340|1003347|P6|COMPLETED|Second Intervention||6
421312|NCT00808340|1003348|P5|COMPLETED|Second Intervention||5
421313|NCT00808340|1003349|P4|COMPLETED|Second Intervention||3
421314|NCT00808340|1003350|P3|COMPLETED|Second Intervention||7
421315|NCT00808340|1003351|P2|COMPLETED|Second Intervention||9
421316|NCT00808340|1003352|P1|COMPLETED|Second Intervention||4
421317|NCT00808340|1003347|P6|STARTED|Second Intervention||6
421318|NCT00808340|1003348|P5|STARTED|Second Intervention||5
421319|NCT00808340|1003349|P4|STARTED|Second Intervention||3
421320|NCT00808340|1003350|P3|STARTED|Second Intervention||7
421321|NCT00808340|1003351|P2|STARTED|Second Intervention||9
421322|NCT00808340|1003352|P1|STARTED|Second Intervention||4
421323|NCT00808340|1003347|P6|NOT COMPLETED|First Intervention||0
421324|NCT00808340|1003348|P5|NOT COMPLETED|First Intervention||0
421325|NCT00808340|1003349|P4|NOT COMPLETED|First Intervention||0
421326|NCT00808340|1003350|P3|NOT COMPLETED|First Intervention||0
421327|NCT00808340|1003351|P2|NOT COMPLETED|First Intervention||0
421328|NCT00808340|1003352|P1|NOT COMPLETED|First Intervention||0
421329|NCT00808340|1003347|P6|COMPLETED|First Intervention||6
421330|NCT00808340|1003348|P5|COMPLETED|First Intervention||5
421331|NCT00808340|1003349|P4|COMPLETED|First Intervention||3
421332|NCT00808340|1003350|P3|COMPLETED|First Intervention||7
421333|NCT00808340|1003351|P2|COMPLETED|First Intervention||9
421334|NCT00808340|1003352|P1|COMPLETED|First Intervention||4
421335|NCT00808340|1003347|P6|STARTED|First Intervention||6
421336|NCT00808340|1003348|P5|STARTED|First Intervention||5
421337|NCT00808340|1003349|P4|STARTED|First Intervention||3
421338|NCT00808340|1003350|P3|STARTED|First Intervention||7
421339|NCT00808340|1003351|P2|STARTED|First Intervention||9
421340|NCT00808340|1003352|P1|STARTED|First Intervention||4
421341|NCT00808249|1003373|P4|NOT COMPLETED|Overall Study||16
421342|NCT00808249|1003374|P3|NOT COMPLETED|Overall Study||22
421343|NCT00808249|1003375|P2|NOT COMPLETED|Overall Study||15
421344|NCT00808249|1003376|P1|NOT COMPLETED|Overall Study||17
421345|NCT00808249|1003373|P4|COMPLETED|Overall Study||90
421346|NCT00808249|1003374|P3|COMPLETED|Overall Study||83
421347|NCT00808249|1003375|P2|COMPLETED|Overall Study||91
421348|NCT00808249|1003376|P1|COMPLETED|Overall Study||90
421349|NCT00808249|1003373|P4|STARTED|Overall Study||106
421350|NCT00808249|1003374|P3|STARTED|Overall Study||105
421351|NCT00808249|1003375|P2|STARTED|Overall Study||106
421352|NCT00808249|1003376|P1|STARTED|Overall Study||107
421353|NCT00808236|1003404|P2|NOT COMPLETED|Overall Study||91
421354|NCT00808236|1003405|P1|NOT COMPLETED|Overall Study||82
421355|NCT00808236|1003404|P2|COMPLETED|Overall Study||13
421356|NCT00808236|1003405|P1|COMPLETED|Overall Study||14
421357|NCT00808236|1003404|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
421358|NCT00808236|1003405|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
421359|NCT00808236|1003404|P2|Achieved ROSC|Overall Study||43
421360|NCT00808236|1003405|P1|Achieved ROSC|Overall Study||33
421361|NCT00808236|1003404|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
421362|NCT00808236|1003405|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
421363|NCT00808236|1003404|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
421364|NCT00808236|1003405|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
421365|NCT00808236|1003404|P2|STARTED|Overall Study||104
421366|NCT00808236|1003405|P1|STARTED|Overall Study||96
421367|NCT00808132|1003438|P5|NOT COMPLETED|Overall Study||100
421368|NCT00808132|1003439|P4|NOT COMPLETED|Overall Study||69
421369|NCT00808132|1003440|P3|NOT COMPLETED|Overall Study||54
421370|NCT00808132|1003441|P2|NOT COMPLETED|Overall Study||88
421371|NCT00808132|1003442|P1|NOT COMPLETED|Overall Study||98
421372|NCT00808132|1003438|P5|COMPLETED|Overall Study||383
421373|NCT00808132|1003439|P4|COMPLETED|Overall Study||159
421374|NCT00808132|1003440|P3|COMPLETED|Overall Study||185
421375|NCT00808132|1003441|P2|COMPLETED|Overall Study||393
421376|NCT00808132|1003442|P1|COMPLETED|Overall Study||357
421377|NCT00808132|1003438|P5|Treated|Overall Study||474
421378|NCT00808132|1003439|P4|Treated|Overall Study||220
421379|NCT00808132|1003440|P3|Treated|Overall Study||230
421380|NCT00808132|1003441|P2|Treated|Overall Study||474
421381|NCT00808132|1003442|P1|Treated|Overall Study||445
421382|NCT00808132|1003438|P5|STARTED|Overall Study||483
421383|NCT00808132|1003439|P4|STARTED|Overall Study||228
421384|NCT00808132|1003440|P3|STARTED|Overall Study||239
421385|NCT00808132|1003441|P2|STARTED|Overall Study||481
421386|NCT00808132|1003442|P1|STARTED|Overall Study||455
421387|NCT00808080|1003514|P1|NOT COMPLETED|Overall Study||6
421388|NCT00808080|1003514|P1|COMPLETED|Overall Study||0
421389|NCT00808080|1003514|P1|STARTED|Overall Study||6
421390|NCT00808067|1003520|P2|NOT COMPLETED|Overall Study||518
421391|NCT00808067|1003521|P1|NOT COMPLETED|Overall Study||481
421392|NCT00808067|1003520|P2|COMPLETED|Overall Study||2438
421393|NCT00808067|1003521|P1|COMPLETED|Overall Study||2446
421394|NCT00808067|1003520|P2|STARTED|Overall Study|Number of patients which are treated.|2956
421395|NCT00808067|1003521|P1|STARTED|Overall Study|Number of patients which are treated.|2927
421396|NCT00808028|1003557|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
421397|NCT00808028|1003558|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
421398|NCT00808028|1003559|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
421399|NCT00808028|1003560|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
421400|NCT00808028|1003557|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
421401|NCT00808028|1003558|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
421402|NCT00808028|1003559|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
421403|NCT00808028|1003560|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
421404|NCT00808028|1003557|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
421405|NCT00808028|1003558|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
421406|NCT00808028|1003559|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
421407|NCT00808028|1003560|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
421408|NCT00808028|1003557|P4|NOT COMPLETED|Stage 1 (6 Months)||15
421409|NCT00808028|1003558|P3|NOT COMPLETED|Stage 1 (6 Months)||7
421410|NCT00808028|1003559|P2|NOT COMPLETED|Stage 1 (6 Months)||1
421411|NCT00808028|1003560|P1|NOT COMPLETED|Stage 1 (6 Months)||5
421412|NCT00808028|1003557|P4|COMPLETED|Stage 1 (6 Months)||183
421413|NCT00808028|1003558|P3|COMPLETED|Stage 1 (6 Months)||191
421414|NCT00808028|1003559|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
421415|NCT00808028|1003560|P1|COMPLETED|Stage 1 (6 Months)||116
421416|NCT00808028|1003557|P4|STARTED|Stage 1 (6 Months)||198
421417|NCT00808028|1003558|P3|STARTED|Stage 1 (6 Months)||198
421418|NCT00808028|1003559|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
421419|NCT00808028|1003560|P1|STARTED|Stage 1 (6 Months)||121
421420|NCT00808015|1003596|P1|NOT COMPLETED|Overall Study||344
421421|NCT00808015|1003596|P1|COMPLETED|Overall Study||1033
421422|NCT00808015|1003596|P1|Treated|Overall Study||1373
421423|NCT00808015|1003596|P1|STARTED|Overall Study||1377
421424|NCT00807989|1003610|P2|NOT COMPLETED|Overall Study||2
421425|NCT00807989|1003611|P1|NOT COMPLETED|Overall Study||3
421426|NCT00807989|1003610|P2|COMPLETED|Overall Study||98
421427|NCT00807989|1003611|P1|COMPLETED|Overall Study||104
421428|NCT00807989|1003610|P2|STARTED|Overall Study||100
421429|NCT00807989|1003611|P1|STARTED|Overall Study||107
421430|NCT00807937|1003625|P4|NOT COMPLETED|Overall Study||15
421431|NCT00807937|1003626|P3|NOT COMPLETED|Overall Study||14
421432|NCT00807937|1003627|P2|NOT COMPLETED|Overall Study||25
421433|NCT00807937|1003628|P1|NOT COMPLETED|Overall Study||27
421434|NCT00807937|1003625|P4|COMPLETED|Overall Study||77
421435|NCT00807937|1003626|P3|COMPLETED|Overall Study||78
421436|NCT00807937|1003627|P2|COMPLETED|Overall Study||67
421437|NCT00807937|1003628|P1|COMPLETED|Overall Study||66
421438|NCT00807937|1003625|P4|STARTED|Overall Study||92
421439|NCT00807937|1003626|P3|STARTED|Overall Study||92
421440|NCT00807937|1003627|P2|STARTED|Overall Study||92
421441|NCT00807937|1003628|P1|STARTED|Overall Study||93
421442|NCT00807885|1003663|P9|NOT COMPLETED|Overall Study||0
421443|NCT00807885|1003664|P8|NOT COMPLETED|Overall Study||0
421444|NCT00807885|1003665|P7|NOT COMPLETED|Overall Study||0
421445|NCT00807885|1003666|P6|NOT COMPLETED|Overall Study||1
421446|NCT00807885|1003667|P5|NOT COMPLETED|Overall Study||0
421447|NCT00807885|1003668|P4|NOT COMPLETED|Overall Study||0
421448|NCT00807885|1003669|P3|NOT COMPLETED|Overall Study||0
421449|NCT00807885|1003670|P2|NOT COMPLETED|Overall Study||0
421450|NCT00807885|1003671|P1|NOT COMPLETED|Overall Study||0
421451|NCT00807885|1003663|P9|COMPLETED|Overall Study||11
421452|NCT00807885|1003664|P8|COMPLETED|Overall Study||11
421453|NCT00807885|1003665|P7|COMPLETED|Overall Study||12
421454|NCT00807885|1003666|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
421455|NCT00807885|1003667|P5|COMPLETED|Overall Study||12
421456|NCT00807885|1003668|P4|COMPLETED|Overall Study||10
421457|NCT00807885|1003669|P3|COMPLETED|Overall Study||11
421458|NCT00807885|1003670|P2|COMPLETED|Overall Study||11
421459|NCT00807885|1003671|P1|COMPLETED|Overall Study||10
421460|NCT00807885|1003663|P9|STARTED|Overall Study||11
421461|NCT00807885|1003664|P8|STARTED|Overall Study||11
421462|NCT00807885|1003665|P7|STARTED|Overall Study||12
421463|NCT00807885|1003666|P6|STARTED|Overall Study||12
421464|NCT00807885|1003667|P5|STARTED|Overall Study||12
421465|NCT00807885|1003668|P4|STARTED|Overall Study||10
421466|NCT00807885|1003669|P3|STARTED|Overall Study||11
421467|NCT00807885|1003670|P2|STARTED|Overall Study||11
421468|NCT00807885|1003671|P1|STARTED|Overall Study||10
421469|NCT00807846|1003720|P2|NOT COMPLETED|Overall Study||4
421470|NCT00807846|1003721|P1|NOT COMPLETED|Overall Study||12
421471|NCT00807846|1003720|P2|COMPLETED|Overall Study||94
421472|NCT00807846|1003721|P1|COMPLETED|Overall Study||88
421473|NCT00807846|1003720|P2|STARTED|Overall Study||98
421474|NCT00807846|1003721|P1|STARTED|Overall Study||100
421475|NCT00807573|1003753|P1|NOT COMPLETED|Overall Study||2
421476|NCT00807573|1003753|P1|COMPLETED|Overall Study||42
421477|NCT00807573|1003753|P1|STARTED|Overall Study||44
421478|NCT00807560|1003759|P2|NOT COMPLETED|Overall Study||0
421479|NCT00807560|1003760|P1|NOT COMPLETED|Overall Study||0
421480|NCT00807560|1003759|P2|COMPLETED|Overall Study||39
421481|NCT00807560|1003760|P1|COMPLETED|Overall Study||38
421482|NCT00807560|1003759|P2|STARTED|Overall Study||39
421483|NCT00807560|1003760|P1|STARTED|Overall Study||38
421484|NCT00807456|1003794|P1|NOT COMPLETED|Overall Study||0
421485|NCT00807456|1003794|P1|COMPLETED|Overall Study||65
421486|NCT00807456|1003794|P1|STARTED|Overall Study||65
421487|NCT00807365|1003798|P1|NOT COMPLETED|Overall Study||5
421488|NCT00807365|1003798|P1|COMPLETED|Overall Study||0
421489|NCT00807365|1003798|P1|STARTED|Overall Study||5
421490|NCT00807248|1003806|P4|NOT COMPLETED|Overall Study||14
421491|NCT00807248|1003807|P3|NOT COMPLETED|Overall Study||18
421492|NCT00807248|1003808|P2|NOT COMPLETED|Overall Study||12
421493|NCT00807248|1003809|P1|NOT COMPLETED|Overall Study||21
421494|NCT00807248|1003806|P4|COMPLETED|Overall Study||126
421495|NCT00807248|1003807|P3|COMPLETED|Overall Study||121
421496|NCT00807248|1003808|P2|COMPLETED|Overall Study||128
421497|NCT00807248|1003809|P1|COMPLETED|Overall Study||50
421498|NCT00807248|1003806|P4|STARTED|Overall Study||140
421499|NCT00807248|1003807|P3|STARTED|Overall Study||139
421500|NCT00807248|1003808|P2|STARTED|Overall Study||140
421501|NCT00807248|1003809|P1|STARTED|Overall Study||71
421502|NCT00807235|1003853|P2|NOT COMPLETED|Overall Study||0
421503|NCT00807235|1003854|P1|NOT COMPLETED|Overall Study||1
421504|NCT00807235|1003853|P2|COMPLETED|Overall Study||6
421505|NCT00807235|1003854|P1|COMPLETED|Overall Study||10
421506|NCT00807235|1003853|P2|STARTED|Overall Study||6
421507|NCT00807235|1003854|P1|STARTED|Overall Study||11
421508|NCT00807209|1003887|P3|NOT COMPLETED|Overall Study||0
421509|NCT00807209|1003888|P2|NOT COMPLETED|Overall Study||0
421510|NCT00807209|1003889|P1|NOT COMPLETED|Overall Study||0
421511|NCT00807209|1003887|P3|COMPLETED|Overall Study||1
421512|NCT00807209|1003888|P2|COMPLETED|Overall Study||1
421513|NCT00807209|1003889|P1|COMPLETED|Overall Study||1
421514|NCT00807209|1003887|P3|STARTED|Overall Study||1
421515|NCT00807209|1003888|P2|STARTED|Overall Study||1
421516|NCT00807209|1003889|P1|STARTED|Overall Study||1
421517|NCT00807092|1003899|P2|NOT COMPLETED|Overall Study||4
421518|NCT00807092|1003900|P1|NOT COMPLETED|Overall Study||1
421519|NCT00807092|1003899|P2|COMPLETED|Overall Study||69
421520|NCT00807092|1003900|P1|COMPLETED|Overall Study||71
421521|NCT00807092|1003899|P2|Exposed to Drug|Overall Study||73
421522|NCT00807092|1003900|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
421523|NCT00807092|1003899|P2|STARTED|Overall Study||73
421524|NCT00807092|1003900|P1|STARTED|Overall Study||72
421525|NCT00807014|1003930|P2|NOT COMPLETED|Overall Study||27
421526|NCT00807014|1003931|P1|NOT COMPLETED|Overall Study||27
421527|NCT00807014|1003930|P2|COMPLETED|Overall Study||58
421528|NCT00807014|1003931|P1|COMPLETED|Overall Study||56
421529|NCT00807014|1003930|P2|STARTED|Overall Study||85
421530|NCT00807014|1003931|P1|STARTED|Overall Study||83
421531|NCT00807001|1003962|P5|NOT COMPLETED|Overall Study||0
421532|NCT00807001|1003963|P4|NOT COMPLETED|Overall Study||0
421533|NCT00807001|1003964|P3|NOT COMPLETED|Overall Study||0
421534|NCT00807001|1003965|P2|NOT COMPLETED|Overall Study||1
421535|NCT00807001|1003966|P1|NOT COMPLETED|Overall Study||0
421536|NCT00807001|1003962|P5|COMPLETED|Overall Study||9
421537|NCT00807001|1003963|P4|COMPLETED|Overall Study||8
421538|NCT00807001|1003964|P3|COMPLETED|Overall Study||8
421539|NCT00807001|1003965|P2|COMPLETED|Overall Study||7
421540|NCT00807001|1003966|P1|COMPLETED|Overall Study||8
421541|NCT00807001|1003962|P5|STARTED|Overall Study||9
421542|NCT00807001|1003963|P4|STARTED|Overall Study||8
421543|NCT00807001|1003964|P3|STARTED|Overall Study||8
421544|NCT00807001|1003965|P2|STARTED|Overall Study||8
421545|NCT00807001|1003966|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
421546|NCT00806819|1003985|P2|NOT COMPLETED|Overall Study||358
421547|NCT00806819|1003986|P1|NOT COMPLETED|Overall Study||346
421548|NCT00806819|1003985|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
421549|NCT00806819|1003986|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
421550|NCT00806819|1003985|P2|STARTED|Overall Study|randomised patients|360
421551|NCT00806819|1003986|P1|STARTED|Overall Study|randomised patients|353
421552|NCT00806624|1004021|P3|NOT COMPLETED|Overall Study||6
421553|NCT00806624|1004022|P2|NOT COMPLETED|Overall Study||12
421554|NCT00806624|1004023|P1|NOT COMPLETED|Overall Study||9
421555|NCT00806624|1004021|P3|COMPLETED|Overall Study||69
421556|NCT00806624|1004022|P2|COMPLETED|Overall Study||68
421557|NCT00806624|1004023|P1|COMPLETED|Overall Study||70
421558|NCT00806624|1004021|P3|STARTED|Overall Study||75
421559|NCT00806624|1004022|P2|STARTED|Overall Study||80
421560|NCT00806624|1004023|P1|STARTED|Overall Study||79
421561|NCT00806598|1004031|P1|NOT COMPLETED|Overall Study||0
421562|NCT00806598|1004031|P1|COMPLETED|Overall Study||48
421563|NCT00806598|1004031|P1|STARTED|Overall Study||48
421564|NCT00806585|1004040|P5|NOT COMPLETED|Overall Study||31
421565|NCT00806585|1004041|P4|NOT COMPLETED|Overall Study||15
421566|NCT00806585|1004042|P3|NOT COMPLETED|Overall Study||32
421567|NCT00806585|1004043|P2|NOT COMPLETED|Overall Study||31
421568|NCT00806585|1004044|P1|NOT COMPLETED|Overall Study||32
421569|NCT00806585|1004040|P5|COMPLETED|Overall Study||106
421570|NCT00806585|1004041|P4|COMPLETED|Overall Study||56
421571|NCT00806585|1004042|P3|COMPLETED|Overall Study||109
421572|NCT00806585|1004043|P2|COMPLETED|Overall Study||103
421573|NCT00806585|1004044|P1|COMPLETED|Overall Study||105
421574|NCT00806585|1004040|P5|STARTED|Overall Study||137
421575|NCT00806585|1004041|P4|STARTED|Overall Study||71
421576|NCT00806585|1004042|P3|STARTED|Overall Study||141
421577|NCT00806585|1004043|P2|STARTED|Overall Study||134
421578|NCT00806585|1004044|P1|STARTED|Overall Study||137
421579|NCT00806546|1004076|P1|NOT COMPLETED|Overall Study||307
421580|NCT00806546|1004076|P1|COMPLETED|Overall Study||207
421581|NCT00806546|1004076|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
421582|NCT00806494|1004080|P1|NOT COMPLETED|Overall Study||80
421583|NCT00806494|1004080|P1|COMPLETED|Overall Study||251
421584|NCT00806494|1004080|P1|STARTED|Overall Study||331
421585|NCT00806416|1004106|P4|NOT COMPLETED|Period 2 - Part II||0
421586|NCT00806416|1004107|P3|NOT COMPLETED|Period 2 - Part II||0
421587|NCT00806416|1004108|P2|NOT COMPLETED|Period 2 - Part II||0
421588|NCT00806416|1004109|P1|NOT COMPLETED|Period 2 - Part II||0
421589|NCT00806416|1004106|P4|COMPLETED|Period 2 - Part II||14
421590|NCT00806416|1004107|P3|COMPLETED|Period 2 - Part II||14
421591|NCT00806416|1004108|P2|COMPLETED|Period 2 - Part II||0
421592|NCT00806416|1004109|P1|COMPLETED|Period 2 - Part II||0
421593|NCT00806416|1004106|P4|STARTED|Period 2 - Part II||14
421594|NCT00806416|1004107|P3|STARTED|Period 2 - Part II||14
421595|NCT00806416|1004108|P2|STARTED|Period 2 - Part II||0
421596|NCT00806416|1004109|P1|STARTED|Period 2 - Part II||0
421597|NCT00806416|1004106|P4|NOT COMPLETED|Period 1 - Part II||2
421598|NCT00806416|1004107|P3|NOT COMPLETED|Period 1 - Part II||0
421599|NCT00806416|1004108|P2|NOT COMPLETED|Period 1 - Part II||0
421600|NCT00806416|1004109|P1|NOT COMPLETED|Period 1 - Part II||0
421601|NCT00806416|1004106|P4|COMPLETED|Period 1 - Part II||14
421602|NCT00806416|1004107|P3|COMPLETED|Period 1 - Part II||14
421603|NCT00806416|1004108|P2|COMPLETED|Period 1 - Part II||0
421604|NCT00806416|1004109|P1|COMPLETED|Period 1 - Part II||0
421605|NCT00806416|1004106|P4|STARTED|Period 1 - Part II||16
421606|NCT00806416|1004107|P3|STARTED|Period 1 - Part II||14
421607|NCT00806416|1004108|P2|STARTED|Period 1 - Part II||0
421608|NCT00806416|1004109|P1|STARTED|Period 1 - Part II||0
421609|NCT00806416|1004106|P4|NOT COMPLETED|Period 2 - Part I||0
421610|NCT00806416|1004107|P3|NOT COMPLETED|Period 2 - Part I||0
421611|NCT00806416|1004108|P2|NOT COMPLETED|Period 2 - Part I||0
421612|NCT00806416|1004109|P1|NOT COMPLETED|Period 2 - Part I||0
421613|NCT00806416|1004106|P4|COMPLETED|Period 2 - Part I||0
421614|NCT00806416|1004107|P3|COMPLETED|Period 2 - Part I||0
421615|NCT00806416|1004108|P2|COMPLETED|Period 2 - Part I||103
421616|NCT00806416|1004109|P1|COMPLETED|Period 2 - Part I||104
421617|NCT00806416|1004106|P4|STARTED|Period 2 - Part I||0
421618|NCT00806416|1004107|P3|STARTED|Period 2 - Part I||0
421619|NCT00806416|1004108|P2|STARTED|Period 2 - Part I||103
421620|NCT00806416|1004109|P1|STARTED|Period 2 - Part I||104
421621|NCT00806416|1004106|P4|NOT COMPLETED|Period 1 - Part I||0
421622|NCT00806416|1004107|P3|NOT COMPLETED|Period 1 - Part I||0
421623|NCT00806416|1004108|P2|NOT COMPLETED|Period 1 - Part I||4
421624|NCT00806416|1004109|P1|NOT COMPLETED|Period 1 - Part I||3
421625|NCT00806416|1004106|P4|COMPLETED|Period 1 - Part I||0
421626|NCT00806416|1004107|P3|COMPLETED|Period 1 - Part I||0
421627|NCT00806416|1004108|P2|COMPLETED|Period 1 - Part I||103
421628|NCT00806416|1004109|P1|COMPLETED|Period 1 - Part I||104
421629|NCT00806416|1004106|P4|STARTED|Period 1 - Part I||0
421630|NCT00806416|1004107|P3|STARTED|Period 1 - Part I||0
421631|NCT00806416|1004108|P2|STARTED|Period 1 - Part I||107
421632|NCT00806416|1004109|P1|STARTED|Period 1 - Part I||107
421633|NCT00806403|1004122|P2|NOT COMPLETED|Overall Study||3
421634|NCT00806403|1004123|P1|NOT COMPLETED|Overall Study||4
421635|NCT00806403|1004122|P2|COMPLETED|Overall Study||98
421636|NCT00806403|1004123|P1|COMPLETED|Overall Study||100
421637|NCT00806403|1004122|P2|STARTED|Overall Study||101
421638|NCT00806403|1004123|P1|STARTED|Overall Study||104
421639|NCT00806390|1004137|P2|NOT COMPLETED|Overall Study||0
421640|NCT00806390|1004138|P1|NOT COMPLETED|Overall Study||0
421641|NCT00806390|1004137|P2|COMPLETED|Overall Study||8
421642|NCT00806390|1004138|P1|COMPLETED|Overall Study||7
421643|NCT00806390|1004137|P2|STARTED|Overall Study||8
421644|NCT00806390|1004138|P1|STARTED|Overall Study||7
421645|NCT00806351|1004146|P2|NOT COMPLETED|Overall Study||4
421646|NCT00806351|1004147|P1|NOT COMPLETED|Overall Study||5
421647|NCT00806351|1004146|P2|COMPLETED|Overall Study||2
421648|NCT00806351|1004147|P1|COMPLETED|Overall Study||10
421649|NCT00806351|1004146|P2|STARTED|Overall Study||6
421650|NCT00806351|1004147|P1|STARTED|Overall Study||15
421651|NCT00806260|1004184|P6|NOT COMPLETED|Period 3||0
421652|NCT00806260|1004185|P5|NOT COMPLETED|Period 3||0
421653|NCT00806260|1004186|P4|NOT COMPLETED|Period 3||0
421654|NCT00806260|1004187|P3|NOT COMPLETED|Period 3||1
421655|NCT00806260|1004188|P2|NOT COMPLETED|Period 3||1
421656|NCT00806260|1004189|P1|NOT COMPLETED|Period 3||1
421657|NCT00806260|1004184|P6|COMPLETED|Period 3||0
421658|NCT00806260|1004185|P5|COMPLETED|Period 3||0
421659|NCT00806260|1004186|P4|COMPLETED|Period 3||12
421660|NCT00806260|1004187|P3|COMPLETED|Period 3||5
421661|NCT00806260|1004188|P2|COMPLETED|Period 3||7
421662|NCT00806260|1004189|P1|COMPLETED|Period 3||12
421663|NCT00806260|1004184|P6|STARTED|Period 3||0
421664|NCT00806260|1004185|P5|STARTED|Period 3||0
421665|NCT00806260|1004186|P4|STARTED|Period 3||12
421666|NCT00806260|1004187|P3|STARTED|Period 3||6
421667|NCT00806260|1004188|P2|STARTED|Period 3||8
421668|NCT00806260|1004189|P1|STARTED|Period 3||13
421669|NCT00806260|1004184|P6|NOT COMPLETED|Period 2||0
421670|NCT00806260|1004185|P5|NOT COMPLETED|Period 2||0
421671|NCT00806260|1004186|P4|NOT COMPLETED|Period 2||2
421672|NCT00806260|1004187|P3|NOT COMPLETED|Period 2||2
421673|NCT00806260|1004188|P2|NOT COMPLETED|Period 2||0
421674|NCT00806260|1004189|P1|NOT COMPLETED|Period 2||2
421675|NCT00806260|1004184|P6|COMPLETED|Period 2||0
421676|NCT00806260|1004185|P5|COMPLETED|Period 2||0
421677|NCT00806260|1004186|P4|COMPLETED|Period 2||12
421678|NCT00806260|1004187|P3|COMPLETED|Period 2||6
421679|NCT00806260|1004188|P2|COMPLETED|Period 2||8
421680|NCT00806260|1004189|P1|COMPLETED|Period 2||13
421681|NCT00806260|1004184|P6|STARTED|Period 2||0
421682|NCT00806260|1004185|P5|STARTED|Period 2||0
421683|NCT00806260|1004186|P4|STARTED|Period 2||14
421684|NCT00806260|1004187|P3|STARTED|Period 2||8
421685|NCT00806260|1004188|P2|STARTED|Period 2||8
421686|NCT00806260|1004189|P1|STARTED|Period 2||15
421687|NCT00806260|1004184|P6|NOT COMPLETED|Period 1 (1 Day)||0
421688|NCT00806260|1004185|P5|NOT COMPLETED|Period 1 (1 Day)||3
421689|NCT00806260|1004186|P4|NOT COMPLETED|Period 1 (1 Day)||0
421690|NCT00806260|1004187|P3|NOT COMPLETED|Period 1 (1 Day)||0
421691|NCT00806260|1004188|P2|NOT COMPLETED|Period 1 (1 Day)||0
421692|NCT00806260|1004189|P1|NOT COMPLETED|Period 1 (1 Day)||0
421693|NCT00806260|1004184|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
421694|NCT00806260|1004185|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
421695|NCT00806260|1004186|P4|COMPLETED|Period 1 (1 Day)||14
421696|NCT00806260|1004187|P3|COMPLETED|Period 1 (1 Day)||8
421697|NCT00806260|1004188|P2|COMPLETED|Period 1 (1 Day)||8
421698|NCT00806260|1004189|P1|COMPLETED|Period 1 (1 Day)||15
421699|NCT00806260|1004184|P6|STARTED|Period 1 (1 Day)||17
421700|NCT00806260|1004185|P5|STARTED|Period 1 (1 Day)||18
421701|NCT00806260|1004186|P4|STARTED|Period 1 (1 Day)||14
421702|NCT00806260|1004187|P3|STARTED|Period 1 (1 Day)||8
421703|NCT00806260|1004188|P2|STARTED|Period 1 (1 Day)||8
421704|NCT00806260|1004189|P1|STARTED|Period 1 (1 Day)||15
421705|NCT00806234|1004204|P3|NOT COMPLETED|Overall Study||12
421706|NCT00806234|1004205|P2|NOT COMPLETED|Overall Study||12
421707|NCT00806234|1004206|P1|NOT COMPLETED|Overall Study||13
421708|NCT00806234|1004204|P3|COMPLETED|Overall Study||37
421709|NCT00806234|1004205|P2|COMPLETED|Overall Study||19
421710|NCT00806234|1004206|P1|COMPLETED|Overall Study||34
421711|NCT00806234|1004204|P3|STARTED|Overall Study||49
421712|NCT00806234|1004205|P2|STARTED|Overall Study||31
421713|NCT00806234|1004206|P1|STARTED|Overall Study||47
421714|NCT00806195|1004227|P4|NOT COMPLETED|Overall Study||106
421715|NCT00806195|1004228|P3|NOT COMPLETED|Overall Study||270
421716|NCT00806195|1004229|P2|NOT COMPLETED|Overall Study||162
421717|NCT00806195|1004230|P1|NOT COMPLETED|Overall Study||514
421718|NCT00806195|1004227|P4|COMPLETED|Overall Study||383
421719|NCT00806195|1004228|P3|COMPLETED|Overall Study||1139
421720|NCT00806195|1004229|P2|COMPLETED|Overall Study||1321
421721|NCT00806195|1004230|P1|COMPLETED|Overall Study||3849
421722|NCT00806195|1004227|P4|STARTED|Overall Study||489
421723|NCT00806195|1004228|P3|STARTED|Overall Study||1409
421724|NCT00806195|1004229|P2|STARTED|Overall Study||1483
421725|NCT00806195|1004230|P1|STARTED|Overall Study||4363
421726|NCT00806078|1004244|P2|NOT COMPLETED|Second Intervention||0
421727|NCT00806078|1004245|P1|NOT COMPLETED|Second Intervention||0
421728|NCT00806078|1004244|P2|COMPLETED|Second Intervention||9
421729|NCT00806078|1004245|P1|COMPLETED|Second Intervention||9
421730|NCT00806078|1004244|P2|STARTED|Second Intervention||9
421731|NCT00806078|1004245|P1|STARTED|Second Intervention||9
421732|NCT00806078|1004244|P2|NOT COMPLETED|7 Day Washout Period||0
421733|NCT00806078|1004245|P1|NOT COMPLETED|7 Day Washout Period||0
421734|NCT00806078|1004244|P2|COMPLETED|7 Day Washout Period||9
421735|NCT00806078|1004245|P1|COMPLETED|7 Day Washout Period||9
421736|NCT00806078|1004244|P2|STARTED|7 Day Washout Period||9
421737|NCT00806078|1004245|P1|STARTED|7 Day Washout Period||9
421738|NCT00806078|1004244|P2|NOT COMPLETED|First Intervention||0
421739|NCT00806078|1004245|P1|NOT COMPLETED|First Intervention||0
421740|NCT00806078|1004244|P2|COMPLETED|First Intervention||9
421741|NCT00806078|1004245|P1|COMPLETED|First Intervention||9
421742|NCT00806078|1004244|P2|STARTED|First Intervention||9
421743|NCT00806078|1004245|P1|STARTED|First Intervention||9
421744|NCT00804908|1004258|P3|NOT COMPLETED|Overall Study||114
421745|NCT00804908|1004259|P2|NOT COMPLETED|Overall Study||116
421746|NCT00804908|1004260|P1|NOT COMPLETED|Overall Study||115
421747|NCT00804908|1004258|P3|COMPLETED|Overall Study||1
421748|NCT00804908|1004259|P2|COMPLETED|Overall Study||0
421749|NCT00804908|1004260|P1|COMPLETED|Overall Study||0
421750|NCT00804908|1004258|P3|STARTED|Overall Study||115
421751|NCT00804908|1004259|P2|STARTED|Overall Study||116
421752|NCT00804908|1004260|P1|STARTED|Overall Study||115
421753|NCT00804843|1004291|P2|NOT COMPLETED|Overall Study||7
421754|NCT00804843|1004292|P1|NOT COMPLETED|Overall Study||10
421755|NCT00804843|1004291|P2|COMPLETED|Overall Study||43
421756|NCT00804843|1004292|P1|COMPLETED|Overall Study||40
421757|NCT00804843|1004291|P2|STARTED|Overall Study||50
421758|NCT00804843|1004292|P1|STARTED|Overall Study||50
421759|NCT00806026|1004308|P6|NOT COMPLETED|Overall Study||32
421760|NCT00806026|1004309|P5|NOT COMPLETED|Overall Study||30
421761|NCT00806026|1004310|P4|NOT COMPLETED|Overall Study||29
421762|NCT00806026|1004311|P3|NOT COMPLETED|Overall Study||93
421763|NCT00806026|1004312|P2|NOT COMPLETED|Overall Study||101
421764|NCT00806026|1004313|P1|NOT COMPLETED|Overall Study||92
421765|NCT00806026|1004308|P6|COMPLETED|Overall Study||29
421766|NCT00806026|1004309|P5|COMPLETED|Overall Study||29
421767|NCT00806026|1004310|P4|COMPLETED|Overall Study||32
421768|NCT00806026|1004311|P3|COMPLETED|Overall Study||89
421769|NCT00806026|1004312|P2|COMPLETED|Overall Study||82
421770|NCT00806026|1004313|P1|COMPLETED|Overall Study||93
421771|NCT00806026|1004308|P6|Treated|Overall Study||61
421772|NCT00806026|1004309|P5|Treated|Overall Study||59
421773|NCT00806026|1004310|P4|Treated|Overall Study||59
421774|NCT00806026|1004311|P3|Treated|Overall Study||180
421775|NCT00806026|1004312|P2|Treated|Overall Study||178
421776|NCT00806026|1004313|P1|Treated|Overall Study||182
421777|NCT00806026|1004308|P6|STARTED|Overall Study||61
421778|NCT00806026|1004309|P5|STARTED|Overall Study||59
421779|NCT00806026|1004310|P4|STARTED|Overall Study||61
421780|NCT00806026|1004311|P3|STARTED|Overall Study||182
421781|NCT00806026|1004312|P2|STARTED|Overall Study||183
421782|NCT00806026|1004313|P1|STARTED|Overall Study||185
421783|NCT00805961|1004408|P1|NOT COMPLETED|Maintenance Treatment||34
421784|NCT00805961|1004408|P1|COMPLETED|Maintenance Treatment||23
421785|NCT00805961|1004408|P1|STARTED|Maintenance Treatment||57
421786|NCT00805961|1004408|P1|NOT COMPLETED|Treatment-Free Interval||7
421787|NCT00805961|1004408|P1|COMPLETED|Treatment-Free Interval||57
421788|NCT00805961|1004408|P1|STARTED|Treatment-Free Interval||64
421789|NCT00805961|1004408|P1|NOT COMPLETED|Modality Therapy||4
421790|NCT00805961|1004408|P1|COMPLETED|Modality Therapy||64
421791|NCT00805961|1004408|P1|STARTED|Modality Therapy||68
421792|NCT00805935|1004418|P4|NOT COMPLETED|Overall Study||11
421793|NCT00805935|1004419|P3|NOT COMPLETED|Overall Study||15
421794|NCT00805935|1004420|P2|NOT COMPLETED|Overall Study||19
421795|NCT00805935|1004421|P1|NOT COMPLETED|Overall Study||13
421796|NCT00805935|1004418|P4|COMPLETED|Overall Study||19
421797|NCT00805935|1004419|P3|COMPLETED|Overall Study||13
421798|NCT00805935|1004420|P2|COMPLETED|Overall Study||8
421799|NCT00805935|1004421|P1|COMPLETED|Overall Study||12
421800|NCT00805935|1004418|P4|STARTED|Overall Study||30
421801|NCT00805935|1004419|P3|STARTED|Overall Study||28
421802|NCT00805935|1004420|P2|STARTED|Overall Study||27
421803|NCT00805935|1004421|P1|STARTED|Overall Study||25
421804|NCT00805870|1004475|P2|NOT COMPLETED|Overall Study||0
421805|NCT00805870|1004476|P1|NOT COMPLETED|Overall Study||0
421806|NCT00805870|1004475|P2|COMPLETED|Overall Study||10
421807|NCT00805870|1004476|P1|COMPLETED|Overall Study||10
421808|NCT00805870|1004475|P2|STARTED|Overall Study||10
421809|NCT00805870|1004476|P1|STARTED|Overall Study||10
421810|NCT00805792|1004488|P1|NOT COMPLETED|Overall Study||5
421811|NCT00805792|1004488|P1|COMPLETED|Overall Study||28
421812|NCT00805792|1004488|P1|STARTED|Overall Study||33
421813|NCT00805766|1004496|P1|NOT COMPLETED|Increased Dose Period||13
421814|NCT00805766|1004496|P1|COMPLETED|Increased Dose Period||26
421815|NCT00805766|1004496|P1|STARTED|Increased Dose Period||39
421816|NCT00805766|1004496|P1|NOT COMPLETED|Screening Period||6
421817|NCT00805766|1004496|P1|COMPLETED|Screening Period||39
421818|NCT00805766|1004496|P1|STARTED|Screening Period||45
421819|NCT00805740|1004505|P2|NOT COMPLETED|Overall Study||4
421820|NCT00805740|1004506|P1|NOT COMPLETED|Overall Study||11
421821|NCT00805740|1004505|P2|COMPLETED|Overall Study||9
421822|NCT00805740|1004506|P1|COMPLETED|Overall Study||17
421823|NCT00805740|1004505|P2|Treated|Overall Study||13
421824|NCT00805740|1004506|P1|Treated|Overall Study||26
421825|NCT00805740|1004505|P2|STARTED|Overall Study||13
421826|NCT00805740|1004506|P1|STARTED|Overall Study||28
421827|NCT00805675|1004531|P3|NOT COMPLETED|Overall Study||1
421828|NCT00805675|1004532|P2|NOT COMPLETED|Overall Study||0
421829|NCT00805675|1004533|P1|NOT COMPLETED|Overall Study||0
421830|NCT00805675|1004531|P3|COMPLETED|Overall Study||15
421831|NCT00805675|1004532|P2|COMPLETED|Overall Study||14
421832|NCT00805675|1004533|P1|COMPLETED|Overall Study||16
421833|NCT00805675|1004531|P3|STARTED|Overall Study||16
421834|NCT00805675|1004532|P2|STARTED|Overall Study||14
421835|NCT00805675|1004533|P1|STARTED|Overall Study||16
421836|NCT00805545|1004567|P2|NOT COMPLETED|Overall Study||3
421837|NCT00805545|1004568|P1|NOT COMPLETED|Overall Study||6
421838|NCT00805545|1004567|P2|COMPLETED|Overall Study||197
421839|NCT00805545|1004568|P1|COMPLETED|Overall Study||194
421840|NCT00805545|1004567|P2|STARTED|Overall Study||200
421841|NCT00805545|1004568|P1|STARTED|Overall Study||200
421842|NCT00805493|1004577|P3|NOT COMPLETED|Overall Study||1
421843|NCT00805493|1004578|P2|NOT COMPLETED|Overall Study||0
421844|NCT00805493|1004579|P1|NOT COMPLETED|Overall Study||2
421845|NCT00805493|1004577|P3|COMPLETED|Overall Study||0
421846|NCT00805493|1004578|P2|COMPLETED|Overall Study||2
421847|NCT00805493|1004579|P1|COMPLETED|Overall Study||1
421848|NCT00805493|1004577|P3|STARTED|Overall Study||1
421849|NCT00805493|1004578|P2|STARTED|Overall Study||2
421850|NCT00805493|1004579|P1|STARTED|Overall Study||3
421851|NCT00805480|1004594|P4|NOT COMPLETED|Overall Study||5
421852|NCT00805480|1004595|P3|NOT COMPLETED|Overall Study||12
421853|NCT00805480|1004596|P2|NOT COMPLETED|Overall Study||7
421854|NCT00805480|1004597|P1|NOT COMPLETED|Overall Study||14
421855|NCT00805480|1004594|P4|COMPLETED|Overall Study||5
421856|NCT00805480|1004595|P3|COMPLETED|Overall Study||19
421857|NCT00805480|1004596|P2|COMPLETED|Overall Study||22
421858|NCT00805480|1004597|P1|COMPLETED|Overall Study||16
421859|NCT00805480|1004594|P4|Pharmacodynamic Analysis Set|Overall Study||10
421860|NCT00805480|1004595|P3|Pharmacodynamic Analysis Set|Overall Study||29
421861|NCT00805480|1004596|P2|Pharmacodynamic Analysis Set|Overall Study||25
421862|NCT00805480|1004597|P1|Pharmacodynamic Analysis Set|Overall Study||30
421863|NCT00805480|1004594|P4|STARTED|Overall Study||10
421864|NCT00805480|1004595|P3|STARTED|Overall Study||31
421865|NCT00805480|1004596|P2|STARTED|Overall Study||29
421866|NCT00805480|1004597|P1|STARTED|Overall Study||30
421867|NCT00805467|1004626|P4|NOT COMPLETED|Overall Study||237
421868|NCT00805467|1004627|P3|NOT COMPLETED|Overall Study||103
421869|NCT00805467|1004628|P2|NOT COMPLETED|Overall Study||34
421870|NCT00805467|1004629|P1|NOT COMPLETED|Overall Study||0
421871|NCT00805467|1004626|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
421872|NCT00805467|1004627|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
421873|NCT00805467|1004628|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
421874|NCT00805467|1004629|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
421875|NCT00805467|1004626|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
421876|NCT00805467|1004627|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
421877|NCT00805467|1004628|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
421878|NCT00805467|1004629|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
421879|NCT00805467|1004626|P4|STARTED|Overall Study|Patients who received treatment|381
421880|NCT00805467|1004627|P3|STARTED|Overall Study|Patients who received treatment|183
421881|NCT00805467|1004628|P2|STARTED|Overall Study|Patients who received treatment|59
421882|NCT00805467|1004629|P1|STARTED|Overall Study|Patients who received treatment|1
421883|NCT00805389|1004652|P5|NOT COMPLETED|Overall Study||13
421884|NCT00805389|1004653|P4|NOT COMPLETED|Overall Study||17
421885|NCT00805389|1004654|P3|NOT COMPLETED|Overall Study||12
421886|NCT00805389|1004655|P2|NOT COMPLETED|Overall Study||5
421887|NCT00805389|1004656|P1|NOT COMPLETED|Overall Study||7
421888|NCT00805389|1004652|P5|COMPLETED|Overall Study||129
421889|NCT00805389|1004653|P4|COMPLETED|Overall Study||128
421890|NCT00805389|1004654|P3|COMPLETED|Overall Study||129
421891|NCT00805389|1004655|P2|COMPLETED|Overall Study||137
421892|NCT00805389|1004656|P1|COMPLETED|Overall Study||136
421893|NCT00805389|1004652|P5|STARTED|Overall Study||142
421894|NCT00805389|1004653|P4|STARTED|Overall Study||145
421895|NCT00805389|1004654|P3|STARTED|Overall Study||141
421896|NCT00805389|1004655|P2|STARTED|Overall Study||142
421897|NCT00805389|1004656|P1|STARTED|Overall Study||143
421898|NCT00805285|1004898|P1|NOT COMPLETED|Overall Study||1
421899|NCT00805285|1004898|P1|COMPLETED|Overall Study||0
421900|NCT00805285|1004898|P1|STARTED|Overall Study||1
421901|NCT00805194|1004908|P2|NOT COMPLETED|Overall Study||654
421902|NCT00805194|1004909|P1|NOT COMPLETED|Overall Study||649
421903|NCT00805194|1004908|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013).|5
421904|NCT00805194|1004909|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013)|6
421905|NCT00805194|1004908|P2|STARTED|Overall Study|randomised patients|659
421906|NCT00805194|1004909|P1|STARTED|Overall Study|randomised patients|655
421907|NCT00805142|1004943|P2|NOT COMPLETED|Maintenance Period||2
421908|NCT00805142|1004944|P1|NOT COMPLETED|Maintenance Period||0
421909|NCT00805142|1004943|P2|COMPLETED|Maintenance Period||30
421910|NCT00805142|1004944|P1|COMPLETED|Maintenance Period||30
421911|NCT00805142|1004943|P2|STARTED|Maintenance Period||32
421912|NCT00805142|1004944|P1|STARTED|Maintenance Period||30
421913|NCT00805142|1004943|P2|NOT COMPLETED|Titration Period||10
421914|NCT00805142|1004944|P1|NOT COMPLETED|Titration Period||6
421915|NCT00805142|1004943|P2|COMPLETED|Titration Period||32
421916|NCT00805142|1004944|P1|COMPLETED|Titration Period||30
421917|NCT00805142|1004943|P2|STARTED|Titration Period||42
421918|NCT00805142|1004944|P1|STARTED|Titration Period||36
421919|NCT00805038|1004970|P2|NOT COMPLETED|Overall Study||0
421920|NCT00805038|1004971|P1|NOT COMPLETED|Overall Study||0
421921|NCT00805038|1004970|P2|COMPLETED|Overall Study||92
421922|NCT00805038|1004971|P1|COMPLETED|Overall Study||75
421923|NCT00805038|1004970|P2|STARTED|Overall Study||92
421924|NCT00805038|1004971|P1|STARTED|Overall Study||75
421925|NCT00805025|1004977|P1|NOT COMPLETED|Overall Study||49
421926|NCT00805025|1004977|P1|COMPLETED|Overall Study||82
421927|NCT00805025|1004977|P1|Enrolled and Treated|Overall Study||89
421928|NCT00805025|1004977|P1|STARTED|Overall Study||131
421929|NCT00804986|1004989|P6|NOT COMPLETED|Overall Study||10
421930|NCT00804986|1004990|P5|NOT COMPLETED|Overall Study||9
421931|NCT00804986|1004991|P4|NOT COMPLETED|Overall Study||8
421932|NCT00804986|1004992|P3|NOT COMPLETED|Overall Study||2
421933|NCT00804986|1004993|P2|NOT COMPLETED|Overall Study||8
421934|NCT00804986|1004994|P1|NOT COMPLETED|Overall Study||1
421935|NCT00804986|1004989|P6|COMPLETED|Overall Study||31
421936|NCT00804986|1004990|P5|COMPLETED|Overall Study||34
421937|NCT00804986|1004991|P4|COMPLETED|Overall Study||34
421938|NCT00804986|1004992|P3|COMPLETED|Overall Study||40
421939|NCT00804986|1004993|P2|COMPLETED|Overall Study||35
421940|NCT00804986|1004994|P1|COMPLETED|Overall Study||35
421941|NCT00804986|1004989|P6|STARTED|Overall Study||41
421942|NCT00804986|1004990|P5|STARTED|Overall Study||43
421943|NCT00804986|1004991|P4|STARTED|Overall Study||42
421944|NCT00804986|1004992|P3|STARTED|Overall Study||42
421945|NCT00804986|1004993|P2|STARTED|Overall Study||43
421946|NCT00804986|1004994|P1|STARTED|Overall Study||36
421947|NCT00804713|1005086|P1|NOT COMPLETED|Overall Study||0
421948|NCT00804713|1005086|P1|COMPLETED|Overall Study||1978
421949|NCT00804713|1005086|P1|STARTED|Overall Study||1978
421950|NCT00804687|1005094|P6|NOT COMPLETED|Period 5: Treatment Period||0
421951|NCT00804687|1005095|P5|NOT COMPLETED|Period 5: Treatment Period||1
421952|NCT00804687|1005096|P4|NOT COMPLETED|Period 5: Treatment Period||0
421953|NCT00804687|1005097|P3|NOT COMPLETED|Period 5: Treatment Period||1
421954|NCT00804687|1005098|P2|NOT COMPLETED|Period 5: Treatment Period||0
421955|NCT00804687|1005099|P1|NOT COMPLETED|Period 5: Treatment Period||1
421956|NCT00804687|1005094|P6|COMPLETED|Period 5: Treatment Period||8
421957|NCT00804687|1005095|P5|COMPLETED|Period 5: Treatment Period||8
421958|NCT00804687|1005096|P4|COMPLETED|Period 5: Treatment Period||8
421959|NCT00804687|1005097|P3|COMPLETED|Period 5: Treatment Period||8
421960|NCT00804687|1005098|P2|COMPLETED|Period 5: Treatment Period||9
421961|NCT00804687|1005099|P1|COMPLETED|Period 5: Treatment Period||8
421962|NCT00804687|1005094|P6|STARTED|Period 5: Treatment Period||8
421963|NCT00804687|1005095|P5|STARTED|Period 5: Treatment Period||9
421964|NCT00804687|1005096|P4|STARTED|Period 5: Treatment Period||8
421965|NCT00804687|1005097|P3|STARTED|Period 5: Treatment Period||9
421966|NCT00804687|1005098|P2|STARTED|Period 5: Treatment Period||9
421967|NCT00804687|1005099|P1|STARTED|Period 5: Treatment Period||9
421968|NCT00804687|1005094|P6|NOT COMPLETED|Period 4: Washout Period||0
421969|NCT00804687|1005095|P5|NOT COMPLETED|Period 4: Washout Period||0
421970|NCT00804687|1005096|P4|NOT COMPLETED|Period 4: Washout Period||0
421971|NCT00804687|1005097|P3|NOT COMPLETED|Period 4: Washout Period||0
421972|NCT00804687|1005098|P2|NOT COMPLETED|Period 4: Washout Period||0
421973|NCT00804687|1005099|P1|NOT COMPLETED|Period 4: Washout Period||0
421974|NCT00804687|1005094|P6|COMPLETED|Period 4: Washout Period||8
421975|NCT00804687|1005095|P5|COMPLETED|Period 4: Washout Period||9
421976|NCT00804687|1005096|P4|COMPLETED|Period 4: Washout Period||8
421977|NCT00804687|1005097|P3|COMPLETED|Period 4: Washout Period||9
421978|NCT00804687|1005098|P2|COMPLETED|Period 4: Washout Period||9
421979|NCT00804687|1005099|P1|COMPLETED|Period 4: Washout Period||9
421980|NCT00804687|1005094|P6|STARTED|Period 4: Washout Period||8
421981|NCT00804687|1005095|P5|STARTED|Period 4: Washout Period||9
421982|NCT00804687|1005096|P4|STARTED|Period 4: Washout Period||8
421983|NCT00804687|1005097|P3|STARTED|Period 4: Washout Period||9
421984|NCT00804687|1005098|P2|STARTED|Period 4: Washout Period||9
421985|NCT00804687|1005099|P1|STARTED|Period 4: Washout Period||9
421986|NCT00804687|1005094|P6|NOT COMPLETED|Period 3: Treatment Period||0
421987|NCT00804687|1005095|P5|NOT COMPLETED|Period 3: Treatment Period||0
421988|NCT00804687|1005096|P4|NOT COMPLETED|Period 3: Treatment Period||1
421989|NCT00804687|1005097|P3|NOT COMPLETED|Period 3: Treatment Period||0
421990|NCT00804687|1005098|P2|NOT COMPLETED|Period 3: Treatment Period||0
421991|NCT00804687|1005099|P1|NOT COMPLETED|Period 3: Treatment Period||0
421992|NCT00804687|1005094|P6|COMPLETED|Period 3: Treatment Period||8
421993|NCT00804687|1005095|P5|COMPLETED|Period 3: Treatment Period||9
421994|NCT00804687|1005096|P4|COMPLETED|Period 3: Treatment Period||8
421995|NCT00804687|1005097|P3|COMPLETED|Period 3: Treatment Period||9
421996|NCT00804687|1005098|P2|COMPLETED|Period 3: Treatment Period||9
421997|NCT00804687|1005099|P1|COMPLETED|Period 3: Treatment Period||9
421998|NCT00804687|1005094|P6|STARTED|Period 3: Treatment Period||8
421999|NCT00804687|1005095|P5|STARTED|Period 3: Treatment Period||9
422000|NCT00804687|1005096|P4|STARTED|Period 3: Treatment Period||9
422001|NCT00804687|1005097|P3|STARTED|Period 3: Treatment Period||9
422002|NCT00804687|1005098|P2|STARTED|Period 3: Treatment Period||9
422003|NCT00804687|1005099|P1|STARTED|Period 3: Treatment Period||9
422004|NCT00804687|1005094|P6|NOT COMPLETED|Period 2: Washout Period||0
422005|NCT00804687|1005095|P5|NOT COMPLETED|Period 2: Washout Period||0
422006|NCT00804687|1005096|P4|NOT COMPLETED|Period 2: Washout Period||0
422007|NCT00804687|1005097|P3|NOT COMPLETED|Period 2: Washout Period||0
422008|NCT00804687|1005098|P2|NOT COMPLETED|Period 2: Washout Period||0
422009|NCT00804687|1005099|P1|NOT COMPLETED|Period 2: Washout Period||0
422010|NCT00804687|1005094|P6|COMPLETED|Period 2: Washout Period||8
422011|NCT00804687|1005095|P5|COMPLETED|Period 2: Washout Period||9
422012|NCT00804687|1005096|P4|COMPLETED|Period 2: Washout Period||9
422013|NCT00804687|1005097|P3|COMPLETED|Period 2: Washout Period||9
422014|NCT00804687|1005098|P2|COMPLETED|Period 2: Washout Period||9
422015|NCT00804687|1005099|P1|COMPLETED|Period 2: Washout Period||9
422016|NCT00804687|1005094|P6|STARTED|Period 2: Washout Period||8
422017|NCT00804687|1005095|P5|STARTED|Period 2: Washout Period||9
422018|NCT00804687|1005096|P4|STARTED|Period 2: Washout Period||9
422019|NCT00804687|1005097|P3|STARTED|Period 2: Washout Period||9
422020|NCT00804687|1005098|P2|STARTED|Period 2: Washout Period||9
422021|NCT00804687|1005099|P1|STARTED|Period 2: Washout Period||9
422022|NCT00804687|1005094|P6|NOT COMPLETED|Period 1: Treatment Period||0
422023|NCT00804687|1005095|P5|NOT COMPLETED|Period 1: Treatment Period||0
422024|NCT00804687|1005096|P4|NOT COMPLETED|Period 1: Treatment Period||0
422025|NCT00804687|1005097|P3|NOT COMPLETED|Period 1: Treatment Period||0
422026|NCT00804687|1005098|P2|NOT COMPLETED|Period 1: Treatment Period||0
422027|NCT00804687|1005099|P1|NOT COMPLETED|Period 1: Treatment Period||0
422028|NCT00804687|1005094|P6|COMPLETED|Period 1: Treatment Period||8
422029|NCT00804687|1005095|P5|COMPLETED|Period 1: Treatment Period||9
422030|NCT00804687|1005096|P4|COMPLETED|Period 1: Treatment Period||9
422031|NCT00804687|1005097|P3|COMPLETED|Period 1: Treatment Period||9
422032|NCT00804687|1005098|P2|COMPLETED|Period 1: Treatment Period||9
422033|NCT00804687|1005099|P1|COMPLETED|Period 1: Treatment Period||9
422034|NCT00804687|1005094|P6|STARTED|Period 1: Treatment Period||8
422035|NCT00804687|1005095|P5|STARTED|Period 1: Treatment Period||9
422036|NCT00804687|1005096|P4|STARTED|Period 1: Treatment Period||9
422037|NCT00804687|1005097|P3|STARTED|Period 1: Treatment Period||9
422038|NCT00804687|1005098|P2|STARTED|Period 1: Treatment Period||9
422039|NCT00804687|1005099|P1|STARTED|Period 1: Treatment Period||9
422040|NCT00804648|1005116|P6|NOT COMPLETED|Third Invervention||0
422041|NCT00804648|1005117|P5|NOT COMPLETED|Third Invervention||0
422042|NCT00804648|1005118|P4|NOT COMPLETED|Third Invervention||0
422043|NCT00804648|1005119|P3|NOT COMPLETED|Third Invervention||0
422044|NCT00804648|1005120|P2|NOT COMPLETED|Third Invervention||0
422045|NCT00804648|1005121|P1|NOT COMPLETED|Third Invervention||0
422046|NCT00804648|1005116|P6|COMPLETED|Third Invervention||8
422047|NCT00804648|1005117|P5|COMPLETED|Third Invervention||4
422048|NCT00804648|1005118|P4|COMPLETED|Third Invervention||4
422049|NCT00804648|1005119|P3|COMPLETED|Third Invervention||6
422050|NCT00804648|1005120|P2|COMPLETED|Third Invervention||5
422051|NCT00804648|1005121|P1|COMPLETED|Third Invervention||3
422052|NCT00804648|1005116|P6|STARTED|Third Invervention||8
422053|NCT00804648|1005117|P5|STARTED|Third Invervention||4
422054|NCT00804648|1005118|P4|STARTED|Third Invervention||4
422055|NCT00804648|1005119|P3|STARTED|Third Invervention||6
422056|NCT00804648|1005120|P2|STARTED|Third Invervention||5
422057|NCT00804648|1005121|P1|STARTED|Third Invervention||3
422058|NCT00804648|1005116|P6|NOT COMPLETED|Second Intervention||0
422059|NCT00804648|1005117|P5|NOT COMPLETED|Second Intervention||0
422060|NCT00804648|1005118|P4|NOT COMPLETED|Second Intervention||0
422061|NCT00804648|1005119|P3|NOT COMPLETED|Second Intervention||0
422062|NCT00804648|1005120|P2|NOT COMPLETED|Second Intervention||0
422063|NCT00804648|1005121|P1|NOT COMPLETED|Second Intervention||0
422064|NCT00804648|1005116|P6|COMPLETED|Second Intervention||8
422065|NCT00804648|1005117|P5|COMPLETED|Second Intervention||4
422066|NCT00804648|1005118|P4|COMPLETED|Second Intervention||4
422067|NCT00804648|1005119|P3|COMPLETED|Second Intervention||6
422068|NCT00804648|1005120|P2|COMPLETED|Second Intervention||5
422069|NCT00804648|1005121|P1|COMPLETED|Second Intervention||3
422070|NCT00804648|1005116|P6|STARTED|Second Intervention||8
422071|NCT00804648|1005117|P5|STARTED|Second Intervention||4
422072|NCT00804648|1005118|P4|STARTED|Second Intervention||4
422073|NCT00804648|1005119|P3|STARTED|Second Intervention||6
422074|NCT00804648|1005120|P2|STARTED|Second Intervention||5
422075|NCT00804648|1005121|P1|STARTED|Second Intervention||3
422076|NCT00804648|1005116|P6|NOT COMPLETED|First Intervention||0
422077|NCT00804648|1005117|P5|NOT COMPLETED|First Intervention||0
422078|NCT00804648|1005118|P4|NOT COMPLETED|First Intervention||0
422079|NCT00804648|1005119|P3|NOT COMPLETED|First Intervention||0
422080|NCT00804648|1005120|P2|NOT COMPLETED|First Intervention||0
422081|NCT00804648|1005121|P1|NOT COMPLETED|First Intervention||0
422082|NCT00804648|1005116|P6|COMPLETED|First Intervention||8
422083|NCT00804648|1005117|P5|COMPLETED|First Intervention||4
422084|NCT00804648|1005118|P4|COMPLETED|First Intervention||4
422085|NCT00804648|1005119|P3|COMPLETED|First Intervention||6
422086|NCT00804648|1005120|P2|COMPLETED|First Intervention||5
422087|NCT00804648|1005121|P1|COMPLETED|First Intervention||3
422088|NCT00804648|1005116|P6|STARTED|First Intervention||8
422089|NCT00804648|1005117|P5|STARTED|First Intervention||4
422090|NCT00804648|1005118|P4|STARTED|First Intervention||4
422091|NCT00804648|1005119|P3|STARTED|First Intervention||6
422092|NCT00804648|1005120|P2|STARTED|First Intervention||5
422093|NCT00804648|1005121|P1|STARTED|First Intervention||3
422094|NCT00804609|1005164|P2|NOT COMPLETED|Overall Study||1
422095|NCT00804609|1005165|P1|NOT COMPLETED|Overall Study||0
422096|NCT00804609|1005164|P2|COMPLETED|Overall Study||14
422097|NCT00804609|1005165|P1|COMPLETED|Overall Study||15
422098|NCT00804609|1005164|P2|STARTED|Overall Study||15
422099|NCT00804609|1005165|P1|STARTED|Overall Study||15
422100|NCT00804596|1005171|P1|NOT COMPLETED|Overall Study||0
422101|NCT00804596|1005171|P1|COMPLETED|Overall Study||74
422102|NCT00804596|1005171|P1|STARTED|Overall Study||74
422103|NCT00804570|1005178|P2|NOT COMPLETED|Overall Study||94
422104|NCT00804570|1005179|P1|NOT COMPLETED|Overall Study||72
422105|NCT00804570|1005178|P2|COMPLETED|Overall Study||94
422106|NCT00804570|1005179|P1|COMPLETED|Overall Study||115
422107|NCT00804570|1005178|P2|STARTED|Overall Study||188
422108|NCT00804570|1005179|P1|STARTED|Overall Study||187
422109|NCT00804193|1005238|P3|NOT COMPLETED|Overall Study||32
422110|NCT00804193|1005239|P2|NOT COMPLETED|Overall Study||44
422111|NCT00804193|1005240|P1|NOT COMPLETED|Overall Study||39
422112|NCT00804193|1005238|P3|COMPLETED|Overall Study||77
422113|NCT00804193|1005239|P2|COMPLETED|Overall Study||180
422114|NCT00804193|1005240|P1|COMPLETED|Overall Study||181
422115|NCT00804193|1005238|P3|STARTED|Overall Study||109
422116|NCT00804193|1005239|P2|STARTED|Overall Study||224
422117|NCT00804193|1005240|P1|STARTED|Overall Study||220
422118|NCT00803959|1005256|P2|NOT COMPLETED|Overall Study||51
422119|NCT00803959|1005257|P1|NOT COMPLETED|Overall Study||56
422120|NCT00803959|1005256|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
422121|NCT00803959|1005257|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
422122|NCT00803959|1005256|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
422123|NCT00803959|1005257|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
422124|NCT00803959|1005256|P2|STARTED|Overall Study||315
422125|NCT00803959|1005257|P1|STARTED|Overall Study||315
422126|NCT00803790|1005289|P4|NOT COMPLETED|Period 2||1
422127|NCT00803790|1005290|P3|NOT COMPLETED|Period 2||1
422128|NCT00803790|1005291|P2|NOT COMPLETED|Period 2||0
422129|NCT00803790|1005292|P1|NOT COMPLETED|Period 2||2
422130|NCT00803790|1005289|P4|COMPLETED|Period 2||30
422131|NCT00803790|1005290|P3|COMPLETED|Period 2||30
422132|NCT00803790|1005291|P2|COMPLETED|Period 2||114
422133|NCT00803790|1005292|P1|COMPLETED|Period 2||114
422134|NCT00803790|1005289|P4|STARTED|Period 2||31
422135|NCT00803790|1005290|P3|STARTED|Period 2||31
422136|NCT00803790|1005291|P2|STARTED|Period 2||114
422137|NCT00803790|1005292|P1|STARTED|Period 2||116
422138|NCT00803790|1005289|P4|NOT COMPLETED|Period 1||4
422139|NCT00803790|1005290|P3|NOT COMPLETED|Period 1||1
422140|NCT00803790|1005291|P2|NOT COMPLETED|Period 1||12
422141|NCT00803790|1005292|P1|NOT COMPLETED|Period 1||9
422142|NCT00803790|1005289|P4|COMPLETED|Period 1||31
422143|NCT00803790|1005290|P3|COMPLETED|Period 1||31
422144|NCT00803790|1005291|P2|COMPLETED|Period 1||114
422145|NCT00803790|1005292|P1|COMPLETED|Period 1||116
422146|NCT00803790|1005289|P4|STARTED|Period 1||35
422147|NCT00803790|1005290|P3|STARTED|Period 1||32
422148|NCT00803790|1005291|P2|STARTED|Period 1||126
422149|NCT00803790|1005292|P1|STARTED|Period 1||125
422150|NCT00803777|1005303|P1|NOT COMPLETED|Overall Study||0
422151|NCT00803777|1005303|P1|COMPLETED|Overall Study||147
422152|NCT00803777|1005303|P1|STARTED|Overall Study||147
422153|NCT00803751|1005313|P2|NOT COMPLETED|Overall Study||0
422154|NCT00803751|1005314|P1|NOT COMPLETED|Overall Study||0
422155|NCT00803751|1005313|P2|COMPLETED|Overall Study||23
422156|NCT00803751|1005314|P1|COMPLETED|Overall Study||26
422157|NCT00803751|1005313|P2|STARTED|Overall Study||23
422158|NCT00803751|1005314|P1|STARTED|Overall Study||26
422159|NCT00803738|1005332|P2|NOT COMPLETED|Overall Study||110
422160|NCT00803738|1005333|P1|NOT COMPLETED|Overall Study||94
422161|NCT00803738|1005332|P2|COMPLETED|Overall Study||176
422162|NCT00803738|1005333|P1|COMPLETED|Overall Study||192
422163|NCT00803738|1005332|P2|STARTED|Overall Study||286
422164|NCT00803738|1005333|P1|STARTED|Overall Study||286
422165|NCT00803712|1005345|P2|NOT COMPLETED|Overall Study||27
422166|NCT00803712|1005346|P1|NOT COMPLETED|Overall Study||36
422167|NCT00803712|1005345|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
422168|NCT00803712|1005346|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
422169|NCT00803712|1005345|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
422170|NCT00803712|1005346|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
422171|NCT00803712|1005345|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
422253|NCT00803400|1005515|P2|STARTED|Overall Study||75
422172|NCT00803712|1005346|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
422173|NCT00803712|1005345|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
422174|NCT00803712|1005346|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
422175|NCT00803686|1005414|P4|NOT COMPLETED|Part 2, Period 3||0
422176|NCT00803686|1005415|P3|NOT COMPLETED|Part 2, Period 3||0
422177|NCT00803686|1005416|P2|NOT COMPLETED|Part 2, Period 3||0
422178|NCT00803686|1005417|P1|NOT COMPLETED|Part 2, Period 3||0
422179|NCT00803686|1005414|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
422180|NCT00803686|1005415|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
422181|NCT00803686|1005416|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
422182|NCT00803686|1005417|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
422183|NCT00803686|1005414|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
422184|NCT00803686|1005415|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
422185|NCT00803686|1005416|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
422186|NCT00803686|1005417|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
422187|NCT00803686|1005414|P4|NOT COMPLETED|Part 1, Period 2||0
422188|NCT00803686|1005415|P3|NOT COMPLETED|Part 1, Period 2||0
422189|NCT00803686|1005416|P2|NOT COMPLETED|Part 1, Period 2||0
422190|NCT00803686|1005417|P1|NOT COMPLETED|Part 1, Period 2||0
422191|NCT00803686|1005414|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
422192|NCT00803686|1005415|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
422193|NCT00803686|1005416|P2|COMPLETED|Part 1, Period 2||6
422194|NCT00803686|1005417|P1|COMPLETED|Part 1, Period 2||6
422195|NCT00803686|1005414|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
422196|NCT00803686|1005415|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
422197|NCT00803686|1005416|P2|STARTED|Part 1, Period 2||6
422198|NCT00803686|1005417|P1|STARTED|Part 1, Period 2||6
422199|NCT00803686|1005414|P4|NOT COMPLETED|Part 1, Period 1||0
422200|NCT00803686|1005415|P3|NOT COMPLETED|Part 1, Period 1||0
422201|NCT00803686|1005416|P2|NOT COMPLETED|Part 1, Period 1||0
422202|NCT00803686|1005417|P1|NOT COMPLETED|Part 1, Period 1||0
422203|NCT00803686|1005414|P4|COMPLETED|Part 1, Period 1||0
422204|NCT00803686|1005415|P3|COMPLETED|Part 1, Period 1||0
422205|NCT00803686|1005416|P2|COMPLETED|Part 1, Period 1||6
422206|NCT00803686|1005417|P1|COMPLETED|Part 1, Period 1||6
422207|NCT00803686|1005414|P4|STARTED|Part 1, Period 1||0
422208|NCT00803686|1005415|P3|STARTED|Part 1, Period 1||0
422209|NCT00803686|1005416|P2|STARTED|Part 1, Period 1||6
422210|NCT00803686|1005417|P1|STARTED|Part 1, Period 1||6
422211|NCT00803647|1005435|P1|NOT COMPLETED|Overall Study||0
422212|NCT00803647|1005435|P1|COMPLETED|Overall Study||20
422213|NCT00803647|1005435|P1|STARTED|Overall Study||20
422214|NCT00803634|1005444|P2|NOT COMPLETED|Overall Study||5
422215|NCT00803634|1005445|P1|NOT COMPLETED|Overall Study||6
422216|NCT00803634|1005444|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
422217|NCT00803634|1005445|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
422218|NCT00803634|1005444|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
422219|NCT00803634|1005445|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
422220|NCT00803634|1005444|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
422221|NCT00803634|1005445|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
422222|NCT00803595|1005474|P3|NOT COMPLETED|Overall Study||16
422223|NCT00803595|1005475|P2|NOT COMPLETED|Overall Study||8
422224|NCT00803595|1005476|P1|NOT COMPLETED|Overall Study||15
422225|NCT00803595|1005474|P3|COMPLETED|Overall Study||322
422226|NCT00803595|1005475|P2|COMPLETED|Overall Study||319
422227|NCT00803595|1005476|P1|COMPLETED|Overall Study||322
422228|NCT00803595|1005474|P3|STARTED|Overall Study||338
422229|NCT00803595|1005475|P2|STARTED|Overall Study||327
422230|NCT00803595|1005476|P1|STARTED|Overall Study||337
422231|NCT00803517|1005489|P2|NOT COMPLETED|Overall Study||0
422232|NCT00803517|1005490|P1|NOT COMPLETED|Overall Study||0
422233|NCT00803517|1005489|P2|COMPLETED|Overall Study||12
422234|NCT00803517|1005490|P1|COMPLETED|Overall Study||12
422235|NCT00803517|1005489|P2|STARTED|Overall Study||12
422236|NCT00803517|1005490|P1|STARTED|Overall Study||12
422237|NCT00803413|1005500|P4|NOT COMPLETED|Overall Period||0
422238|NCT00803413|1005501|P3|NOT COMPLETED|Overall Period||0
422239|NCT00803413|1005502|P2|NOT COMPLETED|Overall Period||0
422240|NCT00803413|1005503|P1|NOT COMPLETED|Overall Period||0
422241|NCT00803413|1005500|P4|COMPLETED|Overall Period||30
422242|NCT00803413|1005501|P3|COMPLETED|Overall Period||29
422243|NCT00803413|1005502|P2|COMPLETED|Overall Period||32
422244|NCT00803413|1005503|P1|COMPLETED|Overall Period||28
422245|NCT00803413|1005500|P4|STARTED|Overall Period||30
422246|NCT00803413|1005501|P3|STARTED|Overall Period||29
422247|NCT00803413|1005502|P2|STARTED|Overall Period||32
422248|NCT00803413|1005503|P1|STARTED|Overall Period||28
422249|NCT00803400|1005515|P2|NOT COMPLETED|Overall Study||24
422250|NCT00803400|1005516|P1|NOT COMPLETED|Overall Study||20
422251|NCT00803400|1005515|P2|COMPLETED|Overall Study||51
422252|NCT00803400|1005516|P1|COMPLETED|Overall Study||55
422254|NCT00803400|1005516|P1|STARTED|Overall Study||75
422255|NCT00803361|1005528|P2|NOT COMPLETED|Overall Study||28
422256|NCT00803361|1005529|P1|NOT COMPLETED|Overall Study||26
422257|NCT00803361|1005528|P2|COMPLETED|Overall Study||74
422258|NCT00803361|1005529|P1|COMPLETED|Overall Study||82
422259|NCT00803361|1005528|P2|STARTED|Overall Study||102
422260|NCT00803361|1005529|P1|STARTED|Overall Study||108
422261|NCT00803283|1005549|P2|NOT COMPLETED|Overall Study||0
422262|NCT00803283|1005550|P1|NOT COMPLETED|Overall Study||0
422263|NCT00803283|1005549|P2|COMPLETED|Overall Study||1
422264|NCT00803283|1005550|P1|COMPLETED|Overall Study||1
422265|NCT00803283|1005549|P2|STARTED|Overall Study||1
422266|NCT00803283|1005550|P1|STARTED|Overall Study||1
422267|NCT00803270|1005576|P2|NOT COMPLETED|Overall Study||2
422268|NCT00803270|1005577|P1|NOT COMPLETED|Overall Study||1
422269|NCT00803270|1005576|P2|COMPLETED|Overall Study||12
422270|NCT00803270|1005577|P1|COMPLETED|Overall Study||12
422271|NCT00803270|1005576|P2|STARTED|Overall Study||14
422272|NCT00803270|1005577|P1|STARTED|Overall Study||13
422273|NCT00803244|1005587|P2|NOT COMPLETED|Overall Study||15
422274|NCT00803244|1005588|P1|NOT COMPLETED|Overall Study||7
422275|NCT00803244|1005587|P2|COMPLETED|Overall Study||178
422276|NCT00803244|1005588|P1|COMPLETED|Overall Study||181
422277|NCT00803244|1005587|P2|STARTED|Overall Study||193
422278|NCT00803244|1005588|P1|STARTED|Overall Study||188
422279|NCT00803179|1005596|P1|NOT COMPLETED|Overall Study||3
422280|NCT00803179|1005596|P1|COMPLETED|Overall Study||2
422281|NCT00803179|1005596|P1|STARTED|Overall Study||5
422282|NCT00803114|1005602|P2|NOT COMPLETED|Overall Study||0
422283|NCT00803114|1005603|P1|NOT COMPLETED|Overall Study||0
422284|NCT00803114|1005602|P2|COMPLETED|Overall Study||115
422285|NCT00803114|1005603|P1|COMPLETED|Overall Study||113
422286|NCT00803114|1005602|P2|STARTED|Overall Study||115
422287|NCT00803114|1005603|P1|STARTED|Overall Study||113
422288|NCT00803101|1005615|P2|NOT COMPLETED|Overall Study||22
422289|NCT00803101|1005616|P1|NOT COMPLETED|Overall Study||18
422290|NCT00803101|1005615|P2|COMPLETED|Overall Study||66
422291|NCT00803101|1005616|P1|COMPLETED|Overall Study||70
422292|NCT00803101|1005615|P2|STARTED|Overall Study||88
422293|NCT00803101|1005616|P1|STARTED|Overall Study||88
422294|NCT00803062|1005638|P4|NOT COMPLETED|Overall Study||0
422295|NCT00803062|1005639|P3|NOT COMPLETED|Overall Study||0
422296|NCT00803062|1005640|P2|NOT COMPLETED|Overall Study||0
422297|NCT00803062|1005641|P1|NOT COMPLETED|Overall Study||0
422298|NCT00803062|1005638|P4|COMPLETED|Overall Study||112
422299|NCT00803062|1005639|P3|COMPLETED|Overall Study||111
422300|NCT00803062|1005640|P2|COMPLETED|Overall Study||115
422301|NCT00803062|1005641|P1|COMPLETED|Overall Study||114
422302|NCT00803062|1005638|P4|STARTED|Overall Study||112
422303|NCT00803062|1005639|P3|STARTED|Overall Study||111
422304|NCT00803062|1005640|P2|STARTED|Overall Study||115
422305|NCT00803062|1005641|P1|STARTED|Overall Study||114
422306|NCT00803049|1005663|P4|NOT COMPLETED|Overall Study||102
422307|NCT00803049|1005664|P3|NOT COMPLETED|Overall Study||44
422308|NCT00803049|1005665|P2|NOT COMPLETED|Overall Study||118
422309|NCT00803049|1005666|P1|NOT COMPLETED|Overall Study||61
422310|NCT00803049|1005663|P4|COMPLETED|Overall Study||151
422311|NCT00803049|1005664|P3|COMPLETED|Overall Study||64
422312|NCT00803049|1005665|P2|COMPLETED|Overall Study||134
422313|NCT00803049|1005666|P1|COMPLETED|Overall Study||68
422314|NCT00803049|1005663|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
422315|NCT00803049|1005664|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
422316|NCT00803049|1005665|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
422317|NCT00803049|1005666|P1|Safety Population|Overall Study||129
422318|NCT00803049|1005663|P4|Treated|Overall Study||251
422319|NCT00803049|1005664|P3|Treated|Overall Study||108
422320|NCT00803049|1005665|P2|Treated|Overall Study||252
422321|NCT00803049|1005666|P1|Treated|Overall Study||129
422322|NCT00803049|1005663|P4|STARTED|Overall Study|Randomized in extension study|253
422323|NCT00803049|1005664|P3|STARTED|Overall Study|Randomized in extension study|108
422324|NCT00803049|1005665|P2|STARTED|Overall Study|Randomized in extension study|252
422325|NCT00803049|1005666|P1|STARTED|Overall Study|Randomized in extension study|129
422326|NCT00803023|1005700|P4|NOT COMPLETED|Overall Study||8
422327|NCT00803023|1005701|P3|NOT COMPLETED|Overall Study||11
422328|NCT00803023|1005702|P2|NOT COMPLETED|Overall Study||8
422329|NCT00803023|1005703|P1|NOT COMPLETED|Overall Study||5
422330|NCT00803023|1005700|P4|COMPLETED|Overall Study||25
422331|NCT00803023|1005701|P3|COMPLETED|Overall Study||20
422332|NCT00803023|1005702|P2|COMPLETED|Overall Study||25
422333|NCT00803023|1005703|P1|COMPLETED|Overall Study||27
422334|NCT00803023|1005700|P4|STARTED|Overall Study||33
422335|NCT00803023|1005701|P3|STARTED|Overall Study||31
422336|NCT00803023|1005702|P2|STARTED|Overall Study||33
422337|NCT00803023|1005703|P1|STARTED|Overall Study||32
422338|NCT00803010|1005715|P2|NOT COMPLETED|Overall Study||0
422339|NCT00803010|1005716|P1|NOT COMPLETED|Overall Study||0
422340|NCT00803010|1005715|P2|COMPLETED|Overall Study||37
422341|NCT00803010|1005716|P1|COMPLETED|Overall Study||37
422342|NCT00803010|1005715|P2|STARTED|Overall Study||37
422343|NCT00803010|1005716|P1|STARTED|Overall Study||37
422344|NCT00802997|1005728|P2|NOT COMPLETED|6 Month to 9 Months||0
422345|NCT00802997|1005729|P1|NOT COMPLETED|6 Month to 9 Months||2
422346|NCT00802997|1005728|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
422347|NCT00802997|1005729|P1|COMPLETED|6 Month to 9 Months||25
422348|NCT00802997|1005728|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
422349|NCT00802997|1005729|P1|STARTED|6 Month to 9 Months||27
422350|NCT00802997|1005728|P2|NOT COMPLETED|3 Months to 6 Months||0
422351|NCT00802997|1005729|P1|NOT COMPLETED|3 Months to 6 Months||7
422352|NCT00802997|1005728|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
422353|NCT00802997|1005729|P1|COMPLETED|3 Months to 6 Months||27
422354|NCT00802997|1005728|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
422355|NCT00802997|1005729|P1|STARTED|3 Months to 6 Months||34
422356|NCT00802997|1005728|P2|NOT COMPLETED|Baseline to 3 Months||0
422357|NCT00802997|1005729|P1|NOT COMPLETED|Baseline to 3 Months||0
422358|NCT00802997|1005728|P2|COMPLETED|Baseline to 3 Months||17
422359|NCT00802997|1005729|P1|COMPLETED|Baseline to 3 Months||34
422360|NCT00802997|1005728|P2|STARTED|Baseline to 3 Months||17
422361|NCT00802997|1005729|P1|STARTED|Baseline to 3 Months||34
422362|NCT00802880|1005739|P1|NOT COMPLETED|Overall Study||0
422363|NCT00802880|1005739|P1|COMPLETED|Overall Study||80
422364|NCT00802880|1005739|P1|STARTED|Overall Study||80
422365|NCT00802867|1005758|P1|NOT COMPLETED|Overall Study||13
422366|NCT00802867|1005758|P1|COMPLETED|Overall Study||976
422367|NCT00802867|1005758|P1|STARTED|Overall Study||989
422368|NCT00802841|1005768|P2|NOT COMPLETED|Overall Study||95
422369|NCT00802841|1005769|P1|NOT COMPLETED|Overall Study||96
422370|NCT00802841|1005768|P2|COMPLETED|Overall Study||0
422371|NCT00802841|1005769|P1|COMPLETED|Overall Study||0
422372|NCT00802841|1005768|P2|Cross-over Set|Overall Study||56
422373|NCT00802841|1005769|P1|Cross-over Set|Overall Study||13
422374|NCT00802841|1005768|P2|Safety Set|Overall Study||93
422375|NCT00802841|1005769|P1|Safety Set|Overall Study||96
422376|NCT00802841|1005768|P2|Full Analysis Set|Overall Study||95
422377|NCT00802841|1005769|P1|Full Analysis Set|Overall Study||96
422378|NCT00802841|1005768|P2|STARTED|Overall Study||95
422379|NCT00802841|1005769|P1|STARTED|Overall Study||96
422380|NCT00802737|1005794|P3|NOT COMPLETED|Overall Study||1
422381|NCT00802737|1005795|P2|NOT COMPLETED|Overall Study||11
422382|NCT00802737|1005796|P1|NOT COMPLETED|Overall Study||17
422383|NCT00802737|1005794|P3|COMPLETED|Overall Study||0
422384|NCT00802737|1005795|P2|COMPLETED|Overall Study||0
422385|NCT00802737|1005796|P1|COMPLETED|Overall Study||0
422386|NCT00802737|1005794|P3|STARTED|Overall Study||1
422387|NCT00802737|1005795|P2|STARTED|Overall Study||11
422388|NCT00802737|1005796|P1|STARTED|Overall Study||17
422389|NCT00802685|1005844|P2|NOT COMPLETED|Overall Study||0
422390|NCT00802685|1005845|P1|NOT COMPLETED|Overall Study||0
422391|NCT00802685|1005844|P2|COMPLETED|Overall Study||51
422392|NCT00802685|1005845|P1|COMPLETED|Overall Study||54
422393|NCT00802685|1005844|P2|STARTED|Overall Study||51
422394|NCT00802685|1005845|P1|STARTED|Overall Study||54
422395|NCT00802672|1005856|P3|NOT COMPLETED|Overall Study||34
422396|NCT00802672|1005857|P2|NOT COMPLETED|Overall Study||52
422397|NCT00802672|1005858|P1|NOT COMPLETED|Overall Study||68
422398|NCT00802672|1005856|P3|COMPLETED|Overall Study||77
422399|NCT00802672|1005857|P2|COMPLETED|Overall Study||174
422400|NCT00802672|1005858|P1|COMPLETED|Overall Study||156
422401|NCT00802672|1005856|P3|STARTED|Overall Study||111
422402|NCT00802672|1005857|P2|STARTED|Overall Study||226
422403|NCT00802672|1005858|P1|STARTED|Overall Study||224
422404|NCT00802659|1005876|P4|NOT COMPLETED|Overall Study||0
422405|NCT00802659|1005877|P3|NOT COMPLETED|Overall Study||0
422406|NCT00802659|1005878|P2|NOT COMPLETED|Overall Study||1
422407|NCT00802659|1005879|P1|NOT COMPLETED|Overall Study||0
422408|NCT00802659|1005876|P4|COMPLETED|Overall Study||0
422409|NCT00802659|1005877|P3|COMPLETED|Overall Study||0
422410|NCT00802659|1005878|P2|COMPLETED|Overall Study||1
422411|NCT00802659|1005879|P1|COMPLETED|Overall Study||0
422412|NCT00802659|1005876|P4|STARTED|Overall Study||0
422413|NCT00802659|1005877|P3|STARTED|Overall Study||0
422414|NCT00802659|1005878|P2|STARTED|Overall Study||2
422415|NCT00802659|1005879|P1|STARTED|Overall Study||0
422416|NCT00802633|1005907|P2|NOT COMPLETED|Overall Study||0
422417|NCT00802633|1005908|P1|NOT COMPLETED|Overall Study||0
422418|NCT00802633|1005907|P2|COMPLETED|Overall Study||40
422419|NCT00802633|1005908|P1|COMPLETED|Overall Study||40
422420|NCT00802633|1005907|P2|STARTED|Overall Study||40
422421|NCT00802633|1005908|P1|STARTED|Overall Study||40
422422|NCT00802529|1005918|P2|NOT COMPLETED|Overall Study||1
422423|NCT00802529|1005919|P1|NOT COMPLETED|Overall Study||0
422424|NCT00802529|1005918|P2|COMPLETED|Overall Study||29
422425|NCT00802529|1005919|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
422426|NCT00802529|1005918|P2|STARTED|Overall Study||30
422427|NCT00802529|1005919|P1|STARTED|Overall Study||30
422428|NCT00802503|1005931|P2|NOT COMPLETED|Overall Study||20
422429|NCT00802503|1005932|P1|NOT COMPLETED|Overall Study||10
422430|NCT00802503|1005931|P2|COMPLETED|Overall Study||133
422431|NCT00802503|1005932|P1|COMPLETED|Overall Study||142
422432|NCT00802503|1005931|P2|STARTED|Overall Study||153
422433|NCT00802503|1005932|P1|STARTED|Overall Study||152
422434|NCT00802412|1005956|P2|NOT COMPLETED|Overall Study||1
422435|NCT00802412|1005957|P1|NOT COMPLETED|Overall Study||2
422436|NCT00802412|1005956|P2|COMPLETED|Overall Study||66
422437|NCT00802412|1005957|P1|COMPLETED|Overall Study||63
422438|NCT00802412|1005956|P2|STARTED|Overall Study||67
422439|NCT00802412|1005957|P1|STARTED|Overall Study||65
422440|NCT00802360|1005969|P4|NOT COMPLETED|Overall Study||22
422441|NCT00802360|1005970|P3|NOT COMPLETED|Overall Study||25
422442|NCT00802360|1005971|P2|NOT COMPLETED|Overall Study||26
422443|NCT00802360|1005972|P1|NOT COMPLETED|Overall Study||24
422444|NCT00802360|1005969|P4|COMPLETED|Overall Study||17
422445|NCT00802360|1005970|P3|COMPLETED|Overall Study||17
422446|NCT00802360|1005971|P2|COMPLETED|Overall Study||16
422447|NCT00802360|1005972|P1|COMPLETED|Overall Study||18
422448|NCT00802360|1005969|P4|STARTED|Overall Study||39
422449|NCT00802360|1005970|P3|STARTED|Overall Study||42
422450|NCT00802360|1005971|P2|STARTED|Overall Study||42
422451|NCT00802360|1005972|P1|STARTED|Overall Study||42
422452|NCT00802204|1006014|P2|NOT COMPLETED|Overall Study||1
422453|NCT00802204|1006015|P1|NOT COMPLETED|Overall Study||1
422454|NCT00802204|1006014|P2|COMPLETED|Overall Study||18
422455|NCT00802204|1006015|P1|COMPLETED|Overall Study||8
422456|NCT00802204|1006014|P2|STARTED|Overall Study||19
422457|NCT00802204|1006015|P1|STARTED|Overall Study||9
422458|NCT00802178|1006039|P1|NOT COMPLETED|Overall Study||113
422459|NCT00802178|1006039|P1|COMPLETED|Overall Study||2335
422460|NCT00802178|1006039|P1|STARTED|Overall Study||2448
422461|NCT00802100|1006049|P3|NOT COMPLETED|Overall Study||4
422462|NCT00802100|1006050|P2|NOT COMPLETED|Overall Study||7
422463|NCT00802100|1006051|P1|NOT COMPLETED|Overall Study||6
422464|NCT00802100|1006049|P3|COMPLETED|Overall Study||2
422465|NCT00802100|1006050|P2|COMPLETED|Overall Study||2
422466|NCT00802100|1006051|P1|COMPLETED|Overall Study||0
422467|NCT00802100|1006049|P3|STARTED|Overall Study||6
422468|NCT00802100|1006050|P2|STARTED|Overall Study||9
422469|NCT00802100|1006051|P1|STARTED|Overall Study||6
422470|NCT00802074|1006066|P6|NOT COMPLETED|Overall Study||0
422471|NCT00802074|1006067|P5|NOT COMPLETED|Overall Study||0
422472|NCT00802074|1006068|P4|NOT COMPLETED|Overall Study||0
422473|NCT00802074|1006069|P3|NOT COMPLETED|Overall Study||1
422474|NCT00802074|1006070|P2|NOT COMPLETED|Overall Study||1
422475|NCT00802074|1006071|P1|NOT COMPLETED|Overall Study||2
422476|NCT00802074|1006066|P6|COMPLETED|Overall Study||7
422477|NCT00802074|1006067|P5|COMPLETED|Overall Study||7
422478|NCT00802074|1006068|P4|COMPLETED|Overall Study||7
422479|NCT00802074|1006069|P3|COMPLETED|Overall Study||6
422480|NCT00802074|1006070|P2|COMPLETED|Overall Study||7
422481|NCT00802074|1006071|P1|COMPLETED|Overall Study||7
422482|NCT00802074|1006066|P6|STARTED|Overall Study||7
422483|NCT00802074|1006067|P5|STARTED|Overall Study||7
422484|NCT00802074|1006068|P4|STARTED|Overall Study||7
422485|NCT00802074|1006069|P3|STARTED|Overall Study||7
422486|NCT00802074|1006070|P2|STARTED|Overall Study||8
422487|NCT00802074|1006071|P1|STARTED|Overall Study||9
422488|NCT00801983|1006105|P2|NOT COMPLETED|Period 2||1
422489|NCT00801983|1006106|P1|NOT COMPLETED|Period 2||2
422490|NCT00801983|1006105|P2|COMPLETED|Period 2||32
422491|NCT00801983|1006106|P1|COMPLETED|Period 2||38
422492|NCT00801983|1006105|P2|STARTED|Period 2||33
422493|NCT00801983|1006106|P1|STARTED|Period 2||40
422494|NCT00801983|1006105|P2|NOT COMPLETED|Period 1||8
422495|NCT00801983|1006106|P1|NOT COMPLETED|Period 1||4
422496|NCT00801983|1006105|P2|COMPLETED|Period 1||33
422497|NCT00801983|1006106|P1|COMPLETED|Period 1||40
422498|NCT00801983|1006105|P2|STARTED|Period 1||41
422499|NCT00801983|1006106|P1|STARTED|Period 1||44
422500|NCT00801892|1006114|P2|NOT COMPLETED|Overall Study||0
422501|NCT00801892|1006115|P1|NOT COMPLETED|Overall Study||0
422502|NCT00801892|1006114|P2|COMPLETED|Overall Study||12
422503|NCT00801892|1006115|P1|COMPLETED|Overall Study||11
422504|NCT00801892|1006114|P2|STARTED|Overall Study||12
422505|NCT00801892|1006115|P1|STARTED|Overall Study||11
422506|NCT00801827|1006121|P1|NOT COMPLETED|Overall Study||0
422507|NCT00801827|1006121|P1|COMPLETED|Overall Study||5
422508|NCT00801827|1006121|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
422509|NCT00801801|1006125|P1|NOT COMPLETED|Overall Study||0
422510|NCT00801801|1006125|P1|COMPLETED|Overall Study||5
422511|NCT00801801|1006125|P1|STARTED|Overall Study||5
422512|NCT00801684|1006130|P1|NOT COMPLETED|Overall Study||0
422513|NCT00801684|1006130|P1|COMPLETED|Overall Study||24
422514|NCT00801684|1006130|P1|STARTED|Overall Study||24
422515|NCT00801632|1006152|P1|NOT COMPLETED|Overall Study||1
422516|NCT00801632|1006152|P1|COMPLETED|Overall Study||4
422517|NCT00801632|1006152|P1|STARTED|Overall Study||5
422518|NCT00801242|1006163|P1|NOT COMPLETED|Overall Study||52
422519|NCT00801242|1006163|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
422520|NCT00801242|1006163|P1|Started Cycle 3|Overall Study||2
422521|NCT00801242|1006163|P1|Started Cycle 2|Overall Study||35
422522|NCT00801242|1006163|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
422523|NCT00801242|1006163|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
422524|NCT00801242|1006163|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
422525|NCT00801242|1006163|P1|STARTED|Overall Study|Randomized participants.|220
422526|NCT00801229|1006176|P2|NOT COMPLETED|Received Study Drug/Placebo||4
422527|NCT00801229|1006177|P1|NOT COMPLETED|Received Study Drug/Placebo||4
422528|NCT00801229|1006176|P2|COMPLETED|Received Study Drug/Placebo||30
422529|NCT00801229|1006177|P1|COMPLETED|Received Study Drug/Placebo||31
422530|NCT00801229|1006176|P2|STARTED|Received Study Drug/Placebo||34
422531|NCT00801229|1006177|P1|STARTED|Received Study Drug/Placebo||35
422532|NCT00801229|1006176|P2|NOT COMPLETED|Signed Consent||3
422533|NCT00801229|1006177|P1|NOT COMPLETED|Signed Consent||3
422534|NCT00801229|1006176|P2|COMPLETED|Signed Consent||34
422535|NCT00801229|1006177|P1|COMPLETED|Signed Consent||35
422536|NCT00801229|1006176|P2|STARTED|Signed Consent||37
422537|NCT00801229|1006177|P1|STARTED|Signed Consent||38
422538|NCT00801138|1006187|P4|NOT COMPLETED|Overall Study||0
422539|NCT00801138|1006188|P3|NOT COMPLETED|Overall Study||0
422540|NCT00801138|1006189|P2|NOT COMPLETED|Overall Study||0
422541|NCT00801138|1006190|P1|NOT COMPLETED|Overall Study||0
422542|NCT00801138|1006187|P4|COMPLETED|Overall Study||54
422543|NCT00801138|1006188|P3|COMPLETED|Overall Study||54
422544|NCT00801138|1006189|P2|COMPLETED|Overall Study||56
422545|NCT00801138|1006190|P1|COMPLETED|Overall Study||54
422546|NCT00801138|1006187|P4|STARTED|Overall Study||54
422547|NCT00801138|1006188|P3|STARTED|Overall Study||54
422548|NCT00801138|1006189|P2|STARTED|Overall Study||56
422549|NCT00801138|1006190|P1|STARTED|Overall Study||54
422550|NCT00801099|1006212|P1|NOT COMPLETED|Overall Study||101
422551|NCT00801099|1006212|P1|COMPLETED|Overall Study||175
422552|NCT00801099|1006212|P1|STARTED|Overall Study||276
422553|NCT00800982|1006218|P2|NOT COMPLETED|Overall Study||3
422554|NCT00800982|1006219|P1|NOT COMPLETED|Overall Study||2
422555|NCT00800982|1006218|P2|COMPLETED|Overall Study||12
422556|NCT00800982|1006219|P1|COMPLETED|Overall Study||13
422557|NCT00800982|1006218|P2|STARTED|Overall Study||15
422558|NCT00800982|1006219|P1|STARTED|Overall Study||15
422559|NCT00800865|1006227|P2|NOT COMPLETED|Overall Study||0
422560|NCT00800865|1006228|P1|NOT COMPLETED|Overall Study||0
422561|NCT00800865|1006227|P2|COMPLETED|Overall Study||16
422562|NCT00800865|1006228|P1|COMPLETED|Overall Study||15
422563|NCT00800865|1006227|P2|STARTED|Overall Study||16
422564|NCT00800865|1006228|P1|STARTED|Overall Study||15
422565|NCT00800839|1006236|P1|NOT COMPLETED|Overall Study||7
422566|NCT00800839|1006236|P1|COMPLETED|Overall Study||49
422567|NCT00800839|1006236|P1|STARTED|Overall Study||56
422568|NCT00800735|1006245|P1|NOT COMPLETED|Overall Study||14
422569|NCT00800735|1006245|P1|COMPLETED|Overall Study||16
422570|NCT00800735|1006245|P1|STARTED|Overall Study||30
422571|NCT00800683|1006251|P2|NOT COMPLETED|Overall Study||19
422572|NCT00800683|1006252|P1|NOT COMPLETED|Overall Study||17
422573|NCT00800683|1006251|P2|COMPLETED|Overall Study|Number who completed treatment|49
422574|NCT00800683|1006252|P1|COMPLETED|Overall Study|Number who completed treatment|48
422575|NCT00800683|1006251|P2|STARTED|Overall Study|Number who started treatment|68
422576|NCT00800683|1006252|P1|STARTED|Overall Study|Number who started treatment|65
422577|NCT00800540|1006298|P2|NOT COMPLETED|Period 2: 6 Weeks||1
422578|NCT00800540|1006299|P1|NOT COMPLETED|Period 2: 6 Weeks||0
422579|NCT00800540|1006298|P2|COMPLETED|Period 2: 6 Weeks||16
422580|NCT00800540|1006299|P1|COMPLETED|Period 2: 6 Weeks||16
422581|NCT00800540|1006298|P2|STARTED|Period 2: 6 Weeks||17
422582|NCT00800540|1006299|P1|STARTED|Period 2: 6 Weeks||16
422583|NCT00800540|1006298|P2|NOT COMPLETED|Washout: 4 Weeks||0
422584|NCT00800540|1006299|P1|NOT COMPLETED|Washout: 4 Weeks||0
422585|NCT00800540|1006298|P2|COMPLETED|Washout: 4 Weeks||17
422586|NCT00800540|1006299|P1|COMPLETED|Washout: 4 Weeks||16
422587|NCT00800540|1006298|P2|STARTED|Washout: 4 Weeks||17
422588|NCT00800540|1006299|P1|STARTED|Washout: 4 Weeks||16
422589|NCT00800540|1006298|P2|NOT COMPLETED|Period One: 6 Weeks||1
422590|NCT00800540|1006299|P1|NOT COMPLETED|Period One: 6 Weeks||1
422591|NCT00800540|1006298|P2|COMPLETED|Period One: 6 Weeks||17
422592|NCT00800540|1006299|P1|COMPLETED|Period One: 6 Weeks||16
422593|NCT00800540|1006298|P2|STARTED|Period One: 6 Weeks||18
422594|NCT00800540|1006299|P1|STARTED|Period One: 6 Weeks||17
422595|NCT00800436|1006334|P7|NOT COMPLETED|Overall Study||0
422596|NCT00800436|1006335|P6|NOT COMPLETED|Overall Study||0
422597|NCT00800436|1006336|P5|NOT COMPLETED|Overall Study||0
422598|NCT00800436|1006337|P4|NOT COMPLETED|Overall Study||1
422599|NCT00800436|1006338|P3|NOT COMPLETED|Overall Study||1
422600|NCT00800436|1006339|P2|NOT COMPLETED|Overall Study||0
422601|NCT00800436|1006340|P1|NOT COMPLETED|Overall Study||0
422602|NCT00800436|1006334|P7|COMPLETED|Overall Study||20
422603|NCT00800436|1006335|P6|COMPLETED|Overall Study||20
422604|NCT00800436|1006336|P5|COMPLETED|Overall Study||6
422605|NCT00800436|1006337|P4|COMPLETED|Overall Study||5
422606|NCT00800436|1006338|P3|COMPLETED|Overall Study||5
422607|NCT00800436|1006339|P2|COMPLETED|Overall Study||6
422608|NCT00800436|1006340|P1|COMPLETED|Overall Study||6
422609|NCT00800436|1006334|P7|STARTED|Overall Study||20
422610|NCT00800436|1006335|P6|STARTED|Overall Study||20
422611|NCT00800436|1006336|P5|STARTED|Overall Study||6
422612|NCT00800436|1006337|P4|STARTED|Overall Study||6
422613|NCT00800436|1006338|P3|STARTED|Overall Study||6
422614|NCT00800436|1006339|P2|STARTED|Overall Study||6
422615|NCT00800436|1006340|P1|STARTED|Overall Study||6
422616|NCT00800384|1006386|P2|NOT COMPLETED|Overall Study||43
422617|NCT00800384|1006387|P1|NOT COMPLETED|Overall Study||41
422618|NCT00800384|1006386|P2|COMPLETED|Overall Study||1210
422619|NCT00800384|1006387|P1|COMPLETED|Overall Study||1206
422620|NCT00800384|1006386|P2|STARTED|Overall Study||1253
422621|NCT00800384|1006387|P1|STARTED|Overall Study||1247
422622|NCT00800345|1006395|P1|NOT COMPLETED|Overall Study||0
422623|NCT00800345|1006395|P1|COMPLETED|Overall Study||33
422624|NCT00800345|1006395|P1|STARTED|Overall Study||33
422625|NCT00800254|1006402|P2|NOT COMPLETED|Overall Study||6
422626|NCT00800254|1006403|P1|NOT COMPLETED|Overall Study||5
422627|NCT00800254|1006402|P2|COMPLETED|Overall Study||25
422628|NCT00800254|1006403|P1|COMPLETED|Overall Study||30
422629|NCT00800254|1006402|P2|3.5 Weeks Post-operatively|Overall Study||31
422630|NCT00800254|1006403|P1|3.5 Weeks Post-operatively|Overall Study||31
422631|NCT00800254|1006402|P2|STARTED|Overall Study||31
422632|NCT00800254|1006403|P1|STARTED|Overall Study||35
422633|NCT00800202|1006425|P2|NOT COMPLETED|Overall Study||24
422634|NCT00800202|1006426|P1|NOT COMPLETED|Overall Study||67
422635|NCT00800202|1006425|P2|COMPLETED|Overall Study||0
422636|NCT00800202|1006426|P1|COMPLETED|Overall Study||0
422637|NCT00800202|1006425|P2|STARTED|Overall Study||24
422638|NCT00800202|1006426|P1|STARTED|Overall Study||67
422639|NCT00799825|1006444|P1|NOT COMPLETED|Overall Study||48
422640|NCT00799825|1006444|P1|COMPLETED|Overall Study||296
422641|NCT00799825|1006444|P1|STARTED|Overall Study||344
422642|NCT00799773|1006452|P2|NOT COMPLETED|Overall Study||0
422643|NCT00799773|1006453|P1|NOT COMPLETED|Overall Study||0
422644|NCT00799773|1006452|P2|COMPLETED|Overall Study||1
422645|NCT00799773|1006453|P1|COMPLETED|Overall Study||2
422646|NCT00799773|1006452|P2|STARTED|Overall Study||1
422647|NCT00799773|1006453|P1|STARTED|Overall Study||2
422648|NCT00799708|1006484|P3|NOT COMPLETED|Overall Study||0
422649|NCT00799708|1006485|P2|NOT COMPLETED|Overall Study||0
422650|NCT00799708|1006486|P1|NOT COMPLETED|Overall Study||1
422651|NCT00799708|1006484|P3|COMPLETED|Overall Study||11
422652|NCT00799708|1006485|P2|COMPLETED|Overall Study||6
422653|NCT00799708|1006486|P1|COMPLETED|Overall Study||9
422654|NCT00799708|1006484|P3|STARTED|Overall Study||11
422655|NCT00799708|1006485|P2|STARTED|Overall Study||6
422656|NCT00799708|1006486|P1|STARTED|Overall Study||10
422657|NCT00799643|1006498|P2|NOT COMPLETED|Overall Study||27
422658|NCT00799643|1006499|P1|NOT COMPLETED|Overall Study||25
422659|NCT00799643|1006498|P2|COMPLETED|Overall Study||119
422660|NCT00799643|1006499|P1|COMPLETED|Overall Study||115
422661|NCT00799643|1006498|P2|STARTED|Overall Study||146
422662|NCT00799643|1006499|P1|STARTED|Overall Study||140
422663|NCT00799604|1006510|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
422664|NCT00799604|1006511|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
422665|NCT00799604|1006512|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
422666|NCT00799604|1006510|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
422667|NCT00799604|1006511|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
422668|NCT00799604|1006512|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
422669|NCT00799604|1006510|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
422670|NCT00799604|1006511|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
422671|NCT00799604|1006512|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
422672|NCT00799604|1006510|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
422673|NCT00799604|1006511|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
422674|NCT00799604|1006512|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
422675|NCT00799604|1006510|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
422676|NCT00799604|1006511|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
422677|NCT00799604|1006512|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
422678|NCT00799604|1006510|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
422679|NCT00799604|1006511|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
422680|NCT00799604|1006512|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
422681|NCT00799591|1006536|P1|NOT COMPLETED|Overall Study||66
422682|NCT00799591|1006536|P1|COMPLETED|Overall Study||90
422683|NCT00799591|1006536|P1|STARTED|Overall Study||156
422684|NCT00799578|1006547|P1|NOT COMPLETED|Overall Study||2
422685|NCT00799578|1006547|P1|COMPLETED|Overall Study||11
422686|NCT00799578|1006547|P1|STARTED|Overall Study||13
422687|NCT00799487|1006554|P3|NOT COMPLETED|Double-Blind Assessment Period||2
422688|NCT00799487|1006555|P2|NOT COMPLETED|Double-Blind Assessment Period||1
422689|NCT00799487|1006556|P1|NOT COMPLETED|Double-Blind Assessment Period||0
422690|NCT00799487|1006554|P3|COMPLETED|Double-Blind Assessment Period||32
422691|NCT00799487|1006555|P2|COMPLETED|Double-Blind Assessment Period||33
422692|NCT00799487|1006556|P1|COMPLETED|Double-Blind Assessment Period||0
422693|NCT00799487|1006554|P3|STARTED|Double-Blind Assessment Period||34
422694|NCT00799487|1006555|P2|STARTED|Double-Blind Assessment Period||34
422695|NCT00799487|1006556|P1|STARTED|Double-Blind Assessment Period||0
422696|NCT00799487|1006554|P3|NOT COMPLETED|Dose Adjustment Period||0
422697|NCT00799487|1006555|P2|NOT COMPLETED|Dose Adjustment Period||0
422698|NCT00799487|1006556|P1|NOT COMPLETED|Dose Adjustment Period||21
422699|NCT00799487|1006554|P3|COMPLETED|Dose Adjustment Period||34
422700|NCT00799487|1006555|P2|COMPLETED|Dose Adjustment Period||34
422701|NCT00799487|1006556|P1|COMPLETED|Dose Adjustment Period||0
422702|NCT00799487|1006554|P3|STARTED|Dose Adjustment Period||34
422703|NCT00799487|1006555|P2|STARTED|Dose Adjustment Period||34
422704|NCT00799487|1006556|P1|STARTED|Dose Adjustment Period||21
422705|NCT00799474|1006636|P1|NOT COMPLETED|Overall Study||0
422706|NCT00799474|1006636|P1|COMPLETED|Overall Study||609
422707|NCT00799474|1006636|P1|STARTED|Overall Study||609
422708|NCT00799422|1006642|P6|NOT COMPLETED|Third Week of Wear||0
422709|NCT00799422|1006643|P5|NOT COMPLETED|Third Week of Wear||0
422710|NCT00799422|1006644|P4|NOT COMPLETED|Third Week of Wear||0
422711|NCT00799422|1006645|P3|NOT COMPLETED|Third Week of Wear||0
422712|NCT00799422|1006646|P2|NOT COMPLETED|Third Week of Wear||0
422713|NCT00799422|1006647|P1|NOT COMPLETED|Third Week of Wear||0
422714|NCT00799422|1006642|P6|COMPLETED|Third Week of Wear||4
422715|NCT00799422|1006643|P5|COMPLETED|Third Week of Wear||4
422716|NCT00799422|1006644|P4|COMPLETED|Third Week of Wear||3
422717|NCT00799422|1006645|P3|COMPLETED|Third Week of Wear||3
422718|NCT00799422|1006646|P2|COMPLETED|Third Week of Wear||4
422719|NCT00799422|1006647|P1|COMPLETED|Third Week of Wear||4
422720|NCT00799422|1006642|P6|STARTED|Third Week of Wear||4
422721|NCT00799422|1006643|P5|STARTED|Third Week of Wear||4
422722|NCT00799422|1006644|P4|STARTED|Third Week of Wear||3
422723|NCT00799422|1006645|P3|STARTED|Third Week of Wear||3
422724|NCT00799422|1006646|P2|STARTED|Third Week of Wear||4
422725|NCT00799422|1006647|P1|STARTED|Third Week of Wear||4
422726|NCT00799422|1006642|P6|NOT COMPLETED|Second Week of Wear||0
422727|NCT00799422|1006643|P5|NOT COMPLETED|Second Week of Wear||0
422728|NCT00799422|1006644|P4|NOT COMPLETED|Second Week of Wear||0
422729|NCT00799422|1006645|P3|NOT COMPLETED|Second Week of Wear||0
422730|NCT00799422|1006646|P2|NOT COMPLETED|Second Week of Wear||0
422731|NCT00799422|1006647|P1|NOT COMPLETED|Second Week of Wear||0
422732|NCT00799422|1006642|P6|COMPLETED|Second Week of Wear||4
422733|NCT00799422|1006643|P5|COMPLETED|Second Week of Wear||4
422734|NCT00799422|1006644|P4|COMPLETED|Second Week of Wear||3
422735|NCT00799422|1006645|P3|COMPLETED|Second Week of Wear||3
422736|NCT00799422|1006646|P2|COMPLETED|Second Week of Wear||4
422737|NCT00799422|1006647|P1|COMPLETED|Second Week of Wear||4
422738|NCT00799422|1006642|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
422739|NCT00799422|1006643|P5|STARTED|Second Week of Wear||4
422740|NCT00799422|1006644|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
422741|NCT00799422|1006645|P3|STARTED|Second Week of Wear||3
422742|NCT00799422|1006646|P2|STARTED|Second Week of Wear||4
422743|NCT00799422|1006647|P1|STARTED|Second Week of Wear||4
422744|NCT00799422|1006642|P6|NOT COMPLETED|First Week of Wear||0
422745|NCT00799422|1006643|P5|NOT COMPLETED|First Week of Wear||0
422746|NCT00799422|1006644|P4|NOT COMPLETED|First Week of Wear||1
422747|NCT00799422|1006645|P3|NOT COMPLETED|First Week of Wear||1
422748|NCT00799422|1006646|P2|NOT COMPLETED|First Week of Wear||0
422749|NCT00799422|1006647|P1|NOT COMPLETED|First Week of Wear||0
422750|NCT00799422|1006642|P6|COMPLETED|First Week of Wear||5
422751|NCT00799422|1006643|P5|COMPLETED|First Week of Wear||4
422752|NCT00799422|1006644|P4|COMPLETED|First Week of Wear||4
422753|NCT00799422|1006645|P3|COMPLETED|First Week of Wear||3
422754|NCT00799422|1006646|P2|COMPLETED|First Week of Wear||4
422755|NCT00799422|1006647|P1|COMPLETED|First Week of Wear||4
422756|NCT00799422|1006642|P6|STARTED|First Week of Wear||5
422757|NCT00799422|1006643|P5|STARTED|First Week of Wear||4
422758|NCT00799422|1006644|P4|STARTED|First Week of Wear||5
422759|NCT00799422|1006645|P3|STARTED|First Week of Wear||4
422760|NCT00799422|1006646|P2|STARTED|First Week of Wear||4
422761|NCT00799422|1006647|P1|STARTED|First Week of Wear||4
422762|NCT00799409|1006664|P3|NOT COMPLETED|Overall Study||0
422763|NCT00799409|1006665|P2|NOT COMPLETED|Overall Study||0
422764|NCT00799409|1006666|P1|NOT COMPLETED|Overall Study||7
422765|NCT00799409|1006664|P3|COMPLETED|Overall Study||35
422766|NCT00799409|1006665|P2|COMPLETED|Overall Study||36
422767|NCT00799409|1006666|P1|COMPLETED|Overall Study||0
422768|NCT00799409|1006664|P3|STARTED|Overall Study||35
422769|NCT00799409|1006665|P2|STARTED|Overall Study||36
422770|NCT00799409|1006666|P1|STARTED|Overall Study||7
422771|NCT00799396|1006746|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
422772|NCT00799396|1006746|P1|COMPLETED|Clopidogrel Plus Aspirin||663
422773|NCT00799396|1006746|P1|STARTED|Clopidogrel Plus Aspirin||669
422774|NCT00799396|1006746|P1|NOT COMPLETED|Clopidogrel Treatment||13
422775|NCT00799396|1006746|P1|COMPLETED|Clopidogrel Treatment||669
422776|NCT00799396|1006746|P1|STARTED|Clopidogrel Treatment||682
422777|NCT00799292|1006753|P2|NOT COMPLETED|Overall Study||0
422778|NCT00799292|1006754|P1|NOT COMPLETED|Overall Study||0
422779|NCT00799292|1006753|P2|COMPLETED|Overall Study||29
422780|NCT00799292|1006754|P1|COMPLETED|Overall Study||29
422781|NCT00799292|1006753|P2|STARTED|Overall Study||29
422782|NCT00799292|1006754|P1|STARTED|Overall Study||29
422783|NCT00799227|1006758|P1|NOT COMPLETED|Overall Study||3
422784|NCT00799227|1006758|P1|COMPLETED|Overall Study||53
422785|NCT00799227|1006758|P1|STARTED|Overall Study||56
422786|NCT00798967|1006767|P2|NOT COMPLETED|Overall Study||4
422787|NCT00798967|1006768|P1|NOT COMPLETED|Overall Study||4
422788|NCT00798967|1006767|P2|COMPLETED|Overall Study||39
422789|NCT00798967|1006768|P1|COMPLETED|Overall Study||39
422790|NCT00798967|1006767|P2|Discontinued During Dosing Period|Overall Study||4
422791|NCT00798967|1006768|P1|Discontinued During Dosing Period|Overall Study||4
422792|NCT00798967|1006767|P2|STARTED|Overall Study||43
422793|NCT00798967|1006768|P1|STARTED|Overall Study||43
422794|NCT00798889|1006776|P1|NOT COMPLETED|Overall Study||314
422795|NCT00798889|1006776|P1|COMPLETED|Overall Study||0
422796|NCT00798889|1006776|P1|Treated|Overall Study||311
422797|NCT00798889|1006776|P1|STARTED|Overall Study||314
422798|NCT00798759|1006782|P2|NOT COMPLETED|Overall Study||13
422799|NCT00798759|1006783|P1|NOT COMPLETED|Overall Study||8
422800|NCT00798759|1006782|P2|COMPLETED|Overall Study||106
422801|NCT00798759|1006783|P1|COMPLETED|Overall Study||109
422802|NCT00798759|1006782|P2|STARTED|Overall Study||119
422803|NCT00798759|1006783|P1|STARTED|Overall Study||117
422804|NCT00798720|1006791|P1|NOT COMPLETED|Overall Study||0
422805|NCT00798720|1006791|P1|COMPLETED|Overall Study||18
422806|NCT00798720|1006791|P1|STARTED|Overall Study||18
422807|NCT00798707|1006801|P3|NOT COMPLETED|Overall Study||22
422808|NCT00798707|1006802|P2|NOT COMPLETED|Overall Study||33
422809|NCT00798707|1006803|P1|NOT COMPLETED|Overall Study||26
422810|NCT00798707|1006801|P3|COMPLETED|Overall Study||215
422811|NCT00798707|1006802|P2|COMPLETED|Overall Study||204
422812|NCT00798707|1006803|P1|COMPLETED|Overall Study||209
422813|NCT00798707|1006801|P3|Treated|Overall Study||236
422814|NCT00798707|1006802|P2|Treated|Overall Study||232
422815|NCT00798707|1006803|P1|Treated|Overall Study||231
422816|NCT00798707|1006801|P3|STARTED|Overall Study||237
422817|NCT00798707|1006802|P2|STARTED|Overall Study||237
422818|NCT00798707|1006803|P1|STARTED|Overall Study||235
422819|NCT00798655|1006853|P1|NOT COMPLETED|Overall Study||2
422820|NCT00798655|1006853|P1|COMPLETED|Overall Study||44
422821|NCT00798655|1006853|P1|STARTED|Overall Study||46
422822|NCT00798603|1006858|P1|NOT COMPLETED|Overall Study||35
422823|NCT00798603|1006858|P1|COMPLETED|Overall Study||27
422824|NCT00798603|1006858|P1|STARTED|Overall Study||62
422825|NCT00798577|1006880|P2|NOT COMPLETED|Overall Study||0
422826|NCT00798577|1006881|P1|NOT COMPLETED|Overall Study||0
422827|NCT00798577|1006880|P2|COMPLETED|Overall Study||7
422828|NCT00798577|1006881|P1|COMPLETED|Overall Study||17
422829|NCT00798577|1006880|P2|STARTED|Overall Study||7
422830|NCT00798577|1006881|P1|STARTED|Overall Study||17
422831|NCT00798486|1006895|P1|NOT COMPLETED|Overall Study||0
422832|NCT00798486|1006895|P1|COMPLETED|Overall Study||110
422833|NCT00798486|1006895|P1|STARTED|Overall Study||110
422834|NCT00798434|1006904|P2|NOT COMPLETED|Open-Label||32
422835|NCT00798434|1006905|P1|NOT COMPLETED|Open-Label||42
422836|NCT00798434|1006904|P2|COMPLETED|Open-Label||282
422837|NCT00798434|1006905|P1|COMPLETED|Open-Label||299
422838|NCT00798434|1006904|P2|Received Treatment|Open-Label||313
422839|NCT00798434|1006905|P1|Received Treatment|Open-Label||341
422840|NCT00798434|1006904|P2|STARTED|Open-Label||314
422841|NCT00798434|1006905|P1|STARTED|Open-Label||341
422842|NCT00798434|1006904|P2|NOT COMPLETED|Double-Blind||84
422843|NCT00798434|1006905|P1|NOT COMPLETED|Double-Blind||55
422844|NCT00798434|1006904|P2|COMPLETED|Double-Blind||314
422845|NCT00798434|1006905|P1|COMPLETED|Double-Blind||341
422846|NCT00798434|1006904|P2|Received Treatment|Double-Blind||392
422847|NCT00798434|1006905|P1|Received Treatment|Double-Blind||393
422848|NCT00798434|1006904|P2|STARTED|Double-Blind||398
422849|NCT00798434|1006905|P1|STARTED|Double-Blind||396
422850|NCT00798369|1006991|P6|NOT COMPLETED|Overall Study||3
422851|NCT00798369|1006992|P5|NOT COMPLETED|Overall Study||1
422852|NCT00798369|1006993|P4|NOT COMPLETED|Overall Study||1
422853|NCT00798369|1006994|P3|NOT COMPLETED|Overall Study||2
422854|NCT00798369|1006995|P2|NOT COMPLETED|Overall Study||1
422855|NCT00798369|1006996|P1|NOT COMPLETED|Overall Study||1
422856|NCT00798369|1006991|P6|COMPLETED|Overall Study||54
422857|NCT00798369|1006992|P5|COMPLETED|Overall Study||27
422858|NCT00798369|1006993|P4|COMPLETED|Overall Study||28
422859|NCT00798369|1006994|P3|COMPLETED|Overall Study||27
422860|NCT00798369|1006995|P2|COMPLETED|Overall Study||28
422861|NCT00798369|1006996|P1|COMPLETED|Overall Study||27
422862|NCT00798369|1006991|P6|STARTED|Overall Study||57
422863|NCT00798369|1006992|P5|STARTED|Overall Study||28
422864|NCT00798369|1006993|P4|STARTED|Overall Study||29
422865|NCT00798369|1006994|P3|STARTED|Overall Study||29
422866|NCT00798369|1006995|P2|STARTED|Overall Study||29
422867|NCT00798369|1006996|P1|STARTED|Overall Study||28
422868|NCT00798317|1007043|P2|NOT COMPLETED|Overall Study||7
422869|NCT00798317|1007044|P1|NOT COMPLETED|Overall Study||10
422870|NCT00798317|1007043|P2|COMPLETED|Overall Study||74
422871|NCT00798317|1007044|P1|COMPLETED|Overall Study||235
422872|NCT00798317|1007043|P2|STARTED|Overall Study||81
422873|NCT00798317|1007044|P1|STARTED|Overall Study||245
422874|NCT00798304|1007055|P3|NOT COMPLETED|Overall Study||10
422875|NCT00798304|1007056|P2|NOT COMPLETED|Overall Study||22
422876|NCT00798304|1007057|P1|NOT COMPLETED|Overall Study||14
422877|NCT00798304|1007055|P3|COMPLETED|Overall Study||0
422878|NCT00798304|1007056|P2|COMPLETED|Overall Study||0
422879|NCT00798304|1007057|P1|COMPLETED|Overall Study||0
422880|NCT00798304|1007055|P3|STARTED|Overall Study||10
422881|NCT00798304|1007056|P2|STARTED|Overall Study||22
422882|NCT00798304|1007057|P1|STARTED|Overall Study||14
422883|NCT00798161|1007090|P7|NOT COMPLETED|Overall Study||10
422884|NCT00798161|1007091|P6|NOT COMPLETED|Overall Study||11
422885|NCT00798161|1007092|P5|NOT COMPLETED|Overall Study||16
422886|NCT00798161|1007093|P4|NOT COMPLETED|Overall Study||21
422887|NCT00798161|1007094|P3|NOT COMPLETED|Overall Study||21
422888|NCT00798161|1007095|P2|NOT COMPLETED|Overall Study||17
422889|NCT00798161|1007096|P1|NOT COMPLETED|Overall Study||18
422890|NCT00798161|1007090|P7|COMPLETED|Overall Study||56
422891|NCT00798161|1007091|P6|COMPLETED|Overall Study||132
422892|NCT00798161|1007092|P5|COMPLETED|Overall Study||127
422893|NCT00798161|1007093|P4|COMPLETED|Overall Study||121
422894|NCT00798161|1007094|P3|COMPLETED|Overall Study||126
422895|NCT00798161|1007095|P2|COMPLETED|Overall Study||127
422896|NCT00798161|1007096|P1|COMPLETED|Overall Study||54
422897|NCT00798161|1007090|P7|STARTED|Overall Study||66
422898|NCT00798161|1007091|P6|STARTED|Overall Study||143
422899|NCT00798161|1007092|P5|STARTED|Overall Study||143
422900|NCT00798161|1007093|P4|STARTED|Overall Study||142
422901|NCT00798161|1007094|P3|STARTED|Overall Study||147
422902|NCT00798161|1007095|P2|STARTED|Overall Study||144
422903|NCT00798161|1007096|P1|STARTED|Overall Study||72
422904|NCT00798135|1007203|P1|NOT COMPLETED|Overall Study||13
422905|NCT00798135|1007203|P1|COMPLETED|Overall Study||0
422906|NCT00798135|1007203|P1|STARTED|Overall Study||13
422907|NCT00798096|1007209|P1|NOT COMPLETED|Overall Study||2
422908|NCT00798096|1007209|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
422909|NCT00798096|1007209|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
422910|NCT00798018|1007220|P4|NOT COMPLETED|Overall Study||0
422911|NCT00798018|1007221|P3|NOT COMPLETED|Overall Study||0
422912|NCT00798018|1007222|P2|NOT COMPLETED|Overall Study||0
422913|NCT00798018|1007223|P1|NOT COMPLETED|Overall Study||0
422914|NCT00798018|1007220|P4|COMPLETED|Overall Study||25
422915|NCT00798018|1007221|P3|COMPLETED|Overall Study||25
422916|NCT00798018|1007222|P2|COMPLETED|Overall Study||25
422917|NCT00798018|1007223|P1|COMPLETED|Overall Study||25
422918|NCT00798018|1007220|P4|STARTED|Overall Study||25
422919|NCT00798018|1007221|P3|STARTED|Overall Study||25
422920|NCT00798018|1007222|P2|STARTED|Overall Study||25
422921|NCT00798018|1007223|P1|STARTED|Overall Study||25
422922|NCT00797966|1007237|P6|NOT COMPLETED|Phase A+||28
422923|NCT00797966|1007238|P5|NOT COMPLETED|Phase A+||0
422924|NCT00797966|1007239|P4|NOT COMPLETED|Phase A+||0
422925|NCT00797966|1007240|P3|NOT COMPLETED|Phase A+||0
422926|NCT00797966|1007241|P2|NOT COMPLETED|Phase A+||0
422927|NCT00797966|1007242|P1|NOT COMPLETED|Phase A+||0
422928|NCT00797966|1007237|P6|COMPLETED|Phase A+||207
422929|NCT00797966|1007238|P5|COMPLETED|Phase A+||0
422930|NCT00797966|1007239|P4|COMPLETED|Phase A+||0
422931|NCT00797966|1007240|P3|COMPLETED|Phase A+||0
422932|NCT00797966|1007241|P2|COMPLETED|Phase A+||0
422933|NCT00797966|1007242|P1|COMPLETED|Phase A+||0
422934|NCT00797966|1007237|P6|STARTED|Phase A+||235
422935|NCT00797966|1007238|P5|STARTED|Phase A+||0
422936|NCT00797966|1007239|P4|STARTED|Phase A+||0
422937|NCT00797966|1007240|P3|STARTED|Phase A+||0
422938|NCT00797966|1007241|P2|STARTED|Phase A+||0
422939|NCT00797966|1007242|P1|STARTED|Phase A+||0
422940|NCT00797966|1007237|P6|NOT COMPLETED|Phase B||0
422941|NCT00797966|1007238|P5|NOT COMPLETED|Phase B||0
422942|NCT00797966|1007239|P4|NOT COMPLETED|Phase B||16
422943|NCT00797966|1007240|P3|NOT COMPLETED|Phase B||21
422944|NCT00797966|1007241|P2|NOT COMPLETED|Phase B||18
422945|NCT00797966|1007242|P1|NOT COMPLETED|Phase B||11
422946|NCT00797966|1007237|P6|COMPLETED|Phase B||0
422947|NCT00797966|1007238|P5|COMPLETED|Phase B||0
422948|NCT00797966|1007239|P4|COMPLETED|Phase B||110
422949|NCT00797966|1007240|P3|COMPLETED|Phase B||100
422950|NCT00797966|1007241|P2|COMPLETED|Phase B||102
422951|NCT00797966|1007242|P1|COMPLETED|Phase B||51
422952|NCT00797966|1007237|P6|STARTED|Phase B||0
422953|NCT00797966|1007238|P5|STARTED|Phase B||0
422954|NCT00797966|1007239|P4|STARTED|Phase B|Randomized participants.|126
422955|NCT00797966|1007240|P3|STARTED|Phase B|Randomized participants.|121
422956|NCT00797966|1007241|P2|STARTED|Phase B|Randomized participants.|120
422957|NCT00797966|1007242|P1|STARTED|Phase B|Randomized participants.|62
422958|NCT00797966|1007237|P6|NOT COMPLETED|Phase A||0
422959|NCT00797966|1007238|P5|NOT COMPLETED|Phase A||185
422960|NCT00797966|1007239|P4|NOT COMPLETED|Phase A||0
422961|NCT00797966|1007240|P3|NOT COMPLETED|Phase A||0
422962|NCT00797966|1007241|P2|NOT COMPLETED|Phase A||0
422963|NCT00797966|1007242|P1|NOT COMPLETED|Phase A||0
422964|NCT00797966|1007237|P6|COMPLETED|Phase A||0
422965|NCT00797966|1007238|P5|COMPLETED|Phase A||664
422966|NCT00797966|1007239|P4|COMPLETED|Phase A||0
422967|NCT00797966|1007240|P3|COMPLETED|Phase A||0
422968|NCT00797966|1007241|P2|COMPLETED|Phase A||0
422969|NCT00797966|1007242|P1|COMPLETED|Phase A||0
422970|NCT00797966|1007237|P6|STARTED|Phase A||0
422971|NCT00797966|1007238|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
422972|NCT00797966|1007239|P4|STARTED|Phase A||0
422973|NCT00797966|1007240|P3|STARTED|Phase A||0
422974|NCT00797966|1007241|P2|STARTED|Phase A||0
422975|NCT00797966|1007242|P1|STARTED|Phase A||0
422976|NCT00797862|1007307|P3|NOT COMPLETED|Overall Study||86
422977|NCT00797862|1007308|P2|NOT COMPLETED|Overall Study||68
422978|NCT00797862|1007309|P1|NOT COMPLETED|Overall Study||124
422979|NCT00797862|1007307|P3|COMPLETED|Overall Study||230
422980|NCT00797862|1007308|P2|COMPLETED|Overall Study||250
422981|NCT00797862|1007309|P1|COMPLETED|Overall Study||496
422982|NCT00797862|1007307|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
422983|NCT00797862|1007308|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
422984|NCT00797862|1007309|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
422985|NCT00797862|1007307|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
422986|NCT00797862|1007308|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
422987|NCT00797862|1007309|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
422988|NCT00797823|1007338|P3|NOT COMPLETED|Second Period (Crossover)||0
422989|NCT00797823|1007339|P2|NOT COMPLETED|Second Period (Crossover)||0
422990|NCT00797823|1007340|P1|NOT COMPLETED|Second Period (Crossover)||0
422991|NCT00797823|1007338|P3|COMPLETED|Second Period (Crossover)||0
422992|NCT00797823|1007339|P2|COMPLETED|Second Period (Crossover)||4
422993|NCT00797823|1007340|P1|COMPLETED|Second Period (Crossover)||3
422994|NCT00797823|1007338|P3|STARTED|Second Period (Crossover)||0
422995|NCT00797823|1007339|P2|STARTED|Second Period (Crossover)||4
422996|NCT00797823|1007340|P1|STARTED|Second Period (Crossover)||3
422997|NCT00797823|1007338|P3|NOT COMPLETED|First Period (Initial Randomization)||0
422998|NCT00797823|1007339|P2|NOT COMPLETED|First Period (Initial Randomization)||0
422999|NCT00797823|1007340|P1|NOT COMPLETED|First Period (Initial Randomization)||1
423000|NCT00797823|1007338|P3|COMPLETED|First Period (Initial Randomization)||0
423001|NCT00797823|1007339|P2|COMPLETED|First Period (Initial Randomization)||4
423002|NCT00797823|1007340|P1|COMPLETED|First Period (Initial Randomization)||3
423003|NCT00797823|1007338|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
423004|NCT00797823|1007339|P2|STARTED|First Period (Initial Randomization)||4
423005|NCT00797823|1007340|P1|STARTED|First Period (Initial Randomization)||4
423006|NCT00797823|1007338|P3|NOT COMPLETED|Pilot Studies||0
423007|NCT00797823|1007339|P2|NOT COMPLETED|Pilot Studies||0
423008|NCT00797823|1007340|P1|NOT COMPLETED|Pilot Studies||0
423009|NCT00797823|1007338|P3|COMPLETED|Pilot Studies||6
423010|NCT00797823|1007339|P2|COMPLETED|Pilot Studies||0
423011|NCT00797823|1007340|P1|COMPLETED|Pilot Studies||0
423012|NCT00797823|1007338|P3|STARTED|Pilot Studies||6
423013|NCT00797823|1007339|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
423014|NCT00797823|1007340|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
423015|NCT00797797|1007351|P2|NOT COMPLETED|Overall Study||43
423016|NCT00797797|1007352|P1|NOT COMPLETED|Overall Study||55
423017|NCT00797797|1007351|P2|COMPLETED|Overall Study||141
423018|NCT00797797|1007352|P1|COMPLETED|Overall Study||123
423019|NCT00797797|1007351|P2|STARTED|Overall Study||184
423020|NCT00797797|1007352|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
423021|NCT00797667|1007363|P3|NOT COMPLETED|Overall Study||127
423022|NCT00797667|1007364|P2|NOT COMPLETED|Overall Study||259
423023|NCT00797667|1007365|P1|NOT COMPLETED|Overall Study||260
423024|NCT00797667|1007363|P3|COMPLETED|Overall Study||4
423025|NCT00797667|1007364|P2|COMPLETED|Overall Study||5
423026|NCT00797667|1007365|P1|COMPLETED|Overall Study||5
423027|NCT00797667|1007363|P3|Treated|Overall Study||130
423028|NCT00797667|1007364|P2|Treated|Overall Study||263
423029|NCT00797667|1007365|P1|Treated|Overall Study||263
423030|NCT00797667|1007363|P3|STARTED|Overall Study||131
423031|NCT00797667|1007364|P2|STARTED|Overall Study||264
423032|NCT00797667|1007365|P1|STARTED|Overall Study||265
423033|NCT00797563|1007391|P1|NOT COMPLETED|Overall Study||1
423034|NCT00797563|1007391|P1|COMPLETED|Overall Study||101
423035|NCT00797563|1007391|P1|STARTED|Overall Study|number of subjects|102
423036|NCT00797511|1007397|P1|NOT COMPLETED|Overall Study||1
423037|NCT00797511|1007397|P1|COMPLETED|Overall Study||131
423038|NCT00797511|1007397|P1|STARTED|Overall Study||132
423039|NCT00797459|1007405|P1|NOT COMPLETED|Overall Study||0
423040|NCT00797459|1007405|P1|COMPLETED|Overall Study||60
423041|NCT00797459|1007405|P1|STARTED|Overall Study||60
423042|NCT00797316|1007415|P2|NOT COMPLETED|Overall Study||32
423043|NCT00797316|1007416|P1|NOT COMPLETED|Overall Study||23
423044|NCT00797316|1007415|P2|COMPLETED|Overall Study||233
423045|NCT00797316|1007416|P1|COMPLETED|Overall Study||244
423046|NCT00797316|1007415|P2|STARTED|Overall Study||265
423047|NCT00797316|1007416|P1|STARTED|Overall Study||267
423048|NCT00797277|1007432|P2|NOT COMPLETED|Overall Study||0
423049|NCT00797277|1007433|P1|NOT COMPLETED|Overall Study||0
423050|NCT00797277|1007432|P2|COMPLETED|Overall Study||30
423051|NCT00797277|1007433|P1|COMPLETED|Overall Study||37
423052|NCT00797277|1007432|P2|STARTED|Overall Study||30
423053|NCT00797277|1007433|P1|STARTED|Overall Study||37
423054|NCT00797212|1007441|P1|NOT COMPLETED|Overall Study||0
423055|NCT00797212|1007441|P1|COMPLETED|Overall Study||50
423056|NCT00797212|1007441|P1|STARTED|Overall Study||50
423057|NCT00797108|1007450|P3|NOT COMPLETED|Overall Study||6
423058|NCT00797108|1007451|P2|NOT COMPLETED|Overall Study||2
423059|NCT00797108|1007452|P1|NOT COMPLETED|Overall Study||4
423060|NCT00797108|1007450|P3|COMPLETED|Overall Study||6
423061|NCT00797108|1007451|P2|COMPLETED|Overall Study||9
423062|NCT00797108|1007452|P1|COMPLETED|Overall Study||8
423063|NCT00797108|1007450|P3|Treated|Overall Study||12
423064|NCT00797108|1007451|P2|Treated|Overall Study||11
423065|NCT00797108|1007452|P1|Treated|Overall Study||10
423066|NCT00797108|1007450|P3|STARTED|Overall Study||12
423067|NCT00797108|1007451|P2|STARTED|Overall Study||11
423068|NCT00797108|1007452|P1|STARTED|Overall Study||12
423069|NCT00796991|1007487|P3|NOT COMPLETED|Overall Study||14
423070|NCT00796991|1007488|P2|NOT COMPLETED|Overall Study||12
423071|NCT00796991|1007489|P1|NOT COMPLETED|Overall Study||15
423072|NCT00796991|1007487|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
423073|NCT00796991|1007488|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
423074|NCT00796991|1007489|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
423075|NCT00796991|1007487|P3|STARTED|Overall Study||20
423076|NCT00796991|1007488|P2|STARTED|Overall Study||19
423077|NCT00796991|1007489|P1|STARTED|Overall Study||20
423078|NCT00796926|1007589|P2|NOT COMPLETED|Overall Study||0
423079|NCT00796926|1007590|P1|NOT COMPLETED|Overall Study||1
423080|NCT00796926|1007589|P2|COMPLETED|Overall Study||15
423081|NCT00796926|1007590|P1|COMPLETED|Overall Study||14
423082|NCT00796926|1007589|P2|STARTED|Overall Study||15
423083|NCT00796926|1007590|P1|STARTED|Overall Study||15
423084|NCT00796822|1007598|P2|NOT COMPLETED|Overall Study||0
423085|NCT00796822|1007599|P1|NOT COMPLETED|Overall Study||3
423086|NCT00796822|1007598|P2|COMPLETED|Overall Study||13
423087|NCT00796822|1007599|P1|COMPLETED|Overall Study||10
423088|NCT00796822|1007598|P2|STARTED|Overall Study||13
423089|NCT00796822|1007599|P1|STARTED|Overall Study||13
423090|NCT00796757|1007605|P1|NOT COMPLETED|Overall Study||86
423091|NCT00796757|1007605|P1|COMPLETED|Overall Study||60
423092|NCT00796757|1007605|P1|STARTED|Overall Study||146
423093|NCT00796744|1007620|P3|NOT COMPLETED|Overall Study||1
423094|NCT00796744|1007621|P2|NOT COMPLETED|Overall Study||0
423095|NCT00796744|1007622|P1|NOT COMPLETED|Overall Study||0
423096|NCT00796744|1007620|P3|COMPLETED|Overall Study||27
423097|NCT00796744|1007621|P2|COMPLETED|Overall Study||26
423098|NCT00796744|1007622|P1|COMPLETED|Overall Study||24
423099|NCT00796744|1007620|P3|STARTED|Overall Study||28
423100|NCT00796744|1007621|P2|STARTED|Overall Study||26
423101|NCT00796744|1007622|P1|STARTED|Overall Study||24
423102|NCT00796718|1007639|P1|NOT COMPLETED|Overall Study||9
423103|NCT00796718|1007639|P1|COMPLETED|Overall Study||53
423104|NCT00796718|1007639|P1|STARTED|Overall Study||62
423105|NCT00796705|1007650|P4|NOT COMPLETED|Overall Study||0
423106|NCT00796705|1007651|P3|NOT COMPLETED|Overall Study||0
423107|NCT00796705|1007652|P2|NOT COMPLETED|Overall Study||0
423108|NCT00796705|1007653|P1|NOT COMPLETED|Overall Study||0
423109|NCT00796705|1007650|P4|COMPLETED|Overall Study||2
423110|NCT00796705|1007651|P3|COMPLETED|Overall Study||4
423111|NCT00796705|1007652|P2|COMPLETED|Overall Study||4
423112|NCT00796705|1007653|P1|COMPLETED|Overall Study||3
423113|NCT00796705|1007650|P4|STARTED|Overall Study||2
423114|NCT00796705|1007651|P3|STARTED|Overall Study||4
423115|NCT00796705|1007652|P2|STARTED|Overall Study||4
423116|NCT00796705|1007653|P1|STARTED|Overall Study||3
423117|NCT00796666|1007691|P2|NOT COMPLETED|Overall Study||64
423118|NCT00796666|1007692|P1|NOT COMPLETED|Overall Study||67
423119|NCT00796666|1007691|P2|COMPLETED|Overall Study||0
423120|NCT00796666|1007692|P1|COMPLETED|Overall Study||0
423121|NCT00796666|1007691|P2|Randomized and Not Treated|Overall Study||0
423122|NCT00796666|1007692|P1|Randomized and Not Treated|Overall Study||1
423123|NCT00796666|1007691|P2|Treated|Overall Study||64
423124|NCT00796666|1007692|P1|Treated|Overall Study||66
423125|NCT00796666|1007691|P2|STARTED|Overall Study||64
423126|NCT00796666|1007692|P1|STARTED|Overall Study||67
423127|NCT00796653|1007726|P4|NOT COMPLETED|Overall Study||40
423128|NCT00796653|1007727|P3|NOT COMPLETED|Overall Study||36
423129|NCT00796653|1007728|P2|NOT COMPLETED|Overall Study||37
423130|NCT00796653|1007729|P1|NOT COMPLETED|Overall Study||51
423131|NCT00796653|1007726|P4|COMPLETED|Overall Study||193
423132|NCT00796653|1007727|P3|COMPLETED|Overall Study||198
423133|NCT00796653|1007728|P2|COMPLETED|Overall Study||195
423134|NCT00796653|1007729|P1|COMPLETED|Overall Study||184
423135|NCT00796653|1007726|P4|STARTED|Overall Study||233
423136|NCT00796653|1007727|P3|STARTED|Overall Study||234
423137|NCT00796653|1007728|P2|STARTED|Overall Study||232
423138|NCT00796653|1007729|P1|STARTED|Overall Study||235
423139|NCT00796614|1007999|P4|NOT COMPLETED|Overall Study||1
423140|NCT00796614|1008000|P3|NOT COMPLETED|Overall Study||3
423141|NCT00796614|1008001|P2|NOT COMPLETED|Overall Study||4
423142|NCT00796614|1008002|P1|NOT COMPLETED|Overall Study||5
423143|NCT00796614|1007999|P4|COMPLETED|Overall Study||40
423144|NCT00796614|1008000|P3|COMPLETED|Overall Study||36
423145|NCT00796614|1008001|P2|COMPLETED|Overall Study||36
423146|NCT00796614|1008002|P1|COMPLETED|Overall Study||36
423147|NCT00796614|1007999|P4|Not Treated|Overall Study||0
423148|NCT00796614|1008000|P3|Not Treated|Overall Study||1
423149|NCT00796614|1008001|P2|Not Treated|Overall Study||0
423150|NCT00796614|1008002|P1|Not Treated|Overall Study||0
423151|NCT00796614|1007999|P4|STARTED|Overall Study||41
423152|NCT00796614|1008000|P3|STARTED|Overall Study||39
423153|NCT00796614|1008001|P2|STARTED|Overall Study||40
423154|NCT00796614|1008002|P1|STARTED|Overall Study||41
423155|NCT00796549|1008044|P1|NOT COMPLETED|Overall Study||218
423156|NCT00796549|1008044|P1|COMPLETED|Overall Study||0
423157|NCT00796549|1008044|P1|Entered|Overall Study|entered and treated|69
423158|NCT00796549|1008044|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
423159|NCT00796523|1008061|P2|NOT COMPLETED|Overall Study||7
423160|NCT00796523|1008062|P1|NOT COMPLETED|Overall Study||9
423161|NCT00796523|1008061|P2|COMPLETED|Overall Study||17
423162|NCT00796523|1008062|P1|COMPLETED|Overall Study||18
423163|NCT00796523|1008061|P2|STARTED|Overall Study||24
423164|NCT00796523|1008062|P1|STARTED|Overall Study||27
423165|NCT00796510|1008072|P2|NOT COMPLETED|Overall Study||0
423166|NCT00796510|1008073|P1|NOT COMPLETED|Overall Study||3
423167|NCT00796510|1008072|P2|COMPLETED|Overall Study||0
423168|NCT00796510|1008073|P1|COMPLETED|Overall Study||0
423169|NCT00796510|1008072|P2|STARTED|Overall Study||0
423170|NCT00796510|1008073|P1|STARTED|Overall Study||3
423171|NCT00796419|1008085|P2|NOT COMPLETED|Overall Study||1
423172|NCT00796419|1008086|P1|NOT COMPLETED|Overall Study||0
423173|NCT00796419|1008085|P2|COMPLETED|Overall Study||13
423174|NCT00796419|1008086|P1|COMPLETED|Overall Study||13
423175|NCT00796419|1008085|P2|STARTED|Overall Study||14
423176|NCT00796419|1008086|P1|STARTED|Overall Study||13
423177|NCT00796367|1008099|P3|NOT COMPLETED|Overall Study||47
423178|NCT00796367|1008100|P2|NOT COMPLETED|Overall Study||25
423179|NCT00796367|1008101|P1|NOT COMPLETED|Overall Study||30
423180|NCT00796367|1008099|P3|COMPLETED|Overall Study||248
423181|NCT00796367|1008100|P2|COMPLETED|Overall Study||129
423182|NCT00796367|1008101|P1|COMPLETED|Overall Study||197
423183|NCT00796367|1008099|P3|STARTED|Overall Study||295
423184|NCT00796367|1008100|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
423185|NCT00796367|1008101|P1|STARTED|Overall Study||227
423186|NCT00796328|1008112|P1|NOT COMPLETED|Overall Study||6
423187|NCT00796328|1008112|P1|COMPLETED|Overall Study||40
423188|NCT00796328|1008112|P1|STARTED|Overall Study||46
423189|NCT00796315|1008116|P3|NOT COMPLETED|Overall Study||0
423190|NCT00796315|1008117|P2|NOT COMPLETED|Overall Study||1
423191|NCT00796315|1008118|P1|NOT COMPLETED|Overall Study||0
423192|NCT00796315|1008116|P3|COMPLETED|Overall Study||15
423193|NCT00796315|1008117|P2|COMPLETED|Overall Study||16
423194|NCT00796315|1008118|P1|COMPLETED|Overall Study||9
423195|NCT00796315|1008116|P3|STARTED|Overall Study||15
423196|NCT00796315|1008117|P2|STARTED|Overall Study||17
423197|NCT00796315|1008118|P1|STARTED|Overall Study||9
423198|NCT00796302|1008131|P2|NOT COMPLETED|Overall Study||18
423199|NCT00796302|1008132|P1|NOT COMPLETED|Overall Study||13
423200|NCT00796302|1008131|P2|COMPLETED|Overall Study||66
423201|NCT00796302|1008132|P1|COMPLETED|Overall Study||71
423202|NCT00796302|1008131|P2|STARTED|Overall Study||84
423203|NCT00796302|1008132|P1|STARTED|Overall Study||84
423204|NCT00796224|1008146|P2|NOT COMPLETED|Overall Study||1
423205|NCT00796224|1008147|P1|NOT COMPLETED|Overall Study||1
423206|NCT00796224|1008146|P2|COMPLETED|Overall Study||18
423207|NCT00796224|1008147|P1|COMPLETED|Overall Study||18
423208|NCT00796224|1008146|P2|STARTED|Overall Study||19
423209|NCT00796224|1008147|P1|STARTED|Overall Study||19
423210|NCT00796120|1008167|P2|NOT COMPLETED|Overall Study||60
423211|NCT00796120|1008168|P1|NOT COMPLETED|Overall Study||61
423212|NCT00796120|1008167|P2|COMPLETED|Overall Study||0
423213|NCT00796120|1008168|P1|COMPLETED|Overall Study||0
423214|NCT00796120|1008167|P2|Treated|Overall Study||57
423215|NCT00796120|1008168|P1|Treated|Overall Study||61
423216|NCT00796120|1008167|P2|STARTED|Overall Study||60
423217|NCT00796120|1008168|P1|STARTED|Overall Study||61
423218|NCT00796003|1008184|P2|NOT COMPLETED|Overall Study||29
423219|NCT00796003|1008185|P1|NOT COMPLETED|Overall Study||3
423220|NCT00796003|1008184|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
423221|NCT00796003|1008185|P1|COMPLETED|Overall Study||0
423222|NCT00796003|1008184|P2|Treated|Overall Study|Number of participants treated|34
423223|NCT00796003|1008185|P1|Treated|Overall Study|Number of participants treated|3
423224|NCT00796003|1008184|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
423225|NCT00796003|1008185|P1|STARTED|Overall Study|Number of participants enrolled|3
423226|NCT00795951|1008206|P1|NOT COMPLETED|Overall Study||2
423227|NCT00795951|1008206|P1|COMPLETED|Overall Study||100
423228|NCT00795951|1008206|P1|STARTED|Overall Study||102
423229|NCT00795886|1008243|P1|NOT COMPLETED|Overall Study||10
423230|NCT00795886|1008243|P1|COMPLETED|Overall Study||53
423231|NCT00795886|1008243|P1|STARTED|Overall Study||63
423232|NCT00795769|1008249|P1|NOT COMPLETED|Overall Study||0
423233|NCT00795769|1008249|P1|COMPLETED|Overall Study||49
423234|NCT00795769|1008249|P1|STARTED|Overall Study||49
423235|NCT00795717|1008255|P2|NOT COMPLETED|Phase II||1
423236|NCT00795717|1008256|P1|NOT COMPLETED|Phase II||0
423237|NCT00795717|1008255|P2|COMPLETED|Phase II||18
423238|NCT00795717|1008256|P1|COMPLETED|Phase II||18
423239|NCT00795717|1008255|P2|STARTED|Phase II||19
423240|NCT00795717|1008256|P1|STARTED|Phase II||18
423241|NCT00795717|1008255|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
423242|NCT00795717|1008256|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
423243|NCT00795717|1008255|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
423244|NCT00795717|1008256|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
423245|NCT00795717|1008255|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
423246|NCT00795717|1008256|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
423247|NCT00795704|1008268|P2|NOT COMPLETED|Overall Study||3
423248|NCT00795704|1008269|P1|NOT COMPLETED|Overall Study||4
423249|NCT00795704|1008268|P2|COMPLETED|Overall Study||9
423250|NCT00795704|1008269|P1|COMPLETED|Overall Study||8
423251|NCT00795704|1008268|P2|STARTED|Overall Study||12
423252|NCT00795704|1008269|P1|STARTED|Overall Study||12
423253|NCT00795639|1008281|P2|NOT COMPLETED|Overall Study||26
423254|NCT00795639|1008282|P1|NOT COMPLETED|Overall Study||21
423255|NCT00795639|1008281|P2|COMPLETED|Overall Study||66
423256|NCT00795639|1008282|P1|COMPLETED|Overall Study||70
423257|NCT00795639|1008281|P2|Randomized and Not Treated|Overall Study||1
423258|NCT00795639|1008282|P1|Randomized and Not Treated|Overall Study||0
423259|NCT00795639|1008281|P2|STARTED|Overall Study||92
423260|NCT00795639|1008282|P1|STARTED|Overall Study||91
423261|NCT00795600|1008294|P2|NOT COMPLETED|Overall Study||4
423262|NCT00795600|1008295|P1|NOT COMPLETED|Overall Study||4
423263|NCT00795600|1008294|P2|COMPLETED|Overall Study||31
423264|NCT00795600|1008295|P1|COMPLETED|Overall Study||21
423265|NCT00795600|1008294|P2|Exposed to Drug|Overall Study||35
423266|NCT00795600|1008295|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
423267|NCT00795600|1008294|P2|STARTED|Overall Study||35
423268|NCT00795600|1008295|P1|STARTED|Overall Study||25
423269|NCT00795535|1008415|P1|NOT COMPLETED|Overall Study||20
423270|NCT00795535|1008415|P1|COMPLETED|Overall Study||75
423271|NCT00795535|1008415|P1|STARTED|Overall Study||95
423272|NCT00795509|1008422|P1|NOT COMPLETED|Overall Study||31
423273|NCT00795509|1008422|P1|COMPLETED|Overall Study||343
423274|NCT00795509|1008422|P1|STARTED|Overall Study||374
423275|NCT00795366|1008429|P2|NOT COMPLETED|Overall Study||0
423276|NCT00795366|1008430|P1|NOT COMPLETED|Overall Study||0
423277|NCT00795366|1008429|P2|COMPLETED|Overall Study||54
423278|NCT00795366|1008430|P1|COMPLETED|Overall Study||42
423279|NCT00795366|1008429|P2|STARTED|Overall Study||54
423280|NCT00795366|1008430|P1|STARTED|Overall Study||42
423281|NCT00795340|1008438|P2|NOT COMPLETED|Overall Study||0
423282|NCT00795340|1008439|P1|NOT COMPLETED|Overall Study||7
423283|NCT00795340|1008438|P2|COMPLETED|Overall Study||153
423284|NCT00795340|1008439|P1|COMPLETED|Overall Study||146
423285|NCT00795340|1008438|P2|STARTED|Overall Study||153
423286|NCT00795340|1008439|P1|STARTED|Overall Study||153
423287|NCT00795288|1008451|P2|NOT COMPLETED|Overall Study||0
423288|NCT00795288|1008452|P1|NOT COMPLETED|Overall Study||0
423289|NCT00795288|1008451|P2|COMPLETED|Overall Study||21
423290|NCT00795288|1008452|P1|COMPLETED|Overall Study||21
423291|NCT00795288|1008451|P2|STARTED|Overall Study||21
423292|NCT00795288|1008452|P1|STARTED|Overall Study||21
423293|NCT00795210|1008465|P3|NOT COMPLETED|Overall Study||2
423294|NCT00795210|1008466|P2|NOT COMPLETED|Overall Study||1
423295|NCT00795210|1008467|P1|NOT COMPLETED|Overall Study||0
423296|NCT00795210|1008465|P3|COMPLETED|Overall Study||3
423297|NCT00795210|1008466|P2|COMPLETED|Overall Study||11
423298|NCT00795210|1008467|P1|COMPLETED|Overall Study||8
423299|NCT00795210|1008465|P3|STARTED|Overall Study||5
423300|NCT00795210|1008466|P2|STARTED|Overall Study||12
423301|NCT00795210|1008467|P1|STARTED|Overall Study||8
423302|NCT00795184|1008478|P2|NOT COMPLETED|Overall Study||13
423303|NCT00795184|1008479|P1|NOT COMPLETED|Overall Study||8
423304|NCT00795184|1008478|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
423305|NCT00795184|1008479|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
423306|NCT00795184|1008478|P2|STARTED|Overall Study||57
423307|NCT00795184|1008479|P1|STARTED|Overall Study||65
423308|NCT00795145|1008490|P7|NOT COMPLETED|Cohort 2||0
423309|NCT00795145|1008491|P6|NOT COMPLETED|Cohort 2||0
423310|NCT00795145|1008492|P5|NOT COMPLETED|Cohort 2||0
423311|NCT00795145|1008493|P4|NOT COMPLETED|Cohort 2||0
423312|NCT00795145|1008494|P3|NOT COMPLETED|Cohort 2||0
423313|NCT00795145|1008495|P2|NOT COMPLETED|Cohort 2||0
423314|NCT00795145|1008496|P1|NOT COMPLETED|Cohort 2||0
423315|NCT00795145|1008490|P7|COMPLETED|Cohort 2||10
423316|NCT00795145|1008491|P6|COMPLETED|Cohort 2||10
423317|NCT00795145|1008492|P5|COMPLETED|Cohort 2||10
423318|NCT00795145|1008493|P4|COMPLETED|Cohort 2||10
423319|NCT00795145|1008494|P3|COMPLETED|Cohort 2||0
423320|NCT00795145|1008495|P2|COMPLETED|Cohort 2||0
423321|NCT00795145|1008496|P1|COMPLETED|Cohort 2||0
423322|NCT00795145|1008490|P7|STARTED|Cohort 2||10
423323|NCT00795145|1008491|P6|STARTED|Cohort 2||10
423324|NCT00795145|1008492|P5|STARTED|Cohort 2||10
423325|NCT00795145|1008493|P4|STARTED|Cohort 2||10
423326|NCT00795145|1008494|P3|STARTED|Cohort 2||0
423327|NCT00795145|1008495|P2|STARTED|Cohort 2||0
423328|NCT00795145|1008496|P1|STARTED|Cohort 2||0
423329|NCT00795145|1008490|P7|NOT COMPLETED|Cohort 1||0
423330|NCT00795145|1008491|P6|NOT COMPLETED|Cohort 1||0
423331|NCT00795145|1008492|P5|NOT COMPLETED|Cohort 1||0
423332|NCT00795145|1008493|P4|NOT COMPLETED|Cohort 1||0
423333|NCT00795145|1008494|P3|NOT COMPLETED|Cohort 1||0
423334|NCT00795145|1008495|P2|NOT COMPLETED|Cohort 1||0
423335|NCT00795145|1008496|P1|NOT COMPLETED|Cohort 1||0
423336|NCT00795145|1008490|P7|COMPLETED|Cohort 1||0
423337|NCT00795145|1008491|P6|COMPLETED|Cohort 1||0
423338|NCT00795145|1008492|P5|COMPLETED|Cohort 1||0
423339|NCT00795145|1008493|P4|COMPLETED|Cohort 1||0
423340|NCT00795145|1008494|P3|COMPLETED|Cohort 1||3
423341|NCT00795145|1008495|P2|COMPLETED|Cohort 1||3
423342|NCT00795145|1008496|P1|COMPLETED|Cohort 1||3
423343|NCT00795145|1008490|P7|STARTED|Cohort 1||0
423344|NCT00795145|1008491|P6|STARTED|Cohort 1||0
423345|NCT00795145|1008492|P5|STARTED|Cohort 1||0
423346|NCT00795145|1008493|P4|STARTED|Cohort 1||0
423347|NCT00795145|1008494|P3|STARTED|Cohort 1||3
423348|NCT00795145|1008495|P2|STARTED|Cohort 1||3
423349|NCT00795145|1008496|P1|STARTED|Cohort 1||3
423350|NCT00795132|1008540|P1|NOT COMPLETED|Overall Study||3
423351|NCT00795132|1008540|P1|COMPLETED|Overall Study||44
423352|NCT00795132|1008540|P1|STARTED|Overall Study||47
423353|NCT00795002|1008554|P2|NOT COMPLETED|Overall Study||2
423354|NCT00795002|1008555|P1|NOT COMPLETED|Overall Study||2
423355|NCT00795002|1008554|P2|COMPLETED|Overall Study||37
423356|NCT00795002|1008555|P1|COMPLETED|Overall Study||37
423357|NCT00795002|1008554|P2|STARTED|Overall Study||39
423358|NCT00795002|1008555|P1|STARTED|Overall Study||39
423359|NCT00794963|1008563|P2|NOT COMPLETED|Overall Study||4
423360|NCT00794963|1008564|P1|NOT COMPLETED|Overall Study||1
423361|NCT00794963|1008563|P2|COMPLETED|Overall Study||0
423362|NCT00794963|1008564|P1|COMPLETED|Overall Study||3
423363|NCT00794963|1008563|P2|STARTED|Overall Study||4
423364|NCT00794963|1008564|P1|STARTED|Overall Study||4
423365|NCT00794924|1008572|P2|NOT COMPLETED|Overall Study||70
423366|NCT00794924|1008573|P1|NOT COMPLETED|Overall Study||60
423367|NCT00794924|1008572|P2|COMPLETED|Overall Study||101
423368|NCT00794924|1008573|P1|COMPLETED|Overall Study||114
423369|NCT00794924|1008572|P2|STARTED|Overall Study|14 patients refused to start the study|171
423370|NCT00794924|1008573|P1|STARTED|Overall Study|14 patients refused to start the study|174
423371|NCT00794820|1008577|P1|NOT COMPLETED|Overall Study||16
423372|NCT00794820|1008577|P1|COMPLETED|Overall Study||50
423373|NCT00794820|1008577|P1|STARTED|Overall Study||66
423374|NCT00794677|1008585|P2|NOT COMPLETED|Second Intervention||0
423375|NCT00794677|1008586|P1|NOT COMPLETED|Second Intervention||0
423376|NCT00794677|1008585|P2|COMPLETED|Second Intervention||13
423377|NCT00794677|1008586|P1|COMPLETED|Second Intervention||11
423378|NCT00794677|1008585|P2|STARTED|Second Intervention||13
423379|NCT00794677|1008586|P1|STARTED|Second Intervention||11
423380|NCT00794677|1008585|P2|NOT COMPLETED|First Intervention||0
423381|NCT00794677|1008586|P1|NOT COMPLETED|First Intervention||2
423382|NCT00794677|1008585|P2|COMPLETED|First Intervention||13
423383|NCT00794677|1008586|P1|COMPLETED|First Intervention||11
423384|NCT00794677|1008585|P2|STARTED|First Intervention||13
423385|NCT00794677|1008586|P1|STARTED|First Intervention||13
423386|NCT00794664|1008608|P2|NOT COMPLETED|Follow-up Period||5
423387|NCT00794664|1008609|P1|NOT COMPLETED|Follow-up Period||1
423388|NCT00794664|1008608|P2|COMPLETED|Follow-up Period||28
423389|NCT00794664|1008609|P1|COMPLETED|Follow-up Period||15
423390|NCT00794664|1008608|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
423391|NCT00794664|1008609|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
423392|NCT00794664|1008608|P2|NOT COMPLETED|Treatment Period||12
423393|NCT00794664|1008609|P1|NOT COMPLETED|Treatment Period||1
423394|NCT00794664|1008608|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
423395|NCT00794664|1008609|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
423396|NCT00794664|1008608|P2|STARTED|Treatment Period||39
423397|NCT00794664|1008609|P1|STARTED|Treatment Period||19
423398|NCT00794560|1008657|P4|NOT COMPLETED|Overall Study||4
423399|NCT00794560|1008658|P3|NOT COMPLETED|Overall Study||4
423400|NCT00794560|1008659|P2|NOT COMPLETED|Overall Study||4
423401|NCT00794560|1008660|P1|NOT COMPLETED|Overall Study||3
423402|NCT00794560|1008657|P4|COMPLETED|Overall Study||34
423403|NCT00794560|1008658|P3|COMPLETED|Overall Study||40
423404|NCT00794560|1008659|P2|COMPLETED|Overall Study||32
423405|NCT00794560|1008660|P1|COMPLETED|Overall Study||33
423406|NCT00794560|1008657|P4|STARTED|Overall Study||38
423407|NCT00794560|1008658|P3|STARTED|Overall Study||44
423408|NCT00794560|1008659|P2|STARTED|Overall Study||36
423409|NCT00794560|1008660|P1|STARTED|Overall Study||36
423410|NCT00794547|1008674|P2|NOT COMPLETED|Overall Study||0
423411|NCT00794547|1008675|P1|NOT COMPLETED|Overall Study||0
423412|NCT00794547|1008674|P2|COMPLETED|Overall Study||16
423413|NCT00794547|1008675|P1|COMPLETED|Overall Study||18
423414|NCT00794547|1008674|P2|STARTED|Overall Study||16
423415|NCT00794547|1008675|P1|STARTED|Overall Study||18
423416|NCT00794508|1008682|P1|NOT COMPLETED|Overall Study||0
423417|NCT00794508|1008682|P1|COMPLETED|Overall Study||10
423418|NCT00794508|1008682|P1|STARTED|Overall Study||10
423419|NCT00794469|1008688|P1|NOT COMPLETED|Overall Study||0
423420|NCT00794469|1008688|P1|COMPLETED|Overall Study||21
423421|NCT00794469|1008688|P1|STARTED|Overall Study||21
423422|NCT00794365|1008693|P1|NOT COMPLETED|Overall Study||79
423423|NCT00794365|1008693|P1|COMPLETED|Overall Study||251
423424|NCT00794365|1008693|P1|STARTED|Overall Study||330
423425|NCT00794313|1008699|P3|NOT COMPLETED|Overall Study||0
423426|NCT00794313|1008700|P2|NOT COMPLETED|Overall Study||0
423427|NCT00794313|1008701|P1|NOT COMPLETED|Overall Study||0
423428|NCT00794313|1008699|P3|COMPLETED|Overall Study||1
423429|NCT00794313|1008700|P2|COMPLETED|Overall Study||1
423430|NCT00794313|1008701|P1|COMPLETED|Overall Study||1
423431|NCT00794313|1008699|P3|STARTED|Overall Study||1
423432|NCT00794313|1008700|P2|STARTED|Overall Study||1
423433|NCT00794313|1008701|P1|STARTED|Overall Study||1
423434|NCT00794196|1008714|P2|NOT COMPLETED|Overall Study||23
423435|NCT00794196|1008715|P1|NOT COMPLETED|Overall Study||5
423436|NCT00794196|1008714|P2|COMPLETED|Overall Study||64
423437|NCT00794196|1008715|P1|COMPLETED|Overall Study||87
423438|NCT00794196|1008714|P2|STARTED|Overall Study||87
423439|NCT00794196|1008715|P1|STARTED|Overall Study||92
423440|NCT00794170|1008725|P2|NOT COMPLETED|Overall Study||3
423441|NCT00794170|1008726|P1|NOT COMPLETED|Overall Study||7
423442|NCT00794170|1008725|P2|COMPLETED|Overall Study||152
423443|NCT00794170|1008726|P1|COMPLETED|Overall Study||150
423444|NCT00794170|1008725|P2|STARTED|Overall Study||155
423445|NCT00794170|1008726|P1|STARTED|Overall Study||157
423446|NCT00794157|1008735|P3|NOT COMPLETED|Overall Study||19
423447|NCT00794157|1008736|P2|NOT COMPLETED|Overall Study||10
423448|NCT00794157|1008737|P1|NOT COMPLETED|Overall Study||10
423449|NCT00794157|1008735|P3|COMPLETED|Overall Study||98
423450|NCT00794157|1008736|P2|COMPLETED|Overall Study||106
423451|NCT00794157|1008737|P1|COMPLETED|Overall Study||104
423452|NCT00794157|1008735|P3|STARTED|Overall Study||117
423453|NCT00794157|1008736|P2|STARTED|Overall Study||116
423454|NCT00794157|1008737|P1|STARTED|Overall Study||114
423455|NCT00794144|1008759|P2|NOT COMPLETED|Overall Study||3
423456|NCT00794144|1008760|P1|NOT COMPLETED|Overall Study||3
423457|NCT00794144|1008759|P2|COMPLETED|Overall Study||63
423458|NCT00794144|1008760|P1|COMPLETED|Overall Study||63
423459|NCT00794144|1008759|P2|STARTED|Overall Study||66
423460|NCT00794144|1008760|P1|STARTED|Overall Study||66
423461|NCT00794118|1008766|P1|NOT COMPLETED|Overall Study||27
423462|NCT00794118|1008766|P1|COMPLETED|Overall Study||272
423463|NCT00794118|1008766|P1|STARTED|Overall Study||299
423464|NCT00793910|1008824|P2|NOT COMPLETED|Overall Study||7
423465|NCT00793910|1008825|P1|NOT COMPLETED|Overall Study||5
423466|NCT00793910|1008824|P2|COMPLETED|Overall Study||46
423467|NCT00793910|1008825|P1|COMPLETED|Overall Study||48
423468|NCT00793910|1008824|P2|STARTED|Overall Study||53
423469|NCT00793910|1008825|P1|STARTED|Overall Study||53
423470|NCT00793871|1008839|P1|NOT COMPLETED|Overall Study||60
423471|NCT00793871|1008839|P1|COMPLETED|Overall Study||0
423472|NCT00793871|1008839|P1|Received Treatment|Overall Study||59
423473|NCT00793871|1008839|P1|STARTED|Overall Study||60
423474|NCT00793819|1008853|P2|NOT COMPLETED|Overall Study||9
423475|NCT00793819|1008854|P1|NOT COMPLETED|Overall Study||14
423476|NCT00793819|1008853|P2|COMPLETED|Overall Study||89
423477|NCT00793819|1008854|P1|COMPLETED|Overall Study||97
423478|NCT00793819|1008853|P2|STARTED|Overall Study||98
423479|NCT00793819|1008854|P1|STARTED|Overall Study||111
423480|NCT00793793|1008872|P12|NOT COMPLETED|Overall Study||6
423481|NCT00793793|1008873|P11|NOT COMPLETED|Overall Study||3
423482|NCT00793793|1008874|P10|NOT COMPLETED|Overall Study||9
423483|NCT00793793|1008875|P9|NOT COMPLETED|Overall Study||9
423484|NCT00793793|1008876|P8|NOT COMPLETED|Overall Study||0
423485|NCT00793793|1008877|P7|NOT COMPLETED|Overall Study||4
423486|NCT00793793|1008878|P6|NOT COMPLETED|Overall Study||2
423487|NCT00793793|1008879|P5|NOT COMPLETED|Overall Study||2
423488|NCT00793793|1008880|P4|NOT COMPLETED|Overall Study||3
423489|NCT00793793|1008881|P3|NOT COMPLETED|Overall Study||2
423490|NCT00793793|1008882|P2|NOT COMPLETED|Overall Study||1
423491|NCT00793793|1008883|P1|NOT COMPLETED|Overall Study||0
423492|NCT00793793|1008872|P12|COMPLETED|Overall Study||1
423493|NCT00793793|1008873|P11|COMPLETED|Overall Study||3
423494|NCT00793793|1008874|P10|COMPLETED|Overall Study||6
423495|NCT00793793|1008875|P9|COMPLETED|Overall Study||6
423496|NCT00793793|1008876|P8|COMPLETED|Overall Study||6
423497|NCT00793793|1008877|P7|COMPLETED|Overall Study||3
423498|NCT00793793|1008878|P6|COMPLETED|Overall Study||4
423499|NCT00793793|1008879|P5|COMPLETED|Overall Study||4
423500|NCT00793793|1008880|P4|COMPLETED|Overall Study||4
423501|NCT00793793|1008881|P3|COMPLETED|Overall Study||5
423502|NCT00793793|1008882|P2|COMPLETED|Overall Study||5
423503|NCT00793793|1008883|P1|COMPLETED|Overall Study||8
423504|NCT00793793|1008872|P12|STARTED|Overall Study||7
423505|NCT00793793|1008873|P11|STARTED|Overall Study||6
423506|NCT00793793|1008874|P10|STARTED|Overall Study||15
423507|NCT00793793|1008875|P9|STARTED|Overall Study||15
423508|NCT00793793|1008876|P8|STARTED|Overall Study||6
423509|NCT00793793|1008877|P7|STARTED|Overall Study||7
423510|NCT00793793|1008878|P6|STARTED|Overall Study||6
423511|NCT00793793|1008879|P5|STARTED|Overall Study||6
423512|NCT00793793|1008880|P4|STARTED|Overall Study||7
423513|NCT00793793|1008881|P3|STARTED|Overall Study||7
423514|NCT00793793|1008882|P2|STARTED|Overall Study||6
423515|NCT00793793|1008883|P1|STARTED|Overall Study||8
423516|NCT00793780|1009258|P2|NOT COMPLETED|Overall Study||1
423517|NCT00793780|1009259|P1|NOT COMPLETED|Overall Study||2
423518|NCT00793780|1009258|P2|COMPLETED|Overall Study||11
423519|NCT00793780|1009259|P1|COMPLETED|Overall Study||10
423520|NCT00793780|1009258|P2|Collected Baseline Data|Overall Study||12
423521|NCT00793780|1009259|P1|Collected Baseline Data|Overall Study||11
423522|NCT00793780|1009258|P2|Randomization|Overall Study||12
423523|NCT00793780|1009259|P1|Randomization|Overall Study||12
423524|NCT00793780|1009258|P2|STARTED|Overall Study||12
423525|NCT00793780|1009259|P1|STARTED|Overall Study||12
423526|NCT00793650|1009277|P2|NOT COMPLETED|Overall Study||0
423527|NCT00793650|1009278|P1|NOT COMPLETED|Overall Study||0
423528|NCT00793650|1009277|P2|COMPLETED|Overall Study||20
423529|NCT00793650|1009278|P1|COMPLETED|Overall Study||19
423530|NCT00793650|1009277|P2|STARTED|Overall Study||20
423531|NCT00793650|1009278|P1|STARTED|Overall Study||19
423532|NCT00793624|1009290|P4|NOT COMPLETED|Overall Study||43
423533|NCT00793624|1009291|P3|NOT COMPLETED|Overall Study||39
423534|NCT00793624|1009292|P2|NOT COMPLETED|Overall Study||36
423535|NCT00793624|1009293|P1|NOT COMPLETED|Overall Study||57
423536|NCT00793624|1009290|P4|COMPLETED|Overall Study||184
423537|NCT00793624|1009291|P3|COMPLETED|Overall Study||186
423538|NCT00793624|1009292|P2|COMPLETED|Overall Study||191
423539|NCT00793624|1009293|P1|COMPLETED|Overall Study||168
423540|NCT00793624|1009290|P4|STARTED|Overall Study||227
423541|NCT00793624|1009291|P3|STARTED|Overall Study||225
423542|NCT00793624|1009292|P2|STARTED|Overall Study||227
423543|NCT00793624|1009293|P1|STARTED|Overall Study||225
423544|NCT00793611|1009561|P2|NOT COMPLETED|Overall Study||0
423545|NCT00793611|1009562|P1|NOT COMPLETED|Overall Study||0
423546|NCT00793611|1009561|P2|COMPLETED|Overall Study||10
423547|NCT00793611|1009562|P1|COMPLETED|Overall Study||10
423548|NCT00793611|1009561|P2|STARTED|Overall Study||10
423549|NCT00793611|1009562|P1|STARTED|Overall Study||10
423550|NCT00793585|1009574|P2|NOT COMPLETED|Overall Study||3
423551|NCT00793585|1009575|P1|NOT COMPLETED|Overall Study||2
423552|NCT00793585|1009574|P2|COMPLETED|Overall Study||18
423553|NCT00793585|1009575|P1|COMPLETED|Overall Study||17
423554|NCT00793585|1009574|P2|STARTED|Overall Study||21
423555|NCT00793585|1009575|P1|STARTED|Overall Study||19
423556|NCT00793572|1009583|P1|NOT COMPLETED|Overall Study||0
423557|NCT00793572|1009583|P1|COMPLETED|Overall Study||32
423558|NCT00793572|1009583|P1|STARTED|Overall Study||32
423559|NCT00793546|1009594|P2|NOT COMPLETED|Overall Study||28
423560|NCT00793546|1009595|P1|NOT COMPLETED|Overall Study||14
423561|NCT00793546|1009594|P2|COMPLETED|Overall Study||0
423562|NCT00793546|1009595|P1|COMPLETED|Overall Study||0
423563|NCT00793546|1009594|P2|STARTED|Overall Study||28
423564|NCT00793546|1009595|P1|STARTED|Overall Study||14
423565|NCT00793520|1009625|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
423566|NCT00793520|1009626|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
423567|NCT00793520|1009625|P2|COMPLETED|Placebo Crossover to Milnacipran||0
423568|NCT00793520|1009626|P1|COMPLETED|Placebo Crossover to Milnacipran||0
423569|NCT00793520|1009625|P2|STARTED|Placebo Crossover to Milnacipran||1
423570|NCT00793520|1009626|P1|STARTED|Placebo Crossover to Milnacipran||0
423571|NCT00793520|1009625|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
423572|NCT00793520|1009626|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
423573|NCT00793520|1009625|P2|COMPLETED|Milnacipran Crossover to Placebo||0
423574|NCT00793520|1009626|P1|COMPLETED|Milnacipran Crossover to Placebo||0
423575|NCT00793520|1009625|P2|STARTED|Milnacipran Crossover to Placebo||0
423576|NCT00793520|1009626|P1|STARTED|Milnacipran Crossover to Placebo||1
423577|NCT00793455|1009636|P2|NOT COMPLETED|Overall Study||0
423578|NCT00793455|1009637|P1|NOT COMPLETED|Overall Study||0
423579|NCT00793455|1009636|P2|COMPLETED|Overall Study||314
423580|NCT00793455|1009637|P1|COMPLETED|Overall Study||314
423581|NCT00793455|1009636|P2|STARTED|Overall Study||314
423582|NCT00793455|1009637|P1|STARTED|Overall Study||314
423583|NCT00793403|1009645|P1|NOT COMPLETED|Overall Study||73
423584|NCT00793403|1009645|P1|COMPLETED|Overall Study||220
423585|NCT00793403|1009645|P1|STARTED|Overall Study||293
423586|NCT00793325|1009692|P1|NOT COMPLETED|Overall Study||19
423587|NCT00793325|1009692|P1|COMPLETED|Overall Study||890
423588|NCT00793325|1009692|P1|STARTED|Overall Study||909
423589|NCT00793169|1009716|P1|NOT COMPLETED|Overall Study||0
423590|NCT00793169|1009716|P1|COMPLETED|Overall Study||19
423591|NCT00793169|1009716|P1|STARTED|Overall Study||19
423592|NCT00793104|1009720|P1|NOT COMPLETED|Overall Study||1
423593|NCT00793104|1009720|P1|COMPLETED|Overall Study||9
423594|NCT00793104|1009720|P1|STARTED|Overall Study||10
423595|NCT00792948|1009728|P1|NOT COMPLETED|Overall Study||28
423596|NCT00792948|1009728|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
423597|NCT00792948|1009728|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
423598|NCT00792935|1009739|P2|NOT COMPLETED|Overall Study||3
423599|NCT00792935|1009740|P1|NOT COMPLETED|Overall Study||4
423600|NCT00792935|1009739|P2|COMPLETED|Overall Study||68
423601|NCT00792935|1009740|P1|COMPLETED|Overall Study||68
423602|NCT00792935|1009739|P2|STARTED|Overall Study||71
423603|NCT00792935|1009740|P1|STARTED|Overall Study||72
423604|NCT00792805|1009751|P3|NOT COMPLETED|Overall Study||33
423605|NCT00792805|1009752|P2|NOT COMPLETED|Overall Study||26
423606|NCT00792805|1009753|P1|NOT COMPLETED|Overall Study||22
423607|NCT00792805|1009751|P3|COMPLETED|Overall Study||154
423608|NCT00792805|1009752|P2|COMPLETED|Overall Study||162
423609|NCT00792805|1009753|P1|COMPLETED|Overall Study||166
423610|NCT00792805|1009751|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
423611|NCT00792805|1009752|P2|Exposed to Study Medication or Placebo|Overall Study||188
423612|NCT00792805|1009753|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
423613|NCT00792805|1009751|P3|STARTED|Overall Study||187
423614|NCT00792805|1009752|P2|STARTED|Overall Study||188
423615|NCT00792805|1009753|P1|STARTED|Overall Study||188
423616|NCT00792688|1009764|P3|NOT COMPLETED|Overall Study||0
423617|NCT00792688|1009765|P2|NOT COMPLETED|Overall Study||0
423618|NCT00792688|1009766|P1|NOT COMPLETED|Overall Study||0
423619|NCT00792688|1009764|P3|COMPLETED|Overall Study||9
423620|NCT00792688|1009765|P2|COMPLETED|Overall Study||8
423621|NCT00792688|1009766|P1|COMPLETED|Overall Study||9
423622|NCT00792688|1009764|P3|STARTED|Overall Study||9
423623|NCT00792688|1009765|P2|STARTED|Overall Study||8
423624|NCT00792688|1009766|P1|STARTED|Overall Study||9
423625|NCT00792636|1009780|P3|NOT COMPLETED|Overall Study||81
423626|NCT00792636|1009781|P2|NOT COMPLETED|Overall Study||81
423627|NCT00792636|1009782|P1|NOT COMPLETED|Overall Study||68
423628|NCT00792636|1009780|P3|COMPLETED|Overall Study||55
423629|NCT00792636|1009781|P2|COMPLETED|Overall Study||55
423630|NCT00792636|1009782|P1|COMPLETED|Overall Study||67
423631|NCT00792636|1009780|P3|STARTED|Overall Study||136
423632|NCT00792636|1009781|P2|STARTED|Overall Study||136
423633|NCT00792636|1009782|P1|STARTED|Overall Study||135
423634|NCT00792610|1009819|P1|NOT COMPLETED|Overall Study||0
423635|NCT00792610|1009819|P1|COMPLETED|Overall Study||127
423636|NCT00792610|1009819|P1|Youths|Overall Study||127
423637|NCT00792610|1009819|P1|STARTED|Overall Study||127
423638|NCT00792298|1009823|P8|NOT COMPLETED|Treatment Period 2||2
423639|NCT00792298|1009824|P7|NOT COMPLETED|Treatment Period 2||1
423640|NCT00792298|1009825|P6|NOT COMPLETED|Treatment Period 2||0
423641|NCT00792298|1009826|P5|NOT COMPLETED|Treatment Period 2||2
423642|NCT00792298|1009827|P4|NOT COMPLETED|Treatment Period 2||2
423643|NCT00792298|1009828|P3|NOT COMPLETED|Treatment Period 2||1
423644|NCT00792298|1009829|P2|NOT COMPLETED|Treatment Period 2||1
423645|NCT00792298|1009830|P1|NOT COMPLETED|Treatment Period 2||1
423646|NCT00792298|1009823|P8|COMPLETED|Treatment Period 2||28
423647|NCT00792298|1009824|P7|COMPLETED|Treatment Period 2||28
423648|NCT00792298|1009825|P6|COMPLETED|Treatment Period 2||27
423649|NCT00792298|1009826|P5|COMPLETED|Treatment Period 2||30
423650|NCT00792298|1009827|P4|COMPLETED|Treatment Period 2||26
423651|NCT00792298|1009828|P3|COMPLETED|Treatment Period 2||30
423652|NCT00792298|1009829|P2|COMPLETED|Treatment Period 2||30
423653|NCT00792298|1009830|P1|COMPLETED|Treatment Period 2||29
423654|NCT00792298|1009823|P8|STARTED|Treatment Period 2||30
423655|NCT00792298|1009824|P7|STARTED|Treatment Period 2||29
423656|NCT00792298|1009825|P6|STARTED|Treatment Period 2||27
423657|NCT00792298|1009826|P5|STARTED|Treatment Period 2||32
423658|NCT00792298|1009827|P4|STARTED|Treatment Period 2||28
423659|NCT00792298|1009828|P3|STARTED|Treatment Period 2||31
423660|NCT00792298|1009829|P2|STARTED|Treatment Period 2||31
423661|NCT00792298|1009830|P1|STARTED|Treatment Period 2||30
423662|NCT00792298|1009823|P8|NOT COMPLETED|Washout||0
423663|NCT00792298|1009824|P7|NOT COMPLETED|Washout||0
423664|NCT00792298|1009825|P6|NOT COMPLETED|Washout||2
423665|NCT00792298|1009826|P5|NOT COMPLETED|Washout||0
423666|NCT00792298|1009827|P4|NOT COMPLETED|Washout||0
423667|NCT00792298|1009828|P3|NOT COMPLETED|Washout||1
423668|NCT00792298|1009829|P2|NOT COMPLETED|Washout||0
423669|NCT00792298|1009830|P1|NOT COMPLETED|Washout||0
423670|NCT00792298|1009823|P8|COMPLETED|Washout||30
423671|NCT00792298|1009824|P7|COMPLETED|Washout||29
423672|NCT00792298|1009825|P6|COMPLETED|Washout||27
423673|NCT00792298|1009826|P5|COMPLETED|Washout||32
423674|NCT00792298|1009827|P4|COMPLETED|Washout||28
423675|NCT00792298|1009828|P3|COMPLETED|Washout||31
423676|NCT00792298|1009829|P2|COMPLETED|Washout||31
423677|NCT00792298|1009830|P1|COMPLETED|Washout||30
423678|NCT00792298|1009823|P8|STARTED|Washout||30
423679|NCT00792298|1009824|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
423680|NCT00792298|1009825|P6|STARTED|Washout||29
423681|NCT00792298|1009826|P5|STARTED|Washout||32
423682|NCT00792298|1009827|P4|STARTED|Washout||28
423683|NCT00792298|1009828|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
423684|NCT00792298|1009829|P2|STARTED|Washout||31
423685|NCT00792298|1009830|P1|STARTED|Washout||30
423686|NCT00792298|1009823|P8|NOT COMPLETED|Treatment Period 1||1
423687|NCT00792298|1009824|P7|NOT COMPLETED|Treatment Period 1||4
423688|NCT00792298|1009825|P6|NOT COMPLETED|Treatment Period 1||3
423689|NCT00792298|1009826|P5|NOT COMPLETED|Treatment Period 1||0
423690|NCT00792298|1009827|P4|NOT COMPLETED|Treatment Period 1||4
423691|NCT00792298|1009828|P3|NOT COMPLETED|Treatment Period 1||2
423692|NCT00792298|1009829|P2|NOT COMPLETED|Treatment Period 1||1
423693|NCT00792298|1009830|P1|NOT COMPLETED|Treatment Period 1||1
423694|NCT00792298|1009823|P8|COMPLETED|Treatment Period 1||30
423695|NCT00792298|1009824|P7|COMPLETED|Treatment Period 1||27
423696|NCT00792298|1009825|P6|COMPLETED|Treatment Period 1||29
423697|NCT00792298|1009826|P5|COMPLETED|Treatment Period 1||32
423698|NCT00792298|1009827|P4|COMPLETED|Treatment Period 1||28
423699|NCT00792298|1009828|P3|COMPLETED|Treatment Period 1||31
423700|NCT00792298|1009829|P2|COMPLETED|Treatment Period 1||31
423701|NCT00792298|1009830|P1|COMPLETED|Treatment Period 1||30
423702|NCT00792298|1009823|P8|STARTED|Treatment Period 1||31
423703|NCT00792298|1009824|P7|STARTED|Treatment Period 1||31
423704|NCT00792298|1009825|P6|STARTED|Treatment Period 1||32
423705|NCT00792298|1009826|P5|STARTED|Treatment Period 1||32
423706|NCT00792298|1009827|P4|STARTED|Treatment Period 1||32
423707|NCT00792298|1009828|P3|STARTED|Treatment Period 1||33
423708|NCT00792298|1009829|P2|STARTED|Treatment Period 1||32
423709|NCT00792298|1009830|P1|STARTED|Treatment Period 1||31
423710|NCT00792259|1009860|P3|NOT COMPLETED|Overall Study||0
423711|NCT00792259|1009861|P2|NOT COMPLETED|Overall Study||0
423712|NCT00792259|1009862|P1|NOT COMPLETED|Overall Study||1
423713|NCT00792259|1009860|P3|COMPLETED|Overall Study||13
423714|NCT00792259|1009861|P2|COMPLETED|Overall Study||20
423715|NCT00792259|1009862|P1|COMPLETED|Overall Study||14
423716|NCT00792259|1009860|P3|STARTED|Overall Study||13
423717|NCT00792259|1009861|P2|STARTED|Overall Study||20
423718|NCT00792259|1009862|P1|STARTED|Overall Study||15
423719|NCT00792116|1009872|P2|NOT COMPLETED|Overall Study||1
423720|NCT00792116|1009873|P1|NOT COMPLETED|Overall Study||1
423721|NCT00792116|1009872|P2|COMPLETED|Overall Study||54
423722|NCT00792116|1009873|P1|COMPLETED|Overall Study||52
423723|NCT00792116|1009872|P2|STARTED|Overall Study||55
423724|NCT00792116|1009873|P1|STARTED|Overall Study||53
423725|NCT00792103|1009883|P1|NOT COMPLETED|Overall Study||133
423726|NCT00792103|1009883|P1|COMPLETED|Overall Study||65
423727|NCT00792103|1009883|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
423728|NCT00791999|1009895|P4|NOT COMPLETED|Overall Study||52
423729|NCT00791999|1009896|P3|NOT COMPLETED|Overall Study||20
423730|NCT00791999|1009897|P2|NOT COMPLETED|Overall Study||16
423731|NCT00791999|1009898|P1|NOT COMPLETED|Overall Study||21
423732|NCT00791999|1009895|P4|COMPLETED|Overall Study||25
423733|NCT00791999|1009896|P3|COMPLETED|Overall Study||65
423734|NCT00791999|1009897|P2|COMPLETED|Overall Study||66
423735|NCT00791999|1009898|P1|COMPLETED|Overall Study||51
423736|NCT00791999|1009895|P4|STARTED|Overall Study||77
423737|NCT00791999|1009896|P3|STARTED|Overall Study||85
423738|NCT00791999|1009897|P2|STARTED|Overall Study||82
423739|NCT00791999|1009898|P1|STARTED|Overall Study||72
423740|NCT00791973|1009914|P2|NOT COMPLETED|Second Intervention (1 Week)||0
423741|NCT00791973|1009915|P1|NOT COMPLETED|Second Intervention (1 Week)||0
423742|NCT00791973|1009914|P2|COMPLETED|Second Intervention (1 Week)||7
423743|NCT00791973|1009915|P1|COMPLETED|Second Intervention (1 Week)||8
423744|NCT00791973|1009914|P2|STARTED|Second Intervention (1 Week)||7
423745|NCT00791973|1009915|P1|STARTED|Second Intervention (1 Week)||8
423746|NCT00791973|1009914|P2|NOT COMPLETED|Washout (1 Week)||0
423747|NCT00791973|1009915|P1|NOT COMPLETED|Washout (1 Week)||0
423748|NCT00791973|1009914|P2|COMPLETED|Washout (1 Week)||7
423749|NCT00791973|1009915|P1|COMPLETED|Washout (1 Week)||8
423750|NCT00791973|1009914|P2|STARTED|Washout (1 Week)||7
423751|NCT00791973|1009915|P1|STARTED|Washout (1 Week)||8
423752|NCT00791973|1009914|P2|NOT COMPLETED|First Intervention (1 Week)||0
423753|NCT00791973|1009915|P1|NOT COMPLETED|First Intervention (1 Week)||0
423754|NCT00791973|1009914|P2|COMPLETED|First Intervention (1 Week)||7
423755|NCT00791973|1009915|P1|COMPLETED|First Intervention (1 Week)||8
423756|NCT00791973|1009914|P2|STARTED|First Intervention (1 Week)||7
423757|NCT00791973|1009915|P1|STARTED|First Intervention (1 Week)||8
423758|NCT00791934|1009923|P1|NOT COMPLETED|Overall Study||15
423759|NCT00791934|1009923|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
423760|NCT00791934|1009923|P1|STARTED|Overall Study||63
423761|NCT00791921|1009933|P2|NOT COMPLETED|Overall Study||96
423762|NCT00791921|1009934|P1|NOT COMPLETED|Overall Study||34
423763|NCT00791921|1009933|P2|COMPLETED|Overall Study||18
423764|NCT00791921|1009934|P1|COMPLETED|Overall Study||82
423765|NCT00791921|1009933|P2|STARTED|Overall Study||114
423766|NCT00791921|1009934|P1|STARTED|Overall Study||116
423767|NCT00791908|1009942|P1|NOT COMPLETED|Overall Study||0
423768|NCT00791908|1009942|P1|COMPLETED|Overall Study||15
423769|NCT00791908|1009942|P1|STARTED|Overall Study||15
423770|NCT00791817|1009952|P2|NOT COMPLETED|2: Single Dose||0
423771|NCT00791817|1009953|P1|NOT COMPLETED|2: Single Dose||0
423772|NCT00791817|1009952|P2|COMPLETED|2: Single Dose||5
423773|NCT00791817|1009953|P1|COMPLETED|2: Single Dose||5
423774|NCT00791817|1009952|P2|STARTED|2: Single Dose||5
423775|NCT00791817|1009953|P1|STARTED|2: Single Dose||5
423776|NCT00791817|1009952|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
423777|NCT00791817|1009953|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
423778|NCT00791817|1009952|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
423779|NCT00791817|1009953|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
423780|NCT00791817|1009952|P2|STARTED|1: Single Dose Followed by Week Washout||5
423781|NCT00791817|1009953|P1|STARTED|1: Single Dose Followed by Week Washout||5
423782|NCT00791778|1009961|P2|NOT COMPLETED|Follow-up||1
423783|NCT00791778|1009962|P1|NOT COMPLETED|Follow-up||5
423784|NCT00791778|1009961|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
423785|NCT00791778|1009962|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
423786|NCT00791778|1009961|P2|STARTED|Follow-up||91
423787|NCT00791778|1009962|P1|STARTED|Follow-up||100
423788|NCT00791778|1009961|P2|NOT COMPLETED|Double-blind Treatment||48
423789|NCT00791778|1009962|P1|NOT COMPLETED|Double-blind Treatment||77
423790|NCT00791778|1009961|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
423791|NCT00791778|1009962|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
423792|NCT00791778|1009961|P2|STARTED|Double-blind Treatment||123
423793|NCT00791778|1009962|P1|STARTED|Double-blind Treatment||123
423794|NCT00791765|1010016|P2|NOT COMPLETED|Weeks 13 to 24||8
423795|NCT00791765|1010017|P1|NOT COMPLETED|Weeks 13 to 24||5
423796|NCT00791765|1010016|P2|COMPLETED|Weeks 13 to 24||49
423797|NCT00791765|1010017|P1|COMPLETED|Weeks 13 to 24||49
423798|NCT00791765|1010016|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
423799|NCT00791765|1010017|P1|STARTED|Weeks 13 to 24||54
423800|NCT00791765|1010016|P2|NOT COMPLETED|Weeks 1 to 12||4
423801|NCT00791765|1010017|P1|NOT COMPLETED|Weeks 1 to 12||8
423802|NCT00791765|1010016|P2|COMPLETED|Weeks 1 to 12||58
423803|NCT00791765|1010017|P1|COMPLETED|Weeks 1 to 12||54
423804|NCT00791765|1010016|P2|Treated|Weeks 1 to 12||59
423805|NCT00791765|1010017|P1|Treated|Weeks 1 to 12||62
423806|NCT00791765|1010016|P2|STARTED|Weeks 1 to 12||62
423807|NCT00791765|1010017|P1|STARTED|Weeks 1 to 12||62
423808|NCT00791700|1010032|P4|NOT COMPLETED|Overall Study||18
423809|NCT00791700|1010033|P3|NOT COMPLETED|Overall Study||4
423810|NCT00791700|1010034|P2|NOT COMPLETED|Overall Study||5
423811|NCT00791700|1010035|P1|NOT COMPLETED|Overall Study||4
423812|NCT00791700|1010032|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
423813|NCT00791700|1010033|P3|COMPLETED|Overall Study||9
423814|NCT00791700|1010034|P2|COMPLETED|Overall Study||26
423815|NCT00791700|1010035|P1|COMPLETED|Overall Study||12
423816|NCT00791700|1010032|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
423817|NCT00791700|1010033|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
423818|NCT00791700|1010034|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
423819|NCT00791700|1010035|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
423820|NCT00791661|1010123|P3|NOT COMPLETED|Period 3||0
423821|NCT00791661|1010124|P2|NOT COMPLETED|Period 3||0
423822|NCT00791661|1010125|P1|NOT COMPLETED|Period 3||0
423823|NCT00791661|1010123|P3|COMPLETED|Period 3||6
423824|NCT00791661|1010124|P2|COMPLETED|Period 3||8
423825|NCT00791661|1010125|P1|COMPLETED|Period 3||8
423826|NCT00791661|1010123|P3|Received Matching Placebo to MK-1006|Period 3||1
423827|NCT00791661|1010124|P2|Received Matching Placebo to MK-1006|Period 3||2
423828|NCT00791661|1010125|P1|Received Matching Placebo to MK-1006|Period 3||2
423829|NCT00791661|1010123|P3|Received MK-1006|Period 3||5
423830|NCT00791661|1010124|P2|Received MK-1006|Period 3||6
423831|NCT00791661|1010125|P1|Received MK-1006|Period 3||6
423832|NCT00791661|1010123|P3|STARTED|Period 3||6
423833|NCT00791661|1010124|P2|STARTED|Period 3||8
423834|NCT00791661|1010125|P1|STARTED|Period 3||8
423835|NCT00791661|1010123|P3|NOT COMPLETED|7 Day Wash-out||0
423836|NCT00791661|1010124|P2|NOT COMPLETED|7 Day Wash-out||0
423837|NCT00791661|1010125|P1|NOT COMPLETED|7 Day Wash-out||0
423838|NCT00791661|1010123|P3|COMPLETED|7 Day Wash-out||6
423839|NCT00791661|1010124|P2|COMPLETED|7 Day Wash-out||8
423840|NCT00791661|1010125|P1|COMPLETED|7 Day Wash-out||8
423841|NCT00791661|1010123|P3|STARTED|7 Day Wash-out||6
423842|NCT00791661|1010124|P2|STARTED|7 Day Wash-out||8
423843|NCT00791661|1010125|P1|STARTED|7 Day Wash-out||8
423844|NCT00791661|1010123|P3|NOT COMPLETED|Period 2||0
423845|NCT00791661|1010124|P2|NOT COMPLETED|Period 2||0
423846|NCT00791661|1010125|P1|NOT COMPLETED|Period 2||0
423847|NCT00791661|1010123|P3|COMPLETED|Period 2||6
423848|NCT00791661|1010124|P2|COMPLETED|Period 2||8
423849|NCT00791661|1010125|P1|COMPLETED|Period 2||8
423850|NCT00791661|1010123|P3|Received Matching Placebo to MK-1006|Period 2||2
423851|NCT00791661|1010124|P2|Received Matching Placebo to MK-1006|Period 2||2
423852|NCT00791661|1010125|P1|Received Matching Placebo to MK-1006|Period 2||2
423853|NCT00791661|1010123|P3|Received MK-1006|Period 2||4
423854|NCT00791661|1010124|P2|Received MK-1006|Period 2||6
423855|NCT00791661|1010125|P1|Received MK-1006|Period 2||6
423856|NCT00791661|1010123|P3|STARTED|Period 2||6
423857|NCT00791661|1010124|P2|STARTED|Period 2||8
423858|NCT00791661|1010125|P1|STARTED|Period 2||8
423859|NCT00791661|1010123|P3|NOT COMPLETED|7 Day Wash-out||2
423860|NCT00791661|1010124|P2|NOT COMPLETED|7 Day Wash-out||0
423861|NCT00791661|1010125|P1|NOT COMPLETED|7 Day Wash-out||0
423862|NCT00791661|1010123|P3|COMPLETED|7 Day Wash-out||6
423863|NCT00791661|1010124|P2|COMPLETED|7 Day Wash-out||8
423864|NCT00791661|1010125|P1|COMPLETED|7 Day Wash-out||8
423865|NCT00791661|1010123|P3|STARTED|7 Day Wash-out||8
423866|NCT00791661|1010124|P2|STARTED|7 Day Wash-out||8
423867|NCT00791661|1010125|P1|STARTED|7 Day Wash-out||8
423868|NCT00791661|1010123|P3|NOT COMPLETED|Period 1||0
423869|NCT00791661|1010124|P2|NOT COMPLETED|Period 1||0
423870|NCT00791661|1010125|P1|NOT COMPLETED|Period 1||0
423871|NCT00791661|1010123|P3|COMPLETED|Period 1||8
423872|NCT00791661|1010124|P2|COMPLETED|Period 1||8
423873|NCT00791661|1010125|P1|COMPLETED|Period 1||8
423874|NCT00791661|1010123|P3|Received Matching Placebo to MK-1006|Period 1||2
423875|NCT00791661|1010124|P2|Received Matching Placebo to MK-1006|Period 1||2
423876|NCT00791661|1010125|P1|Received Matching Placebo to MK-1006|Period 1||2
423877|NCT00791661|1010123|P3|Received MK-1006|Period 1||6
423878|NCT00791661|1010124|P2|Received MK-1006|Period 1||6
423879|NCT00791661|1010125|P1|Received MK-1006|Period 1||6
423880|NCT00791661|1010123|P3|STARTED|Period 1||8
423881|NCT00791661|1010124|P2|STARTED|Period 1||8
423882|NCT00791661|1010125|P1|STARTED|Period 1||8
423883|NCT00791648|1010218|P2|NOT COMPLETED|Overall Study||2
423884|NCT00791648|1010219|P1|NOT COMPLETED|Overall Study||0
423885|NCT00791648|1010218|P2|COMPLETED|Overall Study||307
423886|NCT00791648|1010219|P1|COMPLETED|Overall Study||308
423887|NCT00791648|1010218|P2|STARTED|Overall Study||309
423888|NCT00791648|1010219|P1|STARTED|Overall Study||308
423889|NCT00791557|1010235|P1|NOT COMPLETED|Overall Study||1
423890|NCT00791557|1010235|P1|COMPLETED|Overall Study||1
423891|NCT00791557|1010235|P1|STARTED|Overall Study||2
423892|NCT00791518|1010239|P1|NOT COMPLETED|Overall Study||93
423893|NCT00791518|1010239|P1|COMPLETED|Overall Study||991
423894|NCT00791518|1010239|P1|STARTED|Overall Study||1084
423895|NCT00791492|1010267|P2|NOT COMPLETED|Overall Study||3
423896|NCT00791492|1010268|P1|NOT COMPLETED|Overall Study||6
423897|NCT00791492|1010267|P2|COMPLETED|Overall Study||38
423898|NCT00791492|1010268|P1|COMPLETED|Overall Study||39
423899|NCT00791492|1010267|P2|TREATED|Overall Study||41
423900|NCT00791492|1010268|P1|TREATED|Overall Study||44
423901|NCT00791492|1010267|P2|STARTED|Overall Study||41
423902|NCT00791492|1010268|P1|STARTED|Overall Study||45
423903|NCT00791479|1010316|P6|NOT COMPLETED|Overall Study||3
423904|NCT00791479|1010317|P5|NOT COMPLETED|Overall Study||3
423905|NCT00791479|1010318|P4|NOT COMPLETED|Overall Study||4
423906|NCT00791479|1010319|P3|NOT COMPLETED|Overall Study||0
423907|NCT00791479|1010320|P2|NOT COMPLETED|Overall Study||3
423908|NCT00791479|1010321|P1|NOT COMPLETED|Overall Study||2
423909|NCT00791479|1010316|P6|COMPLETED|Overall Study||29
423910|NCT00791479|1010317|P5|COMPLETED|Overall Study||0
423911|NCT00791479|1010318|P4|COMPLETED|Overall Study||25
423912|NCT00791479|1010319|P3|COMPLETED|Overall Study||34
423913|NCT00791479|1010320|P2|COMPLETED|Overall Study||31
423914|NCT00791479|1010321|P1|COMPLETED|Overall Study||33
423915|NCT00791479|1010316|P6|Received at Least One Dose of Study Drug|Overall Study||32
423916|NCT00791479|1010317|P5|Received at Least One Dose of Study Drug|Overall Study||3
423917|NCT00791479|1010318|P4|Received at Least One Dose of Study Drug|Overall Study||29
423918|NCT00791479|1010319|P3|Received at Least One Dose of Study Drug|Overall Study||34
423919|NCT00791479|1010320|P2|Received at Least One Dose of Study Drug|Overall Study||34
423920|NCT00791479|1010321|P1|Received at Least One Dose of Study Drug|Overall Study||35
423921|NCT00791479|1010316|P6|STARTED|Overall Study||32
423922|NCT00791479|1010317|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
423923|NCT00791479|1010318|P4|STARTED|Overall Study||29
423924|NCT00791479|1010319|P3|STARTED|Overall Study||34
423925|NCT00791479|1010320|P2|STARTED|Overall Study||34
423926|NCT00791479|1010321|P1|STARTED|Overall Study||35
423927|NCT00791388|1010420|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
423928|NCT00791388|1010421|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
423929|NCT00791388|1010422|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
423930|NCT00791388|1010423|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
423931|NCT00791388|1010424|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
423932|NCT00791388|1010420|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
423933|NCT00791388|1010421|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
423934|NCT00791388|1010422|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
423935|NCT00791388|1010423|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
423936|NCT00791388|1010424|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
423937|NCT00791388|1010420|P5|STARTED|Period 4 - 400 mg Dose Group||8
423938|NCT00791388|1010421|P4|STARTED|Period 4 - 400 mg Dose Group||0
423939|NCT00791388|1010422|P3|STARTED|Period 4 - 400 mg Dose Group||0
423940|NCT00791388|1010423|P2|STARTED|Period 4 - 400 mg Dose Group||0
423941|NCT00791388|1010424|P1|STARTED|Period 4 - 400 mg Dose Group||4
423942|NCT00791388|1010420|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
423943|NCT00791388|1010421|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
423944|NCT00791388|1010422|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
423945|NCT00791388|1010423|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
423946|NCT00791388|1010424|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
423947|NCT00791388|1010420|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
423948|NCT00791388|1010421|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
423949|NCT00791388|1010422|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
423950|NCT00791388|1010423|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
423951|NCT00791388|1010424|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
423952|NCT00791388|1010420|P5|STARTED|Period 3 - 200 mg Dose Group||0
423953|NCT00791388|1010421|P4|STARTED|Period 3 - 200 mg Dose Group||8
423954|NCT00791388|1010422|P3|STARTED|Period 3 - 200 mg Dose Group||0
423955|NCT00791388|1010423|P2|STARTED|Period 3 - 200 mg Dose Group||0
423956|NCT00791388|1010424|P1|STARTED|Period 3 - 200 mg Dose Group||3
423957|NCT00791388|1010420|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
423958|NCT00791388|1010421|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
423959|NCT00791388|1010422|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
423960|NCT00791388|1010423|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
423961|NCT00791388|1010424|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
423962|NCT00791388|1010420|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
423963|NCT00791388|1010421|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
423964|NCT00791388|1010422|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
423965|NCT00791388|1010423|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
423966|NCT00791388|1010424|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
423967|NCT00791388|1010420|P5|STARTED|Period 2 - 100 mg Dose Group||0
423968|NCT00791388|1010421|P4|STARTED|Period 2 - 100 mg Dose Group||0
423969|NCT00791388|1010422|P3|STARTED|Period 2 - 100 mg Dose Group||8
423970|NCT00791388|1010423|P2|STARTED|Period 2 - 100 mg Dose Group||0
423971|NCT00791388|1010424|P1|STARTED|Period 2 - 100 mg Dose Group||3
423972|NCT00791388|1010420|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
423973|NCT00791388|1010421|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
423974|NCT00791388|1010422|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
423975|NCT00791388|1010423|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
423976|NCT00791388|1010424|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
423977|NCT00791388|1010420|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
423978|NCT00791388|1010421|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
423979|NCT00791388|1010422|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
423980|NCT00791388|1010423|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
423981|NCT00791388|1010424|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
423982|NCT00791388|1010420|P5|STARTED|Period 1 - 50 mg Dose Group||0
423983|NCT00791388|1010421|P4|STARTED|Period 1 - 50 mg Dose Group||0
423984|NCT00791388|1010422|P3|STARTED|Period 1 - 50 mg Dose Group||0
423985|NCT00791388|1010423|P2|STARTED|Period 1 - 50 mg Dose Group||8
423986|NCT00791388|1010424|P1|STARTED|Period 1 - 50 mg Dose Group||3
423987|NCT00791323|1010453|P2|NOT COMPLETED|Overall Study||0
423988|NCT00791323|1010454|P1|NOT COMPLETED|Overall Study||0
423989|NCT00791323|1010453|P2|COMPLETED|Overall Study||3
423990|NCT00791323|1010454|P1|COMPLETED|Overall Study||6
423991|NCT00791323|1010453|P2|STARTED|Overall Study||3
423992|NCT00791323|1010454|P1|STARTED|Overall Study||6
423993|NCT00791258|1010460|P1|NOT COMPLETED|Overall Study||263
423994|NCT00791258|1010460|P1|COMPLETED|Overall Study||736
423995|NCT00791258|1010460|P1|STARTED|Overall Study||999
423996|NCT00791128|1010522|P1|NOT COMPLETED|Overall Study||9
423997|NCT00791128|1010522|P1|COMPLETED|Overall Study||13
423998|NCT00791128|1010522|P1|STARTED|Overall Study||22
423999|NCT00791102|1010527|P2|NOT COMPLETED|Period 2||0
424000|NCT00791102|1010528|P1|NOT COMPLETED|Period 2||0
424001|NCT00791102|1010527|P2|COMPLETED|Period 2||10
424002|NCT00791102|1010528|P1|COMPLETED|Period 2||10
424003|NCT00791102|1010527|P2|STARTED|Period 2||10
424004|NCT00791102|1010528|P1|STARTED|Period 2||10
424005|NCT00791102|1010527|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
424006|NCT00791102|1010528|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
424007|NCT00791102|1010527|P2|COMPLETED|Washout Period of 2 Weeks||10
424008|NCT00791102|1010528|P1|COMPLETED|Washout Period of 2 Weeks||10
424009|NCT00791102|1010527|P2|STARTED|Washout Period of 2 Weeks||10
424010|NCT00791102|1010528|P1|STARTED|Washout Period of 2 Weeks||10
424011|NCT00791102|1010527|P2|NOT COMPLETED|Period 1||0
424012|NCT00791102|1010528|P1|NOT COMPLETED|Period 1||0
424013|NCT00791102|1010527|P2|COMPLETED|Period 1||10
424014|NCT00791102|1010528|P1|COMPLETED|Period 1||10
424015|NCT00791102|1010527|P2|STARTED|Period 1||10
424016|NCT00791102|1010528|P1|STARTED|Period 1||10
424017|NCT00791089|1010546|P2|NOT COMPLETED|Overall Study||1
424018|NCT00791089|1010547|P1|NOT COMPLETED|Overall Study||0
424019|NCT00791089|1010546|P2|COMPLETED|Overall Study||5
424020|NCT00791089|1010547|P1|COMPLETED|Overall Study||6
424021|NCT00791089|1010546|P2|STARTED|Overall Study||6
424022|NCT00791089|1010547|P1|STARTED|Overall Study||6
424023|NCT00791037|1010553|P1|NOT COMPLETED|Overall Study||0
424024|NCT00791037|1010553|P1|COMPLETED|Overall Study||23
424025|NCT00791037|1010553|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
424026|NCT00791037|1010553|P1|Primary Outcome|Overall Study||19
424027|NCT00791037|1010553|P1|STARTED|Overall Study||23
424028|NCT00790907|1010563|P3|NOT COMPLETED|Overall Study||339
424029|NCT00790907|1010564|P2|NOT COMPLETED|Overall Study||340
424030|NCT00790907|1010565|P1|NOT COMPLETED|Overall Study||455
424031|NCT00790907|1010563|P3|COMPLETED|Overall Study||663
424032|NCT00790907|1010564|P2|COMPLETED|Overall Study||684
424033|NCT00790907|1010565|P1|COMPLETED|Overall Study||754
424034|NCT00790907|1010563|P3|STARTED|Overall Study||1002
424035|NCT00790907|1010564|P2|STARTED|Overall Study||1024
424036|NCT00790907|1010565|P1|STARTED|Overall Study||1209
424037|NCT00790855|1010586|P1|NOT COMPLETED|Overall Study||0
424038|NCT00790855|1010586|P1|COMPLETED|Overall Study||25
424039|NCT00790855|1010586|P1|STARTED|Overall Study||25
424040|NCT00790803|1010591|P1|NOT COMPLETED|Overall Study||0
424041|NCT00790803|1010591|P1|COMPLETED|Overall Study||5
424042|NCT00790803|1010591|P1|STARTED|Overall Study||5
424043|NCT00790790|1010602|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
424044|NCT00790790|1010603|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
424045|NCT00790790|1010604|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
424046|NCT00790790|1010602|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
424047|NCT00790790|1010603|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
424048|NCT00790790|1010604|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
424049|NCT00790790|1010602|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
424050|NCT00790790|1010603|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
424051|NCT00790790|1010604|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
424052|NCT00790790|1010602|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
424053|NCT00790790|1010603|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
424054|NCT00790790|1010604|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
424055|NCT00790790|1010602|P3|COMPLETED|Study Period 2: Therapy Phase||27
424056|NCT00790790|1010603|P2|COMPLETED|Study Period 2: Therapy Phase||32
424057|NCT00790790|1010604|P1|COMPLETED|Study Period 2: Therapy Phase||37
424058|NCT00790790|1010602|P3|STARTED|Study Period 2: Therapy Phase||48
424059|NCT00790790|1010603|P2|STARTED|Study Period 2: Therapy Phase||50
424060|NCT00790790|1010604|P1|STARTED|Study Period 2: Therapy Phase||49
424061|NCT00790751|1010681|P4|NOT COMPLETED|Overall Study||21
424062|NCT00790751|1010682|P3|NOT COMPLETED|Overall Study||20
424063|NCT00790751|1010683|P2|NOT COMPLETED|Overall Study||30
424064|NCT00790751|1010684|P1|NOT COMPLETED|Overall Study||25
424065|NCT00790751|1010681|P4|COMPLETED|Overall Study||141
424066|NCT00790751|1010682|P3|COMPLETED|Overall Study||141
424067|NCT00790751|1010683|P2|COMPLETED|Overall Study||131
424068|NCT00790751|1010684|P1|COMPLETED|Overall Study||137
424069|NCT00790751|1010681|P4|STARTED|Overall Study||162
424070|NCT00790751|1010682|P3|STARTED|Overall Study||161
424071|NCT00790751|1010683|P2|STARTED|Overall Study||161
424072|NCT00790751|1010684|P1|STARTED|Overall Study||162
424073|NCT00790738|1010704|P2|NOT COMPLETED|Overall Study||3
424074|NCT00790738|1010705|P1|NOT COMPLETED|Overall Study||2
424075|NCT00790738|1010704|P2|COMPLETED|Overall Study||3
424076|NCT00790738|1010705|P1|COMPLETED|Overall Study||3
424077|NCT00790738|1010704|P2|STARTED|Overall Study||6
424078|NCT00790738|1010705|P1|STARTED|Overall Study||5
424079|NCT00790673|1010719|P4|NOT COMPLETED|Overall Study||0
424080|NCT00790673|1010720|P3|NOT COMPLETED|Overall Study||0
424081|NCT00790673|1010721|P2|NOT COMPLETED|Overall Study||0
424082|NCT00790673|1010722|P1|NOT COMPLETED|Overall Study||0
424083|NCT00790673|1010719|P4|COMPLETED|Overall Study||8
424084|NCT00790673|1010720|P3|COMPLETED|Overall Study||12
424085|NCT00790673|1010721|P2|COMPLETED|Overall Study||6
424086|NCT00790673|1010722|P1|COMPLETED|Overall Study||6
424087|NCT00790673|1010719|P4|STARTED|Overall Study||8
424088|NCT00790673|1010720|P3|STARTED|Overall Study||12
424089|NCT00790673|1010721|P2|STARTED|Overall Study||6
424090|NCT00790673|1010722|P1|STARTED|Overall Study||6
424091|NCT00790647|1010732|P1|NOT COMPLETED|Overall Study||1
424092|NCT00790647|1010732|P1|COMPLETED|Overall Study||9
424093|NCT00790647|1010732|P1|STARTED|Overall Study||10
424094|NCT00790569|1010742|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
424095|NCT00790569|1010743|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
424096|NCT00790569|1010744|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
424097|NCT00790569|1010742|P3|COMPLETED|End of Study (12 Month Interview)||83
424098|NCT00790569|1010743|P2|COMPLETED|End of Study (12 Month Interview)||26
424099|NCT00790569|1010744|P1|COMPLETED|End of Study (12 Month Interview)||71
424100|NCT00790569|1010742|P3|STARTED|End of Study (12 Month Interview)||133
424101|NCT00790569|1010743|P2|STARTED|End of Study (12 Month Interview)||45
424102|NCT00790569|1010744|P1|STARTED|End of Study (12 Month Interview)||137
424103|NCT00790569|1010742|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
424104|NCT00790569|1010743|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
424105|NCT00790569|1010744|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
424106|NCT00790569|1010742|P3|COMPLETED|End of Treatment (6 Month Interview)||107
424107|NCT00790569|1010743|P2|COMPLETED|End of Treatment (6 Month Interview)||35
424108|NCT00790569|1010744|P1|COMPLETED|End of Treatment (6 Month Interview)||115
424109|NCT00790569|1010742|P3|STARTED|End of Treatment (6 Month Interview)||133
424110|NCT00790569|1010743|P2|STARTED|End of Treatment (6 Month Interview)||45
424111|NCT00790569|1010744|P1|STARTED|End of Treatment (6 Month Interview)||137
424112|NCT00790556|1010767|P2|NOT COMPLETED|Treatment Period 2||0
424113|NCT00790556|1010768|P1|NOT COMPLETED|Treatment Period 2||0
424114|NCT00790556|1010767|P2|COMPLETED|Treatment Period 2||6
424115|NCT00790556|1010768|P1|COMPLETED|Treatment Period 2||6
424116|NCT00790556|1010767|P2|STARTED|Treatment Period 2||6
424117|NCT00790556|1010768|P1|STARTED|Treatment Period 2||6
424118|NCT00790556|1010767|P2|NOT COMPLETED|Washout After Period 1||0
424119|NCT00790556|1010768|P1|NOT COMPLETED|Washout After Period 1||0
424120|NCT00790556|1010767|P2|COMPLETED|Washout After Period 1||6
424121|NCT00790556|1010768|P1|COMPLETED|Washout After Period 1||6
424122|NCT00790556|1010767|P2|STARTED|Washout After Period 1||6
424123|NCT00790556|1010768|P1|STARTED|Washout After Period 1||6
424124|NCT00790556|1010767|P2|NOT COMPLETED|Treatment Period 1||0
424125|NCT00790556|1010768|P1|NOT COMPLETED|Treatment Period 1||2
424126|NCT00790556|1010767|P2|COMPLETED|Treatment Period 1||6
424127|NCT00790556|1010768|P1|COMPLETED|Treatment Period 1||6
424128|NCT00790556|1010767|P2|STARTED|Treatment Period 1||6
424129|NCT00790556|1010768|P1|STARTED|Treatment Period 1||8
424130|NCT00790452|1010780|P2|NOT COMPLETED|Overall Study||0
424131|NCT00790452|1010781|P1|NOT COMPLETED|Overall Study||1
424132|NCT00790452|1010780|P2|COMPLETED|Overall Study||0
424133|NCT00790452|1010781|P1|COMPLETED|Overall Study||0
424134|NCT00790452|1010780|P2|STARTED|Overall Study||0
424135|NCT00790452|1010781|P1|STARTED|Overall Study||1
424136|NCT00790400|1010789|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
424137|NCT00790400|1010790|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
424138|NCT00790400|1010789|P2|COMPLETED|Everolimus Period (Core or Extension)||0
424139|NCT00790400|1010790|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
424140|NCT00790400|1010789|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
424233|NCT00789880|1011074|P5|STARTED|Overall Study||18
424234|NCT00789880|1011075|P4|STARTED|Overall Study||16
424141|NCT00790400|1010790|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
424142|NCT00790400|1010789|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
424143|NCT00790400|1010790|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
424144|NCT00790400|1010789|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
424145|NCT00790400|1010790|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
424146|NCT00790400|1010789|P2|STARTED|Double-blind Period (Core Phase)||39
424147|NCT00790400|1010790|P1|STARTED|Double-blind Period (Core Phase)||79
424148|NCT00790296|1010819|P2|NOT COMPLETED|Overall Study||2
424149|NCT00790296|1010820|P1|NOT COMPLETED|Overall Study||1
424150|NCT00790296|1010819|P2|COMPLETED|Overall Study||4
424151|NCT00790296|1010820|P1|COMPLETED|Overall Study||4
424152|NCT00790296|1010819|P2|STARTED|Overall Study||6
424153|NCT00790296|1010820|P1|STARTED|Overall Study||5
424154|NCT00790270|1010829|P3|NOT COMPLETED|Overall Study||0
424155|NCT00790270|1010830|P2|NOT COMPLETED|Overall Study||0
424156|NCT00790270|1010831|P1|NOT COMPLETED|Overall Study||0
424157|NCT00790270|1010829|P3|COMPLETED|Overall Study||20
424158|NCT00790270|1010830|P2|COMPLETED|Overall Study||20
424159|NCT00790270|1010831|P1|COMPLETED|Overall Study||21
424160|NCT00790270|1010829|P3|STARTED|Overall Study||20
424161|NCT00790270|1010830|P2|STARTED|Overall Study||20
424162|NCT00790270|1010831|P1|STARTED|Overall Study||21
424163|NCT00790218|1010842|P3|NOT COMPLETED|Overall Study||0
424164|NCT00790218|1010843|P2|NOT COMPLETED|Overall Study||0
424165|NCT00790218|1010844|P1|NOT COMPLETED|Overall Study||1
424166|NCT00790218|1010842|P3|COMPLETED|Overall Study||7
424167|NCT00790218|1010843|P2|COMPLETED|Overall Study||6
424168|NCT00790218|1010844|P1|COMPLETED|Overall Study||5
424169|NCT00790218|1010842|P3|STARTED|Overall Study||7
424170|NCT00790218|1010843|P2|STARTED|Overall Study||6
424171|NCT00790218|1010844|P1|STARTED|Overall Study||6
424172|NCT00790205|1010854|P2|NOT COMPLETED|Overall Study||434
424173|NCT00790205|1010855|P1|NOT COMPLETED|Overall Study||360
424174|NCT00790205|1010854|P2|COMPLETED|Overall Study||6905
424175|NCT00790205|1010855|P1|COMPLETED|Overall Study||6972
424176|NCT00790205|1010854|P2|Treated|Overall Study||7274
424177|NCT00790205|1010855|P1|Treated|Overall Study||7266
424178|NCT00790205|1010854|P2|STARTED|Overall Study||7339
424179|NCT00790205|1010855|P1|STARTED|Overall Study||7332
424180|NCT00790192|1010899|P4|NOT COMPLETED|Overall Study||48
424181|NCT00790192|1010900|P3|NOT COMPLETED|Overall Study||23
424182|NCT00790192|1010901|P2|NOT COMPLETED|Overall Study||28
424183|NCT00790192|1010902|P1|NOT COMPLETED|Overall Study||36
424184|NCT00790192|1010899|P4|COMPLETED|Overall Study||74
424185|NCT00790192|1010900|P3|COMPLETED|Overall Study||97
424186|NCT00790192|1010901|P2|COMPLETED|Overall Study||93
424187|NCT00790192|1010902|P1|COMPLETED|Overall Study||89
424188|NCT00790192|1010899|P4|STARTED|Overall Study||122
424189|NCT00790192|1010900|P3|STARTED|Overall Study||120
424190|NCT00790192|1010901|P2|STARTED|Overall Study||121
424191|NCT00790192|1010902|P1|STARTED|Overall Study||125
424192|NCT00790062|1010919|P3|NOT COMPLETED|Overall Study||0
424193|NCT00790062|1010920|P2|NOT COMPLETED|Overall Study||0
424194|NCT00790062|1010921|P1|NOT COMPLETED|Overall Study||0
424195|NCT00790062|1010919|P3|COMPLETED|Overall Study||658
424196|NCT00790062|1010920|P2|COMPLETED|Overall Study||481
424197|NCT00790062|1010921|P1|COMPLETED|Overall Study||659
424198|NCT00790062|1010919|P3|STARTED|Overall Study||658
424199|NCT00790062|1010920|P2|STARTED|Overall Study||481
424200|NCT00790062|1010921|P1|STARTED|Overall Study||659
424201|NCT00790023|1010953|P3|NOT COMPLETED|Overall Study||21
424202|NCT00790023|1010954|P2|NOT COMPLETED|Overall Study||10
424203|NCT00790023|1010955|P1|NOT COMPLETED|Overall Study||11
424204|NCT00790023|1010953|P3|COMPLETED|Overall Study||214
424205|NCT00790023|1010954|P2|COMPLETED|Overall Study||225
424206|NCT00790023|1010955|P1|COMPLETED|Overall Study||226
424207|NCT00790023|1010953|P3|STARTED|Overall Study||235
424208|NCT00790023|1010954|P2|STARTED|Overall Study||235
424209|NCT00790023|1010955|P1|STARTED|Overall Study||237
424210|NCT00789997|1011045|P2|NOT COMPLETED|Overall Study||2
424211|NCT00789997|1011046|P1|NOT COMPLETED|Overall Study||1
424212|NCT00789997|1011045|P2|COMPLETED|Overall Study||38
424213|NCT00789997|1011046|P1|COMPLETED|Overall Study||40
424214|NCT00789997|1011045|P2|STARTED|Overall Study||40
424215|NCT00789997|1011046|P1|STARTED|Overall Study||41
424216|NCT00789958|1011054|P1|NOT COMPLETED|Overall Study||37
424217|NCT00789958|1011054|P1|COMPLETED|Overall Study||68
424218|NCT00789958|1011054|P1|Eligible and Analyzable|Overall Study||79
424219|NCT00789958|1011054|P1|STARTED|Overall Study||105
424220|NCT00789880|1011073|P6|NOT COMPLETED|Overall Study||0
424221|NCT00789880|1011074|P5|NOT COMPLETED|Overall Study||3
424222|NCT00789880|1011075|P4|NOT COMPLETED|Overall Study||1
424223|NCT00789880|1011076|P3|NOT COMPLETED|Overall Study||0
424224|NCT00789880|1011077|P2|NOT COMPLETED|Overall Study||1
424225|NCT00789880|1011078|P1|NOT COMPLETED|Overall Study||1
424226|NCT00789880|1011073|P6|COMPLETED|Overall Study||8
424227|NCT00789880|1011074|P5|COMPLETED|Overall Study||15
424228|NCT00789880|1011075|P4|COMPLETED|Overall Study||15
424229|NCT00789880|1011076|P3|COMPLETED|Overall Study||8
424230|NCT00789880|1011077|P2|COMPLETED|Overall Study||15
424231|NCT00789880|1011078|P1|COMPLETED|Overall Study||15
424232|NCT00789880|1011073|P6|STARTED|Overall Study||8
424235|NCT00789880|1011076|P3|STARTED|Overall Study||8
424236|NCT00789880|1011077|P2|STARTED|Overall Study||16
424237|NCT00789880|1011078|P1|STARTED|Overall Study||16
424238|NCT00789854|1011107|P3|NOT COMPLETED|Overall Study||47
424239|NCT00789854|1011108|P2|NOT COMPLETED|Overall Study||35
424240|NCT00789854|1011109|P1|NOT COMPLETED|Overall Study||49
424241|NCT00789854|1011107|P3|COMPLETED|Overall Study||182
424242|NCT00789854|1011108|P2|COMPLETED|Overall Study||196
424243|NCT00789854|1011109|P1|COMPLETED|Overall Study||179
424244|NCT00789854|1011107|P3|STARTED|Overall Study||229
424245|NCT00789854|1011108|P2|STARTED|Overall Study||231
424246|NCT00789854|1011109|P1|STARTED|Overall Study||228
424247|NCT00789828|1011206|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
424248|NCT00789828|1011207|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
424249|NCT00789828|1011206|P2|COMPLETED|Open-label Extension Period (4 Years)||0
424250|NCT00789828|1011207|P1|COMPLETED|Open-label Extension Period (4 Years)||82
424251|NCT00789828|1011206|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
424252|NCT00789828|1011207|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
424253|NCT00789828|1011206|P2|NOT COMPLETED|Core Period (48 Weeks)||6
424254|NCT00789828|1011207|P1|NOT COMPLETED|Core Period (48 Weeks)||0
424255|NCT00789828|1011206|P2|COMPLETED|Core Period (48 Weeks)||33
424256|NCT00789828|1011207|P1|COMPLETED|Core Period (48 Weeks)||78
424257|NCT00789828|1011206|P2|STARTED|Core Period (48 Weeks)||39
424258|NCT00789828|1011207|P1|STARTED|Core Period (48 Weeks)||78
424259|NCT00789815|1011241|P2|NOT COMPLETED|Overall Study||1
424260|NCT00789815|1011242|P1|NOT COMPLETED|Overall Study||7
424261|NCT00789815|1011241|P2|COMPLETED|Overall Study||249
424262|NCT00789815|1011242|P1|COMPLETED|Overall Study||243
424263|NCT00789815|1011241|P2|STARTED|Overall Study||250
424264|NCT00789815|1011242|P1|STARTED|Overall Study||250
424265|NCT00789802|1011265|P3|NOT COMPLETED|Overall Study||6
424266|NCT00789802|1011266|P2|NOT COMPLETED|Overall Study||7
424267|NCT00789802|1011267|P1|NOT COMPLETED|Overall Study||10
424268|NCT00789802|1011265|P3|COMPLETED|Overall Study||37
424269|NCT00789802|1011266|P2|COMPLETED|Overall Study||35
424270|NCT00789802|1011267|P1|COMPLETED|Overall Study||34
424271|NCT00789802|1011265|P3|STARTED|Overall Study||43
424272|NCT00789802|1011266|P2|STARTED|Overall Study||42
424273|NCT00789802|1011267|P1|STARTED|Overall Study||44
424274|NCT00789737|1011277|P2|NOT COMPLETED|Overall Study||55
424275|NCT00789737|1011278|P1|NOT COMPLETED|Overall Study||48
424276|NCT00789737|1011277|P2|COMPLETED|Overall Study||126
424277|NCT00789737|1011278|P1|COMPLETED|Overall Study||128
424278|NCT00789737|1011277|P2|STARTED|Overall Study||181
424279|NCT00789737|1011278|P1|STARTED|Overall Study||176
424280|NCT00789724|1011310|P2|NOT COMPLETED|Overall Study||0
424281|NCT00789724|1011311|P1|NOT COMPLETED|Overall Study||0
424282|NCT00789724|1011310|P2|COMPLETED|Overall Study||5
424283|NCT00789724|1011311|P1|COMPLETED|Overall Study||5
424284|NCT00789724|1011310|P2|STARTED|Overall Study||5
424285|NCT00789724|1011311|P1|STARTED|Overall Study||5
424286|NCT00789698|1011321|P4|NOT COMPLETED|Overall Study||52
424287|NCT00789698|1011322|P3|NOT COMPLETED|Overall Study||27
424288|NCT00789698|1011323|P2|NOT COMPLETED|Overall Study||33
424289|NCT00789698|1011324|P1|NOT COMPLETED|Overall Study||40
424290|NCT00789698|1011321|P4|COMPLETED|Overall Study||33
424291|NCT00789698|1011322|P3|COMPLETED|Overall Study||29
424292|NCT00789698|1011323|P2|COMPLETED|Overall Study||46
424293|NCT00789698|1011324|P1|COMPLETED|Overall Study||32
424294|NCT00789698|1011321|P4|STARTED|Overall Study||85
424295|NCT00789698|1011322|P3|STARTED|Overall Study||56
424296|NCT00789698|1011323|P2|STARTED|Overall Study||79
424297|NCT00789698|1011324|P1|STARTED|Overall Study||72
424298|NCT00789685|1011338|P1|NOT COMPLETED|Overall Study||12
424299|NCT00789685|1011338|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
424300|NCT00789685|1011338|P1|STARTED|Overall Study||37
424301|NCT00789672|1011346|P2|NOT COMPLETED|Overall Study||0
424302|NCT00789672|1011347|P1|NOT COMPLETED|Overall Study||0
424303|NCT00789672|1011346|P2|COMPLETED|Overall Study||17
424304|NCT00789672|1011347|P1|COMPLETED|Overall Study||16
424305|NCT00789672|1011346|P2|STARTED|Overall Study||17
424306|NCT00789672|1011347|P1|STARTED|Overall Study||16
424307|NCT00789581|1011379|P2|NOT COMPLETED|Adjuvant Therapy||57
424308|NCT00789581|1011380|P1|NOT COMPLETED|Adjuvant Therapy||40
424309|NCT00789581|1011379|P2|COMPLETED|Adjuvant Therapy||234
424310|NCT00789581|1011380|P1|COMPLETED|Adjuvant Therapy||255
424311|NCT00789581|1011379|P2|STARTED|Adjuvant Therapy||291
424312|NCT00789581|1011380|P1|STARTED|Adjuvant Therapy||295
424313|NCT00789581|1011379|P2|NOT COMPLETED|AC Therapy||17
424314|NCT00789581|1011380|P1|NOT COMPLETED|AC Therapy||11
424315|NCT00789581|1011379|P2|COMPLETED|AC Therapy||291
424316|NCT00789581|1011380|P1|COMPLETED|AC Therapy||295
424317|NCT00789581|1011379|P2|STARTED|AC Therapy||308
424318|NCT00789581|1011380|P1|STARTED|AC Therapy||306
424319|NCT00789555|1011391|P3|NOT COMPLETED|Overall Study||159
424320|NCT00789555|1011392|P2|NOT COMPLETED|Overall Study||139
424321|NCT00789555|1011393|P1|NOT COMPLETED|Overall Study||159
424322|NCT00789555|1011391|P3|COMPLETED|Overall Study||263
424323|NCT00789555|1011392|P2|COMPLETED|Overall Study||278
424324|NCT00789555|1011393|P1|COMPLETED|Overall Study||262
424325|NCT00789555|1011391|P3|STARTED|Overall Study||422
424326|NCT00789555|1011392|P2|STARTED|Overall Study||417
424327|NCT00789555|1011393|P1|STARTED|Overall Study||421
424328|NCT00789529|1011418|P2|NOT COMPLETED|Overall Study||1
424329|NCT00789529|1011419|P1|NOT COMPLETED|Overall Study||1
424330|NCT00789529|1011418|P2|COMPLETED|Overall Study||15
424331|NCT00789529|1011419|P1|COMPLETED|Overall Study||15
424332|NCT00789529|1011418|P2|STARTED|Overall Study||16
424333|NCT00789529|1011419|P1|STARTED|Overall Study||16
424334|NCT00789477|1011432|P5|NOT COMPLETED|Overall Study||7
424335|NCT00789477|1011433|P4|NOT COMPLETED|Overall Study||10
424336|NCT00789477|1011434|P3|NOT COMPLETED|Overall Study||11
424337|NCT00789477|1011435|P2|NOT COMPLETED|Overall Study||6
424338|NCT00789477|1011436|P1|NOT COMPLETED|Overall Study||11
424339|NCT00789477|1011432|P5|COMPLETED|Overall Study||38
424340|NCT00789477|1011433|P4|COMPLETED|Overall Study||34
424341|NCT00789477|1011434|P3|COMPLETED|Overall Study||33
424342|NCT00789477|1011435|P2|COMPLETED|Overall Study||38
424343|NCT00789477|1011436|P1|COMPLETED|Overall Study||33
424344|NCT00789477|1011432|P5|Participants Received Treatment|Overall Study|SAF|45
424345|NCT00789477|1011433|P4|Participants Received Treatment|Overall Study|SAF|42
424346|NCT00789477|1011434|P3|Participants Received Treatment|Overall Study|SAF|44
424347|NCT00789477|1011435|P2|Participants Received Treatment|Overall Study|SAF|44
424348|NCT00789477|1011436|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
424349|NCT00789477|1011432|P5|STARTED|Overall Study|randomized|45
424350|NCT00789477|1011433|P4|STARTED|Overall Study|randomized|44
424351|NCT00789477|1011434|P3|STARTED|Overall Study|randomized|44
424352|NCT00789477|1011435|P2|STARTED|Overall Study|randomized|44
424353|NCT00789477|1011436|P1|STARTED|Overall Study|randomized|44
424354|NCT00789438|1011471|P3|NOT COMPLETED|Overall Study||0
424355|NCT00789438|1011472|P2|NOT COMPLETED|Overall Study||0
424356|NCT00789438|1011473|P1|NOT COMPLETED|Overall Study||0
424357|NCT00789438|1011471|P3|COMPLETED|Overall Study||28
424358|NCT00789438|1011472|P2|COMPLETED|Overall Study||20
424359|NCT00789438|1011473|P1|COMPLETED|Overall Study||21
424360|NCT00789438|1011471|P3|STARTED|Overall Study||28
424361|NCT00789438|1011472|P2|STARTED|Overall Study||20
424362|NCT00789438|1011473|P1|STARTED|Overall Study||21
424363|NCT00789373|1011481|P3|NOT COMPLETED|Maintenance||180
424364|NCT00789373|1011482|P2|NOT COMPLETED|Maintenance||359
424365|NCT00789373|1011483|P1|NOT COMPLETED|Maintenance||0
424366|NCT00789373|1011481|P3|COMPLETED|Maintenance||0
424367|NCT00789373|1011482|P2|COMPLETED|Maintenance||0
424368|NCT00789373|1011483|P1|COMPLETED|Maintenance||0
424369|NCT00789373|1011481|P3|STARTED|Maintenance||180
424370|NCT00789373|1011482|P2|STARTED|Maintenance||359
424371|NCT00789373|1011483|P1|STARTED|Maintenance||0
424372|NCT00789373|1011481|P3|NOT COMPLETED|Induction||0
424373|NCT00789373|1011482|P2|NOT COMPLETED|Induction||0
424374|NCT00789373|1011483|P1|NOT COMPLETED|Induction||399
424375|NCT00789373|1011481|P3|COMPLETED|Induction||0
424376|NCT00789373|1011482|P2|COMPLETED|Induction||0
424377|NCT00789373|1011483|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
424378|NCT00789373|1011481|P3|STARTED|Induction||0
424379|NCT00789373|1011482|P2|STARTED|Induction||0
424380|NCT00789373|1011483|P1|STARTED|Induction||939
424381|NCT00789321|1011510|P2|NOT COMPLETED|Overall Study||1
424382|NCT00789321|1011511|P1|NOT COMPLETED|Overall Study||0
424383|NCT00789321|1011510|P2|COMPLETED|Overall Study||22
424384|NCT00789321|1011511|P1|COMPLETED|Overall Study||24
424385|NCT00789321|1011510|P2|STARTED|Overall Study||23
424386|NCT00789321|1011511|P1|STARTED|Overall Study||24
424387|NCT00789256|1011521|P2|NOT COMPLETED|Overall Study||0
424388|NCT00789256|1011522|P1|NOT COMPLETED|Overall Study||0
424389|NCT00789256|1011521|P2|COMPLETED|Overall Study||12
424390|NCT00789256|1011522|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
424391|NCT00789256|1011521|P2|STARTED|Overall Study||12
424392|NCT00789256|1011522|P1|STARTED|Overall Study||14
424393|NCT00789191|1011530|P2|NOT COMPLETED|Overall Study||19
424394|NCT00789191|1011531|P1|NOT COMPLETED|Overall Study||14
424395|NCT00789191|1011530|P2|COMPLETED|Overall Study||92
424396|NCT00789191|1011531|P1|COMPLETED|Overall Study||97
424397|NCT00789191|1011530|P2|Exposed|Overall Study|1 non-compliance|110
424398|NCT00789191|1011531|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
424399|NCT00789191|1011530|P2|STARTED|Overall Study||111
424400|NCT00789191|1011531|P1|STARTED|Overall Study||111
424401|NCT00789113|1011559|P1|NOT COMPLETED|Overall Study||0
424402|NCT00789113|1011559|P1|COMPLETED|Overall Study||12
424403|NCT00789113|1011559|P1|STARTED|Overall Study||12
424404|NCT00789074|1011566|P2|NOT COMPLETED|Overall Study||13
424405|NCT00789074|1011567|P1|NOT COMPLETED|Overall Study||11
424406|NCT00789074|1011566|P2|COMPLETED|Overall Study||35
424407|NCT00789074|1011567|P1|COMPLETED|Overall Study||42
424408|NCT00789074|1011566|P2|STARTED|Overall Study||48
424409|NCT00789074|1011567|P1|STARTED|Overall Study||53
424410|NCT00789035|1011588|P5|NOT COMPLETED|Overall Study||6
424411|NCT00789035|1011589|P4|NOT COMPLETED|Overall Study||1
424412|NCT00789035|1011590|P3|NOT COMPLETED|Overall Study||1
424413|NCT00789035|1011591|P2|NOT COMPLETED|Overall Study||7
424414|NCT00789035|1011592|P1|NOT COMPLETED|Overall Study||6
424415|NCT00789035|1011588|P5|COMPLETED|Overall Study||74
424416|NCT00789035|1011589|P4|COMPLETED|Overall Study||81
424417|NCT00789035|1011590|P3|COMPLETED|Overall Study||80
424418|NCT00789035|1011591|P2|COMPLETED|Overall Study||74
424419|NCT00789035|1011592|P1|COMPLETED|Overall Study||76
424420|NCT00789035|1011588|P5|STARTED|Overall Study||80
424421|NCT00789035|1011589|P4|STARTED|Overall Study||82
424422|NCT00789035|1011590|P3|STARTED|Overall Study||81
424423|NCT00789035|1011591|P2|STARTED|Overall Study||81
424424|NCT00789035|1011592|P1|STARTED|Overall Study||82
424425|NCT00788957|1011651|P6|NOT COMPLETED|Part 3||11
424426|NCT00788957|1011652|P5|NOT COMPLETED|Part 3||9
424427|NCT00788957|1011653|P4|NOT COMPLETED|Part 3||0
424428|NCT00788957|1011654|P3|NOT COMPLETED|Part 3||0
424429|NCT00788957|1011655|P2|NOT COMPLETED|Part 3||0
424430|NCT00788957|1011656|P1|NOT COMPLETED|Part 3||0
424431|NCT00788957|1011651|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
424432|NCT00788957|1011652|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
424433|NCT00788957|1011653|P4|COMPLETED|Part 3||0
424434|NCT00788957|1011654|P3|COMPLETED|Part 3||0
424435|NCT00788957|1011655|P2|COMPLETED|Part 3||0
424436|NCT00788957|1011656|P1|COMPLETED|Part 3||0
424437|NCT00788957|1011651|P6|STARTED|Part 3||12
424438|NCT00788957|1011652|P5|STARTED|Part 3||13
424439|NCT00788957|1011653|P4|STARTED|Part 3||0
424440|NCT00788957|1011654|P3|STARTED|Part 3||0
424441|NCT00788957|1011655|P2|STARTED|Part 3||0
424442|NCT00788957|1011656|P1|STARTED|Part 3||0
424443|NCT00788957|1011651|P6|NOT COMPLETED|Part 2||0
424444|NCT00788957|1011652|P5|NOT COMPLETED|Part 2||0
424445|NCT00788957|1011653|P4|NOT COMPLETED|Part 2||41
424446|NCT00788957|1011654|P3|NOT COMPLETED|Part 2||44
424447|NCT00788957|1011655|P2|NOT COMPLETED|Part 2||42
424448|NCT00788957|1011656|P1|NOT COMPLETED|Part 2||0
424449|NCT00788957|1011651|P6|COMPLETED|Part 2||0
424450|NCT00788957|1011652|P5|COMPLETED|Part 2||0
424451|NCT00788957|1011653|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
424452|NCT00788957|1011654|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
424453|NCT00788957|1011655|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
424454|NCT00788957|1011656|P1|COMPLETED|Part 2||0
424455|NCT00788957|1011651|P6|STARTED|Part 2||0
424456|NCT00788957|1011652|P5|STARTED|Part 2||0
424457|NCT00788957|1011653|P4|STARTED|Part 2||46
424458|NCT00788957|1011654|P3|STARTED|Part 2||48
424459|NCT00788957|1011655|P2|STARTED|Part 2||48
424460|NCT00788957|1011656|P1|STARTED|Part 2||0
424461|NCT00788957|1011651|P6|NOT COMPLETED|Part 1||0
424462|NCT00788957|1011652|P5|NOT COMPLETED|Part 1||0
424463|NCT00788957|1011653|P4|NOT COMPLETED|Part 1||0
424464|NCT00788957|1011654|P3|NOT COMPLETED|Part 1||0
424465|NCT00788957|1011655|P2|NOT COMPLETED|Part 1||0
424466|NCT00788957|1011656|P1|NOT COMPLETED|Part 1||9
424467|NCT00788957|1011651|P6|COMPLETED|Part 1||0
424468|NCT00788957|1011652|P5|COMPLETED|Part 1||0
424469|NCT00788957|1011653|P4|COMPLETED|Part 1||0
424470|NCT00788957|1011654|P3|COMPLETED|Part 1||0
424471|NCT00788957|1011655|P2|COMPLETED|Part 1||0
424472|NCT00788957|1011656|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
424473|NCT00788957|1011651|P6|STARTED|Part 1||0
424474|NCT00788957|1011652|P5|STARTED|Part 1||0
424475|NCT00788957|1011653|P4|STARTED|Part 1||0
424476|NCT00788957|1011654|P3|STARTED|Part 1||0
424477|NCT00788957|1011655|P2|STARTED|Part 1||0
424478|NCT00788957|1011656|P1|STARTED|Part 1||11
424479|NCT00788775|1011712|P2|NOT COMPLETED|Overall Study||8
424480|NCT00788775|1011713|P1|NOT COMPLETED|Overall Study||10
424481|NCT00788775|1011712|P2|COMPLETED|Overall Study||1
424482|NCT00788775|1011713|P1|COMPLETED|Overall Study||1
424483|NCT00788775|1011712|P2|Treated|Overall Study||8
424484|NCT00788775|1011713|P1|Treated|Overall Study||11
424485|NCT00788775|1011712|P2|STARTED|Overall Study||9
424486|NCT00788775|1011713|P1|STARTED|Overall Study||11
424487|NCT00788710|1011728|P3|NOT COMPLETED|Overall Study||6
424488|NCT00788710|1011729|P2|NOT COMPLETED|Overall Study||8
424489|NCT00788710|1011730|P1|NOT COMPLETED|Overall Study||5
424490|NCT00788710|1011728|P3|COMPLETED|Overall Study||138
424491|NCT00788710|1011729|P2|COMPLETED|Overall Study||134
424492|NCT00788710|1011730|P1|COMPLETED|Overall Study||139
424493|NCT00788710|1011728|P3|STARTED|Overall Study||144
424494|NCT00788710|1011729|P2|STARTED|Overall Study||142
424495|NCT00788710|1011730|P1|STARTED|Overall Study||144
424496|NCT00788697|1011744|P1|NOT COMPLETED|Overall Study||109
424497|NCT00788697|1011744|P1|COMPLETED|Overall Study||240
424498|NCT00788697|1011744|P1|STARTED|Overall Study||349
424499|NCT00788593|1011791|P3|NOT COMPLETED|Second Intervention Period||1
424500|NCT00788593|1011792|P2|NOT COMPLETED|Second Intervention Period||1
424501|NCT00788593|1011793|P1|NOT COMPLETED|Second Intervention Period||0
424502|NCT00788593|1011791|P3|COMPLETED|Second Intervention Period||36
424503|NCT00788593|1011792|P2|COMPLETED|Second Intervention Period||37
424504|NCT00788593|1011793|P1|COMPLETED|Second Intervention Period||0
424505|NCT00788593|1011791|P3|STARTED|Second Intervention Period||37
424506|NCT00788593|1011792|P2|STARTED|Second Intervention Period||38
424507|NCT00788593|1011793|P1|STARTED|Second Intervention Period||0
424508|NCT00788593|1011791|P3|NOT COMPLETED|First Intervention Period||0
424509|NCT00788593|1011792|P2|NOT COMPLETED|First Intervention Period||1
424510|NCT00788593|1011793|P1|NOT COMPLETED|First Intervention Period||0
424511|NCT00788593|1011791|P3|COMPLETED|First Intervention Period||37
424512|NCT00788593|1011792|P2|COMPLETED|First Intervention Period||38
424513|NCT00788593|1011793|P1|COMPLETED|First Intervention Period||0
424514|NCT00788593|1011791|P3|STARTED|First Intervention Period||37
424515|NCT00788593|1011792|P2|STARTED|First Intervention Period||39
424516|NCT00788593|1011793|P1|STARTED|First Intervention Period||0
424517|NCT00788593|1011791|P3|NOT COMPLETED|Placebo Run-in Phase||0
424518|NCT00788593|1011792|P2|NOT COMPLETED|Placebo Run-in Phase||0
424519|NCT00788593|1011793|P1|NOT COMPLETED|Placebo Run-in Phase||6
424520|NCT00788593|1011791|P3|COMPLETED|Placebo Run-in Phase||0
424521|NCT00788593|1011792|P2|COMPLETED|Placebo Run-in Phase||0
424522|NCT00788593|1011793|P1|COMPLETED|Placebo Run-in Phase||76
424523|NCT00788593|1011791|P3|STARTED|Placebo Run-in Phase||0
424524|NCT00788593|1011792|P2|STARTED|Placebo Run-in Phase||0
424525|NCT00788593|1011793|P1|STARTED|Placebo Run-in Phase||82
424526|NCT00788372|1011810|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
424527|NCT00788372|1011810|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
424528|NCT00788372|1011810|P1|STARTED|Period 2 (Week 4 to Week 52)||111
424529|NCT00788372|1011810|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
424530|NCT00788372|1011810|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
424531|NCT00788372|1011810|P1|STARTED|Period 1 (up to 4 Weeks)||142
424532|NCT00788255|1011824|P1|NOT COMPLETED|Overall Study||0
424533|NCT00788255|1011824|P1|COMPLETED|Overall Study||25
424534|NCT00788255|1011824|P1|Oxytocin: 0 μU/mL|Overall Study||25
424535|NCT00788255|1011824|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
424536|NCT00788255|1011824|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
424537|NCT00788255|1011824|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
424538|NCT00788255|1011824|P1|STARTED|Overall Study||25
424539|NCT00788073|1011839|P2|NOT COMPLETED|Placebo Then STX209||1
424540|NCT00788073|1011840|P1|NOT COMPLETED|Placebo Then STX209||2
424541|NCT00788073|1011839|P2|COMPLETED|Placebo Then STX209||29
424542|NCT00788073|1011840|P1|COMPLETED|Placebo Then STX209||27
424543|NCT00788073|1011839|P2|STARTED|Placebo Then STX209||30
424544|NCT00788073|1011840|P1|STARTED|Placebo Then STX209||29
424545|NCT00788073|1011839|P2|NOT COMPLETED|STX209 Then Placebo||3
424546|NCT00788073|1011840|P1|NOT COMPLETED|STX209 Then Placebo||1
424547|NCT00788073|1011839|P2|COMPLETED|STX209 Then Placebo||30
424548|NCT00788073|1011840|P1|COMPLETED|STX209 Then Placebo||29
424549|NCT00788073|1011839|P2|STARTED|STX209 Then Placebo||33
424550|NCT00788073|1011840|P1|STARTED|STX209 Then Placebo||30
424551|NCT00788008|1011850|P2|NOT COMPLETED|Overall Study||0
424552|NCT00788008|1011851|P1|NOT COMPLETED|Overall Study||0
424553|NCT00788008|1011850|P2|COMPLETED|Overall Study||101
424554|NCT00788008|1011851|P1|COMPLETED|Overall Study||98
424555|NCT00788008|1011850|P2|STARTED|Overall Study||101
424556|NCT00788008|1011851|P1|STARTED|Overall Study||98
424557|NCT00787943|1011857|P1|NOT COMPLETED|Overall Study||0
424558|NCT00787943|1011857|P1|COMPLETED|Overall Study||10
424559|NCT00787943|1011857|P1|STARTED|Overall Study||10
424560|NCT00787930|1011865|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
424561|NCT00787930|1011865|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
424562|NCT00787930|1011865|P1|STARTED|Continuation Treatment -- up to 12 Month||19
424563|NCT00787930|1011865|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
424564|NCT00787930|1011865|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
424565|NCT00787930|1011865|P1|STARTED|Acute Treatment -- 3 Weeks||19
424566|NCT00787917|1011880|P2|NOT COMPLETED|Open Label||0
424567|NCT00787917|1011881|P1|NOT COMPLETED|Open Label||4
424568|NCT00787917|1011880|P2|COMPLETED|Open Label||0
424569|NCT00787917|1011881|P1|COMPLETED|Open Label||3
424570|NCT00787917|1011880|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
424571|NCT00787917|1011881|P1|STARTED|Open Label||7
424572|NCT00787917|1011880|P2|NOT COMPLETED|Blinded Treatment||2
424573|NCT00787917|1011881|P1|NOT COMPLETED|Blinded Treatment||5
424574|NCT00787917|1011880|P2|COMPLETED|Blinded Treatment||3
424575|NCT00787917|1011881|P1|COMPLETED|Blinded Treatment||4
424576|NCT00787917|1011880|P2|STARTED|Blinded Treatment||5
424577|NCT00787917|1011881|P1|STARTED|Blinded Treatment||9
424578|NCT00787904|1011900|P2|NOT COMPLETED|Overall Study||0
424579|NCT00787904|1011901|P1|NOT COMPLETED|Overall Study||0
424580|NCT00787904|1011900|P2|COMPLETED|Overall Study||13
424581|NCT00787904|1011901|P1|COMPLETED|Overall Study||6
424582|NCT00787904|1011900|P2|STARTED|Overall Study||13
424583|NCT00787904|1011901|P1|STARTED|Overall Study||6
424584|NCT00787891|1011911|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
424585|NCT00787891|1011912|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
424586|NCT00787891|1011911|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
424587|NCT00787891|1011912|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
424588|NCT00787891|1011911|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
424589|NCT00787891|1011912|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
424590|NCT00787891|1011911|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
424591|NCT00787891|1011912|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
424592|NCT00787891|1011911|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
424593|NCT00787891|1011912|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
424594|NCT00787891|1011911|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
424595|NCT00787891|1011912|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
424596|NCT00787852|1011932|P2|NOT COMPLETED|Overall Study||0
424597|NCT00787852|1011933|P1|NOT COMPLETED|Overall Study||1
424598|NCT00787852|1011932|P2|COMPLETED|Overall Study||5
424599|NCT00787852|1011933|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
424600|NCT00787852|1011932|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
424601|NCT00787852|1011933|P1|STARTED|Overall Study||6
424602|NCT00787839|1011939|P1|NOT COMPLETED|Overall Study||404
424603|NCT00787839|1011939|P1|COMPLETED|Overall Study||1535
424604|NCT00787839|1011939|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
424605|NCT00787839|1011939|P1|Completed GCT Screening|Overall Study||1876
424606|NCT00787839|1011939|P1|Consented|Overall Study|consented|1939
424607|NCT00787839|1011939|P1|STARTED|Overall Study||1939
424608|NCT00787800|1011962|P2|NOT COMPLETED|Overall Study||7
424609|NCT00787800|1011963|P1|NOT COMPLETED|Overall Study||3
424610|NCT00787800|1011962|P2|COMPLETED|Overall Study||43
424611|NCT00787800|1011963|P1|COMPLETED|Overall Study||47
424612|NCT00787800|1011962|P2|STARTED|Overall Study||50
424613|NCT00787800|1011963|P1|STARTED|Overall Study||50
424614|NCT00787787|1011979|P1|NOT COMPLETED|Overall Study||7
424615|NCT00787787|1011979|P1|COMPLETED|Overall Study||0
424616|NCT00787787|1011979|P1|STARTED|Overall Study||7
424617|NCT00787761|1011985|P1|NOT COMPLETED|Overall Study||0
424618|NCT00787761|1011985|P1|COMPLETED|Overall Study||24
424619|NCT00787761|1011985|P1|STARTED|Overall Study||24
424620|NCT00787644|1011998|P2|NOT COMPLETED|Overall Study||2
424621|NCT00787644|1011999|P1|NOT COMPLETED|Overall Study||2
424622|NCT00787644|1011998|P2|COMPLETED|Overall Study||9
424623|NCT00787644|1011999|P1|COMPLETED|Overall Study||10
424624|NCT00787644|1011998|P2|STARTED|Overall Study||11
424625|NCT00787644|1011999|P1|STARTED|Overall Study||12
424626|NCT00787618|1012008|P3|NOT COMPLETED|Overall Study||0
424627|NCT00787618|1012009|P2|NOT COMPLETED|Overall Study||0
424628|NCT00787618|1012010|P1|NOT COMPLETED|Overall Study||0
424629|NCT00787618|1012008|P3|COMPLETED|Overall Study||3
424630|NCT00787618|1012009|P2|COMPLETED|Overall Study||0
424631|NCT00787618|1012010|P1|COMPLETED|Overall Study||3
424632|NCT00787618|1012008|P3|STARTED|Overall Study||3
424633|NCT00787618|1012009|P2|STARTED|Overall Study||0
424634|NCT00787618|1012010|P1|STARTED|Overall Study||3
424635|NCT00787605|1012020|P2|NOT COMPLETED|Overall Study||56
424636|NCT00787605|1012021|P1|NOT COMPLETED|Overall Study||46
424637|NCT00787605|1012020|P2|COMPLETED|Overall Study||376
424638|NCT00787605|1012021|P1|COMPLETED|Overall Study||382
424639|NCT00787605|1012020|P2|STARTED|Overall Study||432
424640|NCT00787605|1012021|P1|STARTED|Overall Study||428
424641|NCT00787566|1012040|P3|NOT COMPLETED|Overall Study||0
424642|NCT00787566|1012041|P2|NOT COMPLETED|Overall Study||1
424643|NCT00787566|1012042|P1|NOT COMPLETED|Overall Study||0
424644|NCT00787566|1012040|P3|COMPLETED|Overall Study||22
424645|NCT00787566|1012041|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
424646|NCT00787566|1012042|P1|COMPLETED|Overall Study||21
424647|NCT00787566|1012040|P3|STARTED|Overall Study||22
424648|NCT00787566|1012041|P2|STARTED|Overall Study||25
424649|NCT00787566|1012042|P1|STARTED|Overall Study||21
424650|NCT00787527|1012050|P1|NOT COMPLETED|Overall Study||3
424651|NCT00787527|1012050|P1|COMPLETED|Overall Study||11
424652|NCT00787527|1012050|P1|STARTED|Overall Study||14
424653|NCT00787332|1012060|P2|NOT COMPLETED|Overall Study||0
424654|NCT00787332|1012061|P1|NOT COMPLETED|Overall Study||0
424655|NCT00787332|1012060|P2|COMPLETED|Overall Study||8
424656|NCT00787332|1012061|P1|COMPLETED|Overall Study||8
424657|NCT00787332|1012060|P2|STARTED|Overall Study||8
424658|NCT00787332|1012061|P1|STARTED|Overall Study||8
424659|NCT00787319|1012067|P1|NOT COMPLETED|Overall Study||63
424660|NCT00787319|1012067|P1|COMPLETED|Overall Study||45
424661|NCT00787319|1012067|P1|STARTED|Overall Study||108
424662|NCT00787267|1012079|P1|NOT COMPLETED|Overall Study||12
424663|NCT00787267|1012079|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
424664|NCT00787267|1012079|P1|STARTED|Overall Study|Signed a consent form|37
424665|NCT00787254|1012089|P2|NOT COMPLETED|Overall Study||82
424666|NCT00787254|1012090|P1|NOT COMPLETED|Overall Study||76
424667|NCT00787254|1012089|P2|COMPLETED|Overall Study||99
424668|NCT00787254|1012090|P1|COMPLETED|Overall Study||109
424669|NCT00787254|1012089|P2|STARTED|Overall Study||181
424670|NCT00787254|1012090|P1|STARTED|Overall Study||185
424671|NCT00787241|1012193|P3|NOT COMPLETED|Overall Study||0
424672|NCT00787241|1012194|P2|NOT COMPLETED|Overall Study||0
424673|NCT00787241|1012195|P1|NOT COMPLETED|Overall Study||0
424674|NCT00787241|1012193|P3|COMPLETED|Overall Study||41
424675|NCT00787241|1012194|P2|COMPLETED|Overall Study||143
424676|NCT00787241|1012195|P1|COMPLETED|Overall Study||261
424677|NCT00787241|1012193|P3|STARTED|Overall Study||41
424678|NCT00787241|1012194|P2|STARTED|Overall Study||143
424679|NCT00787241|1012195|P1|STARTED|Overall Study||261
424680|NCT00787202|1012214|P5|NOT COMPLETED|Overall Study||4
424681|NCT00787202|1012215|P4|NOT COMPLETED|Overall Study||2
424682|NCT00787202|1012216|P3|NOT COMPLETED|Overall Study||7
424683|NCT00787202|1012217|P2|NOT COMPLETED|Overall Study||11
424684|NCT00787202|1012218|P1|NOT COMPLETED|Overall Study||14
424685|NCT00787202|1012214|P5|COMPLETED|Overall Study||45
424686|NCT00787202|1012215|P4|COMPLETED|Overall Study||31
424687|NCT00787202|1012216|P3|COMPLETED|Overall Study||26
424688|NCT00787202|1012217|P2|COMPLETED|Overall Study||20
424689|NCT00787202|1012218|P1|COMPLETED|Overall Study||35
424690|NCT00787202|1012214|P5|Treated|Overall Study||49
424691|NCT00787202|1012215|P4|Treated|Overall Study||33
424692|NCT00787202|1012216|P3|Treated|Overall Study||33
424693|NCT00787202|1012217|P2|Treated|Overall Study||31
424694|NCT00787202|1012218|P1|Treated|Overall Study||48
424695|NCT00787202|1012214|P5|STARTED|Overall Study||49
424696|NCT00787202|1012215|P4|STARTED|Overall Study||33
424697|NCT00787202|1012216|P3|STARTED|Overall Study||33
424698|NCT00787202|1012217|P2|STARTED|Overall Study||31
424699|NCT00787202|1012218|P1|STARTED|Overall Study||49
424700|NCT00787189|1012271|P2|NOT COMPLETED|Overall Study||2
424701|NCT00787189|1012272|P1|NOT COMPLETED|Overall Study||2
424702|NCT00787189|1012271|P2|COMPLETED|Overall Study|To study end point.|30
424703|NCT00787189|1012272|P1|COMPLETED|Overall Study|To study end point.|30
424704|NCT00787189|1012271|P2|STARTED|Overall Study||32
424705|NCT00787189|1012272|P1|STARTED|Overall Study||32
424706|NCT00787150|1012281|P3|NOT COMPLETED|Overall Study||5
424707|NCT00787150|1012282|P2|NOT COMPLETED|Overall Study||7
424708|NCT00787150|1012283|P1|NOT COMPLETED|Overall Study||9
424709|NCT00787150|1012281|P3|COMPLETED|Overall Study||66
424710|NCT00787150|1012282|P2|COMPLETED|Overall Study||65
424711|NCT00787150|1012283|P1|COMPLETED|Overall Study||66
424712|NCT00787150|1012281|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
424713|NCT00787150|1012282|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
424714|NCT00787150|1012283|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
424715|NCT00787137|1012328|P3|NOT COMPLETED|Overall Study||1
424716|NCT00787137|1012329|P2|NOT COMPLETED|Overall Study||0
424717|NCT00787137|1012330|P1|NOT COMPLETED|Overall Study||0
424718|NCT00787137|1012328|P3|COMPLETED|Overall Study||4
424719|NCT00787137|1012329|P2|COMPLETED|Overall Study||6
424720|NCT00787137|1012330|P1|COMPLETED|Overall Study||6
424721|NCT00787137|1012328|P3|STARTED|Overall Study||5
424722|NCT00787137|1012329|P2|STARTED|Overall Study||6
424723|NCT00787137|1012330|P1|STARTED|Overall Study||6
424724|NCT00787124|1012352|P2|NOT COMPLETED|Overall Study||0
424725|NCT00787124|1012353|P1|NOT COMPLETED|Overall Study||0
424726|NCT00787124|1012352|P2|COMPLETED|Overall Study||4
424727|NCT00787124|1012353|P1|COMPLETED|Overall Study||4
424728|NCT00787124|1012352|P2|STARTED|Overall Study||4
424729|NCT00787124|1012353|P1|STARTED|Overall Study||4
424730|NCT00787020|1012363|P2|NOT COMPLETED|Overall Study||0
424731|NCT00787020|1012364|P1|NOT COMPLETED|Overall Study||0
424732|NCT00787020|1012363|P2|COMPLETED|Overall Study||13
424733|NCT00787020|1012364|P1|COMPLETED|Overall Study||24
424734|NCT00787020|1012363|P2|STARTED|Overall Study||13
424735|NCT00787020|1012364|P1|STARTED|Overall Study||24
424736|NCT00786994|1012378|P4|NOT COMPLETED|Overall Study||6
424737|NCT00786994|1012379|P3|NOT COMPLETED|Overall Study||2
424738|NCT00786994|1012380|P2|NOT COMPLETED|Overall Study||15
424739|NCT00786994|1012381|P1|NOT COMPLETED|Overall Study||10
424740|NCT00786994|1012378|P4|COMPLETED|Overall Study||22
424741|NCT00786994|1012379|P3|COMPLETED|Overall Study||24
424742|NCT00786994|1012380|P2|COMPLETED|Overall Study||39
424743|NCT00786994|1012381|P1|COMPLETED|Overall Study||47
424744|NCT00786994|1012378|P4|ITT|Overall Study||28
424745|NCT00786994|1012379|P3|ITT|Overall Study||25
424746|NCT00786994|1012380|P2|ITT|Overall Study||51
424747|NCT00786994|1012381|P1|ITT|Overall Study||53
424748|NCT00786994|1012378|P4|STARTED|Overall Study||28
424749|NCT00786994|1012379|P3|STARTED|Overall Study||26
424750|NCT00786994|1012380|P2|STARTED|Overall Study||54
424751|NCT00786994|1012381|P1|STARTED|Overall Study||57
424752|NCT00786916|1012393|P3|NOT COMPLETED|Overall Study||0
424753|NCT00786916|1012394|P2|NOT COMPLETED|Overall Study||0
424754|NCT00786916|1012395|P1|NOT COMPLETED|Overall Study||0
424755|NCT00786916|1012393|P3|COMPLETED|Overall Study||34
424756|NCT00786916|1012394|P2|COMPLETED|Overall Study||36
424757|NCT00786916|1012395|P1|COMPLETED|Overall Study||39
424758|NCT00786916|1012393|P3|STARTED|Overall Study||34
424759|NCT00786916|1012394|P2|STARTED|Overall Study||36
424760|NCT00786916|1012395|P1|STARTED|Overall Study||39
424761|NCT00786864|1012405|P2|NOT COMPLETED|Overall Study||1
424762|NCT00786864|1012406|P1|NOT COMPLETED|Overall Study||1
424763|NCT00786864|1012405|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
424764|NCT00786864|1012406|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
424765|NCT00786864|1012405|P2|STARTED|Overall Study||33
424766|NCT00786864|1012406|P1|STARTED|Overall Study||39
424767|NCT00786838|1012418|P1|NOT COMPLETED|Overall Study||49
424768|NCT00786838|1012418|P1|COMPLETED|Overall Study||26
424769|NCT00786838|1012418|P1|STARTED|Overall Study||75
424770|NCT00786799|1012445|P2|NOT COMPLETED|Overall Study||1
424771|NCT00786799|1012446|P1|NOT COMPLETED|Overall Study||1
424772|NCT00786799|1012445|P2|COMPLETED|Overall Study||12
424773|NCT00786799|1012446|P1|COMPLETED|Overall Study||13
424774|NCT00786799|1012445|P2|STARTED|Overall Study||13
424775|NCT00786799|1012446|P1|STARTED|Overall Study||14
424776|NCT00786682|1012457|P1|NOT COMPLETED|Overall Study||0
424777|NCT00786682|1012457|P1|COMPLETED|Overall Study||11
424778|NCT00786682|1012457|P1|STARTED|Overall Study||11
424779|NCT00786643|1012465|P2|NOT COMPLETED|Overall Study||0
424780|NCT00786643|1012466|P1|NOT COMPLETED|Overall Study||0
424781|NCT00786643|1012465|P2|COMPLETED|Overall Study||28
424782|NCT00786643|1012466|P1|COMPLETED|Overall Study||20
424783|NCT00786643|1012465|P2|STARTED|Overall Study||28
424784|NCT00786643|1012466|P1|STARTED|Overall Study||20
424785|NCT00786565|1012476|P1|NOT COMPLETED|Post Surgery||2
424786|NCT00786565|1012476|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
424787|NCT00786565|1012476|P1|STARTED|Post Surgery||69
424788|NCT00786565|1012476|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
424789|NCT00786565|1012476|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
424790|NCT00786565|1012476|P1|STARTED|Enrollment Prior to Surgery||75
424791|NCT00786487|1012518|P4|NOT COMPLETED|Overall Study||0
424792|NCT00786487|1012519|P3|NOT COMPLETED|Overall Study||0
424793|NCT00786487|1012520|P2|NOT COMPLETED|Overall Study||0
424794|NCT00786487|1012521|P1|NOT COMPLETED|Overall Study||0
424795|NCT00786487|1012518|P4|COMPLETED|Overall Study||7
424796|NCT00786487|1012519|P3|COMPLETED|Overall Study||9
424797|NCT00786487|1012520|P2|COMPLETED|Overall Study||7
424798|NCT00786487|1012521|P1|COMPLETED|Overall Study||10
424799|NCT00786487|1012518|P4|STARTED|Overall Study||7
424800|NCT00786487|1012519|P3|STARTED|Overall Study||9
424801|NCT00786487|1012520|P2|STARTED|Overall Study||7
424802|NCT00786487|1012521|P1|STARTED|Overall Study||10
424803|NCT00786474|1012533|P2|NOT COMPLETED|Overall Study||43
424804|NCT00786474|1012534|P1|NOT COMPLETED|Overall Study||37
424805|NCT00786474|1012533|P2|COMPLETED|Overall Study||891
424806|NCT00786474|1012534|P1|COMPLETED|Overall Study||913
424807|NCT00786474|1012533|P2|STARTED|Overall Study||934
424808|NCT00786474|1012534|P1|STARTED|Overall Study||950
424809|NCT00786422|1012546|P1|NOT COMPLETED|Follow-up Period||3
424810|NCT00786422|1012546|P1|COMPLETED|Follow-up Period||17
424811|NCT00786422|1012546|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
424812|NCT00786422|1012546|P1|NOT COMPLETED|Rivaroxaban Treatment||11
424813|NCT00786422|1012546|P1|COMPLETED|Rivaroxaban Treatment||14
424814|NCT00786422|1012546|P1|STARTED|Rivaroxaban Treatment||25
424815|NCT00786188|1012564|P2|NOT COMPLETED|Overall Study||1
424816|NCT00786188|1012565|P1|NOT COMPLETED|Overall Study||5
424817|NCT00786188|1012564|P2|COMPLETED|Overall Study||51
424818|NCT00786188|1012565|P1|COMPLETED|Overall Study||45
424819|NCT00786188|1012564|P2|STARTED|Overall Study||52
424820|NCT00786188|1012565|P1|STARTED|Overall Study||50
424821|NCT00786032|1012591|P1|NOT COMPLETED|Overall Study||24
424822|NCT00786032|1012591|P1|COMPLETED|Overall Study||3
424823|NCT00786032|1012591|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
424824|NCT00786032|1012591|P1|STARTED|Overall Study||27
424825|NCT00785980|1012601|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
424826|NCT00785980|1012601|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
424827|NCT00785980|1012601|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
424828|NCT00785980|1012601|P1|NOT COMPLETED|Ciprofloxacin Alone||0
424829|NCT00785980|1012601|P1|COMPLETED|Ciprofloxacin Alone||21
424830|NCT00785980|1012601|P1|STARTED|Ciprofloxacin Alone||21
424831|NCT00785980|1012601|P1|NOT COMPLETED|7 Day Washout Period||3
424832|NCT00785980|1012601|P1|COMPLETED|7 Day Washout Period||21
424833|NCT00785980|1012601|P1|STARTED|7 Day Washout Period||24
424834|NCT00785980|1012601|P1|NOT COMPLETED|Quinine Sulfate Alone||0
424835|NCT00785980|1012601|P1|COMPLETED|Quinine Sulfate Alone||24
424836|NCT00785980|1012601|P1|STARTED|Quinine Sulfate Alone||24
424837|NCT00785798|1012612|P1|NOT COMPLETED|Overall Study||1
424838|NCT00785798|1012612|P1|COMPLETED|Overall Study||16
424839|NCT00785798|1012612|P1|STARTED|Overall Study||17
424840|NCT00785785|1012619|P2|NOT COMPLETED|Optional Extension Phase||125
424841|NCT00785785|1012620|P1|NOT COMPLETED|Optional Extension Phase||39
424842|NCT00785785|1012619|P2|COMPLETED|Optional Extension Phase||0
424843|NCT00785785|1012620|P1|COMPLETED|Optional Extension Phase||0
424844|NCT00785785|1012619|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
424845|NCT00785785|1012620|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
424846|NCT00785785|1012619|P2|NOT COMPLETED|Core Phase up to 36 Months||320
424847|NCT00785785|1012620|P1|NOT COMPLETED|Core Phase up to 36 Months||324
424848|NCT00785785|1012619|P2|COMPLETED|Core Phase up to 36 Months||0
424849|NCT00785785|1012620|P1|COMPLETED|Core Phase up to 36 Months||0
424850|NCT00785785|1012619|P2|STARTED|Core Phase up to 36 Months||320
424851|NCT00785785|1012620|P1|STARTED|Core Phase up to 36 Months||324
424852|NCT00785772|1012628|P1|NOT COMPLETED|Overall Study||0
424853|NCT00785772|1012628|P1|COMPLETED|Overall Study||1
424854|NCT00785772|1012628|P1|STARTED|Overall Study||1
424855|NCT00785629|1012638|P4|NOT COMPLETED|Overall Study||16
424856|NCT00785629|1012639|P3|NOT COMPLETED|Overall Study||10
424857|NCT00785629|1012640|P2|NOT COMPLETED|Overall Study||5
424858|NCT00785629|1012641|P1|NOT COMPLETED|Overall Study||8
424859|NCT00785629|1012638|P4|COMPLETED|Overall Study|16 not completed|41
424860|NCT00785629|1012639|P3|COMPLETED|Overall Study|10 not completed|18
424861|NCT00785629|1012640|P2|COMPLETED|Overall Study|5 not completed|25
424862|NCT00785629|1012641|P1|COMPLETED|Overall Study|8 not completed|22
424863|NCT00785629|1012638|P4|STARTED|Overall Study||57
424864|NCT00785629|1012639|P3|STARTED|Overall Study||28
424865|NCT00785629|1012640|P2|STARTED|Overall Study||30
424866|NCT00785629|1012641|P1|STARTED|Overall Study||30
424867|NCT00785577|1012654|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
424868|NCT00785577|1012655|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
424869|NCT00785577|1012656|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
424870|NCT00785577|1012657|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
424871|NCT00785577|1012658|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
424872|NCT00785577|1012654|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
424873|NCT00785577|1012655|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
424874|NCT00785577|1012656|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
424875|NCT00785577|1012657|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
424876|NCT00785577|1012658|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
424877|NCT00785577|1012654|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
424878|NCT00785577|1012655|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
424879|NCT00785577|1012656|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
424880|NCT00785577|1012657|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
424881|NCT00785577|1012658|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
424882|NCT00785577|1012654|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
424883|NCT00785577|1012655|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
424884|NCT00785577|1012656|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
424885|NCT00785577|1012657|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
424886|NCT00785577|1012658|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
424887|NCT00785577|1012654|P5|COMPLETED|Study Period 2: Therapy Phase||27
424888|NCT00785577|1012655|P4|COMPLETED|Study Period 2: Therapy Phase||36
424889|NCT00785577|1012656|P3|COMPLETED|Study Period 2: Therapy Phase||25
424890|NCT00785577|1012657|P2|COMPLETED|Study Period 2: Therapy Phase||36
424891|NCT00785577|1012658|P1|COMPLETED|Study Period 2: Therapy Phase||78
424892|NCT00785577|1012654|P5|STARTED|Study Period 2: Therapy Phase||47
424893|NCT00785577|1012655|P4|STARTED|Study Period 2: Therapy Phase||49
424894|NCT00785577|1012656|P3|STARTED|Study Period 2: Therapy Phase||43
424895|NCT00785577|1012657|P2|STARTED|Study Period 2: Therapy Phase||45
424896|NCT00785577|1012658|P1|STARTED|Study Period 2: Therapy Phase||89
424897|NCT00785512|1012796|P2|NOT COMPLETED|Overall Study||4
424898|NCT00785512|1012797|P1|NOT COMPLETED|Overall Study||3
424899|NCT00785512|1012796|P2|COMPLETED|Overall Study||101
424900|NCT00785512|1012797|P1|COMPLETED|Overall Study||99
424901|NCT00785512|1012796|P2|STARTED|Overall Study||105
424902|NCT00785512|1012797|P1|STARTED|Overall Study||102
424903|NCT00785486|1012806|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
424904|NCT00785486|1012806|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
424905|NCT00785486|1012806|P1|STARTED|Midazolam With Qualaquin at Steady State||23
424906|NCT00785486|1012806|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
424907|NCT00785486|1012806|P1|COMPLETED|Qualaquin Alone at Steady State||23
424908|NCT00785486|1012806|P1|STARTED|Qualaquin Alone at Steady State||23
424909|NCT00785486|1012806|P1|NOT COMPLETED|3 Day Washout||0
424910|NCT00785486|1012806|P1|COMPLETED|3 Day Washout||23
424911|NCT00785486|1012806|P1|STARTED|3 Day Washout||23
424912|NCT00785486|1012806|P1|NOT COMPLETED|Midazolam Alone||1
424913|NCT00785486|1012806|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
424914|NCT00785486|1012806|P1|STARTED|Midazolam Alone||24
424915|NCT00785356|1012830|P1|NOT COMPLETED|Overall Study||8
424916|NCT00785356|1012830|P1|COMPLETED|Overall Study||0
424917|NCT00785356|1012830|P1|STARTED|Overall Study||8
424918|NCT00785291|1012841|P3|NOT COMPLETED|Overall Study||106
424919|NCT00785291|1012842|P2|NOT COMPLETED|Overall Study||149
424920|NCT00785291|1012843|P1|NOT COMPLETED|Overall Study||136
424921|NCT00785291|1012841|P3|COMPLETED|Overall Study||139
424922|NCT00785291|1012842|P2|COMPLETED|Overall Study||122
424923|NCT00785291|1012843|P1|COMPLETED|Overall Study||147
424924|NCT00785291|1012841|P3|STARTED|Overall Study||245
424925|NCT00785291|1012842|P2|STARTED|Overall Study||271
424926|NCT00785291|1012843|P1|STARTED|Overall Study||283
424927|NCT00785213|1012863|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
424928|NCT00785213|1012863|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
424929|NCT00785213|1012863|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
424930|NCT00785213|1012863|P1|NOT COMPLETED|Quinine Sulfate Alone||4
424931|NCT00785213|1012863|P1|COMPLETED|Quinine Sulfate Alone||19
424932|NCT00785213|1012863|P1|STARTED|Quinine Sulfate Alone||23
424933|NCT00785213|1012863|P1|NOT COMPLETED|2 Day Washout Period||0
424934|NCT00785213|1012863|P1|COMPLETED|2 Day Washout Period||23
424935|NCT00785213|1012863|P1|STARTED|2 Day Washout Period||23
424936|NCT00785213|1012863|P1|NOT COMPLETED|Rosiglitazone Alone||0
424937|NCT00785213|1012863|P1|COMPLETED|Rosiglitazone Alone||23
424938|NCT00785213|1012863|P1|STARTED|Rosiglitazone Alone||23
424939|NCT00785044|1012874|P1|NOT COMPLETED|Overall Study||496
424940|NCT00785044|1012874|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
424941|NCT00785044|1012874|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
424942|NCT00785044|1012874|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
424943|NCT00784979|1012879|P1|NOT COMPLETED|Overall Study||6
424944|NCT00784979|1012879|P1|COMPLETED|Overall Study||20
424945|NCT00784979|1012879|P1|STARTED|Overall Study||26
424946|NCT00784927|1012883|P1|NOT COMPLETED|Overall Study||3
424947|NCT00784927|1012883|P1|COMPLETED|Overall Study||33
424948|NCT00784927|1012883|P1|STARTED|Overall Study||36
424949|NCT00784875|1012895|P4|NOT COMPLETED|Period D||1
424950|NCT00784875|1012896|P3|NOT COMPLETED|Period D||6
424951|NCT00784875|1012897|P2|NOT COMPLETED|Period D||4
424952|NCT00784875|1012898|P1|NOT COMPLETED|Period D||5
424953|NCT00784875|1012895|P4|COMPLETED|Period D||87
424954|NCT00784875|1012896|P3|COMPLETED|Period D||88
424955|NCT00784875|1012897|P2|COMPLETED|Period D||85
424956|NCT00784875|1012898|P1|COMPLETED|Period D||86
424957|NCT00784875|1012895|P4|STARTED|Period D||88
424958|NCT00784875|1012896|P3|STARTED|Period D||94
424959|NCT00784875|1012897|P2|STARTED|Period D||89
424960|NCT00784875|1012898|P1|STARTED|Period D||91
424961|NCT00784875|1012895|P4|NOT COMPLETED|Period C||7
424962|NCT00784875|1012896|P3|NOT COMPLETED|Period C||13
424963|NCT00784875|1012897|P2|NOT COMPLETED|Period C||6
424964|NCT00784875|1012898|P1|NOT COMPLETED|Period C||7
424965|NCT00784875|1012895|P4|COMPLETED|Period C||91
424966|NCT00784875|1012896|P3|COMPLETED|Period C||84
424967|NCT00784875|1012897|P2|COMPLETED|Period C||91
424968|NCT00784875|1012898|P1|COMPLETED|Period C||96
424969|NCT00784875|1012895|P4|STARTED|Period C||98
424970|NCT00784875|1012896|P3|STARTED|Period C||97
424971|NCT00784875|1012897|P2|STARTED|Period C||97
424972|NCT00784875|1012898|P1|STARTED|Period C||103
424973|NCT00784875|1012895|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
424974|NCT00784875|1012896|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
424975|NCT00784875|1012897|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
424976|NCT00784875|1012898|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
424977|NCT00784875|1012895|P4|COMPLETED|Period B - Efficacy Endpoint||98
424978|NCT00784875|1012896|P3|COMPLETED|Period B - Efficacy Endpoint||96
424979|NCT00784875|1012897|P2|COMPLETED|Period B - Efficacy Endpoint||101
424980|NCT00784875|1012898|P1|COMPLETED|Period B - Efficacy Endpoint||100
424981|NCT00784875|1012895|P4|Cohort 2|Period B - Efficacy Endpoint||101
424982|NCT00784875|1012896|P3|Cohort 2|Period B - Efficacy Endpoint||102
424983|NCT00784875|1012897|P2|Cohort 2|Period B - Efficacy Endpoint||102
424984|NCT00784875|1012898|P1|Cohort 2|Period B - Efficacy Endpoint||102
424985|NCT00784875|1012895|P4|STARTED|Period B - Efficacy Endpoint||117
424986|NCT00784875|1012896|P3|STARTED|Period B - Efficacy Endpoint||117
424987|NCT00784875|1012897|P2|STARTED|Period B - Efficacy Endpoint||113
424988|NCT00784875|1012898|P1|STARTED|Period B - Efficacy Endpoint||114
424989|NCT00784875|1012895|P4|NOT COMPLETED|Period A - Baseline||182
424990|NCT00784875|1012896|P3|NOT COMPLETED|Period A - Baseline||0
424991|NCT00784875|1012897|P2|NOT COMPLETED|Period A - Baseline||0
424992|NCT00784875|1012898|P1|NOT COMPLETED|Period A - Baseline||0
424993|NCT00784875|1012895|P4|COMPLETED|Period A - Baseline||461
424994|NCT00784875|1012896|P3|COMPLETED|Period A - Baseline||0
424995|NCT00784875|1012897|P2|COMPLETED|Period A - Baseline||0
424996|NCT00784875|1012898|P1|COMPLETED|Period A - Baseline||0
424997|NCT00784875|1012895|P4|STARTED|Period A - Baseline||643
424998|NCT00784875|1012896|P3|STARTED|Period A - Baseline||0
424999|NCT00784875|1012897|P2|STARTED|Period A - Baseline||0
425000|NCT00784875|1012898|P1|STARTED|Period A - Baseline||0
425001|NCT00784849|1013012|P1|NOT COMPLETED|Overall Study||0
425002|NCT00784849|1013012|P1|COMPLETED|Overall Study||62
425003|NCT00784849|1013012|P1|STARTED|Overall Study||62
425004|NCT00784836|1013018|P1|NOT COMPLETED|Overall Study||3
425005|NCT00784836|1013018|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
425006|NCT00784836|1013018|P1|STARTED|Overall Study||3
425007|NCT00784810|1013025|P2|NOT COMPLETED|Overall Study||49
425008|NCT00784810|1013026|P1|NOT COMPLETED|Overall Study||63
425009|NCT00784810|1013025|P2|COMPLETED|Overall Study||74
425010|NCT00784810|1013026|P1|COMPLETED|Overall Study||61
425011|NCT00784810|1013025|P2|STARTED|Overall Study||123
425012|NCT00784810|1013026|P1|STARTED|Overall Study||124
425013|NCT00784784|1013036|P2|NOT COMPLETED|Overall Study||2
425014|NCT00784784|1013037|P1|NOT COMPLETED|Overall Study||2
425015|NCT00784784|1013036|P2|COMPLETED|Overall Study||40
425016|NCT00784784|1013037|P1|COMPLETED|Overall Study||20
425017|NCT00784784|1013036|P2|STARTED|Overall Study||42
425018|NCT00784784|1013037|P1|STARTED|Overall Study||22
425019|NCT00784719|1013052|P7|NOT COMPLETED|Overall Study||5
425020|NCT00784719|1013053|P6|NOT COMPLETED|Overall Study||3
425021|NCT00784719|1013054|P5|NOT COMPLETED|Overall Study||6
425022|NCT00784719|1013055|P4|NOT COMPLETED|Overall Study||0
425023|NCT00784719|1013056|P3|NOT COMPLETED|Overall Study||1
425024|NCT00784719|1013057|P2|NOT COMPLETED|Overall Study||3
425025|NCT00784719|1013058|P1|NOT COMPLETED|Overall Study||3
425026|NCT00784719|1013052|P7|COMPLETED|Overall Study||42
425027|NCT00784719|1013053|P6|COMPLETED|Overall Study||41
425028|NCT00784719|1013054|P5|COMPLETED|Overall Study||42
425029|NCT00784719|1013055|P4|COMPLETED|Overall Study||48
425030|NCT00784719|1013056|P3|COMPLETED|Overall Study||46
425031|NCT00784719|1013057|P2|COMPLETED|Overall Study||43
425032|NCT00784719|1013058|P1|COMPLETED|Overall Study||44
425033|NCT00784719|1013052|P7|STARTED|Overall Study||47
425034|NCT00784719|1013053|P6|STARTED|Overall Study||44
425035|NCT00784719|1013054|P5|STARTED|Overall Study||48
425036|NCT00784719|1013055|P4|STARTED|Overall Study||48
425037|NCT00784719|1013056|P3|STARTED|Overall Study||47
425038|NCT00784719|1013057|P2|STARTED|Overall Study||46
425039|NCT00784719|1013058|P1|STARTED|Overall Study||47
425040|NCT00784654|1013228|P3|NOT COMPLETED|Randomized Withdrawal Period||63
425041|NCT00784654|1013229|P2|NOT COMPLETED|Randomized Withdrawal Period||18
425042|NCT00784654|1013230|P1|NOT COMPLETED|Randomized Withdrawal Period||0
425043|NCT00784654|1013228|P3|COMPLETED|Randomized Withdrawal Period||16
425044|NCT00784654|1013229|P2|COMPLETED|Randomized Withdrawal Period||60
425045|NCT00784654|1013230|P1|COMPLETED|Randomized Withdrawal Period||0
425046|NCT00784654|1013228|P3|STARTED|Randomized Withdrawal Period||79
425047|NCT00784654|1013229|P2|STARTED|Randomized Withdrawal Period||78
425048|NCT00784654|1013230|P1|STARTED|Randomized Withdrawal Period||0
425049|NCT00784654|1013228|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
425050|NCT00784654|1013229|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
425051|NCT00784654|1013230|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
425052|NCT00784654|1013228|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
425053|NCT00784654|1013229|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
425054|NCT00784654|1013230|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
425055|NCT00784654|1013228|P3|STARTED|Open-Label Period (Non-Randomized)||0
425056|NCT00784654|1013229|P2|STARTED|Open-Label Period (Non-Randomized)||0
425057|NCT00784654|1013230|P1|STARTED|Open-Label Period (Non-Randomized)||276
425058|NCT00784563|1013265|P3|NOT COMPLETED|Year 3||3
425059|NCT00784563|1013266|P2|NOT COMPLETED|Year 3||0
425060|NCT00784563|1013267|P1|NOT COMPLETED|Year 3||0
425061|NCT00784563|1013265|P3|COMPLETED|Year 3||14
425062|NCT00784563|1013266|P2|COMPLETED|Year 3||0
425063|NCT00784563|1013267|P1|COMPLETED|Year 3||0
425064|NCT00784563|1013265|P3|STARTED|Year 3||17
425065|NCT00784563|1013266|P2|STARTED|Year 3||0
425066|NCT00784563|1013267|P1|STARTED|Year 3||0
425067|NCT00784563|1013265|P3|NOT COMPLETED|Years 1 & 2||0
425068|NCT00784563|1013266|P2|NOT COMPLETED|Years 1 & 2||5
425069|NCT00784563|1013267|P1|NOT COMPLETED|Years 1 & 2||3
425070|NCT00784563|1013265|P3|COMPLETED|Years 1 & 2||0
425071|NCT00784563|1013266|P2|COMPLETED|Years 1 & 2||17
425072|NCT00784563|1013267|P1|COMPLETED|Years 1 & 2||18
425073|NCT00784563|1013265|P3|STARTED|Years 1 & 2||0
425074|NCT00784563|1013266|P2|STARTED|Years 1 & 2||22
425075|NCT00784563|1013267|P1|STARTED|Years 1 & 2||21
425076|NCT00784550|1013285|P2|NOT COMPLETED|Overall Study||42
425077|NCT00784550|1013286|P1|NOT COMPLETED|Overall Study||36
425078|NCT00784550|1013285|P2|COMPLETED|Overall Study||127
425079|NCT00784550|1013286|P1|COMPLETED|Overall Study||137
425080|NCT00784550|1013285|P2|STARTED|Overall Study||169
425081|NCT00784550|1013286|P1|STARTED|Overall Study||173
425082|NCT00784459|1013304|P2|NOT COMPLETED|Overall Study||2
425083|NCT00784459|1013305|P1|NOT COMPLETED|Overall Study||0
425084|NCT00784459|1013304|P2|COMPLETED|Overall Study||11
425085|NCT00784459|1013305|P1|COMPLETED|Overall Study||11
425086|NCT00784459|1013304|P2|STARTED|Overall Study||13
425087|NCT00784459|1013305|P1|STARTED|Overall Study||11
425088|NCT00784368|1013316|P3|NOT COMPLETED|Overall Study||11
425089|NCT00784368|1013317|P2|NOT COMPLETED|Overall Study||11
425090|NCT00784368|1013318|P1|NOT COMPLETED|Overall Study||8
425091|NCT00784368|1013316|P3|COMPLETED|Overall Study||12
425092|NCT00784368|1013317|P2|COMPLETED|Overall Study||5
425093|NCT00784368|1013318|P1|COMPLETED|Overall Study||8
425094|NCT00784368|1013316|P3|STARTED|Overall Study||23
425095|NCT00784368|1013317|P2|STARTED|Overall Study||16
425096|NCT00784368|1013318|P1|STARTED|Overall Study||16
425097|NCT00784277|1013356|P7|NOT COMPLETED|ER Treatment||15
425098|NCT00784277|1013357|P6|NOT COMPLETED|ER Treatment||24
425099|NCT00784277|1013358|P5|NOT COMPLETED|ER Treatment||9
425100|NCT00784277|1013359|P4|NOT COMPLETED|ER Treatment||0
425101|NCT00784277|1013360|P3|NOT COMPLETED|ER Treatment||0
425102|NCT00784277|1013361|P2|NOT COMPLETED|ER Treatment||0
425103|NCT00784277|1013362|P1|NOT COMPLETED|ER Treatment||0
425104|NCT00784277|1013356|P7|COMPLETED|ER Treatment||76
425105|NCT00784277|1013357|P6|COMPLETED|ER Treatment||226
425106|NCT00784277|1013358|P5|COMPLETED|ER Treatment||113
425107|NCT00784277|1013359|P4|COMPLETED|ER Treatment||0
425108|NCT00784277|1013360|P3|COMPLETED|ER Treatment||0
425109|NCT00784277|1013361|P2|COMPLETED|ER Treatment||0
425110|NCT00784277|1013362|P1|COMPLETED|ER Treatment||0
425111|NCT00784277|1013356|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
425112|NCT00784277|1013357|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
425113|NCT00784277|1013358|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
425114|NCT00784277|1013359|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
425115|NCT00784277|1013360|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
425116|NCT00784277|1013361|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
425117|NCT00784277|1013362|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
425118|NCT00784277|1013356|P7|NOT COMPLETED|IR Treatment||0
425119|NCT00784277|1013357|P6|NOT COMPLETED|IR Treatment||0
425120|NCT00784277|1013358|P5|NOT COMPLETED|IR Treatment||0
425121|NCT00784277|1013359|P4|NOT COMPLETED|IR Treatment||43
425122|NCT00784277|1013360|P3|NOT COMPLETED|IR Treatment||28
425123|NCT00784277|1013361|P2|NOT COMPLETED|IR Treatment||17
425124|NCT00784277|1013362|P1|NOT COMPLETED|IR Treatment||16
425125|NCT00784277|1013356|P7|COMPLETED|IR Treatment||0
425126|NCT00784277|1013357|P6|COMPLETED|IR Treatment||0
425127|NCT00784277|1013358|P5|COMPLETED|IR Treatment||0
425128|NCT00784277|1013359|P4|COMPLETED|IR Treatment||100
425129|NCT00784277|1013360|P3|COMPLETED|IR Treatment||126
425130|NCT00784277|1013361|P2|COMPLETED|IR Treatment||134
425131|NCT00784277|1013362|P1|COMPLETED|IR Treatment||132
425132|NCT00784277|1013356|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
425133|NCT00784277|1013357|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
425134|NCT00784277|1013358|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
425135|NCT00784277|1013359|P4|STARTED|IR Treatment||143
425136|NCT00784277|1013360|P3|STARTED|IR Treatment||154
425137|NCT00784277|1013361|P2|STARTED|IR Treatment||151
425138|NCT00784277|1013362|P1|STARTED|IR Treatment||148
425139|NCT00784238|1013379|P1|NOT COMPLETED|Overall Study||119
425140|NCT00784238|1013379|P1|COMPLETED|Overall Study||170
425141|NCT00784238|1013379|P1|STARTED|Overall Study||289
425142|NCT00784147|1013422|P2|NOT COMPLETED|Overall Study||9
425143|NCT00784147|1013423|P1|NOT COMPLETED|Overall Study||8
425144|NCT00784147|1013422|P2|COMPLETED|Overall Study||45
425145|NCT00784147|1013423|P1|COMPLETED|Overall Study||51
425146|NCT00784147|1013422|P2|STARTED|Overall Study||54
425147|NCT00784147|1013423|P1|STARTED|Overall Study||59
425148|NCT00784095|1013444|P3|NOT COMPLETED|Overall Study||1
425149|NCT00784095|1013445|P2|NOT COMPLETED|Overall Study||1
425150|NCT00784095|1013446|P1|NOT COMPLETED|Overall Study||0
425151|NCT00784095|1013444|P3|COMPLETED|Overall Study||11
425152|NCT00784095|1013445|P2|COMPLETED|Overall Study||11
425153|NCT00784095|1013446|P1|COMPLETED|Overall Study||12
425154|NCT00784095|1013444|P3|STARTED|Overall Study||12
425155|NCT00784095|1013445|P2|STARTED|Overall Study||12
425156|NCT00784095|1013446|P1|STARTED|Overall Study||12
425157|NCT00784030|1013468|P2|NOT COMPLETED|Overall Study||0
425158|NCT00784030|1013469|P1|NOT COMPLETED|Overall Study||0
425159|NCT00784030|1013468|P2|COMPLETED|Overall Study||10
425160|NCT00784030|1013469|P1|COMPLETED|Overall Study||13
425161|NCT00784030|1013468|P2|STARTED|Overall Study||10
425162|NCT00784030|1013469|P1|STARTED|Overall Study||13
425163|NCT00783965|1013477|P2|NOT COMPLETED|Second Intervention (24 Months)||9
425164|NCT00783965|1013478|P1|NOT COMPLETED|Second Intervention (24 Months)||0
425165|NCT00783965|1013477|P2|COMPLETED|Second Intervention (24 Months)||16
425166|NCT00783965|1013478|P1|COMPLETED|Second Intervention (24 Months)||2
425167|NCT00783965|1013477|P2|STARTED|Second Intervention (24 Months)||25
425168|NCT00783965|1013478|P1|STARTED|Second Intervention (24 Months)||2
425169|NCT00783965|1013477|P2|NOT COMPLETED|First Intervention (12 Months)||4
425170|NCT00783965|1013478|P1|NOT COMPLETED|First Intervention (12 Months)||3
425171|NCT00783965|1013477|P2|COMPLETED|First Intervention (12 Months)||25
425172|NCT00783965|1013478|P1|COMPLETED|First Intervention (12 Months)||2
425173|NCT00783965|1013477|P2|STARTED|First Intervention (12 Months)||29
425174|NCT00783965|1013478|P1|STARTED|First Intervention (12 Months)||5
425175|NCT00783952|1013486|P1|NOT COMPLETED|Overall Study||0
425176|NCT00783952|1013486|P1|COMPLETED|Overall Study||8
425177|NCT00783952|1013486|P1|STARTED|Overall Study||8
425178|NCT00783835|1013491|P1|NOT COMPLETED|Overall Study||10
425179|NCT00783835|1013491|P1|COMPLETED|Overall Study||50
425180|NCT00783835|1013491|P1|STARTED|Overall Study||60
425181|NCT00783796|1013503|P1|NOT COMPLETED|Overall Study||6
425182|NCT00783796|1013503|P1|COMPLETED|Overall Study||144
425183|NCT00783796|1013503|P1|STARTED|Overall Study||150
425184|NCT00783718|1013608|P7|NOT COMPLETED|Maintenance Phase||195
425185|NCT00783718|1013609|P6|NOT COMPLETED|Maintenance Phase||41
425186|NCT00783718|1013610|P5|NOT COMPLETED|Maintenance Phase||45
425187|NCT00783718|1013611|P4|NOT COMPLETED|Maintenance Phase||78
425188|NCT00783718|1013612|P3|NOT COMPLETED|Maintenance Phase||0
425189|NCT00783718|1013613|P2|NOT COMPLETED|Maintenance Phase||0
425190|NCT00783718|1013614|P1|NOT COMPLETED|Maintenance Phase||105
425191|NCT00783718|1013608|P7|COMPLETED|Maintenance Phase||135
425192|NCT00783718|1013609|P6|COMPLETED|Maintenance Phase||84
425193|NCT00783718|1013610|P5|COMPLETED|Maintenance Phase||77
425194|NCT00783718|1013611|P4|COMPLETED|Maintenance Phase||48
425195|NCT00783718|1013612|P3|COMPLETED|Maintenance Phase||0
425196|NCT00783718|1013613|P2|COMPLETED|Maintenance Phase||0
425197|NCT00783718|1013614|P1|COMPLETED|Maintenance Phase||30
425198|NCT00783718|1013608|P7|STARTED|Maintenance Phase||330
425199|NCT00783718|1013609|P6|STARTED|Maintenance Phase||125
425200|NCT00783718|1013610|P5|STARTED|Maintenance Phase||122
425201|NCT00783718|1013611|P4|STARTED|Maintenance Phase||126
425202|NCT00783718|1013612|P3|STARTED|Maintenance Phase||0
425203|NCT00783718|1013613|P2|STARTED|Maintenance Phase||0
425204|NCT00783718|1013614|P1|STARTED|Maintenance Phase||135
425205|NCT00783718|1013608|P7|NOT COMPLETED|Induction Phase||0
425206|NCT00783718|1013609|P6|NOT COMPLETED|Induction Phase||0
425207|NCT00783718|1013610|P5|NOT COMPLETED|Induction Phase||0
425208|NCT00783718|1013611|P4|NOT COMPLETED|Induction Phase||0
425209|NCT00783718|1013612|P3|NOT COMPLETED|Induction Phase||36
425210|NCT00783718|1013613|P2|NOT COMPLETED|Induction Phase||7
425211|NCT00783718|1013614|P1|NOT COMPLETED|Induction Phase||14
425212|NCT00783718|1013608|P7|COMPLETED|Induction Phase||0
425213|NCT00783718|1013609|P6|COMPLETED|Induction Phase||0
425214|NCT00783718|1013610|P5|COMPLETED|Induction Phase||0
425215|NCT00783718|1013611|P4|COMPLETED|Induction Phase||0
425216|NCT00783718|1013612|P3|COMPLETED|Induction Phase||485
425217|NCT00783718|1013613|P2|COMPLETED|Induction Phase||218
425218|NCT00783718|1013614|P1|COMPLETED|Induction Phase||135
425219|NCT00783718|1013608|P7|STARTED|Induction Phase||0
425220|NCT00783718|1013609|P6|STARTED|Induction Phase||0
425221|NCT00783718|1013610|P5|STARTED|Induction Phase||0
425222|NCT00783718|1013611|P4|STARTED|Induction Phase||0
425223|NCT00783718|1013612|P3|STARTED|Induction Phase||521
425224|NCT00783718|1013613|P2|STARTED|Induction Phase||225
425225|NCT00783718|1013614|P1|STARTED|Induction Phase||149
425226|NCT00783705|1013642|P2|NOT COMPLETED|Overall Study||5
425227|NCT00783705|1013643|P1|NOT COMPLETED|Overall Study||6
425228|NCT00783705|1013642|P2|COMPLETED|Overall Study||36
425229|NCT00783705|1013643|P1|COMPLETED|Overall Study||38
425230|NCT00783705|1013642|P2|STARTED|Overall Study||41
425231|NCT00783705|1013643|P1|STARTED|Overall Study||44
425232|NCT00783692|1013688|P7|NOT COMPLETED|Maintenance Phase||249
425233|NCT00783692|1013689|P6|NOT COMPLETED|Maintenance Phase||72
425234|NCT00783692|1013690|P5|NOT COMPLETED|Maintenance Phase||81
425235|NCT00783692|1013691|P4|NOT COMPLETED|Maintenance Phase||89
425236|NCT00783692|1013692|P3|NOT COMPLETED|Maintenance Phase||0
425237|NCT00783692|1013693|P2|NOT COMPLETED|Maintenance Phase||0
425238|NCT00783692|1013694|P1|NOT COMPLETED|Maintenance Phase||95
425239|NCT00783692|1013688|P7|COMPLETED|Maintenance Phase||163
425240|NCT00783692|1013689|P6|COMPLETED|Maintenance Phase||82
425241|NCT00783692|1013690|P5|COMPLETED|Maintenance Phase||73
425242|NCT00783692|1013691|P4|COMPLETED|Maintenance Phase||64
425243|NCT00783692|1013692|P3|COMPLETED|Maintenance Phase||0
425244|NCT00783692|1013693|P2|COMPLETED|Maintenance Phase||0
425245|NCT00783692|1013694|P1|COMPLETED|Maintenance Phase||42
425246|NCT00783692|1013688|P7|STARTED|Maintenance Phase||412
425247|NCT00783692|1013689|P6|STARTED|Maintenance Phase||154
425248|NCT00783692|1013690|P5|STARTED|Maintenance Phase||154
425249|NCT00783692|1013691|P4|STARTED|Maintenance Phase||153
425250|NCT00783692|1013692|P3|STARTED|Maintenance Phase||0
425251|NCT00783692|1013693|P2|STARTED|Maintenance Phase||0
425252|NCT00783692|1013694|P1|STARTED|Maintenance Phase||137
425253|NCT00783692|1013688|P7|NOT COMPLETED|Induction Phase||0
425254|NCT00783692|1013689|P6|NOT COMPLETED|Induction Phase||0
425255|NCT00783692|1013690|P5|NOT COMPLETED|Induction Phase||0
425256|NCT00783692|1013691|P4|NOT COMPLETED|Induction Phase||0
425257|NCT00783692|1013692|P3|NOT COMPLETED|Induction Phase||74
425258|NCT00783692|1013693|P2|NOT COMPLETED|Induction Phase||21
425259|NCT00783692|1013694|P1|NOT COMPLETED|Induction Phase||11
425260|NCT00783692|1013688|P7|COMPLETED|Induction Phase||0
425261|NCT00783692|1013689|P6|COMPLETED|Induction Phase||0
425262|NCT00783692|1013690|P5|COMPLETED|Induction Phase||0
425263|NCT00783692|1013691|P4|COMPLETED|Induction Phase||0
425264|NCT00783692|1013692|P3|COMPLETED|Induction Phase||674
425265|NCT00783692|1013693|P2|COMPLETED|Induction Phase||199
425266|NCT00783692|1013694|P1|COMPLETED|Induction Phase||137
425267|NCT00783692|1013688|P7|Treated|Induction Phase||0
425268|NCT00783692|1013689|P6|Treated|Induction Phase||0
425269|NCT00783692|1013690|P5|Treated|Induction Phase||0
425270|NCT00783692|1013691|P4|Treated|Induction Phase||0
425271|NCT00783692|1013692|P3|Treated|Induction Phase||747
425272|NCT00783692|1013693|P2|Treated|Induction Phase||220
425273|NCT00783692|1013694|P1|Treated|Induction Phase||148
425274|NCT00783692|1013688|P7|STARTED|Induction Phase||0
425275|NCT00783692|1013689|P6|STARTED|Induction Phase||0
425276|NCT00783692|1013690|P5|STARTED|Induction Phase||0
425277|NCT00783692|1013691|P4|STARTED|Induction Phase||0
425278|NCT00783692|1013692|P3|STARTED|Induction Phase||748
425279|NCT00783692|1013693|P2|STARTED|Induction Phase||220
425280|NCT00783692|1013694|P1|STARTED|Induction Phase||148
425281|NCT00783614|1013721|P4|NOT COMPLETED|Overall Study||0
425282|NCT00783614|1013722|P3|NOT COMPLETED|Overall Study||0
425283|NCT00783614|1013723|P2|NOT COMPLETED|Overall Study||0
425284|NCT00783614|1013724|P1|NOT COMPLETED|Overall Study||0
425285|NCT00783614|1013721|P4|COMPLETED|Overall Study||5
425286|NCT00783614|1013722|P3|COMPLETED|Overall Study||5
425287|NCT00783614|1013723|P2|COMPLETED|Overall Study||6
425288|NCT00783614|1013724|P1|COMPLETED|Overall Study||6
425289|NCT00783614|1013721|P4|STARTED|Overall Study||5
425290|NCT00783614|1013722|P3|STARTED|Overall Study||5
425291|NCT00783614|1013723|P2|STARTED|Overall Study||6
425292|NCT00783614|1013724|P1|STARTED|Overall Study||6
425293|NCT00783432|1013736|P2|NOT COMPLETED|Overall Study||78
425294|NCT00783432|1013737|P1|NOT COMPLETED|Overall Study||85
425295|NCT00783432|1013736|P2|COMPLETED|Overall Study||354
425296|NCT00783432|1013737|P1|COMPLETED|Overall Study||345
425297|NCT00783432|1013736|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
425298|NCT00783432|1013737|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
425299|NCT00783302|1013747|P1|NOT COMPLETED|Overall Study||35
425300|NCT00783302|1013747|P1|COMPLETED|Overall Study||850
425301|NCT00783302|1013747|P1|STARTED|Overall Study||885
425302|NCT00783263|1013769|P4|NOT COMPLETED|Overall Study||3
425303|NCT00783263|1013770|P3|NOT COMPLETED|Overall Study||3
425304|NCT00783263|1013771|P2|NOT COMPLETED|Overall Study||2
425305|NCT00783263|1013772|P1|NOT COMPLETED|Overall Study||4
425306|NCT00783263|1013769|P4|COMPLETED|Overall Study||118
425307|NCT00783263|1013770|P3|COMPLETED|Overall Study||119
425308|NCT00783263|1013771|P2|COMPLETED|Overall Study||96
425309|NCT00783263|1013772|P1|COMPLETED|Overall Study||95
425310|NCT00783263|1013769|P4|STARTED|Overall Study||121
425311|NCT00783263|1013770|P3|STARTED|Overall Study||122
425312|NCT00783263|1013771|P2|STARTED|Overall Study||98
425313|NCT00783263|1013772|P1|STARTED|Overall Study||99
425314|NCT00783224|1013802|P4|NOT COMPLETED|Overall Study||2
425315|NCT00783224|1013803|P3|NOT COMPLETED|Overall Study||1
425316|NCT00783224|1013804|P2|NOT COMPLETED|Overall Study||0
425317|NCT00783224|1013805|P1|NOT COMPLETED|Overall Study||0
425318|NCT00783224|1013802|P4|COMPLETED|Overall Study||140
425319|NCT00783224|1013803|P3|COMPLETED|Overall Study||142
425320|NCT00783224|1013804|P2|COMPLETED|Overall Study||34
425321|NCT00783224|1013805|P1|COMPLETED|Overall Study||32
425322|NCT00783224|1013802|P4|STARTED|Overall Study||142
425323|NCT00783224|1013803|P3|STARTED|Overall Study||143
425324|NCT00783224|1013804|P2|STARTED|Overall Study||34
425325|NCT00783224|1013805|P1|STARTED|Overall Study||32
425326|NCT00783198|1013817|P3|NOT COMPLETED|Overall Study||42
425327|NCT00783198|1013818|P2|NOT COMPLETED|Overall Study||43
425328|NCT00783198|1013819|P1|NOT COMPLETED|Overall Study||57
425329|NCT00783198|1013817|P3|COMPLETED|Overall Study||146
425330|NCT00783198|1013818|P2|COMPLETED|Overall Study||144
425331|NCT00783198|1013819|P1|COMPLETED|Overall Study||133
425332|NCT00783198|1013817|P3|STARTED|Overall Study||188
425333|NCT00783198|1013818|P2|STARTED|Overall Study||187
425334|NCT00783198|1013819|P1|STARTED|Overall Study||190
425335|NCT00783094|1013842|P3|NOT COMPLETED|Open-Label Extension Period||30
425336|NCT00783094|1013843|P2|NOT COMPLETED|Open-Label Extension Period||19
425337|NCT00783094|1013844|P1|NOT COMPLETED|Open-Label Extension Period||22
425338|NCT00783094|1013842|P3|COMPLETED|Open-Label Extension Period||101
425339|NCT00783094|1013843|P2|COMPLETED|Open-Label Extension Period||109
425340|NCT00783094|1013844|P1|COMPLETED|Open-Label Extension Period||113
425341|NCT00783094|1013842|P3|STARTED|Open-Label Extension Period||131
425342|NCT00783094|1013843|P2|STARTED|Open-Label Extension Period||128
425343|NCT00783094|1013844|P1|STARTED|Open-Label Extension Period||135
425344|NCT00783094|1013842|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
425345|NCT00783094|1013843|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
425346|NCT00783094|1013844|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
425347|NCT00783094|1013842|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
425348|NCT00783094|1013843|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
425349|NCT00783094|1013844|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
425350|NCT00783094|1013842|P3|STARTED|Randomized Double-Blind Treatment Period||140
425351|NCT00783094|1013843|P2|STARTED|Randomized Double-Blind Treatment Period||140
425352|NCT00783094|1013844|P1|STARTED|Randomized Double-Blind Treatment Period||142
425353|NCT00782834|1013920|P1|NOT COMPLETED|Treatment Phase||1
425354|NCT00782834|1013920|P1|COMPLETED|Treatment Phase||13
425355|NCT00782834|1013920|P1|STARTED|Treatment Phase||14
425356|NCT00782834|1013920|P1|NOT COMPLETED|Screened Patients||1
425357|NCT00782834|1013920|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
425358|NCT00782834|1013920|P1|STARTED|Screened Patients||15
425359|NCT00782821|1013929|P4|NOT COMPLETED|Overall Study||2
425360|NCT00782821|1013930|P3|NOT COMPLETED|Overall Study||1
425361|NCT00782821|1013931|P2|NOT COMPLETED|Overall Study||0
425362|NCT00782821|1013932|P1|NOT COMPLETED|Overall Study||0
425363|NCT00782821|1013929|P4|COMPLETED|Overall Study||8
425364|NCT00782821|1013930|P3|COMPLETED|Overall Study||9
425365|NCT00782821|1013931|P2|COMPLETED|Overall Study||10
425366|NCT00782821|1013932|P1|COMPLETED|Overall Study||10
425367|NCT00782821|1013929|P4|STARTED|Overall Study||10
425368|NCT00782821|1013930|P3|STARTED|Overall Study||10
425369|NCT00782821|1013931|P2|STARTED|Overall Study||10
425370|NCT00782821|1013932|P1|STARTED|Overall Study||10
425371|NCT00782717|1013960|P2|NOT COMPLETED|Overall Study||28
425372|NCT00782717|1013961|P1|NOT COMPLETED|Overall Study||15
425373|NCT00782717|1013960|P2|COMPLETED|Overall Study||102
425374|NCT00782717|1013961|P1|COMPLETED|Overall Study||118
425375|NCT00782717|1013960|P2|STARTED|Overall Study||130
425376|NCT00782717|1013961|P1|STARTED|Overall Study||133
425377|NCT00782639|1013971|P2|NOT COMPLETED|Overall Study||0
425378|NCT00782639|1013972|P1|NOT COMPLETED|Overall Study||0
425379|NCT00782639|1013971|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
425380|NCT00782639|1013972|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
425381|NCT00782639|1013971|P2|STARTED|Overall Study||11
425382|NCT00782639|1013972|P1|STARTED|Overall Study||12
425383|NCT00782626|1013988|P1|NOT COMPLETED|Overall Study||7
425384|NCT00782626|1013988|P1|COMPLETED|Overall Study||16
425385|NCT00782626|1013988|P1|STARTED|Overall Study||23
425386|NCT00782509|1013995|P3|NOT COMPLETED|Overall Study||36
425387|NCT00782509|1013996|P2|NOT COMPLETED|Overall Study||24
425388|NCT00782509|1013997|P1|NOT COMPLETED|Overall Study||41
425389|NCT00782509|1013995|P3|COMPLETED|Overall Study||181
425390|NCT00782509|1013996|P2|COMPLETED|Overall Study||185
425391|NCT00782509|1013997|P1|COMPLETED|Overall Study||175
425392|NCT00782509|1013995|P3|STARTED|Overall Study||217
425393|NCT00782509|1013996|P2|STARTED|Overall Study||209
425394|NCT00782509|1013997|P1|STARTED|Overall Study||216
425395|NCT00782496|1014190|P2|NOT COMPLETED|Overall Study||15
425396|NCT00782496|1014191|P1|NOT COMPLETED|Overall Study||14
425397|NCT00782496|1014190|P2|COMPLETED|Overall Study||90
425398|NCT00782496|1014191|P1|COMPLETED|Overall Study||92
425399|NCT00782496|1014190|P2|STARTED|Overall Study||105
425400|NCT00782496|1014191|P1|STARTED|Overall Study||106
425401|NCT00782483|1014198|P1|NOT COMPLETED|Overall Study||6
425402|NCT00782483|1014198|P1|COMPLETED|Overall Study||0
425403|NCT00782483|1014198|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
425404|NCT00782418|1014202|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425405|NCT00782418|1014203|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425406|NCT00782418|1014204|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425407|NCT00782418|1014205|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425408|NCT00782418|1014206|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425409|NCT00782418|1014207|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425410|NCT00782418|1014208|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
425411|NCT00782418|1014202|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
425412|NCT00782418|1014203|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
425413|NCT00782418|1014204|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
425414|NCT00782418|1014205|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
425415|NCT00782418|1014206|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
425416|NCT00782418|1014207|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
425417|NCT00782418|1014208|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
425418|NCT00782418|1014202|P7|STARTED|Period 2 Procedure/Treatment Groups||4
425419|NCT00782418|1014203|P6|STARTED|Period 2 Procedure/Treatment Groups||4
425420|NCT00782418|1014204|P5|STARTED|Period 2 Procedure/Treatment Groups||3
425421|NCT00782418|1014205|P4|STARTED|Period 2 Procedure/Treatment Groups||1
425422|NCT00782418|1014206|P3|STARTED|Period 2 Procedure/Treatment Groups||4
425423|NCT00782418|1014207|P2|STARTED|Period 2 Procedure/Treatment Groups||4
425424|NCT00782418|1014208|P1|STARTED|Period 2 Procedure/Treatment Groups||3
425425|NCT00782418|1014202|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
425426|NCT00782418|1014203|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
425427|NCT00782418|1014204|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
425428|NCT00782418|1014205|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
425429|NCT00782418|1014206|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
425430|NCT00782418|1014207|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
425431|NCT00782418|1014208|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
425432|NCT00782418|1014202|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
425433|NCT00782418|1014203|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
425434|NCT00782418|1014204|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
425435|NCT00782418|1014205|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
425436|NCT00782418|1014206|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
425437|NCT00782418|1014207|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
425438|NCT00782418|1014208|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
425439|NCT00782418|1014202|P7|STARTED|Period 1 Procedure/Treatment Groups||4
425440|NCT00782418|1014203|P6|STARTED|Period 1 Procedure/Treatment Groups||5
425441|NCT00782418|1014204|P5|STARTED|Period 1 Procedure/Treatment Groups||5
425442|NCT00782418|1014205|P4|STARTED|Period 1 Procedure/Treatment Groups||2
425443|NCT00782418|1014206|P3|STARTED|Period 1 Procedure/Treatment Groups||4
425444|NCT00782418|1014207|P2|STARTED|Period 1 Procedure/Treatment Groups||4
425445|NCT00782418|1014208|P1|STARTED|Period 1 Procedure/Treatment Groups||3
425446|NCT00782379|1014228|P1|NOT COMPLETED|Overall Study||0
425447|NCT00782379|1014228|P1|COMPLETED|Overall Study||20
425448|NCT00782379|1014228|P1|STARTED|Overall Study||20
425449|NCT00782340|1014245|P3|NOT COMPLETED|Randomized Double Blind||0
425450|NCT00782340|1014246|P2|NOT COMPLETED|Randomized Double Blind||0
425451|NCT00782340|1014247|P1|NOT COMPLETED|Randomized Double Blind||0
425452|NCT00782340|1014245|P3|COMPLETED|Randomized Double Blind||80
425453|NCT00782340|1014246|P2|COMPLETED|Randomized Double Blind||82
425454|NCT00782340|1014247|P1|COMPLETED|Randomized Double Blind||0
425455|NCT00782340|1014245|P3|STARTED|Randomized Double Blind||80
425456|NCT00782340|1014246|P2|STARTED|Randomized Double Blind||82
425457|NCT00782340|1014247|P1|STARTED|Randomized Double Blind||0
425458|NCT00782340|1014245|P3|NOT COMPLETED|Open Label Titration||0
425459|NCT00782340|1014246|P2|NOT COMPLETED|Open Label Titration||0
425460|NCT00782340|1014247|P1|NOT COMPLETED|Open Label Titration||101
425461|NCT00782340|1014245|P3|COMPLETED|Open Label Titration||0
425462|NCT00782340|1014246|P2|COMPLETED|Open Label Titration||0
425463|NCT00782340|1014247|P1|COMPLETED|Open Label Titration||162
425464|NCT00782340|1014245|P3|STARTED|Open Label Titration||0
425465|NCT00782340|1014246|P2|STARTED|Open Label Titration||0
425466|NCT00782340|1014247|P1|STARTED|Open Label Titration||263
425467|NCT00782288|1014273|P3|NOT COMPLETED|Overall Study||0
425468|NCT00782288|1014274|P2|NOT COMPLETED|Overall Study||0
425469|NCT00782288|1014275|P1|NOT COMPLETED|Overall Study||0
425470|NCT00782288|1014273|P3|COMPLETED|Overall Study||8
425471|NCT00782288|1014274|P2|COMPLETED|Overall Study||8
425472|NCT00782288|1014275|P1|COMPLETED|Overall Study||8
425473|NCT00782288|1014273|P3|STARTED|Overall Study||8
425474|NCT00782288|1014274|P2|STARTED|Overall Study||8
425475|NCT00782288|1014275|P1|STARTED|Overall Study||8
425476|NCT00782210|1014320|P3|NOT COMPLETED|Overall Study||35
425477|NCT00782210|1014321|P2|NOT COMPLETED|Overall Study||35
425478|NCT00782210|1014322|P1|NOT COMPLETED|Overall Study||50
425479|NCT00782210|1014320|P3|COMPLETED|Overall Study||172
425480|NCT00782210|1014321|P2|COMPLETED|Overall Study||173
425481|NCT00782210|1014322|P1|COMPLETED|Overall Study||159
425482|NCT00782210|1014320|P3|STARTED|Overall Study||207
425483|NCT00782210|1014321|P2|STARTED|Overall Study||208
425484|NCT00782210|1014322|P1|STARTED|Overall Study||209
425485|NCT00782184|1014515|P2|NOT COMPLETED|Overall Study||5
425486|NCT00782184|1014516|P1|NOT COMPLETED|Overall Study||4
425487|NCT00782184|1014515|P2|COMPLETED|Overall Study||125
425488|NCT00782184|1014516|P1|COMPLETED|Overall Study||116
425489|NCT00782184|1014515|P2|STARTED|Overall Study||130
425490|NCT00782184|1014516|P1|STARTED|Overall Study||120
425491|NCT00782067|1014551|P1|NOT COMPLETED|Overall Study||95
425492|NCT00782067|1014551|P1|COMPLETED|Overall Study||21
425493|NCT00782067|1014551|P1|Primary Efficacy Population (PEP)|Overall Study||89
425494|NCT00782067|1014551|P1|Treatment Ongoing|Overall Study||21
425495|NCT00782067|1014551|P1|STARTED|Overall Study||116
425496|NCT00781963|1014561|P3|NOT COMPLETED|Overall Study||2
425497|NCT00781963|1014562|P2|NOT COMPLETED|Overall Study||9
425498|NCT00781963|1014563|P1|NOT COMPLETED|Overall Study||8
425499|NCT00781963|1014561|P3|COMPLETED|Overall Study||51
425500|NCT00781963|1014562|P2|COMPLETED|Overall Study||43
425501|NCT00781963|1014563|P1|COMPLETED|Overall Study||46
425502|NCT00781963|1014561|P3|6-month Follow-up|Overall Study||52
425503|NCT00781963|1014562|P2|6-month Follow-up|Overall Study||44
425504|NCT00781963|1014563|P1|6-month Follow-up|Overall Study||48
425505|NCT00781963|1014561|P3|Post-treatment|Overall Study||53
425506|NCT00781963|1014562|P2|Post-treatment|Overall Study||45
425507|NCT00781963|1014563|P1|Post-treatment|Overall Study||52
425508|NCT00781963|1014561|P3|STARTED|Overall Study||53
425509|NCT00781963|1014562|P2|STARTED|Overall Study||52
425510|NCT00781963|1014563|P1|STARTED|Overall Study||54
425511|NCT00781950|1014573|P2|NOT COMPLETED|Overall Study||13
425512|NCT00781950|1014574|P1|NOT COMPLETED|Overall Study||11
425513|NCT00781950|1014573|P2|COMPLETED|Overall Study||45
425514|NCT00781950|1014574|P1|COMPLETED|Overall Study||41
425515|NCT00781950|1014573|P2|STARTED|Overall Study||58
425516|NCT00781950|1014574|P1|STARTED|Overall Study||52
425517|NCT00781937|1014584|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
425518|NCT00781937|1014585|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
425519|NCT00781937|1014584|P2|COMPLETED|Follow up Period (Week 56-68)||141
425520|NCT00781937|1014585|P1|COMPLETED|Follow up Period (Week 56-68)||153
425521|NCT00781937|1014584|P2|STARTED|Follow up Period (Week 56-68)||146
425522|NCT00781937|1014585|P1|STARTED|Follow up Period (Week 56-68)||159
425523|NCT00781937|1014584|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
425524|NCT00781937|1014585|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
425525|NCT00781937|1014584|P2|COMPLETED|Main Trial Period Through Week 56||146
425526|NCT00781937|1014585|P1|COMPLETED|Main Trial Period Through Week 56||159
425527|NCT00781937|1014584|P2|STARTED|Main Trial Period Through Week 56||210
425528|NCT00781937|1014585|P1|STARTED|Main Trial Period Through Week 56||212
425529|NCT00781859|1014643|P2|NOT COMPLETED|Overall Study||9
425530|NCT00781859|1014644|P1|NOT COMPLETED|Overall Study||19
425531|NCT00781859|1014643|P2|COMPLETED|Overall Study||98
425532|NCT00781859|1014644|P1|COMPLETED|Overall Study||200
425533|NCT00781859|1014643|P2|STARTED|Overall Study||107
425534|NCT00781859|1014644|P1|STARTED|Overall Study||219
425535|NCT00781599|1014654|P2|NOT COMPLETED|Overall Study||4
425536|NCT00781599|1014655|P1|NOT COMPLETED|Overall Study||7
425537|NCT00781599|1014654|P2|COMPLETED|Overall Study||32
425538|NCT00781599|1014655|P1|COMPLETED|Overall Study||29
425539|NCT00781599|1014654|P2|STARTED|Overall Study||36
425540|NCT00781599|1014655|P1|STARTED|Overall Study||36
425541|NCT00781508|1014669|P2|NOT COMPLETED|Overall Study||0
425542|NCT00781508|1014670|P1|NOT COMPLETED|Overall Study||0
425543|NCT00781508|1014669|P2|COMPLETED|Overall Study||5
425544|NCT00781508|1014670|P1|COMPLETED|Overall Study||5
425545|NCT00781508|1014669|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
425546|NCT00781508|1014670|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
425547|NCT00781456|1014680|P2|NOT COMPLETED|Overall Study||16
425548|NCT00781456|1014681|P1|NOT COMPLETED|Overall Study||21
425549|NCT00781456|1014680|P2|COMPLETED|Overall Study||35
425550|NCT00781456|1014681|P1|COMPLETED|Overall Study||37
425551|NCT00781456|1014680|P2|Received Study Drug|Overall Study||49
425552|NCT00781456|1014681|P1|Received Study Drug|Overall Study||57
425553|NCT00781456|1014680|P2|STARTED|Overall Study||51
425554|NCT00781456|1014681|P1|STARTED|Overall Study||58
425555|NCT00781391|1014704|P3|NOT COMPLETED|Overall Study||784
425556|NCT00781391|1014705|P2|NOT COMPLETED|Overall Study||807
425557|NCT00781391|1014706|P1|NOT COMPLETED|Overall Study||879
425558|NCT00781391|1014704|P3|COMPLETED|Overall Study||6250
425559|NCT00781391|1014705|P2|COMPLETED|Overall Study||6228
425560|NCT00781391|1014706|P1|COMPLETED|Overall Study||6157
425561|NCT00781391|1014704|P3|Per Protocol Analysis Set|Overall Study||6982
425562|NCT00781391|1014705|P2|Per Protocol Analysis Set|Overall Study||6995
425563|NCT00781391|1014706|P1|Per Protocol Analysis Set|Overall Study||6993
425564|NCT00781391|1014704|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
425565|NCT00781391|1014705|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
425566|NCT00781391|1014706|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
425567|NCT00781391|1014704|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
425568|NCT00781391|1014705|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
425569|NCT00781391|1014706|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
425570|NCT00781391|1014704|P3|STARTED|Overall Study||7034
425571|NCT00781391|1014705|P2|STARTED|Overall Study||7035
425572|NCT00781391|1014706|P1|STARTED|Overall Study||7036
425573|NCT00781365|1014740|P2|NOT COMPLETED|Overall Study||36
425574|NCT00781365|1014741|P1|NOT COMPLETED|Overall Study||34
425575|NCT00781365|1014740|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
425576|NCT00781365|1014741|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
425577|NCT00781365|1014740|P2|STARTED|Overall Study||222
425578|NCT00781365|1014741|P1|STARTED|Overall Study||228
425579|NCT00781326|1014751|P1|NOT COMPLETED|Phase 2||0
425580|NCT00781326|1014751|P1|COMPLETED|Phase 2||0
425581|NCT00781326|1014751|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
425582|NCT00781326|1014751|P1|NOT COMPLETED|Phase I||4
425583|NCT00781326|1014751|P1|COMPLETED|Phase I||2
425584|NCT00781326|1014751|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
425585|NCT00781274|1014755|P1|NOT COMPLETED|Overall Study||2
425586|NCT00781274|1014755|P1|COMPLETED|Overall Study||30
425587|NCT00781274|1014755|P1|STARTED|Overall Study||32
425588|NCT00780416|1014761|P2|NOT COMPLETED|Overall Study||9
425589|NCT00780416|1014762|P1|NOT COMPLETED|Overall Study||12
425590|NCT00780416|1014761|P2|COMPLETED|Overall Study||54
425591|NCT00780416|1014762|P1|COMPLETED|Overall Study||114
425592|NCT00780416|1014761|P2|STARTED|Overall Study||63
425593|NCT00780416|1014762|P1|STARTED|Overall Study||126
425594|NCT00780403|1014768|P2|NOT COMPLETED|Second Intervention||0
425595|NCT00780403|1014769|P1|NOT COMPLETED|Second Intervention||0
425596|NCT00780403|1014768|P2|COMPLETED|Second Intervention||111
425597|NCT00780403|1014769|P1|COMPLETED|Second Intervention||109
425598|NCT00780403|1014768|P2|STARTED|Second Intervention||111
425599|NCT00780403|1014769|P1|STARTED|Second Intervention||109
425600|NCT00780403|1014768|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
425601|NCT00780403|1014769|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
425602|NCT00780403|1014768|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
425603|NCT00780403|1014769|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
425604|NCT00780403|1014768|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
425605|NCT00780403|1014769|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
425606|NCT00780403|1014768|P2|NOT COMPLETED|First Intervention||0
425607|NCT00780403|1014769|P1|NOT COMPLETED|First Intervention||0
425608|NCT00780403|1014768|P2|COMPLETED|First Intervention||111
425609|NCT00780403|1014769|P1|COMPLETED|First Intervention||109
425610|NCT00780403|1014768|P2|STARTED|First Intervention||111
425611|NCT00780403|1014769|P1|STARTED|First Intervention||109
425612|NCT00780338|1014778|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
425613|NCT00780338|1014779|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
425614|NCT00780338|1014778|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
425615|NCT00780338|1014779|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
425616|NCT00780338|1014778|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
425617|NCT00780338|1014779|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
425618|NCT00780338|1014778|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
425619|NCT00780338|1014779|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
425620|NCT00780338|1014778|P2|COMPLETED|Baseline to Mid (1 Year)||164
425621|NCT00780338|1014779|P1|COMPLETED|Baseline to Mid (1 Year)||169
425622|NCT00780338|1014778|P2|STARTED|Baseline to Mid (1 Year)||202
425623|NCT00780338|1014779|P1|STARTED|Baseline to Mid (1 Year)||174
425624|NCT00778375|1014807|P1|NOT COMPLETED|Overall Study||3
425625|NCT00778375|1014807|P1|COMPLETED|Overall Study||119
425626|NCT00778375|1014807|P1|STARTED|Overall Study||122
425627|NCT00781079|1014819|P2|NOT COMPLETED|Overall Study||17
425628|NCT00781079|1014820|P1|NOT COMPLETED|Overall Study||27
425629|NCT00781079|1014819|P2|COMPLETED|Overall Study||116
425630|NCT00781079|1014820|P1|COMPLETED|Overall Study||122
425631|NCT00781079|1014819|P2|STARTED|Overall Study||133
425632|NCT00781079|1014820|P1|STARTED|Overall Study||149
425633|NCT00780910|1014828|P1|NOT COMPLETED|Overall Study||2
425634|NCT00780910|1014828|P1|COMPLETED|Overall Study||107
425635|NCT00780910|1014828|P1|STARTED|Overall Study||109
425636|NCT00780741|1014834|P2|NOT COMPLETED|Overall Study||10
425637|NCT00780741|1014835|P1|NOT COMPLETED|Overall Study||7
425638|NCT00780741|1014834|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
425639|NCT00780741|1014835|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
425640|NCT00780741|1014834|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
425641|NCT00780741|1014835|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
425642|NCT00780741|1014834|P2|STARTED|Overall Study|randomized|81
425643|NCT00780741|1014835|P1|STARTED|Overall Study|randomized|82
425644|NCT00780676|1014852|P5|NOT COMPLETED|Overall Study||0
425645|NCT00780676|1014853|P4|NOT COMPLETED|Overall Study||0
425646|NCT00780676|1014854|P3|NOT COMPLETED|Overall Study||0
425647|NCT00780676|1014855|P2|NOT COMPLETED|Overall Study||0
425648|NCT00780676|1014856|P1|NOT COMPLETED|Overall Study||0
425649|NCT00780676|1014852|P5|COMPLETED|Overall Study||0
425650|NCT00780676|1014853|P4|COMPLETED|Overall Study||0
425651|NCT00780676|1014854|P3|COMPLETED|Overall Study||13
425652|NCT00780676|1014855|P2|COMPLETED|Overall Study||8
425653|NCT00780676|1014856|P1|COMPLETED|Overall Study||9
425654|NCT00780676|1014852|P5|STARTED|Overall Study||0
425655|NCT00780676|1014853|P4|STARTED|Overall Study||0
425656|NCT00780676|1014854|P3|STARTED|Overall Study||13
425657|NCT00780676|1014855|P2|STARTED|Overall Study||8
425658|NCT00780676|1014856|P1|STARTED|Overall Study||9
425659|NCT00780572|1014864|P2|NOT COMPLETED|Overall Study||0
425660|NCT00780572|1014865|P1|NOT COMPLETED|Overall Study||0
425661|NCT00780572|1014864|P2|COMPLETED|Overall Study||298
425662|NCT00780572|1014865|P1|COMPLETED|Overall Study||297
425663|NCT00780572|1014864|P2|STARTED|Overall Study||298
425664|NCT00780572|1014865|P1|STARTED|Overall Study||297
425665|NCT00780455|1014873|P2|NOT COMPLETED|Overall Study||0
425666|NCT00780455|1014874|P1|NOT COMPLETED|Overall Study||0
425667|NCT00780455|1014873|P2|COMPLETED|Overall Study||2
425668|NCT00780455|1014874|P1|COMPLETED|Overall Study||2
425669|NCT00780455|1014873|P2|STARTED|Overall Study||2
425670|NCT00780455|1014874|P1|STARTED|Overall Study||2
425671|NCT00780273|1014898|P1|NOT COMPLETED|Overall Study||2
425672|NCT00780273|1014898|P1|COMPLETED|Overall Study||17
425673|NCT00780273|1014898|P1|STARTED|Overall Study||19
425674|NCT00779857|1014907|P1|NOT COMPLETED|Overall Study||6
425675|NCT00779857|1014907|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
425676|NCT00779857|1014907|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
425677|NCT00779857|1014907|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
425678|NCT00779857|1014907|P1|STARTED|Overall Study|70 patients treated|70
425679|NCT00779779|1014912|P1|NOT COMPLETED|Overall Study||24
425680|NCT00779779|1014912|P1|COMPLETED|Overall Study||498
425681|NCT00779779|1014912|P1|STARTED|Overall Study||522
425682|NCT00779766|1014921|P2|NOT COMPLETED|Overall Study||68
425683|NCT00779766|1014922|P1|NOT COMPLETED|Overall Study||85
425684|NCT00779766|1014921|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
425685|NCT00779766|1014922|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
425686|NCT00779766|1014921|P2|STARTED|Overall Study||3025
425687|NCT00779766|1014922|P1|STARTED|Overall Study||3026
425688|NCT00779701|1015000|P1|NOT COMPLETED|Overall Study||0
425689|NCT00779701|1015000|P1|COMPLETED|Overall Study||27
425690|NCT00779701|1015000|P1|STARTED|Overall Study||27
425691|NCT00779675|1015004|P1|NOT COMPLETED|Extended Treatment Period||46
425692|NCT00779675|1015004|P1|COMPLETED|Extended Treatment Period||147
425693|NCT00779675|1015004|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
425694|NCT00779675|1015004|P1|NOT COMPLETED|Treatment Period||332
425695|NCT00779675|1015004|P1|COMPLETED|Treatment Period||328
425696|NCT00779675|1015004|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
425697|NCT00779558|1015025|P2|NOT COMPLETED|Overall Study||7
425698|NCT00779558|1015026|P1|NOT COMPLETED|Overall Study||4
425699|NCT00779558|1015025|P2|COMPLETED|Overall Study||37
425700|NCT00779558|1015026|P1|COMPLETED|Overall Study||53
425701|NCT00779558|1015025|P2|STARTED|Overall Study||44
425702|NCT00779558|1015026|P1|STARTED|Overall Study||57
425703|NCT00779506|1015040|P1|NOT COMPLETED|Overall Study||29
425704|NCT00779506|1015040|P1|COMPLETED|Overall Study||67
425705|NCT00779506|1015040|P1|Withdrawal Treatment|Overall Study||27
425706|NCT00779506|1015040|P1|Treatment Complete|Overall Study||67
425707|NCT00779506|1015040|P1|MITT|Overall Study||89
425708|NCT00779506|1015040|P1|Assigned|Overall Study||94
425709|NCT00779506|1015040|P1|Screen Failed|Overall Study||2
425710|NCT00779506|1015040|P1|Enrolled|Overall Study||96
425711|NCT00779506|1015040|P1|STARTED|Overall Study||96
425712|NCT00779467|1015054|P4|NOT COMPLETED|Overall Study||19
425713|NCT00779467|1015055|P3|NOT COMPLETED|Overall Study||10
425714|NCT00779467|1015056|P2|NOT COMPLETED|Overall Study||5
425715|NCT00779467|1015057|P1|NOT COMPLETED|Overall Study||15
425716|NCT00779467|1015054|P4|COMPLETED|Overall Study||35
425717|NCT00779467|1015055|P3|COMPLETED|Overall Study||38
425718|NCT00779467|1015056|P2|COMPLETED|Overall Study||40
425719|NCT00779467|1015057|P1|COMPLETED|Overall Study||38
425720|NCT00779467|1015054|P4|STARTED|Overall Study||54
425721|NCT00779467|1015055|P3|STARTED|Overall Study||48
425722|NCT00779467|1015056|P2|STARTED|Overall Study||45
425723|NCT00779467|1015057|P1|STARTED|Overall Study||53
425724|NCT00779311|1015100|P5|NOT COMPLETED|Overall Study||0
425725|NCT00779311|1015101|P4|NOT COMPLETED|Overall Study||0
425726|NCT00779311|1015102|P3|NOT COMPLETED|Overall Study||0
425727|NCT00779311|1015103|P2|NOT COMPLETED|Overall Study||0
425728|NCT00779311|1015104|P1|NOT COMPLETED|Overall Study||0
425729|NCT00779311|1015100|P5|COMPLETED|Overall Study||0
425730|NCT00779311|1015101|P4|COMPLETED|Overall Study||0
425731|NCT00779311|1015102|P3|COMPLETED|Overall Study||0
425732|NCT00779311|1015103|P2|COMPLETED|Overall Study||0
425733|NCT00779311|1015104|P1|COMPLETED|Overall Study||8
425734|NCT00779311|1015100|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
425735|NCT00779311|1015101|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
425736|NCT00779311|1015102|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
425737|NCT00779311|1015103|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
425738|NCT00779311|1015104|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
425739|NCT00779311|1015100|P5|STARTED|Overall Study||0
425740|NCT00779311|1015101|P4|STARTED|Overall Study||0
425741|NCT00779311|1015102|P3|STARTED|Overall Study||0
425742|NCT00779311|1015103|P2|STARTED|Overall Study||0
425743|NCT00779311|1015104|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
425744|NCT00779285|1015126|P1|NOT COMPLETED|Overall Study||0
425745|NCT00779285|1015126|P1|COMPLETED|Overall Study||1
425746|NCT00779285|1015126|P1|STARTED|Overall Study||1
425747|NCT00779259|1015130|P1|NOT COMPLETED|Theophylline With Quinine||0
425748|NCT00779259|1015130|P1|COMPLETED|Theophylline With Quinine||22
425749|NCT00779259|1015130|P1|STARTED|Theophylline With Quinine||22
425750|NCT00779259|1015130|P1|NOT COMPLETED|Quinine Alone||2
425751|NCT00779259|1015130|P1|COMPLETED|Quinine Alone||22
425752|NCT00779259|1015130|P1|STARTED|Quinine Alone||24
425753|NCT00779259|1015130|P1|NOT COMPLETED|4 Day Washout Period||0
425754|NCT00779259|1015130|P1|COMPLETED|4 Day Washout Period||24
425755|NCT00779259|1015130|P1|STARTED|4 Day Washout Period||24
425756|NCT00779259|1015130|P1|NOT COMPLETED|Theophylline Alone||0
425757|NCT00779259|1015130|P1|COMPLETED|Theophylline Alone||24
425758|NCT00779259|1015130|P1|STARTED|Theophylline Alone||24
425759|NCT00779246|1015151|P2|NOT COMPLETED|Overall Study||53
425760|NCT00779246|1015152|P1|NOT COMPLETED|Overall Study||33
425761|NCT00779246|1015151|P2|COMPLETED|Overall Study||715
425762|NCT00779246|1015152|P1|COMPLETED|Overall Study||717
425763|NCT00779246|1015151|P2|STARTED|Overall Study||768
425764|NCT00779246|1015152|P1|STARTED|Overall Study||750
425765|NCT00779155|1015160|P2|NOT COMPLETED|Overall Study||0
425766|NCT00779155|1015161|P1|NOT COMPLETED|Overall Study||0
425767|NCT00779155|1015160|P2|COMPLETED|Overall Study||6
425768|NCT00779155|1015161|P1|COMPLETED|Overall Study||6
425769|NCT00779155|1015160|P2|STARTED|Overall Study||6
425770|NCT00779155|1015161|P1|STARTED|Overall Study||6
425771|NCT00779142|1015167|P1|NOT COMPLETED|Overall Study||3
425772|NCT00779142|1015167|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
425773|NCT00779142|1015167|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
425774|NCT00779116|1015171|P2|NOT COMPLETED|Second Intervention||0
425775|NCT00779116|1015172|P1|NOT COMPLETED|Second Intervention||0
425776|NCT00779116|1015171|P2|COMPLETED|Second Intervention||108
425777|NCT00779116|1015172|P1|COMPLETED|Second Intervention||109
425778|NCT00779116|1015171|P2|STARTED|Second Intervention||108
425779|NCT00779116|1015172|P1|STARTED|Second Intervention||109
425780|NCT00779116|1015171|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
425781|NCT00779116|1015172|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
425782|NCT00779116|1015171|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
425783|NCT00779116|1015172|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
425784|NCT00779116|1015171|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
425785|NCT00779116|1015172|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
425786|NCT00779116|1015171|P2|NOT COMPLETED|First Intervention||0
425787|NCT00779116|1015172|P1|NOT COMPLETED|First Intervention||0
425788|NCT00779116|1015171|P2|COMPLETED|First Intervention||108
425789|NCT00779116|1015172|P1|COMPLETED|First Intervention||109
425790|NCT00779116|1015171|P2|STARTED|First Intervention||108
425791|NCT00779116|1015172|P1|STARTED|First Intervention||109
425792|NCT00779038|1015179|P1|NOT COMPLETED|Overall Study||13
425793|NCT00779038|1015179|P1|COMPLETED|Overall Study||0
425794|NCT00779038|1015179|P1|STARTED|Overall Study||13
425795|NCT00779025|1015188|P1|NOT COMPLETED|Overall Study||1
425796|NCT00779025|1015188|P1|COMPLETED|Overall Study||81
425797|NCT00779025|1015188|P1|STARTED|Overall Study||82
425798|NCT00778999|1015199|P2|NOT COMPLETED|Overall Study||34
425799|NCT00778999|1015200|P1|NOT COMPLETED|Overall Study||28
425800|NCT00778999|1015199|P2|COMPLETED|Overall Study||185
425801|NCT00778999|1015200|P1|COMPLETED|Overall Study||195
425802|NCT00778999|1015199|P2|STARTED|Overall Study||219
425803|NCT00778999|1015200|P1|STARTED|Overall Study||223
425804|NCT00778921|1015209|P3|NOT COMPLETED|Overall Study||28
425805|NCT00778921|1015210|P2|NOT COMPLETED|Overall Study||19
425806|NCT00778921|1015211|P1|NOT COMPLETED|Overall Study||18
425807|NCT00778921|1015209|P3|COMPLETED|Overall Study||255
425808|NCT00778921|1015210|P2|COMPLETED|Overall Study||266
425809|NCT00778921|1015211|P1|COMPLETED|Overall Study||261
425810|NCT00778921|1015209|P3|STARTED|Overall Study||283
425811|NCT00778921|1015210|P2|STARTED|Overall Study||285
425812|NCT00778921|1015211|P1|STARTED|Overall Study||279
425813|NCT00778895|1015228|P3|NOT COMPLETED|ESFU Phase||2
425814|NCT00778895|1015229|P2|NOT COMPLETED|ESFU Phase||12
425815|NCT00778895|1015230|P1|NOT COMPLETED|ESFU Phase||11
425816|NCT00778895|1015228|P3|COMPLETED|ESFU Phase||41
425817|NCT00778895|1015229|P2|COMPLETED|ESFU Phase||155
425818|NCT00778895|1015230|P1|COMPLETED|ESFU Phase||153
425819|NCT00778895|1015228|P3|STARTED|ESFU Phase||43
425820|NCT00778895|1015229|P2|STARTED|ESFU Phase||167
425821|NCT00778895|1015230|P1|STARTED|ESFU Phase||164
425822|NCT00778895|1015228|P3|NOT COMPLETED|Active Phase||0
425823|NCT00778895|1015229|P2|NOT COMPLETED|Active Phase||6
425824|NCT00778895|1015230|P1|NOT COMPLETED|Active Phase||7
425825|NCT00778895|1015228|P3|COMPLETED|Active Phase||43
425826|NCT00778895|1015229|P2|COMPLETED|Active Phase||161
425827|NCT00778895|1015230|P1|COMPLETED|Active Phase||157
425828|NCT00778895|1015228|P3|STARTED|Active Phase||43
425829|NCT00778895|1015229|P2|STARTED|Active Phase||167
425830|NCT00778895|1015230|P1|STARTED|Active Phase||164
425831|NCT00778869|1015268|P1|NOT COMPLETED|Overall Study||0
425832|NCT00778869|1015268|P1|COMPLETED|Overall Study||10
425833|NCT00778869|1015268|P1|STARTED|Overall Study||10
425834|NCT00778830|1015274|P2|NOT COMPLETED|Overall Study||1
425835|NCT00778830|1015275|P1|NOT COMPLETED|Overall Study||0
425836|NCT00778830|1015274|P2|COMPLETED|Overall Study||187
425837|NCT00778830|1015275|P1|COMPLETED|Overall Study||101
425838|NCT00778830|1015274|P2|STARTED|Overall Study||188
425839|NCT00778830|1015275|P1|STARTED|Overall Study||101
425840|NCT00778817|1015287|P1|NOT COMPLETED|Overall Study||4
425841|NCT00778817|1015287|P1|COMPLETED|Overall Study||16
425842|NCT00778817|1015287|P1|STARTED|Overall Study||20
425843|NCT00778648|1015304|P2|NOT COMPLETED|Overall Study||5
425844|NCT00778648|1015305|P1|NOT COMPLETED|Overall Study||9
425845|NCT00778648|1015304|P2|COMPLETED|Overall Study||266
425846|NCT00778648|1015305|P1|COMPLETED|Overall Study||263
425847|NCT00778648|1015304|P2|STARTED|Overall Study||271
425848|NCT00778648|1015305|P1|STARTED|Overall Study||272
425849|NCT00778622|1015314|P3|NOT COMPLETED|Overall Study||15
425850|NCT00778622|1015315|P2|NOT COMPLETED|Overall Study||15
425851|NCT00778622|1015316|P1|NOT COMPLETED|Overall Study||16
425852|NCT00778622|1015314|P3|COMPLETED|Overall Study||109
425853|NCT00778622|1015315|P2|COMPLETED|Overall Study||107
425854|NCT00778622|1015316|P1|COMPLETED|Overall Study||109
425855|NCT00778622|1015314|P3|STARTED|Overall Study||124
425856|NCT00778622|1015315|P2|STARTED|Overall Study||122
425857|NCT00778622|1015316|P1|STARTED|Overall Study||125
425858|NCT00778336|1015373|P4|NOT COMPLETED|3 Month Follow Up||0
425859|NCT00778336|1015374|P3|NOT COMPLETED|3 Month Follow Up||5
425860|NCT00778336|1015375|P2|NOT COMPLETED|3 Month Follow Up||23
425861|NCT00778336|1015376|P1|NOT COMPLETED|3 Month Follow Up||23
425862|NCT00778336|1015373|P4|COMPLETED|3 Month Follow Up||12
425863|NCT00778336|1015374|P3|COMPLETED|3 Month Follow Up||65
425864|NCT00778336|1015375|P2|COMPLETED|3 Month Follow Up||144
425865|NCT00778336|1015376|P1|COMPLETED|3 Month Follow Up||169
425866|NCT00778336|1015373|P4|STARTED|3 Month Follow Up||12
425867|NCT00778336|1015374|P3|STARTED|3 Month Follow Up||70
425868|NCT00778336|1015375|P2|STARTED|3 Month Follow Up||167
425869|NCT00778336|1015376|P1|STARTED|3 Month Follow Up||192
425870|NCT00778336|1015373|P4|NOT COMPLETED|Index Procedure-Discharge||0
425871|NCT00778336|1015374|P3|NOT COMPLETED|Index Procedure-Discharge||2
425872|NCT00778336|1015375|P2|NOT COMPLETED|Index Procedure-Discharge||3
425873|NCT00778336|1015376|P1|NOT COMPLETED|Index Procedure-Discharge||6
425874|NCT00778336|1015373|P4|COMPLETED|Index Procedure-Discharge||12
425875|NCT00778336|1015374|P3|COMPLETED|Index Procedure-Discharge||70
425876|NCT00778336|1015375|P2|COMPLETED|Index Procedure-Discharge||167
425877|NCT00778336|1015376|P1|COMPLETED|Index Procedure-Discharge||192
425878|NCT00778336|1015373|P4|STARTED|Index Procedure-Discharge||12
425879|NCT00778336|1015374|P3|STARTED|Index Procedure-Discharge||72
425880|NCT00778336|1015375|P2|STARTED|Index Procedure-Discharge||170
425881|NCT00778336|1015376|P1|STARTED|Index Procedure-Discharge||198
425882|NCT00778310|1015396|P2|NOT COMPLETED|Overall Study||0
425883|NCT00778310|1015397|P1|NOT COMPLETED|Overall Study||0
425884|NCT00778310|1015396|P2|COMPLETED|Overall Study||26
425885|NCT00778310|1015397|P1|COMPLETED|Overall Study||17
425886|NCT00778310|1015396|P2|Usable Data|Overall Study||21
425887|NCT00778310|1015397|P1|Usable Data|Overall Study||14
425888|NCT00778310|1015396|P2|STARTED|Overall Study||26
425889|NCT00778310|1015397|P1|STARTED|Overall Study||17
425890|NCT00778258|1015414|P9|NOT COMPLETED|Overall Study||4
425891|NCT00778258|1015415|P8|NOT COMPLETED|Overall Study||15
425892|NCT00778258|1015416|P7|NOT COMPLETED|Overall Study||15
425893|NCT00778258|1015417|P6|NOT COMPLETED|Overall Study||10
425894|NCT00778258|1015418|P5|NOT COMPLETED|Overall Study||0
425895|NCT00778258|1015419|P4|NOT COMPLETED|Overall Study||3
425896|NCT00778258|1015420|P3|NOT COMPLETED|Overall Study||10
425897|NCT00778258|1015421|P2|NOT COMPLETED|Overall Study||2
425898|NCT00778258|1015422|P1|NOT COMPLETED|Overall Study||7
425899|NCT00778258|1015414|P9|COMPLETED|Overall Study||6
425900|NCT00778258|1015415|P8|COMPLETED|Overall Study||26
425901|NCT00778258|1015416|P7|COMPLETED|Overall Study||19
425902|NCT00778258|1015417|P6|COMPLETED|Overall Study||13
425903|NCT00778258|1015418|P5|COMPLETED|Overall Study||6
425904|NCT00778258|1015419|P4|COMPLETED|Overall Study||12
425905|NCT00778258|1015420|P3|COMPLETED|Overall Study||10
425906|NCT00778258|1015421|P2|COMPLETED|Overall Study||3
425907|NCT00778258|1015422|P1|COMPLETED|Overall Study||9
425908|NCT00778258|1015414|P9|STARTED|Overall Study||10
425909|NCT00778258|1015415|P8|STARTED|Overall Study||41
425910|NCT00778258|1015416|P7|STARTED|Overall Study||34
425911|NCT00778258|1015417|P6|STARTED|Overall Study||23
425912|NCT00778258|1015418|P5|STARTED|Overall Study||6
425913|NCT00778258|1015419|P4|STARTED|Overall Study||15
425914|NCT00778258|1015420|P3|STARTED|Overall Study||20
425915|NCT00778258|1015421|P2|STARTED|Overall Study||5
425916|NCT00778258|1015422|P1|STARTED|Overall Study||16
425917|NCT00778167|1015477|P3|NOT COMPLETED|Overall Study||0
425918|NCT00778167|1015478|P2|NOT COMPLETED|Overall Study||0
425919|NCT00778167|1015479|P1|NOT COMPLETED|Overall Study||0
425920|NCT00778167|1015477|P3|COMPLETED|Overall Study||4
425921|NCT00778167|1015478|P2|COMPLETED|Overall Study||8
425922|NCT00778167|1015479|P1|COMPLETED|Overall Study||6
425923|NCT00778167|1015477|P3|STARTED|Overall Study||4
425924|NCT00778167|1015478|P2|STARTED|Overall Study||8
425925|NCT00778167|1015479|P1|STARTED|Overall Study||6
425926|NCT00778102|1015489|P2|NOT COMPLETED|Overall Study||22
425927|NCT00778102|1015490|P1|NOT COMPLETED|Overall Study||21
425928|NCT00778102|1015489|P2|COMPLETED|Overall Study||19
425929|NCT00778102|1015490|P1|COMPLETED|Overall Study||18
425930|NCT00778102|1015489|P2|STARTED|Overall Study||41
425931|NCT00778102|1015490|P1|STARTED|Overall Study||39
425932|NCT00777946|1015525|P3|NOT COMPLETED|Overall Study||16
425933|NCT00777946|1015526|P2|NOT COMPLETED|Overall Study||6
425934|NCT00777946|1015527|P1|NOT COMPLETED|Overall Study||21
425935|NCT00777946|1015525|P3|COMPLETED|Overall Study||244
425936|NCT00777946|1015526|P2|COMPLETED|Overall Study||271
425937|NCT00777946|1015527|P1|COMPLETED|Overall Study||262
425938|NCT00777946|1015525|P3|Safety & Full Analysis Sets|Overall Study||260
425939|NCT00777946|1015526|P2|Safety & Full Analysis Sets|Overall Study||276
425940|NCT00777946|1015527|P1|Safety & Full Analysis Sets|Overall Study||282
425941|NCT00777946|1015525|P3|STARTED|Overall Study||260
425942|NCT00777946|1015526|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
426123|NCT00776009|1016042|P6|NOT COMPLETED|Period 3: Third Intervention||0
425943|NCT00777946|1015527|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
425944|NCT00777855|1015550|P2|NOT COMPLETED|Second Intervention||0
425945|NCT00777855|1015551|P1|NOT COMPLETED|Second Intervention||0
425946|NCT00777855|1015550|P2|COMPLETED|Second Intervention||5
425947|NCT00777855|1015551|P1|COMPLETED|Second Intervention||5
425948|NCT00777855|1015550|P2|STARTED|Second Intervention||5
425949|NCT00777855|1015551|P1|STARTED|Second Intervention||5
425950|NCT00777855|1015550|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
425951|NCT00777855|1015551|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
425952|NCT00777855|1015550|P2|COMPLETED|Washout Period (>= 14 Days)||5
425953|NCT00777855|1015551|P1|COMPLETED|Washout Period (>= 14 Days)||5
425954|NCT00777855|1015550|P2|STARTED|Washout Period (>= 14 Days)||5
425955|NCT00777855|1015551|P1|STARTED|Washout Period (>= 14 Days)||5
425956|NCT00777855|1015550|P2|NOT COMPLETED|First Intervention||0
425957|NCT00777855|1015551|P1|NOT COMPLETED|First Intervention||0
425958|NCT00777855|1015550|P2|COMPLETED|First Intervention||5
425959|NCT00777855|1015551|P1|COMPLETED|First Intervention||5
425960|NCT00777855|1015550|P2|STARTED|First Intervention||5
425961|NCT00777855|1015551|P1|STARTED|First Intervention||5
425962|NCT00777803|1015562|P2|NOT COMPLETED|Overall Study||7
425963|NCT00777803|1015563|P1|NOT COMPLETED|Overall Study||15
425964|NCT00777803|1015562|P2|COMPLETED|Overall Study||90
425965|NCT00777803|1015563|P1|COMPLETED|Overall Study||269
425966|NCT00777803|1015562|P2|STARTED|Overall Study||97
425967|NCT00777803|1015563|P1|STARTED|Overall Study||284
425968|NCT00777790|1015598|P3|NOT COMPLETED|Overall Study||0
425969|NCT00777790|1015599|P2|NOT COMPLETED|Overall Study||0
425970|NCT00777790|1015600|P1|NOT COMPLETED|Overall Study||0
425971|NCT00777790|1015598|P3|COMPLETED|Overall Study||88
425972|NCT00777790|1015599|P2|COMPLETED|Overall Study||77
425973|NCT00777790|1015600|P1|COMPLETED|Overall Study||76
425974|NCT00777790|1015598|P3|STARTED|Overall Study||88
425975|NCT00777790|1015599|P2|STARTED|Overall Study||77
425976|NCT00777790|1015600|P1|STARTED|Overall Study||76
425977|NCT00777764|1015610|P2|NOT COMPLETED|Overall Study||1
425978|NCT00777764|1015611|P1|NOT COMPLETED|Overall Study||0
425979|NCT00777764|1015610|P2|COMPLETED|Overall Study||29
425980|NCT00777764|1015611|P1|COMPLETED|Overall Study||30
425981|NCT00777764|1015610|P2|STARTED|Overall Study||30
425982|NCT00777764|1015611|P1|STARTED|Overall Study||30
425983|NCT00777634|1015623|P2|NOT COMPLETED|Overall Study||1
425984|NCT00777634|1015624|P1|NOT COMPLETED|Overall Study||5
425985|NCT00777634|1015623|P2|COMPLETED|Overall Study||133
425986|NCT00777634|1015624|P1|COMPLETED|Overall Study||129
425987|NCT00777634|1015623|P2|STARTED|Overall Study||134
425988|NCT00777634|1015624|P1|STARTED|Overall Study||134
425989|NCT00777608|1015642|P2|NOT COMPLETED|Overall Study||6
425990|NCT00777608|1015643|P1|NOT COMPLETED|Overall Study||4
425991|NCT00777608|1015642|P2|COMPLETED|Overall Study||47
425992|NCT00777608|1015643|P1|COMPLETED|Overall Study||49
425993|NCT00777608|1015642|P2|STARTED|Overall Study||53
425994|NCT00777608|1015643|P1|STARTED|Overall Study||53
425995|NCT00777556|1015653|P1|NOT COMPLETED|Overall Study||66
425996|NCT00777556|1015653|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
425997|NCT00777556|1015653|P1|Used Product|Overall Study||297
425998|NCT00777556|1015653|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
425999|NCT00777556|1015653|P1|Dispensed Product|Overall Study||307
426000|NCT00777556|1015653|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
426001|NCT00777335|1015662|P2|NOT COMPLETED|Overall Study||0
426002|NCT00777335|1015663|P1|NOT COMPLETED|Overall Study||0
426003|NCT00777335|1015662|P2|COMPLETED|Overall Study||2
426004|NCT00777335|1015663|P1|COMPLETED|Overall Study||2
426005|NCT00777335|1015662|P2|STARTED|Overall Study||2
426006|NCT00777335|1015663|P1|STARTED|Overall Study||2
426007|NCT00776659|1015671|P1|NOT COMPLETED|Overall Study||26
426008|NCT00776659|1015671|P1|COMPLETED|Overall Study||13
426009|NCT00776659|1015671|P1|STARTED|Overall Study||39
426010|NCT00776594|1015683|P2|NOT COMPLETED|Overall Study||2
426011|NCT00776594|1015684|P1|NOT COMPLETED|Overall Study||4
426012|NCT00776594|1015683|P2|COMPLETED|Overall Study||34
426013|NCT00776594|1015684|P1|COMPLETED|Overall Study||62
426014|NCT00776594|1015683|P2|STARTED|Overall Study||36
426015|NCT00776594|1015684|P1|STARTED|Overall Study||66
426016|NCT00776555|1015698|P2|NOT COMPLETED|Overall Study||0
426017|NCT00776555|1015699|P1|NOT COMPLETED|Overall Study||3
426018|NCT00776555|1015698|P2|COMPLETED|Overall Study||0
426019|NCT00776555|1015699|P1|COMPLETED|Overall Study||0
426020|NCT00776555|1015698|P2|STARTED|Overall Study||0
426021|NCT00776555|1015699|P1|STARTED|Overall Study||3
426022|NCT00777257|1015712|P3|NOT COMPLETED|Overall Study||9
426023|NCT00777257|1015713|P2|NOT COMPLETED|Overall Study||12
426024|NCT00777257|1015714|P1|NOT COMPLETED|Overall Study||11
426025|NCT00777257|1015712|P3|COMPLETED|Overall Study||442
426026|NCT00777257|1015713|P2|COMPLETED|Overall Study||438
426027|NCT00777257|1015714|P1|COMPLETED|Overall Study||433
426028|NCT00777257|1015712|P3|STARTED|Overall Study||451
426029|NCT00777257|1015713|P2|STARTED|Overall Study||450
426030|NCT00777257|1015714|P1|STARTED|Overall Study||444
426031|NCT00777205|1015733|P2|NOT COMPLETED|Overall Study||71
426032|NCT00777205|1015734|P1|NOT COMPLETED|Overall Study||31
426033|NCT00777205|1015733|P2|COMPLETED|Overall Study||129
426034|NCT00777205|1015734|P1|COMPLETED|Overall Study||212
426035|NCT00777205|1015733|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
426036|NCT00777205|1015734|P1|Intervention Interruption|Overall Study||0
426037|NCT00777205|1015733|P2|STARTED|Overall Study||200
426038|NCT00777205|1015734|P1|STARTED|Overall Study||243
426039|NCT00777179|1015750|P2|NOT COMPLETED|Overall Study||0
426040|NCT00777179|1015751|P1|NOT COMPLETED|Overall Study||0
426041|NCT00777179|1015750|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
426042|NCT00777179|1015751|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
426043|NCT00777179|1015750|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
426044|NCT00777179|1015751|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
426045|NCT00777153|1015768|P3|NOT COMPLETED|Overall Study||37
426046|NCT00777153|1015769|P2|NOT COMPLETED|Overall Study||83
426047|NCT00777153|1015770|P1|NOT COMPLETED|Overall Study||90
426048|NCT00777153|1015768|P3|COMPLETED|Overall Study||28
426049|NCT00777153|1015769|P2|COMPLETED|Overall Study||46
426050|NCT00777153|1015770|P1|COMPLETED|Overall Study||41
426051|NCT00777153|1015768|P3|STARTED|Overall Study||65
426052|NCT00777153|1015769|P2|STARTED|Overall Study||129
426053|NCT00777153|1015770|P1|STARTED|Overall Study||131
426054|NCT00777062|1015795|P2|NOT COMPLETED|Overall Study||5
426055|NCT00777062|1015796|P1|NOT COMPLETED|Overall Study||3
426056|NCT00777062|1015795|P2|COMPLETED|Overall Study||36
426057|NCT00777062|1015796|P1|COMPLETED|Overall Study||36
426058|NCT00777062|1015795|P2|STARTED|Overall Study||41
426059|NCT00777062|1015796|P1|STARTED|Overall Study||39
426060|NCT00777049|1015806|P2|NOT COMPLETED|Overall Study||1
426061|NCT00777049|1015807|P1|NOT COMPLETED|Overall Study||1
426062|NCT00777049|1015806|P2|COMPLETED|Overall Study||20
426063|NCT00777049|1015807|P1|COMPLETED|Overall Study||32
426064|NCT00777049|1015806|P2|STARTED|Overall Study||21
426065|NCT00777049|1015807|P1|STARTED|Overall Study||33
426066|NCT00777023|1015816|P3|NOT COMPLETED|Overall Study||37
426067|NCT00777023|1015817|P2|NOT COMPLETED|Overall Study||41
426068|NCT00777023|1015818|P1|NOT COMPLETED|Overall Study||35
426069|NCT00777023|1015816|P3|COMPLETED|Overall Study||146
426070|NCT00777023|1015817|P2|COMPLETED|Overall Study||149
426071|NCT00777023|1015818|P1|COMPLETED|Overall Study||151
426072|NCT00777023|1015816|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
426073|NCT00777023|1015817|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
426074|NCT00777023|1015818|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
426075|NCT00776997|1015835|P1|NOT COMPLETED|Overall Study||2
426076|NCT00776997|1015835|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
426077|NCT00776997|1015835|P1|STARTED|Overall Study||100
426078|NCT00776984|1015844|P2|NOT COMPLETED|Overall Study||21
426079|NCT00776984|1015845|P1|NOT COMPLETED|Overall Study||31
426080|NCT00776984|1015844|P2|COMPLETED|Overall Study||198
426081|NCT00776984|1015845|P1|COMPLETED|Overall Study||203
426082|NCT00776984|1015844|P2|STARTED|Overall Study||219
426083|NCT00776984|1015845|P1|STARTED|Overall Study||234
426084|NCT00776919|1015919|P4|NOT COMPLETED|Overall Study||39
426085|NCT00776919|1015920|P3|NOT COMPLETED|Overall Study||32
426086|NCT00776919|1015921|P2|NOT COMPLETED|Overall Study||33
426087|NCT00776919|1015922|P1|NOT COMPLETED|Overall Study||27
426088|NCT00776919|1015919|P4|COMPLETED|Overall Study||293
426089|NCT00776919|1015920|P3|COMPLETED|Overall Study||296
426090|NCT00776919|1015921|P2|COMPLETED|Overall Study||295
426091|NCT00776919|1015922|P1|COMPLETED|Overall Study||300
426092|NCT00776919|1015919|P4|STARTED|Overall Study||332
426093|NCT00776919|1015920|P3|STARTED|Overall Study||328
426094|NCT00776919|1015921|P2|STARTED|Overall Study||328
426095|NCT00776919|1015922|P1|STARTED|Overall Study||327
426096|NCT00776789|1015986|P2|NOT COMPLETED|Overall Study||3
426097|NCT00776789|1015987|P1|NOT COMPLETED|Overall Study||3
426098|NCT00776789|1015986|P2|COMPLETED|Overall Study||18
426099|NCT00776789|1015987|P1|COMPLETED|Overall Study||17
426100|NCT00776789|1015986|P2|STARTED|Overall Study||21
426101|NCT00776789|1015987|P1|STARTED|Overall Study||20
426102|NCT00776295|1015999|P1|NOT COMPLETED|Overall Study||0
426103|NCT00776295|1015999|P1|COMPLETED|Overall Study||2
426104|NCT00776295|1015999|P1|STARTED|Overall Study||2
426105|NCT00776230|1016007|P3|NOT COMPLETED|Overall Study||5
426106|NCT00776230|1016008|P2|NOT COMPLETED|Overall Study||3
426107|NCT00776230|1016009|P1|NOT COMPLETED|Overall Study||3
426108|NCT00776230|1016007|P3|COMPLETED|Overall Study||97
426109|NCT00776230|1016008|P2|COMPLETED|Overall Study||100
426110|NCT00776230|1016009|P1|COMPLETED|Overall Study||96
426111|NCT00776230|1016007|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
426112|NCT00776230|1016008|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
426113|NCT00776230|1016009|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
426114|NCT00776230|1016007|P3|STARTED|Overall Study||102
426115|NCT00776230|1016008|P2|STARTED|Overall Study||103
426116|NCT00776230|1016009|P1|STARTED|Overall Study||99
426117|NCT00776100|1016019|P2|NOT COMPLETED|Overall Study||0
426118|NCT00776100|1016020|P1|NOT COMPLETED|Overall Study||1
426119|NCT00776100|1016019|P2|COMPLETED|Overall Study||1
426120|NCT00776100|1016020|P1|COMPLETED|Overall Study||0
426121|NCT00776100|1016019|P2|STARTED|Overall Study||1
426122|NCT00776100|1016020|P1|STARTED|Overall Study||1
426124|NCT00776009|1016043|P5|NOT COMPLETED|Period 3: Third Intervention||0
426125|NCT00776009|1016044|P4|NOT COMPLETED|Period 3: Third Intervention||0
426126|NCT00776009|1016045|P3|NOT COMPLETED|Period 3: Third Intervention||0
426127|NCT00776009|1016046|P2|NOT COMPLETED|Period 3: Third Intervention||0
426128|NCT00776009|1016047|P1|NOT COMPLETED|Period 3: Third Intervention||1
426129|NCT00776009|1016042|P6|COMPLETED|Period 3: Third Intervention||26
426130|NCT00776009|1016043|P5|COMPLETED|Period 3: Third Intervention||26
426131|NCT00776009|1016044|P4|COMPLETED|Period 3: Third Intervention||27
426132|NCT00776009|1016045|P3|COMPLETED|Period 3: Third Intervention||27
426133|NCT00776009|1016046|P2|COMPLETED|Period 3: Third Intervention||27
426134|NCT00776009|1016047|P1|COMPLETED|Period 3: Third Intervention||24
426135|NCT00776009|1016042|P6|STARTED|Period 3: Third Intervention||26
426136|NCT00776009|1016043|P5|STARTED|Period 3: Third Intervention||26
426137|NCT00776009|1016044|P4|STARTED|Period 3: Third Intervention||27
426138|NCT00776009|1016045|P3|STARTED|Period 3: Third Intervention||27
426139|NCT00776009|1016046|P2|STARTED|Period 3: Third Intervention||27
426140|NCT00776009|1016047|P1|STARTED|Period 3: Third Intervention||25
426141|NCT00776009|1016042|P6|NOT COMPLETED|Period 2: Second Intervention||1
426142|NCT00776009|1016043|P5|NOT COMPLETED|Period 2: Second Intervention||0
426143|NCT00776009|1016044|P4|NOT COMPLETED|Period 2: Second Intervention||0
426144|NCT00776009|1016045|P3|NOT COMPLETED|Period 2: Second Intervention||1
426145|NCT00776009|1016046|P2|NOT COMPLETED|Period 2: Second Intervention||0
426146|NCT00776009|1016047|P1|NOT COMPLETED|Period 2: Second Intervention||1
426147|NCT00776009|1016042|P6|COMPLETED|Period 2: Second Intervention||26
426148|NCT00776009|1016043|P5|COMPLETED|Period 2: Second Intervention||26
426149|NCT00776009|1016044|P4|COMPLETED|Period 2: Second Intervention||27
426150|NCT00776009|1016045|P3|COMPLETED|Period 2: Second Intervention||27
426151|NCT00776009|1016046|P2|COMPLETED|Period 2: Second Intervention||27
426152|NCT00776009|1016047|P1|COMPLETED|Period 2: Second Intervention||25
426153|NCT00776009|1016042|P6|STARTED|Period 2: Second Intervention||27
426154|NCT00776009|1016043|P5|STARTED|Period 2: Second Intervention||26
426155|NCT00776009|1016044|P4|STARTED|Period 2: Second Intervention||27
426156|NCT00776009|1016045|P3|STARTED|Period 2: Second Intervention||28
426157|NCT00776009|1016046|P2|STARTED|Period 2: Second Intervention||27
426158|NCT00776009|1016047|P1|STARTED|Period 2: Second Intervention||26
426159|NCT00776009|1016042|P6|NOT COMPLETED|Period 1: First Intervention||0
426160|NCT00776009|1016043|P5|NOT COMPLETED|Period 1: First Intervention||2
426161|NCT00776009|1016044|P4|NOT COMPLETED|Period 1: First Intervention||0
426162|NCT00776009|1016045|P3|NOT COMPLETED|Period 1: First Intervention||1
426163|NCT00776009|1016046|P2|NOT COMPLETED|Period 1: First Intervention||1
426164|NCT00776009|1016047|P1|NOT COMPLETED|Period 1: First Intervention||0
426165|NCT00776009|1016042|P6|COMPLETED|Period 1: First Intervention||27
426166|NCT00776009|1016043|P5|COMPLETED|Period 1: First Intervention||26
426167|NCT00776009|1016044|P4|COMPLETED|Period 1: First Intervention||27
426168|NCT00776009|1016045|P3|COMPLETED|Period 1: First Intervention||28
426169|NCT00776009|1016046|P2|COMPLETED|Period 1: First Intervention||27
426170|NCT00776009|1016047|P1|COMPLETED|Period 1: First Intervention||26
426171|NCT00776009|1016042|P6|STARTED|Period 1: First Intervention||27
426172|NCT00776009|1016043|P5|STARTED|Period 1: First Intervention||28
426173|NCT00776009|1016044|P4|STARTED|Period 1: First Intervention||27
426174|NCT00776009|1016045|P3|STARTED|Period 1: First Intervention||29
426175|NCT00776009|1016046|P2|STARTED|Period 1: First Intervention||28
426176|NCT00776009|1016047|P1|STARTED|Period 1: First Intervention||26
426177|NCT00775983|1016069|P2|NOT COMPLETED|Overall Study||2
426178|NCT00775983|1016070|P1|NOT COMPLETED|Overall Study||1
426179|NCT00775983|1016069|P2|COMPLETED|Overall Study||34
426180|NCT00775983|1016070|P1|COMPLETED|Overall Study||35
426181|NCT00775983|1016069|P2|STARTED|Overall Study||36
426182|NCT00775983|1016070|P1|STARTED|Overall Study||36
426183|NCT00775944|1016082|P4|NOT COMPLETED|Overall Study||16
426184|NCT00775944|1016083|P3|NOT COMPLETED|Overall Study||16
426185|NCT00775944|1016084|P2|NOT COMPLETED|Overall Study||9
426186|NCT00775944|1016085|P1|NOT COMPLETED|Overall Study||15
426187|NCT00775944|1016082|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
426188|NCT00775944|1016083|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
426189|NCT00775944|1016084|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
426190|NCT00775944|1016085|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
426191|NCT00775944|1016082|P4|STARTED|Overall Study||648
426192|NCT00775944|1016083|P3|STARTED|Overall Study||648
426193|NCT00775944|1016084|P2|STARTED|Overall Study||647
426194|NCT00775944|1016085|P1|STARTED|Overall Study||648
426195|NCT00775671|1016113|P2|NOT COMPLETED|Overall Study||0
426196|NCT00775671|1016114|P1|NOT COMPLETED|Overall Study||0
426197|NCT00775671|1016113|P2|COMPLETED|Overall Study||23
426198|NCT00775671|1016114|P1|COMPLETED|Overall Study||23
426199|NCT00775671|1016113|P2|STARTED|Overall Study||23
426200|NCT00775671|1016114|P1|STARTED|Overall Study||23
426201|NCT00775645|1016124|P2|NOT COMPLETED|Overall Study||20
426202|NCT00775645|1016125|P1|NOT COMPLETED|Overall Study||17
426203|NCT00775645|1016124|P2|COMPLETED|Overall Study||181
426204|NCT00775645|1016125|P1|COMPLETED|Overall Study||191
426205|NCT00775645|1016124|P2|STARTED|Overall Study||201
426206|NCT00775645|1016125|P1|STARTED|Overall Study||208
426207|NCT00775606|1016137|P2|NOT COMPLETED|Overall Study||0
426208|NCT00775606|1016138|P1|NOT COMPLETED|Overall Study||3
426209|NCT00775606|1016137|P2|COMPLETED|Overall Study||5
426210|NCT00775606|1016138|P1|COMPLETED|Overall Study||5
426211|NCT00775606|1016137|P2|STARTED|Overall Study||5
426212|NCT00775606|1016138|P1|STARTED|Overall Study||8
426213|NCT00775593|1016148|P1|NOT COMPLETED|Overall Study||7
426214|NCT00775593|1016148|P1|COMPLETED|Overall Study||53
426215|NCT00775593|1016148|P1|STARTED|Overall Study||60
426216|NCT00775528|1016155|P1|NOT COMPLETED|Overall Study||1
426217|NCT00775528|1016155|P1|COMPLETED|Overall Study||18
426218|NCT00775528|1016155|P1|STARTED|Overall Study|Started means number of patients who consented|19
426219|NCT00775463|1016164|P2|NOT COMPLETED|Overall Study||13
426220|NCT00775463|1016165|P1|NOT COMPLETED|Overall Study||11
426221|NCT00775463|1016164|P2|COMPLETED|Overall Study||59
426222|NCT00775463|1016165|P1|COMPLETED|Overall Study||65
426223|NCT00775463|1016164|P2|STARTED|Overall Study||72
426224|NCT00775463|1016165|P1|STARTED|Overall Study||76
426225|NCT00775450|1016202|P5|NOT COMPLETED|Overall Study||2
426226|NCT00775450|1016203|P4|NOT COMPLETED|Overall Study||0
426227|NCT00775450|1016204|P3|NOT COMPLETED|Overall Study||0
426228|NCT00775450|1016205|P2|NOT COMPLETED|Overall Study||0
426229|NCT00775450|1016206|P1|NOT COMPLETED|Overall Study||3
426230|NCT00775450|1016202|P5|COMPLETED|Overall Study||199
426231|NCT00775450|1016203|P4|COMPLETED|Overall Study||108
426232|NCT00775450|1016204|P3|COMPLETED|Overall Study||105
426233|NCT00775450|1016205|P2|COMPLETED|Overall Study||98
426234|NCT00775450|1016206|P1|COMPLETED|Overall Study||292
426235|NCT00775450|1016202|P5|STARTED|Overall Study||201
426236|NCT00775450|1016203|P4|STARTED|Overall Study||108
426237|NCT00775450|1016204|P3|STARTED|Overall Study||105
426238|NCT00775450|1016205|P2|STARTED|Overall Study||98
426239|NCT00775450|1016206|P1|STARTED|Overall Study||295
426240|NCT00775437|1016233|P1|NOT COMPLETED|Overall Study||6
426241|NCT00775437|1016233|P1|COMPLETED|Overall Study||26
426242|NCT00775437|1016233|P1|STARTED|Overall Study||32
426243|NCT00775411|1016283|P1|NOT COMPLETED|Overall Study||1
426244|NCT00775411|1016283|P1|COMPLETED|Overall Study||43
426245|NCT00775411|1016283|P1|STARTED|Overall Study||44
426246|NCT00775346|1016289|P1|NOT COMPLETED|Overall Study||0
426247|NCT00775346|1016289|P1|COMPLETED|Overall Study||92
426248|NCT00775346|1016289|P1|STARTED|Overall Study||92
426249|NCT00775229|1016295|P2|NOT COMPLETED|Overall Study||2
426250|NCT00775229|1016296|P1|NOT COMPLETED|Overall Study||5
426251|NCT00775229|1016295|P2|COMPLETED|Overall Study||24
426252|NCT00775229|1016296|P1|COMPLETED|Overall Study||20
426253|NCT00775229|1016295|P2|STARTED|Overall Study||26
426254|NCT00775229|1016296|P1|STARTED|Overall Study||25
426255|NCT00775203|1016308|P2|NOT COMPLETED|Overall Study||43
426256|NCT00775203|1016309|P1|NOT COMPLETED|Overall Study||62
426257|NCT00775203|1016308|P2|COMPLETED|Overall Study||163
426258|NCT00775203|1016309|P1|COMPLETED|Overall Study||144
426259|NCT00775203|1016308|P2|Received Study Medication|Overall Study||204
426260|NCT00775203|1016309|P1|Received Study Medication|Overall Study||202
426261|NCT00775203|1016308|P2|STARTED|Overall Study||206
426262|NCT00775203|1016309|P1|STARTED|Overall Study||206
426263|NCT00775190|1016343|P2|NOT COMPLETED|Overall Study||5
426264|NCT00775190|1016344|P1|NOT COMPLETED|Overall Study||4
426265|NCT00775190|1016343|P2|COMPLETED|Overall Study||0
426266|NCT00775190|1016344|P1|COMPLETED|Overall Study||3
426267|NCT00775190|1016343|P2|STARTED|Overall Study||5
426268|NCT00775190|1016344|P1|STARTED|Overall Study||7
426269|NCT00775021|1016366|P2|NOT COMPLETED|Second Intervention||1
426270|NCT00775021|1016367|P1|NOT COMPLETED|Second Intervention||0
426271|NCT00775021|1016366|P2|COMPLETED|Second Intervention||59
426272|NCT00775021|1016367|P1|COMPLETED|Second Intervention||62
426273|NCT00775021|1016366|P2|STARTED|Second Intervention||60
426274|NCT00775021|1016367|P1|STARTED|Second Intervention||62
426275|NCT00775021|1016366|P2|NOT COMPLETED|First Intervention||0
426276|NCT00775021|1016367|P1|NOT COMPLETED|First Intervention||1
426277|NCT00775021|1016366|P2|COMPLETED|First Intervention||60
426278|NCT00775021|1016367|P1|COMPLETED|First Intervention||62
426279|NCT00775021|1016366|P2|STARTED|First Intervention||60
426280|NCT00775021|1016367|P1|STARTED|First Intervention||63
426281|NCT00774995|1016385|P4|NOT COMPLETED|Overall Study||0
426282|NCT00774995|1016386|P3|NOT COMPLETED|Overall Study||1
426283|NCT00774995|1016387|P2|NOT COMPLETED|Overall Study||0
426284|NCT00774995|1016388|P1|NOT COMPLETED|Overall Study||0
426285|NCT00774995|1016385|P4|COMPLETED|Overall Study||16
426286|NCT00774995|1016386|P3|COMPLETED|Overall Study||7
426287|NCT00774995|1016387|P2|COMPLETED|Overall Study||16
426288|NCT00774995|1016388|P1|COMPLETED|Overall Study||9
426289|NCT00774995|1016385|P4|STARTED|Overall Study||16
426290|NCT00774995|1016386|P3|STARTED|Overall Study||8
426291|NCT00774995|1016387|P2|STARTED|Overall Study||16
426292|NCT00774995|1016388|P1|STARTED|Overall Study||9
426293|NCT00774930|1016428|P2|NOT COMPLETED|LTOLE Phase||17
426294|NCT00774930|1016429|P1|NOT COMPLETED|LTOLE Phase||15
426295|NCT00774930|1016428|P2|COMPLETED|LTOLE Phase||8
426296|NCT00774930|1016429|P1|COMPLETED|LTOLE Phase||17
426297|NCT00774930|1016428|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
426298|NCT00774930|1016429|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
426299|NCT00774930|1016428|P2|NOT COMPLETED|IOL Phase||9
426300|NCT00774930|1016429|P1|NOT COMPLETED|IOL Phase||13
426301|NCT00774930|1016428|P2|COMPLETED|IOL Phase||37
426302|NCT00774930|1016429|P1|COMPLETED|IOL Phase||43
426303|NCT00774930|1016428|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
426304|NCT00774930|1016429|P1|STARTED|IOL Phase||56
426305|NCT00774930|1016428|P2|NOT COMPLETED|DB Phase||22
426306|NCT00774930|1016429|P1|NOT COMPLETED|DB Phase||14
426307|NCT00774930|1016428|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
426308|NCT00774930|1016429|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
426309|NCT00774930|1016428|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
426310|NCT00774930|1016429|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
426311|NCT00774852|1016457|P2|NOT COMPLETED|Overall Study||41
426312|NCT00774852|1016458|P1|NOT COMPLETED|Overall Study||45
426313|NCT00774852|1016457|P2|COMPLETED|Overall Study||27
426314|NCT00774852|1016458|P1|COMPLETED|Overall Study||24
426315|NCT00774852|1016457|P2|STARTED|Overall Study||68
426316|NCT00774852|1016458|P1|STARTED|Overall Study||69
426317|NCT00774800|1016506|P1|NOT COMPLETED|Intervention 4||1
426318|NCT00774800|1016506|P1|COMPLETED|Intervention 4||21
426319|NCT00774800|1016506|P1|Received at Least One Dose of Study Drug|Intervention 4||21
426320|NCT00774800|1016506|P1|STARTED|Intervention 4||22
426321|NCT00774800|1016506|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
426322|NCT00774800|1016506|P1|COMPLETED|Washout (3 to 10 Days)||22
426323|NCT00774800|1016506|P1|STARTED|Washout (3 to 10 Days)||22
426324|NCT00774800|1016506|P1|NOT COMPLETED|Intervention 3||0
426325|NCT00774800|1016506|P1|COMPLETED|Intervention 3||22
426326|NCT00774800|1016506|P1|Received at Least One Dose of Study Drug|Intervention 3||22
426327|NCT00774800|1016506|P1|STARTED|Intervention 3||22
426328|NCT00774800|1016506|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
426329|NCT00774800|1016506|P1|COMPLETED|Washout (3 to 10 Days)||22
426330|NCT00774800|1016506|P1|STARTED|Washout (3 to 10 Days)||22
426331|NCT00774800|1016506|P1|NOT COMPLETED|Intervention 2||0
426332|NCT00774800|1016506|P1|COMPLETED|Intervention 2||22
426333|NCT00774800|1016506|P1|Received at Least One Dose of Study Drug|Intervention 2||22
426334|NCT00774800|1016506|P1|STARTED|Intervention 2||22
426335|NCT00774800|1016506|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
426336|NCT00774800|1016506|P1|COMPLETED|Washout (3 to 10 Days)||22
426337|NCT00774800|1016506|P1|STARTED|Washout (3 to 10 Days)||22
426338|NCT00774800|1016506|P1|NOT COMPLETED|Intervention 1||0
426339|NCT00774800|1016506|P1|COMPLETED|Intervention 1||22
426340|NCT00774800|1016506|P1|Received at Least One Dose of Study Drug|Intervention 1||22
426341|NCT00774800|1016506|P1|STARTED|Intervention 1||22
426342|NCT00774787|1016528|P1|NOT COMPLETED|Overall Study||1
426343|NCT00774787|1016528|P1|COMPLETED|Overall Study||26
426344|NCT00774787|1016528|P1|STARTED|Overall Study||27
426345|NCT00774748|1016535|P1|NOT COMPLETED|Overall Study||3
426346|NCT00774748|1016535|P1|COMPLETED|Overall Study||18
426347|NCT00774748|1016535|P1|STARTED|Overall Study||21
426348|NCT00774397|1016550|P7|NOT COMPLETED|Overall Study||30
426349|NCT00774397|1016551|P6|NOT COMPLETED|Overall Study||22
426350|NCT00774397|1016552|P5|NOT COMPLETED|Overall Study||46
426351|NCT00774397|1016553|P4|NOT COMPLETED|Overall Study||17
426352|NCT00774397|1016554|P3|NOT COMPLETED|Overall Study||30
426353|NCT00774397|1016555|P2|NOT COMPLETED|Overall Study||13
426354|NCT00774397|1016556|P1|NOT COMPLETED|Overall Study||14
426355|NCT00774397|1016550|P7|COMPLETED|Overall Study||41
426356|NCT00774397|1016551|P6|COMPLETED|Overall Study||54
426357|NCT00774397|1016552|P5|COMPLETED|Overall Study||97
426358|NCT00774397|1016553|P4|COMPLETED|Overall Study||129
426359|NCT00774397|1016554|P3|COMPLETED|Overall Study||113
426360|NCT00774397|1016555|P2|COMPLETED|Overall Study||56
426361|NCT00774397|1016556|P1|COMPLETED|Overall Study||57
426362|NCT00774397|1016550|P7|STARTED|Overall Study||71
426363|NCT00774397|1016551|P6|STARTED|Overall Study||76
426364|NCT00774397|1016552|P5|STARTED|Overall Study||143
426365|NCT00774397|1016553|P4|STARTED|Overall Study||146
426366|NCT00774397|1016554|P3|STARTED|Overall Study||143
426367|NCT00774397|1016555|P2|STARTED|Overall Study||69
426368|NCT00774397|1016556|P1|STARTED|Overall Study||71
426369|NCT00774306|1016792|P4|NOT COMPLETED|Overall Study||5
426370|NCT00774306|1016793|P3|NOT COMPLETED|Overall Study||8
426371|NCT00774306|1016794|P2|NOT COMPLETED|Overall Study||2
426372|NCT00774306|1016795|P1|NOT COMPLETED|Overall Study||18
426373|NCT00774306|1016792|P4|COMPLETED|Overall Study||2
426374|NCT00774306|1016793|P3|COMPLETED|Overall Study||8
426375|NCT00774306|1016794|P2|COMPLETED|Overall Study||3
426376|NCT00774306|1016795|P1|COMPLETED|Overall Study||6
426377|NCT00774306|1016792|P4|STARTED|Overall Study||7
426378|NCT00774306|1016793|P3|STARTED|Overall Study||16
426379|NCT00774306|1016794|P2|STARTED|Overall Study||5
426380|NCT00774306|1016795|P1|STARTED|Overall Study||24
426381|NCT00774267|1016809|P4|NOT COMPLETED|Overall Study||0
426382|NCT00774267|1016810|P3|NOT COMPLETED|Overall Study||0
426383|NCT00774267|1016811|P2|NOT COMPLETED|Overall Study||0
426384|NCT00774267|1016812|P1|NOT COMPLETED|Overall Study||0
426385|NCT00774267|1016809|P4|COMPLETED|Overall Study||135
426386|NCT00774267|1016810|P3|COMPLETED|Overall Study||129
426387|NCT00774267|1016811|P2|COMPLETED|Overall Study||111
426388|NCT00774267|1016812|P1|COMPLETED|Overall Study||132
426389|NCT00774267|1016809|P4|STARTED|Overall Study||135
426390|NCT00774267|1016810|P3|STARTED|Overall Study||129
426391|NCT00774267|1016811|P2|STARTED|Overall Study||111
426392|NCT00774267|1016812|P1|STARTED|Overall Study||132
426393|NCT00774163|1016824|P2|NOT COMPLETED|Overall Study||0
426394|NCT00774163|1016825|P1|NOT COMPLETED|Overall Study||0
426395|NCT00774163|1016824|P2|COMPLETED|Overall Study||15
426396|NCT00774163|1016825|P1|COMPLETED|Overall Study||30
426397|NCT00774163|1016824|P2|STARTED|Overall Study||15
426398|NCT00774163|1016825|P1|STARTED|Overall Study||30
426399|NCT00774046|1016863|P1|NOT COMPLETED|Autologous Transplant||0
426400|NCT00774046|1016863|P1|COMPLETED|Autologous Transplant||4
426401|NCT00774046|1016863|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
426402|NCT00774046|1016863|P1|NOT COMPLETED|Stem Cell Mobilization||3
426403|NCT00774046|1016863|P1|COMPLETED|Stem Cell Mobilization||7
426404|NCT00774046|1016863|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
426405|NCT00774046|1016863|P1|NOT COMPLETED|Induction Therapy||0
426406|NCT00774046|1016863|P1|COMPLETED|Induction Therapy||32
426407|NCT00774046|1016863|P1|STARTED|Induction Therapy||32
426408|NCT00774046|1016863|P1|NOT COMPLETED|Enrollment||28
426409|NCT00774046|1016863|P1|COMPLETED|Enrollment||32
426410|NCT00774046|1016863|P1|STARTED|Enrollment||60
426411|NCT00774046|1016863|P1|NOT COMPLETED|Screening||56
426412|NCT00774046|1016863|P1|COMPLETED|Screening||60
426413|NCT00774046|1016863|P1|STARTED|Screening||116
426414|NCT00773968|1016873|P1|NOT COMPLETED|Overall Study||45
426415|NCT00773968|1016873|P1|COMPLETED|Overall Study||95
426416|NCT00773968|1016873|P1|Treated|Overall Study||111
426417|NCT00773968|1016873|P1|STARTED|Overall Study||140
426418|NCT00773955|1016882|P1|NOT COMPLETED|Overall Study||0
426419|NCT00773955|1016882|P1|COMPLETED|Overall Study||15
426420|NCT00773955|1016882|P1|STARTED|Overall Study||15
426421|NCT00773786|1016889|P2|NOT COMPLETED|Second Intervention (1 Week)||0
426422|NCT00773786|1016890|P1|NOT COMPLETED|Second Intervention (1 Week)||0
426423|NCT00773786|1016889|P2|COMPLETED|Second Intervention (1 Week)||10
426424|NCT00773786|1016890|P1|COMPLETED|Second Intervention (1 Week)||10
426425|NCT00773786|1016889|P2|STARTED|Second Intervention (1 Week)||10
426426|NCT00773786|1016890|P1|STARTED|Second Intervention (1 Week)||10
426427|NCT00773786|1016889|P2|NOT COMPLETED|Washout (1 Week)||0
426428|NCT00773786|1016890|P1|NOT COMPLETED|Washout (1 Week)||0
426429|NCT00773786|1016889|P2|COMPLETED|Washout (1 Week)||10
426430|NCT00773786|1016890|P1|COMPLETED|Washout (1 Week)||10
426431|NCT00773786|1016889|P2|STARTED|Washout (1 Week)||10
426432|NCT00773786|1016890|P1|STARTED|Washout (1 Week)||10
426433|NCT00773786|1016889|P2|NOT COMPLETED|First Intervention (1 Week)||0
426434|NCT00773786|1016890|P1|NOT COMPLETED|First Intervention (1 Week)||0
426435|NCT00773786|1016889|P2|COMPLETED|First Intervention (1 Week)||10
426436|NCT00773786|1016890|P1|COMPLETED|First Intervention (1 Week)||10
426437|NCT00773786|1016889|P2|STARTED|First Intervention (1 Week)||10
426438|NCT00773786|1016890|P1|STARTED|First Intervention (1 Week)||10
426439|NCT00773734|1016904|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
426440|NCT00773734|1016905|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
426441|NCT00773734|1016906|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
426442|NCT00773734|1016907|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
426443|NCT00773734|1016908|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
426444|NCT00773734|1016909|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
426445|NCT00773734|1016904|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
426446|NCT00773734|1016905|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
426447|NCT00773734|1016906|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
426448|NCT00773734|1016907|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
426449|NCT00773734|1016908|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
426450|NCT00773734|1016909|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
426451|NCT00773734|1016904|P6|STARTED|LTE Period: Week 52 to 6 Years||0
426452|NCT00773734|1016905|P5|STARTED|LTE Period: Week 52 to 6 Years||0
426453|NCT00773734|1016906|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
426454|NCT00773734|1016907|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
426455|NCT00773734|1016908|P2|STARTED|LTE Period: Week 52 to 6 Years||0
426456|NCT00773734|1016909|P1|STARTED|LTE Period: Week 52 to 6 Years||0
426457|NCT00773734|1016904|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
426458|NCT00773734|1016905|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
426459|NCT00773734|1016906|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
426460|NCT00773734|1016907|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
426461|NCT00773734|1016908|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
426462|NCT00773734|1016909|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
426463|NCT00773734|1016904|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
426464|NCT00773734|1016905|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
426465|NCT00773734|1016906|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
426466|NCT00773734|1016907|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
426467|NCT00773734|1016908|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
426468|NCT00773734|1016909|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
426469|NCT00773734|1016904|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
426470|NCT00773734|1016905|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
426471|NCT00773734|1016906|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
426472|NCT00773734|1016907|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
426473|NCT00773734|1016908|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
426474|NCT00773734|1016909|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
426475|NCT00773734|1016904|P6|STARTED|Extension: Active Treatment Week 24-52||27
426476|NCT00773734|1016905|P5|STARTED|Extension: Active Treatment Week 24-52||27
426477|NCT00773734|1016906|P4|STARTED|Extension: Active Treatment Week 24-52||58
426478|NCT00773734|1016907|P3|STARTED|Extension: Active Treatment Week 24-52||50
426479|NCT00773734|1016908|P2|STARTED|Extension: Active Treatment Week 24-52||47
426480|NCT00773734|1016909|P1|STARTED|Extension: Active Treatment Week 24-52||0
426481|NCT00773734|1016904|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
426482|NCT00773734|1016905|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
426483|NCT00773734|1016906|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
426484|NCT00773734|1016907|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
426485|NCT00773734|1016908|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
426486|NCT00773734|1016909|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
426487|NCT00773734|1016904|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
426488|NCT00773734|1016905|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
426489|NCT00773734|1016906|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
426490|NCT00773734|1016907|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
426491|NCT00773734|1016908|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
426492|NCT00773734|1016909|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
426493|NCT00773734|1016904|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
426494|NCT00773734|1016905|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
426495|NCT00773734|1016906|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
426496|NCT00773734|1016907|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
426497|NCT00773734|1016908|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
426498|NCT00773734|1016909|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
426499|NCT00773734|1016904|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
426500|NCT00773734|1016905|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
426501|NCT00773734|1016906|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
426502|NCT00773734|1016907|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
426503|NCT00773734|1016908|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
426504|NCT00773734|1016909|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
426505|NCT00773734|1016904|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
426506|NCT00773734|1016905|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
426507|NCT00773734|1016906|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
426508|NCT00773734|1016907|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
426509|NCT00773734|1016908|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
426510|NCT00773734|1016909|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
426511|NCT00773734|1016904|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
426512|NCT00773734|1016905|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
426513|NCT00773734|1016906|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
426514|NCT00773734|1016907|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
426515|NCT00773734|1016908|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
426516|NCT00773734|1016909|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
426517|NCT00773474|1017471|P1|NOT COMPLETED|Overall Study||0
426518|NCT00773474|1017471|P1|COMPLETED|Overall Study||29
426519|NCT00773474|1017471|P1|STARTED|Overall Study||29
426520|NCT00773461|1017480|P2|NOT COMPLETED|Overall Study||4
426521|NCT00773461|1017481|P1|NOT COMPLETED|Overall Study||5
426522|NCT00773461|1017480|P2|COMPLETED|Overall Study||135
426523|NCT00773461|1017481|P1|COMPLETED|Overall Study||65
426524|NCT00773461|1017480|P2|STARTED|Overall Study||139
426525|NCT00773461|1017481|P1|STARTED|Overall Study||70
426526|NCT00773383|1017519|P1|NOT COMPLETED|Overall Study||31
426527|NCT00773383|1017519|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
426528|NCT00773383|1017519|P1|Received Study Drug|Overall Study||34
426529|NCT00773383|1017519|P1|STARTED|Overall Study||35
426530|NCT00773370|1017541|P2|NOT COMPLETED|Overall Study||10
426531|NCT00773370|1017542|P1|NOT COMPLETED|Overall Study||18
426532|NCT00773370|1017541|P2|COMPLETED|Overall Study||23
426533|NCT00773370|1017542|P1|COMPLETED|Overall Study||25
426534|NCT00773370|1017541|P2|STARTED|Overall Study||33
426535|NCT00773370|1017542|P1|STARTED|Overall Study||43
426536|NCT00773279|1017554|P2|NOT COMPLETED|Period 2||6
426537|NCT00773279|1017555|P1|NOT COMPLETED|Period 2||3
426538|NCT00773279|1017554|P2|COMPLETED|Period 2||111
426539|NCT00773279|1017555|P1|COMPLETED|Period 2||111
426540|NCT00773279|1017554|P2|STARTED|Period 2||117
426541|NCT00773279|1017555|P1|STARTED|Period 2||114
426542|NCT00773279|1017554|P2|NOT COMPLETED|Period 1||4
426543|NCT00773279|1017555|P1|NOT COMPLETED|Period 1||7
426544|NCT00773279|1017554|P2|COMPLETED|Period 1||117
426545|NCT00773279|1017555|P1|COMPLETED|Period 1||114
426546|NCT00773279|1017554|P2|STARTED|Period 1||121
426547|NCT00773279|1017555|P1|STARTED|Period 1||121
426548|NCT00773253|1017576|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
426549|NCT00773253|1017577|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
426550|NCT00773253|1017576|P2|COMPLETED|Second Intervention (Week 24-48)||4
426551|NCT00773253|1017577|P1|COMPLETED|Second Intervention (Week 24-48)||5
426552|NCT00773253|1017576|P2|STARTED|Second Intervention (Week 24-48)||4
426553|NCT00773253|1017577|P1|STARTED|Second Intervention (Week 24-48)||5
426554|NCT00773253|1017576|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
426555|NCT00773253|1017577|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
426556|NCT00773253|1017576|P2|COMPLETED|First Intervention (Week 0-24)||4
426557|NCT00773253|1017577|P1|COMPLETED|First Intervention (Week 0-24)||5
426558|NCT00773253|1017576|P2|STARTED|First Intervention (Week 0-24)||5
426559|NCT00773253|1017577|P1|STARTED|First Intervention (Week 0-24)||5
426560|NCT00773136|1017583|P1|NOT COMPLETED|Overall Study||2
426561|NCT00773136|1017583|P1|COMPLETED|Overall Study||19
426562|NCT00773136|1017583|P1|STARTED|Overall Study||21
426563|NCT00773097|1017588|P1|NOT COMPLETED|Overall Study||7
426564|NCT00773097|1017588|P1|COMPLETED|Overall Study||39
426565|NCT00773097|1017588|P1|STARTED|Overall Study||46
426566|NCT00772967|1017594|P6|NOT COMPLETED|Crossover Treatment 3||0
426567|NCT00772967|1017595|P5|NOT COMPLETED|Crossover Treatment 3||1
426568|NCT00772967|1017596|P4|NOT COMPLETED|Crossover Treatment 3||0
426569|NCT00772967|1017597|P3|NOT COMPLETED|Crossover Treatment 3||0
426570|NCT00772967|1017598|P2|NOT COMPLETED|Crossover Treatment 3||0
426571|NCT00772967|1017599|P1|NOT COMPLETED|Crossover Treatment 3||0
426572|NCT00772967|1017594|P6|COMPLETED|Crossover Treatment 3||3
426573|NCT00772967|1017595|P5|COMPLETED|Crossover Treatment 3||3
426574|NCT00772967|1017596|P4|COMPLETED|Crossover Treatment 3||3
426575|NCT00772967|1017597|P3|COMPLETED|Crossover Treatment 3||3
426576|NCT00772967|1017598|P2|COMPLETED|Crossover Treatment 3||4
426577|NCT00772967|1017599|P1|COMPLETED|Crossover Treatment 3||3
426578|NCT00772967|1017594|P6|STARTED|Crossover Treatment 3||3
426579|NCT00772967|1017595|P5|STARTED|Crossover Treatment 3||4
426580|NCT00772967|1017596|P4|STARTED|Crossover Treatment 3||3
426581|NCT00772967|1017597|P3|STARTED|Crossover Treatment 3||3
426582|NCT00772967|1017598|P2|STARTED|Crossover Treatment 3||4
426583|NCT00772967|1017599|P1|STARTED|Crossover Treatment 3||3
426584|NCT00772967|1017594|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
426585|NCT00772967|1017595|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
426586|NCT00772967|1017596|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
426587|NCT00772967|1017597|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
426588|NCT00772967|1017598|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
426589|NCT00772967|1017599|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
426590|NCT00772967|1017594|P6|COMPLETED|Break 2 (4-7 Days)||3
426591|NCT00772967|1017595|P5|COMPLETED|Break 2 (4-7 Days)||4
426592|NCT00772967|1017596|P4|COMPLETED|Break 2 (4-7 Days)||3
426593|NCT00772967|1017597|P3|COMPLETED|Break 2 (4-7 Days)||3
426594|NCT00772967|1017598|P2|COMPLETED|Break 2 (4-7 Days)||4
426595|NCT00772967|1017599|P1|COMPLETED|Break 2 (4-7 Days)||3
426596|NCT00772967|1017594|P6|STARTED|Break 2 (4-7 Days)||3
426597|NCT00772967|1017595|P5|STARTED|Break 2 (4-7 Days)||4
426598|NCT00772967|1017596|P4|STARTED|Break 2 (4-7 Days)||3
426599|NCT00772967|1017597|P3|STARTED|Break 2 (4-7 Days)||3
426600|NCT00772967|1017598|P2|STARTED|Break 2 (4-7 Days)||4
426601|NCT00772967|1017599|P1|STARTED|Break 2 (4-7 Days)||3
426602|NCT00772967|1017594|P6|NOT COMPLETED|Crossover Treatment 2||0
426603|NCT00772967|1017595|P5|NOT COMPLETED|Crossover Treatment 2||0
426604|NCT00772967|1017596|P4|NOT COMPLETED|Crossover Treatment 2||0
426605|NCT00772967|1017597|P3|NOT COMPLETED|Crossover Treatment 2||0
426606|NCT00772967|1017598|P2|NOT COMPLETED|Crossover Treatment 2||0
426607|NCT00772967|1017599|P1|NOT COMPLETED|Crossover Treatment 2||0
426608|NCT00772967|1017594|P6|COMPLETED|Crossover Treatment 2||3
426609|NCT00772967|1017595|P5|COMPLETED|Crossover Treatment 2||4
426610|NCT00772967|1017596|P4|COMPLETED|Crossover Treatment 2||3
426611|NCT00772967|1017597|P3|COMPLETED|Crossover Treatment 2||3
426612|NCT00772967|1017598|P2|COMPLETED|Crossover Treatment 2||4
426613|NCT00772967|1017599|P1|COMPLETED|Crossover Treatment 2||3
426614|NCT00772967|1017594|P6|STARTED|Crossover Treatment 2||3
426615|NCT00772967|1017595|P5|STARTED|Crossover Treatment 2||4
426616|NCT00772967|1017596|P4|STARTED|Crossover Treatment 2||3
426617|NCT00772967|1017597|P3|STARTED|Crossover Treatment 2||3
426618|NCT00772967|1017598|P2|STARTED|Crossover Treatment 2||4
426619|NCT00772967|1017599|P1|STARTED|Crossover Treatment 2||3
426620|NCT00772967|1017594|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
426621|NCT00772967|1017595|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
426622|NCT00772967|1017596|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
426623|NCT00772967|1017597|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
426624|NCT00772967|1017598|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
426625|NCT00772967|1017599|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
426626|NCT00772967|1017594|P6|COMPLETED|Break 1 (4-7 Days)||3
426627|NCT00772967|1017595|P5|COMPLETED|Break 1 (4-7 Days)||4
426628|NCT00772967|1017596|P4|COMPLETED|Break 1 (4-7 Days)||3
426629|NCT00772967|1017597|P3|COMPLETED|Break 1 (4-7 Days)||3
426630|NCT00772967|1017598|P2|COMPLETED|Break 1 (4-7 Days)||4
426631|NCT00772967|1017599|P1|COMPLETED|Break 1 (4-7 Days)||3
426632|NCT00772967|1017594|P6|STARTED|Break 1 (4-7 Days)||3
426633|NCT00772967|1017595|P5|STARTED|Break 1 (4-7 Days)||4
426634|NCT00772967|1017596|P4|STARTED|Break 1 (4-7 Days)||3
426635|NCT00772967|1017597|P3|STARTED|Break 1 (4-7 Days)||3
426636|NCT00772967|1017598|P2|STARTED|Break 1 (4-7 Days)||5
426637|NCT00772967|1017599|P1|STARTED|Break 1 (4-7 Days)||3
426638|NCT00772967|1017594|P6|NOT COMPLETED|Crossover Treatment 1||0
426639|NCT00772967|1017595|P5|NOT COMPLETED|Crossover Treatment 1||0
426640|NCT00772967|1017596|P4|NOT COMPLETED|Crossover Treatment 1||1
426641|NCT00772967|1017597|P3|NOT COMPLETED|Crossover Treatment 1||0
426642|NCT00772967|1017598|P2|NOT COMPLETED|Crossover Treatment 1||0
426643|NCT00772967|1017599|P1|NOT COMPLETED|Crossover Treatment 1||0
426644|NCT00772967|1017594|P6|COMPLETED|Crossover Treatment 1||3
426645|NCT00772967|1017595|P5|COMPLETED|Crossover Treatment 1||4
426646|NCT00772967|1017596|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
426647|NCT00772967|1017597|P3|COMPLETED|Crossover Treatment 1||3
426648|NCT00772967|1017598|P2|COMPLETED|Crossover Treatment 1||5
426649|NCT00772967|1017599|P1|COMPLETED|Crossover Treatment 1||3
426650|NCT00772967|1017594|P6|STARTED|Crossover Treatment 1||3
426651|NCT00772967|1017595|P5|STARTED|Crossover Treatment 1||4
426652|NCT00772967|1017596|P4|STARTED|Crossover Treatment 1||4
426653|NCT00772967|1017597|P3|STARTED|Crossover Treatment 1||3
426654|NCT00772967|1017598|P2|STARTED|Crossover Treatment 1||5
426655|NCT00772967|1017599|P1|STARTED|Crossover Treatment 1||3
426656|NCT00772954|1017619|P3|NOT COMPLETED|Overall Study||1
426657|NCT00772954|1017620|P2|NOT COMPLETED|Overall Study||0
426658|NCT00772954|1017621|P1|NOT COMPLETED|Overall Study||0
426659|NCT00772954|1017619|P3|COMPLETED|Overall Study||11
426660|NCT00772954|1017620|P2|COMPLETED|Overall Study||12
426661|NCT00772954|1017621|P1|COMPLETED|Overall Study||12
426662|NCT00772954|1017619|P3|STARTED|Overall Study||12
426663|NCT00772954|1017620|P2|STARTED|Overall Study||12
426664|NCT00772954|1017621|P1|STARTED|Overall Study||12
426665|NCT00772941|1017629|P1|NOT COMPLETED|Overall Study||682
426666|NCT00772941|1017629|P1|COMPLETED|Overall Study||3257
426667|NCT00772941|1017629|P1|STARTED|Overall Study||3939
426668|NCT00772928|1017660|P2|NOT COMPLETED|Overall Study||41
426669|NCT00772928|1017661|P1|NOT COMPLETED|Overall Study||44
426670|NCT00772928|1017660|P2|COMPLETED|Overall Study||538
426671|NCT00772928|1017661|P1|COMPLETED|Overall Study||543
426672|NCT00772928|1017660|P2|STARTED|Overall Study||579
426673|NCT00772928|1017661|P1|STARTED|Overall Study||587
426674|NCT00772915|1017671|P1|NOT COMPLETED|Overall Study||15
426675|NCT00772915|1017671|P1|COMPLETED|Overall Study||23
426676|NCT00772915|1017671|P1|STARTED|Overall Study||38
426677|NCT00772889|1017678|P3|NOT COMPLETED|Overall Study||16
426678|NCT00772889|1017679|P2|NOT COMPLETED|Overall Study||18
426679|NCT00772889|1017680|P1|NOT COMPLETED|Overall Study||22
426680|NCT00772889|1017678|P3|COMPLETED|Overall Study||187
426681|NCT00772889|1017679|P2|COMPLETED|Overall Study||375
426682|NCT00772889|1017680|P1|COMPLETED|Overall Study||353
426683|NCT00772889|1017678|P3|Completed at Day 21|Overall Study||203
426684|NCT00772889|1017679|P2|Completed at Day 21|Overall Study||390
426685|NCT00772889|1017680|P1|Completed at Day 21|Overall Study||374
426686|NCT00772889|1017678|P3|STARTED|Overall Study||203
426687|NCT00772889|1017679|P2|STARTED|Overall Study||393
426688|NCT00772889|1017680|P1|STARTED|Overall Study||375
426689|NCT00772772|1017733|P1|NOT COMPLETED|Overall Study||0
426690|NCT00772772|1017733|P1|COMPLETED|Overall Study||12
426691|NCT00772772|1017733|P1|STARTED|Overall Study||12
426692|NCT00772707|1017738|P1|NOT COMPLETED|Overall Study||3
426693|NCT00772707|1017738|P1|COMPLETED|Overall Study||111
426694|NCT00772707|1017738|P1|STARTED|Overall Study||114
426695|NCT00772668|1017743|P1|NOT COMPLETED|Overall Study||3
426696|NCT00772668|1017743|P1|COMPLETED|Overall Study||0
426697|NCT00772668|1017743|P1|STARTED|Overall Study||3
426698|NCT00772629|1017749|P2|NOT COMPLETED|Overall Study||0
426699|NCT00772629|1017750|P1|NOT COMPLETED|Overall Study||1
426700|NCT00772629|1017749|P2|COMPLETED|Overall Study||1
426701|NCT00772629|1017750|P1|COMPLETED|Overall Study||16
426702|NCT00772629|1017749|P2|STARTED|Overall Study||1
426703|NCT00772629|1017750|P1|STARTED|Overall Study||17
426704|NCT00772603|1017759|P3|NOT COMPLETED|Overall Study||26
426705|NCT00772603|1017760|P2|NOT COMPLETED|Overall Study||40
426706|NCT00772603|1017761|P1|NOT COMPLETED|Overall Study||52
426707|NCT00772603|1017759|P3|COMPLETED|Overall Study||95
426708|NCT00772603|1017760|P2|COMPLETED|Overall Study||82
426709|NCT00772603|1017761|P1|COMPLETED|Overall Study||71
426710|NCT00772603|1017759|P3|STARTED|Overall Study||121
426711|NCT00772603|1017760|P2|STARTED|Overall Study||122
426712|NCT00772603|1017761|P1|STARTED|Overall Study||123
426713|NCT00772590|1017785|P4|NOT COMPLETED|Overall Study||0
426714|NCT00772590|1017786|P3|NOT COMPLETED|Overall Study||0
426715|NCT00772590|1017787|P2|NOT COMPLETED|Overall Study||0
426716|NCT00772590|1017788|P1|NOT COMPLETED|Overall Study||0
426717|NCT00772590|1017785|P4|COMPLETED|Overall Study||17
426718|NCT00772590|1017786|P3|COMPLETED|Overall Study||18
426719|NCT00772590|1017787|P2|COMPLETED|Overall Study||19
426720|NCT00772590|1017788|P1|COMPLETED|Overall Study||19
426721|NCT00772590|1017785|P4|STARTED|Overall Study||17
426722|NCT00772590|1017786|P3|STARTED|Overall Study||18
426723|NCT00772590|1017787|P2|STARTED|Overall Study||19
426724|NCT00772590|1017788|P1|STARTED|Overall Study||19
426725|NCT00772577|1017800|P2|NOT COMPLETED|Overall Study||23
426726|NCT00772577|1017801|P1|NOT COMPLETED|Overall Study||23
426727|NCT00772577|1017800|P2|COMPLETED|Overall Study||170
426728|NCT00772577|1017801|P1|COMPLETED|Overall Study||170
426729|NCT00772577|1017800|P2|STARTED|Overall Study||193
426730|NCT00772577|1017801|P1|STARTED|Overall Study||193
426731|NCT00772538|1017817|P2|NOT COMPLETED|Overall Study||26
426732|NCT00772538|1017818|P1|NOT COMPLETED|Overall Study||20
426733|NCT00772538|1017817|P2|COMPLETED|Overall Study||211
426734|NCT00772538|1017818|P1|COMPLETED|Overall Study||202
426735|NCT00772538|1017817|P2|STARTED|Overall Study||237
426736|NCT00772538|1017818|P1|STARTED|Overall Study||222
426737|NCT00772447|1017890|P2|NOT COMPLETED|Overall Study||24
426738|NCT00772447|1017891|P1|NOT COMPLETED|Overall Study||20
426739|NCT00772447|1017890|P2|COMPLETED|Overall Study||110
426740|NCT00772447|1017891|P1|COMPLETED|Overall Study||111
426741|NCT00772447|1017890|P2|STARTED|Overall Study||134
426742|NCT00772447|1017891|P1|STARTED|Overall Study||131
426743|NCT00772382|1017919|P1|NOT COMPLETED|Overall Study||55
426744|NCT00772382|1017919|P1|COMPLETED|Overall Study||61
426745|NCT00772382|1017919|P1|STARTED|Overall Study||116
426746|NCT00772369|1017924|P1|NOT COMPLETED|Overall Study||1
426747|NCT00772369|1017924|P1|COMPLETED|Overall Study||3213
426748|NCT00772369|1017924|P1|STARTED|Overall Study||3214
426749|NCT00772304|1017929|P1|NOT COMPLETED|Overall Study||0
426750|NCT00772304|1017929|P1|COMPLETED|Overall Study||102
426751|NCT00772304|1017929|P1|STARTED|Overall Study||102
426752|NCT00772148|1017935|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
426753|NCT00772148|1017936|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
426754|NCT00772148|1017935|P2|COMPLETED|Maintenance Phase (Week 52)||18
426755|NCT00772148|1017936|P1|COMPLETED|Maintenance Phase (Week 52)||17
426756|NCT00772148|1017935|P2|STARTED|Maintenance Phase (Week 52)||23
426757|NCT00772148|1017936|P1|STARTED|Maintenance Phase (Week 52)||21
426758|NCT00772148|1017935|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
426759|NCT00772148|1017936|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
426760|NCT00772148|1017935|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
426761|NCT00772148|1017936|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
426762|NCT00772148|1017935|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
426763|NCT00772148|1017936|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
426764|NCT00772109|1017956|P4|NOT COMPLETED|Overall Study||31
426765|NCT00772109|1017957|P3|NOT COMPLETED|Overall Study||19
426766|NCT00772109|1017958|P2|NOT COMPLETED|Overall Study||19
426767|NCT00772109|1017959|P1|NOT COMPLETED|Overall Study||21
426768|NCT00772109|1017956|P4|COMPLETED|Overall Study||1397
426769|NCT00772109|1017957|P3|COMPLETED|Overall Study||936
426770|NCT00772109|1017958|P2|COMPLETED|Overall Study||934
426771|NCT00772109|1017959|P1|COMPLETED|Overall Study||935
426772|NCT00772109|1017956|P4|STARTED|Overall Study||1428
426773|NCT00772109|1017957|P3|STARTED|Overall Study||955
426774|NCT00772109|1017958|P2|STARTED|Overall Study||953
426775|NCT00772109|1017959|P1|STARTED|Overall Study||956
426776|NCT00772070|1017983|P2|NOT COMPLETED|Overall Study||10
426777|NCT00772070|1017984|P1|NOT COMPLETED|Overall Study||2
426778|NCT00772070|1017983|P2|COMPLETED|Overall Study||61
426779|NCT00772070|1017984|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
426780|NCT00772070|1017983|P2|STARTED|Overall Study||71
426781|NCT00772070|1017984|P1|STARTED|Overall Study||102
426782|NCT00772031|1017996|P2|NOT COMPLETED|Overall Study||43
426783|NCT00772031|1017997|P1|NOT COMPLETED|Overall Study||32
426784|NCT00772031|1017996|P2|COMPLETED|Overall Study||52
426785|NCT00772031|1017997|P1|COMPLETED|Overall Study||64
426786|NCT00772031|1017996|P2|STARTED|Overall Study||95
426787|NCT00772031|1017997|P1|STARTED|Overall Study||96
426788|NCT00772005|1018023|P4|NOT COMPLETED|Overall Study||26
426789|NCT00772005|1018024|P3|NOT COMPLETED|Overall Study||28
426790|NCT00772005|1018025|P2|NOT COMPLETED|Overall Study||30
426791|NCT00772005|1018026|P1|NOT COMPLETED|Overall Study||25
426792|NCT00772005|1018023|P4|COMPLETED|Overall Study||46
426793|NCT00772005|1018024|P3|COMPLETED|Overall Study||44
426794|NCT00772005|1018025|P2|COMPLETED|Overall Study||40
426795|NCT00772005|1018026|P1|COMPLETED|Overall Study||46
426796|NCT00772005|1018023|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
426797|NCT00772005|1018024|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
426798|NCT00772005|1018025|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
426799|NCT00772005|1018026|P1|STARTED|Overall Study||71
426800|NCT00771953|1018714|P2|NOT COMPLETED|Overall Study||10
426801|NCT00771953|1018715|P1|NOT COMPLETED|Overall Study||10
426802|NCT00771953|1018714|P2|COMPLETED|Overall Study||26
426803|NCT00771953|1018715|P1|COMPLETED|Overall Study||26
426804|NCT00771953|1018714|P2|STARTED|Overall Study||36
426805|NCT00771953|1018715|P1|STARTED|Overall Study||36
426806|NCT00771927|1018725|P2|NOT COMPLETED|Overall Study||237
426807|NCT00771927|1018726|P1|NOT COMPLETED|Overall Study||255
426808|NCT00771927|1018725|P2|COMPLETED|Overall Study||256
426809|NCT00771927|1018726|P1|COMPLETED|Overall Study||256
426810|NCT00771927|1018725|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
426811|NCT00771927|1018726|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
426812|NCT00771914|1018738|P4|NOT COMPLETED|Overall Study||2
426813|NCT00771914|1018739|P3|NOT COMPLETED|Overall Study||0
426814|NCT00771914|1018740|P2|NOT COMPLETED|Overall Study||0
426815|NCT00771914|1018741|P1|NOT COMPLETED|Overall Study||0
426816|NCT00771914|1018738|P4|COMPLETED|Overall Study||6
426817|NCT00771914|1018739|P3|COMPLETED|Overall Study||6
426818|NCT00771914|1018740|P2|COMPLETED|Overall Study||6
426819|NCT00771914|1018741|P1|COMPLETED|Overall Study||7
426820|NCT00771914|1018738|P4|STARTED|Overall Study||8
426821|NCT00771914|1018739|P3|STARTED|Overall Study||6
426822|NCT00771914|1018740|P2|STARTED|Overall Study||6
426823|NCT00771914|1018741|P1|STARTED|Overall Study||7
426824|NCT00771875|1018754|P3|NOT COMPLETED|Overall Study||0
426825|NCT00771875|1018755|P2|NOT COMPLETED|Overall Study||1
426826|NCT00771875|1018756|P1|NOT COMPLETED|Overall Study||0
426827|NCT00771875|1018754|P3|COMPLETED|Overall Study||10
426828|NCT00771875|1018755|P2|COMPLETED|Overall Study||9
426829|NCT00771875|1018756|P1|COMPLETED|Overall Study||10
426830|NCT00771875|1018754|P3|STARTED|Overall Study||10
426831|NCT00771875|1018755|P2|STARTED|Overall Study||10
426832|NCT00771875|1018756|P1|STARTED|Overall Study||10
426833|NCT00771849|1018784|P2|NOT COMPLETED|Overall Study||4
426834|NCT00771849|1018785|P1|NOT COMPLETED|Overall Study||2
426835|NCT00771849|1018784|P2|COMPLETED|Overall Study||47
426836|NCT00771849|1018785|P1|COMPLETED|Overall Study||50
426837|NCT00771849|1018784|P2|STARTED|Overall Study|One subject was not vaccinated|51
426838|NCT00771849|1018785|P1|STARTED|Overall Study||52
426839|NCT00771810|1018796|P3|NOT COMPLETED|Overall Study||7
426840|NCT00771810|1018797|P2|NOT COMPLETED|Overall Study||5
426841|NCT00771810|1018798|P1|NOT COMPLETED|Overall Study||5
426842|NCT00771810|1018796|P3|COMPLETED|Overall Study||6
426843|NCT00771810|1018797|P2|COMPLETED|Overall Study||6
426844|NCT00771810|1018798|P1|COMPLETED|Overall Study||5
426845|NCT00771810|1018796|P3|STARTED|Overall Study||13
426846|NCT00771810|1018797|P2|STARTED|Overall Study||11
426847|NCT00771810|1018798|P1|STARTED|Overall Study||10
426848|NCT00771758|1018836|P3|NOT COMPLETED|Overall Study||2
426849|NCT00771758|1018837|P2|NOT COMPLETED|Overall Study||12
426850|NCT00771758|1018838|P1|NOT COMPLETED|Overall Study||8
426851|NCT00771758|1018836|P3|COMPLETED|Overall Study||19
426852|NCT00771758|1018837|P2|COMPLETED|Overall Study||31
426853|NCT00771758|1018838|P1|COMPLETED|Overall Study||36
426854|NCT00771758|1018836|P3|STARTED|Overall Study||21
426855|NCT00771758|1018837|P2|STARTED|Overall Study||43
426856|NCT00771758|1018838|P1|STARTED|Overall Study||44
426857|NCT00771745|1018988|P2|NOT COMPLETED|Overall Study||0
426858|NCT00771745|1018989|P1|NOT COMPLETED|Overall Study||0
426859|NCT00771745|1018988|P2|COMPLETED|Overall Study||5
426860|NCT00771745|1018989|P1|COMPLETED|Overall Study||6
426861|NCT00771745|1018988|P2|STARTED|Overall Study||5
426862|NCT00771745|1018989|P1|STARTED|Overall Study||6
426863|NCT00771667|1018999|P10|NOT COMPLETED|Maintenance Phase||17
426864|NCT00771667|1019000|P9|NOT COMPLETED|Maintenance Phase||22
426865|NCT00771667|1019001|P8|NOT COMPLETED|Maintenance Phase||5
426866|NCT00771667|1019002|P7|NOT COMPLETED|Maintenance Phase||10
426867|NCT00771667|1019003|P6|NOT COMPLETED|Maintenance Phase||7
426868|NCT00771667|1019004|P5|NOT COMPLETED|Maintenance Phase||2
426869|NCT00771667|1019005|P4|NOT COMPLETED|Maintenance Phase||0
426870|NCT00771667|1019006|P3|NOT COMPLETED|Maintenance Phase||0
426871|NCT00771667|1019007|P2|NOT COMPLETED|Maintenance Phase||0
426872|NCT00771667|1019008|P1|NOT COMPLETED|Maintenance Phase||0
426873|NCT00771667|1018999|P10|COMPLETED|Maintenance Phase||92
426874|NCT00771667|1019000|P9|COMPLETED|Maintenance Phase||88
426875|NCT00771667|1019001|P8|COMPLETED|Maintenance Phase||67
426876|NCT00771667|1019002|P7|COMPLETED|Maintenance Phase||63
426877|NCT00771667|1019003|P6|COMPLETED|Maintenance Phase||78
426878|NCT00771667|1019004|P5|COMPLETED|Maintenance Phase||26
426879|NCT00771667|1019005|P4|COMPLETED|Maintenance Phase||0
426880|NCT00771667|1019006|P3|COMPLETED|Maintenance Phase||0
426881|NCT00771667|1019007|P2|COMPLETED|Maintenance Phase||0
426882|NCT00771667|1019008|P1|COMPLETED|Maintenance Phase||0
426883|NCT00771667|1018999|P10|STARTED|Maintenance Phase||109
426884|NCT00771667|1019000|P9|STARTED|Maintenance Phase||110
426885|NCT00771667|1019001|P8|STARTED|Maintenance Phase||72
426886|NCT00771667|1019002|P7|STARTED|Maintenance Phase||73
426887|NCT00771667|1019003|P6|STARTED|Maintenance Phase||85
426888|NCT00771667|1019004|P5|STARTED|Maintenance Phase||28
426889|NCT00771667|1019005|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
426890|NCT00771667|1019006|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
426891|NCT00771667|1019007|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
426892|NCT00771667|1019008|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
426893|NCT00771667|1018999|P10|NOT COMPLETED|Induction Phase||0
426894|NCT00771667|1019000|P9|NOT COMPLETED|Induction Phase||0
426895|NCT00771667|1019001|P8|NOT COMPLETED|Induction Phase||0
426896|NCT00771667|1019002|P7|NOT COMPLETED|Induction Phase||0
426897|NCT00771667|1019003|P6|NOT COMPLETED|Induction Phase||0
426898|NCT00771667|1019004|P5|NOT COMPLETED|Induction Phase||0
426899|NCT00771667|1019005|P4|NOT COMPLETED|Induction Phase||8
426900|NCT00771667|1019006|P3|NOT COMPLETED|Induction Phase||12
426901|NCT00771667|1019007|P2|NOT COMPLETED|Induction Phase||10
426902|NCT00771667|1019008|P1|NOT COMPLETED|Induction Phase||19
426903|NCT00771667|1018999|P10|COMPLETED|Induction Phase||0
426904|NCT00771667|1019000|P9|COMPLETED|Induction Phase||0
426905|NCT00771667|1019001|P8|COMPLETED|Induction Phase||0
426906|NCT00771667|1019002|P7|COMPLETED|Induction Phase||0
426907|NCT00771667|1019003|P6|COMPLETED|Induction Phase||0
426908|NCT00771667|1019004|P5|COMPLETED|Induction Phase||0
426909|NCT00771667|1019005|P4|COMPLETED|Induction Phase||123
426910|NCT00771667|1019006|P3|COMPLETED|Induction Phase||120
426911|NCT00771667|1019007|P2|COMPLETED|Induction Phase||121
426912|NCT00771667|1019008|P1|COMPLETED|Induction Phase||113
426913|NCT00771667|1018999|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
426914|NCT00771667|1019000|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
426915|NCT00771667|1019001|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
426916|NCT00771667|1019002|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
426917|NCT00771667|1019003|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
426918|NCT00771667|1019004|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
426919|NCT00771667|1019005|P4|STARTED|Induction Phase||131
426920|NCT00771667|1019006|P3|STARTED|Induction Phase||132
426921|NCT00771667|1019007|P2|STARTED|Induction Phase||131
426922|NCT00771667|1019008|P1|STARTED|Induction Phase||132
426923|NCT00771615|1019053|P9|NOT COMPLETED|Overall Study||0
426924|NCT00771615|1019054|P8|NOT COMPLETED|Overall Study||1
426925|NCT00771615|1019055|P7|NOT COMPLETED|Overall Study||1
426926|NCT00771615|1019056|P6|NOT COMPLETED|Overall Study||1
426927|NCT00771615|1019057|P5|NOT COMPLETED|Overall Study||0
426928|NCT00771615|1019058|P4|NOT COMPLETED|Overall Study||1
426929|NCT00771615|1019059|P3|NOT COMPLETED|Overall Study||1
426930|NCT00771615|1019060|P2|NOT COMPLETED|Overall Study||2
426931|NCT00771615|1019061|P1|NOT COMPLETED|Overall Study||1
426932|NCT00771615|1019053|P9|COMPLETED|Overall Study|Up to Day 364|41
426933|NCT00771615|1019054|P8|COMPLETED|Overall Study|Up to Day 364|58
426934|NCT00771615|1019055|P7|COMPLETED|Overall Study|Up to Day 364|45
426935|NCT00771615|1019056|P6|COMPLETED|Overall Study|Up to Day 364|60
426936|NCT00771615|1019057|P5|COMPLETED|Overall Study|Up to Day 364|40
426937|NCT00771615|1019058|P4|COMPLETED|Overall Study|Up to Day 364|59
426938|NCT00771615|1019059|P3|COMPLETED|Overall Study|Up to Day 364|40
426939|NCT00771615|1019060|P2|COMPLETED|Overall Study|Up to Day 364|70
426940|NCT00771615|1019061|P1|COMPLETED|Overall Study|Up to Day 364|48
426941|NCT00771615|1019053|P9|STARTED|Overall Study||41
426942|NCT00771615|1019054|P8|STARTED|Overall Study||59
426943|NCT00771615|1019055|P7|STARTED|Overall Study||46
426944|NCT00771615|1019056|P6|STARTED|Overall Study||61
426945|NCT00771615|1019057|P5|STARTED|Overall Study||40
426946|NCT00771615|1019058|P4|STARTED|Overall Study||60
426947|NCT00771615|1019059|P3|STARTED|Overall Study||41
426948|NCT00771615|1019060|P2|STARTED|Overall Study||72
426949|NCT00771615|1019061|P1|STARTED|Overall Study||49
426950|NCT00771602|1019255|P3|NOT COMPLETED|Overall Study||0
426951|NCT00771602|1019256|P2|NOT COMPLETED|Overall Study||0
426952|NCT00771602|1019257|P1|NOT COMPLETED|Overall Study||0
426953|NCT00771602|1019255|P3|COMPLETED|Overall Study||0
426954|NCT00771602|1019256|P2|COMPLETED|Overall Study||0
426955|NCT00771602|1019257|P1|COMPLETED|Overall Study||1
426956|NCT00771602|1019255|P3|STARTED|Overall Study||0
426957|NCT00771602|1019256|P2|STARTED|Overall Study||0
426958|NCT00771602|1019257|P1|STARTED|Overall Study||1
426959|NCT00771537|1019281|P16|NOT COMPLETED|Overall Study||0
426960|NCT00771537|1019282|P15|NOT COMPLETED|Overall Study||0
426961|NCT00771537|1019283|P14|NOT COMPLETED|Overall Study||0
426962|NCT00771537|1019284|P13|NOT COMPLETED|Overall Study||0
426963|NCT00771537|1019285|P12|NOT COMPLETED|Overall Study||0
426964|NCT00771537|1019286|P11|NOT COMPLETED|Overall Study||0
426965|NCT00771537|1019287|P10|NOT COMPLETED|Overall Study||0
426966|NCT00771537|1019288|P9|NOT COMPLETED|Overall Study||0
426967|NCT00771537|1019289|P8|NOT COMPLETED|Overall Study||0
426968|NCT00771537|1019290|P7|NOT COMPLETED|Overall Study||0
426969|NCT00771537|1019291|P6|NOT COMPLETED|Overall Study||0
426970|NCT00771537|1019292|P5|NOT COMPLETED|Overall Study||0
426971|NCT00771537|1019293|P4|NOT COMPLETED|Overall Study||0
426972|NCT00771537|1019294|P3|NOT COMPLETED|Overall Study||0
426973|NCT00771537|1019295|P2|NOT COMPLETED|Overall Study||0
426974|NCT00771537|1019296|P1|NOT COMPLETED|Overall Study||0
426975|NCT00771537|1019281|P16|COMPLETED|Overall Study||122
426976|NCT00771537|1019282|P15|COMPLETED|Overall Study||124
426977|NCT00771537|1019283|P14|COMPLETED|Overall Study||124
426978|NCT00771537|1019284|P13|COMPLETED|Overall Study||128
426979|NCT00771537|1019285|P12|COMPLETED|Overall Study||137
426980|NCT00771537|1019286|P11|COMPLETED|Overall Study||133
426981|NCT00771537|1019287|P10|COMPLETED|Overall Study||119
426982|NCT00771537|1019288|P9|COMPLETED|Overall Study||115
426983|NCT00771537|1019289|P8|COMPLETED|Overall Study||132
426984|NCT00771537|1019290|P7|COMPLETED|Overall Study||128
426985|NCT00771537|1019291|P6|COMPLETED|Overall Study||118
426986|NCT00771537|1019292|P5|COMPLETED|Overall Study||127
426987|NCT00771537|1019293|P4|COMPLETED|Overall Study||114
426988|NCT00771537|1019294|P3|COMPLETED|Overall Study||151
426989|NCT00771537|1019295|P2|COMPLETED|Overall Study||124
426990|NCT00771537|1019296|P1|COMPLETED|Overall Study||135
426991|NCT00771537|1019281|P16|STARTED|Overall Study||122
426992|NCT00771537|1019282|P15|STARTED|Overall Study||124
426993|NCT00771537|1019283|P14|STARTED|Overall Study||124
426994|NCT00771537|1019284|P13|STARTED|Overall Study||128
426995|NCT00771537|1019285|P12|STARTED|Overall Study||137
426996|NCT00771537|1019286|P11|STARTED|Overall Study||133
426997|NCT00771537|1019287|P10|STARTED|Overall Study||119
426998|NCT00771537|1019288|P9|STARTED|Overall Study||115
426999|NCT00771537|1019289|P8|STARTED|Overall Study||132
427000|NCT00771537|1019290|P7|STARTED|Overall Study||128
427001|NCT00771537|1019291|P6|STARTED|Overall Study||118
427002|NCT00771537|1019292|P5|STARTED|Overall Study||127
427003|NCT00771537|1019293|P4|STARTED|Overall Study||114
427004|NCT00771537|1019294|P3|STARTED|Overall Study||151
427005|NCT00771537|1019295|P2|STARTED|Overall Study||124
427006|NCT00771537|1019296|P1|STARTED|Overall Study||135
427007|NCT00771472|1019322|P2|NOT COMPLETED|Overall Study||4
427008|NCT00771472|1019323|P1|NOT COMPLETED|Overall Study||6
427009|NCT00771472|1019322|P2|COMPLETED|Overall Study||0
427010|NCT00771472|1019323|P1|COMPLETED|Overall Study||0
427011|NCT00771472|1019322|P2|STARTED|Overall Study||4
427012|NCT00771472|1019323|P1|STARTED|Overall Study||6
427013|NCT00771407|1019334|P2|NOT COMPLETED|Overall Study||25
427014|NCT00771407|1019335|P1|NOT COMPLETED|Overall Study||20
427015|NCT00771407|1019334|P2|COMPLETED|Overall Study||35
427016|NCT00771407|1019335|P1|COMPLETED|Overall Study||40
427017|NCT00771407|1019334|P2|STARTED|Overall Study||60
427018|NCT00771407|1019335|P1|STARTED|Overall Study||60
427019|NCT00771316|1019343|P2|NOT COMPLETED|Overall Study||1
427020|NCT00771316|1019344|P1|NOT COMPLETED|Overall Study||2
427021|NCT00771316|1019343|P2|COMPLETED|Overall Study||1
427022|NCT00771316|1019344|P1|COMPLETED|Overall Study||2
427023|NCT00771316|1019343|P2|STARTED|Overall Study||2
427024|NCT00771316|1019344|P1|STARTED|Overall Study||4
427025|NCT00771277|1019354|P1|NOT COMPLETED|Overall Study||0
427026|NCT00771277|1019354|P1|COMPLETED|Overall Study||6
427027|NCT00771277|1019354|P1|STARTED|Overall Study||6
427028|NCT00771264|1019362|P2|NOT COMPLETED|Overall Study||5
427029|NCT00771264|1019363|P1|NOT COMPLETED|Overall Study||7
427030|NCT00771264|1019362|P2|COMPLETED|Overall Study||105
427031|NCT00771264|1019363|P1|COMPLETED|Overall Study||103
427032|NCT00771264|1019362|P2|STARTED|Overall Study||110
427033|NCT00771264|1019363|P1|STARTED|Overall Study||110
427034|NCT00771238|1019371|P2|NOT COMPLETED|Overall Study||0
427035|NCT00771238|1019372|P1|NOT COMPLETED|Overall Study||0
427036|NCT00771238|1019371|P2|COMPLETED|Overall Study||21
427037|NCT00771238|1019372|P1|COMPLETED|Overall Study||31
427038|NCT00771238|1019371|P2|STARTED|Overall Study||21
427039|NCT00771238|1019372|P1|STARTED|Overall Study||31
427040|NCT00771173|1019382|P2|NOT COMPLETED|Overall Study||17
427041|NCT00771173|1019383|P1|NOT COMPLETED|Overall Study||22
427042|NCT00771173|1019382|P2|COMPLETED|Overall Study||112
427043|NCT00771173|1019383|P1|COMPLETED|Overall Study||107
427044|NCT00771173|1019382|P2|STARTED|Overall Study||129
427045|NCT00771173|1019383|P1|STARTED|Overall Study||129
427046|NCT00771056|1019389|P1|NOT COMPLETED|Overall Study||5
427047|NCT00771056|1019389|P1|COMPLETED|Overall Study||18
427048|NCT00771056|1019389|P1|STARTED|Overall Study||23
427049|NCT00770991|1019396|P2|NOT COMPLETED|Overall Study||5
427050|NCT00770991|1019397|P1|NOT COMPLETED|Overall Study||5
427051|NCT00770991|1019396|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
427052|NCT00770991|1019397|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
427053|NCT00770991|1019396|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
427054|NCT00770991|1019397|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
427055|NCT00770965|1019413|P4|NOT COMPLETED|Excluded Set||13
427056|NCT00770965|1019414|P3|NOT COMPLETED|Excluded Set||14
427057|NCT00770965|1019415|P2|NOT COMPLETED|Excluded Set||13
427058|NCT00770965|1019416|P1|NOT COMPLETED|Excluded Set||15
427059|NCT00770965|1019413|P4|COMPLETED|Excluded Set||2
427060|NCT00770965|1019414|P3|COMPLETED|Excluded Set||2
427061|NCT00770965|1019415|P2|COMPLETED|Excluded Set||3
427062|NCT00770965|1019416|P1|COMPLETED|Excluded Set||3
427063|NCT00770965|1019413|P4|STARTED|Excluded Set||15
427064|NCT00770965|1019414|P3|STARTED|Excluded Set||16
427065|NCT00770965|1019415|P2|STARTED|Excluded Set||16
427066|NCT00770965|1019416|P1|STARTED|Excluded Set||18
427067|NCT00770965|1019413|P4|NOT COMPLETED|Safety Set||1
427068|NCT00770965|1019414|P3|NOT COMPLETED|Safety Set||1
427069|NCT00770965|1019415|P2|NOT COMPLETED|Safety Set||0
427070|NCT00770965|1019416|P1|NOT COMPLETED|Safety Set||0
427071|NCT00770965|1019413|P4|COMPLETED|Safety Set||4
427072|NCT00770965|1019414|P3|COMPLETED|Safety Set||3
427073|NCT00770965|1019415|P2|COMPLETED|Safety Set||4
427074|NCT00770965|1019416|P1|COMPLETED|Safety Set||2
427075|NCT00770965|1019413|P4|STARTED|Safety Set||5
427076|NCT00770965|1019414|P3|STARTED|Safety Set||4
427077|NCT00770965|1019415|P2|STARTED|Safety Set||4
427078|NCT00770965|1019416|P1|STARTED|Safety Set||2
427079|NCT00770913|1019437|P3|NOT COMPLETED|Overall Study||13
427080|NCT00770913|1019438|P2|NOT COMPLETED|Overall Study||8
427081|NCT00770913|1019439|P1|NOT COMPLETED|Overall Study||11
427082|NCT00770913|1019437|P3|COMPLETED|Overall Study||100
427083|NCT00770913|1019438|P2|COMPLETED|Overall Study||103
427084|NCT00770913|1019439|P1|COMPLETED|Overall Study||102
427085|NCT00770913|1019437|P3|STARTED|Overall Study||113
427086|NCT00770913|1019438|P2|STARTED|Overall Study||111
427087|NCT00770913|1019439|P1|STARTED|Overall Study||113
427088|NCT00770861|1019449|P2|NOT COMPLETED|Overall Study||16
427089|NCT00770861|1019450|P1|NOT COMPLETED|Overall Study||10
427090|NCT00770861|1019449|P2|COMPLETED|Overall Study||120
427091|NCT00770861|1019450|P1|COMPLETED|Overall Study||131
427092|NCT00770861|1019449|P2|STARTED|Overall Study||136
427093|NCT00770861|1019450|P1|STARTED|Overall Study||141
427094|NCT00770809|1019461|P3|NOT COMPLETED|Overall Study||23
427095|NCT00770809|1019462|P2|NOT COMPLETED|Overall Study||10
427096|NCT00770809|1019463|P1|NOT COMPLETED|Overall Study||17
427097|NCT00770809|1019461|P3|COMPLETED|Overall Study||44
427098|NCT00770809|1019462|P2|COMPLETED|Overall Study||110
427099|NCT00770809|1019463|P1|COMPLETED|Overall Study||101
427100|NCT00770809|1019461|P3|STARTED|Overall Study||67
427101|NCT00770809|1019462|P2|STARTED|Overall Study||120
427102|NCT00770809|1019463|P1|STARTED|Overall Study||118
427103|NCT00770770|1019473|P2|NOT COMPLETED|Overall Study||1
427104|NCT00770770|1019474|P1|NOT COMPLETED|Overall Study||10
427105|NCT00770770|1019473|P2|COMPLETED|Overall Study||5
427106|NCT00770770|1019474|P1|COMPLETED|Overall Study||4
427107|NCT00770770|1019473|P2|STARTED|Overall Study||6
427108|NCT00770770|1019474|P1|STARTED|Overall Study||14
427109|NCT00770757|1019480|P1|NOT COMPLETED|Overall Study||0
427110|NCT00770757|1019480|P1|COMPLETED|Overall Study||13
427111|NCT00770757|1019480|P1|STARTED|Overall Study||13
427112|NCT00770692|1019492|P4|NOT COMPLETED|Overall Study||11
427113|NCT00770692|1019493|P3|NOT COMPLETED|Overall Study||14
427114|NCT00770692|1019494|P2|NOT COMPLETED|Overall Study||9
427115|NCT00770692|1019495|P1|NOT COMPLETED|Overall Study||12
427116|NCT00770692|1019492|P4|COMPLETED|Overall Study||66
427117|NCT00770692|1019493|P3|COMPLETED|Overall Study||70
427118|NCT00770692|1019494|P2|COMPLETED|Overall Study||74
427119|NCT00770692|1019495|P1|COMPLETED|Overall Study||69
427120|NCT00770692|1019492|P4|STARTED|Overall Study||77
427121|NCT00770692|1019493|P3|STARTED|Overall Study||84
427122|NCT00770692|1019494|P2|STARTED|Overall Study||83
427123|NCT00770692|1019495|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
427124|NCT00770653|1019523|P2|NOT COMPLETED|Overall Study||29
427125|NCT00770653|1019524|P1|NOT COMPLETED|Overall Study||32
427126|NCT00770653|1019523|P2|COMPLETED|Overall Study||121
427127|NCT00770653|1019524|P1|COMPLETED|Overall Study||123
427128|NCT00770653|1019523|P2|STARTED|Overall Study||150
427129|NCT00770653|1019524|P1|STARTED|Overall Study||155
427130|NCT00770588|1019594|P2|NOT COMPLETED|Overall Study||95
427131|NCT00770588|1019595|P1|NOT COMPLETED|Overall Study||81
427132|NCT00770588|1019594|P2|COMPLETED|Overall Study||53
427133|NCT00770588|1019595|P1|COMPLETED|Overall Study||67
427134|NCT00770588|1019594|P2|STARTED|Overall Study||148
427135|NCT00770588|1019595|P1|STARTED|Overall Study||148
427136|NCT00770562|1019611|P2|NOT COMPLETED|Overall Study||1
427137|NCT00770562|1019612|P1|NOT COMPLETED|Overall Study||1
427138|NCT00770562|1019611|P2|COMPLETED|Overall Study||49
427139|NCT00770562|1019612|P1|COMPLETED|Overall Study||52
427140|NCT00770562|1019611|P2|STARTED|Overall Study||50
427141|NCT00770562|1019612|P1|STARTED|Overall Study||53
427142|NCT00770510|1019623|P1|NOT COMPLETED|Overall Study||5
427143|NCT00770510|1019623|P1|COMPLETED|Overall Study||67
427144|NCT00770510|1019623|P1|STARTED|Overall Study||72
427145|NCT00770484|1019662|P2|NOT COMPLETED|Overall Study||0
427146|NCT00770484|1019663|P1|NOT COMPLETED|Overall Study||1
427147|NCT00770484|1019662|P2|COMPLETED|Overall Study||4
427148|NCT00770484|1019663|P1|COMPLETED|Overall Study||7
427149|NCT00770484|1019662|P2|STARTED|Overall Study||4
427150|NCT00770484|1019663|P1|STARTED|Overall Study||8
427151|NCT00770432|1019671|P2|NOT COMPLETED|Overall Study||7
427152|NCT00770432|1019672|P1|NOT COMPLETED|Overall Study||4
427153|NCT00770432|1019671|P2|COMPLETED|Overall Study||94
427154|NCT00770432|1019672|P1|COMPLETED|Overall Study||98
427155|NCT00770432|1019671|P2|STARTED|Overall Study||101
427156|NCT00770432|1019672|P1|STARTED|Overall Study||102
427157|NCT00770367|1019680|P2|NOT COMPLETED|Second Intervention||0
427158|NCT00770367|1019681|P1|NOT COMPLETED|Second Intervention||2
427159|NCT00770367|1019680|P2|COMPLETED|Second Intervention||15
427160|NCT00770367|1019681|P1|COMPLETED|Second Intervention||16
427161|NCT00770367|1019680|P2|STARTED|Second Intervention||15
427162|NCT00770367|1019681|P1|STARTED|Second Intervention||18
427163|NCT00770367|1019680|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
427164|NCT00770367|1019681|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
427165|NCT00770367|1019680|P2|COMPLETED|Washout Period of 4 Weeks||15
427166|NCT00770367|1019681|P1|COMPLETED|Washout Period of 4 Weeks||18
427167|NCT00770367|1019680|P2|STARTED|Washout Period of 4 Weeks||16
427168|NCT00770367|1019681|P1|STARTED|Washout Period of 4 Weeks||18
427169|NCT00770367|1019680|P2|NOT COMPLETED|First Intervention||2
427170|NCT00770367|1019681|P1|NOT COMPLETED|First Intervention||0
427171|NCT00770367|1019680|P2|COMPLETED|First Intervention||16
427172|NCT00770367|1019681|P1|COMPLETED|First Intervention||18
427173|NCT00770367|1019680|P2|STARTED|First Intervention||18
427174|NCT00770367|1019681|P1|STARTED|First Intervention||18
427175|NCT00770341|1019690|P3|NOT COMPLETED|Overall Study||3
427176|NCT00770341|1019691|P2|NOT COMPLETED|Overall Study||5
427177|NCT00770341|1019692|P1|NOT COMPLETED|Overall Study||12
427178|NCT00770341|1019690|P3|COMPLETED|Overall Study||8
427179|NCT00770341|1019691|P2|COMPLETED|Overall Study||17
427180|NCT00770341|1019692|P1|COMPLETED|Overall Study||77
427181|NCT00770341|1019690|P3|STARTED|Overall Study|Number randomized|11
427182|NCT00770341|1019691|P2|STARTED|Overall Study|Number randomized|22
427183|NCT00770341|1019692|P1|STARTED|Overall Study|Number randomized|89
427184|NCT00770315|1019720|P4|NOT COMPLETED|Overall Study||38
427185|NCT00770315|1019721|P3|NOT COMPLETED|Overall Study||57
427186|NCT00770315|1019722|P2|NOT COMPLETED|Overall Study||43
427187|NCT00770315|1019723|P1|NOT COMPLETED|Overall Study||40
427188|NCT00770315|1019720|P4|COMPLETED|Overall Study||160
427189|NCT00770315|1019721|P3|COMPLETED|Overall Study||137
427190|NCT00770315|1019722|P2|COMPLETED|Overall Study||152
427191|NCT00770315|1019723|P1|COMPLETED|Overall Study||157
427192|NCT00770315|1019720|P4|STARTED|Overall Study||198
427193|NCT00770315|1019721|P3|STARTED|Overall Study||194
427194|NCT00770315|1019722|P2|STARTED|Overall Study||195
427195|NCT00770315|1019723|P1|STARTED|Overall Study||197
427196|NCT00770289|1019749|P1|NOT COMPLETED|Overall Study||6
427197|NCT00770289|1019749|P1|COMPLETED|Overall Study||845
427198|NCT00770289|1019749|P1|STARTED|Overall Study||851
427199|NCT00770211|1019760|P2|NOT COMPLETED|Overall Study||2
427200|NCT00770211|1019761|P1|NOT COMPLETED|Overall Study||1
427201|NCT00770211|1019760|P2|COMPLETED|Overall Study||87
427202|NCT00770211|1019761|P1|COMPLETED|Overall Study||181
427203|NCT00770211|1019760|P2|STARTED|Overall Study||89
427204|NCT00770211|1019761|P1|STARTED|Overall Study||182
427205|NCT00770146|1019777|P2|NOT COMPLETED|Follow-up Period||20
427206|NCT00770146|1019778|P1|NOT COMPLETED|Follow-up Period||11
427207|NCT00770146|1019777|P2|COMPLETED|Follow-up Period||85
427208|NCT00770146|1019778|P1|COMPLETED|Follow-up Period||42
427209|NCT00770146|1019777|P2|STARTED|Follow-up Period||105
427210|NCT00770146|1019778|P1|STARTED|Follow-up Period||53
427211|NCT00770146|1019777|P2|NOT COMPLETED|Treatment Period||45
427212|NCT00770146|1019778|P1|NOT COMPLETED|Treatment Period||9
427213|NCT00770146|1019777|P2|COMPLETED|Treatment Period||60
427214|NCT00770146|1019778|P1|COMPLETED|Treatment Period||44
427215|NCT00770146|1019777|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
427216|NCT00770146|1019778|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
427217|NCT00770146|1019777|P2|Treated|Treatment Period||105
427218|NCT00770146|1019778|P1|Treated|Treatment Period||52
427219|NCT00770146|1019777|P2|STARTED|Treatment Period||105
427220|NCT00770146|1019778|P1|STARTED|Treatment Period||53
427221|NCT00770120|1019822|P1|NOT COMPLETED|Overall Study||61
427222|NCT00770120|1019822|P1|COMPLETED|Overall Study||0
427223|NCT00770120|1019822|P1|Not Analyzable|Overall Study||1
427224|NCT00770120|1019822|P1|Eligible|Overall Study||60
427225|NCT00770120|1019822|P1|STARTED|Overall Study||61
427226|NCT00770029|1019831|P2|NOT COMPLETED|Overall Study||3
427227|NCT00770029|1019832|P1|NOT COMPLETED|Overall Study||6
427228|NCT00770029|1019831|P2|COMPLETED|Overall Study||89
427229|NCT00770029|1019832|P1|COMPLETED|Overall Study||178
427230|NCT00770029|1019831|P2|STARTED|Overall Study||92
427231|NCT00770029|1019832|P1|STARTED|Overall Study||184
427232|NCT00769860|1019848|P2|NOT COMPLETED|Overall Study||0
427233|NCT00769860|1019849|P1|NOT COMPLETED|Overall Study||2
427234|NCT00769860|1019848|P2|COMPLETED|Overall Study||8
427235|NCT00769860|1019849|P1|COMPLETED|Overall Study||14
427236|NCT00769860|1019848|P2|Month 8|Overall Study||8
427237|NCT00769860|1019849|P1|Month 8|Overall Study||14
427238|NCT00769860|1019848|P2|Month 4|Overall Study||8
427239|NCT00769860|1019849|P1|Month 4|Overall Study||16
427240|NCT00769860|1019848|P2|STARTED|Overall Study||8
427241|NCT00769860|1019849|P1|STARTED|Overall Study||16
427242|NCT00769704|1019877|P2|NOT COMPLETED|Overall Study||199
427243|NCT00769704|1019878|P1|NOT COMPLETED|Overall Study||111
427244|NCT00769704|1019877|P2|COMPLETED|Overall Study||97
427245|NCT00769704|1019878|P1|COMPLETED|Overall Study||30
427246|NCT00769704|1019877|P2|Received Treatment|Overall Study||292
427247|NCT00769704|1019878|P1|Received Treatment|Overall Study||127
427248|NCT00769704|1019877|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
427249|NCT00769704|1019878|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
427250|NCT00769704|1019877|P2|STARTED|Overall Study||296
427251|NCT00769704|1019878|P1|STARTED|Overall Study||141
427252|NCT00769652|1019898|P2|NOT COMPLETED|Overall Study||0
427253|NCT00769652|1019899|P1|NOT COMPLETED|Overall Study||0
427254|NCT00769652|1019898|P2|COMPLETED|Overall Study||1
427255|NCT00769652|1019899|P1|COMPLETED|Overall Study||6
427256|NCT00769652|1019898|P2|STARTED|Overall Study||1
427257|NCT00769652|1019899|P1|STARTED|Overall Study||6
427258|NCT00769561|1019911|P2|NOT COMPLETED|Overall Study||5
427259|NCT00769561|1019912|P1|NOT COMPLETED|Overall Study||3
427260|NCT00769561|1019911|P2|COMPLETED|Overall Study||24
427261|NCT00769561|1019912|P1|COMPLETED|Overall Study||26
427262|NCT00769561|1019911|P2|STARTED|Overall Study||29
427263|NCT00769561|1019912|P1|STARTED|Overall Study||29
427264|NCT00769314|1019934|P2|NOT COMPLETED|Overall Study||13
427265|NCT00769314|1019935|P1|NOT COMPLETED|Overall Study||17
427266|NCT00769314|1019934|P2|COMPLETED|Overall Study||384
427267|NCT00769314|1019935|P1|COMPLETED|Overall Study||361
427268|NCT00769314|1019934|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
427269|NCT00769314|1019935|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
427270|NCT00769184|1019961|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
427271|NCT00769184|1019962|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
427272|NCT00769184|1019961|P2|COMPLETED|No Treatment (6 Weeks)||6
427273|NCT00769184|1019962|P1|COMPLETED|No Treatment (6 Weeks)||5
427274|NCT00769184|1019961|P2|STARTED|No Treatment (6 Weeks)||7
427275|NCT00769184|1019962|P1|STARTED|No Treatment (6 Weeks)||6
427276|NCT00769184|1019961|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
427277|NCT00769184|1019962|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
427278|NCT00769184|1019961|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
427279|NCT00769184|1019962|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
427280|NCT00769184|1019961|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
427281|NCT00769184|1019962|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
427282|NCT00769184|1019961|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
427283|NCT00769184|1019962|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
427284|NCT00769184|1019961|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
427285|NCT00769184|1019962|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
427286|NCT00769184|1019961|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
427287|NCT00769184|1019962|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
427288|NCT00769132|1019970|P4|NOT COMPLETED|Period 4||0
427289|NCT00769132|1019971|P3|NOT COMPLETED|Period 4||0
427290|NCT00769132|1019972|P2|NOT COMPLETED|Period 4||1
427291|NCT00769132|1019973|P1|NOT COMPLETED|Period 4||0
427292|NCT00769132|1019970|P4|COMPLETED|Period 4||5
427293|NCT00769132|1019971|P3|COMPLETED|Period 4||6
427294|NCT00769132|1019972|P2|COMPLETED|Period 4||5
427295|NCT00769132|1019973|P1|COMPLETED|Period 4||5
427296|NCT00769132|1019970|P4|STARTED|Period 4||5
427297|NCT00769132|1019971|P3|STARTED|Period 4||6
427298|NCT00769132|1019972|P2|STARTED|Period 4||6
427299|NCT00769132|1019973|P1|STARTED|Period 4||5
427300|NCT00769132|1019970|P4|NOT COMPLETED|Period 3||0
427301|NCT00769132|1019971|P3|NOT COMPLETED|Period 3||0
427302|NCT00769132|1019972|P2|NOT COMPLETED|Period 3||0
427303|NCT00769132|1019973|P1|NOT COMPLETED|Period 3||1
427304|NCT00769132|1019970|P4|COMPLETED|Period 3||5
427305|NCT00769132|1019971|P3|COMPLETED|Period 3||6
427306|NCT00769132|1019972|P2|COMPLETED|Period 3||6
427307|NCT00769132|1019973|P1|COMPLETED|Period 3||5
427308|NCT00769132|1019970|P4|STARTED|Period 3||5
427309|NCT00769132|1019971|P3|STARTED|Period 3||6
427310|NCT00769132|1019972|P2|STARTED|Period 3||6
427311|NCT00769132|1019973|P1|STARTED|Period 3||6
427312|NCT00769132|1019970|P4|NOT COMPLETED|Period 2||1
427313|NCT00769132|1019971|P3|NOT COMPLETED|Period 2||0
427314|NCT00769132|1019972|P2|NOT COMPLETED|Period 2||0
427315|NCT00769132|1019973|P1|NOT COMPLETED|Period 2||0
427316|NCT00769132|1019970|P4|COMPLETED|Period 2||5
427317|NCT00769132|1019971|P3|COMPLETED|Period 2||6
427318|NCT00769132|1019972|P2|COMPLETED|Period 2||6
427319|NCT00769132|1019973|P1|COMPLETED|Period 2||6
427320|NCT00769132|1019970|P4|STARTED|Period 2||6
427321|NCT00769132|1019971|P3|STARTED|Period 2||6
427322|NCT00769132|1019972|P2|STARTED|Period 2||6
427323|NCT00769132|1019973|P1|STARTED|Period 2||6
427324|NCT00769132|1019970|P4|NOT COMPLETED|Period 1||1
427325|NCT00769132|1019971|P3|NOT COMPLETED|Period 1||0
427326|NCT00769132|1019972|P2|NOT COMPLETED|Period 1||0
427327|NCT00769132|1019973|P1|NOT COMPLETED|Period 1||1
427328|NCT00769132|1019970|P4|COMPLETED|Period 1||6
427329|NCT00769132|1019971|P3|COMPLETED|Period 1||6
427330|NCT00769132|1019972|P2|COMPLETED|Period 1||6
427331|NCT00769132|1019973|P1|COMPLETED|Period 1||6
427332|NCT00769132|1019970|P4|STARTED|Period 1||7
427333|NCT00769132|1019971|P3|STARTED|Period 1||6
427334|NCT00769132|1019972|P2|STARTED|Period 1||6
427335|NCT00769132|1019973|P1|STARTED|Period 1||7
427336|NCT00769119|1019989|P2|NOT COMPLETED|Overall Study||3
427337|NCT00769119|1019990|P1|NOT COMPLETED|Overall Study||2
427338|NCT00769119|1019989|P2|COMPLETED|Overall Study||13
427339|NCT00769119|1019990|P1|COMPLETED|Overall Study||20
427340|NCT00769119|1019989|P2|STARTED|Overall Study||16
427341|NCT00769119|1019990|P1|STARTED|Overall Study||22
427342|NCT00769067|1020036|P2|NOT COMPLETED|Overall Study||94
427343|NCT00769067|1020037|P1|NOT COMPLETED|Overall Study||94
427344|NCT00769067|1020036|P2|COMPLETED|Overall Study||0
427345|NCT00769067|1020037|P1|COMPLETED|Overall Study||0
427346|NCT00769067|1020036|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
427347|NCT00769067|1020037|P1|Treated|Overall Study||94
427348|NCT00769067|1020036|P2|STARTED|Overall Study||94
427349|NCT00769067|1020037|P1|STARTED|Overall Study||94
427350|NCT00769015|1020064|P2|NOT COMPLETED|Overall Study||16
427351|NCT00769015|1020065|P1|NOT COMPLETED|Overall Study||9
427352|NCT00769015|1020064|P2|COMPLETED|Overall Study||76
427353|NCT00769015|1020065|P1|COMPLETED|Overall Study||87
427354|NCT00769015|1020064|P2|STARTED|Overall Study||92
427355|NCT00769015|1020065|P1|STARTED|Overall Study||96
427356|NCT00768989|1020085|P2|NOT COMPLETED|On or After Week 36||27
427357|NCT00768989|1020086|P1|NOT COMPLETED|On or After Week 36||51
427358|NCT00768989|1020085|P2|COMPLETED|On or After Week 36||0
427359|NCT00768989|1020086|P1|COMPLETED|On or After Week 36||0
427360|NCT00768989|1020085|P2|STARTED|On or After Week 36||27
427361|NCT00768989|1020086|P1|STARTED|On or After Week 36||51
427362|NCT00768989|1020085|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
427363|NCT00768989|1020086|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
427364|NCT00768989|1020085|P2|COMPLETED|Week 24 to Prior to Week 36||27
427365|NCT00768989|1020086|P1|COMPLETED|Week 24 to Prior to Week 36||51
427366|NCT00768989|1020085|P2|STARTED|Week 24 to Prior to Week 36||27
427367|NCT00768989|1020086|P1|STARTED|Week 24 to Prior to Week 36||59
427368|NCT00768989|1020085|P2|NOT COMPLETED|Prior to Week 24||3
427369|NCT00768989|1020086|P1|NOT COMPLETED|Prior to Week 24||4
427370|NCT00768989|1020085|P2|COMPLETED|Prior to Week 24||27
427371|NCT00768989|1020086|P1|COMPLETED|Prior to Week 24||59
427372|NCT00768989|1020085|P2|STARTED|Prior to Week 24||30
427373|NCT00768989|1020086|P1|STARTED|Prior to Week 24||63
427374|NCT00768898|1020134|P1|NOT COMPLETED|Overall Study||2
427375|NCT00768898|1020134|P1|COMPLETED|Overall Study||28
427376|NCT00768898|1020134|P1|STARTED|Overall Study||30
427377|NCT00768755|1020158|P4|NOT COMPLETED|Phase 2||57
427378|NCT00768755|1020159|P3|NOT COMPLETED|Phase 2||58
427379|NCT00768755|1020160|P2|NOT COMPLETED|Phase 2||55
427380|NCT00768755|1020161|P1|NOT COMPLETED|Phase 2||0
427381|NCT00768755|1020158|P4|COMPLETED|Phase 2||0
427382|NCT00768755|1020159|P3|COMPLETED|Phase 2||0
427383|NCT00768755|1020160|P2|COMPLETED|Phase 2||0
427384|NCT00768755|1020161|P1|COMPLETED|Phase 2||0
427385|NCT00768755|1020158|P4|Treated|Phase 2||55
427386|NCT00768755|1020159|P3|Treated|Phase 2||58
427387|NCT00768755|1020160|P2|Treated|Phase 2||55
427388|NCT00768755|1020161|P1|Treated|Phase 2||0
427389|NCT00768755|1020158|P4|STARTED|Phase 2||57
427390|NCT00768755|1020159|P3|STARTED|Phase 2||58
427391|NCT00768755|1020160|P2|STARTED|Phase 2||55
427392|NCT00768755|1020161|P1|STARTED|Phase 2||0
427393|NCT00768755|1020158|P4|NOT COMPLETED|Phase 1||0
427394|NCT00768755|1020159|P3|NOT COMPLETED|Phase 1||0
427395|NCT00768755|1020160|P2|NOT COMPLETED|Phase 1||0
427396|NCT00768755|1020161|P1|NOT COMPLETED|Phase 1||10
427397|NCT00768755|1020158|P4|COMPLETED|Phase 1||0
427398|NCT00768755|1020159|P3|COMPLETED|Phase 1||0
427399|NCT00768755|1020160|P2|COMPLETED|Phase 1||0
427400|NCT00768755|1020161|P1|COMPLETED|Phase 1||0
427401|NCT00768755|1020158|P4|STARTED|Phase 1||0
427402|NCT00768755|1020159|P3|STARTED|Phase 1||0
427403|NCT00768755|1020160|P2|STARTED|Phase 1||0
427404|NCT00768755|1020161|P1|STARTED|Phase 1||10
427405|NCT00768651|1020185|P1|NOT COMPLETED|Overall Study||1
427406|NCT00768651|1020185|P1|COMPLETED|Overall Study||7
427407|NCT00768651|1020185|P1|STARTED|Overall Study||8
427408|NCT00768599|1020193|P3|NOT COMPLETED|Overall Study||12
427409|NCT00768599|1020194|P2|NOT COMPLETED|Overall Study||16
427410|NCT00768599|1020195|P1|NOT COMPLETED|Overall Study||11
427411|NCT00768599|1020193|P3|COMPLETED|Overall Study||35
427412|NCT00768599|1020194|P2|COMPLETED|Overall Study||27
427413|NCT00768599|1020195|P1|COMPLETED|Overall Study||34
427414|NCT00768599|1020193|P3|STARTED|Overall Study||47
427415|NCT00768599|1020194|P2|STARTED|Overall Study||43
427416|NCT00768599|1020195|P1|STARTED|Overall Study||45
427417|NCT00768560|1020224|P6|NOT COMPLETED|Intervention Set 3||0
427418|NCT00768560|1020225|P5|NOT COMPLETED|Intervention Set 3||0
427419|NCT00768560|1020226|P4|NOT COMPLETED|Intervention Set 3||0
427420|NCT00768560|1020227|P3|NOT COMPLETED|Intervention Set 3||0
427421|NCT00768560|1020228|P2|NOT COMPLETED|Intervention Set 3||0
427422|NCT00768560|1020229|P1|NOT COMPLETED|Intervention Set 3||0
427423|NCT00768560|1020224|P6|COMPLETED|Intervention Set 3||6
427424|NCT00768560|1020225|P5|COMPLETED|Intervention Set 3||6
427425|NCT00768560|1020226|P4|COMPLETED|Intervention Set 3||6
427426|NCT00768560|1020227|P3|COMPLETED|Intervention Set 3||6
427427|NCT00768560|1020228|P2|COMPLETED|Intervention Set 3||5
427428|NCT00768560|1020229|P1|COMPLETED|Intervention Set 3||5
427429|NCT00768560|1020224|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
427430|NCT00768560|1020225|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
427431|NCT00768560|1020226|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
427432|NCT00768560|1020227|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
427433|NCT00768560|1020228|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
427434|NCT00768560|1020229|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
427435|NCT00768560|1020224|P6|NOT COMPLETED|Intervention Set 2||0
427436|NCT00768560|1020225|P5|NOT COMPLETED|Intervention Set 2||0
427437|NCT00768560|1020226|P4|NOT COMPLETED|Intervention Set 2||0
427438|NCT00768560|1020227|P3|NOT COMPLETED|Intervention Set 2||0
427439|NCT00768560|1020228|P2|NOT COMPLETED|Intervention Set 2||0
427440|NCT00768560|1020229|P1|NOT COMPLETED|Intervention Set 2||0
427441|NCT00768560|1020224|P6|COMPLETED|Intervention Set 2||6
427442|NCT00768560|1020225|P5|COMPLETED|Intervention Set 2||6
427443|NCT00768560|1020226|P4|COMPLETED|Intervention Set 2||6
427444|NCT00768560|1020227|P3|COMPLETED|Intervention Set 2||6
427445|NCT00768560|1020228|P2|COMPLETED|Intervention Set 2||5
427446|NCT00768560|1020229|P1|COMPLETED|Intervention Set 2||5
427447|NCT00768560|1020224|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
427448|NCT00768560|1020225|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
427449|NCT00768560|1020226|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
427450|NCT00768560|1020227|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
427451|NCT00768560|1020228|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
427452|NCT00768560|1020229|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
427453|NCT00768560|1020224|P6|NOT COMPLETED|Intervention Set 1||0
427454|NCT00768560|1020225|P5|NOT COMPLETED|Intervention Set 1||0
427455|NCT00768560|1020226|P4|NOT COMPLETED|Intervention Set 1||0
427456|NCT00768560|1020227|P3|NOT COMPLETED|Intervention Set 1||0
427457|NCT00768560|1020228|P2|NOT COMPLETED|Intervention Set 1||1
427458|NCT00768560|1020229|P1|NOT COMPLETED|Intervention Set 1||0
427459|NCT00768560|1020224|P6|COMPLETED|Intervention Set 1||6
427460|NCT00768560|1020225|P5|COMPLETED|Intervention Set 1||6
427461|NCT00768560|1020226|P4|COMPLETED|Intervention Set 1||6
427462|NCT00768560|1020227|P3|COMPLETED|Intervention Set 1||6
427463|NCT00768560|1020228|P2|COMPLETED|Intervention Set 1||5
427464|NCT00768560|1020229|P1|COMPLETED|Intervention Set 1||5
427465|NCT00768560|1020224|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
427466|NCT00768560|1020225|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
427467|NCT00768560|1020226|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
427468|NCT00768560|1020227|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
427469|NCT00768560|1020228|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
427470|NCT00768560|1020229|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
427471|NCT00768560|1020224|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
427472|NCT00768560|1020225|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
427473|NCT00768560|1020226|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
427474|NCT00768560|1020227|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
427475|NCT00768560|1020228|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
427476|NCT00768560|1020229|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
427477|NCT00768521|1020255|P2|NOT COMPLETED|Period 2||0
427478|NCT00768521|1020256|P1|NOT COMPLETED|Period 2||0
427479|NCT00768521|1020255|P2|COMPLETED|Period 2||11
427480|NCT00768521|1020256|P1|COMPLETED|Period 2||9
427481|NCT00768521|1020255|P2|STARTED|Period 2||11
427482|NCT00768521|1020256|P1|STARTED|Period 2||9
427483|NCT00768521|1020255|P2|NOT COMPLETED|Period 1||0
427484|NCT00768521|1020256|P1|NOT COMPLETED|Period 1||0
427485|NCT00768521|1020255|P2|COMPLETED|Period 1||11
427486|NCT00768521|1020256|P1|COMPLETED|Period 1||9
427487|NCT00768521|1020255|P2|STARTED|Period 1||11
427488|NCT00768521|1020256|P1|STARTED|Period 1||9
427489|NCT00768430|1020266|P2|NOT COMPLETED|7 Day Endpoint||3
427490|NCT00768430|1020267|P1|NOT COMPLETED|7 Day Endpoint||2
427491|NCT00768430|1020266|P2|COMPLETED|7 Day Endpoint||22
427492|NCT00768430|1020267|P1|COMPLETED|7 Day Endpoint||45
427493|NCT00768430|1020266|P2|STARTED|7 Day Endpoint||25
427494|NCT00768430|1020267|P1|STARTED|7 Day Endpoint||47
427495|NCT00768430|1020266|P2|NOT COMPLETED|24 Hour Endpoint||0
427496|NCT00768430|1020267|P1|NOT COMPLETED|24 Hour Endpoint||1
427497|NCT00768430|1020266|P2|COMPLETED|24 Hour Endpoint||25
427498|NCT00768430|1020267|P1|COMPLETED|24 Hour Endpoint||47
427499|NCT00768430|1020266|P2|STARTED|24 Hour Endpoint||25
427500|NCT00768430|1020267|P1|STARTED|24 Hour Endpoint||48
427501|NCT00768300|1020275|P2|NOT COMPLETED|Overall Study||163
427502|NCT00768300|1020276|P1|NOT COMPLETED|Overall Study||329
427503|NCT00768300|1020275|P2|COMPLETED|Overall Study||1
427504|NCT00768300|1020276|P1|COMPLETED|Overall Study||1
427505|NCT00768300|1020275|P2|Randomized and Treated|Overall Study||163
427506|NCT00768300|1020276|P1|Randomized and Treated|Overall Study||329
427507|NCT00768300|1020275|P2|STARTED|Overall Study||164
427508|NCT00768300|1020276|P1|STARTED|Overall Study||330
427509|NCT00768222|1020300|P2|NOT COMPLETED|Overall Study||4
427510|NCT00768222|1020301|P1|NOT COMPLETED|Overall Study||4
427511|NCT00768222|1020300|P2|COMPLETED|Overall Study||47
427512|NCT00768222|1020301|P1|COMPLETED|Overall Study||46
427513|NCT00768222|1020300|P2|STARTED|Overall Study||51
427514|NCT00768222|1020301|P1|STARTED|Overall Study||50
427515|NCT00768144|1020323|P1|NOT COMPLETED|Overall Study||36
427516|NCT00768144|1020323|P1|COMPLETED|Overall Study||0
427517|NCT00768144|1020323|P1|STARTED|Overall Study||36
427518|NCT00768118|1020329|P1|NOT COMPLETED|Overall Study||0
427519|NCT00768118|1020329|P1|COMPLETED|Overall Study||11
427520|NCT00768118|1020329|P1|STARTED|Overall Study||11
427521|NCT00768066|1020336|P3|NOT COMPLETED|Overall Study||0
427522|NCT00768066|1020337|P2|NOT COMPLETED|Overall Study||3
427523|NCT00768066|1020338|P1|NOT COMPLETED|Overall Study||3
427524|NCT00768066|1020336|P3|COMPLETED|Overall Study||21
427525|NCT00768066|1020337|P2|COMPLETED|Overall Study||19
427526|NCT00768066|1020338|P1|COMPLETED|Overall Study||19
427527|NCT00768066|1020336|P3|STARTED|Overall Study||21
427528|NCT00768066|1020337|P2|STARTED|Overall Study||22
427529|NCT00768066|1020338|P1|STARTED|Overall Study||22
427530|NCT00768053|1020370|P1|NOT COMPLETED|Overall Study||11
427531|NCT00768053|1020370|P1|COMPLETED|Overall Study||97
427532|NCT00768053|1020370|P1|STARTED|Overall Study||108
427533|NCT00768040|1020401|P2|NOT COMPLETED|Overall Study||3
427534|NCT00768040|1020402|P1|NOT COMPLETED|Overall Study||4
427535|NCT00768040|1020401|P2|COMPLETED|Overall Study||16
427536|NCT00768040|1020402|P1|COMPLETED|Overall Study||16
427537|NCT00768040|1020401|P2|STARTED|Overall Study||19
427538|NCT00768040|1020402|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
427539|NCT00767806|1020410|P2|NOT COMPLETED|Overall Study||47
427540|NCT00767806|1020411|P1|NOT COMPLETED|Overall Study||51
427541|NCT00767806|1020410|P2|COMPLETED|Overall Study||156
427542|NCT00767806|1020411|P1|COMPLETED|Overall Study||147
427543|NCT00767806|1020410|P2|STARTED|Overall Study||203
427544|NCT00767806|1020411|P1|STARTED|Overall Study||198
427545|NCT00767767|1020472|P5|NOT COMPLETED|Overall Study||0
427546|NCT00767767|1020473|P4|NOT COMPLETED|Overall Study||0
427547|NCT00767767|1020474|P3|NOT COMPLETED|Overall Study||0
427548|NCT00767767|1020475|P2|NOT COMPLETED|Overall Study||0
427549|NCT00767767|1020476|P1|NOT COMPLETED|Overall Study||0
427550|NCT00767767|1020472|P5|COMPLETED|Overall Study||3
427551|NCT00767767|1020473|P4|COMPLETED|Overall Study||3
427552|NCT00767767|1020474|P3|COMPLETED|Overall Study||20
427553|NCT00767767|1020475|P2|COMPLETED|Overall Study||20
427554|NCT00767767|1020476|P1|COMPLETED|Overall Study||21
427555|NCT00767767|1020472|P5|STARTED|Overall Study||3
427556|NCT00767767|1020473|P4|STARTED|Overall Study||3
427557|NCT00767767|1020474|P3|STARTED|Overall Study||20
427558|NCT00767767|1020475|P2|STARTED|Overall Study||20
427559|NCT00767767|1020476|P1|STARTED|Overall Study||21
427560|NCT00767676|1020488|P1|NOT COMPLETED|Overall Study||54
427561|NCT00767676|1020488|P1|COMPLETED|Overall Study||205
427562|NCT00767676|1020488|P1|STARTED|Overall Study||259
427563|NCT00767624|1020494|P2|NOT COMPLETED|Overall Study||17
427564|NCT00767624|1020495|P1|NOT COMPLETED|Overall Study||24
427565|NCT00767624|1020494|P2|COMPLETED|Overall Study||58
427566|NCT00767624|1020495|P1|COMPLETED|Overall Study||51
427567|NCT00767624|1020494|P2|STARTED|Overall Study||75
427568|NCT00767624|1020495|P1|STARTED|Overall Study||75
427569|NCT00767572|1020503|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
427570|NCT00767572|1020503|P1|COMPLETED|Second Intervention (12 Weeks)||12
427571|NCT00767572|1020503|P1|STARTED|Second Intervention (12 Weeks)||12
427572|NCT00767572|1020503|P1|NOT COMPLETED|Washout (4 Weeks)||0
427573|NCT00767572|1020503|P1|COMPLETED|Washout (4 Weeks)||12
427574|NCT00767572|1020503|P1|STARTED|Washout (4 Weeks)||12
427575|NCT00767572|1020503|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
427576|NCT00767572|1020503|P1|COMPLETED|First Intervention (12 Weeks)||12
427577|NCT00767572|1020503|P1|STARTED|First Intervention (12 Weeks)||12
427578|NCT00767520|1020511|P2|NOT COMPLETED|Overall Study||17
427579|NCT00767520|1020512|P1|NOT COMPLETED|Overall Study||11
427580|NCT00767520|1020511|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
427581|NCT00767520|1020512|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
427582|NCT00767520|1020511|P2|STARTED|Overall Study||78
427583|NCT00767520|1020512|P1|STARTED|Overall Study||79
427584|NCT00767507|1020538|P4|NOT COMPLETED|Overall Study||3
427585|NCT00767507|1020539|P3|NOT COMPLETED|Overall Study||0
427586|NCT00767507|1020540|P2|NOT COMPLETED|Overall Study||0
427587|NCT00767507|1020541|P1|NOT COMPLETED|Overall Study||0
427588|NCT00767507|1020538|P4|COMPLETED|Overall Study||101
427589|NCT00767507|1020539|P3|COMPLETED|Overall Study||106
427590|NCT00767507|1020540|P2|COMPLETED|Overall Study||6
427591|NCT00767507|1020541|P1|COMPLETED|Overall Study||5
427592|NCT00767507|1020538|P4|STARTED|Overall Study||104
427593|NCT00767507|1020539|P3|STARTED|Overall Study||106
427594|NCT00767507|1020540|P2|STARTED|Overall Study||6
427595|NCT00767507|1020541|P1|STARTED|Overall Study||5
427596|NCT00767455|1020565|P1|NOT COMPLETED|Overall Study||19
427597|NCT00767455|1020565|P1|COMPLETED|Overall Study||40
427598|NCT00767455|1020565|P1|STARTED|Overall Study||59
427599|NCT00767364|1020573|P2|NOT COMPLETED|Overall Study||0
427600|NCT00767364|1020574|P1|NOT COMPLETED|Overall Study||0
427601|NCT00767364|1020573|P2|COMPLETED|Overall Study||3
427602|NCT00767364|1020574|P1|COMPLETED|Overall Study||5
427603|NCT00767364|1020573|P2|STARTED|Overall Study||3
427604|NCT00767364|1020574|P1|STARTED|Overall Study||5
427605|NCT00767338|1020586|P4|NOT COMPLETED|Overall Study||0
427606|NCT00767338|1020587|P3|NOT COMPLETED|Overall Study||0
427607|NCT00767338|1020588|P2|NOT COMPLETED|Overall Study||2
427608|NCT00767338|1020589|P1|NOT COMPLETED|Overall Study||1
427609|NCT00767338|1020586|P4|COMPLETED|Overall Study||0
427610|NCT00767338|1020587|P3|COMPLETED|Overall Study||0
427611|NCT00767338|1020588|P2|COMPLETED|Overall Study||0
427612|NCT00767338|1020589|P1|COMPLETED|Overall Study||0
427613|NCT00767338|1020586|P4|STARTED|Overall Study||0
427614|NCT00767338|1020587|P3|STARTED|Overall Study||0
427615|NCT00767338|1020588|P2|STARTED|Overall Study||2
427616|NCT00767338|1020589|P1|STARTED|Overall Study||1
427617|NCT00767325|1020599|P1|NOT COMPLETED|Overall Study||15
427618|NCT00767325|1020599|P1|COMPLETED|Overall Study||89
427619|NCT00767325|1020599|P1|STARTED|Overall Study||104
427620|NCT00767104|1020610|P2|NOT COMPLETED|Overall Study||2
427621|NCT00767104|1020611|P1|NOT COMPLETED|Overall Study||1
427622|NCT00767104|1020610|P2|COMPLETED|Overall Study||18
427623|NCT00767104|1020611|P1|COMPLETED|Overall Study||19
427624|NCT00767104|1020610|P2|STARTED|Overall Study||20
427625|NCT00767104|1020611|P1|STARTED|Overall Study||20
427626|NCT00767039|1020621|P2|NOT COMPLETED|Overall Study||2
427627|NCT00767039|1020622|P1|NOT COMPLETED|Overall Study||5
427628|NCT00767039|1020621|P2|COMPLETED|Overall Study||23
427629|NCT00767039|1020622|P1|COMPLETED|Overall Study||22
427630|NCT00767039|1020621|P2|STARTED|Overall Study||25
427631|NCT00767039|1020622|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
427632|NCT00767000|1020653|P5|NOT COMPLETED|Optional 104-week Extension||4
427633|NCT00767000|1020654|P4|NOT COMPLETED|Optional 104-week Extension||2
427634|NCT00767000|1020655|P3|NOT COMPLETED|Optional 104-week Extension||7
427635|NCT00767000|1020656|P2|NOT COMPLETED|Optional 104-week Extension||3
427636|NCT00767000|1020657|P1|NOT COMPLETED|Optional 104-week Extension||7
427637|NCT00767000|1020653|P5|COMPLETED|Optional 104-week Extension||0
427638|NCT00767000|1020654|P4|COMPLETED|Optional 104-week Extension||0
427639|NCT00767000|1020655|P3|COMPLETED|Optional 104-week Extension||0
427640|NCT00767000|1020656|P2|COMPLETED|Optional 104-week Extension||0
427641|NCT00767000|1020657|P1|COMPLETED|Optional 104-week Extension||0
427642|NCT00767000|1020653|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
427643|NCT00767000|1020654|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
427644|NCT00767000|1020655|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
427645|NCT00767000|1020656|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
427646|NCT00767000|1020657|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
427647|NCT00767000|1020653|P5|NOT COMPLETED|54-week Study||224
427648|NCT00767000|1020654|P4|NOT COMPLETED|54-week Study||225
427649|NCT00767000|1020655|P3|NOT COMPLETED|54-week Study||109
427650|NCT00767000|1020656|P2|NOT COMPLETED|54-week Study||113
427651|NCT00767000|1020657|P1|NOT COMPLETED|54-week Study||108
427652|NCT00767000|1020653|P5|COMPLETED|54-week Study||7
427653|NCT00767000|1020654|P4|COMPLETED|54-week Study||4
427654|NCT00767000|1020655|P3|COMPLETED|54-week Study||8
427655|NCT00767000|1020656|P2|COMPLETED|54-week Study||4
427656|NCT00767000|1020657|P1|COMPLETED|54-week Study||11
427657|NCT00767000|1020653|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
427658|NCT00767000|1020654|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
427659|NCT00767000|1020655|P3|STARTED|54-week Study||117
427660|NCT00767000|1020656|P2|STARTED|54-week Study||117
427661|NCT00767000|1020657|P1|STARTED|54-week Study||119
427662|NCT00766831|1020699|P1|NOT COMPLETED|Overall Study||115
427663|NCT00766831|1020699|P1|COMPLETED|Overall Study||75
427664|NCT00766831|1020699|P1|STARTED|Overall Study||190
427665|NCT00766753|1020717|P2|NOT COMPLETED|Overall Study||0
427666|NCT00766753|1020718|P1|NOT COMPLETED|Overall Study||0
427667|NCT00766753|1020717|P2|COMPLETED|Overall Study||11
427668|NCT00766753|1020718|P1|COMPLETED|Overall Study||11
427669|NCT00766753|1020717|P2|Completed at Least Four Vaccines|Overall Study||9
427670|NCT00766753|1020718|P1|Completed at Least Four Vaccines|Overall Study||10
427671|NCT00766753|1020717|P2|Received at Least One Vaccine|Overall Study||11
427672|NCT00766753|1020718|P1|Received at Least One Vaccine|Overall Study||11
427673|NCT00766753|1020717|P2|STARTED|Overall Study||11
427674|NCT00766753|1020718|P1|STARTED|Overall Study||11
427675|NCT00766675|1020729|P1|NOT COMPLETED|Overall Study||40
427676|NCT00766675|1020729|P1|COMPLETED|Overall Study||40
427677|NCT00766675|1020729|P1|STARTED|Overall Study||80
427678|NCT00766649|1020742|P1|NOT COMPLETED|Overall Study||10
427679|NCT00766649|1020742|P1|COMPLETED|Overall Study||1
427680|NCT00766649|1020742|P1|STARTED|Overall Study||11
427681|NCT00766636|1020756|P2|NOT COMPLETED|Overall Study||2
427682|NCT00766636|1020757|P1|NOT COMPLETED|Overall Study||3
427683|NCT00766636|1020756|P2|COMPLETED|Overall Study||0
427684|NCT00766636|1020757|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
427685|NCT00766636|1020756|P2|STARTED|Overall Study||2
427686|NCT00766636|1020757|P1|STARTED|Overall Study||3
427687|NCT00766597|1020763|P1|NOT COMPLETED|Overall Study||9
427688|NCT00766597|1020763|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
427689|NCT00766597|1020763|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
427690|NCT00766597|1020763|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
427691|NCT00766597|1020763|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
427692|NCT00766597|1020763|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
427693|NCT00766597|1020763|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
427694|NCT00766532|1020775|P1|NOT COMPLETED|Overall Study||2
427695|NCT00766532|1020775|P1|COMPLETED|Overall Study||10
427696|NCT00766532|1020775|P1|STARTED|Overall Study||12
427697|NCT00766506|1020781|P2|NOT COMPLETED|Overall Study||2
427698|NCT00766506|1020782|P1|NOT COMPLETED|Overall Study||5
427699|NCT00766506|1020781|P2|COMPLETED|Overall Study||48
427700|NCT00766506|1020782|P1|COMPLETED|Overall Study||53
427701|NCT00766506|1020781|P2|STARTED|Overall Study||50
427702|NCT00766506|1020782|P1|STARTED|Overall Study||58
427703|NCT00766493|1020806|P1|NOT COMPLETED|30 Days Post-Procedure||12
427704|NCT00766493|1020806|P1|COMPLETED|30 Days Post-Procedure||238
427705|NCT00766493|1020806|P1|STARTED|30 Days Post-Procedure||250
427706|NCT00766493|1020806|P1|NOT COMPLETED|Pre-Discharge||0
427707|NCT00766493|1020806|P1|COMPLETED|Pre-Discharge||250
427708|NCT00766493|1020806|P1|STARTED|Pre-Discharge||250
427709|NCT00766467|1020816|P2|NOT COMPLETED|Overall Study||8
427710|NCT00766467|1020817|P1|NOT COMPLETED|Overall Study||11
427711|NCT00766467|1020816|P2|COMPLETED|Overall Study||31
427712|NCT00766467|1020817|P1|COMPLETED|Overall Study||31
427713|NCT00766467|1020816|P2|Initiated Treatment|Overall Study||38
427714|NCT00766467|1020817|P1|Initiated Treatment|Overall Study||39
427715|NCT00766467|1020816|P2|STARTED|Overall Study||39
427716|NCT00766467|1020817|P1|STARTED|Overall Study||42
427717|NCT00766415|1020829|P2|NOT COMPLETED|Overall Study||1
427718|NCT00766415|1020830|P1|NOT COMPLETED|Overall Study||0
427719|NCT00766415|1020829|P2|COMPLETED|Overall Study||26
427720|NCT00766415|1020830|P1|COMPLETED|Overall Study||25
427721|NCT00766415|1020829|P2|STARTED|Overall Study||27
427722|NCT00766415|1020830|P1|STARTED|Overall Study||25
427723|NCT00766376|1020878|P1|NOT COMPLETED|Overall Study||27
427724|NCT00766376|1020878|P1|COMPLETED|Overall Study||124
427725|NCT00766376|1020878|P1|STARTED|Overall Study||151
427726|NCT00766363|1020887|P4|NOT COMPLETED|Overall Study||0
427727|NCT00766363|1020888|P3|NOT COMPLETED|Overall Study||0
427728|NCT00766363|1020889|P2|NOT COMPLETED|Overall Study||1
427729|NCT00766363|1020890|P1|NOT COMPLETED|Overall Study||1
427730|NCT00766363|1020887|P4|COMPLETED|Overall Study||12
427731|NCT00766363|1020888|P3|COMPLETED|Overall Study||12
427732|NCT00766363|1020889|P2|COMPLETED|Overall Study||12
427733|NCT00766363|1020890|P1|COMPLETED|Overall Study||11
427734|NCT00766363|1020887|P4|PK POPULATION|Overall Study||13
427735|NCT00766363|1020888|P3|PK POPULATION|Overall Study||10
427736|NCT00766363|1020889|P2|PK POPULATION|Overall Study||13
427737|NCT00766363|1020890|P1|PK POPULATION|Overall Study||12
427738|NCT00766363|1020887|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
427739|NCT00766363|1020888|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
427740|NCT00766363|1020889|P2|SAFETY POPULATION|Overall Study||13
427741|NCT00766363|1020890|P1|SAFETY POPULATION|Overall Study||12
427742|NCT00766363|1020887|P4|STARTED|Overall Study|Number randomized.|12
427743|NCT00766363|1020888|P3|STARTED|Overall Study|Number randomized.|12
427744|NCT00766363|1020889|P2|STARTED|Overall Study||13
427745|NCT00766363|1020890|P1|STARTED|Overall Study||12
427746|NCT00766090|1020929|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
427747|NCT00766090|1020930|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427748|NCT00766090|1020931|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427749|NCT00766090|1020932|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427750|NCT00766090|1020933|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427751|NCT00766090|1020934|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427752|NCT00766090|1020935|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
427753|NCT00766090|1020936|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
427754|NCT00766090|1020937|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
427755|NCT00766090|1020938|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427756|NCT00766090|1020939|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
427757|NCT00766090|1020940|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
427758|NCT00766090|1020929|P12|COMPLETED|Treatment Period 3 (28 Days)||6
427759|NCT00766090|1020930|P11|COMPLETED|Treatment Period 3 (28 Days)||7
427760|NCT00766090|1020931|P10|COMPLETED|Treatment Period 3 (28 Days)||8
427761|NCT00766090|1020932|P9|COMPLETED|Treatment Period 3 (28 Days)||6
427762|NCT00766090|1020933|P8|COMPLETED|Treatment Period 3 (28 Days)||8
427763|NCT00766090|1020934|P7|COMPLETED|Treatment Period 3 (28 Days)||6
427764|NCT00766090|1020935|P6|COMPLETED|Treatment Period 3 (28 Days)||22
427765|NCT00766090|1020936|P5|COMPLETED|Treatment Period 3 (28 Days)||20
427766|NCT00766090|1020937|P4|COMPLETED|Treatment Period 3 (28 Days)||24
427767|NCT00766090|1020938|P3|COMPLETED|Treatment Period 3 (28 Days)||20
427768|NCT00766090|1020939|P2|COMPLETED|Treatment Period 3 (28 Days)||26
427769|NCT00766090|1020940|P1|COMPLETED|Treatment Period 3 (28 Days)||22
427770|NCT00766090|1020929|P12|STARTED|Treatment Period 3 (28 Days)||7
427771|NCT00766090|1020930|P11|STARTED|Treatment Period 3 (28 Days)||7
427772|NCT00766090|1020931|P10|STARTED|Treatment Period 3 (28 Days)||8
427773|NCT00766090|1020932|P9|STARTED|Treatment Period 3 (28 Days)||6
427774|NCT00766090|1020933|P8|STARTED|Treatment Period 3 (28 Days)||8
427775|NCT00766090|1020934|P7|STARTED|Treatment Period 3 (28 Days)||6
427776|NCT00766090|1020935|P6|STARTED|Treatment Period 3 (28 Days)||23
427777|NCT00766090|1020936|P5|STARTED|Treatment Period 3 (28 Days)||21
427778|NCT00766090|1020937|P4|STARTED|Treatment Period 3 (28 Days)||25
427779|NCT00766090|1020938|P3|STARTED|Treatment Period 3 (28 Days)||20
427780|NCT00766090|1020939|P2|STARTED|Treatment Period 3 (28 Days)||27
427781|NCT00766090|1020940|P1|STARTED|Treatment Period 3 (28 Days)||22
427782|NCT00766090|1020929|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
427783|NCT00766090|1020930|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
427784|NCT00766090|1020931|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
427785|NCT00766090|1020932|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
427786|NCT00766090|1020933|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
427787|NCT00766090|1020934|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
427788|NCT00766090|1020935|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
427789|NCT00766090|1020936|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
427790|NCT00766090|1020937|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
427791|NCT00766090|1020938|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
427792|NCT00766090|1020939|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
427793|NCT00766090|1020940|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
427794|NCT00766090|1020929|P12|COMPLETED|Washout Period 2 (14 Days)||7
427795|NCT00766090|1020930|P11|COMPLETED|Washout Period 2 (14 Days)||7
427796|NCT00766090|1020931|P10|COMPLETED|Washout Period 2 (14 Days)||8
427797|NCT00766090|1020932|P9|COMPLETED|Washout Period 2 (14 Days)||6
427798|NCT00766090|1020933|P8|COMPLETED|Washout Period 2 (14 Days)||8
427799|NCT00766090|1020934|P7|COMPLETED|Washout Period 2 (14 Days)||6
427800|NCT00766090|1020935|P6|COMPLETED|Washout Period 2 (14 Days)||23
427801|NCT00766090|1020936|P5|COMPLETED|Washout Period 2 (14 Days)||21
427802|NCT00766090|1020937|P4|COMPLETED|Washout Period 2 (14 Days)||25
427803|NCT00766090|1020938|P3|COMPLETED|Washout Period 2 (14 Days)||20
427804|NCT00766090|1020939|P2|COMPLETED|Washout Period 2 (14 Days)||27
427805|NCT00766090|1020940|P1|COMPLETED|Washout Period 2 (14 Days)||22
427806|NCT00766090|1020929|P12|STARTED|Washout Period 2 (14 Days)||7
427807|NCT00766090|1020930|P11|STARTED|Washout Period 2 (14 Days)||7
427808|NCT00766090|1020931|P10|STARTED|Washout Period 2 (14 Days)||8
427809|NCT00766090|1020932|P9|STARTED|Washout Period 2 (14 Days)||6
427810|NCT00766090|1020933|P8|STARTED|Washout Period 2 (14 Days)||8
427811|NCT00766090|1020934|P7|STARTED|Washout Period 2 (14 Days)||6
427812|NCT00766090|1020935|P6|STARTED|Washout Period 2 (14 Days)||23
427813|NCT00766090|1020936|P5|STARTED|Washout Period 2 (14 Days)||21
427814|NCT00766090|1020937|P4|STARTED|Washout Period 2 (14 Days)||25
427815|NCT00766090|1020938|P3|STARTED|Washout Period 2 (14 Days)||21
427816|NCT00766090|1020939|P2|STARTED|Washout Period 2 (14 Days)||27
427817|NCT00766090|1020940|P1|STARTED|Washout Period 2 (14 Days)||22
427818|NCT00766090|1020929|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427819|NCT00766090|1020930|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427820|NCT00766090|1020931|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427821|NCT00766090|1020932|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427822|NCT00766090|1020933|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427823|NCT00766090|1020934|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427824|NCT00766090|1020935|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427825|NCT00766090|1020936|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
427826|NCT00766090|1020937|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427827|NCT00766090|1020938|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
427828|NCT00766090|1020939|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427829|NCT00766090|1020940|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
427830|NCT00766090|1020929|P12|COMPLETED|Treatment Period 2 (28 Days)||7
427831|NCT00766090|1020930|P11|COMPLETED|Treatment Period 2 (28 Days)||7
427832|NCT00766090|1020931|P10|COMPLETED|Treatment Period 2 (28 Days)||8
427833|NCT00766090|1020932|P9|COMPLETED|Treatment Period 2 (28 Days)||6
427834|NCT00766090|1020933|P8|COMPLETED|Treatment Period 2 (28 Days)||8
427835|NCT00766090|1020934|P7|COMPLETED|Treatment Period 2 (28 Days)||6
427836|NCT00766090|1020935|P6|COMPLETED|Treatment Period 2 (28 Days)||23
427837|NCT00766090|1020936|P5|COMPLETED|Treatment Period 2 (28 Days)||21
427838|NCT00766090|1020937|P4|COMPLETED|Treatment Period 2 (28 Days)||25
427839|NCT00766090|1020938|P3|COMPLETED|Treatment Period 2 (28 Days)||21
427840|NCT00766090|1020939|P2|COMPLETED|Treatment Period 2 (28 Days)||27
427841|NCT00766090|1020940|P1|COMPLETED|Treatment Period 2 (28 Days)||22
427842|NCT00766090|1020929|P12|STARTED|Treatment Period 2 (28 Days)||7
427843|NCT00766090|1020930|P11|STARTED|Treatment Period 2 (28 Days)||7
427844|NCT00766090|1020931|P10|STARTED|Treatment Period 2 (28 Days)||8
427845|NCT00766090|1020932|P9|STARTED|Treatment Period 2 (28 Days)||6
427846|NCT00766090|1020933|P8|STARTED|Treatment Period 2 (28 Days)||8
427847|NCT00766090|1020934|P7|STARTED|Treatment Period 2 (28 Days)||6
427848|NCT00766090|1020935|P6|STARTED|Treatment Period 2 (28 Days)||23
427849|NCT00766090|1020936|P5|STARTED|Treatment Period 2 (28 Days)||23
427850|NCT00766090|1020937|P4|STARTED|Treatment Period 2 (28 Days)||25
427851|NCT00766090|1020938|P3|STARTED|Treatment Period 2 (28 Days)||22
427852|NCT00766090|1020939|P2|STARTED|Treatment Period 2 (28 Days)||27
427853|NCT00766090|1020940|P1|STARTED|Treatment Period 2 (28 Days)||22
427854|NCT00766090|1020929|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
427855|NCT00766090|1020930|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
427856|NCT00766090|1020931|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
427857|NCT00766090|1020932|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
427858|NCT00766090|1020933|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
427859|NCT00766090|1020934|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
427860|NCT00766090|1020935|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
427861|NCT00766090|1020936|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
427862|NCT00766090|1020937|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
427863|NCT00766090|1020938|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
427864|NCT00766090|1020939|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
427865|NCT00766090|1020940|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
427866|NCT00766090|1020929|P12|COMPLETED|Washout Period 1 (14 Days)||7
427867|NCT00766090|1020930|P11|COMPLETED|Washout Period 1 (14 Days)||7
427868|NCT00766090|1020931|P10|COMPLETED|Washout Period 1 (14 Days)||8
427869|NCT00766090|1020932|P9|COMPLETED|Washout Period 1 (14 Days)||6
427870|NCT00766090|1020933|P8|COMPLETED|Washout Period 1 (14 Days)||8
427871|NCT00766090|1020934|P7|COMPLETED|Washout Period 1 (14 Days)||6
427872|NCT00766090|1020935|P6|COMPLETED|Washout Period 1 (14 Days)||23
427873|NCT00766090|1020936|P5|COMPLETED|Washout Period 1 (14 Days)||23
427874|NCT00766090|1020937|P4|COMPLETED|Washout Period 1 (14 Days)||25
427875|NCT00766090|1020938|P3|COMPLETED|Washout Period 1 (14 Days)||22
427876|NCT00766090|1020939|P2|COMPLETED|Washout Period 1 (14 Days)||27
427877|NCT00766090|1020940|P1|COMPLETED|Washout Period 1 (14 Days)||22
427878|NCT00766090|1020929|P12|STARTED|Washout Period 1 (14 Days)||7
427879|NCT00766090|1020930|P11|STARTED|Washout Period 1 (14 Days)||7
427880|NCT00766090|1020931|P10|STARTED|Washout Period 1 (14 Days)||8
427881|NCT00766090|1020932|P9|STARTED|Washout Period 1 (14 Days)||6
427882|NCT00766090|1020933|P8|STARTED|Washout Period 1 (14 Days)||8
427883|NCT00766090|1020934|P7|STARTED|Washout Period 1 (14 Days)||6
427884|NCT00766090|1020935|P6|STARTED|Washout Period 1 (14 Days)||23
427885|NCT00766090|1020936|P5|STARTED|Washout Period 1 (14 Days)||23
427886|NCT00766090|1020937|P4|STARTED|Washout Period 1 (14 Days)||25
427887|NCT00766090|1020938|P3|STARTED|Washout Period 1 (14 Days)||23
427888|NCT00766090|1020939|P2|STARTED|Washout Period 1 (14 Days)||27
427889|NCT00766090|1020940|P1|STARTED|Washout Period 1 (14 Days)||22
427890|NCT00766090|1020929|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427891|NCT00766090|1020930|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427892|NCT00766090|1020931|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427893|NCT00766090|1020932|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
427894|NCT00766090|1020933|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427895|NCT00766090|1020934|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427896|NCT00766090|1020935|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427897|NCT00766090|1020936|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427898|NCT00766090|1020937|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
427899|NCT00766090|1020938|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427900|NCT00766090|1020939|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
427901|NCT00766090|1020940|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
427902|NCT00766090|1020929|P12|COMPLETED|Treatment Period 1 (28 Days)||7
427903|NCT00766090|1020930|P11|COMPLETED|Treatment Period 1 (28 Days)||7
427904|NCT00766090|1020931|P10|COMPLETED|Treatment Period 1 (28 Days)||8
427905|NCT00766090|1020932|P9|COMPLETED|Treatment Period 1 (28 Days)||6
427906|NCT00766090|1020933|P8|COMPLETED|Treatment Period 1 (28 Days)||8
427907|NCT00766090|1020934|P7|COMPLETED|Treatment Period 1 (28 Days)||6
427908|NCT00766090|1020935|P6|COMPLETED|Treatment Period 1 (28 Days)||23
427909|NCT00766090|1020936|P5|COMPLETED|Treatment Period 1 (28 Days)||23
427910|NCT00766090|1020937|P4|COMPLETED|Treatment Period 1 (28 Days)||25
427911|NCT00766090|1020938|P3|COMPLETED|Treatment Period 1 (28 Days)||23
427912|NCT00766090|1020939|P2|COMPLETED|Treatment Period 1 (28 Days)||27
427913|NCT00766090|1020940|P1|COMPLETED|Treatment Period 1 (28 Days)||22
427914|NCT00766090|1020929|P12|STARTED|Treatment Period 1 (28 Days)||7
427915|NCT00766090|1020930|P11|STARTED|Treatment Period 1 (28 Days)||7
427916|NCT00766090|1020931|P10|STARTED|Treatment Period 1 (28 Days)||8
427917|NCT00766090|1020932|P9|STARTED|Treatment Period 1 (28 Days)||7
427918|NCT00766090|1020933|P8|STARTED|Treatment Period 1 (28 Days)||8
427919|NCT00766090|1020934|P7|STARTED|Treatment Period 1 (28 Days)||6
427920|NCT00766090|1020935|P6|STARTED|Treatment Period 1 (28 Days)||23
427921|NCT00766090|1020936|P5|STARTED|Treatment Period 1 (28 Days)||23
427922|NCT00766090|1020937|P4|STARTED|Treatment Period 1 (28 Days)||26
427923|NCT00766090|1020938|P3|STARTED|Treatment Period 1 (28 Days)||23
427924|NCT00766090|1020939|P2|STARTED|Treatment Period 1 (28 Days)||27
427925|NCT00766090|1020940|P1|STARTED|Treatment Period 1 (28 Days)||25
427926|NCT00766051|1020981|P2|NOT COMPLETED|Overall Study||0
427927|NCT00766051|1020982|P1|NOT COMPLETED|Overall Study||2
427928|NCT00766051|1020981|P2|COMPLETED|Overall Study||10
427929|NCT00766051|1020982|P1|COMPLETED|Overall Study||10
427930|NCT00766051|1020981|P2|STARTED|Overall Study||10
427931|NCT00766051|1020982|P1|STARTED|Overall Study||12
427932|NCT00765947|1020992|P1|NOT COMPLETED|Overall Study||24
427933|NCT00765947|1020992|P1|COMPLETED|Overall Study||232
427934|NCT00765947|1020992|P1|STARTED|Overall Study||256
427935|NCT00765895|1021003|P2|NOT COMPLETED|Overall Study||0
427936|NCT00765895|1021004|P1|NOT COMPLETED|Overall Study||0
427937|NCT00765895|1021003|P2|COMPLETED|Overall Study||65
427938|NCT00765895|1021004|P1|COMPLETED|Overall Study||65
427939|NCT00765895|1021003|P2|STARTED|Overall Study||65
427940|NCT00765895|1021004|P1|STARTED|Overall Study||65
427941|NCT00765882|1021013|P3|NOT COMPLETED|Overall Study||36
427942|NCT00765882|1021014|P2|NOT COMPLETED|Overall Study||40
427943|NCT00765882|1021015|P1|NOT COMPLETED|Overall Study||24
427944|NCT00765882|1021013|P3|COMPLETED|Overall Study||169
427945|NCT00765882|1021014|P2|COMPLETED|Overall Study||173
427946|NCT00765882|1021015|P1|COMPLETED|Overall Study||191
427947|NCT00765882|1021013|P3|STARTED|Overall Study||205
427948|NCT00765882|1021014|P2|STARTED|Overall Study||213
427949|NCT00765882|1021015|P1|STARTED|Overall Study||215
427950|NCT00765843|1021047|P3|NOT COMPLETED|Overall Study||3
427951|NCT00765843|1021048|P2|NOT COMPLETED|Overall Study||4
427952|NCT00765843|1021049|P1|NOT COMPLETED|Overall Study||1
427953|NCT00765843|1021047|P3|COMPLETED|Overall Study||23
427954|NCT00765843|1021048|P2|COMPLETED|Overall Study||21
427955|NCT00765843|1021049|P1|COMPLETED|Overall Study||25
427956|NCT00765843|1021047|P3|STARTED|Overall Study||26
427957|NCT00765843|1021048|P2|STARTED|Overall Study||25
427958|NCT00765843|1021049|P1|STARTED|Overall Study||26
427959|NCT00765817|1021059|P2|NOT COMPLETED|Overall Study||22
427960|NCT00765817|1021060|P1|NOT COMPLETED|Overall Study||26
427961|NCT00765817|1021059|P2|COMPLETED|Overall Study||101
427962|NCT00765817|1021060|P1|COMPLETED|Overall Study||112
427963|NCT00765817|1021059|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
427964|NCT00765817|1021060|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
427965|NCT00765765|1021098|P1|NOT COMPLETED|Overall Study||0
427966|NCT00765765|1021098|P1|COMPLETED|Overall Study||6
427967|NCT00765765|1021098|P1|STARTED|Overall Study||6
427968|NCT00765726|1021108|P1|NOT COMPLETED|Overall Study||9
427969|NCT00765726|1021108|P1|COMPLETED|Overall Study||3
427970|NCT00765726|1021108|P1|STARTED|Overall Study||12
427971|NCT00765674|1021116|P4|NOT COMPLETED|Overall Study||25
427972|NCT00765674|1021117|P3|NOT COMPLETED|Overall Study||17
427973|NCT00765674|1021118|P2|NOT COMPLETED|Overall Study||22
427974|NCT00765674|1021119|P1|NOT COMPLETED|Overall Study||21
427975|NCT00765674|1021116|P4|COMPLETED|Overall Study||285
427976|NCT00765674|1021117|P3|COMPLETED|Overall Study||279
427977|NCT00765674|1021118|P2|COMPLETED|Overall Study||276
427978|NCT00765674|1021119|P1|COMPLETED|Overall Study||266
427979|NCT00765674|1021116|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
427980|NCT00765674|1021117|P3|STARTED|Overall Study||296
427981|NCT00765674|1021118|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
427982|NCT00765674|1021119|P1|STARTED|Overall Study||287
427983|NCT00765661|1021143|P2|NOT COMPLETED|Overall Study||0
427984|NCT00765661|1021144|P1|NOT COMPLETED|Overall Study||0
427985|NCT00765661|1021143|P2|COMPLETED|Overall Study||31
427986|NCT00765661|1021144|P1|COMPLETED|Overall Study||32
427987|NCT00765661|1021143|P2|STARTED|Overall Study||31
427988|NCT00765661|1021144|P1|STARTED|Overall Study||32
427989|NCT00765648|1021158|P2|NOT COMPLETED|Overall Study||2
427990|NCT00765648|1021159|P1|NOT COMPLETED|Overall Study||1
427991|NCT00765648|1021158|P2|COMPLETED|Overall Study||114
427992|NCT00765648|1021159|P1|COMPLETED|Overall Study||109
427993|NCT00765648|1021158|P2|STARTED|Overall Study||116
427994|NCT00765648|1021159|P1|STARTED|Overall Study||110
427995|NCT00765570|1021177|P2|NOT COMPLETED|Overall Study||0
427996|NCT00765570|1021178|P1|NOT COMPLETED|Overall Study||2
427997|NCT00765570|1021177|P2|COMPLETED|Overall Study||3
427998|NCT00765570|1021178|P1|COMPLETED|Overall Study||7
427999|NCT00765570|1021177|P2|STARTED|Overall Study||3
428000|NCT00765570|1021178|P1|STARTED|Overall Study||9
428001|NCT00765388|1021186|P2|NOT COMPLETED|Period 2||0
428002|NCT00765388|1021187|P1|NOT COMPLETED|Period 2||0
428003|NCT00765388|1021186|P2|COMPLETED|Period 2||6
428004|NCT00765388|1021187|P1|COMPLETED|Period 2||15
428005|NCT00765388|1021186|P2|STARTED|Period 2||6
428006|NCT00765388|1021187|P1|STARTED|Period 2||15
428007|NCT00765388|1021186|P2|NOT COMPLETED|Period 1||5
428008|NCT00765388|1021187|P1|NOT COMPLETED|Period 1||1
428009|NCT00765388|1021186|P2|COMPLETED|Period 1||6
428010|NCT00765388|1021187|P1|COMPLETED|Period 1||15
428011|NCT00765388|1021186|P2|STARTED|Period 1||11
428012|NCT00765388|1021187|P1|STARTED|Period 1|A cross-over study|16
428013|NCT00765375|1021215|P1|NOT COMPLETED|Overall Study||0
428014|NCT00765375|1021215|P1|COMPLETED|Overall Study||5
428015|NCT00765375|1021215|P1|STARTED|Overall Study||5
428016|NCT00765362|1021221|P1|NOT COMPLETED|Overall Study||137
428017|NCT00765362|1021221|P1|COMPLETED|Overall Study||282
428018|NCT00765362|1021221|P1|STARTED|Overall Study||419
428019|NCT00765336|1021229|P2|NOT COMPLETED|Overall Study||16
428020|NCT00765336|1021230|P1|NOT COMPLETED|Overall Study||19
428021|NCT00765336|1021229|P2|COMPLETED|Overall Study||73
428022|NCT00765336|1021230|P1|COMPLETED|Overall Study||72
428023|NCT00765336|1021229|P2|STARTED|Overall Study||89
428024|NCT00765336|1021230|P1|STARTED|Overall Study||91
428025|NCT00765245|1021238|P2|NOT COMPLETED|Overall Study||2
428026|NCT00765245|1021239|P1|NOT COMPLETED|Overall Study||13
428027|NCT00765245|1021238|P2|COMPLETED|Overall Study||20
428028|NCT00765245|1021239|P1|COMPLETED|Overall Study||9
428029|NCT00765245|1021238|P2|STARTED|Overall Study||22
428030|NCT00765245|1021239|P1|STARTED|Overall Study||22
428031|NCT00765232|1021251|P2|NOT COMPLETED|Overall Study||0
428032|NCT00765232|1021252|P1|NOT COMPLETED|Overall Study||0
428033|NCT00765232|1021251|P2|COMPLETED|Overall Study||54
428034|NCT00765232|1021252|P1|COMPLETED|Overall Study||57
428035|NCT00765232|1021251|P2|STARTED|Overall Study||54
428036|NCT00765232|1021252|P1|STARTED|Overall Study||57
428037|NCT00765206|1021260|P4|NOT COMPLETED|Second Intervention||0
428038|NCT00765206|1021261|P3|NOT COMPLETED|Second Intervention||0
428039|NCT00765206|1021262|P2|NOT COMPLETED|Second Intervention||0
428040|NCT00765206|1021263|P1|NOT COMPLETED|Second Intervention||0
428041|NCT00765206|1021260|P4|COMPLETED|Second Intervention||15
428042|NCT00765206|1021261|P3|COMPLETED|Second Intervention||15
428043|NCT00765206|1021262|P2|COMPLETED|Second Intervention||15
428044|NCT00765206|1021263|P1|COMPLETED|Second Intervention||15
428045|NCT00765206|1021260|P4|STARTED|Second Intervention||15
428046|NCT00765206|1021261|P3|STARTED|Second Intervention||15
428047|NCT00765206|1021262|P2|STARTED|Second Intervention||15
428048|NCT00765206|1021263|P1|STARTED|Second Intervention||15
428049|NCT00765206|1021260|P4|NOT COMPLETED|Washout Period of 14 Days||0
428050|NCT00765206|1021261|P3|NOT COMPLETED|Washout Period of 14 Days||0
428051|NCT00765206|1021262|P2|NOT COMPLETED|Washout Period of 14 Days||0
428052|NCT00765206|1021263|P1|NOT COMPLETED|Washout Period of 14 Days||0
428053|NCT00765206|1021260|P4|COMPLETED|Washout Period of 14 Days||15
428054|NCT00765206|1021261|P3|COMPLETED|Washout Period of 14 Days||15
428055|NCT00765206|1021262|P2|COMPLETED|Washout Period of 14 Days||15
428056|NCT00765206|1021263|P1|COMPLETED|Washout Period of 14 Days||15
428057|NCT00765206|1021260|P4|STARTED|Washout Period of 14 Days||15
428058|NCT00765206|1021261|P3|STARTED|Washout Period of 14 Days||15
428059|NCT00765206|1021262|P2|STARTED|Washout Period of 14 Days||15
428060|NCT00765206|1021263|P1|STARTED|Washout Period of 14 Days||15
428061|NCT00765206|1021260|P4|NOT COMPLETED|First Intervention||0
428062|NCT00765206|1021261|P3|NOT COMPLETED|First Intervention||0
428063|NCT00765206|1021262|P2|NOT COMPLETED|First Intervention||0
428064|NCT00765206|1021263|P1|NOT COMPLETED|First Intervention||0
428065|NCT00765206|1021260|P4|COMPLETED|First Intervention||15
428066|NCT00765206|1021261|P3|COMPLETED|First Intervention||15
428067|NCT00765206|1021262|P2|COMPLETED|First Intervention||15
428068|NCT00765206|1021263|P1|COMPLETED|First Intervention||15
428069|NCT00765206|1021260|P4|STARTED|First Intervention||15
428070|NCT00765206|1021261|P3|STARTED|First Intervention||15
428071|NCT00765206|1021262|P2|STARTED|First Intervention||15
428072|NCT00765206|1021263|P1|STARTED|First Intervention||15
428073|NCT00765193|1021269|P1|NOT COMPLETED|Full Body Examination||0
428074|NCT00765193|1021269|P1|COMPLETED|Full Body Examination||14381
428075|NCT00765193|1021269|P1|STARTED|Full Body Examination||14381
428076|NCT00765193|1021269|P1|NOT COMPLETED|Problem Area Examination||0
428077|NCT00765193|1021269|P1|COMPLETED|Problem Area Examination||14381
428078|NCT00765193|1021269|P1|STARTED|Problem Area Examination||14381
428079|NCT00765128|1021276|P2|NOT COMPLETED|Overall Study||0
428080|NCT00765128|1021277|P1|NOT COMPLETED|Overall Study||0
428081|NCT00765128|1021276|P2|COMPLETED|Overall Study||9
428082|NCT00765128|1021277|P1|COMPLETED|Overall Study||8
428083|NCT00765128|1021276|P2|STARTED|Overall Study||9
428084|NCT00765128|1021277|P1|STARTED|Overall Study||8
428085|NCT00765102|1021285|P1|NOT COMPLETED|Overall Study||31
428086|NCT00765102|1021285|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
428087|NCT00765102|1021285|P1|STARTED|Overall Study||32
428088|NCT00765076|1021310|P3|NOT COMPLETED|Overall Study||1
428089|NCT00765076|1021311|P2|NOT COMPLETED|Overall Study||0
428090|NCT00765076|1021312|P1|NOT COMPLETED|Overall Study||1
428091|NCT00765076|1021310|P3|COMPLETED|Overall Study||49
428092|NCT00765076|1021311|P2|COMPLETED|Overall Study||73
428093|NCT00765076|1021312|P1|COMPLETED|Overall Study||68
428094|NCT00765076|1021310|P3|STARTED|Overall Study||50
428095|NCT00765076|1021311|P2|STARTED|Overall Study||73
428096|NCT00765076|1021312|P1|STARTED|Overall Study||69
428097|NCT00765063|1021365|P1|NOT COMPLETED|Overall Study||32
428098|NCT00765063|1021365|P1|COMPLETED|Overall Study||30
428099|NCT00765063|1021365|P1|STARTED|Overall Study||62
428100|NCT00765037|1021381|P1|NOT COMPLETED|Overall Study||6
428101|NCT00765037|1021381|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
428102|NCT00765037|1021381|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
428103|NCT00764946|1021388|P3|NOT COMPLETED|Overall Study||4
428104|NCT00764946|1021389|P2|NOT COMPLETED|Overall Study||17
428105|NCT00764946|1021390|P1|NOT COMPLETED|Overall Study||13
428106|NCT00764946|1021388|P3|COMPLETED|Overall Study||18
428107|NCT00764946|1021389|P2|COMPLETED|Overall Study||72
428108|NCT00764946|1021390|P1|COMPLETED|Overall Study||85
428109|NCT00764946|1021388|P3|TREATED|Overall Study||21
428110|NCT00764946|1021389|P2|TREATED|Overall Study||88
428111|NCT00764946|1021390|P1|TREATED|Overall Study||97
428112|NCT00764946|1021388|P3|STARTED|Overall Study||22
428113|NCT00764946|1021389|P2|STARTED|Overall Study||89
428114|NCT00764946|1021390|P1|STARTED|Overall Study||98
428115|NCT00764881|1021418|P2|NOT COMPLETED|Overall Study||10
428116|NCT00764881|1021419|P1|NOT COMPLETED|Overall Study||16
428117|NCT00764881|1021418|P2|COMPLETED|Overall Study||99
428118|NCT00764881|1021419|P1|COMPLETED|Overall Study||92
428119|NCT00764881|1021418|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
428120|NCT00764881|1021419|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
428121|NCT00764881|1021418|P2|STARTED|Overall Study||109
428122|NCT00764881|1021419|P1|STARTED|Overall Study||108
428123|NCT00764868|1021643|P1|NOT COMPLETED|Overall Study||113
428124|NCT00764868|1021643|P1|COMPLETED|Overall Study||156
428125|NCT00764868|1021643|P1|STARTED|Overall Study||269
428126|NCT00764790|1021652|P3|NOT COMPLETED|Overall Study||30
428127|NCT00764790|1021653|P2|NOT COMPLETED|Overall Study||41
428128|NCT00764790|1021654|P1|NOT COMPLETED|Overall Study||38
428129|NCT00764790|1021652|P3|COMPLETED|Overall Study||1074
428130|NCT00764790|1021653|P2|COMPLETED|Overall Study||1065
428131|NCT00764790|1021654|P1|COMPLETED|Overall Study||1069
428132|NCT00764790|1021652|P3|STARTED|Overall Study||1104
428133|NCT00764790|1021653|P2|STARTED|Overall Study||1106
428134|NCT00764790|1021654|P1|STARTED|Overall Study||1107
428135|NCT00764673|1021686|P1|NOT COMPLETED|Overall Study||12
428136|NCT00764673|1021686|P1|COMPLETED|Overall Study||59
428137|NCT00764673|1021686|P1|STARTED|Overall Study||71
428138|NCT00764660|1021696|P2|NOT COMPLETED|Overall Study||11
428139|NCT00764660|1021697|P1|NOT COMPLETED|Overall Study||22
428140|NCT00764660|1021696|P2|COMPLETED|Overall Study||55
428141|NCT00764660|1021697|P1|COMPLETED|Overall Study||53
428142|NCT00764660|1021696|P2|STARTED|Overall Study||66
428143|NCT00764660|1021697|P1|STARTED|Overall Study||75
428144|NCT00764504|1021732|P3|NOT COMPLETED|Overall Study||103
428145|NCT00764504|1021733|P2|NOT COMPLETED|Overall Study||70
428146|NCT00764504|1021734|P1|NOT COMPLETED|Overall Study||66
428147|NCT00764504|1021732|P3|COMPLETED|Overall Study||131
428148|NCT00764504|1021733|P2|COMPLETED|Overall Study||71
428149|NCT00764504|1021734|P1|COMPLETED|Overall Study||75
428150|NCT00764504|1021732|P3|STARTED|Overall Study||234
428151|NCT00764504|1021733|P2|STARTED|Overall Study||141
428152|NCT00764504|1021734|P1|STARTED|Overall Study||141
428153|NCT00763490|1021760|P1|NOT COMPLETED|Overall Study||0
428154|NCT00763490|1021760|P1|COMPLETED|Overall Study||20
428155|NCT00763490|1021760|P1|STARTED|Overall Study||20
428156|NCT00764478|1021770|P3|NOT COMPLETED|Overall Study||8
428157|NCT00764478|1021771|P2|NOT COMPLETED|Overall Study||22
428158|NCT00764478|1021772|P1|NOT COMPLETED|Overall Study||15
428159|NCT00764478|1021770|P3|COMPLETED|Overall Study||118
428160|NCT00764478|1021771|P2|COMPLETED|Overall Study||97
428161|NCT00764478|1021772|P1|COMPLETED|Overall Study||107
428162|NCT00764478|1021770|P3|STARTED|Overall Study||126
428163|NCT00764478|1021771|P2|STARTED|Overall Study||119
428164|NCT00764478|1021772|P1|STARTED|Overall Study||122
428165|NCT00764465|1021852|P6|NOT COMPLETED|Overall Study||1
428166|NCT00764465|1021853|P5|NOT COMPLETED|Overall Study||1
428167|NCT00764465|1021854|P4|NOT COMPLETED|Overall Study||1
428168|NCT00764465|1021855|P3|NOT COMPLETED|Overall Study||1
428169|NCT00764465|1021856|P2|NOT COMPLETED|Overall Study||1
428170|NCT00764465|1021857|P1|NOT COMPLETED|Overall Study||2
428171|NCT00764465|1021852|P6|COMPLETED|Overall Study||7
428172|NCT00764465|1021853|P5|COMPLETED|Overall Study||6
428173|NCT00764465|1021854|P4|COMPLETED|Overall Study||6
428174|NCT00764465|1021855|P3|COMPLETED|Overall Study||6
428175|NCT00764465|1021856|P2|COMPLETED|Overall Study||6
428176|NCT00764465|1021857|P1|COMPLETED|Overall Study||7
428177|NCT00764465|1021852|P6|STARTED|Overall Study||8
428178|NCT00764465|1021853|P5|STARTED|Overall Study||7
428179|NCT00764465|1021854|P4|STARTED|Overall Study||7
428180|NCT00764465|1021855|P3|STARTED|Overall Study||7
428181|NCT00764465|1021856|P2|STARTED|Overall Study||7
428182|NCT00764465|1021857|P1|STARTED|Overall Study||9
428183|NCT00764361|1021885|P2|NOT COMPLETED|Overall Study||4
428184|NCT00764361|1021886|P1|NOT COMPLETED|Overall Study||2
428185|NCT00764361|1021885|P2|COMPLETED|Overall Study||3
428186|NCT00764361|1021886|P1|COMPLETED|Overall Study||6
428187|NCT00764361|1021885|P2|STARTED|Overall Study||7
428188|NCT00764361|1021886|P1|STARTED|Overall Study||8
428189|NCT00764309|1021892|P1|NOT COMPLETED|Overall Study||0
428190|NCT00764309|1021892|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
428191|NCT00764309|1021892|P1|STARTED|Overall Study|Number of participants treated.|31
428192|NCT00763971|1021902|P3|NOT COMPLETED|Overall Study||69
428193|NCT00763971|1021903|P2|NOT COMPLETED|Overall Study||38
428194|NCT00763971|1021904|P1|NOT COMPLETED|Overall Study||33
428195|NCT00763971|1021902|P3|COMPLETED|Overall Study||42
428196|NCT00763971|1021903|P2|COMPLETED|Overall Study||74
428197|NCT00763971|1021904|P1|COMPLETED|Overall Study||80
428198|NCT00763971|1021902|P3|STARTED|Overall Study||111
428199|NCT00763971|1021903|P2|STARTED|Overall Study||112
428200|NCT00763971|1021904|P1|STARTED|Overall Study||113
428201|NCT00763958|1021935|P2|NOT COMPLETED|Overall Study||11
428202|NCT00763958|1021936|P1|NOT COMPLETED|Overall Study||14
428203|NCT00763958|1021935|P2|COMPLETED|Overall Study||5
428204|NCT00763958|1021936|P1|COMPLETED|Overall Study||14
428205|NCT00763958|1021935|P2|STARTED|Overall Study||16
428206|NCT00763958|1021936|P1|STARTED|Overall Study||28
428207|NCT00763919|1021946|P1|NOT COMPLETED|Overall Study||13
428208|NCT00763919|1021946|P1|COMPLETED|Overall Study||30
428209|NCT00763919|1021946|P1|STARTED|Overall Study||43
428210|NCT00763867|1021974|P2|NOT COMPLETED|Overall Study||12
428211|NCT00763867|1021975|P1|NOT COMPLETED|Overall Study||5
428212|NCT00763867|1021974|P2|COMPLETED|Overall Study||101
428213|NCT00763867|1021975|P1|COMPLETED|Overall Study||98
428214|NCT00763867|1021974|P2|STARTED|Overall Study||113
428215|NCT00763867|1021975|P1|STARTED|Overall Study||103
428216|NCT00763815|1022071|P2|NOT COMPLETED|Overall Study||84
428217|NCT00763815|1022072|P1|NOT COMPLETED|Overall Study||52
428218|NCT00763815|1022071|P2|COMPLETED|Overall Study||239
428219|NCT00763815|1022072|P1|COMPLETED|Overall Study||109
428220|NCT00763815|1022071|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
428221|NCT00763815|1022072|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
428222|NCT00763815|1022071|P2|Treated/Safety Population|Overall Study||323
428223|NCT00763815|1022072|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
428224|NCT00763815|1022071|P2|STARTED|Overall Study||323
428225|NCT00763815|1022072|P1|STARTED|Overall Study|Randomized.|161
428226|NCT00763750|1022096|P1|NOT COMPLETED|Overall Study||0
428227|NCT00763750|1022096|P1|COMPLETED|Overall Study||25
428228|NCT00763750|1022096|P1|STARTED|Overall Study||25
428229|NCT00763698|1022100|P1|NOT COMPLETED|Overall Study||10
428230|NCT00763698|1022100|P1|COMPLETED|Overall Study||76
428231|NCT00763698|1022100|P1|STARTED|Overall Study||86
428232|NCT00763451|1022110|P4|NOT COMPLETED|Overall Study||30
428233|NCT00763451|1022111|P3|NOT COMPLETED|Overall Study||40
428234|NCT00763451|1022112|P2|NOT COMPLETED|Overall Study||22
428235|NCT00763451|1022113|P1|NOT COMPLETED|Overall Study||13
428236|NCT00763451|1022110|P4|COMPLETED|Overall Study||131
428237|NCT00763451|1022111|P3|COMPLETED|Overall Study||121
428238|NCT00763451|1022112|P2|COMPLETED|Overall Study||60
428239|NCT00763451|1022113|P1|COMPLETED|Overall Study||67
428240|NCT00763451|1022110|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
428241|NCT00763451|1022111|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
428242|NCT00763451|1022112|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
428243|NCT00763451|1022113|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
428244|NCT00763451|1022110|P4|Treated/Safety Population|Overall Study||161
428245|NCT00763451|1022111|P3|Treated/Safety Population|Overall Study||161
428246|NCT00763451|1022112|P2|Treated/Safety Population|Overall Study||81
428342|NCT00762996|1022333|P4|NOT COMPLETED|Period One||1
428247|NCT00763451|1022113|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
428248|NCT00763451|1022110|P4|STARTED|Overall Study||161
428249|NCT00763451|1022111|P3|STARTED|Overall Study||161
428250|NCT00763451|1022112|P2|STARTED|Overall Study||82
428251|NCT00763451|1022113|P1|STARTED|Overall Study|Randomized.|80
428252|NCT00763412|1022147|P2|NOT COMPLETED|Overall Study||4
428253|NCT00763412|1022148|P1|NOT COMPLETED|Overall Study||4
428254|NCT00763412|1022147|P2|COMPLETED|Overall Study||4
428255|NCT00763412|1022148|P1|COMPLETED|Overall Study||4
428256|NCT00763412|1022147|P2|STARTED|Overall Study||8
428257|NCT00763412|1022148|P1|STARTED|Overall Study||8
428258|NCT00763386|1022172|P2|NOT COMPLETED|Overall Study||40
428259|NCT00763386|1022173|P1|NOT COMPLETED|Overall Study||48
428260|NCT00763386|1022172|P2|COMPLETED|Overall Study||127
428261|NCT00763386|1022173|P1|COMPLETED|Overall Study||116
428262|NCT00763386|1022172|P2|STARTED|Overall Study||167
428263|NCT00763386|1022173|P1|STARTED|Overall Study||164
428264|NCT00763360|1022184|P3|NOT COMPLETED|Overall Study||0
428265|NCT00763360|1022185|P2|NOT COMPLETED|Overall Study||2
428266|NCT00763360|1022186|P1|NOT COMPLETED|Overall Study||0
428267|NCT00763360|1022184|P3|COMPLETED|Overall Study||63
428268|NCT00763360|1022185|P2|COMPLETED|Overall Study||58
428269|NCT00763360|1022186|P1|COMPLETED|Overall Study||61
428270|NCT00763360|1022184|P3|STARTED|Overall Study||63
428271|NCT00763360|1022185|P2|STARTED|Overall Study||60
428272|NCT00763360|1022186|P1|STARTED|Overall Study||61
428273|NCT00763321|1022206|P3|NOT COMPLETED|Double-blind Period||29
428274|NCT00763321|1022207|P2|NOT COMPLETED|Double-blind Period||21
428275|NCT00763321|1022208|P1|NOT COMPLETED|Double-blind Period||0
428276|NCT00763321|1022206|P3|COMPLETED|Double-blind Period||84
428277|NCT00763321|1022207|P2|COMPLETED|Double-blind Period||88
428278|NCT00763321|1022208|P1|COMPLETED|Double-blind Period||0
428279|NCT00763321|1022206|P3|STARTED|Double-blind Period||113
428280|NCT00763321|1022207|P2|STARTED|Double-blind Period||109
428281|NCT00763321|1022208|P1|STARTED|Double-blind Period||0
428282|NCT00763321|1022206|P3|NOT COMPLETED|Open-label Period||0
428283|NCT00763321|1022207|P2|NOT COMPLETED|Open-label Period||0
428284|NCT00763321|1022208|P1|NOT COMPLETED|Open-label Period||63
428285|NCT00763321|1022206|P3|COMPLETED|Open-label Period||0
428286|NCT00763321|1022207|P2|COMPLETED|Open-label Period||0
428287|NCT00763321|1022208|P1|COMPLETED|Open-label Period||222
428288|NCT00763321|1022206|P3|STARTED|Open-label Period||0
428289|NCT00763321|1022207|P2|STARTED|Open-label Period||0
428290|NCT00763321|1022208|P1|STARTED|Open-label Period||285
428291|NCT00763282|1022219|P2|NOT COMPLETED|Overall Study||34
428292|NCT00763282|1022220|P1|NOT COMPLETED|Overall Study||32
428293|NCT00763282|1022219|P2|COMPLETED|Overall Study||38
428294|NCT00763282|1022220|P1|COMPLETED|Overall Study||40
428295|NCT00763282|1022219|P2|STARTED|Overall Study||72
428296|NCT00763282|1022220|P1|STARTED|Overall Study||72
428297|NCT00763269|1022236|P2|NOT COMPLETED|Overall Study||13
428298|NCT00763269|1022237|P1|NOT COMPLETED|Overall Study||12
428299|NCT00763269|1022236|P2|COMPLETED|Overall Study||299
428300|NCT00763269|1022237|P1|COMPLETED|Overall Study||302
428301|NCT00763269|1022236|P2|STARTED|Overall Study||312
428302|NCT00763269|1022237|P1|STARTED|Overall Study||314
428303|NCT00763256|1022251|P2|NOT COMPLETED|Overall Study||10
428304|NCT00763256|1022252|P1|NOT COMPLETED|Overall Study||7
428305|NCT00763256|1022251|P2|COMPLETED|Overall Study||8
428306|NCT00763256|1022252|P1|COMPLETED|Overall Study||8
428307|NCT00763256|1022251|P2|STARTED|Overall Study||18
428308|NCT00763256|1022252|P1|STARTED|Overall Study||15
428309|NCT00763139|1022266|P2|NOT COMPLETED|Overall Study||3
428310|NCT00763139|1022267|P1|NOT COMPLETED|Overall Study||5
428311|NCT00763139|1022266|P2|COMPLETED|Overall Study||14
428312|NCT00763139|1022267|P1|COMPLETED|Overall Study||12
428313|NCT00763139|1022266|P2|STARTED|Overall Study||17
428314|NCT00763139|1022267|P1|STARTED|Overall Study||17
428315|NCT00763061|1022289|P2|NOT COMPLETED|Overall Study||13
428316|NCT00763061|1022290|P1|NOT COMPLETED|Overall Study||5
428317|NCT00763061|1022289|P2|COMPLETED|Overall Study||44
428318|NCT00763061|1022290|P1|COMPLETED|Overall Study||49
428319|NCT00763061|1022289|P2|STARTED|Overall Study||57
428320|NCT00763061|1022290|P1|STARTED|Overall Study||54
428321|NCT00763048|1022304|P2|NOT COMPLETED|Overall Study||0
428322|NCT00763048|1022305|P1|NOT COMPLETED|Overall Study||0
428323|NCT00763048|1022304|P2|COMPLETED|Overall Study||18
428324|NCT00763048|1022305|P1|COMPLETED|Overall Study||21
428325|NCT00763048|1022304|P2|STARTED|Overall Study||18
428326|NCT00763048|1022305|P1|STARTED|Overall Study||21
428327|NCT00763009|1022329|P1|NOT COMPLETED|Overall Study||1
428328|NCT00763009|1022329|P1|COMPLETED|Overall Study||7
428329|NCT00763009|1022329|P1|STARTED|Overall Study||8
428330|NCT00762996|1022333|P4|NOT COMPLETED|Period Two||0
428331|NCT00762996|1022334|P3|NOT COMPLETED|Period Two||0
428332|NCT00762996|1022335|P2|NOT COMPLETED|Period Two||0
428333|NCT00762996|1022336|P1|NOT COMPLETED|Period Two||0
428334|NCT00762996|1022333|P4|COMPLETED|Period Two||16
428335|NCT00762996|1022334|P3|COMPLETED|Period Two||13
428336|NCT00762996|1022335|P2|COMPLETED|Period Two||16
428337|NCT00762996|1022336|P1|COMPLETED|Period Two||15
428338|NCT00762996|1022333|P4|STARTED|Period Two||16
428339|NCT00762996|1022334|P3|STARTED|Period Two||13
428340|NCT00762996|1022335|P2|STARTED|Period Two||16
428341|NCT00762996|1022336|P1|STARTED|Period Two||15
428343|NCT00762996|1022334|P3|NOT COMPLETED|Period One||4
428344|NCT00762996|1022335|P2|NOT COMPLETED|Period One||0
428345|NCT00762996|1022336|P1|NOT COMPLETED|Period One||0
428346|NCT00762996|1022333|P4|COMPLETED|Period One||16
428347|NCT00762996|1022334|P3|COMPLETED|Period One||13
428348|NCT00762996|1022335|P2|COMPLETED|Period One||16
428349|NCT00762996|1022336|P1|COMPLETED|Period One||15
428350|NCT00762996|1022333|P4|STARTED|Period One||17
428351|NCT00762996|1022334|P3|STARTED|Period One||17
428352|NCT00762996|1022335|P2|STARTED|Period One||16
428353|NCT00762996|1022336|P1|STARTED|Period One||15
428354|NCT00762970|1022349|P3|NOT COMPLETED|Overall Study||1
428355|NCT00762970|1022350|P2|NOT COMPLETED|Overall Study||9
428356|NCT00762970|1022351|P1|NOT COMPLETED|Overall Study||12
428357|NCT00762970|1022349|P3|COMPLETED|Overall Study||46
428358|NCT00762970|1022350|P2|COMPLETED|Overall Study||35
428359|NCT00762970|1022351|P1|COMPLETED|Overall Study||34
428360|NCT00762970|1022349|P3|STARTED|Overall Study||47
428361|NCT00762970|1022350|P2|STARTED|Overall Study||44
428362|NCT00762970|1022351|P1|STARTED|Overall Study||46
428363|NCT00762892|1022364|P2|NOT COMPLETED|Overall Study||6
428364|NCT00762892|1022365|P1|NOT COMPLETED|Overall Study||5
428365|NCT00762892|1022364|P2|COMPLETED|Overall Study||8
428366|NCT00762892|1022365|P1|COMPLETED|Overall Study||9
428367|NCT00762892|1022364|P2|STARTED|Overall Study||14
428368|NCT00762892|1022365|P1|STARTED|Overall Study||14
428369|NCT00762853|1022381|P2|NOT COMPLETED|Second Treatment Period||0
428370|NCT00762853|1022382|P1|NOT COMPLETED|Second Treatment Period||0
428371|NCT00762853|1022381|P2|COMPLETED|Second Treatment Period||10
428372|NCT00762853|1022382|P1|COMPLETED|Second Treatment Period||10
428373|NCT00762853|1022381|P2|STARTED|Second Treatment Period||10
428374|NCT00762853|1022382|P1|STARTED|Second Treatment Period||10
428375|NCT00762853|1022381|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
428376|NCT00762853|1022382|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
428377|NCT00762853|1022381|P2|COMPLETED|1 Week Washout After Treatment 1||10
428378|NCT00762853|1022382|P1|COMPLETED|1 Week Washout After Treatment 1||10
428379|NCT00762853|1022381|P2|STARTED|1 Week Washout After Treatment 1||10
428380|NCT00762853|1022382|P1|STARTED|1 Week Washout After Treatment 1||10
428381|NCT00762853|1022381|P2|NOT COMPLETED|First Treatment Period||0
428382|NCT00762853|1022382|P1|NOT COMPLETED|First Treatment Period||0
428383|NCT00762853|1022381|P2|COMPLETED|First Treatment Period||10
428384|NCT00762853|1022382|P1|COMPLETED|First Treatment Period||10
428385|NCT00762853|1022381|P2|STARTED|First Treatment Period||10
428386|NCT00762853|1022382|P1|STARTED|First Treatment Period||10
428387|NCT00762788|1022394|P6|NOT COMPLETED|Overall Study||21
428388|NCT00762788|1022395|P5|NOT COMPLETED|Overall Study||13
428389|NCT00762788|1022396|P4|NOT COMPLETED|Overall Study||26
428390|NCT00762788|1022397|P3|NOT COMPLETED|Overall Study||21
428391|NCT00762788|1022398|P2|NOT COMPLETED|Overall Study||37
428392|NCT00762788|1022399|P1|NOT COMPLETED|Overall Study||26
428393|NCT00762788|1022394|P6|COMPLETED|Overall Study||31
428394|NCT00762788|1022395|P5|COMPLETED|Overall Study||30
428395|NCT00762788|1022396|P4|COMPLETED|Overall Study||38
428396|NCT00762788|1022397|P3|COMPLETED|Overall Study||21
428397|NCT00762788|1022398|P2|COMPLETED|Overall Study||21
428398|NCT00762788|1022399|P1|COMPLETED|Overall Study||29
428399|NCT00762788|1022394|P6|STARTED|Overall Study||52
428400|NCT00762788|1022395|P5|STARTED|Overall Study||43
428401|NCT00762788|1022396|P4|STARTED|Overall Study||64
428402|NCT00762788|1022397|P3|STARTED|Overall Study||42
428403|NCT00762788|1022398|P2|STARTED|Overall Study||58
428404|NCT00762788|1022399|P1|STARTED|Overall Study||55
428405|NCT00762762|1022421|P2|NOT COMPLETED|Overall Study||10
428406|NCT00762762|1022422|P1|NOT COMPLETED|Overall Study||8
428407|NCT00762762|1022421|P2|COMPLETED|Overall Study||20
428408|NCT00762762|1022422|P1|COMPLETED|Overall Study||22
428409|NCT00762762|1022421|P2|STARTED|Overall Study||30
428410|NCT00762762|1022422|P1|STARTED|Overall Study||30
428411|NCT00762723|1022439|P3|NOT COMPLETED|Overall Study||3
428412|NCT00762723|1022440|P2|NOT COMPLETED|Overall Study||5
428413|NCT00762723|1022441|P1|NOT COMPLETED|Overall Study||5
428414|NCT00762723|1022439|P3|COMPLETED|Overall Study||0
428415|NCT00762723|1022440|P2|COMPLETED|Overall Study||6
428416|NCT00762723|1022441|P1|COMPLETED|Overall Study||0
428417|NCT00762723|1022439|P3|STARTED|Overall Study||3
428418|NCT00762723|1022440|P2|STARTED|Overall Study||11
428419|NCT00762723|1022441|P1|STARTED|Overall Study||5
428420|NCT00762645|1022451|P2|NOT COMPLETED|Overall Study||2
428421|NCT00762645|1022452|P1|NOT COMPLETED|Overall Study||4
428422|NCT00762645|1022451|P2|COMPLETED|Overall Study||12
428423|NCT00762645|1022452|P1|COMPLETED|Overall Study||12
428424|NCT00762645|1022451|P2|STARTED|Overall Study||14
428425|NCT00762645|1022452|P1|STARTED|Overall Study||16
428426|NCT00762619|1022462|P2|NOT COMPLETED|Overall Study||0
428427|NCT00762619|1022463|P1|NOT COMPLETED|Overall Study||0
428428|NCT00762619|1022462|P2|COMPLETED|Overall Study||50
428429|NCT00762619|1022463|P1|COMPLETED|Overall Study||55
428430|NCT00762619|1022462|P2|STARTED|Overall Study||50
428431|NCT00762619|1022463|P1|STARTED|Overall Study||55
428432|NCT00762606|1022605|P2|NOT COMPLETED|Overall Study||13
428433|NCT00762606|1022606|P1|NOT COMPLETED|Overall Study||18
428434|NCT00762606|1022605|P2|COMPLETED|Overall Study||38
428435|NCT00762606|1022606|P1|COMPLETED|Overall Study||37
428436|NCT00762606|1022605|P2|STARTED|Overall Study||51
428437|NCT00762606|1022606|P1|STARTED|Overall Study||55
428438|NCT00762528|1022616|P2|NOT COMPLETED|Overall Study||0
428439|NCT00762528|1022617|P1|NOT COMPLETED|Overall Study||0
428440|NCT00762528|1022616|P2|COMPLETED|Overall Study||25
428441|NCT00762528|1022617|P1|COMPLETED|Overall Study||24
428442|NCT00762528|1022616|P2|STARTED|Overall Study||25
428443|NCT00762528|1022617|P1|STARTED|Overall Study||24
428444|NCT00762515|1022639|P2|NOT COMPLETED|Overall Study||0
428445|NCT00762515|1022640|P1|NOT COMPLETED|Overall Study||0
428446|NCT00762515|1022639|P2|COMPLETED|Overall Study||22
428447|NCT00762515|1022640|P1|COMPLETED|Overall Study||22
428448|NCT00762515|1022639|P2|STARTED|Overall Study||22
428449|NCT00762515|1022640|P1|STARTED|Overall Study||22
428450|NCT00762502|1022651|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
428451|NCT00762502|1022652|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
428452|NCT00762502|1022653|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
428453|NCT00762502|1022651|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
428454|NCT00762502|1022652|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
428455|NCT00762502|1022653|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
428456|NCT00762502|1022651|P3|STARTED|Month 3 to Month 6 (Period 2)||23
428457|NCT00762502|1022652|P2|STARTED|Month 3 to Month 6 (Period 2)||5
428458|NCT00762502|1022653|P1|STARTED|Month 3 to Month 6 (Period 2)||9
428459|NCT00762502|1022651|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
428460|NCT00762502|1022652|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
428461|NCT00762502|1022653|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
428462|NCT00762502|1022651|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
428463|NCT00762502|1022652|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
428464|NCT00762502|1022653|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
428465|NCT00762502|1022651|P3|STARTED|Baseline to Month 3 (Period 1)||51
428466|NCT00762502|1022652|P2|STARTED|Baseline to Month 3 (Period 1)||25
428467|NCT00762502|1022653|P1|STARTED|Baseline to Month 3 (Period 1)||36
428468|NCT00762476|1022667|P2|NOT COMPLETED|Overall Study||36
428469|NCT00762476|1022668|P1|NOT COMPLETED|Overall Study||23
428470|NCT00762476|1022667|P2|COMPLETED|Overall Study||169
428471|NCT00762476|1022668|P1|COMPLETED|Overall Study||183
428472|NCT00762476|1022667|P2|STARTED|Overall Study||205
428473|NCT00762476|1022668|P1|STARTED|Overall Study||206
428474|NCT00762463|1022680|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
428475|NCT00762463|1022681|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
428476|NCT00762463|1022682|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
428477|NCT00762463|1022683|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
428478|NCT00762463|1022680|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
428479|NCT00762463|1022681|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
428480|NCT00762463|1022682|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
428481|NCT00762463|1022683|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
428482|NCT00762463|1022680|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
428483|NCT00762463|1022681|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
428484|NCT00762463|1022682|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
428485|NCT00762463|1022683|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
428486|NCT00762463|1022680|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
428487|NCT00762463|1022681|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
428488|NCT00762463|1022682|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
428489|NCT00762463|1022683|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
428490|NCT00762463|1022680|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
428491|NCT00762463|1022681|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
428492|NCT00762463|1022682|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
428493|NCT00762463|1022683|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
428494|NCT00762463|1022680|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
428495|NCT00762463|1022681|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
428496|NCT00762463|1022682|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
428497|NCT00762463|1022683|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
428498|NCT00762463|1022680|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
428499|NCT00762463|1022681|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
428500|NCT00762463|1022682|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
428501|NCT00762463|1022683|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
428502|NCT00762463|1022680|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
428503|NCT00762463|1022681|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
428504|NCT00762463|1022682|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
428505|NCT00762463|1022683|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
428506|NCT00762463|1022680|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
428507|NCT00762463|1022681|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
428508|NCT00762463|1022682|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
428509|NCT00762463|1022683|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
428510|NCT00762450|1022768|P3|NOT COMPLETED|3rd Treatment Period||0
428511|NCT00762450|1022769|P2|NOT COMPLETED|3rd Treatment Period||0
428512|NCT00762450|1022770|P1|NOT COMPLETED|3rd Treatment Period||0
428513|NCT00762450|1022768|P3|COMPLETED|3rd Treatment Period||2
428514|NCT00762450|1022769|P2|COMPLETED|3rd Treatment Period||2
428515|NCT00762450|1022770|P1|COMPLETED|3rd Treatment Period||2
428516|NCT00762450|1022768|P3|STARTED|3rd Treatment Period||2
428517|NCT00762450|1022769|P2|STARTED|3rd Treatment Period||2
428518|NCT00762450|1022770|P1|STARTED|3rd Treatment Period||2
428519|NCT00762450|1022768|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
428520|NCT00762450|1022769|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
428521|NCT00762450|1022770|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
428522|NCT00762450|1022768|P3|COMPLETED|Washout After 2nd Treatment Period||2
428523|NCT00762450|1022769|P2|COMPLETED|Washout After 2nd Treatment Period||2
428524|NCT00762450|1022770|P1|COMPLETED|Washout After 2nd Treatment Period||2
428525|NCT00762450|1022768|P3|STARTED|Washout After 2nd Treatment Period||2
428526|NCT00762450|1022769|P2|STARTED|Washout After 2nd Treatment Period||2
428527|NCT00762450|1022770|P1|STARTED|Washout After 2nd Treatment Period||2
428528|NCT00762450|1022768|P3|NOT COMPLETED|2nd Treatment Period||0
428529|NCT00762450|1022769|P2|NOT COMPLETED|2nd Treatment Period||0
428530|NCT00762450|1022770|P1|NOT COMPLETED|2nd Treatment Period||0
428531|NCT00762450|1022768|P3|COMPLETED|2nd Treatment Period||2
428532|NCT00762450|1022769|P2|COMPLETED|2nd Treatment Period||2
428533|NCT00762450|1022770|P1|COMPLETED|2nd Treatment Period||2
428534|NCT00762450|1022768|P3|STARTED|2nd Treatment Period||2
428535|NCT00762450|1022769|P2|STARTED|2nd Treatment Period||2
428536|NCT00762450|1022770|P1|STARTED|2nd Treatment Period||2
428537|NCT00762450|1022768|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
428538|NCT00762450|1022769|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
428539|NCT00762450|1022770|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
428540|NCT00762450|1022768|P3|COMPLETED|Washout After 1st Treatment Period||2
428541|NCT00762450|1022769|P2|COMPLETED|Washout After 1st Treatment Period||2
428542|NCT00762450|1022770|P1|COMPLETED|Washout After 1st Treatment Period||2
428543|NCT00762450|1022768|P3|STARTED|Washout After 1st Treatment Period||2
428544|NCT00762450|1022769|P2|STARTED|Washout After 1st Treatment Period||2
428545|NCT00762450|1022770|P1|STARTED|Washout After 1st Treatment Period||2
428546|NCT00762450|1022768|P3|NOT COMPLETED|1st Treatment Period||0
428547|NCT00762450|1022769|P2|NOT COMPLETED|1st Treatment Period||0
428548|NCT00762450|1022770|P1|NOT COMPLETED|1st Treatment Period||0
428549|NCT00762450|1022768|P3|COMPLETED|1st Treatment Period||2
428550|NCT00762450|1022769|P2|COMPLETED|1st Treatment Period||2
428551|NCT00762450|1022770|P1|COMPLETED|1st Treatment Period||2
428552|NCT00762450|1022768|P3|STARTED|1st Treatment Period||2
428553|NCT00762450|1022769|P2|STARTED|1st Treatment Period||2
428554|NCT00762450|1022770|P1|STARTED|1st Treatment Period||2
428555|NCT00762424|1022780|P2|NOT COMPLETED|Overall Study||0
428556|NCT00762424|1022781|P1|NOT COMPLETED|Overall Study||0
428557|NCT00762424|1022780|P2|COMPLETED|Overall Study||25
428558|NCT00762424|1022781|P1|COMPLETED|Overall Study||28
428559|NCT00762424|1022780|P2|STARTED|Overall Study||25
428560|NCT00762424|1022781|P1|STARTED|Overall Study||28
428561|NCT00762411|1022789|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
428562|NCT00762411|1022790|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
428563|NCT00762411|1022789|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
428564|NCT00762411|1022790|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
428565|NCT00762411|1022789|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
428566|NCT00762411|1022790|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
428567|NCT00762411|1022789|P2|NOT COMPLETED|Delayed Start||26
428568|NCT00762411|1022790|P1|NOT COMPLETED|Delayed Start||17
428569|NCT00762411|1022789|P2|COMPLETED|Delayed Start||8
428570|NCT00762411|1022790|P1|COMPLETED|Delayed Start||5
428571|NCT00762411|1022789|P2|STARTED|Delayed Start||34
428572|NCT00762411|1022790|P1|STARTED|Delayed Start||22
428573|NCT00762411|1022789|P2|NOT COMPLETED|Initial Treatment||521
428574|NCT00762411|1022790|P1|NOT COMPLETED|Initial Treatment||534
428575|NCT00762411|1022789|P2|COMPLETED|Initial Treatment||34
428576|NCT00762411|1022790|P1|COMPLETED|Initial Treatment||22
428577|NCT00762411|1022789|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
428578|NCT00762411|1022790|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
428579|NCT00762411|1022789|P2|STARTED|Initial Treatment||555
428580|NCT00762411|1022790|P1|STARTED|Initial Treatment||556
428581|NCT00762385|1022854|P2|NOT COMPLETED|Second Intervention||3
428582|NCT00762385|1022855|P1|NOT COMPLETED|Second Intervention||3
428583|NCT00762385|1022854|P2|COMPLETED|Second Intervention||39
428584|NCT00762385|1022855|P1|COMPLETED|Second Intervention||46
428585|NCT00762385|1022854|P2|STARTED|Second Intervention||42
428586|NCT00762385|1022855|P1|STARTED|Second Intervention||49
428587|NCT00762385|1022854|P2|NOT COMPLETED|First Intervention||4
428588|NCT00762385|1022855|P1|NOT COMPLETED|First Intervention||2
428589|NCT00762385|1022854|P2|COMPLETED|First Intervention||42
428590|NCT00762385|1022855|P1|COMPLETED|First Intervention||49
428591|NCT00762385|1022854|P2|STARTED|First Intervention||46
428592|NCT00762385|1022855|P1|STARTED|First Intervention||51
428593|NCT00762359|1022867|P2|NOT COMPLETED|Overall Study||57
428594|NCT00762359|1022868|P1|NOT COMPLETED|Overall Study||59
428595|NCT00762359|1022867|P2|COMPLETED|Overall Study||178
428596|NCT00762359|1022868|P1|COMPLETED|Overall Study||167
428597|NCT00762359|1022867|P2|STARTED|Overall Study||235
428598|NCT00762359|1022868|P1|STARTED|Overall Study||226
428599|NCT00762320|1022968|P1|NOT COMPLETED|Overall Study||0
428600|NCT00762320|1022968|P1|COMPLETED|Overall Study||8
428601|NCT00762320|1022968|P1|STARTED|Overall Study||8
428602|NCT00762268|1022985|P2|NOT COMPLETED|Overall Study||2
428603|NCT00762268|1022986|P1|NOT COMPLETED|Overall Study||1
428604|NCT00762268|1022985|P2|COMPLETED|Overall Study||8
428605|NCT00762268|1022986|P1|COMPLETED|Overall Study||9
428606|NCT00762268|1022985|P2|STARTED|Overall Study||10
428607|NCT00762268|1022986|P1|STARTED|Overall Study||10
428608|NCT00762229|1022994|P2|NOT COMPLETED|Overall Study||2
428609|NCT00762229|1022995|P1|NOT COMPLETED|Overall Study||1
428610|NCT00762229|1022994|P2|COMPLETED|Overall Study||22
428611|NCT00762229|1022995|P1|COMPLETED|Overall Study||14
428612|NCT00762229|1022994|P2|STARTED|Overall Study||24
428613|NCT00762229|1022995|P1|STARTED|Overall Study||15
428614|NCT00762216|1023003|P1|NOT COMPLETED|Overall Study||0
428615|NCT00762216|1023003|P1|COMPLETED|Overall Study||71
428616|NCT00762216|1023003|P1|STARTED|Overall Study||71
428617|NCT00762177|1023011|P3|NOT COMPLETED|3rd Treatment Period||0
428618|NCT00762177|1023012|P2|NOT COMPLETED|3rd Treatment Period||0
428619|NCT00762177|1023013|P1|NOT COMPLETED|3rd Treatment Period||0
428620|NCT00762177|1023011|P3|COMPLETED|3rd Treatment Period||8
428621|NCT00762177|1023012|P2|COMPLETED|3rd Treatment Period||8
428622|NCT00762177|1023013|P1|COMPLETED|3rd Treatment Period||8
428623|NCT00762177|1023011|P3|STARTED|3rd Treatment Period||8
428624|NCT00762177|1023012|P2|STARTED|3rd Treatment Period||8
428625|NCT00762177|1023013|P1|STARTED|3rd Treatment Period||8
428626|NCT00762177|1023011|P3|NOT COMPLETED|Washout After 2nd Treatment||0
428627|NCT00762177|1023012|P2|NOT COMPLETED|Washout After 2nd Treatment||0
428628|NCT00762177|1023013|P1|NOT COMPLETED|Washout After 2nd Treatment||0
428629|NCT00762177|1023011|P3|COMPLETED|Washout After 2nd Treatment||8
428630|NCT00762177|1023012|P2|COMPLETED|Washout After 2nd Treatment||8
428631|NCT00762177|1023013|P1|COMPLETED|Washout After 2nd Treatment||8
428632|NCT00762177|1023011|P3|STARTED|Washout After 2nd Treatment||8
428633|NCT00762177|1023012|P2|STARTED|Washout After 2nd Treatment||8
428634|NCT00762177|1023013|P1|STARTED|Washout After 2nd Treatment||8
428635|NCT00762177|1023011|P3|NOT COMPLETED|2nd Treatment Period||0
428636|NCT00762177|1023012|P2|NOT COMPLETED|2nd Treatment Period||0
428637|NCT00762177|1023013|P1|NOT COMPLETED|2nd Treatment Period||0
428638|NCT00762177|1023011|P3|COMPLETED|2nd Treatment Period||8
428639|NCT00762177|1023012|P2|COMPLETED|2nd Treatment Period||8
428640|NCT00762177|1023013|P1|COMPLETED|2nd Treatment Period||8
428641|NCT00762177|1023011|P3|STARTED|2nd Treatment Period||8
428642|NCT00762177|1023012|P2|STARTED|2nd Treatment Period||8
428643|NCT00762177|1023013|P1|STARTED|2nd Treatment Period||8
428644|NCT00762177|1023011|P3|NOT COMPLETED|Washout After 1st Treatment||0
428645|NCT00762177|1023012|P2|NOT COMPLETED|Washout After 1st Treatment||0
428646|NCT00762177|1023013|P1|NOT COMPLETED|Washout After 1st Treatment||0
428647|NCT00762177|1023011|P3|COMPLETED|Washout After 1st Treatment||8
428648|NCT00762177|1023012|P2|COMPLETED|Washout After 1st Treatment||8
428649|NCT00762177|1023013|P1|COMPLETED|Washout After 1st Treatment||8
428650|NCT00762177|1023011|P3|STARTED|Washout After 1st Treatment||8
428651|NCT00762177|1023012|P2|STARTED|Washout After 1st Treatment||8
428652|NCT00762177|1023013|P1|STARTED|Washout After 1st Treatment||8
428653|NCT00762177|1023011|P3|NOT COMPLETED|1st Treatment Period||0
428654|NCT00762177|1023012|P2|NOT COMPLETED|1st Treatment Period||0
428655|NCT00762177|1023013|P1|NOT COMPLETED|1st Treatment Period||0
428656|NCT00762177|1023011|P3|COMPLETED|1st Treatment Period||8
428657|NCT00762177|1023012|P2|COMPLETED|1st Treatment Period||8
428658|NCT00762177|1023013|P1|COMPLETED|1st Treatment Period||8
428659|NCT00762177|1023011|P3|STARTED|1st Treatment Period||8
428660|NCT00762177|1023012|P2|STARTED|1st Treatment Period||8
428661|NCT00762177|1023013|P1|STARTED|1st Treatment Period||8
428662|NCT00762164|1023092|P2|NOT COMPLETED|Overall Study||2
428663|NCT00762164|1023093|P1|NOT COMPLETED|Overall Study||3
428664|NCT00762164|1023092|P2|COMPLETED|Overall Study||15
428665|NCT00762164|1023093|P1|COMPLETED|Overall Study||14
428666|NCT00762164|1023092|P2|STARTED|Overall Study||17
428667|NCT00762164|1023093|P1|STARTED|Overall Study||17
428668|NCT00762086|1023103|P2|NOT COMPLETED|Overall Study||4
428669|NCT00762086|1023104|P1|NOT COMPLETED|Overall Study||6
428670|NCT00762086|1023103|P2|COMPLETED|Overall Study||24
428671|NCT00762086|1023104|P1|COMPLETED|Overall Study||33
428672|NCT00762086|1023103|P2|STARTED|Overall Study||28
428673|NCT00762086|1023104|P1|STARTED|Overall Study||39
428674|NCT00762073|1023114|P4|NOT COMPLETED|Overall Study||3
428675|NCT00762073|1023115|P3|NOT COMPLETED|Overall Study||2
428676|NCT00762073|1023116|P2|NOT COMPLETED|Overall Study||4
428677|NCT00762073|1023117|P1|NOT COMPLETED|Overall Study||4
428678|NCT00762073|1023114|P4|COMPLETED|Overall Study||17
428679|NCT00762073|1023115|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
428680|NCT00762073|1023116|P2|COMPLETED|Overall Study||17
428681|NCT00762073|1023117|P1|COMPLETED|Overall Study||17
428682|NCT00762073|1023114|P4|STARTED|Overall Study||20
428683|NCT00762073|1023115|P3|STARTED|Overall Study||20
428684|NCT00762073|1023116|P2|STARTED|Overall Study||21
428685|NCT00762073|1023117|P1|STARTED|Overall Study||21
428686|NCT00762034|1023181|P2|NOT COMPLETED|Maintenance Period||298
428687|NCT00762034|1023182|P1|NOT COMPLETED|Maintenance Period||294
428688|NCT00762034|1023181|P2|COMPLETED|Maintenance Period||0
428689|NCT00762034|1023182|P1|COMPLETED|Maintenance Period||0
428690|NCT00762034|1023181|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
428691|NCT00762034|1023182|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
428692|NCT00762034|1023181|P2|STARTED|Maintenance Period||298
428693|NCT00762034|1023182|P1|STARTED|Maintenance Period||294
428694|NCT00762034|1023181|P2|NOT COMPLETED|Induction Period||169
428695|NCT00762034|1023182|P1|NOT COMPLETED|Induction Period||178
428696|NCT00762034|1023181|P2|COMPLETED|Induction Period||298
428697|NCT00762034|1023182|P1|COMPLETED|Induction Period||294
428698|NCT00762034|1023181|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
428699|NCT00762034|1023182|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
428700|NCT00762034|1023181|P2|STARTED|Induction Period||467
428701|NCT00762034|1023182|P1|STARTED|Induction Period||472
428702|NCT00762021|1023241|P2|NOT COMPLETED|Overall Study||8
428703|NCT00762021|1023242|P1|NOT COMPLETED|Overall Study||8
428704|NCT00762021|1023241|P2|COMPLETED|Overall Study||44
428705|NCT00762021|1023242|P1|COMPLETED|Overall Study||44
428706|NCT00762021|1023241|P2|STARTED|Overall Study||52
428707|NCT00762021|1023242|P1|STARTED|Overall Study||52
428708|NCT00761969|1023254|P2|NOT COMPLETED|Overall Study||140
428709|NCT00761969|1023255|P1|NOT COMPLETED|Overall Study||200
428710|NCT00761969|1023254|P2|COMPLETED|Overall Study||573
428711|NCT00761969|1023255|P1|COMPLETED|Overall Study||542
428712|NCT00761969|1023254|P2|STARTED|Overall Study||713
428713|NCT00761969|1023255|P1|STARTED|Overall Study||742
428714|NCT00761956|1023265|P2|NOT COMPLETED|Overall Study||54
428715|NCT00761956|1023266|P1|NOT COMPLETED|Overall Study||35
428716|NCT00761956|1023265|P2|COMPLETED|Overall Study||48
428717|NCT00761956|1023266|P1|COMPLETED|Overall Study||52
428718|NCT00761956|1023265|P2|STARTED|Overall Study||102
428719|NCT00761956|1023266|P1|STARTED|Overall Study||87
428720|NCT00761930|1023277|P3|NOT COMPLETED|Overall Study||0
428721|NCT00761930|1023278|P2|NOT COMPLETED|Overall Study||0
428722|NCT00761930|1023279|P1|NOT COMPLETED|Overall Study||0
428723|NCT00761930|1023277|P3|COMPLETED|Overall Study||35
428724|NCT00761930|1023278|P2|COMPLETED|Overall Study||34
428725|NCT00761930|1023279|P1|COMPLETED|Overall Study||34
428726|NCT00761930|1023277|P3|STARTED|Overall Study||35
428727|NCT00761930|1023278|P2|STARTED|Overall Study||34
428728|NCT00761930|1023279|P1|STARTED|Overall Study||34
428729|NCT00761865|1023295|P2|NOT COMPLETED|Overall Study||7
428730|NCT00761865|1023296|P1|NOT COMPLETED|Overall Study||8
428731|NCT00761865|1023295|P2|COMPLETED|Overall Study||11
428732|NCT00761865|1023296|P1|COMPLETED|Overall Study||8
428733|NCT00761865|1023295|P2|STARTED|Overall Study||18
428734|NCT00761865|1023296|P1|STARTED|Overall Study||16
428735|NCT00761761|1023306|P2|NOT COMPLETED|Overall Study||1
428736|NCT00761761|1023307|P1|NOT COMPLETED|Overall Study||6
428737|NCT00761761|1023306|P2|COMPLETED|Overall Study||29
428738|NCT00761761|1023307|P1|COMPLETED|Overall Study||24
428739|NCT00761761|1023306|P2|STARTED|Overall Study||30
428740|NCT00761761|1023307|P1|STARTED|Overall Study||30
428741|NCT00761748|1023319|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
428742|NCT00761748|1023320|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
428743|NCT00761748|1023319|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
428744|NCT00761748|1023320|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
428745|NCT00761748|1023319|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
428746|NCT00761748|1023320|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
428747|NCT00761748|1023319|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
428748|NCT00761748|1023320|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
428749|NCT00761748|1023319|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
428750|NCT00761748|1023320|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
428751|NCT00761748|1023319|P2|STARTED|First Intervention (21 +/- 3 Days)||10
428752|NCT00761748|1023320|P1|STARTED|First Intervention (21 +/- 3 Days)||20
428753|NCT00761735|1023326|P1|NOT COMPLETED|Overall Study||14
428754|NCT00761735|1023326|P1|COMPLETED|Overall Study||80
428755|NCT00761735|1023326|P1|STARTED|Overall Study||94
428756|NCT00761631|1023342|P6|NOT COMPLETED|Overall Study||5
428757|NCT00761631|1023343|P5|NOT COMPLETED|Overall Study||22
428758|NCT00761631|1023344|P4|NOT COMPLETED|Overall Study||3
428759|NCT00761631|1023345|P3|NOT COMPLETED|Overall Study||16
428760|NCT00761631|1023346|P2|NOT COMPLETED|Overall Study||7
428761|NCT00761631|1023347|P1|NOT COMPLETED|Overall Study||15
428762|NCT00761631|1023342|P6|COMPLETED|Overall Study||294
428763|NCT00761631|1023343|P5|COMPLETED|Overall Study||277
428764|NCT00761631|1023344|P4|COMPLETED|Overall Study||116
428765|NCT00761631|1023345|P3|COMPLETED|Overall Study||160
428766|NCT00761631|1023346|P2|COMPLETED|Overall Study||174
428767|NCT00761631|1023347|P1|COMPLETED|Overall Study||111
428768|NCT00761631|1023342|P6|Vaccinated Dose 2|Overall Study||0
428769|NCT00761631|1023343|P5|Vaccinated Dose 2|Overall Study||0
428770|NCT00761631|1023344|P4|Vaccinated Dose 2|Overall Study||0
428771|NCT00761631|1023345|P3|Vaccinated Dose 2|Overall Study||165
428772|NCT00761631|1023346|P2|Vaccinated Dose 2|Overall Study||0
428773|NCT00761631|1023347|P1|Vaccinated Dose 2|Overall Study||112
428774|NCT00761631|1023342|P6|Vaccinated Dose 1|Overall Study||298
428775|NCT00761631|1023343|P5|Vaccinated Dose 1|Overall Study||294
428776|NCT00761631|1023344|P4|Vaccinated Dose 1|Overall Study||118
428777|NCT00761631|1023345|P3|Vaccinated Dose 1|Overall Study||175
428778|NCT00761631|1023346|P2|Vaccinated Dose 1|Overall Study||179
428779|NCT00761631|1023347|P1|Vaccinated Dose 1|Overall Study||124
428780|NCT00761631|1023342|P6|STARTED|Overall Study||299
428781|NCT00761631|1023343|P5|STARTED|Overall Study||299
428782|NCT00761631|1023344|P4|STARTED|Overall Study||119
428783|NCT00761631|1023345|P3|STARTED|Overall Study||176
428784|NCT00761631|1023346|P2|STARTED|Overall Study||181
428785|NCT00761631|1023347|P1|STARTED|Overall Study||126
428786|NCT00761605|1023382|P1|NOT COMPLETED|Overall Study||141
428787|NCT00761605|1023382|P1|COMPLETED|Overall Study||246
428788|NCT00761605|1023382|P1|STARTED|Overall Study||387
428789|NCT00761592|1023411|P2|NOT COMPLETED|Overall Study||1
428790|NCT00761592|1023412|P1|NOT COMPLETED|Overall Study||1
428791|NCT00761592|1023411|P2|COMPLETED|Overall Study||32
428792|NCT00761592|1023412|P1|COMPLETED|Overall Study||31
428793|NCT00761592|1023411|P2|STARTED|Overall Study||33
428794|NCT00761592|1023412|P1|STARTED|Overall Study||32
428795|NCT00761579|1023426|P1|NOT COMPLETED|Overall Study||92
428796|NCT00761579|1023426|P1|COMPLETED|Overall Study||98
428797|NCT00761579|1023426|P1|STARTED|Overall Study||190
428798|NCT00761527|1023459|P1|NOT COMPLETED|Overall Study||22
428799|NCT00761527|1023459|P1|COMPLETED|Overall Study||2958
428800|NCT00761527|1023459|P1|Received One Dose of Study Medication|Overall Study||2978
428801|NCT00761527|1023459|P1|STARTED|Overall Study||2980
428802|NCT00761514|1023466|P1|NOT COMPLETED|Overall Study||7
428803|NCT00761514|1023466|P1|COMPLETED|Overall Study||7
428804|NCT00761514|1023466|P1|STARTED|Overall Study||14
428805|NCT00761462|1023473|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
428806|NCT00761462|1023474|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
428807|NCT00761462|1023473|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
428808|NCT00761462|1023474|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
428809|NCT00761462|1023473|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
428810|NCT00761462|1023474|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
428811|NCT00761462|1023473|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
428812|NCT00761462|1023474|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
428813|NCT00761462|1023473|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
428814|NCT00761462|1023474|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
428815|NCT00761462|1023473|P2|NOT COMPLETED|Treatment||12
428816|NCT00761462|1023474|P1|NOT COMPLETED|Treatment||23
428817|NCT00761462|1023473|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
428818|NCT00761462|1023474|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
428819|NCT00761462|1023473|P2|STARTED|Treatment|Patients enrolled in study group|519
428820|NCT00761462|1023474|P1|STARTED|Treatment|Patients enrolled in study group|510
428821|NCT00761345|1023482|P1|NOT COMPLETED|Overall Study||3
428822|NCT00761345|1023482|P1|COMPLETED|Overall Study||24
428823|NCT00761345|1023482|P1|STARTED|Overall Study||27
428824|NCT00761319|1023488|P2|NOT COMPLETED|Overall Study||34
428825|NCT00761319|1023489|P1|NOT COMPLETED|Overall Study||48
428826|NCT00761319|1023488|P2|COMPLETED|Overall Study||318
428827|NCT00761319|1023489|P1|COMPLETED|Overall Study||305
428828|NCT00761319|1023488|P2|STARTED|Overall Study||352
428829|NCT00761319|1023489|P1|STARTED|Overall Study||353
428830|NCT00761306|1023497|P1|NOT COMPLETED|Overall Study||20
428831|NCT00761306|1023497|P1|COMPLETED|Overall Study||54
428832|NCT00761306|1023497|P1|STARTED|Overall Study||74
428833|NCT00761280|1023508|P2|NOT COMPLETED|First Dose to End of Study||11
428834|NCT00761280|1023509|P1|NOT COMPLETED|First Dose to End of Study||12
428835|NCT00761280|1023508|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
428836|NCT00761280|1023509|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
428837|NCT00761280|1023508|P2|STARTED|First Dose to End of Study||11
428838|NCT00761280|1023509|P1|STARTED|First Dose to End of Study||12
428839|NCT00761280|1023508|P2|NOT COMPLETED|Randomization to First Dose||2
428840|NCT00761280|1023509|P1|NOT COMPLETED|Randomization to First Dose||2
428841|NCT00761280|1023508|P2|COMPLETED|Randomization to First Dose||11
428842|NCT00761280|1023509|P1|COMPLETED|Randomization to First Dose||12
428843|NCT00761280|1023508|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
428844|NCT00761280|1023509|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
428845|NCT00761280|1023508|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
428846|NCT00761280|1023509|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
428847|NCT00761280|1023508|P2|STARTED|Randomization to First Dose||13
428848|NCT00761280|1023509|P1|STARTED|Randomization to First Dose||14
428849|NCT00761215|1023540|P3|NOT COMPLETED|Overall Study||8
428850|NCT00761215|1023541|P2|NOT COMPLETED|Overall Study||4
428851|NCT00761215|1023542|P1|NOT COMPLETED|Overall Study||9
428852|NCT00761215|1023540|P3|COMPLETED|Overall Study||56
428853|NCT00761215|1023541|P2|COMPLETED|Overall Study||60
428854|NCT00761215|1023542|P1|COMPLETED|Overall Study||55
428855|NCT00761215|1023540|P3|STARTED|Overall Study||64
428856|NCT00761215|1023541|P2|STARTED|Overall Study||64
428857|NCT00761215|1023542|P1|STARTED|Overall Study||64
428858|NCT00761202|1023567|P2|NOT COMPLETED|Overall Study||2
428859|NCT00761202|1023568|P1|NOT COMPLETED|Overall Study||1
428860|NCT00761202|1023567|P2|COMPLETED|Overall Study||26
428861|NCT00761202|1023568|P1|COMPLETED|Overall Study||21
428862|NCT00761202|1023567|P2|STARTED|Overall Study||28
428863|NCT00761202|1023568|P1|STARTED|Overall Study||22
428864|NCT00761189|1023584|P1|NOT COMPLETED|Overall Study||185
428865|NCT00761189|1023584|P1|COMPLETED|Overall Study||306
428866|NCT00761189|1023584|P1|STARTED|Overall Study||491
428867|NCT00761176|1023601|P2|NOT COMPLETED|Overall Study||1
428868|NCT00761176|1023602|P1|NOT COMPLETED|Overall Study||2
428869|NCT00761176|1023601|P2|COMPLETED|Overall Study||3
428870|NCT00761176|1023602|P1|COMPLETED|Overall Study||2
428871|NCT00761176|1023601|P2|STARTED|Overall Study||4
428872|NCT00761176|1023602|P1|STARTED|Overall Study||4
428873|NCT00761150|1023611|P3|NOT COMPLETED|Double-blind Period||29
428874|NCT00761150|1023612|P2|NOT COMPLETED|Double-blind Period||14
428875|NCT00761150|1023613|P1|NOT COMPLETED|Double-blind Period||0
428876|NCT00761150|1023611|P3|COMPLETED|Double-blind Period||89
428877|NCT00761150|1023612|P2|COMPLETED|Double-blind Period||106
428878|NCT00761150|1023613|P1|COMPLETED|Double-blind Period||0
428879|NCT00761150|1023611|P3|STARTED|Double-blind Period||118
428880|NCT00761150|1023612|P2|STARTED|Double-blind Period||120
428881|NCT00761150|1023613|P1|STARTED|Double-blind Period||0
428882|NCT00761150|1023611|P3|NOT COMPLETED|Open-label Period||0
428883|NCT00761150|1023612|P2|NOT COMPLETED|Open-label Period||0
428884|NCT00761150|1023613|P1|NOT COMPLETED|Open-label Period||70
428885|NCT00761150|1023611|P3|COMPLETED|Open-label Period||0
428886|NCT00761150|1023612|P2|COMPLETED|Open-label Period||0
428887|NCT00761150|1023613|P1|COMPLETED|Open-label Period||238
428888|NCT00761150|1023611|P3|STARTED|Open-label Period||0
428889|NCT00761150|1023612|P2|STARTED|Open-label Period||0
428890|NCT00761150|1023613|P1|STARTED|Open-label Period||308
428891|NCT00761137|1023622|P1|NOT COMPLETED|Overall Study||0
428892|NCT00761137|1023622|P1|COMPLETED|Overall Study||19
428893|NCT00761137|1023622|P1|3 mg Tropicamide|Overall Study||19
428894|NCT00761137|1023622|P1|1 mg Tropicamide|Overall Study||19
428895|NCT00761137|1023622|P1|0.3 mg Tropicamide|Overall Study||19
428896|NCT00761137|1023622|P1|Placebo|Overall Study||19
428897|NCT00761137|1023622|P1|STARTED|Overall Study||19
428898|NCT00760266|1023635|P2|NOT COMPLETED|Overall Study||18
428899|NCT00760266|1023636|P1|NOT COMPLETED|Overall Study||24
428900|NCT00760266|1023635|P2|COMPLETED|Overall Study||205
428901|NCT00760266|1023636|P1|COMPLETED|Overall Study||204
428902|NCT00760266|1023635|P2|STARTED|Overall Study||223
428903|NCT00760266|1023636|P1|STARTED|Overall Study||228
428904|NCT00760214|1023653|P3|NOT COMPLETED|Overall Study||41
428905|NCT00760214|1023654|P2|NOT COMPLETED|Overall Study||30
428906|NCT00760214|1023655|P1|NOT COMPLETED|Overall Study||30
428907|NCT00760214|1023653|P3|COMPLETED|Overall Study||255
428908|NCT00760214|1023654|P2|COMPLETED|Overall Study||264
428909|NCT00760214|1023655|P1|COMPLETED|Overall Study||265
428910|NCT00760214|1023653|P3|STARTED|Overall Study||296
428911|NCT00760214|1023654|P2|STARTED|Overall Study||294
428912|NCT00760214|1023655|P1|STARTED|Overall Study||295
428913|NCT00761007|1023700|P4|NOT COMPLETED|Overall Study||7
428914|NCT00761007|1023701|P3|NOT COMPLETED|Overall Study||18
428915|NCT00761007|1023702|P2|NOT COMPLETED|Overall Study||11
428916|NCT00761007|1023703|P1|NOT COMPLETED|Overall Study||13
428917|NCT00761007|1023700|P4|COMPLETED|Overall Study||131
428918|NCT00761007|1023701|P3|COMPLETED|Overall Study||121
428919|NCT00761007|1023702|P2|COMPLETED|Overall Study||124
428920|NCT00761007|1023703|P1|COMPLETED|Overall Study||129
428921|NCT00761007|1023700|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
428922|NCT00761007|1023701|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
428923|NCT00761007|1023702|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
428924|NCT00761007|1023703|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
428925|NCT00761007|1023700|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
428926|NCT00761007|1023701|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
428927|NCT00761007|1023702|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
428928|NCT00761007|1023703|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
428929|NCT00761007|1023700|P4|STARTED|Overall Study||138
428930|NCT00761007|1023701|P3|STARTED|Overall Study||139
428931|NCT00761007|1023702|P2|STARTED|Overall Study||135
428932|NCT00761007|1023703|P1|STARTED|Overall Study||142
428933|NCT00760877|1023727|P2|NOT COMPLETED|Overall Study||26
428934|NCT00760877|1023728|P1|NOT COMPLETED|Overall Study||45
428935|NCT00760877|1023727|P2|COMPLETED|Overall Study||77
428936|NCT00760877|1023728|P1|COMPLETED|Overall Study||59
428937|NCT00760877|1023727|P2|Safety Set|Overall Study||103
428938|NCT00760877|1023728|P1|Safety Set|Overall Study||101
428939|NCT00760877|1023727|P2|Cross-over to Nilotinib|Overall Study||46
428940|NCT00760877|1023728|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
428941|NCT00760877|1023727|P2|STARTED|Overall Study||103
428942|NCT00760877|1023728|P1|STARTED|Overall Study||104
428943|NCT00760838|1023746|P2|NOT COMPLETED|Overall Study||2
428944|NCT00760838|1023747|P1|NOT COMPLETED|Overall Study||5
428945|NCT00760838|1023746|P2|COMPLETED|Overall Study||53
428946|NCT00760838|1023747|P1|COMPLETED|Overall Study||49
428947|NCT00760838|1023746|P2|STARTED|Overall Study||55
428948|NCT00760838|1023747|P1|STARTED|Overall Study||54
428949|NCT00760747|1023765|P2|NOT COMPLETED|Study Period III||3
428950|NCT00760747|1023766|P1|NOT COMPLETED|Study Period III||3
428951|NCT00760747|1023765|P2|COMPLETED|Study Period III||38
428952|NCT00760747|1023766|P1|COMPLETED|Study Period III||41
428953|NCT00760747|1023765|P2|STARTED|Study Period III||41
428954|NCT00760747|1023766|P1|STARTED|Study Period III||44
428955|NCT00760747|1023765|P2|NOT COMPLETED|Study Period II||14
428956|NCT00760747|1023766|P1|NOT COMPLETED|Study Period II||13
428957|NCT00760747|1023765|P2|COMPLETED|Study Period II||41
428958|NCT00760747|1023766|P1|COMPLETED|Study Period II||44
428959|NCT00760747|1023765|P2|Received at Least One Dose of Study Drug|Study Period II||54
428960|NCT00760747|1023766|P1|Received at Least One Dose of Study Drug|Study Period II||57
428961|NCT00760747|1023765|P2|STARTED|Study Period II||55
428962|NCT00760747|1023766|P1|STARTED|Study Period II||57
428963|NCT00760669|1023794|P1|NOT COMPLETED|Overall Study||30
428964|NCT00760669|1023794|P1|COMPLETED|Overall Study||1031
428965|NCT00760669|1023794|P1|STARTED|Overall Study||1061
428966|NCT00760617|1023811|P3|NOT COMPLETED|Overall Study||5
428967|NCT00760617|1023812|P2|NOT COMPLETED|Overall Study||2
428968|NCT00760617|1023813|P1|NOT COMPLETED|Overall Study||5
428969|NCT00760617|1023811|P3|COMPLETED|Overall Study||111
428970|NCT00760617|1023812|P2|COMPLETED|Overall Study||142
428971|NCT00760617|1023813|P1|COMPLETED|Overall Study||261
428972|NCT00760617|1023811|P3|STARTED|Overall Study||116
428973|NCT00760617|1023812|P2|STARTED|Overall Study||144
428974|NCT00760617|1023813|P1|STARTED|Overall Study||266
428975|NCT00760578|1023888|P4|NOT COMPLETED|Overall Study||4
428976|NCT00760578|1023889|P3|NOT COMPLETED|Overall Study||5
428977|NCT00760578|1023890|P2|NOT COMPLETED|Overall Study||2
428978|NCT00760578|1023891|P1|NOT COMPLETED|Overall Study||3
428979|NCT00760578|1023888|P4|COMPLETED|Overall Study||18
428980|NCT00760578|1023889|P3|COMPLETED|Overall Study||16
428981|NCT00760578|1023890|P2|COMPLETED|Overall Study||19
428982|NCT00760578|1023891|P1|COMPLETED|Overall Study||19
428983|NCT00760578|1023888|P4|Entered Drug Treatment Period|Overall Study||22
428984|NCT00760578|1023889|P3|Entered Drug Treatment Period|Overall Study||19
428985|NCT00760578|1023890|P2|Entered Drug Treatment Period|Overall Study||20
428986|NCT00760578|1023891|P1|Entered Drug Treatment Period|Overall Study||21
428987|NCT00760578|1023888|P4|STARTED|Overall Study||22
428988|NCT00760578|1023889|P3|STARTED|Overall Study||21
428989|NCT00760578|1023890|P2|STARTED|Overall Study||21
428990|NCT00760578|1023891|P1|STARTED|Overall Study||22
428991|NCT00760552|1023927|P2|NOT COMPLETED|Overall Study||10
428992|NCT00760552|1023928|P1|NOT COMPLETED|Overall Study||13
428993|NCT00760552|1023927|P2|COMPLETED|Overall Study||52
428994|NCT00760552|1023928|P1|COMPLETED|Overall Study||48
428995|NCT00760552|1023927|P2|STARTED|Overall Study||62
428996|NCT00760552|1023928|P1|STARTED|Overall Study||61
428997|NCT00760526|1023936|P2|NOT COMPLETED|Overall Study||4
428998|NCT00760526|1023937|P1|NOT COMPLETED|Overall Study||5
428999|NCT00760526|1023936|P2|COMPLETED|Overall Study||68
429000|NCT00760526|1023937|P1|COMPLETED|Overall Study||69
429001|NCT00760526|1023936|P2|STARTED|Overall Study||72
429002|NCT00760526|1023937|P1|STARTED|Overall Study||74
429003|NCT00760487|1023962|P1|NOT COMPLETED|Overall Study||3
429004|NCT00760487|1023962|P1|COMPLETED|Overall Study||117
429005|NCT00760487|1023962|P1|STARTED|Overall Study||120
429006|NCT00760474|1023968|P2|NOT COMPLETED|Period 2 (P2)||1
429007|NCT00760474|1023969|P1|NOT COMPLETED|Period 2 (P2)||1
429008|NCT00760474|1023968|P2|COMPLETED|Period 2 (P2)||11
429009|NCT00760474|1023969|P1|COMPLETED|Period 2 (P2)||11
429010|NCT00760474|1023968|P2|STARTED|Period 2 (P2)||12
429011|NCT00760474|1023969|P1|STARTED|Period 2 (P2)||12
429012|NCT00760474|1023968|P2|NOT COMPLETED|Placebo Washout Period||1
429013|NCT00760474|1023969|P1|NOT COMPLETED|Placebo Washout Period||0
429014|NCT00760474|1023968|P2|COMPLETED|Placebo Washout Period||12
429015|NCT00760474|1023969|P1|COMPLETED|Placebo Washout Period||12
429016|NCT00760474|1023968|P2|STARTED|Placebo Washout Period||13
429017|NCT00760474|1023969|P1|STARTED|Placebo Washout Period||12
429018|NCT00760474|1023968|P2|NOT COMPLETED|Period 1 (P1)||1
429019|NCT00760474|1023969|P1|NOT COMPLETED|Period 1 (P1)||1
429020|NCT00760474|1023968|P2|COMPLETED|Period 1 (P1)||13
429021|NCT00760474|1023969|P1|COMPLETED|Period 1 (P1)||12
429022|NCT00760474|1023968|P2|Overall Number of Unique Participants|Period 1 (P1)||13
429023|NCT00760474|1023969|P1|Overall Number of Unique Participants|Period 1 (P1)||12
429024|NCT00760474|1023968|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
429025|NCT00760474|1023969|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
429026|NCT00760474|1023968|P2|STARTED|Period 1 (P1)||14
429027|NCT00760474|1023969|P1|STARTED|Period 1 (P1)||13
429028|NCT00760435|1024007|P2|NOT COMPLETED|Overall Study||5
429029|NCT00760435|1024008|P1|NOT COMPLETED|Overall Study||4
429030|NCT00760435|1024007|P2|COMPLETED|Overall Study||93
429031|NCT00760435|1024008|P1|COMPLETED|Overall Study||94
429032|NCT00760435|1024007|P2|STARTED|Overall Study||98
429033|NCT00760435|1024008|P1|STARTED|Overall Study||98
429034|NCT00760383|1024022|P2|NOT COMPLETED|Overall Study||7
429035|NCT00760383|1024023|P1|NOT COMPLETED|Overall Study||5
429036|NCT00760383|1024022|P2|COMPLETED|Overall Study||12
429037|NCT00760383|1024023|P1|COMPLETED|Overall Study||16
429038|NCT00760383|1024022|P2|STARTED|Overall Study||19
429039|NCT00760383|1024023|P1|STARTED|Overall Study||21
429040|NCT00760084|1024033|P1|NOT COMPLETED|Overall Study||10
429041|NCT00760084|1024033|P1|COMPLETED|Overall Study||0
429042|NCT00760084|1024033|P1|STARTED|Overall Study||10
429043|NCT00760019|1024039|P4|NOT COMPLETED|Overall Study||0
429044|NCT00760019|1024040|P3|NOT COMPLETED|Overall Study||0
429045|NCT00760019|1024041|P2|NOT COMPLETED|Overall Study||0
429046|NCT00760019|1024042|P1|NOT COMPLETED|Overall Study||0
429047|NCT00760019|1024039|P4|COMPLETED|Overall Study||14
429048|NCT00760019|1024040|P3|COMPLETED|Overall Study||14
429049|NCT00760019|1024041|P2|COMPLETED|Overall Study||15
429050|NCT00760019|1024042|P1|COMPLETED|Overall Study||15
429051|NCT00760019|1024039|P4|STARTED|Overall Study||14
429052|NCT00760019|1024040|P3|STARTED|Overall Study||14
429053|NCT00760019|1024041|P2|STARTED|Overall Study||15
429054|NCT00760019|1024042|P1|STARTED|Overall Study||15
429055|NCT00759954|1024050|P2|NOT COMPLETED|Overall Study||2
429056|NCT00759954|1024051|P1|NOT COMPLETED|Overall Study||2
429057|NCT00759954|1024050|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
429058|NCT00759954|1024051|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
429059|NCT00759954|1024050|P2|STARTED|Overall Study|All assigned participants entered trial|18
429060|NCT00759954|1024051|P1|STARTED|Overall Study|All assigned participants entered trial|18
429061|NCT00759941|1024065|P2|NOT COMPLETED|Overall Study||1
429062|NCT00759941|1024066|P1|NOT COMPLETED|Overall Study||3
429063|NCT00759941|1024065|P2|COMPLETED|Overall Study||43
429064|NCT00759941|1024066|P1|COMPLETED|Overall Study||39
429065|NCT00759941|1024065|P2|STARTED|Overall Study||44
429066|NCT00759941|1024066|P1|STARTED|Overall Study||42
429067|NCT00759915|1024080|P2|NOT COMPLETED|Overall Study||1
429068|NCT00759915|1024081|P1|NOT COMPLETED|Overall Study||1
429069|NCT00759915|1024080|P2|COMPLETED|Overall Study||17
429070|NCT00759915|1024081|P1|COMPLETED|Overall Study||17
429071|NCT00759915|1024080|P2|STARTED|Overall Study||18
429072|NCT00759915|1024081|P1|STARTED|Overall Study||18
429073|NCT00759902|1024095|P2|NOT COMPLETED|Overall Study||1
429074|NCT00759902|1024096|P1|NOT COMPLETED|Overall Study||0
429075|NCT00759902|1024095|P2|COMPLETED|Overall Study||17
429076|NCT00759902|1024096|P1|COMPLETED|Overall Study||18
429077|NCT00759902|1024095|P2|STARTED|Overall Study||18
429078|NCT00759902|1024096|P1|STARTED|Overall Study||18
429079|NCT00759863|1024110|P2|NOT COMPLETED|Overall Study||18
429080|NCT00759863|1024111|P1|NOT COMPLETED|Overall Study||20
429081|NCT00759863|1024110|P2|COMPLETED|Overall Study||80
429082|NCT00759863|1024111|P1|COMPLETED|Overall Study||124
429083|NCT00759863|1024110|P2|STARTED|Overall Study||98
429084|NCT00759863|1024111|P1|STARTED|Overall Study||144
429085|NCT00759811|1024123|P2|NOT COMPLETED|Overall Study||1
429086|NCT00759811|1024124|P1|NOT COMPLETED|Overall Study||2
429087|NCT00759811|1024123|P2|COMPLETED|Overall Study||24
429088|NCT00759811|1024124|P1|COMPLETED|Overall Study||23
429089|NCT00759811|1024123|P2|STARTED|Overall Study||25
429090|NCT00759811|1024124|P1|STARTED|Overall Study||25
429091|NCT00759785|1024132|P2|NOT COMPLETED|Overall Study||5
429092|NCT00759785|1024133|P1|NOT COMPLETED|Overall Study||12
429093|NCT00759785|1024132|P2|COMPLETED|Overall Study||17
429094|NCT00759785|1024133|P1|COMPLETED|Overall Study||14
429095|NCT00759785|1024132|P2|Treated|Overall Study||20
429096|NCT00759785|1024133|P1|Treated|Overall Study||25
429097|NCT00759785|1024132|P2|STARTED|Overall Study||22
429098|NCT00759785|1024133|P1|STARTED|Overall Study||26
429099|NCT00759772|1024147|P2|NOT COMPLETED|Overall Study||0
429100|NCT00759772|1024148|P1|NOT COMPLETED|Overall Study||0
429101|NCT00759772|1024147|P2|COMPLETED|Overall Study||11
429102|NCT00759772|1024148|P1|COMPLETED|Overall Study||12
429103|NCT00759772|1024147|P2|STARTED|Overall Study||11
429104|NCT00759772|1024148|P1|STARTED|Overall Study||12
429105|NCT00759759|1024156|P2|NOT COMPLETED|Overall Study||1
429106|NCT00759759|1024157|P1|NOT COMPLETED|Overall Study||4
429107|NCT00759759|1024156|P2|COMPLETED|Overall Study||17
429108|NCT00759759|1024157|P1|COMPLETED|Overall Study||14
429109|NCT00759759|1024156|P2|STARTED|Overall Study||18
429110|NCT00759759|1024157|P1|STARTED|Overall Study||18
429111|NCT00759707|1024169|P1|NOT COMPLETED|Overall Study||0
429112|NCT00759707|1024169|P1|COMPLETED|Overall Study||19
429113|NCT00759707|1024169|P1|STARTED|Overall Study||19
429114|NCT00759681|1024175|P2|NOT COMPLETED|Overall Study||10
429115|NCT00759681|1024176|P1|NOT COMPLETED|Overall Study||10
429116|NCT00759681|1024175|P2|COMPLETED|Overall Study||100
429117|NCT00759681|1024176|P1|COMPLETED|Overall Study||97
429118|NCT00759681|1024175|P2|STARTED|Overall Study||110
429119|NCT00759681|1024176|P1|STARTED|Overall Study||107
429120|NCT00759668|1024186|P2|NOT COMPLETED|Overall Study||3
429121|NCT00759668|1024187|P1|NOT COMPLETED|Overall Study||1
429122|NCT00759668|1024186|P2|COMPLETED|Overall Study||15
429123|NCT00759668|1024187|P1|COMPLETED|Overall Study||16
429124|NCT00759668|1024186|P2|STARTED|Overall Study||18
429125|NCT00759668|1024187|P1|STARTED|Overall Study||17
429126|NCT00759655|1024203|P1|NOT COMPLETED|Overall Study||1
429127|NCT00759655|1024203|P1|COMPLETED|Overall Study||0
429128|NCT00759655|1024203|P1|STARTED|Overall Study||1
429129|NCT00759642|1024214|P1|NOT COMPLETED|Overall Study||0
429130|NCT00759642|1024214|P1|COMPLETED|Overall Study||33
429131|NCT00759642|1024214|P1|STARTED|Overall Study||33
429132|NCT00759603|1024218|P1|NOT COMPLETED|Overall Study||0
429133|NCT00759603|1024218|P1|COMPLETED|Overall Study||59
429134|NCT00759603|1024218|P1|STARTED|Overall Study||59
429135|NCT00759577|1024222|P1|NOT COMPLETED|Overall Study||0
429136|NCT00759577|1024222|P1|COMPLETED|Overall Study||36
429137|NCT00759577|1024222|P1|STARTED|Overall Study||36
429138|NCT00759564|1024231|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
429223|NCT00759356|1024423|P1|NOT COMPLETED|Overall Study||1
429139|NCT00759564|1024232|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
429140|NCT00759564|1024233|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
429141|NCT00759564|1024234|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
429142|NCT00759564|1024235|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
429143|NCT00759564|1024231|P5|COMPLETED|Second Intervention Period (4 Days)||3
429144|NCT00759564|1024232|P4|COMPLETED|Second Intervention Period (4 Days)||1
429145|NCT00759564|1024233|P3|COMPLETED|Second Intervention Period (4 Days)||8
429146|NCT00759564|1024234|P2|COMPLETED|Second Intervention Period (4 Days)||8
429147|NCT00759564|1024235|P1|COMPLETED|Second Intervention Period (4 Days)||8
429148|NCT00759564|1024231|P5|STARTED|Second Intervention Period (4 Days)||3
429149|NCT00759564|1024232|P4|STARTED|Second Intervention Period (4 Days)||1
429150|NCT00759564|1024233|P3|STARTED|Second Intervention Period (4 Days)||8
429151|NCT00759564|1024234|P2|STARTED|Second Intervention Period (4 Days)||8
429152|NCT00759564|1024235|P1|STARTED|Second Intervention Period (4 Days)||8
429153|NCT00759564|1024231|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
429154|NCT00759564|1024232|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
429155|NCT00759564|1024233|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
429156|NCT00759564|1024234|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
429157|NCT00759564|1024235|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
429158|NCT00759564|1024231|P5|COMPLETED|Washout Period (at Least 14 Days)||3
429159|NCT00759564|1024232|P4|COMPLETED|Washout Period (at Least 14 Days)||1
429160|NCT00759564|1024233|P3|COMPLETED|Washout Period (at Least 14 Days)||8
429161|NCT00759564|1024234|P2|COMPLETED|Washout Period (at Least 14 Days)||8
429162|NCT00759564|1024235|P1|COMPLETED|Washout Period (at Least 14 Days)||8
429163|NCT00759564|1024231|P5|STARTED|Washout Period (at Least 14 Days)||4
429164|NCT00759564|1024232|P4|STARTED|Washout Period (at Least 14 Days)||1
429165|NCT00759564|1024233|P3|STARTED|Washout Period (at Least 14 Days)||8
429166|NCT00759564|1024234|P2|STARTED|Washout Period (at Least 14 Days)||8
429167|NCT00759564|1024235|P1|STARTED|Washout Period (at Least 14 Days)||8
429168|NCT00759564|1024231|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
429169|NCT00759564|1024232|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
429170|NCT00759564|1024233|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
429171|NCT00759564|1024234|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
429172|NCT00759564|1024235|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
429173|NCT00759564|1024231|P5|COMPLETED|First Intervention Period (4 Days)||4
429174|NCT00759564|1024232|P4|COMPLETED|First Intervention Period (4 Days)||1
429175|NCT00759564|1024233|P3|COMPLETED|First Intervention Period (4 Days)||8
429176|NCT00759564|1024234|P2|COMPLETED|First Intervention Period (4 Days)||8
429177|NCT00759564|1024235|P1|COMPLETED|First Intervention Period (4 Days)||8
429178|NCT00759564|1024231|P5|STARTED|First Intervention Period (4 Days)||4
429179|NCT00759564|1024232|P4|STARTED|First Intervention Period (4 Days)||1
429180|NCT00759564|1024233|P3|STARTED|First Intervention Period (4 Days)||8
429181|NCT00759564|1024234|P2|STARTED|First Intervention Period (4 Days)||8
429182|NCT00759564|1024235|P1|STARTED|First Intervention Period (4 Days)||8
429183|NCT00759525|1024375|P2|NOT COMPLETED|Second Intervention (14 Days)||0
429184|NCT00759525|1024376|P1|NOT COMPLETED|Second Intervention (14 Days)||0
429185|NCT00759525|1024375|P2|COMPLETED|Second Intervention (14 Days)||8
429186|NCT00759525|1024376|P1|COMPLETED|Second Intervention (14 Days)||7
429187|NCT00759525|1024375|P2|STARTED|Second Intervention (14 Days)||8
429188|NCT00759525|1024376|P1|STARTED|Second Intervention (14 Days)||7
429189|NCT00759525|1024375|P2|NOT COMPLETED|Washout (14 Days)||0
429190|NCT00759525|1024376|P1|NOT COMPLETED|Washout (14 Days)||0
429191|NCT00759525|1024375|P2|COMPLETED|Washout (14 Days)||8
429192|NCT00759525|1024376|P1|COMPLETED|Washout (14 Days)||7
429193|NCT00759525|1024375|P2|STARTED|Washout (14 Days)||8
429194|NCT00759525|1024376|P1|STARTED|Washout (14 Days)||7
429195|NCT00759525|1024375|P2|NOT COMPLETED|First Intervention (14 Days)||0
429196|NCT00759525|1024376|P1|NOT COMPLETED|First Intervention (14 Days)||0
429197|NCT00759525|1024375|P2|COMPLETED|First Intervention (14 Days)||8
429198|NCT00759525|1024376|P1|COMPLETED|First Intervention (14 Days)||7
429199|NCT00759525|1024375|P2|STARTED|First Intervention (14 Days)||8
429200|NCT00759525|1024376|P1|STARTED|First Intervention (14 Days)||7
429201|NCT00759473|1024387|P5|NOT COMPLETED|Overall Study||0
429202|NCT00759473|1024388|P4|NOT COMPLETED|Overall Study||0
429203|NCT00759473|1024389|P3|NOT COMPLETED|Overall Study||0
429204|NCT00759473|1024390|P2|NOT COMPLETED|Overall Study||0
429205|NCT00759473|1024391|P1|NOT COMPLETED|Overall Study||0
429206|NCT00759473|1024387|P5|COMPLETED|Overall Study||24
429207|NCT00759473|1024388|P4|COMPLETED|Overall Study||23
429208|NCT00759473|1024389|P3|COMPLETED|Overall Study||12
429209|NCT00759473|1024390|P2|COMPLETED|Overall Study||10
429210|NCT00759473|1024391|P1|COMPLETED|Overall Study||10
429211|NCT00759473|1024387|P5|STARTED|Overall Study||24
429212|NCT00759473|1024388|P4|STARTED|Overall Study||23
429213|NCT00759473|1024389|P3|STARTED|Overall Study||12
429214|NCT00759473|1024390|P2|STARTED|Overall Study||10
429215|NCT00759473|1024391|P1|STARTED|Overall Study||10
429216|NCT00759395|1024405|P2|NOT COMPLETED|Overall Study||2
429217|NCT00759395|1024406|P1|NOT COMPLETED|Overall Study||2
429218|NCT00759395|1024405|P2|COMPLETED|Overall Study||7
429219|NCT00759395|1024406|P1|COMPLETED|Overall Study||11
429220|NCT00759395|1024405|P2|STARTED|Overall Study||9
429221|NCT00759395|1024406|P1|STARTED|Overall Study||13
429222|NCT00759356|1024422|P2|NOT COMPLETED|Overall Study||3
429224|NCT00759356|1024422|P2|COMPLETED|Overall Study||15
429225|NCT00759356|1024423|P1|COMPLETED|Overall Study||17
429226|NCT00759356|1024422|P2|STARTED|Overall Study||18
429227|NCT00759356|1024423|P1|STARTED|Overall Study||18
429228|NCT00759330|1024439|P4|NOT COMPLETED|Overall Study||2
429229|NCT00759330|1024440|P3|NOT COMPLETED|Overall Study||0
429230|NCT00759330|1024441|P2|NOT COMPLETED|Overall Study||1
429231|NCT00759330|1024442|P1|NOT COMPLETED|Overall Study||1
429232|NCT00759330|1024439|P4|COMPLETED|Overall Study||41
429233|NCT00759330|1024440|P3|COMPLETED|Overall Study||22
429234|NCT00759330|1024441|P2|COMPLETED|Overall Study||41
429235|NCT00759330|1024442|P1|COMPLETED|Overall Study||19
429236|NCT00759330|1024439|P4|STARTED|Overall Study||43
429237|NCT00759330|1024440|P3|STARTED|Overall Study||22
429238|NCT00759330|1024441|P2|STARTED|Overall Study||42
429239|NCT00759330|1024442|P1|STARTED|Overall Study||20
429240|NCT00759187|1024491|P3|NOT COMPLETED|Overall Study||0
429241|NCT00759187|1024492|P2|NOT COMPLETED|Overall Study||0
429242|NCT00759187|1024493|P1|NOT COMPLETED|Overall Study||0
429243|NCT00759187|1024491|P3|COMPLETED|Overall Study||9
429244|NCT00759187|1024492|P2|COMPLETED|Overall Study||8
429245|NCT00759187|1024493|P1|COMPLETED|Overall Study||8
429246|NCT00759187|1024491|P3|STARTED|Overall Study||9
429247|NCT00759187|1024492|P2|STARTED|Overall Study||8
429248|NCT00759187|1024493|P1|STARTED|Overall Study||8
429249|NCT00759174|1024503|P2|NOT COMPLETED|Overall Study||2
429250|NCT00759174|1024504|P1|NOT COMPLETED|Overall Study||0
429251|NCT00759174|1024503|P2|COMPLETED|Overall Study||595
429252|NCT00759174|1024504|P1|COMPLETED|Overall Study||76
429253|NCT00759174|1024503|P2|STARTED|Overall Study||597
429254|NCT00759174|1024504|P1|STARTED|Overall Study||76
429255|NCT00759161|1024513|P1|NOT COMPLETED|Overall Study||0
429256|NCT00759161|1024513|P1|COMPLETED|Overall Study||35
429257|NCT00759161|1024513|P1|STARTED|Overall Study||35
429258|NCT00759148|1024528|P2|NOT COMPLETED|Overall Study||32
429259|NCT00759148|1024529|P1|NOT COMPLETED|Overall Study||14
429260|NCT00759148|1024528|P2|COMPLETED|Overall Study||554
429261|NCT00759148|1024529|P1|COMPLETED|Overall Study||579
429262|NCT00759148|1024528|P2|STARTED|Overall Study||586
429263|NCT00759148|1024529|P1|STARTED|Overall Study||593
429264|NCT00759109|1024539|P2|NOT COMPLETED|Overall Study||35
429265|NCT00759109|1024540|P1|NOT COMPLETED|Overall Study||39
429266|NCT00759109|1024539|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
429267|NCT00759109|1024540|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
429268|NCT00759109|1024539|P2|STARTED|Overall Study||76
429269|NCT00759109|1024540|P1|STARTED|Overall Study||74
429270|NCT00759096|1024556|P1|NOT COMPLETED|Overall Study||0
429271|NCT00759096|1024556|P1|COMPLETED|Overall Study||30
429272|NCT00759096|1024556|P1|STARTED|Overall Study||30
429273|NCT00759031|1024562|P2|NOT COMPLETED|Second Intervention (1 Day)||0
429274|NCT00759031|1024563|P1|NOT COMPLETED|Second Intervention (1 Day)||0
429275|NCT00759031|1024562|P2|COMPLETED|Second Intervention (1 Day)||8
429276|NCT00759031|1024563|P1|COMPLETED|Second Intervention (1 Day)||8
429277|NCT00759031|1024562|P2|STARTED|Second Intervention (1 Day)||8
429278|NCT00759031|1024563|P1|STARTED|Second Intervention (1 Day)||8
429279|NCT00759031|1024562|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
429280|NCT00759031|1024563|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
429281|NCT00759031|1024562|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
429282|NCT00759031|1024563|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
429283|NCT00759031|1024562|P2|STARTED|Washout After 1st Intervention (1 Week)||8
429284|NCT00759031|1024563|P1|STARTED|Washout After 1st Intervention (1 Week)||8
429285|NCT00759031|1024562|P2|NOT COMPLETED|First Intervention (1 Day)||1
429286|NCT00759031|1024563|P1|NOT COMPLETED|First Intervention (1 Day)||2
429287|NCT00759031|1024562|P2|COMPLETED|First Intervention (1 Day)||8
429288|NCT00759031|1024563|P1|COMPLETED|First Intervention (1 Day)||8
429289|NCT00759031|1024562|P2|STARTED|First Intervention (1 Day)||9
429290|NCT00759031|1024563|P1|STARTED|First Intervention (1 Day)||10
429291|NCT00758836|1024573|P4|NOT COMPLETED|Overall Study||32
429292|NCT00758836|1024574|P3|NOT COMPLETED|Overall Study||38
429293|NCT00758836|1024575|P2|NOT COMPLETED|Overall Study||26
429294|NCT00758836|1024576|P1|NOT COMPLETED|Overall Study||24
429295|NCT00758836|1024573|P4|COMPLETED|Overall Study||138
429296|NCT00758836|1024574|P3|COMPLETED|Overall Study||133
429297|NCT00758836|1024575|P2|COMPLETED|Overall Study||145
429298|NCT00758836|1024576|P1|COMPLETED|Overall Study||147
429299|NCT00758836|1024573|P4|Treated|Overall Study||138
429300|NCT00758836|1024574|P3|Treated|Overall Study||133
429301|NCT00758836|1024575|P2|Treated|Overall Study||145
429302|NCT00758836|1024576|P1|Treated|Overall Study||147
429303|NCT00758836|1024573|P4|STARTED|Overall Study||170
429304|NCT00758836|1024574|P3|STARTED|Overall Study||171
429305|NCT00758836|1024575|P2|STARTED|Overall Study||171
429306|NCT00758836|1024576|P1|STARTED|Overall Study||171
429307|NCT00758771|1024600|P2|NOT COMPLETED|Overall Study||5
429308|NCT00758771|1024601|P1|NOT COMPLETED|Overall Study||3
429309|NCT00758771|1024600|P2|COMPLETED|Overall Study||15
429310|NCT00758771|1024601|P1|COMPLETED|Overall Study||15
429311|NCT00758771|1024600|P2|STARTED|Overall Study||20
429312|NCT00758771|1024601|P1|STARTED|Overall Study||18
429313|NCT00758758|1024615|P8|NOT COMPLETED|Overall Study||0
429314|NCT00758758|1024616|P7|NOT COMPLETED|Overall Study||14
429315|NCT00758758|1024617|P6|NOT COMPLETED|Overall Study||14
429316|NCT00758758|1024618|P5|NOT COMPLETED|Overall Study||2
429317|NCT00758758|1024619|P4|NOT COMPLETED|Overall Study||2
429318|NCT00758758|1024620|P3|NOT COMPLETED|Overall Study||18
429319|NCT00758758|1024621|P2|NOT COMPLETED|Overall Study||25
429320|NCT00758758|1024622|P1|NOT COMPLETED|Overall Study||3
429321|NCT00758758|1024615|P8|COMPLETED|Overall Study||0
429322|NCT00758758|1024616|P7|COMPLETED|Overall Study||17
429323|NCT00758758|1024617|P6|COMPLETED|Overall Study||36
429324|NCT00758758|1024618|P5|COMPLETED|Overall Study||1
429325|NCT00758758|1024619|P4|COMPLETED|Overall Study||4
429326|NCT00758758|1024620|P3|COMPLETED|Overall Study||35
429327|NCT00758758|1024621|P2|COMPLETED|Overall Study||49
429328|NCT00758758|1024622|P1|COMPLETED|Overall Study||11
429329|NCT00758758|1024615|P8|STARTED|Overall Study||0
429330|NCT00758758|1024616|P7|STARTED|Overall Study||31
429331|NCT00758758|1024617|P6|STARTED|Overall Study||50
429332|NCT00758758|1024618|P5|STARTED|Overall Study||3
429333|NCT00758758|1024619|P4|STARTED|Overall Study||6
429334|NCT00758758|1024620|P3|STARTED|Overall Study||53
429335|NCT00758758|1024621|P2|STARTED|Overall Study||74
429336|NCT00758758|1024622|P1|STARTED|Overall Study||14
429337|NCT00758745|1024650|P2|NOT COMPLETED|Overall Study||21
429338|NCT00758745|1024651|P1|NOT COMPLETED|Overall Study||21
429339|NCT00758745|1024650|P2|COMPLETED|Overall Study||60
429340|NCT00758745|1024651|P1|COMPLETED|Overall Study||60
429341|NCT00758745|1024650|P2|STARTED|Overall Study||81
429342|NCT00758745|1024651|P1|STARTED|Overall Study||81
429343|NCT00758706|1024659|P2|NOT COMPLETED|Overall Study||4
429344|NCT00758706|1024660|P1|NOT COMPLETED|Overall Study||4
429345|NCT00758706|1024659|P2|COMPLETED|Overall Study||25
429346|NCT00758706|1024660|P1|COMPLETED|Overall Study||22
429347|NCT00758706|1024659|P2|STARTED|Overall Study||29
429348|NCT00758706|1024660|P1|STARTED|Overall Study||26
429349|NCT00758680|1024696|P10|NOT COMPLETED|Overall Study||1
429350|NCT00758680|1024697|P9|NOT COMPLETED|Overall Study||2
429351|NCT00758680|1024698|P8|NOT COMPLETED|Overall Study||1
429352|NCT00758680|1024699|P7|NOT COMPLETED|Overall Study||1
429353|NCT00758680|1024700|P6|NOT COMPLETED|Overall Study||0
429354|NCT00758680|1024701|P5|NOT COMPLETED|Overall Study||0
429355|NCT00758680|1024702|P4|NOT COMPLETED|Overall Study||0
429356|NCT00758680|1024703|P3|NOT COMPLETED|Overall Study||0
429357|NCT00758680|1024704|P2|NOT COMPLETED|Overall Study||0
429358|NCT00758680|1024705|P1|NOT COMPLETED|Overall Study||0
429359|NCT00758680|1024696|P10|COMPLETED|Overall Study||28
429360|NCT00758680|1024697|P9|COMPLETED|Overall Study||18
429361|NCT00758680|1024698|P8|COMPLETED|Overall Study||19
429362|NCT00758680|1024699|P7|COMPLETED|Overall Study||6
429363|NCT00758680|1024700|P6|COMPLETED|Overall Study||6
429364|NCT00758680|1024701|P5|COMPLETED|Overall Study||6
429365|NCT00758680|1024702|P4|COMPLETED|Overall Study||6
429366|NCT00758680|1024703|P3|COMPLETED|Overall Study||6
429367|NCT00758680|1024704|P2|COMPLETED|Overall Study||6
429368|NCT00758680|1024705|P1|COMPLETED|Overall Study||6
429369|NCT00758680|1024696|P10|STARTED|Overall Study||29
429370|NCT00758680|1024697|P9|STARTED|Overall Study||20
429371|NCT00758680|1024698|P8|STARTED|Overall Study||20
429372|NCT00758680|1024699|P7|STARTED|Overall Study||7
429373|NCT00758680|1024700|P6|STARTED|Overall Study||6
429374|NCT00758680|1024701|P5|STARTED|Overall Study||6
429375|NCT00758680|1024702|P4|STARTED|Overall Study||6
429376|NCT00758680|1024703|P3|STARTED|Overall Study||6
429377|NCT00758680|1024704|P2|STARTED|Overall Study||6
429378|NCT00758680|1024705|P1|STARTED|Overall Study||6
429379|NCT00758667|1024747|P2|NOT COMPLETED|Overall Study||0
429380|NCT00758667|1024748|P1|NOT COMPLETED|Overall Study||0
429381|NCT00758667|1024747|P2|COMPLETED|Overall Study||11
429382|NCT00758667|1024748|P1|COMPLETED|Overall Study||9
429383|NCT00758667|1024747|P2|STARTED|Overall Study||11
429384|NCT00758667|1024748|P1|STARTED|Overall Study||9
429385|NCT00758602|1024758|P2|NOT COMPLETED|Overall Study||22
429386|NCT00758602|1024759|P1|NOT COMPLETED|Overall Study||19
429387|NCT00758602|1024758|P2|COMPLETED|Overall Study||84
429388|NCT00758602|1024759|P1|COMPLETED|Overall Study||85
429389|NCT00758602|1024758|P2|STARTED|Overall Study||106
429390|NCT00758602|1024759|P1|STARTED|Overall Study||104
429391|NCT00758589|1024785|P4|NOT COMPLETED|Overall Study||6
429392|NCT00758589|1024786|P3|NOT COMPLETED|Overall Study||6
429393|NCT00758589|1024787|P2|NOT COMPLETED|Overall Study||3
429394|NCT00758589|1024788|P1|NOT COMPLETED|Overall Study||3
429395|NCT00758589|1024785|P4|COMPLETED|Overall Study||85
429396|NCT00758589|1024786|P3|COMPLETED|Overall Study||86
429397|NCT00758589|1024787|P2|COMPLETED|Overall Study||87
429398|NCT00758589|1024788|P1|COMPLETED|Overall Study||92
429399|NCT00758589|1024785|P4|STARTED|Overall Study||91
429400|NCT00758589|1024786|P3|STARTED|Overall Study||92
429401|NCT00758589|1024787|P2|STARTED|Overall Study||90
429402|NCT00758589|1024788|P1|STARTED|Overall Study||95
429403|NCT00758576|1024854|P1|NOT COMPLETED|Overall Study||1
429404|NCT00758576|1024854|P1|COMPLETED|Overall Study||63
429405|NCT00758576|1024854|P1|STARTED|Overall Study||64
429406|NCT00758563|1024862|P2|NOT COMPLETED|Overall Study||0
429407|NCT00758563|1024863|P1|NOT COMPLETED|Overall Study||0
429408|NCT00758563|1024862|P2|COMPLETED|Overall Study||8
429409|NCT00758563|1024863|P1|COMPLETED|Overall Study||7
429410|NCT00758563|1024862|P2|STARTED|Overall Study||8
429411|NCT00758563|1024863|P1|STARTED|Overall Study||7
429412|NCT00758550|1024869|P2|NOT COMPLETED|Overall Study||0
429413|NCT00758550|1024870|P1|NOT COMPLETED|Overall Study||0
429414|NCT00758550|1024869|P2|COMPLETED|Overall Study||30
429415|NCT00758550|1024870|P1|COMPLETED|Overall Study||30
429416|NCT00758550|1024869|P2|STARTED|Overall Study||30
429417|NCT00758550|1024870|P1|STARTED|Overall Study||30
429418|NCT00758498|1024881|P3|NOT COMPLETED|Overall Study||5
429419|NCT00758498|1024882|P2|NOT COMPLETED|Overall Study||2
429420|NCT00758498|1024883|P1|NOT COMPLETED|Overall Study||3
429421|NCT00758498|1024881|P3|COMPLETED|Overall Study||137
429422|NCT00758498|1024882|P2|COMPLETED|Overall Study||141
429423|NCT00758498|1024883|P1|COMPLETED|Overall Study||139
429424|NCT00758498|1024881|P3|STARTED|Overall Study||142
429425|NCT00758498|1024882|P2|STARTED|Overall Study||143
429426|NCT00758498|1024883|P1|STARTED|Overall Study||142
429427|NCT00758485|1024968|P2|NOT COMPLETED|Overall Study||3
429428|NCT00758485|1024969|P1|NOT COMPLETED|Overall Study||1
429429|NCT00758485|1024968|P2|COMPLETED|Overall Study||67
429430|NCT00758485|1024969|P1|COMPLETED|Overall Study||69
429431|NCT00758485|1024968|P2|TREATED|Overall Study||68
429432|NCT00758485|1024969|P1|TREATED|Overall Study||69
429433|NCT00758485|1024968|P2|STARTED|Overall Study||70
429434|NCT00758485|1024969|P1|STARTED|Overall Study||70
429435|NCT00758459|1024981|P2|NOT COMPLETED|Overall Study||4
429436|NCT00758459|1024982|P1|NOT COMPLETED|Overall Study||3
429437|NCT00758459|1024981|P2|COMPLETED|Overall Study||35
429438|NCT00758459|1024982|P1|COMPLETED|Overall Study||32
429439|NCT00758459|1024981|P2|STARTED|Overall Study||39
429440|NCT00758459|1024982|P1|STARTED|Overall Study||35
429441|NCT00758420|1025016|P2|NOT COMPLETED|Overall Study||0
429442|NCT00758420|1025017|P1|NOT COMPLETED|Overall Study||0
429443|NCT00758420|1025016|P2|COMPLETED|Overall Study||38
429444|NCT00758420|1025017|P1|COMPLETED|Overall Study||39
429445|NCT00758420|1025016|P2|STARTED|Overall Study||38
429446|NCT00758420|1025017|P1|STARTED|Overall Study||39
429447|NCT00758394|1025027|P4|NOT COMPLETED|4th Intervention||0
429448|NCT00758394|1025028|P3|NOT COMPLETED|4th Intervention||0
429449|NCT00758394|1025029|P2|NOT COMPLETED|4th Intervention||0
429450|NCT00758394|1025030|P1|NOT COMPLETED|4th Intervention||0
429451|NCT00758394|1025027|P4|COMPLETED|4th Intervention||7
429452|NCT00758394|1025028|P3|COMPLETED|4th Intervention||6
429453|NCT00758394|1025029|P2|COMPLETED|4th Intervention||6
429454|NCT00758394|1025030|P1|COMPLETED|4th Intervention||7
429455|NCT00758394|1025027|P4|STARTED|4th Intervention||7
429456|NCT00758394|1025028|P3|STARTED|4th Intervention||6
429457|NCT00758394|1025029|P2|STARTED|4th Intervention||6
429458|NCT00758394|1025030|P1|STARTED|4th Intervention||7
429459|NCT00758394|1025027|P4|NOT COMPLETED|Washout After 3rd Intervention||0
429460|NCT00758394|1025028|P3|NOT COMPLETED|Washout After 3rd Intervention||0
429461|NCT00758394|1025029|P2|NOT COMPLETED|Washout After 3rd Intervention||0
429462|NCT00758394|1025030|P1|NOT COMPLETED|Washout After 3rd Intervention||0
429463|NCT00758394|1025027|P4|COMPLETED|Washout After 3rd Intervention||7
429464|NCT00758394|1025028|P3|COMPLETED|Washout After 3rd Intervention||6
429465|NCT00758394|1025029|P2|COMPLETED|Washout After 3rd Intervention||6
429466|NCT00758394|1025030|P1|COMPLETED|Washout After 3rd Intervention||7
429467|NCT00758394|1025027|P4|STARTED|Washout After 3rd Intervention||7
429468|NCT00758394|1025028|P3|STARTED|Washout After 3rd Intervention||6
429469|NCT00758394|1025029|P2|STARTED|Washout After 3rd Intervention||6
429470|NCT00758394|1025030|P1|STARTED|Washout After 3rd Intervention||7
429471|NCT00758394|1025027|P4|NOT COMPLETED|3rd Intervention||1
429472|NCT00758394|1025028|P3|NOT COMPLETED|3rd Intervention||0
429473|NCT00758394|1025029|P2|NOT COMPLETED|3rd Intervention||0
429474|NCT00758394|1025030|P1|NOT COMPLETED|3rd Intervention||1
429475|NCT00758394|1025027|P4|COMPLETED|3rd Intervention||7
429476|NCT00758394|1025028|P3|COMPLETED|3rd Intervention||6
429477|NCT00758394|1025029|P2|COMPLETED|3rd Intervention||6
429478|NCT00758394|1025030|P1|COMPLETED|3rd Intervention||7
429479|NCT00758394|1025027|P4|STARTED|3rd Intervention||8
429480|NCT00758394|1025028|P3|STARTED|3rd Intervention||6
429481|NCT00758394|1025029|P2|STARTED|3rd Intervention||6
429482|NCT00758394|1025030|P1|STARTED|3rd Intervention||8
429483|NCT00758394|1025027|P4|NOT COMPLETED|Washout After 2nd Intervention||0
429484|NCT00758394|1025028|P3|NOT COMPLETED|Washout After 2nd Intervention||0
429485|NCT00758394|1025029|P2|NOT COMPLETED|Washout After 2nd Intervention||0
429486|NCT00758394|1025030|P1|NOT COMPLETED|Washout After 2nd Intervention||0
429487|NCT00758394|1025027|P4|COMPLETED|Washout After 2nd Intervention||8
429488|NCT00758394|1025028|P3|COMPLETED|Washout After 2nd Intervention||6
429489|NCT00758394|1025029|P2|COMPLETED|Washout After 2nd Intervention||6
429490|NCT00758394|1025030|P1|COMPLETED|Washout After 2nd Intervention||8
429491|NCT00758394|1025027|P4|STARTED|Washout After 2nd Intervention||8
429492|NCT00758394|1025028|P3|STARTED|Washout After 2nd Intervention||6
429493|NCT00758394|1025029|P2|STARTED|Washout After 2nd Intervention||6
429494|NCT00758394|1025030|P1|STARTED|Washout After 2nd Intervention||8
429495|NCT00758394|1025027|P4|NOT COMPLETED|2nd Intervention Order||0
429496|NCT00758394|1025028|P3|NOT COMPLETED|2nd Intervention Order||0
429497|NCT00758394|1025029|P2|NOT COMPLETED|2nd Intervention Order||1
429498|NCT00758394|1025030|P1|NOT COMPLETED|2nd Intervention Order||0
429499|NCT00758394|1025027|P4|COMPLETED|2nd Intervention Order||8
429500|NCT00758394|1025028|P3|COMPLETED|2nd Intervention Order||6
429501|NCT00758394|1025029|P2|COMPLETED|2nd Intervention Order||6
429502|NCT00758394|1025030|P1|COMPLETED|2nd Intervention Order||8
429503|NCT00758394|1025027|P4|STARTED|2nd Intervention Order||8
429504|NCT00758394|1025028|P3|STARTED|2nd Intervention Order||6
429505|NCT00758394|1025029|P2|STARTED|2nd Intervention Order||7
429506|NCT00758394|1025030|P1|STARTED|2nd Intervention Order||8
429507|NCT00758394|1025027|P4|NOT COMPLETED|Washout After 1st Intervention||0
429508|NCT00758394|1025028|P3|NOT COMPLETED|Washout After 1st Intervention||0
429509|NCT00758394|1025029|P2|NOT COMPLETED|Washout After 1st Intervention||0
429510|NCT00758394|1025030|P1|NOT COMPLETED|Washout After 1st Intervention||0
429511|NCT00758394|1025027|P4|COMPLETED|Washout After 1st Intervention||8
429512|NCT00758394|1025028|P3|COMPLETED|Washout After 1st Intervention||6
429513|NCT00758394|1025029|P2|COMPLETED|Washout After 1st Intervention||7
429514|NCT00758394|1025030|P1|COMPLETED|Washout After 1st Intervention||8
429515|NCT00758394|1025027|P4|STARTED|Washout After 1st Intervention||8
429516|NCT00758394|1025028|P3|STARTED|Washout After 1st Intervention||6
429517|NCT00758394|1025029|P2|STARTED|Washout After 1st Intervention||7
429518|NCT00758394|1025030|P1|STARTED|Washout After 1st Intervention||8
429519|NCT00758394|1025027|P4|NOT COMPLETED|1st Intervention||0
429520|NCT00758394|1025028|P3|NOT COMPLETED|1st Intervention||0
429521|NCT00758394|1025029|P2|NOT COMPLETED|1st Intervention||0
429522|NCT00758394|1025030|P1|NOT COMPLETED|1st Intervention||0
429523|NCT00758394|1025027|P4|COMPLETED|1st Intervention||8
429524|NCT00758394|1025028|P3|COMPLETED|1st Intervention||6
429525|NCT00758394|1025029|P2|COMPLETED|1st Intervention||7
429526|NCT00758394|1025030|P1|COMPLETED|1st Intervention||8
429527|NCT00758394|1025027|P4|STARTED|1st Intervention||8
429528|NCT00758394|1025028|P3|STARTED|1st Intervention||6
429529|NCT00758394|1025029|P2|STARTED|1st Intervention||7
429530|NCT00758394|1025030|P1|STARTED|1st Intervention||8
429531|NCT00758342|1025042|P2|NOT COMPLETED|Overall Study||1
429532|NCT00758342|1025043|P1|NOT COMPLETED|Overall Study||4
429533|NCT00758342|1025042|P2|COMPLETED|Overall Study||17
429534|NCT00758342|1025043|P1|COMPLETED|Overall Study||15
429535|NCT00758342|1025042|P2|STARTED|Overall Study||18
429536|NCT00758342|1025043|P1|STARTED|Overall Study||19
429537|NCT00758290|1025051|P2|NOT COMPLETED|Overall Study||0
429538|NCT00758290|1025052|P1|NOT COMPLETED|Overall Study||0
429539|NCT00758290|1025051|P2|COMPLETED|Overall Study||12
429540|NCT00758290|1025052|P1|COMPLETED|Overall Study||11
429541|NCT00758290|1025051|P2|STARTED|Overall Study||12
429542|NCT00758290|1025052|P1|STARTED|Overall Study||11
429543|NCT00758160|1025056|P1|NOT COMPLETED|Overall Study||66
429544|NCT00758160|1025056|P1|COMPLETED|Overall Study||230
429545|NCT00758160|1025056|P1|STARTED|Overall Study||296
429546|NCT00758069|1025077|P3|NOT COMPLETED|Overall Study||1
429547|NCT00758069|1025078|P2|NOT COMPLETED|Overall Study||0
429548|NCT00758069|1025079|P1|NOT COMPLETED|Overall Study||1
429549|NCT00758069|1025077|P3|COMPLETED|Overall Study||27
429550|NCT00758069|1025078|P2|COMPLETED|Overall Study||25
429551|NCT00758069|1025079|P1|COMPLETED|Overall Study||26
429552|NCT00758069|1025077|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
429553|NCT00758069|1025078|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
429554|NCT00758069|1025079|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
429555|NCT00758043|1025094|P4|NOT COMPLETED|Overall Study||100
429556|NCT00758043|1025095|P3|NOT COMPLETED|Overall Study||39
429557|NCT00758043|1025096|P2|NOT COMPLETED|Overall Study||41
429558|NCT00758043|1025097|P1|NOT COMPLETED|Overall Study||1
429559|NCT00758043|1025094|P4|COMPLETED|Overall Study||0
429560|NCT00758043|1025095|P3|COMPLETED|Overall Study||79
429561|NCT00758043|1025096|P2|COMPLETED|Overall Study||119
429562|NCT00758043|1025097|P1|COMPLETED|Overall Study||161
429563|NCT00758043|1025094|P4|STARTED|Overall Study||100
429564|NCT00758043|1025095|P3|STARTED|Overall Study||118
429565|NCT00758043|1025096|P2|STARTED|Overall Study||160
429566|NCT00758043|1025097|P1|STARTED|Overall Study||162
429567|NCT00757848|1025125|P2|NOT COMPLETED|Overall Study||2
429568|NCT00757848|1025126|P1|NOT COMPLETED|Overall Study||3
429569|NCT00757848|1025125|P2|COMPLETED|Overall Study||27
429570|NCT00757848|1025126|P1|COMPLETED|Overall Study||24
429571|NCT00757848|1025125|P2|STARTED|Overall Study||29
429572|NCT00757848|1025126|P1|STARTED|Overall Study||27
429573|NCT00757822|1025172|P2|NOT COMPLETED|Overall Study||31
429574|NCT00757822|1025173|P1|NOT COMPLETED|Overall Study||28
429575|NCT00757822|1025172|P2|COMPLETED|Overall Study||57
429576|NCT00757822|1025173|P1|COMPLETED|Overall Study||64
429577|NCT00757822|1025172|P2|Data Lock, Unblinding Analysis|Overall Study||57
429578|NCT00757822|1025173|P1|Data Lock, Unblinding Analysis|Overall Study||64
429579|NCT00757822|1025172|P2|Withdrawn-protocol Deviation|Overall Study||8
429580|NCT00757822|1025173|P1|Withdrawn-protocol Deviation|Overall Study||9
429581|NCT00757822|1025172|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
429582|NCT00757822|1025173|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
429583|NCT00757822|1025172|P2|Data Entry, QC Assessment|Overall Study||74
429584|NCT00757822|1025173|P1|Data Entry, QC Assessment|Overall Study||85
429585|NCT00757822|1025172|P2|2-6 wk Post-op Assessment|Overall Study||74
429586|NCT00757822|1025173|P1|2-6 wk Post-op Assessment|Overall Study||85
429587|NCT00757822|1025172|P2|24-48 hr Telephone Assessment|Overall Study||74
429588|NCT00757822|1025173|P1|24-48 hr Telephone Assessment|Overall Study||85
429589|NCT00757822|1025172|P2|DOS: Post-operative Assessments|Overall Study||74
429590|NCT00757822|1025173|P1|DOS: Post-operative Assessments|Overall Study||85
429591|NCT00757822|1025172|P2|Received Study Intervention|Overall Study||74
429592|NCT00757822|1025173|P1|Received Study Intervention|Overall Study||85
429593|NCT00757822|1025172|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
429594|NCT00757822|1025173|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
429595|NCT00757822|1025172|P2|Withdrawal by Subject-no Intervention|Overall Study||3
429596|NCT00757822|1025173|P1|Withdrawal by Subject-no Intervention|Overall Study||1
429597|NCT00757822|1025172|P2|Day of Surgery (DOS) Assessment|Overall Study||88
429598|NCT00757822|1025173|P1|Day of Surgery (DOS) Assessment|Overall Study||92
429599|NCT00757822|1025172|P2|STARTED|Overall Study||88
429600|NCT00757822|1025173|P1|STARTED|Overall Study||92
429601|NCT00757783|1025195|P2|NOT COMPLETED|Overall Study||6
429602|NCT00757783|1025196|P1|NOT COMPLETED|Overall Study||5
429603|NCT00757783|1025195|P2|COMPLETED|Overall Study||25
429604|NCT00757783|1025196|P1|COMPLETED|Overall Study||29
429605|NCT00757783|1025195|P2|STARTED|Overall Study||31
429606|NCT00757783|1025196|P1|STARTED|Overall Study||34
429607|NCT00757705|1025232|P1|NOT COMPLETED|Overall Study||121
429608|NCT00757705|1025232|P1|COMPLETED|Overall Study||178
429609|NCT00757705|1025232|P1|STARTED|Overall Study||299
429610|NCT00757666|1025246|P2|NOT COMPLETED|Overall Study||23
429611|NCT00757666|1025247|P1|NOT COMPLETED|Overall Study||22
429612|NCT00757666|1025246|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
429613|NCT00757666|1025247|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
429614|NCT00757666|1025246|P2|STARTED|Overall Study||34
429615|NCT00757666|1025247|P1|STARTED|Overall Study||34
429616|NCT00757627|1025261|P1|NOT COMPLETED|Overall Study||81
429617|NCT00757627|1025261|P1|COMPLETED|Overall Study||419
429618|NCT00757627|1025261|P1|STARTED|Overall Study||500
429619|NCT00757601|1025274|P12|NOT COMPLETED|Period 5||0
429620|NCT00757601|1025275|P11|NOT COMPLETED|Period 5||0
429621|NCT00757601|1025276|P10|NOT COMPLETED|Period 5||0
429622|NCT00757601|1025277|P9|NOT COMPLETED|Period 5||0
429623|NCT00757601|1025278|P8|NOT COMPLETED|Period 5||0
429624|NCT00757601|1025279|P7|NOT COMPLETED|Period 5||0
429625|NCT00757601|1025280|P6|NOT COMPLETED|Period 5||0
429626|NCT00757601|1025281|P5|NOT COMPLETED|Period 5||0
429627|NCT00757601|1025282|P4|NOT COMPLETED|Period 5||0
429628|NCT00757601|1025283|P3|NOT COMPLETED|Period 5||0
429629|NCT00757601|1025284|P2|NOT COMPLETED|Period 5||0
429630|NCT00757601|1025285|P1|NOT COMPLETED|Period 5||0
429631|NCT00757601|1025274|P12|COMPLETED|Period 5||1
429632|NCT00757601|1025275|P11|COMPLETED|Period 5||2
429633|NCT00757601|1025276|P10|COMPLETED|Period 5||1
429634|NCT00757601|1025277|P9|COMPLETED|Period 5||2
429635|NCT00757601|1025278|P8|COMPLETED|Period 5||2
429636|NCT00757601|1025279|P7|COMPLETED|Period 5||2
429637|NCT00757601|1025280|P6|COMPLETED|Period 5||2
429638|NCT00757601|1025281|P5|COMPLETED|Period 5||2
429639|NCT00757601|1025282|P4|COMPLETED|Period 5||2
429640|NCT00757601|1025283|P3|COMPLETED|Period 5||2
429641|NCT00757601|1025284|P2|COMPLETED|Period 5||2
429642|NCT00757601|1025285|P1|COMPLETED|Period 5||2
429643|NCT00757601|1025274|P12|STARTED|Period 5||1
429644|NCT00757601|1025275|P11|STARTED|Period 5||2
429645|NCT00757601|1025276|P10|STARTED|Period 5||1
429646|NCT00757601|1025277|P9|STARTED|Period 5||2
429647|NCT00757601|1025278|P8|STARTED|Period 5||2
429648|NCT00757601|1025279|P7|STARTED|Period 5||2
429649|NCT00757601|1025280|P6|STARTED|Period 5||2
429650|NCT00757601|1025281|P5|STARTED|Period 5||2
429651|NCT00757601|1025282|P4|STARTED|Period 5||2
429652|NCT00757601|1025283|P3|STARTED|Period 5||2
429653|NCT00757601|1025284|P2|STARTED|Period 5||2
429654|NCT00757601|1025285|P1|STARTED|Period 5||2
429655|NCT00757601|1025274|P12|NOT COMPLETED|Period 4||1
429656|NCT00757601|1025275|P11|NOT COMPLETED|Period 4||0
429657|NCT00757601|1025276|P10|NOT COMPLETED|Period 4||1
429658|NCT00757601|1025277|P9|NOT COMPLETED|Period 4||0
429659|NCT00757601|1025278|P8|NOT COMPLETED|Period 4||0
429660|NCT00757601|1025279|P7|NOT COMPLETED|Period 4||0
429661|NCT00757601|1025280|P6|NOT COMPLETED|Period 4||0
429662|NCT00757601|1025281|P5|NOT COMPLETED|Period 4||0
429663|NCT00757601|1025282|P4|NOT COMPLETED|Period 4||0
429664|NCT00757601|1025283|P3|NOT COMPLETED|Period 4||0
429665|NCT00757601|1025284|P2|NOT COMPLETED|Period 4||0
429666|NCT00757601|1025285|P1|NOT COMPLETED|Period 4||0
429667|NCT00757601|1025274|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
429668|NCT00757601|1025275|P11|COMPLETED|Period 4||2
429669|NCT00757601|1025276|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
429670|NCT00757601|1025277|P9|COMPLETED|Period 4||2
429671|NCT00757601|1025278|P8|COMPLETED|Period 4||2
429672|NCT00757601|1025279|P7|COMPLETED|Period 4||2
429673|NCT00757601|1025280|P6|COMPLETED|Period 4||2
429674|NCT00757601|1025281|P5|COMPLETED|Period 4||2
429675|NCT00757601|1025282|P4|COMPLETED|Period 4||2
429676|NCT00757601|1025283|P3|COMPLETED|Period 4||2
429677|NCT00757601|1025284|P2|COMPLETED|Period 4||2
429678|NCT00757601|1025285|P1|COMPLETED|Period 4||2
429679|NCT00757601|1025274|P12|STARTED|Period 4||2
429680|NCT00757601|1025275|P11|STARTED|Period 4||2
429681|NCT00757601|1025276|P10|STARTED|Period 4||2
429682|NCT00757601|1025277|P9|STARTED|Period 4||2
429683|NCT00757601|1025278|P8|STARTED|Period 4||2
429684|NCT00757601|1025279|P7|STARTED|Period 4||2
429685|NCT00757601|1025280|P6|STARTED|Period 4||2
429686|NCT00757601|1025281|P5|STARTED|Period 4||2
429687|NCT00757601|1025282|P4|STARTED|Period 4||2
429688|NCT00757601|1025283|P3|STARTED|Period 4||2
429689|NCT00757601|1025284|P2|STARTED|Period 4||2
429690|NCT00757601|1025285|P1|STARTED|Period 4||2
429691|NCT00757601|1025274|P12|NOT COMPLETED|Period 3||0
429692|NCT00757601|1025275|P11|NOT COMPLETED|Period 3||0
429693|NCT00757601|1025276|P10|NOT COMPLETED|Period 3||0
429694|NCT00757601|1025277|P9|NOT COMPLETED|Period 3||0
429695|NCT00757601|1025278|P8|NOT COMPLETED|Period 3||0
429696|NCT00757601|1025279|P7|NOT COMPLETED|Period 3||0
429697|NCT00757601|1025280|P6|NOT COMPLETED|Period 3||0
429698|NCT00757601|1025281|P5|NOT COMPLETED|Period 3||0
429699|NCT00757601|1025282|P4|NOT COMPLETED|Period 3||0
429700|NCT00757601|1025283|P3|NOT COMPLETED|Period 3||0
429701|NCT00757601|1025284|P2|NOT COMPLETED|Period 3||0
429702|NCT00757601|1025285|P1|NOT COMPLETED|Period 3||0
429703|NCT00757601|1025274|P12|COMPLETED|Period 3||2
429704|NCT00757601|1025275|P11|COMPLETED|Period 3||2
429705|NCT00757601|1025276|P10|COMPLETED|Period 3||2
429706|NCT00757601|1025277|P9|COMPLETED|Period 3||2
429707|NCT00757601|1025278|P8|COMPLETED|Period 3||2
429708|NCT00757601|1025279|P7|COMPLETED|Period 3||2
429709|NCT00757601|1025280|P6|COMPLETED|Period 3||2
429710|NCT00757601|1025281|P5|COMPLETED|Period 3||2
429711|NCT00757601|1025282|P4|COMPLETED|Period 3||2
429712|NCT00757601|1025283|P3|COMPLETED|Period 3||2
429713|NCT00757601|1025284|P2|COMPLETED|Period 3||2
429714|NCT00757601|1025285|P1|COMPLETED|Period 3||2
429715|NCT00757601|1025274|P12|STARTED|Period 3||2
429716|NCT00757601|1025275|P11|STARTED|Period 3||2
429717|NCT00757601|1025276|P10|STARTED|Period 3||2
429718|NCT00757601|1025277|P9|STARTED|Period 3||2
429719|NCT00757601|1025278|P8|STARTED|Period 3||2
429720|NCT00757601|1025279|P7|STARTED|Period 3||2
429721|NCT00757601|1025280|P6|STARTED|Period 3||2
429722|NCT00757601|1025281|P5|STARTED|Period 3||2
429723|NCT00757601|1025282|P4|STARTED|Period 3||2
429724|NCT00757601|1025283|P3|STARTED|Period 3||2
429725|NCT00757601|1025284|P2|STARTED|Period 3||2
429726|NCT00757601|1025285|P1|STARTED|Period 3||2
429727|NCT00757601|1025274|P12|NOT COMPLETED|Period 2||1
429728|NCT00757601|1025275|P11|NOT COMPLETED|Period 2||0
429729|NCT00757601|1025276|P10|NOT COMPLETED|Period 2||0
429730|NCT00757601|1025277|P9|NOT COMPLETED|Period 2||0
429731|NCT00757601|1025278|P8|NOT COMPLETED|Period 2||0
429732|NCT00757601|1025279|P7|NOT COMPLETED|Period 2||0
429733|NCT00757601|1025280|P6|NOT COMPLETED|Period 2||0
429734|NCT00757601|1025281|P5|NOT COMPLETED|Period 2||0
429735|NCT00757601|1025282|P4|NOT COMPLETED|Period 2||0
429736|NCT00757601|1025283|P3|NOT COMPLETED|Period 2||0
429737|NCT00757601|1025284|P2|NOT COMPLETED|Period 2||0
429738|NCT00757601|1025285|P1|NOT COMPLETED|Period 2||0
429739|NCT00757601|1025274|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
429740|NCT00757601|1025275|P11|COMPLETED|Period 2||2
429741|NCT00757601|1025276|P10|COMPLETED|Period 2||2
429742|NCT00757601|1025277|P9|COMPLETED|Period 2||2
429743|NCT00757601|1025278|P8|COMPLETED|Period 2||2
429744|NCT00757601|1025279|P7|COMPLETED|Period 2||2
429745|NCT00757601|1025280|P6|COMPLETED|Period 2||2
429746|NCT00757601|1025281|P5|COMPLETED|Period 2||2
429747|NCT00757601|1025282|P4|COMPLETED|Period 2||2
429748|NCT00757601|1025283|P3|COMPLETED|Period 2||2
429749|NCT00757601|1025284|P2|COMPLETED|Period 2||2
429750|NCT00757601|1025285|P1|COMPLETED|Period 2||2
429751|NCT00757601|1025274|P12|STARTED|Period 2||3
429752|NCT00757601|1025275|P11|STARTED|Period 2||2
429753|NCT00757601|1025276|P10|STARTED|Period 2||2
429754|NCT00757601|1025277|P9|STARTED|Period 2||2
429755|NCT00757601|1025278|P8|STARTED|Period 2||2
429756|NCT00757601|1025279|P7|STARTED|Period 2||2
429757|NCT00757601|1025280|P6|STARTED|Period 2||2
429758|NCT00757601|1025281|P5|STARTED|Period 2||2
429759|NCT00757601|1025282|P4|STARTED|Period 2||2
429760|NCT00757601|1025283|P3|STARTED|Period 2||2
429761|NCT00757601|1025284|P2|STARTED|Period 2||2
429762|NCT00757601|1025285|P1|STARTED|Period 2||2
429763|NCT00757601|1025274|P12|NOT COMPLETED|Period 1||0
429764|NCT00757601|1025275|P11|NOT COMPLETED|Period 1||0
429765|NCT00757601|1025276|P10|NOT COMPLETED|Period 1||0
429766|NCT00757601|1025277|P9|NOT COMPLETED|Period 1||0
429767|NCT00757601|1025278|P8|NOT COMPLETED|Period 1||0
429768|NCT00757601|1025279|P7|NOT COMPLETED|Period 1||0
429769|NCT00757601|1025280|P6|NOT COMPLETED|Period 1||0
429770|NCT00757601|1025281|P5|NOT COMPLETED|Period 1||0
429771|NCT00757601|1025282|P4|NOT COMPLETED|Period 1||0
429772|NCT00757601|1025283|P3|NOT COMPLETED|Period 1||0
429773|NCT00757601|1025284|P2|NOT COMPLETED|Period 1||0
429774|NCT00757601|1025285|P1|NOT COMPLETED|Period 1||0
429775|NCT00757601|1025274|P12|COMPLETED|Period 1||3
429776|NCT00757601|1025275|P11|COMPLETED|Period 1||2
429777|NCT00757601|1025276|P10|COMPLETED|Period 1||2
429778|NCT00757601|1025277|P9|COMPLETED|Period 1||2
429779|NCT00757601|1025278|P8|COMPLETED|Period 1||2
429780|NCT00757601|1025279|P7|COMPLETED|Period 1||2
429781|NCT00757601|1025280|P6|COMPLETED|Period 1||2
429782|NCT00757601|1025281|P5|COMPLETED|Period 1||2
429783|NCT00757601|1025282|P4|COMPLETED|Period 1||2
429784|NCT00757601|1025283|P3|COMPLETED|Period 1||2
429785|NCT00757601|1025284|P2|COMPLETED|Period 1||2
429786|NCT00757601|1025285|P1|COMPLETED|Period 1||2
429787|NCT00757601|1025274|P12|STARTED|Period 1||3
429788|NCT00757601|1025275|P11|STARTED|Period 1||2
429789|NCT00757601|1025276|P10|STARTED|Period 1||2
429790|NCT00757601|1025277|P9|STARTED|Period 1||2
429791|NCT00757601|1025278|P8|STARTED|Period 1||2
429792|NCT00757601|1025279|P7|STARTED|Period 1||2
429793|NCT00757601|1025280|P6|STARTED|Period 1||2
429794|NCT00757601|1025281|P5|STARTED|Period 1||2
429795|NCT00757601|1025282|P4|STARTED|Period 1||2
429796|NCT00757601|1025283|P3|STARTED|Period 1||2
429797|NCT00757601|1025284|P2|STARTED|Period 1||2
429798|NCT00757601|1025285|P1|STARTED|Period 1||2
429799|NCT00757588|1025396|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
429800|NCT00757588|1025397|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
429801|NCT00757588|1025396|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
429802|NCT00757588|1025397|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
429803|NCT00757588|1025396|P2|STARTED|Period 2: Long-term (52-week) Phase||134
429804|NCT00757588|1025397|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
429805|NCT00757588|1025396|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
429806|NCT00757588|1025397|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
430073|NCT00755105|1026126|P1|NOT COMPLETED|Overall Study||9
429807|NCT00757588|1025396|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
429808|NCT00757588|1025397|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
429809|NCT00757588|1025396|P2|STARTED|Period 1: Short-term (24-week) Phase||151
429810|NCT00757588|1025397|P1|STARTED|Period 1: Short-term (24-week) Phase||304
429811|NCT00757484|1025429|P1|NOT COMPLETED|Overall Study||0
429812|NCT00757484|1025429|P1|COMPLETED|Overall Study||491
429813|NCT00757484|1025429|P1|STARTED|Overall Study||491
429814|NCT00757237|1025438|P2|NOT COMPLETED|Overall Study||25
429815|NCT00757237|1025439|P1|NOT COMPLETED|Overall Study||13
429816|NCT00757237|1025438|P2|COMPLETED|Overall Study||111
429817|NCT00757237|1025439|P1|COMPLETED|Overall Study||124
429818|NCT00757237|1025438|P2|Treated|Overall Study||132
429819|NCT00757237|1025439|P1|Treated|Overall Study||136
429820|NCT00757237|1025438|P2|STARTED|Overall Study||136
429821|NCT00757237|1025439|P1|STARTED|Overall Study||137
429822|NCT00757172|1025467|P1|NOT COMPLETED|Overall Study||11
429823|NCT00757172|1025467|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
429824|NCT00757172|1025467|P1|STARTED|Overall Study||65
429825|NCT00757003|1025475|P1|NOT COMPLETED|Overall Study||49
429826|NCT00757003|1025475|P1|COMPLETED|Overall Study||51
429827|NCT00757003|1025475|P1|STARTED|Overall Study||100
429828|NCT00756977|1025483|P2|NOT COMPLETED|Overall Study||11
429829|NCT00756977|1025484|P1|NOT COMPLETED|Overall Study||21
429830|NCT00756977|1025483|P2|COMPLETED|Overall Study||187
429831|NCT00756977|1025484|P1|COMPLETED|Overall Study||175
429832|NCT00756977|1025483|P2|STARTED|Overall Study||198
429833|NCT00756977|1025484|P1|STARTED|Overall Study||196
429834|NCT00756964|1025512|P2|NOT COMPLETED|Overall Study||0
429835|NCT00756964|1025513|P1|NOT COMPLETED|Overall Study||0
429836|NCT00756964|1025512|P2|COMPLETED|Overall Study||13
429837|NCT00756964|1025513|P1|COMPLETED|Overall Study||13
429838|NCT00756964|1025512|P2|STARTED|Overall Study||13
429839|NCT00756964|1025513|P1|STARTED|Overall Study||13
429840|NCT00756938|1025522|P4|NOT COMPLETED|Optional Extension||37
429841|NCT00756938|1025523|P3|NOT COMPLETED|Optional Extension||0
429842|NCT00756938|1025524|P2|NOT COMPLETED|Optional Extension||0
429843|NCT00756938|1025525|P1|NOT COMPLETED|Optional Extension||0
429844|NCT00756938|1025522|P4|COMPLETED|Optional Extension||53
429845|NCT00756938|1025523|P3|COMPLETED|Optional Extension||0
429846|NCT00756938|1025524|P2|COMPLETED|Optional Extension||0
429847|NCT00756938|1025525|P1|COMPLETED|Optional Extension||0
429848|NCT00756938|1025522|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
429849|NCT00756938|1025523|P3|STARTED|Optional Extension||0
429850|NCT00756938|1025524|P2|STARTED|Optional Extension||0
429851|NCT00756938|1025525|P1|STARTED|Optional Extension||0
429852|NCT00756938|1025522|P4|NOT COMPLETED|12-week Base Study||0
429853|NCT00756938|1025523|P3|NOT COMPLETED|12-week Base Study||2
429854|NCT00756938|1025524|P2|NOT COMPLETED|12-week Base Study||0
429855|NCT00756938|1025525|P1|NOT COMPLETED|12-week Base Study||2
429856|NCT00756938|1025522|P4|COMPLETED|12-week Base Study||0
429857|NCT00756938|1025523|P3|COMPLETED|12-week Base Study||32
429858|NCT00756938|1025524|P2|COMPLETED|12-week Base Study||34
429859|NCT00756938|1025525|P1|COMPLETED|12-week Base Study||31
429860|NCT00756938|1025522|P4|STARTED|12-week Base Study||0
429861|NCT00756938|1025523|P3|STARTED|12-week Base Study||34
429862|NCT00756938|1025524|P2|STARTED|12-week Base Study||34
429863|NCT00756938|1025525|P1|STARTED|12-week Base Study||33
429864|NCT00756886|1025553|P2|NOT COMPLETED|Overall Study||7
429865|NCT00756886|1025554|P1|NOT COMPLETED|Overall Study||11
429866|NCT00756886|1025553|P2|COMPLETED|Overall Study||25
429867|NCT00756886|1025554|P1|COMPLETED|Overall Study||30
429868|NCT00756886|1025553|P2|STARTED|Overall Study||32
429869|NCT00756886|1025554|P1|STARTED|Overall Study||41
429870|NCT00756730|1025562|P2|NOT COMPLETED|Overall Study||2
429871|NCT00756730|1025563|P1|NOT COMPLETED|Overall Study||0
429872|NCT00756730|1025562|P2|COMPLETED|Overall Study||22
429873|NCT00756730|1025563|P1|COMPLETED|Overall Study||25
429874|NCT00756730|1025562|P2|STARTED|Overall Study||24
429875|NCT00756730|1025563|P1|STARTED|Overall Study||25
429876|NCT00756678|1025583|P1|NOT COMPLETED|Overall Study||1
429877|NCT00756678|1025583|P1|COMPLETED|Overall Study||50
429878|NCT00756678|1025583|P1|STARTED|Overall Study||51
429879|NCT00756574|1025596|P2|NOT COMPLETED|Overall Study||11
429880|NCT00756574|1025597|P1|NOT COMPLETED|Overall Study||13
429881|NCT00756574|1025596|P2|COMPLETED|Overall Study||210
429882|NCT00756574|1025597|P1|COMPLETED|Overall Study||212
429883|NCT00756574|1025596|P2|STARTED|Overall Study||221
429884|NCT00756574|1025597|P1|STARTED|Overall Study||225
429885|NCT00756561|1025607|P1|NOT COMPLETED|Overall Study||0
429886|NCT00756561|1025607|P1|COMPLETED|Overall Study||10
429887|NCT00756561|1025607|P1|STARTED|Overall Study||10
429888|NCT00756548|1025614|P2|NOT COMPLETED|Overall Study||0
429889|NCT00756548|1025615|P1|NOT COMPLETED|Overall Study||2
429890|NCT00756548|1025614|P2|COMPLETED|Overall Study||185
429891|NCT00756548|1025615|P1|COMPLETED|Overall Study||184
429892|NCT00756548|1025614|P2|STARTED|Overall Study||185
429893|NCT00756548|1025615|P1|STARTED|Overall Study||186
429894|NCT00756470|1025641|P1|NOT COMPLETED|Overall Study||5
429895|NCT00756470|1025641|P1|COMPLETED|Overall Study||10
429896|NCT00756470|1025641|P1|STARTED|Overall Study||15
429897|NCT00756457|1025648|P2|NOT COMPLETED|Overall Study||2
429898|NCT00756457|1025649|P1|NOT COMPLETED|Overall Study||1
429899|NCT00756457|1025648|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
429900|NCT00756457|1025649|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
429901|NCT00756457|1025648|P2|STARTED|Overall Study||19
429902|NCT00756457|1025649|P1|STARTED|Overall Study||20
429903|NCT00756444|1025679|P2|NOT COMPLETED|Overall Study||21
429904|NCT00756444|1025680|P1|NOT COMPLETED|Overall Study||15
429905|NCT00756444|1025679|P2|COMPLETED|Overall Study||13
429906|NCT00756444|1025680|P1|COMPLETED|Overall Study||18
429907|NCT00756444|1025679|P2|STARTED|Overall Study||34
429908|NCT00756444|1025680|P1|STARTED|Overall Study||33
429909|NCT00756314|1025691|P2|NOT COMPLETED|Overall Study||59
429910|NCT00756314|1025692|P1|NOT COMPLETED|Overall Study||2
429911|NCT00756314|1025691|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
429912|NCT00756314|1025692|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
429913|NCT00756314|1025691|P2|STARTED|Overall Study||123
429914|NCT00756314|1025692|P1|STARTED|Overall Study||123
429915|NCT00756093|1025706|P4|NOT COMPLETED|Fourth Intervention||0
429916|NCT00756093|1025707|P3|NOT COMPLETED|Fourth Intervention||0
429917|NCT00756093|1025708|P2|NOT COMPLETED|Fourth Intervention||0
429918|NCT00756093|1025709|P1|NOT COMPLETED|Fourth Intervention||0
429919|NCT00756093|1025706|P4|COMPLETED|Fourth Intervention||5
429920|NCT00756093|1025707|P3|COMPLETED|Fourth Intervention||5
429921|NCT00756093|1025708|P2|COMPLETED|Fourth Intervention||5
429922|NCT00756093|1025709|P1|COMPLETED|Fourth Intervention||5
429923|NCT00756093|1025706|P4|STARTED|Fourth Intervention||5
429924|NCT00756093|1025707|P3|STARTED|Fourth Intervention||5
429925|NCT00756093|1025708|P2|STARTED|Fourth Intervention||5
429926|NCT00756093|1025709|P1|STARTED|Fourth Intervention||5
429927|NCT00756093|1025706|P4|NOT COMPLETED|Third Intervention||0
429928|NCT00756093|1025707|P3|NOT COMPLETED|Third Intervention||0
429929|NCT00756093|1025708|P2|NOT COMPLETED|Third Intervention||0
429930|NCT00756093|1025709|P1|NOT COMPLETED|Third Intervention||0
429931|NCT00756093|1025706|P4|COMPLETED|Third Intervention||5
429932|NCT00756093|1025707|P3|COMPLETED|Third Intervention||5
429933|NCT00756093|1025708|P2|COMPLETED|Third Intervention||5
429934|NCT00756093|1025709|P1|COMPLETED|Third Intervention||5
429935|NCT00756093|1025706|P4|STARTED|Third Intervention||5
429936|NCT00756093|1025707|P3|STARTED|Third Intervention||5
429937|NCT00756093|1025708|P2|STARTED|Third Intervention||5
429938|NCT00756093|1025709|P1|STARTED|Third Intervention||5
429939|NCT00756093|1025706|P4|NOT COMPLETED|Second Intervention||0
429940|NCT00756093|1025707|P3|NOT COMPLETED|Second Intervention||0
429941|NCT00756093|1025708|P2|NOT COMPLETED|Second Intervention||0
429942|NCT00756093|1025709|P1|NOT COMPLETED|Second Intervention||0
429943|NCT00756093|1025706|P4|COMPLETED|Second Intervention||5
429944|NCT00756093|1025707|P3|COMPLETED|Second Intervention||5
429945|NCT00756093|1025708|P2|COMPLETED|Second Intervention||5
429946|NCT00756093|1025709|P1|COMPLETED|Second Intervention||5
429947|NCT00756093|1025706|P4|STARTED|Second Intervention||5
429948|NCT00756093|1025707|P3|STARTED|Second Intervention||5
429949|NCT00756093|1025708|P2|STARTED|Second Intervention||5
429950|NCT00756093|1025709|P1|STARTED|Second Intervention||5
429951|NCT00756093|1025706|P4|NOT COMPLETED|First Intervention||0
429952|NCT00756093|1025707|P3|NOT COMPLETED|First Intervention||0
429953|NCT00756093|1025708|P2|NOT COMPLETED|First Intervention||0
429954|NCT00756093|1025709|P1|NOT COMPLETED|First Intervention||0
429955|NCT00756093|1025706|P4|COMPLETED|First Intervention||5
429956|NCT00756093|1025707|P3|COMPLETED|First Intervention||5
429957|NCT00756093|1025708|P2|COMPLETED|First Intervention||5
429958|NCT00756093|1025709|P1|COMPLETED|First Intervention||5
429959|NCT00756093|1025706|P4|STARTED|First Intervention||5
429960|NCT00756093|1025707|P3|STARTED|First Intervention||5
429961|NCT00756093|1025708|P2|STARTED|First Intervention||5
429962|NCT00756093|1025709|P1|STARTED|First Intervention||5
429963|NCT00756002|1025721|P2|NOT COMPLETED|Placebo Run-out||0
429964|NCT00756002|1025722|P1|NOT COMPLETED|Placebo Run-out||0
429965|NCT00756002|1025721|P2|COMPLETED|Placebo Run-out||0
429966|NCT00756002|1025722|P1|COMPLETED|Placebo Run-out||114
429967|NCT00756002|1025721|P2|STARTED|Placebo Run-out||0
429968|NCT00756002|1025722|P1|STARTED|Placebo Run-out||114
429969|NCT00756002|1025721|P2|NOT COMPLETED|Double-Blind Treatment Period||15
429970|NCT00756002|1025722|P1|NOT COMPLETED|Double-Blind Treatment Period||15
429971|NCT00756002|1025721|P2|COMPLETED|Double-Blind Treatment Period||115
429972|NCT00756002|1025722|P1|COMPLETED|Double-Blind Treatment Period||114
429973|NCT00756002|1025721|P2|STARTED|Double-Blind Treatment Period||130
429974|NCT00756002|1025722|P1|STARTED|Double-Blind Treatment Period||129
429975|NCT00756002|1025721|P2|NOT COMPLETED|Placebo Run-in||0
429976|NCT00756002|1025722|P1|NOT COMPLETED|Placebo Run-in||229
429977|NCT00756002|1025721|P2|COMPLETED|Placebo Run-in||0
429978|NCT00756002|1025722|P1|COMPLETED|Placebo Run-in||259
429979|NCT00756002|1025721|P2|STARTED|Placebo Run-in||0
429980|NCT00756002|1025722|P1|STARTED|Placebo Run-in||488
429981|NCT00755937|1025816|P1|NOT COMPLETED|Observational Follow-up||148
429982|NCT00755937|1025816|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
429983|NCT00755937|1025816|P1|STARTED|Observational Follow-up||392
429984|NCT00755937|1025816|P1|NOT COMPLETED|Recruitment||164
429985|NCT00755937|1025816|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
429986|NCT00755937|1025816|P1|STARTED|Recruitment|Subjects registered in the program|556
429987|NCT00755911|1025828|P2|NOT COMPLETED|Overall Study||0
429988|NCT00755911|1025829|P1|NOT COMPLETED|Overall Study||0
429989|NCT00755911|1025828|P2|COMPLETED|Overall Study||12
429990|NCT00755911|1025829|P1|COMPLETED|Overall Study||12
429991|NCT00755911|1025828|P2|STARTED|Overall Study||12
429992|NCT00755911|1025829|P1|STARTED|Overall Study||12
429993|NCT00755846|1025843|P6|NOT COMPLETED|Overall Study||14
429994|NCT00755846|1025844|P5|NOT COMPLETED|Overall Study||17
429995|NCT00755846|1025845|P4|NOT COMPLETED|Overall Study||13
429996|NCT00755846|1025846|P3|NOT COMPLETED|Overall Study||12
429997|NCT00755846|1025847|P2|NOT COMPLETED|Overall Study||17
429998|NCT00755846|1025848|P1|NOT COMPLETED|Overall Study||25
429999|NCT00755846|1025843|P6|COMPLETED|Overall Study||31
430000|NCT00755846|1025844|P5|COMPLETED|Overall Study||27
430001|NCT00755846|1025845|P4|COMPLETED|Overall Study||32
430002|NCT00755846|1025846|P3|COMPLETED|Overall Study||32
430003|NCT00755846|1025847|P2|COMPLETED|Overall Study||27
430004|NCT00755846|1025848|P1|COMPLETED|Overall Study||18
430005|NCT00755846|1025843|P6|STARTED|Overall Study||45
430006|NCT00755846|1025844|P5|STARTED|Overall Study||44
430007|NCT00755846|1025845|P4|STARTED|Overall Study||45
430008|NCT00755846|1025846|P3|STARTED|Overall Study||44
430009|NCT00755846|1025847|P2|STARTED|Overall Study||44
430010|NCT00755846|1025848|P1|STARTED|Overall Study||43
430011|NCT00755807|1025948|P2|NOT COMPLETED|Open-label Extension Phase||16
430012|NCT00755807|1025949|P1|NOT COMPLETED|Open-label Extension Phase||18
430013|NCT00755807|1025948|P2|COMPLETED|Open-label Extension Phase||93
430014|NCT00755807|1025949|P1|COMPLETED|Open-label Extension Phase||82
430015|NCT00755807|1025948|P2|STARTED|Open-label Extension Phase||109
430016|NCT00755807|1025949|P1|STARTED|Open-label Extension Phase||100
430017|NCT00755807|1025948|P2|NOT COMPLETED|Acute Phase||12
430018|NCT00755807|1025949|P1|NOT COMPLETED|Acute Phase||18
430019|NCT00755807|1025948|P2|COMPLETED|Acute Phase||109
430020|NCT00755807|1025949|P1|COMPLETED|Acute Phase||100
430021|NCT00755807|1025948|P2|STARTED|Acute Phase||121
430022|NCT00755807|1025949|P1|STARTED|Acute Phase||118
430023|NCT00755755|1026013|P3|NOT COMPLETED|Overall Study||3
430024|NCT00755755|1026014|P2|NOT COMPLETED|Overall Study||8
430025|NCT00755755|1026015|P1|NOT COMPLETED|Overall Study||6
430026|NCT00755755|1026013|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
430027|NCT00755755|1026014|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
430028|NCT00755755|1026015|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
430029|NCT00755755|1026013|P3|STARTED|Overall Study|Safety population|48
430030|NCT00755755|1026014|P2|STARTED|Overall Study|Safety population|98
430031|NCT00755755|1026015|P1|STARTED|Overall Study|Safety population|95
430032|NCT00755417|1026029|P3|NOT COMPLETED|Overall Study||42
430033|NCT00755417|1026030|P2|NOT COMPLETED|Overall Study||55
430034|NCT00755417|1026031|P1|NOT COMPLETED|Overall Study||62
430035|NCT00755417|1026029|P3|COMPLETED|Overall Study||135
430036|NCT00755417|1026030|P2|COMPLETED|Overall Study||126
430037|NCT00755417|1026031|P1|COMPLETED|Overall Study||112
430038|NCT00755417|1026029|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
430039|NCT00755417|1026030|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
430040|NCT00755417|1026031|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
430041|NCT00755274|1026050|P2|NOT COMPLETED|Overall Study||0
430042|NCT00755274|1026051|P1|NOT COMPLETED|Overall Study||0
430043|NCT00755274|1026050|P2|COMPLETED|Overall Study||8
430044|NCT00755274|1026051|P1|COMPLETED|Overall Study||24
430045|NCT00755274|1026050|P2|STARTED|Overall Study||8
430046|NCT00755274|1026051|P1|STARTED|Overall Study||24
430047|NCT00755261|1026071|P1|NOT COMPLETED|Overall Study||2
430048|NCT00755261|1026071|P1|COMPLETED|Overall Study||4
430049|NCT00755261|1026071|P1|STARTED|Overall Study||6
430050|NCT00755235|1026077|P2|NOT COMPLETED|Overall Study||9
430051|NCT00755235|1026078|P1|NOT COMPLETED|Overall Study||2
430052|NCT00755235|1026077|P2|COMPLETED|Overall Study||93
430053|NCT00755235|1026078|P1|COMPLETED|Overall Study||104
430054|NCT00755235|1026077|P2|STARTED|Overall Study||102
430055|NCT00755235|1026078|P1|STARTED|Overall Study||106
430056|NCT00755222|1026088|P2|NOT COMPLETED|Overall Study||2
430057|NCT00755222|1026089|P1|NOT COMPLETED|Overall Study||8
430058|NCT00755222|1026088|P2|COMPLETED|Overall Study||34
430059|NCT00755222|1026089|P1|COMPLETED|Overall Study||103
430060|NCT00755222|1026088|P2|STARTED|Overall Study||36
430061|NCT00755222|1026089|P1|STARTED|Overall Study||111
430062|NCT00755196|1026103|P1|NOT COMPLETED|Overall Study||2
430063|NCT00755196|1026103|P1|COMPLETED|Overall Study||28
430064|NCT00755196|1026103|P1|STARTED|Overall Study||30
430065|NCT00755131|1026110|P2|NOT COMPLETED|Overall Study||0
430066|NCT00755131|1026111|P1|NOT COMPLETED|Overall Study||0
430067|NCT00755131|1026110|P2|COMPLETED|Overall Study||38
430068|NCT00755131|1026111|P1|COMPLETED|Overall Study||37
430069|NCT00755131|1026110|P2|STARTED|Overall Study||38
430070|NCT00755131|1026111|P1|STARTED|Overall Study||37
430071|NCT00755105|1026124|P3|NOT COMPLETED|Overall Study||4
430072|NCT00755105|1026125|P2|NOT COMPLETED|Overall Study||11
430074|NCT00755105|1026124|P3|COMPLETED|Overall Study||5
430075|NCT00755105|1026125|P2|COMPLETED|Overall Study||19
430076|NCT00755105|1026126|P1|COMPLETED|Overall Study||29
430077|NCT00755105|1026124|P3|STARTED|Overall Study||9
430078|NCT00755105|1026125|P2|STARTED|Overall Study||30
430079|NCT00755105|1026126|P1|STARTED|Overall Study||38
430080|NCT00755079|1026136|P2|NOT COMPLETED|Overall Study||6
430081|NCT00755079|1026137|P1|NOT COMPLETED|Overall Study||1
430082|NCT00755079|1026136|P2|COMPLETED|Overall Study||16
430083|NCT00755079|1026137|P1|COMPLETED|Overall Study||17
430084|NCT00755079|1026136|P2|STARTED|Overall Study||22
430085|NCT00755079|1026137|P1|STARTED|Overall Study||18
430086|NCT00755040|1026147|P2|NOT COMPLETED|Overall Study||34
430087|NCT00755040|1026148|P1|NOT COMPLETED|Overall Study||43
430088|NCT00755040|1026147|P2|COMPLETED|Overall Study||47
430089|NCT00755040|1026148|P1|COMPLETED|Overall Study||40
430090|NCT00755040|1026147|P2|STARTED|Overall Study||81
430091|NCT00755040|1026148|P1|STARTED|Overall Study||83
430092|NCT00754923|1026156|P1|NOT COMPLETED|Overall Study||0
430093|NCT00754923|1026156|P1|COMPLETED|Overall Study||11
430094|NCT00754923|1026156|P1|STARTED|Overall Study||11
430095|NCT00754832|1026161|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
430096|NCT00754832|1026162|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
430097|NCT00754832|1026161|P2|COMPLETED|Second 6 Weeks Intervention||24
430098|NCT00754832|1026162|P1|COMPLETED|Second 6 Weeks Intervention||17
430099|NCT00754832|1026161|P2|STARTED|Second 6 Weeks Intervention||26
430100|NCT00754832|1026162|P1|STARTED|Second 6 Weeks Intervention||17
430101|NCT00754832|1026161|P2|NOT COMPLETED|2 Weeks Washout||2
430102|NCT00754832|1026162|P1|NOT COMPLETED|2 Weeks Washout||1
430103|NCT00754832|1026161|P2|COMPLETED|2 Weeks Washout||26
430104|NCT00754832|1026162|P1|COMPLETED|2 Weeks Washout||17
430105|NCT00754832|1026161|P2|STARTED|2 Weeks Washout||28
430106|NCT00754832|1026162|P1|STARTED|2 Weeks Washout||18
430107|NCT00754832|1026161|P2|NOT COMPLETED|First 6 Weeks Intervention||2
430108|NCT00754832|1026162|P1|NOT COMPLETED|First 6 Weeks Intervention||8
430109|NCT00754832|1026161|P2|COMPLETED|First 6 Weeks Intervention||28
430110|NCT00754832|1026162|P1|COMPLETED|First 6 Weeks Intervention||18
430111|NCT00754832|1026161|P2|STARTED|First 6 Weeks Intervention||30
430112|NCT00754832|1026162|P1|STARTED|First 6 Weeks Intervention||26
430113|NCT00754793|1026174|P2|NOT COMPLETED|Overall Study||1
430114|NCT00754793|1026175|P1|NOT COMPLETED|Overall Study||0
430115|NCT00754793|1026174|P2|COMPLETED|Overall Study||1
430116|NCT00754793|1026175|P1|COMPLETED|Overall Study||1
430117|NCT00754793|1026174|P2|STARTED|Overall Study||2
430118|NCT00754793|1026175|P1|STARTED|Overall Study||1
430119|NCT00754767|1026183|P2|NOT COMPLETED|Overall Study||0
430120|NCT00754767|1026184|P1|NOT COMPLETED|Overall Study||0
430121|NCT00754767|1026183|P2|COMPLETED|Overall Study||0
430122|NCT00754767|1026184|P1|COMPLETED|Overall Study||2
430123|NCT00754767|1026183|P2|STARTED|Overall Study||0
430124|NCT00754767|1026184|P1|STARTED|Overall Study||2
430125|NCT00754741|1026193|P3|NOT COMPLETED|Overall Study||54
430126|NCT00754741|1026194|P2|NOT COMPLETED|Overall Study||69
430127|NCT00754741|1026195|P1|NOT COMPLETED|Overall Study||57
430128|NCT00754741|1026193|P3|COMPLETED|Overall Study||502
430129|NCT00754741|1026194|P2|COMPLETED|Overall Study||500
430130|NCT00754741|1026195|P1|COMPLETED|Overall Study||510
430131|NCT00754741|1026193|P3|STARTED|Overall Study||556
430132|NCT00754741|1026194|P2|STARTED|Overall Study||569
430133|NCT00754741|1026195|P1|STARTED|Overall Study||567
430134|NCT00754650|1026242|P1|NOT COMPLETED|Overall Study||2
430135|NCT00754650|1026242|P1|COMPLETED|Overall Study||0
430136|NCT00754650|1026242|P1|STARTED|Overall Study||2
430137|NCT00754624|1026247|P1|NOT COMPLETED|Overall Study||69
430138|NCT00754624|1026247|P1|COMPLETED|Overall Study||160
430139|NCT00754624|1026247|P1|STARTED|Overall Study||229
430140|NCT00754572|1026257|P1|NOT COMPLETED|Overall Study||71
430141|NCT00754572|1026257|P1|COMPLETED|Overall Study||347
430142|NCT00754572|1026257|P1|STARTED|Overall Study||418
430143|NCT00754559|1026284|P1|NOT COMPLETED|Overall Study||47
430144|NCT00754559|1026284|P1|COMPLETED|Overall Study||239
430145|NCT00754559|1026284|P1|STARTED|Overall Study||286
430146|NCT00754546|1026308|P1|NOT COMPLETED|Overall Study||0
430147|NCT00754546|1026308|P1|COMPLETED|Overall Study||20
430148|NCT00754546|1026308|P1|STARTED|Overall Study||20
430149|NCT00754494|1026325|P3|NOT COMPLETED|Overall Study||1
430150|NCT00754494|1026326|P2|NOT COMPLETED|Overall Study||0
430151|NCT00754494|1026327|P1|NOT COMPLETED|Overall Study||2
430152|NCT00754494|1026325|P3|COMPLETED|Overall Study||14
430153|NCT00754494|1026326|P2|COMPLETED|Overall Study||15
430154|NCT00754494|1026327|P1|COMPLETED|Overall Study||13
430155|NCT00754494|1026325|P3|STARTED|Overall Study||15
430156|NCT00754494|1026326|P2|STARTED|Overall Study||15
430157|NCT00754494|1026327|P1|STARTED|Overall Study||15
430158|NCT00754468|1026373|P2|NOT COMPLETED|Overall Study||0
430159|NCT00754468|1026374|P1|NOT COMPLETED|Overall Study||0
430160|NCT00754468|1026373|P2|COMPLETED|Overall Study||3
430161|NCT00754468|1026374|P1|COMPLETED|Overall Study||4
430162|NCT00754468|1026373|P2|STARTED|Overall Study||3
430163|NCT00754468|1026374|P1|STARTED|Overall Study||4
430164|NCT00754442|1026384|P2|NOT COMPLETED|Overall Study||3
430165|NCT00754442|1026385|P1|NOT COMPLETED|Overall Study||5
430166|NCT00754442|1026384|P2|COMPLETED|Overall Study||6
430167|NCT00754442|1026385|P1|COMPLETED|Overall Study||6
430168|NCT00754442|1026384|P2|STARTED|Overall Study|patients 9|9
430169|NCT00754442|1026385|P1|STARTED|Overall Study|controls 11|11
430170|NCT00754390|1026392|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
430171|NCT00754390|1026392|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
430172|NCT00754390|1026392|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
430173|NCT00754390|1026392|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
430174|NCT00754390|1026392|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
430175|NCT00754390|1026392|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
430176|NCT00754390|1026392|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
430177|NCT00754390|1026392|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
430178|NCT00754390|1026392|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
430179|NCT00754390|1026392|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
430180|NCT00754390|1026392|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
430181|NCT00754390|1026392|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
430182|NCT00754377|1026401|P2|NOT COMPLETED|Overall Study||0
430183|NCT00754377|1026402|P1|NOT COMPLETED|Overall Study||0
430184|NCT00754377|1026401|P2|COMPLETED|Overall Study||42
430185|NCT00754377|1026402|P1|COMPLETED|Overall Study||50
430186|NCT00754377|1026401|P2|STARTED|Overall Study||42
430187|NCT00754377|1026402|P1|STARTED|Overall Study||50
430188|NCT00754338|1026414|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
430189|NCT00754338|1026415|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
430190|NCT00754338|1026416|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
430191|NCT00754338|1026417|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
430192|NCT00754338|1026414|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
430193|NCT00754338|1026415|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
430194|NCT00754338|1026416|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
430195|NCT00754338|1026417|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
430196|NCT00754338|1026414|P4|STARTED|Second Intervention for Phase1&Phase2||19
430197|NCT00754338|1026415|P3|STARTED|Second Intervention for Phase1&Phase2||16
430198|NCT00754338|1026416|P2|STARTED|Second Intervention for Phase1&Phase2||18
430199|NCT00754338|1026417|P1|STARTED|Second Intervention for Phase1&Phase2||17
430200|NCT00754338|1026414|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
430201|NCT00754338|1026415|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
430202|NCT00754338|1026416|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
430203|NCT00754338|1026417|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
430204|NCT00754338|1026414|P4|COMPLETED|First Intervention for Phase1&Phase2||19
430205|NCT00754338|1026415|P3|COMPLETED|First Intervention for Phase1&Phase2||16
430206|NCT00754338|1026416|P2|COMPLETED|First Intervention for Phase1&Phase2||18
430207|NCT00754338|1026417|P1|COMPLETED|First Intervention for Phase1&Phase2||17
430208|NCT00754338|1026414|P4|STARTED|First Intervention for Phase1&Phase2||19
430209|NCT00754338|1026415|P3|STARTED|First Intervention for Phase1&Phase2||19
430210|NCT00754338|1026416|P2|STARTED|First Intervention for Phase1&Phase2||21
430211|NCT00754338|1026417|P1|STARTED|First Intervention for Phase1&Phase2||17
430212|NCT00754325|1026449|P2|NOT COMPLETED|Progression and Cross-over||21
430213|NCT00754325|1026450|P1|NOT COMPLETED|Progression and Cross-over||0
430214|NCT00754325|1026449|P2|COMPLETED|Progression and Cross-over||0
430215|NCT00754325|1026450|P1|COMPLETED|Progression and Cross-over||0
430216|NCT00754325|1026449|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
430217|NCT00754325|1026450|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
430218|NCT00754325|1026449|P2|NOT COMPLETED|Initial Treatment||49
430219|NCT00754325|1026450|P1|NOT COMPLETED|Initial Treatment||50
430220|NCT00754325|1026449|P2|COMPLETED|Initial Treatment||0
430221|NCT00754325|1026450|P1|COMPLETED|Initial Treatment||0
430222|NCT00754325|1026449|P2|STARTED|Initial Treatment||49
430223|NCT00754325|1026450|P1|STARTED|Initial Treatment||50
430224|NCT00754234|1026469|P1|NOT COMPLETED|Overall Study||3
430314|NCT00753922|1026817|P2|NOT COMPLETED|Overall Study||94
430225|NCT00754234|1026469|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
430226|NCT00754234|1026469|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
430227|NCT00754156|1026475|P2|NOT COMPLETED|Overall Study||0
430228|NCT00754156|1026476|P1|NOT COMPLETED|Overall Study||0
430229|NCT00754156|1026475|P2|COMPLETED|Overall Study||6
430230|NCT00754156|1026476|P1|COMPLETED|Overall Study||8
430231|NCT00754156|1026475|P2|STARTED|Overall Study||6
430232|NCT00754156|1026476|P1|STARTED|Overall Study||8
430233|NCT00754130|1026500|P6|NOT COMPLETED|Period 2 (5 Days)||0
430234|NCT00754130|1026501|P5|NOT COMPLETED|Period 2 (5 Days)||0
430235|NCT00754130|1026502|P4|NOT COMPLETED|Period 2 (5 Days)||0
430236|NCT00754130|1026503|P3|NOT COMPLETED|Period 2 (5 Days)||0
430237|NCT00754130|1026504|P2|NOT COMPLETED|Period 2 (5 Days)||0
430238|NCT00754130|1026505|P1|NOT COMPLETED|Period 2 (5 Days)||0
430239|NCT00754130|1026500|P6|COMPLETED|Period 2 (5 Days)||4
430240|NCT00754130|1026501|P5|COMPLETED|Period 2 (5 Days)||2
430241|NCT00754130|1026502|P4|COMPLETED|Period 2 (5 Days)||2
430242|NCT00754130|1026503|P3|COMPLETED|Period 2 (5 Days)||4
430243|NCT00754130|1026504|P2|COMPLETED|Period 2 (5 Days)||2
430244|NCT00754130|1026505|P1|COMPLETED|Period 2 (5 Days)||2
430245|NCT00754130|1026500|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
430246|NCT00754130|1026501|P5|STARTED|Period 2 (5 Days)||2
430247|NCT00754130|1026502|P4|STARTED|Period 2 (5 Days)||2
430248|NCT00754130|1026503|P3|STARTED|Period 2 (5 Days)||4
430249|NCT00754130|1026504|P2|STARTED|Period 2 (5 Days)||2
430250|NCT00754130|1026505|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
430251|NCT00754130|1026500|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
430252|NCT00754130|1026501|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
430253|NCT00754130|1026502|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
430254|NCT00754130|1026503|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
430255|NCT00754130|1026504|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
430256|NCT00754130|1026505|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
430257|NCT00754130|1026500|P6|COMPLETED|Washout Period (>=8 Days)||4
430258|NCT00754130|1026501|P5|COMPLETED|Washout Period (>=8 Days)||2
430259|NCT00754130|1026502|P4|COMPLETED|Washout Period (>=8 Days)||2
430260|NCT00754130|1026503|P3|COMPLETED|Washout Period (>=8 Days)||4
430261|NCT00754130|1026504|P2|COMPLETED|Washout Period (>=8 Days)||2
430262|NCT00754130|1026505|P1|COMPLETED|Washout Period (>=8 Days)||2
430263|NCT00754130|1026500|P6|STARTED|Washout Period (>=8 Days)||4
430264|NCT00754130|1026501|P5|STARTED|Washout Period (>=8 Days)||2
430265|NCT00754130|1026502|P4|STARTED|Washout Period (>=8 Days)||2
430266|NCT00754130|1026503|P3|STARTED|Washout Period (>=8 Days)||4
430267|NCT00754130|1026504|P2|STARTED|Washout Period (>=8 Days)||2
430268|NCT00754130|1026505|P1|STARTED|Washout Period (>=8 Days)||2
430269|NCT00754130|1026500|P6|NOT COMPLETED|Period 1 (5 Days)||0
430270|NCT00754130|1026501|P5|NOT COMPLETED|Period 1 (5 Days)||0
430271|NCT00754130|1026502|P4|NOT COMPLETED|Period 1 (5 Days)||0
430272|NCT00754130|1026503|P3|NOT COMPLETED|Period 1 (5 Days)||0
430273|NCT00754130|1026504|P2|NOT COMPLETED|Period 1 (5 Days)||0
430274|NCT00754130|1026505|P1|NOT COMPLETED|Period 1 (5 Days)||0
430275|NCT00754130|1026500|P6|COMPLETED|Period 1 (5 Days)||4
430276|NCT00754130|1026501|P5|COMPLETED|Period 1 (5 Days)||2
430277|NCT00754130|1026502|P4|COMPLETED|Period 1 (5 Days)||2
430278|NCT00754130|1026503|P3|COMPLETED|Period 1 (5 Days)||4
430279|NCT00754130|1026504|P2|COMPLETED|Period 1 (5 Days)||2
430280|NCT00754130|1026505|P1|COMPLETED|Period 1 (5 Days)||2
430281|NCT00754130|1026500|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
430282|NCT00754130|1026501|P5|STARTED|Period 1 (5 Days)||2
430283|NCT00754130|1026502|P4|STARTED|Period 1 (5 Days)||2
430284|NCT00754130|1026503|P3|STARTED|Period 1 (5 Days)||4
430285|NCT00754130|1026504|P2|STARTED|Period 1 (5 Days)||2
430286|NCT00754130|1026505|P1|STARTED|Period 1 (5 Days)||2
430287|NCT00754065|1026548|P2|NOT COMPLETED|Overall Study||80
430288|NCT00754065|1026549|P1|NOT COMPLETED|Overall Study||81
430289|NCT00754065|1026548|P2|COMPLETED|Overall Study||126
430290|NCT00754065|1026549|P1|COMPLETED|Overall Study||122
430291|NCT00754065|1026548|P2|Cycle 6|Overall Study||153
430292|NCT00754065|1026549|P1|Cycle 6|Overall Study||141
430293|NCT00754065|1026548|P2|Participants Received Treatment|Overall Study||204
430294|NCT00754065|1026549|P1|Participants Received Treatment|Overall Study||191
430295|NCT00754065|1026548|P2|STARTED|Overall Study||206
430296|NCT00754065|1026549|P1|STARTED|Overall Study||203
430297|NCT00754013|1026789|P2|NOT COMPLETED|Overall Study||5
430298|NCT00754013|1026790|P1|NOT COMPLETED|Overall Study||4
430299|NCT00754013|1026789|P2|COMPLETED|Overall Study||0
430300|NCT00754013|1026790|P1|COMPLETED|Overall Study||0
430301|NCT00754013|1026789|P2|STARTED|Overall Study||5
430302|NCT00754013|1026790|P1|STARTED|Overall Study||4
430303|NCT00753948|1026801|P3|NOT COMPLETED|Overall Study||0
430304|NCT00753948|1026802|P2|NOT COMPLETED|Overall Study||0
430305|NCT00753948|1026803|P1|NOT COMPLETED|Overall Study||0
430306|NCT00753948|1026801|P3|COMPLETED|Overall Study||7
430307|NCT00753948|1026802|P2|COMPLETED|Overall Study||7
430308|NCT00753948|1026803|P1|COMPLETED|Overall Study||9
430309|NCT00753948|1026801|P3|STARTED|Overall Study||7
430310|NCT00753948|1026802|P2|STARTED|Overall Study||7
430311|NCT00753948|1026803|P1|STARTED|Overall Study||9
430312|NCT00753922|1026815|P4|NOT COMPLETED|Overall Study||23
430313|NCT00753922|1026816|P3|NOT COMPLETED|Overall Study||63
430315|NCT00753922|1026818|P1|NOT COMPLETED|Overall Study||246
430316|NCT00753922|1026815|P4|COMPLETED|Overall Study||37
430317|NCT00753922|1026816|P3|COMPLETED|Overall Study||82
430318|NCT00753922|1026817|P2|COMPLETED|Overall Study||157
430319|NCT00753922|1026818|P1|COMPLETED|Overall Study||306
430320|NCT00753922|1026815|P4|STARTED|Overall Study||60
430321|NCT00753922|1026816|P3|STARTED|Overall Study||145
430322|NCT00753922|1026817|P2|STARTED|Overall Study||251
430323|NCT00753922|1026818|P1|STARTED|Overall Study||552
430324|NCT00753896|1026848|P1|NOT COMPLETED|Overall Study||16
430325|NCT00753896|1026848|P1|COMPLETED|Overall Study||118
430326|NCT00753896|1026848|P1|STARTED|Overall Study||134
430327|NCT00753766|1026864|P2|NOT COMPLETED|Overall Study||0
430328|NCT00753766|1026865|P1|NOT COMPLETED|Overall Study||1
430329|NCT00753766|1026864|P2|COMPLETED|Overall Study||0
430330|NCT00753766|1026865|P1|COMPLETED|Overall Study||0
430331|NCT00753766|1026864|P2|STARTED|Overall Study||0
430332|NCT00753766|1026865|P1|STARTED|Overall Study||1
430333|NCT00753714|1026875|P2|NOT COMPLETED|Overall Study||62
430334|NCT00753714|1026876|P1|NOT COMPLETED|Overall Study||60
430335|NCT00753714|1026875|P2|COMPLETED|Overall Study||1
430336|NCT00753714|1026876|P1|COMPLETED|Overall Study||1
430337|NCT00753714|1026875|P2|STARTED|Overall Study||63
430338|NCT00753714|1026876|P1|STARTED|Overall Study||61
430339|NCT00753688|1026892|P2|NOT COMPLETED|Overall Study||246
430340|NCT00753688|1026893|P1|NOT COMPLETED|Overall Study||123
430341|NCT00753688|1026892|P2|COMPLETED|Overall Study||0
430342|NCT00753688|1026893|P1|COMPLETED|Overall Study||0
430343|NCT00753688|1026892|P2|Ongoing - in Follow-up|Overall Study||31
430344|NCT00753688|1026893|P1|Ongoing - in Follow-up|Overall Study||15
430345|NCT00753688|1026892|P2|STARTED|Overall Study||246
430346|NCT00753688|1026893|P1|STARTED|Overall Study||123
430347|NCT00753675|1026922|P3|NOT COMPLETED|Overall Study||56
430348|NCT00753675|1026923|P2|NOT COMPLETED|Overall Study||59
430349|NCT00753675|1026924|P1|NOT COMPLETED|Overall Study||59
430350|NCT00753675|1026922|P3|COMPLETED|Overall Study||0
430351|NCT00753675|1026923|P2|COMPLETED|Overall Study||0
430352|NCT00753675|1026924|P1|COMPLETED|Overall Study||0
430353|NCT00753675|1026922|P3|STARTED|Overall Study||56
430354|NCT00753675|1026923|P2|STARTED|Overall Study||59
430355|NCT00753675|1026924|P1|STARTED|Overall Study||59
430356|NCT00753649|1026946|P2|NOT COMPLETED|Overall Study||0
430357|NCT00753649|1026947|P1|NOT COMPLETED|Overall Study||7
430358|NCT00753649|1026946|P2|COMPLETED|Overall Study||112
430359|NCT00753649|1026947|P1|COMPLETED|Overall Study||105
430360|NCT00753649|1026946|P2|STARTED|Overall Study||112
430361|NCT00753649|1026947|P1|STARTED|Overall Study||112
430362|NCT00753636|1026967|P1|NOT COMPLETED|Overall Study||6
430363|NCT00753636|1026967|P1|COMPLETED|Overall Study||25
430364|NCT00753636|1026967|P1|STARTED|Overall Study||31
430365|NCT00753623|1026979|P2|NOT COMPLETED|Phase II (14 Days)||1
430366|NCT00753623|1026980|P1|NOT COMPLETED|Phase II (14 Days)||0
430367|NCT00753623|1026979|P2|COMPLETED|Phase II (14 Days)||7
430368|NCT00753623|1026980|P1|COMPLETED|Phase II (14 Days)||8
430369|NCT00753623|1026979|P2|STARTED|Phase II (14 Days)||8
430370|NCT00753623|1026980|P1|STARTED|Phase II (14 Days)||8
430371|NCT00753623|1026979|P2|NOT COMPLETED|Washout (7 Days)||0
430372|NCT00753623|1026980|P1|NOT COMPLETED|Washout (7 Days)||1
430373|NCT00753623|1026979|P2|COMPLETED|Washout (7 Days)||8
430374|NCT00753623|1026980|P1|COMPLETED|Washout (7 Days)||8
430375|NCT00753623|1026979|P2|STARTED|Washout (7 Days)||8
430376|NCT00753623|1026980|P1|STARTED|Washout (7 Days)||9
430377|NCT00753623|1026979|P2|NOT COMPLETED|Phase I (14 Days)||4
430378|NCT00753623|1026980|P1|NOT COMPLETED|Phase I (14 Days)||2
430379|NCT00753623|1026979|P2|COMPLETED|Phase I (14 Days)||8
430380|NCT00753623|1026980|P1|COMPLETED|Phase I (14 Days)||9
430381|NCT00753623|1026979|P2|STARTED|Phase I (14 Days)||12
430382|NCT00753623|1026980|P1|STARTED|Phase I (14 Days)||11
430383|NCT00753545|1026988|P2|NOT COMPLETED|Overall Study||108
430384|NCT00753545|1026989|P1|NOT COMPLETED|Overall Study||68
430385|NCT00753545|1026988|P2|COMPLETED|Overall Study|Ongoing study treatment at time of data cut-off|21
430386|NCT00753545|1026989|P1|COMPLETED|Overall Study|Ongoing study treatment at time of data cut-off|68
430387|NCT00753545|1026988|P2|STARTED|Overall Study|Patients randomized|129
430388|NCT00753545|1026989|P1|STARTED|Overall Study|Patients randomized|136
430389|NCT00753519|1027027|P2|NOT COMPLETED|Overall Study||2
430390|NCT00753519|1027028|P1|NOT COMPLETED|Overall Study||0
430391|NCT00753519|1027027|P2|COMPLETED|Overall Study||13
430392|NCT00753519|1027028|P1|COMPLETED|Overall Study||13
430393|NCT00753519|1027027|P2|STARTED|Overall Study||15
430394|NCT00753519|1027028|P1|STARTED|Overall Study||13
430395|NCT00753506|1027050|P2|NOT COMPLETED|Overall Study||2
430396|NCT00753506|1027051|P1|NOT COMPLETED|Overall Study||7
430397|NCT00753506|1027050|P2|COMPLETED|Overall Study||31
430398|NCT00753506|1027051|P1|COMPLETED|Overall Study||26
430399|NCT00753506|1027050|P2|STARTED|Overall Study||33
430400|NCT00753506|1027051|P1|STARTED|Overall Study||33
430401|NCT00753454|1027057|P1|NOT COMPLETED|Overall Study||14
430402|NCT00753454|1027057|P1|COMPLETED|Overall Study||154
430403|NCT00753454|1027057|P1|STARTED|Overall Study||168
430404|NCT00753415|1027091|P10|NOT COMPLETED|Part B||1
430405|NCT00753415|1027092|P9|NOT COMPLETED|Part B||3
430406|NCT00753415|1027093|P8|NOT COMPLETED|Part B||1
430407|NCT00753415|1027094|P7|NOT COMPLETED|Part B||0
430408|NCT00753415|1027095|P6|NOT COMPLETED|Part B||0
430409|NCT00753415|1027096|P5|NOT COMPLETED|Part B||0
430410|NCT00753415|1027097|P4|NOT COMPLETED|Part B||0
430411|NCT00753415|1027098|P3|NOT COMPLETED|Part B||0
430412|NCT00753415|1027099|P2|NOT COMPLETED|Part B||0
430413|NCT00753415|1027100|P1|NOT COMPLETED|Part B||0
430414|NCT00753415|1027091|P10|COMPLETED|Part B||8
430415|NCT00753415|1027092|P9|COMPLETED|Part B||6
430416|NCT00753415|1027093|P8|COMPLETED|Part B||6
430417|NCT00753415|1027094|P7|COMPLETED|Part B||2
430418|NCT00753415|1027095|P6|COMPLETED|Part B||1
430419|NCT00753415|1027096|P5|COMPLETED|Part B||0
430420|NCT00753415|1027097|P4|COMPLETED|Part B||0
430421|NCT00753415|1027098|P3|COMPLETED|Part B||0
430422|NCT00753415|1027099|P2|COMPLETED|Part B||0
430423|NCT00753415|1027100|P1|COMPLETED|Part B||0
430424|NCT00753415|1027091|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
430425|NCT00753415|1027092|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
430426|NCT00753415|1027093|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
430427|NCT00753415|1027094|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
430428|NCT00753415|1027095|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
430429|NCT00753415|1027096|P5|STARTED|Part B||0
430430|NCT00753415|1027097|P4|STARTED|Part B||0
430431|NCT00753415|1027098|P3|STARTED|Part B||0
430432|NCT00753415|1027099|P2|STARTED|Part B||0
430433|NCT00753415|1027100|P1|STARTED|Part B||0
430434|NCT00753415|1027091|P10|NOT COMPLETED|Part A||0
430435|NCT00753415|1027092|P9|NOT COMPLETED|Part A||0
430436|NCT00753415|1027093|P8|NOT COMPLETED|Part A||0
430437|NCT00753415|1027094|P7|NOT COMPLETED|Part A||0
430438|NCT00753415|1027095|P6|NOT COMPLETED|Part A||0
430439|NCT00753415|1027096|P5|NOT COMPLETED|Part A||0
430440|NCT00753415|1027097|P4|NOT COMPLETED|Part A||2
430441|NCT00753415|1027098|P3|NOT COMPLETED|Part A||2
430442|NCT00753415|1027099|P2|NOT COMPLETED|Part A||0
430443|NCT00753415|1027100|P1|NOT COMPLETED|Part A||1
430444|NCT00753415|1027091|P10|COMPLETED|Part A||0
430445|NCT00753415|1027092|P9|COMPLETED|Part A||0
430446|NCT00753415|1027093|P8|COMPLETED|Part A||0
430447|NCT00753415|1027094|P7|COMPLETED|Part A||0
430448|NCT00753415|1027095|P6|COMPLETED|Part A||0
430449|NCT00753415|1027096|P5|COMPLETED|Part A||10
430450|NCT00753415|1027097|P4|COMPLETED|Part A||9
430451|NCT00753415|1027098|P3|COMPLETED|Part A||8
430452|NCT00753415|1027099|P2|COMPLETED|Part A||3
430453|NCT00753415|1027100|P1|COMPLETED|Part A||2
430454|NCT00753415|1027091|P10|STARTED|Part A||0
430455|NCT00753415|1027092|P9|STARTED|Part A||0
430456|NCT00753415|1027093|P8|STARTED|Part A||0
430457|NCT00753415|1027094|P7|STARTED|Part A||0
430458|NCT00753415|1027095|P6|STARTED|Part A||0
430459|NCT00753415|1027096|P5|STARTED|Part A||10
430460|NCT00753415|1027097|P4|STARTED|Part A||11
430461|NCT00753415|1027098|P3|STARTED|Part A||10
430462|NCT00753415|1027099|P2|STARTED|Part A||3
430463|NCT00753415|1027100|P1|STARTED|Part A||3
430464|NCT00753363|1027144|P2|NOT COMPLETED|Overall Study||39
430465|NCT00753363|1027145|P1|NOT COMPLETED|Overall Study||40
430466|NCT00753363|1027144|P2|COMPLETED|Overall Study||21
430467|NCT00753363|1027145|P1|COMPLETED|Overall Study||19
430468|NCT00753363|1027144|P2|STARTED|Overall Study||60
430469|NCT00753363|1027145|P1|STARTED|Overall Study||59
430470|NCT00753337|1027155|P1|NOT COMPLETED|Overall Study||0
430471|NCT00753337|1027155|P1|COMPLETED|Overall Study||123
430472|NCT00753337|1027155|P1|STARTED|Overall Study||123
430473|NCT00753298|1027171|P2|NOT COMPLETED|Overall Study||4
430474|NCT00753298|1027172|P1|NOT COMPLETED|Overall Study||8
430475|NCT00753298|1027171|P2|COMPLETED|Overall Study||94
430476|NCT00753298|1027172|P1|COMPLETED|Overall Study||89
430477|NCT00753298|1027171|P2|STARTED|Overall Study||98
430478|NCT00753298|1027172|P1|STARTED|Overall Study||97
430479|NCT00753272|1027190|P2|NOT COMPLETED|Overall Study||4907
430480|NCT00753272|1027191|P1|NOT COMPLETED|Overall Study||4982
430481|NCT00753272|1027190|P2|COMPLETED|Overall Study||16895
430482|NCT00753272|1027191|P1|COMPLETED|Overall Study||16911
430483|NCT00753272|1027190|P2|STARTED|Overall Study||21802
430484|NCT00753272|1027191|P1|STARTED|Overall Study||21893
430485|NCT00753220|1027257|P1|NOT COMPLETED|Overall Study||5
430486|NCT00753220|1027257|P1|COMPLETED|Overall Study||2
430487|NCT00753220|1027257|P1|STARTED|Overall Study||7
430488|NCT00753142|1027264|P3|NOT COMPLETED|Overall Study||0
430489|NCT00753142|1027265|P2|NOT COMPLETED|Overall Study||0
430490|NCT00753142|1027266|P1|NOT COMPLETED|Overall Study||0
430491|NCT00753142|1027264|P3|COMPLETED|Overall Study||13
430492|NCT00753142|1027265|P2|COMPLETED|Overall Study||7
430493|NCT00753142|1027266|P1|COMPLETED|Overall Study||8
430494|NCT00753142|1027264|P3|STARTED|Overall Study||13
430495|NCT00753142|1027265|P2|STARTED|Overall Study||7
430496|NCT00753142|1027266|P1|STARTED|Overall Study||8
430497|NCT00753012|1027276|P2|NOT COMPLETED|Overall Study||1
430498|NCT00753012|1027277|P1|NOT COMPLETED|Overall Study||8
430499|NCT00753012|1027276|P2|COMPLETED|Overall Study||8
430500|NCT00753012|1027277|P1|COMPLETED|Overall Study||7
430501|NCT00753012|1027276|P2|STARTED|Overall Study||9
430502|NCT00753012|1027277|P1|STARTED|Overall Study||15
430503|NCT00752986|1027290|P3|NOT COMPLETED|Overall Study||2
430504|NCT00752986|1027291|P2|NOT COMPLETED|Overall Study||1
430505|NCT00752986|1027292|P1|NOT COMPLETED|Overall Study||5
430506|NCT00752986|1027290|P3|COMPLETED|Overall Study||9
430507|NCT00752986|1027291|P2|COMPLETED|Overall Study||11
430508|NCT00752986|1027292|P1|COMPLETED|Overall Study||11
430509|NCT00752986|1027290|P3|STARTED|Overall Study||11
430510|NCT00752986|1027291|P2|STARTED|Overall Study||12
430511|NCT00752986|1027292|P1|STARTED|Overall Study||16
430512|NCT00752973|1027309|P1|NOT COMPLETED|Overall Study||0
430513|NCT00752973|1027309|P1|COMPLETED|Overall Study||12
430514|NCT00752973|1027309|P1|STARTED|Overall Study||12
430515|NCT00752895|1027321|P2|NOT COMPLETED|Overall Study||3
430516|NCT00752895|1027322|P1|NOT COMPLETED|Overall Study||8
430517|NCT00752895|1027321|P2|COMPLETED|Overall Study||143
430518|NCT00752895|1027322|P1|COMPLETED|Overall Study||139
430519|NCT00752895|1027321|P2|STARTED|Overall Study||146
430520|NCT00752895|1027322|P1|STARTED|Overall Study||147
430521|NCT00752791|1027330|P1|NOT COMPLETED|Overall Study||16
430522|NCT00752791|1027330|P1|COMPLETED|Overall Study||43
430523|NCT00752791|1027330|P1|STARTED|Overall Study||59
430524|NCT00752726|1027342|P2|NOT COMPLETED|Overall Study||13
430525|NCT00752726|1027343|P1|NOT COMPLETED|Overall Study||11
430526|NCT00752726|1027342|P2|COMPLETED|Overall Study||53
430527|NCT00752726|1027343|P1|COMPLETED|Overall Study||54
430528|NCT00752726|1027342|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
430529|NCT00752726|1027343|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
430530|NCT00752726|1027342|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
430531|NCT00752726|1027343|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
430532|NCT00752726|1027342|P2|STARTED|Overall Study||66
430533|NCT00752726|1027343|P1|STARTED|Overall Study||65
430534|NCT00752622|1027368|P1|NOT COMPLETED|Interventional Phase||8
430535|NCT00752622|1027368|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
430536|NCT00752622|1027368|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
430537|NCT00752622|1027368|P1|NOT COMPLETED|Observational Phase||43
430538|NCT00752622|1027368|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
430539|NCT00752622|1027368|P1|STARTED|Observational Phase||65
430540|NCT00752622|1027368|P1|NOT COMPLETED|Induction Phase||35
430541|NCT00752622|1027368|P1|COMPLETED|Induction Phase||65
430542|NCT00752622|1027368|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
430543|NCT00752609|1027381|P2|NOT COMPLETED|Overall Study||2
430544|NCT00752609|1027382|P1|NOT COMPLETED|Overall Study||9
430545|NCT00752609|1027381|P2|COMPLETED|Overall Study||47
430546|NCT00752609|1027382|P1|COMPLETED|Overall Study||44
430547|NCT00752609|1027381|P2|Full Analysis Set|Overall Study||49
430548|NCT00752609|1027382|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
430549|NCT00752609|1027381|P2|STARTED|Overall Study||49
430550|NCT00752609|1027382|P1|STARTED|Overall Study||53
430551|NCT00752232|1027408|P7|NOT COMPLETED|Overall Study||0
430552|NCT00752232|1027409|P6|NOT COMPLETED|Overall Study||1
430553|NCT00752232|1027410|P5|NOT COMPLETED|Overall Study||3
430554|NCT00752232|1027411|P4|NOT COMPLETED|Overall Study||1
430555|NCT00752232|1027412|P3|NOT COMPLETED|Overall Study||1
430556|NCT00752232|1027413|P2|NOT COMPLETED|Overall Study||0
430557|NCT00752232|1027414|P1|NOT COMPLETED|Overall Study||2
430558|NCT00752232|1027408|P7|COMPLETED|Overall Study||4
430559|NCT00752232|1027409|P6|COMPLETED|Overall Study||5
430560|NCT00752232|1027410|P5|COMPLETED|Overall Study||3
430561|NCT00752232|1027411|P4|COMPLETED|Overall Study||5
430562|NCT00752232|1027412|P3|COMPLETED|Overall Study||5
430563|NCT00752232|1027413|P2|COMPLETED|Overall Study||6
430564|NCT00752232|1027414|P1|COMPLETED|Overall Study||4
430565|NCT00752232|1027408|P7|STARTED|Overall Study||4
430566|NCT00752232|1027409|P6|STARTED|Overall Study||6
430567|NCT00752232|1027410|P5|STARTED|Overall Study||6
430568|NCT00752232|1027411|P4|STARTED|Overall Study||6
430569|NCT00752232|1027412|P3|STARTED|Overall Study||6
430570|NCT00752232|1027413|P2|STARTED|Overall Study||6
430571|NCT00752232|1027414|P1|STARTED|Overall Study||6
430572|NCT00752128|1027486|P1|NOT COMPLETED|Overall Study||4
430573|NCT00752128|1027486|P1|COMPLETED|Overall Study||2345
430574|NCT00752128|1027486|P1|STARTED|Overall Study||2349
430575|NCT00752089|1027491|P1|NOT COMPLETED|Overall Study||6
430576|NCT00752089|1027491|P1|COMPLETED|Overall Study||14
430577|NCT00752089|1027491|P1|Received Placebo|Overall Study||18
430578|NCT00752089|1027491|P1|Received NaF|Overall Study||18
430579|NCT00752089|1027491|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
430580|NCT00752089|1027491|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
430581|NCT00752089|1027491|P1|STARTED|Overall Study||20
430582|NCT00751998|1027505|P1|NOT COMPLETED|Overall Study||20
430583|NCT00751998|1027505|P1|COMPLETED|Overall Study||277
430584|NCT00751998|1027505|P1|STARTED|Overall Study||297
430585|NCT00751972|1027511|P2|NOT COMPLETED|Overall Study||0
430586|NCT00751972|1027512|P1|NOT COMPLETED|Overall Study||0
430587|NCT00751972|1027511|P2|COMPLETED|Overall Study||499
430588|NCT00751972|1027512|P1|COMPLETED|Overall Study||140
430589|NCT00751972|1027511|P2|STARTED|Overall Study||499
430590|NCT00751972|1027512|P1|STARTED|Overall Study||140
430591|NCT00751933|1027524|P4|NOT COMPLETED|Overall Study||1
430592|NCT00751933|1027525|P3|NOT COMPLETED|Overall Study||1
430593|NCT00751933|1027526|P2|NOT COMPLETED|Overall Study||1
430594|NCT00751933|1027527|P1|NOT COMPLETED|Overall Study||0
430595|NCT00751933|1027524|P4|COMPLETED|Overall Study||0
430596|NCT00751933|1027525|P3|COMPLETED|Overall Study||0
430597|NCT00751933|1027526|P2|COMPLETED|Overall Study||0
430598|NCT00751933|1027527|P1|COMPLETED|Overall Study||0
430599|NCT00751933|1027524|P4|STARTED|Overall Study||1
430600|NCT00751933|1027525|P3|STARTED|Overall Study||1
430601|NCT00751933|1027526|P2|STARTED|Overall Study||1
430602|NCT00751933|1027527|P1|STARTED|Overall Study||0
430603|NCT00751881|1027535|P3|NOT COMPLETED|Extension Study Period||66
430604|NCT00751881|1027536|P2|NOT COMPLETED|Extension Study Period||71
430605|NCT00751881|1027537|P1|NOT COMPLETED|Extension Study Period||65
430606|NCT00751881|1027535|P3|COMPLETED|Extension Study Period||167
430607|NCT00751881|1027536|P2|COMPLETED|Extension Study Period||194
430608|NCT00751881|1027537|P1|COMPLETED|Extension Study Period||188
430609|NCT00751881|1027535|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
430610|NCT00751881|1027536|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
430611|NCT00751881|1027537|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
430612|NCT00751881|1027535|P3|NOT COMPLETED|Core Treatment Period||128
430613|NCT00751881|1027536|P2|NOT COMPLETED|Core Treatment Period||135
430614|NCT00751881|1027537|P1|NOT COMPLETED|Core Treatment Period||126
430615|NCT00751881|1027535|P3|COMPLETED|Core Treatment Period||244
430616|NCT00751881|1027536|P2|COMPLETED|Core Treatment Period||273
430617|NCT00751881|1027537|P1|COMPLETED|Core Treatment Period||263
430618|NCT00751881|1027535|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
430619|NCT00751881|1027536|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
430620|NCT00751881|1027537|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
430621|NCT00751881|1027535|P3|STARTED|Core Treatment Period|Randomized|372
430622|NCT00751881|1027536|P2|STARTED|Core Treatment Period|Randomized|408
430623|NCT00751881|1027537|P1|STARTED|Core Treatment Period|Randomized|389
430624|NCT00751790|1027584|P1|NOT COMPLETED|Overall Study||5
430625|NCT00751790|1027584|P1|COMPLETED|Overall Study||115
430626|NCT00751790|1027584|P1|STARTED|Overall Study||120
430627|NCT00751777|1027590|P2|NOT COMPLETED|Overall Study||3
430628|NCT00751777|1027591|P1|NOT COMPLETED|Overall Study||11
430629|NCT00751777|1027590|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
430630|NCT00751777|1027591|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
430631|NCT00751777|1027590|P2|STARTED|Overall Study||39
430632|NCT00751777|1027591|P1|STARTED|Overall Study||81
430633|NCT00751634|1027601|P1|NOT COMPLETED|Overall Study||0
430634|NCT00751634|1027601|P1|COMPLETED|Overall Study||20
430635|NCT00751634|1027601|P1|STARTED|Overall Study||20
430636|NCT00751621|1027609|P1|NOT COMPLETED|Overall Study||4
430637|NCT00751621|1027609|P1|COMPLETED|Overall Study||36
430638|NCT00751621|1027609|P1|STARTED|Overall Study||40
430639|NCT00751530|1027628|P2|NOT COMPLETED|Overall Study||0
430640|NCT00751530|1027629|P1|NOT COMPLETED|Overall Study||0
430641|NCT00751530|1027628|P2|COMPLETED|Overall Study||110
430642|NCT00751530|1027629|P1|COMPLETED|Overall Study||332
430643|NCT00751530|1027628|P2|STARTED|Overall Study||110
430644|NCT00751530|1027629|P1|STARTED|Overall Study||332
430645|NCT00751400|1027643|P1|NOT COMPLETED|Overall Study||10
430646|NCT00751400|1027643|P1|COMPLETED|Overall Study||487
430647|NCT00751400|1027643|P1|Subjects Provided Detailed Use Data|Overall Study||467
430648|NCT00751400|1027643|P1|Subjects Consumed Drug|Overall Study||485
430649|NCT00751400|1027643|P1|Subjects Provided Drug|Overall Study||497
430650|NCT00751400|1027643|P1|STARTED|Overall Study||497
430651|NCT00751348|1027658|P2|NOT COMPLETED|Overall Study||2
430652|NCT00751348|1027659|P1|NOT COMPLETED|Overall Study||6
430653|NCT00751348|1027658|P2|COMPLETED|Overall Study||159
430654|NCT00751348|1027659|P1|COMPLETED|Overall Study||307
430655|NCT00751348|1027658|P2|STARTED|Overall Study||161
430656|NCT00751348|1027659|P1|STARTED|Overall Study||313
430657|NCT00751296|1027681|P1|NOT COMPLETED|Overall Study||2
430658|NCT00751296|1027681|P1|COMPLETED|Overall Study||25
430659|NCT00751296|1027681|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
430660|NCT00751179|1027688|P2|NOT COMPLETED|Overall Study||15
430661|NCT00751179|1027689|P1|NOT COMPLETED|Overall Study||14
430662|NCT00751179|1027688|P2|COMPLETED|Overall Study||70
430663|NCT00751179|1027689|P1|COMPLETED|Overall Study||62
430664|NCT00751179|1027688|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
430665|NCT00751179|1027689|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
430666|NCT00751140|1027709|P1|NOT COMPLETED|Overall Study||1
430667|NCT00751140|1027709|P1|COMPLETED|Overall Study||19
430668|NCT00751140|1027709|P1|STARTED|Overall Study||20
430669|NCT00751114|1027719|P2|NOT COMPLETED|Overall Study||32
430670|NCT00751114|1027720|P1|NOT COMPLETED|Overall Study||38
430671|NCT00751114|1027719|P2|COMPLETED|Overall Study||233
430672|NCT00751114|1027720|P1|COMPLETED|Overall Study||212
430673|NCT00751114|1027719|P2|mITT Population|Overall Study||253
430674|NCT00751114|1027720|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
430675|NCT00751114|1027719|P2|TREATED = Safety Population|Overall Study||264
430676|NCT00751114|1027720|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
430677|NCT00751114|1027719|P2|STARTED|Overall Study||265
430678|NCT00751114|1027720|P1|STARTED|Overall Study|randomized|250
430679|NCT00751036|1027745|P2|NOT COMPLETED|Overall Study||46
430680|NCT00751036|1027746|P1|NOT COMPLETED|Overall Study||48
430681|NCT00751036|1027745|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
430682|NCT00751036|1027746|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
430683|NCT00751036|1027745|P2|STARTED|Overall Study|Started = Treated|46
430684|NCT00751036|1027746|P1|STARTED|Overall Study|Started = Treated|48
430685|NCT00750919|1027758|P1|NOT COMPLETED|Overall Study||58
430686|NCT00750919|1027758|P1|COMPLETED|Overall Study||126
430687|NCT00750919|1027758|P1|STARTED|Overall Study||184
430688|NCT00750893|1027766|P1|NOT COMPLETED|Overall Study||542
430689|NCT00750893|1027766|P1|COMPLETED|Overall Study||2569
430690|NCT00750893|1027766|P1|STARTED|Overall Study||3111
430691|NCT00750880|1027781|P1|NOT COMPLETED|Overall Study||215
430692|NCT00750880|1027781|P1|COMPLETED|Overall Study||1466
430693|NCT00750880|1027781|P1|STARTED|Overall Study||1681
430694|NCT00750867|1027804|P1|NOT COMPLETED|Overall Study||2
430695|NCT00750867|1027804|P1|COMPLETED|Overall Study||7
430696|NCT00750867|1027804|P1|STARTED|Overall Study||9
430697|NCT00750815|1027811|P2|NOT COMPLETED|Overall Study||0
430698|NCT00750815|1027812|P1|NOT COMPLETED|Overall Study||0
430699|NCT00750815|1027811|P2|COMPLETED|Overall Study||46
430700|NCT00750815|1027812|P1|COMPLETED|Overall Study||12
430701|NCT00750815|1027811|P2|STARTED|Overall Study||46
430702|NCT00750815|1027812|P1|STARTED|Overall Study||12
430703|NCT00750737|1027825|P2|NOT COMPLETED|Overall Study||3
430704|NCT00750737|1027826|P1|NOT COMPLETED|Overall Study||3
430705|NCT00750737|1027825|P2|COMPLETED|Overall Study||19
430706|NCT00750737|1027826|P1|COMPLETED|Overall Study||21
430707|NCT00750737|1027825|P2|STARTED|Overall Study||22
430708|NCT00750737|1027826|P1|STARTED|Overall Study||24
430709|NCT00750373|1027836|P2|NOT COMPLETED|Overall Study||0
430710|NCT00750373|1027837|P1|NOT COMPLETED|Overall Study||0
430711|NCT00750373|1027836|P2|COMPLETED|Overall Study||37
430712|NCT00750373|1027837|P1|COMPLETED|Overall Study||39
430713|NCT00750373|1027836|P2|STARTED|Overall Study||37
430714|NCT00750373|1027837|P1|STARTED|Overall Study||39
430715|NCT00750360|1027849|P6|NOT COMPLETED|Overall Study||0
430716|NCT00750360|1027850|P5|NOT COMPLETED|Overall Study||0
430717|NCT00750360|1027851|P4|NOT COMPLETED|Overall Study||0
430718|NCT00750360|1027852|P3|NOT COMPLETED|Overall Study||0
430719|NCT00750360|1027853|P2|NOT COMPLETED|Overall Study||0
430720|NCT00750360|1027854|P1|NOT COMPLETED|Overall Study||0
430721|NCT00750360|1027849|P6|COMPLETED|Overall Study||71
430722|NCT00750360|1027850|P5|COMPLETED|Overall Study||46
430723|NCT00750360|1027851|P4|COMPLETED|Overall Study||79
430724|NCT00750360|1027852|P3|COMPLETED|Overall Study||384
430725|NCT00750360|1027853|P2|COMPLETED|Overall Study||1
430726|NCT00750360|1027854|P1|COMPLETED|Overall Study||294
430727|NCT00750360|1027849|P6|STARTED|Overall Study||71
430728|NCT00750360|1027850|P5|STARTED|Overall Study||46
430729|NCT00750360|1027851|P4|STARTED|Overall Study||79
430730|NCT00750360|1027852|P3|STARTED|Overall Study||384
430731|NCT00750360|1027853|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
430732|NCT00750360|1027854|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
430733|NCT00750308|1027886|P12|NOT COMPLETED|Fourth Treatment||0
430734|NCT00750308|1027887|P11|NOT COMPLETED|Fourth Treatment||0
430735|NCT00750308|1027888|P10|NOT COMPLETED|Fourth Treatment||0
430736|NCT00750308|1027889|P9|NOT COMPLETED|Fourth Treatment||0
430737|NCT00750308|1027890|P8|NOT COMPLETED|Fourth Treatment||0
430738|NCT00750308|1027891|P7|NOT COMPLETED|Fourth Treatment||0
430739|NCT00750308|1027892|P6|NOT COMPLETED|Fourth Treatment||0
430740|NCT00750308|1027893|P5|NOT COMPLETED|Fourth Treatment||0
430741|NCT00750308|1027894|P4|NOT COMPLETED|Fourth Treatment||0
430742|NCT00750308|1027895|P3|NOT COMPLETED|Fourth Treatment||0
430743|NCT00750308|1027896|P2|NOT COMPLETED|Fourth Treatment||0
430744|NCT00750308|1027897|P1|NOT COMPLETED|Fourth Treatment||0
430745|NCT00750308|1027886|P12|COMPLETED|Fourth Treatment||1
430746|NCT00750308|1027887|P11|COMPLETED|Fourth Treatment||1
430747|NCT00750308|1027888|P10|COMPLETED|Fourth Treatment||2
430748|NCT00750308|1027889|P9|COMPLETED|Fourth Treatment||1
430749|NCT00750308|1027890|P8|COMPLETED|Fourth Treatment||2
430750|NCT00750308|1027891|P7|COMPLETED|Fourth Treatment||2
430751|NCT00750308|1027892|P6|COMPLETED|Fourth Treatment||2
430752|NCT00750308|1027893|P5|COMPLETED|Fourth Treatment||1
430753|NCT00750308|1027894|P4|COMPLETED|Fourth Treatment||1
430754|NCT00750308|1027895|P3|COMPLETED|Fourth Treatment||2
430755|NCT00750308|1027896|P2|COMPLETED|Fourth Treatment||1
430756|NCT00750308|1027897|P1|COMPLETED|Fourth Treatment||2
430757|NCT00750308|1027886|P12|STARTED|Fourth Treatment||1
430758|NCT00750308|1027887|P11|STARTED|Fourth Treatment||1
430759|NCT00750308|1027888|P10|STARTED|Fourth Treatment||2
430760|NCT00750308|1027889|P9|STARTED|Fourth Treatment||1
430761|NCT00750308|1027890|P8|STARTED|Fourth Treatment||2
430762|NCT00750308|1027891|P7|STARTED|Fourth Treatment||2
430763|NCT00750308|1027892|P6|STARTED|Fourth Treatment||2
430764|NCT00750308|1027893|P5|STARTED|Fourth Treatment||1
430765|NCT00750308|1027894|P4|STARTED|Fourth Treatment||1
430766|NCT00750308|1027895|P3|STARTED|Fourth Treatment||2
430767|NCT00750308|1027896|P2|STARTED|Fourth Treatment||1
430768|NCT00750308|1027897|P1|STARTED|Fourth Treatment||2
430769|NCT00750308|1027886|P12|NOT COMPLETED|Washout||0
430770|NCT00750308|1027887|P11|NOT COMPLETED|Washout||0
430771|NCT00750308|1027888|P10|NOT COMPLETED|Washout||0
430772|NCT00750308|1027889|P9|NOT COMPLETED|Washout||0
430773|NCT00750308|1027890|P8|NOT COMPLETED|Washout||0
430774|NCT00750308|1027891|P7|NOT COMPLETED|Washout||0
430775|NCT00750308|1027892|P6|NOT COMPLETED|Washout||0
430776|NCT00750308|1027893|P5|NOT COMPLETED|Washout||0
430777|NCT00750308|1027894|P4|NOT COMPLETED|Washout||0
430778|NCT00750308|1027895|P3|NOT COMPLETED|Washout||0
430779|NCT00750308|1027896|P2|NOT COMPLETED|Washout||0
430780|NCT00750308|1027897|P1|NOT COMPLETED|Washout||0
430781|NCT00750308|1027886|P12|COMPLETED|Washout||1
430782|NCT00750308|1027887|P11|COMPLETED|Washout||1
430783|NCT00750308|1027888|P10|COMPLETED|Washout||2
430784|NCT00750308|1027889|P9|COMPLETED|Washout||1
430785|NCT00750308|1027890|P8|COMPLETED|Washout||2
430786|NCT00750308|1027891|P7|COMPLETED|Washout||2
430787|NCT00750308|1027892|P6|COMPLETED|Washout||2
430788|NCT00750308|1027893|P5|COMPLETED|Washout||1
430789|NCT00750308|1027894|P4|COMPLETED|Washout||1
430790|NCT00750308|1027895|P3|COMPLETED|Washout||2
430791|NCT00750308|1027896|P2|COMPLETED|Washout||1
430792|NCT00750308|1027897|P1|COMPLETED|Washout||2
430793|NCT00750308|1027886|P12|STARTED|Washout||1
430794|NCT00750308|1027887|P11|STARTED|Washout||1
430795|NCT00750308|1027888|P10|STARTED|Washout||2
430796|NCT00750308|1027889|P9|STARTED|Washout||1
430797|NCT00750308|1027890|P8|STARTED|Washout||2
430798|NCT00750308|1027891|P7|STARTED|Washout||2
430799|NCT00750308|1027892|P6|STARTED|Washout||2
430800|NCT00750308|1027893|P5|STARTED|Washout||1
430801|NCT00750308|1027894|P4|STARTED|Washout||1
430802|NCT00750308|1027895|P3|STARTED|Washout||2
430803|NCT00750308|1027896|P2|STARTED|Washout||1
430804|NCT00750308|1027897|P1|STARTED|Washout||2
430805|NCT00750308|1027886|P12|NOT COMPLETED|Third Treatment||0
430806|NCT00750308|1027887|P11|NOT COMPLETED|Third Treatment||0
430807|NCT00750308|1027888|P10|NOT COMPLETED|Third Treatment||0
430808|NCT00750308|1027889|P9|NOT COMPLETED|Third Treatment||0
430809|NCT00750308|1027890|P8|NOT COMPLETED|Third Treatment||0
430810|NCT00750308|1027891|P7|NOT COMPLETED|Third Treatment||0
430811|NCT00750308|1027892|P6|NOT COMPLETED|Third Treatment||0
430812|NCT00750308|1027893|P5|NOT COMPLETED|Third Treatment||0
430813|NCT00750308|1027894|P4|NOT COMPLETED|Third Treatment||0
430814|NCT00750308|1027895|P3|NOT COMPLETED|Third Treatment||0
430815|NCT00750308|1027896|P2|NOT COMPLETED|Third Treatment||1
430816|NCT00750308|1027897|P1|NOT COMPLETED|Third Treatment||0
430817|NCT00750308|1027886|P12|COMPLETED|Third Treatment||1
430818|NCT00750308|1027887|P11|COMPLETED|Third Treatment||1
430819|NCT00750308|1027888|P10|COMPLETED|Third Treatment||2
430820|NCT00750308|1027889|P9|COMPLETED|Third Treatment||1
430821|NCT00750308|1027890|P8|COMPLETED|Third Treatment||2
430822|NCT00750308|1027891|P7|COMPLETED|Third Treatment||2
430823|NCT00750308|1027892|P6|COMPLETED|Third Treatment||2
430824|NCT00750308|1027893|P5|COMPLETED|Third Treatment||1
430825|NCT00750308|1027894|P4|COMPLETED|Third Treatment||1
430826|NCT00750308|1027895|P3|COMPLETED|Third Treatment||2
430827|NCT00750308|1027896|P2|COMPLETED|Third Treatment||1
430828|NCT00750308|1027897|P1|COMPLETED|Third Treatment||2
430829|NCT00750308|1027886|P12|STARTED|Third Treatment||1
430830|NCT00750308|1027887|P11|STARTED|Third Treatment||1
430831|NCT00750308|1027888|P10|STARTED|Third Treatment||2
430832|NCT00750308|1027889|P9|STARTED|Third Treatment||1
430833|NCT00750308|1027890|P8|STARTED|Third Treatment||2
430834|NCT00750308|1027891|P7|STARTED|Third Treatment||2
430835|NCT00750308|1027892|P6|STARTED|Third Treatment||2
430836|NCT00750308|1027893|P5|STARTED|Third Treatment||1
430837|NCT00750308|1027894|P4|STARTED|Third Treatment||1
430838|NCT00750308|1027895|P3|STARTED|Third Treatment||2
430839|NCT00750308|1027896|P2|STARTED|Third Treatment||2
430840|NCT00750308|1027897|P1|STARTED|Third Treatment||2
430841|NCT00750308|1027886|P12|NOT COMPLETED|Washout||0
430842|NCT00750308|1027887|P11|NOT COMPLETED|Washout||0
430843|NCT00750308|1027888|P10|NOT COMPLETED|Washout||0
430844|NCT00750308|1027889|P9|NOT COMPLETED|Washout||0
430845|NCT00750308|1027890|P8|NOT COMPLETED|Washout||0
430846|NCT00750308|1027891|P7|NOT COMPLETED|Washout||0
430847|NCT00750308|1027892|P6|NOT COMPLETED|Washout||0
430848|NCT00750308|1027893|P5|NOT COMPLETED|Washout||0
430849|NCT00750308|1027894|P4|NOT COMPLETED|Washout||0
430850|NCT00750308|1027895|P3|NOT COMPLETED|Washout||0
430851|NCT00750308|1027896|P2|NOT COMPLETED|Washout||0
430852|NCT00750308|1027897|P1|NOT COMPLETED|Washout||0
430853|NCT00750308|1027886|P12|COMPLETED|Washout||1
430854|NCT00750308|1027887|P11|COMPLETED|Washout||1
430855|NCT00750308|1027888|P10|COMPLETED|Washout||2
430856|NCT00750308|1027889|P9|COMPLETED|Washout||1
430857|NCT00750308|1027890|P8|COMPLETED|Washout||2
430858|NCT00750308|1027891|P7|COMPLETED|Washout||2
430859|NCT00750308|1027892|P6|COMPLETED|Washout||2
430860|NCT00750308|1027893|P5|COMPLETED|Washout||1
430861|NCT00750308|1027894|P4|COMPLETED|Washout||1
430862|NCT00750308|1027895|P3|COMPLETED|Washout||2
430863|NCT00750308|1027896|P2|COMPLETED|Washout||2
430864|NCT00750308|1027897|P1|COMPLETED|Washout||2
430865|NCT00750308|1027886|P12|STARTED|Washout||1
430866|NCT00750308|1027887|P11|STARTED|Washout||1
430867|NCT00750308|1027888|P10|STARTED|Washout||2
430868|NCT00750308|1027889|P9|STARTED|Washout||1
430869|NCT00750308|1027890|P8|STARTED|Washout||2
430870|NCT00750308|1027891|P7|STARTED|Washout||2
430871|NCT00750308|1027892|P6|STARTED|Washout||2
430872|NCT00750308|1027893|P5|STARTED|Washout||1
430873|NCT00750308|1027894|P4|STARTED|Washout||1
430874|NCT00750308|1027895|P3|STARTED|Washout||2
430875|NCT00750308|1027896|P2|STARTED|Washout||2
430876|NCT00750308|1027897|P1|STARTED|Washout||2
430877|NCT00750308|1027886|P12|NOT COMPLETED|Second Treatment||0
430878|NCT00750308|1027887|P11|NOT COMPLETED|Second Treatment||0
430879|NCT00750308|1027888|P10|NOT COMPLETED|Second Treatment||0
430880|NCT00750308|1027889|P9|NOT COMPLETED|Second Treatment||1
430881|NCT00750308|1027890|P8|NOT COMPLETED|Second Treatment||0
430882|NCT00750308|1027891|P7|NOT COMPLETED|Second Treatment||0
430883|NCT00750308|1027892|P6|NOT COMPLETED|Second Treatment||1
430884|NCT00750308|1027893|P5|NOT COMPLETED|Second Treatment||1
430885|NCT00750308|1027894|P4|NOT COMPLETED|Second Treatment||0
430886|NCT00750308|1027895|P3|NOT COMPLETED|Second Treatment||0
430887|NCT00750308|1027896|P2|NOT COMPLETED|Second Treatment||0
430888|NCT00750308|1027897|P1|NOT COMPLETED|Second Treatment||0
430889|NCT00750308|1027886|P12|COMPLETED|Second Treatment||1
430890|NCT00750308|1027887|P11|COMPLETED|Second Treatment||1
430891|NCT00750308|1027888|P10|COMPLETED|Second Treatment||2
430892|NCT00750308|1027889|P9|COMPLETED|Second Treatment||1
430893|NCT00750308|1027890|P8|COMPLETED|Second Treatment||2
430894|NCT00750308|1027891|P7|COMPLETED|Second Treatment||2
430895|NCT00750308|1027892|P6|COMPLETED|Second Treatment||2
430896|NCT00750308|1027893|P5|COMPLETED|Second Treatment||1
430897|NCT00750308|1027894|P4|COMPLETED|Second Treatment||1
430898|NCT00750308|1027895|P3|COMPLETED|Second Treatment||2
430899|NCT00750308|1027896|P2|COMPLETED|Second Treatment||2
430900|NCT00750308|1027897|P1|COMPLETED|Second Treatment||2
430901|NCT00750308|1027886|P12|STARTED|Second Treatment||1
430902|NCT00750308|1027887|P11|STARTED|Second Treatment||1
430903|NCT00750308|1027888|P10|STARTED|Second Treatment||2
430904|NCT00750308|1027889|P9|STARTED|Second Treatment||2
430905|NCT00750308|1027890|P8|STARTED|Second Treatment||2
430906|NCT00750308|1027891|P7|STARTED|Second Treatment||2
430907|NCT00750308|1027892|P6|STARTED|Second Treatment||3
430908|NCT00750308|1027893|P5|STARTED|Second Treatment||2
430909|NCT00750308|1027894|P4|STARTED|Second Treatment||1
430910|NCT00750308|1027895|P3|STARTED|Second Treatment||2
430911|NCT00750308|1027896|P2|STARTED|Second Treatment||2
430912|NCT00750308|1027897|P1|STARTED|Second Treatment||2
430913|NCT00750308|1027886|P12|NOT COMPLETED|Washout||0
430914|NCT00750308|1027887|P11|NOT COMPLETED|Washout||0
430915|NCT00750308|1027888|P10|NOT COMPLETED|Washout||0
430916|NCT00750308|1027889|P9|NOT COMPLETED|Washout||0
430917|NCT00750308|1027890|P8|NOT COMPLETED|Washout||0
430918|NCT00750308|1027891|P7|NOT COMPLETED|Washout||0
430919|NCT00750308|1027892|P6|NOT COMPLETED|Washout||0
430920|NCT00750308|1027893|P5|NOT COMPLETED|Washout||0
430921|NCT00750308|1027894|P4|NOT COMPLETED|Washout||0
430922|NCT00750308|1027895|P3|NOT COMPLETED|Washout||0
430923|NCT00750308|1027896|P2|NOT COMPLETED|Washout||0
430924|NCT00750308|1027897|P1|NOT COMPLETED|Washout||0
430925|NCT00750308|1027886|P12|COMPLETED|Washout||1
430926|NCT00750308|1027887|P11|COMPLETED|Washout||1
430927|NCT00750308|1027888|P10|COMPLETED|Washout||2
430928|NCT00750308|1027889|P9|COMPLETED|Washout||2
430929|NCT00750308|1027890|P8|COMPLETED|Washout||2
430930|NCT00750308|1027891|P7|COMPLETED|Washout||2
430931|NCT00750308|1027892|P6|COMPLETED|Washout||3
430932|NCT00750308|1027893|P5|COMPLETED|Washout||2
430933|NCT00750308|1027894|P4|COMPLETED|Washout||1
430934|NCT00750308|1027895|P3|COMPLETED|Washout||2
430935|NCT00750308|1027896|P2|COMPLETED|Washout||2
430936|NCT00750308|1027897|P1|COMPLETED|Washout||2
430937|NCT00750308|1027886|P12|STARTED|Washout||1
430938|NCT00750308|1027887|P11|STARTED|Washout||1
430939|NCT00750308|1027888|P10|STARTED|Washout||2
430940|NCT00750308|1027889|P9|STARTED|Washout||2
430941|NCT00750308|1027890|P8|STARTED|Washout||2
430942|NCT00750308|1027891|P7|STARTED|Washout||2
430943|NCT00750308|1027892|P6|STARTED|Washout||3
430944|NCT00750308|1027893|P5|STARTED|Washout||2
430945|NCT00750308|1027894|P4|STARTED|Washout||1
430946|NCT00750308|1027895|P3|STARTED|Washout||2
430947|NCT00750308|1027896|P2|STARTED|Washout||2
430948|NCT00750308|1027897|P1|STARTED|Washout||2
430949|NCT00750308|1027886|P12|NOT COMPLETED|First Treatment||1
430950|NCT00750308|1027887|P11|NOT COMPLETED|First Treatment||1
430951|NCT00750308|1027888|P10|NOT COMPLETED|First Treatment||0
430952|NCT00750308|1027889|P9|NOT COMPLETED|First Treatment||0
430953|NCT00750308|1027890|P8|NOT COMPLETED|First Treatment||1
430954|NCT00750308|1027891|P7|NOT COMPLETED|First Treatment||0
430955|NCT00750308|1027892|P6|NOT COMPLETED|First Treatment||0
430956|NCT00750308|1027893|P5|NOT COMPLETED|First Treatment||0
430957|NCT00750308|1027894|P4|NOT COMPLETED|First Treatment||1
430958|NCT00750308|1027895|P3|NOT COMPLETED|First Treatment||0
430959|NCT00750308|1027896|P2|NOT COMPLETED|First Treatment||1
430960|NCT00750308|1027897|P1|NOT COMPLETED|First Treatment||0
430961|NCT00750308|1027886|P12|COMPLETED|First Treatment||1
430962|NCT00750308|1027887|P11|COMPLETED|First Treatment||1
430963|NCT00750308|1027888|P10|COMPLETED|First Treatment||2
430964|NCT00750308|1027889|P9|COMPLETED|First Treatment||2
430965|NCT00750308|1027890|P8|COMPLETED|First Treatment||2
430966|NCT00750308|1027891|P7|COMPLETED|First Treatment||2
430967|NCT00750308|1027892|P6|COMPLETED|First Treatment||3
430968|NCT00750308|1027893|P5|COMPLETED|First Treatment||2
430969|NCT00750308|1027894|P4|COMPLETED|First Treatment||1
430970|NCT00750308|1027895|P3|COMPLETED|First Treatment||2
430971|NCT00750308|1027896|P2|COMPLETED|First Treatment||2
430972|NCT00750308|1027897|P1|COMPLETED|First Treatment||2
430973|NCT00750308|1027886|P12|STARTED|First Treatment||2
430974|NCT00750308|1027887|P11|STARTED|First Treatment||2
430975|NCT00750308|1027888|P10|STARTED|First Treatment||2
430976|NCT00750308|1027889|P9|STARTED|First Treatment||2
430977|NCT00750308|1027890|P8|STARTED|First Treatment||3
430978|NCT00750308|1027891|P7|STARTED|First Treatment||2
430979|NCT00750308|1027892|P6|STARTED|First Treatment||3
430980|NCT00750308|1027893|P5|STARTED|First Treatment||2
430981|NCT00750308|1027894|P4|STARTED|First Treatment||2
430982|NCT00750308|1027895|P3|STARTED|First Treatment||2
430983|NCT00750308|1027896|P2|STARTED|First Treatment||3
430984|NCT00750308|1027897|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
430985|NCT00750282|1027915|P4|NOT COMPLETED|Overall Study||1
430986|NCT00750282|1027916|P3|NOT COMPLETED|Overall Study||1
430987|NCT00750282|1027917|P2|NOT COMPLETED|Overall Study||1
430988|NCT00750282|1027918|P1|NOT COMPLETED|Overall Study||0
430989|NCT00750282|1027915|P4|COMPLETED|Overall Study||147
430990|NCT00750282|1027916|P3|COMPLETED|Overall Study||125
430991|NCT00750282|1027917|P2|COMPLETED|Overall Study||81
430992|NCT00750282|1027918|P1|COMPLETED|Overall Study||69
430993|NCT00750282|1027915|P4|STARTED|Overall Study||148
430994|NCT00750282|1027916|P3|STARTED|Overall Study||126
430995|NCT00750282|1027917|P2|STARTED|Overall Study||82
430996|NCT00750282|1027918|P1|STARTED|Overall Study||69
430997|NCT00750269|1027947|P5|NOT COMPLETED|Overall Study||10
430998|NCT00750269|1027948|P4|NOT COMPLETED|Overall Study||5
430999|NCT00750269|1027949|P3|NOT COMPLETED|Overall Study||4
431000|NCT00750269|1027950|P2|NOT COMPLETED|Overall Study||1
431001|NCT00750269|1027951|P1|NOT COMPLETED|Overall Study||0
431002|NCT00750269|1027947|P5|COMPLETED|Overall Study||33
431003|NCT00750269|1027948|P4|COMPLETED|Overall Study||38
431004|NCT00750269|1027949|P3|COMPLETED|Overall Study||14
431005|NCT00750269|1027950|P2|COMPLETED|Overall Study||7
431006|NCT00750269|1027951|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
431007|NCT00750269|1027947|P5|STARTED|Overall Study||43
431008|NCT00750269|1027948|P4|STARTED|Overall Study||43
431009|NCT00750269|1027949|P3|STARTED|Overall Study||18
431010|NCT00750269|1027950|P2|STARTED|Overall Study||8
431011|NCT00750269|1027951|P1|STARTED|Overall Study||8
431012|NCT00750204|1027998|P2|NOT COMPLETED|Overall Study||1
431013|NCT00750204|1027999|P1|NOT COMPLETED|Overall Study||1
431014|NCT00750204|1027998|P2|COMPLETED|Overall Study||0
431015|NCT00750204|1027999|P1|COMPLETED|Overall Study||0
431016|NCT00750204|1027998|P2|STARTED|Overall Study||1
431017|NCT00750204|1027999|P1|STARTED|Overall Study||1
431018|NCT00750191|1028007|P2|NOT COMPLETED|Overall Study||10
431019|NCT00750191|1028008|P1|NOT COMPLETED|Overall Study||5
431020|NCT00750191|1028007|P2|COMPLETED|Overall Study||20
431021|NCT00750191|1028008|P1|COMPLETED|Overall Study||22
431022|NCT00750191|1028007|P2|STARTED|Overall Study||30
431023|NCT00750191|1028008|P1|STARTED|Overall Study||27
431024|NCT00750152|1028022|P2|NOT COMPLETED|Overall Study||27
431025|NCT00750152|1028023|P1|NOT COMPLETED|Overall Study||22
431026|NCT00750152|1028022|P2|COMPLETED|Overall Study||141
431027|NCT00750152|1028023|P1|COMPLETED|Overall Study||144
431028|NCT00750152|1028022|P2|STARTED|Overall Study||168
431029|NCT00750152|1028023|P1|STARTED|Overall Study||166
431030|NCT00750139|1028035|P4|NOT COMPLETED|Overall Study||46
431031|NCT00750139|1028036|P3|NOT COMPLETED|Overall Study||101
431032|NCT00750139|1028037|P2|NOT COMPLETED|Overall Study||59
431033|NCT00750139|1028038|P1|NOT COMPLETED|Overall Study||89
431034|NCT00750139|1028035|P4|COMPLETED|Overall Study||73
431035|NCT00750139|1028036|P3|COMPLETED|Overall Study||135
431036|NCT00750139|1028037|P2|COMPLETED|Overall Study||59
431037|NCT00750139|1028038|P1|COMPLETED|Overall Study||145
431038|NCT00750139|1028035|P4|STARTED|Overall Study||119
431039|NCT00750139|1028036|P3|STARTED|Overall Study||236
431040|NCT00750139|1028037|P2|STARTED|Overall Study||118
431041|NCT00750139|1028038|P1|STARTED|Overall Study||234
431042|NCT00750061|1028054|P2|NOT COMPLETED|Overall Study||2
431043|NCT00750061|1028055|P1|NOT COMPLETED|Overall Study||2
431044|NCT00750061|1028054|P2|COMPLETED|Overall Study||18
431045|NCT00750061|1028055|P1|COMPLETED|Overall Study||18
431046|NCT00750061|1028054|P2|STARTED|Overall Study||20
431047|NCT00750061|1028055|P1|STARTED|Overall Study||20
431048|NCT00749996|1028065|P2|NOT COMPLETED|Overall Study||13
431049|NCT00749996|1028066|P1|NOT COMPLETED|Overall Study||18
431050|NCT00749996|1028065|P2|COMPLETED|Overall Study||58
431051|NCT00749996|1028066|P1|COMPLETED|Overall Study||57
431052|NCT00749996|1028065|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
431053|NCT00749996|1028066|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
431054|NCT00749996|1028065|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
431055|NCT00749996|1028066|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
431056|NCT00749996|1028065|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
431057|NCT00749996|1028066|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
431058|NCT00749996|1028065|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
431059|NCT00749996|1028066|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
431060|NCT00749996|1028065|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
431061|NCT00749996|1028066|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
431062|NCT00749996|1028065|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
431063|NCT00749996|1028066|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
431064|NCT00749957|1028076|P2|NOT COMPLETED|Overall Study||0
431065|NCT00749957|1028077|P1|NOT COMPLETED|Overall Study||0
431066|NCT00749957|1028076|P2|COMPLETED|Overall Study||6
431067|NCT00749957|1028077|P1|COMPLETED|Overall Study||6
431068|NCT00749957|1028076|P2|STARTED|Overall Study||6
431069|NCT00749957|1028077|P1|STARTED|Overall Study||6
431070|NCT00749944|1028089|P2|NOT COMPLETED|Overall Study||1
431071|NCT00749944|1028090|P1|NOT COMPLETED|Overall Study||5
431072|NCT00749944|1028089|P2|COMPLETED|Overall Study||54
431073|NCT00749944|1028090|P1|COMPLETED|Overall Study||50
431074|NCT00749944|1028089|P2|STARTED|Overall Study||55
431075|NCT00749944|1028090|P1|STARTED|Overall Study||55
431076|NCT00749931|1028158|P3|NOT COMPLETED|Overall Study||0
431077|NCT00749931|1028159|P2|NOT COMPLETED|Overall Study||0
431078|NCT00749931|1028160|P1|NOT COMPLETED|Overall Study||0
431079|NCT00749931|1028158|P3|COMPLETED|Overall Study||68
431080|NCT00749931|1028159|P2|COMPLETED|Overall Study||298
431081|NCT00749931|1028160|P1|COMPLETED|Overall Study||298
431082|NCT00749931|1028158|P3|STARTED|Overall Study||68
431083|NCT00749931|1028159|P2|STARTED|Overall Study||298
431084|NCT00749931|1028160|P1|STARTED|Overall Study||298
431085|NCT00749775|1028169|P1|NOT COMPLETED|Overall Study||107
431086|NCT00749775|1028169|P1|COMPLETED|Overall Study||3210
431087|NCT00749775|1028169|P1|STARTED|Overall Study||3317
431088|NCT00749684|1028185|P1|NOT COMPLETED|Overall Study||82
431089|NCT00749684|1028185|P1|COMPLETED|Overall Study||56
431090|NCT00749684|1028185|P1|STARTED|Overall Study||138
431091|NCT00749671|1028192|P2|NOT COMPLETED|Overall Study||0
431092|NCT00749671|1028193|P1|NOT COMPLETED|Overall Study||0
431093|NCT00749671|1028192|P2|COMPLETED|Overall Study||9
431094|NCT00749671|1028193|P1|COMPLETED|Overall Study||11
431095|NCT00749671|1028192|P2|STARTED|Overall Study||9
431096|NCT00749671|1028193|P1|STARTED|Overall Study||11
431097|NCT00749580|1028203|P2|NOT COMPLETED|Overall Study||9
431098|NCT00749580|1028204|P1|NOT COMPLETED|Overall Study||4
431099|NCT00749580|1028203|P2|COMPLETED|Overall Study||16
431100|NCT00749580|1028204|P1|COMPLETED|Overall Study|December 2010|17
431101|NCT00749580|1028203|P2|STARTED|Overall Study||25
431102|NCT00749580|1028204|P1|STARTED|Overall Study|September 2008|21
431103|NCT00749476|1028212|P1|NOT COMPLETED|Overall Study||0
431104|NCT00749476|1028212|P1|COMPLETED|Overall Study||1
431105|NCT00749476|1028212|P1|STARTED|Overall Study||1
431106|NCT00749463|1028219|P3|NOT COMPLETED|Overall Study||1
431107|NCT00749463|1028220|P2|NOT COMPLETED|Overall Study||4
431108|NCT00749463|1028221|P1|NOT COMPLETED|Overall Study||1
431109|NCT00749463|1028219|P3|COMPLETED|Overall Study||149
431110|NCT00749463|1028220|P2|COMPLETED|Overall Study||60
431111|NCT00749463|1028221|P1|COMPLETED|Overall Study||85
431112|NCT00749463|1028219|P3|STARTED|Overall Study||150
431113|NCT00749463|1028220|P2|STARTED|Overall Study||64
431114|NCT00749463|1028221|P1|STARTED|Overall Study||86
431115|NCT00749398|1028247|P1|NOT COMPLETED|Overall Study||53
431116|NCT00749398|1028247|P1|COMPLETED|Overall Study||71
431117|NCT00749398|1028247|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
431118|NCT00749268|1028265|P2|NOT COMPLETED|Overall Study||36
431119|NCT00749268|1028266|P1|NOT COMPLETED|Overall Study||34
431120|NCT00749268|1028265|P2|COMPLETED|Overall Study||74
431121|NCT00749268|1028266|P1|COMPLETED|Overall Study||72
431122|NCT00749268|1028265|P2|STARTED|Overall Study||110
431123|NCT00749268|1028266|P1|STARTED|Overall Study||106
431124|NCT00749190|1028295|P7|NOT COMPLETED|Overall Study||1
431125|NCT00749190|1028296|P6|NOT COMPLETED|Overall Study||5
431126|NCT00749190|1028297|P5|NOT COMPLETED|Overall Study||0
431127|NCT00749190|1028298|P4|NOT COMPLETED|Overall Study||5
431128|NCT00749190|1028299|P3|NOT COMPLETED|Overall Study||1
431129|NCT00749190|1028300|P2|NOT COMPLETED|Overall Study||5
431130|NCT00749190|1028301|P1|NOT COMPLETED|Overall Study||5
431131|NCT00749190|1028295|P7|COMPLETED|Overall Study||70
431132|NCT00749190|1028296|P6|COMPLETED|Overall Study||65
431133|NCT00749190|1028297|P5|COMPLETED|Overall Study||70
431134|NCT00749190|1028298|P4|COMPLETED|Overall Study||66
431135|NCT00749190|1028299|P3|COMPLETED|Overall Study||70
431136|NCT00749190|1028300|P2|COMPLETED|Overall Study||66
431137|NCT00749190|1028301|P1|COMPLETED|Overall Study||66
431138|NCT00749190|1028295|P7|STARTED|Overall Study||71
431139|NCT00749190|1028296|P6|STARTED|Overall Study||70
431140|NCT00749190|1028297|P5|STARTED|Overall Study||70
431141|NCT00749190|1028298|P4|STARTED|Overall Study||71
431142|NCT00749190|1028299|P3|STARTED|Overall Study||71
431143|NCT00749190|1028300|P2|STARTED|Overall Study||71
431144|NCT00749190|1028301|P1|STARTED|Overall Study||71
431145|NCT00749073|1028378|P1|NOT COMPLETED|Overall Study||0
431146|NCT00749073|1028378|P1|COMPLETED|Overall Study||10
431147|NCT00749073|1028378|P1|STARTED|Overall Study||10
431148|NCT00748982|1028386|P2|NOT COMPLETED|Overall Study||0
431149|NCT00748982|1028387|P1|NOT COMPLETED|Overall Study||0
431150|NCT00748982|1028386|P2|COMPLETED|Overall Study||4
431151|NCT00748982|1028387|P1|COMPLETED|Overall Study||12
431152|NCT00748982|1028386|P2|STARTED|Overall Study||4
431153|NCT00748982|1028387|P1|STARTED|Overall Study||12
431154|NCT00748969|1028401|P2|NOT COMPLETED|Overall Study||0
431155|NCT00748969|1028402|P1|NOT COMPLETED|Overall Study||0
431156|NCT00748969|1028401|P2|COMPLETED|Overall Study||1
431157|NCT00748969|1028402|P1|COMPLETED|Overall Study||1
431158|NCT00748969|1028401|P2|STARTED|Overall Study||1
431159|NCT00748969|1028402|P1|STARTED|Overall Study||1
431160|NCT00748956|1028411|P3|NOT COMPLETED|Overall Study||0
431161|NCT00748956|1028412|P2|NOT COMPLETED|Overall Study||0
431162|NCT00748956|1028413|P1|NOT COMPLETED|Overall Study||0
431163|NCT00748956|1028411|P3|COMPLETED|Overall Study||5
431164|NCT00748956|1028412|P2|COMPLETED|Overall Study||5
431165|NCT00748956|1028413|P1|COMPLETED|Overall Study||0
431166|NCT00748956|1028411|P3|STARTED|Overall Study||5
431167|NCT00748956|1028412|P2|STARTED|Overall Study||5
431168|NCT00748956|1028413|P1|STARTED|Overall Study||0
431169|NCT00748865|1028436|P2|NOT COMPLETED|Overall Study||0
431170|NCT00748865|1028437|P1|NOT COMPLETED|Overall Study||0
431171|NCT00748865|1028436|P2|COMPLETED|Overall Study||10
431172|NCT00748865|1028437|P1|COMPLETED|Overall Study||10
431173|NCT00748865|1028436|P2|STARTED|Overall Study||10
431174|NCT00748865|1028437|P1|STARTED|Overall Study||10
431175|NCT00748826|1028443|P1|NOT COMPLETED|Overall Study||301
431176|NCT00748826|1028443|P1|COMPLETED|Overall Study||207
431177|NCT00748826|1028443|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
431178|NCT00748709|1028450|P1|NOT COMPLETED|Overall Study||20
431179|NCT00748709|1028450|P1|COMPLETED|Overall Study||0
431180|NCT00748709|1028450|P1|STARTED|Overall Study|Treated|20
431181|NCT00748657|1028462|P1|NOT COMPLETED|Overall Study||0
431182|NCT00748657|1028462|P1|COMPLETED|Overall Study||36
431183|NCT00748657|1028462|P1|STARTED|Overall Study||36
431184|NCT00748579|1028470|P2|NOT COMPLETED|Overall Study||0
431185|NCT00748579|1028471|P1|NOT COMPLETED|Overall Study||0
431186|NCT00748579|1028470|P2|COMPLETED|Overall Study||0
431187|NCT00748579|1028471|P1|COMPLETED|Overall Study||2
431188|NCT00748579|1028470|P2|STARTED|Overall Study||0
431189|NCT00748579|1028471|P1|STARTED|Overall Study||2
431190|NCT00748566|1028477|P1|NOT COMPLETED|Overall Study||112
431191|NCT00748566|1028477|P1|COMPLETED|Overall Study||60
431192|NCT00748566|1028477|P1|STARTED|Overall Study||172
431193|NCT00748241|1028505|P1|NOT COMPLETED|Overall Study||8
431194|NCT00748241|1028505|P1|COMPLETED|Overall Study||11
431195|NCT00748241|1028505|P1|STARTED|Overall Study||19
431196|NCT00748189|1028515|P2|NOT COMPLETED|Overall Study||221
431197|NCT00748189|1028516|P1|NOT COMPLETED|Overall Study||225
431198|NCT00748189|1028515|P2|COMPLETED|Overall Study||0
431199|NCT00748189|1028516|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
431200|NCT00748189|1028515|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
431201|NCT00748189|1028516|P1|Ongoing|Overall Study||155
431202|NCT00748189|1028515|P2|STARTED|Overall Study||221
431203|NCT00748189|1028516|P1|STARTED|Overall Study||226
431204|NCT00748098|1028570|P2|NOT COMPLETED|Second Taper Period||0
431205|NCT00748098|1028571|P1|NOT COMPLETED|Second Taper Period||0
431206|NCT00748098|1028570|P2|COMPLETED|Second Taper Period||61
431207|NCT00748098|1028571|P1|COMPLETED|Second Taper Period||53
431208|NCT00748098|1028570|P2|STARTED|Second Taper Period||61
431209|NCT00748098|1028571|P1|STARTED|Second Taper Period||53
431210|NCT00748098|1028570|P2|NOT COMPLETED|Second Treatment Intervention Period||3
431211|NCT00748098|1028571|P1|NOT COMPLETED|Second Treatment Intervention Period||6
431212|NCT00748098|1028570|P2|COMPLETED|Second Treatment Intervention Period||61
431213|NCT00748098|1028571|P1|COMPLETED|Second Treatment Intervention Period||53
431214|NCT00748098|1028570|P2|STARTED|Second Treatment Intervention Period||64
431215|NCT00748098|1028571|P1|STARTED|Second Treatment Intervention Period||59
431216|NCT00748098|1028570|P2|NOT COMPLETED|1-Week Washout Period||1
431217|NCT00748098|1028571|P1|NOT COMPLETED|1-Week Washout Period||2
431218|NCT00748098|1028570|P2|COMPLETED|1-Week Washout Period||64
431219|NCT00748098|1028571|P1|COMPLETED|1-Week Washout Period||59
431220|NCT00748098|1028570|P2|STARTED|1-Week Washout Period||65
431221|NCT00748098|1028571|P1|STARTED|1-Week Washout Period||61
431222|NCT00748098|1028570|P2|NOT COMPLETED|First Taper Period||1
431223|NCT00748098|1028571|P1|NOT COMPLETED|First Taper Period||3
431224|NCT00748098|1028570|P2|COMPLETED|First Taper Period||65
431225|NCT00748098|1028571|P1|COMPLETED|First Taper Period||61
431226|NCT00748098|1028570|P2|STARTED|First Taper Period||66
431227|NCT00748098|1028571|P1|STARTED|First Taper Period||64
431228|NCT00748098|1028570|P2|NOT COMPLETED|First Treatment Intervention Period||1
431229|NCT00748098|1028571|P1|NOT COMPLETED|First Treatment Intervention Period||5
431230|NCT00748098|1028570|P2|COMPLETED|First Treatment Intervention Period||66
431231|NCT00748098|1028571|P1|COMPLETED|First Treatment Intervention Period||64
431232|NCT00748098|1028570|P2|STARTED|First Treatment Intervention Period||67
431233|NCT00748098|1028571|P1|STARTED|First Treatment Intervention Period||69
431234|NCT00748085|1028631|P1|NOT COMPLETED|Overall Study||0
431235|NCT00748085|1028631|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
431236|NCT00748085|1028631|P1|STARTED|Overall Study||5
431237|NCT00748072|1028638|P2|NOT COMPLETED|Overall Study||0
431238|NCT00748072|1028639|P1|NOT COMPLETED|Overall Study||0
431239|NCT00748072|1028638|P2|COMPLETED|Overall Study||80
431240|NCT00748072|1028639|P1|COMPLETED|Overall Study||82
431241|NCT00748072|1028638|P2|STARTED|Overall Study||80
431242|NCT00748072|1028639|P1|STARTED|Overall Study||82
431243|NCT00747916|1028645|P1|NOT COMPLETED|Overall Study||0
431244|NCT00747916|1028645|P1|COMPLETED|Overall Study||3
431245|NCT00747916|1028645|P1|STARTED|Overall Study||3
431246|NCT00747812|1028652|P2|NOT COMPLETED|Overall Study||3
431247|NCT00747812|1028653|P1|NOT COMPLETED|Overall Study||5
431248|NCT00747812|1028652|P2|COMPLETED|Overall Study||0
431249|NCT00747812|1028653|P1|COMPLETED|Overall Study||0
431250|NCT00747812|1028652|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
431251|NCT00747812|1028653|P1|STARTED|Overall Study||5
431252|NCT00747747|1028664|P3|NOT COMPLETED|Overall Study||0
431253|NCT00747747|1028665|P2|NOT COMPLETED|Overall Study||0
431254|NCT00747747|1028666|P1|NOT COMPLETED|Overall Study||0
431255|NCT00747747|1028664|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
431256|NCT00747747|1028665|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
431339|NCT00747474|1028738|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431257|NCT00747747|1028666|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
431258|NCT00747747|1028664|P3|STARTED|Overall Study||21
431259|NCT00747747|1028665|P2|STARTED|Overall Study||14
431260|NCT00747747|1028666|P1|STARTED|Overall Study||14
431261|NCT00747643|1028691|P2|NOT COMPLETED|Overall Study||27
431262|NCT00747643|1028692|P1|NOT COMPLETED|Overall Study||36
431263|NCT00747643|1028691|P2|COMPLETED|Overall Study||54
431264|NCT00747643|1028692|P1|COMPLETED|Overall Study||46
431265|NCT00747643|1028691|P2|STARTED|Overall Study||81
431266|NCT00747643|1028692|P1|STARTED|Overall Study||82
431267|NCT00747617|1028706|P2|NOT COMPLETED|Overall Study||1
431268|NCT00747617|1028707|P1|NOT COMPLETED|Overall Study||3
431269|NCT00747617|1028706|P2|COMPLETED|Overall Study||11
431270|NCT00747617|1028707|P1|COMPLETED|Overall Study||10
431271|NCT00747617|1028706|P2|STARTED|Overall Study||12
431272|NCT00747617|1028707|P1|STARTED|Overall Study||13
431273|NCT00747565|1028715|P2|NOT COMPLETED|Overall Study||7
431274|NCT00747565|1028716|P1|NOT COMPLETED|Overall Study||14
431275|NCT00747565|1028715|P2|COMPLETED|Overall Study||116
431276|NCT00747565|1028716|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
431277|NCT00747565|1028715|P2|STARTED|Overall Study||123
431278|NCT00747565|1028716|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
431279|NCT00747552|1028724|P1|NOT COMPLETED|Overall Study||0
431280|NCT00747552|1028724|P1|COMPLETED|Overall Study||30
431281|NCT00747552|1028724|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
431282|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431283|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431284|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431285|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431286|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431287|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431288|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431289|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431290|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431291|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431292|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431293|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431294|NCT00747474|1028729|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
431295|NCT00747474|1028730|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431296|NCT00747474|1028731|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431297|NCT00747474|1028732|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431298|NCT00747474|1028733|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431299|NCT00747474|1028734|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431300|NCT00747474|1028735|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431301|NCT00747474|1028736|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431302|NCT00747474|1028737|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431303|NCT00747474|1028738|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431304|NCT00747474|1028739|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431305|NCT00747474|1028740|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
431306|NCT00747474|1028729|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
431307|NCT00747474|1028730|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
431308|NCT00747474|1028731|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
431309|NCT00747474|1028732|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
431310|NCT00747474|1028733|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
431311|NCT00747474|1028734|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
431312|NCT00747474|1028735|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
431313|NCT00747474|1028736|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
431314|NCT00747474|1028737|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
431315|NCT00747474|1028738|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
431316|NCT00747474|1028739|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
431317|NCT00747474|1028740|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
431318|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431319|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431320|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431321|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431322|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431323|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431324|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431325|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431326|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431327|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431328|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431329|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431330|NCT00747474|1028729|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431331|NCT00747474|1028730|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
431332|NCT00747474|1028731|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431333|NCT00747474|1028732|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431334|NCT00747474|1028733|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431335|NCT00747474|1028734|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431336|NCT00747474|1028735|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431337|NCT00747474|1028736|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431338|NCT00747474|1028737|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431340|NCT00747474|1028739|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431341|NCT00747474|1028740|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
431342|NCT00747474|1028729|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
431343|NCT00747474|1028730|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
431344|NCT00747474|1028731|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
431345|NCT00747474|1028732|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
431346|NCT00747474|1028733|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
431347|NCT00747474|1028734|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
431348|NCT00747474|1028735|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
431349|NCT00747474|1028736|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
431350|NCT00747474|1028737|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
431351|NCT00747474|1028738|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
431352|NCT00747474|1028739|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
431353|NCT00747474|1028740|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
431354|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431355|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431356|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431357|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431358|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431359|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431360|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431361|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431362|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431363|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431364|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431365|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431366|NCT00747474|1028729|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431367|NCT00747474|1028730|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431368|NCT00747474|1028731|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
431369|NCT00747474|1028732|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431370|NCT00747474|1028733|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431371|NCT00747474|1028734|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431372|NCT00747474|1028735|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431373|NCT00747474|1028736|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431374|NCT00747474|1028737|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431375|NCT00747474|1028738|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431376|NCT00747474|1028739|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431377|NCT00747474|1028740|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
431378|NCT00747474|1028729|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
431379|NCT00747474|1028730|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
431380|NCT00747474|1028731|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
431381|NCT00747474|1028732|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
431382|NCT00747474|1028733|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
431383|NCT00747474|1028734|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
431384|NCT00747474|1028735|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
431385|NCT00747474|1028736|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
431386|NCT00747474|1028737|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
431387|NCT00747474|1028738|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
431388|NCT00747474|1028739|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
431389|NCT00747474|1028740|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
431390|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431391|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431392|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431393|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431394|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431395|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431396|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431397|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431398|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431399|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431400|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431401|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431402|NCT00747474|1028729|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431403|NCT00747474|1028730|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431404|NCT00747474|1028731|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431405|NCT00747474|1028732|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
431406|NCT00747474|1028733|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431407|NCT00747474|1028734|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431408|NCT00747474|1028735|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431409|NCT00747474|1028736|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431410|NCT00747474|1028737|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431411|NCT00747474|1028738|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431412|NCT00747474|1028739|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431413|NCT00747474|1028740|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
431414|NCT00747474|1028729|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
431415|NCT00747474|1028730|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
431416|NCT00747474|1028731|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
431417|NCT00747474|1028732|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
431418|NCT00747474|1028733|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
431419|NCT00747474|1028734|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
431420|NCT00747474|1028735|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
431421|NCT00747474|1028736|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
431422|NCT00747474|1028737|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
431423|NCT00747474|1028738|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
431424|NCT00747474|1028739|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
431425|NCT00747474|1028740|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
431426|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431427|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431428|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431429|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431430|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
431431|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431432|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431433|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431434|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431435|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431436|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431437|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431438|NCT00747474|1028729|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431439|NCT00747474|1028730|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431440|NCT00747474|1028731|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431441|NCT00747474|1028732|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431442|NCT00747474|1028733|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
431443|NCT00747474|1028734|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431444|NCT00747474|1028735|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431445|NCT00747474|1028736|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431446|NCT00747474|1028737|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431447|NCT00747474|1028738|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431448|NCT00747474|1028739|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431449|NCT00747474|1028740|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
431450|NCT00747474|1028729|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
431451|NCT00747474|1028730|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
431452|NCT00747474|1028731|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
431453|NCT00747474|1028732|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
431454|NCT00747474|1028733|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
431455|NCT00747474|1028734|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
431456|NCT00747474|1028735|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
431457|NCT00747474|1028736|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
431458|NCT00747474|1028737|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
431459|NCT00747474|1028738|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
431460|NCT00747474|1028739|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
431461|NCT00747474|1028740|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
431462|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431463|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431464|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431465|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431466|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431467|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431468|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431469|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431470|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431471|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431472|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431473|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431474|NCT00747474|1028729|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431475|NCT00747474|1028730|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431476|NCT00747474|1028731|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431477|NCT00747474|1028732|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431478|NCT00747474|1028733|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431479|NCT00747474|1028734|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
431480|NCT00747474|1028735|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431481|NCT00747474|1028736|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431482|NCT00747474|1028737|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431483|NCT00747474|1028738|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431484|NCT00747474|1028739|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431485|NCT00747474|1028740|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
431486|NCT00747474|1028729|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
431487|NCT00747474|1028730|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
431488|NCT00747474|1028731|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
431489|NCT00747474|1028732|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
431490|NCT00747474|1028733|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
431491|NCT00747474|1028734|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
431492|NCT00747474|1028735|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
431493|NCT00747474|1028736|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
431494|NCT00747474|1028737|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
431495|NCT00747474|1028738|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
431496|NCT00747474|1028739|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
431497|NCT00747474|1028740|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
431498|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431499|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431500|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431501|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431502|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431503|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431504|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431505|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431506|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431507|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431508|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431509|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431510|NCT00747474|1028729|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431511|NCT00747474|1028730|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431512|NCT00747474|1028731|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431513|NCT00747474|1028732|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431514|NCT00747474|1028733|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431515|NCT00747474|1028734|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431516|NCT00747474|1028735|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
431517|NCT00747474|1028736|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431518|NCT00747474|1028737|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431519|NCT00747474|1028738|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431520|NCT00747474|1028739|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431521|NCT00747474|1028740|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
431522|NCT00747474|1028729|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
431523|NCT00747474|1028730|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
431524|NCT00747474|1028731|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
431525|NCT00747474|1028732|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
431526|NCT00747474|1028733|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
431527|NCT00747474|1028734|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
431528|NCT00747474|1028735|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
431529|NCT00747474|1028736|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
431530|NCT00747474|1028737|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
431531|NCT00747474|1028738|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
431532|NCT00747474|1028739|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
431533|NCT00747474|1028740|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
431534|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431535|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431536|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431537|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431538|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431539|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431540|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431541|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431542|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431543|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431544|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431545|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431546|NCT00747474|1028729|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431547|NCT00747474|1028730|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431548|NCT00747474|1028731|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431549|NCT00747474|1028732|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431550|NCT00747474|1028733|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431551|NCT00747474|1028734|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431552|NCT00747474|1028735|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431553|NCT00747474|1028736|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
431554|NCT00747474|1028737|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431555|NCT00747474|1028738|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431556|NCT00747474|1028739|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431557|NCT00747474|1028740|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
431558|NCT00747474|1028729|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431559|NCT00747474|1028730|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431560|NCT00747474|1028731|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431561|NCT00747474|1028732|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431562|NCT00747474|1028733|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431563|NCT00747474|1028734|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431564|NCT00747474|1028735|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431565|NCT00747474|1028736|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
431566|NCT00747474|1028737|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431567|NCT00747474|1028738|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431568|NCT00747474|1028739|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431569|NCT00747474|1028740|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
431570|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431571|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431572|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431573|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431574|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431575|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431576|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431577|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431578|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431579|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431580|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431581|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431582|NCT00747474|1028729|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431583|NCT00747474|1028730|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431584|NCT00747474|1028731|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431585|NCT00747474|1028732|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431586|NCT00747474|1028733|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431587|NCT00747474|1028734|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431588|NCT00747474|1028735|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431589|NCT00747474|1028736|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431590|NCT00747474|1028737|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
431591|NCT00747474|1028738|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431592|NCT00747474|1028739|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431593|NCT00747474|1028740|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
431594|NCT00747474|1028729|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
431595|NCT00747474|1028730|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
431596|NCT00747474|1028731|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
431597|NCT00747474|1028732|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
431598|NCT00747474|1028733|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
431599|NCT00747474|1028734|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
431600|NCT00747474|1028735|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
431601|NCT00747474|1028736|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
431602|NCT00747474|1028737|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
431603|NCT00747474|1028738|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
431604|NCT00747474|1028739|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
431605|NCT00747474|1028740|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
431606|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431607|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431608|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431609|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431610|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431611|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431612|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431613|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431614|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431615|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431616|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431617|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431618|NCT00747474|1028729|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431619|NCT00747474|1028730|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431620|NCT00747474|1028731|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431621|NCT00747474|1028732|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431622|NCT00747474|1028733|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431623|NCT00747474|1028734|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431624|NCT00747474|1028735|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431625|NCT00747474|1028736|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431626|NCT00747474|1028737|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431627|NCT00747474|1028738|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
431628|NCT00747474|1028739|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431629|NCT00747474|1028740|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
431630|NCT00747474|1028729|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
431631|NCT00747474|1028730|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
431632|NCT00747474|1028731|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
431633|NCT00747474|1028732|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
431634|NCT00747474|1028733|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
431635|NCT00747474|1028734|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
431636|NCT00747474|1028735|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
431637|NCT00747474|1028736|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
431638|NCT00747474|1028737|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
431639|NCT00747474|1028738|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
431640|NCT00747474|1028739|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
431641|NCT00747474|1028740|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
431642|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431643|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431644|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431645|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431646|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431647|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431648|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431649|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431650|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431651|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431652|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431653|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431654|NCT00747474|1028729|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431655|NCT00747474|1028730|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431656|NCT00747474|1028731|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431657|NCT00747474|1028732|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431658|NCT00747474|1028733|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431659|NCT00747474|1028734|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431660|NCT00747474|1028735|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431661|NCT00747474|1028736|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431662|NCT00747474|1028737|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431663|NCT00747474|1028738|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431664|NCT00747474|1028739|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
431665|NCT00747474|1028740|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
431666|NCT00747474|1028729|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
431667|NCT00747474|1028730|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
431668|NCT00747474|1028731|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
431669|NCT00747474|1028732|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
431670|NCT00747474|1028733|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
431671|NCT00747474|1028734|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
431672|NCT00747474|1028735|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
431673|NCT00747474|1028736|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
431674|NCT00747474|1028737|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
431675|NCT00747474|1028738|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
431676|NCT00747474|1028739|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
431677|NCT00747474|1028740|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
431678|NCT00747474|1028729|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431679|NCT00747474|1028730|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431680|NCT00747474|1028731|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431681|NCT00747474|1028732|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431682|NCT00747474|1028733|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431683|NCT00747474|1028734|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431684|NCT00747474|1028735|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431685|NCT00747474|1028736|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431686|NCT00747474|1028737|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431687|NCT00747474|1028738|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431688|NCT00747474|1028739|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431689|NCT00747474|1028740|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431690|NCT00747474|1028729|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431691|NCT00747474|1028730|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431692|NCT00747474|1028731|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431693|NCT00747474|1028732|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431694|NCT00747474|1028733|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431695|NCT00747474|1028734|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431696|NCT00747474|1028735|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431697|NCT00747474|1028736|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431698|NCT00747474|1028737|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431699|NCT00747474|1028738|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431700|NCT00747474|1028739|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
431701|NCT00747474|1028740|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
431702|NCT00747474|1028729|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431703|NCT00747474|1028730|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431704|NCT00747474|1028731|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431705|NCT00747474|1028732|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431706|NCT00747474|1028733|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431707|NCT00747474|1028734|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431708|NCT00747474|1028735|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431709|NCT00747474|1028736|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431710|NCT00747474|1028737|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431711|NCT00747474|1028738|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431712|NCT00747474|1028739|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
431713|NCT00747474|1028740|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
431714|NCT00747461|1028766|P1|NOT COMPLETED|Overall Study||5
431715|NCT00747461|1028766|P1|COMPLETED|Overall Study||0
431716|NCT00747461|1028766|P1|STARTED|Overall Study||5
431717|NCT00747435|1028771|P1|NOT COMPLETED|Overall Study||6
431718|NCT00747435|1028771|P1|COMPLETED|Overall Study||67
431719|NCT00747435|1028771|P1|STARTED|Overall Study||73
431720|NCT00747344|1028781|P4|NOT COMPLETED|After Controlled Period||1
431721|NCT00747344|1028782|P3|NOT COMPLETED|After Controlled Period||0
431722|NCT00747344|1028783|P2|NOT COMPLETED|After Controlled Period||0
431723|NCT00747344|1028784|P1|NOT COMPLETED|After Controlled Period||0
431724|NCT00747344|1028781|P4|COMPLETED|After Controlled Period||56
431725|NCT00747344|1028782|P3|COMPLETED|After Controlled Period||55
431726|NCT00747344|1028783|P2|COMPLETED|After Controlled Period||0
431727|NCT00747344|1028784|P1|COMPLETED|After Controlled Period||0
431728|NCT00747344|1028781|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
431729|NCT00747344|1028782|P3|STARTED|After Controlled Period||55
431730|NCT00747344|1028783|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
431731|NCT00747344|1028784|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
431732|NCT00747344|1028781|P4|NOT COMPLETED|Controlled Period||0
431733|NCT00747344|1028782|P3|NOT COMPLETED|Controlled Period||0
431734|NCT00747344|1028783|P2|NOT COMPLETED|Controlled Period||4
431735|NCT00747344|1028784|P1|NOT COMPLETED|Controlled Period||5
431736|NCT00747344|1028781|P4|COMPLETED|Controlled Period||0
431737|NCT00747344|1028782|P3|COMPLETED|Controlled Period||0
431738|NCT00747344|1028783|P2|COMPLETED|Controlled Period||57
431739|NCT00747344|1028784|P1|COMPLETED|Controlled Period||55
431740|NCT00747344|1028781|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
431741|NCT00747344|1028782|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
431742|NCT00747344|1028783|P2|STARTED|Controlled Period||61
431743|NCT00747344|1028784|P1|STARTED|Controlled Period||60
431744|NCT00747227|1028798|P2|NOT COMPLETED|Overall Study||4
431745|NCT00747227|1028799|P1|NOT COMPLETED|Overall Study||6
431746|NCT00747227|1028798|P2|COMPLETED|Overall Study||120
431747|NCT00747227|1028799|P1|COMPLETED|Overall Study||120
431748|NCT00747227|1028798|P2|STARTED|Overall Study||124
431749|NCT00747227|1028799|P1|STARTED|Overall Study||126
431750|NCT00747214|1028813|P2|NOT COMPLETED|Overall Study||3
431751|NCT00747214|1028814|P1|NOT COMPLETED|Overall Study||8
431752|NCT00747214|1028813|P2|COMPLETED|Overall Study||29
431753|NCT00747214|1028814|P1|COMPLETED|Overall Study||19
431754|NCT00747214|1028813|P2|STARTED|Overall Study||32
431755|NCT00747214|1028814|P1|STARTED|Overall Study||27
431756|NCT00747149|1028828|P2|NOT COMPLETED|Overall Study||43
431757|NCT00747149|1028829|P1|NOT COMPLETED|Overall Study||1
431758|NCT00747149|1028828|P2|COMPLETED|Overall Study||401
431759|NCT00747149|1028829|P1|COMPLETED|Overall Study||153
431760|NCT00747149|1028828|P2|STARTED|Overall Study||444
431761|NCT00747149|1028829|P1|STARTED|Overall Study||154
431762|NCT00747006|1028844|P3|NOT COMPLETED|Overall Study||1
431763|NCT00747006|1028845|P2|NOT COMPLETED|Overall Study||1
431764|NCT00747006|1028846|P1|NOT COMPLETED|Overall Study||3
431765|NCT00747006|1028844|P3|COMPLETED|Overall Study||2
431766|NCT00747006|1028845|P2|COMPLETED|Overall Study||7
431767|NCT00747006|1028846|P1|COMPLETED|Overall Study||4
431768|NCT00747006|1028844|P3|STARTED|Overall Study||3
431769|NCT00747006|1028845|P2|STARTED|Overall Study||8
431770|NCT00747006|1028846|P1|STARTED|Overall Study||7
431771|NCT00746954|1028912|P3|NOT COMPLETED|Overall Study||0
431772|NCT00746954|1028913|P2|NOT COMPLETED|Overall Study||0
431773|NCT00746954|1028914|P1|NOT COMPLETED|Overall Study||0
431774|NCT00746954|1028912|P3|COMPLETED|Overall Study||2
431775|NCT00746954|1028913|P2|COMPLETED|Overall Study||3
431776|NCT00746954|1028914|P1|COMPLETED|Overall Study||3
431777|NCT00746954|1028912|P3|STARTED|Overall Study||2
431778|NCT00746954|1028913|P2|STARTED|Overall Study||3
431779|NCT00746954|1028914|P1|STARTED|Overall Study||3
431780|NCT00746941|1028924|P4|NOT COMPLETED|Overall Study||13
431781|NCT00746941|1028925|P3|NOT COMPLETED|Overall Study||2
431782|NCT00746941|1028926|P2|NOT COMPLETED|Overall Study||4
431783|NCT00746941|1028927|P1|NOT COMPLETED|Overall Study||7
431784|NCT00746941|1028924|P4|COMPLETED|Overall Study||7
431785|NCT00746941|1028925|P3|COMPLETED|Overall Study||3
431786|NCT00746941|1028926|P2|COMPLETED|Overall Study||1
431787|NCT00746941|1028927|P1|COMPLETED|Overall Study||0
431788|NCT00746941|1028924|P4|STARTED|Overall Study||20
431789|NCT00746941|1028925|P3|STARTED|Overall Study||5
431790|NCT00746941|1028926|P2|STARTED|Overall Study||5
431791|NCT00746941|1028927|P1|STARTED|Overall Study||7
431792|NCT00746889|1028955|P2|NOT COMPLETED|Overall Study||4
431793|NCT00746889|1028956|P1|NOT COMPLETED|Overall Study||4
431794|NCT00746889|1028955|P2|COMPLETED|Overall Study||35
431795|NCT00746889|1028956|P1|COMPLETED|Overall Study||36
431796|NCT00746889|1028955|P2|STARTED|Overall Study||39
431797|NCT00746889|1028956|P1|STARTED|Overall Study||40
431798|NCT00746863|1028966|P2|NOT COMPLETED|Overall Study||0
431799|NCT00746863|1028967|P1|NOT COMPLETED|Overall Study||0
431800|NCT00746863|1028966|P2|COMPLETED|Overall Study||21
431801|NCT00746863|1028967|P1|COMPLETED|Overall Study||21
431802|NCT00746863|1028966|P2|STARTED|Overall Study||21
431803|NCT00746863|1028967|P1|STARTED|Overall Study||21
431804|NCT00746798|1028985|P4|NOT COMPLETED|Overall Study||0
431805|NCT00746798|1028986|P3|NOT COMPLETED|Overall Study||3
431806|NCT00746798|1028987|P2|NOT COMPLETED|Overall Study||2
431807|NCT00746798|1028988|P1|NOT COMPLETED|Overall Study||1
431808|NCT00746798|1028985|P4|COMPLETED|Overall Study||120
431809|NCT00746798|1028986|P3|COMPLETED|Overall Study||110
431810|NCT00746798|1028987|P2|COMPLETED|Overall Study||122
431811|NCT00746798|1028988|P1|COMPLETED|Overall Study||121
431812|NCT00746798|1028985|P4|STARTED|Overall Study||120
431813|NCT00746798|1028986|P3|STARTED|Overall Study||113
431814|NCT00746798|1028987|P2|STARTED|Overall Study||124
431815|NCT00746798|1028988|P1|STARTED|Overall Study||122
431816|NCT00746785|1029013|P3|NOT COMPLETED|Overall Study||27
431817|NCT00746785|1029014|P2|NOT COMPLETED|Overall Study||25
431818|NCT00746785|1029015|P1|NOT COMPLETED|Overall Study||29
431819|NCT00746785|1029013|P3|COMPLETED|Overall Study||13
431820|NCT00746785|1029014|P2|COMPLETED|Overall Study||21
431821|NCT00746785|1029015|P1|COMPLETED|Overall Study||14
431822|NCT00746785|1029013|P3|STARTED|Overall Study||40
431823|NCT00746785|1029014|P2|STARTED|Overall Study||46
431824|NCT00746785|1029015|P1|STARTED|Overall Study||43
431825|NCT00746733|1029023|P2|NOT COMPLETED|Fourth Intervention||0
431826|NCT00746733|1029024|P1|NOT COMPLETED|Fourth Intervention||0
431827|NCT00746733|1029023|P2|COMPLETED|Fourth Intervention||11
431828|NCT00746733|1029024|P1|COMPLETED|Fourth Intervention||10
431829|NCT00746733|1029023|P2|STARTED|Fourth Intervention||11
431830|NCT00746733|1029024|P1|STARTED|Fourth Intervention||10
431831|NCT00746733|1029023|P2|NOT COMPLETED|Third Intervention||1
431832|NCT00746733|1029024|P1|NOT COMPLETED|Third Intervention||1
431833|NCT00746733|1029023|P2|COMPLETED|Third Intervention||11
431834|NCT00746733|1029024|P1|COMPLETED|Third Intervention||10
431835|NCT00746733|1029023|P2|STARTED|Third Intervention||12
431836|NCT00746733|1029024|P1|STARTED|Third Intervention||11
431837|NCT00746733|1029023|P2|NOT COMPLETED|Second Intervention||0
431838|NCT00746733|1029024|P1|NOT COMPLETED|Second Intervention||1
431839|NCT00746733|1029023|P2|COMPLETED|Second Intervention||12
431840|NCT00746733|1029024|P1|COMPLETED|Second Intervention||11
431841|NCT00746733|1029023|P2|STARTED|Second Intervention||12
431842|NCT00746733|1029024|P1|STARTED|Second Intervention||12
431843|NCT00746733|1029023|P2|NOT COMPLETED|First Intervention||0
431844|NCT00746733|1029024|P1|NOT COMPLETED|First Intervention||0
431845|NCT00746733|1029023|P2|COMPLETED|First Intervention||12
431846|NCT00746733|1029024|P1|COMPLETED|First Intervention||12
431847|NCT00746733|1029023|P2|STARTED|First Intervention||12
431848|NCT00746733|1029024|P1|STARTED|First Intervention||12
431849|NCT00746694|1029084|P1|NOT COMPLETED|Overall Study||0
431850|NCT00746694|1029084|P1|COMPLETED|Overall Study||154
431851|NCT00746694|1029084|P1|STARTED|Overall Study||154
431852|NCT00746668|1029089|P7|NOT COMPLETED|Overall Study||0
431853|NCT00746668|1029090|P6|NOT COMPLETED|Overall Study||0
431854|NCT00746668|1029091|P5|NOT COMPLETED|Overall Study||0
431855|NCT00746668|1029092|P4|NOT COMPLETED|Overall Study||0
431856|NCT00746668|1029093|P3|NOT COMPLETED|Overall Study||0
431857|NCT00746668|1029094|P2|NOT COMPLETED|Overall Study||0
431858|NCT00746668|1029095|P1|NOT COMPLETED|Overall Study||0
431859|NCT00746668|1029089|P7|COMPLETED|Overall Study||5
431860|NCT00746668|1029090|P6|COMPLETED|Overall Study||5
431861|NCT00746668|1029091|P5|COMPLETED|Overall Study||5
431862|NCT00746668|1029092|P4|COMPLETED|Overall Study||5
431863|NCT00746668|1029093|P3|COMPLETED|Overall Study||5
431864|NCT00746668|1029094|P2|COMPLETED|Overall Study||5
431865|NCT00746668|1029095|P1|COMPLETED|Overall Study||6
431866|NCT00746668|1029089|P7|STARTED|Overall Study||5
431867|NCT00746668|1029090|P6|STARTED|Overall Study||5
431868|NCT00746668|1029091|P5|STARTED|Overall Study||5
431869|NCT00746668|1029092|P4|STARTED|Overall Study||5
431870|NCT00746668|1029093|P3|STARTED|Overall Study||5
431871|NCT00746668|1029094|P2|STARTED|Overall Study||5
431872|NCT00746668|1029095|P1|STARTED|Overall Study||6
431873|NCT00746590|1029108|P1|NOT COMPLETED|Overall Study||1
431874|NCT00746590|1029108|P1|COMPLETED|Overall Study||0
431875|NCT00746590|1029108|P1|STARTED|Overall Study||1
431876|NCT00746564|1029112|P1|NOT COMPLETED|Overall Study||2
431877|NCT00746564|1029112|P1|COMPLETED|Overall Study||73
431878|NCT00746564|1029112|P1|STARTED|Overall Study||75
431879|NCT00746551|1029127|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
431880|NCT00746551|1029128|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
431881|NCT00746551|1029127|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
431882|NCT00746551|1029128|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
431883|NCT00746551|1029127|P2|STARTED|At Delivery (GA of 39 Weeks)||40
431884|NCT00746551|1029128|P1|STARTED|At Delivery (GA of 39 Weeks)||40
431885|NCT00746551|1029127|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
431886|NCT00746551|1029128|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
431887|NCT00746551|1029127|P2|COMPLETED|At Gestational Age of 36 Weeks||36
431888|NCT00746551|1029128|P1|COMPLETED|At Gestational Age of 36 Weeks||38
431889|NCT00746551|1029127|P2|STARTED|At Gestational Age of 36 Weeks||40
431890|NCT00746551|1029128|P1|STARTED|At Gestational Age of 36 Weeks||40
431891|NCT00746512|1029140|P4|NOT COMPLETED|Overall Study||0
431892|NCT00746512|1029141|P3|NOT COMPLETED|Overall Study||0
431893|NCT00746512|1029142|P2|NOT COMPLETED|Overall Study||0
431894|NCT00746512|1029143|P1|NOT COMPLETED|Overall Study||0
431895|NCT00746512|1029140|P4|COMPLETED|Overall Study||9
431896|NCT00746512|1029141|P3|COMPLETED|Overall Study||18
431897|NCT00746512|1029142|P2|COMPLETED|Overall Study||10
431898|NCT00746512|1029143|P1|COMPLETED|Overall Study||8
431899|NCT00746512|1029140|P4|STARTED|Overall Study||9
431900|NCT00746512|1029141|P3|STARTED|Overall Study||18
431901|NCT00746512|1029142|P2|STARTED|Overall Study||10
431902|NCT00746512|1029143|P1|STARTED|Overall Study||8
431903|NCT00746421|1029159|P2|NOT COMPLETED|Overall Study||2
431904|NCT00746421|1029160|P1|NOT COMPLETED|Overall Study||7
431905|NCT00746421|1029159|P2|COMPLETED|Overall Study||9
431906|NCT00746421|1029160|P1|COMPLETED|Overall Study||5
431907|NCT00746421|1029159|P2|STARTED|Overall Study||11
431908|NCT00746421|1029160|P1|STARTED|Overall Study||12
431909|NCT00746395|1029170|P2|NOT COMPLETED|Overall Study||0
431910|NCT00746395|1029171|P1|NOT COMPLETED|Overall Study||0
431911|NCT00746395|1029170|P2|COMPLETED|Overall Study||20
431912|NCT00746395|1029171|P1|COMPLETED|Overall Study||20
431913|NCT00746395|1029170|P2|STARTED|Overall Study||20
431914|NCT00746395|1029171|P1|STARTED|Overall Study||20
431915|NCT00746356|1029179|P2|NOT COMPLETED|Overall Study||7
431916|NCT00746356|1029180|P1|NOT COMPLETED|Overall Study||11
431917|NCT00746356|1029179|P2|COMPLETED|Overall Study||40
431918|NCT00746356|1029180|P1|COMPLETED|Overall Study||70
431919|NCT00746356|1029179|P2|STARTED|Overall Study||47
431920|NCT00746356|1029180|P1|STARTED|Overall Study||81
431921|NCT00746330|1029192|P4|NOT COMPLETED|Period 4||0
431922|NCT00746330|1029193|P3|NOT COMPLETED|Period 4||0
431923|NCT00746330|1029194|P2|NOT COMPLETED|Period 4||0
431924|NCT00746330|1029195|P1|NOT COMPLETED|Period 4||0
431925|NCT00746330|1029192|P4|COMPLETED|Period 4||7
431926|NCT00746330|1029193|P3|COMPLETED|Period 4||8
431927|NCT00746330|1029194|P2|COMPLETED|Period 4||9
431928|NCT00746330|1029195|P1|COMPLETED|Period 4||7
431929|NCT00746330|1029192|P4|STARTED|Period 4||7
431930|NCT00746330|1029193|P3|STARTED|Period 4||8
431931|NCT00746330|1029194|P2|STARTED|Period 4||9
431932|NCT00746330|1029195|P1|STARTED|Period 4||7
431933|NCT00746330|1029192|P4|NOT COMPLETED|Period 3||0
431934|NCT00746330|1029193|P3|NOT COMPLETED|Period 3||0
431935|NCT00746330|1029194|P2|NOT COMPLETED|Period 3||0
431936|NCT00746330|1029195|P1|NOT COMPLETED|Period 3||0
431937|NCT00746330|1029192|P4|COMPLETED|Period 3||7
431938|NCT00746330|1029193|P3|COMPLETED|Period 3||8
431939|NCT00746330|1029194|P2|COMPLETED|Period 3||9
431940|NCT00746330|1029195|P1|COMPLETED|Period 3||7
431941|NCT00746330|1029192|P4|STARTED|Period 3||7
431942|NCT00746330|1029193|P3|STARTED|Period 3||8
431943|NCT00746330|1029194|P2|STARTED|Period 3||9
431944|NCT00746330|1029195|P1|STARTED|Period 3||7
431945|NCT00746330|1029192|P4|NOT COMPLETED|Period 2||0
431946|NCT00746330|1029193|P3|NOT COMPLETED|Period 2||0
431947|NCT00746330|1029194|P2|NOT COMPLETED|Period 2||0
431948|NCT00746330|1029195|P1|NOT COMPLETED|Period 2||0
431949|NCT00746330|1029192|P4|COMPLETED|Period 2||7
431950|NCT00746330|1029193|P3|COMPLETED|Period 2||8
431951|NCT00746330|1029194|P2|COMPLETED|Period 2||9
431952|NCT00746330|1029195|P1|COMPLETED|Period 2||7
431953|NCT00746330|1029192|P4|STARTED|Period 2||7
431954|NCT00746330|1029193|P3|STARTED|Period 2||8
431955|NCT00746330|1029194|P2|STARTED|Period 2||9
431956|NCT00746330|1029195|P1|STARTED|Period 2||7
431957|NCT00746330|1029192|P4|NOT COMPLETED|Period 1||0
431958|NCT00746330|1029193|P3|NOT COMPLETED|Period 1||1
431959|NCT00746330|1029194|P2|NOT COMPLETED|Period 1||0
431960|NCT00746330|1029195|P1|NOT COMPLETED|Period 1||0
431961|NCT00746330|1029192|P4|COMPLETED|Period 1||7
431962|NCT00746330|1029193|P3|COMPLETED|Period 1||8
431963|NCT00746330|1029194|P2|COMPLETED|Period 1||9
431964|NCT00746330|1029195|P1|COMPLETED|Period 1||7
431965|NCT00746330|1029192|P4|STARTED|Period 1||7
431966|NCT00746330|1029193|P3|STARTED|Period 1||9
431967|NCT00746330|1029194|P2|STARTED|Period 1||9
431968|NCT00746330|1029195|P1|STARTED|Period 1||7
431969|NCT00746239|1029223|P1|NOT COMPLETED|Overall Study||6
431970|NCT00746239|1029223|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
431971|NCT00746239|1029223|P1|STARTED|Overall Study||11
431972|NCT00746187|1029229|P2|NOT COMPLETED|Overall Study||2
431973|NCT00746187|1029230|P1|NOT COMPLETED|Overall Study||3
431974|NCT00746187|1029229|P2|COMPLETED|Overall Study||16
431975|NCT00746187|1029230|P1|COMPLETED|Overall Study||15
431976|NCT00746187|1029229|P2|STARTED|Overall Study||18
431977|NCT00746187|1029230|P1|STARTED|Overall Study||18
431978|NCT00746096|1029238|P2|NOT COMPLETED|Overall Study||3
431979|NCT00746096|1029239|P1|NOT COMPLETED|Overall Study||10
431980|NCT00746096|1029238|P2|COMPLETED|Overall Study||54
431981|NCT00746096|1029239|P1|COMPLETED|Overall Study||48
431982|NCT00746096|1029238|P2|STARTED|Overall Study||57
431983|NCT00746096|1029239|P1|STARTED|Overall Study||58
431984|NCT00745940|1029249|P2|NOT COMPLETED|Overall Study||10
431985|NCT00745940|1029250|P1|NOT COMPLETED|Overall Study||19
431986|NCT00745940|1029249|P2|COMPLETED|Overall Study||38
431987|NCT00745940|1029250|P1|COMPLETED|Overall Study||38
431988|NCT00745940|1029249|P2|STARTED|Overall Study||48
431989|NCT00745940|1029250|P1|STARTED|Overall Study||57
431990|NCT00745901|1029266|P2|NOT COMPLETED|Overall Study||21
431991|NCT00745901|1029267|P1|NOT COMPLETED|Overall Study||24
431992|NCT00745901|1029266|P2|COMPLETED|Overall Study||156
431993|NCT00745901|1029267|P1|COMPLETED|Overall Study||154
431994|NCT00745901|1029266|P2|STARTED|Overall Study|Number of Patients Randomized|177
431995|NCT00745901|1029267|P1|STARTED|Overall Study|Number of Patients Randomized|178
431996|NCT00745875|1029313|P2|NOT COMPLETED|Overall Study||4
431997|NCT00745875|1029314|P1|NOT COMPLETED|Overall Study||4
431998|NCT00745875|1029313|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
431999|NCT00745875|1029314|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
432000|NCT00745875|1029313|P2|STARTED|Overall Study|Started – Number of patients randomised|30
432001|NCT00745875|1029314|P1|STARTED|Overall Study|Started – Number of patients randomised|36
432002|NCT00745095|1029328|P6|NOT COMPLETED|Overall Study||123
432003|NCT00745095|1029329|P5|NOT COMPLETED|Overall Study||122
432004|NCT00745095|1029330|P4|NOT COMPLETED|Overall Study||3
432005|NCT00745095|1029331|P3|NOT COMPLETED|Overall Study||3
432006|NCT00745095|1029332|P2|NOT COMPLETED|Overall Study||2
432007|NCT00745095|1029333|P1|NOT COMPLETED|Overall Study||1
432008|NCT00745095|1029328|P6|COMPLETED|Overall Study||27
432009|NCT00745095|1029329|P5|COMPLETED|Overall Study||28
432010|NCT00745095|1029330|P4|COMPLETED|Overall Study||12
432011|NCT00745095|1029331|P3|COMPLETED|Overall Study||12
432012|NCT00745095|1029332|P2|COMPLETED|Overall Study||13
432013|NCT00745095|1029333|P1|COMPLETED|Overall Study||14
432014|NCT00745095|1029328|P6|STARTED|Overall Study||150
432015|NCT00745095|1029329|P5|STARTED|Overall Study||150
432016|NCT00745095|1029330|P4|STARTED|Overall Study||15
432017|NCT00745095|1029331|P3|STARTED|Overall Study||15
432018|NCT00745095|1029332|P2|STARTED|Overall Study||15
432019|NCT00745095|1029333|P1|STARTED|Overall Study||15
432020|NCT00745030|1029355|P2|NOT COMPLETED|Overall Study||0
432021|NCT00745030|1029356|P1|NOT COMPLETED|Overall Study||0
432022|NCT00745030|1029355|P2|COMPLETED|Overall Study||2
432023|NCT00745030|1029356|P1|COMPLETED|Overall Study||1
432024|NCT00745030|1029355|P2|STARTED|Overall Study||2
432025|NCT00745030|1029356|P1|STARTED|Overall Study||1
432026|NCT00744978|1029364|P2|NOT COMPLETED|Period 2||1
432027|NCT00744978|1029365|P1|NOT COMPLETED|Period 2||0
432028|NCT00744978|1029364|P2|COMPLETED|Period 2||28
432029|NCT00744978|1029365|P1|COMPLETED|Period 2||26
432030|NCT00744978|1029364|P2|STARTED|Period 2||29
432031|NCT00744978|1029365|P1|STARTED|Period 2||26
432032|NCT00744978|1029364|P2|NOT COMPLETED|Placebo Washout||0
432033|NCT00744978|1029365|P1|NOT COMPLETED|Placebo Washout||0
432034|NCT00744978|1029364|P2|COMPLETED|Placebo Washout||29
432035|NCT00744978|1029365|P1|COMPLETED|Placebo Washout||26
432036|NCT00744978|1029364|P2|STARTED|Placebo Washout||29
432037|NCT00744978|1029365|P1|STARTED|Placebo Washout||26
432038|NCT00744978|1029364|P2|NOT COMPLETED|Period 1||5
432039|NCT00744978|1029365|P1|NOT COMPLETED|Period 1||6
432040|NCT00744978|1029364|P2|COMPLETED|Period 1||29
432041|NCT00744978|1029365|P1|COMPLETED|Period 1||26
432042|NCT00744978|1029364|P2|Treated|Period 1||33
432043|NCT00744978|1029365|P1|Treated|Period 1||31
432044|NCT00744978|1029364|P2|STARTED|Period 1||34
432045|NCT00744978|1029365|P1|STARTED|Period 1||32
432046|NCT00744939|1029417|P1|NOT COMPLETED|Overall Study||91
432047|NCT00744939|1029417|P1|COMPLETED|Overall Study||77
432048|NCT00744939|1029417|P1|Treatment Received|Overall Study||141
432049|NCT00744939|1029417|P1|STARTED|Overall Study||168
432050|NCT00745823|1029455|P2|NOT COMPLETED|Overall Study||386
432051|NCT00745823|1029456|P1|NOT COMPLETED|Overall Study||385
432052|NCT00745823|1029455|P2|COMPLETED|Overall Study||3
432053|NCT00745823|1029456|P1|COMPLETED|Overall Study||1
432054|NCT00745823|1029455|P2|TREATED Week 0 - 96|Overall Study||388
432055|NCT00745823|1029456|P1|TREATED Week 0 - 96|Overall Study||382
432056|NCT00745823|1029455|P2|STARTED|Overall Study||389
432057|NCT00745823|1029456|P1|STARTED|Overall Study||386
432058|NCT00745498|1029483|P3|NOT COMPLETED|Overall Study||8
432059|NCT00745498|1029484|P2|NOT COMPLETED|Overall Study||6
432060|NCT00745498|1029485|P1|NOT COMPLETED|Overall Study||5
432061|NCT00745498|1029483|P3|COMPLETED|Overall Study||34
432062|NCT00745498|1029484|P2|COMPLETED|Overall Study||37
432063|NCT00745498|1029485|P1|COMPLETED|Overall Study||36
432064|NCT00745498|1029483|P3|STARTED|Overall Study||42
432065|NCT00745498|1029484|P2|STARTED|Overall Study||43
432066|NCT00745498|1029485|P1|STARTED|Overall Study||41
432067|NCT00745368|1029499|P1|NOT COMPLETED|Overall Study||3
432068|NCT00745368|1029499|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
432069|NCT00745368|1029499|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
432070|NCT00745290|1029512|P2|NOT COMPLETED|Overall Study||0
432071|NCT00745290|1029513|P1|NOT COMPLETED|Overall Study||0
432072|NCT00745290|1029512|P2|COMPLETED|Overall Study||122
432073|NCT00745290|1029513|P1|COMPLETED|Overall Study||123
432074|NCT00745290|1029512|P2|STARTED|Overall Study||122
432075|NCT00745290|1029513|P1|STARTED|Overall Study||123
432076|NCT00745251|1029521|P2|NOT COMPLETED|Overall Study||3
432077|NCT00745251|1029522|P1|NOT COMPLETED|Overall Study||2
432078|NCT00745251|1029521|P2|COMPLETED|Overall Study||19
432079|NCT00745251|1029522|P1|COMPLETED|Overall Study||21
432080|NCT00745251|1029521|P2|STARTED|Overall Study||22
432081|NCT00745251|1029522|P1|STARTED|Overall Study||23
432082|NCT00744874|1029530|P1|NOT COMPLETED|Overall Study||4
432083|NCT00744874|1029530|P1|COMPLETED|Overall Study||51
432084|NCT00744874|1029530|P1|STARTED|Overall Study||55
432085|NCT00744848|1029548|P2|NOT COMPLETED|Overall Study||0
432086|NCT00744848|1029549|P1|NOT COMPLETED|Overall Study||0
432087|NCT00744848|1029548|P2|COMPLETED|Overall Study||101
432088|NCT00744848|1029549|P1|COMPLETED|Overall Study||103
432089|NCT00744848|1029548|P2|STARTED|Overall Study||101
432090|NCT00744848|1029549|P1|STARTED|Overall Study||103
432091|NCT00744757|1029555|P1|NOT COMPLETED|Overall Study||21
432092|NCT00744757|1029555|P1|COMPLETED|Overall Study||16
432093|NCT00744757|1029555|P1|STARTED|Overall Study||37
432094|NCT00744692|1029568|P1|NOT COMPLETED|Overall Study||0
432095|NCT00744692|1029568|P1|COMPLETED|Overall Study||22
432096|NCT00744692|1029568|P1|STARTED|Overall Study||22
432097|NCT00744653|1029580|P1|NOT COMPLETED|Overall Study||16
432098|NCT00744653|1029580|P1|COMPLETED|Overall Study||1
432099|NCT00744653|1029580|P1|STARTED|Overall Study||17
432100|NCT00744627|1029588|P2|NOT COMPLETED|Overall Study||22
432101|NCT00744627|1029589|P1|NOT COMPLETED|Overall Study||25
432102|NCT00744627|1029588|P2|COMPLETED|Overall Study||128
432103|NCT00744627|1029589|P1|COMPLETED|Overall Study||126
432104|NCT00744627|1029588|P2|Treated|Overall Study||150
432105|NCT00744627|1029589|P1|Treated|Overall Study||150
432106|NCT00744627|1029588|P2|STARTED|Overall Study||150
432107|NCT00744627|1029589|P1|STARTED|Overall Study||151
432108|NCT00744523|1029645|P2|NOT COMPLETED|30 Days After the Procedure||5
432109|NCT00744523|1029646|P1|NOT COMPLETED|30 Days After the Procedure||0
432110|NCT00744523|1029645|P2|COMPLETED|30 Days After the Procedure||220
432111|NCT00744523|1029646|P1|COMPLETED|30 Days After the Procedure||37
432112|NCT00744523|1029645|P2|STARTED|30 Days After the Procedure||225
432113|NCT00744523|1029646|P1|STARTED|30 Days After the Procedure||37
432114|NCT00744523|1029645|P2|NOT COMPLETED|Procedure||0
432115|NCT00744523|1029646|P1|NOT COMPLETED|Procedure||0
432116|NCT00744523|1029645|P2|COMPLETED|Procedure||225
432117|NCT00744523|1029646|P1|COMPLETED|Procedure||37
432118|NCT00744523|1029645|P2|STARTED|Procedure||225
432119|NCT00744523|1029646|P1|STARTED|Procedure||37
432120|NCT00744497|1029666|P2|NOT COMPLETED|Overall Study||762
432121|NCT00744497|1029667|P1|NOT COMPLETED|Overall Study||760
432122|NCT00744497|1029666|P2|COMPLETED|Overall Study||0
432123|NCT00744497|1029667|P1|COMPLETED|Overall Study||0
432124|NCT00744497|1029666|P2|Received Treatment|Overall Study||761
432125|NCT00744497|1029667|P1|Received Treatment|Overall Study||757
432126|NCT00744497|1029666|P2|STARTED|Overall Study|Randomized|762
432127|NCT00744497|1029667|P1|STARTED|Overall Study|Randomized|760
432128|NCT00744380|1029703|P2|NOT COMPLETED|Overall Study||0
432129|NCT00744380|1029704|P1|NOT COMPLETED|Overall Study||0
432130|NCT00744380|1029703|P2|COMPLETED|Overall Study||11
432131|NCT00744380|1029704|P1|COMPLETED|Overall Study||12
432132|NCT00744380|1029703|P2|STARTED|Overall Study||11
432133|NCT00744380|1029704|P1|STARTED|Overall Study||12
432134|NCT00744328|1029727|P3|NOT COMPLETED|Overall Study||8
432135|NCT00744328|1029728|P2|NOT COMPLETED|Overall Study||8
432136|NCT00744328|1029729|P1|NOT COMPLETED|Overall Study||7
432137|NCT00744328|1029727|P3|COMPLETED|Overall Study||21
432138|NCT00744328|1029728|P2|COMPLETED|Overall Study||22
432139|NCT00744328|1029729|P1|COMPLETED|Overall Study||19
432140|NCT00744328|1029727|P3|STARTED|Overall Study||29
432141|NCT00744328|1029728|P2|STARTED|Overall Study||30
432142|NCT00744328|1029729|P1|STARTED|Overall Study||26
432143|NCT00744263|1029739|P2|NOT COMPLETED|Overall Study||5320
432144|NCT00744263|1029740|P1|NOT COMPLETED|Overall Study||5236
432145|NCT00744263|1029739|P2|COMPLETED|Overall Study||36936
432146|NCT00744263|1029740|P1|COMPLETED|Overall Study||37004
432147|NCT00744263|1029739|P2|STARTED|Overall Study||42256
432148|NCT00744263|1029740|P1|STARTED|Overall Study||42240
432149|NCT00744237|1029763|P3|NOT COMPLETED|Overall Study||15
432150|NCT00744237|1029764|P2|NOT COMPLETED|Overall Study||27
432151|NCT00744237|1029765|P1|NOT COMPLETED|Overall Study||27
432152|NCT00744237|1029763|P3|COMPLETED|Overall Study||59
432153|NCT00744237|1029764|P2|COMPLETED|Overall Study||46
432154|NCT00744237|1029765|P1|COMPLETED|Overall Study||56
432155|NCT00744237|1029763|P3|STARTED|Overall Study||74
432156|NCT00744237|1029764|P2|STARTED|Overall Study||73
432157|NCT00744237|1029765|P1|STARTED|Overall Study||83
432158|NCT00744055|1029778|P2|NOT COMPLETED|Overall Study||14
432159|NCT00744055|1029779|P1|NOT COMPLETED|Overall Study||7
432160|NCT00744055|1029778|P2|COMPLETED|Overall Study||32
432161|NCT00744055|1029779|P1|COMPLETED|Overall Study||43
432162|NCT00744055|1029778|P2|STARTED|Overall Study||46
432163|NCT00744055|1029779|P1|STARTED|Overall Study||50
432164|NCT00744042|1029787|P1|NOT COMPLETED|Overall Study||1
432165|NCT00744042|1029787|P1|COMPLETED|Overall Study||10
432166|NCT00744042|1029787|P1|STARTED|Overall Study||11
432167|NCT00743730|1029803|P3|NOT COMPLETED|Overall Study||5
432168|NCT00743730|1029804|P2|NOT COMPLETED|Overall Study||4
432169|NCT00743730|1029805|P1|NOT COMPLETED|Overall Study||5
432170|NCT00743730|1029803|P3|COMPLETED|Overall Study||28
432171|NCT00743730|1029804|P2|COMPLETED|Overall Study||30
432172|NCT00743730|1029805|P1|COMPLETED|Overall Study||22
432173|NCT00743730|1029803|P3|STARTED|Overall Study||33
432174|NCT00743730|1029804|P2|STARTED|Overall Study||34
432175|NCT00743730|1029805|P1|STARTED|Overall Study||27
432176|NCT00743717|1029818|P2|NOT COMPLETED|Overall Study||0
432177|NCT00743717|1029819|P1|NOT COMPLETED|Overall Study||0
432178|NCT00743717|1029818|P2|COMPLETED|Overall Study||2
432179|NCT00743717|1029819|P1|COMPLETED|Overall Study||2
432180|NCT00743717|1029818|P2|STARTED|Overall Study||2
432181|NCT00743717|1029819|P1|STARTED|Overall Study||2
432182|NCT00743652|1029830|P5|NOT COMPLETED|Overall Study||0
432183|NCT00743652|1029831|P4|NOT COMPLETED|Overall Study||4
432184|NCT00743652|1029832|P3|NOT COMPLETED|Overall Study||2
432185|NCT00743652|1029833|P2|NOT COMPLETED|Overall Study||3
432186|NCT00743652|1029834|P1|NOT COMPLETED|Overall Study||10
432187|NCT00743652|1029830|P5|COMPLETED|Overall Study||79
432188|NCT00743652|1029831|P4|COMPLETED|Overall Study||63
432189|NCT00743652|1029832|P3|COMPLETED|Overall Study||23
432190|NCT00743652|1029833|P2|COMPLETED|Overall Study||48
432191|NCT00743652|1029834|P1|COMPLETED|Overall Study||141
432192|NCT00743652|1029830|P5|Toddler Dose|Overall Study||0
432193|NCT00743652|1029831|P4|Toddler Dose|Overall Study||0
432194|NCT00743652|1029832|P3|Toddler Dose|Overall Study||16
432195|NCT00743652|1029833|P2|Toddler Dose|Overall Study||23
432196|NCT00743652|1029834|P1|Toddler Dose|Overall Study||15
432197|NCT00743652|1029830|P5|Vaccinated Dose 3|Overall Study||0
432198|NCT00743652|1029831|P4|Vaccinated Dose 3|Overall Study||0
432199|NCT00743652|1029832|P3|Vaccinated Dose 3|Overall Study||0
432200|NCT00743652|1029833|P2|Vaccinated Dose 3|Overall Study||0
432201|NCT00743652|1029834|P1|Vaccinated Dose 3|Overall Study||74
432202|NCT00743652|1029830|P5|Vaccinated Dose 2|Overall Study||0
432203|NCT00743652|1029831|P4|Vaccinated Dose 2|Overall Study||49
432204|NCT00743652|1029832|P3|Vaccinated Dose 2|Overall Study||0
432205|NCT00743652|1029833|P2|Vaccinated Dose 2|Overall Study||41
432206|NCT00743652|1029834|P1|Vaccinated Dose 2|Overall Study||112
432207|NCT00743652|1029830|P5|Vaccinated Dose 1|Overall Study||79
432208|NCT00743652|1029831|P4|Vaccinated Dose 1|Overall Study||66
432209|NCT00743652|1029832|P3|Vaccinated Dose 1|Overall Study||25
432210|NCT00743652|1029833|P2|Vaccinated Dose 1|Overall Study||51
432211|NCT00743652|1029834|P1|Vaccinated Dose 1|Overall Study||151
432212|NCT00743652|1029830|P5|STARTED|Overall Study||79
432213|NCT00743652|1029831|P4|STARTED|Overall Study||67
432214|NCT00743652|1029832|P3|STARTED|Overall Study||25
432215|NCT00743652|1029833|P2|STARTED|Overall Study||51
432216|NCT00743652|1029834|P1|STARTED|Overall Study||151
432217|NCT00743574|1029909|P1|NOT COMPLETED|Overall Study||24
432218|NCT00743574|1029909|P1|COMPLETED|Overall Study||12
432219|NCT00743574|1029909|P1|Dropped Out After Initiating Trial|Overall Study||3
432220|NCT00743574|1029909|P1|Further Exclusions|Overall Study||8
432221|NCT00743574|1029909|P1|Dropped Out Before Eligibility Testing|Overall Study||13
432222|NCT00743574|1029909|P1|STARTED|Overall Study||36
432223|NCT00743509|1029918|P1|NOT COMPLETED|Overall Study||2
432224|NCT00743509|1029918|P1|COMPLETED|Overall Study||47
432225|NCT00743509|1029918|P1|STARTED|Overall Study||49
432226|NCT00743483|1029923|P1|NOT COMPLETED|Treatment Period||1
432227|NCT00743483|1029923|P1|COMPLETED|Treatment Period||13
432228|NCT00743483|1029923|P1|STARTED|Treatment Period||14
432229|NCT00743483|1029923|P1|NOT COMPLETED|Baseline Period||1
432230|NCT00743483|1029923|P1|COMPLETED|Baseline Period||14
432231|NCT00743483|1029923|P1|STARTED|Baseline Period||15
432232|NCT00743444|1029927|P2|NOT COMPLETED|Second Intervention||0
432233|NCT00743444|1029928|P1|NOT COMPLETED|Second Intervention||0
432234|NCT00743444|1029927|P2|COMPLETED|Second Intervention||11
432235|NCT00743444|1029928|P1|COMPLETED|Second Intervention||14
432236|NCT00743444|1029927|P2|STARTED|Second Intervention||11
432237|NCT00743444|1029928|P1|STARTED|Second Intervention||14
432238|NCT00743444|1029927|P2|NOT COMPLETED|Washout Period||1
432239|NCT00743444|1029928|P1|NOT COMPLETED|Washout Period||0
432240|NCT00743444|1029927|P2|COMPLETED|Washout Period||11
432241|NCT00743444|1029928|P1|COMPLETED|Washout Period||14
432242|NCT00743444|1029927|P2|STARTED|Washout Period||12
432243|NCT00743444|1029928|P1|STARTED|Washout Period||14
432244|NCT00743444|1029927|P2|NOT COMPLETED|First Intervention||1
432245|NCT00743444|1029928|P1|NOT COMPLETED|First Intervention||0
432246|NCT00743444|1029927|P2|COMPLETED|First Intervention||12
432247|NCT00743444|1029928|P1|COMPLETED|First Intervention||14
432248|NCT00743444|1029927|P2|STARTED|First Intervention||13
432249|NCT00743444|1029928|P1|STARTED|First Intervention||14
432250|NCT00743431|1029937|P1|NOT COMPLETED|Overall Study||126
432251|NCT00743431|1029937|P1|COMPLETED|Overall Study||98
432252|NCT00743431|1029937|P1|STARTED|Overall Study||224
432253|NCT00743288|1029941|P7|NOT COMPLETED|Overall Study||9
432254|NCT00743288|1029942|P6|NOT COMPLETED|Overall Study||5
432255|NCT00743288|1029943|P5|NOT COMPLETED|Overall Study||6
432256|NCT00743288|1029944|P4|NOT COMPLETED|Overall Study||7
432257|NCT00743288|1029945|P3|NOT COMPLETED|Overall Study||5
432258|NCT00743288|1029946|P2|NOT COMPLETED|Overall Study||3
432259|NCT00743288|1029947|P1|NOT COMPLETED|Overall Study||3
432260|NCT00743288|1029941|P7|COMPLETED|Overall Study||0
432261|NCT00743288|1029942|P6|COMPLETED|Overall Study||1
432262|NCT00743288|1029943|P5|COMPLETED|Overall Study||0
432263|NCT00743288|1029944|P4|COMPLETED|Overall Study||0
432264|NCT00743288|1029945|P3|COMPLETED|Overall Study||1
432265|NCT00743288|1029946|P2|COMPLETED|Overall Study||0
432266|NCT00743288|1029947|P1|COMPLETED|Overall Study||0
432267|NCT00743288|1029941|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
432268|NCT00743288|1029942|P6|STARTED|Overall Study||6
432269|NCT00743288|1029943|P5|STARTED|Overall Study||6
432270|NCT00743288|1029944|P4|STARTED|Overall Study||7
432271|NCT00743288|1029945|P3|STARTED|Overall Study||6
432272|NCT00743288|1029946|P2|STARTED|Overall Study||3
432273|NCT00743288|1029947|P1|STARTED|Overall Study||3
432274|NCT00743275|1029961|P2|NOT COMPLETED|Overall Study||1
432275|NCT00743275|1029962|P1|NOT COMPLETED|Overall Study||0
432276|NCT00743275|1029961|P2|COMPLETED|Overall Study||60
432277|NCT00743275|1029962|P1|COMPLETED|Overall Study||59
432278|NCT00743275|1029961|P2|STARTED|Overall Study||61
432279|NCT00743275|1029962|P1|STARTED|Overall Study||59
432280|NCT00743262|1029974|P1|NOT COMPLETED|Overall Study||0
432281|NCT00743262|1029974|P1|COMPLETED|Overall Study||15
432282|NCT00743262|1029974|P1|STARTED|Overall Study||15
432283|NCT00743249|1029982|P2|NOT COMPLETED|Overall Study||6
432284|NCT00743249|1029983|P1|NOT COMPLETED|Overall Study||2
432285|NCT00743249|1029982|P2|COMPLETED|Overall Study||24
432286|NCT00743249|1029983|P1|COMPLETED|Overall Study||28
432287|NCT00743249|1029982|P2|STARTED|Overall Study||30
432288|NCT00743249|1029983|P1|STARTED|Overall Study||30
432289|NCT00743197|1029993|P2|NOT COMPLETED|Overall Study||2
432290|NCT00743197|1029994|P1|NOT COMPLETED|Overall Study||1
432291|NCT00743197|1029993|P2|COMPLETED|Overall Study||0
432292|NCT00743197|1029994|P1|COMPLETED|Overall Study||0
432293|NCT00743197|1029993|P2|STARTED|Overall Study||2
432294|NCT00743197|1029994|P1|STARTED|Overall Study||1
432295|NCT00743106|1030002|P2|NOT COMPLETED|Overall Study||5
432296|NCT00743106|1030003|P1|NOT COMPLETED|Overall Study||8
432297|NCT00743106|1030002|P2|COMPLETED|Overall Study||43
432298|NCT00743106|1030003|P1|COMPLETED|Overall Study||34
432299|NCT00743106|1030002|P2|STARTED|Overall Study||48
432300|NCT00743106|1030003|P1|STARTED|Overall Study||42
432301|NCT00743093|1030011|P2|NOT COMPLETED|Extended Dosing Period||0
432302|NCT00743093|1030012|P1|NOT COMPLETED|Extended Dosing Period||3
432303|NCT00743093|1030011|P2|COMPLETED|Extended Dosing Period||1
432304|NCT00743093|1030012|P1|COMPLETED|Extended Dosing Period||48
432305|NCT00743093|1030011|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
432306|NCT00743093|1030012|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
432307|NCT00743093|1030011|P2|NOT COMPLETED|Base Study Period||5
432308|NCT00743093|1030012|P1|NOT COMPLETED|Base Study Period||19
432309|NCT00743093|1030011|P2|COMPLETED|Base Study Period||47
432310|NCT00743093|1030012|P1|COMPLETED|Base Study Period||205
432311|NCT00743093|1030011|P2|STARTED|Base Study Period||52
432312|NCT00743093|1030012|P1|STARTED|Base Study Period||224
432313|NCT00742924|1030024|P4|NOT COMPLETED|Overall Study||6
432314|NCT00742924|1030025|P3|NOT COMPLETED|Overall Study||4
432315|NCT00742924|1030026|P2|NOT COMPLETED|Overall Study||2
432316|NCT00742924|1030027|P1|NOT COMPLETED|Overall Study||5
432317|NCT00742924|1030024|P4|COMPLETED|Overall Study||0
432318|NCT00742924|1030025|P3|COMPLETED|Overall Study||2
432319|NCT00742924|1030026|P2|COMPLETED|Overall Study||4
432320|NCT00742924|1030027|P1|COMPLETED|Overall Study||1
432321|NCT00742924|1030024|P4|STARTED|Overall Study||6
432322|NCT00742924|1030025|P3|STARTED|Overall Study||6
432323|NCT00742924|1030026|P2|STARTED|Overall Study||6
432324|NCT00742924|1030027|P1|STARTED|Overall Study||6
432325|NCT00742885|1030039|P2|NOT COMPLETED|Overall Study||0
432326|NCT00742885|1030040|P1|NOT COMPLETED|Overall Study||1
432327|NCT00742885|1030039|P2|COMPLETED|Overall Study|to Day 182|50
432328|NCT00742885|1030040|P1|COMPLETED|Overall Study|to Day 182|49
432329|NCT00742885|1030039|P2|STARTED|Overall Study||50
432330|NCT00742885|1030040|P1|STARTED|Overall Study||50
432331|NCT00742872|1030088|P2|NOT COMPLETED|Overall Study||8
432332|NCT00742872|1030089|P1|NOT COMPLETED|Overall Study||12
432333|NCT00742872|1030088|P2|COMPLETED|Overall Study||12
432334|NCT00742872|1030089|P1|COMPLETED|Overall Study||9
432335|NCT00742872|1030088|P2|STARTED|Overall Study||20
432336|NCT00742872|1030089|P1|STARTED|Overall Study||21
432337|NCT00742781|1030095|P1|NOT COMPLETED|Overall Study||3
432338|NCT00742781|1030095|P1|COMPLETED|Overall Study||18
432339|NCT00742781|1030095|P1|STARTED|Overall Study||21
432340|NCT00742625|1030104|P1|NOT COMPLETED|Consolidation||21
432341|NCT00742625|1030104|P1|COMPLETED|Consolidation||20
432342|NCT00742625|1030104|P1|STARTED|Consolidation||41
432343|NCT00742625|1030104|P1|NOT COMPLETED|Remission Induction||54
432344|NCT00742625|1030104|P1|COMPLETED|Remission Induction||41
432345|NCT00742625|1030104|P1|STARTED|Remission Induction||95
432346|NCT00742508|1030115|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
432347|NCT00742508|1030116|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
432348|NCT00742508|1030115|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
432349|NCT00742508|1030116|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
432350|NCT00742508|1030115|P2|STARTED|4-Week Exploratory Evaluation Period||8
432351|NCT00742508|1030116|P1|STARTED|4-Week Exploratory Evaluation Period||0
432352|NCT00742508|1030115|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
432353|NCT00742508|1030116|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
432354|NCT00742508|1030115|P2|COMPLETED|8-Week Primary Evaluation Period||8
432355|NCT00742508|1030116|P1|COMPLETED|8-Week Primary Evaluation Period||11
432356|NCT00742508|1030115|P2|STARTED|8-Week Primary Evaluation Period||19
432357|NCT00742508|1030116|P1|STARTED|8-Week Primary Evaluation Period||22
432358|NCT00742417|1030180|P2|NOT COMPLETED|Maintenance II||0
432359|NCT00742417|1030181|P1|NOT COMPLETED|Maintenance II||0
432360|NCT00742417|1030180|P2|COMPLETED|Maintenance II||19
432361|NCT00742417|1030181|P1|COMPLETED|Maintenance II||16
432362|NCT00742417|1030180|P2|STARTED|Maintenance II||19
432363|NCT00742417|1030181|P1|STARTED|Maintenance II||16
432364|NCT00742417|1030180|P2|NOT COMPLETED|Maintenance I||0
432365|NCT00742417|1030181|P1|NOT COMPLETED|Maintenance I||0
432366|NCT00742417|1030180|P2|COMPLETED|Maintenance I||19
432367|NCT00742417|1030181|P1|COMPLETED|Maintenance I||16
432368|NCT00742417|1030180|P2|STARTED|Maintenance I||19
432369|NCT00742417|1030181|P1|STARTED|Maintenance I||16
432370|NCT00742417|1030180|P2|NOT COMPLETED|Intensive Period||1
432371|NCT00742417|1030181|P1|NOT COMPLETED|Intensive Period||3
432372|NCT00742417|1030180|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
432373|NCT00742417|1030181|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
432374|NCT00742417|1030180|P2|STARTED|Intensive Period||20
432375|NCT00742417|1030181|P1|STARTED|Intensive Period||19
432376|NCT00742417|1030180|P2|NOT COMPLETED|Randomized||1
432377|NCT00742417|1030181|P1|NOT COMPLETED|Randomized||2
432378|NCT00742417|1030180|P2|COMPLETED|Randomized||20
432379|NCT00742417|1030181|P1|COMPLETED|Randomized||19
432380|NCT00742417|1030180|P2|STARTED|Randomized||21
432381|NCT00742417|1030181|P1|STARTED|Randomized||21
432382|NCT00742391|1030205|P2|NOT COMPLETED|Overall Study||1
432383|NCT00742391|1030206|P1|NOT COMPLETED|Overall Study||4
432384|NCT00742391|1030205|P2|COMPLETED|Overall Study||128
432385|NCT00742391|1030206|P1|COMPLETED|Overall Study||122
432386|NCT00742391|1030205|P2|STARTED|Overall Study||129
432387|NCT00742391|1030206|P1|STARTED|Overall Study||126
432388|NCT00742326|1030216|P2|NOT COMPLETED|Overall Study||1
432389|NCT00742326|1030217|P1|NOT COMPLETED|Overall Study||0
432390|NCT00742326|1030216|P2|COMPLETED|Overall Study||6
432391|NCT00742326|1030217|P1|COMPLETED|Overall Study||6
432392|NCT00742326|1030216|P2|STARTED|Overall Study||7
432393|NCT00742326|1030217|P1|STARTED|Overall Study||6
432394|NCT00742313|1030227|P2|NOT COMPLETED|Overall Study||0
432395|NCT00742313|1030228|P1|NOT COMPLETED|Overall Study||1
432396|NCT00742313|1030227|P2|COMPLETED|Overall Study||19
432397|NCT00742313|1030228|P1|COMPLETED|Overall Study||24
432398|NCT00742313|1030227|P2|STARTED|Overall Study||19
432399|NCT00742313|1030228|P1|STARTED|Overall Study||25
432400|NCT00742274|1030236|P2|NOT COMPLETED|Overall Study||3
432401|NCT00742274|1030237|P1|NOT COMPLETED|Overall Study||3
432402|NCT00742274|1030236|P2|COMPLETED|Overall Study||28
432403|NCT00742274|1030237|P1|COMPLETED|Overall Study||27
432404|NCT00742274|1030236|P2|STARTED|Overall Study||31
432405|NCT00742274|1030237|P1|STARTED|Overall Study||30
432406|NCT00742235|1030245|P2|NOT COMPLETED|Overall Study||31
432407|NCT00742235|1030246|P1|NOT COMPLETED|Overall Study||0
432408|NCT00742235|1030245|P2|COMPLETED|Overall Study||36
432409|NCT00742235|1030246|P1|COMPLETED|Overall Study||32
432410|NCT00742235|1030245|P2|STARTED|Overall Study||67
432411|NCT00742235|1030246|P1|STARTED|Overall Study||32
432412|NCT00742209|1030259|P5|NOT COMPLETED|Overall Study||25
432413|NCT00742209|1030260|P4|NOT COMPLETED|Overall Study||37
432414|NCT00742209|1030261|P3|NOT COMPLETED|Overall Study||46
432415|NCT00742209|1030262|P2|NOT COMPLETED|Overall Study||18
432416|NCT00742209|1030263|P1|NOT COMPLETED|Overall Study||34
432417|NCT00742209|1030259|P5|COMPLETED|Overall Study||37
432418|NCT00742209|1030260|P4|COMPLETED|Overall Study||97
432419|NCT00742209|1030261|P3|COMPLETED|Overall Study||88
432420|NCT00742209|1030262|P2|COMPLETED|Overall Study||49
432421|NCT00742209|1030263|P1|COMPLETED|Overall Study||95
432422|NCT00742209|1030259|P5|STARTED|Overall Study||62
432423|NCT00742209|1030260|P4|STARTED|Overall Study||134
432424|NCT00742209|1030261|P3|STARTED|Overall Study||134
432425|NCT00742209|1030262|P2|STARTED|Overall Study||67
432426|NCT00742209|1030263|P1|STARTED|Overall Study||129
432427|NCT00742183|1030366|P2|NOT COMPLETED|Overall Study||12
432428|NCT00742183|1030367|P1|NOT COMPLETED|Overall Study||9
432429|NCT00742183|1030366|P2|COMPLETED|Overall Study||39
432430|NCT00742183|1030367|P1|COMPLETED|Overall Study||40
432431|NCT00742183|1030366|P2|STARTED|Overall Study||51
432432|NCT00742183|1030367|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
432433|NCT00742170|1030375|P2|NOT COMPLETED|Overall Study||5
432434|NCT00742170|1030376|P1|NOT COMPLETED|Overall Study||2
432435|NCT00742170|1030375|P2|COMPLETED|Overall Study||24
432436|NCT00742170|1030376|P1|COMPLETED|Overall Study||24
432437|NCT00742170|1030375|P2|STARTED|Overall Study||29
432438|NCT00742170|1030376|P1|STARTED|Overall Study||26
432439|NCT00742079|1030386|P2|NOT COMPLETED|Overall Study||1
432440|NCT00742079|1030387|P1|NOT COMPLETED|Overall Study||0
432441|NCT00742079|1030386|P2|COMPLETED|Overall Study||9
432442|NCT00742079|1030387|P1|COMPLETED|Overall Study||11
432443|NCT00742079|1030386|P2|Week 2 (Received Dose 2)|Overall Study||9
432444|NCT00742079|1030387|P1|Week 2 (Received Dose 2)|Overall Study||11
432445|NCT00742079|1030386|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
432446|NCT00742079|1030387|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
432447|NCT00742079|1030386|P2|STARTED|Overall Study||10
432448|NCT00742079|1030387|P1|STARTED|Overall Study||11
432449|NCT00742053|1030393|P1|NOT COMPLETED|Overall Study||0
432450|NCT00742053|1030393|P1|COMPLETED|Overall Study||7
432451|NCT00742053|1030393|P1|STARTED|Overall Study||7
432452|NCT00741988|1030399|P2|NOT COMPLETED|Overall Study||4
432453|NCT00741988|1030400|P1|NOT COMPLETED|Overall Study||4
432454|NCT00741988|1030399|P2|COMPLETED|Overall Study||36
432455|NCT00741988|1030400|P1|COMPLETED|Overall Study||38
432456|NCT00741988|1030399|P2|STARTED|Overall Study||40
432457|NCT00741988|1030400|P1|STARTED|Overall Study||42
432458|NCT00741936|1030412|P2|NOT COMPLETED|Overall Study||8
432459|NCT00741936|1030413|P1|NOT COMPLETED|Overall Study||9
432460|NCT00741936|1030412|P2|COMPLETED|Overall Study||52
432461|NCT00741936|1030413|P1|COMPLETED|Overall Study||51
432462|NCT00741936|1030412|P2|STARTED|Overall Study||60
432463|NCT00741936|1030413|P1|STARTED|Overall Study||60
432464|NCT00741858|1030441|P2|NOT COMPLETED|Overall Study||0
432465|NCT00741858|1030442|P1|NOT COMPLETED|Overall Study||0
432466|NCT00741858|1030441|P2|COMPLETED|Overall Study||18
432467|NCT00741858|1030442|P1|COMPLETED|Overall Study||16
432468|NCT00741858|1030441|P2|STARTED|Overall Study||18
432469|NCT00741858|1030442|P1|STARTED|Overall Study||16
432470|NCT00741819|1030448|P1|NOT COMPLETED|Overall Study||8
432471|NCT00741819|1030448|P1|COMPLETED|Overall Study||65
432472|NCT00741819|1030448|P1|STARTED|Overall Study||73
432473|NCT00741611|1030462|P3|NOT COMPLETED|Overall Study||3
432474|NCT00741611|1030463|P2|NOT COMPLETED|Overall Study||2
432475|NCT00741611|1030464|P1|NOT COMPLETED|Overall Study||0
432476|NCT00741611|1030462|P3|COMPLETED|Overall Study||26
432477|NCT00741611|1030463|P2|COMPLETED|Overall Study||1
432478|NCT00741611|1030464|P1|COMPLETED|Overall Study||4
432479|NCT00741611|1030462|P3|STARTED|Overall Study||29
432480|NCT00741611|1030463|P2|STARTED|Overall Study||3
432481|NCT00741611|1030464|P1|STARTED|Overall Study||4
432482|NCT00741598|1030483|P2|NOT COMPLETED|Overall Study||9
432483|NCT00741598|1030484|P1|NOT COMPLETED|Overall Study||9
432484|NCT00741598|1030483|P2|COMPLETED|Overall Study||30
432485|NCT00741598|1030484|P1|COMPLETED|Overall Study||24
432486|NCT00741598|1030483|P2|STARTED|Overall Study||39
432487|NCT00741598|1030484|P1|STARTED|Overall Study||33
432488|NCT00741468|1030498|P1|NOT COMPLETED|Overall Study||0
432489|NCT00741468|1030498|P1|COMPLETED|Overall Study||18
432490|NCT00741468|1030498|P1|STARTED|Overall Study||18
432491|NCT00741390|1030506|P4|NOT COMPLETED|Visit 2||1
432492|NCT00741390|1030507|P3|NOT COMPLETED|Visit 2||1
432493|NCT00741390|1030508|P2|NOT COMPLETED|Visit 2||0
432494|NCT00741390|1030509|P1|NOT COMPLETED|Visit 2||0
432495|NCT00741390|1030506|P4|COMPLETED|Visit 2||60
432496|NCT00741390|1030507|P3|COMPLETED|Visit 2||54
432497|NCT00741390|1030508|P2|COMPLETED|Visit 2||61
432498|NCT00741390|1030509|P1|COMPLETED|Visit 2||59
432499|NCT00741390|1030506|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
432500|NCT00741390|1030507|P3|STARTED|Visit 2||55
432501|NCT00741390|1030508|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
432502|NCT00741390|1030509|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
432503|NCT00741390|1030506|P4|NOT COMPLETED|Visit 1||1
432504|NCT00741390|1030507|P3|NOT COMPLETED|Visit 1||7
432505|NCT00741390|1030508|P2|NOT COMPLETED|Visit 1||0
432506|NCT00741390|1030509|P1|NOT COMPLETED|Visit 1||2
432507|NCT00741390|1030506|P4|COMPLETED|Visit 1||62
432508|NCT00741390|1030507|P3|COMPLETED|Visit 1||55
432509|NCT00741390|1030508|P2|COMPLETED|Visit 1||63
432510|NCT00741390|1030509|P1|COMPLETED|Visit 1||60
432511|NCT00741390|1030506|P4|STARTED|Visit 1||63
432512|NCT00741390|1030507|P3|STARTED|Visit 1||62
432513|NCT00741390|1030508|P2|STARTED|Visit 1||63
432514|NCT00741390|1030509|P1|STARTED|Visit 1||62
432515|NCT00741338|1030530|P2|NOT COMPLETED|Overall Study||1
432516|NCT00741338|1030531|P1|NOT COMPLETED|Overall Study||0
432517|NCT00741338|1030530|P2|COMPLETED|Overall Study||2
432518|NCT00741338|1030531|P1|COMPLETED|Overall Study||3
432519|NCT00741338|1030530|P2|STARTED|Overall Study||3
432520|NCT00741338|1030531|P1|STARTED|Overall Study||3
432521|NCT00741286|1030541|P2|NOT COMPLETED|Overall Study||19
432522|NCT00741286|1030542|P1|NOT COMPLETED|Overall Study||20
432523|NCT00741286|1030541|P2|COMPLETED|Overall Study||81
432524|NCT00741286|1030542|P1|COMPLETED|Overall Study||83
432525|NCT00741286|1030541|P2|STARTED|Overall Study||100
432526|NCT00741286|1030542|P1|STARTED|Overall Study||103
432527|NCT00741273|1030552|P2|NOT COMPLETED|Overall Study||0
432528|NCT00741273|1030553|P1|NOT COMPLETED|Overall Study||0
432529|NCT00741273|1030552|P2|COMPLETED|Overall Study||8
432530|NCT00741273|1030553|P1|COMPLETED|Overall Study||8
432531|NCT00741273|1030552|P2|STARTED|Overall Study||8
432532|NCT00741273|1030553|P1|STARTED|Overall Study||8
432533|NCT00741156|1030569|P1|NOT COMPLETED|Overall Study||0
432534|NCT00741156|1030569|P1|COMPLETED|Overall Study||12
432535|NCT00741156|1030569|P1|STARTED|Overall Study||12
432536|NCT00741104|1030584|P1|NOT COMPLETED|Overall Study||0
432537|NCT00741104|1030584|P1|COMPLETED|Overall Study||363
432538|NCT00741104|1030584|P1|STARTED|Overall Study||363
432539|NCT00741091|1030591|P1|NOT COMPLETED|Overall Study||57
432540|NCT00741091|1030591|P1|COMPLETED|Overall Study||1040
432541|NCT00741091|1030591|P1|STARTED|Overall Study||1097
432542|NCT00741039|1030601|P2|NOT COMPLETED|Overall Study||0
432543|NCT00741039|1030602|P1|NOT COMPLETED|Overall Study||2
432544|NCT00741039|1030601|P2|COMPLETED|Overall Study||25
432545|NCT00741039|1030602|P1|COMPLETED|Overall Study||100
432546|NCT00741039|1030601|P2|STARTED|Overall Study||25
432547|NCT00741039|1030602|P1|STARTED|Overall Study||102
432548|NCT00741026|1030608|P1|NOT COMPLETED|Overall Study||0
432549|NCT00741026|1030608|P1|COMPLETED|Overall Study||15
432550|NCT00741026|1030608|P1|STARTED|Overall Study||15
432551|NCT00741013|1030639|P3|NOT COMPLETED|Overall Study||1
432552|NCT00741013|1030640|P2|NOT COMPLETED|Overall Study||2
432553|NCT00741013|1030641|P1|NOT COMPLETED|Overall Study||1
432554|NCT00741013|1030639|P3|COMPLETED|Overall Study||6
432555|NCT00741013|1030640|P2|COMPLETED|Overall Study||6
432556|NCT00741013|1030641|P1|COMPLETED|Overall Study||6
432557|NCT00741013|1030639|P3|STARTED|Overall Study||7
432558|NCT00741013|1030640|P2|STARTED|Overall Study||8
432559|NCT00741013|1030641|P1|STARTED|Overall Study||7
432560|NCT00740857|1030655|P3|NOT COMPLETED|Overall Study||0
432561|NCT00740857|1030656|P2|NOT COMPLETED|Overall Study||0
432562|NCT00740857|1030657|P1|NOT COMPLETED|Overall Study||1
432563|NCT00740857|1030655|P3|COMPLETED|Overall Study||90
432564|NCT00740857|1030656|P2|COMPLETED|Overall Study||88
432565|NCT00740857|1030657|P1|COMPLETED|Overall Study||32
432566|NCT00740857|1030655|P3|STARTED|Overall Study||90
432567|NCT00740857|1030656|P2|STARTED|Overall Study||88
432568|NCT00740857|1030657|P1|STARTED|Overall Study||33
432569|NCT00740831|1030689|P3|NOT COMPLETED|Overall Study||6
432570|NCT00740831|1030690|P2|NOT COMPLETED|Overall Study||3
432571|NCT00740831|1030691|P1|NOT COMPLETED|Overall Study||4
432572|NCT00740831|1030689|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
432573|NCT00740831|1030690|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
432574|NCT00740831|1030691|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
432575|NCT00740831|1030689|P3|STARTED|Overall Study|Safety population|101
432576|NCT00740831|1030690|P2|STARTED|Overall Study|Safety population|103
432577|NCT00740831|1030691|P1|STARTED|Overall Study|Safety population|97
432578|NCT00740792|1030712|P4|NOT COMPLETED|Overall Study||10
432579|NCT00740792|1030713|P3|NOT COMPLETED|Overall Study||9
432580|NCT00740792|1030714|P2|NOT COMPLETED|Overall Study||8
432581|NCT00740792|1030715|P1|NOT COMPLETED|Overall Study||10
432582|NCT00740792|1030712|P4|COMPLETED|Overall Study||190
432583|NCT00740792|1030713|P3|COMPLETED|Overall Study||180
432584|NCT00740792|1030714|P2|COMPLETED|Overall Study||186
432585|NCT00740792|1030715|P1|COMPLETED|Overall Study||183
432586|NCT00740792|1030712|P4|STARTED|Overall Study||200
432587|NCT00740792|1030713|P3|STARTED|Overall Study||189
432588|NCT00740792|1030714|P2|STARTED|Overall Study||194
432589|NCT00740792|1030715|P1|STARTED|Overall Study||193
432590|NCT00740779|1030736|P3|NOT COMPLETED|Overall Study||13
432591|NCT00740779|1030737|P2|NOT COMPLETED|Overall Study||14
432592|NCT00740779|1030738|P1|NOT COMPLETED|Overall Study||9
432593|NCT00740779|1030736|P3|COMPLETED|Overall Study||41
432594|NCT00740779|1030737|P2|COMPLETED|Overall Study||31
432595|NCT00740779|1030738|P1|COMPLETED|Overall Study||43
432596|NCT00740779|1030736|P3|STARTED|Overall Study||54
432597|NCT00740779|1030737|P2|STARTED|Overall Study||45
432598|NCT00740779|1030738|P1|STARTED|Overall Study||52
432599|NCT00740727|1030746|P1|NOT COMPLETED|Overall Study||0
432600|NCT00740727|1030746|P1|COMPLETED|Overall Study||18
432601|NCT00740727|1030746|P1|STARTED|Overall Study||18
432602|NCT00740714|1030755|P3|NOT COMPLETED|Overall Study||29
432603|NCT00740714|1030756|P2|NOT COMPLETED|Overall Study||19
432604|NCT00740714|1030757|P1|NOT COMPLETED|Overall Study||17
432605|NCT00740714|1030755|P3|COMPLETED|Overall Study||174
432606|NCT00740714|1030756|P2|COMPLETED|Overall Study||182
432607|NCT00740714|1030757|P1|COMPLETED|Overall Study||179
432608|NCT00740714|1030755|P3|Active Patients at Study Termination|Overall Study||33
432609|NCT00740714|1030756|P2|Active Patients at Study Termination|Overall Study||12
432610|NCT00740714|1030757|P1|Active Patients at Study Termination|Overall Study||24
432611|NCT00740714|1030755|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
432612|NCT00740714|1030756|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
432613|NCT00740714|1030757|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
432614|NCT00740714|1030755|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
432615|NCT00740714|1030756|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
432616|NCT00740714|1030757|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
432617|NCT00740636|1030833|P2|NOT COMPLETED|Overall Study||4
432618|NCT00740636|1030834|P1|NOT COMPLETED|Overall Study||2
432619|NCT00740636|1030833|P2|COMPLETED|Overall Study||63
432620|NCT00740636|1030834|P1|COMPLETED|Overall Study||23
432621|NCT00740636|1030833|P2|STARTED|Overall Study||67
432622|NCT00740636|1030834|P1|STARTED|Overall Study||25
432623|NCT00740597|1030840|P1|NOT COMPLETED|Overall Study||1
432624|NCT00740597|1030840|P1|COMPLETED|Overall Study||0
432625|NCT00740597|1030840|P1|STARTED|Overall Study||1
432626|NCT00740584|1030844|P1|NOT COMPLETED|Overall Study||1
432627|NCT00740584|1030844|P1|COMPLETED|Overall Study||11
432628|NCT00740584|1030844|P1|STARTED|Overall Study||12
432629|NCT00740480|1030848|P1|NOT COMPLETED|Overall Study||2
432630|NCT00740480|1030848|P1|COMPLETED|Overall Study||23
432631|NCT00740480|1030848|P1|STARTED|Overall Study||25
432632|NCT00740220|1030852|P1|NOT COMPLETED|Overall Study||9
432633|NCT00740220|1030852|P1|COMPLETED|Overall Study||88
432634|NCT00740220|1030852|P1|STARTED|Overall Study||97
432635|NCT00740207|1030858|P2|NOT COMPLETED|Overall Study||0
432636|NCT00740207|1030859|P1|NOT COMPLETED|Overall Study||0
432637|NCT00740207|1030858|P2|COMPLETED|Overall Study||16
432638|NCT00740207|1030859|P1|COMPLETED|Overall Study||17
432639|NCT00740207|1030858|P2|STARTED|Overall Study||16
432640|NCT00740207|1030859|P1|STARTED|Overall Study||17
432641|NCT00740181|1030871|P1|NOT COMPLETED|Overall Study||0
432642|NCT00740181|1030871|P1|COMPLETED|Overall Study||9
432643|NCT00740181|1030871|P1|STARTED|Overall Study||9
432644|NCT00740051|1030877|P2|NOT COMPLETED|Overall Study||32
432645|NCT00740051|1030878|P1|NOT COMPLETED|Overall Study||18
432646|NCT00740051|1030877|P2|COMPLETED|Overall Study||119
432647|NCT00740051|1030878|P1|COMPLETED|Overall Study||58
432648|NCT00740051|1030877|P2|STARTED|Overall Study||151
432649|NCT00740051|1030878|P1|STARTED|Overall Study||76
432650|NCT00739999|1030900|P2|NOT COMPLETED|Overall Study||0
432651|NCT00739999|1030901|P1|NOT COMPLETED|Overall Study||0
432652|NCT00739999|1030900|P2|COMPLETED|Overall Study||24
432653|NCT00739999|1030901|P1|COMPLETED|Overall Study||15
432654|NCT00739999|1030900|P2|STARTED|Overall Study||24
432655|NCT00739999|1030901|P1|STARTED|Overall Study||15
432656|NCT00739973|1030981|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
432657|NCT00739973|1030982|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
432658|NCT00739973|1030983|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
432659|NCT00739973|1030984|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
432660|NCT00739973|1030985|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
432740|NCT00739765|1031140|P3|STARTED|Overall Study||32
432661|NCT00739973|1030986|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
432662|NCT00739973|1030987|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
432663|NCT00739973|1030988|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
432664|NCT00739973|1030989|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
432665|NCT00739973|1030981|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
432666|NCT00739973|1030982|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
432667|NCT00739973|1030983|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
432668|NCT00739973|1030984|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
432669|NCT00739973|1030985|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
432670|NCT00739973|1030986|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
432671|NCT00739973|1030987|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
432672|NCT00739973|1030988|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
432673|NCT00739973|1030989|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
432674|NCT00739973|1030981|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
432675|NCT00739973|1030982|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
432676|NCT00739973|1030983|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
432677|NCT00739973|1030984|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
432678|NCT00739973|1030985|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
432679|NCT00739973|1030986|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
432680|NCT00739973|1030987|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
432759|NCT00739661|1031184|P2|NOT COMPLETED|Overall Study||42
432681|NCT00739973|1030988|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
432682|NCT00739973|1030989|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
432683|NCT00739973|1030981|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432684|NCT00739973|1030982|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432685|NCT00739973|1030983|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432686|NCT00739973|1030984|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432687|NCT00739973|1030985|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432688|NCT00739973|1030986|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432689|NCT00739973|1030987|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432690|NCT00739973|1030988|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432691|NCT00739973|1030989|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
432692|NCT00739973|1030981|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432693|NCT00739973|1030982|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432694|NCT00739973|1030983|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432695|NCT00739973|1030984|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432696|NCT00739973|1030985|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432697|NCT00739973|1030986|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432698|NCT00739973|1030987|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432699|NCT00739973|1030988|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
432700|NCT00739973|1030989|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
432701|NCT00739973|1030981|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
432702|NCT00739973|1030982|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
432703|NCT00739973|1030983|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
432704|NCT00739973|1030984|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
432705|NCT00739973|1030985|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
432706|NCT00739973|1030986|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
432707|NCT00739973|1030987|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
432708|NCT00739973|1030988|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
432709|NCT00739973|1030989|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
432710|NCT00739934|1031075|P1|NOT COMPLETED|Voriconazole Oral||3
432711|NCT00739934|1031075|P1|COMPLETED|Voriconazole Oral||31
432712|NCT00739934|1031075|P1|STARTED|Voriconazole Oral||34
432713|NCT00739934|1031075|P1|NOT COMPLETED|Voriconazole IV||6
432714|NCT00739934|1031075|P1|COMPLETED|Voriconazole IV||34
432715|NCT00739934|1031075|P1|STARTED|Voriconazole IV||40
432716|NCT00739908|1031097|P2|NOT COMPLETED|Overall Study||25
432717|NCT00739908|1031098|P1|NOT COMPLETED|Overall Study||25
432718|NCT00739908|1031097|P2|COMPLETED|Overall Study||118
432719|NCT00739908|1031098|P1|COMPLETED|Overall Study||117
432720|NCT00739908|1031097|P2|STARTED|Overall Study||143
432721|NCT00739908|1031098|P1|STARTED|Overall Study||142
432722|NCT00739882|1031118|P2|NOT COMPLETED|Open-label Period||5
432723|NCT00739882|1031119|P1|NOT COMPLETED|Open-label Period||10
432724|NCT00739882|1031118|P2|COMPLETED|Open-label Period||9
432725|NCT00739882|1031119|P1|COMPLETED|Open-label Period||7
432726|NCT00739882|1031118|P2|STARTED|Open-label Period||14
432727|NCT00739882|1031119|P1|STARTED|Open-label Period||17
432728|NCT00739882|1031118|P2|NOT COMPLETED|Double-blind Period||11
432729|NCT00739882|1031119|P1|NOT COMPLETED|Double-blind Period||19
432730|NCT00739882|1031118|P2|COMPLETED|Double-blind Period||14
432731|NCT00739882|1031119|P1|COMPLETED|Double-blind Period||32
432732|NCT00739882|1031118|P2|STARTED|Double-blind Period||25
432733|NCT00739882|1031119|P1|STARTED|Double-blind Period||51
432734|NCT00739765|1031140|P3|NOT COMPLETED|Overall Study||11
432735|NCT00739765|1031141|P2|NOT COMPLETED|Overall Study||11
432736|NCT00739765|1031142|P1|NOT COMPLETED|Overall Study||6
432737|NCT00739765|1031140|P3|COMPLETED|Overall Study||21
432738|NCT00739765|1031141|P2|COMPLETED|Overall Study||27
432739|NCT00739765|1031142|P1|COMPLETED|Overall Study||34
432741|NCT00739765|1031141|P2|STARTED|Overall Study||38
432742|NCT00739765|1031142|P1|STARTED|Overall Study||40
432743|NCT00739674|1031155|P2|NOT COMPLETED|Overall Study||122
432744|NCT00739674|1031156|P1|NOT COMPLETED|Overall Study||181
432745|NCT00739674|1031155|P2|COMPLETED|Overall Study||335
432746|NCT00739674|1031156|P1|COMPLETED|Overall Study||354
432747|NCT00739674|1031155|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
432748|NCT00739674|1031156|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
432749|NCT00739674|1031155|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
432750|NCT00739674|1031156|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
432751|NCT00739674|1031155|P2|No Follow-up Data|Overall Study||18
432752|NCT00739674|1031156|P1|No Follow-up Data|Overall Study||33
432753|NCT00739674|1031155|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
432754|NCT00739674|1031156|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
432755|NCT00739674|1031155|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
432756|NCT00739674|1031156|P1|Screening Failures|Overall Study||19
432757|NCT00739674|1031155|P2|STARTED|Overall Study||457
432758|NCT00739674|1031156|P1|STARTED|Overall Study||535
432760|NCT00739661|1031185|P1|NOT COMPLETED|Overall Study||46
432761|NCT00739661|1031184|P2|COMPLETED|Overall Study||10
432762|NCT00739661|1031185|P1|COMPLETED|Overall Study||6
432763|NCT00739661|1031184|P2|STARTED|Overall Study||52
432764|NCT00739661|1031185|P1|STARTED|Overall Study||52
432765|NCT00739648|1031197|P2|NOT COMPLETED|Overall Study||53
432766|NCT00739648|1031198|P1|NOT COMPLETED|Overall Study||26
432767|NCT00739648|1031197|P2|COMPLETED|Overall Study||161
432768|NCT00739648|1031198|P1|COMPLETED|Overall Study||82
432769|NCT00739648|1031197|P2|STARTED|Overall Study||214
432770|NCT00739648|1031198|P1|STARTED|Overall Study||108
432771|NCT00739596|1031212|P2|NOT COMPLETED|Overall Study||17
432772|NCT00739596|1031213|P1|NOT COMPLETED|Overall Study||25
432773|NCT00739596|1031212|P2|COMPLETED|Overall Study||149
432774|NCT00739596|1031213|P1|COMPLETED|Overall Study||141
432775|NCT00739596|1031212|P2|STARTED|Overall Study||166
432776|NCT00739596|1031213|P1|STARTED|Overall Study||166
432777|NCT00739583|1031229|P2|NOT COMPLETED|Overall Study||0
432778|NCT00739583|1031230|P1|NOT COMPLETED|Overall Study||0
432779|NCT00739583|1031229|P2|COMPLETED|Overall Study||10
432780|NCT00739583|1031230|P1|COMPLETED|Overall Study||10
432781|NCT00739583|1031229|P2|STARTED|Overall Study||10
432782|NCT00739583|1031230|P1|STARTED|Overall Study||10
432783|NCT00739336|1031242|P2|NOT COMPLETED|Overall Study||0
432784|NCT00739336|1031243|P1|NOT COMPLETED|Overall Study||4
432785|NCT00739336|1031242|P2|COMPLETED|Overall Study||24
432786|NCT00739336|1031243|P1|COMPLETED|Overall Study||17
432787|NCT00739336|1031242|P2|STARTED|Overall Study||24
432788|NCT00739336|1031243|P1|STARTED|Overall Study||21
432789|NCT00739310|1031255|P1|NOT COMPLETED|Overall Study||7
432790|NCT00739310|1031255|P1|COMPLETED|Overall Study||22
432791|NCT00739310|1031255|P1|STARTED|Overall Study||29
432792|NCT00739297|1031260|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
432793|NCT00739297|1031261|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
432794|NCT00739297|1031262|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
432795|NCT00739297|1031263|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
432796|NCT00739297|1031264|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
432797|NCT00739297|1031265|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
432798|NCT00739297|1031266|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
432799|NCT00739297|1031260|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
432800|NCT00739297|1031261|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
432801|NCT00739297|1031262|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
432802|NCT00739297|1031263|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
432803|NCT00739297|1031264|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
432804|NCT00739297|1031265|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
432805|NCT00739297|1031266|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
432806|NCT00739297|1031260|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
432807|NCT00739297|1031261|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
432808|NCT00739297|1031262|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
432809|NCT00739297|1031263|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
432810|NCT00739297|1031264|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
432811|NCT00739297|1031265|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
432812|NCT00739297|1031266|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
432813|NCT00739297|1031260|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432814|NCT00739297|1031261|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432815|NCT00739297|1031262|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432816|NCT00739297|1031263|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432817|NCT00739297|1031264|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432818|NCT00739297|1031265|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432819|NCT00739297|1031266|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
432820|NCT00739297|1031260|P7|COMPLETED|Third Washout Period of 4-7 Days||66
432821|NCT00739297|1031261|P6|COMPLETED|Third Washout Period of 4-7 Days||8
432822|NCT00739297|1031262|P5|COMPLETED|Third Washout Period of 4-7 Days||6
432823|NCT00739297|1031263|P4|COMPLETED|Third Washout Period of 4-7 Days||18
432824|NCT00739297|1031264|P3|COMPLETED|Third Washout Period of 4-7 Days||6
432825|NCT00739297|1031265|P2|COMPLETED|Third Washout Period of 4-7 Days||12
432826|NCT00739297|1031266|P1|COMPLETED|Third Washout Period of 4-7 Days||16
432827|NCT00739297|1031260|P7|STARTED|Third Washout Period of 4-7 Days||66
432828|NCT00739297|1031261|P6|STARTED|Third Washout Period of 4-7 Days||8
432829|NCT00739297|1031262|P5|STARTED|Third Washout Period of 4-7 Days||6
432830|NCT00739297|1031263|P4|STARTED|Third Washout Period of 4-7 Days||18
432831|NCT00739297|1031264|P3|STARTED|Third Washout Period of 4-7 Days||6
432832|NCT00739297|1031265|P2|STARTED|Third Washout Period of 4-7 Days||12
432833|NCT00739297|1031266|P1|STARTED|Third Washout Period of 4-7 Days||16
432834|NCT00739297|1031260|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432835|NCT00739297|1031261|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432836|NCT00739297|1031262|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432837|NCT00739297|1031263|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432838|NCT00739297|1031264|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432839|NCT00739297|1031265|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432840|NCT00739297|1031266|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
432841|NCT00739297|1031260|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
432842|NCT00739297|1031261|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
432843|NCT00739297|1031262|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
432844|NCT00739297|1031263|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
432845|NCT00739297|1031264|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
432846|NCT00739297|1031265|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
432847|NCT00739297|1031266|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
432848|NCT00739297|1031260|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
432849|NCT00739297|1031261|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
432850|NCT00739297|1031262|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
432851|NCT00739297|1031263|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
432852|NCT00739297|1031264|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
432853|NCT00739297|1031265|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
432854|NCT00739297|1031266|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
432855|NCT00739297|1031260|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432856|NCT00739297|1031261|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432857|NCT00739297|1031262|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432858|NCT00739297|1031263|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432859|NCT00739297|1031264|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432860|NCT00739297|1031265|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432861|NCT00739297|1031266|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
432862|NCT00739297|1031260|P7|COMPLETED|Second Washout Period of 4-7 Days||66
432863|NCT00739297|1031261|P6|COMPLETED|Second Washout Period of 4-7 Days||10
432864|NCT00739297|1031262|P5|COMPLETED|Second Washout Period of 4-7 Days||6
432865|NCT00739297|1031263|P4|COMPLETED|Second Washout Period of 4-7 Days||14
432866|NCT00739297|1031264|P3|COMPLETED|Second Washout Period of 4-7 Days||10
432867|NCT00739297|1031265|P2|COMPLETED|Second Washout Period of 4-7 Days||8
432868|NCT00739297|1031266|P1|COMPLETED|Second Washout Period of 4-7 Days||18
432869|NCT00739297|1031260|P7|STARTED|Second Washout Period of 4-7 Days||66
432870|NCT00739297|1031261|P6|STARTED|Second Washout Period of 4-7 Days||10
432871|NCT00739297|1031262|P5|STARTED|Second Washout Period of 4-7 Days||6
432872|NCT00739297|1031263|P4|STARTED|Second Washout Period of 4-7 Days||14
432873|NCT00739297|1031264|P3|STARTED|Second Washout Period of 4-7 Days||10
432874|NCT00739297|1031265|P2|STARTED|Second Washout Period of 4-7 Days||8
432875|NCT00739297|1031266|P1|STARTED|Second Washout Period of 4-7 Days||18
432876|NCT00739297|1031260|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432877|NCT00739297|1031261|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432878|NCT00739297|1031262|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432879|NCT00739297|1031263|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432880|NCT00739297|1031264|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432881|NCT00739297|1031265|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432882|NCT00739297|1031266|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
432883|NCT00739297|1031260|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
432884|NCT00739297|1031261|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
432885|NCT00739297|1031262|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
432886|NCT00739297|1031263|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
432887|NCT00739297|1031264|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
432888|NCT00739297|1031265|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
432889|NCT00739297|1031266|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
432890|NCT00739297|1031260|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
432891|NCT00739297|1031261|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
432892|NCT00739297|1031262|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
432893|NCT00739297|1031263|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
432894|NCT00739297|1031264|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
432895|NCT00739297|1031265|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
432896|NCT00739297|1031266|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
432897|NCT00739297|1031260|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
432898|NCT00739297|1031261|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
432899|NCT00739297|1031262|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
432900|NCT00739297|1031263|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
432901|NCT00739297|1031264|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
432902|NCT00739297|1031265|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
432903|NCT00739297|1031266|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
432904|NCT00739297|1031260|P7|COMPLETED|First Washout Period of 4-7 Days||66
432905|NCT00739297|1031261|P6|COMPLETED|First Washout Period of 4-7 Days||9
432906|NCT00739297|1031262|P5|COMPLETED|First Washout Period of 4-7 Days||6
432907|NCT00739297|1031263|P4|COMPLETED|First Washout Period of 4-7 Days||17
432908|NCT00739297|1031264|P3|COMPLETED|First Washout Period of 4-7 Days||6
432909|NCT00739297|1031265|P2|COMPLETED|First Washout Period of 4-7 Days||11
432910|NCT00739297|1031266|P1|COMPLETED|First Washout Period of 4-7 Days||17
432911|NCT00739297|1031260|P7|STARTED|First Washout Period of 4-7 Days||68
432912|NCT00739297|1031261|P6|STARTED|First Washout Period of 4-7 Days||9
432913|NCT00739297|1031262|P5|STARTED|First Washout Period of 4-7 Days||6
432914|NCT00739297|1031263|P4|STARTED|First Washout Period of 4-7 Days||19
432915|NCT00739297|1031264|P3|STARTED|First Washout Period of 4-7 Days||6
432916|NCT00739297|1031265|P2|STARTED|First Washout Period of 4-7 Days||11
432917|NCT00739297|1031266|P1|STARTED|First Washout Period of 4-7 Days||17
432918|NCT00739297|1031260|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432919|NCT00739297|1031261|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432920|NCT00739297|1031262|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432921|NCT00739297|1031263|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432922|NCT00739297|1031264|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432923|NCT00739297|1031265|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432924|NCT00739297|1031266|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
432925|NCT00739297|1031260|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
432926|NCT00739297|1031261|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
432927|NCT00739297|1031262|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
432928|NCT00739297|1031263|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
432929|NCT00739297|1031264|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
432930|NCT00739297|1031265|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
432931|NCT00739297|1031266|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
432932|NCT00739297|1031260|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
432933|NCT00739297|1031261|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
432934|NCT00739297|1031262|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
432935|NCT00739297|1031263|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
432936|NCT00739297|1031264|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
432937|NCT00739297|1031265|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
432938|NCT00739297|1031266|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
432939|NCT00738062|1031297|P3|NOT COMPLETED|Open-Label Extension||0
432940|NCT00738062|1031298|P2|NOT COMPLETED|Open-Label Extension||0
432941|NCT00738062|1031299|P1|NOT COMPLETED|Open-Label Extension||17
432942|NCT00738062|1031297|P3|COMPLETED|Open-Label Extension||0
432943|NCT00738062|1031298|P2|COMPLETED|Open-Label Extension||0
432944|NCT00738062|1031299|P1|COMPLETED|Open-Label Extension||57
432945|NCT00738062|1031297|P3|STARTED|Open-Label Extension||0
432946|NCT00738062|1031298|P2|STARTED|Open-Label Extension||0
432947|NCT00738062|1031299|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
432948|NCT00738062|1031297|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
432949|NCT00738062|1031298|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
432950|NCT00738062|1031299|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
432951|NCT00738062|1031297|P3|COMPLETED|2 Week Randomized Withdrawal||37
432952|NCT00738062|1031298|P2|COMPLETED|2 Week Randomized Withdrawal||38
432953|NCT00738062|1031299|P1|COMPLETED|2 Week Randomized Withdrawal||0
432954|NCT00738062|1031297|P3|STARTED|2 Week Randomized Withdrawal||37
432955|NCT00738062|1031298|P2|STARTED|2 Week Randomized Withdrawal||38
432956|NCT00738062|1031299|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
432957|NCT00738062|1031297|P3|NOT COMPLETED|Open Label Treatment||0
432958|NCT00738062|1031298|P2|NOT COMPLETED|Open Label Treatment||0
432959|NCT00738062|1031299|P1|NOT COMPLETED|Open Label Treatment||28
432960|NCT00738062|1031297|P3|COMPLETED|Open Label Treatment||0
432961|NCT00738062|1031298|P2|COMPLETED|Open Label Treatment||0
432962|NCT00738062|1031299|P1|COMPLETED|Open Label Treatment||75
432963|NCT00738062|1031297|P3|STARTED|Open Label Treatment||0
432964|NCT00738062|1031298|P2|STARTED|Open Label Treatment||0
432965|NCT00738062|1031299|P1|STARTED|Open Label Treatment||103
432966|NCT00738049|1031326|P2|NOT COMPLETED|Washout||0
432967|NCT00738049|1031327|P1|NOT COMPLETED|Washout||0
432968|NCT00738049|1031326|P2|COMPLETED|Washout||7
432969|NCT00738049|1031327|P1|COMPLETED|Washout||13
432970|NCT00738049|1031326|P2|STARTED|Washout||7
432971|NCT00738049|1031327|P1|STARTED|Washout||13
432972|NCT00738049|1031326|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
432973|NCT00738049|1031327|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
432974|NCT00738049|1031326|P2|COMPLETED|2nd Intervention(14 Days)||7
432975|NCT00738049|1031327|P1|COMPLETED|2nd Intervention(14 Days)||13
432976|NCT00738049|1031326|P2|STARTED|2nd Intervention(14 Days)||7
432977|NCT00738049|1031327|P1|STARTED|2nd Intervention(14 Days)||13
432978|NCT00738049|1031326|P2|NOT COMPLETED|1st Intervention(14 Days)||0
432979|NCT00738049|1031327|P1|NOT COMPLETED|1st Intervention(14 Days)||0
432980|NCT00738049|1031326|P2|COMPLETED|1st Intervention(14 Days)||7
432981|NCT00738049|1031327|P1|COMPLETED|1st Intervention(14 Days)||13
432982|NCT00738049|1031326|P2|STARTED|1st Intervention(14 Days)||7
432983|NCT00738049|1031327|P1|STARTED|1st Intervention(14 Days)||13
432984|NCT00738023|1031341|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
432985|NCT00738023|1031342|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
432986|NCT00738023|1031341|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
432987|NCT00738023|1031342|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
432988|NCT00738023|1031341|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
432989|NCT00738023|1031342|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
432990|NCT00738023|1031341|P2|NOT COMPLETED|Saline Infusion||0
432991|NCT00738023|1031342|P1|NOT COMPLETED|Saline Infusion||0
432992|NCT00738023|1031341|P2|COMPLETED|Saline Infusion||0
432993|NCT00738023|1031342|P1|COMPLETED|Saline Infusion||19
432994|NCT00738023|1031341|P2|STARTED|Saline Infusion||0
432995|NCT00738023|1031342|P1|STARTED|Saline Infusion||19
432996|NCT00738023|1031341|P2|NOT COMPLETED|Intralipid Infusion||0
432997|NCT00738023|1031342|P1|NOT COMPLETED|Intralipid Infusion||0
432998|NCT00738023|1031341|P2|COMPLETED|Intralipid Infusion||13
432999|NCT00738023|1031342|P1|COMPLETED|Intralipid Infusion||19
433000|NCT00738023|1031341|P2|STARTED|Intralipid Infusion||13
433001|NCT00738023|1031342|P1|STARTED|Intralipid Infusion||19
433002|NCT00739102|1031350|P1|NOT COMPLETED|Overall Study||15
433003|NCT00739102|1031350|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
433004|NCT00739102|1031350|P1|STARTED|Overall Study||250
433005|NCT00739063|1031366|P1|NOT COMPLETED|Overall Study||8
433006|NCT00739063|1031366|P1|COMPLETED|Overall Study||3
433007|NCT00739063|1031366|P1|STARTED|Overall Study||11
433008|NCT00739050|1031370|P2|NOT COMPLETED|Overall Study||0
433009|NCT00739050|1031371|P1|NOT COMPLETED|Overall Study||1
433010|NCT00739050|1031370|P2|COMPLETED|Overall Study||0
433011|NCT00739050|1031371|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
433012|NCT00739050|1031370|P2|STARTED|Overall Study||0
433013|NCT00739050|1031371|P1|STARTED|Overall Study||4
433014|NCT00739024|1031385|P2|NOT COMPLETED|Overall Study||0
433015|NCT00739024|1031386|P1|NOT COMPLETED|Overall Study||0
433016|NCT00739024|1031385|P2|COMPLETED|Overall Study||6
433017|NCT00739024|1031386|P1|COMPLETED|Overall Study||7
433018|NCT00739024|1031385|P2|STARTED|Overall Study||6
433019|NCT00739024|1031386|P1|STARTED|Overall Study||7
433020|NCT00738972|1031396|P4|NOT COMPLETED|Overall Study||1
433021|NCT00738972|1031397|P3|NOT COMPLETED|Overall Study||0
433022|NCT00738972|1031398|P2|NOT COMPLETED|Overall Study||0
433023|NCT00738972|1031399|P1|NOT COMPLETED|Overall Study||0
433024|NCT00738972|1031396|P4|COMPLETED|Overall Study||2
433025|NCT00738972|1031397|P3|COMPLETED|Overall Study||3
433026|NCT00738972|1031398|P2|COMPLETED|Overall Study||3
433027|NCT00738972|1031399|P1|COMPLETED|Overall Study||3
433028|NCT00738972|1031396|P4|STARTED|Overall Study||3
433029|NCT00738972|1031397|P3|STARTED|Overall Study||3
433030|NCT00738972|1031398|P2|STARTED|Overall Study||3
433031|NCT00738972|1031399|P1|STARTED|Overall Study||3
433032|NCT00738881|1031411|P2|NOT COMPLETED|Overall Study||2
433033|NCT00738881|1031412|P1|NOT COMPLETED|Overall Study||0
433034|NCT00738881|1031411|P2|COMPLETED|Overall Study||10
433035|NCT00738881|1031412|P1|COMPLETED|Overall Study||11
433036|NCT00738881|1031411|P2|STARTED|Overall Study||12
433037|NCT00738881|1031412|P1|STARTED|Overall Study||11
433038|NCT00738699|1031426|P2|NOT COMPLETED|Overall Study||140
433039|NCT00738699|1031427|P1|NOT COMPLETED|Overall Study||275
433040|NCT00738699|1031426|P2|COMPLETED|Overall Study||0
433041|NCT00738699|1031427|P1|COMPLETED|Overall Study||0
433042|NCT00738699|1031426|P2|Participants Treated|Overall Study||139
433043|NCT00738699|1031427|P1|Participants Treated|Overall Study||273
433044|NCT00738699|1031426|P2|Participants Not Treated|Overall Study||1
433045|NCT00738699|1031427|P1|Participants Not Treated|Overall Study||2
433046|NCT00738699|1031426|P2|STARTED|Overall Study||140
433047|NCT00738699|1031427|P1|STARTED|Overall Study||275
433048|NCT00738673|1031445|P2|NOT COMPLETED|Overall Study||11
433049|NCT00738673|1031446|P1|NOT COMPLETED|Overall Study||24
433050|NCT00738673|1031445|P2|COMPLETED|Overall Study||1
433051|NCT00738673|1031446|P1|COMPLETED|Overall Study||1
433052|NCT00738673|1031445|P2|Intent to Treat Population|Overall Study||12
433053|NCT00738673|1031446|P1|Intent to Treat Population|Overall Study||24
433054|NCT00738673|1031445|P2|STARTED|Overall Study||12
433055|NCT00738673|1031446|P1|STARTED|Overall Study||25
433056|NCT00738543|1031474|P1|NOT COMPLETED|Control||0
433057|NCT00738543|1031474|P1|COMPLETED|Control||48
433058|NCT00738543|1031474|P1|STARTED|Control||48
433059|NCT00738543|1031474|P1|NOT COMPLETED|Sodium Hypochlorite||0
433060|NCT00738543|1031474|P1|COMPLETED|Sodium Hypochlorite||48
433061|NCT00738543|1031474|P1|STARTED|Sodium Hypochlorite||48
433062|NCT00738543|1031474|P1|NOT COMPLETED|Povidone Iodine||0
433063|NCT00738543|1031474|P1|COMPLETED|Povidone Iodine||48
433064|NCT00738543|1031474|P1|STARTED|Povidone Iodine||48
433065|NCT00738530|1031484|P2|NOT COMPLETED|Overall Study||238
433066|NCT00738530|1031485|P1|NOT COMPLETED|Overall Study||234
433067|NCT00738530|1031484|P2|COMPLETED|Overall Study||84
433068|NCT00738530|1031485|P1|COMPLETED|Overall Study||93
433069|NCT00738530|1031484|P2|Treated|Overall Study||316
433070|NCT00738530|1031485|P1|Treated|Overall Study||325
433071|NCT00738530|1031484|P2|STARTED|Overall Study||322
433072|NCT00738530|1031485|P1|STARTED|Overall Study||327
433073|NCT00738426|1031511|P2|NOT COMPLETED|Overall Study||3
433074|NCT00738426|1031512|P1|NOT COMPLETED|Overall Study||2
433075|NCT00738426|1031511|P2|COMPLETED|Overall Study||32
433076|NCT00738426|1031512|P1|COMPLETED|Overall Study||35
433077|NCT00738426|1031511|P2|STARTED|Overall Study||35
433078|NCT00738426|1031512|P1|STARTED|Overall Study||37
433079|NCT00738400|1031520|P2|NOT COMPLETED|Overall Study||7
433080|NCT00738400|1031521|P1|NOT COMPLETED|Overall Study||4
433081|NCT00738400|1031520|P2|COMPLETED|Overall Study||67
433082|NCT00738400|1031521|P1|COMPLETED|Overall Study||72
433083|NCT00738400|1031520|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
433084|NCT00738400|1031521|P1|ITT (Intent To Treatment) Population|Overall Study||75
433085|NCT00738400|1031520|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
433086|NCT00738400|1031521|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
433087|NCT00738400|1031520|P2|STARTED|Overall Study||74
433088|NCT00738400|1031521|P1|STARTED|Overall Study||76
433089|NCT00738374|1031542|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
433090|NCT00738374|1031543|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
433091|NCT00738374|1031544|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
433092|NCT00738374|1031545|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
433093|NCT00738374|1031542|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
433094|NCT00738374|1031543|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
433095|NCT00738374|1031544|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
433096|NCT00738374|1031545|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
433097|NCT00738374|1031542|P4|STARTED|Maintenance Treatment/Observation Phase||32
433098|NCT00738374|1031543|P3|STARTED|Maintenance Treatment/Observation Phase||34
433099|NCT00738374|1031544|P2|STARTED|Maintenance Treatment/Observation Phase||7
433100|NCT00738374|1031545|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
433101|NCT00738374|1031542|P4|NOT COMPLETED|Induction Treatment Phase||0
433102|NCT00738374|1031543|P3|NOT COMPLETED|Induction Treatment Phase||0
433103|NCT00738374|1031544|P2|NOT COMPLETED|Induction Treatment Phase||0
433104|NCT00738374|1031545|P1|NOT COMPLETED|Induction Treatment Phase||24
433105|NCT00738374|1031542|P4|COMPLETED|Induction Treatment Phase||0
433106|NCT00738374|1031543|P3|COMPLETED|Induction Treatment Phase||0
433107|NCT00738374|1031544|P2|COMPLETED|Induction Treatment Phase||0
433108|NCT00738374|1031545|P1|COMPLETED|Induction Treatment Phase||73
433109|NCT00738374|1031542|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
433110|NCT00738374|1031543|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
433111|NCT00738374|1031544|P2|STARTED|Induction Treatment Phase||0
433112|NCT00738374|1031545|P1|STARTED|Induction Treatment Phase||97
433113|NCT00738361|1031577|P1|NOT COMPLETED|Overall Study||0
433114|NCT00738361|1031577|P1|COMPLETED|Overall Study||4
433115|NCT00738361|1031577|P1|STARTED|Overall Study||4
433116|NCT00738283|1031583|P1|NOT COMPLETED|Overall Study||4
433117|NCT00738283|1031583|P1|COMPLETED|Overall Study||13
433118|NCT00738283|1031583|P1|STARTED|Overall Study||17
433119|NCT00737737|1031589|P2|NOT COMPLETED|Overall Study||0
433120|NCT00737737|1031590|P1|NOT COMPLETED|Overall Study||0
433121|NCT00737737|1031589|P2|COMPLETED|Overall Study||2
433122|NCT00737737|1031590|P1|COMPLETED|Overall Study||2
433123|NCT00737737|1031589|P2|STARTED|Overall Study||2
433124|NCT00737737|1031590|P1|STARTED|Overall Study||2
433125|NCT00737711|1031598|P1|NOT COMPLETED|Overall Study||31
433126|NCT00737711|1031598|P1|COMPLETED|Overall Study||158
433127|NCT00737711|1031598|P1|STARTED|Overall Study||189
433128|NCT00737672|1031631|P2|NOT COMPLETED|Overall Study||83
433129|NCT00737672|1031632|P1|NOT COMPLETED|Overall Study||80
433130|NCT00737672|1031631|P2|COMPLETED|Overall Study||65
433131|NCT00737672|1031632|P1|COMPLETED|Overall Study||65
433132|NCT00737672|1031631|P2|Per Protocol Population|Overall Study||138
433133|NCT00737672|1031632|P1|Per Protocol Population|Overall Study||131
433134|NCT00737672|1031631|P2|Exclusions Due to Protocol Deviations|Overall Study||10
433135|NCT00737672|1031632|P1|Exclusions Due to Protocol Deviations|Overall Study||14
433136|NCT00737672|1031631|P2|STARTED|Overall Study||148
433137|NCT00737672|1031632|P1|STARTED|Overall Study||145
433138|NCT00737633|1031670|P2|NOT COMPLETED|Overall Study||57
433139|NCT00737633|1031671|P1|NOT COMPLETED|Overall Study||44
433140|NCT00737633|1031670|P2|COMPLETED|Overall Study||0
433141|NCT00737633|1031671|P1|COMPLETED|Overall Study||0
433142|NCT00737633|1031670|P2|STARTED|Overall Study||57
433143|NCT00737633|1031671|P1|STARTED|Overall Study||44
433144|NCT00737594|1031682|P3|NOT COMPLETED|Overall Study||0
433145|NCT00737594|1031683|P2|NOT COMPLETED|Overall Study||0
433146|NCT00737594|1031684|P1|NOT COMPLETED|Overall Study||0
433147|NCT00737594|1031682|P3|COMPLETED|Overall Study||0
433148|NCT00737594|1031683|P2|COMPLETED|Overall Study||0
433149|NCT00737594|1031684|P1|COMPLETED|Overall Study||0
433150|NCT00737594|1031682|P3|STARTED|Overall Study||0
433151|NCT00737594|1031683|P2|STARTED|Overall Study||0
433152|NCT00737594|1031684|P1|STARTED|Overall Study||0
433153|NCT00737568|1031694|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
433154|NCT00737568|1031695|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
433155|NCT00737568|1031694|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
433156|NCT00737568|1031695|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
433157|NCT00737568|1031694|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
433158|NCT00737568|1031695|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
433159|NCT00737568|1031694|P2|NOT COMPLETED|Treatment Period Through Week 240||21
433160|NCT00737568|1031695|P1|NOT COMPLETED|Treatment Period Through Week 240||20
433161|NCT00737568|1031694|P2|COMPLETED|Treatment Period Through Week 240||118
433162|NCT00737568|1031695|P1|COMPLETED|Treatment Period Through Week 240||121
433163|NCT00737568|1031694|P2|STARTED|Treatment Period Through Week 240||139
433164|NCT00737568|1031695|P1|STARTED|Treatment Period Through Week 240||141
433165|NCT00737529|1031725|P1|NOT COMPLETED|Overall Study||112
433166|NCT00737529|1031725|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 02 July 2012|22
433167|NCT00737529|1031725|P1|STARTED|Overall Study||134
433168|NCT00737477|1031739|P1|NOT COMPLETED|Overall Study||34
433169|NCT00737477|1031739|P1|COMPLETED|Overall Study||62
433170|NCT00737477|1031739|P1|STARTED|Overall Study||96
433171|NCT00737464|1031755|P1|NOT COMPLETED|Overall Study||18
433172|NCT00737464|1031755|P1|COMPLETED|Overall Study||114
433173|NCT00737464|1031755|P1|STARTED|Overall Study||132
433174|NCT00737438|1031776|P1|NOT COMPLETED|Overall Study||3
433175|NCT00737438|1031776|P1|COMPLETED|Overall Study||20
433176|NCT00737438|1031776|P1|STARTED|Overall Study||23
433177|NCT00737360|1031780|P1|NOT COMPLETED|Overall Study||0
433178|NCT00737360|1031780|P1|COMPLETED|Overall Study||27
433179|NCT00737360|1031780|P1|STARTED|Overall Study||27
433180|NCT00737282|1031789|P1|NOT COMPLETED|Overall Study||175
433181|NCT00737282|1031789|P1|COMPLETED|Overall Study||0
433182|NCT00737282|1031789|P1|STARTED|Overall Study||175
433183|NCT00737243|1031795|P1|NOT COMPLETED|Overall Study||95
433184|NCT00737243|1031795|P1|COMPLETED|Overall Study||194
433185|NCT00737243|1031795|P1|Empiric CUP Therapy|Overall Study||29
433186|NCT00737243|1031795|P1|Site Specific Therapy Less Responsive|Overall Study||79
433187|NCT00737243|1031795|P1|Site Specific Therapy More Responsive|Overall Study||115
433188|NCT00737243|1031795|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
433189|NCT00737243|1031795|P1|Treated|Overall Study||223
433190|NCT00737243|1031795|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
433191|NCT00737243|1031795|P1|Successful Assay Performed|Overall Study||252
433192|NCT00737243|1031795|P1|STARTED|Overall Study||289
433193|NCT00737204|1031803|P2|NOT COMPLETED|Overall Study||6
433194|NCT00737204|1031804|P1|NOT COMPLETED|Overall Study||0
433195|NCT00737204|1031803|P2|COMPLETED|Overall Study||28
433196|NCT00737204|1031804|P1|COMPLETED|Overall Study||36
433197|NCT00737204|1031803|P2|STARTED|Overall Study||34
433198|NCT00737204|1031804|P1|STARTED|Overall Study||36
433199|NCT00737178|1031818|P2|NOT COMPLETED|Overall Study||9
433200|NCT00737178|1031819|P1|NOT COMPLETED|Overall Study||5
433201|NCT00737178|1031818|P2|COMPLETED|Overall Study||76
433202|NCT00737178|1031819|P1|COMPLETED|Overall Study||66
433203|NCT00737178|1031818|P2|STARTED|Overall Study||85
433204|NCT00737178|1031819|P1|STARTED|Overall Study||71
433205|NCT00737100|1031832|P3|NOT COMPLETED|Overall Study||7
433206|NCT00737100|1031833|P2|NOT COMPLETED|Overall Study||7
433207|NCT00737100|1031834|P1|NOT COMPLETED|Overall Study||7
433208|NCT00737100|1031832|P3|COMPLETED|Overall Study||169
433209|NCT00737100|1031833|P2|COMPLETED|Overall Study||159
433210|NCT00737100|1031834|P1|COMPLETED|Overall Study||161
433211|NCT00737100|1031832|P3|STARTED|Overall Study||176
433212|NCT00737100|1031833|P2|STARTED|Overall Study||166
433213|NCT00737100|1031834|P1|STARTED|Overall Study||168
433214|NCT00737061|1031878|P1|NOT COMPLETED|1 Year Wearing Period||17
433215|NCT00737061|1031878|P1|COMPLETED|1 Year Wearing Period||553
433216|NCT00737061|1031878|P1|STARTED|1 Year Wearing Period||570
433217|NCT00737061|1031878|P1|NOT COMPLETED|Waiting Period||75
433218|NCT00737061|1031878|P1|COMPLETED|Waiting Period||570
433219|NCT00737061|1031878|P1|STARTED|Waiting Period||645
433220|NCT00737048|1031895|P3|NOT COMPLETED|Overall Study||4
433221|NCT00737048|1031896|P2|NOT COMPLETED|Overall Study||6
433222|NCT00737048|1031897|P1|NOT COMPLETED|Overall Study||3
433223|NCT00737048|1031895|P3|COMPLETED|Overall Study||126
433224|NCT00737048|1031896|P2|COMPLETED|Overall Study||60
433225|NCT00737048|1031897|P1|COMPLETED|Overall Study||129
433226|NCT00737048|1031895|P3|STARTED|Overall Study||130
433227|NCT00737048|1031896|P2|STARTED|Overall Study||66
433228|NCT00737048|1031897|P1|STARTED|Overall Study||132
433229|NCT00736996|1031941|P3|NOT COMPLETED|Overall Study||2
433230|NCT00736996|1031942|P2|NOT COMPLETED|Overall Study||9
433231|NCT00736996|1031943|P1|NOT COMPLETED|Overall Study||1
433232|NCT00736996|1031941|P3|COMPLETED|Overall Study||25
433233|NCT00736996|1031942|P2|COMPLETED|Overall Study||17
433234|NCT00736996|1031943|P1|COMPLETED|Overall Study||24
433235|NCT00736996|1031941|P3|STARTED|Overall Study||27
433236|NCT00736996|1031942|P2|STARTED|Overall Study||26
433237|NCT00736996|1031943|P1|STARTED|Overall Study||25
433238|NCT00736957|1031957|P1|NOT COMPLETED|Overall Study||122
433239|NCT00736957|1031957|P1|COMPLETED|Overall Study||97
433240|NCT00736957|1031957|P1|Treated|Overall Study||190
433241|NCT00736957|1031957|P1|STARTED|Overall Study||219
433242|NCT00736944|1031967|P1|NOT COMPLETED|Definitive Treatment||1
433243|NCT00736944|1031967|P1|COMPLETED|Definitive Treatment||28
433244|NCT00736944|1031967|P1|STARTED|Definitive Treatment||29
433245|NCT00736944|1031967|P1|NOT COMPLETED|Induction||1
433246|NCT00736944|1031967|P1|COMPLETED|Induction||29
433247|NCT00736944|1031967|P1|STARTED|Induction||30
433248|NCT00736879|1031998|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
433249|NCT00736879|1031999|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
433250|NCT00736879|1032000|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
433251|NCT00736879|1032001|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
433252|NCT00736879|1031998|P4|COMPLETED|Follow up Period - No Drug Treatment||62
433253|NCT00736879|1031999|P3|COMPLETED|Follow up Period - No Drug Treatment||66
433254|NCT00736879|1032000|P2|COMPLETED|Follow up Period - No Drug Treatment||67
433255|NCT00736879|1032001|P1|COMPLETED|Follow up Period - No Drug Treatment||65
433256|NCT00736879|1031998|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
433257|NCT00736879|1031999|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
433258|NCT00736879|1032000|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
433259|NCT00736879|1032001|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
433260|NCT00736879|1031998|P4|NOT COMPLETED|Double Blind Treatment Period||5
433261|NCT00736879|1031999|P3|NOT COMPLETED|Double Blind Treatment Period||7
433262|NCT00736879|1032000|P2|NOT COMPLETED|Double Blind Treatment Period||4
433263|NCT00736879|1032001|P1|NOT COMPLETED|Double Blind Treatment Period||3
433264|NCT00736879|1031998|P4|COMPLETED|Double Blind Treatment Period||63
433265|NCT00736879|1031999|P3|COMPLETED|Double Blind Treatment Period||67
433266|NCT00736879|1032000|P2|COMPLETED|Double Blind Treatment Period||68
433267|NCT00736879|1032001|P1|COMPLETED|Double Blind Treatment Period||65
433268|NCT00736879|1031998|P4|STARTED|Double Blind Treatment Period||68
433269|NCT00736879|1031999|P3|STARTED|Double Blind Treatment Period||74
433270|NCT00736879|1032000|P2|STARTED|Double Blind Treatment Period||72
433271|NCT00736879|1032001|P1|STARTED|Double Blind Treatment Period||68
433272|NCT00736853|1032055|P3|NOT COMPLETED|Double-Blind Period||48
433273|NCT00736853|1032056|P2|NOT COMPLETED|Double-Blind Period||24
433274|NCT00736853|1032057|P1|NOT COMPLETED|Double-Blind Period||0
433275|NCT00736853|1032055|P3|COMPLETED|Double-Blind Period||45
433276|NCT00736853|1032056|P2|COMPLETED|Double-Blind Period||70
433277|NCT00736853|1032057|P1|COMPLETED|Double-Blind Period||0
433278|NCT00736853|1032055|P3|STARTED|Double-Blind Period||93
433279|NCT00736853|1032056|P2|STARTED|Double-Blind Period||94
433280|NCT00736853|1032057|P1|STARTED|Double-Blind Period||0
433281|NCT00736853|1032055|P3|NOT COMPLETED|Open-Label Period||0
433282|NCT00736853|1032056|P2|NOT COMPLETED|Open-Label Period||0
433283|NCT00736853|1032057|P1|NOT COMPLETED|Open-Label Period||132
433284|NCT00736853|1032055|P3|COMPLETED|Open-Label Period||0
433285|NCT00736853|1032056|P2|COMPLETED|Open-Label Period||0
433286|NCT00736853|1032057|P1|COMPLETED|Open-Label Period||187
433287|NCT00736853|1032055|P3|Treated|Open-Label Period||0
433288|NCT00736853|1032056|P2|Treated|Open-Label Period||0
433289|NCT00736853|1032057|P1|Treated|Open-Label Period||277
433290|NCT00736853|1032055|P3|STARTED|Open-Label Period||0
433291|NCT00736853|1032056|P2|STARTED|Open-Label Period||0
433292|NCT00736853|1032057|P1|STARTED|Open-Label Period||319
433293|NCT00736840|1032097|P1|NOT COMPLETED|Overall Study||13
433294|NCT00736840|1032097|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
433295|NCT00736840|1032097|P1|STARTED|Overall Study||414
433296|NCT00736723|1032104|P2|NOT COMPLETED|Overall Study||3
433297|NCT00736723|1032105|P1|NOT COMPLETED|Overall Study||4
433298|NCT00736723|1032104|P2|COMPLETED|Overall Study||18
433299|NCT00736723|1032105|P1|COMPLETED|Overall Study||26
433300|NCT00736723|1032104|P2|STARTED|Overall Study||21
433301|NCT00736723|1032105|P1|STARTED|Overall Study||30
433302|NCT00736580|1032113|P2|NOT COMPLETED|Overall Study||0
433303|NCT00736580|1032114|P1|NOT COMPLETED|Overall Study||0
433304|NCT00736580|1032113|P2|COMPLETED|Overall Study||123
433305|NCT00736580|1032114|P1|COMPLETED|Overall Study||117
433306|NCT00736580|1032113|P2|STARTED|Overall Study||123
433307|NCT00736580|1032114|P1|STARTED|Overall Study||117
433308|NCT00736502|1032120|P1|NOT COMPLETED|Overall Study||65
433309|NCT00736502|1032120|P1|COMPLETED|Overall Study||213
433310|NCT00736502|1032120|P1|STARTED|Overall Study|Entered and treated.|278
433311|NCT00736489|1032126|P6|NOT COMPLETED|Period 6||0
433312|NCT00736489|1032127|P5|NOT COMPLETED|Period 6||0
433313|NCT00736489|1032128|P4|NOT COMPLETED|Period 6||0
433314|NCT00736489|1032129|P3|NOT COMPLETED|Period 6||0
433315|NCT00736489|1032130|P2|NOT COMPLETED|Period 6||0
433316|NCT00736489|1032131|P1|NOT COMPLETED|Period 6||0
433317|NCT00736489|1032126|P6|COMPLETED|Period 6||5
433318|NCT00736489|1032127|P5|COMPLETED|Period 6||7
433319|NCT00736489|1032128|P4|COMPLETED|Period 6||7
433320|NCT00736489|1032129|P3|COMPLETED|Period 6||6
433321|NCT00736489|1032130|P2|COMPLETED|Period 6||5
433322|NCT00736489|1032131|P1|COMPLETED|Period 6||5
433323|NCT00736489|1032126|P6|STARTED|Period 6||5
433324|NCT00736489|1032127|P5|STARTED|Period 6||7
433325|NCT00736489|1032128|P4|STARTED|Period 6||7
433326|NCT00736489|1032129|P3|STARTED|Period 6||6
433327|NCT00736489|1032130|P2|STARTED|Period 6||5
433328|NCT00736489|1032131|P1|STARTED|Period 6||5
433329|NCT00736489|1032126|P6|NOT COMPLETED|Period 5||0
433330|NCT00736489|1032127|P5|NOT COMPLETED|Period 5||0
433331|NCT00736489|1032128|P4|NOT COMPLETED|Period 5||0
433332|NCT00736489|1032129|P3|NOT COMPLETED|Period 5||0
433333|NCT00736489|1032130|P2|NOT COMPLETED|Period 5||0
433334|NCT00736489|1032131|P1|NOT COMPLETED|Period 5||0
433335|NCT00736489|1032126|P6|COMPLETED|Period 5||5
433336|NCT00736489|1032127|P5|COMPLETED|Period 5||7
433337|NCT00736489|1032128|P4|COMPLETED|Period 5||7
433338|NCT00736489|1032129|P3|COMPLETED|Period 5||6
433339|NCT00736489|1032130|P2|COMPLETED|Period 5||5
433340|NCT00736489|1032131|P1|COMPLETED|Period 5||5
433341|NCT00736489|1032126|P6|STARTED|Period 5||5
433342|NCT00736489|1032127|P5|STARTED|Period 5||7
433343|NCT00736489|1032128|P4|STARTED|Period 5||7
433344|NCT00736489|1032129|P3|STARTED|Period 5||6
433345|NCT00736489|1032130|P2|STARTED|Period 5||5
433346|NCT00736489|1032131|P1|STARTED|Period 5||5
433347|NCT00736489|1032126|P6|NOT COMPLETED|Period 4||0
433348|NCT00736489|1032127|P5|NOT COMPLETED|Period 4||0
433349|NCT00736489|1032128|P4|NOT COMPLETED|Period 4||0
433350|NCT00736489|1032129|P3|NOT COMPLETED|Period 4||0
433351|NCT00736489|1032130|P2|NOT COMPLETED|Period 4||0
433352|NCT00736489|1032131|P1|NOT COMPLETED|Period 4||0
433353|NCT00736489|1032126|P6|COMPLETED|Period 4||5
433354|NCT00736489|1032127|P5|COMPLETED|Period 4||7
433355|NCT00736489|1032128|P4|COMPLETED|Period 4||7
433356|NCT00736489|1032129|P3|COMPLETED|Period 4||6
433357|NCT00736489|1032130|P2|COMPLETED|Period 4||5
433358|NCT00736489|1032131|P1|COMPLETED|Period 4||5
433359|NCT00736489|1032126|P6|STARTED|Period 4||5
433360|NCT00736489|1032127|P5|STARTED|Period 4||7
433361|NCT00736489|1032128|P4|STARTED|Period 4||7
433362|NCT00736489|1032129|P3|STARTED|Period 4||6
433363|NCT00736489|1032130|P2|STARTED|Period 4||5
433364|NCT00736489|1032131|P1|STARTED|Period 4||5
433365|NCT00736489|1032126|P6|NOT COMPLETED|Period 3||0
433366|NCT00736489|1032127|P5|NOT COMPLETED|Period 3||0
433367|NCT00736489|1032128|P4|NOT COMPLETED|Period 3||0
433368|NCT00736489|1032129|P3|NOT COMPLETED|Period 3||0
433369|NCT00736489|1032130|P2|NOT COMPLETED|Period 3||0
433370|NCT00736489|1032131|P1|NOT COMPLETED|Period 3||0
433371|NCT00736489|1032126|P6|COMPLETED|Period 3||5
433372|NCT00736489|1032127|P5|COMPLETED|Period 3||7
433373|NCT00736489|1032128|P4|COMPLETED|Period 3||7
433374|NCT00736489|1032129|P3|COMPLETED|Period 3||6
433375|NCT00736489|1032130|P2|COMPLETED|Period 3||5
433376|NCT00736489|1032131|P1|COMPLETED|Period 3||5
433377|NCT00736489|1032126|P6|STARTED|Period 3||5
433378|NCT00736489|1032127|P5|STARTED|Period 3||7
433379|NCT00736489|1032128|P4|STARTED|Period 3||7
433380|NCT00736489|1032129|P3|STARTED|Period 3||6
433381|NCT00736489|1032130|P2|STARTED|Period 3||5
433382|NCT00736489|1032131|P1|STARTED|Period 3||5
433383|NCT00736489|1032126|P6|NOT COMPLETED|Period 2||0
433384|NCT00736489|1032127|P5|NOT COMPLETED|Period 2||0
433385|NCT00736489|1032128|P4|NOT COMPLETED|Period 2||0
433386|NCT00736489|1032129|P3|NOT COMPLETED|Period 2||0
433387|NCT00736489|1032130|P2|NOT COMPLETED|Period 2||0
433388|NCT00736489|1032131|P1|NOT COMPLETED|Period 2||0
433389|NCT00736489|1032126|P6|COMPLETED|Period 2||5
433390|NCT00736489|1032127|P5|COMPLETED|Period 2||7
433391|NCT00736489|1032128|P4|COMPLETED|Period 2||7
433392|NCT00736489|1032129|P3|COMPLETED|Period 2||6
433393|NCT00736489|1032130|P2|COMPLETED|Period 2||5
433394|NCT00736489|1032131|P1|COMPLETED|Period 2||5
433395|NCT00736489|1032126|P6|STARTED|Period 2||5
433396|NCT00736489|1032127|P5|STARTED|Period 2||7
433397|NCT00736489|1032128|P4|STARTED|Period 2||7
433398|NCT00736489|1032129|P3|STARTED|Period 2||6
433399|NCT00736489|1032130|P2|STARTED|Period 2||5
433400|NCT00736489|1032131|P1|STARTED|Period 2||5
433401|NCT00736489|1032126|P6|NOT COMPLETED|Period 1||1
433402|NCT00736489|1032127|P5|NOT COMPLETED|Period 1||0
433403|NCT00736489|1032128|P4|NOT COMPLETED|Period 1||0
433404|NCT00736489|1032129|P3|NOT COMPLETED|Period 1||0
433405|NCT00736489|1032130|P2|NOT COMPLETED|Period 1||0
433406|NCT00736489|1032131|P1|NOT COMPLETED|Period 1||1
433407|NCT00736489|1032126|P6|COMPLETED|Period 1||5
433408|NCT00736489|1032127|P5|COMPLETED|Period 1||7
433409|NCT00736489|1032128|P4|COMPLETED|Period 1||7
433410|NCT00736489|1032129|P3|COMPLETED|Period 1||6
433411|NCT00736489|1032130|P2|COMPLETED|Period 1||5
433412|NCT00736489|1032131|P1|COMPLETED|Period 1||5
433413|NCT00736489|1032126|P6|STARTED|Period 1||6
433414|NCT00736489|1032127|P5|STARTED|Period 1||7
433415|NCT00736489|1032128|P4|STARTED|Period 1||7
433416|NCT00736489|1032129|P3|STARTED|Period 1||6
433417|NCT00736489|1032130|P2|STARTED|Period 1||5
433418|NCT00736489|1032131|P1|STARTED|Period 1|Cross-over study|6
433419|NCT00736476|1032285|P2|NOT COMPLETED|Overall Study||0
433420|NCT00736476|1032286|P1|NOT COMPLETED|Overall Study||1
433421|NCT00736476|1032285|P2|COMPLETED|Overall Study||27
433422|NCT00736476|1032286|P1|COMPLETED|Overall Study||35
433423|NCT00736476|1032285|P2|STARTED|Overall Study||27
433424|NCT00736476|1032286|P1|STARTED|Overall Study||36
433425|NCT00736385|1032308|P2|NOT COMPLETED|Overall Study||3
433426|NCT00736385|1032309|P1|NOT COMPLETED|Overall Study||2
433427|NCT00736385|1032308|P2|COMPLETED|Overall Study||2
433428|NCT00736385|1032309|P1|COMPLETED|Overall Study||2
433429|NCT00736385|1032308|P2|STARTED|Overall Study||5
433430|NCT00736385|1032309|P1|STARTED|Overall Study||4
433431|NCT00736333|1032321|P1|NOT COMPLETED|Overall Study||111
433432|NCT00736333|1032321|P1|COMPLETED|Overall Study||56
433433|NCT00736333|1032321|P1|STARTED|Overall Study||167
433434|NCT00736255|1032332|P2|NOT COMPLETED|Overall Study||1
433435|NCT00736255|1032333|P1|NOT COMPLETED|Overall Study||3
433436|NCT00736255|1032332|P2|COMPLETED|Overall Study||14
433437|NCT00736255|1032333|P1|COMPLETED|Overall Study||14
433438|NCT00736255|1032332|P2|STARTED|Overall Study||15
433439|NCT00736255|1032333|P1|STARTED|Overall Study||17
433440|NCT00736242|1032343|P1|NOT COMPLETED|Overall Study||125
433441|NCT00736242|1032343|P1|COMPLETED|Overall Study||107
433442|NCT00736242|1032343|P1|Participants in Safety Analysis Set|Overall Study||229
433443|NCT00736242|1032343|P1|STARTED|Overall Study||232
433444|NCT00736229|1032357|P3|NOT COMPLETED|Overall Study||0
433445|NCT00736229|1032358|P2|NOT COMPLETED|Overall Study||0
433446|NCT00736229|1032359|P1|NOT COMPLETED|Overall Study||0
433447|NCT00736229|1032357|P3|COMPLETED|Overall Study||84
433448|NCT00736229|1032358|P2|COMPLETED|Overall Study||71
433449|NCT00736229|1032359|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
433450|NCT00736229|1032357|P3|STARTED|Overall Study|Historic Control|84
433451|NCT00736229|1032358|P2|STARTED|Overall Study|Historic control|71
433452|NCT00736229|1032359|P1|STARTED|Overall Study|Actively Enrolled|40
433453|NCT00736190|1032372|P1|NOT COMPLETED|Overall Study||3
433454|NCT00736190|1032372|P1|COMPLETED|Overall Study||87
433455|NCT00736190|1032372|P1|STARTED|Overall Study||90
433456|NCT00736125|1032387|P2|NOT COMPLETED|Overall Study||2
433457|NCT00736125|1032388|P1|NOT COMPLETED|Overall Study||1
433458|NCT00736125|1032387|P2|COMPLETED|Overall Study||8
433459|NCT00736125|1032388|P1|COMPLETED|Overall Study||9
433460|NCT00736125|1032387|P2|STARTED|Overall Study||10
433461|NCT00736125|1032388|P1|STARTED|Overall Study||10
433462|NCT00736099|1032398|P2|NOT COMPLETED|Overall Study||58
433463|NCT00736099|1032399|P1|NOT COMPLETED|Overall Study||183
433464|NCT00736099|1032398|P2|COMPLETED|Overall Study|Number who completed treatment.|531
433465|NCT00736099|1032399|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
433466|NCT00736099|1032398|P2|STARTED|Overall Study|Number who started treatment.|589
433467|NCT00736099|1032399|P1|STARTED|Overall Study|Number who started treatment.|1532
433468|NCT00736073|1032497|P2|NOT COMPLETED|Overall Study||0
433469|NCT00736073|1032498|P1|NOT COMPLETED|Overall Study||0
433470|NCT00736073|1032497|P2|COMPLETED|Overall Study||39
433471|NCT00736073|1032498|P1|COMPLETED|Overall Study||34
433472|NCT00736073|1032497|P2|STARTED|Overall Study||39
433473|NCT00736073|1032498|P1|STARTED|Overall Study||34
433474|NCT00736034|1032508|P1|NOT COMPLETED|Overall Study||2
433475|NCT00736034|1032508|P1|COMPLETED|Overall Study||16
433476|NCT00736034|1032508|P1|STARTED|Overall Study||18
433477|NCT00735969|1032512|P1|NOT COMPLETED|Overall Study||0
433478|NCT00735969|1032512|P1|COMPLETED|Overall Study||21
433479|NCT00735969|1032512|P1|STARTED|Overall Study||21
433480|NCT00735943|1032516|P1|NOT COMPLETED|Overall Study||2
433481|NCT00735943|1032516|P1|COMPLETED|Overall Study||20
433482|NCT00735943|1032516|P1|STARTED|Overall Study||22
433483|NCT00735917|1032533|P1|NOT COMPLETED|Overall Study||0
433484|NCT00735917|1032533|P1|COMPLETED|Overall Study||19
433485|NCT00735917|1032533|P1|STARTED|Overall Study||19
433486|NCT00735904|1032541|P1|NOT COMPLETED|Overall Study||38
433487|NCT00735904|1032541|P1|COMPLETED|Overall Study||0
433488|NCT00735904|1032541|P1|STARTED|Overall Study||38
433489|NCT00735839|1032550|P2|NOT COMPLETED|Overall Study||0
433490|NCT00735839|1032551|P1|NOT COMPLETED|Overall Study||0
433491|NCT00735839|1032550|P2|COMPLETED|Overall Study||10
433492|NCT00735839|1032551|P1|COMPLETED|Overall Study||30
433493|NCT00735839|1032550|P2|STARTED|Overall Study||10
433494|NCT00735839|1032551|P1|STARTED|Overall Study||30
433495|NCT00735787|1032561|P2|NOT COMPLETED|Period 2||1
433496|NCT00735787|1032562|P1|NOT COMPLETED|Period 2||5
433497|NCT00735787|1032561|P2|COMPLETED|Period 2||40
433498|NCT00735787|1032562|P1|COMPLETED|Period 2||13
433499|NCT00735787|1032561|P2|STARTED|Period 2||41
433500|NCT00735787|1032562|P1|STARTED|Period 2||18
433501|NCT00735787|1032561|P2|NOT COMPLETED|Period 1||8
433502|NCT00735787|1032562|P1|NOT COMPLETED|Period 1||6
433503|NCT00735787|1032561|P2|COMPLETED|Period 1||41
433504|NCT00735787|1032562|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
433505|NCT00735787|1032561|P2|STARTED|Period 1||49
433506|NCT00735787|1032562|P1|STARTED|Period 1||23
433507|NCT00735709|1032610|P4|NOT COMPLETED|Overall Study||18
433508|NCT00735709|1032611|P3|NOT COMPLETED|Overall Study||11
433509|NCT00735709|1032612|P2|NOT COMPLETED|Overall Study||13
433510|NCT00735709|1032613|P1|NOT COMPLETED|Overall Study||13
433511|NCT00735709|1032610|P4|COMPLETED|Overall Study||122
433512|NCT00735709|1032611|P3|COMPLETED|Overall Study||129
433513|NCT00735709|1032612|P2|COMPLETED|Overall Study||127
433514|NCT00735709|1032613|P1|COMPLETED|Overall Study||127
433515|NCT00735709|1032610|P4|Treated|Overall Study||139
433516|NCT00735709|1032611|P3|Treated|Overall Study||140
433517|NCT00735709|1032612|P2|Treated|Overall Study||140
433518|NCT00735709|1032613|P1|Treated|Overall Study||140
433519|NCT00735709|1032610|P4|STARTED|Overall Study||140
433520|NCT00735709|1032611|P3|STARTED|Overall Study||140
433521|NCT00735709|1032612|P2|STARTED|Overall Study||140
433522|NCT00735709|1032613|P1|STARTED|Overall Study||140
433523|NCT00735696|1032723|P1|NOT COMPLETED|Overall Study||2
433524|NCT00735696|1032723|P1|COMPLETED|Overall Study||39
433525|NCT00735696|1032723|P1|Received Any Quantity of Study Drug|Overall Study||40
433526|NCT00735696|1032723|P1|STARTED|Overall Study||41
433527|NCT00735670|1032737|P2|NOT COMPLETED|Overall Study||5
433528|NCT00735670|1032738|P1|NOT COMPLETED|Overall Study||4
433529|NCT00735670|1032737|P2|COMPLETED|Overall Study||6
433530|NCT00735670|1032738|P1|COMPLETED|Overall Study||6
433531|NCT00735670|1032737|P2|STARTED|Overall Study||11
433532|NCT00735670|1032738|P1|STARTED|Overall Study||10
433533|NCT00735644|1032751|P5|NOT COMPLETED|Overall Study||0
433534|NCT00735644|1032752|P4|NOT COMPLETED|Overall Study||1
433535|NCT00735644|1032753|P3|NOT COMPLETED|Overall Study||1
433536|NCT00735644|1032754|P2|NOT COMPLETED|Overall Study||2
433537|NCT00735644|1032755|P1|NOT COMPLETED|Overall Study||0
433538|NCT00735644|1032751|P5|COMPLETED|Overall Study||102
433539|NCT00735644|1032752|P4|COMPLETED|Overall Study||198
433540|NCT00735644|1032753|P3|COMPLETED|Overall Study||295
433541|NCT00735644|1032754|P2|COMPLETED|Overall Study||298
433542|NCT00735644|1032755|P1|COMPLETED|Overall Study||303
433543|NCT00735644|1032751|P5|STARTED|Overall Study||102
433544|NCT00735644|1032752|P4|STARTED|Overall Study||199
433545|NCT00735644|1032753|P3|STARTED|Overall Study||296
433546|NCT00735644|1032754|P2|STARTED|Overall Study||300
433547|NCT00735644|1032755|P1|STARTED|Overall Study||303
433548|NCT00735618|1032792|P1|NOT COMPLETED|Overall Study||0
433549|NCT00735618|1032792|P1|COMPLETED|Overall Study||19
433550|NCT00735618|1032792|P1|STARTED|Overall Study||19
433551|NCT00735553|1032799|P1|NOT COMPLETED|Overall Study||77
433552|NCT00735553|1032799|P1|COMPLETED|Overall Study||0
433553|NCT00735553|1032799|P1|STARTED|Overall Study||77
433554|NCT00735475|1032809|P2|NOT COMPLETED|Overall Study||11
433555|NCT00735475|1032810|P1|NOT COMPLETED|Overall Study||8
433556|NCT00735475|1032809|P2|COMPLETED|Overall Study||626
433557|NCT00735475|1032810|P1|COMPLETED|Overall Study||623
433558|NCT00735475|1032809|P2|STARTED|Overall Study||637
433559|NCT00735475|1032810|P1|STARTED|Overall Study||631
433560|NCT00735462|1032831|P3|NOT COMPLETED|Overall Study||28
433561|NCT00735462|1032832|P2|NOT COMPLETED|Overall Study||55
433562|NCT00735462|1032833|P1|NOT COMPLETED|Overall Study||63
433563|NCT00735462|1032831|P3|COMPLETED|Overall Study||77
433564|NCT00735462|1032832|P2|COMPLETED|Overall Study||149
433565|NCT00735462|1032833|P1|COMPLETED|Overall Study||139
433566|NCT00735462|1032831|P3|STARTED|Overall Study||105
433567|NCT00735462|1032832|P2|STARTED|Overall Study||204
433568|NCT00735462|1032833|P1|STARTED|Overall Study||202
433569|NCT00735449|1032846|P2|NOT COMPLETED|Overall Study||6
433570|NCT00735449|1032847|P1|NOT COMPLETED|Overall Study||7
433571|NCT00735449|1032846|P2|COMPLETED|Overall Study||96
433572|NCT00735449|1032847|P1|COMPLETED|Overall Study||95
433573|NCT00735449|1032846|P2|STARTED|Overall Study||102
433574|NCT00735449|1032847|P1|STARTED|Overall Study||102
433575|NCT00735436|1032861|P1|NOT COMPLETED|Overall Study||0
433576|NCT00735436|1032861|P1|COMPLETED|Overall Study||18
433577|NCT00735436|1032861|P1|STARTED|Overall Study||18
433578|NCT00735397|1032870|P1|NOT COMPLETED|Overall Study||1183
433579|NCT00735397|1032870|P1|COMPLETED|Overall Study||35
433580|NCT00735397|1032870|P1|STARTED|Overall Study||1218
433581|NCT00735371|1032884|P4|NOT COMPLETED|Overall Study||10
433582|NCT00735371|1032885|P3|NOT COMPLETED|Overall Study||11
433583|NCT00735371|1032886|P2|NOT COMPLETED|Overall Study||13
433584|NCT00735371|1032887|P1|NOT COMPLETED|Overall Study||15
433585|NCT00735371|1032884|P4|COMPLETED|Overall Study||69
433586|NCT00735371|1032885|P3|COMPLETED|Overall Study||67
433587|NCT00735371|1032886|P2|COMPLETED|Overall Study||66
433588|NCT00735371|1032887|P1|COMPLETED|Overall Study||63
433589|NCT00735371|1032884|P4|STARTED|Overall Study||79
433590|NCT00735371|1032885|P3|STARTED|Overall Study||78
433591|NCT00735371|1032886|P2|STARTED|Overall Study||79
433592|NCT00735371|1032887|P1|STARTED|Overall Study||78
433593|NCT00735306|1032905|P1|NOT COMPLETED|Overall Study||0
433594|NCT00735306|1032905|P1|COMPLETED|Overall Study||12
433595|NCT00735306|1032905|P1|STARTED|Overall Study||12
433596|NCT00735072|1032913|P2|NOT COMPLETED|Overall Study||1
433597|NCT00735072|1032914|P1|NOT COMPLETED|Overall Study||1
433598|NCT00735072|1032913|P2|COMPLETED|Overall Study||21
433599|NCT00735072|1032914|P1|COMPLETED|Overall Study||22
433600|NCT00735072|1032913|P2|STARTED|Overall Study||22
433601|NCT00735072|1032914|P1|STARTED|Overall Study||23
433602|NCT00735007|1032920|P1|NOT COMPLETED|Overall Study||5
433603|NCT00735007|1032920|P1|COMPLETED|Overall Study||101
433604|NCT00735007|1032920|P1|STARTED|Overall Study||106
433605|NCT00734994|1032945|P1|NOT COMPLETED|Overall Study||1
433606|NCT00734994|1032945|P1|COMPLETED|Overall Study||14
433607|NCT00734994|1032945|P1|STARTED|Overall Study||15
433608|NCT00734968|1032952|P2|NOT COMPLETED|Overall Study||1
433609|NCT00734968|1032953|P1|NOT COMPLETED|Overall Study||1
433610|NCT00734968|1032952|P2|COMPLETED|Overall Study||75
433611|NCT00734968|1032953|P1|COMPLETED|Overall Study||76
433612|NCT00734968|1032952|P2|STARTED|Overall Study||76
433613|NCT00734968|1032953|P1|STARTED|Overall Study||77
433614|NCT00734929|1032965|P2|NOT COMPLETED|Overall Study||5
433615|NCT00734929|1032966|P1|NOT COMPLETED|Overall Study||6
433616|NCT00734929|1032965|P2|COMPLETED|Overall Study||53
433617|NCT00734929|1032966|P1|COMPLETED|Overall Study||51
433618|NCT00734929|1032965|P2|STARTED|Overall Study||58
433619|NCT00734929|1032966|P1|STARTED|Overall Study||57
433620|NCT00734851|1032994|P1|NOT COMPLETED|Overall Study||21
433621|NCT00734851|1032994|P1|COMPLETED|Overall Study||13
433622|NCT00734851|1032994|P1|STARTED|Overall Study||34
433623|NCT00734799|1033006|P2|NOT COMPLETED|Overall Study||4
433624|NCT00734799|1033007|P1|NOT COMPLETED|Overall Study||0
433625|NCT00734799|1033006|P2|COMPLETED|Overall Study||9
433626|NCT00734799|1033007|P1|COMPLETED|Overall Study||9
433627|NCT00734799|1033006|P2|STARTED|Overall Study||13
433628|NCT00734799|1033007|P1|STARTED|Overall Study||9
433629|NCT00734747|1033015|P1|NOT COMPLETED|6 Month Follow-up||3
433630|NCT00734747|1033015|P1|COMPLETED|6 Month Follow-up||66
433631|NCT00734747|1033015|P1|STARTED|6 Month Follow-up||69
433632|NCT00734747|1033015|P1|NOT COMPLETED|SRS Procedure||3
433633|NCT00734747|1033015|P1|COMPLETED|SRS Procedure||69
433634|NCT00734747|1033015|P1|STARTED|SRS Procedure||72
433635|NCT00734734|1033022|P1|NOT COMPLETED|Overall Study||0
433636|NCT00734734|1033022|P1|COMPLETED|Overall Study||64
433637|NCT00734734|1033022|P1|STARTED|Overall Study||64
433638|NCT00734656|1033029|P4|NOT COMPLETED|Lab Session 4||1
433639|NCT00734656|1033030|P3|NOT COMPLETED|Lab Session 4||0
433640|NCT00734656|1033031|P2|NOT COMPLETED|Lab Session 4||0
433641|NCT00734656|1033032|P1|NOT COMPLETED|Lab Session 4||0
433642|NCT00734656|1033029|P4|COMPLETED|Lab Session 4||19
433643|NCT00734656|1033030|P3|COMPLETED|Lab Session 4||16
433644|NCT00734656|1033031|P2|COMPLETED|Lab Session 4||18
433645|NCT00734656|1033032|P1|COMPLETED|Lab Session 4||20
433646|NCT00734656|1033029|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
433647|NCT00734656|1033030|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
433648|NCT00734656|1033031|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
433649|NCT00734656|1033032|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
433650|NCT00734656|1033029|P4|NOT COMPLETED|Washout 3||1
433651|NCT00734656|1033030|P3|NOT COMPLETED|Washout 3||0
433652|NCT00734656|1033031|P2|NOT COMPLETED|Washout 3||0
433653|NCT00734656|1033032|P1|NOT COMPLETED|Washout 3||1
433654|NCT00734656|1033029|P4|COMPLETED|Washout 3||18
433655|NCT00734656|1033030|P3|COMPLETED|Washout 3||20
433656|NCT00734656|1033031|P2|COMPLETED|Washout 3||19
433657|NCT00734656|1033032|P1|COMPLETED|Washout 3||17
433658|NCT00734656|1033029|P4|STARTED|Washout 3||19
433659|NCT00734656|1033030|P3|STARTED|Washout 3||20
433660|NCT00734656|1033031|P2|STARTED|Washout 3||19
433661|NCT00734656|1033032|P1|STARTED|Washout 3||18
433662|NCT00734656|1033029|P4|NOT COMPLETED|Lab Session 3||0
433663|NCT00734656|1033030|P3|NOT COMPLETED|Lab Session 3||0
433664|NCT00734656|1033031|P2|NOT COMPLETED|Lab Session 3||0
433665|NCT00734656|1033032|P1|NOT COMPLETED|Lab Session 3||0
433666|NCT00734656|1033029|P4|COMPLETED|Lab Session 3||19
433667|NCT00734656|1033030|P3|COMPLETED|Lab Session 3||20
433668|NCT00734656|1033031|P2|COMPLETED|Lab Session 3||19
433669|NCT00734656|1033032|P1|COMPLETED|Lab Session 3||18
433670|NCT00734656|1033029|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
433671|NCT00734656|1033030|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
433672|NCT00734656|1033031|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
433673|NCT00734656|1033032|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
433674|NCT00734656|1033029|P4|NOT COMPLETED|Washout 2||0
433675|NCT00734656|1033030|P3|NOT COMPLETED|Washout 2||1
433676|NCT00734656|1033031|P2|NOT COMPLETED|Washout 2||1
433677|NCT00734656|1033032|P1|NOT COMPLETED|Washout 2||1
433678|NCT00734656|1033029|P4|COMPLETED|Washout 2||19
433679|NCT00734656|1033030|P3|COMPLETED|Washout 2||20
433680|NCT00734656|1033031|P2|COMPLETED|Washout 2||20
433681|NCT00734656|1033032|P1|COMPLETED|Washout 2||17
433682|NCT00734656|1033029|P4|STARTED|Washout 2||19
433683|NCT00734656|1033030|P3|STARTED|Washout 2||21
433684|NCT00734656|1033031|P2|STARTED|Washout 2||21
433685|NCT00734656|1033032|P1|STARTED|Washout 2||18
433686|NCT00734656|1033029|P4|NOT COMPLETED|Lab Session 2||1
433687|NCT00734656|1033030|P3|NOT COMPLETED|Lab Session 2||0
433688|NCT00734656|1033031|P2|NOT COMPLETED|Lab Session 2||0
433689|NCT00734656|1033032|P1|NOT COMPLETED|Lab Session 2||1
433690|NCT00734656|1033029|P4|COMPLETED|Lab Session 2||19
433691|NCT00734656|1033030|P3|COMPLETED|Lab Session 2||21
433692|NCT00734656|1033031|P2|COMPLETED|Lab Session 2||21
433693|NCT00734656|1033032|P1|COMPLETED|Lab Session 2||18
433694|NCT00734656|1033029|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
433695|NCT00734656|1033030|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
433696|NCT00734656|1033031|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
433697|NCT00734656|1033032|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
433698|NCT00734656|1033029|P4|NOT COMPLETED|Washout 1||3
433699|NCT00734656|1033030|P3|NOT COMPLETED|Washout 1||2
433700|NCT00734656|1033031|P2|NOT COMPLETED|Washout 1||5
433701|NCT00734656|1033032|P1|NOT COMPLETED|Washout 1||1
433702|NCT00734656|1033029|P4|COMPLETED|Washout 1||18
433703|NCT00734656|1033030|P3|COMPLETED|Washout 1||24
433704|NCT00734656|1033031|P2|COMPLETED|Washout 1||18
433705|NCT00734656|1033032|P1|COMPLETED|Washout 1||21
433706|NCT00734656|1033029|P4|STARTED|Washout 1||21
433707|NCT00734656|1033030|P3|STARTED|Washout 1||26
433708|NCT00734656|1033031|P2|STARTED|Washout 1||23
433709|NCT00734656|1033032|P1|STARTED|Washout 1||22
433710|NCT00734656|1033029|P4|NOT COMPLETED|Lab Session 1||0
433711|NCT00734656|1033030|P3|NOT COMPLETED|Lab Session 1||0
433712|NCT00734656|1033031|P2|NOT COMPLETED|Lab Session 1||0
433713|NCT00734656|1033032|P1|NOT COMPLETED|Lab Session 1||2
433714|NCT00734656|1033029|P4|COMPLETED|Lab Session 1||21
433715|NCT00734656|1033030|P3|COMPLETED|Lab Session 1||26
433716|NCT00734656|1033031|P2|COMPLETED|Lab Session 1||23
433717|NCT00734656|1033032|P1|COMPLETED|Lab Session 1||22
433718|NCT00734656|1033029|P4|STARTED|Lab Session 1||21
433719|NCT00734656|1033030|P3|STARTED|Lab Session 1||26
433720|NCT00734656|1033031|P2|STARTED|Lab Session 1||23
433721|NCT00734656|1033032|P1|STARTED|Lab Session 1||24
433722|NCT00734630|1033056|P2|NOT COMPLETED|Overall Study||33
433723|NCT00734630|1033057|P1|NOT COMPLETED|Overall Study||29
433724|NCT00734630|1033056|P2|COMPLETED|Overall Study||200
433725|NCT00734630|1033057|P1|COMPLETED|Overall Study||229
433726|NCT00734630|1033056|P2|STARTED|Overall Study||233
433727|NCT00734630|1033057|P1|STARTED|Overall Study||258
433728|NCT00734617|1033067|P2|NOT COMPLETED|Overall Study||102
433729|NCT00734617|1033068|P1|NOT COMPLETED|Overall Study||107
433730|NCT00734617|1033067|P2|COMPLETED|Overall Study||128
433731|NCT00734617|1033068|P1|COMPLETED|Overall Study||142
433732|NCT00734617|1033067|P2|STARTED|Overall Study||230
433733|NCT00734617|1033068|P1|STARTED|Overall Study||249
433734|NCT00734604|1033080|P6|NOT COMPLETED|Overall Study||6
433735|NCT00734604|1033081|P5|NOT COMPLETED|Overall Study||8
433736|NCT00734604|1033082|P4|NOT COMPLETED|Overall Study||9
433737|NCT00734604|1033083|P3|NOT COMPLETED|Overall Study||6
433738|NCT00734604|1033084|P2|NOT COMPLETED|Overall Study||12
433739|NCT00734604|1033085|P1|NOT COMPLETED|Overall Study||3
433740|NCT00734604|1033080|P6|COMPLETED|Overall Study||58
433741|NCT00734604|1033081|P5|COMPLETED|Overall Study||55
433742|NCT00734604|1033082|P4|COMPLETED|Overall Study||54
433743|NCT00734604|1033083|P3|COMPLETED|Overall Study||57
433744|NCT00734604|1033084|P2|COMPLETED|Overall Study||51
433745|NCT00734604|1033085|P1|COMPLETED|Overall Study||59
433746|NCT00734604|1033080|P6|STARTED|Overall Study||64
433747|NCT00734604|1033081|P5|STARTED|Overall Study||63
433748|NCT00734604|1033082|P4|STARTED|Overall Study||63
433749|NCT00734604|1033083|P3|STARTED|Overall Study||63
433750|NCT00734604|1033084|P2|STARTED|Overall Study||63
433751|NCT00734604|1033085|P1|STARTED|Overall Study||62
433752|NCT00734591|1033135|P2|NOT COMPLETED|Prospective Period||44
433753|NCT00734591|1033136|P1|NOT COMPLETED|Prospective Period||51
433754|NCT00734591|1033135|P2|COMPLETED|Prospective Period||1229
433755|NCT00734591|1033136|P1|COMPLETED|Prospective Period||1307
433756|NCT00734591|1033135|P2|STARTED|Prospective Period||1273
433757|NCT00734591|1033136|P1|STARTED|Prospective Period||1358
433758|NCT00734591|1033135|P2|NOT COMPLETED|Screening for Prospective Period||2291
433759|NCT00734591|1033136|P1|NOT COMPLETED|Screening for Prospective Period||2517
433760|NCT00734591|1033135|P2|COMPLETED|Screening for Prospective Period||1273
433761|NCT00734591|1033136|P1|COMPLETED|Screening for Prospective Period||1358
433762|NCT00734591|1033135|P2|STARTED|Screening for Prospective Period||3564
433763|NCT00734591|1033136|P1|STARTED|Screening for Prospective Period||3875
433764|NCT00734591|1033135|P2|NOT COMPLETED|Retrospective Period||0
433765|NCT00734591|1033136|P1|NOT COMPLETED|Retrospective Period||0
433766|NCT00734591|1033135|P2|COMPLETED|Retrospective Period||3564
433767|NCT00734591|1033136|P1|COMPLETED|Retrospective Period||3875
433768|NCT00734591|1033135|P2|STARTED|Retrospective Period||3564
433769|NCT00734591|1033136|P1|STARTED|Retrospective Period||3875
433770|NCT00734578|1033151|P3|NOT COMPLETED|Overall Study||25
433771|NCT00734578|1033152|P2|NOT COMPLETED|Overall Study||25
433772|NCT00734578|1033153|P1|NOT COMPLETED|Overall Study||33
433773|NCT00734578|1033151|P3|COMPLETED|Overall Study||129
433774|NCT00734578|1033152|P2|COMPLETED|Overall Study||128
433775|NCT00734578|1033153|P1|COMPLETED|Overall Study||121
433776|NCT00734578|1033151|P3|STARTED|Overall Study||154
433777|NCT00734578|1033152|P2|STARTED|Overall Study||153
433778|NCT00734578|1033153|P1|STARTED|Overall Study||154
433779|NCT00734539|1033187|P2|NOT COMPLETED|Long Term Follow up||31
433780|NCT00734539|1033188|P1|NOT COMPLETED|Long Term Follow up||34
433781|NCT00734539|1033187|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
433782|NCT00734539|1033188|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
433783|NCT00734539|1033187|P2|STARTED|Long Term Follow up||138
433784|NCT00734539|1033188|P1|STARTED|Long Term Follow up||152
433785|NCT00734539|1033187|P2|NOT COMPLETED|Main Study||35
433786|NCT00734539|1033188|P1|NOT COMPLETED|Main Study||37
433787|NCT00734539|1033187|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
433788|NCT00734539|1033188|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
433789|NCT00734539|1033187|P2|STARTED|Main Study||173
433790|NCT00734539|1033188|P1|STARTED|Main Study||189
433791|NCT00734500|1033216|P1|NOT COMPLETED|Overall Study||1
433792|NCT00734500|1033216|P1|COMPLETED|Overall Study||14
433793|NCT00734500|1033216|P1|STARTED|Overall Study||15
433794|NCT00734474|1033230|P9|NOT COMPLETED|Overall Study||82
433795|NCT00734474|1033231|P8|NOT COMPLETED|Overall Study||129
433796|NCT00734474|1033232|P7|NOT COMPLETED|Overall Study||24
433797|NCT00734474|1033233|P6|NOT COMPLETED|Overall Study||25
433798|NCT00734474|1033234|P5|NOT COMPLETED|Overall Study||118
433799|NCT00734474|1033235|P4|NOT COMPLETED|Overall Study||10
433800|NCT00734474|1033236|P3|NOT COMPLETED|Overall Study||112
433801|NCT00734474|1033237|P2|NOT COMPLETED|Overall Study||30
433802|NCT00734474|1033238|P1|NOT COMPLETED|Overall Study||15
433803|NCT00734474|1033230|P9|COMPLETED|Overall Study||95
433804|NCT00734474|1033231|P8|COMPLETED|Overall Study||186
433805|NCT00734474|1033232|P7|COMPLETED|Overall Study||0
433806|NCT00734474|1033233|P6|COMPLETED|Overall Study||0
433807|NCT00734474|1033234|P5|COMPLETED|Overall Study||184
433808|NCT00734474|1033235|P4|COMPLETED|Overall Study||0
433809|NCT00734474|1033236|P3|COMPLETED|Overall Study||192
433810|NCT00734474|1033237|P2|COMPLETED|Overall Study||0
433811|NCT00734474|1033238|P1|COMPLETED|Overall Study||0
433812|NCT00734474|1033230|P9|Completed 52-Week Visit|Overall Study||112
433813|NCT00734474|1033231|P8|Completed 52-Week Visit|Overall Study||238
433814|NCT00734474|1033232|P7|Completed 52-Week Visit|Overall Study||0
433815|NCT00734474|1033233|P6|Completed 52-Week Visit|Overall Study||0
433816|NCT00734474|1033234|P5|Completed 52-Week Visit|Overall Study||243
433817|NCT00734474|1033235|P4|Completed 52-Week Visit|Overall Study||0
433818|NCT00734474|1033236|P3|Completed 52-Week Visit|Overall Study||238
433819|NCT00734474|1033237|P2|Completed 52-Week Visit|Overall Study||0
433820|NCT00734474|1033238|P1|Completed 52-Week Visit|Overall Study||0
433821|NCT00734474|1033230|P9|Completed 26-Week Visit|Overall Study||124
433822|NCT00734474|1033231|P8|Completed 26-Week Visit|Overall Study||270
433823|NCT00734474|1033232|P7|Completed 26-Week Visit|Overall Study||2
433824|NCT00734474|1033233|P6|Completed 26-Week Visit|Overall Study||2
433825|NCT00734474|1033234|P5|Completed 26-Week Visit|Overall Study||268
433826|NCT00734474|1033235|P4|Completed 26-Week Visit|Overall Study||2
433827|NCT00734474|1033236|P3|Completed 26-Week Visit|Overall Study||258
433828|NCT00734474|1033237|P2|Completed 26-Week Visit|Overall Study||0
433829|NCT00734474|1033238|P1|Completed 26-Week Visit|Overall Study||0
433830|NCT00734474|1033230|P9|Entered Study After Dose Decision Point|Overall Study||139
433831|NCT00734474|1033231|P8|Entered Study After Dose Decision Point|Overall Study||273
433832|NCT00734474|1033232|P7|Entered Study After Dose Decision Point|Overall Study||0
433833|NCT00734474|1033233|P6|Entered Study After Dose Decision Point|Overall Study||0
433834|NCT00734474|1033234|P5|Entered Study After Dose Decision Point|Overall Study||281
433835|NCT00734474|1033235|P4|Entered Study After Dose Decision Point|Overall Study||0
433836|NCT00734474|1033236|P3|Entered Study After Dose Decision Point|Overall Study||279
433837|NCT00734474|1033237|P2|Entered Study After Dose Decision Point|Overall Study||0
433838|NCT00734474|1033238|P1|Entered Study After Dose Decision Point|Overall Study||0
433839|NCT00734474|1033230|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
433840|NCT00734474|1033231|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
433841|NCT00734474|1033232|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
433842|NCT00734474|1033233|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
433843|NCT00734474|1033234|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
433844|NCT00734474|1033235|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
433845|NCT00734474|1033236|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
433846|NCT00734474|1033237|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
433847|NCT00734474|1033238|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
433848|NCT00734474|1033230|P9|Entered Study Before Dose Decision Point|Overall Study||38
433849|NCT00734474|1033231|P8|Entered Study Before Dose Decision Point|Overall Study||42
433850|NCT00734474|1033232|P7|Entered Study Before Dose Decision Point|Overall Study||24
433851|NCT00734474|1033233|P6|Entered Study Before Dose Decision Point|Overall Study||25
433852|NCT00734474|1033234|P5|Entered Study Before Dose Decision Point|Overall Study||21
433853|NCT00734474|1033235|P4|Entered Study Before Dose Decision Point|Overall Study||10
433854|NCT00734474|1033236|P3|Entered Study Before Dose Decision Point|Overall Study||25
433855|NCT00734474|1033237|P2|Entered Study Before Dose Decision Point|Overall Study||30
433856|NCT00734474|1033238|P1|Entered Study Before Dose Decision Point|Overall Study||15
433857|NCT00734474|1033230|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
433858|NCT00734474|1033231|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
433859|NCT00734474|1033232|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
433860|NCT00734474|1033233|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
433861|NCT00734474|1033234|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
433862|NCT00734474|1033235|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
433863|NCT00734474|1033236|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
433864|NCT00734474|1033237|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
433865|NCT00734474|1033238|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
433866|NCT00734474|1033230|P9|STARTED|Overall Study||177
433867|NCT00734474|1033231|P8|STARTED|Overall Study||315
433868|NCT00734474|1033232|P7|STARTED|Overall Study||24
433869|NCT00734474|1033233|P6|STARTED|Overall Study||25
433870|NCT00734474|1033234|P5|STARTED|Overall Study||302
433871|NCT00734474|1033235|P4|STARTED|Overall Study||10
433872|NCT00734474|1033236|P3|STARTED|Overall Study||304
433873|NCT00734474|1033237|P2|STARTED|Overall Study||30
433874|NCT00734474|1033238|P1|STARTED|Overall Study||15
433875|NCT00734409|1033407|P2|NOT COMPLETED|Overall Study||0
433876|NCT00734409|1033408|P1|NOT COMPLETED|Overall Study||0
433877|NCT00734409|1033407|P2|COMPLETED|Overall Study||145
433878|NCT00734409|1033408|P1|COMPLETED|Overall Study||155
433879|NCT00734409|1033407|P2|STARTED|Overall Study||145
433880|NCT00734409|1033408|P1|STARTED|Overall Study||155
433881|NCT00734344|1033420|P2|NOT COMPLETED|Overall Study||0
433882|NCT00734344|1033421|P1|NOT COMPLETED|Overall Study||0
433883|NCT00734344|1033420|P2|COMPLETED|Overall Study||9
433884|NCT00734344|1033421|P1|COMPLETED|Overall Study||9
433885|NCT00734344|1033420|P2|STARTED|Overall Study||9
433886|NCT00734344|1033421|P1|STARTED|Overall Study||9
433887|NCT00734305|1033491|P7|NOT COMPLETED|Overall Study||0
433888|NCT00734305|1033492|P6|NOT COMPLETED|Overall Study||0
433889|NCT00734305|1033493|P5|NOT COMPLETED|Overall Study||0
433890|NCT00734305|1033494|P4|NOT COMPLETED|Overall Study||0
433891|NCT00734305|1033495|P3|NOT COMPLETED|Overall Study||0
433892|NCT00734305|1033496|P2|NOT COMPLETED|Overall Study||0
433893|NCT00734305|1033497|P1|NOT COMPLETED|Overall Study||1
433894|NCT00734305|1033491|P7|COMPLETED|Overall Study||18
433895|NCT00734305|1033492|P6|COMPLETED|Overall Study||4
433896|NCT00734305|1033493|P5|COMPLETED|Overall Study||5
433897|NCT00734305|1033494|P4|COMPLETED|Overall Study||3
433898|NCT00734305|1033495|P3|COMPLETED|Overall Study||4
433899|NCT00734305|1033496|P2|COMPLETED|Overall Study||3
433900|NCT00734305|1033497|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
433901|NCT00734305|1033491|P7|STARTED|Overall Study||18
433902|NCT00734305|1033492|P6|STARTED|Overall Study||4
433903|NCT00734305|1033493|P5|STARTED|Overall Study||5
433904|NCT00734305|1033494|P4|STARTED|Overall Study||3
433905|NCT00734305|1033495|P3|STARTED|Overall Study||4
433906|NCT00734305|1033496|P2|STARTED|Overall Study||3
433907|NCT00734305|1033497|P1|STARTED|Overall Study||7
433908|NCT00734214|1033528|P2|NOT COMPLETED|Overall Study||4
433909|NCT00734214|1033529|P1|NOT COMPLETED|Overall Study||4
433910|NCT00734214|1033528|P2|COMPLETED|Overall Study||126
433911|NCT00734214|1033529|P1|COMPLETED|Overall Study||124
433912|NCT00734214|1033528|P2|STARTED|Overall Study||130
433913|NCT00734214|1033529|P1|STARTED|Overall Study||128
433914|NCT00734162|1033539|P4|NOT COMPLETED|Open-Label Phase||3
433915|NCT00734162|1033540|P3|NOT COMPLETED|Open-Label Phase||1
433916|NCT00734162|1033541|P2|NOT COMPLETED|Open-Label Phase||2
433917|NCT00734162|1033542|P1|NOT COMPLETED|Open-Label Phase||3
433918|NCT00734162|1033539|P4|COMPLETED|Open-Label Phase||36
433919|NCT00734162|1033540|P3|COMPLETED|Open-Label Phase||12
433920|NCT00734162|1033541|P2|COMPLETED|Open-Label Phase||39
433921|NCT00734162|1033542|P1|COMPLETED|Open-Label Phase||7
433922|NCT00734162|1033539|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
433923|NCT00734162|1033540|P3|STARTED|Open-Label Phase||13
433924|NCT00734162|1033541|P2|STARTED|Open-Label Phase||41
433925|NCT00734162|1033542|P1|STARTED|Open-Label Phase||10
433926|NCT00734162|1033539|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
433927|NCT00734162|1033540|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
433928|NCT00734162|1033541|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
433929|NCT00734162|1033542|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
433930|NCT00734162|1033539|P4|COMPLETED|Randomized Phase (Through Week 72)||37
433931|NCT00734162|1033540|P3|COMPLETED|Randomized Phase (Through Week 72)||13
433932|NCT00734162|1033541|P2|COMPLETED|Randomized Phase (Through Week 72)||41
433933|NCT00734162|1033542|P1|COMPLETED|Randomized Phase (Through Week 72)||10
433934|NCT00734162|1033539|P4|STARTED|Randomized Phase (Through Week 72)||41
433935|NCT00734162|1033540|P3|STARTED|Randomized Phase (Through Week 72)||13
433936|NCT00734162|1033541|P2|STARTED|Randomized Phase (Through Week 72)||42
433937|NCT00734162|1033542|P1|STARTED|Randomized Phase (Through Week 72)||10
433938|NCT00734149|1033766|P1|NOT COMPLETED|Overall Study||1
433939|NCT00734149|1033766|P1|COMPLETED|Overall Study||44
433940|NCT00734149|1033766|P1|STARTED|Overall Study||45
433941|NCT00734097|1033773|P1|NOT COMPLETED|Open Label||16
433942|NCT00734097|1033773|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
433943|NCT00734097|1033773|P1|Per Protocol|Open Label||301
433944|NCT00734097|1033773|P1|Full Analysis|Open Label||311
433945|NCT00734097|1033773|P1|Safety Analysis|Open Label||317
433946|NCT00734097|1033773|P1|STARTED|Open Label|Full analysis performed in 311|317
433947|NCT00734097|1033773|P1|NOT COMPLETED|Screening||20
433948|NCT00734097|1033773|P1|COMPLETED|Screening|20 participants were screening failure.|317
433949|NCT00734097|1033773|P1|STARTED|Screening||337
433950|NCT00734071|1033790|P2|NOT COMPLETED|Overall Study||27
433951|NCT00734071|1033791|P1|NOT COMPLETED|Overall Study||38
433952|NCT00734071|1033790|P2|COMPLETED|Overall Study||125
433953|NCT00734071|1033791|P1|COMPLETED|Overall Study||114
433954|NCT00734071|1033790|P2|Treated|Overall Study||148
433955|NCT00734071|1033791|P1|Treated|Overall Study||151
433956|NCT00734071|1033790|P2|STARTED|Overall Study||152
433957|NCT00734071|1033791|P1|STARTED|Overall Study||152
433958|NCT00733993|1033847|P2|NOT COMPLETED|Overall Study||0
433959|NCT00733993|1033848|P1|NOT COMPLETED|Overall Study||0
433960|NCT00733993|1033847|P2|COMPLETED|Overall Study||10
433961|NCT00733993|1033848|P1|COMPLETED|Overall Study||13
433962|NCT00733993|1033847|P2|STARTED|Overall Study||10
433963|NCT00733993|1033848|P1|STARTED|Overall Study||13
433964|NCT00733954|1033883|P2|NOT COMPLETED|Overall Study||2
433965|NCT00733954|1033884|P1|NOT COMPLETED|Overall Study||8
433966|NCT00733954|1033883|P2|COMPLETED|Overall Study||123
433967|NCT00733954|1033884|P1|COMPLETED|Overall Study||116
433968|NCT00733954|1033883|P2|STARTED|Overall Study||125
433969|NCT00733954|1033884|P1|STARTED|Overall Study||124
433970|NCT00733824|1033931|P5|NOT COMPLETED|Phase II||0
433971|NCT00733824|1033932|P4|NOT COMPLETED|Phase II||0
433972|NCT00733824|1033933|P3|NOT COMPLETED|Phase II||0
433973|NCT00733824|1033934|P2|NOT COMPLETED|Phase II||0
433974|NCT00733824|1033935|P1|NOT COMPLETED|Phase II||0
433975|NCT00733824|1033931|P5|COMPLETED|Phase II||36
433976|NCT00733824|1033932|P4|COMPLETED|Phase II||0
433977|NCT00733824|1033933|P3|COMPLETED|Phase II||0
433978|NCT00733824|1033934|P2|COMPLETED|Phase II||0
433979|NCT00733824|1033935|P1|COMPLETED|Phase II||0
433980|NCT00733824|1033931|P5|STARTED|Phase II||36
433981|NCT00733824|1033932|P4|STARTED|Phase II||0
433982|NCT00733824|1033933|P3|STARTED|Phase II||0
433983|NCT00733824|1033934|P2|STARTED|Phase II||0
433984|NCT00733824|1033935|P1|STARTED|Phase II||0
433985|NCT00733824|1033931|P5|NOT COMPLETED|Phase I||0
433986|NCT00733824|1033932|P4|NOT COMPLETED|Phase I||0
433987|NCT00733824|1033933|P3|NOT COMPLETED|Phase I||0
433988|NCT00733824|1033934|P2|NOT COMPLETED|Phase I||0
433989|NCT00733824|1033935|P1|NOT COMPLETED|Phase I||1
433990|NCT00733824|1033931|P5|COMPLETED|Phase I||0
433991|NCT00733824|1033932|P4|COMPLETED|Phase I||6
433992|NCT00733824|1033933|P3|COMPLETED|Phase I||6
433993|NCT00733824|1033934|P2|COMPLETED|Phase I||3
433994|NCT00733824|1033935|P1|COMPLETED|Phase I||9
433995|NCT00733824|1033931|P5|STARTED|Phase I||0
433996|NCT00733824|1033932|P4|STARTED|Phase I||6
433997|NCT00733824|1033933|P3|STARTED|Phase I||6
433998|NCT00733824|1033934|P2|STARTED|Phase I||3
433999|NCT00733824|1033935|P1|STARTED|Phase I||10
434000|NCT00733746|1033954|P1|NOT COMPLETED|Overall Study||5
434001|NCT00733746|1033954|P1|COMPLETED|Overall Study||114
434002|NCT00733746|1033954|P1|STARTED|Overall Study||119
434003|NCT00733512|1033962|P1|NOT COMPLETED|Overall Study||0
434004|NCT00733512|1033962|P1|COMPLETED|Overall Study||146
434005|NCT00733512|1033962|P1|STARTED|Overall Study||146
434006|NCT00733499|1033969|P2|NOT COMPLETED|24 Months Follow-up||1
434007|NCT00733499|1033970|P1|NOT COMPLETED|24 Months Follow-up||0
434008|NCT00733499|1033969|P2|COMPLETED|24 Months Follow-up||95
434009|NCT00733499|1033970|P1|COMPLETED|24 Months Follow-up||99
434010|NCT00733499|1033969|P2|STARTED|24 Months Follow-up||96
434011|NCT00733499|1033970|P1|STARTED|24 Months Follow-up||99
434012|NCT00733499|1033969|P2|NOT COMPLETED|12 Months Follow-up||1
434013|NCT00733499|1033970|P1|NOT COMPLETED|12 Months Follow-up||2
434014|NCT00733499|1033969|P2|COMPLETED|12 Months Follow-up||96
434015|NCT00733499|1033970|P1|COMPLETED|12 Months Follow-up||99
434016|NCT00733499|1033969|P2|STARTED|12 Months Follow-up||97
434017|NCT00733499|1033970|P1|STARTED|12 Months Follow-up||101
434018|NCT00733499|1033969|P2|NOT COMPLETED|6 Months Follow-up||3
434019|NCT00733499|1033970|P1|NOT COMPLETED|6 Months Follow-up||0
434020|NCT00733499|1033969|P2|COMPLETED|6 Months Follow-up||97
434021|NCT00733499|1033970|P1|COMPLETED|6 Months Follow-up||101
434022|NCT00733499|1033969|P2|STARTED|6 Months Follow-up||100
434023|NCT00733499|1033970|P1|STARTED|6 Months Follow-up||101
434024|NCT00733499|1033969|P2|NOT COMPLETED|3 Months Follow-up||2
434025|NCT00733499|1033970|P1|NOT COMPLETED|3 Months Follow-up||1
434026|NCT00733499|1033969|P2|COMPLETED|3 Months Follow-up||100
434027|NCT00733499|1033970|P1|COMPLETED|3 Months Follow-up||101
434028|NCT00733499|1033969|P2|STARTED|3 Months Follow-up||102
434029|NCT00733499|1033970|P1|STARTED|3 Months Follow-up||102
434030|NCT00733499|1033969|P2|NOT COMPLETED|Pre-operative||1
434031|NCT00733499|1033970|P1|NOT COMPLETED|Pre-operative||0
434032|NCT00733499|1033969|P2|COMPLETED|Pre-operative||102
434033|NCT00733499|1033970|P1|COMPLETED|Pre-operative||102
434034|NCT00733499|1033969|P2|STARTED|Pre-operative||103
434035|NCT00733499|1033970|P1|STARTED|Pre-operative||102
434036|NCT00733421|1033978|P2|NOT COMPLETED|Overall Study||1
434037|NCT00733421|1033979|P1|NOT COMPLETED|Overall Study||1
434038|NCT00733421|1033978|P2|COMPLETED|Overall Study|All but one randomised patient|49
434039|NCT00733421|1033979|P1|COMPLETED|Overall Study|All but one randomsied patient|49
434040|NCT00733421|1033978|P2|STARTED|Overall Study|November 2008|50
434041|NCT00733421|1033979|P1|STARTED|Overall Study|November 2008|50
434042|NCT00733369|1034003|P2|NOT COMPLETED|Overall Study||9
434043|NCT00733369|1034004|P1|NOT COMPLETED|Overall Study||10
434044|NCT00733369|1034003|P2|COMPLETED|Overall Study||47
434045|NCT00733369|1034004|P1|COMPLETED|Overall Study||40
434046|NCT00733369|1034003|P2|STARTED|Overall Study||56
434047|NCT00733369|1034004|P1|STARTED|Overall Study||50
434048|NCT00733330|1034122|P2|NOT COMPLETED|Overall Study||4
434049|NCT00733330|1034123|P1|NOT COMPLETED|Overall Study||2
434050|NCT00733330|1034122|P2|COMPLETED|Overall Study||48
434051|NCT00733330|1034123|P1|COMPLETED|Overall Study||30
434052|NCT00733330|1034122|P2|STARTED|Overall Study||52
434053|NCT00733330|1034123|P1|STARTED|Overall Study||32
434054|NCT00733291|1034207|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
434055|NCT00733291|1034208|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
434056|NCT00733291|1034209|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
434057|NCT00733291|1034210|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
434058|NCT00733291|1034207|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
434059|NCT00733291|1034208|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
434060|NCT00733291|1034209|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
434061|NCT00733291|1034210|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
434062|NCT00733291|1034207|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
434063|NCT00733291|1034208|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
434064|NCT00733291|1034209|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
434065|NCT00733291|1034210|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
434066|NCT00733291|1034207|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
434067|NCT00733291|1034208|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
434068|NCT00733291|1034209|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
434069|NCT00733291|1034210|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
434070|NCT00733291|1034207|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
434071|NCT00733291|1034208|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
434072|NCT00733291|1034209|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
434073|NCT00733291|1034210|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
434074|NCT00733291|1034207|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
434075|NCT00733291|1034208|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
434076|NCT00733291|1034209|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
434077|NCT00733291|1034210|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
434078|NCT00733291|1034207|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
434079|NCT00733291|1034208|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
434080|NCT00733291|1034209|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
434081|NCT00733291|1034210|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
434082|NCT00733291|1034207|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
434083|NCT00733291|1034208|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
434084|NCT00733291|1034209|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
434085|NCT00733291|1034210|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
434086|NCT00733291|1034207|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
434087|NCT00733291|1034208|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
434088|NCT00733291|1034209|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
434089|NCT00733291|1034210|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
434090|NCT00733278|1034232|P1|NOT COMPLETED|Overall Study||0
434091|NCT00733278|1034232|P1|COMPLETED|Overall Study||7
434092|NCT00733278|1034232|P1|STARTED|Overall Study||7
434093|NCT00733226|1034239|P2|NOT COMPLETED|Overall Study||0
434094|NCT00733226|1034240|P1|NOT COMPLETED|Overall Study||5
434095|NCT00733226|1034239|P2|COMPLETED|Overall Study||40
434096|NCT00733226|1034240|P1|COMPLETED|Overall Study||35
434097|NCT00733226|1034239|P2|STARTED|Overall Study||40
434098|NCT00733226|1034240|P1|STARTED|Overall Study||40
434099|NCT00733135|1034256|P1|NOT COMPLETED|Overall Study||2
434100|NCT00733135|1034256|P1|COMPLETED|Overall Study||131
434101|NCT00733135|1034256|P1|STARTED|Overall Study||133
434102|NCT00733096|1034268|P3|NOT COMPLETED|Overall Study||0
434103|NCT00733096|1034269|P2|NOT COMPLETED|Overall Study||0
434104|NCT00733096|1034270|P1|NOT COMPLETED|Overall Study||0
434105|NCT00733096|1034268|P3|COMPLETED|Overall Study||30
434106|NCT00733096|1034269|P2|COMPLETED|Overall Study||26
434107|NCT00733096|1034270|P1|COMPLETED|Overall Study||28
434108|NCT00733096|1034268|P3|STARTED|Overall Study||30
434109|NCT00733096|1034269|P2|STARTED|Overall Study||26
434110|NCT00733096|1034270|P1|STARTED|Overall Study||28
434111|NCT00733005|1034289|P2|NOT COMPLETED|Overall Study||3
434112|NCT00733005|1034290|P1|NOT COMPLETED|Overall Study||2
434113|NCT00733005|1034289|P2|COMPLETED|Overall Study||159
434114|NCT00733005|1034290|P1|COMPLETED|Overall Study||160
434115|NCT00733005|1034289|P2|STARTED|Overall Study||162
434116|NCT00733005|1034290|P1|STARTED|Overall Study||162
434117|NCT00732992|1034300|P2|NOT COMPLETED|Overall Study||6
434118|NCT00732992|1034301|P1|NOT COMPLETED|Overall Study||6
434119|NCT00732992|1034300|P2|COMPLETED|Overall Study||0
434120|NCT00732992|1034301|P1|COMPLETED|Overall Study||0
434121|NCT00732992|1034300|P2|STARTED|Overall Study||6
434122|NCT00732992|1034301|P1|STARTED|Overall Study||6
434123|NCT00732940|1034320|P2|NOT COMPLETED|Overall Study||3
434124|NCT00732940|1034321|P1|NOT COMPLETED|Overall Study||2
434125|NCT00732940|1034320|P2|COMPLETED|Overall Study||25
434126|NCT00732940|1034321|P1|COMPLETED|Overall Study||26
434127|NCT00732940|1034320|P2|STARTED|Overall Study||28
434128|NCT00732940|1034321|P1|STARTED|Overall Study||28
434129|NCT00732901|1034391|P2|NOT COMPLETED|Overall Study||0
434130|NCT00732901|1034392|P1|NOT COMPLETED|Overall Study||0
434131|NCT00732901|1034391|P2|COMPLETED|Overall Study||12
434132|NCT00732901|1034392|P1|COMPLETED|Overall Study||11
434133|NCT00732901|1034391|P2|STARTED|Overall Study||12
434134|NCT00732901|1034392|P1|STARTED|Overall Study||11
434135|NCT00732875|1034402|P1|NOT COMPLETED|Overall Study||35
434136|NCT00732875|1034402|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
434137|NCT00732875|1034402|P1|STARTED|Overall Study||92
434138|NCT00732758|1034410|P2|NOT COMPLETED|Overall Study||16
434139|NCT00732758|1034411|P1|NOT COMPLETED|Overall Study||8
434140|NCT00732758|1034410|P2|COMPLETED|Overall Study||63
434141|NCT00732758|1034411|P1|COMPLETED|Overall Study||70
434142|NCT00732758|1034410|P2|STARTED|Overall Study||79
434143|NCT00732758|1034411|P1|STARTED|Overall Study||78
434144|NCT00732680|1034423|P1|NOT COMPLETED|Overall Study||0
434145|NCT00732680|1034423|P1|COMPLETED|Overall Study||9
434146|NCT00732680|1034423|P1|STARTED|Overall Study||9
434147|NCT00732654|1034430|P3|NOT COMPLETED|Overall Study||0
434148|NCT00732654|1034431|P2|NOT COMPLETED|Overall Study||1
434149|NCT00732654|1034432|P1|NOT COMPLETED|Overall Study||0
434150|NCT00732654|1034430|P3|COMPLETED|Overall Study||10
434151|NCT00732654|1034431|P2|COMPLETED|Overall Study||9
434152|NCT00732654|1034432|P1|COMPLETED|Overall Study||10
434153|NCT00732654|1034430|P3|STARTED|Overall Study||10
434154|NCT00732654|1034431|P2|STARTED|Overall Study||10
434155|NCT00732654|1034432|P1|STARTED|Overall Study||10
434156|NCT00732641|1034451|P2|NOT COMPLETED|Overall Study||112
434157|NCT00732641|1034452|P1|NOT COMPLETED|Overall Study||106
434158|NCT00732641|1034451|P2|COMPLETED|Overall Study||9
434159|NCT00732641|1034452|P1|COMPLETED|Overall Study||17
434160|NCT00732641|1034451|P2|STARTED|Overall Study||121
434161|NCT00732641|1034452|P1|STARTED|Overall Study||123
434162|NCT00732615|1034472|P2|NOT COMPLETED|Overall Study||5
434163|NCT00732615|1034473|P1|NOT COMPLETED|Overall Study||7
434164|NCT00732615|1034472|P2|COMPLETED|Overall Study||79
434165|NCT00732615|1034473|P1|COMPLETED|Overall Study||33
434166|NCT00732615|1034472|P2|STARTED|Overall Study||84
434167|NCT00732615|1034473|P1|STARTED|Overall Study||40
434168|NCT00732472|1034489|P4|NOT COMPLETED|Overall Study||3
434169|NCT00732472|1034490|P3|NOT COMPLETED|Overall Study||1
434170|NCT00732472|1034491|P2|NOT COMPLETED|Overall Study||3
434171|NCT00732472|1034492|P1|NOT COMPLETED|Overall Study||0
434172|NCT00732472|1034489|P4|COMPLETED|Overall Study||6
434173|NCT00732472|1034490|P3|COMPLETED|Overall Study||9
434174|NCT00732472|1034491|P2|COMPLETED|Overall Study||7
434175|NCT00732472|1034492|P1|COMPLETED|Overall Study||9
434176|NCT00732472|1034489|P4|STARTED|Overall Study||9
434177|NCT00732472|1034490|P3|STARTED|Overall Study||10
434178|NCT00732472|1034491|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
434179|NCT00732472|1034492|P1|STARTED|Overall Study||9
434180|NCT00732381|1034592|P2|NOT COMPLETED|Overall Study||1
434181|NCT00732381|1034593|P1|NOT COMPLETED|Overall Study||2
434182|NCT00732381|1034592|P2|COMPLETED|Overall Study||174
434183|NCT00732381|1034593|P1|COMPLETED|Overall Study||174
434184|NCT00732381|1034592|P2|STARTED|Overall Study||175
434185|NCT00732381|1034593|P1|STARTED|Overall Study||176
434186|NCT00732303|1034601|P1|NOT COMPLETED|Overall Study||2
434187|NCT00732303|1034601|P1|COMPLETED|Overall Study||6
434188|NCT00732303|1034601|P1|STARTED|Overall Study||8
434189|NCT00732238|1034609|P2|NOT COMPLETED|Overall Study||1
434190|NCT00732238|1034610|P1|NOT COMPLETED|Overall Study||5
434191|NCT00732238|1034609|P2|COMPLETED|Overall Study||27
434192|NCT00732238|1034610|P1|COMPLETED|Overall Study||28
434193|NCT00732238|1034609|P2|STARTED|Overall Study||28
434194|NCT00732238|1034610|P1|STARTED|Overall Study||33
434195|NCT00732225|1034623|P5|NOT COMPLETED|Overall Study||6
434196|NCT00732225|1034624|P4|NOT COMPLETED|Overall Study||4
434197|NCT00732225|1034625|P3|NOT COMPLETED|Overall Study||3
434198|NCT00732225|1034626|P2|NOT COMPLETED|Overall Study||8
434199|NCT00732225|1034627|P1|NOT COMPLETED|Overall Study||11
434200|NCT00732225|1034623|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
434201|NCT00732225|1034624|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
434202|NCT00732225|1034625|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
434203|NCT00732225|1034626|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
434204|NCT00732225|1034627|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
434205|NCT00732225|1034623|P5|STARTED|Overall Study|55 eyes of 54 patients|54
434206|NCT00732225|1034624|P4|STARTED|Overall Study|33 eyes of 33 patients|33
434207|NCT00732225|1034625|P3|STARTED|Overall Study|26 eyes of 26 patients|26
434208|NCT00732225|1034626|P2|STARTED|Overall Study|41 eyes of 40 patients|40
434209|NCT00732225|1034627|P1|STARTED|Overall Study|76 eyes of 71 patients|71
434210|NCT00732212|1034678|P2|NOT COMPLETED|Overall Study||0
434211|NCT00732212|1034679|P1|NOT COMPLETED|Overall Study||0
434212|NCT00732212|1034678|P2|COMPLETED|Overall Study||123
434213|NCT00732212|1034679|P1|COMPLETED|Overall Study||112
434214|NCT00732212|1034678|P2|Temporarily Suspended|Overall Study||50
434215|NCT00732212|1034679|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
434216|NCT00732212|1034678|P2|STARTED|Overall Study||123
434217|NCT00732212|1034679|P1|STARTED|Overall Study||112
434218|NCT00732160|1034713|P4|NOT COMPLETED|Overall Study||2
434219|NCT00732160|1034714|P3|NOT COMPLETED|Overall Study||3
434220|NCT00732160|1034715|P2|NOT COMPLETED|Overall Study||4
434221|NCT00732160|1034716|P1|NOT COMPLETED|Overall Study||5
434222|NCT00732160|1034713|P4|COMPLETED|Overall Study||3
434223|NCT00732160|1034714|P3|COMPLETED|Overall Study||3
434224|NCT00732160|1034715|P2|COMPLETED|Overall Study||1
434225|NCT00732160|1034716|P1|COMPLETED|Overall Study||2
434226|NCT00732160|1034713|P4|LS Aldosterone|Overall Study||5
434227|NCT00732160|1034714|P3|LS Aldosterone|Overall Study||6
434228|NCT00732160|1034715|P2|LS Aldosterone|Overall Study||1
434229|NCT00732160|1034716|P1|LS Aldosterone|Overall Study||2
434230|NCT00732160|1034713|P4|LS Vehicle|Overall Study||5
434231|NCT00732160|1034714|P3|LS Vehicle|Overall Study||6
434232|NCT00732160|1034715|P2|LS Vehicle|Overall Study||1
434233|NCT00732160|1034716|P1|LS Vehicle|Overall Study||2
434234|NCT00732160|1034713|P4|HS Aldosterone|Overall Study||3
434235|NCT00732160|1034714|P3|HS Aldosterone|Overall Study||3
434236|NCT00732160|1034715|P2|HS Aldosterone|Overall Study||5
434237|NCT00732160|1034716|P1|HS Aldosterone|Overall Study||7
434238|NCT00732160|1034713|P4|HS Vehicle|Overall Study||3
434239|NCT00732160|1034714|P3|HS Vehicle|Overall Study||3
434240|NCT00732160|1034715|P2|HS Vehicle|Overall Study||5
434241|NCT00732160|1034716|P1|HS Vehicle|Overall Study||7
434242|NCT00732160|1034713|P4|STARTED|Overall Study||5
434243|NCT00732160|1034714|P3|STARTED|Overall Study||6
434244|NCT00732160|1034715|P2|STARTED|Overall Study||5
434245|NCT00732160|1034716|P1|STARTED|Overall Study||7
434246|NCT00732069|1034730|P6|NOT COMPLETED|Third Study Drug||0
434247|NCT00732069|1034731|P5|NOT COMPLETED|Third Study Drug||0
434248|NCT00732069|1034732|P4|NOT COMPLETED|Third Study Drug||0
434249|NCT00732069|1034733|P3|NOT COMPLETED|Third Study Drug||0
434250|NCT00732069|1034734|P2|NOT COMPLETED|Third Study Drug||0
434251|NCT00732069|1034735|P1|NOT COMPLETED|Third Study Drug||0
434252|NCT00732069|1034730|P6|COMPLETED|Third Study Drug||2
434253|NCT00732069|1034731|P5|COMPLETED|Third Study Drug||3
434254|NCT00732069|1034732|P4|COMPLETED|Third Study Drug||2
434255|NCT00732069|1034733|P3|COMPLETED|Third Study Drug||3
434256|NCT00732069|1034734|P2|COMPLETED|Third Study Drug||3
434257|NCT00732069|1034735|P1|COMPLETED|Third Study Drug||2
434258|NCT00732069|1034730|P6|STARTED|Third Study Drug||2
434259|NCT00732069|1034731|P5|STARTED|Third Study Drug||3
434260|NCT00732069|1034732|P4|STARTED|Third Study Drug||2
434261|NCT00732069|1034733|P3|STARTED|Third Study Drug||3
434262|NCT00732069|1034734|P2|STARTED|Third Study Drug||3
434263|NCT00732069|1034735|P1|STARTED|Third Study Drug||2
434264|NCT00732069|1034730|P6|NOT COMPLETED|Washout After Second Study Drug||0
434265|NCT00732069|1034731|P5|NOT COMPLETED|Washout After Second Study Drug||0
434266|NCT00732069|1034732|P4|NOT COMPLETED|Washout After Second Study Drug||0
434267|NCT00732069|1034733|P3|NOT COMPLETED|Washout After Second Study Drug||0
434268|NCT00732069|1034734|P2|NOT COMPLETED|Washout After Second Study Drug||0
434269|NCT00732069|1034735|P1|NOT COMPLETED|Washout After Second Study Drug||0
434270|NCT00732069|1034730|P6|COMPLETED|Washout After Second Study Drug||2
434271|NCT00732069|1034731|P5|COMPLETED|Washout After Second Study Drug||3
434272|NCT00732069|1034732|P4|COMPLETED|Washout After Second Study Drug||2
434273|NCT00732069|1034733|P3|COMPLETED|Washout After Second Study Drug||3
434274|NCT00732069|1034734|P2|COMPLETED|Washout After Second Study Drug||3
434275|NCT00732069|1034735|P1|COMPLETED|Washout After Second Study Drug||2
434276|NCT00732069|1034730|P6|STARTED|Washout After Second Study Drug||2
434277|NCT00732069|1034731|P5|STARTED|Washout After Second Study Drug||3
434278|NCT00732069|1034732|P4|STARTED|Washout After Second Study Drug||2
434279|NCT00732069|1034733|P3|STARTED|Washout After Second Study Drug||3
434280|NCT00732069|1034734|P2|STARTED|Washout After Second Study Drug||3
434281|NCT00732069|1034735|P1|STARTED|Washout After Second Study Drug||2
434282|NCT00732069|1034730|P6|NOT COMPLETED|Second Study Drug||0
434283|NCT00732069|1034731|P5|NOT COMPLETED|Second Study Drug||0
434284|NCT00732069|1034732|P4|NOT COMPLETED|Second Study Drug||0
434285|NCT00732069|1034733|P3|NOT COMPLETED|Second Study Drug||0
434286|NCT00732069|1034734|P2|NOT COMPLETED|Second Study Drug||0
434287|NCT00732069|1034735|P1|NOT COMPLETED|Second Study Drug||0
434288|NCT00732069|1034730|P6|COMPLETED|Second Study Drug||2
434289|NCT00732069|1034731|P5|COMPLETED|Second Study Drug||3
434290|NCT00732069|1034732|P4|COMPLETED|Second Study Drug||2
434291|NCT00732069|1034733|P3|COMPLETED|Second Study Drug||3
434292|NCT00732069|1034734|P2|COMPLETED|Second Study Drug||3
434293|NCT00732069|1034735|P1|COMPLETED|Second Study Drug||2
434294|NCT00732069|1034730|P6|STARTED|Second Study Drug||2
434295|NCT00732069|1034731|P5|STARTED|Second Study Drug||3
434296|NCT00732069|1034732|P4|STARTED|Second Study Drug||2
434297|NCT00732069|1034733|P3|STARTED|Second Study Drug||3
434298|NCT00732069|1034734|P2|STARTED|Second Study Drug||3
434299|NCT00732069|1034735|P1|STARTED|Second Study Drug||2
434300|NCT00732069|1034730|P6|NOT COMPLETED|Washout After First Study Drug||0
434301|NCT00732069|1034731|P5|NOT COMPLETED|Washout After First Study Drug||0
434302|NCT00732069|1034732|P4|NOT COMPLETED|Washout After First Study Drug||0
434303|NCT00732069|1034733|P3|NOT COMPLETED|Washout After First Study Drug||0
434304|NCT00732069|1034734|P2|NOT COMPLETED|Washout After First Study Drug||0
434305|NCT00732069|1034735|P1|NOT COMPLETED|Washout After First Study Drug||1
434306|NCT00732069|1034730|P6|COMPLETED|Washout After First Study Drug||2
434307|NCT00732069|1034731|P5|COMPLETED|Washout After First Study Drug||3
434308|NCT00732069|1034732|P4|COMPLETED|Washout After First Study Drug||2
434309|NCT00732069|1034733|P3|COMPLETED|Washout After First Study Drug||3
434310|NCT00732069|1034734|P2|COMPLETED|Washout After First Study Drug||3
434311|NCT00732069|1034735|P1|COMPLETED|Washout After First Study Drug||2
434312|NCT00732069|1034730|P6|STARTED|Washout After First Study Drug||2
434313|NCT00732069|1034731|P5|STARTED|Washout After First Study Drug||3
434314|NCT00732069|1034732|P4|STARTED|Washout After First Study Drug||2
434315|NCT00732069|1034733|P3|STARTED|Washout After First Study Drug||3
434316|NCT00732069|1034734|P2|STARTED|Washout After First Study Drug||3
434317|NCT00732069|1034735|P1|STARTED|Washout After First Study Drug||3
434318|NCT00732069|1034730|P6|NOT COMPLETED|First Study Drug||0
434319|NCT00732069|1034731|P5|NOT COMPLETED|First Study Drug||0
434320|NCT00732069|1034732|P4|NOT COMPLETED|First Study Drug||0
434321|NCT00732069|1034733|P3|NOT COMPLETED|First Study Drug||0
434322|NCT00732069|1034734|P2|NOT COMPLETED|First Study Drug||0
434323|NCT00732069|1034735|P1|NOT COMPLETED|First Study Drug||0
434324|NCT00732069|1034730|P6|COMPLETED|First Study Drug||2
434325|NCT00732069|1034731|P5|COMPLETED|First Study Drug||3
434326|NCT00732069|1034732|P4|COMPLETED|First Study Drug||2
434327|NCT00732069|1034733|P3|COMPLETED|First Study Drug||3
434328|NCT00732069|1034734|P2|COMPLETED|First Study Drug||3
434329|NCT00732069|1034735|P1|COMPLETED|First Study Drug||3
434330|NCT00732069|1034730|P6|STARTED|First Study Drug||2
434331|NCT00732069|1034731|P5|STARTED|First Study Drug||3
434332|NCT00732069|1034732|P4|STARTED|First Study Drug||2
434333|NCT00732069|1034733|P3|STARTED|First Study Drug||3
434334|NCT00732069|1034734|P2|STARTED|First Study Drug||3
434335|NCT00732069|1034735|P1|STARTED|First Study Drug||3
434336|NCT00732030|1034746|P1|NOT COMPLETED|Overall Study||2
434337|NCT00732030|1034746|P1|COMPLETED|Overall Study||24
434338|NCT00732030|1034746|P1|STARTED|Overall Study||26
434339|NCT00731939|1034753|P1|NOT COMPLETED|Overall Study||34
434340|NCT00731939|1034753|P1|COMPLETED|Overall Study||90
434341|NCT00731939|1034753|P1|STARTED|Overall Study||124
434342|NCT00731874|1034803|P2|NOT COMPLETED|Overall Study||0
434343|NCT00731874|1034804|P1|NOT COMPLETED|Overall Study||0
434344|NCT00731874|1034803|P2|COMPLETED|Overall Study||13
434345|NCT00731874|1034804|P1|COMPLETED|Overall Study||10
434346|NCT00731874|1034803|P2|STARTED|Overall Study||13
434347|NCT00731874|1034804|P1|STARTED|Overall Study||10
434348|NCT00731822|1034814|P2|NOT COMPLETED|Overall Study||1
434349|NCT00731822|1034815|P1|NOT COMPLETED|Overall Study||4
434350|NCT00731822|1034814|P2|COMPLETED|Overall Study||39
434351|NCT00731822|1034815|P1|COMPLETED|Overall Study||16
434352|NCT00731822|1034814|P2|STARTED|Overall Study||40
434353|NCT00731822|1034815|P1|STARTED|Overall Study||20
434354|NCT00731783|1034829|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
434355|NCT00731783|1034830|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
434356|NCT00731783|1034829|P2|COMPLETED|12 Month Follow-Up Visit||58
434357|NCT00731783|1034830|P1|COMPLETED|12 Month Follow-Up Visit||68
434358|NCT00731783|1034829|P2|STARTED|12 Month Follow-Up Visit||65
434359|NCT00731783|1034830|P1|STARTED|12 Month Follow-Up Visit||74
434360|NCT00731783|1034829|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
434361|NCT00731783|1034830|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
434362|NCT00731783|1034829|P2|COMPLETED|Six Month Follow-Up Visit||64
434363|NCT00731783|1034830|P1|COMPLETED|Six Month Follow-Up Visit||71
434364|NCT00731783|1034829|P2|STARTED|Six Month Follow-Up Visit||67
434365|NCT00731783|1034830|P1|STARTED|Six Month Follow-Up Visit||77
434366|NCT00731783|1034829|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
434367|NCT00731783|1034830|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
434368|NCT00731783|1034829|P2|COMPLETED|Three Month Follow-Up Visit||57
434369|NCT00731783|1034830|P1|COMPLETED|Three Month Follow-Up Visit||72
434370|NCT00731783|1034829|P2|STARTED|Three Month Follow-Up Visit||73
434371|NCT00731783|1034830|P1|STARTED|Three Month Follow-Up Visit||79
434372|NCT00731783|1034829|P2|NOT COMPLETED|One Month Follow-Up Visit||22
434373|NCT00731783|1034830|P1|NOT COMPLETED|One Month Follow-Up Visit||14
434374|NCT00731783|1034829|P2|COMPLETED|One Month Follow-Up Visit||69
434375|NCT00731783|1034830|P1|COMPLETED|One Month Follow-Up Visit||78
434376|NCT00731783|1034829|P2|STARTED|One Month Follow-Up Visit||91
434377|NCT00731783|1034830|P1|STARTED|One Month Follow-Up Visit||92
434378|NCT00731731|1034853|P3|NOT COMPLETED|Overall Study||3
434379|NCT00731731|1034854|P2|NOT COMPLETED|Overall Study||0
434380|NCT00731731|1034855|P1|NOT COMPLETED|Overall Study||0
434381|NCT00731731|1034853|P3|COMPLETED|Overall Study||107
434382|NCT00731731|1034854|P2|COMPLETED|Overall Study||3
434383|NCT00731731|1034855|P1|COMPLETED|Overall Study||12
434384|NCT00731731|1034853|P3|STARTED|Overall Study||110
434385|NCT00731731|1034854|P2|STARTED|Overall Study||3
434386|NCT00731731|1034855|P1|STARTED|Overall Study||12
434387|NCT00731692|1034873|P3|NOT COMPLETED|Extension Phase||301
434388|NCT00731692|1034874|P2|NOT COMPLETED|Extension Phase||196
434389|NCT00731692|1034875|P1|NOT COMPLETED|Extension Phase||74
434390|NCT00731692|1034873|P3|COMPLETED|Extension Phase||0
434391|NCT00731692|1034874|P2|COMPLETED|Extension Phase||0
434392|NCT00731692|1034875|P1|COMPLETED|Extension Phase||0
434393|NCT00731692|1034873|P3|STARTED|Extension Phase||301
434394|NCT00731692|1034874|P2|STARTED|Extension Phase||196
434395|NCT00731692|1034875|P1|STARTED|Extension Phase||74
434396|NCT00731692|1034873|P3|NOT COMPLETED|Core Study (36 Months)||170
434397|NCT00731692|1034874|P2|NOT COMPLETED|Core Study (36 Months)||116
434398|NCT00731692|1034875|P1|NOT COMPLETED|Core Study (36 Months)||68
434399|NCT00731692|1034873|P3|COMPLETED|Core Study (36 Months)||317
434400|NCT00731692|1034874|P2|COMPLETED|Core Study (36 Months)||220
434401|NCT00731692|1034875|P1|COMPLETED|Core Study (36 Months)||79
434402|NCT00731692|1034873|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
434493|NCT00731042|1035131|P2|NOT COMPLETED|Second Intervention||2
434403|NCT00731692|1034874|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
434404|NCT00731692|1034875|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
434405|NCT00731692|1034873|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
434406|NCT00731692|1034874|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
434407|NCT00731692|1034875|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
434408|NCT00731692|1034873|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
434409|NCT00731692|1034874|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
434410|NCT00731692|1034875|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
434411|NCT00731692|1034873|P3|Safety Set (SAF)|Core Study (36 Months)||487
434412|NCT00731692|1034874|P2|Safety Set (SAF)|Core Study (36 Months)||336
434413|NCT00731692|1034875|P1|Safety Set (SAF)|Core Study (36 Months)||0
434414|NCT00731692|1034873|P3|STARTED|Core Study (36 Months)||487
434415|NCT00731692|1034874|P2|STARTED|Core Study (36 Months)||336
434416|NCT00731692|1034875|P1|STARTED|Core Study (36 Months)||147
434417|NCT00731679|1034921|P2|NOT COMPLETED|Overall Study||26
434418|NCT00731679|1034922|P1|NOT COMPLETED|Overall Study||22
434419|NCT00731679|1034921|P2|COMPLETED|Overall Study||283
434420|NCT00731679|1034922|P1|COMPLETED|Overall Study||292
434421|NCT00731679|1034921|P2|STARTED|Overall Study||309
434422|NCT00731679|1034922|P1|STARTED|Overall Study||314
434423|NCT00731666|1034930|P1|NOT COMPLETED|Overall Study||12
434424|NCT00731666|1034930|P1|COMPLETED|Overall Study||28
434425|NCT00731666|1034930|P1|STARTED|Overall Study||40
434426|NCT00731653|1034936|P1|NOT COMPLETED|Overall Study||9
434427|NCT00731653|1034936|P1|COMPLETED|Overall Study||72
434428|NCT00731653|1034936|P1|STARTED|Overall Study||81
434429|NCT00731640|1034942|P2|NOT COMPLETED|Overall Study||0
434430|NCT00731640|1034943|P1|NOT COMPLETED|Overall Study||0
434431|NCT00731640|1034942|P2|COMPLETED|Overall Study||32
434432|NCT00731640|1034943|P1|COMPLETED|Overall Study||20
434433|NCT00731640|1034942|P2|STARTED|Overall Study||32
434434|NCT00731640|1034943|P1|STARTED|Overall Study||20
434435|NCT00731614|1034957|P2|NOT COMPLETED|Overall Study||13
434436|NCT00731614|1034958|P1|NOT COMPLETED|Overall Study||7
434437|NCT00731614|1034957|P2|COMPLETED|Overall Study||18
434438|NCT00731614|1034958|P1|COMPLETED|Overall Study||16
434439|NCT00731614|1034957|P2|12 Weeks Posttreatment|Overall Study||23
434440|NCT00731614|1034958|P1|12 Weeks Posttreatment|Overall Study||18
434441|NCT00731614|1034957|P2|End of Treatment|Overall Study||24
434442|NCT00731614|1034958|P1|End of Treatment|Overall Study||16
434443|NCT00731614|1034957|P2|STARTED|Overall Study||31
434444|NCT00731614|1034958|P1|STARTED|Overall Study||23
434445|NCT00731549|1034964|P1|NOT COMPLETED|Overall Study||223
434446|NCT00731549|1034964|P1|COMPLETED|Overall Study||858
434447|NCT00731549|1034964|P1|STARTED|Overall Study||1081
434448|NCT00731484|1034977|P1|NOT COMPLETED|Overall Study||0
434449|NCT00731484|1034977|P1|COMPLETED|Overall Study||233
434450|NCT00731484|1034977|P1|STARTED|Overall Study||233
434451|NCT00731341|1034981|P1|NOT COMPLETED|Overall Study||0
434452|NCT00731341|1034981|P1|COMPLETED|Overall Study||3
434453|NCT00731341|1034981|P1|STARTED|Overall Study||3
434454|NCT00731211|1034990|P1|NOT COMPLETED|Overall Study||0
434455|NCT00731211|1034990|P1|COMPLETED|Overall Study||55
434456|NCT00731211|1034990|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
434457|NCT00731198|1034997|P2|NOT COMPLETED|Overall Study||6
434458|NCT00731198|1034998|P1|NOT COMPLETED|Overall Study||6
434459|NCT00731198|1034997|P2|COMPLETED|Overall Study||319
434460|NCT00731198|1034998|P1|COMPLETED|Overall Study||319
434461|NCT00731198|1034997|P2|STARTED|Overall Study||325
434462|NCT00731198|1034998|P1|STARTED|Overall Study||325
434463|NCT00731133|1035004|P1|NOT COMPLETED|Overall Study||10
434464|NCT00731133|1035004|P1|COMPLETED|Overall Study||5
434465|NCT00731133|1035004|P1|STARTED|Overall Study||15
434466|NCT00731120|1035012|P3|NOT COMPLETED|Overall Study||36
434467|NCT00731120|1035013|P2|NOT COMPLETED|Overall Study||43
434468|NCT00731120|1035014|P1|NOT COMPLETED|Overall Study||42
434469|NCT00731120|1035012|P3|COMPLETED|Overall Study||116
434470|NCT00731120|1035013|P2|COMPLETED|Overall Study||109
434471|NCT00731120|1035014|P1|COMPLETED|Overall Study||111
434472|NCT00731120|1035012|P3|Treated|Overall Study||152
434473|NCT00731120|1035013|P2|Treated|Overall Study||151
434474|NCT00731120|1035014|P1|Treated|Overall Study||153
434475|NCT00731120|1035012|P3|STARTED|Overall Study||152
434476|NCT00731120|1035013|P2|STARTED|Overall Study||152
434477|NCT00731120|1035014|P1|STARTED|Overall Study||153
434478|NCT00731094|1035051|P2|NOT COMPLETED|Overall Study||11
434479|NCT00731094|1035052|P1|NOT COMPLETED|Overall Study||18
434480|NCT00731094|1035051|P2|COMPLETED|Overall Study||105
434481|NCT00731094|1035052|P1|COMPLETED|Overall Study||98
434482|NCT00731094|1035051|P2|Month 6|Overall Study||107
434483|NCT00731094|1035052|P1|Month 6|Overall Study||101
434484|NCT00731094|1035051|P2|STARTED|Overall Study||116
434485|NCT00731094|1035052|P1|STARTED|Overall Study||116
434486|NCT00731055|1035122|P1|NOT COMPLETED|Overall Study||0
434487|NCT00731055|1035122|P1|COMPLETED|Overall Study||16
434488|NCT00731055|1035122|P1|Received Varenicline 2.0 mg|Overall Study||16
434489|NCT00731055|1035122|P1|Received Varenicline 1.0 mg|Overall Study||16
434490|NCT00731055|1035122|P1|Received Varenicline 0.5 mg|Overall Study||16
434491|NCT00731055|1035122|P1|Received Placebo|Overall Study||16
434492|NCT00731055|1035122|P1|STARTED|Overall Study|This is a within-subjects study design.|16
434494|NCT00731042|1035132|P1|NOT COMPLETED|Second Intervention||0
434495|NCT00731042|1035131|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
434496|NCT00731042|1035132|P1|COMPLETED|Second Intervention||16
434497|NCT00731042|1035131|P2|STARTED|Second Intervention||17
434498|NCT00731042|1035132|P1|STARTED|Second Intervention||16
434499|NCT00731042|1035131|P2|NOT COMPLETED|Wash-out||0
434500|NCT00731042|1035132|P1|NOT COMPLETED|Wash-out||0
434501|NCT00731042|1035131|P2|COMPLETED|Wash-out||17
434502|NCT00731042|1035132|P1|COMPLETED|Wash-out||16
434503|NCT00731042|1035131|P2|STARTED|Wash-out||17
434504|NCT00731042|1035132|P1|STARTED|Wash-out||16
434505|NCT00731042|1035131|P2|NOT COMPLETED|First Intervention||0
434506|NCT00731042|1035132|P1|NOT COMPLETED|First Intervention||0
434507|NCT00731042|1035131|P2|COMPLETED|First Intervention||17
434508|NCT00731042|1035132|P1|COMPLETED|First Intervention||16
434509|NCT00731042|1035131|P2|STARTED|First Intervention||17
434510|NCT00731042|1035132|P1|STARTED|First Intervention||16
434511|NCT00730964|1035138|P1|NOT COMPLETED|Overall Study||0
434512|NCT00730964|1035138|P1|COMPLETED|Overall Study||1039
434513|NCT00730964|1035138|P1|STARTED|Overall Study||1039
434514|NCT00730925|1035143|P1|NOT COMPLETED|Overall Study||41
434515|NCT00730925|1035143|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
434516|NCT00730925|1035143|P1|STARTED|Overall Study||41
434517|NCT00730912|1035153|P3|NOT COMPLETED|Overall Study||1
434518|NCT00730912|1035154|P2|NOT COMPLETED|Overall Study||0
434519|NCT00730912|1035155|P1|NOT COMPLETED|Overall Study||0
434520|NCT00730912|1035153|P3|COMPLETED|Overall Study||103
434521|NCT00730912|1035154|P2|COMPLETED|Overall Study||104
434522|NCT00730912|1035155|P1|COMPLETED|Overall Study||53
434523|NCT00730912|1035153|P3|STARTED|Overall Study||104
434524|NCT00730912|1035154|P2|STARTED|Overall Study||104
434525|NCT00730912|1035155|P1|STARTED|Overall Study||53
434526|NCT00730847|1035166|P1|NOT COMPLETED|Overall Study||131
434527|NCT00730847|1035166|P1|COMPLETED|Overall Study||465
434528|NCT00730847|1035166|P1|STARTED|Overall Study||596
434529|NCT00730756|1035175|P2|NOT COMPLETED|Overall Study||5
434530|NCT00730756|1035176|P1|NOT COMPLETED|Overall Study||4
434531|NCT00730756|1035175|P2|COMPLETED|Overall Study||48
434532|NCT00730756|1035176|P1|COMPLETED|Overall Study||45
434533|NCT00730756|1035175|P2|STARTED|Overall Study||53
434534|NCT00730756|1035176|P1|STARTED|Overall Study||49
434535|NCT00730730|1035198|P1|NOT COMPLETED|Overall Study||0
434536|NCT00730730|1035198|P1|COMPLETED|Overall Study||50
434537|NCT00730730|1035198|P1|STARTED|Overall Study||50
434538|NCT00730691|1035210|P5|NOT COMPLETED|Overall Study||50
434539|NCT00730691|1035211|P4|NOT COMPLETED|Overall Study||45
434540|NCT00730691|1035212|P3|NOT COMPLETED|Overall Study||39
434541|NCT00730691|1035213|P2|NOT COMPLETED|Overall Study||36
434542|NCT00730691|1035214|P1|NOT COMPLETED|Overall Study||36
434543|NCT00730691|1035210|P5|COMPLETED|Overall Study||106
434544|NCT00730691|1035211|P4|COMPLETED|Overall Study||111
434545|NCT00730691|1035212|P3|COMPLETED|Overall Study||117
434546|NCT00730691|1035213|P2|COMPLETED|Overall Study||120
434547|NCT00730691|1035214|P1|COMPLETED|Overall Study||121
434548|NCT00730691|1035210|P5|STARTED|Overall Study||156
434549|NCT00730691|1035211|P4|STARTED|Overall Study||156
434550|NCT00730691|1035212|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
434551|NCT00730691|1035213|P2|STARTED|Overall Study||156
434552|NCT00730691|1035214|P1|STARTED|Overall Study||157
434553|NCT00730639|1035306|P5|NOT COMPLETED|Overall Study||131
434554|NCT00730639|1035307|P4|NOT COMPLETED|Overall Study||54
434555|NCT00730639|1035308|P3|NOT COMPLETED|Overall Study||86
434556|NCT00730639|1035309|P2|NOT COMPLETED|Overall Study||18
434557|NCT00730639|1035310|P1|NOT COMPLETED|Overall Study||17
434558|NCT00730639|1035306|P5|COMPLETED|Overall Study||0
434559|NCT00730639|1035307|P4|COMPLETED|Overall Study||0
434560|NCT00730639|1035308|P3|COMPLETED|Overall Study||0
434561|NCT00730639|1035309|P2|COMPLETED|Overall Study||0
434562|NCT00730639|1035310|P1|COMPLETED|Overall Study||0
434563|NCT00730639|1035306|P5|STARTED|Overall Study||131
434564|NCT00730639|1035307|P4|STARTED|Overall Study||54
434565|NCT00730639|1035308|P3|STARTED|Overall Study||86
434566|NCT00730639|1035309|P2|STARTED|Overall Study||18
434567|NCT00730639|1035310|P1|STARTED|Overall Study||17
434568|NCT00730353|1035374|P1|NOT COMPLETED|Overall Study||0
434569|NCT00730353|1035374|P1|COMPLETED|Overall Study||28
434570|NCT00730353|1035374|P1|STARTED|Overall Study||28
434571|NCT00730327|1035384|P2|NOT COMPLETED|Overall Study||37
434572|NCT00730327|1035385|P1|NOT COMPLETED|Overall Study||27
434573|NCT00730327|1035384|P2|COMPLETED|Overall Study||93
434574|NCT00730327|1035385|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
434575|NCT00730327|1035384|P2|Completed Week 26|Overall Study||99
434576|NCT00730327|1035385|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
434577|NCT00730327|1035384|P2|STARTED|Overall Study||130
434578|NCT00730327|1035385|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
434579|NCT00730275|1035410|P4|NOT COMPLETED|Overall Study||1
434580|NCT00730275|1035411|P3|NOT COMPLETED|Overall Study||0
434581|NCT00730275|1035412|P2|NOT COMPLETED|Overall Study||0
434582|NCT00730275|1035413|P1|NOT COMPLETED|Overall Study||0
434583|NCT00730275|1035410|P4|COMPLETED|Overall Study||8
434584|NCT00730275|1035411|P3|COMPLETED|Overall Study||8
434585|NCT00730275|1035412|P2|COMPLETED|Overall Study||9
434586|NCT00730275|1035413|P1|COMPLETED|Overall Study||9
434587|NCT00730275|1035410|P4|STARTED|Overall Study||9
434588|NCT00730275|1035411|P3|STARTED|Overall Study||8
434589|NCT00730275|1035412|P2|STARTED|Overall Study||9
434590|NCT00730275|1035413|P1|STARTED|Overall Study||9
434591|NCT00730236|1035439|P1|NOT COMPLETED|Overall Study||6
434592|NCT00730236|1035439|P1|COMPLETED|Overall Study||23
434593|NCT00730236|1035439|P1|STARTED|Overall Study||29
434594|NCT00730132|1035454|P1|NOT COMPLETED|Overall Study||155
434595|NCT00730132|1035454|P1|COMPLETED|Overall Study||557
434596|NCT00730132|1035454|P1|STARTED|Overall Study||712
434597|NCT00730041|1035472|P2|NOT COMPLETED|Overall Study||2
434598|NCT00730041|1035473|P1|NOT COMPLETED|Overall Study||0
434599|NCT00730041|1035472|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
434600|NCT00730041|1035473|P1|COMPLETED|Overall Study||26
434601|NCT00730041|1035472|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
434602|NCT00730041|1035473|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
434603|NCT00730028|1035496|P5|NOT COMPLETED|Overall Study||82
434604|NCT00730028|1035497|P4|NOT COMPLETED|Overall Study||56
434605|NCT00730028|1035498|P3|NOT COMPLETED|Overall Study||45
434606|NCT00730028|1035499|P2|NOT COMPLETED|Overall Study||66
434607|NCT00730028|1035500|P1|NOT COMPLETED|Overall Study||60
434608|NCT00730028|1035496|P5|COMPLETED|Overall Study||175
434609|NCT00730028|1035497|P4|COMPLETED|Overall Study||207
434610|NCT00730028|1035498|P3|COMPLETED|Overall Study||221
434611|NCT00730028|1035499|P2|COMPLETED|Overall Study||194
434612|NCT00730028|1035500|P1|COMPLETED|Overall Study||204
434613|NCT00730028|1035496|P5|STARTED|Overall Study||257
434614|NCT00730028|1035497|P4|STARTED|Overall Study||263
434615|NCT00730028|1035498|P3|STARTED|Overall Study||266
434616|NCT00730028|1035499|P2|STARTED|Overall Study||260
434617|NCT00730028|1035500|P1|STARTED|Overall Study||264
434618|NCT00730015|1035550|P3|NOT COMPLETED|Overall Study||32
434619|NCT00730015|1035551|P2|NOT COMPLETED|Overall Study||40
434620|NCT00730015|1035552|P1|NOT COMPLETED|Overall Study||31
434621|NCT00730015|1035550|P3|COMPLETED|Overall Study||177
434622|NCT00730015|1035551|P2|COMPLETED|Overall Study||177
434623|NCT00730015|1035552|P1|COMPLETED|Overall Study||186
434624|NCT00730015|1035550|P3|STARTED|Overall Study||209
434625|NCT00730015|1035551|P2|STARTED|Overall Study||217
434626|NCT00730015|1035552|P1|STARTED|Overall Study||217
434627|NCT00729937|1035592|P6|NOT COMPLETED|Overall Study||37
434628|NCT00729937|1035593|P5|NOT COMPLETED|Overall Study||28
434629|NCT00729937|1035594|P4|NOT COMPLETED|Overall Study||34
434630|NCT00729937|1035595|P3|NOT COMPLETED|Overall Study||29
434631|NCT00729937|1035596|P2|NOT COMPLETED|Overall Study||88
434632|NCT00729937|1035597|P1|NOT COMPLETED|Overall Study||74
434633|NCT00729937|1035592|P6|COMPLETED|Overall Study||214
434634|NCT00729937|1035593|P5|COMPLETED|Overall Study||221
434635|NCT00729937|1035594|P4|COMPLETED|Overall Study||215
434636|NCT00729937|1035595|P3|COMPLETED|Overall Study||222
434637|NCT00729937|1035596|P2|COMPLETED|Overall Study||548
434638|NCT00729937|1035597|P1|COMPLETED|Overall Study||555
434639|NCT00729937|1035592|P6|STARTED|Overall Study||251
434640|NCT00729937|1035593|P5|STARTED|Overall Study||249
434641|NCT00729937|1035594|P4|STARTED|Overall Study||249
434642|NCT00729937|1035595|P3|STARTED|Overall Study||251
434643|NCT00729937|1035596|P2|STARTED|Overall Study||636
434644|NCT00729937|1035597|P1|STARTED|Overall Study||629
434645|NCT00729924|1035791|P1|NOT COMPLETED|Overall Study||0
434646|NCT00729924|1035791|P1|COMPLETED|Overall Study||40
434647|NCT00729924|1035791|P1|STARTED|Overall Study||40
434648|NCT00729859|1035801|P3|NOT COMPLETED|Overall Study||0
434649|NCT00729859|1035802|P2|NOT COMPLETED|Overall Study||2
434650|NCT00729859|1035803|P1|NOT COMPLETED|Overall Study||0
434651|NCT00729859|1035801|P3|COMPLETED|Overall Study||8
434652|NCT00729859|1035802|P2|COMPLETED|Overall Study||6
434653|NCT00729859|1035803|P1|COMPLETED|Overall Study||8
434654|NCT00729859|1035801|P3|STARTED|Overall Study||8
434655|NCT00729859|1035802|P2|STARTED|Overall Study||8
434656|NCT00729859|1035803|P1|STARTED|Overall Study||8
434657|NCT00729846|1035840|P2|NOT COMPLETED|Overall Study||0
434658|NCT00729846|1035841|P1|NOT COMPLETED|Overall Study||0
434659|NCT00729846|1035840|P2|COMPLETED|Overall Study||11
434660|NCT00729846|1035841|P1|COMPLETED|Overall Study||11
434661|NCT00729846|1035840|P2|STARTED|Overall Study||11
434662|NCT00729846|1035841|P1|STARTED|Overall Study||11
434663|NCT00729833|1035847|P4|NOT COMPLETED|Overall Study||6
434664|NCT00729833|1035848|P3|NOT COMPLETED|Overall Study||12
434665|NCT00729833|1035849|P2|NOT COMPLETED|Overall Study||7
434666|NCT00729833|1035850|P1|NOT COMPLETED|Overall Study||20
434667|NCT00729833|1035847|P4|COMPLETED|Overall Study||0
434668|NCT00729833|1035848|P3|COMPLETED|Overall Study||0
434669|NCT00729833|1035849|P2|COMPLETED|Overall Study||0
434670|NCT00729833|1035850|P1|COMPLETED|Overall Study||0
434671|NCT00729833|1035847|P4|STARTED|Overall Study||6
434672|NCT00729833|1035848|P3|STARTED|Overall Study||12
434673|NCT00729833|1035849|P2|STARTED|Overall Study||7
434674|NCT00729833|1035850|P1|STARTED|Overall Study||20
434675|NCT00729807|1035889|P1|NOT COMPLETED|Overall Study||0
434676|NCT00729807|1035889|P1|COMPLETED|Overall Study||6
434677|NCT00729807|1035889|P1|STARTED|Overall Study||6
434678|NCT00729781|1035893|P1|NOT COMPLETED|Long-term Follow-up Study||0
434679|NCT00729781|1035893|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
434680|NCT00729781|1035893|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
434681|NCT00729781|1035893|P1|NOT COMPLETED|Original Study||0
434682|NCT00729781|1035893|P1|COMPLETED|Original Study||45
434683|NCT00729781|1035893|P1|STARTED|Original Study||45
434684|NCT00729690|1035902|P3|NOT COMPLETED|Overall Study||2
434685|NCT00729690|1035903|P2|NOT COMPLETED|Overall Study||2
434686|NCT00729690|1035904|P1|NOT COMPLETED|Overall Study||0
434687|NCT00729690|1035902|P3|COMPLETED|Overall Study||14
434688|NCT00729690|1035903|P2|COMPLETED|Overall Study||14
434689|NCT00729690|1035904|P1|COMPLETED|Overall Study||16
434690|NCT00729690|1035902|P3|STARTED|Overall Study||16
434691|NCT00729690|1035903|P2|STARTED|Overall Study||16
434692|NCT00729690|1035904|P1|STARTED|Overall Study||16
434693|NCT00729677|1035921|P1|NOT COMPLETED|Overall Study||0
434694|NCT00729677|1035921|P1|COMPLETED|Overall Study||64
434695|NCT00729677|1035921|P1|STARTED|Overall Study||64
434696|NCT00729651|1035934|P2|NOT COMPLETED|Overall Study||18
434697|NCT00729651|1035935|P1|NOT COMPLETED|Overall Study||19
434698|NCT00729651|1035934|P2|COMPLETED|Overall Study||152
434699|NCT00729651|1035935|P1|COMPLETED|Overall Study||154
434700|NCT00729651|1035934|P2|STARTED|Overall Study||170
434701|NCT00729651|1035935|P1|STARTED|Overall Study||173
434702|NCT00729612|1035947|P1|NOT COMPLETED|Overall Study||10
434703|NCT00729612|1035947|P1|COMPLETED|Overall Study||53
434704|NCT00729612|1035947|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
434705|NCT00729612|1035947|P1|Received Cycle 2|Overall Study||54
434706|NCT00729612|1035947|P1|Did Not Receive Cycle 2|Overall Study||7
434707|NCT00729612|1035947|P1|Received Cycle 1|Overall Study||62
434708|NCT00729612|1035947|P1|Died Before Cycle 1|Overall Study||1
434709|NCT00729612|1035947|P1|STARTED|Overall Study||63
434710|NCT00729560|1035954|P1|NOT COMPLETED|Overall Study||3
434711|NCT00729560|1035954|P1|COMPLETED|Overall Study||5
434712|NCT00729560|1035954|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
434713|NCT00729521|1035961|P3|NOT COMPLETED|Overall Study||0
434714|NCT00729521|1035962|P2|NOT COMPLETED|Overall Study||0
434715|NCT00729521|1035963|P1|NOT COMPLETED|Overall Study||0
434716|NCT00729521|1035961|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
434717|NCT00729521|1035962|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
434718|NCT00729521|1035963|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
434719|NCT00729521|1035961|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
434720|NCT00729521|1035962|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
434721|NCT00729521|1035963|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
434722|NCT00729482|1035971|P1|NOT COMPLETED|Overall Study||0
434723|NCT00729482|1035971|P1|COMPLETED|Overall Study||54
434724|NCT00729482|1035971|P1|STARTED|Overall Study||54
434725|NCT00729469|1035980|P2|NOT COMPLETED|Overall Study||47
434726|NCT00729469|1035981|P1|NOT COMPLETED|Overall Study||53
434727|NCT00729469|1035980|P2|COMPLETED|Overall Study||416
434728|NCT00729469|1035981|P1|COMPLETED|Overall Study||403
434729|NCT00729469|1035980|P2|STARTED|Overall Study||463
434730|NCT00729469|1035981|P1|STARTED|Overall Study||456
434731|NCT00729430|1036019|P2|NOT COMPLETED|Overall Study||50
434732|NCT00729430|1036020|P1|NOT COMPLETED|Overall Study||47
434733|NCT00729430|1036019|P2|COMPLETED|Overall Study||128
434734|NCT00729430|1036020|P1|COMPLETED|Overall Study||133
434735|NCT00729430|1036019|P2|STARTED|Overall Study||178
434736|NCT00729430|1036020|P1|STARTED|Overall Study||180
434737|NCT00729365|1036035|P3|NOT COMPLETED|Overall Study||7
434738|NCT00729365|1036036|P2|NOT COMPLETED|Overall Study||6
434739|NCT00729365|1036037|P1|NOT COMPLETED|Overall Study||33
434740|NCT00729365|1036035|P3|COMPLETED|Overall Study|Study terminated|0
434741|NCT00729365|1036036|P2|COMPLETED|Overall Study|Study Terminated|0
434742|NCT00729365|1036037|P1|COMPLETED|Overall Study|Study terminated|0
434743|NCT00729365|1036035|P3|STARTED|Overall Study||7
434744|NCT00729365|1036036|P2|STARTED|Overall Study||6
434745|NCT00729365|1036037|P1|STARTED|Overall Study||33
434746|NCT00729326|1036050|P2|NOT COMPLETED|Overall Study||9
434747|NCT00729326|1036051|P1|NOT COMPLETED|Overall Study||10
434748|NCT00729326|1036050|P2|COMPLETED|Overall Study||33
434749|NCT00729326|1036051|P1|COMPLETED|Overall Study||31
434750|NCT00729326|1036050|P2|STARTED|Overall Study||42
434751|NCT00729326|1036051|P1|STARTED|Overall Study||41
434752|NCT00729248|1036093|P1|NOT COMPLETED|Overall Study||2
434753|NCT00729248|1036093|P1|COMPLETED|Overall Study||10
434754|NCT00729248|1036093|P1|STARTED|Overall Study||12
434755|NCT00729183|1036100|P2|NOT COMPLETED|Overall Study||15
434756|NCT00729183|1036101|P1|NOT COMPLETED|Overall Study||25
434757|NCT00729183|1036100|P2|COMPLETED|Overall Study|Completed 24 month visit|90
434758|NCT00729183|1036101|P1|COMPLETED|Overall Study|Completed 24 month visit|84
434759|NCT00729183|1036100|P2|STARTED|Overall Study||105
434760|NCT00729183|1036101|P1|STARTED|Overall Study||109
434761|NCT00729157|1036133|P1|NOT COMPLETED|Overall Study||1
434762|NCT00729157|1036133|P1|COMPLETED|Overall Study||40
434763|NCT00729157|1036133|P1|STARTED|Overall Study||41
434764|NCT00728988|1036143|P2|NOT COMPLETED|Overall Study||88
434765|NCT00728988|1036144|P1|NOT COMPLETED|Overall Study||93
434766|NCT00728988|1036143|P2|COMPLETED|Overall Study||164
434767|NCT00728988|1036144|P1|COMPLETED|Overall Study||154
434768|NCT00728988|1036143|P2|Full Analysis Set|Overall Study||172
434769|NCT00728988|1036144|P1|Full Analysis Set|Overall Study||163
434770|NCT00728988|1036143|P2|Treated|Overall Study||250
434771|NCT00728988|1036144|P1|Treated|Overall Study||245
434772|NCT00728988|1036143|P2|STARTED|Overall Study||252
434773|NCT00728988|1036144|P1|STARTED|Overall Study||247
434774|NCT00728962|1036162|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
434775|NCT00728962|1036162|P1|COMPLETED|Two Year Post Placement Follow-up||59
434776|NCT00728962|1036162|P1|STARTED|Two Year Post Placement Follow-up||62
434777|NCT00728962|1036162|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
434778|NCT00728962|1036162|P1|COMPLETED|One Year Post Placement Follow-up||62
434779|NCT00728962|1036162|P1|STARTED|One Year Post Placement Follow-up||62
434780|NCT00728962|1036162|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
434781|NCT00728962|1036162|P1|COMPLETED|Permanent Prosthesis Placement||62
434782|NCT00728962|1036162|P1|STARTED|Permanent Prosthesis Placement||65
434783|NCT00728962|1036162|P1|NOT COMPLETED|Implant Placement Surgery||10
434784|NCT00728962|1036162|P1|COMPLETED|Implant Placement Surgery||65
434785|NCT00728962|1036162|P1|STARTED|Implant Placement Surgery||75
434786|NCT00728923|1036166|P1|NOT COMPLETED|Overall Study||0
434787|NCT00728923|1036166|P1|COMPLETED|Overall Study||9
434788|NCT00728923|1036166|P1|STARTED|Overall Study||9
434789|NCT00728910|1036171|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
434790|NCT00728910|1036171|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
434791|NCT00728910|1036171|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
434792|NCT00728910|1036171|P1|NOT COMPLETED|Atorvastatin+ABT335||0
434793|NCT00728910|1036171|P1|COMPLETED|Atorvastatin+ABT335||22
434794|NCT00728910|1036171|P1|STARTED|Atorvastatin+ABT335||22
434795|NCT00728910|1036171|P1|NOT COMPLETED|Atorvastatin||3
434796|NCT00728910|1036171|P1|COMPLETED|Atorvastatin||22
434797|NCT00728910|1036171|P1|STARTED|Atorvastatin||25
434798|NCT00728884|1036183|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
434799|NCT00728884|1036183|P1|COMPLETED|Two Year Post Placement Follow-up||145
434800|NCT00728884|1036183|P1|STARTED|Two Year Post Placement Follow-up||145
434801|NCT00728884|1036183|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
434802|NCT00728884|1036183|P1|COMPLETED|One Year Post Placement Follow-up||145
434803|NCT00728884|1036183|P1|STARTED|One Year Post Placement Follow-up||149
434804|NCT00728884|1036183|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
434805|NCT00728884|1036183|P1|COMPLETED|Permanent Prosthesis Placement||149
434806|NCT00728884|1036183|P1|STARTED|Permanent Prosthesis Placement||162
434807|NCT00728884|1036183|P1|NOT COMPLETED|Implant Placement Surgery||0
434808|NCT00728884|1036183|P1|COMPLETED|Implant Placement Surgery||162
434809|NCT00728884|1036183|P1|STARTED|Implant Placement Surgery||162
434810|NCT00728845|1036189|P2|NOT COMPLETED|Overall Study||0
434811|NCT00728845|1036190|P1|NOT COMPLETED|Overall Study||0
434812|NCT00728845|1036189|P2|COMPLETED|Overall Study||0
434813|NCT00728845|1036190|P1|COMPLETED|Overall Study||8
434814|NCT00728845|1036189|P2|STARTED|Overall Study||0
434815|NCT00728845|1036190|P1|STARTED|Overall Study||8
434816|NCT00728754|1036206|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
434817|NCT00728754|1036207|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
434818|NCT00728754|1036206|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
434819|NCT00728754|1036207|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
434820|NCT00728754|1036206|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
434821|NCT00728754|1036207|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
434822|NCT00728754|1036206|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
434823|NCT00728754|1036207|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
434824|NCT00728754|1036206|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
434825|NCT00728754|1036207|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
434826|NCT00728754|1036206|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
434827|NCT00728754|1036207|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
434828|NCT00728754|1036206|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
434829|NCT00728754|1036207|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
434830|NCT00728754|1036206|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
434831|NCT00728754|1036207|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
434832|NCT00728754|1036206|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
434833|NCT00728754|1036207|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
434834|NCT00728754|1036206|P2|NOT COMPLETED|Implant Placement Surgery||0
434835|NCT00728754|1036207|P1|NOT COMPLETED|Implant Placement Surgery||0
434836|NCT00728754|1036206|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
434837|NCT00728754|1036207|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
434838|NCT00728754|1036206|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
434839|NCT00728754|1036207|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
434840|NCT00728728|1036215|P2|NOT COMPLETED|Overall Study||12
434841|NCT00728728|1036216|P1|NOT COMPLETED|Overall Study||4
434842|NCT00728728|1036215|P2|COMPLETED|Overall Study||34
434843|NCT00728728|1036216|P1|COMPLETED|Overall Study||38
434844|NCT00728728|1036215|P2|STARTED|Overall Study||46
434845|NCT00728728|1036216|P1|STARTED|Overall Study||42
434846|NCT00726986|1036234|P1|NOT COMPLETED|Maintenance Phase||3
434847|NCT00726986|1036234|P1|COMPLETED|Maintenance Phase||0
434848|NCT00726986|1036234|P1|STARTED|Maintenance Phase||3
434849|NCT00726986|1036234|P1|NOT COMPLETED|Induction Phase||15
434850|NCT00726986|1036234|P1|COMPLETED|Induction Phase||3
434851|NCT00726986|1036234|P1|Maintance|Induction Phase||3
434852|NCT00726986|1036234|P1|STARTED|Induction Phase||18
434853|NCT00726895|1036241|P2|NOT COMPLETED|Second Intervention||0
434854|NCT00726895|1036242|P1|NOT COMPLETED|Second Intervention||0
434855|NCT00726895|1036241|P2|COMPLETED|Second Intervention||11
434856|NCT00726895|1036242|P1|COMPLETED|Second Intervention||12
434857|NCT00726895|1036241|P2|STARTED|Second Intervention||11
434858|NCT00726895|1036242|P1|STARTED|Second Intervention||12
434859|NCT00726895|1036241|P2|NOT COMPLETED|Washout Period of 7 Days||1
434860|NCT00726895|1036242|P1|NOT COMPLETED|Washout Period of 7 Days||0
434861|NCT00726895|1036241|P2|COMPLETED|Washout Period of 7 Days||11
434862|NCT00726895|1036242|P1|COMPLETED|Washout Period of 7 Days||12
434863|NCT00726895|1036241|P2|STARTED|Washout Period of 7 Days||12
434864|NCT00726895|1036242|P1|STARTED|Washout Period of 7 Days||12
434865|NCT00726895|1036241|P2|NOT COMPLETED|First Intervention||0
434866|NCT00726895|1036242|P1|NOT COMPLETED|First Intervention||0
434867|NCT00726895|1036241|P2|COMPLETED|First Intervention||12
434868|NCT00726895|1036242|P1|COMPLETED|First Intervention||12
434869|NCT00726895|1036241|P2|STARTED|First Intervention||12
434870|NCT00726895|1036242|P1|STARTED|First Intervention||12
434871|NCT00726882|1036255|P1|NOT COMPLETED|Overall Study||22
434872|NCT00726882|1036255|P1|COMPLETED|Overall Study||13
434873|NCT00726882|1036255|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
434874|NCT00726882|1036255|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
434875|NCT00726882|1036255|P1|STARTED|Overall Study||35
434876|NCT00726830|1036263|P2|NOT COMPLETED|Overall Study||0
434877|NCT00726830|1036264|P1|NOT COMPLETED|Overall Study||0
434878|NCT00726830|1036263|P2|COMPLETED|Overall Study||0
434879|NCT00726830|1036264|P1|COMPLETED|Overall Study||1
434880|NCT00726830|1036263|P2|STARTED|Overall Study||0
434881|NCT00726830|1036264|P1|STARTED|Overall Study||1
434882|NCT00728689|1036272|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
434883|NCT00728689|1036273|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
434884|NCT00728689|1036272|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
434885|NCT00728689|1036273|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
434886|NCT00728689|1036272|P2|STARTED|Second Intervention (Days 11 - 13)||6
434887|NCT00728689|1036273|P1|STARTED|Second Intervention (Days 11 - 13)||5
434888|NCT00728689|1036272|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
434889|NCT00728689|1036273|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
434890|NCT00728689|1036272|P2|COMPLETED|Washout Period (Days 4 - 10)||6
434891|NCT00728689|1036273|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
434892|NCT00728689|1036272|P2|STARTED|Washout Period (Days 4 - 10)||6
434893|NCT00728689|1036273|P1|STARTED|Washout Period (Days 4 - 10)||6
434894|NCT00728689|1036272|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
434895|NCT00728689|1036273|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
434896|NCT00728689|1036272|P2|COMPLETED|First Intervention (Days 1 - 3)||6
434897|NCT00728689|1036273|P1|COMPLETED|First Intervention (Days 1 - 3)||6
434898|NCT00728689|1036272|P2|STARTED|First Intervention (Days 1 - 3)||6
434899|NCT00728689|1036273|P1|STARTED|First Intervention (Days 1 - 3)||6
434900|NCT00728507|1036291|P2|NOT COMPLETED|Overall Study||8
434901|NCT00728507|1036292|P1|NOT COMPLETED|Overall Study||2
434902|NCT00728507|1036291|P2|COMPLETED|Overall Study||51
434903|NCT00728507|1036292|P1|COMPLETED|Overall Study||60
434904|NCT00728507|1036291|P2|STARTED|Overall Study||59
434905|NCT00728507|1036292|P1|STARTED|Overall Study||62
434906|NCT00728494|1036302|P2|NOT COMPLETED|Overall Study||7
434907|NCT00728494|1036303|P1|NOT COMPLETED|Overall Study||9
434908|NCT00728494|1036302|P2|COMPLETED|Overall Study||32
434909|NCT00728494|1036303|P1|COMPLETED|Overall Study||51
434910|NCT00728494|1036302|P2|STARTED|Overall Study||39
434911|NCT00728494|1036303|P1|STARTED|Overall Study||60
434912|NCT00728481|1036321|P2|NOT COMPLETED|Overall Study||4
434913|NCT00728481|1036322|P1|NOT COMPLETED|Overall Study||1
434914|NCT00728481|1036321|P2|COMPLETED|Overall Study||28
434915|NCT00728481|1036322|P1|COMPLETED|Overall Study||18
434916|NCT00728481|1036321|P2|STARTED|Overall Study||32
434917|NCT00728481|1036322|P1|STARTED|Overall Study||19
434918|NCT00728416|1036340|P2|NOT COMPLETED|Overall Study||2
434919|NCT00728416|1036341|P1|NOT COMPLETED|Overall Study||2
434920|NCT00728416|1036340|P2|COMPLETED|Overall Study||163
434921|NCT00728416|1036341|P1|COMPLETED|Overall Study||166
434922|NCT00728416|1036340|P2|STARTED|Overall Study||165
434923|NCT00728416|1036341|P1|STARTED|Overall Study||168
434924|NCT00728260|1036349|P1|NOT COMPLETED|Overall Study||0
434925|NCT00728260|1036349|P1|COMPLETED|Overall Study||1421
434926|NCT00728260|1036349|P1|STARTED|Overall Study||1421
434927|NCT00728182|1036357|P2|NOT COMPLETED|Overall Study||3
434928|NCT00728182|1036358|P1|NOT COMPLETED|Overall Study||3
434929|NCT00728182|1036357|P2|COMPLETED|Overall Study||90
434930|NCT00728182|1036358|P1|COMPLETED|Overall Study||89
434931|NCT00728182|1036357|P2|STARTED|Overall Study||93
434932|NCT00728182|1036358|P1|STARTED|Overall Study||92
434933|NCT00728130|1036386|P1|NOT COMPLETED|Overall Study||3
434934|NCT00728130|1036386|P1|COMPLETED|Overall Study||19
434935|NCT00728130|1036386|P1|STARTED|Overall Study||22
434936|NCT00727961|1036391|P1|NOT COMPLETED|Overall Study||37
434937|NCT00727961|1036391|P1|COMPLETED|Overall Study||21
434938|NCT00727961|1036391|P1|STARTED|Overall Study||58
434939|NCT00727909|1036401|P4|NOT COMPLETED|Overall Study||5
434940|NCT00727909|1036402|P3|NOT COMPLETED|Overall Study||9
434941|NCT00727909|1036403|P2|NOT COMPLETED|Overall Study||11
434942|NCT00727909|1036404|P1|NOT COMPLETED|Overall Study||5
434943|NCT00727909|1036401|P4|COMPLETED|Overall Study||70
434944|NCT00727909|1036402|P3|COMPLETED|Overall Study||58
434945|NCT00727909|1036403|P2|COMPLETED|Overall Study||61
434946|NCT00727909|1036404|P1|COMPLETED|Overall Study||60
434947|NCT00727909|1036401|P4|STARTED|Overall Study||75
434948|NCT00727909|1036402|P3|STARTED|Overall Study||67
434949|NCT00727909|1036403|P2|STARTED|Overall Study||72
434950|NCT00727909|1036404|P1|STARTED|Overall Study||65
434951|NCT00727857|1036411|P3|NOT COMPLETED|Overall Study||68
434952|NCT00727857|1036412|P2|NOT COMPLETED|Overall Study||64
434953|NCT00727857|1036413|P1|NOT COMPLETED|Overall Study||44
434954|NCT00727857|1036411|P3|COMPLETED|Overall Study||142
434955|NCT00727857|1036412|P2|COMPLETED|Overall Study||125
434956|NCT00727857|1036413|P1|COMPLETED|Overall Study||157
434957|NCT00727857|1036411|P3|STARTED|Overall Study||210
434958|NCT00727857|1036412|P2|STARTED|Overall Study||189
434959|NCT00727857|1036413|P1|STARTED|Overall Study||201
434960|NCT00727844|1036501|P4|NOT COMPLETED|Second Randomization||0
434961|NCT00727844|1036502|P3|NOT COMPLETED|Second Randomization||0
434962|NCT00727844|1036503|P2|NOT COMPLETED|Second Randomization||0
434963|NCT00727844|1036504|P1|NOT COMPLETED|Second Randomization||0
434964|NCT00727844|1036501|P4|COMPLETED|Second Randomization||16
434965|NCT00727844|1036502|P3|COMPLETED|Second Randomization||17
434966|NCT00727844|1036503|P2|COMPLETED|Second Randomization||0
434967|NCT00727844|1036504|P1|COMPLETED|Second Randomization||0
434968|NCT00727844|1036501|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
434969|NCT00727844|1036502|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
434970|NCT00727844|1036503|P2|STARTED|Second Randomization||0
434971|NCT00727844|1036504|P1|STARTED|Second Randomization||0
434972|NCT00727844|1036501|P4|NOT COMPLETED|Initial Randomization||0
434973|NCT00727844|1036502|P3|NOT COMPLETED|Initial Randomization||0
434974|NCT00727844|1036503|P2|NOT COMPLETED|Initial Randomization||0
434975|NCT00727844|1036504|P1|NOT COMPLETED|Initial Randomization||2
434976|NCT00727844|1036501|P4|COMPLETED|Initial Randomization||0
434977|NCT00727844|1036502|P3|COMPLETED|Initial Randomization||0
434978|NCT00727844|1036503|P2|COMPLETED|Initial Randomization||20
434979|NCT00727844|1036504|P1|COMPLETED|Initial Randomization||19
434980|NCT00727844|1036501|P4|Included in MITT Analysis|Initial Randomization||0
434981|NCT00727844|1036502|P3|Included in MITT Analysis|Initial Randomization||0
434982|NCT00727844|1036503|P2|Included in MITT Analysis|Initial Randomization||20
434983|NCT00727844|1036504|P1|Included in MITT Analysis|Initial Randomization||19
434984|NCT00727844|1036501|P4|STARTED|Initial Randomization||0
434985|NCT00727844|1036502|P3|STARTED|Initial Randomization||0
434986|NCT00727844|1036503|P2|STARTED|Initial Randomization||20
434987|NCT00727844|1036504|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
434988|NCT00726752|1036509|P1|NOT COMPLETED|Overall Study||6
434989|NCT00726752|1036509|P1|COMPLETED|Overall Study||0
434990|NCT00726752|1036509|P1|STARTED|Overall Study||6
434991|NCT00726739|1036525|P2|NOT COMPLETED|Overall Study||0
434992|NCT00726739|1036526|P1|NOT COMPLETED|Overall Study||1
434993|NCT00726739|1036525|P2|COMPLETED|Overall Study||10
434994|NCT00726739|1036526|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
434995|NCT00726739|1036525|P2|STARTED|Overall Study||10
434996|NCT00726739|1036526|P1|STARTED|Overall Study||11
434997|NCT00726713|1036542|P2|NOT COMPLETED|Overall Study||7
434998|NCT00726713|1036543|P1|NOT COMPLETED|Overall Study||7
434999|NCT00726713|1036542|P2|COMPLETED|Overall Study||101
435000|NCT00726713|1036543|P1|COMPLETED|Overall Study||99
435001|NCT00726713|1036542|P2|STARTED|Overall Study||108
435002|NCT00726713|1036543|P1|STARTED|Overall Study||106
435003|NCT00727740|1036571|P2|NOT COMPLETED|Overall Study||0
435004|NCT00727740|1036572|P1|NOT COMPLETED|Overall Study||0
435005|NCT00727740|1036571|P2|COMPLETED|Overall Study||61
435006|NCT00727740|1036572|P1|COMPLETED|Overall Study||56
435007|NCT00727740|1036571|P2|STARTED|Overall Study||61
435008|NCT00727740|1036572|P1|STARTED|Overall Study||56
435009|NCT00727714|1036578|P1|NOT COMPLETED|Overall Study||2
435010|NCT00727714|1036578|P1|COMPLETED|Overall Study||93
435011|NCT00727714|1036578|P1|STARTED|Overall Study||95
435012|NCT00727649|1036588|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
435013|NCT00727649|1036589|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
435014|NCT00727649|1036588|P2|COMPLETED|Second Intervention (4-weeks)||34
435015|NCT00727649|1036589|P1|COMPLETED|Second Intervention (4-weeks)||29
435016|NCT00727649|1036588|P2|STARTED|Second Intervention (4-weeks)||37
435017|NCT00727649|1036589|P1|STARTED|Second Intervention (4-weeks)||30
435018|NCT00727649|1036588|P2|NOT COMPLETED|Wash-out (2-weeks)||3
435019|NCT00727649|1036589|P1|NOT COMPLETED|Wash-out (2-weeks)||4
435020|NCT00727649|1036588|P2|COMPLETED|Wash-out (2-weeks)||37
435021|NCT00727649|1036589|P1|COMPLETED|Wash-out (2-weeks)||30
435022|NCT00727649|1036588|P2|STARTED|Wash-out (2-weeks)||40
435023|NCT00727649|1036589|P1|STARTED|Wash-out (2-weeks)||34
435024|NCT00727649|1036588|P2|NOT COMPLETED|First Intervention (4-weeks)||3
435025|NCT00727649|1036589|P1|NOT COMPLETED|First Intervention (4-weeks)||3
435026|NCT00727649|1036588|P2|COMPLETED|First Intervention (4-weeks)||40
435027|NCT00727649|1036589|P1|COMPLETED|First Intervention (4-weeks)||34
435028|NCT00727649|1036588|P2|STARTED|First Intervention (4-weeks)||43
435029|NCT00727649|1036589|P1|STARTED|First Intervention (4-weeks)||37
435030|NCT00727636|1036603|P2|NOT COMPLETED|Overall Study||0
435031|NCT00727636|1036604|P1|NOT COMPLETED|Overall Study||4
435032|NCT00727636|1036603|P2|COMPLETED|Overall Study||15
435033|NCT00727636|1036604|P1|COMPLETED|Overall Study||33
435034|NCT00727636|1036603|P2|STARTED|Overall Study||15
435035|NCT00727636|1036604|P1|STARTED|Overall Study||37
435036|NCT00727597|1036618|P2|NOT COMPLETED|Overall Study||0
435037|NCT00727597|1036619|P1|NOT COMPLETED|Overall Study||0
435038|NCT00727597|1036618|P2|COMPLETED|Overall Study||50
435039|NCT00727597|1036619|P1|COMPLETED|Overall Study||51
435040|NCT00727597|1036618|P2|STARTED|Overall Study||50
435041|NCT00727597|1036619|P1|STARTED|Overall Study||51
435042|NCT00727571|1036631|P4|NOT COMPLETED|Overall Study||6
435043|NCT00727571|1036632|P3|NOT COMPLETED|Overall Study||30
435044|NCT00727571|1036633|P2|NOT COMPLETED|Overall Study||55
435045|NCT00727571|1036634|P1|NOT COMPLETED|Overall Study||1
435046|NCT00727571|1036631|P4|COMPLETED|Overall Study||163
435047|NCT00727571|1036632|P3|COMPLETED|Overall Study||135
435048|NCT00727571|1036633|P2|COMPLETED|Overall Study||173
435049|NCT00727571|1036634|P1|COMPLETED|Overall Study||231
435050|NCT00727571|1036631|P4|STARTED|Overall Study||169
435051|NCT00727571|1036632|P3|STARTED|Overall Study||165
435052|NCT00727571|1036633|P2|STARTED|Overall Study||228
435053|NCT00727571|1036634|P1|STARTED|Overall Study||232
435054|NCT00727558|1036661|P2|NOT COMPLETED|Overall Study||3
435055|NCT00727558|1036662|P1|NOT COMPLETED|Overall Study||2
435056|NCT00727558|1036661|P2|COMPLETED|Overall Study||118
435057|NCT00727558|1036662|P1|COMPLETED|Overall Study||125
435058|NCT00727558|1036661|P2|STARTED|Overall Study||121
435059|NCT00727558|1036662|P1|STARTED|Overall Study||127
435060|NCT00727506|1036686|P6|NOT COMPLETED|Overall Study||37
435061|NCT00727506|1036687|P5|NOT COMPLETED|Overall Study||40
435062|NCT00727506|1036688|P4|NOT COMPLETED|Overall Study||38
435063|NCT00727506|1036689|P3|NOT COMPLETED|Overall Study||18
435064|NCT00727506|1036690|P2|NOT COMPLETED|Overall Study||8
435065|NCT00727506|1036691|P1|NOT COMPLETED|Overall Study||6
435066|NCT00727506|1036686|P6|COMPLETED|Overall Study|On treatment at data cutoff May 12, 2011|2
435067|NCT00727506|1036687|P5|COMPLETED|Overall Study|On treatment at data cutoff May 12, 2011|1
435068|NCT00727506|1036688|P4|COMPLETED|Overall Study|On treatment at data cutoff May 12, 2011|1
435069|NCT00727506|1036689|P3|COMPLETED|Overall Study||0
435070|NCT00727506|1036690|P2|COMPLETED|Overall Study||0
435071|NCT00727506|1036691|P1|COMPLETED|Overall Study||0
435072|NCT00727506|1036686|P6|STARTED|Overall Study|Randomized|39
435073|NCT00727506|1036687|P5|STARTED|Overall Study|Randomized|41
435074|NCT00727506|1036688|P4|STARTED|Overall Study|Randomized|39
435075|NCT00727506|1036689|P3|STARTED|Overall Study|Entered|18
435076|NCT00727506|1036690|P2|STARTED|Overall Study|Entered|8
435077|NCT00727506|1036691|P1|STARTED|Overall Study|Entered|6
435078|NCT00727402|1036711|P1|NOT COMPLETED|Overall Study||116
435079|NCT00727402|1036711|P1|COMPLETED|Overall Study||89
435080|NCT00727402|1036711|P1|STARTED|Overall Study||205
435081|NCT00727337|1036719|P4|NOT COMPLETED|Overall Study||7
435082|NCT00727337|1036720|P3|NOT COMPLETED|Overall Study||9
435083|NCT00727337|1036721|P2|NOT COMPLETED|Overall Study||10
435084|NCT00727337|1036722|P1|NOT COMPLETED|Overall Study||10
435085|NCT00727337|1036719|P4|COMPLETED|Overall Study||61
435086|NCT00727337|1036720|P3|COMPLETED|Overall Study||64
435087|NCT00727337|1036721|P2|COMPLETED|Overall Study||63
435088|NCT00727337|1036722|P1|COMPLETED|Overall Study||55
435089|NCT00727337|1036719|P4|STARTED|Overall Study||68
435090|NCT00727337|1036720|P3|STARTED|Overall Study||73
435091|NCT00727337|1036721|P2|STARTED|Overall Study||73
435092|NCT00727337|1036722|P1|STARTED|Overall Study||65
435093|NCT00727311|1036732|P1|NOT COMPLETED|Overall Study||1107
435094|NCT00727311|1036732|P1|COMPLETED|Overall Study||1195
435095|NCT00727311|1036732|P1|STARTED|Overall Study||2302
435096|NCT00727298|1036739|P1|NOT COMPLETED|Overall Study||1257
435097|NCT00727298|1036739|P1|COMPLETED|Overall Study||3228
435098|NCT00727298|1036739|P1|STARTED|Overall Study||4485
435099|NCT00727272|1036745|P3|NOT COMPLETED|Period III||0
435100|NCT00727272|1036746|P2|NOT COMPLETED|Period III||0
435101|NCT00727272|1036747|P1|NOT COMPLETED|Period III||0
435102|NCT00727272|1036745|P3|COMPLETED|Period III||7
435103|NCT00727272|1036746|P2|COMPLETED|Period III||9
435104|NCT00727272|1036747|P1|COMPLETED|Period III||9
435105|NCT00727272|1036745|P3|STARTED|Period III||7
435106|NCT00727272|1036746|P2|STARTED|Period III||9
435107|NCT00727272|1036747|P1|STARTED|Period III||9
435108|NCT00727272|1036745|P3|NOT COMPLETED|Washout Period B||1
435109|NCT00727272|1036746|P2|NOT COMPLETED|Washout Period B||0
435110|NCT00727272|1036747|P1|NOT COMPLETED|Washout Period B||0
435111|NCT00727272|1036745|P3|COMPLETED|Washout Period B|personal reasons|7
435112|NCT00727272|1036746|P2|COMPLETED|Washout Period B||9
435113|NCT00727272|1036747|P1|COMPLETED|Washout Period B||9
435114|NCT00727272|1036745|P3|STARTED|Washout Period B||8
435115|NCT00727272|1036746|P2|STARTED|Washout Period B||9
435116|NCT00727272|1036747|P1|STARTED|Washout Period B||9
435117|NCT00727272|1036745|P3|NOT COMPLETED|Period II||0
435118|NCT00727272|1036746|P2|NOT COMPLETED|Period II||0
435119|NCT00727272|1036747|P1|NOT COMPLETED|Period II||0
435120|NCT00727272|1036745|P3|COMPLETED|Period II||8
435121|NCT00727272|1036746|P2|COMPLETED|Period II||9
435122|NCT00727272|1036747|P1|COMPLETED|Period II||9
435123|NCT00727272|1036745|P3|STARTED|Period II||8
435124|NCT00727272|1036746|P2|STARTED|Period II||9
435125|NCT00727272|1036747|P1|STARTED|Period II||9
435126|NCT00727272|1036745|P3|NOT COMPLETED|Washout Period A||1
435127|NCT00727272|1036746|P2|NOT COMPLETED|Washout Period A||0
435128|NCT00727272|1036747|P1|NOT COMPLETED|Washout Period A||0
435129|NCT00727272|1036745|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
435130|NCT00727272|1036746|P2|COMPLETED|Washout Period A||9
435131|NCT00727272|1036747|P1|COMPLETED|Washout Period A||9
435132|NCT00727272|1036745|P3|STARTED|Washout Period A||9
435133|NCT00727272|1036746|P2|STARTED|Washout Period A||9
435134|NCT00727272|1036747|P1|STARTED|Washout Period A||9
435135|NCT00727272|1036745|P3|NOT COMPLETED|Period I||0
435136|NCT00727272|1036746|P2|NOT COMPLETED|Period I||0
435137|NCT00727272|1036747|P1|NOT COMPLETED|Period I||0
435138|NCT00727272|1036745|P3|COMPLETED|Period I||9
435139|NCT00727272|1036746|P2|COMPLETED|Period I||9
435140|NCT00727272|1036747|P1|COMPLETED|Period I||9
435141|NCT00727272|1036745|P3|STARTED|Period I||9
435142|NCT00727272|1036746|P2|STARTED|Period I||9
435143|NCT00727272|1036747|P1|STARTED|Period I||9
435144|NCT00727259|1036764|P1|NOT COMPLETED|Overall Study||1055
435145|NCT00727259|1036764|P1|COMPLETED|Overall Study||940
435146|NCT00727259|1036764|P1|STARTED|Overall Study||1995
435147|NCT00727220|1036771|P2|NOT COMPLETED|Overall Study||4
435148|NCT00727220|1036772|P1|NOT COMPLETED|Overall Study||1
435149|NCT00727220|1036771|P2|COMPLETED|Overall Study||17
435150|NCT00727220|1036772|P1|COMPLETED|Overall Study||20
435151|NCT00727220|1036771|P2|STARTED|Overall Study||21
435152|NCT00727220|1036772|P1|STARTED|Overall Study||21
435153|NCT00727194|1036778|P3|NOT COMPLETED|Treatment Period 2||0
435154|NCT00727194|1036779|P2|NOT COMPLETED|Treatment Period 2||1
435155|NCT00727194|1036780|P1|NOT COMPLETED|Treatment Period 2||0
435156|NCT00727194|1036778|P3|COMPLETED|Treatment Period 2||0
435157|NCT00727194|1036779|P2|COMPLETED|Treatment Period 2||5
435158|NCT00727194|1036780|P1|COMPLETED|Treatment Period 2||6
435159|NCT00727194|1036778|P3|STARTED|Treatment Period 2||0
435160|NCT00727194|1036779|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
435161|NCT00727194|1036780|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
435162|NCT00727194|1036778|P3|NOT COMPLETED|Washout Period||0
435163|NCT00727194|1036779|P2|NOT COMPLETED|Washout Period||0
435164|NCT00727194|1036780|P1|NOT COMPLETED|Washout Period||0
435165|NCT00727194|1036778|P3|COMPLETED|Washout Period||0
435166|NCT00727194|1036779|P2|COMPLETED|Washout Period||7
435167|NCT00727194|1036780|P1|COMPLETED|Washout Period||7
435168|NCT00727194|1036778|P3|STARTED|Washout Period||0
435169|NCT00727194|1036779|P2|STARTED|Washout Period||7
435170|NCT00727194|1036780|P1|STARTED|Washout Period||7
435171|NCT00727194|1036778|P3|NOT COMPLETED|Treatment Period 1||0
435172|NCT00727194|1036779|P2|NOT COMPLETED|Treatment Period 1||0
435173|NCT00727194|1036780|P1|NOT COMPLETED|Treatment Period 1||0
435174|NCT00727194|1036778|P3|COMPLETED|Treatment Period 1||0
435175|NCT00727194|1036779|P2|COMPLETED|Treatment Period 1||7
435176|NCT00727194|1036780|P1|COMPLETED|Treatment Period 1||7
435177|NCT00727194|1036778|P3|STARTED|Treatment Period 1||0
435178|NCT00727194|1036779|P2|STARTED|Treatment Period 1||7
435179|NCT00727194|1036780|P1|STARTED|Treatment Period 1||7
435180|NCT00727194|1036778|P3|NOT COMPLETED|Screening Period||16
435181|NCT00727194|1036779|P2|NOT COMPLETED|Screening Period||0
435182|NCT00727194|1036780|P1|NOT COMPLETED|Screening Period||0
435183|NCT00727194|1036778|P3|COMPLETED|Screening Period||0
435184|NCT00727194|1036779|P2|COMPLETED|Screening Period||7
435185|NCT00727194|1036780|P1|COMPLETED|Screening Period||7
435186|NCT00727194|1036778|P3|STARTED|Screening Period||16
435187|NCT00727194|1036779|P2|STARTED|Screening Period||7
435188|NCT00727194|1036780|P1|STARTED|Screening Period||7
435189|NCT00727090|1036816|P2|NOT COMPLETED|Overall Study||0
435190|NCT00727090|1036817|P1|NOT COMPLETED|Overall Study||0
435191|NCT00727090|1036816|P2|COMPLETED|Overall Study||3
435192|NCT00727090|1036817|P1|COMPLETED|Overall Study||3
435193|NCT00727090|1036816|P2|STARTED|Overall Study||3
435194|NCT00727090|1036817|P1|STARTED|Overall Study||3
435195|NCT00727064|1036835|P2|NOT COMPLETED|Overall Study||0
435196|NCT00727064|1036836|P1|NOT COMPLETED|Overall Study||0
435197|NCT00727064|1036835|P2|COMPLETED|Overall Study||7
435198|NCT00727064|1036836|P1|COMPLETED|Overall Study||7
435199|NCT00727064|1036835|P2|STARTED|Overall Study||7
435200|NCT00727064|1036836|P1|STARTED|Overall Study||7
435201|NCT00727025|1036852|P1|NOT COMPLETED|Overall Study||23
435202|NCT00727025|1036852|P1|COMPLETED|Overall Study||51
435203|NCT00727025|1036852|P1|STARTED|Overall Study||74
435204|NCT00726999|1036864|P2|NOT COMPLETED|Overall Study||1
435205|NCT00726999|1036865|P1|NOT COMPLETED|Overall Study||3
435206|NCT00726999|1036864|P2|COMPLETED|Overall Study||30
435207|NCT00726999|1036865|P1|COMPLETED|Overall Study||29
435208|NCT00726999|1036864|P2|STARTED|Overall Study||31
435209|NCT00726999|1036865|P1|STARTED|Overall Study||32
435210|NCT00726661|1036877|P2|NOT COMPLETED|Overall Study||418
435211|NCT00726661|1036878|P1|NOT COMPLETED|Overall Study||814
435212|NCT00726661|1036877|P2|COMPLETED|Overall Study||17
435213|NCT00726661|1036878|P1|COMPLETED|Overall Study||18
435214|NCT00726661|1036877|P2|STARTED|Overall Study||435
435215|NCT00726661|1036878|P1|STARTED|Overall Study||832
435216|NCT00726622|1036895|P2|NOT COMPLETED|Overall Study||3
435217|NCT00726622|1036896|P1|NOT COMPLETED|Overall Study||18
435218|NCT00726622|1036895|P2|COMPLETED|Overall Study||240
435219|NCT00726622|1036896|P1|COMPLETED|Overall Study||225
435220|NCT00726622|1036895|P2|STARTED|Overall Study||243
435221|NCT00726622|1036896|P1|STARTED|Overall Study||243
435222|NCT00726609|1036914|P1|NOT COMPLETED|Overall Study||98
435223|NCT00726609|1036914|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
435224|NCT00726609|1036914|P1|STARTED|Overall Study||214
435225|NCT00726557|1036918|P1|NOT COMPLETED|Overall Study||128
435226|NCT00726557|1036918|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
435227|NCT00726557|1036918|P1|STARTED|Overall Study||246
435228|NCT00726453|1036925|P2|NOT COMPLETED|38 mm Length Group||3
435229|NCT00726453|1036926|P1|NOT COMPLETED|38 mm Length Group||0
435230|NCT00726453|1036925|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
435231|NCT00726453|1036926|P1|COMPLETED|38 mm Length Group||0
435232|NCT00726453|1036925|P2|STARTED|38 mm Length Group||114
435233|NCT00726453|1036926|P1|STARTED|38 mm Length Group||0
435234|NCT00726453|1036925|P2|NOT COMPLETED|Primary Enrollment Group||0
435235|NCT00726453|1036926|P1|NOT COMPLETED|Primary Enrollment Group||31
435236|NCT00726453|1036925|P2|COMPLETED|Primary Enrollment Group||0
435237|NCT00726453|1036926|P1|COMPLETED|Primary Enrollment Group||1371
435238|NCT00726453|1036925|P2|STARTED|Primary Enrollment Group||0
435239|NCT00726453|1036926|P1|STARTED|Primary Enrollment Group||1402
435240|NCT00726414|1036936|P2|NOT COMPLETED|Second Intervention||0
435241|NCT00726414|1036937|P1|NOT COMPLETED|Second Intervention||0
435242|NCT00726414|1036936|P2|COMPLETED|Second Intervention||11
435243|NCT00726414|1036937|P1|COMPLETED|Second Intervention||11
435244|NCT00726414|1036936|P2|STARTED|Second Intervention||11
435245|NCT00726414|1036937|P1|STARTED|Second Intervention||11
435246|NCT00726414|1036936|P2|NOT COMPLETED|Washout Period of 7 Days||0
435247|NCT00726414|1036937|P1|NOT COMPLETED|Washout Period of 7 Days||0
435248|NCT00726414|1036936|P2|COMPLETED|Washout Period of 7 Days||11
435249|NCT00726414|1036937|P1|COMPLETED|Washout Period of 7 Days||11
435250|NCT00726414|1036936|P2|STARTED|Washout Period of 7 Days||11
435251|NCT00726414|1036937|P1|STARTED|Washout Period of 7 Days||11
435252|NCT00726414|1036936|P2|NOT COMPLETED|First Intervention||0
435253|NCT00726414|1036937|P1|NOT COMPLETED|First Intervention||0
435254|NCT00726414|1036936|P2|COMPLETED|First Intervention||11
435255|NCT00726414|1036937|P1|COMPLETED|First Intervention||11
435256|NCT00726414|1036936|P2|STARTED|First Intervention||11
435257|NCT00726414|1036937|P1|STARTED|First Intervention||11
435258|NCT00726375|1036947|P1|NOT COMPLETED|Overall Study||0
435259|NCT00726375|1036947|P1|COMPLETED|Overall Study||34
435260|NCT00726375|1036947|P1|STARTED|Overall Study||34
435261|NCT00726232|1036958|P6|NOT COMPLETED|Overall Study||4
435262|NCT00726232|1036959|P5|NOT COMPLETED|Overall Study||5
435263|NCT00726232|1036960|P4|NOT COMPLETED|Overall Study||1
435264|NCT00726232|1036961|P3|NOT COMPLETED|Overall Study||0
435265|NCT00726232|1036962|P2|NOT COMPLETED|Overall Study||1
435266|NCT00726232|1036963|P1|NOT COMPLETED|Overall Study||5
435267|NCT00726232|1036958|P6|COMPLETED|Overall Study||5
435268|NCT00726232|1036959|P5|COMPLETED|Overall Study||17
435269|NCT00726232|1036960|P4|COMPLETED|Overall Study||7
435270|NCT00726232|1036961|P3|COMPLETED|Overall Study||7
435271|NCT00726232|1036962|P2|COMPLETED|Overall Study||7
435272|NCT00726232|1036963|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
435273|NCT00726232|1036958|P6|STARTED|Overall Study||9
435274|NCT00726232|1036959|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
435275|NCT00726232|1036960|P4|STARTED|Overall Study||8
435276|NCT00726232|1036961|P3|STARTED|Overall Study||7
435277|NCT00726232|1036962|P2|STARTED|Overall Study||8
435278|NCT00726232|1036963|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
435279|NCT00726180|1037007|P1|NOT COMPLETED|Overall Study||0
435280|NCT00726180|1037007|P1|COMPLETED|Overall Study||1
435281|NCT00726180|1037007|P1|STARTED|Overall Study||1
435282|NCT00726063|1037013|P2|NOT COMPLETED|Overall Study||7
435283|NCT00726063|1037014|P1|NOT COMPLETED|Overall Study||9
435284|NCT00726063|1037013|P2|COMPLETED|Overall Study|Number of implants = 239|112
435285|NCT00726063|1037014|P1|COMPLETED|Overall Study|Number of implants =230|113
435286|NCT00726063|1037013|P2|STARTED|Overall Study|Number of implants= 246|119
435287|NCT00726063|1037014|P1|STARTED|Overall Study|Number of implants= 239|122
435288|NCT00726037|1037020|P1|NOT COMPLETED|Overall Study||0
435289|NCT00726037|1037020|P1|COMPLETED|Overall Study||7
435290|NCT00726037|1037020|P1|STARTED|Overall Study||7
435291|NCT00725985|1037028|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
435292|NCT00725985|1037029|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
435293|NCT00725985|1037030|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
435294|NCT00725985|1037031|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435295|NCT00725985|1037032|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435296|NCT00725985|1037033|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435297|NCT00725985|1037034|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435298|NCT00725985|1037035|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435299|NCT00725985|1037036|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435300|NCT00725985|1037037|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435301|NCT00725985|1037038|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435302|NCT00725985|1037039|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
435303|NCT00725985|1037028|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
435304|NCT00725985|1037029|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
435305|NCT00725985|1037030|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
435306|NCT00725985|1037031|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
435307|NCT00725985|1037032|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
435308|NCT00725985|1037033|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
435309|NCT00725985|1037034|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
435310|NCT00725985|1037035|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
435311|NCT00725985|1037036|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
435312|NCT00725985|1037037|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
435313|NCT00725985|1037038|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
435314|NCT00725985|1037039|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
435315|NCT00725985|1037028|P12|STARTED|LTFU (No Cladribine Treatment)||14
435316|NCT00725985|1037029|P11|STARTED|LTFU (No Cladribine Treatment)||36
435317|NCT00725985|1037030|P10|STARTED|LTFU (No Cladribine Treatment)||34
435318|NCT00725985|1037031|P9|STARTED|LTFU (No Cladribine Treatment)||0
435319|NCT00725985|1037032|P8|STARTED|LTFU (No Cladribine Treatment)||0
435320|NCT00725985|1037033|P7|STARTED|LTFU (No Cladribine Treatment)||0
435321|NCT00725985|1037034|P6|STARTED|LTFU (No Cladribine Treatment)||0
435322|NCT00725985|1037035|P5|STARTED|LTFU (No Cladribine Treatment)||0
435323|NCT00725985|1037036|P4|STARTED|LTFU (No Cladribine Treatment)||0
435324|NCT00725985|1037037|P3|STARTED|LTFU (No Cladribine Treatment)||0
435325|NCT00725985|1037038|P2|STARTED|LTFU (No Cladribine Treatment)||0
435326|NCT00725985|1037039|P1|STARTED|LTFU (No Cladribine Treatment)||0
435327|NCT00725985|1037028|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435328|NCT00725985|1037029|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435329|NCT00725985|1037030|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435330|NCT00725985|1037031|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
435331|NCT00725985|1037032|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
435332|NCT00725985|1037033|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
435333|NCT00725985|1037034|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435334|NCT00725985|1037035|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435335|NCT00725985|1037036|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435336|NCT00725985|1037037|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435337|NCT00725985|1037038|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435338|NCT00725985|1037039|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
435339|NCT00725985|1037028|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
435340|NCT00725985|1037029|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
435341|NCT00725985|1037030|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
435342|NCT00725985|1037031|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
435343|NCT00725985|1037032|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
435344|NCT00725985|1037033|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
435345|NCT00725985|1037034|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
435346|NCT00725985|1037035|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
435347|NCT00725985|1037036|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
435348|NCT00725985|1037037|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
435349|NCT00725985|1037038|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
435350|NCT00725985|1037039|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
435351|NCT00725985|1037028|P12|STARTED|LTFU (With Cladribine Treatment)||0
435352|NCT00725985|1037029|P11|STARTED|LTFU (With Cladribine Treatment)||0
435353|NCT00725985|1037030|P10|STARTED|LTFU (With Cladribine Treatment)||0
435354|NCT00725985|1037031|P9|STARTED|LTFU (With Cladribine Treatment)||17
435355|NCT00725985|1037032|P8|STARTED|LTFU (With Cladribine Treatment)||9
435356|NCT00725985|1037033|P7|STARTED|LTFU (With Cladribine Treatment)||9
435357|NCT00725985|1037034|P6|STARTED|LTFU (With Cladribine Treatment)||0
435358|NCT00725985|1037035|P5|STARTED|LTFU (With Cladribine Treatment)||0
435359|NCT00725985|1037036|P4|STARTED|LTFU (With Cladribine Treatment)||0
435360|NCT00725985|1037037|P3|STARTED|LTFU (With Cladribine Treatment)||0
435361|NCT00725985|1037038|P2|STARTED|LTFU (With Cladribine Treatment)||0
435362|NCT00725985|1037039|P1|STARTED|LTFU (With Cladribine Treatment)||0
435363|NCT00725985|1037028|P12|NOT COMPLETED|OLMP||0
435364|NCT00725985|1037029|P11|NOT COMPLETED|OLMP||0
435365|NCT00725985|1037030|P10|NOT COMPLETED|OLMP||0
435366|NCT00725985|1037031|P9|NOT COMPLETED|OLMP||0
435367|NCT00725985|1037032|P8|NOT COMPLETED|OLMP||0
435368|NCT00725985|1037033|P7|NOT COMPLETED|OLMP||0
435369|NCT00725985|1037034|P6|NOT COMPLETED|OLMP||53
435370|NCT00725985|1037035|P5|NOT COMPLETED|OLMP||23
435371|NCT00725985|1037036|P4|NOT COMPLETED|OLMP||18
435372|NCT00725985|1037037|P3|NOT COMPLETED|OLMP||0
435373|NCT00725985|1037038|P2|NOT COMPLETED|OLMP||0
435374|NCT00725985|1037039|P1|NOT COMPLETED|OLMP||0
435375|NCT00725985|1037028|P12|COMPLETED|OLMP||0
435376|NCT00725985|1037029|P11|COMPLETED|OLMP||0
435377|NCT00725985|1037030|P10|COMPLETED|OLMP||0
435378|NCT00725985|1037031|P9|COMPLETED|OLMP||0
435379|NCT00725985|1037032|P8|COMPLETED|OLMP||0
435380|NCT00725985|1037033|P7|COMPLETED|OLMP||0
435381|NCT00725985|1037034|P6|COMPLETED|OLMP||7
435382|NCT00725985|1037035|P5|COMPLETED|OLMP||2
435383|NCT00725985|1037036|P4|COMPLETED|OLMP||6
435384|NCT00725985|1037037|P3|COMPLETED|OLMP||0
435385|NCT00725985|1037038|P2|COMPLETED|OLMP||0
435386|NCT00725985|1037039|P1|COMPLETED|OLMP||0
435387|NCT00725985|1037028|P12|STARTED|OLMP||0
435388|NCT00725985|1037029|P11|STARTED|OLMP||0
435389|NCT00725985|1037030|P10|STARTED|OLMP||0
435390|NCT00725985|1037031|P9|STARTED|OLMP||0
435391|NCT00725985|1037032|P8|STARTED|OLMP||0
435392|NCT00725985|1037033|P7|STARTED|OLMP||0
435393|NCT00725985|1037034|P6|STARTED|OLMP||60
435394|NCT00725985|1037035|P5|STARTED|OLMP||25
435395|NCT00725985|1037036|P4|STARTED|OLMP||24
435396|NCT00725985|1037037|P3|STARTED|OLMP||0
435397|NCT00725985|1037038|P2|STARTED|OLMP||0
435398|NCT00725985|1037039|P1|STARTED|OLMP||0
435399|NCT00725985|1037028|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435400|NCT00725985|1037029|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435401|NCT00725985|1037030|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435402|NCT00725985|1037031|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435403|NCT00725985|1037032|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435404|NCT00725985|1037033|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435405|NCT00725985|1037034|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435406|NCT00725985|1037035|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435407|NCT00725985|1037036|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
435408|NCT00725985|1037037|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
435409|NCT00725985|1037038|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
435410|NCT00725985|1037039|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
435411|NCT00725985|1037028|P12|COMPLETED|ITP (Up to 96 Weeks)||0
435412|NCT00725985|1037029|P11|COMPLETED|ITP (Up to 96 Weeks)||0
435413|NCT00725985|1037030|P10|COMPLETED|ITP (Up to 96 Weeks)||0
435414|NCT00725985|1037031|P9|COMPLETED|ITP (Up to 96 Weeks)||0
435415|NCT00725985|1037032|P8|COMPLETED|ITP (Up to 96 Weeks)||0
435416|NCT00725985|1037033|P7|COMPLETED|ITP (Up to 96 Weeks)||0
435417|NCT00725985|1037034|P6|COMPLETED|ITP (Up to 96 Weeks)||0
435418|NCT00725985|1037035|P5|COMPLETED|ITP (Up to 96 Weeks)||0
435419|NCT00725985|1037036|P4|COMPLETED|ITP (Up to 96 Weeks)||0
435420|NCT00725985|1037037|P3|COMPLETED|ITP (Up to 96 Weeks)||104
435421|NCT00725985|1037038|P2|COMPLETED|ITP (Up to 96 Weeks)||131
435422|NCT00725985|1037039|P1|COMPLETED|ITP (Up to 96 Weeks)||104
435423|NCT00725985|1037028|P12|Treated|ITP (Up to 96 Weeks)||0
435424|NCT00725985|1037029|P11|Treated|ITP (Up to 96 Weeks)||0
435425|NCT00725985|1037030|P10|Treated|ITP (Up to 96 Weeks)||0
435426|NCT00725985|1037031|P9|Treated|ITP (Up to 96 Weeks)||0
435427|NCT00725985|1037032|P8|Treated|ITP (Up to 96 Weeks)||0
435428|NCT00725985|1037033|P7|Treated|ITP (Up to 96 Weeks)||0
435429|NCT00725985|1037034|P6|Treated|ITP (Up to 96 Weeks)||0
435430|NCT00725985|1037035|P5|Treated|ITP (Up to 96 Weeks)||0
435431|NCT00725985|1037036|P4|Treated|ITP (Up to 96 Weeks)||0
435432|NCT00725985|1037037|P3|Treated|ITP (Up to 96 Weeks)||206
435433|NCT00725985|1037038|P2|Treated|ITP (Up to 96 Weeks)||206
435434|NCT00725985|1037039|P1|Treated|ITP (Up to 96 Weeks)||204
435435|NCT00725985|1037028|P12|STARTED|ITP (Up to 96 Weeks)||0
435436|NCT00725985|1037029|P11|STARTED|ITP (Up to 96 Weeks)||0
435437|NCT00725985|1037030|P10|STARTED|ITP (Up to 96 Weeks)||0
435438|NCT00725985|1037031|P9|STARTED|ITP (Up to 96 Weeks)||0
435439|NCT00725985|1037032|P8|STARTED|ITP (Up to 96 Weeks)||0
435440|NCT00725985|1037033|P7|STARTED|ITP (Up to 96 Weeks)||0
435441|NCT00725985|1037034|P6|STARTED|ITP (Up to 96 Weeks)||0
435442|NCT00725985|1037035|P5|STARTED|ITP (Up to 96 Weeks)||0
435443|NCT00725985|1037036|P4|STARTED|ITP (Up to 96 Weeks)||0
435444|NCT00725985|1037037|P3|STARTED|ITP (Up to 96 Weeks)||206
435445|NCT00725985|1037038|P2|STARTED|ITP (Up to 96 Weeks)||206
435446|NCT00725985|1037039|P1|STARTED|ITP (Up to 96 Weeks)||205
435447|NCT00725920|1037067|P2|NOT COMPLETED|Overall Study||6
435448|NCT00725920|1037068|P1|NOT COMPLETED|Overall Study||3
435449|NCT00725920|1037067|P2|COMPLETED|Overall Study||12
435450|NCT00725920|1037068|P1|COMPLETED|Overall Study||14
435451|NCT00725920|1037067|P2|STARTED|Overall Study||18
435452|NCT00725920|1037068|P1|STARTED|Overall Study||17
435453|NCT00725842|1037074|P1|NOT COMPLETED|Overall Study||40
435454|NCT00725842|1037074|P1|COMPLETED|Overall Study||57
435455|NCT00725842|1037074|P1|Participants Eligible for Analysis|Overall Study||90
435456|NCT00725842|1037074|P1|STARTED|Overall Study||97
435457|NCT00725751|1037083|P2|NOT COMPLETED|Overall Study||108
435458|NCT00725751|1037084|P1|NOT COMPLETED|Overall Study||34
435459|NCT00725751|1037083|P2|COMPLETED|Overall Study||150
435460|NCT00725751|1037084|P1|COMPLETED|Overall Study||56
435461|NCT00725751|1037083|P2|STARTED|Overall Study||258
435462|NCT00725751|1037084|P1|STARTED|Overall Study||90
435463|NCT00725725|1037096|P3|NOT COMPLETED|Overall Study||5
435464|NCT00725725|1037097|P2|NOT COMPLETED|Overall Study||4
435465|NCT00725725|1037098|P1|NOT COMPLETED|Overall Study||4
435466|NCT00725725|1037096|P3|COMPLETED|Overall Study||12
435467|NCT00725725|1037097|P2|COMPLETED|Overall Study||11
435468|NCT00725725|1037098|P1|COMPLETED|Overall Study||10
435469|NCT00725725|1037096|P3|Treated|Overall Study||14
435470|NCT00725725|1037097|P2|Treated|Overall Study||15
435471|NCT00725725|1037098|P1|Treated|Overall Study||11
435472|NCT00725725|1037096|P3|STARTED|Overall Study||17
435473|NCT00725725|1037097|P2|STARTED|Overall Study||15
435474|NCT00725725|1037098|P1|STARTED|Overall Study||14
435475|NCT00725621|1037139|P1|NOT COMPLETED|Overall Study||271
435476|NCT00725621|1037139|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
435477|NCT00725621|1037139|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
435478|NCT00725608|1037162|P1|NOT COMPLETED|Overall Study||167
435479|NCT00725608|1037162|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
435480|NCT00725608|1037162|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
435481|NCT00725543|1037168|P1|NOT COMPLETED|Overall Study||153
435482|NCT00725543|1037168|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
435483|NCT00725543|1037168|P1|STARTED|Overall Study||358
435484|NCT00725530|1037177|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
435485|NCT00725530|1037178|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
435486|NCT00725530|1037177|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
435487|NCT00725530|1037178|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
435488|NCT00725530|1037177|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
435489|NCT00725530|1037178|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
435490|NCT00725530|1037177|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
435491|NCT00725530|1037178|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
435492|NCT00725530|1037177|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
435493|NCT00725530|1037178|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
435494|NCT00725530|1037177|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
435495|NCT00725530|1037178|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
435496|NCT00725504|1037184|P1|NOT COMPLETED|Overall Study||0
435497|NCT00725504|1037184|P1|COMPLETED|Overall Study||71
435498|NCT00725504|1037184|P1|STARTED|Overall Study||71
435499|NCT00725491|1037193|P2|NOT COMPLETED|Overall Study||18
435500|NCT00725491|1037194|P1|NOT COMPLETED|Overall Study||9
435501|NCT00725491|1037193|P2|COMPLETED|Overall Study||102
435502|NCT00725491|1037194|P1|COMPLETED|Overall Study||104
435503|NCT00725491|1037193|P2|STARTED|Overall Study|Intent-to-Treat Group|120
435504|NCT00725491|1037194|P1|STARTED|Overall Study|Intent-to-Treat Group|113
435505|NCT00725452|1037200|P1|NOT COMPLETED|Overall Study||11
435506|NCT00725452|1037200|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
435507|NCT00725452|1037200|P1|STARTED|Overall Study||26
435508|NCT00725361|1037209|P1|NOT COMPLETED|Overall Study||4
435509|NCT00725361|1037209|P1|COMPLETED|Overall Study||16
435510|NCT00725361|1037209|P1|STARTED|Overall Study||20
435511|NCT00725296|1037217|P1|NOT COMPLETED|Overall Study||62
435512|NCT00725296|1037217|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
435513|NCT00725296|1037217|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
435514|NCT00725270|1037228|P2|NOT COMPLETED|Overall Study||0
435515|NCT00725270|1037229|P1|NOT COMPLETED|Overall Study||0
435516|NCT00725270|1037228|P2|COMPLETED|Overall Study||7
435517|NCT00725270|1037229|P1|COMPLETED|Overall Study||5
435518|NCT00725270|1037228|P2|STARTED|Overall Study||7
435519|NCT00725270|1037229|P1|STARTED|Overall Study||5
435520|NCT00725205|1037237|P1|NOT COMPLETED|Overall Study||87
435521|NCT00725205|1037237|P1|COMPLETED|Overall Study||207
435522|NCT00725205|1037237|P1|STARTED|Overall Study||294
435523|NCT00725153|1037243|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
435524|NCT00725153|1037244|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
435525|NCT00725153|1037243|P2|COMPLETED|Period Two, 10 Hours of Wear||28
435526|NCT00725153|1037244|P1|COMPLETED|Period Two, 10 Hours of Wear||27
435527|NCT00725153|1037243|P2|STARTED|Period Two, 10 Hours of Wear||28
435528|NCT00725153|1037244|P1|STARTED|Period Two, 10 Hours of Wear||27
435529|NCT00725153|1037243|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
435530|NCT00725153|1037244|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
435531|NCT00725153|1037243|P2|COMPLETED|Period One, 10 Hours of Wear||28
435532|NCT00725153|1037244|P1|COMPLETED|Period One, 10 Hours of Wear||27
435533|NCT00725153|1037243|P2|STARTED|Period One, 10 Hours of Wear||28
435534|NCT00725153|1037244|P1|STARTED|Period One, 10 Hours of Wear||27
435535|NCT00725101|1037250|P1|NOT COMPLETED|Overall Study||495
435536|NCT00725101|1037250|P1|COMPLETED|Overall Study||1205
435537|NCT00725101|1037250|P1|STARTED|Overall Study||1700
435538|NCT00725075|1037273|P3|NOT COMPLETED|Overall Study||9
435539|NCT00725075|1037274|P2|NOT COMPLETED|Overall Study||8
435540|NCT00725075|1037275|P1|NOT COMPLETED|Overall Study||11
435541|NCT00725075|1037273|P3|COMPLETED|Overall Study||61
435542|NCT00725075|1037274|P2|COMPLETED|Overall Study||65
435543|NCT00725075|1037275|P1|COMPLETED|Overall Study||61
435544|NCT00725075|1037273|P3|Treated|Overall Study||70
435545|NCT00725075|1037274|P2|Treated|Overall Study||73
435546|NCT00725075|1037275|P1|Treated|Overall Study||71
435547|NCT00725075|1037273|P3|STARTED|Overall Study||70
435548|NCT00725075|1037274|P2|STARTED|Overall Study||73
435549|NCT00725075|1037275|P1|STARTED|Overall Study||72
435550|NCT00725049|1037321|P2|NOT COMPLETED|Overall Study||0
435551|NCT00725049|1037322|P1|NOT COMPLETED|Overall Study||0
435552|NCT00725049|1037321|P2|COMPLETED|Overall Study||20
435553|NCT00725049|1037322|P1|COMPLETED|Overall Study||17
435554|NCT00725049|1037321|P2|STARTED|Overall Study||20
435555|NCT00725049|1037322|P1|STARTED|Overall Study||17
435556|NCT00725010|1037328|P1|NOT COMPLETED|Overall Study||25
435557|NCT00725010|1037328|P1|COMPLETED|Overall Study||25
435558|NCT00725010|1037328|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
435559|NCT00724984|1037342|P6|NOT COMPLETED|Overall Study||5
435560|NCT00724984|1037343|P5|NOT COMPLETED|Overall Study||4
435561|NCT00724984|1037344|P4|NOT COMPLETED|Overall Study||2
435562|NCT00724984|1037345|P3|NOT COMPLETED|Overall Study||0
435563|NCT00724984|1037346|P2|NOT COMPLETED|Overall Study||1
435564|NCT00724984|1037347|P1|NOT COMPLETED|Overall Study||1
435565|NCT00724984|1037342|P6|COMPLETED|Overall Study||9
435566|NCT00724984|1037343|P5|COMPLETED|Overall Study||12
435567|NCT00724984|1037344|P4|COMPLETED|Overall Study||7
435568|NCT00724984|1037345|P3|COMPLETED|Overall Study||3
435569|NCT00724984|1037346|P2|COMPLETED|Overall Study||7
435570|NCT00724984|1037347|P1|COMPLETED|Overall Study||4
435571|NCT00724984|1037342|P6|STARTED|Overall Study||14
435572|NCT00724984|1037343|P5|STARTED|Overall Study||16
435573|NCT00724984|1037344|P4|STARTED|Overall Study||9
435574|NCT00724984|1037345|P3|STARTED|Overall Study||3
435575|NCT00724984|1037346|P2|STARTED|Overall Study||8
435576|NCT00724984|1037347|P1|STARTED|Overall Study||5
435577|NCT00724958|1037361|P1|NOT COMPLETED|Overall Study||182
435578|NCT00724958|1037361|P1|COMPLETED|Overall Study||166
435579|NCT00724958|1037361|P1|STARTED|Overall Study||348
435580|NCT00724945|1037370|P2|NOT COMPLETED|Period 2||0
435581|NCT00724945|1037371|P1|NOT COMPLETED|Period 2||4
435582|NCT00724945|1037370|P2|COMPLETED|Period 2||54
435583|NCT00724945|1037371|P1|COMPLETED|Period 2||51
435584|NCT00724945|1037370|P2|STARTED|Period 2||54
435585|NCT00724945|1037371|P1|STARTED|Period 2||55
435586|NCT00724945|1037370|P2|NOT COMPLETED|Period 1||1
435587|NCT00724945|1037371|P1|NOT COMPLETED|Period 1||3
435588|NCT00724945|1037370|P2|COMPLETED|Period 1||54
435589|NCT00724945|1037371|P1|COMPLETED|Period 1||55
435590|NCT00724945|1037370|P2|STARTED|Period 1||55
435591|NCT00724945|1037371|P1|STARTED|Period 1||58
435592|NCT00724932|1037383|P2|NOT COMPLETED|Overall Study||3
435593|NCT00724932|1037384|P1|NOT COMPLETED|Overall Study||5
435594|NCT00724932|1037383|P2|COMPLETED|Overall Study||67
435595|NCT00724932|1037384|P1|COMPLETED|Overall Study||65
435596|NCT00724932|1037383|P2|STARTED|Overall Study||70
435597|NCT00724932|1037384|P1|STARTED|Overall Study||70
435598|NCT00724893|1037455|P2|NOT COMPLETED|Overall Study||458
435599|NCT00724893|1037456|P1|NOT COMPLETED|Overall Study||364
435600|NCT00724893|1037455|P2|COMPLETED|Overall Study||670
435601|NCT00724893|1037456|P1|COMPLETED|Overall Study||938
435602|NCT00724893|1037455|P2|STARTED|Overall Study||1128
435603|NCT00724893|1037456|P1|STARTED|Overall Study||1302
435604|NCT00724867|1037524|P1|NOT COMPLETED|Overall Study||128
435605|NCT00724867|1037524|P1|COMPLETED|Overall Study||140
435606|NCT00724867|1037524|P1|STARTED|Overall Study||268
435607|NCT00724854|1037564|P2|NOT COMPLETED|Overall Study||31
435608|NCT00724854|1037565|P1|NOT COMPLETED|Overall Study||403
435609|NCT00724854|1037564|P2|COMPLETED|Overall Study||41
435610|NCT00724854|1037565|P1|COMPLETED|Overall Study||607
435611|NCT00724854|1037564|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
435612|NCT00724854|1037565|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
435613|NCT00724815|1037582|P2|NOT COMPLETED|Overall Study||39
435614|NCT00724815|1037583|P1|NOT COMPLETED|Overall Study||43
435615|NCT00724815|1037582|P2|COMPLETED|Overall Study||226
435616|NCT00724815|1037583|P1|COMPLETED|Overall Study||222
435617|NCT00724815|1037582|P2|STARTED|Overall Study|subjects randomized|265
435618|NCT00724815|1037583|P1|STARTED|Overall Study|subjects randomized|265
435619|NCT00724750|1037597|P2|NOT COMPLETED|Overall Study||0
435620|NCT00724750|1037598|P1|NOT COMPLETED|Overall Study||0
435621|NCT00724750|1037597|P2|COMPLETED|Overall Study||42
435622|NCT00724750|1037598|P1|COMPLETED|Overall Study||45
435623|NCT00724750|1037597|P2|STARTED|Overall Study||42
435624|NCT00724750|1037598|P1|STARTED|Overall Study||45
435625|NCT00724711|1037616|P2|NOT COMPLETED|Overall Study||17
435626|NCT00724711|1037617|P1|NOT COMPLETED|Overall Study||17
435627|NCT00724711|1037616|P2|COMPLETED|Overall Study||139
435628|NCT00724711|1037617|P1|COMPLETED|Overall Study||138
435629|NCT00724711|1037616|P2|STARTED|Overall Study||156
435630|NCT00724711|1037617|P1|STARTED|Overall Study||155
435631|NCT00724698|1037649|P1|NOT COMPLETED|Overall Study||90
435632|NCT00724698|1037649|P1|COMPLETED|Overall Study||2921
435633|NCT00724698|1037649|P1|STARTED|Overall Study||3011
435634|NCT00724594|1037656|P4|NOT COMPLETED|Overall Study||1
435635|NCT00724594|1037657|P3|NOT COMPLETED|Overall Study||0
435636|NCT00724594|1037658|P2|NOT COMPLETED|Overall Study||0
435637|NCT00724594|1037659|P1|NOT COMPLETED|Overall Study||0
435638|NCT00724594|1037656|P4|COMPLETED|Overall Study||10
435639|NCT00724594|1037657|P3|COMPLETED|Overall Study||11
435640|NCT00724594|1037658|P2|COMPLETED|Overall Study||12
435641|NCT00724594|1037659|P1|COMPLETED|Overall Study||12
435642|NCT00724594|1037656|P4|STARTED|Overall Study||11
435643|NCT00724594|1037657|P3|STARTED|Overall Study||11
435644|NCT00724594|1037658|P2|STARTED|Overall Study||12
435645|NCT00724594|1037659|P1|STARTED|Overall Study||12
435646|NCT00724568|1037682|P2|NOT COMPLETED|Overall Study||0
435647|NCT00724568|1037683|P1|NOT COMPLETED|Overall Study||0
435648|NCT00724568|1037682|P2|COMPLETED|Overall Study||32
435649|NCT00724568|1037683|P1|COMPLETED|Overall Study||42
435650|NCT00724568|1037682|P2|STARTED|Overall Study||32
435651|NCT00724568|1037683|P1|STARTED|Overall Study||42
435652|NCT00724477|1037688|P1|NOT COMPLETED|Overall Study||0
435653|NCT00724477|1037688|P1|COMPLETED|Overall Study||1663
435654|NCT00724477|1037688|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
435655|NCT00724464|1037692|P1|NOT COMPLETED|Overall Study||23
435656|NCT00724464|1037692|P1|COMPLETED|Overall Study||309
435657|NCT00724464|1037692|P1|STARTED|Overall Study||332
435658|NCT00724451|1037704|P1|NOT COMPLETED|Overall Study||802
435659|NCT00724451|1037704|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
435660|NCT00724451|1037704|P1|Received Antiviral Treatment|Overall Study||500
435661|NCT00724451|1037704|P1|STARTED|Overall Study||1128
435662|NCT00724373|1037710|P1|NOT COMPLETED|Overall Study||171
435663|NCT00724373|1037710|P1|COMPLETED|Overall Study||271
435664|NCT00724373|1037710|P1|STARTED|Overall Study||442
435665|NCT00724347|1037714|P1|NOT COMPLETED|Overall Study||2
435666|NCT00724347|1037714|P1|COMPLETED|Overall Study||16
435667|NCT00724347|1037714|P1|Baseline Testing|Overall Study||18
435668|NCT00724347|1037714|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
435669|NCT00724308|1037720|P2|NOT COMPLETED|Overall Study||97
435670|NCT00724308|1037721|P1|NOT COMPLETED|Overall Study||80
435671|NCT00724308|1037720|P2|COMPLETED|Overall Study||210
435672|NCT00724308|1037721|P1|COMPLETED|Overall Study||190
435673|NCT00724308|1037720|P2|STARTED|Overall Study||307
435674|NCT00724308|1037721|P1|STARTED|Overall Study||270
435675|NCT00724282|1037727|P1|NOT COMPLETED|Overall Study||4
435676|NCT00724282|1037727|P1|COMPLETED|Overall Study||16
435677|NCT00724282|1037727|P1|STARTED|Overall Study||20
435678|NCT00724243|1037731|P1|NOT COMPLETED|Overall Study||15
435679|NCT00724243|1037731|P1|COMPLETED|Overall Study||18
435680|NCT00724243|1037731|P1|STARTED|Overall Study||33
435681|NCT00724152|1037741|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
435682|NCT00724152|1037742|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
435683|NCT00724152|1037743|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
435684|NCT00724152|1037741|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
435685|NCT00724152|1037742|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
435686|NCT00724152|1037743|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
435687|NCT00724152|1037741|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
435688|NCT00724152|1037742|P2|STARTED|Three-arm Study Period (+Standard Care)||2
435689|NCT00724152|1037743|P1|STARTED|Three-arm Study Period (+Standard Care)||4
435690|NCT00724152|1037741|P3|NOT COMPLETED|Two-arm Study Period||0
435691|NCT00724152|1037742|P2|NOT COMPLETED|Two-arm Study Period||2
435692|NCT00724152|1037743|P1|NOT COMPLETED|Two-arm Study Period||3
435693|NCT00724152|1037741|P3|COMPLETED|Two-arm Study Period||0
435694|NCT00724152|1037742|P2|COMPLETED|Two-arm Study Period||9
435695|NCT00724152|1037743|P1|COMPLETED|Two-arm Study Period||11
435696|NCT00724152|1037741|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
435697|NCT00724152|1037742|P2|STARTED|Two-arm Study Period||11
435698|NCT00724152|1037743|P1|STARTED|Two-arm Study Period||14
435699|NCT00724126|1037760|P2|NOT COMPLETED|Overall Study||15
435700|NCT00724126|1037761|P1|NOT COMPLETED|Overall Study||19
435701|NCT00724126|1037760|P2|COMPLETED|Overall Study||301
435702|NCT00724126|1037761|P1|COMPLETED|Overall Study||302
435703|NCT00724126|1037760|P2|STARTED|Overall Study||316
435704|NCT00724126|1037761|P1|STARTED|Overall Study||321
435705|NCT00724061|1037769|P1|NOT COMPLETED|Maintenance Therapy||0
435706|NCT00724061|1037769|P1|COMPLETED|Maintenance Therapy||2
435707|NCT00724061|1037769|P1|STARTED|Maintenance Therapy||2
435708|NCT00724061|1037769|P1|NOT COMPLETED|Dose Escalation Phase||5
435709|NCT00724061|1037769|P1|COMPLETED|Dose Escalation Phase||2
435710|NCT00724061|1037769|P1|STARTED|Dose Escalation Phase||7
435711|NCT00724009|1037773|P1|NOT COMPLETED|Overall Study||0
435712|NCT00724009|1037773|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
435713|NCT00724009|1037773|P1|STARTED|Overall Study||29
435714|NCT00723957|1037786|P2|NOT COMPLETED|Overall Study||53
435715|NCT00723957|1037787|P1|NOT COMPLETED|Overall Study||51
435716|NCT00723957|1037786|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
435717|NCT00723957|1037787|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
435718|NCT00723957|1037786|P2|STARTED|Overall Study|Randomized|99
435719|NCT00723957|1037787|P1|STARTED|Overall Study|Randomized|98
435720|NCT00723944|1037811|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
435721|NCT00723944|1037812|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
435722|NCT00723944|1037811|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
435723|NCT00723944|1037812|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
435724|NCT00723944|1037811|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
435725|NCT00723944|1037812|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
435726|NCT00723944|1037811|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
435727|NCT00723944|1037812|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
435728|NCT00723944|1037811|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
435729|NCT00723944|1037812|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
435730|NCT00723944|1037811|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
435731|NCT00723944|1037812|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
435732|NCT00723944|1037811|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
435733|NCT00723944|1037812|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
435734|NCT00723944|1037811|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
435735|NCT00723944|1037812|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
435736|NCT00723944|1037811|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
435737|NCT00723944|1037812|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
435738|NCT00723944|1037811|P2|NOT COMPLETED|Implant Placement Surgery||0
435739|NCT00723944|1037812|P1|NOT COMPLETED|Implant Placement Surgery||0
435740|NCT00723944|1037811|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
435741|NCT00723944|1037812|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
435742|NCT00723944|1037811|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
435743|NCT00723944|1037812|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
435744|NCT00723931|1037818|P1|NOT COMPLETED|Overall Study||0
435745|NCT00723931|1037818|P1|COMPLETED|Overall Study||1267
435746|NCT00723931|1037818|P1|STARTED|Overall Study||1267
435747|NCT00723892|1037825|P2|NOT COMPLETED|Overall Study||87
435748|NCT00723892|1037826|P1|NOT COMPLETED|Overall Study||107
435749|NCT00723892|1037825|P2|COMPLETED|Overall Study||168
435750|NCT00723892|1037826|P1|COMPLETED|Overall Study||206
435751|NCT00723892|1037825|P2|STARTED|Overall Study||255
435752|NCT00723892|1037826|P1|STARTED|Overall Study||313
435753|NCT00723840|1037833|P1|NOT COMPLETED|Overall Study||82
435754|NCT00723840|1037833|P1|COMPLETED|Overall Study||163
435755|NCT00723840|1037833|P1|STARTED|Overall Study||245
435756|NCT00723827|1037844|P1|NOT COMPLETED|Overall Study||0
435757|NCT00723827|1037844|P1|COMPLETED|Overall Study||682
435758|NCT00723827|1037844|P1|STARTED|Overall Study||682
435759|NCT00722800|1037854|P2|NOT COMPLETED|Overall Study||0
435760|NCT00722800|1037855|P1|NOT COMPLETED|Overall Study||2
435761|NCT00722800|1037854|P2|COMPLETED|Overall Study||2
435762|NCT00722800|1037855|P1|COMPLETED|Overall Study||0
435763|NCT00722800|1037854|P2|STARTED|Overall Study||2
435764|NCT00722800|1037855|P1|STARTED|Overall Study||2
435765|NCT00722761|1037867|P2|NOT COMPLETED|Overall Study||6
435766|NCT00722761|1037868|P1|NOT COMPLETED|Overall Study||6
435767|NCT00722761|1037867|P2|COMPLETED|Overall Study||8
435768|NCT00722761|1037868|P1|COMPLETED|Overall Study||10
435769|NCT00722761|1037867|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
435770|NCT00722761|1037868|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
435771|NCT00722761|1037867|P2|STARTED|Overall Study||14
435772|NCT00722761|1037868|P1|STARTED|Overall Study||16
435773|NCT00723801|1037878|P2|NOT COMPLETED|Overall Study||3
435774|NCT00723801|1037879|P1|NOT COMPLETED|Overall Study||3
435775|NCT00723801|1037878|P2|COMPLETED|Overall Study||17
435776|NCT00723801|1037879|P1|COMPLETED|Overall Study||17
435777|NCT00723801|1037878|P2|STARTED|Overall Study||20
435778|NCT00723801|1037879|P1|STARTED|Overall Study||20
435779|NCT00723788|1037887|P1|NOT COMPLETED|Overall Study||0
435780|NCT00723788|1037887|P1|COMPLETED|Overall Study||21
435781|NCT00723788|1037887|P1|STARTED|Overall Study||21
435782|NCT00723749|1037893|P1|NOT COMPLETED|Overall Study||163
435783|NCT00723749|1037893|P1|COMPLETED|Overall Study||182
435784|NCT00723749|1037893|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
435785|NCT00723736|1037900|P1|NOT COMPLETED|Overall Study||1
435786|NCT00723736|1037900|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
435787|NCT00723736|1037900|P1|STARTED|Overall Study||100
435788|NCT00723710|1037904|P1|NOT COMPLETED|Overall Study||174
435789|NCT00723710|1037904|P1|COMPLETED|Overall Study||120
435790|NCT00723710|1037904|P1|STARTED|Overall Study||294
435791|NCT00723697|1037908|P1|NOT COMPLETED|Overall Study||18
435792|NCT00723697|1037908|P1|COMPLETED|Overall Study||1289
435793|NCT00723697|1037908|P1|STARTED|Overall Study||1307
435794|NCT00723645|1037916|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
435795|NCT00723645|1037916|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
435796|NCT00723645|1037916|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
435797|NCT00723645|1037916|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
435798|NCT00723645|1037916|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
435799|NCT00723645|1037916|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
435800|NCT00723645|1037916|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
435801|NCT00723645|1037916|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
435802|NCT00723645|1037916|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
435803|NCT00723632|1037921|P1|NOT COMPLETED|Overall Study||203
435804|NCT00723632|1037921|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
435805|NCT00723632|1037921|P1|STARTED|Overall Study||901
435806|NCT00723606|1037929|P2|NOT COMPLETED|Overall Study||7
435807|NCT00723606|1037930|P1|NOT COMPLETED|Overall Study||4
435808|NCT00723606|1037929|P2|COMPLETED|Overall Study||180
435809|NCT00723606|1037930|P1|COMPLETED|Overall Study||185
435810|NCT00723606|1037929|P2|STARTED|Overall Study||187
435811|NCT00723606|1037930|P1|STARTED|Overall Study||189
435812|NCT00723580|1037946|P1|NOT COMPLETED|Overall Study||0
435813|NCT00723580|1037946|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
435814|NCT00723580|1037946|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
435815|NCT00723580|1037946|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
435816|NCT00723554|1037950|P1|NOT COMPLETED|Overall Study||29
435817|NCT00723554|1037950|P1|COMPLETED|Overall Study||34
435818|NCT00723554|1037950|P1|STARTED|Overall Study||63
435819|NCT00723528|1038000|P7|NOT COMPLETED|Period 2: After Controlled Period||4
435820|NCT00723528|1038001|P6|NOT COMPLETED|Period 2: After Controlled Period||6
435821|NCT00723528|1038002|P5|NOT COMPLETED|Period 2: After Controlled Period||2
435822|NCT00723528|1038003|P4|NOT COMPLETED|Period 2: After Controlled Period||1
435823|NCT00723528|1038004|P3|NOT COMPLETED|Period 2: After Controlled Period||0
435824|NCT00723528|1038005|P2|NOT COMPLETED|Period 2: After Controlled Period||0
435825|NCT00723528|1038006|P1|NOT COMPLETED|Period 2: After Controlled Period||0
435826|NCT00723528|1038000|P7|COMPLETED|Period 2: After Controlled Period||54
435827|NCT00723528|1038001|P6|COMPLETED|Period 2: After Controlled Period||58
435828|NCT00723528|1038002|P5|COMPLETED|Period 2: After Controlled Period||11
435829|NCT00723528|1038003|P4|COMPLETED|Period 2: After Controlled Period||14
435830|NCT00723528|1038004|P3|COMPLETED|Period 2: After Controlled Period||0
435831|NCT00723528|1038005|P2|COMPLETED|Period 2: After Controlled Period||0
435832|NCT00723528|1038006|P1|COMPLETED|Period 2: After Controlled Period||0
435833|NCT00723528|1038000|P7|STARTED|Period 2: After Controlled Period||58
435834|NCT00723528|1038001|P6|STARTED|Period 2: After Controlled Period||64
435835|NCT00723528|1038002|P5|STARTED|Period 2: After Controlled Period||13
435836|NCT00723528|1038003|P4|STARTED|Period 2: After Controlled Period||15
435837|NCT00723528|1038004|P3|STARTED|Period 2: After Controlled Period||0
435838|NCT00723528|1038005|P2|STARTED|Period 2: After Controlled Period||0
435839|NCT00723528|1038006|P1|STARTED|Period 2: After Controlled Period||0
435840|NCT00723528|1038000|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
435841|NCT00723528|1038001|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
435842|NCT00723528|1038002|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
435843|NCT00723528|1038003|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
435844|NCT00723528|1038004|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
435845|NCT00723528|1038005|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
435846|NCT00723528|1038006|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
435847|NCT00723528|1038000|P7|COMPLETED|Period 1: Controlled Period (CP)||0
435848|NCT00723528|1038001|P6|COMPLETED|Period 1: Controlled Period (CP)||0
435849|NCT00723528|1038002|P5|COMPLETED|Period 1: Controlled Period (CP)||0
435850|NCT00723528|1038003|P4|COMPLETED|Period 1: Controlled Period (CP)||0
435851|NCT00723528|1038004|P3|COMPLETED|Period 1: Controlled Period (CP)||58
435852|NCT00723528|1038005|P2|COMPLETED|Period 1: Controlled Period (CP)||64
435853|NCT00723528|1038006|P1|COMPLETED|Period 1: Controlled Period (CP)||28
435854|NCT00723528|1038000|P7|STARTED|Period 1: Controlled Period (CP)||0
435855|NCT00723528|1038001|P6|STARTED|Period 1: Controlled Period (CP)||0
435856|NCT00723528|1038002|P5|STARTED|Period 1: Controlled Period (CP)||0
435857|NCT00723528|1038003|P4|STARTED|Period 1: Controlled Period (CP)||0
435858|NCT00723528|1038004|P3|STARTED|Period 1: Controlled Period (CP)||62
435859|NCT00723528|1038005|P2|STARTED|Period 1: Controlled Period (CP)||64
435860|NCT00723528|1038006|P1|STARTED|Period 1: Controlled Period (CP)||32
435861|NCT00723489|1038068|P4|NOT COMPLETED|Overall Study||3
435862|NCT00723489|1038069|P3|NOT COMPLETED|Overall Study||0
435863|NCT00723489|1038070|P2|NOT COMPLETED|Overall Study||4
435864|NCT00723489|1038071|P1|NOT COMPLETED|Overall Study||1
435865|NCT00723489|1038068|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
435866|NCT00723489|1038069|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
435867|NCT00723489|1038070|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
435868|NCT00723489|1038071|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
435869|NCT00723489|1038068|P4|STARTED|Overall Study||23
435870|NCT00723489|1038069|P3|STARTED|Overall Study||19
435871|NCT00723489|1038070|P2|STARTED|Overall Study||19
435872|NCT00723489|1038071|P1|STARTED|Overall Study||21
435873|NCT00723450|1038099|P3|NOT COMPLETED|Randomized Phase||67
435874|NCT00723450|1038100|P2|NOT COMPLETED|Randomized Phase||65
435875|NCT00723450|1038101|P1|NOT COMPLETED|Randomized Phase||0
435876|NCT00723450|1038099|P3|COMPLETED|Randomized Phase||20
435877|NCT00723450|1038100|P2|COMPLETED|Randomized Phase||21
435878|NCT00723450|1038101|P1|COMPLETED|Randomized Phase||0
435879|NCT00723450|1038099|P3|STARTED|Randomized Phase||87
435880|NCT00723450|1038100|P2|STARTED|Randomized Phase||86
435881|NCT00723450|1038101|P1|STARTED|Randomized Phase||0
435882|NCT00723450|1038099|P3|NOT COMPLETED|Open-Label Phase||0
435883|NCT00723450|1038100|P2|NOT COMPLETED|Open-Label Phase||0
435884|NCT00723450|1038101|P1|NOT COMPLETED|Open-Label Phase||125
435885|NCT00723450|1038099|P3|COMPLETED|Open-Label Phase||0
435886|NCT00723450|1038100|P2|COMPLETED|Open-Label Phase||0
435887|NCT00723450|1038101|P1|COMPLETED|Open-Label Phase||173
435888|NCT00723450|1038099|P3|STARTED|Open-Label Phase||0
435889|NCT00723450|1038100|P2|STARTED|Open-Label Phase||0
435890|NCT00723450|1038101|P1|STARTED|Open-Label Phase||298
435891|NCT00723294|1038142|P1|NOT COMPLETED|Overall Study||13
435892|NCT00723294|1038142|P1|COMPLETED|Overall Study||86
435893|NCT00723294|1038142|P1|STARTED|Overall Study||99
435894|NCT00723255|1038147|P1|NOT COMPLETED|Overall Study||4
435895|NCT00723255|1038147|P1|COMPLETED|Overall Study|Eligible and treated patients|49
435896|NCT00723255|1038147|P1|STARTED|Overall Study||53
435897|NCT00723229|1038168|P2|NOT COMPLETED|Second Intervention||0
435898|NCT00723229|1038169|P1|NOT COMPLETED|Second Intervention||0
435899|NCT00723229|1038168|P2|COMPLETED|Second Intervention||20
435900|NCT00723229|1038169|P1|COMPLETED|Second Intervention||18
435901|NCT00723229|1038168|P2|STARTED|Second Intervention||20
435902|NCT00723229|1038169|P1|STARTED|Second Intervention||18
435903|NCT00723229|1038168|P2|NOT COMPLETED|First Intervention||3
435904|NCT00723229|1038169|P1|NOT COMPLETED|First Intervention||7
435905|NCT00723229|1038168|P2|COMPLETED|First Intervention||20
435906|NCT00723229|1038169|P1|COMPLETED|First Intervention||18
435907|NCT00723229|1038168|P2|STARTED|First Intervention||23
435908|NCT00723229|1038169|P1|STARTED|First Intervention||25
435909|NCT00723203|1038181|P1|NOT COMPLETED|Overall Study||3
435910|NCT00723203|1038181|P1|COMPLETED|Overall Study||13
435911|NCT00723203|1038181|P1|STARTED|Overall Study||16
435912|NCT00723190|1038185|P1|NOT COMPLETED|Overall Study||142
435913|NCT00723190|1038185|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
435914|NCT00723190|1038185|P1|SAFETY POPULATION|Overall Study||301
435915|NCT00723190|1038185|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
435916|NCT00723177|1038203|P3|NOT COMPLETED|Overall Study||5
435917|NCT00723177|1038204|P2|NOT COMPLETED|Overall Study||4
435918|NCT00723177|1038205|P1|NOT COMPLETED|Overall Study||5
435919|NCT00723177|1038203|P3|COMPLETED|Overall Study||10
435920|NCT00723177|1038204|P2|COMPLETED|Overall Study||10
435921|NCT00723177|1038205|P1|COMPLETED|Overall Study||10
435922|NCT00723177|1038203|P3|STARTED|Overall Study||15
435923|NCT00723177|1038204|P2|STARTED|Overall Study||14
435924|NCT00723177|1038205|P1|STARTED|Overall Study||15
435925|NCT00723125|1038218|P2|NOT COMPLETED|Overall Study||6
435926|NCT00723125|1038219|P1|NOT COMPLETED|Overall Study||18
435927|NCT00723125|1038218|P2|COMPLETED|Overall Study||21
435928|NCT00723125|1038219|P1|COMPLETED|Overall Study||15
435929|NCT00723125|1038218|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
435930|NCT00723125|1038219|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
435931|NCT00723073|1038231|P2|NOT COMPLETED|Overall Study||0
435932|NCT00723073|1038232|P1|NOT COMPLETED|Overall Study||0
435933|NCT00723073|1038231|P2|COMPLETED|Overall Study||174
435934|NCT00723073|1038232|P1|COMPLETED|Overall Study||149
435935|NCT00723073|1038231|P2|STARTED|Overall Study||174
435936|NCT00723073|1038232|P1|STARTED|Overall Study||149
435937|NCT00723021|1038256|P5|NOT COMPLETED|Intervention Period 5||0
435938|NCT00723021|1038257|P4|NOT COMPLETED|Intervention Period 5||0
435939|NCT00723021|1038258|P3|NOT COMPLETED|Intervention Period 5||0
435940|NCT00723021|1038259|P2|NOT COMPLETED|Intervention Period 5||0
435941|NCT00723021|1038260|P1|NOT COMPLETED|Intervention Period 5||0
435942|NCT00723021|1038256|P5|COMPLETED|Intervention Period 5||2
435943|NCT00723021|1038257|P4|COMPLETED|Intervention Period 5||3
435944|NCT00723021|1038258|P3|COMPLETED|Intervention Period 5||3
435945|NCT00723021|1038259|P2|COMPLETED|Intervention Period 5||3
435946|NCT00723021|1038260|P1|COMPLETED|Intervention Period 5||3
435947|NCT00723021|1038256|P5|STARTED|Intervention Period 5||2
435948|NCT00723021|1038257|P4|STARTED|Intervention Period 5||3
435949|NCT00723021|1038258|P3|STARTED|Intervention Period 5||3
435950|NCT00723021|1038259|P2|STARTED|Intervention Period 5||3
435951|NCT00723021|1038260|P1|STARTED|Intervention Period 5||3
435952|NCT00723021|1038256|P5|NOT COMPLETED|Intervention Period 4||1
435953|NCT00723021|1038257|P4|NOT COMPLETED|Intervention Period 4||0
435954|NCT00723021|1038258|P3|NOT COMPLETED|Intervention Period 4||0
435955|NCT00723021|1038259|P2|NOT COMPLETED|Intervention Period 4||0
435956|NCT00723021|1038260|P1|NOT COMPLETED|Intervention Period 4||0
435957|NCT00723021|1038256|P5|COMPLETED|Intervention Period 4||2
435958|NCT00723021|1038257|P4|COMPLETED|Intervention Period 4||3
435959|NCT00723021|1038258|P3|COMPLETED|Intervention Period 4||3
435960|NCT00723021|1038259|P2|COMPLETED|Intervention Period 4||3
435961|NCT00723021|1038260|P1|COMPLETED|Intervention Period 4||3
435962|NCT00723021|1038256|P5|STARTED|Intervention Period 4||3
435963|NCT00723021|1038257|P4|STARTED|Intervention Period 4||3
435964|NCT00723021|1038258|P3|STARTED|Intervention Period 4||3
435965|NCT00723021|1038259|P2|STARTED|Intervention Period 4||3
435966|NCT00723021|1038260|P1|STARTED|Intervention Period 4||3
435967|NCT00723021|1038256|P5|NOT COMPLETED|Intervention Period 3||0
435968|NCT00723021|1038257|P4|NOT COMPLETED|Intervention Period 3||0
435969|NCT00723021|1038258|P3|NOT COMPLETED|Intervention Period 3||0
435970|NCT00723021|1038259|P2|NOT COMPLETED|Intervention Period 3||0
435971|NCT00723021|1038260|P1|NOT COMPLETED|Intervention Period 3||0
435972|NCT00723021|1038256|P5|COMPLETED|Intervention Period 3||3
435973|NCT00723021|1038257|P4|COMPLETED|Intervention Period 3||3
435974|NCT00723021|1038258|P3|COMPLETED|Intervention Period 3||3
435975|NCT00723021|1038259|P2|COMPLETED|Intervention Period 3||3
435976|NCT00723021|1038260|P1|COMPLETED|Intervention Period 3||3
435977|NCT00723021|1038256|P5|STARTED|Intervention Period 3||3
435978|NCT00723021|1038257|P4|STARTED|Intervention Period 3||3
435979|NCT00723021|1038258|P3|STARTED|Intervention Period 3||3
435980|NCT00723021|1038259|P2|STARTED|Intervention Period 3||3
435981|NCT00723021|1038260|P1|STARTED|Intervention Period 3||3
435982|NCT00723021|1038256|P5|NOT COMPLETED|Intervention Period 2||0
435983|NCT00723021|1038257|P4|NOT COMPLETED|Intervention Period 2||0
435984|NCT00723021|1038258|P3|NOT COMPLETED|Intervention Period 2||0
435985|NCT00723021|1038259|P2|NOT COMPLETED|Intervention Period 2||0
435986|NCT00723021|1038260|P1|NOT COMPLETED|Intervention Period 2||0
435987|NCT00723021|1038256|P5|COMPLETED|Intervention Period 2||3
435988|NCT00723021|1038257|P4|COMPLETED|Intervention Period 2||3
435989|NCT00723021|1038258|P3|COMPLETED|Intervention Period 2||3
435990|NCT00723021|1038259|P2|COMPLETED|Intervention Period 2||3
435991|NCT00723021|1038260|P1|COMPLETED|Intervention Period 2||3
435992|NCT00723021|1038256|P5|STARTED|Intervention Period 2||3
435993|NCT00723021|1038257|P4|STARTED|Intervention Period 2||3
435994|NCT00723021|1038258|P3|STARTED|Intervention Period 2||3
435995|NCT00723021|1038259|P2|STARTED|Intervention Period 2||3
435996|NCT00723021|1038260|P1|STARTED|Intervention Period 2||3
435997|NCT00723021|1038256|P5|NOT COMPLETED|Intervention Period 1||0
435998|NCT00723021|1038257|P4|NOT COMPLETED|Intervention Period 1||0
435999|NCT00723021|1038258|P3|NOT COMPLETED|Intervention Period 1||0
436000|NCT00723021|1038259|P2|NOT COMPLETED|Intervention Period 1||0
436001|NCT00723021|1038260|P1|NOT COMPLETED|Intervention Period 1||0
436002|NCT00723021|1038256|P5|COMPLETED|Intervention Period 1||3
436003|NCT00723021|1038257|P4|COMPLETED|Intervention Period 1||3
436004|NCT00723021|1038258|P3|COMPLETED|Intervention Period 1||3
436005|NCT00723021|1038259|P2|COMPLETED|Intervention Period 1||3
436006|NCT00723021|1038260|P1|COMPLETED|Intervention Period 1||3
436007|NCT00723021|1038256|P5|STARTED|Intervention Period 1||3
436008|NCT00723021|1038257|P4|STARTED|Intervention Period 1||3
436009|NCT00723021|1038258|P3|STARTED|Intervention Period 1||3
436010|NCT00723021|1038259|P2|STARTED|Intervention Period 1||3
436011|NCT00723021|1038260|P1|STARTED|Intervention Period 1||3
436012|NCT00723008|1038314|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
436013|NCT00723008|1038315|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
436014|NCT00723008|1038314|P2|COMPLETED|4-Week Unblinded Treatment||3
436015|NCT00723008|1038315|P1|COMPLETED|4-Week Unblinded Treatment||4
436016|NCT00723008|1038314|P2|STARTED|4-Week Unblinded Treatment||4
436017|NCT00723008|1038315|P1|STARTED|4-Week Unblinded Treatment||5
436018|NCT00723008|1038314|P2|NOT COMPLETED|4-Week Double Blinded||5
436019|NCT00723008|1038315|P1|NOT COMPLETED|4-Week Double Blinded||5
436020|NCT00723008|1038314|P2|COMPLETED|4-Week Double Blinded||4
436021|NCT00723008|1038315|P1|COMPLETED|4-Week Double Blinded||5
436022|NCT00723008|1038314|P2|STARTED|4-Week Double Blinded||9
436023|NCT00723008|1038315|P1|STARTED|4-Week Double Blinded||10
436024|NCT00723008|1038314|P2|NOT COMPLETED|Enrollment||0
436025|NCT00723008|1038315|P1|NOT COMPLETED|Enrollment||1
436026|NCT00723008|1038314|P2|COMPLETED|Enrollment||9
436027|NCT00723008|1038315|P1|COMPLETED|Enrollment||10
436028|NCT00723008|1038314|P2|STARTED|Enrollment||9
436029|NCT00723008|1038315|P1|STARTED|Enrollment||11
436030|NCT00722865|1038337|P1|NOT COMPLETED|Overall Study||2
436031|NCT00722865|1038337|P1|COMPLETED|Overall Study||23
436032|NCT00722865|1038337|P1|STARTED|Overall Study||25
436033|NCT00722722|1038348|P3|NOT COMPLETED|Overall Study||0
436034|NCT00722722|1038349|P2|NOT COMPLETED|Overall Study||0
436035|NCT00722722|1038350|P1|NOT COMPLETED|Overall Study||0
436036|NCT00722722|1038348|P3|COMPLETED|Overall Study||10
436037|NCT00722722|1038349|P2|COMPLETED|Overall Study||5
436038|NCT00722722|1038350|P1|COMPLETED|Overall Study||3
436039|NCT00722722|1038348|P3|STARTED|Overall Study||10
436040|NCT00722722|1038349|P2|STARTED|Overall Study||5
436041|NCT00722722|1038350|P1|STARTED|Overall Study||3
436042|NCT00722566|1038360|P2|NOT COMPLETED|Overall Study||35
436043|NCT00722566|1038361|P1|NOT COMPLETED|Overall Study||67
436044|NCT00722566|1038360|P2|COMPLETED|Overall Study|Completed 8 cycles|39
436045|NCT00722566|1038361|P1|COMPLETED|Overall Study|Completed 8 cycles|81
436046|NCT00722566|1038360|P2|STARTED|Overall Study||74
436047|NCT00722566|1038361|P1|STARTED|Overall Study|One patient randomized and not dosed|148
436048|NCT00722553|1038369|P1|NOT COMPLETED|Overall Study||0
436049|NCT00722553|1038369|P1|COMPLETED|Overall Study||30
436050|NCT00722553|1038369|P1|STARTED|Overall Study||30
436051|NCT00722436|1038379|P2|NOT COMPLETED|Overall Study||0
436052|NCT00722436|1038380|P1|NOT COMPLETED|Overall Study||0
436053|NCT00722436|1038379|P2|COMPLETED|Overall Study||11
436054|NCT00722436|1038380|P1|COMPLETED|Overall Study||9
436055|NCT00722436|1038379|P2|STARTED|Overall Study||11
436056|NCT00722436|1038380|P1|STARTED|Overall Study||9
436057|NCT00722423|1038394|P2|NOT COMPLETED|Overall Study||1
436058|NCT00722423|1038395|P1|NOT COMPLETED|Overall Study||0
436059|NCT00722423|1038394|P2|COMPLETED|Overall Study||181
436060|NCT00722423|1038395|P1|COMPLETED|Overall Study||182
436061|NCT00722423|1038394|P2|STARTED|Overall Study||182
436062|NCT00722423|1038395|P1|STARTED|Overall Study||182
436063|NCT00722371|1038410|P7|NOT COMPLETED|Overall Study||51
436064|NCT00722371|1038411|P6|NOT COMPLETED|Overall Study||53
436065|NCT00722371|1038412|P5|NOT COMPLETED|Overall Study||48
436066|NCT00722371|1038413|P4|NOT COMPLETED|Overall Study||63
436067|NCT00722371|1038414|P3|NOT COMPLETED|Overall Study||65
436068|NCT00722371|1038415|P2|NOT COMPLETED|Overall Study||72
436069|NCT00722371|1038416|P1|NOT COMPLETED|Overall Study||56
436070|NCT00722371|1038410|P7|COMPLETED|Overall Study||179
436071|NCT00722371|1038411|P6|COMPLETED|Overall Study||178
436072|NCT00722371|1038412|P5|COMPLETED|Overall Study||182
436073|NCT00722371|1038413|P4|COMPLETED|Overall Study||167
436074|NCT00722371|1038414|P3|COMPLETED|Overall Study||168
436075|NCT00722371|1038415|P2|COMPLETED|Overall Study||158
436076|NCT00722371|1038416|P1|COMPLETED|Overall Study||175
436077|NCT00722371|1038410|P7|STARTED|Overall Study||230
436078|NCT00722371|1038411|P6|STARTED|Overall Study||231
436079|NCT00722371|1038412|P5|STARTED|Overall Study||230
436080|NCT00722371|1038413|P4|STARTED|Overall Study||230
436081|NCT00722371|1038414|P3|STARTED|Overall Study||233
436082|NCT00722371|1038415|P2|STARTED|Overall Study||230
436083|NCT00722371|1038416|P1|STARTED|Overall Study||231
436084|NCT00722137|1038469|P2|NOT COMPLETED|Overall Study||45
436085|NCT00722137|1038470|P1|NOT COMPLETED|Overall Study||48
436086|NCT00722137|1038469|P2|COMPLETED|Overall Study||199
436087|NCT00722137|1038470|P1|COMPLETED|Overall Study||195
436088|NCT00722137|1038469|P2|STARTED|Overall Study||244
436089|NCT00722137|1038470|P1|STARTED|Overall Study||243
436090|NCT00722124|1038497|P3|NOT COMPLETED|Overall Study||20
436091|NCT00722124|1038498|P2|NOT COMPLETED|Overall Study||14
436092|NCT00722124|1038499|P1|NOT COMPLETED|Overall Study||17
436093|NCT00722124|1038497|P3|COMPLETED|Overall Study||20
436094|NCT00722124|1038498|P2|COMPLETED|Overall Study||26
436095|NCT00722124|1038499|P1|COMPLETED|Overall Study||23
436096|NCT00722124|1038497|P3|STARTED|Overall Study||40
436097|NCT00722124|1038498|P2|STARTED|Overall Study||40
436098|NCT00722124|1038499|P1|STARTED|Overall Study||40
436099|NCT00722072|1038507|P1|NOT COMPLETED|Overall Study||3
436100|NCT00722072|1038507|P1|COMPLETED|Overall Study||9
436101|NCT00722072|1038507|P1|STARTED|Overall Study||12
436102|NCT00722020|1038513|P2|NOT COMPLETED|Overall Study||0
436103|NCT00722020|1038514|P1|NOT COMPLETED|Overall Study||0
436104|NCT00722020|1038513|P2|COMPLETED|Overall Study||24
436105|NCT00722020|1038514|P1|COMPLETED|Overall Study||19
436106|NCT00722020|1038513|P2|STARTED|Overall Study||24
436107|NCT00722020|1038514|P1|STARTED|Overall Study||19
436108|NCT00721968|1038524|P2|NOT COMPLETED|Overall Study||0
436109|NCT00721968|1038525|P1|NOT COMPLETED|Overall Study||2
436110|NCT00721968|1038524|P2|COMPLETED|Overall Study||17
436111|NCT00721968|1038525|P1|COMPLETED|Overall Study||25
436112|NCT00721968|1038524|P2|STARTED|Overall Study||17
436113|NCT00721968|1038525|P1|STARTED|Overall Study||27
436114|NCT00721734|1038538|P5|NOT COMPLETED|Overall Study||6
436115|NCT00721734|1038539|P4|NOT COMPLETED|Overall Study||6
436116|NCT00721734|1038540|P3|NOT COMPLETED|Overall Study||8
436117|NCT00721734|1038541|P2|NOT COMPLETED|Overall Study||12
436118|NCT00721734|1038542|P1|NOT COMPLETED|Overall Study||8
436119|NCT00721734|1038538|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
436120|NCT00721734|1038539|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
436121|NCT00721734|1038540|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
436122|NCT00721734|1038541|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
436123|NCT00721734|1038542|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
436124|NCT00721734|1038538|P5|STARTED|Overall Study||8
436125|NCT00721734|1038539|P4|STARTED|Overall Study||8
436126|NCT00721734|1038540|P3|STARTED|Overall Study||10
436127|NCT00721734|1038541|P2|STARTED|Overall Study||12
436128|NCT00721734|1038542|P1|STARTED|Overall Study||12
436129|NCT00721617|1038654|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
436130|NCT00721617|1038654|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
436131|NCT00721617|1038654|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
436132|NCT00721617|1038654|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
436133|NCT00721617|1038654|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
436134|NCT00721617|1038654|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
436135|NCT00721617|1038654|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
436136|NCT00721617|1038654|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
436137|NCT00721617|1038654|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
436138|NCT00721617|1038654|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
436139|NCT00721617|1038654|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
436140|NCT00721617|1038654|P1|STARTED|8 Hours Into Dextrose Infusion||12
436141|NCT00721617|1038654|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
436142|NCT00721617|1038654|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
436143|NCT00721617|1038654|P1|STARTED|4 Hours Into Dextrose Infusion||12
436144|NCT00721617|1038654|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
436145|NCT00721617|1038654|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
436146|NCT00721617|1038654|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
436147|NCT00721617|1038654|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
436148|NCT00721617|1038654|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
436149|NCT00721617|1038654|P1|STARTED|8 Hours Into Intralipid Infusion||12
436150|NCT00721617|1038654|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
436151|NCT00721617|1038654|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
436152|NCT00721617|1038654|P1|STARTED|4 Hours Into Intralipid Infusion||12
436153|NCT00721617|1038654|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
436154|NCT00721617|1038654|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
436155|NCT00721617|1038654|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
436156|NCT00721617|1038654|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
436157|NCT00721617|1038654|P1|COMPLETED|8 Hours Into Saline Infusion||12
436158|NCT00721617|1038654|P1|STARTED|8 Hours Into Saline Infusion||12
436159|NCT00721617|1038654|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
436160|NCT00721617|1038654|P1|COMPLETED|4 Hours Into Saline Infusion||12
436161|NCT00721617|1038654|P1|STARTED|4 Hours Into Saline Infusion||12
436162|NCT00721617|1038654|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
436163|NCT00721617|1038654|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
436164|NCT00721617|1038654|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
436165|NCT00721578|1038678|P2|NOT COMPLETED|Overall Study||2
436166|NCT00721578|1038679|P1|NOT COMPLETED|Overall Study||2
436167|NCT00721578|1038678|P2|COMPLETED|Overall Study||9
436168|NCT00721578|1038679|P1|COMPLETED|Overall Study||10
436169|NCT00721578|1038678|P2|STARTED|Overall Study||11
436170|NCT00721578|1038679|P1|STARTED|Overall Study||12
436171|NCT00721539|1038691|P1|NOT COMPLETED|Overall Study||0
436172|NCT00721539|1038691|P1|COMPLETED|Overall Study||9
436173|NCT00721539|1038691|P1|STARTED|Overall Study||9
436174|NCT00721500|1038698|P4|NOT COMPLETED|Period Three||0
436175|NCT00721500|1038699|P3|NOT COMPLETED|Period Three||0
436176|NCT00721500|1038700|P2|NOT COMPLETED|Period Three||0
436177|NCT00721500|1038701|P1|NOT COMPLETED|Period Three||0
436178|NCT00721500|1038698|P4|COMPLETED|Period Three||6
436179|NCT00721500|1038699|P3|COMPLETED|Period Three||6
436180|NCT00721500|1038700|P2|COMPLETED|Period Three||7
436181|NCT00721500|1038701|P1|COMPLETED|Period Three||6
436182|NCT00721500|1038698|P4|STARTED|Period Three||6
436183|NCT00721500|1038699|P3|STARTED|Period Three||6
436184|NCT00721500|1038700|P2|STARTED|Period Three||7
436185|NCT00721500|1038701|P1|STARTED|Period Three||6
436186|NCT00721500|1038698|P4|NOT COMPLETED|Period Two||0
436187|NCT00721500|1038699|P3|NOT COMPLETED|Period Two||0
436188|NCT00721500|1038700|P2|NOT COMPLETED|Period Two||0
436189|NCT00721500|1038701|P1|NOT COMPLETED|Period Two||0
436190|NCT00721500|1038698|P4|COMPLETED|Period Two||6
436191|NCT00721500|1038699|P3|COMPLETED|Period Two||6
436192|NCT00721500|1038700|P2|COMPLETED|Period Two||7
436193|NCT00721500|1038701|P1|COMPLETED|Period Two||6
436194|NCT00721500|1038698|P4|STARTED|Period Two||6
436195|NCT00721500|1038699|P3|STARTED|Period Two||6
436196|NCT00721500|1038700|P2|STARTED|Period Two||7
436197|NCT00721500|1038701|P1|STARTED|Period Two||6
436198|NCT00721500|1038698|P4|NOT COMPLETED|Period One||0
436199|NCT00721500|1038699|P3|NOT COMPLETED|Period One||0
436200|NCT00721500|1038700|P2|NOT COMPLETED|Period One||0
436201|NCT00721500|1038701|P1|NOT COMPLETED|Period One||0
436202|NCT00721500|1038698|P4|COMPLETED|Period One||6
436203|NCT00721500|1038699|P3|COMPLETED|Period One||6
436204|NCT00721500|1038700|P2|COMPLETED|Period One||7
436205|NCT00721500|1038701|P1|COMPLETED|Period One||6
436206|NCT00721500|1038698|P4|STARTED|Period One||6
436207|NCT00721500|1038699|P3|STARTED|Period One||6
436208|NCT00721500|1038700|P2|STARTED|Period One||7
436209|NCT00721500|1038701|P1|STARTED|Period One||6
436210|NCT00721409|1038722|P3|NOT COMPLETED|Overall Study||81
436211|NCT00721409|1038723|P2|NOT COMPLETED|Overall Study||84
436212|NCT00721409|1038724|P1|NOT COMPLETED|Overall Study||12
436213|NCT00721409|1038722|P3|COMPLETED|Overall Study||0
436214|NCT00721409|1038723|P2|COMPLETED|Overall Study||0
436215|NCT00721409|1038724|P1|COMPLETED|Overall Study||0
436216|NCT00721409|1038722|P3|Treated|Overall Study||77
436217|NCT00721409|1038723|P2|Treated|Overall Study||83
436218|NCT00721409|1038724|P1|Treated|Overall Study||12
436219|NCT00721409|1038722|P3|STARTED|Overall Study||81
436220|NCT00721409|1038723|P2|STARTED|Overall Study||84
436221|NCT00721409|1038724|P1|STARTED|Overall Study||12
436222|NCT00721396|1038851|P4|NOT COMPLETED|Overall Study||10
436223|NCT00721396|1038852|P3|NOT COMPLETED|Overall Study||10
436224|NCT00721396|1038853|P2|NOT COMPLETED|Overall Study||36
436225|NCT00721396|1038854|P1|NOT COMPLETED|Overall Study||30
436226|NCT00721396|1038851|P4|COMPLETED|Overall Study||302
436227|NCT00721396|1038852|P3|COMPLETED|Overall Study||308
436228|NCT00721396|1038853|P2|COMPLETED|Overall Study||592
436229|NCT00721396|1038854|P1|COMPLETED|Overall Study||597
436230|NCT00721396|1038851|P4|STARTED|Overall Study||312
436231|NCT00721396|1038852|P3|STARTED|Overall Study||318
436232|NCT00721396|1038853|P2|STARTED|Overall Study||628
436233|NCT00721396|1038854|P1|STARTED|Overall Study||627
436234|NCT00721357|1038892|P2|NOT COMPLETED|Overall Study||0
436235|NCT00721357|1038893|P1|NOT COMPLETED|Overall Study||0
436236|NCT00721357|1038892|P2|COMPLETED|Overall Study||15
436237|NCT00721357|1038893|P1|COMPLETED|Overall Study||15
436238|NCT00721357|1038892|P2|STARTED|Overall Study||15
436239|NCT00721357|1038893|P1|STARTED|Overall Study||15
436240|NCT00721279|1038901|P2|NOT COMPLETED|Overall Study||24
436241|NCT00721279|1038902|P1|NOT COMPLETED|Overall Study||36
436242|NCT00721279|1038901|P2|COMPLETED|Overall Study||73
436243|NCT00721279|1038902|P1|COMPLETED|Overall Study||416
436244|NCT00721279|1038901|P2|STARTED|Overall Study||97
436245|NCT00721279|1038902|P1|STARTED|Overall Study||452
436246|NCT00721253|1038916|P3|NOT COMPLETED|Overall Study||0
436247|NCT00721253|1038917|P2|NOT COMPLETED|Overall Study||0
436248|NCT00721253|1038918|P1|NOT COMPLETED|Overall Study||0
436249|NCT00721253|1038916|P3|COMPLETED|Overall Study||0
436250|NCT00721253|1038917|P2|COMPLETED|Overall Study||22
436251|NCT00721253|1038918|P1|COMPLETED|Overall Study||20
436252|NCT00721253|1038916|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
436253|NCT00721253|1038917|P2|STARTED|Overall Study||22
436254|NCT00721253|1038918|P1|STARTED|Overall Study||20
436255|NCT00721227|1038930|P2|NOT COMPLETED|Overall Study||0
436256|NCT00721227|1038931|P1|NOT COMPLETED|Overall Study||4
436257|NCT00721227|1038930|P2|COMPLETED|Overall Study||6
436258|NCT00721227|1038931|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
436259|NCT00721227|1038930|P2|STARTED|Overall Study||6
436260|NCT00721227|1038931|P1|STARTED|Overall Study||9
436261|NCT00721214|1038941|P1|NOT COMPLETED|Overall Study||4
436262|NCT00721214|1038941|P1|COMPLETED|Overall Study||12
436263|NCT00721214|1038941|P1|STARTED|Overall Study||16
436264|NCT00721188|1038952|P1|NOT COMPLETED|Overall Study||0
436265|NCT00721188|1038952|P1|COMPLETED|Overall Study||11
436266|NCT00721188|1038952|P1|STARTED|Overall Study||11
436267|NCT00721175|1038969|P2|NOT COMPLETED|Overall Study||0
436268|NCT00721175|1038970|P1|NOT COMPLETED|Overall Study||0
436269|NCT00721175|1038969|P2|COMPLETED|Overall Study||54
436270|NCT00721175|1038970|P1|COMPLETED|Overall Study||54
436271|NCT00721175|1038969|P2|STARTED|Overall Study||54
436272|NCT00721175|1038970|P1|STARTED|Overall Study||54
436273|NCT00721162|1038982|P1|NOT COMPLETED|Overall Study||0
436274|NCT00721162|1038982|P1|COMPLETED|Overall Study||60
436275|NCT00721162|1038982|P1|Received Any Amount of Study Drug|Overall Study||60
436276|NCT00721162|1038982|P1|STARTED|Overall Study||60
436277|NCT00721149|1038991|P1|NOT COMPLETED|Overall Study||1
436278|NCT00721149|1038991|P1|COMPLETED|Overall Study||9
436279|NCT00721149|1038991|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
436280|NCT00721123|1039000|P1|NOT COMPLETED|Overall Study||183
436281|NCT00721123|1039000|P1|COMPLETED|Overall Study||355
436282|NCT00721123|1039000|P1|STARTED|Overall Study||538
436283|NCT00720941|1039076|P2|NOT COMPLETED|Overall Study||415
436284|NCT00720941|1039077|P1|NOT COMPLETED|Overall Study||413
436285|NCT00720941|1039076|P2|COMPLETED|Overall Study||138
436286|NCT00720941|1039077|P1|COMPLETED|Overall Study||144
436287|NCT00720941|1039076|P2|Ongoing|Overall Study||23
436288|NCT00720941|1039077|P1|Ongoing|Overall Study||34
436289|NCT00720941|1039076|P2|STARTED|Overall Study||553
436290|NCT00720941|1039077|P1|STARTED|Overall Study||557
436291|NCT00720798|1039117|P1|NOT COMPLETED|Overall Study||756
436292|NCT00720798|1039117|P1|COMPLETED|Overall Study||1311
436293|NCT00720798|1039117|P1|STARTED|Overall Study||2067
436294|NCT00720759|1039140|P4|NOT COMPLETED|Overall Study||0
436295|NCT00720759|1039141|P3|NOT COMPLETED|Overall Study||1
436296|NCT00720759|1039142|P2|NOT COMPLETED|Overall Study||1
436297|NCT00720759|1039143|P1|NOT COMPLETED|Overall Study||0
436298|NCT00720759|1039140|P4|COMPLETED|Overall Study||6
436299|NCT00720759|1039141|P3|COMPLETED|Overall Study||5
436300|NCT00720759|1039142|P2|COMPLETED|Overall Study||5
436301|NCT00720759|1039143|P1|COMPLETED|Overall Study||6
436302|NCT00720759|1039140|P4|STARTED|Overall Study||6
436303|NCT00720759|1039141|P3|STARTED|Overall Study||6
436304|NCT00720759|1039142|P2|STARTED|Overall Study||6
436305|NCT00720759|1039143|P1|STARTED|Overall Study||6
436306|NCT00720629|1039153|P1|NOT COMPLETED|Overall Study||0
436307|NCT00720629|1039153|P1|COMPLETED|Overall Study||8
436308|NCT00720629|1039153|P1|STARTED|Overall Study||8
436309|NCT00720499|1039163|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
436310|NCT00720499|1039164|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
436311|NCT00720499|1039163|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
436312|NCT00720499|1039164|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
436313|NCT00720499|1039163|P2|STARTED|Treatment Period 2 (4 Weeks)||70
436314|NCT00720499|1039164|P1|STARTED|Treatment Period 2 (4 Weeks)||66
436315|NCT00720499|1039163|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
436316|NCT00720499|1039164|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
436317|NCT00720499|1039163|P2|COMPLETED|Washout Period (2 Weeks)||70
436318|NCT00720499|1039164|P1|COMPLETED|Washout Period (2 Weeks)||66
436319|NCT00720499|1039163|P2|STARTED|Washout Period (2 Weeks)||70
436320|NCT00720499|1039164|P1|STARTED|Washout Period (2 Weeks)||66
436321|NCT00720499|1039163|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
436322|NCT00720499|1039164|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
436323|NCT00720499|1039163|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
436324|NCT00720499|1039164|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
436325|NCT00720499|1039163|P2|STARTED|Treatment Period 1 (4 Weeks)||72
436326|NCT00720499|1039164|P1|STARTED|Treatment Period 1 (4 Weeks)||69
436327|NCT00720473|1039228|P2|NOT COMPLETED|Overall Study||8
436328|NCT00720473|1039229|P1|NOT COMPLETED|Overall Study||30
436329|NCT00720473|1039228|P2|COMPLETED|Overall Study||16
436330|NCT00720473|1039229|P1|COMPLETED|Overall Study||15
436331|NCT00720473|1039228|P2|STARTED|Overall Study||24
436332|NCT00720473|1039229|P1|STARTED|Overall Study||45
436333|NCT00720434|1039257|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
436334|NCT00720434|1039258|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
436335|NCT00720434|1039259|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
436336|NCT00720434|1039260|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
436337|NCT00720434|1039257|P4|COMPLETED|Open-Label Period (Week 5-72)||4
436338|NCT00720434|1039258|P3|COMPLETED|Open-Label Period (Week 5-72)||4
436339|NCT00720434|1039259|P2|COMPLETED|Open-Label Period (Week 5-72)||5
436340|NCT00720434|1039260|P1|COMPLETED|Open-Label Period (Week 5-72)||4
436341|NCT00720434|1039257|P4|STARTED|Open-Label Period (Week 5-72)||8
436342|NCT00720434|1039258|P3|STARTED|Open-Label Period (Week 5-72)||8
436343|NCT00720434|1039259|P2|STARTED|Open-Label Period (Week 5-72)||8
436344|NCT00720434|1039260|P1|STARTED|Open-Label Period (Week 5-72)||10
436345|NCT00720434|1039257|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
436346|NCT00720434|1039258|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
436347|NCT00720434|1039259|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
436348|NCT00720434|1039260|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
436349|NCT00720434|1039257|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
436350|NCT00720434|1039258|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
436351|NCT00720434|1039259|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
436352|NCT00720434|1039260|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
436353|NCT00720434|1039257|P4|STARTED|Double-Blind Period (Week 1-4)||8
436354|NCT00720434|1039258|P3|STARTED|Double-Blind Period (Week 1-4)||8
436355|NCT00720434|1039259|P2|STARTED|Double-Blind Period (Week 1-4)||9
436356|NCT00720434|1039260|P1|STARTED|Double-Blind Period (Week 1-4)||10
436357|NCT00720382|1039284|P2|NOT COMPLETED|Overall Study||59
436358|NCT00720382|1039285|P1|NOT COMPLETED|Overall Study||176
436359|NCT00720382|1039284|P2|COMPLETED|Overall Study||178
436360|NCT00720382|1039285|P1|COMPLETED|Overall Study||290
436361|NCT00720382|1039284|P2|STARTED|Overall Study||237
436362|NCT00720382|1039285|P1|STARTED|Overall Study||466
436363|NCT00720369|1039295|P2|NOT COMPLETED|Overall Study||0
436364|NCT00720369|1039296|P1|NOT COMPLETED|Overall Study||1
436365|NCT00720369|1039295|P2|COMPLETED|Overall Study||8
436366|NCT00720369|1039296|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
436367|NCT00720369|1039295|P2|STARTED|Overall Study||8
436368|NCT00720369|1039296|P1|STARTED|Overall Study||11
436369|NCT00720343|1039304|P1|NOT COMPLETED|Overall Study||6
436370|NCT00720343|1039304|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
436371|NCT00720343|1039304|P1|STARTED|Overall Study||54
436372|NCT00720330|1039313|P3|NOT COMPLETED|Overall Study||0
436373|NCT00720330|1039314|P2|NOT COMPLETED|Overall Study||0
436374|NCT00720330|1039315|P1|NOT COMPLETED|Overall Study||0
436375|NCT00720330|1039313|P3|COMPLETED|Overall Study||3
436376|NCT00720330|1039314|P2|COMPLETED|Overall Study||4
436377|NCT00720330|1039315|P1|COMPLETED|Overall Study||5
436378|NCT00720330|1039313|P3|STARTED|Overall Study||3
436379|NCT00720330|1039314|P2|STARTED|Overall Study||4
436380|NCT00720330|1039315|P1|STARTED|Overall Study||5
436381|NCT00720278|1039338|P3|NOT COMPLETED|Overall Study||6
436382|NCT00720278|1039339|P2|NOT COMPLETED|Overall Study||4
436383|NCT00720278|1039340|P1|NOT COMPLETED|Overall Study||7
436384|NCT00720278|1039338|P3|COMPLETED|Overall Study||172
436385|NCT00720278|1039339|P2|COMPLETED|Overall Study||166
436386|NCT00720278|1039340|P1|COMPLETED|Overall Study||171
436387|NCT00720278|1039338|P3|STARTED|Overall Study|1 subject was randomized in error|178
436388|NCT00720278|1039339|P2|STARTED|Overall Study|1 subject was randomized in error|170
436389|NCT00720278|1039340|P1|STARTED|Overall Study|1 subject was randomized in error|178
436390|NCT00720226|1039362|P2|NOT COMPLETED|Overall Study||4
436391|NCT00720226|1039363|P1|NOT COMPLETED|Overall Study||7
436392|NCT00720226|1039362|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
436393|NCT00720226|1039363|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
436394|NCT00720226|1039362|P2|STARTED|Overall Study||52
436395|NCT00720226|1039363|P1|STARTED|Overall Study||54
436396|NCT00720122|1039371|P1|NOT COMPLETED|Overall Study||9
436397|NCT00720122|1039371|P1|COMPLETED|Overall Study||19
436398|NCT00720122|1039371|P1|STARTED|Overall Study||28
436399|NCT00720109|1039375|P3|NOT COMPLETED|Risk Stratification Period||8
436400|NCT00720109|1039376|P2|NOT COMPLETED|Risk Stratification Period||15
436401|NCT00720109|1039377|P1|NOT COMPLETED|Risk Stratification Period||0
436402|NCT00720109|1039375|P3|COMPLETED|Risk Stratification Period||1
436403|NCT00720109|1039376|P2|COMPLETED|Risk Stratification Period||33
436404|NCT00720109|1039377|P1|COMPLETED|Risk Stratification Period||0
436405|NCT00720109|1039375|P3|STARTED|Risk Stratification Period||9
436406|NCT00720109|1039376|P2|STARTED|Risk Stratification Period||48
436407|NCT00720109|1039377|P1|STARTED|Risk Stratification Period||0
436408|NCT00720109|1039375|P3|NOT COMPLETED|Induction Period||0
436409|NCT00720109|1039376|P2|NOT COMPLETED|Induction Period||0
436410|NCT00720109|1039377|P1|NOT COMPLETED|Induction Period||6
436411|NCT00720109|1039375|P3|COMPLETED|Induction Period||0
436412|NCT00720109|1039376|P2|COMPLETED|Induction Period||0
436413|NCT00720109|1039377|P1|COMPLETED|Induction Period||57
436414|NCT00720109|1039375|P3|STARTED|Induction Period||0
436415|NCT00720109|1039376|P2|STARTED|Induction Period||0
436416|NCT00720109|1039377|P1|STARTED|Induction Period||63
436417|NCT00720096|1039397|P2|NOT COMPLETED|Overall Study||2
436418|NCT00720096|1039398|P1|NOT COMPLETED|Overall Study||0
436419|NCT00720096|1039397|P2|COMPLETED|Overall Study||0
436420|NCT00720096|1039398|P1|COMPLETED|Overall Study||2
436421|NCT00720096|1039397|P2|STARTED|Overall Study||2
436422|NCT00720096|1039398|P1|STARTED|Overall Study||2
436423|NCT00720083|1039408|P2|NOT COMPLETED|Overall Study||2
436424|NCT00720083|1039409|P1|NOT COMPLETED|Overall Study||1
436425|NCT00720083|1039408|P2|COMPLETED|Overall Study||13
436426|NCT00720083|1039409|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
436427|NCT00720083|1039408|P2|STARTED|Overall Study||15
436428|NCT00720083|1039409|P1|STARTED|Overall Study||17
436429|NCT00720057|1039417|P2|NOT COMPLETED|Overall Study||3
436430|NCT00720057|1039418|P1|NOT COMPLETED|Overall Study||1
436431|NCT00720057|1039417|P2|COMPLETED|Overall Study||156
436432|NCT00720057|1039418|P1|COMPLETED|Overall Study||152
436433|NCT00720057|1039417|P2|STARTED|Overall Study||159
436434|NCT00720057|1039418|P1|STARTED|Overall Study||153
436435|NCT00719953|1039434|P1|NOT COMPLETED|Overall Study||4
436436|NCT00719953|1039434|P1|COMPLETED|Overall Study||26
436437|NCT00719953|1039434|P1|STARTED|Overall Study||30
436438|NCT00719914|1039440|P2|NOT COMPLETED|Overall Study||0
436439|NCT00719914|1039441|P1|NOT COMPLETED|Overall Study||0
436440|NCT00719914|1039440|P2|COMPLETED|Overall Study||7
436441|NCT00719914|1039441|P1|COMPLETED|Overall Study||10
436442|NCT00719914|1039440|P2|STARTED|Overall Study||7
436443|NCT00719914|1039441|P1|STARTED|Overall Study||10
436444|NCT00719901|1039447|P1|NOT COMPLETED|Overall Study||11
436445|NCT00719901|1039447|P1|COMPLETED|Overall Study||0
436446|NCT00719901|1039447|P1|STARTED|Overall Study||11
436447|NCT00719862|1039459|P2|NOT COMPLETED|Overall Study||6
436448|NCT00719862|1039460|P1|NOT COMPLETED|Overall Study||8
436449|NCT00719862|1039459|P2|COMPLETED|Overall Study||233
436450|NCT00719862|1039460|P1|COMPLETED|Overall Study||234
436451|NCT00719862|1039459|P2|STARTED|Overall Study|1 subject was randomized in error|239
436452|NCT00719862|1039460|P1|STARTED|Overall Study||242
436453|NCT00719849|1039478|P2|NOT COMPLETED|Overall Study||1
436454|NCT00719849|1039479|P1|NOT COMPLETED|Overall Study||0
436455|NCT00719849|1039478|P2|COMPLETED|Overall Study||8
436456|NCT00719849|1039479|P1|COMPLETED|Overall Study||4
436457|NCT00719849|1039478|P2|STARTED|Overall Study||9
436458|NCT00719849|1039479|P1|STARTED|Overall Study||4
436459|NCT00719810|1039518|P3|NOT COMPLETED|Overall Study||8
436460|NCT00719810|1039519|P2|NOT COMPLETED|Overall Study||4
436461|NCT00719810|1039520|P1|NOT COMPLETED|Overall Study||3
436462|NCT00719810|1039518|P3|COMPLETED|Overall Study||42
436463|NCT00719810|1039519|P2|COMPLETED|Overall Study||47
436464|NCT00719810|1039520|P1|COMPLETED|Overall Study||46
436465|NCT00719810|1039518|P3|STARTED|Overall Study||50
436466|NCT00719810|1039519|P2|STARTED|Overall Study||51
436467|NCT00719810|1039520|P1|STARTED|Overall Study||49
436468|NCT00719732|1039531|P1|NOT COMPLETED|Overall Study||22
436469|NCT00719732|1039531|P1|COMPLETED|Overall Study||196
436470|NCT00719732|1039531|P1|STARTED|Overall Study||218
436471|NCT00719706|1039537|P2|NOT COMPLETED|Overall Study||6
436472|NCT00719706|1039538|P1|NOT COMPLETED|Overall Study||9
436473|NCT00719706|1039537|P2|COMPLETED|Overall Study||14
436474|NCT00719706|1039538|P1|COMPLETED|Overall Study||11
436475|NCT00719706|1039537|P2|STARTED|Overall Study||20
436476|NCT00719706|1039538|P1|STARTED|Overall Study||20
436477|NCT00719680|1039552|P1|NOT COMPLETED|Overall Study||5
436478|NCT00719680|1039552|P1|COMPLETED|Overall Study||16
436479|NCT00719680|1039552|P1|STARTED|Overall Study||21
436480|NCT00719615|1039575|P3|NOT COMPLETED|Overall Study||0
436481|NCT00719615|1039576|P2|NOT COMPLETED|Overall Study||0
436482|NCT00719615|1039577|P1|NOT COMPLETED|Overall Study||0
436483|NCT00719615|1039575|P3|COMPLETED|Overall Study||24
436484|NCT00719615|1039576|P2|COMPLETED|Overall Study||45
436485|NCT00719615|1039577|P1|COMPLETED|Overall Study||42
436486|NCT00719615|1039575|P3|STARTED|Overall Study||24
436487|NCT00719615|1039576|P2|STARTED|Overall Study||45
436488|NCT00719615|1039577|P1|STARTED|Overall Study||42
436489|NCT00719563|1039587|P2|NOT COMPLETED|Overall Study||42
436490|NCT00719563|1039588|P1|NOT COMPLETED|Overall Study||38
436491|NCT00719563|1039587|P2|COMPLETED|Overall Study||128
436492|NCT00719563|1039588|P1|COMPLETED|Overall Study||133
436493|NCT00719563|1039587|P2|STARTED|Overall Study||170
436494|NCT00719563|1039588|P1|STARTED|Overall Study||171
436495|NCT00719537|1039620|P2|NOT COMPLETED|Overall Study||1
436496|NCT00719537|1039621|P1|NOT COMPLETED|Overall Study||1
436497|NCT00719537|1039620|P2|COMPLETED|Overall Study||0
436498|NCT00719537|1039621|P1|COMPLETED|Overall Study||1
436499|NCT00719537|1039620|P2|STARTED|Overall Study||1
436500|NCT00719537|1039621|P1|STARTED|Overall Study||2
436501|NCT00719472|1039627|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
436502|NCT00719472|1039627|P1|COMPLETED|Received Cycle 2 Treatment||304
436503|NCT00719472|1039627|P1|STARTED|Received Cycle 2 Treatment||372
436504|NCT00719472|1039627|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
436505|NCT00719472|1039627|P1|COMPLETED|Received Cycle 1 Treatment||372
436506|NCT00719472|1039627|P1|STARTED|Received Cycle 1 Treatment||425
436507|NCT00719472|1039627|P1|NOT COMPLETED|Enrolled in Study||26
436508|NCT00719472|1039627|P1|COMPLETED|Enrolled in Study||425
436509|NCT00719472|1039627|P1|STARTED|Enrolled in Study||451
436510|NCT00719355|1039638|P2|NOT COMPLETED|Overall Study||13
436511|NCT00719355|1039639|P1|NOT COMPLETED|Overall Study||18
436512|NCT00719355|1039638|P2|COMPLETED|Overall Study||39
436513|NCT00719355|1039639|P1|COMPLETED|Overall Study||33
436514|NCT00719355|1039638|P2|Completed 32 Weeks|Overall Study||39
436515|NCT00719355|1039639|P1|Completed 32 Weeks|Overall Study||33
436516|NCT00719355|1039638|P2|Completed 24 Weeks|Overall Study||43
436517|NCT00719355|1039639|P1|Completed 24 Weeks|Overall Study||34
436518|NCT00719355|1039638|P2|Completed 12 Weeks|Overall Study||46
436519|NCT00719355|1039639|P1|Completed 12 Weeks|Overall Study||43
436520|NCT00719355|1039638|P2|Completed 6 Weeks|Overall Study||48
436521|NCT00719355|1039639|P1|Completed 6 Weeks|Overall Study||49
436522|NCT00719355|1039638|P2|STARTED|Overall Study||52
436523|NCT00719355|1039639|P1|STARTED|Overall Study||51
436524|NCT00719329|1039650|P3|NOT COMPLETED|Overall Study||1
436525|NCT00719329|1039651|P2|NOT COMPLETED|Overall Study||2
436526|NCT00719329|1039652|P1|NOT COMPLETED|Overall Study||0
436527|NCT00719329|1039650|P3|COMPLETED|Overall Study||646
436528|NCT00719329|1039651|P2|COMPLETED|Overall Study||569
436529|NCT00719329|1039652|P1|COMPLETED|Overall Study||705
436530|NCT00719329|1039650|P3|Day 7 Swab|Overall Study||561
436531|NCT00719329|1039651|P2|Day 7 Swab|Overall Study||467
436532|NCT00719329|1039652|P1|Day 7 Swab|Overall Study||593
436533|NCT00719329|1039650|P3|Day 3 Swab|Overall Study||578
436534|NCT00719329|1039651|P2|Day 3 Swab|Overall Study||501
436535|NCT00719329|1039652|P1|Day 3 Swab|Overall Study||614
436536|NCT00719329|1039650|P3|Day 1 Swab|Overall Study||646
436537|NCT00719329|1039651|P2|Day 1 Swab|Overall Study||569
436538|NCT00719329|1039652|P1|Day 1 Swab|Overall Study||705
436539|NCT00719329|1039650|P3|STARTED|Overall Study||647
436540|NCT00719329|1039651|P2|STARTED|Overall Study||571
436541|NCT00719329|1039652|P1|STARTED|Overall Study||705
436542|NCT00719264|1039668|P2|NOT COMPLETED|Overall Study||183
436543|NCT00719264|1039669|P1|NOT COMPLETED|Overall Study||182
436544|NCT00719264|1039668|P2|COMPLETED|Overall Study||0
436545|NCT00719264|1039669|P1|COMPLETED|Overall Study||0
436546|NCT00719264|1039668|P2|Safety Set|Overall Study||181
436547|NCT00719264|1039669|P1|Safety Set|Overall Study||180
436548|NCT00719264|1039668|P2|Full Analysis Set|Overall Study||183
436549|NCT00719264|1039669|P1|Full Analysis Set|Overall Study||182
436550|NCT00719264|1039668|P2|STARTED|Overall Study||183
436551|NCT00719264|1039669|P1|STARTED|Overall Study||182
436552|NCT00719212|1039688|P1|NOT COMPLETED|Overall Study||44
436553|NCT00719212|1039688|P1|COMPLETED|Overall Study||17
436554|NCT00719212|1039688|P1|STARTED|Overall Study||61
436555|NCT00719186|1039700|P2|NOT COMPLETED|Overall Study||0
436556|NCT00719186|1039701|P1|NOT COMPLETED|Overall Study||0
436557|NCT00719186|1039700|P2|COMPLETED|Overall Study||374
436558|NCT00719186|1039701|P1|COMPLETED|Overall Study||376
436559|NCT00719186|1039700|P2|STARTED|Overall Study||374
436560|NCT00719186|1039701|P1|STARTED|Overall Study||376
436561|NCT00719160|1039713|P2|NOT COMPLETED|Overall Study||0
436562|NCT00719160|1039714|P1|NOT COMPLETED|Overall Study||0
436563|NCT00719160|1039713|P2|COMPLETED|Overall Study||6
436564|NCT00719160|1039714|P1|COMPLETED|Overall Study||6
436565|NCT00719160|1039713|P2|STARTED|Overall Study||6
436566|NCT00719160|1039714|P1|STARTED|Overall Study||6
436567|NCT00719134|1039721|P1|NOT COMPLETED|Overall Study||10
436568|NCT00719134|1039721|P1|COMPLETED|Overall Study||66
436569|NCT00719134|1039721|P1|STARTED|Overall Study||76
436570|NCT00719043|1039734|P7|NOT COMPLETED|Overall Study||28
436571|NCT00719043|1039735|P6|NOT COMPLETED|Overall Study||34
436572|NCT00719043|1039736|P5|NOT COMPLETED|Overall Study||27
436573|NCT00719043|1039737|P4|NOT COMPLETED|Overall Study||23
436574|NCT00719043|1039738|P3|NOT COMPLETED|Overall Study||20
436575|NCT00719043|1039739|P2|NOT COMPLETED|Overall Study||25
436576|NCT00719043|1039740|P1|NOT COMPLETED|Overall Study||32
436577|NCT00719043|1039734|P7|COMPLETED|Overall Study|Up to Day 909|92
436578|NCT00719043|1039735|P6|COMPLETED|Overall Study|Up to Day 909|86
436579|NCT00719043|1039736|P5|COMPLETED|Overall Study|Up to Day 909|95
436580|NCT00719043|1039737|P4|COMPLETED|Overall Study|Up to Day 909|96
436581|NCT00719043|1039738|P3|COMPLETED|Overall Study|Up to Day 909|99
436582|NCT00719043|1039739|P2|COMPLETED|Overall Study|Up to Day 909|96
436583|NCT00719043|1039740|P1|COMPLETED|Overall Study|Up to Day 909|88
436584|NCT00719043|1039734|P7|STARTED|Overall Study||120
436585|NCT00719043|1039735|P6|STARTED|Overall Study||120
436586|NCT00719043|1039736|P5|STARTED|Overall Study||122
436587|NCT00719043|1039737|P4|STARTED|Overall Study||119
436588|NCT00719043|1039738|P3|STARTED|Overall Study||119
436589|NCT00719043|1039739|P2|STARTED|Overall Study||121
436590|NCT00719043|1039740|P1|STARTED|Overall Study||120
436591|NCT00718887|1039864|P2|NOT COMPLETED|Overall Study||9
436592|NCT00718887|1039865|P1|NOT COMPLETED|Overall Study||5
436593|NCT00718887|1039864|P2|COMPLETED|Overall Study||68
436594|NCT00718887|1039865|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
436595|NCT00718887|1039864|P2|STARTED|Overall Study|Participants who received treatment.|77
436596|NCT00718887|1039865|P1|STARTED|Overall Study|Participants who received treatment.|89
436597|NCT00718861|1039889|P2|NOT COMPLETED|Overall Study||18
436598|NCT00718861|1039890|P1|NOT COMPLETED|Overall Study||21
436599|NCT00718861|1039889|P2|COMPLETED|Overall Study||77
436600|NCT00718861|1039890|P1|COMPLETED|Overall Study||74
436601|NCT00718861|1039889|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
436602|NCT00718861|1039890|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
436603|NCT00718861|1039889|P2|Safety Set|Overall Study||95
436604|NCT00718861|1039890|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
436605|NCT00718861|1039889|P2|STARTED|Overall Study||95
436606|NCT00718861|1039890|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
436607|NCT00718809|1039918|P2|NOT COMPLETED|Overall Study||9
436608|NCT00718809|1039919|P1|NOT COMPLETED|Overall Study||12
436609|NCT00718809|1039918|P2|COMPLETED|Overall Study||0
436610|NCT00718809|1039919|P1|COMPLETED|Overall Study||0
436611|NCT00718809|1039918|P2|STARTED|Overall Study||9
436612|NCT00718809|1039919|P1|STARTED|Overall Study||12
436613|NCT00718770|1039933|P1|NOT COMPLETED|Overall Study||8
436614|NCT00718770|1039933|P1|COMPLETED|Overall Study||2
436615|NCT00718770|1039933|P1|STARTED|Overall Study||10
436616|NCT00718640|1039937|P1|NOT COMPLETED|Overall Study||7
436617|NCT00718640|1039937|P1|COMPLETED|Overall Study||3
436618|NCT00718640|1039937|P1|STARTED|Overall Study||10
436619|NCT00718523|1039951|P2|NOT COMPLETED|Overall Study||24
436620|NCT00718523|1039952|P1|NOT COMPLETED|Overall Study||18
436621|NCT00718523|1039951|P2|COMPLETED|Overall Study||62
436622|NCT00718523|1039952|P1|COMPLETED|Overall Study||66
436623|NCT00718523|1039951|P2|STARTED|Overall Study||86
436624|NCT00718523|1039952|P1|STARTED|Overall Study||84
436625|NCT00718328|1039964|P2|NOT COMPLETED|Overall Study||0
436626|NCT00718328|1039965|P1|NOT COMPLETED|Overall Study||1
436627|NCT00718328|1039964|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
436628|NCT00718328|1039965|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
436629|NCT00718328|1039964|P2|STARTED|Overall Study||0
436630|NCT00718328|1039965|P1|STARTED|Overall Study||1
436631|NCT00718315|1039974|P3|NOT COMPLETED|Overall Study||21
436632|NCT00718315|1039975|P2|NOT COMPLETED|Overall Study||22
436633|NCT00718315|1039976|P1|NOT COMPLETED|Overall Study||19
436634|NCT00718315|1039974|P3|COMPLETED|Overall Study||46
436635|NCT00718315|1039975|P2|COMPLETED|Overall Study||45
436636|NCT00718315|1039976|P1|COMPLETED|Overall Study||48
436637|NCT00718315|1039974|P3|STARTED|Overall Study||67
436638|NCT00718315|1039975|P2|STARTED|Overall Study||67
436639|NCT00718315|1039976|P1|STARTED|Overall Study||67
436640|NCT00718302|1040010|P2|NOT COMPLETED|Overall Study||0
436641|NCT00718302|1040011|P1|NOT COMPLETED|Overall Study||0
436642|NCT00718302|1040010|P2|COMPLETED|Overall Study||114
436643|NCT00718302|1040011|P1|COMPLETED|Overall Study||119
436644|NCT00718302|1040010|P2|STARTED|Overall Study||114
436645|NCT00718302|1040011|P1|STARTED|Overall Study||119
436646|NCT00718237|1040027|P2|NOT COMPLETED|Overall Study||15
436647|NCT00718237|1040028|P1|NOT COMPLETED|Overall Study||13
436648|NCT00718237|1040027|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
436649|NCT00718237|1040028|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
436650|NCT00718237|1040027|P2|Vaccinated at Visit 3|Overall Study||369
436651|NCT00718237|1040028|P1|Vaccinated at Visit 3|Overall Study||371
436652|NCT00718237|1040027|P2|Vaccinated at Visit 2|Overall Study||374
436653|NCT00718237|1040028|P1|Vaccinated at Visit 2|Overall Study||373
436654|NCT00718237|1040027|P2|Vaccinated at Visit 1|Overall Study||381
436655|NCT00718237|1040028|P1|Vaccinated at Visit 1|Overall Study||380
436656|NCT00718237|1040027|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
436657|NCT00718237|1040028|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
436658|NCT00718120|1040040|P2|NOT COMPLETED|Overall Study||0
436659|NCT00718120|1040041|P1|NOT COMPLETED|Overall Study||0
436660|NCT00718120|1040040|P2|COMPLETED|Overall Study||55
436661|NCT00718120|1040041|P1|COMPLETED|Overall Study||55
436662|NCT00718120|1040040|P2|STARTED|Overall Study||55
436663|NCT00718120|1040041|P1|STARTED|Overall Study||55
436664|NCT00718081|1040062|P3|NOT COMPLETED|Overall Study||21
436665|NCT00718081|1040063|P2|NOT COMPLETED|Overall Study||4
436666|NCT00718081|1040064|P1|NOT COMPLETED|Overall Study||7
436667|NCT00718081|1040062|P3|COMPLETED|Overall Study||9
436668|NCT00718081|1040063|P2|COMPLETED|Overall Study||25
436669|NCT00718081|1040064|P1|COMPLETED|Overall Study||22
436670|NCT00718081|1040062|P3|STARTED|Overall Study||30
436671|NCT00718081|1040063|P2|STARTED|Overall Study||29
436672|NCT00718081|1040064|P1|STARTED|Overall Study||29
436673|NCT00718042|1040081|P6|NOT COMPLETED|Donor Follow-up||0
436674|NCT00718042|1040082|P5|NOT COMPLETED|Donor Follow-up||19
436675|NCT00718042|1040083|P4|NOT COMPLETED|Donor Follow-up||0
436676|NCT00718042|1040084|P3|NOT COMPLETED|Donor Follow-up||0
436677|NCT00718042|1040085|P2|NOT COMPLETED|Donor Follow-up||0
436678|NCT00718042|1040086|P1|NOT COMPLETED|Donor Follow-up||13
436679|NCT00718042|1040081|P6|COMPLETED|Donor Follow-up||0
436680|NCT00718042|1040082|P5|COMPLETED|Donor Follow-up||24
436681|NCT00718042|1040083|P4|COMPLETED|Donor Follow-up||0
436682|NCT00718042|1040084|P3|COMPLETED|Donor Follow-up||0
436683|NCT00718042|1040085|P2|COMPLETED|Donor Follow-up||0
436684|NCT00718042|1040086|P1|COMPLETED|Donor Follow-up||23
436685|NCT00718042|1040081|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
436686|NCT00718042|1040082|P5|STARTED|Donor Follow-up||43
436687|NCT00718042|1040083|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
436688|NCT00718042|1040084|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
436689|NCT00718042|1040085|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
436690|NCT00718042|1040086|P1|STARTED|Donor Follow-up||36
436691|NCT00718042|1040081|P6|NOT COMPLETED|ESA Chagas Testing||0
436692|NCT00718042|1040082|P5|NOT COMPLETED|ESA Chagas Testing||0
436693|NCT00718042|1040083|P4|NOT COMPLETED|ESA Chagas Testing||0
436694|NCT00718042|1040084|P3|NOT COMPLETED|ESA Chagas Testing||0
436695|NCT00718042|1040085|P2|NOT COMPLETED|ESA Chagas Testing||0
436696|NCT00718042|1040086|P1|NOT COMPLETED|ESA Chagas Testing||0
436697|NCT00718042|1040081|P6|COMPLETED|ESA Chagas Testing||330
436698|NCT00718042|1040082|P5|COMPLETED|ESA Chagas Testing||43
436699|NCT00718042|1040083|P4|COMPLETED|ESA Chagas Testing||110
436700|NCT00718042|1040084|P3|COMPLETED|ESA Chagas Testing||524
436701|NCT00718042|1040085|P2|COMPLETED|ESA Chagas Testing||287
436702|NCT00718042|1040086|P1|COMPLETED|ESA Chagas Testing||36
436703|NCT00718042|1040081|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
436704|NCT00718042|1040082|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
436705|NCT00718042|1040083|P4|STARTED|ESA Chagas Testing||110
436706|NCT00718042|1040084|P3|STARTED|ESA Chagas Testing||524
436707|NCT00718042|1040085|P2|STARTED|ESA Chagas Testing||287
436708|NCT00718042|1040086|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
436709|NCT00718042|1040081|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
436710|NCT00718042|1040082|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
436711|NCT00718042|1040083|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
436712|NCT00718042|1040084|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
436713|NCT00718042|1040085|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
436714|NCT00718042|1040086|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
436715|NCT00718042|1040081|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
436716|NCT00718042|1040082|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
436717|NCT00718042|1040083|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
436718|NCT00718042|1040084|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
436719|NCT00718042|1040085|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
436720|NCT00718042|1040086|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
436721|NCT00718042|1040081|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
436722|NCT00718042|1040082|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
436723|NCT00718042|1040083|P4|STARTED|ABBOTT PRISM Chagas Testing||110
436724|NCT00718042|1040084|P3|STARTED|ABBOTT PRISM Chagas Testing||525
436725|NCT00718042|1040085|P2|STARTED|ABBOTT PRISM Chagas Testing||289
436726|NCT00718042|1040086|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
436727|NCT00717977|1040098|P1|NOT COMPLETED|Overall Study||0
436728|NCT00717977|1040098|P1|COMPLETED|Overall Study||74
436729|NCT00717977|1040098|P1|STARTED|Overall Study||74
436730|NCT00717886|1040126|P1|NOT COMPLETED|Overall Study||4
436731|NCT00717886|1040126|P1|COMPLETED|Overall Study||9
436732|NCT00717886|1040126|P1|STARTED|Overall Study||13
436733|NCT00717873|1040132|P2|NOT COMPLETED|Overall Study||0
436734|NCT00717873|1040133|P1|NOT COMPLETED|Overall Study||0
436735|NCT00717873|1040132|P2|COMPLETED|Overall Study||59
436736|NCT00717873|1040133|P1|COMPLETED|Overall Study||46
436737|NCT00717873|1040132|P2|STARTED|Overall Study||59
436738|NCT00717873|1040133|P1|STARTED|Overall Study||46
436739|NCT00717860|1040141|P2|NOT COMPLETED|Overall Study||28
436740|NCT00717860|1040142|P1|NOT COMPLETED|Overall Study||27
436741|NCT00717860|1040141|P2|COMPLETED|Overall Study||32
436742|NCT00717860|1040142|P1|COMPLETED|Overall Study||34
436743|NCT00717860|1040141|P2|STARTED|Overall Study||60
436744|NCT00717860|1040142|P1|STARTED|Overall Study||61
436745|NCT00717756|1040152|P1|NOT COMPLETED|Overall Study||1
436746|NCT00717756|1040152|P1|COMPLETED|Overall Study||40
436747|NCT00717756|1040152|P1|STARTED|Overall Study||41
436748|NCT00717522|1040156|P1|NOT COMPLETED|Overall Study||7
436749|NCT00717522|1040156|P1|COMPLETED|Overall Study||0
436750|NCT00717522|1040156|P1|STARTED|Overall Study||7
436751|NCT00717418|1040165|P4|NOT COMPLETED|1-Year Follow-Up||4
436752|NCT00717418|1040166|P3|NOT COMPLETED|1-Year Follow-Up||434
436753|NCT00717418|1040167|P2|NOT COMPLETED|1-Year Follow-Up||51
436754|NCT00717418|1040168|P1|NOT COMPLETED|1-Year Follow-Up||147
436755|NCT00717418|1040165|P4|COMPLETED|1-Year Follow-Up||0
436756|NCT00717418|1040166|P3|COMPLETED|1-Year Follow-Up||74
436757|NCT00717418|1040167|P2|COMPLETED|1-Year Follow-Up||23
436758|NCT00717418|1040168|P1|COMPLETED|1-Year Follow-Up||33
436759|NCT00717418|1040165|P4|STARTED|1-Year Follow-Up||4
436760|NCT00717418|1040166|P3|STARTED|1-Year Follow-Up||508
436761|NCT00717418|1040167|P2|STARTED|1-Year Follow-Up||74
436762|NCT00717418|1040168|P1|STARTED|1-Year Follow-Up||180
436763|NCT00717418|1040165|P4|NOT COMPLETED|Baseline||15
436764|NCT00717418|1040166|P3|NOT COMPLETED|Baseline||0
436765|NCT00717418|1040167|P2|NOT COMPLETED|Baseline||0
436766|NCT00717418|1040168|P1|NOT COMPLETED|Baseline||0
436767|NCT00717418|1040165|P4|COMPLETED|Baseline||4
436768|NCT00717418|1040166|P3|COMPLETED|Baseline||508
436769|NCT00717418|1040167|P2|COMPLETED|Baseline||74
436770|NCT00717418|1040168|P1|COMPLETED|Baseline||180
436771|NCT00717418|1040165|P4|STARTED|Baseline||19
436772|NCT00717418|1040166|P3|STARTED|Baseline||508
436773|NCT00717418|1040167|P2|STARTED|Baseline||74
436774|NCT00717418|1040168|P1|STARTED|Baseline||180
436775|NCT00717405|1040173|P1|NOT COMPLETED|Overall Study||0
436776|NCT00717405|1040173|P1|COMPLETED|Overall Study||52
436777|NCT00717405|1040173|P1|STARTED|Overall Study||52
436778|NCT00717314|1040192|P2|NOT COMPLETED|Overall Study||10
436779|NCT00717314|1040193|P1|NOT COMPLETED|Overall Study||6
436780|NCT00717314|1040192|P2|COMPLETED|Overall Study||34
436781|NCT00717314|1040193|P1|COMPLETED|Overall Study||37
436782|NCT00717314|1040192|P2|STARTED|Overall Study||44
436783|NCT00717314|1040193|P1|STARTED|Overall Study||43
436784|NCT00717288|1040214|P3|NOT COMPLETED|Overall Study||0
436785|NCT00717288|1040215|P2|NOT COMPLETED|Overall Study||0
436786|NCT00717288|1040216|P1|NOT COMPLETED|Overall Study||0
436787|NCT00717288|1040214|P3|COMPLETED|Overall Study||25
436788|NCT00717288|1040215|P2|COMPLETED|Overall Study||29
436789|NCT00717288|1040216|P1|COMPLETED|Overall Study||28
436790|NCT00717288|1040214|P3|STARTED|Overall Study||25
436791|NCT00717288|1040215|P2|STARTED|Overall Study||29
436792|NCT00717288|1040216|P1|STARTED|Overall Study||28
436793|NCT00717275|1040230|P1|NOT COMPLETED|Overall Study||3
436794|NCT00717275|1040230|P1|COMPLETED|Overall Study||0
436795|NCT00717275|1040230|P1|STARTED|Overall Study||3
436796|NCT00717249|1040236|P2|NOT COMPLETED|Overall Study||15
436797|NCT00717249|1040237|P1|NOT COMPLETED|Overall Study||22
436798|NCT00717249|1040236|P2|COMPLETED|Overall Study||150
436799|NCT00717249|1040237|P1|COMPLETED|Overall Study||304
436800|NCT00717249|1040236|P2|STARTED|Overall Study||165
436801|NCT00717249|1040237|P1|STARTED|Overall Study||326
436802|NCT00717236|1040251|P2|NOT COMPLETED|Open-Label Period||21
436803|NCT00717236|1040252|P1|NOT COMPLETED|Open-Label Period||125
436804|NCT00717236|1040251|P2|COMPLETED|Open-Label Period||163
436805|NCT00717236|1040252|P1|COMPLETED|Open-Label Period||646
436806|NCT00717236|1040251|P2|STARTED|Open-Label Period||184
436807|NCT00717236|1040252|P1|STARTED|Open-Label Period||771
436808|NCT00717236|1040251|P2|NOT COMPLETED|Double-Blind Period||28
436809|NCT00717236|1040252|P1|NOT COMPLETED|Double-Blind Period||80
436810|NCT00717236|1040251|P2|COMPLETED|Double-Blind Period||184
436811|NCT00717236|1040252|P1|COMPLETED|Double-Blind Period||771
436812|NCT00717236|1040251|P2|STARTED|Double-Blind Period||212
436813|NCT00717236|1040252|P1|STARTED|Double-Blind Period||851
436814|NCT00717197|1040321|P1|NOT COMPLETED|Overall Study||7
436815|NCT00717197|1040321|P1|COMPLETED|Overall Study||23
436816|NCT00717197|1040321|P1|STARTED|Overall Study||30
436817|NCT00717093|1040327|P2|NOT COMPLETED|Overall Study||48
436818|NCT00717093|1040328|P1|NOT COMPLETED|Overall Study||44
436819|NCT00717093|1040327|P2|COMPLETED|Overall Study||170
436820|NCT00717093|1040328|P1|COMPLETED|Overall Study||170
436821|NCT00717093|1040327|P2|Received Treatment|Overall Study||218
436822|NCT00717093|1040328|P1|Received Treatment|Overall Study||213
436823|NCT00717093|1040327|P2|STARTED|Overall Study||218
436824|NCT00717093|1040328|P1|STARTED|Overall Study||214
436825|NCT00717067|1040345|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
436826|NCT00717067|1040346|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
436827|NCT00717067|1040347|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
436828|NCT00717067|1040348|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
436829|NCT00717067|1040349|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
436830|NCT00717067|1040345|P5|COMPLETED|Part 2: End Stage Renal Disease||6
436831|NCT00717067|1040346|P4|COMPLETED|Part 2: End Stage Renal Disease||0
436832|NCT00717067|1040347|P3|COMPLETED|Part 2: End Stage Renal Disease||0
436833|NCT00717067|1040348|P2|COMPLETED|Part 2: End Stage Renal Disease||0
436834|NCT00717067|1040349|P1|COMPLETED|Part 2: End Stage Renal Disease||0
436835|NCT00717067|1040345|P5|STARTED|Part 2: End Stage Renal Disease||6
436836|NCT00717067|1040346|P4|STARTED|Part 2: End Stage Renal Disease||0
436837|NCT00717067|1040347|P3|STARTED|Part 2: End Stage Renal Disease||0
436838|NCT00717067|1040348|P2|STARTED|Part 2: End Stage Renal Disease||0
436839|NCT00717067|1040349|P1|STARTED|Part 2: End Stage Renal Disease||0
436840|NCT00717067|1040345|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
436841|NCT00717067|1040346|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
436842|NCT00717067|1040347|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
436843|NCT00717067|1040348|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
436844|NCT00717067|1040349|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
436845|NCT00717067|1040345|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
436846|NCT00717067|1040346|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
436847|NCT00717067|1040347|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
436848|NCT00717067|1040348|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
436849|NCT00717067|1040349|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
436850|NCT00717067|1040345|P5|STARTED|Part 1b: Severe Renal Impairment||0
436851|NCT00717067|1040346|P4|STARTED|Part 1b: Severe Renal Impairment||6
436852|NCT00717067|1040347|P3|STARTED|Part 1b: Severe Renal Impairment||0
436853|NCT00717067|1040348|P2|STARTED|Part 1b: Severe Renal Impairment||0
436854|NCT00717067|1040349|P1|STARTED|Part 1b: Severe Renal Impairment||0
436855|NCT00717067|1040345|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
436856|NCT00717067|1040346|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
436857|NCT00717067|1040347|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
436858|NCT00717067|1040348|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
436859|NCT00717067|1040349|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
436860|NCT00717067|1040345|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
436861|NCT00717067|1040346|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
436862|NCT00717067|1040347|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
436863|NCT00717067|1040348|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
436864|NCT00717067|1040349|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
436865|NCT00717067|1040345|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
436866|NCT00717067|1040346|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
436867|NCT00717067|1040347|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
436868|NCT00717067|1040348|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
436869|NCT00717067|1040349|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
436870|NCT00717054|1040433|P2|NOT COMPLETED|Overall Study||0
436871|NCT00717054|1040434|P1|NOT COMPLETED|Overall Study||0
436872|NCT00717054|1040433|P2|COMPLETED|Overall Study||57
436873|NCT00717054|1040434|P1|COMPLETED|Overall Study||58
436874|NCT00717054|1040433|P2|STARTED|Overall Study||57
436875|NCT00717054|1040434|P1|STARTED|Overall Study||58
436876|NCT00717041|1040446|P1|NOT COMPLETED|Overall Study||0
436877|NCT00717041|1040446|P1|COMPLETED|Overall Study||1206
436878|NCT00717041|1040446|P1|STARTED|Overall Study||1206
436879|NCT00716976|1040456|P2|NOT COMPLETED|Overall Study||9
436880|NCT00716976|1040457|P1|NOT COMPLETED|Overall Study||20
436881|NCT00716976|1040456|P2|COMPLETED|Overall Study||57
436882|NCT00716976|1040457|P1|COMPLETED|Overall Study||45
436883|NCT00716976|1040456|P2|STARTED|Overall Study||66
436884|NCT00716976|1040457|P1|STARTED|Overall Study||65
436885|NCT00716963|1040477|P6|NOT COMPLETED|Overall Study||0
436886|NCT00716963|1040478|P5|NOT COMPLETED|Overall Study||0
436887|NCT00716963|1040479|P4|NOT COMPLETED|Overall Study||0
436888|NCT00716963|1040480|P3|NOT COMPLETED|Overall Study||0
436889|NCT00716963|1040481|P2|NOT COMPLETED|Overall Study||0
436890|NCT00716963|1040482|P1|NOT COMPLETED|Overall Study||1
436891|NCT00716963|1040477|P6|COMPLETED|Overall Study||1
436892|NCT00716963|1040478|P5|COMPLETED|Overall Study||1
436893|NCT00716963|1040479|P4|COMPLETED|Overall Study||1
436894|NCT00716963|1040480|P3|COMPLETED|Overall Study||1
436895|NCT00716963|1040481|P2|COMPLETED|Overall Study||1
436896|NCT00716963|1040482|P1|COMPLETED|Overall Study||1
436897|NCT00716963|1040477|P6|STARTED|Overall Study||1
436898|NCT00716963|1040478|P5|STARTED|Overall Study||1
436899|NCT00716963|1040479|P4|STARTED|Overall Study||1
436900|NCT00716963|1040480|P3|STARTED|Overall Study||1
436901|NCT00716963|1040481|P2|STARTED|Overall Study||1
436902|NCT00716963|1040482|P1|STARTED|Overall Study||2
436903|NCT00716859|1040495|P2|NOT COMPLETED|Overall Study||5
436904|NCT00716859|1040496|P1|NOT COMPLETED|Overall Study||9
436905|NCT00716859|1040495|P2|COMPLETED|Overall Study||64
436906|NCT00716859|1040496|P1|COMPLETED|Overall Study||61
436907|NCT00716859|1040495|P2|Received Treatment|Overall Study||68
436908|NCT00716859|1040496|P1|Received Treatment|Overall Study||69
436909|NCT00716859|1040495|P2|STARTED|Overall Study||69
436910|NCT00716859|1040496|P1|STARTED|Overall Study||70
436911|NCT00716820|1040520|P1|NOT COMPLETED|Overall Study||0
436912|NCT00716820|1040520|P1|COMPLETED|Overall Study||472
436913|NCT00716820|1040520|P1|STARTED|Overall Study||472
436914|NCT00716807|1040555|P4|NOT COMPLETED|Overall Study||0
436915|NCT00716807|1040556|P3|NOT COMPLETED|Overall Study||0
436916|NCT00716807|1040557|P2|NOT COMPLETED|Overall Study||0
436917|NCT00716807|1040558|P1|NOT COMPLETED|Overall Study||0
436918|NCT00716807|1040555|P4|COMPLETED|Overall Study||15
436919|NCT00716807|1040556|P3|COMPLETED|Overall Study||18
436920|NCT00716807|1040557|P2|COMPLETED|Overall Study||5
436921|NCT00716807|1040558|P1|COMPLETED|Overall Study||8
436922|NCT00716807|1040555|P4|STARTED|Overall Study||15
436923|NCT00716807|1040556|P3|STARTED|Overall Study||18
436924|NCT00716807|1040557|P2|STARTED|Overall Study||5
436925|NCT00716807|1040558|P1|STARTED|Overall Study||8
436926|NCT00716742|1040571|P3|NOT COMPLETED|3 Year Follow-up||21
436927|NCT00716742|1040572|P2|NOT COMPLETED|3 Year Follow-up||32
436928|NCT00716742|1040573|P1|NOT COMPLETED|3 Year Follow-up||30
436929|NCT00716742|1040571|P3|COMPLETED|3 Year Follow-up||29
436930|NCT00716742|1040572|P2|COMPLETED|3 Year Follow-up||35
436931|NCT00716742|1040573|P1|COMPLETED|3 Year Follow-up||26
436932|NCT00716742|1040571|P3|STARTED|3 Year Follow-up||50
436933|NCT00716742|1040572|P2|STARTED|3 Year Follow-up||67
436934|NCT00716742|1040573|P1|STARTED|3 Year Follow-up||56
436935|NCT00716742|1040571|P3|NOT COMPLETED|2 Year Follow-up||102
436936|NCT00716742|1040572|P2|NOT COMPLETED|2 Year Follow-up||96
436937|NCT00716742|1040573|P1|NOT COMPLETED|2 Year Follow-up||104
436938|NCT00716742|1040571|P3|COMPLETED|2 Year Follow-up||50
436939|NCT00716742|1040572|P2|COMPLETED|2 Year Follow-up||67
436940|NCT00716742|1040573|P1|COMPLETED|2 Year Follow-up||56
436941|NCT00716742|1040571|P3|STARTED|2 Year Follow-up||152
436942|NCT00716742|1040572|P2|STARTED|2 Year Follow-up||163
436943|NCT00716742|1040573|P1|STARTED|2 Year Follow-up||160
436944|NCT00716742|1040571|P3|NOT COMPLETED|1 Year Follow-up||200
436945|NCT00716742|1040572|P2|NOT COMPLETED|1 Year Follow-up||193
436946|NCT00716742|1040573|P1|NOT COMPLETED|1 Year Follow-up||187
436947|NCT00716742|1040571|P3|COMPLETED|1 Year Follow-up||152
436948|NCT00716742|1040572|P2|COMPLETED|1 Year Follow-up||163
436949|NCT00716742|1040573|P1|COMPLETED|1 Year Follow-up||160
436950|NCT00716742|1040571|P3|STARTED|1 Year Follow-up||352
436951|NCT00716742|1040572|P2|STARTED|1 Year Follow-up||356
436952|NCT00716742|1040573|P1|STARTED|1 Year Follow-up||347
436953|NCT00716742|1040571|P3|NOT COMPLETED|Baseline||13
436954|NCT00716742|1040572|P2|NOT COMPLETED|Baseline||14
436955|NCT00716742|1040573|P1|NOT COMPLETED|Baseline||17
436956|NCT00716742|1040571|P3|COMPLETED|Baseline||352
436957|NCT00716742|1040572|P2|COMPLETED|Baseline||356
436958|NCT00716742|1040573|P1|COMPLETED|Baseline||347
436959|NCT00716742|1040571|P3|STARTED|Baseline||365
436960|NCT00716742|1040572|P2|STARTED|Baseline||370
436961|NCT00716742|1040573|P1|STARTED|Baseline||364
436962|NCT00716625|1040581|P1|NOT COMPLETED|Overall Study||1
436963|NCT00716625|1040581|P1|COMPLETED|Overall Study||1673
436964|NCT00716625|1040581|P1|STARTED|Overall Study||1674
436965|NCT00716482|1040606|P1|NOT COMPLETED|Overall Study||119
436966|NCT00716482|1040606|P1|COMPLETED|Overall Study||1562
436967|NCT00716482|1040606|P1|STARTED|Overall Study||1681
436968|NCT00716456|1040619|P3|NOT COMPLETED|Overall Study||0
436969|NCT00716456|1040620|P2|NOT COMPLETED|Overall Study||2
436970|NCT00716456|1040621|P1|NOT COMPLETED|Overall Study||0
436971|NCT00716456|1040619|P3|COMPLETED|Overall Study||13
436972|NCT00716456|1040620|P2|COMPLETED|Overall Study||3
436973|NCT00716456|1040621|P1|COMPLETED|Overall Study||3
436974|NCT00716456|1040619|P3|STARTED|Overall Study||13
436975|NCT00716456|1040620|P2|STARTED|Overall Study||5
436976|NCT00716456|1040621|P1|STARTED|Overall Study||3
436977|NCT00716443|1040629|P1|NOT COMPLETED|Overall Study||0
436978|NCT00716443|1040629|P1|COMPLETED|Overall Study||51
436979|NCT00716443|1040629|P1|STARTED|Overall Study||51
436980|NCT00716417|1040672|P10|NOT COMPLETED|Overall Study||3
436981|NCT00716417|1040673|P9|NOT COMPLETED|Overall Study||5
436982|NCT00716417|1040674|P8|NOT COMPLETED|Overall Study||3
436983|NCT00716417|1040675|P7|NOT COMPLETED|Overall Study||7
436984|NCT00716417|1040676|P6|NOT COMPLETED|Overall Study||3
436985|NCT00716417|1040677|P5|NOT COMPLETED|Overall Study||1
436986|NCT00716417|1040678|P4|NOT COMPLETED|Overall Study||11
436987|NCT00716417|1040679|P3|NOT COMPLETED|Overall Study||5
436988|NCT00716417|1040680|P2|NOT COMPLETED|Overall Study||6
436989|NCT00716417|1040681|P1|NOT COMPLETED|Overall Study||3
436990|NCT00716417|1040672|P10|COMPLETED|Overall Study||0
436991|NCT00716417|1040673|P9|COMPLETED|Overall Study||0
436992|NCT00716417|1040674|P8|COMPLETED|Overall Study||0
436993|NCT00716417|1040675|P7|COMPLETED|Overall Study||0
436994|NCT00716417|1040676|P6|COMPLETED|Overall Study||0
436995|NCT00716417|1040677|P5|COMPLETED|Overall Study||0
436996|NCT00716417|1040678|P4|COMPLETED|Overall Study||0
436997|NCT00716417|1040679|P3|COMPLETED|Overall Study||0
436998|NCT00716417|1040680|P2|COMPLETED|Overall Study||0
436999|NCT00716417|1040681|P1|COMPLETED|Overall Study||0
437000|NCT00716417|1040672|P10|STARTED|Overall Study||3
437001|NCT00716417|1040673|P9|STARTED|Overall Study||5
437002|NCT00716417|1040674|P8|STARTED|Overall Study||3
437003|NCT00716417|1040675|P7|STARTED|Overall Study||7
437004|NCT00716417|1040676|P6|STARTED|Overall Study||3
437005|NCT00716417|1040677|P5|STARTED|Overall Study||1
437006|NCT00716417|1040678|P4|STARTED|Overall Study||11
437007|NCT00716417|1040679|P3|STARTED|Overall Study||5
437008|NCT00716417|1040680|P2|STARTED|Overall Study||6
437009|NCT00716417|1040681|P1|STARTED|Overall Study||3
437010|NCT00716092|1040728|P3|NOT COMPLETED|Overall Study||0
437011|NCT00716092|1040729|P2|NOT COMPLETED|Overall Study||1
437012|NCT00716092|1040730|P1|NOT COMPLETED|Overall Study||2
437013|NCT00716092|1040728|P3|COMPLETED|Overall Study||41
437014|NCT00716092|1040729|P2|COMPLETED|Overall Study||39
437015|NCT00716092|1040730|P1|COMPLETED|Overall Study||38
437016|NCT00716092|1040728|P3|STARTED|Overall Study||41
437017|NCT00716092|1040729|P2|STARTED|Overall Study||40
437018|NCT00716092|1040730|P1|STARTED|Overall Study||40
437019|NCT00716079|1040761|P2|NOT COMPLETED|Overall Study||15
437020|NCT00716079|1040762|P1|NOT COMPLETED|Overall Study||9
437021|NCT00716079|1040761|P2|COMPLETED|Overall Study||1421
437022|NCT00716079|1040762|P1|COMPLETED|Overall Study||1394
437023|NCT00716079|1040761|P2|STARTED|Overall Study||1436
437024|NCT00716079|1040762|P1|STARTED|Overall Study||1403
437025|NCT00715962|1040772|P2|NOT COMPLETED|Overall Study||2
437026|NCT00715962|1040773|P1|NOT COMPLETED|Overall Study||6
437027|NCT00715962|1040772|P2|COMPLETED|Overall Study||48
437028|NCT00715962|1040773|P1|COMPLETED|Overall Study||44
437029|NCT00715962|1040772|P2|STARTED|Overall Study||50
437030|NCT00715962|1040773|P1|STARTED|Overall Study||50
437031|NCT00715949|1040783|P1|NOT COMPLETED|Overall Study||4
437032|NCT00715949|1040783|P1|COMPLETED|Overall Study|116 patients completed first test|116
437033|NCT00715949|1040783|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
437034|NCT00715910|1040791|P6|NOT COMPLETED|Booster and ESFU Phase||13
437035|NCT00715910|1040792|P5|NOT COMPLETED|Booster and ESFU Phase||2
437036|NCT00715910|1040793|P4|NOT COMPLETED|Booster and ESFU Phase||11
437037|NCT00715910|1040794|P3|NOT COMPLETED|Booster and ESFU Phase||0
437038|NCT00715910|1040795|P2|NOT COMPLETED|Booster and ESFU Phase||0
437039|NCT00715910|1040796|P1|NOT COMPLETED|Booster and ESFU Phase||0
437040|NCT00715910|1040791|P6|COMPLETED|Booster and ESFU Phase||88
437041|NCT00715910|1040792|P5|COMPLETED|Booster and ESFU Phase||36
437042|NCT00715910|1040793|P4|COMPLETED|Booster and ESFU Phase||172
437043|NCT00715910|1040794|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
437044|NCT00715910|1040795|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
437045|NCT00715910|1040796|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
437046|NCT00715910|1040791|P6|STARTED|Booster and ESFU Phase||101
437047|NCT00715910|1040792|P5|STARTED|Booster and ESFU Phase||38
437048|NCT00715910|1040793|P4|STARTED|Booster and ESFU Phase||183
437049|NCT00715910|1040794|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
437050|NCT00715910|1040795|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
437051|NCT00715910|1040796|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
437052|NCT00715910|1040791|P6|NOT COMPLETED|Year 5||0
437053|NCT00715910|1040792|P5|NOT COMPLETED|Year 5||0
437054|NCT00715910|1040793|P4|NOT COMPLETED|Year 5||0
437055|NCT00715910|1040794|P3|NOT COMPLETED|Year 5||0
437056|NCT00715910|1040795|P2|NOT COMPLETED|Year 5||0
437057|NCT00715910|1040796|P1|NOT COMPLETED|Year 5||0
437058|NCT00715910|1040791|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
437059|NCT00715910|1040792|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
437060|NCT00715910|1040793|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
437061|NCT00715910|1040794|P3|COMPLETED|Year 5||38
437062|NCT00715910|1040795|P2|COMPLETED|Year 5||56
437063|NCT00715910|1040796|P1|COMPLETED|Year 5||218
437064|NCT00715910|1040791|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
437065|NCT00715910|1040792|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
437066|NCT00715910|1040793|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
437067|NCT00715910|1040794|P3|STARTED|Year 5||38
437068|NCT00715910|1040795|P2|STARTED|Year 5||56
437069|NCT00715910|1040796|P1|STARTED|Year 5||218
437070|NCT00715910|1040791|P6|NOT COMPLETED|Year 3||0
437071|NCT00715910|1040792|P5|NOT COMPLETED|Year 3||0
437072|NCT00715910|1040793|P4|NOT COMPLETED|Year 3||0
437073|NCT00715910|1040794|P3|NOT COMPLETED|Year 3||0
437074|NCT00715910|1040795|P2|NOT COMPLETED|Year 3||0
437075|NCT00715910|1040796|P1|NOT COMPLETED|Year 3||0
437076|NCT00715910|1040791|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
437077|NCT00715910|1040792|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
437078|NCT00715910|1040793|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
437079|NCT00715910|1040794|P3|COMPLETED|Year 3||56
437080|NCT00715910|1040795|P2|COMPLETED|Year 3||86
437081|NCT00715910|1040796|P1|COMPLETED|Year 3||345
437082|NCT00715910|1040791|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
437083|NCT00715910|1040792|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
437084|NCT00715910|1040793|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
437085|NCT00715910|1040794|P3|STARTED|Year 3||56
437086|NCT00715910|1040795|P2|STARTED|Year 3||86
437087|NCT00715910|1040796|P1|STARTED|Year 3||345
437088|NCT00715910|1040791|P6|NOT COMPLETED|Year 1||0
437089|NCT00715910|1040792|P5|NOT COMPLETED|Year 1||0
437090|NCT00715910|1040793|P4|NOT COMPLETED|Year 1||0
437091|NCT00715910|1040794|P3|NOT COMPLETED|Year 1||0
437092|NCT00715910|1040795|P2|NOT COMPLETED|Year 1||0
437093|NCT00715910|1040796|P1|NOT COMPLETED|Year 1||0
437094|NCT00715910|1040791|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
437095|NCT00715910|1040792|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
437096|NCT00715910|1040793|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
437097|NCT00715910|1040794|P3|COMPLETED|Year 1||68
437098|NCT00715910|1040795|P2|COMPLETED|Year 1||147
437099|NCT00715910|1040796|P1|COMPLETED|Year 1||433
437100|NCT00715910|1040791|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
437101|NCT00715910|1040792|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
437102|NCT00715910|1040793|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
437103|NCT00715910|1040794|P3|STARTED|Year 1||68
437104|NCT00715910|1040795|P2|STARTED|Year 1||147
437105|NCT00715910|1040796|P1|STARTED|Year 1||433
437106|NCT00715884|1040872|P2|NOT COMPLETED|Overall Study||1
437107|NCT00715884|1040873|P1|NOT COMPLETED|Overall Study||8
437108|NCT00715884|1040872|P2|COMPLETED|Overall Study||225
437109|NCT00715884|1040873|P1|COMPLETED|Overall Study||444
437110|NCT00715884|1040872|P2|STARTED|Overall Study||226
437111|NCT00715884|1040873|P1|STARTED|Overall Study||452
437112|NCT00715754|1040915|P1|NOT COMPLETED|Overall Study||0
437113|NCT00715754|1040915|P1|COMPLETED|Overall Study||47
437114|NCT00715754|1040915|P1|STARTED|Overall Study||47
437115|NCT00715741|1040925|P4|NOT COMPLETED|Overall Study||0
437116|NCT00715741|1040926|P3|NOT COMPLETED|Overall Study||0
437117|NCT00715741|1040927|P2|NOT COMPLETED|Overall Study||0
437118|NCT00715741|1040928|P1|NOT COMPLETED|Overall Study||0
437119|NCT00715741|1040925|P4|COMPLETED|Overall Study||25
437120|NCT00715741|1040926|P3|COMPLETED|Overall Study||25
437121|NCT00715741|1040927|P2|COMPLETED|Overall Study||25
437122|NCT00715741|1040928|P1|COMPLETED|Overall Study||25
437123|NCT00715741|1040925|P4|STARTED|Overall Study||25
437124|NCT00715741|1040926|P3|STARTED|Overall Study||25
437125|NCT00715741|1040927|P2|STARTED|Overall Study||25
437126|NCT00715741|1040928|P1|STARTED|Overall Study||25
437127|NCT00715676|1040953|P3|NOT COMPLETED|Overall Study||32
437128|NCT00715676|1040954|P2|NOT COMPLETED|Overall Study||11
437129|NCT00715676|1040955|P1|NOT COMPLETED|Overall Study||6
437130|NCT00715676|1040953|P3|COMPLETED|Overall Study||21
437131|NCT00715676|1040954|P2|COMPLETED|Overall Study||43
437132|NCT00715676|1040955|P1|COMPLETED|Overall Study||43
437133|NCT00715676|1040953|P3|STARTED|Overall Study||53
437134|NCT00715676|1040954|P2|STARTED|Overall Study||54
437135|NCT00715676|1040955|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
437136|NCT00715650|1040983|P2|NOT COMPLETED|Follow-up||5
437137|NCT00715650|1040984|P1|NOT COMPLETED|Follow-up||13
437138|NCT00715650|1040983|P2|COMPLETED|Follow-up||37
437139|NCT00715650|1040984|P1|COMPLETED|Follow-up||29
437140|NCT00715650|1040983|P2|Completed Month 6 Follow-up|Follow-up||37
437141|NCT00715650|1040984|P1|Completed Month 6 Follow-up|Follow-up||29
437142|NCT00715650|1040983|P2|Completed Month 3 Follow-up|Follow-up||40
437143|NCT00715650|1040984|P1|Completed Month 3 Follow-up|Follow-up||35
437144|NCT00715650|1040983|P2|Completed Month 1 Follow-up|Follow-up||38
437145|NCT00715650|1040984|P1|Completed Month 1 Follow-up|Follow-up||40
437146|NCT00715650|1040983|P2|STARTED|Follow-up||42
437147|NCT00715650|1040984|P1|STARTED|Follow-up||42
437148|NCT00715650|1040983|P2|NOT COMPLETED|Intervention||3
437149|NCT00715650|1040984|P1|NOT COMPLETED|Intervention||5
437150|NCT00715650|1040983|P2|COMPLETED|Intervention||42
437151|NCT00715650|1040984|P1|COMPLETED|Intervention||42
437152|NCT00715650|1040983|P2|Attended ≥ 3 Sessions|Intervention||17
437153|NCT00715650|1040984|P1|Attended ≥ 3 Sessions|Intervention||23
437154|NCT00715650|1040983|P2|Attended ≥ 2 Sessions|Intervention||33
437155|NCT00715650|1040984|P1|Attended ≥ 2 Sessions|Intervention||36
437156|NCT00715650|1040983|P2|Received Any Session|Intervention||38
437157|NCT00715650|1040984|P1|Received Any Session|Intervention||39
437158|NCT00715650|1040983|P2|STARTED|Intervention||45
437159|NCT00715650|1040984|P1|STARTED|Intervention||47
437160|NCT00715624|1040998|P2|NOT COMPLETED|Overall Study||116
437161|NCT00715624|1040999|P1|NOT COMPLETED|Overall Study||52
437162|NCT00715624|1040998|P2|COMPLETED|Overall Study||213
437163|NCT00715624|1040999|P1|COMPLETED|Overall Study||115
437164|NCT00715624|1040998|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
437165|NCT00715624|1040999|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
437166|NCT00715624|1040998|P2|Treated/Safety Population|Overall Study||328
437167|NCT00715624|1040999|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
437168|NCT00715624|1040998|P2|STARTED|Overall Study||329
437169|NCT00715624|1040999|P1|STARTED|Overall Study|Randomized|167
437170|NCT00715559|1041027|P1|NOT COMPLETED|Overall Study||1
437171|NCT00715559|1041027|P1|COMPLETED|Overall Study||2
437172|NCT00715559|1041027|P1|STARTED|Overall Study||3
437173|NCT00715403|1041041|P7|NOT COMPLETED|Overall Study||1
437174|NCT00715403|1041042|P6|NOT COMPLETED|Overall Study||19
437175|NCT00715403|1041043|P5|NOT COMPLETED|Overall Study||6
437176|NCT00715403|1041044|P4|NOT COMPLETED|Overall Study||9
437177|NCT00715403|1041045|P3|NOT COMPLETED|Overall Study||4
437178|NCT00715403|1041046|P2|NOT COMPLETED|Overall Study||1
437179|NCT00715403|1041047|P1|NOT COMPLETED|Overall Study||1
437180|NCT00715403|1041041|P7|COMPLETED|Overall Study||0
437181|NCT00715403|1041042|P6|COMPLETED|Overall Study||0
437182|NCT00715403|1041043|P5|COMPLETED|Overall Study||0
437183|NCT00715403|1041044|P4|COMPLETED|Overall Study||0
437184|NCT00715403|1041045|P3|COMPLETED|Overall Study||0
437185|NCT00715403|1041046|P2|COMPLETED|Overall Study||0
437186|NCT00715403|1041047|P1|COMPLETED|Overall Study||0
437187|NCT00715403|1041041|P7|STARTED|Overall Study||1
437188|NCT00715403|1041042|P6|STARTED|Overall Study||19
437189|NCT00715403|1041043|P5|STARTED|Overall Study||6
437190|NCT00715403|1041044|P4|STARTED|Overall Study||9
437191|NCT00715403|1041045|P3|STARTED|Overall Study||4
437192|NCT00715403|1041046|P2|STARTED|Overall Study||1
437193|NCT00715403|1041047|P1|STARTED|Overall Study||1
437194|NCT00715390|1041182|P1|NOT COMPLETED|Overall Study||0
437195|NCT00715390|1041182|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
437196|NCT00715390|1041182|P1|Eligible|Overall Study||234
437197|NCT00715390|1041182|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
437198|NCT00715299|1041186|P1|NOT COMPLETED|Overall Study||6
437199|NCT00715299|1041186|P1|COMPLETED|Overall Study||30
437200|NCT00715299|1041186|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
437201|NCT00715208|1041192|P2|NOT COMPLETED|Overall Study||9
437202|NCT00715208|1041193|P1|NOT COMPLETED|Overall Study||1
437203|NCT00715208|1041192|P2|COMPLETED|Overall Study||39
437204|NCT00715208|1041193|P1|COMPLETED|Overall Study||6
437205|NCT00715208|1041192|P2|STARTED|Overall Study||48
437206|NCT00715208|1041193|P1|STARTED|Overall Study||7
437207|NCT00715117|1041209|P2|NOT COMPLETED|Overall Study||1
437208|NCT00715117|1041210|P1|NOT COMPLETED|Overall Study||0
437209|NCT00715117|1041209|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
437210|NCT00715117|1041210|P1|COMPLETED|Overall Study||6
437211|NCT00715117|1041209|P2|Completion fo 8 Week Study|Overall Study||6
437212|NCT00715117|1041210|P1|Completion fo 8 Week Study|Overall Study||6
437213|NCT00715117|1041209|P2|STARTED|Overall Study||6
437214|NCT00715117|1041210|P1|STARTED|Overall Study||6
437215|NCT00715104|1041224|P3|NOT COMPLETED|Overall Study||0
437216|NCT00715104|1041225|P2|NOT COMPLETED|Overall Study||0
437217|NCT00715104|1041226|P1|NOT COMPLETED|Overall Study||0
437218|NCT00715104|1041224|P3|COMPLETED|Overall Study||8
437219|NCT00715104|1041225|P2|COMPLETED|Overall Study||16
437220|NCT00715104|1041226|P1|COMPLETED|Overall Study||18
437221|NCT00715104|1041224|P3|STARTED|Overall Study||8
437222|NCT00715104|1041225|P2|STARTED|Overall Study||16
437223|NCT00715104|1041226|P1|STARTED|Overall Study||18
437224|NCT00715078|1041278|P3|NOT COMPLETED|Overall Study||38
437225|NCT00715078|1041279|P2|NOT COMPLETED|Overall Study||36
437226|NCT00715078|1041280|P1|NOT COMPLETED|Overall Study||30
437227|NCT00715078|1041278|P3|COMPLETED|Overall Study||3
437228|NCT00715078|1041279|P2|COMPLETED|Overall Study||4
437229|NCT00715078|1041280|P1|COMPLETED|Overall Study||11
437230|NCT00715078|1041278|P3|Received ≥ 1 Leukapheresis|Overall Study||40
437231|NCT00715078|1041279|P2|Received ≥ 1 Leukapheresis|Overall Study||40
437232|NCT00715078|1041280|P1|Received ≥ 1 Leukapheresis|Overall Study||40
437233|NCT00715078|1041278|P3|Received ≥ 1 Study Infusion|Overall Study||39
437234|NCT00715078|1041279|P2|Received ≥ 1 Study Infusion|Overall Study||40
437235|NCT00715078|1041280|P1|Received ≥ 1 Study Infusion|Overall Study||40
437236|NCT00715078|1041278|P3|STARTED|Overall Study||41
437237|NCT00715078|1041279|P2|STARTED|Overall Study||40
437238|NCT00715078|1041280|P1|STARTED|Overall Study||41
437239|NCT00715026|1041288|P1|NOT COMPLETED|Overall Study||10
437240|NCT00715026|1041288|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
437241|NCT00715026|1041288|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
437242|NCT00715026|1041288|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
437243|NCT00714948|1041293|P1|NOT COMPLETED|Overall Study||2
437244|NCT00714948|1041293|P1|COMPLETED|Overall Study||0
437245|NCT00714948|1041293|P1|STARTED|Overall Study||2
437246|NCT00714870|1041299|P2|NOT COMPLETED|Overall Study||5
437247|NCT00714870|1041300|P1|NOT COMPLETED|Overall Study||27
437248|NCT00714870|1041299|P2|COMPLETED|Overall Study||22
437249|NCT00714870|1041300|P1|COMPLETED|Overall Study||22
437250|NCT00714870|1041299|P2|STARTED|Overall Study||27
437251|NCT00714870|1041300|P1|STARTED|Overall Study||49
437252|NCT00714792|1041308|P2|NOT COMPLETED|Overall Study||0
437253|NCT00714792|1041309|P1|NOT COMPLETED|Overall Study||0
437254|NCT00714792|1041308|P2|COMPLETED|Overall Study||8
437255|NCT00714792|1041309|P1|COMPLETED|Overall Study||10
437256|NCT00714792|1041308|P2|STARTED|Overall Study||8
437257|NCT00714792|1041309|P1|STARTED|Overall Study||10
437258|NCT00714714|1041315|P1|NOT COMPLETED|Overall Study||1
437259|NCT00714714|1041315|P1|COMPLETED|Overall Study||24
437260|NCT00714714|1041315|P1|STARTED|Overall Study||25
437261|NCT00714688|1041324|P3|NOT COMPLETED|Overall Study||37
437262|NCT00714688|1041325|P2|NOT COMPLETED|Overall Study||35
437263|NCT00714688|1041326|P1|NOT COMPLETED|Overall Study||29
437264|NCT00714688|1041324|P3|COMPLETED|Overall Study||55
437265|NCT00714688|1041325|P2|COMPLETED|Overall Study||55
437266|NCT00714688|1041326|P1|COMPLETED|Overall Study||68
437267|NCT00714688|1041324|P3|STARTED|Overall Study||92
437268|NCT00714688|1041325|P2|STARTED|Overall Study||90
437269|NCT00714688|1041326|P1|STARTED|Overall Study||97
437270|NCT00714571|1041349|P6|NOT COMPLETED|Stage 2||0
437271|NCT00714571|1041350|P5|NOT COMPLETED|Stage 2||0
437272|NCT00714571|1041351|P4|NOT COMPLETED|Stage 2||0
437273|NCT00714571|1041352|P3|NOT COMPLETED|Stage 2||0
437274|NCT00714571|1041353|P2|NOT COMPLETED|Stage 2||0
437275|NCT00714571|1041354|P1|NOT COMPLETED|Stage 2||0
437276|NCT00714571|1041349|P6|COMPLETED|Stage 2||15
437277|NCT00714571|1041350|P5|COMPLETED|Stage 2||15
437278|NCT00714571|1041351|P4|COMPLETED|Stage 2||0
437279|NCT00714571|1041352|P3|COMPLETED|Stage 2||0
437280|NCT00714571|1041353|P2|COMPLETED|Stage 2||0
437281|NCT00714571|1041354|P1|COMPLETED|Stage 2||0
437282|NCT00714571|1041349|P6|STARTED|Stage 2||15
437283|NCT00714571|1041350|P5|STARTED|Stage 2||15
437284|NCT00714571|1041351|P4|STARTED|Stage 2||0
437285|NCT00714571|1041352|P3|STARTED|Stage 2||0
437286|NCT00714571|1041353|P2|STARTED|Stage 2||0
437287|NCT00714571|1041354|P1|STARTED|Stage 2||0
437288|NCT00714571|1041349|P6|NOT COMPLETED|Stage 1||0
437289|NCT00714571|1041350|P5|NOT COMPLETED|Stage 1||0
437290|NCT00714571|1041351|P4|NOT COMPLETED|Stage 1||0
437291|NCT00714571|1041352|P3|NOT COMPLETED|Stage 1||1
437292|NCT00714571|1041353|P2|NOT COMPLETED|Stage 1||0
437293|NCT00714571|1041354|P1|NOT COMPLETED|Stage 1||0
437294|NCT00714571|1041349|P6|COMPLETED|Stage 1||0
437295|NCT00714571|1041350|P5|COMPLETED|Stage 1||0
437296|NCT00714571|1041351|P4|COMPLETED|Stage 1||14
437297|NCT00714571|1041352|P3|COMPLETED|Stage 1||10
437298|NCT00714571|1041353|P2|COMPLETED|Stage 1||15
437299|NCT00714571|1041354|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
437300|NCT00714571|1041349|P6|STARTED|Stage 1||0
437301|NCT00714571|1041350|P5|STARTED|Stage 1||0
437302|NCT00714571|1041351|P4|STARTED|Stage 1||14
437303|NCT00714571|1041352|P3|STARTED|Stage 1||11
437304|NCT00714571|1041353|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
437305|NCT00714571|1041354|P1|STARTED|Stage 1||12
437306|NCT00714493|1041368|P1|NOT COMPLETED|Overall Study||49
437307|NCT00714493|1041368|P1|COMPLETED|Overall Study||154
437308|NCT00714493|1041368|P1|STARTED|Overall Study||203
437309|NCT00714389|1041378|P1|NOT COMPLETED|Overall Study||0
437310|NCT00714389|1041378|P1|COMPLETED|Overall Study||12
437311|NCT00714389|1041378|P1|STARTED|Overall Study||12
437312|NCT00714311|1041385|P2|NOT COMPLETED|Overall Study||22
437313|NCT00714311|1041386|P1|NOT COMPLETED|Overall Study||13
437314|NCT00714311|1041385|P2|COMPLETED|Overall Study||30
437315|NCT00714311|1041386|P1|COMPLETED|Overall Study||39
437316|NCT00714311|1041385|P2|STARTED|Overall Study||52
437317|NCT00714311|1041386|P1|STARTED|Overall Study||52
437318|NCT00714285|1041396|P4|NOT COMPLETED|Overall Study||1
437319|NCT00714285|1041397|P3|NOT COMPLETED|Overall Study||0
437320|NCT00714285|1041398|P2|NOT COMPLETED|Overall Study||3
437321|NCT00714285|1041399|P1|NOT COMPLETED|Overall Study||0
437322|NCT00714285|1041396|P4|COMPLETED|Overall Study|Completed upto Day 180|104
437323|NCT00714285|1041397|P3|COMPLETED|Overall Study|Completed upto Day 180|105
437324|NCT00714285|1041398|P2|COMPLETED|Overall Study|Completed upto Day 180|102
437325|NCT00714285|1041399|P1|COMPLETED|Overall Study|Completed upto Day 180|105
437326|NCT00714285|1041396|P4|STARTED|Overall Study||105
437327|NCT00714285|1041397|P3|STARTED|Overall Study||105
437328|NCT00714285|1041398|P2|STARTED|Overall Study||105
437329|NCT00714285|1041399|P1|STARTED|Overall Study||105
437330|NCT00714259|1041449|P1|NOT COMPLETED|Overall Study||2
437331|NCT00714259|1041449|P1|COMPLETED|Overall Study||3
437332|NCT00714259|1041449|P1|STARTED|Overall Study||5
437333|NCT00714233|1041463|P4|NOT COMPLETED|Overall Study||4
437334|NCT00714233|1041464|P3|NOT COMPLETED|Overall Study||1
437335|NCT00714233|1041465|P2|NOT COMPLETED|Overall Study||1
437336|NCT00714233|1041466|P1|NOT COMPLETED|Overall Study||4
437337|NCT00714233|1041463|P4|COMPLETED|Overall Study||6
437338|NCT00714233|1041464|P3|COMPLETED|Overall Study||10
437339|NCT00714233|1041465|P2|COMPLETED|Overall Study||10
437340|NCT00714233|1041466|P1|COMPLETED|Overall Study||6
437341|NCT00714233|1041463|P4|STARTED|Overall Study||10
437342|NCT00714233|1041464|P3|STARTED|Overall Study||11
437343|NCT00714233|1041465|P2|STARTED|Overall Study||11
437344|NCT00714233|1041466|P1|STARTED|Overall Study||10
437345|NCT00714168|1041495|P2|NOT COMPLETED|Overall Study||59
437346|NCT00714168|1041496|P1|NOT COMPLETED|Overall Study||44
437347|NCT00714168|1041495|P2|COMPLETED|Overall Study||139
437348|NCT00714168|1041496|P1|COMPLETED|Overall Study||121
437349|NCT00714168|1041495|P2|STARTED|Overall Study||198
437350|NCT00714168|1041496|P1|STARTED|Overall Study||165
437351|NCT00714051|1041512|P2|NOT COMPLETED|Overall Study||1
437352|NCT00714051|1041513|P1|NOT COMPLETED|Overall Study||1
437353|NCT00714051|1041512|P2|COMPLETED|Overall Study||27
437354|NCT00714051|1041513|P1|COMPLETED|Overall Study||26
437355|NCT00714051|1041512|P2|STARTED|Overall Study||28
437356|NCT00714051|1041513|P1|STARTED|Overall Study||27
437357|NCT00713830|1041521|P2|NOT COMPLETED|Overall Study||177
437358|NCT00713830|1041522|P1|NOT COMPLETED|Overall Study||82
437359|NCT00713830|1041521|P2|COMPLETED|Overall Study||396
437360|NCT00713830|1041522|P1|COMPLETED|Overall Study||204
437361|NCT00713830|1041521|P2|Subgroup for Standardized Meal Test|Overall Study||313
437362|NCT00713830|1041522|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
437363|NCT00713830|1041521|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
437364|NCT00713830|1041522|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
437365|NCT00713830|1041521|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
437366|NCT00713830|1041522|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
437367|NCT00713830|1041521|P2|STARTED|Overall Study||573
437368|NCT00713830|1041522|P1|STARTED|Overall Study|Randomized.|286
437369|NCT00713817|1041560|P2|NOT COMPLETED|Overall Study||0
437370|NCT00713817|1041561|P1|NOT COMPLETED|Overall Study||0
437371|NCT00713817|1041560|P2|COMPLETED|Overall Study||9
437372|NCT00713817|1041561|P1|COMPLETED|Overall Study||10
437373|NCT00713817|1041560|P2|STARTED|Overall Study||9
437374|NCT00713817|1041561|P1|STARTED|Overall Study||10
437375|NCT00713700|1041579|P1|NOT COMPLETED|Overall Study||4
437376|NCT00713700|1041579|P1|COMPLETED|Overall Study||188
437377|NCT00713700|1041579|P1|STARTED|Overall Study||192
437378|NCT00713661|1041588|P4|NOT COMPLETED|Overall Study||0
437379|NCT00713661|1041589|P3|NOT COMPLETED|Overall Study||0
437380|NCT00713661|1041590|P2|NOT COMPLETED|Overall Study||0
437381|NCT00713661|1041591|P1|NOT COMPLETED|Overall Study||0
437382|NCT00713661|1041588|P4|COMPLETED|Overall Study||5
437383|NCT00713661|1041589|P3|COMPLETED|Overall Study||4
437384|NCT00713661|1041590|P2|COMPLETED|Overall Study||9
437385|NCT00713661|1041591|P1|COMPLETED|Overall Study||7
437386|NCT00713661|1041588|P4|STARTED|Overall Study||5
437387|NCT00713661|1041589|P3|STARTED|Overall Study||4
437388|NCT00713661|1041590|P2|STARTED|Overall Study||9
437389|NCT00713661|1041591|P1|STARTED|Overall Study||7
437390|NCT00713648|1041605|P1|NOT COMPLETED|Overall Study||8
437391|NCT00713648|1041605|P1|COMPLETED|Overall Study||33
437392|NCT00713648|1041605|P1|STARTED|Overall Study||41
437393|NCT00713609|1041618|P6|NOT COMPLETED|Overall Study||8
437394|NCT00713609|1041619|P5|NOT COMPLETED|Overall Study||19
437395|NCT00713609|1041620|P4|NOT COMPLETED|Overall Study||9
437396|NCT00713609|1041621|P3|NOT COMPLETED|Overall Study||15
437397|NCT00713609|1041622|P2|NOT COMPLETED|Overall Study||15
437398|NCT00713609|1041623|P1|NOT COMPLETED|Overall Study||21
437399|NCT00713609|1041618|P6|COMPLETED|Overall Study||47
437400|NCT00713609|1041619|P5|COMPLETED|Overall Study||87
437401|NCT00713609|1041620|P4|COMPLETED|Overall Study||99
437402|NCT00713609|1041621|P3|COMPLETED|Overall Study||92
437403|NCT00713609|1041622|P2|COMPLETED|Overall Study||90
437404|NCT00713609|1041623|P1|COMPLETED|Overall Study||85
437405|NCT00713609|1041618|P6|STARTED|Overall Study||55
437406|NCT00713609|1041619|P5|STARTED|Overall Study||106
437407|NCT00713609|1041620|P4|STARTED|Overall Study||108
437408|NCT00713609|1041621|P3|STARTED|Overall Study||107
437409|NCT00713609|1041622|P2|STARTED|Overall Study||105
437410|NCT00713609|1041623|P1|STARTED|Overall Study||106
437411|NCT00713596|1041658|P3|NOT COMPLETED|Overall Study||2
437412|NCT00713596|1041659|P2|NOT COMPLETED|Overall Study||3
437413|NCT00713596|1041660|P1|NOT COMPLETED|Overall Study||2
437414|NCT00713596|1041658|P3|COMPLETED|Overall Study||6
437415|NCT00713596|1041659|P2|COMPLETED|Overall Study||5
437416|NCT00713596|1041660|P1|COMPLETED|Overall Study||7
437417|NCT00713596|1041658|P3|STARTED|Overall Study||8
437418|NCT00713596|1041659|P2|STARTED|Overall Study||8
437419|NCT00713596|1041660|P1|STARTED|Overall Study||9
437420|NCT00713544|1041677|P6|NOT COMPLETED|Overall Study||9
437421|NCT00713544|1041678|P5|NOT COMPLETED|Overall Study||8
437422|NCT00713544|1041679|P4|NOT COMPLETED|Overall Study||10
437423|NCT00713544|1041680|P3|NOT COMPLETED|Overall Study||11
437424|NCT00713544|1041681|P2|NOT COMPLETED|Overall Study||6
437425|NCT00713544|1041682|P1|NOT COMPLETED|Overall Study||7
437426|NCT00713544|1041677|P6|COMPLETED|Overall Study||67
437427|NCT00713544|1041678|P5|COMPLETED|Overall Study||57
437428|NCT00713544|1041679|P4|COMPLETED|Overall Study||66
437429|NCT00713544|1041680|P3|COMPLETED|Overall Study||41
437430|NCT00713544|1041681|P2|COMPLETED|Overall Study||46
437431|NCT00713544|1041682|P1|COMPLETED|Overall Study||45
437432|NCT00713544|1041677|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
437433|NCT00713544|1041678|P5|STARTED|Overall Study||65
437434|NCT00713544|1041679|P4|STARTED|Overall Study||76
437435|NCT00713544|1041680|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
437436|NCT00713544|1041681|P2|STARTED|Overall Study||52
437437|NCT00713544|1041682|P1|STARTED|Overall Study||52
437438|NCT00713479|1041720|P2|NOT COMPLETED|Next Medication Condition||0
437439|NCT00713479|1041721|P1|NOT COMPLETED|Next Medication Condition||0
437440|NCT00713479|1041720|P2|COMPLETED|Next Medication Condition||6
437441|NCT00713479|1041721|P1|COMPLETED|Next Medication Condition||2
437442|NCT00713479|1041720|P2|STARTED|Next Medication Condition||6
437443|NCT00713479|1041721|P1|STARTED|Next Medication Condition||2
437444|NCT00713479|1041720|P2|NOT COMPLETED|Washout||0
437445|NCT00713479|1041721|P1|NOT COMPLETED|Washout||0
437446|NCT00713479|1041720|P2|COMPLETED|Washout||6
437447|NCT00713479|1041721|P1|COMPLETED|Washout||2
437448|NCT00713479|1041720|P2|STARTED|Washout||6
437449|NCT00713479|1041721|P1|STARTED|Washout||2
437450|NCT00713479|1041720|P2|NOT COMPLETED|First Medication Condition||0
437451|NCT00713479|1041721|P1|NOT COMPLETED|First Medication Condition||4
437452|NCT00713479|1041720|P2|COMPLETED|First Medication Condition||6
437453|NCT00713479|1041721|P1|COMPLETED|First Medication Condition||2
437454|NCT00713479|1041720|P2|STARTED|First Medication Condition||6
437455|NCT00713479|1041721|P1|STARTED|First Medication Condition||6
437456|NCT00713349|1041733|P1|NOT COMPLETED|Overall Study||1
437457|NCT00713349|1041733|P1|COMPLETED|Overall Study||24
437458|NCT00713349|1041733|P1|STARTED|Overall Study||25
437459|NCT00713323|1041739|P1|NOT COMPLETED|Overall Study||146
437460|NCT00713323|1041739|P1|COMPLETED|Overall Study||234
437461|NCT00713323|1041739|P1|STARTED|Overall Study||380
437462|NCT00713310|1041752|P2|NOT COMPLETED|Overall Study||6
437463|NCT00713310|1041753|P1|NOT COMPLETED|Overall Study||5
437464|NCT00713310|1041752|P2|COMPLETED|Overall Study||36
437465|NCT00713310|1041753|P1|COMPLETED|Overall Study||36
437466|NCT00713310|1041752|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
437467|NCT00713310|1041753|P1|mITT Population|Overall Study||41
437468|NCT00713310|1041752|P2|STARTED|Overall Study||42
437469|NCT00713310|1041753|P1|STARTED|Overall Study||41
437470|NCT00713258|1041763|P2|NOT COMPLETED|Overall Study||6
437471|NCT00713258|1041764|P1|NOT COMPLETED|Overall Study||5
437472|NCT00713258|1041763|P2|COMPLETED|Overall Study||28
437473|NCT00713258|1041764|P1|COMPLETED|Overall Study||36
437474|NCT00713258|1041763|P2|STARTED|Overall Study||34
437475|NCT00713258|1041764|P1|STARTED|Overall Study||41
437476|NCT00713219|1041772|P1|NOT COMPLETED|Overall Study||2
437477|NCT00713219|1041772|P1|COMPLETED|Overall Study||12
437478|NCT00713219|1041772|P1|STARTED|Overall Study||14
437479|NCT00713206|1041778|P2|NOT COMPLETED|Overall Study||3
437480|NCT00713206|1041779|P1|NOT COMPLETED|Overall Study||7
437481|NCT00713206|1041778|P2|COMPLETED|Overall Study||27
437482|NCT00713206|1041779|P1|COMPLETED|Overall Study||55
437483|NCT00713206|1041778|P2|STARTED|Overall Study||30
437484|NCT00713206|1041779|P1|STARTED|Overall Study||62
437485|NCT00712985|1041785|P1|NOT COMPLETED|Overall Study||5
437486|NCT00712985|1041785|P1|COMPLETED|Overall Study||13
437487|NCT00712985|1041785|P1|STARTED|Overall Study||18
437488|NCT00712959|1041791|P2|NOT COMPLETED|Overall Study||3
437489|NCT00712959|1041792|P1|NOT COMPLETED|Overall Study||19
437490|NCT00712959|1041791|P2|COMPLETED|Overall Study||404
437491|NCT00712959|1041792|P1|COMPLETED|Overall Study||342
437492|NCT00712959|1041791|P2|STARTED|Overall Study||407
437493|NCT00712959|1041792|P1|STARTED|Overall Study||361
437494|NCT00712920|1041813|P3|NOT COMPLETED|Overall Study||12
437495|NCT00712920|1041814|P2|NOT COMPLETED|Overall Study||17
437496|NCT00712920|1041815|P1|NOT COMPLETED|Overall Study||17
437497|NCT00712920|1041813|P3|COMPLETED|Overall Study||180
437498|NCT00712920|1041814|P2|COMPLETED|Overall Study||180
437499|NCT00712920|1041815|P1|COMPLETED|Overall Study||175
437500|NCT00712920|1041813|P3|STARTED|Overall Study||192
437501|NCT00712920|1041814|P2|STARTED|Overall Study|3 subjects were randomized in error|197
437502|NCT00712920|1041815|P1|STARTED|Overall Study||192
437503|NCT00712725|1041843|P8|NOT COMPLETED|Overall Study||11
437504|NCT00712725|1041844|P7|NOT COMPLETED|Overall Study||22
437505|NCT00712725|1041845|P6|NOT COMPLETED|Overall Study||16
437506|NCT00712725|1041846|P5|NOT COMPLETED|Overall Study||19
437507|NCT00712725|1041847|P4|NOT COMPLETED|Overall Study||17
437508|NCT00712725|1041848|P3|NOT COMPLETED|Overall Study||10
437509|NCT00712725|1041849|P2|NOT COMPLETED|Overall Study||6
437510|NCT00712725|1041850|P1|NOT COMPLETED|Overall Study||29
437511|NCT00712725|1041843|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
437512|NCT00712725|1041844|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
437513|NCT00712725|1041845|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
437514|NCT00712725|1041846|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
437515|NCT00712725|1041847|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
437516|NCT00712725|1041848|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
437517|NCT00712725|1041849|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
437518|NCT00712725|1041850|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
437519|NCT00712725|1041843|P8|STARTED|Overall Study||74
437520|NCT00712725|1041844|P7|STARTED|Overall Study||83
437521|NCT00712725|1041845|P6|STARTED|Overall Study||84
437522|NCT00712725|1041846|P5|STARTED|Overall Study||86
437523|NCT00712725|1041847|P4|STARTED|Overall Study||84
437524|NCT00712725|1041848|P3|STARTED|Overall Study||57
437525|NCT00712725|1041849|P2|STARTED|Overall Study||39
437526|NCT00712725|1041850|P1|STARTED|Overall Study||169
437527|NCT00712673|1041911|P4|NOT COMPLETED|Overall Study||70
437528|NCT00712673|1041912|P3|NOT COMPLETED|Overall Study||57
437529|NCT00712673|1041913|P2|NOT COMPLETED|Overall Study||21
437530|NCT00712673|1041914|P1|NOT COMPLETED|Overall Study||21
437531|NCT00712673|1041911|P4|COMPLETED|Overall Study||185
437532|NCT00712673|1041912|P3|COMPLETED|Overall Study||198
437533|NCT00712673|1041913|P2|COMPLETED|Overall Study||64
437534|NCT00712673|1041914|P1|COMPLETED|Overall Study||64
437535|NCT00712673|1041911|P4|Subgroup for Standardized Meal Test|Overall Study||0
437536|NCT00712673|1041912|P3|Subgroup for Standardized Meal Test|Overall Study||255
437537|NCT00712673|1041913|P2|Subgroup for Standardized Meal Test|Overall Study||0
437538|NCT00712673|1041914|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
437539|NCT00712673|1041911|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
437540|NCT00712673|1041912|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
437541|NCT00712673|1041913|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
437542|NCT00712673|1041914|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
437543|NCT00712673|1041911|P4|Safety Population|Overall Study||255
437544|NCT00712673|1041912|P3|Safety Population|Overall Study||255
437545|NCT00712673|1041913|P2|Safety Population|Overall Study||85
437546|NCT00712673|1041914|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
437547|NCT00712673|1041911|P4|STARTED|Overall Study||255
437548|NCT00712673|1041912|P3|STARTED|Overall Study||255
437549|NCT00712673|1041913|P2|STARTED|Overall Study||85
437550|NCT00712673|1041914|P1|STARTED|Overall Study|Randomized.|85
437551|NCT00712543|1041978|P2|NOT COMPLETED|Day 8-14||2
437552|NCT00712543|1041979|P1|NOT COMPLETED|Day 8-14||0
437553|NCT00712543|1041978|P2|COMPLETED|Day 8-14||25
437554|NCT00712543|1041979|P1|COMPLETED|Day 8-14||23
437555|NCT00712543|1041978|P2|STARTED|Day 8-14||27
437556|NCT00712543|1041979|P1|STARTED|Day 8-14||23
437557|NCT00712543|1041978|P2|NOT COMPLETED|Day 1-7||0
437558|NCT00712543|1041979|P1|NOT COMPLETED|Day 1-7||0
437559|NCT00712543|1041978|P2|COMPLETED|Day 1-7||27
437560|NCT00712543|1041979|P1|COMPLETED|Day 1-7||23
437561|NCT00712543|1041978|P2|STARTED|Day 1-7||27
437562|NCT00712543|1041979|P1|STARTED|Day 1-7||23
437563|NCT00712530|1041988|P3|NOT COMPLETED|Overall Study||0
437564|NCT00712530|1041989|P2|NOT COMPLETED|Overall Study||0
437565|NCT00712530|1041990|P1|NOT COMPLETED|Overall Study||0
437566|NCT00712530|1041988|P3|COMPLETED|Overall Study||3
437567|NCT00712530|1041989|P2|COMPLETED|Overall Study||3
437568|NCT00712530|1041990|P1|COMPLETED|Overall Study||3
437569|NCT00712530|1041988|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
437570|NCT00712530|1041989|P2|STARTED|Overall Study||3
437571|NCT00712530|1041990|P1|STARTED|Overall Study||3
437572|NCT00712348|1042013|P1|NOT COMPLETED|Overall Study||1
437573|NCT00712348|1042013|P1|COMPLETED|Overall Study||30
437574|NCT00712348|1042013|P1|STARTED|Overall Study||31
437575|NCT00712335|1042025|P5|NOT COMPLETED|Overall Study||0
437576|NCT00712335|1042026|P4|NOT COMPLETED|Overall Study||5
437577|NCT00712335|1042027|P3|NOT COMPLETED|Overall Study||5
437578|NCT00712335|1042028|P2|NOT COMPLETED|Overall Study||17
437579|NCT00712335|1042029|P1|NOT COMPLETED|Overall Study||3
437580|NCT00712335|1042025|P5|COMPLETED|Overall Study||30
437581|NCT00712335|1042026|P4|COMPLETED|Overall Study||19
437582|NCT00712335|1042027|P3|COMPLETED|Overall Study||6
437583|NCT00712335|1042028|P2|COMPLETED|Overall Study||15
437584|NCT00712335|1042029|P1|COMPLETED|Overall Study||5
437585|NCT00712335|1042025|P5|STARTED|Overall Study||30
437586|NCT00712335|1042026|P4|STARTED|Overall Study||24
437587|NCT00712335|1042027|P3|STARTED|Overall Study||11
437588|NCT00712335|1042028|P2|STARTED|Overall Study||32
437589|NCT00712335|1042029|P1|STARTED|Overall Study||8
437590|NCT00712244|1042075|P4|NOT COMPLETED|Overall Study||1
437591|NCT00712244|1042076|P3|NOT COMPLETED|Overall Study||2
437592|NCT00712244|1042077|P2|NOT COMPLETED|Overall Study||1
437593|NCT00712244|1042078|P1|NOT COMPLETED|Overall Study||4
437594|NCT00712244|1042075|P4|COMPLETED|Overall Study||26
437595|NCT00712244|1042076|P3|COMPLETED|Overall Study||25
437596|NCT00712244|1042077|P2|COMPLETED|Overall Study||28
437597|NCT00712244|1042078|P1|COMPLETED|Overall Study||25
437598|NCT00712244|1042075|P4|STARTED|Overall Study||27
437599|NCT00712244|1042076|P3|STARTED|Overall Study||27
437600|NCT00712244|1042077|P2|STARTED|Overall Study||29
437601|NCT00712244|1042078|P1|STARTED|Overall Study||29
437602|NCT00712179|1042120|P1|NOT COMPLETED|Overall Study||12
437603|NCT00712179|1042120|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
437604|NCT00712179|1042120|P1|STARTED|Overall Study||49
437605|NCT00712166|1042126|P2|NOT COMPLETED|Overall Study||1
437606|NCT00712166|1042127|P1|NOT COMPLETED|Overall Study||0
437607|NCT00712166|1042126|P2|COMPLETED|Overall Study||75
437608|NCT00712166|1042127|P1|COMPLETED|Overall Study||81
437609|NCT00712166|1042126|P2|STARTED|Overall Study||76
437610|NCT00712166|1042127|P1|STARTED|Overall Study||81
437611|NCT00712075|1042154|P3|NOT COMPLETED|Overall Study||11
437612|NCT00712075|1042155|P2|NOT COMPLETED|Overall Study||4
437613|NCT00712075|1042156|P1|NOT COMPLETED|Overall Study||5
437614|NCT00712075|1042154|P3|COMPLETED|Overall Study||14
437615|NCT00712075|1042155|P2|COMPLETED|Overall Study||26
437616|NCT00712075|1042156|P1|COMPLETED|Overall Study||17
437617|NCT00712075|1042154|P3|STARTED|Overall Study||25
437618|NCT00712075|1042155|P2|STARTED|Overall Study||30
437619|NCT00712075|1042156|P1|STARTED|Overall Study||22
437620|NCT00712010|1042170|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
437621|NCT00712010|1042170|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
437622|NCT00712010|1042170|P1|STARTED|7th and Last Protein Testing (1 Day)||23
437623|NCT00712010|1042170|P1|NOT COMPLETED|Washout (7 Days)||0
437624|NCT00712010|1042170|P1|COMPLETED|Washout (7 Days)||23
437625|NCT00712010|1042170|P1|STARTED|Washout (7 Days)||23
437626|NCT00712010|1042170|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
437627|NCT00712010|1042170|P1|COMPLETED|6th Protein Testing (1 Day)||23
437628|NCT00712010|1042170|P1|STARTED|6th Protein Testing (1 Day)||23
437629|NCT00712010|1042170|P1|NOT COMPLETED|Washout (7 Days)||0
437630|NCT00712010|1042170|P1|COMPLETED|Washout (7 Days)||23
437631|NCT00712010|1042170|P1|STARTED|Washout (7 Days)||23
437632|NCT00712010|1042170|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
437633|NCT00712010|1042170|P1|COMPLETED|5th Protein Testing (1 Day)||23
437634|NCT00712010|1042170|P1|STARTED|5th Protein Testing (1 Day)||23
437635|NCT00712010|1042170|P1|NOT COMPLETED|Washout (7 Days)||1
437636|NCT00712010|1042170|P1|COMPLETED|Washout (7 Days)||23
437637|NCT00712010|1042170|P1|STARTED|Washout (7 Days)||24
437638|NCT00712010|1042170|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
437639|NCT00712010|1042170|P1|COMPLETED|4th Protein Testing (1 Day)||24
437640|NCT00712010|1042170|P1|STARTED|4th Protein Testing (1 Day)||24
437641|NCT00712010|1042170|P1|NOT COMPLETED|Washout (7 Days)||0
437642|NCT00712010|1042170|P1|COMPLETED|Washout (7 Days)||24
437643|NCT00712010|1042170|P1|STARTED|Washout (7 Days)||24
437644|NCT00712010|1042170|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
437645|NCT00712010|1042170|P1|COMPLETED|3rd Protein Testing (1 Day)||24
437646|NCT00712010|1042170|P1|STARTED|3rd Protein Testing (1 Day)||24
437647|NCT00712010|1042170|P1|NOT COMPLETED|Washout (7 Days)||0
437648|NCT00712010|1042170|P1|COMPLETED|Washout (7 Days)||24
437649|NCT00712010|1042170|P1|STARTED|Washout (7 Days)||24
437650|NCT00712010|1042170|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
437651|NCT00712010|1042170|P1|COMPLETED|2nd Protein Testing (1 Day)||24
437652|NCT00712010|1042170|P1|STARTED|2nd Protein Testing (1 Day)||24
437653|NCT00712010|1042170|P1|NOT COMPLETED|Washout (7 Days)||0
437654|NCT00712010|1042170|P1|COMPLETED|Washout (7 Days)||24
437655|NCT00712010|1042170|P1|STARTED|Washout (7 Days)||24
437656|NCT00712010|1042170|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
437657|NCT00712010|1042170|P1|COMPLETED|1st Protein Testing (1 Day)||24
437658|NCT00712010|1042170|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
437659|NCT00711997|1042195|P2|NOT COMPLETED|Overall Study||0
437660|NCT00711997|1042196|P1|NOT COMPLETED|Overall Study||0
437661|NCT00711997|1042195|P2|COMPLETED|Overall Study||6
437662|NCT00711997|1042196|P1|COMPLETED|Overall Study||3
437663|NCT00711997|1042195|P2|STARTED|Overall Study||6
437664|NCT00711997|1042196|P1|STARTED|Overall Study||3
437665|NCT00711971|1042209|P3|NOT COMPLETED|Overall Study||1
437666|NCT00711971|1042210|P2|NOT COMPLETED|Overall Study||4
437667|NCT00711971|1042211|P1|NOT COMPLETED|Overall Study||3
437668|NCT00711971|1042209|P3|COMPLETED|Overall Study||41
437669|NCT00711971|1042210|P2|COMPLETED|Overall Study||38
437670|NCT00711971|1042211|P1|COMPLETED|Overall Study||39
437671|NCT00711971|1042209|P3|STARTED|Overall Study||42
437672|NCT00711971|1042210|P2|STARTED|Overall Study||42
437673|NCT00711971|1042211|P1|STARTED|Overall Study||42
437674|NCT00711880|1042245|P2|NOT COMPLETED|Overall Study||7
437675|NCT00711880|1042246|P1|NOT COMPLETED|Overall Study||13
437676|NCT00711880|1042245|P2|COMPLETED|Overall Study||55
437677|NCT00711880|1042246|P1|COMPLETED|Overall Study||50
437678|NCT00711880|1042245|P2|STARTED|Overall Study||62
437679|NCT00711880|1042246|P1|STARTED|Overall Study||63
437680|NCT00711867|1042284|P2|NOT COMPLETED|Overall Study||4
437681|NCT00711867|1042285|P1|NOT COMPLETED|Overall Study||5
437682|NCT00711867|1042284|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
437683|NCT00711867|1042285|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
437684|NCT00711867|1042284|P2|STARTED|Overall Study||25
437685|NCT00711867|1042285|P1|STARTED|Overall Study||30
437686|NCT00711828|1042291|P1|NOT COMPLETED|Overall Study||0
437687|NCT00711828|1042291|P1|COMPLETED|Overall Study||21
437688|NCT00711828|1042291|P1|STARTED|Overall Study||21
437689|NCT00711802|1042308|P8|NOT COMPLETED|Overall Study||2
437690|NCT00711802|1042309|P7|NOT COMPLETED|Overall Study||5
437691|NCT00711802|1042310|P6|NOT COMPLETED|Overall Study||8
437692|NCT00711802|1042311|P5|NOT COMPLETED|Overall Study||14
437693|NCT00711802|1042312|P4|NOT COMPLETED|Overall Study||3
437694|NCT00711802|1042313|P3|NOT COMPLETED|Overall Study||6
437695|NCT00711802|1042314|P2|NOT COMPLETED|Overall Study||6
437696|NCT00711802|1042315|P1|NOT COMPLETED|Overall Study||2
437697|NCT00711802|1042308|P8|COMPLETED|Overall Study||13
437698|NCT00711802|1042309|P7|COMPLETED|Overall Study||25
437699|NCT00711802|1042310|P6|COMPLETED|Overall Study||34
437700|NCT00711802|1042311|P5|COMPLETED|Overall Study||69
437701|NCT00711802|1042312|P4|COMPLETED|Overall Study||35
437702|NCT00711802|1042313|P3|COMPLETED|Overall Study||69
437703|NCT00711802|1042314|P2|COMPLETED|Overall Study||32
437704|NCT00711802|1042315|P1|COMPLETED|Overall Study||73
437705|NCT00711802|1042308|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
437706|NCT00711802|1042309|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
437707|NCT00711802|1042310|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
437708|NCT00711802|1042311|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
437709|NCT00711802|1042312|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
437804|NCT00710996|1042859|P1|NOT COMPLETED|Overall Study||1
437710|NCT00711802|1042313|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
437711|NCT00711802|1042314|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
437712|NCT00711802|1042315|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
437713|NCT00711802|1042308|P8|STARTED|Overall Study||15
437714|NCT00711802|1042309|P7|STARTED|Overall Study||30
437715|NCT00711802|1042310|P6|STARTED|Overall Study||42
437716|NCT00711802|1042311|P5|STARTED|Overall Study||83
437717|NCT00711802|1042312|P4|STARTED|Overall Study||38
437718|NCT00711802|1042313|P3|STARTED|Overall Study||75
437719|NCT00711802|1042314|P2|STARTED|Overall Study||38
437720|NCT00711802|1042315|P1|STARTED|Overall Study||75
437721|NCT00711646|1042347|P2|NOT COMPLETED|Overall Study||3
437722|NCT00711646|1042348|P1|NOT COMPLETED|Overall Study||12
437723|NCT00711646|1042347|P2|COMPLETED|Overall Study||62
437724|NCT00711646|1042348|P1|COMPLETED|Overall Study||112
437725|NCT00711646|1042347|P2|STARTED|Overall Study||65
437726|NCT00711646|1042348|P1|STARTED|Overall Study||124
437727|NCT00711594|1042370|P4|NOT COMPLETED|Overall Study||62
437728|NCT00711594|1042371|P3|NOT COMPLETED|Overall Study||6
437729|NCT00711594|1042372|P2|NOT COMPLETED|Overall Study||3
437730|NCT00711594|1042373|P1|NOT COMPLETED|Overall Study||3
437731|NCT00711594|1042370|P4|COMPLETED|Overall Study||0
437732|NCT00711594|1042371|P3|COMPLETED|Overall Study||0
437733|NCT00711594|1042372|P2|COMPLETED|Overall Study||0
437734|NCT00711594|1042373|P1|COMPLETED|Overall Study||0
437735|NCT00711594|1042370|P4|STARTED|Overall Study||62
437736|NCT00711594|1042371|P3|STARTED|Overall Study||6
437737|NCT00711594|1042372|P2|STARTED|Overall Study||3
437738|NCT00711594|1042373|P1|STARTED|Overall Study||3
437739|NCT00711555|1042410|P1|NOT COMPLETED|Overall Study||3
437740|NCT00711555|1042410|P1|COMPLETED|Overall Study||19
437741|NCT00711555|1042410|P1|STARTED|Overall Study||22
437742|NCT00711529|1042419|P2|NOT COMPLETED|Overall Study||6
437743|NCT00711529|1042420|P1|NOT COMPLETED|Overall Study||4
437744|NCT00711529|1042419|P2|COMPLETED|Overall Study||8
437745|NCT00711529|1042420|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
437746|NCT00711529|1042419|P2|STARTED|Overall Study||14
437747|NCT00711529|1042420|P1|STARTED|Overall Study||13
437748|NCT00711516|1042444|P2|NOT COMPLETED|Overall Study||3
437749|NCT00711516|1042445|P1|NOT COMPLETED|Overall Study||1
437750|NCT00711516|1042444|P2|COMPLETED|Overall Study||16
437751|NCT00711516|1042445|P1|COMPLETED|Overall Study||20
437752|NCT00711516|1042444|P2|STARTED|Overall Study||19
437753|NCT00711516|1042445|P1|STARTED|Overall Study||21
437754|NCT00711490|1042539|P1|NOT COMPLETED|Overall Study||0
437755|NCT00711490|1042539|P1|COMPLETED|Overall Study||5
437756|NCT00711490|1042539|P1|STARTED|Overall Study||5
437757|NCT00711477|1042552|P2|NOT COMPLETED|Overall Study||3
437758|NCT00711477|1042553|P1|NOT COMPLETED|Overall Study||3
437759|NCT00711477|1042552|P2|COMPLETED|Overall Study||20
437760|NCT00711477|1042553|P1|COMPLETED|Overall Study||20
437761|NCT00711477|1042552|P2|STARTED|Overall Study||23
437762|NCT00711477|1042553|P1|STARTED|Overall Study||23
437763|NCT00711425|1042581|P1|NOT COMPLETED|Overall Study||4
437764|NCT00711425|1042581|P1|COMPLETED|Overall Study||41
437765|NCT00711425|1042581|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
437766|NCT00711347|1042589|P2|NOT COMPLETED|Overall Study||0
437767|NCT00711347|1042590|P1|NOT COMPLETED|Overall Study||0
437768|NCT00711347|1042589|P2|COMPLETED|Overall Study||14
437769|NCT00711347|1042590|P1|COMPLETED|Overall Study||14
437770|NCT00711347|1042589|P2|STARTED|Overall Study||14
437771|NCT00711347|1042590|P1|STARTED|Overall Study||14
437772|NCT00711191|1042609|P3|NOT COMPLETED|Overall Study||12
437773|NCT00711191|1042610|P2|NOT COMPLETED|Overall Study||5
437774|NCT00711191|1042611|P1|NOT COMPLETED|Overall Study||3
437775|NCT00711191|1042609|P3|COMPLETED|Overall Study||1
437776|NCT00711191|1042610|P2|COMPLETED|Overall Study||1
437777|NCT00711191|1042611|P1|COMPLETED|Overall Study||0
437778|NCT00711191|1042609|P3|STARTED|Overall Study||13
437779|NCT00711191|1042610|P2|STARTED|Overall Study||6
437780|NCT00711191|1042611|P1|STARTED|Overall Study||3
437781|NCT00711113|1042648|P1|NOT COMPLETED|Overall Study||11
437782|NCT00711113|1042648|P1|COMPLETED|Overall Study||36
437783|NCT00711113|1042648|P1|STARTED|Overall Study||47
437784|NCT00711100|1042654|P1|NOT COMPLETED|Overall Study||13
437785|NCT00711100|1042654|P1|COMPLETED|Overall Study||91
437786|NCT00711100|1042654|P1|STARTED|Overall Study||104
437787|NCT00711087|1042672|P2|NOT COMPLETED|Overall Study||0
437788|NCT00711087|1042673|P1|NOT COMPLETED|Overall Study||1
437789|NCT00711087|1042672|P2|COMPLETED|Overall Study||0
437790|NCT00711087|1042673|P1|COMPLETED|Overall Study||0
437791|NCT00711087|1042672|P2|STARTED|Overall Study||0
437792|NCT00711087|1042673|P1|STARTED|Overall Study||1
437793|NCT00711022|1042679|P1|NOT COMPLETED|Overall Study||11
437794|NCT00711022|1042679|P1|COMPLETED|Overall Study||40
437795|NCT00711022|1042679|P1|STARTED|Overall Study||51
437796|NCT00711009|1042685|P2|NOT COMPLETED|Overall Study||19
437797|NCT00711009|1042686|P1|NOT COMPLETED|Overall Study||15
437798|NCT00711009|1042685|P2|COMPLETED|Overall Study||82
437799|NCT00711009|1042686|P1|COMPLETED|Overall Study||90
437800|NCT00711009|1042685|P2|STARTED|Overall Study||101
437801|NCT00711009|1042686|P1|STARTED|Overall Study||105
437802|NCT00710996|1042857|P3|NOT COMPLETED|Overall Study||0
437803|NCT00710996|1042858|P2|NOT COMPLETED|Overall Study||4
437805|NCT00710996|1042857|P3|COMPLETED|Overall Study||21
437806|NCT00710996|1042858|P2|COMPLETED|Overall Study||16
437807|NCT00710996|1042859|P1|COMPLETED|Overall Study||16
437808|NCT00710996|1042857|P3|STARTED|Overall Study||21
437809|NCT00710996|1042858|P2|STARTED|Overall Study||20
437810|NCT00710996|1042859|P1|STARTED|Overall Study||17
437811|NCT00710970|1042867|P1|NOT COMPLETED|Overall Study||10
437812|NCT00710970|1042867|P1|COMPLETED|Overall Study||18
437813|NCT00710970|1042867|P1|STARTED|Overall Study||28
437814|NCT00710944|1042874|P3|NOT COMPLETED|Overall Study||2
437815|NCT00710944|1042875|P2|NOT COMPLETED|Overall Study||9
437816|NCT00710944|1042876|P1|NOT COMPLETED|Overall Study||10
437817|NCT00710944|1042874|P3|COMPLETED|Overall Study||17
437818|NCT00710944|1042875|P2|COMPLETED|Overall Study||49
437819|NCT00710944|1042876|P1|COMPLETED|Overall Study||45
437820|NCT00710944|1042874|P3|STARTED|Overall Study||19
437821|NCT00710944|1042875|P2|STARTED|Overall Study||58
437822|NCT00710944|1042876|P1|STARTED|Overall Study||55
437823|NCT00710931|1042884|P1|NOT COMPLETED|Overall Study||5
437824|NCT00710931|1042884|P1|COMPLETED|Overall Study||29
437825|NCT00710931|1042884|P1|STARTED|Overall Study||34
437826|NCT00710905|1042888|P1|NOT COMPLETED|Overall Study||16
437827|NCT00710905|1042888|P1|COMPLETED|Overall Study||34
437828|NCT00710905|1042888|P1|STARTED|Overall Study||50
437829|NCT00710879|1042894|P2|NOT COMPLETED|Overall Study||4
437830|NCT00710879|1042895|P1|NOT COMPLETED|Overall Study||2
437831|NCT00710879|1042894|P2|COMPLETED|Overall Study||113
437832|NCT00710879|1042895|P1|COMPLETED|Overall Study||58
437833|NCT00710879|1042894|P2|STARTED|Overall Study||117
437834|NCT00710879|1042895|P1|STARTED|Overall Study||60
437835|NCT00710866|1042907|P2|NOT COMPLETED|Overall Study||6
437836|NCT00710866|1042908|P1|NOT COMPLETED|Overall Study||9
437837|NCT00710866|1042907|P2|COMPLETED|Overall Study||128
437838|NCT00710866|1042908|P1|COMPLETED|Overall Study||124
437839|NCT00710866|1042907|P2|STARTED|Overall Study||134
437840|NCT00710866|1042908|P1|STARTED|Overall Study||133
437841|NCT00710840|1042930|P2|NOT COMPLETED|Overall Study||3
437842|NCT00710840|1042931|P1|NOT COMPLETED|Overall Study||0
437843|NCT00710840|1042930|P2|COMPLETED|Overall Study||19
437844|NCT00710840|1042931|P1|COMPLETED|Overall Study||22
437845|NCT00710840|1042930|P2|STARTED|Overall Study||22
437846|NCT00710840|1042931|P1|STARTED|Overall Study||22
437847|NCT00710814|1042945|P2|NOT COMPLETED|Overall Study||3
437848|NCT00710814|1042946|P1|NOT COMPLETED|Overall Study||1
437849|NCT00710814|1042945|P2|COMPLETED|Overall Study||13
437850|NCT00710814|1042946|P1|COMPLETED|Overall Study||14
437851|NCT00710814|1042945|P2|STARTED|Overall Study||16
437852|NCT00710814|1042946|P1|STARTED|Overall Study||15
437853|NCT00710762|1042954|P2|NOT COMPLETED|Overall Study||40
437854|NCT00710762|1042955|P1|NOT COMPLETED|Overall Study||39
437855|NCT00710762|1042954|P2|COMPLETED|Overall Study||0
437856|NCT00710762|1042955|P1|COMPLETED|Overall Study||5
437857|NCT00710762|1042954|P2|STARTED|Overall Study||40
437858|NCT00710762|1042955|P1|STARTED|Overall Study||44
437859|NCT00710749|1042971|P2|NOT COMPLETED|Second Intervention||0
437860|NCT00710749|1042972|P1|NOT COMPLETED|Second Intervention||0
437861|NCT00710749|1042971|P2|COMPLETED|Second Intervention||30
437862|NCT00710749|1042972|P1|COMPLETED|Second Intervention||29
437863|NCT00710749|1042971|P2|STARTED|Second Intervention||30
437864|NCT00710749|1042972|P1|STARTED|Second Intervention||29
437865|NCT00710749|1042971|P2|NOT COMPLETED|First Intervention||0
437866|NCT00710749|1042972|P1|NOT COMPLETED|First Intervention||1
437867|NCT00710749|1042971|P2|COMPLETED|First Intervention||30
437868|NCT00710749|1042972|P1|COMPLETED|First Intervention||29
437869|NCT00710749|1042971|P2|STARTED|First Intervention||30
437870|NCT00710749|1042972|P1|STARTED|First Intervention||30
437871|NCT00710749|1042971|P2|NOT COMPLETED|Clinic Baseline Recording||0
437872|NCT00710749|1042972|P1|NOT COMPLETED|Clinic Baseline Recording||0
437873|NCT00710749|1042971|P2|COMPLETED|Clinic Baseline Recording||30
437874|NCT00710749|1042972|P1|COMPLETED|Clinic Baseline Recording||30
437875|NCT00710749|1042971|P2|STARTED|Clinic Baseline Recording||30
437876|NCT00710749|1042972|P1|STARTED|Clinic Baseline Recording||30
437877|NCT00710606|1042982|P2|NOT COMPLETED|Overall Study||2
437878|NCT00710606|1042983|P1|NOT COMPLETED|Overall Study||0
437879|NCT00710606|1042982|P2|COMPLETED|Overall Study||18
437880|NCT00710606|1042983|P1|COMPLETED|Overall Study||20
437881|NCT00710606|1042982|P2|STARTED|Overall Study||20
437882|NCT00710606|1042983|P1|STARTED|Overall Study||20
437883|NCT00710593|1042995|P2|NOT COMPLETED|Overall Study||5
437884|NCT00710593|1042996|P1|NOT COMPLETED|Overall Study||15
437885|NCT00710593|1042995|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
437886|NCT00710593|1042996|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
437887|NCT00710593|1042995|P2|STARTED|Overall Study||30
437888|NCT00710593|1042996|P1|STARTED|Overall Study||69
437889|NCT00710554|1043039|P2|NOT COMPLETED|Overall Study||24
437890|NCT00710554|1043040|P1|NOT COMPLETED|Overall Study||49
437891|NCT00710554|1043039|P2|COMPLETED|Overall Study||94
437892|NCT00710554|1043040|P1|COMPLETED|Overall Study||79
437893|NCT00710554|1043039|P2|STARTED|Overall Study||118
437894|NCT00710554|1043040|P1|STARTED|Overall Study||128
437895|NCT00710424|1043068|P2|NOT COMPLETED|Overall Study||23
437896|NCT00710424|1043069|P1|NOT COMPLETED|Overall Study||44
437897|NCT00710424|1043068|P2|COMPLETED|Overall Study||125
437898|NCT00710424|1043069|P1|COMPLETED|Overall Study||105
437899|NCT00710424|1043068|P2|STARTED|Overall Study||148
437900|NCT00710424|1043069|P1|STARTED|Overall Study||149
437901|NCT00710385|1043093|P1|NOT COMPLETED|Overall Study||5
437902|NCT00710385|1043093|P1|COMPLETED|Overall Study||12
437903|NCT00710385|1043093|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
437904|NCT00710203|1043110|P1|NOT COMPLETED|Overall Study||0
437905|NCT00710203|1043110|P1|COMPLETED|Overall Study||10
437906|NCT00710203|1043110|P1|STARTED|Overall Study||10
437907|NCT00710021|1043139|P3|NOT COMPLETED|Overall Study||1
437908|NCT00710021|1043140|P2|NOT COMPLETED|Overall Study||3
437909|NCT00710021|1043141|P1|NOT COMPLETED|Overall Study||1
437910|NCT00710021|1043139|P3|COMPLETED|Overall Study||18
437911|NCT00710021|1043140|P2|COMPLETED|Overall Study||16
437912|NCT00710021|1043141|P1|COMPLETED|Overall Study||18
437913|NCT00710021|1043139|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
437914|NCT00710021|1043140|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
437915|NCT00710021|1043141|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
437916|NCT00710021|1043139|P3|STARTED|Overall Study||19
437917|NCT00710021|1043140|P2|STARTED|Overall Study||19
437918|NCT00710021|1043141|P1|STARTED|Overall Study||19
437919|NCT00709956|1043256|P2|NOT COMPLETED|Overall Study||4
437920|NCT00709956|1043257|P1|NOT COMPLETED|Overall Study||3
437921|NCT00709956|1043256|P2|COMPLETED|Overall Study||33
437922|NCT00709956|1043257|P1|COMPLETED|Overall Study||30
437923|NCT00709956|1043256|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
437924|NCT00709956|1043257|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
437925|NCT00709956|1043256|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
437926|NCT00709956|1043257|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
437927|NCT00709891|1043265|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
437928|NCT00709891|1043265|P1|COMPLETED|Longitudinal Follow-up Phase||5020
437929|NCT00709891|1043265|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
437930|NCT00709891|1043265|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
437931|NCT00709891|1043265|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
437932|NCT00709891|1043265|P1|STARTED|Baseline, Cross-sectional Phase||47208
437933|NCT00709878|1043274|P4|NOT COMPLETED|Overall Study||0
437934|NCT00709878|1043275|P3|NOT COMPLETED|Overall Study||0
437935|NCT00709878|1043276|P2|NOT COMPLETED|Overall Study||0
437936|NCT00709878|1043277|P1|NOT COMPLETED|Overall Study||0
437937|NCT00709878|1043274|P4|COMPLETED|Overall Study||8
437938|NCT00709878|1043275|P3|COMPLETED|Overall Study||8
437939|NCT00709878|1043276|P2|COMPLETED|Overall Study||8
437940|NCT00709878|1043277|P1|COMPLETED|Overall Study||8
437941|NCT00709878|1043274|P4|STARTED|Overall Study||8
437942|NCT00709878|1043275|P3|STARTED|Overall Study||8
437943|NCT00709878|1043276|P2|STARTED|Overall Study||8
437944|NCT00709878|1043277|P1|STARTED|Overall Study||8
437945|NCT00709852|1043287|P2|NOT COMPLETED|Period 2||2
437946|NCT00709852|1043288|P1|NOT COMPLETED|Period 2||9
437947|NCT00709852|1043287|P2|COMPLETED|Period 2||169
437948|NCT00709852|1043288|P1|COMPLETED|Period 2||211
437949|NCT00709852|1043287|P2|STARTED|Period 2||171
437950|NCT00709852|1043288|P1|STARTED|Period 2||220
437951|NCT00709852|1043287|P2|NOT COMPLETED|Period 1||3
437952|NCT00709852|1043288|P1|NOT COMPLETED|Period 1||8
437953|NCT00709852|1043287|P2|COMPLETED|Period 1||171
437954|NCT00709852|1043288|P1|COMPLETED|Period 1||220
437955|NCT00709852|1043287|P2|STARTED|Period 1||174
437956|NCT00709852|1043288|P1|STARTED|Period 1||228
437957|NCT00709826|1043443|P2|NOT COMPLETED|Overall Study||1
437958|NCT00709826|1043444|P1|NOT COMPLETED|Overall Study||2
437959|NCT00709826|1043443|P2|COMPLETED|Overall Study||38
437960|NCT00709826|1043444|P1|COMPLETED|Overall Study||68
437961|NCT00709826|1043443|P2|STARTED|Overall Study||39
437962|NCT00709826|1043444|P1|STARTED|Overall Study||70
437963|NCT00708734|1043452|P1|NOT COMPLETED|Overall Study||7
437964|NCT00708734|1043452|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
437965|NCT00708734|1043452|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
437966|NCT00708721|1043456|P4|NOT COMPLETED|Overall Study||0
437967|NCT00708721|1043457|P3|NOT COMPLETED|Overall Study||0
437968|NCT00708721|1043458|P2|NOT COMPLETED|Overall Study||0
437969|NCT00708721|1043459|P1|NOT COMPLETED|Overall Study||0
437970|NCT00708721|1043456|P4|COMPLETED|Overall Study||2
437971|NCT00708721|1043457|P3|COMPLETED|Overall Study||3
437972|NCT00708721|1043458|P2|COMPLETED|Overall Study||4
437973|NCT00708721|1043459|P1|COMPLETED|Overall Study||2
437974|NCT00708721|1043456|P4|STARTED|Overall Study||2
437975|NCT00708721|1043457|P3|STARTED|Overall Study||3
437976|NCT00708721|1043458|P2|STARTED|Overall Study||4
437977|NCT00708721|1043459|P1|STARTED|Overall Study||2
437978|NCT00708708|1043472|P1|NOT COMPLETED|Overall Study||742
437979|NCT00708708|1043472|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
437980|NCT00708708|1043472|P1|STARTED|Overall Study||955
437981|NCT00708682|1043520|P1|NOT COMPLETED|Toddler Dose||8
437982|NCT00708682|1043520|P1|COMPLETED|Toddler Dose||183
437983|NCT00708682|1043520|P1|STARTED|Toddler Dose||191
437984|NCT00708682|1043520|P1|NOT COMPLETED|After Infant Series||1
437985|NCT00708682|1043520|P1|COMPLETED|After Infant Series||191
437986|NCT00708682|1043520|P1|STARTED|After Infant Series||192
437987|NCT00708682|1043520|P1|NOT COMPLETED|Infant Series||33
437988|NCT00708682|1043520|P1|COMPLETED|Infant Series||192
437989|NCT00708682|1043520|P1|Vaccinated Dose 3|Infant Series||194
437990|NCT00708682|1043520|P1|Vaccinated Dose 2|Infant Series||214
437991|NCT00708682|1043520|P1|Vaccinated Dose 1|Infant Series||223
437992|NCT00708682|1043520|P1|STARTED|Infant Series||225
437993|NCT00708643|1043541|P2|NOT COMPLETED|Overall Study||1
437994|NCT00708643|1043542|P1|NOT COMPLETED|Overall Study||0
437995|NCT00708643|1043541|P2|COMPLETED|Overall Study||39
437996|NCT00708643|1043542|P1|COMPLETED|Overall Study||40
437997|NCT00708643|1043541|P2|STARTED|Overall Study||40
437998|NCT00708643|1043542|P1|STARTED|Overall Study||40
437999|NCT00709761|1043558|P1|NOT COMPLETED|Overall Study||47
438000|NCT00709761|1043558|P1|COMPLETED|Overall Study||13
438001|NCT00709761|1043558|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
438002|NCT00709761|1043558|P1|STARTED|Overall Study||60
438003|NCT00709735|1043569|P2|NOT COMPLETED|Overall Study||2
438004|NCT00709735|1043570|P1|NOT COMPLETED|Overall Study||3
438005|NCT00709735|1043569|P2|COMPLETED|Overall Study||10
438006|NCT00709735|1043570|P1|COMPLETED|Overall Study||8
438007|NCT00709735|1043569|P2|STARTED|Overall Study||12
438008|NCT00709735|1043570|P1|STARTED|Overall Study||11
438009|NCT00709722|1043578|P1|NOT COMPLETED|Overall Study||1
438010|NCT00709722|1043578|P1|COMPLETED|Overall Study||20
438011|NCT00709722|1043578|P1|STARTED|Overall Study||21
438012|NCT00709618|1043584|P1|NOT COMPLETED|Overall Study||30
438013|NCT00709618|1043584|P1|COMPLETED|Overall Study||14
438014|NCT00709618|1043584|P1|STARTED|Overall Study||44
438015|NCT00709592|1043596|P2|NOT COMPLETED|Overall Study||1
438016|NCT00709592|1043597|P1|NOT COMPLETED|Overall Study||0
438017|NCT00709592|1043596|P2|COMPLETED|Overall Study||22
438018|NCT00709592|1043597|P1|COMPLETED|Overall Study||19
438019|NCT00709592|1043596|P2|STARTED|Overall Study||23
438020|NCT00709592|1043597|P1|STARTED|Overall Study||19
438021|NCT00709319|1043617|P1|NOT COMPLETED|Overall Study||6
438022|NCT00709319|1043617|P1|COMPLETED|Overall Study||81
438023|NCT00709319|1043617|P1|STARTED|Overall Study||87
438024|NCT00709228|1043625|P1|NOT COMPLETED|Overall Study||332
438025|NCT00709228|1043625|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
438026|NCT00709228|1043625|P1|STARTED|Overall Study||496
438027|NCT00709124|1043631|P2|NOT COMPLETED|Overall Study||1
438028|NCT00709124|1043632|P1|NOT COMPLETED|Overall Study||4
438029|NCT00709124|1043631|P2|COMPLETED|Overall Study||17
438030|NCT00709124|1043632|P1|COMPLETED|Overall Study||12
438031|NCT00709124|1043631|P2|STARTED|Overall Study||18
438032|NCT00709124|1043632|P1|STARTED|Overall Study||16
438033|NCT00709111|1043638|P1|NOT COMPLETED|Overall Study||2
438034|NCT00709111|1043638|P1|COMPLETED|Overall Study||32
438035|NCT00709111|1043638|P1|Week 22/24|Overall Study||33
438036|NCT00709111|1043638|P1|STARTED|Overall Study||34
438037|NCT00709098|1043679|P3|NOT COMPLETED|Open-label Period||14
438038|NCT00709098|1043680|P2|NOT COMPLETED|Open-label Period||0
438039|NCT00709098|1043681|P1|NOT COMPLETED|Open-label Period||0
438040|NCT00709098|1043679|P3|COMPLETED|Open-label Period||18
438041|NCT00709098|1043680|P2|COMPLETED|Open-label Period||0
438042|NCT00709098|1043681|P1|COMPLETED|Open-label Period||0
438043|NCT00709098|1043679|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
438044|NCT00709098|1043680|P2|STARTED|Open-label Period||0
438045|NCT00709098|1043681|P1|STARTED|Open-label Period||0
438046|NCT00709098|1043679|P3|NOT COMPLETED|Double-blind Period||0
438047|NCT00709098|1043680|P2|NOT COMPLETED|Double-blind Period||8
438048|NCT00709098|1043681|P1|NOT COMPLETED|Double-blind Period||6
438049|NCT00709098|1043679|P3|COMPLETED|Double-blind Period||0
438050|NCT00709098|1043680|P2|COMPLETED|Double-blind Period||16
438051|NCT00709098|1043681|P1|COMPLETED|Double-blind Period||19
438052|NCT00709098|1043679|P3|STARTED|Double-blind Period||0
438053|NCT00709098|1043680|P2|STARTED|Double-blind Period||24
438054|NCT00709098|1043681|P1|STARTED|Double-blind Period||25
438055|NCT00709059|1043700|P1|NOT COMPLETED|Overall Study||94
438056|NCT00709059|1043700|P1|COMPLETED|Overall Study||444
438057|NCT00709059|1043700|P1|STARTED|Overall Study||538
438058|NCT00708942|1043709|P5|NOT COMPLETED|Overall Study||1
438059|NCT00708942|1043710|P4|NOT COMPLETED|Overall Study||0
438060|NCT00708942|1043711|P3|NOT COMPLETED|Overall Study||2
438061|NCT00708942|1043712|P2|NOT COMPLETED|Overall Study||1
438062|NCT00708942|1043713|P1|NOT COMPLETED|Overall Study||7
438063|NCT00708942|1043709|P5|COMPLETED|Overall Study||2
438064|NCT00708942|1043710|P4|COMPLETED|Overall Study||10
438065|NCT00708942|1043711|P3|COMPLETED|Overall Study||9
438066|NCT00708942|1043712|P2|COMPLETED|Overall Study||11
438067|NCT00708942|1043713|P1|COMPLETED|Overall Study||40
438068|NCT00708942|1043709|P5|STARTED|Overall Study||3
438069|NCT00708942|1043710|P4|STARTED|Overall Study||10
438070|NCT00708942|1043711|P3|STARTED|Overall Study||11
438071|NCT00708942|1043712|P2|STARTED|Overall Study||12
438072|NCT00708942|1043713|P1|STARTED|Overall Study||47
438073|NCT00708877|1043735|P1|NOT COMPLETED|Overall Study||0
438074|NCT00708877|1043735|P1|COMPLETED|Overall Study||5
438075|NCT00708877|1043735|P1|STARTED|Overall Study||5
438076|NCT00708851|1043739|P1|NOT COMPLETED|Overall Study||0
438077|NCT00708851|1043739|P1|COMPLETED|Overall Study||12
438078|NCT00708851|1043739|P1|STARTED|Overall Study||12
438079|NCT00708526|1043749|P2|NOT COMPLETED|Return of Cognitive Function||0
438080|NCT00708526|1043750|P1|NOT COMPLETED|Return of Cognitive Function||0
438081|NCT00708526|1043749|P2|COMPLETED|Return of Cognitive Function||11
438082|NCT00708526|1043750|P1|COMPLETED|Return of Cognitive Function||11
438083|NCT00708526|1043749|P2|STARTED|Return of Cognitive Function||11
438084|NCT00708526|1043750|P1|STARTED|Return of Cognitive Function||11
438085|NCT00708526|1043749|P2|NOT COMPLETED|Wake up After Anesthesia||0
438086|NCT00708526|1043750|P1|NOT COMPLETED|Wake up After Anesthesia||0
438087|NCT00708526|1043749|P2|COMPLETED|Wake up After Anesthesia||11
438088|NCT00708526|1043750|P1|COMPLETED|Wake up After Anesthesia||11
438089|NCT00708526|1043749|P2|STARTED|Wake up After Anesthesia||11
438090|NCT00708526|1043750|P1|STARTED|Wake up After Anesthesia||11
438091|NCT00708500|1043761|P3|NOT COMPLETED|FOLLOWUP||15
438092|NCT00708500|1043762|P2|NOT COMPLETED|FOLLOWUP||15
438093|NCT00708500|1043763|P1|NOT COMPLETED|FOLLOWUP||40
438094|NCT00708500|1043761|P3|COMPLETED|FOLLOWUP||143
438095|NCT00708500|1043762|P2|COMPLETED|FOLLOWUP||136
438096|NCT00708500|1043763|P1|COMPLETED|FOLLOWUP||37
438097|NCT00708500|1043761|P3|STARTED|FOLLOWUP||158
438098|NCT00708500|1043762|P2|STARTED|FOLLOWUP||151
438099|NCT00708500|1043763|P1|STARTED|FOLLOWUP||77
438100|NCT00708500|1043761|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
438101|NCT00708500|1043762|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
438102|NCT00708500|1043763|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
438103|NCT00708500|1043761|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
438104|NCT00708500|1043762|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
438105|NCT00708500|1043763|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
438106|NCT00708500|1043761|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
438107|NCT00708500|1043762|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
438108|NCT00708500|1043763|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
438109|NCT00708500|1043761|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
438110|NCT00708500|1043762|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
438111|NCT00708500|1043763|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
438112|NCT00708500|1043761|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
438113|NCT00708500|1043762|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
438114|NCT00708500|1043763|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
438115|NCT00708500|1043761|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
438116|NCT00708500|1043762|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
438117|NCT00708500|1043763|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
438118|NCT00708500|1043761|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
438119|NCT00708500|1043762|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
438120|NCT00708500|1043763|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
438121|NCT00708461|1043782|P2|NOT COMPLETED|Overall Study||200
438122|NCT00708461|1043783|P1|NOT COMPLETED|Overall Study||141
438123|NCT00708461|1043782|P2|COMPLETED|Overall Study||795
438124|NCT00708461|1043783|P1|COMPLETED|Overall Study||611
438125|NCT00708461|1043782|P2|STARTED|Overall Study||995
438126|NCT00708461|1043783|P1|STARTED|Overall Study||752
438127|NCT00708435|1043791|P2|NOT COMPLETED|Overall Study||17
438128|NCT00708435|1043792|P1|NOT COMPLETED|Overall Study||25
438129|NCT00708435|1043791|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
438130|NCT00708435|1043792|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
438131|NCT00708435|1043791|P2|STARTED|Overall Study||109
438132|NCT00708435|1043792|P1|STARTED|Overall Study||107
438133|NCT00708422|1043819|P2|NOT COMPLETED|Overall Study||1
438134|NCT00708422|1043820|P1|NOT COMPLETED|Overall Study||4
438135|NCT00708422|1043819|P2|COMPLETED|Overall Study||114
438136|NCT00708422|1043820|P1|COMPLETED|Overall Study||112
438137|NCT00708422|1043819|P2|STARTED|Overall Study||115
438138|NCT00708422|1043820|P1|STARTED|Overall Study||116
438139|NCT00708305|1043828|P4|NOT COMPLETED|Period 4||0
438140|NCT00708305|1043829|P3|NOT COMPLETED|Period 4||0
438141|NCT00708305|1043830|P2|NOT COMPLETED|Period 4||0
438142|NCT00708305|1043831|P1|NOT COMPLETED|Period 4||0
438143|NCT00708305|1043828|P4|COMPLETED|Period 4||14
438144|NCT00708305|1043829|P3|COMPLETED|Period 4||14
438145|NCT00708305|1043830|P2|COMPLETED|Period 4||14
438146|NCT00708305|1043831|P1|COMPLETED|Period 4||12
438147|NCT00708305|1043828|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
438148|NCT00708305|1043829|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
438149|NCT00708305|1043830|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
438150|NCT00708305|1043831|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
438151|NCT00708305|1043828|P4|NOT COMPLETED|Period 3||0
438152|NCT00708305|1043829|P3|NOT COMPLETED|Period 3||0
438153|NCT00708305|1043830|P2|NOT COMPLETED|Period 3||2
438154|NCT00708305|1043831|P1|NOT COMPLETED|Period 3||1
438155|NCT00708305|1043828|P4|COMPLETED|Period 3||14
438156|NCT00708305|1043829|P3|COMPLETED|Period 3||14
438157|NCT00708305|1043830|P2|COMPLETED|Period 3||12
438158|NCT00708305|1043831|P1|COMPLETED|Period 3||14
438159|NCT00708305|1043828|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
438240|NCT00708123|1043996|P4|NOT COMPLETED|Period 4||0
438160|NCT00708305|1043829|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
438161|NCT00708305|1043830|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
438162|NCT00708305|1043831|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
438163|NCT00708305|1043828|P4|NOT COMPLETED|Period 2||1
438164|NCT00708305|1043829|P3|NOT COMPLETED|Period 2||0
438165|NCT00708305|1043830|P2|NOT COMPLETED|Period 2||2
438166|NCT00708305|1043831|P1|NOT COMPLETED|Period 2||1
438167|NCT00708305|1043828|P4|COMPLETED|Period 2||14
438168|NCT00708305|1043829|P3|COMPLETED|Period 2||16
438169|NCT00708305|1043830|P2|COMPLETED|Period 2||13
438170|NCT00708305|1043831|P1|COMPLETED|Period 2||14
438171|NCT00708305|1043828|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
438172|NCT00708305|1043829|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
438173|NCT00708305|1043830|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
438174|NCT00708305|1043831|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
438175|NCT00708305|1043828|P4|NOT COMPLETED|Period 1||2
438176|NCT00708305|1043829|P3|NOT COMPLETED|Period 1||1
438177|NCT00708305|1043830|P2|NOT COMPLETED|Period 1||0
438178|NCT00708305|1043831|P1|NOT COMPLETED|Period 1||1
438179|NCT00708305|1043828|P4|COMPLETED|Period 1||14
438180|NCT00708305|1043829|P3|COMPLETED|Period 1||16
438181|NCT00708305|1043830|P2|COMPLETED|Period 1||16
438182|NCT00708305|1043831|P1|COMPLETED|Period 1||15
438183|NCT00708305|1043828|P4|STARTED|Period 1||16
438184|NCT00708305|1043829|P3|STARTED|Period 1||17
438185|NCT00708305|1043830|P2|STARTED|Period 1||16
438186|NCT00708305|1043831|P1|STARTED|Period 1||16
438187|NCT00708214|1043866|P3|NOT COMPLETED|Overall Study||8
438188|NCT00708214|1043867|P2|NOT COMPLETED|Overall Study||13
438189|NCT00708214|1043868|P1|NOT COMPLETED|Overall Study||7
438190|NCT00708214|1043866|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
438191|NCT00708214|1043867|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
438192|NCT00708214|1043868|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
438193|NCT00708214|1043866|P3|STARTED|Overall Study||8
438194|NCT00708214|1043867|P2|STARTED|Overall Study||13
438195|NCT00708214|1043868|P1|STARTED|Overall Study||7
438196|NCT00708201|1043911|P2|NOT COMPLETED|Overall Study||6
438197|NCT00708201|1043912|P1|NOT COMPLETED|Overall Study||7
438198|NCT00708201|1043911|P2|COMPLETED|Overall Study||137
438199|NCT00708201|1043912|P1|COMPLETED|Overall Study||130
438200|NCT00708201|1043911|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
438201|NCT00708201|1043912|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
438202|NCT00708201|1043911|P2|STARTED|Overall Study||143
438203|NCT00708201|1043912|P1|STARTED|Overall Study||137
438204|NCT00708175|1043936|P2|NOT COMPLETED|Overall Study||21
438205|NCT00708175|1043937|P1|NOT COMPLETED|Overall Study||18
438206|NCT00708175|1043936|P2|COMPLETED|Overall Study||57
438207|NCT00708175|1043937|P1|COMPLETED|Overall Study||60
438208|NCT00708175|1043936|P2|STARTED|Overall Study||78
438209|NCT00708175|1043937|P1|STARTED|Overall Study||78
438210|NCT00708162|1043953|P2|NOT COMPLETED|Open-Label Phase||30
438211|NCT00708162|1043954|P1|NOT COMPLETED|Open-Label Phase||44
438212|NCT00708162|1043953|P2|COMPLETED|Open-Label Phase||121
438213|NCT00708162|1043954|P1|COMPLETED|Open-Label Phase||152
438214|NCT00708162|1043953|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
438215|NCT00708162|1043954|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
438216|NCT00708162|1043953|P2|NOT COMPLETED|Randomized Phase||154
438217|NCT00708162|1043954|P1|NOT COMPLETED|Randomized Phase||156
438218|NCT00708162|1043953|P2|COMPLETED|Randomized Phase||209
438219|NCT00708162|1043954|P1|COMPLETED|Randomized Phase||205
438220|NCT00708162|1043953|P2|Randomized and Treated|Randomized Phase||358
438221|NCT00708162|1043954|P1|Randomized and Treated|Randomized Phase||354
438222|NCT00708162|1043953|P2|STARTED|Randomized Phase||363
438223|NCT00708162|1043954|P1|STARTED|Randomized Phase||361
438224|NCT00708123|1043995|P5|NOT COMPLETED|Period 5||0
438225|NCT00708123|1043996|P4|NOT COMPLETED|Period 5||0
438226|NCT00708123|1043997|P3|NOT COMPLETED|Period 5||0
438227|NCT00708123|1043998|P2|NOT COMPLETED|Period 5||0
438228|NCT00708123|1043999|P1|NOT COMPLETED|Period 5||0
438229|NCT00708123|1043995|P5|COMPLETED|Period 5||10
438230|NCT00708123|1043996|P4|COMPLETED|Period 5||11
438231|NCT00708123|1043997|P3|COMPLETED|Period 5||11
438232|NCT00708123|1043998|P2|COMPLETED|Period 5||10
438233|NCT00708123|1043999|P1|COMPLETED|Period 5||10
438234|NCT00708123|1043995|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
438235|NCT00708123|1043996|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
438236|NCT00708123|1043997|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
438237|NCT00708123|1043998|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
438238|NCT00708123|1043999|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
438239|NCT00708123|1043995|P5|NOT COMPLETED|Period 4||0
438241|NCT00708123|1043997|P3|NOT COMPLETED|Period 4||0
438242|NCT00708123|1043998|P2|NOT COMPLETED|Period 4||1
438243|NCT00708123|1043999|P1|NOT COMPLETED|Period 4||0
438244|NCT00708123|1043995|P5|COMPLETED|Period 4||11
438245|NCT00708123|1043996|P4|COMPLETED|Period 4||10
438246|NCT00708123|1043997|P3|COMPLETED|Period 4||10
438247|NCT00708123|1043998|P2|COMPLETED|Period 4||11
438248|NCT00708123|1043999|P1|COMPLETED|Period 4||10
438249|NCT00708123|1043995|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
438250|NCT00708123|1043996|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
438251|NCT00708123|1043997|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
438252|NCT00708123|1043998|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
438253|NCT00708123|1043999|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
438254|NCT00708123|1043995|P5|NOT COMPLETED|Period 3||0
438255|NCT00708123|1043996|P4|NOT COMPLETED|Period 3||1
438256|NCT00708123|1043997|P3|NOT COMPLETED|Period 3||1
438257|NCT00708123|1043998|P2|NOT COMPLETED|Period 3||0
438258|NCT00708123|1043999|P1|NOT COMPLETED|Period 3||0
438259|NCT00708123|1043995|P5|COMPLETED|Period 3||10
438260|NCT00708123|1043996|P4|COMPLETED|Period 3||11
438261|NCT00708123|1043997|P3|COMPLETED|Period 3||10
438262|NCT00708123|1043998|P2|COMPLETED|Period 3||10
438263|NCT00708123|1043999|P1|COMPLETED|Period 3||12
438264|NCT00708123|1043995|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
438265|NCT00708123|1043996|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
438266|NCT00708123|1043997|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
438267|NCT00708123|1043998|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
438268|NCT00708123|1043999|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
438269|NCT00708123|1043995|P5|NOT COMPLETED|Period 2||0
438270|NCT00708123|1043996|P4|NOT COMPLETED|Period 2||1
438271|NCT00708123|1043997|P3|NOT COMPLETED|Period 2||0
438272|NCT00708123|1043998|P2|NOT COMPLETED|Period 2||0
438273|NCT00708123|1043999|P1|NOT COMPLETED|Period 2||1
438274|NCT00708123|1043995|P5|COMPLETED|Period 2||11
438275|NCT00708123|1043996|P4|COMPLETED|Period 2||10
438276|NCT00708123|1043997|P3|COMPLETED|Period 2||12
438277|NCT00708123|1043998|P2|COMPLETED|Period 2||12
438278|NCT00708123|1043999|P1|COMPLETED|Period 2||10
438279|NCT00708123|1043995|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
438280|NCT00708123|1043996|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
438281|NCT00708123|1043997|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
438282|NCT00708123|1043998|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
438283|NCT00708123|1043999|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
438284|NCT00708123|1043995|P5|NOT COMPLETED|Period 1||0
438285|NCT00708123|1043996|P4|NOT COMPLETED|Period 1||1
438286|NCT00708123|1043997|P3|NOT COMPLETED|Period 1||1
438287|NCT00708123|1043998|P2|NOT COMPLETED|Period 1||1
438288|NCT00708123|1043999|P1|NOT COMPLETED|Period 1||0
438289|NCT00708123|1043995|P5|COMPLETED|Period 1||12
438290|NCT00708123|1043996|P4|COMPLETED|Period 1||11
438291|NCT00708123|1043997|P3|COMPLETED|Period 1||11
438292|NCT00708123|1043998|P2|COMPLETED|Period 1||11
438293|NCT00708123|1043999|P1|COMPLETED|Period 1||12
438294|NCT00708123|1043995|P5|STARTED|Period 1||12
438295|NCT00708123|1043996|P4|STARTED|Period 1||12
438296|NCT00708123|1043997|P3|STARTED|Period 1||12
438297|NCT00708123|1043998|P2|STARTED|Period 1||12
438298|NCT00708123|1043999|P1|STARTED|Period 1||12
438299|NCT00708110|1044023|P4|NOT COMPLETED|Overall Study||0
438300|NCT00708110|1044024|P3|NOT COMPLETED|Overall Study||0
438301|NCT00708110|1044025|P2|NOT COMPLETED|Overall Study||0
438302|NCT00708110|1044026|P1|NOT COMPLETED|Overall Study||0
438303|NCT00708110|1044023|P4|COMPLETED|Overall Study||10
438304|NCT00708110|1044024|P3|COMPLETED|Overall Study||9
438305|NCT00708110|1044025|P2|COMPLETED|Overall Study||9
438306|NCT00708110|1044026|P1|COMPLETED|Overall Study||7
438307|NCT00708110|1044023|P4|STARTED|Overall Study||10
438308|NCT00708110|1044024|P3|STARTED|Overall Study||9
438309|NCT00708110|1044025|P2|STARTED|Overall Study||9
438310|NCT00708110|1044026|P1|STARTED|Overall Study||7
438311|NCT00708097|1044132|P5|NOT COMPLETED|Period 5||0
438312|NCT00708097|1044133|P4|NOT COMPLETED|Period 5||0
438313|NCT00708097|1044134|P3|NOT COMPLETED|Period 5||0
438314|NCT00708097|1044135|P2|NOT COMPLETED|Period 5||0
438315|NCT00708097|1044136|P1|NOT COMPLETED|Period 5||0
438316|NCT00708097|1044132|P5|COMPLETED|Period 5||12
438317|NCT00708097|1044133|P4|COMPLETED|Period 5||10
438318|NCT00708097|1044134|P3|COMPLETED|Period 5||11
438319|NCT00708097|1044135|P2|COMPLETED|Period 5||9
438320|NCT00708097|1044136|P1|COMPLETED|Period 5||8
438321|NCT00708097|1044132|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
438322|NCT00708097|1044133|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
438323|NCT00708097|1044134|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
438324|NCT00708097|1044135|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
438325|NCT00708097|1044136|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
438326|NCT00708097|1044132|P5|NOT COMPLETED|Period 4||0
438327|NCT00708097|1044133|P4|NOT COMPLETED|Period 4||0
438328|NCT00708097|1044134|P3|NOT COMPLETED|Period 4||0
438329|NCT00708097|1044135|P2|NOT COMPLETED|Period 4||0
438330|NCT00708097|1044136|P1|NOT COMPLETED|Period 4||0
438331|NCT00708097|1044132|P5|COMPLETED|Period 4||8
438332|NCT00708097|1044133|P4|COMPLETED|Period 4||11
438333|NCT00708097|1044134|P3|COMPLETED|Period 4||10
438334|NCT00708097|1044135|P2|COMPLETED|Period 4||9
438335|NCT00708097|1044136|P1|COMPLETED|Period 4||12
438336|NCT00708097|1044132|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
438337|NCT00708097|1044133|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
438338|NCT00708097|1044134|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
438339|NCT00708097|1044135|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
438340|NCT00708097|1044136|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
438341|NCT00708097|1044132|P5|NOT COMPLETED|Period 3||0
438342|NCT00708097|1044133|P4|NOT COMPLETED|Period 3||0
438343|NCT00708097|1044134|P3|NOT COMPLETED|Period 3||0
438344|NCT00708097|1044135|P2|NOT COMPLETED|Period 3||0
438345|NCT00708097|1044136|P1|NOT COMPLETED|Period 3||0
438346|NCT00708097|1044132|P5|COMPLETED|Period 3||10
438347|NCT00708097|1044133|P4|COMPLETED|Period 3||10
438348|NCT00708097|1044134|P3|COMPLETED|Period 3||10
438349|NCT00708097|1044135|P2|COMPLETED|Period 3||11
438350|NCT00708097|1044136|P1|COMPLETED|Period 3||9
438351|NCT00708097|1044132|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
438352|NCT00708097|1044133|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
438353|NCT00708097|1044134|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
438354|NCT00708097|1044135|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
438355|NCT00708097|1044136|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
438356|NCT00708097|1044132|P5|NOT COMPLETED|Period 2||0
438357|NCT00708097|1044133|P4|NOT COMPLETED|Period 2||1
438358|NCT00708097|1044134|P3|NOT COMPLETED|Period 2||1
438359|NCT00708097|1044135|P2|NOT COMPLETED|Period 2||1
438360|NCT00708097|1044136|P1|NOT COMPLETED|Period 2||0
438361|NCT00708097|1044132|P5|COMPLETED|Period 2||10
438362|NCT00708097|1044133|P4|COMPLETED|Period 2||10
438363|NCT00708097|1044134|P3|COMPLETED|Period 2||9
438364|NCT00708097|1044135|P2|COMPLETED|Period 2||11
438365|NCT00708097|1044136|P1|COMPLETED|Period 2||10
438366|NCT00708097|1044132|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
438367|NCT00708097|1044133|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
438368|NCT00708097|1044134|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
438369|NCT00708097|1044135|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
438370|NCT00708097|1044136|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
438371|NCT00708097|1044132|P5|NOT COMPLETED|Period 1||1
438372|NCT00708097|1044133|P4|NOT COMPLETED|Period 1||2
438373|NCT00708097|1044134|P3|NOT COMPLETED|Period 1||0
438374|NCT00708097|1044135|P2|NOT COMPLETED|Period 1||1
438375|NCT00708097|1044136|P1|NOT COMPLETED|Period 1||0
438376|NCT00708097|1044132|P5|COMPLETED|Period 1||10
438377|NCT00708097|1044133|P4|COMPLETED|Period 1||9
438378|NCT00708097|1044134|P3|COMPLETED|Period 1||12
438379|NCT00708097|1044135|P2|COMPLETED|Period 1||11
438380|NCT00708097|1044136|P1|COMPLETED|Period 1||11
438381|NCT00708097|1044132|P5|STARTED|Period 1||11
438382|NCT00708097|1044133|P4|STARTED|Period 1||11
438383|NCT00708097|1044134|P3|STARTED|Period 1||12
438384|NCT00708097|1044135|P2|STARTED|Period 1||12
438385|NCT00708097|1044136|P1|STARTED|Period 1||11
438386|NCT00708071|1044166|P1|NOT COMPLETED|Overall Study||0
438387|NCT00708071|1044166|P1|COMPLETED|Overall Study||45
438388|NCT00708071|1044166|P1|STARTED|Overall Study|Randomized and treated|45
438389|NCT00708032|1044246|P2|NOT COMPLETED|Overall Study||16
438390|NCT00708032|1044247|P1|NOT COMPLETED|Overall Study||10
438391|NCT00708032|1044246|P2|COMPLETED|Overall Study||22
438392|NCT00708032|1044247|P1|COMPLETED|Overall Study||26
438393|NCT00708032|1044246|P2|STARTED|Overall Study||38
438394|NCT00708032|1044247|P1|STARTED|Overall Study||36
438395|NCT00708019|1044263|P2|NOT COMPLETED|Overall Study||15
438396|NCT00708019|1044264|P1|NOT COMPLETED|Overall Study||15
438397|NCT00708019|1044263|P2|COMPLETED|Overall Study||78
438398|NCT00708019|1044264|P1|COMPLETED|Overall Study||77
438399|NCT00708019|1044263|P2|STARTED|Overall Study||93
438400|NCT00708019|1044264|P1|STARTED|Overall Study||92
438401|NCT00707993|1044274|P2|NOT COMPLETED|Overall Study||94
438402|NCT00707993|1044275|P1|NOT COMPLETED|Overall Study||89
438403|NCT00707993|1044274|P2|COMPLETED|Overall Study||125
438404|NCT00707993|1044275|P1|COMPLETED|Overall Study||133
438405|NCT00707993|1044274|P2|STARTED|Overall Study||219
438406|NCT00707993|1044275|P1|STARTED|Overall Study||222
438407|NCT00707980|1044317|P1|NOT COMPLETED|Overall Study||310
438408|NCT00707980|1044317|P1|COMPLETED|Overall Study||526
438409|NCT00707980|1044317|P1|Received Treatment|Overall Study||834
438410|NCT00707980|1044317|P1|STARTED|Overall Study||836
438411|NCT00707967|1044335|P3|NOT COMPLETED|Overall Study||0
438412|NCT00707967|1044336|P2|NOT COMPLETED|Overall Study||0
438413|NCT00707967|1044337|P1|NOT COMPLETED|Overall Study||0
438414|NCT00707967|1044335|P3|COMPLETED|Overall Study||7
438415|NCT00707967|1044336|P2|COMPLETED|Overall Study||8
438416|NCT00707967|1044337|P1|COMPLETED|Overall Study||22
438417|NCT00707967|1044335|P3|STARTED|Overall Study||7
438418|NCT00707967|1044336|P2|STARTED|Overall Study||8
438419|NCT00707967|1044337|P1|STARTED|Overall Study||22
438420|NCT00707954|1044401|P5|NOT COMPLETED|Overall Study||1
438421|NCT00707954|1044402|P4|NOT COMPLETED|Overall Study||0
438422|NCT00707954|1044403|P3|NOT COMPLETED|Overall Study||0
438423|NCT00707954|1044404|P2|NOT COMPLETED|Overall Study||0
438424|NCT00707954|1044405|P1|NOT COMPLETED|Overall Study||0
438425|NCT00707954|1044401|P5|COMPLETED|Overall Study||9
438426|NCT00707954|1044402|P4|COMPLETED|Overall Study||13
438427|NCT00707954|1044403|P3|COMPLETED|Overall Study||14
438428|NCT00707954|1044404|P2|COMPLETED|Overall Study||12
438429|NCT00707954|1044405|P1|COMPLETED|Overall Study||12
438430|NCT00707954|1044401|P5|STARTED|Overall Study||10
438431|NCT00707954|1044402|P4|STARTED|Overall Study||13
438432|NCT00707954|1044403|P3|STARTED|Overall Study||14
438433|NCT00707954|1044404|P2|STARTED|Overall Study||12
438434|NCT00707954|1044405|P1|STARTED|Overall Study||12
438435|NCT00707915|1044417|P1|NOT COMPLETED|Overall Study||0
438436|NCT00707915|1044417|P1|COMPLETED|Overall Study||30
438437|NCT00707915|1044417|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
438438|NCT00707915|1044417|P1|STARTED|Overall Study||30
438439|NCT00707863|1044428|P2|NOT COMPLETED|Overall Study||3
438440|NCT00707863|1044429|P1|NOT COMPLETED|Overall Study||0
438441|NCT00707863|1044428|P2|COMPLETED|Overall Study||8
438442|NCT00707863|1044429|P1|COMPLETED|Overall Study||6
438443|NCT00707863|1044428|P2|STARTED|Overall Study||11
438444|NCT00707863|1044429|P1|STARTED|Overall Study||6
438445|NCT00707759|1044437|P2|NOT COMPLETED|Overall Study||2
438446|NCT00707759|1044438|P1|NOT COMPLETED|Overall Study||2
438447|NCT00707759|1044437|P2|COMPLETED|Overall Study||12
438448|NCT00707759|1044438|P1|COMPLETED|Overall Study||12
438449|NCT00707759|1044437|P2|STARTED|Overall Study||14
438450|NCT00707759|1044438|P1|STARTED|Overall Study||14
438451|NCT00707746|1044446|P2|NOT COMPLETED|Follow-up Period||0
438452|NCT00707746|1044447|P1|NOT COMPLETED|Follow-up Period||0
438453|NCT00707746|1044446|P2|COMPLETED|Follow-up Period||21
438454|NCT00707746|1044447|P1|COMPLETED|Follow-up Period||12
438455|NCT00707746|1044446|P2|STARTED|Follow-up Period||21
438456|NCT00707746|1044447|P1|STARTED|Follow-up Period||12
438457|NCT00707746|1044446|P2|NOT COMPLETED|Treatment Period||5
438458|NCT00707746|1044447|P1|NOT COMPLETED|Treatment Period||2
438459|NCT00707746|1044446|P2|COMPLETED|Treatment Period||17
438460|NCT00707746|1044447|P1|COMPLETED|Treatment Period||10
438461|NCT00707746|1044446|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
438462|NCT00707746|1044447|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
438463|NCT00707746|1044446|P2|STARTED|Treatment Period||22
438464|NCT00707746|1044447|P1|STARTED|Treatment Period||12
438465|NCT00707655|1044495|P2|NOT COMPLETED|Overall Study||2
438466|NCT00707655|1044496|P1|NOT COMPLETED|Overall Study||0
438467|NCT00707655|1044495|P2|COMPLETED|Overall Study||3
438468|NCT00707655|1044496|P1|COMPLETED|Overall Study||3
438469|NCT00707655|1044495|P2|STARTED|Overall Study||5
438470|NCT00707655|1044496|P1|STARTED|Overall Study||3
438471|NCT00707577|1044508|P2|NOT COMPLETED|Overall Study||38
438472|NCT00707577|1044509|P1|NOT COMPLETED|Overall Study||54
438473|NCT00707577|1044508|P2|COMPLETED|Overall Study||118
438474|NCT00707577|1044509|P1|COMPLETED|Overall Study||120
438475|NCT00707577|1044508|P2|STARTED|Overall Study||156
438476|NCT00707577|1044509|P1|STARTED|Overall Study||174
438477|NCT00707486|1044515|P1|NOT COMPLETED|Overall Study||1
438478|NCT00707486|1044515|P1|COMPLETED|Overall Study||71
438479|NCT00707486|1044515|P1|STARTED|Overall Study||72
438480|NCT00707447|1044526|P2|NOT COMPLETED|Overall Study||8
438481|NCT00707447|1044527|P1|NOT COMPLETED|Overall Study||8
438482|NCT00707447|1044526|P2|COMPLETED|Overall Study||85
438483|NCT00707447|1044527|P1|COMPLETED|Overall Study||81
438484|NCT00707447|1044526|P2|STARTED|Overall Study||93
438485|NCT00707447|1044527|P1|STARTED|Overall Study||89
438486|NCT00707343|1044551|P1|NOT COMPLETED|Overall Study||0
438487|NCT00707343|1044551|P1|COMPLETED|Overall Study||15
438488|NCT00707343|1044551|P1|STARTED|Overall Study||15
438489|NCT00707239|1044558|P3|NOT COMPLETED|Overall Study||14
438490|NCT00707239|1044559|P2|NOT COMPLETED|Overall Study||11
438491|NCT00707239|1044560|P1|NOT COMPLETED|Overall Study||19
438492|NCT00707239|1044558|P3|COMPLETED|Overall Study||21
438493|NCT00707239|1044559|P2|COMPLETED|Overall Study||25
438494|NCT00707239|1044560|P1|COMPLETED|Overall Study||18
438495|NCT00707239|1044558|P3|Treated|Overall Study||34
438496|NCT00707239|1044559|P2|Treated|Overall Study||35
438497|NCT00707239|1044560|P1|Treated|Overall Study||36
438498|NCT00707239|1044558|P3|STARTED|Overall Study||35
438499|NCT00707239|1044559|P2|STARTED|Overall Study||36
438500|NCT00707239|1044560|P1|STARTED|Overall Study||37
438501|NCT00707174|1044608|P2|NOT COMPLETED|Overall Study||7
438502|NCT00707174|1044609|P1|NOT COMPLETED|Overall Study||5
438503|NCT00707174|1044608|P2|COMPLETED|Overall Study||37
438504|NCT00707174|1044609|P1|COMPLETED|Overall Study||41
438505|NCT00707174|1044608|P2|STARTED|Overall Study||44
438506|NCT00707174|1044609|P1|STARTED|Overall Study||46
438507|NCT00707161|1044615|P1|NOT COMPLETED|Overall Study||6
438508|NCT00707161|1044615|P1|COMPLETED|Overall Study||0
438509|NCT00707161|1044615|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
438510|NCT00707057|1044621|P2|NOT COMPLETED|Overall Study||4
438511|NCT00707057|1044622|P1|NOT COMPLETED|Overall Study||8
438512|NCT00707057|1044621|P2|COMPLETED|Overall Study||83
438513|NCT00707057|1044622|P1|COMPLETED|Overall Study||161
438514|NCT00707057|1044621|P2|STARTED|Overall Study||87
438515|NCT00707057|1044622|P1|STARTED|Overall Study||169
438516|NCT00707031|1044656|P2|NOT COMPLETED|Overall Study||99
438517|NCT00707031|1044657|P1|NOT COMPLETED|Overall Study||104
438518|NCT00707031|1044656|P2|COMPLETED|Overall Study||220
438519|NCT00707031|1044657|P1|COMPLETED|Overall Study||216
438520|NCT00707031|1044656|P2|Modified Intent-to-Treat Population|Overall Study||315
438521|NCT00707031|1044657|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
438522|NCT00707031|1044656|P2|Treated/Safety Population|Overall Study||316
438523|NCT00707031|1044657|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
438524|NCT00707031|1044656|P2|STARTED|Overall Study||319
438525|NCT00707031|1044657|P1|STARTED|Overall Study|Randomized|320
438526|NCT00706992|1044686|P7|NOT COMPLETED|Overall Study||3
438527|NCT00706992|1044687|P6|NOT COMPLETED|Overall Study||2
438528|NCT00706992|1044688|P5|NOT COMPLETED|Overall Study||4
438529|NCT00706992|1044689|P4|NOT COMPLETED|Overall Study||2
438530|NCT00706992|1044690|P3|NOT COMPLETED|Overall Study||6
438531|NCT00706992|1044691|P2|NOT COMPLETED|Overall Study||5
438532|NCT00706992|1044692|P1|NOT COMPLETED|Overall Study||5
438533|NCT00706992|1044686|P7|COMPLETED|Overall Study||3
438534|NCT00706992|1044687|P6|COMPLETED|Overall Study||3
438535|NCT00706992|1044688|P5|COMPLETED|Overall Study||2
438536|NCT00706992|1044689|P4|COMPLETED|Overall Study||6
438537|NCT00706992|1044690|P3|COMPLETED|Overall Study||3
438538|NCT00706992|1044691|P2|COMPLETED|Overall Study||3
438539|NCT00706992|1044692|P1|COMPLETED|Overall Study||3
438540|NCT00706992|1044686|P7|STARTED|Overall Study||6
438541|NCT00706992|1044687|P6|STARTED|Overall Study||5
438542|NCT00706992|1044688|P5|STARTED|Overall Study||6
438543|NCT00706992|1044689|P4|STARTED|Overall Study||8
438544|NCT00706992|1044690|P3|STARTED|Overall Study||9
438545|NCT00706992|1044691|P2|STARTED|Overall Study||8
438546|NCT00706992|1044692|P1|STARTED|Overall Study||8
438547|NCT00706979|1044711|P2|NOT COMPLETED|Overall Study||0
438548|NCT00706979|1044712|P1|NOT COMPLETED|Overall Study||0
438549|NCT00706979|1044711|P2|COMPLETED|Overall Study||423
438550|NCT00706979|1044712|P1|COMPLETED|Overall Study||426
438551|NCT00706979|1044711|P2|STARTED|Overall Study||423
438552|NCT00706979|1044712|P1|STARTED|Overall Study||426
438553|NCT00706966|1044724|P1|NOT COMPLETED|Overall Study||1
438554|NCT00706966|1044724|P1|COMPLETED|Overall Study||9
438555|NCT00706966|1044724|P1|STARTED|Overall Study||10
438556|NCT00706914|1044760|P3|NOT COMPLETED|Overall Study||1
438557|NCT00706914|1044761|P2|NOT COMPLETED|Overall Study||4
438558|NCT00706914|1044762|P1|NOT COMPLETED|Overall Study||6
438559|NCT00706914|1044760|P3|COMPLETED|Overall Study||30
438560|NCT00706914|1044761|P2|COMPLETED|Overall Study||58
438561|NCT00706914|1044762|P1|COMPLETED|Overall Study||57
438562|NCT00706914|1044760|P3|STARTED|Overall Study||31
438563|NCT00706914|1044761|P2|STARTED|Overall Study||62
438564|NCT00706914|1044762|P1|STARTED|Overall Study||63
438565|NCT00706901|1044785|P3|NOT COMPLETED|Overall Study||8
438566|NCT00706901|1044786|P2|NOT COMPLETED|Overall Study||5
438567|NCT00706901|1044787|P1|NOT COMPLETED|Overall Study||8
438568|NCT00706901|1044785|P3|COMPLETED|Overall Study||51
438569|NCT00706901|1044786|P2|COMPLETED|Overall Study||57
438570|NCT00706901|1044787|P1|COMPLETED|Overall Study||51
438571|NCT00706901|1044785|P3|STARTED|Overall Study||59
438572|NCT00706901|1044786|P2|STARTED|Overall Study||62
438573|NCT00706901|1044787|P1|STARTED|Overall Study||59
438574|NCT00706849|1044812|P2|NOT COMPLETED|Follow-up Period||3
438575|NCT00706849|1044813|P1|NOT COMPLETED|Follow-up Period||0
438576|NCT00706849|1044812|P2|COMPLETED|Follow-up Period||25
438577|NCT00706849|1044813|P1|COMPLETED|Follow-up Period||3
438578|NCT00706849|1044812|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
438579|NCT00706849|1044813|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
438580|NCT00706849|1044812|P2|NOT COMPLETED|Treatment Period||10
438581|NCT00706849|1044813|P1|NOT COMPLETED|Treatment Period||0
438582|NCT00706849|1044812|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
438583|NCT00706849|1044813|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
438584|NCT00706849|1044812|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
438585|NCT00706849|1044813|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
438586|NCT00706849|1044812|P2|STARTED|Treatment Period||83
438587|NCT00706849|1044813|P1|STARTED|Treatment Period||41
438588|NCT00706836|1044857|P1|NOT COMPLETED|Overall Study||0
438589|NCT00706836|1044857|P1|COMPLETED|Overall Study||16
438590|NCT00706836|1044857|P1|STARTED|Overall Study||16
438591|NCT00706823|1044867|P2|NOT COMPLETED|Overall Study||0
438592|NCT00706823|1044868|P1|NOT COMPLETED|Overall Study||0
438593|NCT00706823|1044867|P2|COMPLETED|Overall Study||25
438594|NCT00706823|1044868|P1|COMPLETED|Overall Study||25
438595|NCT00706823|1044867|P2|STARTED|Overall Study||25
438596|NCT00706823|1044868|P1|STARTED|Overall Study||25
438597|NCT00706810|1044884|P1|NOT COMPLETED|Overall Study||1
438598|NCT00706810|1044884|P1|COMPLETED|Overall Study||7
438599|NCT00706810|1044884|P1|STARTED|Overall Study||8
438600|NCT00706797|1044891|P2|NOT COMPLETED|Overall Study||71
438601|NCT00706797|1044892|P1|NOT COMPLETED|Overall Study||69
438602|NCT00706797|1044891|P2|COMPLETED|Overall Study||0
438603|NCT00706797|1044892|P1|COMPLETED|Overall Study||1
438604|NCT00706797|1044891|P2|Safety Population|Overall Study||71
438605|NCT00706797|1044892|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
438606|NCT00706797|1044891|P2|STARTED|Overall Study||71
438607|NCT00706797|1044892|P1|STARTED|Overall Study||70
438608|NCT00706784|1044934|P2|NOT COMPLETED|Overall Study||0
438609|NCT00706784|1044935|P1|NOT COMPLETED|Overall Study||0
438610|NCT00706784|1044934|P2|COMPLETED|Overall Study||3
438611|NCT00706784|1044935|P1|COMPLETED|Overall Study||3
438612|NCT00706784|1044934|P2|STARTED|Overall Study||3
438613|NCT00706784|1044935|P1|STARTED|Overall Study||3
438614|NCT00706719|1044944|P3|NOT COMPLETED|Overall Study||4
438615|NCT00706719|1044945|P2|NOT COMPLETED|Overall Study||1
438616|NCT00706719|1044946|P1|NOT COMPLETED|Overall Study||0
438617|NCT00706719|1044944|P3|COMPLETED|Overall Study||1
438618|NCT00706719|1044945|P2|COMPLETED|Overall Study||6
438619|NCT00706719|1044946|P1|COMPLETED|Overall Study||5
438620|NCT00706719|1044944|P3|STARTED|Overall Study||5
438621|NCT00706719|1044945|P2|STARTED|Overall Study||7
438622|NCT00706719|1044946|P1|STARTED|Overall Study||5
438623|NCT00706706|1044961|P1|NOT COMPLETED|Overall Study||105
438624|NCT00706706|1044961|P1|COMPLETED|Overall Study||0
438625|NCT00706706|1044961|P1|STARTED|Overall Study||105
438626|NCT00706654|1044971|P4|NOT COMPLETED|Depot Maintenance Phase||70
438627|NCT00706654|1044972|P3|NOT COMPLETED|Depot Maintenance Phase||88
438628|NCT00706654|1044973|P2|NOT COMPLETED|Depot Maintenance Phase||69
438629|NCT00706654|1044974|P1|NOT COMPLETED|Depot Maintenance Phase||0
438630|NCT00706654|1044971|P4|COMPLETED|Depot Maintenance Phase||61
438631|NCT00706654|1044972|P3|COMPLETED|Depot Maintenance Phase||178
438632|NCT00706654|1044973|P2|COMPLETED|Depot Maintenance Phase||196
438633|NCT00706654|1044974|P1|COMPLETED|Depot Maintenance Phase||0
438634|NCT00706654|1044971|P4|STARTED|Depot Maintenance Phase||131
438635|NCT00706654|1044972|P3|STARTED|Depot Maintenance Phase||266
438636|NCT00706654|1044973|P2|STARTED|Depot Maintenance Phase||265
438637|NCT00706654|1044974|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
438638|NCT00706654|1044971|P4|NOT COMPLETED|Oral Stabilization Phase||0
438639|NCT00706654|1044972|P3|NOT COMPLETED|Oral Stabilization Phase||0
438640|NCT00706654|1044973|P2|NOT COMPLETED|Oral Stabilization Phase||0
438641|NCT00706654|1044974|P1|NOT COMPLETED|Oral Stabilization Phase||180
438642|NCT00706654|1044971|P4|COMPLETED|Oral Stabilization Phase||0
438643|NCT00706654|1044972|P3|COMPLETED|Oral Stabilization Phase||0
438644|NCT00706654|1044973|P2|COMPLETED|Oral Stabilization Phase||0
438645|NCT00706654|1044974|P1|COMPLETED|Oral Stabilization Phase||662
438734|NCT00706355|1045493|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
438646|NCT00706654|1044971|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438647|NCT00706654|1044972|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438648|NCT00706654|1044973|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438649|NCT00706654|1044974|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
438650|NCT00706654|1044971|P4|NOT COMPLETED|Conversion Phase||0
438651|NCT00706654|1044972|P3|NOT COMPLETED|Conversion Phase||0
438652|NCT00706654|1044973|P2|NOT COMPLETED|Conversion Phase||0
438653|NCT00706654|1044974|P1|NOT COMPLETED|Conversion Phase||95
438654|NCT00706654|1044971|P4|COMPLETED|Conversion Phase||0
438655|NCT00706654|1044972|P3|COMPLETED|Conversion Phase||0
438656|NCT00706654|1044973|P2|COMPLETED|Conversion Phase||0
438657|NCT00706654|1044974|P1|COMPLETED|Conversion Phase||614
438658|NCT00706654|1044971|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
438659|NCT00706654|1044972|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
438660|NCT00706654|1044973|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
438661|NCT00706654|1044974|P1|STARTED|Conversion Phase||709
438662|NCT00706641|1044993|P1|NOT COMPLETED|Radical Cystectomy||1
438663|NCT00706641|1044993|P1|COMPLETED|Radical Cystectomy||22
438664|NCT00706641|1044993|P1|STARTED|Radical Cystectomy||23
438665|NCT00706641|1044993|P1|NOT COMPLETED|Dasatinib Administration||2
438666|NCT00706641|1044993|P1|COMPLETED|Dasatinib Administration||23
438667|NCT00706641|1044993|P1|Toxicity Evaluation|Dasatinib Administration||24
438668|NCT00706641|1044993|P1|STARTED|Dasatinib Administration||25
438669|NCT00706628|1045007|P4|NOT COMPLETED|Overall Study||3
438670|NCT00706628|1045008|P3|NOT COMPLETED|Overall Study||16
438671|NCT00706628|1045009|P2|NOT COMPLETED|Overall Study||21
438672|NCT00706628|1045010|P1|NOT COMPLETED|Overall Study||47
438673|NCT00706628|1045007|P4|COMPLETED|Overall Study||0
438674|NCT00706628|1045008|P3|COMPLETED|Overall Study||0
438675|NCT00706628|1045009|P2|COMPLETED|Overall Study||0
438676|NCT00706628|1045010|P1|COMPLETED|Overall Study||0
438677|NCT00706628|1045007|P4|STARTED|Overall Study||3
438678|NCT00706628|1045008|P3|STARTED|Overall Study||16
438679|NCT00706628|1045009|P2|STARTED|Overall Study||21
438680|NCT00706628|1045010|P1|STARTED|Overall Study||47
438681|NCT00706589|1045060|P2|NOT COMPLETED|Overall Study||4
438682|NCT00706589|1045061|P1|NOT COMPLETED|Overall Study||3
438683|NCT00706589|1045060|P2|COMPLETED|Overall Study||25
438684|NCT00706589|1045061|P1|COMPLETED|Overall Study||29
438685|NCT00706589|1045060|P2|STARTED|Overall Study||29
438686|NCT00706589|1045061|P1|STARTED|Overall Study||32
438687|NCT00706563|1045069|P2|NOT COMPLETED|Overall Study||0
438688|NCT00706563|1045070|P1|NOT COMPLETED|Overall Study||0
438689|NCT00706563|1045069|P2|COMPLETED|Overall Study||59
438690|NCT00706563|1045070|P1|COMPLETED|Overall Study||61
438691|NCT00706563|1045069|P2|STARTED|Overall Study||59
438692|NCT00706563|1045070|P1|STARTED|Overall Study||61
438693|NCT00706550|1045094|P2|NOT COMPLETED|Overall Study||28
438694|NCT00706550|1045095|P1|NOT COMPLETED|Overall Study||7
438695|NCT00706550|1045094|P2|COMPLETED|Overall Study||36
438696|NCT00706550|1045095|P1|COMPLETED|Overall Study||36
438697|NCT00706550|1045094|P2|STARTED|Overall Study||64
438698|NCT00706550|1045095|P1|STARTED|Overall Study||43
438699|NCT00706485|1045111|P1|NOT COMPLETED|Overall Study||0
438700|NCT00706485|1045111|P1|COMPLETED|Overall Study||5
438701|NCT00706485|1045111|P1|STARTED|Overall Study||5
438702|NCT00706446|1045123|P6|NOT COMPLETED|Overall Study||38
438703|NCT00706446|1045124|P5|NOT COMPLETED|Overall Study||44
438704|NCT00706446|1045125|P4|NOT COMPLETED|Overall Study||22
438705|NCT00706446|1045126|P3|NOT COMPLETED|Overall Study||37
438706|NCT00706446|1045127|P2|NOT COMPLETED|Overall Study||49
438707|NCT00706446|1045128|P1|NOT COMPLETED|Overall Study||26
438708|NCT00706446|1045123|P6|COMPLETED|Overall Study||7
438709|NCT00706446|1045124|P5|COMPLETED|Overall Study||10
438710|NCT00706446|1045125|P4|COMPLETED|Overall Study||4
438711|NCT00706446|1045126|P3|COMPLETED|Overall Study||7
438712|NCT00706446|1045127|P2|COMPLETED|Overall Study||8
438713|NCT00706446|1045128|P1|COMPLETED|Overall Study||3
438714|NCT00706446|1045123|P6|STARTED|Overall Study||45
438715|NCT00706446|1045124|P5|STARTED|Overall Study||54
438716|NCT00706446|1045125|P4|STARTED|Overall Study||26
438717|NCT00706446|1045126|P3|STARTED|Overall Study||44
438718|NCT00706446|1045127|P2|STARTED|Overall Study||57
438719|NCT00706446|1045128|P1|STARTED|Overall Study||29
438720|NCT00706433|1045170|P4|NOT COMPLETED|Overall Study||2
438721|NCT00706433|1045171|P3|NOT COMPLETED|Overall Study||10
438722|NCT00706433|1045172|P2|NOT COMPLETED|Overall Study||3
438723|NCT00706433|1045173|P1|NOT COMPLETED|Overall Study||5
438724|NCT00706433|1045170|P4|COMPLETED|Overall Study||64
438725|NCT00706433|1045171|P3|COMPLETED|Overall Study||57
438726|NCT00706433|1045172|P2|COMPLETED|Overall Study||62
438727|NCT00706433|1045173|P1|COMPLETED|Overall Study||63
438728|NCT00706433|1045170|P4|STARTED|Overall Study||66
438729|NCT00706433|1045171|P3|STARTED|Overall Study||67
438730|NCT00706433|1045172|P2|STARTED|Overall Study||65
438731|NCT00706433|1045173|P1|STARTED|Overall Study||68
438732|NCT00706355|1045491|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
438733|NCT00706355|1045492|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
438735|NCT00706355|1045494|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
438736|NCT00706355|1045491|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
438737|NCT00706355|1045492|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
438738|NCT00706355|1045493|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
438739|NCT00706355|1045494|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
438740|NCT00706355|1045491|P4|STARTED|Period 4: PF-04217903 150 mg||4
438741|NCT00706355|1045492|P3|STARTED|Period 4: PF-04217903 150 mg||0
438742|NCT00706355|1045493|P2|STARTED|Period 4: PF-04217903 150 mg||0
438743|NCT00706355|1045494|P1|STARTED|Period 4: PF-04217903 150 mg||0
438744|NCT00706355|1045491|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
438745|NCT00706355|1045492|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
438746|NCT00706355|1045493|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
438747|NCT00706355|1045494|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
438748|NCT00706355|1045491|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
438749|NCT00706355|1045492|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
438750|NCT00706355|1045493|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
438751|NCT00706355|1045494|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
438752|NCT00706355|1045491|P4|STARTED|Period 3: PF-04217903 200 mg||0
438753|NCT00706355|1045492|P3|STARTED|Period 3: PF-04217903 200 mg||2
438754|NCT00706355|1045493|P2|STARTED|Period 3: PF-04217903 200 mg||0
438755|NCT00706355|1045494|P1|STARTED|Period 3: PF-04217903 200 mg||0
438756|NCT00706355|1045491|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
438757|NCT00706355|1045492|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
438758|NCT00706355|1045493|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
438759|NCT00706355|1045494|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
438760|NCT00706355|1045491|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
438761|NCT00706355|1045492|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
438762|NCT00706355|1045493|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
438763|NCT00706355|1045494|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
438764|NCT00706355|1045491|P4|STARTED|Period 2: PF-04217903 100 mg||0
438765|NCT00706355|1045492|P3|STARTED|Period 2: PF-04217903 100 mg||0
438766|NCT00706355|1045493|P2|STARTED|Period 2: PF-04217903 100 mg||7
438767|NCT00706355|1045494|P1|STARTED|Period 2: PF-04217903 100 mg||0
438768|NCT00706355|1045491|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
438769|NCT00706355|1045492|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
438770|NCT00706355|1045493|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
438771|NCT00706355|1045494|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
438772|NCT00706355|1045491|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
438773|NCT00706355|1045492|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
438774|NCT00706355|1045493|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
438775|NCT00706355|1045494|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
438776|NCT00706355|1045491|P4|STARTED|Period 1: PF-04217903 50 mg||0
438777|NCT00706355|1045492|P3|STARTED|Period 1: PF-04217903 50 mg||0
438778|NCT00706355|1045493|P2|STARTED|Period 1: PF-04217903 50 mg||0
438779|NCT00706355|1045494|P1|STARTED|Period 1: PF-04217903 50 mg||3
438780|NCT00706342|1045546|P1|NOT COMPLETED|Overall Study||18
438781|NCT00706342|1045546|P1|COMPLETED|Overall Study||0
438782|NCT00706342|1045546|P1|STARTED|Overall Study||18
438783|NCT00706329|1045555|P1|NOT COMPLETED|Overall Study||0
438784|NCT00706329|1045555|P1|COMPLETED|Overall Study||25
438785|NCT00706329|1045555|P1|STARTED|Overall Study||25
438786|NCT00706134|1045563|P4|NOT COMPLETED|Overall Study||11
438787|NCT00706134|1045564|P3|NOT COMPLETED|Overall Study||6
438788|NCT00706134|1045565|P2|NOT COMPLETED|Overall Study||19
438789|NCT00706134|1045566|P1|NOT COMPLETED|Overall Study||20
438790|NCT00706134|1045563|P4|COMPLETED|Overall Study||175
438791|NCT00706134|1045564|P3|COMPLETED|Overall Study||183
438792|NCT00706134|1045565|P2|COMPLETED|Overall Study||173
438793|NCT00706134|1045566|P1|COMPLETED|Overall Study||169
438794|NCT00706134|1045563|P4|Entered Double-blind Period|Overall Study||186
438795|NCT00706134|1045564|P3|Entered Double-blind Period|Overall Study||189
438796|NCT00706134|1045565|P2|Entered Double-blind Period|Overall Study||192
438797|NCT00706134|1045566|P1|Entered Double-blind Period|Overall Study||187
438798|NCT00706134|1045563|P4|STARTED|Overall Study||186
438799|NCT00706134|1045564|P3|STARTED|Overall Study||189
438800|NCT00706134|1045565|P2|STARTED|Overall Study||192
438801|NCT00706134|1045566|P1|STARTED|Overall Study||189
438802|NCT00706121|1045600|P4|NOT COMPLETED|Overall Study||352
438803|NCT00706121|1045601|P3|NOT COMPLETED|Overall Study||404
438804|NCT00706121|1045602|P2|NOT COMPLETED|Overall Study||396
438805|NCT00706121|1045603|P1|NOT COMPLETED|Overall Study||396
438806|NCT00706121|1045600|P4|COMPLETED|Overall Study||1577
438807|NCT00706121|1045601|P3|COMPLETED|Overall Study||1626
438808|NCT00706121|1045602|P2|COMPLETED|Overall Study||1700
438809|NCT00706121|1045603|P1|COMPLETED|Overall Study||1643
438810|NCT00706121|1045600|P4|STARTED|Overall Study||1929
438811|NCT00706121|1045601|P3|STARTED|Overall Study||2030
438812|NCT00706121|1045602|P2|STARTED|Overall Study||2096
438813|NCT00706121|1045603|P1|STARTED|Overall Study||2039
438814|NCT00706095|1045632|P3|NOT COMPLETED|Overall Study||5
438815|NCT00706095|1045633|P2|NOT COMPLETED|Overall Study||7
438816|NCT00706095|1045634|P1|NOT COMPLETED|Overall Study||6
438817|NCT00706095|1045632|P3|COMPLETED|Overall Study||0
438818|NCT00706095|1045633|P2|COMPLETED|Overall Study||0
438819|NCT00706095|1045634|P1|COMPLETED|Overall Study||0
438820|NCT00706095|1045632|P3|STARTED|Overall Study||5
438821|NCT00706095|1045633|P2|STARTED|Overall Study||7
438822|NCT00706095|1045634|P1|STARTED|Overall Study||6
438823|NCT00706004|1045648|P1|NOT COMPLETED|Overall Study||2
438824|NCT00706004|1045648|P1|COMPLETED|Overall Study||7
438825|NCT00706004|1045648|P1|STARTED|Overall Study||9
438826|NCT00705939|1045676|P3|NOT COMPLETED|Overall Study||4
438827|NCT00705939|1045677|P2|NOT COMPLETED|Overall Study||2
438828|NCT00705939|1045678|P1|NOT COMPLETED|Overall Study||0
438829|NCT00705939|1045676|P3|COMPLETED|Overall Study||14
438830|NCT00705939|1045677|P2|COMPLETED|Overall Study||12
438831|NCT00705939|1045678|P1|COMPLETED|Overall Study||12
438832|NCT00705939|1045676|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
438833|NCT00705939|1045677|P2|STARTED|Overall Study||14
438834|NCT00705939|1045678|P1|STARTED|Overall Study||12
438835|NCT00705874|1045708|P7|NOT COMPLETED|Overall Study||0
438836|NCT00705874|1045709|P6|NOT COMPLETED|Overall Study||4
438837|NCT00705874|1045710|P5|NOT COMPLETED|Overall Study||12
438838|NCT00705874|1045711|P4|NOT COMPLETED|Overall Study||1
438839|NCT00705874|1045712|P3|NOT COMPLETED|Overall Study||2
438840|NCT00705874|1045713|P2|NOT COMPLETED|Overall Study||1
438841|NCT00705874|1045714|P1|NOT COMPLETED|Overall Study||2
438842|NCT00705874|1045708|P7|COMPLETED|Overall Study||3
438843|NCT00705874|1045709|P6|COMPLETED|Overall Study||28
438844|NCT00705874|1045710|P5|COMPLETED|Overall Study||36
438845|NCT00705874|1045711|P4|COMPLETED|Overall Study||33
438846|NCT00705874|1045712|P3|COMPLETED|Overall Study||32
438847|NCT00705874|1045713|P2|COMPLETED|Overall Study||8
438848|NCT00705874|1045714|P1|COMPLETED|Overall Study||10
438849|NCT00705874|1045708|P7|STARTED|Overall Study||3
438850|NCT00705874|1045709|P6|STARTED|Overall Study||32
438851|NCT00705874|1045710|P5|STARTED|Overall Study||48
438852|NCT00705874|1045711|P4|STARTED|Overall Study||34
438853|NCT00705874|1045712|P3|STARTED|Overall Study||34
438854|NCT00705874|1045713|P2|STARTED|Overall Study||9
438855|NCT00705874|1045714|P1|STARTED|Overall Study||12
438856|NCT00705783|1045732|P3|NOT COMPLETED|Depot Maintenance Phase||131
438857|NCT00705783|1045733|P2|NOT COMPLETED|Depot Maintenance Phase||246
438858|NCT00705783|1045734|P1|NOT COMPLETED|Depot Maintenance Phase||0
438859|NCT00705783|1045732|P3|COMPLETED|Depot Maintenance Phase||3
438860|NCT00705783|1045733|P2|COMPLETED|Depot Maintenance Phase||23
438861|NCT00705783|1045734|P1|COMPLETED|Depot Maintenance Phase||0
438862|NCT00705783|1045732|P3|STARTED|Depot Maintenance Phase||134
438863|NCT00705783|1045733|P2|STARTED|Depot Maintenance Phase||269
438864|NCT00705783|1045734|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
438865|NCT00705783|1045732|P3|NOT COMPLETED|Depot Stabilization Phase||0
438866|NCT00705783|1045733|P2|NOT COMPLETED|Depot Stabilization Phase||0
438867|NCT00705783|1045734|P1|NOT COMPLETED|Depot Stabilization Phase||173
438868|NCT00705783|1045732|P3|COMPLETED|Depot Stabilization Phase||0
438869|NCT00705783|1045733|P2|COMPLETED|Depot Stabilization Phase||0
438870|NCT00705783|1045734|P1|COMPLETED|Depot Stabilization Phase||403
438871|NCT00705783|1045732|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438872|NCT00705783|1045733|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438873|NCT00705783|1045734|P1|STARTED|Depot Stabilization Phase||576
438874|NCT00705783|1045732|P3|NOT COMPLETED|Oral Stabilization Phase||0
438875|NCT00705783|1045733|P2|NOT COMPLETED|Oral Stabilization Phase||0
438876|NCT00705783|1045734|P1|NOT COMPLETED|Oral Stabilization Phase||134
438877|NCT00705783|1045732|P3|COMPLETED|Oral Stabilization Phase||0
438878|NCT00705783|1045733|P2|COMPLETED|Oral Stabilization Phase||0
438879|NCT00705783|1045734|P1|COMPLETED|Oral Stabilization Phase||576
438880|NCT00705783|1045732|P3|Received Study Medication|Oral Stabilization Phase||0
438881|NCT00705783|1045733|P2|Received Study Medication|Oral Stabilization Phase||0
438882|NCT00705783|1045734|P1|Received Study Medication|Oral Stabilization Phase||709
438883|NCT00705783|1045732|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438884|NCT00705783|1045733|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
438885|NCT00705783|1045734|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
438886|NCT00705783|1045732|P3|NOT COMPLETED|Conversion Phase||0
438887|NCT00705783|1045733|P2|NOT COMPLETED|Conversion Phase||0
438888|NCT00705783|1045734|P1|NOT COMPLETED|Conversion Phase||133
438889|NCT00705783|1045732|P3|COMPLETED|Conversion Phase||0
438890|NCT00705783|1045733|P2|COMPLETED|Conversion Phase||0
438891|NCT00705783|1045734|P1|COMPLETED|Conversion Phase||500
438892|NCT00705783|1045732|P3|Received Study Medication|Conversion Phase||0
438893|NCT00705783|1045733|P2|Received Study Medication|Conversion Phase||0
438894|NCT00705783|1045734|P1|Received Study Medication|Conversion Phase||632
438895|NCT00705783|1045732|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
438896|NCT00705783|1045733|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
438897|NCT00705783|1045734|P1|STARTED|Conversion Phase||633
438898|NCT00705757|1045764|P3|NOT COMPLETED|Overall Study||11
438899|NCT00705757|1045765|P2|NOT COMPLETED|Overall Study||8
438900|NCT00705757|1045766|P1|NOT COMPLETED|Overall Study||13
438901|NCT00705757|1045764|P3|COMPLETED|Overall Study||17
438902|NCT00705757|1045765|P2|COMPLETED|Overall Study||21
438903|NCT00705757|1045766|P1|COMPLETED|Overall Study||19
438904|NCT00705757|1045764|P3|STARTED|Overall Study||28
438905|NCT00705757|1045765|P2|STARTED|Overall Study||29
438906|NCT00705757|1045766|P1|STARTED|Overall Study||32
438907|NCT00705718|1045776|P2|NOT COMPLETED|Overall Study||22
438908|NCT00705718|1045777|P1|NOT COMPLETED|Overall Study||7
438909|NCT00705718|1045776|P2|COMPLETED|Overall Study||128
438910|NCT00705718|1045777|P1|COMPLETED|Overall Study||37
438911|NCT00705718|1045776|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
438912|NCT00705718|1045777|P1|12 Month Follow up|Overall Study|2 Deaths|37
438913|NCT00705718|1045776|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
438914|NCT00705718|1045777|P1|6 Month Follow up|Overall Study|3 Deaths|40
438915|NCT00705718|1045776|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
438916|NCT00705718|1045777|P1|1 Month Follow up|Overall Study|1 Death|43
438917|NCT00705718|1045776|P2|STARTED|Overall Study||150
438918|NCT00705718|1045777|P1|STARTED|Overall Study||44
438919|NCT00705679|1045798|P5|NOT COMPLETED|Overall Study||69
438920|NCT00705679|1045799|P4|NOT COMPLETED|Overall Study||80
438921|NCT00705679|1045800|P3|NOT COMPLETED|Overall Study||115
438922|NCT00705679|1045801|P2|NOT COMPLETED|Overall Study||139
438923|NCT00705679|1045802|P1|NOT COMPLETED|Overall Study||65
438924|NCT00705679|1045798|P5|COMPLETED|Overall Study||934
438925|NCT00705679|1045799|P4|COMPLETED|Overall Study||927
438926|NCT00705679|1045800|P3|COMPLETED|Overall Study||894
438927|NCT00705679|1045801|P2|COMPLETED|Overall Study||864
438928|NCT00705679|1045802|P1|COMPLETED|Overall Study||942
438929|NCT00705679|1045798|P5|STARTED|Overall Study||1003
438930|NCT00705679|1045799|P4|STARTED|Overall Study||1007
438931|NCT00705679|1045800|P3|STARTED|Overall Study||1009
438932|NCT00705679|1045801|P2|STARTED|Overall Study||1003
438933|NCT00705679|1045802|P1|STARTED|Overall Study||1007
438934|NCT00705666|1045837|P1|NOT COMPLETED|Overall Study||339
438935|NCT00705666|1045837|P1|COMPLETED|Overall Study||450
438936|NCT00705666|1045837|P1|STARTED|Overall Study||789
438937|NCT00705653|1045841|P1|NOT COMPLETED|Overall Study||0
438938|NCT00705653|1045841|P1|COMPLETED|Overall Study||46
438939|NCT00705653|1045841|P1|STARTED|Overall Study||46
438940|NCT00705614|1045848|P2|NOT COMPLETED|Switch to Remicade||49
438941|NCT00705614|1045849|P1|NOT COMPLETED|Switch to Remicade||0
438942|NCT00705614|1045848|P2|COMPLETED|Switch to Remicade||249
438943|NCT00705614|1045849|P1|COMPLETED|Switch to Remicade||0
438944|NCT00705614|1045848|P2|STARTED|Switch to Remicade||298
438945|NCT00705614|1045849|P1|STARTED|Switch to Remicade||0
438946|NCT00705614|1045848|P2|NOT COMPLETED|Initial Intervention||321
438947|NCT00705614|1045849|P1|NOT COMPLETED|Initial Intervention||518
438948|NCT00705614|1045848|P2|COMPLETED|Initial Intervention||800
438949|NCT00705614|1045849|P1|COMPLETED|Initial Intervention||1023
438950|NCT00705614|1045848|P2|STARTED|Initial Intervention||1121
438951|NCT00705614|1045849|P1|STARTED|Initial Intervention||1541
438952|NCT00705575|1045898|P2|NOT COMPLETED|Overall Study||46
438953|NCT00705575|1045899|P1|NOT COMPLETED|Overall Study||23
438954|NCT00705575|1045898|P2|COMPLETED|Overall Study||293
438955|NCT00705575|1045899|P1|COMPLETED|Overall Study||326
438956|NCT00705575|1045898|P2|STARTED|Overall Study||339
438957|NCT00705575|1045899|P1|STARTED|Overall Study||349
438958|NCT00705536|1045913|P4|NOT COMPLETED|Completed Study||0
438959|NCT00705536|1045914|P3|NOT COMPLETED|Completed Study||0
438960|NCT00705536|1045915|P2|NOT COMPLETED|Completed Study||0
438961|NCT00705536|1045916|P1|NOT COMPLETED|Completed Study||0
438962|NCT00705536|1045913|P4|COMPLETED|Completed Study||6
438963|NCT00705536|1045914|P3|COMPLETED|Completed Study||7
438964|NCT00705536|1045915|P2|COMPLETED|Completed Study||6
438965|NCT00705536|1045916|P1|COMPLETED|Completed Study||6
438966|NCT00705536|1045913|P4|STARTED|Completed Study||6
438967|NCT00705536|1045914|P3|STARTED|Completed Study||7
438968|NCT00705536|1045915|P2|STARTED|Completed Study||6
438969|NCT00705536|1045916|P1|STARTED|Completed Study||6
438970|NCT00705536|1045913|P4|NOT COMPLETED|Start Period 2||0
438971|NCT00705536|1045914|P3|NOT COMPLETED|Start Period 2||0
438972|NCT00705536|1045915|P2|NOT COMPLETED|Start Period 2||0
438973|NCT00705536|1045916|P1|NOT COMPLETED|Start Period 2||0
438974|NCT00705536|1045913|P4|COMPLETED|Start Period 2||6
438975|NCT00705536|1045914|P3|COMPLETED|Start Period 2||7
438976|NCT00705536|1045915|P2|COMPLETED|Start Period 2||6
438977|NCT00705536|1045916|P1|COMPLETED|Start Period 2||6
438978|NCT00705536|1045913|P4|STARTED|Start Period 2||6
438979|NCT00705536|1045914|P3|STARTED|Start Period 2||7
438980|NCT00705536|1045915|P2|STARTED|Start Period 2||6
438981|NCT00705536|1045916|P1|STARTED|Start Period 2||6
438982|NCT00705536|1045913|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
438983|NCT00705536|1045914|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
438984|NCT00705536|1045915|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
438985|NCT00705536|1045916|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
438986|NCT00705536|1045913|P4|COMPLETED|Washout Period of at Least 6 Days||6
438987|NCT00705536|1045914|P3|COMPLETED|Washout Period of at Least 6 Days||7
438988|NCT00705536|1045915|P2|COMPLETED|Washout Period of at Least 6 Days||6
438989|NCT00705536|1045916|P1|COMPLETED|Washout Period of at Least 6 Days||6
438990|NCT00705536|1045913|P4|STARTED|Washout Period of at Least 6 Days||6
438991|NCT00705536|1045914|P3|STARTED|Washout Period of at Least 6 Days||7
438992|NCT00705536|1045915|P2|STARTED|Washout Period of at Least 6 Days||6
438993|NCT00705536|1045916|P1|STARTED|Washout Period of at Least 6 Days||6
438994|NCT00705536|1045913|P4|NOT COMPLETED|Start Period 1||1
438995|NCT00705536|1045914|P3|NOT COMPLETED|Start Period 1||0
438996|NCT00705536|1045915|P2|NOT COMPLETED|Start Period 1||0
438997|NCT00705536|1045916|P1|NOT COMPLETED|Start Period 1||0
438998|NCT00705536|1045913|P4|COMPLETED|Start Period 1||6
438999|NCT00705536|1045914|P3|COMPLETED|Start Period 1||7
439000|NCT00705536|1045915|P2|COMPLETED|Start Period 1||6
439001|NCT00705536|1045916|P1|COMPLETED|Start Period 1||6
439002|NCT00705536|1045913|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
439003|NCT00705536|1045914|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
439004|NCT00705536|1045915|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
439005|NCT00705536|1045916|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
439006|NCT00705536|1045913|P4|STARTED|Start Period 1||7
439007|NCT00705536|1045914|P3|STARTED|Start Period 1||7
439008|NCT00705536|1045915|P2|STARTED|Start Period 1||6
439009|NCT00705536|1045916|P1|STARTED|Start Period 1||6
439010|NCT00705523|1045977|P2|NOT COMPLETED|Overall Study||3
439011|NCT00705523|1045978|P1|NOT COMPLETED|Overall Study||2
439012|NCT00705523|1045977|P2|COMPLETED|Overall Study||18
439013|NCT00705523|1045978|P1|COMPLETED|Overall Study||17
439014|NCT00705523|1045977|P2|STARTED|Overall Study||21
439015|NCT00705523|1045978|P1|STARTED|Overall Study||19
439016|NCT00705432|1045992|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
439017|NCT00705432|1045993|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
439018|NCT00705432|1045994|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
439019|NCT00705432|1045995|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
439020|NCT00705432|1045996|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
439021|NCT00705432|1045997|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
439022|NCT00705432|1045992|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
439023|NCT00705432|1045993|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
439024|NCT00705432|1045994|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
439025|NCT00705432|1045995|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
439026|NCT00705432|1045996|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
439027|NCT00705432|1045997|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
439028|NCT00705432|1045992|P6|STARTED|Follow-up Period (Upto Week 72)||53
439029|NCT00705432|1045993|P5|STARTED|Follow-up Period (Upto Week 72)||44
439030|NCT00705432|1045994|P4|STARTED|Follow-up Period (Upto Week 72)||42
439031|NCT00705432|1045995|P3|STARTED|Follow-up Period (Upto Week 72)||291
439032|NCT00705432|1045996|P2|STARTED|Follow-up Period (Upto Week 72)||295
439033|NCT00705432|1045997|P1|STARTED|Follow-up Period (Upto Week 72)||278
439034|NCT00705432|1045992|P6|NOT COMPLETED|Treatment Period||30
439035|NCT00705432|1045993|P5|NOT COMPLETED|Treatment Period||28
439036|NCT00705432|1045994|P4|NOT COMPLETED|Treatment Period||41
439037|NCT00705432|1045995|P3|NOT COMPLETED|Treatment Period||121
439038|NCT00705432|1045996|P2|NOT COMPLETED|Treatment Period||111
439039|NCT00705432|1045997|P1|NOT COMPLETED|Treatment Period||163
439040|NCT00705432|1045992|P6|COMPLETED|Treatment Period||25
439041|NCT00705432|1045993|P5|COMPLETED|Treatment Period||24
439042|NCT00705432|1045994|P4|COMPLETED|Treatment Period||11
439043|NCT00705432|1045995|P3|COMPLETED|Treatment Period||190
439044|NCT00705432|1045996|P2|COMPLETED|Treatment Period||205
439045|NCT00705432|1045997|P1|COMPLETED|Treatment Period||148
439046|NCT00705432|1045992|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
439047|NCT00705432|1045993|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
439048|NCT00705432|1045994|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
439049|NCT00705432|1045995|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
439050|NCT00705432|1045996|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
439051|NCT00705432|1045997|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
439052|NCT00705432|1045992|P6|STARTED|Treatment Period||55
439053|NCT00705432|1045993|P5|STARTED|Treatment Period||52
439054|NCT00705432|1045994|P4|STARTED|Treatment Period||52
439055|NCT00705432|1045995|P3|STARTED|Treatment Period||311
439056|NCT00705432|1045996|P2|STARTED|Treatment Period||316
439057|NCT00705432|1045997|P1|STARTED|Treatment Period||311
439058|NCT00705406|1046034|P2|NOT COMPLETED|Overall Study||5
439059|NCT00705406|1046035|P1|NOT COMPLETED|Overall Study||4
439060|NCT00705406|1046034|P2|COMPLETED|Overall Study||197
439061|NCT00705406|1046035|P1|COMPLETED|Overall Study||199
439062|NCT00705406|1046034|P2|STARTED|Overall Study||202
439063|NCT00705406|1046035|P1|STARTED|Overall Study||203
439064|NCT00705367|1046059|P2|NOT COMPLETED|Long-term Extension Period||0
439065|NCT00705367|1046060|P1|NOT COMPLETED|Long-term Extension Period||9
439066|NCT00705367|1046059|P2|COMPLETED|Long-term Extension Period||0
439067|NCT00705367|1046060|P1|COMPLETED|Long-term Extension Period||0
439068|NCT00705367|1046059|P2|STARTED|Long-term Extension Period||0
439069|NCT00705367|1046060|P1|STARTED|Long-term Extension Period||9
439070|NCT00705367|1046059|P2|NOT COMPLETED|Short-term Period||0
439071|NCT00705367|1046060|P1|NOT COMPLETED|Short-term Period||0
439072|NCT00705367|1046059|P2|COMPLETED|Short-term Period||3
439073|NCT00705367|1046060|P1|COMPLETED|Short-term Period||6
439074|NCT00705367|1046059|P2|STARTED|Short-term Period||3
439075|NCT00705367|1046060|P1|STARTED|Short-term Period||6
439076|NCT00705341|1046087|P4|NOT COMPLETED|Phase 2: Trial||4
439077|NCT00705341|1046088|P3|NOT COMPLETED|Phase 2: Trial||7
439078|NCT00705341|1046089|P2|NOT COMPLETED|Phase 2: Trial||0
439079|NCT00705341|1046090|P1|NOT COMPLETED|Phase 2: Trial||0
439080|NCT00705341|1046087|P4|COMPLETED|Phase 2: Trial||28
439081|NCT00705341|1046088|P3|COMPLETED|Phase 2: Trial||23
439082|NCT00705341|1046089|P2|COMPLETED|Phase 2: Trial||0
439083|NCT00705341|1046090|P1|COMPLETED|Phase 2: Trial||0
439174|NCT00704938|1046260|P1|STARTED|Overall Study||2
439084|NCT00705341|1046087|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
439085|NCT00705341|1046088|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
439086|NCT00705341|1046089|P2|STARTED|Phase 2: Trial||0
439087|NCT00705341|1046090|P1|STARTED|Phase 2: Trial||0
439088|NCT00705341|1046087|P4|NOT COMPLETED|Phase 1:Control Challenge||0
439089|NCT00705341|1046088|P3|NOT COMPLETED|Phase 1:Control Challenge||0
439090|NCT00705341|1046089|P2|NOT COMPLETED|Phase 1:Control Challenge||0
439091|NCT00705341|1046090|P1|NOT COMPLETED|Phase 1:Control Challenge||0
439092|NCT00705341|1046087|P4|COMPLETED|Phase 1:Control Challenge||0
439093|NCT00705341|1046088|P3|COMPLETED|Phase 1:Control Challenge||0
439094|NCT00705341|1046089|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
439095|NCT00705341|1046090|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
439096|NCT00705341|1046087|P4|STARTED|Phase 1:Control Challenge||0
439097|NCT00705341|1046088|P3|STARTED|Phase 1:Control Challenge||0
439098|NCT00705341|1046089|P2|STARTED|Phase 1:Control Challenge||93
439099|NCT00705341|1046090|P1|STARTED|Phase 1:Control Challenge||126
439100|NCT00705289|1046098|P1|NOT COMPLETED|Overall Study||131
439101|NCT00705289|1046098|P1|COMPLETED|Overall Study||597
439102|NCT00705289|1046098|P1|STARTED|Overall Study||728
439103|NCT00705263|1046122|P1|NOT COMPLETED|Overall Study||2
439104|NCT00705263|1046122|P1|COMPLETED|Overall Study||108
439105|NCT00705263|1046122|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
439106|NCT00705250|1046126|P1|NOT COMPLETED|Overall Study||2
439107|NCT00705250|1046126|P1|COMPLETED|Overall Study||34
439108|NCT00705250|1046126|P1|STARTED|Overall Study||36
439109|NCT00705224|1046130|P1|NOT COMPLETED|Overall Study||11
439110|NCT00705224|1046130|P1|COMPLETED|Overall Study||239
439111|NCT00705224|1046130|P1|STARTED|Overall Study||250
439112|NCT00705159|1046146|P4|NOT COMPLETED|Overall Study||4
439113|NCT00705159|1046147|P3|NOT COMPLETED|Overall Study||5
439114|NCT00705159|1046148|P2|NOT COMPLETED|Overall Study||2
439115|NCT00705159|1046149|P1|NOT COMPLETED|Overall Study||0
439116|NCT00705159|1046146|P4|COMPLETED|Overall Study||30
439117|NCT00705159|1046147|P3|COMPLETED|Overall Study||29
439118|NCT00705159|1046148|P2|COMPLETED|Overall Study||33
439119|NCT00705159|1046149|P1|COMPLETED|Overall Study||34
439120|NCT00705159|1046146|P4|STARTED|Overall Study||34
439121|NCT00705159|1046147|P3|STARTED|Overall Study||34
439122|NCT00705159|1046148|P2|STARTED|Overall Study||35
439123|NCT00705159|1046149|P1|STARTED|Overall Study||34
439124|NCT00705146|1046169|P2|NOT COMPLETED|Overall Study||1
439125|NCT00705146|1046170|P1|NOT COMPLETED|Overall Study||1
439126|NCT00705146|1046169|P2|COMPLETED|Overall Study||23
439127|NCT00705146|1046170|P1|COMPLETED|Overall Study||31
439128|NCT00705146|1046169|P2|STARTED|Overall Study||24
439129|NCT00705146|1046170|P1|STARTED|Overall Study||32
439130|NCT00705107|1046178|P1|NOT COMPLETED|Overall Study||49
439131|NCT00705107|1046178|P1|COMPLETED|Overall Study||218
439132|NCT00705107|1046178|P1|STARTED|Overall Study||267
439133|NCT00705081|1046185|P2|NOT COMPLETED|Overall Study||0
439134|NCT00705081|1046186|P1|NOT COMPLETED|Overall Study||0
439135|NCT00705081|1046185|P2|COMPLETED|Overall Study||198
439136|NCT00705081|1046186|P1|COMPLETED|Overall Study||255
439137|NCT00705081|1046185|P2|STARTED|Overall Study||198
439138|NCT00705081|1046186|P1|STARTED|Overall Study||255
439139|NCT00705016|1046199|P3|NOT COMPLETED|Overall Study||58
439140|NCT00705016|1046200|P2|NOT COMPLETED|Overall Study||58
439141|NCT00705016|1046201|P1|NOT COMPLETED|Overall Study||60
439142|NCT00705016|1046199|P3|COMPLETED|Overall Study||4
439143|NCT00705016|1046200|P2|COMPLETED|Overall Study||2
439144|NCT00705016|1046201|P1|COMPLETED|Overall Study||2
439145|NCT00705016|1046199|P3|STARTED|Overall Study||62
439146|NCT00705016|1046200|P2|STARTED|Overall Study||60
439147|NCT00705016|1046201|P1|STARTED|Overall Study||62
439148|NCT00705003|1046230|P3|NOT COMPLETED|Treated||3
439149|NCT00705003|1046231|P2|NOT COMPLETED|Treated||6
439150|NCT00705003|1046232|P1|NOT COMPLETED|Treated||13
439151|NCT00705003|1046230|P3|COMPLETED|Treated||30
439152|NCT00705003|1046231|P2|COMPLETED|Treated||28
439153|NCT00705003|1046232|P1|COMPLETED|Treated||54
439154|NCT00705003|1046230|P3|STARTED|Treated||33
439155|NCT00705003|1046231|P2|STARTED|Treated||34
439156|NCT00705003|1046232|P1|STARTED|Treated||67
439157|NCT00705003|1046230|P3|NOT COMPLETED|Enrolled||1
439158|NCT00705003|1046231|P2|NOT COMPLETED|Enrolled||3
439159|NCT00705003|1046232|P1|NOT COMPLETED|Enrolled||4
439160|NCT00705003|1046230|P3|COMPLETED|Enrolled||33
439161|NCT00705003|1046231|P2|COMPLETED|Enrolled||34
439162|NCT00705003|1046232|P1|COMPLETED|Enrolled||67
439163|NCT00705003|1046230|P3|STARTED|Enrolled||34
439164|NCT00705003|1046231|P2|STARTED|Enrolled||37
439165|NCT00705003|1046232|P1|STARTED|Enrolled||71
439166|NCT00704964|1046252|P1|NOT COMPLETED|Overall Study||328
439167|NCT00704964|1046252|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
439168|NCT00704964|1046252|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
439169|NCT00704938|1046259|P2|NOT COMPLETED|Overall Study||0
439170|NCT00704938|1046260|P1|NOT COMPLETED|Overall Study||0
439171|NCT00704938|1046259|P2|COMPLETED|Overall Study||1
439172|NCT00704938|1046260|P1|COMPLETED|Overall Study||2
439173|NCT00704938|1046259|P2|STARTED|Overall Study||1
439175|NCT00704912|1046271|P3|NOT COMPLETED|Overall Study||7
439176|NCT00704912|1046272|P2|NOT COMPLETED|Overall Study||4
439177|NCT00704912|1046273|P1|NOT COMPLETED|Overall Study||6
439178|NCT00704912|1046271|P3|COMPLETED|Overall Study||43
439179|NCT00704912|1046272|P2|COMPLETED|Overall Study||45
439180|NCT00704912|1046273|P1|COMPLETED|Overall Study||44
439181|NCT00704912|1046271|P3|STARTED|Overall Study||50
439182|NCT00704912|1046272|P2|STARTED|Overall Study||49
439183|NCT00704912|1046273|P1|STARTED|Overall Study||50
439184|NCT00704847|1046292|P2|NOT COMPLETED|Overall Study||170
439185|NCT00704847|1046293|P1|NOT COMPLETED|Overall Study||221
439186|NCT00704847|1046292|P2|COMPLETED|Overall Study||339
439187|NCT00704847|1046293|P1|COMPLETED|Overall Study||300
439188|NCT00704847|1046292|P2|STARTED|Overall Study||509
439189|NCT00704847|1046293|P1|STARTED|Overall Study||521
439190|NCT00704808|1046301|P1|NOT COMPLETED|Overall Study||131
439191|NCT00704808|1046301|P1|COMPLETED|Overall Study||49
439192|NCT00704808|1046301|P1|STARTED|Overall Study||180
439193|NCT00704769|1046305|P1|NOT COMPLETED|Overall Study||0
439194|NCT00704769|1046305|P1|COMPLETED|Overall Study||591
439195|NCT00704769|1046305|P1|STARTED|Overall Study||591
439196|NCT00704730|1046312|P2|NOT COMPLETED|Overall Study||96
439197|NCT00704730|1046313|P1|NOT COMPLETED|Overall Study||121
439198|NCT00704730|1046312|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
439199|NCT00704730|1046313|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
439200|NCT00704730|1046312|P2|STARTED|Overall Study|Randomized|111
439201|NCT00704730|1046313|P1|STARTED|Overall Study|Randomized|219
439202|NCT00704717|1046329|P1|NOT COMPLETED|Overall Study||0
439203|NCT00704717|1046329|P1|COMPLETED|Overall Study||185
439204|NCT00704717|1046329|P1|STARTED|Overall Study||185
439205|NCT00704535|1046333|P1|NOT COMPLETED|Overall Study||146
439206|NCT00704535|1046333|P1|COMPLETED|Overall Study||3959
439207|NCT00704535|1046333|P1|STARTED|Overall Study||4105
439208|NCT00704522|1046346|P2|NOT COMPLETED|Overall Study||45
439209|NCT00704522|1046347|P1|NOT COMPLETED|Overall Study||183
439210|NCT00704522|1046346|P2|COMPLETED|Overall Study||75
439211|NCT00704522|1046347|P1|COMPLETED|Overall Study||298
439212|NCT00704522|1046346|P2|STARTED|Overall Study||120
439213|NCT00704522|1046347|P1|STARTED|Overall Study||481
439214|NCT00704418|1046356|P2|NOT COMPLETED|Overall Study||6
439215|NCT00704418|1046357|P1|NOT COMPLETED|Overall Study||5
439216|NCT00704418|1046356|P2|COMPLETED|Overall Study||72
439217|NCT00704418|1046357|P1|COMPLETED|Overall Study||73
439218|NCT00704418|1046356|P2|STARTED|Overall Study||78
439219|NCT00704418|1046357|P1|STARTED|Overall Study||78
439220|NCT00704405|1046370|P5|NOT COMPLETED|Overall Study (C Population)||0
439221|NCT00704405|1046371|P4|NOT COMPLETED|Overall Study (C Population)||1
439222|NCT00704405|1046372|P3|NOT COMPLETED|Overall Study (C Population)||1
439223|NCT00704405|1046373|P2|NOT COMPLETED|Overall Study (C Population)||3
439224|NCT00704405|1046374|P1|NOT COMPLETED|Overall Study (C Population)||1
439225|NCT00704405|1046370|P5|COMPLETED|Overall Study (C Population)||14
439226|NCT00704405|1046371|P4|COMPLETED|Overall Study (C Population)||14
439227|NCT00704405|1046372|P3|COMPLETED|Overall Study (C Population)||14
439228|NCT00704405|1046373|P2|COMPLETED|Overall Study (C Population)||11
439229|NCT00704405|1046374|P1|COMPLETED|Overall Study (C Population)||15
439230|NCT00704405|1046370|P5|STARTED|Overall Study (C Population)||14
439231|NCT00704405|1046371|P4|STARTED|Overall Study (C Population)||15
439232|NCT00704405|1046372|P3|STARTED|Overall Study (C Population)||15
439233|NCT00704405|1046373|P2|STARTED|Overall Study (C Population)||14
439234|NCT00704405|1046374|P1|STARTED|Overall Study (C Population)||16
439235|NCT00704405|1046370|P5|NOT COMPLETED|Overall Study (NC Population)||5
439236|NCT00704405|1046371|P4|NOT COMPLETED|Overall Study (NC Population)||4
439237|NCT00704405|1046372|P3|NOT COMPLETED|Overall Study (NC Population)||3
439238|NCT00704405|1046373|P2|NOT COMPLETED|Overall Study (NC Population)||4
439239|NCT00704405|1046374|P1|NOT COMPLETED|Overall Study (NC Population)||5
439240|NCT00704405|1046370|P5|COMPLETED|Overall Study (NC Population)||37
439241|NCT00704405|1046371|P4|COMPLETED|Overall Study (NC Population)||38
439242|NCT00704405|1046372|P3|COMPLETED|Overall Study (NC Population)||38
439243|NCT00704405|1046373|P2|COMPLETED|Overall Study (NC Population)||40
439244|NCT00704405|1046374|P1|COMPLETED|Overall Study (NC Population)||37
439245|NCT00704405|1046370|P5|STARTED|Overall Study (NC Population)||42
439246|NCT00704405|1046371|P4|STARTED|Overall Study (NC Population)||42
439247|NCT00704405|1046372|P3|STARTED|Overall Study (NC Population)||41
439248|NCT00704405|1046373|P2|STARTED|Overall Study (NC Population)||44
439249|NCT00704405|1046374|P1|STARTED|Overall Study (NC Population)||42
439250|NCT00704379|1046404|P2|NOT COMPLETED|Overall Study||7
439251|NCT00704379|1046405|P1|NOT COMPLETED|Overall Study||7
439252|NCT00704379|1046404|P2|COMPLETED|Overall Study||41
439253|NCT00704379|1046405|P1|COMPLETED|Overall Study||39
439254|NCT00704379|1046404|P2|STARTED|Overall Study||48
439255|NCT00704379|1046405|P1|STARTED|Overall Study||46
439256|NCT00704353|1046423|P2|NOT COMPLETED|Overall Study||114
439257|NCT00704353|1046424|P1|NOT COMPLETED|Overall Study||98
439258|NCT00704353|1046423|P2|COMPLETED|Overall Study||255
439259|NCT00704353|1046424|P1|COMPLETED|Overall Study||268
439260|NCT00704353|1046423|P2|STARTED|Overall Study||369
439261|NCT00704353|1046424|P1|STARTED|Overall Study||366
439262|NCT00704340|1046432|P2|NOT COMPLETED|Overall Study||2
439263|NCT00704340|1046433|P1|NOT COMPLETED|Overall Study||2
439264|NCT00704340|1046432|P2|COMPLETED|Overall Study||115
439265|NCT00704340|1046433|P1|COMPLETED|Overall Study||118
439266|NCT00704340|1046432|P2|STARTED|Overall Study||117
439267|NCT00704340|1046433|P1|STARTED|Overall Study||120
439268|NCT00704184|1046448|P5|NOT COMPLETED|Open-Label Treatment||3
439269|NCT00704184|1046449|P4|NOT COMPLETED|Open-Label Treatment||5
439270|NCT00704184|1046450|P3|NOT COMPLETED|Open-Label Treatment||4
439271|NCT00704184|1046451|P2|NOT COMPLETED|Open-Label Treatment||2
439272|NCT00704184|1046452|P1|NOT COMPLETED|Open-Label Treatment||1
439273|NCT00704184|1046448|P5|COMPLETED|Open-Label Treatment||16
439274|NCT00704184|1046449|P4|COMPLETED|Open-Label Treatment||13
439275|NCT00704184|1046450|P3|COMPLETED|Open-Label Treatment||16
439276|NCT00704184|1046451|P2|COMPLETED|Open-Label Treatment||16
439277|NCT00704184|1046452|P1|COMPLETED|Open-Label Treatment||18
439278|NCT00704184|1046448|P5|STARTED|Open-Label Treatment||19
439279|NCT00704184|1046449|P4|STARTED|Open-Label Treatment||18
439280|NCT00704184|1046450|P3|STARTED|Open-Label Treatment||20
439281|NCT00704184|1046451|P2|STARTED|Open-Label Treatment||18
439282|NCT00704184|1046452|P1|STARTED|Open-Label Treatment||19
439283|NCT00704184|1046448|P5|NOT COMPLETED|Double-Blind Treatment||0
439284|NCT00704184|1046449|P4|NOT COMPLETED|Double-Blind Treatment||0
439285|NCT00704184|1046450|P3|NOT COMPLETED|Double-Blind Treatment||0
439286|NCT00704184|1046451|P2|NOT COMPLETED|Double-Blind Treatment||0
439287|NCT00704184|1046452|P1|NOT COMPLETED|Double-Blind Treatment||1
439288|NCT00704184|1046448|P5|COMPLETED|Double-Blind Treatment||19
439289|NCT00704184|1046449|P4|COMPLETED|Double-Blind Treatment||18
439290|NCT00704184|1046450|P3|COMPLETED|Double-Blind Treatment||20
439291|NCT00704184|1046451|P2|COMPLETED|Double-Blind Treatment||18
439292|NCT00704184|1046452|P1|COMPLETED|Double-Blind Treatment||19
439293|NCT00704184|1046448|P5|Treated|Double-Blind Treatment||19
439294|NCT00704184|1046449|P4|Treated|Double-Blind Treatment||18
439295|NCT00704184|1046450|P3|Treated|Double-Blind Treatment||20
439296|NCT00704184|1046451|P2|Treated|Double-Blind Treatment||18
439297|NCT00704184|1046452|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
439298|NCT00704184|1046448|P5|STARTED|Double-Blind Treatment||19
439299|NCT00704184|1046449|P4|STARTED|Double-Blind Treatment||18
439300|NCT00704184|1046450|P3|STARTED|Double-Blind Treatment||20
439301|NCT00704184|1046451|P2|STARTED|Double-Blind Treatment||18
439302|NCT00704184|1046452|P1|STARTED|Double-Blind Treatment||20
439303|NCT00704171|1046491|P2|NOT COMPLETED|Overall Study||0
439304|NCT00704171|1046492|P1|NOT COMPLETED|Overall Study||1
439305|NCT00704171|1046491|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
439306|NCT00704171|1046492|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
439307|NCT00704171|1046491|P2|STARTED|Overall Study||59
439308|NCT00704171|1046492|P1|STARTED|Overall Study||62
439309|NCT00704132|1046510|P2|NOT COMPLETED|Overall Study||2
439310|NCT00704132|1046511|P1|NOT COMPLETED|Overall Study||1
439311|NCT00704132|1046510|P2|COMPLETED|Overall Study||22
439312|NCT00704132|1046511|P1|COMPLETED|Overall Study||25
439313|NCT00704132|1046510|P2|STARTED|Overall Study||24
439314|NCT00704132|1046511|P1|STARTED|Overall Study||26
439315|NCT00704028|1046519|P2|NOT COMPLETED|Overall Study||21
439316|NCT00704028|1046520|P1|NOT COMPLETED|Overall Study||12
439317|NCT00704028|1046519|P2|COMPLETED|Overall Study||57
439318|NCT00704028|1046520|P1|COMPLETED|Overall Study||70
439319|NCT00704028|1046519|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
439320|NCT00704028|1046520|P1|STARTED|Overall Study||82
439321|NCT00703976|1046528|P2|NOT COMPLETED|Overall Study||0
439322|NCT00703976|1046529|P1|NOT COMPLETED|Overall Study||0
439323|NCT00703976|1046528|P2|COMPLETED|Overall Study||41
439324|NCT00703976|1046529|P1|COMPLETED|Overall Study||37
439325|NCT00703976|1046528|P2|STARTED|Overall Study||41
439326|NCT00703976|1046529|P1|STARTED|Overall Study||37
439327|NCT00703963|1046539|P2|NOT COMPLETED|Overall Study||14
439328|NCT00703963|1046540|P1|NOT COMPLETED|Overall Study||7
439329|NCT00703963|1046539|P2|COMPLETED|Overall Study||86
439330|NCT00703963|1046540|P1|COMPLETED|Overall Study||93
439331|NCT00703963|1046539|P2|STARTED|Overall Study||100
439332|NCT00703963|1046540|P1|STARTED|Overall Study||100
439333|NCT00703937|1046552|P2|NOT COMPLETED|Overall Study||93
439334|NCT00703937|1046553|P1|NOT COMPLETED|Overall Study||65
439335|NCT00703937|1046552|P2|COMPLETED|Overall Study||267
439336|NCT00703937|1046553|P1|COMPLETED|Overall Study||278
439337|NCT00703937|1046552|P2|STARTED|Overall Study||360
439338|NCT00703937|1046553|P1|STARTED|Overall Study||343
439339|NCT00703924|1046561|P2|NOT COMPLETED|Overall Study||1
439340|NCT00703924|1046562|P1|NOT COMPLETED|Overall Study||1
439341|NCT00703924|1046561|P2|COMPLETED|Overall Study||41
439342|NCT00703924|1046562|P1|COMPLETED|Overall Study||49
439343|NCT00703924|1046561|P2|STARTED|Overall Study||42
439344|NCT00703924|1046562|P1|STARTED|Overall Study||50
439345|NCT00703911|1046578|P1|NOT COMPLETED|Overall Study||10
439346|NCT00703911|1046578|P1|COMPLETED|Overall Study||92
439347|NCT00703911|1046578|P1|STARTED|Overall Study||102
439348|NCT00703885|1046606|P1|NOT COMPLETED|Overall Study||0
439349|NCT00703885|1046606|P1|COMPLETED|Overall Study||16
439350|NCT00703885|1046606|P1|STARTED|Overall Study||16
439351|NCT00703846|1046611|P1|NOT COMPLETED|Overall Study||137
439352|NCT00703846|1046611|P1|COMPLETED|Overall Study||363
439353|NCT00703846|1046611|P1|STARTED|Overall Study||500
439354|NCT00703781|1046627|P2|NOT COMPLETED|Overall Study||2
439355|NCT00703781|1046628|P1|NOT COMPLETED|Overall Study||2
439356|NCT00703781|1046627|P2|COMPLETED|Overall Study||61
439357|NCT00703781|1046628|P1|COMPLETED|Overall Study||61
439358|NCT00703781|1046627|P2|STARTED|Overall Study||63
439359|NCT00703781|1046628|P1|STARTED|Overall Study||63
439360|NCT00703729|1046638|P2|NOT COMPLETED|Overall Study||3
439361|NCT00703729|1046639|P1|NOT COMPLETED|Overall Study||0
439362|NCT00703729|1046638|P2|COMPLETED|Overall Study||21
439363|NCT00703729|1046639|P1|COMPLETED|Overall Study||25
439364|NCT00703729|1046638|P2|STARTED|Overall Study||24
439365|NCT00703729|1046639|P1|STARTED|Overall Study||25
439366|NCT00703677|1046673|P1|NOT COMPLETED|Overall Study||3
439367|NCT00703677|1046673|P1|COMPLETED|Overall Study||14
439368|NCT00703677|1046673|P1|STARTED|Overall Study||17
439369|NCT00703534|1046688|P2|NOT COMPLETED|Overall Study||25
439370|NCT00703534|1046689|P1|NOT COMPLETED|Overall Study||30
439371|NCT00703534|1046688|P2|COMPLETED|Overall Study||218
439372|NCT00703534|1046689|P1|COMPLETED|Overall Study||205
439373|NCT00703534|1046688|P2|STARTED|Overall Study||243
439374|NCT00703534|1046689|P1|STARTED|Overall Study||235
439375|NCT00703508|1046695|P1|NOT COMPLETED|Overall Study||0
439376|NCT00703508|1046695|P1|COMPLETED|Overall Study||26
439377|NCT00703508|1046695|P1|STARTED|Overall Study||26
439378|NCT00703391|1046709|P2|NOT COMPLETED|Overall Study||0
439379|NCT00703391|1046710|P1|NOT COMPLETED|Overall Study||0
439380|NCT00703391|1046709|P2|COMPLETED|Overall Study||6
439381|NCT00703391|1046710|P1|COMPLETED|Overall Study||12
439382|NCT00703391|1046709|P2|STARTED|Overall Study||6
439383|NCT00703391|1046710|P1|STARTED|Overall Study||12
439384|NCT00703339|1046754|P1|NOT COMPLETED|Overall Study||0
439385|NCT00703339|1046754|P1|COMPLETED|Overall Study||1
439386|NCT00703339|1046754|P1|STARTED|Overall Study||1
439387|NCT00703326|1046760|P2|NOT COMPLETED|Overall Study||225
439388|NCT00703326|1046761|P1|NOT COMPLETED|Overall Study||447
439389|NCT00703326|1046760|P2|COMPLETED|Overall Study||160
439390|NCT00703326|1046761|P1|COMPLETED|Overall Study||312
439391|NCT00703326|1046760|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
439392|NCT00703326|1046761|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
439393|NCT00703326|1046760|P2|STARTED|Overall Study||385
439394|NCT00703326|1046761|P1|STARTED|Overall Study||759
439395|NCT00703261|1046783|P2|NOT COMPLETED|Overall Study||6
439396|NCT00703261|1046784|P1|NOT COMPLETED|Overall Study||6
439397|NCT00703261|1046783|P2|COMPLETED|Overall Study||35
439398|NCT00703261|1046784|P1|COMPLETED|Overall Study||36
439399|NCT00703261|1046783|P2|STARTED|Overall Study||41
439400|NCT00703261|1046784|P1|STARTED|Overall Study||42
439401|NCT00703157|1046793|P2|NOT COMPLETED|Overall Study||2
439402|NCT00703157|1046794|P1|NOT COMPLETED|Overall Study||4
439403|NCT00703157|1046793|P2|COMPLETED|Overall Study||24
439404|NCT00703157|1046794|P1|COMPLETED|Overall Study||22
439405|NCT00703157|1046793|P2|24 Months FU|Overall Study||24
439406|NCT00703157|1046794|P1|24 Months FU|Overall Study||22
439407|NCT00703157|1046793|P2|6 Months FU|Overall Study||25
439408|NCT00703157|1046794|P1|6 Months FU|Overall Study||25
439409|NCT00703157|1046793|P2|STARTED|Overall Study||26
439410|NCT00703157|1046794|P1|STARTED|Overall Study||26
439411|NCT00703118|1046828|P3|NOT COMPLETED|Overall Study||22
439412|NCT00703118|1046829|P2|NOT COMPLETED|Overall Study||16
439413|NCT00703118|1046830|P1|NOT COMPLETED|Overall Study||21
439414|NCT00703118|1046828|P3|COMPLETED|Overall Study||110
439415|NCT00703118|1046829|P2|COMPLETED|Overall Study||248
439416|NCT00703118|1046830|P1|COMPLETED|Overall Study||245
439417|NCT00703118|1046828|P3|STARTED|Overall Study||132
439418|NCT00703118|1046829|P2|STARTED|Overall Study||264
439419|NCT00703118|1046830|P1|STARTED|Overall Study||266
439420|NCT00703092|1046861|P1|NOT COMPLETED|Overall Study||2
439421|NCT00703092|1046861|P1|COMPLETED|Overall Study||0
439422|NCT00703092|1046861|P1|STARTED|Overall Study||2
439423|NCT00703053|1046874|P9|NOT COMPLETED|Overall Study||1
439424|NCT00703053|1046875|P8|NOT COMPLETED|Overall Study||6
439425|NCT00703053|1046876|P7|NOT COMPLETED|Overall Study||7
439426|NCT00703053|1046877|P6|NOT COMPLETED|Overall Study||6
439427|NCT00703053|1046878|P5|NOT COMPLETED|Overall Study||1
439428|NCT00703053|1046879|P4|NOT COMPLETED|Overall Study||3
439429|NCT00703053|1046880|P3|NOT COMPLETED|Overall Study||3
439430|NCT00703053|1046881|P2|NOT COMPLETED|Overall Study||2
439431|NCT00703053|1046882|P1|NOT COMPLETED|Overall Study||1
439432|NCT00703053|1046874|P9|COMPLETED|Overall Study||102
439433|NCT00703053|1046875|P8|COMPLETED|Overall Study||91
439434|NCT00703053|1046876|P7|COMPLETED|Overall Study||45
439435|NCT00703053|1046877|P6|COMPLETED|Overall Study||43
439436|NCT00703053|1046878|P5|COMPLETED|Overall Study||50
439437|NCT00703053|1046879|P4|COMPLETED|Overall Study||46
439438|NCT00703053|1046880|P3|COMPLETED|Overall Study||48
439439|NCT00703053|1046881|P2|COMPLETED|Overall Study||24
439440|NCT00703053|1046882|P1|COMPLETED|Overall Study||26
439441|NCT00703053|1046874|P9|STARTED|Overall Study||103
439442|NCT00703053|1046875|P8|STARTED|Overall Study||97
439443|NCT00703053|1046876|P7|STARTED|Overall Study||52
439444|NCT00703053|1046877|P6|STARTED|Overall Study||49
439445|NCT00703053|1046878|P5|STARTED|Overall Study||51
439446|NCT00703053|1046879|P4|STARTED|Overall Study||49
439447|NCT00703053|1046880|P3|STARTED|Overall Study||51
439448|NCT00703053|1046881|P2|STARTED|Overall Study||26
439449|NCT00703053|1046882|P1|STARTED|Overall Study||27
439450|NCT00703014|1047068|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
439451|NCT00703014|1047069|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
439452|NCT00703014|1047070|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
439453|NCT00703014|1047071|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
439454|NCT00703014|1047068|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
439455|NCT00703014|1047069|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
439456|NCT00703014|1047070|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
439457|NCT00703014|1047071|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
439458|NCT00703014|1047068|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
439459|NCT00703014|1047069|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
439460|NCT00703014|1047070|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
439461|NCT00703014|1047071|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
439462|NCT00703014|1047068|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
439463|NCT00703014|1047069|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
439464|NCT00703014|1047070|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
439465|NCT00703014|1047071|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
439466|NCT00703014|1047068|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
439467|NCT00703014|1047069|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
439468|NCT00703014|1047070|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
439469|NCT00703014|1047071|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
439470|NCT00703014|1047068|P4|COMPLETED|Mothers Follow Up Trial P05712||0
439471|NCT00703014|1047069|P3|COMPLETED|Mothers Follow Up Trial P05712||0
439472|NCT00703014|1047070|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
439473|NCT00703014|1047071|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
439474|NCT00703014|1047068|P4|STARTED|Mothers Follow Up Trial P05712||0
439475|NCT00703014|1047069|P3|STARTED|Mothers Follow Up Trial P05712||0
439476|NCT00703014|1047070|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
439477|NCT00703014|1047071|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
439478|NCT00703014|1047068|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
439479|NCT00703014|1047069|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
439480|NCT00703014|1047070|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
439481|NCT00703014|1047071|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
439482|NCT00703014|1047068|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
439483|NCT00703014|1047069|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
439484|NCT00703014|1047070|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
439485|NCT00703014|1047071|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
439486|NCT00703014|1047068|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
439487|NCT00703014|1047069|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
439488|NCT00703014|1047070|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
439489|NCT00703014|1047071|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
439490|NCT00703014|1047068|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
439491|NCT00703014|1047069|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
439492|NCT00703014|1047070|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
439493|NCT00703014|1047071|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
439494|NCT00703014|1047068|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
439495|NCT00703014|1047069|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
439496|NCT00703014|1047070|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
439497|NCT00703014|1047071|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
439498|NCT00702949|1047092|P3|NOT COMPLETED|Overall Study||8
439499|NCT00702949|1047093|P2|NOT COMPLETED|Overall Study||9
439500|NCT00702949|1047094|P1|NOT COMPLETED|Overall Study||5
439501|NCT00702949|1047092|P3|COMPLETED|Overall Study||54
439502|NCT00702949|1047093|P2|COMPLETED|Overall Study||57
439503|NCT00702949|1047094|P1|COMPLETED|Overall Study||58
439504|NCT00702949|1047092|P3|Evaluable for Primary Endpoint|Overall Study||51
439505|NCT00702949|1047093|P2|Evaluable for Primary Endpoint|Overall Study||56
439506|NCT00702949|1047094|P1|Evaluable for Primary Endpoint|Overall Study||56
439507|NCT00702949|1047092|P3|STARTED|Overall Study||62
439508|NCT00702949|1047093|P2|STARTED|Overall Study||66
439509|NCT00702949|1047094|P1|STARTED|Overall Study||63
439510|NCT00702923|1047119|P1|NOT COMPLETED|Overall Study||1
439511|NCT00702923|1047119|P1|COMPLETED|Overall Study||11
439512|NCT00702923|1047119|P1|STARTED|Overall Study||12
439513|NCT00702884|1047128|P1|NOT COMPLETED|Overall Study||0
439514|NCT00702884|1047128|P1|COMPLETED|Overall Study||25
439515|NCT00702884|1047128|P1|STARTED|Overall Study||25
439516|NCT00702845|1047142|P2|NOT COMPLETED|Overall Study||8
439517|NCT00702845|1047143|P1|NOT COMPLETED|Overall Study||22
439518|NCT00702845|1047142|P2|COMPLETED|Overall Study||121
439519|NCT00702845|1047143|P1|COMPLETED|Overall Study||246
439520|NCT00702845|1047142|P2|Randomized|Overall Study||128
439521|NCT00702845|1047143|P1|Randomized|Overall Study||268
439522|NCT00702845|1047142|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
439523|NCT00702845|1047143|P1|STARTED|Overall Study||268
439524|NCT00702780|1047183|P2|NOT COMPLETED|Overall Study||8
439525|NCT00702780|1047184|P1|NOT COMPLETED|Overall Study||9
439526|NCT00702780|1047183|P2|COMPLETED|Overall Study||29
439527|NCT00702780|1047184|P1|COMPLETED|Overall Study||28
439528|NCT00702780|1047183|P2|STARTED|Overall Study||37
439529|NCT00702780|1047184|P1|STARTED|Overall Study||37
439530|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
439531|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
439532|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
439533|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
439534|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
439535|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
439536|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
439537|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
439538|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
439539|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
439540|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
439541|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
439542|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
439543|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
439544|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
439545|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
439546|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
439547|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
439548|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
439549|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
439550|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
439551|NCT00702754|1047192|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
439552|NCT00702754|1047192|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
439553|NCT00702754|1047192|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
439554|NCT00702715|1047205|P2|NOT COMPLETED|Overall Study||0
439555|NCT00702715|1047206|P1|NOT COMPLETED|Overall Study||1
439556|NCT00702715|1047205|P2|COMPLETED|Overall Study||33
439557|NCT00702715|1047206|P1|COMPLETED|Overall Study||34
439558|NCT00702715|1047205|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
439559|NCT00702715|1047206|P1|STARTED|Overall Study||35
439560|NCT00702702|1047219|P1|NOT COMPLETED|Overall Study||56
439561|NCT00702702|1047219|P1|COMPLETED|Overall Study||0
439562|NCT00702702|1047219|P1|STARTED|Overall Study||56
439563|NCT00702689|1047227|P1|NOT COMPLETED|Overall Study||6
439564|NCT00702689|1047227|P1|COMPLETED|Overall Study||14
439565|NCT00702689|1047227|P1|STARTED|Overall Study||20
439566|NCT00702650|1047238|P1|NOT COMPLETED|Overall Study||20
439567|NCT00702650|1047238|P1|COMPLETED|Overall Study||135
439568|NCT00702650|1047238|P1|STARTED|Overall Study||155
439569|NCT00702624|1047258|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
439570|NCT00702624|1047259|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
439571|NCT00702624|1047260|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
439572|NCT00702624|1047261|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
439573|NCT00702624|1047258|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
439574|NCT00702624|1047259|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
439575|NCT00702624|1047260|P2|COMPLETED|Fetuses/Infant Follow-up||0
439576|NCT00702624|1047261|P1|COMPLETED|Fetuses/Infant Follow-up||0
439577|NCT00702624|1047258|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
439578|NCT00702624|1047259|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
439579|NCT00702624|1047260|P2|Live Born Infants|Fetuses/Infant Follow-up||0
439580|NCT00702624|1047261|P1|Live Born Infants|Fetuses/Infant Follow-up||0
439581|NCT00702624|1047258|P4|STARTED|Fetuses/Infant Follow-up||55
439582|NCT00702624|1047259|P3|STARTED|Fetuses/Infant Follow-up||88
439583|NCT00702624|1047260|P2|STARTED|Fetuses/Infant Follow-up||0
439584|NCT00702624|1047261|P1|STARTED|Fetuses/Infant Follow-up||0
439585|NCT00702624|1047258|P4|NOT COMPLETED|Expectant Mother Follow-up||0
439586|NCT00702624|1047259|P3|NOT COMPLETED|Expectant Mother Follow-up||0
439587|NCT00702624|1047260|P2|NOT COMPLETED|Expectant Mother Follow-up||0
439588|NCT00702624|1047261|P1|NOT COMPLETED|Expectant Mother Follow-up||7
439589|NCT00702624|1047258|P4|COMPLETED|Expectant Mother Follow-up||0
439590|NCT00702624|1047259|P3|COMPLETED|Expectant Mother Follow-up||0
439591|NCT00702624|1047260|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
439592|NCT00702624|1047261|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
439593|NCT00702624|1047258|P4|STARTED|Expectant Mother Follow-up||0
439594|NCT00702624|1047259|P3|STARTED|Expectant Mother Follow-up||0
439595|NCT00702624|1047260|P2|STARTED|Expectant Mother Follow-up||45
439596|NCT00702624|1047261|P1|STARTED|Expectant Mother Follow-up||68
439597|NCT00702624|1047258|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
439598|NCT00702624|1047259|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
439599|NCT00702624|1047260|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
439600|NCT00702624|1047261|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
439601|NCT00702624|1047258|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
439602|NCT00702624|1047259|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
439603|NCT00702624|1047260|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
439604|NCT00702624|1047261|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
439605|NCT00702624|1047258|P4|STARTED|Base Study P05690 (NCT00702845)||0
439606|NCT00702624|1047259|P3|STARTED|Base Study P05690 (NCT00702845)||0
439607|NCT00702624|1047260|P2|STARTED|Base Study P05690 (NCT00702845)||128
439608|NCT00702624|1047261|P1|STARTED|Base Study P05690 (NCT00702845)||268
439609|NCT00702546|1047279|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
439610|NCT00702546|1047280|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
439611|NCT00702546|1047279|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
439612|NCT00702546|1047280|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
439683|NCT00702520|1047302|P2|STARTED|Base Study P05788 - Assigned Treatment||25
439613|NCT00702546|1047279|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
439614|NCT00702546|1047280|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
439615|NCT00702546|1047279|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
439616|NCT00702546|1047280|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
439617|NCT00702546|1047279|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
439618|NCT00702546|1047280|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
439619|NCT00702546|1047279|P2|STARTED|Base Study P05690 (NCT00702845)||128
439620|NCT00702546|1047280|P1|STARTED|Base Study P05690 (NCT00702845)||268
439621|NCT00702520|1047300|P4|NOT COMPLETED|Follow-up Study P05783||0
439622|NCT00702520|1047301|P3|NOT COMPLETED|Follow-up Study P05783||0
439623|NCT00702520|1047302|P2|NOT COMPLETED|Follow-up Study P05783||0
439624|NCT00702520|1047303|P1|NOT COMPLETED|Follow-up Study P05783||0
439625|NCT00702520|1047300|P4|COMPLETED|Follow-up Study P05783||11
439626|NCT00702520|1047301|P3|COMPLETED|Follow-up Study P05783||8
439627|NCT00702520|1047302|P2|COMPLETED|Follow-up Study P05783||8
439628|NCT00702520|1047303|P1|COMPLETED|Follow-up Study P05783||7
439629|NCT00702520|1047300|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
439630|NCT00702520|1047301|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
439631|NCT00702520|1047302|P2|STARTED|Follow-up Study P05783||8
439632|NCT00702520|1047303|P1|STARTED|Follow-up Study P05783||7
439633|NCT00702520|1047300|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
439634|NCT00702520|1047301|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
439635|NCT00702520|1047302|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
439636|NCT00702520|1047303|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
439637|NCT00702520|1047300|P4|COMPLETED|Base Study P05788 - Follow-Up||0
439638|NCT00702520|1047301|P3|COMPLETED|Base Study P05788 - Follow-Up||0
439639|NCT00702520|1047302|P2|COMPLETED|Base Study P05788 - Follow-Up||8
439640|NCT00702520|1047303|P1|COMPLETED|Base Study P05788 - Follow-Up||7
439641|NCT00702520|1047300|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
439642|NCT00702520|1047301|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
439643|NCT00702520|1047302|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
439644|NCT00702520|1047303|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
439645|NCT00702520|1047300|P4|STARTED|Base Study P05788 - Follow-Up||0
439646|NCT00702520|1047301|P3|STARTED|Base Study P05788 - Follow-Up||0
439647|NCT00702520|1047302|P2|STARTED|Base Study P05788 - Follow-Up||18
439648|NCT00702520|1047303|P1|STARTED|Base Study P05788 - Follow-Up||22
439649|NCT00702520|1047300|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
439650|NCT00702520|1047301|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
439651|NCT00702520|1047302|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
439652|NCT00702520|1047303|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
439653|NCT00702520|1047300|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
439654|NCT00702520|1047301|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
439655|NCT00702520|1047302|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
439656|NCT00702520|1047303|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
439657|NCT00702520|1047300|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
439658|NCT00702520|1047301|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
439659|NCT00702520|1047302|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
439660|NCT00702520|1047303|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
439661|NCT00702520|1047300|P4|STARTED|Base Study P05788 - Embryo Transfer||0
439662|NCT00702520|1047301|P3|STARTED|Base Study P05788 - Embryo Transfer||0
439663|NCT00702520|1047302|P2|STARTED|Base Study P05788 - Embryo Transfer||24
439664|NCT00702520|1047303|P1|STARTED|Base Study P05788 - Embryo Transfer||25
439665|NCT00702520|1047300|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
439666|NCT00702520|1047301|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
439812|NCT00701805|1047575|P3|NOT COMPLETED|Overall Study||7
439667|NCT00702520|1047302|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
439668|NCT00702520|1047303|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
439669|NCT00702520|1047300|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
439670|NCT00702520|1047301|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
439671|NCT00702520|1047302|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
439672|NCT00702520|1047303|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
439673|NCT00702520|1047300|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
439674|NCT00702520|1047301|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
439675|NCT00702520|1047302|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
439676|NCT00702520|1047303|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
439677|NCT00702520|1047300|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
439678|NCT00702520|1047301|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
439679|NCT00702520|1047302|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
439680|NCT00702520|1047303|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
439681|NCT00702520|1047300|P4|STARTED|Base Study P05788 - Assigned Treatment||0
439682|NCT00702520|1047301|P3|STARTED|Base Study P05788 - Assigned Treatment||0
439684|NCT00702520|1047303|P1|STARTED|Base Study P05788 - Assigned Treatment||25
439685|NCT00702507|1047319|P1|NOT COMPLETED|Follow-up Phase||27
439686|NCT00702507|1047319|P1|COMPLETED|Follow-up Phase||132
439687|NCT00702507|1047319|P1|STARTED|Follow-up Phase||159
439688|NCT00702507|1047319|P1|NOT COMPLETED|Initial Treatment Phase||41
439689|NCT00702507|1047319|P1|COMPLETED|Initial Treatment Phase||159
439690|NCT00702507|1047319|P1|STARTED|Initial Treatment Phase||200
439691|NCT00702468|1047333|P2|NOT COMPLETED|Overall Study||16
439692|NCT00702468|1047334|P1|NOT COMPLETED|Overall Study||3
439693|NCT00702468|1047333|P2|COMPLETED|Overall Study||2
439694|NCT00702468|1047334|P1|COMPLETED|Overall Study||15
439695|NCT00702468|1047333|P2|STARTED|Overall Study||18
439696|NCT00702468|1047334|P1|STARTED|Overall Study||18
439697|NCT00702403|1047356|P1|NOT COMPLETED|From Engraftment to Study Completion||27
439698|NCT00702403|1047356|P1|COMPLETED|From Engraftment to Study Completion||13
439699|NCT00702403|1047356|P1|Patient Drop-outs|From Engraftment to Study Completion||27
439700|NCT00702403|1047356|P1|STARTED|From Engraftment to Study Completion||40
439701|NCT00702403|1047356|P1|NOT COMPLETED|From Consent to Engraftment||17
439702|NCT00702403|1047356|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
439703|NCT00702403|1047356|P1|Ineligible for Study Drug|From Consent to Engraftment||17
439704|NCT00702403|1047356|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
439705|NCT00702377|1047366|P2|NOT COMPLETED|Overall Study||3
439706|NCT00702377|1047367|P1|NOT COMPLETED|Overall Study||1
439707|NCT00702377|1047366|P2|COMPLETED|Overall Study||53
439708|NCT00702377|1047367|P1|COMPLETED|Overall Study||52
439709|NCT00702377|1047366|P2|STARTED|Overall Study||56
439710|NCT00702377|1047367|P1|STARTED|Overall Study||53
439711|NCT00702364|1047379|P2|NOT COMPLETED|Overall Study||4
439712|NCT00702364|1047380|P1|NOT COMPLETED|Overall Study||2
439713|NCT00702364|1047379|P2|COMPLETED|Overall Study||25
439714|NCT00702364|1047380|P1|COMPLETED|Overall Study||24
439715|NCT00702364|1047379|P2|STARTED|Overall Study||29
439716|NCT00702364|1047380|P1|STARTED|Overall Study||26
439717|NCT00702338|1047392|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
439718|NCT00702338|1047393|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
439719|NCT00702338|1047394|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
439720|NCT00702338|1047392|P3|COMPLETED|Follow-up Study: Infant FU||0
439721|NCT00702338|1047393|P2|COMPLETED|Follow-up Study: Infant FU||0
439722|NCT00702338|1047394|P1|COMPLETED|Follow-up Study: Infant FU||0
439723|NCT00702338|1047392|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
439724|NCT00702338|1047393|P2|STARTED|Follow-up Study: Infant FU||0
439725|NCT00702338|1047394|P1|STARTED|Follow-up Study: Infant FU||0
439726|NCT00702338|1047392|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
439727|NCT00702338|1047393|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
439728|NCT00702338|1047394|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
439729|NCT00702338|1047392|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
439730|NCT00702338|1047393|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
439731|NCT00702338|1047394|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
439732|NCT00702338|1047392|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
439733|NCT00702338|1047393|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
439734|NCT00702338|1047394|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
439735|NCT00702338|1047392|P3|NOT COMPLETED|Base Study (NCT00697255)||0
439736|NCT00702338|1047393|P2|NOT COMPLETED|Base Study (NCT00697255)||2
439737|NCT00702338|1047394|P1|NOT COMPLETED|Base Study (NCT00697255)||3
439738|NCT00702338|1047392|P3|COMPLETED|Base Study (NCT00697255)||0
439739|NCT00702338|1047393|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
439740|NCT00702338|1047394|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
439741|NCT00702338|1047392|P3|STARTED|Base Study (NCT00697255)||0
439742|NCT00702338|1047393|P2|STARTED|Base Study (NCT00697255)||3
439743|NCT00702338|1047394|P1|STARTED|Base Study (NCT00697255)||5
439744|NCT00702325|1047410|P2|NOT COMPLETED|Overall Study||53
439745|NCT00702325|1047411|P1|NOT COMPLETED|Overall Study||38
439746|NCT00702325|1047410|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
439747|NCT00702325|1047411|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
439748|NCT00702325|1047410|P2|STARTED|Overall Study|Randomized|155
439749|NCT00702325|1047411|P1|STARTED|Overall Study|Randomized|156
439750|NCT00702299|1047463|P1|NOT COMPLETED|Overall Study||0
439751|NCT00702299|1047463|P1|COMPLETED|Overall Study||15
439752|NCT00702299|1047463|P1|STARTED|Overall Study||15
439753|NCT00702273|1047476|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
439754|NCT00702273|1047477|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
439755|NCT00702273|1047476|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
439756|NCT00702273|1047477|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
439757|NCT00702273|1047476|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
439758|NCT00702273|1047477|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
439759|NCT00702273|1047476|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
439760|NCT00702273|1047477|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
439761|NCT00702273|1047476|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
439762|NCT00702273|1047477|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
439763|NCT00702273|1047476|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
439764|NCT00702273|1047477|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
439765|NCT00702273|1047476|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
439766|NCT00702273|1047477|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
439767|NCT00702234|1047495|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
439768|NCT00702234|1047496|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
439769|NCT00702234|1047495|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
439770|NCT00702234|1047496|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
439771|NCT00702234|1047495|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
439772|NCT00702234|1047496|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
439773|NCT00702234|1047495|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
439774|NCT00702234|1047496|P1|STARTED|Follow-up Study: Fetuses/Infants||0
439775|NCT00702234|1047495|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
439776|NCT00702234|1047496|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
439777|NCT00702234|1047495|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
439778|NCT00702234|1047496|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
439779|NCT00702234|1047495|P2|STARTED|Follow-up Study: Expectant Mothers||0
439780|NCT00702234|1047496|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
439781|NCT00702234|1047495|P2|NOT COMPLETED|Base Study (NCT00696878)||0
439782|NCT00702234|1047496|P1|NOT COMPLETED|Base Study (NCT00696878)||504
439783|NCT00702234|1047495|P2|COMPLETED|Base Study (NCT00696878)||0
439784|NCT00702234|1047496|P1|COMPLETED|Base Study (NCT00696878)||178
439785|NCT00702234|1047495|P2|STARTED|Base Study (NCT00696878)||0
439786|NCT00702234|1047496|P1|STARTED|Base Study (NCT00696878)||682
439787|NCT00702221|1047507|P2|NOT COMPLETED|Overall Study||3
439788|NCT00702221|1047508|P1|NOT COMPLETED|Overall Study||4
439789|NCT00702221|1047507|P2|COMPLETED|Overall Study||7
439790|NCT00702221|1047508|P1|COMPLETED|Overall Study||6
439791|NCT00702221|1047507|P2|STARTED|Overall Study||10
439792|NCT00702221|1047508|P1|STARTED|Overall Study||10
439793|NCT00702208|1047514|P1|NOT COMPLETED|Overall Study||31
439794|NCT00702208|1047514|P1|COMPLETED|Overall Study||167
439795|NCT00702208|1047514|P1|STARTED|Overall Study||198
439796|NCT00702143|1047523|P3|NOT COMPLETED|Overall Study||1
439797|NCT00702143|1047524|P2|NOT COMPLETED|Overall Study||0
439798|NCT00702143|1047525|P1|NOT COMPLETED|Overall Study||0
439799|NCT00702143|1047523|P3|COMPLETED|Overall Study||78
439800|NCT00702143|1047524|P2|COMPLETED|Overall Study||60
439801|NCT00702143|1047525|P1|COMPLETED|Overall Study||45
439802|NCT00702143|1047523|P3|STARTED|Overall Study||79
439803|NCT00702143|1047524|P2|STARTED|Overall Study||60
439804|NCT00702143|1047525|P1|STARTED|Overall Study||45
439805|NCT00701935|1047539|P2|NOT COMPLETED|Overall Study||11
439806|NCT00701935|1047540|P1|NOT COMPLETED|Overall Study||16
439807|NCT00701935|1047539|P2|COMPLETED|Overall Study||26
439808|NCT00701935|1047540|P1|COMPLETED|Overall Study||27
439809|NCT00701935|1047539|P2|STARTED|Overall Study||37
439810|NCT00701935|1047540|P1|STARTED|Overall Study||43
439811|NCT00701805|1047574|P4|NOT COMPLETED|Overall Study||4
439813|NCT00701805|1047576|P2|NOT COMPLETED|Overall Study||4
439814|NCT00701805|1047577|P1|NOT COMPLETED|Overall Study||3
439815|NCT00701805|1047574|P4|COMPLETED|Overall Study||22
439816|NCT00701805|1047575|P3|COMPLETED|Overall Study||16
439817|NCT00701805|1047576|P2|COMPLETED|Overall Study||25
439818|NCT00701805|1047577|P1|COMPLETED|Overall Study||23
439819|NCT00701805|1047574|P4|STARTED|Overall Study||26
439820|NCT00701805|1047575|P3|STARTED|Overall Study||23
439821|NCT00701805|1047576|P2|STARTED|Overall Study||29
439822|NCT00701805|1047577|P1|STARTED|Overall Study||26
439823|NCT00701779|1047627|P1|NOT COMPLETED|Overall Study||9
439824|NCT00701779|1047627|P1|COMPLETED|Overall Study||54
439825|NCT00701779|1047627|P1|12 Month|Overall Study||54
439826|NCT00701779|1047627|P1|9 Month|Overall Study||56
439827|NCT00701779|1047627|P1|6 Month|Overall Study||58
439828|NCT00701779|1047627|P1|3 Month|Overall Study||60
439829|NCT00701779|1047627|P1|STARTED|Overall Study||63
439830|NCT00701727|1047636|P2|NOT COMPLETED|Second Treatment Period||0
439831|NCT00701727|1047637|P1|NOT COMPLETED|Second Treatment Period||2
439832|NCT00701727|1047636|P2|COMPLETED|Second Treatment Period||13
439833|NCT00701727|1047637|P1|COMPLETED|Second Treatment Period||13
439834|NCT00701727|1047636|P2|STARTED|Second Treatment Period||13
439835|NCT00701727|1047637|P1|STARTED|Second Treatment Period||15
439836|NCT00701727|1047636|P2|NOT COMPLETED|First Treatment Period||2
439837|NCT00701727|1047637|P1|NOT COMPLETED|First Treatment Period||1
439838|NCT00701727|1047636|P2|COMPLETED|First Treatment Period||13
439839|NCT00701727|1047637|P1|COMPLETED|First Treatment Period||15
439840|NCT00701727|1047636|P2|STARTED|First Treatment Period||15
439841|NCT00701727|1047637|P1|STARTED|First Treatment Period||16
439842|NCT00701675|1047658|P3|NOT COMPLETED|Overall Study||7
439843|NCT00701675|1047659|P2|NOT COMPLETED|Overall Study||8
439844|NCT00701675|1047660|P1|NOT COMPLETED|Overall Study||4
439845|NCT00701675|1047658|P3|COMPLETED|Overall Study||7
439846|NCT00701675|1047659|P2|COMPLETED|Overall Study||6
439847|NCT00701675|1047660|P1|COMPLETED|Overall Study||10
439848|NCT00701675|1047658|P3|STARTED|Overall Study||14
439849|NCT00701675|1047659|P2|STARTED|Overall Study||14
439850|NCT00701675|1047660|P1|STARTED|Overall Study||14
439851|NCT00701662|1047668|P1|NOT COMPLETED|Overall Study||1
439852|NCT00701662|1047668|P1|COMPLETED|Overall Study||7
439853|NCT00701662|1047668|P1|STARTED|Overall Study||8
439854|NCT00701636|1047687|P2|NOT COMPLETED|Overall Study||0
439855|NCT00701636|1047688|P1|NOT COMPLETED|Overall Study||0
439856|NCT00701636|1047687|P2|COMPLETED|Overall Study||15
439857|NCT00701636|1047688|P1|COMPLETED|Overall Study||15
439858|NCT00701636|1047687|P2|STARTED|Overall Study||15
439859|NCT00701636|1047688|P1|STARTED|Overall Study||15
439860|NCT00701558|1047693|P1|NOT COMPLETED|Overall Study||15
439861|NCT00701558|1047693|P1|COMPLETED|Overall Study||4
439862|NCT00701558|1047693|P1|STARTED|Overall Study||19
439863|NCT00701441|1047701|P2|NOT COMPLETED|Overall Study||4
439864|NCT00701441|1047702|P1|NOT COMPLETED|Overall Study||0
439865|NCT00701441|1047701|P2|COMPLETED|Overall Study||12
439866|NCT00701441|1047702|P1|COMPLETED|Overall Study||9
439867|NCT00701441|1047701|P2|STARTED|Overall Study||16
439868|NCT00701441|1047702|P1|STARTED|Overall Study||9
439869|NCT00701415|1047714|P2|NOT COMPLETED|Overall Study||1
439870|NCT00701415|1047715|P1|NOT COMPLETED|Overall Study||1
439871|NCT00701415|1047714|P2|COMPLETED|Overall Study||14
439872|NCT00701415|1047715|P1|COMPLETED|Overall Study||15
439873|NCT00701415|1047714|P2|STARTED|Overall Study||15
439874|NCT00701415|1047715|P1|STARTED|Overall Study||16
439875|NCT00701389|1047725|P4|NOT COMPLETED|Period 4||0
439876|NCT00701389|1047726|P3|NOT COMPLETED|Period 4||0
439877|NCT00701389|1047727|P2|NOT COMPLETED|Period 4||0
439878|NCT00701389|1047728|P1|NOT COMPLETED|Period 4||0
439879|NCT00701389|1047725|P4|COMPLETED|Period 4||6
439880|NCT00701389|1047726|P3|COMPLETED|Period 4||6
439881|NCT00701389|1047727|P2|COMPLETED|Period 4||6
439882|NCT00701389|1047728|P1|COMPLETED|Period 4||6
439883|NCT00701389|1047725|P4|STARTED|Period 4||6
439884|NCT00701389|1047726|P3|STARTED|Period 4||6
439885|NCT00701389|1047727|P2|STARTED|Period 4||6
439886|NCT00701389|1047728|P1|STARTED|Period 4||6
439887|NCT00701389|1047725|P4|NOT COMPLETED|Period 3||0
439888|NCT00701389|1047726|P3|NOT COMPLETED|Period 3||0
439889|NCT00701389|1047727|P2|NOT COMPLETED|Period 3||0
439890|NCT00701389|1047728|P1|NOT COMPLETED|Period 3||0
439891|NCT00701389|1047725|P4|COMPLETED|Period 3||6
439892|NCT00701389|1047726|P3|COMPLETED|Period 3||6
439893|NCT00701389|1047727|P2|COMPLETED|Period 3||6
439894|NCT00701389|1047728|P1|COMPLETED|Period 3||6
439895|NCT00701389|1047725|P4|STARTED|Period 3||6
439896|NCT00701389|1047726|P3|STARTED|Period 3||6
439897|NCT00701389|1047727|P2|STARTED|Period 3||6
439898|NCT00701389|1047728|P1|STARTED|Period 3||6
439899|NCT00701389|1047725|P4|NOT COMPLETED|Period 2||0
439900|NCT00701389|1047726|P3|NOT COMPLETED|Period 2||0
439901|NCT00701389|1047727|P2|NOT COMPLETED|Period 2||0
439902|NCT00701389|1047728|P1|NOT COMPLETED|Period 2||0
439903|NCT00701389|1047725|P4|COMPLETED|Period 2||6
439904|NCT00701389|1047726|P3|COMPLETED|Period 2||6
439905|NCT00701389|1047727|P2|COMPLETED|Period 2||6
439906|NCT00701389|1047728|P1|COMPLETED|Period 2||6
439907|NCT00701389|1047725|P4|STARTED|Period 2||6
439908|NCT00701389|1047726|P3|STARTED|Period 2||6
439909|NCT00701389|1047727|P2|STARTED|Period 2||6
439910|NCT00701389|1047728|P1|STARTED|Period 2||6
439911|NCT00701389|1047725|P4|NOT COMPLETED|Period 1||0
439912|NCT00701389|1047726|P3|NOT COMPLETED|Period 1||0
439913|NCT00701389|1047727|P2|NOT COMPLETED|Period 1||0
439914|NCT00701389|1047728|P1|NOT COMPLETED|Period 1||0
439915|NCT00701389|1047725|P4|COMPLETED|Period 1||6
439916|NCT00701389|1047726|P3|COMPLETED|Period 1||6
439917|NCT00701389|1047727|P2|COMPLETED|Period 1||6
439918|NCT00701389|1047728|P1|COMPLETED|Period 1||6
439919|NCT00701389|1047725|P4|STARTED|Period 1||6
439920|NCT00701389|1047726|P3|STARTED|Period 1||6
439921|NCT00701389|1047727|P2|STARTED|Period 1||6
439922|NCT00701389|1047728|P1|STARTED|Period 1||6
439923|NCT00701363|1047750|P4|NOT COMPLETED|Treatment Phase 2||0
439924|NCT00701363|1047751|P3|NOT COMPLETED|Treatment Phase 2||2
439925|NCT00701363|1047752|P2|NOT COMPLETED|Treatment Phase 2||0
439926|NCT00701363|1047753|P1|NOT COMPLETED|Treatment Phase 2||0
439927|NCT00701363|1047750|P4|COMPLETED|Treatment Phase 2||26
439928|NCT00701363|1047751|P3|COMPLETED|Treatment Phase 2||68
439929|NCT00701363|1047752|P2|COMPLETED|Treatment Phase 2||13
439930|NCT00701363|1047753|P1|COMPLETED|Treatment Phase 2||0
439931|NCT00701363|1047750|P4|STARTED|Treatment Phase 2||26
439932|NCT00701363|1047751|P3|STARTED|Treatment Phase 2||70
439933|NCT00701363|1047752|P2|STARTED|Treatment Phase 2||13
439934|NCT00701363|1047753|P1|STARTED|Treatment Phase 2||0
439935|NCT00701363|1047750|P4|NOT COMPLETED|Treatment Phase 1||0
439936|NCT00701363|1047751|P3|NOT COMPLETED|Treatment Phase 1||0
439937|NCT00701363|1047752|P2|NOT COMPLETED|Treatment Phase 1||0
439938|NCT00701363|1047753|P1|NOT COMPLETED|Treatment Phase 1||15
439939|NCT00701363|1047750|P4|COMPLETED|Treatment Phase 1||0
439940|NCT00701363|1047751|P3|COMPLETED|Treatment Phase 1||0
439941|NCT00701363|1047752|P2|COMPLETED|Treatment Phase 1||0
439942|NCT00701363|1047753|P1|COMPLETED|Treatment Phase 1||109
439943|NCT00701363|1047750|P4|STARTED|Treatment Phase 1||0
439944|NCT00701363|1047751|P3|STARTED|Treatment Phase 1||0
439945|NCT00701363|1047752|P2|STARTED|Treatment Phase 1||0
439946|NCT00701363|1047753|P1|STARTED|Treatment Phase 1||124
439947|NCT00701363|1047750|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
439948|NCT00701363|1047751|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
439949|NCT00701363|1047752|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
439950|NCT00701363|1047753|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
439951|NCT00701363|1047750|P4|COMPLETED|Screening (Pre-assignment) Phase||0
439952|NCT00701363|1047751|P3|COMPLETED|Screening (Pre-assignment) Phase||0
439953|NCT00701363|1047752|P2|COMPLETED|Screening (Pre-assignment) Phase||0
439954|NCT00701363|1047753|P1|COMPLETED|Screening (Pre-assignment) Phase||124
439955|NCT00701363|1047750|P4|STARTED|Screening (Pre-assignment) Phase||0
439956|NCT00701363|1047751|P3|STARTED|Screening (Pre-assignment) Phase||0
439957|NCT00701363|1047752|P2|STARTED|Screening (Pre-assignment) Phase||0
439958|NCT00701363|1047753|P1|STARTED|Screening (Pre-assignment) Phase||128
439959|NCT00701311|1047793|P1|NOT COMPLETED|Overall Study||8
439960|NCT00701311|1047793|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
439961|NCT00701311|1047793|P1|STARTED|Overall Study||17
439962|NCT00701129|1047797|P1|NOT COMPLETED|Overall Study||2
439963|NCT00701129|1047797|P1|COMPLETED|Overall Study||2
439964|NCT00701129|1047797|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
439965|NCT00701129|1047797|P1|STARTED|Overall Study||4
439966|NCT00701103|1047819|P11|NOT COMPLETED|Overall Study||11
439967|NCT00701103|1047820|P10|NOT COMPLETED|Overall Study||11
439968|NCT00701103|1047821|P9|NOT COMPLETED|Overall Study||9
439969|NCT00701103|1047822|P8|NOT COMPLETED|Overall Study||7
439970|NCT00701103|1047823|P7|NOT COMPLETED|Overall Study||8
439971|NCT00701103|1047824|P6|NOT COMPLETED|Overall Study||6
439972|NCT00701103|1047825|P5|NOT COMPLETED|Overall Study||6
439973|NCT00701103|1047826|P4|NOT COMPLETED|Overall Study||6
439974|NCT00701103|1047827|P3|NOT COMPLETED|Overall Study||8
439975|NCT00701103|1047828|P2|NOT COMPLETED|Overall Study||3
439976|NCT00701103|1047829|P1|NOT COMPLETED|Overall Study||5
439977|NCT00701103|1047819|P11|COMPLETED|Overall Study||0
439978|NCT00701103|1047820|P10|COMPLETED|Overall Study||0
439979|NCT00701103|1047821|P9|COMPLETED|Overall Study||0
439980|NCT00701103|1047822|P8|COMPLETED|Overall Study||0
439981|NCT00701103|1047823|P7|COMPLETED|Overall Study||0
439982|NCT00701103|1047824|P6|COMPLETED|Overall Study||0
439983|NCT00701103|1047825|P5|COMPLETED|Overall Study||0
439984|NCT00701103|1047826|P4|COMPLETED|Overall Study||0
439985|NCT00701103|1047827|P3|COMPLETED|Overall Study||0
439986|NCT00701103|1047828|P2|COMPLETED|Overall Study||0
439987|NCT00701103|1047829|P1|COMPLETED|Overall Study||0
439988|NCT00701103|1047819|P11|STARTED|Overall Study||11
439989|NCT00701103|1047820|P10|STARTED|Overall Study||11
439990|NCT00701103|1047821|P9|STARTED|Overall Study||9
439991|NCT00701103|1047822|P8|STARTED|Overall Study||7
439992|NCT00701103|1047823|P7|STARTED|Overall Study||8
439993|NCT00701103|1047824|P6|STARTED|Overall Study||6
439994|NCT00701103|1047825|P5|STARTED|Overall Study||6
439995|NCT00701103|1047826|P4|STARTED|Overall Study||6
439996|NCT00701103|1047827|P3|STARTED|Overall Study||8
439997|NCT00701103|1047828|P2|STARTED|Overall Study||3
439998|NCT00701103|1047829|P1|STARTED|Overall Study||5
439999|NCT00701090|1047935|P2|NOT COMPLETED|Overall Study||51
440000|NCT00701090|1047936|P1|NOT COMPLETED|Overall Study||48
440001|NCT00701090|1047935|P2|COMPLETED|Overall Study||468
440002|NCT00701090|1047936|P1|COMPLETED|Overall Study||468
440003|NCT00701090|1047935|P2|STARTED|Overall Study||519
440004|NCT00701090|1047936|P1|STARTED|Overall Study||516
440005|NCT00701064|1047954|P2|NOT COMPLETED|Overall Study||4
440006|NCT00701064|1047955|P1|NOT COMPLETED|Overall Study||4
440007|NCT00701064|1047954|P2|COMPLETED|Overall Study||32
440008|NCT00701064|1047955|P1|COMPLETED|Overall Study||31
440009|NCT00701064|1047954|P2|STARTED|Overall Study||36
440010|NCT00701064|1047955|P1|STARTED|Overall Study||35
440011|NCT00701051|1047963|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
440012|NCT00701051|1047964|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
440013|NCT00701051|1047965|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
440014|NCT00701051|1047963|P3|COMPLETED|Detraining Intervention (Optional)||6
440015|NCT00701051|1047964|P2|COMPLETED|Detraining Intervention (Optional)||6
440016|NCT00701051|1047965|P1|COMPLETED|Detraining Intervention (Optional)||0
440017|NCT00701051|1047963|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
440018|NCT00701051|1047964|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
440019|NCT00701051|1047965|P1|STARTED|Detraining Intervention (Optional)||0
440020|NCT00701051|1047963|P3|NOT COMPLETED|Exercise Intervention||3
440021|NCT00701051|1047964|P2|NOT COMPLETED|Exercise Intervention||5
440022|NCT00701051|1047965|P1|NOT COMPLETED|Exercise Intervention||0
440023|NCT00701051|1047963|P3|COMPLETED|Exercise Intervention||9
440024|NCT00701051|1047964|P2|COMPLETED|Exercise Intervention||14
440025|NCT00701051|1047965|P1|COMPLETED|Exercise Intervention||0
440026|NCT00701051|1047963|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
440027|NCT00701051|1047964|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
440028|NCT00701051|1047965|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
440029|NCT00701051|1047963|P3|NOT COMPLETED|Screening||0
440030|NCT00701051|1047964|P2|NOT COMPLETED|Screening||0
440031|NCT00701051|1047965|P1|NOT COMPLETED|Screening||59
440032|NCT00701051|1047963|P3|COMPLETED|Screening||0
440033|NCT00701051|1047964|P2|COMPLETED|Screening||0
440034|NCT00701051|1047965|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
440035|NCT00701051|1047963|P3|STARTED|Screening||0
440036|NCT00701051|1047964|P2|STARTED|Screening||0
440037|NCT00701051|1047965|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
440038|NCT00701038|1047983|P2|NOT COMPLETED|Overall Study||4
440039|NCT00701038|1047984|P1|NOT COMPLETED|Overall Study||4
440040|NCT00701038|1047983|P2|COMPLETED|Overall Study||23
440041|NCT00701038|1047984|P1|COMPLETED|Overall Study||23
440042|NCT00701038|1047983|P2|STARTED|Overall Study||27
440043|NCT00701038|1047984|P1|STARTED|Overall Study||27
440044|NCT00700999|1047992|P2|NOT COMPLETED|Overall Study||9
440045|NCT00700999|1047993|P1|NOT COMPLETED|Overall Study||15
440046|NCT00700999|1047992|P2|COMPLETED|Overall Study||20
440047|NCT00700999|1047993|P1|COMPLETED|Overall Study||21
440048|NCT00700999|1047992|P2|Second MRI Scan|Overall Study||18
440049|NCT00700999|1047993|P1|Second MRI Scan|Overall Study||19
440050|NCT00700999|1047992|P2|First MRI Scan|Overall Study||22
440051|NCT00700999|1047993|P1|First MRI Scan|Overall Study||29
440052|NCT00700999|1047992|P2|STARTED|Overall Study||29
440053|NCT00700999|1047993|P1|STARTED|Overall Study||36
440054|NCT00700973|1048001|P2|NOT COMPLETED|Overall Study||7
440055|NCT00700973|1048002|P1|NOT COMPLETED|Overall Study||8
440056|NCT00700973|1048001|P2|COMPLETED|Overall Study||63
440057|NCT00700973|1048002|P1|COMPLETED|Overall Study||63
440058|NCT00700973|1048001|P2|STARTED|Overall Study||70
440059|NCT00700973|1048002|P1|STARTED|Overall Study||71
440060|NCT00700817|1048013|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
440061|NCT00700817|1048014|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
440062|NCT00700817|1048015|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
440063|NCT00700817|1048016|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
440064|NCT00700817|1048017|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
440065|NCT00700817|1048013|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
440066|NCT00700817|1048014|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
440067|NCT00700817|1048015|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
440068|NCT00700817|1048016|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
440069|NCT00700817|1048017|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
440070|NCT00700817|1048013|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
440071|NCT00700817|1048014|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
440072|NCT00700817|1048015|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
440073|NCT00700817|1048016|P2|STARTED|Week 52-78 (Extension Period 2)||150
440074|NCT00700817|1048017|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
440075|NCT00700817|1048013|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
440076|NCT00700817|1048014|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
440077|NCT00700817|1048015|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
440078|NCT00700817|1048016|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
440079|NCT00700817|1048017|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
440080|NCT00700817|1048013|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
440081|NCT00700817|1048014|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
440082|NCT00700817|1048015|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
440083|NCT00700817|1048016|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
440084|NCT00700817|1048017|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
440085|NCT00700817|1048013|P5|STARTED|Week 26-52 (Extension Period 1)||0
440086|NCT00700817|1048014|P4|STARTED|Week 26-52 (Extension Period 1)||0
440087|NCT00700817|1048015|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
440088|NCT00700817|1048016|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
440089|NCT00700817|1048017|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
440090|NCT00700817|1048013|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
440091|NCT00700817|1048014|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
440092|NCT00700817|1048015|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
440093|NCT00700817|1048016|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
440094|NCT00700817|1048017|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
440095|NCT00700817|1048013|P5|COMPLETED|Week 0-26 (Main Period)||0
440096|NCT00700817|1048014|P4|COMPLETED|Week 0-26 (Main Period)||0
440097|NCT00700817|1048015|P3|COMPLETED|Week 0-26 (Main Period)||194
440098|NCT00700817|1048016|P2|COMPLETED|Week 0-26 (Main Period)||191
440099|NCT00700817|1048017|P1|COMPLETED|Week 0-26 (Main Period)||169
440100|NCT00700817|1048013|P5|Exposed|Week 0-26 (Main Period)||0
440101|NCT00700817|1048014|P4|Exposed|Week 0-26 (Main Period)||0
440102|NCT00700817|1048015|P3|Exposed|Week 0-26 (Main Period)||219
440103|NCT00700817|1048016|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
440104|NCT00700817|1048017|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
440105|NCT00700817|1048013|P5|STARTED|Week 0-26 (Main Period)||0
440106|NCT00700817|1048014|P4|STARTED|Week 0-26 (Main Period)||0
440107|NCT00700817|1048015|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
440108|NCT00700817|1048016|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
440109|NCT00700817|1048017|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
440110|NCT00700804|1048399|P2|NOT COMPLETED|Overall Study||4
440111|NCT00700804|1048400|P1|NOT COMPLETED|Overall Study||3
440112|NCT00700804|1048399|P2|COMPLETED|Overall Study||13
440113|NCT00700804|1048400|P1|COMPLETED|Overall Study||14
440114|NCT00700804|1048399|P2|STARTED|Overall Study||17
440115|NCT00700804|1048400|P1|STARTED|Overall Study||17
440116|NCT00700752|1048408|P2|NOT COMPLETED|Second Intervention||0
440117|NCT00700752|1048409|P1|NOT COMPLETED|Second Intervention||0
440118|NCT00700752|1048408|P2|COMPLETED|Second Intervention||18
440119|NCT00700752|1048409|P1|COMPLETED|Second Intervention||20
440120|NCT00700752|1048408|P2|STARTED|Second Intervention||18
440121|NCT00700752|1048409|P1|STARTED|Second Intervention||20
440122|NCT00700752|1048408|P2|NOT COMPLETED|First Intervention||2
440123|NCT00700752|1048409|P1|NOT COMPLETED|First Intervention||0
440124|NCT00700752|1048408|P2|COMPLETED|First Intervention||18
440125|NCT00700752|1048409|P1|COMPLETED|First Intervention||20
440126|NCT00700752|1048408|P2|STARTED|First Intervention||20
440127|NCT00700752|1048409|P1|STARTED|First Intervention||20
440128|NCT00700739|1048417|P2|NOT COMPLETED|Overall Study||4
440129|NCT00700739|1048418|P1|NOT COMPLETED|Overall Study||4
440130|NCT00700739|1048417|P2|COMPLETED|Overall Study||12
440131|NCT00700739|1048418|P1|COMPLETED|Overall Study||18
440132|NCT00700739|1048417|P2|STARTED|Overall Study||16
440133|NCT00700739|1048418|P1|STARTED|Overall Study||22
440134|NCT00700713|1048457|P3|NOT COMPLETED|Overall Study||2
440135|NCT00700713|1048458|P2|NOT COMPLETED|Overall Study||0
440136|NCT00700713|1048459|P1|NOT COMPLETED|Overall Study||1
440137|NCT00700713|1048457|P3|COMPLETED|Overall Study||65
440138|NCT00700713|1048458|P2|COMPLETED|Overall Study||66
440139|NCT00700713|1048459|P1|COMPLETED|Overall Study||47
440140|NCT00700713|1048457|P3|STARTED|Overall Study||67
440141|NCT00700713|1048458|P2|STARTED|Overall Study||66
440142|NCT00700713|1048459|P1|STARTED|Overall Study||48
440143|NCT00700635|1048476|P3|NOT COMPLETED|Overall Study||1
440144|NCT00700635|1048477|P2|NOT COMPLETED|Overall Study||8
440145|NCT00700635|1048478|P1|NOT COMPLETED|Overall Study||11
440146|NCT00700635|1048476|P3|COMPLETED|Overall Study||110
440147|NCT00700635|1048477|P2|COMPLETED|Overall Study||103
440148|NCT00700635|1048478|P1|COMPLETED|Overall Study||100
440149|NCT00700635|1048476|P3|STARTED|Overall Study||111
440150|NCT00700635|1048477|P2|STARTED|Overall Study||111
440151|NCT00700635|1048478|P1|STARTED|Overall Study||111
440152|NCT00700622|1048500|P2|NOT COMPLETED|Overall Study||5
440153|NCT00700622|1048501|P1|NOT COMPLETED|Overall Study||13
440154|NCT00700622|1048500|P2|COMPLETED|Overall Study||60
440155|NCT00700622|1048501|P1|COMPLETED|Overall Study||52
440156|NCT00700622|1048500|P2|STARTED|Overall Study||65
440157|NCT00700622|1048501|P1|STARTED|Overall Study||65
440158|NCT00700570|1048509|P2|NOT COMPLETED|Overall Study||26
440159|NCT00700570|1048510|P1|NOT COMPLETED|Overall Study||11
440160|NCT00700570|1048509|P2|COMPLETED|Overall Study||0
440161|NCT00700570|1048510|P1|COMPLETED|Overall Study||8
440162|NCT00700570|1048509|P2|STARTED|Overall Study||26
440163|NCT00700570|1048510|P1|STARTED|Overall Study||19
440164|NCT00700440|1048522|P1|NOT COMPLETED|Overall Study||0
440165|NCT00700440|1048522|P1|COMPLETED|Overall Study||100
440166|NCT00700440|1048522|P1|STARTED|Overall Study||100
440167|NCT00700427|1048526|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
440168|NCT00700427|1048527|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
440169|NCT00700427|1048528|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
440170|NCT00700427|1048529|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
440171|NCT00700427|1048530|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
440172|NCT00700427|1048526|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
440173|NCT00700427|1048527|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
440174|NCT00700427|1048528|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
440175|NCT00700427|1048529|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
440176|NCT00700427|1048530|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
440177|NCT00700427|1048526|P5|STARTED|Study Period 4 (Open-Label Extension)||180
440178|NCT00700427|1048527|P4|STARTED|Study Period 4 (Open-Label Extension)||0
440179|NCT00700427|1048528|P3|STARTED|Study Period 4 (Open-Label Extension)||0
440180|NCT00700427|1048529|P2|STARTED|Study Period 4 (Open-Label Extension)||0
440181|NCT00700427|1048530|P1|STARTED|Study Period 4 (Open-Label Extension)||0
440182|NCT00700427|1048526|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
440183|NCT00700427|1048527|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
440184|NCT00700427|1048528|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
440185|NCT00700427|1048529|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
440186|NCT00700427|1048530|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
440187|NCT00700427|1048526|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
440188|NCT00700427|1048527|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
440189|NCT00700427|1048528|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
440190|NCT00700427|1048529|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
440191|NCT00700427|1048530|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
440192|NCT00700427|1048526|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
440193|NCT00700427|1048527|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
440194|NCT00700427|1048528|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
440195|NCT00700427|1048529|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
440196|NCT00700427|1048530|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
440197|NCT00700427|1048526|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
440198|NCT00700427|1048527|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
440199|NCT00700427|1048528|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
440200|NCT00700427|1048529|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
440201|NCT00700427|1048530|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
440202|NCT00700427|1048526|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
440203|NCT00700427|1048527|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
440204|NCT00700427|1048528|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
440205|NCT00700427|1048529|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
440206|NCT00700427|1048530|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
440207|NCT00700427|1048526|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
440208|NCT00700427|1048527|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
440209|NCT00700427|1048528|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
440210|NCT00700427|1048529|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
440211|NCT00700427|1048530|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
440212|NCT00700427|1048526|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440213|NCT00700427|1048527|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440214|NCT00700427|1048528|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440215|NCT00700427|1048529|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440216|NCT00700427|1048530|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
440217|NCT00700427|1048526|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440218|NCT00700427|1048527|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440219|NCT00700427|1048528|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440220|NCT00700427|1048529|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
440221|NCT00700427|1048530|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
440222|NCT00700427|1048526|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
440223|NCT00700427|1048527|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
440224|NCT00700427|1048528|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
440225|NCT00700427|1048529|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
440226|NCT00700427|1048530|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
440227|NCT00700427|1048526|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
440228|NCT00700427|1048527|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
440229|NCT00700427|1048528|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
440230|NCT00700427|1048529|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
440231|NCT00700427|1048530|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
440232|NCT00700401|1048552|P1|NOT COMPLETED|Overall Study||94
440233|NCT00700401|1048552|P1|COMPLETED|Overall Study||168
440234|NCT00700401|1048552|P1|STARTED|Overall Study||262
440235|NCT00700375|1048565|P2|NOT COMPLETED|Overall Study||0
440236|NCT00700375|1048566|P1|NOT COMPLETED|Overall Study||0
440237|NCT00700375|1048565|P2|COMPLETED|Overall Study||29
440238|NCT00700375|1048566|P1|COMPLETED|Overall Study||30
440239|NCT00700375|1048565|P2|2 Days After Creatinine Mesurement|Overall Study||29
440240|NCT00700375|1048566|P1|2 Days After Creatinine Mesurement|Overall Study||30
440241|NCT00700375|1048565|P2|STARTED|Overall Study||29
440242|NCT00700375|1048566|P1|STARTED|Overall Study||30
440243|NCT00700310|1048576|P4|NOT COMPLETED|Overall Study||26
440244|NCT00700310|1048577|P3|NOT COMPLETED|Overall Study||16
440245|NCT00700310|1048578|P2|NOT COMPLETED|Overall Study||26
440246|NCT00700310|1048579|P1|NOT COMPLETED|Overall Study||21
440247|NCT00700310|1048576|P4|COMPLETED|Overall Study||145
440248|NCT00700310|1048577|P3|COMPLETED|Overall Study||158
440249|NCT00700310|1048578|P2|COMPLETED|Overall Study||154
440250|NCT00700310|1048579|P1|COMPLETED|Overall Study||166
440251|NCT00700310|1048576|P4|STARTED|Overall Study||171
440252|NCT00700310|1048577|P3|STARTED|Overall Study||174
440253|NCT00700310|1048578|P2|STARTED|Overall Study||180
440254|NCT00700310|1048579|P1|STARTED|Overall Study||187
440255|NCT00700271|1048599|P2|NOT COMPLETED|Overall Study||12
440256|NCT00700271|1048600|P1|NOT COMPLETED|Overall Study||14
440257|NCT00700271|1048599|P2|COMPLETED|Overall Study||256
440258|NCT00700271|1048600|P1|COMPLETED|Overall Study||264
440259|NCT00700271|1048599|P2|STARTED|Overall Study||268
440260|NCT00700271|1048600|P1|STARTED|Overall Study||278
440261|NCT00700180|1048628|P2|NOT COMPLETED|Overall Study||149
440262|NCT00700180|1048629|P1|NOT COMPLETED|Overall Study||154
440263|NCT00700180|1048628|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
440264|NCT00700180|1048629|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
440265|NCT00700180|1048628|P2|STARTED|Overall Study||149
440266|NCT00700180|1048629|P1|STARTED|Overall Study||154
440267|NCT00700141|1048651|P1|NOT COMPLETED|Overall Study||0
440268|NCT00700141|1048651|P1|COMPLETED|Overall Study||482
440269|NCT00700141|1048651|P1|STARTED|Overall Study||482
440270|NCT00700115|1048658|P2|NOT COMPLETED|Overall Study||1
440271|NCT00700115|1048659|P1|NOT COMPLETED|Overall Study||1
440272|NCT00700115|1048658|P2|COMPLETED|Overall Study||19
440273|NCT00700115|1048659|P1|COMPLETED|Overall Study||39
440274|NCT00700115|1048658|P2|STARTED|Overall Study||20
440275|NCT00700115|1048659|P1|STARTED|Overall Study||40
440276|NCT00700102|1048669|P2|NOT COMPLETED|Overall Study||395
440277|NCT00700102|1048670|P1|NOT COMPLETED|Overall Study||402
440278|NCT00700102|1048669|P2|COMPLETED|Overall Study||14
440279|NCT00700102|1048670|P1|COMPLETED|Overall Study||9
440280|NCT00700102|1048669|P2|Received at Least One Dose|Overall Study||403
440281|NCT00700102|1048670|P1|Received at Least One Dose|Overall Study||407
440282|NCT00700102|1048669|P2|Intention to Treat|Overall Study||409
440283|NCT00700102|1048670|P1|Intention to Treat|Overall Study||410
440284|NCT00700102|1048669|P2|STARTED|Overall Study||409
440285|NCT00700102|1048670|P1|STARTED|Overall Study||411
440286|NCT00700063|1048694|P8|NOT COMPLETED|Overall Study||0
440287|NCT00700063|1048695|P7|NOT COMPLETED|Overall Study||0
440288|NCT00700063|1048696|P6|NOT COMPLETED|Overall Study||0
440289|NCT00700063|1048697|P5|NOT COMPLETED|Overall Study||2
440290|NCT00700063|1048698|P4|NOT COMPLETED|Overall Study||2
440291|NCT00700063|1048699|P3|NOT COMPLETED|Overall Study||0
440292|NCT00700063|1048700|P2|NOT COMPLETED|Overall Study||0
440293|NCT00700063|1048701|P1|NOT COMPLETED|Overall Study||1
440294|NCT00700063|1048694|P8|COMPLETED|Overall Study||33
440295|NCT00700063|1048695|P7|COMPLETED|Overall Study||32
440296|NCT00700063|1048696|P6|COMPLETED|Overall Study||34
440297|NCT00700063|1048697|P5|COMPLETED|Overall Study||31
440298|NCT00700063|1048698|P4|COMPLETED|Overall Study||31
440299|NCT00700063|1048699|P3|COMPLETED|Overall Study||33
440300|NCT00700063|1048700|P2|COMPLETED|Overall Study||34
440301|NCT00700063|1048701|P1|COMPLETED|Overall Study||32
440302|NCT00700063|1048694|P8|STARTED|Overall Study||33
440303|NCT00700063|1048695|P7|STARTED|Overall Study||32
440304|NCT00700063|1048696|P6|STARTED|Overall Study||34
440305|NCT00700063|1048697|P5|STARTED|Overall Study||33
440306|NCT00700063|1048698|P4|STARTED|Overall Study||33
440307|NCT00700063|1048699|P3|STARTED|Overall Study||33
440308|NCT00700063|1048700|P2|STARTED|Overall Study||34
440309|NCT00700063|1048701|P1|STARTED|Overall Study||33
440310|NCT00700011|1048809|P2|NOT COMPLETED|Overall Study||1
440311|NCT00700011|1048810|P1|NOT COMPLETED|Overall Study||0
440312|NCT00700011|1048809|P2|COMPLETED|Overall Study||1
440313|NCT00700011|1048810|P1|COMPLETED|Overall Study||8
440314|NCT00700011|1048809|P2|STARTED|Overall Study||2
440315|NCT00700011|1048810|P1|STARTED|Overall Study||8
440316|NCT00699998|1048826|P4|NOT COMPLETED|Overall Study||82
440317|NCT00699998|1048827|P3|NOT COMPLETED|Overall Study||206
440318|NCT00699998|1048828|P2|NOT COMPLETED|Overall Study||86
440319|NCT00699998|1048829|P1|NOT COMPLETED|Overall Study||199
440320|NCT00699998|1048826|P4|COMPLETED|Overall Study||958
440321|NCT00699998|1048827|P3|COMPLETED|Overall Study||3417
440322|NCT00699998|1048828|P2|COMPLETED|Overall Study||957
440323|NCT00699998|1048829|P1|COMPLETED|Overall Study||3421
440324|NCT00699998|1048826|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
440325|NCT00699998|1048827|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
440326|NCT00699998|1048828|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
440327|NCT00699998|1048829|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
440328|NCT00699998|1048826|P4|STARTED|Overall Study||1040
440329|NCT00699998|1048827|P3|STARTED|Overall Study||3623
440330|NCT00699998|1048828|P2|STARTED|Overall Study||1043
440331|NCT00699998|1048829|P1|STARTED|Overall Study||3620
440332|NCT00699972|1048874|P3|NOT COMPLETED|Overall Study||35
440333|NCT00699972|1048875|P2|NOT COMPLETED|Overall Study||19
440334|NCT00699972|1048876|P1|NOT COMPLETED|Overall Study||16
440335|NCT00699972|1048874|P3|COMPLETED|Overall Study||100
440336|NCT00699972|1048875|P2|COMPLETED|Overall Study||114
440337|NCT00699972|1048876|P1|COMPLETED|Overall Study||106
440338|NCT00699972|1048874|P3|STARTED|Overall Study||135
440339|NCT00699972|1048875|P2|STARTED|Overall Study||133
440340|NCT00699972|1048876|P1|STARTED|Overall Study||122
440341|NCT00699842|1048893|P3|NOT COMPLETED|Overall Study||0
440342|NCT00699842|1048894|P2|NOT COMPLETED|Overall Study||1
440343|NCT00699842|1048895|P1|NOT COMPLETED|Overall Study||0
440344|NCT00699842|1048893|P3|COMPLETED|Overall Study||0
440345|NCT00699842|1048894|P2|COMPLETED|Overall Study||4
440346|NCT00699842|1048895|P1|COMPLETED|Overall Study||3
440347|NCT00699842|1048893|P3|STARTED|Overall Study||0
440348|NCT00699842|1048894|P2|STARTED|Overall Study||5
440349|NCT00699842|1048895|P1|STARTED|Overall Study||3
440350|NCT00699816|1048908|P2|NOT COMPLETED|Overall Study||3
440351|NCT00699816|1048909|P1|NOT COMPLETED|Overall Study||1
440352|NCT00699816|1048908|P2|COMPLETED|Overall Study||112
440353|NCT00699816|1048909|P1|COMPLETED|Overall Study||114
440354|NCT00699816|1048908|P2|STARTED|Overall Study||115
440355|NCT00699816|1048909|P1|STARTED|Overall Study||115
440356|NCT00699751|1048927|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
440357|NCT00699751|1048928|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
440358|NCT00699751|1048927|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
440359|NCT00699751|1048928|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
440438|NCT00699608|1049036|P5|STARTED|Second Intervention||14
440360|NCT00699751|1048927|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
440361|NCT00699751|1048928|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
440362|NCT00699751|1048927|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
440363|NCT00699751|1048928|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
440364|NCT00699751|1048927|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
440365|NCT00699751|1048928|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
440366|NCT00699751|1048927|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
440367|NCT00699751|1048928|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
440368|NCT00699751|1048927|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
440369|NCT00699751|1048928|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
440370|NCT00699751|1048927|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
440371|NCT00699751|1048928|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
440372|NCT00699751|1048927|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
440373|NCT00699751|1048928|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
440374|NCT00699751|1048927|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
440375|NCT00699751|1048928|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
440376|NCT00699751|1048927|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
440377|NCT00699751|1048928|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
440378|NCT00699751|1048927|P2|STARTED|Period 1: Without/Before Drug Switch||307
440379|NCT00699751|1048928|P1|STARTED|Period 1: Without/Before Drug Switch||614
440380|NCT00699699|1049013|P1|NOT COMPLETED|Overall Study||57
440381|NCT00699699|1049013|P1|COMPLETED|Overall Study||1223
440382|NCT00699699|1049013|P1|STARTED|Overall Study||1280
440383|NCT00699660|1049022|P2|NOT COMPLETED|Overall Study||8
440384|NCT00699660|1049023|P1|NOT COMPLETED|Overall Study||14
440385|NCT00699660|1049022|P2|COMPLETED|Overall Study||208
440386|NCT00699660|1049023|P1|COMPLETED|Overall Study||176
440387|NCT00699660|1049022|P2|STARTED|Overall Study||216
440388|NCT00699660|1049023|P1|STARTED|Overall Study||190
440389|NCT00699608|1049035|P6|NOT COMPLETED|Third Intervention||0
440390|NCT00699608|1049036|P5|NOT COMPLETED|Third Intervention||0
440391|NCT00699608|1049037|P4|NOT COMPLETED|Third Intervention||0
440392|NCT00699608|1049038|P3|NOT COMPLETED|Third Intervention||0
440393|NCT00699608|1049039|P2|NOT COMPLETED|Third Intervention||0
440394|NCT00699608|1049040|P1|NOT COMPLETED|Third Intervention||0
440395|NCT00699608|1049035|P6|COMPLETED|Third Intervention||15
440396|NCT00699608|1049036|P5|COMPLETED|Third Intervention||14
440397|NCT00699608|1049037|P4|COMPLETED|Third Intervention||14
440398|NCT00699608|1049038|P3|COMPLETED|Third Intervention||13
440399|NCT00699608|1049039|P2|COMPLETED|Third Intervention||15
440400|NCT00699608|1049040|P1|COMPLETED|Third Intervention||16
440401|NCT00699608|1049035|P6|STARTED|Third Intervention||15
440402|NCT00699608|1049036|P5|STARTED|Third Intervention||14
440403|NCT00699608|1049037|P4|STARTED|Third Intervention||14
440404|NCT00699608|1049038|P3|STARTED|Third Intervention||13
440405|NCT00699608|1049039|P2|STARTED|Third Intervention||15
440406|NCT00699608|1049040|P1|STARTED|Third Intervention||16
440407|NCT00699608|1049035|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
440408|NCT00699608|1049036|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
440409|NCT00699608|1049037|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
440410|NCT00699608|1049038|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
440411|NCT00699608|1049039|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
440412|NCT00699608|1049040|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
440413|NCT00699608|1049035|P6|COMPLETED|Second 4-14 Day Washout Period||15
440414|NCT00699608|1049036|P5|COMPLETED|Second 4-14 Day Washout Period||14
440415|NCT00699608|1049037|P4|COMPLETED|Second 4-14 Day Washout Period||14
440416|NCT00699608|1049038|P3|COMPLETED|Second 4-14 Day Washout Period||13
440417|NCT00699608|1049039|P2|COMPLETED|Second 4-14 Day Washout Period||15
440418|NCT00699608|1049040|P1|COMPLETED|Second 4-14 Day Washout Period||16
440419|NCT00699608|1049035|P6|STARTED|Second 4-14 Day Washout Period||15
440420|NCT00699608|1049036|P5|STARTED|Second 4-14 Day Washout Period||14
440421|NCT00699608|1049037|P4|STARTED|Second 4-14 Day Washout Period||14
440422|NCT00699608|1049038|P3|STARTED|Second 4-14 Day Washout Period||13
440423|NCT00699608|1049039|P2|STARTED|Second 4-14 Day Washout Period||15
440424|NCT00699608|1049040|P1|STARTED|Second 4-14 Day Washout Period||16
440425|NCT00699608|1049035|P6|NOT COMPLETED|Second Intervention||0
440426|NCT00699608|1049036|P5|NOT COMPLETED|Second Intervention||0
440427|NCT00699608|1049037|P4|NOT COMPLETED|Second Intervention||1
440428|NCT00699608|1049038|P3|NOT COMPLETED|Second Intervention||1
440429|NCT00699608|1049039|P2|NOT COMPLETED|Second Intervention||0
440430|NCT00699608|1049040|P1|NOT COMPLETED|Second Intervention||0
440431|NCT00699608|1049035|P6|COMPLETED|Second Intervention||15
440432|NCT00699608|1049036|P5|COMPLETED|Second Intervention||14
440433|NCT00699608|1049037|P4|COMPLETED|Second Intervention||14
440434|NCT00699608|1049038|P3|COMPLETED|Second Intervention||13
440435|NCT00699608|1049039|P2|COMPLETED|Second Intervention||15
440436|NCT00699608|1049040|P1|COMPLETED|Second Intervention||16
440437|NCT00699608|1049035|P6|STARTED|Second Intervention||15
440439|NCT00699608|1049037|P4|STARTED|Second Intervention||15
440440|NCT00699608|1049038|P3|STARTED|Second Intervention||14
440441|NCT00699608|1049039|P2|STARTED|Second Intervention||15
440442|NCT00699608|1049040|P1|STARTED|Second Intervention||16
440443|NCT00699608|1049035|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
440444|NCT00699608|1049036|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
440445|NCT00699608|1049037|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
440446|NCT00699608|1049038|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
440447|NCT00699608|1049039|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
440448|NCT00699608|1049040|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
440449|NCT00699608|1049035|P6|COMPLETED|First 4-14 Day Washout Period||15
440450|NCT00699608|1049036|P5|COMPLETED|First 4-14 Day Washout Period||14
440451|NCT00699608|1049037|P4|COMPLETED|First 4-14 Day Washout Period||15
440452|NCT00699608|1049038|P3|COMPLETED|First 4-14 Day Washout Period||14
440453|NCT00699608|1049039|P2|COMPLETED|First 4-14 Day Washout Period||15
440454|NCT00699608|1049040|P1|COMPLETED|First 4-14 Day Washout Period||16
440455|NCT00699608|1049035|P6|STARTED|First 4-14 Day Washout Period||15
440456|NCT00699608|1049036|P5|STARTED|First 4-14 Day Washout Period||14
440457|NCT00699608|1049037|P4|STARTED|First 4-14 Day Washout Period||15
440458|NCT00699608|1049038|P3|STARTED|First 4-14 Day Washout Period||14
440459|NCT00699608|1049039|P2|STARTED|First 4-14 Day Washout Period||15
440460|NCT00699608|1049040|P1|STARTED|First 4-14 Day Washout Period||16
440461|NCT00699608|1049035|P6|NOT COMPLETED|First Intervention||0
440462|NCT00699608|1049036|P5|NOT COMPLETED|First Intervention||1
440463|NCT00699608|1049037|P4|NOT COMPLETED|First Intervention||0
440464|NCT00699608|1049038|P3|NOT COMPLETED|First Intervention||1
440465|NCT00699608|1049039|P2|NOT COMPLETED|First Intervention||0
440466|NCT00699608|1049040|P1|NOT COMPLETED|First Intervention||0
440467|NCT00699608|1049035|P6|COMPLETED|First Intervention||15
440468|NCT00699608|1049036|P5|COMPLETED|First Intervention||14
440469|NCT00699608|1049037|P4|COMPLETED|First Intervention||15
440470|NCT00699608|1049038|P3|COMPLETED|First Intervention||14
440471|NCT00699608|1049039|P2|COMPLETED|First Intervention||15
440472|NCT00699608|1049040|P1|COMPLETED|First Intervention||16
440473|NCT00699608|1049035|P6|STARTED|First Intervention||15
440474|NCT00699608|1049036|P5|STARTED|First Intervention||15
440475|NCT00699608|1049037|P4|STARTED|First Intervention||15
440476|NCT00699608|1049038|P3|STARTED|First Intervention||15
440477|NCT00699608|1049039|P2|STARTED|First Intervention||15
440478|NCT00699608|1049040|P1|STARTED|First Intervention||16
440479|NCT00699582|1049093|P3|NOT COMPLETED|Overall Study||28
440480|NCT00699582|1049094|P2|NOT COMPLETED|Overall Study||22
440481|NCT00699582|1049095|P1|NOT COMPLETED|Overall Study||18
440482|NCT00699582|1049093|P3|COMPLETED|Overall Study||93
440483|NCT00699582|1049094|P2|COMPLETED|Overall Study||108
440484|NCT00699582|1049095|P1|COMPLETED|Overall Study||120
440485|NCT00699582|1049093|P3|STARTED|Overall Study||121
440486|NCT00699582|1049094|P2|STARTED|Overall Study||130
440487|NCT00699582|1049095|P1|STARTED|Overall Study||138
440488|NCT00699491|1049115|P6|NOT COMPLETED|Overall Study||0
440489|NCT00699491|1049116|P5|NOT COMPLETED|Overall Study||0
440490|NCT00699491|1049117|P4|NOT COMPLETED|Overall Study||0
440491|NCT00699491|1049118|P3|NOT COMPLETED|Overall Study||0
440492|NCT00699491|1049119|P2|NOT COMPLETED|Overall Study||0
440493|NCT00699491|1049120|P1|NOT COMPLETED|Overall Study||0
440494|NCT00699491|1049115|P6|COMPLETED|Overall Study||22
440495|NCT00699491|1049116|P5|COMPLETED|Overall Study||8
440496|NCT00699491|1049117|P4|COMPLETED|Overall Study||6
440497|NCT00699491|1049118|P3|COMPLETED|Overall Study||7
440498|NCT00699491|1049119|P2|COMPLETED|Overall Study||2
440499|NCT00699491|1049120|P1|COMPLETED|Overall Study||3
440500|NCT00699491|1049115|P6|STARTED|Overall Study||22
440501|NCT00699491|1049116|P5|STARTED|Overall Study||8
440502|NCT00699491|1049117|P4|STARTED|Overall Study||6
440503|NCT00699491|1049118|P3|STARTED|Overall Study||7
440504|NCT00699491|1049119|P2|STARTED|Overall Study||2
440505|NCT00699491|1049120|P1|STARTED|Overall Study||3
440506|NCT00699413|1049141|P2|NOT COMPLETED|Overall Study||2
440507|NCT00699413|1049142|P1|NOT COMPLETED|Overall Study||0
440508|NCT00699413|1049141|P2|COMPLETED|Overall Study||2
440509|NCT00699413|1049142|P1|COMPLETED|Overall Study||4
440510|NCT00699413|1049141|P2|STARTED|Overall Study||4
440511|NCT00699413|1049142|P1|STARTED|Overall Study||4
440512|NCT00699400|1049151|P6|NOT COMPLETED|Overall Study||11
440513|NCT00699400|1049152|P5|NOT COMPLETED|Overall Study||0
440514|NCT00699400|1049153|P4|NOT COMPLETED|Overall Study||0
440515|NCT00699400|1049154|P3|NOT COMPLETED|Overall Study||0
440516|NCT00699400|1049155|P2|NOT COMPLETED|Overall Study||0
440517|NCT00699400|1049156|P1|NOT COMPLETED|Overall Study||0
440518|NCT00699400|1049151|P6|COMPLETED|Overall Study||0
440519|NCT00699400|1049152|P5|COMPLETED|Overall Study||4
440520|NCT00699400|1049153|P4|COMPLETED|Overall Study||6
440521|NCT00699400|1049154|P3|COMPLETED|Overall Study||138
440522|NCT00699400|1049155|P2|COMPLETED|Overall Study||3
440523|NCT00699400|1049156|P1|COMPLETED|Overall Study||42
440524|NCT00699400|1049151|P6|STARTED|Overall Study||11
440525|NCT00699400|1049152|P5|STARTED|Overall Study||4
440526|NCT00699400|1049153|P4|STARTED|Overall Study||6
440527|NCT00699400|1049154|P3|STARTED|Overall Study||138
440528|NCT00699400|1049155|P2|STARTED|Overall Study||3
440529|NCT00699400|1049156|P1|STARTED|Overall Study||42
440530|NCT00699374|1049190|P2|NOT COMPLETED|Overall Study||544
440531|NCT00699374|1049191|P1|NOT COMPLETED|Overall Study||530
440532|NCT00699374|1049190|P2|COMPLETED|Overall Study||0
440533|NCT00699374|1049191|P1|COMPLETED|Overall Study||0
440534|NCT00699374|1049190|P2|Treated|Overall Study||542
440535|NCT00699374|1049191|P1|Treated|Overall Study||526
440536|NCT00699374|1049190|P2|STARTED|Overall Study||544
440537|NCT00699374|1049191|P1|STARTED|Overall Study||530
440538|NCT00699348|1049203|P1|NOT COMPLETED|Overall Study||90
440539|NCT00699348|1049203|P1|COMPLETED|Overall Study||261
440540|NCT00699348|1049203|P1|STARTED|Overall Study||351
440541|NCT00699335|1049212|P1|NOT COMPLETED|Overall Study||228
440542|NCT00699335|1049212|P1|COMPLETED|Overall Study||5080
440543|NCT00699335|1049212|P1|STARTED|Overall Study||5308
440544|NCT00699283|1049245|P2|NOT COMPLETED|Overall Study||8
440545|NCT00699283|1049246|P1|NOT COMPLETED|Overall Study||33
440546|NCT00699283|1049245|P2|COMPLETED|Overall Study||7
440547|NCT00699283|1049246|P1|COMPLETED|Overall Study||14
440548|NCT00699283|1049245|P2|STARTED|Overall Study||15
440549|NCT00699283|1049246|P1|STARTED|Overall Study||47
440550|NCT00699192|1049254|P3|NOT COMPLETED|Overall Study||11
440551|NCT00699192|1049255|P2|NOT COMPLETED|Overall Study||12
440552|NCT00699192|1049256|P1|NOT COMPLETED|Overall Study||16
440553|NCT00699192|1049254|P3|COMPLETED|Overall Study||261
440554|NCT00699192|1049255|P2|COMPLETED|Overall Study||260
440555|NCT00699192|1049256|P1|COMPLETED|Overall Study||259
440556|NCT00699192|1049254|P3|STARTED|Overall Study||272
440557|NCT00699192|1049255|P2|STARTED|Overall Study||272
440558|NCT00699192|1049256|P1|STARTED|Overall Study||275
440559|NCT00699153|1049278|P2|NOT COMPLETED|Overall Study||2
440560|NCT00699153|1049279|P1|NOT COMPLETED|Overall Study||3
440561|NCT00699153|1049278|P2|COMPLETED|Overall Study||200
440562|NCT00699153|1049279|P1|COMPLETED|Overall Study||200
440563|NCT00699153|1049278|P2|STARTED|Overall Study|Intent to treat population|202
440564|NCT00699153|1049279|P1|STARTED|Overall Study|Intent to treat population|203
440565|NCT00699140|1049291|P1|NOT COMPLETED|Overall Study||0
440566|NCT00699140|1049291|P1|COMPLETED|Overall Study||18
440567|NCT00699140|1049291|P1|STARTED|Overall Study||18
440568|NCT00698932|1049305|P2|NOT COMPLETED|Overall Study||36
440569|NCT00698932|1049306|P1|NOT COMPLETED|Overall Study||22
440570|NCT00698932|1049305|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
440571|NCT00698932|1049306|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
440572|NCT00698932|1049305|P2|STARTED|Overall Study|Randomized and treated|284
440573|NCT00698932|1049306|P1|STARTED|Overall Study|Randomized and treated|284
440574|NCT00698841|1049322|P1|NOT COMPLETED|Overall Study||18
440575|NCT00698841|1049322|P1|COMPLETED|Overall Study||33
440576|NCT00698841|1049322|P1|STARTED|Overall Study||51
440577|NCT00698815|1049336|P3|NOT COMPLETED|Overall Study||10
440578|NCT00698815|1049337|P2|NOT COMPLETED|Overall Study||14
440579|NCT00698815|1049338|P1|NOT COMPLETED|Overall Study||10
440580|NCT00698815|1049336|P3|COMPLETED|Overall Study||31
440581|NCT00698815|1049337|P2|COMPLETED|Overall Study||33
440582|NCT00698815|1049338|P1|COMPLETED|Overall Study||32
440583|NCT00698815|1049336|P3|STARTED|Overall Study||41
440584|NCT00698815|1049337|P2|STARTED|Overall Study||47
440585|NCT00698815|1049338|P1|STARTED|Overall Study||42
440586|NCT00698685|1049355|P1|NOT COMPLETED|Overall Study||2
440587|NCT00698685|1049355|P1|COMPLETED|Overall Study||12
440588|NCT00698685|1049355|P1|STARTED|Overall Study||14
440589|NCT00698646|1049363|P3|NOT COMPLETED|Overall Study||29
440590|NCT00698646|1049364|P2|NOT COMPLETED|Overall Study||31
440591|NCT00698646|1049365|P1|NOT COMPLETED|Overall Study||36
440592|NCT00698646|1049363|P3|COMPLETED|Overall Study||99
440593|NCT00698646|1049364|P2|COMPLETED|Overall Study||97
440594|NCT00698646|1049365|P1|COMPLETED|Overall Study||92
440595|NCT00698646|1049363|P3|STARTED|Overall Study||128
440596|NCT00698646|1049364|P2|STARTED|Overall Study||128
440597|NCT00698646|1049365|P1|STARTED|Overall Study||128
440598|NCT00698581|1049390|P2|NOT COMPLETED|Overall Study||12
440599|NCT00698581|1049391|P1|NOT COMPLETED|Overall Study||45
440600|NCT00698581|1049390|P2|COMPLETED|Overall Study||8
440601|NCT00698581|1049391|P1|COMPLETED|Overall Study||23
440602|NCT00698581|1049390|P2|STARTED|Overall Study||20
440603|NCT00698581|1049391|P1|STARTED|Overall Study||68
440604|NCT00698516|1049402|P1|NOT COMPLETED|Overall Study||5
440605|NCT00698516|1049402|P1|COMPLETED|Overall Study||45
440606|NCT00698516|1049402|P1|STARTED|Overall Study||50
440607|NCT00698451|1049420|P1|NOT COMPLETED|Overall Study||39
440608|NCT00698451|1049420|P1|COMPLETED|Overall Study||15
440609|NCT00698451|1049420|P1|STARTED|Overall Study||54
440610|NCT00698204|1049427|P2|NOT COMPLETED|Overall Study||0
440611|NCT00698204|1049428|P1|NOT COMPLETED|Overall Study||1
440612|NCT00698204|1049427|P2|COMPLETED|Overall Study||20
440613|NCT00698204|1049428|P1|COMPLETED|Overall Study||19
440614|NCT00698204|1049427|P2|STARTED|Overall Study||20
440615|NCT00698204|1049428|P1|STARTED|Overall Study||20
440616|NCT00698139|1049439|P3|NOT COMPLETED|Overall Study||0
440617|NCT00698139|1049440|P2|NOT COMPLETED|Overall Study||0
440618|NCT00698139|1049441|P1|NOT COMPLETED|Overall Study||0
440619|NCT00698139|1049439|P3|COMPLETED|Overall Study||1
440620|NCT00698139|1049440|P2|COMPLETED|Overall Study||1
440621|NCT00698139|1049441|P1|COMPLETED|Overall Study||1
440622|NCT00698139|1049439|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
440623|NCT00698139|1049440|P2|2nd Visit|Overall Study||1
440624|NCT00698139|1049441|P1|2nd Visit|Overall Study||1
440625|NCT00698139|1049439|P3|STARTED|Overall Study||1
440626|NCT00698139|1049440|P2|STARTED|Overall Study||1
440627|NCT00698139|1049441|P1|STARTED|Overall Study||1
440628|NCT00698035|1049457|P2|NOT COMPLETED|Overall Study||2
440629|NCT00698035|1049458|P1|NOT COMPLETED|Overall Study||4
440630|NCT00698035|1049457|P2|COMPLETED|Overall Study||34
440631|NCT00698035|1049458|P1|COMPLETED|Overall Study||35
440632|NCT00698035|1049457|P2|STARTED|Overall Study||36
440633|NCT00698035|1049458|P1|STARTED|Overall Study||39
440634|NCT00698022|1049478|P3|NOT COMPLETED|Overall Study||2
440635|NCT00698022|1049479|P2|NOT COMPLETED|Overall Study||10
440636|NCT00698022|1049480|P1|NOT COMPLETED|Overall Study||16
440637|NCT00698022|1049478|P3|COMPLETED|Overall Study||14
440638|NCT00698022|1049479|P2|COMPLETED|Overall Study||20
440639|NCT00698022|1049480|P1|COMPLETED|Overall Study||14
440640|NCT00698022|1049478|P3|STARTED|Overall Study||16
440641|NCT00698022|1049479|P2|STARTED|Overall Study||30
440642|NCT00698022|1049480|P1|STARTED|Overall Study||30
440643|NCT00698009|1049488|P1|NOT COMPLETED|Overall Study||1
440644|NCT00698009|1049488|P1|COMPLETED|Overall Study||0
440645|NCT00698009|1049488|P1|STARTED|Overall Study||1
440646|NCT00697827|1049494|P2|NOT COMPLETED|Overall Study||1
440647|NCT00697827|1049495|P1|NOT COMPLETED|Overall Study||2
440648|NCT00697827|1049494|P2|COMPLETED|Overall Study||15
440649|NCT00697827|1049495|P1|COMPLETED|Overall Study||26
440650|NCT00697827|1049494|P2|STARTED|Overall Study||16
440651|NCT00697827|1049495|P1|STARTED|Overall Study||28
440652|NCT00697801|1049506|P3|NOT COMPLETED|Overall Study||24
440653|NCT00697801|1049507|P2|NOT COMPLETED|Overall Study||12
440654|NCT00697801|1049508|P1|NOT COMPLETED|Overall Study||12
440655|NCT00697801|1049506|P3|COMPLETED|Overall Study||45
440656|NCT00697801|1049507|P2|COMPLETED|Overall Study||58
440657|NCT00697801|1049508|P1|COMPLETED|Overall Study||57
440658|NCT00697801|1049506|P3|STARTED|Overall Study||69
440659|NCT00697801|1049507|P2|STARTED|Overall Study||70
440660|NCT00697801|1049508|P1|STARTED|Overall Study||69
440661|NCT00697697|1049524|P2|NOT COMPLETED|Overall Study||54
440662|NCT00697697|1049525|P1|NOT COMPLETED|Overall Study||49
440663|NCT00697697|1049524|P2|COMPLETED|Overall Study||44
440664|NCT00697697|1049525|P1|COMPLETED|Overall Study||45
440665|NCT00697697|1049524|P2|STARTED|Overall Study||98
440666|NCT00697697|1049525|P1|STARTED|Overall Study||94
440667|NCT00697619|1049535|P2|NOT COMPLETED|Overall Study||8
440668|NCT00697619|1049536|P1|NOT COMPLETED|Overall Study||6
440669|NCT00697619|1049535|P2|COMPLETED|Overall Study||22
440670|NCT00697619|1049536|P1|COMPLETED|Overall Study||24
440671|NCT00697619|1049535|P2|STARTED|Overall Study||30
440672|NCT00697619|1049536|P1|STARTED|Overall Study||30
440673|NCT00697593|1049542|P1|NOT COMPLETED|Overall Study||19
440674|NCT00697593|1049542|P1|COMPLETED|Overall Study||51
440675|NCT00697593|1049542|P1|STARTED|Overall Study||70
440676|NCT00697541|1049575|P2|NOT COMPLETED|Overall Study||1
440677|NCT00697541|1049576|P1|NOT COMPLETED|Overall Study||2
440678|NCT00697541|1049575|P2|COMPLETED|Overall Study||9
440679|NCT00697541|1049576|P1|COMPLETED|Overall Study||8
440680|NCT00697541|1049575|P2|STARTED|Overall Study||10
440681|NCT00697541|1049576|P1|STARTED|Overall Study||10
440682|NCT00697515|1049586|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
440683|NCT00697515|1049587|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
440684|NCT00697515|1049586|P2|COMPLETED|Second Intervention (Crossover Period)||51
440685|NCT00697515|1049587|P1|COMPLETED|Second Intervention (Crossover Period)||52
440686|NCT00697515|1049586|P2|STARTED|Second Intervention (Crossover Period)||52
440687|NCT00697515|1049587|P1|STARTED|Second Intervention (Crossover Period)||53
440688|NCT00697515|1049586|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
440689|NCT00697515|1049587|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
440690|NCT00697515|1049586|P2|COMPLETED|First Intervention (Crossover Period)||52
440691|NCT00697515|1049587|P1|COMPLETED|First Intervention (Crossover Period)||53
440692|NCT00697515|1049586|P2|STARTED|First Intervention (Crossover Period)||64
440693|NCT00697515|1049587|P1|STARTED|First Intervention (Crossover Period)||63
440694|NCT00697515|1049586|P2|NOT COMPLETED|Dose Optimization Period||0
440695|NCT00697515|1049587|P1|NOT COMPLETED|Dose Optimization Period||15
440696|NCT00697515|1049586|P2|COMPLETED|Dose Optimization Period||0
440697|NCT00697515|1049587|P1|COMPLETED|Dose Optimization Period||127
440698|NCT00697515|1049586|P2|STARTED|Dose Optimization Period||0
440699|NCT00697515|1049587|P1|STARTED|Dose Optimization Period||142
440700|NCT00697255|1049617|P2|NOT COMPLETED|Stage 1b||2
440701|NCT00697255|1049618|P1|NOT COMPLETED|Stage 1b||0
440702|NCT00697255|1049617|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
440703|NCT00697255|1049618|P1|COMPLETED|Stage 1b||0
440704|NCT00697255|1049617|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
440705|NCT00697255|1049618|P1|STARTED|Stage 1b||0
440706|NCT00697255|1049617|P2|NOT COMPLETED|Stage 1a||0
440707|NCT00697255|1049618|P1|NOT COMPLETED|Stage 1a||3
440708|NCT00697255|1049617|P2|COMPLETED|Stage 1a||0
440709|NCT00697255|1049618|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
440710|NCT00697255|1049617|P2|STARTED|Stage 1a||0
440711|NCT00697255|1049618|P1|STARTED|Stage 1a||5
440712|NCT00697190|1049634|P2|NOT COMPLETED|Second Intervention||0
440713|NCT00697190|1049635|P1|NOT COMPLETED|Second Intervention||0
440714|NCT00697190|1049634|P2|COMPLETED|Second Intervention||20
440715|NCT00697190|1049635|P1|COMPLETED|Second Intervention||18
440716|NCT00697190|1049634|P2|STARTED|Second Intervention||20
440717|NCT00697190|1049635|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
440718|NCT00697190|1049634|P2|NOT COMPLETED|First Intervention||0
440719|NCT00697190|1049635|P1|NOT COMPLETED|First Intervention||0
440720|NCT00697190|1049634|P2|COMPLETED|First Intervention||20
440721|NCT00697190|1049635|P1|COMPLETED|First Intervention||19
440722|NCT00697190|1049634|P2|STARTED|First Intervention||20
440723|NCT00697190|1049635|P1|STARTED|First Intervention||19
440724|NCT00697112|1049669|P1|NOT COMPLETED|Overall Study||10
440725|NCT00697112|1049669|P1|COMPLETED|Overall Study||43
440726|NCT00697112|1049669|P1|Met the Inclusion Criteria|Overall Study||52
440727|NCT00697112|1049669|P1|STARTED|Overall Study||53
440728|NCT00697073|1049693|P1|NOT COMPLETED|Overall Study||9
440729|NCT00697073|1049693|P1|COMPLETED|Overall Study||59
440730|NCT00697073|1049693|P1|STARTED|Overall Study||68
440731|NCT00696878|1049697|P1|NOT COMPLETED|Overall Study||504
440732|NCT00696878|1049697|P1|COMPLETED|Overall Study||178
440733|NCT00696878|1049697|P1|STARTED|Overall Study||682
440734|NCT00696800|1049771|P2|NOT COMPLETED|Overall Study||48
440735|NCT00696800|1049772|P1|NOT COMPLETED|Overall Study||85
440736|NCT00696800|1049771|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
440737|NCT00696800|1049772|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
440738|NCT00696800|1049771|P2|Treated (ITT)|Overall Study|The ITT group|750
440739|NCT00696800|1049772|P1|Treated (ITT)|Overall Study|The ITT group|756
440740|NCT00696800|1049771|P2|STARTED|Overall Study||752
440741|NCT00696800|1049772|P1|STARTED|Overall Study||757
440742|NCT00696787|1049825|P3|NOT COMPLETED|Overall Study||26
440743|NCT00696787|1049826|P2|NOT COMPLETED|Overall Study||20
440744|NCT00696787|1049827|P1|NOT COMPLETED|Overall Study||15
440745|NCT00696787|1049825|P3|COMPLETED|Overall Study||17
440746|NCT00696787|1049826|P2|COMPLETED|Overall Study||22
440747|NCT00696787|1049827|P1|COMPLETED|Overall Study||25
440748|NCT00696787|1049825|P3|STARTED|Overall Study||43
440749|NCT00696787|1049826|P2|STARTED|Overall Study||42
440750|NCT00696787|1049827|P1|STARTED|Overall Study||40
440751|NCT00696774|1049841|P3|NOT COMPLETED|Period III||0
440752|NCT00696774|1049842|P2|NOT COMPLETED|Period III||7
440753|NCT00696774|1049843|P1|NOT COMPLETED|Period III||7
440754|NCT00696774|1049841|P3|COMPLETED|Period III||0
440755|NCT00696774|1049842|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
440756|NCT00696774|1049843|P1|COMPLETED|Period III||106
440757|NCT00696774|1049841|P3|STARTED|Period III||0
440758|NCT00696774|1049842|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
440759|NCT00696774|1049843|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
440760|NCT00696774|1049841|P3|NOT COMPLETED|Period II||36
440761|NCT00696774|1049842|P2|NOT COMPLETED|Period II||0
440762|NCT00696774|1049843|P1|NOT COMPLETED|Period II||0
440763|NCT00696774|1049841|P3|COMPLETED|Period II||0
440764|NCT00696774|1049842|P2|COMPLETED|Period II||91
440765|NCT00696774|1049843|P1|COMPLETED|Period II||115
440766|NCT00696774|1049841|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
440767|NCT00696774|1049842|P2|STARTED|Period II||91
440768|NCT00696774|1049843|P1|STARTED|Period II||115
440769|NCT00696761|1049881|P4|NOT COMPLETED|Overall Study||10
440770|NCT00696761|1049882|P3|NOT COMPLETED|Overall Study||11
440771|NCT00696761|1049883|P2|NOT COMPLETED|Overall Study||26
440772|NCT00696761|1049884|P1|NOT COMPLETED|Overall Study||20
440773|NCT00696761|1049881|P4|COMPLETED|Overall Study||44
440774|NCT00696761|1049882|P3|COMPLETED|Overall Study||30
440775|NCT00696761|1049883|P2|COMPLETED|Overall Study||50
440776|NCT00696761|1049884|P1|COMPLETED|Overall Study||41
440777|NCT00696761|1049881|P4|STARTED|Overall Study||54
440778|NCT00696761|1049882|P3|STARTED|Overall Study||41
440779|NCT00696761|1049883|P2|STARTED|Overall Study||76
440780|NCT00696761|1049884|P1|STARTED|Overall Study||61
440781|NCT00696696|1049898|P1|NOT COMPLETED|Overall Study||18
440782|NCT00696696|1049898|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
440783|NCT00696696|1049898|P1|STARTED|Overall Study||44
440784|NCT00696618|1049907|P3|NOT COMPLETED|Overall Study||0
440785|NCT00696618|1049908|P2|NOT COMPLETED|Overall Study||0
440786|NCT00696618|1049909|P1|NOT COMPLETED|Overall Study||0
440787|NCT00696618|1049907|P3|COMPLETED|Overall Study||3
440788|NCT00696618|1049908|P2|COMPLETED|Overall Study||3
440789|NCT00696618|1049909|P1|COMPLETED|Overall Study||3
440790|NCT00696618|1049907|P3|STARTED|Overall Study||3
440791|NCT00696618|1049908|P2|STARTED|Overall Study||3
440792|NCT00696618|1049909|P1|STARTED|Overall Study||3
440793|NCT00696488|1049923|P1|NOT COMPLETED|Overall Study||0
440794|NCT00696488|1049923|P1|COMPLETED|Overall Study||20
440795|NCT00696488|1049923|P1|STARTED|Overall Study||20
440796|NCT00696449|1049931|P4|NOT COMPLETED|Overall Study||3
440797|NCT00696449|1049932|P3|NOT COMPLETED|Overall Study||1
440798|NCT00696449|1049933|P2|NOT COMPLETED|Overall Study||6
440799|NCT00696449|1049934|P1|NOT COMPLETED|Overall Study||3
440800|NCT00696449|1049931|P4|COMPLETED|Overall Study||13
440801|NCT00696449|1049932|P3|COMPLETED|Overall Study||14
440802|NCT00696449|1049933|P2|COMPLETED|Overall Study||9
440803|NCT00696449|1049934|P1|COMPLETED|Overall Study||12
440804|NCT00696449|1049931|P4|STARTED|Overall Study||16
440805|NCT00696449|1049932|P3|STARTED|Overall Study||15
440806|NCT00696449|1049933|P2|STARTED|Overall Study||15
440807|NCT00696449|1049934|P1|STARTED|Overall Study||15
440808|NCT00696436|1049949|P5|NOT COMPLETED|Overall Study||13
440809|NCT00696436|1049950|P4|NOT COMPLETED|Overall Study||22
440810|NCT00696436|1049951|P3|NOT COMPLETED|Overall Study||28
440811|NCT00696436|1049952|P2|NOT COMPLETED|Overall Study||30
440812|NCT00696436|1049953|P1|NOT COMPLETED|Overall Study||23
440813|NCT00696436|1049949|P5|COMPLETED|Overall Study||141
440814|NCT00696436|1049950|P4|COMPLETED|Overall Study||268
440815|NCT00696436|1049951|P3|COMPLETED|Overall Study||254
440816|NCT00696436|1049952|P2|COMPLETED|Overall Study||255
440817|NCT00696436|1049953|P1|COMPLETED|Overall Study||257
440818|NCT00696436|1049949|P5|STARTED|Overall Study|Randomized participants only.|154
440819|NCT00696436|1049950|P4|STARTED|Overall Study|Randomized participants only.|290
440820|NCT00696436|1049951|P3|STARTED|Overall Study|Randomized participants only.|282
440821|NCT00696436|1049952|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
440822|NCT00696436|1049953|P1|STARTED|Overall Study|Randomized participants only.|280
440823|NCT00696423|1050037|P2|NOT COMPLETED|Overall Study||5
440824|NCT00696423|1050038|P1|NOT COMPLETED|Overall Study||0
440825|NCT00696423|1050037|P2|COMPLETED|Overall Study||218
440826|NCT00696423|1050038|P1|COMPLETED|Overall Study||244
440827|NCT00696423|1050037|P2|STARTED|Overall Study||223
440828|NCT00696423|1050038|P1|STARTED|Overall Study||244
440829|NCT00696384|1050068|P3|NOT COMPLETED|Double Blind Phase||6
440830|NCT00696384|1050069|P2|NOT COMPLETED|Double Blind Phase||11
440831|NCT00696384|1050070|P1|NOT COMPLETED|Double Blind Phase||0
440832|NCT00696384|1050068|P3|COMPLETED|Double Blind Phase||145
440833|NCT00696384|1050069|P2|COMPLETED|Double Blind Phase||137
440834|NCT00696384|1050070|P1|COMPLETED|Double Blind Phase||0
440835|NCT00696384|1050068|P3|STARTED|Double Blind Phase||151
440836|NCT00696384|1050069|P2|STARTED|Double Blind Phase||148
440837|NCT00696384|1050070|P1|STARTED|Double Blind Phase||0
440838|NCT00696384|1050068|P3|NOT COMPLETED|Open Label Phase||0
440839|NCT00696384|1050069|P2|NOT COMPLETED|Open Label Phase||0
440840|NCT00696384|1050070|P1|NOT COMPLETED|Open Label Phase||119
440841|NCT00696384|1050068|P3|COMPLETED|Open Label Phase||0
440842|NCT00696384|1050069|P2|COMPLETED|Open Label Phase||0
440843|NCT00696384|1050070|P1|COMPLETED|Open Label Phase||299
440844|NCT00696384|1050068|P3|STARTED|Open Label Phase||0
440845|NCT00696384|1050069|P2|STARTED|Open Label Phase||0
440846|NCT00696384|1050070|P1|STARTED|Open Label Phase||418
440847|NCT00696293|1050084|P1|NOT COMPLETED|Overall Study||2
440848|NCT00696293|1050084|P1|COMPLETED|Overall Study||28
440849|NCT00696293|1050084|P1|STARTED|Overall Study||30
440850|NCT00696241|1050094|P5|NOT COMPLETED|Overall Study||12
440851|NCT00696241|1050095|P4|NOT COMPLETED|Overall Study||14
440852|NCT00696241|1050096|P3|NOT COMPLETED|Overall Study||24
440853|NCT00696241|1050097|P2|NOT COMPLETED|Overall Study||22
440854|NCT00696241|1050098|P1|NOT COMPLETED|Overall Study||24
440855|NCT00696241|1050094|P5|COMPLETED|Overall Study||130
440856|NCT00696241|1050095|P4|COMPLETED|Overall Study||268
440857|NCT00696241|1050096|P3|COMPLETED|Overall Study||261
440858|NCT00696241|1050097|P2|COMPLETED|Overall Study||261
440859|NCT00696241|1050098|P1|COMPLETED|Overall Study||259
440860|NCT00696241|1050094|P5|STARTED|Overall Study||142
440861|NCT00696241|1050095|P4|STARTED|Overall Study||282
440862|NCT00696241|1050096|P3|STARTED|Overall Study||285
440863|NCT00696241|1050097|P2|STARTED|Overall Study||283
440864|NCT00696241|1050098|P1|STARTED|Overall Study||283
440865|NCT00696072|1050182|P2|NOT COMPLETED|Overall Study||63
440866|NCT00696072|1050183|P1|NOT COMPLETED|Overall Study||57
440867|NCT00696072|1050182|P2|COMPLETED|Overall Study||0
440868|NCT00696072|1050183|P1|COMPLETED|Overall Study||0
440869|NCT00696072|1050182|P2|STARTED|Overall Study||63
440870|NCT00696072|1050183|P1|STARTED|Overall Study||57
440871|NCT00696020|1050204|P4|NOT COMPLETED|Overall Study||4
440872|NCT00696020|1050205|P3|NOT COMPLETED|Overall Study||3
440873|NCT00696020|1050206|P2|NOT COMPLETED|Overall Study||2
440874|NCT00696020|1050207|P1|NOT COMPLETED|Overall Study||4
440875|NCT00696020|1050204|P4|COMPLETED|Overall Study||84
440876|NCT00696020|1050205|P3|COMPLETED|Overall Study||90
440877|NCT00696020|1050206|P2|COMPLETED|Overall Study||87
440878|NCT00696020|1050207|P1|COMPLETED|Overall Study||86
440879|NCT00696020|1050204|P4|STARTED|Overall Study||88
440880|NCT00696020|1050205|P3|STARTED|Overall Study||93
440881|NCT00696020|1050206|P2|STARTED|Overall Study||89
440882|NCT00696020|1050207|P1|STARTED|Overall Study||90
440883|NCT00695955|1050315|P1|NOT COMPLETED|Cohort 2||104
440884|NCT00695955|1050315|P1|COMPLETED|Cohort 2||203
440885|NCT00695955|1050315|P1|STARTED|Cohort 2||307
440886|NCT00695955|1050315|P1|NOT COMPLETED|Cohort 1||102
440887|NCT00695955|1050315|P1|COMPLETED|Cohort 1||260
440888|NCT00695955|1050315|P1|STARTED|Cohort 1||362
440889|NCT00695903|1050327|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
440890|NCT00695903|1050328|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
440891|NCT00695903|1050327|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
440892|NCT00695903|1050328|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
440893|NCT00695903|1050327|P2|STARTED|Had Test of Cure (TOC) Assessment||4
440894|NCT00695903|1050328|P1|STARTED|Had Test of Cure (TOC) Assessment||7
440990|NCT00694551|1050594|P3|NOT COMPLETED|Overall Study||1
440895|NCT00695903|1050327|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
440896|NCT00695903|1050328|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
440897|NCT00695903|1050327|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
440898|NCT00695903|1050328|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
440899|NCT00695903|1050327|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
440900|NCT00695903|1050328|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
440901|NCT00695903|1050327|P2|STARTED|Had End of Therapy (EOT) Assessment||19
440902|NCT00695903|1050328|P1|STARTED|Had End of Therapy (EOT) Assessment||19
440903|NCT00695864|1050340|P1|NOT COMPLETED|Ondansetron||5
440904|NCT00695864|1050340|P1|COMPLETED|Ondansetron||9
440905|NCT00695864|1050340|P1|STARTED|Ondansetron||14
440906|NCT00695864|1050340|P1|NOT COMPLETED|Placebo||5
440907|NCT00695864|1050340|P1|COMPLETED|Placebo||9
440908|NCT00695864|1050340|P1|STARTED|Placebo||14
440909|NCT00695669|1050350|P4|NOT COMPLETED|Overall Study||4
440910|NCT00695669|1050351|P3|NOT COMPLETED|Overall Study||3
440911|NCT00695669|1050352|P2|NOT COMPLETED|Overall Study||4
440912|NCT00695669|1050353|P1|NOT COMPLETED|Overall Study||4
440913|NCT00695669|1050350|P4|COMPLETED|Overall Study||74
440914|NCT00695669|1050351|P3|COMPLETED|Overall Study||75
440915|NCT00695669|1050352|P2|COMPLETED|Overall Study||74
440916|NCT00695669|1050353|P1|COMPLETED|Overall Study||74
440917|NCT00695669|1050350|P4|STARTED|Overall Study||78
440918|NCT00695669|1050351|P3|STARTED|Overall Study||78
440919|NCT00695669|1050352|P2|STARTED|Overall Study||78
440920|NCT00695669|1050353|P1|STARTED|Overall Study||78
440921|NCT00695565|1050429|P2|NOT COMPLETED|Overall Study||9
440922|NCT00695565|1050430|P1|NOT COMPLETED|Overall Study||13
440923|NCT00695565|1050429|P2|COMPLETED|Overall Study||81
440924|NCT00695565|1050430|P1|COMPLETED|Overall Study||77
440925|NCT00695565|1050429|P2|STARTED|Overall Study||90
440926|NCT00695565|1050430|P1|STARTED|Overall Study||90
440927|NCT00695500|1050464|P2|NOT COMPLETED|Overall Study||5
440928|NCT00695500|1050465|P1|NOT COMPLETED|Overall Study||3
440929|NCT00695500|1050464|P2|COMPLETED|Overall Study||17
440930|NCT00695500|1050465|P1|COMPLETED|Overall Study||21
440931|NCT00695500|1050464|P2|STARTED|Overall Study||22
440932|NCT00695500|1050465|P1|STARTED|Overall Study||24
440933|NCT00695435|1050475|P3|NOT COMPLETED|Overall Study||0
440934|NCT00695435|1050476|P2|NOT COMPLETED|Overall Study||0
440935|NCT00695435|1050477|P1|NOT COMPLETED|Overall Study||0
440936|NCT00695435|1050475|P3|COMPLETED|Overall Study||7
440937|NCT00695435|1050476|P2|COMPLETED|Overall Study||7
440938|NCT00695435|1050477|P1|COMPLETED|Overall Study||7
440939|NCT00695435|1050475|P3|STARTED|Overall Study||7
440940|NCT00695435|1050476|P2|STARTED|Overall Study||7
440941|NCT00695435|1050477|P1|STARTED|Overall Study||7
440942|NCT00695396|1050491|P3|NOT COMPLETED|Overall Study||8
440943|NCT00695396|1050492|P2|NOT COMPLETED|Overall Study||8
440944|NCT00695396|1050493|P1|NOT COMPLETED|Overall Study||7
440945|NCT00695396|1050491|P3|COMPLETED|Overall Study||1
440946|NCT00695396|1050492|P2|COMPLETED|Overall Study||0
440947|NCT00695396|1050493|P1|COMPLETED|Overall Study||1
440948|NCT00695396|1050491|P3|STARTED|Overall Study||9
440949|NCT00695396|1050492|P2|STARTED|Overall Study||8
440950|NCT00695396|1050493|P1|STARTED|Overall Study||8
440951|NCT00695318|1050509|P2|NOT COMPLETED|Overall Study||1
440952|NCT00695318|1050510|P1|NOT COMPLETED|Overall Study||5
440953|NCT00695318|1050509|P2|COMPLETED|Overall Study||6
440954|NCT00695318|1050510|P1|COMPLETED|Overall Study||5
440955|NCT00695318|1050509|P2|STARTED|Overall Study||7
440956|NCT00695318|1050510|P1|STARTED|Overall Study||10
440957|NCT00695292|1050521|P1|NOT COMPLETED|Overall Study||0
440958|NCT00695292|1050521|P1|COMPLETED|Overall Study||37
440959|NCT00695292|1050521|P1|STARTED|Overall Study||37
440960|NCT00695188|1050528|P2|NOT COMPLETED|Overall Study||0
440961|NCT00695188|1050529|P1|NOT COMPLETED|Overall Study||0
440962|NCT00695188|1050528|P2|COMPLETED|Overall Study||9
440963|NCT00695188|1050529|P1|COMPLETED|Overall Study||10
440964|NCT00695188|1050528|P2|STARTED|Overall Study||9
440965|NCT00695188|1050529|P1|STARTED|Overall Study||10
440966|NCT00695136|1050535|P1|NOT COMPLETED|Overall Study||2
440967|NCT00695136|1050535|P1|COMPLETED|Overall Study||5
440968|NCT00695136|1050535|P1|STARTED|Overall Study|7|7
440969|NCT00695097|1050541|P2|NOT COMPLETED|Overall Study||0
440970|NCT00695097|1050542|P1|NOT COMPLETED|Overall Study||1
440971|NCT00695097|1050541|P2|COMPLETED|Overall Study||5
440972|NCT00695097|1050542|P1|COMPLETED|Overall Study||9
440973|NCT00695097|1050541|P2|STARTED|Overall Study||5
440974|NCT00695097|1050542|P1|STARTED|Overall Study||10
440975|NCT00695019|1050551|P3|NOT COMPLETED|Overall Study||10
440976|NCT00695019|1050552|P2|NOT COMPLETED|Overall Study||14
440977|NCT00695019|1050553|P1|NOT COMPLETED|Overall Study||13
440978|NCT00695019|1050551|P3|COMPLETED|Overall Study||47
440979|NCT00695019|1050552|P2|COMPLETED|Overall Study||39
440980|NCT00695019|1050553|P1|COMPLETED|Overall Study||46
440981|NCT00695019|1050551|P3|STARTED|Overall Study||57
440982|NCT00695019|1050552|P2|STARTED|Overall Study||53
440983|NCT00695019|1050553|P1|STARTED|Overall Study||59
440984|NCT00694603|1050582|P1|NOT COMPLETED|Overall Study||0
440985|NCT00694603|1050582|P1|COMPLETED|Overall Study||18
440986|NCT00694603|1050582|P1|STARTED|Overall Study||18
440987|NCT00694564|1050587|P1|NOT COMPLETED|Overall Study||2
440988|NCT00694564|1050587|P1|COMPLETED|Overall Study||6
440989|NCT00694564|1050587|P1|STARTED|Overall Study||8
440991|NCT00694551|1050595|P2|NOT COMPLETED|Overall Study||0
440992|NCT00694551|1050596|P1|NOT COMPLETED|Overall Study||1
440993|NCT00694551|1050594|P3|COMPLETED|Overall Study||8
440994|NCT00694551|1050595|P2|COMPLETED|Overall Study||10
440995|NCT00694551|1050596|P1|COMPLETED|Overall Study||9
440996|NCT00694551|1050594|P3|STARTED|Overall Study||9
440997|NCT00694551|1050595|P2|STARTED|Overall Study||10
440998|NCT00694551|1050596|P1|STARTED|Overall Study||10
440999|NCT00694369|1050615|P5|NOT COMPLETED|Overall Study||6
441000|NCT00694369|1050616|P4|NOT COMPLETED|Overall Study||3
441001|NCT00694369|1050617|P3|NOT COMPLETED|Overall Study||2
441002|NCT00694369|1050618|P2|NOT COMPLETED|Overall Study||3
441003|NCT00694369|1050619|P1|NOT COMPLETED|Overall Study||1
441004|NCT00694369|1050615|P5|COMPLETED|Overall Study||56
441005|NCT00694369|1050616|P4|COMPLETED|Overall Study||189
441006|NCT00694369|1050617|P3|COMPLETED|Overall Study||95
441007|NCT00694369|1050618|P2|COMPLETED|Overall Study||188
441008|NCT00694369|1050619|P1|COMPLETED|Overall Study||45
441009|NCT00694369|1050615|P5|STARTED|Overall Study||62
441010|NCT00694369|1050616|P4|STARTED|Overall Study||192
441011|NCT00694369|1050617|P3|STARTED|Overall Study||97
441012|NCT00694369|1050618|P2|STARTED|Overall Study||191
441013|NCT00694369|1050619|P1|STARTED|Overall Study||46
441014|NCT00694356|1050639|P3|NOT COMPLETED|Overall Study||6
441015|NCT00694356|1050640|P2|NOT COMPLETED|Overall Study||6
441016|NCT00694356|1050641|P1|NOT COMPLETED|Overall Study||3
441017|NCT00694356|1050639|P3|COMPLETED|Overall Study||0
441018|NCT00694356|1050640|P2|COMPLETED|Overall Study||0
441019|NCT00694356|1050641|P1|COMPLETED|Overall Study||0
441020|NCT00694356|1050639|P3|STARTED|Overall Study||6
441021|NCT00694356|1050640|P2|STARTED|Overall Study||6
441022|NCT00694356|1050641|P1|STARTED|Overall Study||3
441023|NCT00694304|1050676|P1|NOT COMPLETED|Overall Study||207
441024|NCT00694304|1050676|P1|COMPLETED|Overall Study||328
441025|NCT00694304|1050676|P1|STARTED|Overall Study||535
441026|NCT00694161|1050689|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
441027|NCT00694161|1050689|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
441028|NCT00694161|1050689|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
441029|NCT00694161|1050689|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
441030|NCT00694161|1050689|P1|COMPLETED|Part 1 (up to Week 6)||35
441031|NCT00694161|1050689|P1|STARTED|Part 1 (up to Week 6)||35
441032|NCT00694122|1050728|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
441033|NCT00694122|1050729|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
441034|NCT00694122|1050728|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
441035|NCT00694122|1050729|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
441036|NCT00694122|1050728|P2|STARTED|Second Intervention (3-4 Weeks)||5
441037|NCT00694122|1050729|P1|STARTED|Second Intervention (3-4 Weeks)||10
441038|NCT00694122|1050728|P2|NOT COMPLETED|Washout (1 Day)||0
441039|NCT00694122|1050729|P1|NOT COMPLETED|Washout (1 Day)||0
441040|NCT00694122|1050728|P2|COMPLETED|Washout (1 Day)||5
441041|NCT00694122|1050729|P1|COMPLETED|Washout (1 Day)||10
441042|NCT00694122|1050728|P2|STARTED|Washout (1 Day)||5
441043|NCT00694122|1050729|P1|STARTED|Washout (1 Day)||10
441044|NCT00694122|1050728|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
441045|NCT00694122|1050729|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
441046|NCT00694122|1050728|P2|COMPLETED|First Intervention (3-4 Weeks)||5
441047|NCT00694122|1050729|P1|COMPLETED|First Intervention (3-4 Weeks)||10
441048|NCT00694122|1050728|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
441049|NCT00694122|1050729|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
441050|NCT00694109|1050745|P1|NOT COMPLETED|Overall Study||117
441051|NCT00694109|1050745|P1|COMPLETED|Overall Study||25
441052|NCT00694109|1050745|P1|Completed Consented Length of Treatment|Overall Study||60
441053|NCT00694109|1050745|P1|Consented 2 Years Additional Treatment|Overall Study||42
441054|NCT00694109|1050745|P1|Treated|Overall Study||141
441055|NCT00694109|1050745|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
441056|NCT00694096|1050769|P1|NOT COMPLETED|Overall Study||5
441057|NCT00694096|1050769|P1|COMPLETED|Overall Study||20
441058|NCT00694096|1050769|P1|STARTED|Overall Study||25
441059|NCT00694070|1050775|P1|NOT COMPLETED|Overall Study||0
441060|NCT00694070|1050775|P1|COMPLETED|Overall Study||51
441061|NCT00694070|1050775|P1|STARTED|Overall Study||51
441062|NCT00694018|1050783|P2|NOT COMPLETED|Overall Study||9
441063|NCT00694018|1050784|P1|NOT COMPLETED|Overall Study||13
441064|NCT00694018|1050783|P2|COMPLETED|Overall Study||102
441065|NCT00694018|1050784|P1|COMPLETED|Overall Study||105
441066|NCT00694018|1050783|P2|6 Months|Overall Study||101
441067|NCT00694018|1050784|P1|6 Months|Overall Study||106
441068|NCT00694018|1050783|P2|STARTED|Overall Study||111
441069|NCT00694018|1050784|P1|STARTED|Overall Study||118
441070|NCT00693992|1050792|P2|NOT COMPLETED|Overall Study||0
441071|NCT00693992|1050793|P1|NOT COMPLETED|Overall Study||0
441072|NCT00693992|1050792|P2|COMPLETED|Overall Study||104
441073|NCT00693992|1050793|P1|COMPLETED|Overall Study||106
441074|NCT00693992|1050792|P2|STARTED|Overall Study||104
441075|NCT00693992|1050793|P1|STARTED|Overall Study||106
441076|NCT00693784|1050805|P1|NOT COMPLETED|Overall Study||4
441077|NCT00693784|1050805|P1|COMPLETED|Overall Study||11
441078|NCT00693784|1050805|P1|104-week Extended Follow-up|Overall Study||11
441079|NCT00693784|1050805|P1|52-week Extended Follow-up|Overall Study||13
441080|NCT00693784|1050805|P1|26-Week Primary Endpoint|Overall Study||15
441081|NCT00693784|1050805|P1|STARTED|Overall Study||15
441082|NCT00693719|1050811|P1|NOT COMPLETED|Overall Study||0
441083|NCT00693719|1050811|P1|COMPLETED|Overall Study||31
441084|NCT00693719|1050811|P1|STARTED|Overall Study||31
441085|NCT00693706|1050818|P2|NOT COMPLETED|Overall Study||1
441086|NCT00693706|1050819|P1|NOT COMPLETED|Overall Study||0
441087|NCT00693706|1050818|P2|COMPLETED|Overall Study||98
441088|NCT00693706|1050819|P1|COMPLETED|Overall Study||101
441089|NCT00693706|1050818|P2|STARTED|Overall Study||99
441090|NCT00693706|1050819|P1|STARTED|Overall Study||101
441091|NCT00693693|1050846|P3|NOT COMPLETED|Overall Study||2
441092|NCT00693693|1050847|P2|NOT COMPLETED|Overall Study||1
441093|NCT00693693|1050848|P1|NOT COMPLETED|Overall Study||1
441094|NCT00693693|1050846|P3|COMPLETED|Overall Study||7
441095|NCT00693693|1050847|P2|COMPLETED|Overall Study||8
441096|NCT00693693|1050848|P1|COMPLETED|Overall Study||6
441097|NCT00693693|1050846|P3|STARTED|Overall Study||9
441098|NCT00693693|1050847|P2|STARTED|Overall Study||9
441099|NCT00693693|1050848|P1|STARTED|Overall Study||7
441100|NCT00693654|1050858|P2|NOT COMPLETED|Overall Study||0
441101|NCT00693654|1050859|P1|NOT COMPLETED|Overall Study||0
441102|NCT00693654|1050858|P2|COMPLETED|Overall Study||14
441103|NCT00693654|1050859|P1|COMPLETED|Overall Study||14
441104|NCT00693654|1050858|P2|STARTED|Overall Study||14
441105|NCT00693654|1050859|P1|STARTED|Overall Study||14
441106|NCT00693628|1050869|P2|NOT COMPLETED|Overall Study||0
441107|NCT00693628|1050870|P1|NOT COMPLETED|Overall Study||0
441108|NCT00693628|1050869|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
441109|NCT00693628|1050870|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
441110|NCT00693628|1050869|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
441111|NCT00693628|1050870|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
441112|NCT00693498|1050878|P2|NOT COMPLETED|Overall Study||0
441113|NCT00693498|1050879|P1|NOT COMPLETED|Overall Study||0
441114|NCT00693498|1050878|P2|COMPLETED|Overall Study||81
441115|NCT00693498|1050879|P1|COMPLETED|Overall Study||81
441116|NCT00693498|1050878|P2|STARTED|Overall Study||81
441117|NCT00693498|1050879|P1|STARTED|Overall Study||81
441118|NCT00693485|1050888|P3|NOT COMPLETED|Overall Study||0
441119|NCT00693485|1050889|P2|NOT COMPLETED|Overall Study||2
441120|NCT00693485|1050890|P1|NOT COMPLETED|Overall Study||0
441121|NCT00693485|1050888|P3|COMPLETED|Overall Study||24
441122|NCT00693485|1050889|P2|COMPLETED|Overall Study||19
441123|NCT00693485|1050890|P1|COMPLETED|Overall Study||25
441124|NCT00693485|1050888|P3|STARTED|Overall Study||24
441125|NCT00693485|1050889|P2|STARTED|Overall Study||21
441126|NCT00693485|1050890|P1|STARTED|Overall Study||25
441127|NCT00693472|1050905|P4|NOT COMPLETED|Part 2||2
441128|NCT00693472|1050906|P3|NOT COMPLETED|Part 2||2
441129|NCT00693472|1050907|P2|NOT COMPLETED|Part 2||0
441130|NCT00693472|1050908|P1|NOT COMPLETED|Part 2||0
441131|NCT00693472|1050905|P4|COMPLETED|Part 2||4
441132|NCT00693472|1050906|P3|COMPLETED|Part 2||6
441133|NCT00693472|1050907|P2|COMPLETED|Part 2||0
441134|NCT00693472|1050908|P1|COMPLETED|Part 2||0
441135|NCT00693472|1050905|P4|STARTED|Part 2||6
441136|NCT00693472|1050906|P3|STARTED|Part 2||8
441137|NCT00693472|1050907|P2|STARTED|Part 2||0
441138|NCT00693472|1050908|P1|STARTED|Part 2||0
441139|NCT00693472|1050905|P4|NOT COMPLETED|Part 1||0
441140|NCT00693472|1050906|P3|NOT COMPLETED|Part 1||0
441141|NCT00693472|1050907|P2|NOT COMPLETED|Part 1||4
441142|NCT00693472|1050908|P1|NOT COMPLETED|Part 1||6
441143|NCT00693472|1050905|P4|COMPLETED|Part 1||0
441144|NCT00693472|1050906|P3|COMPLETED|Part 1||0
441145|NCT00693472|1050907|P2|COMPLETED|Part 1||9
441146|NCT00693472|1050908|P1|COMPLETED|Part 1||13
441147|NCT00693472|1050905|P4|STARTED|Part 1||0
441148|NCT00693472|1050906|P3|STARTED|Part 1||0
441149|NCT00693472|1050907|P2|STARTED|Part 1||13
441150|NCT00693472|1050908|P1|STARTED|Part 1||19
441151|NCT00693420|1050928|P2|NOT COMPLETED|Overall Study||15
441152|NCT00693420|1050929|P1|NOT COMPLETED|Overall Study||6
441153|NCT00693420|1050928|P2|COMPLETED|Overall Study||126
441154|NCT00693420|1050929|P1|COMPLETED|Overall Study||131
441155|NCT00693420|1050928|P2|STARTED|Overall Study||141
441156|NCT00693420|1050929|P1|STARTED|Overall Study||137
441157|NCT00693303|1050953|P1|NOT COMPLETED|Overall Study||0
441158|NCT00693303|1050953|P1|COMPLETED|Overall Study||21
441159|NCT00693303|1050953|P1|STARTED|Overall Study||21
441160|NCT00693238|1050959|P2|NOT COMPLETED|Overall Study||0
441161|NCT00693238|1050960|P1|NOT COMPLETED|Overall Study||0
441162|NCT00693238|1050959|P2|COMPLETED|Overall Study||106
441163|NCT00693238|1050960|P1|COMPLETED|Overall Study||122
441164|NCT00693238|1050959|P2|STARTED|Overall Study||106
441165|NCT00693238|1050960|P1|STARTED|Overall Study||122
441166|NCT00693225|1050968|P2|NOT COMPLETED|Overall Study||5
441167|NCT00693225|1050969|P1|NOT COMPLETED|Overall Study||2
441168|NCT00693225|1050968|P2|COMPLETED|Overall Study||43
441169|NCT00693225|1050969|P1|COMPLETED|Overall Study||41
441170|NCT00693225|1050968|P2|STARTED|Overall Study||48
441171|NCT00693225|1050969|P1|STARTED|Overall Study||43
441172|NCT00693160|1050981|P2|NOT COMPLETED|Overall Study||0
441173|NCT00693160|1050982|P1|NOT COMPLETED|Overall Study||0
441174|NCT00693160|1050981|P2|COMPLETED|Overall Study||16
441175|NCT00693160|1050982|P1|COMPLETED|Overall Study||14
441176|NCT00693160|1050981|P2|STARTED|Overall Study||16
441177|NCT00693160|1050982|P1|STARTED|Overall Study||14
441178|NCT00693017|1050992|P2|NOT COMPLETED|Overall Study||2
441179|NCT00693017|1050993|P1|NOT COMPLETED|Overall Study||2
441180|NCT00693017|1050992|P2|COMPLETED|Overall Study||0
441181|NCT00693017|1050993|P1|COMPLETED|Overall Study||0
441182|NCT00693017|1050992|P2|STARTED|Overall Study||2
441183|NCT00693017|1050993|P1|STARTED|Overall Study||2
441184|NCT00692913|1051003|P2|NOT COMPLETED|Overall Study||30
441185|NCT00692913|1051004|P1|NOT COMPLETED|Overall Study||29
441186|NCT00692913|1051003|P2|COMPLETED|Overall Study||228
441187|NCT00692913|1051004|P1|COMPLETED|Overall Study||228
441188|NCT00692913|1051003|P2|STARTED|Overall Study||258
441189|NCT00692913|1051004|P1|STARTED|Overall Study||257
441190|NCT00692770|1051026|P2|NOT COMPLETED|Overall Study||558
441191|NCT00692770|1051027|P1|NOT COMPLETED|Overall Study||556
441192|NCT00692770|1051026|P2|COMPLETED|Overall Study||0
441193|NCT00692770|1051027|P1|COMPLETED|Overall Study||0
441194|NCT00692770|1051026|P2|Participants Received Treatment|Overall Study||554
441195|NCT00692770|1051027|P1|Participants Received Treatment|Overall Study||553
441196|NCT00692770|1051026|P2|STARTED|Overall Study||558
441197|NCT00692770|1051027|P1|STARTED|Overall Study||556
441198|NCT00691704|1051045|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
441199|NCT00691704|1051045|P1|COMPLETED|Two Years of Maintenance Therapy||3
441200|NCT00691704|1051045|P1|STARTED|Two Years of Maintenance Therapy||16
441201|NCT00691704|1051045|P1|NOT COMPLETED|Induction Therapy||2
441202|NCT00691704|1051045|P1|COMPLETED|Induction Therapy||16
441203|NCT00691704|1051045|P1|STARTED|Induction Therapy||18
441204|NCT00691665|1051055|P2|NOT COMPLETED|Overall Study||0
441205|NCT00691665|1051056|P1|NOT COMPLETED|Overall Study||0
441206|NCT00691665|1051055|P2|COMPLETED|Overall Study||65
441207|NCT00691665|1051056|P1|COMPLETED|Overall Study||65
441208|NCT00691665|1051055|P2|STARTED|Overall Study||65
441209|NCT00691665|1051056|P1|STARTED|Overall Study||65
441210|NCT00691652|1051068|P1|NOT COMPLETED|Overall Study||1
441211|NCT00691652|1051068|P1|COMPLETED|Overall Study||1
441212|NCT00691652|1051068|P1|STARTED|Overall Study||2
441213|NCT00691483|1051074|P2|NOT COMPLETED|Overall Study||25
441214|NCT00691483|1051075|P1|NOT COMPLETED|Overall Study||68
441215|NCT00691483|1051074|P2|COMPLETED|Overall Study||141
441216|NCT00691483|1051075|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
441217|NCT00691483|1051074|P2|Received Treatment|Overall Study||165
441218|NCT00691483|1051075|P1|Received Treatment|Overall Study||486
441219|NCT00691483|1051074|P2|STARTED|Overall Study||166
441220|NCT00691483|1051075|P1|STARTED|Overall Study||493
441221|NCT00692692|1051091|P2|NOT COMPLETED|Overall Study||0
441222|NCT00692692|1051092|P1|NOT COMPLETED|Overall Study||0
441223|NCT00692692|1051091|P2|COMPLETED|Overall Study||16
441224|NCT00692692|1051092|P1|COMPLETED|Overall Study||20
441225|NCT00692692|1051091|P2|STARTED|Overall Study||16
441226|NCT00692692|1051092|P1|STARTED|Overall Study||20
441227|NCT00692419|1051100|P2|NOT COMPLETED|Overall Study||18
441228|NCT00692419|1051101|P1|NOT COMPLETED|Overall Study||16
441229|NCT00692419|1051100|P2|COMPLETED|Overall Study||102
441230|NCT00692419|1051101|P1|COMPLETED|Overall Study||84
441231|NCT00692419|1051100|P2|STARTED|Overall Study||120
441232|NCT00692419|1051101|P1|STARTED|Overall Study||100
441233|NCT00692406|1051111|P1|NOT COMPLETED|Overall Study||57
441234|NCT00692406|1051111|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
441235|NCT00692406|1051111|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
441236|NCT00692341|1051125|P3|NOT COMPLETED|Overall Study||0
441237|NCT00692341|1051126|P2|NOT COMPLETED|Overall Study||0
441238|NCT00692341|1051127|P1|NOT COMPLETED|Overall Study||0
441239|NCT00692341|1051125|P3|COMPLETED|Overall Study||8
441240|NCT00692341|1051126|P2|COMPLETED|Overall Study||8
441241|NCT00692341|1051127|P1|COMPLETED|Overall Study||8
441242|NCT00692341|1051125|P3|STARTED|Overall Study||8
441243|NCT00692341|1051126|P2|STARTED|Overall Study||8
441244|NCT00692341|1051127|P1|STARTED|Overall Study||8
441245|NCT00692237|1051173|P2|NOT COMPLETED|Overall Study||4
441246|NCT00692237|1051174|P1|NOT COMPLETED|Overall Study||1
441247|NCT00692237|1051173|P2|COMPLETED|Overall Study||25
441248|NCT00692237|1051174|P1|COMPLETED|Overall Study||29
441249|NCT00692237|1051173|P2|STARTED|Overall Study||29
441250|NCT00692237|1051174|P1|STARTED|Overall Study||30
441251|NCT00692211|1051184|P2|NOT COMPLETED|Overall Study||0
441252|NCT00692211|1051185|P1|NOT COMPLETED|Overall Study||0
441253|NCT00692211|1051184|P2|COMPLETED|Overall Study||202
441254|NCT00692211|1051185|P1|COMPLETED|Overall Study||202
441255|NCT00692211|1051184|P2|STARTED|Overall Study||202
441256|NCT00692211|1051185|P1|STARTED|Overall Study||202
441257|NCT00692198|1051193|P2|NOT COMPLETED|Overall Study||0
441258|NCT00692198|1051194|P1|NOT COMPLETED|Overall Study||0
441259|NCT00692198|1051193|P2|COMPLETED|Overall Study||370
441260|NCT00692198|1051194|P1|COMPLETED|Overall Study||368
441261|NCT00692198|1051193|P2|STARTED|Overall Study||370
441262|NCT00692198|1051194|P1|STARTED|Overall Study||368
441263|NCT00692185|1051229|P2|NOT COMPLETED|Overall Study||3
441264|NCT00692185|1051230|P1|NOT COMPLETED|Overall Study||3
441265|NCT00692185|1051229|P2|COMPLETED|Overall Study||9
441266|NCT00692185|1051230|P1|COMPLETED|Overall Study||8
441267|NCT00692185|1051229|P2|STARTED|Overall Study||12
441268|NCT00692185|1051230|P1|STARTED|Overall Study||11
441269|NCT00692003|1051238|P2|NOT COMPLETED|Overall Study||1
441270|NCT00692003|1051239|P1|NOT COMPLETED|Overall Study||5
441271|NCT00692003|1051238|P2|COMPLETED|Overall Study||0
441272|NCT00692003|1051239|P1|COMPLETED|Overall Study||0
441273|NCT00692003|1051238|P2|STARTED|Overall Study||1
441274|NCT00692003|1051239|P1|STARTED|Overall Study||5
441275|NCT00691938|1051254|P7|NOT COMPLETED|Overall Study||0
441276|NCT00691938|1051255|P6|NOT COMPLETED|Overall Study||0
441277|NCT00691938|1051256|P5|NOT COMPLETED|Overall Study||0
441278|NCT00691938|1051257|P4|NOT COMPLETED|Overall Study||0
441279|NCT00691938|1051258|P3|NOT COMPLETED|Overall Study||0
441280|NCT00691938|1051259|P2|NOT COMPLETED|Overall Study||0
441281|NCT00691938|1051260|P1|NOT COMPLETED|Overall Study||1
441282|NCT00691938|1051254|P7|COMPLETED|Overall Study||14
441283|NCT00691938|1051255|P6|COMPLETED|Overall Study||6
441284|NCT00691938|1051256|P5|COMPLETED|Overall Study||10
441285|NCT00691938|1051257|P4|COMPLETED|Overall Study||8
441286|NCT00691938|1051258|P3|COMPLETED|Overall Study||6
441287|NCT00691938|1051259|P2|COMPLETED|Overall Study||3
441288|NCT00691938|1051260|P1|COMPLETED|Overall Study||4
441289|NCT00691938|1051254|P7|STARTED|Overall Study||14
441290|NCT00691938|1051255|P6|STARTED|Overall Study||6
441291|NCT00691938|1051256|P5|STARTED|Overall Study||10
441292|NCT00691938|1051257|P4|STARTED|Overall Study||8
441293|NCT00691938|1051258|P3|STARTED|Overall Study||6
441294|NCT00691938|1051259|P2|STARTED|Overall Study||3
441295|NCT00691938|1051260|P1|STARTED|Overall Study||5
441296|NCT00691808|1051284|P3|NOT COMPLETED|Overall Study||0
441297|NCT00691808|1051285|P2|NOT COMPLETED|Overall Study||1
441298|NCT00691808|1051286|P1|NOT COMPLETED|Overall Study||0
441299|NCT00691808|1051284|P3|COMPLETED|Overall Study||32
441300|NCT00691808|1051285|P2|COMPLETED|Overall Study||35
441301|NCT00691808|1051286|P1|COMPLETED|Overall Study||35
441302|NCT00691808|1051284|P3|STARTED|Overall Study||32
441303|NCT00691808|1051285|P2|STARTED|Overall Study||36
441304|NCT00691808|1051286|P1|STARTED|Overall Study||35
441305|NCT00691327|1051329|P2|NOT COMPLETED|Overall Study||2508
441306|NCT00691327|1051330|P1|NOT COMPLETED|Overall Study||2841
441307|NCT00691327|1051329|P2|COMPLETED|Overall Study||36766
441308|NCT00691327|1051330|P1|COMPLETED|Overall Study||42214
441309|NCT00691327|1051329|P2|STARTED|Overall Study||39274
441310|NCT00691327|1051330|P1|STARTED|Overall Study||45055
441311|NCT00691210|1051346|P8|NOT COMPLETED|Overall Study||0
441312|NCT00691210|1051347|P7|NOT COMPLETED|Overall Study||0
441313|NCT00691210|1051348|P6|NOT COMPLETED|Overall Study||1
441314|NCT00691210|1051349|P5|NOT COMPLETED|Overall Study||0
441315|NCT00691210|1051350|P4|NOT COMPLETED|Overall Study||3
441316|NCT00691210|1051351|P3|NOT COMPLETED|Overall Study||0
441317|NCT00691210|1051352|P2|NOT COMPLETED|Overall Study||0
441318|NCT00691210|1051353|P1|NOT COMPLETED|Overall Study||0
441319|NCT00691210|1051346|P8|COMPLETED|Overall Study||0
441320|NCT00691210|1051347|P7|COMPLETED|Overall Study||6
441321|NCT00691210|1051348|P6|COMPLETED|Overall Study||6
441322|NCT00691210|1051349|P5|COMPLETED|Overall Study||5
441323|NCT00691210|1051350|P4|COMPLETED|Overall Study||6
441324|NCT00691210|1051351|P3|COMPLETED|Overall Study||3
441325|NCT00691210|1051352|P2|COMPLETED|Overall Study||5
441326|NCT00691210|1051353|P1|COMPLETED|Overall Study||3
441327|NCT00691210|1051346|P8|STARTED|Overall Study||0
441328|NCT00691210|1051347|P7|STARTED|Overall Study||6
441329|NCT00691210|1051348|P6|STARTED|Overall Study||7
441330|NCT00691210|1051349|P5|STARTED|Overall Study||5
441331|NCT00691210|1051350|P4|STARTED|Overall Study||9
441332|NCT00691210|1051351|P3|STARTED|Overall Study||3
441333|NCT00691210|1051352|P2|STARTED|Overall Study||5
441334|NCT00691210|1051353|P1|STARTED|Overall Study||3
441335|NCT00691197|1051373|P2|NOT COMPLETED|Overall Study||5
441336|NCT00691197|1051374|P1|NOT COMPLETED|Overall Study||11
441337|NCT00691197|1051373|P2|COMPLETED|Overall Study||75
441338|NCT00691197|1051374|P1|COMPLETED|Overall Study||155
441339|NCT00691197|1051373|P2|STARTED|Overall Study||80
441340|NCT00691197|1051374|P1|STARTED|Overall Study||166
441341|NCT00691132|1051388|P2|NOT COMPLETED|Overall Study||13
441342|NCT00691132|1051389|P1|NOT COMPLETED|Overall Study||12
441343|NCT00691132|1051388|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
441344|NCT00691132|1051389|P1|COMPLETED|Overall Study||41
441345|NCT00691132|1051388|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
441346|NCT00691132|1051389|P1|STARTED|Overall Study||53
441347|NCT00691093|1051408|P1|NOT COMPLETED|Overall Study||7
441348|NCT00691093|1051408|P1|COMPLETED|Overall Study||816
441349|NCT00691093|1051408|P1|STARTED|Overall Study||823
441350|NCT00691054|1051442|P1|NOT COMPLETED|Overall Study||1
441351|NCT00691054|1051442|P1|COMPLETED|Overall Study||19
441352|NCT00691054|1051442|P1|STARTED|Overall Study||20
441353|NCT00691028|1051454|P4|NOT COMPLETED|Double-blind Period||0
441354|NCT00691028|1051455|P3|NOT COMPLETED|Double-blind Period||9
441355|NCT00691028|1051456|P2|NOT COMPLETED|Double-blind Period||13
441356|NCT00691028|1051457|P1|NOT COMPLETED|Double-blind Period||13
441357|NCT00691028|1051454|P4|COMPLETED|Double-blind Period||0
441358|NCT00691028|1051455|P3|COMPLETED|Double-blind Period||95
441359|NCT00691028|1051456|P2|COMPLETED|Double-blind Period||91
441360|NCT00691028|1051457|P1|COMPLETED|Double-blind Period||86
441361|NCT00691028|1051454|P4|STARTED|Double-blind Period||0
441362|NCT00691028|1051455|P3|STARTED|Double-blind Period||104
441363|NCT00691028|1051456|P2|STARTED|Double-blind Period||104
441364|NCT00691028|1051457|P1|STARTED|Double-blind Period||99
441365|NCT00691028|1051454|P4|NOT COMPLETED|Open-label Period||20
441366|NCT00691028|1051455|P3|NOT COMPLETED|Open-label Period||0
441367|NCT00691028|1051456|P2|NOT COMPLETED|Open-label Period||0
441368|NCT00691028|1051457|P1|NOT COMPLETED|Open-label Period||0
441369|NCT00691028|1051454|P4|COMPLETED|Open-label Period||307
441370|NCT00691028|1051455|P3|COMPLETED|Open-label Period||0
441371|NCT00691028|1051456|P2|COMPLETED|Open-label Period||0
441372|NCT00691028|1051457|P1|COMPLETED|Open-label Period||0
441373|NCT00691028|1051454|P4|STARTED|Open-label Period||327
441374|NCT00691028|1051455|P3|STARTED|Open-label Period||0
441375|NCT00691028|1051456|P2|STARTED|Open-label Period||0
441376|NCT00691028|1051457|P1|STARTED|Open-label Period||0
441377|NCT00690898|1051490|P1|NOT COMPLETED|TREATMENT||26
441378|NCT00690898|1051490|P1|COMPLETED|TREATMENT||64
441379|NCT00690898|1051490|P1|STARTED|TREATMENT|Total number of patients treated.|90
441380|NCT00690898|1051490|P1|NOT COMPLETED|SCREENING||18
441381|NCT00690898|1051490|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
441382|NCT00690898|1051490|P1|STARTED|SCREENING|Total of patients screened for the study.|108
441383|NCT00690833|1051504|P1|NOT COMPLETED|Overall Study||2
441384|NCT00690833|1051504|P1|COMPLETED|Overall Study||39
441385|NCT00690833|1051504|P1|STARTED|Overall Study||41
441386|NCT00690820|1051510|P2|NOT COMPLETED|Period 2||0
441387|NCT00690820|1051511|P1|NOT COMPLETED|Period 2||0
441388|NCT00690820|1051510|P2|COMPLETED|Period 2||8
441389|NCT00690820|1051511|P1|COMPLETED|Period 2||8
441390|NCT00690820|1051510|P2|STARTED|Period 2||8
441391|NCT00690820|1051511|P1|STARTED|Period 2||8
441392|NCT00690820|1051510|P2|NOT COMPLETED|Period 1||1
441393|NCT00690820|1051511|P1|NOT COMPLETED|Period 1||0
441394|NCT00690820|1051510|P2|COMPLETED|Period 1||8
441395|NCT00690820|1051511|P1|COMPLETED|Period 1||8
441396|NCT00690820|1051510|P2|STARTED|Period 1||9
441397|NCT00690820|1051511|P1|STARTED|Period 1||8
441398|NCT00690794|1051533|P2|NOT COMPLETED|Overall Study||35
441399|NCT00690794|1051534|P1|NOT COMPLETED|Overall Study||21
441400|NCT00690794|1051533|P2|COMPLETED|Overall Study||328
441401|NCT00690794|1051534|P1|COMPLETED|Overall Study||342
441402|NCT00690794|1051533|P2|STARTED|Overall Study||363
441403|NCT00690794|1051534|P1|STARTED|Overall Study||363
441404|NCT00690755|1051549|P7|NOT COMPLETED|Overall Study||0
441405|NCT00690755|1051550|P6|NOT COMPLETED|Overall Study||4
441406|NCT00690755|1051551|P5|NOT COMPLETED|Overall Study||0
441407|NCT00690755|1051552|P4|NOT COMPLETED|Overall Study||5
441408|NCT00690755|1051553|P3|NOT COMPLETED|Overall Study||46
441409|NCT00690755|1051554|P2|NOT COMPLETED|Overall Study||0
441410|NCT00690755|1051555|P1|NOT COMPLETED|Overall Study||2
441411|NCT00690755|1051549|P7|COMPLETED|Overall Study||0
441412|NCT00690755|1051550|P6|COMPLETED|Overall Study||6
441413|NCT00690755|1051551|P5|COMPLETED|Overall Study||0
441414|NCT00690755|1051552|P4|COMPLETED|Overall Study||15
441415|NCT00690755|1051553|P3|COMPLETED|Overall Study||51
441416|NCT00690755|1051554|P2|COMPLETED|Overall Study||0
441417|NCT00690755|1051555|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
441418|NCT00690755|1051549|P7|STARTED|Overall Study||0
441419|NCT00690755|1051550|P6|STARTED|Overall Study||10
441420|NCT00690755|1051551|P5|STARTED|Overall Study||0
441421|NCT00690755|1051552|P4|STARTED|Overall Study||20
441422|NCT00690755|1051553|P3|STARTED|Overall Study||97
441423|NCT00690755|1051554|P2|STARTED|Overall Study||0
441424|NCT00690755|1051555|P1|STARTED|Overall Study||30
441425|NCT00690612|1051571|P1|NOT COMPLETED|Overall Study||3
441426|NCT00690612|1051571|P1|COMPLETED|Overall Study||32
441427|NCT00690612|1051571|P1|STARTED|Overall Study||35
441428|NCT00690573|1051576|P1|NOT COMPLETED|Overall Study||9
441429|NCT00690573|1051576|P1|COMPLETED|Overall Study||16
441430|NCT00690573|1051576|P1|STARTED|Overall Study||25
441431|NCT00690495|1051586|P2|NOT COMPLETED|Overall Study||0
441432|NCT00690495|1051587|P1|NOT COMPLETED|Overall Study||0
441433|NCT00690495|1051586|P2|COMPLETED|Overall Study||50
441434|NCT00690495|1051587|P1|COMPLETED|Overall Study||50
441435|NCT00690495|1051586|P2|Primary Endpoint|Overall Study||50
441436|NCT00690495|1051587|P1|Primary Endpoint|Overall Study||50
441437|NCT00690495|1051586|P2|STARTED|Overall Study||50
441438|NCT00690495|1051587|P1|STARTED|Overall Study||50
441439|NCT00690482|1051595|P2|NOT COMPLETED|Overall Study||3
441440|NCT00690482|1051596|P1|NOT COMPLETED|Overall Study||4
441441|NCT00690482|1051595|P2|COMPLETED|Overall Study||54
441442|NCT00690482|1051596|P1|COMPLETED|Overall Study||57
441443|NCT00690482|1051595|P2|STARTED|Overall Study||57
441444|NCT00690482|1051596|P1|STARTED|Overall Study||61
441445|NCT00690443|1051630|P2|NOT COMPLETED|Overall Study||2
441446|NCT00690443|1051631|P1|NOT COMPLETED|Overall Study||1
441447|NCT00690443|1051630|P2|COMPLETED|Overall Study||19
441448|NCT00690443|1051631|P1|COMPLETED|Overall Study||22
441449|NCT00690443|1051630|P2|STARTED|Overall Study||21
441450|NCT00690443|1051631|P1|STARTED|Overall Study||23
441451|NCT00690430|1051641|P3|NOT COMPLETED|Extension Phase||13
441452|NCT00690430|1051642|P2|NOT COMPLETED|Extension Phase||5
441453|NCT00690430|1051643|P1|NOT COMPLETED|Extension Phase||18
441454|NCT00690430|1051641|P3|COMPLETED|Extension Phase||2
441455|NCT00690430|1051642|P2|COMPLETED|Extension Phase||1
441456|NCT00690430|1051643|P1|COMPLETED|Extension Phase||2
441547|NCT00689351|1051808|P1|COMPLETED|Infant Series of Dosing||85
441457|NCT00690430|1051641|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
441458|NCT00690430|1051642|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
441459|NCT00690430|1051643|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
441460|NCT00690430|1051641|P3|NOT COMPLETED|Core Phase||0
441461|NCT00690430|1051642|P2|NOT COMPLETED|Core Phase||23
441462|NCT00690430|1051643|P1|NOT COMPLETED|Core Phase||18
441463|NCT00690430|1051641|P3|COMPLETED|Core Phase||0
441464|NCT00690430|1051642|P2|COMPLETED|Core Phase||34
441465|NCT00690430|1051643|P1|COMPLETED|Core Phase||35
441466|NCT00690430|1051641|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
441467|NCT00690430|1051642|P2|STARTED|Core Phase||57
441468|NCT00690430|1051643|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
441469|NCT00690339|1051674|P4|NOT COMPLETED|Overall Study||25
441470|NCT00690339|1051675|P3|NOT COMPLETED|Overall Study||57
441471|NCT00690339|1051676|P2|NOT COMPLETED|Overall Study||81
441472|NCT00690339|1051677|P1|NOT COMPLETED|Overall Study||117
441473|NCT00690339|1051674|P4|COMPLETED|Overall Study||43
441474|NCT00690339|1051675|P3|COMPLETED|Overall Study||99
441475|NCT00690339|1051676|P2|COMPLETED|Overall Study||144
441476|NCT00690339|1051677|P1|COMPLETED|Overall Study||375
441477|NCT00690339|1051674|P4|STARTED|Overall Study||68
441478|NCT00690339|1051675|P3|STARTED|Overall Study||156
441479|NCT00690339|1051676|P2|STARTED|Overall Study||225
441480|NCT00690339|1051677|P1|STARTED|Overall Study||492
441481|NCT00690040|1051693|P2|NOT COMPLETED|Overall Study||0
441482|NCT00690040|1051694|P1|NOT COMPLETED|Overall Study||0
441483|NCT00690040|1051693|P2|COMPLETED|Overall Study||148
441484|NCT00690040|1051694|P1|COMPLETED|Overall Study||145
441485|NCT00690040|1051693|P2|STARTED|Overall Study||148
441486|NCT00690040|1051694|P1|STARTED|Overall Study||145
441487|NCT00689884|1051700|P1|NOT COMPLETED|Overall Study||0
441488|NCT00689884|1051700|P1|COMPLETED|Overall Study||7
441489|NCT00689884|1051700|P1|STARTED|Overall Study||7
441490|NCT00689871|1051709|P4|NOT COMPLETED|Overall Study||7
441491|NCT00689871|1051710|P3|NOT COMPLETED|Overall Study||73
441492|NCT00689871|1051711|P2|NOT COMPLETED|Overall Study||52
441493|NCT00689871|1051712|P1|NOT COMPLETED|Overall Study||175
441494|NCT00689871|1051709|P4|COMPLETED|Overall Study|4 Patients discontinued|8
441495|NCT00689871|1051710|P3|COMPLETED|Overall Study|28 Patients discontinued|74
441496|NCT00689871|1051711|P2|COMPLETED|Overall Study|35 Patients discontinued|46
441497|NCT00689871|1051712|P1|COMPLETED|Overall Study|35 Patients discontinued|280
441498|NCT00689871|1051709|P4|STARTED|Overall Study|25 Implants|15
441499|NCT00689871|1051710|P3|STARTED|Overall Study|288 Implants|147
441500|NCT00689871|1051711|P2|STARTED|Overall Study|127 Implants|98
441501|NCT00689871|1051712|P1|STARTED|Overall Study|908 Implants|455
441502|NCT00689819|1051728|P2|NOT COMPLETED|Overall Study||15
441503|NCT00689819|1051729|P1|NOT COMPLETED|Overall Study||20
441504|NCT00689819|1051728|P2|COMPLETED|Overall Study||43
441505|NCT00689819|1051729|P1|COMPLETED|Overall Study||45
441506|NCT00689819|1051728|P2|STARTED|Overall Study||58
441507|NCT00689819|1051729|P1|STARTED|Overall Study||65
441508|NCT00689793|1051739|P2|NOT COMPLETED|Overall Study||5
441509|NCT00689793|1051740|P1|NOT COMPLETED|Overall Study||4
441510|NCT00689793|1051739|P2|COMPLETED|Overall Study||71
441511|NCT00689793|1051740|P1|COMPLETED|Overall Study||74
441512|NCT00689793|1051739|P2|STARTED|Overall Study||76
441513|NCT00689793|1051740|P1|STARTED|Overall Study||78
441514|NCT00689611|1051758|P2|NOT COMPLETED|Overall Study||46
441515|NCT00689611|1051759|P1|NOT COMPLETED|Overall Study||41
441516|NCT00689611|1051758|P2|COMPLETED|Overall Study||146
441517|NCT00689611|1051759|P1|COMPLETED|Overall Study||159
441518|NCT00689611|1051758|P2|STARTED|Overall Study||192
441519|NCT00689611|1051759|P1|STARTED|Overall Study||200
441520|NCT00689481|1051769|P2|NOT COMPLETED|Overall Study||14
441521|NCT00689481|1051770|P1|NOT COMPLETED|Overall Study||24
441522|NCT00689481|1051769|P2|COMPLETED|Overall Study||95
441523|NCT00689481|1051770|P1|COMPLETED|Overall Study||190
441524|NCT00689481|1051769|P2|STARTED|Overall Study||109
441525|NCT00689481|1051770|P1|STARTED|Overall Study||214
441526|NCT00689390|1051788|P2|NOT COMPLETED|Overall Study||10
441527|NCT00689390|1051789|P1|NOT COMPLETED|Overall Study||426
441528|NCT00689390|1051788|P2|COMPLETED|Overall Study||37
441529|NCT00689390|1051789|P1|COMPLETED|Overall Study||1481
441530|NCT00689390|1051788|P2|STARTED|Overall Study||47
441531|NCT00689390|1051789|P1|STARTED|Overall Study||1907
441532|NCT00689351|1051807|P2|NOT COMPLETED|Toddler Dose||0
441533|NCT00689351|1051808|P1|NOT COMPLETED|Toddler Dose||0
441534|NCT00689351|1051807|P2|COMPLETED|Toddler Dose||88
441535|NCT00689351|1051808|P1|COMPLETED|Toddler Dose||84
441536|NCT00689351|1051807|P2|STARTED|Toddler Dose||88
441537|NCT00689351|1051808|P1|STARTED|Toddler Dose||84
441538|NCT00689351|1051807|P2|NOT COMPLETED|After Infant Series||0
441539|NCT00689351|1051808|P1|NOT COMPLETED|After Infant Series||1
441540|NCT00689351|1051807|P2|COMPLETED|After Infant Series||88
441541|NCT00689351|1051808|P1|COMPLETED|After Infant Series||84
441542|NCT00689351|1051807|P2|STARTED|After Infant Series||88
441543|NCT00689351|1051808|P1|STARTED|After Infant Series||85
441544|NCT00689351|1051807|P2|NOT COMPLETED|Infant Series of Dosing||1
441545|NCT00689351|1051808|P1|NOT COMPLETED|Infant Series of Dosing||6
441546|NCT00689351|1051807|P2|COMPLETED|Infant Series of Dosing||88
441548|NCT00689351|1051807|P2|Vaccinated Dose 3|Infant Series of Dosing||88
441549|NCT00689351|1051808|P1|Vaccinated Dose 3|Infant Series of Dosing||85
441550|NCT00689351|1051807|P2|Vaccinated Dose 2|Infant Series of Dosing||88
441551|NCT00689351|1051808|P1|Vaccinated Dose 2|Infant Series of Dosing||86
441552|NCT00689351|1051807|P2|Vaccinated Dose 1|Infant Series of Dosing||89
441553|NCT00689351|1051808|P1|Vaccinated Dose 1|Infant Series of Dosing||88
441554|NCT00689351|1051807|P2|STARTED|Infant Series of Dosing||89
441555|NCT00689351|1051808|P1|STARTED|Infant Series of Dosing||91
441556|NCT00689338|1051840|P1|NOT COMPLETED|Overall Study||143
441557|NCT00689338|1051840|P1|COMPLETED|Overall Study||73
441558|NCT00689338|1051840|P1|STARTED|Overall Study||216
441559|NCT00689299|1051853|P3|NOT COMPLETED|Overall Study||5
441560|NCT00689299|1051854|P2|NOT COMPLETED|Overall Study||3
441561|NCT00689299|1051855|P1|NOT COMPLETED|Overall Study||7
441562|NCT00689299|1051853|P3|COMPLETED|Overall Study||49
441563|NCT00689299|1051854|P2|COMPLETED|Overall Study||54
441564|NCT00689299|1051855|P1|COMPLETED|Overall Study||51
441565|NCT00689299|1051853|P3|STARTED|Overall Study||54
441566|NCT00689299|1051854|P2|STARTED|Overall Study||57
441567|NCT00689299|1051855|P1|STARTED|Overall Study||58
441568|NCT00689260|1051865|P2|NOT COMPLETED|Overall Study||0
441569|NCT00689260|1051866|P1|NOT COMPLETED|Overall Study||2
441570|NCT00689260|1051865|P2|COMPLETED|Overall Study||21
441571|NCT00689260|1051866|P1|COMPLETED|Overall Study||19
441572|NCT00689260|1051865|P2|STARTED|Overall Study||21
441573|NCT00689260|1051866|P1|STARTED|Overall Study||21
441574|NCT00689221|1051884|P2|NOT COMPLETED|Overall Study||36
441575|NCT00689221|1051885|P1|NOT COMPLETED|Overall Study||39
441576|NCT00689221|1051884|P2|COMPLETED|Overall Study||237
441577|NCT00689221|1051885|P1|COMPLETED|Overall Study||233
441578|NCT00689221|1051884|P2|STARTED|Overall Study||273
441579|NCT00689221|1051885|P1|STARTED|Overall Study||272
441580|NCT00689117|1051914|P4|NOT COMPLETED|Overall Study||31
441581|NCT00689117|1051915|P3|NOT COMPLETED|Overall Study||59
441582|NCT00689117|1051916|P2|NOT COMPLETED|Overall Study||51
441583|NCT00689117|1051917|P1|NOT COMPLETED|Overall Study||62
441584|NCT00689117|1051914|P4|COMPLETED|Overall Study||211
441585|NCT00689117|1051915|P3|COMPLETED|Overall Study||405
441586|NCT00689117|1051916|P2|COMPLETED|Overall Study||416
441587|NCT00689117|1051917|P1|COMPLETED|Overall Study||414
441588|NCT00689117|1051914|P4|STARTED|Overall Study||242
441589|NCT00689117|1051915|P3|STARTED|Overall Study||464
441590|NCT00689117|1051916|P2|STARTED|Overall Study||467
441591|NCT00689117|1051917|P1|STARTED|Overall Study||476
441592|NCT00689104|1051947|P4|NOT COMPLETED|Overall Study||50
441593|NCT00689104|1051948|P3|NOT COMPLETED|Overall Study||45
441594|NCT00689104|1051949|P2|NOT COMPLETED|Overall Study||57
441595|NCT00689104|1051950|P1|NOT COMPLETED|Overall Study||44
441596|NCT00689104|1051947|P4|COMPLETED|Overall Study||445
441597|NCT00689104|1051948|P3|COMPLETED|Overall Study||453
441598|NCT00689104|1051949|P2|COMPLETED|Overall Study||440
441599|NCT00689104|1051950|P1|COMPLETED|Overall Study||453
441600|NCT00689104|1051947|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
441601|NCT00689104|1051948|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
441602|NCT00689104|1051949|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
441603|NCT00689104|1051950|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
441604|NCT00689104|1051947|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
441605|NCT00689104|1051948|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
441606|NCT00689104|1051949|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
441607|NCT00689104|1051950|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
441693|NCT00688701|1052204|P1|STARTED|Overall Study|Randomized|61
441608|NCT00689104|1051947|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
441609|NCT00689104|1051948|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
441610|NCT00689104|1051949|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
441611|NCT00689104|1051950|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
441612|NCT00689104|1051947|P4|STARTED|Overall Study||495
441613|NCT00689104|1051948|P3|STARTED|Overall Study||498
441614|NCT00689104|1051949|P2|STARTED|Overall Study||497
441615|NCT00689104|1051950|P1|STARTED|Overall Study||497
441616|NCT00689091|1052082|P2|NOT COMPLETED|Overall Study||1394
441617|NCT00689091|1052083|P1|NOT COMPLETED|Overall Study||1371
441618|NCT00689091|1052082|P2|COMPLETED|Overall Study||9376
441619|NCT00689091|1052083|P1|COMPLETED|Overall Study||9460
441620|NCT00689091|1052082|P2|STARTED|Overall Study||10770
441621|NCT00689091|1052083|P1|STARTED|Overall Study||10831
441622|NCT00689052|1052091|P2|NOT COMPLETED|Overall Study||30
441623|NCT00689052|1052092|P1|NOT COMPLETED|Overall Study||31
441624|NCT00689052|1052091|P2|COMPLETED|Overall Study||0
441625|NCT00689052|1052092|P1|COMPLETED|Overall Study||0
441626|NCT00689052|1052091|P2|STARTED|Overall Study||30
441627|NCT00689052|1052092|P1|STARTED|Overall Study||31
441628|NCT00689026|1052124|P2|NOT COMPLETED|Overall Study||6
441629|NCT00689026|1052125|P1|NOT COMPLETED|Overall Study||13
441630|NCT00689026|1052124|P2|COMPLETED|Overall Study||24
441631|NCT00689026|1052125|P1|COMPLETED|Overall Study||17
441632|NCT00689026|1052124|P2|STARTED|Overall Study||30
441633|NCT00689026|1052125|P1|STARTED|Overall Study||30
441634|NCT00688870|1052133|P2|NOT COMPLETED|Toddler Dose||0
441635|NCT00688870|1052134|P1|NOT COMPLETED|Toddler Dose||0
441636|NCT00688870|1052133|P2|COMPLETED|Toddler Dose||84
441637|NCT00688870|1052134|P1|COMPLETED|Toddler Dose||80
441638|NCT00688870|1052133|P2|STARTED|Toddler Dose||84
441639|NCT00688870|1052134|P1|STARTED|Toddler Dose||80
441640|NCT00688870|1052133|P2|NOT COMPLETED|After Infant Series||0
441641|NCT00688870|1052134|P1|NOT COMPLETED|After Infant Series||0
441642|NCT00688870|1052133|P2|COMPLETED|After Infant Series||84
441643|NCT00688870|1052134|P1|COMPLETED|After Infant Series||80
441644|NCT00688870|1052133|P2|STARTED|After Infant Series||84
441645|NCT00688870|1052134|P1|STARTED|After Infant Series||80
441646|NCT00688870|1052133|P2|NOT COMPLETED|Infant Series||0
441647|NCT00688870|1052134|P1|NOT COMPLETED|Infant Series||4
441648|NCT00688870|1052133|P2|COMPLETED|Infant Series||84
441649|NCT00688870|1052134|P1|COMPLETED|Infant Series||80
441650|NCT00688870|1052133|P2|Vaccinated Dose 3|Infant Series||84
441651|NCT00688870|1052134|P1|Vaccinated Dose 3|Infant Series||80
441652|NCT00688870|1052133|P2|Vaccinated Dose 2|Infant Series||84
441653|NCT00688870|1052134|P1|Vaccinated Dose 2|Infant Series||80
441654|NCT00688870|1052133|P2|Vaccinated Dose 1|Infant Series||84
441655|NCT00688870|1052134|P1|Vaccinated Dose 1|Infant Series||83
441656|NCT00688870|1052133|P2|STARTED|Infant Series||84
441657|NCT00688870|1052134|P1|STARTED|Infant Series||84
441658|NCT00688844|1052166|P1|NOT COMPLETED|Overall Study||10
441659|NCT00688844|1052166|P1|COMPLETED|Overall Study||48
441660|NCT00688844|1052166|P1|STARTED|Overall Study||58
441661|NCT00688753|1052176|P1|NOT COMPLETED|Overall Study||92
441662|NCT00688753|1052176|P1|COMPLETED|Overall Study||0
441663|NCT00688753|1052176|P1|STARTED|Overall Study||92
441664|NCT00688740|1052187|P2|NOT COMPLETED|Overall Study||35
441665|NCT00688740|1052188|P1|NOT COMPLETED|Overall Study||66
441666|NCT00688740|1052187|P2|COMPLETED|Overall Study||711
441667|NCT00688740|1052188|P1|COMPLETED|Overall Study||679
441668|NCT00688740|1052187|P2|STARTED|Overall Study||746
441669|NCT00688740|1052188|P1|STARTED|Overall Study||745
441670|NCT00688701|1052201|P4|NOT COMPLETED|Overall Study||11
441671|NCT00688701|1052202|P3|NOT COMPLETED|Overall Study||10
441672|NCT00688701|1052203|P2|NOT COMPLETED|Overall Study||5
441673|NCT00688701|1052204|P1|NOT COMPLETED|Overall Study||4
441674|NCT00688701|1052201|P4|COMPLETED|Overall Study||108
441675|NCT00688701|1052202|P3|COMPLETED|Overall Study||110
441676|NCT00688701|1052203|P2|COMPLETED|Overall Study||56
441677|NCT00688701|1052204|P1|COMPLETED|Overall Study||57
441678|NCT00688701|1052201|P4|Subgroup for Standardized Meal Test|Overall Study||65
441679|NCT00688701|1052202|P3|Subgroup for Standardized Meal Test|Overall Study||60
441680|NCT00688701|1052203|P2|Subgroup for Standardized Meal Test|Overall Study||35
441681|NCT00688701|1052204|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
441682|NCT00688701|1052201|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
441683|NCT00688701|1052202|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
441684|NCT00688701|1052203|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
441685|NCT00688701|1052204|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
441686|NCT00688701|1052201|P4|Treated/Safety Population|Overall Study||119
441687|NCT00688701|1052202|P3|Treated/Safety Population|Overall Study||120
441688|NCT00688701|1052203|P2|Treated/Safety Population|Overall Study||61
441689|NCT00688701|1052204|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
441690|NCT00688701|1052201|P4|STARTED|Overall Study||119
441691|NCT00688701|1052202|P3|STARTED|Overall Study||120
441692|NCT00688701|1052203|P2|STARTED|Overall Study||61
441694|NCT00688688|1052245|P3|NOT COMPLETED|Overall Study||192
441695|NCT00688688|1052246|P2|NOT COMPLETED|Overall Study||179
441696|NCT00688688|1052247|P1|NOT COMPLETED|Overall Study||186
441697|NCT00688688|1052245|P3|COMPLETED|Overall Study||621
441698|NCT00688688|1052246|P2|COMPLETED|Overall Study||645
441699|NCT00688688|1052247|P1|COMPLETED|Overall Study||629
441700|NCT00688688|1052245|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
441701|NCT00688688|1052246|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
441702|NCT00688688|1052247|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
441703|NCT00688688|1052245|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
441704|NCT00688688|1052246|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
441705|NCT00688688|1052247|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
441706|NCT00688688|1052245|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
441707|NCT00688688|1052246|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
441708|NCT00688688|1052247|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
441709|NCT00688688|1052245|P3|STARTED|Overall Study||813
441710|NCT00688688|1052246|P2|STARTED|Overall Study||824
441711|NCT00688688|1052247|P1|STARTED|Overall Study||815
441712|NCT00688662|1052338|P2|NOT COMPLETED|Overall Study||18
441713|NCT00688662|1052339|P1|NOT COMPLETED|Overall Study||23
441714|NCT00688662|1052338|P2|COMPLETED|Overall Study||55
441715|NCT00688662|1052339|P1|COMPLETED|Overall Study||118
441716|NCT00688662|1052338|P2|STARTED|Overall Study||73
441717|NCT00688662|1052339|P1|STARTED|Overall Study||141
441718|NCT00688636|1052349|P2|NOT COMPLETED|Overall Study||1
441719|NCT00688636|1052350|P1|NOT COMPLETED|Overall Study||2
441720|NCT00688636|1052349|P2|COMPLETED|Overall Study||12
441721|NCT00688636|1052350|P1|COMPLETED|Overall Study||9
441722|NCT00688636|1052349|P2|STARTED|Overall Study||13
441723|NCT00688636|1052350|P1|STARTED|Overall Study||11
441724|NCT00688545|1052366|P2|NOT COMPLETED|Overall Study||15
441725|NCT00688545|1052367|P1|NOT COMPLETED|Overall Study||5
441726|NCT00688545|1052366|P2|COMPLETED|Overall Study||204
441727|NCT00688545|1052367|P1|COMPLETED|Overall Study||50
441728|NCT00688545|1052366|P2|Switched Treatment at Least Once|Overall Study||13
441729|NCT00688545|1052367|P1|Switched Treatment at Least Once|Overall Study||6
441730|NCT00688545|1052366|P2|STARTED|Overall Study||219
441731|NCT00688545|1052367|P1|STARTED|Overall Study||55
441732|NCT00688519|1052377|P2|NOT COMPLETED|Overall Study||15
441733|NCT00688519|1052378|P1|NOT COMPLETED|Overall Study||19
441734|NCT00688519|1052377|P2|COMPLETED|Overall Study||98
441735|NCT00688519|1052378|P1|COMPLETED|Overall Study||204
441736|NCT00688519|1052377|P2|STARTED|Overall Study||113
441737|NCT00688519|1052378|P1|STARTED|Overall Study||223
441738|NCT00688467|1052396|P2|NOT COMPLETED|Treatment Period 2||2
441739|NCT00688467|1052397|P1|NOT COMPLETED|Treatment Period 2||0
441740|NCT00688467|1052396|P2|COMPLETED|Treatment Period 2||6
441741|NCT00688467|1052397|P1|COMPLETED|Treatment Period 2||7
441742|NCT00688467|1052396|P2|STARTED|Treatment Period 2||8
441743|NCT00688467|1052397|P1|STARTED|Treatment Period 2||7
441744|NCT00688467|1052396|P2|NOT COMPLETED|Treatment Period 1||2
441745|NCT00688467|1052397|P1|NOT COMPLETED|Treatment Period 1||2
441746|NCT00688467|1052396|P2|COMPLETED|Treatment Period 1||8
441747|NCT00688467|1052397|P1|COMPLETED|Treatment Period 1||7
441748|NCT00688467|1052396|P2|STARTED|Treatment Period 1||10
441749|NCT00688467|1052397|P1|STARTED|Treatment Period 1||9
441750|NCT00688103|1052429|P2|NOT COMPLETED|Overall Study||13
441751|NCT00688103|1052430|P1|NOT COMPLETED|Overall Study||30
441752|NCT00688103|1052429|P2|COMPLETED|Overall Study||64
441753|NCT00688103|1052430|P1|COMPLETED|Overall Study||44
441754|NCT00688103|1052429|P2|Actually Treated|Overall Study||76
441755|NCT00688103|1052430|P1|Actually Treated|Overall Study||71
441756|NCT00688103|1052429|P2|STARTED|Overall Study||77
441757|NCT00688103|1052430|P1|STARTED|Overall Study||74
441758|NCT00688064|1052442|P2|NOT COMPLETED|Overall Study||26
441759|NCT00688064|1052443|P1|NOT COMPLETED|Overall Study||21
441760|NCT00688064|1052442|P2|COMPLETED|Overall Study||201
441761|NCT00688064|1052443|P1|COMPLETED|Overall Study||211
441762|NCT00688064|1052442|P2|STARTED|Overall Study||227
441763|NCT00688064|1052443|P1|STARTED|Overall Study||232
441764|NCT00687973|1052459|P2|NOT COMPLETED|Overall Study||38
441765|NCT00687973|1052460|P1|NOT COMPLETED|Overall Study||24
441766|NCT00687973|1052459|P2|COMPLETED|Overall Study||162
441767|NCT00687973|1052460|P1|COMPLETED|Overall Study||169
441768|NCT00687973|1052459|P2|STARTED|Overall Study||200
441769|NCT00687973|1052460|P1|STARTED|Overall Study||193
441770|NCT00687908|1052489|P2|NOT COMPLETED|Overall Study||42
441771|NCT00687908|1052490|P1|NOT COMPLETED|Overall Study||18
441772|NCT00687908|1052489|P2|COMPLETED|Overall Study||78
441773|NCT00687908|1052490|P1|COMPLETED|Overall Study||105
441774|NCT00687908|1052489|P2|STARTED|Overall Study||120
441775|NCT00687908|1052490|P1|STARTED|Overall Study||123
441776|NCT00687856|1052504|P1|NOT COMPLETED|Overall Study||0
441777|NCT00687856|1052504|P1|COMPLETED|Overall Study||211
441778|NCT00687856|1052504|P1|STARTED|Overall Study||211
441779|NCT00687830|1052510|P2|NOT COMPLETED|Overall Study||0
441780|NCT00687830|1052511|P1|NOT COMPLETED|Overall Study||0
441781|NCT00687830|1052510|P2|COMPLETED|Overall Study||68
441782|NCT00687830|1052511|P1|COMPLETED|Overall Study||68
441783|NCT00687830|1052510|P2|STARTED|Overall Study||68
441784|NCT00687830|1052511|P1|STARTED|Overall Study||68
441785|NCT00687804|1052522|P3|NOT COMPLETED|Open-Label Extension Study||11
441786|NCT00687804|1052523|P2|NOT COMPLETED|Open-Label Extension Study||11
441787|NCT00687804|1052524|P1|NOT COMPLETED|Open-Label Extension Study||10
441788|NCT00687804|1052522|P3|COMPLETED|Open-Label Extension Study||63
441789|NCT00687804|1052523|P2|COMPLETED|Open-Label Extension Study||72
441790|NCT00687804|1052524|P1|COMPLETED|Open-Label Extension Study||73
441791|NCT00687804|1052522|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
441792|NCT00687804|1052523|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
441793|NCT00687804|1052524|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
441794|NCT00687804|1052522|P3|STARTED|Open-Label Extension Study||74
441795|NCT00687804|1052523|P2|STARTED|Open-Label Extension Study||83
441796|NCT00687804|1052524|P1|STARTED|Open-Label Extension Study||83
441797|NCT00687804|1052522|P3|NOT COMPLETED|Core Study||13
441798|NCT00687804|1052523|P2|NOT COMPLETED|Core Study||15
441799|NCT00687804|1052524|P1|NOT COMPLETED|Core Study||14
441800|NCT00687804|1052522|P3|COMPLETED|Core Study||98
441801|NCT00687804|1052523|P2|COMPLETED|Core Study||103
441802|NCT00687804|1052524|P1|COMPLETED|Core Study||102
441803|NCT00687804|1052522|P3|STARTED|Core Study||111
441804|NCT00687804|1052523|P2|STARTED|Core Study||118
441805|NCT00687804|1052524|P1|STARTED|Core Study||116
441806|NCT00687713|1052569|P2|NOT COMPLETED|Overall Study||40
441807|NCT00687713|1052570|P1|NOT COMPLETED|Overall Study||32
441808|NCT00687713|1052569|P2|COMPLETED|Overall Study||64
441809|NCT00687713|1052570|P1|COMPLETED|Overall Study||68
441810|NCT00687713|1052569|P2|STARTED|Overall Study||104
441811|NCT00687713|1052570|P1|STARTED|Overall Study||100
441812|NCT00687674|1052578|P1|NOT COMPLETED|Overall Study||2
441813|NCT00687674|1052578|P1|COMPLETED|Overall Study||11
441814|NCT00687674|1052578|P1|STARTED|Overall Study||13
441815|NCT00687609|1052585|P1|NOT COMPLETED|Overall Study||3
441816|NCT00687609|1052585|P1|COMPLETED|Overall Study||4
441817|NCT00687609|1052585|P1|STARTED|Overall Study||7
441818|NCT00687544|1052599|P1|NOT COMPLETED|Overall Study||11
441819|NCT00687544|1052599|P1|COMPLETED|Overall Study||0
441820|NCT00687544|1052599|P1|STARTED|Overall Study||11
441821|NCT00687531|1052608|P1|NOT COMPLETED|Overall Study||135
441822|NCT00687531|1052608|P1|COMPLETED|Overall Study||250
441823|NCT00687531|1052608|P1|RECEIVED TREATMENT|Overall Study||281
441824|NCT00687531|1052608|P1|STARTED|Overall Study|Completed screening procedures|385
441825|NCT00687453|1052624|P2|NOT COMPLETED|Overall Study||6
441826|NCT00687453|1052625|P1|NOT COMPLETED|Overall Study||3
441827|NCT00687453|1052624|P2|COMPLETED|Overall Study||7
441828|NCT00687453|1052625|P1|COMPLETED|Overall Study||8
441829|NCT00687453|1052624|P2|STARTED|Overall Study||13
441830|NCT00687453|1052625|P1|STARTED|Overall Study||11
441831|NCT00687440|1052631|P1|NOT COMPLETED|Overall Study||12
441832|NCT00687440|1052631|P1|COMPLETED|Overall Study||15
441833|NCT00687440|1052631|P1|STARTED|Overall Study|Number of screened participants|27
441834|NCT00687401|1052635|P1|NOT COMPLETED|Overall Study||30
441835|NCT00687401|1052635|P1|COMPLETED|Overall Study||129
441836|NCT00687401|1052635|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
441837|NCT00687362|1052640|P1|NOT COMPLETED|Overall Study||3
441838|NCT00687362|1052640|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
441839|NCT00687362|1052640|P1|STARTED|Overall Study||22
441840|NCT00687323|1052644|P1|NOT COMPLETED|Overall Study||180
441841|NCT00687323|1052644|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
441842|NCT00687323|1052644|P1|Received Treatment|Overall Study||47
441843|NCT00687323|1052644|P1|STARTED|Overall Study|Number of screened participants|195
441844|NCT00687297|1052660|P2|NOT COMPLETED|Maintenance||1
441845|NCT00687297|1052661|P1|NOT COMPLETED|Maintenance||3
441846|NCT00687297|1052660|P2|COMPLETED|Maintenance||25
441847|NCT00687297|1052661|P1|COMPLETED|Maintenance||29
441848|NCT00687297|1052660|P2|STARTED|Maintenance||26
441849|NCT00687297|1052661|P1|STARTED|Maintenance||32
441850|NCT00687297|1052660|P2|NOT COMPLETED|Induction||55
441851|NCT00687297|1052661|P1|NOT COMPLETED|Induction||45
441852|NCT00687297|1052660|P2|COMPLETED|Induction||26
441853|NCT00687297|1052661|P1|COMPLETED|Induction||32
441854|NCT00687297|1052660|P2|STARTED|Induction||81
441855|NCT00687297|1052661|P1|STARTED|Induction||77
441856|NCT00687297|1052660|P2|NOT COMPLETED|Randomization||1
441857|NCT00687297|1052661|P1|NOT COMPLETED|Randomization||3
441858|NCT00687297|1052660|P2|COMPLETED|Randomization||81
441859|NCT00687297|1052661|P1|COMPLETED|Randomization||77
441860|NCT00687297|1052660|P2|STARTED|Randomization||82
441861|NCT00687297|1052661|P1|STARTED|Randomization||80
441862|NCT00687219|1052671|P1|NOT COMPLETED|Overall Study||51
441863|NCT00687219|1052671|P1|COMPLETED|Overall Study||51
441864|NCT00687219|1052671|P1|STARTED|Overall Study||102
441865|NCT00687193|1052683|P6|NOT COMPLETED|Overall Study||4
441866|NCT00687193|1052684|P5|NOT COMPLETED|Overall Study||2
441867|NCT00687193|1052685|P4|NOT COMPLETED|Overall Study||4
441868|NCT00687193|1052686|P3|NOT COMPLETED|Overall Study||2
441869|NCT00687193|1052687|P2|NOT COMPLETED|Overall Study||4
441870|NCT00687193|1052688|P1|NOT COMPLETED|Overall Study||2
441871|NCT00687193|1052683|P6|COMPLETED|Overall Study||48
441872|NCT00687193|1052684|P5|COMPLETED|Overall Study||52
441873|NCT00687193|1052685|P4|COMPLETED|Overall Study||49
441874|NCT00687193|1052686|P3|COMPLETED|Overall Study||50
441875|NCT00687193|1052687|P2|COMPLETED|Overall Study||49
441876|NCT00687193|1052688|P1|COMPLETED|Overall Study||51
441877|NCT00687193|1052683|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
441878|NCT00687193|1052684|P5|STARTED|Overall Study||54
441879|NCT00687193|1052685|P4|STARTED|Overall Study||53
441880|NCT00687193|1052686|P3|STARTED|Overall Study||52
441881|NCT00687193|1052687|P2|STARTED|Overall Study||53
441882|NCT00687193|1052688|P1|STARTED|Overall Study||53
441883|NCT00686166|1052852|P1|NOT COMPLETED|Overall Study||20
441884|NCT00686166|1052852|P1|COMPLETED|Overall Study||63
441885|NCT00686166|1052852|P1|Eligible and Began Protocol Therapy|Overall Study||74
441886|NCT00686166|1052852|P1|Eligible|Overall Study||78
441887|NCT00686166|1052852|P1|STARTED|Overall Study||83
441888|NCT00686127|1052864|P2|NOT COMPLETED|Overall Study||6
441889|NCT00686127|1052865|P1|NOT COMPLETED|Overall Study||14
441890|NCT00686127|1052864|P2|COMPLETED|Overall Study||1
441891|NCT00686127|1052865|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
441892|NCT00686127|1052864|P2|STARTED|Overall Study||7
441893|NCT00686127|1052865|P1|STARTED|Overall Study||14
441894|NCT00686075|1052881|P10|NOT COMPLETED|Overall Study||10
441895|NCT00686075|1052882|P9|NOT COMPLETED|Overall Study||6
441896|NCT00686075|1052883|P8|NOT COMPLETED|Overall Study||2
441897|NCT00686075|1052884|P7|NOT COMPLETED|Overall Study||0
441898|NCT00686075|1052885|P6|NOT COMPLETED|Overall Study||3
441899|NCT00686075|1052886|P5|NOT COMPLETED|Overall Study||4
441900|NCT00686075|1052887|P4|NOT COMPLETED|Overall Study||9
441901|NCT00686075|1052888|P3|NOT COMPLETED|Overall Study||6
441902|NCT00686075|1052889|P2|NOT COMPLETED|Overall Study||10
441903|NCT00686075|1052890|P1|NOT COMPLETED|Overall Study||8
441904|NCT00686075|1052881|P10|COMPLETED|Overall Study||69
441905|NCT00686075|1052882|P9|COMPLETED|Overall Study||75
441906|NCT00686075|1052883|P8|COMPLETED|Overall Study||76
441907|NCT00686075|1052884|P7|COMPLETED|Overall Study||82
441908|NCT00686075|1052885|P6|COMPLETED|Overall Study||37
441909|NCT00686075|1052886|P5|COMPLETED|Overall Study||36
441910|NCT00686075|1052887|P4|COMPLETED|Overall Study||71
441911|NCT00686075|1052888|P3|COMPLETED|Overall Study||74
441912|NCT00686075|1052889|P2|COMPLETED|Overall Study||71
441913|NCT00686075|1052890|P1|COMPLETED|Overall Study||71
441914|NCT00686075|1052881|P10|Treated|Overall Study||78
441915|NCT00686075|1052882|P9|Treated|Overall Study||80
441916|NCT00686075|1052883|P8|Treated|Overall Study||77
441917|NCT00686075|1052884|P7|Treated|Overall Study||82
441918|NCT00686075|1052885|P6|Treated|Overall Study||40
441919|NCT00686075|1052886|P5|Treated|Overall Study||40
441920|NCT00686075|1052887|P4|Treated|Overall Study||80
441921|NCT00686075|1052888|P3|Treated|Overall Study||80
441922|NCT00686075|1052889|P2|Treated|Overall Study||79
441923|NCT00686075|1052890|P1|Treated|Overall Study||78
441924|NCT00686075|1052881|P10|STARTED|Overall Study||79
441925|NCT00686075|1052882|P9|STARTED|Overall Study||81
441926|NCT00686075|1052883|P8|STARTED|Overall Study||78
441927|NCT00686075|1052884|P7|STARTED|Overall Study||82
441928|NCT00686075|1052885|P6|STARTED|Overall Study||40
441929|NCT00686075|1052886|P5|STARTED|Overall Study||40
441930|NCT00686075|1052887|P4|STARTED|Overall Study||80
441931|NCT00686075|1052888|P3|STARTED|Overall Study||80
441932|NCT00686075|1052889|P2|STARTED|Overall Study||81
441933|NCT00686075|1052890|P1|STARTED|Overall Study||79
441934|NCT00686036|1053084|P2|NOT COMPLETED|Overall Study||6
441935|NCT00686036|1053085|P1|NOT COMPLETED|Overall Study||9
441936|NCT00686036|1053084|P2|COMPLETED|Overall Study||2
441937|NCT00686036|1053085|P1|COMPLETED|Overall Study||0
441938|NCT00686036|1053084|P2|STARTED|Overall Study||8
441939|NCT00686036|1053085|P1|STARTED|Overall Study||9
441940|NCT00685945|1053097|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
441941|NCT00685945|1053097|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
441942|NCT00685945|1053097|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
441943|NCT00685945|1053097|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
441944|NCT00685945|1053097|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
441945|NCT00685945|1053097|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
441946|NCT00685945|1053097|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
441947|NCT00685945|1053097|P1|COMPLETED|L-NMMA + Bradykinin||23
441948|NCT00685945|1053097|P1|STARTED|L-NMMA + Bradykinin||24
441949|NCT00685945|1053097|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
441950|NCT00685945|1053097|P1|COMPLETED|Control (Bradykinin Infusion)||24
441951|NCT00685945|1053097|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
441952|NCT00687167|1053112|P2|NOT COMPLETED|Second Intervention||0
441953|NCT00687167|1053113|P1|NOT COMPLETED|Second Intervention||0
441954|NCT00687167|1053112|P2|COMPLETED|Second Intervention||17
441955|NCT00687167|1053113|P1|COMPLETED|Second Intervention||17
441956|NCT00687167|1053112|P2|STARTED|Second Intervention||17
441957|NCT00687167|1053113|P1|STARTED|Second Intervention||17
441958|NCT00687167|1053112|P2|NOT COMPLETED|Washout Period of 28 Days||0
441959|NCT00687167|1053113|P1|NOT COMPLETED|Washout Period of 28 Days||0
441960|NCT00687167|1053112|P2|COMPLETED|Washout Period of 28 Days||17
441961|NCT00687167|1053113|P1|COMPLETED|Washout Period of 28 Days||17
441962|NCT00687167|1053112|P2|STARTED|Washout Period of 28 Days||17
441963|NCT00687167|1053113|P1|STARTED|Washout Period of 28 Days||17
441964|NCT00687167|1053112|P2|NOT COMPLETED|First Intervention||0
441965|NCT00687167|1053113|P1|NOT COMPLETED|First Intervention||0
441966|NCT00687167|1053112|P2|COMPLETED|First Intervention||17
441967|NCT00687167|1053113|P1|COMPLETED|First Intervention||17
441968|NCT00687167|1053112|P2|STARTED|First Intervention||17
441969|NCT00687167|1053113|P1|STARTED|First Intervention||17
441970|NCT00687076|1053123|P2|NOT COMPLETED|Overall Study||30
441971|NCT00687076|1053124|P1|NOT COMPLETED|Overall Study||32
441972|NCT00687076|1053123|P2|COMPLETED|Overall Study||21
441973|NCT00687076|1053124|P1|COMPLETED|Overall Study||19
441974|NCT00687076|1053123|P2|STARTED|Overall Study||51
441975|NCT00687076|1053124|P1|STARTED|Overall Study||51
441976|NCT00686998|1053135|P3|NOT COMPLETED|Overall Study||4
441977|NCT00686998|1053136|P2|NOT COMPLETED|Overall Study||8
441978|NCT00686998|1053137|P1|NOT COMPLETED|Overall Study||13
441979|NCT00686998|1053135|P3|COMPLETED|Overall Study||18
441980|NCT00686998|1053136|P2|COMPLETED|Overall Study||33
441981|NCT00686998|1053137|P1|COMPLETED|Overall Study||30
441982|NCT00686998|1053135|P3|Completed Scheduled Treatment|Overall Study||18
441983|NCT00686998|1053136|P2|Completed Scheduled Treatment|Overall Study||33
441984|NCT00686998|1053137|P1|Completed Scheduled Treatment|Overall Study||30
441985|NCT00686998|1053135|P3|Eligible for Efficacy Analysis|Overall Study||21
441986|NCT00686998|1053136|P2|Eligible for Efficacy Analysis|Overall Study||39
441987|NCT00686998|1053137|P1|Eligible for Efficacy Analysis|Overall Study||42
441988|NCT00686998|1053135|P3|Received Treatment|Overall Study||22
441989|NCT00686998|1053136|P2|Received Treatment|Overall Study||41
441990|NCT00686998|1053137|P1|Received Treatment|Overall Study||43
441991|NCT00686998|1053135|P3|Randomized|Overall Study||22
441992|NCT00686998|1053136|P2|Randomized|Overall Study||41
441993|NCT00686998|1053137|P1|Randomized|Overall Study||43
441994|NCT00686998|1053135|P3|STARTED|Overall Study|Randomized & received study medication|22
441995|NCT00686998|1053136|P2|STARTED|Overall Study|Randomized & received study medication|41
441996|NCT00686998|1053137|P1|STARTED|Overall Study|Randomized & received study medication|43
441997|NCT00686959|1053147|P2|NOT COMPLETED|Overall Study||117
441998|NCT00686959|1053148|P1|NOT COMPLETED|Overall Study||124
441999|NCT00686959|1053147|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
442000|NCT00686959|1053148|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
442001|NCT00686959|1053147|P2|Entered Consolidation Phase|Overall Study||202
442002|NCT00686959|1053148|P1|Entered Consolidation Phase|Overall Study||229
442003|NCT00686959|1053147|P2|Received at Least One Dose of Study Drug|Overall Study||272
442004|NCT00686959|1053148|P1|Received at Least One Dose of Study Drug|Overall Study||283
442005|NCT00686959|1053147|P2|STARTED|Overall Study||297
442006|NCT00686959|1053148|P1|STARTED|Overall Study||301
442007|NCT00686894|1053166|P1|NOT COMPLETED|Overall Study||6
442008|NCT00686894|1053166|P1|COMPLETED|Overall Study||1
442009|NCT00686894|1053166|P1|STARTED|Overall Study||7
442010|NCT00686881|1053172|P2|NOT COMPLETED|Overall Study||81
442011|NCT00686881|1053173|P1|NOT COMPLETED|Overall Study||82
442012|NCT00686881|1053172|P2|COMPLETED|Overall Study||53
442013|NCT00686881|1053173|P1|COMPLETED|Overall Study||45
442014|NCT00686881|1053172|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
442015|NCT00686881|1053173|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
442016|NCT00686855|1053185|P2|NOT COMPLETED|Overall Study||1
442017|NCT00686855|1053186|P1|NOT COMPLETED|Overall Study||1
442018|NCT00686855|1053185|P2|COMPLETED|Overall Study||17
442019|NCT00686855|1053186|P1|COMPLETED|Overall Study||27
442020|NCT00686855|1053185|P2|STARTED|Overall Study||18
442021|NCT00686855|1053186|P1|STARTED|Overall Study||28
442022|NCT00686842|1053192|P1|NOT COMPLETED|Overall Study||0
442023|NCT00686842|1053192|P1|COMPLETED|Overall Study||17
442024|NCT00686842|1053192|P1|STARTED|Overall Study||17
442025|NCT00686803|1053199|P3|NOT COMPLETED|Overall Study||0
442026|NCT00686803|1053200|P2|NOT COMPLETED|Overall Study||0
442027|NCT00686803|1053201|P1|NOT COMPLETED|Overall Study||0
442028|NCT00686803|1053199|P3|COMPLETED|Overall Study||3
442029|NCT00686803|1053200|P2|COMPLETED|Overall Study||12
442030|NCT00686803|1053201|P1|COMPLETED|Overall Study||6
442031|NCT00686803|1053199|P3|STARTED|Overall Study||3
442032|NCT00686803|1053200|P2|STARTED|Overall Study||12
442033|NCT00686803|1053201|P1|STARTED|Overall Study||6
442034|NCT00686790|1053212|P1|NOT COMPLETED|Overall Study||16
442035|NCT00686790|1053212|P1|COMPLETED|Overall Study||32
442036|NCT00686790|1053212|P1|STARTED|Overall Study||48
442037|NCT00686777|1053220|P1|NOT COMPLETED|Overall Study||10
442038|NCT00686777|1053220|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
442039|NCT00686777|1053220|P1|Completed 24 Weeks of Follow-up|Overall Study||70
442040|NCT00686777|1053220|P1|Included in Follow-up (All Treated)|Overall Study||75
442041|NCT00686777|1053220|P1|Completed 48 Weeks of Treatment|Overall Study||65
442042|NCT00686777|1053220|P1|Completed 24 Weeks of Treatment|Overall Study||69
442043|NCT00686777|1053220|P1|STARTED|Overall Study||75
442044|NCT00686725|1053228|P2|NOT COMPLETED|Overall Study||42
442045|NCT00686725|1053229|P1|NOT COMPLETED|Overall Study||46
442046|NCT00686725|1053228|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
442139|NCT00686205|1053438|P2|COMPLETED|Overall Study||1524
442047|NCT00686725|1053229|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
442048|NCT00686725|1053228|P2|STARTED|Overall Study||52
442049|NCT00686725|1053229|P1|STARTED|Overall Study||47
442050|NCT00686712|1053254|P3|NOT COMPLETED|Overall Study||13
442051|NCT00686712|1053255|P2|NOT COMPLETED|Overall Study||11
442052|NCT00686712|1053256|P1|NOT COMPLETED|Overall Study||10
442053|NCT00686712|1053254|P3|COMPLETED|Overall Study||17
442054|NCT00686712|1053255|P2|COMPLETED|Overall Study||14
442055|NCT00686712|1053256|P1|COMPLETED|Overall Study||20
442056|NCT00686712|1053254|P3|STARTED|Overall Study||30
442057|NCT00686712|1053255|P2|STARTED|Overall Study||25
442058|NCT00686712|1053256|P1|STARTED|Overall Study||30
442059|NCT00686699|1053284|P2|NOT COMPLETED|Treatment Period 2||0
442060|NCT00686699|1053285|P1|NOT COMPLETED|Treatment Period 2||0
442061|NCT00686699|1053284|P2|COMPLETED|Treatment Period 2||5
442062|NCT00686699|1053285|P1|COMPLETED|Treatment Period 2||4
442063|NCT00686699|1053284|P2|STARTED|Treatment Period 2||5
442064|NCT00686699|1053285|P1|STARTED|Treatment Period 2||4
442065|NCT00686699|1053284|P2|NOT COMPLETED|Treatment Period 1||2
442066|NCT00686699|1053285|P1|NOT COMPLETED|Treatment Period 1||0
442067|NCT00686699|1053284|P2|COMPLETED|Treatment Period 1||5
442068|NCT00686699|1053285|P1|COMPLETED|Treatment Period 1||4
442069|NCT00686699|1053284|P2|STARTED|Treatment Period 1||7
442070|NCT00686699|1053285|P1|STARTED|Treatment Period 1||4
442071|NCT00686686|1053309|P1|NOT COMPLETED|Overall Study||6
442072|NCT00686686|1053309|P1|COMPLETED|Overall Study||17
442073|NCT00686686|1053309|P1|STARTED|Overall Study||23
442074|NCT00686647|1053317|P1|NOT COMPLETED|Overall Study||2
442075|NCT00686647|1053317|P1|COMPLETED|Overall Study||91
442076|NCT00686647|1053317|P1|STARTED|Overall Study||93
442077|NCT00686634|1053323|P1|NOT COMPLETED|Overall Study||6
442078|NCT00686634|1053323|P1|COMPLETED|Overall Study||102
442079|NCT00686634|1053323|P1|STARTED|Overall Study||108
442080|NCT00686595|1053330|P1|NOT COMPLETED|Overall Study||7
442081|NCT00686595|1053330|P1|COMPLETED|Overall Study||31
442082|NCT00686595|1053330|P1|STARTED|Overall Study||38
442083|NCT00686543|1053359|P4|NOT COMPLETED|Overall Study||3
442084|NCT00686543|1053360|P3|NOT COMPLETED|Overall Study||5
442085|NCT00686543|1053361|P2|NOT COMPLETED|Overall Study||1
442086|NCT00686543|1053362|P1|NOT COMPLETED|Overall Study||14
442087|NCT00686543|1053359|P4|COMPLETED|Overall Study||17
442088|NCT00686543|1053360|P3|COMPLETED|Overall Study||15
442089|NCT00686543|1053361|P2|COMPLETED|Overall Study||20
442090|NCT00686543|1053362|P1|COMPLETED|Overall Study||0
442091|NCT00686543|1053359|P4|STARTED|Overall Study||20
442092|NCT00686543|1053360|P3|STARTED|Overall Study||20
442093|NCT00686543|1053361|P2|STARTED|Overall Study||21
442094|NCT00686543|1053362|P1|STARTED|Overall Study||14
442095|NCT00686517|1053383|P3|NOT COMPLETED|Follow-up||10
442096|NCT00686517|1053384|P2|NOT COMPLETED|Follow-up||10
442097|NCT00686517|1053385|P1|NOT COMPLETED|Follow-up||8
442098|NCT00686517|1053383|P3|COMPLETED|Follow-up||29
442099|NCT00686517|1053384|P2|COMPLETED|Follow-up||28
442100|NCT00686517|1053385|P1|COMPLETED|Follow-up||29
442101|NCT00686517|1053383|P3|STARTED|Follow-up||39
442102|NCT00686517|1053384|P2|STARTED|Follow-up||38
442103|NCT00686517|1053385|P1|STARTED|Follow-up||37
442104|NCT00686517|1053383|P3|NOT COMPLETED|Treatment||1
442105|NCT00686517|1053384|P2|NOT COMPLETED|Treatment||3
442106|NCT00686517|1053385|P1|NOT COMPLETED|Treatment||6
442107|NCT00686517|1053383|P3|COMPLETED|Treatment||42
442108|NCT00686517|1053384|P2|COMPLETED|Treatment||40
442109|NCT00686517|1053385|P1|COMPLETED|Treatment||38
442110|NCT00686517|1053383|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
442111|NCT00686517|1053384|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
442112|NCT00686517|1053385|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
442113|NCT00686517|1053383|P3|STARTED|Treatment||43
442114|NCT00686517|1053384|P2|STARTED|Treatment||43
442115|NCT00686517|1053385|P1|STARTED|Treatment||44
442116|NCT00686335|1053408|P1|NOT COMPLETED|Treatment Period||0
442117|NCT00686335|1053408|P1|COMPLETED|Treatment Period||7
442118|NCT00686335|1053408|P1|STARTED|Treatment Period||7
442119|NCT00686335|1053408|P1|NOT COMPLETED|Run-in Period||5
442120|NCT00686335|1053408|P1|COMPLETED|Run-in Period||7
442121|NCT00686335|1053408|P1|STARTED|Run-in Period||12
442122|NCT00686257|1053416|P2|NOT COMPLETED|Overall Study||0
442123|NCT00686257|1053417|P1|NOT COMPLETED|Overall Study||0
442124|NCT00686257|1053416|P2|COMPLETED|Overall Study||31
442125|NCT00686257|1053417|P1|COMPLETED|Overall Study||29
442126|NCT00686257|1053416|P2|STARTED|Overall Study||31
442127|NCT00686257|1053417|P1|STARTED|Overall Study||29
442128|NCT00686231|1053426|P3|NOT COMPLETED|Overall Study||0
442129|NCT00686231|1053427|P2|NOT COMPLETED|Overall Study||0
442130|NCT00686231|1053428|P1|NOT COMPLETED|Overall Study||0
442131|NCT00686231|1053426|P3|COMPLETED|Overall Study||20
442132|NCT00686231|1053427|P2|COMPLETED|Overall Study||20
442133|NCT00686231|1053428|P1|COMPLETED|Overall Study||20
442134|NCT00686231|1053426|P3|STARTED|Overall Study||20
442135|NCT00686231|1053427|P2|STARTED|Overall Study||20
442136|NCT00686231|1053428|P1|STARTED|Overall Study||20
442137|NCT00686205|1053438|P2|NOT COMPLETED|Overall Study||981
442138|NCT00686205|1053439|P1|NOT COMPLETED|Overall Study||6007
442140|NCT00686205|1053439|P1|COMPLETED|Overall Study||15599
442141|NCT00686205|1053438|P2|STARTED|Overall Study||2505
442142|NCT00686205|1053439|P1|STARTED|Overall Study||21606
442143|NCT00685880|1053447|P2|NOT COMPLETED|Overall Study||0
442144|NCT00685880|1053448|P1|NOT COMPLETED|Overall Study||0
442145|NCT00685880|1053447|P2|COMPLETED|Overall Study||2
442146|NCT00685880|1053448|P1|COMPLETED|Overall Study||0
442147|NCT00685880|1053447|P2|STARTED|Overall Study||2
442148|NCT00685880|1053448|P1|STARTED|Overall Study||0
442149|NCT00685802|1053454|P2|NOT COMPLETED|Second Intervention||0
442150|NCT00685802|1053455|P1|NOT COMPLETED|Second Intervention||0
442151|NCT00685802|1053454|P2|COMPLETED|Second Intervention||15
442152|NCT00685802|1053455|P1|COMPLETED|Second Intervention||14
442153|NCT00685802|1053454|P2|STARTED|Second Intervention||15
442154|NCT00685802|1053455|P1|STARTED|Second Intervention||14
442155|NCT00685802|1053454|P2|NOT COMPLETED|Washout Period of 7 Days||1
442156|NCT00685802|1053455|P1|NOT COMPLETED|Washout Period of 7 Days||2
442157|NCT00685802|1053454|P2|COMPLETED|Washout Period of 7 Days||15
442158|NCT00685802|1053455|P1|COMPLETED|Washout Period of 7 Days||14
442159|NCT00685802|1053454|P2|STARTED|Washout Period of 7 Days||16
442160|NCT00685802|1053455|P1|STARTED|Washout Period of 7 Days||16
442161|NCT00685802|1053454|P2|NOT COMPLETED|First Intervention||0
442162|NCT00685802|1053455|P1|NOT COMPLETED|First Intervention||0
442163|NCT00685802|1053454|P2|COMPLETED|First Intervention||16
442164|NCT00685802|1053455|P1|COMPLETED|First Intervention||16
442165|NCT00685802|1053454|P2|STARTED|First Intervention||16
442166|NCT00685802|1053455|P1|STARTED|First Intervention||16
442167|NCT00685763|1053465|P1|NOT COMPLETED|Overall Study||2
442168|NCT00685763|1053465|P1|COMPLETED|Overall Study||11
442169|NCT00685763|1053465|P1|STARTED|Overall Study||13
442170|NCT00685698|1053469|P1|NOT COMPLETED|Overall Study||13
442171|NCT00685698|1053469|P1|COMPLETED|Overall Study||25
442172|NCT00685698|1053469|P1|STARTED|Overall Study||38
442173|NCT00685685|1053504|P2|NOT COMPLETED|Second Intervention||0
442174|NCT00685685|1053505|P1|NOT COMPLETED|Second Intervention||0
442175|NCT00685685|1053504|P2|COMPLETED|Second Intervention||26
442176|NCT00685685|1053505|P1|COMPLETED|Second Intervention||25
442177|NCT00685685|1053504|P2|STARTED|Second Intervention||26
442178|NCT00685685|1053505|P1|STARTED|Second Intervention||25
442179|NCT00685685|1053504|P2|NOT COMPLETED|Washout Period of 7 Days||1
442180|NCT00685685|1053505|P1|NOT COMPLETED|Washout Period of 7 Days||2
442181|NCT00685685|1053504|P2|COMPLETED|Washout Period of 7 Days||26
442182|NCT00685685|1053505|P1|COMPLETED|Washout Period of 7 Days||25
442183|NCT00685685|1053504|P2|STARTED|Washout Period of 7 Days||27
442184|NCT00685685|1053505|P1|STARTED|Washout Period of 7 Days||27
442185|NCT00685685|1053504|P2|NOT COMPLETED|First Intervention||0
442186|NCT00685685|1053505|P1|NOT COMPLETED|First Intervention||0
442187|NCT00685685|1053504|P2|COMPLETED|First Intervention||27
442188|NCT00685685|1053505|P1|COMPLETED|First Intervention||27
442189|NCT00685685|1053504|P2|STARTED|First Intervention||27
442190|NCT00685685|1053505|P1|STARTED|First Intervention||27
442191|NCT00685659|1053518|P3|NOT COMPLETED|Overall Study||15
442192|NCT00685659|1053519|P2|NOT COMPLETED|Overall Study||25
442193|NCT00685659|1053520|P1|NOT COMPLETED|Overall Study||31
442194|NCT00685659|1053518|P3|COMPLETED|Overall Study||92
442195|NCT00685659|1053519|P2|COMPLETED|Overall Study||81
442196|NCT00685659|1053520|P1|COMPLETED|Overall Study||77
442197|NCT00685659|1053518|P3|STARTED|Overall Study||107
442198|NCT00685659|1053519|P2|STARTED|Overall Study||106
442199|NCT00685659|1053520|P1|STARTED|Overall Study||108
442200|NCT00685516|1053546|P3|NOT COMPLETED|Overall Study||7
442201|NCT00685516|1053547|P2|NOT COMPLETED|Overall Study||5
442202|NCT00685516|1053548|P1|NOT COMPLETED|Overall Study||8
442203|NCT00685516|1053546|P3|COMPLETED|Overall Study||26
442204|NCT00685516|1053547|P2|COMPLETED|Overall Study||33
442205|NCT00685516|1053548|P1|COMPLETED|Overall Study||34
442206|NCT00685516|1053546|P3|STARTED|Overall Study||33
442207|NCT00685516|1053547|P2|STARTED|Overall Study||38
442208|NCT00685516|1053548|P1|STARTED|Overall Study||42
442209|NCT00685477|1053565|P6|NOT COMPLETED|Overall Study||0
442210|NCT00685477|1053566|P5|NOT COMPLETED|Overall Study||0
442211|NCT00685477|1053567|P4|NOT COMPLETED|Overall Study||0
442212|NCT00685477|1053568|P3|NOT COMPLETED|Overall Study||0
442213|NCT00685477|1053569|P2|NOT COMPLETED|Overall Study||0
442214|NCT00685477|1053570|P1|NOT COMPLETED|Overall Study||0
442215|NCT00685477|1053565|P6|COMPLETED|Overall Study||10
442216|NCT00685477|1053566|P5|COMPLETED|Overall Study||10
442217|NCT00685477|1053567|P4|COMPLETED|Overall Study||10
442218|NCT00685477|1053568|P3|COMPLETED|Overall Study||10
442219|NCT00685477|1053569|P2|COMPLETED|Overall Study||10
442220|NCT00685477|1053570|P1|COMPLETED|Overall Study||10
442221|NCT00685477|1053565|P6|STARTED|Overall Study||10
442222|NCT00685477|1053566|P5|STARTED|Overall Study||10
442223|NCT00685477|1053567|P4|STARTED|Overall Study||10
442224|NCT00685477|1053568|P3|STARTED|Overall Study||10
442225|NCT00685477|1053569|P2|STARTED|Overall Study||10
442226|NCT00685477|1053570|P1|STARTED|Overall Study||10
442227|NCT00685373|1053579|P1|NOT COMPLETED|Overall Study||15
442228|NCT00685373|1053579|P1|COMPLETED|Overall Study||151
442229|NCT00685373|1053579|P1|STARTED|Overall Study||166
442230|NCT00685334|1053588|P2|NOT COMPLETED|Overall Study||7
442231|NCT00685334|1053589|P1|NOT COMPLETED|Overall Study||10
442232|NCT00685334|1053588|P2|COMPLETED|Overall Study||3
442233|NCT00685334|1053589|P1|COMPLETED|Overall Study||2
442234|NCT00685334|1053588|P2|STARTED|Overall Study||10
442235|NCT00685334|1053589|P1|STARTED|Overall Study||12
442236|NCT00685295|1053599|P2|NOT COMPLETED|Overall Study||0
442237|NCT00685295|1053600|P1|NOT COMPLETED|Overall Study||0
442238|NCT00685295|1053599|P2|COMPLETED|Overall Study||30
442239|NCT00685295|1053600|P1|COMPLETED|Overall Study||30
442240|NCT00685295|1053599|P2|STARTED|Overall Study||30
442241|NCT00685295|1053600|P1|STARTED|Overall Study||30
442242|NCT00685165|1053610|P2|NOT COMPLETED|Second Intervention||0
442243|NCT00685165|1053611|P1|NOT COMPLETED|Second Intervention||0
442244|NCT00685165|1053610|P2|COMPLETED|Second Intervention||11
442245|NCT00685165|1053611|P1|COMPLETED|Second Intervention||10
442246|NCT00685165|1053610|P2|STARTED|Second Intervention||11
442247|NCT00685165|1053611|P1|STARTED|Second Intervention||10
442248|NCT00685165|1053610|P2|NOT COMPLETED|Washout Period of 14 Days||0
442249|NCT00685165|1053611|P1|NOT COMPLETED|Washout Period of 14 Days||1
442250|NCT00685165|1053610|P2|COMPLETED|Washout Period of 14 Days||11
442251|NCT00685165|1053611|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
442252|NCT00685165|1053610|P2|STARTED|Washout Period of 14 Days||11
442253|NCT00685165|1053611|P1|STARTED|Washout Period of 14 Days||11
442254|NCT00685165|1053610|P2|NOT COMPLETED|First Intervention||0
442255|NCT00685165|1053611|P1|NOT COMPLETED|First Intervention||0
442256|NCT00685165|1053610|P2|COMPLETED|First Intervention||11
442257|NCT00685165|1053611|P1|COMPLETED|First Intervention||11
442258|NCT00685165|1053610|P2|STARTED|First Intervention||11
442259|NCT00685165|1053611|P1|STARTED|First Intervention||11
442260|NCT00685139|1053621|P2|NOT COMPLETED|Second Intervention||0
442261|NCT00685139|1053622|P1|NOT COMPLETED|Second Intervention||0
442262|NCT00685139|1053621|P2|COMPLETED|Second Intervention||17
442263|NCT00685139|1053622|P1|COMPLETED|Second Intervention||17
442264|NCT00685139|1053621|P2|STARTED|Second Intervention||17
442265|NCT00685139|1053622|P1|STARTED|Second Intervention||17
442266|NCT00685139|1053621|P2|NOT COMPLETED|Washout Period of 28 Days||0
442267|NCT00685139|1053622|P1|NOT COMPLETED|Washout Period of 28 Days||0
442268|NCT00685139|1053621|P2|COMPLETED|Washout Period of 28 Days||17
442269|NCT00685139|1053622|P1|COMPLETED|Washout Period of 28 Days||17
442270|NCT00685139|1053621|P2|STARTED|Washout Period of 28 Days||17
442271|NCT00685139|1053622|P1|STARTED|Washout Period of 28 Days||17
442272|NCT00685139|1053621|P2|NOT COMPLETED|First Intervention||0
442273|NCT00685139|1053622|P1|NOT COMPLETED|First Intervention||0
442274|NCT00685139|1053621|P2|COMPLETED|First Intervention||17
442275|NCT00685139|1053622|P1|COMPLETED|First Intervention||17
442276|NCT00685139|1053621|P2|STARTED|First Intervention||17
442277|NCT00685139|1053622|P1|STARTED|First Intervention||17
442278|NCT00685035|1053630|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
442279|NCT00685035|1053631|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
442280|NCT00685035|1053630|P2|COMPLETED|Period 3: 2nd Intervention||8
442281|NCT00685035|1053631|P1|COMPLETED|Period 3: 2nd Intervention||8
442282|NCT00685035|1053630|P2|STARTED|Period 3: 2nd Intervention||8
442283|NCT00685035|1053631|P1|STARTED|Period 3: 2nd Intervention||8
442284|NCT00685035|1053630|P2|NOT COMPLETED|Period 2: 2-day Washout||0
442285|NCT00685035|1053631|P1|NOT COMPLETED|Period 2: 2-day Washout||0
442286|NCT00685035|1053630|P2|COMPLETED|Period 2: 2-day Washout||8
442287|NCT00685035|1053631|P1|COMPLETED|Period 2: 2-day Washout||8
442288|NCT00685035|1053630|P2|STARTED|Period 2: 2-day Washout||8
442289|NCT00685035|1053631|P1|STARTED|Period 2: 2-day Washout||8
442290|NCT00685035|1053630|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
442291|NCT00685035|1053631|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
442292|NCT00685035|1053630|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
442293|NCT00685035|1053631|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
442294|NCT00685035|1053630|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
442295|NCT00685035|1053631|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
442296|NCT00684996|1053655|P1|NOT COMPLETED|Overall Study||5
442297|NCT00684996|1053655|P1|COMPLETED|Overall Study||0
442298|NCT00684996|1053655|P1|Eligible|Overall Study||5
442299|NCT00684996|1053655|P1|STARTED|Overall Study||5
442300|NCT00684983|1053670|P2|NOT COMPLETED|Overall Study||0
442301|NCT00684983|1053671|P1|NOT COMPLETED|Overall Study||0
442302|NCT00684983|1053670|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
442303|NCT00684983|1053671|P1|COMPLETED|Overall Study||19
442304|NCT00684983|1053670|P2|STARTED|Overall Study||45
442305|NCT00684983|1053671|P1|STARTED|Overall Study||19
442306|NCT00684814|1053677|P2|NOT COMPLETED|Second Intervention||0
442307|NCT00684814|1053678|P1|NOT COMPLETED|Second Intervention||1
442308|NCT00684814|1053677|P2|COMPLETED|Second Intervention||15
442309|NCT00684814|1053678|P1|COMPLETED|Second Intervention||16
442310|NCT00684814|1053677|P2|STARTED|Second Intervention||15
442311|NCT00684814|1053678|P1|STARTED|Second Intervention||17
442312|NCT00684814|1053677|P2|NOT COMPLETED|Washout Period of 7 Days||4
442313|NCT00684814|1053678|P1|NOT COMPLETED|Washout Period of 7 Days||2
442314|NCT00684814|1053677|P2|COMPLETED|Washout Period of 7 Days||15
442315|NCT00684814|1053678|P1|COMPLETED|Washout Period of 7 Days||17
442316|NCT00684814|1053677|P2|STARTED|Washout Period of 7 Days||19
442317|NCT00684814|1053678|P1|STARTED|Washout Period of 7 Days||19
442318|NCT00684814|1053677|P2|NOT COMPLETED|First Intervention||0
442319|NCT00684814|1053678|P1|NOT COMPLETED|First Intervention||0
442320|NCT00684814|1053677|P2|COMPLETED|First Intervention||19
442321|NCT00684814|1053678|P1|COMPLETED|First Intervention||19
442322|NCT00684814|1053677|P2|STARTED|First Intervention||19
442323|NCT00684814|1053678|P1|STARTED|First Intervention||19
442324|NCT00684762|1053688|P2|NOT COMPLETED|Second Intervention||0
442325|NCT00684762|1053689|P1|NOT COMPLETED|Second Intervention||0
442326|NCT00684762|1053688|P2|COMPLETED|Second Intervention||14
442327|NCT00684762|1053689|P1|COMPLETED|Second Intervention||14
442328|NCT00684762|1053688|P2|STARTED|Second Intervention||14
442329|NCT00684762|1053689|P1|STARTED|Second Intervention||14
442330|NCT00684762|1053688|P2|NOT COMPLETED|Washout Period of 7 Days||2
442331|NCT00684762|1053689|P1|NOT COMPLETED|Washout Period of 7 Days||2
442332|NCT00684762|1053688|P2|COMPLETED|Washout Period of 7 Days||14
442333|NCT00684762|1053689|P1|COMPLETED|Washout Period of 7 Days||14
442334|NCT00684762|1053688|P2|STARTED|Washout Period of 7 Days||16
442335|NCT00684762|1053689|P1|STARTED|Washout Period of 7 Days||16
442336|NCT00684762|1053688|P2|NOT COMPLETED|First Intervention||0
442337|NCT00684762|1053689|P1|NOT COMPLETED|First Intervention||0
442338|NCT00684762|1053688|P2|COMPLETED|First Intervention||16
442339|NCT00684762|1053689|P1|COMPLETED|First Intervention||16
442340|NCT00684762|1053688|P2|STARTED|First Intervention||16
442341|NCT00684762|1053689|P1|STARTED|First Intervention||16
442342|NCT00684749|1053699|P1|NOT COMPLETED|Overall Study||0
442343|NCT00684749|1053699|P1|COMPLETED|Overall Study||142
442344|NCT00684749|1053699|P1|STARTED|Overall Study||142
442345|NCT00684723|1053703|P2|NOT COMPLETED|Second Intervention||0
442346|NCT00684723|1053704|P1|NOT COMPLETED|Second Intervention||0
442347|NCT00684723|1053703|P2|COMPLETED|Second Intervention||27
442348|NCT00684723|1053704|P1|COMPLETED|Second Intervention||27
442349|NCT00684723|1053703|P2|STARTED|Second Intervention||27
442350|NCT00684723|1053704|P1|STARTED|Second Intervention||27
442351|NCT00684723|1053703|P2|NOT COMPLETED|Washout Period of 7 Days||0
442352|NCT00684723|1053704|P1|NOT COMPLETED|Washout Period of 7 Days||0
442353|NCT00684723|1053703|P2|COMPLETED|Washout Period of 7 Days||27
442354|NCT00684723|1053704|P1|COMPLETED|Washout Period of 7 Days||27
442355|NCT00684723|1053703|P2|STARTED|Washout Period of 7 Days||27
442356|NCT00684723|1053704|P1|STARTED|Washout Period of 7 Days||27
442357|NCT00684723|1053703|P2|NOT COMPLETED|First Intervention||0
442358|NCT00684723|1053704|P1|NOT COMPLETED|First Intervention||0
442359|NCT00684723|1053703|P2|COMPLETED|First Intervention||27
442360|NCT00684723|1053704|P1|COMPLETED|First Intervention||27
442361|NCT00684723|1053703|P2|STARTED|First Intervention||27
442362|NCT00684723|1053704|P1|STARTED|First Intervention||27
442363|NCT00684671|1053717|P3|NOT COMPLETED|Overall Study||0
442364|NCT00684671|1053718|P2|NOT COMPLETED|Overall Study||0
442365|NCT00684671|1053719|P1|NOT COMPLETED|Overall Study||3
442366|NCT00684671|1053717|P3|COMPLETED|Overall Study||164
442367|NCT00684671|1053718|P2|COMPLETED|Overall Study||170
442368|NCT00684671|1053719|P1|COMPLETED|Overall Study||169
442369|NCT00684671|1053717|P3|STARTED|Overall Study||164
442370|NCT00684671|1053718|P2|STARTED|Overall Study||170
442371|NCT00684671|1053719|P1|STARTED|Overall Study||172
442372|NCT00684645|1053748|P1|NOT COMPLETED|Overall Study||114
442373|NCT00684645|1053748|P1|COMPLETED|Overall Study||72
442374|NCT00684645|1053748|P1|STARTED|Overall Study||186
442375|NCT00684593|1053768|P2|NOT COMPLETED|Overall Study||2
442376|NCT00684593|1053769|P1|NOT COMPLETED|Overall Study||0
442377|NCT00684593|1053768|P2|COMPLETED|Overall Study||8
442378|NCT00684593|1053769|P1|COMPLETED|Overall Study||21
442379|NCT00684593|1053768|P2|STARTED|Overall Study||10
442380|NCT00684593|1053769|P1|STARTED|Overall Study||21
442381|NCT00684567|1053781|P1|NOT COMPLETED|Monotherapy Period||14
442382|NCT00684567|1053781|P1|COMPLETED|Monotherapy Period||9
442383|NCT00684567|1053781|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
442384|NCT00684567|1053781|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
442385|NCT00684567|1053781|P1|COMPLETED|Concomitant Radiotherapy Period||28
442386|NCT00684567|1053781|P1|STARTED|Concomitant Radiotherapy Period||30
442387|NCT00684554|1053791|P2|NOT COMPLETED|Overall Study||0
442388|NCT00684554|1053792|P1|NOT COMPLETED|Overall Study||0
442389|NCT00684554|1053791|P2|COMPLETED|Overall Study||10
442390|NCT00684554|1053792|P1|COMPLETED|Overall Study||10
442391|NCT00684554|1053791|P2|STARTED|Overall Study||10
442392|NCT00684554|1053792|P1|STARTED|Overall Study||10
442393|NCT00684541|1053802|P2|NOT COMPLETED|Overall Study||3
442394|NCT00684541|1053803|P1|NOT COMPLETED|Overall Study||3
442395|NCT00684541|1053802|P2|COMPLETED|Overall Study||23
442396|NCT00684541|1053803|P1|COMPLETED|Overall Study||20
442397|NCT00684541|1053802|P2|STARTED|Overall Study||26
442398|NCT00684541|1053803|P1|STARTED|Overall Study||23
442399|NCT00684515|1053814|P3|NOT COMPLETED|Overall Study||1
442400|NCT00684515|1053815|P2|NOT COMPLETED|Overall Study||3
442401|NCT00684515|1053816|P1|NOT COMPLETED|Overall Study||4
442402|NCT00684515|1053814|P3|COMPLETED|Overall Study||27
442403|NCT00684515|1053815|P2|COMPLETED|Overall Study||26
442404|NCT00684515|1053816|P1|COMPLETED|Overall Study||29
442405|NCT00684515|1053814|P3|STARTED|Overall Study||28
442406|NCT00684515|1053815|P2|STARTED|Overall Study||29
442407|NCT00684515|1053816|P1|STARTED|Overall Study||33
442408|NCT00684424|1053839|P1|NOT COMPLETED|Overall Study||5
442409|NCT00684424|1053839|P1|COMPLETED|Overall Study||194
442410|NCT00684424|1053839|P1|STARTED|Overall Study||199
442411|NCT00684411|1053854|P1|NOT COMPLETED|Overall Study||12
442412|NCT00684411|1053854|P1|COMPLETED|Overall Study||0
442413|NCT00684411|1053854|P1|Disease Evaluable|Overall Study||11
442414|NCT00684411|1053854|P1|STARTED|Overall Study||12
442415|NCT00684320|1053862|P2|NOT COMPLETED|Overall Study||0
442416|NCT00684320|1053863|P1|NOT COMPLETED|Overall Study||4
442417|NCT00684320|1053862|P2|COMPLETED|Overall Study||22
442418|NCT00684320|1053863|P1|COMPLETED|Overall Study||22
442419|NCT00684320|1053862|P2|STARTED|Overall Study||22
442420|NCT00684320|1053863|P1|STARTED|Overall Study||26
442421|NCT00684307|1053876|P5|NOT COMPLETED|Overall Study||25
442422|NCT00684307|1053877|P4|NOT COMPLETED|Overall Study||32
442423|NCT00684307|1053878|P3|NOT COMPLETED|Overall Study||28
442424|NCT00684307|1053879|P2|NOT COMPLETED|Overall Study||22
442425|NCT00684307|1053880|P1|NOT COMPLETED|Overall Study||24
442426|NCT00684307|1053876|P5|COMPLETED|Overall Study||293
442427|NCT00684307|1053877|P4|COMPLETED|Overall Study||128
442428|NCT00684307|1053878|P3|COMPLETED|Overall Study||128
442429|NCT00684307|1053879|P2|COMPLETED|Overall Study||129
442430|NCT00684307|1053880|P1|COMPLETED|Overall Study||140
442431|NCT00684307|1053876|P5|On Treatment Period Completed|Overall Study||293
442432|NCT00684307|1053877|P4|On Treatment Period Completed|Overall Study||128
442433|NCT00684307|1053878|P3|On Treatment Period Completed|Overall Study||128
442434|NCT00684307|1053879|P2|On Treatment Period Completed|Overall Study||129
442435|NCT00684307|1053880|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
442436|NCT00684307|1053876|P5|On Treatment Period Started|Overall Study||318
442437|NCT00684307|1053877|P4|On Treatment Period Started|Overall Study||160
442438|NCT00684307|1053878|P3|On Treatment Period Started|Overall Study||156
442439|NCT00684307|1053879|P2|On Treatment Period Started|Overall Study||151
442440|NCT00684307|1053880|P1|On Treatment Period Started|Overall Study||164
442441|NCT00684307|1053876|P5|STARTED|Overall Study||318
442442|NCT00684307|1053877|P4|STARTED|Overall Study||160
442443|NCT00684307|1053878|P3|STARTED|Overall Study||156
442444|NCT00684307|1053879|P2|STARTED|Overall Study||151
442445|NCT00684307|1053880|P1|STARTED|Overall Study|Patients who received treatment|164
442446|NCT00684255|1053947|P1|NOT COMPLETED|Overall Study||0
442447|NCT00684255|1053947|P1|COMPLETED|Overall Study||1
442448|NCT00684255|1053947|P1|STARTED|Overall Study||1
442449|NCT00684242|1053952|P1|NOT COMPLETED|Overall Study||0
442450|NCT00684242|1053952|P1|COMPLETED|Overall Study||3
442451|NCT00684242|1053952|P1|STARTED|Overall Study||3
442452|NCT00684203|1053962|P6|NOT COMPLETED|Overall Study||0
442453|NCT00684203|1053963|P5|NOT COMPLETED|Overall Study||0
442454|NCT00684203|1053964|P4|NOT COMPLETED|Overall Study||0
442455|NCT00684203|1053965|P3|NOT COMPLETED|Overall Study||9
442456|NCT00684203|1053966|P2|NOT COMPLETED|Overall Study||8
442457|NCT00684203|1053967|P1|NOT COMPLETED|Overall Study||9
442458|NCT00684203|1053962|P6|COMPLETED|Overall Study||2
442459|NCT00684203|1053963|P5|COMPLETED|Overall Study||17
442460|NCT00684203|1053964|P4|COMPLETED|Overall Study||6
442461|NCT00684203|1053965|P3|COMPLETED|Overall Study||12
442462|NCT00684203|1053966|P2|COMPLETED|Overall Study||23
442463|NCT00684203|1053967|P1|COMPLETED|Overall Study||31
442464|NCT00684203|1053962|P6|STARTED|Overall Study||2
442465|NCT00684203|1053963|P5|STARTED|Overall Study||17
442466|NCT00684203|1053964|P4|STARTED|Overall Study||6
442467|NCT00684203|1053965|P3|STARTED|Overall Study||21
442468|NCT00684203|1053966|P2|STARTED|Overall Study||31
442469|NCT00684203|1053967|P1|STARTED|Overall Study||40
442470|NCT00684177|1054028|P2|NOT COMPLETED|Overall Study||23
442471|NCT00684177|1054029|P1|NOT COMPLETED|Overall Study||21
442472|NCT00684177|1054028|P2|COMPLETED|Overall Study||141
442473|NCT00684177|1054029|P1|COMPLETED|Overall Study||322
442474|NCT00684177|1054028|P2|STARTED|Overall Study||164
442475|NCT00684177|1054029|P1|STARTED|Overall Study||343
442476|NCT00684138|1054047|P2|NOT COMPLETED|Overall Study||8
442477|NCT00684138|1054048|P1|NOT COMPLETED|Overall Study||3
442478|NCT00684138|1054047|P2|COMPLETED|Overall Study||131
442479|NCT00684138|1054048|P1|COMPLETED|Overall Study||138
442480|NCT00684138|1054047|P2|STARTED|Overall Study||139
442481|NCT00684138|1054048|P1|STARTED|Overall Study||141
442482|NCT00684073|1054064|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
442483|NCT00684073|1054064|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
442484|NCT00684073|1054064|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
442485|NCT00684073|1054064|P1|NOT COMPLETED|Selection||7
442486|NCT00684073|1054064|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
442487|NCT00684073|1054064|P1|STARTED|Selection||60
442488|NCT00684060|1054074|P2|NOT COMPLETED|Overall Study||3
442489|NCT00684060|1054075|P1|NOT COMPLETED|Overall Study||3
442490|NCT00684060|1054074|P2|COMPLETED|Overall Study||26
442491|NCT00684060|1054075|P1|COMPLETED|Overall Study||55
442492|NCT00684060|1054074|P2|STARTED|Overall Study||29
442493|NCT00684060|1054075|P1|STARTED|Overall Study||58
442494|NCT00684047|1054098|P3|NOT COMPLETED|Overall Study||5
442495|NCT00684047|1054099|P2|NOT COMPLETED|Overall Study||16
442496|NCT00684047|1054100|P1|NOT COMPLETED|Overall Study||13
442497|NCT00684047|1054098|P3|COMPLETED|Overall Study||52
442498|NCT00684047|1054099|P2|COMPLETED|Overall Study||94
442499|NCT00684047|1054100|P1|COMPLETED|Overall Study||59
442500|NCT00684047|1054098|P3|STARTED|Overall Study||57
442501|NCT00684047|1054099|P2|STARTED|Overall Study||110
442502|NCT00684047|1054100|P1|STARTED|Overall Study||72
442503|NCT00684021|1054114|P4|NOT COMPLETED|Overall Study||2
442504|NCT00684021|1054115|P3|NOT COMPLETED|Overall Study||2
442505|NCT00684021|1054116|P2|NOT COMPLETED|Overall Study||2
442506|NCT00684021|1054117|P1|NOT COMPLETED|Overall Study||2
442507|NCT00684021|1054114|P4|COMPLETED|Overall Study||15
442508|NCT00684021|1054115|P3|COMPLETED|Overall Study||34
442509|NCT00684021|1054116|P2|COMPLETED|Overall Study||22
442510|NCT00684021|1054117|P1|COMPLETED|Overall Study||41
442511|NCT00684021|1054114|P4|STARTED|Overall Study||17
442512|NCT00684021|1054115|P3|STARTED|Overall Study||36
442513|NCT00684021|1054116|P2|STARTED|Overall Study||24
442514|NCT00684021|1054117|P1|STARTED|Overall Study||43
442515|NCT00683930|1054158|P3|NOT COMPLETED|Overall Study||9
442516|NCT00683930|1054159|P2|NOT COMPLETED|Overall Study||3
442517|NCT00683930|1054160|P1|NOT COMPLETED|Overall Study||7
442518|NCT00683930|1054158|P3|COMPLETED|Overall Study||28
442519|NCT00683930|1054159|P2|COMPLETED|Overall Study||18
442520|NCT00683930|1054160|P1|COMPLETED|Overall Study||29
442521|NCT00683930|1054158|P3|STARTED|Overall Study||37
442522|NCT00683930|1054159|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
442523|NCT00683930|1054160|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
442524|NCT00683917|1054178|P1|NOT COMPLETED|Overall Study||10
442525|NCT00683917|1054178|P1|COMPLETED|Overall Study||0
442526|NCT00683917|1054178|P1|STARTED|Overall Study||10
442527|NCT00683904|1054188|P2|NOT COMPLETED|Dose Level 2||2
442528|NCT00683904|1054189|P1|NOT COMPLETED|Dose Level 2||0
442529|NCT00683904|1054188|P2|COMPLETED|Dose Level 2||4
442530|NCT00683904|1054189|P1|COMPLETED|Dose Level 2||0
442531|NCT00683904|1054188|P2|STARTED|Dose Level 2||6
442532|NCT00683904|1054189|P1|STARTED|Dose Level 2||0
442533|NCT00683904|1054188|P2|NOT COMPLETED|Dose Level 1||0
442534|NCT00683904|1054189|P1|NOT COMPLETED|Dose Level 1||3
442535|NCT00683904|1054188|P2|COMPLETED|Dose Level 1||0
442536|NCT00683904|1054189|P1|COMPLETED|Dose Level 1||3
442537|NCT00683904|1054188|P2|STARTED|Dose Level 1||0
442538|NCT00683904|1054189|P1|STARTED|Dose Level 1||6
442539|NCT00683878|1054225|P3|NOT COMPLETED|Overall Study||14
442540|NCT00683878|1054226|P2|NOT COMPLETED|Overall Study||16
442541|NCT00683878|1054227|P1|NOT COMPLETED|Overall Study||23
442542|NCT00683878|1054225|P3|COMPLETED|Overall Study||126
442543|NCT00683878|1054226|P2|COMPLETED|Overall Study||125
442544|NCT00683878|1054227|P1|COMPLETED|Overall Study||116
442545|NCT00683878|1054225|P3|STARTED|Overall Study||140
442546|NCT00683878|1054226|P2|STARTED|Overall Study||141
442547|NCT00683878|1054227|P1|STARTED|Overall Study||139
442548|NCT00683826|1054256|P1|NOT COMPLETED|Overall Study||1
442549|NCT00683826|1054256|P1|COMPLETED|Overall Study||7
442550|NCT00683826|1054256|P1|4g Leucine|Overall Study||7
442551|NCT00683826|1054256|P1|8g Leucine|Overall Study||8
442552|NCT00683826|1054256|P1|0g Leucine|Overall Study||8
442553|NCT00683826|1054256|P1|STARTED|Overall Study||8
442554|NCT00683800|1054266|P2|NOT COMPLETED|Overall Study||366
442555|NCT00683800|1054267|P1|NOT COMPLETED|Overall Study||432
442556|NCT00683800|1054266|P2|COMPLETED|Overall Study||719
442557|NCT00683800|1054267|P1|COMPLETED|Overall Study||669
442558|NCT00683800|1054266|P2|Treated|Overall Study||1052
442559|NCT00683800|1054267|P1|Treated|Overall Study||1066
442560|NCT00683800|1054266|P2|STARTED|Overall Study||1085
442561|NCT00683800|1054267|P1|STARTED|Overall Study||1101
442562|NCT00683787|1054334|P3|NOT COMPLETED|Overall Study||2
442563|NCT00683787|1054335|P2|NOT COMPLETED|Overall Study||3
442564|NCT00683787|1054336|P1|NOT COMPLETED|Overall Study||3
442565|NCT00683787|1054334|P3|COMPLETED|Overall Study||0
442566|NCT00683787|1054335|P2|COMPLETED|Overall Study||0
442567|NCT00683787|1054336|P1|COMPLETED|Overall Study||0
442568|NCT00683787|1054334|P3|STARTED|Overall Study||2
442569|NCT00683787|1054335|P2|STARTED|Overall Study||3
442570|NCT00683787|1054336|P1|STARTED|Overall Study||3
442571|NCT00683774|1054355|P2|NOT COMPLETED|Overall Study||1
442572|NCT00683774|1054356|P1|NOT COMPLETED|Overall Study||3
442573|NCT00683774|1054355|P2|COMPLETED|Overall Study||9
442574|NCT00683774|1054356|P1|COMPLETED|Overall Study||8
442575|NCT00683774|1054355|P2|STARTED|Overall Study||10
442576|NCT00683774|1054356|P1|STARTED|Overall Study||11
442577|NCT00683696|1054366|P2|NOT COMPLETED|Overall Study||405
442578|NCT00683696|1054367|P1|NOT COMPLETED|Overall Study||404
442579|NCT00683696|1054366|P2|COMPLETED|Overall Study||0
442580|NCT00683696|1054367|P1|COMPLETED|Overall Study||0
442581|NCT00683696|1054366|P2|STARTED|Overall Study||405
442582|NCT00683696|1054367|P1|STARTED|Overall Study||404
442583|NCT00683657|1054376|P2|NOT COMPLETED|Overall Study||1
442584|NCT00683657|1054377|P1|NOT COMPLETED|Overall Study||1
442585|NCT00683657|1054376|P2|COMPLETED|Overall Study||46
442586|NCT00683657|1054377|P1|COMPLETED|Overall Study||45
442587|NCT00683657|1054376|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
442588|NCT00683657|1054377|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
442589|NCT00683657|1054376|P2|STARTED|Overall Study||47
442590|NCT00683657|1054377|P1|STARTED|Overall Study||46
442591|NCT00683618|1054394|P3|NOT COMPLETED|Extension Treatment Period||0
442592|NCT00683618|1054395|P2|NOT COMPLETED|Extension Treatment Period||0
442593|NCT00683618|1054396|P1|NOT COMPLETED|Extension Treatment Period||3
442594|NCT00683618|1054394|P3|COMPLETED|Extension Treatment Period||0
442595|NCT00683618|1054395|P2|COMPLETED|Extension Treatment Period||23
442596|NCT00683618|1054396|P1|COMPLETED|Extension Treatment Period||33
442597|NCT00683618|1054394|P3|STARTED|Extension Treatment Period||0
442598|NCT00683618|1054395|P2|STARTED|Extension Treatment Period||23
442599|NCT00683618|1054396|P1|STARTED|Extension Treatment Period||36
442600|NCT00683618|1054394|P3|NOT COMPLETED|Randomised Treatment Period||6
442601|NCT00683618|1054395|P2|NOT COMPLETED|Randomised Treatment Period||2
442602|NCT00683618|1054396|P1|NOT COMPLETED|Randomised Treatment Period||6
442603|NCT00683618|1054394|P3|COMPLETED|Randomised Treatment Period||140
442604|NCT00683618|1054395|P2|COMPLETED|Randomised Treatment Period||143
442605|NCT00683618|1054396|P1|COMPLETED|Randomised Treatment Period||139
442606|NCT00683618|1054394|P3|STARTED|Randomised Treatment Period||146
442607|NCT00683618|1054395|P2|STARTED|Randomised Treatment Period||145
442608|NCT00683618|1054396|P1|STARTED|Randomised Treatment Period||145
442609|NCT00683592|1054446|P2|NOT COMPLETED|Overall Study||46
442610|NCT00683592|1054447|P1|NOT COMPLETED|Overall Study||47
442611|NCT00683592|1054446|P2|COMPLETED|Overall Study||195
442612|NCT00683592|1054447|P1|COMPLETED|Overall Study||193
442613|NCT00683592|1054446|P2|Safety Population|Overall Study||233
442614|NCT00683592|1054447|P1|Safety Population|Overall Study||235
442615|NCT00683592|1054446|P2|Intent to Treat Population|Overall Study||232
442616|NCT00683592|1054447|P1|Intent to Treat Population|Overall Study||231
442617|NCT00683592|1054446|P2|STARTED|Overall Study||241
442618|NCT00683592|1054447|P1|STARTED|Overall Study||240
442619|NCT00683475|1054465|P2|NOT COMPLETED|Overall Study||3
442620|NCT00683475|1054466|P1|NOT COMPLETED|Overall Study||4
442621|NCT00683475|1054465|P2|COMPLETED|Overall Study||66
442622|NCT00683475|1054466|P1|COMPLETED|Overall Study||65
442623|NCT00683475|1054465|P2|Received Any Quantity of Study Drug|Overall Study||66
442624|NCT00683475|1054466|P1|Received Any Quantity of Study Drug|Overall Study||66
442625|NCT00683475|1054465|P2|STARTED|Overall Study||69
442626|NCT00683475|1054466|P1|STARTED|Overall Study||69
442627|NCT00683449|1054501|P5|NOT COMPLETED|Overall Study||0
442628|NCT00683449|1054502|P4|NOT COMPLETED|Overall Study||0
442629|NCT00683449|1054503|P3|NOT COMPLETED|Overall Study||0
442630|NCT00683449|1054504|P2|NOT COMPLETED|Overall Study||1
442631|NCT00683449|1054505|P1|NOT COMPLETED|Overall Study||0
442632|NCT00683449|1054501|P5|COMPLETED|Overall Study||2
442633|NCT00683449|1054502|P4|COMPLETED|Overall Study||6
442634|NCT00683449|1054503|P3|COMPLETED|Overall Study||3
442635|NCT00683449|1054504|P2|COMPLETED|Overall Study||12
442636|NCT00683449|1054505|P1|COMPLETED|Overall Study||5
442637|NCT00683449|1054501|P5|STARTED|Overall Study||2
442638|NCT00683449|1054502|P4|STARTED|Overall Study||6
442639|NCT00683449|1054503|P3|STARTED|Overall Study||3
442640|NCT00683449|1054504|P2|STARTED|Overall Study||13
442641|NCT00683449|1054505|P1|STARTED|Overall Study||5
442642|NCT00683410|1054527|P1|NOT COMPLETED|Overall Study||0
442643|NCT00683410|1054527|P1|COMPLETED|Overall Study||3366
442644|NCT00683410|1054527|P1|Vaccinated Dose 4|Overall Study||175
442645|NCT00683410|1054527|P1|Vaccinated Dose 3|Overall Study||817
442646|NCT00683410|1054527|P1|Vaccinated Dose 2|Overall Study||1623
442647|NCT00683410|1054527|P1|Vaccinated Dose 1|Overall Study||3240
442648|NCT00683410|1054527|P1|STARTED|Overall Study||3366
442649|NCT00683384|1054531|P1|NOT COMPLETED|Overall Study||2
442650|NCT00683384|1054531|P1|COMPLETED|Overall Study||91
442651|NCT00683384|1054531|P1|STARTED|Overall Study||93
442652|NCT00683332|1054535|P1|NOT COMPLETED|Overall Study||0
442653|NCT00683332|1054535|P1|COMPLETED|Overall Study||621
442654|NCT00683332|1054535|P1|STARTED|Overall Study||621
442655|NCT00683293|1054541|P2|NOT COMPLETED|Overall Study||3
442656|NCT00683293|1054542|P1|NOT COMPLETED|Overall Study||2
442657|NCT00683293|1054541|P2|COMPLETED|Overall Study||47
442658|NCT00683293|1054542|P1|COMPLETED|Overall Study||48
442659|NCT00683293|1054541|P2|STARTED|Overall Study||50
442660|NCT00683293|1054542|P1|STARTED|Overall Study||50
442661|NCT00683163|1054552|P2|NOT COMPLETED|Overall Study||0
442662|NCT00683163|1054553|P1|NOT COMPLETED|Overall Study||0
442663|NCT00683163|1054552|P2|COMPLETED|Overall Study||22
442664|NCT00683163|1054553|P1|COMPLETED|Overall Study||22
442665|NCT00683163|1054552|P2|STARTED|Overall Study||22
442666|NCT00683163|1054553|P1|STARTED|Overall Study||22
442667|NCT00683085|1054561|P1|NOT COMPLETED|Overall Study||0
442668|NCT00683085|1054561|P1|COMPLETED|Overall Study||2
442669|NCT00683085|1054561|P1|STARTED|Overall Study||2
442670|NCT00683046|1054566|P1|NOT COMPLETED|Overall Study||0
442671|NCT00683046|1054566|P1|COMPLETED|Overall Study||204
442672|NCT00683046|1054566|P1|STARTED|Overall Study||204
442673|NCT00683020|1054573|P2|NOT COMPLETED|Overall Study||55
442674|NCT00683020|1054574|P1|NOT COMPLETED|Overall Study||55
442675|NCT00683020|1054573|P2|COMPLETED|Overall Study||125
442676|NCT00683020|1054574|P1|COMPLETED|Overall Study||127
442677|NCT00683020|1054573|P2|STARTED|Overall Study||180
442678|NCT00683020|1054574|P1|STARTED|Overall Study||182
442679|NCT00682890|1054604|P2|NOT COMPLETED|Overall Study||2
442680|NCT00682890|1054605|P1|NOT COMPLETED|Overall Study||2
442681|NCT00682890|1054604|P2|COMPLETED|Overall Study||9
442682|NCT00682890|1054605|P1|COMPLETED|Overall Study||10
442683|NCT00682890|1054604|P2|STARTED|Overall Study||11
442684|NCT00682890|1054605|P1|STARTED|Overall Study||12
442685|NCT00682851|1054615|P2|NOT COMPLETED|Overall Study||0
442686|NCT00682851|1054616|P1|NOT COMPLETED|Overall Study||0
442687|NCT00682851|1054615|P2|COMPLETED|Overall Study||268
442688|NCT00682851|1054616|P1|COMPLETED|Overall Study||251
442689|NCT00682851|1054615|P2|STARTED|Overall Study||268
442690|NCT00682851|1054616|P1|STARTED|Overall Study||251
442691|NCT00682838|1054632|P4|NOT COMPLETED|Overall Study||0
442692|NCT00682838|1054633|P3|NOT COMPLETED|Overall Study||0
442693|NCT00682838|1054634|P2|NOT COMPLETED|Overall Study||0
442694|NCT00682838|1054635|P1|NOT COMPLETED|Overall Study||0
442695|NCT00682838|1054632|P4|COMPLETED|Overall Study||73
442696|NCT00682838|1054633|P3|COMPLETED|Overall Study||75
442697|NCT00682838|1054634|P2|COMPLETED|Overall Study||67
442698|NCT00682838|1054635|P1|COMPLETED|Overall Study||65
442699|NCT00682838|1054632|P4|STARTED|Overall Study||73
442700|NCT00682838|1054633|P3|STARTED|Overall Study||75
442701|NCT00682838|1054634|P2|STARTED|Overall Study||67
442702|NCT00682838|1054635|P1|STARTED|Overall Study||65
442703|NCT00682786|1054647|P2|NOT COMPLETED|Overall Study||3
442704|NCT00682786|1054648|P1|NOT COMPLETED|Overall Study||2
442705|NCT00682786|1054647|P2|COMPLETED|Overall Study||34
442706|NCT00682786|1054648|P1|COMPLETED|Overall Study||96
442707|NCT00682786|1054647|P2|STARTED|Overall Study||37
442708|NCT00682786|1054648|P1|STARTED|Overall Study||98
442709|NCT00682734|1054681|P3|NOT COMPLETED|48 Hour Follow-up||11
442710|NCT00682734|1054682|P2|NOT COMPLETED|48 Hour Follow-up||6
442711|NCT00682734|1054683|P1|NOT COMPLETED|48 Hour Follow-up||6
442712|NCT00682734|1054681|P3|COMPLETED|48 Hour Follow-up||106
442713|NCT00682734|1054682|P2|COMPLETED|48 Hour Follow-up||111
442714|NCT00682734|1054683|P1|COMPLETED|48 Hour Follow-up||107
442715|NCT00682734|1054681|P3|STARTED|48 Hour Follow-up||117
442716|NCT00682734|1054682|P2|STARTED|48 Hour Follow-up||117
442717|NCT00682734|1054683|P1|STARTED|48 Hour Follow-up||113
442718|NCT00682734|1054681|P3|NOT COMPLETED|Emergency Department Portion||1
442719|NCT00682734|1054682|P2|NOT COMPLETED|Emergency Department Portion||1
442720|NCT00682734|1054683|P1|NOT COMPLETED|Emergency Department Portion||0
442721|NCT00682734|1054681|P3|COMPLETED|Emergency Department Portion||117
442722|NCT00682734|1054682|P2|COMPLETED|Emergency Department Portion||117
442723|NCT00682734|1054683|P1|COMPLETED|Emergency Department Portion||113
442724|NCT00682734|1054681|P3|STARTED|Emergency Department Portion||118
442725|NCT00682734|1054682|P2|STARTED|Emergency Department Portion||118
442726|NCT00682734|1054683|P1|STARTED|Emergency Department Portion||113
442727|NCT00682643|1054693|P2|NOT COMPLETED|Overall Study||169
442728|NCT00682643|1054694|P1|NOT COMPLETED|Overall Study||78
442729|NCT00682643|1054693|P2|COMPLETED|Overall Study||199
442730|NCT00682643|1054694|P1|COMPLETED|Overall Study||104
442731|NCT00682643|1054693|P2|STARTED|Overall Study||368
442732|NCT00682643|1054694|P1|STARTED|Overall Study||182
442733|NCT00682565|1054729|P3|NOT COMPLETED|Overall Study||0
442734|NCT00682565|1054730|P2|NOT COMPLETED|Overall Study||2
442735|NCT00682565|1054731|P1|NOT COMPLETED|Overall Study||1
442736|NCT00682565|1054729|P3|COMPLETED|Overall Study||29
442737|NCT00682565|1054730|P2|COMPLETED|Overall Study||32
442738|NCT00682565|1054731|P1|COMPLETED|Overall Study||30
442739|NCT00682565|1054729|P3|STARTED|Overall Study||29
442740|NCT00682565|1054730|P2|STARTED|Overall Study||34
442741|NCT00682565|1054731|P1|STARTED|Overall Study||31
442742|NCT00682539|1054755|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
442743|NCT00682539|1054756|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
442744|NCT00682539|1054757|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
442745|NCT00682539|1054755|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
442746|NCT00682539|1054756|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
442747|NCT00682539|1054757|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
442748|NCT00682539|1054755|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
442749|NCT00682539|1054756|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
442750|NCT00682539|1054757|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
442751|NCT00682539|1054755|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
442752|NCT00682539|1054756|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
442753|NCT00682539|1054757|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
442754|NCT00682539|1054755|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
442755|NCT00682539|1054756|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
442756|NCT00682539|1054757|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
442757|NCT00682539|1054755|P3|STARTED|Bevacizumab vs Triamcinolone||0
442758|NCT00682539|1054756|P2|STARTED|Bevacizumab vs Triamcinolone||16
442759|NCT00682539|1054757|P1|STARTED|Bevacizumab vs Triamcinolone||18
442760|NCT00682461|1054770|P2|NOT COMPLETED|Overall Study||31
442761|NCT00682461|1054771|P1|NOT COMPLETED|Overall Study||25
442762|NCT00682461|1054770|P2|COMPLETED|Overall Study||69
442763|NCT00682461|1054771|P1|COMPLETED|Overall Study||75
442764|NCT00682461|1054770|P2|STARTED|Overall Study||100
442765|NCT00682461|1054771|P1|STARTED|Overall Study||100
442766|NCT00682357|1054788|P3|NOT COMPLETED|Overall Study||0
442767|NCT00682357|1054789|P2|NOT COMPLETED|Overall Study||0
442768|NCT00682357|1054790|P1|NOT COMPLETED|Overall Study||0
442769|NCT00682357|1054788|P3|COMPLETED|Overall Study||5
442770|NCT00682357|1054789|P2|COMPLETED|Overall Study||10
442771|NCT00682357|1054790|P1|COMPLETED|Overall Study||10
442772|NCT00682357|1054788|P3|STARTED|Overall Study||5
442773|NCT00682357|1054789|P2|STARTED|Overall Study||10
442774|NCT00682357|1054790|P1|STARTED|Overall Study||10
442775|NCT00681889|1054807|P1|NOT COMPLETED|Overall Study||0
442776|NCT00681889|1054807|P1|COMPLETED|Overall Study||9
442777|NCT00681889|1054807|P1|STARTED|Overall Study||9
442778|NCT00681863|1054811|P1|NOT COMPLETED|Overall Study||23
442779|NCT00681863|1054811|P1|COMPLETED|Overall Study||22
442780|NCT00681863|1054811|P1|STARTED|Overall Study||45
442781|NCT00681824|1054859|P3|NOT COMPLETED|Overall Study||1
442782|NCT00681824|1054860|P2|NOT COMPLETED|Overall Study||1
442783|NCT00681824|1054861|P1|NOT COMPLETED|Overall Study||1
442784|NCT00681824|1054859|P3|COMPLETED|Overall Study||33
442785|NCT00681824|1054860|P2|COMPLETED|Overall Study||12
442786|NCT00681824|1054861|P1|COMPLETED|Overall Study||27
442787|NCT00681824|1054859|P3|STARTED|Overall Study||34
442788|NCT00681824|1054860|P2|STARTED|Overall Study||13
442789|NCT00681824|1054861|P1|STARTED|Overall Study||28
442790|NCT00681811|1054879|P2|NOT COMPLETED|Overall Study||4
442791|NCT00681811|1054880|P1|NOT COMPLETED|Overall Study||3
442792|NCT00681811|1054879|P2|COMPLETED|Overall Study||1
442793|NCT00681811|1054880|P1|COMPLETED|Overall Study||3
442794|NCT00681811|1054879|P2|STARTED|Overall Study||5
442795|NCT00681811|1054880|P1|STARTED|Overall Study||6
442796|NCT00681668|1054908|P1|NOT COMPLETED|Overall Study||2
442797|NCT00681668|1054908|P1|COMPLETED|Overall Study||3
442798|NCT00681668|1054908|P1|STARTED|Overall Study||5
442799|NCT00681629|1054917|P2|NOT COMPLETED|Overall Study||2
442800|NCT00681629|1054918|P1|NOT COMPLETED|Overall Study||5
442801|NCT00681629|1054917|P2|COMPLETED|Overall Study||0
442802|NCT00681629|1054918|P1|COMPLETED|Overall Study||0
442894|NCT00680953|1055247|P1|NOT COMPLETED|Overall Study||86
442803|NCT00681629|1054917|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
442804|NCT00681629|1054918|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
442805|NCT00681590|1054964|P2|NOT COMPLETED|Overall Study||12
442806|NCT00681590|1054965|P1|NOT COMPLETED|Overall Study||2
442807|NCT00681590|1054964|P2|COMPLETED|Overall Study||59
442808|NCT00681590|1054965|P1|COMPLETED|Overall Study||32
442809|NCT00681590|1054964|P2|STARTED|Overall Study||71
442810|NCT00681590|1054965|P1|STARTED|Overall Study||34
442811|NCT00681564|1054975|P2|NOT COMPLETED|Overall Study||8
442812|NCT00681564|1054976|P1|NOT COMPLETED|Overall Study||6
442813|NCT00681564|1054975|P2|COMPLETED|Overall Study||47
442814|NCT00681564|1054976|P1|COMPLETED|Overall Study||41
442815|NCT00681564|1054975|P2|STARTED|Overall Study||55
442816|NCT00681564|1054976|P1|STARTED|Overall Study||47
442817|NCT00681538|1055006|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
442818|NCT00681538|1055007|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
442819|NCT00681538|1055006|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
442820|NCT00681538|1055007|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
442821|NCT00681538|1055006|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
442822|NCT00681538|1055007|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
442823|NCT00681538|1055006|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
442824|NCT00681538|1055007|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
442825|NCT00681538|1055006|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
442826|NCT00681538|1055007|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
442827|NCT00681538|1055006|P2|STARTED|Phase A- 4 Weeks Single Blind||0
442828|NCT00681538|1055007|P1|STARTED|Phase A- 4 Weeks Single Blind||572
442829|NCT00681473|1055037|P1|NOT COMPLETED|Overall Study||0
442830|NCT00681473|1055037|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
442831|NCT00681473|1055037|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
442832|NCT00681291|1055045|P2|NOT COMPLETED|Overall Study||27
442833|NCT00681291|1055046|P1|NOT COMPLETED|Overall Study||13
442834|NCT00681291|1055045|P2|COMPLETED|Overall Study||57
442835|NCT00681291|1055046|P1|COMPLETED|Overall Study||75
442836|NCT00681291|1055045|P2|STARTED|Overall Study||84
442837|NCT00681291|1055046|P1|STARTED|Overall Study||88
442838|NCT00681265|1055058|P1|NOT COMPLETED|Overall Study||0
442839|NCT00681265|1055058|P1|COMPLETED|Overall Study||16
442840|NCT00681265|1055058|P1|STARTED|Overall Study||16
442841|NCT00681187|1055068|P2|NOT COMPLETED|Overall Study||2
442842|NCT00681187|1055069|P1|NOT COMPLETED|Overall Study||1
442843|NCT00681187|1055068|P2|COMPLETED|Overall Study||13
442844|NCT00681187|1055069|P1|COMPLETED|Overall Study||10
442845|NCT00681187|1055068|P2|STARTED|Overall Study||15
442846|NCT00681187|1055069|P1|STARTED|Overall Study||11
442847|NCT00681109|1055104|P3|NOT COMPLETED|Overall Study||0
442848|NCT00681109|1055105|P2|NOT COMPLETED|Overall Study||6
442849|NCT00681109|1055106|P1|NOT COMPLETED|Overall Study||2
442850|NCT00681109|1055104|P3|COMPLETED|Overall Study||15
442851|NCT00681109|1055105|P2|COMPLETED|Overall Study||24
442852|NCT00681109|1055106|P1|COMPLETED|Overall Study||28
442853|NCT00681109|1055104|P3|STARTED|Overall Study||15
442854|NCT00681109|1055105|P2|STARTED|Overall Study||30
442855|NCT00681109|1055106|P1|STARTED|Overall Study||30
442856|NCT00680316|1055116|P2|NOT COMPLETED|Overall Study||0
442857|NCT00680316|1055117|P1|NOT COMPLETED|Overall Study||0
442858|NCT00680316|1055116|P2|COMPLETED|Overall Study||2
442859|NCT00680316|1055117|P1|COMPLETED|Overall Study||1
442860|NCT00680316|1055116|P2|STARTED|Overall Study||2
442861|NCT00680316|1055117|P1|STARTED|Overall Study||1
442862|NCT00679211|1055129|P1|NOT COMPLETED|Overall Study||110
442863|NCT00679211|1055129|P1|COMPLETED|Overall Study||0
442864|NCT00679211|1055129|P1|STARTED|Overall Study||110
442865|NCT00679172|1055146|P5|NOT COMPLETED|Overall Study||0
442866|NCT00679172|1055147|P4|NOT COMPLETED|Overall Study||1
442867|NCT00679172|1055148|P3|NOT COMPLETED|Overall Study||1
442868|NCT00679172|1055149|P2|NOT COMPLETED|Overall Study||1
442869|NCT00679172|1055150|P1|NOT COMPLETED|Overall Study||1
442870|NCT00679172|1055146|P5|COMPLETED|Overall Study||37
442871|NCT00679172|1055147|P4|COMPLETED|Overall Study||38
442872|NCT00679172|1055148|P3|COMPLETED|Overall Study||35
442873|NCT00679172|1055149|P2|COMPLETED|Overall Study||37
442874|NCT00679172|1055150|P1|COMPLETED|Overall Study||36
442875|NCT00679172|1055146|P5|STARTED|Overall Study||37
442876|NCT00679172|1055147|P4|STARTED|Overall Study||39
442877|NCT00679172|1055148|P3|STARTED|Overall Study||36
442878|NCT00679172|1055149|P2|STARTED|Overall Study||38
442879|NCT00679172|1055150|P1|STARTED|Overall Study||37
442880|NCT00679081|1055213|P1|NOT COMPLETED|Overall Study||1
442881|NCT00679081|1055213|P1|COMPLETED|Overall Study||14
442882|NCT00679081|1055213|P1|STARTED|Overall Study|Study design was within-subject control.|15
442883|NCT00679055|1055223|P2|NOT COMPLETED|Overall Study||5
442884|NCT00679055|1055224|P1|NOT COMPLETED|Overall Study||2
442885|NCT00679055|1055223|P2|COMPLETED|Overall Study||1
442886|NCT00679055|1055224|P1|COMPLETED|Overall Study||6
442887|NCT00679055|1055223|P2|STARTED|Overall Study||6
442888|NCT00679055|1055224|P1|STARTED|Overall Study||8
442889|NCT00681044|1055234|P1|NOT COMPLETED|Overall Study||0
442890|NCT00681044|1055234|P1|COMPLETED|Overall Study||4
442891|NCT00681044|1055234|P1|STARTED|Overall Study||4
442892|NCT00680953|1055245|P3|NOT COMPLETED|Overall Study||47
442893|NCT00680953|1055246|P2|NOT COMPLETED|Overall Study||95
442895|NCT00680953|1055245|P3|COMPLETED|Overall Study||204
442896|NCT00680953|1055246|P2|COMPLETED|Overall Study||416
442897|NCT00680953|1055247|P1|COMPLETED|Overall Study||414
442898|NCT00680953|1055245|P3|STARTED|Overall Study||251
442899|NCT00680953|1055246|P2|STARTED|Overall Study||511
442900|NCT00680953|1055247|P1|STARTED|Overall Study||500
442901|NCT00680914|1055263|P2|NOT COMPLETED|Overall Study||4
442902|NCT00680914|1055264|P1|NOT COMPLETED|Overall Study||10
442903|NCT00680914|1055263|P2|COMPLETED|Overall Study||125
442904|NCT00680914|1055264|P1|COMPLETED|Overall Study||364
442905|NCT00680914|1055263|P2|STARTED|Overall Study||129
442906|NCT00680914|1055264|P1|STARTED|Overall Study||374
442907|NCT00680901|1055298|P2|NOT COMPLETED|Overall Study||76
442908|NCT00680901|1055299|P1|NOT COMPLETED|Overall Study||73
442909|NCT00680901|1055298|P2|COMPLETED|Overall Study||197
442910|NCT00680901|1055299|P1|COMPLETED|Overall Study||199
442911|NCT00680901|1055298|P2|Ongoing: In Follow Up|Overall Study||41
442912|NCT00680901|1055299|P1|Ongoing: In Follow Up|Overall Study||45
442913|NCT00680901|1055298|P2|Ongoing: On Study Treatment|Overall Study||13
442914|NCT00680901|1055299|P1|Ongoing: On Study Treatment|Overall Study||16
442915|NCT00680901|1055298|P2|STARTED|Overall Study||273
442916|NCT00680901|1055299|P1|STARTED|Overall Study||272
442917|NCT00680862|1055331|P1|NOT COMPLETED|Overall Study||0
442918|NCT00680862|1055331|P1|COMPLETED|Overall Study||25
442919|NCT00680862|1055331|P1|STARTED|Overall Study||25
442920|NCT00680836|1055337|P2|NOT COMPLETED|Overall Study||2
442921|NCT00680836|1055338|P1|NOT COMPLETED|Overall Study||8
442922|NCT00680836|1055337|P2|COMPLETED|Overall Study||25
442923|NCT00680836|1055338|P1|COMPLETED|Overall Study||19
442924|NCT00680836|1055337|P2|STARTED|Overall Study||27
442925|NCT00680836|1055338|P1|STARTED|Overall Study||27
442926|NCT00680797|1055358|P4|NOT COMPLETED|Overall Study||0
442927|NCT00680797|1055359|P3|NOT COMPLETED|Overall Study||0
442928|NCT00680797|1055360|P2|NOT COMPLETED|Overall Study||0
442929|NCT00680797|1055361|P1|NOT COMPLETED|Overall Study||0
442930|NCT00680797|1055358|P4|COMPLETED|Overall Study||8
442931|NCT00680797|1055359|P3|COMPLETED|Overall Study||8
442932|NCT00680797|1055360|P2|COMPLETED|Overall Study||8
442933|NCT00680797|1055361|P1|COMPLETED|Overall Study||9
442934|NCT00680797|1055358|P4|STARTED|Overall Study||8
442935|NCT00680797|1055359|P3|STARTED|Overall Study||8
442936|NCT00680797|1055360|P2|STARTED|Overall Study||8
442937|NCT00680797|1055361|P1|STARTED|Overall Study||9
442938|NCT00680771|1055373|P2|NOT COMPLETED|Overall Study||2
442939|NCT00680771|1055374|P1|NOT COMPLETED|Overall Study||6
442940|NCT00680771|1055373|P2|COMPLETED|Overall Study||11
442941|NCT00680771|1055374|P1|COMPLETED|Overall Study||9
442942|NCT00680771|1055373|P2|STARTED|Overall Study||13
442943|NCT00680771|1055374|P1|STARTED|Overall Study||15
442944|NCT00680745|1055384|P4|NOT COMPLETED|Overall Study||13
442945|NCT00680745|1055385|P3|NOT COMPLETED|Overall Study||10
442946|NCT00680745|1055386|P2|NOT COMPLETED|Overall Study||13
442947|NCT00680745|1055387|P1|NOT COMPLETED|Overall Study||14
442948|NCT00680745|1055384|P4|COMPLETED|Overall Study||133
442949|NCT00680745|1055385|P3|COMPLETED|Overall Study||141
442950|NCT00680745|1055386|P2|COMPLETED|Overall Study||132
442951|NCT00680745|1055387|P1|COMPLETED|Overall Study||140
442952|NCT00680745|1055384|P4|STARTED|Overall Study|Safety Analysis Set|146
442953|NCT00680745|1055385|P3|STARTED|Overall Study|Safety Analysis Set|151
442954|NCT00680745|1055386|P2|STARTED|Overall Study|Safety Analysis Set|145
442955|NCT00680745|1055387|P1|STARTED|Overall Study|Safety Analysis Set|154
442956|NCT00680706|1055419|P2|NOT COMPLETED|Overall Study||5
442957|NCT00680706|1055420|P1|NOT COMPLETED|Overall Study||7
442958|NCT00680706|1055419|P2|COMPLETED|Overall Study||55
442959|NCT00680706|1055420|P1|COMPLETED|Overall Study||63
442960|NCT00680706|1055419|P2|STARTED|Overall Study||60
442961|NCT00680706|1055420|P1|STARTED|Overall Study||70
442962|NCT00680628|1055430|P2|NOT COMPLETED|Overall Study||0
442963|NCT00680628|1055431|P1|NOT COMPLETED|Overall Study||0
442964|NCT00680628|1055430|P2|COMPLETED|Overall Study||40
442965|NCT00680628|1055431|P1|COMPLETED|Overall Study||43
442966|NCT00680628|1055430|P2|STARTED|Overall Study||40
442967|NCT00680628|1055431|P1|STARTED|Overall Study||43
442968|NCT00680524|1055441|P1|NOT COMPLETED|Overall Study||3
442969|NCT00680524|1055441|P1|COMPLETED|Overall Study||17
442970|NCT00680524|1055441|P1|STARTED|Overall Study||20
442971|NCT00680459|1055447|P2|NOT COMPLETED|Overall Study||0
442972|NCT00680459|1055448|P1|NOT COMPLETED|Overall Study||0
442973|NCT00680459|1055447|P2|COMPLETED|Overall Study||6
442974|NCT00680459|1055448|P1|COMPLETED|Overall Study||7
442975|NCT00680459|1055447|P2|STARTED|Overall Study||6
442976|NCT00680459|1055448|P1|STARTED|Overall Study||7
442977|NCT00680407|1055461|P3|NOT COMPLETED|Overall Study||3
442978|NCT00680407|1055462|P2|NOT COMPLETED|Overall Study||5
442979|NCT00680407|1055463|P1|NOT COMPLETED|Overall Study||8
442980|NCT00680407|1055461|P3|COMPLETED|Overall Study||22
442981|NCT00680407|1055462|P2|COMPLETED|Overall Study||22
442982|NCT00680407|1055463|P1|COMPLETED|Overall Study||18
442983|NCT00680407|1055461|P3|STARTED|Overall Study||25
442984|NCT00680407|1055462|P2|STARTED|Overall Study||27
442985|NCT00680407|1055463|P1|STARTED|Overall Study||26
442986|NCT00680368|1055477|P1|NOT COMPLETED|Overall Study||15
442987|NCT00680368|1055477|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
442988|NCT00680368|1055477|P1|STARTED|Overall Study||112
442989|NCT00680225|1055483|P1|NOT COMPLETED|Overall Study||2
442990|NCT00680225|1055483|P1|COMPLETED|Overall Study||8
442991|NCT00680225|1055483|P1|STARTED|Overall Study||10
442992|NCT00680186|1055490|P2|NOT COMPLETED|Overall Study||116
442993|NCT00680186|1055491|P1|NOT COMPLETED|Overall Study||125
442994|NCT00680186|1055490|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
442995|NCT00680186|1055491|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
442996|NCT00680186|1055490|P2|STARTED|Overall Study|Started treatment.|1288
442997|NCT00680186|1055491|P1|STARTED|Overall Study|Started treatment.|1280
442998|NCT00680121|1055517|P2|NOT COMPLETED|Overall Study||23
442999|NCT00680121|1055518|P1|NOT COMPLETED|Overall Study||27
443000|NCT00680121|1055517|P2|COMPLETED|Overall Study||37
443001|NCT00680121|1055518|P1|COMPLETED|Overall Study||33
443002|NCT00680121|1055517|P2|STARTED|Overall Study||60
443003|NCT00680121|1055518|P1|STARTED|Overall Study||60
443004|NCT00680056|1055532|P2|NOT COMPLETED|Second Intervention||1
443005|NCT00680056|1055533|P1|NOT COMPLETED|Second Intervention||3
443006|NCT00680056|1055532|P2|COMPLETED|Second Intervention||14
443007|NCT00680056|1055533|P1|COMPLETED|Second Intervention||12
443008|NCT00680056|1055532|P2|STARTED|Second Intervention||15
443009|NCT00680056|1055533|P1|STARTED|Second Intervention||15
443010|NCT00680056|1055532|P2|NOT COMPLETED|Washout Period of One Week||0
443011|NCT00680056|1055533|P1|NOT COMPLETED|Washout Period of One Week||0
443012|NCT00680056|1055532|P2|COMPLETED|Washout Period of One Week||15
443013|NCT00680056|1055533|P1|COMPLETED|Washout Period of One Week||15
443014|NCT00680056|1055532|P2|STARTED|Washout Period of One Week||15
443015|NCT00680056|1055533|P1|STARTED|Washout Period of One Week||15
443016|NCT00680056|1055532|P2|NOT COMPLETED|First Intervention||2
443017|NCT00680056|1055533|P1|NOT COMPLETED|First Intervention||1
443018|NCT00680056|1055532|P2|COMPLETED|First Intervention||15
443019|NCT00680056|1055533|P1|COMPLETED|First Intervention||15
443020|NCT00680056|1055532|P2|STARTED|First Intervention||17
443021|NCT00680056|1055533|P1|STARTED|First Intervention||16
443022|NCT00680043|1055544|P3|NOT COMPLETED|Overall Study||4
443023|NCT00680043|1055545|P2|NOT COMPLETED|Overall Study||1
443024|NCT00680043|1055546|P1|NOT COMPLETED|Overall Study||2
443025|NCT00680043|1055544|P3|COMPLETED|Overall Study||34
443026|NCT00680043|1055545|P2|COMPLETED|Overall Study||36
443027|NCT00680043|1055546|P1|COMPLETED|Overall Study||37
443028|NCT00680043|1055544|P3|STARTED|Overall Study||38
443029|NCT00680043|1055545|P2|STARTED|Overall Study||37
443030|NCT00680043|1055546|P1|STARTED|Overall Study||39
443031|NCT00680017|1055562|P2|NOT COMPLETED|Overall Study||12
443032|NCT00680017|1055563|P1|NOT COMPLETED|Overall Study||17
443033|NCT00680017|1055562|P2|COMPLETED|Overall Study||128
443034|NCT00680017|1055563|P1|COMPLETED|Overall Study||123
443035|NCT00680017|1055562|P2|STARTED|Overall Study||140
443036|NCT00680017|1055563|P1|STARTED|Overall Study||140
443037|NCT00679952|1055573|P2|NOT COMPLETED|Overall Study||0
443038|NCT00679952|1055574|P1|NOT COMPLETED|Overall Study||0
443039|NCT00679952|1055573|P2|COMPLETED|Overall Study||82
443040|NCT00679952|1055574|P1|COMPLETED|Overall Study||86
443041|NCT00679952|1055573|P2|STARTED|Overall Study||82
443042|NCT00679952|1055574|P1|STARTED|Overall Study||86
443043|NCT00679939|1055582|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
443044|NCT00679939|1055583|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
443045|NCT00679939|1055582|P2|COMPLETED|24-Week Open-Label (OL) Period||80
443046|NCT00679939|1055583|P1|COMPLETED|24-Week Open-Label (OL) Period||69
443047|NCT00679939|1055582|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
443048|NCT00679939|1055583|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
443049|NCT00679939|1055582|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
443050|NCT00679939|1055583|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
443051|NCT00679939|1055582|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
443052|NCT00679939|1055583|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
443053|NCT00679939|1055582|P2|STARTED|52-Week Double-Blind (DB) Period||112
443054|NCT00679939|1055583|P1|STARTED|52-Week Double-Blind (DB) Period||114
443055|NCT00679913|1055734|P2|NOT COMPLETED|Overall Study||13
443056|NCT00679913|1055735|P1|NOT COMPLETED|Overall Study||18
443057|NCT00679913|1055734|P2|COMPLETED|Overall Study||86
443058|NCT00679913|1055735|P1|COMPLETED|Overall Study||83
443059|NCT00679913|1055734|P2|STARTED|Overall Study||99
443060|NCT00679913|1055735|P1|STARTED|Overall Study||101
443061|NCT00679783|1055750|P7|NOT COMPLETED|Overall Study||1
443062|NCT00679783|1055751|P6|NOT COMPLETED|Overall Study||0
443063|NCT00679783|1055752|P5|NOT COMPLETED|Overall Study||1
443064|NCT00679783|1055753|P4|NOT COMPLETED|Overall Study||20
443065|NCT00679783|1055754|P3|NOT COMPLETED|Overall Study||1
443066|NCT00679783|1055755|P2|NOT COMPLETED|Overall Study||3
443067|NCT00679783|1055756|P1|NOT COMPLETED|Overall Study||2
443068|NCT00679783|1055750|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
443069|NCT00679783|1055751|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
443070|NCT00679783|1055752|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
443071|NCT00679783|1055753|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
443072|NCT00679783|1055754|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
443073|NCT00679783|1055755|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
443074|NCT00679783|1055756|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
443075|NCT00679783|1055750|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
443076|NCT00679783|1055751|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
443077|NCT00679783|1055752|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
443078|NCT00679783|1055753|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
443079|NCT00679783|1055754|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
443080|NCT00679783|1055755|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
443081|NCT00679783|1055756|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
443082|NCT00679627|1055809|P2|NOT COMPLETED|Overall Study||685
443083|NCT00679627|1055810|P1|NOT COMPLETED|Overall Study||699
443084|NCT00679627|1055809|P2|COMPLETED|Overall Study||339
443085|NCT00679627|1055810|P1|COMPLETED|Overall Study||322
443086|NCT00679627|1055809|P2|STARTED|Overall Study||1024
443087|NCT00679627|1055810|P1|STARTED|Overall Study||1021
443088|NCT00679432|1055836|P4|NOT COMPLETED|Overall Study||32
443089|NCT00679432|1055837|P3|NOT COMPLETED|Overall Study||53
443090|NCT00679432|1055838|P2|NOT COMPLETED|Overall Study||38
443091|NCT00679432|1055839|P1|NOT COMPLETED|Overall Study||37
443092|NCT00679432|1055836|P4|COMPLETED|Overall Study||95
443093|NCT00679432|1055837|P3|COMPLETED|Overall Study||76
443094|NCT00679432|1055838|P2|COMPLETED|Overall Study||89
443095|NCT00679432|1055839|P1|COMPLETED|Overall Study||89
443096|NCT00679432|1055836|P4|STARTED|Overall Study||127
443097|NCT00679432|1055837|P3|STARTED|Overall Study||129
443098|NCT00679432|1055838|P2|STARTED|Overall Study||127
443099|NCT00679432|1055839|P1|STARTED|Overall Study||126
443100|NCT00679380|1055861|P4|NOT COMPLETED|Overall Study||28
443101|NCT00679380|1055862|P3|NOT COMPLETED|Overall Study||35
443102|NCT00679380|1055863|P2|NOT COMPLETED|Overall Study||33
443103|NCT00679380|1055864|P1|NOT COMPLETED|Overall Study||42
443104|NCT00679380|1055861|P4|COMPLETED|Overall Study||61
443105|NCT00679380|1055862|P3|COMPLETED|Overall Study||68
443106|NCT00679380|1055863|P2|COMPLETED|Overall Study||76
443107|NCT00679380|1055864|P1|COMPLETED|Overall Study||67
443108|NCT00679380|1055861|P4|STARTED|Overall Study||89
443109|NCT00679380|1055862|P3|STARTED|Overall Study||103
443110|NCT00679380|1055863|P2|STARTED|Overall Study||109
443111|NCT00679380|1055864|P1|STARTED|Overall Study||109
443112|NCT00679367|1055882|P1|NOT COMPLETED|Overall Study||12
443113|NCT00679367|1055882|P1|COMPLETED|Overall Study||4
443114|NCT00679367|1055882|P1|STARTED|Overall Study||16
443115|NCT00679354|1055888|P1|NOT COMPLETED|Overall Study||30
443116|NCT00679354|1055888|P1|COMPLETED|Overall Study||0
443117|NCT00679354|1055888|P1|STARTED|Overall Study||30
443118|NCT00679341|1055894|P2|NOT COMPLETED|Overall Study||51
443119|NCT00679341|1055895|P1|NOT COMPLETED|Overall Study||53
443120|NCT00679341|1055894|P2|COMPLETED|Overall Study||19
443121|NCT00679341|1055895|P1|COMPLETED|Overall Study||14
443122|NCT00679341|1055894|P2|STARTED|Overall Study||70
443123|NCT00679341|1055895|P1|STARTED|Overall Study||67
443124|NCT00679302|1055915|P2|NOT COMPLETED|Overall Study||4
443125|NCT00679302|1055916|P1|NOT COMPLETED|Overall Study||8
443126|NCT00679302|1055915|P2|COMPLETED|Overall Study||73
443127|NCT00679302|1055916|P1|COMPLETED|Overall Study||76
443128|NCT00679302|1055915|P2|STARTED|Overall Study||77
443129|NCT00679302|1055916|P1|STARTED|Overall Study||84
443130|NCT00679263|1055927|P3|NOT COMPLETED|Visit 2/Dose 1||0
443131|NCT00679263|1055928|P2|NOT COMPLETED|Visit 2/Dose 1||1
443132|NCT00679263|1055929|P1|NOT COMPLETED|Visit 2/Dose 1||2
443133|NCT00679263|1055927|P3|COMPLETED|Visit 2/Dose 1||11
443134|NCT00679263|1055928|P2|COMPLETED|Visit 2/Dose 1||5
443135|NCT00679263|1055929|P1|COMPLETED|Visit 2/Dose 1||9
443136|NCT00679263|1055927|P3|STARTED|Visit 2/Dose 1||11
443137|NCT00679263|1055928|P2|STARTED|Visit 2/Dose 1||6
443138|NCT00679263|1055929|P1|STARTED|Visit 2/Dose 1||11
443139|NCT00679263|1055927|P3|NOT COMPLETED|Visit 3/Dose 2||0
443140|NCT00679263|1055928|P2|NOT COMPLETED|Visit 3/Dose 2||5
443141|NCT00679263|1055929|P1|NOT COMPLETED|Visit 3/Dose 2||1
443142|NCT00679263|1055927|P3|COMPLETED|Visit 3/Dose 2||11
443143|NCT00679263|1055928|P2|COMPLETED|Visit 3/Dose 2||6
443144|NCT00679263|1055929|P1|COMPLETED|Visit 3/Dose 2||9
443145|NCT00679263|1055927|P3|STARTED|Visit 3/Dose 2||11
443146|NCT00679263|1055928|P2|STARTED|Visit 3/Dose 2||11
443147|NCT00679263|1055929|P1|STARTED|Visit 3/Dose 2||10
443148|NCT00678899|1055940|P1|NOT COMPLETED|Overall Study||1
443149|NCT00678899|1055940|P1|COMPLETED|Overall Study||49
443150|NCT00678899|1055940|P1|STARTED|Overall Study||50
443151|NCT00678834|1055950|P3|NOT COMPLETED|Overall Study||9
443152|NCT00678834|1055951|P2|NOT COMPLETED|Overall Study||0
443153|NCT00678834|1055952|P1|NOT COMPLETED|Overall Study||16
443154|NCT00678834|1055950|P3|COMPLETED|Overall Study||16
443155|NCT00678834|1055951|P2|COMPLETED|Overall Study||15
443156|NCT00678834|1055952|P1|COMPLETED|Overall Study||24
443157|NCT00678834|1055950|P3|STARTED|Overall Study||25
443158|NCT00678834|1055951|P2|STARTED|Overall Study||15
443159|NCT00678834|1055952|P1|STARTED|Overall Study||40
443160|NCT00678795|1055972|P2|NOT COMPLETED|Overall Study||6
443161|NCT00678795|1055973|P1|NOT COMPLETED|Overall Study||11
443162|NCT00678795|1055972|P2|COMPLETED|Overall Study||62
443163|NCT00678795|1055973|P1|COMPLETED|Overall Study||56
443164|NCT00678795|1055972|P2|STARTED|Overall Study||68
443165|NCT00678795|1055973|P1|STARTED|Overall Study||67
443166|NCT00678691|1055995|P2|NOT COMPLETED|Overall Study||4
443167|NCT00678691|1055996|P1|NOT COMPLETED|Overall Study||6
443168|NCT00678691|1055995|P2|COMPLETED|Overall Study||24
443169|NCT00678691|1055996|P1|COMPLETED|Overall Study||21
443170|NCT00678691|1055995|P2|STARTED|Overall Study||28
443171|NCT00678691|1055996|P1|STARTED|Overall Study||27
443172|NCT00678639|1056004|P2|NOT COMPLETED|Overall Study||0
443173|NCT00678639|1056005|P1|NOT COMPLETED|Overall Study||2
443174|NCT00678639|1056004|P2|COMPLETED|Overall Study||57
443175|NCT00678639|1056005|P1|COMPLETED|Overall Study||51
443176|NCT00678639|1056004|P2|Hospital Discharge|Overall Study||57
443177|NCT00678639|1056005|P1|Hospital Discharge|Overall Study||53
443178|NCT00678639|1056004|P2|STARTED|Overall Study||57
443179|NCT00678639|1056005|P1|STARTED|Overall Study||53
443180|NCT00678587|1056020|P2|NOT COMPLETED|Overall Study||18
443181|NCT00678587|1056021|P1|NOT COMPLETED|Overall Study||20
443182|NCT00678587|1056020|P2|COMPLETED|Overall Study||127
443183|NCT00678587|1056021|P1|COMPLETED|Overall Study||127
443184|NCT00678587|1056020|P2|STARTED|Overall Study||145
443185|NCT00678587|1056021|P1|STARTED|Overall Study||147
443186|NCT00678535|1056055|P2|NOT COMPLETED|Overall Study||98
443187|NCT00678535|1056056|P1|NOT COMPLETED|Overall Study||93
443188|NCT00678535|1056055|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
443189|NCT00678535|1056056|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
443190|NCT00678535|1056055|P2|STARTED|Overall Study|ITT population|449
443191|NCT00678535|1056056|P1|STARTED|Overall Study|ITT population|455
443192|NCT00678470|1056072|P1|NOT COMPLETED|Overall Study||3
443193|NCT00678470|1056072|P1|COMPLETED|Overall Study||15
443194|NCT00678470|1056072|P1|STARTED|Overall Study||18
443195|NCT00678418|1056078|P2|NOT COMPLETED|Part B (Open Label)||0
443196|NCT00678418|1056079|P1|NOT COMPLETED|Part B (Open Label)||43
443197|NCT00678418|1056078|P2|COMPLETED|Part B (Open Label)||0
443198|NCT00678418|1056079|P1|COMPLETED|Part B (Open Label)||71
443199|NCT00678418|1056078|P2|STARTED|Part B (Open Label)||0
443200|NCT00678418|1056079|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
443201|NCT00678418|1056078|P2|NOT COMPLETED|Part A (Double Blind)||77
443202|NCT00678418|1056079|P1|NOT COMPLETED|Part A (Double Blind)||59
443203|NCT00678418|1056078|P2|COMPLETED|Part A (Double Blind)||47
443204|NCT00678418|1056079|P1|COMPLETED|Part A (Double Blind)||67
443205|NCT00678418|1056078|P2|STARTED|Part A (Double Blind)||124
443206|NCT00678418|1056079|P1|STARTED|Part A (Double Blind)||126
443207|NCT00678392|1056095|P2|NOT COMPLETED|Overall Study||362
443208|NCT00678392|1056096|P1|NOT COMPLETED|Overall Study||361
443209|NCT00678392|1056095|P2|COMPLETED|Overall Study||0
443210|NCT00678392|1056096|P1|COMPLETED|Overall Study||0
443211|NCT00678392|1056095|P2|Treated|Overall Study||355
443212|NCT00678392|1056096|P1|Treated|Overall Study||359
443213|NCT00678392|1056095|P2|STARTED|Overall Study||362
443214|NCT00678392|1056096|P1|STARTED|Overall Study||361
443215|NCT00678288|1056130|P2|NOT COMPLETED|Overall Study||6
443216|NCT00678288|1056131|P1|NOT COMPLETED|Overall Study||10
443217|NCT00678288|1056130|P2|COMPLETED|Overall Study||0
443218|NCT00678288|1056131|P1|COMPLETED|Overall Study||0
443219|NCT00678288|1056130|P2|STARTED|Overall Study||6
443220|NCT00678288|1056131|P1|STARTED|Overall Study||10
443221|NCT00678249|1056148|P3|NOT COMPLETED|Overall Study||0
443222|NCT00678249|1056149|P2|NOT COMPLETED|Overall Study||0
443223|NCT00678249|1056150|P1|NOT COMPLETED|Overall Study||0
443224|NCT00678249|1056148|P3|COMPLETED|Overall Study||37
443225|NCT00678249|1056149|P2|COMPLETED|Overall Study||93
443226|NCT00678249|1056150|P1|COMPLETED|Overall Study||97
443227|NCT00678249|1056148|P3|STARTED|Overall Study||37
443228|NCT00678249|1056149|P2|STARTED|Overall Study||93
443229|NCT00678249|1056150|P1|STARTED|Overall Study||97
443230|NCT00678210|1056186|P4|NOT COMPLETED|Overall Study||20
443231|NCT00678210|1056187|P3|NOT COMPLETED|Overall Study||6
443232|NCT00678210|1056188|P2|NOT COMPLETED|Overall Study||11
443233|NCT00678210|1056189|P1|NOT COMPLETED|Overall Study||11
443234|NCT00678210|1056186|P4|COMPLETED|Overall Study||30
443235|NCT00678210|1056187|P3|COMPLETED|Overall Study||43
443236|NCT00678210|1056188|P2|COMPLETED|Overall Study||38
443237|NCT00678210|1056189|P1|COMPLETED|Overall Study||38
443238|NCT00678210|1056186|P4|STARTED|Overall Study||50
443239|NCT00678210|1056187|P3|STARTED|Overall Study||49
443240|NCT00678210|1056188|P2|STARTED|Overall Study||49
443241|NCT00678210|1056189|P1|STARTED|Overall Study||49
443242|NCT00678041|1056225|P2|NOT COMPLETED|Overall Study||5
443243|NCT00678041|1056226|P1|NOT COMPLETED|Overall Study||5
443244|NCT00678041|1056225|P2|COMPLETED|Overall Study||0
443245|NCT00678041|1056226|P1|COMPLETED|Overall Study||0
443246|NCT00678041|1056225|P2|STARTED|Overall Study||5
443247|NCT00678041|1056226|P1|STARTED|Overall Study||5
443248|NCT00678015|1056238|P1|NOT COMPLETED|Overall Study||0
443249|NCT00678015|1056238|P1|COMPLETED|Overall Study||12
443250|NCT00678015|1056238|P1|STARTED|Overall Study||12
443251|NCT00677924|1056247|P2|NOT COMPLETED|Overall Study||0
443252|NCT00677924|1056248|P1|NOT COMPLETED|Overall Study||0
443253|NCT00677924|1056247|P2|COMPLETED|Overall Study||6
443254|NCT00677924|1056248|P1|COMPLETED|Overall Study||3
443255|NCT00677924|1056247|P2|STARTED|Overall Study||6
443256|NCT00677924|1056248|P1|STARTED|Overall Study||3
443257|NCT00677898|1056258|P2|NOT COMPLETED|Overall Study||18
443258|NCT00677898|1056259|P1|NOT COMPLETED|Overall Study||20
443259|NCT00677898|1056258|P2|COMPLETED|Overall Study||102
443260|NCT00677898|1056259|P1|COMPLETED|Overall Study||99
443261|NCT00677898|1056258|P2|STARTED|Overall Study||120
443262|NCT00677898|1056259|P1|STARTED|Overall Study||119
443263|NCT00677833|1056279|P4|NOT COMPLETED|Overall Study||3
443264|NCT00677833|1056280|P3|NOT COMPLETED|Overall Study||2
443265|NCT00677833|1056281|P2|NOT COMPLETED|Overall Study||0
443266|NCT00677833|1056282|P1|NOT COMPLETED|Overall Study||4
443267|NCT00677833|1056279|P4|COMPLETED|Overall Study||128
443268|NCT00677833|1056280|P3|COMPLETED|Overall Study||122
443269|NCT00677833|1056281|P2|COMPLETED|Overall Study||51
443270|NCT00677833|1056282|P1|COMPLETED|Overall Study||51
443271|NCT00677833|1056279|P4|STARTED|Overall Study||131
443272|NCT00677833|1056280|P3|STARTED|Overall Study||124
443273|NCT00677833|1056281|P2|STARTED|Overall Study||51
443274|NCT00677833|1056282|P1|STARTED|Overall Study||55
443275|NCT00677820|1056332|P2|NOT COMPLETED|Overall Study||0
443276|NCT00677820|1056333|P1|NOT COMPLETED|Overall Study||1
443277|NCT00677820|1056332|P2|COMPLETED|Overall Study||60
443278|NCT00677820|1056333|P1|COMPLETED|Overall Study||239
443279|NCT00677820|1056332|P2|STARTED|Overall Study||60
443280|NCT00677820|1056333|P1|STARTED|Overall Study||240
443281|NCT00677807|1056354|P3|NOT COMPLETED|Overall Study||20
443282|NCT00677807|1056355|P2|NOT COMPLETED|Overall Study||11
443283|NCT00677807|1056356|P1|NOT COMPLETED|Overall Study||18
443284|NCT00677807|1056354|P3|COMPLETED|Overall Study||105
443285|NCT00677807|1056355|P2|COMPLETED|Overall Study||135
443286|NCT00677807|1056356|P1|COMPLETED|Overall Study||126
443287|NCT00677807|1056354|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
443288|NCT00677807|1056355|P2|Safety/ITT: Received Study Drug|Overall Study||146
443289|NCT00677807|1056356|P1|Safety/ITT: Received Study Drug|Overall Study||144
443290|NCT00677807|1056354|P3|STARTED|Overall Study||125
443291|NCT00677807|1056355|P2|STARTED|Overall Study||146
443292|NCT00677807|1056356|P1|STARTED|Overall Study||144
443293|NCT00677690|1056387|P2|NOT COMPLETED|Overall Study||0
443294|NCT00677690|1056388|P1|NOT COMPLETED|Overall Study||0
443295|NCT00677690|1056387|P2|COMPLETED|Overall Study||41
443296|NCT00677690|1056388|P1|COMPLETED|Overall Study||42
443297|NCT00677690|1056387|P2|STARTED|Overall Study||41
443298|NCT00677690|1056388|P1|STARTED|Overall Study||42
443299|NCT00677534|1056402|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
443300|NCT00677534|1056402|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
443301|NCT00677534|1056402|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
443302|NCT00677534|1056402|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
443303|NCT00677534|1056402|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
443304|NCT00677534|1056402|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
443305|NCT00677534|1056402|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
443306|NCT00677534|1056402|P1|COMPLETED|Washout (Weeks 1-4)||7
443307|NCT00677534|1056402|P1|STARTED|Washout (Weeks 1-4)||10
443308|NCT00677365|1056410|P4|NOT COMPLETED|Overall Study||3
443309|NCT00677365|1056411|P3|NOT COMPLETED|Overall Study||2
443310|NCT00677365|1056412|P2|NOT COMPLETED|Overall Study||1
443311|NCT00677365|1056413|P1|NOT COMPLETED|Overall Study||2
443312|NCT00677365|1056410|P4|COMPLETED|Overall Study||36
443313|NCT00677365|1056411|P3|COMPLETED|Overall Study||35
443314|NCT00677365|1056412|P2|COMPLETED|Overall Study||37
443315|NCT00677365|1056413|P1|COMPLETED|Overall Study||35
443316|NCT00677365|1056410|P4|STARTED|Overall Study||39
443317|NCT00677365|1056411|P3|STARTED|Overall Study||37
443318|NCT00677365|1056412|P2|STARTED|Overall Study||38
443319|NCT00677365|1056413|P1|STARTED|Overall Study||37
443320|NCT00677352|1056445|P2|NOT COMPLETED|Tapering Phase||10
443321|NCT00677352|1056446|P1|NOT COMPLETED|Tapering Phase||6
443322|NCT00677352|1056445|P2|COMPLETED|Tapering Phase||112
443323|NCT00677352|1056446|P1|COMPLETED|Tapering Phase||126
443324|NCT00677352|1056445|P2|STARTED|Tapering Phase||122
443325|NCT00677352|1056446|P1|STARTED|Tapering Phase||132
443326|NCT00677352|1056445|P2|NOT COMPLETED|Treatment Phase||42
443327|NCT00677352|1056446|P1|NOT COMPLETED|Treatment Phase||25
443328|NCT00677352|1056445|P2|COMPLETED|Treatment Phase||122
443329|NCT00677352|1056446|P1|COMPLETED|Treatment Phase||132
443330|NCT00677352|1056445|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
443331|NCT00677352|1056446|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
443332|NCT00677235|1056466|P2|NOT COMPLETED|Overall Study||38
443333|NCT00677235|1056467|P1|NOT COMPLETED|Overall Study||41
443334|NCT00677235|1056466|P2|COMPLETED|Overall Study||94
443335|NCT00677235|1056467|P1|COMPLETED|Overall Study||97
443336|NCT00677235|1056466|P2|STARTED|Overall Study||132
443337|NCT00677235|1056467|P1|STARTED|Overall Study||138
443338|NCT00677092|1056507|P1|NOT COMPLETED|Overall Study||6
443339|NCT00677092|1056507|P1|COMPLETED|Overall Study||6
443340|NCT00677092|1056507|P1|Received Study Treatment|Overall Study||11
443341|NCT00677092|1056507|P1|STARTED|Overall Study||12
443342|NCT00677014|1056519|P3|NOT COMPLETED|Overall Study||49
443343|NCT00677014|1056520|P2|NOT COMPLETED|Overall Study||41
443344|NCT00677014|1056521|P1|NOT COMPLETED|Overall Study||44
443345|NCT00677014|1056519|P3|COMPLETED|Overall Study||283
443346|NCT00677014|1056520|P2|COMPLETED|Overall Study||282
443347|NCT00677014|1056521|P1|COMPLETED|Overall Study||281
443348|NCT00677014|1056519|P3|STARTED|Overall Study||332
443349|NCT00677014|1056520|P2|STARTED|Overall Study||323
443350|NCT00677014|1056521|P1|STARTED|Overall Study||325
443351|NCT00676897|1056531|P2|NOT COMPLETED|Overall Study||0
443352|NCT00676897|1056532|P1|NOT COMPLETED|Overall Study||0
443353|NCT00676897|1056531|P2|COMPLETED|Overall Study||10
443354|NCT00676897|1056532|P1|COMPLETED|Overall Study||8
443355|NCT00676897|1056531|P2|STARTED|Overall Study||10
443356|NCT00676897|1056532|P1|STARTED|Overall Study||8
443357|NCT00676806|1056542|P2|NOT COMPLETED|Overall Study||0
443358|NCT00676806|1056543|P1|NOT COMPLETED|Overall Study||0
443359|NCT00676806|1056542|P2|COMPLETED|Overall Study||3
443360|NCT00676806|1056543|P1|COMPLETED|Overall Study||3
443361|NCT00676806|1056542|P2|STARTED|Overall Study||3
443362|NCT00676806|1056543|P1|STARTED|Overall Study||3
443363|NCT00676793|1056559|P1|NOT COMPLETED|Overall Study||13
443364|NCT00676793|1056559|P1|COMPLETED|Overall Study||19
443365|NCT00676793|1056559|P1|STARTED|Overall Study||32
443366|NCT00676780|1056564|P1|NOT COMPLETED|Overall Study||7
443367|NCT00676780|1056564|P1|COMPLETED|Overall Study||26
443368|NCT00676780|1056564|P1|STARTED|Overall Study||33
443369|NCT00676715|1056574|P4|NOT COMPLETED|Overall Study||40
443370|NCT00676715|1056575|P3|NOT COMPLETED|Overall Study||41
443371|NCT00676715|1056576|P2|NOT COMPLETED|Overall Study||47
443372|NCT00676715|1056577|P1|NOT COMPLETED|Overall Study||40
443373|NCT00676715|1056574|P4|COMPLETED|Overall Study||14
443374|NCT00676715|1056575|P3|COMPLETED|Overall Study||14
443375|NCT00676715|1056576|P2|COMPLETED|Overall Study||8
443376|NCT00676715|1056577|P1|COMPLETED|Overall Study||14
443377|NCT00676715|1056574|P4|STARTED|Overall Study||54
443378|NCT00676715|1056575|P3|STARTED|Overall Study||55
443379|NCT00676715|1056576|P2|STARTED|Overall Study||55
443380|NCT00676715|1056577|P1|STARTED|Overall Study||54
443381|NCT00676689|1056607|P1|NOT COMPLETED|Overall Study||61
443382|NCT00676689|1056607|P1|COMPLETED|Overall Study||20
443383|NCT00676689|1056607|P1|1 Year Follow-up|Overall Study||64
443384|NCT00676689|1056607|P1|30 Day Follow-up|Overall Study||78
443385|NCT00676689|1056607|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
443386|NCT00676689|1056607|P1|STARTED|Overall Study||81
443387|NCT00676676|1056613|P1|NOT COMPLETED|Overall Study||0
443388|NCT00676676|1056613|P1|COMPLETED|Overall Study||9
443389|NCT00676676|1056613|P1|STARTED|Overall Study||9
443390|NCT00676650|1056619|P2|NOT COMPLETED|Overall Study||289
443391|NCT00676650|1056620|P1|NOT COMPLETED|Overall Study||584
443392|NCT00676650|1056619|P2|COMPLETED|Overall Study||0
443393|NCT00676650|1056620|P1|COMPLETED|Overall Study||0
443394|NCT00676650|1056619|P2|Treated|Overall Study||285
443395|NCT00676650|1056620|P1|Treated|Overall Study||581
443396|NCT00676650|1056619|P2|STARTED|Overall Study||289
443397|NCT00676650|1056620|P1|STARTED|Overall Study||584
443398|NCT00676585|1056640|P2|NOT COMPLETED|Overall Study||0
443399|NCT00676585|1056641|P1|NOT COMPLETED|Overall Study||0
443400|NCT00676585|1056640|P2|COMPLETED|Overall Study||25
443401|NCT00676585|1056641|P1|COMPLETED|Overall Study||25
443402|NCT00676585|1056640|P2|STARTED|Overall Study||25
443403|NCT00676585|1056641|P1|STARTED|Overall Study||25
443404|NCT00676520|1056651|P1|NOT COMPLETED|Overall Study||731
443405|NCT00676520|1056651|P1|COMPLETED|Overall Study||7309
443406|NCT00676520|1056651|P1|STARTED|Overall Study||8040
443407|NCT00676494|1056708|P1|NOT COMPLETED|Overall Study||14
443408|NCT00676494|1056708|P1|COMPLETED|Overall Study||158
443409|NCT00676494|1056708|P1|STARTED|Overall Study||172
443410|NCT00676455|1056714|P1|NOT COMPLETED|Overall Study||0
443411|NCT00676455|1056714|P1|COMPLETED|Overall Study||14
443412|NCT00676455|1056714|P1|STARTED|Overall Study||14
443413|NCT00676403|1056725|P6|NOT COMPLETED|Overall Study||5
443414|NCT00676403|1056726|P5|NOT COMPLETED|Overall Study||1
443415|NCT00676403|1056727|P4|NOT COMPLETED|Overall Study||5
443416|NCT00676403|1056728|P3|NOT COMPLETED|Overall Study||1
443417|NCT00676403|1056729|P2|NOT COMPLETED|Overall Study||2
443418|NCT00676403|1056730|P1|NOT COMPLETED|Overall Study||2
443419|NCT00676403|1056725|P6|COMPLETED|Overall Study||18
443420|NCT00676403|1056726|P5|COMPLETED|Overall Study||23
443421|NCT00676403|1056727|P4|COMPLETED|Overall Study||17
443422|NCT00676403|1056728|P3|COMPLETED|Overall Study||22
443423|NCT00676403|1056729|P2|COMPLETED|Overall Study||20
443424|NCT00676403|1056730|P1|COMPLETED|Overall Study||21
443425|NCT00676403|1056725|P6|STARTED|Overall Study||23
443426|NCT00676403|1056726|P5|STARTED|Overall Study||24
443427|NCT00676403|1056727|P4|STARTED|Overall Study||22
443428|NCT00676403|1056728|P3|STARTED|Overall Study||23
443429|NCT00676403|1056729|P2|STARTED|Overall Study||22
443430|NCT00676403|1056730|P1|STARTED|Overall Study||23
443431|NCT00676364|1056860|P2|NOT COMPLETED|Overall Study||0
443432|NCT00676364|1056861|P1|NOT COMPLETED|Overall Study||0
443433|NCT00676364|1056860|P2|COMPLETED|Overall Study||57
443434|NCT00676364|1056861|P1|COMPLETED|Overall Study||57
443435|NCT00676364|1056860|P2|STARTED|Overall Study||57
443436|NCT00676364|1056861|P1|STARTED|Overall Study||57
443437|NCT00676338|1056873|P4|NOT COMPLETED|Overall Study||23
443438|NCT00676338|1056874|P3|NOT COMPLETED|Overall Study||30
443439|NCT00676338|1056875|P2|NOT COMPLETED|Overall Study||33
443440|NCT00676338|1056876|P1|NOT COMPLETED|Overall Study||38
443441|NCT00676338|1056873|P4|COMPLETED|Overall Study||140
443442|NCT00676338|1056874|P3|COMPLETED|Overall Study||133
443443|NCT00676338|1056875|P2|COMPLETED|Overall Study||213
443444|NCT00676338|1056876|P1|COMPLETED|Overall Study||210
443445|NCT00676338|1056873|P4|STARTED|Overall Study||163
443446|NCT00676338|1056874|P3|STARTED|Overall Study||163
443447|NCT00676338|1056875|P2|STARTED|Overall Study||246
443448|NCT00676338|1056876|P1|STARTED|Overall Study||248
443449|NCT00676208|1056928|P2|NOT COMPLETED|Overall Study||6
443450|NCT00676208|1056929|P1|NOT COMPLETED|Overall Study||2
443451|NCT00676208|1056928|P2|COMPLETED|Overall Study||13
443452|NCT00676208|1056929|P1|COMPLETED|Overall Study||12
443453|NCT00676208|1056928|P2|STARTED|Overall Study||19
443454|NCT00676208|1056929|P1|STARTED|Overall Study||14
443455|NCT00676195|1056937|P1|NOT COMPLETED|Overall Study||3
443456|NCT00676195|1056937|P1|COMPLETED|Overall Study||21
443457|NCT00676195|1056937|P1|STARTED|Overall Study||24
443458|NCT00676182|1056947|P1|NOT COMPLETED|Overall Study||0
443459|NCT00676182|1056947|P1|COMPLETED|Overall Study||75
443460|NCT00676182|1056947|P1|STARTED|Overall Study||75
443461|NCT00676143|1056962|P2|NOT COMPLETED|Overall Study||260
443462|NCT00676143|1056963|P1|NOT COMPLETED|Overall Study||156
443463|NCT00676143|1056962|P2|COMPLETED|Overall Study||398
443464|NCT00676143|1056963|P1|COMPLETED|Overall Study||285
443465|NCT00676143|1056962|P2|Treated|Overall Study||654
443466|NCT00676143|1056963|P1|Treated|Overall Study||439
443467|NCT00676143|1056962|P2|STARTED|Overall Study||658
443468|NCT00676143|1056963|P1|STARTED|Overall Study||441
443469|NCT00676130|1057003|P2|NOT COMPLETED|Overall Study||4
443470|NCT00676130|1057004|P1|NOT COMPLETED|Overall Study||3
443471|NCT00676130|1057003|P2|COMPLETED|Overall Study||73
443472|NCT00676130|1057004|P1|COMPLETED|Overall Study||73
443473|NCT00676130|1057003|P2|STARTED|Overall Study||77
443474|NCT00676130|1057004|P1|STARTED|Overall Study||76
443475|NCT00676091|1057014|P2|NOT COMPLETED|Toddler Dose||0
443476|NCT00676091|1057015|P1|NOT COMPLETED|Toddler Dose||3
443477|NCT00676091|1057014|P2|COMPLETED|Toddler Dose||156
443478|NCT00676091|1057015|P1|COMPLETED|Toddler Dose||153
443479|NCT00676091|1057014|P2|STARTED|Toddler Dose||156
443480|NCT00676091|1057015|P1|STARTED|Toddler Dose||156
443481|NCT00676091|1057014|P2|NOT COMPLETED|After Infant Series||3
443482|NCT00676091|1057015|P1|NOT COMPLETED|After Infant Series||1
443483|NCT00676091|1057014|P2|COMPLETED|After Infant Series||156
443484|NCT00676091|1057015|P1|COMPLETED|After Infant Series||156
443485|NCT00676091|1057014|P2|STARTED|After Infant Series||159
443486|NCT00676091|1057015|P1|STARTED|After Infant Series||157
443487|NCT00676091|1057014|P2|NOT COMPLETED|Infant Series||18
443488|NCT00676091|1057015|P1|NOT COMPLETED|Infant Series||20
443489|NCT00676091|1057014|P2|COMPLETED|Infant Series||159
443490|NCT00676091|1057015|P1|COMPLETED|Infant Series||157
443491|NCT00676091|1057014|P2|Vaccinated Dose 3|Infant Series||161
443492|NCT00676091|1057015|P1|Vaccinated Dose 3|Infant Series||158
443493|NCT00676091|1057014|P2|Vaccinated Dose 2|Infant Series||162
443494|NCT00676091|1057015|P1|Vaccinated Dose 2|Infant Series||159
443495|NCT00676091|1057014|P2|Vaccinated Dose 1|Infant Series||162
443496|NCT00676091|1057015|P1|Vaccinated Dose 1|Infant Series||163
443497|NCT00676091|1057014|P2|STARTED|Infant Series||177
443498|NCT00676091|1057015|P1|STARTED|Infant Series||177
443499|NCT00676065|1057050|P3|NOT COMPLETED|Overall Study||0
443500|NCT00676065|1057051|P2|NOT COMPLETED|Overall Study||0
443501|NCT00676065|1057052|P1|NOT COMPLETED|Overall Study||0
443502|NCT00676065|1057050|P3|COMPLETED|Overall Study||26341
443503|NCT00676065|1057051|P2|COMPLETED|Overall Study||15428
443504|NCT00676065|1057052|P1|COMPLETED|Overall Study||16534
443505|NCT00676065|1057050|P3|STARTED|Overall Study||26341
443506|NCT00676065|1057051|P2|STARTED|Overall Study||15428
443507|NCT00676065|1057052|P1|STARTED|Overall Study||16534
443508|NCT00676026|1057066|P1|NOT COMPLETED|Overall Study||0
443509|NCT00676026|1057066|P1|COMPLETED|Overall Study||8
443510|NCT00676026|1057066|P1|STARTED|Overall Study||8
443511|NCT00675987|1057072|P2|NOT COMPLETED|Overall Study||0
443512|NCT00675987|1057073|P1|NOT COMPLETED|Overall Study||0
443513|NCT00675987|1057072|P2|COMPLETED|Overall Study||27
443514|NCT00675987|1057073|P1|COMPLETED|Overall Study||26
443515|NCT00675987|1057072|P2|STARTED|Overall Study||27
443516|NCT00675987|1057073|P1|STARTED|Overall Study||26
443517|NCT00675948|1057083|P2|NOT COMPLETED|Overall Study||3
443518|NCT00675948|1057084|P1|NOT COMPLETED|Overall Study||39
443519|NCT00675948|1057083|P2|COMPLETED|Overall Study||1
443520|NCT00675948|1057084|P1|COMPLETED|Overall Study||0
443521|NCT00675948|1057083|P2|STARTED|Overall Study||4
443522|NCT00675948|1057084|P1|STARTED|Overall Study||39
443523|NCT00675922|1057094|P1|NOT COMPLETED|Overall Study||0
443524|NCT00675922|1057094|P1|COMPLETED|Overall Study||98
443525|NCT00675922|1057094|P1|STARTED|Overall Study||98
443526|NCT00675909|1057102|P3|NOT COMPLETED|Overall Study||0
443527|NCT00675909|1057103|P2|NOT COMPLETED|Overall Study||0
443528|NCT00675909|1057104|P1|NOT COMPLETED|Overall Study||0
443529|NCT00675909|1057102|P3|COMPLETED|Overall Study||60
443530|NCT00675909|1057103|P2|COMPLETED|Overall Study||60
443531|NCT00675909|1057104|P1|COMPLETED|Overall Study||60
443532|NCT00675909|1057102|P3|STARTED|Overall Study||60
443533|NCT00675909|1057103|P2|STARTED|Overall Study||60
443534|NCT00675909|1057104|P1|STARTED|Overall Study||60
443535|NCT00675792|1057114|P2|NOT COMPLETED|Overall Study||0
443536|NCT00675792|1057115|P1|NOT COMPLETED|Overall Study||0
443537|NCT00675792|1057114|P2|COMPLETED|Overall Study||49
443538|NCT00675792|1057115|P1|COMPLETED|Overall Study||51
443539|NCT00675792|1057114|P2|STARTED|Overall Study||49
443540|NCT00675792|1057115|P1|STARTED|Overall Study||51
443541|NCT00675766|1057135|P4|NOT COMPLETED|Overall Study||26
443542|NCT00675766|1057136|P3|NOT COMPLETED|Overall Study||21
443543|NCT00675766|1057137|P2|NOT COMPLETED|Overall Study||5
443544|NCT00675766|1057138|P1|NOT COMPLETED|Overall Study||6
443545|NCT00675766|1057135|P4|COMPLETED|Overall Study||11
443546|NCT00675766|1057136|P3|COMPLETED|Overall Study||29
443547|NCT00675766|1057137|P2|COMPLETED|Overall Study||25
443548|NCT00675766|1057138|P1|COMPLETED|Overall Study||100
443549|NCT00675766|1057135|P4|Year 3|Overall Study||11
443550|NCT00675766|1057136|P3|Year 3|Overall Study||29
443551|NCT00675766|1057137|P2|Year 3|Overall Study||25
443552|NCT00675766|1057138|P1|Year 3|Overall Study||100
443553|NCT00675766|1057135|P4|Year 2|Overall Study||20
443554|NCT00675766|1057136|P3|Year 2|Overall Study||34
443555|NCT00675766|1057137|P2|Year 2|Overall Study||28
443556|NCT00675766|1057138|P1|Year 2|Overall Study||105
443557|NCT00675766|1057135|P4|STARTED|Overall Study||37
443558|NCT00675766|1057136|P3|STARTED|Overall Study||50
443559|NCT00675766|1057137|P2|STARTED|Overall Study||30
443560|NCT00675766|1057138|P1|STARTED|Overall Study||106
443561|NCT00675597|1057148|P1|NOT COMPLETED|Overall Study||3
443562|NCT00675597|1057148|P1|COMPLETED|Overall Study||23
443563|NCT00675597|1057148|P1|STARTED|Overall Study||26
443564|NCT00675584|1057154|P2|NOT COMPLETED|Overall Study||26
443565|NCT00675584|1057155|P1|NOT COMPLETED|Overall Study||39
443566|NCT00675584|1057154|P2|COMPLETED|Overall Study||113
443567|NCT00675584|1057155|P1|COMPLETED|Overall Study||100
443568|NCT00675584|1057154|P2|STARTED|Overall Study||139
443569|NCT00675584|1057155|P1|STARTED|Overall Study||139
443570|NCT00675558|1057164|P3|NOT COMPLETED|Second Operation||0
443571|NCT00675558|1057165|P2|NOT COMPLETED|Second Operation||0
443572|NCT00675558|1057166|P1|NOT COMPLETED|Second Operation||0
443573|NCT00675558|1057164|P3|COMPLETED|Second Operation||10
443574|NCT00675558|1057165|P2|COMPLETED|Second Operation||0
443575|NCT00675558|1057166|P1|COMPLETED|Second Operation||0
443576|NCT00675558|1057164|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
443577|NCT00675558|1057165|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
443578|NCT00675558|1057166|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
443579|NCT00675558|1057164|P3|NOT COMPLETED|Surgery||0
443580|NCT00675558|1057165|P2|NOT COMPLETED|Surgery||0
443581|NCT00675558|1057166|P1|NOT COMPLETED|Surgery||0
443582|NCT00675558|1057164|P3|COMPLETED|Surgery||30
443583|NCT00675558|1057165|P2|COMPLETED|Surgery||10
443584|NCT00675558|1057166|P1|COMPLETED|Surgery||10
443585|NCT00675558|1057164|P3|STARTED|Surgery||30
443586|NCT00675558|1057165|P2|STARTED|Surgery||10
443587|NCT00675558|1057166|P1|STARTED|Surgery||10
443588|NCT00675506|1057182|P2|NOT COMPLETED|Overall Study||12
443589|NCT00675506|1057183|P1|NOT COMPLETED|Overall Study||12
443590|NCT00675506|1057182|P2|COMPLETED|Overall Study||17
443591|NCT00675506|1057183|P1|COMPLETED|Overall Study||19
443592|NCT00675506|1057182|P2|Received Intervention|Overall Study||29
443593|NCT00675506|1057183|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
443594|NCT00675506|1057182|P2|STARTED|Overall Study||29
443595|NCT00675506|1057183|P1|STARTED|Overall Study||31
443596|NCT00675441|1057195|P1|NOT COMPLETED|Overall Study||3
443597|NCT00675441|1057195|P1|COMPLETED|Overall Study||2
443598|NCT00675441|1057195|P1|STARTED|Overall Study||5
443599|NCT00675428|1057201|P2|NOT COMPLETED|Overall Study||3
443600|NCT00675428|1057202|P1|NOT COMPLETED|Overall Study||3
443601|NCT00675428|1057201|P2|COMPLETED|Overall Study||0
443602|NCT00675428|1057202|P1|COMPLETED|Overall Study||0
443603|NCT00675428|1057201|P2|STARTED|Overall Study||3
443604|NCT00675428|1057202|P1|STARTED|Overall Study||3
443605|NCT00675415|1057222|P2|NOT COMPLETED|Overall Study||8
443606|NCT00675415|1057223|P1|NOT COMPLETED|Overall Study||8
443607|NCT00675415|1057222|P2|COMPLETED|Overall Study||123
443608|NCT00675415|1057223|P1|COMPLETED|Overall Study||124
443609|NCT00675415|1057222|P2|STARTED|Overall Study||131
443610|NCT00675415|1057223|P1|STARTED|Overall Study||132
443611|NCT00675259|1057229|P1|NOT COMPLETED|Overall Study||14
443612|NCT00675259|1057229|P1|COMPLETED|Overall Study||19
443613|NCT00675259|1057229|P1|STARTED|Overall Study||33
443614|NCT00675103|1057238|P1|NOT COMPLETED|Overall Study||3
443615|NCT00675103|1057238|P1|COMPLETED|Overall Study||4
443616|NCT00675103|1057238|P1|STARTED|Overall Study||7
443617|NCT00674986|1057245|P2|NOT COMPLETED|Overall Study||81
443618|NCT00674986|1057246|P1|NOT COMPLETED|Overall Study||43
443619|NCT00674986|1057245|P2|COMPLETED|Overall Study||188
443620|NCT00674986|1057246|P1|COMPLETED|Overall Study||187
443621|NCT00674986|1057245|P2|Intent to Treat Population|Overall Study||256
443622|NCT00674986|1057246|P1|Intent to Treat Population|Overall Study||227
443623|NCT00674986|1057245|P2|STARTED|Overall Study||269
443624|NCT00674986|1057246|P1|STARTED|Overall Study||230
443625|NCT00674973|1057267|P2|NOT COMPLETED|Overall Study||102
443626|NCT00674973|1057268|P1|NOT COMPLETED|Overall Study||100
443627|NCT00674973|1057267|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
443628|NCT00674973|1057268|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
443629|NCT00674973|1057267|P2|Switch to Open-Label Erlotinib|Overall Study||0
443630|NCT00674973|1057268|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
443631|NCT00674973|1057267|P2|STARTED|Overall Study||104
443632|NCT00674973|1057268|P1|STARTED|Overall Study||103
443633|NCT00674817|1057282|P1|NOT COMPLETED|Period 6||0
443634|NCT00674817|1057282|P1|COMPLETED|Period 6||38
443635|NCT00674817|1057282|P1|STARTED|Period 6||38
443636|NCT00674817|1057282|P1|NOT COMPLETED|Period 5||0
443637|NCT00674817|1057282|P1|COMPLETED|Period 5||38
443638|NCT00674817|1057282|P1|STARTED|Period 5||38
443639|NCT00674817|1057282|P1|NOT COMPLETED|Period 4||1
443640|NCT00674817|1057282|P1|COMPLETED|Period 4||38
443641|NCT00674817|1057282|P1|STARTED|Period 4||39
443642|NCT00674817|1057282|P1|NOT COMPLETED|Period 3||2
443643|NCT00674817|1057282|P1|COMPLETED|Period 3||39
443644|NCT00674817|1057282|P1|STARTED|Period 3||41
443645|NCT00674817|1057282|P1|NOT COMPLETED|Period 2||0
443646|NCT00674817|1057282|P1|COMPLETED|Period 2||41
443647|NCT00674817|1057282|P1|STARTED|Period 2||41
443648|NCT00674817|1057282|P1|NOT COMPLETED|Period 1||3
443649|NCT00674817|1057282|P1|COMPLETED|Period 1||41
443650|NCT00674817|1057282|P1|STARTED|Period 1||44
443651|NCT00674765|1057430|P2|NOT COMPLETED|Overall Study||29
443652|NCT00674765|1057431|P1|NOT COMPLETED|Overall Study||36
443653|NCT00674765|1057430|P2|COMPLETED|Overall Study||46
443654|NCT00674765|1057431|P1|COMPLETED|Overall Study||45
443655|NCT00674765|1057430|P2|STARTED|Overall Study||75
443656|NCT00674765|1057431|P1|STARTED|Overall Study||81
443657|NCT00674739|1057440|P3|NOT COMPLETED|Overall Study||32
443658|NCT00674739|1057441|P2|NOT COMPLETED|Overall Study||59
443659|NCT00674739|1057442|P1|NOT COMPLETED|Overall Study||57
443660|NCT00674739|1057440|P3|COMPLETED|Overall Study||65
443661|NCT00674739|1057441|P2|COMPLETED|Overall Study||136
443662|NCT00674739|1057442|P1|COMPLETED|Overall Study||121
443663|NCT00674739|1057440|P3|STARTED|Overall Study||97
443664|NCT00674739|1057441|P2|STARTED|Overall Study||195
443665|NCT00674739|1057442|P1|STARTED|Overall Study||178
443666|NCT00674700|1057459|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
443667|NCT00674700|1057460|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
443668|NCT00674700|1057461|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
443669|NCT00674700|1057459|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
443670|NCT00674700|1057460|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
443671|NCT00674700|1057461|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
443672|NCT00674700|1057459|P3|STARTED|Year 2 Follow-up Without Treatment||153
443673|NCT00674700|1057460|P2|STARTED|Year 2 Follow-up Without Treatment||135
443674|NCT00674700|1057461|P1|STARTED|Year 2 Follow-up Without Treatment||139
443675|NCT00674700|1057459|P3|NOT COMPLETED|Year 1||17
443676|NCT00674700|1057460|P2|NOT COMPLETED|Year 1||34
443677|NCT00674700|1057461|P1|NOT COMPLETED|Year 1||31
443678|NCT00674700|1057459|P3|COMPLETED|Year 1||153
443679|NCT00674700|1057460|P2|COMPLETED|Year 1||135
443680|NCT00674700|1057461|P1|COMPLETED|Year 1||139
443681|NCT00674700|1057459|P3|STARTED|Year 1||170
443682|NCT00674700|1057460|P2|STARTED|Year 1||169
443683|NCT00674700|1057461|P1|STARTED|Year 1||170
443684|NCT00674661|1057474|P2|NOT COMPLETED|Overall Study||15
443685|NCT00674661|1057475|P1|NOT COMPLETED|Overall Study||11
443686|NCT00674661|1057474|P2|COMPLETED|Overall Study||48
443687|NCT00674661|1057475|P1|COMPLETED|Overall Study||56
443688|NCT00674661|1057474|P2|STARTED|Overall Study||63
443689|NCT00674661|1057475|P1|STARTED|Overall Study||67
443690|NCT00674622|1057484|P3|NOT COMPLETED|Overall Study||0
443691|NCT00674622|1057485|P2|NOT COMPLETED|Overall Study||4
443692|NCT00674622|1057486|P1|NOT COMPLETED|Overall Study||1
443693|NCT00674622|1057484|P3|COMPLETED|Overall Study||22
443694|NCT00674622|1057485|P2|COMPLETED|Overall Study||18
443695|NCT00674622|1057486|P1|COMPLETED|Overall Study||21
443696|NCT00674622|1057484|P3|STARTED|Overall Study||22
443697|NCT00674622|1057485|P2|STARTED|Overall Study||22
443698|NCT00674622|1057486|P1|STARTED|Overall Study||22
443699|NCT00674609|1057509|P3|NOT COMPLETED|Overall Study||8
443700|NCT00674609|1057510|P2|NOT COMPLETED|Overall Study||13
443701|NCT00674609|1057511|P1|NOT COMPLETED|Overall Study||12
443702|NCT00674609|1057509|P3|COMPLETED|Overall Study||51
443703|NCT00674609|1057510|P2|COMPLETED|Overall Study||45
443704|NCT00674609|1057511|P1|COMPLETED|Overall Study||48
443705|NCT00674609|1057509|P3|STARTED|Overall Study||59
443706|NCT00674609|1057510|P2|STARTED|Overall Study||58
443707|NCT00674609|1057511|P1|STARTED|Overall Study||60
443708|NCT00674492|1057543|P1|NOT COMPLETED|Overall Study||0
443709|NCT00674492|1057543|P1|COMPLETED|Overall Study||21
443710|NCT00674492|1057543|P1|STARTED|Overall Study||21
443711|NCT00674466|1057550|P3|NOT COMPLETED|Overall Study||9
443712|NCT00674466|1057551|P2|NOT COMPLETED|Overall Study||8
443713|NCT00674466|1057552|P1|NOT COMPLETED|Overall Study||7
443714|NCT00674466|1057550|P3|COMPLETED|Overall Study||21
443715|NCT00674466|1057551|P2|COMPLETED|Overall Study||22
443716|NCT00674466|1057552|P1|COMPLETED|Overall Study||23
443717|NCT00674466|1057550|P3|STARTED|Overall Study||30
443718|NCT00674466|1057551|P2|STARTED|Overall Study||30
443719|NCT00674466|1057552|P1|STARTED|Overall Study||30
443720|NCT00674362|1057568|P2|NOT COMPLETED|Open Label||0
443721|NCT00674362|1057569|P1|NOT COMPLETED|Open Label||2
443722|NCT00674362|1057568|P2|COMPLETED|Open Label||7
443723|NCT00674362|1057569|P1|COMPLETED|Open Label||18
443724|NCT00674362|1057568|P2|STARTED|Open Label||7
443725|NCT00674362|1057569|P1|STARTED|Open Label||20
443726|NCT00674362|1057568|P2|NOT COMPLETED|Double Blind||18
443727|NCT00674362|1057569|P1|NOT COMPLETED|Double Blind||12
443728|NCT00674362|1057568|P2|COMPLETED|Double Blind||80
443729|NCT00674362|1057569|P1|COMPLETED|Double Blind||84
443730|NCT00674362|1057568|P2|STARTED|Double Blind||98
443731|NCT00674362|1057569|P1|STARTED|Double Blind||96
443732|NCT00674323|1057637|P3|NOT COMPLETED|Overall Study||0
443733|NCT00674323|1057638|P2|NOT COMPLETED|Overall Study||1
443734|NCT00674323|1057639|P1|NOT COMPLETED|Overall Study||1
443735|NCT00674323|1057637|P3|COMPLETED|Overall Study||21
443736|NCT00674323|1057638|P2|COMPLETED|Overall Study||20
443737|NCT00674323|1057639|P1|COMPLETED|Overall Study||18
443738|NCT00674323|1057637|P3|STARTED|Overall Study||21
443739|NCT00674323|1057638|P2|STARTED|Overall Study||21
443740|NCT00674323|1057639|P1|STARTED|Overall Study||19
443741|NCT00674206|1057656|P1|NOT COMPLETED|Overall Study||0
443742|NCT00674206|1057656|P1|COMPLETED|Overall Study||6
443743|NCT00674206|1057656|P1|STARTED|Overall Study||6
443744|NCT00674154|1057663|P2|NOT COMPLETED|Overall Study||3
443745|NCT00674154|1057664|P1|NOT COMPLETED|Overall Study||3
443746|NCT00674154|1057663|P2|COMPLETED|Overall Study||20
443747|NCT00674154|1057664|P1|COMPLETED|Overall Study||20
443748|NCT00674154|1057663|P2|STARTED|Overall Study||23
443749|NCT00674154|1057664|P1|STARTED|Overall Study||23
443750|NCT00674128|1057672|P2|NOT COMPLETED|Overall Study||23
443751|NCT00674128|1057673|P1|NOT COMPLETED|Overall Study||25
443752|NCT00674128|1057672|P2|COMPLETED|Overall Study||21
443753|NCT00674128|1057673|P1|COMPLETED|Overall Study||25
443754|NCT00674128|1057672|P2|STARTED|Overall Study||44
443755|NCT00674128|1057673|P1|STARTED|Overall Study||50
443756|NCT00674115|1057679|P4|NOT COMPLETED|Third Intervention||0
443757|NCT00674115|1057680|P3|NOT COMPLETED|Third Intervention||0
443758|NCT00674115|1057681|P2|NOT COMPLETED|Third Intervention||0
443759|NCT00674115|1057682|P1|NOT COMPLETED|Third Intervention||0
443760|NCT00674115|1057679|P4|COMPLETED|Third Intervention||0
443761|NCT00674115|1057680|P3|COMPLETED|Third Intervention||0
443762|NCT00674115|1057681|P2|COMPLETED|Third Intervention||16
443763|NCT00674115|1057682|P1|COMPLETED|Third Intervention||14
443764|NCT00674115|1057679|P4|STARTED|Third Intervention||0
443765|NCT00674115|1057680|P3|STARTED|Third Intervention||0
443766|NCT00674115|1057681|P2|STARTED|Third Intervention||16
443767|NCT00674115|1057682|P1|STARTED|Third Intervention||14
443768|NCT00674115|1057679|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
443769|NCT00674115|1057680|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
443770|NCT00674115|1057681|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
443771|NCT00674115|1057682|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
443772|NCT00674115|1057679|P4|COMPLETED|Washout Period of 2 Weeks||0
443773|NCT00674115|1057680|P3|COMPLETED|Washout Period of 2 Weeks||0
443774|NCT00674115|1057681|P2|COMPLETED|Washout Period of 2 Weeks||16
443775|NCT00674115|1057682|P1|COMPLETED|Washout Period of 2 Weeks||14
443776|NCT00674115|1057679|P4|STARTED|Washout Period of 2 Weeks||0
443777|NCT00674115|1057680|P3|STARTED|Washout Period of 2 Weeks||0
443778|NCT00674115|1057681|P2|STARTED|Washout Period of 2 Weeks||16
443779|NCT00674115|1057682|P1|STARTED|Washout Period of 2 Weeks||14
443780|NCT00674115|1057679|P4|NOT COMPLETED|Second Intervention||0
443781|NCT00674115|1057680|P3|NOT COMPLETED|Second Intervention||0
443782|NCT00674115|1057681|P2|NOT COMPLETED|Second Intervention||0
443783|NCT00674115|1057682|P1|NOT COMPLETED|Second Intervention||0
443784|NCT00674115|1057679|P4|COMPLETED|Second Intervention||16
443785|NCT00674115|1057680|P3|COMPLETED|Second Intervention||14
443786|NCT00674115|1057681|P2|COMPLETED|Second Intervention||16
443787|NCT00674115|1057682|P1|COMPLETED|Second Intervention||14
443788|NCT00674115|1057679|P4|STARTED|Second Intervention||16
443789|NCT00674115|1057680|P3|STARTED|Second Intervention||14
443790|NCT00674115|1057681|P2|STARTED|Second Intervention||16
443791|NCT00674115|1057682|P1|STARTED|Second Intervention||14
443792|NCT00674115|1057679|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
443793|NCT00674115|1057680|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
443794|NCT00674115|1057681|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
443795|NCT00674115|1057682|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
443796|NCT00674115|1057679|P4|COMPLETED|Washout Period of 2 Weeks||16
443797|NCT00674115|1057680|P3|COMPLETED|Washout Period of 2 Weeks||14
443798|NCT00674115|1057681|P2|COMPLETED|Washout Period of 2 Weeks||16
443799|NCT00674115|1057682|P1|COMPLETED|Washout Period of 2 Weeks||14
443800|NCT00674115|1057679|P4|STARTED|Washout Period of 2 Weeks||16
443801|NCT00674115|1057680|P3|STARTED|Washout Period of 2 Weeks||14
443802|NCT00674115|1057681|P2|STARTED|Washout Period of 2 Weeks||16
443803|NCT00674115|1057682|P1|STARTED|Washout Period of 2 Weeks||14
443804|NCT00674115|1057679|P4|NOT COMPLETED|First Intervention||0
443805|NCT00674115|1057680|P3|NOT COMPLETED|First Intervention||0
443806|NCT00674115|1057681|P2|NOT COMPLETED|First Intervention||0
443807|NCT00674115|1057682|P1|NOT COMPLETED|First Intervention||0
443808|NCT00674115|1057679|P4|COMPLETED|First Intervention||16
443809|NCT00674115|1057680|P3|COMPLETED|First Intervention||14
443810|NCT00674115|1057681|P2|COMPLETED|First Intervention||16
443811|NCT00674115|1057682|P1|COMPLETED|First Intervention||14
443812|NCT00674115|1057679|P4|STARTED|First Intervention||16
443813|NCT00674115|1057680|P3|STARTED|First Intervention||14
443814|NCT00674115|1057681|P2|STARTED|First Intervention||16
443815|NCT00674115|1057682|P1|STARTED|First Intervention||14
443816|NCT00673959|1057691|P2|NOT COMPLETED|Overall Study||0
443817|NCT00673959|1057692|P1|NOT COMPLETED|Overall Study||0
443818|NCT00673959|1057691|P2|COMPLETED|Overall Study||10
443819|NCT00673959|1057692|P1|COMPLETED|Overall Study||10
443820|NCT00673959|1057691|P2|STARTED|Overall Study||10
443821|NCT00673959|1057692|P1|STARTED|Overall Study||10
443822|NCT00673933|1057698|P1|NOT COMPLETED|Overall Study||3
443823|NCT00673933|1057698|P1|COMPLETED|Overall Study||17
443824|NCT00673933|1057698|P1|STARTED|Overall Study||20
443825|NCT00673881|1057714|P1|NOT COMPLETED|Overall Study||1
443826|NCT00673881|1057714|P1|COMPLETED|Overall Study||24
443827|NCT00673881|1057714|P1|STARTED|Overall Study||25
443828|NCT00673855|1057721|P2|NOT COMPLETED|Second Intervention||0
443829|NCT00673855|1057722|P1|NOT COMPLETED|Second Intervention||0
443830|NCT00673855|1057721|P2|COMPLETED|Second Intervention||10
443831|NCT00673855|1057722|P1|COMPLETED|Second Intervention||10
443832|NCT00673855|1057721|P2|STARTED|Second Intervention||10
443833|NCT00673855|1057722|P1|STARTED|Second Intervention||10
443834|NCT00673855|1057721|P2|NOT COMPLETED|First Intervention||0
443835|NCT00673855|1057722|P1|NOT COMPLETED|First Intervention||0
443836|NCT00673855|1057721|P2|COMPLETED|First Intervention||10
443837|NCT00673855|1057722|P1|COMPLETED|First Intervention||10
443838|NCT00673855|1057721|P2|STARTED|First Intervention||10
443839|NCT00673855|1057722|P1|STARTED|First Intervention||10
443840|NCT00673816|1057728|P1|NOT COMPLETED|Overall Study||2
443841|NCT00673816|1057728|P1|COMPLETED|Overall Study||0
443842|NCT00673816|1057728|P1|STARTED|Overall Study||2
443843|NCT00673764|1057735|P2|NOT COMPLETED|Overall Study||0
443844|NCT00673764|1057736|P1|NOT COMPLETED|Overall Study||0
443845|NCT00673764|1057735|P2|COMPLETED|Overall Study||24
443846|NCT00673764|1057736|P1|COMPLETED|Overall Study||24
443847|NCT00673764|1057735|P2|STARTED|Overall Study||24
443848|NCT00673764|1057736|P1|STARTED|Overall Study||24
443849|NCT00673738|1057744|P1|NOT COMPLETED|Overall Study||0
443850|NCT00673738|1057744|P1|COMPLETED|Overall Study||27
443851|NCT00673738|1057744|P1|STARTED|Overall Study||27
443852|NCT00673712|1057752|P2|NOT COMPLETED|Overall Study||0
443853|NCT00673712|1057753|P1|NOT COMPLETED|Overall Study||0
443854|NCT00673712|1057752|P2|COMPLETED|Overall Study||326
443855|NCT00673712|1057753|P1|COMPLETED|Overall Study||321
443856|NCT00673712|1057752|P2|STARTED|Overall Study||326
443857|NCT00673712|1057753|P1|STARTED|Overall Study||321
443858|NCT00673673|1057763|P1|NOT COMPLETED|Overall Study||36
443859|NCT00673673|1057763|P1|COMPLETED|Overall Study||3
443860|NCT00673673|1057763|P1|STARTED|Overall Study||39
443861|NCT00673660|1057769|P1|NOT COMPLETED|Overall Study||107
443862|NCT00673660|1057769|P1|COMPLETED|Overall Study||268
443863|NCT00673660|1057769|P1|STARTED|Overall Study||375
443864|NCT00673595|1057782|P2|NOT COMPLETED|Overall Study||0
443865|NCT00673595|1057783|P1|NOT COMPLETED|Overall Study||0
443866|NCT00673595|1057782|P2|COMPLETED|Overall Study||11
443867|NCT00673595|1057783|P1|COMPLETED|Overall Study||8
443868|NCT00673595|1057782|P2|STARTED|Overall Study||11
443869|NCT00673595|1057783|P1|STARTED|Overall Study||8
443870|NCT00673465|1057791|P12|NOT COMPLETED|Part 2 (India)||0
443871|NCT00673465|1057792|P11|NOT COMPLETED|Part 2 (India)||0
443872|NCT00673465|1057793|P10|NOT COMPLETED|Part 2 (India)||0
443873|NCT00673465|1057794|P9|NOT COMPLETED|Part 2 (India)||0
443874|NCT00673465|1057795|P8|NOT COMPLETED|Part 2 (India)||0
443875|NCT00673465|1057796|P7|NOT COMPLETED|Part 2 (India)||0
443876|NCT00673465|1057797|P6|NOT COMPLETED|Part 2 (India)||0
443877|NCT00673465|1057798|P5|NOT COMPLETED|Part 2 (India)||0
443878|NCT00673465|1057799|P4|NOT COMPLETED|Part 2 (India)||0
443879|NCT00673465|1057800|P3|NOT COMPLETED|Part 2 (India)||0
443880|NCT00673465|1057801|P2|NOT COMPLETED|Part 2 (India)||0
443881|NCT00673465|1057802|P1|NOT COMPLETED|Part 2 (India)||0
443882|NCT00673465|1057791|P12|COMPLETED|Part 2 (India)||0
443883|NCT00673465|1057792|P11|COMPLETED|Part 2 (India)||0
443884|NCT00673465|1057793|P10|COMPLETED|Part 2 (India)||0
443885|NCT00673465|1057794|P9|COMPLETED|Part 2 (India)||0
443886|NCT00673465|1057795|P8|COMPLETED|Part 2 (India)||0
443887|NCT00673465|1057796|P7|COMPLETED|Part 2 (India)||0
443888|NCT00673465|1057797|P6|COMPLETED|Part 2 (India)||0
443889|NCT00673465|1057798|P5|COMPLETED|Part 2 (India)||0
443890|NCT00673465|1057799|P4|COMPLETED|Part 2 (India)||0
443891|NCT00673465|1057800|P3|COMPLETED|Part 2 (India)||0
443892|NCT00673465|1057801|P2|COMPLETED|Part 2 (India)||0
443893|NCT00673465|1057802|P1|COMPLETED|Part 2 (India)||0
443894|NCT00673465|1057791|P12|STARTED|Part 2 (India)||0
443895|NCT00673465|1057792|P11|STARTED|Part 2 (India)||0
443896|NCT00673465|1057793|P10|STARTED|Part 2 (India)||0
443897|NCT00673465|1057794|P9|STARTED|Part 2 (India)||0
443898|NCT00673465|1057795|P8|STARTED|Part 2 (India)||0
443899|NCT00673465|1057796|P7|STARTED|Part 2 (India)||0
443900|NCT00673465|1057797|P6|STARTED|Part 2 (India)||0
443901|NCT00673465|1057798|P5|STARTED|Part 2 (India)||0
443902|NCT00673465|1057799|P4|STARTED|Part 2 (India)||0
443903|NCT00673465|1057800|P3|STARTED|Part 2 (India)||0
443904|NCT00673465|1057801|P2|STARTED|Part 2 (India)||0
443905|NCT00673465|1057802|P1|STARTED|Part 2 (India)||0
443906|NCT00673465|1057791|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
443907|NCT00673465|1057792|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
443908|NCT00673465|1057793|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
443909|NCT00673465|1057794|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
443910|NCT00673465|1057795|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
443911|NCT00673465|1057796|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
443912|NCT00673465|1057797|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
443913|NCT00673465|1057798|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
443914|NCT00673465|1057799|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
443915|NCT00673465|1057800|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
443916|NCT00673465|1057801|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
443917|NCT00673465|1057802|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
443918|NCT00673465|1057791|P12|COMPLETED|Part 1/Period 3 (United States)||0
443919|NCT00673465|1057792|P11|COMPLETED|Part 1/Period 3 (United States)||0
443920|NCT00673465|1057793|P10|COMPLETED|Part 1/Period 3 (United States)||0
443921|NCT00673465|1057794|P9|COMPLETED|Part 1/Period 3 (United States)||0
443922|NCT00673465|1057795|P8|COMPLETED|Part 1/Period 3 (United States)||0
443923|NCT00673465|1057796|P7|COMPLETED|Part 1/Period 3 (United States)||0
443924|NCT00673465|1057797|P6|COMPLETED|Part 1/Period 3 (United States)||1
443925|NCT00673465|1057798|P5|COMPLETED|Part 1/Period 3 (United States)||1
443926|NCT00673465|1057799|P4|COMPLETED|Part 1/Period 3 (United States)||3
443927|NCT00673465|1057800|P3|COMPLETED|Part 1/Period 3 (United States)||3
443928|NCT00673465|1057801|P2|COMPLETED|Part 1/Period 3 (United States)||3
443929|NCT00673465|1057802|P1|COMPLETED|Part 1/Period 3 (United States)||3
443930|NCT00673465|1057791|P12|STARTED|Part 1/Period 3 (United States)||0
443931|NCT00673465|1057792|P11|STARTED|Part 1/Period 3 (United States)||0
443932|NCT00673465|1057793|P10|STARTED|Part 1/Period 3 (United States)||0
443933|NCT00673465|1057794|P9|STARTED|Part 1/Period 3 (United States)||0
443934|NCT00673465|1057795|P8|STARTED|Part 1/Period 3 (United States)||0
443935|NCT00673465|1057796|P7|STARTED|Part 1/Period 3 (United States)||0
443936|NCT00673465|1057797|P6|STARTED|Part 1/Period 3 (United States)||1
443937|NCT00673465|1057798|P5|STARTED|Part 1/Period 3 (United States)||1
443938|NCT00673465|1057799|P4|STARTED|Part 1/Period 3 (United States)||3
443939|NCT00673465|1057800|P3|STARTED|Part 1/Period 3 (United States)||3
443940|NCT00673465|1057801|P2|STARTED|Part 1/Period 3 (United States)||3
443941|NCT00673465|1057802|P1|STARTED|Part 1/Period 3 (United States)||3
443942|NCT00673465|1057791|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
443943|NCT00673465|1057792|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
443944|NCT00673465|1057793|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
443945|NCT00673465|1057794|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
443946|NCT00673465|1057795|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
443947|NCT00673465|1057796|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
443948|NCT00673465|1057797|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
443949|NCT00673465|1057798|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
443950|NCT00673465|1057799|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
443951|NCT00673465|1057800|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
443952|NCT00673465|1057801|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
443953|NCT00673465|1057802|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
443954|NCT00673465|1057791|P12|COMPLETED|Part 1/Period 2 (United States)||0
443955|NCT00673465|1057792|P11|COMPLETED|Part 1/Period 2 (United States)||0
443956|NCT00673465|1057793|P10|COMPLETED|Part 1/Period 2 (United States)||0
443957|NCT00673465|1057794|P9|COMPLETED|Part 1/Period 2 (United States)||0
443958|NCT00673465|1057795|P8|COMPLETED|Part 1/Period 2 (United States)||0
443959|NCT00673465|1057796|P7|COMPLETED|Part 1/Period 2 (United States)||0
443960|NCT00673465|1057797|P6|COMPLETED|Part 1/Period 2 (United States)||1
443961|NCT00673465|1057798|P5|COMPLETED|Part 1/Period 2 (United States)||1
443962|NCT00673465|1057799|P4|COMPLETED|Part 1/Period 2 (United States)||3
443963|NCT00673465|1057800|P3|COMPLETED|Part 1/Period 2 (United States)||3
443964|NCT00673465|1057801|P2|COMPLETED|Part 1/Period 2 (United States)||3
443965|NCT00673465|1057802|P1|COMPLETED|Part 1/Period 2 (United States)||3
443966|NCT00673465|1057791|P12|STARTED|Part 1/Period 2 (United States)||0
443967|NCT00673465|1057792|P11|STARTED|Part 1/Period 2 (United States)||0
443968|NCT00673465|1057793|P10|STARTED|Part 1/Period 2 (United States)||0
443969|NCT00673465|1057794|P9|STARTED|Part 1/Period 2 (United States)||0
443970|NCT00673465|1057795|P8|STARTED|Part 1/Period 2 (United States)||0
443971|NCT00673465|1057796|P7|STARTED|Part 1/Period 2 (United States)||0
443972|NCT00673465|1057797|P6|STARTED|Part 1/Period 2 (United States)||1
443973|NCT00673465|1057798|P5|STARTED|Part 1/Period 2 (United States)||2
443974|NCT00673465|1057799|P4|STARTED|Part 1/Period 2 (United States)||3
443975|NCT00673465|1057800|P3|STARTED|Part 1/Period 2 (United States)||3
443976|NCT00673465|1057801|P2|STARTED|Part 1/Period 2 (United States)||3
443977|NCT00673465|1057802|P1|STARTED|Part 1/Period 2 (United States)||3
443978|NCT00673465|1057791|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
443979|NCT00673465|1057792|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
443980|NCT00673465|1057793|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
443981|NCT00673465|1057794|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
443982|NCT00673465|1057795|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
443983|NCT00673465|1057796|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
443984|NCT00673465|1057797|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
443985|NCT00673465|1057798|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
443986|NCT00673465|1057799|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
443987|NCT00673465|1057800|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
443988|NCT00673465|1057801|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
443989|NCT00673465|1057802|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
443990|NCT00673465|1057791|P12|COMPLETED|Part 1/Period 1 (United States)||0
443991|NCT00673465|1057792|P11|COMPLETED|Part 1/Period 1 (United States)||0
443992|NCT00673465|1057793|P10|COMPLETED|Part 1/Period 1 (United States)||0
443993|NCT00673465|1057794|P9|COMPLETED|Part 1/Period 1 (United States)||0
443994|NCT00673465|1057795|P8|COMPLETED|Part 1/Period 1 (United States)||0
443995|NCT00673465|1057796|P7|COMPLETED|Part 1/Period 1 (United States)||0
443996|NCT00673465|1057797|P6|COMPLETED|Part 1/Period 1 (United States)||1
443997|NCT00673465|1057798|P5|COMPLETED|Part 1/Period 1 (United States)||2
443998|NCT00673465|1057799|P4|COMPLETED|Part 1/Period 1 (United States)||3
443999|NCT00673465|1057800|P3|COMPLETED|Part 1/Period 1 (United States)||3
444000|NCT00673465|1057801|P2|COMPLETED|Part 1/Period 1 (United States)||3
444001|NCT00673465|1057802|P1|COMPLETED|Part 1/Period 1 (United States)||3
444002|NCT00673465|1057791|P12|STARTED|Part 1/Period 1 (United States)||0
444003|NCT00673465|1057792|P11|STARTED|Part 1/Period 1 (United States)||0
444004|NCT00673465|1057793|P10|STARTED|Part 1/Period 1 (United States)||0
444005|NCT00673465|1057794|P9|STARTED|Part 1/Period 1 (United States)||0
444006|NCT00673465|1057795|P8|STARTED|Part 1/Period 1 (United States)||0
444007|NCT00673465|1057796|P7|STARTED|Part 1/Period 1 (United States)||0
444008|NCT00673465|1057797|P6|STARTED|Part 1/Period 1 (United States)||2
444009|NCT00673465|1057798|P5|STARTED|Part 1/Period 1 (United States)||3
444010|NCT00673465|1057799|P4|STARTED|Part 1/Period 1 (United States)||3
444011|NCT00673465|1057800|P3|STARTED|Part 1/Period 1 (United States)||3
444012|NCT00673465|1057801|P2|STARTED|Part 1/Period 1 (United States)||3
444013|NCT00673465|1057802|P1|STARTED|Part 1/Period 1 (United States)||3
444014|NCT00673452|1057851|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
444015|NCT00673452|1057852|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
444016|NCT00673452|1057851|P2|COMPLETED|Continuation Double-Blind Phase||153
444017|NCT00673452|1057852|P1|COMPLETED|Continuation Double-Blind Phase||151
444018|NCT00673452|1057851|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
444019|NCT00673452|1057852|P1|STARTED|Continuation Double-Blind Phase||176
444020|NCT00673452|1057851|P2|NOT COMPLETED|Acute Double-Blind Phase||80
444021|NCT00673452|1057852|P1|NOT COMPLETED|Acute Double-Blind Phase||87
444022|NCT00673452|1057851|P2|COMPLETED|Acute Double-Blind Phase||187
444023|NCT00673452|1057852|P1|COMPLETED|Acute Double-Blind Phase||176
444024|NCT00673452|1057851|P2|STARTED|Acute Double-Blind Phase||267
444025|NCT00673452|1057852|P1|STARTED|Acute Double-Blind Phase||263
444026|NCT00673439|1057886|P1|NOT COMPLETED|Overall Study||0
444027|NCT00673439|1057886|P1|COMPLETED|Overall Study||3
444028|NCT00673439|1057886|P1|STARTED|Overall Study||3
444029|NCT00673400|1057890|P1|NOT COMPLETED|Overall Study||0
444030|NCT00673400|1057890|P1|COMPLETED|Overall Study||52
444031|NCT00673400|1057890|P1|STARTED|Overall Study||52
444032|NCT00673387|1057915|P8|NOT COMPLETED|Overall Study||35
444033|NCT00673387|1057916|P7|NOT COMPLETED|Overall Study||30
444034|NCT00673387|1057917|P6|NOT COMPLETED|Overall Study||34
444035|NCT00673387|1057918|P5|NOT COMPLETED|Overall Study||30
444036|NCT00673387|1057919|P4|NOT COMPLETED|Overall Study||26
444037|NCT00673387|1057920|P3|NOT COMPLETED|Overall Study||31
444038|NCT00673387|1057921|P2|NOT COMPLETED|Overall Study||23
444039|NCT00673387|1057922|P1|NOT COMPLETED|Overall Study||29
444040|NCT00673387|1057915|P8|COMPLETED|Overall Study||40
444041|NCT00673387|1057916|P7|COMPLETED|Overall Study||48
444042|NCT00673387|1057917|P6|COMPLETED|Overall Study||44
444043|NCT00673387|1057918|P5|COMPLETED|Overall Study||48
444044|NCT00673387|1057919|P4|COMPLETED|Overall Study||49
444045|NCT00673387|1057920|P3|COMPLETED|Overall Study||41
444046|NCT00673387|1057921|P2|COMPLETED|Overall Study||54
444047|NCT00673387|1057922|P1|COMPLETED|Overall Study||46
444048|NCT00673387|1057915|P8|STARTED|Overall Study||75
444049|NCT00673387|1057916|P7|STARTED|Overall Study||78
444050|NCT00673387|1057917|P6|STARTED|Overall Study||78
444051|NCT00673387|1057918|P5|STARTED|Overall Study||78
444052|NCT00673387|1057919|P4|STARTED|Overall Study||75
444053|NCT00673387|1057920|P3|STARTED|Overall Study||72
444054|NCT00673387|1057921|P2|STARTED|Overall Study||77
444055|NCT00673387|1057922|P1|STARTED|Overall Study||75
444056|NCT00673361|1058138|P1|NOT COMPLETED|Overall Study||2
444057|NCT00673361|1058138|P1|COMPLETED|Overall Study||7
444058|NCT00673361|1058138|P1|STARTED|Overall Study||9
444059|NCT00673257|1058142|P1|NOT COMPLETED|Overall Study||5
444060|NCT00673257|1058142|P1|COMPLETED|Overall Study||102
444061|NCT00673257|1058142|P1|STARTED|Overall Study||107
444062|NCT00673231|1058151|P4|NOT COMPLETED|Overall Study||18
444063|NCT00673231|1058152|P3|NOT COMPLETED|Overall Study||26
444064|NCT00673231|1058153|P2|NOT COMPLETED|Overall Study||22
444065|NCT00673231|1058154|P1|NOT COMPLETED|Overall Study||29
444066|NCT00673231|1058151|P4|COMPLETED|Overall Study||178
444067|NCT00673231|1058152|P3|COMPLETED|Overall Study||186
444068|NCT00673231|1058153|P2|COMPLETED|Overall Study||180
444069|NCT00673231|1058154|P1|COMPLETED|Overall Study||168
444070|NCT00673231|1058151|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
444071|NCT00673231|1058152|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
444072|NCT00673231|1058153|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
444073|NCT00673231|1058154|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
444074|NCT00673179|1058186|P2|NOT COMPLETED|Overall Study||0
444075|NCT00673179|1058187|P1|NOT COMPLETED|Overall Study||3
444076|NCT00673179|1058186|P2|COMPLETED|Overall Study||0
444077|NCT00673179|1058187|P1|COMPLETED|Overall Study||4
444078|NCT00673179|1058186|P2|STARTED|Overall Study||0
444079|NCT00673179|1058187|P1|STARTED|Overall Study||7
444080|NCT00673153|1058193|P1|NOT COMPLETED|Overall Study||1
444081|NCT00673153|1058193|P1|COMPLETED|Overall Study||30
444082|NCT00673153|1058193|P1|STARTED|Overall Study||31
444083|NCT00673127|1058201|P1|NOT COMPLETED|Overall Study||0
444084|NCT00673127|1058201|P1|COMPLETED|Overall Study||57
444085|NCT00673127|1058201|P1|STARTED|Overall Study||57
444086|NCT00673114|1058206|P1|NOT COMPLETED|Overall Study||0
444087|NCT00673114|1058206|P1|COMPLETED|Overall Study||3
444088|NCT00673114|1058206|P1|STARTED|Overall Study||3
444089|NCT00673075|1058219|P2|NOT COMPLETED|Overall Study||7
444090|NCT00673075|1058220|P1|NOT COMPLETED|Overall Study||9
444091|NCT00673075|1058219|P2|COMPLETED|Overall Study||11
444092|NCT00673075|1058220|P1|COMPLETED|Overall Study||12
444093|NCT00673075|1058219|P2|STARTED|Overall Study||18
444094|NCT00673075|1058220|P1|STARTED|Overall Study||21
444095|NCT00673049|1058236|P4|NOT COMPLETED|After Progression on Erlotinib||83
444096|NCT00673049|1058237|P3|NOT COMPLETED|After Progression on Erlotinib||0
444097|NCT00673049|1058238|P2|NOT COMPLETED|After Progression on Erlotinib||0
444098|NCT00673049|1058239|P1|NOT COMPLETED|After Progression on Erlotinib||0
444099|NCT00673049|1058236|P4|COMPLETED|After Progression on Erlotinib||0
444100|NCT00673049|1058237|P3|COMPLETED|After Progression on Erlotinib||0
444101|NCT00673049|1058238|P2|COMPLETED|After Progression on Erlotinib||0
444102|NCT00673049|1058239|P1|COMPLETED|After Progression on Erlotinib||0
444103|NCT00673049|1058236|P4|STARTED|After Progression on Erlotinib||83
444104|NCT00673049|1058237|P3|STARTED|After Progression on Erlotinib||0
444105|NCT00673049|1058238|P2|STARTED|After Progression on Erlotinib||0
444106|NCT00673049|1058239|P1|STARTED|After Progression on Erlotinib||0
444107|NCT00673049|1058236|P4|NOT COMPLETED|Before Progression on Erlotinib||0
444108|NCT00673049|1058237|P3|NOT COMPLETED|Before Progression on Erlotinib||1
444109|NCT00673049|1058238|P2|NOT COMPLETED|Before Progression on Erlotinib||290
444110|NCT00673049|1058239|P1|NOT COMPLETED|Before Progression on Erlotinib||292
444111|NCT00673049|1058236|P4|COMPLETED|Before Progression on Erlotinib||0
444112|NCT00673049|1058237|P3|COMPLETED|Before Progression on Erlotinib||0
444113|NCT00673049|1058238|P2|COMPLETED|Before Progression on Erlotinib||0
444114|NCT00673049|1058239|P1|COMPLETED|Before Progression on Erlotinib||0
444115|NCT00673049|1058236|P4|Treated|Before Progression on Erlotinib||0
444116|NCT00673049|1058237|P3|Treated|Before Progression on Erlotinib||1
444117|NCT00673049|1058238|P2|Treated|Before Progression on Erlotinib||289
444118|NCT00673049|1058239|P1|Treated|Before Progression on Erlotinib||289
444119|NCT00673049|1058236|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
444120|NCT00673049|1058237|P3|STARTED|Before Progression on Erlotinib||1
444121|NCT00673049|1058238|P2|STARTED|Before Progression on Erlotinib||290
444122|NCT00673049|1058239|P1|STARTED|Before Progression on Erlotinib||292
444123|NCT00672984|1058263|P3|NOT COMPLETED|Third Intervention||1
444124|NCT00672984|1058264|P2|NOT COMPLETED|Third Intervention||0
444125|NCT00672984|1058265|P1|NOT COMPLETED|Third Intervention||1
444126|NCT00672984|1058263|P3|COMPLETED|Third Intervention||23
444127|NCT00672984|1058264|P2|COMPLETED|Third Intervention||17
444128|NCT00672984|1058265|P1|COMPLETED|Third Intervention||21
444129|NCT00672984|1058263|P3|STARTED|Third Intervention||24
444130|NCT00672984|1058264|P2|STARTED|Third Intervention||17
444131|NCT00672984|1058265|P1|STARTED|Third Intervention||22
444132|NCT00672984|1058263|P3|NOT COMPLETED|Second Intervention||1
444133|NCT00672984|1058264|P2|NOT COMPLETED|Second Intervention||6
444134|NCT00672984|1058265|P1|NOT COMPLETED|Second Intervention||0
444135|NCT00672984|1058263|P3|COMPLETED|Second Intervention||24
444136|NCT00672984|1058264|P2|COMPLETED|Second Intervention||17
444137|NCT00672984|1058265|P1|COMPLETED|Second Intervention||22
444138|NCT00672984|1058263|P3|STARTED|Second Intervention||25
444139|NCT00672984|1058264|P2|STARTED|Second Intervention||23
444140|NCT00672984|1058265|P1|STARTED|Second Intervention||22
444141|NCT00672984|1058263|P3|NOT COMPLETED|First Intervention||2
444142|NCT00672984|1058264|P2|NOT COMPLETED|First Intervention||2
444143|NCT00672984|1058265|P1|NOT COMPLETED|First Intervention||9
444144|NCT00672984|1058263|P3|COMPLETED|First Intervention||25
444145|NCT00672984|1058264|P2|COMPLETED|First Intervention||23
444146|NCT00672984|1058265|P1|COMPLETED|First Intervention||22
444147|NCT00672984|1058263|P3|STARTED|First Intervention||27
444148|NCT00672984|1058264|P2|STARTED|First Intervention||25
444149|NCT00672984|1058265|P1|STARTED|First Intervention||31
444150|NCT00672958|1058316|P2|NOT COMPLETED|Overall Study||56
444151|NCT00672958|1058317|P1|NOT COMPLETED|Overall Study||64
444152|NCT00672958|1058316|P2|COMPLETED|Overall Study||244
444153|NCT00672958|1058317|P1|COMPLETED|Overall Study||236
444154|NCT00672958|1058316|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
444155|NCT00672958|1058317|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
444156|NCT00672958|1058316|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
444157|NCT00672958|1058317|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
444158|NCT00672958|1058316|P2|STARTED|Overall Study||300
444159|NCT00672958|1058317|P1|STARTED|Overall Study||300
444160|NCT00672932|1058349|P2|NOT COMPLETED|Overall Study||0
444161|NCT00672932|1058350|P1|NOT COMPLETED|Overall Study||0
444162|NCT00672932|1058349|P2|COMPLETED|Overall Study||9
444163|NCT00672932|1058350|P1|COMPLETED|Overall Study||9
444164|NCT00672932|1058349|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
444165|NCT00672932|1058350|P1|Rolled Over to Raltegravir|Overall Study||0
444166|NCT00672932|1058349|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
444167|NCT00672932|1058350|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
444168|NCT00672932|1058349|P2|Completed Initial 12-week Assignment|Overall Study||9
444169|NCT00672932|1058350|P1|Completed Initial 12-week Assignment|Overall Study||9
444170|NCT00672932|1058349|P2|STARTED|Overall Study||9
444171|NCT00672932|1058350|P1|STARTED|Overall Study||9
444172|NCT00672854|1058360|P2|NOT COMPLETED|Overall Study||0
444173|NCT00672854|1058361|P1|NOT COMPLETED|Overall Study||0
444174|NCT00672854|1058360|P2|COMPLETED|Overall Study||51
444175|NCT00672854|1058361|P1|COMPLETED|Overall Study||49
444176|NCT00672854|1058360|P2|STARTED|Overall Study||51
444177|NCT00672854|1058361|P1|STARTED|Overall Study||49
444178|NCT00672841|1058369|P2|NOT COMPLETED|Overall Study||15
444179|NCT00672841|1058370|P1|NOT COMPLETED|Overall Study||1
444180|NCT00672841|1058369|P2|COMPLETED|Overall Study||32
444181|NCT00672841|1058370|P1|COMPLETED|Overall Study||16
444182|NCT00672841|1058369|P2|STARTED|Overall Study||47
444183|NCT00672841|1058370|P1|STARTED|Overall Study||17
444184|NCT00672646|1058385|P3|NOT COMPLETED|Overall Study||3
444185|NCT00672646|1058386|P2|NOT COMPLETED|Overall Study||1
444186|NCT00672646|1058387|P1|NOT COMPLETED|Overall Study||0
444187|NCT00672646|1058385|P3|COMPLETED|Overall Study||37
444188|NCT00672646|1058386|P2|COMPLETED|Overall Study||22
444189|NCT00672646|1058387|P1|COMPLETED|Overall Study||40
444190|NCT00672646|1058385|P3|STARTED|Overall Study||40
444191|NCT00672646|1058386|P2|STARTED|Overall Study||23
444192|NCT00672646|1058387|P1|STARTED|Overall Study||40
444193|NCT00672633|1058412|P2|NOT COMPLETED|Overall Study||1
444194|NCT00672633|1058413|P1|NOT COMPLETED|Overall Study||0
444195|NCT00672633|1058412|P2|COMPLETED|Overall Study||12
444196|NCT00672633|1058413|P1|COMPLETED|Overall Study||12
444197|NCT00672633|1058412|P2|STARTED|Overall Study||13
444198|NCT00672633|1058413|P1|STARTED|Overall Study||12
444199|NCT00672620|1058427|P4|NOT COMPLETED|Overall Study||42
444200|NCT00672620|1058428|P3|NOT COMPLETED|Overall Study||31
444201|NCT00672620|1058429|P2|NOT COMPLETED|Overall Study||54
444202|NCT00672620|1058430|P1|NOT COMPLETED|Overall Study||33
444203|NCT00672620|1058427|P4|COMPLETED|Overall Study||110
444204|NCT00672620|1058428|P3|COMPLETED|Overall Study||122
444205|NCT00672620|1058429|P2|COMPLETED|Overall Study||99
444206|NCT00672620|1058430|P1|COMPLETED|Overall Study||120
444207|NCT00672620|1058427|P4|Treated|Overall Study||150
444208|NCT00672620|1058428|P3|Treated|Overall Study||153
444209|NCT00672620|1058429|P2|Treated|Overall Study||149
444210|NCT00672620|1058430|P1|Treated|Overall Study||151
444211|NCT00672620|1058427|P4|STARTED|Overall Study||152
444212|NCT00672620|1058428|P3|STARTED|Overall Study||153
444213|NCT00672620|1058429|P2|STARTED|Overall Study||153
444214|NCT00672620|1058430|P1|STARTED|Overall Study||153
444215|NCT00672594|1058484|P1|NOT COMPLETED|Overall Study||3
444216|NCT00672594|1058484|P1|COMPLETED|Overall Study||27
444217|NCT00672594|1058484|P1|STARTED|Overall Study||30
444218|NCT00672555|1058495|P1|NOT COMPLETED|Overall Study||6
444219|NCT00672555|1058495|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
444220|NCT00672555|1058495|P1|STARTED|Overall Study||70
444221|NCT00672490|1058506|P2|NOT COMPLETED|Overall Study||32
444222|NCT00672490|1058507|P1|NOT COMPLETED|Overall Study||24
444223|NCT00672490|1058506|P2|COMPLETED|Overall Study||157
444224|NCT00672490|1058507|P1|COMPLETED|Overall Study||163
444225|NCT00672490|1058506|P2|STARTED|Overall Study||189
444226|NCT00672490|1058507|P1|STARTED|Overall Study||187
444227|NCT00672438|1058531|P2|NOT COMPLETED|Infusion 2||0
444228|NCT00672438|1058532|P1|NOT COMPLETED|Infusion 2||0
444229|NCT00672438|1058531|P2|COMPLETED|Infusion 2||118
444230|NCT00672438|1058532|P1|COMPLETED|Infusion 2||119
444231|NCT00672438|1058531|P2|STARTED|Infusion 2||118
444232|NCT00672438|1058532|P1|STARTED|Infusion 2||119
444233|NCT00672438|1058531|P2|NOT COMPLETED|Washout||0
444234|NCT00672438|1058532|P1|NOT COMPLETED|Washout||0
444235|NCT00672438|1058531|P2|COMPLETED|Washout||118
444236|NCT00672438|1058532|P1|COMPLETED|Washout||119
444237|NCT00672438|1058531|P2|STARTED|Washout||118
444238|NCT00672438|1058532|P1|STARTED|Washout||119
444239|NCT00672438|1058531|P2|NOT COMPLETED|Infusion 1||0
444240|NCT00672438|1058532|P1|NOT COMPLETED|Infusion 1||0
444241|NCT00672438|1058531|P2|COMPLETED|Infusion 1||118
444242|NCT00672438|1058532|P1|COMPLETED|Infusion 1||119
444243|NCT00672438|1058531|P2|STARTED|Infusion 1||118
444244|NCT00672438|1058532|P1|STARTED|Infusion 1||119
444245|NCT00672256|1058563|P1|NOT COMPLETED|Overall Study||44
444246|NCT00672256|1058563|P1|COMPLETED|Overall Study||18
444247|NCT00672256|1058563|P1|STARTED|Overall Study|January 2007|62
444248|NCT00672243|1058570|P1|NOT COMPLETED|Overall Study||0
444249|NCT00672243|1058570|P1|COMPLETED|Overall Study||32
444250|NCT00672243|1058570|P1|STARTED|Overall Study||32
444251|NCT00672204|1058578|P1|NOT COMPLETED|Overall Study||20
444252|NCT00672204|1058578|P1|COMPLETED|Overall Study||3
444253|NCT00672204|1058578|P1|STARTED|Overall Study||23
444254|NCT00672178|1058582|P1|NOT COMPLETED|Overall Study||0
444255|NCT00672178|1058582|P1|COMPLETED|Overall Study||1
444256|NCT00672178|1058582|P1|STARTED|Overall Study||1
444257|NCT00672100|1058589|P3|NOT COMPLETED|Overall Study||0
444258|NCT00672100|1058590|P2|NOT COMPLETED|Overall Study||0
444259|NCT00672100|1058591|P1|NOT COMPLETED|Overall Study||0
444260|NCT00672100|1058589|P3|COMPLETED|Overall Study||12
444261|NCT00672100|1058590|P2|COMPLETED|Overall Study||12
444262|NCT00672100|1058591|P1|COMPLETED|Overall Study||12
444263|NCT00672100|1058589|P3|PACU (Within 8 Hours)|Overall Study||12
444264|NCT00672100|1058590|P2|PACU (Within 8 Hours)|Overall Study||12
444265|NCT00672100|1058591|P1|PACU (Within 8 Hours)|Overall Study||12
444266|NCT00672100|1058589|P3|STARTED|Overall Study||12
444267|NCT00672100|1058590|P2|STARTED|Overall Study||12
444268|NCT00672100|1058591|P1|STARTED|Overall Study||12
444269|NCT00671970|1058608|P2|NOT COMPLETED|Overall Study||0
444270|NCT00671970|1058609|P1|NOT COMPLETED|Overall Study||0
444271|NCT00671970|1058608|P2|COMPLETED|Overall Study||25
444272|NCT00671970|1058609|P1|COMPLETED|Overall Study||32
444273|NCT00671970|1058608|P2|STARTED|Overall Study||25
444274|NCT00671970|1058609|P1|STARTED|Overall Study||32
444275|NCT00671931|1058637|P5|NOT COMPLETED|Overall Study||1
444276|NCT00671931|1058638|P4|NOT COMPLETED|Overall Study||2
444277|NCT00671931|1058639|P3|NOT COMPLETED|Overall Study||0
444278|NCT00671931|1058640|P2|NOT COMPLETED|Overall Study||0
444279|NCT00671931|1058641|P1|NOT COMPLETED|Overall Study||1
444280|NCT00671931|1058637|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
444281|NCT00671931|1058638|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
444282|NCT00671931|1058639|P3|COMPLETED|Overall Study|all completed|9
444283|NCT00671931|1058640|P2|COMPLETED|Overall Study|All completed|8
444284|NCT00671931|1058641|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
444285|NCT00671931|1058637|P5|STARTED|Overall Study||8
444286|NCT00671931|1058638|P4|STARTED|Overall Study||10
444287|NCT00671931|1058639|P3|STARTED|Overall Study||9
444288|NCT00671931|1058640|P2|STARTED|Overall Study||8
444289|NCT00671931|1058641|P1|STARTED|Overall Study||9
444290|NCT00671918|1058653|P1|NOT COMPLETED|Overall Study||17
444291|NCT00671918|1058653|P1|COMPLETED|Overall Study||169
444292|NCT00671918|1058653|P1|STARTED|Overall Study||186
444293|NCT00671879|1058661|P3|NOT COMPLETED|Overall Study||6
444294|NCT00671879|1058662|P2|NOT COMPLETED|Overall Study||4
444295|NCT00671879|1058663|P1|NOT COMPLETED|Overall Study||0
444296|NCT00671879|1058661|P3|COMPLETED|Overall Study||274
444297|NCT00671879|1058662|P2|COMPLETED|Overall Study||275
444298|NCT00671879|1058663|P1|COMPLETED|Overall Study||281
444299|NCT00671879|1058661|P3|STARTED|Overall Study||280
444300|NCT00671879|1058662|P2|STARTED|Overall Study||279
444301|NCT00671879|1058663|P1|STARTED|Overall Study||281
444302|NCT00671853|1058676|P2|NOT COMPLETED|Overall Study||27
444303|NCT00671853|1058677|P1|NOT COMPLETED|Overall Study||20
444304|NCT00671853|1058676|P2|COMPLETED|Overall Study||18
444305|NCT00671853|1058677|P1|COMPLETED|Overall Study||26
444306|NCT00671853|1058676|P2|STARTED|Overall Study||45
444307|NCT00671853|1058677|P1|STARTED|Overall Study||46
444308|NCT00671788|1058693|P1|NOT COMPLETED|Overall Study||14
444309|NCT00671788|1058693|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
444310|NCT00671788|1058693|P1|STARTED|Overall Study||35
444311|NCT00671749|1058700|P1|NOT COMPLETED|Overall Study||8
444312|NCT00671749|1058700|P1|COMPLETED|Overall Study||92
444313|NCT00671749|1058700|P1|STARTED|Overall Study||100
444314|NCT00671671|1058712|P2|NOT COMPLETED|Overall Study||0
444315|NCT00671671|1058713|P1|NOT COMPLETED|Overall Study||0
444316|NCT00671671|1058712|P2|COMPLETED|Overall Study||10
444317|NCT00671671|1058713|P1|COMPLETED|Overall Study||10
444318|NCT00671671|1058712|P2|STARTED|Overall Study||10
444319|NCT00671671|1058713|P1|STARTED|Overall Study||10
444320|NCT00671606|1058739|P1|NOT COMPLETED|Overall Study||0
444321|NCT00671606|1058739|P1|COMPLETED|Overall Study||5
444322|NCT00671606|1058739|P1|STARTED|Overall Study||5
444323|NCT00671554|1058743|P1|NOT COMPLETED|Overall Study||3
444324|NCT00671554|1058743|P1|COMPLETED|Overall Study||0
444325|NCT00671554|1058743|P1|STARTED|Overall Study||3
444326|NCT00671528|1058751|P3|NOT COMPLETED|Overall Study||0
444327|NCT00671528|1058752|P2|NOT COMPLETED|Overall Study||0
444328|NCT00671528|1058753|P1|NOT COMPLETED|Overall Study||0
444329|NCT00671528|1058751|P3|COMPLETED|Overall Study||1
444330|NCT00671528|1058752|P2|COMPLETED|Overall Study||1
444331|NCT00671528|1058753|P1|COMPLETED|Overall Study||1
444332|NCT00671528|1058751|P3|STARTED|Overall Study||1
444333|NCT00671528|1058752|P2|STARTED|Overall Study||1
444334|NCT00671528|1058753|P1|STARTED|Overall Study||1
444335|NCT00671515|1058764|P1|NOT COMPLETED|Phase 2||4
444336|NCT00671515|1058764|P1|COMPLETED|Phase 2||9
444337|NCT00671515|1058764|P1|STARTED|Phase 2||13
444338|NCT00671515|1058764|P1|NOT COMPLETED|Phase 1||3
444339|NCT00671515|1058764|P1|COMPLETED|Phase 1||20
444340|NCT00671515|1058764|P1|STARTED|Phase 1||23
444341|NCT00671502|1058772|P3|NOT COMPLETED|Overall Study||27
444342|NCT00671502|1058773|P2|NOT COMPLETED|Overall Study||39
444343|NCT00671502|1058774|P1|NOT COMPLETED|Overall Study||39
444344|NCT00671502|1058772|P3|COMPLETED|Overall Study||252
444345|NCT00671502|1058773|P2|COMPLETED|Overall Study||241
444346|NCT00671502|1058774|P1|COMPLETED|Overall Study||242
444347|NCT00671502|1058772|P3|STARTED|Overall Study||279
444348|NCT00671502|1058773|P2|STARTED|Overall Study||280
444349|NCT00671502|1058774|P1|STARTED|Overall Study||281
444350|NCT00671437|1058782|P1|NOT COMPLETED|Overall Study||15
444351|NCT00671437|1058782|P1|COMPLETED|Overall Study||27
444352|NCT00671437|1058782|P1|STARTED|Overall Study||42
444353|NCT00671177|1058803|P2|NOT COMPLETED|Overall Study||1
444354|NCT00671177|1058804|P1|NOT COMPLETED|Overall Study||2
444355|NCT00671177|1058803|P2|COMPLETED|Overall Study||114
444356|NCT00671177|1058804|P1|COMPLETED|Overall Study||112
444357|NCT00671177|1058803|P2|STARTED|Overall Study||115
444358|NCT00671177|1058804|P1|STARTED|Overall Study||114
444359|NCT00671060|1058816|P2|NOT COMPLETED|Overall Study||1
444360|NCT00671060|1058817|P1|NOT COMPLETED|Overall Study||1
444361|NCT00671060|1058816|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
444362|NCT00671060|1058817|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
444363|NCT00671060|1058816|P2|STARTED|Overall Study||76
444364|NCT00671060|1058817|P1|STARTED|Overall Study||77
444365|NCT00670982|1058825|P2|NOT COMPLETED|Overall Study||0
444366|NCT00670982|1058826|P1|NOT COMPLETED|Overall Study||0
444367|NCT00670982|1058825|P2|COMPLETED|Overall Study||7
444368|NCT00670982|1058826|P1|COMPLETED|Overall Study||22
444369|NCT00670982|1058825|P2|STARTED|Overall Study||7
444370|NCT00670982|1058826|P1|STARTED|Overall Study||22
444371|NCT00670956|1058835|P1|NOT COMPLETED|Overall Study||0
444372|NCT00670956|1058835|P1|COMPLETED|Overall Study||1
444373|NCT00670956|1058835|P1|STARTED|Overall Study||1
444374|NCT00670930|1058843|P2|NOT COMPLETED|Overall Study||1
444375|NCT00670930|1058844|P1|NOT COMPLETED|Overall Study||1
444376|NCT00670930|1058843|P2|COMPLETED|Overall Study||12
444377|NCT00670930|1058844|P1|COMPLETED|Overall Study||22
444378|NCT00670930|1058843|P2|Intent to Treat (ITT) Population|Overall Study||12
444379|NCT00670930|1058844|P1|Intent to Treat (ITT) Population|Overall Study||23
444380|NCT00670930|1058843|P2|STARTED|Overall Study||13
444381|NCT00670930|1058844|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
444382|NCT00670800|1058860|P2|NOT COMPLETED|Overall Study||2
444383|NCT00670800|1058861|P1|NOT COMPLETED|Overall Study||0
444384|NCT00670800|1058860|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
444385|NCT00670800|1058861|P1|COMPLETED|Overall Study||7
444386|NCT00670800|1058860|P2|STARTED|Overall Study||7
444387|NCT00670800|1058861|P1|STARTED|Overall Study||7
444388|NCT00670748|1058881|P4|NOT COMPLETED|Overall Study||1
444389|NCT00670748|1058882|P3|NOT COMPLETED|Overall Study||2
444390|NCT00670748|1058883|P2|NOT COMPLETED|Overall Study||2
444391|NCT00670748|1058884|P1|NOT COMPLETED|Overall Study||3
444392|NCT00670748|1058881|P4|COMPLETED|Overall Study||4
444393|NCT00670748|1058882|P3|COMPLETED|Overall Study||5
444394|NCT00670748|1058883|P2|COMPLETED|Overall Study||14
444395|NCT00670748|1058884|P1|COMPLETED|Overall Study||14
444396|NCT00670748|1058881|P4|STARTED|Overall Study||5
444397|NCT00670748|1058882|P3|STARTED|Overall Study||7
444398|NCT00670748|1058883|P2|STARTED|Overall Study||16
444399|NCT00670748|1058884|P1|STARTED|Overall Study||17
444400|NCT00670709|1058904|P2|NOT COMPLETED|Overall Study||0
444401|NCT00670709|1058905|P1|NOT COMPLETED|Overall Study||0
444402|NCT00670709|1058904|P2|COMPLETED|Overall Study||15
444403|NCT00670709|1058905|P1|COMPLETED|Overall Study||27
444404|NCT00670709|1058904|P2|STARTED|Overall Study||15
444405|NCT00670709|1058905|P1|STARTED|Overall Study||27
444406|NCT00670540|1058913|P1|NOT COMPLETED|Overall Study||3325
444407|NCT00670540|1058913|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
444408|NCT00670540|1058913|P1|STARTED|Overall Study||8256
444409|NCT00670462|1058925|P2|NOT COMPLETED|Overall Study||31
444410|NCT00670462|1058926|P1|NOT COMPLETED|Overall Study||30
444411|NCT00670462|1058925|P2|COMPLETED|Overall Study||76
444412|NCT00670462|1058926|P1|COMPLETED|Overall Study||76
444413|NCT00670462|1058925|P2|STARTED|Overall Study||107
444414|NCT00670462|1058926|P1|STARTED|Overall Study||106
444415|NCT00670449|1058958|P4|NOT COMPLETED|Overall Study||8
444416|NCT00670449|1058959|P3|NOT COMPLETED|Overall Study||9
444417|NCT00670449|1058960|P2|NOT COMPLETED|Overall Study||10
444418|NCT00670449|1058961|P1|NOT COMPLETED|Overall Study||9
444419|NCT00670449|1058958|P4|COMPLETED|Overall Study||15
444420|NCT00670449|1058959|P3|COMPLETED|Overall Study||18
444421|NCT00670449|1058960|P2|COMPLETED|Overall Study||36
444422|NCT00670449|1058961|P1|COMPLETED|Overall Study||38
444423|NCT00670449|1058958|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
444424|NCT00670449|1058959|P3|Switched to 0.5mg (Open Label)|Overall Study||23
444425|NCT00670449|1058960|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
444426|NCT00670449|1058961|P1|Switched to 0.5mg (Open Label)|Overall Study||45
444427|NCT00670449|1058958|P4|STARTED|Overall Study||23
444428|NCT00670449|1058959|P3|STARTED|Overall Study||27
444429|NCT00670449|1058960|P2|STARTED|Overall Study||46
444430|NCT00670449|1058961|P1|STARTED|Overall Study||47
444431|NCT00670306|1058985|P1|NOT COMPLETED|Overall Study||55
444432|NCT00670306|1058985|P1|COMPLETED|Overall Study||473
444433|NCT00670306|1058985|P1|STARTED|Overall Study||528
444434|NCT00670267|1058989|P1|NOT COMPLETED|Overall Study||1
444435|NCT00670267|1058989|P1|COMPLETED|Overall Study||9
444436|NCT00670267|1058989|P1|STARTED|Overall Study||10
444437|NCT00670241|1059000|P3|NOT COMPLETED|Overall Study||27
444438|NCT00670241|1059001|P2|NOT COMPLETED|Overall Study||21
444439|NCT00670241|1059002|P1|NOT COMPLETED|Overall Study||12
444440|NCT00670241|1059000|P3|COMPLETED|Overall Study||64
444441|NCT00670241|1059001|P2|COMPLETED|Overall Study||163
444442|NCT00670241|1059002|P1|COMPLETED|Overall Study||171
444443|NCT00670241|1059000|P3|STARTED|Overall Study||91
444444|NCT00670241|1059001|P2|STARTED|Overall Study||184
444445|NCT00670241|1059002|P1|STARTED|Overall Study||183
444446|NCT00670228|1059024|P2|NOT COMPLETED|Overall Study||3
444447|NCT00670228|1059025|P1|NOT COMPLETED|Overall Study||5
444448|NCT00670228|1059024|P2|COMPLETED|Overall Study||12
444449|NCT00670228|1059025|P1|COMPLETED|Overall Study||13
444450|NCT00670228|1059024|P2|STARTED|Overall Study||15
444451|NCT00670228|1059025|P1|STARTED|Overall Study||18
444452|NCT00670202|1059039|P2|NOT COMPLETED|Overall Study||0
444453|NCT00670202|1059040|P1|NOT COMPLETED|Overall Study||0
444454|NCT00670202|1059039|P2|COMPLETED|Overall Study||0
444455|NCT00670202|1059040|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
444456|NCT00670202|1059039|P2|STARTED|Overall Study||0
444457|NCT00670202|1059040|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
444458|NCT00670111|1059049|P3|NOT COMPLETED|Six Months to Twelve Months||0
444459|NCT00670111|1059050|P2|NOT COMPLETED|Six Months to Twelve Months||0
444460|NCT00670111|1059051|P1|NOT COMPLETED|Six Months to Twelve Months||0
444461|NCT00670111|1059049|P3|COMPLETED|Six Months to Twelve Months||0
444462|NCT00670111|1059050|P2|COMPLETED|Six Months to Twelve Months||8
444463|NCT00670111|1059051|P1|COMPLETED|Six Months to Twelve Months||4
444464|NCT00670111|1059049|P3|STARTED|Six Months to Twelve Months||0
444465|NCT00670111|1059050|P2|STARTED|Six Months to Twelve Months||8
444466|NCT00670111|1059051|P1|STARTED|Six Months to Twelve Months||4
444467|NCT00670111|1059049|P3|NOT COMPLETED|One Month to Six Months||0
444468|NCT00670111|1059050|P2|NOT COMPLETED|One Month to Six Months||0
444469|NCT00670111|1059051|P1|NOT COMPLETED|One Month to Six Months||0
444470|NCT00670111|1059049|P3|COMPLETED|One Month to Six Months||0
444471|NCT00670111|1059050|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
444472|NCT00670111|1059051|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
444473|NCT00670111|1059049|P3|STARTED|One Month to Six Months||0
444474|NCT00670111|1059050|P2|STARTED|One Month to Six Months||8
444475|NCT00670111|1059051|P1|STARTED|One Month to Six Months||4
444476|NCT00670111|1059049|P3|NOT COMPLETED|One Month Period B||0
444477|NCT00670111|1059050|P2|NOT COMPLETED|One Month Period B||0
444478|NCT00670111|1059051|P1|NOT COMPLETED|One Month Period B||0
444479|NCT00670111|1059049|P3|COMPLETED|One Month Period B||0
444480|NCT00670111|1059050|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
444481|NCT00670111|1059051|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
444482|NCT00670111|1059049|P3|STARTED|One Month Period B||0
444483|NCT00670111|1059050|P2|STARTED|One Month Period B||8
444484|NCT00670111|1059051|P1|STARTED|One Month Period B||4
444485|NCT00670111|1059049|P3|NOT COMPLETED|One Month Period A||0
444486|NCT00670111|1059050|P2|NOT COMPLETED|One Month Period A||0
444487|NCT00670111|1059051|P1|NOT COMPLETED|One Month Period A||0
444488|NCT00670111|1059049|P3|COMPLETED|One Month Period A||0
444489|NCT00670111|1059050|P2|COMPLETED|One Month Period A||8
444490|NCT00670111|1059051|P1|COMPLETED|One Month Period A||4
444491|NCT00670111|1059049|P3|STARTED|One Month Period A||0
444492|NCT00670111|1059050|P2|STARTED|One Month Period A||8
444493|NCT00670111|1059051|P1|STARTED|One Month Period A||4
444494|NCT00670111|1059049|P3|NOT COMPLETED|Enrollment to One Month||19
444495|NCT00670111|1059050|P2|NOT COMPLETED|Enrollment to One Month||0
444496|NCT00670111|1059051|P1|NOT COMPLETED|Enrollment to One Month||1
444497|NCT00670111|1059049|P3|COMPLETED|Enrollment to One Month||0
444498|NCT00670111|1059050|P2|COMPLETED|Enrollment to One Month||8
444499|NCT00670111|1059051|P1|COMPLETED|Enrollment to One Month||4
444500|NCT00670111|1059049|P3|STARTED|Enrollment to One Month||19
444501|NCT00670111|1059050|P2|STARTED|Enrollment to One Month||8
444502|NCT00670111|1059051|P1|STARTED|Enrollment to One Month||5
444503|NCT00670007|1059059|P1|NOT COMPLETED|Overall Study||9
444504|NCT00670007|1059059|P1|COMPLETED|Overall Study||131
444505|NCT00670007|1059059|P1|STARTED|Overall Study||140
444506|NCT00669955|1059086|P2|NOT COMPLETED|Overall Study||27
444507|NCT00669955|1059087|P1|NOT COMPLETED|Overall Study||14
444508|NCT00669955|1059086|P2|COMPLETED|Overall Study||195
444509|NCT00669955|1059087|P1|COMPLETED|Overall Study||204
444510|NCT00669955|1059086|P2|STARTED|Overall Study||222
444511|NCT00669955|1059087|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
444512|NCT00669942|1059117|P12|NOT COMPLETED|Healthy Volunteers||0
444513|NCT00669942|1059118|P11|NOT COMPLETED|Healthy Volunteers||1
444514|NCT00669942|1059119|P10|NOT COMPLETED|Healthy Volunteers||0
444515|NCT00669942|1059120|P9|NOT COMPLETED|Healthy Volunteers||0
444516|NCT00669942|1059121|P8|NOT COMPLETED|Healthy Volunteers||0
444517|NCT00669942|1059122|P7|NOT COMPLETED|Healthy Volunteers||0
444518|NCT00669942|1059123|P6|NOT COMPLETED|Healthy Volunteers||0
444519|NCT00669942|1059124|P5|NOT COMPLETED|Healthy Volunteers||0
444520|NCT00669942|1059125|P4|NOT COMPLETED|Healthy Volunteers||0
444521|NCT00669942|1059126|P3|NOT COMPLETED|Healthy Volunteers||0
444522|NCT00669942|1059127|P2|NOT COMPLETED|Healthy Volunteers||0
444523|NCT00669942|1059128|P1|NOT COMPLETED|Healthy Volunteers||0
444524|NCT00669942|1059117|P12|COMPLETED|Healthy Volunteers||2
444525|NCT00669942|1059118|P11|COMPLETED|Healthy Volunteers||2
444526|NCT00669942|1059119|P10|COMPLETED|Healthy Volunteers||3
444527|NCT00669942|1059120|P9|COMPLETED|Healthy Volunteers||0
444528|NCT00669942|1059121|P8|COMPLETED|Healthy Volunteers||0
444529|NCT00669942|1059122|P7|COMPLETED|Healthy Volunteers||0
444530|NCT00669942|1059123|P6|COMPLETED|Healthy Volunteers||0
444531|NCT00669942|1059124|P5|COMPLETED|Healthy Volunteers||0
444532|NCT00669942|1059125|P4|COMPLETED|Healthy Volunteers||0
444533|NCT00669942|1059126|P3|COMPLETED|Healthy Volunteers||0
444534|NCT00669942|1059127|P2|COMPLETED|Healthy Volunteers||0
444535|NCT00669942|1059128|P1|COMPLETED|Healthy Volunteers||0
444536|NCT00669942|1059117|P12|STARTED|Healthy Volunteers||2
444537|NCT00669942|1059118|P11|STARTED|Healthy Volunteers||3
444538|NCT00669942|1059119|P10|STARTED|Healthy Volunteers||3
444539|NCT00669942|1059120|P9|STARTED|Healthy Volunteers||0
444540|NCT00669942|1059121|P8|STARTED|Healthy Volunteers||0
444541|NCT00669942|1059122|P7|STARTED|Healthy Volunteers||0
444542|NCT00669942|1059123|P6|STARTED|Healthy Volunteers||0
444543|NCT00669942|1059124|P5|STARTED|Healthy Volunteers||0
444544|NCT00669942|1059125|P4|STARTED|Healthy Volunteers||0
444545|NCT00669942|1059126|P3|STARTED|Healthy Volunteers||0
444546|NCT00669942|1059127|P2|STARTED|Healthy Volunteers||0
444547|NCT00669942|1059128|P1|STARTED|Healthy Volunteers||0
444548|NCT00669942|1059117|P12|NOT COMPLETED|Parts 2 and 3||0
444549|NCT00669942|1059118|P11|NOT COMPLETED|Parts 2 and 3||0
444550|NCT00669942|1059119|P10|NOT COMPLETED|Parts 2 and 3||0
444551|NCT00669942|1059120|P9|NOT COMPLETED|Parts 2 and 3||3
444552|NCT00669942|1059121|P8|NOT COMPLETED|Parts 2 and 3||2
444553|NCT00669942|1059122|P7|NOT COMPLETED|Parts 2 and 3||0
444554|NCT00669942|1059123|P6|NOT COMPLETED|Parts 2 and 3||2
444555|NCT00669942|1059124|P5|NOT COMPLETED|Parts 2 and 3||0
444556|NCT00669942|1059125|P4|NOT COMPLETED|Parts 2 and 3||0
444557|NCT00669942|1059126|P3|NOT COMPLETED|Parts 2 and 3||0
444558|NCT00669942|1059127|P2|NOT COMPLETED|Parts 2 and 3||0
444559|NCT00669942|1059128|P1|NOT COMPLETED|Parts 2 and 3||0
444560|NCT00669942|1059117|P12|COMPLETED|Parts 2 and 3||0
444561|NCT00669942|1059118|P11|COMPLETED|Parts 2 and 3||0
444562|NCT00669942|1059119|P10|COMPLETED|Parts 2 and 3||0
444563|NCT00669942|1059120|P9|COMPLETED|Parts 2 and 3||23
444564|NCT00669942|1059121|P8|COMPLETED|Parts 2 and 3||24
444565|NCT00669942|1059122|P7|COMPLETED|Parts 2 and 3||6
444566|NCT00669942|1059123|P6|COMPLETED|Parts 2 and 3||4
444567|NCT00669942|1059124|P5|COMPLETED|Parts 2 and 3||0
444568|NCT00669942|1059125|P4|COMPLETED|Parts 2 and 3||0
444569|NCT00669942|1059126|P3|COMPLETED|Parts 2 and 3||0
444570|NCT00669942|1059127|P2|COMPLETED|Parts 2 and 3||0
444571|NCT00669942|1059128|P1|COMPLETED|Parts 2 and 3||0
444572|NCT00669942|1059117|P12|STARTED|Parts 2 and 3||0
444573|NCT00669942|1059118|P11|STARTED|Parts 2 and 3||0
444574|NCT00669942|1059119|P10|STARTED|Parts 2 and 3||0
444575|NCT00669942|1059120|P9|STARTED|Parts 2 and 3||26
444576|NCT00669942|1059121|P8|STARTED|Parts 2 and 3||26
444577|NCT00669942|1059122|P7|STARTED|Parts 2 and 3||6
444578|NCT00669942|1059123|P6|STARTED|Parts 2 and 3||6
444579|NCT00669942|1059124|P5|STARTED|Parts 2 and 3||0
444580|NCT00669942|1059125|P4|STARTED|Parts 2 and 3||0
444581|NCT00669942|1059126|P3|STARTED|Parts 2 and 3||0
444582|NCT00669942|1059127|P2|STARTED|Parts 2 and 3||0
444583|NCT00669942|1059128|P1|STARTED|Parts 2 and 3||0
444584|NCT00669942|1059117|P12|NOT COMPLETED|Part 1||0
444585|NCT00669942|1059118|P11|NOT COMPLETED|Part 1||0
444586|NCT00669942|1059119|P10|NOT COMPLETED|Part 1||0
444587|NCT00669942|1059120|P9|NOT COMPLETED|Part 1||0
444588|NCT00669942|1059121|P8|NOT COMPLETED|Part 1||0
444589|NCT00669942|1059122|P7|NOT COMPLETED|Part 1||0
444590|NCT00669942|1059123|P6|NOT COMPLETED|Part 1||0
444591|NCT00669942|1059124|P5|NOT COMPLETED|Part 1||0
444592|NCT00669942|1059125|P4|NOT COMPLETED|Part 1||0
444593|NCT00669942|1059126|P3|NOT COMPLETED|Part 1||0
444594|NCT00669942|1059127|P2|NOT COMPLETED|Part 1||0
444595|NCT00669942|1059128|P1|NOT COMPLETED|Part 1||0
444596|NCT00669942|1059117|P12|COMPLETED|Part 1||0
444597|NCT00669942|1059118|P11|COMPLETED|Part 1||0
444598|NCT00669942|1059119|P10|COMPLETED|Part 1||0
444599|NCT00669942|1059120|P9|COMPLETED|Part 1||0
444600|NCT00669942|1059121|P8|COMPLETED|Part 1||0
444601|NCT00669942|1059122|P7|COMPLETED|Part 1||0
444602|NCT00669942|1059123|P6|COMPLETED|Part 1||0
444603|NCT00669942|1059124|P5|COMPLETED|Part 1||8
444604|NCT00669942|1059125|P4|COMPLETED|Part 1||6
444605|NCT00669942|1059126|P3|COMPLETED|Part 1||6
444606|NCT00669942|1059127|P2|COMPLETED|Part 1||6
444607|NCT00669942|1059128|P1|COMPLETED|Part 1||6
444608|NCT00669942|1059117|P12|STARTED|Part 1||0
444609|NCT00669942|1059118|P11|STARTED|Part 1||0
444610|NCT00669942|1059119|P10|STARTED|Part 1||0
444611|NCT00669942|1059120|P9|STARTED|Part 1||0
444612|NCT00669942|1059121|P8|STARTED|Part 1||0
444613|NCT00669942|1059122|P7|STARTED|Part 1||0
444614|NCT00669942|1059123|P6|STARTED|Part 1||0
444615|NCT00669942|1059124|P5|STARTED|Part 1||8
444616|NCT00669942|1059125|P4|STARTED|Part 1||6
444617|NCT00669942|1059126|P3|STARTED|Part 1||6
444618|NCT00669942|1059127|P2|STARTED|Part 1||6
444619|NCT00669942|1059128|P1|STARTED|Part 1||6
444620|NCT00669916|1059192|P2|NOT COMPLETED|Overall Study||0
444621|NCT00669916|1059193|P1|NOT COMPLETED|Overall Study||0
444622|NCT00669916|1059192|P2|COMPLETED|Overall Study||18
444623|NCT00669916|1059193|P1|COMPLETED|Overall Study||18
444624|NCT00669916|1059192|P2|STARTED|Overall Study||18
444625|NCT00669916|1059193|P1|STARTED|Overall Study||18
444626|NCT00669903|1059211|P4|NOT COMPLETED|Overall Study||4
444627|NCT00669903|1059212|P3|NOT COMPLETED|Overall Study||5
444628|NCT00669903|1059213|P2|NOT COMPLETED|Overall Study||5
444629|NCT00669903|1059214|P1|NOT COMPLETED|Overall Study||1
444630|NCT00669903|1059211|P4|COMPLETED|Overall Study||18
444631|NCT00669903|1059212|P3|COMPLETED|Overall Study||13
444632|NCT00669903|1059213|P2|COMPLETED|Overall Study||32
444633|NCT00669903|1059214|P1|COMPLETED|Overall Study||22
444634|NCT00669903|1059211|P4|Completed Treatment Period|Overall Study||19
444635|NCT00669903|1059212|P3|Completed Treatment Period|Overall Study||13
444636|NCT00669903|1059213|P2|Completed Treatment Period|Overall Study||33
444637|NCT00669903|1059214|P1|Completed Treatment Period|Overall Study||23
444638|NCT00669903|1059211|P4|STARTED|Overall Study||22
444639|NCT00669903|1059212|P3|STARTED|Overall Study||18
444640|NCT00669903|1059213|P2|STARTED|Overall Study||37
444641|NCT00669903|1059214|P1|STARTED|Overall Study||23
444642|NCT00669864|1059244|P1|NOT COMPLETED|Overall Study||9
444643|NCT00669864|1059244|P1|COMPLETED|Overall Study||284
444644|NCT00669864|1059244|P1|STARTED|Overall Study||293
444645|NCT00669682|1059253|P1|NOT COMPLETED|Overall Study||0
444646|NCT00669682|1059253|P1|COMPLETED|Overall Study||9
444647|NCT00669682|1059253|P1|STARTED|Overall Study||9
444648|NCT00669617|1059258|P5|NOT COMPLETED|Period 5||0
444649|NCT00669617|1059259|P4|NOT COMPLETED|Period 5||0
444650|NCT00669617|1059260|P3|NOT COMPLETED|Period 5||0
444651|NCT00669617|1059261|P2|NOT COMPLETED|Period 5||0
444652|NCT00669617|1059262|P1|NOT COMPLETED|Period 5||0
444653|NCT00669617|1059258|P5|COMPLETED|Period 5||17
444654|NCT00669617|1059259|P4|COMPLETED|Period 5||18
444655|NCT00669617|1059260|P3|COMPLETED|Period 5||17
444656|NCT00669617|1059261|P2|COMPLETED|Period 5||17
444657|NCT00669617|1059262|P1|COMPLETED|Period 5||17
444658|NCT00669617|1059258|P5|STARTED|Period 5||17
444659|NCT00669617|1059259|P4|STARTED|Period 5||18
444660|NCT00669617|1059260|P3|STARTED|Period 5||17
444661|NCT00669617|1059261|P2|STARTED|Period 5||17
444662|NCT00669617|1059262|P1|STARTED|Period 5||17
444663|NCT00669617|1059258|P5|NOT COMPLETED|Period 4||0
444664|NCT00669617|1059259|P4|NOT COMPLETED|Period 4||0
444665|NCT00669617|1059260|P3|NOT COMPLETED|Period 4||0
444666|NCT00669617|1059261|P2|NOT COMPLETED|Period 4||0
444667|NCT00669617|1059262|P1|NOT COMPLETED|Period 4||0
444668|NCT00669617|1059258|P5|COMPLETED|Period 4||17
444669|NCT00669617|1059259|P4|COMPLETED|Period 4||18
444670|NCT00669617|1059260|P3|COMPLETED|Period 4||17
444671|NCT00669617|1059261|P2|COMPLETED|Period 4||17
444672|NCT00669617|1059262|P1|COMPLETED|Period 4||17
444673|NCT00669617|1059258|P5|STARTED|Period 4||17
444674|NCT00669617|1059259|P4|STARTED|Period 4||18
444675|NCT00669617|1059260|P3|STARTED|Period 4||17
444676|NCT00669617|1059261|P2|STARTED|Period 4||17
444677|NCT00669617|1059262|P1|STARTED|Period 4||17
444678|NCT00669617|1059258|P5|NOT COMPLETED|Period 3||0
444679|NCT00669617|1059259|P4|NOT COMPLETED|Period 3||0
444680|NCT00669617|1059260|P3|NOT COMPLETED|Period 3||0
444681|NCT00669617|1059261|P2|NOT COMPLETED|Period 3||0
444682|NCT00669617|1059262|P1|NOT COMPLETED|Period 3||1
444683|NCT00669617|1059258|P5|COMPLETED|Period 3||17
444684|NCT00669617|1059259|P4|COMPLETED|Period 3||18
444685|NCT00669617|1059260|P3|COMPLETED|Period 3||17
444686|NCT00669617|1059261|P2|COMPLETED|Period 3||17
444687|NCT00669617|1059262|P1|COMPLETED|Period 3||17
444688|NCT00669617|1059258|P5|STARTED|Period 3||17
444689|NCT00669617|1059259|P4|STARTED|Period 3||18
444690|NCT00669617|1059260|P3|STARTED|Period 3||17
444691|NCT00669617|1059261|P2|STARTED|Period 3||17
444692|NCT00669617|1059262|P1|STARTED|Period 3||18
444693|NCT00669617|1059258|P5|NOT COMPLETED|Period 2||0
444694|NCT00669617|1059259|P4|NOT COMPLETED|Period 2||0
444695|NCT00669617|1059260|P3|NOT COMPLETED|Period 2||0
444696|NCT00669617|1059261|P2|NOT COMPLETED|Period 2||0
444697|NCT00669617|1059262|P1|NOT COMPLETED|Period 2||0
444698|NCT00669617|1059258|P5|COMPLETED|Period 2||17
444699|NCT00669617|1059259|P4|COMPLETED|Period 2||18
444700|NCT00669617|1059260|P3|COMPLETED|Period 2||17
444701|NCT00669617|1059261|P2|COMPLETED|Period 2||17
444702|NCT00669617|1059262|P1|COMPLETED|Period 2||18
444703|NCT00669617|1059258|P5|STARTED|Period 2||17
444704|NCT00669617|1059259|P4|STARTED|Period 2||18
444705|NCT00669617|1059260|P3|STARTED|Period 2||17
444706|NCT00669617|1059261|P2|STARTED|Period 2||17
444707|NCT00669617|1059262|P1|STARTED|Period 2||18
444708|NCT00669617|1059258|P5|NOT COMPLETED|Period 1||1
444709|NCT00669617|1059259|P4|NOT COMPLETED|Period 1||0
444710|NCT00669617|1059260|P3|NOT COMPLETED|Period 1||1
444711|NCT00669617|1059261|P2|NOT COMPLETED|Period 1||0
444712|NCT00669617|1059262|P1|NOT COMPLETED|Period 1||0
444713|NCT00669617|1059258|P5|COMPLETED|Period 1||17
444714|NCT00669617|1059259|P4|COMPLETED|Period 1||18
444715|NCT00669617|1059260|P3|COMPLETED|Period 1||17
444716|NCT00669617|1059261|P2|COMPLETED|Period 1||17
444717|NCT00669617|1059262|P1|COMPLETED|Period 1||18
444718|NCT00669617|1059258|P5|STARTED|Period 1||18
444719|NCT00669617|1059259|P4|STARTED|Period 1||18
444720|NCT00669617|1059260|P3|STARTED|Period 1||18
444721|NCT00669617|1059261|P2|STARTED|Period 1||17
444722|NCT00669617|1059262|P1|STARTED|Period 1||18
444723|NCT00669578|1059276|P2|NOT COMPLETED|Overall Study||0
444724|NCT00669578|1059277|P1|NOT COMPLETED|Overall Study||0
444725|NCT00669578|1059276|P2|COMPLETED|Overall Study||65
444726|NCT00669578|1059277|P1|COMPLETED|Overall Study||12
444727|NCT00669578|1059276|P2|STARTED|Overall Study||65
444728|NCT00669578|1059277|P1|STARTED|Overall Study||12
444729|NCT00669552|1059290|P1|NOT COMPLETED|Overall Study||0
444730|NCT00669552|1059290|P1|COMPLETED|Overall Study||11
444731|NCT00669552|1059290|P1|STARTED|Overall Study||11
444732|NCT00669539|1059296|P2|NOT COMPLETED|Overall Study||9
444733|NCT00669539|1059297|P1|NOT COMPLETED|Overall Study||8
444734|NCT00669539|1059296|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
444735|NCT00669539|1059297|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
444736|NCT00669539|1059296|P2|STARTED|Overall Study||52
444737|NCT00669539|1059297|P1|STARTED|Overall Study||94
444738|NCT00669461|1059303|P1|NOT COMPLETED|Overall Study||0
444739|NCT00669461|1059303|P1|COMPLETED|Overall Study||1
444740|NCT00669461|1059303|P1|STARTED|Overall Study||1
444741|NCT00669396|1059310|P2|NOT COMPLETED|Overall Study||12
444742|NCT00669396|1059311|P1|NOT COMPLETED|Overall Study||10
444743|NCT00669396|1059310|P2|COMPLETED|Overall Study||22
444744|NCT00669396|1059311|P1|COMPLETED|Overall Study||13
444745|NCT00669396|1059310|P2|STARTED|Overall Study||34
444746|NCT00669396|1059311|P1|STARTED|Overall Study||23
444747|NCT00669331|1059325|P2|NOT COMPLETED|Blinded Treatment Period||39
444748|NCT00669331|1059326|P1|NOT COMPLETED|Blinded Treatment Period||42
444749|NCT00669331|1059325|P2|COMPLETED|Blinded Treatment Period||189
444750|NCT00669331|1059326|P1|COMPLETED|Blinded Treatment Period||191
444751|NCT00669331|1059325|P2|STARTED|Blinded Treatment Period||228
444752|NCT00669331|1059326|P1|STARTED|Blinded Treatment Period||233
444753|NCT00669331|1059325|P2|NOT COMPLETED|Randomisation to First Dose||13
444754|NCT00669331|1059326|P1|NOT COMPLETED|Randomisation to First Dose||11
444755|NCT00669331|1059325|P2|COMPLETED|Randomisation to First Dose||228
444756|NCT00669331|1059326|P1|COMPLETED|Randomisation to First Dose||233
444757|NCT00669331|1059325|P2|STARTED|Randomisation to First Dose||241
444758|NCT00669331|1059326|P1|STARTED|Randomisation to First Dose||244
444759|NCT00669318|1059368|P1|NOT COMPLETED|Overall Study||2
444760|NCT00669318|1059368|P1|COMPLETED|Overall Study||39
444761|NCT00669318|1059368|P1|STARTED|Overall Study||41
444762|NCT00669279|1059378|P2|NOT COMPLETED|Overall Study||0
444763|NCT00669279|1059379|P1|NOT COMPLETED|Overall Study||0
444764|NCT00669279|1059378|P2|COMPLETED|Overall Study||19
444765|NCT00669279|1059379|P1|COMPLETED|Overall Study||22
444766|NCT00669279|1059378|P2|STARTED|Overall Study||19
444767|NCT00669279|1059379|P1|STARTED|Overall Study||22
444768|NCT00669240|1059385|P1|NOT COMPLETED|Overall Study||165
444769|NCT00669240|1059385|P1|COMPLETED|Overall Study||402
444770|NCT00669240|1059385|P1|Received Treatment|Overall Study||551
444771|NCT00669240|1059385|P1|Assigned to Treatment|Overall Study||566
444772|NCT00669240|1059385|P1|STARTED|Overall Study||567
444773|NCT00669214|1059401|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
444774|NCT00669214|1059402|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
444775|NCT00669214|1059401|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
444776|NCT00669214|1059402|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
444777|NCT00669214|1059401|P2|STARTED|Open-Label Treatment Period (Week 24)||55
444778|NCT00669214|1059402|P1|STARTED|Open-Label Treatment Period (Week 24)||22
444779|NCT00669214|1059401|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
444780|NCT00669214|1059402|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
444781|NCT00669214|1059401|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
444782|NCT00669214|1059402|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
444783|NCT00669214|1059401|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
444784|NCT00669214|1059402|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
444785|NCT00669110|1059436|P2|NOT COMPLETED|Overall Study||13
444786|NCT00669110|1059437|P1|NOT COMPLETED|Overall Study||8
444787|NCT00669110|1059436|P2|COMPLETED|Overall Study||7
444788|NCT00669110|1059437|P1|COMPLETED|Overall Study||12
444789|NCT00669110|1059436|P2|STARTED|Overall Study||20
444790|NCT00669110|1059437|P1|STARTED|Overall Study||20
444791|NCT00669071|1059473|P1|NOT COMPLETED|Overall Study||4
444792|NCT00669071|1059473|P1|COMPLETED|Overall Study||52
444793|NCT00669071|1059473|P1|STARTED|Overall Study||56
444794|NCT00669032|1059494|P2|NOT COMPLETED|Overall Study||59
444795|NCT00669032|1059495|P1|NOT COMPLETED|Overall Study||44
444796|NCT00669032|1059494|P2|COMPLETED|Overall Study||94
444797|NCT00669032|1059495|P1|COMPLETED|Overall Study||109
444798|NCT00669032|1059494|P2|STARTED|Overall Study||153
444799|NCT00669032|1059495|P1|STARTED|Overall Study||153
444800|NCT00669019|1059523|P1|NOT COMPLETED|Overall Study||0
444801|NCT00669019|1059523|P1|COMPLETED|Overall Study||23
444802|NCT00669019|1059523|P1|STARTED|Overall Study||23
444803|NCT00668902|1059531|P3|NOT COMPLETED|Overall Study||0
444804|NCT00668902|1059532|P2|NOT COMPLETED|Overall Study||0
444805|NCT00668902|1059533|P1|NOT COMPLETED|Overall Study||0
444806|NCT00668902|1059531|P3|COMPLETED|Overall Study||5
444807|NCT00668902|1059532|P2|COMPLETED|Overall Study||10
444808|NCT00668902|1059533|P1|COMPLETED|Overall Study||10
444809|NCT00668902|1059531|P3|STARTED|Overall Study||5
444810|NCT00668902|1059532|P2|STARTED|Overall Study||10
444811|NCT00668902|1059533|P1|STARTED|Overall Study||10
444812|NCT00668863|1059541|P1|NOT COMPLETED|Overall Study||71
444813|NCT00668863|1059541|P1|COMPLETED|Overall Study||0
444814|NCT00668863|1059541|P1|STARTED|Overall Study||71
444815|NCT00668785|1059560|P1|NOT COMPLETED|Overall Study||0
444816|NCT00668785|1059560|P1|COMPLETED|Overall Study||6
444817|NCT00668785|1059560|P1|STARTED|Overall Study||6
444818|NCT00668746|1059566|P2|NOT COMPLETED|Overall Study||1
444819|NCT00668746|1059567|P1|NOT COMPLETED|Overall Study||2
444820|NCT00668746|1059566|P2|COMPLETED|Overall Study||11
444821|NCT00668746|1059567|P1|COMPLETED|Overall Study||21
444822|NCT00668746|1059566|P2|STARTED|Overall Study||12
444823|NCT00668746|1059567|P1|STARTED|Overall Study||23
444824|NCT00668733|1059587|P2|NOT COMPLETED|Overall Study||7
444825|NCT00668733|1059588|P1|NOT COMPLETED|Overall Study||2
444826|NCT00668733|1059587|P2|COMPLETED|Overall Study||83
444827|NCT00668733|1059588|P1|COMPLETED|Overall Study||87
444828|NCT00668733|1059587|P2|STARTED|Overall Study||90
444829|NCT00668733|1059588|P1|STARTED|Overall Study||89
444830|NCT00668564|1059594|P1|NOT COMPLETED|Overall Study||0
444831|NCT00668564|1059594|P1|COMPLETED|Overall Study||18
444832|NCT00668564|1059594|P1|STARTED|Overall Study||18
444833|NCT00668525|1059602|P3|NOT COMPLETED|Overall Study||53
444834|NCT00668525|1059603|P2|NOT COMPLETED|Overall Study||93
444835|NCT00668525|1059604|P1|NOT COMPLETED|Overall Study||77
444836|NCT00668525|1059602|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
444837|NCT00668525|1059603|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
444838|NCT00668525|1059604|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
444839|NCT00668525|1059602|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
444840|NCT00668525|1059603|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
444841|NCT00668525|1059604|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
444842|NCT00668434|1059617|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
444843|NCT00668434|1059618|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
444844|NCT00668434|1059617|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
444845|NCT00668434|1059618|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
444846|NCT00668434|1059617|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
444847|NCT00668434|1059618|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
444848|NCT00668434|1059617|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
444849|NCT00668434|1059618|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
444850|NCT00668434|1059617|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
444851|NCT00668434|1059618|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
444852|NCT00668434|1059617|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
444853|NCT00668434|1059618|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
444854|NCT00668395|1059633|P3|NOT COMPLETED|Overall Study||1
444855|NCT00668395|1059634|P2|NOT COMPLETED|Overall Study||6
444856|NCT00668395|1059635|P1|NOT COMPLETED|Overall Study||6
444857|NCT00668395|1059633|P3|COMPLETED|Overall Study||5
444858|NCT00668395|1059634|P2|COMPLETED|Overall Study||16
444859|NCT00668395|1059635|P1|COMPLETED|Overall Study||39
444860|NCT00668395|1059633|P3|STARTED|Overall Study||6
444861|NCT00668395|1059634|P2|STARTED|Overall Study||22
444862|NCT00668395|1059635|P1|STARTED|Overall Study||45
444863|NCT00668382|1059643|P1|NOT COMPLETED|Overall Study||0
444864|NCT00668382|1059643|P1|COMPLETED|Overall Study||11
444865|NCT00668382|1059643|P1|STARTED|Overall Study|beginning of trial|11
444866|NCT00668317|1059647|P1|NOT COMPLETED|Overall Study||2
444867|NCT00668317|1059647|P1|COMPLETED|Overall Study||3
444868|NCT00668317|1059647|P1|STARTED|Overall Study||5
444869|NCT00668265|1059653|P2|NOT COMPLETED|Overall Study||5
444870|NCT00668265|1059654|P1|NOT COMPLETED|Overall Study||9
444871|NCT00668265|1059653|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
444956|NCT00667732|1059828|P3|NOT COMPLETED|Randomization (24 Weeks)||0
444872|NCT00668265|1059654|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
444873|NCT00668265|1059653|P2|STARTED|Overall Study||5
444874|NCT00668265|1059654|P1|STARTED|Overall Study||9
444875|NCT00668200|1059662|P1|NOT COMPLETED|Overall Study||3
444876|NCT00668200|1059662|P1|COMPLETED|Overall Study||77
444877|NCT00668200|1059662|P1|Intent to Treat (ITT)|Overall Study||80
444878|NCT00668200|1059662|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
444879|NCT00668200|1059662|P1|STARTED|Overall Study||80
444880|NCT00667992|1059670|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
444881|NCT00667992|1059671|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
444882|NCT00667992|1059670|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
444883|NCT00667992|1059671|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
444884|NCT00667992|1059670|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
444885|NCT00667992|1059671|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
444886|NCT00667992|1059670|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
444887|NCT00667992|1059671|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
444888|NCT00667992|1059670|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
444889|NCT00667992|1059671|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
444890|NCT00667992|1059670|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
444891|NCT00667992|1059671|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
444892|NCT00667992|1059670|P2|NOT COMPLETED|Wash-out||5
444893|NCT00667992|1059671|P1|NOT COMPLETED|Wash-out||7
444894|NCT00667992|1059670|P2|COMPLETED|Wash-out||36
444895|NCT00667992|1059671|P1|COMPLETED|Wash-out||34
444896|NCT00667992|1059670|P2|STARTED|Wash-out||41
444897|NCT00667992|1059671|P1|STARTED|Wash-out||41
444898|NCT00667992|1059670|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
444899|NCT00667992|1059671|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
444900|NCT00667992|1059670|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
444901|NCT00667992|1059671|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
444902|NCT00667992|1059670|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
444903|NCT00667992|1059671|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
444904|NCT00667992|1059670|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
444905|NCT00667992|1059671|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
444906|NCT00667992|1059670|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
444907|NCT00667992|1059671|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
444908|NCT00667992|1059670|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
444909|NCT00667992|1059671|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
444910|NCT00667875|1059728|P3|NOT COMPLETED|Overall Study||13
444911|NCT00667875|1059729|P2|NOT COMPLETED|Overall Study||11
444912|NCT00667875|1059730|P1|NOT COMPLETED|Overall Study||10
444913|NCT00667875|1059728|P3|COMPLETED|Overall Study||8
444914|NCT00667875|1059729|P2|COMPLETED|Overall Study||10
444915|NCT00667875|1059730|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
444916|NCT00667875|1059728|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
444917|NCT00667875|1059729|P2|STARTED|Overall Study||21
444918|NCT00667875|1059730|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
444919|NCT00667849|1059740|P2|NOT COMPLETED|Overall Study||121
444920|NCT00667849|1059741|P1|NOT COMPLETED|Overall Study||108
444921|NCT00667849|1059740|P2|COMPLETED|Overall Study||130
444922|NCT00667849|1059741|P1|COMPLETED|Overall Study||142
444923|NCT00667849|1059740|P2|STARTED|Overall Study||251
444924|NCT00667849|1059741|P1|STARTED|Overall Study||250
444925|NCT00667810|1059755|P4|NOT COMPLETED|Overall Study||2
444926|NCT00667810|1059756|P3|NOT COMPLETED|Overall Study||222
444927|NCT00667810|1059757|P2|NOT COMPLETED|Overall Study||170
444928|NCT00667810|1059758|P1|NOT COMPLETED|Overall Study||167
444929|NCT00667810|1059755|P4|COMPLETED|Overall Study||9
444930|NCT00667810|1059756|P3|COMPLETED|Overall Study||124
444931|NCT00667810|1059757|P2|COMPLETED|Overall Study||94
444932|NCT00667810|1059758|P1|COMPLETED|Overall Study||102
444933|NCT00667810|1059755|P4|Treated|Overall Study||11
444934|NCT00667810|1059756|P3|Treated|Overall Study||344
444935|NCT00667810|1059757|P2|Treated|Overall Study||263
444936|NCT00667810|1059758|P1|Treated|Overall Study||267
444937|NCT00667810|1059755|P4|STARTED|Overall Study||11
444938|NCT00667810|1059756|P3|STARTED|Overall Study||346
444939|NCT00667810|1059757|P2|STARTED|Overall Study||264
444940|NCT00667810|1059758|P1|STARTED|Overall Study||269
444941|NCT00667745|1059817|P2|NOT COMPLETED|Overall Study||21
444942|NCT00667745|1059818|P1|NOT COMPLETED|Overall Study||25
444943|NCT00667745|1059817|P2|COMPLETED|Overall Study||121
444944|NCT00667745|1059818|P1|COMPLETED|Overall Study||116
444945|NCT00667745|1059817|P2|STARTED|Overall Study||142
444946|NCT00667745|1059818|P1|STARTED|Overall Study||141
444947|NCT00667732|1059828|P3|NOT COMPLETED|Extension (26 Weeks)||0
444948|NCT00667732|1059829|P2|NOT COMPLETED|Extension (26 Weeks)||0
444949|NCT00667732|1059830|P1|NOT COMPLETED|Extension (26 Weeks)||0
444950|NCT00667732|1059828|P3|COMPLETED|Extension (26 Weeks)||17
444951|NCT00667732|1059829|P2|COMPLETED|Extension (26 Weeks)||14
444952|NCT00667732|1059830|P1|COMPLETED|Extension (26 Weeks)||0
444953|NCT00667732|1059828|P3|STARTED|Extension (26 Weeks)||17
444954|NCT00667732|1059829|P2|STARTED|Extension (26 Weeks)||14
444955|NCT00667732|1059830|P1|STARTED|Extension (26 Weeks)||0
444957|NCT00667732|1059829|P2|NOT COMPLETED|Randomization (24 Weeks)||1
444958|NCT00667732|1059830|P1|NOT COMPLETED|Randomization (24 Weeks)||0
444959|NCT00667732|1059828|P3|COMPLETED|Randomization (24 Weeks)||17
444960|NCT00667732|1059829|P2|COMPLETED|Randomization (24 Weeks)||16
444961|NCT00667732|1059830|P1|COMPLETED|Randomization (24 Weeks)||0
444962|NCT00667732|1059828|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
444963|NCT00667732|1059829|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
444964|NCT00667732|1059830|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
444965|NCT00667732|1059828|P3|STARTED|Randomization (24 Weeks)||17
444966|NCT00667732|1059829|P2|STARTED|Randomization (24 Weeks)||17
444967|NCT00667732|1059830|P1|STARTED|Randomization (24 Weeks)||0
444968|NCT00667732|1059828|P3|NOT COMPLETED|Run -In (8 Weeks)||0
444969|NCT00667732|1059829|P2|NOT COMPLETED|Run -In (8 Weeks)||0
444970|NCT00667732|1059830|P1|NOT COMPLETED|Run -In (8 Weeks)||7
444971|NCT00667732|1059828|P3|COMPLETED|Run -In (8 Weeks)||0
444972|NCT00667732|1059829|P2|COMPLETED|Run -In (8 Weeks)||0
444973|NCT00667732|1059830|P1|COMPLETED|Run -In (8 Weeks)||34
444974|NCT00667732|1059828|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
444975|NCT00667732|1059829|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
444976|NCT00667732|1059830|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
444977|NCT00667732|1059828|P3|STARTED|Run -In (8 Weeks)||0
444978|NCT00667732|1059829|P2|STARTED|Run -In (8 Weeks)||0
444979|NCT00667732|1059830|P1|STARTED|Run -In (8 Weeks)||41
444980|NCT00667693|1059843|P2|NOT COMPLETED|Overall Study||2
444981|NCT00667693|1059844|P1|NOT COMPLETED|Overall Study||0
444982|NCT00667693|1059843|P2|COMPLETED|Overall Study||50
444983|NCT00667693|1059844|P1|COMPLETED|Overall Study||49
444984|NCT00667693|1059843|P2|STARTED|Overall Study||52
444985|NCT00667693|1059844|P1|STARTED|Overall Study||49
444986|NCT00667602|1059853|P3|NOT COMPLETED|Overall Study||18
444987|NCT00667602|1059854|P2|NOT COMPLETED|Overall Study||15
444988|NCT00667602|1059855|P1|NOT COMPLETED|Overall Study||8
444989|NCT00667602|1059853|P3|COMPLETED|Overall Study||197
444990|NCT00667602|1059854|P2|COMPLETED|Overall Study||213
444991|NCT00667602|1059855|P1|COMPLETED|Overall Study||211
444992|NCT00667602|1059853|P3|STARTED|Overall Study||215
444993|NCT00667602|1059854|P2|STARTED|Overall Study||228
444994|NCT00667602|1059855|P1|STARTED|Overall Study||219
444995|NCT00667589|1059905|P4|NOT COMPLETED|Overall Study||1
444996|NCT00667589|1059906|P3|NOT COMPLETED|Overall Study||3
444997|NCT00667589|1059907|P2|NOT COMPLETED|Overall Study||0
444998|NCT00667589|1059908|P1|NOT COMPLETED|Overall Study||1
444999|NCT00667589|1059905|P4|COMPLETED|Overall Study||1
445000|NCT00667589|1059906|P3|COMPLETED|Overall Study||0
445001|NCT00667589|1059907|P2|COMPLETED|Overall Study||0
445002|NCT00667589|1059908|P1|COMPLETED|Overall Study||0
445003|NCT00667589|1059905|P4|STARTED|Overall Study||2
445004|NCT00667589|1059906|P3|STARTED|Overall Study||3
445005|NCT00667589|1059907|P2|STARTED|Overall Study||0
445006|NCT00667589|1059908|P1|STARTED|Overall Study||1
445007|NCT00667576|1059923|P5|NOT COMPLETED|Overall Study||1
445008|NCT00667576|1059924|P4|NOT COMPLETED|Overall Study||4
445009|NCT00667576|1059925|P3|NOT COMPLETED|Overall Study||2
445010|NCT00667576|1059926|P2|NOT COMPLETED|Overall Study||1
445011|NCT00667576|1059927|P1|NOT COMPLETED|Overall Study||2
445012|NCT00667576|1059923|P5|COMPLETED|Overall Study||29
445013|NCT00667576|1059924|P4|COMPLETED|Overall Study||27
445014|NCT00667576|1059925|P3|COMPLETED|Overall Study||29
445015|NCT00667576|1059926|P2|COMPLETED|Overall Study||30
445016|NCT00667576|1059927|P1|COMPLETED|Overall Study||28
445017|NCT00667576|1059923|P5|STARTED|Overall Study||30
445018|NCT00667576|1059924|P4|STARTED|Overall Study||31
445019|NCT00667576|1059925|P3|STARTED|Overall Study||31
445020|NCT00667576|1059926|P2|STARTED|Overall Study||31
445021|NCT00667576|1059927|P1|STARTED|Overall Study||30
445022|NCT00667563|1059974|P1|NOT COMPLETED|Overall Study||24
445023|NCT00667563|1059974|P1|COMPLETED|Overall Study||126
445024|NCT00667563|1059974|P1|STARTED|Overall Study||150
445025|NCT00667511|1059984|P1|NOT COMPLETED|Intervention 2: Home NHD||4
445026|NCT00667511|1059984|P1|COMPLETED|Intervention 2: Home NHD||39
445027|NCT00667511|1059984|P1|STARTED|Intervention 2: Home NHD||43
445028|NCT00667511|1059984|P1|NOT COMPLETED|Training/Transition Period||8
445029|NCT00667511|1059984|P1|COMPLETED|Training/Transition Period||43
445030|NCT00667511|1059984|P1|STARTED|Training/Transition Period||51
445031|NCT00667511|1059984|P1|NOT COMPLETED|Intervention 1: Home DHD||7
445032|NCT00667511|1059984|P1|COMPLETED|Intervention 1: Home DHD||51
445033|NCT00667511|1059984|P1|STARTED|Intervention 1: Home DHD||58
445034|NCT00667459|1059994|P2|NOT COMPLETED|Overall Study||45
445035|NCT00667459|1059995|P1|NOT COMPLETED|Overall Study||8
445036|NCT00667459|1059994|P2|COMPLETED|Overall Study||220
445037|NCT00667459|1059995|P1|COMPLETED|Overall Study||272
445038|NCT00667459|1059994|P2|STARTED|Overall Study||265
445039|NCT00667459|1059995|P1|STARTED|Overall Study||280
445040|NCT00667446|1060037|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
445041|NCT00667446|1060038|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
445042|NCT00667446|1060037|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
445043|NCT00667446|1060038|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
445044|NCT00667446|1060037|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
445045|NCT00667446|1060038|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
445046|NCT00667446|1060037|P2|NOT COMPLETED|Treatment Period (36 Months)||25
445047|NCT00667446|1060038|P1|NOT COMPLETED|Treatment Period (36 Months)||23
445048|NCT00667446|1060037|P2|COMPLETED|Treatment Period (36 Months)||13
445049|NCT00667446|1060038|P1|COMPLETED|Treatment Period (36 Months)||11
445050|NCT00667446|1060037|P2|STARTED|Treatment Period (36 Months)||38
445051|NCT00667446|1060038|P1|STARTED|Treatment Period (36 Months)||34
445052|NCT00667420|1060060|P1|NOT COMPLETED|Overall Study||10
445053|NCT00667420|1060060|P1|COMPLETED|Overall Study||7
445054|NCT00667420|1060060|P1|Completion of Surgery/Re-staging|Overall Study||11
445055|NCT00667420|1060060|P1|Completion of Pre-operative EOX-P|Overall Study||15
445056|NCT00667420|1060060|P1|STARTED|Overall Study||17
445057|NCT00667394|1060070|P2|NOT COMPLETED|Overall Study||0
445058|NCT00667394|1060071|P1|NOT COMPLETED|Overall Study||4
445059|NCT00667394|1060070|P2|COMPLETED|Overall Study||1
445060|NCT00667394|1060071|P1|COMPLETED|Overall Study||37
445061|NCT00667394|1060070|P2|STARTED|Overall Study||1
445062|NCT00667394|1060071|P1|STARTED|Overall Study||41
445063|NCT00667381|1060081|P2|NOT COMPLETED|Overall Study||0
445064|NCT00667381|1060082|P1|NOT COMPLETED|Overall Study||0
445065|NCT00667381|1060081|P2|COMPLETED|Overall Study||503
445066|NCT00667381|1060082|P1|COMPLETED|Overall Study||501
445067|NCT00667381|1060081|P2|STARTED|Overall Study||503
445068|NCT00667381|1060082|P1|STARTED|Overall Study||501
445069|NCT00667368|1060098|P2|NOT COMPLETED|Overall Study||172
445070|NCT00667368|1060099|P1|NOT COMPLETED|Overall Study||200
445071|NCT00667368|1060098|P2|COMPLETED|Overall Study||511
445072|NCT00667368|1060099|P1|COMPLETED|Overall Study||482
445073|NCT00667368|1060098|P2|STARTED|Overall Study||683
445074|NCT00667368|1060099|P1|STARTED|Overall Study||682
445075|NCT00667355|1060107|P1|NOT COMPLETED|Overall Study||11
445076|NCT00667355|1060107|P1|COMPLETED|Overall Study||30
445077|NCT00667355|1060107|P1|STARTED|Overall Study||41
445078|NCT00667342|1060132|P3|NOT COMPLETED|Overall Study||9
445079|NCT00667342|1060133|P2|NOT COMPLETED|Overall Study||0
445080|NCT00667342|1060134|P1|NOT COMPLETED|Overall Study||14
445081|NCT00667342|1060132|P3|COMPLETED|Overall Study||3
445082|NCT00667342|1060133|P2|COMPLETED|Overall Study||0
445083|NCT00667342|1060134|P1|COMPLETED|Overall Study||17
445084|NCT00667342|1060132|P3|STARTED|Overall Study||12
445085|NCT00667342|1060133|P2|STARTED|Overall Study||0
445086|NCT00667342|1060134|P1|STARTED|Overall Study||31
445087|NCT00667277|1060172|P1|NOT COMPLETED|Overall Study||2
445088|NCT00667277|1060172|P1|COMPLETED|Overall Study||11
445089|NCT00667277|1060172|P1|STARTED|Overall Study||13
445090|NCT00667251|1060179|P2|NOT COMPLETED|Overall Study||95
445091|NCT00667251|1060180|P1|NOT COMPLETED|Overall Study||70
445092|NCT00667251|1060179|P2|COMPLETED|Overall Study||231
445093|NCT00667251|1060180|P1|COMPLETED|Overall Study||256
445094|NCT00667251|1060179|P2|Not Started|Overall Study||1
445095|NCT00667251|1060180|P1|Not Started|Overall Study||4
445096|NCT00667251|1060179|P2|Monotherapy|Overall Study||232
445097|NCT00667251|1060180|P1|Monotherapy|Overall Study||225
445098|NCT00667251|1060179|P2|Combination Rx|Overall Study||325
445099|NCT00667251|1060180|P1|Combination Rx|Overall Study||322
445100|NCT00667251|1060179|P2|STARTED|Overall Study||326
445101|NCT00667251|1060180|P1|STARTED|Overall Study||326
445102|NCT00667225|1060206|P2|NOT COMPLETED|Overall Study||1
445103|NCT00667225|1060207|P1|NOT COMPLETED|Overall Study||1
445104|NCT00667225|1060206|P2|COMPLETED|Overall Study||12
445105|NCT00667225|1060207|P1|COMPLETED|Overall Study||15
445106|NCT00667225|1060206|P2|STARTED|Overall Study||13
445107|NCT00667225|1060207|P1|STARTED|Overall Study||16
445108|NCT00667186|1060217|P2|NOT COMPLETED|Overall Study||0
445109|NCT00667186|1060218|P1|NOT COMPLETED|Overall Study||0
445110|NCT00667186|1060217|P2|COMPLETED|Overall Study||4880
445111|NCT00667186|1060218|P1|COMPLETED|Overall Study||4692
445112|NCT00667186|1060217|P2|STARTED|Overall Study||4880
445113|NCT00667186|1060218|P1|STARTED|Overall Study||4692
445114|NCT00667095|1060228|P2|NOT COMPLETED|Overall Study||1
445115|NCT00667095|1060229|P1|NOT COMPLETED|Overall Study||0
445116|NCT00667095|1060228|P2|COMPLETED|Overall Study||9
445117|NCT00667095|1060229|P1|COMPLETED|Overall Study||11
445118|NCT00667095|1060228|P2|STARTED|Overall Study||10
445119|NCT00667095|1060229|P1|STARTED|Overall Study||11
445120|NCT00666965|1060249|P4|NOT COMPLETED|Overall Study||15
445121|NCT00666965|1060250|P3|NOT COMPLETED|Overall Study||2
445122|NCT00666965|1060251|P2|NOT COMPLETED|Overall Study||4
445123|NCT00666965|1060252|P1|NOT COMPLETED|Overall Study||3
445124|NCT00666965|1060249|P4|COMPLETED|Overall Study||42
445125|NCT00666965|1060250|P3|COMPLETED|Overall Study||56
445126|NCT00666965|1060251|P2|COMPLETED|Overall Study||53
445127|NCT00666965|1060252|P1|COMPLETED|Overall Study||55
445128|NCT00666965|1060249|P4|STARTED|Overall Study||57
445129|NCT00666965|1060250|P3|STARTED|Overall Study||58
445130|NCT00666965|1060251|P2|STARTED|Overall Study||57
445131|NCT00666965|1060252|P1|STARTED|Overall Study||58
445132|NCT00666926|1060282|P16|NOT COMPLETED|Overall Study||8
445133|NCT00666926|1060283|P15|NOT COMPLETED|Overall Study||7
445134|NCT00666926|1060284|P14|NOT COMPLETED|Overall Study||4
445135|NCT00666926|1060285|P13|NOT COMPLETED|Overall Study||3
445136|NCT00666926|1060286|P12|NOT COMPLETED|Overall Study||33
445137|NCT00666926|1060287|P11|NOT COMPLETED|Overall Study||6
445138|NCT00666926|1060288|P10|NOT COMPLETED|Overall Study||10
445139|NCT00666926|1060289|P9|NOT COMPLETED|Overall Study||3
445140|NCT00666926|1060290|P8|NOT COMPLETED|Overall Study||1
445141|NCT00666926|1060291|P7|NOT COMPLETED|Overall Study||4
445142|NCT00666926|1060292|P6|NOT COMPLETED|Overall Study||4
445143|NCT00666926|1060293|P5|NOT COMPLETED|Overall Study||3
445144|NCT00666926|1060294|P4|NOT COMPLETED|Overall Study||4
445145|NCT00666926|1060295|P3|NOT COMPLETED|Overall Study||3
445146|NCT00666926|1060296|P2|NOT COMPLETED|Overall Study||4
445147|NCT00666926|1060297|P1|NOT COMPLETED|Overall Study||2
445148|NCT00666926|1060282|P16|COMPLETED|Overall Study||0
445149|NCT00666926|1060283|P15|COMPLETED|Overall Study||0
445150|NCT00666926|1060284|P14|COMPLETED|Overall Study||0
445151|NCT00666926|1060285|P13|COMPLETED|Overall Study||0
445152|NCT00666926|1060286|P12|COMPLETED|Overall Study||0
445153|NCT00666926|1060287|P11|COMPLETED|Overall Study||0
445154|NCT00666926|1060288|P10|COMPLETED|Overall Study||0
445155|NCT00666926|1060289|P9|COMPLETED|Overall Study||0
445156|NCT00666926|1060290|P8|COMPLETED|Overall Study||0
445157|NCT00666926|1060291|P7|COMPLETED|Overall Study||0
445158|NCT00666926|1060292|P6|COMPLETED|Overall Study||0
445159|NCT00666926|1060293|P5|COMPLETED|Overall Study||0
445160|NCT00666926|1060294|P4|COMPLETED|Overall Study||0
445161|NCT00666926|1060295|P3|COMPLETED|Overall Study||0
445162|NCT00666926|1060296|P2|COMPLETED|Overall Study||0
445163|NCT00666926|1060297|P1|COMPLETED|Overall Study||0
445164|NCT00666926|1060282|P16|STARTED|Overall Study||8
445165|NCT00666926|1060283|P15|STARTED|Overall Study||7
445166|NCT00666926|1060284|P14|STARTED|Overall Study||4
445167|NCT00666926|1060285|P13|STARTED|Overall Study||3
445168|NCT00666926|1060286|P12|STARTED|Overall Study||33
445169|NCT00666926|1060287|P11|STARTED|Overall Study||6
445170|NCT00666926|1060288|P10|STARTED|Overall Study||10
445171|NCT00666926|1060289|P9|STARTED|Overall Study||3
445172|NCT00666926|1060290|P8|STARTED|Overall Study||1
445173|NCT00666926|1060291|P7|STARTED|Overall Study||4
445174|NCT00666926|1060292|P6|STARTED|Overall Study||4
445175|NCT00666926|1060293|P5|STARTED|Overall Study||3
445176|NCT00666926|1060294|P4|STARTED|Overall Study||4
445177|NCT00666926|1060295|P3|STARTED|Overall Study||3
445178|NCT00666926|1060296|P2|STARTED|Overall Study||4
445179|NCT00666926|1060297|P1|STARTED|Overall Study||2
445180|NCT00666848|1060591|P3|NOT COMPLETED|Overall Study||0
445181|NCT00666848|1060592|P2|NOT COMPLETED|Overall Study||0
445182|NCT00666848|1060593|P1|NOT COMPLETED|Overall Study||0
445183|NCT00666848|1060591|P3|COMPLETED|Overall Study|finished Aim 3|7
445184|NCT00666848|1060592|P2|COMPLETED|Overall Study|finished Aim 1|9
445185|NCT00666848|1060593|P1|COMPLETED|Overall Study|finished Aim 2|8
445186|NCT00666848|1060591|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
445187|NCT00666848|1060592|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
445188|NCT00666848|1060593|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
445189|NCT00666757|1060606|P2|NOT COMPLETED|Overall Study||97
445190|NCT00666757|1060607|P1|NOT COMPLETED|Overall Study||100
445191|NCT00666757|1060606|P2|COMPLETED|Overall Study||281
445192|NCT00666757|1060607|P1|COMPLETED|Overall Study||272
445193|NCT00666757|1060606|P2|STARTED|Overall Study||378
445194|NCT00666757|1060607|P1|STARTED|Overall Study||372
445195|NCT00666718|1060666|P2|NOT COMPLETED|Overall Study||18
445196|NCT00666718|1060667|P1|NOT COMPLETED|Overall Study||12
445197|NCT00666718|1060666|P2|COMPLETED|Overall Study||169
445198|NCT00666718|1060667|P1|COMPLETED|Overall Study||175
445199|NCT00666718|1060666|P2|STARTED|Overall Study||187
445200|NCT00666718|1060667|P1|STARTED|Overall Study||187
445201|NCT00666705|1060693|P1|NOT COMPLETED|Overall Study||1
445202|NCT00666705|1060693|P1|COMPLETED|Overall Study||17
445203|NCT00666705|1060693|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
445204|NCT00666705|1060693|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
445205|NCT00666705|1060693|P1|Washout (Days 4 - 5)|Overall Study||18
445206|NCT00666705|1060693|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
445207|NCT00666705|1060693|P1|STARTED|Overall Study||18
445208|NCT00666679|1060712|P2|NOT COMPLETED|Second Intervention||1
445209|NCT00666679|1060713|P1|NOT COMPLETED|Second Intervention||1
445210|NCT00666679|1060712|P2|COMPLETED|Second Intervention||64
445211|NCT00666679|1060713|P1|COMPLETED|Second Intervention||61
445212|NCT00666679|1060712|P2|STARTED|Second Intervention||65
445213|NCT00666679|1060713|P1|STARTED|Second Intervention||62
445214|NCT00666679|1060712|P2|NOT COMPLETED|Washout Period of 1 Week||2
445215|NCT00666679|1060713|P1|NOT COMPLETED|Washout Period of 1 Week||0
445216|NCT00666679|1060712|P2|COMPLETED|Washout Period of 1 Week||65
445217|NCT00666679|1060713|P1|COMPLETED|Washout Period of 1 Week||62
445218|NCT00666679|1060712|P2|STARTED|Washout Period of 1 Week||67
445219|NCT00666679|1060713|P1|STARTED|Washout Period of 1 Week||62
445220|NCT00666679|1060712|P2|NOT COMPLETED|First Intervention||1
445221|NCT00666679|1060713|P1|NOT COMPLETED|First Intervention||4
445222|NCT00666679|1060712|P2|COMPLETED|First Intervention||67
445223|NCT00666679|1060713|P1|COMPLETED|First Intervention||62
445224|NCT00666679|1060712|P2|STARTED|First Intervention||68
445225|NCT00666679|1060713|P1|STARTED|First Intervention||66
445226|NCT00666666|1060733|P1|NOT COMPLETED|Overall Study||0
445227|NCT00666666|1060733|P1|COMPLETED|Overall Study||55
445228|NCT00666666|1060733|P1|STARTED|Overall Study||55
445229|NCT00666588|1060743|P4|NOT COMPLETED|Overall Study||2
445230|NCT00666588|1060744|P3|NOT COMPLETED|Overall Study||0
445231|NCT00666588|1060745|P2|NOT COMPLETED|Overall Study||0
445232|NCT00666588|1060746|P1|NOT COMPLETED|Overall Study||4
445233|NCT00666588|1060743|P4|COMPLETED|Overall Study||20
445234|NCT00666588|1060744|P3|COMPLETED|Overall Study||6
445235|NCT00666588|1060745|P2|COMPLETED|Overall Study||6
445236|NCT00666588|1060746|P1|COMPLETED|Overall Study||14
445237|NCT00666588|1060743|P4|STARTED|Overall Study||22
445238|NCT00666588|1060744|P3|STARTED|Overall Study||6
445239|NCT00666588|1060745|P2|STARTED|Overall Study||6
445240|NCT00666588|1060746|P1|STARTED|Overall Study||18
445241|NCT00666562|1060763|P3|NOT COMPLETED|Overall Study||0
445242|NCT00666562|1060764|P2|NOT COMPLETED|Overall Study||2
445243|NCT00666562|1060765|P1|NOT COMPLETED|Overall Study||0
445244|NCT00666562|1060763|P3|COMPLETED|Overall Study||10
445245|NCT00666562|1060764|P2|COMPLETED|Overall Study||8
445246|NCT00666562|1060765|P1|COMPLETED|Overall Study||11
445247|NCT00666562|1060763|P3|STARTED|Overall Study||10
445248|NCT00666562|1060764|P2|STARTED|Overall Study||10
445249|NCT00666562|1060765|P1|STARTED|Overall Study||11
445250|NCT00666536|1060812|P2|NOT COMPLETED|Overall Study||37
445251|NCT00666536|1060813|P1|NOT COMPLETED|Overall Study||33
445252|NCT00666536|1060812|P2|COMPLETED|Overall Study||322
445253|NCT00666536|1060813|P1|COMPLETED|Overall Study||336
445254|NCT00666536|1060812|P2|STARTED|Overall Study||359
445255|NCT00666536|1060813|P1|STARTED|Overall Study||369
445256|NCT00666458|1060831|P2|NOT COMPLETED|Overall Study||24
445257|NCT00666458|1060832|P1|NOT COMPLETED|Overall Study||38
445258|NCT00666458|1060831|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
445259|NCT00666458|1060832|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
445260|NCT00666458|1060831|P2|STARTED|Overall Study|Randomized and treated|398
445261|NCT00666458|1060832|P1|STARTED|Overall Study|Randomized and treated|403
445262|NCT00666406|1060844|P2|NOT COMPLETED|Second PK Infusion||0
445263|NCT00666406|1060845|P1|NOT COMPLETED|Second PK Infusion||0
445264|NCT00666406|1060844|P2|COMPLETED|Second PK Infusion||3
445265|NCT00666406|1060845|P1|COMPLETED|Second PK Infusion||6
445266|NCT00666406|1060844|P2|STARTED|Second PK Infusion||3
445267|NCT00666406|1060845|P1|STARTED|Second PK Infusion||6
445268|NCT00666406|1060844|P2|NOT COMPLETED|First PK Infusion||0
445269|NCT00666406|1060845|P1|NOT COMPLETED|First PK Infusion||0
445270|NCT00666406|1060844|P2|COMPLETED|First PK Infusion||3
445271|NCT00666406|1060845|P1|COMPLETED|First PK Infusion||6
445272|NCT00666406|1060844|P2|STARTED|First PK Infusion||3
445273|NCT00666406|1060845|P1|STARTED|First PK Infusion||6
445274|NCT00666328|1060920|P1|NOT COMPLETED|Overall Study||5
445275|NCT00666328|1060920|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
445276|NCT00666328|1060920|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
445277|NCT00666328|1060920|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
445278|NCT00666276|1060933|P1|NOT COMPLETED|Overall Study||34
445279|NCT00666276|1060933|P1|COMPLETED|Overall Study||970
445280|NCT00666276|1060933|P1|STARTED|Overall Study||1004
445281|NCT00666263|1060957|P2|NOT COMPLETED|End of Study Visit||0
445282|NCT00666263|1060958|P1|NOT COMPLETED|End of Study Visit||0
445283|NCT00666263|1060957|P2|COMPLETED|End of Study Visit||22
445284|NCT00666263|1060958|P1|COMPLETED|End of Study Visit||22
445285|NCT00666263|1060957|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
445286|NCT00666263|1060958|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
445287|NCT00666263|1060957|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
445288|NCT00666263|1060958|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
445289|NCT00666263|1060957|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
445290|NCT00666263|1060958|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
445291|NCT00666263|1060957|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
445292|NCT00666263|1060958|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
445293|NCT00666263|1060957|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
445294|NCT00666263|1060958|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
445295|NCT00666263|1060957|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
445296|NCT00666263|1060958|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
445297|NCT00666263|1060957|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
445298|NCT00666263|1060958|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
445299|NCT00666263|1060957|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
445300|NCT00666263|1060958|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
445301|NCT00666263|1060957|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
445302|NCT00666263|1060958|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
445303|NCT00666263|1060957|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
445304|NCT00666263|1060958|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
445305|NCT00666263|1060957|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
445306|NCT00666263|1060958|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
445307|NCT00666263|1060957|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
445308|NCT00666263|1060958|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
445309|NCT00666263|1060957|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
445310|NCT00666263|1060958|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
445311|NCT00666263|1060957|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
445312|NCT00666263|1060958|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
445313|NCT00666263|1060957|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
445314|NCT00666263|1060958|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
445315|NCT00666263|1060957|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
445316|NCT00666263|1060958|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
445317|NCT00666224|1061102|P2|NOT COMPLETED|Open-Label||85
445318|NCT00666224|1061103|P1|NOT COMPLETED|Open-Label||35
445319|NCT00666224|1061102|P2|COMPLETED|Open-Label||126
445320|NCT00666224|1061103|P1|COMPLETED|Open-Label||163
445321|NCT00666224|1061102|P2|STARTED|Open-Label||211
445322|NCT00666224|1061103|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
445323|NCT00666224|1061102|P2|NOT COMPLETED|Double-Blind||27
445324|NCT00666224|1061103|P1|NOT COMPLETED|Double-Blind||45
445325|NCT00666224|1061102|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
445326|NCT00666224|1061103|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
445327|NCT00666224|1061102|P2|STARTED|Double-Blind||238
445328|NCT00666224|1061103|P1|STARTED|Double-Blind||243
445329|NCT00666211|1061122|P2|NOT COMPLETED|Overall Study||38
445330|NCT00666211|1061123|P1|NOT COMPLETED|Overall Study||20
445331|NCT00666211|1061122|P2|COMPLETED|Overall Study||18
445332|NCT00666211|1061123|P1|COMPLETED|Overall Study||22
445333|NCT00666211|1061122|P2|STARTED|Overall Study||56
445334|NCT00666211|1061123|P1|STARTED|Overall Study||42
445335|NCT00666198|1061141|P1|NOT COMPLETED|Overall Study||33
445336|NCT00666198|1061141|P1|COMPLETED|Overall Study||3304
445337|NCT00666198|1061141|P1|STARTED|Overall Study||3337
445338|NCT00666029|1061156|P2|NOT COMPLETED|Overall Study||0
445339|NCT00666029|1061157|P1|NOT COMPLETED|Overall Study||1
445340|NCT00666029|1061156|P2|COMPLETED|Overall Study||20
445341|NCT00666029|1061157|P1|COMPLETED|Overall Study||19
445342|NCT00666029|1061156|P2|STARTED|Overall Study||20
445343|NCT00666029|1061157|P1|STARTED|Overall Study||20
445344|NCT00665925|1061169|P4|NOT COMPLETED|Overall Study||21
445345|NCT00665925|1061170|P3|NOT COMPLETED|Overall Study||26
445346|NCT00665925|1061171|P2|NOT COMPLETED|Overall Study||17
445347|NCT00665925|1061172|P1|NOT COMPLETED|Overall Study||15
445348|NCT00665925|1061169|P4|COMPLETED|Overall Study|Participants completed the study|131
445349|NCT00665925|1061170|P3|COMPLETED|Overall Study|Participants completed the study|126
445350|NCT00665925|1061171|P2|COMPLETED|Overall Study|Participants completed the study|59
445351|NCT00665925|1061172|P1|COMPLETED|Overall Study|Participants completed the study|62
445352|NCT00665925|1061169|P4|STARTED|Overall Study|Participants randomized|152
445353|NCT00665925|1061170|P3|STARTED|Overall Study|Participants randomized|152
445354|NCT00665925|1061171|P2|STARTED|Overall Study|Participants randomized|76
445355|NCT00665925|1061172|P1|STARTED|Overall Study|Participants randomized|77
445356|NCT00665847|1061583|P1|NOT COMPLETED|Overall Study||25
445357|NCT00665847|1061583|P1|COMPLETED|Overall Study||76
445358|NCT00665847|1061583|P1|STARTED|Overall Study||101
445359|NCT00665704|1061595|P1|NOT COMPLETED|Overall Study||0
445360|NCT00665704|1061595|P1|COMPLETED|Overall Study||9
445361|NCT00665704|1061595|P1|STARTED|Overall Study||9
445362|NCT00665626|1061602|P2|NOT COMPLETED|Overall Study||22
445363|NCT00665626|1061603|P1|NOT COMPLETED|Overall Study||10
445364|NCT00665626|1061602|P2|COMPLETED|Overall Study|Participants completed the study|124
445365|NCT00665626|1061603|P1|COMPLETED|Overall Study|Participants completed the study|63
445366|NCT00665626|1061602|P2|STARTED|Overall Study|Participants randomized|146
445367|NCT00665626|1061603|P1|STARTED|Overall Study|Participants randomized|73
445368|NCT00665470|1061671|P2|NOT COMPLETED|Overall Study||0
445369|NCT00665470|1061672|P1|NOT COMPLETED|Overall Study||0
445370|NCT00665470|1061671|P2|COMPLETED|Overall Study||0
445371|NCT00665470|1061672|P1|COMPLETED|Overall Study||10
445372|NCT00665470|1061671|P2|STARTED|Overall Study||0
445373|NCT00665470|1061672|P1|STARTED|Overall Study||10
445374|NCT00665444|1061680|P1|NOT COMPLETED|Overall Study||2
445375|NCT00665444|1061680|P1|COMPLETED|Overall Study||1
445376|NCT00665444|1061680|P1|STARTED|Overall Study||3
445377|NCT00665431|1061688|P3|NOT COMPLETED|Overall Study||24
445378|NCT00665431|1061689|P2|NOT COMPLETED|Overall Study||57
445379|NCT00665431|1061690|P1|NOT COMPLETED|Overall Study||40
445380|NCT00665431|1061688|P3|COMPLETED|Overall Study||98
445381|NCT00665431|1061689|P2|COMPLETED|Overall Study||188
445382|NCT00665431|1061690|P1|COMPLETED|Overall Study||203
445383|NCT00665431|1061688|P3|STARTED|Overall Study|Safety population|122
445384|NCT00665431|1061689|P2|STARTED|Overall Study|Safety population|245
445385|NCT00665431|1061690|P1|STARTED|Overall Study|Safety population|243
445386|NCT00665366|1061733|P2|NOT COMPLETED|Overall Study||59
445387|NCT00665366|1061734|P1|NOT COMPLETED|Overall Study||58
445388|NCT00665366|1061733|P2|COMPLETED|Overall Study||122
445389|NCT00665366|1061734|P1|COMPLETED|Overall Study||131
445390|NCT00665366|1061733|P2|STARTED|Overall Study|Participants randomized|181
445391|NCT00665366|1061734|P1|STARTED|Overall Study|Participants randomized|189
445392|NCT00665353|1061762|P1|NOT COMPLETED|Study Step 2||14
445393|NCT00665353|1061762|P1|COMPLETED|Study Step 2||2
445394|NCT00665353|1061762|P1|STARTED|Study Step 2||16
445395|NCT00665353|1061762|P1|NOT COMPLETED|Study Step 1||3
445396|NCT00665353|1061762|P1|COMPLETED|Study Step 1||16
445397|NCT00665353|1061762|P1|STARTED|Study Step 1||19
445398|NCT00665132|1061772|P1|NOT COMPLETED|Overall Study||0
445399|NCT00665132|1061772|P1|COMPLETED|Overall Study||10
445400|NCT00665132|1061772|P1|STARTED|Overall Study||10
445401|NCT00665002|1061779|P1|NOT COMPLETED|Overall Study||12
445402|NCT00665002|1061779|P1|COMPLETED|Overall Study||4
445403|NCT00665002|1061779|P1|STARTED|Overall Study||16
445404|NCT00664742|1061784|P1|NOT COMPLETED|Overall Study||126
445405|NCT00664742|1061784|P1|COMPLETED|Overall Study||481
445406|NCT00664742|1061784|P1|STARTED|Overall Study||607
445407|NCT00664560|1061792|P3|NOT COMPLETED|Overall Study||19
445408|NCT00664560|1061793|P2|NOT COMPLETED|Overall Study||35
445409|NCT00664560|1061794|P1|NOT COMPLETED|Overall Study||39
445410|NCT00664560|1061792|P3|COMPLETED|Overall Study||105
445411|NCT00664560|1061793|P2|COMPLETED|Overall Study||208
445412|NCT00664560|1061794|P1|COMPLETED|Overall Study||208
445413|NCT00664560|1061792|P3|STARTED|Overall Study|Safety Population|124
445414|NCT00664560|1061793|P2|STARTED|Overall Study|Safety Population|243
445415|NCT00664560|1061794|P1|STARTED|Overall Study|Safety Population|247
445416|NCT00664534|1061837|P2|NOT COMPLETED|Overall Study||33
445417|NCT00664534|1061838|P1|NOT COMPLETED|Overall Study||41
445418|NCT00664534|1061837|P2|COMPLETED|Overall Study||138
445419|NCT00664534|1061838|P1|COMPLETED|Overall Study||132
445420|NCT00664534|1061837|P2|STARTED|Overall Study||171
445421|NCT00664534|1061838|P1|STARTED|Overall Study||173
445422|NCT00664521|1061866|P2|NOT COMPLETED|Overall Study||1
445423|NCT00664521|1061867|P1|NOT COMPLETED|Overall Study||6
445424|NCT00664521|1061866|P2|COMPLETED|Overall Study||8
445425|NCT00664521|1061867|P1|COMPLETED|Overall Study||12
445426|NCT00664521|1061866|P2|STARTED|Overall Study||9
445427|NCT00664521|1061867|P1|STARTED|Overall Study||18
445428|NCT00664430|1061887|P1|NOT COMPLETED|Overall Study||13
445429|NCT00664430|1061887|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
445430|NCT00664430|1061887|P1|STARTED|Overall Study||13
445431|NCT00664326|1061893|P1|NOT COMPLETED|Overall Study||24
445432|NCT00664326|1061893|P1|COMPLETED|Overall Study||25
445433|NCT00664326|1061893|P1|STARTED|Overall Study||49
445434|NCT00664105|1061912|P1|NOT COMPLETED|Overall Study||24
445435|NCT00664105|1061912|P1|COMPLETED|Overall Study||39
445436|NCT00664105|1061912|P1|STARTED|Overall Study||63
445437|NCT00664066|1061919|P1|NOT COMPLETED|Overall Study||3
445438|NCT00664066|1061919|P1|COMPLETED|Overall Study||0
445439|NCT00664066|1061919|P1|STARTED|Overall Study||3
445440|NCT00663962|1061925|P2|NOT COMPLETED|Overall Study||0
445441|NCT00663962|1061926|P1|NOT COMPLETED|Overall Study||1
445442|NCT00663962|1061925|P2|COMPLETED|Overall Study||8
445443|NCT00663962|1061926|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
445444|NCT00663962|1061925|P2|STARTED|Overall Study||8
445445|NCT00663962|1061926|P1|STARTED|Overall Study||7
445446|NCT00663923|1061932|P1|NOT COMPLETED|Overall Study||2
445447|NCT00663923|1061932|P1|COMPLETED|Overall Study||48
445448|NCT00663923|1061932|P1|STARTED|Overall Study||50
445449|NCT00663858|1061949|P3|NOT COMPLETED|Overall Study||20
445450|NCT00663858|1061950|P2|NOT COMPLETED|Overall Study||10
445451|NCT00663858|1061951|P1|NOT COMPLETED|Overall Study||34
445452|NCT00663858|1061949|P3|COMPLETED|Overall Study||82
445453|NCT00663858|1061950|P2|COMPLETED|Overall Study||96
445454|NCT00663858|1061951|P1|COMPLETED|Overall Study||178
445455|NCT00663858|1061949|P3|STARTED|Overall Study||102
445456|NCT00663858|1061950|P2|STARTED|Overall Study||106
445457|NCT00663858|1061951|P1|STARTED|Overall Study||212
445458|NCT00663819|1061961|P2|NOT COMPLETED|Overall Study||0
445459|NCT00663819|1061962|P1|NOT COMPLETED|Overall Study||0
445460|NCT00663819|1061961|P2|COMPLETED|Overall Study||135
445461|NCT00663819|1061962|P1|COMPLETED|Overall Study||123
445462|NCT00663819|1061961|P2|STARTED|Overall Study||135
445463|NCT00663819|1061962|P1|STARTED|Overall Study||123
445464|NCT00663793|1061970|P2|NOT COMPLETED|Overall Study||0
445465|NCT00663793|1061971|P1|NOT COMPLETED|Overall Study||0
445466|NCT00663793|1061970|P2|COMPLETED|Overall Study||8
445467|NCT00663793|1061971|P1|COMPLETED|Overall Study||8
445468|NCT00663793|1061970|P2|STARTED|Overall Study||8
445469|NCT00663793|1061971|P1|STARTED|Overall Study||8
445470|NCT00663702|1061983|P2|NOT COMPLETED|Overall Study||10
445471|NCT00663702|1061984|P1|NOT COMPLETED|Overall Study||18
445472|NCT00663702|1061983|P2|COMPLETED|Overall Study||61
445473|NCT00663702|1061984|P1|COMPLETED|Overall Study||34
445474|NCT00663702|1061983|P2|STARTED|Overall Study||71
445475|NCT00663702|1061984|P1|STARTED|Overall Study||52
445476|NCT00663403|1062007|P1|NOT COMPLETED|Overall Study||0
445477|NCT00663403|1062007|P1|COMPLETED|Overall Study||8
445478|NCT00663403|1062007|P1|STARTED|Overall Study||8
445479|NCT00663260|1062020|P3|NOT COMPLETED|Overall Study||16
445480|NCT00663260|1062021|P2|NOT COMPLETED|Overall Study||11
445481|NCT00663260|1062022|P1|NOT COMPLETED|Overall Study||21
445482|NCT00663260|1062020|P3|COMPLETED|Overall Study||69
445483|NCT00663260|1062021|P2|COMPLETED|Overall Study||72
445484|NCT00663260|1062022|P1|COMPLETED|Overall Study||63
445485|NCT00663260|1062020|P3|STARTED|Overall Study||85
445486|NCT00663260|1062021|P2|STARTED|Overall Study||83
445487|NCT00663260|1062022|P1|STARTED|Overall Study||84
445488|NCT00663234|1062036|P1|NOT COMPLETED|Overall Study||1
445489|NCT00663234|1062036|P1|COMPLETED|Overall Study||27
445490|NCT00663234|1062036|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
445491|NCT00663234|1062036|P1|STARTED|Overall Study||28
445492|NCT00663208|1062069|P7|NOT COMPLETED|Follow-up Period||1
445493|NCT00663208|1062070|P6|NOT COMPLETED|Follow-up Period||0
445494|NCT00663208|1062071|P5|NOT COMPLETED|Follow-up Period||0
445495|NCT00663208|1062072|P4|NOT COMPLETED|Follow-up Period||2
445496|NCT00663208|1062073|P3|NOT COMPLETED|Follow-up Period||3
445497|NCT00663208|1062074|P2|NOT COMPLETED|Follow-up Period||0
445498|NCT00663208|1062075|P1|NOT COMPLETED|Follow-up Period||3
445499|NCT00663208|1062069|P7|COMPLETED|Follow-up Period||5
445500|NCT00663208|1062070|P6|COMPLETED|Follow-up Period||4
445501|NCT00663208|1062071|P5|COMPLETED|Follow-up Period||4
445502|NCT00663208|1062072|P4|COMPLETED|Follow-up Period||2
445503|NCT00663208|1062073|P3|COMPLETED|Follow-up Period||1
445504|NCT00663208|1062074|P2|COMPLETED|Follow-up Period||3
445505|NCT00663208|1062075|P1|COMPLETED|Follow-up Period||1
445506|NCT00663208|1062069|P7|STARTED|Follow-up Period||6
445507|NCT00663208|1062070|P6|STARTED|Follow-up Period||4
445508|NCT00663208|1062071|P5|STARTED|Follow-up Period||4
445509|NCT00663208|1062072|P4|STARTED|Follow-up Period||4
445510|NCT00663208|1062073|P3|STARTED|Follow-up Period||4
445511|NCT00663208|1062074|P2|STARTED|Follow-up Period||3
445512|NCT00663208|1062075|P1|STARTED|Follow-up Period||4
445513|NCT00663208|1062069|P7|NOT COMPLETED|Treatment Period||0
445514|NCT00663208|1062070|P6|NOT COMPLETED|Treatment Period||0
445515|NCT00663208|1062071|P5|NOT COMPLETED|Treatment Period||0
445516|NCT00663208|1062072|P4|NOT COMPLETED|Treatment Period||0
445517|NCT00663208|1062073|P3|NOT COMPLETED|Treatment Period||0
445518|NCT00663208|1062074|P2|NOT COMPLETED|Treatment Period||1
445519|NCT00663208|1062075|P1|NOT COMPLETED|Treatment Period||0
445520|NCT00663208|1062069|P7|COMPLETED|Treatment Period||6
445521|NCT00663208|1062070|P6|COMPLETED|Treatment Period||4
445522|NCT00663208|1062071|P5|COMPLETED|Treatment Period||4
445523|NCT00663208|1062072|P4|COMPLETED|Treatment Period||4
445524|NCT00663208|1062073|P3|COMPLETED|Treatment Period||4
445525|NCT00663208|1062074|P2|COMPLETED|Treatment Period||3
445526|NCT00663208|1062075|P1|COMPLETED|Treatment Period||4
445527|NCT00663208|1062069|P7|STARTED|Treatment Period||6
445528|NCT00663208|1062070|P6|STARTED|Treatment Period||4
445529|NCT00663208|1062071|P5|STARTED|Treatment Period||4
445530|NCT00663208|1062072|P4|STARTED|Treatment Period||4
445531|NCT00663208|1062073|P3|STARTED|Treatment Period||4
445532|NCT00663208|1062074|P2|STARTED|Treatment Period||4
445533|NCT00663208|1062075|P1|STARTED|Treatment Period||4
445534|NCT00663169|1062227|P2|NOT COMPLETED|Overall Study||0
445535|NCT00663169|1062228|P1|NOT COMPLETED|Overall Study||0
445536|NCT00663169|1062227|P2|COMPLETED|Overall Study||3
445537|NCT00663169|1062228|P1|COMPLETED|Overall Study||3
445538|NCT00663169|1062227|P2|STARTED|Overall Study||3
445539|NCT00663169|1062228|P1|STARTED|Overall Study||3
445540|NCT00663117|1062253|P2|NOT COMPLETED|Overall Study||0
445541|NCT00663117|1062254|P1|NOT COMPLETED|Overall Study||1
445542|NCT00663117|1062253|P2|COMPLETED|Overall Study||20
445543|NCT00663117|1062254|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
445544|NCT00663117|1062253|P2|STARTED|Overall Study||20
445545|NCT00663117|1062254|P1|STARTED|Overall Study||20
445546|NCT00663052|1062268|P2|NOT COMPLETED|Overall Study||10
445547|NCT00663052|1062269|P1|NOT COMPLETED|Overall Study||12
445548|NCT00663052|1062268|P2|COMPLETED|Overall Study||127
445549|NCT00663052|1062269|P1|COMPLETED|Overall Study||124
445550|NCT00663052|1062268|P2|STARTED|Overall Study||137
445551|NCT00663052|1062269|P1|STARTED|Overall Study||136
445552|NCT00663026|1062352|P3|NOT COMPLETED|Overall Study||4
445553|NCT00663026|1062353|P2|NOT COMPLETED|Overall Study||6
445554|NCT00663026|1062354|P1|NOT COMPLETED|Overall Study||2
445555|NCT00663026|1062352|P3|COMPLETED|Overall Study||27
445556|NCT00663026|1062353|P2|COMPLETED|Overall Study||23
445557|NCT00663026|1062354|P1|COMPLETED|Overall Study||17
445558|NCT00663026|1062352|P3|STARTED|Overall Study||31
445559|NCT00663026|1062353|P2|STARTED|Overall Study||29
445560|NCT00663026|1062354|P1|STARTED|Overall Study||19
445561|NCT00662909|1062377|P3|NOT COMPLETED|Overall Study||53
445562|NCT00662909|1062378|P2|NOT COMPLETED|Overall Study||59
445563|NCT00662909|1062379|P1|NOT COMPLETED|Overall Study||69
445564|NCT00662909|1062377|P3|COMPLETED|Overall Study||380
445565|NCT00662909|1062378|P2|COMPLETED|Overall Study||383
445566|NCT00662909|1062379|P1|COMPLETED|Overall Study||385
445567|NCT00662909|1062377|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
445568|NCT00662909|1062378|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
445569|NCT00662909|1062379|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
445570|NCT00662909|1062377|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
445571|NCT00662909|1062378|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
445572|NCT00662909|1062379|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
445573|NCT00662909|1062377|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
445574|NCT00662909|1062378|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
445575|NCT00662909|1062379|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
445576|NCT00662909|1062377|P3|STARTED|Overall Study||433
445577|NCT00662909|1062378|P2|STARTED|Overall Study||442
445578|NCT00662909|1062379|P1|STARTED|Overall Study||454
445579|NCT00662857|1062477|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
445580|NCT00662857|1062478|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
445581|NCT00662857|1062477|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
445582|NCT00662857|1062478|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
445583|NCT00662857|1062477|P2|STARTED|Lispro Dosing Period (1 Day)||14
445584|NCT00662857|1062478|P1|STARTED|Lispro Dosing Period (1 Day)||12
445585|NCT00662857|1062477|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
445586|NCT00662857|1062478|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
445587|NCT00662857|1062477|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
445588|NCT00662857|1062478|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
445589|NCT00662857|1062477|P2|STARTED|Washout 2 (3 - 14 Days)||14
445590|NCT00662857|1062478|P1|STARTED|Washout 2 (3 - 14 Days)||13
445591|NCT00662857|1062477|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
445592|NCT00662857|1062478|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
445593|NCT00662857|1062477|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
445594|NCT00662857|1062478|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
445595|NCT00662857|1062477|P2|STARTED|TI Dosing Period 2 (1 Day)||14
445596|NCT00662857|1062478|P1|STARTED|TI Dosing Period 2 (1 Day)||13
445597|NCT00662857|1062477|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
445598|NCT00662857|1062478|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
445599|NCT00662857|1062477|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
445600|NCT00662857|1062478|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
445601|NCT00662857|1062477|P2|STARTED|Washout 1 (3 - 14 Days)||16
445602|NCT00662857|1062478|P1|STARTED|Washout 1 (3 - 14 Days)||13
445603|NCT00662857|1062477|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
445604|NCT00662857|1062478|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
445605|NCT00662857|1062477|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
445606|NCT00662857|1062478|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
445607|NCT00662857|1062477|P2|STARTED|TI Dosing Period 1 (1 Day)||16
445608|NCT00662857|1062478|P1|STARTED|TI Dosing Period 1 (1 Day)||13
445609|NCT00662831|1062493|P2|NOT COMPLETED|Overall Study||59
445610|NCT00662831|1062494|P1|NOT COMPLETED|Overall Study||106
445611|NCT00662831|1062493|P2|COMPLETED|Overall Study||33
445612|NCT00662831|1062494|P1|COMPLETED|Overall Study||78
445613|NCT00662831|1062493|P2|STARTED|Overall Study||92
445614|NCT00662831|1062494|P1|STARTED|Overall Study||184
445615|NCT00662818|1062534|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
445616|NCT00662818|1062535|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
445617|NCT00662818|1062534|P2|COMPLETED|Period 2 (6 Weeks)||41
445618|NCT00662818|1062535|P1|COMPLETED|Period 2 (6 Weeks)||38
445619|NCT00662818|1062534|P2|STARTED|Period 2 (6 Weeks)||53
445620|NCT00662818|1062535|P1|STARTED|Period 2 (6 Weeks)||51
445621|NCT00662818|1062534|P2|NOT COMPLETED|Wash-Out (14 Days)||5
445622|NCT00662818|1062535|P1|NOT COMPLETED|Wash-Out (14 Days)||5
445623|NCT00662818|1062534|P2|COMPLETED|Wash-Out (14 Days)||53
445624|NCT00662818|1062535|P1|COMPLETED|Wash-Out (14 Days)||51
445625|NCT00662818|1062534|P2|STARTED|Wash-Out (14 Days)||58
445626|NCT00662818|1062535|P1|STARTED|Wash-Out (14 Days)||56
445627|NCT00662818|1062534|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
445628|NCT00662818|1062535|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
445629|NCT00662818|1062534|P2|COMPLETED|Period 1 (6 Weeks)||58
445630|NCT00662818|1062535|P1|COMPLETED|Period 1 (6 Weeks)||56
445631|NCT00662818|1062534|P2|Treated|Period 1 (6 Weeks)||58
445632|NCT00662818|1062535|P1|Treated|Period 1 (6 Weeks)||56
445633|NCT00662818|1062534|P2|STARTED|Period 1 (6 Weeks)||81
445634|NCT00662818|1062535|P1|STARTED|Period 1 (6 Weeks)||84
445635|NCT00662675|1062559|P2|NOT COMPLETED|Overall Study||0
445636|NCT00662675|1062560|P1|NOT COMPLETED|Overall Study||0
445637|NCT00662675|1062559|P2|COMPLETED|Overall Study||20
445638|NCT00662675|1062560|P1|COMPLETED|Overall Study||20
445639|NCT00662675|1062559|P2|STARTED|Overall Study||20
445640|NCT00662675|1062560|P1|STARTED|Overall Study||20
445641|NCT00662649|1062574|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
445642|NCT00662649|1062575|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
445643|NCT00662649|1062576|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
445644|NCT00662649|1062577|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
445645|NCT00662649|1062578|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
445646|NCT00662649|1062574|P5|COMPLETED|Extension Study (Month 24 to 60)||126
445647|NCT00662649|1062575|P4|COMPLETED|Extension Study (Month 24 to 60)||112
445648|NCT00662649|1062576|P3|COMPLETED|Extension Study (Month 24 to 60)||0
445649|NCT00662649|1062577|P2|COMPLETED|Extension Study (Month 24 to 60)||290
445650|NCT00662649|1062578|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
445651|NCT00662649|1062574|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
445652|NCT00662649|1062575|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
445653|NCT00662649|1062576|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
445654|NCT00662649|1062577|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
445655|NCT00662649|1062578|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
445656|NCT00662649|1062574|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
445657|NCT00662649|1062575|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
445658|NCT00662649|1062576|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
445829|NCT00661674|1063003|P4|NOT COMPLETED|Overall Study||0
445659|NCT00662649|1062577|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
445660|NCT00662649|1062578|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
445661|NCT00662649|1062574|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
445662|NCT00662649|1062575|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
445663|NCT00662649|1062576|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
445664|NCT00662649|1062577|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
445665|NCT00662649|1062578|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
445666|NCT00662649|1062574|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
445667|NCT00662649|1062575|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
445668|NCT00662649|1062576|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
445669|NCT00662649|1062577|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
445670|NCT00662649|1062578|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
445671|NCT00662649|1062574|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
445672|NCT00662649|1062575|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
445673|NCT00662649|1062576|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
445674|NCT00662649|1062577|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
445675|NCT00662649|1062578|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
445676|NCT00662649|1062574|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
445677|NCT00662649|1062575|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
445678|NCT00662649|1062576|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
445679|NCT00662649|1062577|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
445680|NCT00662649|1062578|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
445681|NCT00662649|1062574|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
445682|NCT00662649|1062575|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
445683|NCT00662649|1062576|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
445684|NCT00662649|1062577|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
445685|NCT00662649|1062578|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
445686|NCT00662649|1062574|P5|STARTED|Extension Study (Month 24 to 60)||155
445687|NCT00662649|1062575|P4|STARTED|Extension Study (Month 24 to 60)||145
445688|NCT00662649|1062576|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
445689|NCT00662649|1062577|P2|STARTED|Extension Study (Month 24 to 60)||331
445690|NCT00662649|1062578|P1|STARTED|Extension Study (Month 24 to 60)||289
445691|NCT00662649|1062574|P5|NOT COMPLETED|Core Study (24 Months)||0
445692|NCT00662649|1062575|P4|NOT COMPLETED|Core Study (24 Months)||0
445693|NCT00662649|1062576|P3|NOT COMPLETED|Core Study (24 Months)||86
445694|NCT00662649|1062577|P2|NOT COMPLETED|Core Study (24 Months)||56
445695|NCT00662649|1062578|P1|NOT COMPLETED|Core Study (24 Months)||97
445696|NCT00662649|1062574|P5|COMPLETED|Core Study (24 Months)||0
445697|NCT00662649|1062575|P4|COMPLETED|Core Study (24 Months)||0
445698|NCT00662649|1062576|P3|COMPLETED|Core Study (24 Months)||332
445699|NCT00662649|1062577|P2|COMPLETED|Core Study (24 Months)||369
445700|NCT00662649|1062578|P1|COMPLETED|Core Study (24 Months)||332
445701|NCT00662649|1062574|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
445702|NCT00662649|1062575|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
445703|NCT00662649|1062576|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
445704|NCT00662649|1062577|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
445705|NCT00662649|1062578|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
445706|NCT00662649|1062574|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
445707|NCT00662649|1062575|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
445708|NCT00662649|1062576|P3|STARTED|Core Study (24 Months)||418
445709|NCT00662649|1062577|P2|STARTED|Core Study (24 Months)||425
445710|NCT00662649|1062578|P1|STARTED|Core Study (24 Months)||429
445711|NCT00662558|1062618|P2|NOT COMPLETED|Overall Study||110
445712|NCT00662558|1062619|P1|NOT COMPLETED|Overall Study||56
445713|NCT00662558|1062618|P2|COMPLETED|Overall Study||294
445714|NCT00662558|1062619|P1|COMPLETED|Overall Study||342
445715|NCT00662558|1062618|P2|Received Treatment|Overall Study||396
445716|NCT00662558|1062619|P1|Received Treatment|Overall Study||396
445717|NCT00662558|1062618|P2|STARTED|Overall Study||404
445718|NCT00662558|1062619|P1|STARTED|Overall Study||398
445719|NCT00662545|1062653|P2|NOT COMPLETED|Overall Study||0
445720|NCT00662545|1062654|P1|NOT COMPLETED|Overall Study||0
445721|NCT00662545|1062653|P2|COMPLETED|Overall Study||5
445722|NCT00662545|1062654|P1|COMPLETED|Overall Study||5
445723|NCT00662545|1062653|P2|STARTED|Overall Study||5
445724|NCT00662545|1062654|P1|STARTED|Overall Study||5
445725|NCT00662532|1062670|P2|NOT COMPLETED|Overall Study||2
445726|NCT00662532|1062671|P1|NOT COMPLETED|Overall Study||0
445727|NCT00662532|1062670|P2|COMPLETED|Overall Study||20
445728|NCT00662532|1062671|P1|COMPLETED|Overall Study||22
445729|NCT00662532|1062670|P2|STARTED|Overall Study||22
445730|NCT00662532|1062671|P1|STARTED|Overall Study||22
445731|NCT00662389|1062681|P1|NOT COMPLETED|Overall Study||0
445732|NCT00662389|1062681|P1|COMPLETED|Overall Study||4
445733|NCT00662389|1062681|P1|STARTED|Overall Study||4
445734|NCT00662363|1062686|P2|NOT COMPLETED|Overall Study||10
445735|NCT00662363|1062687|P1|NOT COMPLETED|Overall Study||11
445736|NCT00662363|1062686|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
445737|NCT00662363|1062687|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
445738|NCT00662363|1062686|P2|STARTED|Overall Study||32
445739|NCT00662363|1062687|P1|STARTED|Overall Study||32
445740|NCT00662311|1062698|P3|NOT COMPLETED|Overall Study||0
445741|NCT00662311|1062699|P2|NOT COMPLETED|Overall Study||0
445742|NCT00662311|1062700|P1|NOT COMPLETED|Overall Study||1
445743|NCT00662311|1062698|P3|COMPLETED|Overall Study||0
445744|NCT00662311|1062699|P2|COMPLETED|Overall Study||0
445745|NCT00662311|1062700|P1|COMPLETED|Overall Study||4
445746|NCT00662311|1062698|P3|STARTED|Overall Study||0
445747|NCT00662311|1062699|P2|STARTED|Overall Study||0
445748|NCT00662311|1062700|P1|STARTED|Overall Study||5
445749|NCT00662207|1062723|P1|NOT COMPLETED|Overall Study||0
445750|NCT00662207|1062723|P1|COMPLETED|Overall Study||3
445751|NCT00662207|1062723|P1|STARTED|Overall Study||3
445752|NCT00662129|1062730|P1|NOT COMPLETED|Overall Study||3
445753|NCT00662129|1062730|P1|COMPLETED|Overall Study||47
445754|NCT00662129|1062730|P1|STARTED|Overall Study||50
445755|NCT00662038|1062740|P1|NOT COMPLETED|Overall Study||631
445756|NCT00662038|1062740|P1|COMPLETED|Overall Study||427
445757|NCT00662038|1062740|P1|STARTED|Overall Study||1058
445758|NCT00662025|1062744|P1|NOT COMPLETED|Overall Study||63
445759|NCT00662025|1062744|P1|COMPLETED|Overall Study||0
445760|NCT00662025|1062744|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
445761|NCT00662012|1062764|P1|NOT COMPLETED|Overall Study||87
445762|NCT00662012|1062764|P1|COMPLETED|Overall Study||327
445763|NCT00662012|1062764|P1|STARTED|Overall Study||414
445764|NCT00661999|1062772|P3|NOT COMPLETED|Overall Study||57
445765|NCT00661999|1062773|P2|NOT COMPLETED|Overall Study||50
445766|NCT00661999|1062774|P1|NOT COMPLETED|Overall Study||59
445767|NCT00661999|1062772|P3|COMPLETED|Overall Study||106
445768|NCT00661999|1062773|P2|COMPLETED|Overall Study||113
445769|NCT00661999|1062774|P1|COMPLETED|Overall Study||105
445770|NCT00661999|1062772|P3|STARTED|Overall Study||163
445771|NCT00661999|1062773|P2|STARTED|Overall Study||163
445772|NCT00661999|1062774|P1|STARTED|Overall Study||164
445773|NCT00661960|1062830|P3|NOT COMPLETED|Overall Study||1
445774|NCT00661960|1062831|P2|NOT COMPLETED|Overall Study||3
445775|NCT00661960|1062832|P1|NOT COMPLETED|Overall Study||0
445776|NCT00661960|1062830|P3|COMPLETED|Overall Study||9
445777|NCT00661960|1062831|P2|COMPLETED|Overall Study||7
445778|NCT00661960|1062832|P1|COMPLETED|Overall Study||5
445779|NCT00661960|1062830|P3|STARTED|Overall Study||10
445780|NCT00661960|1062831|P2|STARTED|Overall Study||10
445781|NCT00661960|1062832|P1|STARTED|Overall Study||5
445782|NCT00661895|1062842|P2|NOT COMPLETED|Overall Study||0
445783|NCT00661895|1062843|P1|NOT COMPLETED|Overall Study||0
445784|NCT00661895|1062842|P2|COMPLETED|Overall Study||50
445785|NCT00661895|1062843|P1|COMPLETED|Overall Study||49
445786|NCT00661895|1062842|P2|STARTED|Overall Study||50
445787|NCT00661895|1062843|P1|STARTED|Overall Study||49
445788|NCT00661830|1062851|P2|NOT COMPLETED|Overall Study||42
445789|NCT00661830|1062852|P1|NOT COMPLETED|Overall Study||40
445790|NCT00661830|1062851|P2|COMPLETED|Overall Study||6
445791|NCT00661830|1062852|P1|COMPLETED|Overall Study||9
445792|NCT00661830|1062851|P2|STARTED|Overall Study||48
445793|NCT00661830|1062852|P1|STARTED|Overall Study||49
445794|NCT00661778|1062864|P1|NOT COMPLETED|Overall Study||50
445795|NCT00661778|1062864|P1|COMPLETED|Overall Study||0
445796|NCT00661778|1062864|P1|STARTED|Overall Study||50
445797|NCT00661726|1062871|P1|NOT COMPLETED|Overall Study||1
445798|NCT00661726|1062871|P1|COMPLETED|Overall Study||5
445799|NCT00661726|1062871|P1|STARTED|Overall Study||6
445800|NCT00661713|1062894|P8|NOT COMPLETED|Overall Study||11
445801|NCT00661713|1062895|P7|NOT COMPLETED|Overall Study||64
445802|NCT00661713|1062896|P6|NOT COMPLETED|Overall Study||37
445803|NCT00661713|1062897|P5|NOT COMPLETED|Overall Study||20
445804|NCT00661713|1062898|P4|NOT COMPLETED|Overall Study||28
445805|NCT00661713|1062899|P3|NOT COMPLETED|Overall Study||17
445806|NCT00661713|1062900|P2|NOT COMPLETED|Overall Study||39
445807|NCT00661713|1062901|P1|NOT COMPLETED|Overall Study||16
445808|NCT00661713|1062894|P8|COMPLETED|Overall Study||117
445809|NCT00661713|1062895|P7|COMPLETED|Overall Study||309
445810|NCT00661713|1062896|P6|COMPLETED|Overall Study||216
445811|NCT00661713|1062897|P5|COMPLETED|Overall Study||107
445812|NCT00661713|1062898|P4|COMPLETED|Overall Study||219
445813|NCT00661713|1062899|P3|COMPLETED|Overall Study||111
445814|NCT00661713|1062900|P2|COMPLETED|Overall Study||208
445815|NCT00661713|1062901|P1|COMPLETED|Overall Study||112
445816|NCT00661713|1062894|P8|STARTED|Overall Study||128
445817|NCT00661713|1062895|P7|STARTED|Overall Study||373
445818|NCT00661713|1062896|P6|STARTED|Overall Study||253
445819|NCT00661713|1062897|P5|STARTED|Overall Study||127
445820|NCT00661713|1062898|P4|STARTED|Overall Study||247
445821|NCT00661713|1062899|P3|STARTED|Overall Study||128
445822|NCT00661713|1062900|P2|STARTED|Overall Study||247
445823|NCT00661713|1062901|P1|STARTED|Overall Study||128
445824|NCT00661687|1062991|P1|NOT COMPLETED|Overall Study||15
445825|NCT00661687|1062991|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
445826|NCT00661687|1062991|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
445827|NCT00661674|1063001|P6|NOT COMPLETED|Overall Study||0
445828|NCT00661674|1063002|P5|NOT COMPLETED|Overall Study||0
445830|NCT00661674|1063004|P3|NOT COMPLETED|Overall Study||0
445831|NCT00661674|1063005|P2|NOT COMPLETED|Overall Study||0
445832|NCT00661674|1063006|P1|NOT COMPLETED|Overall Study||0
445833|NCT00661674|1063001|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
445834|NCT00661674|1063002|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
445835|NCT00661674|1063003|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
445836|NCT00661674|1063004|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
445837|NCT00661674|1063005|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
445838|NCT00661674|1063006|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
445839|NCT00661674|1063001|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
445840|NCT00661674|1063002|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
445841|NCT00661674|1063003|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
445842|NCT00661674|1063004|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
445843|NCT00661674|1063005|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
445844|NCT00661674|1063006|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
445845|NCT00661661|1063019|P2|NOT COMPLETED|Overall Study||39
445846|NCT00661661|1063020|P1|NOT COMPLETED|Overall Study||140
445847|NCT00661661|1063019|P2|COMPLETED|Overall Study||66
445848|NCT00661661|1063020|P1|COMPLETED|Overall Study||242
445849|NCT00661661|1063019|P2|STARTED|Overall Study||105
445850|NCT00661661|1063020|P1|STARTED|Overall Study||382
445851|NCT00661622|1063096|P2|NOT COMPLETED|Overall Study||0
445852|NCT00661622|1063097|P1|NOT COMPLETED|Overall Study||1
445853|NCT00661622|1063096|P2|COMPLETED|Overall Study||27
445854|NCT00661622|1063097|P1|COMPLETED|Overall Study||25
445855|NCT00661622|1063096|P2|STARTED|Overall Study||27
445856|NCT00661622|1063097|P1|STARTED|Overall Study||26
445857|NCT00661609|1063111|P1|NOT COMPLETED|Overall Study||41
445858|NCT00661609|1063111|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
445859|NCT00661609|1063111|P1|STARTED|Overall Study|All dosed patients|41
445860|NCT00661583|1063121|P3|NOT COMPLETED|Overall Study||0
445861|NCT00661583|1063122|P2|NOT COMPLETED|Overall Study||0
445862|NCT00661583|1063123|P1|NOT COMPLETED|Overall Study||0
445863|NCT00661583|1063121|P3|COMPLETED|Overall Study||10
445864|NCT00661583|1063122|P2|COMPLETED|Overall Study||10
445865|NCT00661583|1063123|P1|COMPLETED|Overall Study||10
445866|NCT00661583|1063121|P3|STARTED|Overall Study||10
445867|NCT00661583|1063122|P2|STARTED|Overall Study||10
445868|NCT00661583|1063123|P1|STARTED|Overall Study||10
445869|NCT00661570|1063140|P1|NOT COMPLETED|Overall Study||0
445870|NCT00661570|1063140|P1|COMPLETED|Overall Study||26
445871|NCT00661570|1063140|P1|STARTED|Overall Study||26
445872|NCT00661544|1063147|P1|NOT COMPLETED|Overall Study||0
445873|NCT00661544|1063147|P1|COMPLETED|Overall Study||48
445874|NCT00661544|1063147|P1|STARTED|Overall Study||48
445875|NCT00661531|1063151|P1|NOT COMPLETED|Overall Study||3
445876|NCT00661531|1063151|P1|COMPLETED|Overall Study||8
445877|NCT00661531|1063151|P1|STARTED|Overall Study||11
445878|NCT00661505|1063156|P1|NOT COMPLETED|Overall Study||30
445879|NCT00661505|1063156|P1|COMPLETED|Overall Study||102
445880|NCT00661505|1063156|P1|STARTED|Overall Study||132
445881|NCT00661492|1063184|P2|NOT COMPLETED|Overall Study||29
445882|NCT00661492|1063185|P1|NOT COMPLETED|Overall Study||68
445883|NCT00661492|1063184|P2|COMPLETED|Overall Study||11
445884|NCT00661492|1063185|P1|COMPLETED|Overall Study||7
445885|NCT00661492|1063184|P2|STARTED|Overall Study||40
445886|NCT00661492|1063185|P1|STARTED|Overall Study||75
445887|NCT00661479|1063209|P4|NOT COMPLETED|Overall Study||0
445888|NCT00661479|1063210|P3|NOT COMPLETED|Overall Study||0
445889|NCT00661479|1063211|P2|NOT COMPLETED|Overall Study||0
445890|NCT00661479|1063212|P1|NOT COMPLETED|Overall Study||0
445891|NCT00661479|1063209|P4|COMPLETED|Overall Study||3
445892|NCT00661479|1063210|P3|COMPLETED|Overall Study||3
445893|NCT00661479|1063211|P2|COMPLETED|Overall Study||3
445894|NCT00661479|1063212|P1|COMPLETED|Overall Study||12
445895|NCT00661479|1063209|P4|STARTED|Overall Study||3
445896|NCT00661479|1063210|P3|STARTED|Overall Study||3
445897|NCT00661479|1063211|P2|STARTED|Overall Study||3
445898|NCT00661479|1063212|P1|STARTED|Overall Study||12
445899|NCT00661453|1063225|P1|NOT COMPLETED|Overall Study||13
445900|NCT00661453|1063225|P1|COMPLETED|Overall Study||25
445901|NCT00661453|1063225|P1|STARTED|Overall Study||38
445902|NCT00661427|1063231|P2|NOT COMPLETED|Overall Study||7
445903|NCT00661427|1063232|P1|NOT COMPLETED|Overall Study||5
445904|NCT00661427|1063231|P2|COMPLETED|Overall Study||19
445905|NCT00661427|1063232|P1|COMPLETED|Overall Study||30
445906|NCT00661427|1063231|P2|STARTED|Overall Study||26
445907|NCT00661427|1063232|P1|STARTED|Overall Study||35
445908|NCT00661388|1063238|P1|NOT COMPLETED|Overall Study||24
445909|NCT00661388|1063238|P1|COMPLETED|Overall Study||51
445910|NCT00661388|1063238|P1|STARTED|Overall Study||75
445911|NCT00661362|1063261|P2|NOT COMPLETED|Overall Study||40
445912|NCT00661362|1063262|P1|NOT COMPLETED|Overall Study||29
445913|NCT00661362|1063261|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
445914|NCT00661362|1063262|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
445915|NCT00661362|1063261|P2|STARTED|Overall Study|Randomized and treated|287
445916|NCT00661362|1063262|P1|STARTED|Overall Study|Randomized and treated|283
445917|NCT00661258|1063280|P2|NOT COMPLETED|Overall Study||1
445918|NCT00661258|1063281|P1|NOT COMPLETED|Overall Study||3
445919|NCT00661258|1063280|P2|COMPLETED|Overall Study||33
445920|NCT00661258|1063281|P1|COMPLETED|Overall Study||31
445921|NCT00661258|1063280|P2|STARTED|Overall Study||34
445922|NCT00661258|1063281|P1|STARTED|Overall Study||34
445923|NCT00661193|1063291|P2|NOT COMPLETED|Overall Study||26
445924|NCT00661193|1063292|P1|NOT COMPLETED|Overall Study||33
445925|NCT00661193|1063291|P2|COMPLETED|Overall Study||0
445926|NCT00661193|1063292|P1|COMPLETED|Overall Study||0
445927|NCT00661193|1063291|P2|STARTED|Overall Study||26
445928|NCT00661193|1063292|P1|STARTED|Overall Study||33
445929|NCT00661089|1063302|P2|NOT COMPLETED|Overall Study||2
445930|NCT00661089|1063303|P1|NOT COMPLETED|Overall Study||0
445931|NCT00661089|1063302|P2|COMPLETED|Overall Study||9
445932|NCT00661089|1063303|P1|COMPLETED|Overall Study||10
445933|NCT00661089|1063302|P2|STARTED|Overall Study||11
445934|NCT00661089|1063303|P1|STARTED|Overall Study||10
445935|NCT00660985|1063313|P2|NOT COMPLETED|Overall Study||0
445936|NCT00660985|1063314|P1|NOT COMPLETED|Overall Study||1
445937|NCT00660985|1063313|P2|COMPLETED|Overall Study||25
445938|NCT00660985|1063314|P1|COMPLETED|Overall Study||25
445939|NCT00660985|1063313|P2|STARTED|Overall Study||25
445940|NCT00660985|1063314|P1|STARTED|Overall Study||26
445941|NCT00660907|1063338|P2|NOT COMPLETED|Overall Study||94
445942|NCT00660907|1063339|P1|NOT COMPLETED|Overall Study||84
445943|NCT00660907|1063338|P2|COMPLETED|Overall Study||314
445944|NCT00660907|1063339|P1|COMPLETED|Overall Study||322
445945|NCT00660907|1063338|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
445946|NCT00660907|1063339|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
445947|NCT00660829|1063353|P2|NOT COMPLETED|Overall Study||19
445948|NCT00660829|1063354|P1|NOT COMPLETED|Overall Study||18
445949|NCT00660829|1063353|P2|COMPLETED|Overall Study||249
445950|NCT00660829|1063354|P1|COMPLETED|Overall Study||250
445951|NCT00660829|1063353|P2|STARTED|Overall Study|2 subjects were randomized in error|268
445952|NCT00660829|1063354|P1|STARTED|Overall Study|2 subjects were randomized in error|268
445953|NCT00660816|1063372|P2|NOT COMPLETED|Overall Study||19
445954|NCT00660816|1063373|P1|NOT COMPLETED|Overall Study||20
445955|NCT00660816|1063372|P2|COMPLETED|Overall Study||3
445956|NCT00660816|1063373|P1|COMPLETED|Overall Study||4
445957|NCT00660816|1063372|P2|STARTED|Overall Study||22
445958|NCT00660816|1063373|P1|STARTED|Overall Study||24
445959|NCT00660699|1063385|P1|NOT COMPLETED|Overall Study||2
445960|NCT00660699|1063385|P1|COMPLETED|Overall Study||48
445961|NCT00660699|1063385|P1|STARTED|Overall Study||50
445962|NCT00660660|1063401|P2|NOT COMPLETED|Overall Study||9
445963|NCT00660660|1063402|P1|NOT COMPLETED|Overall Study||5
445964|NCT00660660|1063401|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
445965|NCT00660660|1063402|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
445966|NCT00660660|1063401|P2|Met Criteria for MITT Population|Overall Study||125
445967|NCT00660660|1063402|P1|Met Criteria for MITT Population|Overall Study||137
445968|NCT00660660|1063401|P2|STARTED|Overall Study|Randomized|133
445969|NCT00660660|1063402|P1|STARTED|Overall Study|Randomized|143
445970|NCT00660595|1063502|P2|NOT COMPLETED|Overall Study||9
445971|NCT00660595|1063503|P1|NOT COMPLETED|Overall Study||18
445972|NCT00660595|1063502|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
445973|NCT00660595|1063503|P1|COMPLETED|Overall Study||1
445974|NCT00660595|1063502|P2|STARTED|Overall Study||10
445975|NCT00660595|1063503|P1|STARTED|Overall Study||19
445976|NCT00660543|1063515|P1|NOT COMPLETED|Overall Study||0
445977|NCT00660543|1063515|P1|COMPLETED|Overall Study||14
445978|NCT00660543|1063515|P1|STARTED|Overall Study||14
445979|NCT00660517|1063528|P4|NOT COMPLETED|Overall Study||7
445980|NCT00660517|1063529|P3|NOT COMPLETED|Overall Study||7
445981|NCT00660517|1063530|P2|NOT COMPLETED|Overall Study||8
445982|NCT00660517|1063531|P1|NOT COMPLETED|Overall Study||8
445983|NCT00660517|1063528|P4|COMPLETED|Overall Study||144
445984|NCT00660517|1063529|P3|COMPLETED|Overall Study||144
445985|NCT00660517|1063530|P2|COMPLETED|Overall Study||144
445986|NCT00660517|1063531|P1|COMPLETED|Overall Study||145
445987|NCT00660517|1063528|P4|STARTED|Overall Study||151
445988|NCT00660517|1063529|P3|STARTED|Overall Study||151
445989|NCT00660517|1063530|P2|STARTED|Overall Study||152
445990|NCT00660517|1063531|P1|STARTED|Overall Study||153
445991|NCT00660504|1063551|P2|NOT COMPLETED|Overall Study||1
445992|NCT00660504|1063552|P1|NOT COMPLETED|Overall Study||0
445993|NCT00660504|1063551|P2|COMPLETED|Overall Study||150
445994|NCT00660504|1063552|P1|COMPLETED|Overall Study||149
445995|NCT00660504|1063551|P2|STARTED|Overall Study||151
445996|NCT00660504|1063552|P1|STARTED|Overall Study||149
445997|NCT00660400|1063564|P1|NOT COMPLETED|Overall Study||4
445998|NCT00660400|1063564|P1|COMPLETED|Overall Study||21
445999|NCT00660400|1063564|P1|STARTED|Overall Study||25
446000|NCT00660387|1063573|P2|NOT COMPLETED|Overall Study||3
446001|NCT00660387|1063574|P1|NOT COMPLETED|Overall Study||2
446002|NCT00660387|1063573|P2|COMPLETED|Overall Study||31
446003|NCT00660387|1063574|P1|COMPLETED|Overall Study||35
446004|NCT00660387|1063573|P2|STARTED|Overall Study||34
446005|NCT00660387|1063574|P1|STARTED|Overall Study||37
446006|NCT00660348|1063628|P2|NOT COMPLETED|Overall Study||0
446007|NCT00660348|1063629|P1|NOT COMPLETED|Overall Study||1
446008|NCT00660348|1063628|P2|COMPLETED|Overall Study||0
446009|NCT00660348|1063629|P1|COMPLETED|Overall Study||0
446010|NCT00660348|1063628|P2|STARTED|Overall Study||0
446011|NCT00660348|1063629|P1|STARTED|Overall Study||1
446012|NCT00660309|1063637|P2|NOT COMPLETED|Overall Study||3
446013|NCT00660309|1063638|P1|NOT COMPLETED|Overall Study||2
446014|NCT00660309|1063637|P2|COMPLETED|Overall Study||19
446015|NCT00660309|1063638|P1|COMPLETED|Overall Study||21
446016|NCT00660309|1063637|P2|Pharmacodynamic Analysis Set|Overall Study||20
446017|NCT00660309|1063638|P1|Pharmacodynamic Analysis Set|Overall Study||22
446018|NCT00660309|1063637|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
446019|NCT00660309|1063638|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
446020|NCT00660309|1063637|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
446021|NCT00660309|1063638|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
446022|NCT00660192|1063679|P2|NOT COMPLETED|Overall Study||3
446023|NCT00660192|1063680|P1|NOT COMPLETED|Overall Study||2
446024|NCT00660192|1063679|P2|COMPLETED|Overall Study||10
446025|NCT00660192|1063680|P1|COMPLETED|Overall Study||10
446026|NCT00660192|1063679|P2|STARTED|Overall Study||13
446027|NCT00660192|1063680|P1|STARTED|Overall Study||12
446028|NCT00660179|1063691|P3|NOT COMPLETED|Overall Study||41
446029|NCT00660179|1063692|P2|NOT COMPLETED|Overall Study||58
446030|NCT00660179|1063693|P1|NOT COMPLETED|Overall Study||56
446031|NCT00660179|1063691|P3|COMPLETED|Overall Study||201
446032|NCT00660179|1063692|P2|COMPLETED|Overall Study||192
446033|NCT00660179|1063693|P1|COMPLETED|Overall Study||194
446034|NCT00660179|1063691|P3|STARTED|Overall Study||242
446035|NCT00660179|1063692|P2|STARTED|Overall Study||250
446036|NCT00660179|1063693|P1|STARTED|Overall Study||250
446037|NCT00660075|1063727|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
446038|NCT00660075|1063728|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
446039|NCT00660075|1063727|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
446040|NCT00660075|1063728|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
446041|NCT00660075|1063727|P2|STARTED|Second Intervention (Week 11 to Week 16||18
446042|NCT00660075|1063728|P1|STARTED|Second Intervention (Week 11 to Week 16||18
446043|NCT00660075|1063727|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
446044|NCT00660075|1063728|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
446045|NCT00660075|1063727|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
446046|NCT00660075|1063728|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
446047|NCT00660075|1063727|P2|STARTED|Washout Period (Week 7 to Week 10)||18
446048|NCT00660075|1063728|P1|STARTED|Washout Period (Week 7 to Week 10)||18
446049|NCT00660075|1063727|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
446050|NCT00660075|1063728|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
446051|NCT00660075|1063727|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
446052|NCT00660075|1063728|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
446053|NCT00660075|1063727|P2|STARTED|First Intervention (Week 1 to Week 6)||18
446054|NCT00660075|1063728|P1|STARTED|First Intervention (Week 1 to Week 6)||18
446055|NCT00660049|1063734|P1|NOT COMPLETED|Overall Study||6
446056|NCT00660049|1063734|P1|COMPLETED|Overall Study||6
446057|NCT00660049|1063734|P1|STARTED|Overall Study||12
446058|NCT00660023|1063738|P1|NOT COMPLETED|Overall Study||29
446059|NCT00660023|1063738|P1|COMPLETED|Overall Study||95
446060|NCT00660023|1063738|P1|Treated|Overall Study||114
446061|NCT00660023|1063738|P1|STARTED|Overall Study||124
446062|NCT00660010|1063749|P1|NOT COMPLETED|Overall Study||9
446063|NCT00660010|1063749|P1|COMPLETED|Overall Study||46
446064|NCT00660010|1063749|P1|STARTED|Overall Study||55
446065|NCT00659984|1063763|P1|NOT COMPLETED|Overall Study||1
446066|NCT00659984|1063763|P1|COMPLETED|Overall Study||14
446067|NCT00659984|1063763|P1|STARTED|Overall Study||15
446068|NCT00659945|1063776|P2|NOT COMPLETED|Overall Study||0
446069|NCT00659945|1063777|P1|NOT COMPLETED|Overall Study||0
446070|NCT00659945|1063776|P2|COMPLETED|Overall Study||75
446071|NCT00659945|1063777|P1|COMPLETED|Overall Study||75
446072|NCT00659945|1063776|P2|STARTED|Overall Study||75
446073|NCT00659945|1063777|P1|STARTED|Overall Study||75
446074|NCT00659815|1063785|P2|NOT COMPLETED|Overall Study||4
446075|NCT00659815|1063786|P1|NOT COMPLETED|Overall Study||4
446076|NCT00659815|1063785|P2|COMPLETED|Overall Study||147
446077|NCT00659815|1063786|P1|COMPLETED|Overall Study||153
446078|NCT00659815|1063785|P2|STARTED|Overall Study||151
446079|NCT00659815|1063786|P1|STARTED|Overall Study||157
446080|NCT00659789|1063798|P2|NOT COMPLETED|Overall Study||7
446081|NCT00659789|1063799|P1|NOT COMPLETED|Overall Study||7
446082|NCT00659789|1063798|P2|COMPLETED|Overall Study||36
446083|NCT00659789|1063799|P1|COMPLETED|Overall Study||86
446084|NCT00659789|1063798|P2|STARTED|Overall Study||43
446085|NCT00659789|1063799|P1|STARTED|Overall Study||93
446086|NCT00659737|1063817|P2|NOT COMPLETED|Overall Study||0
446087|NCT00659737|1063818|P1|NOT COMPLETED|Overall Study||0
446088|NCT00659737|1063817|P2|COMPLETED|Overall Study||58
446089|NCT00659737|1063818|P1|COMPLETED|Overall Study||57
446090|NCT00659737|1063817|P2|STARTED|Overall Study||58
446091|NCT00659737|1063818|P1|STARTED|Overall Study||57
446092|NCT00659724|1063824|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
446093|NCT00659724|1063824|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
446094|NCT00659724|1063824|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
446095|NCT00659724|1063824|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
446096|NCT00659724|1063824|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
446097|NCT00659724|1063824|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
446098|NCT00659633|1063842|P1|NOT COMPLETED|Overall Study||0
446099|NCT00659633|1063842|P1|COMPLETED|Overall Study||10
446100|NCT00659633|1063842|P1|STARTED|Overall Study||10
446101|NCT00659607|1063846|P1|NOT COMPLETED|Overall Study||316
446102|NCT00659607|1063846|P1|COMPLETED|Overall Study||3616
446103|NCT00659607|1063846|P1|STARTED|Overall Study||3932
446104|NCT00659581|1063864|P1|NOT COMPLETED|Overall Study||8582
446105|NCT00659581|1063864|P1|COMPLETED|Overall Study||12412
446106|NCT00659581|1063864|P1|STARTED|Overall Study||20994
446107|NCT00659529|1063876|P1|NOT COMPLETED|Overall Study||16
446108|NCT00659529|1063876|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
446109|NCT00659529|1063876|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
446110|NCT00659529|1063876|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
446111|NCT00659490|1063883|P3|NOT COMPLETED|Overall Study||1
446112|NCT00659490|1063884|P2|NOT COMPLETED|Overall Study||0
446113|NCT00659490|1063885|P1|NOT COMPLETED|Overall Study||2
446114|NCT00659490|1063883|P3|COMPLETED|Overall Study||30
446115|NCT00659490|1063884|P2|COMPLETED|Overall Study||59
446116|NCT00659490|1063885|P1|COMPLETED|Overall Study||59
446117|NCT00659490|1063883|P3|STARTED|Overall Study||31
446118|NCT00659490|1063884|P2|STARTED|Overall Study||59
446119|NCT00659490|1063885|P1|STARTED|Overall Study||61
446120|NCT00659438|1063958|P2|NOT COMPLETED|Overall Study||8
446121|NCT00659438|1063959|P1|NOT COMPLETED|Overall Study||14
446122|NCT00659438|1063958|P2|COMPLETED|Overall Study||40
446123|NCT00659438|1063959|P1|COMPLETED|Overall Study||33
446124|NCT00659438|1063958|P2|Safety Analysis Set|Overall Study||47
446125|NCT00659438|1063959|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
446126|NCT00659438|1063958|P2|Secondary Analysis Set|Overall Study||48
446127|NCT00659438|1063959|P1|Secondary Analysis Set|Overall Study||47
446128|NCT00659438|1063958|P2|Assessable Set : Primary Analysis|Overall Study||45
446129|NCT00659438|1063959|P1|Assessable Set : Primary Analysis|Overall Study||44
446130|NCT00659438|1063958|P2|STARTED|Overall Study||48
446131|NCT00659438|1063959|P1|STARTED|Overall Study||47
446132|NCT00659373|1063983|P2|NOT COMPLETED|Overall Study||7
446133|NCT00659373|1063984|P1|NOT COMPLETED|Overall Study||5
446134|NCT00659373|1063983|P2|COMPLETED|Overall Study||54
446135|NCT00659373|1063984|P1|COMPLETED|Overall Study||20
446136|NCT00659373|1063983|P2|STARTED|Overall Study||61
446137|NCT00659373|1063984|P1|STARTED|Overall Study||25
446138|NCT00659360|1063990|P1|NOT COMPLETED|Overall Study||0
446139|NCT00659360|1063990|P1|COMPLETED|Overall Study||17
446140|NCT00659360|1063990|P1|STARTED|Overall Study||17
446141|NCT00659334|1064005|P7|NOT COMPLETED|Overall Study||1
446142|NCT00659334|1064006|P6|NOT COMPLETED|Overall Study||0
446143|NCT00659334|1064007|P5|NOT COMPLETED|Overall Study||0
446144|NCT00659334|1064008|P4|NOT COMPLETED|Overall Study||0
446145|NCT00659334|1064009|P3|NOT COMPLETED|Overall Study||0
446146|NCT00659334|1064010|P2|NOT COMPLETED|Overall Study||5
446147|NCT00659334|1064011|P1|NOT COMPLETED|Overall Study||8
446148|NCT00659334|1064005|P7|COMPLETED|Overall Study|1 screen failure|20
446149|NCT00659334|1064006|P6|COMPLETED|Overall Study||0
446150|NCT00659334|1064007|P5|COMPLETED|Overall Study||1
446151|NCT00659334|1064008|P4|COMPLETED|Overall Study||2
446152|NCT00659334|1064009|P3|COMPLETED|Overall Study||5
446153|NCT00659334|1064010|P2|COMPLETED|Overall Study|5 Screen failures|36
446154|NCT00659334|1064011|P1|COMPLETED|Overall Study|8 Screen failures|38
446155|NCT00659334|1064005|P7|STARTED|Overall Study||21
446156|NCT00659334|1064006|P6|STARTED|Overall Study||0
446157|NCT00659334|1064007|P5|STARTED|Overall Study||1
446158|NCT00659334|1064008|P4|STARTED|Overall Study||2
446159|NCT00659334|1064009|P3|STARTED|Overall Study||5
446160|NCT00659334|1064010|P2|STARTED|Overall Study||41
446161|NCT00659334|1064011|P1|STARTED|Overall Study||46
446162|NCT00659295|1064029|P2|NOT COMPLETED|Overall Study||5603
446163|NCT00659295|1064030|P1|NOT COMPLETED|Overall Study||2708
446164|NCT00659295|1064029|P2|COMPLETED|Overall Study||32038
446165|NCT00659295|1064030|P1|COMPLETED|Overall Study||10821
446166|NCT00659295|1064029|P2|STARTED|Overall Study||37641
446167|NCT00659295|1064030|P1|STARTED|Overall Study||13529
446168|NCT00659269|1064038|P2|NOT COMPLETED|Overall Study||1
446169|NCT00659269|1064039|P1|NOT COMPLETED|Overall Study||1
446170|NCT00659269|1064038|P2|COMPLETED|Overall Study||161
446171|NCT00659269|1064039|P1|COMPLETED|Overall Study||156
446172|NCT00659269|1064038|P2|Group 3 (Taxanes)|Overall Study||97
446173|NCT00659269|1064039|P1|Group 3 (Taxanes)|Overall Study||92
446174|NCT00659269|1064038|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
446175|NCT00659269|1064039|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
446176|NCT00659269|1064038|P2|Group 1 (Heavy Metals)|Overall Study||52
446177|NCT00659269|1064039|P1|Group 1 (Heavy Metals)|Overall Study||52
446178|NCT00659269|1064038|P2|STARTED|Overall Study||162
446179|NCT00659269|1064039|P1|STARTED|Overall Study||157
446180|NCT00659230|1064069|P2|NOT COMPLETED|Overall Study||12
446181|NCT00659230|1064070|P1|NOT COMPLETED|Overall Study||9
446182|NCT00659230|1064069|P2|COMPLETED|Overall Study||37
446183|NCT00659230|1064070|P1|COMPLETED|Overall Study||42
446184|NCT00659230|1064069|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
446185|NCT00659230|1064070|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
446186|NCT00659165|1064084|P2|NOT COMPLETED|Overall Study||0
446187|NCT00659165|1064085|P1|NOT COMPLETED|Overall Study||0
446188|NCT00659165|1064084|P2|COMPLETED|Overall Study||5
446189|NCT00659165|1064085|P1|COMPLETED|Overall Study||5
446190|NCT00659165|1064084|P2|STARTED|Overall Study||5
446191|NCT00659165|1064085|P1|STARTED|Overall Study||5
446192|NCT00659061|1064093|P2|NOT COMPLETED|Overall Study||15
446193|NCT00659061|1064094|P1|NOT COMPLETED|Overall Study||21
446194|NCT00659061|1064093|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
446195|NCT00659061|1064094|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
446196|NCT00659061|1064093|P2|STARTED|Overall Study||302
446197|NCT00659061|1064094|P1|STARTED|Overall Study||308
446198|NCT00658996|1064112|P2|NOT COMPLETED|Second Intervention||1
446199|NCT00658996|1064113|P1|NOT COMPLETED|Second Intervention||1
446200|NCT00658996|1064112|P2|COMPLETED|Second Intervention||104
446201|NCT00658996|1064113|P1|COMPLETED|Second Intervention||105
446202|NCT00658996|1064112|P2|STARTED|Second Intervention||105
446203|NCT00658996|1064113|P1|STARTED|Second Intervention||106
446204|NCT00658996|1064112|P2|NOT COMPLETED|Crossover Period||1
446205|NCT00658996|1064113|P1|NOT COMPLETED|Crossover Period||2
446206|NCT00658996|1064112|P2|COMPLETED|Crossover Period||105
446207|NCT00658996|1064113|P1|COMPLETED|Crossover Period||106
446208|NCT00658996|1064112|P2|STARTED|Crossover Period||106
446209|NCT00658996|1064113|P1|STARTED|Crossover Period||108
446210|NCT00658996|1064112|P2|NOT COMPLETED|First Intervention||1
446211|NCT00658996|1064113|P1|NOT COMPLETED|First Intervention||1
446212|NCT00658996|1064112|P2|COMPLETED|First Intervention||106
446213|NCT00658996|1064113|P1|COMPLETED|First Intervention||108
446214|NCT00658996|1064112|P2|STARTED|First Intervention||107
446215|NCT00658996|1064113|P1|STARTED|First Intervention||109
446216|NCT00658814|1064125|P2|NOT COMPLETED|Maintenance Therapy||1
446217|NCT00658814|1064126|P1|NOT COMPLETED|Maintenance Therapy||3
446218|NCT00658814|1064125|P2|COMPLETED|Maintenance Therapy||7
446219|NCT00658814|1064126|P1|COMPLETED|Maintenance Therapy||17
446220|NCT00658814|1064125|P2|Eligible|Maintenance Therapy||8
446221|NCT00658814|1064126|P1|Eligible|Maintenance Therapy||19
446222|NCT00658814|1064125|P2|STARTED|Maintenance Therapy||8
446223|NCT00658814|1064126|P1|STARTED|Maintenance Therapy||20
446224|NCT00658814|1064125|P2|NOT COMPLETED|Consolidation Therapy||3
446225|NCT00658814|1064126|P1|NOT COMPLETED|Consolidation Therapy||2
446226|NCT00658814|1064125|P2|COMPLETED|Consolidation Therapy||10
446227|NCT00658814|1064126|P1|COMPLETED|Consolidation Therapy||22
446228|NCT00658814|1064125|P2|Eligible|Consolidation Therapy||11
446229|NCT00658814|1064126|P1|Eligible|Consolidation Therapy||22
446230|NCT00658814|1064125|P2|STARTED|Consolidation Therapy||13
446231|NCT00658814|1064126|P1|STARTED|Consolidation Therapy||24
446232|NCT00658814|1064125|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
446233|NCT00658814|1064126|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
446234|NCT00658814|1064125|P2|COMPLETED|Remission Induction Chemotherapy||41
446235|NCT00658814|1064126|P1|COMPLETED|Remission Induction Chemotherapy||75
446236|NCT00658814|1064125|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
446237|NCT00658814|1064126|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
446238|NCT00658814|1064125|P2|Eligible|Remission Induction Chemotherapy||57
446239|NCT00658814|1064126|P1|Eligible|Remission Induction Chemotherapy||82
446240|NCT00658814|1064125|P2|STARTED|Remission Induction Chemotherapy||59
446241|NCT00658814|1064126|P1|STARTED|Remission Induction Chemotherapy||83
446242|NCT00658788|1064140|P1|NOT COMPLETED|Overall Study||74
446243|NCT00658788|1064140|P1|COMPLETED|Overall Study||231
446244|NCT00658788|1064140|P1|STARTED|Overall Study||305
446245|NCT00658775|1064195|P2|NOT COMPLETED|Overall Study||43
446246|NCT00658775|1064196|P1|NOT COMPLETED|Overall Study||42
446247|NCT00658775|1064195|P2|COMPLETED|Overall Study||485
446248|NCT00658775|1064196|P1|COMPLETED|Overall Study||495
446249|NCT00658775|1064195|P2|STARTED|Overall Study|Treated|528
446250|NCT00658775|1064196|P1|STARTED|Overall Study|Treated|537
446251|NCT00658736|1064208|P2|NOT COMPLETED|Overall Study||2
446252|NCT00658736|1064209|P1|NOT COMPLETED|Overall Study||6
446253|NCT00658736|1064208|P2|COMPLETED|Overall Study||19
446254|NCT00658736|1064209|P1|COMPLETED|Overall Study||13
446255|NCT00658736|1064208|P2|STARTED|Overall Study||21
446256|NCT00658736|1064209|P1|STARTED|Overall Study||19
446257|NCT00658723|1064219|P3|NOT COMPLETED|Overall Study||7
446258|NCT00658723|1064220|P2|NOT COMPLETED|Overall Study||4
446259|NCT00658723|1064221|P1|NOT COMPLETED|Overall Study||4
446260|NCT00658723|1064219|P3|COMPLETED|Overall Study||44
446261|NCT00658723|1064220|P2|COMPLETED|Overall Study||26
446262|NCT00658723|1064221|P1|COMPLETED|Overall Study||56
446263|NCT00658723|1064219|P3|STARTED|Overall Study||51
446264|NCT00658723|1064220|P2|STARTED|Overall Study||30
446265|NCT00658723|1064221|P1|STARTED|Overall Study||60
446266|NCT00658697|1064248|P1|NOT COMPLETED|Overall Study||0
446267|NCT00658697|1064248|P1|COMPLETED|Overall Study||41
446268|NCT00658697|1064248|P1|STARTED|Overall Study||41
446269|NCT00658684|1064259|P4|NOT COMPLETED|Overall Study||1
446270|NCT00658684|1064260|P3|NOT COMPLETED|Overall Study||3
446271|NCT00658684|1064261|P2|NOT COMPLETED|Overall Study||15
446272|NCT00658684|1064262|P1|NOT COMPLETED|Overall Study||19
446273|NCT00658684|1064259|P4|COMPLETED|Overall Study||27
446274|NCT00658684|1064260|P3|COMPLETED|Overall Study||22
446275|NCT00658684|1064261|P2|COMPLETED|Overall Study||84
446276|NCT00658684|1064262|P1|COMPLETED|Overall Study||133
446277|NCT00658684|1064259|P4|STARTED|Overall Study||28
446278|NCT00658684|1064260|P3|STARTED|Overall Study||25
446279|NCT00658684|1064261|P2|STARTED|Overall Study||99
446280|NCT00658684|1064262|P1|STARTED|Overall Study||152
446281|NCT00658658|1064317|P5|NOT COMPLETED|Overall Study||5
446282|NCT00658658|1064318|P4|NOT COMPLETED|Overall Study||2
446283|NCT00658658|1064319|P3|NOT COMPLETED|Overall Study||0
446284|NCT00658658|1064320|P2|NOT COMPLETED|Overall Study||2
446285|NCT00658658|1064321|P1|NOT COMPLETED|Overall Study||5
446286|NCT00658658|1064317|P5|COMPLETED|Overall Study||3
446287|NCT00658658|1064318|P4|COMPLETED|Overall Study||4
446288|NCT00658658|1064319|P3|COMPLETED|Overall Study||4
446289|NCT00658658|1064320|P2|COMPLETED|Overall Study||5
446290|NCT00658658|1064321|P1|COMPLETED|Overall Study||1
446291|NCT00658658|1064317|P5|STARTED|Overall Study||8
446292|NCT00658658|1064318|P4|STARTED|Overall Study||6
446293|NCT00658658|1064319|P3|STARTED|Overall Study||4
446294|NCT00658658|1064320|P2|STARTED|Overall Study||7
446295|NCT00658658|1064321|P1|STARTED|Overall Study||6
446296|NCT00658632|1064380|P2|NOT COMPLETED|Overall Study||65
446297|NCT00658632|1064381|P1|NOT COMPLETED|Overall Study||64
446298|NCT00658632|1064380|P2|COMPLETED|Overall Study||633
446299|NCT00658632|1064381|P1|COMPLETED|Overall Study||618
446300|NCT00658632|1064380|P2|STARTED|Overall Study|Treated|698
446301|NCT00658632|1064381|P1|STARTED|Overall Study|Treated|682
446302|NCT00658619|1064396|P5|NOT COMPLETED|Overall Study||2
446303|NCT00658619|1064397|P4|NOT COMPLETED|Overall Study||12
446304|NCT00658619|1064398|P3|NOT COMPLETED|Overall Study||10
446305|NCT00658619|1064399|P2|NOT COMPLETED|Overall Study||1
446306|NCT00658619|1064400|P1|NOT COMPLETED|Overall Study||0
446307|NCT00658619|1064396|P5|COMPLETED|Overall Study||21
446308|NCT00658619|1064397|P4|COMPLETED|Overall Study||37
446309|NCT00658619|1064398|P3|COMPLETED|Overall Study||31
446310|NCT00658619|1064399|P2|COMPLETED|Overall Study||2
446311|NCT00658619|1064400|P1|COMPLETED|Overall Study||3
446312|NCT00658619|1064396|P5|STARTED|Overall Study||23
446313|NCT00658619|1064397|P4|STARTED|Overall Study||49
446314|NCT00658619|1064398|P3|STARTED|Overall Study||41
446315|NCT00658619|1064399|P2|STARTED|Overall Study||3
446316|NCT00658619|1064400|P1|STARTED|Overall Study||3
446317|NCT00658606|1064422|P2|NOT COMPLETED|Overall Study||23
446318|NCT00658606|1064423|P1|NOT COMPLETED|Overall Study||16
446319|NCT00658606|1064422|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
446320|NCT00658606|1064423|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
446321|NCT00658606|1064422|P2|Completed Treatment|Overall Study||44
446322|NCT00658606|1064423|P1|Completed Treatment|Overall Study||42
446323|NCT00658606|1064422|P2|STARTED|Overall Study||49
446324|NCT00658606|1064423|P1|STARTED|Overall Study||49
446325|NCT00658567|1064452|P3|NOT COMPLETED|Overall Study||6
446326|NCT00658567|1064453|P2|NOT COMPLETED|Overall Study||4
446327|NCT00658567|1064454|P1|NOT COMPLETED|Overall Study||8
446328|NCT00658567|1064452|P3|COMPLETED|Overall Study||35
446329|NCT00658567|1064453|P2|COMPLETED|Overall Study||38
446330|NCT00658567|1064454|P1|COMPLETED|Overall Study||32
446331|NCT00658567|1064452|P3|STARTED|Overall Study||41
446332|NCT00658567|1064453|P2|STARTED|Overall Study||42
446333|NCT00658567|1064454|P1|STARTED|Overall Study||40
446334|NCT00658541|1064465|P2|NOT COMPLETED|Second Intervention||0
446335|NCT00658541|1064466|P1|NOT COMPLETED|Second Intervention||0
446336|NCT00658541|1064465|P2|COMPLETED|Second Intervention||17
446337|NCT00658541|1064466|P1|COMPLETED|Second Intervention||18
446338|NCT00658541|1064465|P2|STARTED|Second Intervention||17
446339|NCT00658541|1064466|P1|STARTED|Second Intervention||18
446340|NCT00658541|1064465|P2|NOT COMPLETED|Washout Period of 7 Days||2
446341|NCT00658541|1064466|P1|NOT COMPLETED|Washout Period of 7 Days||1
446342|NCT00658541|1064465|P2|COMPLETED|Washout Period of 7 Days||17
446343|NCT00658541|1064466|P1|COMPLETED|Washout Period of 7 Days||18
446344|NCT00658541|1064465|P2|STARTED|Washout Period of 7 Days||19
446345|NCT00658541|1064466|P1|STARTED|Washout Period of 7 Days||19
446346|NCT00658541|1064465|P2|NOT COMPLETED|First Intervention||0
446347|NCT00658541|1064466|P1|NOT COMPLETED|First Intervention||0
446348|NCT00658541|1064465|P2|COMPLETED|First Intervention||19
446349|NCT00658541|1064466|P1|COMPLETED|First Intervention||19
446350|NCT00658541|1064465|P2|STARTED|First Intervention||19
446351|NCT00658541|1064466|P1|STARTED|First Intervention||19
446352|NCT00658528|1064478|P2|NOT COMPLETED|Overall Study||45
446353|NCT00658528|1064479|P1|NOT COMPLETED|Overall Study||40
446354|NCT00658528|1064478|P2|COMPLETED|Overall Study||479
446355|NCT00658528|1064479|P1|COMPLETED|Overall Study||491
446356|NCT00658528|1064478|P2|STARTED|Overall Study|Treated|524
446357|NCT00658528|1064479|P1|STARTED|Overall Study|Treated|531
446358|NCT00658411|1064489|P1|NOT COMPLETED|Overall Study||0
446359|NCT00658411|1064489|P1|COMPLETED|Overall Study||5
446360|NCT00658411|1064489|P1|STARTED|Overall Study||5
446361|NCT00658385|1064497|P1|NOT COMPLETED|Overall Study||0
446362|NCT00658385|1064497|P1|COMPLETED|Overall Study||5
446363|NCT00658385|1064497|P1|STARTED|Overall Study||5
446364|NCT00658333|1064503|P2|NOT COMPLETED|Overall Study||1
446365|NCT00658333|1064504|P1|NOT COMPLETED|Overall Study||2
446366|NCT00658333|1064503|P2|COMPLETED|Overall Study||14
446367|NCT00658333|1064504|P1|COMPLETED|Overall Study||13
446368|NCT00658333|1064503|P2|STARTED|Overall Study||15
446369|NCT00658333|1064504|P1|STARTED|Overall Study||15
446370|NCT00658320|1064514|P2|NOT COMPLETED|Extension Study: After Month 24||0
446371|NCT00658320|1064515|P1|NOT COMPLETED|Extension Study: After Month 24||2
446372|NCT00658320|1064514|P2|COMPLETED|Extension Study: After Month 24||0
446373|NCT00658320|1064515|P1|COMPLETED|Extension Study: After Month 24||42
446374|NCT00658320|1064514|P2|STARTED|Extension Study: After Month 24||0
446375|NCT00658320|1064515|P1|STARTED|Extension Study: After Month 24||44
446376|NCT00658320|1064514|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
446377|NCT00658320|1064515|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
446378|NCT00658320|1064514|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
446379|NCT00658320|1064515|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
446380|NCT00658320|1064514|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
446381|NCT00658320|1064515|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
446382|NCT00658320|1064514|P2|STARTED|Extension Study: Month 12 to Month 24||57
446383|NCT00658320|1064515|P1|STARTED|Extension Study: Month 12 to Month 24||53
446384|NCT00658320|1064514|P2|NOT COMPLETED|Core Study: 12 Months||3
446385|NCT00658320|1064515|P1|NOT COMPLETED|Core Study: 12 Months||5
446386|NCT00658320|1064514|P2|COMPLETED|Core Study: 12 Months||58
446387|NCT00658320|1064515|P1|COMPLETED|Core Study: 12 Months||56
446388|NCT00658320|1064514|P2|STARTED|Core Study: 12 Months||61
446389|NCT00658320|1064515|P1|STARTED|Core Study: 12 Months||61
446390|NCT00658138|1064538|P1|NOT COMPLETED|Overall Study||21
446391|NCT00658138|1064538|P1|COMPLETED|Overall Study||40
446392|NCT00658138|1064538|P1|STARTED|Overall Study||61
446393|NCT00658112|1064543|P1|NOT COMPLETED|Overall Study||9
446394|NCT00658112|1064543|P1|COMPLETED|Overall Study||11
446395|NCT00658112|1064543|P1|STARTED|Overall Study||20
446396|NCT00657709|1064552|P5|NOT COMPLETED|Overall Study||33
446397|NCT00657709|1064553|P4|NOT COMPLETED|Overall Study||14
446398|NCT00657709|1064554|P3|NOT COMPLETED|Overall Study||28
446399|NCT00657709|1064555|P2|NOT COMPLETED|Overall Study||33
446400|NCT00657709|1064556|P1|NOT COMPLETED|Overall Study||23
446401|NCT00657709|1064552|P5|COMPLETED|Overall Study||457
446402|NCT00657709|1064553|P4|COMPLETED|Overall Study||645
446403|NCT00657709|1064554|P3|COMPLETED|Overall Study||792
446404|NCT00657709|1064555|P2|COMPLETED|Overall Study||795
446405|NCT00657709|1064556|P1|COMPLETED|Overall Study||810
446406|NCT00657709|1064552|P5|STARTED|Overall Study||490
446407|NCT00657709|1064553|P4|STARTED|Overall Study||659
446408|NCT00657709|1064554|P3|STARTED|Overall Study||820
446409|NCT00657709|1064555|P2|STARTED|Overall Study||828
446410|NCT00657709|1064556|P1|STARTED|Overall Study||833
446411|NCT00657657|1064597|P1|NOT COMPLETED|Overall Study||0
446412|NCT00657657|1064597|P1|COMPLETED|Overall Study||29
446413|NCT00657657|1064597|P1|STARTED|Overall Study||29
446414|NCT00657553|1064607|P2|NOT COMPLETED|Overall Study||5
446415|NCT00657553|1064608|P1|NOT COMPLETED|Overall Study||5
446416|NCT00657553|1064607|P2|COMPLETED|Overall Study||0
446417|NCT00657553|1064608|P1|COMPLETED|Overall Study||0
446418|NCT00657553|1064607|P2|STARTED|Overall Study||5
446419|NCT00657553|1064608|P1|STARTED|Overall Study||5
446420|NCT00657371|1064614|P1|NOT COMPLETED|Overall Study||39
446421|NCT00657371|1064614|P1|COMPLETED|Overall Study||249
446422|NCT00657371|1064614|P1|STARTED|Overall Study||288
446423|NCT00657358|1064619|P1|NOT COMPLETED|Overall Study||6
446424|NCT00657358|1064619|P1|COMPLETED|Overall Study||16
446425|NCT00657358|1064619|P1|STARTED|Overall Study||22
446426|NCT00657280|1064627|P1|NOT COMPLETED|Overall Study||0
446427|NCT00657280|1064627|P1|COMPLETED|Overall Study||16
446428|NCT00657280|1064627|P1|STARTED|Overall Study||16
446429|NCT00657267|1064631|P1|NOT COMPLETED|Overall Study||54
446430|NCT00657267|1064631|P1|COMPLETED|Overall Study||4
446431|NCT00657267|1064631|P1|STARTED|Overall Study||58
446432|NCT00657150|1064641|P2|NOT COMPLETED|Treatment||97
446433|NCT00657150|1064642|P1|NOT COMPLETED|Treatment||107
446434|NCT00657150|1064641|P2|COMPLETED|Treatment||906
446435|NCT00657150|1064642|P1|COMPLETED|Treatment||903
446436|NCT00657150|1064641|P2|STARTED|Treatment||1003
446437|NCT00657150|1064642|P1|STARTED|Treatment||1010
446438|NCT00657150|1064641|P2|NOT COMPLETED|Overall Study||93
446439|NCT00657150|1064642|P1|NOT COMPLETED|Overall Study||115
446440|NCT00657150|1064641|P2|COMPLETED|Overall Study||910
446441|NCT00657150|1064642|P1|COMPLETED|Overall Study||895
446442|NCT00657150|1064641|P2|STARTED|Overall Study||1003
446443|NCT00657150|1064642|P1|STARTED|Overall Study||1010
446444|NCT00657046|1064673|P3|NOT COMPLETED|Overall Study||2
446445|NCT00657046|1064674|P2|NOT COMPLETED|Overall Study||3
446446|NCT00657046|1064675|P1|NOT COMPLETED|Overall Study||4
446447|NCT00657046|1064673|P3|COMPLETED|Overall Study||21
446448|NCT00657046|1064674|P2|COMPLETED|Overall Study||29
446449|NCT00657046|1064675|P1|COMPLETED|Overall Study||26
446450|NCT00657046|1064673|P3|Had Visits up to Visit 18|Overall Study||23
446451|NCT00657046|1064674|P2|Had Visits up to Visit 18|Overall Study||30
446452|NCT00657046|1064675|P1|Had Visits up to Visit 18|Overall Study||28
446453|NCT00657046|1064673|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
446454|NCT00657046|1064674|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
446455|NCT00657046|1064675|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
446456|NCT00657046|1064673|P3|STARTED|Overall Study||23
446457|NCT00657046|1064674|P2|STARTED|Overall Study||32
446458|NCT00657046|1064675|P1|STARTED|Overall Study||30
446459|NCT00657020|1064707|P2|NOT COMPLETED|PERIOD 2||0
446460|NCT00657020|1064708|P1|NOT COMPLETED|PERIOD 2||0
446461|NCT00657020|1064707|P2|COMPLETED|PERIOD 2||11
446462|NCT00657020|1064708|P1|COMPLETED|PERIOD 2||11
446463|NCT00657020|1064707|P2|STARTED|PERIOD 2||11
446464|NCT00657020|1064708|P1|STARTED|PERIOD 2||11
446465|NCT00657020|1064707|P2|NOT COMPLETED|PERIOD 1||1
446466|NCT00657020|1064708|P1|NOT COMPLETED|PERIOD 1||0
446467|NCT00657020|1064707|P2|COMPLETED|PERIOD 1||11
446468|NCT00657020|1064708|P1|COMPLETED|PERIOD 1||11
446469|NCT00657020|1064707|P2|STARTED|PERIOD 1||12
446470|NCT00657020|1064708|P1|STARTED|PERIOD 1||11
446471|NCT00656968|1064738|P2|NOT COMPLETED|Overall Study||0
446472|NCT00656968|1064739|P1|NOT COMPLETED|Overall Study||0
446473|NCT00656968|1064738|P2|COMPLETED|Overall Study||117
446474|NCT00656968|1064739|P1|COMPLETED|Overall Study||115
446475|NCT00656968|1064738|P2|STARTED|Overall Study||117
446476|NCT00656968|1064739|P1|STARTED|Overall Study||115
446477|NCT00656916|1064749|P2|NOT COMPLETED|Overall Study||0
446478|NCT00656916|1064750|P1|NOT COMPLETED|Overall Study||0
446479|NCT00656916|1064749|P2|COMPLETED|Overall Study||0
446480|NCT00656916|1064750|P1|COMPLETED|Overall Study||1
446481|NCT00656916|1064749|P2|STARTED|Overall Study||0
446482|NCT00656916|1064750|P1|STARTED|Overall Study||1
446483|NCT00656851|1064758|P2|NOT COMPLETED|Overall Study||4
446484|NCT00656851|1064759|P1|NOT COMPLETED|Overall Study||0
446485|NCT00656851|1064758|P2|COMPLETED|Overall Study||8
446486|NCT00656851|1064759|P1|COMPLETED|Overall Study||12
446487|NCT00656851|1064758|P2|STARTED|Overall Study||12
446488|NCT00656851|1064759|P1|STARTED|Overall Study||12
446489|NCT00656799|1064781|P1|NOT COMPLETED|Overall Study||2
446490|NCT00656799|1064781|P1|COMPLETED|Overall Study||4
446491|NCT00656799|1064781|P1|STARTED|Overall Study||6
446492|NCT00656669|1064803|P1|NOT COMPLETED|AC (Cycles 6-9)||2
446493|NCT00656669|1064803|P1|COMPLETED|AC (Cycles 6-9)||15
446494|NCT00656669|1064803|P1|STARTED|AC (Cycles 6-9)||17
446495|NCT00656669|1064803|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
446496|NCT00656669|1064803|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
446497|NCT00656669|1064803|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
446498|NCT00656669|1064803|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
446499|NCT00656669|1064803|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
446500|NCT00656669|1064803|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
446501|NCT00656656|1064812|P1|NOT COMPLETED|Overall Study||0
446502|NCT00656656|1064812|P1|COMPLETED|Overall Study||23
446503|NCT00656656|1064812|P1|STARTED|Overall Study||23
446504|NCT00656630|1064820|P3|NOT COMPLETED|Overall Study||2
446505|NCT00656630|1064821|P2|NOT COMPLETED|Overall Study||2
446506|NCT00656630|1064822|P1|NOT COMPLETED|Overall Study||2
446507|NCT00656630|1064820|P3|COMPLETED|Overall Study||17
446508|NCT00656630|1064821|P2|COMPLETED|Overall Study||25
446509|NCT00656630|1064822|P1|COMPLETED|Overall Study||20
446510|NCT00656630|1064820|P3|STARTED|Overall Study||19
446511|NCT00656630|1064821|P2|STARTED|Overall Study||27
446512|NCT00656630|1064822|P1|STARTED|Overall Study||22
446513|NCT00656617|1064842|P1|NOT COMPLETED|Overall Study||7
446514|NCT00656617|1064842|P1|COMPLETED|Overall Study||99
446515|NCT00656617|1064842|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
446516|NCT00656617|1064842|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
446517|NCT00656617|1064842|P1|STARTED|Overall Study||106
446518|NCT00656487|1064851|P3|NOT COMPLETED|Overall Study||0
446519|NCT00656487|1064852|P2|NOT COMPLETED|Overall Study||4
446520|NCT00656487|1064853|P1|NOT COMPLETED|Overall Study||2
446521|NCT00656487|1064851|P3|COMPLETED|Overall Study||20
446522|NCT00656487|1064852|P2|COMPLETED|Overall Study||19
446523|NCT00656487|1064853|P1|COMPLETED|Overall Study||21
446524|NCT00656487|1064851|P3|STARTED|Overall Study||20
446525|NCT00656487|1064852|P2|STARTED|Overall Study||23
446526|NCT00656487|1064853|P1|STARTED|Overall Study||23
446527|NCT00656474|1064876|P1|NOT COMPLETED|Overall Study||1
446528|NCT00656474|1064876|P1|COMPLETED|Overall Study||11
446529|NCT00656474|1064876|P1|STARTED|Overall Study||12
446530|NCT00656448|1064885|P2|NOT COMPLETED|Overall Study||0
446531|NCT00656448|1064886|P1|NOT COMPLETED|Overall Study||0
446532|NCT00656448|1064885|P2|COMPLETED|Overall Study||25
446533|NCT00656448|1064886|P1|COMPLETED|Overall Study||25
446534|NCT00656448|1064885|P2|STARTED|Overall Study||25
446535|NCT00656448|1064886|P1|STARTED|Overall Study||25
446536|NCT00656370|1064894|P1|NOT COMPLETED|Overall Study||10
446537|NCT00656370|1064894|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1.|15
446538|NCT00656370|1064894|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
446539|NCT00656292|1064902|P2|NOT COMPLETED|Overall Study||5
446540|NCT00656292|1064903|P1|NOT COMPLETED|Overall Study||3
446541|NCT00656292|1064902|P2|COMPLETED|Overall Study||24
446542|NCT00656292|1064903|P1|COMPLETED|Overall Study||29
446543|NCT00656292|1064902|P2|STARTED|Overall Study||29
446544|NCT00656292|1064903|P1|STARTED|Overall Study||32
446545|NCT00656201|1064921|P2|NOT COMPLETED|Overall Study||32
446546|NCT00656201|1064922|P1|NOT COMPLETED|Overall Study||29
446547|NCT00656201|1064921|P2|COMPLETED|Overall Study||201
446548|NCT00656201|1064922|P1|COMPLETED|Overall Study||206
446549|NCT00656201|1064921|P2|STARTED|Overall Study||233
446550|NCT00656201|1064922|P1|STARTED|Overall Study||235
446551|NCT00656175|1064930|P2|NOT COMPLETED|Overall Study||1
446552|NCT00656175|1064931|P1|NOT COMPLETED|Overall Study||1
446553|NCT00656175|1064930|P2|COMPLETED|Overall Study||20
446554|NCT00656175|1064931|P1|COMPLETED|Overall Study||17
446555|NCT00656175|1064930|P2|STARTED|Overall Study||21
446556|NCT00656175|1064931|P1|STARTED|Overall Study||18
446557|NCT00656136|1064939|P2|NOT COMPLETED|Overall Study||390
446558|NCT00656136|1064940|P1|NOT COMPLETED|Overall Study||195
446559|NCT00656136|1064939|P2|COMPLETED|Overall Study||0
446560|NCT00656136|1064940|P1|COMPLETED|Overall Study||0
446561|NCT00656136|1064939|P2|STARTED|Overall Study|Randomised patients.|390
446562|NCT00656136|1064940|P1|STARTED|Overall Study|Randomised patients.|195
446563|NCT00656084|1064950|P1|NOT COMPLETED|Overall Study||7
446564|NCT00656084|1064950|P1|COMPLETED|Overall Study||9
446565|NCT00656084|1064950|P1|STARTED|Overall Study||16
446566|NCT00656058|1064957|P1|NOT COMPLETED|Overall Study||6
446567|NCT00656058|1064957|P1|COMPLETED|Overall Study||19
446568|NCT00656058|1064957|P1|STARTED|Overall Study||25
446569|NCT00655889|1064966|P1|NOT COMPLETED|Overall Study||2
446570|NCT00655889|1064966|P1|COMPLETED|Overall Study||11
446571|NCT00655889|1064966|P1|STARTED|Overall Study||13
446572|NCT00655863|1064974|P3|NOT COMPLETED|Overall Study||1
446573|NCT00655863|1064975|P2|NOT COMPLETED|Overall Study||0
446574|NCT00655863|1064976|P1|NOT COMPLETED|Overall Study||0
446575|NCT00655863|1064974|P3|COMPLETED|Overall Study||21
446576|NCT00655863|1064975|P2|COMPLETED|Overall Study||25
446577|NCT00655863|1064976|P1|COMPLETED|Overall Study||24
446578|NCT00655863|1064974|P3|STARTED|Overall Study||22
446579|NCT00655863|1064975|P2|STARTED|Overall Study||25
446580|NCT00655863|1064976|P1|STARTED|Overall Study||24
446581|NCT00655850|1065035|P1|NOT COMPLETED|Overall Study||3
446582|NCT00655850|1065035|P1|COMPLETED|Overall Study||36
446583|NCT00655850|1065035|P1|STARTED|Overall Study||39
446584|NCT00655824|1065042|P1|NOT COMPLETED|Follow-up (FU) Period||66
446585|NCT00655824|1065042|P1|COMPLETED|Follow-up (FU) Period||13
446586|NCT00655824|1065042|P1|STARTED|Follow-up (FU) Period|A participant who withdrew from the Treatment Phase could still enter the Follow-up Phase.|79
446587|NCT00655824|1065042|P1|NOT COMPLETED|Treatment Period||84
446588|NCT00655824|1065042|P1|COMPLETED|Treatment Period||8
446589|NCT00655824|1065042|P1|STARTED|Treatment Period||92
446590|NCT00655746|1065086|P1|NOT COMPLETED|Overall Study||1
446591|NCT00655746|1065086|P1|COMPLETED|Overall Study||13
446592|NCT00655746|1065086|P1|STARTED|Overall Study||14
446593|NCT00655733|1065105|P2|NOT COMPLETED|Overall Study||8
446594|NCT00655733|1065106|P1|NOT COMPLETED|Overall Study||7
446595|NCT00655733|1065105|P2|COMPLETED|Overall Study||42
446596|NCT00655733|1065106|P1|COMPLETED|Overall Study||44
446597|NCT00655733|1065105|P2|STARTED|Overall Study||50
446598|NCT00655733|1065106|P1|STARTED|Overall Study||51
446599|NCT00655668|1065112|P1|NOT COMPLETED|Overall Study||54
446600|NCT00655668|1065112|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
446601|NCT00655668|1065112|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
446602|NCT00655642|1065124|P4|NOT COMPLETED|Overall Study||2
446603|NCT00655642|1065125|P3|NOT COMPLETED|Overall Study||2
446604|NCT00655642|1065126|P2|NOT COMPLETED|Overall Study||3
446605|NCT00655642|1065127|P1|NOT COMPLETED|Overall Study||1
446606|NCT00655642|1065124|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
446607|NCT00655642|1065125|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
446608|NCT00655642|1065126|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
446609|NCT00655642|1065127|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
446610|NCT00655642|1065124|P4|STARTED|Overall Study||41
446611|NCT00655642|1065125|P3|STARTED|Overall Study||45
446612|NCT00655642|1065126|P2|STARTED|Overall Study||43
446613|NCT00655642|1065127|P1|STARTED|Overall Study||42
446614|NCT00655629|1065139|P2|NOT COMPLETED|Overall Study||23
446615|NCT00655629|1065140|P1|NOT COMPLETED|Overall Study||21
446616|NCT00655629|1065139|P2|COMPLETED|Overall Study||144
446617|NCT00655629|1065140|P1|COMPLETED|Overall Study||151
446618|NCT00655629|1065139|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
446619|NCT00655629|1065140|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
446620|NCT00655629|1065139|P2|STARTED|Overall Study||167
446621|NCT00655629|1065140|P1|STARTED|Overall Study||172
446622|NCT00655564|1065176|P1|NOT COMPLETED|Overall Study||3
446623|NCT00655564|1065176|P1|COMPLETED|Overall Study||12
446624|NCT00655564|1065176|P1|STARTED|Overall Study||15
446625|NCT00655551|1065184|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
446626|NCT00655551|1065185|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
446627|NCT00655551|1065186|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
446628|NCT00655551|1065184|P3|COMPLETED|Period 4 (up to 7 Days)||0
446629|NCT00655551|1065185|P2|COMPLETED|Period 4 (up to 7 Days)||23
446630|NCT00655551|1065186|P1|COMPLETED|Period 4 (up to 7 Days)||0
446631|NCT00655551|1065184|P3|STARTED|Period 4 (up to 7 Days)||0
446632|NCT00655551|1065185|P2|STARTED|Period 4 (up to 7 Days)||25
446633|NCT00655551|1065186|P1|STARTED|Period 4 (up to 7 Days)||0
446634|NCT00655551|1065184|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
446635|NCT00655551|1065185|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
446636|NCT00655551|1065186|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
446637|NCT00655551|1065184|P3|COMPLETED|Period 3 (up to 7 Days)||21
446638|NCT00655551|1065185|P2|COMPLETED|Period 3 (up to 7 Days)||0
446639|NCT00655551|1065186|P1|COMPLETED|Period 3 (up to 7 Days)||0
446640|NCT00655551|1065184|P3|STARTED|Period 3 (up to 7 Days)||25
446641|NCT00655551|1065185|P2|STARTED|Period 3 (up to 7 Days)||0
446642|NCT00655551|1065186|P1|STARTED|Period 3 (up to 7 Days)||0
446643|NCT00655551|1065184|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
446644|NCT00655551|1065185|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
446645|NCT00655551|1065186|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
446646|NCT00655551|1065184|P3|COMPLETED|Period 2 (up to 7 Days)||0
446647|NCT00655551|1065185|P2|COMPLETED|Period 2 (up to 7 Days)||24
446648|NCT00655551|1065186|P1|COMPLETED|Period 2 (up to 7 Days)||0
446649|NCT00655551|1065184|P3|STARTED|Period 2 (up to 7 Days)||0
446650|NCT00655551|1065185|P2|STARTED|Period 2 (up to 7 Days)||25
446651|NCT00655551|1065186|P1|STARTED|Period 2 (up to 7 Days)||0
446652|NCT00655551|1065184|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
446653|NCT00655551|1065185|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
446654|NCT00655551|1065186|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
446655|NCT00655551|1065184|P3|COMPLETED|Period 1 (up to 7 Days)||0
446656|NCT00655551|1065185|P2|COMPLETED|Period 1 (up to 7 Days)||0
446657|NCT00655551|1065186|P1|COMPLETED|Period 1 (up to 7 Days)||25
446658|NCT00655551|1065184|P3|STARTED|Period 1 (up to 7 Days)||0
446659|NCT00655551|1065185|P2|STARTED|Period 1 (up to 7 Days)||0
446660|NCT00655551|1065186|P1|STARTED|Period 1 (up to 7 Days)||25
446661|NCT00655551|1065184|P3|NOT COMPLETED|All Periods Combined||4
446662|NCT00655551|1065185|P2|NOT COMPLETED|All Periods Combined||3
446663|NCT00655551|1065186|P1|NOT COMPLETED|All Periods Combined||0
446664|NCT00655551|1065184|P3|COMPLETED|All Periods Combined||21
446665|NCT00655551|1065185|P2|COMPLETED|All Periods Combined||47
446666|NCT00655551|1065186|P1|COMPLETED|All Periods Combined||25
446667|NCT00655551|1065184|P3|STARTED|All Periods Combined||25
446668|NCT00655551|1065185|P2|STARTED|All Periods Combined||50
446669|NCT00655551|1065186|P1|STARTED|All Periods Combined||25
446670|NCT00655486|1065200|P1|NOT COMPLETED|Overall Study||28
446671|NCT00655486|1065200|P1|COMPLETED|Overall Study||69
446672|NCT00655486|1065200|P1|STARTED|Overall Study||97
446673|NCT00655356|1065207|P2|NOT COMPLETED|Overall Study||10
446674|NCT00655356|1065208|P1|NOT COMPLETED|Overall Study||17
446675|NCT00655356|1065207|P2|COMPLETED|Overall Study||98
446676|NCT00655356|1065208|P1|COMPLETED|Overall Study||93
446677|NCT00655356|1065207|P2|STARTED|Overall Study||108
446678|NCT00655356|1065208|P1|STARTED|Overall Study||110
446679|NCT00655083|1065222|P2|NOT COMPLETED|Overall Study||0
446680|NCT00655083|1065223|P1|NOT COMPLETED|Overall Study||0
446681|NCT00655083|1065222|P2|COMPLETED|Overall Study||8
446682|NCT00655083|1065223|P1|COMPLETED|Overall Study||12
446683|NCT00655083|1065222|P2|STARTED|Overall Study||8
446684|NCT00655083|1065223|P1|STARTED|Overall Study||12
446685|NCT00654992|1065237|P2|NOT COMPLETED|Overall Study||0
446686|NCT00654992|1065238|P1|NOT COMPLETED|Overall Study||0
446687|NCT00654992|1065237|P2|COMPLETED|Overall Study||35
446688|NCT00654992|1065238|P1|COMPLETED|Overall Study||36
446689|NCT00654992|1065237|P2|STARTED|Overall Study||35
446690|NCT00654992|1065238|P1|STARTED|Overall Study||36
446691|NCT00654953|1065247|P3|NOT COMPLETED|Overall Study||22
446692|NCT00654953|1065248|P2|NOT COMPLETED|Overall Study||28
446693|NCT00654953|1065249|P1|NOT COMPLETED|Overall Study||30
446694|NCT00654953|1065247|P3|COMPLETED|Overall Study||8
446695|NCT00654953|1065248|P2|COMPLETED|Overall Study||8
446696|NCT00654953|1065249|P1|COMPLETED|Overall Study||6
446697|NCT00654953|1065247|P3|STARTED|Overall Study||30
446698|NCT00654953|1065248|P2|STARTED|Overall Study||36
446699|NCT00654953|1065249|P1|STARTED|Overall Study||36
446700|NCT00654940|1065259|P2|NOT COMPLETED|Period 2||0
446701|NCT00654940|1065260|P1|NOT COMPLETED|Period 2||0
446702|NCT00654940|1065259|P2|COMPLETED|Period 2||11
446703|NCT00654940|1065260|P1|COMPLETED|Period 2||12
446704|NCT00654940|1065259|P2|STARTED|Period 2||11
446705|NCT00654940|1065260|P1|STARTED|Period 2||12
446706|NCT00654940|1065259|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
446707|NCT00654940|1065260|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
446708|NCT00654940|1065259|P2|COMPLETED|Washout Period of 2 Weeks||11
446709|NCT00654940|1065260|P1|COMPLETED|Washout Period of 2 Weeks||12
446710|NCT00654940|1065259|P2|STARTED|Washout Period of 2 Weeks||11
446711|NCT00654940|1065260|P1|STARTED|Washout Period of 2 Weeks||12
446712|NCT00654940|1065259|P2|NOT COMPLETED|Period 1||1
446713|NCT00654940|1065260|P1|NOT COMPLETED|Period 1||1
446714|NCT00654940|1065259|P2|COMPLETED|Period 1||11
446715|NCT00654940|1065260|P1|COMPLETED|Period 1||12
446716|NCT00654940|1065259|P2|Received Study Treatment|Period 1||12
446717|NCT00654940|1065260|P1|Received Study Treatment|Period 1||12
446718|NCT00654940|1065259|P2|STARTED|Period 1|Assigned to study treatment.|12
446719|NCT00654940|1065260|P1|STARTED|Period 1|Assigned to study treatment.|13
446720|NCT00654927|1065272|P1|NOT COMPLETED|Overall Study||107
446721|NCT00654927|1065272|P1|COMPLETED|Overall Study||70
446722|NCT00654927|1065272|P1|STARTED|Overall Study||177
446723|NCT00654901|1065284|P4|NOT COMPLETED|Overall Study||0
446724|NCT00654901|1065285|P3|NOT COMPLETED|Overall Study||2
446725|NCT00654901|1065286|P2|NOT COMPLETED|Overall Study||0
446726|NCT00654901|1065287|P1|NOT COMPLETED|Overall Study||4
446727|NCT00654901|1065284|P4|COMPLETED|Overall Study||113
446728|NCT00654901|1065285|P3|COMPLETED|Overall Study||250
446729|NCT00654901|1065286|P2|COMPLETED|Overall Study||262
446730|NCT00654901|1065287|P1|COMPLETED|Overall Study||250
446731|NCT00654901|1065284|P4|STARTED|Overall Study||113
446732|NCT00654901|1065285|P3|STARTED|Overall Study||252
446733|NCT00654901|1065286|P2|STARTED|Overall Study||262
446734|NCT00654901|1065287|P1|STARTED|Overall Study||254
446735|NCT00654875|1065307|P2|NOT COMPLETED|Overall Study||17
446736|NCT00654875|1065308|P1|NOT COMPLETED|Overall Study||17
446737|NCT00654875|1065307|P2|COMPLETED|Overall Study||147
446738|NCT00654875|1065308|P1|COMPLETED|Overall Study||147
446739|NCT00654875|1065307|P2|STARTED|Overall Study||164
446740|NCT00654875|1065308|P1|STARTED|Overall Study||164
446741|NCT00654784|1065328|P2|NOT COMPLETED|Overall Study||0
446742|NCT00654784|1065329|P1|NOT COMPLETED|Overall Study||0
446743|NCT00654784|1065328|P2|COMPLETED|Overall Study||8
446744|NCT00654784|1065329|P1|COMPLETED|Overall Study||13
446745|NCT00654784|1065328|P2|STARTED|Overall Study||8
446746|NCT00654784|1065329|P1|STARTED|Overall Study||13
446747|NCT00654745|1065335|P1|NOT COMPLETED|Overall Study||43
446748|NCT00654745|1065335|P1|COMPLETED|Overall Study||164
446749|NCT00654745|1065335|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
446750|NCT00654654|1065373|P1|NOT COMPLETED|Overall Study||7
446751|NCT00654654|1065373|P1|COMPLETED|Overall Study||43
446752|NCT00654654|1065373|P1|STARTED|Overall Study||50
446753|NCT00654641|1065380|P2|NOT COMPLETED|Overall Study||3
446754|NCT00654641|1065381|P1|NOT COMPLETED|Overall Study||2
446755|NCT00654641|1065380|P2|COMPLETED|Overall Study||23
446756|NCT00654641|1065381|P1|COMPLETED|Overall Study||26
446757|NCT00654641|1065380|P2|STARTED|Overall Study||26
446758|NCT00654641|1065381|P1|STARTED|Overall Study||28
446759|NCT00654628|1065387|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
446760|NCT00654628|1065387|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
446761|NCT00654628|1065387|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
446762|NCT00654628|1065387|P1|NOT COMPLETED|6-week Active Treatment Period||21
446763|NCT00654628|1065387|P1|COMPLETED|6-week Active Treatment Period||152
446764|NCT00654628|1065387|P1|STARTED|6-week Active Treatment Period||173
446765|NCT00654511|1065406|P4|NOT COMPLETED|Overall Study||0
446766|NCT00654511|1065407|P3|NOT COMPLETED|Overall Study||0
446767|NCT00654511|1065408|P2|NOT COMPLETED|Overall Study||0
446768|NCT00654511|1065409|P1|NOT COMPLETED|Overall Study||0
446769|NCT00654511|1065406|P4|COMPLETED|Overall Study||25
446770|NCT00654511|1065407|P3|COMPLETED|Overall Study||25
446771|NCT00654511|1065408|P2|COMPLETED|Overall Study||25
446772|NCT00654511|1065409|P1|COMPLETED|Overall Study||26
446773|NCT00654511|1065406|P4|STARTED|Overall Study||25
446774|NCT00654511|1065407|P3|STARTED|Overall Study||25
446775|NCT00654511|1065408|P2|STARTED|Overall Study||25
446776|NCT00654511|1065409|P1|STARTED|Overall Study||26
446777|NCT00654498|1065425|P2|NOT COMPLETED|Overall Study||12
446778|NCT00654498|1065426|P1|NOT COMPLETED|Overall Study||14
446779|NCT00654498|1065425|P2|COMPLETED|Overall Study||91
446780|NCT00654498|1065426|P1|COMPLETED|Overall Study||189
446781|NCT00654498|1065425|P2|STARTED|Overall Study||103
446782|NCT00654498|1065426|P1|STARTED|Overall Study||203
446783|NCT00654420|1065458|P4|NOT COMPLETED|Phase II||38
446784|NCT00654420|1065459|P3|NOT COMPLETED|Phase II||37
446785|NCT00654420|1065460|P2|NOT COMPLETED|Phase II||0
446786|NCT00654420|1065461|P1|NOT COMPLETED|Phase II||0
446787|NCT00654420|1065458|P4|COMPLETED|Phase II||0
446788|NCT00654420|1065459|P3|COMPLETED|Phase II||0
446789|NCT00654420|1065460|P2|COMPLETED|Phase II||0
446790|NCT00654420|1065461|P1|COMPLETED|Phase II||0
446791|NCT00654420|1065458|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
446792|NCT00654420|1065459|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
446793|NCT00654420|1065460|P2|STARTED|Phase II||0
446794|NCT00654420|1065461|P1|STARTED|Phase II||0
446795|NCT00654420|1065458|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
446796|NCT00654420|1065459|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
446797|NCT00654420|1065460|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
446798|NCT00654420|1065461|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
446799|NCT00654420|1065458|P4|COMPLETED|Phase I (Dose Escalation)||0
446800|NCT00654420|1065459|P3|COMPLETED|Phase I (Dose Escalation)||0
446801|NCT00654420|1065460|P2|COMPLETED|Phase I (Dose Escalation)||0
446802|NCT00654420|1065461|P1|COMPLETED|Phase I (Dose Escalation)||0
446803|NCT00654420|1065458|P4|STARTED|Phase I (Dose Escalation)||0
446804|NCT00654420|1065459|P3|STARTED|Phase I (Dose Escalation)||0
446805|NCT00654420|1065460|P2|STARTED|Phase I (Dose Escalation)||16
446806|NCT00654420|1065461|P1|STARTED|Phase I (Dose Escalation)||4
446807|NCT00654381|1065487|P6|NOT COMPLETED|Extension Stage||3
446808|NCT00654381|1065488|P5|NOT COMPLETED|Extension Stage||3
446809|NCT00654381|1065489|P4|NOT COMPLETED|Extension Stage||9
446810|NCT00654381|1065490|P3|NOT COMPLETED|Extension Stage||11
446811|NCT00654381|1065491|P2|NOT COMPLETED|Extension Stage||2
446812|NCT00654381|1065492|P1|NOT COMPLETED|Extension Stage||1
446813|NCT00654381|1065487|P6|COMPLETED|Extension Stage||73
446814|NCT00654381|1065488|P5|COMPLETED|Extension Stage||68
446815|NCT00654381|1065489|P4|COMPLETED|Extension Stage||142
446816|NCT00654381|1065490|P3|COMPLETED|Extension Stage||142
446817|NCT00654381|1065491|P2|COMPLETED|Extension Stage||36
446818|NCT00654381|1065492|P1|COMPLETED|Extension Stage||33
446819|NCT00654381|1065487|P6|STARTED|Extension Stage||76
446820|NCT00654381|1065488|P5|STARTED|Extension Stage||71
446821|NCT00654381|1065489|P4|STARTED|Extension Stage||151
446822|NCT00654381|1065490|P3|STARTED|Extension Stage||153
446823|NCT00654381|1065491|P2|STARTED|Extension Stage||38
446824|NCT00654381|1065492|P1|STARTED|Extension Stage||34
446825|NCT00654381|1065487|P6|NOT COMPLETED|2nd Stage||3
446826|NCT00654381|1065488|P5|NOT COMPLETED|2nd Stage||8
446827|NCT00654381|1065489|P4|NOT COMPLETED|2nd Stage||4
446828|NCT00654381|1065490|P3|NOT COMPLETED|2nd Stage||3
446829|NCT00654381|1065491|P2|NOT COMPLETED|2nd Stage||0
446830|NCT00654381|1065492|P1|NOT COMPLETED|2nd Stage||2
446831|NCT00654381|1065487|P6|COMPLETED|2nd Stage||76
446832|NCT00654381|1065488|P5|COMPLETED|2nd Stage||71
446833|NCT00654381|1065489|P4|COMPLETED|2nd Stage||151
446834|NCT00654381|1065490|P3|COMPLETED|2nd Stage||153
446835|NCT00654381|1065491|P2|COMPLETED|2nd Stage||38
446836|NCT00654381|1065492|P1|COMPLETED|2nd Stage||34
446837|NCT00654381|1065487|P6|STARTED|2nd Stage||79
446838|NCT00654381|1065488|P5|STARTED|2nd Stage||79
446839|NCT00654381|1065489|P4|STARTED|2nd Stage||155
446840|NCT00654381|1065490|P3|STARTED|2nd Stage||156
446841|NCT00654381|1065491|P2|STARTED|2nd Stage||38
446842|NCT00654381|1065492|P1|STARTED|2nd Stage||36
446843|NCT00654381|1065487|P6|NOT COMPLETED|1st Stage||2
446844|NCT00654381|1065488|P5|NOT COMPLETED|1st Stage||2
446845|NCT00654381|1065489|P4|NOT COMPLETED|1st Stage||5
446846|NCT00654381|1065490|P3|NOT COMPLETED|1st Stage||3
446847|NCT00654381|1065491|P2|NOT COMPLETED|1st Stage||3
446848|NCT00654381|1065492|P1|NOT COMPLETED|1st Stage||3
446849|NCT00654381|1065487|P6|COMPLETED|1st Stage||79
446850|NCT00654381|1065488|P5|COMPLETED|1st Stage||79
446851|NCT00654381|1065489|P4|COMPLETED|1st Stage||155
446852|NCT00654381|1065490|P3|COMPLETED|1st Stage||156
446853|NCT00654381|1065491|P2|COMPLETED|1st Stage||38
446854|NCT00654381|1065492|P1|COMPLETED|1st Stage||36
446855|NCT00654381|1065487|P6|STARTED|1st Stage||81
446856|NCT00654381|1065488|P5|STARTED|1st Stage||81
446857|NCT00654381|1065489|P4|STARTED|1st Stage||160
446858|NCT00654381|1065490|P3|STARTED|1st Stage||159
446859|NCT00654381|1065491|P2|STARTED|1st Stage||41
446860|NCT00654381|1065492|P1|STARTED|1st Stage||39
446861|NCT00654368|1065529|P3|NOT COMPLETED|Overall Study||32
446862|NCT00654368|1065530|P2|NOT COMPLETED|Overall Study||48
446863|NCT00654368|1065531|P1|NOT COMPLETED|Overall Study||53
446864|NCT00654368|1065529|P3|COMPLETED|Overall Study||75
446865|NCT00654368|1065530|P2|COMPLETED|Overall Study||50
446866|NCT00654368|1065531|P1|COMPLETED|Overall Study||0
446867|NCT00654368|1065529|P3|STARTED|Overall Study||107
446868|NCT00654368|1065530|P2|STARTED|Overall Study||98
446869|NCT00654368|1065531|P1|STARTED|Overall Study||53
446870|NCT00654355|1065564|P2|NOT COMPLETED|Overall Study||2
446871|NCT00654355|1065565|P1|NOT COMPLETED|Overall Study||2
446872|NCT00654355|1065564|P2|COMPLETED|Overall Study||13
446873|NCT00654355|1065565|P1|COMPLETED|Overall Study||13
446874|NCT00654355|1065564|P2|STARTED|Overall Study||15
446875|NCT00654355|1065565|P1|STARTED|Overall Study||15
446876|NCT00654329|1065579|P4|NOT COMPLETED|Overall Study||0
446877|NCT00654329|1065580|P3|NOT COMPLETED|Overall Study||0
446878|NCT00654329|1065581|P2|NOT COMPLETED|Overall Study||0
446879|NCT00654329|1065582|P1|NOT COMPLETED|Overall Study||0
446880|NCT00654329|1065579|P4|COMPLETED|Overall Study||27
446881|NCT00654329|1065580|P3|COMPLETED|Overall Study||23
446882|NCT00654329|1065581|P2|COMPLETED|Overall Study||28
446883|NCT00654329|1065582|P1|COMPLETED|Overall Study||23
446884|NCT00654329|1065579|P4|STARTED|Overall Study||27
446885|NCT00654329|1065580|P3|STARTED|Overall Study||23
446886|NCT00654329|1065581|P2|STARTED|Overall Study||28
446887|NCT00654329|1065582|P1|STARTED|Overall Study||23
446888|NCT00654186|1065596|P1|NOT COMPLETED|Overall Study||5
446889|NCT00654186|1065596|P1|COMPLETED|Overall Study||27
446890|NCT00654186|1065596|P1|STARTED|Overall Study||32
446891|NCT00654147|1065604|P2|NOT COMPLETED|Overall Study||4
446892|NCT00654147|1065605|P1|NOT COMPLETED|Overall Study||2
446893|NCT00654147|1065604|P2|COMPLETED|Overall Study||19
446894|NCT00654147|1065605|P1|COMPLETED|Overall Study||19
446895|NCT00654147|1065604|P2|STARTED|Overall Study||23
446896|NCT00654147|1065605|P1|STARTED|Overall Study||21
446897|NCT00654095|1065621|P1|NOT COMPLETED|Overall Study||32
446898|NCT00654095|1065621|P1|COMPLETED|Overall Study||114
446899|NCT00654095|1065621|P1|STARTED|Overall Study||146
446900|NCT00654030|1065625|P1|NOT COMPLETED|Overall Study||2
446901|NCT00654030|1065625|P1|COMPLETED|Overall Study||10
446902|NCT00654030|1065625|P1|STARTED|Overall Study||12
446903|NCT00654004|1065631|P2|NOT COMPLETED|Overall Study||0
446904|NCT00654004|1065632|P1|NOT COMPLETED|Overall Study||1
446905|NCT00654004|1065631|P2|COMPLETED|Overall Study||12
446906|NCT00654004|1065632|P1|COMPLETED|Overall Study||13
446907|NCT00654004|1065631|P2|STARTED|Overall Study||12
446908|NCT00654004|1065632|P1|STARTED|Overall Study||14
446909|NCT00653939|1065648|P2|NOT COMPLETED|Overall Study||15
446910|NCT00653939|1065649|P1|NOT COMPLETED|Overall Study||12
446911|NCT00653939|1065648|P2|COMPLETED|Overall Study||17
446912|NCT00653939|1065649|P1|COMPLETED|Overall Study||19
446913|NCT00653939|1065648|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
446914|NCT00653939|1065649|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
446915|NCT00653861|1065665|P1|NOT COMPLETED|Overall Study||0
446916|NCT00653861|1065665|P1|COMPLETED|Overall Study||72
446917|NCT00653861|1065665|P1|STARTED|Overall Study||72
446918|NCT00653523|1065674|P1|NOT COMPLETED|Overall Study||19
446919|NCT00653523|1065674|P1|COMPLETED|Overall Study||132
446920|NCT00653523|1065674|P1|STARTED|Overall Study||151
446921|NCT00653328|1065678|P1|NOT COMPLETED|Overall Study||15
446922|NCT00653328|1065678|P1|COMPLETED|Overall Study||0
446923|NCT00653328|1065678|P1|STARTED|Overall Study||15
446924|NCT00653263|1065685|P1|NOT COMPLETED|Overall Study||2
446925|NCT00653263|1065685|P1|COMPLETED|Overall Study||6
446926|NCT00653263|1065685|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
446927|NCT00653224|1065693|P2|NOT COMPLETED|Overall Study||7
446928|NCT00653224|1065694|P1|NOT COMPLETED|Overall Study||7
446929|NCT00653224|1065693|P2|COMPLETED|Overall Study||280
446930|NCT00653224|1065694|P1|COMPLETED|Overall Study||286
446931|NCT00653224|1065693|P2|STARTED|Overall Study||287
446932|NCT00653224|1065694|P1|STARTED|Overall Study||293
446933|NCT00653159|1065880|P2|NOT COMPLETED|Overall Study||3
446934|NCT00653159|1065881|P1|NOT COMPLETED|Overall Study||5
446935|NCT00653159|1065880|P2|COMPLETED|Overall Study||9
446936|NCT00653159|1065881|P1|COMPLETED|Overall Study||6
446937|NCT00653159|1065880|P2|STARTED|Overall Study||12
446938|NCT00653159|1065881|P1|STARTED|Overall Study||11
446939|NCT00653133|1065897|P2|NOT COMPLETED|Overall Study||0
446940|NCT00653133|1065898|P1|NOT COMPLETED|Overall Study||0
446941|NCT00653133|1065897|P2|COMPLETED|Overall Study||497
446942|NCT00653133|1065898|P1|COMPLETED|Overall Study||1324
446943|NCT00653133|1065897|P2|STARTED|Overall Study||497
446944|NCT00653133|1065898|P1|STARTED|Overall Study||1324
446945|NCT00653068|1065908|P1|NOT COMPLETED|Overall Study||50
446946|NCT00653068|1065908|P1|COMPLETED|Overall Study||20
446947|NCT00653068|1065908|P1|STARTED|Overall Study||70
446948|NCT00652938|1065922|P3|NOT COMPLETED|Overall Study||5
446949|NCT00652938|1065923|P2|NOT COMPLETED|Overall Study||7
446950|NCT00652938|1065924|P1|NOT COMPLETED|Overall Study||1
446951|NCT00652938|1065922|P3|COMPLETED|Overall Study||242
446952|NCT00652938|1065923|P2|COMPLETED|Overall Study||240
446953|NCT00652938|1065924|P1|COMPLETED|Overall Study||246
446954|NCT00652938|1065922|P3|STARTED|Overall Study||247
446955|NCT00652938|1065923|P2|STARTED|Overall Study||247
446956|NCT00652938|1065924|P1|STARTED|Overall Study||247
446957|NCT00652899|1065989|P1|NOT COMPLETED|Overall Study||2
446958|NCT00652899|1065989|P1|COMPLETED|Overall Study||12
446959|NCT00652899|1065989|P1|STARTED|Overall Study||14
446960|NCT00652834|1065999|P1|NOT COMPLETED|Overall Study||5
446961|NCT00652834|1065999|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
446962|NCT00652834|1065999|P1|STARTED|Overall Study||23
446963|NCT00652626|1066010|P7|NOT COMPLETED|Extension Phase||3
446964|NCT00652626|1066011|P6|NOT COMPLETED|Extension Phase||12
446965|NCT00652626|1066012|P5|NOT COMPLETED|Extension Phase||0
446966|NCT00652626|1066013|P4|NOT COMPLETED|Extension Phase||0
446967|NCT00652626|1066014|P3|NOT COMPLETED|Extension Phase||0
446968|NCT00652626|1066015|P2|NOT COMPLETED|Extension Phase||0
446969|NCT00652626|1066016|P1|NOT COMPLETED|Extension Phase||0
446970|NCT00652626|1066010|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
446971|NCT00652626|1066011|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
446972|NCT00652626|1066012|P5|COMPLETED|Extension Phase||0
446973|NCT00652626|1066013|P4|COMPLETED|Extension Phase||0
446974|NCT00652626|1066014|P3|COMPLETED|Extension Phase||0
446975|NCT00652626|1066015|P2|COMPLETED|Extension Phase||0
446976|NCT00652626|1066016|P1|COMPLETED|Extension Phase||0
446977|NCT00652626|1066010|P7|STARTED|Extension Phase||4
446978|NCT00652626|1066011|P6|STARTED|Extension Phase||14
446979|NCT00652626|1066012|P5|STARTED|Extension Phase||0
446980|NCT00652626|1066013|P4|STARTED|Extension Phase||0
446981|NCT00652626|1066014|P3|STARTED|Extension Phase||0
446982|NCT00652626|1066015|P2|STARTED|Extension Phase||0
446983|NCT00652626|1066016|P1|STARTED|Extension Phase||0
446984|NCT00652626|1066010|P7|NOT COMPLETED|Initial Treatment Phase||0
446985|NCT00652626|1066011|P6|NOT COMPLETED|Initial Treatment Phase||0
446986|NCT00652626|1066012|P5|NOT COMPLETED|Initial Treatment Phase||3
446987|NCT00652626|1066013|P4|NOT COMPLETED|Initial Treatment Phase||1
446988|NCT00652626|1066014|P3|NOT COMPLETED|Initial Treatment Phase||1
446989|NCT00652626|1066015|P2|NOT COMPLETED|Initial Treatment Phase||0
446990|NCT00652626|1066016|P1|NOT COMPLETED|Initial Treatment Phase||0
446991|NCT00652626|1066010|P7|COMPLETED|Initial Treatment Phase||0
446992|NCT00652626|1066011|P6|COMPLETED|Initial Treatment Phase||0
446993|NCT00652626|1066012|P5|COMPLETED|Initial Treatment Phase||5
446994|NCT00652626|1066013|P4|COMPLETED|Initial Treatment Phase||5
446995|NCT00652626|1066014|P3|COMPLETED|Initial Treatment Phase||6
446996|NCT00652626|1066015|P2|COMPLETED|Initial Treatment Phase||5
446997|NCT00652626|1066016|P1|COMPLETED|Initial Treatment Phase||5
446998|NCT00652626|1066010|P7|Received Study Drug|Initial Treatment Phase||0
446999|NCT00652626|1066011|P6|Received Study Drug|Initial Treatment Phase||0
447000|NCT00652626|1066012|P5|Received Study Drug|Initial Treatment Phase||6
447001|NCT00652626|1066013|P4|Received Study Drug|Initial Treatment Phase||5
447002|NCT00652626|1066014|P3|Received Study Drug|Initial Treatment Phase||6
447003|NCT00652626|1066015|P2|Received Study Drug|Initial Treatment Phase||5
447004|NCT00652626|1066016|P1|Received Study Drug|Initial Treatment Phase||5
447005|NCT00652626|1066010|P7|STARTED|Initial Treatment Phase||0
447006|NCT00652626|1066011|P6|STARTED|Initial Treatment Phase||0
447007|NCT00652626|1066012|P5|STARTED|Initial Treatment Phase||8
447008|NCT00652626|1066013|P4|STARTED|Initial Treatment Phase||6
447009|NCT00652626|1066014|P3|STARTED|Initial Treatment Phase||7
447010|NCT00652626|1066015|P2|STARTED|Initial Treatment Phase||5
447011|NCT00652626|1066016|P1|STARTED|Initial Treatment Phase||5
447012|NCT00652366|1066085|P5|NOT COMPLETED|Overall Study||36
447013|NCT00652366|1066086|P4|NOT COMPLETED|Overall Study||179
447014|NCT00652366|1066087|P3|NOT COMPLETED|Overall Study||71
447015|NCT00652366|1066088|P2|NOT COMPLETED|Overall Study||75
447016|NCT00652366|1066089|P1|NOT COMPLETED|Overall Study||106
447017|NCT00652366|1066085|P5|COMPLETED|Overall Study||0
447018|NCT00652366|1066086|P4|COMPLETED|Overall Study||0
447019|NCT00652366|1066087|P3|COMPLETED|Overall Study||0
447020|NCT00652366|1066088|P2|COMPLETED|Overall Study||0
447021|NCT00652366|1066089|P1|COMPLETED|Overall Study||0
447022|NCT00652366|1066085|P5|STARTED|Overall Study||36
447023|NCT00652366|1066086|P4|STARTED|Overall Study||179
447024|NCT00652366|1066087|P3|STARTED|Overall Study||71
447025|NCT00652366|1066088|P2|STARTED|Overall Study||75
447026|NCT00652366|1066089|P1|STARTED|Overall Study||106
447027|NCT00652340|1066124|P2|NOT COMPLETED|Overall Study||3
447028|NCT00652340|1066125|P1|NOT COMPLETED|Overall Study||4
447029|NCT00652340|1066124|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
447030|NCT00652340|1066125|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
447031|NCT00652340|1066124|P2|STARTED|Overall Study||42
447032|NCT00652340|1066125|P1|STARTED|Overall Study||78
447033|NCT00652327|1066135|P2|NOT COMPLETED|Overall Study||5
447034|NCT00652327|1066136|P1|NOT COMPLETED|Overall Study||0
447035|NCT00652327|1066135|P2|COMPLETED|Overall Study||36
447036|NCT00652327|1066136|P1|COMPLETED|Overall Study||42
447037|NCT00652327|1066135|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
447038|NCT00652327|1066136|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
447039|NCT00652314|1066144|P2|NOT COMPLETED|Overall Study||9
447040|NCT00652314|1066145|P1|NOT COMPLETED|Overall Study||9
447041|NCT00652314|1066144|P2|COMPLETED|Overall Study||26
447042|NCT00652314|1066145|P1|COMPLETED|Overall Study||53
447043|NCT00652314|1066144|P2|STARTED|Overall Study||35
447044|NCT00652314|1066145|P1|STARTED|Overall Study||62
447045|NCT00652145|1066161|P2|NOT COMPLETED|Overall Study||0
447046|NCT00652145|1066162|P1|NOT COMPLETED|Overall Study||0
447047|NCT00652145|1066161|P2|COMPLETED|Overall Study||26
447048|NCT00652145|1066162|P1|COMPLETED|Overall Study||26
447049|NCT00652145|1066161|P2|STARTED|Overall Study||26
447050|NCT00652145|1066162|P1|STARTED|Overall Study||26
447051|NCT00652093|1066178|P6|NOT COMPLETED|Overall Study||0
447052|NCT00652093|1066179|P5|NOT COMPLETED|Overall Study||2
447053|NCT00652093|1066180|P4|NOT COMPLETED|Overall Study||0
447054|NCT00652093|1066181|P3|NOT COMPLETED|Overall Study||1
447055|NCT00652093|1066182|P2|NOT COMPLETED|Overall Study||0
447056|NCT00652093|1066183|P1|NOT COMPLETED|Overall Study||0
447057|NCT00652093|1066178|P6|COMPLETED|Overall Study||4
447058|NCT00652093|1066179|P5|COMPLETED|Overall Study||2
447059|NCT00652093|1066180|P4|COMPLETED|Overall Study||4
447060|NCT00652093|1066181|P3|COMPLETED|Overall Study||3
447061|NCT00652093|1066182|P2|COMPLETED|Overall Study||4
447062|NCT00652093|1066183|P1|COMPLETED|Overall Study||4
447063|NCT00652093|1066178|P6|STARTED|Overall Study||4
447064|NCT00652093|1066179|P5|STARTED|Overall Study||4
447065|NCT00652093|1066180|P4|STARTED|Overall Study||4
447066|NCT00652093|1066181|P3|STARTED|Overall Study||4
447067|NCT00652093|1066182|P2|STARTED|Overall Study||4
447068|NCT00652093|1066183|P1|STARTED|Overall Study||4
447069|NCT00652028|1066267|P4|NOT COMPLETED|Overall Study||0
447070|NCT00652028|1066268|P3|NOT COMPLETED|Overall Study||1
447071|NCT00652028|1066269|P2|NOT COMPLETED|Overall Study||1
447072|NCT00652028|1066270|P1|NOT COMPLETED|Overall Study||1
447073|NCT00652028|1066267|P4|COMPLETED|Overall Study||14
447074|NCT00652028|1066268|P3|COMPLETED|Overall Study||14
447075|NCT00652028|1066269|P2|COMPLETED|Overall Study||13
447076|NCT00652028|1066270|P1|COMPLETED|Overall Study||15
447077|NCT00652028|1066267|P4|STARTED|Overall Study||14
447078|NCT00652028|1066268|P3|STARTED|Overall Study||15
447079|NCT00652028|1066269|P2|STARTED|Overall Study||14
447080|NCT00652028|1066270|P1|STARTED|Overall Study||16
447081|NCT00651924|1066314|P2|NOT COMPLETED|Overall Study||7
447082|NCT00651924|1066315|P1|NOT COMPLETED|Overall Study||0
447083|NCT00651924|1066314|P2|COMPLETED|Overall Study||2
447084|NCT00651924|1066315|P1|COMPLETED|Overall Study||18
447085|NCT00651924|1066314|P2|STARTED|Overall Study||9
447086|NCT00651924|1066315|P1|STARTED|Overall Study||18
447087|NCT00651820|1066321|P1|NOT COMPLETED|Overall Study||2
447088|NCT00651820|1066321|P1|COMPLETED|Overall Study||26
447089|NCT00651820|1066321|P1|STARTED|Overall Study||28
447090|NCT00651755|1066328|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
447091|NCT00651755|1066329|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
447092|NCT00651755|1066328|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
447093|NCT00651755|1066329|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
447094|NCT00651755|1066328|P2|STARTED|Cycle 2 (Second 21 Days)||9
447095|NCT00651755|1066329|P1|STARTED|Cycle 2 (Second 21 Days)||10
447096|NCT00651755|1066328|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
447097|NCT00651755|1066329|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
447098|NCT00651755|1066328|P2|COMPLETED|Cycle 1 (First 21 Days)||9
447099|NCT00651755|1066329|P1|COMPLETED|Cycle 1 (First 21 Days)||10
447100|NCT00651755|1066328|P2|STARTED|Cycle 1 (First 21 Days)||9
447101|NCT00651755|1066329|P1|STARTED|Cycle 1 (First 21 Days)||11
447102|NCT00651625|1066347|P2|NOT COMPLETED|Overall Study||0
447103|NCT00651625|1066348|P1|NOT COMPLETED|Overall Study||0
447104|NCT00651625|1066347|P2|COMPLETED|Overall Study||218
447105|NCT00651625|1066348|P1|COMPLETED|Overall Study||219
447106|NCT00651625|1066347|P2|STARTED|Overall Study||218
447107|NCT00651625|1066348|P1|STARTED|Overall Study||219
447108|NCT00651482|1066360|P1|NOT COMPLETED|Overall Study||0
447109|NCT00651482|1066360|P1|COMPLETED|Overall Study||10
447110|NCT00651482|1066360|P1|STARTED|Overall Study||10
447111|NCT00651313|1066374|P2|NOT COMPLETED|Overall Study||6
447112|NCT00651313|1066375|P1|NOT COMPLETED|Overall Study||6
447113|NCT00651313|1066374|P2|COMPLETED|Overall Study||37
447114|NCT00651313|1066375|P1|COMPLETED|Overall Study||35
447115|NCT00651313|1066374|P2|STARTED|Overall Study||43
447116|NCT00651313|1066375|P1|STARTED|Overall Study||41
447117|NCT00651261|1066383|P2|NOT COMPLETED|Overall Study||306
447118|NCT00651261|1066384|P1|NOT COMPLETED|Overall Study||291
447119|NCT00651261|1066383|P2|COMPLETED|Overall Study||51
447120|NCT00651261|1066384|P1|COMPLETED|Overall Study||69
447121|NCT00651261|1066383|P2|STARTED|Overall Study||357
447122|NCT00651261|1066384|P1|STARTED|Overall Study||360
447123|NCT00651183|1066400|P2|NOT COMPLETED|Overall Study||10
447124|NCT00651183|1066401|P1|NOT COMPLETED|Overall Study||20
447125|NCT00651183|1066400|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
447126|NCT00651183|1066401|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
447127|NCT00651183|1066400|P2|STARTED|Overall Study||97
447128|NCT00651183|1066401|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
447129|NCT00651157|1066413|P1|NOT COMPLETED|Overall Study||2
447130|NCT00651157|1066413|P1|COMPLETED|Overall Study||21
447131|NCT00651157|1066413|P1|STARTED|Overall Study||23
447132|NCT00651118|1066423|P4|NOT COMPLETED|Overall Study||7
447133|NCT00651118|1066424|P3|NOT COMPLETED|Overall Study||11
447134|NCT00651118|1066425|P2|NOT COMPLETED|Overall Study||7
447135|NCT00651118|1066426|P1|NOT COMPLETED|Overall Study||9
447136|NCT00651118|1066423|P4|COMPLETED|Overall Study||203
447137|NCT00651118|1066424|P3|COMPLETED|Overall Study||197
447138|NCT00651118|1066425|P2|COMPLETED|Overall Study||200
447139|NCT00651118|1066426|P1|COMPLETED|Overall Study||198
447140|NCT00651118|1066423|P4|STARTED|Overall Study||210
447141|NCT00651118|1066424|P3|STARTED|Overall Study||208
447142|NCT00651118|1066425|P2|STARTED|Overall Study||207
447143|NCT00651118|1066426|P1|STARTED|Overall Study||207
447144|NCT00651040|1066446|P2|NOT COMPLETED|Overall Study||1
447145|NCT00651040|1066447|P1|NOT COMPLETED|Overall Study||3
447146|NCT00651040|1066446|P2|COMPLETED|Overall Study||14
447147|NCT00651040|1066447|P1|COMPLETED|Overall Study||13
447148|NCT00651040|1066446|P2|STARTED|Overall Study||15
447149|NCT00651040|1066447|P1|STARTED|Overall Study||16
447150|NCT00650858|1066456|P3|NOT COMPLETED|Overall Study||0
447151|NCT00650858|1066457|P2|NOT COMPLETED|Overall Study||0
447152|NCT00650858|1066458|P1|NOT COMPLETED|Overall Study||0
447153|NCT00650858|1066456|P3|COMPLETED|Overall Study||36
447154|NCT00650858|1066457|P2|COMPLETED|Overall Study||8
447155|NCT00650858|1066458|P1|COMPLETED|Overall Study||8
447156|NCT00650858|1066456|P3|STARTED|Overall Study||36
447157|NCT00650858|1066457|P2|STARTED|Overall Study||8
447158|NCT00650858|1066458|P1|STARTED|Overall Study||8
447159|NCT00650845|1066474|P2|NOT COMPLETED|Overall Study||13
447160|NCT00650845|1066475|P1|NOT COMPLETED|Overall Study||5
447161|NCT00650845|1066474|P2|COMPLETED|Overall Study||44
447162|NCT00650845|1066475|P1|COMPLETED|Overall Study||70
447163|NCT00650845|1066474|P2|STARTED|Overall Study||57
447164|NCT00650845|1066475|P1|STARTED|Overall Study||75
447165|NCT00650806|1066495|P4|NOT COMPLETED|Overall Study||26
447166|NCT00650806|1066496|P3|NOT COMPLETED|Overall Study||29
447167|NCT00650806|1066497|P2|NOT COMPLETED|Overall Study||21
447168|NCT00650806|1066498|P1|NOT COMPLETED|Overall Study||18
447169|NCT00650806|1066495|P4|COMPLETED|Overall Study||70
447170|NCT00650806|1066496|P3|COMPLETED|Overall Study||64
447171|NCT00650806|1066497|P2|COMPLETED|Overall Study||77
447172|NCT00650806|1066498|P1|COMPLETED|Overall Study||71
447173|NCT00650806|1066495|P4|STARTED|Overall Study||96
447174|NCT00650806|1066496|P3|STARTED|Overall Study||93
447175|NCT00650806|1066497|P2|STARTED|Overall Study||98
447176|NCT00650806|1066498|P1|STARTED|Overall Study||89
447177|NCT00650767|1066540|P4|NOT COMPLETED|Overall Study||11
447178|NCT00650767|1066541|P3|NOT COMPLETED|Overall Study||14
447179|NCT00650767|1066542|P2|NOT COMPLETED|Overall Study||9
447180|NCT00650767|1066543|P1|NOT COMPLETED|Overall Study||5
447181|NCT00650767|1066540|P4|COMPLETED|Overall Study||39
447182|NCT00650767|1066541|P3|COMPLETED|Overall Study||36
447183|NCT00650767|1066542|P2|COMPLETED|Overall Study||41
447184|NCT00650767|1066543|P1|COMPLETED|Overall Study||46
447185|NCT00650767|1066540|P4|STARTED|Overall Study||50
447186|NCT00650767|1066541|P3|STARTED|Overall Study||50
447187|NCT00650767|1066542|P2|STARTED|Overall Study||50
447188|NCT00650767|1066543|P1|STARTED|Overall Study||51
447189|NCT00650585|1067047|P2|NOT COMPLETED|Overall Study||1477
447190|NCT00650585|1067048|P1|NOT COMPLETED|Overall Study||1797
447191|NCT00650585|1067047|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
447192|NCT00650585|1067048|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
447193|NCT00650585|1067047|P2|STARTED|Overall Study||3990
447194|NCT00650585|1067048|P1|STARTED|Overall Study||4348
447195|NCT00650546|1067068|P1|NOT COMPLETED|Overall Study||0
447196|NCT00650546|1067068|P1|COMPLETED|Overall Study||8
447197|NCT00650546|1067068|P1|STARTED|Overall Study||8
447198|NCT00650260|1067075|P2|NOT COMPLETED|Overall Study||0
447199|NCT00650260|1067076|P1|NOT COMPLETED|Overall Study||0
447200|NCT00650260|1067075|P2|COMPLETED|Overall Study||21
447201|NCT00650260|1067076|P1|COMPLETED|Overall Study||21
447202|NCT00650260|1067075|P2|STARTED|Overall Study||21
447203|NCT00650260|1067076|P1|STARTED|Overall Study||21
447204|NCT00650104|1067092|P1|NOT COMPLETED|Overall Study||41
447205|NCT00650104|1067092|P1|COMPLETED|Overall Study||42
447206|NCT00650104|1067092|P1|STARTED|Overall Study||83
447207|NCT00650091|1067107|P3|NOT COMPLETED|Amended Study Design||0
447208|NCT00650091|1067108|P2|NOT COMPLETED|Amended Study Design||20
447209|NCT00650091|1067109|P1|NOT COMPLETED|Amended Study Design||23
447210|NCT00650091|1067107|P3|COMPLETED|Amended Study Design||0
447211|NCT00650091|1067108|P2|COMPLETED|Amended Study Design||111
447212|NCT00650091|1067109|P1|COMPLETED|Amended Study Design||110
447213|NCT00650091|1067107|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
447214|NCT00650091|1067108|P2|STARTED|Amended Study Design||131
447215|NCT00650091|1067109|P1|STARTED|Amended Study Design||133
447216|NCT00650091|1067107|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
447217|NCT00650091|1067108|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
447218|NCT00650091|1067109|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
447219|NCT00650091|1067107|P3|COMPLETED|Initial Study Design - Interim Analysis||77
447220|NCT00650091|1067108|P2|COMPLETED|Initial Study Design - Interim Analysis||78
447221|NCT00650091|1067109|P1|COMPLETED|Initial Study Design - Interim Analysis||81
447222|NCT00650091|1067107|P3|STARTED|Initial Study Design - Interim Analysis||77
447223|NCT00650091|1067108|P2|STARTED|Initial Study Design - Interim Analysis||78
447224|NCT00650091|1067109|P1|STARTED|Initial Study Design - Interim Analysis||81
447225|NCT00650078|1067129|P2|NOT COMPLETED|Overall Study||13
447226|NCT00650078|1067130|P1|NOT COMPLETED|Overall Study||14
447227|NCT00650078|1067129|P2|COMPLETED|Overall Study||106
447228|NCT00650078|1067130|P1|COMPLETED|Overall Study||217
447229|NCT00650078|1067129|P2|STARTED|Overall Study||119
447230|NCT00650078|1067130|P1|STARTED|Overall Study||231
447231|NCT00649961|1067138|P1|NOT COMPLETED|Overall Study||0
447232|NCT00649961|1067138|P1|COMPLETED|Overall Study||18
447233|NCT00649961|1067138|P1|STARTED|Overall Study||18
447234|NCT00649792|1067142|P1|NOT COMPLETED|Overall Study||68
447235|NCT00649792|1067142|P1|COMPLETED|Overall Study||146
447236|NCT00649792|1067142|P1|STARTED|Overall Study||214
447237|NCT00649428|1067152|P2|NOT COMPLETED|Overall Study||15
447238|NCT00649428|1067153|P1|NOT COMPLETED|Overall Study||20
447239|NCT00649428|1067152|P2|COMPLETED|Overall Study||88
447240|NCT00649428|1067153|P1|COMPLETED|Overall Study||80
447241|NCT00649428|1067152|P2|STARTED|Overall Study||103
447242|NCT00649428|1067153|P1|STARTED|Overall Study||100
447243|NCT00649389|1067169|P4|NOT COMPLETED|Overall Study||111
447244|NCT00649389|1067170|P3|NOT COMPLETED|Overall Study||88
447245|NCT00649389|1067171|P2|NOT COMPLETED|Overall Study||106
447246|NCT00649389|1067172|P1|NOT COMPLETED|Overall Study||71
447247|NCT00649389|1067169|P4|COMPLETED|Overall Study||516
447248|NCT00649389|1067170|P3|COMPLETED|Overall Study||512
447249|NCT00649389|1067171|P2|COMPLETED|Overall Study||531
447250|NCT00649389|1067172|P1|COMPLETED|Overall Study||557
447251|NCT00649389|1067169|P4|STARTED|Overall Study||627
447252|NCT00649389|1067170|P3|STARTED|Overall Study||600
447253|NCT00649389|1067171|P2|STARTED|Overall Study||637
447254|NCT00649389|1067172|P1|STARTED|Overall Study||628
447255|NCT00649220|1067194|P1|NOT COMPLETED|Overall Study||3
447256|NCT00649220|1067194|P1|COMPLETED|Overall Study||16
447257|NCT00649220|1067194|P1|STARTED|Overall Study||19
447258|NCT00648908|1067205|P1|NOT COMPLETED|Overall Study||115
447259|NCT00648908|1067205|P1|COMPLETED|Overall Study||154
447260|NCT00648908|1067205|P1|STARTED|Overall Study||269
447261|NCT00648895|1067215|P2|NOT COMPLETED|Overall Study||1
447262|NCT00648895|1067216|P1|NOT COMPLETED|Overall Study||0
447263|NCT00648895|1067215|P2|COMPLETED|Overall Study||5
447264|NCT00648895|1067216|P1|COMPLETED|Overall Study||6
447265|NCT00648895|1067215|P2|STARTED|Overall Study||6
447266|NCT00648895|1067216|P1|STARTED|Overall Study||6
447267|NCT00648167|1067222|P1|NOT COMPLETED|Overall Study||7
447268|NCT00648167|1067222|P1|COMPLETED|Overall Study||48
447269|NCT00648167|1067222|P1|Start Dose 6 g/Day|Overall Study||21
447270|NCT00648167|1067222|P1|Start Dose 4.5 g/Day|Overall Study||34
447271|NCT00648167|1067222|P1|STARTED|Overall Study||55
447272|NCT00648115|1067229|P3|NOT COMPLETED|Overall Study||0
447273|NCT00648115|1067230|P2|NOT COMPLETED|Overall Study||0
447274|NCT00648115|1067231|P1|NOT COMPLETED|Overall Study||0
447275|NCT00648115|1067229|P3|COMPLETED|Overall Study||27
447276|NCT00648115|1067230|P2|COMPLETED|Overall Study||42
447277|NCT00648115|1067231|P1|COMPLETED|Overall Study||42
447278|NCT00648115|1067229|P3|STARTED|Overall Study||27
447279|NCT00648115|1067230|P2|STARTED|Overall Study||42
447280|NCT00648115|1067231|P1|STARTED|Overall Study||42
447281|NCT00648037|1067242|P1|NOT COMPLETED|Overall Study||16
447282|NCT00648037|1067242|P1|COMPLETED|Overall Study||10
447283|NCT00648037|1067242|P1|STARTED|Overall Study||26
447284|NCT00647998|1067248|P2|NOT COMPLETED|Overall Study||0
447285|NCT00647998|1067249|P1|NOT COMPLETED|Overall Study||0
447286|NCT00647998|1067248|P2|COMPLETED|Overall Study||9
447287|NCT00647998|1067249|P1|COMPLETED|Overall Study||9
447288|NCT00647998|1067248|P2|STARTED|Overall Study||9
447289|NCT00647998|1067249|P1|STARTED|Overall Study||9
447290|NCT00647699|1067261|P2|NOT COMPLETED|Overall Study||12
447291|NCT00647699|1067262|P1|NOT COMPLETED|Overall Study||8
447292|NCT00647699|1067261|P2|COMPLETED|Overall Study||62
447293|NCT00647699|1067262|P1|COMPLETED|Overall Study||65
447294|NCT00647699|1067261|P2|STARTED|Overall Study||74
447295|NCT00647699|1067262|P1|STARTED|Overall Study||73
447296|NCT00647556|1067270|P2|NOT COMPLETED|Overall Study||2
447297|NCT00647556|1067271|P1|NOT COMPLETED|Overall Study||3
447298|NCT00647556|1067270|P2|COMPLETED|Overall Study||13
447299|NCT00647556|1067271|P1|COMPLETED|Overall Study||12
447300|NCT00647556|1067270|P2|STARTED|Overall Study||15
447301|NCT00647556|1067271|P1|STARTED|Overall Study||15
447302|NCT00647400|1067287|P2|NOT COMPLETED|Overall Study||13
447303|NCT00647400|1067288|P1|NOT COMPLETED|Overall Study||22
447304|NCT00647400|1067287|P2|COMPLETED|Overall Study||45
447305|NCT00647400|1067288|P1|COMPLETED|Overall Study||67
447306|NCT00647400|1067287|P2|STARTED|Overall Study||58
447307|NCT00647400|1067288|P1|STARTED|Overall Study||89
447308|NCT00647270|1067301|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
447309|NCT00647270|1067302|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
447310|NCT00647270|1067303|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
447311|NCT00647270|1067301|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
447312|NCT00647270|1067302|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
447313|NCT00647270|1067303|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
447314|NCT00647270|1067301|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
447315|NCT00647270|1067302|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
447316|NCT00647270|1067303|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
447317|NCT00647270|1067301|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
447318|NCT00647270|1067302|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
447319|NCT00647270|1067303|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
447320|NCT00647270|1067301|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
447321|NCT00647270|1067302|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
447322|NCT00647270|1067303|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
447323|NCT00647270|1067301|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
447324|NCT00647270|1067302|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
447325|NCT00647270|1067303|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
447326|NCT00646958|1067329|P3|NOT COMPLETED|Overall Study||9
447327|NCT00646958|1067330|P2|NOT COMPLETED|Overall Study||9
447328|NCT00646958|1067331|P1|NOT COMPLETED|Overall Study||11
447329|NCT00646958|1067329|P3|COMPLETED|Overall Study||40
447330|NCT00646958|1067330|P2|COMPLETED|Overall Study||41
447331|NCT00646958|1067331|P1|COMPLETED|Overall Study||40
447332|NCT00646958|1067329|P3|STARTED|Overall Study|No. Participants Randomized|49
447333|NCT00646958|1067330|P2|STARTED|Overall Study|No. Participants Randomized|50
447334|NCT00646958|1067331|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
447335|NCT00646776|1067344|P2|NOT COMPLETED|Overall Study||13
447336|NCT00646776|1067345|P1|NOT COMPLETED|Overall Study||1
447337|NCT00646776|1067344|P2|COMPLETED|Overall Study||5
447338|NCT00646776|1067345|P1|COMPLETED|Overall Study||14
447339|NCT00646776|1067344|P2|STARTED|Overall Study|Treated on Day 1|18
447340|NCT00646776|1067345|P1|STARTED|Overall Study|Treated on Day 1|15
447341|NCT00646763|1067394|P2|NOT COMPLETED|Overall Study||0
447342|NCT00646763|1067395|P1|NOT COMPLETED|Overall Study||0
447343|NCT00646763|1067394|P2|COMPLETED|Overall Study||17
447344|NCT00646763|1067395|P1|COMPLETED|Overall Study||18
447345|NCT00646763|1067394|P2|STARTED|Overall Study||17
447346|NCT00646763|1067395|P1|STARTED|Overall Study||18
447347|NCT00646646|1067409|P4|NOT COMPLETED|Overall Study||0
447348|NCT00646646|1067410|P3|NOT COMPLETED|Overall Study||0
447349|NCT00646646|1067411|P2|NOT COMPLETED|Overall Study||0
447350|NCT00646646|1067412|P1|NOT COMPLETED|Overall Study||0
447351|NCT00646646|1067409|P4|COMPLETED|Overall Study||20
447352|NCT00646646|1067410|P3|COMPLETED|Overall Study||15
447353|NCT00646646|1067411|P2|COMPLETED|Overall Study||15
447354|NCT00646646|1067412|P1|COMPLETED|Overall Study||15
447355|NCT00646646|1067409|P4|STARTED|Overall Study||20
447356|NCT00646646|1067410|P3|STARTED|Overall Study||15
447357|NCT00646646|1067411|P2|STARTED|Overall Study||15
447358|NCT00646646|1067412|P1|STARTED|Overall Study||15
447359|NCT00646581|1067424|P2|NOT COMPLETED|Overall Study||0
447360|NCT00646581|1067425|P1|NOT COMPLETED|Overall Study||0
447361|NCT00646581|1067424|P2|COMPLETED|Overall Study||15
447362|NCT00646581|1067425|P1|COMPLETED|Overall Study||15
447363|NCT00646581|1067424|P2|STARTED|Overall Study||15
447364|NCT00646581|1067425|P1|STARTED|Overall Study||15
447365|NCT00646399|1067443|P2|NOT COMPLETED|Overall Study||74
447366|NCT00646399|1067444|P1|NOT COMPLETED|Overall Study||83
447367|NCT00646399|1067443|P2|COMPLETED|Overall Study||713
447368|NCT00646399|1067444|P1|COMPLETED|Overall Study||709
447369|NCT00646399|1067443|P2|STARTED|Overall Study||787
447370|NCT00646399|1067444|P1|STARTED|Overall Study||792
447371|NCT00646282|1067452|P2|NOT COMPLETED|Overall Study||4
447372|NCT00646282|1067453|P1|NOT COMPLETED|Overall Study||4
447373|NCT00646282|1067452|P2|COMPLETED|Overall Study||0
447374|NCT00646282|1067453|P1|COMPLETED|Overall Study||0
447375|NCT00646282|1067452|P2|STARTED|Overall Study||4
447376|NCT00646282|1067453|P1|STARTED|Overall Study||4
447377|NCT00646048|1067459|P1|NOT COMPLETED|Overall Study||16
447378|NCT00646048|1067459|P1|COMPLETED|Overall Study||27
447379|NCT00646048|1067459|P1|STARTED|Overall Study||43
447380|NCT00645970|1067467|P2|NOT COMPLETED|Overall Study||186
447381|NCT00645970|1067468|P1|NOT COMPLETED|Overall Study||109
447382|NCT00645970|1067467|P2|COMPLETED|Overall Study||32
447383|NCT00645970|1067468|P1|COMPLETED|Overall Study||32
447384|NCT00645970|1067467|P2|1 Year|Overall Study||42
447385|NCT00645970|1067468|P1|1 Year|Overall Study||37
447386|NCT00645970|1067467|P2|6 Months|Overall Study||97
447387|NCT00645970|1067468|P1|6 Months|Overall Study||58
447388|NCT00645970|1067467|P2|STARTED|Overall Study||218
447389|NCT00645970|1067468|P1|STARTED|Overall Study||141
447390|NCT00645944|1067476|P2|NOT COMPLETED|Received Medication||3
447391|NCT00645944|1067477|P1|NOT COMPLETED|Received Medication||6
447392|NCT00645944|1067476|P2|COMPLETED|Received Medication||14
447393|NCT00645944|1067477|P1|COMPLETED|Received Medication||13
447394|NCT00645944|1067476|P2|STARTED|Received Medication||17
447395|NCT00645944|1067477|P1|STARTED|Received Medication||19
447396|NCT00645944|1067476|P2|NOT COMPLETED|Randomized||2
447397|NCT00645944|1067477|P1|NOT COMPLETED|Randomized||1
447398|NCT00645944|1067476|P2|COMPLETED|Randomized||17
447399|NCT00645944|1067477|P1|COMPLETED|Randomized||19
447400|NCT00645944|1067476|P2|STARTED|Randomized||19
447401|NCT00645944|1067477|P1|STARTED|Randomized||20
447402|NCT00645853|1067485|P2|NOT COMPLETED|Overall Study||57
447403|NCT00645853|1067486|P1|NOT COMPLETED|Overall Study||92
447404|NCT00645853|1067485|P2|COMPLETED|Overall Study||178
447405|NCT00645853|1067486|P1|COMPLETED|Overall Study||196
447406|NCT00645853|1067485|P2|AZ Study Closure in Hungary|Overall Study||40
447407|NCT00645853|1067486|P1|AZ Study Closure in Hungary|Overall Study||60
447408|NCT00645853|1067485|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
447409|NCT00645853|1067486|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
447410|NCT00645853|1067485|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
447411|NCT00645853|1067486|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
447412|NCT00645853|1067485|P2|STARTED|Overall Study||235
447413|NCT00645853|1067486|P1|STARTED|Overall Study||288
447414|NCT00645827|1067506|P2|NOT COMPLETED|Overall Study||0
447415|NCT00645827|1067507|P1|NOT COMPLETED|Overall Study||0
447416|NCT00645827|1067506|P2|COMPLETED|Overall Study||17
447417|NCT00645827|1067507|P1|COMPLETED|Overall Study||14
447418|NCT00645827|1067506|P2|STARTED|Overall Study||17
447419|NCT00645827|1067507|P1|STARTED|Overall Study||14
447420|NCT00645788|1067517|P4|NOT COMPLETED|Overall Study||14
447421|NCT00645788|1067518|P3|NOT COMPLETED|Overall Study||18
447422|NCT00645788|1067519|P2|NOT COMPLETED|Overall Study||27
447423|NCT00645788|1067520|P1|NOT COMPLETED|Overall Study||20
447424|NCT00645788|1067517|P4|COMPLETED|Overall Study||21
447425|NCT00645788|1067518|P3|COMPLETED|Overall Study||47
447426|NCT00645788|1067519|P2|COMPLETED|Overall Study||67
447427|NCT00645788|1067520|P1|COMPLETED|Overall Study||74
447428|NCT00645788|1067517|P4|Participants Receive Treatment|Overall Study||35
447429|NCT00645788|1067518|P3|Participants Receive Treatment|Overall Study||65
447430|NCT00645788|1067519|P2|Participants Receive Treatment|Overall Study||93
447431|NCT00645788|1067520|P1|Participants Receive Treatment|Overall Study||93
447432|NCT00645788|1067517|P4|STARTED|Overall Study||35
447433|NCT00645788|1067518|P3|STARTED|Overall Study||65
447434|NCT00645788|1067519|P2|STARTED|Overall Study||94
447435|NCT00645788|1067520|P1|STARTED|Overall Study||94
447436|NCT00645762|1067570|P1|NOT COMPLETED|Overall Study||4
447437|NCT00645762|1067570|P1|COMPLETED|Overall Study||67
447438|NCT00645762|1067570|P1|STARTED|Overall Study||71
447439|NCT00645671|1067578|P2|NOT COMPLETED|Overall Study||6
447440|NCT00645671|1067579|P1|NOT COMPLETED|Overall Study||1
447441|NCT00645671|1067578|P2|COMPLETED|Overall Study||193
447442|NCT00645671|1067579|P1|COMPLETED|Overall Study||200
447443|NCT00645671|1067578|P2|STARTED|Overall Study||199
447444|NCT00645671|1067579|P1|STARTED|Overall Study||201
447445|NCT00645593|1067593|P2|NOT COMPLETED|Overall Study||0
447446|NCT00645593|1067594|P1|NOT COMPLETED|Overall Study||1
447447|NCT00645593|1067593|P2|COMPLETED|Overall Study||60
447448|NCT00645593|1067594|P1|COMPLETED|Overall Study||28
447449|NCT00645593|1067593|P2|STARTED|Overall Study||60
447450|NCT00645593|1067594|P1|STARTED|Overall Study||29
447451|NCT00645567|1067606|P1|NOT COMPLETED|Overall Study||1
447452|NCT00645567|1067606|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
447453|NCT00645567|1067606|P1|STARTED|Overall Study||5
447454|NCT00645528|1067614|P1|NOT COMPLETED|Overall Study||7
447455|NCT00645528|1067614|P1|COMPLETED|Overall Study||32
447456|NCT00645528|1067614|P1|STARTED|Overall Study||39
447457|NCT00645411|1067627|P4|NOT COMPLETED|Overall Study||103
447458|NCT00645411|1067628|P3|NOT COMPLETED|Overall Study||151
447459|NCT00645411|1067629|P2|NOT COMPLETED|Overall Study||6
447460|NCT00645411|1067630|P1|NOT COMPLETED|Overall Study||13
447461|NCT00645411|1067627|P4|COMPLETED|Overall Study||919
447462|NCT00645411|1067628|P3|COMPLETED|Overall Study||1457
447463|NCT00645411|1067629|P2|COMPLETED|Overall Study||312
447464|NCT00645411|1067630|P1|COMPLETED|Overall Study||643
447465|NCT00645411|1067627|P4|STARTED|Overall Study||1022
447466|NCT00645411|1067628|P3|STARTED|Overall Study||1608
447467|NCT00645411|1067629|P2|STARTED|Overall Study||318
447468|NCT00645411|1067630|P1|STARTED|Overall Study||656
447469|NCT00645359|1067662|P1|NOT COMPLETED|Overall Study||0
447470|NCT00645359|1067662|P1|COMPLETED|Overall Study||9
447471|NCT00645359|1067662|P1|STARTED|Overall Study||9
447472|NCT00645333|1067667|P1|NOT COMPLETED|Overall Study||0
447473|NCT00645333|1067667|P1|COMPLETED|Overall Study||30
447474|NCT00645333|1067667|P1|STARTED|Overall Study||30
447475|NCT00645164|1067672|P1|NOT COMPLETED|Overall Study||7
447476|NCT00645164|1067672|P1|COMPLETED|Overall Study||52
447477|NCT00645164|1067672|P1|STARTED|Overall Study||59
447478|NCT00645099|1067678|P2|NOT COMPLETED|Overall Study||42
447479|NCT00645099|1067679|P1|NOT COMPLETED|Overall Study||71
447480|NCT00645099|1067678|P2|COMPLETED|Overall Study||178
447481|NCT00645099|1067679|P1|COMPLETED|Overall Study||168
447482|NCT00645099|1067678|P2|STARTED|Overall Study||220
447483|NCT00645099|1067679|P1|STARTED|Overall Study||239
447484|NCT00645047|1067723|P2|NOT COMPLETED|Overall Study||39
447485|NCT00645047|1067724|P1|NOT COMPLETED|Overall Study||43
447486|NCT00645047|1067723|P2|COMPLETED|Overall Study||65
447487|NCT00645047|1067724|P1|COMPLETED|Overall Study|6 month follow up|60
447488|NCT00645047|1067723|P2|Post|Overall Study||80
447489|NCT00645047|1067724|P1|Post|Overall Study||74
447490|NCT00645047|1067723|P2|STARTED|Overall Study||104
447491|NCT00645047|1067724|P1|STARTED|Overall Study||103
447492|NCT00644995|1067748|P2|NOT COMPLETED|Overall Study||4
447493|NCT00644995|1067749|P1|NOT COMPLETED|Overall Study||2
447494|NCT00644995|1067748|P2|COMPLETED|Overall Study||23
447495|NCT00644995|1067749|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
447496|NCT00644995|1067748|P2|Completed 4 Month Assessment|Overall Study||24
447497|NCT00644995|1067749|P1|Completed 4 Month Assessment|Overall Study||23
447498|NCT00644995|1067748|P2|STARTED|Overall Study||27
447499|NCT00644995|1067749|P1|STARTED|Overall Study||25
447500|NCT00644969|1067769|P2|NOT COMPLETED|Post Treatment Phase||3
447501|NCT00644969|1067770|P1|NOT COMPLETED|Post Treatment Phase||10
447502|NCT00644969|1067769|P2|COMPLETED|Post Treatment Phase||37
447503|NCT00644969|1067770|P1|COMPLETED|Post Treatment Phase||61
447504|NCT00644969|1067769|P2|STARTED|Post Treatment Phase||40
447505|NCT00644969|1067770|P1|STARTED|Post Treatment Phase||71
447506|NCT00644969|1067769|P2|NOT COMPLETED|Treatment Phase||3
447507|NCT00644969|1067770|P1|NOT COMPLETED|Treatment Phase||14
447508|NCT00644969|1067769|P2|COMPLETED|Treatment Phase||40
447509|NCT00644969|1067770|P1|COMPLETED|Treatment Phase||71
447510|NCT00644969|1067769|P2|STARTED|Treatment Phase||43
447511|NCT00644969|1067770|P1|STARTED|Treatment Phase||85
447512|NCT00644917|1067816|P1|NOT COMPLETED|Overall Study||2
447513|NCT00644917|1067816|P1|COMPLETED|Overall Study||36
447514|NCT00644917|1067816|P1|STARTED|Overall Study||38
447515|NCT00644787|1067824|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
447516|NCT00644787|1067825|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
447517|NCT00644787|1067826|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
447518|NCT00644787|1067824|P3|COMPLETED|Period 2: Double Blind Phase||55
447519|NCT00644787|1067825|P2|COMPLETED|Period 2: Double Blind Phase||49
447520|NCT00644787|1067826|P1|COMPLETED|Period 2: Double Blind Phase||0
447521|NCT00644787|1067824|P3|STARTED|Period 2: Double Blind Phase||62
447522|NCT00644787|1067825|P2|STARTED|Period 2: Double Blind Phase||58
447523|NCT00644787|1067826|P1|STARTED|Period 2: Double Blind Phase||0
447524|NCT00644787|1067824|P3|NOT COMPLETED|Period 1: Titration Phase||0
447525|NCT00644787|1067825|P2|NOT COMPLETED|Period 1: Titration Phase||0
447526|NCT00644787|1067826|P1|NOT COMPLETED|Period 1: Titration Phase||27
447527|NCT00644787|1067824|P3|COMPLETED|Period 1: Titration Phase||0
447528|NCT00644787|1067825|P2|COMPLETED|Period 1: Titration Phase||0
447529|NCT00644787|1067826|P1|COMPLETED|Period 1: Titration Phase||129
447530|NCT00644787|1067824|P3|STARTED|Period 1: Titration Phase||0
447531|NCT00644787|1067825|P2|STARTED|Period 1: Titration Phase||0
447532|NCT00644787|1067826|P1|STARTED|Period 1: Titration Phase||156
447533|NCT00644657|1067854|P1|NOT COMPLETED|Overall Study||0
447534|NCT00644657|1067854|P1|COMPLETED|Overall Study||27
447535|NCT00644657|1067854|P1|STARTED|Overall Study||27
447536|NCT00644592|1067861|P2|NOT COMPLETED|Overall Study||0
447537|NCT00644592|1067862|P1|NOT COMPLETED|Overall Study||0
447538|NCT00644592|1067861|P2|COMPLETED|Overall Study||6
447539|NCT00644592|1067862|P1|COMPLETED|Overall Study||5
447540|NCT00644592|1067861|P2|STARTED|Overall Study||6
447541|NCT00644592|1067862|P1|STARTED|Overall Study||5
447542|NCT00644332|1067868|P1|NOT COMPLETED|Overall Study||21
447543|NCT00644332|1067868|P1|COMPLETED|Overall Study||150
447544|NCT00644332|1067868|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
447545|NCT00644280|1067883|P2|NOT COMPLETED|Overall Study||0
447546|NCT00644280|1067884|P1|NOT COMPLETED|Overall Study||0
447547|NCT00644280|1067883|P2|COMPLETED|Overall Study||5
447548|NCT00644280|1067884|P1|COMPLETED|Overall Study||6
447549|NCT00644280|1067883|P2|STARTED|Overall Study||5
447550|NCT00644280|1067884|P1|STARTED|Overall Study||6
447551|NCT00644189|1067892|P4|NOT COMPLETED|Phase II||0
447552|NCT00644189|1067893|P3|NOT COMPLETED|Phase II||0
447553|NCT00644189|1067894|P2|NOT COMPLETED|Phase II||0
447554|NCT00644189|1067895|P1|NOT COMPLETED|Phase II||0
447555|NCT00644189|1067892|P4|COMPLETED|Phase II||50
447556|NCT00644189|1067893|P3|COMPLETED|Phase II||0
447557|NCT00644189|1067894|P2|COMPLETED|Phase II||0
447558|NCT00644189|1067895|P1|COMPLETED|Phase II||0
447559|NCT00644189|1067892|P4|Completed All 6 Cycles of Treatment|Phase II||19
447560|NCT00644189|1067893|P3|Completed All 6 Cycles of Treatment|Phase II||0
447561|NCT00644189|1067894|P2|Completed All 6 Cycles of Treatment|Phase II||0
447562|NCT00644189|1067895|P1|Completed All 6 Cycles of Treatment|Phase II||0
447563|NCT00644189|1067892|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
447564|NCT00644189|1067893|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
447565|NCT00644189|1067894|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
447566|NCT00644189|1067895|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
447567|NCT00644189|1067892|P4|NOT COMPLETED|Phase I||0
447568|NCT00644189|1067893|P3|NOT COMPLETED|Phase I||0
447569|NCT00644189|1067894|P2|NOT COMPLETED|Phase I||0
447570|NCT00644189|1067895|P1|NOT COMPLETED|Phase I||0
447571|NCT00644189|1067892|P4|COMPLETED|Phase I||18
447572|NCT00644189|1067893|P3|COMPLETED|Phase I||6
447573|NCT00644189|1067894|P2|COMPLETED|Phase I||3
447574|NCT00644189|1067895|P1|COMPLETED|Phase I||3
447575|NCT00644189|1067892|P4|STARTED|Phase I||18
447576|NCT00644189|1067893|P3|STARTED|Phase I||6
447577|NCT00644189|1067894|P2|STARTED|Phase I||3
447578|NCT00644189|1067895|P1|STARTED|Phase I||3
447579|NCT00644059|1067911|P3|NOT COMPLETED|Overall Study||65
447580|NCT00644059|1067912|P2|NOT COMPLETED|Overall Study||123
447581|NCT00644059|1067913|P1|NOT COMPLETED|Overall Study||124
447582|NCT00644059|1067911|P3|COMPLETED|Overall Study||969
447583|NCT00644059|1067912|P2|COMPLETED|Overall Study||1726
447584|NCT00644059|1067913|P1|COMPLETED|Overall Study||1895
447585|NCT00644059|1067911|P3|STARTED|Overall Study||1034
447586|NCT00644059|1067912|P2|STARTED|Overall Study||1849
447587|NCT00644059|1067913|P1|STARTED|Overall Study||2019
447588|NCT00643201|1067999|P2|NOT COMPLETED|Completed Study Follow Up||79
447589|NCT00643201|1068000|P1|NOT COMPLETED|Completed Study Follow Up||70
447590|NCT00643201|1067999|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
447591|NCT00643201|1068000|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
447592|NCT00643201|1067999|P2|STARTED|Completed Study Follow Up||2639
447593|NCT00643201|1068000|P1|STARTED|Completed Study Follow Up||2617
447594|NCT00643201|1067999|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
447595|NCT00643201|1068000|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
447596|NCT00643201|1067999|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
447597|NCT00643201|1068000|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
447598|NCT00643201|1067999|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
447599|NCT00643201|1068000|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
447600|NCT00643916|1068052|P6|NOT COMPLETED|Overall Study||1
447601|NCT00643916|1068053|P5|NOT COMPLETED|Overall Study||2
447602|NCT00643916|1068054|P4|NOT COMPLETED|Overall Study||2
447603|NCT00643916|1068055|P3|NOT COMPLETED|Overall Study||6
447604|NCT00643916|1068056|P2|NOT COMPLETED|Overall Study||6
447605|NCT00643916|1068057|P1|NOT COMPLETED|Overall Study||4
447606|NCT00643916|1068052|P6|COMPLETED|Overall Study||66
447607|NCT00643916|1068053|P5|COMPLETED|Overall Study||57
447608|NCT00643916|1068054|P4|COMPLETED|Overall Study||60
447609|NCT00643916|1068055|P3|COMPLETED|Overall Study||62
447610|NCT00643916|1068056|P2|COMPLETED|Overall Study||61
447611|NCT00643916|1068057|P1|COMPLETED|Overall Study||51
447612|NCT00643916|1068052|P6|STARTED|Overall Study||67
447613|NCT00643916|1068053|P5|STARTED|Overall Study||59
447614|NCT00643916|1068054|P4|STARTED|Overall Study||62
447615|NCT00643916|1068055|P3|STARTED|Overall Study||68
447616|NCT00643916|1068056|P2|STARTED|Overall Study||67
447617|NCT00643916|1068057|P1|STARTED|Overall Study||55
447618|NCT00643851|1068080|P3|NOT COMPLETED|Overall Study||30
447619|NCT00643851|1068081|P2|NOT COMPLETED|Overall Study||33
447620|NCT00643851|1068082|P1|NOT COMPLETED|Overall Study||17
447621|NCT00643851|1068080|P3|COMPLETED|Overall Study||171
447622|NCT00643851|1068081|P2|COMPLETED|Overall Study||170
447623|NCT00643851|1068082|P1|COMPLETED|Overall Study||177
447624|NCT00643851|1068080|P3|STARTED|Overall Study||201
447625|NCT00643851|1068081|P2|STARTED|Overall Study||203
447626|NCT00643851|1068082|P1|STARTED|Overall Study||194
447627|NCT00643760|1068110|P5|NOT COMPLETED|Overall Study||19
447628|NCT00643760|1068111|P4|NOT COMPLETED|Overall Study||38
447629|NCT00643760|1068112|P3|NOT COMPLETED|Overall Study||19
447630|NCT00643760|1068113|P2|NOT COMPLETED|Overall Study||15
447631|NCT00643760|1068114|P1|NOT COMPLETED|Overall Study||30
447632|NCT00643760|1068110|P5|COMPLETED|Overall Study||47
447633|NCT00643760|1068111|P4|COMPLETED|Overall Study||79
447634|NCT00643760|1068112|P3|COMPLETED|Overall Study||37
447635|NCT00643760|1068113|P2|COMPLETED|Overall Study||47
447636|NCT00643760|1068114|P1|COMPLETED|Overall Study||90
447637|NCT00643760|1068110|P5|ITT Population|Overall Study||66
447638|NCT00643760|1068111|P4|ITT Population|Overall Study||116
447639|NCT00643760|1068112|P3|ITT Population|Overall Study||56
447640|NCT00643760|1068113|P2|ITT Population|Overall Study||62
447641|NCT00643760|1068114|P1|ITT Population|Overall Study||120
447642|NCT00643760|1068110|P5|Safety Population/Treated With Drug|Overall Study||66
447643|NCT00643760|1068111|P4|Safety Population/Treated With Drug|Overall Study||116
447644|NCT00643760|1068112|P3|Safety Population/Treated With Drug|Overall Study||56
447645|NCT00643760|1068113|P2|Safety Population/Treated With Drug|Overall Study||62
447646|NCT00643760|1068114|P1|Safety Population/Treated With Drug|Overall Study||120
447647|NCT00643760|1068110|P5|STARTED|Overall Study||66
447648|NCT00643760|1068111|P4|STARTED|Overall Study||117
447649|NCT00643760|1068112|P3|STARTED|Overall Study||56
447650|NCT00643760|1068113|P2|STARTED|Overall Study||62
447651|NCT00643760|1068114|P1|STARTED|Overall Study||120
447652|NCT00643682|1068218|P2|NOT COMPLETED|Overall Study||509
447653|NCT00643682|1068219|P1|NOT COMPLETED|Overall Study||522
447654|NCT00643682|1068218|P2|COMPLETED|Overall Study||492
447655|NCT00643682|1068219|P1|COMPLETED|Overall Study||477
447656|NCT00643682|1068218|P2|STARTED|Overall Study||1001
447657|NCT00643682|1068219|P1|STARTED|Overall Study||999
447658|NCT00643604|1068231|P1|NOT COMPLETED|Overall Study||1
447659|NCT00643604|1068231|P1|COMPLETED|Overall Study||6
447660|NCT00643604|1068231|P1|STARTED|Overall Study||7
447661|NCT00643578|1068248|P2|NOT COMPLETED|Overall Study||0
447662|NCT00643578|1068249|P1|NOT COMPLETED|Overall Study||2
447663|NCT00643578|1068248|P2|COMPLETED|Overall Study||6
447664|NCT00643578|1068249|P1|COMPLETED|Overall Study||4
447665|NCT00643578|1068248|P2|STARTED|Overall Study||6
447666|NCT00643578|1068249|P1|STARTED|Overall Study||6
447667|NCT00643565|1068259|P2|NOT COMPLETED|Overall Study||74
447668|NCT00643565|1068260|P1|NOT COMPLETED|Overall Study||80
447669|NCT00643565|1068259|P2|COMPLETED|Overall Study||0
447670|NCT00643565|1068260|P1|COMPLETED|Overall Study||0
447671|NCT00643565|1068259|P2|STARTED|Overall Study||74
447672|NCT00643565|1068260|P1|STARTED|Overall Study||80
447673|NCT00643487|1068282|P1|NOT COMPLETED|Overall Study||3
447674|NCT00643487|1068282|P1|COMPLETED|Overall Study||5
447675|NCT00643487|1068282|P1|STARTED|Overall Study||8
447676|NCT00643448|1068289|P3|NOT COMPLETED|Overall Study||6
447677|NCT00643448|1068290|P2|NOT COMPLETED|Overall Study||5
447678|NCT00643448|1068291|P1|NOT COMPLETED|Overall Study||4
447679|NCT00643448|1068289|P3|COMPLETED|Overall Study||16
447680|NCT00643448|1068290|P2|COMPLETED|Overall Study||17
447681|NCT00643448|1068291|P1|COMPLETED|Overall Study||17
447682|NCT00643448|1068289|P3|STARTED|Overall Study||22
447683|NCT00643448|1068290|P2|STARTED|Overall Study||22
447684|NCT00643448|1068291|P1|STARTED|Overall Study||21
447685|NCT00643097|1068309|P3|NOT COMPLETED|Overall Study||0
447686|NCT00643097|1068310|P2|NOT COMPLETED|Overall Study||0
447687|NCT00643097|1068311|P1|NOT COMPLETED|Overall Study||0
447688|NCT00643097|1068309|P3|COMPLETED|Overall Study||10
447689|NCT00643097|1068310|P2|COMPLETED|Overall Study||12
447690|NCT00643097|1068311|P1|COMPLETED|Overall Study||18
447691|NCT00643097|1068309|P3|STARTED|Overall Study||10
447692|NCT00643097|1068310|P2|STARTED|Overall Study||12
447693|NCT00643097|1068311|P1|STARTED|Overall Study||18
447694|NCT00643006|1068330|P2|NOT COMPLETED|Overall Study||4
447695|NCT00643006|1068331|P1|NOT COMPLETED|Overall Study||5
447696|NCT00643006|1068330|P2|COMPLETED|Overall Study||29
447697|NCT00643006|1068331|P1|COMPLETED|Overall Study||29
447698|NCT00643006|1068330|P2|STARTED|Overall Study||33
447699|NCT00643006|1068331|P1|STARTED|Overall Study||34
447700|NCT00642993|1068341|P2|NOT COMPLETED|Overall Study||16
447701|NCT00642993|1068342|P1|NOT COMPLETED|Overall Study||106
447702|NCT00642993|1068341|P2|COMPLETED|Overall Study||118
447703|NCT00642993|1068342|P1|COMPLETED|Overall Study||161
447704|NCT00642993|1068341|P2|STARTED|Overall Study||134
447705|NCT00642993|1068342|P1|STARTED|Overall Study||267
447706|NCT00642902|1068360|P4|NOT COMPLETED|Overall Study||40
447707|NCT00642902|1068361|P3|NOT COMPLETED|Overall Study||43
447708|NCT00642902|1068362|P2|NOT COMPLETED|Overall Study||42
447709|NCT00642902|1068363|P1|NOT COMPLETED|Overall Study||40
447710|NCT00642902|1068360|P4|COMPLETED|Overall Study||25
447711|NCT00642902|1068361|P3|COMPLETED|Overall Study||21
447712|NCT00642902|1068362|P2|COMPLETED|Overall Study||21
447713|NCT00642902|1068363|P1|COMPLETED|Overall Study||23
447714|NCT00642902|1068360|P4|Treated|Overall Study||65
447715|NCT00642902|1068361|P3|Treated|Overall Study||63
447716|NCT00642902|1068362|P2|Treated|Overall Study||63
447717|NCT00642902|1068363|P1|Treated|Overall Study||63
447718|NCT00642902|1068360|P4|STARTED|Overall Study||65
447719|NCT00642902|1068361|P3|STARTED|Overall Study||64
447720|NCT00642902|1068362|P2|STARTED|Overall Study||63
447721|NCT00642902|1068363|P1|STARTED|Overall Study||63
447722|NCT00642850|1068385|P1|NOT COMPLETED|Overall Study||33
447723|NCT00642850|1068385|P1|COMPLETED|Overall Study||155
447724|NCT00642850|1068385|P1|STARTED|Overall Study||188
447725|NCT00642811|1068401|P6|NOT COMPLETED|Overall Study||1
447726|NCT00642811|1068402|P5|NOT COMPLETED|Overall Study||1
447727|NCT00642811|1068403|P4|NOT COMPLETED|Overall Study||1
447728|NCT00642811|1068404|P3|NOT COMPLETED|Overall Study||0
447729|NCT00642811|1068405|P2|NOT COMPLETED|Overall Study||4
447730|NCT00642811|1068406|P1|NOT COMPLETED|Overall Study||3
447731|NCT00642811|1068401|P6|COMPLETED|Overall Study||13
447732|NCT00642811|1068402|P5|COMPLETED|Overall Study||13
447733|NCT00642811|1068403|P4|COMPLETED|Overall Study||15
447734|NCT00642811|1068404|P3|COMPLETED|Overall Study||13
447735|NCT00642811|1068405|P2|COMPLETED|Overall Study||17
447736|NCT00642811|1068406|P1|COMPLETED|Overall Study||17
447737|NCT00642811|1068401|P6|STARTED|Overall Study||14
447738|NCT00642811|1068402|P5|STARTED|Overall Study||14
447739|NCT00642811|1068403|P4|STARTED|Overall Study||16
447740|NCT00642811|1068404|P3|STARTED|Overall Study||13
447741|NCT00642811|1068405|P2|STARTED|Overall Study||21
447742|NCT00642811|1068406|P1|STARTED|Overall Study||20
447743|NCT00642772|1068428|P1|NOT COMPLETED|Overall Study||10
447744|NCT00642772|1068428|P1|COMPLETED|Overall Study||14
447745|NCT00642772|1068428|P1|STARTED|Overall Study||24
447746|NCT00642759|1068432|P1|NOT COMPLETED|Overall Study||1
447747|NCT00642759|1068432|P1|COMPLETED|Overall Study||35
447748|NCT00642759|1068432|P1|STARTED|Overall Study||36
447749|NCT00642746|1068441|P2|NOT COMPLETED|Overall Study||0
447750|NCT00642746|1068442|P1|NOT COMPLETED|Overall Study||1
447751|NCT00642746|1068441|P2|COMPLETED|Overall Study||1
447752|NCT00642746|1068442|P1|COMPLETED|Overall Study||9
447753|NCT00642746|1068441|P2|STARTED|Overall Study||1
447754|NCT00642746|1068442|P1|STARTED|Overall Study||10
447755|NCT00642707|1068456|P4|NOT COMPLETED|Overall Study||2
447756|NCT00642707|1068457|P3|NOT COMPLETED|Overall Study||0
447757|NCT00642707|1068458|P2|NOT COMPLETED|Overall Study||0
447758|NCT00642707|1068459|P1|NOT COMPLETED|Overall Study||1
447759|NCT00642707|1068456|P4|COMPLETED|Overall Study||8
447760|NCT00642707|1068457|P3|COMPLETED|Overall Study||12
447761|NCT00642707|1068458|P2|COMPLETED|Overall Study||11
447762|NCT00642707|1068459|P1|COMPLETED|Overall Study||10
447763|NCT00642707|1068456|P4|STARTED|Overall Study||10
447764|NCT00642707|1068457|P3|STARTED|Overall Study||12
447765|NCT00642707|1068458|P2|STARTED|Overall Study||11
447766|NCT00642707|1068459|P1|STARTED|Overall Study||11
447767|NCT00642694|1068471|P2|NOT COMPLETED|Overall Study||4
447768|NCT00642694|1068472|P1|NOT COMPLETED|Overall Study||6
447769|NCT00642694|1068471|P2|COMPLETED|Overall Study||11
447770|NCT00642694|1068472|P1|COMPLETED|Overall Study||8
447771|NCT00642694|1068471|P2|STARTED|Overall Study||15
447772|NCT00642694|1068472|P1|STARTED|Overall Study||14
447773|NCT00642668|1068480|P1|NOT COMPLETED|Overall Study||14
447774|NCT00642668|1068480|P1|COMPLETED|Overall Study||21
447775|NCT00642668|1068480|P1|STARTED|Overall Study||35
447776|NCT00642642|1068488|P1|NOT COMPLETED|Treatment & Follow Up||17
447777|NCT00642642|1068488|P1|COMPLETED|Treatment & Follow Up||92
447778|NCT00642642|1068488|P1|STARTED|Treatment & Follow Up||109
447779|NCT00642642|1068488|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
447780|NCT00642642|1068488|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
447781|NCT00642642|1068488|P1|STARTED|Biopsy & Product Manufacture||122
447782|NCT00642616|1068505|P4|NOT COMPLETED|Overall Study||7
447783|NCT00642616|1068506|P3|NOT COMPLETED|Overall Study||9
447784|NCT00642616|1068507|P2|NOT COMPLETED|Overall Study||7
447785|NCT00642616|1068508|P1|NOT COMPLETED|Overall Study||9
447786|NCT00642616|1068505|P4|COMPLETED|Overall Study||1
447787|NCT00642616|1068506|P3|COMPLETED|Overall Study||0
447788|NCT00642616|1068507|P2|COMPLETED|Overall Study||1
447789|NCT00642616|1068508|P1|COMPLETED|Overall Study||0
447790|NCT00642616|1068505|P4|STARTED|Overall Study||8
447791|NCT00642616|1068506|P3|STARTED|Overall Study||9
447792|NCT00642616|1068507|P2|STARTED|Overall Study||8
447793|NCT00642616|1068508|P1|STARTED|Overall Study||9
447794|NCT00642603|1068532|P2|NOT COMPLETED|Overall Study||18
447795|NCT00642603|1068533|P1|NOT COMPLETED|Overall Study||21
447796|NCT00642603|1068532|P2|COMPLETED|Overall Study||2
447797|NCT00642603|1068533|P1|COMPLETED|Overall Study||0
447798|NCT00642603|1068532|P2|Safety Population|Overall Study||20
447799|NCT00642603|1068533|P1|Safety Population|Overall Study||19
447800|NCT00642603|1068532|P2|STARTED|Overall Study||20
447801|NCT00642603|1068533|P1|STARTED|Overall Study||21
447802|NCT00642473|1068541|P2|NOT COMPLETED|Overall Study||11
447803|NCT00642473|1068542|P1|NOT COMPLETED|Overall Study||4
447804|NCT00642473|1068541|P2|COMPLETED|Overall Study||5
447805|NCT00642473|1068542|P1|COMPLETED|Overall Study||14
447806|NCT00642473|1068541|P2|STARTED|Overall Study||16
447807|NCT00642473|1068542|P1|STARTED|Overall Study||18
447808|NCT00642460|1068556|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
447809|NCT00642460|1068557|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
447810|NCT00642460|1068558|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
447811|NCT00642460|1068559|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
447812|NCT00642460|1068560|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
447813|NCT00642460|1068561|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
447814|NCT00642460|1068556|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
447815|NCT00642460|1068557|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
447816|NCT00642460|1068558|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
447817|NCT00642460|1068559|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
447818|NCT00642460|1068560|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
447819|NCT00642460|1068561|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
447820|NCT00642460|1068556|P6|STARTED|Part III: Open-Label Up to Week 260||59
447821|NCT00642460|1068557|P5|STARTED|Part III: Open-Label Up to Week 260||53
447822|NCT00642460|1068558|P4|STARTED|Part III: Open-Label Up to Week 260||0
447823|NCT00642460|1068559|P3|STARTED|Part III: Open-Label Up to Week 260||0
447824|NCT00642460|1068560|P2|STARTED|Part III: Open-Label Up to Week 260||0
447825|NCT00642460|1068561|P1|STARTED|Part III: Open-Label Up to Week 260||0
447826|NCT00642460|1068556|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
447827|NCT00642460|1068557|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
447828|NCT00642460|1068558|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
447829|NCT00642460|1068559|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
447830|NCT00642460|1068560|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
447831|NCT00642460|1068561|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
447832|NCT00642460|1068556|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
447833|NCT00642460|1068557|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
447834|NCT00642460|1068558|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
447835|NCT00642460|1068559|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
447836|NCT00642460|1068560|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
447837|NCT00642460|1068561|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
447838|NCT00642460|1068556|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
447922|NCT00641862|1068739|P2|NOT COMPLETED|Overall Study||38
447839|NCT00642460|1068557|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
447840|NCT00642460|1068558|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
447841|NCT00642460|1068559|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
447842|NCT00642460|1068560|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
447843|NCT00642460|1068561|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
447844|NCT00642460|1068556|P6|STARTED|Part II: Open-Label Up to Week 92||0
447845|NCT00642460|1068557|P5|STARTED|Part II: Open-Label Up to Week 92||0
447846|NCT00642460|1068558|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
447847|NCT00642460|1068559|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
447848|NCT00642460|1068560|P2|STARTED|Part II: Open-Label Up to Week 92||40
447849|NCT00642460|1068561|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
447850|NCT00642460|1068556|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
447851|NCT00642460|1068557|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
447852|NCT00642460|1068558|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
447853|NCT00642460|1068559|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
447854|NCT00642460|1068560|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
447855|NCT00642460|1068561|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
447856|NCT00642460|1068556|P6|COMPLETED|Part I: 12 Week Double-Blind||0
447857|NCT00642460|1068557|P5|COMPLETED|Part I: 12 Week Double-Blind||0
447858|NCT00642460|1068558|P4|COMPLETED|Part I: 12 Week Double-Blind||0
447859|NCT00642460|1068559|P3|COMPLETED|Part I: 12 Week Double-Blind||36
447860|NCT00642460|1068560|P2|COMPLETED|Part I: 12 Week Double-Blind||37
447861|NCT00642460|1068561|P1|COMPLETED|Part I: 12 Week Double-Blind||36
447862|NCT00642460|1068556|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
447863|NCT00642460|1068557|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
447864|NCT00642460|1068558|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
447865|NCT00642460|1068559|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
447866|NCT00642460|1068560|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
447867|NCT00642460|1068561|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
447868|NCT00642460|1068556|P6|STARTED|Part I: 12 Week Double-Blind||0
447869|NCT00642460|1068557|P5|STARTED|Part I: 12 Week Double-Blind||0
447870|NCT00642460|1068558|P4|STARTED|Part I: 12 Week Double-Blind||0
447871|NCT00642460|1068559|P3|STARTED|Part I: 12 Week Double-Blind||37
447872|NCT00642460|1068560|P2|STARTED|Part I: 12 Week Double-Blind||38
447873|NCT00642460|1068561|P1|STARTED|Part I: 12 Week Double-Blind||37
447874|NCT00642369|1068627|P2|NOT COMPLETED|Overall Study||6
447875|NCT00642369|1068628|P1|NOT COMPLETED|Overall Study||5
447876|NCT00642369|1068627|P2|COMPLETED|Overall Study||24
447877|NCT00642369|1068628|P1|COMPLETED|Overall Study||25
447878|NCT00642369|1068627|P2|STARTED|Overall Study||30
447879|NCT00642369|1068628|P1|STARTED|Overall Study||30
447880|NCT00642356|1068638|P2|NOT COMPLETED|Overall Study||3
447881|NCT00642356|1068639|P1|NOT COMPLETED|Overall Study||2
447882|NCT00642356|1068638|P2|COMPLETED|Overall Study||4
447883|NCT00642356|1068639|P1|COMPLETED|Overall Study||5
447884|NCT00642356|1068638|P2|STARTED|Overall Study||7
447885|NCT00642356|1068639|P1|STARTED|Overall Study||7
447886|NCT00642304|1068647|P1|NOT COMPLETED|Overall Study||6
447887|NCT00642304|1068647|P1|COMPLETED|Overall Study||14
447888|NCT00642304|1068647|P1|STARTED|Overall Study||20
447889|NCT00642278|1068663|P7|NOT COMPLETED|Overall Study||5
447890|NCT00642278|1068664|P6|NOT COMPLETED|Overall Study||7
447891|NCT00642278|1068665|P5|NOT COMPLETED|Overall Study||8
447892|NCT00642278|1068666|P4|NOT COMPLETED|Overall Study||9
447893|NCT00642278|1068667|P3|NOT COMPLETED|Overall Study||5
447894|NCT00642278|1068668|P2|NOT COMPLETED|Overall Study||5
447895|NCT00642278|1068669|P1|NOT COMPLETED|Overall Study||10
447896|NCT00642278|1068663|P7|COMPLETED|Overall Study||60
447897|NCT00642278|1068664|P6|COMPLETED|Overall Study||57
447898|NCT00642278|1068665|P5|COMPLETED|Overall Study||56
447899|NCT00642278|1068666|P4|COMPLETED|Overall Study||56
447900|NCT00642278|1068667|P3|COMPLETED|Overall Study||59
447901|NCT00642278|1068668|P2|COMPLETED|Overall Study||59
447902|NCT00642278|1068669|P1|COMPLETED|Overall Study||55
447903|NCT00642278|1068663|P7|STARTED|Overall Study||65
447904|NCT00642278|1068664|P6|STARTED|Overall Study||64
447905|NCT00642278|1068665|P5|STARTED|Overall Study||64
447906|NCT00642278|1068666|P4|STARTED|Overall Study||65
447907|NCT00642278|1068667|P3|STARTED|Overall Study||64
447908|NCT00642278|1068668|P2|STARTED|Overall Study||64
447909|NCT00642278|1068669|P1|STARTED|Overall Study||65
447910|NCT00642174|1068722|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
447911|NCT00642174|1068723|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
447912|NCT00642174|1068722|P2|COMPLETED|Period 2 - Crossover Drug||16
447913|NCT00642174|1068723|P1|COMPLETED|Period 2 - Crossover Drug||18
447914|NCT00642174|1068722|P2|STARTED|Period 2 - Crossover Drug||16
447915|NCT00642174|1068723|P1|STARTED|Period 2 - Crossover Drug||18
447916|NCT00642174|1068722|P2|NOT COMPLETED|Period 1 - Initial Drug||1
447917|NCT00642174|1068723|P1|NOT COMPLETED|Period 1 - Initial Drug||0
447918|NCT00642174|1068722|P2|COMPLETED|Period 1 - Initial Drug||16
447919|NCT00642174|1068723|P1|COMPLETED|Period 1 - Initial Drug||18
447920|NCT00642174|1068722|P2|STARTED|Period 1 - Initial Drug||17
447921|NCT00642174|1068723|P1|STARTED|Period 1 - Initial Drug||18
447923|NCT00641862|1068740|P1|NOT COMPLETED|Overall Study||44
447924|NCT00641862|1068739|P2|COMPLETED|Overall Study||145
447925|NCT00641862|1068740|P1|COMPLETED|Overall Study||139
447926|NCT00641862|1068739|P2|STARTED|Overall Study||183
447927|NCT00641862|1068740|P1|STARTED|Overall Study||183
447928|NCT00641745|1068748|P2|NOT COMPLETED|Overall Study||113
447929|NCT00641745|1068749|P1|NOT COMPLETED|Overall Study||280
447930|NCT00641745|1068748|P2|COMPLETED|Overall Study||89
447931|NCT00641745|1068749|P1|COMPLETED|Overall Study||147
447932|NCT00641745|1068748|P2|STARTED|Overall Study||202
447933|NCT00641745|1068749|P1|STARTED|Overall Study||427
447934|NCT00641719|1068757|P2|NOT COMPLETED|Overall Study||37
447935|NCT00641719|1068758|P1|NOT COMPLETED|Overall Study||30
447936|NCT00641719|1068757|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
447937|NCT00641719|1068758|P1|COMPLETED|Overall Study||99
447938|NCT00641719|1068757|P2|STARTED|Overall Study||129
447939|NCT00641719|1068758|P1|STARTED|Overall Study||129
447940|NCT00641706|1068782|P2|NOT COMPLETED|Overall Study||3
447941|NCT00641706|1068783|P1|NOT COMPLETED|Overall Study||9
447942|NCT00641706|1068782|P2|COMPLETED|Overall Study||4
447943|NCT00641706|1068783|P1|COMPLETED|Overall Study||28
447944|NCT00641706|1068782|P2|STARTED|Overall Study||7
447945|NCT00641706|1068783|P1|STARTED|Overall Study||37
447946|NCT00641667|1068795|P1|NOT COMPLETED|Overall Study||6
447947|NCT00641667|1068795|P1|COMPLETED|Overall Study||60
447948|NCT00641667|1068795|P1|STARTED|Overall Study||66
447949|NCT00641641|1068805|P1|NOT COMPLETED|Overall Study||0
447950|NCT00641641|1068805|P1|COMPLETED|Overall Study||16
447951|NCT00641641|1068805|P1|STARTED|Overall Study||16
447952|NCT00641563|1068809|P2|NOT COMPLETED|Infusion 2||0
447953|NCT00641563|1068810|P1|NOT COMPLETED|Infusion 2||0
447954|NCT00641563|1068809|P2|COMPLETED|Infusion 2||5
447955|NCT00641563|1068810|P1|COMPLETED|Infusion 2||5
447956|NCT00641563|1068809|P2|STARTED|Infusion 2||5
447957|NCT00641563|1068810|P1|STARTED|Infusion 2||5
447958|NCT00641563|1068809|P2|NOT COMPLETED|Infusion 1||0
447959|NCT00641563|1068810|P1|NOT COMPLETED|Infusion 1||0
447960|NCT00641563|1068809|P2|COMPLETED|Infusion 1||5
447961|NCT00641563|1068810|P1|COMPLETED|Infusion 1||5
447962|NCT00641563|1068809|P2|STARTED|Infusion 1||5
447963|NCT00641563|1068810|P1|STARTED|Infusion 1||5
447964|NCT00641537|1068823|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
447965|NCT00641537|1068824|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
447966|NCT00641537|1068825|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
447967|NCT00641537|1068826|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
447968|NCT00641537|1068827|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
447969|NCT00641537|1068828|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
447970|NCT00641537|1068829|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
447971|NCT00641537|1068830|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
447972|NCT00641537|1068823|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
447973|NCT00641537|1068824|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
447974|NCT00641537|1068825|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
447975|NCT00641537|1068826|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
447976|NCT00641537|1068827|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
447977|NCT00641537|1068828|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
447978|NCT00641537|1068829|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
447979|NCT00641537|1068830|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
447980|NCT00641537|1068823|P8|STARTED|24-Week Supplemental Follow-up Period||11
447981|NCT00641537|1068824|P7|STARTED|24-Week Supplemental Follow-up Period||9
447982|NCT00641537|1068825|P6|STARTED|24-Week Supplemental Follow-up Period||15
447983|NCT00641537|1068826|P5|STARTED|24-Week Supplemental Follow-up Period||198
447984|NCT00641537|1068827|P4|STARTED|24-Week Supplemental Follow-up Period||151
447985|NCT00641537|1068828|P3|STARTED|24-Week Supplemental Follow-up Period||143
447986|NCT00641537|1068829|P2|STARTED|24-Week Supplemental Follow-up Period||69
447987|NCT00641537|1068830|P1|STARTED|24-Week Supplemental Follow-up Period||75
447988|NCT00641537|1068823|P8|NOT COMPLETED|96-week Period||6
447989|NCT00641537|1068824|P7|NOT COMPLETED|96-week Period||5
447990|NCT00641537|1068825|P6|NOT COMPLETED|96-week Period||7
447991|NCT00641537|1068826|P5|NOT COMPLETED|96-week Period||18
447992|NCT00641537|1068827|P4|NOT COMPLETED|96-week Period||12
447993|NCT00641537|1068828|P3|NOT COMPLETED|96-week Period||20
447994|NCT00641537|1068829|P2|NOT COMPLETED|96-week Period||10
447995|NCT00641537|1068830|P1|NOT COMPLETED|96-week Period||9
447996|NCT00641537|1068823|P8|COMPLETED|96-week Period||16
447997|NCT00641537|1068824|P7|COMPLETED|96-week Period||12
447998|NCT00641537|1068825|P6|COMPLETED|96-week Period||15
447999|NCT00641537|1068826|P5|COMPLETED|96-week Period||226
448000|NCT00641537|1068827|P4|COMPLETED|96-week Period||174
448001|NCT00641537|1068828|P3|COMPLETED|96-week Period||166
448002|NCT00641537|1068829|P2|COMPLETED|96-week Period||82
448003|NCT00641537|1068830|P1|COMPLETED|96-week Period||89
448004|NCT00641537|1068823|P8|STARTED|96-week Period||22
448005|NCT00641537|1068824|P7|STARTED|96-week Period||17
448006|NCT00641537|1068825|P6|STARTED|96-week Period||22
448007|NCT00641537|1068826|P5|STARTED|96-week Period||244
448008|NCT00641537|1068827|P4|STARTED|96-week Period||186
448009|NCT00641537|1068828|P3|STARTED|96-week Period||186
448010|NCT00641537|1068829|P2|STARTED|96-week Period||92
448011|NCT00641537|1068830|P1|STARTED|96-week Period||98
448012|NCT00641056|1068885|P2|NOT COMPLETED|Overall Study||25
448013|NCT00641056|1068886|P1|NOT COMPLETED|Overall Study||29
448014|NCT00641056|1068885|P2|COMPLETED|Overall Study||209
448015|NCT00641056|1068886|P1|COMPLETED|Overall Study||204
448016|NCT00641056|1068885|P2|Intent to Treat (ITT)|Overall Study||223
448017|NCT00641056|1068886|P1|Intent to Treat (ITT)|Overall Study||233
448018|NCT00641056|1068885|P2|STARTED|Overall Study||234
448019|NCT00641056|1068886|P1|STARTED|Overall Study||233
448020|NCT00641043|1068914|P2|NOT COMPLETED|Overall Study||15
448021|NCT00641043|1068915|P1|NOT COMPLETED|Overall Study||19
448022|NCT00641043|1068914|P2|COMPLETED|Overall Study|number who completed treatment|244
448023|NCT00641043|1068915|P1|COMPLETED|Overall Study|number who completed treatment|111
448024|NCT00641043|1068914|P2|STARTED|Overall Study|number who started treatment|259
448025|NCT00641043|1068915|P1|STARTED|Overall Study|number who started treatment|130
448026|NCT00640978|1068945|P1|NOT COMPLETED|Overall Study||0
448027|NCT00640978|1068945|P1|COMPLETED|Overall Study||15
448028|NCT00640978|1068945|P1|STARTED|Overall Study||15
448029|NCT00640926|1068952|P3|NOT COMPLETED|Overall Study||8
448030|NCT00640926|1068953|P2|NOT COMPLETED|Overall Study||6
448031|NCT00640926|1068954|P1|NOT COMPLETED|Overall Study||8
448032|NCT00640926|1068952|P3|COMPLETED|Overall Study||45
448033|NCT00640926|1068953|P2|COMPLETED|Overall Study||46
448034|NCT00640926|1068954|P1|COMPLETED|Overall Study||45
448035|NCT00640926|1068952|P3|STARTED|Overall Study||53
448036|NCT00640926|1068953|P2|STARTED|Overall Study||52
448037|NCT00640926|1068954|P1|STARTED|Overall Study||53
448038|NCT00640835|1068967|P2|NOT COMPLETED|Overall Study||57
448039|NCT00640835|1068968|P1|NOT COMPLETED|Overall Study||76
448040|NCT00640835|1068967|P2|COMPLETED|Overall Study||131
448041|NCT00640835|1068968|P1|COMPLETED|Overall Study||118
448042|NCT00640835|1068967|P2|STARTED|Overall Study||188
448043|NCT00640835|1068968|P1|STARTED|Overall Study||194
448044|NCT00640822|1068979|P3|NOT COMPLETED|Overall Study||25
448045|NCT00640822|1068980|P2|NOT COMPLETED|Overall Study||59
448046|NCT00640822|1068981|P1|NOT COMPLETED|Overall Study||43
448047|NCT00640822|1068979|P3|COMPLETED|Overall Study||77
448048|NCT00640822|1068980|P2|COMPLETED|Overall Study||258
448049|NCT00640822|1068981|P1|COMPLETED|Overall Study||279
448050|NCT00640822|1068979|P3|STARTED|Overall Study||102
448051|NCT00640822|1068980|P2|STARTED|Overall Study||317
448052|NCT00640822|1068981|P1|STARTED|Overall Study||322
448053|NCT00640614|1068991|P2|NOT COMPLETED|Overall Study||0
448054|NCT00640614|1068992|P1|NOT COMPLETED|Overall Study||1
448055|NCT00640614|1068991|P2|COMPLETED|Overall Study||110
448056|NCT00640614|1068992|P1|COMPLETED|Overall Study||124
448057|NCT00640614|1068991|P2|STARTED|Overall Study||110
448058|NCT00640614|1068992|P1|STARTED|Overall Study||125
448059|NCT00640601|1069034|P1|NOT COMPLETED|Overall Study||112
448060|NCT00640601|1069034|P1|COMPLETED|Overall Study||183
448061|NCT00640601|1069034|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
448062|NCT00640562|1069050|P2|NOT COMPLETED|Overall Study||26
448063|NCT00640562|1069051|P1|NOT COMPLETED|Overall Study||18
448064|NCT00640562|1069050|P2|COMPLETED|Overall Study||81
448065|NCT00640562|1069051|P1|COMPLETED|Overall Study||91
448066|NCT00640562|1069050|P2|STARTED|Overall Study||107
448067|NCT00640562|1069051|P1|STARTED|Overall Study||109
448068|NCT00640510|1069079|P2|NOT COMPLETED|Overall Study||2
448069|NCT00640510|1069080|P1|NOT COMPLETED|Overall Study||1
448070|NCT00640510|1069079|P2|COMPLETED|Overall Study||15
448071|NCT00640510|1069080|P1|COMPLETED|Overall Study||16
448072|NCT00640510|1069079|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
448073|NCT00640510|1069080|P1|STARTED|Overall Study||17
448074|NCT00640393|1069092|P3|NOT COMPLETED|Part 2||3
448075|NCT00640393|1069093|P2|NOT COMPLETED|Part 2||10
448076|NCT00640393|1069094|P1|NOT COMPLETED|Part 2||0
448077|NCT00640393|1069092|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
448078|NCT00640393|1069093|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
448079|NCT00640393|1069094|P1|COMPLETED|Part 2||0
448080|NCT00640393|1069092|P3|STARTED|Part 2||38
448081|NCT00640393|1069093|P2|STARTED|Part 2||37
448082|NCT00640393|1069094|P1|STARTED|Part 2||0
448083|NCT00640393|1069092|P3|NOT COMPLETED|Randomization||0
448084|NCT00640393|1069093|P2|NOT COMPLETED|Randomization||0
448085|NCT00640393|1069094|P1|NOT COMPLETED|Randomization||19
448086|NCT00640393|1069092|P3|COMPLETED|Randomization||0
448087|NCT00640393|1069093|P2|COMPLETED|Randomization||0
448088|NCT00640393|1069094|P1|COMPLETED|Randomization||75
448089|NCT00640393|1069092|P3|STARTED|Randomization||0
448090|NCT00640393|1069093|P2|STARTED|Randomization||0
448091|NCT00640393|1069094|P1|STARTED|Randomization||94
448092|NCT00640393|1069092|P3|NOT COMPLETED|Part 1||0
448093|NCT00640393|1069093|P2|NOT COMPLETED|Part 1||0
448094|NCT00640393|1069094|P1|NOT COMPLETED|Part 1||5
448095|NCT00640393|1069092|P3|COMPLETED|Part 1||0
448096|NCT00640393|1069093|P2|COMPLETED|Part 1||0
448097|NCT00640393|1069094|P1|COMPLETED|Part 1||94
448098|NCT00640393|1069092|P3|STARTED|Part 1||0
448099|NCT00640393|1069093|P2|STARTED|Part 1||0
448100|NCT00640393|1069094|P1|STARTED|Part 1||99
448101|NCT00640341|1069159|P3|NOT COMPLETED|Overall Study||7
448102|NCT00640341|1069160|P2|NOT COMPLETED|Overall Study||5
448103|NCT00640341|1069161|P1|NOT COMPLETED|Overall Study||21
448104|NCT00640341|1069159|P3|COMPLETED|Overall Study||163
448105|NCT00640341|1069160|P2|COMPLETED|Overall Study||165
448106|NCT00640341|1069161|P1|COMPLETED|Overall Study||149
448107|NCT00640341|1069159|P3|Eligible Participants at Baseline|Overall Study||168
448108|NCT00640341|1069160|P2|Eligible Participants at Baseline|Overall Study||167
448109|NCT00640341|1069161|P1|Eligible Participants at Baseline|Overall Study||165
448110|NCT00640341|1069159|P3|STARTED|Overall Study||170
448111|NCT00640341|1069160|P2|STARTED|Overall Study||170
448112|NCT00640341|1069161|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
448113|NCT00640328|1069181|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
448114|NCT00640328|1069182|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
448115|NCT00640328|1069183|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
448116|NCT00640328|1069184|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
448117|NCT00640328|1069185|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
448118|NCT00640328|1069186|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
448119|NCT00640328|1069181|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
448120|NCT00640328|1069182|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
448121|NCT00640328|1069183|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
448122|NCT00640328|1069184|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
448123|NCT00640328|1069185|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
448124|NCT00640328|1069186|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
448125|NCT00640328|1069181|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
448126|NCT00640328|1069182|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
448127|NCT00640328|1069183|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
448128|NCT00640328|1069184|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
448129|NCT00640328|1069185|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
448130|NCT00640328|1069186|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
448131|NCT00640328|1069181|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
448132|NCT00640328|1069182|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
448133|NCT00640328|1069183|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
448134|NCT00640328|1069184|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
448135|NCT00640328|1069185|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
448136|NCT00640328|1069186|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
448137|NCT00640328|1069181|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
448138|NCT00640328|1069182|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
448139|NCT00640328|1069183|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
448140|NCT00640328|1069184|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
448141|NCT00640328|1069185|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
448142|NCT00640328|1069186|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
448143|NCT00640328|1069181|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
448144|NCT00640328|1069182|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
448145|NCT00640328|1069183|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
448146|NCT00640328|1069184|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
448147|NCT00640328|1069185|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
448148|NCT00640328|1069186|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
448149|NCT00640328|1069181|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
448150|NCT00640328|1069182|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
448151|NCT00640328|1069183|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
448152|NCT00640328|1069184|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
448153|NCT00640328|1069185|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
448154|NCT00640328|1069186|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
448155|NCT00640328|1069181|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
448156|NCT00640328|1069182|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
448157|NCT00640328|1069183|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
448158|NCT00640328|1069184|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
448159|NCT00640328|1069185|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
448160|NCT00640328|1069186|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
448161|NCT00640328|1069181|P6|STARTED|First Treatment Period (Weeks 0-24)||4
448162|NCT00640328|1069182|P5|STARTED|First Treatment Period (Weeks 0-24)||4
448163|NCT00640328|1069183|P4|STARTED|First Treatment Period (Weeks 0-24)||4
448164|NCT00640328|1069184|P3|STARTED|First Treatment Period (Weeks 0-24)||7
448165|NCT00640328|1069185|P2|STARTED|First Treatment Period (Weeks 0-24)||11
448166|NCT00640328|1069186|P1|STARTED|First Treatment Period (Weeks 0-24)||8
448167|NCT00640315|1069352|P2|NOT COMPLETED|Overall Study||1
448168|NCT00640315|1069353|P1|NOT COMPLETED|Overall Study||0
448169|NCT00640315|1069352|P2|COMPLETED|Overall Study||12
448170|NCT00640315|1069353|P1|COMPLETED|Overall Study||10
448171|NCT00640315|1069352|P2|Participants Received Treatment|Overall Study||13
448172|NCT00640315|1069353|P1|Participants Received Treatment|Overall Study||10
448173|NCT00640315|1069352|P2|STARTED|Overall Study||13
448174|NCT00640315|1069353|P1|STARTED|Overall Study||10
448175|NCT00640042|1069479|P1|NOT COMPLETED|Treatment||926
448176|NCT00640042|1069479|P1|COMPLETED|Treatment||561
448177|NCT00640042|1069479|P1|STARTED|Treatment||1487
448178|NCT00640042|1069479|P1|NOT COMPLETED|Enrollment||83
448179|NCT00640042|1069479|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
448180|NCT00640042|1069479|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
448181|NCT00640016|1069495|P4|NOT COMPLETED|Overall Study||3
448182|NCT00640016|1069496|P3|NOT COMPLETED|Overall Study||3
448183|NCT00640016|1069497|P2|NOT COMPLETED|Overall Study||2
448184|NCT00640016|1069498|P1|NOT COMPLETED|Overall Study||2
448185|NCT00640016|1069495|P4|COMPLETED|Overall Study||1
448186|NCT00640016|1069496|P3|COMPLETED|Overall Study||1
448187|NCT00640016|1069497|P2|COMPLETED|Overall Study||1
448188|NCT00640016|1069498|P1|COMPLETED|Overall Study||1
448189|NCT00640016|1069495|P4|Treated|Overall Study||4
448190|NCT00640016|1069496|P3|Treated|Overall Study||4
448191|NCT00640016|1069497|P2|Treated|Overall Study||2
448192|NCT00640016|1069498|P1|Treated|Overall Study||3
448193|NCT00640016|1069495|P4|STARTED|Overall Study||4
448194|NCT00640016|1069496|P3|STARTED|Overall Study||4
448195|NCT00640016|1069497|P2|STARTED|Overall Study||3
448196|NCT00640016|1069498|P1|STARTED|Overall Study||3
448197|NCT00639860|1069542|P1|NOT COMPLETED|Overall Study||0
448198|NCT00639860|1069542|P1|COMPLETED|Overall Study||10
448199|NCT00639860|1069542|P1|STARTED|Overall Study||10
448200|NCT00639769|1069550|P1|NOT COMPLETED|Overall Study||40
448201|NCT00639769|1069550|P1|COMPLETED|Overall Study||0
448202|NCT00639769|1069550|P1|STARTED|Overall Study||40
448203|NCT00639717|1069555|P1|NOT COMPLETED|Overall Study||0
448204|NCT00639717|1069555|P1|COMPLETED|Overall Study||48
448205|NCT00639717|1069555|P1|STARTED|Overall Study||48
448206|NCT00639678|1069567|P4|NOT COMPLETED|Overall Study||0
448207|NCT00639678|1069568|P3|NOT COMPLETED|Overall Study||11
448208|NCT00639678|1069569|P2|NOT COMPLETED|Overall Study||1
448209|NCT00639678|1069570|P1|NOT COMPLETED|Overall Study||4
448210|NCT00639678|1069567|P4|COMPLETED|Overall Study||23
448211|NCT00639678|1069568|P3|COMPLETED|Overall Study||206
448212|NCT00639678|1069569|P2|COMPLETED|Overall Study||5
448213|NCT00639678|1069570|P1|COMPLETED|Overall Study||70
448214|NCT00639678|1069567|P4|STARTED|Overall Study||23
448215|NCT00639678|1069568|P3|STARTED|Overall Study||217
448216|NCT00639678|1069569|P2|STARTED|Overall Study||6
448217|NCT00639678|1069570|P1|STARTED|Overall Study||74
448218|NCT00639509|1069630|P1|NOT COMPLETED|Overall Study||1
448219|NCT00639509|1069630|P1|COMPLETED|Overall Study||23
448220|NCT00639509|1069630|P1|STARTED|Overall Study||24
448221|NCT00639457|1069638|P2|NOT COMPLETED|Overall Study||3
448222|NCT00639457|1069639|P1|NOT COMPLETED|Overall Study||2
448223|NCT00639457|1069638|P2|COMPLETED|Overall Study||19
448224|NCT00639457|1069639|P1|COMPLETED|Overall Study||20
448225|NCT00639457|1069638|P2|STARTED|Overall Study||22
448226|NCT00639457|1069639|P1|STARTED|Overall Study||22
448227|NCT00639418|1069677|P4|NOT COMPLETED|Overall Study||0
448228|NCT00639418|1069678|P3|NOT COMPLETED|Overall Study||0
448229|NCT00639418|1069679|P2|NOT COMPLETED|Overall Study||0
448230|NCT00639418|1069680|P1|NOT COMPLETED|Overall Study||0
448231|NCT00639418|1069677|P4|COMPLETED|Overall Study||46930
448232|NCT00639418|1069678|P3|COMPLETED|Overall Study||36496
448233|NCT00639418|1069679|P2|COMPLETED|Overall Study||35967
448234|NCT00639418|1069680|P1|COMPLETED|Overall Study||28101
448235|NCT00639418|1069677|P4|STARTED|Overall Study||46930
448236|NCT00639418|1069678|P3|STARTED|Overall Study||36496
448237|NCT00639418|1069679|P2|STARTED|Overall Study||35967
448238|NCT00639418|1069680|P1|STARTED|Overall Study||28101
448239|NCT00639379|1069698|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
448240|NCT00639379|1069699|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
448241|NCT00639379|1069698|P2|COMPLETED|Period 2 - 2 Weeks||45
448242|NCT00639379|1069699|P1|COMPLETED|Period 2 - 2 Weeks||39
448243|NCT00639379|1069698|P2|STARTED|Period 2 - 2 Weeks||45
448244|NCT00639379|1069699|P1|STARTED|Period 2 - 2 Weeks||39
448245|NCT00639379|1069698|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
448246|NCT00639379|1069699|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
448247|NCT00639379|1069698|P2|COMPLETED|Period 1 - 2 Weeks||45
448248|NCT00639379|1069699|P1|COMPLETED|Period 1 - 2 Weeks||39
448249|NCT00639379|1069698|P2|STARTED|Period 1 - 2 Weeks||45
448250|NCT00639379|1069699|P1|STARTED|Period 1 - 2 Weeks||44
448251|NCT00639223|1069715|P2|NOT COMPLETED|Overall Study||2
448252|NCT00639223|1069716|P1|NOT COMPLETED|Overall Study||0
448253|NCT00639223|1069715|P2|COMPLETED|Overall Study||19
448254|NCT00639223|1069716|P1|COMPLETED|Overall Study||22
448255|NCT00639223|1069715|P2|STARTED|Overall Study||21
448256|NCT00639223|1069716|P1|STARTED|Overall Study||22
448257|NCT00639158|1069726|P2|NOT COMPLETED|Overall Study||30
448258|NCT00639158|1069727|P1|NOT COMPLETED|Overall Study||26
448259|NCT00639158|1069726|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
448260|NCT00639158|1069727|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
448261|NCT00639158|1069726|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
448262|NCT00639158|1069727|P1|STARTED|Overall Study|All randomized subjects were treated.|272
448263|NCT00639093|1069749|P2|NOT COMPLETED|Overall Study||0
448264|NCT00639093|1069750|P1|NOT COMPLETED|Overall Study||0
448265|NCT00639093|1069749|P2|COMPLETED|Overall Study|46|46
448266|NCT00639093|1069750|P1|COMPLETED|Overall Study|45|45
448267|NCT00639093|1069749|P2|STARTED|Overall Study|46|46
448268|NCT00639093|1069750|P1|STARTED|Overall Study|45|45
448269|NCT00639002|1069756|P1|NOT COMPLETED|Overall Study||13
448270|NCT00639002|1069756|P1|COMPLETED|Overall Study||0
448271|NCT00639002|1069756|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
448272|NCT00639002|1069756|P1|Received Ruxolitinib|Overall Study||13
448273|NCT00639002|1069756|P1|STARTED|Overall Study||13
448274|NCT00638989|1069765|P3|NOT COMPLETED|Overall Study||1
448275|NCT00638989|1069766|P2|NOT COMPLETED|Overall Study||0
448276|NCT00638989|1069767|P1|NOT COMPLETED|Overall Study||0
448277|NCT00638989|1069765|P3|COMPLETED|Overall Study||9
448278|NCT00638989|1069766|P2|COMPLETED|Overall Study||10
448279|NCT00638989|1069767|P1|COMPLETED|Overall Study||10
448280|NCT00638989|1069765|P3|STARTED|Overall Study||10
448281|NCT00638989|1069766|P2|STARTED|Overall Study||10
448282|NCT00638989|1069767|P1|STARTED|Overall Study||10
448283|NCT00638963|1069807|P2|NOT COMPLETED|Overall Study||0
448284|NCT00638963|1069808|P1|NOT COMPLETED|Overall Study||1
448285|NCT00638963|1069807|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
448286|NCT00638963|1069808|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
448287|NCT00638963|1069807|P2|STARTED|Overall Study|Received randomized treatment assignment|3
448288|NCT00638963|1069808|P1|STARTED|Overall Study|Received randomized treatment assignment|3
448289|NCT00638937|1069827|P1|NOT COMPLETED|Overall Study||0
448290|NCT00638937|1069827|P1|COMPLETED|Overall Study||37
448291|NCT00638937|1069827|P1|STARTED|Overall Study||37
448292|NCT00638924|1069837|P1|NOT COMPLETED|Overall Study||0
448293|NCT00638924|1069837|P1|COMPLETED|Overall Study||40
448294|NCT00638924|1069837|P1|2 Months|Overall Study||40
448295|NCT00638924|1069837|P1|STARTED|Overall Study||40
448296|NCT00638885|1069842|P1|NOT COMPLETED|Overall Study||0
448297|NCT00638885|1069842|P1|COMPLETED|Overall Study||142
448298|NCT00638885|1069842|P1|STARTED|Overall Study||142
448299|NCT00638846|1069848|P2|NOT COMPLETED|Overall Study||6
448300|NCT00638846|1069849|P1|NOT COMPLETED|Overall Study||4
448301|NCT00638846|1069848|P2|COMPLETED|Overall Study||133
448302|NCT00638846|1069849|P1|COMPLETED|Overall Study||133
448303|NCT00638846|1069848|P2|STARTED|Overall Study||139
448304|NCT00638846|1069849|P1|STARTED|Overall Study||137
448305|NCT00638820|1069865|P1|NOT COMPLETED|Overall Study||0
448306|NCT00638820|1069865|P1|COMPLETED|Overall Study||3
448307|NCT00638820|1069865|P1|STARTED|Overall Study||3
448308|NCT00638716|1069875|P3|NOT COMPLETED|Overall Study||12
448309|NCT00638716|1069876|P2|NOT COMPLETED|Overall Study||15
448310|NCT00638716|1069877|P1|NOT COMPLETED|Overall Study||7
448311|NCT00638716|1069875|P3|COMPLETED|Overall Study||46
448312|NCT00638716|1069876|P2|COMPLETED|Overall Study||37
448313|NCT00638716|1069877|P1|COMPLETED|Overall Study||43
448314|NCT00638716|1069875|P3|STARTED|Overall Study||58
448315|NCT00638716|1069876|P2|STARTED|Overall Study||52
448316|NCT00638716|1069877|P1|STARTED|Overall Study||50
448317|NCT00638690|1069893|P2|NOT COMPLETED|Overall Study||342
448318|NCT00638690|1069894|P1|NOT COMPLETED|Overall Study||681
448319|NCT00638690|1069893|P2|COMPLETED|Overall Study||56
448320|NCT00638690|1069894|P1|COMPLETED|Overall Study||116
448321|NCT00638690|1069893|P2|STARTED|Overall Study||398
448322|NCT00638690|1069894|P1|STARTED|Overall Study||797
448323|NCT00638651|1069907|P1|NOT COMPLETED|Overall Study||0
448324|NCT00638651|1069907|P1|COMPLETED|Overall Study||3
448325|NCT00638651|1069907|P1|STARTED|Overall Study||3
448326|NCT00638443|1069912|P2|NOT COMPLETED|Second Intervention||0
448327|NCT00638443|1069913|P1|NOT COMPLETED|Second Intervention||0
448328|NCT00638443|1069912|P2|COMPLETED|Second Intervention||14
448329|NCT00638443|1069913|P1|COMPLETED|Second Intervention||12
448330|NCT00638443|1069912|P2|STARTED|Second Intervention||14
448331|NCT00638443|1069913|P1|STARTED|Second Intervention||12
448332|NCT00638443|1069912|P2|NOT COMPLETED|Washout||0
448333|NCT00638443|1069913|P1|NOT COMPLETED|Washout||0
448334|NCT00638443|1069912|P2|COMPLETED|Washout||14
448335|NCT00638443|1069913|P1|COMPLETED|Washout||12
448336|NCT00638443|1069912|P2|STARTED|Washout||14
448337|NCT00638443|1069913|P1|STARTED|Washout||12
448338|NCT00638443|1069912|P2|NOT COMPLETED|First Intervention||1
448339|NCT00638443|1069913|P1|NOT COMPLETED|First Intervention||2
448340|NCT00638443|1069912|P2|COMPLETED|First Intervention||14
448341|NCT00638443|1069913|P1|COMPLETED|First Intervention||12
448342|NCT00638443|1069912|P2|STARTED|First Intervention||15
448343|NCT00638443|1069913|P1|STARTED|First Intervention||14
448344|NCT00638378|1069941|P1|NOT COMPLETED|Overall Study||22
448345|NCT00638378|1069941|P1|COMPLETED|Overall Study||0
448346|NCT00638378|1069941|P1|STARTED|Overall Study||22
448347|NCT00638365|1069951|P3|NOT COMPLETED|Overall Study||0
448348|NCT00638365|1069952|P2|NOT COMPLETED|Overall Study||0
448349|NCT00638365|1069953|P1|NOT COMPLETED|Overall Study||0
448350|NCT00638365|1069951|P3|COMPLETED|Overall Study||8
448351|NCT00638365|1069952|P2|COMPLETED|Overall Study||10
448352|NCT00638365|1069953|P1|COMPLETED|Overall Study||9
448353|NCT00638365|1069951|P3|STARTED|Overall Study||8
448354|NCT00638365|1069952|P2|STARTED|Overall Study||10
448355|NCT00638365|1069953|P1|STARTED|Overall Study||9
448356|NCT00638235|1069970|P9|NOT COMPLETED|Overall Study||18
448357|NCT00638235|1069971|P8|NOT COMPLETED|Overall Study||1
448358|NCT00638235|1069972|P7|NOT COMPLETED|Overall Study||0
448359|NCT00638235|1069973|P6|NOT COMPLETED|Overall Study||26
448360|NCT00638235|1069974|P5|NOT COMPLETED|Overall Study||13
448361|NCT00638235|1069975|P4|NOT COMPLETED|Overall Study||10
448362|NCT00638235|1069976|P3|NOT COMPLETED|Overall Study||18
448363|NCT00638235|1069977|P2|NOT COMPLETED|Overall Study||3
448364|NCT00638235|1069978|P1|NOT COMPLETED|Overall Study||31
448365|NCT00638235|1069970|P9|COMPLETED|Overall Study||124
448366|NCT00638235|1069971|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
448367|NCT00638235|1069972|P7|COMPLETED|Overall Study||23
448368|NCT00638235|1069973|P6|COMPLETED|Overall Study||113
448369|NCT00638235|1069974|P5|COMPLETED|Overall Study||42
448370|NCT00638235|1069975|P4|COMPLETED|Overall Study||46
448371|NCT00638235|1069976|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
448372|NCT00638235|1069977|P2|COMPLETED|Overall Study||23
448373|NCT00638235|1069978|P1|COMPLETED|Overall Study||110
448374|NCT00638235|1069970|P9|STARTED|Overall Study||142
448375|NCT00638235|1069971|P8|STARTED|Overall Study||35
448376|NCT00638235|1069972|P7|STARTED|Overall Study||23
448377|NCT00638235|1069973|P6|STARTED|Overall Study||139
448378|NCT00638235|1069974|P5|STARTED|Overall Study||55
448379|NCT00638235|1069975|P4|STARTED|Overall Study||56
448380|NCT00638235|1069976|P3|STARTED|Overall Study||81
448381|NCT00638235|1069977|P2|STARTED|Overall Study||26
448382|NCT00638235|1069978|P1|STARTED|Overall Study||141
448383|NCT00638222|1070379|P3|NOT COMPLETED|Overall Study||0
448384|NCT00638222|1070380|P2|NOT COMPLETED|Overall Study||0
448385|NCT00638222|1070381|P1|NOT COMPLETED|Overall Study||0
448386|NCT00638222|1070379|P3|COMPLETED|Overall Study||6
448387|NCT00638222|1070380|P2|COMPLETED|Overall Study||0
448388|NCT00638222|1070381|P1|COMPLETED|Overall Study||0
448389|NCT00638222|1070379|P3|STARTED|Overall Study||6
448390|NCT00638222|1070380|P2|STARTED|Overall Study||0
448391|NCT00638222|1070381|P1|STARTED|Overall Study||0
448392|NCT00638183|1070388|P1|NOT COMPLETED|Overall Study||119
448393|NCT00638183|1070388|P1|COMPLETED|Overall Study||266
448394|NCT00638183|1070388|P1|STARTED|Overall Study||385
448395|NCT00638157|1070397|P2|NOT COMPLETED|Overall Study||4
448396|NCT00638157|1070398|P1|NOT COMPLETED|Overall Study||7
448397|NCT00638157|1070397|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
448398|NCT00638157|1070398|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
448399|NCT00638157|1070397|P2|Treated|Overall Study||12
448400|NCT00638157|1070398|P1|Treated|Overall Study||10
448401|NCT00638157|1070397|P2|STARTED|Overall Study||12
448402|NCT00638157|1070398|P1|STARTED|Overall Study||12
448403|NCT00638027|1070408|P2|NOT COMPLETED|Overall Study||2
448404|NCT00638027|1070409|P1|NOT COMPLETED|Overall Study||0
448405|NCT00638027|1070408|P2|COMPLETED|Overall Study|all 10 included in analyses|8
448406|NCT00638027|1070409|P1|COMPLETED|Overall Study||11
448407|NCT00638027|1070408|P2|STARTED|Overall Study||10
448408|NCT00638027|1070409|P1|STARTED|Overall Study||11
448409|NCT00638014|1070421|P2|NOT COMPLETED|Overall Study||0
448410|NCT00638014|1070422|P1|NOT COMPLETED|Overall Study||0
448411|NCT00638014|1070421|P2|COMPLETED|Overall Study||28
448412|NCT00638014|1070422|P1|COMPLETED|Overall Study||23
448413|NCT00638014|1070421|P2|STARTED|Overall Study||28
448414|NCT00638014|1070422|P1|STARTED|Overall Study||23
448415|NCT00637923|1070432|P2|NOT COMPLETED|Overall Study||19
448416|NCT00637923|1070433|P1|NOT COMPLETED|Overall Study||30
448417|NCT00637923|1070432|P2|COMPLETED|Overall Study||18
448418|NCT00637923|1070433|P1|COMPLETED|Overall Study||45
448419|NCT00637923|1070432|P2|STARTED|Overall Study||37
448420|NCT00637923|1070433|P1|STARTED|Overall Study||75
448421|NCT00637806|1070456|P4|NOT COMPLETED|Extension Phase||1
448422|NCT00637806|1070457|P3|NOT COMPLETED|Extension Phase||0
448423|NCT00637806|1070458|P2|NOT COMPLETED|Extension Phase||0
448424|NCT00637806|1070459|P1|NOT COMPLETED|Extension Phase||0
448425|NCT00637806|1070456|P4|COMPLETED|Extension Phase||0
448426|NCT00637806|1070457|P3|COMPLETED|Extension Phase||0
448427|NCT00637806|1070458|P2|COMPLETED|Extension Phase||0
448428|NCT00637806|1070459|P1|COMPLETED|Extension Phase||0
448429|NCT00637806|1070456|P4|STARTED|Extension Phase||1
448430|NCT00637806|1070457|P3|STARTED|Extension Phase||0
448431|NCT00637806|1070458|P2|STARTED|Extension Phase||0
448432|NCT00637806|1070459|P1|STARTED|Extension Phase||0
448433|NCT00637806|1070456|P4|NOT COMPLETED|Double-blind Phase||0
448434|NCT00637806|1070457|P3|NOT COMPLETED|Double-blind Phase||1
448435|NCT00637806|1070458|P2|NOT COMPLETED|Double-blind Phase||0
448436|NCT00637806|1070459|P1|NOT COMPLETED|Double-blind Phase||2
448437|NCT00637806|1070456|P4|COMPLETED|Double-blind Phase||0
448438|NCT00637806|1070457|P3|COMPLETED|Double-blind Phase||1
448439|NCT00637806|1070458|P2|COMPLETED|Double-blind Phase||0
448440|NCT00637806|1070459|P1|COMPLETED|Double-blind Phase||0
448441|NCT00637806|1070456|P4|STARTED|Double-blind Phase||0
448442|NCT00637806|1070457|P3|STARTED|Double-blind Phase||2
448443|NCT00637806|1070458|P2|STARTED|Double-blind Phase||0
448444|NCT00637806|1070459|P1|STARTED|Double-blind Phase||2
448445|NCT00637780|1070477|P1|NOT COMPLETED|Overall Study||0
448446|NCT00637780|1070477|P1|COMPLETED|Overall Study||2
448447|NCT00637780|1070477|P1|STARTED|Overall Study||2
448448|NCT00637728|1070494|P3|NOT COMPLETED|Extension Phase||0
448449|NCT00637728|1070495|P2|NOT COMPLETED|Extension Phase||0
448450|NCT00637728|1070496|P1|NOT COMPLETED|Extension Phase||0
448451|NCT00637728|1070494|P3|COMPLETED|Extension Phase||0
448452|NCT00637728|1070495|P2|COMPLETED|Extension Phase||0
448453|NCT00637728|1070496|P1|COMPLETED|Extension Phase||0
448454|NCT00637728|1070494|P3|STARTED|Extension Phase||0
448455|NCT00637728|1070495|P2|STARTED|Extension Phase||0
448456|NCT00637728|1070496|P1|STARTED|Extension Phase||0
448457|NCT00637728|1070494|P3|NOT COMPLETED|Double-blind Phase||0
448458|NCT00637728|1070495|P2|NOT COMPLETED|Double-blind Phase||1
448459|NCT00637728|1070496|P1|NOT COMPLETED|Double-blind Phase||4
448460|NCT00637728|1070494|P3|COMPLETED|Double-blind Phase||0
448461|NCT00637728|1070495|P2|COMPLETED|Double-blind Phase||0
448462|NCT00637728|1070496|P1|COMPLETED|Double-blind Phase||0
448463|NCT00637728|1070494|P3|STARTED|Double-blind Phase||0
448464|NCT00637728|1070495|P2|STARTED|Double-blind Phase||1
448465|NCT00637728|1070496|P1|STARTED|Double-blind Phase||4
448466|NCT00637572|1070511|P2|NOT COMPLETED|Overall Study||7
448467|NCT00637572|1070512|P1|NOT COMPLETED|Overall Study||3
448468|NCT00637572|1070511|P2|COMPLETED|Overall Study||24
448469|NCT00637572|1070512|P1|COMPLETED|Overall Study||29
448470|NCT00637572|1070511|P2|STARTED|Overall Study||31
448471|NCT00637572|1070512|P1|STARTED|Overall Study||32
448472|NCT00637494|1070540|P2|NOT COMPLETED|Overall Study||43
448473|NCT00637494|1070541|P1|NOT COMPLETED|Overall Study||32
448474|NCT00637494|1070540|P2|COMPLETED|Overall Study||108
448475|NCT00637494|1070541|P1|COMPLETED|Overall Study||109
448476|NCT00637494|1070540|P2|STARTED|Overall Study||151
448477|NCT00637494|1070541|P1|STARTED|Overall Study||141
448478|NCT00637416|1070551|P2|NOT COMPLETED|Overall Study||2
448479|NCT00637416|1070552|P1|NOT COMPLETED|Overall Study||1
448480|NCT00637416|1070551|P2|COMPLETED|Overall Study||3
448481|NCT00637416|1070552|P1|COMPLETED|Overall Study||3
448482|NCT00637416|1070551|P2|STARTED|Overall Study||5
448483|NCT00637416|1070552|P1|STARTED|Overall Study||4
448484|NCT00637377|1070562|P4|NOT COMPLETED|Overall Study||29
448485|NCT00637377|1070563|P3|NOT COMPLETED|Overall Study||37
448486|NCT00637377|1070564|P2|NOT COMPLETED|Overall Study||32
448487|NCT00637377|1070565|P1|NOT COMPLETED|Overall Study||27
448488|NCT00637377|1070562|P4|COMPLETED|Overall Study||284
448489|NCT00637377|1070563|P3|COMPLETED|Overall Study||274
448490|NCT00637377|1070564|P2|COMPLETED|Overall Study||281
448491|NCT00637377|1070565|P1|COMPLETED|Overall Study||276
448492|NCT00637377|1070562|P4|Participants Treated (FAS)|Overall Study||306
448493|NCT00637377|1070563|P3|Participants Treated (FAS)|Overall Study||296
448494|NCT00637377|1070564|P2|Participants Treated (FAS)|Overall Study||309
448495|NCT00637377|1070565|P1|Participants Treated (FAS)|Overall Study||291
448496|NCT00637377|1070562|P4|Participants Received Treatment|Overall Study|safety population|307
448497|NCT00637377|1070563|P3|Participants Received Treatment|Overall Study|safety population|297
448498|NCT00637377|1070564|P2|Participants Received Treatment|Overall Study|safety population|309
448499|NCT00637377|1070565|P1|Participants Received Treatment|Overall Study|safety population|291
448500|NCT00637377|1070562|P4|STARTED|Overall Study||313
448501|NCT00637377|1070563|P3|STARTED|Overall Study||311
448502|NCT00637377|1070564|P2|STARTED|Overall Study||313
448503|NCT00637377|1070565|P1|STARTED|Overall Study||303
448504|NCT00637312|1070593|P2|NOT COMPLETED|Overall Study||17
448505|NCT00637312|1070594|P1|NOT COMPLETED|Overall Study||42
448506|NCT00637312|1070593|P2|COMPLETED|Overall Study||19
448507|NCT00637312|1070594|P1|COMPLETED|Overall Study||30
448508|NCT00637312|1070593|P2|STARTED|Overall Study||36
448509|NCT00637312|1070594|P1|STARTED|Overall Study||72
448510|NCT00637299|1070602|P2|NOT COMPLETED|Overall Study||0
448511|NCT00637299|1070603|P1|NOT COMPLETED|Overall Study||0
448512|NCT00637299|1070602|P2|COMPLETED|Overall Study||10
448513|NCT00637299|1070603|P1|COMPLETED|Overall Study||10
448514|NCT00637299|1070602|P2|STARTED|Overall Study||10
448515|NCT00637299|1070603|P1|STARTED|Overall Study||10
448516|NCT00637273|1070614|P3|NOT COMPLETED|Overall Study||41
448517|NCT00637273|1070615|P2|NOT COMPLETED|Overall Study||28
448518|NCT00637273|1070616|P1|NOT COMPLETED|Overall Study||43
448519|NCT00637273|1070614|P3|COMPLETED|Overall Study||131
448520|NCT00637273|1070615|P2|COMPLETED|Overall Study||144
448521|NCT00637273|1070616|P1|COMPLETED|Overall Study||127
448522|NCT00637273|1070614|P3|Intent to Treat (ITT)|Overall Study||165
448523|NCT00637273|1070615|P2|Intent to Treat (ITT)|Overall Study||166
448524|NCT00637273|1070616|P1|Intent to Treat (ITT)|Overall Study||160
448525|NCT00637273|1070614|P3|STARTED|Overall Study||172
448526|NCT00637273|1070615|P2|STARTED|Overall Study||172
448527|NCT00637273|1070616|P1|STARTED|Overall Study||170
448528|NCT00637247|1070659|P2|NOT COMPLETED|Overall Study||0
448529|NCT00637247|1070660|P1|NOT COMPLETED|Overall Study||0
448530|NCT00637247|1070659|P2|COMPLETED|Overall Study||70
448531|NCT00637247|1070660|P1|COMPLETED|Overall Study||72
448532|NCT00637247|1070659|P2|STARTED|Overall Study||70
448533|NCT00637247|1070660|P1|STARTED|Overall Study||72
448534|NCT00637195|1070672|P2|NOT COMPLETED|Overall Study||1
448535|NCT00637195|1070673|P1|NOT COMPLETED|Overall Study||3
448536|NCT00637195|1070672|P2|COMPLETED|Overall Study||75
448537|NCT00637195|1070673|P1|COMPLETED|Overall Study||73
448538|NCT00637195|1070672|P2|STARTED|Overall Study||76
448539|NCT00637195|1070673|P1|STARTED|Overall Study||76
448540|NCT00637156|1070709|P2|NOT COMPLETED|Overall Study||24
448541|NCT00637156|1070710|P1|NOT COMPLETED|Overall Study||10
448542|NCT00637156|1070709|P2|COMPLETED|Overall Study||164
448543|NCT00637156|1070710|P1|COMPLETED|Overall Study||199
448544|NCT00637156|1070709|P2|STARTED|Overall Study||188
448545|NCT00637156|1070710|P1|STARTED|Overall Study||209
448546|NCT00637000|1070752|P2|NOT COMPLETED|Overall Study||3
448547|NCT00637000|1070753|P1|NOT COMPLETED|Overall Study||4
448548|NCT00637000|1070752|P2|COMPLETED|Overall Study||15
448549|NCT00637000|1070753|P1|COMPLETED|Overall Study||16
448550|NCT00637000|1070752|P2|Evaluable|Overall Study||16
448551|NCT00637000|1070753|P1|Evaluable|Overall Study||18
448552|NCT00637000|1070752|P2|STARTED|Overall Study|Randomized and treated|18
448553|NCT00637000|1070753|P1|STARTED|Overall Study|Randomized and treated|20
448554|NCT00636987|1070793|P1|NOT COMPLETED|Overall Study||189
448555|NCT00636987|1070793|P1|COMPLETED|Overall Study||108
448556|NCT00636987|1070793|P1|STARTED|Overall Study||297
448557|NCT00636961|1070803|P2|NOT COMPLETED|Period 2||0
448558|NCT00636961|1070804|P1|NOT COMPLETED|Period 2||1
448559|NCT00636961|1070803|P2|COMPLETED|Period 2||12
448560|NCT00636961|1070804|P1|COMPLETED|Period 2||12
448561|NCT00636961|1070803|P2|STARTED|Period 2||12
448562|NCT00636961|1070804|P1|STARTED|Period 2||13
448563|NCT00636961|1070803|P2|NOT COMPLETED|Period 1||1
448564|NCT00636961|1070804|P1|NOT COMPLETED|Period 1||1
448565|NCT00636961|1070803|P2|COMPLETED|Period 1||12
448566|NCT00636961|1070804|P1|COMPLETED|Period 1||13
448567|NCT00636961|1070803|P2|STARTED|Period 1||13
448568|NCT00636961|1070804|P1|STARTED|Period 1||14
448569|NCT00636818|1070818|P1|NOT COMPLETED|Overall Study||11
448570|NCT00636818|1070818|P1|COMPLETED|Overall Study||34
448571|NCT00636818|1070818|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
448572|NCT00636818|1070818|P1|STARTED|Overall Study||45
448573|NCT00636805|1070833|P1|NOT COMPLETED|Overall Study||0
448574|NCT00636805|1070833|P1|COMPLETED|Overall Study||63
448575|NCT00636805|1070833|P1|STARTED|Overall Study||63
448576|NCT00636792|1070843|P1|NOT COMPLETED|Overall Study||33
448577|NCT00636792|1070843|P1|COMPLETED|Overall Study||40
448578|NCT00636792|1070843|P1|STARTED|Overall Study||73
448579|NCT00636701|1070850|P2|NOT COMPLETED|Overall Study||0
448580|NCT00636701|1070851|P1|NOT COMPLETED|Overall Study||0
448581|NCT00636701|1070850|P2|COMPLETED|Overall Study||2
448582|NCT00636701|1070851|P1|COMPLETED|Overall Study||2
448583|NCT00636701|1070850|P2|STARTED|Overall Study||2
448584|NCT00636701|1070851|P1|STARTED|Overall Study||2
448585|NCT00636649|1070859|P2|NOT COMPLETED|Overall Study||0
448586|NCT00636649|1070860|P1|NOT COMPLETED|Overall Study||0
448587|NCT00636649|1070859|P2|COMPLETED|Overall Study||20
448588|NCT00636649|1070860|P1|COMPLETED|Overall Study||20
448589|NCT00636649|1070859|P2|STARTED|Overall Study||20
448590|NCT00636649|1070860|P1|STARTED|Overall Study||20
448591|NCT00636636|1070890|P2|NOT COMPLETED|Overall Study||39
448592|NCT00636636|1070891|P1|NOT COMPLETED|Overall Study||36
448593|NCT00636636|1070890|P2|COMPLETED|Overall Study||192
448594|NCT00636636|1070891|P1|COMPLETED|Overall Study||185
448595|NCT00636636|1070890|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
448596|NCT00636636|1070891|P1|379|Overall Study||186
448597|NCT00636636|1070890|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
448598|NCT00636636|1070891|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
448599|NCT00636636|1070890|P2|STARTED|Overall Study||231
448600|NCT00636636|1070891|P1|STARTED|Overall Study||221
448601|NCT00636610|1070907|P2|NOT COMPLETED|Overall Study||83
448602|NCT00636610|1070908|P1|NOT COMPLETED|Overall Study||92
448603|NCT00636610|1070907|P2|COMPLETED|Overall Study||18
448604|NCT00636610|1070908|P1|COMPLETED|Overall Study||6
448605|NCT00636610|1070907|P2|STARTED|Overall Study||101
448606|NCT00636610|1070908|P1|STARTED|Overall Study||98
448607|NCT00636441|1070925|P7|NOT COMPLETED|Overall Study||18
448608|NCT00636441|1070926|P6|NOT COMPLETED|Overall Study||1
448609|NCT00636441|1070927|P5|NOT COMPLETED|Overall Study||0
448610|NCT00636441|1070928|P4|NOT COMPLETED|Overall Study||0
448611|NCT00636441|1070929|P3|NOT COMPLETED|Overall Study||1
448612|NCT00636441|1070930|P2|NOT COMPLETED|Overall Study||1
448613|NCT00636441|1070931|P1|NOT COMPLETED|Overall Study||0
448614|NCT00636441|1070925|P7|COMPLETED|Overall Study||0
448615|NCT00636441|1070926|P6|COMPLETED|Overall Study||6
448616|NCT00636441|1070927|P5|COMPLETED|Overall Study||6
448617|NCT00636441|1070928|P4|COMPLETED|Overall Study||6
448618|NCT00636441|1070929|P3|COMPLETED|Overall Study||5
448619|NCT00636441|1070930|P2|COMPLETED|Overall Study||6
448620|NCT00636441|1070931|P1|COMPLETED|Overall Study||6
448621|NCT00636441|1070925|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
448622|NCT00636441|1070926|P6|Assigned Treatment|Overall Study||7
448623|NCT00636441|1070927|P5|Assigned Treatment|Overall Study||6
448624|NCT00636441|1070928|P4|Assigned Treatment|Overall Study||6
448625|NCT00636441|1070929|P3|Assigned Treatment|Overall Study||6
448626|NCT00636441|1070930|P2|Assigned Treatment|Overall Study||7
448627|NCT00636441|1070931|P1|Assigned Treatment|Overall Study||6
448628|NCT00636441|1070925|P7|STARTED|Overall Study||18
448629|NCT00636441|1070926|P6|STARTED|Overall Study||7
448630|NCT00636441|1070927|P5|STARTED|Overall Study||6
448631|NCT00636441|1070928|P4|STARTED|Overall Study||6
448632|NCT00636441|1070929|P3|STARTED|Overall Study||6
448633|NCT00636441|1070930|P2|STARTED|Overall Study||7
448634|NCT00636441|1070931|P1|STARTED|Overall Study||6
448635|NCT00636389|1070960|P2|NOT COMPLETED|Period 2 - 1 Week||0
448636|NCT00636389|1070961|P1|NOT COMPLETED|Period 2 - 1 Week||0
448637|NCT00636389|1070960|P2|COMPLETED|Period 2 - 1 Week||5
448638|NCT00636389|1070961|P1|COMPLETED|Period 2 - 1 Week||7
448639|NCT00636389|1070960|P2|STARTED|Period 2 - 1 Week||5
448640|NCT00636389|1070961|P1|STARTED|Period 2 - 1 Week||7
448641|NCT00636389|1070960|P2|NOT COMPLETED|Period 1 - 1 Week||0
448642|NCT00636389|1070961|P1|NOT COMPLETED|Period 1 - 1 Week||0
448643|NCT00636389|1070960|P2|COMPLETED|Period 1 - 1 Week||5
448644|NCT00636389|1070961|P1|COMPLETED|Period 1 - 1 Week||7
448645|NCT00636389|1070960|P2|STARTED|Period 1 - 1 Week||5
448646|NCT00636389|1070961|P1|STARTED|Period 1 - 1 Week||7
448647|NCT00636363|1070974|P3|NOT COMPLETED|Overall Study||18
448648|NCT00636363|1070975|P2|NOT COMPLETED|Overall Study||20
448649|NCT00636363|1070976|P1|NOT COMPLETED|Overall Study||13
448650|NCT00636363|1070974|P3|COMPLETED|Overall Study||163
448651|NCT00636363|1070975|P2|COMPLETED|Overall Study||156
448652|NCT00636363|1070976|P1|COMPLETED|Overall Study||165
448653|NCT00636363|1070974|P3|STARTED|Overall Study||181
448654|NCT00636363|1070975|P2|STARTED|Overall Study||176
448655|NCT00636363|1070976|P1|STARTED|Overall Study||178
448656|NCT00636220|1070990|P1|NOT COMPLETED|Overall Study||0
448657|NCT00636220|1070990|P1|COMPLETED|Overall Study||101
448658|NCT00636220|1070990|P1|STARTED|Overall Study||101
448659|NCT00636207|1070997|P7|NOT COMPLETED|Overall Study||0
448660|NCT00636207|1070998|P6|NOT COMPLETED|Overall Study||0
448661|NCT00636207|1070999|P5|NOT COMPLETED|Overall Study||1
448662|NCT00636207|1071000|P4|NOT COMPLETED|Overall Study||0
448663|NCT00636207|1071001|P3|NOT COMPLETED|Overall Study||0
448664|NCT00636207|1071002|P2|NOT COMPLETED|Overall Study||1
448665|NCT00636207|1071003|P1|NOT COMPLETED|Overall Study||1
448666|NCT00636207|1070997|P7|COMPLETED|Overall Study||3
448667|NCT00636207|1070998|P6|COMPLETED|Overall Study||1
448668|NCT00636207|1070999|P5|COMPLETED|Overall Study||8
448669|NCT00636207|1071000|P4|COMPLETED|Overall Study||6
448670|NCT00636207|1071001|P3|COMPLETED|Overall Study||18
448671|NCT00636207|1071002|P2|COMPLETED|Overall Study||7
448672|NCT00636207|1071003|P1|COMPLETED|Overall Study||0
448673|NCT00636207|1070997|P7|STARTED|Overall Study||3
448674|NCT00636207|1070998|P6|STARTED|Overall Study||1
448675|NCT00636207|1070999|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
448676|NCT00636207|1071000|P4|STARTED|Overall Study||6
448677|NCT00636207|1071001|P3|STARTED|Overall Study||18
448678|NCT00636207|1071002|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
448679|NCT00636207|1071003|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
448680|NCT00636194|1071067|P2|NOT COMPLETED|Overall Study||0
448681|NCT00636194|1071068|P1|NOT COMPLETED|Overall Study||3
448682|NCT00636194|1071067|P2|COMPLETED|Overall Study||175
448683|NCT00636194|1071068|P1|COMPLETED|Overall Study||172
448684|NCT00636194|1071067|P2|STARTED|Overall Study||175
448685|NCT00636194|1071068|P1|STARTED|Overall Study||175
448686|NCT00636168|1071080|P2|NOT COMPLETED|Treated With Study Drug||411
448687|NCT00636168|1071081|P1|NOT COMPLETED|Treated With Study Drug||447
448688|NCT00636168|1071080|P2|COMPLETED|Treated With Study Drug||63
448689|NCT00636168|1071081|P1|COMPLETED|Treated With Study Drug||24
448690|NCT00636168|1071080|P2|STARTED|Treated With Study Drug||474
448691|NCT00636168|1071081|P1|STARTED|Treated With Study Drug||471
448692|NCT00636168|1071080|P2|NOT COMPLETED|Randomized to Study Drug||2
448693|NCT00636168|1071081|P1|NOT COMPLETED|Randomized to Study Drug||4
448694|NCT00636168|1071080|P2|COMPLETED|Randomized to Study Drug||474
448695|NCT00636168|1071081|P1|COMPLETED|Randomized to Study Drug||471
448696|NCT00636168|1071080|P2|STARTED|Randomized to Study Drug||476
448697|NCT00636168|1071081|P1|STARTED|Randomized to Study Drug||475
448698|NCT00636155|1071101|P1|NOT COMPLETED|Overall Study||18
448699|NCT00636155|1071101|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
448700|NCT00636155|1071101|P1|STARTED|Overall Study||20
448701|NCT00636077|1071107|P4|NOT COMPLETED|Week 4||0
448702|NCT00636077|1071108|P3|NOT COMPLETED|Week 4||0
448703|NCT00636077|1071109|P2|NOT COMPLETED|Week 4||0
448704|NCT00636077|1071110|P1|NOT COMPLETED|Week 4||0
448705|NCT00636077|1071107|P4|COMPLETED|Week 4||3
448706|NCT00636077|1071108|P3|COMPLETED|Week 4||3
448707|NCT00636077|1071109|P2|COMPLETED|Week 4||3
448708|NCT00636077|1071110|P1|COMPLETED|Week 4||3
448709|NCT00636077|1071107|P4|STARTED|Week 4||3
448710|NCT00636077|1071108|P3|STARTED|Week 4||3
448711|NCT00636077|1071109|P2|STARTED|Week 4||3
448712|NCT00636077|1071110|P1|STARTED|Week 4||3
448713|NCT00636077|1071107|P4|NOT COMPLETED|Week 3||0
448714|NCT00636077|1071108|P3|NOT COMPLETED|Week 3||0
448715|NCT00636077|1071109|P2|NOT COMPLETED|Week 3||0
448716|NCT00636077|1071110|P1|NOT COMPLETED|Week 3||0
448717|NCT00636077|1071107|P4|COMPLETED|Week 3||3
448718|NCT00636077|1071108|P3|COMPLETED|Week 3||3
448719|NCT00636077|1071109|P2|COMPLETED|Week 3||3
448720|NCT00636077|1071110|P1|COMPLETED|Week 3||3
448721|NCT00636077|1071107|P4|STARTED|Week 3||3
448722|NCT00636077|1071108|P3|STARTED|Week 3||3
448723|NCT00636077|1071109|P2|STARTED|Week 3||3
448724|NCT00636077|1071110|P1|STARTED|Week 3||3
448725|NCT00636077|1071107|P4|NOT COMPLETED|Week 2||0
448726|NCT00636077|1071108|P3|NOT COMPLETED|Week 2||0
448727|NCT00636077|1071109|P2|NOT COMPLETED|Week 2||0
448728|NCT00636077|1071110|P1|NOT COMPLETED|Week 2||0
448729|NCT00636077|1071107|P4|COMPLETED|Week 2||3
448730|NCT00636077|1071108|P3|COMPLETED|Week 2||3
448731|NCT00636077|1071109|P2|COMPLETED|Week 2||3
448732|NCT00636077|1071110|P1|COMPLETED|Week 2||3
448733|NCT00636077|1071107|P4|STARTED|Week 2||3
448734|NCT00636077|1071108|P3|STARTED|Week 2||3
448735|NCT00636077|1071109|P2|STARTED|Week 2||3
448736|NCT00636077|1071110|P1|STARTED|Week 2||3
448737|NCT00636077|1071107|P4|NOT COMPLETED|Week 1||0
448738|NCT00636077|1071108|P3|NOT COMPLETED|Week 1||0
448739|NCT00636077|1071109|P2|NOT COMPLETED|Week 1||0
448740|NCT00636077|1071110|P1|NOT COMPLETED|Week 1||0
448741|NCT00636077|1071107|P4|COMPLETED|Week 1||3
448742|NCT00636077|1071108|P3|COMPLETED|Week 1||3
448743|NCT00636077|1071109|P2|COMPLETED|Week 1||3
448744|NCT00636077|1071110|P1|COMPLETED|Week 1||3
448745|NCT00636077|1071107|P4|STARTED|Week 1||3
448746|NCT00636077|1071108|P3|STARTED|Week 1||3
448747|NCT00636077|1071109|P2|STARTED|Week 1||3
448748|NCT00636077|1071110|P1|STARTED|Week 1||3
448749|NCT00635882|1071146|P6|NOT COMPLETED|Overall Study||0
448750|NCT00635882|1071147|P5|NOT COMPLETED|Overall Study||0
448751|NCT00635882|1071148|P4|NOT COMPLETED|Overall Study||0
448752|NCT00635882|1071149|P3|NOT COMPLETED|Overall Study||0
448753|NCT00635882|1071150|P2|NOT COMPLETED|Overall Study||0
448754|NCT00635882|1071151|P1|NOT COMPLETED|Overall Study||1
448755|NCT00635882|1071146|P6|COMPLETED|Overall Study||13
448756|NCT00635882|1071147|P5|COMPLETED|Overall Study||16
448757|NCT00635882|1071148|P4|COMPLETED|Overall Study||15
448758|NCT00635882|1071149|P3|COMPLETED|Overall Study||12
448759|NCT00635882|1071150|P2|COMPLETED|Overall Study||17
448760|NCT00635882|1071151|P1|COMPLETED|Overall Study||19
448761|NCT00635882|1071146|P6|STARTED|Overall Study||13
448762|NCT00635882|1071147|P5|STARTED|Overall Study||16
448763|NCT00635882|1071148|P4|STARTED|Overall Study||15
448764|NCT00635882|1071149|P3|STARTED|Overall Study||12
448765|NCT00635882|1071150|P2|STARTED|Overall Study||17
448766|NCT00635882|1071151|P1|STARTED|Overall Study||20
448767|NCT00635830|1071215|P2|NOT COMPLETED|Overall Study||0
448768|NCT00635830|1071216|P1|NOT COMPLETED|Overall Study||0
448769|NCT00635830|1071215|P2|COMPLETED|Overall Study||20
448770|NCT00635830|1071216|P1|COMPLETED|Overall Study||20
448771|NCT00635830|1071215|P2|STARTED|Overall Study||20
448772|NCT00635830|1071216|P1|STARTED|Overall Study||20
448773|NCT00635817|1071226|P4|NOT COMPLETED|Overall Study||0
448774|NCT00635817|1071227|P3|NOT COMPLETED|Overall Study||2
448775|NCT00635817|1071228|P2|NOT COMPLETED|Overall Study||2
448776|NCT00635817|1071229|P1|NOT COMPLETED|Overall Study||6
448777|NCT00635817|1071226|P4|COMPLETED|Overall Study||21
448778|NCT00635817|1071227|P3|COMPLETED|Overall Study||19
448779|NCT00635817|1071228|P2|COMPLETED|Overall Study||19
448780|NCT00635817|1071229|P1|COMPLETED|Overall Study||15
448781|NCT00635817|1071226|P4|STARTED|Overall Study||21
448782|NCT00635817|1071227|P3|STARTED|Overall Study||21
448783|NCT00635817|1071228|P2|STARTED|Overall Study||21
448784|NCT00635817|1071229|P1|STARTED|Overall Study||21
448785|NCT00635804|1071281|P8|NOT COMPLETED|Overall Study||0
448786|NCT00635804|1071282|P7|NOT COMPLETED|Overall Study||0
448787|NCT00635804|1071283|P6|NOT COMPLETED|Overall Study||1
448788|NCT00635804|1071284|P5|NOT COMPLETED|Overall Study||0
448789|NCT00635804|1071285|P4|NOT COMPLETED|Overall Study||0
448790|NCT00635804|1071286|P3|NOT COMPLETED|Overall Study||0
448791|NCT00635804|1071287|P2|NOT COMPLETED|Overall Study||0
448792|NCT00635804|1071288|P1|NOT COMPLETED|Overall Study||1
448793|NCT00635804|1071281|P8|COMPLETED|Overall Study||14
448794|NCT00635804|1071282|P7|COMPLETED|Overall Study||3
448795|NCT00635804|1071283|P6|COMPLETED|Overall Study||11
448796|NCT00635804|1071284|P5|COMPLETED|Overall Study||6
448797|NCT00635804|1071285|P4|COMPLETED|Overall Study||6
448798|NCT00635804|1071286|P3|COMPLETED|Overall Study||6
448799|NCT00635804|1071287|P2|COMPLETED|Overall Study||6
448800|NCT00635804|1071288|P1|COMPLETED|Overall Study||6
448801|NCT00635804|1071281|P8|STARTED|Overall Study||14
448802|NCT00635804|1071282|P7|STARTED|Overall Study||3
448803|NCT00635804|1071283|P6|STARTED|Overall Study||12
448804|NCT00635804|1071284|P5|STARTED|Overall Study||6
448805|NCT00635804|1071285|P4|STARTED|Overall Study||6
448806|NCT00635804|1071286|P3|STARTED|Overall Study||6
448807|NCT00635804|1071287|P2|STARTED|Overall Study||6
448808|NCT00635804|1071288|P1|STARTED|Overall Study||7
448809|NCT00635700|1071387|P2|NOT COMPLETED|Overall Study||14
448810|NCT00635700|1071388|P1|NOT COMPLETED|Overall Study||15
448811|NCT00635700|1071387|P2|COMPLETED|Overall Study||13
448812|NCT00635700|1071388|P1|COMPLETED|Overall Study||9
448813|NCT00635700|1071387|P2|STARTED|Overall Study||27
448814|NCT00635700|1071388|P1|STARTED|Overall Study||24
448815|NCT00635661|1071394|P1|NOT COMPLETED|Overall Study||4
448816|NCT00635661|1071394|P1|COMPLETED|Overall Study||30
448817|NCT00635661|1071394|P1|STARTED|Overall Study||34
448818|NCT00635648|1071398|P1|NOT COMPLETED|Overall Study||37
448819|NCT00635648|1071398|P1|COMPLETED|Overall Study||26
448820|NCT00635648|1071398|P1|STARTED|Overall Study||63
448821|NCT00635609|1071407|P2|NOT COMPLETED|Overall Study||3
448822|NCT00635609|1071408|P1|NOT COMPLETED|Overall Study||7
448823|NCT00635609|1071407|P2|COMPLETED|Overall Study||42
448824|NCT00635609|1071408|P1|COMPLETED|Overall Study||41
448825|NCT00635609|1071407|P2|STARTED|Overall Study||45
448826|NCT00635609|1071408|P1|STARTED|Overall Study||48
448827|NCT00635570|1071420|P2|NOT COMPLETED|Overall Study||11
448828|NCT00635570|1071421|P1|NOT COMPLETED|Overall Study||15
448829|NCT00635570|1071420|P2|COMPLETED|Overall Study||126
448830|NCT00635570|1071421|P1|COMPLETED|Overall Study||121
448831|NCT00635570|1071420|P2|STARTED|Overall Study||137
448832|NCT00635570|1071421|P1|STARTED|Overall Study||136
448833|NCT00635492|1071435|P2|NOT COMPLETED|Overall Study||282
448834|NCT00635492|1071436|P1|NOT COMPLETED|Overall Study||279
448835|NCT00635492|1071435|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
448836|NCT00635492|1071436|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
448837|NCT00635492|1071435|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
448838|NCT00635492|1071436|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
448839|NCT00635479|1071482|P2|NOT COMPLETED|Overall Study||18
448840|NCT00635479|1071483|P1|NOT COMPLETED|Overall Study||6
448841|NCT00635479|1071482|P2|COMPLETED|Overall Study||42
448842|NCT00635479|1071483|P1|COMPLETED|Overall Study||49
448843|NCT00635479|1071482|P2|STARTED|Overall Study||60
448844|NCT00635479|1071483|P1|STARTED|Overall Study||55
448845|NCT00635427|1071494|P5|NOT COMPLETED|Overall Study||8
448846|NCT00635427|1071495|P4|NOT COMPLETED|Overall Study||9
448847|NCT00635427|1071496|P3|NOT COMPLETED|Overall Study||11
448848|NCT00635427|1071497|P2|NOT COMPLETED|Overall Study||6
448849|NCT00635427|1071498|P1|NOT COMPLETED|Overall Study||12
448850|NCT00635427|1071494|P5|COMPLETED|Overall Study||30
448851|NCT00635427|1071495|P4|COMPLETED|Overall Study||7
448852|NCT00635427|1071496|P3|COMPLETED|Overall Study||5
448853|NCT00635427|1071497|P2|COMPLETED|Overall Study||6
448854|NCT00635427|1071498|P1|COMPLETED|Overall Study||1
448855|NCT00635427|1071494|P5|STARTED|Overall Study||38
448856|NCT00635427|1071495|P4|STARTED|Overall Study||16
448857|NCT00635427|1071496|P3|STARTED|Overall Study||16
448858|NCT00635427|1071497|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
448859|NCT00635427|1071498|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
448860|NCT00635362|1071520|P2|NOT COMPLETED|Overall Study||8
448861|NCT00635362|1071521|P1|NOT COMPLETED|Overall Study||13
448862|NCT00635362|1071520|P2|COMPLETED|Overall Study||12
448863|NCT00635362|1071521|P1|COMPLETED|Overall Study||9
448864|NCT00635362|1071520|P2|STARTED|Overall Study||20
448865|NCT00635362|1071521|P1|STARTED|Overall Study||22
448866|NCT00635349|1071537|P2|NOT COMPLETED|Overall Study||48
448867|NCT00635349|1071538|P1|NOT COMPLETED|Overall Study||44
448868|NCT00635349|1071537|P2|COMPLETED|Overall Study||19
448869|NCT00635349|1071538|P1|COMPLETED|Overall Study||29
448870|NCT00635349|1071537|P2|STARTED|Overall Study||67
448871|NCT00635349|1071538|P1|STARTED|Overall Study||73
448872|NCT00635232|1071561|P5|NOT COMPLETED|Overall Study||8
448873|NCT00635232|1071562|P4|NOT COMPLETED|Overall Study||10
448874|NCT00635232|1071563|P3|NOT COMPLETED|Overall Study||3
448875|NCT00635232|1071564|P2|NOT COMPLETED|Overall Study||20
448876|NCT00635232|1071565|P1|NOT COMPLETED|Overall Study||14
448877|NCT00635232|1071561|P5|COMPLETED|Overall Study||20
448878|NCT00635232|1071562|P4|COMPLETED|Overall Study||48
448879|NCT00635232|1071563|P3|COMPLETED|Overall Study||55
448880|NCT00635232|1071564|P2|COMPLETED|Overall Study||39
448881|NCT00635232|1071565|P1|COMPLETED|Overall Study||44
448882|NCT00635232|1071561|P5|STARTED|Overall Study||28
448883|NCT00635232|1071562|P4|STARTED|Overall Study||58
448884|NCT00635232|1071563|P3|STARTED|Overall Study||58
448885|NCT00635232|1071564|P2|STARTED|Overall Study||59
448886|NCT00635232|1071565|P1|STARTED|Overall Study||58
448887|NCT00635219|1071592|P5|NOT COMPLETED|Overall Study||42
448888|NCT00635219|1071593|P4|NOT COMPLETED|Overall Study||34
448889|NCT00635219|1071594|P3|NOT COMPLETED|Overall Study||35
448890|NCT00635219|1071595|P2|NOT COMPLETED|Overall Study||25
448891|NCT00635219|1071596|P1|NOT COMPLETED|Overall Study||25
448892|NCT00635219|1071592|P5|COMPLETED|Overall Study||113
448893|NCT00635219|1071593|P4|COMPLETED|Overall Study||117
448894|NCT00635219|1071594|P3|COMPLETED|Overall Study||122
448895|NCT00635219|1071595|P2|COMPLETED|Overall Study||130
448896|NCT00635219|1071596|P1|COMPLETED|Overall Study||123
448897|NCT00635219|1071592|P5|STARTED|Overall Study||155
448898|NCT00635219|1071593|P4|STARTED|Overall Study||151
448899|NCT00635219|1071594|P3|STARTED|Overall Study||157
448900|NCT00635219|1071595|P2|STARTED|Overall Study||155
448901|NCT00635219|1071596|P1|STARTED|Overall Study||148
448902|NCT00635154|1071653|P1|NOT COMPLETED|Overall Study||33
448903|NCT00635154|1071653|P1|COMPLETED|Overall Study||21
448904|NCT00635154|1071653|P1|STARTED|Overall Study||54
448905|NCT00635102|1071665|P2|NOT COMPLETED|Overall Study||8
448906|NCT00635102|1071666|P1|NOT COMPLETED|Overall Study||7
448907|NCT00635102|1071665|P2|COMPLETED|Overall Study||22
448908|NCT00635102|1071666|P1|COMPLETED|Overall Study||20
448909|NCT00635102|1071665|P2|STARTED|Overall Study||30
448910|NCT00635102|1071666|P1|STARTED|Overall Study||27
448911|NCT00635089|1071760|P1|NOT COMPLETED|Overall Study||78
448912|NCT00635089|1071760|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
448913|NCT00635089|1071760|P1|Completed >/= 16 Weeks of Study|Overall Study||181
448914|NCT00635089|1071760|P1|STARTED|Overall Study||190
448915|NCT00635050|1071787|P1|NOT COMPLETED|Overall Study||1
448916|NCT00635050|1071787|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
448917|NCT00635050|1071787|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
448918|NCT00635024|1071794|P1|NOT COMPLETED|Overall Study||1
448919|NCT00635024|1071794|P1|COMPLETED|Overall Study||0
448920|NCT00635024|1071794|P1|STARTED|Overall Study||1
448921|NCT00634933|1071805|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
448922|NCT00634933|1071806|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
448923|NCT00634933|1071807|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
448924|NCT00634933|1071808|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
448925|NCT00634933|1071809|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
448926|NCT00634933|1071805|P5|COMPLETED|Part B: Week 24 to Week 52||22
448927|NCT00634933|1071806|P4|COMPLETED|Part B: Week 24 to Week 52||25
448928|NCT00634933|1071807|P3|COMPLETED|Part B: Week 24 to Week 52||33
448929|NCT00634933|1071808|P2|COMPLETED|Part B: Week 24 to Week 52||42
448930|NCT00634933|1071809|P1|COMPLETED|Part B: Week 24 to Week 52||0
448931|NCT00634933|1071805|P5|STARTED|Part B: Week 24 to Week 52||32
448932|NCT00634933|1071806|P4|STARTED|Part B: Week 24 to Week 52||31
448933|NCT00634933|1071807|P3|STARTED|Part B: Week 24 to Week 52||55
448934|NCT00634933|1071808|P2|STARTED|Part B: Week 24 to Week 52||56
448935|NCT00634933|1071809|P1|STARTED|Part B: Week 24 to Week 52||0
448936|NCT00634933|1071805|P5|NOT COMPLETED|Between Part A and Part B||0
448937|NCT00634933|1071806|P4|NOT COMPLETED|Between Part A and Part B||0
448938|NCT00634933|1071807|P3|NOT COMPLETED|Between Part A and Part B||0
448939|NCT00634933|1071808|P2|NOT COMPLETED|Between Part A and Part B||1
448940|NCT00634933|1071809|P1|NOT COMPLETED|Between Part A and Part B||0
448941|NCT00634933|1071805|P5|COMPLETED|Between Part A and Part B||32
448942|NCT00634933|1071806|P4|COMPLETED|Between Part A and Part B||31
448943|NCT00634933|1071807|P3|COMPLETED|Between Part A and Part B||55
448944|NCT00634933|1071808|P2|COMPLETED|Between Part A and Part B||56
448945|NCT00634933|1071809|P1|COMPLETED|Between Part A and Part B||0
448946|NCT00634933|1071805|P5|STARTED|Between Part A and Part B||32
448947|NCT00634933|1071806|P4|STARTED|Between Part A and Part B||31
448948|NCT00634933|1071807|P3|STARTED|Between Part A and Part B||55
448949|NCT00634933|1071808|P2|STARTED|Between Part A and Part B||57
448950|NCT00634933|1071809|P1|STARTED|Between Part A and Part B||0
448951|NCT00634933|1071805|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
448952|NCT00634933|1071806|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
448953|NCT00634933|1071807|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
448954|NCT00634933|1071808|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
448955|NCT00634933|1071809|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
448956|NCT00634933|1071805|P5|COMPLETED|Part A: Baseline to Week 24||0
448957|NCT00634933|1071806|P4|COMPLETED|Part A: Baseline to Week 24||0
448958|NCT00634933|1071807|P3|COMPLETED|Part A: Baseline to Week 24||55
448959|NCT00634933|1071808|P2|COMPLETED|Part A: Baseline to Week 24||57
448960|NCT00634933|1071809|P1|COMPLETED|Part A: Baseline to Week 24||63
448961|NCT00634933|1071805|P5|STARTED|Part A: Baseline to Week 24||0
448962|NCT00634933|1071806|P4|STARTED|Part A: Baseline to Week 24||0
448963|NCT00634933|1071807|P3|STARTED|Part A: Baseline to Week 24||73
448964|NCT00634933|1071808|P2|STARTED|Part A: Baseline to Week 24||75
448965|NCT00634933|1071809|P1|STARTED|Part A: Baseline to Week 24||74
448966|NCT00634920|1071878|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
448967|NCT00634920|1071879|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
448968|NCT00634920|1071880|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
448969|NCT00634920|1071878|P3|COMPLETED|Period 2 - Post-Randomization||0
448970|NCT00634920|1071879|P2|COMPLETED|Period 2 - Post-Randomization||68
448971|NCT00634920|1071880|P1|COMPLETED|Period 2 - Post-Randomization||43
448972|NCT00634920|1071878|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
448973|NCT00634920|1071879|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
448974|NCT00634920|1071880|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
448975|NCT00634920|1071878|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
448976|NCT00634920|1071879|P2|STARTED|Period 2 - Post-Randomization||100
448977|NCT00634920|1071880|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
448978|NCT00634920|1071878|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
448979|NCT00634920|1071879|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
448980|NCT00634920|1071880|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
448981|NCT00634920|1071878|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
448982|NCT00634920|1071879|P2|COMPLETED|Period 1 - Pre-Randomization||0
448983|NCT00634920|1071880|P1|COMPLETED|Period 1 - Pre-Randomization||0
448984|NCT00634920|1071878|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
448985|NCT00634920|1071879|P2|STARTED|Period 1 - Pre-Randomization||0
448986|NCT00634920|1071880|P1|STARTED|Period 1 - Pre-Randomization||0
448987|NCT00634907|1071924|P2|NOT COMPLETED|Overall Study||17
448988|NCT00634907|1071925|P1|NOT COMPLETED|Overall Study||17
448989|NCT00634907|1071924|P2|COMPLETED|Overall Study||115
448990|NCT00634907|1071925|P1|COMPLETED|Overall Study||114
448991|NCT00634907|1071924|P2|STARTED|Overall Study||132
448992|NCT00634907|1071925|P1|STARTED|Overall Study||131
448993|NCT00634842|1071949|P2|NOT COMPLETED|Overall Study||18
448994|NCT00634842|1071950|P1|NOT COMPLETED|Overall Study||15
448995|NCT00634842|1071949|P2|COMPLETED|Overall Study||104
448996|NCT00634842|1071950|P1|COMPLETED|Overall Study||107
448997|NCT00634842|1071949|P2|STARTED|Overall Study||122
448998|NCT00634842|1071950|P1|STARTED|Overall Study||122
448999|NCT00634647|1071962|P1|NOT COMPLETED|Overall Study||9
449000|NCT00634647|1071962|P1|COMPLETED|Overall Study||15
449001|NCT00634647|1071962|P1|STARTED|Overall Study||24
449002|NCT00634621|1071967|P1|NOT COMPLETED|Overall Study||0
449003|NCT00634621|1071967|P1|COMPLETED|Overall Study||283
449004|NCT00634621|1071967|P1|STARTED|Overall Study||283
449005|NCT00634582|1071975|P1|NOT COMPLETED|Overall Study||0
449006|NCT00634582|1071975|P1|COMPLETED|Overall Study||2
449007|NCT00634582|1071975|P1|STARTED|Overall Study||2
449008|NCT00634569|1071981|P2|NOT COMPLETED|Overall Study||5
449009|NCT00634569|1071982|P1|NOT COMPLETED|Overall Study||0
449010|NCT00634569|1071981|P2|COMPLETED|Overall Study||5
449011|NCT00634569|1071982|P1|COMPLETED|Overall Study||14
449012|NCT00634569|1071981|P2|STARTED|Overall Study||10
449013|NCT00634569|1071982|P1|STARTED|Overall Study||14
449014|NCT00634543|1071996|P2|NOT COMPLETED|Overall Study||21
449015|NCT00634543|1071997|P1|NOT COMPLETED|Overall Study||19
449016|NCT00634543|1071996|P2|COMPLETED|Overall Study||63
449017|NCT00634543|1071997|P1|COMPLETED|Overall Study||59
449018|NCT00634543|1071996|P2|Treated|Overall Study||80
449019|NCT00634543|1071997|P1|Treated|Overall Study||76
449020|NCT00634543|1071996|P2|STARTED|Overall Study||84
449021|NCT00634543|1071997|P1|STARTED|Overall Study||78
449022|NCT00634504|1072015|P2|NOT COMPLETED|Overall Study||0
449023|NCT00634504|1072016|P1|NOT COMPLETED|Overall Study||1
449024|NCT00634504|1072015|P2|COMPLETED|Overall Study||9
449025|NCT00634504|1072016|P1|COMPLETED|Overall Study||10
449026|NCT00634504|1072015|P2|STARTED|Overall Study||9
449027|NCT00634504|1072016|P1|STARTED|Overall Study||11
449028|NCT00633360|1072024|P2|NOT COMPLETED|Overall Study||3
449029|NCT00633360|1072025|P1|NOT COMPLETED|Overall Study||4
449030|NCT00633360|1072024|P2|COMPLETED|Overall Study||13
449031|NCT00633360|1072025|P1|COMPLETED|Overall Study||12
449032|NCT00633360|1072024|P2|STARTED|Overall Study||16
449033|NCT00633360|1072025|P1|STARTED|Overall Study||16
449034|NCT00633256|1072035|P2|NOT COMPLETED|Overall Study||3
449035|NCT00633256|1072036|P1|NOT COMPLETED|Overall Study||4
449036|NCT00633256|1072035|P2|COMPLETED|Overall Study||10
449037|NCT00633256|1072036|P1|COMPLETED|Overall Study||8
449038|NCT00633256|1072035|P2|STARTED|Overall Study||13
449039|NCT00633256|1072036|P1|STARTED|Overall Study||12
449040|NCT00633243|1072048|P2|NOT COMPLETED|Overall Study||7
449041|NCT00633243|1072049|P1|NOT COMPLETED|Overall Study||1
449042|NCT00633243|1072048|P2|COMPLETED|Overall Study||2
449043|NCT00633243|1072049|P1|COMPLETED|Overall Study||11
449044|NCT00633243|1072048|P2|STARTED|Overall Study||9
449045|NCT00633243|1072049|P1|STARTED|Overall Study||12
449046|NCT00633217|1072057|P2|NOT COMPLETED|Overall Study||23
449047|NCT00633217|1072058|P1|NOT COMPLETED|Overall Study||15
449048|NCT00633217|1072057|P2|COMPLETED|Overall Study||103
449049|NCT00633217|1072058|P1|COMPLETED|Overall Study||106
449050|NCT00633217|1072057|P2|STARTED|Overall Study||126
449051|NCT00633217|1072058|P1|STARTED|Overall Study||121
449052|NCT00633152|1072070|P2|NOT COMPLETED|Overall Study||6
449053|NCT00633152|1072071|P1|NOT COMPLETED|Overall Study||14
449054|NCT00633152|1072070|P2|COMPLETED|Overall Study||41
449055|NCT00633152|1072071|P1|COMPLETED|Overall Study||89
449056|NCT00633152|1072070|P2|Clinically Evaluable Population|Overall Study||39
449057|NCT00633152|1072071|P1|Clinically Evaluable Population|Overall Study||86
449058|NCT00633152|1072070|P2|MITT and Safety Population|Overall Study||45
449059|NCT00633152|1072071|P1|MITT and Safety Population|Overall Study||98
449060|NCT00633152|1072070|P2|STARTED|Overall Study||47
449061|NCT00633152|1072071|P1|STARTED|Overall Study||103
449062|NCT00634322|1072082|P3|NOT COMPLETED|Overall Study||0
449063|NCT00634322|1072083|P2|NOT COMPLETED|Overall Study||0
449064|NCT00634322|1072084|P1|NOT COMPLETED|Overall Study||0
449065|NCT00634322|1072082|P3|COMPLETED|Overall Study||5
449066|NCT00634322|1072083|P2|COMPLETED|Overall Study||1
449067|NCT00634322|1072084|P1|COMPLETED|Overall Study||1
449068|NCT00634322|1072082|P3|STARTED|Overall Study||5
449069|NCT00634322|1072083|P2|STARTED|Overall Study||1
449070|NCT00634322|1072084|P1|STARTED|Overall Study||1
449071|NCT00634270|1072094|P2|NOT COMPLETED|Overall Study||1
449072|NCT00634270|1072095|P1|NOT COMPLETED|Overall Study||3
449073|NCT00634270|1072094|P2|COMPLETED|Overall Study||12
449074|NCT00634270|1072095|P1|COMPLETED|Overall Study||46
449075|NCT00634270|1072094|P2|STARTED|Overall Study||13
449076|NCT00634270|1072095|P1|STARTED|Overall Study|February 12, 2008|49
449077|NCT00634244|1072122|P3|NOT COMPLETED|Overall Study||0
449078|NCT00634244|1072123|P2|NOT COMPLETED|Overall Study||13
449079|NCT00634244|1072124|P1|NOT COMPLETED|Overall Study||1
449080|NCT00634244|1072122|P3|COMPLETED|Overall Study||20
449081|NCT00634244|1072123|P2|COMPLETED|Overall Study||24
449082|NCT00634244|1072124|P1|COMPLETED|Overall Study||34
449083|NCT00634244|1072122|P3|Eligible and Treated|Overall Study||20
449084|NCT00634244|1072123|P2|Eligible and Treated|Overall Study||36
449085|NCT00634244|1072124|P1|Eligible and Treated|Overall Study||35
449086|NCT00634244|1072122|P3|STARTED|Overall Study||20
449087|NCT00634244|1072123|P2|STARTED|Overall Study||37
449088|NCT00634244|1072124|P1|STARTED|Overall Study||35
449089|NCT00634179|1072135|P1|NOT COMPLETED|Phase II: Maintenance||1
449090|NCT00634179|1072135|P1|COMPLETED|Phase II: Maintenance||29
449091|NCT00634179|1072135|P1|STARTED|Phase II: Maintenance||30
449092|NCT00634179|1072135|P1|NOT COMPLETED|Phase I: Induction||0
449093|NCT00634179|1072135|P1|COMPLETED|Phase I: Induction||19
449094|NCT00634179|1072135|P1|STARTED|Phase I: Induction||19
449095|NCT00634166|1072144|P2|NOT COMPLETED|Overall Study||60
449096|NCT00634166|1072145|P1|NOT COMPLETED|Overall Study||60
449097|NCT00634166|1072144|P2|COMPLETED|Overall Study||78
449098|NCT00634166|1072145|P1|COMPLETED|Overall Study||22
449099|NCT00634166|1072144|P2|STARTED|Overall Study||138
449100|NCT00634166|1072145|P1|STARTED|Overall Study||82
449101|NCT00634114|1072154|P3|NOT COMPLETED|Overall Study||39
449102|NCT00634114|1072155|P2|NOT COMPLETED|Overall Study||35
449103|NCT00634114|1072156|P1|NOT COMPLETED|Overall Study||28
449104|NCT00634114|1072154|P3|COMPLETED|Overall Study|Completed|148
449105|NCT00634114|1072155|P2|COMPLETED|Overall Study|Completed|154
449106|NCT00634114|1072156|P1|COMPLETED|Overall Study|Completed|160
449107|NCT00634114|1072154|P3|STARTED|Overall Study|Randomised|187
449108|NCT00634114|1072155|P2|STARTED|Overall Study|Randomised|189
449109|NCT00634114|1072156|P1|STARTED|Overall Study|Randomised|188
449110|NCT00634088|1072174|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
449111|NCT00634088|1072175|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
449112|NCT00634088|1072176|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
449113|NCT00634088|1072177|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
449114|NCT00634088|1072174|P4|COMPLETED|Time Period 4: Triplet Combination||0
449115|NCT00634088|1072175|P3|COMPLETED|Time Period 4: Triplet Combination||0
449116|NCT00634088|1072176|P2|COMPLETED|Time Period 4: Triplet Combination||0
449117|NCT00634088|1072177|P1|COMPLETED|Time Period 4: Triplet Combination||0
449118|NCT00634088|1072174|P4|STARTED|Time Period 4: Triplet Combination||0
449119|NCT00634088|1072175|P3|STARTED|Time Period 4: Triplet Combination||0
449120|NCT00634088|1072176|P2|STARTED|Time Period 4: Triplet Combination||0
449121|NCT00634088|1072177|P1|STARTED|Time Period 4: Triplet Combination||0
449122|NCT00634088|1072174|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
449123|NCT00634088|1072175|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
449124|NCT00634088|1072176|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
449125|NCT00634088|1072177|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
449126|NCT00634088|1072174|P4|COMPLETED|Time Period 3: Dose Level 3||0
449127|NCT00634088|1072175|P3|COMPLETED|Time Period 3: Dose Level 3||0
449128|NCT00634088|1072176|P2|COMPLETED|Time Period 3: Dose Level 3||0
449129|NCT00634088|1072177|P1|COMPLETED|Time Period 3: Dose Level 3||0
449130|NCT00634088|1072174|P4|STARTED|Time Period 3: Dose Level 3||0
449131|NCT00634088|1072175|P3|STARTED|Time Period 3: Dose Level 3||1
449132|NCT00634088|1072176|P2|STARTED|Time Period 3: Dose Level 3||0
449133|NCT00634088|1072177|P1|STARTED|Time Period 3: Dose Level 3||0
449134|NCT00634088|1072174|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
449135|NCT00634088|1072175|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
449136|NCT00634088|1072176|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
449137|NCT00634088|1072177|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
449138|NCT00634088|1072174|P4|COMPLETED|Time Period 2: Dose Level 2||0
449139|NCT00634088|1072175|P3|COMPLETED|Time Period 2: Dose Level 2||0
449140|NCT00634088|1072176|P2|COMPLETED|Time Period 2: Dose Level 2||0
449141|NCT00634088|1072177|P1|COMPLETED|Time Period 2: Dose Level 2||0
449142|NCT00634088|1072174|P4|STARTED|Time Period 2: Dose Level 2||0
449143|NCT00634088|1072175|P3|STARTED|Time Period 2: Dose Level 2||0
449144|NCT00634088|1072176|P2|STARTED|Time Period 2: Dose Level 2||3
449145|NCT00634088|1072177|P1|STARTED|Time Period 2: Dose Level 2||0
449146|NCT00634088|1072174|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
449147|NCT00634088|1072175|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
449148|NCT00634088|1072176|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
449149|NCT00634088|1072177|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
449150|NCT00634088|1072174|P4|COMPLETED|Time Period 1: Dose Level 1||0
449151|NCT00634088|1072175|P3|COMPLETED|Time Period 1: Dose Level 1||0
449152|NCT00634088|1072176|P2|COMPLETED|Time Period 1: Dose Level 1||0
449153|NCT00634088|1072177|P1|COMPLETED|Time Period 1: Dose Level 1||0
449154|NCT00634088|1072174|P4|STARTED|Time Period 1: Dose Level 1||0
449155|NCT00634088|1072175|P3|STARTED|Time Period 1: Dose Level 1||0
449156|NCT00634088|1072176|P2|STARTED|Time Period 1: Dose Level 1||0
449157|NCT00634088|1072177|P1|STARTED|Time Period 1: Dose Level 1||6
449158|NCT00634049|1072228|P1|NOT COMPLETED|Overall Study||3
449159|NCT00634049|1072228|P1|COMPLETED|Overall Study||146
449160|NCT00634049|1072228|P1|STARTED|Overall Study||149
449161|NCT00634010|1072307|P2|NOT COMPLETED|Overall Study||14
449162|NCT00634010|1072308|P1|NOT COMPLETED|Overall Study||10
449163|NCT00634010|1072307|P2|COMPLETED|Overall Study||4
449164|NCT00634010|1072308|P1|COMPLETED|Overall Study||8
449165|NCT00634010|1072307|P2|STARTED|Overall Study||18
449166|NCT00634010|1072308|P1|STARTED|Overall Study||18
449167|NCT00633984|1072316|P2|NOT COMPLETED|Overall Study||13
449168|NCT00633984|1072317|P1|NOT COMPLETED|Overall Study||9
449169|NCT00633984|1072316|P2|COMPLETED|Overall Study||69
449170|NCT00633984|1072317|P1|COMPLETED|Overall Study||78
449171|NCT00633984|1072316|P2|STARTED|Overall Study||82
449172|NCT00633984|1072317|P1|STARTED|Overall Study||87
449173|NCT00633932|1072328|P3|NOT COMPLETED|Overall Study||11
449174|NCT00633932|1072329|P2|NOT COMPLETED|Overall Study||14
449175|NCT00633932|1072330|P1|NOT COMPLETED|Overall Study||12
449176|NCT00633932|1072328|P3|COMPLETED|Overall Study||180
449177|NCT00633932|1072329|P2|COMPLETED|Overall Study||176
449178|NCT00633932|1072330|P1|COMPLETED|Overall Study||179
449179|NCT00633932|1072328|P3|STARTED|Overall Study|Randomised|191
449180|NCT00633932|1072329|P2|STARTED|Overall Study|Randomised|190
449181|NCT00633932|1072330|P1|STARTED|Overall Study|Randomised|191
449182|NCT00633919|1072343|P2|NOT COMPLETED|Overall Study||22
449183|NCT00633919|1072344|P1|NOT COMPLETED|Overall Study||27
449184|NCT00633919|1072343|P2|COMPLETED|Overall Study||39
449185|NCT00633919|1072344|P1|COMPLETED|Overall Study||36
449186|NCT00633919|1072343|P2|STARTED|Overall Study||61
449187|NCT00633919|1072344|P1|STARTED|Overall Study||63
449188|NCT00633893|1072361|P3|NOT COMPLETED|Overall Study||188
449189|NCT00633893|1072362|P2|NOT COMPLETED|Overall Study||129
449190|NCT00633893|1072363|P1|NOT COMPLETED|Overall Study||114
449191|NCT00633893|1072361|P3|COMPLETED|Overall Study||641
449192|NCT00633893|1072362|P2|COMPLETED|Overall Study||684
449193|NCT00633893|1072363|P1|COMPLETED|Overall Study||726
449194|NCT00633893|1072361|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
449195|NCT00633893|1072362|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
449196|NCT00633893|1072363|P1|STARTED|Overall Study||840
449197|NCT00633880|1072437|P3|NOT COMPLETED|Randomized Double Blind||0
449198|NCT00633880|1072438|P2|NOT COMPLETED|Randomized Double Blind||0
449199|NCT00633880|1072439|P1|NOT COMPLETED|Randomized Double Blind||0
449200|NCT00633880|1072437|P3|COMPLETED|Randomized Double Blind||51
449201|NCT00633880|1072438|P2|COMPLETED|Randomized Double Blind||50
449202|NCT00633880|1072439|P1|COMPLETED|Randomized Double Blind||0
449203|NCT00633880|1072437|P3|STARTED|Randomized Double Blind||51
449204|NCT00633880|1072438|P2|STARTED|Randomized Double Blind||50
449205|NCT00633880|1072439|P1|STARTED|Randomized Double Blind||0
449206|NCT00633880|1072437|P3|NOT COMPLETED|Open Label Titration||0
449207|NCT00633880|1072438|P2|NOT COMPLETED|Open Label Titration||0
449208|NCT00633880|1072439|P1|NOT COMPLETED|Open Label Titration||80
449209|NCT00633880|1072437|P3|COMPLETED|Open Label Titration||0
449210|NCT00633880|1072438|P2|COMPLETED|Open Label Titration||0
449211|NCT00633880|1072439|P1|COMPLETED|Open Label Titration||101
449212|NCT00633880|1072437|P3|STARTED|Open Label Titration||0
449213|NCT00633880|1072438|P2|STARTED|Open Label Titration||0
449214|NCT00633880|1072439|P1|STARTED|Open Label Titration||181
449215|NCT00633867|1072468|P2|NOT COMPLETED|Overall Study||0
449216|NCT00633867|1072469|P1|NOT COMPLETED|Overall Study||0
449217|NCT00633867|1072468|P2|COMPLETED|Overall Study||60
449218|NCT00633867|1072469|P1|COMPLETED|Overall Study||60
449219|NCT00633867|1072468|P2|STARTED|Overall Study||60
449220|NCT00633867|1072469|P1|STARTED|Overall Study||60
449221|NCT00633750|1072475|P1|NOT COMPLETED|Overall Study||5
449222|NCT00633750|1072475|P1|COMPLETED|Overall Study||42
449223|NCT00633750|1072475|P1|STARTED|Overall Study||47
449224|NCT00633594|1072484|P3|NOT COMPLETED|Overall Study||10
449225|NCT00633594|1072485|P2|NOT COMPLETED|Overall Study||5
449226|NCT00633594|1072486|P1|NOT COMPLETED|Overall Study||0
449227|NCT00633594|1072484|P3|COMPLETED|Overall Study||16
449228|NCT00633594|1072485|P2|COMPLETED|Overall Study||3
449229|NCT00633594|1072486|P1|COMPLETED|Overall Study||5
449230|NCT00633594|1072484|P3|STARTED|Overall Study||26
449231|NCT00633594|1072485|P2|STARTED|Overall Study||8
449232|NCT00633594|1072486|P1|STARTED|Overall Study||5
449233|NCT00633477|1072515|P2|NOT COMPLETED|Overall Study||0
449234|NCT00633477|1072516|P1|NOT COMPLETED|Overall Study||2
449235|NCT00633477|1072515|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
449236|NCT00633477|1072516|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
449237|NCT00633477|1072515|P2|Completed Study Through Day 28|Overall Study||8
449238|NCT00633477|1072516|P1|Completed Study Through Day 28|Overall Study||4
449239|NCT00633477|1072515|P2|Prematurely Discontinued Study Drug|Overall Study||0
449240|NCT00633477|1072516|P1|Prematurely Discontinued Study Drug|Overall Study||1
449241|NCT00633477|1072515|P2|Randomized But Not Treated|Overall Study||0
449242|NCT00633477|1072516|P1|Randomized But Not Treated|Overall Study||1
449243|NCT00633477|1072515|P2|STARTED|Overall Study||11
449244|NCT00633477|1072516|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
449245|NCT00633464|1072532|P2|NOT COMPLETED|Overall Study||2
449246|NCT00633464|1072533|P1|NOT COMPLETED|Overall Study||0
449247|NCT00633464|1072532|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
449248|NCT00633464|1072533|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
449249|NCT00633464|1072532|P2|Treated|Overall Study||37
449250|NCT00633464|1072533|P1|Treated|Overall Study||40
449251|NCT00633464|1072532|P2|STARTED|Overall Study||39
449252|NCT00633464|1072533|P1|STARTED|Overall Study||40
449253|NCT00633399|1072555|P2|NOT COMPLETED|Overall Study||15
449254|NCT00633399|1072556|P1|NOT COMPLETED|Overall Study||22
449255|NCT00633399|1072555|P2|COMPLETED|Overall Study||53
449256|NCT00633399|1072556|P1|COMPLETED|Overall Study||49
449257|NCT00633399|1072555|P2|STARTED|Overall Study||68
449258|NCT00633399|1072556|P1|STARTED|Overall Study||71
449259|NCT00633139|1072569|P3|NOT COMPLETED|Overall Study||1
449260|NCT00633139|1072570|P2|NOT COMPLETED|Overall Study||1
449261|NCT00633139|1072571|P1|NOT COMPLETED|Overall Study||0
449262|NCT00633139|1072569|P3|COMPLETED|Overall Study||3
449263|NCT00633139|1072570|P2|COMPLETED|Overall Study||4
449264|NCT00633139|1072571|P1|COMPLETED|Overall Study||4
449265|NCT00633139|1072569|P3|STARTED|Overall Study||4
449266|NCT00633139|1072570|P2|STARTED|Overall Study||5
449267|NCT00633139|1072571|P1|STARTED|Overall Study||4
449268|NCT00633126|1072585|P1|NOT COMPLETED|Overall Study||1
449269|NCT00633126|1072585|P1|COMPLETED|Overall Study||8
449270|NCT00633126|1072585|P1|STARTED|Overall Study||9
449271|NCT00633087|1072590|P1|NOT COMPLETED|Overall Study||0
449272|NCT00633087|1072590|P1|COMPLETED|Overall Study||12
449273|NCT00633087|1072590|P1|STARTED|Overall Study||12
449274|NCT00633074|1072599|P2|NOT COMPLETED|Overall Study||0
449275|NCT00633074|1072600|P1|NOT COMPLETED|Overall Study||1
449276|NCT00633074|1072599|P2|COMPLETED|Overall Study||360
449277|NCT00633074|1072600|P1|COMPLETED|Overall Study||359
449278|NCT00633074|1072599|P2|STARTED|Overall Study||360
449279|NCT00633074|1072600|P1|STARTED|Overall Study||360
449280|NCT00633009|1072631|P3|NOT COMPLETED|Overall Study||1
449281|NCT00633009|1072632|P2|NOT COMPLETED|Overall Study||4
449282|NCT00633009|1072633|P1|NOT COMPLETED|Overall Study||4
449283|NCT00633009|1072631|P3|COMPLETED|Overall Study||10
449284|NCT00633009|1072632|P2|COMPLETED|Overall Study||23
449285|NCT00633009|1072633|P1|COMPLETED|Overall Study||8
449286|NCT00633009|1072631|P3|STARTED|Overall Study||11
449287|NCT00633009|1072632|P2|STARTED|Overall Study||27
449288|NCT00633009|1072633|P1|STARTED|Overall Study||12
449289|NCT00632931|1072644|P3|NOT COMPLETED|Part 2||24
449290|NCT00632931|1072645|P2|NOT COMPLETED|Part 2||0
449291|NCT00632931|1072646|P1|NOT COMPLETED|Part 2||0
449292|NCT00632931|1072644|P3|COMPLETED|Part 2||0
449293|NCT00632931|1072645|P2|COMPLETED|Part 2||0
449294|NCT00632931|1072646|P1|COMPLETED|Part 2||0
449295|NCT00632931|1072644|P3|STARTED|Part 2||24
449296|NCT00632931|1072645|P2|STARTED|Part 2||0
449297|NCT00632931|1072646|P1|STARTED|Part 2||0
449298|NCT00632931|1072644|P3|NOT COMPLETED|Post-Part 1 Washout||0
449299|NCT00632931|1072645|P2|NOT COMPLETED|Post-Part 1 Washout||0
449300|NCT00632931|1072646|P1|NOT COMPLETED|Post-Part 1 Washout||0
449301|NCT00632931|1072644|P3|COMPLETED|Post-Part 1 Washout||0
449302|NCT00632931|1072645|P2|COMPLETED|Post-Part 1 Washout||12
449303|NCT00632931|1072646|P1|COMPLETED|Post-Part 1 Washout||12
449304|NCT00632931|1072644|P3|STARTED|Post-Part 1 Washout||0
449305|NCT00632931|1072645|P2|STARTED|Post-Part 1 Washout||12
449306|NCT00632931|1072646|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
449307|NCT00632931|1072644|P3|NOT COMPLETED|Part 1, Period 2||0
449308|NCT00632931|1072645|P2|NOT COMPLETED|Part 1, Period 2||0
449309|NCT00632931|1072646|P1|NOT COMPLETED|Part 1, Period 2||0
449310|NCT00632931|1072644|P3|COMPLETED|Part 1, Period 2||0
449311|NCT00632931|1072645|P2|COMPLETED|Part 1, Period 2||12
449312|NCT00632931|1072646|P1|COMPLETED|Part 1, Period 2||11
449313|NCT00632931|1072644|P3|STARTED|Part 1, Period 2||0
449314|NCT00632931|1072645|P2|STARTED|Part 1, Period 2||12
449315|NCT00632931|1072646|P1|STARTED|Part 1, Period 2||11
449316|NCT00632931|1072644|P3|NOT COMPLETED|Part 1, Washout||0
449317|NCT00632931|1072645|P2|NOT COMPLETED|Part 1, Washout||0
449318|NCT00632931|1072646|P1|NOT COMPLETED|Part 1, Washout||0
449319|NCT00632931|1072644|P3|COMPLETED|Part 1, Washout||0
449320|NCT00632931|1072645|P2|COMPLETED|Part 1, Washout||12
449321|NCT00632931|1072646|P1|COMPLETED|Part 1, Washout||11
449322|NCT00632931|1072644|P3|STARTED|Part 1, Washout||0
449323|NCT00632931|1072645|P2|STARTED|Part 1, Washout||12
449324|NCT00632931|1072646|P1|STARTED|Part 1, Washout||11
449325|NCT00632931|1072644|P3|NOT COMPLETED|Part 1, Period 1||0
449326|NCT00632931|1072645|P2|NOT COMPLETED|Part 1, Period 1||0
449327|NCT00632931|1072646|P1|NOT COMPLETED|Part 1, Period 1||2
449328|NCT00632931|1072644|P3|COMPLETED|Part 1, Period 1||0
449329|NCT00632931|1072645|P2|COMPLETED|Part 1, Period 1||12
449330|NCT00632931|1072646|P1|COMPLETED|Part 1, Period 1||11
449331|NCT00632931|1072644|P3|STARTED|Part 1, Period 1||0
449332|NCT00632931|1072645|P2|STARTED|Part 1, Period 1||12
449333|NCT00632931|1072646|P1|STARTED|Part 1, Period 1||13
449334|NCT00632814|1072668|P3|NOT COMPLETED|Overall Study||0
449335|NCT00632814|1072669|P2|NOT COMPLETED|Overall Study||0
449336|NCT00632814|1072670|P1|NOT COMPLETED|Overall Study||0
449337|NCT00632814|1072668|P3|COMPLETED|Overall Study||8
449338|NCT00632814|1072669|P2|COMPLETED|Overall Study||13
449339|NCT00632814|1072670|P1|COMPLETED|Overall Study||11
449340|NCT00632814|1072668|P3|STARTED|Overall Study||8
449341|NCT00632814|1072669|P2|STARTED|Overall Study||13
449342|NCT00632814|1072670|P1|STARTED|Overall Study||11
449343|NCT00632749|1072716|P14|NOT COMPLETED|Overall Study||6
449344|NCT00632749|1072717|P13|NOT COMPLETED|Overall Study||3
449345|NCT00632749|1072718|P12|NOT COMPLETED|Overall Study||4
449346|NCT00632749|1072719|P11|NOT COMPLETED|Overall Study||7
449347|NCT00632749|1072720|P10|NOT COMPLETED|Overall Study||3
449348|NCT00632749|1072721|P9|NOT COMPLETED|Overall Study||5
449349|NCT00632749|1072722|P8|NOT COMPLETED|Overall Study||4
449350|NCT00632749|1072723|P7|NOT COMPLETED|Overall Study||5
449351|NCT00632749|1072724|P6|NOT COMPLETED|Overall Study||8
449352|NCT00632749|1072725|P5|NOT COMPLETED|Overall Study||7
449353|NCT00632749|1072726|P4|NOT COMPLETED|Overall Study||4
449354|NCT00632749|1072727|P3|NOT COMPLETED|Overall Study||3
449355|NCT00632749|1072728|P2|NOT COMPLETED|Overall Study||5
449356|NCT00632749|1072729|P1|NOT COMPLETED|Overall Study||4
449357|NCT00632749|1072716|P14|COMPLETED|Overall Study||0
449358|NCT00632749|1072717|P13|COMPLETED|Overall Study||0
449359|NCT00632749|1072718|P12|COMPLETED|Overall Study||0
449360|NCT00632749|1072719|P11|COMPLETED|Overall Study||0
449361|NCT00632749|1072720|P10|COMPLETED|Overall Study||0
449362|NCT00632749|1072721|P9|COMPLETED|Overall Study||0
449363|NCT00632749|1072722|P8|COMPLETED|Overall Study||0
449364|NCT00632749|1072723|P7|COMPLETED|Overall Study||0
449365|NCT00632749|1072724|P6|COMPLETED|Overall Study||0
449366|NCT00632749|1072725|P5|COMPLETED|Overall Study||0
449367|NCT00632749|1072726|P4|COMPLETED|Overall Study||0
449368|NCT00632749|1072727|P3|COMPLETED|Overall Study||0
449369|NCT00632749|1072728|P2|COMPLETED|Overall Study||0
449370|NCT00632749|1072729|P1|COMPLETED|Overall Study||0
449371|NCT00632749|1072716|P14|Not Treated|Overall Study||0
449372|NCT00632749|1072717|P13|Not Treated|Overall Study||0
449373|NCT00632749|1072718|P12|Not Treated|Overall Study||0
449374|NCT00632749|1072719|P11|Not Treated|Overall Study||0
449375|NCT00632749|1072720|P10|Not Treated|Overall Study||0
449376|NCT00632749|1072721|P9|Not Treated|Overall Study||0
449377|NCT00632749|1072722|P8|Not Treated|Overall Study||0
449378|NCT00632749|1072723|P7|Not Treated|Overall Study||1
449379|NCT00632749|1072724|P6|Not Treated|Overall Study||1
449380|NCT00632749|1072725|P5|Not Treated|Overall Study||0
449381|NCT00632749|1072726|P4|Not Treated|Overall Study||0
449382|NCT00632749|1072727|P3|Not Treated|Overall Study||0
449383|NCT00632749|1072728|P2|Not Treated|Overall Study||2
449384|NCT00632749|1072729|P1|Not Treated|Overall Study||0
449385|NCT00632749|1072716|P14|Treated|Overall Study||6
449386|NCT00632749|1072717|P13|Treated|Overall Study||3
449387|NCT00632749|1072718|P12|Treated|Overall Study||4
449388|NCT00632749|1072719|P11|Treated|Overall Study||7
449389|NCT00632749|1072720|P10|Treated|Overall Study||3
449390|NCT00632749|1072721|P9|Treated|Overall Study||5
449391|NCT00632749|1072722|P8|Treated|Overall Study||4
449392|NCT00632749|1072723|P7|Treated|Overall Study||4
449393|NCT00632749|1072724|P6|Treated|Overall Study||7
449394|NCT00632749|1072725|P5|Treated|Overall Study||7
449395|NCT00632749|1072726|P4|Treated|Overall Study||4
449396|NCT00632749|1072727|P3|Treated|Overall Study||3
449397|NCT00632749|1072728|P2|Treated|Overall Study||3
449398|NCT00632749|1072729|P1|Treated|Overall Study||4
449399|NCT00632749|1072716|P14|STARTED|Overall Study||6
449400|NCT00632749|1072717|P13|STARTED|Overall Study||3
449401|NCT00632749|1072718|P12|STARTED|Overall Study||4
449402|NCT00632749|1072719|P11|STARTED|Overall Study||7
449403|NCT00632749|1072720|P10|STARTED|Overall Study||3
449404|NCT00632749|1072721|P9|STARTED|Overall Study||5
449405|NCT00632749|1072722|P8|STARTED|Overall Study||4
449406|NCT00632749|1072723|P7|STARTED|Overall Study||5
449407|NCT00632749|1072724|P6|STARTED|Overall Study||8
449408|NCT00632749|1072725|P5|STARTED|Overall Study||7
449409|NCT00632749|1072726|P4|STARTED|Overall Study||4
449410|NCT00632749|1072727|P3|STARTED|Overall Study||3
449411|NCT00632749|1072728|P2|STARTED|Overall Study||5
449412|NCT00632749|1072729|P1|STARTED|Overall Study||4
449413|NCT00632736|1073023|P1|NOT COMPLETED|Overall Study||268
449414|NCT00632736|1073023|P1|COMPLETED|Overall Study||151
449415|NCT00632736|1073023|P1|STARTED|Overall Study||419
449416|NCT00632632|1073030|P2|NOT COMPLETED|Overall Study||3
449417|NCT00632632|1073031|P1|NOT COMPLETED|Overall Study||0
449418|NCT00632632|1073030|P2|COMPLETED|Overall Study||9
449419|NCT00632632|1073031|P1|COMPLETED|Overall Study||13
449420|NCT00632632|1073030|P2|STARTED|Overall Study||12
449421|NCT00632632|1073031|P1|STARTED|Overall Study||13
449422|NCT00632619|1073043|P2|NOT COMPLETED|Overall Study||4
449423|NCT00632619|1073044|P1|NOT COMPLETED|Overall Study||8
449424|NCT00632619|1073043|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
449425|NCT00632619|1073044|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
449426|NCT00632619|1073043|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
449427|NCT00632619|1073044|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
449428|NCT00632541|1073058|P1|NOT COMPLETED|Overall Study||7
449429|NCT00632541|1073058|P1|COMPLETED|Overall Study||11
449430|NCT00632541|1073058|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
449431|NCT00632502|1073064|P2|NOT COMPLETED|Overall Study||1
449432|NCT00632502|1073065|P1|NOT COMPLETED|Overall Study||3
449433|NCT00632502|1073064|P2|COMPLETED|Overall Study||11
449434|NCT00632502|1073065|P1|COMPLETED|Overall Study||22
449435|NCT00632502|1073064|P2|Completed Treatment|Overall Study||9
449436|NCT00632502|1073065|P1|Completed Treatment|Overall Study||19
449437|NCT00632502|1073064|P2|Treated|Overall Study||12
449438|NCT00632502|1073065|P1|Treated|Overall Study||22
449439|NCT00632502|1073064|P2|STARTED|Overall Study||12
449440|NCT00632502|1073065|P1|STARTED|Overall Study||25
449441|NCT00632489|1073093|P3|NOT COMPLETED|Overall Study||0
449442|NCT00632489|1073094|P2|NOT COMPLETED|Overall Study||5
449443|NCT00632489|1073095|P1|NOT COMPLETED|Overall Study||15
449444|NCT00632489|1073093|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
449445|NCT00632489|1073094|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
449446|NCT00632489|1073095|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
449447|NCT00632489|1073093|P3|STARTED|Overall Study||0
449448|NCT00632489|1073094|P2|STARTED|Overall Study||5
449449|NCT00632489|1073095|P1|STARTED|Overall Study||15
449450|NCT00632463|1073109|P3|NOT COMPLETED|Overall Study||0
449451|NCT00632463|1073110|P2|NOT COMPLETED|Overall Study||1
449452|NCT00632463|1073111|P1|NOT COMPLETED|Overall Study||0
449453|NCT00632463|1073109|P3|COMPLETED|Overall Study||7
449454|NCT00632463|1073110|P2|COMPLETED|Overall Study||6
449455|NCT00632463|1073111|P1|COMPLETED|Overall Study||7
449456|NCT00632463|1073109|P3|STARTED|Overall Study||7
449457|NCT00632463|1073110|P2|STARTED|Overall Study||7
449458|NCT00632463|1073111|P1|STARTED|Overall Study||7
449459|NCT00632424|1073128|P1|NOT COMPLETED|Overall Study||18
449460|NCT00632424|1073128|P1|COMPLETED|Overall Study||0
449461|NCT00632424|1073128|P1|STARTED|Overall Study||18
449462|NCT00632411|1073152|P2|NOT COMPLETED|Overall Study||176
449463|NCT00632411|1073153|P1|NOT COMPLETED|Overall Study||160
449464|NCT00632411|1073152|P2|COMPLETED|Overall Study||473
449465|NCT00632411|1073153|P1|COMPLETED|Overall Study||489
449466|NCT00632411|1073152|P2|STARTED|Overall Study||649
449467|NCT00632411|1073153|P1|STARTED|Overall Study||649
449468|NCT00632281|1073159|P1|NOT COMPLETED|Overall Study||0
449469|NCT00632281|1073159|P1|COMPLETED|Overall Study||38
449470|NCT00632281|1073159|P1|STARTED|Overall Study||38
449471|NCT00632229|1073166|P2|NOT COMPLETED|Overall Study||6
449472|NCT00632229|1073167|P1|NOT COMPLETED|Overall Study||6
449473|NCT00632229|1073166|P2|COMPLETED|Overall Study||11
449474|NCT00632229|1073167|P1|COMPLETED|Overall Study||11
449475|NCT00632229|1073166|P2|STARTED|Overall Study||17
449476|NCT00632229|1073167|P1|STARTED|Overall Study||17
449477|NCT00632203|1073177|P2|NOT COMPLETED|Overall Study||0
449478|NCT00632203|1073178|P1|NOT COMPLETED|Overall Study||1
449479|NCT00632203|1073177|P2|COMPLETED|Overall Study||27
449480|NCT00632203|1073178|P1|COMPLETED|Overall Study||25
449481|NCT00632203|1073177|P2|STARTED|Overall Study||27
449482|NCT00632203|1073178|P1|STARTED|Overall Study||26
449483|NCT00632099|1073198|P2|NOT COMPLETED|Overall Study||3
449484|NCT00632099|1073199|P1|NOT COMPLETED|Overall Study||3
449485|NCT00632099|1073198|P2|COMPLETED|Overall Study||8
449486|NCT00632099|1073199|P1|COMPLETED|Overall Study||7
449487|NCT00632099|1073198|P2|STARTED|Overall Study||11
449488|NCT00632099|1073199|P1|STARTED|Overall Study||10
449489|NCT00631969|1073207|P2|NOT COMPLETED|Overall Study||21
449490|NCT00631969|1073208|P1|NOT COMPLETED|Overall Study||15
449491|NCT00631969|1073207|P2|COMPLETED|Overall Study||155
449492|NCT00631969|1073208|P1|COMPLETED|Overall Study||171
449493|NCT00631969|1073207|P2|Received Treatment|Overall Study|safety population|174
449494|NCT00631969|1073208|P1|Received Treatment|Overall Study|safety population|184
449495|NCT00631969|1073207|P2|STARTED|Overall Study||176
449496|NCT00631969|1073208|P1|STARTED|Overall Study||186
449497|NCT00631917|1073254|P2|NOT COMPLETED|Overall Study||108
449498|NCT00631917|1073255|P1|NOT COMPLETED|Overall Study||88
449499|NCT00631917|1073254|P2|COMPLETED|Overall Study||291
449500|NCT00631917|1073255|P1|COMPLETED|Overall Study||287
449501|NCT00631917|1073254|P2|STARTED|Overall Study||399
449502|NCT00631917|1073255|P1|STARTED|Overall Study||375
449503|NCT00631748|1073271|P2|NOT COMPLETED|Overall Study||22
449504|NCT00631748|1073272|P1|NOT COMPLETED|Overall Study||18
449505|NCT00631748|1073271|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
449506|NCT00631748|1073272|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
449507|NCT00631748|1073271|P2|STARTED|Overall Study||31
449508|NCT00631748|1073272|P1|STARTED|Overall Study||29
449509|NCT00631696|1073282|P2|NOT COMPLETED|Overall Study||40
449510|NCT00631696|1073283|P1|NOT COMPLETED|Overall Study||37
449511|NCT00631696|1073282|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
449512|NCT00631696|1073283|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
449513|NCT00631696|1073282|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
449514|NCT00631696|1073283|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
449515|NCT00631696|1073282|P2|Received Study Treatment (Tx)|Overall Study||109
449516|NCT00631696|1073283|P1|Received Study Treatment (Tx)|Overall Study||111
449517|NCT00631696|1073282|P2|STARTED|Overall Study||110
449518|NCT00631696|1073283|P1|STARTED|Overall Study||112
449519|NCT00631670|1073309|P2|NOT COMPLETED|Overall Study||0
449520|NCT00631670|1073310|P1|NOT COMPLETED|Overall Study||0
449521|NCT00631670|1073309|P2|COMPLETED|Overall Study||0
449522|NCT00631670|1073310|P1|COMPLETED|Overall Study||21
449523|NCT00631670|1073309|P2|STARTED|Overall Study||0
449524|NCT00631670|1073310|P1|STARTED|Overall Study||21
449525|NCT00631657|1073326|P3|NOT COMPLETED|7-Day Discontinuation Period||1
449526|NCT00631657|1073327|P2|NOT COMPLETED|7-Day Discontinuation Period||1
449527|NCT00631657|1073328|P1|NOT COMPLETED|7-Day Discontinuation Period||2
449528|NCT00631657|1073326|P3|COMPLETED|7-Day Discontinuation Period||65
449529|NCT00631657|1073327|P2|COMPLETED|7-Day Discontinuation Period||136
449530|NCT00631657|1073328|P1|COMPLETED|7-Day Discontinuation Period||65
449531|NCT00631657|1073326|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
449621|NCT00631007|1073523|P5|NOT COMPLETED|Overall Study||12
449532|NCT00631657|1073327|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
449533|NCT00631657|1073328|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
449534|NCT00631657|1073326|P3|STARTED|7-Day Discontinuation Period||66
449535|NCT00631657|1073327|P2|STARTED|7-Day Discontinuation Period||137
449536|NCT00631657|1073328|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
449537|NCT00631657|1073326|P3|NOT COMPLETED|6-Month Treatment Period||50
449538|NCT00631657|1073327|P2|NOT COMPLETED|6-Month Treatment Period||0
449539|NCT00631657|1073328|P1|NOT COMPLETED|6-Month Treatment Period||141
449540|NCT00631657|1073326|P3|COMPLETED|6-Month Treatment Period||66
449541|NCT00631657|1073327|P2|COMPLETED|6-Month Treatment Period||0
449542|NCT00631657|1073328|P1|COMPLETED|6-Month Treatment Period||203
449637|NCT00631007|1073527|P1|STARTED|Overall Study||60
449543|NCT00631657|1073326|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
449544|NCT00631657|1073327|P2|Treated|6-Month Treatment Period||0
449545|NCT00631657|1073328|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
449546|NCT00631657|1073326|P3|STARTED|6-Month Treatment Period||116
449547|NCT00631657|1073327|P2|STARTED|6-Month Treatment Period||0
449548|NCT00631657|1073328|P1|STARTED|6-Month Treatment Period||344
449549|NCT00631540|1073355|P1|NOT COMPLETED|Overall Study||14
449550|NCT00631540|1073355|P1|COMPLETED|Overall Study||86
449551|NCT00631540|1073355|P1|STARTED|Overall Study||100
449552|NCT00631488|1073367|P3|NOT COMPLETED|Overall Study||2
449553|NCT00631488|1073368|P2|NOT COMPLETED|Overall Study||2
449554|NCT00631488|1073369|P1|NOT COMPLETED|Overall Study||4
449555|NCT00631488|1073367|P3|COMPLETED|Overall Study||47
449556|NCT00631488|1073368|P2|COMPLETED|Overall Study||47
449557|NCT00631488|1073369|P1|COMPLETED|Overall Study||44
449558|NCT00631488|1073367|P3|Completed Post-Treatment Period|Overall Study||47
449559|NCT00631488|1073368|P2|Completed Post-Treatment Period|Overall Study||47
449560|NCT00631488|1073369|P1|Completed Post-Treatment Period|Overall Study||44
449561|NCT00631488|1073367|P3|STARTED|Overall Study||49
449562|NCT00631488|1073368|P2|STARTED|Overall Study||49
449563|NCT00631488|1073369|P1|STARTED|Overall Study||48
449564|NCT00631475|1073389|P1|NOT COMPLETED|Overall Study||45
449565|NCT00631475|1073389|P1|COMPLETED|Overall Study||83
449566|NCT00631475|1073389|P1|STARTED|Overall Study||128
449567|NCT00631449|1073399|P2|NOT COMPLETED|Overall Study||0
449568|NCT00631449|1073400|P1|NOT COMPLETED|Overall Study||0
449569|NCT00631449|1073399|P2|COMPLETED|Overall Study||15
449570|NCT00631449|1073400|P1|COMPLETED|Overall Study||15
449571|NCT00631449|1073399|P2|STARTED|Overall Study||15
449572|NCT00631449|1073400|P1|STARTED|Overall Study||15
449573|NCT00631410|1073408|P2|NOT COMPLETED|Overall Study||6
449574|NCT00631410|1073409|P1|NOT COMPLETED|Overall Study||6
449575|NCT00631410|1073408|P2|COMPLETED|Overall Study||0
449576|NCT00631410|1073409|P1|COMPLETED|Overall Study||0
449577|NCT00631410|1073408|P2|STARTED|Overall Study||6
449578|NCT00631410|1073409|P1|STARTED|Overall Study||6
449579|NCT00631371|1073428|P2|NOT COMPLETED|Overall Study||391
449580|NCT00631371|1073429|P1|NOT COMPLETED|Overall Study||400
449581|NCT00631371|1073428|P2|COMPLETED|Overall Study||0
449582|NCT00631371|1073429|P1|COMPLETED|Overall Study||0
449583|NCT00631371|1073428|P2|Treated|Overall Study||391
449584|NCT00631371|1073429|P1|Treated|Overall Study||393
449585|NCT00631371|1073428|P2|STARTED|Overall Study||391
449586|NCT00631371|1073429|P1|STARTED|Overall Study||400
449587|NCT00631358|1073443|P2|NOT COMPLETED|Overall Study||2
449588|NCT00631358|1073444|P1|NOT COMPLETED|Overall Study||6
449589|NCT00631358|1073443|P2|COMPLETED|Overall Study||45
449590|NCT00631358|1073444|P1|COMPLETED|Overall Study||44
449591|NCT00631358|1073443|P2|STARTED|Overall Study||47
449592|NCT00631358|1073444|P1|STARTED|Overall Study||50
449593|NCT00631189|1073462|P4|NOT COMPLETED|Treatment Phase||7
449594|NCT00631189|1073463|P3|NOT COMPLETED|Treatment Phase||11
449595|NCT00631189|1073464|P2|NOT COMPLETED|Treatment Phase||7
449596|NCT00631189|1073465|P1|NOT COMPLETED|Treatment Phase||0
449597|NCT00631189|1073462|P4|COMPLETED|Treatment Phase||103
449598|NCT00631189|1073463|P3|COMPLETED|Treatment Phase||92
449599|NCT00631189|1073464|P2|COMPLETED|Treatment Phase||97
449600|NCT00631189|1073465|P1|COMPLETED|Treatment Phase||0
449601|NCT00631189|1073462|P4|STARTED|Treatment Phase||110
449602|NCT00631189|1073463|P3|STARTED|Treatment Phase||103
449603|NCT00631189|1073464|P2|STARTED|Treatment Phase||104
449604|NCT00631189|1073465|P1|STARTED|Treatment Phase||0
449605|NCT00631189|1073462|P4|NOT COMPLETED|Initial Phase||0
449606|NCT00631189|1073463|P3|NOT COMPLETED|Initial Phase||0
449607|NCT00631189|1073464|P2|NOT COMPLETED|Initial Phase||0
449608|NCT00631189|1073465|P1|NOT COMPLETED|Initial Phase||351
449609|NCT00631189|1073462|P4|COMPLETED|Initial Phase||0
449610|NCT00631189|1073463|P3|COMPLETED|Initial Phase||0
449611|NCT00631189|1073464|P2|COMPLETED|Initial Phase||0
449612|NCT00631189|1073465|P1|COMPLETED|Initial Phase||317
449613|NCT00631189|1073462|P4|STARTED|Initial Phase||0
449614|NCT00631189|1073463|P3|STARTED|Initial Phase||0
449615|NCT00631189|1073464|P2|STARTED|Initial Phase||0
449616|NCT00631189|1073465|P1|STARTED|Initial Phase||668
449617|NCT00631020|1073507|P1|NOT COMPLETED|Overall Study||8
449618|NCT00631020|1073507|P1|COMPLETED|Overall Study||26
449619|NCT00631020|1073507|P1|STARTED|Overall Study||34
449620|NCT00631007|1073522|P6|NOT COMPLETED|Overall Study||15
449622|NCT00631007|1073524|P4|NOT COMPLETED|Overall Study||9
449623|NCT00631007|1073525|P3|NOT COMPLETED|Overall Study||10
449624|NCT00631007|1073526|P2|NOT COMPLETED|Overall Study||11
449625|NCT00631007|1073527|P1|NOT COMPLETED|Overall Study||11
449626|NCT00631007|1073522|P6|COMPLETED|Overall Study||46
449627|NCT00631007|1073523|P5|COMPLETED|Overall Study||48
449628|NCT00631007|1073524|P4|COMPLETED|Overall Study||53
449629|NCT00631007|1073525|P3|COMPLETED|Overall Study||53
449630|NCT00631007|1073526|P2|COMPLETED|Overall Study||50
449631|NCT00631007|1073527|P1|COMPLETED|Overall Study||49
449632|NCT00631007|1073522|P6|STARTED|Overall Study||61
449633|NCT00631007|1073523|P5|STARTED|Overall Study||60
449634|NCT00631007|1073524|P4|STARTED|Overall Study||62
449635|NCT00631007|1073525|P3|STARTED|Overall Study||63
449636|NCT00631007|1073526|P2|STARTED|Overall Study||61
449638|NCT00630994|1073547|P1|NOT COMPLETED|Overall Study||4
449639|NCT00630994|1073547|P1|COMPLETED|Overall Study||0
449640|NCT00630994|1073547|P1|STARTED|Overall Study||4
449641|NCT00630955|1073558|P3|NOT COMPLETED|Overall Study||12
449642|NCT00630955|1073559|P2|NOT COMPLETED|Overall Study||6
449643|NCT00630955|1073560|P1|NOT COMPLETED|Overall Study||3
449644|NCT00630955|1073558|P3|COMPLETED|Overall Study||28
449645|NCT00630955|1073559|P2|COMPLETED|Overall Study||31
449646|NCT00630955|1073560|P1|COMPLETED|Overall Study||31
449647|NCT00630955|1073558|P3|STARTED|Overall Study||40
449648|NCT00630955|1073559|P2|STARTED|Overall Study||37
449649|NCT00630955|1073560|P1|STARTED|Overall Study||34
449650|NCT00630916|1073571|P1|NOT COMPLETED|Overall Study||210
449651|NCT00630916|1073571|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
449652|NCT00630916|1073571|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
449653|NCT00630916|1073571|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
449654|NCT00630877|1073581|P3|NOT COMPLETED|Overall Study||10
449655|NCT00630877|1073582|P2|NOT COMPLETED|Overall Study||15
449656|NCT00630877|1073583|P1|NOT COMPLETED|Overall Study||19
449657|NCT00630877|1073581|P3|COMPLETED|Overall Study||80
449658|NCT00630877|1073582|P2|COMPLETED|Overall Study||75
449659|NCT00630877|1073583|P1|COMPLETED|Overall Study||72
449660|NCT00630877|1073581|P3|STARTED|Overall Study||90
449661|NCT00630877|1073582|P2|STARTED|Overall Study||90
449662|NCT00630877|1073583|P1|STARTED|Overall Study|For all arms, started means treated.|91
449663|NCT00630864|1073601|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
449664|NCT00630864|1073601|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
449665|NCT00630864|1073601|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
449666|NCT00630864|1073601|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
449667|NCT00630864|1073601|P1|COMPLETED|Part 1 (up to Week 6)||20
449668|NCT00630864|1073601|P1|STARTED|Part 1 (up to Week 6)||21
449669|NCT00630838|1073640|P2|NOT COMPLETED|Overall Study||2
449670|NCT00630838|1073641|P1|NOT COMPLETED|Overall Study||0
449671|NCT00630838|1073640|P2|COMPLETED|Overall Study||28
449672|NCT00630838|1073641|P1|COMPLETED|Overall Study||32
449673|NCT00630838|1073640|P2|STARTED|Overall Study||30
449674|NCT00630838|1073641|P1|STARTED|Overall Study||32
449675|NCT00630825|1073653|P4|NOT COMPLETED|Overall Study||6
449676|NCT00630825|1073654|P3|NOT COMPLETED|Overall Study||8
449677|NCT00630825|1073655|P2|NOT COMPLETED|Overall Study||7
449678|NCT00630825|1073656|P1|NOT COMPLETED|Overall Study||9
449679|NCT00630825|1073653|P4|COMPLETED|Overall Study||60
449680|NCT00630825|1073654|P3|COMPLETED|Overall Study||58
449681|NCT00630825|1073655|P2|COMPLETED|Overall Study||58
449682|NCT00630825|1073656|P1|COMPLETED|Overall Study||56
449683|NCT00630825|1073653|P4|Received at Least One Dose of Study Drug|Overall Study||66
449684|NCT00630825|1073654|P3|Received at Least One Dose of Study Drug|Overall Study||66
449685|NCT00630825|1073655|P2|Received at Least One Dose of Study Drug|Overall Study||65
449686|NCT00630825|1073656|P1|Received at Least One Dose of Study Drug|Overall Study||65
449687|NCT00630825|1073653|P4|STARTED|Overall Study||66
449688|NCT00630825|1073654|P3|STARTED|Overall Study||66
449689|NCT00630825|1073655|P2|STARTED|Overall Study||65
449690|NCT00630825|1073656|P1|STARTED|Overall Study||65
449691|NCT00630786|1073728|P3|NOT COMPLETED|Overall Study||2
449692|NCT00630786|1073729|P2|NOT COMPLETED|Overall Study||2
449693|NCT00630786|1073730|P1|NOT COMPLETED|Overall Study||1
449694|NCT00630786|1073728|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
449695|NCT00630786|1073729|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
449696|NCT00630786|1073730|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
449697|NCT00630786|1073728|P3|Received Study Medication|Overall Study||8
449698|NCT00630786|1073729|P2|Received Study Medication|Overall Study||25
449699|NCT00630786|1073730|P1|Received Study Medication|Overall Study||19
449700|NCT00630786|1073728|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
449701|NCT00630786|1073729|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
449702|NCT00630786|1073730|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
449703|NCT00630747|1073749|P1|NOT COMPLETED|Overall Study||9
449704|NCT00630747|1073749|P1|COMPLETED|Overall Study||85
449705|NCT00630747|1073749|P1|Participants Treated in Phase I of Study|Overall Study||94
449706|NCT00630747|1073749|P1|STARTED|Overall Study||94
449707|NCT00630734|1073761|P3|NOT COMPLETED|Overall Study||1
449708|NCT00630734|1073762|P2|NOT COMPLETED|Overall Study||1
449709|NCT00630734|1073763|P1|NOT COMPLETED|Overall Study||2
449710|NCT00630734|1073761|P3|COMPLETED|Overall Study||7
449711|NCT00630734|1073762|P2|COMPLETED|Overall Study||12
449712|NCT00630734|1073763|P1|COMPLETED|Overall Study||9
449713|NCT00630734|1073761|P3|STARTED|Overall Study||8
449714|NCT00630734|1073762|P2|STARTED|Overall Study||13
449715|NCT00630734|1073763|P1|STARTED|Overall Study||11
449716|NCT00629850|1073800|P2|NOT COMPLETED|Overall Study||0
449717|NCT00629850|1073801|P1|NOT COMPLETED|Overall Study||0
449718|NCT00629850|1073800|P2|COMPLETED|Overall Study||0
449719|NCT00629850|1073801|P1|COMPLETED|Overall Study||1
449720|NCT00629850|1073800|P2|STARTED|Overall Study||0
449721|NCT00629850|1073801|P1|STARTED|Overall Study||1
449722|NCT00630539|1073815|P4|NOT COMPLETED|Overall Study||3
449723|NCT00630539|1073816|P3|NOT COMPLETED|Overall Study||1
449724|NCT00630539|1073817|P2|NOT COMPLETED|Overall Study||4
449725|NCT00630539|1073818|P1|NOT COMPLETED|Overall Study||1
449726|NCT00630539|1073815|P4|COMPLETED|Overall Study||27
449727|NCT00630539|1073816|P3|COMPLETED|Overall Study||28
449728|NCT00630539|1073817|P2|COMPLETED|Overall Study||29
449729|NCT00630539|1073818|P1|COMPLETED|Overall Study||33
449730|NCT00630539|1073815|P4|STARTED|Overall Study||30
449731|NCT00630539|1073816|P3|STARTED|Overall Study||29
449732|NCT00630539|1073817|P2|STARTED|Overall Study||33
449733|NCT00630539|1073818|P1|STARTED|Overall Study||34
449734|NCT00630487|1073874|P2|NOT COMPLETED|Overall Study||0
449735|NCT00630487|1073875|P1|NOT COMPLETED|Overall Study||0
449736|NCT00630487|1073874|P2|COMPLETED|Overall Study||0
449737|NCT00630487|1073875|P1|COMPLETED|Overall Study||0
449738|NCT00630487|1073874|P2|STARTED|Overall Study||0
449739|NCT00630487|1073875|P1|STARTED|Overall Study||0
449740|NCT00630409|1073909|P1|NOT COMPLETED|Overall Study||1
449741|NCT00630409|1073909|P1|COMPLETED|Overall Study||4
449742|NCT00630409|1073909|P1|STARTED|Overall Study||5
449743|NCT00630396|1073914|P1|NOT COMPLETED|Overall Study||7
449744|NCT00630396|1073914|P1|COMPLETED|Overall Study||53
449745|NCT00630396|1073914|P1|STARTED|Overall Study||60
449746|NCT00630344|1073920|P1|NOT COMPLETED|Overall Study||0
449747|NCT00630344|1073920|P1|COMPLETED|Overall Study||36
449748|NCT00630344|1073920|P1|STARTED|Overall Study||36
449749|NCT00630331|1073927|P3|NOT COMPLETED|Overall Study||188
449750|NCT00630331|1073928|P2|NOT COMPLETED|Overall Study||166
449751|NCT00630331|1073929|P1|NOT COMPLETED|Overall Study||206
449752|NCT00630331|1073927|P3|COMPLETED|Overall Study||3712
449753|NCT00630331|1073928|P2|COMPLETED|Overall Study||3510
449754|NCT00630331|1073929|P1|COMPLETED|Overall Study||3622
449755|NCT00630331|1073927|P3|STARTED|Overall Study||3900
449756|NCT00630331|1073928|P2|STARTED|Overall Study||3676
449757|NCT00630331|1073929|P1|STARTED|Overall Study||3828
449758|NCT00630305|1073970|P1|NOT COMPLETED|Overall Study||2
449759|NCT00630305|1073970|P1|COMPLETED|Overall Study||35
449760|NCT00630305|1073970|P1|STARTED|Overall Study||37
449761|NCT00630292|1073992|P1|NOT COMPLETED|Overall Study||1
449762|NCT00630292|1073992|P1|COMPLETED|Overall Study||5
449763|NCT00630292|1073992|P1|STARTED|Overall Study||6
449764|NCT00630058|1073998|P2|NOT COMPLETED|Overall Study||4
449765|NCT00630058|1073999|P1|NOT COMPLETED|Overall Study||4
449766|NCT00630058|1073998|P2|COMPLETED|Overall Study||6
449767|NCT00630058|1073999|P1|COMPLETED|Overall Study||6
449768|NCT00630058|1073998|P2|STARTED|Overall Study||10
449769|NCT00630058|1073999|P1|STARTED|Overall Study||10
449770|NCT00629772|1074017|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
449771|NCT00629772|1074018|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
449772|NCT00629772|1074017|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
449773|NCT00629772|1074018|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
449774|NCT00629772|1074017|P2|STARTED|Second Intervention Week 14 - Week 26||12
449775|NCT00629772|1074018|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
449776|NCT00629772|1074017|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
449777|NCT00629772|1074018|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
449778|NCT00629772|1074017|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
449779|NCT00629772|1074018|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
449780|NCT00629772|1074017|P2|STARTED|First Intervention - Day 0 - Week 14||12
449781|NCT00629772|1074018|P1|STARTED|First Intervention - Day 0 - Week 14||12
449782|NCT00629707|1074038|P2|NOT COMPLETED|Overall Study||2
449783|NCT00629707|1074039|P1|NOT COMPLETED|Overall Study||0
449784|NCT00629707|1074038|P2|COMPLETED|Overall Study||8
449785|NCT00629707|1074039|P1|COMPLETED|Overall Study||10
449786|NCT00629707|1074038|P2|STARTED|Overall Study||10
449787|NCT00629707|1074039|P1|STARTED|Overall Study||10
449788|NCT00629525|1074045|P1|NOT COMPLETED|Overall Study||3
449789|NCT00629525|1074045|P1|COMPLETED|Overall Study||32
449790|NCT00629525|1074045|P1|STARTED|Overall Study||35
449791|NCT00629499|1074053|P1|NOT COMPLETED|Overall Study||0
449792|NCT00629499|1074053|P1|COMPLETED|Overall Study||63
449793|NCT00629499|1074053|P1|STARTED|Overall Study||63
449794|NCT00629265|1074059|P2|NOT COMPLETED|Overall Study||20
449795|NCT00629265|1074060|P1|NOT COMPLETED|Overall Study||32
449796|NCT00629265|1074059|P2|COMPLETED|Overall Study||34
449797|NCT00629265|1074060|P1|COMPLETED|Overall Study||84
449798|NCT00629265|1074059|P2|STARTED|Overall Study||54
449799|NCT00629265|1074060|P1|STARTED|Overall Study||116
449800|NCT00629239|1074070|P2|NOT COMPLETED|Overall Study||4
449801|NCT00629239|1074071|P1|NOT COMPLETED|Overall Study||8
449802|NCT00629239|1074070|P2|COMPLETED|Overall Study||28
449803|NCT00629239|1074071|P1|COMPLETED|Overall Study||26
449804|NCT00629239|1074070|P2|STARTED|Overall Study||32
449805|NCT00629239|1074071|P1|STARTED|Overall Study||34
449806|NCT00629018|1074105|P2|NOT COMPLETED|Overall Study||0
449807|NCT00629018|1074106|P1|NOT COMPLETED|Overall Study||0
449808|NCT00629018|1074105|P2|COMPLETED|Overall Study||55
449809|NCT00629018|1074106|P1|COMPLETED|Overall Study||55
449810|NCT00629018|1074105|P2|STARTED|Overall Study||55
449811|NCT00629018|1074106|P1|STARTED|Overall Study||55
449812|NCT00628927|1074116|P2|NOT COMPLETED|Overall Study||0
449813|NCT00628927|1074117|P1|NOT COMPLETED|Overall Study||8
449814|NCT00628927|1074116|P2|COMPLETED|Overall Study||30
449815|NCT00628927|1074117|P1|COMPLETED|Overall Study||175
449816|NCT00628927|1074116|P2|STARTED|Overall Study||30
449817|NCT00628927|1074117|P1|STARTED|Overall Study||183
449818|NCT00628901|1074130|P2|NOT COMPLETED|Overall Study||1
449819|NCT00628901|1074131|P1|NOT COMPLETED|Overall Study||3
449820|NCT00628901|1074130|P2|COMPLETED|Overall Study||29
449821|NCT00628901|1074131|P1|COMPLETED|Overall Study||27
449822|NCT00628901|1074130|P2|STARTED|Overall Study||30
449823|NCT00628901|1074131|P1|STARTED|Overall Study||30
449824|NCT00628862|1074162|P3|NOT COMPLETED|Overall Study||22
449825|NCT00628862|1074163|P2|NOT COMPLETED|Overall Study||17
449826|NCT00628862|1074164|P1|NOT COMPLETED|Overall Study||11
449827|NCT00628862|1074162|P3|COMPLETED|Overall Study|randomised patients|186
449828|NCT00628862|1074163|P2|COMPLETED|Overall Study|randomised patients|182
449829|NCT00628862|1074164|P1|COMPLETED|Overall Study|randomised patients|195
449830|NCT00628862|1074162|P3|STARTED|Overall Study|randomised patients|208
449831|NCT00628862|1074163|P2|STARTED|Overall Study|randomised patients|199
449832|NCT00628862|1074164|P1|STARTED|Overall Study|randomised patients|206
449833|NCT00628758|1074210|P2|NOT COMPLETED|Overall Study||42
449834|NCT00628758|1074211|P1|NOT COMPLETED|Overall Study||44
449835|NCT00628758|1074210|P2|COMPLETED|Overall Study||179
449836|NCT00628758|1074211|P1|COMPLETED|Overall Study||165
449837|NCT00628758|1074210|P2|STARTED|Overall Study||221
449838|NCT00628758|1074211|P1|STARTED|Overall Study||209
449839|NCT00628628|1074225|P2|NOT COMPLETED|Overall Study||0
449840|NCT00628628|1074226|P1|NOT COMPLETED|Overall Study||0
449841|NCT00628628|1074225|P2|COMPLETED|Overall Study||40
449842|NCT00628628|1074226|P1|COMPLETED|Overall Study||40
449843|NCT00628628|1074225|P2|STARTED|Overall Study||40
449844|NCT00628628|1074226|P1|STARTED|Overall Study||40
449845|NCT00628446|1074232|P1|NOT COMPLETED|Overall Study||7
449846|NCT00628446|1074232|P1|COMPLETED|Overall Study||38
449847|NCT00628446|1074232|P1|STARTED|Overall Study||45
449848|NCT00628407|1074237|P1|NOT COMPLETED|Overall Study||0
449849|NCT00628407|1074237|P1|COMPLETED|Overall Study||13
449850|NCT00628407|1074237|P1|STARTED|Overall Study||13
449851|NCT00628355|1074243|P2|NOT COMPLETED|Overall Study||1
449852|NCT00628355|1074244|P1|NOT COMPLETED|Overall Study||1
449853|NCT00628355|1074243|P2|COMPLETED|Overall Study||14
449854|NCT00628355|1074244|P1|COMPLETED|Overall Study||14
449855|NCT00628355|1074243|P2|STARTED|Overall Study||15
449856|NCT00628355|1074244|P1|STARTED|Overall Study||15
449857|NCT00628251|1074255|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
449858|NCT00628251|1074256|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
449859|NCT00628251|1074257|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
449860|NCT00628251|1074255|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
449861|NCT00628251|1074256|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
449862|NCT00628251|1074257|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
449863|NCT00628251|1074255|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
449864|NCT00628251|1074256|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
449865|NCT00628251|1074257|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
449866|NCT00628251|1074255|P3|NOT COMPLETED|Randomised Part||8
449867|NCT00628251|1074256|P2|NOT COMPLETED|Randomised Part||0
449868|NCT00628251|1074257|P1|NOT COMPLETED|Randomised Part||0
449869|NCT00628251|1074255|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
449870|NCT00628251|1074256|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
449871|NCT00628251|1074257|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
449872|NCT00628251|1074255|P3|STARTED|Randomised Part|Patients randomised|33
449873|NCT00628251|1074256|P2|STARTED|Randomised Part|Patients randomised|32
449874|NCT00628251|1074257|P1|STARTED|Randomised Part|Patients randomised|32
449875|NCT00628212|1074300|P4|NOT COMPLETED|Overall Study||5
449876|NCT00628212|1074301|P3|NOT COMPLETED|Overall Study||3
449877|NCT00628212|1074302|P2|NOT COMPLETED|Overall Study||1
449878|NCT00628212|1074303|P1|NOT COMPLETED|Overall Study||3
449879|NCT00628212|1074300|P4|COMPLETED|Overall Study||76
449880|NCT00628212|1074301|P3|COMPLETED|Overall Study||76
449881|NCT00628212|1074302|P2|COMPLETED|Overall Study||83
449882|NCT00628212|1074303|P1|COMPLETED|Overall Study||77
449883|NCT00628212|1074300|P4|STARTED|Overall Study||81
449884|NCT00628212|1074301|P3|STARTED|Overall Study||79
449885|NCT00628212|1074302|P2|STARTED|Overall Study||84
449886|NCT00628212|1074303|P1|STARTED|Overall Study||80
449887|NCT00628147|1074327|P2|NOT COMPLETED|Overall Study||1
449888|NCT00628147|1074328|P1|NOT COMPLETED|Overall Study||7
449889|NCT00628147|1074327|P2|COMPLETED|Overall Study||141
449890|NCT00628147|1074328|P1|COMPLETED|Overall Study||135
449891|NCT00628147|1074327|P2|STARTED|Overall Study||142
449892|NCT00628147|1074328|P1|STARTED|Overall Study||142
449893|NCT00628134|1074340|P2|NOT COMPLETED|Overall Study||0
449894|NCT00628134|1074341|P1|NOT COMPLETED|Overall Study||0
449895|NCT00628134|1074340|P2|COMPLETED|Overall Study||4
449896|NCT00628134|1074341|P1|COMPLETED|Overall Study||4
449897|NCT00628134|1074340|P2|STARTED|Overall Study||4
449898|NCT00628134|1074341|P1|STARTED|Overall Study||4
449899|NCT00628108|1074351|P2|NOT COMPLETED|Overall Study||3
449900|NCT00628108|1074352|P1|NOT COMPLETED|Overall Study||1
449901|NCT00628108|1074351|P2|COMPLETED|Overall Study||43
449902|NCT00628108|1074352|P1|COMPLETED|Overall Study||22
449994|NCT00627393|1074645|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
449903|NCT00628108|1074351|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
449904|NCT00628108|1074352|P1|Safety Population|Overall Study||24
449905|NCT00628108|1074351|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
449906|NCT00628108|1074352|P1|STARTED|Overall Study||23
449907|NCT00628030|1074384|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
449908|NCT00628030|1074385|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
449909|NCT00628030|1074384|P2|COMPLETED|Post to 6 Month Follow-up||33
449910|NCT00628030|1074385|P1|COMPLETED|Post to 6 Month Follow-up||27
449911|NCT00628030|1074384|P2|STARTED|Post to 6 Month Follow-up||63
449912|NCT00628030|1074385|P1|STARTED|Post to 6 Month Follow-up||59
449913|NCT00628030|1074384|P2|NOT COMPLETED|Baseline to Post-Assessment||29
449914|NCT00628030|1074385|P1|NOT COMPLETED|Baseline to Post-Assessment||33
449915|NCT00628030|1074384|P2|COMPLETED|Baseline to Post-Assessment||63
449916|NCT00628030|1074385|P1|COMPLETED|Baseline to Post-Assessment||59
449917|NCT00628030|1074384|P2|STARTED|Baseline to Post-Assessment||92
449918|NCT00628030|1074385|P1|STARTED|Baseline to Post-Assessment||92
449919|NCT00627926|1074402|P3|NOT COMPLETED|Overall Study||95
449920|NCT00627926|1074403|P2|NOT COMPLETED|Overall Study||104
449921|NCT00627926|1074404|P1|NOT COMPLETED|Overall Study||159
449922|NCT00627926|1074402|P3|COMPLETED|Overall Study||268
449923|NCT00627926|1074403|P2|COMPLETED|Overall Study||260
449924|NCT00627926|1074404|P1|COMPLETED|Overall Study||202
449925|NCT00627926|1074402|P3|STARTED|Overall Study||363
449926|NCT00627926|1074403|P2|STARTED|Overall Study||364
449927|NCT00627926|1074404|P1|STARTED|Overall Study||361
449928|NCT00627861|1074448|P1|NOT COMPLETED|Overall Study||0
449929|NCT00627861|1074448|P1|COMPLETED|Overall Study||1
449930|NCT00627861|1074448|P1|STARTED|Overall Study||1
449931|NCT00627705|1074456|P2|NOT COMPLETED|Overall Study||6
449932|NCT00627705|1074457|P1|NOT COMPLETED|Overall Study||2
449933|NCT00627705|1074456|P2|COMPLETED|Overall Study||12
449934|NCT00627705|1074457|P1|COMPLETED|Overall Study||13
449935|NCT00627705|1074456|P2|STARTED|Overall Study||18
449936|NCT00627705|1074457|P1|STARTED|Overall Study||15
449937|NCT00627679|1074477|P4|NOT COMPLETED|Overall Study||0
449938|NCT00627679|1074478|P3|NOT COMPLETED|Overall Study||0
449939|NCT00627679|1074479|P2|NOT COMPLETED|Overall Study||0
449940|NCT00627679|1074480|P1|NOT COMPLETED|Overall Study||0
449941|NCT00627679|1074477|P4|COMPLETED|Overall Study||4
449942|NCT00627679|1074478|P3|COMPLETED|Overall Study||4
449943|NCT00627679|1074479|P2|COMPLETED|Overall Study||4
449944|NCT00627679|1074480|P1|COMPLETED|Overall Study||4
449945|NCT00627679|1074477|P4|STARTED|Overall Study||4
449946|NCT00627679|1074478|P3|STARTED|Overall Study||4
449947|NCT00627679|1074479|P2|STARTED|Overall Study||4
449948|NCT00627679|1074480|P1|STARTED|Overall Study||4
449949|NCT00627523|1074508|P2|NOT COMPLETED|Overall Study||2
449950|NCT00627523|1074509|P1|NOT COMPLETED|Overall Study||2
449951|NCT00627523|1074508|P2|COMPLETED|Overall Study||20
449952|NCT00627523|1074509|P1|COMPLETED|Overall Study||19
449953|NCT00627523|1074508|P2|STARTED|Overall Study||22
449954|NCT00627523|1074509|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
449955|NCT00627497|1074537|P4|NOT COMPLETED|Overall Study||0
449956|NCT00627497|1074538|P3|NOT COMPLETED|Overall Study||0
449957|NCT00627497|1074539|P2|NOT COMPLETED|Overall Study||1
449958|NCT00627497|1074540|P1|NOT COMPLETED|Overall Study||1
449959|NCT00627497|1074537|P4|COMPLETED|Overall Study||2
449960|NCT00627497|1074538|P3|COMPLETED|Overall Study||4
449961|NCT00627497|1074539|P2|COMPLETED|Overall Study||11
449962|NCT00627497|1074540|P1|COMPLETED|Overall Study||13
449963|NCT00627497|1074537|P4|STARTED|Overall Study||2
449964|NCT00627497|1074538|P3|STARTED|Overall Study||4
449965|NCT00627497|1074539|P2|STARTED|Overall Study||12
449966|NCT00627497|1074540|P1|STARTED|Overall Study||14
449967|NCT00627445|1074600|P2|NOT COMPLETED|Overall Study||12
449968|NCT00627445|1074601|P1|NOT COMPLETED|Overall Study||9
449969|NCT00627445|1074600|P2|COMPLETED|Overall Study||210
449970|NCT00627445|1074601|P1|COMPLETED|Overall Study||210
449971|NCT00627445|1074600|P2|Exposed to Study Drug|Overall Study||222
449972|NCT00627445|1074601|P1|Exposed to Study Drug|Overall Study||219
449973|NCT00627445|1074600|P2|STARTED|Overall Study||222
449974|NCT00627445|1074601|P1|STARTED|Overall Study||219
449975|NCT00627406|1074625|P4|NOT COMPLETED|Overall Study||0
449976|NCT00627406|1074626|P3|NOT COMPLETED|Overall Study||0
449977|NCT00627406|1074627|P2|NOT COMPLETED|Overall Study||0
449978|NCT00627406|1074628|P1|NOT COMPLETED|Overall Study||0
449979|NCT00627406|1074625|P4|COMPLETED|Overall Study||141
449980|NCT00627406|1074626|P3|COMPLETED|Overall Study||125
449981|NCT00627406|1074627|P2|COMPLETED|Overall Study||58
449982|NCT00627406|1074628|P1|COMPLETED|Overall Study||60
449983|NCT00627406|1074625|P4|STARTED|Overall Study||141
449984|NCT00627406|1074626|P3|STARTED|Overall Study||125
449985|NCT00627406|1074627|P2|STARTED|Overall Study||58
449986|NCT00627406|1074628|P1|STARTED|Overall Study||60
449987|NCT00627393|1074644|P2|NOT COMPLETED|Per-Protocol Analysis||13
449988|NCT00627393|1074645|P1|NOT COMPLETED|Per-Protocol Analysis||10
449989|NCT00627393|1074644|P2|COMPLETED|Per-Protocol Analysis||35
449990|NCT00627393|1074645|P1|COMPLETED|Per-Protocol Analysis||39
449991|NCT00627393|1074644|P2|STARTED|Per-Protocol Analysis||48
449992|NCT00627393|1074645|P1|STARTED|Per-Protocol Analysis||49
449993|NCT00627393|1074644|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
449995|NCT00627393|1074644|P2|COMPLETED|Intention-To-Treat Analysis||48
449996|NCT00627393|1074645|P1|COMPLETED|Intention-To-Treat Analysis||49
449997|NCT00627393|1074644|P2|STARTED|Intention-To-Treat Analysis||56
449998|NCT00627393|1074645|P1|STARTED|Intention-To-Treat Analysis||58
449999|NCT00627094|1074666|P2|NOT COMPLETED|Overall Study||15
450000|NCT00627094|1074667|P1|NOT COMPLETED|Overall Study||12
450001|NCT00627094|1074666|P2|COMPLETED|Overall Study||45
450002|NCT00627094|1074667|P1|COMPLETED|Overall Study||48
450003|NCT00627094|1074666|P2|STARTED|Overall Study||60
450004|NCT00627094|1074667|P1|STARTED|Overall Study||60
450005|NCT00627042|1074679|P1|NOT COMPLETED|Overall Study||2
450006|NCT00627042|1074679|P1|COMPLETED|Overall Study||40
450007|NCT00627042|1074679|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
450008|NCT00627042|1074679|P1|STARTED|Overall Study||42
450009|NCT00627016|1074691|P2|NOT COMPLETED|Overall Study||6
450010|NCT00627016|1074692|P1|NOT COMPLETED|Overall Study||6
450011|NCT00627016|1074691|P2|COMPLETED|Overall Study||146
450012|NCT00627016|1074692|P1|COMPLETED|Overall Study||147
450013|NCT00627016|1074691|P2|STARTED|Overall Study||152
450014|NCT00627016|1074692|P1|STARTED|Overall Study||153
450015|NCT00626925|1074704|P2|NOT COMPLETED|Overall Study||9
450016|NCT00626925|1074705|P1|NOT COMPLETED|Overall Study||12
450017|NCT00626925|1074704|P2|COMPLETED|Overall Study||62
450018|NCT00626925|1074705|P1|COMPLETED|Overall Study||55
450019|NCT00626925|1074704|P2|STARTED|Overall Study||71
450020|NCT00626925|1074705|P1|STARTED|Overall Study||67
450021|NCT00626821|1074731|P1|NOT COMPLETED|Overall Study||221
450022|NCT00626821|1074731|P1|COMPLETED|Overall Study||2796
450023|NCT00626821|1074731|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
450024|NCT00626821|1074731|P1|STARTED|Overall Study||3017
450025|NCT00626808|1074739|P4|NOT COMPLETED|Overall Study||0
450026|NCT00626808|1074740|P3|NOT COMPLETED|Overall Study||0
450027|NCT00626808|1074741|P2|NOT COMPLETED|Overall Study||0
450028|NCT00626808|1074742|P1|NOT COMPLETED|Overall Study||0
450029|NCT00626808|1074739|P4|COMPLETED|Overall Study||2906
450030|NCT00626808|1074740|P3|COMPLETED|Overall Study||30011
450031|NCT00626808|1074741|P2|COMPLETED|Overall Study||34316
450032|NCT00626808|1074742|P1|COMPLETED|Overall Study||254464
450033|NCT00626808|1074739|P4|STARTED|Overall Study||2906
450034|NCT00626808|1074740|P3|STARTED|Overall Study||30011
450035|NCT00626808|1074741|P2|STARTED|Overall Study||34316
450036|NCT00626808|1074742|P1|STARTED|Overall Study||254464
450037|NCT00626782|1074810|P2|NOT COMPLETED|Overall Study||0
450038|NCT00626782|1074811|P1|NOT COMPLETED|Overall Study||0
450039|NCT00626782|1074810|P2|COMPLETED|Overall Study||12
450040|NCT00626782|1074811|P1|COMPLETED|Overall Study||12
450041|NCT00626782|1074810|P2|STARTED|Overall Study||12
450042|NCT00626782|1074811|P1|STARTED|Overall Study||12
450043|NCT00626743|1074819|P2|NOT COMPLETED|Treatment Period 2||0
450044|NCT00626743|1074820|P1|NOT COMPLETED|Treatment Period 2||0
450045|NCT00626743|1074819|P2|COMPLETED|Treatment Period 2||6
450046|NCT00626743|1074820|P1|COMPLETED|Treatment Period 2||6
450047|NCT00626743|1074819|P2|STARTED|Treatment Period 2||6
450048|NCT00626743|1074820|P1|STARTED|Treatment Period 2||6
450049|NCT00626743|1074819|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
450050|NCT00626743|1074820|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
450051|NCT00626743|1074819|P2|COMPLETED|Wash-out Period of 6 Days||6
450052|NCT00626743|1074820|P1|COMPLETED|Wash-out Period of 6 Days||6
450053|NCT00626743|1074819|P2|STARTED|Wash-out Period of 6 Days||6
450054|NCT00626743|1074820|P1|STARTED|Wash-out Period of 6 Days||6
450055|NCT00626743|1074819|P2|NOT COMPLETED|Treatment Period 1||1
450056|NCT00626743|1074820|P1|NOT COMPLETED|Treatment Period 1||0
450057|NCT00626743|1074819|P2|COMPLETED|Treatment Period 1||6
450058|NCT00626743|1074820|P1|COMPLETED|Treatment Period 1||6
450059|NCT00626743|1074819|P2|STARTED|Treatment Period 1||7
450060|NCT00626743|1074820|P1|STARTED|Treatment Period 1||6
450061|NCT00626639|1074830|P2|NOT COMPLETED|Overall Study||2
450062|NCT00626639|1074831|P1|NOT COMPLETED|Overall Study||2
450063|NCT00626639|1074830|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
450064|NCT00626639|1074831|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
450065|NCT00626639|1074830|P2|STARTED|Overall Study||3
450066|NCT00626639|1074831|P1|STARTED|Overall Study||2
450067|NCT00626574|1074849|P2|NOT COMPLETED|Overall Study||0
450068|NCT00626574|1074850|P1|NOT COMPLETED|Overall Study||0
450069|NCT00626574|1074849|P2|COMPLETED|Overall Study||1
450070|NCT00626574|1074850|P1|COMPLETED|Overall Study||2
450071|NCT00626574|1074849|P2|STARTED|Overall Study||1
450072|NCT00626574|1074850|P1|STARTED|Overall Study||2
450073|NCT00626561|1074856|P1|NOT COMPLETED|Overall Study||4
450074|NCT00626561|1074856|P1|COMPLETED|Overall Study||0
450075|NCT00626561|1074856|P1|STARTED|Overall Study||4
450076|NCT00626548|1074862|P2|NOT COMPLETED|Overall Study||716
450077|NCT00626548|1074863|P1|NOT COMPLETED|Overall Study||705
450078|NCT00626548|1074862|P2|COMPLETED|Overall Study||0
450079|NCT00626548|1074863|P1|COMPLETED|Overall Study||0
450080|NCT00626548|1074862|P2|Patients Received Treatment|Overall Study||712
450081|NCT00626548|1074863|P1|Patients Received Treatment|Overall Study||703
450082|NCT00626548|1074862|P2|STARTED|Overall Study||716
450083|NCT00626548|1074863|P1|STARTED|Overall Study||705
450084|NCT00626522|1074877|P6|NOT COMPLETED|Overall Study||2
450085|NCT00626522|1074878|P5|NOT COMPLETED|Overall Study||7
450086|NCT00626522|1074879|P4|NOT COMPLETED|Overall Study||2
450087|NCT00626522|1074880|P3|NOT COMPLETED|Overall Study||8
450088|NCT00626522|1074881|P2|NOT COMPLETED|Overall Study||7
450089|NCT00626522|1074882|P1|NOT COMPLETED|Overall Study||6
450090|NCT00626522|1074877|P6|COMPLETED|Overall Study||57
450091|NCT00626522|1074878|P5|COMPLETED|Overall Study||58
450092|NCT00626522|1074879|P4|COMPLETED|Overall Study||74
450093|NCT00626522|1074880|P3|COMPLETED|Overall Study||117
450094|NCT00626522|1074881|P2|COMPLETED|Overall Study||113
450095|NCT00626522|1074882|P1|COMPLETED|Overall Study||115
450096|NCT00626522|1074877|P6|STARTED|Overall Study||59
450097|NCT00626522|1074878|P5|STARTED|Overall Study||65
450098|NCT00626522|1074879|P4|STARTED|Overall Study||76
450099|NCT00626522|1074880|P3|STARTED|Overall Study||125
450100|NCT00626522|1074881|P2|STARTED|Overall Study||120
450101|NCT00626522|1074882|P1|STARTED|Overall Study||121
450102|NCT00626444|1074920|P1|NOT COMPLETED|Overall Study||0
450103|NCT00626444|1074920|P1|COMPLETED|Overall Study||2
450104|NCT00626444|1074920|P1|STARTED|Overall Study||2
450105|NCT00626431|1074927|P2|NOT COMPLETED|Overall Study||45
450106|NCT00626431|1074928|P1|NOT COMPLETED|Overall Study||17
450107|NCT00626431|1074927|P2|COMPLETED|Overall Study||114
450108|NCT00626431|1074928|P1|COMPLETED|Overall Study||134
450109|NCT00626431|1074927|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
450110|NCT00626431|1074928|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
450111|NCT00626392|1074949|P6|NOT COMPLETED|Coadministration Period||6
450112|NCT00626392|1074950|P5|NOT COMPLETED|Coadministration Period||5
450113|NCT00626392|1074951|P4|NOT COMPLETED|Coadministration Period||7
450114|NCT00626392|1074952|P3|NOT COMPLETED|Coadministration Period||10
450115|NCT00626392|1074953|P2|NOT COMPLETED|Coadministration Period||5
450116|NCT00626392|1074954|P1|NOT COMPLETED|Coadministration Period||4
450117|NCT00626392|1074949|P6|COMPLETED|Coadministration Period||38
450118|NCT00626392|1074950|P5|COMPLETED|Coadministration Period||36
450119|NCT00626392|1074951|P4|COMPLETED|Coadministration Period||36
450120|NCT00626392|1074952|P3|COMPLETED|Coadministration Period||31
450121|NCT00626392|1074953|P2|COMPLETED|Coadministration Period||38
450122|NCT00626392|1074954|P1|COMPLETED|Coadministration Period||40
450123|NCT00626392|1074949|P6|STARTED|Coadministration Period||44
450124|NCT00626392|1074950|P5|STARTED|Coadministration Period||41
450125|NCT00626392|1074951|P4|STARTED|Coadministration Period||43
450126|NCT00626392|1074952|P3|STARTED|Coadministration Period||41
450127|NCT00626392|1074953|P2|STARTED|Coadministration Period||43
450128|NCT00626392|1074954|P1|STARTED|Coadministration Period||44
450129|NCT00626392|1074949|P6|NOT COMPLETED|Run-in Period||1
450130|NCT00626392|1074950|P5|NOT COMPLETED|Run-in Period||4
450131|NCT00626392|1074951|P4|NOT COMPLETED|Run-in Period||1
450132|NCT00626392|1074952|P3|NOT COMPLETED|Run-in Period||3
450133|NCT00626392|1074953|P2|NOT COMPLETED|Run-in Period||1
450134|NCT00626392|1074954|P1|NOT COMPLETED|Run-in Period||1
450135|NCT00626392|1074949|P6|COMPLETED|Run-in Period||44
450136|NCT00626392|1074950|P5|COMPLETED|Run-in Period||41
450137|NCT00626392|1074951|P4|COMPLETED|Run-in Period||43
450138|NCT00626392|1074952|P3|COMPLETED|Run-in Period||41
450139|NCT00626392|1074953|P2|COMPLETED|Run-in Period||43
450140|NCT00626392|1074954|P1|COMPLETED|Run-in Period||44
450141|NCT00626392|1074949|P6|STARTED|Run-in Period||45
450142|NCT00626392|1074950|P5|STARTED|Run-in Period||45
450143|NCT00626392|1074951|P4|STARTED|Run-in Period||44
450144|NCT00626392|1074952|P3|STARTED|Run-in Period||44
450145|NCT00626392|1074953|P2|STARTED|Run-in Period||44
450146|NCT00626392|1074954|P1|STARTED|Run-in Period||45
450147|NCT00626340|1074966|P1|NOT COMPLETED|Overall Study||0
450148|NCT00626340|1074966|P1|COMPLETED|Overall Study||18
450149|NCT00626340|1074966|P1|STARTED|Overall Study||18
450150|NCT00626327|1074973|P3|NOT COMPLETED|Overall Study||88
450151|NCT00626327|1074974|P2|NOT COMPLETED|Overall Study||59
450152|NCT00626327|1074975|P1|NOT COMPLETED|Overall Study||78
450153|NCT00626327|1074973|P3|COMPLETED|Overall Study||422
450154|NCT00626327|1074974|P2|COMPLETED|Overall Study||557
450155|NCT00626327|1074975|P1|COMPLETED|Overall Study||426
450156|NCT00626327|1074973|P3|STARTED|Overall Study||510
450157|NCT00626327|1074974|P2|STARTED|Overall Study||616
450158|NCT00626327|1074975|P1|STARTED|Overall Study||504
450159|NCT00626275|1075001|P8|NOT COMPLETED|Part B||1
450160|NCT00626275|1075002|P7|NOT COMPLETED|Part B||1
450161|NCT00626275|1075003|P6|NOT COMPLETED|Part B||0
450162|NCT00626275|1075004|P5|NOT COMPLETED|Part B||0
450163|NCT00626275|1075005|P4|NOT COMPLETED|Part B||0
450164|NCT00626275|1075006|P3|NOT COMPLETED|Part B||0
450165|NCT00626275|1075007|P2|NOT COMPLETED|Part B||0
450166|NCT00626275|1075008|P1|NOT COMPLETED|Part B||0
450167|NCT00626275|1075001|P8|COMPLETED|Part B||23
450168|NCT00626275|1075002|P7|COMPLETED|Part B||19
450169|NCT00626275|1075003|P6|COMPLETED|Part B||0
450170|NCT00626275|1075004|P5|COMPLETED|Part B||0
450171|NCT00626275|1075005|P4|COMPLETED|Part B||0
450172|NCT00626275|1075006|P3|COMPLETED|Part B||0
450173|NCT00626275|1075007|P2|COMPLETED|Part B||0
450174|NCT00626275|1075008|P1|COMPLETED|Part B||0
450175|NCT00626275|1075001|P8|STARTED|Part B||24
450176|NCT00626275|1075002|P7|STARTED|Part B||20
450177|NCT00626275|1075003|P6|STARTED|Part B||0
450178|NCT00626275|1075004|P5|STARTED|Part B||0
450179|NCT00626275|1075005|P4|STARTED|Part B||0
450180|NCT00626275|1075006|P3|STARTED|Part B||0
450181|NCT00626275|1075007|P2|STARTED|Part B||0
450182|NCT00626275|1075008|P1|STARTED|Part B||0
450183|NCT00626275|1075001|P8|NOT COMPLETED|Re-randomization Period for Part B||0
450184|NCT00626275|1075002|P7|NOT COMPLETED|Re-randomization Period for Part B||0
450185|NCT00626275|1075003|P6|NOT COMPLETED|Re-randomization Period for Part B||0
450186|NCT00626275|1075004|P5|NOT COMPLETED|Re-randomization Period for Part B||0
450187|NCT00626275|1075005|P4|NOT COMPLETED|Re-randomization Period for Part B||0
450188|NCT00626275|1075006|P3|NOT COMPLETED|Re-randomization Period for Part B||0
450189|NCT00626275|1075007|P2|NOT COMPLETED|Re-randomization Period for Part B||0
450190|NCT00626275|1075008|P1|NOT COMPLETED|Re-randomization Period for Part B||0
450191|NCT00626275|1075001|P8|COMPLETED|Re-randomization Period for Part B||24
450192|NCT00626275|1075002|P7|COMPLETED|Re-randomization Period for Part B||20
450193|NCT00626275|1075003|P6|COMPLETED|Re-randomization Period for Part B||0
450194|NCT00626275|1075004|P5|COMPLETED|Re-randomization Period for Part B||0
450195|NCT00626275|1075005|P4|COMPLETED|Re-randomization Period for Part B||0
450196|NCT00626275|1075006|P3|COMPLETED|Re-randomization Period for Part B||0
450197|NCT00626275|1075007|P2|COMPLETED|Re-randomization Period for Part B||0
450198|NCT00626275|1075008|P1|COMPLETED|Re-randomization Period for Part B||0
450199|NCT00626275|1075001|P8|STARTED|Re-randomization Period for Part B||24
450200|NCT00626275|1075002|P7|STARTED|Re-randomization Period for Part B||20
450201|NCT00626275|1075003|P6|STARTED|Re-randomization Period for Part B||0
450202|NCT00626275|1075004|P5|STARTED|Re-randomization Period for Part B||0
450203|NCT00626275|1075005|P4|STARTED|Re-randomization Period for Part B||0
450204|NCT00626275|1075006|P3|STARTED|Re-randomization Period for Part B||0
450205|NCT00626275|1075007|P2|STARTED|Re-randomization Period for Part B||0
450206|NCT00626275|1075008|P1|STARTED|Re-randomization Period for Part B||0
450207|NCT00626275|1075001|P8|NOT COMPLETED|Part A - Treatment Period 3||0
450208|NCT00626275|1075002|P7|NOT COMPLETED|Part A - Treatment Period 3||0
450209|NCT00626275|1075003|P6|NOT COMPLETED|Part A - Treatment Period 3||0
450210|NCT00626275|1075004|P5|NOT COMPLETED|Part A - Treatment Period 3||0
450211|NCT00626275|1075005|P4|NOT COMPLETED|Part A - Treatment Period 3||0
450212|NCT00626275|1075006|P3|NOT COMPLETED|Part A - Treatment Period 3||0
450213|NCT00626275|1075007|P2|NOT COMPLETED|Part A - Treatment Period 3||0
450214|NCT00626275|1075008|P1|NOT COMPLETED|Part A - Treatment Period 3||0
450215|NCT00626275|1075001|P8|COMPLETED|Part A - Treatment Period 3||0
450216|NCT00626275|1075002|P7|COMPLETED|Part A - Treatment Period 3||0
450217|NCT00626275|1075003|P6|COMPLETED|Part A - Treatment Period 3||8
450218|NCT00626275|1075004|P5|COMPLETED|Part A - Treatment Period 3||9
450219|NCT00626275|1075005|P4|COMPLETED|Part A - Treatment Period 3||8
450220|NCT00626275|1075006|P3|COMPLETED|Part A - Treatment Period 3||6
450221|NCT00626275|1075007|P2|COMPLETED|Part A - Treatment Period 3||7
450222|NCT00626275|1075008|P1|COMPLETED|Part A - Treatment Period 3||6
450223|NCT00626275|1075001|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
450224|NCT00626275|1075002|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
450225|NCT00626275|1075003|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
450226|NCT00626275|1075004|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
450227|NCT00626275|1075005|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
450228|NCT00626275|1075006|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
450229|NCT00626275|1075007|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
450230|NCT00626275|1075008|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
450231|NCT00626275|1075001|P8|STARTED|Part A - Treatment Period 3||0
450232|NCT00626275|1075002|P7|STARTED|Part A - Treatment Period 3||0
450233|NCT00626275|1075003|P6|STARTED|Part A - Treatment Period 3||8
450234|NCT00626275|1075004|P5|STARTED|Part A - Treatment Period 3||9
450235|NCT00626275|1075005|P4|STARTED|Part A - Treatment Period 3||8
450236|NCT00626275|1075006|P3|STARTED|Part A - Treatment Period 3||6
450237|NCT00626275|1075007|P2|STARTED|Part A - Treatment Period 3||7
450238|NCT00626275|1075008|P1|STARTED|Part A - Treatment Period 3||6
450239|NCT00626275|1075001|P8|NOT COMPLETED|Part A - Washout Period 2||0
450240|NCT00626275|1075002|P7|NOT COMPLETED|Part A - Washout Period 2||0
450241|NCT00626275|1075003|P6|NOT COMPLETED|Part A - Washout Period 2||0
450242|NCT00626275|1075004|P5|NOT COMPLETED|Part A - Washout Period 2||0
450243|NCT00626275|1075005|P4|NOT COMPLETED|Part A - Washout Period 2||0
450244|NCT00626275|1075006|P3|NOT COMPLETED|Part A - Washout Period 2||0
450245|NCT00626275|1075007|P2|NOT COMPLETED|Part A - Washout Period 2||0
450246|NCT00626275|1075008|P1|NOT COMPLETED|Part A - Washout Period 2||0
450247|NCT00626275|1075001|P8|COMPLETED|Part A - Washout Period 2||0
450248|NCT00626275|1075002|P7|COMPLETED|Part A - Washout Period 2||0
450249|NCT00626275|1075003|P6|COMPLETED|Part A - Washout Period 2||8
450250|NCT00626275|1075004|P5|COMPLETED|Part A - Washout Period 2||9
450251|NCT00626275|1075005|P4|COMPLETED|Part A - Washout Period 2||8
450252|NCT00626275|1075006|P3|COMPLETED|Part A - Washout Period 2||6
450253|NCT00626275|1075007|P2|COMPLETED|Part A - Washout Period 2||7
450254|NCT00626275|1075008|P1|COMPLETED|Part A - Washout Period 2||6
450255|NCT00626275|1075001|P8|STARTED|Part A - Washout Period 2||0
450256|NCT00626275|1075002|P7|STARTED|Part A - Washout Period 2||0
450257|NCT00626275|1075003|P6|STARTED|Part A - Washout Period 2||8
450258|NCT00626275|1075004|P5|STARTED|Part A - Washout Period 2||9
450259|NCT00626275|1075005|P4|STARTED|Part A - Washout Period 2||8
450260|NCT00626275|1075006|P3|STARTED|Part A - Washout Period 2||6
450261|NCT00626275|1075007|P2|STARTED|Part A - Washout Period 2||7
450262|NCT00626275|1075008|P1|STARTED|Part A - Washout Period 2||6
450263|NCT00626275|1075001|P8|NOT COMPLETED|Part A - Treatment Period 2||0
450264|NCT00626275|1075002|P7|NOT COMPLETED|Part A - Treatment Period 2||0
450265|NCT00626275|1075003|P6|NOT COMPLETED|Part A - Treatment Period 2||0
450266|NCT00626275|1075004|P5|NOT COMPLETED|Part A - Treatment Period 2||0
450267|NCT00626275|1075005|P4|NOT COMPLETED|Part A - Treatment Period 2||0
450268|NCT00626275|1075006|P3|NOT COMPLETED|Part A - Treatment Period 2||0
450269|NCT00626275|1075007|P2|NOT COMPLETED|Part A - Treatment Period 2||0
450270|NCT00626275|1075008|P1|NOT COMPLETED|Part A - Treatment Period 2||0
450271|NCT00626275|1075001|P8|COMPLETED|Part A - Treatment Period 2||0
450272|NCT00626275|1075002|P7|COMPLETED|Part A - Treatment Period 2||0
450273|NCT00626275|1075003|P6|COMPLETED|Part A - Treatment Period 2||8
450274|NCT00626275|1075004|P5|COMPLETED|Part A - Treatment Period 2||9
450275|NCT00626275|1075005|P4|COMPLETED|Part A - Treatment Period 2||8
450276|NCT00626275|1075006|P3|COMPLETED|Part A - Treatment Period 2||6
450277|NCT00626275|1075007|P2|COMPLETED|Part A - Treatment Period 2||7
450278|NCT00626275|1075008|P1|COMPLETED|Part A - Treatment Period 2||6
450279|NCT00626275|1075001|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
450280|NCT00626275|1075002|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
450281|NCT00626275|1075003|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
450282|NCT00626275|1075004|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
450283|NCT00626275|1075005|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
450284|NCT00626275|1075006|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
450285|NCT00626275|1075007|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
450286|NCT00626275|1075008|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
450287|NCT00626275|1075001|P8|STARTED|Part A - Treatment Period 2||0
450288|NCT00626275|1075002|P7|STARTED|Part A - Treatment Period 2||0
450289|NCT00626275|1075003|P6|STARTED|Part A - Treatment Period 2||8
450290|NCT00626275|1075004|P5|STARTED|Part A - Treatment Period 2||9
450291|NCT00626275|1075005|P4|STARTED|Part A - Treatment Period 2||8
450292|NCT00626275|1075006|P3|STARTED|Part A - Treatment Period 2||6
450293|NCT00626275|1075007|P2|STARTED|Part A - Treatment Period 2||7
450294|NCT00626275|1075008|P1|STARTED|Part A - Treatment Period 2||6
450295|NCT00626275|1075001|P8|NOT COMPLETED|Part A - Washout Period 1||0
450296|NCT00626275|1075002|P7|NOT COMPLETED|Part A - Washout Period 1||0
450297|NCT00626275|1075003|P6|NOT COMPLETED|Part A - Washout Period 1||0
450298|NCT00626275|1075004|P5|NOT COMPLETED|Part A - Washout Period 1||0
450299|NCT00626275|1075005|P4|NOT COMPLETED|Part A - Washout Period 1||0
450300|NCT00626275|1075006|P3|NOT COMPLETED|Part A - Washout Period 1||0
450301|NCT00626275|1075007|P2|NOT COMPLETED|Part A - Washout Period 1||0
450302|NCT00626275|1075008|P1|NOT COMPLETED|Part A - Washout Period 1||0
450303|NCT00626275|1075001|P8|COMPLETED|Part A - Washout Period 1||0
450304|NCT00626275|1075002|P7|COMPLETED|Part A - Washout Period 1||0
450305|NCT00626275|1075003|P6|COMPLETED|Part A - Washout Period 1||8
450306|NCT00626275|1075004|P5|COMPLETED|Part A - Washout Period 1||9
450307|NCT00626275|1075005|P4|COMPLETED|Part A - Washout Period 1||8
450308|NCT00626275|1075006|P3|COMPLETED|Part A - Washout Period 1||6
450309|NCT00626275|1075007|P2|COMPLETED|Part A - Washout Period 1||7
450310|NCT00626275|1075008|P1|COMPLETED|Part A - Washout Period 1||6
450311|NCT00626275|1075001|P8|STARTED|Part A - Washout Period 1||0
450312|NCT00626275|1075002|P7|STARTED|Part A - Washout Period 1||0
450313|NCT00626275|1075003|P6|STARTED|Part A - Washout Period 1||8
450314|NCT00626275|1075004|P5|STARTED|Part A - Washout Period 1||9
450315|NCT00626275|1075005|P4|STARTED|Part A - Washout Period 1||8
450316|NCT00626275|1075006|P3|STARTED|Part A - Washout Period 1||6
450317|NCT00626275|1075007|P2|STARTED|Part A - Washout Period 1||7
450318|NCT00626275|1075008|P1|STARTED|Part A - Washout Period 1||6
450319|NCT00626275|1075001|P8|NOT COMPLETED|Part A - Treatment Period 1||0
450320|NCT00626275|1075002|P7|NOT COMPLETED|Part A - Treatment Period 1||0
450321|NCT00626275|1075003|P6|NOT COMPLETED|Part A - Treatment Period 1||0
450322|NCT00626275|1075004|P5|NOT COMPLETED|Part A - Treatment Period 1||0
450323|NCT00626275|1075005|P4|NOT COMPLETED|Part A - Treatment Period 1||0
450324|NCT00626275|1075006|P3|NOT COMPLETED|Part A - Treatment Period 1||1
450325|NCT00626275|1075007|P2|NOT COMPLETED|Part A - Treatment Period 1||0
450326|NCT00626275|1075008|P1|NOT COMPLETED|Part A - Treatment Period 1||1
450327|NCT00626275|1075001|P8|COMPLETED|Part A - Treatment Period 1||0
450328|NCT00626275|1075002|P7|COMPLETED|Part A - Treatment Period 1||0
450329|NCT00626275|1075003|P6|COMPLETED|Part A - Treatment Period 1||8
450330|NCT00626275|1075004|P5|COMPLETED|Part A - Treatment Period 1||9
450331|NCT00626275|1075005|P4|COMPLETED|Part A - Treatment Period 1||8
450332|NCT00626275|1075006|P3|COMPLETED|Part A - Treatment Period 1||6
450333|NCT00626275|1075007|P2|COMPLETED|Part A - Treatment Period 1||7
450334|NCT00626275|1075008|P1|COMPLETED|Part A - Treatment Period 1||6
450335|NCT00626275|1075001|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
450336|NCT00626275|1075002|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
450337|NCT00626275|1075003|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
450338|NCT00626275|1075004|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
450339|NCT00626275|1075005|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
450340|NCT00626275|1075006|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
450341|NCT00626275|1075007|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
450342|NCT00626275|1075008|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
450343|NCT00626275|1075001|P8|STARTED|Part A - Treatment Period 1||0
450344|NCT00626275|1075002|P7|STARTED|Part A - Treatment Period 1||0
450345|NCT00626275|1075003|P6|STARTED|Part A - Treatment Period 1||8
450346|NCT00626275|1075004|P5|STARTED|Part A - Treatment Period 1||9
450347|NCT00626275|1075005|P4|STARTED|Part A - Treatment Period 1||8
450348|NCT00626275|1075006|P3|STARTED|Part A - Treatment Period 1||7
450349|NCT00626275|1075007|P2|STARTED|Part A - Treatment Period 1||7
450350|NCT00626275|1075008|P1|STARTED|Part A - Treatment Period 1||7
450351|NCT00626210|1075048|P1|NOT COMPLETED|Overall Study||0
450352|NCT00626210|1075048|P1|COMPLETED|Overall Study||2
450353|NCT00626210|1075048|P1|STARTED|Overall Study||2
450354|NCT00626093|1075052|P1|NOT COMPLETED|Overall Study||23
450355|NCT00626093|1075052|P1|COMPLETED|Overall Study||54
450356|NCT00626093|1075052|P1|STARTED|Overall Study||77
450357|NCT00626028|1075059|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
450358|NCT00626028|1075060|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
450359|NCT00626028|1075059|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
450360|NCT00626028|1075060|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
450361|NCT00626028|1075059|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
450362|NCT00626028|1075060|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
450363|NCT00626028|1075059|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
450364|NCT00626028|1075060|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
450365|NCT00626028|1075059|P2|COMPLETED|Washout Period of 10 Minutes||59
450366|NCT00626028|1075060|P1|COMPLETED|Washout Period of 10 Minutes||62
450367|NCT00626028|1075059|P2|STARTED|Washout Period of 10 Minutes||59
450368|NCT00626028|1075060|P1|STARTED|Washout Period of 10 Minutes||62
450369|NCT00626028|1075059|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
450370|NCT00626028|1075060|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
450371|NCT00626028|1075059|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
450372|NCT00626028|1075060|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
450373|NCT00626028|1075059|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
450374|NCT00626028|1075060|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
450375|NCT00626028|1075059|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
450376|NCT00626028|1075060|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
450377|NCT00626028|1075059|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
450378|NCT00626028|1075060|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
450379|NCT00626028|1075059|P2|STARTED|Treatment 1 NO First, O2 Last||68
450380|NCT00626028|1075060|P1|STARTED|Treatment 1 NO First, O2 Last||68
450381|NCT00625989|1075070|P2|NOT COMPLETED|Overall Study||0
450382|NCT00625989|1075071|P1|NOT COMPLETED|Overall Study||0
450383|NCT00625989|1075070|P2|COMPLETED|Overall Study||6
450384|NCT00625989|1075071|P1|COMPLETED|Overall Study||6
450385|NCT00625989|1075070|P2|STARTED|Overall Study||6
450386|NCT00625989|1075071|P1|STARTED|Overall Study||6
450387|NCT00625872|1075080|P2|NOT COMPLETED|Overall Study||6
450388|NCT00625872|1075081|P1|NOT COMPLETED|Overall Study||4
450389|NCT00625872|1075080|P2|COMPLETED|Overall Study||5
450390|NCT00625872|1075081|P1|COMPLETED|Overall Study||8
450391|NCT00625872|1075080|P2|Treated|Overall Study||10
450392|NCT00625872|1075081|P1|Treated|Overall Study||12
450393|NCT00625872|1075080|P2|STARTED|Overall Study||11
450394|NCT00625872|1075081|P1|STARTED|Overall Study||12
450395|NCT00625820|1075191|P1|NOT COMPLETED|Overall Study||1
450396|NCT00625820|1075191|P1|COMPLETED|Overall Study||16
450397|NCT00625820|1075191|P1|STARTED|Overall Study||17
450398|NCT00625742|1075197|P1|NOT COMPLETED|Overall Study||12
450399|NCT00625742|1075197|P1|COMPLETED|Overall Study||3
450400|NCT00625742|1075197|P1|STARTED|Overall Study||15
450401|NCT00625729|1075202|P1|NOT COMPLETED|Overall Study||0
450402|NCT00625729|1075202|P1|COMPLETED|Overall Study||6
450403|NCT00625729|1075202|P1|STARTED|Overall Study||6
450404|NCT00625586|1075211|P1|NOT COMPLETED|Overall Study||1
450405|NCT00625586|1075211|P1|COMPLETED|Overall Study||1
450406|NCT00625586|1075211|P1|STARTED|Overall Study||2
450407|NCT00625404|1075223|P2|NOT COMPLETED|Overall Study||173
450408|NCT00625404|1075224|P1|NOT COMPLETED|Overall Study||207
450409|NCT00625404|1075223|P2|COMPLETED|Overall Study||885
450410|NCT00625404|1075224|P1|COMPLETED|Overall Study||855
450411|NCT00625404|1075223|P2|STARTED|Overall Study||1058
450412|NCT00625404|1075224|P1|STARTED|Overall Study||1062
450413|NCT00625391|1075254|P4|NOT COMPLETED|Overall Study||1
450414|NCT00625391|1075255|P3|NOT COMPLETED|Overall Study||5
450415|NCT00625391|1075256|P2|NOT COMPLETED|Overall Study||8
450416|NCT00625391|1075257|P1|NOT COMPLETED|Overall Study||7
450417|NCT00625391|1075254|P4|COMPLETED|Overall Study||37
450418|NCT00625391|1075255|P3|COMPLETED|Overall Study||37
450419|NCT00625391|1075256|P2|COMPLETED|Overall Study||39
450420|NCT00625391|1075257|P1|COMPLETED|Overall Study||37
450421|NCT00625391|1075254|P4|STARTED|Overall Study||38
450422|NCT00625391|1075255|P3|STARTED|Overall Study||42
450423|NCT00625391|1075256|P2|STARTED|Overall Study||47
450424|NCT00625391|1075257|P1|STARTED|Overall Study||44
450425|NCT00625365|1075271|P1|NOT COMPLETED|Overall Study||7
450426|NCT00625365|1075271|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
450427|NCT00625365|1075271|P1|STARTED|Overall Study||1060
450428|NCT00625183|1075277|P1|NOT COMPLETED|Overall Study||1
450429|NCT00625183|1075277|P1|COMPLETED|Overall Study||4
450430|NCT00625183|1075277|P1|STARTED|Overall Study||5
450431|NCT00625131|1075286|P3|NOT COMPLETED|Overall Study||5
450432|NCT00625131|1075287|P2|NOT COMPLETED|Overall Study||2
450433|NCT00625131|1075288|P1|NOT COMPLETED|Overall Study||4
450434|NCT00625131|1075286|P3|COMPLETED|Overall Study||0
450435|NCT00625131|1075287|P2|COMPLETED|Overall Study||42
450436|NCT00625131|1075288|P1|COMPLETED|Overall Study||34
450437|NCT00625131|1075286|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
450438|NCT00625131|1075287|P2|STARTED|Overall Study||44
450439|NCT00625131|1075288|P1|STARTED|Overall Study||38
450440|NCT00624832|1075302|P4|NOT COMPLETED|Overall Study||1
450441|NCT00624832|1075303|P3|NOT COMPLETED|Overall Study||0
450442|NCT00624832|1075304|P2|NOT COMPLETED|Overall Study||1
450443|NCT00624832|1075305|P1|NOT COMPLETED|Overall Study||2
450444|NCT00624832|1075302|P4|COMPLETED|Overall Study||15
450445|NCT00624832|1075303|P3|COMPLETED|Overall Study||10
450446|NCT00624832|1075304|P2|COMPLETED|Overall Study||15
450447|NCT00624832|1075305|P1|COMPLETED|Overall Study||16
450448|NCT00624832|1075302|P4|STARTED|Overall Study||16
450449|NCT00624832|1075303|P3|STARTED|Overall Study||10
450450|NCT00624832|1075304|P2|STARTED|Overall Study||16
450451|NCT00624832|1075305|P1|STARTED|Overall Study||18
450452|NCT00624806|1075319|P2|NOT COMPLETED|Overall Study||0
450453|NCT00624806|1075320|P1|NOT COMPLETED|Overall Study||0
450454|NCT00624806|1075319|P2|COMPLETED|Overall Study||8
450455|NCT00624806|1075320|P1|COMPLETED|Overall Study||10
450456|NCT00624806|1075319|P2|STARTED|Overall Study||8
450457|NCT00624806|1075320|P1|STARTED|Overall Study||10
450458|NCT00624780|1075336|P6|NOT COMPLETED|Follow-up (Week 26)||0
450459|NCT00624780|1075337|P5|NOT COMPLETED|Follow-up (Week 26)||2
450460|NCT00624780|1075338|P4|NOT COMPLETED|Follow-up (Week 26)||0
450461|NCT00624780|1075339|P3|NOT COMPLETED|Follow-up (Week 26)||2
450462|NCT00624780|1075340|P2|NOT COMPLETED|Follow-up (Week 26)||1
450463|NCT00624780|1075341|P1|NOT COMPLETED|Follow-up (Week 26)||2
450464|NCT00624780|1075336|P6|COMPLETED|Follow-up (Week 26)||29
450465|NCT00624780|1075337|P5|COMPLETED|Follow-up (Week 26)||93
450466|NCT00624780|1075338|P4|COMPLETED|Follow-up (Week 26)||26
450467|NCT00624780|1075339|P3|COMPLETED|Follow-up (Week 26)||89
450468|NCT00624780|1075340|P2|COMPLETED|Follow-up (Week 26)||27
450469|NCT00624780|1075341|P1|COMPLETED|Follow-up (Week 26)||102
450470|NCT00624780|1075336|P6|STARTED|Follow-up (Week 26)||29
450471|NCT00624780|1075337|P5|STARTED|Follow-up (Week 26)||95
450472|NCT00624780|1075338|P4|STARTED|Follow-up (Week 26)||26
450473|NCT00624780|1075339|P3|STARTED|Follow-up (Week 26)||91
450474|NCT00624780|1075340|P2|STARTED|Follow-up (Week 26)||28
450475|NCT00624780|1075341|P1|STARTED|Follow-up (Week 26)||104
450476|NCT00624780|1075336|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
450477|NCT00624780|1075337|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
450478|NCT00624780|1075338|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
450479|NCT00624780|1075339|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
450480|NCT00624780|1075340|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
450481|NCT00624780|1075341|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
450482|NCT00624780|1075336|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
450483|NCT00624780|1075337|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
450484|NCT00624780|1075338|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
450485|NCT00624780|1075339|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
450486|NCT00624780|1075340|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
450487|NCT00624780|1075341|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
450488|NCT00624780|1075336|P6|STARTED|Treatment Discontinuation (Week 25)||30
450489|NCT00624780|1075337|P5|STARTED|Treatment Discontinuation (Week 25)||95
450490|NCT00624780|1075338|P4|STARTED|Treatment Discontinuation (Week 25)||27
450491|NCT00624780|1075339|P3|STARTED|Treatment Discontinuation (Week 25)||94
450492|NCT00624780|1075340|P2|STARTED|Treatment Discontinuation (Week 25)||28
450493|NCT00624780|1075341|P1|STARTED|Treatment Discontinuation (Week 25)||106
450494|NCT00624780|1075336|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
450495|NCT00624780|1075337|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
450496|NCT00624780|1075338|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
450497|NCT00624780|1075339|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
450498|NCT00624780|1075340|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
450499|NCT00624780|1075341|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
450500|NCT00624780|1075336|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
450501|NCT00624780|1075337|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
450502|NCT00624780|1075338|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
450503|NCT00624780|1075339|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
450504|NCT00624780|1075340|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
450505|NCT00624780|1075341|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
450506|NCT00624780|1075336|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
450507|NCT00624780|1075337|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
450508|NCT00624780|1075338|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
450509|NCT00624780|1075339|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
450510|NCT00624780|1075340|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
450511|NCT00624780|1075341|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
450512|NCT00624780|1075336|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
450513|NCT00624780|1075337|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
450514|NCT00624780|1075338|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
450515|NCT00624780|1075339|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
450516|NCT00624780|1075340|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
450517|NCT00624780|1075341|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
450518|NCT00624780|1075336|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
450519|NCT00624780|1075337|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
450520|NCT00624780|1075338|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
450521|NCT00624780|1075339|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
450522|NCT00624780|1075340|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
450523|NCT00624780|1075341|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
450524|NCT00624780|1075336|P6|STARTED|Treatment Optimization (Up to Week 12)||50
450525|NCT00624780|1075337|P5|STARTED|Treatment Optimization (Up to Week 12)||153
450526|NCT00624780|1075338|P4|STARTED|Treatment Optimization (Up to Week 12)||52
450527|NCT00624780|1075339|P3|STARTED|Treatment Optimization (Up to Week 12)||154
450528|NCT00624780|1075340|P2|STARTED|Treatment Optimization (Up to Week 12)||52
450529|NCT00624780|1075341|P1|STARTED|Treatment Optimization (Up to Week 12)||154
450530|NCT00624585|1075523|P1|NOT COMPLETED|Overall Study||12
450531|NCT00624585|1075523|P1|COMPLETED|Overall Study||6
450532|NCT00624585|1075523|P1|STARTED|Overall Study||18
450533|NCT00624559|1075534|P4|NOT COMPLETED|Overall Study||0
450534|NCT00624559|1075535|P3|NOT COMPLETED|Overall Study||0
450535|NCT00624559|1075536|P2|NOT COMPLETED|Overall Study||0
450536|NCT00624559|1075537|P1|NOT COMPLETED|Overall Study||0
450537|NCT00624559|1075534|P4|COMPLETED|Overall Study||3
450538|NCT00624559|1075535|P3|COMPLETED|Overall Study||3
450539|NCT00624559|1075536|P2|COMPLETED|Overall Study||3
450540|NCT00624559|1075537|P1|COMPLETED|Overall Study||3
450541|NCT00624559|1075534|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
450542|NCT00624559|1075535|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
450543|NCT00624559|1075536|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
450544|NCT00624559|1075537|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
450545|NCT00624520|1075553|P2|NOT COMPLETED|Overall Study||8
450546|NCT00624520|1075554|P1|NOT COMPLETED|Overall Study||12
450547|NCT00624520|1075553|P2|COMPLETED|Overall Study||39
450548|NCT00624520|1075554|P1|COMPLETED|Overall Study||44
450549|NCT00624520|1075553|P2|STARTED|Overall Study||47
450550|NCT00624520|1075554|P1|STARTED|Overall Study||56
450551|NCT00624468|1075581|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
450552|NCT00624468|1075582|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
450553|NCT00624468|1075583|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
450554|NCT00624468|1075584|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
450555|NCT00624468|1075581|P4|COMPLETED|Safety Follow-up (SFU) Period||11
450556|NCT00624468|1075582|P3|COMPLETED|Safety Follow-up (SFU) Period||11
450557|NCT00624468|1075583|P2|COMPLETED|Safety Follow-up (SFU) Period||0
450558|NCT00624468|1075584|P1|COMPLETED|Safety Follow-up (SFU) Period||0
450559|NCT00624468|1075581|P4|STARTED|Safety Follow-up (SFU) Period||14
450560|NCT00624468|1075582|P3|STARTED|Safety Follow-up (SFU) Period||13
450561|NCT00624468|1075583|P2|STARTED|Safety Follow-up (SFU) Period||0
450562|NCT00624468|1075584|P1|STARTED|Safety Follow-up (SFU) Period||0
450563|NCT00624468|1075581|P4|NOT COMPLETED|Double-blind Period||0
450564|NCT00624468|1075582|P3|NOT COMPLETED|Double-blind Period||0
450565|NCT00624468|1075583|P2|NOT COMPLETED|Double-blind Period||13
450566|NCT00624468|1075584|P1|NOT COMPLETED|Double-blind Period||14
450567|NCT00624468|1075581|P4|COMPLETED|Double-blind Period||0
450568|NCT00624468|1075582|P3|COMPLETED|Double-blind Period||0
450569|NCT00624468|1075583|P2|COMPLETED|Double-blind Period||4
450570|NCT00624468|1075584|P1|COMPLETED|Double-blind Period||3
450571|NCT00624468|1075581|P4|STARTED|Double-blind Period||0
450572|NCT00624468|1075582|P3|STARTED|Double-blind Period||0
450573|NCT00624468|1075583|P2|STARTED|Double-blind Period||17
450574|NCT00624468|1075584|P1|STARTED|Double-blind Period||17
450575|NCT00624442|1075615|P5|NOT COMPLETED|Overall Study||2
450576|NCT00624442|1075616|P4|NOT COMPLETED|Overall Study||0
450577|NCT00624442|1075617|P3|NOT COMPLETED|Overall Study||2
450578|NCT00624442|1075618|P2|NOT COMPLETED|Overall Study||1
450579|NCT00624442|1075619|P1|NOT COMPLETED|Overall Study||0
450580|NCT00624442|1075615|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
450581|NCT00624442|1075616|P4|COMPLETED|Overall Study||8
450582|NCT00624442|1075617|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
450583|NCT00624442|1075618|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
450584|NCT00624442|1075619|P1|COMPLETED|Overall Study||8
450585|NCT00624442|1075615|P5|STARTED|Overall Study||10
450586|NCT00624442|1075616|P4|STARTED|Overall Study||8
450587|NCT00624442|1075617|P3|STARTED|Overall Study||10
450588|NCT00624442|1075618|P2|STARTED|Overall Study||9
450589|NCT00624442|1075619|P1|STARTED|Overall Study||8
450590|NCT00624416|1075645|P1|NOT COMPLETED|Overall Study||0
450591|NCT00624416|1075645|P1|COMPLETED|Overall Study||10
450592|NCT00624416|1075645|P1|STARTED|Overall Study||10
450593|NCT00624377|1075651|P1|NOT COMPLETED|Overall Study||644
450594|NCT00624377|1075651|P1|COMPLETED|Overall Study||1387
450595|NCT00624377|1075651|P1|STARTED|Overall Study||2031
450596|NCT00624338|1075665|P3|NOT COMPLETED|Overall Study||46
450597|NCT00624338|1075666|P2|NOT COMPLETED|Overall Study||83
450598|NCT00624338|1075667|P1|NOT COMPLETED|Overall Study||47
450599|NCT00624338|1075665|P3|COMPLETED|Overall Study||111
450600|NCT00624338|1075666|P2|COMPLETED|Overall Study||62
450601|NCT00624338|1075667|P1|COMPLETED|Overall Study||112
450602|NCT00624338|1075665|P3|Treated|Overall Study||154
450603|NCT00624338|1075666|P2|Treated|Overall Study||144
450604|NCT00624338|1075667|P1|Treated|Overall Study||157
450605|NCT00624338|1075665|P3|STARTED|Overall Study||157
450606|NCT00624338|1075666|P2|STARTED|Overall Study||145
450607|NCT00624338|1075667|P1|STARTED|Overall Study||159
450608|NCT00624286|1075689|P2|NOT COMPLETED|Overall Study||27
450609|NCT00624286|1075690|P1|NOT COMPLETED|Overall Study||25
450610|NCT00624286|1075689|P2|COMPLETED|Overall Study||178
450611|NCT00624286|1075690|P1|COMPLETED|Overall Study||186
450612|NCT00624286|1075689|P2|STARTED|Overall Study||205
450613|NCT00624286|1075690|P1|STARTED|Overall Study||211
450614|NCT00624234|1075704|P6|NOT COMPLETED|Overall Study||0
450615|NCT00624234|1075705|P5|NOT COMPLETED|Overall Study||0
450616|NCT00624234|1075706|P4|NOT COMPLETED|Overall Study||0
450617|NCT00624234|1075707|P3|NOT COMPLETED|Overall Study||0
450618|NCT00624234|1075708|P2|NOT COMPLETED|Overall Study||0
450619|NCT00624234|1075709|P1|NOT COMPLETED|Overall Study||0
450620|NCT00624234|1075704|P6|COMPLETED|Overall Study||14
450621|NCT00624234|1075705|P5|COMPLETED|Overall Study||18
450622|NCT00624234|1075706|P4|COMPLETED|Overall Study||14
450623|NCT00624234|1075707|P3|COMPLETED|Overall Study||26
450624|NCT00624234|1075708|P2|COMPLETED|Overall Study||9
450625|NCT00624234|1075709|P1|COMPLETED|Overall Study||8
450626|NCT00624234|1075704|P6|STARTED|Overall Study||14
450627|NCT00624234|1075705|P5|STARTED|Overall Study||18
450628|NCT00624234|1075706|P4|STARTED|Overall Study||14
450629|NCT00624234|1075707|P3|STARTED|Overall Study||26
450630|NCT00624234|1075708|P2|STARTED|Overall Study||9
450631|NCT00624234|1075709|P1|STARTED|Overall Study||8
450632|NCT00624221|1075725|P2|NOT COMPLETED|Overall Study||0
450633|NCT00624221|1075726|P1|NOT COMPLETED|Overall Study||0
450634|NCT00624221|1075725|P2|COMPLETED|Overall Study||20
450635|NCT00624221|1075726|P1|COMPLETED|Overall Study||20
450636|NCT00624221|1075725|P2|STARTED|Overall Study||20
450637|NCT00624221|1075726|P1|STARTED|Overall Study||20
450638|NCT00624195|1075734|P2|NOT COMPLETED|Overall Study||7
450639|NCT00624195|1075735|P1|NOT COMPLETED|Overall Study||3
450640|NCT00624195|1075734|P2|COMPLETED|Overall Study||23
450641|NCT00624195|1075735|P1|COMPLETED|Overall Study||26
450642|NCT00624195|1075734|P2|STARTED|Overall Study||30
450643|NCT00624195|1075735|P1|STARTED|Overall Study||29
450644|NCT00624065|1075743|P2|NOT COMPLETED|Overall Study||24
450645|NCT00624065|1075744|P1|NOT COMPLETED|Overall Study||19
450646|NCT00624065|1075743|P2|COMPLETED|Overall Study||192
450647|NCT00624065|1075744|P1|COMPLETED|Overall Study||197
450648|NCT00624065|1075743|P2|STARTED|Overall Study||216
450649|NCT00624065|1075744|P1|STARTED|Overall Study||216
450650|NCT00624052|1075756|P4|NOT COMPLETED|Overall Study||4
450651|NCT00624052|1075757|P3|NOT COMPLETED|Overall Study||3
450652|NCT00624052|1075758|P2|NOT COMPLETED|Overall Study||14
450653|NCT00624052|1075759|P1|NOT COMPLETED|Overall Study||15
450654|NCT00624052|1075756|P4|COMPLETED|Overall Study||88
450655|NCT00624052|1075757|P3|COMPLETED|Overall Study||88
450656|NCT00624052|1075758|P2|COMPLETED|Overall Study||422
450657|NCT00624052|1075759|P1|COMPLETED|Overall Study||204
450658|NCT00624052|1075756|P4|STARTED|Overall Study||92
450659|NCT00624052|1075757|P3|STARTED|Overall Study||91
450660|NCT00624052|1075758|P2|STARTED|Overall Study||436
450661|NCT00624052|1075759|P1|STARTED|Overall Study||219
450662|NCT00623974|1075812|P4|NOT COMPLETED|Overall Study||0
450663|NCT00623974|1075813|P3|NOT COMPLETED|Overall Study||0
450664|NCT00623974|1075814|P2|NOT COMPLETED|Overall Study||0
450665|NCT00623974|1075815|P1|NOT COMPLETED|Overall Study||0
450666|NCT00623974|1075812|P4|COMPLETED|Overall Study||0
450667|NCT00623974|1075813|P3|COMPLETED|Overall Study||0
450668|NCT00623974|1075814|P2|COMPLETED|Overall Study||0
450669|NCT00623974|1075815|P1|COMPLETED|Overall Study||0
450670|NCT00623974|1075812|P4|STARTED|Overall Study||0
450671|NCT00623974|1075813|P3|STARTED|Overall Study||0
450672|NCT00623974|1075814|P2|STARTED|Overall Study||0
450673|NCT00623974|1075815|P1|STARTED|Overall Study||0
450674|NCT00623935|1075825|P1|NOT COMPLETED|Overall Study||2
450675|NCT00623935|1075825|P1|COMPLETED|Overall Study||54
450676|NCT00623935|1075825|P1|STARTED|Overall Study||56
450677|NCT00623831|1075832|P2|NOT COMPLETED|Overall Study||1
450678|NCT00623831|1075833|P1|NOT COMPLETED|Overall Study||1
450679|NCT00623831|1075832|P2|COMPLETED|Overall Study||3
450680|NCT00623831|1075833|P1|COMPLETED|Overall Study||12
450681|NCT00623831|1075832|P2|STARTED|Overall Study||4
450682|NCT00623831|1075833|P1|STARTED|Overall Study||13
450683|NCT00623805|1075845|P2|NOT COMPLETED|Overall Study||22
450684|NCT00623805|1075846|P1|NOT COMPLETED|Overall Study||20
450685|NCT00623805|1075845|P2|COMPLETED|Overall Study||39
450686|NCT00623805|1075846|P1|COMPLETED|Overall Study||42
450687|NCT00623805|1075845|P2|STARTED|Overall Study||61
450688|NCT00623805|1075846|P1|STARTED|Overall Study||62
450689|NCT00623779|1075863|P3|NOT COMPLETED|Overall Study||1
450690|NCT00623779|1075864|P2|NOT COMPLETED|Overall Study||3
450691|NCT00623779|1075865|P1|NOT COMPLETED|Overall Study||3
450692|NCT00623779|1075863|P3|COMPLETED|Overall Study||44
450693|NCT00623779|1075864|P2|COMPLETED|Overall Study||39
450694|NCT00623779|1075865|P1|COMPLETED|Overall Study||38
450695|NCT00623779|1075863|P3|STARTED|Overall Study||45
450696|NCT00623779|1075864|P2|STARTED|Overall Study||42
450697|NCT00623779|1075865|P1|STARTED|Overall Study||41
450698|NCT00623766|1075914|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
450699|NCT00623766|1075915|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
450700|NCT00623766|1075914|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
450701|NCT00623766|1075915|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
450702|NCT00623766|1075914|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
450703|NCT00623766|1075915|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
450704|NCT00623766|1075914|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
450705|NCT00623766|1075915|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
450706|NCT00623766|1075914|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
450707|NCT00623766|1075915|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
450708|NCT00623766|1075914|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
450709|NCT00623766|1075915|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
450710|NCT00623727|1075939|P2|NOT COMPLETED|Open Label Extension Period||0
450711|NCT00623727|1075940|P1|NOT COMPLETED|Open Label Extension Period||0
450712|NCT00623727|1075939|P2|COMPLETED|Open Label Extension Period||0
450713|NCT00623727|1075940|P1|COMPLETED|Open Label Extension Period||20
450714|NCT00623727|1075939|P2|STARTED|Open Label Extension Period||0
450715|NCT00623727|1075940|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
450716|NCT00623727|1075939|P2|NOT COMPLETED|Open Label Follow-up||8
450717|NCT00623727|1075940|P1|NOT COMPLETED|Open Label Follow-up||0
450718|NCT00623727|1075939|P2|COMPLETED|Open Label Follow-up||18
450719|NCT00623727|1075940|P1|COMPLETED|Open Label Follow-up||0
450720|NCT00623727|1075939|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
450721|NCT00623727|1075940|P1|STARTED|Open Label Follow-up||0
450722|NCT00623727|1075939|P2|NOT COMPLETED|Double Blind (DB)||32
450723|NCT00623727|1075940|P1|NOT COMPLETED|Double Blind (DB)||36
450724|NCT00623727|1075939|P2|COMPLETED|Double Blind (DB)||41
450725|NCT00623727|1075940|P1|COMPLETED|Double Blind (DB)||34
450726|NCT00623727|1075939|P2|Participants Received Treatment|Double Blind (DB)||72
450727|NCT00623727|1075940|P1|Participants Received Treatment|Double Blind (DB)||67
450728|NCT00623727|1075939|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
450729|NCT00623727|1075940|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
450730|NCT00623714|1075960|P2|NOT COMPLETED|Period 2||0
450731|NCT00623714|1075961|P1|NOT COMPLETED|Period 2||0
450732|NCT00623714|1075960|P2|COMPLETED|Period 2||7
450733|NCT00623714|1075961|P1|COMPLETED|Period 2||6
450734|NCT00623714|1075960|P2|STARTED|Period 2||7
450735|NCT00623714|1075961|P1|STARTED|Period 2||6
450736|NCT00623714|1075960|P2|NOT COMPLETED|Period 1||0
450737|NCT00623714|1075961|P1|NOT COMPLETED|Period 1||0
450738|NCT00623714|1075960|P2|COMPLETED|Period 1||7
450739|NCT00623714|1075961|P1|COMPLETED|Period 1||6
450740|NCT00623714|1075960|P2|STARTED|Period 1||7
450741|NCT00623714|1075961|P1|STARTED|Period 1||6
450742|NCT00623636|1075971|P2|NOT COMPLETED|Open Label||412
450743|NCT00623636|1075972|P1|NOT COMPLETED|Open Label||0
450744|NCT00623636|1075971|P2|COMPLETED|Open Label||263
450745|NCT00623636|1075972|P1|COMPLETED|Open Label||0
450746|NCT00623636|1075971|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
450747|NCT00623636|1075972|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
450748|NCT00623636|1075971|P2|NOT COMPLETED|Double Blind||28
450749|NCT00623636|1075972|P1|NOT COMPLETED|Double Blind||33
450750|NCT00623636|1075971|P2|COMPLETED|Double Blind||422
450751|NCT00623636|1075972|P1|COMPLETED|Double Blind||419
450752|NCT00623636|1075971|P2|STARTED|Double Blind||450
450753|NCT00623636|1075972|P1|STARTED|Double Blind||452
450754|NCT00623597|1075995|P2|NOT COMPLETED|Overall Study||0
450755|NCT00623597|1075996|P1|NOT COMPLETED|Overall Study||1
450756|NCT00623597|1075995|P2|COMPLETED|Overall Study||13
450757|NCT00623597|1075996|P1|COMPLETED|Overall Study||4
450758|NCT00623597|1075995|P2|STARTED|Overall Study||13
450759|NCT00623597|1075996|P1|STARTED|Overall Study||5
450760|NCT00623545|1076059|P1|NOT COMPLETED|Overall Study||10
450761|NCT00623545|1076059|P1|COMPLETED|Overall Study||18
450762|NCT00623545|1076059|P1|STARTED|Overall Study||28
450763|NCT00623506|1076066|P2|NOT COMPLETED|Overall Study||4
450764|NCT00623506|1076067|P1|NOT COMPLETED|Overall Study||4
450765|NCT00623506|1076066|P2|COMPLETED|Overall Study||11
450766|NCT00623506|1076067|P1|COMPLETED|Overall Study||11
450767|NCT00623506|1076066|P2|Week 4|Overall Study||11
450768|NCT00623506|1076067|P1|Week 4|Overall Study||11
450769|NCT00623506|1076066|P2|STARTED|Overall Study||15
450770|NCT00623506|1076067|P1|STARTED|Overall Study||15
450771|NCT00623480|1076079|P2|NOT COMPLETED|Overall Study||7
450772|NCT00623480|1076080|P1|NOT COMPLETED|Overall Study||7
450773|NCT00623480|1076079|P2|COMPLETED|Overall Study||35
450774|NCT00623480|1076080|P1|COMPLETED|Overall Study||35
450775|NCT00623480|1076079|P2|STARTED|Overall Study||42
450776|NCT00623480|1076080|P1|STARTED|Overall Study||42
450777|NCT00623467|1076092|P1|NOT COMPLETED|Overall Study||7
450778|NCT00623467|1076092|P1|COMPLETED|Overall Study||336
450779|NCT00623467|1076092|P1|STARTED|Overall Study||343
450780|NCT00623441|1076156|P1|NOT COMPLETED|Overall Study||0
450781|NCT00623441|1076156|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
450782|NCT00623441|1076156|P1|STARTED|Overall Study||8314
450783|NCT00623428|1076162|P2|NOT COMPLETED|Follow-up Period||15
450784|NCT00623428|1076163|P1|NOT COMPLETED|Follow-up Period||29
450785|NCT00623428|1076162|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
450786|NCT00623428|1076163|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
450787|NCT00623428|1076162|P2|STARTED|Follow-up Period||93
450788|NCT00623428|1076163|P1|STARTED|Follow-up Period||95
450789|NCT00623428|1076162|P2|NOT COMPLETED|Treatment Period||27
450790|NCT00623428|1076163|P1|NOT COMPLETED|Treatment Period||0
450791|NCT00623428|1076162|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
450792|NCT00623428|1076163|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
450793|NCT00623428|1076162|P2|STARTED|Treatment Period||93
450794|NCT00623428|1076163|P1|STARTED|Treatment Period||95
450795|NCT00623233|1076181|P1|NOT COMPLETED|Overall Study||24
450796|NCT00623233|1076181|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
450797|NCT00623233|1076181|P1|STARTED|Overall Study||52
450798|NCT00623194|1076188|P1|NOT COMPLETED|Overall Study||5
450799|NCT00623194|1076188|P1|COMPLETED|Overall Study||141
450800|NCT00623194|1076188|P1|STARTED|Overall Study||146
450801|NCT00623181|1076210|P2|NOT COMPLETED|Overall Study||0
450802|NCT00623181|1076211|P1|NOT COMPLETED|Overall Study||0
450803|NCT00623181|1076210|P2|COMPLETED|Overall Study||54
450804|NCT00623181|1076211|P1|COMPLETED|Overall Study||56
450805|NCT00623181|1076210|P2|STARTED|Overall Study||54
450806|NCT00623181|1076211|P1|STARTED|Overall Study||56
450807|NCT00623103|1076225|P2|NOT COMPLETED|Overall Study||113
450808|NCT00623103|1076226|P1|NOT COMPLETED|Overall Study||111
450809|NCT00623103|1076225|P2|COMPLETED|Overall Study||175
450810|NCT00623103|1076226|P1|COMPLETED|Overall Study||184
450811|NCT00623103|1076225|P2|Safety Set: Received Study Drug|Overall Study||288
450812|NCT00623103|1076226|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
450813|NCT00623103|1076225|P2|STARTED|Overall Study||288
450814|NCT00623103|1076226|P1|STARTED|Overall Study||295
450815|NCT00623012|1076246|P1|NOT COMPLETED|Overall Study||0
450816|NCT00623012|1076246|P1|COMPLETED|Overall Study||2
450817|NCT00623012|1076246|P1|STARTED|Overall Study||2
450818|NCT00622908|1076254|P2|NOT COMPLETED|Overall Study||10
450819|NCT00622908|1076255|P1|NOT COMPLETED|Overall Study||3
450820|NCT00622908|1076254|P2|COMPLETED|Overall Study||122
450821|NCT00622908|1076255|P1|COMPLETED|Overall Study||134
450822|NCT00622908|1076254|P2|STARTED|Overall Study|Intent to treat population|132
450823|NCT00622908|1076255|P1|STARTED|Overall Study|Intent to treat population|137
450824|NCT00622869|1076270|P3|NOT COMPLETED|Overall Study||39
450825|NCT00622869|1076271|P2|NOT COMPLETED|Overall Study||57
450826|NCT00622869|1076272|P1|NOT COMPLETED|Overall Study||43
450827|NCT00622869|1076270|P3|COMPLETED|Overall Study||204
450828|NCT00622869|1076271|P2|COMPLETED|Overall Study||174
450829|NCT00622869|1076272|P1|COMPLETED|Overall Study||202
450830|NCT00622869|1076270|P3|STARTED|Overall Study||243
450831|NCT00622869|1076271|P2|STARTED|Overall Study||231
450832|NCT00622869|1076272|P1|STARTED|Overall Study||245
450833|NCT00622739|1076291|P2|NOT COMPLETED|Overall Study||6
450834|NCT00622739|1076292|P1|NOT COMPLETED|Overall Study||2
450835|NCT00622739|1076291|P2|COMPLETED|Overall Study||9
450836|NCT00622739|1076292|P1|COMPLETED|Overall Study||11
450837|NCT00622739|1076291|P2|STARTED|Overall Study||15
450838|NCT00622739|1076292|P1|STARTED|Overall Study||13
450839|NCT00622726|1076300|P2|NOT COMPLETED|August, 2010 to April, 2013||5
450840|NCT00622726|1076301|P1|NOT COMPLETED|August, 2010 to April, 2013||1
450841|NCT00622726|1076300|P2|COMPLETED|August, 2010 to April, 2013||68
450842|NCT00622726|1076301|P1|COMPLETED|August, 2010 to April, 2013||69
450843|NCT00622726|1076300|P2|STARTED|August, 2010 to April, 2013||73
450844|NCT00622726|1076301|P1|STARTED|August, 2010 to April, 2013||70
450845|NCT00622726|1076300|P2|NOT COMPLETED|March, 2008 to August, 2010||2
450846|NCT00622726|1076301|P1|NOT COMPLETED|March, 2008 to August, 2010||5
450847|NCT00622726|1076300|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
450848|NCT00622726|1076301|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
450849|NCT00622726|1076300|P2|STARTED|March, 2008 to August, 2010||75
450850|NCT00622726|1076301|P1|STARTED|March, 2008 to August, 2010||75
450851|NCT00622713|1076311|P1|NOT COMPLETED|Overall Study||59
450852|NCT00622713|1076311|P1|COMPLETED|Overall Study||169
450853|NCT00622713|1076311|P1|Intent to Treat (ITT) Population|Overall Study||218
450854|NCT00622713|1076311|P1|Exposed to Study Drug|Overall Study||226
450855|NCT00622713|1076311|P1|STARTED|Overall Study||228
450856|NCT00622700|1076322|P7|NOT COMPLETED|Extension Treatment Period||30
450857|NCT00622700|1076323|P6|NOT COMPLETED|Extension Treatment Period||17
450858|NCT00622700|1076324|P5|NOT COMPLETED|Extension Treatment Period||39
450859|NCT00622700|1076325|P4|NOT COMPLETED|Extension Treatment Period||21
450860|NCT00622700|1076326|P3|NOT COMPLETED|Extension Treatment Period||0
450861|NCT00622700|1076327|P2|NOT COMPLETED|Extension Treatment Period||0
450862|NCT00622700|1076328|P1|NOT COMPLETED|Extension Treatment Period||0
450863|NCT00622700|1076322|P7|COMPLETED|Extension Treatment Period||120
450864|NCT00622700|1076323|P6|COMPLETED|Extension Treatment Period||50
450865|NCT00622700|1076324|P5|COMPLETED|Extension Treatment Period||103
450866|NCT00622700|1076325|P4|COMPLETED|Extension Treatment Period||43
450867|NCT00622700|1076326|P3|COMPLETED|Extension Treatment Period||0
450868|NCT00622700|1076327|P2|COMPLETED|Extension Treatment Period||0
450869|NCT00622700|1076328|P1|COMPLETED|Extension Treatment Period||0
450870|NCT00622700|1076322|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
450871|NCT00622700|1076323|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
450872|NCT00622700|1076324|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
450873|NCT00622700|1076325|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
450874|NCT00622700|1076326|P3|STARTED|Extension Treatment Period||0
450875|NCT00622700|1076327|P2|STARTED|Extension Treatment Period||0
450876|NCT00622700|1076328|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
450877|NCT00622700|1076322|P7|NOT COMPLETED|Core Treatment Period||0
450878|NCT00622700|1076323|P6|NOT COMPLETED|Core Treatment Period||0
450879|NCT00622700|1076324|P5|NOT COMPLETED|Core Treatment Period||0
450880|NCT00622700|1076325|P4|NOT COMPLETED|Core Treatment Period||0
450881|NCT00622700|1076326|P3|NOT COMPLETED|Core Treatment Period||53
450882|NCT00622700|1076327|P2|NOT COMPLETED|Core Treatment Period||55
450883|NCT00622700|1076328|P1|NOT COMPLETED|Core Treatment Period||56
450884|NCT00622700|1076322|P7|COMPLETED|Core Treatment Period||0
450885|NCT00622700|1076323|P6|COMPLETED|Core Treatment Period||0
450886|NCT00622700|1076324|P5|COMPLETED|Core Treatment Period||0
450887|NCT00622700|1076325|P4|COMPLETED|Core Treatment Period||0
450888|NCT00622700|1076326|P3|COMPLETED|Core Treatment Period||163
450889|NCT00622700|1076327|P2|COMPLETED|Core Treatment Period||150
450890|NCT00622700|1076328|P1|COMPLETED|Core Treatment Period||141
450891|NCT00622700|1076322|P7|Treated|Core Treatment Period||0
450892|NCT00622700|1076323|P6|Treated|Core Treatment Period||0
450893|NCT00622700|1076324|P5|Treated|Core Treatment Period||0
450894|NCT00622700|1076325|P4|Treated|Core Treatment Period||0
450895|NCT00622700|1076326|P3|Treated|Core Treatment Period||214
450896|NCT00622700|1076327|P2|Treated|Core Treatment Period||203
450897|NCT00622700|1076328|P1|Treated|Core Treatment Period||197
450898|NCT00622700|1076322|P7|STARTED|Core Treatment Period||0
450899|NCT00622700|1076323|P6|STARTED|Core Treatment Period||0
450900|NCT00622700|1076324|P5|STARTED|Core Treatment Period||0
450901|NCT00622700|1076325|P4|STARTED|Core Treatment Period||0
450902|NCT00622700|1076326|P3|STARTED|Core Treatment Period||216
450903|NCT00622700|1076327|P2|STARTED|Core Treatment Period||205
450904|NCT00622700|1076328|P1|STARTED|Core Treatment Period||197
450905|NCT00622635|1076387|P6|NOT COMPLETED|Treatment Period 3||0
450906|NCT00622635|1076388|P5|NOT COMPLETED|Treatment Period 3||0
450907|NCT00622635|1076389|P4|NOT COMPLETED|Treatment Period 3||3
450908|NCT00622635|1076390|P3|NOT COMPLETED|Treatment Period 3||0
450909|NCT00622635|1076391|P2|NOT COMPLETED|Treatment Period 3||0
450910|NCT00622635|1076392|P1|NOT COMPLETED|Treatment Period 3||0
450911|NCT00622635|1076387|P6|COMPLETED|Treatment Period 3||10
450912|NCT00622635|1076388|P5|COMPLETED|Treatment Period 3||9
450913|NCT00622635|1076389|P4|COMPLETED|Treatment Period 3||10
450914|NCT00622635|1076390|P3|COMPLETED|Treatment Period 3||10
450915|NCT00622635|1076391|P2|COMPLETED|Treatment Period 3||10
450916|NCT00622635|1076392|P1|COMPLETED|Treatment Period 3||12
450917|NCT00622635|1076387|P6|STARTED|Treatment Period 3||10
450918|NCT00622635|1076388|P5|STARTED|Treatment Period 3||9
450919|NCT00622635|1076389|P4|STARTED|Treatment Period 3||13
450920|NCT00622635|1076390|P3|STARTED|Treatment Period 3||10
450921|NCT00622635|1076391|P2|STARTED|Treatment Period 3||10
450922|NCT00622635|1076392|P1|STARTED|Treatment Period 3||12
450923|NCT00622635|1076387|P6|NOT COMPLETED|Treatment Period 2||0
450924|NCT00622635|1076388|P5|NOT COMPLETED|Treatment Period 2||0
450925|NCT00622635|1076389|P4|NOT COMPLETED|Treatment Period 2||0
450926|NCT00622635|1076390|P3|NOT COMPLETED|Treatment Period 2||0
450927|NCT00622635|1076391|P2|NOT COMPLETED|Treatment Period 2||0
450928|NCT00622635|1076392|P1|NOT COMPLETED|Treatment Period 2||1
450929|NCT00622635|1076387|P6|COMPLETED|Treatment Period 2||10
450930|NCT00622635|1076388|P5|COMPLETED|Treatment Period 2||9
450931|NCT00622635|1076389|P4|COMPLETED|Treatment Period 2||13
450932|NCT00622635|1076390|P3|COMPLETED|Treatment Period 2||10
450933|NCT00622635|1076391|P2|COMPLETED|Treatment Period 2||10
450934|NCT00622635|1076392|P1|COMPLETED|Treatment Period 2||12
450935|NCT00622635|1076387|P6|STARTED|Treatment Period 2||10
450936|NCT00622635|1076388|P5|STARTED|Treatment Period 2||9
450937|NCT00622635|1076389|P4|STARTED|Treatment Period 2||13
450938|NCT00622635|1076390|P3|STARTED|Treatment Period 2||10
450939|NCT00622635|1076391|P2|STARTED|Treatment Period 2||10
450940|NCT00622635|1076392|P1|STARTED|Treatment Period 2||13
450941|NCT00622635|1076387|P6|NOT COMPLETED|Treatment Period 1||0
450942|NCT00622635|1076388|P5|NOT COMPLETED|Treatment Period 1||1
450943|NCT00622635|1076389|P4|NOT COMPLETED|Treatment Period 1||0
450944|NCT00622635|1076390|P3|NOT COMPLETED|Treatment Period 1||1
450945|NCT00622635|1076391|P2|NOT COMPLETED|Treatment Period 1||1
450946|NCT00622635|1076392|P1|NOT COMPLETED|Treatment Period 1||0
450947|NCT00622635|1076387|P6|COMPLETED|Treatment Period 1||10
450948|NCT00622635|1076388|P5|COMPLETED|Treatment Period 1||9
450949|NCT00622635|1076389|P4|COMPLETED|Treatment Period 1||13
450950|NCT00622635|1076390|P3|COMPLETED|Treatment Period 1||10
450951|NCT00622635|1076391|P2|COMPLETED|Treatment Period 1||10
450952|NCT00622635|1076392|P1|COMPLETED|Treatment Period 1||13
450953|NCT00622635|1076387|P6|STARTED|Treatment Period 1||10
450954|NCT00622635|1076388|P5|STARTED|Treatment Period 1||10
450955|NCT00622635|1076389|P4|STARTED|Treatment Period 1||13
450956|NCT00622635|1076390|P3|STARTED|Treatment Period 1||11
450957|NCT00622635|1076391|P2|STARTED|Treatment Period 1||11
450958|NCT00622635|1076392|P1|STARTED|Treatment Period 1||13
450959|NCT00622518|1076459|P2|NOT COMPLETED|Overall Study||0
450960|NCT00622518|1076460|P1|NOT COMPLETED|Overall Study||0
450961|NCT00622518|1076459|P2|COMPLETED|Overall Study||60
450962|NCT00622518|1076460|P1|COMPLETED|Overall Study||59
450963|NCT00622518|1076459|P2|STARTED|Overall Study||60
450964|NCT00622518|1076460|P1|STARTED|Overall Study||59
450965|NCT00622440|1076470|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
450966|NCT00622440|1076471|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
450967|NCT00622440|1076470|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
450968|NCT00622440|1076471|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
450969|NCT00622440|1076470|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
450970|NCT00622440|1076471|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
450971|NCT00622440|1076470|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
450972|NCT00622440|1076471|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
450973|NCT00622440|1076470|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
450974|NCT00622440|1076471|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
450975|NCT00622440|1076470|P2|STARTED|Week 12 - Week 48 (Treatment)||34
450976|NCT00622440|1076471|P1|STARTED|Week 12 - Week 48 (Treatment)||31
450977|NCT00622440|1076470|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
450978|NCT00622440|1076471|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
450979|NCT00622440|1076470|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
450980|NCT00622440|1076471|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
450981|NCT00622440|1076470|P2|STARTED|Baseline - Week 12 (Treatment)||35
450982|NCT00622440|1076471|P1|STARTED|Baseline - Week 12 (Treatment)||35
450983|NCT00622427|1076485|P2|NOT COMPLETED|Overall Study||0
450984|NCT00622427|1076486|P1|NOT COMPLETED|Overall Study||0
450985|NCT00622427|1076485|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
450986|NCT00622427|1076486|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
450987|NCT00622427|1076485|P2|STARTED|Overall Study||16
450988|NCT00622427|1076486|P1|STARTED|Overall Study||16
450989|NCT00622401|1076497|P3|NOT COMPLETED|Overall Study||0
450990|NCT00622401|1076498|P2|NOT COMPLETED|Overall Study||2
450991|NCT00622401|1076499|P1|NOT COMPLETED|Overall Study||3
450992|NCT00622401|1076497|P3|COMPLETED|Overall Study||0
450993|NCT00622401|1076498|P2|COMPLETED|Overall Study||0
450994|NCT00622401|1076499|P1|COMPLETED|Overall Study||3
450995|NCT00622401|1076497|P3|STARTED|Overall Study|Never Opened|0
450996|NCT00622401|1076498|P2|STARTED|Overall Study||2
450997|NCT00622401|1076499|P1|STARTED|Overall Study||6
450998|NCT00622388|1076503|P1|NOT COMPLETED|Overall Study||72
450999|NCT00622388|1076503|P1|COMPLETED|Overall Study||9
451000|NCT00622388|1076503|P1|STARTED|Overall Study||81
451001|NCT00622336|1076521|P1|NOT COMPLETED|Extension Phase||21
451002|NCT00622336|1076521|P1|COMPLETED|Extension Phase||0
451003|NCT00622336|1076521|P1|STARTED|Extension Phase||21
451004|NCT00622336|1076521|P1|NOT COMPLETED|Treatment Phase||309
451005|NCT00622336|1076521|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
451006|NCT00622336|1076521|P1|Safety Population|Treatment Phase||330
451007|NCT00622336|1076521|P1|STARTED|Treatment Phase||330
451008|NCT00622284|1076532|P2|NOT COMPLETED|Overall Study||171
451009|NCT00622284|1076533|P1|NOT COMPLETED|Overall Study||189
451010|NCT00622284|1076532|P2|COMPLETED|Overall Study|Number who completed treatment.|604
451011|NCT00622284|1076533|P1|COMPLETED|Overall Study|Number who completed treatment.|587
451012|NCT00622284|1076532|P2|STARTED|Overall Study|Number who started treatment.|775
451013|NCT00622284|1076533|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
451014|NCT00622167|1076595|P1|NOT COMPLETED|Overall Study||20
451015|NCT00622167|1076595|P1|COMPLETED|Overall Study||4
451016|NCT00622167|1076595|P1|STARTED|Overall Study||24
451017|NCT00621985|1076599|P1|NOT COMPLETED|Dexamethasone Admission||1
451018|NCT00621985|1076599|P1|COMPLETED|Dexamethasone Admission||4
451019|NCT00621985|1076599|P1|STARTED|Dexamethasone Admission||5
451020|NCT00621985|1076599|P1|NOT COMPLETED|Hydrocortisone Admission||0
451021|NCT00621985|1076599|P1|COMPLETED|Hydrocortisone Admission||5
451022|NCT00621985|1076599|P1|STARTED|Hydrocortisone Admission||5
451023|NCT00621959|1076607|P2|NOT COMPLETED|Overall Study||9
451024|NCT00621959|1076608|P1|NOT COMPLETED|Overall Study||7
451025|NCT00621959|1076607|P2|COMPLETED|Overall Study||292
451026|NCT00621959|1076608|P1|COMPLETED|Overall Study||288
451027|NCT00621959|1076607|P2|STARTED|Overall Study||301
451117|NCT00621348|1076814|P2|STARTED|Overall Study||53
451028|NCT00621959|1076608|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
451029|NCT00621946|1076618|P2|NOT COMPLETED|Overall Study||1
451030|NCT00621946|1076619|P1|NOT COMPLETED|Overall Study||0
451031|NCT00621946|1076618|P2|COMPLETED|Overall Study||12
451032|NCT00621946|1076619|P1|COMPLETED|Overall Study||13
451033|NCT00621946|1076618|P2|STARTED|Overall Study||13
451034|NCT00621946|1076619|P1|STARTED|Overall Study||13
451035|NCT00621933|1076635|P1|NOT COMPLETED|Overall Study||0
451036|NCT00621933|1076635|P1|COMPLETED|Overall Study||399
451037|NCT00621933|1076635|P1|STARTED|Overall Study||399
451038|NCT00621855|1076647|P5|NOT COMPLETED|Overall Study||55
451039|NCT00621855|1076648|P4|NOT COMPLETED|Overall Study||67
451040|NCT00621855|1076649|P3|NOT COMPLETED|Overall Study||81
451041|NCT00621855|1076650|P2|NOT COMPLETED|Overall Study||61
451042|NCT00621855|1076651|P1|NOT COMPLETED|Overall Study||76
451043|NCT00621855|1076647|P5|COMPLETED|Overall Study|Completed means completed treatment|318
451044|NCT00621855|1076648|P4|COMPLETED|Overall Study|Completed means completed treatment|284
451045|NCT00621855|1076649|P3|COMPLETED|Overall Study|Completed means completed treatment|330
451046|NCT00621855|1076650|P2|COMPLETED|Overall Study|Completed means completed treatment|310
451047|NCT00621855|1076651|P1|COMPLETED|Overall Study|Completed means completed treatment|296
451048|NCT00621855|1076647|P5|STARTED|Overall Study|Started means randomised to treatment|373
451049|NCT00621855|1076648|P4|STARTED|Overall Study|Started means randomised to treatment|351
451050|NCT00621855|1076649|P3|STARTED|Overall Study|Started means randomised to treatment|411
451051|NCT00621855|1076650|P2|STARTED|Overall Study|Started means randomised to treatment|371
451052|NCT00621855|1076651|P1|STARTED|Overall Study|Started means randomised to treatment|372
451053|NCT00621842|1076693|P1|NOT COMPLETED|Overall Study||19
451054|NCT00621842|1076693|P1|COMPLETED|Overall Study||38
451055|NCT00621842|1076693|P1|STARTED|Overall Study||57
451056|NCT00621777|1076710|P2|NOT COMPLETED|Randomized Phase||19
451057|NCT00621777|1076711|P1|NOT COMPLETED|Randomized Phase||7
451058|NCT00621777|1076710|P2|COMPLETED|Randomized Phase||28
451059|NCT00621777|1076711|P1|COMPLETED|Randomized Phase||33
451060|NCT00621777|1076710|P2|STARTED|Randomized Phase||47
451061|NCT00621777|1076711|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
451062|NCT00621777|1076710|P2|NOT COMPLETED|Open Phase||0
451063|NCT00621777|1076711|P1|NOT COMPLETED|Open Phase||116
451064|NCT00621777|1076710|P2|COMPLETED|Open Phase||0
451065|NCT00621777|1076711|P1|COMPLETED|Open Phase||87
451066|NCT00621777|1076710|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
451067|NCT00621777|1076711|P1|STARTED|Open Phase||203
451068|NCT00621764|1076722|P4|NOT COMPLETED|Overall Study||1
451069|NCT00621764|1076723|P3|NOT COMPLETED|Overall Study||0
451070|NCT00621764|1076724|P2|NOT COMPLETED|Overall Study||0
451071|NCT00621764|1076725|P1|NOT COMPLETED|Overall Study||0
451072|NCT00621764|1076722|P4|COMPLETED|Overall Study||98
451073|NCT00621764|1076723|P3|COMPLETED|Overall Study||101
451074|NCT00621764|1076724|P2|COMPLETED|Overall Study||50
451075|NCT00621764|1076725|P1|COMPLETED|Overall Study||50
451076|NCT00621764|1076722|P4|STARTED|Overall Study||99
451077|NCT00621764|1076723|P3|STARTED|Overall Study||101
451078|NCT00621764|1076724|P2|STARTED|Overall Study||50
451079|NCT00621764|1076725|P1|STARTED|Overall Study||50
451080|NCT00621686|1076757|P2|NOT COMPLETED|Overall Study||0
451081|NCT00621686|1076758|P1|NOT COMPLETED|Overall Study||0
451082|NCT00621686|1076757|P2|COMPLETED|Overall Study||35
451083|NCT00621686|1076758|P1|COMPLETED|Overall Study||19
451084|NCT00621686|1076757|P2|STARTED|Overall Study||35
451085|NCT00621686|1076758|P1|STARTED|Overall Study||19
451086|NCT00621621|1076771|P2|NOT COMPLETED|Overall Study||0
451087|NCT00621621|1076772|P1|NOT COMPLETED|Overall Study||30
451088|NCT00621621|1076771|P2|COMPLETED|Overall Study||705
451089|NCT00621621|1076772|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
451090|NCT00621621|1076771|P2|STARTED|Overall Study||705
451091|NCT00621621|1076772|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
451092|NCT00621582|1076780|P1|NOT COMPLETED|Overall Study||106
451093|NCT00621582|1076780|P1|COMPLETED|Overall Study||4812
451094|NCT00621582|1076780|P1|STARTED|Overall Study||4918
451095|NCT00621543|1076787|P1|NOT COMPLETED|Overall Study||23
451096|NCT00621543|1076787|P1|COMPLETED|Overall Study||97
451097|NCT00621543|1076787|P1|STARTED|Overall Study||120
451098|NCT00621517|1076794|P2|NOT COMPLETED|Overall Study||7
451099|NCT00621517|1076795|P1|NOT COMPLETED|Overall Study||7
451100|NCT00621517|1076794|P2|COMPLETED|Overall Study||24
451101|NCT00621517|1076795|P1|COMPLETED|Overall Study||22
451102|NCT00621517|1076794|P2|STARTED|Overall Study||31
451103|NCT00621517|1076795|P1|STARTED|Overall Study||29
451104|NCT00621504|1076803|P2|NOT COMPLETED|Overall Study||25
451105|NCT00621504|1076804|P1|NOT COMPLETED|Overall Study||26
451106|NCT00621504|1076803|P2|COMPLETED|Overall Study||282
451107|NCT00621504|1076804|P1|COMPLETED|Overall Study||273
451108|NCT00621504|1076803|P2|STARTED|Overall Study||307
451109|NCT00621504|1076804|P1|STARTED|Overall Study||299
451110|NCT00621348|1076813|P3|NOT COMPLETED|Overall Study||0
451111|NCT00621348|1076814|P2|NOT COMPLETED|Overall Study||0
451112|NCT00621348|1076815|P1|NOT COMPLETED|Overall Study||0
451113|NCT00621348|1076813|P3|COMPLETED|Overall Study||56
451114|NCT00621348|1076814|P2|COMPLETED|Overall Study||53
451115|NCT00621348|1076815|P1|COMPLETED|Overall Study||58
451116|NCT00621348|1076813|P3|STARTED|Overall Study||56
451118|NCT00621348|1076815|P1|STARTED|Overall Study||58
451119|NCT00621322|1076838|P6|NOT COMPLETED|Overall Study||4
451120|NCT00621322|1076839|P5|NOT COMPLETED|Overall Study||1
451121|NCT00621322|1076840|P4|NOT COMPLETED|Overall Study||3
451122|NCT00621322|1076841|P3|NOT COMPLETED|Overall Study||2
451123|NCT00621322|1076842|P2|NOT COMPLETED|Overall Study||0
451124|NCT00621322|1076843|P1|NOT COMPLETED|Overall Study||1
451125|NCT00621322|1076838|P6|COMPLETED|Overall Study||36
451126|NCT00621322|1076839|P5|COMPLETED|Overall Study||39
451127|NCT00621322|1076840|P4|COMPLETED|Overall Study||37
451128|NCT00621322|1076841|P3|COMPLETED|Overall Study||38
451129|NCT00621322|1076842|P2|COMPLETED|Overall Study||10
451130|NCT00621322|1076843|P1|COMPLETED|Overall Study||9
451131|NCT00621322|1076838|P6|STARTED|Overall Study||40
451132|NCT00621322|1076839|P5|STARTED|Overall Study||40
451133|NCT00621322|1076840|P4|STARTED|Overall Study||40
451134|NCT00621322|1076841|P3|STARTED|Overall Study||40
451135|NCT00621322|1076842|P2|STARTED|Overall Study||10
451136|NCT00621322|1076843|P1|STARTED|Overall Study||10
451137|NCT00621296|1076923|P1|NOT COMPLETED|Overall Study||14
451138|NCT00621296|1076923|P1|COMPLETED|Overall Study||1
451139|NCT00621296|1076923|P1|STARTED|Overall Study||15
451140|NCT00621257|1076932|P5|NOT COMPLETED|Overall Study||9
451141|NCT00621257|1076933|P4|NOT COMPLETED|Overall Study||6
451142|NCT00621257|1076934|P3|NOT COMPLETED|Overall Study||3
451143|NCT00621257|1076935|P2|NOT COMPLETED|Overall Study||3
451144|NCT00621257|1076936|P1|NOT COMPLETED|Overall Study||4
451145|NCT00621257|1076932|P5|COMPLETED|Overall Study||22
451146|NCT00621257|1076933|P4|COMPLETED|Overall Study||26
451147|NCT00621257|1076934|P3|COMPLETED|Overall Study||20
451148|NCT00621257|1076935|P2|COMPLETED|Overall Study||21
451149|NCT00621257|1076936|P1|COMPLETED|Overall Study||20
451150|NCT00621257|1076932|P5|STARTED|Overall Study||31
451151|NCT00621257|1076933|P4|STARTED|Overall Study||32
451152|NCT00621257|1076934|P3|STARTED|Overall Study||23
451153|NCT00621257|1076935|P2|STARTED|Overall Study||24
451154|NCT00621257|1076936|P1|STARTED|Overall Study||24
451155|NCT00620126|1076950|P2|NOT COMPLETED|Overall Study||5
451156|NCT00620126|1076951|P1|NOT COMPLETED|Overall Study||11
451157|NCT00620126|1076950|P2|COMPLETED|Overall Study||17
451158|NCT00620126|1076951|P1|COMPLETED|Overall Study||14
451159|NCT00620126|1076950|P2|STARTED|Overall Study||22
451160|NCT00620126|1076951|P1|STARTED|Overall Study||25
451161|NCT00620113|1076965|P4|NOT COMPLETED|Overall Study||10
451162|NCT00620113|1076966|P3|NOT COMPLETED|Overall Study||5
451163|NCT00620113|1076967|P2|NOT COMPLETED|Overall Study||7
451164|NCT00620113|1076968|P1|NOT COMPLETED|Overall Study||13
451165|NCT00620113|1076965|P4|COMPLETED|Overall Study||59
451166|NCT00620113|1076966|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
451167|NCT00620113|1076967|P2|COMPLETED|Overall Study||67
451168|NCT00620113|1076968|P1|COMPLETED|Overall Study||60
451169|NCT00620113|1076965|P4|Efficacy/Safety Population|Overall Study||69
451170|NCT00620113|1076966|P3|Efficacy/Safety Population|Overall Study||70
451171|NCT00620113|1076967|P2|Efficacy/Safety Population|Overall Study||74
451172|NCT00620113|1076968|P1|Efficacy/Safety Population|Overall Study||73
451173|NCT00620113|1076965|P4|STARTED|Overall Study||69
451174|NCT00620113|1076966|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
451175|NCT00620113|1076967|P2|STARTED|Overall Study||74
451176|NCT00620113|1076968|P1|STARTED|Overall Study||73
451177|NCT00621192|1077022|P4|NOT COMPLETED|Overall Study||3
451178|NCT00621192|1077023|P3|NOT COMPLETED|Overall Study||5
451179|NCT00621192|1077024|P2|NOT COMPLETED|Overall Study||9
451180|NCT00621192|1077025|P1|NOT COMPLETED|Overall Study||4
451181|NCT00621192|1077022|P4|COMPLETED|Overall Study||24
451182|NCT00621192|1077023|P3|COMPLETED|Overall Study||26
451183|NCT00621192|1077024|P2|COMPLETED|Overall Study||94
451184|NCT00621192|1077025|P1|COMPLETED|Overall Study||35
451185|NCT00621192|1077022|P4|Efficacy Population|Overall Study||27
451186|NCT00621192|1077023|P3|Efficacy Population|Overall Study||28
451187|NCT00621192|1077024|P2|Efficacy Population|Overall Study||101
451188|NCT00621192|1077025|P1|Efficacy Population|Overall Study||39
451189|NCT00621192|1077022|P4|Safety Population|Overall Study||27
451190|NCT00621192|1077023|P3|Safety Population|Overall Study||31
451191|NCT00621192|1077024|P2|Safety Population|Overall Study||103
451192|NCT00621192|1077025|P1|Safety Population|Overall Study||39
451193|NCT00621192|1077022|P4|STARTED|Overall Study||27
451194|NCT00621192|1077023|P3|STARTED|Overall Study||31
451195|NCT00621192|1077024|P2|STARTED|Overall Study||103
451196|NCT00621192|1077025|P1|STARTED|Overall Study||39
451197|NCT00621153|1077049|P2|NOT COMPLETED|Overall Study||15
451198|NCT00621153|1077050|P1|NOT COMPLETED|Overall Study||20
451199|NCT00621153|1077049|P2|COMPLETED|Overall Study|completed|101
451200|NCT00621153|1077050|P1|COMPLETED|Overall Study|completed|97
451201|NCT00621153|1077049|P2|Discontinued|Overall Study||15
451202|NCT00621153|1077050|P1|Discontinued|Overall Study||20
451203|NCT00621153|1077049|P2|STARTED|Overall Study|randomised|116
451204|NCT00621153|1077050|P1|STARTED|Overall Study|randomised|117
451205|NCT00621140|1077058|P2|NOT COMPLETED|Overall Study||18
451206|NCT00621140|1077059|P1|NOT COMPLETED|Overall Study||15
451207|NCT00621140|1077058|P2|COMPLETED|Overall Study|number who completed treatment|318
451208|NCT00621140|1077059|P1|COMPLETED|Overall Study|number who completed treatment|152
451209|NCT00621140|1077058|P2|STARTED|Overall Study|number who started treatment|336
451210|NCT00621140|1077059|P1|STARTED|Overall Study|number who started treatment|167
451211|NCT00621049|1077093|P2|NOT COMPLETED|Maintenance Treatment||0
451212|NCT00621049|1077094|P1|NOT COMPLETED|Maintenance Treatment||15
451213|NCT00621049|1077093|P2|COMPLETED|Maintenance Treatment||0
451214|NCT00621049|1077094|P1|COMPLETED|Maintenance Treatment||34
451215|NCT00621049|1077093|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
451216|NCT00621049|1077094|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
451217|NCT00621049|1077093|P2|NOT COMPLETED|Adjuvant Treatment||10
451218|NCT00621049|1077094|P1|NOT COMPLETED|Adjuvant Treatment||3
451219|NCT00621049|1077093|P2|COMPLETED|Adjuvant Treatment||47
451220|NCT00621049|1077094|P1|COMPLETED|Adjuvant Treatment||52
451221|NCT00621049|1077093|P2|STARTED|Adjuvant Treatment||57
451222|NCT00621049|1077094|P1|STARTED|Adjuvant Treatment||55
451223|NCT00621023|1077106|P1|NOT COMPLETED|Overall Study||6
451224|NCT00621023|1077106|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
451225|NCT00621023|1077106|P1|STARTED|Overall Study||6
451226|NCT00620854|1077118|P6|NOT COMPLETED|Period 3||0
451227|NCT00620854|1077119|P5|NOT COMPLETED|Period 3||0
451228|NCT00620854|1077120|P4|NOT COMPLETED|Period 3||0
451229|NCT00620854|1077121|P3|NOT COMPLETED|Period 3||0
451230|NCT00620854|1077122|P2|NOT COMPLETED|Period 3||0
451231|NCT00620854|1077123|P1|NOT COMPLETED|Period 3||0
451232|NCT00620854|1077118|P6|COMPLETED|Period 3||4
451233|NCT00620854|1077119|P5|COMPLETED|Period 3||4
451234|NCT00620854|1077120|P4|COMPLETED|Period 3||3
451235|NCT00620854|1077121|P3|COMPLETED|Period 3||3
451236|NCT00620854|1077122|P2|COMPLETED|Period 3||4
451237|NCT00620854|1077123|P1|COMPLETED|Period 3||4
451238|NCT00620854|1077118|P6|STARTED|Period 3||4
451239|NCT00620854|1077119|P5|STARTED|Period 3||4
451240|NCT00620854|1077120|P4|STARTED|Period 3||3
451241|NCT00620854|1077121|P3|STARTED|Period 3||3
451242|NCT00620854|1077122|P2|STARTED|Period 3||4
451243|NCT00620854|1077123|P1|STARTED|Period 3||4
451244|NCT00620854|1077118|P6|NOT COMPLETED|Washout 2||0
451245|NCT00620854|1077119|P5|NOT COMPLETED|Washout 2||0
451246|NCT00620854|1077120|P4|NOT COMPLETED|Washout 2||0
451247|NCT00620854|1077121|P3|NOT COMPLETED|Washout 2||0
451248|NCT00620854|1077122|P2|NOT COMPLETED|Washout 2||0
451249|NCT00620854|1077123|P1|NOT COMPLETED|Washout 2||0
451250|NCT00620854|1077118|P6|COMPLETED|Washout 2||4
451251|NCT00620854|1077119|P5|COMPLETED|Washout 2||4
451252|NCT00620854|1077120|P4|COMPLETED|Washout 2||3
451253|NCT00620854|1077121|P3|COMPLETED|Washout 2||3
451254|NCT00620854|1077122|P2|COMPLETED|Washout 2||4
451255|NCT00620854|1077123|P1|COMPLETED|Washout 2||4
451256|NCT00620854|1077118|P6|STARTED|Washout 2||4
451257|NCT00620854|1077119|P5|STARTED|Washout 2||4
451258|NCT00620854|1077120|P4|STARTED|Washout 2||3
451259|NCT00620854|1077121|P3|STARTED|Washout 2||3
451260|NCT00620854|1077122|P2|STARTED|Washout 2||4
451261|NCT00620854|1077123|P1|STARTED|Washout 2||4
451262|NCT00620854|1077118|P6|NOT COMPLETED|Period 2||0
451263|NCT00620854|1077119|P5|NOT COMPLETED|Period 2||0
451264|NCT00620854|1077120|P4|NOT COMPLETED|Period 2||0
451265|NCT00620854|1077121|P3|NOT COMPLETED|Period 2||0
451266|NCT00620854|1077122|P2|NOT COMPLETED|Period 2||0
451267|NCT00620854|1077123|P1|NOT COMPLETED|Period 2||0
451268|NCT00620854|1077118|P6|COMPLETED|Period 2||4
451269|NCT00620854|1077119|P5|COMPLETED|Period 2||4
451270|NCT00620854|1077120|P4|COMPLETED|Period 2||3
451271|NCT00620854|1077121|P3|COMPLETED|Period 2||3
451272|NCT00620854|1077122|P2|COMPLETED|Period 2||4
451273|NCT00620854|1077123|P1|COMPLETED|Period 2||4
451274|NCT00620854|1077118|P6|STARTED|Period 2||4
451275|NCT00620854|1077119|P5|STARTED|Period 2||4
451276|NCT00620854|1077120|P4|STARTED|Period 2||3
451277|NCT00620854|1077121|P3|STARTED|Period 2||3
451278|NCT00620854|1077122|P2|STARTED|Period 2||4
451279|NCT00620854|1077123|P1|STARTED|Period 2||4
451280|NCT00620854|1077118|P6|NOT COMPLETED|Washout 1||0
451281|NCT00620854|1077119|P5|NOT COMPLETED|Washout 1||0
451282|NCT00620854|1077120|P4|NOT COMPLETED|Washout 1||1
451283|NCT00620854|1077121|P3|NOT COMPLETED|Washout 1||1
451284|NCT00620854|1077122|P2|NOT COMPLETED|Washout 1||0
451285|NCT00620854|1077123|P1|NOT COMPLETED|Washout 1||0
451286|NCT00620854|1077118|P6|COMPLETED|Washout 1||4
451287|NCT00620854|1077119|P5|COMPLETED|Washout 1||4
451288|NCT00620854|1077120|P4|COMPLETED|Washout 1||3
451289|NCT00620854|1077121|P3|COMPLETED|Washout 1||3
451290|NCT00620854|1077122|P2|COMPLETED|Washout 1||4
451291|NCT00620854|1077123|P1|COMPLETED|Washout 1||4
451292|NCT00620854|1077118|P6|STARTED|Washout 1||4
451293|NCT00620854|1077119|P5|STARTED|Washout 1||4
451294|NCT00620854|1077120|P4|STARTED|Washout 1||4
451295|NCT00620854|1077121|P3|STARTED|Washout 1||4
451296|NCT00620854|1077122|P2|STARTED|Washout 1||4
451297|NCT00620854|1077123|P1|STARTED|Washout 1||4
451298|NCT00620854|1077118|P6|NOT COMPLETED|Period 1||0
451299|NCT00620854|1077119|P5|NOT COMPLETED|Period 1||0
451300|NCT00620854|1077120|P4|NOT COMPLETED|Period 1||0
451301|NCT00620854|1077121|P3|NOT COMPLETED|Period 1||0
451302|NCT00620854|1077122|P2|NOT COMPLETED|Period 1||0
451303|NCT00620854|1077123|P1|NOT COMPLETED|Period 1||0
451304|NCT00620854|1077118|P6|COMPLETED|Period 1||4
451305|NCT00620854|1077119|P5|COMPLETED|Period 1||4
451306|NCT00620854|1077120|P4|COMPLETED|Period 1||4
451307|NCT00620854|1077121|P3|COMPLETED|Period 1||4
451308|NCT00620854|1077122|P2|COMPLETED|Period 1||4
451309|NCT00620854|1077123|P1|COMPLETED|Period 1||4
451310|NCT00620854|1077118|P6|STARTED|Period 1||4
451311|NCT00620854|1077119|P5|STARTED|Period 1||4
451312|NCT00620854|1077120|P4|STARTED|Period 1||4
451313|NCT00620854|1077121|P3|STARTED|Period 1||4
451314|NCT00620854|1077122|P2|STARTED|Period 1||4
451315|NCT00620854|1077123|P1|STARTED|Period 1||4
451316|NCT00620828|1077136|P2|NOT COMPLETED|Overall Study||0
451317|NCT00620828|1077137|P1|NOT COMPLETED|Overall Study||0
451318|NCT00620828|1077136|P2|COMPLETED|Overall Study||35
451319|NCT00620828|1077137|P1|COMPLETED|Overall Study||32
451320|NCT00620828|1077136|P2|Number of Subjects Enrolled = 67|Overall Study||35
451321|NCT00620828|1077137|P1|Number of Subjects Enrolled = 67|Overall Study||32
451322|NCT00620828|1077136|P2|STARTED|Overall Study||35
451323|NCT00620828|1077137|P1|STARTED|Overall Study||32
451324|NCT00620815|1077154|P3|NOT COMPLETED|Overall Study||7
451325|NCT00620815|1077155|P2|NOT COMPLETED|Overall Study||11
451326|NCT00620815|1077156|P1|NOT COMPLETED|Overall Study||4
451327|NCT00620815|1077154|P3|COMPLETED|Overall Study||192
451328|NCT00620815|1077155|P2|COMPLETED|Overall Study||192
451329|NCT00620815|1077156|P1|COMPLETED|Overall Study||195
451330|NCT00620815|1077154|P3|STARTED|Overall Study||199
451331|NCT00620815|1077155|P2|STARTED|Overall Study||203
451332|NCT00620815|1077156|P1|STARTED|Overall Study||199
451333|NCT00620776|1077196|P2|NOT COMPLETED|Overall Study||16
451334|NCT00620776|1077197|P1|NOT COMPLETED|Overall Study||12
451335|NCT00620776|1077196|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
451336|NCT00620776|1077197|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
451337|NCT00620776|1077196|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
451338|NCT00620776|1077197|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
451339|NCT00620776|1077196|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
451340|NCT00620776|1077197|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
451341|NCT00620763|1077225|P2|NOT COMPLETED|Period: Second Intervention||0
451342|NCT00620763|1077226|P1|NOT COMPLETED|Period: Second Intervention||1
451343|NCT00620763|1077225|P2|COMPLETED|Period: Second Intervention||7
451344|NCT00620763|1077226|P1|COMPLETED|Period: Second Intervention||9
451345|NCT00620763|1077225|P2|STARTED|Period: Second Intervention||7
451346|NCT00620763|1077226|P1|STARTED|Period: Second Intervention||10
451347|NCT00620763|1077225|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
451348|NCT00620763|1077226|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
451349|NCT00620763|1077225|P2|COMPLETED|Period: Washout Period of 1 Week||7
451350|NCT00620763|1077226|P1|COMPLETED|Period: Washout Period of 1 Week||10
451351|NCT00620763|1077225|P2|STARTED|Period: Washout Period of 1 Week||7
451352|NCT00620763|1077226|P1|STARTED|Period: Washout Period of 1 Week||10
451353|NCT00620763|1077225|P2|NOT COMPLETED|Period: First Intervention||5
451354|NCT00620763|1077226|P1|NOT COMPLETED|Period: First Intervention||0
451355|NCT00620763|1077225|P2|COMPLETED|Period: First Intervention||7
451356|NCT00620763|1077226|P1|COMPLETED|Period: First Intervention||10
451357|NCT00620763|1077225|P2|STARTED|Period: First Intervention||12
451358|NCT00620763|1077226|P1|STARTED|Period: First Intervention||10
451359|NCT00620750|1077232|P1|NOT COMPLETED|Overall Study||25
451360|NCT00620750|1077232|P1|COMPLETED|Overall Study||40
451361|NCT00620750|1077232|P1|STARTED|Overall Study||65
451362|NCT00620711|1077236|P1|NOT COMPLETED|Overall Study||0
451363|NCT00620711|1077236|P1|COMPLETED|Overall Study||4
451364|NCT00620711|1077236|P1|STARTED|Overall Study||4
451365|NCT00620698|1077241|P1|NOT COMPLETED|Overall Study||29
451366|NCT00620698|1077241|P1|COMPLETED|Overall Study||60
451367|NCT00620698|1077241|P1|STARTED|Overall Study||89
451368|NCT00620659|1077247|P6|NOT COMPLETED|Treatment Period 3||0
451369|NCT00620659|1077248|P5|NOT COMPLETED|Treatment Period 3||0
451370|NCT00620659|1077249|P4|NOT COMPLETED|Treatment Period 3||1
451371|NCT00620659|1077250|P3|NOT COMPLETED|Treatment Period 3||0
451372|NCT00620659|1077251|P2|NOT COMPLETED|Treatment Period 3||2
451373|NCT00620659|1077252|P1|NOT COMPLETED|Treatment Period 3||0
451374|NCT00620659|1077247|P6|COMPLETED|Treatment Period 3||20
451375|NCT00620659|1077248|P5|COMPLETED|Treatment Period 3||15
451376|NCT00620659|1077249|P4|COMPLETED|Treatment Period 3||17
451377|NCT00620659|1077250|P3|COMPLETED|Treatment Period 3||19
451378|NCT00620659|1077251|P2|COMPLETED|Treatment Period 3||16
451379|NCT00620659|1077252|P1|COMPLETED|Treatment Period 3||16
451380|NCT00620659|1077247|P6|STARTED|Treatment Period 3||20
451381|NCT00620659|1077248|P5|STARTED|Treatment Period 3||15
451382|NCT00620659|1077249|P4|STARTED|Treatment Period 3||18
451383|NCT00620659|1077250|P3|STARTED|Treatment Period 3||19
451384|NCT00620659|1077251|P2|STARTED|Treatment Period 3||18
451385|NCT00620659|1077252|P1|STARTED|Treatment Period 3||16
451386|NCT00620659|1077247|P6|NOT COMPLETED|Placebo Washout Period 2||0
451387|NCT00620659|1077248|P5|NOT COMPLETED|Placebo Washout Period 2||0
451388|NCT00620659|1077249|P4|NOT COMPLETED|Placebo Washout Period 2||0
451389|NCT00620659|1077250|P3|NOT COMPLETED|Placebo Washout Period 2||0
451390|NCT00620659|1077251|P2|NOT COMPLETED|Placebo Washout Period 2||0
451391|NCT00620659|1077252|P1|NOT COMPLETED|Placebo Washout Period 2||2
451392|NCT00620659|1077247|P6|COMPLETED|Placebo Washout Period 2||20
451393|NCT00620659|1077248|P5|COMPLETED|Placebo Washout Period 2||15
451394|NCT00620659|1077249|P4|COMPLETED|Placebo Washout Period 2||18
451395|NCT00620659|1077250|P3|COMPLETED|Placebo Washout Period 2||19
451396|NCT00620659|1077251|P2|COMPLETED|Placebo Washout Period 2||18
451397|NCT00620659|1077252|P1|COMPLETED|Placebo Washout Period 2||16
451398|NCT00620659|1077247|P6|STARTED|Placebo Washout Period 2||20
451399|NCT00620659|1077248|P5|STARTED|Placebo Washout Period 2||15
451400|NCT00620659|1077249|P4|STARTED|Placebo Washout Period 2||18
451401|NCT00620659|1077250|P3|STARTED|Placebo Washout Period 2||19
451402|NCT00620659|1077251|P2|STARTED|Placebo Washout Period 2||18
451403|NCT00620659|1077252|P1|STARTED|Placebo Washout Period 2||18
451404|NCT00620659|1077247|P6|NOT COMPLETED|Treatment Period 2||0
451405|NCT00620659|1077248|P5|NOT COMPLETED|Treatment Period 2||5
451406|NCT00620659|1077249|P4|NOT COMPLETED|Treatment Period 2||0
451407|NCT00620659|1077250|P3|NOT COMPLETED|Treatment Period 2||1
451408|NCT00620659|1077251|P2|NOT COMPLETED|Treatment Period 2||3
451409|NCT00620659|1077252|P1|NOT COMPLETED|Treatment Period 2||0
451410|NCT00620659|1077247|P6|COMPLETED|Treatment Period 2||20
451411|NCT00620659|1077248|P5|COMPLETED|Treatment Period 2||15
451412|NCT00620659|1077249|P4|COMPLETED|Treatment Period 2||18
451413|NCT00620659|1077250|P3|COMPLETED|Treatment Period 2||19
451414|NCT00620659|1077251|P2|COMPLETED|Treatment Period 2||18
451415|NCT00620659|1077252|P1|COMPLETED|Treatment Period 2||18
451416|NCT00620659|1077247|P6|STARTED|Treatment Period 2||20
451417|NCT00620659|1077248|P5|STARTED|Treatment Period 2||20
451418|NCT00620659|1077249|P4|STARTED|Treatment Period 2||18
451419|NCT00620659|1077250|P3|STARTED|Treatment Period 2||20
451420|NCT00620659|1077251|P2|STARTED|Treatment Period 2||21
451421|NCT00620659|1077252|P1|STARTED|Treatment Period 2||18
451422|NCT00620659|1077247|P6|NOT COMPLETED|Placebo Washout Period 1||0
451423|NCT00620659|1077248|P5|NOT COMPLETED|Placebo Washout Period 1||0
451424|NCT00620659|1077249|P4|NOT COMPLETED|Placebo Washout Period 1||1
451425|NCT00620659|1077250|P3|NOT COMPLETED|Placebo Washout Period 1||0
451426|NCT00620659|1077251|P2|NOT COMPLETED|Placebo Washout Period 1||0
451427|NCT00620659|1077252|P1|NOT COMPLETED|Placebo Washout Period 1||0
451428|NCT00620659|1077247|P6|COMPLETED|Placebo Washout Period 1||20
451429|NCT00620659|1077248|P5|COMPLETED|Placebo Washout Period 1||20
451430|NCT00620659|1077249|P4|COMPLETED|Placebo Washout Period 1||18
451431|NCT00620659|1077250|P3|COMPLETED|Placebo Washout Period 1||20
451432|NCT00620659|1077251|P2|COMPLETED|Placebo Washout Period 1||21
451433|NCT00620659|1077252|P1|COMPLETED|Placebo Washout Period 1||18
451434|NCT00620659|1077247|P6|STARTED|Placebo Washout Period 1||20
451435|NCT00620659|1077248|P5|STARTED|Placebo Washout Period 1||20
451436|NCT00620659|1077249|P4|STARTED|Placebo Washout Period 1||19
451437|NCT00620659|1077250|P3|STARTED|Placebo Washout Period 1||20
451438|NCT00620659|1077251|P2|STARTED|Placebo Washout Period 1||21
451439|NCT00620659|1077252|P1|STARTED|Placebo Washout Period 1||18
451440|NCT00620659|1077247|P6|NOT COMPLETED|Treatment Period 1||0
451441|NCT00620659|1077248|P5|NOT COMPLETED|Treatment Period 1||1
451442|NCT00620659|1077249|P4|NOT COMPLETED|Treatment Period 1||3
451443|NCT00620659|1077250|P3|NOT COMPLETED|Treatment Period 1||1
451444|NCT00620659|1077251|P2|NOT COMPLETED|Treatment Period 1||0
451445|NCT00620659|1077252|P1|NOT COMPLETED|Treatment Period 1||3
451446|NCT00620659|1077247|P6|COMPLETED|Treatment Period 1||20
451447|NCT00620659|1077248|P5|COMPLETED|Treatment Period 1||20
451448|NCT00620659|1077249|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
451449|NCT00620659|1077250|P3|COMPLETED|Treatment Period 1||20
451450|NCT00620659|1077251|P2|COMPLETED|Treatment Period 1||21
451451|NCT00620659|1077252|P1|COMPLETED|Treatment Period 1||18
451452|NCT00620659|1077247|P6|STARTED|Treatment Period 1||20
451453|NCT00620659|1077248|P5|STARTED|Treatment Period 1||21
451454|NCT00620659|1077249|P4|STARTED|Treatment Period 1||21
451455|NCT00620659|1077250|P3|STARTED|Treatment Period 1||21
451456|NCT00620659|1077251|P2|STARTED|Treatment Period 1||21
451457|NCT00620659|1077252|P1|STARTED|Treatment Period 1||21
451458|NCT00620555|1077270|P1|NOT COMPLETED|Overall Study||21
451459|NCT00620555|1077270|P1|COMPLETED|Overall Study||44
451460|NCT00620555|1077270|P1|STARTED|Overall Study||65
451461|NCT00620542|1077279|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
451462|NCT00620542|1077280|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
451463|NCT00620542|1077281|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
451464|NCT00620542|1077282|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
451465|NCT00620542|1077279|P4|COMPLETED|Part B (2 Year Core Study)||547
451466|NCT00620542|1077280|P3|COMPLETED|Part B (2 Year Core Study)||546
451467|NCT00620542|1077281|P2|COMPLETED|Part B (2 Year Core Study)||0
451468|NCT00620542|1077282|P1|COMPLETED|Part B (2 Year Core Study)||0
451469|NCT00620542|1077279|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
451470|NCT00620542|1077280|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
451471|NCT00620542|1077281|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
451472|NCT00620542|1077282|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
451473|NCT00620542|1077279|P4|Received Treatment|Part B (2 Year Core Study)||689
451474|NCT00620542|1077280|P3|Received Treatment|Part B (2 Year Core Study)||691
451475|NCT00620542|1077281|P2|Received Treatment|Part B (2 Year Core Study)||0
451476|NCT00620542|1077282|P1|Received Treatment|Part B (2 Year Core Study)||0
451477|NCT00620542|1077279|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
451478|NCT00620542|1077280|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
451479|NCT00620542|1077281|P2|STARTED|Part B (2 Year Core Study)||0
451480|NCT00620542|1077282|P1|STARTED|Part B (2 Year Core Study)||0
451481|NCT00620542|1077279|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
451482|NCT00620542|1077280|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
451483|NCT00620542|1077281|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
451484|NCT00620542|1077282|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
451485|NCT00620542|1077279|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
451486|NCT00620542|1077280|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
451487|NCT00620542|1077281|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
451488|NCT00620542|1077282|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
451489|NCT00620542|1077279|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
451490|NCT00620542|1077280|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
451491|NCT00620542|1077281|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
451492|NCT00620542|1077282|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
451493|NCT00620542|1077279|P4|STARTED|Part A (Run-in - 2 Weeks)||0
451494|NCT00620542|1077280|P3|STARTED|Part A (Run-in - 2 Weeks)||0
451495|NCT00620542|1077281|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
451496|NCT00620542|1077282|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
451497|NCT00620464|1077322|P2|NOT COMPLETED|Overall Study||24
451498|NCT00620464|1077323|P1|NOT COMPLETED|Overall Study||20
451499|NCT00620464|1077322|P2|COMPLETED|Overall Study||32
451500|NCT00620464|1077323|P1|COMPLETED|Overall Study||32
451501|NCT00620464|1077322|P2|STARTED|Overall Study||56
451502|NCT00620464|1077323|P1|STARTED|Overall Study||52
451503|NCT00620425|1077331|P1|NOT COMPLETED|Overall Study||0
451504|NCT00620425|1077331|P1|COMPLETED|Overall Study||18
451505|NCT00620425|1077331|P1|STARTED|Overall Study||18
451506|NCT00620373|1077342|P1|NOT COMPLETED|Overall Study||33
451507|NCT00620373|1077342|P1|COMPLETED|Overall Study||936
451508|NCT00620373|1077342|P1|STARTED|Overall Study||969
451509|NCT00620282|1077361|P3|NOT COMPLETED|Overall Study||1
451510|NCT00620282|1077362|P2|NOT COMPLETED|Overall Study||2
451511|NCT00620282|1077363|P1|NOT COMPLETED|Overall Study||0
451512|NCT00620282|1077361|P3|COMPLETED|Overall Study||16
451513|NCT00620282|1077362|P2|COMPLETED|Overall Study||14
451514|NCT00620282|1077363|P1|COMPLETED|Overall Study||16
451515|NCT00620282|1077361|P3|STARTED|Overall Study||17
451516|NCT00620282|1077362|P2|STARTED|Overall Study||16
451517|NCT00620282|1077363|P1|STARTED|Overall Study||16
451518|NCT00620074|1077410|P1|NOT COMPLETED|Overall Study||1
451519|NCT00620074|1077410|P1|COMPLETED|Overall Study||5
451520|NCT00620074|1077410|P1|STARTED|Overall Study||6
451521|NCT00620035|1077418|P1|NOT COMPLETED|Overall Study||145
451522|NCT00620035|1077418|P1|COMPLETED|Overall Study||156
451523|NCT00620035|1077418|P1|STARTED|Overall Study||301
451524|NCT00620022|1077428|P2|NOT COMPLETED|Treatment Period 2||2
451525|NCT00620022|1077429|P1|NOT COMPLETED|Treatment Period 2||2
451526|NCT00620022|1077428|P2|COMPLETED|Treatment Period 2||35
451527|NCT00620022|1077429|P1|COMPLETED|Treatment Period 2||39
451528|NCT00620022|1077428|P2|STARTED|Treatment Period 2||37
451529|NCT00620022|1077429|P1|STARTED|Treatment Period 2||41
451530|NCT00620022|1077428|P2|NOT COMPLETED|Treatment Period 1||6
451531|NCT00620022|1077429|P1|NOT COMPLETED|Treatment Period 1||5
451532|NCT00620022|1077428|P2|COMPLETED|Treatment Period 1||37
451533|NCT00620022|1077429|P1|COMPLETED|Treatment Period 1||41
451534|NCT00620022|1077428|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
451535|NCT00620022|1077429|P1|STARTED|Treatment Period 1||46
451536|NCT00619970|1077440|P3|NOT COMPLETED|Overall Study||2
451537|NCT00619970|1077441|P2|NOT COMPLETED|Overall Study||3
451538|NCT00619970|1077442|P1|NOT COMPLETED|Overall Study||0
451539|NCT00619970|1077440|P3|COMPLETED|Overall Study||24
451540|NCT00619970|1077441|P2|COMPLETED|Overall Study||46
451541|NCT00619970|1077442|P1|COMPLETED|Overall Study||40
451542|NCT00619970|1077440|P3|STARTED|Overall Study||26
451543|NCT00619970|1077441|P2|STARTED|Overall Study||49
451544|NCT00619970|1077442|P1|STARTED|Overall Study||40
451545|NCT00619957|1077454|P2|NOT COMPLETED|Month 48 Open-Label||17
451546|NCT00619957|1077455|P1|NOT COMPLETED|Month 48 Open-Label||12
451547|NCT00619957|1077454|P2|COMPLETED|Month 48 Open-Label||134
451548|NCT00619957|1077455|P1|COMPLETED|Month 48 Open-Label||55
451549|NCT00619957|1077454|P2|STARTED|Month 48 Open-Label||151
451550|NCT00619957|1077455|P1|STARTED|Month 48 Open-Label||67
451551|NCT00619957|1077454|P2|NOT COMPLETED|Month 24 Double-Blind||17
451552|NCT00619957|1077455|P1|NOT COMPLETED|Month 24 Double-Blind||18
451553|NCT00619957|1077454|P2|COMPLETED|Month 24 Double-Blind||175
451554|NCT00619957|1077455|P1|COMPLETED|Month 24 Double-Blind||75
451555|NCT00619957|1077454|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
451556|NCT00619957|1077455|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
451557|NCT00619957|1077454|P2|STARTED|Month 24 Double-Blind||192
451558|NCT00619957|1077455|P1|STARTED|Month 24 Double-Blind||93
451559|NCT00619918|1077537|P2|NOT COMPLETED|Overall Study||22
451560|NCT00619918|1077538|P1|NOT COMPLETED|Overall Study||20
451561|NCT00619918|1077537|P2|COMPLETED|Overall Study||195
451562|NCT00619918|1077538|P1|COMPLETED|Overall Study||210
451563|NCT00619918|1077537|P2|STARTED|Overall Study||217
451564|NCT00619918|1077538|P1|STARTED|Overall Study||230
451565|NCT00619892|1077548|P2|NOT COMPLETED|Overall Study||2
451566|NCT00619892|1077549|P1|NOT COMPLETED|Overall Study||3
451567|NCT00619892|1077548|P2|COMPLETED|Overall Study||11
451568|NCT00619892|1077549|P1|COMPLETED|Overall Study||10
451569|NCT00619892|1077548|P2|STARTED|Overall Study||13
451570|NCT00619892|1077549|P1|STARTED|Overall Study||13
451571|NCT00619827|1077559|P2|NOT COMPLETED|Overall Study||4
451572|NCT00619827|1077560|P1|NOT COMPLETED|Overall Study||3
451573|NCT00619827|1077559|P2|COMPLETED|Overall Study||40
451574|NCT00619827|1077560|P1|COMPLETED|Overall Study||42
451575|NCT00619827|1077559|P2|STARTED|Overall Study||44
451576|NCT00619827|1077560|P1|STARTED|Overall Study||45
451577|NCT00619801|1077568|P2|NOT COMPLETED|Overall Study||3
451578|NCT00619801|1077569|P1|NOT COMPLETED|Overall Study||1
451579|NCT00619801|1077568|P2|COMPLETED|Overall Study||111
451580|NCT00619801|1077569|P1|COMPLETED|Overall Study||58
451581|NCT00619801|1077568|P2|Safety Population|Overall Study||114
451582|NCT00619801|1077569|P1|Safety Population|Overall Study||59
451583|NCT00619801|1077568|P2|STARTED|Overall Study||114
451584|NCT00619801|1077569|P1|STARTED|Overall Study||59
451585|NCT00619762|1077599|P1|NOT COMPLETED|Overall Study||3
451586|NCT00619762|1077599|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
451587|NCT00619762|1077599|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
451588|NCT00619684|1077604|P1|NOT COMPLETED|Overall Study||0
451589|NCT00619684|1077604|P1|COMPLETED|Overall Study||18
451590|NCT00619684|1077604|P1|STARTED|Overall Study||18
451591|NCT00619645|1077613|P1|NOT COMPLETED|Overall Study||1
451592|NCT00619645|1077613|P1|COMPLETED|Overall Study||7
451593|NCT00619645|1077613|P1|STARTED|Overall Study||8
451594|NCT00619619|1077627|P8|NOT COMPLETED|Overall Study||3
451595|NCT00619619|1077628|P7|NOT COMPLETED|Overall Study||1
451596|NCT00619619|1077629|P6|NOT COMPLETED|Overall Study||0
451597|NCT00619619|1077630|P5|NOT COMPLETED|Overall Study||2
451598|NCT00619619|1077631|P4|NOT COMPLETED|Overall Study||1
451599|NCT00619619|1077632|P3|NOT COMPLETED|Overall Study||1
451600|NCT00619619|1077633|P2|NOT COMPLETED|Overall Study||0
451601|NCT00619619|1077634|P1|NOT COMPLETED|Overall Study||0
451602|NCT00619619|1077627|P8|COMPLETED|Overall Study||5
451603|NCT00619619|1077628|P7|COMPLETED|Overall Study||7
451604|NCT00619619|1077629|P6|COMPLETED|Overall Study||7
451605|NCT00619619|1077630|P5|COMPLETED|Overall Study||5
451606|NCT00619619|1077631|P4|COMPLETED|Overall Study||6
451607|NCT00619619|1077632|P3|COMPLETED|Overall Study||8
451608|NCT00619619|1077633|P2|COMPLETED|Overall Study||7
451609|NCT00619619|1077634|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
451610|NCT00619619|1077627|P8|Entered the Extension Study|Overall Study||7
451611|NCT00619619|1077628|P7|Entered the Extension Study|Overall Study||6
451612|NCT00619619|1077629|P6|Entered the Extension Study|Overall Study||6
451613|NCT00619619|1077630|P5|Entered the Extension Study|Overall Study||7
451614|NCT00619619|1077631|P4|Entered the Extension Study|Overall Study||3
451615|NCT00619619|1077632|P3|Entered the Extension Study|Overall Study||8
451616|NCT00619619|1077633|P2|Entered the Extension Study|Overall Study||5
451617|NCT00619619|1077634|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
451618|NCT00619619|1077627|P8|STARTED|Overall Study||8
451619|NCT00619619|1077628|P7|STARTED|Overall Study||8
451620|NCT00619619|1077629|P6|STARTED|Overall Study||7
451621|NCT00619619|1077630|P5|STARTED|Overall Study||7
451622|NCT00619619|1077631|P4|STARTED|Overall Study||7
451623|NCT00619619|1077632|P3|STARTED|Overall Study||9
451624|NCT00619619|1077633|P2|STARTED|Overall Study||7
451625|NCT00619619|1077634|P1|STARTED|Overall Study||6
451626|NCT00619502|1077721|P2|NOT COMPLETED|Overall Study||10
451627|NCT00619502|1077722|P1|NOT COMPLETED|Overall Study||8
451628|NCT00619502|1077721|P2|COMPLETED|Overall Study||114
451629|NCT00619502|1077722|P1|COMPLETED|Overall Study||122
451630|NCT00619502|1077721|P2|STARTED|Overall Study||124
451631|NCT00619502|1077722|P1|STARTED|Overall Study||130
451632|NCT00619489|1077734|P2|NOT COMPLETED|Overall Study||34
451633|NCT00619489|1077735|P1|NOT COMPLETED|Overall Study||23
451634|NCT00619489|1077734|P2|COMPLETED|Overall Study||1
451635|NCT00619489|1077735|P1|COMPLETED|Overall Study||14
451636|NCT00619489|1077734|P2|STARTED|Overall Study||35
451637|NCT00619489|1077735|P1|STARTED|Overall Study||37
451638|NCT00619476|1077757|P4|NOT COMPLETED|Overall Study||34
451639|NCT00619476|1077758|P3|NOT COMPLETED|Overall Study||24
451640|NCT00619476|1077759|P2|NOT COMPLETED|Overall Study||22
451641|NCT00619476|1077760|P1|NOT COMPLETED|Overall Study||31
451642|NCT00619476|1077757|P4|COMPLETED|Overall Study||56
451643|NCT00619476|1077758|P3|COMPLETED|Overall Study||60
451644|NCT00619476|1077759|P2|COMPLETED|Overall Study||85
451645|NCT00619476|1077760|P1|COMPLETED|Overall Study||64
451646|NCT00619476|1077757|P4|Safety Population|Overall Study||87
451647|NCT00619476|1077758|P3|Safety Population|Overall Study||82
451648|NCT00619476|1077759|P2|Safety Population|Overall Study||107
451649|NCT00619476|1077760|P1|Safety Population|Overall Study||95
451650|NCT00619476|1077757|P4|Intent-to-Treat Population|Overall Study||87
451651|NCT00619476|1077758|P3|Intent-to-Treat Population|Overall Study||82
451652|NCT00619476|1077759|P2|Intent-to-Treat Population|Overall Study||107
451653|NCT00619476|1077760|P1|Intent-to-Treat Population|Overall Study||95
451654|NCT00619476|1077757|P4|STARTED|Overall Study||90
451655|NCT00619476|1077758|P3|STARTED|Overall Study||84
451656|NCT00619476|1077759|P2|STARTED|Overall Study||107
451657|NCT00619476|1077760|P1|STARTED|Overall Study||95
451658|NCT00619385|1077845|P3|NOT COMPLETED|Overall Study||4
451659|NCT00619385|1077846|P2|NOT COMPLETED|Overall Study||2
451660|NCT00619385|1077847|P1|NOT COMPLETED|Overall Study||1
451661|NCT00619385|1077845|P3|COMPLETED|Overall Study||6
451662|NCT00619385|1077846|P2|COMPLETED|Overall Study||6
451663|NCT00619385|1077847|P1|COMPLETED|Overall Study||6
451664|NCT00619385|1077845|P3|STARTED|Overall Study||10
451665|NCT00619385|1077846|P2|STARTED|Overall Study||8
451666|NCT00619385|1077847|P1|STARTED|Overall Study||7
451667|NCT00619359|1077862|P2|NOT COMPLETED|Overall Study||81
451668|NCT00619359|1077863|P1|NOT COMPLETED|Overall Study||67
451669|NCT00619359|1077862|P2|COMPLETED|Overall Study||1094
451670|NCT00619359|1077863|P1|COMPLETED|Overall Study||1080
451671|NCT00619359|1077862|P2|STARTED|Overall Study||1175
451672|NCT00619359|1077863|P1|STARTED|Overall Study||1147
451673|NCT00619307|1077875|P2|NOT COMPLETED|Overall Study||4
451674|NCT00619307|1077876|P1|NOT COMPLETED|Overall Study||4
451675|NCT00619307|1077875|P2|COMPLETED|Overall Study||53
451676|NCT00619307|1077876|P1|COMPLETED|Overall Study||56
451677|NCT00619307|1077875|P2|STARTED|Overall Study||57
451678|NCT00619307|1077876|P1|STARTED|Overall Study||60
451679|NCT00619242|1077890|P1|NOT COMPLETED|Overall Study||0
451680|NCT00619242|1077890|P1|COMPLETED|Overall Study||3
451681|NCT00619242|1077890|P1|STARTED|Overall Study||3
451682|NCT00619229|1077896|P2|NOT COMPLETED|Overall Study||2
451683|NCT00619229|1077897|P1|NOT COMPLETED|Overall Study||4
451684|NCT00619229|1077896|P2|COMPLETED|Overall Study||16
451685|NCT00619229|1077897|P1|COMPLETED|Overall Study||14
451686|NCT00619229|1077896|P2|Full Analysis Set (FAS)|Overall Study||17
451687|NCT00619229|1077897|P1|Full Analysis Set (FAS)|Overall Study||16
451688|NCT00619229|1077896|P2|STARTED|Overall Study||18
451689|NCT00619229|1077897|P1|STARTED|Overall Study||18
451690|NCT00619190|1077925|P2|NOT COMPLETED|Overall Study||0
451691|NCT00619190|1077926|P1|NOT COMPLETED|Overall Study||1
451692|NCT00619190|1077925|P2|COMPLETED|Overall Study||9
451693|NCT00619190|1077926|P1|COMPLETED|Overall Study||20
451694|NCT00619190|1077925|P2|STARTED|Overall Study||9
451695|NCT00619190|1077926|P1|STARTED|Overall Study||21
451696|NCT00619177|1077936|P1|NOT COMPLETED|Overall Study||508
451697|NCT00619177|1077936|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
451698|NCT00619177|1077936|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
451699|NCT00619151|1077946|P2|NOT COMPLETED|Overall Study||0
451700|NCT00619151|1077947|P1|NOT COMPLETED|Overall Study||1
451701|NCT00619151|1077946|P2|COMPLETED|Overall Study||0
451702|NCT00619151|1077947|P1|COMPLETED|Overall Study||1
451703|NCT00619151|1077946|P2|STARTED|Overall Study||0
451704|NCT00619151|1077947|P1|STARTED|Overall Study||2
451705|NCT00619112|1077955|P1|NOT COMPLETED|Overall Study||0
451706|NCT00619112|1077955|P1|COMPLETED|Overall Study|enrolled all patients from Nov 2007 to Jan 2012|60
451707|NCT00619112|1077955|P1|STARTED|Overall Study||60
451708|NCT00619099|1077961|P2|NOT COMPLETED|Overall Study||19
451709|NCT00619099|1077962|P1|NOT COMPLETED|Overall Study||33
451710|NCT00619099|1077961|P2|COMPLETED|Overall Study||4
451711|NCT00619099|1077962|P1|COMPLETED|Overall Study||11
451712|NCT00619099|1077961|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
451713|NCT00619099|1077962|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
451714|NCT00619099|1077961|P2|STARTED|Overall Study|All randomized subjects|23
451715|NCT00619099|1077962|P1|STARTED|Overall Study|All randomized subjects|44
451716|NCT00619073|1077968|P2|NOT COMPLETED|Second Intervention - 60 Days||0
451717|NCT00619073|1077969|P1|NOT COMPLETED|Second Intervention - 60 Days||0
451718|NCT00619073|1077968|P2|COMPLETED|Second Intervention - 60 Days||8
451719|NCT00619073|1077969|P1|COMPLETED|Second Intervention - 60 Days||8
451720|NCT00619073|1077968|P2|STARTED|Second Intervention - 60 Days||8
451721|NCT00619073|1077969|P1|STARTED|Second Intervention - 60 Days||8
451722|NCT00619073|1077968|P2|NOT COMPLETED|Washout Period (30 Days)||0
451723|NCT00619073|1077969|P1|NOT COMPLETED|Washout Period (30 Days)||0
451724|NCT00619073|1077968|P2|COMPLETED|Washout Period (30 Days)||8
451725|NCT00619073|1077969|P1|COMPLETED|Washout Period (30 Days)||8
451726|NCT00619073|1077968|P2|STARTED|Washout Period (30 Days)||8
451727|NCT00619073|1077969|P1|STARTED|Washout Period (30 Days)||8
451728|NCT00619073|1077968|P2|NOT COMPLETED|First Intervention - 60 Days||0
451729|NCT00619073|1077969|P1|NOT COMPLETED|First Intervention - 60 Days||0
451730|NCT00619073|1077968|P2|COMPLETED|First Intervention - 60 Days||8
451731|NCT00619073|1077969|P1|COMPLETED|First Intervention - 60 Days||8
451732|NCT00619073|1077968|P2|STARTED|First Intervention - 60 Days||8
451733|NCT00619073|1077969|P1|STARTED|First Intervention - 60 Days||8
451734|NCT00619060|1077975|P2|NOT COMPLETED|Overall Study||0
451735|NCT00619060|1077976|P1|NOT COMPLETED|Overall Study||0
451736|NCT00619060|1077975|P2|COMPLETED|Overall Study||12
451737|NCT00619060|1077976|P1|COMPLETED|Overall Study||10
451738|NCT00619060|1077975|P2|STARTED|Overall Study||12
451739|NCT00619060|1077976|P1|STARTED|Overall Study||10
451740|NCT00618995|1077984|P4|NOT COMPLETED|Period 4||0
451741|NCT00618995|1077985|P3|NOT COMPLETED|Period 4||0
451742|NCT00618995|1077986|P2|NOT COMPLETED|Period 4||0
451743|NCT00618995|1077987|P1|NOT COMPLETED|Period 4||1
451744|NCT00618995|1077984|P4|COMPLETED|Period 4||6
451745|NCT00618995|1077985|P3|COMPLETED|Period 4||4
451746|NCT00618995|1077986|P2|COMPLETED|Period 4||6
451747|NCT00618995|1077987|P1|COMPLETED|Period 4||5
451748|NCT00618995|1077984|P4|STARTED|Period 4||6
451749|NCT00618995|1077985|P3|STARTED|Period 4||4
451750|NCT00618995|1077986|P2|STARTED|Period 4||6
451751|NCT00618995|1077987|P1|STARTED|Period 4||6
451752|NCT00618995|1077984|P4|NOT COMPLETED|Period 3||0
451753|NCT00618995|1077985|P3|NOT COMPLETED|Period 3||0
451754|NCT00618995|1077986|P2|NOT COMPLETED|Period 3||0
451755|NCT00618995|1077987|P1|NOT COMPLETED|Period 3||0
451756|NCT00618995|1077984|P4|COMPLETED|Period 3||6
451757|NCT00618995|1077985|P3|COMPLETED|Period 3||4
451758|NCT00618995|1077986|P2|COMPLETED|Period 3||6
451759|NCT00618995|1077987|P1|COMPLETED|Period 3||6
451760|NCT00618995|1077984|P4|STARTED|Period 3||6
451761|NCT00618995|1077985|P3|STARTED|Period 3||4
451762|NCT00618995|1077986|P2|STARTED|Period 3||6
451763|NCT00618995|1077987|P1|STARTED|Period 3||6
451764|NCT00618995|1077984|P4|NOT COMPLETED|Period 2||0
451765|NCT00618995|1077985|P3|NOT COMPLETED|Period 2||1
451766|NCT00618995|1077986|P2|NOT COMPLETED|Period 2||0
451767|NCT00618995|1077987|P1|NOT COMPLETED|Period 2||0
451768|NCT00618995|1077984|P4|COMPLETED|Period 2||6
451769|NCT00618995|1077985|P3|COMPLETED|Period 2||4
451770|NCT00618995|1077986|P2|COMPLETED|Period 2||6
451771|NCT00618995|1077987|P1|COMPLETED|Period 2||6
451772|NCT00618995|1077984|P4|STARTED|Period 2||6
451773|NCT00618995|1077985|P3|STARTED|Period 2||5
451774|NCT00618995|1077986|P2|STARTED|Period 2||6
451775|NCT00618995|1077987|P1|STARTED|Period 2||6
451776|NCT00618995|1077984|P4|NOT COMPLETED|Period 1||0
451777|NCT00618995|1077985|P3|NOT COMPLETED|Period 1||2
451778|NCT00618995|1077986|P2|NOT COMPLETED|Period 1||1
451779|NCT00618995|1077987|P1|NOT COMPLETED|Period 1||0
451780|NCT00618995|1077984|P4|COMPLETED|Period 1||6
451781|NCT00618995|1077985|P3|COMPLETED|Period 1||5
451782|NCT00618995|1077986|P2|COMPLETED|Period 1||6
451783|NCT00618995|1077987|P1|COMPLETED|Period 1||6
451784|NCT00618995|1077984|P4|STARTED|Period 1||6
451785|NCT00618995|1077985|P3|STARTED|Period 1||7
451786|NCT00618995|1077986|P2|STARTED|Period 1||7
451787|NCT00618995|1077987|P1|STARTED|Period 1||6
451788|NCT00618982|1078001|P1|NOT COMPLETED|Overall Study||50
451789|NCT00618982|1078001|P1|COMPLETED|Overall Study||33
451790|NCT00618982|1078001|P1|STARTED|Overall Study||83
451791|NCT00618956|1078024|P2|NOT COMPLETED|Overall Study||50
451792|NCT00618956|1078025|P1|NOT COMPLETED|Overall Study||25
451793|NCT00618956|1078024|P2|COMPLETED|Overall Study||160
451794|NCT00618956|1078025|P1|COMPLETED|Overall Study||86
451795|NCT00618956|1078024|P2|STARTED|Overall Study||210
451796|NCT00618956|1078025|P1|STARTED|Overall Study||111
451797|NCT00618839|1078041|P1|NOT COMPLETED|Overall Study||0
451798|NCT00618839|1078041|P1|COMPLETED|Overall Study||15
451799|NCT00618839|1078041|P1|STARTED|Overall Study||15
451800|NCT00618826|1078050|P1|NOT COMPLETED|Overall Study||1
451801|NCT00618826|1078050|P1|COMPLETED|Overall Study||13
451802|NCT00618826|1078050|P1|STARTED|Overall Study||14
451803|NCT00618813|1078055|P1|NOT COMPLETED|Overall Study||4
451804|NCT00618813|1078055|P1|COMPLETED|Overall Study||31
451805|NCT00618813|1078055|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
451806|NCT00618813|1078055|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
451807|NCT00618813|1078055|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
451808|NCT00618813|1078055|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
451809|NCT00618813|1078055|P1|STARTED|Overall Study||35
451810|NCT00618787|1078065|P2|NOT COMPLETED|Overall Study||2
451811|NCT00618787|1078066|P1|NOT COMPLETED|Overall Study||3
451812|NCT00618787|1078065|P2|COMPLETED|Overall Study||21
451813|NCT00618787|1078066|P1|COMPLETED|Overall Study||19
451814|NCT00618787|1078065|P2|STARTED|Overall Study||23
451815|NCT00618787|1078066|P1|STARTED|Overall Study||22
451816|NCT00618774|1078074|P2|NOT COMPLETED|Overall Study||3
451817|NCT00618774|1078075|P1|NOT COMPLETED|Overall Study||6
451818|NCT00618774|1078074|P2|COMPLETED|Overall Study||45
451819|NCT00618774|1078075|P1|COMPLETED|Overall Study||205
451820|NCT00618774|1078074|P2|STARTED|Overall Study||48
451821|NCT00618774|1078075|P1|STARTED|Overall Study||211
451822|NCT00618748|1078108|P3|NOT COMPLETED|Overall Study||14
451823|NCT00618748|1078109|P2|NOT COMPLETED|Overall Study||5
451824|NCT00618748|1078110|P1|NOT COMPLETED|Overall Study||11
451825|NCT00618748|1078108|P3|COMPLETED|Overall Study||6
451826|NCT00618748|1078109|P2|COMPLETED|Overall Study||20
451827|NCT00618748|1078110|P1|COMPLETED|Overall Study||45
451828|NCT00618748|1078108|P3|STARTED|Overall Study||20
451829|NCT00618748|1078109|P2|STARTED|Overall Study||25
451830|NCT00618748|1078110|P1|STARTED|Overall Study||56
451831|NCT00618722|1078155|P4|NOT COMPLETED|Overall Study||4
451832|NCT00618722|1078156|P3|NOT COMPLETED|Overall Study||3
451833|NCT00618722|1078157|P2|NOT COMPLETED|Overall Study||2
451834|NCT00618722|1078158|P1|NOT COMPLETED|Overall Study||3
451835|NCT00618722|1078155|P4|COMPLETED|Overall Study||18
451836|NCT00618722|1078156|P3|COMPLETED|Overall Study||19
451837|NCT00618722|1078157|P2|COMPLETED|Overall Study||18
451838|NCT00618722|1078158|P1|COMPLETED|Overall Study||18
451839|NCT00618722|1078155|P4|Received Treatment|Overall Study||22
451840|NCT00618722|1078156|P3|Received Treatment|Overall Study||22
451841|NCT00618722|1078157|P2|Received Treatment|Overall Study||20
451842|NCT00618722|1078158|P1|Received Treatment|Overall Study||20
451843|NCT00618722|1078155|P4|STARTED|Overall Study||22
451844|NCT00618722|1078156|P3|STARTED|Overall Study||22
451845|NCT00618722|1078157|P2|STARTED|Overall Study||20
451846|NCT00618722|1078158|P1|STARTED|Overall Study||21
451847|NCT00618618|1078196|P4|NOT COMPLETED|Overall Study||1
451848|NCT00618618|1078197|P3|NOT COMPLETED|Overall Study||3
451849|NCT00618618|1078198|P2|NOT COMPLETED|Overall Study||3
451850|NCT00618618|1078199|P1|NOT COMPLETED|Overall Study||4
451851|NCT00618618|1078196|P4|COMPLETED|Overall Study||13
451852|NCT00618618|1078197|P3|COMPLETED|Overall Study||18
451853|NCT00618618|1078198|P2|COMPLETED|Overall Study||11
451854|NCT00618618|1078199|P1|COMPLETED|Overall Study||20
451855|NCT00618618|1078196|P4|Received Treatment|Overall Study||14
451856|NCT00618618|1078197|P3|Received Treatment|Overall Study||20
451857|NCT00618618|1078198|P2|Received Treatment|Overall Study||13
451858|NCT00618618|1078199|P1|Received Treatment|Overall Study||24
451859|NCT00618618|1078196|P4|STARTED|Overall Study||14
451860|NCT00618618|1078197|P3|STARTED|Overall Study||21
451861|NCT00618618|1078198|P2|STARTED|Overall Study||14
451862|NCT00618618|1078199|P1|STARTED|Overall Study||24
451863|NCT00618540|1078245|P1|NOT COMPLETED|Overall Study||0
451864|NCT00618540|1078245|P1|COMPLETED|Overall Study||1
451865|NCT00618540|1078245|P1|STARTED|Overall Study||1
451866|NCT00618514|1078258|P3|NOT COMPLETED|Overall Study||4
451867|NCT00618514|1078259|P2|NOT COMPLETED|Overall Study||12
451868|NCT00618514|1078260|P1|NOT COMPLETED|Overall Study||11
451869|NCT00618514|1078258|P3|COMPLETED|Overall Study||12
451870|NCT00618514|1078259|P2|COMPLETED|Overall Study||26
451871|NCT00618514|1078260|P1|COMPLETED|Overall Study||25
451872|NCT00618514|1078258|P3|STARTED|Overall Study||16
451873|NCT00618514|1078259|P2|STARTED|Overall Study||38
451874|NCT00618514|1078260|P1|STARTED|Overall Study||36
451875|NCT00618449|1078280|P2|NOT COMPLETED|Overall Study||110
451876|NCT00618449|1078281|P1|NOT COMPLETED|Overall Study||98
451877|NCT00618449|1078280|P2|COMPLETED|Overall Study||558
451878|NCT00618449|1078281|P1|COMPLETED|Overall Study||581
451879|NCT00618449|1078280|P2|1-year, Post-treatment|Overall Study||558
451880|NCT00618449|1078281|P1|1-year, Post-treatment|Overall Study||581
451881|NCT00618449|1078280|P2|1-month, Post-treatment|Overall Study||656
451882|NCT00618449|1078281|P1|1-month, Post-treatment|Overall Study||666
451883|NCT00618449|1078280|P2|STARTED|Overall Study||668
451884|NCT00618449|1078281|P1|STARTED|Overall Study||679
451885|NCT00618436|1078289|P2|NOT COMPLETED|Overall Study||0
451886|NCT00618436|1078290|P1|NOT COMPLETED|Overall Study||0
451887|NCT00618436|1078289|P2|COMPLETED|Overall Study||18
451888|NCT00618436|1078290|P1|COMPLETED|Overall Study||34
451889|NCT00618436|1078289|P2|STARTED|Overall Study||18
451890|NCT00618436|1078290|P1|STARTED|Overall Study||34
451891|NCT00618410|1078300|P2|NOT COMPLETED|Second Intervention||0
451892|NCT00618410|1078301|P1|NOT COMPLETED|Second Intervention||0
451893|NCT00618410|1078300|P2|COMPLETED|Second Intervention||5
451894|NCT00618410|1078301|P1|COMPLETED|Second Intervention||7
451895|NCT00618410|1078300|P2|STARTED|Second Intervention||5
451896|NCT00618410|1078301|P1|STARTED|Second Intervention||7
451897|NCT00618410|1078300|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
451898|NCT00618410|1078301|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
451899|NCT00618410|1078300|P2|COMPLETED|Washout Period (2 Weeks)||5
451900|NCT00618410|1078301|P1|COMPLETED|Washout Period (2 Weeks)||7
451901|NCT00618410|1078300|P2|STARTED|Washout Period (2 Weeks)||6
451902|NCT00618410|1078301|P1|STARTED|Washout Period (2 Weeks)||7
451903|NCT00618410|1078300|P2|NOT COMPLETED|First Intervention||0
451904|NCT00618410|1078301|P1|NOT COMPLETED|First Intervention||0
451905|NCT00618410|1078300|P2|COMPLETED|First Intervention||6
451906|NCT00618410|1078301|P1|COMPLETED|First Intervention||7
451907|NCT00618410|1078300|P2|STARTED|First Intervention||6
451908|NCT00618410|1078301|P1|STARTED|First Intervention||7
451909|NCT00618371|1078317|P1|NOT COMPLETED|Overall Study||2
451910|NCT00618371|1078317|P1|COMPLETED|Overall Study||10
451911|NCT00618371|1078317|P1|STARTED|Overall Study||12
451912|NCT00618332|1078324|P2|NOT COMPLETED|Overall Study||0
451913|NCT00618332|1078325|P1|NOT COMPLETED|Overall Study||0
451914|NCT00618332|1078324|P2|COMPLETED|Overall Study||20
451915|NCT00618332|1078325|P1|COMPLETED|Overall Study||20
451916|NCT00618332|1078324|P2|STARTED|Overall Study||20
451917|NCT00618332|1078325|P1|STARTED|Overall Study||20
451918|NCT00618072|1078350|P3|NOT COMPLETED|Overall Study||4
451919|NCT00618072|1078351|P2|NOT COMPLETED|Overall Study||1
451920|NCT00618072|1078352|P1|NOT COMPLETED|Overall Study||2
451921|NCT00618072|1078350|P3|COMPLETED|Overall Study||11
451922|NCT00618072|1078351|P2|COMPLETED|Overall Study||14
451923|NCT00618072|1078352|P1|COMPLETED|Overall Study||14
451924|NCT00618072|1078350|P3|STARTED|Overall Study||15
451925|NCT00618072|1078351|P2|STARTED|Overall Study||15
451926|NCT00618072|1078352|P1|STARTED|Overall Study||16
451927|NCT00617981|1078386|P2|NOT COMPLETED|Overall Study||102
451928|NCT00617981|1078387|P1|NOT COMPLETED|Overall Study||110
451929|NCT00617981|1078386|P2|COMPLETED|Overall Study||245
451930|NCT00617981|1078387|P1|COMPLETED|Overall Study||244
451931|NCT00617981|1078386|P2|STARTED|Overall Study||347
451932|NCT00617981|1078387|P1|STARTED|Overall Study||354
451933|NCT00617929|1078393|P1|NOT COMPLETED|Overall Study||1
451934|NCT00617929|1078393|P1|COMPLETED|Overall Study||11
451935|NCT00617929|1078393|P1|STARTED|Overall Study||12
451936|NCT00617903|1078405|P2|NOT COMPLETED|Overall Study||7
451937|NCT00617903|1078406|P1|NOT COMPLETED|Overall Study||3
451938|NCT00617903|1078405|P2|COMPLETED|Overall Study||35
451939|NCT00617903|1078406|P1|COMPLETED|Overall Study||38
451940|NCT00617903|1078405|P2|STARTED|Overall Study||42
451941|NCT00617903|1078406|P1|STARTED|Overall Study||41
451942|NCT00617890|1078452|P4|NOT COMPLETED|Overall Study||115
451943|NCT00617890|1078453|P3|NOT COMPLETED|Overall Study||35
451944|NCT00617890|1078454|P2|NOT COMPLETED|Overall Study||28
451945|NCT00617890|1078455|P1|NOT COMPLETED|Overall Study||31
451946|NCT00617890|1078452|P4|COMPLETED|Overall Study||1
451947|NCT00617890|1078453|P3|COMPLETED|Overall Study||0
451948|NCT00617890|1078454|P2|COMPLETED|Overall Study||5
451949|NCT00617890|1078455|P1|COMPLETED|Overall Study||4
451950|NCT00617890|1078452|P4|Received Treatment|Overall Study||115
451951|NCT00617890|1078453|P3|Received Treatment|Overall Study||34
451952|NCT00617890|1078454|P2|Received Treatment|Overall Study||33
451953|NCT00617890|1078455|P1|Received Treatment|Overall Study||34
451954|NCT00617890|1078452|P4|STARTED|Overall Study||116
451955|NCT00617890|1078453|P3|STARTED|Overall Study||35
451956|NCT00617890|1078454|P2|STARTED|Overall Study||33
451957|NCT00617890|1078455|P1|STARTED|Overall Study||35
451958|NCT00617851|1078491|P4|NOT COMPLETED|Overall Study||25
451959|NCT00617851|1078492|P3|NOT COMPLETED|Overall Study||45
451960|NCT00617851|1078493|P2|NOT COMPLETED|Overall Study||40
451961|NCT00617851|1078494|P1|NOT COMPLETED|Overall Study||47
451962|NCT00617851|1078491|P4|COMPLETED|Overall Study||192
451963|NCT00617851|1078492|P3|COMPLETED|Overall Study||384
451964|NCT00617851|1078493|P2|COMPLETED|Overall Study||391
451965|NCT00617851|1078494|P1|COMPLETED|Overall Study||383
451966|NCT00617851|1078491|P4|STARTED|Overall Study||217
451967|NCT00617851|1078492|P3|STARTED|Overall Study||429
451968|NCT00617851|1078493|P2|STARTED|Overall Study||431
451969|NCT00617851|1078494|P1|STARTED|Overall Study||430
451970|NCT00617773|1078532|P1|NOT COMPLETED|Overall Study||24
451971|NCT00617773|1078532|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
451972|NCT00617773|1078532|P1|STARTED|Overall Study||31
451973|NCT00617708|1078550|P3|NOT COMPLETED|Overall Study||64
451974|NCT00617708|1078551|P2|NOT COMPLETED|Overall Study||60
451975|NCT00617708|1078552|P1|NOT COMPLETED|Overall Study||10
451976|NCT00617708|1078550|P3|COMPLETED|Overall Study||0
451977|NCT00617708|1078551|P2|COMPLETED|Overall Study||0
451978|NCT00617708|1078552|P1|COMPLETED|Overall Study||0
451979|NCT00617708|1078550|P3|Eligible and Began Protocol Therapy|Overall Study||59
451980|NCT00617708|1078551|P2|Eligible and Began Protocol Therapy|Overall Study||57
451981|NCT00617708|1078552|P1|Eligible and Began Protocol Therapy|Overall Study||9
451982|NCT00617708|1078550|P3|STARTED|Overall Study||64
451983|NCT00617708|1078551|P2|STARTED|Overall Study||60
451984|NCT00617708|1078552|P1|STARTED|Overall Study||10
451985|NCT00617669|1078569|P2|NOT COMPLETED|Overall Study||451
451986|NCT00617669|1078570|P1|NOT COMPLETED|Overall Study||430
451987|NCT00617669|1078569|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
451988|NCT00617669|1078570|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
451989|NCT00617669|1078569|P2|Patients Who Received IP|Overall Study||525
451990|NCT00617669|1078570|P1|Patients Who Received IP|Overall Study||522
451991|NCT00617669|1078569|P2|STARTED|Overall Study||528
451992|NCT00617669|1078570|P1|STARTED|Overall Study||524
451993|NCT00617604|1078592|P2|NOT COMPLETED|Overall Study||20
451994|NCT00617604|1078593|P1|NOT COMPLETED|Overall Study||18
451995|NCT00617604|1078592|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
451996|NCT00617604|1078593|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
451997|NCT00617604|1078592|P2|Completed 12 Weeks of Treatment|Overall Study||83
451998|NCT00617604|1078593|P1|Completed 12 Weeks of Treatment|Overall Study||89
451999|NCT00617604|1078592|P2|Received Treatment|Overall Study||105
452000|NCT00617604|1078593|P1|Received Treatment|Overall Study||107
452001|NCT00617604|1078592|P2|STARTED|Overall Study||108
452002|NCT00617604|1078593|P1|STARTED|Overall Study||110
452003|NCT00617591|1078637|P1|NOT COMPLETED|Overall Study||10
452004|NCT00617591|1078637|P1|COMPLETED|Overall Study||47
452005|NCT00617591|1078637|P1|STARTED|Overall Study||57
452006|NCT00617461|1078645|P2|NOT COMPLETED|6-Day Down-Titration Period||2
452007|NCT00617461|1078646|P1|NOT COMPLETED|6-Day Down-Titration Period||2
452008|NCT00617461|1078645|P2|COMPLETED|6-Day Down-Titration Period||35
452009|NCT00617461|1078646|P1|COMPLETED|6-Day Down-Titration Period||39
452010|NCT00617461|1078645|P2|STARTED|6-Day Down-Titration Period||37
452011|NCT00617461|1078646|P1|STARTED|6-Day Down-Titration Period||41
452012|NCT00617461|1078645|P2|NOT COMPLETED|Second Treatment Intervention Period||4
452013|NCT00617461|1078646|P1|NOT COMPLETED|Second Treatment Intervention Period||0
452014|NCT00617461|1078645|P2|COMPLETED|Second Treatment Intervention Period||37
452015|NCT00617461|1078646|P1|COMPLETED|Second Treatment Intervention Period||41
452016|NCT00617461|1078645|P2|STARTED|Second Treatment Intervention Period||41
452017|NCT00617461|1078646|P1|STARTED|Second Treatment Intervention Period||41
452018|NCT00617461|1078645|P2|NOT COMPLETED|4-Day Crossover Period||0
452019|NCT00617461|1078646|P1|NOT COMPLETED|4-Day Crossover Period||1
452020|NCT00617461|1078645|P2|COMPLETED|4-Day Crossover Period||40
452021|NCT00617461|1078646|P1|COMPLETED|4-Day Crossover Period||41
452022|NCT00617461|1078645|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
452023|NCT00617461|1078646|P1|STARTED|4-Day Crossover Period||42
452024|NCT00617461|1078645|P2|NOT COMPLETED|First Treatment Intervention Period||3
452025|NCT00617461|1078646|P1|NOT COMPLETED|First Treatment Intervention Period||10
452026|NCT00617461|1078645|P2|COMPLETED|First Treatment Intervention Period||41
452027|NCT00617461|1078646|P1|COMPLETED|First Treatment Intervention Period||42
452028|NCT00617461|1078645|P2|STARTED|First Treatment Intervention Period||44
452029|NCT00617461|1078646|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
452030|NCT00617409|1078702|P3|NOT COMPLETED|Overall Study||27
452031|NCT00617409|1078703|P2|NOT COMPLETED|Overall Study||18
452032|NCT00617409|1078704|P1|NOT COMPLETED|Overall Study||16
452033|NCT00617409|1078702|P3|COMPLETED|Overall Study||4
452034|NCT00617409|1078703|P2|COMPLETED|Overall Study||2
452035|NCT00617409|1078704|P1|COMPLETED|Overall Study||2
452036|NCT00617409|1078702|P3|STARTED|Overall Study||31
452037|NCT00617409|1078703|P2|STARTED|Overall Study||20
452038|NCT00617409|1078704|P1|STARTED|Overall Study||18
452039|NCT00617396|1078715|P1|NOT COMPLETED|Overall Study||0
452040|NCT00617396|1078715|P1|COMPLETED|Overall Study||25
452041|NCT00617396|1078715|P1|STARTED|Overall Study||25
452042|NCT00617357|1078719|P1|NOT COMPLETED|Overall Study||16
452043|NCT00617357|1078719|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
452044|NCT00617357|1078719|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
452045|NCT00617305|1078732|P3|NOT COMPLETED|Overall Study||1
452046|NCT00617305|1078733|P2|NOT COMPLETED|Overall Study||0
452047|NCT00617305|1078734|P1|NOT COMPLETED|Overall Study||8
452048|NCT00617305|1078732|P3|COMPLETED|Overall Study||0
452049|NCT00617305|1078733|P2|COMPLETED|Overall Study||4
452050|NCT00617305|1078734|P1|COMPLETED|Overall Study||25
452051|NCT00617305|1078732|P3|Completed 24-week Primary Analysis|Overall Study||0
452052|NCT00617305|1078733|P2|Completed 24-week Primary Analysis|Overall Study||4
452053|NCT00617305|1078734|P1|Completed 24-week Primary Analysis|Overall Study||31
452054|NCT00617305|1078732|P3|STARTED|Overall Study||1
452055|NCT00617305|1078733|P2|STARTED|Overall Study||4
452056|NCT00617305|1078734|P1|STARTED|Overall Study||33
452057|NCT00617279|1078790|P2|NOT COMPLETED|Overall Study||17
452058|NCT00617279|1078791|P1|NOT COMPLETED|Overall Study||14
452059|NCT00617279|1078790|P2|COMPLETED|Overall Study||0
452060|NCT00617279|1078791|P1|COMPLETED|Overall Study||0
452061|NCT00617279|1078790|P2|STARTED|Overall Study||17
452062|NCT00617279|1078791|P1|STARTED|Overall Study||14
452063|NCT00617240|1078847|P2|NOT COMPLETED|Overall Study||0
452064|NCT00617240|1078848|P1|NOT COMPLETED|Overall Study||1
452065|NCT00617240|1078847|P2|COMPLETED|Overall Study||4
452066|NCT00617240|1078848|P1|COMPLETED|Overall Study||4
452067|NCT00617240|1078847|P2|STARTED|Overall Study||4
452068|NCT00617240|1078848|P1|STARTED|Overall Study||5
452069|NCT00617201|1078868|P2|NOT COMPLETED|Overall Study||13
452070|NCT00617201|1078869|P1|NOT COMPLETED|Overall Study||9
452071|NCT00617201|1078868|P2|COMPLETED|Overall Study||12
452072|NCT00617201|1078869|P1|COMPLETED|Overall Study||16
452073|NCT00617201|1078868|P2|STARTED|Overall Study||25
452074|NCT00617201|1078869|P1|STARTED|Overall Study||25
452075|NCT00617188|1078877|P1|NOT COMPLETED|Overall Study||0
452076|NCT00617188|1078877|P1|COMPLETED|Overall Study||26
452077|NCT00617188|1078877|P1|STARTED|Overall Study||26
452078|NCT00617175|1078888|P2|NOT COMPLETED|Overall Study||0
452079|NCT00617175|1078889|P1|NOT COMPLETED|Overall Study||0
452080|NCT00617175|1078888|P2|COMPLETED|Overall Study||948
452081|NCT00617175|1078889|P1|COMPLETED|Overall Study||954
452082|NCT00617175|1078888|P2|STARTED|Overall Study||948
452083|NCT00617175|1078889|P1|STARTED|Overall Study||954
452084|NCT00617123|1078897|P2|NOT COMPLETED|Study Treatment Period||16
452085|NCT00617123|1078898|P1|NOT COMPLETED|Study Treatment Period||17
452086|NCT00617123|1078897|P2|COMPLETED|Study Treatment Period||79
452087|NCT00617123|1078898|P1|COMPLETED|Study Treatment Period||81
452088|NCT00617123|1078897|P2|Treated|Study Treatment Period||95
452089|NCT00617123|1078898|P1|Treated|Study Treatment Period|1 participant was not treated|97
452090|NCT00617123|1078897|P2|STARTED|Study Treatment Period||95
452091|NCT00617123|1078898|P1|STARTED|Study Treatment Period||98
452092|NCT00617123|1078897|P2|NOT COMPLETED|Referral Screening Period||26
452093|NCT00617123|1078898|P1|NOT COMPLETED|Referral Screening Period||39
452094|NCT00617123|1078897|P2|COMPLETED|Referral Screening Period||95
452095|NCT00617123|1078898|P1|COMPLETED|Referral Screening Period||98
452096|NCT00617123|1078897|P2|STARTED|Referral Screening Period||121
452097|NCT00617123|1078898|P1|STARTED|Referral Screening Period||137
452098|NCT00617097|1078914|P2|NOT COMPLETED|Overall Study||0
452099|NCT00617097|1078915|P1|NOT COMPLETED|Overall Study||0
452100|NCT00617097|1078914|P2|COMPLETED|Overall Study||25
452101|NCT00617097|1078915|P1|COMPLETED|Overall Study||25
452102|NCT00617097|1078914|P2|STARTED|Overall Study||25
452103|NCT00617097|1078915|P1|STARTED|Overall Study||25
452104|NCT00617084|1078929|P2|NOT COMPLETED|Overall Study||26
452105|NCT00617084|1078930|P1|NOT COMPLETED|Overall Study||21
452106|NCT00617084|1078929|P2|COMPLETED|Overall Study||1126
452107|NCT00617084|1078930|P1|COMPLETED|Overall Study||1119
452108|NCT00617084|1078929|P2|STARTED|Overall Study||1152
452109|NCT00617084|1078930|P1|STARTED|Overall Study||1140
452110|NCT00617058|1078941|P3|NOT COMPLETED|Overall Study||0
452111|NCT00617058|1078942|P2|NOT COMPLETED|Overall Study||0
452112|NCT00617058|1078943|P1|NOT COMPLETED|Overall Study||0
452113|NCT00617058|1078941|P3|COMPLETED|Overall Study||0
452114|NCT00617058|1078942|P2|COMPLETED|Overall Study||0
452115|NCT00617058|1078943|P1|COMPLETED|Overall Study||1
452116|NCT00617058|1078941|P3|STARTED|Overall Study||0
452117|NCT00617058|1078942|P2|STARTED|Overall Study||0
452118|NCT00617058|1078943|P1|STARTED|Overall Study||1
452119|NCT00616967|1078983|P3|NOT COMPLETED|Overall Study||1
452120|NCT00616967|1078984|P2|NOT COMPLETED|Overall Study||0
452121|NCT00616967|1078985|P1|NOT COMPLETED|Overall Study||0
452122|NCT00616967|1078983|P3|COMPLETED|Overall Study||30
452123|NCT00616967|1078984|P2|COMPLETED|Overall Study||31
452124|NCT00616967|1078985|P1|COMPLETED|Overall Study||6
452125|NCT00616967|1078983|P3|STARTED|Overall Study||31
452126|NCT00616967|1078984|P2|STARTED|Overall Study||31
452127|NCT00616967|1078985|P1|STARTED|Overall Study||6
452128|NCT00616928|1078998|P4|NOT COMPLETED|Overall Study||7
452129|NCT00616928|1078999|P3|NOT COMPLETED|Overall Study||17
452130|NCT00616928|1079000|P2|NOT COMPLETED|Overall Study||18
452131|NCT00616928|1079001|P1|NOT COMPLETED|Overall Study||62
452132|NCT00616928|1078998|P4|COMPLETED|Overall Study||364
452133|NCT00616928|1078999|P3|COMPLETED|Overall Study||1101
452134|NCT00616928|1079000|P2|COMPLETED|Overall Study||750
452135|NCT00616928|1079001|P1|COMPLETED|Overall Study||2242
452136|NCT00616928|1078998|P4|STARTED|Overall Study||371
452137|NCT00616928|1078999|P3|STARTED|Overall Study||1118
452138|NCT00616928|1079000|P2|STARTED|Overall Study||768
452139|NCT00616928|1079001|P1|STARTED|Overall Study||2304
452140|NCT00616902|1079065|P2|NOT COMPLETED|Overall Study||6
452141|NCT00616902|1079066|P1|NOT COMPLETED|Overall Study||6
452142|NCT00616902|1079065|P2|COMPLETED|Overall Study||0
452143|NCT00616902|1079066|P1|COMPLETED|Overall Study||0
452144|NCT00616902|1079065|P2|STARTED|Overall Study||6
452145|NCT00616902|1079066|P1|STARTED|Overall Study||6
452146|NCT00616772|1079092|P2|NOT COMPLETED|Overall Study||102
452147|NCT00616772|1079093|P1|NOT COMPLETED|Overall Study||115
452148|NCT00616772|1079092|P2|COMPLETED|Overall Study||240
452149|NCT00616772|1079093|P1|COMPLETED|Overall Study||225
452150|NCT00616772|1079092|P2|Treated|Overall Study||339
452151|NCT00616772|1079093|P1|Treated|Overall Study||337
452152|NCT00616772|1079092|P2|STARTED|Overall Study||342
452153|NCT00616772|1079093|P1|STARTED|Overall Study||340
452154|NCT00616759|1079109|P2|NOT COMPLETED|Overall Study||2
452155|NCT00616759|1079110|P1|NOT COMPLETED|Overall Study||3
452156|NCT00616759|1079109|P2|COMPLETED|Overall Study||8
452157|NCT00616759|1079110|P1|COMPLETED|Overall Study||7
452158|NCT00616759|1079109|P2|STARTED|Overall Study||10
452159|NCT00616759|1079110|P1|STARTED|Overall Study||10
452160|NCT00616655|1079119|P3|NOT COMPLETED|Overall Study||48
452161|NCT00616655|1079120|P2|NOT COMPLETED|Overall Study||41
452162|NCT00616655|1079121|P1|NOT COMPLETED|Overall Study||35
452163|NCT00616655|1079119|P3|COMPLETED|Overall Study||103
452164|NCT00616655|1079120|P2|COMPLETED|Overall Study||112
452165|NCT00616655|1079121|P1|COMPLETED|Overall Study||117
452166|NCT00616655|1079119|P3|STARTED|Overall Study||151
452167|NCT00616655|1079120|P2|STARTED|Overall Study||153
452168|NCT00616655|1079121|P1|STARTED|Overall Study||152
452169|NCT00616642|1079161|P2|NOT COMPLETED|Overall Study||1
452170|NCT00616642|1079162|P1|NOT COMPLETED|Overall Study||0
452171|NCT00616642|1079161|P2|COMPLETED|Overall Study||0
452172|NCT00616642|1079162|P1|COMPLETED|Overall Study||0
452173|NCT00616642|1079161|P2|STARTED|Overall Study||1
452174|NCT00616642|1079162|P1|STARTED|Overall Study||0
452175|NCT00616629|1079173|P5|NOT COMPLETED|Overall Study||0
452176|NCT00616629|1079174|P4|NOT COMPLETED|Overall Study||0
452177|NCT00616629|1079175|P3|NOT COMPLETED|Overall Study||1
452178|NCT00616629|1079176|P2|NOT COMPLETED|Overall Study||2
452179|NCT00616629|1079177|P1|NOT COMPLETED|Overall Study||2
452180|NCT00616629|1079173|P5|COMPLETED|Overall Study||12
452181|NCT00616629|1079174|P4|COMPLETED|Overall Study||2
452182|NCT00616629|1079175|P3|COMPLETED|Overall Study||13
452183|NCT00616629|1079176|P2|COMPLETED|Overall Study||12
452184|NCT00616629|1079177|P1|COMPLETED|Overall Study||11
452185|NCT00616629|1079173|P5|STARTED|Overall Study||12
452186|NCT00616629|1079174|P4|STARTED|Overall Study||2
452187|NCT00616629|1079175|P3|STARTED|Overall Study|One patient never received study drug|14
452188|NCT00616629|1079176|P2|STARTED|Overall Study|Two patients never received study drug|14
452189|NCT00616629|1079177|P1|STARTED|Overall Study|Two patients never received study drug|13
452190|NCT00616603|1079222|P3|NOT COMPLETED|Overall Study||2
452191|NCT00616603|1079223|P2|NOT COMPLETED|Overall Study||0
452192|NCT00616603|1079224|P1|NOT COMPLETED|Overall Study||2
452193|NCT00616603|1079222|P3|COMPLETED|Overall Study||13
452194|NCT00616603|1079223|P2|COMPLETED|Overall Study||14
452195|NCT00616603|1079224|P1|COMPLETED|Overall Study||12
452196|NCT00616603|1079222|P3|STARTED|Overall Study||15
452197|NCT00616603|1079223|P2|STARTED|Overall Study||14
452198|NCT00616603|1079224|P1|STARTED|Overall Study||14
452199|NCT00616577|1079235|P3|NOT COMPLETED|Overall Study||0
452200|NCT00616577|1079236|P2|NOT COMPLETED|Overall Study||0
452201|NCT00616577|1079237|P1|NOT COMPLETED|Overall Study||0
452202|NCT00616577|1079235|P3|COMPLETED|Overall Study||7
452203|NCT00616577|1079236|P2|COMPLETED|Overall Study||9
452204|NCT00616577|1079237|P1|COMPLETED|Overall Study||6
452205|NCT00616577|1079235|P3|STARTED|Overall Study||7
452206|NCT00616577|1079236|P2|STARTED|Overall Study||9
452207|NCT00616577|1079237|P1|STARTED|Overall Study||6
452208|NCT00616434|1079247|P2|NOT COMPLETED|Overall Study||8
452209|NCT00616434|1079248|P1|NOT COMPLETED|Overall Study||6
452210|NCT00616434|1079247|P2|COMPLETED|Overall Study||53
452211|NCT00616434|1079248|P1|COMPLETED|Overall Study||56
452212|NCT00616434|1079247|P2|STARTED|Overall Study||61
452213|NCT00616434|1079248|P1|STARTED|Overall Study||62
452214|NCT00616421|1079261|P3|NOT COMPLETED|Overall Study||41
452215|NCT00616421|1079262|P2|NOT COMPLETED|Overall Study||38
452216|NCT00616421|1079263|P1|NOT COMPLETED|Overall Study||26
452217|NCT00616421|1079261|P3|COMPLETED|Overall Study||1229
452218|NCT00616421|1079262|P2|COMPLETED|Overall Study||1240
452219|NCT00616421|1079263|P1|COMPLETED|Overall Study||333
452220|NCT00616421|1079261|P3|STARTED|Overall Study||1270
452221|NCT00616421|1079262|P2|STARTED|Overall Study||1278
452222|NCT00616421|1079263|P1|STARTED|Overall Study||359
452223|NCT00616343|1079300|P1|NOT COMPLETED|Overall Study||0
452224|NCT00616343|1079300|P1|COMPLETED|Overall Study||9
452225|NCT00616343|1079300|P1|STARTED|Overall Study||9
452226|NCT00616239|1079304|P1|NOT COMPLETED|Overall Study||2
452227|NCT00616239|1079304|P1|COMPLETED|Overall Study||18
452228|NCT00616239|1079304|P1|STARTED|Overall Study||20
452229|NCT00616200|1079308|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
452230|NCT00616200|1079308|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
452231|NCT00616200|1079308|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
452232|NCT00616200|1079308|P1|NOT COMPLETED|Two Week Standard Diet||1
452233|NCT00616200|1079308|P1|COMPLETED|Two Week Standard Diet||16
452234|NCT00616200|1079308|P1|STARTED|Two Week Standard Diet||17
452235|NCT00616122|1079314|P1|NOT COMPLETED|Overall Study||7
452236|NCT00616122|1079314|P1|COMPLETED|Overall Study||25
452237|NCT00616122|1079314|P1|STARTED|Overall Study||32
452238|NCT00616109|1079321|P1|NOT COMPLETED|Overall Study||0
452239|NCT00616109|1079321|P1|COMPLETED|Overall Study||16
452240|NCT00616109|1079321|P1|STARTED|Overall Study||16
452241|NCT00616018|1079328|P1|NOT COMPLETED|Overall Study||3
452242|NCT00616018|1079328|P1|COMPLETED|Overall Study||24
452243|NCT00616018|1079328|P1|STARTED|Overall Study||27
452244|NCT00615992|1079333|P1|NOT COMPLETED|Overall Study||67
452245|NCT00615992|1079333|P1|COMPLETED|Overall Study||687
452246|NCT00615992|1079333|P1|STARTED|Overall Study||754
452247|NCT00615927|1079344|P2|NOT COMPLETED|Overall Study||0
452248|NCT00615927|1079345|P1|NOT COMPLETED|Overall Study||0
452249|NCT00615927|1079344|P2|COMPLETED|Overall Study||32
452250|NCT00615927|1079345|P1|COMPLETED|Overall Study||32
452251|NCT00615927|1079344|P2|STARTED|Overall Study||32
452252|NCT00615927|1079345|P1|STARTED|Overall Study||32
452253|NCT00615914|1079359|P1|NOT COMPLETED|Overall Study||637
452254|NCT00615914|1079359|P1|COMPLETED|Overall Study||1008
452255|NCT00615914|1079359|P1|STARTED|Overall Study|The number of patients enrolled|1645
452256|NCT00615901|1079366|P1|NOT COMPLETED|Overall Study||9
452257|NCT00615901|1079366|P1|COMPLETED|Overall Study||29
452258|NCT00615901|1079366|P1|STARTED|Overall Study||38
452259|NCT00615836|1079374|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
452260|NCT00615836|1079375|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
452261|NCT00615836|1079376|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
452262|NCT00615836|1079377|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
452263|NCT00615836|1079378|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
452264|NCT00615836|1079374|P5|COMPLETED|Extension Study (FE992026 CS31)||0
452265|NCT00615836|1079375|P4|COMPLETED|Extension Study (FE992026 CS31)||53
452266|NCT00615836|1079376|P3|COMPLETED|Extension Study (FE992026 CS31)||59
452267|NCT00615836|1079377|P2|COMPLETED|Extension Study (FE992026 CS31)||58
452268|NCT00615836|1079378|P1|COMPLETED|Extension Study (FE992026 CS31)||0
452269|NCT00615836|1079374|P5|STARTED|Extension Study (FE992026 CS31)||0
452270|NCT00615836|1079375|P4|STARTED|Extension Study (FE992026 CS31)||137
452271|NCT00615836|1079376|P3|STARTED|Extension Study (FE992026 CS31)||132
452272|NCT00615836|1079377|P2|STARTED|Extension Study (FE992026 CS31)||144
452273|NCT00615836|1079378|P1|STARTED|Extension Study (FE992026 CS31)||141
452274|NCT00615836|1079374|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
452275|NCT00615836|1079375|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
452276|NCT00615836|1079376|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
452277|NCT00615836|1079377|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
452278|NCT00615836|1079378|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
452279|NCT00615836|1079374|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
452280|NCT00615836|1079375|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
452281|NCT00615836|1079376|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
452282|NCT00615836|1079377|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
452283|NCT00615836|1079378|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
452284|NCT00615836|1079374|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
452285|NCT00615836|1079375|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
452286|NCT00615836|1079376|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
452378|NCT00615199|1079542|P3|COMPLETED|Overall Study||33
452287|NCT00615836|1079377|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
452288|NCT00615836|1079378|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
452289|NCT00615836|1079374|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
452290|NCT00615836|1079375|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
452291|NCT00615836|1079376|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
452292|NCT00615836|1079377|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
452293|NCT00615836|1079378|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
452294|NCT00615719|1079438|P1|NOT COMPLETED|Overall Study||5
452295|NCT00615719|1079438|P1|COMPLETED|Overall Study||30
452296|NCT00615719|1079438|P1|STARTED|Overall Study||35
452297|NCT00615589|1079442|P1|NOT COMPLETED|Overall Study||0
452298|NCT00615589|1079442|P1|COMPLETED|Overall Study||22
452299|NCT00615589|1079442|P1|STARTED|Overall Study||22
452300|NCT00615550|1079452|P2|NOT COMPLETED|Overall Study||1
452301|NCT00615550|1079453|P1|NOT COMPLETED|Overall Study||6
452302|NCT00615550|1079452|P2|COMPLETED|Overall Study||235
452303|NCT00615550|1079453|P1|COMPLETED|Overall Study||223
452304|NCT00615550|1079452|P2|STARTED|Overall Study||236
452305|NCT00615550|1079453|P1|STARTED|Overall Study||229
452306|NCT00615472|1079469|P2|NOT COMPLETED|Overall Study||0
452307|NCT00615472|1079470|P1|NOT COMPLETED|Overall Study||0
452308|NCT00615472|1079469|P2|COMPLETED|Overall Study||28
452309|NCT00615472|1079470|P1|COMPLETED|Overall Study||30
452310|NCT00615472|1079469|P2|STARTED|Overall Study||28
452311|NCT00615472|1079470|P1|STARTED|Overall Study||30
452312|NCT00615459|1079476|P4|NOT COMPLETED|Period III||0
452313|NCT00615459|1079477|P3|NOT COMPLETED|Period III||1
452314|NCT00615459|1079478|P2|NOT COMPLETED|Period III||3
452315|NCT00615459|1079479|P1|NOT COMPLETED|Period III||0
452316|NCT00615459|1079476|P4|COMPLETED|Period III||41
452317|NCT00615459|1079477|P3|COMPLETED|Period III||39
452318|NCT00615459|1079478|P2|COMPLETED|Period III||37
452319|NCT00615459|1079479|P1|COMPLETED|Period III||36
452320|NCT00615459|1079476|P4|STARTED|Period III||41
452321|NCT00615459|1079477|P3|STARTED|Period III||40
452322|NCT00615459|1079478|P2|STARTED|Period III||40
452323|NCT00615459|1079479|P1|STARTED|Period III||36
452324|NCT00615459|1079476|P4|NOT COMPLETED|Period II||1
452325|NCT00615459|1079477|P3|NOT COMPLETED|Period II||0
452326|NCT00615459|1079478|P2|NOT COMPLETED|Period II||0
452327|NCT00615459|1079479|P1|NOT COMPLETED|Period II||1
452328|NCT00615459|1079476|P4|COMPLETED|Period II||41
452329|NCT00615459|1079477|P3|COMPLETED|Period II||40
452330|NCT00615459|1079478|P2|COMPLETED|Period II||40
452331|NCT00615459|1079479|P1|COMPLETED|Period II||36
452332|NCT00615459|1079476|P4|STARTED|Period II||42
452333|NCT00615459|1079477|P3|STARTED|Period II||40
452334|NCT00615459|1079478|P2|STARTED|Period II||40
452335|NCT00615459|1079479|P1|STARTED|Period II||37
452336|NCT00615459|1079476|P4|NOT COMPLETED|Period I||1
452337|NCT00615459|1079477|P3|NOT COMPLETED|Period I||2
452338|NCT00615459|1079478|P2|NOT COMPLETED|Period I||1
452339|NCT00615459|1079479|P1|NOT COMPLETED|Period I||4
452340|NCT00615459|1079476|P4|COMPLETED|Period I||42
452341|NCT00615459|1079477|P3|COMPLETED|Period I||40
452342|NCT00615459|1079478|P2|COMPLETED|Period I||40
452343|NCT00615459|1079479|P1|COMPLETED|Period I||37
452344|NCT00615459|1079476|P4|STARTED|Period I||43
452345|NCT00615459|1079477|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
452346|NCT00615459|1079478|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
452347|NCT00615459|1079479|P1|STARTED|Period I||41
452348|NCT00615433|1079497|P4|NOT COMPLETED|Overall Study||45
452349|NCT00615433|1079498|P3|NOT COMPLETED|Overall Study||39
452350|NCT00615433|1079499|P2|NOT COMPLETED|Overall Study||53
452351|NCT00615433|1079500|P1|NOT COMPLETED|Overall Study||43
452352|NCT00615433|1079497|P4|COMPLETED|Overall Study||71
452353|NCT00615433|1079498|P3|COMPLETED|Overall Study||84
452354|NCT00615433|1079499|P2|COMPLETED|Overall Study||66
452355|NCT00615433|1079500|P1|COMPLETED|Overall Study||77
452356|NCT00615433|1079497|P4|STARTED|Overall Study||116
452357|NCT00615433|1079498|P3|STARTED|Overall Study||123
452358|NCT00615433|1079499|P2|STARTED|Overall Study||119
452359|NCT00615433|1079500|P1|STARTED|Overall Study||120
452360|NCT00615290|1079514|P1|NOT COMPLETED|Overall Study||8
452361|NCT00615290|1079514|P1|COMPLETED|Overall Study||34
452362|NCT00615290|1079514|P1|STARTED|Overall Study||42
452363|NCT00615264|1079528|P2|NOT COMPLETED|Overall Study||52
452364|NCT00615264|1079529|P1|NOT COMPLETED|Overall Study||50
452365|NCT00615264|1079528|P2|COMPLETED|Overall Study||180
452366|NCT00615264|1079529|P1|COMPLETED|Overall Study||175
452367|NCT00615264|1079528|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
452368|NCT00615264|1079529|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
452369|NCT00615264|1079528|P2|Received at Least One Dose (ITT)|Overall Study||231
452370|NCT00615264|1079529|P1|Received at Least One Dose (ITT)|Overall Study||225
452371|NCT00615264|1079528|P2|STARTED|Overall Study||232
452372|NCT00615264|1079529|P1|STARTED|Overall Study||225
452373|NCT00615199|1079541|P4|NOT COMPLETED|Overall Study||2
452374|NCT00615199|1079542|P3|NOT COMPLETED|Overall Study||1
452375|NCT00615199|1079543|P2|NOT COMPLETED|Overall Study||2
452376|NCT00615199|1079544|P1|NOT COMPLETED|Overall Study||8
452377|NCT00615199|1079541|P4|COMPLETED|Overall Study||33
452379|NCT00615199|1079543|P2|COMPLETED|Overall Study||34
452380|NCT00615199|1079544|P1|COMPLETED|Overall Study||26
452381|NCT00615199|1079541|P4|STARTED|Overall Study||35
452382|NCT00615199|1079542|P3|STARTED|Overall Study||34
452383|NCT00615199|1079543|P2|STARTED|Overall Study||36
452384|NCT00615199|1079544|P1|STARTED|Overall Study||34
452385|NCT00615108|1079578|P1|NOT COMPLETED|Overall Study||507
452386|NCT00615108|1079578|P1|COMPLETED|Overall Study||2641
452387|NCT00615108|1079578|P1|STARTED|Overall Study||3148
452388|NCT00615069|1079593|P1|NOT COMPLETED|Overall Study||16
452389|NCT00615069|1079593|P1|COMPLETED|Overall Study||19
452390|NCT00615069|1079593|P1|STARTED|Overall Study||35
452391|NCT00615056|1079602|P4|NOT COMPLETED|Overall Study||35
452392|NCT00615056|1079603|P3|NOT COMPLETED|Overall Study||36
452393|NCT00615056|1079604|P2|NOT COMPLETED|Overall Study||51
452394|NCT00615056|1079605|P1|NOT COMPLETED|Overall Study||49
452395|NCT00615056|1079602|P4|COMPLETED|Overall Study||0
452396|NCT00615056|1079603|P3|COMPLETED|Overall Study||0
452397|NCT00615056|1079604|P2|COMPLETED|Overall Study||0
452398|NCT00615056|1079605|P1|COMPLETED|Overall Study||0
452399|NCT00615056|1079602|P4|Treated|Overall Study||35
452400|NCT00615056|1079603|P3|Treated|Overall Study||36
452401|NCT00615056|1079604|P2|Treated|Overall Study||51
452402|NCT00615056|1079605|P1|Treated|Overall Study||46
452403|NCT00615056|1079602|P4|STARTED|Overall Study||35
452404|NCT00615056|1079603|P3|STARTED|Overall Study||36
452405|NCT00615056|1079604|P2|STARTED|Overall Study||51
452406|NCT00615056|1079605|P1|STARTED|Overall Study||49
452407|NCT00615030|1079635|P12|NOT COMPLETED|Period III||0
452408|NCT00615030|1079636|P11|NOT COMPLETED|Period III||0
452409|NCT00615030|1079637|P10|NOT COMPLETED|Period III||0
452410|NCT00615030|1079638|P9|NOT COMPLETED|Period III||0
452411|NCT00615030|1079639|P8|NOT COMPLETED|Period III||0
452412|NCT00615030|1079640|P7|NOT COMPLETED|Period III||0
452413|NCT00615030|1079641|P6|NOT COMPLETED|Period III||0
452414|NCT00615030|1079642|P5|NOT COMPLETED|Period III||0
452415|NCT00615030|1079643|P4|NOT COMPLETED|Period III||1
452416|NCT00615030|1079644|P3|NOT COMPLETED|Period III||0
452417|NCT00615030|1079645|P2|NOT COMPLETED|Period III||0
452418|NCT00615030|1079646|P1|NOT COMPLETED|Period III||1
452419|NCT00615030|1079635|P12|COMPLETED|Period III||6
452420|NCT00615030|1079636|P11|COMPLETED|Period III||7
452421|NCT00615030|1079637|P10|COMPLETED|Period III||8
452422|NCT00615030|1079638|P9|COMPLETED|Period III||7
452423|NCT00615030|1079639|P8|COMPLETED|Period III||7
452424|NCT00615030|1079640|P7|COMPLETED|Period III||6
452425|NCT00615030|1079641|P6|COMPLETED|Period III||5
452426|NCT00615030|1079642|P5|COMPLETED|Period III||8
452427|NCT00615030|1079643|P4|COMPLETED|Period III||6
452428|NCT00615030|1079644|P3|COMPLETED|Period III||8
452429|NCT00615030|1079645|P2|COMPLETED|Period III||8
452430|NCT00615030|1079646|P1|COMPLETED|Period III||7
452431|NCT00615030|1079635|P12|STARTED|Period III||6
452432|NCT00615030|1079636|P11|STARTED|Period III||7
452433|NCT00615030|1079637|P10|STARTED|Period III||8
452434|NCT00615030|1079638|P9|STARTED|Period III||7
452435|NCT00615030|1079639|P8|STARTED|Period III||7
452436|NCT00615030|1079640|P7|STARTED|Period III||6
452437|NCT00615030|1079641|P6|STARTED|Period III||5
452438|NCT00615030|1079642|P5|STARTED|Period III||8
452439|NCT00615030|1079643|P4|STARTED|Period III||7
452440|NCT00615030|1079644|P3|STARTED|Period III||8
452441|NCT00615030|1079645|P2|STARTED|Period III||8
452442|NCT00615030|1079646|P1|STARTED|Period III||8
452443|NCT00615030|1079635|P12|NOT COMPLETED|Period II||0
452444|NCT00615030|1079636|P11|NOT COMPLETED|Period II||0
452445|NCT00615030|1079637|P10|NOT COMPLETED|Period II||0
452446|NCT00615030|1079638|P9|NOT COMPLETED|Period II||1
452447|NCT00615030|1079639|P8|NOT COMPLETED|Period II||0
452448|NCT00615030|1079640|P7|NOT COMPLETED|Period II||1
452449|NCT00615030|1079641|P6|NOT COMPLETED|Period II||0
452450|NCT00615030|1079642|P5|NOT COMPLETED|Period II||0
452451|NCT00615030|1079643|P4|NOT COMPLETED|Period II||1
452452|NCT00615030|1079644|P3|NOT COMPLETED|Period II||1
452453|NCT00615030|1079645|P2|NOT COMPLETED|Period II||0
452454|NCT00615030|1079646|P1|NOT COMPLETED|Period II||0
452455|NCT00615030|1079635|P12|COMPLETED|Period II||6
452456|NCT00615030|1079636|P11|COMPLETED|Period II||7
452457|NCT00615030|1079637|P10|COMPLETED|Period II||8
452458|NCT00615030|1079638|P9|COMPLETED|Period II||7
452459|NCT00615030|1079639|P8|COMPLETED|Period II||7
452460|NCT00615030|1079640|P7|COMPLETED|Period II||6
452461|NCT00615030|1079641|P6|COMPLETED|Period II||5
452462|NCT00615030|1079642|P5|COMPLETED|Period II||8
452463|NCT00615030|1079643|P4|COMPLETED|Period II||7
452464|NCT00615030|1079644|P3|COMPLETED|Period II||8
452465|NCT00615030|1079645|P2|COMPLETED|Period II||8
452466|NCT00615030|1079646|P1|COMPLETED|Period II||8
452467|NCT00615030|1079635|P12|STARTED|Period II||6
452468|NCT00615030|1079636|P11|STARTED|Period II||7
452469|NCT00615030|1079637|P10|STARTED|Period II||8
452470|NCT00615030|1079638|P9|STARTED|Period II||8
452471|NCT00615030|1079639|P8|STARTED|Period II||7
452472|NCT00615030|1079640|P7|STARTED|Period II||7
452473|NCT00615030|1079641|P6|STARTED|Period II||5
452474|NCT00615030|1079642|P5|STARTED|Period II||8
452475|NCT00615030|1079643|P4|STARTED|Period II||8
452476|NCT00615030|1079644|P3|STARTED|Period II||9
452477|NCT00615030|1079645|P2|STARTED|Period II||8
452478|NCT00615030|1079646|P1|STARTED|Period II||8
452479|NCT00615030|1079635|P12|NOT COMPLETED|Period I||1
452480|NCT00615030|1079636|P11|NOT COMPLETED|Period I||1
452481|NCT00615030|1079637|P10|NOT COMPLETED|Period I||0
452482|NCT00615030|1079638|P9|NOT COMPLETED|Period I||1
452483|NCT00615030|1079639|P8|NOT COMPLETED|Period I||0
452484|NCT00615030|1079640|P7|NOT COMPLETED|Period I||0
452485|NCT00615030|1079641|P6|NOT COMPLETED|Period I||1
452486|NCT00615030|1079642|P5|NOT COMPLETED|Period I||1
452487|NCT00615030|1079643|P4|NOT COMPLETED|Period I||0
452488|NCT00615030|1079644|P3|NOT COMPLETED|Period I||0
452489|NCT00615030|1079645|P2|NOT COMPLETED|Period I||0
452490|NCT00615030|1079646|P1|NOT COMPLETED|Period I||1
452491|NCT00615030|1079635|P12|COMPLETED|Period I||6
452492|NCT00615030|1079636|P11|COMPLETED|Period I||7
452493|NCT00615030|1079637|P10|COMPLETED|Period I||8
452494|NCT00615030|1079638|P9|COMPLETED|Period I||8
452495|NCT00615030|1079639|P8|COMPLETED|Period I||7
452496|NCT00615030|1079640|P7|COMPLETED|Period I||7
452497|NCT00615030|1079641|P6|COMPLETED|Period I||5
452498|NCT00615030|1079642|P5|COMPLETED|Period I||8
452499|NCT00615030|1079643|P4|COMPLETED|Period I||8
452500|NCT00615030|1079644|P3|COMPLETED|Period I||9
452501|NCT00615030|1079645|P2|COMPLETED|Period I||8
452502|NCT00615030|1079646|P1|COMPLETED|Period I||8
452503|NCT00615030|1079635|P12|STARTED|Period I||7
452504|NCT00615030|1079636|P11|STARTED|Period I||8
452505|NCT00615030|1079637|P10|STARTED|Period I||8
452506|NCT00615030|1079638|P9|STARTED|Period I||9
452507|NCT00615030|1079639|P8|STARTED|Period I||7
452508|NCT00615030|1079640|P7|STARTED|Period I||7
452509|NCT00615030|1079641|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
452510|NCT00615030|1079642|P5|STARTED|Period I||9
452511|NCT00615030|1079643|P4|STARTED|Period I||8
452512|NCT00615030|1079644|P3|STARTED|Period I||9
452513|NCT00615030|1079645|P2|STARTED|Period I||8
452514|NCT00615030|1079646|P1|STARTED|Period I||9
452515|NCT00615017|1079666|P6|NOT COMPLETED|Overall Study||3
452516|NCT00615017|1079667|P5|NOT COMPLETED|Overall Study||1
452517|NCT00615017|1079668|P4|NOT COMPLETED|Overall Study||1
452518|NCT00615017|1079669|P3|NOT COMPLETED|Overall Study||5
452519|NCT00615017|1079670|P2|NOT COMPLETED|Overall Study||1
452520|NCT00615017|1079671|P1|NOT COMPLETED|Overall Study||0
452521|NCT00615017|1079666|P6|COMPLETED|Overall Study|Patient completed the study drug|20
452522|NCT00615017|1079667|P5|COMPLETED|Overall Study|Patient completed the study drug|7
452523|NCT00615017|1079668|P4|COMPLETED|Overall Study|Patient completed the study drug|9
452524|NCT00615017|1079669|P3|COMPLETED|Overall Study|Patient completed the study drug|7
452525|NCT00615017|1079670|P2|COMPLETED|Overall Study|Patient completed the study drug|8
452526|NCT00615017|1079671|P1|COMPLETED|Overall Study|Patient completed the study drug|8
452527|NCT00615017|1079666|P6|STARTED|Overall Study|Patients received treatment|23
452528|NCT00615017|1079667|P5|STARTED|Overall Study|Patients received treatment|8
452529|NCT00615017|1079668|P4|STARTED|Overall Study|Patients received treatment|10
452530|NCT00615017|1079669|P3|STARTED|Overall Study|Patients received treatment|12
452531|NCT00615017|1079670|P2|STARTED|Overall Study|Patients received treatment|9
452532|NCT00615017|1079671|P1|STARTED|Overall Study|Patients received treatment|8
452533|NCT00614991|1079829|P6|NOT COMPLETED|Overall Study||0
452534|NCT00614991|1079830|P5|NOT COMPLETED|Overall Study||1
452535|NCT00614991|1079831|P4|NOT COMPLETED|Overall Study||0
452536|NCT00614991|1079832|P3|NOT COMPLETED|Overall Study||0
452537|NCT00614991|1079833|P2|NOT COMPLETED|Overall Study||3
452538|NCT00614991|1079834|P1|NOT COMPLETED|Overall Study||3
452539|NCT00614991|1079829|P6|COMPLETED|Overall Study||6
452540|NCT00614991|1079830|P5|COMPLETED|Overall Study||6
452541|NCT00614991|1079831|P4|COMPLETED|Overall Study||7
452542|NCT00614991|1079832|P3|COMPLETED|Overall Study||7
452543|NCT00614991|1079833|P2|COMPLETED|Overall Study||6
452544|NCT00614991|1079834|P1|COMPLETED|Overall Study||5
452545|NCT00614991|1079829|P6|STARTED|Overall Study||6
452546|NCT00614991|1079830|P5|STARTED|Overall Study||7
452547|NCT00614991|1079831|P4|STARTED|Overall Study||7
452548|NCT00614991|1079832|P3|STARTED|Overall Study||7
452549|NCT00614991|1079833|P2|STARTED|Overall Study||9
452550|NCT00614991|1079834|P1|STARTED|Overall Study||8
452551|NCT00614939|1079868|P2|NOT COMPLETED|Overall Study||43
452552|NCT00614939|1079869|P1|NOT COMPLETED|Overall Study||35
452553|NCT00614939|1079868|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
452554|NCT00614939|1079869|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
452555|NCT00614939|1079868|P2|STARTED|Overall Study|Randomized and treated|85
452556|NCT00614939|1079869|P1|STARTED|Overall Study|Randomized and treated|85
452557|NCT00614926|1079903|P2|NOT COMPLETED|Overall Study||0
452558|NCT00614926|1079904|P1|NOT COMPLETED|Overall Study||4
452559|NCT00614926|1079903|P2|COMPLETED|Overall Study||7
452560|NCT00614926|1079904|P1|COMPLETED|Overall Study||21
452561|NCT00614926|1079903|P2|STARTED|Overall Study||7
452562|NCT00614926|1079904|P1|STARTED|Overall Study||25
452563|NCT00614913|1079912|P1|NOT COMPLETED|Overall Study||0
452564|NCT00614913|1079912|P1|COMPLETED|Overall Study||76
452565|NCT00614913|1079912|P1|STARTED|Overall Study||76
452566|NCT00614874|1079917|P1|NOT COMPLETED|Overall Study||2
452567|NCT00614874|1079917|P1|COMPLETED|Overall Study||14
452568|NCT00614874|1079917|P1|STARTED|Overall Study||16
452569|NCT00614614|1079926|P5|NOT COMPLETED|Booster Vaccination Phase||13
452570|NCT00614614|1079927|P4|NOT COMPLETED|Booster Vaccination Phase||19
452571|NCT00614614|1079928|P3|NOT COMPLETED|Booster Vaccination Phase||27
452572|NCT00614614|1079929|P2|NOT COMPLETED|Booster Vaccination Phase||6
452573|NCT00614614|1079930|P1|NOT COMPLETED|Booster Vaccination Phase||0
452574|NCT00614614|1079926|P5|COMPLETED|Booster Vaccination Phase||396
452575|NCT00614614|1079927|P4|COMPLETED|Booster Vaccination Phase||210
452576|NCT00614614|1079928|P3|COMPLETED|Booster Vaccination Phase||405
452577|NCT00614614|1079929|P2|COMPLETED|Booster Vaccination Phase||227
452578|NCT00614614|1079930|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
452579|NCT00614614|1079926|P5|STARTED|Booster Vaccination Phase||409
452580|NCT00614614|1079927|P4|STARTED|Booster Vaccination Phase||229
452581|NCT00614614|1079928|P3|STARTED|Booster Vaccination Phase||432
452582|NCT00614614|1079929|P2|STARTED|Booster Vaccination Phase||233
452583|NCT00614614|1079930|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
452584|NCT00614614|1079926|P5|NOT COMPLETED|Primary Vaccination Phase||0
452585|NCT00614614|1079927|P4|NOT COMPLETED|Primary Vaccination Phase||0
452586|NCT00614614|1079928|P3|NOT COMPLETED|Primary Vaccination Phase||0
452587|NCT00614614|1079929|P2|NOT COMPLETED|Primary Vaccination Phase||17
452588|NCT00614614|1079930|P1|NOT COMPLETED|Primary Vaccination Phase||90
452589|NCT00614614|1079926|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
452590|NCT00614614|1079927|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
452591|NCT00614614|1079928|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
452592|NCT00614614|1079929|P2|COMPLETED|Primary Vaccination Phase||265
452593|NCT00614614|1079930|P1|COMPLETED|Primary Vaccination Phase||1182
452594|NCT00614614|1079926|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
452595|NCT00614614|1079927|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
452596|NCT00614614|1079928|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
452597|NCT00614614|1079929|P2|STARTED|Primary Vaccination Phase||282
452598|NCT00614614|1079930|P1|STARTED|Primary Vaccination Phase||1272
452599|NCT00614575|1080053|P1|NOT COMPLETED|Overall Study||228
452600|NCT00614575|1080053|P1|COMPLETED|Overall Study||861
452601|NCT00614575|1080053|P1|STARTED|Overall Study|The number of patients enrolled.|1089
452602|NCT00614523|1080064|P2|NOT COMPLETED|Overall Study||131
452603|NCT00614523|1080065|P1|NOT COMPLETED|Overall Study||63
452604|NCT00614523|1080064|P2|COMPLETED|Overall Study||36
452605|NCT00614523|1080065|P1|COMPLETED|Overall Study||20
452606|NCT00614523|1080064|P2|STARTED|Overall Study||167
452607|NCT00614523|1080065|P1|STARTED|Overall Study||83
452608|NCT00614484|1080089|P1|NOT COMPLETED|Overall Study||0
452609|NCT00614484|1080089|P1|COMPLETED|Overall Study||28
452610|NCT00614484|1080089|P1|STARTED|Overall Study||28
452611|NCT00614458|1080094|P1|NOT COMPLETED|Overall Study||0
452612|NCT00614458|1080094|P1|COMPLETED|Overall Study||6
452613|NCT00614458|1080094|P1|STARTED|Overall Study||6
452614|NCT00614445|1080100|P2|NOT COMPLETED|Overall Study||49
452615|NCT00614445|1080101|P1|NOT COMPLETED|Overall Study||28
452616|NCT00614445|1080100|P2|COMPLETED|Overall Study||91
452617|NCT00614445|1080101|P1|COMPLETED|Overall Study||112
452618|NCT00614445|1080100|P2|STARTED|Overall Study||140
452619|NCT00614445|1080101|P1|STARTED|Overall Study||140
452620|NCT00614406|1080109|P2|NOT COMPLETED|Overall Study||0
452621|NCT00614406|1080110|P1|NOT COMPLETED|Overall Study||0
452622|NCT00614406|1080109|P2|COMPLETED|Overall Study||4
452623|NCT00614406|1080110|P1|COMPLETED|Overall Study||7
452624|NCT00614406|1080109|P2|STARTED|Overall Study||4
452625|NCT00614406|1080110|P1|STARTED|Overall Study||7
452626|NCT00614393|1080121|P5|NOT COMPLETED|Overall Study||180
452627|NCT00614393|1080122|P4|NOT COMPLETED|Overall Study||180
452628|NCT00614393|1080123|P3|NOT COMPLETED|Overall Study||10
452629|NCT00614393|1080124|P2|NOT COMPLETED|Overall Study||8
452630|NCT00614393|1080125|P1|NOT COMPLETED|Overall Study||180
452631|NCT00614393|1080121|P5|COMPLETED|Overall Study||0
452632|NCT00614393|1080122|P4|COMPLETED|Overall Study||0
452633|NCT00614393|1080123|P3|COMPLETED|Overall Study||0
452634|NCT00614393|1080124|P2|COMPLETED|Overall Study||0
452635|NCT00614393|1080125|P1|COMPLETED|Overall Study||0
452636|NCT00614393|1080121|P5|Treated|Overall Study||178
452637|NCT00614393|1080122|P4|Treated|Overall Study||180
452638|NCT00614393|1080123|P3|Treated|Overall Study||10
452639|NCT00614393|1080124|P2|Treated|Overall Study||8
452640|NCT00614393|1080125|P1|Treated|Overall Study||180
452641|NCT00614393|1080121|P5|STARTED|Overall Study||180
452642|NCT00614393|1080122|P4|STARTED|Overall Study||180
452643|NCT00614393|1080123|P3|STARTED|Overall Study||10
452644|NCT00614393|1080124|P2|STARTED|Overall Study||8
452645|NCT00614393|1080125|P1|STARTED|Overall Study||180
452646|NCT00614380|1080171|P4|NOT COMPLETED|Overall Study||2
452647|NCT00614380|1080172|P3|NOT COMPLETED|Overall Study||1
452648|NCT00614380|1080173|P2|NOT COMPLETED|Overall Study||8
452649|NCT00614380|1080174|P1|NOT COMPLETED|Overall Study||35
452650|NCT00614380|1080171|P4|COMPLETED|Overall Study||179
452651|NCT00614380|1080172|P3|COMPLETED|Overall Study||24
452652|NCT00614380|1080173|P2|COMPLETED|Overall Study||198
452653|NCT00614380|1080174|P1|COMPLETED|Overall Study||529
452654|NCT00614380|1080171|P4|STARTED|Overall Study||181
452655|NCT00614380|1080172|P3|STARTED|Overall Study||25
452656|NCT00614380|1080173|P2|STARTED|Overall Study||206
452657|NCT00614380|1080174|P1|STARTED|Overall Study||564
452658|NCT00614315|1080223|P1|NOT COMPLETED|Overall Study||0
452659|NCT00614315|1080223|P1|COMPLETED|Overall Study||30
452660|NCT00614315|1080223|P1|STARTED|Overall Study||30
452661|NCT00614198|1080230|P2|NOT COMPLETED|Stage 2||12
452662|NCT00614198|1080231|P1|NOT COMPLETED|Stage 2||8
452663|NCT00614198|1080230|P2|COMPLETED|Stage 2||17
452664|NCT00614198|1080231|P1|COMPLETED|Stage 2||18
452665|NCT00614198|1080230|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
452666|NCT00614198|1080231|P1|STARTED|Stage 2||26
452667|NCT00614198|1080230|P2|NOT COMPLETED|Stage 1||5
452668|NCT00614198|1080231|P1|NOT COMPLETED|Stage 1||12
452669|NCT00614198|1080230|P2|COMPLETED|Stage 1||29
452670|NCT00614198|1080231|P1|COMPLETED|Stage 1||26
452671|NCT00614198|1080230|P2|STARTED|Stage 1||34
452672|NCT00614198|1080231|P1|STARTED|Stage 1||38
452673|NCT00614120|1080241|P4|NOT COMPLETED|Overall Study||16
452674|NCT00614120|1080242|P3|NOT COMPLETED|Overall Study||59
452675|NCT00614120|1080243|P2|NOT COMPLETED|Overall Study||46
452676|NCT00614120|1080244|P1|NOT COMPLETED|Overall Study||29
452677|NCT00614120|1080241|P4|COMPLETED|Overall Study||215
452678|NCT00614120|1080242|P3|COMPLETED|Overall Study||175
452679|NCT00614120|1080243|P2|COMPLETED|Overall Study||187
452680|NCT00614120|1080244|P1|COMPLETED|Overall Study||202
452681|NCT00614120|1080241|P4|Exposed to Study Drug|Overall Study||231
452682|NCT00614120|1080242|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
452683|NCT00614120|1080243|P2|Exposed to Study Drug|Overall Study||233
452684|NCT00614120|1080244|P1|Exposed to Study Drug|Overall Study||231
452685|NCT00614120|1080241|P4|STARTED|Overall Study|Randomised|231
452686|NCT00614120|1080242|P3|STARTED|Overall Study|Randomised|234
452687|NCT00614120|1080243|P2|STARTED|Overall Study|Randomised|233
452688|NCT00614120|1080244|P1|STARTED|Overall Study|Randomised|231
452689|NCT00614055|1080285|P3|NOT COMPLETED|Overall Study||5
452690|NCT00614055|1080286|P2|NOT COMPLETED|Overall Study||6
452691|NCT00614055|1080287|P1|NOT COMPLETED|Overall Study||4
452692|NCT00614055|1080285|P3|COMPLETED|Overall Study||55
452693|NCT00614055|1080286|P2|COMPLETED|Overall Study||53
452694|NCT00614055|1080287|P1|COMPLETED|Overall Study||55
452695|NCT00614055|1080285|P3|Exposed|Overall Study||60
452696|NCT00614055|1080286|P2|Exposed|Overall Study||59
452697|NCT00614055|1080287|P1|Exposed|Overall Study||59
452698|NCT00614055|1080285|P3|STARTED|Overall Study||60
452699|NCT00614055|1080286|P2|STARTED|Overall Study||59
452700|NCT00614055|1080287|P1|STARTED|Overall Study||59
452701|NCT00613951|1080334|P3|NOT COMPLETED|Overall Study||5
452702|NCT00613951|1080335|P2|NOT COMPLETED|Overall Study||5
452703|NCT00613951|1080336|P1|NOT COMPLETED|Overall Study||7
452704|NCT00613951|1080334|P3|COMPLETED|Overall Study||57
452705|NCT00613951|1080335|P2|COMPLETED|Overall Study||54
452706|NCT00613951|1080336|P1|COMPLETED|Overall Study||54
452707|NCT00613951|1080334|P3|Exposed|Overall Study||62
452708|NCT00613951|1080335|P2|Exposed|Overall Study||59
452709|NCT00613951|1080336|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
452710|NCT00613951|1080334|P3|STARTED|Overall Study||62
452711|NCT00613951|1080335|P2|STARTED|Overall Study||59
452712|NCT00613951|1080336|P1|STARTED|Overall Study||61
452713|NCT00613938|1080381|P4|NOT COMPLETED|Overall Study||26
452714|NCT00613938|1080382|P3|NOT COMPLETED|Overall Study||23
452715|NCT00613938|1080383|P2|NOT COMPLETED|Overall Study||28
452716|NCT00613938|1080384|P1|NOT COMPLETED|Overall Study||20
452717|NCT00613938|1080381|P4|COMPLETED|Overall Study||253
452718|NCT00613938|1080382|P3|COMPLETED|Overall Study||255
452719|NCT00613938|1080383|P2|COMPLETED|Overall Study||247
452720|NCT00613938|1080384|P1|COMPLETED|Overall Study||49
452721|NCT00613938|1080381|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
452722|NCT00613938|1080382|P3|STARTED|Overall Study||278
452723|NCT00613938|1080383|P2|STARTED|Overall Study||275
452724|NCT00613938|1080384|P1|STARTED|Overall Study||69
452725|NCT00613925|1080416|P2|NOT COMPLETED|Overall Study||1
452726|NCT00613925|1080417|P1|NOT COMPLETED|Overall Study||0
452727|NCT00613925|1080416|P2|COMPLETED|Overall Study||32
452728|NCT00613925|1080417|P1|COMPLETED|Overall Study||37
452729|NCT00613925|1080416|P2|STARTED|Overall Study||33
452730|NCT00613925|1080417|P1|STARTED|Overall Study||37
452731|NCT00613730|1080425|P1|NOT COMPLETED|Overall Study||3
452732|NCT00613730|1080425|P1|COMPLETED|Overall Study||0
452733|NCT00613730|1080425|P1|STARTED|Overall Study||3
452734|NCT00613626|1080434|P3|NOT COMPLETED|Overall Study||0
452735|NCT00613626|1080435|P2|NOT COMPLETED|Overall Study||1
452736|NCT00613626|1080436|P1|NOT COMPLETED|Overall Study||0
452737|NCT00613626|1080434|P3|COMPLETED|Overall Study||7
452738|NCT00613626|1080435|P2|COMPLETED|Overall Study||33
452739|NCT00613626|1080436|P1|COMPLETED|Overall Study||33
452740|NCT00613626|1080434|P3|1st Dose ZD6474|Overall Study||7
452741|NCT00613626|1080435|P2|1st Dose ZD6474|Overall Study||34
452742|NCT00613626|1080436|P1|1st Dose ZD6474|Overall Study||33
452743|NCT00613626|1080434|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
452744|NCT00613626|1080435|P2|STARTED|Overall Study||34
452745|NCT00613626|1080436|P1|STARTED|Overall Study||33
452746|NCT00613574|1080452|P1|NOT COMPLETED|Overall Study||6
452747|NCT00613574|1080452|P1|COMPLETED|Overall Study||401
452748|NCT00613574|1080452|P1|STARTED|Overall Study||407
452749|NCT00613509|1080464|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
452750|NCT00613509|1080465|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
452751|NCT00613509|1080464|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
452752|NCT00613509|1080465|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
452753|NCT00613509|1080464|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
452754|NCT00613509|1080465|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
452755|NCT00613509|1080464|P2|NOT COMPLETED|Cycle 1||8
452756|NCT00613509|1080465|P1|NOT COMPLETED|Cycle 1||5
452757|NCT00613509|1080464|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
452758|NCT00613509|1080465|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
452759|NCT00613509|1080464|P2|STARTED|Cycle 1||12
452760|NCT00613509|1080465|P1|STARTED|Cycle 1||11
452761|NCT00613405|1080489|P2|NOT COMPLETED|Overall Study||0
452762|NCT00613405|1080490|P1|NOT COMPLETED|Overall Study||0
452763|NCT00613405|1080489|P2|COMPLETED|Overall Study||42
452764|NCT00613405|1080490|P1|COMPLETED|Overall Study||45
452765|NCT00613405|1080489|P2|STARTED|Overall Study||42
452766|NCT00613405|1080490|P1|STARTED|Overall Study||45
452767|NCT00613379|1080499|P3|NOT COMPLETED|Overall Study||0
452768|NCT00613379|1080500|P2|NOT COMPLETED|Overall Study||0
452769|NCT00613379|1080501|P1|NOT COMPLETED|Overall Study||0
452770|NCT00613379|1080499|P3|COMPLETED|Overall Study||11
452771|NCT00613379|1080500|P2|COMPLETED|Overall Study||10
452772|NCT00613379|1080501|P1|COMPLETED|Overall Study||10
452773|NCT00613379|1080499|P3|STARTED|Overall Study||11
452774|NCT00613379|1080500|P2|STARTED|Overall Study||10
452775|NCT00613379|1080501|P1|STARTED|Overall Study||10
452776|NCT00613366|1080511|P2|NOT COMPLETED|Overall Study||2
452777|NCT00613366|1080512|P1|NOT COMPLETED|Overall Study||3
452778|NCT00613366|1080511|P2|COMPLETED|Overall Study||18
452779|NCT00613366|1080512|P1|COMPLETED|Overall Study||17
452780|NCT00613366|1080511|P2|STARTED|Overall Study||20
452781|NCT00613366|1080512|P1|STARTED|Overall Study||20
452782|NCT00613327|1080520|P1|NOT COMPLETED|Overall Study||101
452783|NCT00613327|1080520|P1|COMPLETED|Overall Study||244
452784|NCT00613327|1080520|P1|STARTED|Overall Study||345
452785|NCT00613314|1080539|P1|NOT COMPLETED|Overall Study||155
452786|NCT00613314|1080539|P1|COMPLETED|Overall Study||15113
452787|NCT00613314|1080539|P1|STARTED|Overall Study||15268
452788|NCT00613301|1080547|P1|NOT COMPLETED|Overall Study||228
452789|NCT00613301|1080547|P1|COMPLETED|Overall Study||188
452790|NCT00613301|1080547|P1|STARTED|Overall Study||416
452791|NCT00613106|1080556|P2|NOT COMPLETED|Overall Study||9
452792|NCT00613106|1080557|P1|NOT COMPLETED|Overall Study||20
452793|NCT00613106|1080556|P2|COMPLETED|Overall Study||38
452794|NCT00613106|1080557|P1|COMPLETED|Overall Study||112
452795|NCT00613106|1080556|P2|STARTED|Overall Study||47
452796|NCT00613106|1080557|P1|STARTED|Overall Study||132
452797|NCT00613080|1080563|P1|NOT COMPLETED|Overall Study||11
452798|NCT00613080|1080563|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
452799|NCT00613080|1080563|P1|STARTED|Overall Study||79
452800|NCT00613028|1080569|P2|NOT COMPLETED|Overall Study||1
452801|NCT00613028|1080570|P1|NOT COMPLETED|Overall Study||0
452802|NCT00613028|1080569|P2|COMPLETED|Overall Study||12
452803|NCT00613028|1080570|P1|COMPLETED|Overall Study||10
452804|NCT00613028|1080569|P2|STARTED|Overall Study||13
452805|NCT00613028|1080570|P1|STARTED|Overall Study||10
452806|NCT00613015|1080590|P6|NOT COMPLETED|Overall Study||3
452807|NCT00613015|1080591|P5|NOT COMPLETED|Overall Study||2
452808|NCT00613015|1080592|P4|NOT COMPLETED|Overall Study||3
452809|NCT00613015|1080593|P3|NOT COMPLETED|Overall Study||3
452810|NCT00613015|1080594|P2|NOT COMPLETED|Overall Study||1
452811|NCT00613015|1080595|P1|NOT COMPLETED|Overall Study||0
452812|NCT00613015|1080590|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
452813|NCT00613015|1080591|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
452814|NCT00613015|1080592|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
452815|NCT00613015|1080593|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
452816|NCT00613015|1080594|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
452817|NCT00613015|1080595|P1|COMPLETED|Overall Study||13
452818|NCT00613015|1080590|P6|STARTED|Overall Study||19
452819|NCT00613015|1080591|P5|STARTED|Overall Study||15
452820|NCT00613015|1080592|P4|STARTED|Overall Study||24
452821|NCT00613015|1080593|P3|STARTED|Overall Study||26
452822|NCT00613015|1080594|P2|STARTED|Overall Study||12
452823|NCT00613015|1080595|P1|STARTED|Overall Study||13
452824|NCT00612924|1080617|P2|NOT COMPLETED|Overall Study||9
452825|NCT00612924|1080618|P1|NOT COMPLETED|Overall Study||7
452826|NCT00612924|1080617|P2|COMPLETED|Overall Study||85
452827|NCT00612924|1080618|P1|COMPLETED|Overall Study||94
452828|NCT00612924|1080617|P2|STARTED|Overall Study||94
452829|NCT00612924|1080618|P1|STARTED|Overall Study||101
452830|NCT00612807|1080631|P2|NOT COMPLETED|Overall Study||0
452831|NCT00612807|1080632|P1|NOT COMPLETED|Overall Study||2
452832|NCT00612807|1080631|P2|COMPLETED|Overall Study||28
452833|NCT00612807|1080632|P1|COMPLETED|Overall Study||12
452834|NCT00612807|1080631|P2|STARTED|Overall Study||28
452835|NCT00612807|1080632|P1|STARTED|Overall Study||14
452836|NCT00612690|1080642|P2|NOT COMPLETED|Overall Study||118
452837|NCT00612690|1080643|P1|NOT COMPLETED|Overall Study||115
452838|NCT00612690|1080642|P2|COMPLETED|Overall Study||89
452839|NCT00612690|1080643|P1|COMPLETED|Overall Study||160
452840|NCT00612690|1080642|P2|STARTED|Overall Study||207
452841|NCT00612690|1080643|P1|STARTED|Overall Study||275
452842|NCT00612677|1080651|P1|NOT COMPLETED|Overall Study||1
452843|NCT00612677|1080651|P1|COMPLETED|Overall Study||0
452844|NCT00612677|1080651|P1|STARTED|Overall Study||1
452845|NCT00612573|1080661|P4|NOT COMPLETED|Overall Study||13
452846|NCT00612573|1080662|P3|NOT COMPLETED|Overall Study||9
452847|NCT00612573|1080663|P2|NOT COMPLETED|Overall Study||14
452848|NCT00612573|1080664|P1|NOT COMPLETED|Overall Study||12
452849|NCT00612573|1080661|P4|COMPLETED|Overall Study||54
452850|NCT00612573|1080662|P3|COMPLETED|Overall Study||52
452851|NCT00612573|1080663|P2|COMPLETED|Overall Study||51
452852|NCT00612573|1080664|P1|COMPLETED|Overall Study||52
452853|NCT00612573|1080661|P4|STARTED|Overall Study||67
452854|NCT00612573|1080662|P3|STARTED|Overall Study||61
452855|NCT00612573|1080663|P2|STARTED|Overall Study||65
452856|NCT00612573|1080664|P1|STARTED|Overall Study||64
452857|NCT00612534|1080690|P4|NOT COMPLETED|Overall Study||17
452858|NCT00612534|1080691|P3|NOT COMPLETED|Overall Study||7
452859|NCT00612534|1080692|P2|NOT COMPLETED|Overall Study||17
452860|NCT00612534|1080693|P1|NOT COMPLETED|Overall Study||13
452861|NCT00612534|1080690|P4|COMPLETED|Overall Study||7
452862|NCT00612534|1080691|P3|COMPLETED|Overall Study||13
452863|NCT00612534|1080692|P2|COMPLETED|Overall Study||9
452864|NCT00612534|1080693|P1|COMPLETED|Overall Study||11
452865|NCT00612534|1080690|P4|STARTED|Overall Study||24
452866|NCT00612534|1080691|P3|STARTED|Overall Study||20
452867|NCT00612534|1080692|P2|STARTED|Overall Study||26
452868|NCT00612534|1080693|P1|STARTED|Overall Study||24
452869|NCT00612508|1080705|P2|NOT COMPLETED|Overall Study||4
452870|NCT00612508|1080706|P1|NOT COMPLETED|Overall Study||3
452871|NCT00612508|1080705|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
452872|NCT00612508|1080706|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
452873|NCT00612508|1080705|P2|STARTED|Overall Study||7
452874|NCT00612508|1080706|P1|STARTED|Overall Study||7
452875|NCT00612430|1080716|P2|NOT COMPLETED|Overall Study||0
452876|NCT00612430|1080717|P1|NOT COMPLETED|Overall Study||0
452877|NCT00612430|1080716|P2|COMPLETED|Overall Study||27
452878|NCT00612430|1080717|P1|COMPLETED|Overall Study||32
452879|NCT00612430|1080716|P2|STARTED|Overall Study||27
452880|NCT00612430|1080717|P1|STARTED|Overall Study||32
452881|NCT00612352|1080733|P2|NOT COMPLETED|Overall Study||6
452882|NCT00612352|1080734|P1|NOT COMPLETED|Overall Study||9
452883|NCT00612352|1080733|P2|COMPLETED|Overall Study||109
452884|NCT00612352|1080734|P1|COMPLETED|Overall Study||56
452885|NCT00612352|1080733|P2|Placebo|Overall Study||4
452886|NCT00612352|1080734|P1|Placebo|Overall Study||4
452887|NCT00612352|1080733|P2|40%mg|Overall Study||0
452888|NCT00612352|1080734|P1|40%mg|Overall Study||1
452889|NCT00612352|1080733|P2|100%mg|Overall Study||1
452890|NCT00612352|1080734|P1|100%mg|Overall Study||2
452891|NCT00612352|1080733|P2|Placebo & 100%mg|Overall Study||0
452892|NCT00612352|1080734|P1|Placebo & 100%mg|Overall Study||1
452893|NCT00612352|1080733|P2|40%mg & 100%mg|Overall Study||1
452894|NCT00612352|1080734|P1|40%mg & 100%mg|Overall Study||1
452895|NCT00612352|1080733|P2|STARTED|Overall Study||115
452896|NCT00612352|1080734|P1|STARTED|Overall Study||65
452897|NCT00612339|1080848|P1|NOT COMPLETED|Overall Study||0
452898|NCT00612339|1080848|P1|COMPLETED|Overall Study||41
452899|NCT00612339|1080848|P1|STARTED|Overall Study||41
452900|NCT00612313|1080854|P2|NOT COMPLETED|Overall Study||13
452901|NCT00612313|1080855|P1|NOT COMPLETED|Overall Study||17
452902|NCT00612313|1080854|P2|COMPLETED|Overall Study||62
452903|NCT00612313|1080855|P1|COMPLETED|Overall Study||52
452904|NCT00612313|1080854|P2|STARTED|Overall Study||75
452905|NCT00612313|1080855|P1|STARTED|Overall Study||69
452906|NCT00612222|1080871|P1|NOT COMPLETED|Overall Study||0
452907|NCT00612222|1080871|P1|COMPLETED|Overall Study||4
452908|NCT00612222|1080871|P1|STARTED|Overall Study||4
452909|NCT00612105|1080879|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
452910|NCT00612105|1080880|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
452911|NCT00612105|1080879|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
452912|NCT00612105|1080880|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
452913|NCT00612105|1080879|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
452914|NCT00612105|1080880|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
452915|NCT00612105|1080879|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
452916|NCT00612105|1080880|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
452917|NCT00612105|1080879|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
452918|NCT00612105|1080880|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
452919|NCT00612105|1080879|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
452920|NCT00612105|1080880|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
452921|NCT00612105|1080879|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
452922|NCT00612105|1080880|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
452923|NCT00612105|1080879|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
452924|NCT00612105|1080880|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
452925|NCT00612105|1080879|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
452926|NCT00612105|1080880|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
452927|NCT00612066|1080930|P1|NOT COMPLETED|Overall Study||1
452928|NCT00612066|1080930|P1|COMPLETED|Overall Study||1
452929|NCT00612066|1080930|P1|STARTED|Overall Study||2
452930|NCT00612040|1080937|P3|NOT COMPLETED|Overall Study||7
452931|NCT00612040|1080938|P2|NOT COMPLETED|Overall Study||7
452932|NCT00612040|1080939|P1|NOT COMPLETED|Overall Study||5
452933|NCT00612040|1080937|P3|COMPLETED|Overall Study||52
452934|NCT00612040|1080938|P2|COMPLETED|Overall Study||52
452935|NCT00612040|1080939|P1|COMPLETED|Overall Study||55
452936|NCT00612040|1080937|P3|Exposed|Overall Study||59
452937|NCT00612040|1080938|P2|Exposed|Overall Study||59
452938|NCT00612040|1080939|P1|Exposed|Overall Study||60
452939|NCT00612040|1080937|P3|STARTED|Overall Study||59
452940|NCT00612040|1080938|P2|STARTED|Overall Study||59
452941|NCT00612040|1080939|P1|STARTED|Overall Study||60
452942|NCT00611897|1080983|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
452943|NCT00611897|1080984|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
452944|NCT00611897|1080983|P2|COMPLETED|Day 2: Crossover Treatment||8
452945|NCT00611897|1080984|P1|COMPLETED|Day 2: Crossover Treatment||8
452946|NCT00611897|1080983|P2|STARTED|Day 2: Crossover Treatment||8
452947|NCT00611897|1080984|P1|STARTED|Day 2: Crossover Treatment||8
452948|NCT00611897|1080983|P2|NOT COMPLETED|Day 1: Initial Treatment||0
452949|NCT00611897|1080984|P1|NOT COMPLETED|Day 1: Initial Treatment||0
452950|NCT00611897|1080983|P2|COMPLETED|Day 1: Initial Treatment||8
452951|NCT00611897|1080984|P1|COMPLETED|Day 1: Initial Treatment||8
452952|NCT00611897|1080983|P2|STARTED|Day 1: Initial Treatment||8
452953|NCT00611897|1080984|P1|STARTED|Day 1: Initial Treatment||8
452954|NCT00611884|1081012|P4|NOT COMPLETED|Overall Study||6
452955|NCT00611884|1081013|P3|NOT COMPLETED|Overall Study||4
452956|NCT00611884|1081014|P2|NOT COMPLETED|Overall Study||9
452957|NCT00611884|1081015|P1|NOT COMPLETED|Overall Study||9
452958|NCT00611884|1081012|P4|COMPLETED|Overall Study||56
452959|NCT00611884|1081013|P3|COMPLETED|Overall Study||58
452960|NCT00611884|1081014|P2|COMPLETED|Overall Study||51
452961|NCT00611884|1081015|P1|COMPLETED|Overall Study||52
452962|NCT00611884|1081012|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
452963|NCT00611884|1081013|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
452964|NCT00611884|1081014|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
452965|NCT00611884|1081015|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
452966|NCT00611884|1081012|P4|STARTED|Overall Study||62
452967|NCT00611884|1081013|P3|STARTED|Overall Study||62
452968|NCT00611884|1081014|P2|STARTED|Overall Study||60
452969|NCT00611884|1081015|P1|STARTED|Overall Study||61
452970|NCT00611806|1081071|P2|NOT COMPLETED|Overall Study||3
452971|NCT00611806|1081072|P1|NOT COMPLETED|Overall Study||16
452972|NCT00611806|1081071|P2|COMPLETED|Overall Study||43
452973|NCT00611806|1081072|P1|COMPLETED|Overall Study||78
452974|NCT00611806|1081071|P2|STARTED|Overall Study||46
452975|NCT00611806|1081072|P1|STARTED|Overall Study||94
452976|NCT00611767|1081086|P2|NOT COMPLETED|Overall Study||2
452977|NCT00611767|1081087|P1|NOT COMPLETED|Overall Study||9
452978|NCT00611767|1081086|P2|COMPLETED|Overall Study||22
452979|NCT00611767|1081087|P1|COMPLETED|Overall Study||40
452980|NCT00611767|1081086|P2|Placebo Test Day|Overall Study||1
452981|NCT00611767|1081087|P1|Placebo Test Day|Overall Study||6
452982|NCT00611767|1081086|P2|Thiopental Test Day|Overall Study||1
452983|NCT00611767|1081087|P1|Thiopental Test Day|Overall Study||3
452984|NCT00611767|1081086|P2|STARTED|Overall Study||24
452985|NCT00611767|1081087|P1|STARTED|Overall Study||49
452986|NCT00611715|1081249|P2|NOT COMPLETED|Overall Study||6
452987|NCT00611715|1081250|P1|NOT COMPLETED|Overall Study||41
452988|NCT00611715|1081249|P2|COMPLETED|Overall Study||0
452989|NCT00611715|1081250|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
452990|NCT00611715|1081249|P2|STARTED|Overall Study||6
452991|NCT00611715|1081250|P1|STARTED|Overall Study||42
452992|NCT00611624|1081262|P1|NOT COMPLETED|Overall Study||0
452993|NCT00611624|1081262|P1|COMPLETED|Overall Study||28
452994|NCT00611624|1081262|P1|STARTED|Overall Study||28
452995|NCT00611559|1081270|P3|NOT COMPLETED|Overall Study||1
452996|NCT00611559|1081271|P2|NOT COMPLETED|Overall Study||1
452997|NCT00611559|1081272|P1|NOT COMPLETED|Overall Study||1
452998|NCT00611559|1081270|P3|COMPLETED|Overall Study||56
452999|NCT00611559|1081271|P2|COMPLETED|Overall Study||114
453000|NCT00611559|1081272|P1|COMPLETED|Overall Study||110
453001|NCT00611559|1081270|P3|STARTED|Overall Study||57
453002|NCT00611559|1081271|P2|STARTED|Overall Study||115
453003|NCT00611559|1081272|P1|STARTED|Overall Study||111
453004|NCT00611533|1081331|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
453005|NCT00611533|1081332|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
453006|NCT00611533|1081331|P2|COMPLETED|Second Intervention (6 Weeks)||4
453007|NCT00611533|1081332|P1|COMPLETED|Second Intervention (6 Weeks)||8
453008|NCT00611533|1081331|P2|STARTED|Second Intervention (6 Weeks)||6
453009|NCT00611533|1081332|P1|STARTED|Second Intervention (6 Weeks)||8
453010|NCT00611533|1081331|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
453011|NCT00611533|1081332|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
453012|NCT00611533|1081331|P2|COMPLETED|First Intervention (6 Weeks)||6
453013|NCT00611533|1081332|P1|COMPLETED|First Intervention (6 Weeks)||8
453014|NCT00611533|1081331|P2|STARTED|First Intervention (6 Weeks)||8
453015|NCT00611533|1081332|P1|STARTED|First Intervention (6 Weeks)||8
453016|NCT00611468|1081351|P4|NOT COMPLETED|Overall Study||0
453017|NCT00611468|1081352|P3|NOT COMPLETED|Overall Study||0
453018|NCT00611468|1081353|P2|NOT COMPLETED|Overall Study||1
453019|NCT00611468|1081354|P1|NOT COMPLETED|Overall Study||0
453020|NCT00611468|1081351|P4|COMPLETED|Overall Study||13
453021|NCT00611468|1081352|P3|COMPLETED|Overall Study||6
453022|NCT00611468|1081353|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
453023|NCT00611468|1081354|P1|COMPLETED|Overall Study||3
453024|NCT00611468|1081351|P4|STARTED|Overall Study||13
453025|NCT00611468|1081352|P3|STARTED|Overall Study||6
453026|NCT00611468|1081353|P2|STARTED|Overall Study||7
453027|NCT00611468|1081354|P1|STARTED|Overall Study||3
453028|NCT00611455|1081366|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
453029|NCT00611455|1081367|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
453030|NCT00611455|1081368|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
453031|NCT00611455|1081366|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
453032|NCT00611455|1081367|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
453033|NCT00611455|1081368|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
453034|NCT00611455|1081366|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
453035|NCT00611455|1081367|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
453036|NCT00611455|1081368|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
453037|NCT00611455|1081366|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
453038|NCT00611455|1081367|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
453039|NCT00611455|1081368|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
453040|NCT00611455|1081366|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
453041|NCT00611455|1081367|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
453042|NCT00611455|1081368|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
453043|NCT00611455|1081366|P3|STARTED|OL Treatment Period (120 Weeks)||0
453044|NCT00611455|1081367|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
453045|NCT00611455|1081368|P1|STARTED|OL Treatment Period (120 Weeks)||0
453046|NCT00611455|1081366|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
453047|NCT00611455|1081367|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
453048|NCT00611455|1081368|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
453049|NCT00611455|1081366|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
453050|NCT00611455|1081367|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
453051|NCT00611455|1081368|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
453052|NCT00611455|1081366|P3|STARTED|DB Treatment Period (24 Weeks)||0
453053|NCT00611455|1081367|P2|STARTED|DB Treatment Period (24 Weeks)||131
453054|NCT00611455|1081368|P1|STARTED|DB Treatment Period (24 Weeks)||134
453055|NCT00611442|1081496|P2|NOT COMPLETED|Overall Study||2
453056|NCT00611442|1081497|P1|NOT COMPLETED|Overall Study||1
453057|NCT00611442|1081496|P2|COMPLETED|Overall Study||94
453058|NCT00611442|1081497|P1|COMPLETED|Overall Study||94
453059|NCT00611442|1081496|P2|STARTED|Overall Study||96
453060|NCT00611442|1081497|P1|STARTED|Overall Study||95
453061|NCT00611403|1081511|P2|NOT COMPLETED|Post Treatment Extension Phase||1
453062|NCT00611403|1081512|P1|NOT COMPLETED|Post Treatment Extension Phase||4
453063|NCT00611403|1081511|P2|COMPLETED|Post Treatment Extension Phase||24
453064|NCT00611403|1081512|P1|COMPLETED|Post Treatment Extension Phase||22
453065|NCT00611403|1081511|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
453066|NCT00611403|1081512|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
453067|NCT00611403|1081511|P2|NOT COMPLETED|Treatment Phase||11
453068|NCT00611403|1081512|P1|NOT COMPLETED|Treatment Phase||6
453069|NCT00611403|1081511|P2|COMPLETED|Treatment Phase||58
453070|NCT00611403|1081512|P1|COMPLETED|Treatment Phase||62
453071|NCT00611403|1081511|P2|STARTED|Treatment Phase||69
453072|NCT00611403|1081512|P1|STARTED|Treatment Phase||68
453073|NCT00611325|1081524|P2|NOT COMPLETED|Overall Study||0
453074|NCT00611325|1081525|P1|NOT COMPLETED|Overall Study||0
453075|NCT00611325|1081524|P2|COMPLETED|Overall Study||28
453076|NCT00611325|1081525|P1|COMPLETED|Overall Study||28
453077|NCT00611325|1081524|P2|STARTED|Overall Study||28
453078|NCT00611325|1081525|P1|STARTED|Overall Study||28
453079|NCT00611247|1081541|P2|NOT COMPLETED|Overall Study||21
453080|NCT00611247|1081542|P1|NOT COMPLETED|Overall Study||2
453081|NCT00611247|1081541|P2|COMPLETED|Overall Study||10
453082|NCT00611247|1081542|P1|COMPLETED|Overall Study||3
453083|NCT00611247|1081541|P2|STARTED|Overall Study||31
453084|NCT00611247|1081542|P1|STARTED|Overall Study||5
453085|NCT00611130|1081554|P2|NOT COMPLETED|Overall Study||47
453086|NCT00611130|1081555|P1|NOT COMPLETED|Overall Study||49
453087|NCT00611130|1081554|P2|COMPLETED|Overall Study||47
453088|NCT00611130|1081555|P1|COMPLETED|Overall Study||43
453089|NCT00611130|1081554|P2|Completed 12 Week Treatment Phase|Overall Study||64
453090|NCT00611130|1081555|P1|Completed 12 Week Treatment Phase|Overall Study||61
453091|NCT00611130|1081554|P2|STARTED|Overall Study||94
453092|NCT00611130|1081555|P1|STARTED|Overall Study||92
453093|NCT00611026|1081565|P3|NOT COMPLETED|Double-blind Treatment Period||98
453094|NCT00611026|1081566|P2|NOT COMPLETED|Double-blind Treatment Period||88
453095|NCT00611026|1081567|P1|NOT COMPLETED|Double-blind Treatment Period||47
453096|NCT00611026|1081565|P3|COMPLETED|Double-blind Treatment Period||862
453097|NCT00611026|1081566|P2|COMPLETED|Double-blind Treatment Period||885
453098|NCT00611026|1081567|P1|COMPLETED|Double-blind Treatment Period||431
453099|NCT00611026|1081565|P3|STARTED|Double-blind Treatment Period||960
453100|NCT00611026|1081566|P2|STARTED|Double-blind Treatment Period||973
453101|NCT00611026|1081567|P1|STARTED|Double-blind Treatment Period||478
453102|NCT00611026|1081565|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
453103|NCT00611026|1081566|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
453104|NCT00611026|1081567|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
453105|NCT00611026|1081565|P3|COMPLETED|Randomized to Double-blind Treatment||960
453106|NCT00611026|1081566|P2|COMPLETED|Randomized to Double-blind Treatment||973
453107|NCT00611026|1081567|P1|COMPLETED|Randomized to Double-blind Treatment||478
453108|NCT00611026|1081565|P3|STARTED|Randomized to Double-blind Treatment||963
453109|NCT00611026|1081566|P2|STARTED|Randomized to Double-blind Treatment||974
453110|NCT00611026|1081567|P1|STARTED|Randomized to Double-blind Treatment||480
453111|NCT00610987|1081633|P2|NOT COMPLETED|Overall Study||0
453112|NCT00610987|1081634|P1|NOT COMPLETED|Overall Study||0
453113|NCT00610987|1081633|P2|COMPLETED|Overall Study||71
453114|NCT00610987|1081634|P1|COMPLETED|Overall Study||75
453115|NCT00610987|1081633|P2|STARTED|Overall Study||71
453116|NCT00610987|1081634|P1|STARTED|Overall Study||75
453117|NCT00610883|1081640|P1|NOT COMPLETED|Overall Study||0
453118|NCT00610883|1081640|P1|COMPLETED|Overall Study||17
453119|NCT00610883|1081640|P1|STARTED|Overall Study||17
453123|NCT00610740|1081651|P1|NOT COMPLETED|Overall Study||0
453124|NCT00610740|1081651|P1|COMPLETED|Overall Study||18
453125|NCT00610740|1081651|P1|STARTED|Overall Study||18
453126|NCT00610714|1081659|P2|NOT COMPLETED|Overall Study||24
453127|NCT00610714|1081660|P1|NOT COMPLETED|Overall Study||26
453128|NCT00610714|1081659|P2|COMPLETED|Overall Study||82
453129|NCT00610714|1081660|P1|COMPLETED|Overall Study||79
453130|NCT00610714|1081659|P2|STARTED|Overall Study||106
453131|NCT00610714|1081660|P1|STARTED|Overall Study||105
453132|NCT00610701|1081672|P2|NOT COMPLETED|Overall Study||11
453133|NCT00610701|1081673|P1|NOT COMPLETED|Overall Study||10
453134|NCT00610701|1081672|P2|COMPLETED|Overall Study||9
453135|NCT00610701|1081673|P1|COMPLETED|Overall Study||5
453136|NCT00610701|1081672|P2|STARTED|Overall Study||20
453137|NCT00610701|1081673|P1|STARTED|Overall Study||15
453138|NCT00610688|1081682|P3|NOT COMPLETED|Overall Study||8
453139|NCT00610688|1081683|P2|NOT COMPLETED|Overall Study||13
453140|NCT00610688|1081684|P1|NOT COMPLETED|Overall Study||9
453141|NCT00610688|1081682|P3|COMPLETED|Overall Study||55
453142|NCT00610688|1081683|P2|COMPLETED|Overall Study||52
453143|NCT00610688|1081684|P1|COMPLETED|Overall Study||55
453144|NCT00610688|1081682|P3|STARTED|Overall Study||63
453145|NCT00610688|1081683|P2|STARTED|Overall Study||65
453146|NCT00610688|1081684|P1|STARTED|Overall Study||64
453147|NCT00610675|1081698|P1|NOT COMPLETED|Overall Study||220
453148|NCT00610675|1081698|P1|COMPLETED|Overall Study||126
453149|NCT00610675|1081698|P1|Treated|Overall Study||342
453150|NCT00610675|1081698|P1|STARTED|Overall Study||346
453151|NCT00610649|1081720|P11|NOT COMPLETED|Overall Study||1
453152|NCT00610649|1081721|P10|NOT COMPLETED|Overall Study||1
453153|NCT00610649|1081722|P9|NOT COMPLETED|Overall Study||0
453154|NCT00610649|1081723|P8|NOT COMPLETED|Overall Study||0
453155|NCT00610649|1081724|P7|NOT COMPLETED|Overall Study||0
453156|NCT00610649|1081725|P6|NOT COMPLETED|Overall Study||0
453157|NCT00610649|1081726|P5|NOT COMPLETED|Overall Study||0
453158|NCT00610649|1081727|P4|NOT COMPLETED|Overall Study||0
453159|NCT00610649|1081728|P3|NOT COMPLETED|Overall Study||0
453160|NCT00610649|1081729|P2|NOT COMPLETED|Overall Study||1
453161|NCT00610649|1081730|P1|NOT COMPLETED|Overall Study||1
453162|NCT00610649|1081720|P11|COMPLETED|Overall Study||9
453163|NCT00610649|1081721|P10|COMPLETED|Overall Study||9
453164|NCT00610649|1081722|P9|COMPLETED|Overall Study||10
453165|NCT00610649|1081723|P8|COMPLETED|Overall Study||2
453166|NCT00610649|1081724|P7|COMPLETED|Overall Study||4
453167|NCT00610649|1081725|P6|COMPLETED|Overall Study||2
453168|NCT00610649|1081726|P5|COMPLETED|Overall Study||4
453169|NCT00610649|1081727|P4|COMPLETED|Overall Study||2
453170|NCT00610649|1081728|P3|COMPLETED|Overall Study||4
453171|NCT00610649|1081729|P2|COMPLETED|Overall Study||1
453172|NCT00610649|1081730|P1|COMPLETED|Overall Study||3
453173|NCT00610649|1081720|P11|STARTED|Overall Study||10
453174|NCT00610649|1081721|P10|STARTED|Overall Study||10
453175|NCT00610649|1081722|P9|STARTED|Overall Study||10
453176|NCT00610649|1081723|P8|STARTED|Overall Study||2
453177|NCT00610649|1081724|P7|STARTED|Overall Study||4
453178|NCT00610649|1081725|P6|STARTED|Overall Study||2
453179|NCT00610649|1081726|P5|STARTED|Overall Study||4
453180|NCT00610649|1081727|P4|STARTED|Overall Study||2
453181|NCT00610649|1081728|P3|STARTED|Overall Study||4
453182|NCT00610649|1081729|P2|STARTED|Overall Study||2
453183|NCT00610649|1081730|P1|STARTED|Overall Study||4
453184|NCT00610532|1081784|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
453185|NCT00610532|1081784|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
453186|NCT00610532|1081784|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
453187|NCT00610532|1081784|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
453188|NCT00610532|1081784|P1|COMPLETED|Intravenous Phenytoin Alone||8
453189|NCT00610532|1081784|P1|STARTED|Intravenous Phenytoin Alone||8
453190|NCT00610441|1081794|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
453191|NCT00610441|1081795|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
453192|NCT00610441|1081796|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
453193|NCT00610441|1081797|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
453194|NCT00610441|1081794|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
453195|NCT00610441|1081795|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
453196|NCT00610441|1081796|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
453197|NCT00610441|1081797|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
453198|NCT00610441|1081794|P4|STARTED|Treatment Period 2 - 3 Weeks||16
453199|NCT00610441|1081795|P3|STARTED|Treatment Period 2 - 3 Weeks||9
453200|NCT00610441|1081796|P2|STARTED|Treatment Period 2 - 3 Weeks||13
453201|NCT00610441|1081797|P1|STARTED|Treatment Period 2 - 3 Weeks||12
453202|NCT00610441|1081794|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
453203|NCT00610441|1081795|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
453204|NCT00610441|1081796|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
453205|NCT00610441|1081797|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
453206|NCT00610441|1081794|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
453207|NCT00610441|1081795|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
453208|NCT00610441|1081796|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
453209|NCT00610441|1081797|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
453210|NCT00610441|1081794|P4|STARTED|Placebo Washout Period - 2 Weeks||16
453211|NCT00610441|1081795|P3|STARTED|Placebo Washout Period - 2 Weeks||11
453212|NCT00610441|1081796|P2|STARTED|Placebo Washout Period - 2 Weeks||14
453213|NCT00610441|1081797|P1|STARTED|Placebo Washout Period - 2 Weeks||12
453214|NCT00610441|1081794|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
453215|NCT00610441|1081795|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
453216|NCT00610441|1081796|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
453217|NCT00610441|1081797|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
453218|NCT00610441|1081794|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
453219|NCT00610441|1081795|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
453220|NCT00610441|1081796|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
453221|NCT00610441|1081797|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
453222|NCT00610441|1081794|P4|STARTED|Treatment Period 1 - 3 Weeks||18
453223|NCT00610441|1081795|P3|STARTED|Treatment Period 1 - 3 Weeks||18
453224|NCT00610441|1081796|P2|STARTED|Treatment Period 1 - 3 Weeks||16
453225|NCT00610441|1081797|P1|STARTED|Treatment Period 1 - 3 Weeks||15
453226|NCT00610363|1081890|P2|NOT COMPLETED|Overall Study||3
453227|NCT00610363|1081891|P1|NOT COMPLETED|Overall Study||11
453228|NCT00610363|1081890|P2|COMPLETED|Overall Study||38
453229|NCT00610363|1081891|P1|COMPLETED|Overall Study||31
453230|NCT00610363|1081890|P2|STARTED|Overall Study||41
453231|NCT00610363|1081891|P1|STARTED|Overall Study||42
453232|NCT00610311|1081909|P1|NOT COMPLETED|Overall Study||0
453233|NCT00610311|1081909|P1|COMPLETED|Overall Study||3
453234|NCT00610311|1081909|P1|STARTED|Overall Study||3
453235|NCT00610207|1081916|P1|NOT COMPLETED|Overall Study||3
453236|NCT00610207|1081916|P1|COMPLETED|Overall Study||18
453237|NCT00610207|1081916|P1|STARTED|Overall Study||21
453238|NCT00610168|1081923|P2|NOT COMPLETED|Overall Study||0
453239|NCT00610168|1081924|P1|NOT COMPLETED|Overall Study||2
453240|NCT00610168|1081923|P2|COMPLETED|Overall Study||7
453241|NCT00610168|1081924|P1|COMPLETED|Overall Study||73
453242|NCT00610168|1081923|P2|STARTED|Overall Study||7
453243|NCT00610168|1081924|P1|STARTED|Overall Study||75
453244|NCT00610155|1081943|P6|NOT COMPLETED|Period 3||0
453245|NCT00610155|1081944|P5|NOT COMPLETED|Period 3||0
453246|NCT00610155|1081945|P4|NOT COMPLETED|Period 3||0
453247|NCT00610155|1081946|P3|NOT COMPLETED|Period 3||0
453248|NCT00610155|1081947|P2|NOT COMPLETED|Period 3||0
453249|NCT00610155|1081948|P1|NOT COMPLETED|Period 3||1
453250|NCT00610155|1081943|P6|COMPLETED|Period 3||1
453251|NCT00610155|1081944|P5|COMPLETED|Period 3||3
453252|NCT00610155|1081945|P4|COMPLETED|Period 3||3
453253|NCT00610155|1081946|P3|COMPLETED|Period 3||3
453254|NCT00610155|1081947|P2|COMPLETED|Period 3||3
453255|NCT00610155|1081948|P1|COMPLETED|Period 3||3
453256|NCT00610155|1081943|P6|STARTED|Period 3||1
453257|NCT00610155|1081944|P5|STARTED|Period 3||3
453258|NCT00610155|1081945|P4|STARTED|Period 3||3
453259|NCT00610155|1081946|P3|STARTED|Period 3||3
453260|NCT00610155|1081947|P2|STARTED|Period 3||3
453261|NCT00610155|1081948|P1|STARTED|Period 3||4
453262|NCT00610155|1081943|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
453263|NCT00610155|1081944|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
453264|NCT00610155|1081945|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
453265|NCT00610155|1081946|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
453266|NCT00610155|1081947|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
453267|NCT00610155|1081948|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
453268|NCT00610155|1081943|P6|COMPLETED|Washout Period 2 (7 Days)||1
453269|NCT00610155|1081944|P5|COMPLETED|Washout Period 2 (7 Days)||3
453270|NCT00610155|1081945|P4|COMPLETED|Washout Period 2 (7 Days)||3
453271|NCT00610155|1081946|P3|COMPLETED|Washout Period 2 (7 Days)||3
453272|NCT00610155|1081947|P2|COMPLETED|Washout Period 2 (7 Days)||3
453273|NCT00610155|1081948|P1|COMPLETED|Washout Period 2 (7 Days)||4
453274|NCT00610155|1081943|P6|STARTED|Washout Period 2 (7 Days)||1
453275|NCT00610155|1081944|P5|STARTED|Washout Period 2 (7 Days)||3
453276|NCT00610155|1081945|P4|STARTED|Washout Period 2 (7 Days)||3
453277|NCT00610155|1081946|P3|STARTED|Washout Period 2 (7 Days)||3
453278|NCT00610155|1081947|P2|STARTED|Washout Period 2 (7 Days)||3
453279|NCT00610155|1081948|P1|STARTED|Washout Period 2 (7 Days)||4
453280|NCT00610155|1081943|P6|NOT COMPLETED|Period 2||0
453281|NCT00610155|1081944|P5|NOT COMPLETED|Period 2||0
453282|NCT00610155|1081945|P4|NOT COMPLETED|Period 2||0
453283|NCT00610155|1081946|P3|NOT COMPLETED|Period 2||0
453284|NCT00610155|1081947|P2|NOT COMPLETED|Period 2||0
453285|NCT00610155|1081948|P1|NOT COMPLETED|Period 2||0
453286|NCT00610155|1081943|P6|COMPLETED|Period 2||1
453287|NCT00610155|1081944|P5|COMPLETED|Period 2||3
453288|NCT00610155|1081945|P4|COMPLETED|Period 2||3
453289|NCT00610155|1081946|P3|COMPLETED|Period 2||3
453290|NCT00610155|1081947|P2|COMPLETED|Period 2||3
453291|NCT00610155|1081948|P1|COMPLETED|Period 2||4
453292|NCT00610155|1081943|P6|STARTED|Period 2||1
453293|NCT00610155|1081944|P5|STARTED|Period 2||3
453294|NCT00610155|1081945|P4|STARTED|Period 2||3
453295|NCT00610155|1081946|P3|STARTED|Period 2||3
453296|NCT00610155|1081947|P2|STARTED|Period 2||3
453297|NCT00610155|1081948|P1|STARTED|Period 2||4
453298|NCT00610155|1081943|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
453299|NCT00610155|1081944|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
453300|NCT00610155|1081945|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
453301|NCT00610155|1081946|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
453302|NCT00610155|1081947|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
453303|NCT00610155|1081948|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
453304|NCT00610155|1081943|P6|COMPLETED|Washout Period 1 (7 Days)||1
453305|NCT00610155|1081944|P5|COMPLETED|Washout Period 1 (7 Days)||3
453306|NCT00610155|1081945|P4|COMPLETED|Washout Period 1 (7 Days)||3
453307|NCT00610155|1081946|P3|COMPLETED|Washout Period 1 (7 Days)||3
453308|NCT00610155|1081947|P2|COMPLETED|Washout Period 1 (7 Days)||3
453309|NCT00610155|1081948|P1|COMPLETED|Washout Period 1 (7 Days)||4
453310|NCT00610155|1081943|P6|STARTED|Washout Period 1 (7 Days)||1
453311|NCT00610155|1081944|P5|STARTED|Washout Period 1 (7 Days)||3
453312|NCT00610155|1081945|P4|STARTED|Washout Period 1 (7 Days)||3
453313|NCT00610155|1081946|P3|STARTED|Washout Period 1 (7 Days)||3
453314|NCT00610155|1081947|P2|STARTED|Washout Period 1 (7 Days)||3
453315|NCT00610155|1081948|P1|STARTED|Washout Period 1 (7 Days)||4
453316|NCT00610155|1081943|P6|NOT COMPLETED|Period 1||0
453317|NCT00610155|1081944|P5|NOT COMPLETED|Period 1||0
453318|NCT00610155|1081945|P4|NOT COMPLETED|Period 1||0
453319|NCT00610155|1081946|P3|NOT COMPLETED|Period 1||1
453320|NCT00610155|1081947|P2|NOT COMPLETED|Period 1||0
453321|NCT00610155|1081948|P1|NOT COMPLETED|Period 1||0
453322|NCT00610155|1081943|P6|COMPLETED|Period 1||1
453323|NCT00610155|1081944|P5|COMPLETED|Period 1||3
453324|NCT00610155|1081945|P4|COMPLETED|Period 1||3
453325|NCT00610155|1081946|P3|COMPLETED|Period 1||3
453326|NCT00610155|1081947|P2|COMPLETED|Period 1||3
453327|NCT00610155|1081948|P1|COMPLETED|Period 1||4
453328|NCT00610155|1081943|P6|STARTED|Period 1||1
453329|NCT00610155|1081944|P5|STARTED|Period 1||3
453330|NCT00610155|1081945|P4|STARTED|Period 1||3
453331|NCT00610155|1081946|P3|STARTED|Period 1||4
453332|NCT00610155|1081947|P2|STARTED|Period 1||3
453333|NCT00610155|1081948|P1|STARTED|Period 1||4
453334|NCT00610129|1081995|P1|NOT COMPLETED|Overall Study||3
453335|NCT00610129|1081995|P1|COMPLETED|Overall Study||25
453336|NCT00610129|1081995|P1|STARTED|Overall Study||28
453337|NCT00609986|1082001|P2|NOT COMPLETED|Overall Study||3
453338|NCT00609986|1082002|P1|NOT COMPLETED|Overall Study||8
453339|NCT00609986|1082001|P2|COMPLETED|Overall Study||49
453340|NCT00609986|1082002|P1|COMPLETED|Overall Study||44
453341|NCT00609986|1082001|P2|Received Transplant|Overall Study||49
453342|NCT00609986|1082002|P1|Received Transplant|Overall Study||44
453343|NCT00609986|1082001|P2|STARTED|Overall Study||52
453344|NCT00609986|1082002|P1|STARTED|Overall Study||52
453345|NCT00609973|1082016|P2|NOT COMPLETED|Overall Study||6
453346|NCT00609973|1082017|P1|NOT COMPLETED|Overall Study||8
453347|NCT00609973|1082016|P2|COMPLETED|Overall Study||10
453348|NCT00609973|1082017|P1|COMPLETED|Overall Study||9
453349|NCT00609973|1082016|P2|STARTED|Overall Study||16
453350|NCT00609973|1082017|P1|STARTED|Overall Study||17
453351|NCT00609947|1082025|P1|NOT COMPLETED|Overall Study||1
453352|NCT00609947|1082025|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
453353|NCT00609947|1082025|P1|STARTED|Overall Study||241
453354|NCT00609869|1082030|P1|NOT COMPLETED|Overall Study||11
453355|NCT00609869|1082030|P1|COMPLETED|Overall Study||18
453356|NCT00609869|1082030|P1|STARTED|Overall Study||29
453357|NCT00609804|1082038|P2|NOT COMPLETED|Overall Study||28
453358|NCT00609804|1082039|P1|NOT COMPLETED|Overall Study||25
453359|NCT00609804|1082038|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
453360|NCT00609804|1082039|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
453361|NCT00609804|1082038|P2|STARTED|Overall Study||28
453362|NCT00609804|1082039|P1|STARTED|Overall Study||25
453363|NCT00609765|1082049|P1|NOT COMPLETED|Overall Study||1
453364|NCT00609765|1082049|P1|COMPLETED|Overall Study||0
453365|NCT00609765|1082049|P1|STARTED|Overall Study||1
453366|NCT00609739|1082054|P1|NOT COMPLETED|Overall Study||0
453367|NCT00609739|1082054|P1|COMPLETED|Overall Study||1
453368|NCT00609739|1082054|P1|STARTED|Overall Study||1
453369|NCT00609674|1082063|P2|NOT COMPLETED|Overall Study||7
453370|NCT00609674|1082064|P1|NOT COMPLETED|Overall Study||7
453371|NCT00609674|1082063|P2|COMPLETED|Overall Study||153
453372|NCT00609674|1082064|P1|COMPLETED|Overall Study||148
453373|NCT00609674|1082063|P2|STARTED|Overall Study||160
453374|NCT00609674|1082064|P1|STARTED|Overall Study||155
453375|NCT00609622|1082100|P2|NOT COMPLETED|Overall Study||95
453376|NCT00609622|1082101|P1|NOT COMPLETED|Overall Study||96
453377|NCT00609622|1082100|P2|COMPLETED|Overall Study||0
453378|NCT00609622|1082101|P1|COMPLETED|Overall Study||0
453379|NCT00609622|1082100|P2|STARTED|Overall Study||95
453380|NCT00609622|1082101|P1|STARTED|Overall Study||96
453381|NCT00609518|1082123|P2|NOT COMPLETED|Overall Study||40
453382|NCT00609518|1082124|P1|NOT COMPLETED|Overall Study||43
453383|NCT00609518|1082123|P2|COMPLETED|Overall Study||17
453384|NCT00609518|1082124|P1|COMPLETED|Overall Study||11
453385|NCT00609518|1082123|P2|Completed 6 Treatment Cycles|Overall Study||22
453386|NCT00609518|1082124|P1|Completed 6 Treatment Cycles|Overall Study||19
453387|NCT00609518|1082123|P2|STARTED|Overall Study||57
453388|NCT00609518|1082124|P1|STARTED|Overall Study||54
453389|NCT00609492|1082139|P3|NOT COMPLETED|Overall Study||7
453390|NCT00609492|1082140|P2|NOT COMPLETED|Overall Study||3
453391|NCT00609492|1082141|P1|NOT COMPLETED|Overall Study||1
453392|NCT00609492|1082139|P3|COMPLETED|Overall Study||122
453393|NCT00609492|1082140|P2|COMPLETED|Overall Study||69
453394|NCT00609492|1082141|P1|COMPLETED|Overall Study||43
453395|NCT00609492|1082139|P3|STARTED|Overall Study||129
453396|NCT00609492|1082140|P2|STARTED|Overall Study||72
453397|NCT00609492|1082141|P1|STARTED|Overall Study||44
453398|NCT00609466|1082226|P3|NOT COMPLETED|Overall Study||4
453399|NCT00609466|1082227|P2|NOT COMPLETED|Overall Study||6
453400|NCT00609466|1082228|P1|NOT COMPLETED|Overall Study||2
453401|NCT00609466|1082226|P3|COMPLETED|Overall Study||95
453402|NCT00609466|1082227|P2|COMPLETED|Overall Study||90
453403|NCT00609466|1082228|P1|COMPLETED|Overall Study||94
453404|NCT00609466|1082226|P3|STARTED|Overall Study||99
453405|NCT00609466|1082227|P2|STARTED|Overall Study||96
453406|NCT00609466|1082228|P1|STARTED|Overall Study||96
453407|NCT00609362|1082256|P2|NOT COMPLETED|Overall Study||1
453408|NCT00609362|1082257|P1|NOT COMPLETED|Overall Study||3
453409|NCT00609362|1082256|P2|COMPLETED|Overall Study||27
453410|NCT00609362|1082257|P1|COMPLETED|Overall Study||26
453411|NCT00609362|1082256|P2|STARTED|Overall Study||28
453412|NCT00609362|1082257|P1|STARTED|Overall Study||29
453413|NCT00609245|1082267|P1|NOT COMPLETED|Overall Study||1
453414|NCT00609245|1082267|P1|COMPLETED|Overall Study||12
453415|NCT00609245|1082267|P1|STARTED|Overall Study||13
453416|NCT00609167|1082275|P2|NOT COMPLETED|Overall Study||7
453417|NCT00609167|1082276|P1|NOT COMPLETED|Overall Study||8
453418|NCT00609167|1082275|P2|COMPLETED|Overall Study||23
453419|NCT00609167|1082276|P1|COMPLETED|Overall Study||25
453420|NCT00609167|1082275|P2|STARTED|Overall Study||30
453421|NCT00609167|1082276|P1|STARTED|Overall Study||33
453422|NCT00608985|1082302|P4|NOT COMPLETED|Overall Study||9
453423|NCT00608985|1082303|P3|NOT COMPLETED|Overall Study||6
453424|NCT00608985|1082304|P2|NOT COMPLETED|Overall Study||13
453425|NCT00608985|1082305|P1|NOT COMPLETED|Overall Study||16
453426|NCT00608985|1082302|P4|COMPLETED|Overall Study|Completed follow-up|159
453427|NCT00608985|1082303|P3|COMPLETED|Overall Study|Completed follow-up|170
453428|NCT00608985|1082304|P2|COMPLETED|Overall Study|Completed follow-up|173
453429|NCT00608985|1082305|P1|COMPLETED|Overall Study|Completed follow-up|161
453430|NCT00608985|1082302|P4|Completed Double-blind Treatment|Overall Study||161
453431|NCT00608985|1082303|P3|Completed Double-blind Treatment|Overall Study||171
453432|NCT00608985|1082304|P2|Completed Double-blind Treatment|Overall Study||174
453433|NCT00608985|1082305|P1|Completed Double-blind Treatment|Overall Study||163
453434|NCT00608985|1082302|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
453435|NCT00608985|1082303|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
453436|NCT00608985|1082304|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
453437|NCT00608985|1082305|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
453438|NCT00608959|1082337|P1|NOT COMPLETED|Part 2||0
453439|NCT00608959|1082337|P1|COMPLETED|Part 2||25
453440|NCT00608959|1082337|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
453441|NCT00608959|1082337|P1|NOT COMPLETED|Part 1||1
453442|NCT00608959|1082337|P1|COMPLETED|Part 1||24
453443|NCT00608959|1082337|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
453444|NCT00608907|1082350|P3|NOT COMPLETED|Overall Study||1
453445|NCT00608907|1082351|P2|NOT COMPLETED|Overall Study||0
453446|NCT00608907|1082352|P1|NOT COMPLETED|Overall Study||12
453447|NCT00608907|1082350|P3|COMPLETED|Overall Study||17
453448|NCT00608907|1082351|P2|COMPLETED|Overall Study||13
453449|NCT00608907|1082352|P1|COMPLETED|Overall Study||18
453450|NCT00608907|1082350|P3|STARTED|Overall Study||18
453451|NCT00608907|1082351|P2|STARTED|Overall Study||13
453452|NCT00608907|1082352|P1|STARTED|Overall Study||30
453453|NCT00608881|1082362|P2|NOT COMPLETED|Overall Study||66
453454|NCT00608881|1082363|P1|NOT COMPLETED|Overall Study||79
453455|NCT00608881|1082362|P2|COMPLETED|Overall Study||240
453456|NCT00608881|1082363|P1|COMPLETED|Overall Study||224
453457|NCT00608881|1082362|P2|STARTED|Overall Study||306
453458|NCT00608881|1082363|P1|STARTED|Overall Study||303
453459|NCT00608868|1082397|P1|NOT COMPLETED|Overall Study||15
453460|NCT00608868|1082397|P1|COMPLETED|Overall Study||141
453461|NCT00608868|1082397|P1|Per Protocol (PP) Population|Overall Study||121
453462|NCT00608868|1082397|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
453463|NCT00608868|1082397|P1|Treatment Completed|Overall Study||141
453464|NCT00608868|1082397|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
453465|NCT00608868|1082397|P1|Enrolled|Overall Study||156
453466|NCT00608868|1082397|P1|STARTED|Overall Study||156
453467|NCT00608842|1082408|P4|NOT COMPLETED|Overall Study||1
453468|NCT00608842|1082409|P3|NOT COMPLETED|Overall Study||2
453469|NCT00608842|1082410|P2|NOT COMPLETED|Overall Study||1
453470|NCT00608842|1082411|P1|NOT COMPLETED|Overall Study||1
453471|NCT00608842|1082408|P4|COMPLETED|Overall Study||16
453472|NCT00608842|1082409|P3|COMPLETED|Overall Study||13
453473|NCT00608842|1082410|P2|COMPLETED|Overall Study||14
453474|NCT00608842|1082411|P1|COMPLETED|Overall Study||14
453475|NCT00608842|1082408|P4|STARTED|Overall Study||17
453476|NCT00608842|1082409|P3|STARTED|Overall Study||15
453477|NCT00608842|1082410|P2|STARTED|Overall Study||15
453478|NCT00608842|1082411|P1|STARTED|Overall Study||15
453479|NCT00608829|1082445|P1|NOT COMPLETED|Overall Study||15
453480|NCT00608829|1082445|P1|COMPLETED|Overall Study||8
453481|NCT00608829|1082445|P1|STARTED|Overall Study||23
453482|NCT00608777|1082449|P1|NOT COMPLETED|Overall Study||0
453483|NCT00608777|1082449|P1|COMPLETED|Overall Study||6
453484|NCT00608777|1082449|P1|STARTED|Overall Study||6
453485|NCT00608634|1082456|P3|NOT COMPLETED|Overall Study||1
453486|NCT00608634|1082457|P2|NOT COMPLETED|Overall Study||1
453487|NCT00608634|1082458|P1|NOT COMPLETED|Overall Study||2
453488|NCT00608634|1082456|P3|COMPLETED|Overall Study||27
453489|NCT00608634|1082457|P2|COMPLETED|Overall Study||26
453490|NCT00608634|1082458|P1|COMPLETED|Overall Study||26
453491|NCT00608634|1082456|P3|STARTED|Overall Study||28
453492|NCT00608634|1082457|P2|STARTED|Overall Study||27
453493|NCT00608634|1082458|P1|STARTED|Overall Study||28
453494|NCT00608582|1082471|P2|NOT COMPLETED|Overall Study||4
453495|NCT00608582|1082472|P1|NOT COMPLETED|Overall Study||4
453496|NCT00608582|1082471|P2|COMPLETED|Overall Study||7
453497|NCT00608582|1082472|P1|COMPLETED|Overall Study||10
453498|NCT00608582|1082471|P2|STARTED|Overall Study||11
453499|NCT00608582|1082472|P1|STARTED|Overall Study||14
453500|NCT00608569|1082482|P2|NOT COMPLETED|Overall Study||9
453501|NCT00608569|1082483|P1|NOT COMPLETED|Overall Study||10
453502|NCT00608569|1082482|P2|COMPLETED|Overall Study||119
453503|NCT00608569|1082483|P1|COMPLETED|Overall Study||119
453504|NCT00608569|1082482|P2|STARTED|Overall Study||128
453505|NCT00608569|1082483|P1|STARTED|Overall Study||129
453506|NCT00608543|1082503|P1|NOT COMPLETED|Overall Study||4
453507|NCT00608543|1082503|P1|COMPLETED|Overall Study||13
453508|NCT00608543|1082503|P1|STARTED|Overall Study||17
453509|NCT00608530|1082514|P2|NOT COMPLETED|Overall Study||5
453510|NCT00608530|1082515|P1|NOT COMPLETED|Overall Study||11
453511|NCT00608530|1082514|P2|COMPLETED|Overall Study||28
453512|NCT00608530|1082515|P1|COMPLETED|Overall Study||22
453513|NCT00608530|1082514|P2|Attended > 0 Treatment Sessions|Overall Study||31
453514|NCT00608530|1082515|P1|Attended > 0 Treatment Sessions|Overall Study||28
453515|NCT00608530|1082514|P2|STARTED|Overall Study|Randomized|33
453516|NCT00608530|1082515|P1|STARTED|Overall Study|Randomized|33
453517|NCT00608517|1082528|P3|NOT COMPLETED|Overall Study||0
453518|NCT00608517|1082529|P2|NOT COMPLETED|Overall Study||0
453519|NCT00608517|1082530|P1|NOT COMPLETED|Overall Study||1
453520|NCT00608517|1082528|P3|COMPLETED|Overall Study||1
453521|NCT00608517|1082529|P2|COMPLETED|Overall Study||3
453522|NCT00608517|1082530|P1|COMPLETED|Overall Study||1
453523|NCT00608517|1082528|P3|STARTED|Overall Study||1
453524|NCT00608517|1082529|P2|STARTED|Overall Study||3
453525|NCT00608517|1082530|P1|STARTED|Overall Study||2
453526|NCT00608491|1082558|P2|NOT COMPLETED|Overall Study||22
453527|NCT00608491|1082559|P1|NOT COMPLETED|Overall Study||21
453528|NCT00608491|1082558|P2|COMPLETED|Overall Study||72
453529|NCT00608491|1082559|P1|COMPLETED|Overall Study||73
453530|NCT00608491|1082558|P2|STARTED|Overall Study||94
453531|NCT00608491|1082559|P1|STARTED|Overall Study||94
453532|NCT00608465|1082703|P1|NOT COMPLETED|Overall Study||0
453533|NCT00608465|1082703|P1|COMPLETED|Overall Study||4
453534|NCT00608465|1082703|P1|STARTED|Overall Study||4
453535|NCT00608426|1082710|P2|NOT COMPLETED|Overall Study||905
453536|NCT00608426|1082711|P1|NOT COMPLETED|Overall Study||836
453537|NCT00608426|1082710|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
453538|NCT00608426|1082711|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
453539|NCT00608426|1082710|P2|STARTED|Overall Study||2519
453540|NCT00608426|1082711|P1|STARTED|Overall Study||2604
453541|NCT00608322|1082723|P2|NOT COMPLETED|Overall Study||1
453542|NCT00608322|1082724|P1|NOT COMPLETED|Overall Study||2
453543|NCT00608322|1082723|P2|COMPLETED|Overall Study||22
453544|NCT00608322|1082724|P1|COMPLETED|Overall Study||24
453545|NCT00608322|1082723|P2|STARTED|Overall Study||23
453546|NCT00608322|1082724|P1|STARTED|Overall Study||26
453547|NCT00608244|1082730|P1|NOT COMPLETED|Overall Study||2
453548|NCT00608244|1082730|P1|COMPLETED|Overall Study||57
453549|NCT00608244|1082730|P1|STARTED|Overall Study||59
453550|NCT00608205|1082741|P2|NOT COMPLETED|Overall Study||3
453551|NCT00608205|1082742|P1|NOT COMPLETED|Overall Study||3
453552|NCT00608205|1082741|P2|COMPLETED|Overall Study||31
453553|NCT00608205|1082742|P1|COMPLETED|Overall Study||32
453554|NCT00608205|1082741|P2|STARTED|Overall Study||34
453555|NCT00608205|1082742|P1|STARTED|Overall Study||35
453556|NCT00608140|1082832|P2|NOT COMPLETED|Overall Study||1
453557|NCT00608140|1082833|P1|NOT COMPLETED|Overall Study||1
453558|NCT00608140|1082832|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
453559|NCT00608140|1082833|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
453560|NCT00608140|1082832|P2|STARTED|Overall Study||1
453561|NCT00608140|1082833|P1|STARTED|Overall Study||1
453562|NCT00608023|1082844|P3|NOT COMPLETED|Overall Study||14
453563|NCT00608023|1082845|P2|NOT COMPLETED|Overall Study||22
453564|NCT00608023|1082846|P1|NOT COMPLETED|Overall Study||12
453565|NCT00608023|1082844|P3|COMPLETED|Overall Study||72
453566|NCT00608023|1082845|P2|COMPLETED|Overall Study||63
453567|NCT00608023|1082846|P1|COMPLETED|Overall Study||80
453568|NCT00608023|1082844|P3|STARTED|Overall Study||86
453569|NCT00608023|1082845|P2|STARTED|Overall Study||85
453570|NCT00608023|1082846|P1|STARTED|Overall Study||92
453571|NCT00607919|1082868|P2|NOT COMPLETED|Open-Label Phase||12
453572|NCT00607919|1082869|P1|NOT COMPLETED|Open-Label Phase||10
453573|NCT00607919|1082868|P2|COMPLETED|Open-Label Phase||59
453574|NCT00607919|1082869|P1|COMPLETED|Open-Label Phase||74
453575|NCT00607919|1082868|P2|STARTED|Open-Label Phase||71
453576|NCT00607919|1082869|P1|STARTED|Open-Label Phase||84
453577|NCT00607919|1082868|P2|NOT COMPLETED|Acute Phase||16
453578|NCT00607919|1082869|P1|NOT COMPLETED|Acute Phase||34
453579|NCT00607919|1082868|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
453580|NCT00607919|1082869|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
453581|NCT00607919|1082868|P2|STARTED|Acute Phase||89
453582|NCT00607919|1082869|P1|STARTED|Acute Phase||120
453583|NCT00607880|1082927|P2|NOT COMPLETED|Overall Study||0
453584|NCT00607880|1082928|P1|NOT COMPLETED|Overall Study||1
453585|NCT00607880|1082927|P2|COMPLETED|Overall Study||50
453586|NCT00607880|1082928|P1|COMPLETED|Overall Study||49
453587|NCT00607880|1082927|P2|STARTED|Overall Study||50
453588|NCT00607880|1082928|P1|STARTED|Overall Study||50
453589|NCT00607867|1082942|P2|NOT COMPLETED|Overall Study||0
453590|NCT00607867|1082943|P1|NOT COMPLETED|Overall Study||0
453591|NCT00607867|1082942|P2|COMPLETED|Overall Study||7
453592|NCT00607867|1082943|P1|COMPLETED|Overall Study||7
453593|NCT00607867|1082942|P2|STARTED|Overall Study||7
453594|NCT00607867|1082943|P1|STARTED|Overall Study||7
453595|NCT00607815|1082961|P2|NOT COMPLETED|Overall Study||11
453596|NCT00607815|1082962|P1|NOT COMPLETED|Overall Study||23
453597|NCT00607815|1082961|P2|COMPLETED|Overall Study||25
453598|NCT00607815|1082962|P1|COMPLETED|Overall Study||20
453599|NCT00607815|1082961|P2|STARTED|Overall Study||36
453600|NCT00607815|1082962|P1|STARTED|Overall Study||43
453601|NCT00607789|1082978|P2|NOT COMPLETED|Overall Study||6
453602|NCT00607789|1082979|P1|NOT COMPLETED|Overall Study||7
453603|NCT00607789|1082978|P2|COMPLETED|Overall Study||14
453604|NCT00607789|1082979|P1|COMPLETED|Overall Study||13
453605|NCT00607789|1082978|P2|STARTED|Overall Study||20
453606|NCT00607789|1082979|P1|STARTED|Overall Study|20 participants were randomized in each group|20
453607|NCT00607724|1082994|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
453608|NCT00607724|1082995|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
453609|NCT00607724|1082996|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
453610|NCT00607724|1082997|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
453611|NCT00607724|1082998|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
453612|NCT00607724|1082999|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
453613|NCT00607724|1083000|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
453614|NCT00607724|1082994|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
453615|NCT00607724|1082995|P6|COMPLETED|Stage 2: Expanded Cohort||0
453616|NCT00607724|1082996|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
453617|NCT00607724|1082997|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
453618|NCT00607724|1082998|P3|COMPLETED|Stage 2: Expanded Cohort||0
453619|NCT00607724|1082999|P2|COMPLETED|Stage 2: Expanded Cohort||0
453620|NCT00607724|1083000|P1|COMPLETED|Stage 2: Expanded Cohort||0
453621|NCT00607724|1082994|P7|STARTED|Stage 2: Expanded Cohort||16
453622|NCT00607724|1082995|P6|STARTED|Stage 2: Expanded Cohort||12
453623|NCT00607724|1082996|P5|STARTED|Stage 2: Expanded Cohort||14
453624|NCT00607724|1082997|P4|STARTED|Stage 2: Expanded Cohort||6
453625|NCT00607724|1082998|P3|STARTED|Stage 2: Expanded Cohort||0
453626|NCT00607724|1082999|P2|STARTED|Stage 2: Expanded Cohort||0
453627|NCT00607724|1083000|P1|STARTED|Stage 2: Expanded Cohort||0
453628|NCT00607724|1082994|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
453629|NCT00607724|1082995|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
453630|NCT00607724|1082996|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
453631|NCT00607724|1082997|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
453632|NCT00607724|1082998|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
453633|NCT00607724|1082999|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
453634|NCT00607724|1083000|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
453635|NCT00607724|1082994|P7|COMPLETED|Stage 1: Dose Escalation||0
453636|NCT00607724|1082995|P6|COMPLETED|Stage 1: Dose Escalation||0
453637|NCT00607724|1082996|P5|COMPLETED|Stage 1: Dose Escalation||0
453638|NCT00607724|1082997|P4|COMPLETED|Stage 1: Dose Escalation||0
453639|NCT00607724|1082998|P3|COMPLETED|Stage 1: Dose Escalation||0
453640|NCT00607724|1082999|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
453641|NCT00607724|1083000|P1|COMPLETED|Stage 1: Dose Escalation||0
453642|NCT00607724|1082994|P7|STARTED|Stage 1: Dose Escalation||0
453643|NCT00607724|1082995|P6|STARTED|Stage 1: Dose Escalation||0
453644|NCT00607724|1082996|P5|STARTED|Stage 1: Dose Escalation||0
453645|NCT00607724|1082997|P4|STARTED|Stage 1: Dose Escalation||0
453646|NCT00607724|1082998|P3|STARTED|Stage 1: Dose Escalation||4
453647|NCT00607724|1082999|P2|STARTED|Stage 1: Dose Escalation||9
453648|NCT00607724|1083000|P1|STARTED|Stage 1: Dose Escalation||7
453649|NCT00607672|1083079|P3|NOT COMPLETED|Overall Study||5
453650|NCT00607672|1083080|P2|NOT COMPLETED|Overall Study||3
453651|NCT00607672|1083081|P1|NOT COMPLETED|Overall Study||4
453652|NCT00607672|1083079|P3|COMPLETED|Overall Study||22
453653|NCT00607672|1083080|P2|COMPLETED|Overall Study||24
453654|NCT00607672|1083081|P1|COMPLETED|Overall Study||28
453655|NCT00607672|1083079|P3|STARTED|Overall Study||27
453656|NCT00607672|1083080|P2|STARTED|Overall Study||27
453657|NCT00607672|1083081|P1|STARTED|Overall Study||32
453658|NCT00607594|1083125|P1|NOT COMPLETED|Overall Study||0
453659|NCT00607594|1083125|P1|COMPLETED|Overall Study||21
453660|NCT00607594|1083125|P1|STARTED|Overall Study||21
453661|NCT00607477|1083134|P2|NOT COMPLETED|Overall Study||0
453662|NCT00607477|1083135|P1|NOT COMPLETED|Overall Study||0
453663|NCT00607477|1083134|P2|COMPLETED|Overall Study||2
453664|NCT00607477|1083135|P1|COMPLETED|Overall Study||0
453665|NCT00607477|1083134|P2|STARTED|Overall Study||2
453666|NCT00607477|1083135|P1|STARTED|Overall Study||0
453667|NCT00607386|1083141|P1|NOT COMPLETED|Overall Study||1
453668|NCT00607386|1083141|P1|COMPLETED|Overall Study||27
453669|NCT00607386|1083141|P1|STARTED|Overall Study||28
453670|NCT00607373|1083156|P2|NOT COMPLETED|Follow-up Period||5
453671|NCT00607373|1083157|P1|NOT COMPLETED|Follow-up Period||1
453672|NCT00607373|1083156|P2|COMPLETED|Follow-up Period||6
453673|NCT00607373|1083157|P1|COMPLETED|Follow-up Period||0
453674|NCT00607373|1083156|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
453675|NCT00607373|1083157|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
453676|NCT00607373|1083156|P2|NOT COMPLETED|Treatment Period||6
453677|NCT00607373|1083157|P1|NOT COMPLETED|Treatment Period||0
453678|NCT00607373|1083156|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
453679|NCT00607373|1083157|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
453680|NCT00607373|1083156|P2|STARTED|Treatment Period||34
453681|NCT00607373|1083157|P1|STARTED|Treatment Period||17
453682|NCT00607321|1083201|P1|NOT COMPLETED|Overall Study||0
453683|NCT00607321|1083201|P1|COMPLETED|Overall Study||60
453684|NCT00607321|1083201|P1|STARTED|Overall Study||60
453685|NCT00607269|1083211|P2|NOT COMPLETED|Overall Study||0
453686|NCT00607269|1083212|P1|NOT COMPLETED|Overall Study||0
453687|NCT00607269|1083211|P2|COMPLETED|Overall Study||64
453688|NCT00607269|1083212|P1|COMPLETED|Overall Study||67
453689|NCT00607269|1083211|P2|STARTED|Overall Study||64
453690|NCT00607269|1083212|P1|STARTED|Overall Study||67
453691|NCT00607243|1083226|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
453692|NCT00607243|1083227|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
453693|NCT00607243|1083226|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
453694|NCT00607243|1083227|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
453695|NCT00607243|1083226|P2|STARTED|Telephone Safety Assessment Period||41
453696|NCT00607243|1083227|P1|STARTED|Telephone Safety Assessment Period||82
453697|NCT00607243|1083226|P2|NOT COMPLETED|Initial Post-vaccination Period||0
453698|NCT00607243|1083227|P1|NOT COMPLETED|Initial Post-vaccination Period||0
453699|NCT00607243|1083226|P2|COMPLETED|Initial Post-vaccination Period||41
453700|NCT00607243|1083227|P1|COMPLETED|Initial Post-vaccination Period||82
453701|NCT00607243|1083226|P2|STARTED|Initial Post-vaccination Period||41
453702|NCT00607243|1083227|P1|STARTED|Initial Post-vaccination Period||82
453703|NCT00607126|1083235|P2|NOT COMPLETED|Overall Study||0
453704|NCT00607126|1083236|P1|NOT COMPLETED|Overall Study||0
453705|NCT00607126|1083235|P2|COMPLETED|Overall Study||19
453706|NCT00607126|1083236|P1|COMPLETED|Overall Study||17
453707|NCT00607126|1083235|P2|STARTED|Overall Study||19
453708|NCT00607126|1083236|P1|STARTED|Overall Study||17
453709|NCT00607113|1083250|P2|NOT COMPLETED|Overall Study||0
453710|NCT00607113|1083251|P1|NOT COMPLETED|Overall Study||0
453711|NCT00607113|1083250|P2|COMPLETED|Overall Study||20
453712|NCT00607113|1083251|P1|COMPLETED|Overall Study||19
453713|NCT00607113|1083250|P2|STARTED|Overall Study||20
453714|NCT00607113|1083251|P1|STARTED|Overall Study||19
453715|NCT00607087|1083259|P3|NOT COMPLETED|Period 3||0
453716|NCT00607087|1083260|P2|NOT COMPLETED|Period 3||2
453717|NCT00607087|1083261|P1|NOT COMPLETED|Period 3||2
453718|NCT00607087|1083259|P3|COMPLETED|Period 3||84
453719|NCT00607087|1083260|P2|COMPLETED|Period 3||84
453720|NCT00607087|1083261|P1|COMPLETED|Period 3||84
453721|NCT00607087|1083259|P3|STARTED|Period 3||84
453722|NCT00607087|1083260|P2|STARTED|Period 3||86
453723|NCT00607087|1083261|P1|STARTED|Period 3||86
453724|NCT00607087|1083259|P3|NOT COMPLETED|Period 2||5
453725|NCT00607087|1083260|P2|NOT COMPLETED|Period 2||3
453726|NCT00607087|1083261|P1|NOT COMPLETED|Period 2||1
453727|NCT00607087|1083259|P3|COMPLETED|Period 2||84
453728|NCT00607087|1083260|P2|COMPLETED|Period 2||86
453729|NCT00607087|1083261|P1|COMPLETED|Period 2||86
453730|NCT00607087|1083259|P3|STARTED|Period 2||89
453731|NCT00607087|1083260|P2|STARTED|Period 2||89
453732|NCT00607087|1083261|P1|STARTED|Period 2||87
453733|NCT00607087|1083259|P3|NOT COMPLETED|Period 1||5
453734|NCT00607087|1083260|P2|NOT COMPLETED|Period 1||6
453735|NCT00607087|1083261|P1|NOT COMPLETED|Period 1||12
453736|NCT00607087|1083259|P3|COMPLETED|Period 1||89
453737|NCT00607087|1083260|P2|COMPLETED|Period 1||89
453738|NCT00607087|1083261|P1|COMPLETED|Period 1||87
453739|NCT00607087|1083259|P3|STARTED|Period 1||94
453740|NCT00607087|1083260|P2|STARTED|Period 1||95
453741|NCT00607087|1083261|P1|STARTED|Period 1||99
453742|NCT00607087|1083259|P3|NOT COMPLETED|Overall Study||10
453743|NCT00607087|1083260|P2|NOT COMPLETED|Overall Study||11
453744|NCT00607087|1083261|P1|NOT COMPLETED|Overall Study||15
453745|NCT00607087|1083259|P3|COMPLETED|Overall Study||84
453746|NCT00607087|1083260|P2|COMPLETED|Overall Study||84
453747|NCT00607087|1083261|P1|COMPLETED|Overall Study||84
453748|NCT00607087|1083259|P3|STARTED|Overall Study||94
453749|NCT00607087|1083260|P2|STARTED|Overall Study||95
453750|NCT00607087|1083261|P1|STARTED|Overall Study||99
453751|NCT00607048|1083319|P6|NOT COMPLETED|Overall Study||5
453752|NCT00607048|1083320|P5|NOT COMPLETED|Overall Study||6
453753|NCT00607048|1083321|P4|NOT COMPLETED|Overall Study||3
453754|NCT00607048|1083322|P3|NOT COMPLETED|Overall Study||4
453755|NCT00607048|1083323|P2|NOT COMPLETED|Overall Study||4
453756|NCT00607048|1083324|P1|NOT COMPLETED|Overall Study||3
453757|NCT00607048|1083319|P6|COMPLETED|Overall Study||2
453758|NCT00607048|1083320|P5|COMPLETED|Overall Study||0
453759|NCT00607048|1083321|P4|COMPLETED|Overall Study||0
453760|NCT00607048|1083322|P3|COMPLETED|Overall Study||3
453761|NCT00607048|1083323|P2|COMPLETED|Overall Study||2
453762|NCT00607048|1083324|P1|COMPLETED|Overall Study||0
453763|NCT00607048|1083319|P6|STARTED|Overall Study||7
453764|NCT00607048|1083320|P5|STARTED|Overall Study||6
453765|NCT00607048|1083321|P4|STARTED|Overall Study||3
453766|NCT00607048|1083322|P3|STARTED|Overall Study||7
453767|NCT00607048|1083323|P2|STARTED|Overall Study||6
453768|NCT00607048|1083324|P1|STARTED|Overall Study||3
453769|NCT00606944|1083408|P2|NOT COMPLETED|Overall Study||0
453770|NCT00606944|1083409|P1|NOT COMPLETED|Overall Study||0
453771|NCT00606944|1083408|P2|COMPLETED|Overall Study||100
453772|NCT00606944|1083409|P1|COMPLETED|Overall Study||98
453773|NCT00606944|1083408|P2|STARTED|Overall Study||100
453774|NCT00606944|1083409|P1|STARTED|Overall Study||98
453775|NCT00606931|1083415|P1|NOT COMPLETED|Overall Study||3
453776|NCT00606931|1083415|P1|COMPLETED|Overall Study||19
453777|NCT00606931|1083415|P1|STARTED|Overall Study||22
453778|NCT00606905|1083423|P2|NOT COMPLETED|Overall Study||15
453779|NCT00606905|1083424|P1|NOT COMPLETED|Overall Study||15
453780|NCT00606905|1083423|P2|COMPLETED|Overall Study||24
453781|NCT00606905|1083424|P1|COMPLETED|Overall Study||23
453782|NCT00606905|1083423|P2|Pregnancy|Overall Study||33
453783|NCT00606905|1083424|P1|Pregnancy|Overall Study||29
453784|NCT00606905|1083423|P2|STARTED|Overall Study||39
453785|NCT00606905|1083424|P1|STARTED|Overall Study||38
453786|NCT00606892|1083430|P2|NOT COMPLETED|Second Intervention||0
453787|NCT00606892|1083431|P1|NOT COMPLETED|Second Intervention||0
453788|NCT00606892|1083430|P2|COMPLETED|Second Intervention||4
453789|NCT00606892|1083431|P1|COMPLETED|Second Intervention||8
453790|NCT00606892|1083430|P2|STARTED|Second Intervention||4
453791|NCT00606892|1083431|P1|STARTED|Second Intervention||8
453792|NCT00606892|1083430|P2|NOT COMPLETED|Washout Period||0
453793|NCT00606892|1083431|P1|NOT COMPLETED|Washout Period||0
453794|NCT00606892|1083430|P2|COMPLETED|Washout Period||4
453795|NCT00606892|1083431|P1|COMPLETED|Washout Period||8
453796|NCT00606892|1083430|P2|STARTED|Washout Period||4
453797|NCT00606892|1083431|P1|STARTED|Washout Period||8
453798|NCT00606892|1083430|P2|NOT COMPLETED|First Intervention||4
453799|NCT00606892|1083431|P1|NOT COMPLETED|First Intervention||1
453800|NCT00606892|1083430|P2|COMPLETED|First Intervention||4
453801|NCT00606892|1083431|P1|COMPLETED|First Intervention||8
453802|NCT00606892|1083430|P2|STARTED|First Intervention||8
453803|NCT00606892|1083431|P1|STARTED|First Intervention||9
453804|NCT00606892|1083430|P2|NOT COMPLETED|Adaptation||0
453805|NCT00606892|1083431|P1|NOT COMPLETED|Adaptation||0
453806|NCT00606892|1083430|P2|COMPLETED|Adaptation||8
453807|NCT00606892|1083431|P1|COMPLETED|Adaptation||9
453808|NCT00606892|1083430|P2|STARTED|Adaptation||8
453809|NCT00606892|1083431|P1|STARTED|Adaptation||9
453810|NCT00606801|1083465|P2|NOT COMPLETED|Intervention||3
453811|NCT00606801|1083466|P1|NOT COMPLETED|Intervention||3
453812|NCT00606801|1083465|P2|COMPLETED|Intervention||14
453813|NCT00606801|1083466|P1|COMPLETED|Intervention||14
453814|NCT00606801|1083465|P2|STARTED|Intervention||17
453815|NCT00606801|1083466|P1|STARTED|Intervention||17
453816|NCT00606801|1083465|P2|NOT COMPLETED|Adaptation||0
453817|NCT00606801|1083466|P1|NOT COMPLETED|Adaptation||0
453818|NCT00606801|1083465|P2|COMPLETED|Adaptation||17
453819|NCT00606801|1083466|P1|COMPLETED|Adaptation||17
453820|NCT00606801|1083465|P2|STARTED|Adaptation||17
453821|NCT00606801|1083466|P1|STARTED|Adaptation||17
453822|NCT00606684|1083494|P7|NOT COMPLETED|Double-Blind Treatment Period||8
453823|NCT00606684|1083495|P6|NOT COMPLETED|Double-Blind Treatment Period||9
453824|NCT00606684|1083496|P5|NOT COMPLETED|Double-Blind Treatment Period||9
453825|NCT00606684|1083497|P4|NOT COMPLETED|Double-Blind Treatment Period||10
453826|NCT00606684|1083498|P3|NOT COMPLETED|Double-Blind Treatment Period||11
453827|NCT00606684|1083499|P2|NOT COMPLETED|Double-Blind Treatment Period||16
453828|NCT00606684|1083500|P1|NOT COMPLETED|Double-Blind Treatment Period||0
453829|NCT00606684|1083494|P7|COMPLETED|Double-Blind Treatment Period||91
453830|NCT00606684|1083495|P6|COMPLETED|Double-Blind Treatment Period||92
453831|NCT00606684|1083496|P5|COMPLETED|Double-Blind Treatment Period||92
453832|NCT00606684|1083497|P4|COMPLETED|Double-Blind Treatment Period||91
453833|NCT00606684|1083498|P3|COMPLETED|Double-Blind Treatment Period||88
453834|NCT00606684|1083499|P2|COMPLETED|Double-Blind Treatment Period||85
453835|NCT00606684|1083500|P1|COMPLETED|Double-Blind Treatment Period||0
453836|NCT00606684|1083494|P7|STARTED|Double-Blind Treatment Period||99
453837|NCT00606684|1083495|P6|STARTED|Double-Blind Treatment Period||101
453838|NCT00606684|1083496|P5|STARTED|Double-Blind Treatment Period||101
453839|NCT00606684|1083497|P4|STARTED|Double-Blind Treatment Period||101
453840|NCT00606684|1083498|P3|STARTED|Double-Blind Treatment Period||99
453841|NCT00606684|1083499|P2|STARTED|Double-Blind Treatment Period||101
453842|NCT00606684|1083500|P1|STARTED|Double-Blind Treatment Period||0
453843|NCT00606684|1083494|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
453844|NCT00606684|1083495|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
453845|NCT00606684|1083496|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
453846|NCT00606684|1083497|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
453847|NCT00606684|1083498|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
453848|NCT00606684|1083499|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
453849|NCT00606684|1083500|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
453850|NCT00606684|1083494|P7|COMPLETED|2-week Single-Blind Run-in Period||0
453851|NCT00606684|1083495|P6|COMPLETED|2-week Single-Blind Run-in Period||0
453852|NCT00606684|1083496|P5|COMPLETED|2-week Single-Blind Run-in Period||0
453853|NCT00606684|1083497|P4|COMPLETED|2-week Single-Blind Run-in Period||0
453854|NCT00606684|1083498|P3|COMPLETED|2-week Single-Blind Run-in Period||0
453855|NCT00606684|1083499|P2|COMPLETED|2-week Single-Blind Run-in Period||0
453856|NCT00606684|1083500|P1|COMPLETED|2-week Single-Blind Run-in Period||605
453857|NCT00606684|1083494|P7|STARTED|2-week Single-Blind Run-in Period||0
453858|NCT00606684|1083495|P6|STARTED|2-week Single-Blind Run-in Period||0
453859|NCT00606684|1083496|P5|STARTED|2-week Single-Blind Run-in Period||0
453860|NCT00606684|1083497|P4|STARTED|2-week Single-Blind Run-in Period||0
453861|NCT00606684|1083498|P3|STARTED|2-week Single-Blind Run-in Period||0
453862|NCT00606684|1083499|P2|STARTED|2-week Single-Blind Run-in Period||0
453863|NCT00606684|1083500|P1|STARTED|2-week Single-Blind Run-in Period||851
453864|NCT00606632|1083532|P1|NOT COMPLETED|Overall Study||22
453865|NCT00606632|1083532|P1|COMPLETED|Overall Study||204
453866|NCT00606632|1083532|P1|STARTED|Overall Study||226
453867|NCT00606593|1083539|P10|NOT COMPLETED|Overall Study||0
453868|NCT00606593|1083540|P9|NOT COMPLETED|Overall Study||1
453869|NCT00606593|1083541|P8|NOT COMPLETED|Overall Study||2
453870|NCT00606593|1083542|P7|NOT COMPLETED|Overall Study||1
453871|NCT00606593|1083543|P6|NOT COMPLETED|Overall Study||0
453872|NCT00606593|1083544|P5|NOT COMPLETED|Overall Study||1
453873|NCT00606593|1083545|P4|NOT COMPLETED|Overall Study||1
453874|NCT00606593|1083546|P3|NOT COMPLETED|Overall Study||2
453875|NCT00606593|1083547|P2|NOT COMPLETED|Overall Study||0
453876|NCT00606593|1083548|P1|NOT COMPLETED|Overall Study||1
453877|NCT00606593|1083539|P10|COMPLETED|Overall Study||11
453878|NCT00606593|1083540|P9|COMPLETED|Overall Study||11
453879|NCT00606593|1083541|P8|COMPLETED|Overall Study||9
453880|NCT00606593|1083542|P7|COMPLETED|Overall Study||10
453881|NCT00606593|1083543|P6|COMPLETED|Overall Study||11
453882|NCT00606593|1083544|P5|COMPLETED|Overall Study||11
453883|NCT00606593|1083545|P4|COMPLETED|Overall Study||10
453884|NCT00606593|1083546|P3|COMPLETED|Overall Study||9
453885|NCT00606593|1083547|P2|COMPLETED|Overall Study||11
453886|NCT00606593|1083548|P1|COMPLETED|Overall Study||10
453887|NCT00606593|1083539|P10|5th Double-blind Treatment|Overall Study||11
453888|NCT00606593|1083540|P9|5th Double-blind Treatment|Overall Study||11
453889|NCT00606593|1083541|P8|5th Double-blind Treatment|Overall Study||9
453890|NCT00606593|1083542|P7|5th Double-blind Treatment|Overall Study||10
453891|NCT00606593|1083543|P6|5th Double-blind Treatment|Overall Study||11
453892|NCT00606593|1083544|P5|5th Double-blind Treatment|Overall Study||11
453893|NCT00606593|1083545|P4|5th Double-blind Treatment|Overall Study||10
453894|NCT00606593|1083546|P3|5th Double-blind Treatment|Overall Study||9
453895|NCT00606593|1083547|P2|5th Double-blind Treatment|Overall Study||11
453896|NCT00606593|1083548|P1|5th Double-blind Treatment|Overall Study||10
453897|NCT00606593|1083539|P10|4th Double-blind Treatment|Overall Study||11
453898|NCT00606593|1083540|P9|4th Double-blind Treatment|Overall Study||11
453899|NCT00606593|1083541|P8|4th Double-blind Treatment|Overall Study||9
453900|NCT00606593|1083542|P7|4th Double-blind Treatment|Overall Study||10
453901|NCT00606593|1083543|P6|4th Double-blind Treatment|Overall Study||11
453902|NCT00606593|1083544|P5|4th Double-blind Treatment|Overall Study||11
453903|NCT00606593|1083545|P4|4th Double-blind Treatment|Overall Study||10
453904|NCT00606593|1083546|P3|4th Double-blind Treatment|Overall Study||10
453905|NCT00606593|1083547|P2|4th Double-blind Treatment|Overall Study||11
453906|NCT00606593|1083548|P1|4th Double-blind Treatment|Overall Study||10
453907|NCT00606593|1083539|P10|3rd Double-blind Treatment|Overall Study||11
453908|NCT00606593|1083540|P9|3rd Double-blind Treatment|Overall Study||12
453909|NCT00606593|1083541|P8|3rd Double-blind Treatment|Overall Study||9
453910|NCT00606593|1083542|P7|3rd Double-blind Treatment|Overall Study||10
453911|NCT00606593|1083543|P6|3rd Double-blind Treatment|Overall Study||11
453912|NCT00606593|1083544|P5|3rd Double-blind Treatment|Overall Study||11
453913|NCT00606593|1083545|P4|3rd Double-blind Treatment|Overall Study||10
453914|NCT00606593|1083546|P3|3rd Double-blind Treatment|Overall Study||10
453915|NCT00606593|1083547|P2|3rd Double-blind Treatment|Overall Study||11
453916|NCT00606593|1083548|P1|3rd Double-blind Treatment|Overall Study||11
453917|NCT00606593|1083539|P10|2nd Double-blind Treatment|Overall Study||11
453918|NCT00606593|1083540|P9|2nd Double-blind Treatment|Overall Study||12
453919|NCT00606593|1083541|P8|2nd Double-blind Treatment|Overall Study||9
453920|NCT00606593|1083542|P7|2nd Double-blind Treatment|Overall Study||10
453921|NCT00606593|1083543|P6|2nd Double-blind Treatment|Overall Study||11
453922|NCT00606593|1083544|P5|2nd Double-blind Treatment|Overall Study||12
453923|NCT00606593|1083545|P4|2nd Double-blind Treatment|Overall Study||10
453924|NCT00606593|1083546|P3|2nd Double-blind Treatment|Overall Study||11
453925|NCT00606593|1083547|P2|2nd Double-blind Treatment|Overall Study||11
453926|NCT00606593|1083548|P1|2nd Double-blind Treatment|Overall Study||11
453927|NCT00606593|1083539|P10|1st Double-blind Treatment|Overall Study||11
453928|NCT00606593|1083540|P9|1st Double-blind Treatment|Overall Study||12
453929|NCT00606593|1083541|P8|1st Double-blind Treatment|Overall Study||11
453930|NCT00606593|1083542|P7|1st Double-blind Treatment|Overall Study||11
453931|NCT00606593|1083543|P6|1st Double-blind Treatment|Overall Study||11
453932|NCT00606593|1083544|P5|1st Double-blind Treatment|Overall Study||12
453933|NCT00606593|1083545|P4|1st Double-blind Treatment|Overall Study||11
453934|NCT00606593|1083546|P3|1st Double-blind Treatment|Overall Study||11
453935|NCT00606593|1083547|P2|1st Double-blind Treatment|Overall Study||11
453936|NCT00606593|1083548|P1|1st Double-blind Treatment|Overall Study||11
453937|NCT00606593|1083539|P10|STARTED|Overall Study|Randomized participants|11
453938|NCT00606593|1083540|P9|STARTED|Overall Study|Randomized participants|12
453939|NCT00606593|1083541|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
453940|NCT00606593|1083542|P7|STARTED|Overall Study|Randomized participants|11
453941|NCT00606593|1083543|P6|STARTED|Overall Study|Randomized participants|11
453942|NCT00606593|1083544|P5|STARTED|Overall Study|Randomized participants|12
453943|NCT00606593|1083545|P4|STARTED|Overall Study|Randomized participants|11
453944|NCT00606593|1083546|P3|STARTED|Overall Study|Randomized participants|11
453945|NCT00606593|1083547|P2|STARTED|Overall Study|Randomized participants|11
453946|NCT00606593|1083548|P1|STARTED|Overall Study|Randomized participants|11
453947|NCT00606580|1083569|P3|NOT COMPLETED|Overall Study||22
453948|NCT00606580|1083570|P2|NOT COMPLETED|Overall Study||3
453949|NCT00606580|1083571|P1|NOT COMPLETED|Overall Study||2
453950|NCT00606580|1083569|P3|COMPLETED|Overall Study||103
453951|NCT00606580|1083570|P2|COMPLETED|Overall Study||122
453952|NCT00606580|1083571|P1|COMPLETED|Overall Study||123
453953|NCT00606580|1083569|P3|STARTED|Overall Study||125
453954|NCT00606580|1083570|P2|STARTED|Overall Study||125
453955|NCT00606580|1083571|P1|STARTED|Overall Study||125
453956|NCT00606554|1083614|P2|NOT COMPLETED|Overall Study||0
453957|NCT00606554|1083615|P1|NOT COMPLETED|Overall Study||0
453958|NCT00606554|1083614|P2|COMPLETED|Overall Study||18
453959|NCT00606554|1083615|P1|COMPLETED|Overall Study||15
453960|NCT00606554|1083614|P2|STARTED|Overall Study||18
453961|NCT00606554|1083615|P1|STARTED|Overall Study||15
453962|NCT00606502|1083627|P2|NOT COMPLETED|Treatment||3
453963|NCT00606502|1083628|P1|NOT COMPLETED|Treatment||0
453964|NCT00606502|1083627|P2|COMPLETED|Treatment||98
453965|NCT00606502|1083628|P1|COMPLETED|Treatment||97
453966|NCT00606502|1083627|P2|STARTED|Treatment||101
453967|NCT00606502|1083628|P1|STARTED|Treatment||97
453968|NCT00606502|1083627|P2|NOT COMPLETED|Randomization||0
453969|NCT00606502|1083628|P1|NOT COMPLETED|Randomization||3
453970|NCT00606502|1083627|P2|COMPLETED|Randomization||101
453971|NCT00606502|1083628|P1|COMPLETED|Randomization||97
453972|NCT00606502|1083627|P2|STARTED|Randomization||101
453973|NCT00606502|1083628|P1|STARTED|Randomization||100
453974|NCT00606489|1083642|P2|NOT COMPLETED|Overall Study||0
453975|NCT00606489|1083643|P1|NOT COMPLETED|Overall Study||0
453976|NCT00606489|1083642|P2|COMPLETED|Overall Study||40
453977|NCT00606489|1083643|P1|COMPLETED|Overall Study||21
453978|NCT00606489|1083642|P2|STARTED|Overall Study||40
453979|NCT00606489|1083643|P1|STARTED|Overall Study||21
453980|NCT00606320|1083649|P1|NOT COMPLETED|Overall Study||37
453981|NCT00606320|1083649|P1|COMPLETED|Overall Study||22
453982|NCT00606320|1083649|P1|STARTED|Overall Study||59
453983|NCT00606281|1083656|P2|NOT COMPLETED|Overall Study||66
453984|NCT00606281|1083657|P1|NOT COMPLETED|Overall Study||56
453985|NCT00606281|1083656|P2|COMPLETED|Overall Study||64
453986|NCT00606281|1083657|P1|COMPLETED|Overall Study||72
453987|NCT00606281|1083656|P2|STARTED|Overall Study||130
453988|NCT00606281|1083657|P1|STARTED|Overall Study||128
453989|NCT00606229|1083665|P1|NOT COMPLETED|Overall Study||22
453990|NCT00606229|1083665|P1|COMPLETED|Overall Study||19
453991|NCT00606229|1083665|P1|STARTED|Overall Study||41
453992|NCT00606177|1083672|P2|NOT COMPLETED|Overall Study||25
453993|NCT00606177|1083673|P1|NOT COMPLETED|Overall Study||27
453994|NCT00606177|1083672|P2|COMPLETED|Overall Study||19
453995|NCT00606177|1083673|P1|COMPLETED|Overall Study||28
453996|NCT00606177|1083672|P2|STARTED|Overall Study||44
453997|NCT00606177|1083673|P1|STARTED|Overall Study||55
453998|NCT00606138|1083683|P2|NOT COMPLETED|Overall Study||0
453999|NCT00606138|1083684|P1|NOT COMPLETED|Overall Study||0
454000|NCT00606138|1083683|P2|COMPLETED|Overall Study||2
454001|NCT00606138|1083684|P1|COMPLETED|Overall Study||6
454002|NCT00606138|1083683|P2|STARTED|Overall Study||2
454003|NCT00606138|1083684|P1|STARTED|Overall Study||6
454004|NCT00606086|1083700|P2|NOT COMPLETED|Overall Study||15
454005|NCT00606086|1083701|P1|NOT COMPLETED|Overall Study||12
454006|NCT00606086|1083700|P2|COMPLETED|Overall Study||53
454007|NCT00606086|1083701|P1|COMPLETED|Overall Study||60
454008|NCT00606086|1083700|P2|STARTED|Overall Study||68
454009|NCT00606086|1083701|P1|STARTED|Overall Study||72
454010|NCT00606034|1083707|P1|NOT COMPLETED|Overall Study||1
454011|NCT00606034|1083707|P1|COMPLETED|Overall Study||20
454012|NCT00606034|1083707|P1|STARTED|Overall Study||21
454013|NCT00606021|1083715|P3|NOT COMPLETED|Maintenance Phase||17
454014|NCT00606021|1083716|P2|NOT COMPLETED|Maintenance Phase||23
454015|NCT00606021|1083717|P1|NOT COMPLETED|Maintenance Phase||0
454016|NCT00606021|1083715|P3|COMPLETED|Maintenance Phase||10
454017|NCT00606021|1083716|P2|COMPLETED|Maintenance Phase||5
454018|NCT00606021|1083717|P1|COMPLETED|Maintenance Phase||0
454019|NCT00606021|1083715|P3|STARTED|Maintenance Phase||27
454020|NCT00606021|1083716|P2|STARTED|Maintenance Phase||28
454021|NCT00606021|1083717|P1|STARTED|Maintenance Phase||0
454022|NCT00606021|1083715|P3|NOT COMPLETED|Induction Phase||0
454023|NCT00606021|1083716|P2|NOT COMPLETED|Induction Phase||0
454024|NCT00606021|1083717|P1|NOT COMPLETED|Induction Phase||87
454025|NCT00606021|1083715|P3|COMPLETED|Induction Phase||0
454026|NCT00606021|1083716|P2|COMPLETED|Induction Phase||0
454027|NCT00606021|1083717|P1|COMPLETED|Induction Phase||19
454028|NCT00606021|1083715|P3|STARTED|Induction Phase||0
454029|NCT00606021|1083716|P2|STARTED|Induction Phase||0
454030|NCT00606021|1083717|P1|STARTED|Induction Phase||106
454031|NCT00606008|1083735|P1|NOT COMPLETED|Overall Study||5
454032|NCT00606008|1083735|P1|COMPLETED|Overall Study||25
454033|NCT00606008|1083735|P1|STARTED|Overall Study||30
454034|NCT00605917|1083749|P1|NOT COMPLETED|Overall Study||79
454035|NCT00605917|1083749|P1|COMPLETED|Overall Study||908
454036|NCT00605917|1083749|P1|STARTED|Overall Study||987
454037|NCT00605904|1083790|P2|NOT COMPLETED|Infusion Sessions||3
454038|NCT00605904|1083791|P1|NOT COMPLETED|Infusion Sessions||1
454039|NCT00605904|1083790|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
454040|NCT00605904|1083791|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
454041|NCT00605904|1083790|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
454042|NCT00605904|1083791|P1|Yohimbine Infusion|Infusion Sessions||12
454043|NCT00605904|1083790|P2|mCPP Infusion|Infusion Sessions||13
454044|NCT00605904|1083791|P1|mCPP Infusion|Infusion Sessions||12
454045|NCT00605904|1083790|P2|Saline Infusion|Infusion Sessions||14
454046|NCT00605904|1083791|P1|Saline Infusion|Infusion Sessions||13
454047|NCT00605904|1083790|P2|STARTED|Infusion Sessions||16
454048|NCT00605904|1083791|P1|STARTED|Infusion Sessions||13
454049|NCT00605904|1083790|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
454050|NCT00605904|1083791|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
454051|NCT00605904|1083790|P2|COMPLETED|Baseline Data Collection and Dosing||16
454052|NCT00605904|1083791|P1|COMPLETED|Baseline Data Collection and Dosing||13
454053|NCT00605904|1083790|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
454054|NCT00605904|1083791|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
454055|NCT00605865|1083801|P1|NOT COMPLETED|Overall Study||115
454056|NCT00605865|1083801|P1|COMPLETED|Overall Study||2157
454057|NCT00605865|1083801|P1|STARTED|Overall Study||2272
454058|NCT00605839|1083843|P3|NOT COMPLETED|Overall Study||0
454059|NCT00605839|1083844|P2|NOT COMPLETED|Overall Study||0
454060|NCT00605839|1083845|P1|NOT COMPLETED|Overall Study||1
454061|NCT00605839|1083843|P3|COMPLETED|Overall Study||28
454062|NCT00605839|1083844|P2|COMPLETED|Overall Study||37
454157|NCT00605280|1084153|P2|COMPLETED|Year 3 Extension||0
454063|NCT00605839|1083845|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
454064|NCT00605839|1083843|P3|STARTED|Overall Study||28
454065|NCT00605839|1083844|P2|STARTED|Overall Study||37
454066|NCT00605839|1083845|P1|STARTED|Overall Study||40
454067|NCT00605813|1083853|P1|NOT COMPLETED|Overall Study||25
454068|NCT00605813|1083853|P1|COMPLETED|Overall Study||517
454069|NCT00605813|1083853|P1|STARTED|Overall Study||542
454070|NCT00605722|1083866|P1|NOT COMPLETED|Overall Study||51
454071|NCT00605722|1083866|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
454072|NCT00605722|1083866|P1|STARTED|Overall Study||51
454073|NCT00605696|1083878|P2|NOT COMPLETED|Overall Study||0
454074|NCT00605696|1083879|P1|NOT COMPLETED|Overall Study||0
454075|NCT00605696|1083878|P2|COMPLETED|Overall Study||11
454076|NCT00605696|1083879|P1|COMPLETED|Overall Study||7
454077|NCT00605696|1083878|P2|STARTED|Overall Study||11
454078|NCT00605696|1083879|P1|STARTED|Overall Study||7
454079|NCT00605657|1083887|P1|NOT COMPLETED|Overall Study||2
454080|NCT00605657|1083887|P1|COMPLETED|Overall Study||3
454081|NCT00605657|1083887|P1|STARTED|Overall Study||5
454082|NCT00605540|1083892|P1|NOT COMPLETED|Overall Study||38
454083|NCT00605540|1083892|P1|COMPLETED|Overall Study||95
454084|NCT00605540|1083892|P1|STARTED|Overall Study||133
454085|NCT00605475|1083910|P10|NOT COMPLETED|Overall Study||2
454086|NCT00605475|1083911|P9|NOT COMPLETED|Overall Study||2
454087|NCT00605475|1083912|P8|NOT COMPLETED|Overall Study||0
454088|NCT00605475|1083913|P7|NOT COMPLETED|Overall Study||1
454089|NCT00605475|1083914|P6|NOT COMPLETED|Overall Study||2
454090|NCT00605475|1083915|P5|NOT COMPLETED|Overall Study||1
454091|NCT00605475|1083916|P4|NOT COMPLETED|Overall Study||0
454092|NCT00605475|1083917|P3|NOT COMPLETED|Overall Study||0
454093|NCT00605475|1083918|P2|NOT COMPLETED|Overall Study||0
454094|NCT00605475|1083919|P1|NOT COMPLETED|Overall Study||0
454095|NCT00605475|1083910|P10|COMPLETED|Overall Study||8
454096|NCT00605475|1083911|P9|COMPLETED|Overall Study||18
454097|NCT00605475|1083912|P8|COMPLETED|Overall Study||24
454098|NCT00605475|1083913|P7|COMPLETED|Overall Study||22
454099|NCT00605475|1083914|P6|COMPLETED|Overall Study||22
454100|NCT00605475|1083915|P5|COMPLETED|Overall Study||24
454101|NCT00605475|1083916|P4|COMPLETED|Overall Study||45
454102|NCT00605475|1083917|P3|COMPLETED|Overall Study||45
454103|NCT00605475|1083918|P2|COMPLETED|Overall Study||5
454104|NCT00605475|1083919|P1|COMPLETED|Overall Study||10
454105|NCT00605475|1083910|P10|STARTED|Overall Study||10
454106|NCT00605475|1083911|P9|STARTED|Overall Study||20
454107|NCT00605475|1083912|P8|STARTED|Overall Study||24
454108|NCT00605475|1083913|P7|STARTED|Overall Study||23
454109|NCT00605475|1083914|P6|STARTED|Overall Study||24
454110|NCT00605475|1083915|P5|STARTED|Overall Study||25
454111|NCT00605475|1083916|P4|STARTED|Overall Study||45
454112|NCT00605475|1083917|P3|STARTED|Overall Study||45
454113|NCT00605475|1083918|P2|STARTED|Overall Study||5
454114|NCT00605475|1083919|P1|STARTED|Overall Study||10
454115|NCT00605423|1084043|P2|NOT COMPLETED|Overall Study||0
454116|NCT00605423|1084044|P1|NOT COMPLETED|Overall Study||0
454117|NCT00605423|1084043|P2|COMPLETED|Overall Study||2
454118|NCT00605423|1084044|P1|COMPLETED|Overall Study||4
454119|NCT00605423|1084043|P2|STARTED|Overall Study||2
454120|NCT00605423|1084044|P1|STARTED|Overall Study||4
454121|NCT00605384|1084056|P2|NOT COMPLETED|Overall Study||1
454122|NCT00605384|1084057|P1|NOT COMPLETED|Overall Study||1
454123|NCT00605384|1084056|P2|COMPLETED|Overall Study|study terminated early|0
454124|NCT00605384|1084057|P1|COMPLETED|Overall Study|study terminated early|0
454125|NCT00605384|1084056|P2|STARTED|Overall Study||1
454126|NCT00605384|1084057|P1|STARTED|Overall Study||1
454127|NCT00605358|1084087|P2|NOT COMPLETED|Overall Study||0
454128|NCT00605358|1084088|P1|NOT COMPLETED|Overall Study||0
454129|NCT00605358|1084087|P2|COMPLETED|Overall Study||80
454130|NCT00605358|1084088|P1|COMPLETED|Overall Study||81
454131|NCT00605358|1084087|P2|STARTED|Overall Study||80
454132|NCT00605358|1084088|P1|STARTED|Overall Study||81
454133|NCT00605345|1084096|P2|NOT COMPLETED|Overall Study||3
454134|NCT00605345|1084097|P1|NOT COMPLETED|Overall Study||1
454135|NCT00605345|1084096|P2|COMPLETED|Overall Study||22
454136|NCT00605345|1084097|P1|COMPLETED|Overall Study||45
454137|NCT00605345|1084096|P2|STARTED|Overall Study||25
454138|NCT00605345|1084097|P1|STARTED|Overall Study||46
454139|NCT00605306|1084115|P2|NOT COMPLETED|Overall Study||1
454140|NCT00605306|1084116|P1|NOT COMPLETED|Overall Study||0
454141|NCT00605306|1084115|P2|COMPLETED|Overall Study||13
454142|NCT00605306|1084116|P1|COMPLETED|Overall Study||14
454143|NCT00605306|1084115|P2|STARTED|Overall Study||14
454144|NCT00605306|1084116|P1|STARTED|Overall Study||14
454145|NCT00605293|1084130|P2|NOT COMPLETED|Overall Study||5
454146|NCT00605293|1084131|P1|NOT COMPLETED|Overall Study||17
454147|NCT00605293|1084130|P2|COMPLETED|Overall Study||31
454148|NCT00605293|1084131|P1|COMPLETED|Overall Study||48
454149|NCT00605293|1084130|P2|STARTED|Overall Study||36
454150|NCT00605293|1084131|P1|STARTED|Overall Study||65
454151|NCT00605280|1084151|P4|NOT COMPLETED|Year 3 Extension||9
454152|NCT00605280|1084152|P3|NOT COMPLETED|Year 3 Extension||0
454153|NCT00605280|1084153|P2|NOT COMPLETED|Year 3 Extension||0
454154|NCT00605280|1084154|P1|NOT COMPLETED|Year 3 Extension||8
454155|NCT00605280|1084151|P4|COMPLETED|Year 3 Extension||45
454156|NCT00605280|1084152|P3|COMPLETED|Year 3 Extension||0
454158|NCT00605280|1084154|P1|COMPLETED|Year 3 Extension||38
454159|NCT00605280|1084151|P4|Received 0.3 mg Treatment|Year 3 Extension||54
454160|NCT00605280|1084152|P3|Received 0.3 mg Treatment|Year 3 Extension||0
454161|NCT00605280|1084153|P2|Received 0.3 mg Treatment|Year 3 Extension||0
454162|NCT00605280|1084154|P1|Received 0.3 mg Treatment|Year 3 Extension||46
454163|NCT00605280|1084151|P4|STARTED|Year 3 Extension||54
454164|NCT00605280|1084152|P3|STARTED|Year 3 Extension||0
454165|NCT00605280|1084153|P2|STARTED|Year 3 Extension||0
454166|NCT00605280|1084154|P1|STARTED|Year 3 Extension||46
454167|NCT00605280|1084151|P4|NOT COMPLETED|Year 2||22
454168|NCT00605280|1084152|P3|NOT COMPLETED|Year 2||6
454169|NCT00605280|1084153|P2|NOT COMPLETED|Year 2||6
454170|NCT00605280|1084154|P1|NOT COMPLETED|Year 2||24
454171|NCT00605280|1084151|P4|COMPLETED|Year 2||102
454172|NCT00605280|1084152|P3|COMPLETED|Year 2||0
454173|NCT00605280|1084153|P2|COMPLETED|Year 2||5
454174|NCT00605280|1084154|P1|COMPLETED|Year 2||102
454175|NCT00605280|1084151|P4|Received 0.3 mg Treatment|Year 2||0
454176|NCT00605280|1084152|P3|Received 0.3 mg Treatment|Year 2||2
454177|NCT00605280|1084153|P2|Received 0.3 mg Treatment|Year 2||3
454178|NCT00605280|1084154|P1|Received 0.3 mg Treatment|Year 2||126
454179|NCT00605280|1084151|P4|STARTED|Year 2||124
454180|NCT00605280|1084152|P3|STARTED|Year 2||6
454181|NCT00605280|1084153|P2|STARTED|Year 2||11
454182|NCT00605280|1084154|P1|STARTED|Year 2||126
454183|NCT00605280|1084151|P4|NOT COMPLETED|Year 1||19
454184|NCT00605280|1084152|P3|NOT COMPLETED|Year 1||1
454185|NCT00605280|1084153|P2|NOT COMPLETED|Year 1||11
454186|NCT00605280|1084154|P1|NOT COMPLETED|Year 1||19
454187|NCT00605280|1084151|P4|COMPLETED|Year 1||124
454188|NCT00605280|1084152|P3|COMPLETED|Year 1||6
454189|NCT00605280|1084153|P2|COMPLETED|Year 1||11
454190|NCT00605280|1084154|P1|COMPLETED|Year 1||126
454191|NCT00605280|1084151|P4|Received 0.3 mg Treatment|Year 1||0
454192|NCT00605280|1084152|P3|Received 0.3 mg Treatment|Year 1||3
454193|NCT00605280|1084153|P2|Received 0.3 mg Treatment|Year 1||13
454194|NCT00605280|1084154|P1|Received 0.3 mg Treatment|Year 1||144
454195|NCT00605280|1084151|P4|STARTED|Year 1||143
454196|NCT00605280|1084152|P3|STARTED|Year 1||7
454197|NCT00605280|1084153|P2|STARTED|Year 1||22
454198|NCT00605280|1084154|P1|STARTED|Year 1||145
454199|NCT00605267|1084188|P2|NOT COMPLETED|Overall Study||9
454200|NCT00605267|1084189|P1|NOT COMPLETED|Overall Study||3
454201|NCT00605267|1084188|P2|COMPLETED|Overall Study|Breast surgery performed|90
454202|NCT00605267|1084189|P1|COMPLETED|Overall Study|Breast surgery performed|95
454203|NCT00605267|1084188|P2|STARTED|Overall Study||99
454204|NCT00605267|1084189|P1|STARTED|Overall Study||98
454205|NCT00605202|1084227|P2|NOT COMPLETED|Second Intervention||0
454206|NCT00605202|1084228|P1|NOT COMPLETED|Second Intervention||0
454207|NCT00605202|1084227|P2|COMPLETED|Second Intervention||5
454208|NCT00605202|1084228|P1|COMPLETED|Second Intervention||5
454209|NCT00605202|1084227|P2|STARTED|Second Intervention||5
454210|NCT00605202|1084228|P1|STARTED|Second Intervention||5
454211|NCT00605202|1084227|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
454212|NCT00605202|1084228|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
454213|NCT00605202|1084227|P2|COMPLETED|Washout Period of 3 Weeks||5
454214|NCT00605202|1084228|P1|COMPLETED|Washout Period of 3 Weeks||5
454215|NCT00605202|1084227|P2|STARTED|Washout Period of 3 Weeks||5
454216|NCT00605202|1084228|P1|STARTED|Washout Period of 3 Weeks||5
454217|NCT00605202|1084227|P2|NOT COMPLETED|First Intervention||0
454218|NCT00605202|1084228|P1|NOT COMPLETED|First Intervention||0
454219|NCT00605202|1084227|P2|COMPLETED|First Intervention||5
454220|NCT00605202|1084228|P1|COMPLETED|First Intervention||5
454221|NCT00605202|1084227|P2|STARTED|First Intervention||5
454222|NCT00605202|1084228|P1|STARTED|First Intervention||5
454223|NCT00605176|1084237|P3|NOT COMPLETED|Overall Study||9
454224|NCT00605176|1084238|P2|NOT COMPLETED|Overall Study||6
454225|NCT00605176|1084239|P1|NOT COMPLETED|Overall Study||11
454226|NCT00605176|1084237|P3|COMPLETED|Overall Study||150
454227|NCT00605176|1084238|P2|COMPLETED|Overall Study||154
454228|NCT00605176|1084239|P1|COMPLETED|Overall Study||149
454229|NCT00605176|1084237|P3|STARTED|Overall Study||159
454230|NCT00605176|1084238|P2|STARTED|Overall Study||160
454231|NCT00605176|1084239|P1|STARTED|Overall Study||160
454232|NCT00605150|1084256|P1|NOT COMPLETED|Overall Study||1
454233|NCT00605150|1084256|P1|COMPLETED|Overall Study||10
454234|NCT00605150|1084256|P1|STARTED|Overall Study|11 started|11
454235|NCT00605085|1084262|P2|NOT COMPLETED|Overall Study||25
454236|NCT00605085|1084263|P1|NOT COMPLETED|Overall Study||50
454237|NCT00605085|1084262|P2|COMPLETED|Overall Study||638
454238|NCT00605085|1084263|P1|COMPLETED|Overall Study||1962
454239|NCT00605085|1084262|P2|STARTED|Overall Study||663
454240|NCT00605085|1084263|P1|STARTED|Overall Study||2012
454241|NCT00605072|1084272|P3|NOT COMPLETED|Overall Study||4
454242|NCT00605072|1084273|P2|NOT COMPLETED|Overall Study||11
454243|NCT00605072|1084274|P1|NOT COMPLETED|Overall Study||7
454244|NCT00605072|1084272|P3|COMPLETED|Overall Study||11
454245|NCT00605072|1084273|P2|COMPLETED|Overall Study||9
454246|NCT00605072|1084274|P1|COMPLETED|Overall Study||11
454247|NCT00605072|1084272|P3|STARTED|Overall Study||15
454248|NCT00605072|1084273|P2|STARTED|Overall Study||20
454249|NCT00605072|1084274|P1|STARTED|Overall Study||18
454250|NCT00605033|1084296|P2|NOT COMPLETED|Overall Study||8
454251|NCT00605033|1084297|P1|NOT COMPLETED|Overall Study||7
454252|NCT00605033|1084296|P2|COMPLETED|Overall Study||90
454253|NCT00605033|1084297|P1|COMPLETED|Overall Study||136
454254|NCT00605033|1084296|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
454255|NCT00605033|1084297|P1|STARTED|Overall Study||143
454256|NCT00604968|1084303|P1|NOT COMPLETED|Overall Study||0
454257|NCT00604968|1084303|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
454258|NCT00604968|1084303|P1|STARTED|Overall Study||25
454259|NCT00604851|1084318|P2|NOT COMPLETED|Overall Study||26
454260|NCT00604851|1084319|P1|NOT COMPLETED|Overall Study||17
454261|NCT00604851|1084318|P2|COMPLETED|Overall Study||131
454262|NCT00604851|1084319|P1|COMPLETED|Overall Study||132
454263|NCT00604851|1084318|P2|STARTED|Overall Study||157
454264|NCT00604851|1084319|P1|STARTED|Overall Study||149
454265|NCT00604812|1084328|P6|NOT COMPLETED|Overall Study||0
454266|NCT00604812|1084329|P5|NOT COMPLETED|Overall Study||0
454267|NCT00604812|1084330|P4|NOT COMPLETED|Overall Study||0
454268|NCT00604812|1084331|P3|NOT COMPLETED|Overall Study||0
454269|NCT00604812|1084332|P2|NOT COMPLETED|Overall Study||0
454270|NCT00604812|1084333|P1|NOT COMPLETED|Overall Study||0
454271|NCT00604812|1084328|P6|COMPLETED|Overall Study||1
454272|NCT00604812|1084329|P5|COMPLETED|Overall Study||5
454273|NCT00604812|1084330|P4|COMPLETED|Overall Study||3
454274|NCT00604812|1084331|P3|COMPLETED|Overall Study||10
454275|NCT00604812|1084332|P2|COMPLETED|Overall Study||3
454276|NCT00604812|1084333|P1|COMPLETED|Overall Study||9
454277|NCT00604812|1084328|P6|STARTED|Overall Study||1
454278|NCT00604812|1084329|P5|STARTED|Overall Study||5
454279|NCT00604812|1084330|P4|STARTED|Overall Study||3
454280|NCT00604812|1084331|P3|STARTED|Overall Study||10
454281|NCT00604812|1084332|P2|STARTED|Overall Study||3
454282|NCT00604812|1084333|P1|STARTED|Overall Study||9
454283|NCT00604786|1084355|P2|NOT COMPLETED|Overall Study||0
454284|NCT00604786|1084356|P1|NOT COMPLETED|Overall Study||2
454285|NCT00604786|1084355|P2|COMPLETED|Overall Study||4
454286|NCT00604786|1084356|P1|COMPLETED|Overall Study||12
454287|NCT00604786|1084355|P2|STARTED|Overall Study||4
454288|NCT00604786|1084356|P1|STARTED|Overall Study||14
454289|NCT00604721|1084362|P1|NOT COMPLETED|Overall Study||2
454290|NCT00604721|1084362|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
454291|NCT00604721|1084362|P1|STARTED|Overall Study||19
454292|NCT00604708|1084370|P2|NOT COMPLETED|Overall Study||40
454293|NCT00604708|1084371|P1|NOT COMPLETED|Overall Study||31
454294|NCT00604708|1084370|P2|COMPLETED|Overall Study||397
454295|NCT00604708|1084371|P1|COMPLETED|Overall Study||399
454296|NCT00604708|1084370|P2|STARTED|Overall Study||437
454297|NCT00604708|1084371|P1|STARTED|Overall Study||430
454298|NCT00604695|1084381|P2|NOT COMPLETED|Overall Study||4
454299|NCT00604695|1084382|P1|NOT COMPLETED|Overall Study||0
454300|NCT00604695|1084381|P2|COMPLETED|Overall Study||16
454301|NCT00604695|1084382|P1|COMPLETED|Overall Study||20
454302|NCT00604695|1084381|P2|STARTED|Overall Study||20
454303|NCT00604695|1084382|P1|STARTED|Overall Study||20
454304|NCT00604669|1084404|P1|NOT COMPLETED|Overall Study||7
454305|NCT00604669|1084404|P1|COMPLETED|Overall Study||163
454306|NCT00604669|1084404|P1|STARTED|Overall Study||170
454307|NCT00604565|1084410|P2|NOT COMPLETED|Overall Study||3
454308|NCT00604565|1084411|P1|NOT COMPLETED|Overall Study||0
454309|NCT00604565|1084410|P2|COMPLETED|Overall Study||4
454310|NCT00604565|1084411|P1|COMPLETED|Overall Study||4
454311|NCT00604565|1084410|P2|STARTED|Overall Study||7
454312|NCT00604565|1084411|P1|STARTED|Overall Study||4
454313|NCT00604552|1084421|P2|NOT COMPLETED|Overall Study||0
454314|NCT00604552|1084422|P1|NOT COMPLETED|Overall Study||0
454315|NCT00604552|1084421|P2|COMPLETED|Overall Study||160
454316|NCT00604552|1084422|P1|COMPLETED|Overall Study||189
454317|NCT00604552|1084421|P2|STARTED|Overall Study||160
454318|NCT00604552|1084422|P1|STARTED|Overall Study||189
454319|NCT00604500|1084428|P1|NOT COMPLETED|Overall Study||11
454320|NCT00604500|1084428|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
454321|NCT00604500|1084428|P1|STARTED|Overall Study||272
454322|NCT00604461|1084435|P1|NOT COMPLETED|Overall Study||1
454323|NCT00604461|1084435|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
454324|NCT00604461|1084435|P1|STARTED|Overall Study||13
454325|NCT00604383|1084442|P2|NOT COMPLETED|Overall Study||84
454326|NCT00604383|1084443|P1|NOT COMPLETED|Overall Study||87
454327|NCT00604383|1084442|P2|COMPLETED|Overall Study||256
454328|NCT00604383|1084443|P1|COMPLETED|Overall Study||258
454329|NCT00604383|1084442|P2|Received Extended Treatment|Overall Study||141
454330|NCT00604383|1084443|P1|Received Extended Treatment|Overall Study||136
454331|NCT00604383|1084442|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
454332|NCT00604383|1084443|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
454333|NCT00604383|1084442|P2|STARTED|Overall Study||340
454334|NCT00604383|1084443|P1|STARTED|Overall Study||345
454335|NCT00604279|1084459|P2|NOT COMPLETED|Overall Study||38
454336|NCT00604279|1084460|P1|NOT COMPLETED|Overall Study||64
454337|NCT00604279|1084459|P2|COMPLETED|Overall Study||185
454338|NCT00604279|1084460|P1|COMPLETED|Overall Study||165
454339|NCT00604279|1084459|P2|STARTED|Overall Study||223
454340|NCT00604279|1084460|P1|STARTED|Overall Study||229
454341|NCT00604214|1084476|P2|NOT COMPLETED|Day 91 to Day 180||32
454342|NCT00604214|1084477|P1|NOT COMPLETED|Day 91 to Day 180||26
454343|NCT00604214|1084476|P2|COMPLETED|Day 91 to Day 180||521
454344|NCT00604214|1084477|P1|COMPLETED|Day 91 to Day 180||529
454345|NCT00604214|1084476|P2|STARTED|Day 91 to Day 180||553
454346|NCT00604214|1084477|P1|STARTED|Day 91 to Day 180||555
454347|NCT00604214|1084476|P2|NOT COMPLETED|Day 29 to Day 90||79
454348|NCT00604214|1084477|P1|NOT COMPLETED|Day 29 to Day 90||68
454349|NCT00604214|1084476|P2|COMPLETED|Day 29 to Day 90||553
454350|NCT00604214|1084477|P1|COMPLETED|Day 29 to Day 90||555
454351|NCT00604214|1084476|P2|STARTED|Day 29 to Day 90||632
454352|NCT00604214|1084477|P1|STARTED|Day 29 to Day 90||623
454353|NCT00604214|1084476|P2|NOT COMPLETED|Baseline to Day 28||213
454354|NCT00604214|1084477|P1|NOT COMPLETED|Baseline to Day 28||228
454355|NCT00604214|1084476|P2|COMPLETED|Baseline to Day 28||632
454356|NCT00604214|1084477|P1|COMPLETED|Baseline to Day 28||623
454357|NCT00604214|1084476|P2|Received Study Drug|Baseline to Day 28||833
454358|NCT00604214|1084477|P1|Received Study Drug|Baseline to Day 28||833
454359|NCT00604214|1084476|P2|STARTED|Baseline to Day 28||845
454360|NCT00604214|1084477|P1|STARTED|Baseline to Day 28||851
454361|NCT00604188|1084509|P2|NOT COMPLETED|Overall Study||25
454362|NCT00604188|1084510|P1|NOT COMPLETED|Overall Study||27
454363|NCT00604188|1084509|P2|COMPLETED|Overall Study||70
454364|NCT00604188|1084510|P1|COMPLETED|Overall Study||66
454365|NCT00604188|1084509|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
454366|NCT00604188|1084510|P1|STARTED|Overall Study||93
454367|NCT00604175|1084533|P3|NOT COMPLETED|Week 29 Through Week 72||4
454368|NCT00604175|1084534|P2|NOT COMPLETED|Week 29 Through Week 72||7
454369|NCT00604175|1084535|P1|NOT COMPLETED|Week 29 Through Week 72||12
454370|NCT00604175|1084533|P3|COMPLETED|Week 29 Through Week 72||89
454371|NCT00604175|1084534|P2|COMPLETED|Week 29 Through Week 72||85
454372|NCT00604175|1084535|P1|COMPLETED|Week 29 Through Week 72||108
454373|NCT00604175|1084533|P3|STARTED|Week 29 Through Week 72||93
454374|NCT00604175|1084534|P2|STARTED|Week 29 Through Week 72||92
454375|NCT00604175|1084535|P1|STARTED|Week 29 Through Week 72||120
454376|NCT00604175|1084533|P3|NOT COMPLETED|Entry Through Week 28||1
454377|NCT00604175|1084534|P2|NOT COMPLETED|Entry Through Week 28||3
454378|NCT00604175|1084535|P1|NOT COMPLETED|Entry Through Week 28||10
454379|NCT00604175|1084533|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
454380|NCT00604175|1084534|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
454381|NCT00604175|1084535|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
454382|NCT00604175|1084533|P3|STARTED|Entry Through Week 28||94
454383|NCT00604175|1084534|P2|STARTED|Entry Through Week 28||95
454384|NCT00604175|1084535|P1|STARTED|Entry Through Week 28||130
454385|NCT00604162|1084588|P1|NOT COMPLETED|Overall Study||4
454386|NCT00604162|1084588|P1|COMPLETED|Overall Study||328
454387|NCT00604162|1084588|P1|STARTED|Overall Study||332
454388|NCT00604045|1084601|P2|NOT COMPLETED|Overall Study||1
454389|NCT00604045|1084602|P1|NOT COMPLETED|Overall Study||1
454390|NCT00604045|1084601|P2|COMPLETED|Overall Study||9
454391|NCT00604045|1084602|P1|COMPLETED|Overall Study||14
454392|NCT00604045|1084601|P2|STARTED|Overall Study||10
454393|NCT00604045|1084602|P1|STARTED|Overall Study||15
454394|NCT00604019|1084610|P2|NOT COMPLETED|Overall Study||0
454395|NCT00604019|1084611|P1|NOT COMPLETED|Overall Study||0
454396|NCT00604019|1084610|P2|COMPLETED|Overall Study||118
454397|NCT00604019|1084611|P1|COMPLETED|Overall Study||134
454398|NCT00604019|1084610|P2|STARTED|Overall Study||118
454399|NCT00604019|1084611|P1|STARTED|Overall Study||134
454400|NCT00603993|1084617|P1|NOT COMPLETED|Overall Study||20
454401|NCT00603993|1084617|P1|COMPLETED|Overall Study||68
454402|NCT00603993|1084617|P1|STARTED|Overall Study||88
454403|NCT00603915|1084630|P1|NOT COMPLETED|Overall Study||1
454404|NCT00603915|1084630|P1|COMPLETED|Overall Study||19
454405|NCT00603915|1084630|P1|STARTED|Overall Study||20
454406|NCT00603902|1084638|P3|NOT COMPLETED|Overall Study||769
454407|NCT00603902|1084639|P2|NOT COMPLETED|Overall Study||686
454408|NCT00603902|1084640|P1|NOT COMPLETED|Overall Study||329
454409|NCT00603902|1084638|P3|COMPLETED|Overall Study||834
454410|NCT00603902|1084639|P2|COMPLETED|Overall Study||917
454411|NCT00603902|1084640|P1|COMPLETED|Overall Study||473
454412|NCT00603902|1084638|P3|STARTED|Overall Study||1603
454413|NCT00603902|1084639|P2|STARTED|Overall Study||1603
454414|NCT00603902|1084640|P1|STARTED|Overall Study||802
454415|NCT00603889|1084651|P1|NOT COMPLETED|Overall Study||0
454416|NCT00603889|1084651|P1|COMPLETED|Overall Study||12
454417|NCT00603889|1084651|P1|STARTED|Overall Study||12
454418|NCT00603837|1084660|P2|NOT COMPLETED|Overall Study||0
454419|NCT00603837|1084661|P1|NOT COMPLETED|Overall Study||3
454420|NCT00603837|1084660|P2|COMPLETED|Overall Study||19
454421|NCT00603837|1084661|P1|COMPLETED|Overall Study||17
454422|NCT00603837|1084660|P2|STARTED|Overall Study||19
454423|NCT00603837|1084661|P1|STARTED|Overall Study||20
454424|NCT00603798|1084670|P3|NOT COMPLETED|Overall Study||10
454425|NCT00603798|1084671|P2|NOT COMPLETED|Overall Study||7
454426|NCT00603798|1084672|P1|NOT COMPLETED|Overall Study||10
454427|NCT00603798|1084670|P3|COMPLETED|Overall Study||154
454428|NCT00603798|1084671|P2|COMPLETED|Overall Study||157
454429|NCT00603798|1084672|P1|COMPLETED|Overall Study||152
454430|NCT00603798|1084670|P3|STARTED|Overall Study||164
454431|NCT00603798|1084671|P2|STARTED|Overall Study||164
454432|NCT00603798|1084672|P1|STARTED|Overall Study||162
454433|NCT00603746|1084695|P6|NOT COMPLETED|Overall Study||13
454434|NCT00603746|1084696|P5|NOT COMPLETED|Overall Study||17
454435|NCT00603746|1084697|P4|NOT COMPLETED|Overall Study||13
454436|NCT00603746|1084698|P3|NOT COMPLETED|Overall Study||8
454437|NCT00603746|1084699|P2|NOT COMPLETED|Overall Study||18
454438|NCT00603746|1084700|P1|NOT COMPLETED|Overall Study||38
454439|NCT00603746|1084695|P6|COMPLETED|Overall Study||97
454440|NCT00603746|1084696|P5|COMPLETED|Overall Study||85
454441|NCT00603746|1084697|P4|COMPLETED|Overall Study||94
454442|NCT00603746|1084698|P3|COMPLETED|Overall Study||93
454443|NCT00603746|1084699|P2|COMPLETED|Overall Study||81
454444|NCT00603746|1084700|P1|COMPLETED|Overall Study||65
454445|NCT00603746|1084695|P6|STARTED|Overall Study||110
454446|NCT00603746|1084696|P5|STARTED|Overall Study||102
454447|NCT00603746|1084697|P4|STARTED|Overall Study||107
454448|NCT00603746|1084698|P3|STARTED|Overall Study||101
454449|NCT00603746|1084699|P2|STARTED|Overall Study||99
454450|NCT00603746|1084700|P1|STARTED|Overall Study||103
454451|NCT00603733|1084848|P2|NOT COMPLETED|Maintenance Phase ITT||16
454452|NCT00603733|1084849|P1|NOT COMPLETED|Maintenance Phase ITT||10
454453|NCT00603733|1084848|P2|COMPLETED|Maintenance Phase ITT||66
454454|NCT00603733|1084849|P1|COMPLETED|Maintenance Phase ITT||61
454455|NCT00603733|1084848|P2|STARTED|Maintenance Phase ITT||82
454456|NCT00603733|1084849|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
454457|NCT00603733|1084848|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
454458|NCT00603733|1084849|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
454459|NCT00603733|1084848|P2|COMPLETED|Run-In Phase - 4 Weeks||36
454460|NCT00603733|1084849|P1|COMPLETED|Run-In Phase - 4 Weeks||35
454461|NCT00603733|1084848|P2|STARTED|Run-In Phase - 4 Weeks||49
454462|NCT00603733|1084849|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
454463|NCT00603733|1084848|P2|NOT COMPLETED|Active Phase ITT||17
454464|NCT00603733|1084849|P1|NOT COMPLETED|Active Phase ITT||11
454465|NCT00603733|1084848|P2|COMPLETED|Active Phase ITT||78
454466|NCT00603733|1084849|P1|COMPLETED|Active Phase ITT||84
454467|NCT00603733|1084848|P2|STARTED|Active Phase ITT||95
454468|NCT00603733|1084849|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
454469|NCT00603642|1084861|P2|NOT COMPLETED|Overall Study||0
454470|NCT00603642|1084862|P1|NOT COMPLETED|Overall Study||0
454471|NCT00603642|1084861|P2|COMPLETED|Overall Study||22
454472|NCT00603642|1084862|P1|COMPLETED|Overall Study||12
454473|NCT00603642|1084861|P2|STARTED|Overall Study||22
454474|NCT00603642|1084862|P1|STARTED|Overall Study||12
454475|NCT00603590|1084878|P2|NOT COMPLETED|Overall Study||51
454476|NCT00603590|1084879|P1|NOT COMPLETED|Overall Study||76
454477|NCT00603590|1084878|P2|COMPLETED|Overall Study||183
454478|NCT00603590|1084879|P1|COMPLETED|Overall Study||165
454479|NCT00603590|1084878|P2|Eight Months|Overall Study||194
454480|NCT00603590|1084879|P1|Eight Months|Overall Study||178
454481|NCT00603590|1084878|P2|Four Months|Overall Study||200
454482|NCT00603590|1084879|P1|Four Months|Overall Study||187
454483|NCT00603590|1084878|P2|One Month|Overall Study||212
454484|NCT00603590|1084879|P1|One Month|Overall Study||204
454485|NCT00603590|1084878|P2|STARTED|Overall Study||234
454486|NCT00603590|1084879|P1|STARTED|Overall Study||241
454487|NCT00603564|1084891|P2|NOT COMPLETED|Overall Study||0
454488|NCT00603564|1084892|P1|NOT COMPLETED|Overall Study||0
454489|NCT00603564|1084891|P2|COMPLETED|Overall Study|February 2008|27
454490|NCT00603564|1084892|P1|COMPLETED|Overall Study|February 2008|20
454491|NCT00603564|1084891|P2|STARTED|Overall Study|January 2006|27
454492|NCT00603564|1084892|P1|STARTED|Overall Study|January 2006|20
454493|NCT00603538|1084903|P3|NOT COMPLETED|Overall Study||2
454494|NCT00603538|1084904|P2|NOT COMPLETED|Overall Study||4
454495|NCT00603538|1084905|P1|NOT COMPLETED|Overall Study||3
454496|NCT00603538|1084903|P3|COMPLETED|Overall Study||4
454497|NCT00603538|1084904|P2|COMPLETED|Overall Study||3
454498|NCT00603538|1084905|P1|COMPLETED|Overall Study||3
454499|NCT00603538|1084903|P3|STARTED|Overall Study||6
454500|NCT00603538|1084904|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
454501|NCT00603538|1084905|P1|STARTED|Overall Study||6
454502|NCT00603525|1084945|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
454503|NCT00603525|1084946|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
454504|NCT00603525|1084947|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
454505|NCT00603525|1084945|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
454506|NCT00603525|1084946|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
454507|NCT00603525|1084947|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
454508|NCT00603525|1084945|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
454509|NCT00603525|1084946|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
454510|NCT00603525|1084947|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
454511|NCT00603525|1084945|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
454512|NCT00603525|1084946|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
454513|NCT00603525|1084947|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
454514|NCT00603525|1084945|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
454515|NCT00603525|1084946|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
454516|NCT00603525|1084947|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
454517|NCT00603525|1084945|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
454518|NCT00603525|1084946|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
454519|NCT00603525|1084947|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
454520|NCT00603525|1084945|P3|STARTED|OL Treatment Period (120 Weeks)||0
454521|NCT00603525|1084946|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
454522|NCT00603525|1084947|P1|STARTED|OL Treatment Period (120 Weeks)||0
454523|NCT00603525|1084945|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
454524|NCT00603525|1084946|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
454525|NCT00603525|1084947|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
454526|NCT00603525|1084945|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
454527|NCT00603525|1084946|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
454528|NCT00603525|1084947|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
454529|NCT00603525|1084945|P3|STARTED|DB Treatment Period (24 Weeks)||0
454530|NCT00603525|1084946|P2|STARTED|DB Treatment Period (24 Weeks)||85
454531|NCT00603525|1084947|P1|STARTED|DB Treatment Period (24 Weeks)||84
454532|NCT00603512|1085079|P5|NOT COMPLETED|Overall Study||5
454533|NCT00603512|1085080|P4|NOT COMPLETED|Overall Study||7
454534|NCT00603512|1085081|P3|NOT COMPLETED|Overall Study||5
454535|NCT00603512|1085082|P2|NOT COMPLETED|Overall Study||5
454536|NCT00603512|1085083|P1|NOT COMPLETED|Overall Study||2
454537|NCT00603512|1085079|P5|COMPLETED|Overall Study||23
454538|NCT00603512|1085080|P4|COMPLETED|Overall Study||21
454539|NCT00603512|1085081|P3|COMPLETED|Overall Study||23
454540|NCT00603512|1085082|P2|COMPLETED|Overall Study||23
454541|NCT00603512|1085083|P1|COMPLETED|Overall Study||26
454542|NCT00603512|1085079|P5|Treated|Overall Study||28
454543|NCT00603512|1085080|P4|Treated|Overall Study||26
454544|NCT00603512|1085081|P3|Treated|Overall Study||27
454545|NCT00603512|1085082|P2|Treated|Overall Study||27
454546|NCT00603512|1085083|P1|Treated|Overall Study||28
454547|NCT00603512|1085079|P5|STARTED|Overall Study||28
454548|NCT00603512|1085080|P4|STARTED|Overall Study||28
454549|NCT00603512|1085081|P3|STARTED|Overall Study||28
454550|NCT00603512|1085082|P2|STARTED|Overall Study||28
454551|NCT00603512|1085083|P1|STARTED|Overall Study||28
454552|NCT00603473|1085225|P1|NOT COMPLETED|Overall Study||9
454553|NCT00603473|1085225|P1|COMPLETED|Overall Study||80
454554|NCT00603473|1085225|P1|STARTED|Overall Study||89
454555|NCT00603447|1085238|P7|NOT COMPLETED|Overall Study||24
454556|NCT00603447|1085239|P6|NOT COMPLETED|Overall Study||2
454557|NCT00603447|1085240|P5|NOT COMPLETED|Overall Study||5
454558|NCT00603447|1085241|P4|NOT COMPLETED|Overall Study||2
454559|NCT00603447|1085242|P3|NOT COMPLETED|Overall Study||2
454560|NCT00603447|1085243|P2|NOT COMPLETED|Overall Study||3
454561|NCT00603447|1085244|P1|NOT COMPLETED|Overall Study||0
454562|NCT00603447|1085238|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
454563|NCT00603447|1085239|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
454564|NCT00603447|1085240|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
454565|NCT00603447|1085241|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
454566|NCT00603447|1085242|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
454567|NCT00603447|1085243|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
454568|NCT00603447|1085244|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
454569|NCT00603447|1085238|P7|STARTED|Overall Study||44
454570|NCT00603447|1085239|P6|STARTED|Overall Study||8
454571|NCT00603447|1085240|P5|STARTED|Overall Study||6
454572|NCT00603447|1085241|P4|STARTED|Overall Study||6
454573|NCT00603447|1085242|P3|STARTED|Overall Study||8
454574|NCT00603447|1085243|P2|STARTED|Overall Study||6
454575|NCT00603447|1085244|P1|STARTED|Overall Study||6
454576|NCT00603408|1085266|P1|NOT COMPLETED|Overall Study||0
454577|NCT00603408|1085266|P1|COMPLETED|Overall Study||5
454578|NCT00603408|1085266|P1|STARTED|Overall Study||5
454579|NCT00603382|1085283|P6|NOT COMPLETED|Overall Study||18
454580|NCT00603382|1085284|P5|NOT COMPLETED|Overall Study||9
454581|NCT00603382|1085285|P4|NOT COMPLETED|Overall Study||12
454582|NCT00603382|1085286|P3|NOT COMPLETED|Overall Study||9
454583|NCT00603382|1085287|P2|NOT COMPLETED|Overall Study||14
454584|NCT00603382|1085288|P1|NOT COMPLETED|Overall Study||18
454585|NCT00603382|1085283|P6|COMPLETED|Overall Study||84
454586|NCT00603382|1085284|P5|COMPLETED|Overall Study||86
454587|NCT00603382|1085285|P4|COMPLETED|Overall Study||98
454588|NCT00603382|1085286|P3|COMPLETED|Overall Study||91
454589|NCT00603382|1085287|P2|COMPLETED|Overall Study||83
454590|NCT00603382|1085288|P1|COMPLETED|Overall Study||76
454591|NCT00603382|1085283|P6|STARTED|Overall Study||102
454592|NCT00603382|1085284|P5|STARTED|Overall Study||95
454593|NCT00603382|1085285|P4|STARTED|Overall Study||110
454594|NCT00603382|1085286|P3|STARTED|Overall Study||100
454595|NCT00603382|1085287|P2|STARTED|Overall Study||97
454596|NCT00603382|1085288|P1|STARTED|Overall Study||94
454597|NCT00603304|1085436|P2|NOT COMPLETED|Overall Study||31
454598|NCT00603304|1085437|P1|NOT COMPLETED|Overall Study||32
454599|NCT00603304|1085436|P2|COMPLETED|Overall Study||155
454600|NCT00603304|1085437|P1|COMPLETED|Overall Study||151
454601|NCT00603304|1085436|P2|STARTED|Overall Study||186
454602|NCT00603304|1085437|P1|STARTED|Overall Study||183
454603|NCT00603291|1085474|P3|NOT COMPLETED|Overall Study||96
454604|NCT00603291|1085475|P2|NOT COMPLETED|Overall Study||87
454605|NCT00603291|1085476|P1|NOT COMPLETED|Overall Study||20
454606|NCT00603291|1085474|P3|COMPLETED|Overall Study||157
454607|NCT00603291|1085475|P2|COMPLETED|Overall Study||169
454608|NCT00603291|1085476|P1|COMPLETED|Overall Study||75
454609|NCT00603291|1085474|P3|STARTED|Overall Study||253
454610|NCT00603291|1085475|P2|STARTED|Overall Study||256
454611|NCT00603291|1085476|P1|STARTED|Overall Study||95
454612|NCT00603278|1085493|P6|NOT COMPLETED|Overall Study||19
454613|NCT00603278|1085494|P5|NOT COMPLETED|Overall Study||13
454614|NCT00603278|1085495|P4|NOT COMPLETED|Overall Study||11
454615|NCT00603278|1085496|P3|NOT COMPLETED|Overall Study||14
454616|NCT00603278|1085497|P2|NOT COMPLETED|Overall Study||17
454617|NCT00603278|1085498|P1|NOT COMPLETED|Overall Study||41
454618|NCT00603278|1085493|P6|COMPLETED|Overall Study||81
454619|NCT00603278|1085494|P5|COMPLETED|Overall Study||86
454620|NCT00603278|1085495|P4|COMPLETED|Overall Study||92
454621|NCT00603278|1085496|P3|COMPLETED|Overall Study||87
454622|NCT00603278|1085497|P2|COMPLETED|Overall Study||88
454623|NCT00603278|1085498|P1|COMPLETED|Overall Study||66
454624|NCT00603278|1085493|P6|STARTED|Overall Study||100
454625|NCT00603278|1085494|P5|STARTED|Overall Study||99
454626|NCT00603278|1085495|P4|STARTED|Overall Study||103
454627|NCT00603278|1085496|P3|STARTED|Overall Study||101
454628|NCT00603278|1085497|P2|STARTED|Overall Study||105
454629|NCT00603278|1085498|P1|STARTED|Overall Study||107
454630|NCT00603265|1085647|P3|NOT COMPLETED|Overall Study||5
454631|NCT00603265|1085648|P2|NOT COMPLETED|Overall Study||16
454632|NCT00603265|1085649|P1|NOT COMPLETED|Overall Study||7
454633|NCT00603265|1085647|P3|COMPLETED|Overall Study||67
454634|NCT00603265|1085648|P2|COMPLETED|Overall Study||62
454635|NCT00603265|1085649|P1|COMPLETED|Overall Study||69
454636|NCT00603265|1085647|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
454637|NCT00603265|1085648|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
454638|NCT00603265|1085649|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
454639|NCT00603265|1085647|P3|STARTED|Overall Study||72
454640|NCT00603265|1085648|P2|STARTED|Overall Study||78
454641|NCT00603265|1085649|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
454642|NCT00603239|1085677|P2|NOT COMPLETED|Overall Study||4
454643|NCT00603239|1085678|P1|NOT COMPLETED|Overall Study||15
454644|NCT00603239|1085677|P2|COMPLETED|Overall Study||50
454645|NCT00603239|1085678|P1|COMPLETED|Overall Study||96
454646|NCT00603239|1085677|P2|STARTED|Overall Study||54
454647|NCT00603239|1085678|P1|STARTED|Overall Study||111
454648|NCT00603187|1085704|P1|NOT COMPLETED|Overall Study||0
454649|NCT00603187|1085704|P1|COMPLETED|Overall Study||4
454650|NCT00603187|1085704|P1|STARTED|Overall Study||4
454651|NCT00603044|1085712|P2|NOT COMPLETED|Overall Study||0
454652|NCT00603044|1085713|P1|NOT COMPLETED|Overall Study||0
454653|NCT00603044|1085712|P2|COMPLETED|Overall Study||13
454654|NCT00603044|1085713|P1|COMPLETED|Overall Study||11
454655|NCT00603044|1085712|P2|STARTED|Overall Study||13
454656|NCT00603044|1085713|P1|STARTED|Overall Study||11
454657|NCT00603018|1085729|P1|NOT COMPLETED|Overall Study||0
454658|NCT00603018|1085729|P1|COMPLETED|Overall Study||23
454659|NCT00603018|1085729|P1|STARTED|Overall Study||23
454660|NCT00602979|1085739|P5|NOT COMPLETED|Overall Study||3
454661|NCT00602979|1085740|P4|NOT COMPLETED|Overall Study||3
454662|NCT00602979|1085741|P3|NOT COMPLETED|Overall Study||3
454663|NCT00602979|1085742|P2|NOT COMPLETED|Overall Study||3
454664|NCT00602979|1085743|P1|NOT COMPLETED|Overall Study||3
454665|NCT00602979|1085739|P5|COMPLETED|Overall Study||45
454666|NCT00602979|1085740|P4|COMPLETED|Overall Study||45
454667|NCT00602979|1085741|P3|COMPLETED|Overall Study||45
454668|NCT00602979|1085742|P2|COMPLETED|Overall Study||45
454669|NCT00602979|1085743|P1|COMPLETED|Overall Study||45
454670|NCT00602979|1085739|P5|STARTED|Overall Study||48
454671|NCT00602979|1085740|P4|STARTED|Overall Study||48
454672|NCT00602979|1085741|P3|STARTED|Overall Study||48
454673|NCT00602979|1085742|P2|STARTED|Overall Study||48
454674|NCT00602979|1085743|P1|STARTED|Overall Study||48
454675|NCT00602927|1085757|P2|NOT COMPLETED|Period 3: 13 Days||3
454676|NCT00602927|1085758|P1|NOT COMPLETED|Period 3: 13 Days||2
454677|NCT00602927|1085757|P2|COMPLETED|Period 3: 13 Days||9
454678|NCT00602927|1085758|P1|COMPLETED|Period 3: 13 Days||13
454679|NCT00602927|1085757|P2|STARTED|Period 3: 13 Days||12
454680|NCT00602927|1085758|P1|STARTED|Period 3: 13 Days||15
454681|NCT00602927|1085757|P2|NOT COMPLETED|Period 2: 14 Days||2
454682|NCT00602927|1085758|P1|NOT COMPLETED|Period 2: 14 Days||0
454683|NCT00602927|1085757|P2|COMPLETED|Period 2: 14 Days||12
454684|NCT00602927|1085758|P1|COMPLETED|Period 2: 14 Days||15
454685|NCT00602927|1085757|P2|STARTED|Period 2: 14 Days||14
454686|NCT00602927|1085758|P1|STARTED|Period 2: 14 Days||15
454687|NCT00602927|1085757|P2|NOT COMPLETED|Period 1: 13 Days||5
454688|NCT00602927|1085758|P1|NOT COMPLETED|Period 1: 13 Days||4
454689|NCT00602927|1085757|P2|COMPLETED|Period 1: 13 Days||14
454690|NCT00602927|1085758|P1|COMPLETED|Period 1: 13 Days||15
454691|NCT00602927|1085757|P2|STARTED|Period 1: 13 Days||19
454692|NCT00602927|1085758|P1|STARTED|Period 1: 13 Days||19
454693|NCT00602836|1085766|P1|NOT COMPLETED|Overall Study||5
454694|NCT00602836|1085766|P1|COMPLETED|Overall Study||39
454695|NCT00602836|1085766|P1|STARTED|Overall Study||44
454696|NCT00602771|1085772|P2|NOT COMPLETED|Overall Study||0
454697|NCT00602771|1085773|P1|NOT COMPLETED|Overall Study||1
454698|NCT00602771|1085772|P2|COMPLETED|Overall Study||21
454699|NCT00602771|1085773|P1|COMPLETED|Overall Study||62
454700|NCT00602771|1085772|P2|STARTED|Overall Study||21
454701|NCT00602771|1085773|P1|STARTED|Overall Study||63
454702|NCT00602641|1085781|P2|NOT COMPLETED|Overall Study||152
454703|NCT00602641|1085782|P1|NOT COMPLETED|Overall Study||154
454704|NCT00602641|1085781|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
454705|NCT00602641|1085782|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
454706|NCT00602641|1085781|P2|Started Protocol Therapy|Overall Study||150
454707|NCT00602641|1085782|P1|Started Protocol Therapy|Overall Study||148
454708|NCT00602641|1085781|P2|STARTED|Overall Study||152
454709|NCT00602641|1085782|P1|STARTED|Overall Study||154
454710|NCT00602537|1085796|P2|NOT COMPLETED|Follow Up Study Comparison||3
454711|NCT00602537|1085797|P1|NOT COMPLETED|Follow Up Study Comparison||11
454712|NCT00602537|1085796|P2|COMPLETED|Follow Up Study Comparison||14
454713|NCT00602537|1085797|P1|COMPLETED|Follow Up Study Comparison||31
454714|NCT00602537|1085796|P2|STARTED|Follow Up Study Comparison||17
454715|NCT00602537|1085797|P1|STARTED|Follow Up Study Comparison||42
454716|NCT00602537|1085796|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
454717|NCT00602537|1085797|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
454718|NCT00602537|1085796|P2|COMPLETED|12 Week Double Blind Comparison||17
454719|NCT00602537|1085797|P1|COMPLETED|12 Week Double Blind Comparison||42
454720|NCT00602537|1085796|P2|Responded|12 Week Double Blind Comparison||22
454721|NCT00602537|1085797|P1|Responded|12 Week Double Blind Comparison||44
454722|NCT00602537|1085796|P2|STARTED|12 Week Double Blind Comparison||64
454723|NCT00602537|1085797|P1|STARTED|12 Week Double Blind Comparison||65
454724|NCT00602472|1085807|P2|NOT COMPLETED|Overall Study||58
454725|NCT00602472|1085808|P1|NOT COMPLETED|Overall Study||21
454726|NCT00602472|1085807|P2|COMPLETED|Overall Study|number who completed treatment|734
454727|NCT00602472|1085808|P1|COMPLETED|Overall Study|number who completed treatment|242
454728|NCT00602472|1085807|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
454729|NCT00602472|1085808|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
454730|NCT00602459|1085842|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
454731|NCT00602459|1085843|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
454732|NCT00602459|1085844|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
454733|NCT00602459|1085845|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
454734|NCT00602459|1085842|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
454735|NCT00602459|1085843|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
454736|NCT00602459|1085844|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
454737|NCT00602459|1085845|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
454738|NCT00602459|1085842|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
454739|NCT00602459|1085843|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
454740|NCT00602459|1085844|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
454741|NCT00602459|1085845|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
454742|NCT00602459|1085842|P4|NOT COMPLETED|Initial Registration/Randomization||0
454743|NCT00602459|1085843|P3|NOT COMPLETED|Initial Registration/Randomization||3
454744|NCT00602459|1085844|P2|NOT COMPLETED|Initial Registration/Randomization||10
454745|NCT00602459|1085845|P1|NOT COMPLETED|Initial Registration/Randomization||5
454746|NCT00602459|1085842|P4|COMPLETED|Initial Registration/Randomization||0
454747|NCT00602459|1085843|P3|COMPLETED|Initial Registration/Randomization||137
454748|NCT00602459|1085844|P2|COMPLETED|Initial Registration/Randomization||130
454749|NCT00602459|1085845|P1|COMPLETED|Initial Registration/Randomization||133
454750|NCT00602459|1085842|P4|STARTED|Initial Registration/Randomization||0
454751|NCT00602459|1085843|P3|STARTED|Initial Registration/Randomization||140
454752|NCT00602459|1085844|P2|STARTED|Initial Registration/Randomization||140
454753|NCT00602459|1085845|P1|STARTED|Initial Registration/Randomization||138
454754|NCT00602446|1085861|P1|NOT COMPLETED|Overall Study||0
454755|NCT00602446|1085861|P1|COMPLETED|Overall Study||3
454756|NCT00602446|1085861|P1|STARTED|Overall Study||3
454757|NCT00602420|1085868|P2|NOT COMPLETED|Overall Study||24
454758|NCT00602420|1085869|P1|NOT COMPLETED|Overall Study||25
454759|NCT00602420|1085868|P2|COMPLETED|Overall Study||229
454760|NCT00602420|1085869|P1|COMPLETED|Overall Study||232
454761|NCT00602420|1085868|P2|STARTED|Overall Study||253
454762|NCT00602420|1085869|P1|STARTED|Overall Study||257
454763|NCT00602355|1085878|P3|NOT COMPLETED|Overall Study||10
454764|NCT00602355|1085879|P2|NOT COMPLETED|Overall Study||18
454765|NCT00602355|1085880|P1|NOT COMPLETED|Overall Study||9
454766|NCT00602355|1085878|P3|COMPLETED|Overall Study||43
454767|NCT00602355|1085879|P2|COMPLETED|Overall Study||38
454768|NCT00602355|1085880|P1|COMPLETED|Overall Study||44
454769|NCT00602355|1085878|P3|STARTED|Overall Study||53
454770|NCT00602355|1085879|P2|STARTED|Overall Study||56
454771|NCT00602355|1085880|P1|STARTED|Overall Study||53
454772|NCT00602290|1085903|P3|NOT COMPLETED|Overall Study||1
454773|NCT00602290|1085904|P2|NOT COMPLETED|Overall Study||2
454774|NCT00602290|1085905|P1|NOT COMPLETED|Overall Study||2
454775|NCT00602290|1085903|P3|COMPLETED|Overall Study||46
454776|NCT00602290|1085904|P2|COMPLETED|Overall Study||46
454777|NCT00602290|1085905|P1|COMPLETED|Overall Study||46
454778|NCT00602290|1085903|P3|STARTED|Overall Study||47
454779|NCT00602290|1085904|P2|STARTED|Overall Study||48
454780|NCT00602290|1085905|P1|STARTED|Overall Study||48
454781|NCT00602043|1085913|P1|NOT COMPLETED|Overall Study||5
454782|NCT00602043|1085913|P1|COMPLETED|Overall Study||15
454783|NCT00602043|1085913|P1|STARTED|Overall Study||20
454784|NCT00601965|1085922|P4|NOT COMPLETED|Overall Study||1
454785|NCT00601965|1085923|P3|NOT COMPLETED|Overall Study||0
454786|NCT00601965|1085924|P2|NOT COMPLETED|Overall Study||2
454787|NCT00601965|1085925|P1|NOT COMPLETED|Overall Study||0
454788|NCT00601965|1085922|P4|COMPLETED|Overall Study||17
454789|NCT00601965|1085923|P3|COMPLETED|Overall Study||19
454790|NCT00601965|1085924|P2|COMPLETED|Overall Study||16
454791|NCT00601965|1085925|P1|COMPLETED|Overall Study||18
454792|NCT00601965|1085922|P4|STARTED|Overall Study||18
454793|NCT00601965|1085923|P3|STARTED|Overall Study||19
454794|NCT00601965|1085924|P2|STARTED|Overall Study||18
454795|NCT00601965|1085925|P1|STARTED|Overall Study||18
454796|NCT00601952|1085941|P2|NOT COMPLETED|Overall Study||0
454797|NCT00601952|1085942|P1|NOT COMPLETED|Overall Study||2
454798|NCT00601952|1085941|P2|COMPLETED|Overall Study||17
454799|NCT00601952|1085942|P1|COMPLETED|Overall Study||12
454800|NCT00601952|1085941|P2|STARTED|Overall Study||17
454801|NCT00601952|1085942|P1|STARTED|Overall Study||14
454802|NCT00601926|1085948|P1|NOT COMPLETED|Overall Study||0
454803|NCT00601926|1085948|P1|COMPLETED|Overall Study||5
454804|NCT00601926|1085948|P1|STARTED|Overall Study||5
454805|NCT00601900|1085956|P2|NOT COMPLETED|Overall Study||3
454806|NCT00601900|1085957|P1|NOT COMPLETED|Overall Study||0
454807|NCT00601900|1085956|P2|COMPLETED|Overall Study||196
454808|NCT00601900|1085957|P1|COMPLETED|Overall Study||195
454809|NCT00601900|1085956|P2|STARTED|Overall Study||199
454810|NCT00601900|1085957|P1|STARTED|Overall Study||195
454811|NCT00601835|1085973|P2|NOT COMPLETED|Overall Study||14
454812|NCT00601835|1085974|P1|NOT COMPLETED|Overall Study||60
454813|NCT00601835|1085973|P2|COMPLETED|Overall Study||686
454814|NCT00601835|1085974|P1|COMPLETED|Overall Study||2890
454815|NCT00601835|1085973|P2|STARTED|Overall Study||700
454816|NCT00601835|1085974|P1|STARTED|Overall Study||2950
454817|NCT00601796|1085984|P1|NOT COMPLETED|Overall Study||0
454818|NCT00601796|1085984|P1|COMPLETED|Overall Study||24
454819|NCT00601796|1085984|P1|STARTED|Overall Study||24
454820|NCT00601731|1086003|P4|NOT COMPLETED|Overall Study||1
454821|NCT00601731|1086004|P3|NOT COMPLETED|Overall Study||15
454822|NCT00601731|1086005|P2|NOT COMPLETED|Overall Study||0
454823|NCT00601731|1086006|P1|NOT COMPLETED|Overall Study||23
454824|NCT00601731|1086003|P4|COMPLETED|Overall Study||29
454825|NCT00601731|1086004|P3|COMPLETED|Overall Study||151
454826|NCT00601731|1086005|P2|COMPLETED|Overall Study||43
454827|NCT00601731|1086006|P1|COMPLETED|Overall Study||120
454828|NCT00601731|1086003|P4|STARTED|Overall Study||30
454829|NCT00601731|1086004|P3|STARTED|Overall Study||166
454830|NCT00601731|1086005|P2|STARTED|Overall Study||43
454831|NCT00601731|1086006|P1|STARTED|Overall Study||143
454832|NCT00601718|1086056|P1|NOT COMPLETED|Overall Study||0
454833|NCT00601718|1086056|P1|COMPLETED|Overall Study||29
454834|NCT00601718|1086056|P1|STARTED|Overall Study||29
454835|NCT00601640|1086066|P3|NOT COMPLETED|Overall Study||10
454836|NCT00601640|1086067|P2|NOT COMPLETED|Overall Study||5
454837|NCT00601640|1086068|P1|NOT COMPLETED|Overall Study||5
454838|NCT00601640|1086066|P3|COMPLETED|Overall Study||42
454839|NCT00601640|1086067|P2|COMPLETED|Overall Study||47
454840|NCT00601640|1086068|P1|COMPLETED|Overall Study||47
454841|NCT00601640|1086066|P3|STARTED|Overall Study||52
454842|NCT00601640|1086067|P2|STARTED|Overall Study||52
454843|NCT00601640|1086068|P1|STARTED|Overall Study||52
454844|NCT00601627|1086082|P1|NOT COMPLETED|Overall Study||0
454845|NCT00601627|1086082|P1|COMPLETED|Overall Study||51
454846|NCT00601627|1086082|P1|STARTED|Overall Study||51
454847|NCT00601523|1086093|P2|NOT COMPLETED|Overall Study||26
454848|NCT00601523|1086094|P1|NOT COMPLETED|Overall Study||77
454849|NCT00601523|1086093|P2|COMPLETED|Overall Study||117
454850|NCT00601523|1086094|P1|COMPLETED|Overall Study||291
454851|NCT00601523|1086093|P2|STARTED|Overall Study||143
454852|NCT00601523|1086094|P1|STARTED|Overall Study||368
454853|NCT00601458|1086129|P3|NOT COMPLETED|Overall Study||2
454854|NCT00601458|1086130|P2|NOT COMPLETED|Overall Study||5
454855|NCT00601458|1086131|P1|NOT COMPLETED|Overall Study||4
454856|NCT00601458|1086129|P3|COMPLETED|Overall Study||28
454857|NCT00601458|1086130|P2|COMPLETED|Overall Study||29
454858|NCT00601458|1086131|P1|COMPLETED|Overall Study||32
454859|NCT00601458|1086129|P3|STARTED|Overall Study||30
454860|NCT00601458|1086130|P2|STARTED|Overall Study||34
454861|NCT00601458|1086131|P1|STARTED|Overall Study||36
454862|NCT00601419|1086142|P1|NOT COMPLETED|Overall Study||4
454863|NCT00601419|1086142|P1|COMPLETED|Overall Study||226
454864|NCT00601419|1086142|P1|STARTED|Overall Study||230
454865|NCT00601367|1086166|P1|NOT COMPLETED|Overall Study||187
454866|NCT00601367|1086166|P1|COMPLETED|Overall Study||293
454867|NCT00601367|1086166|P1|STARTED|Overall Study||480
454868|NCT00601354|1086172|P2|NOT COMPLETED|Overall Study||5
454869|NCT00601354|1086173|P1|NOT COMPLETED|Overall Study||4
454870|NCT00601354|1086172|P2|COMPLETED|Overall Study||4
454871|NCT00601354|1086173|P1|COMPLETED|Overall Study||4
454872|NCT00601354|1086172|P2|STARTED|Overall Study||9
454873|NCT00601354|1086173|P1|STARTED|Overall Study||8
454874|NCT00601250|1086185|P2|NOT COMPLETED|Overall Study||39
454875|NCT00601250|1086186|P1|NOT COMPLETED|Overall Study||14
454876|NCT00601250|1086185|P2|COMPLETED|Overall Study|number who completed treatment|484
454877|NCT00601250|1086186|P1|COMPLETED|Overall Study|number who completed treatment|163
454878|NCT00601250|1086185|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
454879|NCT00601250|1086186|P1|STARTED|Overall Study|number who started treatment|177
454880|NCT00601146|1086220|P1|NOT COMPLETED|Overall Study||161
454881|NCT00601146|1086220|P1|COMPLETED|Overall Study||39
454882|NCT00601146|1086220|P1|STARTED|Overall Study||200
454883|NCT00601107|1086228|P4|NOT COMPLETED|Overall Study||12
454884|NCT00601107|1086229|P3|NOT COMPLETED|Overall Study||12
454885|NCT00601107|1086230|P2|NOT COMPLETED|Overall Study||9
454886|NCT00601107|1086231|P1|NOT COMPLETED|Overall Study||13
454887|NCT00601107|1086228|P4|COMPLETED|Overall Study||13
454888|NCT00601107|1086229|P3|COMPLETED|Overall Study||16
454889|NCT00601107|1086230|P2|COMPLETED|Overall Study||22
454890|NCT00601107|1086231|P1|COMPLETED|Overall Study||14
454891|NCT00601107|1086228|P4|Treated|Overall Study||25
454892|NCT00601107|1086229|P3|Treated|Overall Study||28
454893|NCT00601107|1086230|P2|Treated|Overall Study||31
454894|NCT00601107|1086231|P1|Treated|Overall Study||27
454895|NCT00601107|1086228|P4|STARTED|Overall Study||25
454896|NCT00601107|1086229|P3|STARTED|Overall Study||28
454897|NCT00601107|1086230|P2|STARTED|Overall Study||31
454898|NCT00601107|1086231|P1|STARTED|Overall Study|Randomized.|27
454899|NCT00600938|1086251|P4|NOT COMPLETED|Extension Study||1
454900|NCT00600938|1086252|P3|NOT COMPLETED|Extension Study||9
454901|NCT00600938|1086253|P2|NOT COMPLETED|Extension Study||5
454902|NCT00600938|1086254|P1|NOT COMPLETED|Extension Study||9
454903|NCT00600938|1086251|P4|COMPLETED|Extension Study||0
454904|NCT00600938|1086252|P3|COMPLETED|Extension Study||33
454905|NCT00600938|1086253|P2|COMPLETED|Extension Study||24
454906|NCT00600938|1086254|P1|COMPLETED|Extension Study||65
454907|NCT00600938|1086251|P4|Extension Safety Set|Extension Study||1
454908|NCT00600938|1086252|P3|Extension Safety Set|Extension Study||42
454909|NCT00600938|1086253|P2|Extension Safety Set|Extension Study||29
454910|NCT00600938|1086254|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
454911|NCT00600938|1086251|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
454912|NCT00600938|1086252|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
454913|NCT00600938|1086253|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
454914|NCT00600938|1086254|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
454915|NCT00600938|1086251|P4|NOT COMPLETED|Core Study||0
454916|NCT00600938|1086252|P3|NOT COMPLETED|Core Study||0
454917|NCT00600938|1086253|P2|NOT COMPLETED|Core Study||21
454918|NCT00600938|1086254|P1|NOT COMPLETED|Core Study||16
454919|NCT00600938|1086251|P4|COMPLETED|Core Study||0
454920|NCT00600938|1086252|P3|COMPLETED|Core Study||0
454921|NCT00600938|1086253|P2|COMPLETED|Core Study||78
454922|NCT00600938|1086254|P1|COMPLETED|Core Study||82
454923|NCT00600938|1086251|P4|Per Protocol Set (PPS)|Core Study||0
454924|NCT00600938|1086252|P3|Per Protocol Set (PPS)|Core Study||0
454925|NCT00600938|1086253|P2|Per Protocol Set (PPS)|Core Study||81
454926|NCT00600938|1086254|P1|Per Protocol Set (PPS)|Core Study||91
454927|NCT00600938|1086251|P4|Core Safety Set|Core Study||0
454928|NCT00600938|1086252|P3|Core Safety Set|Core Study||0
454929|NCT00600938|1086253|P2|Core Safety Set|Core Study||91
454930|NCT00600938|1086254|P1|Core Safety Set|Core Study||96
454931|NCT00600938|1086251|P4|STARTED|Core Study||0
454932|NCT00600938|1086252|P3|STARTED|Core Study||0
454933|NCT00600938|1086253|P2|STARTED|Core Study||99
454934|NCT00600938|1086254|P1|STARTED|Core Study||98
454935|NCT00600886|1086318|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
454936|NCT00600886|1086319|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
454937|NCT00600886|1086318|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
454938|NCT00600886|1086319|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
454939|NCT00600886|1086318|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
454940|NCT00600886|1086319|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
454941|NCT00600886|1086318|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
454942|NCT00600886|1086319|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
454943|NCT00600886|1086318|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
454944|NCT00600886|1086319|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
454945|NCT00600886|1086318|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
454946|NCT00600886|1086319|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
454947|NCT00600886|1086318|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
454948|NCT00600886|1086319|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
454949|NCT00600886|1086318|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
454950|NCT00600886|1086319|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
454951|NCT00600886|1086318|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
454952|NCT00600886|1086319|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
454953|NCT00600886|1086318|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
454954|NCT00600886|1086319|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
454955|NCT00600886|1086318|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
454956|NCT00600886|1086319|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
454957|NCT00600886|1086318|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
454958|NCT00600886|1086319|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
455034|NCT00600171|1086547|P6|COMPLETED|Overall Study||97
455035|NCT00600171|1086548|P5|COMPLETED|Overall Study||93
454959|NCT00600886|1086318|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
454960|NCT00600886|1086319|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
454961|NCT00600886|1086318|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
454962|NCT00600886|1086319|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
454963|NCT00600886|1086318|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
454964|NCT00600886|1086319|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
454965|NCT00600886|1086318|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
454966|NCT00600886|1086319|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
454967|NCT00600886|1086318|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
454968|NCT00600886|1086319|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
454969|NCT00600886|1086318|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
454970|NCT00600886|1086319|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
454971|NCT00600886|1086318|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
454972|NCT00600886|1086319|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
454973|NCT00600886|1086318|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
454974|NCT00600886|1086319|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
454975|NCT00600821|1086383|P2|NOT COMPLETED|Overall Study||60
454976|NCT00600821|1086384|P1|NOT COMPLETED|Overall Study||58
454977|NCT00600821|1086383|P2|COMPLETED|Overall Study||0
454978|NCT00600821|1086384|P1|COMPLETED|Overall Study||0
454979|NCT00600821|1086383|P2|Treated|Overall Study||59
454980|NCT00600821|1086384|P1|Treated|Overall Study||58
454981|NCT00600821|1086383|P2|STARTED|Overall Study||60
454982|NCT00600821|1086384|P1|STARTED|Overall Study||58
454983|NCT00600756|1086412|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
454984|NCT00600756|1086413|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
454985|NCT00600756|1086412|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
454986|NCT00600756|1086413|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
454987|NCT00600756|1086412|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
454988|NCT00600756|1086413|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
454989|NCT00600756|1086412|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
454990|NCT00600756|1086413|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
454991|NCT00600756|1086412|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
454992|NCT00600756|1086413|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
454993|NCT00600756|1086412|P2|STARTED|Overall Study Analysis After 12 Months||403
454994|NCT00600756|1086413|P1|STARTED|Overall Study Analysis After 12 Months||395
454995|NCT00600756|1086412|P2|NOT COMPLETED|Analysis After 6 Months||120
454996|NCT00600756|1086413|P1|NOT COMPLETED|Analysis After 6 Months||131
454997|NCT00600756|1086412|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
454998|NCT00600756|1086413|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
454999|NCT00600756|1086412|P2|STARTED|Analysis After 6 Months||403
455000|NCT00600756|1086413|P1|STARTED|Analysis After 6 Months||395
455001|NCT00600743|1086483|P4|NOT COMPLETED|Overall Study||0
455002|NCT00600743|1086484|P3|NOT COMPLETED|Overall Study||0
455003|NCT00600743|1086485|P2|NOT COMPLETED|Overall Study||0
455004|NCT00600743|1086486|P1|NOT COMPLETED|Overall Study||0
455005|NCT00600743|1086483|P4|COMPLETED|Overall Study||7
455006|NCT00600743|1086484|P3|COMPLETED|Overall Study||8
455007|NCT00600743|1086485|P2|COMPLETED|Overall Study||4
455008|NCT00600743|1086486|P1|COMPLETED|Overall Study||4
455009|NCT00600743|1086483|P4|STARTED|Overall Study||7
455010|NCT00600743|1086484|P3|STARTED|Overall Study||8
455011|NCT00600743|1086485|P2|STARTED|Overall Study||4
455012|NCT00600743|1086486|P1|STARTED|Overall Study||4
455013|NCT00600704|1086515|P2|NOT COMPLETED|Overall Study||0
455014|NCT00600704|1086516|P1|NOT COMPLETED|Overall Study||0
455015|NCT00600704|1086515|P2|COMPLETED|Overall Study||92
455016|NCT00600704|1086516|P1|COMPLETED|Overall Study||100
455017|NCT00600704|1086515|P2|STARTED|Overall Study||92
455018|NCT00600704|1086516|P1|STARTED|Overall Study||100
455019|NCT00600613|1086522|P1|NOT COMPLETED|Overall Study||1
455020|NCT00600613|1086522|P1|COMPLETED|Overall Study||5
455021|NCT00600613|1086522|P1|STARTED|Overall Study||6
455022|NCT00600353|1086528|P2|NOT COMPLETED|Overall Study||1
455023|NCT00600353|1086529|P1|NOT COMPLETED|Overall Study||1
455024|NCT00600353|1086528|P2|COMPLETED|Overall Study||9
455025|NCT00600353|1086529|P1|COMPLETED|Overall Study||9
455026|NCT00600353|1086528|P2|STARTED|Overall Study||10
455027|NCT00600353|1086529|P1|STARTED|Overall Study||10
455028|NCT00600171|1086547|P6|NOT COMPLETED|Overall Study||5
455029|NCT00600171|1086548|P5|NOT COMPLETED|Overall Study||8
455030|NCT00600171|1086549|P4|NOT COMPLETED|Overall Study||12
455031|NCT00600171|1086550|P3|NOT COMPLETED|Overall Study||10
455032|NCT00600171|1086551|P2|NOT COMPLETED|Overall Study||17
455033|NCT00600171|1086552|P1|NOT COMPLETED|Overall Study||16
455036|NCT00600171|1086549|P4|COMPLETED|Overall Study||88
455037|NCT00600171|1086550|P3|COMPLETED|Overall Study||91
455038|NCT00600171|1086551|P2|COMPLETED|Overall Study||84
455039|NCT00600171|1086552|P1|COMPLETED|Overall Study||86
455040|NCT00600171|1086547|P6|STARTED|Overall Study||102
455041|NCT00600171|1086548|P5|STARTED|Overall Study||101
455042|NCT00600171|1086549|P4|STARTED|Overall Study||100
455043|NCT00600171|1086550|P3|STARTED|Overall Study||101
455044|NCT00600171|1086551|P2|STARTED|Overall Study||101
455045|NCT00600171|1086552|P1|STARTED|Overall Study||102
455046|NCT00600119|1086626|P6|NOT COMPLETED|Follow-up Period||1
455047|NCT00600119|1086627|P5|NOT COMPLETED|Follow-up Period||0
455048|NCT00600119|1086628|P4|NOT COMPLETED|Follow-up Period||0
455049|NCT00600119|1086629|P3|NOT COMPLETED|Follow-up Period||0
455050|NCT00600119|1086630|P2|NOT COMPLETED|Follow-up Period||0
455051|NCT00600119|1086631|P1|NOT COMPLETED|Follow-up Period||1
455052|NCT00600119|1086626|P6|COMPLETED|Follow-up Period||20
455053|NCT00600119|1086627|P5|COMPLETED|Follow-up Period||31
455054|NCT00600119|1086628|P4|COMPLETED|Follow-up Period||28
455055|NCT00600119|1086629|P3|COMPLETED|Follow-up Period||27
455056|NCT00600119|1086630|P2|COMPLETED|Follow-up Period||28
455057|NCT00600119|1086631|P1|COMPLETED|Follow-up Period||26
455058|NCT00600119|1086626|P6|STARTED|Follow-up Period||21
455059|NCT00600119|1086627|P5|STARTED|Follow-up Period||31
455060|NCT00600119|1086628|P4|STARTED|Follow-up Period||28
455061|NCT00600119|1086629|P3|STARTED|Follow-up Period||27
455062|NCT00600119|1086630|P2|STARTED|Follow-up Period||28
455063|NCT00600119|1086631|P1|STARTED|Follow-up Period||27
455064|NCT00600119|1086626|P6|NOT COMPLETED|Double-blind Treatment Period||14
455065|NCT00600119|1086627|P5|NOT COMPLETED|Double-blind Treatment Period||6
455066|NCT00600119|1086628|P4|NOT COMPLETED|Double-blind Treatment Period||2
455067|NCT00600119|1086629|P3|NOT COMPLETED|Double-blind Treatment Period||0
455068|NCT00600119|1086630|P2|NOT COMPLETED|Double-blind Treatment Period||5
455069|NCT00600119|1086631|P1|NOT COMPLETED|Double-blind Treatment Period||5
455070|NCT00600119|1086626|P6|COMPLETED|Double-blind Treatment Period||21
455071|NCT00600119|1086627|P5|COMPLETED|Double-blind Treatment Period||31
455072|NCT00600119|1086628|P4|COMPLETED|Double-blind Treatment Period||28
455073|NCT00600119|1086629|P3|COMPLETED|Double-blind Treatment Period||27
455074|NCT00600119|1086630|P2|COMPLETED|Double-blind Treatment Period||28
455075|NCT00600119|1086631|P1|COMPLETED|Double-blind Treatment Period||27
455076|NCT00600119|1086626|P6|STARTED|Double-blind Treatment Period||35
455077|NCT00600119|1086627|P5|STARTED|Double-blind Treatment Period||37
455078|NCT00600119|1086628|P4|STARTED|Double-blind Treatment Period||30
455079|NCT00600119|1086629|P3|STARTED|Double-blind Treatment Period||27
455080|NCT00600119|1086630|P2|STARTED|Double-blind Treatment Period||33
455081|NCT00600119|1086631|P1|STARTED|Double-blind Treatment Period||32
455082|NCT00600119|1086626|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
455083|NCT00600119|1086627|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
455084|NCT00600119|1086628|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
455085|NCT00600119|1086629|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
455086|NCT00600119|1086630|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
455087|NCT00600119|1086631|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
455088|NCT00600119|1086626|P6|COMPLETED|Single-blind Placebo run-in Period||35
455089|NCT00600119|1086627|P5|COMPLETED|Single-blind Placebo run-in Period||37
455090|NCT00600119|1086628|P4|COMPLETED|Single-blind Placebo run-in Period||30
455091|NCT00600119|1086629|P3|COMPLETED|Single-blind Placebo run-in Period||27
455092|NCT00600119|1086630|P2|COMPLETED|Single-blind Placebo run-in Period||33
455093|NCT00600119|1086631|P1|COMPLETED|Single-blind Placebo run-in Period||32
455094|NCT00600119|1086626|P6|STARTED|Single-blind Placebo run-in Period||37
455095|NCT00600119|1086627|P5|STARTED|Single-blind Placebo run-in Period||39
455096|NCT00600119|1086628|P4|STARTED|Single-blind Placebo run-in Period||31
455097|NCT00600119|1086629|P3|STARTED|Single-blind Placebo run-in Period||29
455098|NCT00600119|1086630|P2|STARTED|Single-blind Placebo run-in Period||35
455099|NCT00600119|1086631|P1|STARTED|Single-blind Placebo run-in Period||36
455100|NCT00600080|1086663|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
455101|NCT00600080|1086664|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
455102|NCT00600080|1086663|P2|COMPLETED|Period 2: One-week to Two-weeks||32
455103|NCT00600080|1086664|P1|COMPLETED|Period 2: One-week to Two-weeks||28
455104|NCT00600080|1086663|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
455105|NCT00600080|1086664|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
455106|NCT00600080|1086663|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
455107|NCT00600080|1086664|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
455108|NCT00600080|1086663|P2|COMPLETED|Period 1: Baseline to One-week||32
455109|NCT00600080|1086664|P1|COMPLETED|Period 1: Baseline to One-week||28
455110|NCT00600080|1086663|P2|STARTED|Period 1: Baseline to One-week||32
455111|NCT00600080|1086664|P1|STARTED|Period 1: Baseline to One-week||28
455112|NCT00600067|1086678|P2|NOT COMPLETED|Overall Study||7
455113|NCT00600067|1086679|P1|NOT COMPLETED|Overall Study||3
455114|NCT00600067|1086678|P2|COMPLETED|Overall Study||68
455115|NCT00600067|1086679|P1|COMPLETED|Overall Study||52
455116|NCT00600067|1086678|P2|STARTED|Overall Study||75
455117|NCT00600067|1086679|P1|STARTED|Overall Study||55
455118|NCT00600028|1086689|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
455208|NCT00599014|1087021|P1|STARTED|Overall Study||335
455119|NCT00600028|1086690|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
455120|NCT00600028|1086689|P2|COMPLETED|Second Intervention (12 Weeks)||8
455121|NCT00600028|1086690|P1|COMPLETED|Second Intervention (12 Weeks)||12
455122|NCT00600028|1086689|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
455123|NCT00600028|1086690|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
455124|NCT00600028|1086689|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
455125|NCT00600028|1086690|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
455126|NCT00600028|1086689|P2|COMPLETED|First Intervention (12 Weeks)||10
455127|NCT00600028|1086690|P1|COMPLETED|First Intervention (12 Weeks)||12
455128|NCT00600028|1086689|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
455129|NCT00600028|1086690|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
455130|NCT00600015|1086704|P2|NOT COMPLETED|Overall Study||35
455131|NCT00600015|1086705|P1|NOT COMPLETED|Overall Study||60
455132|NCT00600015|1086704|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
455133|NCT00600015|1086705|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
455134|NCT00600015|1086704|P2|STARTED|Overall Study||55
455135|NCT00600015|1086705|P1|STARTED|Overall Study||111
455136|NCT00599924|1086720|P7|NOT COMPLETED|Overall Study||5
455137|NCT00599924|1086721|P6|NOT COMPLETED|Overall Study||4
455138|NCT00599924|1086722|P5|NOT COMPLETED|Overall Study||6
455139|NCT00599924|1086723|P4|NOT COMPLETED|Overall Study||8
455140|NCT00599924|1086724|P3|NOT COMPLETED|Overall Study||2
455141|NCT00599924|1086725|P2|NOT COMPLETED|Overall Study||5
455142|NCT00599924|1086726|P1|NOT COMPLETED|Overall Study||3
455143|NCT00599924|1086720|P7|COMPLETED|Overall Study||3
455144|NCT00599924|1086721|P6|COMPLETED|Overall Study||2
455145|NCT00599924|1086722|P5|COMPLETED|Overall Study||3
455146|NCT00599924|1086723|P4|COMPLETED|Overall Study||4
455147|NCT00599924|1086724|P3|COMPLETED|Overall Study||3
455148|NCT00599924|1086725|P2|COMPLETED|Overall Study||4
455149|NCT00599924|1086726|P1|COMPLETED|Overall Study||1
455150|NCT00599924|1086720|P7|STARTED|Overall Study||8
455151|NCT00599924|1086721|P6|STARTED|Overall Study||6
455152|NCT00599924|1086722|P5|STARTED|Overall Study||9
455153|NCT00599924|1086723|P4|STARTED|Overall Study||12
455154|NCT00599924|1086724|P3|STARTED|Overall Study||5
455155|NCT00599924|1086725|P2|STARTED|Overall Study||9
455156|NCT00599924|1086726|P1|STARTED|Overall Study||4
455157|NCT00599872|1086813|P2|NOT COMPLETED|Overall Study||33
455158|NCT00599872|1086814|P1|NOT COMPLETED|Overall Study||49
455159|NCT00599872|1086813|P2|COMPLETED|Overall Study||181
455160|NCT00599872|1086814|P1|COMPLETED|Overall Study||167
455161|NCT00599872|1086813|P2|STARTED|Overall Study||214
455162|NCT00599872|1086814|P1|STARTED|Overall Study||216
455163|NCT00599755|1086830|P1|NOT COMPLETED|Overall Study||19
455164|NCT00599755|1086830|P1|COMPLETED|Overall Study||49
455165|NCT00599755|1086830|P1|STARTED|Overall Study||68
455166|NCT00599521|1086841|P2|NOT COMPLETED|Overall Study||69
455167|NCT00599521|1086842|P1|NOT COMPLETED|Overall Study||60
455168|NCT00599521|1086841|P2|COMPLETED|Overall Study||462
455169|NCT00599521|1086842|P1|COMPLETED|Overall Study||475
455170|NCT00599521|1086841|P2|STARTED|Overall Study||531
455171|NCT00599521|1086842|P1|STARTED|Overall Study||535
455172|NCT00599339|1086856|P1|NOT COMPLETED|Overall Study||664
455173|NCT00599339|1086856|P1|COMPLETED|Overall Study||1531
455174|NCT00599339|1086856|P1|Safety Set|Overall Study||2179
455175|NCT00599339|1086856|P1|STARTED|Overall Study||2195
455176|NCT00599326|1086958|P1|NOT COMPLETED|Overall Study||2
455177|NCT00599326|1086958|P1|COMPLETED|Overall Study||8
455178|NCT00599326|1086958|P1|STARTED|Overall Study||10
455179|NCT00599313|1086963|P1|NOT COMPLETED|Overall Study||36
455180|NCT00599313|1086963|P1|COMPLETED|Overall Study||0
455181|NCT00599313|1086963|P1|STARTED|Overall Study||36
455182|NCT00599248|1086974|P2|NOT COMPLETED|Overall Study||0
455183|NCT00599248|1086975|P1|NOT COMPLETED|Overall Study||0
455184|NCT00599248|1086974|P2|COMPLETED|Overall Study||3
455185|NCT00599248|1086975|P1|COMPLETED|Overall Study||9
455186|NCT00599248|1086974|P2|STARTED|Overall Study||3
455187|NCT00599248|1086975|P1|STARTED|Overall Study||9
455188|NCT00599196|1086983|P1|NOT COMPLETED|Overall Study||381
455189|NCT00599196|1086983|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
455190|NCT00599196|1086983|P1|STARTED|Overall Study||381
455191|NCT00599131|1086989|P1|NOT COMPLETED|Overall Study||0
455192|NCT00599131|1086989|P1|COMPLETED|Overall Study||4
455193|NCT00599131|1086989|P1|STARTED|Overall Study||4
455194|NCT00599053|1086999|P2|NOT COMPLETED|Overall Study||0
455195|NCT00599053|1087000|P1|NOT COMPLETED|Overall Study||0
455196|NCT00599053|1086999|P2|COMPLETED|Overall Study||2
455197|NCT00599053|1087000|P1|COMPLETED|Overall Study||5
455198|NCT00599053|1086999|P2|STARTED|Overall Study||2
455199|NCT00599053|1087000|P1|STARTED|Overall Study||5
455200|NCT00599027|1087014|P2|NOT COMPLETED|Overall Study||3
455201|NCT00599027|1087015|P1|NOT COMPLETED|Overall Study||1
455202|NCT00599027|1087014|P2|COMPLETED|Overall Study||22
455203|NCT00599027|1087015|P1|COMPLETED|Overall Study||25
455204|NCT00599027|1087014|P2|STARTED|Overall Study||25
455205|NCT00599027|1087015|P1|STARTED|Overall Study||26
455206|NCT00599014|1087021|P1|NOT COMPLETED|Overall Study||0
455207|NCT00599014|1087021|P1|COMPLETED|Overall Study||335
455209|NCT00598871|1087028|P2|NOT COMPLETED|Overall Study||1
455210|NCT00598871|1087029|P1|NOT COMPLETED|Overall Study||0
455211|NCT00598871|1087028|P2|COMPLETED|Overall Study||8
455212|NCT00598871|1087029|P1|COMPLETED|Overall Study||3
455213|NCT00598871|1087028|P2|STARTED|Overall Study||9
455214|NCT00598871|1087029|P1|STARTED|Overall Study||3
455215|NCT00598832|1087039|P2|NOT COMPLETED|Overall Study||82
455216|NCT00598832|1087040|P1|NOT COMPLETED|Overall Study||62
455217|NCT00598832|1087039|P2|COMPLETED|Overall Study||460
455218|NCT00598832|1087040|P1|COMPLETED|Overall Study||471
455219|NCT00598832|1087039|P2|STARTED|Overall Study||542
455220|NCT00598832|1087040|P1|STARTED|Overall Study||533
455221|NCT00598819|1087054|P1|NOT COMPLETED|Overall Study||0
455222|NCT00598819|1087054|P1|COMPLETED|Overall Study||14
455223|NCT00598819|1087054|P1|STARTED|Overall Study||14
455224|NCT00598702|1087070|P8|NOT COMPLETED|Overall Study||0
455225|NCT00598702|1087071|P7|NOT COMPLETED|Overall Study||1
455226|NCT00598702|1087072|P6|NOT COMPLETED|Overall Study||12
455227|NCT00598702|1087073|P5|NOT COMPLETED|Overall Study||3
455228|NCT00598702|1087074|P4|NOT COMPLETED|Overall Study||8
455229|NCT00598702|1087075|P3|NOT COMPLETED|Overall Study||2
455230|NCT00598702|1087076|P2|NOT COMPLETED|Overall Study||2
455231|NCT00598702|1087077|P1|NOT COMPLETED|Overall Study||0
455232|NCT00598702|1087070|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
455233|NCT00598702|1087071|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
455234|NCT00598702|1087072|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
455235|NCT00598702|1087073|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
455236|NCT00598702|1087074|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
455237|NCT00598702|1087075|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
455238|NCT00598702|1087076|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
455239|NCT00598702|1087077|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
455240|NCT00598702|1087070|P8|STARTED|Overall Study||4
455241|NCT00598702|1087071|P7|STARTED|Overall Study||1
455242|NCT00598702|1087072|P6|STARTED|Overall Study||42
455243|NCT00598702|1087073|P5|STARTED|Overall Study||9
455244|NCT00598702|1087074|P4|STARTED|Overall Study||33
455245|NCT00598702|1087075|P3|STARTED|Overall Study||7
455246|NCT00598702|1087076|P2|STARTED|Overall Study||3
455247|NCT00598702|1087077|P1|STARTED|Overall Study||1
455248|NCT00598689|1087121|P2|NOT COMPLETED|Overall Study||0
455249|NCT00598689|1087122|P1|NOT COMPLETED|Overall Study||0
455250|NCT00598689|1087121|P2|COMPLETED|Overall Study||40
455251|NCT00598689|1087122|P1|COMPLETED|Overall Study||40
455252|NCT00598689|1087121|P2|STARTED|Overall Study||40
455253|NCT00598689|1087122|P1|STARTED|Overall Study||40
455254|NCT00598650|1087132|P1|NOT COMPLETED|Overall Study||27
455255|NCT00598650|1087132|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
455256|NCT00598650|1087132|P1|STARTED|Overall Study||108
455257|NCT00598559|1087142|P3|NOT COMPLETED|Overall Study||3
455258|NCT00598559|1087143|P2|NOT COMPLETED|Overall Study||28
455259|NCT00598559|1087144|P1|NOT COMPLETED|Overall Study||27
455260|NCT00598559|1087142|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
455261|NCT00598559|1087143|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
455262|NCT00598559|1087144|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
455263|NCT00598559|1087142|P3|STARTED|Overall Study||30
455264|NCT00598559|1087143|P2|STARTED|Overall Study||91
455265|NCT00598559|1087144|P1|STARTED|Overall Study||92
455266|NCT00598507|1087161|P1|NOT COMPLETED|Overall Study||0
455267|NCT00598507|1087161|P1|COMPLETED|Overall Study||35
455268|NCT00598507|1087161|P1|STARTED|Overall Study||35
455269|NCT00598442|1087171|P3|NOT COMPLETED|Overall Study||24
455270|NCT00598442|1087172|P2|NOT COMPLETED|Overall Study||39
455271|NCT00598442|1087173|P1|NOT COMPLETED|Overall Study||43
455272|NCT00598442|1087171|P3|COMPLETED|Overall Study||139
455273|NCT00598442|1087172|P2|COMPLETED|Overall Study||124
455274|NCT00598442|1087173|P1|COMPLETED|Overall Study||124
455275|NCT00598442|1087171|P3|STARTED|Overall Study||163
455276|NCT00598442|1087172|P2|STARTED|Overall Study||163
455277|NCT00598442|1087173|P1|STARTED|Overall Study||167
455278|NCT00598273|1087190|P3|NOT COMPLETED|Overall Study||39
455279|NCT00598273|1087191|P2|NOT COMPLETED|Overall Study||38
455280|NCT00598273|1087192|P1|NOT COMPLETED|Overall Study||41
455281|NCT00598273|1087190|P3|COMPLETED|Overall Study||125
455282|NCT00598273|1087191|P2|COMPLETED|Overall Study||127
455283|NCT00598273|1087192|P1|COMPLETED|Overall Study||120
455284|NCT00598273|1087190|P3|STARTED|Overall Study||164
455285|NCT00598273|1087191|P2|STARTED|Overall Study||165
455286|NCT00598273|1087192|P1|STARTED|Overall Study||161
455287|NCT00598078|1087206|P2|NOT COMPLETED|Period 3 (Day 3)||0
455288|NCT00598078|1087207|P1|NOT COMPLETED|Period 3 (Day 3)||0
455289|NCT00598078|1087206|P2|COMPLETED|Period 3 (Day 3)||10
455290|NCT00598078|1087207|P1|COMPLETED|Period 3 (Day 3)||9
455291|NCT00598078|1087206|P2|STARTED|Period 3 (Day 3)||10
455292|NCT00598078|1087207|P1|STARTED|Period 3 (Day 3)||9
455293|NCT00598078|1087206|P2|NOT COMPLETED|Period 2 (Day 2)||0
455294|NCT00598078|1087207|P1|NOT COMPLETED|Period 2 (Day 2)||1
455295|NCT00598078|1087206|P2|COMPLETED|Period 2 (Day 2)||10
455296|NCT00598078|1087207|P1|COMPLETED|Period 2 (Day 2)||9
455297|NCT00598078|1087206|P2|STARTED|Period 2 (Day 2)||10
455298|NCT00598078|1087207|P1|STARTED|Period 2 (Day 2)||10
455299|NCT00598078|1087206|P2|NOT COMPLETED|Period 1 (Day 1)||0
455300|NCT00598078|1087207|P1|NOT COMPLETED|Period 1 (Day 1)||0
455301|NCT00598078|1087206|P2|COMPLETED|Period 1 (Day 1)||10
455302|NCT00598078|1087207|P1|COMPLETED|Period 1 (Day 1)||10
455303|NCT00598078|1087206|P2|STARTED|Period 1 (Day 1)||10
455304|NCT00598078|1087207|P1|STARTED|Period 1 (Day 1)||10
455305|NCT00597909|1087218|P3|NOT COMPLETED|Overall Study||0
455306|NCT00597909|1087219|P2|NOT COMPLETED|Overall Study||0
455307|NCT00597909|1087220|P1|NOT COMPLETED|Overall Study||0
455308|NCT00597909|1087218|P3|COMPLETED|Overall Study||0
455309|NCT00597909|1087219|P2|COMPLETED|Overall Study||0
455310|NCT00597909|1087220|P1|COMPLETED|Overall Study||0
455311|NCT00597909|1087218|P3|STARTED|Overall Study||0
455312|NCT00597909|1087219|P2|STARTED|Overall Study||0
455313|NCT00597909|1087220|P1|STARTED|Overall Study||0
455314|NCT00597896|1087230|P2|NOT COMPLETED|Overall Study||2
455315|NCT00597896|1087231|P1|NOT COMPLETED|Overall Study||3
455316|NCT00597896|1087230|P2|COMPLETED|Overall Study||24
455317|NCT00597896|1087231|P1|COMPLETED|Overall Study||21
455318|NCT00597896|1087230|P2|STARTED|Overall Study||26
455319|NCT00597896|1087231|P1|STARTED|Overall Study||24
455320|NCT00597753|1087259|P2|NOT COMPLETED|Overall Study||69
455321|NCT00597753|1087260|P1|NOT COMPLETED|Overall Study||166
455322|NCT00597753|1087259|P2|COMPLETED|Overall Study||202
455323|NCT00597753|1087260|P1|COMPLETED|Overall Study||366
455324|NCT00597753|1087259|P2|STARTED|Overall Study||271
455325|NCT00597753|1087260|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
455326|NCT00597727|1087274|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
455327|NCT00597727|1087275|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
455328|NCT00597727|1087276|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
455329|NCT00597727|1087277|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
455330|NCT00597727|1087278|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
455331|NCT00597727|1087274|P5|COMPLETED|Open-label Extended Maintenance Phase||1
455332|NCT00597727|1087275|P4|COMPLETED|Open-label Extended Maintenance Phase||14
455333|NCT00597727|1087276|P3|COMPLETED|Open-label Extended Maintenance Phase||23
455334|NCT00597727|1087277|P2|COMPLETED|Open-label Extended Maintenance Phase||0
455335|NCT00597727|1087278|P1|COMPLETED|Open-label Extended Maintenance Phase||0
455336|NCT00597727|1087274|P5|STARTED|Open-label Extended Maintenance Phase||3
455337|NCT00597727|1087275|P4|STARTED|Open-label Extended Maintenance Phase||17
455338|NCT00597727|1087276|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
455339|NCT00597727|1087277|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
455340|NCT00597727|1087278|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
455341|NCT00597727|1087274|P5|NOT COMPLETED|12 Month Blinded Phase||1
455342|NCT00597727|1087275|P4|NOT COMPLETED|12 Month Blinded Phase||10
455343|NCT00597727|1087276|P3|NOT COMPLETED|12 Month Blinded Phase||0
455344|NCT00597727|1087277|P2|NOT COMPLETED|12 Month Blinded Phase||0
455345|NCT00597727|1087278|P1|NOT COMPLETED|12 Month Blinded Phase||0
455346|NCT00597727|1087274|P5|COMPLETED|12 Month Blinded Phase||3
455347|NCT00597727|1087275|P4|COMPLETED|12 Month Blinded Phase||17
455348|NCT00597727|1087276|P3|COMPLETED|12 Month Blinded Phase||0
455349|NCT00597727|1087277|P2|COMPLETED|12 Month Blinded Phase||15
455350|NCT00597727|1087278|P1|COMPLETED|12 Month Blinded Phase||14
455351|NCT00597727|1087274|P5|STARTED|12 Month Blinded Phase||4
455352|NCT00597727|1087275|P4|STARTED|12 Month Blinded Phase||27
455353|NCT00597727|1087276|P3|STARTED|12 Month Blinded Phase||0
455354|NCT00597727|1087277|P2|STARTED|12 Month Blinded Phase||15
455355|NCT00597727|1087278|P1|STARTED|12 Month Blinded Phase||14
455356|NCT00597714|1087294|P3|NOT COMPLETED|Overall Study||10
455357|NCT00597714|1087295|P2|NOT COMPLETED|Overall Study||46
455358|NCT00597714|1087296|P1|NOT COMPLETED|Overall Study||56
455359|NCT00597714|1087294|P3|COMPLETED|Overall Study||84
455360|NCT00597714|1087295|P2|COMPLETED|Overall Study||11
455361|NCT00597714|1087296|P1|COMPLETED|Overall Study||24
455362|NCT00597714|1087294|P3|STARTED|Overall Study||94
455363|NCT00597714|1087295|P2|STARTED|Overall Study||57
455364|NCT00597714|1087296|P1|STARTED|Overall Study||80
455365|NCT00597701|1087308|P2|NOT COMPLETED|Overall Study||8
455366|NCT00597701|1087309|P1|NOT COMPLETED|Overall Study||7
455367|NCT00597701|1087308|P2|COMPLETED|Overall Study||13
455368|NCT00597701|1087309|P1|COMPLETED|Overall Study||18
455369|NCT00597701|1087308|P2|STARTED|Overall Study||21
455370|NCT00597701|1087309|P1|STARTED|Overall Study||25
455371|NCT00597675|1087317|P2|NOT COMPLETED|Open Label Phase||0
455372|NCT00597675|1087318|P1|NOT COMPLETED|Open Label Phase||0
455373|NCT00597675|1087317|P2|COMPLETED|Open Label Phase||5
455374|NCT00597675|1087318|P1|COMPLETED|Open Label Phase||2
455375|NCT00597675|1087317|P2|STARTED|Open Label Phase||5
455376|NCT00597675|1087318|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
455377|NCT00597675|1087317|P2|NOT COMPLETED|Blinded Phase||1
455378|NCT00597675|1087318|P1|NOT COMPLETED|Blinded Phase||2
455379|NCT00597675|1087317|P2|COMPLETED|Blinded Phase||5
455380|NCT00597675|1087318|P1|COMPLETED|Blinded Phase||2
455381|NCT00597675|1087317|P2|STARTED|Blinded Phase||6
455382|NCT00597675|1087318|P1|STARTED|Blinded Phase||4
455383|NCT00597584|1087331|P2|NOT COMPLETED|Overall Study||63
455384|NCT00597584|1087332|P1|NOT COMPLETED|Overall Study||128
455385|NCT00597584|1087331|P2|COMPLETED|Overall Study||211
455386|NCT00597584|1087332|P1|COMPLETED|Overall Study||421
455387|NCT00597584|1087331|P2|STARTED|Overall Study||274
455388|NCT00597584|1087332|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
455389|NCT00597558|1087342|P1|NOT COMPLETED|Overall Study||4
455390|NCT00597558|1087342|P1|COMPLETED|Overall Study||9
455391|NCT00597558|1087342|P1|STARTED|Overall Study||13
455392|NCT00597545|1087350|P2|NOT COMPLETED|Overall Study||0
455393|NCT00597545|1087351|P1|NOT COMPLETED|Overall Study||0
455394|NCT00597545|1087350|P2|COMPLETED|Overall Study||6
455395|NCT00597545|1087351|P1|COMPLETED|Overall Study||4
455396|NCT00597545|1087350|P2|STARTED|Overall Study||6
455397|NCT00597545|1087351|P1|STARTED|Overall Study||4
455398|NCT00597519|1087357|P1|NOT COMPLETED|Overall Study||1
455399|NCT00597519|1087357|P1|COMPLETED|Overall Study||27
455400|NCT00597519|1087357|P1|STARTED|Overall Study||28
455401|NCT00597506|1087361|P1|NOT COMPLETED|Overall Study||1
455402|NCT00597506|1087361|P1|COMPLETED|Overall Study||49
455403|NCT00597506|1087361|P1|STARTED|Overall Study||50
455404|NCT00597493|1087366|P1|NOT COMPLETED|Overall Study||0
455405|NCT00597493|1087366|P1|COMPLETED|Overall Study||32
455406|NCT00597493|1087366|P1|STARTED|Overall Study||32
455407|NCT00597428|1087385|P2|NOT COMPLETED|Overall Study||71
455408|NCT00597428|1087386|P1|NOT COMPLETED|Overall Study||61
455409|NCT00597428|1087385|P2|COMPLETED|Overall Study||152
455410|NCT00597428|1087386|P1|COMPLETED|Overall Study||153
455411|NCT00597428|1087385|P2|STARTED|Overall Study||223
455412|NCT00597428|1087386|P1|STARTED|Overall Study||214
455413|NCT00597402|1087402|P1|NOT COMPLETED|Overall Study||0
455414|NCT00597402|1087402|P1|COMPLETED|Overall Study||125
455415|NCT00597402|1087402|P1|STARTED|Overall Study||125
455416|NCT00597376|1087411|P2|NOT COMPLETED|Overall Study||4
455417|NCT00597376|1087412|P1|NOT COMPLETED|Overall Study||8
455418|NCT00597376|1087411|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
455419|NCT00597376|1087412|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
455420|NCT00597376|1087411|P2|STARTED|Overall Study||53
455421|NCT00597376|1087412|P1|STARTED|Overall Study||51
455422|NCT00597272|1087429|P7|NOT COMPLETED|Overall Study||0
455423|NCT00597272|1087430|P6|NOT COMPLETED|Overall Study||0
455424|NCT00597272|1087431|P5|NOT COMPLETED|Overall Study||0
455425|NCT00597272|1087432|P4|NOT COMPLETED|Overall Study||0
455426|NCT00597272|1087433|P3|NOT COMPLETED|Overall Study||0
455427|NCT00597272|1087434|P2|NOT COMPLETED|Overall Study||0
455428|NCT00597272|1087435|P1|NOT COMPLETED|Overall Study||0
455429|NCT00597272|1087429|P7|COMPLETED|Overall Study||10
455430|NCT00597272|1087430|P6|COMPLETED|Overall Study||10
455431|NCT00597272|1087431|P5|COMPLETED|Overall Study||1
455432|NCT00597272|1087432|P4|COMPLETED|Overall Study||1
455433|NCT00597272|1087433|P3|COMPLETED|Overall Study||10
455434|NCT00597272|1087434|P2|COMPLETED|Overall Study||1
455435|NCT00597272|1087435|P1|COMPLETED|Overall Study||1
455436|NCT00597272|1087429|P7|STARTED|Overall Study||10
455437|NCT00597272|1087430|P6|STARTED|Overall Study||10
455438|NCT00597272|1087431|P5|STARTED|Overall Study||1
455439|NCT00597272|1087432|P4|STARTED|Overall Study||1
455440|NCT00597272|1087433|P3|STARTED|Overall Study||10
455441|NCT00597272|1087434|P2|STARTED|Overall Study||1
455442|NCT00597272|1087435|P1|STARTED|Overall Study||1
455443|NCT00597207|1087453|P2|NOT COMPLETED|Overall Study||7
455444|NCT00597207|1087454|P1|NOT COMPLETED|Overall Study||5
455445|NCT00597207|1087453|P2|COMPLETED|Overall Study||2125
455446|NCT00597207|1087454|P1|COMPLETED|Overall Study||2094
455447|NCT00597207|1087453|P2|STARTED|Overall Study||2132
455448|NCT00597207|1087454|P1|STARTED|Overall Study||2099
455449|NCT00597116|1087462|P2|NOT COMPLETED|Overall Study||11
455450|NCT00597116|1087463|P1|NOT COMPLETED|Overall Study||14
455451|NCT00597116|1087462|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
455452|NCT00597116|1087463|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
455453|NCT00597116|1087462|P2|STARTED|Overall Study||11
455454|NCT00597116|1087463|P1|STARTED|Overall Study||14
455455|NCT00597038|1087477|P2|NOT COMPLETED|Overall Study||4
455456|NCT00597038|1087478|P1|NOT COMPLETED|Overall Study||2
455457|NCT00597038|1087477|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
455458|NCT00597038|1087478|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
455459|NCT00597038|1087477|P2|STARTED|Overall Study||34
455460|NCT00597038|1087478|P1|STARTED|Overall Study||16
455461|NCT00597012|1087489|P2|NOT COMPLETED|Overall Study||8
455462|NCT00597012|1087490|P1|NOT COMPLETED|Overall Study||13
455463|NCT00597012|1087489|P2|COMPLETED|Overall Study||169
455464|NCT00597012|1087490|P1|COMPLETED|Overall Study||161
455465|NCT00597012|1087489|P2|STARTED|Overall Study||177
455466|NCT00597012|1087490|P1|STARTED|Overall Study||174
455467|NCT00596960|1087502|P2|NOT COMPLETED|Overall Study||9
455468|NCT00596960|1087503|P1|NOT COMPLETED|Overall Study||11
455469|NCT00596960|1087502|P2|COMPLETED|Overall Study||60
455470|NCT00596960|1087503|P1|COMPLETED|Overall Study||59
455471|NCT00596960|1087502|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
455472|NCT00596960|1087503|P1|STARTED|Overall Study||70
455473|NCT00596947|1087515|P2|NOT COMPLETED|Overall Study||3
455474|NCT00596947|1087516|P1|NOT COMPLETED|Overall Study||6
455475|NCT00596947|1087515|P2|COMPLETED|Overall Study||6
455476|NCT00596947|1087516|P1|COMPLETED|Overall Study||3
455477|NCT00596947|1087515|P2|STARTED|Overall Study||9
455478|NCT00596947|1087516|P1|STARTED|Overall Study||9
455479|NCT00596934|1087556|P1|NOT COMPLETED|Overall Study||2
455480|NCT00596934|1087556|P1|COMPLETED|Overall Study||7
455481|NCT00596934|1087556|P1|STARTED|Overall Study||9
455482|NCT00596830|1087569|P2|NOT COMPLETED|Overall Study||339
455483|NCT00596830|1087570|P1|NOT COMPLETED|Overall Study||342
455484|NCT00596830|1087569|P2|COMPLETED|Overall Study||0
455485|NCT00596830|1087570|P1|COMPLETED|Overall Study||0
455486|NCT00596830|1087569|P2|Treated|Overall Study||332
455487|NCT00596830|1087570|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
455488|NCT00596830|1087569|P2|STARTED|Overall Study||339
455489|NCT00596830|1087570|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
455490|NCT00596817|1087596|P2|NOT COMPLETED|Double-blind Period||79
455491|NCT00596817|1087597|P1|NOT COMPLETED|Double-blind Period||88
455492|NCT00596817|1087596|P2|COMPLETED|Double-blind Period||125
455493|NCT00596817|1087597|P1|COMPLETED|Double-blind Period||104
455494|NCT00596817|1087596|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
455495|NCT00596817|1087597|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
455496|NCT00596817|1087596|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
455497|NCT00596817|1087597|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
455498|NCT00596817|1087596|P2|COMPLETED|Open-label Period to Double-blind Period||400
455499|NCT00596817|1087597|P1|COMPLETED|Open-label Period to Double-blind Period||0
455500|NCT00596817|1087596|P2|STARTED|Open-label Period to Double-blind Period||492
455501|NCT00596817|1087597|P1|STARTED|Open-label Period to Double-blind Period||0
455502|NCT00596817|1087596|P2|NOT COMPLETED|Open-label Period||147
455503|NCT00596817|1087597|P1|NOT COMPLETED|Open-label Period||0
455504|NCT00596817|1087596|P2|COMPLETED|Open-label Period||492
455505|NCT00596817|1087597|P1|COMPLETED|Open-label Period||0
455506|NCT00596817|1087596|P2|STARTED|Open-label Period||639
455507|NCT00596817|1087597|P1|STARTED|Open-label Period||0
455508|NCT00596752|1087622|P2|NOT COMPLETED|Overall Study||143
455509|NCT00596752|1087623|P1|NOT COMPLETED|Overall Study||126
455510|NCT00596752|1087622|P2|COMPLETED|Overall Study||282
455511|NCT00596752|1087623|P1|COMPLETED|Overall Study||289
455512|NCT00596752|1087622|P2|Randomized and Treated|Overall Study||424
455513|NCT00596752|1087623|P1|Randomized and Treated|Overall Study||415
455514|NCT00596752|1087622|P2|STARTED|Overall Study||425
455515|NCT00596752|1087623|P1|STARTED|Overall Study||415
455516|NCT00596687|1087653|P2|NOT COMPLETED|Overall Study||9
455517|NCT00596687|1087654|P1|NOT COMPLETED|Overall Study||14
455518|NCT00596687|1087653|P2|COMPLETED|Overall Study||107
455519|NCT00596687|1087654|P1|COMPLETED|Overall Study||104
455520|NCT00596687|1087653|P2|STARTED|Overall Study||116
455521|NCT00596687|1087654|P1|STARTED|Overall Study||118
455522|NCT00596635|1087665|P3|NOT COMPLETED|Overall Study||8
455523|NCT00596635|1087666|P2|NOT COMPLETED|Overall Study||13
455524|NCT00596635|1087667|P1|NOT COMPLETED|Overall Study||7
455525|NCT00596635|1087665|P3|COMPLETED|Overall Study||11
455526|NCT00596635|1087666|P2|COMPLETED|Overall Study||7
455527|NCT00596635|1087667|P1|COMPLETED|Overall Study||10
455528|NCT00596635|1087665|P3|STARTED|Overall Study||19
455529|NCT00596635|1087666|P2|STARTED|Overall Study||20
455530|NCT00596635|1087667|P1|STARTED|Overall Study||17
455531|NCT00596622|1087684|P1|NOT COMPLETED|Overall Study||13
455532|NCT00596622|1087684|P1|COMPLETED|Overall Study||33
455533|NCT00596622|1087684|P1|STARTED|Overall Study||46
455534|NCT00596466|1087693|P1|NOT COMPLETED|Overall Study||17
455535|NCT00596466|1087693|P1|COMPLETED|Overall Study||58
455536|NCT00596466|1087693|P1|Enrolled, Treated|Overall Study||73
455537|NCT00596466|1087693|P1|STARTED|Overall Study||75
455538|NCT00596453|1087701|P2|NOT COMPLETED|Overall Study||3
455539|NCT00596453|1087702|P1|NOT COMPLETED|Overall Study||1
455540|NCT00596453|1087701|P2|COMPLETED|Overall Study||12
455541|NCT00596453|1087702|P1|COMPLETED|Overall Study||12
455542|NCT00596453|1087701|P2|STARTED|Overall Study||15
455543|NCT00596453|1087702|P1|STARTED|Overall Study||13
455544|NCT00596440|1087710|P2|NOT COMPLETED|Overall Study||80
455545|NCT00596440|1087711|P1|NOT COMPLETED|Overall Study||65
455546|NCT00596440|1087710|P2|COMPLETED|Overall Study||41
455547|NCT00596440|1087711|P1|COMPLETED|Overall Study||48
455548|NCT00596440|1087710|P2|Showed to First Treatment Session|Overall Study||52
455549|NCT00596440|1087711|P1|Showed to First Treatment Session|Overall Study||61
455550|NCT00596440|1087710|P2|Showed to Eligibility Visit|Overall Study||72
455551|NCT00596440|1087711|P1|Showed to Eligibility Visit|Overall Study||85
455552|NCT00596440|1087710|P2|STARTED|Overall Study||121
455553|NCT00596440|1087711|P1|STARTED|Overall Study||113
455554|NCT00596427|1087723|P2|NOT COMPLETED|Overall Study||2
455555|NCT00596427|1087724|P1|NOT COMPLETED|Overall Study||4
455556|NCT00596427|1087723|P2|COMPLETED|Overall Study||28
455557|NCT00596427|1087724|P1|COMPLETED|Overall Study||26
455558|NCT00596427|1087723|P2|STARTED|Overall Study||30
455559|NCT00596427|1087724|P1|STARTED|Overall Study||30
455560|NCT00596362|1087752|P1|NOT COMPLETED|Overall Study||1
455561|NCT00596362|1087752|P1|COMPLETED|Overall Study||0
455562|NCT00596362|1087752|P1|STARTED|Overall Study||1
455563|NCT00596271|1087759|P3|NOT COMPLETED|Overall Study||1
455564|NCT00596271|1087760|P2|NOT COMPLETED|Overall Study||6
455565|NCT00596271|1087761|P1|NOT COMPLETED|Overall Study||5
455566|NCT00596271|1087759|P3|COMPLETED|Overall Study||61
455567|NCT00596271|1087760|P2|COMPLETED|Overall Study||59
455568|NCT00596271|1087761|P1|COMPLETED|Overall Study||60
455569|NCT00596271|1087759|P3|STARTED|Overall Study||62
455570|NCT00596271|1087760|P2|STARTED|Overall Study||65
455571|NCT00596271|1087761|P1|STARTED|Overall Study||65
455572|NCT00596167|1087770|P1|NOT COMPLETED|Overall Study||0
455573|NCT00596167|1087770|P1|COMPLETED|Overall Study||6
455574|NCT00596167|1087770|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
455575|NCT00596102|1087777|P3|NOT COMPLETED|Up to Month 60||637
455576|NCT00596102|1087778|P2|NOT COMPLETED|Up to Month 60||338
455577|NCT00596102|1087779|P1|NOT COMPLETED|Up to Month 60||2181
455578|NCT00596102|1087777|P3|COMPLETED|Up to Month 60||0
455579|NCT00596102|1087778|P2|COMPLETED|Up to Month 60||0
455580|NCT00596102|1087779|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
455581|NCT00596102|1087777|P3|STARTED|Up to Month 60||637
455582|NCT00596102|1087778|P2|STARTED|Up to Month 60||338
455583|NCT00596102|1087779|P1|STARTED|Up to Month 60||2283
455584|NCT00596102|1087777|P3|NOT COMPLETED|Up to Month 6||0
455585|NCT00596102|1087778|P2|NOT COMPLETED|Up to Month 6||0
455586|NCT00596102|1087779|P1|NOT COMPLETED|Up to Month 6||0
455587|NCT00596102|1087777|P3|COMPLETED|Up to Month 6||637
455588|NCT00596102|1087778|P2|COMPLETED|Up to Month 6||338
455589|NCT00596102|1087779|P1|COMPLETED|Up to Month 6||2283
455590|NCT00596102|1087777|P3|STARTED|Up to Month 6||637
455591|NCT00596102|1087778|P2|STARTED|Up to Month 6||338
455592|NCT00596102|1087779|P1|STARTED|Up to Month 6||2283
455593|NCT00596011|1087788|P2|NOT COMPLETED|Overall Study||10
455594|NCT00596011|1087789|P1|NOT COMPLETED|Overall Study||13
455595|NCT00596011|1087788|P2|COMPLETED|Overall Study||38
455596|NCT00596011|1087789|P1|COMPLETED|Overall Study||36
455597|NCT00596011|1087788|P2|STARTED|Overall Study||48
455598|NCT00596011|1087789|P1|STARTED|Overall Study||49
455599|NCT00595959|1087805|P1|NOT COMPLETED|Overall Study||2
455600|NCT00595959|1087805|P1|COMPLETED|Overall Study||63
455601|NCT00595959|1087805|P1|STARTED|Overall Study||65
455602|NCT00595946|1087822|P2|NOT COMPLETED|Overall Study||69
455603|NCT00595946|1087823|P1|NOT COMPLETED|Overall Study||64
455604|NCT00595946|1087822|P2|COMPLETED|Overall Study||152
455605|NCT00595946|1087823|P1|COMPLETED|Overall Study||154
455606|NCT00595946|1087822|P2|STARTED|Overall Study||221
455607|NCT00595946|1087823|P1|STARTED|Overall Study||218
455608|NCT00595920|1087839|P1|NOT COMPLETED|Overall Study||116
455609|NCT00595920|1087839|P1|COMPLETED|Overall Study||0
455610|NCT00595920|1087839|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
455611|NCT00595920|1087839|P1|STARTED|Overall Study||116
455612|NCT00595881|1087843|P1|NOT COMPLETED|Overall Study||0
455613|NCT00595881|1087843|P1|COMPLETED|Overall Study||420
455614|NCT00595881|1087843|P1|STARTED|Overall Study||420
455615|NCT00595868|1087850|P2|NOT COMPLETED|Overall Study||50
455616|NCT00595868|1087851|P1|NOT COMPLETED|Overall Study||45
455617|NCT00595868|1087850|P2|COMPLETED|Overall Study||61
455618|NCT00595868|1087851|P1|COMPLETED|Overall Study||62
455619|NCT00595868|1087850|P2|STARTED|Overall Study||111
455620|NCT00595868|1087851|P1|STARTED|Overall Study||107
455621|NCT00595790|1087862|P3|NOT COMPLETED|Overall Study||3
455622|NCT00595790|1087863|P2|NOT COMPLETED|Overall Study||1
455623|NCT00595790|1087864|P1|NOT COMPLETED|Overall Study||2
455624|NCT00595790|1087862|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
455625|NCT00595790|1087863|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
455626|NCT00595790|1087864|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
455627|NCT00595790|1087862|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
455722|NCT00595114|1088052|P2|COMPLETED|Overall Study||19
455723|NCT00595114|1088053|P1|COMPLETED|Overall Study||24
455628|NCT00595790|1087863|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
455629|NCT00595790|1087864|P1|STARTED|Overall Study||125
455630|NCT00595764|1087874|P2|NOT COMPLETED|Overall Study||43
455631|NCT00595764|1087875|P1|NOT COMPLETED|Overall Study||39
455632|NCT00595764|1087874|P2|COMPLETED|Overall Study||27
455633|NCT00595764|1087875|P1|COMPLETED|Overall Study||32
455634|NCT00595764|1087874|P2|STARTED|Overall Study||70
455635|NCT00595764|1087875|P1|STARTED|Overall Study||71
455636|NCT00595582|1087889|P1|NOT COMPLETED|Overall Study||10
455637|NCT00595582|1087889|P1|COMPLETED|Overall Study||0
455638|NCT00595582|1087889|P1|STARTED|Overall Study||10
455639|NCT00595556|1087895|P2|NOT COMPLETED|Overall Study||1
455640|NCT00595556|1087896|P1|NOT COMPLETED|Overall Study||3
455641|NCT00595556|1087895|P2|COMPLETED|Overall Study||19
455642|NCT00595556|1087896|P1|COMPLETED|Overall Study||17
455643|NCT00595556|1087895|P2|STARTED|Overall Study||20
455644|NCT00595556|1087896|P1|STARTED|Overall Study||20
455645|NCT00595530|1087910|P1|NOT COMPLETED|Overall Study||0
455646|NCT00595530|1087910|P1|COMPLETED|Overall Study||3
455647|NCT00595530|1087910|P1|STARTED|Overall Study||3
455648|NCT00595517|1087914|P1|NOT COMPLETED|Overall Study||19
455649|NCT00595517|1087914|P1|COMPLETED|Overall Study||111
455650|NCT00595517|1087914|P1|STARTED|Overall Study||130
455651|NCT00595504|1087923|P2|NOT COMPLETED|Overall Study||3
455652|NCT00595504|1087924|P1|NOT COMPLETED|Overall Study||2
455653|NCT00595504|1087923|P2|COMPLETED|Overall Study||6
455654|NCT00595504|1087924|P1|COMPLETED|Overall Study||14
455655|NCT00595504|1087923|P2|STARTED|Overall Study||9
455656|NCT00595504|1087924|P1|STARTED|Overall Study||16
455657|NCT00595465|1087937|P3|NOT COMPLETED|Overall Study||7
455658|NCT00595465|1087938|P2|NOT COMPLETED|Overall Study||4
455659|NCT00595465|1087939|P1|NOT COMPLETED|Overall Study||6
455660|NCT00595465|1087937|P3|COMPLETED|Overall Study||121
455661|NCT00595465|1087938|P2|COMPLETED|Overall Study||125
455662|NCT00595465|1087939|P1|COMPLETED|Overall Study||124
455663|NCT00595465|1087937|P3|STARTED|Overall Study||128
455664|NCT00595465|1087938|P2|STARTED|Overall Study||129
455665|NCT00595465|1087939|P1|STARTED|Overall Study||130
455666|NCT00595413|1087951|P4|NOT COMPLETED|Overall Study||4
455667|NCT00595413|1087952|P3|NOT COMPLETED|Overall Study||8
455668|NCT00595413|1087953|P2|NOT COMPLETED|Overall Study||5
455669|NCT00595413|1087954|P1|NOT COMPLETED|Overall Study||7
455670|NCT00595413|1087951|P4|COMPLETED|Overall Study||75
455671|NCT00595413|1087952|P3|COMPLETED|Overall Study||70
455672|NCT00595413|1087953|P2|COMPLETED|Overall Study||73
455673|NCT00595413|1087954|P1|COMPLETED|Overall Study||69
455674|NCT00595413|1087951|P4|STARTED|Overall Study||79
455675|NCT00595413|1087952|P3|STARTED|Overall Study||78
455676|NCT00595413|1087953|P2|STARTED|Overall Study||78
455677|NCT00595413|1087954|P1|STARTED|Overall Study||76
455678|NCT00595361|1087982|P2|NOT COMPLETED|Overall Study||0
455679|NCT00595361|1087983|P1|NOT COMPLETED|Overall Study||0
455680|NCT00595361|1087982|P2|COMPLETED|Overall Study||18
455681|NCT00595361|1087983|P1|COMPLETED|Overall Study||12
455682|NCT00595361|1087982|P2|STARTED|Overall Study||18
455683|NCT00595361|1087983|P1|STARTED|Overall Study||12
455684|NCT00595335|1087995|P2|NOT COMPLETED|Six Months to Twelve Months||1
455685|NCT00595335|1087996|P1|NOT COMPLETED|Six Months to Twelve Months||1
455686|NCT00595335|1087995|P2|COMPLETED|Six Months to Twelve Months||9
455687|NCT00595335|1087996|P1|COMPLETED|Six Months to Twelve Months||10
455688|NCT00595335|1087995|P2|STARTED|Six Months to Twelve Months||10
455689|NCT00595335|1087996|P1|STARTED|Six Months to Twelve Months||11
455690|NCT00595335|1087995|P2|NOT COMPLETED|Baseline to Six Months||2
455691|NCT00595335|1087996|P1|NOT COMPLETED|Baseline to Six Months||2
455692|NCT00595335|1087995|P2|COMPLETED|Baseline to Six Months||10
455693|NCT00595335|1087996|P1|COMPLETED|Baseline to Six Months||11
455694|NCT00595335|1087995|P2|STARTED|Baseline to Six Months||12
455695|NCT00595335|1087996|P1|STARTED|Baseline to Six Months||13
455696|NCT00595309|1088016|P1|NOT COMPLETED|Overall Study||4
455697|NCT00595309|1088016|P1|COMPLETED|Overall Study||194
455698|NCT00595309|1088016|P1|STARTED|Overall Study||198
455699|NCT00595270|1088023|P3|NOT COMPLETED|Overall Study||8
455700|NCT00595270|1088024|P2|NOT COMPLETED|Overall Study||10
455701|NCT00595270|1088025|P1|NOT COMPLETED|Overall Study||6
455702|NCT00595270|1088023|P3|COMPLETED|Overall Study||108
455703|NCT00595270|1088024|P2|COMPLETED|Overall Study||107
455704|NCT00595270|1088025|P1|COMPLETED|Overall Study||110
455705|NCT00595270|1088023|P3|STARTED|Overall Study||116
455706|NCT00595270|1088024|P2|STARTED|Overall Study||117
455707|NCT00595270|1088025|P1|STARTED|Overall Study||116
455708|NCT00595153|1088036|P3|NOT COMPLETED|Overall Study||25
455709|NCT00595153|1088037|P2|NOT COMPLETED|Overall Study||16
455710|NCT00595153|1088038|P1|NOT COMPLETED|Overall Study||4
455711|NCT00595153|1088036|P3|COMPLETED|Overall Study||36
455712|NCT00595153|1088037|P2|COMPLETED|Overall Study||26
455713|NCT00595153|1088038|P1|COMPLETED|Overall Study||20
455714|NCT00595153|1088036|P3|STARTED|Overall Study||61
455715|NCT00595153|1088037|P2|STARTED|Overall Study||42
455716|NCT00595153|1088038|P1|STARTED|Overall Study||24
455717|NCT00595127|1088046|P1|NOT COMPLETED|Overall Study||10
455718|NCT00595127|1088046|P1|COMPLETED|Overall Study||11
455719|NCT00595127|1088046|P1|STARTED|Overall Study||21
455720|NCT00595114|1088052|P2|NOT COMPLETED|Overall Study||0
455721|NCT00595114|1088053|P1|NOT COMPLETED|Overall Study||0
455724|NCT00595114|1088052|P2|STARTED|Overall Study||19
455725|NCT00595114|1088053|P1|STARTED|Overall Study||24
455726|NCT00595088|1088059|P1|NOT COMPLETED|Overall Study||40
455727|NCT00595088|1088059|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
455728|NCT00595088|1088059|P1|STARTED|Overall Study||47
455729|NCT00595075|1088068|P2|NOT COMPLETED|Overall Study||0
455730|NCT00595075|1088069|P1|NOT COMPLETED|Overall Study||1
455731|NCT00595075|1088068|P2|COMPLETED|Overall Study||5
455732|NCT00595075|1088069|P1|COMPLETED|Overall Study||5
455733|NCT00595075|1088068|P2|STARTED|Overall Study||5
455734|NCT00595075|1088069|P1|STARTED|Overall Study||6
455735|NCT00594958|1088090|P3|NOT COMPLETED|Overall Study||10
455736|NCT00594958|1088091|P2|NOT COMPLETED|Overall Study||3
455737|NCT00594958|1088092|P1|NOT COMPLETED|Overall Study||14
455738|NCT00594958|1088090|P3|COMPLETED|Overall Study||202
455739|NCT00594958|1088091|P2|COMPLETED|Overall Study||210
455740|NCT00594958|1088092|P1|COMPLETED|Overall Study||200
455741|NCT00594958|1088090|P3|Randomized and at Least 1 Vaccination|Overall Study||211
455742|NCT00594958|1088091|P2|Randomized and at Least 1 Vaccination|Overall Study||213
455743|NCT00594958|1088092|P1|Randomized and at Least 1 Vaccination|Overall Study||212
455744|NCT00594958|1088090|P3|STARTED|Overall Study||212
455745|NCT00594958|1088091|P2|STARTED|Overall Study||213
455746|NCT00594958|1088092|P1|STARTED|Overall Study||214
455747|NCT00594945|1088103|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
455748|NCT00594945|1088104|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
455749|NCT00594945|1088105|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
455750|NCT00594945|1088103|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
455751|NCT00594945|1088104|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
455752|NCT00594945|1088105|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
455753|NCT00594945|1088103|P3|STARTED|Cohort 2 / Treatment Period 2||2
455754|NCT00594945|1088104|P2|STARTED|Cohort 2 / Treatment Period 2||3
455755|NCT00594945|1088105|P1|STARTED|Cohort 2 / Treatment Period 2||0
455756|NCT00594945|1088103|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
455757|NCT00594945|1088104|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
455758|NCT00594945|1088105|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
455759|NCT00594945|1088103|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
455760|NCT00594945|1088104|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
455761|NCT00594945|1088105|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
455762|NCT00594945|1088103|P3|STARTED|Cohort 1 / Treatment Period 1||2
455763|NCT00594945|1088104|P2|STARTED|Cohort 1 / Treatment Period 1||0
455764|NCT00594945|1088105|P1|STARTED|Cohort 1 / Treatment Period 1||4
455765|NCT00594906|1088113|P2|NOT COMPLETED|Overall Study||2
455766|NCT00594906|1088114|P1|NOT COMPLETED|Overall Study||1
455767|NCT00594906|1088113|P2|COMPLETED|Overall Study||1
455768|NCT00594906|1088114|P1|COMPLETED|Overall Study||6
455769|NCT00594906|1088113|P2|STARTED|Overall Study||3
455770|NCT00594906|1088114|P1|STARTED|Overall Study||7
455771|NCT00594880|1088122|P2|NOT COMPLETED|Overall Study||1
455772|NCT00594880|1088123|P1|NOT COMPLETED|Overall Study||2
455773|NCT00594880|1088122|P2|COMPLETED|Overall Study||10
455774|NCT00594880|1088123|P1|COMPLETED|Overall Study||10
455775|NCT00594880|1088122|P2|STARTED|Overall Study||11
455776|NCT00594880|1088123|P1|STARTED|Overall Study||12
455777|NCT00594854|1088135|P2|NOT COMPLETED|Overall Study||10
455778|NCT00594854|1088136|P1|NOT COMPLETED|Overall Study||7
455779|NCT00594854|1088135|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
455780|NCT00594854|1088136|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
455781|NCT00594854|1088135|P2|STARTED|Overall Study||11
455782|NCT00594854|1088136|P1|STARTED|Overall Study||9
455783|NCT00594815|1088146|P1|NOT COMPLETED|Overall Study||9
455784|NCT00594815|1088146|P1|COMPLETED|Overall Study||43
455785|NCT00594815|1088146|P1|STARTED|Overall Study||52
455786|NCT00594685|1088151|P1|NOT COMPLETED|Overall Study||0
455787|NCT00594685|1088151|P1|COMPLETED|Overall Study||10
455788|NCT00594685|1088151|P1|STARTED|Overall Study||10
455789|NCT00594659|1088171|P3|NOT COMPLETED|Overall Study||7
455790|NCT00594659|1088172|P2|NOT COMPLETED|Overall Study||9
455791|NCT00594659|1088173|P1|NOT COMPLETED|Overall Study||13
455792|NCT00594659|1088171|P3|COMPLETED|Overall Study||9
455793|NCT00594659|1088172|P2|COMPLETED|Overall Study||21
455794|NCT00594659|1088173|P1|COMPLETED|Overall Study||16
455795|NCT00594659|1088171|P3|STARTED|Overall Study||16
455796|NCT00594659|1088172|P2|STARTED|Overall Study||30
455797|NCT00594659|1088173|P1|STARTED|Overall Study||29
455798|NCT00594646|1088184|P1|NOT COMPLETED|Overall Study||16
455799|NCT00594646|1088184|P1|COMPLETED|Overall Study||84
455800|NCT00594646|1088184|P1|STARTED|Overall Study||100
455801|NCT00594568|1088192|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
455802|NCT00594568|1088193|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
455803|NCT00594568|1088194|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
455804|NCT00594568|1088192|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
455805|NCT00594568|1088193|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
455806|NCT00594568|1088194|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
455807|NCT00594568|1088192|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
455808|NCT00594568|1088193|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
455809|NCT00594568|1088194|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
455810|NCT00594568|1088192|P3|NOT COMPLETED|Delayed Start||66
455811|NCT00594568|1088193|P2|NOT COMPLETED|Delayed Start||77
455812|NCT00594568|1088194|P1|NOT COMPLETED|Delayed Start||98
455813|NCT00594568|1088192|P3|COMPLETED|Delayed Start||55
455814|NCT00594568|1088193|P2|COMPLETED|Delayed Start||76
455815|NCT00594568|1088194|P1|COMPLETED|Delayed Start||91
455816|NCT00594568|1088192|P3|STARTED|Delayed Start||121
455817|NCT00594568|1088193|P2|STARTED|Delayed Start||153
455818|NCT00594568|1088194|P1|STARTED|Delayed Start||189
455819|NCT00594568|1088192|P3|NOT COMPLETED|Initial Treatment||408
455820|NCT00594568|1088193|P2|NOT COMPLETED|Initial Treatment||354
455821|NCT00594568|1088194|P1|NOT COMPLETED|Initial Treatment||312
455822|NCT00594568|1088192|P3|COMPLETED|Initial Treatment||121
455823|NCT00594568|1088193|P2|COMPLETED|Initial Treatment||153
455824|NCT00594568|1088194|P1|COMPLETED|Initial Treatment||189
455825|NCT00594568|1088192|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
455826|NCT00594568|1088193|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
455827|NCT00594568|1088194|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
455828|NCT00594568|1088192|P3|STARTED|Initial Treatment||529
455829|NCT00594568|1088193|P2|STARTED|Initial Treatment||507
455830|NCT00594568|1088194|P1|STARTED|Initial Treatment||501
455831|NCT00594516|1088282|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
455832|NCT00594516|1088283|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
455833|NCT00594516|1088284|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
455834|NCT00594516|1088282|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
455835|NCT00594516|1088283|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
455836|NCT00594516|1088284|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
455837|NCT00594516|1088282|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
455838|NCT00594516|1088283|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
455839|NCT00594516|1088284|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
455840|NCT00594516|1088282|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
455841|NCT00594516|1088283|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
455842|NCT00594516|1088284|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
455843|NCT00594516|1088282|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
455844|NCT00594516|1088283|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
455845|NCT00594516|1088284|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
455846|NCT00594516|1088282|P3|STARTED|Open Label (OL): Tapentadol IR||0
455847|NCT00594516|1088283|P2|STARTED|Open Label (OL): Tapentadol IR||0
455848|NCT00594516|1088284|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
455849|NCT00594464|1088292|P1|NOT COMPLETED|Overall Study||3
455850|NCT00594464|1088292|P1|COMPLETED|Overall Study||11
455851|NCT00594464|1088292|P1|STARTED|Overall Study||14
455852|NCT00594425|1088307|P3|NOT COMPLETED|Overall Study||10
455853|NCT00594425|1088308|P2|NOT COMPLETED|Overall Study||14
455854|NCT00594425|1088309|P1|NOT COMPLETED|Overall Study||7
455855|NCT00594425|1088307|P3|COMPLETED|Overall Study||42
455856|NCT00594425|1088308|P2|COMPLETED|Overall Study||34
455857|NCT00594425|1088309|P1|COMPLETED|Overall Study||43
455858|NCT00594425|1088307|P3|STARTED|Overall Study||52
455859|NCT00594425|1088308|P2|STARTED|Overall Study||48
455860|NCT00594425|1088309|P1|STARTED|Overall Study||50
455861|NCT00594399|1088421|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
455862|NCT00594399|1088422|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
455863|NCT00594399|1088423|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
455864|NCT00594399|1088421|P3|COMPLETED|Rerandomization Arm 1 Only||82
455865|NCT00594399|1088422|P2|COMPLETED|Rerandomization Arm 1 Only||114
455866|NCT00594399|1088423|P1|COMPLETED|Rerandomization Arm 1 Only||79
455867|NCT00594399|1088421|P3|Rerandomization|Rerandomization Arm 1 Only||82
455868|NCT00594399|1088422|P2|Rerandomization|Rerandomization Arm 1 Only||114
455869|NCT00594399|1088423|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
455870|NCT00594399|1088421|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
455871|NCT00594399|1088422|P2|STARTED|Rerandomization Arm 1 Only||118
455872|NCT00594399|1088423|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
455873|NCT00594399|1088421|P3|NOT COMPLETED|Initial 3 Month Counseling||0
455874|NCT00594399|1088422|P2|NOT COMPLETED|Initial 3 Month Counseling||4
455875|NCT00594399|1088423|P1|NOT COMPLETED|Initial 3 Month Counseling||17
455876|NCT00594399|1088421|P3|COMPLETED|Initial 3 Month Counseling||0
455877|NCT00594399|1088422|P2|COMPLETED|Initial 3 Month Counseling||118
455878|NCT00594399|1088423|P1|COMPLETED|Initial 3 Month Counseling||163
455879|NCT00594399|1088421|P3|STARTED|Initial 3 Month Counseling||0
455880|NCT00594399|1088422|P2|STARTED|Initial 3 Month Counseling||122
455881|NCT00594399|1088423|P1|STARTED|Initial 3 Month Counseling||180
455882|NCT00594386|1088445|P1|NOT COMPLETED|Overall Study||258
455883|NCT00594386|1088445|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
455884|NCT00594386|1088445|P1|STARTED|Overall Study||258
455885|NCT00594308|1088451|P1|NOT COMPLETED|Overall Study||0
455886|NCT00594308|1088451|P1|COMPLETED|Overall Study||10
455887|NCT00594308|1088451|P1|STARTED|Overall Study||10
455888|NCT00594256|1088459|P1|NOT COMPLETED|Overall Study||0
455889|NCT00594256|1088459|P1|COMPLETED|Overall Study||8
455890|NCT00594256|1088459|P1|STARTED|Overall Study||8
455891|NCT00594230|1088469|P2|NOT COMPLETED|Overall Study||9
455892|NCT00594230|1088470|P1|NOT COMPLETED|Overall Study||15
455893|NCT00594230|1088469|P2|COMPLETED|Overall Study||1
455894|NCT00594230|1088470|P1|COMPLETED|Overall Study||1
455895|NCT00594230|1088469|P2|STARTED|Overall Study||10
455896|NCT00594230|1088470|P1|STARTED|Overall Study||16
455897|NCT00594204|1088478|P2|NOT COMPLETED|Overall Study||45
455898|NCT00594204|1088479|P1|NOT COMPLETED|Overall Study||58
455899|NCT00594204|1088478|P2|COMPLETED|Overall Study||154
455900|NCT00594204|1088479|P1|COMPLETED|Overall Study||336
455901|NCT00594204|1088478|P2|Received Treatment|Overall Study||198
455902|NCT00594204|1088479|P1|Received Treatment|Overall Study||390
455903|NCT00594204|1088478|P2|STARTED|Overall Study||199
455904|NCT00594204|1088479|P1|STARTED|Overall Study||394
455905|NCT00594178|1088489|P1|NOT COMPLETED|Overall Study||5
455906|NCT00594178|1088489|P1|COMPLETED|Overall Study||12
455907|NCT00594178|1088489|P1|STARTED|Overall Study||17
455908|NCT00594165|1088494|P1|NOT COMPLETED|Overall Study||217
455909|NCT00594165|1088494|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
455910|NCT00594165|1088494|P1|STARTED|Overall Study||217
455911|NCT00594100|1088500|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
455912|NCT00594100|1088500|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
455913|NCT00594100|1088500|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
455914|NCT00594100|1088500|P1|NOT COMPLETED|Procedure||9
455915|NCT00594100|1088500|P1|COMPLETED|Procedure||236
455916|NCT00594100|1088500|P1|STARTED|Procedure||245
455917|NCT00594035|1088511|P2|NOT COMPLETED|Overall Study||3
455918|NCT00594035|1088512|P1|NOT COMPLETED|Overall Study||2
455919|NCT00594035|1088511|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
455920|NCT00594035|1088512|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
455921|NCT00594035|1088511|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
455922|NCT00594035|1088512|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
455923|NCT00594022|1088520|P2|NOT COMPLETED|Overall Study||0
455924|NCT00594022|1088521|P1|NOT COMPLETED|Overall Study||0
455925|NCT00594022|1088520|P2|COMPLETED|Overall Study||173
455926|NCT00594022|1088521|P1|COMPLETED|Overall Study||176
455927|NCT00594022|1088520|P2|STARTED|Overall Study||173
455928|NCT00594022|1088521|P1|STARTED|Overall Study||176
455929|NCT00593957|1088538|P3|NOT COMPLETED|Overall Study||2
455930|NCT00593957|1088539|P2|NOT COMPLETED|Overall Study||1
455931|NCT00593957|1088540|P1|NOT COMPLETED|Overall Study||0
455932|NCT00593957|1088538|P3|COMPLETED|Overall Study||10
455933|NCT00593957|1088539|P2|COMPLETED|Overall Study||12
455934|NCT00593957|1088540|P1|COMPLETED|Overall Study||13
455935|NCT00593957|1088538|P3|STARTED|Overall Study||12
455936|NCT00593957|1088539|P2|STARTED|Overall Study||13
455937|NCT00593957|1088540|P1|STARTED|Overall Study||13
455938|NCT00593918|1088564|P2|NOT COMPLETED|Overall Study||24
455939|NCT00593918|1088565|P1|NOT COMPLETED|Overall Study||5
455940|NCT00593918|1088564|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
455941|NCT00593918|1088565|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
455942|NCT00593918|1088564|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
455943|NCT00593918|1088565|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
455944|NCT00593866|1088573|P1|NOT COMPLETED|Overall Study||0
455945|NCT00593866|1088573|P1|COMPLETED|Overall Study||50
455946|NCT00593866|1088573|P1|STARTED|Overall Study||50
455947|NCT00593840|1088578|P1|NOT COMPLETED|Overall Study||1
455948|NCT00593840|1088578|P1|COMPLETED|Overall Study||72
455949|NCT00593840|1088578|P1|STARTED|Overall Study||73
455950|NCT00593827|1088590|P2|NOT COMPLETED|Overall Study||2
455951|NCT00593827|1088591|P1|NOT COMPLETED|Overall Study||0
455952|NCT00593827|1088590|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
455953|NCT00593827|1088591|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
455954|NCT00593827|1088590|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
455955|NCT00593827|1088591|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
455956|NCT00593827|1088590|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
455957|NCT00593827|1088591|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
455958|NCT00593827|1088590|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
455959|NCT00593827|1088591|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
455960|NCT00593814|1088615|P2|NOT COMPLETED|Overall Study||0
455961|NCT00593814|1088616|P1|NOT COMPLETED|Overall Study||24
455962|NCT00593814|1088615|P2|COMPLETED|Overall Study||120
455963|NCT00593814|1088616|P1|COMPLETED|Overall Study||115
455964|NCT00593814|1088615|P2|STARTED|Overall Study||120
455965|NCT00593814|1088616|P1|STARTED|Overall Study||139
455966|NCT00593736|1088626|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
455967|NCT00593736|1088627|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
455968|NCT00593736|1088628|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
455969|NCT00593736|1088629|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
455970|NCT00593736|1088626|P4|COMPLETED|Treatment Period and Placebo Run-out||28
455971|NCT00593736|1088627|P3|COMPLETED|Treatment Period and Placebo Run-out||30
455972|NCT00593736|1088628|P2|COMPLETED|Treatment Period and Placebo Run-out||31
455973|NCT00593736|1088629|P1|COMPLETED|Treatment Period and Placebo Run-out||29
455974|NCT00593736|1088626|P4|STARTED|Treatment Period and Placebo Run-out||32
455975|NCT00593736|1088627|P3|STARTED|Treatment Period and Placebo Run-out||35
455976|NCT00593736|1088628|P2|STARTED|Treatment Period and Placebo Run-out||33
455977|NCT00593736|1088629|P1|STARTED|Treatment Period and Placebo Run-out||32
455978|NCT00593736|1088626|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
455979|NCT00593736|1088627|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
455980|NCT00593736|1088628|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
455981|NCT00593736|1088629|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
455982|NCT00593736|1088626|P4|COMPLETED|Screening Period and Placebo Run-in||132
455983|NCT00593736|1088627|P3|COMPLETED|Screening Period and Placebo Run-in||0
455984|NCT00593736|1088628|P2|COMPLETED|Screening Period and Placebo Run-in||0
455985|NCT00593736|1088629|P1|COMPLETED|Screening Period and Placebo Run-in||0
455986|NCT00593736|1088626|P4|STARTED|Screening Period and Placebo Run-in||549
455987|NCT00593736|1088627|P3|STARTED|Screening Period and Placebo Run-in||0
455988|NCT00593736|1088628|P2|STARTED|Screening Period and Placebo Run-in||0
455989|NCT00593736|1088629|P1|STARTED|Screening Period and Placebo Run-in||0
455990|NCT00593684|1088877|P2|NOT COMPLETED|Overall Study||1
455991|NCT00593684|1088878|P1|NOT COMPLETED|Overall Study||2
455992|NCT00593684|1088877|P2|COMPLETED|Overall Study||24
455993|NCT00593684|1088878|P1|COMPLETED|Overall Study||23
455994|NCT00593684|1088877|P2|STARTED|Overall Study||25
455995|NCT00593684|1088878|P1|STARTED|Overall Study||25
455996|NCT00593645|1088890|P1|NOT COMPLETED|Overall Study||0
455997|NCT00593645|1088890|P1|COMPLETED|Overall Study||7
455998|NCT00593645|1088890|P1|STARTED|Overall Study||7
455999|NCT00593606|1088904|P1|NOT COMPLETED|Overall Study||27
456000|NCT00593606|1088904|P1|COMPLETED|Overall Study||97
456001|NCT00593606|1088904|P1|Treatment Period Completed|Overall Study||99
456002|NCT00593606|1088904|P1|Full Analysis Set|Overall Study||114
456003|NCT00593606|1088904|P1|Start of Treatment - Safety Set|Overall Study||116
456004|NCT00593606|1088904|P1|STARTED|Overall Study||124
456005|NCT00593450|1089004|P4|NOT COMPLETED|Overall Study||29
456006|NCT00593450|1089005|P3|NOT COMPLETED|Overall Study||13
456007|NCT00593450|1089006|P2|NOT COMPLETED|Overall Study||21
456008|NCT00593450|1089007|P1|NOT COMPLETED|Overall Study||17
456009|NCT00593450|1089004|P4|COMPLETED|Overall Study||271
456010|NCT00593450|1089005|P3|COMPLETED|Overall Study||285
456011|NCT00593450|1089006|P2|COMPLETED|Overall Study||265
456012|NCT00593450|1089007|P1|COMPLETED|Overall Study||284
456013|NCT00593450|1089004|P4|STARTED|Overall Study||300
456014|NCT00593450|1089005|P3|STARTED|Overall Study||298
456015|NCT00593450|1089006|P2|STARTED|Overall Study||286
456016|NCT00593450|1089007|P1|STARTED|Overall Study||301
456017|NCT00593372|1089079|P2|NOT COMPLETED|Overall Study||0
456018|NCT00593372|1089080|P1|NOT COMPLETED|Overall Study||0
456019|NCT00593372|1089079|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
456020|NCT00593372|1089080|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
456021|NCT00593372|1089079|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
456022|NCT00593372|1089080|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
456023|NCT00593346|1089086|P1|NOT COMPLETED|Overall Study||0
456024|NCT00593346|1089086|P1|COMPLETED|Overall Study||151
456025|NCT00593346|1089086|P1|STARTED|Overall Study||151
456026|NCT00593333|1089103|P2|NOT COMPLETED|Overall Study||11
456027|NCT00593333|1089104|P1|NOT COMPLETED|Overall Study||10
456028|NCT00593333|1089103|P2|COMPLETED|Overall Study||45
456029|NCT00593333|1089104|P1|COMPLETED|Overall Study||44
456030|NCT00593333|1089103|P2|STARTED|Overall Study||56
456031|NCT00593333|1089104|P1|STARTED|Overall Study||54
456032|NCT00593320|1089112|P2|NOT COMPLETED|Overall Study||0
456033|NCT00593320|1089113|P1|NOT COMPLETED|Overall Study||0
456034|NCT00593320|1089112|P2|COMPLETED|Overall Study||1
456035|NCT00593320|1089113|P1|COMPLETED|Overall Study||1
456036|NCT00593320|1089112|P2|STARTED|Overall Study||1
456037|NCT00593320|1089113|P1|STARTED|Overall Study||1
456038|NCT00593112|1089127|P2|NOT COMPLETED|Overall Study||0
456039|NCT00593112|1089128|P1|NOT COMPLETED|Overall Study||10
456040|NCT00593112|1089127|P2|COMPLETED|Overall Study||12
456041|NCT00593112|1089128|P1|COMPLETED|Overall Study||17
456042|NCT00593112|1089127|P2|STARTED|Overall Study||12
456043|NCT00593112|1089128|P1|STARTED|Overall Study||27
456044|NCT00592943|1089140|P2|NOT COMPLETED|Overall Study||0
456045|NCT00592943|1089141|P1|NOT COMPLETED|Overall Study||0
456046|NCT00592943|1089140|P2|COMPLETED|Overall Study||6
456047|NCT00592943|1089141|P1|COMPLETED|Overall Study||6
456048|NCT00592943|1089140|P2|STARTED|Overall Study||6
456049|NCT00592943|1089141|P1|STARTED|Overall Study||6
456050|NCT00592904|1089155|P4|NOT COMPLETED|Overall Study||11
456051|NCT00592904|1089156|P3|NOT COMPLETED|Overall Study||17
456052|NCT00592904|1089157|P2|NOT COMPLETED|Overall Study||55
456053|NCT00592904|1089158|P1|NOT COMPLETED|Overall Study||25
456054|NCT00592904|1089155|P4|COMPLETED|Overall Study||19
456055|NCT00592904|1089156|P3|COMPLETED|Overall Study||10
456056|NCT00592904|1089157|P2|COMPLETED|Overall Study||93
456057|NCT00592904|1089158|P1|COMPLETED|Overall Study||32
456058|NCT00592904|1089155|P4|STARTED|Overall Study||30
456059|NCT00592904|1089156|P3|STARTED|Overall Study||27
456060|NCT00592904|1089157|P2|STARTED|Overall Study||148
456061|NCT00592904|1089158|P1|STARTED|Overall Study||57
456062|NCT00592852|1089184|P1|NOT COMPLETED|Overall Study||6
456063|NCT00592852|1089184|P1|COMPLETED|Overall Study||7
456064|NCT00592852|1089184|P1|STARTED|Overall Study||13
456065|NCT00592839|1089192|P3|NOT COMPLETED|Overall Study||6
456066|NCT00592839|1089193|P2|NOT COMPLETED|Overall Study||4
456067|NCT00592839|1089194|P1|NOT COMPLETED|Overall Study||2
456068|NCT00592839|1089192|P3|COMPLETED|Overall Study||46
456069|NCT00592839|1089193|P2|COMPLETED|Overall Study||48
456070|NCT00592839|1089194|P1|COMPLETED|Overall Study||51
456071|NCT00592839|1089192|P3|STARTED|Overall Study||52
456072|NCT00592839|1089193|P2|STARTED|Overall Study||52
456073|NCT00592839|1089194|P1|STARTED|Overall Study||53
456074|NCT00592774|1089222|P5|NOT COMPLETED|Overall Study||14
456075|NCT00592774|1089223|P4|NOT COMPLETED|Overall Study||14
456076|NCT00592774|1089224|P3|NOT COMPLETED|Overall Study||4
456077|NCT00592774|1089225|P2|NOT COMPLETED|Overall Study||32
456078|NCT00592774|1089226|P1|NOT COMPLETED|Overall Study||11
456079|NCT00592774|1089222|P5|COMPLETED|Overall Study||9
456080|NCT00592774|1089223|P4|COMPLETED|Overall Study||8
456081|NCT00592774|1089224|P3|COMPLETED|Overall Study||18
456082|NCT00592774|1089225|P2|COMPLETED|Overall Study||21
456083|NCT00592774|1089226|P1|COMPLETED|Overall Study||15
456084|NCT00592774|1089222|P5|STARTED|Overall Study||23
456085|NCT00592774|1089223|P4|STARTED|Overall Study||22
456086|NCT00592774|1089224|P3|STARTED|Overall Study||22
456087|NCT00592774|1089225|P2|STARTED|Overall Study||53
456088|NCT00592774|1089226|P1|STARTED|Overall Study||26
456089|NCT00592761|1089283|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
456090|NCT00592761|1089284|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
456091|NCT00592761|1089283|P2|COMPLETED|Second Intervention (2 Weeks)||9
456092|NCT00592761|1089284|P1|COMPLETED|Second Intervention (2 Weeks)||9
456093|NCT00592761|1089283|P2|STARTED|Second Intervention (2 Weeks)||9
456094|NCT00592761|1089284|P1|STARTED|Second Intervention (2 Weeks)||9
456095|NCT00592761|1089283|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
456096|NCT00592761|1089284|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
456097|NCT00592761|1089283|P2|COMPLETED|First Intervention (2 Weeks)||9
456098|NCT00592761|1089284|P1|COMPLETED|First Intervention (2 Weeks)||9
456099|NCT00592761|1089283|P2|STARTED|First Intervention (2 Weeks)||9
456100|NCT00592761|1089284|P1|STARTED|First Intervention (2 Weeks)||9
456101|NCT00592683|1089298|P2|NOT COMPLETED|Overall Study||4
456102|NCT00592683|1089299|P1|NOT COMPLETED|Overall Study||4
456103|NCT00592683|1089298|P2|COMPLETED|Overall Study||6
456104|NCT00592683|1089299|P1|COMPLETED|Overall Study||6
456105|NCT00592683|1089298|P2|STARTED|Overall Study||10
456106|NCT00592683|1089299|P1|STARTED|Overall Study||10
456107|NCT00592631|1089309|P2|NOT COMPLETED|Overall Study||2
456108|NCT00592631|1089310|P1|NOT COMPLETED|Overall Study||0
456109|NCT00592631|1089309|P2|COMPLETED|Overall Study||9
456110|NCT00592631|1089310|P1|COMPLETED|Overall Study||16
456111|NCT00592631|1089309|P2|STARTED|Overall Study||11
456112|NCT00592631|1089310|P1|STARTED|Overall Study||16
456113|NCT00592488|1089318|P2|NOT COMPLETED|Overall Study||0
456114|NCT00592488|1089319|P1|NOT COMPLETED|Overall Study||0
456115|NCT00592488|1089318|P2|COMPLETED|Overall Study||7
456116|NCT00592488|1089319|P1|COMPLETED|Overall Study||6
456117|NCT00592488|1089318|P2|STARTED|Overall Study||7
456118|NCT00592488|1089319|P1|STARTED|Overall Study||6
456119|NCT00592475|1089328|P3|NOT COMPLETED|Overall Study||0
456120|NCT00592475|1089329|P2|NOT COMPLETED|Overall Study||0
456121|NCT00592475|1089330|P1|NOT COMPLETED|Overall Study||0
456122|NCT00592475|1089328|P3|COMPLETED|Overall Study||5
456123|NCT00592475|1089329|P2|COMPLETED|Overall Study||9
456124|NCT00592475|1089330|P1|COMPLETED|Overall Study||6
456125|NCT00592475|1089328|P3|STARTED|Overall Study||5
456126|NCT00592475|1089329|P2|STARTED|Overall Study||9
456127|NCT00592475|1089330|P1|STARTED|Overall Study||6
456128|NCT00592384|1089355|P2|NOT COMPLETED|Overall Study||6
456129|NCT00592384|1089356|P1|NOT COMPLETED|Overall Study||5
456130|NCT00592384|1089355|P2|COMPLETED|Overall Study||63
456131|NCT00592384|1089356|P1|COMPLETED|Overall Study||59
456132|NCT00592384|1089355|P2|STARTED|Overall Study||69
456133|NCT00592384|1089356|P1|STARTED|Overall Study||64
456134|NCT00592358|1089364|P1|NOT COMPLETED|Overall Study||6
456135|NCT00592358|1089364|P1|COMPLETED|Overall Study||11
456136|NCT00592358|1089364|P1|STARTED|Overall Study||17
456137|NCT00592319|1089371|P2|NOT COMPLETED|Overall Study||3
456138|NCT00592319|1089372|P1|NOT COMPLETED|Overall Study||0
456139|NCT00592319|1089371|P2|COMPLETED|Overall Study||5
456140|NCT00592319|1089372|P1|COMPLETED|Overall Study||2
456141|NCT00592319|1089371|P2|STARTED|Overall Study||8
456142|NCT00592319|1089372|P1|STARTED|Overall Study||2
456143|NCT00592176|1089380|P1|NOT COMPLETED|Overall Study||0
456144|NCT00592176|1089380|P1|COMPLETED|Overall Study||5
456145|NCT00592176|1089380|P1|STARTED|Overall Study||5
456146|NCT00592124|1089391|P6|NOT COMPLETED|Overall Study||3
456147|NCT00592124|1089392|P5|NOT COMPLETED|Overall Study||3
456148|NCT00592124|1089393|P4|NOT COMPLETED|Overall Study||3
456149|NCT00592124|1089394|P3|NOT COMPLETED|Overall Study||6
456150|NCT00592124|1089395|P2|NOT COMPLETED|Overall Study||5
456151|NCT00592124|1089396|P1|NOT COMPLETED|Overall Study||4
456152|NCT00592124|1089391|P6|COMPLETED|Overall Study||24
456153|NCT00592124|1089392|P5|COMPLETED|Overall Study||24
456154|NCT00592124|1089393|P4|COMPLETED|Overall Study||24
456155|NCT00592124|1089394|P3|COMPLETED|Overall Study||24
456156|NCT00592124|1089395|P2|COMPLETED|Overall Study||24
456157|NCT00592124|1089396|P1|COMPLETED|Overall Study||24
456158|NCT00592124|1089391|P6|STARTED|Overall Study||27
456159|NCT00592124|1089392|P5|STARTED|Overall Study||27
456160|NCT00592124|1089393|P4|STARTED|Overall Study||27
456161|NCT00592124|1089394|P3|STARTED|Overall Study||30
456162|NCT00592124|1089395|P2|STARTED|Overall Study||29
456163|NCT00592124|1089396|P1|STARTED|Overall Study||28
456164|NCT00592072|1089447|P2|NOT COMPLETED|Second Sequence||0
456165|NCT00592072|1089448|P1|NOT COMPLETED|Second Sequence||0
456166|NCT00592072|1089447|P2|COMPLETED|Second Sequence||5
456167|NCT00592072|1089448|P1|COMPLETED|Second Sequence||5
456168|NCT00592072|1089447|P2|STARTED|Second Sequence||5
456169|NCT00592072|1089448|P1|STARTED|Second Sequence||5
456170|NCT00592072|1089447|P2|NOT COMPLETED|Wash Out Period||1
456171|NCT00592072|1089448|P1|NOT COMPLETED|Wash Out Period||1
456172|NCT00592072|1089447|P2|COMPLETED|Wash Out Period||5
456173|NCT00592072|1089448|P1|COMPLETED|Wash Out Period||5
456174|NCT00592072|1089447|P2|STARTED|Wash Out Period||6
456175|NCT00592072|1089448|P1|STARTED|Wash Out Period||6
456176|NCT00592072|1089447|P2|NOT COMPLETED|First Sequence||0
456177|NCT00592072|1089448|P1|NOT COMPLETED|First Sequence||0
456178|NCT00592072|1089447|P2|COMPLETED|First Sequence||6
456179|NCT00592072|1089448|P1|COMPLETED|First Sequence||6
456180|NCT00592072|1089447|P2|STARTED|First Sequence||6
456181|NCT00592072|1089448|P1|STARTED|First Sequence||6
456182|NCT00592007|1089470|P1|NOT COMPLETED|Overall Study||2
456183|NCT00592007|1089470|P1|COMPLETED|Overall Study||5
456184|NCT00592007|1089470|P1|STARTED|Overall Study||7
456185|NCT00591864|1089475|P1|NOT COMPLETED|Overall Study||5
456186|NCT00591864|1089475|P1|COMPLETED|Overall Study||84
456187|NCT00591864|1089475|P1|STARTED|Overall Study||89
456188|NCT00591851|1089481|P1|NOT COMPLETED|Overall Study||6
456189|NCT00591851|1089481|P1|COMPLETED|Overall Study||64
456190|NCT00591851|1089481|P1|STARTED|Overall Study||70
456191|NCT00591825|1089489|P4|NOT COMPLETED|Overall Study||0
456192|NCT00591825|1089490|P3|NOT COMPLETED|Overall Study||0
456193|NCT00591825|1089491|P2|NOT COMPLETED|Overall Study||0
456194|NCT00591825|1089492|P1|NOT COMPLETED|Overall Study||0
456195|NCT00591825|1089489|P4|COMPLETED|Overall Study||14
456196|NCT00591825|1089490|P3|COMPLETED|Overall Study||13
456197|NCT00591825|1089491|P2|COMPLETED|Overall Study||13
456198|NCT00591825|1089492|P1|COMPLETED|Overall Study||14
456199|NCT00591825|1089489|P4|STARTED|Overall Study||14
456200|NCT00591825|1089490|P3|STARTED|Overall Study||13
456201|NCT00591825|1089491|P2|STARTED|Overall Study||13
456202|NCT00591825|1089492|P1|STARTED|Overall Study||14
456203|NCT00591773|1089521|P3|NOT COMPLETED|Overall Study||16
456204|NCT00591773|1089522|P2|NOT COMPLETED|Overall Study||24
456205|NCT00591773|1089523|P1|NOT COMPLETED|Overall Study||16
456206|NCT00591773|1089521|P3|COMPLETED|Overall Study||168
456207|NCT00591773|1089522|P2|COMPLETED|Overall Study||158
456208|NCT00591773|1089523|P1|COMPLETED|Overall Study||169
456209|NCT00591773|1089521|P3|STARTED|Overall Study||184
456210|NCT00591773|1089522|P2|STARTED|Overall Study||182
456211|NCT00591773|1089523|P1|STARTED|Overall Study||185
456212|NCT00591760|1089575|P2|NOT COMPLETED|Overall Study||0
456213|NCT00591760|1089576|P1|NOT COMPLETED|Overall Study||0
456214|NCT00591760|1089575|P2|COMPLETED|Overall Study||28
456215|NCT00591760|1089576|P1|COMPLETED|Overall Study||28
456216|NCT00591760|1089575|P2|STARTED|Overall Study||28
456217|NCT00591760|1089576|P1|STARTED|Overall Study||28
456218|NCT00591734|1089582|P1|NOT COMPLETED|Overall Study||53
456219|NCT00591734|1089582|P1|COMPLETED|Overall Study||4
456220|NCT00591734|1089582|P1|STARTED|Overall Study||57
456221|NCT00591721|1089588|P2|NOT COMPLETED|Overall Study||22
456222|NCT00591721|1089589|P1|NOT COMPLETED|Overall Study||21
456223|NCT00591721|1089588|P2|COMPLETED|Overall Study||70
456224|NCT00591721|1089589|P1|COMPLETED|Overall Study||68
456225|NCT00591721|1089588|P2|STARTED|Overall Study||92
456226|NCT00591721|1089589|P1|STARTED|Overall Study||89
456227|NCT00591591|1089597|P2|NOT COMPLETED|Overall Study||39
456228|NCT00591591|1089598|P1|NOT COMPLETED|Overall Study||11
456229|NCT00591591|1089597|P2|COMPLETED|Overall Study||94
456230|NCT00591591|1089598|P1|COMPLETED|Overall Study||165
456231|NCT00591591|1089597|P2|STARTED|Overall Study||133
456232|NCT00591591|1089598|P1|STARTED|Overall Study||176
456233|NCT00591578|1089615|P3|NOT COMPLETED|Open-Label Extension Phase||0
456234|NCT00591578|1089616|P2|NOT COMPLETED|Open-Label Extension Phase||10
456235|NCT00591578|1089617|P1|NOT COMPLETED|Open-Label Extension Phase||6
456236|NCT00591578|1089615|P3|COMPLETED|Open-Label Extension Phase||0
456237|NCT00591578|1089616|P2|COMPLETED|Open-Label Extension Phase||105
456238|NCT00591578|1089617|P1|COMPLETED|Open-Label Extension Phase||49
456239|NCT00591578|1089615|P3|STARTED|Open-Label Extension Phase||0
456240|NCT00591578|1089616|P2|STARTED|Open-Label Extension Phase||115
456241|NCT00591578|1089617|P1|STARTED|Open-Label Extension Phase||55
456242|NCT00591578|1089615|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
456243|NCT00591578|1089616|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
456244|NCT00591578|1089617|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
456245|NCT00591578|1089615|P3|COMPLETED|Double-Blind Treatment Phase||244
456246|NCT00591578|1089616|P2|COMPLETED|Double-Blind Treatment Phase||249
456247|NCT00591578|1089617|P1|COMPLETED|Double-Blind Treatment Phase||249
456248|NCT00591578|1089615|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
456249|NCT00591578|1089616|P2|STARTED|Double-Blind Treatment Phase||329
456250|NCT00591578|1089617|P1|STARTED|Double-Blind Treatment Phase||327
456251|NCT00591565|1089668|P1|NOT COMPLETED|Overall Study||5
456252|NCT00591565|1089668|P1|COMPLETED|Overall Study||8
456253|NCT00591565|1089668|P1|STARTED|Overall Study||13
456254|NCT00591370|1089672|P1|NOT COMPLETED|Overall Study||2
456255|NCT00591370|1089672|P1|COMPLETED|Overall Study||49
456256|NCT00591370|1089672|P1|STARTED|Overall Study||51
456257|NCT00591344|1089680|P2|NOT COMPLETED|Overall Study||8
456258|NCT00591344|1089681|P1|NOT COMPLETED|Overall Study||5
456345|NCT00591006|1089875|P6|NOT COMPLETED|Overall Study||0
456259|NCT00591344|1089680|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
456260|NCT00591344|1089681|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
456261|NCT00591344|1089680|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
456262|NCT00591344|1089681|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
456263|NCT00591344|1089680|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
456264|NCT00591344|1089681|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
456265|NCT00591305|1089693|P2|NOT COMPLETED|Overall Study||0
456266|NCT00591305|1089694|P1|NOT COMPLETED|Overall Study||0
456267|NCT00591305|1089693|P2|COMPLETED|Overall Study||0
456268|NCT00591305|1089694|P1|COMPLETED|Overall Study||1
456269|NCT00591305|1089693|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
456270|NCT00591305|1089694|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
456271|NCT00591305|1089693|P2|STARTED|Overall Study||0
456272|NCT00591305|1089694|P1|STARTED|Overall Study||1
456273|NCT00591266|1089707|P3|NOT COMPLETED|Overall Study||14
456274|NCT00591266|1089708|P2|NOT COMPLETED|Overall Study||11
456275|NCT00591266|1089709|P1|NOT COMPLETED|Overall Study||9
456276|NCT00591266|1089707|P3|COMPLETED|Overall Study||175
456277|NCT00591266|1089708|P2|COMPLETED|Overall Study||177
456278|NCT00591266|1089709|P1|COMPLETED|Overall Study||180
456279|NCT00591266|1089707|P3|STARTED|Overall Study|Randomized only|189
456280|NCT00591266|1089708|P2|STARTED|Overall Study|Randomized only|188
456281|NCT00591266|1089709|P1|STARTED|Overall Study|Randomized only|189
456282|NCT00591253|1089762|P3|NOT COMPLETED|Overall Study||15
456283|NCT00591253|1089763|P2|NOT COMPLETED|Overall Study||21
456284|NCT00591253|1089764|P1|NOT COMPLETED|Overall Study||14
456285|NCT00591253|1089762|P3|COMPLETED|Overall Study||123
456286|NCT00591253|1089763|P2|COMPLETED|Overall Study||116
456287|NCT00591253|1089764|P1|COMPLETED|Overall Study||126
456288|NCT00591253|1089762|P3|STARTED|Overall Study|Randomized or Treated|138
456289|NCT00591253|1089763|P2|STARTED|Overall Study|Randomized or Treated|137
456290|NCT00591253|1089764|P1|STARTED|Overall Study|Randomized or Treated|140
456291|NCT00591240|1089816|P2|NOT COMPLETED|Overall Study||0
456292|NCT00591240|1089817|P1|NOT COMPLETED|Overall Study||0
456293|NCT00591240|1089816|P2|COMPLETED|Overall Study||222
456294|NCT00591240|1089817|P1|COMPLETED|Overall Study||116
456295|NCT00591240|1089816|P2|STARTED|Overall Study||222
456296|NCT00591240|1089817|P1|STARTED|Overall Study||116
456297|NCT00591227|1089825|P2|NOT COMPLETED|Overall Study||0
456298|NCT00591227|1089826|P1|NOT COMPLETED|Overall Study||0
456299|NCT00591227|1089825|P2|COMPLETED|Overall Study||87
456300|NCT00591227|1089826|P1|COMPLETED|Overall Study||89
456301|NCT00591227|1089825|P2|STARTED|Overall Study||87
456302|NCT00591227|1089826|P1|STARTED|Overall Study||89
456303|NCT00591214|1089832|P1|NOT COMPLETED|Overall Study||8
456304|NCT00591214|1089832|P1|COMPLETED|Overall Study||2
456305|NCT00591214|1089832|P1|STARTED|Overall Study||10
456306|NCT00591149|1089841|P1|NOT COMPLETED|Overall Study||5
456307|NCT00591149|1089841|P1|COMPLETED|Overall Study||11
456308|NCT00591149|1089841|P1|STARTED|Overall Study||16
456309|NCT00591019|1089845|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
456310|NCT00591019|1089846|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
456311|NCT00591019|1089845|P2|COMPLETED|Intevention 2 (14 Days)||3
456312|NCT00591019|1089846|P1|COMPLETED|Intevention 2 (14 Days)||2
456313|NCT00591019|1089845|P2|STARTED|Intevention 2 (14 Days)||3
456314|NCT00591019|1089846|P1|STARTED|Intevention 2 (14 Days)||2
456315|NCT00591019|1089845|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
456316|NCT00591019|1089846|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
456317|NCT00591019|1089845|P2|COMPLETED|Intervention 1 (14 Days)||3
456318|NCT00591019|1089846|P1|COMPLETED|Intervention 1 (14 Days)||2
456319|NCT00591019|1089845|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
456320|NCT00591019|1089846|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
456321|NCT00591019|1089845|P2|NOT COMPLETED|Baseline (1 Day)||0
456322|NCT00591019|1089846|P1|NOT COMPLETED|Baseline (1 Day)||0
456323|NCT00591019|1089845|P2|COMPLETED|Baseline (1 Day)||4
456324|NCT00591019|1089846|P1|COMPLETED|Baseline (1 Day)||3
456325|NCT00591019|1089845|P2|STARTED|Baseline (1 Day)||4
456326|NCT00591019|1089846|P1|STARTED|Baseline (1 Day)||3
456327|NCT00591006|1089857|P24|NOT COMPLETED|Overall Study||1
456328|NCT00591006|1089858|P23|NOT COMPLETED|Overall Study||1
456329|NCT00591006|1089859|P22|NOT COMPLETED|Overall Study||0
456330|NCT00591006|1089860|P21|NOT COMPLETED|Overall Study||0
456331|NCT00591006|1089861|P20|NOT COMPLETED|Overall Study||0
456332|NCT00591006|1089862|P19|NOT COMPLETED|Overall Study||0
456333|NCT00591006|1089863|P18|NOT COMPLETED|Overall Study||0
456334|NCT00591006|1089864|P17|NOT COMPLETED|Overall Study||0
456335|NCT00591006|1089865|P16|NOT COMPLETED|Overall Study||1
456336|NCT00591006|1089866|P15|NOT COMPLETED|Overall Study||0
456337|NCT00591006|1089867|P14|NOT COMPLETED|Overall Study||0
456338|NCT00591006|1089868|P13|NOT COMPLETED|Overall Study||0
456339|NCT00591006|1089869|P12|NOT COMPLETED|Overall Study||0
456340|NCT00591006|1089870|P11|NOT COMPLETED|Overall Study||0
456341|NCT00591006|1089871|P10|NOT COMPLETED|Overall Study||0
456342|NCT00591006|1089872|P9|NOT COMPLETED|Overall Study||0
456343|NCT00591006|1089873|P8|NOT COMPLETED|Overall Study||0
456344|NCT00591006|1089874|P7|NOT COMPLETED|Overall Study||0
456346|NCT00591006|1089876|P5|NOT COMPLETED|Overall Study||0
456347|NCT00591006|1089877|P4|NOT COMPLETED|Overall Study||0
456348|NCT00591006|1089878|P3|NOT COMPLETED|Overall Study||0
456349|NCT00591006|1089879|P2|NOT COMPLETED|Overall Study||0
456350|NCT00591006|1089880|P1|NOT COMPLETED|Overall Study||0
456351|NCT00591006|1089857|P24|COMPLETED|Overall Study||0
456352|NCT00591006|1089858|P23|COMPLETED|Overall Study||0
456353|NCT00591006|1089859|P22|COMPLETED|Overall Study||1
456354|NCT00591006|1089860|P21|COMPLETED|Overall Study||0
456355|NCT00591006|1089861|P20|COMPLETED|Overall Study||1
456356|NCT00591006|1089862|P19|COMPLETED|Overall Study||0
456357|NCT00591006|1089863|P18|COMPLETED|Overall Study||1
456358|NCT00591006|1089864|P17|COMPLETED|Overall Study||0
456359|NCT00591006|1089865|P16|COMPLETED|Overall Study||0
456360|NCT00591006|1089866|P15|COMPLETED|Overall Study||0
456361|NCT00591006|1089867|P14|COMPLETED|Overall Study||2
456362|NCT00591006|1089868|P13|COMPLETED|Overall Study||1
456363|NCT00591006|1089869|P12|COMPLETED|Overall Study||1
456364|NCT00591006|1089870|P11|COMPLETED|Overall Study||0
456365|NCT00591006|1089871|P10|COMPLETED|Overall Study||1
456366|NCT00591006|1089872|P9|COMPLETED|Overall Study||1
456367|NCT00591006|1089873|P8|COMPLETED|Overall Study||0
456368|NCT00591006|1089874|P7|COMPLETED|Overall Study||1
456369|NCT00591006|1089875|P6|COMPLETED|Overall Study||0
456370|NCT00591006|1089876|P5|COMPLETED|Overall Study||1
456371|NCT00591006|1089877|P4|COMPLETED|Overall Study||1
456372|NCT00591006|1089878|P3|COMPLETED|Overall Study||1
456373|NCT00591006|1089879|P2|COMPLETED|Overall Study||0
456374|NCT00591006|1089880|P1|COMPLETED|Overall Study||1
456375|NCT00591006|1089857|P24|Treatment #4|Overall Study||0
456376|NCT00591006|1089858|P23|Treatment #4|Overall Study||0
456377|NCT00591006|1089859|P22|Treatment #4|Overall Study||1
456378|NCT00591006|1089860|P21|Treatment #4|Overall Study||0
456379|NCT00591006|1089861|P20|Treatment #4|Overall Study||1
456380|NCT00591006|1089862|P19|Treatment #4|Overall Study||0
456381|NCT00591006|1089863|P18|Treatment #4|Overall Study||1
456382|NCT00591006|1089864|P17|Treatment #4|Overall Study||0
456383|NCT00591006|1089865|P16|Treatment #4|Overall Study||0
456384|NCT00591006|1089866|P15|Treatment #4|Overall Study||0
456385|NCT00591006|1089867|P14|Treatment #4|Overall Study||2
456386|NCT00591006|1089868|P13|Treatment #4|Overall Study||1
456387|NCT00591006|1089869|P12|Treatment #4|Overall Study||1
456388|NCT00591006|1089870|P11|Treatment #4|Overall Study||0
456389|NCT00591006|1089871|P10|Treatment #4|Overall Study||1
456390|NCT00591006|1089872|P9|Treatment #4|Overall Study||1
456391|NCT00591006|1089873|P8|Treatment #4|Overall Study||0
456392|NCT00591006|1089874|P7|Treatment #4|Overall Study||1
456393|NCT00591006|1089875|P6|Treatment #4|Overall Study||0
456394|NCT00591006|1089876|P5|Treatment #4|Overall Study||1
456395|NCT00591006|1089877|P4|Treatment #4|Overall Study||1
456396|NCT00591006|1089878|P3|Treatment #4|Overall Study||1
456397|NCT00591006|1089879|P2|Treatment #4|Overall Study||0
456398|NCT00591006|1089880|P1|Treatment #4|Overall Study||1
456399|NCT00591006|1089857|P24|Treatment #3|Overall Study||1
456400|NCT00591006|1089858|P23|Treatment #3|Overall Study||1
456401|NCT00591006|1089859|P22|Treatment #3|Overall Study||1
456402|NCT00591006|1089860|P21|Treatment #3|Overall Study||0
456403|NCT00591006|1089861|P20|Treatment #3|Overall Study||1
456404|NCT00591006|1089862|P19|Treatment #3|Overall Study||0
456405|NCT00591006|1089863|P18|Treatment #3|Overall Study||1
456406|NCT00591006|1089864|P17|Treatment #3|Overall Study||0
456407|NCT00591006|1089865|P16|Treatment #3|Overall Study||0
456408|NCT00591006|1089866|P15|Treatment #3|Overall Study||0
456409|NCT00591006|1089867|P14|Treatment #3|Overall Study||2
456410|NCT00591006|1089868|P13|Treatment #3|Overall Study||1
456411|NCT00591006|1089869|P12|Treatment #3|Overall Study||1
456412|NCT00591006|1089870|P11|Treatment #3|Overall Study||0
456413|NCT00591006|1089871|P10|Treatment #3|Overall Study||1
456414|NCT00591006|1089872|P9|Treatment #3|Overall Study||1
456415|NCT00591006|1089873|P8|Treatment #3|Overall Study||0
456416|NCT00591006|1089874|P7|Treatment #3|Overall Study||1
456417|NCT00591006|1089875|P6|Treatment #3|Overall Study||0
456418|NCT00591006|1089876|P5|Treatment #3|Overall Study||1
456419|NCT00591006|1089877|P4|Treatment #3|Overall Study||1
456420|NCT00591006|1089878|P3|Treatment #3|Overall Study||1
456421|NCT00591006|1089879|P2|Treatment #3|Overall Study||0
456422|NCT00591006|1089880|P1|Treatment #3|Overall Study||1
456423|NCT00591006|1089857|P24|Treatment #2|Overall Study||1
456424|NCT00591006|1089858|P23|Treatment #2|Overall Study||1
456425|NCT00591006|1089859|P22|Treatment #2|Overall Study||1
456426|NCT00591006|1089860|P21|Treatment #2|Overall Study||0
456427|NCT00591006|1089861|P20|Treatment #2|Overall Study||1
456428|NCT00591006|1089862|P19|Treatment #2|Overall Study||0
456429|NCT00591006|1089863|P18|Treatment #2|Overall Study||1
456430|NCT00591006|1089864|P17|Treatment #2|Overall Study||0
456431|NCT00591006|1089865|P16|Treatment #2|Overall Study||0
456432|NCT00591006|1089866|P15|Treatment #2|Overall Study||0
456433|NCT00591006|1089867|P14|Treatment #2|Overall Study||2
456434|NCT00591006|1089868|P13|Treatment #2|Overall Study||1
456435|NCT00591006|1089869|P12|Treatment #2|Overall Study||1
456436|NCT00591006|1089870|P11|Treatment #2|Overall Study||0
456437|NCT00591006|1089871|P10|Treatment #2|Overall Study||1
456438|NCT00591006|1089872|P9|Treatment #2|Overall Study||1
456439|NCT00591006|1089873|P8|Treatment #2|Overall Study||0
456440|NCT00591006|1089874|P7|Treatment #2|Overall Study||1
456441|NCT00591006|1089875|P6|Treatment #2|Overall Study||0
456442|NCT00591006|1089876|P5|Treatment #2|Overall Study||1
456443|NCT00591006|1089877|P4|Treatment #2|Overall Study||1
456444|NCT00591006|1089878|P3|Treatment #2|Overall Study||1
456445|NCT00591006|1089879|P2|Treatment #2|Overall Study||0
456446|NCT00591006|1089880|P1|Treatment #2|Overall Study||1
456447|NCT00591006|1089857|P24|STARTED|Overall Study||1
456448|NCT00591006|1089858|P23|STARTED|Overall Study||1
456449|NCT00591006|1089859|P22|STARTED|Overall Study||1
456450|NCT00591006|1089860|P21|STARTED|Overall Study||0
456451|NCT00591006|1089861|P20|STARTED|Overall Study||1
456452|NCT00591006|1089862|P19|STARTED|Overall Study||0
456453|NCT00591006|1089863|P18|STARTED|Overall Study||1
456454|NCT00591006|1089864|P17|STARTED|Overall Study||0
456455|NCT00591006|1089865|P16|STARTED|Overall Study||1
456456|NCT00591006|1089866|P15|STARTED|Overall Study||0
456457|NCT00591006|1089867|P14|STARTED|Overall Study||2
456458|NCT00591006|1089868|P13|STARTED|Overall Study||1
456459|NCT00591006|1089869|P12|STARTED|Overall Study||1
456460|NCT00591006|1089870|P11|STARTED|Overall Study||0
456461|NCT00591006|1089871|P10|STARTED|Overall Study||1
456462|NCT00591006|1089872|P9|STARTED|Overall Study||1
456463|NCT00591006|1089873|P8|STARTED|Overall Study||0
456464|NCT00591006|1089874|P7|STARTED|Overall Study||1
456465|NCT00591006|1089875|P6|STARTED|Overall Study||0
456466|NCT00591006|1089876|P5|STARTED|Overall Study||1
456467|NCT00591006|1089877|P4|STARTED|Overall Study||1
456468|NCT00591006|1089878|P3|STARTED|Overall Study||1
456469|NCT00591006|1089879|P2|STARTED|Overall Study||0
456470|NCT00591006|1089880|P1|STARTED|Overall Study||1
456471|NCT00590967|1089900|P2|NOT COMPLETED|Overall Study||5
456472|NCT00590967|1089901|P1|NOT COMPLETED|Overall Study||3
456473|NCT00590967|1089900|P2|COMPLETED|Overall Study||20
456474|NCT00590967|1089901|P1|COMPLETED|Overall Study||41
456475|NCT00590967|1089900|P2|STARTED|Overall Study||25
456476|NCT00590967|1089901|P1|STARTED|Overall Study||44
456477|NCT00590902|1089913|P1|NOT COMPLETED|Overall Study||1
456478|NCT00590902|1089913|P1|COMPLETED|Overall Study||80
456479|NCT00590902|1089913|P1|STARTED|Overall Study||81
456480|NCT00590889|1089919|P2|NOT COMPLETED|Overall Study||299
456481|NCT00590889|1089920|P1|NOT COMPLETED|Overall Study||286
456482|NCT00590889|1089919|P2|COMPLETED|Overall Study||104
456483|NCT00590889|1089920|P1|COMPLETED|Overall Study||118
456484|NCT00590889|1089919|P2|STARTED|Overall Study||403
456485|NCT00590889|1089920|P1|STARTED|Overall Study||404
456486|NCT00590863|1089929|P3|NOT COMPLETED|Overall Study||78
456487|NCT00590863|1089930|P2|NOT COMPLETED|Overall Study||82
456488|NCT00590863|1089931|P1|NOT COMPLETED|Overall Study||84
456489|NCT00590863|1089929|P3|COMPLETED|Overall Study||146
456490|NCT00590863|1089930|P2|COMPLETED|Overall Study||138
456491|NCT00590863|1089931|P1|COMPLETED|Overall Study||137
456492|NCT00590863|1089929|P3|STARTED|Overall Study||224
456493|NCT00590863|1089930|P2|STARTED|Overall Study||220
456494|NCT00590863|1089931|P1|STARTED|Overall Study||221
456495|NCT00590772|1089942|P1|NOT COMPLETED|Overall Study||0
456496|NCT00590772|1089942|P1|COMPLETED|Overall Study||31
456497|NCT00590772|1089942|P1|STARTED|Overall Study||31
456498|NCT00590759|1089948|P1|NOT COMPLETED|Overall Study||80
456499|NCT00590759|1089948|P1|COMPLETED|Overall Study||70
456500|NCT00590759|1089948|P1|STARTED|Overall Study||150
456501|NCT00590720|1089955|P2|NOT COMPLETED|Overall Study||1
456502|NCT00590720|1089956|P1|NOT COMPLETED|Overall Study||1
456503|NCT00590720|1089955|P2|COMPLETED|Overall Study||6
456504|NCT00590720|1089956|P1|COMPLETED|Overall Study||3
456505|NCT00590720|1089955|P2|STARTED|Overall Study||7
456506|NCT00590720|1089956|P1|STARTED|Overall Study||4
456507|NCT00590590|1090001|P3|NOT COMPLETED|Overall Study||6
456508|NCT00590590|1090002|P2|NOT COMPLETED|Overall Study||6
456509|NCT00590590|1090003|P1|NOT COMPLETED|Overall Study||7
456510|NCT00590590|1090001|P3|COMPLETED|Overall Study||21
456511|NCT00590590|1090002|P2|COMPLETED|Overall Study||33
456512|NCT00590590|1090003|P1|COMPLETED|Overall Study||32
456513|NCT00590590|1090001|P3|STARTED|Overall Study||27
456514|NCT00590590|1090002|P2|STARTED|Overall Study||39
456515|NCT00590590|1090003|P1|STARTED|Overall Study||39
456516|NCT00590577|1090030|P4|NOT COMPLETED|Overall Study||93
456517|NCT00590577|1090031|P3|NOT COMPLETED|Overall Study||73
456518|NCT00590577|1090032|P2|NOT COMPLETED|Overall Study||76
456519|NCT00590577|1090033|P1|NOT COMPLETED|Overall Study||77
456520|NCT00590577|1090030|P4|COMPLETED|Overall Study||71
456521|NCT00590577|1090031|P3|COMPLETED|Overall Study||90
456522|NCT00590577|1090032|P2|COMPLETED|Overall Study||89
456523|NCT00590577|1090033|P1|COMPLETED|Overall Study||83
456524|NCT00590577|1090030|P4|STARTED|Overall Study||164
456525|NCT00590577|1090031|P3|STARTED|Overall Study||163
456526|NCT00590577|1090032|P2|STARTED|Overall Study||165
456527|NCT00590577|1090033|P1|STARTED|Overall Study||160
456528|NCT00590564|1090051|P1|NOT COMPLETED|Overall Study||18
456529|NCT00590564|1090051|P1|COMPLETED|Overall Study||24
456530|NCT00590564|1090051|P1|STARTED|Overall Study||42
456531|NCT00590538|1090055|P1|NOT COMPLETED|Overall Study||2
456532|NCT00590538|1090055|P1|COMPLETED|Overall Study||7
456533|NCT00590538|1090055|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
456534|NCT00590460|1090063|P1|NOT COMPLETED|Overall Study||0
456535|NCT00590460|1090063|P1|COMPLETED|Overall Study||5
456536|NCT00590460|1090063|P1|STARTED|Overall Study||5
456537|NCT00590369|1090077|P2|NOT COMPLETED|Overall Study||0
456538|NCT00590369|1090078|P1|NOT COMPLETED|Overall Study||0
456539|NCT00590369|1090077|P2|COMPLETED|Overall Study||5
456540|NCT00590369|1090078|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
456541|NCT00590369|1090077|P2|STARTED|Overall Study||5
456542|NCT00590369|1090078|P1|STARTED|Overall Study||6
456543|NCT00590317|1090096|P2|NOT COMPLETED|Overall Study||5
456544|NCT00590317|1090097|P1|NOT COMPLETED|Overall Study||1
456545|NCT00590317|1090096|P2|COMPLETED|Overall Study||27
456546|NCT00590317|1090097|P1|COMPLETED|Overall Study||31
456547|NCT00590317|1090096|P2|STARTED|Overall Study||32
456548|NCT00590317|1090097|P1|STARTED|Overall Study||32
456549|NCT00590226|1090109|P2|NOT COMPLETED|Overall Study||0
456550|NCT00590226|1090110|P1|NOT COMPLETED|Overall Study||0
456551|NCT00590226|1090109|P2|COMPLETED|Overall Study||63
456552|NCT00590226|1090110|P1|COMPLETED|Overall Study||67
456553|NCT00590226|1090109|P2|STARTED|Overall Study||63
456554|NCT00590226|1090110|P1|STARTED|Overall Study||67
456555|NCT00590161|1090120|P2|NOT COMPLETED|Overall Study||3
456556|NCT00590161|1090121|P1|NOT COMPLETED|Overall Study||3
456557|NCT00590161|1090120|P2|COMPLETED|Overall Study||26
456558|NCT00590161|1090121|P1|COMPLETED|Overall Study||23
456559|NCT00590161|1090120|P2|STARTED|Overall Study||29
456560|NCT00590161|1090121|P1|STARTED|Overall Study||26
456561|NCT00590044|1090129|P2|NOT COMPLETED|Overall Study||2
456562|NCT00590044|1090130|P1|NOT COMPLETED|Overall Study||4
456563|NCT00590044|1090129|P2|COMPLETED|Overall Study||34
456564|NCT00590044|1090130|P1|COMPLETED|Overall Study||34
456565|NCT00590044|1090129|P2|STARTED|Overall Study||36
456566|NCT00590044|1090130|P1|STARTED|Overall Study||38
456567|NCT00590031|1090136|P1|NOT COMPLETED|Overall Study||6
456568|NCT00590031|1090136|P1|COMPLETED|Overall Study||55
456569|NCT00590031|1090136|P1|STARTED|Overall Study||61
456570|NCT00590018|1090143|P2|NOT COMPLETED|Overall Study||0
456571|NCT00590018|1090144|P1|NOT COMPLETED|Overall Study||0
456572|NCT00590018|1090143|P2|COMPLETED|Overall Study||9
456573|NCT00590018|1090144|P1|COMPLETED|Overall Study||9
456574|NCT00590018|1090143|P2|STARTED|Overall Study||9
456575|NCT00590018|1090144|P1|STARTED|Overall Study||9
456576|NCT00590005|1090152|P2|NOT COMPLETED|Overall Study||0
456577|NCT00590005|1090153|P1|NOT COMPLETED|Overall Study||0
456578|NCT00590005|1090152|P2|COMPLETED|Overall Study||119
456579|NCT00590005|1090153|P1|COMPLETED|Overall Study||106
456580|NCT00590005|1090152|P2|STARTED|Overall Study||119
456581|NCT00590005|1090153|P1|STARTED|Overall Study||106
456582|NCT00589979|1090163|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
456583|NCT00589979|1090164|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
456584|NCT00589979|1090165|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
456585|NCT00589979|1090163|P3|COMPLETED|Double-Blind Treatment Period 3||38
456586|NCT00589979|1090164|P2|COMPLETED|Double-Blind Treatment Period 3||46
456587|NCT00589979|1090165|P1|COMPLETED|Double-Blind Treatment Period 3||0
456588|NCT00589979|1090163|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
456589|NCT00589979|1090164|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
456590|NCT00589979|1090165|P1|STARTED|Double-Blind Treatment Period 3||0
456591|NCT00589979|1090163|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
456592|NCT00589979|1090164|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
456593|NCT00589979|1090165|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
456594|NCT00589979|1090163|P3|COMPLETED|Double-Blind Treatment Period 2||39
456595|NCT00589979|1090164|P2|COMPLETED|Double-Blind Treatment Period 2||47
456596|NCT00589979|1090165|P1|COMPLETED|Double-Blind Treatment Period 2||0
456597|NCT00589979|1090163|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
456598|NCT00589979|1090164|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
456599|NCT00589979|1090165|P1|STARTED|Double-Blind Treatment Period 2||0
456600|NCT00589979|1090163|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
456601|NCT00589979|1090164|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
456602|NCT00589979|1090165|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
456603|NCT00589979|1090163|P3|COMPLETED|Double-Blind Treatment Period 1||41
456604|NCT00589979|1090164|P2|COMPLETED|Double-Blind Treatment Period 1||48
456605|NCT00589979|1090165|P1|COMPLETED|Double-Blind Treatment Period 1||0
456606|NCT00589979|1090163|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
456607|NCT00589979|1090164|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
456608|NCT00589979|1090165|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
456609|NCT00589979|1090163|P3|NOT COMPLETED|Run-In Period||0
456610|NCT00589979|1090164|P2|NOT COMPLETED|Run-In Period||0
456611|NCT00589979|1090165|P1|NOT COMPLETED|Run-In Period||76
456612|NCT00589979|1090163|P3|COMPLETED|Run-In Period||0
456613|NCT00589979|1090164|P2|COMPLETED|Run-In Period||0
456614|NCT00589979|1090165|P1|COMPLETED|Run-In Period||93
456615|NCT00589979|1090163|P3|STARTED|Run-In Period||0
456616|NCT00589979|1090164|P2|STARTED|Run-In Period||0
456617|NCT00589979|1090165|P1|STARTED|Run-In Period||169
456618|NCT00589914|1090204|P2|NOT COMPLETED|Overall Study||137
456619|NCT00589914|1090205|P1|NOT COMPLETED|Overall Study||150
456620|NCT00589914|1090204|P2|COMPLETED|Overall Study||471
456621|NCT00589914|1090205|P1|COMPLETED|Overall Study||456
456622|NCT00589914|1090204|P2|STARTED|Overall Study||608
456623|NCT00589914|1090205|P1|STARTED|Overall Study||606
456624|NCT00589888|1090215|P5|NOT COMPLETED|64-gram Oral Fat Load||0
456625|NCT00589888|1090216|P4|NOT COMPLETED|64-gram Oral Fat Load||0
456626|NCT00589888|1090217|P3|NOT COMPLETED|64-gram Oral Fat Load||0
456627|NCT00589888|1090218|P2|NOT COMPLETED|64-gram Oral Fat Load||0
456628|NCT00589888|1090219|P1|NOT COMPLETED|64-gram Oral Fat Load||0
456629|NCT00589888|1090215|P5|COMPLETED|64-gram Oral Fat Load||13
456630|NCT00589888|1090216|P4|COMPLETED|64-gram Oral Fat Load||0
456631|NCT00589888|1090217|P3|COMPLETED|64-gram Oral Fat Load||0
456632|NCT00589888|1090218|P2|COMPLETED|64-gram Oral Fat Load||0
456633|NCT00589888|1090219|P1|COMPLETED|64-gram Oral Fat Load||0
456634|NCT00589888|1090215|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
456635|NCT00589888|1090216|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
456636|NCT00589888|1090217|P3|STARTED|64-gram Oral Fat Load||0
456637|NCT00589888|1090218|P2|STARTED|64-gram Oral Fat Load||0
456638|NCT00589888|1090219|P1|STARTED|64-gram Oral Fat Load||0
456639|NCT00589888|1090215|P5|NOT COMPLETED|32-gram Oral Fat Load||0
456640|NCT00589888|1090216|P4|NOT COMPLETED|32-gram Oral Fat Load||0
456641|NCT00589888|1090217|P3|NOT COMPLETED|32-gram Oral Fat Load||0
456642|NCT00589888|1090218|P2|NOT COMPLETED|32-gram Oral Fat Load||0
456643|NCT00589888|1090219|P1|NOT COMPLETED|32-gram Oral Fat Load||0
456644|NCT00589888|1090215|P5|COMPLETED|32-gram Oral Fat Load||0
456645|NCT00589888|1090216|P4|COMPLETED|32-gram Oral Fat Load||13
456646|NCT00589888|1090217|P3|COMPLETED|32-gram Oral Fat Load||0
456647|NCT00589888|1090218|P2|COMPLETED|32-gram Oral Fat Load||0
456648|NCT00589888|1090219|P1|COMPLETED|32-gram Oral Fat Load||0
456649|NCT00589888|1090215|P5|STARTED|32-gram Oral Fat Load||0
456650|NCT00589888|1090216|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
456651|NCT00589888|1090217|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
456652|NCT00589888|1090218|P2|STARTED|32-gram Oral Fat Load||0
456653|NCT00589888|1090219|P1|STARTED|32-gram Oral Fat Load||0
456654|NCT00589888|1090215|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
456655|NCT00589888|1090216|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
456656|NCT00589888|1090217|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
456657|NCT00589888|1090218|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
456658|NCT00589888|1090219|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
456659|NCT00589888|1090215|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
456660|NCT00589888|1090216|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
456661|NCT00589888|1090217|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
456662|NCT00589888|1090218|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
456663|NCT00589888|1090219|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
456664|NCT00589888|1090215|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
456665|NCT00589888|1090216|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
456666|NCT00589888|1090217|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
456667|NCT00589888|1090218|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
456668|NCT00589888|1090219|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
456669|NCT00589888|1090215|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
456670|NCT00589888|1090216|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
456671|NCT00589888|1090217|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
456672|NCT00589888|1090218|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
456673|NCT00589888|1090219|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
456674|NCT00589888|1090215|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
456675|NCT00589888|1090216|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
456676|NCT00589888|1090217|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
456677|NCT00589888|1090218|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
456678|NCT00589888|1090219|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
456679|NCT00589888|1090215|P5|STARTED|Intralipid 20% @ 20cc/hr||0
456680|NCT00589888|1090216|P4|STARTED|Intralipid 20% @ 20cc/hr||0
456681|NCT00589888|1090217|P3|STARTED|Intralipid 20% @ 20cc/hr||0
456682|NCT00589888|1090218|P2|STARTED|Intralipid 20% @ 20cc/hr||13
456683|NCT00589888|1090219|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
456684|NCT00589888|1090215|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
456685|NCT00589888|1090216|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
456686|NCT00589888|1090217|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
456687|NCT00589888|1090218|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
456688|NCT00589888|1090219|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
456689|NCT00589888|1090215|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
456690|NCT00589888|1090216|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
456691|NCT00589888|1090217|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
456692|NCT00589888|1090218|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
456693|NCT00589888|1090219|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
456694|NCT00589888|1090215|P5|STARTED|Normal Saline @ 40cc/Hour||0
456695|NCT00589888|1090216|P4|STARTED|Normal Saline @ 40cc/Hour||0
456696|NCT00589888|1090217|P3|STARTED|Normal Saline @ 40cc/Hour||0
456697|NCT00589888|1090218|P2|STARTED|Normal Saline @ 40cc/Hour||0
456698|NCT00589888|1090219|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
456699|NCT00589849|1090231|P1|NOT COMPLETED|Overall Study||0
456700|NCT00589849|1090231|P1|COMPLETED|Overall Study||32
456701|NCT00589849|1090231|P1|STARTED|Overall Study||32
456702|NCT00589784|1090237|P2|NOT COMPLETED|Overall Study||10
456703|NCT00589784|1090238|P1|NOT COMPLETED|Overall Study||1
456704|NCT00589784|1090237|P2|COMPLETED|Overall Study||4
456705|NCT00589784|1090238|P1|COMPLETED|Overall Study||35
456706|NCT00589784|1090237|P2|STARTED|Overall Study||14
456707|NCT00589784|1090238|P1|STARTED|Overall Study||36
456708|NCT00589693|1090245|P2|NOT COMPLETED|Overall Study||29
456709|NCT00589693|1090246|P1|NOT COMPLETED|Overall Study||44
456710|NCT00589693|1090245|P2|COMPLETED|Overall Study||83
456711|NCT00589693|1090246|P1|COMPLETED|Overall Study||71
456712|NCT00589693|1090245|P2|STARTED|Overall Study||112
456713|NCT00589693|1090246|P1|STARTED|Overall Study||115
456714|NCT00589667|1090260|P1|NOT COMPLETED|Overall Study||3
456715|NCT00589667|1090260|P1|COMPLETED|Overall Study||23
456716|NCT00589667|1090260|P1|STARTED|Overall Study||26
456717|NCT00589628|1090267|P2|NOT COMPLETED|Overall Study||1
456718|NCT00589628|1090268|P1|NOT COMPLETED|Overall Study||0
456719|NCT00589628|1090267|P2|COMPLETED|Overall Study||5
456720|NCT00589628|1090268|P1|COMPLETED|Overall Study||7
456721|NCT00589628|1090267|P2|STARTED|Overall Study||6
456722|NCT00589628|1090268|P1|STARTED|Overall Study||7
456723|NCT00589602|1090274|P1|NOT COMPLETED|Overall Study||1
456724|NCT00589602|1090274|P1|COMPLETED|Overall Study||12
456725|NCT00589602|1090274|P1|STARTED|Overall Study||13
456726|NCT00589563|1090282|P1|NOT COMPLETED|Overall Study||0
456727|NCT00589563|1090282|P1|COMPLETED|Overall Study||32
456728|NCT00589563|1090282|P1|STARTED|Overall Study||32
456729|NCT00589550|1090299|P1|NOT COMPLETED|Overall Study||1
456730|NCT00589550|1090299|P1|COMPLETED|Overall Study||0
456731|NCT00589550|1090299|P1|Withdrew From Study|Overall Study||1
456732|NCT00589550|1090299|P1|STARTED|Overall Study||1
456733|NCT00589303|1090311|P2|NOT COMPLETED|Overall Study||1
456734|NCT00589303|1090312|P1|NOT COMPLETED|Overall Study||2
456735|NCT00589303|1090311|P2|COMPLETED|Overall Study||12
456736|NCT00589303|1090312|P1|COMPLETED|Overall Study||12
456737|NCT00589303|1090311|P2|STARTED|Overall Study||13
456738|NCT00589303|1090312|P1|STARTED|Overall Study||14
456739|NCT00589290|1090318|P1|NOT COMPLETED|Overall Study||1
456740|NCT00589290|1090318|P1|COMPLETED|Overall Study||40
456741|NCT00589290|1090318|P1|STARTED|Overall Study||41
456742|NCT00589277|1090328|P2|NOT COMPLETED|Overall Study||286
456743|NCT00589277|1090329|P1|NOT COMPLETED|Overall Study||460
456744|NCT00589277|1090328|P2|COMPLETED|Overall Study||524
456745|NCT00589277|1090329|P1|COMPLETED|Overall Study||762
456746|NCT00589277|1090328|P2|Completed 3 Month Follow Up|Overall Study||524
456747|NCT00589277|1090329|P1|Completed 3 Month Follow Up|Overall Study||762
456748|NCT00589277|1090328|P2|Completed 2 Week Follow Up|Overall Study||424
456749|NCT00589277|1090329|P1|Completed 2 Week Follow Up|Overall Study||603
456750|NCT00589277|1090328|P2|STARTED|Overall Study||810
456751|NCT00589277|1090329|P1|STARTED|Overall Study||1222
456752|NCT00589108|1090342|P3|NOT COMPLETED|Overall Study||5
456753|NCT00589108|1090343|P2|NOT COMPLETED|Overall Study||4
456754|NCT00589108|1090344|P1|NOT COMPLETED|Overall Study||4
456755|NCT00589108|1090342|P3|COMPLETED|Overall Study||75
456756|NCT00589108|1090343|P2|COMPLETED|Overall Study||76
456757|NCT00589108|1090344|P1|COMPLETED|Overall Study||76
456758|NCT00589108|1090342|P3|STARTED|Overall Study||80
456759|NCT00589108|1090343|P2|STARTED|Overall Study||80
456760|NCT00589108|1090344|P1|STARTED|Overall Study||80
456761|NCT00588237|1090364|P1|NOT COMPLETED|Overall Study||4
456762|NCT00588237|1090364|P1|COMPLETED|Overall Study||38
456763|NCT00588237|1090364|P1|STARTED|Overall Study||42
456764|NCT00588965|1090368|P1|NOT COMPLETED|Overall Study||0
456765|NCT00588965|1090368|P1|COMPLETED|Overall Study||35
456766|NCT00588965|1090368|P1|STARTED|Overall Study||35
456767|NCT00588952|1090378|P2|NOT COMPLETED|Overall Study||7
456768|NCT00588952|1090379|P1|NOT COMPLETED|Overall Study||3
456769|NCT00588952|1090378|P2|COMPLETED|Overall Study||63
456770|NCT00588952|1090379|P1|COMPLETED|Overall Study||26
456771|NCT00588952|1090378|P2|STARTED|Overall Study||70
456772|NCT00588952|1090379|P1|STARTED|Overall Study||29
456773|NCT00588900|1090399|P1|NOT COMPLETED|Overall Study||0
456774|NCT00588900|1090399|P1|COMPLETED|Overall Study||5
456775|NCT00588900|1090399|P1|STARTED|Overall Study||5
456776|NCT00588861|1090407|P2|NOT COMPLETED|10 Years||114
456777|NCT00588861|1090408|P1|NOT COMPLETED|10 Years||107
456778|NCT00588861|1090407|P2|COMPLETED|10 Years||0
456779|NCT00588861|1090408|P1|COMPLETED|10 Years||0
456780|NCT00588861|1090407|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
456781|NCT00588861|1090408|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
456782|NCT00588861|1090407|P2|NOT COMPLETED|8 Years||114
456783|NCT00588861|1090408|P1|NOT COMPLETED|8 Years||105
456784|NCT00588861|1090407|P2|COMPLETED|8 Years||0
456785|NCT00588861|1090408|P1|COMPLETED|8 Years||2
456786|NCT00588861|1090407|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
456787|NCT00588861|1090408|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
456788|NCT00588861|1090407|P2|NOT COMPLETED|6 Years||109
456789|NCT00588861|1090408|P1|NOT COMPLETED|6 Years||104
456790|NCT00588861|1090407|P2|COMPLETED|6 Years||5
456791|NCT00588861|1090408|P1|COMPLETED|6 Years||3
456792|NCT00588861|1090407|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
456793|NCT00588861|1090408|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
456794|NCT00588861|1090407|P2|NOT COMPLETED|4 Years||103
456795|NCT00588861|1090408|P1|NOT COMPLETED|4 Years||91
456796|NCT00588861|1090407|P2|COMPLETED|4 Years||11
456797|NCT00588861|1090408|P1|COMPLETED|4 Years||16
456798|NCT00588861|1090407|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
456799|NCT00588861|1090408|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
456800|NCT00588861|1090407|P2|NOT COMPLETED|2 Years||87
456801|NCT00588861|1090408|P1|NOT COMPLETED|2 Years||92
456802|NCT00588861|1090407|P2|COMPLETED|2 Years||27
456803|NCT00588861|1090408|P1|COMPLETED|2 Years||15
456804|NCT00588861|1090407|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
456805|NCT00588861|1090408|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
456806|NCT00588861|1090407|P2|NOT COMPLETED|1 Year||82
456807|NCT00588861|1090408|P1|NOT COMPLETED|1 Year||89
456808|NCT00588861|1090407|P2|COMPLETED|1 Year||32
456809|NCT00588861|1090408|P1|COMPLETED|1 Year||18
456810|NCT00588861|1090407|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
456811|NCT00588861|1090408|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
456812|NCT00588861|1090407|P2|NOT COMPLETED|6 Months||73
456813|NCT00588861|1090408|P1|NOT COMPLETED|6 Months||98
456814|NCT00588861|1090407|P2|COMPLETED|6 Months||41
456815|NCT00588861|1090408|P1|COMPLETED|6 Months||9
456816|NCT00588861|1090407|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
456817|NCT00588861|1090408|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
456818|NCT00588861|1090407|P2|NOT COMPLETED|Pre-Operative||86
456819|NCT00588861|1090408|P1|NOT COMPLETED|Pre-Operative||95
456820|NCT00588861|1090407|P2|COMPLETED|Pre-Operative||114
456821|NCT00588861|1090408|P1|COMPLETED|Pre-Operative||107
456822|NCT00588861|1090407|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
456823|NCT00588861|1090408|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
456824|NCT00588848|1090418|P2|NOT COMPLETED|Overall Study||0
456825|NCT00588848|1090419|P1|NOT COMPLETED|Overall Study||0
456826|NCT00588848|1090418|P2|COMPLETED|Overall Study||8
456827|NCT00588848|1090419|P1|COMPLETED|Overall Study||3
456828|NCT00588848|1090418|P2|STARTED|Overall Study||8
456829|NCT00588848|1090419|P1|STARTED|Overall Study||3
456830|NCT00588822|1090427|P1|NOT COMPLETED|Overall Study||8
456831|NCT00588822|1090427|P1|COMPLETED|Overall Study||13
456832|NCT00588822|1090427|P1|STARTED|Overall Study||21
456833|NCT00588809|1090436|P1|NOT COMPLETED|Overall Study||0
456834|NCT00588809|1090436|P1|COMPLETED|Overall Study||47
456835|NCT00588809|1090436|P1|STARTED|Overall Study||47
456836|NCT00588731|1090447|P2|NOT COMPLETED|Overall Study||2
456837|NCT00588731|1090448|P1|NOT COMPLETED|Overall Study||3
456838|NCT00588731|1090447|P2|COMPLETED|Overall Study||18
456839|NCT00588731|1090448|P1|COMPLETED|Overall Study||18
456840|NCT00588731|1090447|P2|STARTED|Overall Study||20
456841|NCT00588731|1090448|P1|STARTED|Overall Study||21
456842|NCT00588692|1090458|P2|NOT COMPLETED|Overall Study||3
456843|NCT00588692|1090459|P1|NOT COMPLETED|Overall Study||7
456844|NCT00588692|1090458|P2|COMPLETED|Overall Study||27
456845|NCT00588692|1090459|P1|COMPLETED|Overall Study||23
456846|NCT00588692|1090458|P2|STARTED|Overall Study||30
456847|NCT00588692|1090459|P1|STARTED|Overall Study||30
456848|NCT00588666|1090495|P1|NOT COMPLETED|Overall Study||4
456849|NCT00588666|1090495|P1|COMPLETED|Overall Study||47
456850|NCT00588666|1090495|P1|STARTED|Overall Study||51
456851|NCT00588640|1090500|P1|NOT COMPLETED|Overall Study||2
456852|NCT00588640|1090500|P1|COMPLETED|Overall Study||8
456853|NCT00588640|1090500|P1|STARTED|Overall Study||10
456854|NCT00588536|1090504|P1|NOT COMPLETED|Overall Study||0
456855|NCT00588536|1090504|P1|COMPLETED|Overall Study||5
456856|NCT00588536|1090504|P1|STARTED|Overall Study||5
456857|NCT00588471|1090510|P2|NOT COMPLETED|Overall Study||0
456858|NCT00588471|1090511|P1|NOT COMPLETED|Overall Study||0
456859|NCT00588471|1090510|P2|COMPLETED|Overall Study||29
456860|NCT00588471|1090511|P1|COMPLETED|Overall Study||28
456861|NCT00588471|1090510|P2|STARTED|Overall Study||29
456862|NCT00588471|1090511|P1|STARTED|Overall Study||28
456863|NCT00588445|1090519|P1|NOT COMPLETED|Overall Study||15
456864|NCT00588445|1090519|P1|COMPLETED|Overall Study||50
456865|NCT00588445|1090519|P1|STARTED|Overall Study||65
456866|NCT00588406|1090527|P2|NOT COMPLETED|Overall Study||0
456867|NCT00588406|1090528|P1|NOT COMPLETED|Overall Study||0
456868|NCT00588406|1090527|P2|COMPLETED|Overall Study||49
456869|NCT00588406|1090528|P1|COMPLETED|Overall Study||46
456870|NCT00588406|1090527|P2|STARTED|Overall Study||49
456871|NCT00588406|1090528|P1|STARTED|Overall Study||46
456872|NCT00588380|1090536|P1|NOT COMPLETED|Overall Study||0
456873|NCT00588380|1090536|P1|COMPLETED|Overall Study||88
456874|NCT00588380|1090536|P1|STARTED|Overall Study||88
456875|NCT00588354|1090543|P2|NOT COMPLETED|Baseline to 4 Weeks||1
456876|NCT00588354|1090544|P1|NOT COMPLETED|Baseline to 4 Weeks||0
456877|NCT00588354|1090543|P2|COMPLETED|Baseline to 4 Weeks||14
456878|NCT00588354|1090544|P1|COMPLETED|Baseline to 4 Weeks||9
456879|NCT00588354|1090543|P2|STARTED|Baseline to 4 Weeks||15
456880|NCT00588354|1090544|P1|STARTED|Baseline to 4 Weeks||9
456881|NCT00588354|1090543|P2|NOT COMPLETED|Baseline to 2 Weeks||0
456882|NCT00588354|1090544|P1|NOT COMPLETED|Baseline to 2 Weeks||2
456883|NCT00588354|1090543|P2|COMPLETED|Baseline to 2 Weeks||15
456884|NCT00588354|1090544|P1|COMPLETED|Baseline to 2 Weeks||9
456885|NCT00588354|1090543|P2|STARTED|Baseline to 2 Weeks||15
456886|NCT00588354|1090544|P1|STARTED|Baseline to 2 Weeks||11
456887|NCT00588341|1090564|P1|NOT COMPLETED|Overall Study||5
456888|NCT00588341|1090564|P1|COMPLETED|Overall Study||19
456889|NCT00588341|1090564|P1|STARTED|Overall Study||24
456890|NCT00588159|1090570|P2|NOT COMPLETED|Overall Study||11
456891|NCT00588159|1090571|P1|NOT COMPLETED|Overall Study||15
456892|NCT00588159|1090570|P2|COMPLETED|Overall Study||63
456893|NCT00588159|1090571|P1|COMPLETED|Overall Study||57
456894|NCT00588159|1090570|P2|STARTED|Overall Study||74
456895|NCT00588159|1090571|P1|STARTED|Overall Study||72
456896|NCT00588146|1090587|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
456897|NCT00588146|1090588|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
456898|NCT00588146|1090587|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
456899|NCT00588146|1090588|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
456900|NCT00588146|1090587|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
456901|NCT00588146|1090588|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
456902|NCT00588146|1090587|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
456903|NCT00588146|1090588|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
456904|NCT00588146|1090587|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
456905|NCT00588146|1090588|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
456906|NCT00588146|1090587|P2|STARTED|First Intervention (Baseline to 6 mo)||5
456907|NCT00588146|1090588|P1|STARTED|First Intervention (Baseline to 6 mo)||5
456908|NCT00588094|1090594|P1|NOT COMPLETED|Overall Study||5
456909|NCT00588094|1090594|P1|COMPLETED|Overall Study||15
456910|NCT00588094|1090594|P1|STARTED|Overall Study||20
456911|NCT00587990|1090601|P3|NOT COMPLETED|Overall Study||0
456912|NCT00587990|1090602|P2|NOT COMPLETED|Overall Study||0
456913|NCT00587990|1090603|P1|NOT COMPLETED|Overall Study||0
456914|NCT00587990|1090601|P3|COMPLETED|Overall Study||3
456915|NCT00587990|1090602|P2|COMPLETED|Overall Study||4
456916|NCT00587990|1090603|P1|COMPLETED|Overall Study||2
456917|NCT00587990|1090601|P3|STARTED|Overall Study||3
456918|NCT00587990|1090602|P2|STARTED|Overall Study||4
456919|NCT00587990|1090603|P1|STARTED|Overall Study||2
456920|NCT00587964|1090611|P1|NOT COMPLETED|Overall Study||12
456921|NCT00587964|1090611|P1|COMPLETED|Overall Study||39
456922|NCT00587964|1090611|P1|STARTED|Overall Study||51
456923|NCT00587860|1090617|P2|NOT COMPLETED|Overall Study||5
456924|NCT00587860|1090618|P1|NOT COMPLETED|Overall Study||5
456925|NCT00587860|1090617|P2|COMPLETED|Overall Study||30
456926|NCT00587860|1090618|P1|COMPLETED|Overall Study||30
456927|NCT00587860|1090617|P2|STARTED|Overall Study||35
456928|NCT00587860|1090618|P1|STARTED|Overall Study||35
456929|NCT00587847|1090638|P1|NOT COMPLETED|Overall Study||7
456930|NCT00587847|1090638|P1|COMPLETED|Overall Study||5
456931|NCT00587847|1090638|P1|STARTED|Overall Study||12
456932|NCT00587834|1090643|P1|NOT COMPLETED|Overall Study||0
456933|NCT00587834|1090643|P1|COMPLETED|Overall Study||96
456934|NCT00587834|1090643|P1|STARTED|Overall Study||96
456935|NCT00587769|1090659|P1|NOT COMPLETED|Overall Study||0
456936|NCT00587769|1090659|P1|COMPLETED|Overall Study||38
456937|NCT00587769|1090659|P1|STARTED|Overall Study||38
456938|NCT00587678|1090667|P3|NOT COMPLETED|Overall Study||8
456939|NCT00587678|1090668|P2|NOT COMPLETED|Overall Study||4
456940|NCT00587678|1090669|P1|NOT COMPLETED|Overall Study||6
456941|NCT00587678|1090667|P3|COMPLETED|Overall Study||33
456942|NCT00587678|1090668|P2|COMPLETED|Overall Study||18
456943|NCT00587678|1090669|P1|COMPLETED|Overall Study||16
456944|NCT00587678|1090667|P3|STARTED|Overall Study||41
456945|NCT00587678|1090668|P2|STARTED|Overall Study||22
456946|NCT00587678|1090669|P1|STARTED|Overall Study||22
456947|NCT00587639|1090707|P1|NOT COMPLETED|Overall Study||1
456948|NCT00587639|1090707|P1|COMPLETED|Overall Study||7
456949|NCT00587639|1090707|P1|STARTED|Overall Study||8
456950|NCT00587587|1090714|P2|NOT COMPLETED|Overall Study||1
456951|NCT00587587|1090715|P1|NOT COMPLETED|Overall Study||6
456952|NCT00587587|1090714|P2|COMPLETED|Overall Study||12
456953|NCT00587587|1090715|P1|COMPLETED|Overall Study||11
456954|NCT00587587|1090714|P2|STARTED|Overall Study||13
456955|NCT00587587|1090715|P1|STARTED|Overall Study||17
456956|NCT00587483|1090738|P3|NOT COMPLETED|Overall Study||0
456957|NCT00587483|1090739|P2|NOT COMPLETED|Overall Study||0
456958|NCT00587483|1090740|P1|NOT COMPLETED|Overall Study||0
456959|NCT00587483|1090738|P3|COMPLETED|Overall Study||112
456960|NCT00587483|1090739|P2|COMPLETED|Overall Study||115
456961|NCT00587483|1090740|P1|COMPLETED|Overall Study||115
456962|NCT00587483|1090738|P3|STARTED|Overall Study||112
456963|NCT00587483|1090739|P2|STARTED|Overall Study||115
456964|NCT00587483|1090740|P1|STARTED|Overall Study||115
456965|NCT00587457|1090769|P3|NOT COMPLETED|Overall Study||5
456966|NCT00587457|1090770|P2|NOT COMPLETED|Overall Study||3
456967|NCT00587457|1090771|P1|NOT COMPLETED|Overall Study||3
456968|NCT00587457|1090769|P3|COMPLETED|Overall Study||0
456969|NCT00587457|1090770|P2|COMPLETED|Overall Study||0
456970|NCT00587457|1090771|P1|COMPLETED|Overall Study||0
456971|NCT00587457|1090769|P3|STARTED|Overall Study||5
456972|NCT00587457|1090770|P2|STARTED|Overall Study||3
456973|NCT00587457|1090771|P1|STARTED|Overall Study||3
456974|NCT00587431|1090808|P2|NOT COMPLETED|Overall Study||1
456975|NCT00587431|1090809|P1|NOT COMPLETED|Overall Study||1
456976|NCT00587431|1090808|P2|COMPLETED|Overall Study||38
456977|NCT00587431|1090809|P1|COMPLETED|Overall Study||62
456978|NCT00587431|1090808|P2|STARTED|Overall Study||39
456979|NCT00587431|1090809|P1|STARTED|Overall Study||63
456980|NCT00587288|1090820|P2|NOT COMPLETED|Overall Study||9
456981|NCT00587288|1090821|P1|NOT COMPLETED|Overall Study||3
456982|NCT00587288|1090820|P2|COMPLETED|Overall Study||44
456983|NCT00587288|1090821|P1|COMPLETED|Overall Study||50
456984|NCT00587288|1090820|P2|STARTED|Overall Study||53
456985|NCT00587288|1090821|P1|STARTED|Overall Study||53
456986|NCT00587223|1090839|P1|NOT COMPLETED|Overall Study||1
456987|NCT00587223|1090839|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
456988|NCT00587223|1090839|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
456989|NCT00587171|1090856|P2|NOT COMPLETED|Overall Study||1
456990|NCT00587171|1090857|P1|NOT COMPLETED|Overall Study||1
456991|NCT00587171|1090856|P2|COMPLETED|Overall Study||9
456992|NCT00587171|1090857|P1|COMPLETED|Overall Study||8
456993|NCT00587171|1090856|P2|STARTED|Overall Study||10
456994|NCT00587171|1090857|P1|STARTED|Overall Study||9
456995|NCT00587158|1090887|P2|NOT COMPLETED|Overall Study||8
456996|NCT00587158|1090888|P1|NOT COMPLETED|Overall Study||5
456997|NCT00587158|1090887|P2|COMPLETED|Overall Study||43
456998|NCT00587158|1090888|P1|COMPLETED|Overall Study||44
456999|NCT00587158|1090887|P2|Continued in Study|Overall Study||46
457000|NCT00587158|1090888|P1|Continued in Study|Overall Study||45
457001|NCT00587158|1090887|P2|STARTED|Overall Study||51
457002|NCT00587158|1090888|P1|STARTED|Overall Study||49
457003|NCT00587132|1090922|P4|NOT COMPLETED|Overall Study||0
457004|NCT00587132|1090923|P3|NOT COMPLETED|Overall Study||0
457005|NCT00587132|1090924|P2|NOT COMPLETED|Overall Study||0
457006|NCT00587132|1090925|P1|NOT COMPLETED|Overall Study||0
457007|NCT00587132|1090922|P4|COMPLETED|Overall Study||0
457008|NCT00587132|1090923|P3|COMPLETED|Overall Study||0
457009|NCT00587132|1090924|P2|COMPLETED|Overall Study||0
457010|NCT00587132|1090925|P1|COMPLETED|Overall Study||4
457011|NCT00587132|1090922|P4|STARTED|Overall Study||0
457012|NCT00587132|1090923|P3|STARTED|Overall Study||0
457013|NCT00587132|1090924|P2|STARTED|Overall Study||0
457014|NCT00587132|1090925|P1|STARTED|Overall Study||4
457015|NCT00587054|1090935|P1|NOT COMPLETED|Overall Study||9
457016|NCT00587054|1090935|P1|COMPLETED|Overall Study||120
457017|NCT00587054|1090935|P1|STARTED|Overall Study||129
457018|NCT00587041|1090942|P3|NOT COMPLETED|Overall Study||0
457019|NCT00587041|1090943|P2|NOT COMPLETED|Overall Study||0
457020|NCT00587041|1090944|P1|NOT COMPLETED|Overall Study||0
457021|NCT00587041|1090942|P3|COMPLETED|Overall Study||14
457022|NCT00587041|1090943|P2|COMPLETED|Overall Study||14
457023|NCT00587041|1090944|P1|COMPLETED|Overall Study||12
457024|NCT00587041|1090942|P3|STARTED|Overall Study||14
457025|NCT00587041|1090943|P2|STARTED|Overall Study||14
457026|NCT00587041|1090944|P1|STARTED|Overall Study||12
457027|NCT00586898|1090955|P1|NOT COMPLETED|Overall Study||7
457028|NCT00586898|1090955|P1|COMPLETED|Overall Study||29
457029|NCT00586898|1090955|P1|STARTED|Overall Study||36
457030|NCT00586846|1090959|P1|NOT COMPLETED|Overall Study||6
457031|NCT00586846|1090959|P1|COMPLETED|Overall Study||34
457032|NCT00586846|1090959|P1|STARTED|Overall Study||40
457033|NCT00586820|1090965|P2|NOT COMPLETED|Overall Study||0
457034|NCT00586820|1090966|P1|NOT COMPLETED|Overall Study||1
457035|NCT00586820|1090965|P2|COMPLETED|Overall Study||11
457036|NCT00586820|1090966|P1|COMPLETED|Overall Study||11
457037|NCT00586820|1090965|P2|STARTED|Overall Study||11
457038|NCT00586820|1090966|P1|STARTED|Overall Study||12
457039|NCT00586729|1090976|P2|NOT COMPLETED|Overall Study||1
457040|NCT00586729|1090977|P1|NOT COMPLETED|Overall Study||3
457041|NCT00586729|1090976|P2|COMPLETED|Overall Study||8
457042|NCT00586729|1090977|P1|COMPLETED|Overall Study||11
457043|NCT00586729|1090976|P2|STARTED|Overall Study||9
457044|NCT00586729|1090977|P1|STARTED|Overall Study||14
457045|NCT00586716|1090989|P2|NOT COMPLETED|Overall Study||0
457046|NCT00586716|1090990|P1|NOT COMPLETED|Overall Study||0
457047|NCT00586716|1090989|P2|COMPLETED|Overall Study||8
457048|NCT00586716|1090990|P1|COMPLETED|Overall Study||14
457049|NCT00586716|1090989|P2|STARTED|Overall Study||8
457050|NCT00586716|1090990|P1|STARTED|Overall Study||14
457051|NCT00586703|1090997|P1|NOT COMPLETED|Overall Study||12
457052|NCT00586703|1090997|P1|COMPLETED|Overall Study||4
457053|NCT00586703|1090997|P1|STARTED|Overall Study||16
457054|NCT00586690|1091004|P2|NOT COMPLETED|Overall Study||0
457055|NCT00586690|1091005|P1|NOT COMPLETED|Overall Study||16
457056|NCT00586690|1091004|P2|COMPLETED|Overall Study||22
457057|NCT00586690|1091005|P1|COMPLETED|Overall Study||5
457058|NCT00586690|1091004|P2|STARTED|Overall Study||22
457059|NCT00586690|1091005|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
457060|NCT00586664|1091015|P3|NOT COMPLETED|Overall Study||1
457061|NCT00586664|1091016|P2|NOT COMPLETED|Overall Study||7
457062|NCT00586664|1091017|P1|NOT COMPLETED|Overall Study||5
457063|NCT00586664|1091015|P3|COMPLETED|Overall Study||43
457064|NCT00586664|1091016|P2|COMPLETED|Overall Study||36
457065|NCT00586664|1091017|P1|COMPLETED|Overall Study||38
457066|NCT00586664|1091015|P3|STARTED|Overall Study||44
457067|NCT00586664|1091016|P2|STARTED|Overall Study||43
457068|NCT00586664|1091017|P1|STARTED|Overall Study||43
457069|NCT00586625|1091063|P2|NOT COMPLETED|Overall Study||17
457070|NCT00586625|1091064|P1|NOT COMPLETED|Overall Study||43
457071|NCT00586625|1091063|P2|COMPLETED|Overall Study||269
457072|NCT00586625|1091064|P1|COMPLETED|Overall Study||532
457073|NCT00586625|1091063|P2|STARTED|Overall Study||286
457074|NCT00586625|1091064|P1|STARTED|Overall Study||575
457075|NCT00586612|1091072|P2|NOT COMPLETED|Booster Phase||1
457076|NCT00586612|1091073|P1|NOT COMPLETED|Booster Phase||3
457077|NCT00586612|1091072|P2|COMPLETED|Booster Phase||143
457078|NCT00586612|1091073|P1|COMPLETED|Booster Phase||151
457079|NCT00586612|1091072|P2|STARTED|Booster Phase||144
457080|NCT00586612|1091073|P1|STARTED|Booster Phase||154
457081|NCT00586612|1091072|P2|NOT COMPLETED|Primary Phase||3
457082|NCT00586612|1091073|P1|NOT COMPLETED|Primary Phase||1
457083|NCT00586612|1091072|P2|COMPLETED|Primary Phase||147
457084|NCT00586612|1091073|P1|COMPLETED|Primary Phase||162
457085|NCT00586612|1091072|P2|STARTED|Primary Phase||150
457086|NCT00586612|1091073|P1|STARTED|Primary Phase||163
457087|NCT00586573|1091139|P1|NOT COMPLETED|Overall Study||6
457088|NCT00586573|1091139|P1|COMPLETED|Overall Study||28
457089|NCT00586573|1091139|P1|STARTED|Overall Study||34
457090|NCT00586521|1091143|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
457091|NCT00586521|1091143|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
457092|NCT00586521|1091143|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
457093|NCT00586521|1091143|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
457094|NCT00586521|1091143|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
457095|NCT00586521|1091143|P1|STARTED|On Demand Treatment (Months 1-6)||20
457096|NCT00586495|1091150|P1|NOT COMPLETED|Follow-up||92
457097|NCT00586495|1091150|P1|COMPLETED|Follow-up||0
457098|NCT00586495|1091150|P1|STARTED|Follow-up||92
457099|NCT00586495|1091150|P1|NOT COMPLETED|Treatment Period||95
457100|NCT00586495|1091150|P1|COMPLETED|Treatment Period||0
457101|NCT00586495|1091150|P1|STARTED|Treatment Period||95
457102|NCT00586482|1091162|P2|NOT COMPLETED|Overall Study||0
457103|NCT00586482|1091163|P1|NOT COMPLETED|Overall Study||0
457104|NCT00586482|1091162|P2|COMPLETED|Overall Study||24
457105|NCT00586482|1091163|P1|COMPLETED|Overall Study||22
457106|NCT00586482|1091162|P2|STARTED|Overall Study||24
457107|NCT00586482|1091163|P1|STARTED|Overall Study||22
457108|NCT00586469|1091179|P2|NOT COMPLETED|Overall Study||1
457109|NCT00586469|1091180|P1|NOT COMPLETED|Overall Study||0
457110|NCT00586469|1091179|P2|COMPLETED|Overall Study||499
457111|NCT00586469|1091180|P1|COMPLETED|Overall Study||500
457112|NCT00586469|1091179|P2|STARTED|Overall Study||500
457113|NCT00586469|1091180|P1|STARTED|Overall Study||500
457114|NCT00586339|1091207|P3|NOT COMPLETED|Overall Study||6
457115|NCT00586339|1091208|P2|NOT COMPLETED|Overall Study||7
457116|NCT00586339|1091209|P1|NOT COMPLETED|Overall Study||7
457117|NCT00586339|1091207|P3|COMPLETED|Overall Study||24
457118|NCT00586339|1091208|P2|COMPLETED|Overall Study||52
457119|NCT00586339|1091209|P1|COMPLETED|Overall Study||54
457120|NCT00586339|1091207|P3|STARTED|Overall Study||30
457121|NCT00586339|1091208|P2|STARTED|Overall Study||59
457122|NCT00586339|1091209|P1|STARTED|Overall Study||61
457123|NCT00586326|1091301|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
457124|NCT00586326|1091301|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
457125|NCT00586326|1091301|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
457126|NCT00586326|1091301|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
457127|NCT00586326|1091301|P1|COMPLETED|Device Placed toTreatment-ITT||100
457128|NCT00586326|1091301|P1|STARTED|Device Placed toTreatment-ITT||118
457129|NCT00586326|1091301|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
457130|NCT00586326|1091301|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
457131|NCT00586326|1091301|P1|STARTED|Enrollment to Device Placement-Enrolled||133
457132|NCT00586313|1091312|P1|NOT COMPLETED|Overall Study||2
457133|NCT00586313|1091312|P1|COMPLETED|Overall Study||19
457134|NCT00586313|1091312|P1|STARTED|Overall Study||21
457135|NCT00586261|1091319|P2|NOT COMPLETED|Overall Study||0
457136|NCT00586261|1091320|P1|NOT COMPLETED|Overall Study||0
457137|NCT00586261|1091319|P2|COMPLETED|Overall Study||19
457138|NCT00586261|1091320|P1|COMPLETED|Overall Study||17
457139|NCT00586261|1091319|P2|STARTED|Overall Study||19
457140|NCT00586261|1091320|P1|STARTED|Overall Study||17
457141|NCT00586196|1091328|P2|NOT COMPLETED|Overall Study||0
457142|NCT00586196|1091329|P1|NOT COMPLETED|Overall Study||0
457143|NCT00586196|1091328|P2|COMPLETED|Overall Study||9
457144|NCT00586196|1091329|P1|COMPLETED|Overall Study||7
457145|NCT00586196|1091328|P2|STARTED|Overall Study||9
457146|NCT00586196|1091329|P1|STARTED|Overall Study||7
457153|NCT00586157|1091348|P2|NOT COMPLETED|Second Intervention||1
457154|NCT00586157|1091349|P1|NOT COMPLETED|Second Intervention||2
457155|NCT00586157|1091348|P2|COMPLETED|Second Intervention||14
457156|NCT00586157|1091349|P1|COMPLETED|Second Intervention||12
457157|NCT00586157|1091348|P2|STARTED|Second Intervention||15
457158|NCT00586157|1091349|P1|STARTED|Second Intervention||14
457159|NCT00586157|1091348|P2|NOT COMPLETED|First Intervention||0
457160|NCT00586157|1091349|P1|NOT COMPLETED|First Intervention||1
457161|NCT00586157|1091348|P2|COMPLETED|First Intervention||15
457162|NCT00586157|1091349|P1|COMPLETED|First Intervention||14
457163|NCT00586157|1091348|P2|STARTED|First Intervention||15
457164|NCT00586157|1091349|P1|STARTED|First Intervention||15
457165|NCT00586105|1091359|P1|NOT COMPLETED|Overall Study||39
457166|NCT00586105|1091359|P1|COMPLETED|Overall Study||0
457167|NCT00586105|1091359|P1|STARTED|Overall Study||39
457168|NCT00586066|1091374|P2|NOT COMPLETED|Overall Study||10
457169|NCT00586066|1091375|P1|NOT COMPLETED|Overall Study||18
457170|NCT00586066|1091374|P2|COMPLETED|Overall Study||14
457171|NCT00586066|1091375|P1|COMPLETED|Overall Study||30
457172|NCT00586066|1091374|P2|STARTED|Overall Study||24
457173|NCT00586066|1091375|P1|STARTED|Overall Study||48
457174|NCT00585975|1091387|P2|NOT COMPLETED|Overall Study||13
457175|NCT00585975|1091388|P1|NOT COMPLETED|Overall Study||15
457176|NCT00585975|1091387|P2|COMPLETED|Overall Study||278
457177|NCT00585975|1091388|P1|COMPLETED|Overall Study||262
457178|NCT00585975|1091387|P2|STARTED|Overall Study||291
457179|NCT00585975|1091388|P1|STARTED|Overall Study||277
457180|NCT00585923|1091398|P2|NOT COMPLETED|Overall Study||33
457181|NCT00585923|1091399|P1|NOT COMPLETED|Overall Study||31
457182|NCT00585923|1091398|P2|COMPLETED|Overall Study||26
457183|NCT00585923|1091399|P1|COMPLETED|Overall Study||25
457184|NCT00585923|1091398|P2|STARTED|Overall Study||59
457185|NCT00585923|1091399|P1|STARTED|Overall Study||56
457186|NCT00585910|1091413|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
457187|NCT00585910|1091413|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
457188|NCT00585910|1091413|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
457189|NCT00585910|1091413|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
457190|NCT00585910|1091413|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
457191|NCT00585910|1091413|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
457192|NCT00585715|1091421|P2|NOT COMPLETED|Overall Study||0
457193|NCT00585715|1091422|P1|NOT COMPLETED|Overall Study||3
457194|NCT00585715|1091421|P2|COMPLETED|Overall Study||11
457195|NCT00585715|1091422|P1|COMPLETED|Overall Study||8
457196|NCT00585715|1091421|P2|STARTED|Overall Study||11
457197|NCT00585715|1091422|P1|STARTED|Overall Study||11
457198|NCT00585689|1091430|P1|NOT COMPLETED|Overall Study||7
457199|NCT00585689|1091430|P1|COMPLETED|Overall Study||22
457200|NCT00585689|1091430|P1|STARTED|Overall Study||29
457201|NCT00585650|1091436|P2|NOT COMPLETED|Overall Study||0
457202|NCT00585650|1091437|P1|NOT COMPLETED|Overall Study||0
457203|NCT00585650|1091436|P2|COMPLETED|Overall Study||12
457204|NCT00585650|1091437|P1|COMPLETED|Overall Study||8
457205|NCT00585650|1091436|P2|STARTED|Overall Study||12
457206|NCT00585650|1091437|P1|STARTED|Overall Study||8
457207|NCT00585637|1091447|P4|NOT COMPLETED|6-month Time Point||6
457208|NCT00585637|1091448|P3|NOT COMPLETED|6-month Time Point||11
457209|NCT00585637|1091449|P2|NOT COMPLETED|6-month Time Point||13
457210|NCT00585637|1091450|P1|NOT COMPLETED|6-month Time Point||6
457211|NCT00585637|1091447|P4|COMPLETED|6-month Time Point||77
457212|NCT00585637|1091448|P3|COMPLETED|6-month Time Point||72
457213|NCT00585637|1091449|P2|COMPLETED|6-month Time Point||68
457214|NCT00585637|1091450|P1|COMPLETED|6-month Time Point||75
457215|NCT00585637|1091447|P4|STARTED|6-month Time Point||83
457216|NCT00585637|1091448|P3|STARTED|6-month Time Point||83
457217|NCT00585637|1091449|P2|STARTED|6-month Time Point||81
457218|NCT00585637|1091450|P1|STARTED|6-month Time Point||81
457219|NCT00585637|1091447|P4|NOT COMPLETED|3-month Time Point||5
457220|NCT00585637|1091448|P3|NOT COMPLETED|3-month Time Point||7
457221|NCT00585637|1091449|P2|NOT COMPLETED|3-month Time Point||14
457222|NCT00585637|1091450|P1|NOT COMPLETED|3-month Time Point||10
457223|NCT00585637|1091447|P4|COMPLETED|3-month Time Point||78
457224|NCT00585637|1091448|P3|COMPLETED|3-month Time Point||76
457225|NCT00585637|1091449|P2|COMPLETED|3-month Time Point||67
457226|NCT00585637|1091450|P1|COMPLETED|3-month Time Point||71
457227|NCT00585637|1091447|P4|STARTED|3-month Time Point||83
457228|NCT00585637|1091448|P3|STARTED|3-month Time Point||83
457229|NCT00585637|1091449|P2|STARTED|3-month Time Point||81
457230|NCT00585637|1091450|P1|STARTED|3-month Time Point||81
457231|NCT00585637|1091447|P4|NOT COMPLETED|Baseline||0
457232|NCT00585637|1091448|P3|NOT COMPLETED|Baseline||0
457233|NCT00585637|1091449|P2|NOT COMPLETED|Baseline||0
457234|NCT00585637|1091450|P1|NOT COMPLETED|Baseline||0
457235|NCT00585637|1091447|P4|COMPLETED|Baseline||83
457236|NCT00585637|1091448|P3|COMPLETED|Baseline||83
457237|NCT00585637|1091449|P2|COMPLETED|Baseline||81
457238|NCT00585637|1091450|P1|COMPLETED|Baseline||81
457239|NCT00585637|1091447|P4|STARTED|Baseline||83
457240|NCT00585637|1091448|P3|STARTED|Baseline||83
457241|NCT00585637|1091449|P2|STARTED|Baseline||81
457242|NCT00585637|1091450|P1|STARTED|Baseline||81
457243|NCT00585533|1091476|P1|NOT COMPLETED|Overall Study||9
457244|NCT00585533|1091476|P1|COMPLETED|Overall Study||31
457245|NCT00585533|1091476|P1|STARTED|Overall Study||40
457246|NCT00585494|1091481|P1|NOT COMPLETED|Overall Study||56
457247|NCT00585494|1091481|P1|COMPLETED|Overall Study||244
457248|NCT00585494|1091481|P1|STARTED|Overall Study||300
457249|NCT00585468|1091485|P2|NOT COMPLETED|Second Intervention||0
457250|NCT00585468|1091486|P1|NOT COMPLETED|Second Intervention||0
457251|NCT00585468|1091485|P2|COMPLETED|Second Intervention||10
457252|NCT00585468|1091486|P1|COMPLETED|Second Intervention||9
457253|NCT00585468|1091485|P2|STARTED|Second Intervention||10
457254|NCT00585468|1091486|P1|STARTED|Second Intervention||9
457255|NCT00585468|1091485|P2|NOT COMPLETED|First Intervention||1
457256|NCT00585468|1091486|P1|NOT COMPLETED|First Intervention||1
457257|NCT00585468|1091485|P2|COMPLETED|First Intervention||10
457258|NCT00585468|1091486|P1|COMPLETED|First Intervention||9
457259|NCT00585468|1091485|P2|STARTED|First Intervention||11
457260|NCT00585468|1091486|P1|STARTED|First Intervention||10
457261|NCT00585377|1091506|P1|NOT COMPLETED|Overall Study||0
457262|NCT00585377|1091506|P1|COMPLETED|Overall Study||50
457263|NCT00585377|1091506|P1|STARTED|Overall Study||50
457264|NCT00585351|1091518|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
457265|NCT00585351|1091519|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
457266|NCT00585351|1091520|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
457267|NCT00585351|1091521|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
457268|NCT00585351|1091522|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
457269|NCT00585351|1091523|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
457270|NCT00585351|1091524|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
457271|NCT00585351|1091525|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
457272|NCT00585351|1091518|P8|COMPLETED|Enrollment Period (Intervention)||2
457273|NCT00585351|1091519|P7|COMPLETED|Enrollment Period (Intervention)||5
457274|NCT00585351|1091520|P6|COMPLETED|Enrollment Period (Intervention)||5
457275|NCT00585351|1091521|P5|COMPLETED|Enrollment Period (Intervention)||3
457276|NCT00585351|1091522|P4|COMPLETED|Enrollment Period (Intervention)||15
457277|NCT00585351|1091523|P3|COMPLETED|Enrollment Period (Intervention)||15
457278|NCT00585351|1091524|P2|COMPLETED|Enrollment Period (Intervention)||0
457279|NCT00585351|1091525|P1|COMPLETED|Enrollment Period (Intervention)||0
457280|NCT00585351|1091518|P8|STARTED|Enrollment Period (Intervention)||3
457281|NCT00585351|1091519|P7|STARTED|Enrollment Period (Intervention)||7
457282|NCT00585351|1091520|P6|STARTED|Enrollment Period (Intervention)||7
457283|NCT00585351|1091521|P5|STARTED|Enrollment Period (Intervention)||5
457284|NCT00585351|1091522|P4|STARTED|Enrollment Period (Intervention)||15
457285|NCT00585351|1091523|P3|STARTED|Enrollment Period (Intervention)||15
457286|NCT00585351|1091524|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
457287|NCT00585351|1091525|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
457288|NCT00585351|1091518|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
457289|NCT00585351|1091519|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
457290|NCT00585351|1091520|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
457291|NCT00585351|1091521|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
457292|NCT00585351|1091522|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
457293|NCT00585351|1091523|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
457294|NCT00585351|1091524|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
457295|NCT00585351|1091525|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
457296|NCT00585351|1091518|P8|COMPLETED|Notification Period (Informed Consent)||0
457297|NCT00585351|1091519|P7|COMPLETED|Notification Period (Informed Consent)||0
457298|NCT00585351|1091520|P6|COMPLETED|Notification Period (Informed Consent)||0
457299|NCT00585351|1091521|P5|COMPLETED|Notification Period (Informed Consent)||0
457300|NCT00585351|1091522|P4|COMPLETED|Notification Period (Informed Consent)||0
457301|NCT00585351|1091523|P3|COMPLETED|Notification Period (Informed Consent)||0
457302|NCT00585351|1091524|P2|COMPLETED|Notification Period (Informed Consent)||25
457303|NCT00585351|1091525|P1|COMPLETED|Notification Period (Informed Consent)||27
457304|NCT00585351|1091518|P8|STARTED|Notification Period (Informed Consent)||0
457305|NCT00585351|1091519|P7|STARTED|Notification Period (Informed Consent)||0
457306|NCT00585351|1091520|P6|STARTED|Notification Period (Informed Consent)||0
457307|NCT00585351|1091521|P5|STARTED|Notification Period (Informed Consent)||0
457308|NCT00585351|1091522|P4|STARTED|Notification Period (Informed Consent)||0
457309|NCT00585351|1091523|P3|STARTED|Notification Period (Informed Consent)||0
457310|NCT00585351|1091524|P2|STARTED|Notification Period (Informed Consent)||50
457311|NCT00585351|1091525|P1|STARTED|Notification Period (Informed Consent)||50
457312|NCT00585312|1091541|P2|NOT COMPLETED|Overall Study||44
457313|NCT00585312|1091542|P1|NOT COMPLETED|Overall Study||51
457314|NCT00585312|1091541|P2|COMPLETED|Overall Study||7
457315|NCT00585312|1091542|P1|COMPLETED|Overall Study||4
457316|NCT00585312|1091541|P2|Treated|Overall Study||48
457317|NCT00585312|1091542|P1|Treated|Overall Study||53
457318|NCT00585312|1091541|P2|STARTED|Overall Study|STARTED=Randomized|51
457319|NCT00585312|1091542|P1|STARTED|Overall Study|STARTED=Randomized|55
457320|NCT00585286|1091554|P1|NOT COMPLETED|Overall Study||1
457321|NCT00585286|1091554|P1|COMPLETED|Overall Study||14
457322|NCT00585286|1091554|P1|STARTED|Overall Study||15
457323|NCT00585221|1091561|P1|NOT COMPLETED|Overall Study||8
457324|NCT00585221|1091561|P1|COMPLETED|Overall Study||0
457325|NCT00585221|1091561|P1|STARTED|Overall Study||8
457326|NCT00585182|1091566|P1|NOT COMPLETED|Overall Study||0
457327|NCT00585182|1091566|P1|COMPLETED|Overall Study||28
457328|NCT00585182|1091566|P1|STARTED|Overall Study||28
457329|NCT00585169|1091571|P1|NOT COMPLETED|Overall Study||1
457330|NCT00585169|1091571|P1|COMPLETED|Overall Study||28
457331|NCT00585169|1091571|P1|STARTED|Overall Study||29
457332|NCT00585104|1091577|P1|NOT COMPLETED|Overall Study||4
457333|NCT00585104|1091577|P1|COMPLETED|Overall Study||6
457334|NCT00585104|1091577|P1|STARTED|Overall Study||10
457335|NCT00585078|1091581|P1|NOT COMPLETED|Overall Study||40
457336|NCT00585078|1091581|P1|COMPLETED|Overall Study||0
457337|NCT00585078|1091581|P1|Response Evaluable|Overall Study||24
457338|NCT00585078|1091581|P1|Toxicity Evaluable|Overall Study||36
457339|NCT00585078|1091581|P1|Treated|Overall Study||37
457340|NCT00585078|1091581|P1|STARTED|Overall Study||40
457341|NCT00585039|1091590|P2|NOT COMPLETED|Overall Study||0
457342|NCT00585039|1091591|P1|NOT COMPLETED|Overall Study||2
457343|NCT00585039|1091590|P2|COMPLETED|Overall Study||44
457344|NCT00585039|1091591|P1|COMPLETED|Overall Study||55
457345|NCT00585039|1091590|P2|STARTED|Overall Study||44
457346|NCT00585039|1091591|P1|STARTED|Overall Study||57
457347|NCT00585013|1091601|P2|NOT COMPLETED|Overall Study||0
457348|NCT00585013|1091602|P1|NOT COMPLETED|Overall Study||0
457349|NCT00585013|1091601|P2|COMPLETED|Overall Study||8
457350|NCT00585013|1091602|P1|COMPLETED|Overall Study||8
457351|NCT00585013|1091601|P2|STARTED|Overall Study||8
457352|NCT00585013|1091602|P1|STARTED|Overall Study||8
457353|NCT00584987|1091620|P4|NOT COMPLETED|Overall Study||1
457354|NCT00584987|1091621|P3|NOT COMPLETED|Overall Study||1
457355|NCT00584987|1091622|P2|NOT COMPLETED|Overall Study||1
457356|NCT00584987|1091623|P1|NOT COMPLETED|Overall Study||1
457357|NCT00584987|1091620|P4|COMPLETED|Overall Study||15
457358|NCT00584987|1091621|P3|COMPLETED|Overall Study||16
457359|NCT00584987|1091622|P2|COMPLETED|Overall Study||15
457360|NCT00584987|1091623|P1|COMPLETED|Overall Study||14
457361|NCT00584987|1091620|P4|STARTED|Overall Study||16
457362|NCT00584987|1091621|P3|STARTED|Overall Study||17
457363|NCT00584987|1091622|P2|STARTED|Overall Study||16
457364|NCT00584987|1091623|P1|STARTED|Overall Study||15
457365|NCT00584948|1091655|P2|NOT COMPLETED|Overall Study||11
457366|NCT00584948|1091656|P1|NOT COMPLETED|Overall Study||13
457367|NCT00584948|1091655|P2|COMPLETED|Overall Study||36
457368|NCT00584948|1091656|P1|COMPLETED|Overall Study||34
457369|NCT00584948|1091655|P2|STARTED|Overall Study||47
457370|NCT00584948|1091656|P1|STARTED|Overall Study||47
457371|NCT00584935|1091664|P1|NOT COMPLETED|Overall Study||0
457372|NCT00584935|1091664|P1|COMPLETED|Overall Study||3
457373|NCT00584935|1091664|P1|STARTED|Overall Study||3
457374|NCT00584909|1091668|P1|NOT COMPLETED|Overall Study||4
457375|NCT00584909|1091668|P1|COMPLETED|Overall Study||9
457376|NCT00584909|1091668|P1|STARTED|Overall Study||13
457377|NCT00584857|1091673|P1|NOT COMPLETED|Overall Study||0
457378|NCT00584857|1091673|P1|COMPLETED|Overall Study||30
457379|NCT00584857|1091673|P1|STARTED|Overall Study||30
457380|NCT00584831|1091678|P19|NOT COMPLETED|Intervention 4||0
457381|NCT00584831|1091679|P18|NOT COMPLETED|Intervention 4||0
457382|NCT00584831|1091680|P17|NOT COMPLETED|Intervention 4||0
457383|NCT00584831|1091681|P16|NOT COMPLETED|Intervention 4||0
457384|NCT00584831|1091682|P15|NOT COMPLETED|Intervention 4||0
457385|NCT00584831|1091683|P14|NOT COMPLETED|Intervention 4||0
457386|NCT00584831|1091684|P13|NOT COMPLETED|Intervention 4||0
457387|NCT00584831|1091685|P12|NOT COMPLETED|Intervention 4||0
457388|NCT00584831|1091686|P11|NOT COMPLETED|Intervention 4||0
457389|NCT00584831|1091687|P10|NOT COMPLETED|Intervention 4||0
457390|NCT00584831|1091688|P9|NOT COMPLETED|Intervention 4||0
457391|NCT00584831|1091689|P8|NOT COMPLETED|Intervention 4||0
457392|NCT00584831|1091690|P7|NOT COMPLETED|Intervention 4||0
457393|NCT00584831|1091691|P6|NOT COMPLETED|Intervention 4||0
457394|NCT00584831|1091692|P5|NOT COMPLETED|Intervention 4||0
457395|NCT00584831|1091693|P4|NOT COMPLETED|Intervention 4||0
457396|NCT00584831|1091694|P3|NOT COMPLETED|Intervention 4||0
457397|NCT00584831|1091695|P2|NOT COMPLETED|Intervention 4||0
457398|NCT00584831|1091696|P1|NOT COMPLETED|Intervention 4||0
457399|NCT00584831|1091678|P19|COMPLETED|Intervention 4||1
457400|NCT00584831|1091679|P18|COMPLETED|Intervention 4||1
457401|NCT00584831|1091680|P17|COMPLETED|Intervention 4||4
457402|NCT00584831|1091681|P16|COMPLETED|Intervention 4||1
457403|NCT00584831|1091682|P15|COMPLETED|Intervention 4||2
457404|NCT00584831|1091683|P14|COMPLETED|Intervention 4||1
457405|NCT00584831|1091684|P13|COMPLETED|Intervention 4||2
457406|NCT00584831|1091685|P12|COMPLETED|Intervention 4||1
457407|NCT00584831|1091686|P11|COMPLETED|Intervention 4||2
457408|NCT00584831|1091687|P10|COMPLETED|Intervention 4||2
457409|NCT00584831|1091688|P9|COMPLETED|Intervention 4||3
457410|NCT00584831|1091689|P8|COMPLETED|Intervention 4||2
457411|NCT00584831|1091690|P7|COMPLETED|Intervention 4||6
457412|NCT00584831|1091691|P6|COMPLETED|Intervention 4||1
457413|NCT00584831|1091692|P5|COMPLETED|Intervention 4||2
457414|NCT00584831|1091693|P4|COMPLETED|Intervention 4||1
457415|NCT00584831|1091694|P3|COMPLETED|Intervention 4||2
457416|NCT00584831|1091695|P2|COMPLETED|Intervention 4||3
457417|NCT00584831|1091696|P1|COMPLETED|Intervention 4||1
457418|NCT00584831|1091678|P19|STARTED|Intervention 4||1
457419|NCT00584831|1091679|P18|STARTED|Intervention 4||1
457420|NCT00584831|1091680|P17|STARTED|Intervention 4||4
457421|NCT00584831|1091681|P16|STARTED|Intervention 4||1
457422|NCT00584831|1091682|P15|STARTED|Intervention 4||2
457423|NCT00584831|1091683|P14|STARTED|Intervention 4||1
457424|NCT00584831|1091684|P13|STARTED|Intervention 4||2
457425|NCT00584831|1091685|P12|STARTED|Intervention 4||1
457426|NCT00584831|1091686|P11|STARTED|Intervention 4||2
457427|NCT00584831|1091687|P10|STARTED|Intervention 4||2
457428|NCT00584831|1091688|P9|STARTED|Intervention 4||3
457429|NCT00584831|1091689|P8|STARTED|Intervention 4||2
457430|NCT00584831|1091690|P7|STARTED|Intervention 4||6
457431|NCT00584831|1091691|P6|STARTED|Intervention 4||1
457432|NCT00584831|1091692|P5|STARTED|Intervention 4||2
457433|NCT00584831|1091693|P4|STARTED|Intervention 4||1
457434|NCT00584831|1091694|P3|STARTED|Intervention 4||2
457435|NCT00584831|1091695|P2|STARTED|Intervention 4||3
457436|NCT00584831|1091696|P1|STARTED|Intervention 4||1
457437|NCT00584831|1091678|P19|NOT COMPLETED|Intervention 3||0
457438|NCT00584831|1091679|P18|NOT COMPLETED|Intervention 3||0
457439|NCT00584831|1091680|P17|NOT COMPLETED|Intervention 3||0
457440|NCT00584831|1091681|P16|NOT COMPLETED|Intervention 3||0
457441|NCT00584831|1091682|P15|NOT COMPLETED|Intervention 3||0
457442|NCT00584831|1091683|P14|NOT COMPLETED|Intervention 3||0
457443|NCT00584831|1091684|P13|NOT COMPLETED|Intervention 3||0
457444|NCT00584831|1091685|P12|NOT COMPLETED|Intervention 3||0
457445|NCT00584831|1091686|P11|NOT COMPLETED|Intervention 3||0
457446|NCT00584831|1091687|P10|NOT COMPLETED|Intervention 3||0
457447|NCT00584831|1091688|P9|NOT COMPLETED|Intervention 3||0
457448|NCT00584831|1091689|P8|NOT COMPLETED|Intervention 3||0
457449|NCT00584831|1091690|P7|NOT COMPLETED|Intervention 3||0
457450|NCT00584831|1091691|P6|NOT COMPLETED|Intervention 3||0
457451|NCT00584831|1091692|P5|NOT COMPLETED|Intervention 3||0
457452|NCT00584831|1091693|P4|NOT COMPLETED|Intervention 3||0
457453|NCT00584831|1091694|P3|NOT COMPLETED|Intervention 3||0
457454|NCT00584831|1091695|P2|NOT COMPLETED|Intervention 3||0
457455|NCT00584831|1091696|P1|NOT COMPLETED|Intervention 3||0
457456|NCT00584831|1091678|P19|COMPLETED|Intervention 3||1
457457|NCT00584831|1091679|P18|COMPLETED|Intervention 3||1
457458|NCT00584831|1091680|P17|COMPLETED|Intervention 3||4
457459|NCT00584831|1091681|P16|COMPLETED|Intervention 3||1
457460|NCT00584831|1091682|P15|COMPLETED|Intervention 3||3
457461|NCT00584831|1091683|P14|COMPLETED|Intervention 3||1
457462|NCT00584831|1091684|P13|COMPLETED|Intervention 3||2
457463|NCT00584831|1091685|P12|COMPLETED|Intervention 3||1
457464|NCT00584831|1091686|P11|COMPLETED|Intervention 3||2
457465|NCT00584831|1091687|P10|COMPLETED|Intervention 3||2
457466|NCT00584831|1091688|P9|COMPLETED|Intervention 3||4
457467|NCT00584831|1091689|P8|COMPLETED|Intervention 3||2
457468|NCT00584831|1091690|P7|COMPLETED|Intervention 3||6
457469|NCT00584831|1091691|P6|COMPLETED|Intervention 3||1
457470|NCT00584831|1091692|P5|COMPLETED|Intervention 3||2
457471|NCT00584831|1091693|P4|COMPLETED|Intervention 3||1
457472|NCT00584831|1091694|P3|COMPLETED|Intervention 3||2
457473|NCT00584831|1091695|P2|COMPLETED|Intervention 3||3
457474|NCT00584831|1091696|P1|COMPLETED|Intervention 3||1
457475|NCT00584831|1091678|P19|STARTED|Intervention 3||1
457476|NCT00584831|1091679|P18|STARTED|Intervention 3||1
457477|NCT00584831|1091680|P17|STARTED|Intervention 3||4
457478|NCT00584831|1091681|P16|STARTED|Intervention 3||1
457479|NCT00584831|1091682|P15|STARTED|Intervention 3||3
457480|NCT00584831|1091683|P14|STARTED|Intervention 3||1
457481|NCT00584831|1091684|P13|STARTED|Intervention 3||2
457482|NCT00584831|1091685|P12|STARTED|Intervention 3||1
457483|NCT00584831|1091686|P11|STARTED|Intervention 3||2
457484|NCT00584831|1091687|P10|STARTED|Intervention 3||2
457485|NCT00584831|1091688|P9|STARTED|Intervention 3||4
457486|NCT00584831|1091689|P8|STARTED|Intervention 3||2
457487|NCT00584831|1091690|P7|STARTED|Intervention 3||6
457488|NCT00584831|1091691|P6|STARTED|Intervention 3||1
457489|NCT00584831|1091692|P5|STARTED|Intervention 3||2
457490|NCT00584831|1091693|P4|STARTED|Intervention 3||1
457491|NCT00584831|1091694|P3|STARTED|Intervention 3||2
457492|NCT00584831|1091695|P2|STARTED|Intervention 3||3
457493|NCT00584831|1091696|P1|STARTED|Intervention 3||1
457494|NCT00584831|1091678|P19|NOT COMPLETED|Intervention 2||0
457495|NCT00584831|1091679|P18|NOT COMPLETED|Intervention 2||0
457496|NCT00584831|1091680|P17|NOT COMPLETED|Intervention 2||0
457497|NCT00584831|1091681|P16|NOT COMPLETED|Intervention 2||0
457498|NCT00584831|1091682|P15|NOT COMPLETED|Intervention 2||0
457499|NCT00584831|1091683|P14|NOT COMPLETED|Intervention 2||0
457500|NCT00584831|1091684|P13|NOT COMPLETED|Intervention 2||0
457501|NCT00584831|1091685|P12|NOT COMPLETED|Intervention 2||0
457502|NCT00584831|1091686|P11|NOT COMPLETED|Intervention 2||0
457503|NCT00584831|1091687|P10|NOT COMPLETED|Intervention 2||0
457504|NCT00584831|1091688|P9|NOT COMPLETED|Intervention 2||0
457505|NCT00584831|1091689|P8|NOT COMPLETED|Intervention 2||0
457506|NCT00584831|1091690|P7|NOT COMPLETED|Intervention 2||0
457507|NCT00584831|1091691|P6|NOT COMPLETED|Intervention 2||0
457508|NCT00584831|1091692|P5|NOT COMPLETED|Intervention 2||0
457509|NCT00584831|1091693|P4|NOT COMPLETED|Intervention 2||0
457510|NCT00584831|1091694|P3|NOT COMPLETED|Intervention 2||0
457511|NCT00584831|1091695|P2|NOT COMPLETED|Intervention 2||0
457512|NCT00584831|1091696|P1|NOT COMPLETED|Intervention 2||0
457513|NCT00584831|1091678|P19|COMPLETED|Intervention 2||1
457514|NCT00584831|1091679|P18|COMPLETED|Intervention 2||1
457515|NCT00584831|1091680|P17|COMPLETED|Intervention 2||4
457516|NCT00584831|1091681|P16|COMPLETED|Intervention 2||1
457517|NCT00584831|1091682|P15|COMPLETED|Intervention 2||3
457518|NCT00584831|1091683|P14|COMPLETED|Intervention 2||1
457519|NCT00584831|1091684|P13|COMPLETED|Intervention 2||2
457520|NCT00584831|1091685|P12|COMPLETED|Intervention 2||1
457521|NCT00584831|1091686|P11|COMPLETED|Intervention 2||2
457522|NCT00584831|1091687|P10|COMPLETED|Intervention 2||2
457523|NCT00584831|1091688|P9|COMPLETED|Intervention 2||4
457524|NCT00584831|1091689|P8|COMPLETED|Intervention 2||2
457525|NCT00584831|1091690|P7|COMPLETED|Intervention 2||6
457526|NCT00584831|1091691|P6|COMPLETED|Intervention 2||1
457527|NCT00584831|1091692|P5|COMPLETED|Intervention 2||2
457528|NCT00584831|1091693|P4|COMPLETED|Intervention 2||1
457529|NCT00584831|1091694|P3|COMPLETED|Intervention 2||2
457530|NCT00584831|1091695|P2|COMPLETED|Intervention 2||3
457531|NCT00584831|1091696|P1|COMPLETED|Intervention 2||1
457532|NCT00584831|1091678|P19|STARTED|Intervention 2||1
457533|NCT00584831|1091679|P18|STARTED|Intervention 2||1
457534|NCT00584831|1091680|P17|STARTED|Intervention 2||4
457535|NCT00584831|1091681|P16|STARTED|Intervention 2||1
457536|NCT00584831|1091682|P15|STARTED|Intervention 2||3
457537|NCT00584831|1091683|P14|STARTED|Intervention 2||1
457538|NCT00584831|1091684|P13|STARTED|Intervention 2||2
457539|NCT00584831|1091685|P12|STARTED|Intervention 2||1
457540|NCT00584831|1091686|P11|STARTED|Intervention 2||2
457541|NCT00584831|1091687|P10|STARTED|Intervention 2||2
457542|NCT00584831|1091688|P9|STARTED|Intervention 2||4
457543|NCT00584831|1091689|P8|STARTED|Intervention 2||2
457544|NCT00584831|1091690|P7|STARTED|Intervention 2||6
457545|NCT00584831|1091691|P6|STARTED|Intervention 2||1
457546|NCT00584831|1091692|P5|STARTED|Intervention 2||2
457547|NCT00584831|1091693|P4|STARTED|Intervention 2||1
457548|NCT00584831|1091694|P3|STARTED|Intervention 2||2
457549|NCT00584831|1091695|P2|STARTED|Intervention 2||3
457550|NCT00584831|1091696|P1|STARTED|Intervention 2||1
457551|NCT00584831|1091678|P19|NOT COMPLETED|Intervention 1||0
457552|NCT00584831|1091679|P18|NOT COMPLETED|Intervention 1||0
457553|NCT00584831|1091680|P17|NOT COMPLETED|Intervention 1||0
457554|NCT00584831|1091681|P16|NOT COMPLETED|Intervention 1||0
457555|NCT00584831|1091682|P15|NOT COMPLETED|Intervention 1||0
457556|NCT00584831|1091683|P14|NOT COMPLETED|Intervention 1||0
457557|NCT00584831|1091684|P13|NOT COMPLETED|Intervention 1||0
457558|NCT00584831|1091685|P12|NOT COMPLETED|Intervention 1||0
457559|NCT00584831|1091686|P11|NOT COMPLETED|Intervention 1||0
457560|NCT00584831|1091687|P10|NOT COMPLETED|Intervention 1||0
457561|NCT00584831|1091688|P9|NOT COMPLETED|Intervention 1||0
457562|NCT00584831|1091689|P8|NOT COMPLETED|Intervention 1||0
457563|NCT00584831|1091690|P7|NOT COMPLETED|Intervention 1||0
457564|NCT00584831|1091691|P6|NOT COMPLETED|Intervention 1||0
457565|NCT00584831|1091692|P5|NOT COMPLETED|Intervention 1||0
457566|NCT00584831|1091693|P4|NOT COMPLETED|Intervention 1||0
457567|NCT00584831|1091694|P3|NOT COMPLETED|Intervention 1||0
457568|NCT00584831|1091695|P2|NOT COMPLETED|Intervention 1||0
457569|NCT00584831|1091696|P1|NOT COMPLETED|Intervention 1||0
457570|NCT00584831|1091678|P19|COMPLETED|Intervention 1||1
457571|NCT00584831|1091679|P18|COMPLETED|Intervention 1||1
457572|NCT00584831|1091680|P17|COMPLETED|Intervention 1||4
457573|NCT00584831|1091681|P16|COMPLETED|Intervention 1||1
457574|NCT00584831|1091682|P15|COMPLETED|Intervention 1||3
457575|NCT00584831|1091683|P14|COMPLETED|Intervention 1||1
457576|NCT00584831|1091684|P13|COMPLETED|Intervention 1||2
457577|NCT00584831|1091685|P12|COMPLETED|Intervention 1||1
457578|NCT00584831|1091686|P11|COMPLETED|Intervention 1||2
457579|NCT00584831|1091687|P10|COMPLETED|Intervention 1||2
457580|NCT00584831|1091688|P9|COMPLETED|Intervention 1||4
457581|NCT00584831|1091689|P8|COMPLETED|Intervention 1||2
457582|NCT00584831|1091690|P7|COMPLETED|Intervention 1||6
457583|NCT00584831|1091691|P6|COMPLETED|Intervention 1||1
457584|NCT00584831|1091692|P5|COMPLETED|Intervention 1||2
457585|NCT00584831|1091693|P4|COMPLETED|Intervention 1||1
457586|NCT00584831|1091694|P3|COMPLETED|Intervention 1||2
457587|NCT00584831|1091695|P2|COMPLETED|Intervention 1||3
457588|NCT00584831|1091696|P1|COMPLETED|Intervention 1||1
457589|NCT00584831|1091678|P19|STARTED|Intervention 1||1
457590|NCT00584831|1091679|P18|STARTED|Intervention 1||1
457591|NCT00584831|1091680|P17|STARTED|Intervention 1||4
457592|NCT00584831|1091681|P16|STARTED|Intervention 1||1
457593|NCT00584831|1091682|P15|STARTED|Intervention 1||3
457594|NCT00584831|1091683|P14|STARTED|Intervention 1||1
457595|NCT00584831|1091684|P13|STARTED|Intervention 1||2
457596|NCT00584831|1091685|P12|STARTED|Intervention 1||1
457597|NCT00584831|1091686|P11|STARTED|Intervention 1||2
457598|NCT00584831|1091687|P10|STARTED|Intervention 1||2
457599|NCT00584831|1091688|P9|STARTED|Intervention 1||4
457600|NCT00584831|1091689|P8|STARTED|Intervention 1||2
457601|NCT00584831|1091690|P7|STARTED|Intervention 1||6
457602|NCT00584831|1091691|P6|STARTED|Intervention 1||1
457603|NCT00584831|1091692|P5|STARTED|Intervention 1||2
457604|NCT00584831|1091693|P4|STARTED|Intervention 1||1
457605|NCT00584831|1091694|P3|STARTED|Intervention 1||2
457606|NCT00584831|1091695|P2|STARTED|Intervention 1||3
457607|NCT00584831|1091696|P1|STARTED|Intervention 1||1
457608|NCT00584740|1091720|P2|NOT COMPLETED|Overall Study||6
457609|NCT00584740|1091721|P1|NOT COMPLETED|Overall Study||12
457610|NCT00584740|1091720|P2|COMPLETED|Overall Study||14
457611|NCT00584740|1091721|P1|COMPLETED|Overall Study||27
457612|NCT00584740|1091720|P2|STARTED|Overall Study||20
457613|NCT00584740|1091721|P1|STARTED|Overall Study||39
457614|NCT00584727|1091739|P6|NOT COMPLETED|Third Intervention||2
457615|NCT00584727|1091740|P5|NOT COMPLETED|Third Intervention||4
457616|NCT00584727|1091741|P4|NOT COMPLETED|Third Intervention||0
457617|NCT00584727|1091742|P3|NOT COMPLETED|Third Intervention||1
457618|NCT00584727|1091743|P2|NOT COMPLETED|Third Intervention||0
457619|NCT00584727|1091744|P1|NOT COMPLETED|Third Intervention||0
457620|NCT00584727|1091739|P6|COMPLETED|Third Intervention||14
457621|NCT00584727|1091740|P5|COMPLETED|Third Intervention||12
457622|NCT00584727|1091741|P4|COMPLETED|Third Intervention||14
457623|NCT00584727|1091742|P3|COMPLETED|Third Intervention||14
457624|NCT00584727|1091743|P2|COMPLETED|Third Intervention||17
457625|NCT00584727|1091744|P1|COMPLETED|Third Intervention||17
457626|NCT00584727|1091739|P6|STARTED|Third Intervention||16
457627|NCT00584727|1091740|P5|STARTED|Third Intervention||16
457628|NCT00584727|1091741|P4|STARTED|Third Intervention||14
457629|NCT00584727|1091742|P3|STARTED|Third Intervention||15
457630|NCT00584727|1091743|P2|STARTED|Third Intervention||17
457631|NCT00584727|1091744|P1|STARTED|Third Intervention||17
457632|NCT00584727|1091739|P6|NOT COMPLETED|Second Intervention||0
457633|NCT00584727|1091740|P5|NOT COMPLETED|Second Intervention||0
457634|NCT00584727|1091741|P4|NOT COMPLETED|Second Intervention||0
457635|NCT00584727|1091742|P3|NOT COMPLETED|Second Intervention||0
457636|NCT00584727|1091743|P2|NOT COMPLETED|Second Intervention||0
457637|NCT00584727|1091744|P1|NOT COMPLETED|Second Intervention||0
457638|NCT00584727|1091739|P6|COMPLETED|Second Intervention||16
457639|NCT00584727|1091740|P5|COMPLETED|Second Intervention||16
457640|NCT00584727|1091741|P4|COMPLETED|Second Intervention||14
457641|NCT00584727|1091742|P3|COMPLETED|Second Intervention||15
457642|NCT00584727|1091743|P2|COMPLETED|Second Intervention||17
457643|NCT00584727|1091744|P1|COMPLETED|Second Intervention||17
457644|NCT00584727|1091739|P6|STARTED|Second Intervention||16
457645|NCT00584727|1091740|P5|STARTED|Second Intervention||16
457646|NCT00584727|1091741|P4|STARTED|Second Intervention||14
457647|NCT00584727|1091742|P3|STARTED|Second Intervention||15
457648|NCT00584727|1091743|P2|STARTED|Second Intervention||17
457649|NCT00584727|1091744|P1|STARTED|Second Intervention||17
457650|NCT00584727|1091739|P6|NOT COMPLETED|First Intervention||0
457651|NCT00584727|1091740|P5|NOT COMPLETED|First Intervention||0
457652|NCT00584727|1091741|P4|NOT COMPLETED|First Intervention||0
457653|NCT00584727|1091742|P3|NOT COMPLETED|First Intervention||1
457654|NCT00584727|1091743|P2|NOT COMPLETED|First Intervention||0
457655|NCT00584727|1091744|P1|NOT COMPLETED|First Intervention||0
457656|NCT00584727|1091739|P6|COMPLETED|First Intervention||16
457657|NCT00584727|1091740|P5|COMPLETED|First Intervention||16
457658|NCT00584727|1091741|P4|COMPLETED|First Intervention||14
457659|NCT00584727|1091742|P3|COMPLETED|First Intervention||15
457660|NCT00584727|1091743|P2|COMPLETED|First Intervention||17
457661|NCT00584727|1091744|P1|COMPLETED|First Intervention||17
457662|NCT00584727|1091739|P6|STARTED|First Intervention||16
457663|NCT00584727|1091740|P5|STARTED|First Intervention||16
457664|NCT00584727|1091741|P4|STARTED|First Intervention||14
457665|NCT00584727|1091742|P3|STARTED|First Intervention||16
457666|NCT00584727|1091743|P2|STARTED|First Intervention||17
457667|NCT00584727|1091744|P1|STARTED|First Intervention||17
457668|NCT00584701|1091768|P1|NOT COMPLETED|Follow-up||12
457669|NCT00584701|1091768|P1|COMPLETED|Follow-up||34
457670|NCT00584701|1091768|P1|STARTED|Follow-up||46
457671|NCT00584701|1091768|P1|NOT COMPLETED|Active Risperidone||3
457672|NCT00584701|1091768|P1|COMPLETED|Active Risperidone||46
457673|NCT00584701|1091768|P1|STARTED|Active Risperidone||49
457674|NCT00584480|1091773|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
457675|NCT00584480|1091773|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
457676|NCT00584480|1091773|P1|STARTED|Second 8 Weeks (40 Treatments)||10
457677|NCT00584480|1091773|P1|NOT COMPLETED|4-Week Break From Treatment||0
457678|NCT00584480|1091773|P1|COMPLETED|4-Week Break From Treatment||10
457679|NCT00584480|1091773|P1|STARTED|4-Week Break From Treatment||10
457680|NCT00584480|1091773|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
457681|NCT00584480|1091773|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
457682|NCT00584480|1091773|P1|STARTED|First 8 Weeks (40 Treatments)||10
457683|NCT00584454|1091777|P1|NOT COMPLETED|Overall Study||4
457684|NCT00584454|1091777|P1|COMPLETED|Overall Study||6
457685|NCT00584454|1091777|P1|STARTED|Overall Study||10
457686|NCT00584415|1091781|P1|NOT COMPLETED|Overall Study||7
457687|NCT00584415|1091781|P1|COMPLETED|Overall Study||112
457688|NCT00584415|1091781|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
457689|NCT00584220|1091786|P2|NOT COMPLETED|Second Period||0
457690|NCT00584220|1091787|P1|NOT COMPLETED|Second Period||0
457691|NCT00584220|1091786|P2|COMPLETED|Second Period||39
457692|NCT00584220|1091787|P1|COMPLETED|Second Period||48
457693|NCT00584220|1091786|P2|STARTED|Second Period||39
457694|NCT00584220|1091787|P1|STARTED|Second Period||48
457695|NCT00584220|1091786|P2|NOT COMPLETED|First Period||0
457696|NCT00584220|1091787|P1|NOT COMPLETED|First Period||0
457697|NCT00584220|1091786|P2|COMPLETED|First Period||39
457698|NCT00584220|1091787|P1|COMPLETED|First Period||48
457699|NCT00584220|1091786|P2|STARTED|First Period||39
457700|NCT00584220|1091787|P1|STARTED|First Period||48
457701|NCT00584077|1091795|P1|NOT COMPLETED|Overall Study||0
457702|NCT00584077|1091795|P1|COMPLETED|Overall Study||15
457703|NCT00584077|1091795|P1|STARTED|Overall Study||15
457704|NCT00583947|1091801|P2|NOT COMPLETED|Open Label Period||0
457705|NCT00583947|1091802|P1|NOT COMPLETED|Open Label Period||0
457706|NCT00583947|1091801|P2|COMPLETED|Open Label Period||24
457707|NCT00583947|1091802|P1|COMPLETED|Open Label Period||22
457708|NCT00583947|1091801|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
457709|NCT00583947|1091802|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
457710|NCT00583947|1091801|P2|NOT COMPLETED|Washout||0
457711|NCT00583947|1091802|P1|NOT COMPLETED|Washout||0
457712|NCT00583947|1091801|P2|COMPLETED|Washout||24
457713|NCT00583947|1091802|P1|COMPLETED|Washout||22
457714|NCT00583947|1091801|P2|STARTED|Washout||24
457715|NCT00583947|1091802|P1|STARTED|Washout||22
457716|NCT00583947|1091801|P2|NOT COMPLETED|Cross-over Period||2
457717|NCT00583947|1091802|P1|NOT COMPLETED|Cross-over Period||5
457718|NCT00583947|1091801|P2|COMPLETED|Cross-over Period||24
457719|NCT00583947|1091802|P1|COMPLETED|Cross-over Period||22
457720|NCT00583947|1091801|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
457721|NCT00583947|1091802|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
457722|NCT00583908|1091852|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
457723|NCT00583908|1091853|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
457724|NCT00583908|1091854|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
457725|NCT00583908|1091855|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
457726|NCT00583908|1091856|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
457727|NCT00583908|1091857|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
457728|NCT00583908|1091858|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
457729|NCT00583908|1091859|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
457730|NCT00583908|1091860|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
457731|NCT00583908|1091861|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
457732|NCT00583908|1091862|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
457733|NCT00583908|1091863|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
457734|NCT00583908|1091852|P12|COMPLETED|Period 4 - Fourth Intervention||1
457735|NCT00583908|1091853|P11|COMPLETED|Period 4 - Fourth Intervention||1
457736|NCT00583908|1091854|P10|COMPLETED|Period 4 - Fourth Intervention||1
457737|NCT00583908|1091855|P9|COMPLETED|Period 4 - Fourth Intervention||1
457738|NCT00583908|1091856|P8|COMPLETED|Period 4 - Fourth Intervention||1
457739|NCT00583908|1091857|P7|COMPLETED|Period 4 - Fourth Intervention||1
457740|NCT00583908|1091858|P6|COMPLETED|Period 4 - Fourth Intervention||1
457741|NCT00583908|1091859|P5|COMPLETED|Period 4 - Fourth Intervention||2
457742|NCT00583908|1091860|P4|COMPLETED|Period 4 - Fourth Intervention||1
457743|NCT00583908|1091861|P3|COMPLETED|Period 4 - Fourth Intervention||1
457744|NCT00583908|1091862|P2|COMPLETED|Period 4 - Fourth Intervention||2
457745|NCT00583908|1091863|P1|COMPLETED|Period 4 - Fourth Intervention||1
457746|NCT00583908|1091852|P12|STARTED|Period 4 - Fourth Intervention||1
457747|NCT00583908|1091853|P11|STARTED|Period 4 - Fourth Intervention||1
457748|NCT00583908|1091854|P10|STARTED|Period 4 - Fourth Intervention||1
457749|NCT00583908|1091855|P9|STARTED|Period 4 - Fourth Intervention||1
457750|NCT00583908|1091856|P8|STARTED|Period 4 - Fourth Intervention||1
457751|NCT00583908|1091857|P7|STARTED|Period 4 - Fourth Intervention||1
457752|NCT00583908|1091858|P6|STARTED|Period 4 - Fourth Intervention||1
457753|NCT00583908|1091859|P5|STARTED|Period 4 - Fourth Intervention||2
457754|NCT00583908|1091860|P4|STARTED|Period 4 - Fourth Intervention||1
457755|NCT00583908|1091861|P3|STARTED|Period 4 - Fourth Intervention||1
457756|NCT00583908|1091862|P2|STARTED|Period 4 - Fourth Intervention||2
457757|NCT00583908|1091863|P1|STARTED|Period 4 - Fourth Intervention||1
457758|NCT00583908|1091852|P12|NOT COMPLETED|Period 3 - Third Intervention||0
457759|NCT00583908|1091853|P11|NOT COMPLETED|Period 3 - Third Intervention||0
457760|NCT00583908|1091854|P10|NOT COMPLETED|Period 3 - Third Intervention||0
457761|NCT00583908|1091855|P9|NOT COMPLETED|Period 3 - Third Intervention||0
457762|NCT00583908|1091856|P8|NOT COMPLETED|Period 3 - Third Intervention||0
457763|NCT00583908|1091857|P7|NOT COMPLETED|Period 3 - Third Intervention||0
457764|NCT00583908|1091858|P6|NOT COMPLETED|Period 3 - Third Intervention||0
457765|NCT00583908|1091859|P5|NOT COMPLETED|Period 3 - Third Intervention||0
457766|NCT00583908|1091860|P4|NOT COMPLETED|Period 3 - Third Intervention||0
457767|NCT00583908|1091861|P3|NOT COMPLETED|Period 3 - Third Intervention||0
457768|NCT00583908|1091862|P2|NOT COMPLETED|Period 3 - Third Intervention||0
457769|NCT00583908|1091863|P1|NOT COMPLETED|Period 3 - Third Intervention||0
457770|NCT00583908|1091852|P12|COMPLETED|Period 3 - Third Intervention||1
457771|NCT00583908|1091853|P11|COMPLETED|Period 3 - Third Intervention||1
457772|NCT00583908|1091854|P10|COMPLETED|Period 3 - Third Intervention||1
457773|NCT00583908|1091855|P9|COMPLETED|Period 3 - Third Intervention||1
457774|NCT00583908|1091856|P8|COMPLETED|Period 3 - Third Intervention||1
457775|NCT00583908|1091857|P7|COMPLETED|Period 3 - Third Intervention||1
457776|NCT00583908|1091858|P6|COMPLETED|Period 3 - Third Intervention||1
457777|NCT00583908|1091859|P5|COMPLETED|Period 3 - Third Intervention||2
457778|NCT00583908|1091860|P4|COMPLETED|Period 3 - Third Intervention||1
457779|NCT00583908|1091861|P3|COMPLETED|Period 3 - Third Intervention||1
457780|NCT00583908|1091862|P2|COMPLETED|Period 3 - Third Intervention||2
457781|NCT00583908|1091863|P1|COMPLETED|Period 3 - Third Intervention||1
457782|NCT00583908|1091852|P12|STARTED|Period 3 - Third Intervention||1
457783|NCT00583908|1091853|P11|STARTED|Period 3 - Third Intervention||1
457784|NCT00583908|1091854|P10|STARTED|Period 3 - Third Intervention||1
457785|NCT00583908|1091855|P9|STARTED|Period 3 - Third Intervention||1
457786|NCT00583908|1091856|P8|STARTED|Period 3 - Third Intervention||1
457787|NCT00583908|1091857|P7|STARTED|Period 3 - Third Intervention||1
457788|NCT00583908|1091858|P6|STARTED|Period 3 - Third Intervention||1
457789|NCT00583908|1091859|P5|STARTED|Period 3 - Third Intervention||2
457790|NCT00583908|1091860|P4|STARTED|Period 3 - Third Intervention||1
457791|NCT00583908|1091861|P3|STARTED|Period 3 - Third Intervention||1
457792|NCT00583908|1091862|P2|STARTED|Period 3 - Third Intervention||2
457793|NCT00583908|1091863|P1|STARTED|Period 3 - Third Intervention||1
457794|NCT00583908|1091852|P12|NOT COMPLETED|Period 2 - Second Intervention||0
457795|NCT00583908|1091853|P11|NOT COMPLETED|Period 2 - Second Intervention||0
457796|NCT00583908|1091854|P10|NOT COMPLETED|Period 2 - Second Intervention||0
457797|NCT00583908|1091855|P9|NOT COMPLETED|Period 2 - Second Intervention||0
457798|NCT00583908|1091856|P8|NOT COMPLETED|Period 2 - Second Intervention||0
457799|NCT00583908|1091857|P7|NOT COMPLETED|Period 2 - Second Intervention||0
457800|NCT00583908|1091858|P6|NOT COMPLETED|Period 2 - Second Intervention||0
457801|NCT00583908|1091859|P5|NOT COMPLETED|Period 2 - Second Intervention||0
457802|NCT00583908|1091860|P4|NOT COMPLETED|Period 2 - Second Intervention||0
457803|NCT00583908|1091861|P3|NOT COMPLETED|Period 2 - Second Intervention||0
457804|NCT00583908|1091862|P2|NOT COMPLETED|Period 2 - Second Intervention||0
457805|NCT00583908|1091863|P1|NOT COMPLETED|Period 2 - Second Intervention||0
457806|NCT00583908|1091852|P12|COMPLETED|Period 2 - Second Intervention||1
457807|NCT00583908|1091853|P11|COMPLETED|Period 2 - Second Intervention||1
457808|NCT00583908|1091854|P10|COMPLETED|Period 2 - Second Intervention||1
457809|NCT00583908|1091855|P9|COMPLETED|Period 2 - Second Intervention||1
457810|NCT00583908|1091856|P8|COMPLETED|Period 2 - Second Intervention||1
457811|NCT00583908|1091857|P7|COMPLETED|Period 2 - Second Intervention||1
457812|NCT00583908|1091858|P6|COMPLETED|Period 2 - Second Intervention||1
457813|NCT00583908|1091859|P5|COMPLETED|Period 2 - Second Intervention||2
457814|NCT00583908|1091860|P4|COMPLETED|Period 2 - Second Intervention||1
457815|NCT00583908|1091861|P3|COMPLETED|Period 2 - Second Intervention||1
457816|NCT00583908|1091862|P2|COMPLETED|Period 2 - Second Intervention||2
457817|NCT00583908|1091863|P1|COMPLETED|Period 2 - Second Intervention||1
457818|NCT00583908|1091852|P12|STARTED|Period 2 - Second Intervention||1
457819|NCT00583908|1091853|P11|STARTED|Period 2 - Second Intervention||1
457820|NCT00583908|1091854|P10|STARTED|Period 2 - Second Intervention||1
457821|NCT00583908|1091855|P9|STARTED|Period 2 - Second Intervention||1
457822|NCT00583908|1091856|P8|STARTED|Period 2 - Second Intervention||1
457823|NCT00583908|1091857|P7|STARTED|Period 2 - Second Intervention||1
457824|NCT00583908|1091858|P6|STARTED|Period 2 - Second Intervention||1
457825|NCT00583908|1091859|P5|STARTED|Period 2 - Second Intervention||2
457826|NCT00583908|1091860|P4|STARTED|Period 2 - Second Intervention||1
457827|NCT00583908|1091861|P3|STARTED|Period 2 - Second Intervention||1
457828|NCT00583908|1091862|P2|STARTED|Period 2 - Second Intervention||2
457829|NCT00583908|1091863|P1|STARTED|Period 2 - Second Intervention||1
457830|NCT00583908|1091852|P12|NOT COMPLETED|Period 1 - First Intervention||0
457831|NCT00583908|1091853|P11|NOT COMPLETED|Period 1 - First Intervention||0
457832|NCT00583908|1091854|P10|NOT COMPLETED|Period 1 - First Intervention||0
457833|NCT00583908|1091855|P9|NOT COMPLETED|Period 1 - First Intervention||0
457834|NCT00583908|1091856|P8|NOT COMPLETED|Period 1 - First Intervention||0
457835|NCT00583908|1091857|P7|NOT COMPLETED|Period 1 - First Intervention||0
457836|NCT00583908|1091858|P6|NOT COMPLETED|Period 1 - First Intervention||0
457837|NCT00583908|1091859|P5|NOT COMPLETED|Period 1 - First Intervention||0
457838|NCT00583908|1091860|P4|NOT COMPLETED|Period 1 - First Intervention||0
457839|NCT00583908|1091861|P3|NOT COMPLETED|Period 1 - First Intervention||0
457840|NCT00583908|1091862|P2|NOT COMPLETED|Period 1 - First Intervention||0
457841|NCT00583908|1091863|P1|NOT COMPLETED|Period 1 - First Intervention||0
457842|NCT00583908|1091852|P12|COMPLETED|Period 1 - First Intervention||1
457843|NCT00583908|1091853|P11|COMPLETED|Period 1 - First Intervention||1
457844|NCT00583908|1091854|P10|COMPLETED|Period 1 - First Intervention||1
457845|NCT00583908|1091855|P9|COMPLETED|Period 1 - First Intervention||1
457846|NCT00583908|1091856|P8|COMPLETED|Period 1 - First Intervention||1
457847|NCT00583908|1091857|P7|COMPLETED|Period 1 - First Intervention||1
457848|NCT00583908|1091858|P6|COMPLETED|Period 1 - First Intervention||1
457849|NCT00583908|1091859|P5|COMPLETED|Period 1 - First Intervention||2
457850|NCT00583908|1091860|P4|COMPLETED|Period 1 - First Intervention||1
457851|NCT00583908|1091861|P3|COMPLETED|Period 1 - First Intervention||1
457852|NCT00583908|1091862|P2|COMPLETED|Period 1 - First Intervention||2
457853|NCT00583908|1091863|P1|COMPLETED|Period 1 - First Intervention||1
457854|NCT00583908|1091852|P12|STARTED|Period 1 - First Intervention||1
457855|NCT00583908|1091853|P11|STARTED|Period 1 - First Intervention||1
457856|NCT00583908|1091854|P10|STARTED|Period 1 - First Intervention||1
457857|NCT00583908|1091855|P9|STARTED|Period 1 - First Intervention||1
457858|NCT00583908|1091856|P8|STARTED|Period 1 - First Intervention||1
457859|NCT00583908|1091857|P7|STARTED|Period 1 - First Intervention||1
457860|NCT00583908|1091858|P6|STARTED|Period 1 - First Intervention||1
457861|NCT00583908|1091859|P5|STARTED|Period 1 - First Intervention||2
457862|NCT00583908|1091860|P4|STARTED|Period 1 - First Intervention||1
457863|NCT00583908|1091861|P3|STARTED|Period 1 - First Intervention||1
457864|NCT00583908|1091862|P2|STARTED|Period 1 - First Intervention||2
457865|NCT00583908|1091863|P1|STARTED|Period 1 - First Intervention||1
457866|NCT00583713|1091920|P3|NOT COMPLETED|Overall Study||0
457867|NCT00583713|1091921|P2|NOT COMPLETED|Overall Study||0
457868|NCT00583713|1091922|P1|NOT COMPLETED|Overall Study||0
457869|NCT00583713|1091920|P3|COMPLETED|Overall Study||6
457870|NCT00583713|1091921|P2|COMPLETED|Overall Study||6
457871|NCT00583713|1091922|P1|COMPLETED|Overall Study||6
457872|NCT00583713|1091920|P3|STARTED|Overall Study||6
457873|NCT00583713|1091921|P2|STARTED|Overall Study||6
457874|NCT00583713|1091922|P1|STARTED|Overall Study||6
457875|NCT00583700|1091947|P2|NOT COMPLETED|Overall Study||4
457876|NCT00583700|1091948|P1|NOT COMPLETED|Overall Study||3
457877|NCT00583700|1091947|P2|COMPLETED|Overall Study||23
457878|NCT00583700|1091948|P1|COMPLETED|Overall Study||24
457879|NCT00583700|1091947|P2|STARTED|Overall Study||27
457880|NCT00583700|1091948|P1|STARTED|Overall Study||27
457881|NCT00583661|1091956|P1|NOT COMPLETED|Overall Study||0
457882|NCT00583661|1091956|P1|COMPLETED|Overall Study||48
457883|NCT00583661|1091956|P1|STARTED|Overall Study||48
457884|NCT00583622|1091963|P1|NOT COMPLETED|Overall Study||0
457885|NCT00583622|1091963|P1|COMPLETED|Overall Study||12
457886|NCT00583622|1091963|P1|STARTED|Overall Study||12
457887|NCT00583596|1091968|P1|NOT COMPLETED|Overall Study||284
457888|NCT00583596|1091968|P1|COMPLETED|Overall Study||152
457889|NCT00583596|1091968|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
457890|NCT00583557|1091973|P1|NOT COMPLETED|Overall Study||70
457891|NCT00583557|1091973|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
457892|NCT00583557|1091973|P1|Received at Least 1 Dose Belimumab|Overall Study||153
457893|NCT00583557|1091973|P1|STARTED|Overall Study||155
457894|NCT00583492|1091979|P2|NOT COMPLETED|Overall Study||0
457895|NCT00583492|1091980|P1|NOT COMPLETED|Overall Study||0
457896|NCT00583492|1091979|P2|COMPLETED|Overall Study||23
457897|NCT00583492|1091980|P1|COMPLETED|Overall Study||21
457898|NCT00583492|1091979|P2|STARTED|Overall Study||23
457899|NCT00583492|1091980|P1|STARTED|Overall Study||21
457900|NCT00583453|1091998|P2|NOT COMPLETED|Overall Study||2
457901|NCT00583453|1091999|P1|NOT COMPLETED|Overall Study||0
457902|NCT00583453|1091998|P2|COMPLETED|Overall Study||6
457903|NCT00583453|1091999|P1|COMPLETED|Overall Study||9
457904|NCT00583453|1091998|P2|STARTED|Overall Study||8
457905|NCT00583453|1091999|P1|STARTED|Overall Study||9
457906|NCT00583362|1092013|P1|NOT COMPLETED|Overall Study||202
457907|NCT00583362|1092013|P1|COMPLETED|Overall Study||96
457908|NCT00583362|1092013|P1|STARTED|Overall Study||298
457909|NCT00583219|1092037|P1|NOT COMPLETED|Phase 2||1
457910|NCT00583219|1092037|P1|COMPLETED|Phase 2||21
457911|NCT00583219|1092037|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
457912|NCT00583219|1092037|P1|NOT COMPLETED|Phase 1||0
457913|NCT00583219|1092037|P1|COMPLETED|Phase 1||9
457914|NCT00583219|1092037|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
457915|NCT00583115|1092054|P1|NOT COMPLETED|Overall Study||1
457916|NCT00583115|1092054|P1|COMPLETED|Overall Study||0
457917|NCT00583115|1092054|P1|STARTED|Overall Study||1
457918|NCT00582972|1092059|P1|NOT COMPLETED|Overall Study||2
457919|NCT00582972|1092059|P1|COMPLETED|Overall Study||21
457920|NCT00582972|1092059|P1|STARTED|Overall Study||23
457921|NCT00582946|1092064|P1|NOT COMPLETED|Overall Study||0
457922|NCT00582946|1092064|P1|COMPLETED|Overall Study||16
457923|NCT00582946|1092064|P1|STARTED|Overall Study||16
457924|NCT00582933|1092068|P1|NOT COMPLETED|Overall Study||3
457925|NCT00582933|1092068|P1|COMPLETED|Overall Study||92
457926|NCT00582933|1092068|P1|STARTED|Overall Study||95
457927|NCT00582907|1092072|P4|NOT COMPLETED|4th Course||0
457928|NCT00582907|1092073|P3|NOT COMPLETED|4th Course||0
457929|NCT00582907|1092074|P2|NOT COMPLETED|4th Course||0
457930|NCT00582907|1092075|P1|NOT COMPLETED|4th Course||0
457931|NCT00582907|1092072|P4|COMPLETED|4th Course||3
457932|NCT00582907|1092073|P3|COMPLETED|4th Course||3
457933|NCT00582907|1092074|P2|COMPLETED|4th Course||3
457934|NCT00582907|1092075|P1|COMPLETED|4th Course||2
457935|NCT00582907|1092072|P4|STARTED|4th Course||3
457936|NCT00582907|1092073|P3|STARTED|4th Course||3
457937|NCT00582907|1092074|P2|STARTED|4th Course||3
457938|NCT00582907|1092075|P1|STARTED|4th Course||2
457939|NCT00582907|1092072|P4|NOT COMPLETED|3rd Course||0
457940|NCT00582907|1092073|P3|NOT COMPLETED|3rd Course||0
457941|NCT00582907|1092074|P2|NOT COMPLETED|3rd Course||0
457942|NCT00582907|1092075|P1|NOT COMPLETED|3rd Course||0
457943|NCT00582907|1092072|P4|COMPLETED|3rd Course||3
457944|NCT00582907|1092073|P3|COMPLETED|3rd Course||3
457945|NCT00582907|1092074|P2|COMPLETED|3rd Course||3
457946|NCT00582907|1092075|P1|COMPLETED|3rd Course||2
457947|NCT00582907|1092072|P4|STARTED|3rd Course||3
457948|NCT00582907|1092073|P3|STARTED|3rd Course||3
457949|NCT00582907|1092074|P2|STARTED|3rd Course||3
457950|NCT00582907|1092075|P1|STARTED|3rd Course||2
457951|NCT00582907|1092072|P4|NOT COMPLETED|2nd Course||0
457952|NCT00582907|1092073|P3|NOT COMPLETED|2nd Course||0
457953|NCT00582907|1092074|P2|NOT COMPLETED|2nd Course||0
457954|NCT00582907|1092075|P1|NOT COMPLETED|2nd Course||1
457955|NCT00582907|1092072|P4|COMPLETED|2nd Course||3
457956|NCT00582907|1092073|P3|COMPLETED|2nd Course||3
457957|NCT00582907|1092074|P2|COMPLETED|2nd Course||3
457958|NCT00582907|1092075|P1|COMPLETED|2nd Course||2
457959|NCT00582907|1092072|P4|STARTED|2nd Course||3
457960|NCT00582907|1092073|P3|STARTED|2nd Course||3
457961|NCT00582907|1092074|P2|STARTED|2nd Course||3
457962|NCT00582907|1092075|P1|STARTED|2nd Course||3
457963|NCT00582907|1092072|P4|NOT COMPLETED|1st Course||1
457964|NCT00582907|1092073|P3|NOT COMPLETED|1st Course||0
457965|NCT00582907|1092074|P2|NOT COMPLETED|1st Course||0
457966|NCT00582907|1092075|P1|NOT COMPLETED|1st Course||1
457967|NCT00582907|1092072|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
457968|NCT00582907|1092073|P3|COMPLETED|1st Course||3
457969|NCT00582907|1092074|P2|COMPLETED|1st Course||3
457970|NCT00582907|1092075|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
457971|NCT00582907|1092072|P4|STARTED|1st Course||4
457972|NCT00582907|1092073|P3|STARTED|1st Course||3
457973|NCT00582907|1092074|P2|STARTED|1st Course||3
457974|NCT00582907|1092075|P1|STARTED|1st Course||4
457975|NCT00582894|1092107|P1|NOT COMPLETED|Overall Study||0
457976|NCT00582894|1092107|P1|COMPLETED|Overall Study||17
457977|NCT00582894|1092107|P1|Day 100 Post Transplant|Overall Study||17
457978|NCT00582894|1092107|P1|STARTED|Overall Study||17
457979|NCT00582790|1092114|P1|NOT COMPLETED|Overall Study||1
457980|NCT00582790|1092114|P1|COMPLETED|Overall Study||11
457981|NCT00582790|1092114|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
457982|NCT00582738|1092123|P2|NOT COMPLETED|Overall Study||18
457983|NCT00582738|1092124|P1|NOT COMPLETED|Overall Study||9
457984|NCT00582738|1092123|P2|COMPLETED|Overall Study||4
457985|NCT00582738|1092124|P1|COMPLETED|Overall Study||12
457986|NCT00582738|1092123|P2|STARTED|Overall Study||22
457987|NCT00582738|1092124|P1|STARTED|Overall Study||21
457988|NCT00582712|1092148|P1|NOT COMPLETED|Overall Study||4
457989|NCT00582712|1092148|P1|COMPLETED|Overall Study||1
457990|NCT00582712|1092148|P1|STARTED|Overall Study||5
457991|NCT00582660|1092154|P2|NOT COMPLETED|Overall Study||0
457992|NCT00582660|1092155|P1|NOT COMPLETED|Overall Study||0
457993|NCT00582660|1092154|P2|COMPLETED|Overall Study||20
457994|NCT00582660|1092155|P1|COMPLETED|Overall Study||20
457995|NCT00582660|1092154|P2|STARTED|Overall Study||20
457996|NCT00582660|1092155|P1|STARTED|Overall Study||20
457997|NCT00582608|1092163|P1|NOT COMPLETED|Overall Study||12
457998|NCT00582608|1092163|P1|COMPLETED|Overall Study||0
457999|NCT00582608|1092163|P1|STARTED|Overall Study||12
458000|NCT00582556|1092170|P3|NOT COMPLETED|Overall Study||2
458001|NCT00582556|1092171|P2|NOT COMPLETED|Overall Study||1
458002|NCT00582556|1092172|P1|NOT COMPLETED|Overall Study||0
458003|NCT00582556|1092170|P3|COMPLETED|Overall Study||12
458004|NCT00582556|1092171|P2|COMPLETED|Overall Study||14
458005|NCT00582556|1092172|P1|COMPLETED|Overall Study||14
458006|NCT00582556|1092170|P3|STARTED|Overall Study||14
458007|NCT00582556|1092171|P2|STARTED|Overall Study||15
458008|NCT00582556|1092172|P1|STARTED|Overall Study||14
458009|NCT00582517|1092191|P2|NOT COMPLETED|Overall Study||0
458010|NCT00582517|1092192|P1|NOT COMPLETED|Overall Study||0
458011|NCT00582517|1092191|P2|COMPLETED|Overall Study||55
458012|NCT00582517|1092192|P1|COMPLETED|Overall Study||45
458013|NCT00582517|1092191|P2|STARTED|Overall Study||55
458014|NCT00582517|1092192|P1|STARTED|Overall Study||45
458015|NCT00582491|1092200|P2|NOT COMPLETED|Overall Study||0
458016|NCT00582491|1092201|P1|NOT COMPLETED|Overall Study||1
458017|NCT00582491|1092200|P2|COMPLETED|Overall Study||10
458018|NCT00582491|1092201|P1|COMPLETED|Overall Study||10
458019|NCT00582491|1092200|P2|STARTED|Overall Study||10
458020|NCT00582491|1092201|P1|STARTED|Overall Study||11
458021|NCT00582426|1092225|P2|NOT COMPLETED|Overall Study||13
458022|NCT00582426|1092226|P1|NOT COMPLETED|Overall Study||20
458023|NCT00582426|1092225|P2|COMPLETED|Overall Study||58
458024|NCT00582426|1092226|P1|COMPLETED|Overall Study||48
458025|NCT00582426|1092225|P2|STARTED|Overall Study||71
458026|NCT00582426|1092226|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
458027|NCT00582400|1092252|P1|NOT COMPLETED|Overall Study||3
458028|NCT00582400|1092252|P1|COMPLETED|Overall Study||6
458029|NCT00582400|1092252|P1|STARTED|Overall Study||9
458030|NCT00582361|1092261|P2|NOT COMPLETED|Overall Study||0
458031|NCT00582361|1092262|P1|NOT COMPLETED|Overall Study||0
458032|NCT00582361|1092261|P2|COMPLETED|Overall Study||38
458033|NCT00582361|1092262|P1|COMPLETED|Overall Study||25
458034|NCT00582361|1092261|P2|STARTED|Overall Study||38
458035|NCT00582361|1092262|P1|STARTED|Overall Study||25
458036|NCT00582309|1092273|P3|NOT COMPLETED|Overall Study||2
458037|NCT00582309|1092274|P2|NOT COMPLETED|Overall Study||0
458038|NCT00582309|1092275|P1|NOT COMPLETED|Overall Study||0
458039|NCT00582309|1092273|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
458040|NCT00582309|1092274|P2|COMPLETED|Overall Study||49
458041|NCT00582309|1092275|P1|COMPLETED|Overall Study||56
458042|NCT00582309|1092273|P3|STARTED|Overall Study||46
458043|NCT00582309|1092274|P2|STARTED|Overall Study||49
458044|NCT00582309|1092275|P1|STARTED|Overall Study||56
458045|NCT00582205|1092283|P1|NOT COMPLETED|Overall Study||10
458046|NCT00582205|1092283|P1|COMPLETED|Overall Study||11
458047|NCT00582205|1092283|P1|STARTED|Overall Study||21
458048|NCT00582114|1092290|P2|NOT COMPLETED|Overall Study||54
458049|NCT00582114|1092291|P1|NOT COMPLETED|Overall Study||42
458050|NCT00582114|1092290|P2|COMPLETED|Overall Study||46
458051|NCT00582114|1092291|P1|COMPLETED|Overall Study||58
458052|NCT00582114|1092290|P2|STARTED|Overall Study||100
458053|NCT00582114|1092291|P1|STARTED|Overall Study||100
458054|NCT00582075|1092299|P1|NOT COMPLETED|Overall Study||0
458055|NCT00582075|1092299|P1|COMPLETED|Overall Study||25
458056|NCT00582075|1092299|P1|STARTED|Overall Study||25
458057|NCT00582036|1092306|P2|NOT COMPLETED|Overall Study||1
458058|NCT00582036|1092307|P1|NOT COMPLETED|Overall Study||0
458059|NCT00582036|1092306|P2|COMPLETED|Overall Study|One patient withdrew consent|5
458060|NCT00582036|1092307|P1|COMPLETED|Overall Study||5
458061|NCT00582036|1092306|P2|STARTED|Overall Study||6
458062|NCT00582036|1092307|P1|STARTED|Overall Study||5
458063|NCT00582010|1092315|P2|NOT COMPLETED|Overall Study||1
458064|NCT00582010|1092316|P1|NOT COMPLETED|Overall Study||0
458065|NCT00582010|1092315|P2|COMPLETED|Overall Study||39
458066|NCT00582010|1092316|P1|COMPLETED|Overall Study||40
458067|NCT00582010|1092315|P2|STARTED|Overall Study||40
458068|NCT00582010|1092316|P1|STARTED|Overall Study||40
458069|NCT00581971|1092338|P1|NOT COMPLETED|Overall Study||0
458070|NCT00581971|1092338|P1|COMPLETED|Overall Study||30
458071|NCT00581971|1092338|P1|STARTED|Overall Study||30
458072|NCT00581945|1092345|P2|NOT COMPLETED|Overall Study||10
458073|NCT00581945|1092346|P1|NOT COMPLETED|Overall Study||9
458074|NCT00581945|1092345|P2|COMPLETED|Overall Study||63
458075|NCT00581945|1092346|P1|COMPLETED|Overall Study||65
458076|NCT00581945|1092345|P2|STARTED|Overall Study||73
458077|NCT00581945|1092346|P1|STARTED|Overall Study||74
458078|NCT00581919|1092362|P1|NOT COMPLETED|Overall Study||24
458079|NCT00581919|1092362|P1|COMPLETED|Overall Study||8
458080|NCT00581919|1092362|P1|STARTED|Overall Study||32
458081|NCT00581867|1092368|P2|NOT COMPLETED|Second Intervention||0
458082|NCT00581867|1092369|P1|NOT COMPLETED|Second Intervention||0
458083|NCT00581867|1092368|P2|COMPLETED|Second Intervention||14
458084|NCT00581867|1092369|P1|COMPLETED|Second Intervention||15
458085|NCT00581867|1092368|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
458086|NCT00581867|1092369|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
458087|NCT00581867|1092368|P2|NOT COMPLETED|First Intervention||0
458088|NCT00581867|1092369|P1|NOT COMPLETED|First Intervention||0
458089|NCT00581867|1092368|P2|COMPLETED|First Intervention||15
458090|NCT00581867|1092369|P1|COMPLETED|First Intervention||16
458091|NCT00581867|1092368|P2|STARTED|First Intervention||15
458092|NCT00581867|1092369|P1|STARTED|First Intervention||16
458093|NCT00581854|1092377|P1|NOT COMPLETED|Overall Study||0
458094|NCT00581854|1092377|P1|COMPLETED|Overall Study||22
458095|NCT00581854|1092377|P1|STARTED|Overall Study||22
458096|NCT00581828|1092381|P1|NOT COMPLETED|Overall Study||1
458097|NCT00581828|1092381|P1|COMPLETED|Overall Study||18
458098|NCT00581828|1092381|P1|STARTED|Overall Study||19
458099|NCT00581776|1092385|P1|NOT COMPLETED|Overall Study||3
458100|NCT00581776|1092385|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
458101|NCT00581776|1092385|P1|STARTED|Overall Study||30
458102|NCT00581581|1092394|P2|NOT COMPLETED|Overall Study||0
458103|NCT00581581|1092395|P1|NOT COMPLETED|Overall Study||0
458104|NCT00581581|1092394|P2|COMPLETED|Overall Study||30
458105|NCT00581581|1092395|P1|COMPLETED|Overall Study||32
458106|NCT00581581|1092394|P2|STARTED|Overall Study||30
458107|NCT00581581|1092395|P1|STARTED|Overall Study||32
458108|NCT00581555|1092403|P2|NOT COMPLETED|Overall Study||20
458109|NCT00581555|1092404|P1|NOT COMPLETED|Overall Study||43
458110|NCT00581555|1092403|P2|COMPLETED|Overall Study||38
458111|NCT00581555|1092404|P1|COMPLETED|Overall Study||19
458112|NCT00581555|1092403|P2|STARTED|Overall Study||58
458113|NCT00581555|1092404|P1|STARTED|Overall Study||62
458114|NCT00581542|1092428|P2|NOT COMPLETED|Overall Study||23
458115|NCT00581542|1092429|P1|NOT COMPLETED|Overall Study||11
458116|NCT00581542|1092428|P2|COMPLETED|Overall Study||39
458117|NCT00581542|1092429|P1|COMPLETED|Overall Study||51
458118|NCT00581542|1092428|P2|STARTED|Overall Study||62
458119|NCT00581542|1092429|P1|STARTED|Overall Study||62
458120|NCT00581529|1092437|P1|NOT COMPLETED|Overall Study||0
458121|NCT00581529|1092437|P1|COMPLETED|Overall Study||34
458122|NCT00581529|1092437|P1|STARTED|Overall Study||34
458123|NCT00581399|1092444|P2|NOT COMPLETED|Overall Study||0
458124|NCT00581399|1092445|P1|NOT COMPLETED|Overall Study||0
458125|NCT00581399|1092444|P2|COMPLETED|Overall Study||48
458126|NCT00581399|1092445|P1|COMPLETED|Overall Study||46
458127|NCT00581399|1092444|P2|STARTED|Overall Study||48
458128|NCT00581399|1092445|P1|STARTED|Overall Study||46
458129|NCT00581386|1092456|P3|NOT COMPLETED|Overall Study||0
458130|NCT00581386|1092457|P2|NOT COMPLETED|Overall Study||0
458131|NCT00581386|1092458|P1|NOT COMPLETED|Overall Study||0
458132|NCT00581386|1092456|P3|COMPLETED|Overall Study|04/15/2009|72
458133|NCT00581386|1092457|P2|COMPLETED|Overall Study|04/15/2009|73
458134|NCT00581386|1092458|P1|COMPLETED|Overall Study|04/15/2009|73
458135|NCT00581386|1092456|P3|STARTED|Overall Study|05/30/2007|72
458136|NCT00581386|1092457|P2|STARTED|Overall Study|05/30/2007|73
458137|NCT00581386|1092458|P1|STARTED|Overall Study|05/30/2007|73
458138|NCT00581360|1092481|P1|NOT COMPLETED|Overall Study||1
458139|NCT00581360|1092481|P1|COMPLETED|Overall Study||9
458140|NCT00581360|1092481|P1|STARTED|Overall Study||10
458141|NCT00581347|1092491|P2|NOT COMPLETED|Overall Study||0
458142|NCT00581347|1092492|P1|NOT COMPLETED|Overall Study||0
458143|NCT00581347|1092491|P2|COMPLETED|Overall Study||3707
458144|NCT00581347|1092492|P1|COMPLETED|Overall Study||3839
458145|NCT00581347|1092491|P2|STARTED|Overall Study||3707
458146|NCT00581347|1092492|P1|STARTED|Overall Study||3839
458147|NCT00581308|1092500|P1|NOT COMPLETED|Month 12||21
458148|NCT00581308|1092500|P1|COMPLETED|Month 12||177
458149|NCT00581308|1092500|P1|STARTED|Month 12||198
458150|NCT00581308|1092500|P1|NOT COMPLETED|Month 6||5
458151|NCT00581308|1092500|P1|COMPLETED|Month 6||198
458152|NCT00581308|1092500|P1|STARTED|Month 6||203
458153|NCT00581308|1092500|P1|NOT COMPLETED|Month 1||9
458154|NCT00581308|1092500|P1|COMPLETED|Month 1||203
458155|NCT00581308|1092500|P1|STARTED|Month 1||212
458156|NCT00581308|1092500|P1|NOT COMPLETED|Pre Discharge||3
458157|NCT00581308|1092500|P1|COMPLETED|Pre Discharge||212
458158|NCT00581308|1092500|P1|STARTED|Pre Discharge||215
458159|NCT00581256|1092510|P2|NOT COMPLETED|Overall Study||0
458160|NCT00581256|1092511|P1|NOT COMPLETED|Overall Study||0
458161|NCT00581256|1092510|P2|COMPLETED|Overall Study||26
458162|NCT00581256|1092511|P1|COMPLETED|Overall Study||28
458163|NCT00581256|1092510|P2|STARTED|Overall Study||26
458164|NCT00581256|1092511|P1|STARTED|Overall Study||28
458165|NCT00581230|1092523|P1|NOT COMPLETED|Overall Study||0
458166|NCT00581230|1092523|P1|COMPLETED|Overall Study||51
458167|NCT00581230|1092523|P1|Laryngoscopy With RAMP|Overall Study||51
458168|NCT00581230|1092523|P1|Laryngoscopy Without RAMP|Overall Study||51
458169|NCT00581230|1092523|P1|STARTED|Overall Study||51
458170|NCT00581113|1092532|P2|NOT COMPLETED|Overall Study||1
458171|NCT00581113|1092533|P1|NOT COMPLETED|Overall Study||0
458172|NCT00581113|1092532|P2|COMPLETED|Overall Study||3
458173|NCT00581113|1092533|P1|COMPLETED|Overall Study||4
458174|NCT00581113|1092532|P2|STARTED|Overall Study||4
458175|NCT00581113|1092533|P1|STARTED|Overall Study||4
458176|NCT00581100|1092543|P2|NOT COMPLETED|Overall Study||5
458177|NCT00581100|1092544|P1|NOT COMPLETED|Overall Study||7
458178|NCT00581100|1092543|P2|COMPLETED|Overall Study||29
458179|NCT00581100|1092544|P1|COMPLETED|Overall Study||31
458180|NCT00581100|1092543|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
458181|NCT00581100|1092544|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
458182|NCT00581100|1092543|P2|STARTED|Overall Study||34
458183|NCT00581100|1092544|P1|STARTED|Overall Study||38
458184|NCT00581061|1092580|P1|NOT COMPLETED|Overall Study||0
458185|NCT00581061|1092580|P1|COMPLETED|Overall Study||13
458186|NCT00581061|1092580|P1|STARTED|Overall Study||13
458187|NCT00580983|1092586|P1|NOT COMPLETED|Overall Study||7
458188|NCT00580983|1092586|P1|COMPLETED|Overall Study||73
458189|NCT00580983|1092586|P1|STARTED|Overall Study||80
458190|NCT00580970|1092593|P1|NOT COMPLETED|Treatment (Lovastatin)||19
458191|NCT00580970|1092593|P1|COMPLETED|Treatment (Lovastatin)||53
458192|NCT00580970|1092593|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
458193|NCT00580970|1092593|P1|STARTED|Treatment (Lovastatin)||72
458194|NCT00580970|1092593|P1|NOT COMPLETED|Pre-treatment||1
458195|NCT00580970|1092593|P1|COMPLETED|Pre-treatment||72
458196|NCT00580970|1092593|P1|STARTED|Pre-treatment||73
458197|NCT00580957|1092599|P2|NOT COMPLETED|Overall Study||7
458198|NCT00580957|1092600|P1|NOT COMPLETED|Overall Study||7
458199|NCT00580957|1092599|P2|COMPLETED|Overall Study||21
458200|NCT00580957|1092600|P1|COMPLETED|Overall Study||21
458201|NCT00580957|1092599|P2|STARTED|Overall Study||28
458202|NCT00580957|1092600|P1|STARTED|Overall Study||28
458203|NCT00580866|1092608|P2|NOT COMPLETED|Overall Study||2
458204|NCT00580866|1092609|P1|NOT COMPLETED|Overall Study||2
458205|NCT00580866|1092608|P2|COMPLETED|Overall Study||5
458206|NCT00580866|1092609|P1|COMPLETED|Overall Study||8
458207|NCT00580866|1092608|P2|STARTED|Overall Study||7
458208|NCT00580866|1092609|P1|STARTED|Overall Study||10
458209|NCT00580853|1092620|P3|NOT COMPLETED|Overall Study||0
458210|NCT00580853|1092621|P2|NOT COMPLETED|Overall Study||0
458211|NCT00580853|1092622|P1|NOT COMPLETED|Overall Study||0
458212|NCT00580853|1092620|P3|COMPLETED|Overall Study||21
458213|NCT00580853|1092621|P2|COMPLETED|Overall Study||21
458214|NCT00580853|1092622|P1|COMPLETED|Overall Study||20
458215|NCT00580853|1092620|P3|STARTED|Overall Study||21
458216|NCT00580853|1092621|P2|STARTED|Overall Study||21
458217|NCT00580853|1092622|P1|STARTED|Overall Study||20
458218|NCT00580840|1092633|P4|NOT COMPLETED|Double-Blind||15
458219|NCT00580840|1092634|P3|NOT COMPLETED|Double-Blind||9
458220|NCT00580840|1092635|P2|NOT COMPLETED|Double-Blind||7
458221|NCT00580840|1092636|P1|NOT COMPLETED|Double-Blind||0
458222|NCT00580840|1092633|P4|COMPLETED|Double-Blind||54
458223|NCT00580840|1092634|P3|COMPLETED|Double-Blind||61
458224|NCT00580840|1092635|P2|COMPLETED|Double-Blind||63
458225|NCT00580840|1092636|P1|COMPLETED|Double-Blind||0
458226|NCT00580840|1092633|P4|STARTED|Double-Blind||69
458227|NCT00580840|1092634|P3|STARTED|Double-Blind||70
458228|NCT00580840|1092635|P2|STARTED|Double-Blind||70
458229|NCT00580840|1092636|P1|STARTED|Double-Blind||0
458230|NCT00580840|1092633|P4|NOT COMPLETED|Run-in||0
458231|NCT00580840|1092634|P3|NOT COMPLETED|Run-in||0
458232|NCT00580840|1092635|P2|NOT COMPLETED|Run-in||0
458233|NCT00580840|1092636|P1|NOT COMPLETED|Run-in||124
458234|NCT00580840|1092633|P4|COMPLETED|Run-in||0
458235|NCT00580840|1092634|P3|COMPLETED|Run-in||0
458236|NCT00580840|1092635|P2|COMPLETED|Run-in||0
458237|NCT00580840|1092636|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
458238|NCT00580840|1092633|P4|STARTED|Run-in||0
458239|NCT00580840|1092634|P3|STARTED|Run-in||0
458240|NCT00580840|1092635|P2|STARTED|Run-in||0
458241|NCT00580840|1092636|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
458242|NCT00580801|1092744|P3|NOT COMPLETED|Overall Study||3
458243|NCT00580801|1092745|P2|NOT COMPLETED|Overall Study||1
458244|NCT00580801|1092746|P1|NOT COMPLETED|Overall Study||6
458245|NCT00580801|1092744|P3|COMPLETED|Overall Study||5
458246|NCT00580801|1092745|P2|COMPLETED|Overall Study||7
458247|NCT00580801|1092746|P1|COMPLETED|Overall Study||2
458248|NCT00580801|1092744|P3|STARTED|Overall Study||8
458249|NCT00580801|1092745|P2|STARTED|Overall Study||8
458250|NCT00580801|1092746|P1|STARTED|Overall Study||8
458251|NCT00580788|1092785|P4|NOT COMPLETED|Overall Study||1
458252|NCT00580788|1092786|P3|NOT COMPLETED|Overall Study||0
458253|NCT00580788|1092787|P2|NOT COMPLETED|Overall Study||0
458254|NCT00580788|1092788|P1|NOT COMPLETED|Overall Study||0
458255|NCT00580788|1092785|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
458256|NCT00580788|1092786|P3|COMPLETED|Overall Study||3
458257|NCT00580788|1092787|P2|COMPLETED|Overall Study||6
458258|NCT00580788|1092788|P1|COMPLETED|Overall Study||3
458259|NCT00580788|1092785|P4|STARTED|Overall Study||2
458260|NCT00580788|1092786|P3|STARTED|Overall Study||3
458261|NCT00580788|1092787|P2|STARTED|Overall Study||6
458262|NCT00580788|1092788|P1|STARTED|Overall Study||3
458263|NCT00580723|1092846|P1|NOT COMPLETED|Overall Study||8
458264|NCT00580723|1092846|P1|COMPLETED|Overall Study||16
458265|NCT00580723|1092846|P1|STARTED|Overall Study||24
458266|NCT00580671|1092855|P3|NOT COMPLETED|Overall Study||17
458267|NCT00580671|1092856|P2|NOT COMPLETED|Overall Study||16
458268|NCT00580671|1092857|P1|NOT COMPLETED|Overall Study||16
458269|NCT00580671|1092855|P3|COMPLETED|Overall Study||34
458270|NCT00580671|1092856|P2|COMPLETED|Overall Study||35
458271|NCT00580671|1092857|P1|COMPLETED|Overall Study||35
458272|NCT00580671|1092855|P3|STARTED|Overall Study||51
458273|NCT00580671|1092856|P2|STARTED|Overall Study||51
458274|NCT00580671|1092857|P1|STARTED|Overall Study||51
458275|NCT00580606|1092873|P2|NOT COMPLETED|Open Label (OL)||12
458276|NCT00580606|1092874|P1|NOT COMPLETED|Open Label (OL)||9
458277|NCT00580606|1092873|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
458278|NCT00580606|1092874|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
458279|NCT00580606|1092873|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
458280|NCT00580606|1092874|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
458281|NCT00580606|1092873|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
458282|NCT00580606|1092874|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
458283|NCT00580606|1092873|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
458284|NCT00580606|1092874|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
458285|NCT00580606|1092873|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
458286|NCT00580606|1092874|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
458287|NCT00580606|1092873|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
458288|NCT00580606|1092874|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
458289|NCT00580606|1092873|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
458290|NCT00580606|1092874|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
458291|NCT00580606|1092873|P2|NOT COMPLETED|Double Blind (DB)||0
458292|NCT00580606|1092874|P1|NOT COMPLETED|Double Blind (DB)||0
458293|NCT00580606|1092873|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
458294|NCT00580606|1092874|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
458295|NCT00580606|1092873|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
458296|NCT00580606|1092874|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
458297|NCT00580606|1092873|P2|STARTED|Double Blind (DB)||20
458298|NCT00580606|1092874|P1|STARTED|Double Blind (DB)||20
458299|NCT00580502|1092892|P1|NOT COMPLETED|Overall Study||0
458300|NCT00580502|1092892|P1|COMPLETED|Overall Study||50
458301|NCT00580502|1092892|P1|STARTED|Overall Study||50
458302|NCT00580398|1092901|P2|NOT COMPLETED|Overall Study||0
458303|NCT00580398|1092902|P1|NOT COMPLETED|Overall Study||0
458304|NCT00580398|1092901|P2|COMPLETED|Overall Study||32
458305|NCT00580398|1092902|P1|COMPLETED|Overall Study||17
458306|NCT00580398|1092901|P2|STARTED|Overall Study||32
458307|NCT00580398|1092902|P1|STARTED|Overall Study||17
458308|NCT00580372|1092910|P1|NOT COMPLETED|Overall Study||0
458309|NCT00580372|1092910|P1|COMPLETED|Overall Study||231
458310|NCT00580372|1092910|P1|STARTED|Overall Study||231
458311|NCT00580333|1092914|P1|NOT COMPLETED|Overall Study||0
458312|NCT00580333|1092914|P1|COMPLETED|Overall Study||51
458313|NCT00580333|1092914|P1|STARTED|Overall Study||51
458314|NCT00580294|1092921|P1|NOT COMPLETED|Overall Study||0
458315|NCT00580294|1092921|P1|COMPLETED|Overall Study||12
458316|NCT00580294|1092921|P1|STARTED|Overall Study||12
458317|NCT00580229|1092925|P1|NOT COMPLETED|Overall Study||0
458318|NCT00580229|1092925|P1|COMPLETED|Overall Study||50
458319|NCT00580229|1092925|P1|STARTED|Overall Study||50
458320|NCT00580151|1092931|P2|NOT COMPLETED|Overall Study||0
458321|NCT00580151|1092932|P1|NOT COMPLETED|Overall Study||0
458322|NCT00580151|1092931|P2|COMPLETED|Overall Study||0
458323|NCT00580151|1092932|P1|COMPLETED|Overall Study||9
458324|NCT00580151|1092931|P2|STARTED|Overall Study||0
458325|NCT00580151|1092932|P1|STARTED|Overall Study||9
458326|NCT00580138|1092940|P1|NOT COMPLETED|Overall Study||0
458327|NCT00580138|1092940|P1|COMPLETED|Overall Study||30
458328|NCT00580138|1092940|P1|STARTED|Overall Study||30
458329|NCT00580073|1092944|P1|NOT COMPLETED|Overall Study||0
458330|NCT00580073|1092944|P1|COMPLETED|Overall Study||6
458331|NCT00580073|1092944|P1|STARTED|Overall Study||6
458332|NCT00580034|1092950|P2|NOT COMPLETED|Overall Study||0
458333|NCT00580034|1092951|P1|NOT COMPLETED|Overall Study||10
458334|NCT00580034|1092950|P2|COMPLETED|Overall Study||88
458335|NCT00580034|1092951|P1|COMPLETED|Overall Study||78
458336|NCT00580034|1092950|P2|STARTED|Overall Study||88
458337|NCT00580034|1092951|P1|STARTED|Overall Study||88
458338|NCT00579982|1092957|P1|NOT COMPLETED|Overall Study||8
458339|NCT00579982|1092957|P1|COMPLETED|Overall Study||89
458340|NCT00579982|1092957|P1|STARTED|Overall Study||97
458341|NCT00579826|1092978|P2|NOT COMPLETED|Overall Study||3
458342|NCT00579826|1092979|P1|NOT COMPLETED|Overall Study||5
458343|NCT00579826|1092978|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
458344|NCT00579826|1092979|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
458345|NCT00579826|1092978|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
458346|NCT00579826|1092979|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
458347|NCT00579826|1092978|P2|STARTED|Overall Study||26
458348|NCT00579826|1092979|P1|STARTED|Overall Study||29
458349|NCT00579813|1092991|P2|NOT COMPLETED|Overall Study||0
458350|NCT00579813|1092992|P1|NOT COMPLETED|Overall Study||0
458351|NCT00579813|1092991|P2|COMPLETED|Overall Study||10
458352|NCT00579813|1092992|P1|COMPLETED|Overall Study||60
458353|NCT00579813|1092991|P2|STARTED|Overall Study||10
458354|NCT00579813|1092992|P1|STARTED|Overall Study||60
458355|NCT00579670|1093013|P5|NOT COMPLETED|Overall Study||0
458356|NCT00579670|1093014|P4|NOT COMPLETED|Overall Study||22
458357|NCT00579670|1093015|P3|NOT COMPLETED|Overall Study||4
458358|NCT00579670|1093016|P2|NOT COMPLETED|Overall Study||1
458359|NCT00579670|1093017|P1|NOT COMPLETED|Overall Study||2
458360|NCT00579670|1093013|P5|COMPLETED|Overall Study||5
458361|NCT00579670|1093014|P4|COMPLETED|Overall Study||263
458362|NCT00579670|1093015|P3|COMPLETED|Overall Study||84
458363|NCT00579670|1093016|P2|COMPLETED|Overall Study||56
458364|NCT00579670|1093017|P1|COMPLETED|Overall Study||13
458365|NCT00579670|1093013|P5|Population: Within SmPC (Completed)|Overall Study||0
458366|NCT00579670|1093014|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
458367|NCT00579670|1093015|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
458368|NCT00579670|1093016|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
458369|NCT00579670|1093017|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
458370|NCT00579670|1093013|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
458371|NCT00579670|1093014|P4|Population: Within SmPC (Started)|Overall Study||159
458372|NCT00579670|1093015|P3|Population: Within SmPC (Started)|Overall Study||83
458373|NCT00579670|1093016|P2|Population: Within SmPC (Started)|Overall Study||56
458374|NCT00579670|1093017|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
458375|NCT00579670|1093013|P5|STARTED|Overall Study||5
458376|NCT00579670|1093014|P4|STARTED|Overall Study||285
458377|NCT00579670|1093015|P3|STARTED|Overall Study||88
458378|NCT00579670|1093016|P2|STARTED|Overall Study||57
458379|NCT00579670|1093017|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
458380|NCT00579501|1093229|P1|NOT COMPLETED|Overall Study||29
458381|NCT00579501|1093229|P1|COMPLETED|Overall Study||0
458382|NCT00579501|1093229|P1|STARTED|Overall Study||29
458383|NCT00579345|1093242|P8|NOT COMPLETED|Overall Study||2
458384|NCT00579345|1093243|P7|NOT COMPLETED|Overall Study||0
458385|NCT00579345|1093244|P6|NOT COMPLETED|Overall Study||0
458386|NCT00579345|1093245|P5|NOT COMPLETED|Overall Study||0
458387|NCT00579345|1093246|P4|NOT COMPLETED|Overall Study||1
458388|NCT00579345|1093247|P3|NOT COMPLETED|Overall Study||2
458389|NCT00579345|1093248|P2|NOT COMPLETED|Overall Study||1
458390|NCT00579345|1093249|P1|NOT COMPLETED|Overall Study||5
458391|NCT00579345|1093242|P8|COMPLETED|Overall Study||42
458392|NCT00579345|1093243|P7|COMPLETED|Overall Study||57
458393|NCT00579345|1093244|P6|COMPLETED|Overall Study||78
458394|NCT00579345|1093245|P5|COMPLETED|Overall Study||90
458395|NCT00579345|1093246|P4|COMPLETED|Overall Study||143
458396|NCT00579345|1093247|P3|COMPLETED|Overall Study||389
458397|NCT00579345|1093248|P2|COMPLETED|Overall Study||168
458398|NCT00579345|1093249|P1|COMPLETED|Overall Study||544
458399|NCT00579345|1093242|P8|STARTED|Overall Study||44
458400|NCT00579345|1093243|P7|STARTED|Overall Study||57
458401|NCT00579345|1093244|P6|STARTED|Overall Study||78
458402|NCT00579345|1093245|P5|STARTED|Overall Study||90
458403|NCT00579345|1093246|P4|STARTED|Overall Study||144
458404|NCT00579345|1093247|P3|STARTED|Overall Study||391
458405|NCT00579345|1093248|P2|STARTED|Overall Study||169
458406|NCT00579345|1093249|P1|STARTED|Overall Study||549
458407|NCT00579254|1093281|P1|NOT COMPLETED|Overall Study||112
458408|NCT00579254|1093281|P1|COMPLETED|Overall Study||0
458409|NCT00579254|1093281|P1|STARTED|Overall Study||112
458410|NCT00579137|1093285|P1|NOT COMPLETED|Overall Study||0
458411|NCT00579137|1093285|P1|COMPLETED|Overall Study||3
458412|NCT00579137|1093285|P1|STARTED|Overall Study||3
458413|NCT00579111|1093294|P2|NOT COMPLETED|Overall Study||1
458414|NCT00579111|1093295|P1|NOT COMPLETED|Overall Study||2
458415|NCT00579111|1093294|P2|COMPLETED|Overall Study||0
458416|NCT00579111|1093295|P1|COMPLETED|Overall Study||1
458417|NCT00579111|1093294|P2|STARTED|Overall Study||1
458418|NCT00579111|1093295|P1|STARTED|Overall Study||3
458419|NCT00579098|1093305|P2|NOT COMPLETED|Overall Study||8
458420|NCT00579098|1093306|P1|NOT COMPLETED|Overall Study||9
458421|NCT00579098|1093305|P2|COMPLETED|Overall Study||55
458422|NCT00579098|1093306|P1|COMPLETED|Overall Study||53
458423|NCT00579098|1093305|P2|STARTED|Overall Study||63
458424|NCT00579098|1093306|P1|STARTED|Overall Study||62
458425|NCT00579059|1093322|P2|NOT COMPLETED|Overall Study||10
458426|NCT00579059|1093323|P1|NOT COMPLETED|Overall Study||21
458427|NCT00579059|1093322|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
458428|NCT00579059|1093323|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
458429|NCT00579059|1093322|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
458430|NCT00579059|1093323|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
458431|NCT00579059|1093322|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
458432|NCT00579059|1093323|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
458433|NCT00579059|1093322|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
458434|NCT00579059|1093323|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
458435|NCT00579059|1093322|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
458436|NCT00579059|1093323|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
458437|NCT00579059|1093322|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
458438|NCT00579059|1093323|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
458439|NCT00579059|1093322|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
458440|NCT00579059|1093323|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
458441|NCT00578968|1093334|P3|NOT COMPLETED|Intervention||0
458442|NCT00578968|1093335|P2|NOT COMPLETED|Intervention||0
458443|NCT00578968|1093336|P1|NOT COMPLETED|Intervention||0
458444|NCT00578968|1093334|P3|COMPLETED|Intervention||0
458445|NCT00578968|1093335|P2|COMPLETED|Intervention||12
458446|NCT00578968|1093336|P1|COMPLETED|Intervention||12
458447|NCT00578968|1093334|P3|STARTED|Intervention||0
458448|NCT00578968|1093335|P2|STARTED|Intervention||12
458449|NCT00578968|1093336|P1|STARTED|Intervention||12
458450|NCT00578968|1093334|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
458451|NCT00578968|1093335|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
458452|NCT00578968|1093336|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
458453|NCT00578968|1093334|P3|COMPLETED|Baseline (Prior to Intervention)||12
458454|NCT00578968|1093335|P2|COMPLETED|Baseline (Prior to Intervention)||12
458455|NCT00578968|1093336|P1|COMPLETED|Baseline (Prior to Intervention)||12
458456|NCT00578968|1093334|P3|STARTED|Baseline (Prior to Intervention)||12
458457|NCT00578968|1093335|P2|STARTED|Baseline (Prior to Intervention)||12
458458|NCT00578968|1093336|P1|STARTED|Baseline (Prior to Intervention)||12
458459|NCT00578942|1093397|P1|NOT COMPLETED|Overall Study||1
458460|NCT00578942|1093397|P1|COMPLETED|Overall Study||47
458461|NCT00578942|1093397|P1|STARTED|Overall Study||48
458462|NCT00578929|1093407|P4|NOT COMPLETED|Randomized Period||14
458463|NCT00578929|1093408|P3|NOT COMPLETED|Randomized Period||8
458464|NCT00578929|1093409|P2|NOT COMPLETED|Randomized Period||14
458465|NCT00578929|1093410|P1|NOT COMPLETED|Randomized Period||17
458466|NCT00578929|1093407|P4|COMPLETED|Randomized Period||283
458467|NCT00578929|1093408|P3|COMPLETED|Randomized Period||288
458468|NCT00578929|1093409|P2|COMPLETED|Randomized Period||283
458469|NCT00578929|1093410|P1|COMPLETED|Randomized Period||281
458470|NCT00578929|1093407|P4|STARTED|Randomized Period||297
458471|NCT00578929|1093408|P3|STARTED|Randomized Period||296
458472|NCT00578929|1093409|P2|STARTED|Randomized Period||297
458473|NCT00578929|1093410|P1|STARTED|Randomized Period||298
458474|NCT00578929|1093407|P4|NOT COMPLETED|Vehicle Run-In Period||0
458475|NCT00578929|1093408|P3|NOT COMPLETED|Vehicle Run-In Period||0
458476|NCT00578929|1093409|P2|NOT COMPLETED|Vehicle Run-In Period||0
458477|NCT00578929|1093410|P1|NOT COMPLETED|Vehicle Run-In Period||0
458478|NCT00578929|1093407|P4|COMPLETED|Vehicle Run-In Period||0
458479|NCT00578929|1093408|P3|COMPLETED|Vehicle Run-In Period||0
458480|NCT00578929|1093409|P2|COMPLETED|Vehicle Run-In Period||2388
458481|NCT00578929|1093410|P1|COMPLETED|Vehicle Run-In Period||0
458482|NCT00578929|1093407|P4|STARTED|Vehicle Run-In Period||0
458483|NCT00578929|1093408|P3|STARTED|Vehicle Run-In Period||0
458484|NCT00578929|1093409|P2|STARTED|Vehicle Run-In Period||2388
458485|NCT00578929|1093410|P1|STARTED|Vehicle Run-In Period||0
458486|NCT00578903|1093425|P1|NOT COMPLETED|Overall Study||0
458487|NCT00578903|1093425|P1|COMPLETED|Overall Study||22
458488|NCT00578903|1093425|P1|STARTED|Overall Study||22
458489|NCT00578864|1093436|P2|NOT COMPLETED|Overall Study||0
458490|NCT00578864|1093437|P1|NOT COMPLETED|Overall Study||1
458491|NCT00578864|1093436|P2|COMPLETED|Overall Study||6
458492|NCT00578864|1093437|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
458493|NCT00578864|1093436|P2|STARTED|Overall Study||6
458494|NCT00578864|1093437|P1|STARTED|Overall Study||7
458495|NCT00578812|1093453|P2|NOT COMPLETED|Overall Study||7
458496|NCT00578812|1093454|P1|NOT COMPLETED|Overall Study||6
458497|NCT00578812|1093453|P2|COMPLETED|Overall Study||185
458498|NCT00578812|1093454|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
458499|NCT00578812|1093453|P2|STARTED|Overall Study||192
458500|NCT00578812|1093454|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
458501|NCT00578786|1093493|P3|NOT COMPLETED|Overall Study||30
458502|NCT00578786|1093494|P2|NOT COMPLETED|Overall Study||66
458503|NCT00578786|1093495|P1|NOT COMPLETED|Overall Study||39
458504|NCT00578786|1093493|P3|COMPLETED|Overall Study||67
458505|NCT00578786|1093494|P2|COMPLETED|Overall Study||124
458506|NCT00578786|1093495|P1|COMPLETED|Overall Study||57
458507|NCT00578786|1093493|P3|STARTED|Overall Study||97
458508|NCT00578786|1093494|P2|STARTED|Overall Study||190
458509|NCT00578786|1093495|P1|STARTED|Overall Study||96
458510|NCT00578734|1093576|P2|NOT COMPLETED|Overall Study||0
458511|NCT00578734|1093577|P1|NOT COMPLETED|Overall Study||0
458512|NCT00578734|1093576|P2|COMPLETED|Overall Study||81
458513|NCT00578734|1093577|P1|COMPLETED|Overall Study||84
458514|NCT00578734|1093576|P2|STARTED|Overall Study||81
458515|NCT00578734|1093577|P1|STARTED|Overall Study||84
458516|NCT00578617|1093587|P2|NOT COMPLETED|Overall Study||0
458517|NCT00578617|1093588|P1|NOT COMPLETED|Overall Study||0
458518|NCT00578617|1093587|P2|COMPLETED|Overall Study||29
458519|NCT00578617|1093588|P1|COMPLETED|Overall Study||31
458520|NCT00578617|1093587|P2|STARTED|Overall Study||29
458521|NCT00578617|1093588|P1|STARTED|Overall Study||31
458522|NCT00578565|1093594|P1|NOT COMPLETED|Overall Study||3
458523|NCT00578565|1093594|P1|COMPLETED|Overall Study||7
458524|NCT00578565|1093594|P1|STARTED|Overall Study||10
458525|NCT00578552|1093606|P3|NOT COMPLETED|Overall Study||15
458526|NCT00578552|1093607|P2|NOT COMPLETED|Overall Study||14
458527|NCT00578552|1093608|P1|NOT COMPLETED|Overall Study||15
458528|NCT00578552|1093606|P3|COMPLETED|Overall Study||11
458529|NCT00578552|1093607|P2|COMPLETED|Overall Study||13
458530|NCT00578552|1093608|P1|COMPLETED|Overall Study||12
458531|NCT00578552|1093606|P3|STARTED|Overall Study||26
458532|NCT00578552|1093607|P2|STARTED|Overall Study||27
458533|NCT00578552|1093608|P1|STARTED|Overall Study||27
458534|NCT00578539|1093616|P1|NOT COMPLETED|Overall Study||0
458535|NCT00578539|1093616|P1|COMPLETED|Overall Study||24
458536|NCT00578539|1093616|P1|STARTED|Overall Study||24
458537|NCT00577655|1093622|P2|NOT COMPLETED|Overall Study||4
458538|NCT00577655|1093623|P1|NOT COMPLETED|Overall Study||1
458539|NCT00577655|1093622|P2|COMPLETED|Overall Study||47
458540|NCT00577655|1093623|P1|COMPLETED|Overall Study||51
458541|NCT00577655|1093622|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
458542|NCT00577655|1093623|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
458543|NCT00577642|1093661|P1|NOT COMPLETED|Overall Study||1
458544|NCT00577642|1093661|P1|COMPLETED|Overall Study||28
458545|NCT00577642|1093661|P1|STARTED|Overall Study||29
458546|NCT00577629|1093665|P1|NOT COMPLETED|Long Term Follow-Up||25
458547|NCT00577629|1093665|P1|COMPLETED|Long Term Follow-Up||13
458548|NCT00577629|1093665|P1|STARTED|Long Term Follow-Up||38
458549|NCT00577629|1093665|P1|NOT COMPLETED|Treatment Period||1
458550|NCT00577629|1093665|P1|COMPLETED|Treatment Period||38
458551|NCT00577629|1093665|P1|STARTED|Treatment Period||39
458552|NCT00578461|1093673|P1|NOT COMPLETED|Overall Study||0
458553|NCT00578461|1093673|P1|COMPLETED|Overall Study||26
458554|NCT00578461|1093673|P1|STARTED|Overall Study||26
458555|NCT00578448|1093677|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
458556|NCT00578448|1093677|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
458557|NCT00578448|1093677|P1|STARTED|1 Year Long Term Extension (LTE)||9
458558|NCT00578448|1093677|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
458559|NCT00578448|1093677|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
458560|NCT00578448|1093677|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
458561|NCT00578383|1093695|P4|NOT COMPLETED|Overall Study||6
458562|NCT00578383|1093696|P3|NOT COMPLETED|Overall Study||6
458563|NCT00578383|1093697|P2|NOT COMPLETED|Overall Study||16
458564|NCT00578383|1093698|P1|NOT COMPLETED|Overall Study||16
458565|NCT00578383|1093695|P4|COMPLETED|Overall Study||9
458566|NCT00578383|1093696|P3|COMPLETED|Overall Study||13
458567|NCT00578383|1093697|P2|COMPLETED|Overall Study||20
458568|NCT00578383|1093698|P1|COMPLETED|Overall Study||21
458569|NCT00578383|1093695|P4|STARTED|Overall Study||15
458570|NCT00578383|1093696|P3|STARTED|Overall Study||19
458571|NCT00578383|1093697|P2|STARTED|Overall Study||36
458572|NCT00578383|1093698|P1|STARTED|Overall Study||37
458573|NCT00578331|1093730|P2|NOT COMPLETED|Overall Study||125
458574|NCT00578331|1093731|P1|NOT COMPLETED|Overall Study||116
458575|NCT00578331|1093730|P2|COMPLETED|Overall Study||320
458576|NCT00578331|1093731|P1|COMPLETED|Overall Study||329
458577|NCT00578331|1093730|P2|STARTED|Overall Study||445
458578|NCT00578331|1093731|P1|STARTED|Overall Study||445
458579|NCT00578318|1093741|P2|NOT COMPLETED|Overall Study||0
458580|NCT00578318|1093742|P1|NOT COMPLETED|Overall Study||3
458581|NCT00578318|1093741|P2|COMPLETED|Overall Study||8
458582|NCT00578318|1093742|P1|COMPLETED|Overall Study||5
458583|NCT00578318|1093741|P2|STARTED|Overall Study||8
458584|NCT00578318|1093742|P1|STARTED|Overall Study||8
458585|NCT00578305|1093751|P3|NOT COMPLETED|Safety Follow-up Phase||46
458586|NCT00578305|1093752|P2|NOT COMPLETED|Safety Follow-up Phase||45
458587|NCT00578305|1093753|P1|NOT COMPLETED|Safety Follow-up Phase||46
458588|NCT00578305|1093751|P3|COMPLETED|Safety Follow-up Phase||8
458589|NCT00578305|1093752|P2|COMPLETED|Safety Follow-up Phase||9
458590|NCT00578305|1093753|P1|COMPLETED|Safety Follow-up Phase||11
458677|NCT00577824|1094115|P3|COMPLETED|Overall Study||34
458591|NCT00578305|1093751|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
458592|NCT00578305|1093752|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
458593|NCT00578305|1093753|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
458594|NCT00578305|1093751|P3|NOT COMPLETED|Extension Phase||3
458595|NCT00578305|1093752|P2|NOT COMPLETED|Extension Phase||1
458596|NCT00578305|1093753|P1|NOT COMPLETED|Extension Phase||4
458597|NCT00578305|1093751|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
458598|NCT00578305|1093752|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
458599|NCT00578305|1093753|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
458600|NCT00578305|1093751|P3|STARTED|Extension Phase||43
458601|NCT00578305|1093752|P2|STARTED|Extension Phase||50
458602|NCT00578305|1093753|P1|STARTED|Extension Phase||53
458603|NCT00578305|1093751|P3|NOT COMPLETED|Double-blind Treatment Phase||14
458604|NCT00578305|1093752|P2|NOT COMPLETED|Double-blind Treatment Phase||4
458605|NCT00578305|1093753|P1|NOT COMPLETED|Double-blind Treatment Phase||3
458606|NCT00578305|1093751|P3|COMPLETED|Double-blind Treatment Phase||49
458607|NCT00578305|1093752|P2|COMPLETED|Double-blind Treatment Phase||56
458608|NCT00578305|1093753|P1|COMPLETED|Double-blind Treatment Phase||59
458609|NCT00578305|1093751|P3|Treated|Double-blind Treatment Phase||63
458610|NCT00578305|1093752|P2|Treated|Double-blind Treatment Phase||60
458611|NCT00578305|1093753|P1|Treated|Double-blind Treatment Phase||62
458612|NCT00578305|1093751|P3|STARTED|Double-blind Treatment Phase||63
458613|NCT00578305|1093752|P2|STARTED|Double-blind Treatment Phase||60
458614|NCT00578305|1093753|P1|STARTED|Double-blind Treatment Phase||62
458615|NCT00578279|1093814|P2|NOT COMPLETED|Overall Study||0
458616|NCT00578279|1093815|P1|NOT COMPLETED|Overall Study||0
458617|NCT00578279|1093814|P2|COMPLETED|Overall Study||10
458618|NCT00578279|1093815|P1|COMPLETED|Overall Study||10
458619|NCT00578279|1093814|P2|STARTED|Overall Study||10
458620|NCT00578279|1093815|P1|STARTED|Overall Study||10
458621|NCT00578227|1093824|P3|NOT COMPLETED|Overall Study||4
458622|NCT00578227|1093825|P2|NOT COMPLETED|Overall Study||2
458623|NCT00578227|1093826|P1|NOT COMPLETED|Overall Study||5
458624|NCT00578227|1093824|P3|COMPLETED|Overall Study||267
458625|NCT00578227|1093825|P2|COMPLETED|Overall Study||268
458626|NCT00578227|1093826|P1|COMPLETED|Overall Study||267
458627|NCT00578227|1093824|P3|STARTED|Overall Study||271
458628|NCT00578227|1093825|P2|STARTED|Overall Study||270
458629|NCT00578227|1093826|P1|STARTED|Overall Study||272
458630|NCT00578214|1093899|P3|NOT COMPLETED|Overall Study||0
458631|NCT00578214|1093900|P2|NOT COMPLETED|Overall Study||0
458632|NCT00578214|1093901|P1|NOT COMPLETED|Overall Study||0
458633|NCT00578214|1093899|P3|COMPLETED|Overall Study||31
458634|NCT00578214|1093900|P2|COMPLETED|Overall Study||22
458635|NCT00578214|1093901|P1|COMPLETED|Overall Study||22
458636|NCT00578214|1093899|P3|STARTED|Overall Study||31
458637|NCT00578214|1093900|P2|STARTED|Overall Study||22
458638|NCT00578214|1093901|P1|STARTED|Overall Study||22
458639|NCT00578175|1093951|P3|NOT COMPLETED|Overall Study||24
458640|NCT00578175|1093952|P2|NOT COMPLETED|Overall Study||43
458641|NCT00578175|1093953|P1|NOT COMPLETED|Overall Study||70
458642|NCT00578175|1093951|P3|COMPLETED|Overall Study||365
458643|NCT00578175|1093952|P2|COMPLETED|Overall Study||646
458644|NCT00578175|1093953|P1|COMPLETED|Overall Study||635
458645|NCT00578175|1093951|P3|STARTED|Overall Study||389
458646|NCT00578175|1093952|P2|STARTED|Overall Study||689
458647|NCT00578175|1093953|P1|STARTED|Overall Study||705
458648|NCT00578136|1094032|P2|NOT COMPLETED|Overall Study||1
458649|NCT00578136|1094033|P1|NOT COMPLETED|Overall Study||1
458650|NCT00578136|1094032|P2|COMPLETED|Overall Study||26
458651|NCT00578136|1094033|P1|COMPLETED|Overall Study||26
458652|NCT00578136|1094032|P2|STARTED|Overall Study||27
458653|NCT00578136|1094033|P1|STARTED|Overall Study||27
458654|NCT00578071|1094041|P1|NOT COMPLETED|Overall Study||0
458655|NCT00578071|1094041|P1|COMPLETED|Overall Study||29
458656|NCT00578071|1094041|P1|STARTED|Overall Study||29
458657|NCT00577889|1094051|P3|NOT COMPLETED|Overall Study||0
458658|NCT00577889|1094052|P2|NOT COMPLETED|Overall Study||0
458659|NCT00577889|1094053|P1|NOT COMPLETED|Overall Study||1
458660|NCT00577889|1094051|P3|COMPLETED|Overall Study||6
458661|NCT00577889|1094052|P2|COMPLETED|Overall Study||6
458662|NCT00577889|1094053|P1|COMPLETED|Overall Study||8
458663|NCT00577889|1094051|P3|STARTED|Overall Study||6
458664|NCT00577889|1094052|P2|STARTED|Overall Study||6
458665|NCT00577889|1094053|P1|STARTED|Overall Study||9
458666|NCT00577863|1094072|P2|NOT COMPLETED|Overall Study||14
458667|NCT00577863|1094073|P1|NOT COMPLETED|Overall Study||10
458668|NCT00577863|1094072|P2|COMPLETED|Overall Study||94
458669|NCT00577863|1094073|P1|COMPLETED|Overall Study||82
458670|NCT00577863|1094072|P2|Received at Least One Injection|Overall Study||107
458671|NCT00577863|1094073|P1|Received at Least One Injection|Overall Study||92
458672|NCT00577863|1094072|P2|STARTED|Overall Study||108
458673|NCT00577863|1094073|P1|STARTED|Overall Study||92
458674|NCT00577824|1094115|P3|NOT COMPLETED|Overall Study||2
458675|NCT00577824|1094116|P2|NOT COMPLETED|Overall Study||20
458676|NCT00577824|1094117|P1|NOT COMPLETED|Overall Study||7
458678|NCT00577824|1094116|P2|COMPLETED|Overall Study||53
458679|NCT00577824|1094117|P1|COMPLETED|Overall Study||65
458680|NCT00577824|1094115|P3|Full Analysis Set|Overall Study||35
458681|NCT00577824|1094116|P2|Full Analysis Set|Overall Study||72
458682|NCT00577824|1094117|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
458683|NCT00577824|1094115|P3|STARTED|Overall Study||36
458684|NCT00577824|1094116|P2|STARTED|Overall Study||73
458685|NCT00577824|1094117|P1|STARTED|Overall Study|Started=Randomized|72
458686|NCT00577772|1094175|P2|NOT COMPLETED|Overall Study||1
458687|NCT00577772|1094176|P1|NOT COMPLETED|Overall Study||0
458688|NCT00577772|1094175|P2|COMPLETED|Overall Study||6
458689|NCT00577772|1094176|P1|COMPLETED|Overall Study||10
458690|NCT00577772|1094175|P2|STARTED|Overall Study||7
458691|NCT00577772|1094176|P1|STARTED|Overall Study||10
458692|NCT00577720|1094186|P4|NOT COMPLETED|Overall Study||7
458693|NCT00577720|1094187|P3|NOT COMPLETED|Overall Study||1
458694|NCT00577720|1094188|P2|NOT COMPLETED|Overall Study||1
458695|NCT00577720|1094189|P1|NOT COMPLETED|Overall Study||4
458696|NCT00577720|1094186|P4|COMPLETED|Overall Study||65
458697|NCT00577720|1094187|P3|COMPLETED|Overall Study||35
458698|NCT00577720|1094188|P2|COMPLETED|Overall Study||35
458699|NCT00577720|1094189|P1|COMPLETED|Overall Study||33
458700|NCT00577720|1094186|P4|ITT (Intent to Treat) Population|Overall Study||65
458701|NCT00577720|1094187|P3|ITT (Intent to Treat) Population|Overall Study||35
458702|NCT00577720|1094188|P2|ITT (Intent to Treat) Population|Overall Study||35
458703|NCT00577720|1094189|P1|ITT (Intent to Treat) Population|Overall Study||34
458704|NCT00577720|1094186|P4|STARTED|Overall Study||72
458705|NCT00577720|1094187|P3|STARTED|Overall Study||36
458706|NCT00577720|1094188|P2|STARTED|Overall Study||36
458707|NCT00577720|1094189|P1|STARTED|Overall Study||37
458708|NCT00577707|1094207|P1|NOT COMPLETED|Overall Study||3
458709|NCT00577707|1094207|P1|COMPLETED|Overall Study||6
458710|NCT00577707|1094207|P1|STARTED|Overall Study||9
458711|NCT00577512|1094211|P1|NOT COMPLETED|Overall Study||4
458712|NCT00577512|1094211|P1|COMPLETED|Overall Study||0
458713|NCT00577512|1094211|P1|STARTED|Overall Study||4
458714|NCT00577473|1094217|P2|NOT COMPLETED|Overall Study||24
458715|NCT00577473|1094218|P1|NOT COMPLETED|Overall Study||21
458716|NCT00577473|1094217|P2|COMPLETED|Overall Study||123
458717|NCT00577473|1094218|P1|COMPLETED|Overall Study||133
458718|NCT00577473|1094217|P2|ITT Population|Overall Study||136
458719|NCT00577473|1094218|P1|ITT Population|Overall Study||150
458720|NCT00577473|1094217|P2|STARTED|Overall Study||147
458721|NCT00577473|1094218|P1|STARTED|Overall Study||154
458722|NCT00577460|1094249|P3|NOT COMPLETED|Overall Study||27
458723|NCT00577460|1094250|P2|NOT COMPLETED|Overall Study||19
458724|NCT00577460|1094251|P1|NOT COMPLETED|Overall Study||16
458725|NCT00577460|1094249|P3|COMPLETED|Overall Study||112
458726|NCT00577460|1094250|P2|COMPLETED|Overall Study||104
458727|NCT00577460|1094251|P1|COMPLETED|Overall Study||113
458728|NCT00577460|1094249|P3|STARTED|Overall Study||139
458729|NCT00577460|1094250|P2|STARTED|Overall Study||123
458730|NCT00577460|1094251|P1|STARTED|Overall Study||129
458731|NCT00577395|1094360|P2|NOT COMPLETED|Overall Study||6
458732|NCT00577395|1094361|P1|NOT COMPLETED|Overall Study||7
458733|NCT00577395|1094360|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
458734|NCT00577395|1094361|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
458735|NCT00577395|1094360|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
458736|NCT00577395|1094361|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
458737|NCT00577382|1094371|P2|NOT COMPLETED|Overall Study||31
458738|NCT00577382|1094372|P1|NOT COMPLETED|Overall Study||21
458823|NCT00576901|1094612|P1|STARTED|Overall Study||23
458739|NCT00577382|1094371|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
458740|NCT00577382|1094372|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
458741|NCT00577382|1094371|P2|STARTED|Overall Study||31
458742|NCT00577382|1094372|P1|STARTED|Overall Study||21
458743|NCT00577356|1094384|P1|NOT COMPLETED|Overall Study||0
458744|NCT00577356|1094384|P1|COMPLETED|Overall Study||6
458745|NCT00577356|1094384|P1|STARTED|Overall Study||6
458746|NCT00577135|1094392|P4|NOT COMPLETED|Overall Study||0
458747|NCT00577135|1094393|P3|NOT COMPLETED|Overall Study||0
458748|NCT00577135|1094394|P2|NOT COMPLETED|Overall Study||0
458749|NCT00577135|1094395|P1|NOT COMPLETED|Overall Study||0
458750|NCT00577135|1094392|P4|COMPLETED|Overall Study||75
458751|NCT00577135|1094393|P3|COMPLETED|Overall Study||77
458752|NCT00577135|1094394|P2|COMPLETED|Overall Study||82
458753|NCT00577135|1094395|P1|COMPLETED|Overall Study||74
458754|NCT00577135|1094392|P4|STARTED|Overall Study||75
458755|NCT00577135|1094393|P3|STARTED|Overall Study||77
458756|NCT00577135|1094394|P2|STARTED|Overall Study||82
458757|NCT00577135|1094395|P1|STARTED|Overall Study||74
458758|NCT00577122|1094515|P2|NOT COMPLETED|Overall Study||16
458759|NCT00577122|1094516|P1|NOT COMPLETED|Overall Study||14
458760|NCT00577122|1094515|P2|COMPLETED|Overall Study||0
458761|NCT00577122|1094516|P1|COMPLETED|Overall Study||0
458762|NCT00577122|1094515|P2|STARTED|Overall Study||16
458763|NCT00577122|1094516|P1|STARTED|Overall Study||14
458764|NCT00577096|1094530|P2|NOT COMPLETED|Long Term Participation||0
458765|NCT00577096|1094531|P1|NOT COMPLETED|Long Term Participation||0
458766|NCT00577096|1094530|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
458767|NCT00577096|1094531|P1|COMPLETED|Long Term Participation||34
458768|NCT00577096|1094530|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
458769|NCT00577096|1094531|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
458770|NCT00577096|1094530|P2|NOT COMPLETED|Short Term Participation||8
458771|NCT00577096|1094531|P1|NOT COMPLETED|Short Term Participation||7
458772|NCT00577096|1094530|P2|COMPLETED|Short Term Participation||58
458773|NCT00577096|1094531|P1|COMPLETED|Short Term Participation||62
458774|NCT00577096|1094530|P2|STARTED|Short Term Participation||66
458775|NCT00577096|1094531|P1|STARTED|Short Term Participation||69
458776|NCT00577083|1094557|P2|NOT COMPLETED|Second Intervention (14days)||0
458777|NCT00577083|1094558|P1|NOT COMPLETED|Second Intervention (14days)||0
458778|NCT00577083|1094557|P2|COMPLETED|Second Intervention (14days)||52
458779|NCT00577083|1094558|P1|COMPLETED|Second Intervention (14days)||48
458780|NCT00577083|1094557|P2|STARTED|Second Intervention (14days)||52
458781|NCT00577083|1094558|P1|STARTED|Second Intervention (14days)||48
458782|NCT00577083|1094557|P2|NOT COMPLETED|Washout (14 Days)||0
458783|NCT00577083|1094558|P1|NOT COMPLETED|Washout (14 Days)||0
458784|NCT00577083|1094557|P2|COMPLETED|Washout (14 Days)||52
458785|NCT00577083|1094558|P1|COMPLETED|Washout (14 Days)||48
458786|NCT00577083|1094557|P2|STARTED|Washout (14 Days)||52
458787|NCT00577083|1094558|P1|STARTED|Washout (14 Days)||48
458788|NCT00577083|1094557|P2|NOT COMPLETED|First Intervention (14 Days)||0
458789|NCT00577083|1094558|P1|NOT COMPLETED|First Intervention (14 Days)||0
458790|NCT00577083|1094557|P2|COMPLETED|First Intervention (14 Days)||52
458791|NCT00577083|1094558|P1|COMPLETED|First Intervention (14 Days)||48
458792|NCT00577083|1094557|P2|STARTED|First Intervention (14 Days)||52
458793|NCT00577083|1094558|P1|STARTED|First Intervention (14 Days)||48
458794|NCT00577031|1094564|P1|NOT COMPLETED|Overall Study||205
458795|NCT00577031|1094564|P1|COMPLETED|Overall Study||0
458796|NCT00577031|1094564|P1|STARTED|Overall Study||205
458797|NCT00577005|1094585|P2|NOT COMPLETED|Overall Study||3
458798|NCT00577005|1094586|P1|NOT COMPLETED|Overall Study||5
458799|NCT00577005|1094585|P2|COMPLETED|Overall Study||9
458800|NCT00577005|1094586|P1|COMPLETED|Overall Study||11
458801|NCT00577005|1094585|P2|STARTED|Overall Study||12
458802|NCT00577005|1094586|P1|STARTED|Overall Study||16
458803|NCT00576927|1094600|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
458804|NCT00576927|1094600|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
458805|NCT00576927|1094600|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
458806|NCT00576927|1094600|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
458807|NCT00576927|1094600|P1|COMPLETED|Sleep Hygiene With Study Drug||22
458808|NCT00576927|1094600|P1|STARTED|Sleep Hygiene With Study Drug||22
458809|NCT00576927|1094600|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
458810|NCT00576927|1094600|P1|COMPLETED|Sleep Hygiene With the Placebo||22
458811|NCT00576927|1094600|P1|STARTED|Sleep Hygiene With the Placebo||23
458812|NCT00576927|1094600|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
458813|NCT00576927|1094600|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
458814|NCT00576927|1094600|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
458815|NCT00576927|1094600|P1|NOT COMPLETED|Baseline||13
458816|NCT00576927|1094600|P1|COMPLETED|Baseline||30
458817|NCT00576927|1094600|P1|STARTED|Baseline||43
458818|NCT00576927|1094600|P1|NOT COMPLETED|Clinical Assessment||36
458819|NCT00576927|1094600|P1|COMPLETED|Clinical Assessment||43
458820|NCT00576927|1094600|P1|STARTED|Clinical Assessment||79
458821|NCT00576901|1094612|P1|NOT COMPLETED|Overall Study||3
458822|NCT00576901|1094612|P1|COMPLETED|Overall Study||20
458824|NCT00576823|1094623|P3|NOT COMPLETED|40-week Safety Extension Phase||0
458825|NCT00576823|1094624|P2|NOT COMPLETED|40-week Safety Extension Phase||0
458826|NCT00576823|1094625|P1|NOT COMPLETED|40-week Safety Extension Phase||1
458827|NCT00576823|1094623|P3|COMPLETED|40-week Safety Extension Phase||6
458828|NCT00576823|1094624|P2|COMPLETED|40-week Safety Extension Phase||6
458829|NCT00576823|1094625|P1|COMPLETED|40-week Safety Extension Phase||10
458830|NCT00576823|1094623|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
458831|NCT00576823|1094624|P2|STARTED|40-week Safety Extension Phase||6
458832|NCT00576823|1094625|P1|STARTED|40-week Safety Extension Phase||11
458833|NCT00576823|1094623|P3|NOT COMPLETED|12-week Efficacy Phase||0
458834|NCT00576823|1094624|P2|NOT COMPLETED|12-week Efficacy Phase||0
458835|NCT00576823|1094625|P1|NOT COMPLETED|12-week Efficacy Phase||1
458836|NCT00576823|1094623|P3|COMPLETED|12-week Efficacy Phase||7
458837|NCT00576823|1094624|P2|COMPLETED|12-week Efficacy Phase||6
458838|NCT00576823|1094625|P1|COMPLETED|12-week Efficacy Phase||11
458839|NCT00576823|1094623|P3|STARTED|12-week Efficacy Phase||7
458840|NCT00576823|1094624|P2|STARTED|12-week Efficacy Phase||6
458841|NCT00576823|1094625|P1|STARTED|12-week Efficacy Phase||12
458842|NCT00576758|1094641|P2|NOT COMPLETED|Follow-up Period||17
458843|NCT00576758|1094642|P1|NOT COMPLETED|Follow-up Period||27
458844|NCT00576758|1094641|P2|COMPLETED|Follow-up Period||34
458845|NCT00576758|1094642|P1|COMPLETED|Follow-up Period||28
458846|NCT00576758|1094641|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
458847|NCT00576758|1094642|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
458848|NCT00576758|1094641|P2|NOT COMPLETED|Extension Treatment Period||43
458849|NCT00576758|1094642|P1|NOT COMPLETED|Extension Treatment Period||42
458850|NCT00576758|1094641|P2|COMPLETED|Extension Treatment Period||30
458851|NCT00576758|1094642|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
458852|NCT00576758|1094641|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
458853|NCT00576758|1094642|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
458854|NCT00576758|1094641|P2|NOT COMPLETED|Induction Treatment Period||5
458855|NCT00576758|1094642|P1|NOT COMPLETED|Induction Treatment Period||8
458856|NCT00576758|1094641|P2|COMPLETED|Induction Treatment Period||83
458857|NCT00576758|1094642|P1|COMPLETED|Induction Treatment Period||79
458858|NCT00576758|1094641|P2|Received Treatment|Induction Treatment Period||87
458859|NCT00576758|1094642|P1|Received Treatment|Induction Treatment Period||86
458860|NCT00576758|1094641|P2|STARTED|Induction Treatment Period||88
458861|NCT00576758|1094642|P1|STARTED|Induction Treatment Period||87
458862|NCT00576732|1094688|P6|NOT COMPLETED|OPEN LABEL||8
458863|NCT00576732|1094689|P5|NOT COMPLETED|OPEN LABEL||4
458864|NCT00576732|1094690|P4|NOT COMPLETED|OPEN LABEL||11
458865|NCT00576732|1094691|P3|NOT COMPLETED|OPEN LABEL||0
458866|NCT00576732|1094692|P2|NOT COMPLETED|OPEN LABEL||0
458867|NCT00576732|1094693|P1|NOT COMPLETED|OPEN LABEL||0
458868|NCT00576732|1094688|P6|COMPLETED|OPEN LABEL||17
458869|NCT00576732|1094689|P5|COMPLETED|OPEN LABEL||20
458870|NCT00576732|1094690|P4|COMPLETED|OPEN LABEL||19
458871|NCT00576732|1094691|P3|COMPLETED|OPEN LABEL||0
458872|NCT00576732|1094692|P2|COMPLETED|OPEN LABEL||0
458873|NCT00576732|1094693|P1|COMPLETED|OPEN LABEL||0
458874|NCT00576732|1094688|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
458875|NCT00576732|1094689|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
458876|NCT00576732|1094690|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
458877|NCT00576732|1094691|P3|STARTED|OPEN LABEL||0
458878|NCT00576732|1094692|P2|STARTED|OPEN LABEL||0
458879|NCT00576732|1094693|P1|STARTED|OPEN LABEL||0
458880|NCT00576732|1094688|P6|NOT COMPLETED|DOUBLE BLIND||0
458881|NCT00576732|1094689|P5|NOT COMPLETED|DOUBLE BLIND||0
458882|NCT00576732|1094690|P4|NOT COMPLETED|DOUBLE BLIND||0
458883|NCT00576732|1094691|P3|NOT COMPLETED|DOUBLE BLIND||6
458884|NCT00576732|1094692|P2|NOT COMPLETED|DOUBLE BLIND||5
458885|NCT00576732|1094693|P1|NOT COMPLETED|DOUBLE BLIND||8
458886|NCT00576732|1094688|P6|COMPLETED|DOUBLE BLIND||0
458887|NCT00576732|1094689|P5|COMPLETED|DOUBLE BLIND||0
458888|NCT00576732|1094690|P4|COMPLETED|DOUBLE BLIND||0
458889|NCT00576732|1094691|P3|COMPLETED|DOUBLE BLIND||25
458890|NCT00576732|1094692|P2|COMPLETED|DOUBLE BLIND||25
458891|NCT00576732|1094693|P1|COMPLETED|DOUBLE BLIND||27
458892|NCT00576732|1094688|P6|STARTED|DOUBLE BLIND||0
458893|NCT00576732|1094689|P5|STARTED|DOUBLE BLIND||0
458894|NCT00576732|1094690|P4|STARTED|DOUBLE BLIND||0
458895|NCT00576732|1094691|P3|STARTED|DOUBLE BLIND||31
458896|NCT00576732|1094692|P2|STARTED|DOUBLE BLIND||30
458897|NCT00576732|1094693|P1|STARTED|DOUBLE BLIND||35
458898|NCT00576693|1094725|P2|NOT COMPLETED|Overall Study||24
458899|NCT00576693|1094726|P1|NOT COMPLETED|Overall Study||10
458900|NCT00576693|1094725|P2|COMPLETED|Overall Study||203
458901|NCT00576693|1094726|P1|COMPLETED|Overall Study||214
458902|NCT00576693|1094725|P2|STARTED|Overall Study||227
458903|NCT00576693|1094726|P1|STARTED|Overall Study||224
458904|NCT00576628|1094732|P1|NOT COMPLETED|Overall Study||43
458905|NCT00576628|1094732|P1|COMPLETED|Overall Study||82
458906|NCT00576628|1094732|P1|STARTED|Overall Study||125
458907|NCT00576576|1094752|P1|NOT COMPLETED|Overall Study||7
458908|NCT00576576|1094752|P1|COMPLETED|Overall Study||20
458909|NCT00576576|1094752|P1|STARTED|Overall Study||27
458910|NCT00576524|1094760|P2|NOT COMPLETED|Overall Study||0
458911|NCT00576524|1094761|P1|NOT COMPLETED|Overall Study||0
458912|NCT00576524|1094760|P2|COMPLETED|Overall Study||0
458913|NCT00576524|1094761|P1|COMPLETED|Overall Study||2
458914|NCT00576524|1094760|P2|STARTED|Overall Study||0
458915|NCT00576524|1094761|P1|STARTED|Overall Study||2
458916|NCT00576472|1094786|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
458917|NCT00576472|1094787|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
458918|NCT00576472|1094788|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
458919|NCT00576472|1094789|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
458920|NCT00576472|1094790|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
458921|NCT00576472|1094791|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
458922|NCT00576472|1094792|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
458923|NCT00576472|1094793|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
458924|NCT00576472|1094794|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
458925|NCT00576472|1094795|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
458926|NCT00576472|1094796|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
458927|NCT00576472|1094797|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
458928|NCT00576472|1094798|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
458929|NCT00576472|1094799|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
458930|NCT00576472|1094800|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
458931|NCT00576472|1094786|P15|COMPLETED|MPH Home Maintenance Phase||68
458932|NCT00576472|1094787|P14|COMPLETED|MPH Home Maintenance Phase||0
458933|NCT00576472|1094788|P13|COMPLETED|MPH Home Maintenance Phase||0
458934|NCT00576472|1094789|P12|COMPLETED|MPH Home Maintenance Phase||0
458935|NCT00576472|1094790|P11|COMPLETED|MPH Home Maintenance Phase||0
458936|NCT00576472|1094791|P10|COMPLETED|MPH Home Maintenance Phase||0
458937|NCT00576472|1094792|P9|COMPLETED|MPH Home Maintenance Phase||0
458938|NCT00576472|1094793|P8|COMPLETED|MPH Home Maintenance Phase||0
458939|NCT00576472|1094794|P7|COMPLETED|MPH Home Maintenance Phase||0
458940|NCT00576472|1094795|P6|COMPLETED|MPH Home Maintenance Phase||0
458941|NCT00576472|1094796|P5|COMPLETED|MPH Home Maintenance Phase||0
458942|NCT00576472|1094797|P4|COMPLETED|MPH Home Maintenance Phase||0
458943|NCT00576472|1094798|P3|COMPLETED|MPH Home Maintenance Phase||0
458944|NCT00576472|1094799|P2|COMPLETED|MPH Home Maintenance Phase||0
458945|NCT00576472|1094800|P1|COMPLETED|MPH Home Maintenance Phase||0
458946|NCT00576472|1094786|P15|STARTED|MPH Home Maintenance Phase||91
458947|NCT00576472|1094787|P14|STARTED|MPH Home Maintenance Phase||27
458948|NCT00576472|1094788|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458949|NCT00576472|1094789|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458950|NCT00576472|1094790|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458951|NCT00576472|1094791|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458952|NCT00576472|1094792|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458953|NCT00576472|1094793|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458954|NCT00576472|1094794|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458955|NCT00576472|1094795|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458956|NCT00576472|1094796|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458957|NCT00576472|1094797|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458958|NCT00576472|1094798|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458959|NCT00576472|1094799|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458960|NCT00576472|1094800|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
458961|NCT00576472|1094786|P15|NOT COMPLETED|MPH Cross Over Phase||0
458962|NCT00576472|1094787|P14|NOT COMPLETED|MPH Cross Over Phase||0
458963|NCT00576472|1094788|P13|NOT COMPLETED|MPH Cross Over Phase||0
458964|NCT00576472|1094789|P12|NOT COMPLETED|MPH Cross Over Phase||1
458965|NCT00576472|1094790|P11|NOT COMPLETED|MPH Cross Over Phase||1
458966|NCT00576472|1094791|P10|NOT COMPLETED|MPH Cross Over Phase||0
458967|NCT00576472|1094792|P9|NOT COMPLETED|MPH Cross Over Phase||2
458968|NCT00576472|1094793|P8|NOT COMPLETED|MPH Cross Over Phase||0
458969|NCT00576472|1094794|P7|NOT COMPLETED|MPH Cross Over Phase||12
458970|NCT00576472|1094795|P6|NOT COMPLETED|MPH Cross Over Phase||0
458971|NCT00576472|1094796|P5|NOT COMPLETED|MPH Cross Over Phase||0
458972|NCT00576472|1094797|P4|NOT COMPLETED|MPH Cross Over Phase||0
458973|NCT00576472|1094798|P3|NOT COMPLETED|MPH Cross Over Phase||0
458974|NCT00576472|1094799|P2|NOT COMPLETED|MPH Cross Over Phase||0
458975|NCT00576472|1094800|P1|NOT COMPLETED|MPH Cross Over Phase||0
458976|NCT00576472|1094786|P15|COMPLETED|MPH Cross Over Phase||0
458977|NCT00576472|1094787|P14|COMPLETED|MPH Cross Over Phase||0
458978|NCT00576472|1094788|P13|COMPLETED|MPH Cross Over Phase||21
458979|NCT00576472|1094789|P12|COMPLETED|MPH Cross Over Phase||17
458980|NCT00576472|1094790|P11|COMPLETED|MPH Cross Over Phase||22
458981|NCT00576472|1094791|P10|COMPLETED|MPH Cross Over Phase||22
458982|NCT00576472|1094792|P9|COMPLETED|MPH Cross Over Phase||16
458983|NCT00576472|1094793|P8|COMPLETED|MPH Cross Over Phase||20
458984|NCT00576472|1094794|P7|COMPLETED|MPH Cross Over Phase||0
458985|NCT00576472|1094795|P6|COMPLETED|MPH Cross Over Phase||0
458986|NCT00576472|1094796|P5|COMPLETED|MPH Cross Over Phase||0
458987|NCT00576472|1094797|P4|COMPLETED|MPH Cross Over Phase||0
458988|NCT00576472|1094798|P3|COMPLETED|MPH Cross Over Phase||0
458989|NCT00576472|1094799|P2|COMPLETED|MPH Cross Over Phase||0
458990|NCT00576472|1094800|P1|COMPLETED|MPH Cross Over Phase||0
458991|NCT00576472|1094786|P15|STARTED|MPH Cross Over Phase||0
458992|NCT00576472|1094787|P14|STARTED|MPH Cross Over Phase||0
458993|NCT00576472|1094788|P13|STARTED|MPH Cross Over Phase||21
458994|NCT00576472|1094789|P12|STARTED|MPH Cross Over Phase||18
458995|NCT00576472|1094790|P11|STARTED|MPH Cross Over Phase||23
458996|NCT00576472|1094791|P10|STARTED|MPH Cross Over Phase||22
458997|NCT00576472|1094792|P9|STARTED|MPH Cross Over Phase||18
458998|NCT00576472|1094793|P8|STARTED|MPH Cross Over Phase||20
458999|NCT00576472|1094794|P7|STARTED|MPH Cross Over Phase||12
459000|NCT00576472|1094795|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
459001|NCT00576472|1094796|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
459002|NCT00576472|1094797|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
459003|NCT00576472|1094798|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
459004|NCT00576472|1094799|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
459005|NCT00576472|1094800|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
459006|NCT00576472|1094786|P15|NOT COMPLETED|MPH In-Lab Phase||0
459007|NCT00576472|1094787|P14|NOT COMPLETED|MPH In-Lab Phase||0
459008|NCT00576472|1094788|P13|NOT COMPLETED|MPH In-Lab Phase||0
459009|NCT00576472|1094789|P12|NOT COMPLETED|MPH In-Lab Phase||0
459010|NCT00576472|1094790|P11|NOT COMPLETED|MPH In-Lab Phase||0
459011|NCT00576472|1094791|P10|NOT COMPLETED|MPH In-Lab Phase||0
459012|NCT00576472|1094792|P9|NOT COMPLETED|MPH In-Lab Phase||0
459013|NCT00576472|1094793|P8|NOT COMPLETED|MPH In-Lab Phase||0
459014|NCT00576472|1094794|P7|NOT COMPLETED|MPH In-Lab Phase||0
459015|NCT00576472|1094795|P6|NOT COMPLETED|MPH In-Lab Phase||0
459016|NCT00576472|1094796|P5|NOT COMPLETED|MPH In-Lab Phase||0
459017|NCT00576472|1094797|P4|NOT COMPLETED|MPH In-Lab Phase||335
459018|NCT00576472|1094798|P3|NOT COMPLETED|MPH In-Lab Phase||0
459019|NCT00576472|1094799|P2|NOT COMPLETED|MPH In-Lab Phase||0
459020|NCT00576472|1094800|P1|NOT COMPLETED|MPH In-Lab Phase||0
459021|NCT00576472|1094786|P15|COMPLETED|MPH In-Lab Phase||0
459022|NCT00576472|1094787|P14|COMPLETED|MPH In-Lab Phase||0
459023|NCT00576472|1094788|P13|COMPLETED|MPH In-Lab Phase||0
459024|NCT00576472|1094789|P12|COMPLETED|MPH In-Lab Phase||0
459025|NCT00576472|1094790|P11|COMPLETED|MPH In-Lab Phase||0
459026|NCT00576472|1094791|P10|COMPLETED|MPH In-Lab Phase||0
459027|NCT00576472|1094792|P9|COMPLETED|MPH In-Lab Phase||0
459028|NCT00576472|1094793|P8|COMPLETED|MPH In-Lab Phase||0
459029|NCT00576472|1094794|P7|COMPLETED|MPH In-Lab Phase||0
459030|NCT00576472|1094795|P6|COMPLETED|MPH In-Lab Phase||67
459031|NCT00576472|1094796|P5|COMPLETED|MPH In-Lab Phase||67
459032|NCT00576472|1094797|P4|COMPLETED|MPH In-Lab Phase||0
459033|NCT00576472|1094798|P3|COMPLETED|MPH In-Lab Phase||0
459034|NCT00576472|1094799|P2|COMPLETED|MPH In-Lab Phase||0
459035|NCT00576472|1094800|P1|COMPLETED|MPH In-Lab Phase||0
459036|NCT00576472|1094786|P15|STARTED|MPH In-Lab Phase||0
459037|NCT00576472|1094787|P14|STARTED|MPH In-Lab Phase||0
459038|NCT00576472|1094788|P13|STARTED|MPH In-Lab Phase||0
459039|NCT00576472|1094789|P12|STARTED|MPH In-Lab Phase||0
459040|NCT00576472|1094790|P11|STARTED|MPH In-Lab Phase||0
459041|NCT00576472|1094791|P10|STARTED|MPH In-Lab Phase||0
459042|NCT00576472|1094792|P9|STARTED|MPH In-Lab Phase||0
459043|NCT00576472|1094793|P8|STARTED|MPH In-Lab Phase||0
459044|NCT00576472|1094794|P7|STARTED|MPH In-Lab Phase||0
459045|NCT00576472|1094795|P6|STARTED|MPH In-Lab Phase||67
459046|NCT00576472|1094796|P5|STARTED|MPH In-Lab Phase||67
459047|NCT00576472|1094797|P4|STARTED|MPH In-Lab Phase||335
459048|NCT00576472|1094798|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
459049|NCT00576472|1094799|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
459050|NCT00576472|1094800|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
459051|NCT00576472|1094786|P15|NOT COMPLETED|Initial Screening||0
459052|NCT00576472|1094787|P14|NOT COMPLETED|Initial Screening||0
459053|NCT00576472|1094788|P13|NOT COMPLETED|Initial Screening||0
459054|NCT00576472|1094789|P12|NOT COMPLETED|Initial Screening||0
459055|NCT00576472|1094790|P11|NOT COMPLETED|Initial Screening||0
459056|NCT00576472|1094791|P10|NOT COMPLETED|Initial Screening||0
459057|NCT00576472|1094792|P9|NOT COMPLETED|Initial Screening||0
459058|NCT00576472|1094793|P8|NOT COMPLETED|Initial Screening||0
459059|NCT00576472|1094794|P7|NOT COMPLETED|Initial Screening||0
459060|NCT00576472|1094795|P6|NOT COMPLETED|Initial Screening||0
459061|NCT00576472|1094796|P5|NOT COMPLETED|Initial Screening||0
459062|NCT00576472|1094797|P4|NOT COMPLETED|Initial Screening||0
459063|NCT00576472|1094798|P3|NOT COMPLETED|Initial Screening||0
459064|NCT00576472|1094799|P2|NOT COMPLETED|Initial Screening||0
459065|NCT00576472|1094800|P1|NOT COMPLETED|Initial Screening||0
459066|NCT00576472|1094786|P15|COMPLETED|Initial Screening||0
459067|NCT00576472|1094787|P14|COMPLETED|Initial Screening||0
459068|NCT00576472|1094788|P13|COMPLETED|Initial Screening||0
459069|NCT00576472|1094789|P12|COMPLETED|Initial Screening||0
459070|NCT00576472|1094790|P11|COMPLETED|Initial Screening||0
459071|NCT00576472|1094791|P10|COMPLETED|Initial Screening||0
459072|NCT00576472|1094792|P9|COMPLETED|Initial Screening||0
459073|NCT00576472|1094793|P8|COMPLETED|Initial Screening||0
459074|NCT00576472|1094794|P7|COMPLETED|Initial Screening||0
459075|NCT00576472|1094795|P6|COMPLETED|Initial Screening||0
459076|NCT00576472|1094796|P5|COMPLETED|Initial Screening||0
459077|NCT00576472|1094797|P4|COMPLETED|Initial Screening||0
459078|NCT00576472|1094798|P3|COMPLETED|Initial Screening||199
459079|NCT00576472|1094799|P2|COMPLETED|Initial Screening||40
459080|NCT00576472|1094800|P1|COMPLETED|Initial Screening||230
459081|NCT00576472|1094786|P15|STARTED|Initial Screening||0
459082|NCT00576472|1094787|P14|STARTED|Initial Screening||0
459083|NCT00576472|1094788|P13|STARTED|Initial Screening||0
459084|NCT00576472|1094789|P12|STARTED|Initial Screening||0
459085|NCT00576472|1094790|P11|STARTED|Initial Screening||0
459086|NCT00576472|1094791|P10|STARTED|Initial Screening||0
459087|NCT00576472|1094792|P9|STARTED|Initial Screening||0
459088|NCT00576472|1094793|P8|STARTED|Initial Screening||0
459089|NCT00576472|1094794|P7|STARTED|Initial Screening||0
459090|NCT00576472|1094795|P6|STARTED|Initial Screening||0
459091|NCT00576472|1094796|P5|STARTED|Initial Screening||0
459092|NCT00576472|1094797|P4|STARTED|Initial Screening||0
459093|NCT00576472|1094798|P3|STARTED|Initial Screening||199
459094|NCT00576472|1094799|P2|STARTED|Initial Screening||40
459095|NCT00576472|1094800|P1|STARTED|Initial Screening||230
459096|NCT00576420|1094893|P3|NOT COMPLETED|Overall Study||1
459097|NCT00576420|1094894|P2|NOT COMPLETED|Overall Study||0
459098|NCT00576420|1094895|P1|NOT COMPLETED|Overall Study||0
459099|NCT00576420|1094893|P3|COMPLETED|Overall Study||22
459100|NCT00576420|1094894|P2|COMPLETED|Overall Study||24
459101|NCT00576420|1094895|P1|COMPLETED|Overall Study||26
459102|NCT00576420|1094893|P3|STARTED|Overall Study||23
459103|NCT00576420|1094894|P2|STARTED|Overall Study||24
459104|NCT00576420|1094895|P1|STARTED|Overall Study||26
459105|NCT00576381|1095060|P1|NOT COMPLETED|Overall Study||7
459106|NCT00576381|1095060|P1|COMPLETED|Overall Study||23
459107|NCT00576381|1095060|P1|STARTED|Overall Study||30
459108|NCT00576316|1095064|P1|NOT COMPLETED|Overall Study||20
459109|NCT00576316|1095064|P1|COMPLETED|Overall Study|Number of patients who completed study|181
459110|NCT00576316|1095064|P1|STARTED|Overall Study|Number of patients recruited|201
459111|NCT00576303|1095069|P1|NOT COMPLETED|Long Term Safety Period||16
459112|NCT00576303|1095069|P1|COMPLETED|Long Term Safety Period||162
459113|NCT00576303|1095069|P1|STARTED|Long Term Safety Period||178
459114|NCT00576303|1095069|P1|NOT COMPLETED|Efficacy Evaluation Period||5
459115|NCT00576303|1095069|P1|COMPLETED|Efficacy Evaluation Period||178
459116|NCT00576303|1095069|P1|STARTED|Efficacy Evaluation Period||183
459117|NCT00576303|1095069|P1|NOT COMPLETED|Dose Titration Period||17
459118|NCT00576303|1095069|P1|COMPLETED|Dose Titration Period||183
459119|NCT00576303|1095069|P1|STARTED|Dose Titration Period||200
459120|NCT00576251|1095080|P2|NOT COMPLETED|Overall Study||1
459121|NCT00576251|1095081|P1|NOT COMPLETED|Overall Study||1
459122|NCT00576251|1095080|P2|COMPLETED|Overall Study||111
459123|NCT00576251|1095081|P1|COMPLETED|Overall Study||108
459124|NCT00576251|1095080|P2|STARTED|Overall Study||112
459125|NCT00576251|1095081|P1|STARTED|Overall Study||109
459126|NCT00576199|1095087|P1|NOT COMPLETED|Overall Study||30
459127|NCT00576199|1095087|P1|COMPLETED|Overall Study||0
459128|NCT00576199|1095087|P1|STARTED|Overall Study||30
459129|NCT00576147|1095096|P1|NOT COMPLETED|Overall Study||0
459130|NCT00576147|1095096|P1|COMPLETED|Overall Study||431
459131|NCT00576147|1095096|P1|STARTED|Overall Study||431
459132|NCT00576056|1095100|P1|NOT COMPLETED|Overall Study||14
459133|NCT00576056|1095100|P1|COMPLETED|Overall Study||5
459134|NCT00576056|1095100|P1|STARTED|Overall Study||19
459135|NCT00575965|1095105|P1|NOT COMPLETED|Overall Study||0
459136|NCT00575965|1095105|P1|COMPLETED|Overall Study||18
459137|NCT00575965|1095105|P1|STARTED|Overall Study||18
459138|NCT00575887|1095110|P1|NOT COMPLETED|Overall Study||0
459139|NCT00575887|1095110|P1|COMPLETED|Overall Study||25
459140|NCT00575887|1095110|P1|STARTED|Overall Study||25
459141|NCT00575666|1095116|P2|NOT COMPLETED|Overall Study||3
459142|NCT00575666|1095117|P1|NOT COMPLETED|Overall Study||4
459143|NCT00575666|1095116|P2|COMPLETED|Overall Study||21
459144|NCT00575666|1095117|P1|COMPLETED|Overall Study||17
459145|NCT00575666|1095116|P2|STARTED|Overall Study||24
459146|NCT00575666|1095117|P1|STARTED|Overall Study||21
459147|NCT00575588|1095157|P2|NOT COMPLETED|Overall Study||283
459148|NCT00575588|1095158|P1|NOT COMPLETED|Overall Study||263
459149|NCT00575588|1095157|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
459150|NCT00575588|1095158|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
459151|NCT00575588|1095157|P2|STARTED|Overall Study|Randomized and treated|430
459152|NCT00575588|1095158|P1|STARTED|Overall Study|Randomized and treated|428
459153|NCT00575510|1095181|P3|NOT COMPLETED|Overall Study||17
459154|NCT00575510|1095182|P2|NOT COMPLETED|Overall Study||13
459155|NCT00575510|1095183|P1|NOT COMPLETED|Overall Study||12
459156|NCT00575510|1095181|P3|COMPLETED|Overall Study||96
459157|NCT00575510|1095182|P2|COMPLETED|Overall Study||101
459158|NCT00575510|1095183|P1|COMPLETED|Overall Study||102
459159|NCT00575510|1095181|P3|STARTED|Overall Study||113
459160|NCT00575510|1095182|P2|STARTED|Overall Study||114
459161|NCT00575510|1095183|P1|STARTED|Overall Study||114
459162|NCT00575380|1095196|P2|NOT COMPLETED|Overall Study||3
459163|NCT00575380|1095197|P1|NOT COMPLETED|Overall Study||1
459164|NCT00575380|1095196|P2|COMPLETED|Overall Study||55
459165|NCT00575380|1095197|P1|COMPLETED|Overall Study||57
459166|NCT00575380|1095196|P2|STARTED|Overall Study||58
459167|NCT00575380|1095197|P1|STARTED|Overall Study||58
459168|NCT00575367|1095207|P2|NOT COMPLETED|Overall Study||0
459169|NCT00575367|1095208|P1|NOT COMPLETED|Overall Study||0
459170|NCT00575367|1095207|P2|COMPLETED|Overall Study||18
459171|NCT00575367|1095208|P1|COMPLETED|Overall Study||19
459172|NCT00575367|1095207|P2|STARTED|Overall Study||18
459173|NCT00575367|1095208|P1|STARTED|Overall Study||19
459174|NCT00575185|1095216|P2|NOT COMPLETED|Overall Study||0
459175|NCT00575185|1095217|P1|NOT COMPLETED|Overall Study||0
459176|NCT00575185|1095216|P2|COMPLETED|Overall Study||11
459177|NCT00575185|1095217|P1|COMPLETED|Overall Study||12
459178|NCT00575185|1095216|P2|STARTED|Overall Study||11
459179|NCT00575185|1095217|P1|STARTED|Overall Study||12
459180|NCT00575146|1095225|P1|NOT COMPLETED|Overall Study||3
459181|NCT00575146|1095225|P1|COMPLETED|Overall Study||17
459182|NCT00575146|1095225|P1|STARTED|Overall Study||20
459183|NCT00575094|1095231|P1|NOT COMPLETED|Overall Study||3
459184|NCT00575094|1095231|P1|COMPLETED|Overall Study||6
459185|NCT00575094|1095231|P1|STARTED|Overall Study||9
459186|NCT00575042|1095235|P1|NOT COMPLETED|Overall Study||3
459187|NCT00575042|1095235|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
459188|NCT00575042|1095235|P1|STARTED|Overall Study||20
459189|NCT00575029|1095240|P1|NOT COMPLETED|Overall Study||0
459190|NCT00575029|1095240|P1|COMPLETED|Overall Study||7
459191|NCT00575029|1095240|P1|STARTED|Overall Study||7
459192|NCT00575016|1095249|P4|NOT COMPLETED|Treatment Cycle 2||0
459193|NCT00575016|1095250|P3|NOT COMPLETED|Treatment Cycle 2||0
459194|NCT00575016|1095251|P2|NOT COMPLETED|Treatment Cycle 2||0
459195|NCT00575016|1095252|P1|NOT COMPLETED|Treatment Cycle 2||1
459196|NCT00575016|1095249|P4|COMPLETED|Treatment Cycle 2||0
459197|NCT00575016|1095250|P3|COMPLETED|Treatment Cycle 2||0
459198|NCT00575016|1095251|P2|COMPLETED|Treatment Cycle 2||0
459199|NCT00575016|1095252|P1|COMPLETED|Treatment Cycle 2||30
459200|NCT00575016|1095249|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
459201|NCT00575016|1095250|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
459202|NCT00575016|1095251|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
459203|NCT00575016|1095252|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
459204|NCT00575016|1095249|P4|NOT COMPLETED|Treatment Cycle 1||5
459205|NCT00575016|1095250|P3|NOT COMPLETED|Treatment Cycle 1||4
459206|NCT00575016|1095251|P2|NOT COMPLETED|Treatment Cycle 1||5
459207|NCT00575016|1095252|P1|NOT COMPLETED|Treatment Cycle 1||9
459208|NCT00575016|1095249|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
459209|NCT00575016|1095250|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
459210|NCT00575016|1095251|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
459211|NCT00575016|1095252|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
459212|NCT00575016|1095249|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
459213|NCT00575016|1095250|P3|STARTED|Treatment Cycle 1||19
459214|NCT00575016|1095251|P2|STARTED|Treatment Cycle 1||21
459215|NCT00575016|1095252|P1|STARTED|Treatment Cycle 1||17
459216|NCT00574990|1095273|P3|NOT COMPLETED|Overall Study||0
459217|NCT00574990|1095274|P2|NOT COMPLETED|Overall Study||0
459218|NCT00574990|1095275|P1|NOT COMPLETED|Overall Study||0
459219|NCT00574990|1095273|P3|COMPLETED|Overall Study||8
459220|NCT00574990|1095274|P2|COMPLETED|Overall Study||19
459221|NCT00574990|1095275|P1|COMPLETED|Overall Study||12
459222|NCT00574990|1095273|P3|STARTED|Overall Study||8
459223|NCT00574990|1095274|P2|STARTED|Overall Study||19
459224|NCT00574990|1095275|P1|STARTED|Overall Study||12
459225|NCT00574912|1095286|P1|NOT COMPLETED|Overall Study||8
459226|NCT00574912|1095286|P1|COMPLETED|Overall Study||12
459227|NCT00574912|1095286|P1|Completed 2.0|Overall Study||12
459228|NCT00574912|1095286|P1|Completed 1.5|Overall Study||12
459229|NCT00574912|1095286|P1|Completed 1.0|Overall Study||12
459230|NCT00574912|1095286|P1|Completed 0.5|Overall Study||12
459231|NCT00574912|1095286|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
459232|NCT00574912|1095286|P1|STARTED|Overall Study||20
459233|NCT00574873|1095300|P2|NOT COMPLETED|Overall Study||251
459234|NCT00574873|1095301|P1|NOT COMPLETED|Overall Study||238
459235|NCT00574873|1095300|P2|COMPLETED|Overall Study||1
459236|NCT00574873|1095301|P1|COMPLETED|Overall Study||12
459237|NCT00574873|1095300|P2|Treated|Overall Study||251
459238|NCT00574873|1095301|P1|Treated|Overall Study||248
459239|NCT00574873|1095300|P2|STARTED|Overall Study||252
459240|NCT00574873|1095301|P1|STARTED|Overall Study||250
459241|NCT00574847|1095319|P2|NOT COMPLETED|Overall Study||7
459242|NCT00574847|1095320|P1|NOT COMPLETED|Overall Study||8
459243|NCT00574847|1095319|P2|COMPLETED|Overall Study||56
459244|NCT00574847|1095320|P1|COMPLETED|Overall Study||56
459245|NCT00574847|1095319|P2|STARTED|Overall Study||63
459246|NCT00574847|1095320|P1|STARTED|Overall Study||64
459247|NCT00574834|1095355|P3|NOT COMPLETED|Overall Study||0
459248|NCT00574834|1095356|P2|NOT COMPLETED|Overall Study||0
459249|NCT00574834|1095357|P1|NOT COMPLETED|Overall Study||0
459250|NCT00574834|1095355|P3|COMPLETED|Overall Study||4
459251|NCT00574834|1095356|P2|COMPLETED|Overall Study||4
459252|NCT00574834|1095357|P1|COMPLETED|Overall Study||9
459253|NCT00574834|1095355|P3|STARTED|Overall Study||4
459254|NCT00574834|1095356|P2|STARTED|Overall Study||4
459255|NCT00574834|1095357|P1|STARTED|Overall Study||9
459256|NCT00574795|1095365|P1|NOT COMPLETED|Toddler Dose||1
459257|NCT00574795|1095365|P1|COMPLETED|Toddler Dose||184
459258|NCT00574795|1095365|P1|STARTED|Toddler Dose||185
459259|NCT00574795|1095365|P1|NOT COMPLETED|After Infant Series||3
459260|NCT00574795|1095365|P1|COMPLETED|After Infant Series||185
459261|NCT00574795|1095365|P1|STARTED|After Infant Series||188
459262|NCT00574795|1095365|P1|NOT COMPLETED|Infant Series||5
459263|NCT00574795|1095365|P1|COMPLETED|Infant Series||188
459264|NCT00574795|1095365|P1|Vaccinated Dose 3|Infant Series||190
459265|NCT00574795|1095365|P1|Vaccinated Dose 2|Infant Series||190
459266|NCT00574795|1095365|P1|Vaccinated Dose 1|Infant Series||193
459267|NCT00574795|1095365|P1|STARTED|Infant Series||193
459268|NCT00574704|1095386|P4|NOT COMPLETED|Overall Study||0
459269|NCT00574704|1095387|P3|NOT COMPLETED|Overall Study||1
459270|NCT00574704|1095388|P2|NOT COMPLETED|Overall Study||0
459271|NCT00574704|1095389|P1|NOT COMPLETED|Overall Study||0
459272|NCT00574704|1095386|P4|COMPLETED|Overall Study||10
459273|NCT00574704|1095387|P3|COMPLETED|Overall Study||9
459274|NCT00574704|1095388|P2|COMPLETED|Overall Study||10
459275|NCT00574704|1095389|P1|COMPLETED|Overall Study||10
459276|NCT00574704|1095386|P4|STARTED|Overall Study||10
459277|NCT00574704|1095387|P3|STARTED|Overall Study||10
459278|NCT00574704|1095388|P2|STARTED|Overall Study||10
459279|NCT00574704|1095389|P1|STARTED|Overall Study||10
459280|NCT00574548|1095401|P2|NOT COMPLETED|Overall Study||16
459281|NCT00574548|1095402|P1|NOT COMPLETED|Overall Study||61
459282|NCT00574548|1095401|P2|COMPLETED|Overall Study||222
459283|NCT00574548|1095402|P1|COMPLETED|Overall Study||421
459284|NCT00574548|1095401|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
459285|NCT00574548|1095402|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
459286|NCT00574548|1095401|P2|Received Vax 2|Overall Study||223
459287|NCT00574548|1095402|P1|Received Vax 2|Overall Study||427
459288|NCT00574548|1095401|P2|Withdrawn Before Vax 2|Overall Study||11
459289|NCT00574548|1095402|P1|Withdrawn Before Vax 2|Overall Study||41
459290|NCT00574548|1095401|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
459291|NCT00574548|1095402|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
459292|NCT00574548|1095401|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
459293|NCT00574548|1095402|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
459294|NCT00574548|1095401|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
459295|NCT00574548|1095402|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
459296|NCT00574548|1095401|P2|STARTED|Overall Study||238
459297|NCT00574548|1095402|P1|STARTED|Overall Study||482
459298|NCT00574405|1095448|P2|NOT COMPLETED|Overall Study||2
459299|NCT00574405|1095449|P1|NOT COMPLETED|Overall Study||3
459300|NCT00574405|1095448|P2|COMPLETED|Overall Study||10
459301|NCT00574405|1095449|P1|COMPLETED|Overall Study||9
459302|NCT00574405|1095448|P2|STARTED|Overall Study||12
459303|NCT00574405|1095449|P1|STARTED|Overall Study||12
459304|NCT00574340|1095455|P2|NOT COMPLETED|Study 2 (2 Days)||0
459305|NCT00574340|1095456|P1|NOT COMPLETED|Study 2 (2 Days)||0
459306|NCT00574340|1095455|P2|COMPLETED|Study 2 (2 Days)||6
459307|NCT00574340|1095456|P1|COMPLETED|Study 2 (2 Days)||6
459308|NCT00574340|1095455|P2|STARTED|Study 2 (2 Days)||6
459309|NCT00574340|1095456|P1|STARTED|Study 2 (2 Days)||6
459310|NCT00574340|1095455|P2|NOT COMPLETED|Study 1 (2 Days)||0
459311|NCT00574340|1095456|P1|NOT COMPLETED|Study 1 (2 Days)||0
459312|NCT00574340|1095455|P2|COMPLETED|Study 1 (2 Days)||10
459313|NCT00574340|1095456|P1|COMPLETED|Study 1 (2 Days)||10
459314|NCT00574340|1095455|P2|STARTED|Study 1 (2 Days)||10
459315|NCT00574340|1095456|P1|STARTED|Study 1 (2 Days)||10
459316|NCT00574288|1095469|P7|NOT COMPLETED|Overall Study||42
459317|NCT00574288|1095470|P6|NOT COMPLETED|Overall Study||30
459318|NCT00574288|1095471|P5|NOT COMPLETED|Overall Study||1
459319|NCT00574288|1095472|P4|NOT COMPLETED|Overall Study||2
459320|NCT00574288|1095473|P3|NOT COMPLETED|Overall Study||0
459321|NCT00574288|1095474|P2|NOT COMPLETED|Overall Study||1
459322|NCT00574288|1095475|P1|NOT COMPLETED|Overall Study||13
459323|NCT00574288|1095469|P7|COMPLETED|Overall Study||0
459324|NCT00574288|1095470|P6|COMPLETED|Overall Study||0
459325|NCT00574288|1095471|P5|COMPLETED|Overall Study||2
459326|NCT00574288|1095472|P4|COMPLETED|Overall Study||1
459327|NCT00574288|1095473|P3|COMPLETED|Overall Study||3
459328|NCT00574288|1095474|P2|COMPLETED|Overall Study||2
459329|NCT00574288|1095475|P1|COMPLETED|Overall Study||7
459330|NCT00574288|1095469|P7|STARTED|Overall Study||42
459331|NCT00574288|1095470|P6|STARTED|Overall Study||30
459332|NCT00574288|1095471|P5|STARTED|Overall Study||3
459333|NCT00574288|1095472|P4|STARTED|Overall Study||3
459334|NCT00574288|1095473|P3|STARTED|Overall Study||3
459335|NCT00574288|1095474|P2|STARTED|Overall Study||3
459336|NCT00574288|1095475|P1|STARTED|Overall Study||20
459337|NCT00574275|1095513|P2|NOT COMPLETED|Overall Study||271
459338|NCT00574275|1095514|P1|NOT COMPLETED|Overall Study||275
459339|NCT00574275|1095513|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
459340|NCT00574275|1095514|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
459341|NCT00574275|1095513|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
459342|NCT00574275|1095514|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
459343|NCT00574275|1095513|P2|TREATED|Overall Study||268
459344|NCT00574275|1095514|P1|TREATED|Overall Study||273
459345|NCT00574275|1095513|P2|STARTED|Overall Study||271
459346|NCT00574275|1095514|P1|STARTED|Overall Study||275
459347|NCT00574249|1095532|P2|NOT COMPLETED|Overall Study||28
459348|NCT00574249|1095533|P1|NOT COMPLETED|Overall Study||26
459349|NCT00574249|1095532|P2|COMPLETED|Overall Study||338
459350|NCT00574249|1095533|P1|COMPLETED|Overall Study||338
459351|NCT00574249|1095532|P2|STARTED|Overall Study||366
459352|NCT00574249|1095533|P1|STARTED|Overall Study||364
459353|NCT00574171|1095573|P1|NOT COMPLETED|Overall Study||0
459354|NCT00574171|1095573|P1|COMPLETED|Overall Study||29
459355|NCT00574171|1095573|P1|STARTED|Overall Study||29
459356|NCT00574145|1095579|P2|NOT COMPLETED|Overall Study||1
459357|NCT00574145|1095580|P1|NOT COMPLETED|Overall Study||2
459358|NCT00574145|1095579|P2|COMPLETED|Overall Study||21
459359|NCT00574145|1095580|P1|COMPLETED|Overall Study||20
459360|NCT00574145|1095579|P2|STARTED|Overall Study||22
459361|NCT00574145|1095580|P1|STARTED|Overall Study||22
459362|NCT00574080|1095592|P2|NOT COMPLETED|Overall Study||10
459363|NCT00574080|1095593|P1|NOT COMPLETED|Overall Study||10
459364|NCT00574080|1095592|P2|COMPLETED|Overall Study||0
459365|NCT00574080|1095593|P1|COMPLETED|Overall Study||0
459366|NCT00574080|1095592|P2|STARTED|Overall Study||10
459367|NCT00574080|1095593|P1|STARTED|Overall Study||10
459368|NCT00574067|1095602|P4|NOT COMPLETED|Overall Study||0
459369|NCT00574067|1095603|P3|NOT COMPLETED|Overall Study||0
459370|NCT00574067|1095604|P2|NOT COMPLETED|Overall Study||1
459371|NCT00574067|1095605|P1|NOT COMPLETED|Overall Study||1
459372|NCT00574067|1095602|P4|COMPLETED|Overall Study||53
459373|NCT00574067|1095603|P3|COMPLETED|Overall Study||54
459374|NCT00574067|1095604|P2|COMPLETED|Overall Study||52
459375|NCT00574067|1095605|P1|COMPLETED|Overall Study||52
459376|NCT00574067|1095602|P4|STARTED|Overall Study||53
459377|NCT00574067|1095603|P3|STARTED|Overall Study||54
459378|NCT00574067|1095604|P2|STARTED|Overall Study||53
459379|NCT00574067|1095605|P1|STARTED|Overall Study||53
459380|NCT00573937|1095641|P2|NOT COMPLETED|Overall Study||1
459381|NCT00573937|1095642|P1|NOT COMPLETED|Overall Study||0
459382|NCT00573937|1095641|P2|COMPLETED|Overall Study||0
459383|NCT00573937|1095642|P1|COMPLETED|Overall Study||0
459384|NCT00573937|1095641|P2|STARTED|Overall Study||1
459385|NCT00573937|1095642|P1|STARTED|Overall Study||0
459386|NCT00573859|1095650|P1|NOT COMPLETED|Smoking Versus Abstinence||12
459387|NCT00573859|1095650|P1|COMPLETED|Smoking Versus Abstinence||15
459388|NCT00573859|1095650|P1|STARTED|Smoking Versus Abstinence||27
459389|NCT00573859|1095650|P1|NOT COMPLETED|Medication Versus Placebo||12
459390|NCT00573859|1095650|P1|COMPLETED|Medication Versus Placebo||15
459391|NCT00573859|1095650|P1|STARTED|Medication Versus Placebo||27
459392|NCT00573768|1095659|P3|NOT COMPLETED|Overall Study||4
459393|NCT00573768|1095660|P2|NOT COMPLETED|Overall Study||2
459394|NCT00573768|1095661|P1|NOT COMPLETED|Overall Study||2
459395|NCT00573768|1095659|P3|COMPLETED|Overall Study||87
459396|NCT00573768|1095660|P2|COMPLETED|Overall Study||89
459397|NCT00573768|1095661|P1|COMPLETED|Overall Study||87
459398|NCT00573768|1095659|P3|STARTED|Overall Study||91
459399|NCT00573768|1095660|P2|STARTED|Overall Study||91
459400|NCT00573768|1095661|P1|STARTED|Overall Study||89
459401|NCT00573755|1095671|P2|NOT COMPLETED|Overall Study||0
459402|NCT00573755|1095672|P1|NOT COMPLETED|Overall Study||1
459403|NCT00573755|1095671|P2|COMPLETED|Overall Study||2
459404|NCT00573755|1095672|P1|COMPLETED|Overall Study||1
459405|NCT00573755|1095671|P2|STARTED|Overall Study||2
459406|NCT00573755|1095672|P1|STARTED|Overall Study||2
459407|NCT00573534|1095688|P1|NOT COMPLETED|Overall Study||3
459408|NCT00573534|1095688|P1|COMPLETED|Overall Study||5
459409|NCT00573534|1095688|P1|STARTED|Overall Study||8
459410|NCT00573508|1095695|P2|NOT COMPLETED|Overall Study||41
459411|NCT00573508|1095696|P1|NOT COMPLETED|Overall Study||64
459412|NCT00573508|1095695|P2|COMPLETED|Overall Study||345
459413|NCT00573508|1095696|P1|COMPLETED|Overall Study||318
459414|NCT00573508|1095695|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
459415|NCT00573508|1095696|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
459416|NCT00573508|1095695|P2|STARTED|Overall Study||386
459417|NCT00573508|1095696|P1|STARTED|Overall Study||382
459418|NCT00573469|1095729|P3|NOT COMPLETED|Overall Study||4
459419|NCT00573469|1095730|P2|NOT COMPLETED|Overall Study||4
459420|NCT00573469|1095731|P1|NOT COMPLETED|Overall Study||6
459421|NCT00573469|1095729|P3|COMPLETED|Overall Study||22
459422|NCT00573469|1095730|P2|COMPLETED|Overall Study||21
459423|NCT00573469|1095731|P1|COMPLETED|Overall Study||20
459424|NCT00573469|1095729|P3|STARTED|Overall Study||26
459425|NCT00573469|1095730|P2|STARTED|Overall Study||25
459426|NCT00573469|1095731|P1|STARTED|Overall Study||26
459427|NCT00573443|1095754|P3|NOT COMPLETED|Open-Label Extension Phase||0
459428|NCT00573443|1095755|P2|NOT COMPLETED|Open-Label Extension Phase||0
459429|NCT00573443|1095756|P1|NOT COMPLETED|Open-Label Extension Phase||18
459430|NCT00573443|1095754|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459431|NCT00573443|1095755|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459432|NCT00573443|1095756|P1|COMPLETED|Open-Label Extension Phase||235
459433|NCT00573443|1095754|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459434|NCT00573443|1095755|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459435|NCT00573443|1095756|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
459436|NCT00573443|1095754|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459437|NCT00573443|1095755|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459438|NCT00573443|1095756|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
459439|NCT00573443|1095754|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459440|NCT00573443|1095755|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
459441|NCT00573443|1095756|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
459442|NCT00573443|1095754|P3|NOT COMPLETED|Double-Blind Phase||15
459443|NCT00573443|1095755|P2|NOT COMPLETED|Double-Blind Phase||19
459444|NCT00573443|1095756|P1|NOT COMPLETED|Double-Blind Phase||9
459445|NCT00573443|1095754|P3|COMPLETED|Double-Blind Phase||94
459446|NCT00573443|1095755|P2|COMPLETED|Double-Blind Phase||88
459447|NCT00573443|1095756|P1|COMPLETED|Double-Blind Phase||101
459448|NCT00573443|1095754|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
459449|NCT00573443|1095755|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
459540|NCT00573170|1095896|P6|STARTED|Second Washout Period||55
459450|NCT00573443|1095756|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
459451|NCT00573443|1095754|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
459452|NCT00573443|1095755|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
459453|NCT00573443|1095756|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
459454|NCT00573443|1095754|P3|STARTED|Double-Blind Phase||109
459455|NCT00573443|1095755|P2|STARTED|Double-Blind Phase||107
459456|NCT00573443|1095756|P1|STARTED|Double-Blind Phase||110
459457|NCT00573430|1095786|P3|NOT COMPLETED|Overall Study||10
459458|NCT00573430|1095787|P2|NOT COMPLETED|Overall Study||5
459459|NCT00573430|1095788|P1|NOT COMPLETED|Overall Study||1
459460|NCT00573430|1095786|P3|COMPLETED|Overall Study||33
459461|NCT00573430|1095787|P2|COMPLETED|Overall Study||40
459462|NCT00573430|1095788|P1|COMPLETED|Overall Study||39
459463|NCT00573430|1095786|P3|STARTED|Overall Study|randomized|43
459464|NCT00573430|1095787|P2|STARTED|Overall Study|randomized|45
459465|NCT00573430|1095788|P1|STARTED|Overall Study|randomized|40
459466|NCT00573391|1095810|P2|NOT COMPLETED|Overall Study||2
459467|NCT00573391|1095811|P1|NOT COMPLETED|Overall Study||3
459468|NCT00573391|1095810|P2|COMPLETED|Overall Study||0
459469|NCT00573391|1095811|P1|COMPLETED|Overall Study||0
459470|NCT00573391|1095810|P2|STARTED|Overall Study||2
459471|NCT00573391|1095811|P1|STARTED|Overall Study||3
459472|NCT00573313|1095821|P4|NOT COMPLETED|Overall Study||0
459473|NCT00573313|1095822|P3|NOT COMPLETED|Overall Study||6
459474|NCT00573313|1095823|P2|NOT COMPLETED|Overall Study||0
459475|NCT00573313|1095824|P1|NOT COMPLETED|Overall Study||5
459476|NCT00573313|1095821|P4|COMPLETED|Overall Study||26
459477|NCT00573313|1095822|P3|COMPLETED|Overall Study||13
459478|NCT00573313|1095823|P2|COMPLETED|Overall Study||28
459479|NCT00573313|1095824|P1|COMPLETED|Overall Study||13
459480|NCT00573313|1095821|P4|STARTED|Overall Study||26
459481|NCT00573313|1095822|P3|STARTED|Overall Study|Nineteen recruited to start.|19
459482|NCT00573313|1095823|P2|STARTED|Overall Study||28
459483|NCT00573313|1095824|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
459484|NCT00573287|1095834|P2|NOT COMPLETED|Overall Study||3
459485|NCT00573287|1095835|P1|NOT COMPLETED|Overall Study||4
459486|NCT00573287|1095834|P2|COMPLETED|Overall Study||4
459487|NCT00573287|1095835|P1|COMPLETED|Overall Study||3
459488|NCT00573287|1095834|P2|STARTED|Overall Study||7
459489|NCT00573287|1095835|P1|STARTED|Overall Study||7
459490|NCT00573261|1095843|P2|NOT COMPLETED|Overall Study||5
459491|NCT00573261|1095844|P1|NOT COMPLETED|Overall Study||6
459492|NCT00573261|1095843|P2|COMPLETED|Overall Study||15
459493|NCT00573261|1095844|P1|COMPLETED|Overall Study||14
459494|NCT00573261|1095843|P2|STARTED|Overall Study||20
459495|NCT00573261|1095844|P1|STARTED|Overall Study||20
459496|NCT00573248|1095872|P2|NOT COMPLETED|Overall Study||11
459497|NCT00573248|1095873|P1|NOT COMPLETED|Overall Study||15
459498|NCT00573248|1095872|P2|COMPLETED|Overall Study||27
459499|NCT00573248|1095873|P1|COMPLETED|Overall Study||25
459500|NCT00573248|1095872|P2|Nicotine Patches and Placebo Patches|Overall Study||27
459501|NCT00573248|1095873|P1|Nicotine Patches and Placebo Patches|Overall Study||25
459502|NCT00573248|1095872|P2|STARTED|Overall Study||38
459503|NCT00573248|1095873|P1|STARTED|Overall Study||40
459504|NCT00573183|1095887|P2|NOT COMPLETED|Overall Study||63
459505|NCT00573183|1095888|P1|NOT COMPLETED|Overall Study||72
459506|NCT00573183|1095887|P2|COMPLETED|Overall Study||174
459507|NCT00573183|1095888|P1|COMPLETED|Overall Study||162
459508|NCT00573183|1095887|P2|STARTED|Overall Study||237
459509|NCT00573183|1095888|P1|STARTED|Overall Study||234
459510|NCT00573170|1095896|P6|NOT COMPLETED|Third Treatment Period||2
459511|NCT00573170|1095897|P5|NOT COMPLETED|Third Treatment Period||0
459512|NCT00573170|1095898|P4|NOT COMPLETED|Third Treatment Period||0
459513|NCT00573170|1095899|P3|NOT COMPLETED|Third Treatment Period||0
459514|NCT00573170|1095900|P2|NOT COMPLETED|Third Treatment Period||0
459515|NCT00573170|1095901|P1|NOT COMPLETED|Third Treatment Period||1
459516|NCT00573170|1095896|P6|COMPLETED|Third Treatment Period||51
459517|NCT00573170|1095897|P5|COMPLETED|Third Treatment Period||51
459518|NCT00573170|1095898|P4|COMPLETED|Third Treatment Period||56
459519|NCT00573170|1095899|P3|COMPLETED|Third Treatment Period||55
459520|NCT00573170|1095900|P2|COMPLETED|Third Treatment Period||54
459521|NCT00573170|1095901|P1|COMPLETED|Third Treatment Period||50
459522|NCT00573170|1095896|P6|STARTED|Third Treatment Period||53
459523|NCT00573170|1095897|P5|STARTED|Third Treatment Period||51
459524|NCT00573170|1095898|P4|STARTED|Third Treatment Period||56
459525|NCT00573170|1095899|P3|STARTED|Third Treatment Period||55
459526|NCT00573170|1095900|P2|STARTED|Third Treatment Period||54
459527|NCT00573170|1095901|P1|STARTED|Third Treatment Period||51
459528|NCT00573170|1095896|P6|NOT COMPLETED|Second Washout Period||2
459529|NCT00573170|1095897|P5|NOT COMPLETED|Second Washout Period||8
459530|NCT00573170|1095898|P4|NOT COMPLETED|Second Washout Period||5
459531|NCT00573170|1095899|P3|NOT COMPLETED|Second Washout Period||4
459532|NCT00573170|1095900|P2|NOT COMPLETED|Second Washout Period||4
459533|NCT00573170|1095901|P1|NOT COMPLETED|Second Washout Period||5
459534|NCT00573170|1095896|P6|COMPLETED|Second Washout Period||53
459535|NCT00573170|1095897|P5|COMPLETED|Second Washout Period||51
459536|NCT00573170|1095898|P4|COMPLETED|Second Washout Period||56
459537|NCT00573170|1095899|P3|COMPLETED|Second Washout Period||55
459538|NCT00573170|1095900|P2|COMPLETED|Second Washout Period||54
459539|NCT00573170|1095901|P1|COMPLETED|Second Washout Period||51
459541|NCT00573170|1095897|P5|STARTED|Second Washout Period||59
459542|NCT00573170|1095898|P4|STARTED|Second Washout Period||61
459543|NCT00573170|1095899|P3|STARTED|Second Washout Period||59
459544|NCT00573170|1095900|P2|STARTED|Second Washout Period||58
459545|NCT00573170|1095901|P1|STARTED|Second Washout Period||56
459546|NCT00573170|1095896|P6|NOT COMPLETED|Second Treatment Period||0
459547|NCT00573170|1095897|P5|NOT COMPLETED|Second Treatment Period||0
459548|NCT00573170|1095898|P4|NOT COMPLETED|Second Treatment Period||0
459549|NCT00573170|1095899|P3|NOT COMPLETED|Second Treatment Period||0
459550|NCT00573170|1095900|P2|NOT COMPLETED|Second Treatment Period||0
459551|NCT00573170|1095901|P1|NOT COMPLETED|Second Treatment Period||0
459552|NCT00573170|1095896|P6|COMPLETED|Second Treatment Period||55
459553|NCT00573170|1095897|P5|COMPLETED|Second Treatment Period||59
459554|NCT00573170|1095898|P4|COMPLETED|Second Treatment Period||61
459555|NCT00573170|1095899|P3|COMPLETED|Second Treatment Period||59
459556|NCT00573170|1095900|P2|COMPLETED|Second Treatment Period||58
459557|NCT00573170|1095901|P1|COMPLETED|Second Treatment Period||56
459558|NCT00573170|1095896|P6|STARTED|Second Treatment Period||55
459559|NCT00573170|1095897|P5|STARTED|Second Treatment Period||59
459560|NCT00573170|1095898|P4|STARTED|Second Treatment Period||61
459561|NCT00573170|1095899|P3|STARTED|Second Treatment Period||59
459562|NCT00573170|1095900|P2|STARTED|Second Treatment Period||58
459563|NCT00573170|1095901|P1|STARTED|Second Treatment Period||56
459564|NCT00573170|1095896|P6|NOT COMPLETED|First Washout Period||7
459565|NCT00573170|1095897|P5|NOT COMPLETED|First Washout Period||3
459566|NCT00573170|1095898|P4|NOT COMPLETED|First Washout Period||5
459567|NCT00573170|1095899|P3|NOT COMPLETED|First Washout Period||1
459568|NCT00573170|1095900|P2|NOT COMPLETED|First Washout Period||2
459569|NCT00573170|1095901|P1|NOT COMPLETED|First Washout Period||8
459570|NCT00573170|1095896|P6|COMPLETED|First Washout Period||55
459571|NCT00573170|1095897|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
459572|NCT00573170|1095898|P4|COMPLETED|First Washout Period||61
459573|NCT00573170|1095899|P3|COMPLETED|First Washout Period||59
459574|NCT00573170|1095900|P2|COMPLETED|First Washout Period||58
459575|NCT00573170|1095901|P1|COMPLETED|First Washout Period||56
459576|NCT00573170|1095896|P6|STARTED|First Washout Period||62
459577|NCT00573170|1095897|P5|STARTED|First Washout Period||62
459578|NCT00573170|1095898|P4|STARTED|First Washout Period||66
459579|NCT00573170|1095899|P3|STARTED|First Washout Period||60
459580|NCT00573170|1095900|P2|STARTED|First Washout Period||60
459581|NCT00573170|1095901|P1|STARTED|First Washout Period||64
459582|NCT00573170|1095896|P6|NOT COMPLETED|First Treatment Period||0
459583|NCT00573170|1095897|P5|NOT COMPLETED|First Treatment Period||1
459584|NCT00573170|1095898|P4|NOT COMPLETED|First Treatment Period||0
459585|NCT00573170|1095899|P3|NOT COMPLETED|First Treatment Period||0
459586|NCT00573170|1095900|P2|NOT COMPLETED|First Treatment Period||0
459587|NCT00573170|1095901|P1|NOT COMPLETED|First Treatment Period||0
459588|NCT00573170|1095896|P6|COMPLETED|First Treatment Period||62
459589|NCT00573170|1095897|P5|COMPLETED|First Treatment Period||62
459590|NCT00573170|1095898|P4|COMPLETED|First Treatment Period||66
459591|NCT00573170|1095899|P3|COMPLETED|First Treatment Period||60
459592|NCT00573170|1095900|P2|COMPLETED|First Treatment Period||60
459593|NCT00573170|1095901|P1|COMPLETED|First Treatment Period||64
459594|NCT00573170|1095896|P6|STARTED|First Treatment Period||62
459595|NCT00573170|1095897|P5|STARTED|First Treatment Period||63
459596|NCT00573170|1095898|P4|STARTED|First Treatment Period||66
459597|NCT00573170|1095899|P3|STARTED|First Treatment Period||60
459598|NCT00573170|1095900|P2|STARTED|First Treatment Period||60
459599|NCT00573170|1095901|P1|STARTED|First Treatment Period||64
459600|NCT00573157|1095977|P2|NOT COMPLETED|Overall Study||2
459601|NCT00573157|1095978|P1|NOT COMPLETED|Overall Study||4
459602|NCT00573157|1095977|P2|COMPLETED|Overall Study||0
459603|NCT00573157|1095978|P1|COMPLETED|Overall Study||0
459604|NCT00573157|1095977|P2|STARTED|Overall Study||2
459605|NCT00573157|1095978|P1|STARTED|Overall Study||4
459606|NCT00573144|1095990|P2|NOT COMPLETED|Overall Study||3
459607|NCT00573144|1095991|P1|NOT COMPLETED|Overall Study||2
459608|NCT00573144|1095990|P2|COMPLETED|Overall Study||25
459609|NCT00573144|1095991|P1|COMPLETED|Overall Study||28
459610|NCT00573144|1095990|P2|STARTED|Overall Study||28
459611|NCT00573144|1095991|P1|STARTED|Overall Study||30
459612|NCT00573131|1096003|P2|NOT COMPLETED|Overall Study||8
459613|NCT00573131|1096004|P1|NOT COMPLETED|Overall Study||10
459614|NCT00573131|1096003|P2|COMPLETED|Overall Study||57
459615|NCT00573131|1096004|P1|COMPLETED|Overall Study||62
459616|NCT00573131|1096003|P2|STARTED|Overall Study||65
459617|NCT00573131|1096004|P1|STARTED|Overall Study||72
459618|NCT00573066|1096010|P1|NOT COMPLETED|Overall Study||20
459619|NCT00573066|1096010|P1|COMPLETED|Overall Study||36
459620|NCT00573066|1096010|P1|STARTED|Overall Study||56
459621|NCT00572910|1096020|P11|NOT COMPLETED|Overall Study||3
459622|NCT00572910|1096021|P10|NOT COMPLETED|Overall Study||6
459623|NCT00572910|1096022|P9|NOT COMPLETED|Overall Study||3
459624|NCT00572910|1096023|P8|NOT COMPLETED|Overall Study||4
459625|NCT00572910|1096024|P7|NOT COMPLETED|Overall Study||4
459626|NCT00572910|1096025|P6|NOT COMPLETED|Overall Study||3
459627|NCT00572910|1096026|P5|NOT COMPLETED|Overall Study||2
459628|NCT00572910|1096027|P4|NOT COMPLETED|Overall Study||4
459629|NCT00572910|1096028|P3|NOT COMPLETED|Overall Study||2
459630|NCT00572910|1096029|P2|NOT COMPLETED|Overall Study||3
459631|NCT00572910|1096030|P1|NOT COMPLETED|Overall Study||4
459632|NCT00572910|1096020|P11|COMPLETED|Overall Study||15
459633|NCT00572910|1096021|P10|COMPLETED|Overall Study||13
459634|NCT00572910|1096022|P9|COMPLETED|Overall Study||16
459635|NCT00572910|1096023|P8|COMPLETED|Overall Study||15
459636|NCT00572910|1096024|P7|COMPLETED|Overall Study||15
459637|NCT00572910|1096025|P6|COMPLETED|Overall Study||16
459638|NCT00572910|1096026|P5|COMPLETED|Overall Study||17
459639|NCT00572910|1096027|P4|COMPLETED|Overall Study||14
459640|NCT00572910|1096028|P3|COMPLETED|Overall Study||17
459641|NCT00572910|1096029|P2|COMPLETED|Overall Study||15
459642|NCT00572910|1096030|P1|COMPLETED|Overall Study||15
459643|NCT00572910|1096020|P11|STARTED|Overall Study||18
459644|NCT00572910|1096021|P10|STARTED|Overall Study||19
459645|NCT00572910|1096022|P9|STARTED|Overall Study||19
459646|NCT00572910|1096023|P8|STARTED|Overall Study||19
459647|NCT00572910|1096024|P7|STARTED|Overall Study||19
459648|NCT00572910|1096025|P6|STARTED|Overall Study||19
459649|NCT00572910|1096026|P5|STARTED|Overall Study||19
459650|NCT00572910|1096027|P4|STARTED|Overall Study||18
459651|NCT00572910|1096028|P3|STARTED|Overall Study||19
459652|NCT00572910|1096029|P2|STARTED|Overall Study||18
459653|NCT00572910|1096030|P1|STARTED|Overall Study||19
459654|NCT00572897|1096078|P2|NOT COMPLETED|Overall Study||0
459655|NCT00572897|1096079|P1|NOT COMPLETED|Overall Study||0
459656|NCT00572897|1096078|P2|COMPLETED|Overall Study||34
459657|NCT00572897|1096079|P1|COMPLETED|Overall Study||32
459658|NCT00572897|1096078|P2|STARTED|Overall Study||34
459659|NCT00572897|1096079|P1|STARTED|Overall Study||32
459660|NCT00572832|1096097|P2|NOT COMPLETED|Overall Study||12
459661|NCT00572832|1096098|P1|NOT COMPLETED|Overall Study||0
459662|NCT00572832|1096097|P2|COMPLETED|Overall Study||88
459663|NCT00572832|1096098|P1|COMPLETED|Overall Study||100
459664|NCT00572832|1096097|P2|STARTED|Overall Study||100
459665|NCT00572832|1096098|P1|STARTED|Overall Study||100
459666|NCT00572728|1096104|P1|NOT COMPLETED|Overall Study||39
459667|NCT00572728|1096104|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
459668|NCT00572728|1096104|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
459669|NCT00572728|1096104|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
459670|NCT00572728|1096104|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
459671|NCT00572728|1096104|P1|Pathology Complete|Overall Study||51
459672|NCT00572728|1096104|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
459673|NCT00572728|1096104|P1|Second Chemotherapy Initiated|Overall Study||59
459674|NCT00572728|1096104|P1|Completed FLT2 Scan|Overall Study||60
459675|NCT00572728|1096104|P1|First Therapy Initiated|Overall Study||65
459676|NCT00572728|1096104|P1|Completed FLT1 Scan|Overall Study||67
459677|NCT00572728|1096104|P1|On Study|Overall Study||71
459678|NCT00572728|1096104|P1|Did Not Withdraw|Overall Study||72
459679|NCT00572728|1096104|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
459680|NCT00572728|1096104|P1|Eligible|Overall Study||87
459681|NCT00572728|1096104|P1|STARTED|Overall Study|Registered|90
459682|NCT00572624|1096118|P2|NOT COMPLETED|Overall Study||4
459683|NCT00572624|1096119|P1|NOT COMPLETED|Overall Study||17
459684|NCT00572624|1096118|P2|COMPLETED|Overall Study||10
459685|NCT00572624|1096119|P1|COMPLETED|Overall Study||20
459686|NCT00572624|1096118|P2|STARTED|Overall Study||14
459687|NCT00572624|1096119|P1|STARTED|Overall Study||37
459688|NCT00572572|1096147|P2|NOT COMPLETED|Overall Study||6
459689|NCT00572572|1096148|P1|NOT COMPLETED|Overall Study||3
459690|NCT00572572|1096147|P2|COMPLETED|Overall Study||28
459691|NCT00572572|1096148|P1|COMPLETED|Overall Study||32
459692|NCT00572572|1096147|P2|STARTED|Overall Study||34
459693|NCT00572572|1096148|P1|STARTED|Overall Study||35
459694|NCT00572533|1096166|P2|NOT COMPLETED|Overall Study||3
459695|NCT00572533|1096167|P1|NOT COMPLETED|Overall Study||7
459696|NCT00572533|1096166|P2|COMPLETED|Overall Study||28
459697|NCT00572533|1096167|P1|COMPLETED|Overall Study||24
459698|NCT00572533|1096166|P2|STARTED|Overall Study||31
459699|NCT00572533|1096167|P1|STARTED|Overall Study||31
459700|NCT00572260|1096187|P1|NOT COMPLETED|Overall Study||0
459701|NCT00572260|1096187|P1|COMPLETED|Overall Study||11
459702|NCT00572260|1096187|P1|STARTED|Overall Study||11
459703|NCT00572156|1096195|P4|NOT COMPLETED|Overall Study||25
459704|NCT00572156|1096196|P3|NOT COMPLETED|Overall Study||27
459705|NCT00572156|1096197|P2|NOT COMPLETED|Overall Study||26
459706|NCT00572156|1096198|P1|NOT COMPLETED|Overall Study||26
459707|NCT00572156|1096195|P4|COMPLETED|Overall Study||1
459708|NCT00572156|1096196|P3|COMPLETED|Overall Study||0
459709|NCT00572156|1096197|P2|COMPLETED|Overall Study||1
459710|NCT00572156|1096198|P1|COMPLETED|Overall Study||0
459711|NCT00572156|1096195|P4|STARTED|Overall Study||26
459712|NCT00572156|1096196|P3|STARTED|Overall Study||27
459713|NCT00572156|1096197|P2|STARTED|Overall Study||27
459714|NCT00572156|1096198|P1|STARTED|Overall Study||26
459715|NCT00572117|1096258|P2|NOT COMPLETED|Overall Study||2
459716|NCT00572117|1096259|P1|NOT COMPLETED|Overall Study||2
459717|NCT00572117|1096258|P2|COMPLETED|Overall Study||5
459718|NCT00572117|1096259|P1|COMPLETED|Overall Study||3
459719|NCT00572117|1096258|P2|STARTED|Overall Study||7
459720|NCT00572117|1096259|P1|STARTED|Overall Study||5
459721|NCT00572039|1096269|P2|NOT COMPLETED|Overall Study||10
459722|NCT00572039|1096270|P1|NOT COMPLETED|Overall Study||16
459723|NCT00572039|1096269|P2|COMPLETED|Overall Study||110
459724|NCT00572039|1096270|P1|COMPLETED|Overall Study||105
459725|NCT00572039|1096269|P2|STARTED|Overall Study||120
459726|NCT00572039|1096270|P1|STARTED|Overall Study||121
459727|NCT00571987|1096282|P1|NOT COMPLETED|Overall Study||7
459728|NCT00571987|1096282|P1|COMPLETED|Overall Study||100
459729|NCT00571987|1096282|P1|STARTED|Overall Study||107
459730|NCT00571974|1096289|P2|NOT COMPLETED|Phase II||4
459731|NCT00571974|1096290|P1|NOT COMPLETED|Phase II||0
459732|NCT00571974|1096289|P2|COMPLETED|Phase II||17
459733|NCT00571974|1096290|P1|COMPLETED|Phase II||0
459734|NCT00571974|1096289|P2|STARTED|Phase II|3 participants are from phase I|21
459735|NCT00571974|1096290|P1|STARTED|Phase II||0
459736|NCT00571974|1096289|P2|NOT COMPLETED|Phase I||0
459737|NCT00571974|1096290|P1|NOT COMPLETED|Phase I||0
459738|NCT00571974|1096289|P2|COMPLETED|Phase I||0
459739|NCT00571974|1096290|P1|COMPLETED|Phase I||9
459740|NCT00571974|1096289|P2|STARTED|Phase I||0
459741|NCT00571974|1096290|P1|STARTED|Phase I||9
459742|NCT00571961|1096296|P1|NOT COMPLETED|Overall Study||0
459743|NCT00571961|1096296|P1|COMPLETED|Overall Study||12
459744|NCT00571961|1096296|P1|STARTED|Overall Study||12
459745|NCT00571948|1096302|P2|NOT COMPLETED|Overall Study||14
459746|NCT00571948|1096303|P1|NOT COMPLETED|Overall Study||11
459747|NCT00571948|1096302|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
459748|NCT00571948|1096303|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
459749|NCT00571948|1096302|P2|STARTED|Overall Study||66
459750|NCT00571948|1096303|P1|STARTED|Overall Study||66
459751|NCT00571922|1096311|P2|NOT COMPLETED|Overall Study||36
459752|NCT00571922|1096312|P1|NOT COMPLETED|Overall Study||36
459753|NCT00571922|1096311|P2|COMPLETED|Overall Study||0
459754|NCT00571922|1096312|P1|COMPLETED|Overall Study||0
459755|NCT00571922|1096311|P2|STARTED|Overall Study||36
459756|NCT00571922|1096312|P1|STARTED|Overall Study||36
459757|NCT00571701|1096322|P2|NOT COMPLETED|Second Intervention 12 Months||1
459758|NCT00571701|1096323|P1|NOT COMPLETED|Second Intervention 12 Months||3
459759|NCT00571701|1096322|P2|COMPLETED|Second Intervention 12 Months||20
459760|NCT00571701|1096323|P1|COMPLETED|Second Intervention 12 Months||13
459761|NCT00571701|1096322|P2|STARTED|Second Intervention 12 Months||21
459762|NCT00571701|1096323|P1|STARTED|Second Intervention 12 Months||16
459763|NCT00571701|1096322|P2|NOT COMPLETED|First Intervention 12 Months||1
459764|NCT00571701|1096323|P1|NOT COMPLETED|First Intervention 12 Months||3
459765|NCT00571701|1096322|P2|COMPLETED|First Intervention 12 Months||21
459766|NCT00571701|1096323|P1|COMPLETED|First Intervention 12 Months||16
459767|NCT00571701|1096322|P2|STARTED|First Intervention 12 Months||22
459768|NCT00571701|1096323|P1|STARTED|First Intervention 12 Months||19
459769|NCT00571662|1096347|P1|NOT COMPLETED|Overall Study||8
459770|NCT00571662|1096347|P1|COMPLETED|Overall Study||68
459771|NCT00571662|1096347|P1|STARTED|Overall Study||76
459772|NCT00571649|1096355|P2|NOT COMPLETED|Follow-up Period||528
459773|NCT00571649|1096356|P1|NOT COMPLETED|Follow-up Period||545
459774|NCT00571649|1096355|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
459775|NCT00571649|1096356|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
459776|NCT00571649|1096355|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
459777|NCT00571649|1096356|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
459778|NCT00571649|1096355|P2|NOT COMPLETED|Treatment Period||1004
459779|NCT00571649|1096356|P1|NOT COMPLETED|Treatment Period||1092
459780|NCT00571649|1096355|P2|COMPLETED|Treatment Period||3047
459781|NCT00571649|1096356|P1|COMPLETED|Treatment Period||2958
459782|NCT00571649|1096355|P2|Day 35|Treatment Period||3115
459783|NCT00571649|1096356|P1|Day 35|Treatment Period||3033
459784|NCT00571649|1096355|P2|Day 10|Treatment Period||3499
459785|NCT00571649|1096356|P1|Day 10|Treatment Period||3454
459786|NCT00571649|1096355|P2|Participants Received Treatment|Treatment Period||4001
459787|NCT00571649|1096356|P1|Participants Received Treatment|Treatment Period||3997
459788|NCT00571649|1096355|P2|STARTED|Treatment Period||4051
459789|NCT00571649|1096356|P1|STARTED|Treatment Period||4050
459790|NCT00571428|1096390|P2|NOT COMPLETED|Overall Study||0
459791|NCT00571428|1096391|P1|NOT COMPLETED|Overall Study||0
459792|NCT00571428|1096390|P2|COMPLETED|Overall Study||18
459793|NCT00571428|1096391|P1|COMPLETED|Overall Study||15
459794|NCT00571428|1096390|P2|STARTED|Overall Study||18
459795|NCT00571428|1096391|P1|STARTED|Overall Study||15
459796|NCT00571324|1096423|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
459797|NCT00571324|1096424|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
459798|NCT00571324|1096423|P2|COMPLETED|Intervention 2 (7 Hours)||4
459799|NCT00571324|1096424|P1|COMPLETED|Intervention 2 (7 Hours)||5
459800|NCT00571324|1096423|P2|STARTED|Intervention 2 (7 Hours)||4
459801|NCT00571324|1096424|P1|STARTED|Intervention 2 (7 Hours)||5
459802|NCT00571324|1096423|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
459803|NCT00571324|1096424|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
459804|NCT00571324|1096423|P2|COMPLETED|Intervention 1 (7 Hours)||4
459805|NCT00571324|1096424|P1|COMPLETED|Intervention 1 (7 Hours)||5
459806|NCT00571324|1096423|P2|STARTED|Intervention 1 (7 Hours)||4
459807|NCT00571324|1096424|P1|STARTED|Intervention 1 (7 Hours)||5
459808|NCT00571194|1096436|P1|NOT COMPLETED|Overall Study||0
459809|NCT00571194|1096436|P1|COMPLETED|Overall Study||7
459810|NCT00571194|1096436|P1|STARTED|Overall Study||7
459811|NCT00571103|1096440|P1|NOT COMPLETED|Overall Study||2
459812|NCT00571103|1096440|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
459813|NCT00571103|1096440|P1|STARTED|Overall Study||28
459814|NCT00571038|1096447|P2|NOT COMPLETED|Overall Study||14
459815|NCT00571038|1096448|P1|NOT COMPLETED|Overall Study||11
459816|NCT00571038|1096447|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
459817|NCT00571038|1096448|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
459818|NCT00571038|1096447|P2|18 Month Survey Only|Overall Study||163
459819|NCT00571038|1096448|P1|18 Month Survey Only|Overall Study||199
459820|NCT00571038|1096447|P2|6 Month Follow up|Overall Study||176
459821|NCT00571038|1096448|P1|6 Month Follow up|Overall Study||208
459822|NCT00571038|1096447|P2|STARTED|Overall Study||185
459823|NCT00571038|1096448|P1|STARTED|Overall Study||219
459824|NCT00570960|1096496|P2|NOT COMPLETED|Overall Study||0
459825|NCT00570960|1096497|P1|NOT COMPLETED|Overall Study||0
459826|NCT00570960|1096496|P2|COMPLETED|Overall Study||4
459827|NCT00570960|1096497|P1|COMPLETED|Overall Study||4
459828|NCT00570960|1096496|P2|STARTED|Overall Study||4
459829|NCT00570960|1096497|P1|STARTED|Overall Study||4
459830|NCT00570921|1096503|P1|NOT COMPLETED|Overall Study||2
459831|NCT00570921|1096503|P1|COMPLETED|Overall Study||31
459832|NCT00570921|1096503|P1|STARTED|Overall Study||33
459833|NCT00570908|1096509|P1|NOT COMPLETED|Overall Study||7
459834|NCT00570908|1096509|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
459835|NCT00570908|1096509|P1|STARTED|Overall Study||12
459836|NCT00570778|1096513|P4|NOT COMPLETED|Overall Study||4
459837|NCT00570778|1096514|P3|NOT COMPLETED|Overall Study||7
459838|NCT00570778|1096515|P2|NOT COMPLETED|Overall Study||4
459839|NCT00570778|1096516|P1|NOT COMPLETED|Overall Study||4
459840|NCT00570778|1096513|P4|COMPLETED|Overall Study||34
459841|NCT00570778|1096514|P3|COMPLETED|Overall Study||30
459842|NCT00570778|1096515|P2|COMPLETED|Overall Study||34
459843|NCT00570778|1096516|P1|COMPLETED|Overall Study||37
459844|NCT00570778|1096513|P4|Modified Intent-to-treat Population|Overall Study||37
459845|NCT00570778|1096514|P3|Modified Intent-to-treat Population|Overall Study||35
459846|NCT00570778|1096515|P2|Modified Intent-to-treat Population|Overall Study||37
459847|NCT00570778|1096516|P1|Modified Intent-to-treat Population|Overall Study||40
459848|NCT00570778|1096513|P4|Safety Population: Received Study Drug|Overall Study||38
459849|NCT00570778|1096514|P3|Safety Population: Received Study Drug|Overall Study||36
459850|NCT00570778|1096515|P2|Safety Population: Received Study Drug|Overall Study||38
459851|NCT00570778|1096516|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
459852|NCT00570778|1096513|P4|STARTED|Overall Study||38
459853|NCT00570778|1096514|P3|STARTED|Overall Study||37
459854|NCT00570778|1096515|P2|STARTED|Overall Study||38
459855|NCT00570778|1096516|P1|STARTED|Overall Study||41
459856|NCT00570765|1096537|P3|NOT COMPLETED|Overall Study||0
459857|NCT00570765|1096538|P2|NOT COMPLETED|Overall Study||7
459858|NCT00570765|1096539|P1|NOT COMPLETED|Overall Study||4
459859|NCT00570765|1096537|P3|COMPLETED|Overall Study||23
459860|NCT00570765|1096538|P2|COMPLETED|Overall Study||9
459861|NCT00570765|1096539|P1|COMPLETED|Overall Study||16
459862|NCT00570765|1096537|P3|STARTED|Overall Study||23
459863|NCT00570765|1096538|P2|STARTED|Overall Study||16
459864|NCT00570765|1096539|P1|STARTED|Overall Study||20
459865|NCT00570739|1096557|P4|NOT COMPLETED|Overall Study||12
459866|NCT00570739|1096558|P3|NOT COMPLETED|Overall Study||16
459867|NCT00570739|1096559|P2|NOT COMPLETED|Overall Study||21
459868|NCT00570739|1096560|P1|NOT COMPLETED|Overall Study||21
459869|NCT00570739|1096557|P4|COMPLETED|Overall Study||96
459870|NCT00570739|1096558|P3|COMPLETED|Overall Study||92
459871|NCT00570739|1096559|P2|COMPLETED|Overall Study||124
459872|NCT00570739|1096560|P1|COMPLETED|Overall Study||120
459873|NCT00570739|1096557|P4|STARTED|Overall Study||108
459874|NCT00570739|1096558|P3|STARTED|Overall Study||108
459875|NCT00570739|1096559|P2|STARTED|Overall Study||145
459876|NCT00570739|1096560|P1|STARTED|Overall Study||141
459877|NCT00570713|1096712|P2|NOT COMPLETED|Overall Study||77
459878|NCT00570713|1096713|P1|NOT COMPLETED|Overall Study||78
459879|NCT00570713|1096712|P2|COMPLETED|Overall Study||0
459880|NCT00570713|1096713|P1|COMPLETED|Overall Study||0
459881|NCT00570713|1096712|P2|STARTED|Overall Study||77
459882|NCT00570713|1096713|P1|STARTED|Overall Study||78
459883|NCT00570687|1096725|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459884|NCT00570687|1096726|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459885|NCT00570687|1096727|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459886|NCT00570687|1096728|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459887|NCT00570687|1096729|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459888|NCT00570687|1096730|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459889|NCT00570687|1096731|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459890|NCT00570687|1096732|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459891|NCT00570687|1096733|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459892|NCT00570687|1096734|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459893|NCT00570687|1096725|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459894|NCT00570687|1096726|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459895|NCT00570687|1096727|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459896|NCT00570687|1096728|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459897|NCT00570687|1096729|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459898|NCT00570687|1096730|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
459899|NCT00570687|1096731|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
459900|NCT00570687|1096732|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
459901|NCT00570687|1096733|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
459902|NCT00570687|1096734|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
459903|NCT00570687|1096725|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
459904|NCT00570687|1096726|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
459905|NCT00570687|1096727|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
459906|NCT00570687|1096728|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
459907|NCT00570687|1096729|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
459908|NCT00570687|1096730|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
459909|NCT00570687|1096731|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
459910|NCT00570687|1096732|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
459911|NCT00570687|1096733|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
459912|NCT00570687|1096734|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
459913|NCT00570687|1096725|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459914|NCT00570687|1096726|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459915|NCT00570687|1096727|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459916|NCT00570687|1096728|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459917|NCT00570687|1096729|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459918|NCT00570687|1096730|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459919|NCT00570687|1096731|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459920|NCT00570687|1096732|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459921|NCT00570687|1096733|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459922|NCT00570687|1096734|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459923|NCT00570687|1096725|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459924|NCT00570687|1096726|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459925|NCT00570687|1096727|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459926|NCT00570687|1096728|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459927|NCT00570687|1096729|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459928|NCT00570687|1096730|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
459929|NCT00570687|1096731|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
459930|NCT00570687|1096732|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
459931|NCT00570687|1096733|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
459932|NCT00570687|1096734|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
459933|NCT00570687|1096725|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
459934|NCT00570687|1096726|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
459935|NCT00570687|1096727|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
459936|NCT00570687|1096728|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
459937|NCT00570687|1096729|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
459938|NCT00570687|1096730|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
459939|NCT00570687|1096731|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
459940|NCT00570687|1096732|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
459941|NCT00570687|1096733|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
459942|NCT00570687|1096734|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
459943|NCT00570687|1096725|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459944|NCT00570687|1096726|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459945|NCT00570687|1096727|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459946|NCT00570687|1096728|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459947|NCT00570687|1096729|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459948|NCT00570687|1096730|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459949|NCT00570687|1096731|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459950|NCT00570687|1096732|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459951|NCT00570687|1096733|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459952|NCT00570687|1096734|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459953|NCT00570687|1096725|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459954|NCT00570687|1096726|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459955|NCT00570687|1096727|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459956|NCT00570687|1096728|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459957|NCT00570687|1096729|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459958|NCT00570687|1096730|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
459959|NCT00570687|1096731|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
459960|NCT00570687|1096732|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
459961|NCT00570687|1096733|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
459962|NCT00570687|1096734|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
459963|NCT00570687|1096725|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
459964|NCT00570687|1096726|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
459965|NCT00570687|1096727|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
459966|NCT00570687|1096728|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
459967|NCT00570687|1096729|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
459968|NCT00570687|1096730|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
459969|NCT00570687|1096731|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
459970|NCT00570687|1096732|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
459971|NCT00570687|1096733|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
459972|NCT00570687|1096734|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
459973|NCT00570687|1096725|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459974|NCT00570687|1096726|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459975|NCT00570687|1096727|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459976|NCT00570687|1096728|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459977|NCT00570687|1096729|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459978|NCT00570687|1096730|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459979|NCT00570687|1096731|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459980|NCT00570687|1096732|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459981|NCT00570687|1096733|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459982|NCT00570687|1096734|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459983|NCT00570687|1096725|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459984|NCT00570687|1096726|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459985|NCT00570687|1096727|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459986|NCT00570687|1096728|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459987|NCT00570687|1096729|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459988|NCT00570687|1096730|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
459989|NCT00570687|1096731|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
459990|NCT00570687|1096732|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
459991|NCT00570687|1096733|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
459992|NCT00570687|1096734|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
459993|NCT00570687|1096725|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
459994|NCT00570687|1096726|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
459995|NCT00570687|1096727|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
459996|NCT00570687|1096728|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
459997|NCT00570687|1096729|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
459998|NCT00570687|1096730|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
459999|NCT00570687|1096731|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
460000|NCT00570687|1096732|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
460001|NCT00570687|1096733|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
460002|NCT00570687|1096734|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
460003|NCT00570687|1096725|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460004|NCT00570687|1096726|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460005|NCT00570687|1096727|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460006|NCT00570687|1096728|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460007|NCT00570687|1096729|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460008|NCT00570687|1096730|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460009|NCT00570687|1096731|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460010|NCT00570687|1096732|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460011|NCT00570687|1096733|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460012|NCT00570687|1096734|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460013|NCT00570687|1096725|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460014|NCT00570687|1096726|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460015|NCT00570687|1096727|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460016|NCT00570687|1096728|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460017|NCT00570687|1096729|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460018|NCT00570687|1096730|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
460019|NCT00570687|1096731|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
460020|NCT00570687|1096732|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
460021|NCT00570687|1096733|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
460022|NCT00570687|1096734|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
460023|NCT00570687|1096725|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
460024|NCT00570687|1096726|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
460025|NCT00570687|1096727|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
460026|NCT00570687|1096728|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
460027|NCT00570687|1096729|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
460028|NCT00570687|1096730|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
460029|NCT00570687|1096731|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
460030|NCT00570687|1096732|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
460031|NCT00570687|1096733|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
460032|NCT00570687|1096734|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
460033|NCT00570687|1096725|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460034|NCT00570687|1096726|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460035|NCT00570687|1096727|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460036|NCT00570687|1096728|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460037|NCT00570687|1096729|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460038|NCT00570687|1096730|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460039|NCT00570687|1096731|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460040|NCT00570687|1096732|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460041|NCT00570687|1096733|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460042|NCT00570687|1096734|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460043|NCT00570687|1096725|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460044|NCT00570687|1096726|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460045|NCT00570687|1096727|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460046|NCT00570687|1096728|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460047|NCT00570687|1096729|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460048|NCT00570687|1096730|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
460049|NCT00570687|1096731|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
460050|NCT00570687|1096732|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
460051|NCT00570687|1096733|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
460052|NCT00570687|1096734|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
460053|NCT00570687|1096725|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
460054|NCT00570687|1096726|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
460055|NCT00570687|1096727|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
460056|NCT00570687|1096728|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
460057|NCT00570687|1096729|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
460058|NCT00570687|1096730|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
460059|NCT00570687|1096731|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
460060|NCT00570687|1096732|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
460061|NCT00570687|1096733|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
460062|NCT00570687|1096734|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
460063|NCT00570687|1096725|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460064|NCT00570687|1096726|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460065|NCT00570687|1096727|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460066|NCT00570687|1096728|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460067|NCT00570687|1096729|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460068|NCT00570687|1096730|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460069|NCT00570687|1096731|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460070|NCT00570687|1096732|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460071|NCT00570687|1096733|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460072|NCT00570687|1096734|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460073|NCT00570687|1096725|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460074|NCT00570687|1096726|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460075|NCT00570687|1096727|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460076|NCT00570687|1096728|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460077|NCT00570687|1096729|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460078|NCT00570687|1096730|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
460079|NCT00570687|1096731|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
460080|NCT00570687|1096732|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
460081|NCT00570687|1096733|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
460082|NCT00570687|1096734|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
460083|NCT00570687|1096725|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
460084|NCT00570687|1096726|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
460085|NCT00570687|1096727|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
460086|NCT00570687|1096728|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
460087|NCT00570687|1096729|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
460088|NCT00570687|1096730|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
460089|NCT00570687|1096731|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
460090|NCT00570687|1096732|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
460091|NCT00570687|1096733|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
460092|NCT00570687|1096734|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
460093|NCT00570687|1096725|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460094|NCT00570687|1096726|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460095|NCT00570687|1096727|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460096|NCT00570687|1096728|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
460097|NCT00570687|1096729|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460098|NCT00570687|1096730|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460099|NCT00570687|1096731|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460100|NCT00570687|1096732|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460101|NCT00570687|1096733|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460102|NCT00570687|1096734|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460103|NCT00570687|1096725|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460104|NCT00570687|1096726|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460105|NCT00570687|1096727|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460106|NCT00570687|1096728|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460107|NCT00570687|1096729|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460108|NCT00570687|1096730|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460109|NCT00570687|1096731|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460110|NCT00570687|1096732|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460111|NCT00570687|1096733|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460112|NCT00570687|1096734|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
460113|NCT00570687|1096725|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460114|NCT00570687|1096726|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460115|NCT00570687|1096727|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460116|NCT00570687|1096728|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
460117|NCT00570687|1096729|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460118|NCT00570687|1096730|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460119|NCT00570687|1096731|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460120|NCT00570687|1096732|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460121|NCT00570687|1096733|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460122|NCT00570687|1096734|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
460123|NCT00570687|1096725|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460124|NCT00570687|1096726|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460125|NCT00570687|1096727|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460126|NCT00570687|1096728|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460127|NCT00570687|1096729|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460128|NCT00570687|1096730|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460129|NCT00570687|1096731|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460130|NCT00570687|1096732|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460131|NCT00570687|1096733|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460132|NCT00570687|1096734|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460133|NCT00570687|1096725|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460134|NCT00570687|1096726|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460135|NCT00570687|1096727|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460136|NCT00570687|1096728|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
460137|NCT00570687|1096729|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460138|NCT00570687|1096730|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460139|NCT00570687|1096731|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460140|NCT00570687|1096732|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460141|NCT00570687|1096733|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460142|NCT00570687|1096734|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
460143|NCT00570687|1096725|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460144|NCT00570687|1096726|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460145|NCT00570687|1096727|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460146|NCT00570687|1096728|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
460147|NCT00570687|1096729|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460148|NCT00570687|1096730|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460149|NCT00570687|1096731|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460150|NCT00570687|1096732|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460151|NCT00570687|1096733|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460152|NCT00570687|1096734|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
460153|NCT00570687|1096725|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460154|NCT00570687|1096726|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
460155|NCT00570687|1096727|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460156|NCT00570687|1096728|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460157|NCT00570687|1096729|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460158|NCT00570687|1096730|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460159|NCT00570687|1096731|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460160|NCT00570687|1096732|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460161|NCT00570687|1096733|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460162|NCT00570687|1096734|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460163|NCT00570687|1096725|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460164|NCT00570687|1096726|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460165|NCT00570687|1096727|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460166|NCT00570687|1096728|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
460167|NCT00570687|1096729|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460168|NCT00570687|1096730|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460169|NCT00570687|1096731|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460170|NCT00570687|1096732|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460171|NCT00570687|1096733|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460172|NCT00570687|1096734|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
460173|NCT00570687|1096725|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460174|NCT00570687|1096726|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
460175|NCT00570687|1096727|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460176|NCT00570687|1096728|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
460177|NCT00570687|1096729|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460178|NCT00570687|1096730|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460179|NCT00570687|1096731|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460180|NCT00570687|1096732|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460181|NCT00570687|1096733|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460182|NCT00570687|1096734|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
460183|NCT00570687|1096725|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460184|NCT00570687|1096726|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460185|NCT00570687|1096727|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460186|NCT00570687|1096728|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460187|NCT00570687|1096729|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460188|NCT00570687|1096730|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460189|NCT00570687|1096731|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460190|NCT00570687|1096732|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460191|NCT00570687|1096733|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460192|NCT00570687|1096734|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460193|NCT00570687|1096725|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460194|NCT00570687|1096726|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
460195|NCT00570687|1096727|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460196|NCT00570687|1096728|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
460197|NCT00570687|1096729|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460198|NCT00570687|1096730|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460199|NCT00570687|1096731|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460200|NCT00570687|1096732|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460201|NCT00570687|1096733|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460202|NCT00570687|1096734|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
460203|NCT00570687|1096725|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460204|NCT00570687|1096726|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
460205|NCT00570687|1096727|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460206|NCT00570687|1096728|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
460207|NCT00570687|1096729|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460208|NCT00570687|1096730|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460209|NCT00570687|1096731|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460210|NCT00570687|1096732|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460211|NCT00570687|1096733|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460212|NCT00570687|1096734|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
460213|NCT00570687|1096725|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
460214|NCT00570687|1096726|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
460215|NCT00570687|1096727|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
460216|NCT00570687|1096728|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
460217|NCT00570687|1096729|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
460218|NCT00570687|1096730|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
460219|NCT00570687|1096731|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460220|NCT00570687|1096732|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460221|NCT00570687|1096733|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460222|NCT00570687|1096734|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460223|NCT00570687|1096725|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460224|NCT00570687|1096726|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
460225|NCT00570687|1096727|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460226|NCT00570687|1096728|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
460227|NCT00570687|1096729|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460228|NCT00570687|1096730|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460229|NCT00570687|1096731|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460230|NCT00570687|1096732|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460231|NCT00570687|1096733|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460232|NCT00570687|1096734|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
460233|NCT00570687|1096725|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
460234|NCT00570687|1096726|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
460235|NCT00570687|1096727|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
460236|NCT00570687|1096728|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
460237|NCT00570687|1096729|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
460238|NCT00570687|1096730|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
460239|NCT00570687|1096731|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
460240|NCT00570687|1096732|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
460241|NCT00570687|1096733|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
460242|NCT00570687|1096734|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
460243|NCT00570687|1096725|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460244|NCT00570687|1096726|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460245|NCT00570687|1096727|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460246|NCT00570687|1096728|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460247|NCT00570687|1096729|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460248|NCT00570687|1096730|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460249|NCT00570687|1096731|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460250|NCT00570687|1096732|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460251|NCT00570687|1096733|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460252|NCT00570687|1096734|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460253|NCT00570687|1096725|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460254|NCT00570687|1096726|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460255|NCT00570687|1096727|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460256|NCT00570687|1096728|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460257|NCT00570687|1096729|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460258|NCT00570687|1096730|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460259|NCT00570687|1096731|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460260|NCT00570687|1096732|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460261|NCT00570687|1096733|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460262|NCT00570687|1096734|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460263|NCT00570687|1096725|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460264|NCT00570687|1096726|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460265|NCT00570687|1096727|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460266|NCT00570687|1096728|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460267|NCT00570687|1096729|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460268|NCT00570687|1096730|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
460269|NCT00570687|1096731|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460270|NCT00570687|1096732|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460271|NCT00570687|1096733|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460272|NCT00570687|1096734|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
460273|NCT00570687|1096725|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460274|NCT00570687|1096726|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460275|NCT00570687|1096727|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460276|NCT00570687|1096728|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460277|NCT00570687|1096729|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460278|NCT00570687|1096730|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460279|NCT00570687|1096731|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460280|NCT00570687|1096732|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460281|NCT00570687|1096733|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460282|NCT00570687|1096734|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460283|NCT00570687|1096725|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
460284|NCT00570687|1096726|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
460285|NCT00570687|1096727|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
460286|NCT00570687|1096728|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
460287|NCT00570687|1096729|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
460288|NCT00570687|1096730|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
460289|NCT00570687|1096731|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460290|NCT00570687|1096732|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460291|NCT00570687|1096733|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460292|NCT00570687|1096734|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
460293|NCT00570687|1096725|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
460294|NCT00570687|1096726|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
460295|NCT00570687|1096727|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
460296|NCT00570687|1096728|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
460297|NCT00570687|1096729|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
460298|NCT00570687|1096730|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
460299|NCT00570687|1096731|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
460300|NCT00570687|1096732|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
460301|NCT00570687|1096733|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
460302|NCT00570687|1096734|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
460303|NCT00570687|1096725|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460304|NCT00570687|1096726|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460305|NCT00570687|1096727|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460306|NCT00570687|1096728|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460307|NCT00570687|1096729|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460308|NCT00570687|1096730|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460309|NCT00570687|1096731|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460310|NCT00570687|1096732|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460311|NCT00570687|1096733|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460312|NCT00570687|1096734|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460313|NCT00570687|1096725|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460314|NCT00570687|1096726|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460315|NCT00570687|1096727|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460316|NCT00570687|1096728|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460317|NCT00570687|1096729|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460318|NCT00570687|1096730|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460319|NCT00570687|1096731|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460320|NCT00570687|1096732|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460321|NCT00570687|1096733|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460322|NCT00570687|1096734|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460323|NCT00570687|1096725|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460324|NCT00570687|1096726|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460325|NCT00570687|1096727|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460326|NCT00570687|1096728|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460327|NCT00570687|1096729|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460328|NCT00570687|1096730|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
460329|NCT00570687|1096731|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460330|NCT00570687|1096732|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460331|NCT00570687|1096733|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460332|NCT00570687|1096734|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
460333|NCT00570687|1096725|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460334|NCT00570687|1096726|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460335|NCT00570687|1096727|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460336|NCT00570687|1096728|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460337|NCT00570687|1096729|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460338|NCT00570687|1096730|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460339|NCT00570687|1096731|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460340|NCT00570687|1096732|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460341|NCT00570687|1096733|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460342|NCT00570687|1096734|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460343|NCT00570687|1096725|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
460344|NCT00570687|1096726|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
460345|NCT00570687|1096727|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
460346|NCT00570687|1096728|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
460347|NCT00570687|1096729|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
460348|NCT00570687|1096730|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
460349|NCT00570687|1096731|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460350|NCT00570687|1096732|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460351|NCT00570687|1096733|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460352|NCT00570687|1096734|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
460353|NCT00570687|1096725|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
460354|NCT00570687|1096726|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
460355|NCT00570687|1096727|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
460356|NCT00570687|1096728|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
460357|NCT00570687|1096729|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
460358|NCT00570687|1096730|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
460359|NCT00570687|1096731|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
460360|NCT00570687|1096732|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
460361|NCT00570687|1096733|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
460362|NCT00570687|1096734|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
460363|NCT00570687|1096725|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460364|NCT00570687|1096726|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460365|NCT00570687|1096727|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460366|NCT00570687|1096728|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460367|NCT00570687|1096729|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460368|NCT00570687|1096730|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460369|NCT00570687|1096731|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460370|NCT00570687|1096732|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460371|NCT00570687|1096733|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460372|NCT00570687|1096734|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460373|NCT00570687|1096725|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460374|NCT00570687|1096726|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460375|NCT00570687|1096727|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460376|NCT00570687|1096728|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460377|NCT00570687|1096729|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460378|NCT00570687|1096730|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460379|NCT00570687|1096731|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460380|NCT00570687|1096732|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460381|NCT00570687|1096733|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460382|NCT00570687|1096734|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460383|NCT00570687|1096725|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460384|NCT00570687|1096726|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460385|NCT00570687|1096727|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460386|NCT00570687|1096728|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460387|NCT00570687|1096729|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460388|NCT00570687|1096730|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
460389|NCT00570687|1096731|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460390|NCT00570687|1096732|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460391|NCT00570687|1096733|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460392|NCT00570687|1096734|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
460393|NCT00570674|1096760|P7|NOT COMPLETED|Overall Study||0
460394|NCT00570674|1096761|P6|NOT COMPLETED|Overall Study||0
460395|NCT00570674|1096762|P5|NOT COMPLETED|Overall Study||0
460396|NCT00570674|1096763|P4|NOT COMPLETED|Overall Study||0
460397|NCT00570674|1096764|P3|NOT COMPLETED|Overall Study||1
460398|NCT00570674|1096765|P2|NOT COMPLETED|Overall Study||0
460399|NCT00570674|1096766|P1|NOT COMPLETED|Overall Study||0
460400|NCT00570674|1096760|P7|COMPLETED|Overall Study||0
460401|NCT00570674|1096761|P6|COMPLETED|Overall Study||10
460402|NCT00570674|1096762|P5|COMPLETED|Overall Study||3
460403|NCT00570674|1096763|P4|COMPLETED|Overall Study||3
460404|NCT00570674|1096764|P3|COMPLETED|Overall Study||3
460405|NCT00570674|1096765|P2|COMPLETED|Overall Study||3
460406|NCT00570674|1096766|P1|COMPLETED|Overall Study||6
460407|NCT00570674|1096760|P7|Treated|Overall Study||0
460408|NCT00570674|1096761|P6|Treated|Overall Study||10
460409|NCT00570674|1096762|P5|Treated|Overall Study||3
460410|NCT00570674|1096763|P4|Treated|Overall Study||3
460411|NCT00570674|1096764|P3|Treated|Overall Study||3
460412|NCT00570674|1096765|P2|Treated|Overall Study||3
460413|NCT00570674|1096766|P1|Treated|Overall Study||6
460414|NCT00570674|1096760|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
460415|NCT00570674|1096761|P6|STARTED|Overall Study||10
460416|NCT00570674|1096762|P5|STARTED|Overall Study||3
460417|NCT00570674|1096763|P4|STARTED|Overall Study||3
460418|NCT00570674|1096764|P3|STARTED|Overall Study||4
460419|NCT00570674|1096765|P2|STARTED|Overall Study||3
460420|NCT00570674|1096766|P1|STARTED|Overall Study||6
460421|NCT00570531|1096778|P1|NOT COMPLETED|Overall Study||0
460422|NCT00570531|1096778|P1|COMPLETED|Overall Study||6
460423|NCT00570531|1096778|P1|STARTED|Overall Study||6
460424|NCT00570505|1096784|P1|NOT COMPLETED|Overall Study||41
460425|NCT00570505|1096784|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
460426|NCT00570505|1096784|P1|STARTED|Overall Study||149
460427|NCT00570492|1096797|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
460428|NCT00570492|1096798|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
460429|NCT00570492|1096799|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
460430|NCT00570492|1096797|P3|COMPLETED|52-week Double-blind Treatment Period||186
460431|NCT00570492|1096798|P2|COMPLETED|52-week Double-blind Treatment Period||187
460432|NCT00570492|1096799|P1|COMPLETED|52-week Double-blind Treatment Period||0
460433|NCT00570492|1096797|P3|STARTED|52-week Double-blind Treatment Period||237
460434|NCT00570492|1096798|P2|STARTED|52-week Double-blind Treatment Period||237
460435|NCT00570492|1096799|P1|STARTED|52-week Double-blind Treatment Period||0
460436|NCT00570492|1096797|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
460437|NCT00570492|1096798|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
460438|NCT00570492|1096799|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
460439|NCT00570492|1096797|P3|COMPLETED|16-week Single-blind Baseline Period||0
460440|NCT00570492|1096798|P2|COMPLETED|16-week Single-blind Baseline Period||0
460441|NCT00570492|1096799|P1|COMPLETED|16-week Single-blind Baseline Period||474
460442|NCT00570492|1096797|P3|STARTED|16-week Single-blind Baseline Period||0
460443|NCT00570492|1096798|P2|STARTED|16-week Single-blind Baseline Period||0
460444|NCT00570492|1096799|P1|STARTED|16-week Single-blind Baseline Period||910
460445|NCT00570401|1096837|P1|NOT COMPLETED|Overall Study||2
460446|NCT00570401|1096837|P1|COMPLETED|Overall Study||19
460447|NCT00570401|1096837|P1|STARTED|Overall Study||21
460448|NCT00570362|1096843|P2|NOT COMPLETED|Overall Study||0
460449|NCT00570362|1096844|P1|NOT COMPLETED|Overall Study||0
460450|NCT00570362|1096843|P2|COMPLETED|Overall Study||30
460451|NCT00570362|1096844|P1|COMPLETED|Overall Study||19
460452|NCT00570362|1096843|P2|STARTED|Overall Study||30
460453|NCT00570362|1096844|P1|STARTED|Overall Study||19
460454|NCT00570349|1096853|P3|NOT COMPLETED|Overall Study||0
460455|NCT00570349|1096854|P2|NOT COMPLETED|Overall Study||0
460456|NCT00570349|1096855|P1|NOT COMPLETED|Overall Study||0
460457|NCT00570349|1096853|P3|COMPLETED|Overall Study||6
460458|NCT00570349|1096854|P2|COMPLETED|Overall Study||6
460459|NCT00570349|1096855|P1|COMPLETED|Overall Study||6
460460|NCT00570349|1096853|P3|STARTED|Overall Study||6
460461|NCT00570349|1096854|P2|STARTED|Overall Study||6
460462|NCT00570349|1096855|P1|STARTED|Overall Study||6
460463|NCT00570310|1096871|P2|NOT COMPLETED|Overall Study||6
460464|NCT00570310|1096872|P1|NOT COMPLETED|Overall Study||2
460465|NCT00570310|1096871|P2|COMPLETED|Overall Study||45
460466|NCT00570310|1096872|P1|COMPLETED|Overall Study||51
460467|NCT00570310|1096871|P2|STARTED|Overall Study||51
460468|NCT00570310|1096872|P1|STARTED|Overall Study||53
460469|NCT00570232|1096880|P1|NOT COMPLETED|Overall Study||23
460470|NCT00570232|1096880|P1|COMPLETED|Overall Study||8
460471|NCT00570232|1096880|P1|STARTED|Overall Study||31
460472|NCT00570141|1096886|P1|NOT COMPLETED|Overall Study||3
460473|NCT00570141|1096886|P1|COMPLETED|Overall Study||10
460474|NCT00570141|1096886|P1|STARTED|Overall Study||13
460475|NCT00570089|1096891|P2|NOT COMPLETED|Perod 2||0
460476|NCT00570089|1096892|P1|NOT COMPLETED|Perod 2||0
460477|NCT00570089|1096891|P2|COMPLETED|Perod 2||10
460478|NCT00570089|1096892|P1|COMPLETED|Perod 2||10
460479|NCT00570089|1096891|P2|STARTED|Perod 2||10
460480|NCT00570089|1096892|P1|STARTED|Perod 2||10
460481|NCT00570089|1096891|P2|NOT COMPLETED|Period 1||0
460482|NCT00570089|1096892|P1|NOT COMPLETED|Period 1||0
460483|NCT00570089|1096891|P2|COMPLETED|Period 1||10
460484|NCT00570089|1096892|P1|COMPLETED|Period 1||10
460485|NCT00570089|1096891|P2|STARTED|Period 1||10
460486|NCT00570089|1096892|P1|STARTED|Period 1||10
460487|NCT00570037|1096902|P2|NOT COMPLETED|Overall Study||69
460488|NCT00570037|1096903|P1|NOT COMPLETED|Overall Study||44
460489|NCT00570037|1096902|P2|COMPLETED|Overall Study||237
460490|NCT00570037|1096903|P1|COMPLETED|Overall Study||194
460491|NCT00570037|1096902|P2|STARTED|Overall Study||306
460492|NCT00570037|1096903|P1|STARTED|Overall Study||238
460493|NCT00569946|1096913|P1|NOT COMPLETED|Overall Study||59
460494|NCT00569946|1096913|P1|COMPLETED|Overall Study||5
460495|NCT00569946|1096913|P1|STARTED|Overall Study||64
460496|NCT00569868|1096929|P1|NOT COMPLETED|Overall Study||0
460497|NCT00569868|1096929|P1|COMPLETED|Overall Study||11
460498|NCT00569868|1096929|P1|STARTED|Overall Study||11
460499|NCT00569855|1096933|P1|NOT COMPLETED|Overall Study||0
460500|NCT00569855|1096933|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
460501|NCT00569855|1096933|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
460502|NCT00569803|1096945|P8|NOT COMPLETED|Overall Study||1
460503|NCT00569803|1096946|P7|NOT COMPLETED|Overall Study||0
460504|NCT00569803|1096947|P6|NOT COMPLETED|Overall Study||0
460505|NCT00569803|1096948|P5|NOT COMPLETED|Overall Study||0
460506|NCT00569803|1096949|P4|NOT COMPLETED|Overall Study||1
460507|NCT00569803|1096950|P3|NOT COMPLETED|Overall Study||0
460508|NCT00569803|1096951|P2|NOT COMPLETED|Overall Study||0
460509|NCT00569803|1096952|P1|NOT COMPLETED|Overall Study||1
460510|NCT00569803|1096945|P8|COMPLETED|Overall Study||5
460511|NCT00569803|1096946|P7|COMPLETED|Overall Study||10
460512|NCT00569803|1096947|P6|COMPLETED|Overall Study||5
460513|NCT00569803|1096948|P5|COMPLETED|Overall Study||5
460514|NCT00569803|1096949|P4|COMPLETED|Overall Study||5
460515|NCT00569803|1096950|P3|COMPLETED|Overall Study||5
460516|NCT00569803|1096951|P2|COMPLETED|Overall Study||5
460517|NCT00569803|1096952|P1|COMPLETED|Overall Study||4
460518|NCT00569803|1096945|P8|STARTED|Overall Study||6
460519|NCT00569803|1096946|P7|STARTED|Overall Study||10
460520|NCT00569803|1096947|P6|STARTED|Overall Study||5
460521|NCT00569803|1096948|P5|STARTED|Overall Study||5
460522|NCT00569803|1096949|P4|STARTED|Overall Study||6
460523|NCT00569803|1096950|P3|STARTED|Overall Study||5
460524|NCT00569803|1096951|P2|STARTED|Overall Study||5
460525|NCT00569803|1096952|P1|STARTED|Overall Study||5
460526|NCT00569777|1097079|P2|NOT COMPLETED|Overall Study||3
460527|NCT00569777|1097080|P1|NOT COMPLETED|Overall Study||10
460528|NCT00569777|1097079|P2|COMPLETED|Overall Study||101
460529|NCT00569777|1097080|P1|COMPLETED|Overall Study||196
460530|NCT00569777|1097079|P2|STARTED|Overall Study||104
460531|NCT00569777|1097080|P1|STARTED|Overall Study||206
460532|NCT00569673|1097122|P1|NOT COMPLETED|Overall Study||0
460533|NCT00569673|1097122|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
460534|NCT00569673|1097122|P1|STARTED|Overall Study|Total number participants enrolled on study|71
460535|NCT00569660|1097126|P1|NOT COMPLETED|Overall Study||0
460536|NCT00569660|1097126|P1|COMPLETED|Overall Study||34
460537|NCT00569660|1097126|P1|STARTED|Overall Study||34
460538|NCT00569582|1097130|P1|NOT COMPLETED|Overall Study||16
460539|NCT00569582|1097130|P1|COMPLETED|Overall Study||34
460540|NCT00569582|1097130|P1|STARTED|Overall Study||50
460541|NCT00569530|1097137|P2|NOT COMPLETED|Overall Study||0
460542|NCT00569530|1097138|P1|NOT COMPLETED|Overall Study||0
460543|NCT00569530|1097137|P2|COMPLETED|Overall Study||42
460544|NCT00569530|1097138|P1|COMPLETED|Overall Study||43
460545|NCT00569530|1097137|P2|STARTED|Overall Study||42
460546|NCT00569530|1097138|P1|STARTED|Overall Study||43
460547|NCT00569374|1097146|P1|NOT COMPLETED|Overall Study||4
460548|NCT00569374|1097146|P1|COMPLETED|Overall Study||4
460549|NCT00569374|1097146|P1|STARTED|Overall Study||8
460550|NCT00569270|1097156|P2|NOT COMPLETED|Period: Second Intervention||0
460551|NCT00569270|1097157|P1|NOT COMPLETED|Period: Second Intervention||0
460552|NCT00569270|1097156|P2|COMPLETED|Period: Second Intervention||14
460553|NCT00569270|1097157|P1|COMPLETED|Period: Second Intervention||15
460554|NCT00569270|1097156|P2|29 Days|Period: Second Intervention||14
460555|NCT00569270|1097157|P1|29 Days|Period: Second Intervention||15
460556|NCT00569270|1097156|P2|STARTED|Period: Second Intervention||14
460557|NCT00569270|1097157|P1|STARTED|Period: Second Intervention||15
460558|NCT00569270|1097156|P2|NOT COMPLETED|Period: First Intervention||1
460559|NCT00569270|1097157|P1|NOT COMPLETED|Period: First Intervention||0
460560|NCT00569270|1097156|P2|COMPLETED|Period: First Intervention||14
460561|NCT00569270|1097157|P1|COMPLETED|Period: First Intervention||15
460562|NCT00569270|1097156|P2|STARTED|Period: First Intervention||15
460563|NCT00569270|1097157|P1|STARTED|Period: First Intervention|randomized cross over study|15
460564|NCT00569231|1097192|P1|NOT COMPLETED|Overall Study||7
460565|NCT00569231|1097192|P1|COMPLETED|Overall Study||11
460566|NCT00569231|1097192|P1|STARTED|Overall Study||18
460567|NCT00569192|1097202|P3|NOT COMPLETED|Overall Study||25
460568|NCT00569192|1097203|P2|NOT COMPLETED|Overall Study||20
460569|NCT00569192|1097204|P1|NOT COMPLETED|Overall Study||23
460570|NCT00569192|1097202|P3|COMPLETED|Overall Study||99
460571|NCT00569192|1097203|P2|COMPLETED|Overall Study||105
460572|NCT00569192|1097204|P1|COMPLETED|Overall Study||88
460573|NCT00569192|1097202|P3|STARTED|Overall Study||124
460574|NCT00569192|1097203|P2|STARTED|Overall Study||125
460575|NCT00569192|1097204|P1|STARTED|Overall Study||111
460576|NCT00569166|1097230|P3|NOT COMPLETED|Overall Study||4
460577|NCT00569166|1097231|P2|NOT COMPLETED|Overall Study||6
460578|NCT00569166|1097232|P1|NOT COMPLETED|Overall Study||9
460579|NCT00569166|1097230|P3|COMPLETED|Overall Study||27
460580|NCT00569166|1097231|P2|COMPLETED|Overall Study||25
460581|NCT00569166|1097232|P1|COMPLETED|Overall Study||21
460582|NCT00569166|1097230|P3|STARTED|Overall Study||31
460583|NCT00569166|1097231|P2|STARTED|Overall Study||31
460584|NCT00569166|1097232|P1|STARTED|Overall Study||30
460585|NCT00569127|1097242|P2|NOT COMPLETED|Overall Study||213
460586|NCT00569127|1097243|P1|NOT COMPLETED|Overall Study||214
460587|NCT00569127|1097242|P2|COMPLETED|Overall Study||0
460588|NCT00569127|1097243|P1|COMPLETED|Overall Study||0
460589|NCT00569127|1097242|P2|Eligible|Overall Study||202
460590|NCT00569127|1097243|P1|Eligible|Overall Study||200
460591|NCT00569127|1097242|P2|STARTED|Overall Study||213
460592|NCT00569127|1097243|P1|STARTED|Overall Study||214
460593|NCT00569010|1097263|P4|NOT COMPLETED|Overall Study||0
460594|NCT00569010|1097264|P3|NOT COMPLETED|Overall Study||0
460595|NCT00569010|1097265|P2|NOT COMPLETED|Overall Study||0
460596|NCT00569010|1097266|P1|NOT COMPLETED|Overall Study||0
460597|NCT00569010|1097263|P4|COMPLETED|Overall Study||11
460598|NCT00569010|1097264|P3|COMPLETED|Overall Study||11
460599|NCT00569010|1097265|P2|COMPLETED|Overall Study||6
460600|NCT00569010|1097266|P1|COMPLETED|Overall Study||6
460601|NCT00569010|1097263|P4|STARTED|Overall Study||11
460602|NCT00569010|1097264|P3|STARTED|Overall Study||11
460603|NCT00569010|1097265|P2|STARTED|Overall Study||6
460604|NCT00569010|1097266|P1|STARTED|Overall Study||6
460605|NCT00568958|1097278|P2|NOT COMPLETED|Follow-Up||4
460606|NCT00568958|1097279|P1|NOT COMPLETED|Follow-Up||8
460607|NCT00568958|1097278|P2|COMPLETED|Follow-Up||63
460608|NCT00568958|1097279|P1|COMPLETED|Follow-Up||53
460609|NCT00568958|1097278|P2|STARTED|Follow-Up||67
460610|NCT00568958|1097279|P1|STARTED|Follow-Up||61
460611|NCT00568958|1097278|P2|NOT COMPLETED|Allocation||3
460612|NCT00568958|1097279|P1|NOT COMPLETED|Allocation||9
460613|NCT00568958|1097278|P2|COMPLETED|Allocation||67
460614|NCT00568958|1097279|P1|COMPLETED|Allocation||61
460615|NCT00568958|1097278|P2|STARTED|Allocation||70
460616|NCT00568958|1097279|P1|STARTED|Allocation||70
460617|NCT00568854|1097299|P2|NOT COMPLETED|Overall Study||0
460618|NCT00568854|1097300|P1|NOT COMPLETED|Overall Study||0
460619|NCT00568854|1097299|P2|COMPLETED|Overall Study||4
460620|NCT00568854|1097300|P1|COMPLETED|Overall Study||6
460621|NCT00568854|1097299|P2|STARTED|Overall Study||4
460622|NCT00568854|1097300|P1|STARTED|Overall Study||6
460623|NCT00568776|1097312|P4|NOT COMPLETED|Overall Study||72
460624|NCT00568776|1097313|P3|NOT COMPLETED|Overall Study||74
460625|NCT00568776|1097314|P2|NOT COMPLETED|Overall Study||36
460626|NCT00568776|1097315|P1|NOT COMPLETED|Overall Study||30
460627|NCT00568776|1097312|P4|COMPLETED|Overall Study||19
460628|NCT00568776|1097313|P3|COMPLETED|Overall Study||15
460629|NCT00568776|1097314|P2|COMPLETED|Overall Study||52
460630|NCT00568776|1097315|P1|COMPLETED|Overall Study||53
460631|NCT00568776|1097312|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
460632|NCT00568776|1097313|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
460633|NCT00568776|1097314|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
460634|NCT00568776|1097315|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
460635|NCT00568685|1097352|P3|NOT COMPLETED|Overall Study||5
460636|NCT00568685|1097353|P2|NOT COMPLETED|Overall Study||5
460637|NCT00568685|1097354|P1|NOT COMPLETED|Overall Study||10
460638|NCT00568685|1097352|P3|COMPLETED|Overall Study||46
460639|NCT00568685|1097353|P2|COMPLETED|Overall Study||46
460640|NCT00568685|1097354|P1|COMPLETED|Overall Study||41
460641|NCT00568685|1097352|P3|STARTED|Overall Study||51
460642|NCT00568685|1097353|P2|STARTED|Overall Study||51
460643|NCT00568685|1097354|P1|STARTED|Overall Study||51
460644|NCT00568555|1097388|P2|NOT COMPLETED|Overall Study||1
460645|NCT00568555|1097389|P1|NOT COMPLETED|Overall Study||1
460646|NCT00568555|1097388|P2|COMPLETED|Overall Study||14
460647|NCT00568555|1097389|P1|COMPLETED|Overall Study||15
460648|NCT00568555|1097388|P2|STARTED|Overall Study||15
460649|NCT00568555|1097389|P1|STARTED|Overall Study||16
460650|NCT00568451|1097407|P4|NOT COMPLETED|Overall Study||7
460651|NCT00568451|1097408|P3|NOT COMPLETED|Overall Study||2
460652|NCT00568451|1097409|P2|NOT COMPLETED|Overall Study||0
460653|NCT00568451|1097410|P1|NOT COMPLETED|Overall Study||0
460654|NCT00568451|1097407|P4|COMPLETED|Overall Study||2
460655|NCT00568451|1097408|P3|COMPLETED|Overall Study||0
460656|NCT00568451|1097409|P2|COMPLETED|Overall Study||0
460657|NCT00568451|1097410|P1|COMPLETED|Overall Study||0
460658|NCT00568451|1097407|P4|STARTED|Overall Study||9
460659|NCT00568451|1097408|P3|STARTED|Overall Study||2
460660|NCT00568451|1097409|P2|STARTED|Overall Study||0
460661|NCT00568451|1097410|P1|STARTED|Overall Study||0
460662|NCT00568399|1097426|P1|NOT COMPLETED|Overall Study||15
460663|NCT00568399|1097426|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
460664|NCT00568399|1097426|P1|STARTED|Overall Study||37
460665|NCT00568386|1097432|P2|NOT COMPLETED|Overall Study||0
460666|NCT00568386|1097433|P1|NOT COMPLETED|Overall Study||0
460667|NCT00568386|1097432|P2|COMPLETED|Overall Study||20
460668|NCT00568386|1097433|P1|COMPLETED|Overall Study||20
460669|NCT00568386|1097432|P2|STARTED|Overall Study||20
460670|NCT00568386|1097433|P1|STARTED|Overall Study||20
460671|NCT00568178|1097441|P6|NOT COMPLETED|Open Label Extension||80
460672|NCT00568178|1097442|P5|NOT COMPLETED|Open Label Extension||79
460673|NCT00568178|1097443|P4|NOT COMPLETED|Open Label Extension||0
460674|NCT00568178|1097444|P3|NOT COMPLETED|Open Label Extension||0
460675|NCT00568178|1097445|P2|NOT COMPLETED|Open Label Extension||0
460676|NCT00568178|1097446|P1|NOT COMPLETED|Open Label Extension||0
460677|NCT00568178|1097441|P6|COMPLETED|Open Label Extension||54
460678|NCT00568178|1097442|P5|COMPLETED|Open Label Extension||55
460679|NCT00568178|1097443|P4|COMPLETED|Open Label Extension||0
460680|NCT00568178|1097444|P3|COMPLETED|Open Label Extension||0
460681|NCT00568178|1097445|P2|COMPLETED|Open Label Extension||0
460682|NCT00568178|1097446|P1|COMPLETED|Open Label Extension||0
460683|NCT00568178|1097441|P6|STARTED|Open Label Extension||134
460684|NCT00568178|1097442|P5|STARTED|Open Label Extension||134
460685|NCT00568178|1097443|P4|STARTED|Open Label Extension||0
460686|NCT00568178|1097444|P3|STARTED|Open Label Extension||0
460687|NCT00568178|1097445|P2|STARTED|Open Label Extension||0
460688|NCT00568178|1097446|P1|STARTED|Open Label Extension||0
460689|NCT00568178|1097441|P6|NOT COMPLETED|Double Blind Base Study||0
460690|NCT00568178|1097442|P5|NOT COMPLETED|Double Blind Base Study||0
460691|NCT00568178|1097443|P4|NOT COMPLETED|Double Blind Base Study||5
460692|NCT00568178|1097444|P3|NOT COMPLETED|Double Blind Base Study||1
460693|NCT00568178|1097445|P2|NOT COMPLETED|Double Blind Base Study||6
460694|NCT00568178|1097446|P1|NOT COMPLETED|Double Blind Base Study||6
460695|NCT00568178|1097441|P6|COMPLETED|Double Blind Base Study||0
460696|NCT00568178|1097442|P5|COMPLETED|Double Blind Base Study||0
460697|NCT00568178|1097443|P4|COMPLETED|Double Blind Base Study||25
460698|NCT00568178|1097444|P3|COMPLETED|Double Blind Base Study||29
460699|NCT00568178|1097445|P2|COMPLETED|Double Blind Base Study||118
460700|NCT00568178|1097446|P1|COMPLETED|Double Blind Base Study||116
460701|NCT00568178|1097441|P6|STARTED|Double Blind Base Study||0
460702|NCT00568178|1097442|P5|STARTED|Double Blind Base Study||0
460703|NCT00568178|1097443|P4|STARTED|Double Blind Base Study||30
460704|NCT00568178|1097444|P3|STARTED|Double Blind Base Study||30
460705|NCT00568178|1097445|P2|STARTED|Double Blind Base Study||124
460706|NCT00568178|1097446|P1|STARTED|Double Blind Base Study||122
460707|NCT00568087|1097464|P2|NOT COMPLETED|Overall Study||7
460708|NCT00568087|1097465|P1|NOT COMPLETED|Overall Study||7
460709|NCT00568087|1097464|P2|COMPLETED|Overall Study||17
460710|NCT00568087|1097465|P1|COMPLETED|Overall Study||15
460711|NCT00568087|1097464|P2|Received Intervention|Overall Study||23
460712|NCT00568087|1097465|P1|Received Intervention|Overall Study||21
460713|NCT00568087|1097464|P2|STARTED|Overall Study||24
460714|NCT00568087|1097465|P1|STARTED|Overall Study||22
460715|NCT00568061|1097477|P2|NOT COMPLETED|Overall Study||2
460716|NCT00568061|1097478|P1|NOT COMPLETED|Overall Study||5
460717|NCT00568061|1097477|P2|COMPLETED|Overall Study||14
460718|NCT00568061|1097478|P1|COMPLETED|Overall Study||8
460719|NCT00568061|1097477|P2|STARTED|Overall Study||16
460720|NCT00568061|1097478|P1|STARTED|Overall Study||13
460721|NCT00568022|1097487|P3|NOT COMPLETED|Overall Study||0
460722|NCT00568022|1097488|P2|NOT COMPLETED|Overall Study||0
460723|NCT00568022|1097489|P1|NOT COMPLETED|Overall Study||0
460724|NCT00568022|1097487|P3|COMPLETED|Overall Study||3
460725|NCT00568022|1097488|P2|COMPLETED|Overall Study||3
460726|NCT00568022|1097489|P1|COMPLETED|Overall Study||3
460727|NCT00568022|1097487|P3|STARTED|Overall Study||3
460728|NCT00568022|1097488|P2|STARTED|Overall Study||3
460729|NCT00568022|1097489|P1|STARTED|Overall Study||3
460730|NCT00567996|1097522|P3|NOT COMPLETED|Overall Study||70
460731|NCT00567996|1097523|P2|NOT COMPLETED|Overall Study||50
460732|NCT00567996|1097524|P1|NOT COMPLETED|Overall Study||44
460733|NCT00567996|1097522|P3|COMPLETED|Overall Study||265
460734|NCT00567996|1097523|P2|COMPLETED|Overall Study||284
460735|NCT00567996|1097524|P1|COMPLETED|Overall Study||289
460736|NCT00567996|1097522|P3|Intent-to-treat: Received Study Drug|Overall Study||335
460737|NCT00567996|1097523|P2|Intent-to-treat: Received Study Drug|Overall Study||333
460738|NCT00567996|1097524|P1|Intent-to-treat: Received Study Drug|Overall Study||330
460739|NCT00567996|1097522|P3|STARTED|Overall Study||335
460740|NCT00567996|1097523|P2|STARTED|Overall Study||334
460741|NCT00567996|1097524|P1|STARTED|Overall Study|Randomized participants|333
460742|NCT00567892|1097540|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
460743|NCT00567892|1097541|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
460744|NCT00567892|1097542|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
460745|NCT00567892|1097543|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
460746|NCT00567892|1097540|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
460747|NCT00567892|1097541|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
460748|NCT00567892|1097542|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
460749|NCT00567892|1097543|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
460750|NCT00567892|1097540|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
460751|NCT00567892|1097541|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
460752|NCT00567892|1097542|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
460753|NCT00567892|1097543|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
460754|NCT00567892|1097540|P4|NOT COMPLETED|Washout (2 Weeks)||0
460755|NCT00567892|1097541|P3|NOT COMPLETED|Washout (2 Weeks)||0
460756|NCT00567892|1097542|P2|NOT COMPLETED|Washout (2 Weeks)||0
460757|NCT00567892|1097543|P1|NOT COMPLETED|Washout (2 Weeks)||0
460758|NCT00567892|1097540|P4|COMPLETED|Washout (2 Weeks)||6
460759|NCT00567892|1097541|P3|COMPLETED|Washout (2 Weeks)||9
460760|NCT00567892|1097542|P2|COMPLETED|Washout (2 Weeks)||7
460761|NCT00567892|1097543|P1|COMPLETED|Washout (2 Weeks)||7
460762|NCT00567892|1097540|P4|STARTED|Washout (2 Weeks)||6
460763|NCT00567892|1097541|P3|STARTED|Washout (2 Weeks)||9
460764|NCT00567892|1097542|P2|STARTED|Washout (2 Weeks)||7
460765|NCT00567892|1097543|P1|STARTED|Washout (2 Weeks)||7
460766|NCT00567892|1097540|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
460767|NCT00567892|1097541|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
460768|NCT00567892|1097542|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
460769|NCT00567892|1097543|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
460770|NCT00567892|1097540|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
460771|NCT00567892|1097541|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
460772|NCT00567892|1097542|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
460773|NCT00567892|1097543|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
460774|NCT00567892|1097540|P4|STARTED|First Treatment (2 or 4 Weeks)||10
460775|NCT00567892|1097541|P3|STARTED|First Treatment (2 or 4 Weeks)||10
460776|NCT00567892|1097542|P2|STARTED|First Treatment (2 or 4 Weeks)||7
460777|NCT00567892|1097543|P1|STARTED|First Treatment (2 or 4 Weeks)||7
460778|NCT00567879|1097561|P6|NOT COMPLETED|Overall Study||3
460779|NCT00567879|1097562|P5|NOT COMPLETED|Overall Study||12
460780|NCT00567879|1097563|P4|NOT COMPLETED|Overall Study||6
460781|NCT00567879|1097564|P3|NOT COMPLETED|Overall Study||21
460782|NCT00567879|1097565|P2|NOT COMPLETED|Overall Study||7
460783|NCT00567879|1097566|P1|NOT COMPLETED|Overall Study||7
460784|NCT00567879|1097561|P6|COMPLETED|Overall Study||0
460785|NCT00567879|1097562|P5|COMPLETED|Overall Study||0
460786|NCT00567879|1097563|P4|COMPLETED|Overall Study||0
460787|NCT00567879|1097564|P3|COMPLETED|Overall Study||0
460788|NCT00567879|1097565|P2|COMPLETED|Overall Study||0
460789|NCT00567879|1097566|P1|COMPLETED|Overall Study||0
460790|NCT00567879|1097561|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
460791|NCT00567879|1097562|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
460792|NCT00567879|1097563|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
460884|NCT00567320|1097741|P1|NOT COMPLETED|Overall Study||0
460793|NCT00567879|1097564|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
460794|NCT00567879|1097565|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
460795|NCT00567879|1097566|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
460796|NCT00567879|1097561|P6|STARTED|Overall Study||3
460797|NCT00567879|1097562|P5|STARTED|Overall Study||12
460798|NCT00567879|1097563|P4|STARTED|Overall Study||6
460799|NCT00567879|1097564|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
460800|NCT00567879|1097565|P2|STARTED|Overall Study||7
460801|NCT00567879|1097566|P1|STARTED|Overall Study||7
460802|NCT00567840|1097592|P5|NOT COMPLETED|Overall Study||0
460803|NCT00567840|1097593|P4|NOT COMPLETED|Overall Study||1
460804|NCT00567840|1097594|P3|NOT COMPLETED|Overall Study||1
460805|NCT00567840|1097595|P2|NOT COMPLETED|Overall Study||0
460806|NCT00567840|1097596|P1|NOT COMPLETED|Overall Study||2
460807|NCT00567840|1097592|P5|COMPLETED|Overall Study||8
460808|NCT00567840|1097593|P4|COMPLETED|Overall Study||14
460809|NCT00567840|1097594|P3|COMPLETED|Overall Study||15
460810|NCT00567840|1097595|P2|COMPLETED|Overall Study||15
460811|NCT00567840|1097596|P1|COMPLETED|Overall Study||13
460812|NCT00567840|1097592|P5|STARTED|Overall Study||8
460813|NCT00567840|1097593|P4|STARTED|Overall Study||15
460814|NCT00567840|1097594|P3|STARTED|Overall Study||16
460815|NCT00567840|1097595|P2|STARTED|Overall Study||15
460816|NCT00567840|1097596|P1|STARTED|Overall Study||15
460817|NCT00566579|1097635|P2|NOT COMPLETED|Overall Study||0
460818|NCT00566579|1097636|P1|NOT COMPLETED|Overall Study||0
460819|NCT00566579|1097635|P2|COMPLETED|Overall Study||31
460820|NCT00566579|1097636|P1|COMPLETED|Overall Study||29
460821|NCT00566579|1097635|P2|STARTED|Overall Study||31
460822|NCT00566579|1097636|P1|STARTED|Overall Study||29
460823|NCT00566501|1097644|P2|NOT COMPLETED|Overall Study||126
460824|NCT00566501|1097645|P1|NOT COMPLETED|Overall Study||156
460825|NCT00566501|1097644|P2|COMPLETED|Overall Study||210
460826|NCT00566501|1097645|P1|COMPLETED|Overall Study||423
460827|NCT00566501|1097644|P2|Not Determined|Overall Study||0
460828|NCT00566501|1097645|P1|Not Determined|Overall Study||1
460829|NCT00566501|1097644|P2|Other ( Not Specified)|Overall Study||21
460830|NCT00566501|1097645|P1|Other ( Not Specified)|Overall Study||24
460831|NCT00566501|1097644|P2|Medication Non-compliance|Overall Study||0
460832|NCT00566501|1097645|P1|Medication Non-compliance|Overall Study||5
460833|NCT00566501|1097644|P2|Protocol Violation|Overall Study||2
460834|NCT00566501|1097645|P1|Protocol Violation|Overall Study||2
460835|NCT00566501|1097644|P2|Request of Investigator or Sponsor|Overall Study||7
460836|NCT00566501|1097645|P1|Request of Investigator or Sponsor|Overall Study||6
460837|NCT00566501|1097644|P2|Withdraw of Consent by Subject|Overall Study||30
460838|NCT00566501|1097645|P1|Withdraw of Consent by Subject|Overall Study||33
460839|NCT00566501|1097644|P2|Lack of Efficacy|Overall Study||3
460840|NCT00566501|1097645|P1|Lack of Efficacy|Overall Study||8
460841|NCT00566501|1097644|P2|Adverse Event|Overall Study||59
460842|NCT00566501|1097645|P1|Adverse Event|Overall Study||68
460843|NCT00566501|1097644|P2|Discontinued|Overall Study||122
460844|NCT00566501|1097645|P1|Discontinued|Overall Study||146
460845|NCT00566501|1097644|P2|Safety Population|Overall Study||332
460846|NCT00566501|1097645|P1|Safety Population|Overall Study||570
460847|NCT00566501|1097644|P2|STARTED|Overall Study||336
460848|NCT00566501|1097645|P1|STARTED|Overall Study||579
460849|NCT00566462|1097651|P1|NOT COMPLETED|Overall Study||0
460850|NCT00566462|1097651|P1|COMPLETED|Overall Study||1
460851|NCT00566462|1097651|P1|STARTED|Overall Study||1
460852|NCT00567593|1097656|P1|NOT COMPLETED|Overall Study||2
460853|NCT00567593|1097656|P1|COMPLETED|Overall Study||10
460854|NCT00567593|1097656|P1|STARTED|Overall Study||12
460855|NCT00567541|1097662|P2|NOT COMPLETED|Overall Study||1
460856|NCT00567541|1097663|P1|NOT COMPLETED|Overall Study||0
460857|NCT00567541|1097662|P2|COMPLETED|Overall Study||8
460858|NCT00567541|1097663|P1|COMPLETED|Overall Study||7
460859|NCT00567541|1097662|P2|STARTED|Overall Study||9
460860|NCT00567541|1097663|P1|STARTED|Overall Study||7
460861|NCT00567502|1097673|P4|NOT COMPLETED|Overall Study||87
460862|NCT00567502|1097674|P3|NOT COMPLETED|Overall Study||908
460863|NCT00567502|1097675|P2|NOT COMPLETED|Overall Study||33
460864|NCT00567502|1097676|P1|NOT COMPLETED|Overall Study||241
460865|NCT00567502|1097673|P4|COMPLETED|Overall Study||23
460866|NCT00567502|1097674|P3|COMPLETED|Overall Study||1758
460867|NCT00567502|1097675|P2|COMPLETED|Overall Study||108
460868|NCT00567502|1097676|P1|COMPLETED|Overall Study||563
460869|NCT00567502|1097673|P4|Initiated Treatment|Overall Study||38
460870|NCT00567502|1097674|P3|Initiated Treatment|Overall Study||2666
460871|NCT00567502|1097675|P2|Initiated Treatment|Overall Study||141
460872|NCT00567502|1097676|P1|Initiated Treatment|Overall Study||804
460873|NCT00567502|1097673|P4|STARTED|Overall Study||110
460874|NCT00567502|1097674|P3|STARTED|Overall Study||2666
460875|NCT00567502|1097675|P2|STARTED|Overall Study||141
460876|NCT00567502|1097676|P1|STARTED|Overall Study||804
460877|NCT00567476|1097713|P2|NOT COMPLETED|Overall Study||4
460878|NCT00567476|1097714|P1|NOT COMPLETED|Overall Study||8
460879|NCT00567476|1097713|P2|COMPLETED|Overall Study||34
460880|NCT00567476|1097714|P1|COMPLETED|Overall Study||70
460881|NCT00567476|1097713|P2|STARTED|Overall Study||38
460882|NCT00567476|1097714|P1|STARTED|Overall Study||78
460883|NCT00567320|1097740|P2|NOT COMPLETED|Overall Study||0
460885|NCT00567320|1097740|P2|COMPLETED|Overall Study||18
460886|NCT00567320|1097741|P1|COMPLETED|Overall Study||13
460887|NCT00567320|1097740|P2|STARTED|Overall Study||18
460888|NCT00567320|1097741|P1|STARTED|Overall Study||13
460889|NCT00567307|1097749|P2|NOT COMPLETED|Overall Study||1
460890|NCT00567307|1097750|P1|NOT COMPLETED|Overall Study||12
460891|NCT00567307|1097749|P2|COMPLETED|Overall Study||104
460892|NCT00567307|1097750|P1|COMPLETED|Overall Study||99
460893|NCT00567307|1097749|P2|STARTED|Overall Study||105
460894|NCT00567307|1097750|P1|STARTED|Overall Study||111
460895|NCT00567268|1097756|P1|NOT COMPLETED|Overall Study||50
460896|NCT00567268|1097756|P1|COMPLETED|Overall Study||1144
460897|NCT00567268|1097756|P1|STARTED|Overall Study||1194
460898|NCT00567255|1097807|P2|NOT COMPLETED|Overall Study||228
460899|NCT00567255|1097808|P1|NOT COMPLETED|Overall Study||463
460900|NCT00567255|1097807|P2|COMPLETED|Overall Study||267
460901|NCT00567255|1097808|P1|COMPLETED|Overall Study||538
460902|NCT00567255|1097807|P2|STARTED|Overall Study||495
460903|NCT00567255|1097808|P1|STARTED|Overall Study||1001
460904|NCT00567242|1097854|P2|NOT COMPLETED|Overall Study||0
460905|NCT00567242|1097855|P1|NOT COMPLETED|Overall Study||0
460906|NCT00567242|1097854|P2|COMPLETED|Overall Study||7
460907|NCT00567242|1097855|P1|COMPLETED|Overall Study||7
460908|NCT00567242|1097854|P2|STARTED|Overall Study||7
460909|NCT00567242|1097855|P1|STARTED|Overall Study||7
460910|NCT00567229|1097865|P1|NOT COMPLETED|Overall Study||0
460911|NCT00567229|1097865|P1|COMPLETED|Overall Study||3
460912|NCT00567229|1097865|P1|STARTED|Overall Study||3
460913|NCT00567190|1097871|P2|NOT COMPLETED|Overall Study||264
460914|NCT00567190|1097872|P1|NOT COMPLETED|Overall Study||210
460915|NCT00567190|1097871|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
460916|NCT00567190|1097872|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
460917|NCT00567190|1097871|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
460918|NCT00567190|1097872|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
460919|NCT00567164|1097892|P3|NOT COMPLETED|Overall Study||72
460920|NCT00567164|1097893|P2|NOT COMPLETED|Overall Study||73
460921|NCT00567164|1097894|P1|NOT COMPLETED|Overall Study||546
460922|NCT00567164|1097892|P3|COMPLETED|Overall Study||160
460923|NCT00567164|1097893|P2|COMPLETED|Overall Study||161
460924|NCT00567164|1097894|P1|COMPLETED|Overall Study||875
460925|NCT00567164|1097892|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
460926|NCT00567164|1097893|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
460927|NCT00567164|1097894|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
460928|NCT00567164|1097892|P3|STARTED|Overall Study||232
460929|NCT00567164|1097893|P2|STARTED|Overall Study||234
460930|NCT00567164|1097894|P1|STARTED|Overall Study||1421
460931|NCT00567112|1097966|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
460932|NCT00567112|1097967|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
460933|NCT00567112|1097968|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
460934|NCT00567112|1097966|P3|COMPLETED|Treatment Period 4 (3 Days)||3
460935|NCT00567112|1097967|P2|COMPLETED|Treatment Period 4 (3 Days)||7
460936|NCT00567112|1097968|P1|COMPLETED|Treatment Period 4 (3 Days)||4
460937|NCT00567112|1097966|P3|STARTED|Treatment Period 4 (3 Days)||3
460938|NCT00567112|1097967|P2|STARTED|Treatment Period 4 (3 Days)||7
460939|NCT00567112|1097968|P1|STARTED|Treatment Period 4 (3 Days)||4
460940|NCT00567112|1097966|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
460941|NCT00567112|1097967|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
460942|NCT00567112|1097968|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
460943|NCT00567112|1097966|P3|COMPLETED|Washout Period 3 (3 Days)||3
460944|NCT00567112|1097967|P2|COMPLETED|Washout Period 3 (3 Days)||7
460945|NCT00567112|1097968|P1|COMPLETED|Washout Period 3 (3 Days)||4
460946|NCT00567112|1097966|P3|STARTED|Washout Period 3 (3 Days)||3
460947|NCT00567112|1097967|P2|STARTED|Washout Period 3 (3 Days)||7
460948|NCT00567112|1097968|P1|STARTED|Washout Period 3 (3 Days)||7
460949|NCT00567112|1097966|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
460950|NCT00567112|1097967|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
460951|NCT00567112|1097968|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
460952|NCT00567112|1097966|P3|COMPLETED|Treatment Period 3 (3 Days)||3
460953|NCT00567112|1097967|P2|COMPLETED|Treatment Period 3 (3 Days)||7
460954|NCT00567112|1097968|P1|COMPLETED|Treatment Period 3 (3 Days)||7
460955|NCT00567112|1097966|P3|STARTED|Treatment Period 3 (3 Days)||3
460956|NCT00567112|1097967|P2|STARTED|Treatment Period 3 (3 Days)||7
460957|NCT00567112|1097968|P1|STARTED|Treatment Period 3 (3 Days)||7
460958|NCT00567112|1097966|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
460959|NCT00567112|1097967|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
460960|NCT00567112|1097968|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
460961|NCT00567112|1097966|P3|COMPLETED|Washout Period 2 (3 Days)||3
460962|NCT00567112|1097967|P2|COMPLETED|Washout Period 2 (3 Days)||7
460963|NCT00567112|1097968|P1|COMPLETED|Washout Period 2 (3 Days)||7
460964|NCT00567112|1097966|P3|STARTED|Washout Period 2 (3 Days)||3
460965|NCT00567112|1097967|P2|STARTED|Washout Period 2 (3 Days)||7
460966|NCT00567112|1097968|P1|STARTED|Washout Period 2 (3 Days)||7
460967|NCT00567112|1097966|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
460968|NCT00567112|1097967|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
460969|NCT00567112|1097968|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
460970|NCT00567112|1097966|P3|COMPLETED|Treatment Period 2 (3 Days)||3
460971|NCT00567112|1097967|P2|COMPLETED|Treatment Period 2 (3 Days)||7
460972|NCT00567112|1097968|P1|COMPLETED|Treatment Period 2 (3 Days)||7
460973|NCT00567112|1097966|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
460974|NCT00567112|1097967|P2|STARTED|Treatment Period 2 (3 Days)||8
460975|NCT00567112|1097968|P1|STARTED|Treatment Period 2 (3 Days)||7
460976|NCT00567112|1097966|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
460977|NCT00567112|1097967|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
460978|NCT00567112|1097968|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
460979|NCT00567112|1097966|P3|COMPLETED|Washout Period 1 (3 Days)||0
460980|NCT00567112|1097967|P2|COMPLETED|Washout Period 1 (3 Days)||8
460981|NCT00567112|1097968|P1|COMPLETED|Washout Period 1 (3 Days)||7
460982|NCT00567112|1097966|P3|STARTED|Washout Period 1 (3 Days)||0
460983|NCT00567112|1097967|P2|STARTED|Washout Period 1 (3 Days)||8
460984|NCT00567112|1097968|P1|STARTED|Washout Period 1 (3 Days)||7
460985|NCT00567112|1097966|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
460986|NCT00567112|1097967|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
460987|NCT00567112|1097968|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
460988|NCT00567112|1097966|P3|COMPLETED|Treatment Period 1 (3 Days)||0
460989|NCT00567112|1097967|P2|COMPLETED|Treatment Period 1 (3 Days)||8
460990|NCT00567112|1097968|P1|COMPLETED|Treatment Period 1 (3 Days)||7
460991|NCT00567112|1097966|P3|STARTED|Treatment Period 1 (3 Days)||0
460992|NCT00567112|1097967|P2|STARTED|Treatment Period 1 (3 Days)||8
460993|NCT00567112|1097968|P1|STARTED|Treatment Period 1 (3 Days)||7
460994|NCT00567008|1097992|P2|NOT COMPLETED|Overall Study||1
460995|NCT00567008|1097993|P1|NOT COMPLETED|Overall Study||1
460996|NCT00567008|1097992|P2|COMPLETED|Overall Study||18
460997|NCT00567008|1097993|P1|COMPLETED|Overall Study||17
460998|NCT00567008|1097992|P2|STARTED|Overall Study||19
460999|NCT00567008|1097993|P1|STARTED|Overall Study||18
461000|NCT00566995|1097999|P1|NOT COMPLETED|Overall Study||8
461001|NCT00566995|1097999|P1|COMPLETED|Overall Study||29
461002|NCT00566995|1097999|P1|STARTED|Overall Study||37
461003|NCT00566982|1098006|P2|NOT COMPLETED|Overall Study||69
461004|NCT00566982|1098007|P1|NOT COMPLETED|Overall Study||8
461005|NCT00566982|1098006|P2|COMPLETED|Overall Study||294
461006|NCT00566982|1098007|P1|COMPLETED|Overall Study||55
461007|NCT00566982|1098006|P2|STARTED|Overall Study||363
461008|NCT00566982|1098007|P1|STARTED|Overall Study||63
461009|NCT00566969|1098032|P3|NOT COMPLETED|Overall Study||12
461010|NCT00566969|1098033|P2|NOT COMPLETED|Overall Study||9
461011|NCT00566969|1098034|P1|NOT COMPLETED|Overall Study||15
461012|NCT00566969|1098032|P3|COMPLETED|Overall Study||23
461013|NCT00566969|1098033|P2|COMPLETED|Overall Study||28
461014|NCT00566969|1098034|P1|COMPLETED|Overall Study||19
461015|NCT00566969|1098032|P3|STARTED|Overall Study||35
461016|NCT00566969|1098033|P2|STARTED|Overall Study||37
461017|NCT00566969|1098034|P1|STARTED|Overall Study||34
461018|NCT00566943|1098044|P2|NOT COMPLETED|Overall Study||0
461019|NCT00566943|1098045|P1|NOT COMPLETED|Overall Study||0
461020|NCT00566943|1098044|P2|COMPLETED|Overall Study||49
461021|NCT00566943|1098045|P1|COMPLETED|Overall Study||52
461022|NCT00566943|1098044|P2|STARTED|Overall Study||49
461023|NCT00566943|1098045|P1|STARTED|Overall Study||52
461024|NCT00566930|1098060|P3|NOT COMPLETED|Overall Study||1
461025|NCT00566930|1098061|P2|NOT COMPLETED|Overall Study||4
461026|NCT00566930|1098062|P1|NOT COMPLETED|Overall Study||2
461027|NCT00566930|1098060|P3|COMPLETED|Overall Study||32
461028|NCT00566930|1098061|P2|COMPLETED|Overall Study||32
461029|NCT00566930|1098062|P1|COMPLETED|Overall Study||27
461030|NCT00566930|1098060|P3|STARTED|Overall Study||33
461031|NCT00566930|1098061|P2|STARTED|Overall Study||36
461032|NCT00566930|1098062|P1|STARTED|Overall Study||29
461033|NCT00566735|1098072|P2|NOT COMPLETED|Overall Study||7
461034|NCT00566735|1098073|P1|NOT COMPLETED|Overall Study||2
461035|NCT00566735|1098072|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
461125|NCT00565643|1098424|P1|STARTED|Overall Study||380
461036|NCT00566735|1098073|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
461037|NCT00566735|1098072|P2|Withdrew Before Baseline Measures|Overall Study||7
461038|NCT00566735|1098073|P1|Withdrew Before Baseline Measures|Overall Study||2
461039|NCT00566735|1098072|P2|STARTED|Overall Study||19
461040|NCT00566735|1098073|P1|STARTED|Overall Study||20
461041|NCT00566722|1098086|P3|NOT COMPLETED|Overall Study||9
461042|NCT00566722|1098087|P2|NOT COMPLETED|Overall Study||5
461043|NCT00566722|1098088|P1|NOT COMPLETED|Overall Study||2
461044|NCT00566722|1098086|P3|COMPLETED|Overall Study||73
461045|NCT00566722|1098087|P2|COMPLETED|Overall Study||24
461046|NCT00566722|1098088|P1|COMPLETED|Overall Study||39
461047|NCT00566722|1098086|P3|STARTED|Overall Study||82
461048|NCT00566722|1098087|P2|STARTED|Overall Study||29
461049|NCT00566722|1098088|P1|STARTED|Overall Study||41
461050|NCT00566709|1098134|P2|NOT COMPLETED|Overall Study||0
461051|NCT00566709|1098135|P1|NOT COMPLETED|Overall Study||5
461052|NCT00566709|1098134|P2|COMPLETED|Overall Study||51
461053|NCT00566709|1098135|P1|COMPLETED|Overall Study||46
461054|NCT00566709|1098134|P2|STARTED|Overall Study||51
461055|NCT00566709|1098135|P1|STARTED|Overall Study||51
461056|NCT00566696|1098151|P1|NOT COMPLETED|Overall Study||42
461057|NCT00566696|1098151|P1|COMPLETED|Overall Study||31
461058|NCT00566696|1098151|P1|STARTED|Overall Study||73
461059|NCT00566631|1098159|P1|NOT COMPLETED|Part 2: Extension Phase||82
461060|NCT00566631|1098159|P1|COMPLETED|Part 2: Extension Phase||57
461061|NCT00566631|1098159|P1|STARTED|Part 2: Extension Phase||139
461062|NCT00566631|1098159|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
461063|NCT00566631|1098159|P1|COMPLETED|Between Treatment and Extension Phase||139
461064|NCT00566631|1098159|P1|STARTED|Between Treatment and Extension Phase||234
461065|NCT00566631|1098159|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
461066|NCT00566631|1098159|P1|COMPLETED|Part 1: Core Treatment Phase||234
461067|NCT00566631|1098159|P1|STARTED|Part 1: Core Treatment Phase||294
461068|NCT00566254|1098176|P2|NOT COMPLETED|Overall Study||14
461069|NCT00566254|1098177|P1|NOT COMPLETED|Overall Study||10
461070|NCT00566254|1098176|P2|COMPLETED|Overall Study||93
461071|NCT00566254|1098177|P1|COMPLETED|Overall Study||90
461072|NCT00566254|1098176|P2|STARTED|Overall Study||107
461073|NCT00566254|1098177|P1|STARTED|Overall Study||100
461074|NCT00566150|1098191|P2|NOT COMPLETED|Overall Study||5
461075|NCT00566150|1098192|P1|NOT COMPLETED|Overall Study||9
461076|NCT00566150|1098191|P2|COMPLETED|Overall Study||11
461077|NCT00566150|1098192|P1|COMPLETED|Overall Study||10
461078|NCT00566150|1098191|P2|STARTED|Overall Study||16
461079|NCT00566150|1098192|P1|STARTED|Overall Study||19
461080|NCT00566111|1098206|P2|NOT COMPLETED|Overall Study||2
461081|NCT00566111|1098207|P1|NOT COMPLETED|Overall Study||0
461082|NCT00566111|1098206|P2|COMPLETED|Overall Study||1
461083|NCT00566111|1098207|P1|COMPLETED|Overall Study||2
461084|NCT00566111|1098206|P2|STARTED|Overall Study||3
461085|NCT00566111|1098207|P1|STARTED|Overall Study||2
461086|NCT00566020|1098221|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
461087|NCT00566020|1098222|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
461088|NCT00566020|1098221|P2|COMPLETED|46-week Long-term Administration Phase||68
461089|NCT00566020|1098222|P1|COMPLETED|46-week Long-term Administration Phase||0
461090|NCT00566020|1098221|P2|STARTED|46-week Long-term Administration Phase||85
461091|NCT00566020|1098222|P1|STARTED|46-week Long-term Administration Phase||0
461092|NCT00566020|1098221|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
461093|NCT00566020|1098222|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
461094|NCT00566020|1098221|P2|COMPLETED|6-week Dosage Adjustment Phase||0
461095|NCT00566020|1098222|P1|COMPLETED|6-week Dosage Adjustment Phase||85
461096|NCT00566020|1098221|P2|STARTED|6-week Dosage Adjustment Phase||0
461097|NCT00566020|1098222|P1|STARTED|6-week Dosage Adjustment Phase||92
461098|NCT00565812|1098250|P3|NOT COMPLETED|Overall Study||130
461099|NCT00565812|1098251|P2|NOT COMPLETED|Overall Study||135
461100|NCT00565812|1098252|P1|NOT COMPLETED|Overall Study||144
461101|NCT00565812|1098250|P3|COMPLETED|Overall Study||356
461102|NCT00565812|1098251|P2|COMPLETED|Overall Study||351
461103|NCT00565812|1098252|P1|COMPLETED|Overall Study||341
461104|NCT00565812|1098250|P3|STARTED|Overall Study||486
461105|NCT00565812|1098251|P2|STARTED|Overall Study||486
461106|NCT00565812|1098252|P1|STARTED|Overall Study||485
461107|NCT00565747|1098391|P2|NOT COMPLETED|Overall Study||73
461108|NCT00565747|1098392|P1|NOT COMPLETED|Overall Study||67
461109|NCT00565747|1098391|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
461110|NCT00565747|1098392|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
461111|NCT00565747|1098391|P2|STARTED|Overall Study||678
461112|NCT00565747|1098392|P1|STARTED|Overall Study||654
461113|NCT00565721|1098402|P1|NOT COMPLETED|Overall Study||17
461114|NCT00565721|1098402|P1|COMPLETED|Overall Study||16
461115|NCT00565721|1098402|P1|STARTED|Overall Study||33
461116|NCT00565643|1098423|P2|NOT COMPLETED|Overall Study||0
461117|NCT00565643|1098424|P1|NOT COMPLETED|Overall Study||0
461118|NCT00565643|1098423|P2|COMPLETED|Overall Study||373
461119|NCT00565643|1098424|P1|COMPLETED|Overall Study||380
461120|NCT00565643|1098423|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
461121|NCT00565643|1098424|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
461122|NCT00565643|1098423|P2|Safety Data|Overall Study||373
461123|NCT00565643|1098424|P1|Safety Data|Overall Study||380
461124|NCT00565643|1098423|P2|STARTED|Overall Study||373
461126|NCT00565604|1098442|P1|NOT COMPLETED|Overall Study||4
461127|NCT00565604|1098442|P1|COMPLETED|Overall Study||39
461128|NCT00565604|1098442|P1|6 Month|Overall Study||39
461129|NCT00565604|1098442|P1|6 Week|Overall Study||39
461130|NCT00565604|1098442|P1|2 Week|Overall Study||41
461131|NCT00565604|1098442|P1|7 Day|Overall Study||41
461132|NCT00565604|1098442|P1|STARTED|Overall Study||43
461133|NCT00565461|1098453|P4|NOT COMPLETED|Overall Study||3
461134|NCT00565461|1098454|P3|NOT COMPLETED|Overall Study||1
461135|NCT00565461|1098455|P2|NOT COMPLETED|Overall Study||1
461136|NCT00565461|1098456|P1|NOT COMPLETED|Overall Study||0
461137|NCT00565461|1098453|P4|COMPLETED|Overall Study||37
461138|NCT00565461|1098454|P3|COMPLETED|Overall Study||39
461139|NCT00565461|1098455|P2|COMPLETED|Overall Study||39
461140|NCT00565461|1098456|P1|COMPLETED|Overall Study||40
461141|NCT00565461|1098453|P4|STARTED|Overall Study||40
461142|NCT00565461|1098454|P3|STARTED|Overall Study||40
461143|NCT00565461|1098455|P2|STARTED|Overall Study||40
461144|NCT00565461|1098456|P1|STARTED|Overall Study||40
461145|NCT00565448|1098470|P2|NOT COMPLETED|Overall Study||2
461146|NCT00565448|1098471|P1|NOT COMPLETED|Overall Study||3
461147|NCT00565448|1098470|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
461148|NCT00565448|1098471|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
461149|NCT00565448|1098470|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
461150|NCT00565448|1098471|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
461151|NCT00565409|1098482|P4|NOT COMPLETED|Period 2 Double-Blind||59
461152|NCT00565409|1098483|P3|NOT COMPLETED|Period 2 Double-Blind||27
461153|NCT00565409|1098484|P2|NOT COMPLETED|Period 2 Double-Blind||21
461154|NCT00565409|1098485|P1|NOT COMPLETED|Period 2 Double-Blind||0
461155|NCT00565409|1098482|P4|COMPLETED|Period 2 Double-Blind||141
461156|NCT00565409|1098483|P3|COMPLETED|Period 2 Double-Blind||175
461157|NCT00565409|1098484|P2|COMPLETED|Period 2 Double-Blind||181
461158|NCT00565409|1098485|P1|COMPLETED|Period 2 Double-Blind||0
461159|NCT00565409|1098482|P4|STARTED|Period 2 Double-Blind||200
461160|NCT00565409|1098483|P3|STARTED|Period 2 Double-Blind||202
461161|NCT00565409|1098484|P2|STARTED|Period 2 Double-Blind||202
461162|NCT00565409|1098485|P1|STARTED|Period 2 Double-Blind||0
461163|NCT00565409|1098482|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
461164|NCT00565409|1098483|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
461165|NCT00565409|1098484|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
461166|NCT00565409|1098485|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
461167|NCT00565409|1098482|P4|COMPLETED|After Period 1, Prior to Period 2||0
461168|NCT00565409|1098483|P3|COMPLETED|After Period 1, Prior to Period 2||0
461169|NCT00565409|1098484|P2|COMPLETED|After Period 1, Prior to Period 2||0
461170|NCT00565409|1098485|P1|COMPLETED|After Period 1, Prior to Period 2||604
461171|NCT00565409|1098482|P4|STARTED|After Period 1, Prior to Period 2||0
461172|NCT00565409|1098483|P3|STARTED|After Period 1, Prior to Period 2||0
461173|NCT00565409|1098484|P2|STARTED|After Period 1, Prior to Period 2||0
461174|NCT00565409|1098485|P1|STARTED|After Period 1, Prior to Period 2||756
461175|NCT00565409|1098482|P4|NOT COMPLETED|Period 1 Open Label||0
461176|NCT00565409|1098483|P3|NOT COMPLETED|Period 1 Open Label||0
461177|NCT00565409|1098484|P2|NOT COMPLETED|Period 1 Open Label||0
461178|NCT00565409|1098485|P1|NOT COMPLETED|Period 1 Open Label||78
461179|NCT00565409|1098482|P4|COMPLETED|Period 1 Open Label||0
461180|NCT00565409|1098483|P3|COMPLETED|Period 1 Open Label||0
461181|NCT00565409|1098484|P2|COMPLETED|Period 1 Open Label||0
461182|NCT00565409|1098485|P1|COMPLETED|Period 1 Open Label||756
461183|NCT00565409|1098482|P4|STARTED|Period 1 Open Label||0
461184|NCT00565409|1098483|P3|STARTED|Period 1 Open Label||0
461185|NCT00565409|1098484|P2|STARTED|Period 1 Open Label||0
461186|NCT00565409|1098485|P1|STARTED|Period 1 Open Label||834
461187|NCT00565370|1098587|P1|NOT COMPLETED|Overall Study||0
461188|NCT00565370|1098587|P1|COMPLETED|Overall Study||21
461189|NCT00565370|1098587|P1|STARTED|Overall Study||21
461190|NCT00565266|1098595|P1|NOT COMPLETED|Overall Study||36
461191|NCT00565266|1098595|P1|COMPLETED|Overall Study||174
461192|NCT00565266|1098595|P1|STARTED|Overall Study||210
461193|NCT00565136|1098603|P1|NOT COMPLETED|Overall Study||3
461194|NCT00565136|1098603|P1|COMPLETED|Overall Study||26
461195|NCT00565136|1098603|P1|STARTED|Overall Study||29
461196|NCT00565084|1098621|P3|NOT COMPLETED|Third Treatment Period||0
461197|NCT00565084|1098622|P2|NOT COMPLETED|Third Treatment Period||0
461198|NCT00565084|1098623|P1|NOT COMPLETED|Third Treatment Period||0
461199|NCT00565084|1098621|P3|COMPLETED|Third Treatment Period||11
461200|NCT00565084|1098622|P2|COMPLETED|Third Treatment Period||11
461201|NCT00565084|1098623|P1|COMPLETED|Third Treatment Period||11
461202|NCT00565084|1098621|P3|STARTED|Third Treatment Period||11
461203|NCT00565084|1098622|P2|STARTED|Third Treatment Period||11
461204|NCT00565084|1098623|P1|STARTED|Third Treatment Period||11
461205|NCT00565084|1098621|P3|NOT COMPLETED|Second Treatment Period||0
461206|NCT00565084|1098622|P2|NOT COMPLETED|Second Treatment Period||0
461207|NCT00565084|1098623|P1|NOT COMPLETED|Second Treatment Period||0
461208|NCT00565084|1098621|P3|COMPLETED|Second Treatment Period||11
461209|NCT00565084|1098622|P2|COMPLETED|Second Treatment Period||11
461210|NCT00565084|1098623|P1|COMPLETED|Second Treatment Period||11
461211|NCT00565084|1098621|P3|STARTED|Second Treatment Period||11
461212|NCT00565084|1098622|P2|STARTED|Second Treatment Period||11
461213|NCT00565084|1098623|P1|STARTED|Second Treatment Period||11
461214|NCT00565084|1098621|P3|NOT COMPLETED|First Treatment Period||0
461215|NCT00565084|1098622|P2|NOT COMPLETED|First Treatment Period||0
461216|NCT00565084|1098623|P1|NOT COMPLETED|First Treatment Period||0
461217|NCT00565084|1098621|P3|COMPLETED|First Treatment Period||11
461218|NCT00565084|1098622|P2|COMPLETED|First Treatment Period||11
461219|NCT00565084|1098623|P1|COMPLETED|First Treatment Period||11
461220|NCT00565084|1098621|P3|STARTED|First Treatment Period||11
461221|NCT00565084|1098622|P2|STARTED|First Treatment Period||11
461222|NCT00565084|1098623|P1|STARTED|First Treatment Period||11
461223|NCT00565058|1098633|P2|NOT COMPLETED|Overall Study||0
461224|NCT00565058|1098634|P1|NOT COMPLETED|Overall Study||1
461225|NCT00565058|1098633|P2|COMPLETED|Overall Study||15
461226|NCT00565058|1098634|P1|COMPLETED|Overall Study||9
461227|NCT00565058|1098633|P2|STARTED|Overall Study||15
461228|NCT00565058|1098634|P1|STARTED|Overall Study||10
461229|NCT00565045|1098644|P2|NOT COMPLETED|Overall Study||3
461230|NCT00565045|1098645|P1|NOT COMPLETED|Overall Study||1
461231|NCT00565045|1098644|P2|COMPLETED|Overall Study||8
461232|NCT00565045|1098645|P1|COMPLETED|Overall Study||9
461233|NCT00565045|1098644|P2|STARTED|Overall Study||11
461234|NCT00565045|1098645|P1|STARTED|Overall Study||10
461235|NCT00564954|1098661|P2|NOT COMPLETED|Period 2- 1 Week||0
461236|NCT00564954|1098662|P1|NOT COMPLETED|Period 2- 1 Week||0
461237|NCT00564954|1098661|P2|COMPLETED|Period 2- 1 Week||42
461238|NCT00564954|1098662|P1|COMPLETED|Period 2- 1 Week||44
461239|NCT00564954|1098661|P2|STARTED|Period 2- 1 Week||42
461240|NCT00564954|1098662|P1|STARTED|Period 2- 1 Week||44
461241|NCT00564954|1098661|P2|NOT COMPLETED|Period 1- 1 Week||0
461242|NCT00564954|1098662|P1|NOT COMPLETED|Period 1- 1 Week||0
461243|NCT00564954|1098661|P2|COMPLETED|Period 1- 1 Week||42
461244|NCT00564954|1098662|P1|COMPLETED|Period 1- 1 Week||44
461245|NCT00564954|1098661|P2|STARTED|Period 1- 1 Week||42
461246|NCT00564954|1098662|P1|STARTED|Period 1- 1 Week||44
461247|NCT00564902|1098681|P3|NOT COMPLETED|Overall Study||4
461248|NCT00564902|1098682|P2|NOT COMPLETED|Overall Study||4
461249|NCT00564902|1098683|P1|NOT COMPLETED|Overall Study||1
461250|NCT00564902|1098681|P3|COMPLETED|Overall Study||21
461251|NCT00564902|1098682|P2|COMPLETED|Overall Study||21
461252|NCT00564902|1098683|P1|COMPLETED|Overall Study||9
461253|NCT00564902|1098681|P3|12 Months|Overall Study||21
461254|NCT00564902|1098682|P2|12 Months|Overall Study||21
461255|NCT00564902|1098683|P1|12 Months|Overall Study||9
461256|NCT00564902|1098681|P3|8 Months|Overall Study||21
461257|NCT00564902|1098682|P2|8 Months|Overall Study||22
461258|NCT00564902|1098683|P1|8 Months|Overall Study||9
461259|NCT00564902|1098681|P3|4 Months|Overall Study||23
461260|NCT00564902|1098682|P2|4 Months|Overall Study||24
461261|NCT00564902|1098683|P1|4 Months|Overall Study||9
461262|NCT00564902|1098681|P3|STARTED|Overall Study||25
461263|NCT00564902|1098682|P2|STARTED|Overall Study||25
461264|NCT00564902|1098683|P1|STARTED|Overall Study||10
461265|NCT00564889|1098715|P1|NOT COMPLETED|Overall Study||29
461266|NCT00564889|1098715|P1|COMPLETED|Overall Study||6
461267|NCT00564889|1098715|P1|STARTED|Overall Study||35
461268|NCT00564876|1098723|P1|NOT COMPLETED|Overall Study||0
461269|NCT00564876|1098723|P1|COMPLETED|Overall Study||2
461270|NCT00564876|1098723|P1|STARTED|Overall Study||2
461271|NCT00564850|1098730|P1|NOT COMPLETED|Overall Study||2
461272|NCT00564850|1098730|P1|COMPLETED|Overall Study||35
461273|NCT00564850|1098730|P1|STARTED|Overall Study||37
461274|NCT00564733|1098748|P1|NOT COMPLETED|Overall Study||9
461275|NCT00564733|1098748|P1|COMPLETED|Overall Study||46
461276|NCT00564733|1098748|P1|STARTED|Overall Study||55
461277|NCT00564681|1098756|P4|NOT COMPLETED|Overall Study||2
461278|NCT00564681|1098757|P3|NOT COMPLETED|Overall Study||3
461279|NCT00564681|1098758|P2|NOT COMPLETED|Overall Study||3
461280|NCT00564681|1098759|P1|NOT COMPLETED|Overall Study||11
461281|NCT00564681|1098756|P4|COMPLETED|Overall Study||19
461282|NCT00564681|1098757|P3|COMPLETED|Overall Study||40
461283|NCT00564681|1098758|P2|COMPLETED|Overall Study||58
461284|NCT00564681|1098759|P1|COMPLETED|Overall Study||106
461285|NCT00564681|1098756|P4|STARTED|Overall Study||21
461286|NCT00564681|1098757|P3|STARTED|Overall Study||43
461287|NCT00564681|1098758|P2|STARTED|Overall Study||61
461288|NCT00564681|1098759|P1|STARTED|Overall Study||117
461289|NCT00564629|1098782|P2|NOT COMPLETED|Overall Study||9
461290|NCT00564629|1098783|P1|NOT COMPLETED|Overall Study||15
461291|NCT00564629|1098782|P2|COMPLETED|Overall Study||45
461292|NCT00564629|1098783|P1|COMPLETED|Overall Study||36
461293|NCT00564629|1098782|P2|STARTED|Overall Study||54
461294|NCT00564629|1098783|P1|STARTED|Overall Study||51
461295|NCT00564486|1098808|P4|NOT COMPLETED|Overall Study||7
461296|NCT00564486|1098809|P3|NOT COMPLETED|Overall Study||3
461297|NCT00564486|1098810|P2|NOT COMPLETED|Overall Study||1
461298|NCT00564486|1098811|P1|NOT COMPLETED|Overall Study||7
461299|NCT00564486|1098808|P4|COMPLETED|Overall Study||60
461300|NCT00564486|1098809|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
461301|NCT00564486|1098810|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
461302|NCT00564486|1098811|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
461303|NCT00564486|1098808|P4|STARTED|Overall Study||67
461304|NCT00564486|1098809|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
461305|NCT00564486|1098810|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
461306|NCT00564486|1098811|P1|STARTED|Overall Study||43
461307|NCT00564447|1098835|P8|NOT COMPLETED|Overall Study||0
461308|NCT00564447|1098836|P7|NOT COMPLETED|Overall Study||0
461309|NCT00564447|1098837|P6|NOT COMPLETED|Overall Study||0
461310|NCT00564447|1098838|P5|NOT COMPLETED|Overall Study||0
461311|NCT00564447|1098839|P4|NOT COMPLETED|Overall Study||0
461312|NCT00564447|1098840|P3|NOT COMPLETED|Overall Study||0
461313|NCT00564447|1098841|P2|NOT COMPLETED|Overall Study||0
461314|NCT00564447|1098842|P1|NOT COMPLETED|Overall Study||0
461315|NCT00564447|1098835|P8|COMPLETED|Overall Study||6
461316|NCT00564447|1098836|P7|COMPLETED|Overall Study||6
461317|NCT00564447|1098837|P6|COMPLETED|Overall Study||6
461318|NCT00564447|1098838|P5|COMPLETED|Overall Study||6
461319|NCT00564447|1098839|P4|COMPLETED|Overall Study||6
461320|NCT00564447|1098840|P3|COMPLETED|Overall Study||6
461321|NCT00564447|1098841|P2|COMPLETED|Overall Study||6
461322|NCT00564447|1098842|P1|COMPLETED|Overall Study||6
461323|NCT00564447|1098835|P8|STARTED|Overall Study||6
461324|NCT00564447|1098836|P7|STARTED|Overall Study||6
461325|NCT00564447|1098837|P6|STARTED|Overall Study||6
461326|NCT00564447|1098838|P5|STARTED|Overall Study||6
461327|NCT00564447|1098839|P4|STARTED|Overall Study||6
461328|NCT00564447|1098840|P3|STARTED|Overall Study||6
461329|NCT00564447|1098841|P2|STARTED|Overall Study||6
461330|NCT00564447|1098842|P1|STARTED|Overall Study||6
461331|NCT00564278|1098862|P2|NOT COMPLETED|Overall Study||42
461332|NCT00564278|1098863|P1|NOT COMPLETED|Overall Study||47
461333|NCT00564278|1098862|P2|COMPLETED|Overall Study||56
461334|NCT00564278|1098863|P1|COMPLETED|Overall Study||50
461335|NCT00564278|1098862|P2|STARTED|Overall Study||98
461336|NCT00564278|1098863|P1|STARTED|Overall Study||97
461337|NCT00564265|1098879|P1|NOT COMPLETED|Overall Study||0
461338|NCT00564265|1098879|P1|COMPLETED|Overall Study||24
461339|NCT00564265|1098879|P1|STARTED|Overall Study||24
461340|NCT00563797|1098885|P2|NOT COMPLETED|Overall Study||2
461341|NCT00563797|1098886|P1|NOT COMPLETED|Overall Study||7
461342|NCT00563797|1098885|P2|COMPLETED|Overall Study||8
461343|NCT00563797|1098886|P1|COMPLETED|Overall Study||4
461344|NCT00563797|1098885|P2|Follow-Up|Overall Study||10
461345|NCT00563797|1098886|P1|Follow-Up|Overall Study||11
461346|NCT00563797|1098885|P2|Received Allocated Intervention|Overall Study||10
461347|NCT00563797|1098886|P1|Received Allocated Intervention|Overall Study||11
461348|NCT00563797|1098885|P2|STARTED|Overall Study||10
461349|NCT00563797|1098886|P1|STARTED|Overall Study||11
461350|NCT00563706|1098907|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461351|NCT00563706|1098908|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461352|NCT00563706|1098909|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461353|NCT00563706|1098910|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461354|NCT00563706|1098911|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461355|NCT00563706|1098912|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461356|NCT00563706|1098913|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461357|NCT00563706|1098914|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461358|NCT00563706|1098915|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
461359|NCT00563706|1098907|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
461360|NCT00563706|1098908|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
461361|NCT00563706|1098909|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
461362|NCT00563706|1098910|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
461363|NCT00563706|1098911|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
461364|NCT00563706|1098912|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
461365|NCT00563706|1098913|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
461366|NCT00563706|1098914|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
461367|NCT00563706|1098915|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
461368|NCT00563706|1098907|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
461369|NCT00563706|1098908|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
461370|NCT00563706|1098909|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
461371|NCT00563706|1098910|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
461372|NCT00563706|1098911|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
461373|NCT00563706|1098912|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
461374|NCT00563706|1098913|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
461375|NCT00563706|1098914|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
461376|NCT00563706|1098915|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
461377|NCT00563706|1098907|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
461378|NCT00563706|1098908|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
461379|NCT00563706|1098909|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
461380|NCT00563706|1098910|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
461381|NCT00563706|1098911|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
461382|NCT00563706|1098912|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
461383|NCT00563706|1098913|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
461384|NCT00563706|1098914|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
461385|NCT00563706|1098915|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
461386|NCT00563706|1098907|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
461387|NCT00563706|1098908|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
461388|NCT00563706|1098909|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
461389|NCT00563706|1098910|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
461390|NCT00563706|1098911|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
461391|NCT00563706|1098912|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
461392|NCT00563706|1098913|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
461393|NCT00563706|1098914|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
461394|NCT00563706|1098915|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
461395|NCT00563706|1098907|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
461396|NCT00563706|1098908|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
461397|NCT00563706|1098909|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
461398|NCT00563706|1098910|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
461399|NCT00563706|1098911|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
461400|NCT00563706|1098912|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
461401|NCT00563706|1098913|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
461402|NCT00563706|1098914|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
461403|NCT00563706|1098915|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
461404|NCT00563576|1099018|P2|NOT COMPLETED|Overall Study||14
461405|NCT00563576|1099019|P1|NOT COMPLETED|Overall Study||14
461406|NCT00563576|1099018|P2|COMPLETED|Overall Study||22
461407|NCT00563576|1099019|P1|COMPLETED|Overall Study||21
461408|NCT00563576|1099018|P2|STARTED|Overall Study||36
461409|NCT00563576|1099019|P1|STARTED|Overall Study||35
461410|NCT00563381|1099031|P2|NOT COMPLETED|Overall Study||648
461411|NCT00563381|1099032|P1|NOT COMPLETED|Overall Study||585
461412|NCT00563381|1099031|P2|COMPLETED|Overall Study|Completed treatment|3021
461413|NCT00563381|1099032|P1|COMPLETED|Overall Study|Completed treatment|3122
461414|NCT00563381|1099031|P2|STARTED|Overall Study|Started treatment|3669
461415|NCT00563381|1099032|P1|STARTED|Overall Study|Started treatment|3707
461416|NCT00563368|1099105|P7|NOT COMPLETED|Overall Study||33
461417|NCT00563368|1099106|P6|NOT COMPLETED|Overall Study||30
461418|NCT00563368|1099107|P5|NOT COMPLETED|Overall Study||28
461419|NCT00563368|1099108|P4|NOT COMPLETED|Overall Study||29
461420|NCT00563368|1099109|P3|NOT COMPLETED|Overall Study||30
461421|NCT00563368|1099110|P2|NOT COMPLETED|Overall Study||30
461422|NCT00563368|1099111|P1|NOT COMPLETED|Overall Study||35
461423|NCT00563368|1099105|P7|COMPLETED|Overall Study||75
461424|NCT00563368|1099106|P6|COMPLETED|Overall Study||77
461425|NCT00563368|1099107|P5|COMPLETED|Overall Study||80
461426|NCT00563368|1099108|P4|COMPLETED|Overall Study||78
461427|NCT00563368|1099109|P3|COMPLETED|Overall Study||78
461428|NCT00563368|1099110|P2|COMPLETED|Overall Study||79
461429|NCT00563368|1099111|P1|COMPLETED|Overall Study||74
461430|NCT00563368|1099105|P7|STARTED|Overall Study||108
461431|NCT00563368|1099106|P6|STARTED|Overall Study||107
461432|NCT00563368|1099107|P5|STARTED|Overall Study||108
461433|NCT00563368|1099108|P4|STARTED|Overall Study||107
461434|NCT00563368|1099109|P3|STARTED|Overall Study||108
461435|NCT00563368|1099110|P2|STARTED|Overall Study||109
461436|NCT00563368|1099111|P1|STARTED|Overall Study||109
461437|NCT00563316|1099134|P1|NOT COMPLETED|Overall Study||12
461438|NCT00563316|1099134|P1|COMPLETED|Overall Study||16
461439|NCT00563316|1099134|P1|Received Investigational Product|Overall Study||27
461440|NCT00563316|1099134|P1|STARTED|Overall Study||28
461441|NCT00563290|1099147|P2|NOT COMPLETED|Overall Study||0
461442|NCT00563290|1099148|P1|NOT COMPLETED|Overall Study||0
461443|NCT00563290|1099147|P2|COMPLETED|Overall Study||4
461444|NCT00563290|1099148|P1|COMPLETED|Overall Study||3
461445|NCT00563290|1099147|P2|STARTED|Overall Study||4
461446|NCT00563290|1099148|P1|STARTED|Overall Study||3
461447|NCT00562861|1099159|P2|NOT COMPLETED|Overall Study||11
461448|NCT00562861|1099160|P1|NOT COMPLETED|Overall Study||20
461449|NCT00562861|1099159|P2|COMPLETED|Overall Study||48
461450|NCT00562861|1099160|P1|COMPLETED|Overall Study||40
461451|NCT00562861|1099159|P2|STARTED|Overall Study||59
461452|NCT00562861|1099160|P1|STARTED|Overall Study||60
461453|NCT00562627|1099169|P3|NOT COMPLETED|Overall Study||1
461454|NCT00562627|1099170|P2|NOT COMPLETED|Overall Study||1
461455|NCT00562627|1099171|P1|NOT COMPLETED|Overall Study||1
461456|NCT00562627|1099169|P3|COMPLETED|Overall Study||33
461457|NCT00562627|1099170|P2|COMPLETED|Overall Study||33
461458|NCT00562627|1099171|P1|COMPLETED|Overall Study||33
461459|NCT00562627|1099169|P3|STARTED|Overall Study||34
461460|NCT00562627|1099170|P2|STARTED|Overall Study||34
461461|NCT00562627|1099171|P1|STARTED|Overall Study||34
461462|NCT00562588|1099187|P2|NOT COMPLETED|Overall Study||99
461463|NCT00562588|1099188|P1|NOT COMPLETED|Overall Study||92
461464|NCT00562588|1099187|P2|COMPLETED|Overall Study||184
461465|NCT00562588|1099188|P1|COMPLETED|Overall Study||168
461466|NCT00562588|1099187|P2|STARTED|Overall Study||283
461467|NCT00562588|1099188|P1|STARTED|Overall Study||260
461468|NCT00562484|1099218|P2|NOT COMPLETED|Overall Study||104
461469|NCT00562484|1099219|P1|NOT COMPLETED|Overall Study||206
461470|NCT00562484|1099218|P2|COMPLETED|Overall Study||4907
461471|NCT00562484|1099219|P1|COMPLETED|Overall Study||9827
461472|NCT00562484|1099218|P2|STARTED|Overall Study||5011
461473|NCT00562484|1099219|P1|STARTED|Overall Study||10033
461474|NCT00562354|1099251|P2|NOT COMPLETED|Overall Study||2
461475|NCT00562354|1099252|P1|NOT COMPLETED|Overall Study||0
461476|NCT00562354|1099251|P2|COMPLETED|Overall Study||135
461477|NCT00562354|1099252|P1|COMPLETED|Overall Study||134
461478|NCT00562354|1099251|P2|Evaluable Immunogenicity Population|Overall Study||134
461479|NCT00562354|1099252|P1|Evaluable Immunogenicity Population|Overall Study||134
461480|NCT00562354|1099251|P2|Received Study Treatment|Overall Study||136
461481|NCT00562354|1099252|P1|Received Study Treatment|Overall Study||134
461482|NCT00562354|1099251|P2|STARTED|Overall Study||137
461483|NCT00562354|1099252|P1|STARTED|Overall Study||134
461484|NCT00562328|1099293|P1|NOT COMPLETED|Overall Study||0
461485|NCT00562328|1099293|P1|COMPLETED|Overall Study||33
461486|NCT00562328|1099293|P1|STARTED|Overall Study||33
461487|NCT00562315|1099297|P1|NOT COMPLETED|Overall Study||0
461488|NCT00562315|1099297|P1|COMPLETED|Overall Study||93
461489|NCT00562315|1099297|P1|STARTED|Overall Study||93
461490|NCT00562302|1099314|P2|NOT COMPLETED|Overall Study||32
461491|NCT00562302|1099315|P1|NOT COMPLETED|Overall Study||20
461492|NCT00562302|1099314|P2|COMPLETED|Overall Study||137
461493|NCT00562302|1099315|P1|COMPLETED|Overall Study||150
461494|NCT00562302|1099314|P2|STARTED|Overall Study||169
461495|NCT00562302|1099315|P1|STARTED|Overall Study||170
461496|NCT00562159|1099337|P2|NOT COMPLETED|Overall Study||33
461497|NCT00562159|1099338|P1|NOT COMPLETED|Overall Study||38
461498|NCT00562159|1099337|P2|COMPLETED|Overall Study||192
461499|NCT00562159|1099338|P1|COMPLETED|Overall Study||175
461500|NCT00562159|1099337|P2|STARTED|Overall Study||225
461501|NCT00562159|1099338|P1|STARTED|Overall Study||213
461502|NCT00562120|1099350|P4|NOT COMPLETED|Fourth Intervention Period||0
461503|NCT00562120|1099351|P3|NOT COMPLETED|Fourth Intervention Period||0
461504|NCT00562120|1099352|P2|NOT COMPLETED|Fourth Intervention Period||0
461505|NCT00562120|1099353|P1|NOT COMPLETED|Fourth Intervention Period||0
461506|NCT00562120|1099350|P4|COMPLETED|Fourth Intervention Period||5
461507|NCT00562120|1099351|P3|COMPLETED|Fourth Intervention Period||5
461508|NCT00562120|1099352|P2|COMPLETED|Fourth Intervention Period||5
461509|NCT00562120|1099353|P1|COMPLETED|Fourth Intervention Period||4
461510|NCT00562120|1099350|P4|STARTED|Fourth Intervention Period||5
461511|NCT00562120|1099351|P3|STARTED|Fourth Intervention Period||5
461512|NCT00562120|1099352|P2|STARTED|Fourth Intervention Period||5
461513|NCT00562120|1099353|P1|STARTED|Fourth Intervention Period||4
461514|NCT00562120|1099350|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
461515|NCT00562120|1099351|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
461516|NCT00562120|1099352|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
461517|NCT00562120|1099353|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
461518|NCT00562120|1099350|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
461519|NCT00562120|1099351|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
461520|NCT00562120|1099352|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
461521|NCT00562120|1099353|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
461522|NCT00562120|1099350|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
461523|NCT00562120|1099351|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
461524|NCT00562120|1099352|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
461525|NCT00562120|1099353|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
461526|NCT00562120|1099350|P4|NOT COMPLETED|Third Intervention Period||0
461527|NCT00562120|1099351|P3|NOT COMPLETED|Third Intervention Period||0
461528|NCT00562120|1099352|P2|NOT COMPLETED|Third Intervention Period||0
461529|NCT00562120|1099353|P1|NOT COMPLETED|Third Intervention Period||0
461530|NCT00562120|1099350|P4|COMPLETED|Third Intervention Period||5
461531|NCT00562120|1099351|P3|COMPLETED|Third Intervention Period||5
461532|NCT00562120|1099352|P2|COMPLETED|Third Intervention Period||5
461533|NCT00562120|1099353|P1|COMPLETED|Third Intervention Period||4
461534|NCT00562120|1099350|P4|STARTED|Third Intervention Period||5
461535|NCT00562120|1099351|P3|STARTED|Third Intervention Period||5
461536|NCT00562120|1099352|P2|STARTED|Third Intervention Period||5
461537|NCT00562120|1099353|P1|STARTED|Third Intervention Period||4
461538|NCT00562120|1099350|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
461539|NCT00562120|1099351|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
461540|NCT00562120|1099352|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
461541|NCT00562120|1099353|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
461542|NCT00562120|1099350|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
461543|NCT00562120|1099351|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
461544|NCT00562120|1099352|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
461545|NCT00562120|1099353|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
461546|NCT00562120|1099350|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
461547|NCT00562120|1099351|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
461548|NCT00562120|1099352|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
461549|NCT00562120|1099353|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
461550|NCT00562120|1099350|P4|NOT COMPLETED|Second Intervention Period||0
461551|NCT00562120|1099351|P3|NOT COMPLETED|Second Intervention Period||0
461552|NCT00562120|1099352|P2|NOT COMPLETED|Second Intervention Period||0
461553|NCT00562120|1099353|P1|NOT COMPLETED|Second Intervention Period||0
461554|NCT00562120|1099350|P4|COMPLETED|Second Intervention Period||5
461555|NCT00562120|1099351|P3|COMPLETED|Second Intervention Period||5
461556|NCT00562120|1099352|P2|COMPLETED|Second Intervention Period||5
461557|NCT00562120|1099353|P1|COMPLETED|Second Intervention Period||4
461558|NCT00562120|1099350|P4|STARTED|Second Intervention Period||5
461559|NCT00562120|1099351|P3|STARTED|Second Intervention Period||5
461560|NCT00562120|1099352|P2|STARTED|Second Intervention Period||5
461561|NCT00562120|1099353|P1|STARTED|Second Intervention Period||4
461562|NCT00562120|1099350|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
461563|NCT00562120|1099351|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
461564|NCT00562120|1099352|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
461565|NCT00562120|1099353|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
461566|NCT00562120|1099350|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
461567|NCT00562120|1099351|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
461568|NCT00562120|1099352|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
461569|NCT00562120|1099353|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
461570|NCT00562120|1099350|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
461571|NCT00562120|1099351|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
461572|NCT00562120|1099352|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
461573|NCT00562120|1099353|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
461574|NCT00562120|1099350|P4|NOT COMPLETED|First Intervention Period||0
461575|NCT00562120|1099351|P3|NOT COMPLETED|First Intervention Period||0
461576|NCT00562120|1099352|P2|NOT COMPLETED|First Intervention Period||0
461577|NCT00562120|1099353|P1|NOT COMPLETED|First Intervention Period||2
461578|NCT00562120|1099350|P4|COMPLETED|First Intervention Period||5
461579|NCT00562120|1099351|P3|COMPLETED|First Intervention Period||5
461580|NCT00562120|1099352|P2|COMPLETED|First Intervention Period||5
461581|NCT00562120|1099353|P1|COMPLETED|First Intervention Period||4
461582|NCT00562120|1099350|P4|Treated|First Intervention Period||5
461583|NCT00562120|1099351|P3|Treated|First Intervention Period||5
461584|NCT00562120|1099352|P2|Treated|First Intervention Period||5
461585|NCT00562120|1099353|P1|Treated|First Intervention Period||5
461586|NCT00562120|1099350|P4|STARTED|First Intervention Period||5
461587|NCT00562120|1099351|P3|STARTED|First Intervention Period||5
461588|NCT00562120|1099352|P2|STARTED|First Intervention Period||5
461589|NCT00562120|1099353|P1|STARTED|First Intervention Period||6
461590|NCT00562094|1099385|P1|NOT COMPLETED|Overall Study||62
461591|NCT00562094|1099385|P1|COMPLETED|Overall Study||8554
461592|NCT00562094|1099385|P1|STARTED|Overall Study||8616
461593|NCT00561977|1099400|P3|NOT COMPLETED|Overall Study||2
461594|NCT00561977|1099401|P2|NOT COMPLETED|Overall Study||3
461595|NCT00561977|1099402|P1|NOT COMPLETED|Overall Study||0
461596|NCT00561977|1099400|P3|COMPLETED|Overall Study||10
461597|NCT00561977|1099401|P2|COMPLETED|Overall Study||9
461598|NCT00561977|1099402|P1|COMPLETED|Overall Study||12
461599|NCT00561977|1099400|P3|STARTED|Overall Study||12
461600|NCT00561977|1099401|P2|STARTED|Overall Study||12
461601|NCT00561977|1099402|P1|STARTED|Overall Study||12
461602|NCT00561951|1099428|P3|NOT COMPLETED|Overall Study||32
461603|NCT00561951|1099429|P2|NOT COMPLETED|Overall Study||34
461604|NCT00561951|1099430|P1|NOT COMPLETED|Overall Study||33
461605|NCT00561951|1099428|P3|COMPLETED|Overall Study||281
461606|NCT00561951|1099429|P2|COMPLETED|Overall Study||286
461607|NCT00561951|1099430|P1|COMPLETED|Overall Study||285
461608|NCT00561951|1099428|P3|STARTED|Overall Study||313
461609|NCT00561951|1099429|P2|STARTED|Overall Study||320
461610|NCT00561951|1099430|P1|STARTED|Overall Study||318
461611|NCT00561925|1099486|P5|NOT COMPLETED|Open-Label Extension Period||50
461612|NCT00561925|1099487|P4|NOT COMPLETED|Open-Label Extension Period||43
461613|NCT00561925|1099488|P3|NOT COMPLETED|Open-Label Extension Period||0
461614|NCT00561925|1099489|P2|NOT COMPLETED|Open-Label Extension Period||0
461615|NCT00561925|1099490|P1|NOT COMPLETED|Open-Label Extension Period||0
461616|NCT00561925|1099486|P5|COMPLETED|Open-Label Extension Period||328
461617|NCT00561925|1099487|P4|COMPLETED|Open-Label Extension Period||315
461618|NCT00561925|1099488|P3|COMPLETED|Open-Label Extension Period||0
461619|NCT00561925|1099489|P2|COMPLETED|Open-Label Extension Period||1
461620|NCT00561925|1099490|P1|COMPLETED|Open-Label Extension Period||0
461621|NCT00561925|1099486|P5|STARTED|Open-Label Extension Period||378
461622|NCT00561925|1099487|P4|STARTED|Open-Label Extension Period||358
461623|NCT00561925|1099488|P3|STARTED|Open-Label Extension Period||0
461624|NCT00561925|1099489|P2|STARTED|Open-Label Extension Period||1
461625|NCT00561925|1099490|P1|STARTED|Open-Label Extension Period||0
461626|NCT00561925|1099486|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
461627|NCT00561925|1099487|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
461628|NCT00561925|1099488|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
461629|NCT00561925|1099489|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
461630|NCT00561925|1099490|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
461631|NCT00561925|1099486|P5|COMPLETED|144-week Double-blind, Double-dummy||0
461632|NCT00561925|1099487|P4|COMPLETED|144-week Double-blind, Double-dummy||0
461633|NCT00561925|1099488|P3|COMPLETED|144-week Double-blind, Double-dummy||378
461634|NCT00561925|1099489|P2|COMPLETED|144-week Double-blind, Double-dummy||358
461635|NCT00561925|1099490|P1|COMPLETED|144-week Double-blind, Double-dummy||0
461636|NCT00561925|1099486|P5|STARTED|144-week Double-blind, Double-dummy||0
461637|NCT00561925|1099487|P4|STARTED|144-week Double-blind, Double-dummy||0
461638|NCT00561925|1099488|P3|STARTED|144-week Double-blind, Double-dummy||505
461639|NCT00561925|1099489|P2|STARTED|144-week Double-blind, Double-dummy||508
461640|NCT00561925|1099490|P1|STARTED|144-week Double-blind, Double-dummy||0
461641|NCT00561925|1099486|P5|NOT COMPLETED|14 Day Lead-In Period||0
461642|NCT00561925|1099487|P4|NOT COMPLETED|14 Day Lead-In Period||0
461643|NCT00561925|1099488|P3|NOT COMPLETED|14 Day Lead-In Period||0
461644|NCT00561925|1099489|P2|NOT COMPLETED|14 Day Lead-In Period||0
461645|NCT00561925|1099490|P1|NOT COMPLETED|14 Day Lead-In Period||55
461646|NCT00561925|1099486|P5|COMPLETED|14 Day Lead-In Period||0
461647|NCT00561925|1099487|P4|COMPLETED|14 Day Lead-In Period||0
461648|NCT00561925|1099488|P3|COMPLETED|14 Day Lead-In Period||0
461649|NCT00561925|1099489|P2|COMPLETED|14 Day Lead-In Period||0
461650|NCT00561925|1099490|P1|COMPLETED|14 Day Lead-In Period||1013
461651|NCT00561925|1099486|P5|STARTED|14 Day Lead-In Period||0
461652|NCT00561925|1099487|P4|STARTED|14 Day Lead-In Period||0
461653|NCT00561925|1099488|P3|STARTED|14 Day Lead-In Period||0
461654|NCT00561925|1099489|P2|STARTED|14 Day Lead-In Period||0
461655|NCT00561925|1099490|P1|STARTED|14 Day Lead-In Period||1068
461656|NCT00561912|1099539|P1|NOT COMPLETED|Overall Study||1
461657|NCT00561912|1099539|P1|COMPLETED|Overall Study||1
461658|NCT00561912|1099539|P1|STARTED|Overall Study||2
461659|NCT00561834|1099543|P1|NOT COMPLETED|Overall Study||0
461660|NCT00561834|1099543|P1|COMPLETED|Overall Study||2
461661|NCT00561834|1099543|P1|STARTED|Overall Study||2
461662|NCT00561821|1099551|P4|NOT COMPLETED|Overall Study||3
461663|NCT00561821|1099552|P3|NOT COMPLETED|Overall Study||2
461664|NCT00561821|1099553|P2|NOT COMPLETED|Overall Study||6
461665|NCT00561821|1099554|P1|NOT COMPLETED|Overall Study||5
461666|NCT00561821|1099551|P4|COMPLETED|Overall Study||133
461667|NCT00561821|1099552|P3|COMPLETED|Overall Study||132
461668|NCT00561821|1099553|P2|COMPLETED|Overall Study||130
461669|NCT00561821|1099554|P1|COMPLETED|Overall Study||127
461670|NCT00561821|1099551|P4|Treated|Overall Study||136
461671|NCT00561821|1099552|P3|Treated|Overall Study||133
461672|NCT00561821|1099553|P2|Treated|Overall Study||136
461673|NCT00561821|1099554|P1|Treated|Overall Study||132
461674|NCT00561821|1099551|P4|STARTED|Overall Study||136
461675|NCT00561821|1099552|P3|STARTED|Overall Study||134
461676|NCT00561821|1099553|P2|STARTED|Overall Study||136
461677|NCT00561821|1099554|P1|STARTED|Overall Study||132
461678|NCT00561795|1099630|P4|NOT COMPLETED|Overall Study||0
461679|NCT00561795|1099631|P3|NOT COMPLETED|Overall Study||0
461680|NCT00561795|1099632|P2|NOT COMPLETED|Overall Study||6
461681|NCT00561795|1099633|P1|NOT COMPLETED|Overall Study||4
461682|NCT00561795|1099630|P4|COMPLETED|Overall Study||0
461683|NCT00561795|1099631|P3|COMPLETED|Overall Study||0
461684|NCT00561795|1099632|P2|COMPLETED|Overall Study||0
461685|NCT00561795|1099633|P1|COMPLETED|Overall Study||2
461686|NCT00561795|1099630|P4|STARTED|Overall Study||0
461687|NCT00561795|1099631|P3|STARTED|Overall Study||0
461688|NCT00561795|1099632|P2|STARTED|Overall Study||6
461689|NCT00561795|1099633|P1|STARTED|Overall Study||6
461690|NCT00561730|1099653|P1|NOT COMPLETED|Overall Study||9
461691|NCT00561730|1099653|P1|COMPLETED|Overall Study||1986
461692|NCT00561730|1099653|P1|STARTED|Overall Study||1995
461693|NCT00561678|1099669|P2|NOT COMPLETED|Overall Study||6
461694|NCT00561678|1099670|P1|NOT COMPLETED|Overall Study||8
461695|NCT00561678|1099669|P2|COMPLETED|Overall Study||201
461696|NCT00561678|1099670|P1|COMPLETED|Overall Study||189
461697|NCT00561678|1099669|P2|STARTED|Overall Study||207
461698|NCT00561678|1099670|P1|STARTED|Overall Study||197
461699|NCT00561652|1099688|P2|NOT COMPLETED|Overall Study||1
461700|NCT00561652|1099689|P1|NOT COMPLETED|Overall Study||0
461701|NCT00561652|1099688|P2|COMPLETED|Overall Study||19
461702|NCT00561652|1099689|P1|COMPLETED|Overall Study||10
461703|NCT00561652|1099688|P2|STARTED|Overall Study||20
461704|NCT00561652|1099689|P1|STARTED|Overall Study||10
461705|NCT00561600|1099709|P2|NOT COMPLETED|Overall Study||16
461706|NCT00561600|1099710|P1|NOT COMPLETED|Overall Study||18
461707|NCT00561600|1099709|P2|COMPLETED|Overall Study||119
461708|NCT00561600|1099710|P1|COMPLETED|Overall Study||112
461709|NCT00561600|1099709|P2|STARTED|Overall Study||135
461710|NCT00561600|1099710|P1|STARTED|Overall Study||130
461711|NCT00561574|1099772|P2|NOT COMPLETED|Overall Study||58
461712|NCT00561574|1099773|P1|NOT COMPLETED|Overall Study||48
461713|NCT00561574|1099772|P2|COMPLETED|Overall Study||73
461714|NCT00561574|1099773|P1|COMPLETED|Overall Study||80
461715|NCT00561574|1099772|P2|STARTED|Overall Study||131
461716|NCT00561574|1099773|P1|STARTED|Overall Study||128
461717|NCT00561470|1099799|P2|NOT COMPLETED|Overall Study||612
461718|NCT00561470|1099800|P1|NOT COMPLETED|Overall Study||614
461719|NCT00561470|1099799|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
461720|NCT00561470|1099800|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
461721|NCT00561470|1099799|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
461722|NCT00561470|1099800|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
461723|NCT00561470|1099799|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
461724|NCT00561470|1099800|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
461725|NCT00561470|1099799|P2|TREATED|Overall Study||607
461726|NCT00561470|1099800|P1|TREATED|Overall Study||609
461727|NCT00561470|1099799|P2|STARTED|Overall Study||612
461728|NCT00561470|1099800|P1|STARTED|Overall Study||614
461729|NCT00561457|1099814|P1|NOT COMPLETED|Overall Study||24
461730|NCT00561457|1099814|P1|COMPLETED|Overall Study||110
461731|NCT00561457|1099814|P1|STARTED|Overall Study||134
461732|NCT00561431|1099820|P2|NOT COMPLETED|Overall Study||0
461733|NCT00561431|1099821|P1|NOT COMPLETED|Overall Study||0
461734|NCT00561431|1099820|P2|COMPLETED|Overall Study||100
461735|NCT00561431|1099821|P1|COMPLETED|Overall Study||100
461736|NCT00561431|1099820|P2|STARTED|Overall Study||100
461737|NCT00561431|1099821|P1|STARTED|Overall Study||100
461738|NCT00561418|1099829|P1|NOT COMPLETED|Overall Study||0
461739|NCT00561418|1099829|P1|COMPLETED|Overall Study||23
461740|NCT00561418|1099829|P1|STARTED|Overall Study||23
461741|NCT00561392|1099836|P1|NOT COMPLETED|Overall Study||53
461742|NCT00561392|1099836|P1|COMPLETED|Overall Study||155
461743|NCT00561392|1099836|P1|STARTED|Overall Study||208
461744|NCT00561353|1099858|P10|NOT COMPLETED|Overall Study||2
461745|NCT00561353|1099859|P9|NOT COMPLETED|Overall Study||7
461746|NCT00561353|1099860|P8|NOT COMPLETED|Overall Study||4
461747|NCT00561353|1099861|P7|NOT COMPLETED|Overall Study||6
461748|NCT00561353|1099862|P6|NOT COMPLETED|Overall Study||6
461749|NCT00561353|1099863|P5|NOT COMPLETED|Overall Study||1
461750|NCT00561353|1099864|P4|NOT COMPLETED|Overall Study||6
461751|NCT00561353|1099865|P3|NOT COMPLETED|Overall Study||3
461752|NCT00561353|1099866|P2|NOT COMPLETED|Overall Study||3
461753|NCT00561353|1099867|P1|NOT COMPLETED|Overall Study||5
461754|NCT00561353|1099858|P10|COMPLETED|Overall Study||3
461755|NCT00561353|1099859|P9|COMPLETED|Overall Study||2
461756|NCT00561353|1099860|P8|COMPLETED|Overall Study||6
461757|NCT00561353|1099861|P7|COMPLETED|Overall Study||3
461758|NCT00561353|1099862|P6|COMPLETED|Overall Study||3
461759|NCT00561353|1099863|P5|COMPLETED|Overall Study||5
461760|NCT00561353|1099864|P4|COMPLETED|Overall Study||12
461761|NCT00561353|1099865|P3|COMPLETED|Overall Study||10
461762|NCT00561353|1099866|P2|COMPLETED|Overall Study||16
461763|NCT00561353|1099867|P1|COMPLETED|Overall Study||13
461764|NCT00561353|1099858|P10|STARTED|Overall Study||5
461765|NCT00561353|1099859|P9|STARTED|Overall Study||9
461766|NCT00561353|1099860|P8|STARTED|Overall Study||10
461767|NCT00561353|1099861|P7|STARTED|Overall Study||9
461768|NCT00561353|1099862|P6|STARTED|Overall Study||9
461769|NCT00561353|1099863|P5|STARTED|Overall Study||6
461770|NCT00561353|1099864|P4|STARTED|Overall Study||18
461771|NCT00561353|1099865|P3|STARTED|Overall Study||13
461772|NCT00561353|1099866|P2|STARTED|Overall Study||19
461773|NCT00561353|1099867|P1|STARTED|Overall Study||18
461774|NCT00561340|1100022|P2|NOT COMPLETED|Overall Study||0
461775|NCT00561340|1100023|P1|NOT COMPLETED|Overall Study||6
461776|NCT00561340|1100022|P2|COMPLETED|Overall Study||16
461777|NCT00561340|1100023|P1|COMPLETED|Overall Study||7
461778|NCT00561340|1100022|P2|STARTED|Overall Study||16
461779|NCT00561340|1100023|P1|STARTED|Overall Study||13
461780|NCT00561145|1100033|P2|NOT COMPLETED|Overall Study||0
461781|NCT00561145|1100034|P1|NOT COMPLETED|Overall Study||0
461782|NCT00561145|1100033|P2|COMPLETED|Overall Study||17
461783|NCT00561145|1100034|P1|COMPLETED|Overall Study||15
461784|NCT00561145|1100033|P2|STARTED|Overall Study||17
461785|NCT00561145|1100034|P1|STARTED|Overall Study||15
461786|NCT00561015|1100046|P6|NOT COMPLETED|Overall Study||3
461787|NCT00561015|1100047|P5|NOT COMPLETED|Overall Study||1
461788|NCT00561015|1100048|P4|NOT COMPLETED|Overall Study||1
461789|NCT00561015|1100049|P3|NOT COMPLETED|Overall Study||0
461790|NCT00561015|1100050|P2|NOT COMPLETED|Overall Study||0
461791|NCT00561015|1100051|P1|NOT COMPLETED|Overall Study||4
461792|NCT00561015|1100046|P6|COMPLETED|Overall Study||6
461793|NCT00561015|1100047|P5|COMPLETED|Overall Study||8
461794|NCT00561015|1100048|P4|COMPLETED|Overall Study||7
461795|NCT00561015|1100049|P3|COMPLETED|Overall Study||9
461796|NCT00561015|1100050|P2|COMPLETED|Overall Study||5
461797|NCT00561015|1100051|P1|COMPLETED|Overall Study||5
461798|NCT00561015|1100046|P6|STARTED|Overall Study||9
461799|NCT00561015|1100047|P5|STARTED|Overall Study||9
461800|NCT00561015|1100048|P4|STARTED|Overall Study||8
461801|NCT00561015|1100049|P3|STARTED|Overall Study||9
461802|NCT00561015|1100050|P2|STARTED|Overall Study||5
461803|NCT00561015|1100051|P1|STARTED|Overall Study||9
461804|NCT00561002|1100127|P2|NOT COMPLETED|Overall Study||0
461805|NCT00561002|1100128|P1|NOT COMPLETED|Overall Study||0
461806|NCT00561002|1100127|P2|COMPLETED|Overall Study||9
461807|NCT00561002|1100128|P1|COMPLETED|Overall Study||23
461808|NCT00561002|1100127|P2|STARTED|Overall Study||9
461809|NCT00561002|1100128|P1|STARTED|Overall Study||23
461810|NCT00560950|1100142|P2|NOT COMPLETED|Overall Study||0
461811|NCT00560950|1100143|P1|NOT COMPLETED|Overall Study||1
461812|NCT00560950|1100142|P2|COMPLETED|Overall Study||71
461813|NCT00560950|1100143|P1|COMPLETED|Overall Study||71
461814|NCT00560950|1100142|P2|STARTED|Overall Study||71
461815|NCT00560950|1100143|P1|STARTED|Overall Study||72
461816|NCT00560937|1100181|P2|NOT COMPLETED|Overall Study||2
461817|NCT00560937|1100182|P1|NOT COMPLETED|Overall Study||1
461818|NCT00560937|1100181|P2|COMPLETED|Overall Study||9
461819|NCT00560937|1100182|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
461820|NCT00560937|1100181|P2|STARTED|Overall Study||11
461821|NCT00560937|1100182|P1|STARTED|Overall Study||10
461822|NCT00560885|1100198|P1|NOT COMPLETED|Overall Study||8
461823|NCT00560885|1100198|P1|COMPLETED|Overall Study||47
461824|NCT00560885|1100198|P1|2 Year Follow-up|Overall Study||47
461825|NCT00560885|1100198|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
461826|NCT00560885|1100198|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
461827|NCT00560885|1100198|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
461828|NCT00560885|1100198|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
461829|NCT00560885|1100198|P1|STARTED|Overall Study||55
461830|NCT00560859|1100207|P2|NOT COMPLETED|Overall Study||24
461831|NCT00560859|1100208|P1|NOT COMPLETED|Overall Study||32
461832|NCT00560859|1100207|P2|COMPLETED|Overall Study||203
461833|NCT00560859|1100208|P1|COMPLETED|Overall Study||194
461834|NCT00560859|1100207|P2|STARTED|Overall Study||227
461835|NCT00560859|1100208|P1|STARTED|Overall Study||226
461836|NCT00560833|1100223|P5|NOT COMPLETED|Overall Study||42
461837|NCT00560833|1100224|P4|NOT COMPLETED|Overall Study||31
461838|NCT00560833|1100225|P3|NOT COMPLETED|Overall Study||39
461839|NCT00560833|1100226|P2|NOT COMPLETED|Overall Study||26
461840|NCT00560833|1100227|P1|NOT COMPLETED|Overall Study||44
461841|NCT00560833|1100223|P5|COMPLETED|Overall Study||114
461842|NCT00560833|1100224|P4|COMPLETED|Overall Study||124
461843|NCT00560833|1100225|P3|COMPLETED|Overall Study||121
461844|NCT00560833|1100226|P2|COMPLETED|Overall Study||129
461845|NCT00560833|1100227|P1|COMPLETED|Overall Study||273
461846|NCT00560833|1100223|P5|Treated|Overall Study|One participant was randomized but not treated|155
461847|NCT00560833|1100224|P4|Treated|Overall Study||155
461848|NCT00560833|1100225|P3|Treated|Overall Study||160
461849|NCT00560833|1100226|P2|Treated|Overall Study|One participant was randomized but not treated|154
461850|NCT00560833|1100227|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
461851|NCT00560833|1100223|P5|STARTED|Overall Study||156
461852|NCT00560833|1100224|P4|STARTED|Overall Study||155
461853|NCT00560833|1100225|P3|STARTED|Overall Study||160
461854|NCT00560833|1100226|P2|STARTED|Overall Study||155
461855|NCT00560833|1100227|P1|STARTED|Overall Study||317
461856|NCT00560794|1100259|P1|NOT COMPLETED|Overall Study||11
461857|NCT00560794|1100259|P1|COMPLETED|Overall Study||10
461858|NCT00560794|1100259|P1|Completed 1 Treatment Cycle|Overall Study||20
461859|NCT00560794|1100259|P1|STARTED|Overall Study||21
461860|NCT00560703|1100278|P2|NOT COMPLETED|Overall Study||6
461861|NCT00560703|1100279|P1|NOT COMPLETED|Overall Study||0
461862|NCT00560703|1100278|P2|COMPLETED|Overall Study||18
461863|NCT00560703|1100279|P1|COMPLETED|Overall Study||46
461864|NCT00560703|1100278|P2|STARTED|Overall Study||24
461865|NCT00560703|1100279|P1|STARTED|Overall Study||46
461866|NCT00560612|1100289|P2|NOT COMPLETED|Overall Study||0
461867|NCT00560612|1100290|P1|NOT COMPLETED|Overall Study||0
461868|NCT00560612|1100289|P2|COMPLETED|Overall Study||7
461869|NCT00560612|1100290|P1|COMPLETED|Overall Study||5
461870|NCT00560612|1100289|P2|STARTED|Overall Study||7
461871|NCT00560612|1100290|P1|STARTED|Overall Study||5
461872|NCT00560573|1100296|P6|NOT COMPLETED|Overall Study||13
461873|NCT00560573|1100297|P5|NOT COMPLETED|Overall Study||7
461874|NCT00560573|1100298|P4|NOT COMPLETED|Overall Study||10
461875|NCT00560573|1100299|P3|NOT COMPLETED|Overall Study||6
461876|NCT00560573|1100300|P2|NOT COMPLETED|Overall Study||3
461877|NCT00560573|1100301|P1|NOT COMPLETED|Overall Study||6
461878|NCT00560573|1100296|P6|COMPLETED|Overall Study||0
461879|NCT00560573|1100297|P5|COMPLETED|Overall Study||1
461880|NCT00560573|1100298|P4|COMPLETED|Overall Study||0
461881|NCT00560573|1100299|P3|COMPLETED|Overall Study||0
461882|NCT00560573|1100300|P2|COMPLETED|Overall Study||0
461883|NCT00560573|1100301|P1|COMPLETED|Overall Study||0
461884|NCT00560573|1100296|P6|Treated|Overall Study||13
461885|NCT00560573|1100297|P5|Treated|Overall Study||7
461886|NCT00560573|1100298|P4|Treated|Overall Study||10
461887|NCT00560573|1100299|P3|Treated|Overall Study||6
461888|NCT00560573|1100300|P2|Treated|Overall Study||3
461889|NCT00560573|1100301|P1|Treated|Overall Study||6
461890|NCT00560573|1100296|P6|STARTED|Overall Study||13
461891|NCT00560573|1100297|P5|STARTED|Overall Study||8
461892|NCT00560573|1100298|P4|STARTED|Overall Study||10
461893|NCT00560573|1100299|P3|STARTED|Overall Study||6
461894|NCT00560573|1100300|P2|STARTED|Overall Study||3
461895|NCT00560573|1100301|P1|STARTED|Overall Study||6
461896|NCT00560560|1100355|P2|NOT COMPLETED|Overall Study||83
461897|NCT00560560|1100356|P1|NOT COMPLETED|Overall Study||85
461898|NCT00560560|1100355|P2|COMPLETED|Overall Study||0
461899|NCT00560560|1100356|P1|COMPLETED|Overall Study||0
461900|NCT00560560|1100355|P2|STARTED|Overall Study||83
461901|NCT00560560|1100356|P1|STARTED|Overall Study||85
461902|NCT00560508|1100378|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
461903|NCT00560508|1100379|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
461904|NCT00560508|1100378|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
461905|NCT00560508|1100379|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
461906|NCT00560508|1100378|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
461907|NCT00560508|1100379|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
461908|NCT00560508|1100378|P2|NOT COMPLETED|12 Week Double-blind Period||3
461909|NCT00560508|1100379|P1|NOT COMPLETED|12 Week Double-blind Period||5
461910|NCT00560508|1100378|P2|COMPLETED|12 Week Double-blind Period||53
461911|NCT00560508|1100379|P1|COMPLETED|12 Week Double-blind Period||51
461912|NCT00560508|1100378|P2|STARTED|12 Week Double-blind Period||56
461913|NCT00560508|1100379|P1|STARTED|12 Week Double-blind Period||56
461914|NCT00560417|1100438|P2|NOT COMPLETED|Overall Study||17
461915|NCT00560417|1100439|P1|NOT COMPLETED|Overall Study||17
461916|NCT00560417|1100438|P2|COMPLETED|Overall Study||151
461917|NCT00560417|1100439|P1|COMPLETED|Overall Study||154
461918|NCT00560417|1100438|P2|Intention to Treat (ITT) Population|Overall Study||167
461919|NCT00560417|1100439|P1|Intention to Treat (ITT) Population|Overall Study||170
461920|NCT00560417|1100438|P2|STARTED|Overall Study||168
461921|NCT00560417|1100439|P1|STARTED|Overall Study||171
461922|NCT00560404|1100467|P2|NOT COMPLETED|Overall Study||21
461923|NCT00560404|1100468|P1|NOT COMPLETED|Overall Study||36
461924|NCT00560404|1100467|P2|COMPLETED|Overall Study||100
461925|NCT00560404|1100468|P1|COMPLETED|Overall Study||76
461926|NCT00560404|1100467|P2|STARTED|Overall Study||121
461927|NCT00560404|1100468|P1|STARTED|Overall Study||112
461928|NCT00560391|1100515|P5|NOT COMPLETED|Overall Study||2
461929|NCT00560391|1100516|P4|NOT COMPLETED|Overall Study||1
461930|NCT00560391|1100517|P3|NOT COMPLETED|Overall Study||0
461931|NCT00560391|1100518|P2|NOT COMPLETED|Overall Study||0
461932|NCT00560391|1100519|P1|NOT COMPLETED|Overall Study||0
461933|NCT00560391|1100515|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
461934|NCT00560391|1100516|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
461935|NCT00560391|1100517|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
461936|NCT00560391|1100518|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
461937|NCT00560391|1100519|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
461938|NCT00560391|1100515|P5|STARTED|Overall Study|Participants who received treatment|17
461939|NCT00560391|1100516|P4|STARTED|Overall Study|Participants who received treatment|6
461940|NCT00560391|1100517|P3|STARTED|Overall Study|Participants who received treatment|3
461941|NCT00560391|1100518|P2|STARTED|Overall Study|Participants who received treatment|3
461942|NCT00560391|1100519|P1|STARTED|Overall Study|Participants who received treatment|6
461943|NCT00560352|1100575|P3|NOT COMPLETED|Overall Study||4
461944|NCT00560352|1100576|P2|NOT COMPLETED|Overall Study||3
461945|NCT00560352|1100577|P1|NOT COMPLETED|Overall Study||7
461946|NCT00560352|1100575|P3|COMPLETED|Overall Study||0
461947|NCT00560352|1100576|P2|COMPLETED|Overall Study||0
461948|NCT00560352|1100577|P1|COMPLETED|Overall Study||0
461949|NCT00560352|1100575|P3|STARTED|Overall Study||4
461950|NCT00560352|1100576|P2|STARTED|Overall Study||3
461951|NCT00560352|1100577|P1|STARTED|Overall Study||7
461952|NCT00560313|1100594|P1|NOT COMPLETED|Overall Study||6
461953|NCT00560313|1100594|P1|COMPLETED|Overall Study||48
461954|NCT00560313|1100594|P1|STARTED|Overall Study||54
461955|NCT00560235|1100621|P3|NOT COMPLETED|Phase 2||97
461956|NCT00560235|1100622|P2|NOT COMPLETED|Phase 2||0
461957|NCT00560235|1100623|P1|NOT COMPLETED|Phase 2||0
461958|NCT00560235|1100621|P3|COMPLETED|Phase 2||10
461959|NCT00560235|1100622|P2|COMPLETED|Phase 2||0
461960|NCT00560235|1100623|P1|COMPLETED|Phase 2||0
461961|NCT00560235|1100621|P3|STARTED|Phase 2||107
461962|NCT00560235|1100622|P2|STARTED|Phase 2||0
461963|NCT00560235|1100623|P1|STARTED|Phase 2||0
461964|NCT00560235|1100621|P3|NOT COMPLETED|Phase 1B||0
461965|NCT00560235|1100622|P2|NOT COMPLETED|Phase 1B||19
461966|NCT00560235|1100623|P1|NOT COMPLETED|Phase 1B||0
461967|NCT00560235|1100621|P3|COMPLETED|Phase 1B||0
461968|NCT00560235|1100622|P2|COMPLETED|Phase 1B||2
461969|NCT00560235|1100623|P1|COMPLETED|Phase 1B||0
461970|NCT00560235|1100621|P3|STARTED|Phase 1B||0
461971|NCT00560235|1100622|P2|STARTED|Phase 1B||21
461972|NCT00560235|1100623|P1|STARTED|Phase 1B||0
461973|NCT00560235|1100621|P3|NOT COMPLETED|Phase 1||0
461974|NCT00560235|1100622|P2|NOT COMPLETED|Phase 1||0
461975|NCT00560235|1100623|P1|NOT COMPLETED|Phase 1||8
461976|NCT00560235|1100621|P3|COMPLETED|Phase 1||0
461977|NCT00560235|1100622|P2|COMPLETED|Phase 1||0
461978|NCT00560235|1100623|P1|COMPLETED|Phase 1||2
461979|NCT00560235|1100621|P3|STARTED|Phase 1||0
461980|NCT00560235|1100622|P2|STARTED|Phase 1||0
461981|NCT00560235|1100623|P1|STARTED|Phase 1||10
461982|NCT00560105|1100654|P2|NOT COMPLETED|Overall Study||2
461983|NCT00560105|1100655|P1|NOT COMPLETED|Overall Study||1
461984|NCT00560105|1100654|P2|COMPLETED|Overall Study||18
461985|NCT00560105|1100655|P1|COMPLETED|Overall Study||19
461986|NCT00560105|1100654|P2|STARTED|Overall Study||20
461987|NCT00560105|1100655|P1|STARTED|Overall Study||20
461988|NCT00560066|1100669|P2|NOT COMPLETED|Overall Study||22
461989|NCT00560066|1100670|P1|NOT COMPLETED|Overall Study||6
461990|NCT00560066|1100669|P2|COMPLETED|Overall Study||980
461991|NCT00560066|1100670|P1|COMPLETED|Overall Study||390
461992|NCT00560066|1100669|P2|STARTED|Overall Study||1002
461993|NCT00560066|1100670|P1|STARTED|Overall Study||396
461994|NCT00559988|1100702|P2|NOT COMPLETED|Overall Study||352
461995|NCT00559988|1100703|P1|NOT COMPLETED|Overall Study||351
461996|NCT00559988|1100702|P2|COMPLETED|Overall Study||1009
461997|NCT00559988|1100703|P1|COMPLETED|Overall Study||1006
461998|NCT00559988|1100702|P2|STARTED|Overall Study||1361
461999|NCT00559988|1100703|P1|STARTED|Overall Study||1357
462000|NCT00559962|1100717|P8|NOT COMPLETED|Overall Study||4
462001|NCT00559962|1100718|P7|NOT COMPLETED|Overall Study||5
462002|NCT00559962|1100719|P6|NOT COMPLETED|Overall Study||5
462003|NCT00559962|1100720|P5|NOT COMPLETED|Overall Study||14
462004|NCT00559962|1100721|P4|NOT COMPLETED|Overall Study||5
462005|NCT00559962|1100722|P3|NOT COMPLETED|Overall Study||10
462006|NCT00559962|1100723|P2|NOT COMPLETED|Overall Study||9
462007|NCT00559962|1100724|P1|NOT COMPLETED|Overall Study||2
462008|NCT00559962|1100717|P8|COMPLETED|Overall Study||25
462009|NCT00559962|1100718|P7|COMPLETED|Overall Study||28
462010|NCT00559962|1100719|P6|COMPLETED|Overall Study||23
462011|NCT00559962|1100720|P5|COMPLETED|Overall Study||21
462012|NCT00559962|1100721|P4|COMPLETED|Overall Study||29
462013|NCT00559962|1100722|P3|COMPLETED|Overall Study||24
462014|NCT00559962|1100723|P2|COMPLETED|Overall Study||25
462015|NCT00559962|1100724|P1|COMPLETED|Overall Study||31
462016|NCT00559962|1100717|P8|STARTED|Overall Study||29
462017|NCT00559962|1100718|P7|STARTED|Overall Study||33
462018|NCT00559962|1100719|P6|STARTED|Overall Study||28
462019|NCT00559962|1100720|P5|STARTED|Overall Study||35
462020|NCT00559962|1100721|P4|STARTED|Overall Study||34
462021|NCT00559962|1100722|P3|STARTED|Overall Study||34
462022|NCT00559962|1100723|P2|STARTED|Overall Study||34
462023|NCT00559962|1100724|P1|STARTED|Overall Study||33
462024|NCT00559949|1100744|P1|NOT COMPLETED|Overall Study||7
462025|NCT00559949|1100744|P1|COMPLETED|Overall Study||32
462026|NCT00559949|1100744|P1|STARTED|Overall Study||39
462027|NCT00559936|1100751|P1|NOT COMPLETED|Overall Study||4
462028|NCT00559936|1100751|P1|COMPLETED|Overall Study||20
462029|NCT00559936|1100751|P1|STARTED|Overall Study||24
462030|NCT00559897|1100756|P1|NOT COMPLETED|Overall Study||0
462031|NCT00559897|1100756|P1|COMPLETED|Overall Study||6
462032|NCT00559897|1100756|P1|STARTED|Overall Study||6
462033|NCT00559754|1100760|P1|NOT COMPLETED|Overall Study||11
462034|NCT00559754|1100760|P1|COMPLETED|Overall Study||61
462035|NCT00559754|1100760|P1|STARTED|Overall Study||72
462036|NCT00559637|1100784|P1|NOT COMPLETED|Overall Study||54
462037|NCT00559637|1100784|P1|COMPLETED|Overall Study||130
462038|NCT00559637|1100784|P1|STARTED|Overall Study||184
462039|NCT00559585|1100797|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
462040|NCT00559585|1100798|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
462041|NCT00559585|1100797|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
462042|NCT00559585|1100798|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
462043|NCT00559585|1100797|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
462044|NCT00559585|1100798|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
462045|NCT00559585|1100797|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
462046|NCT00559585|1100798|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
462047|NCT00559585|1100797|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
462048|NCT00559585|1100798|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
462049|NCT00559585|1100797|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
462050|NCT00559585|1100798|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
462051|NCT00559585|1100797|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
462052|NCT00559585|1100798|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
462053|NCT00559585|1100797|P2|COMPLETED|Double Blind ST Period Main Study||676
462054|NCT00559585|1100798|P1|COMPLETED|Double Blind ST Period Main Study||693
462055|NCT00559585|1100797|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
462056|NCT00559585|1100798|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
462057|NCT00559507|1100858|P1|NOT COMPLETED|Overall Study||3
462058|NCT00559507|1100858|P1|COMPLETED|Overall Study||9
462059|NCT00559507|1100858|P1|STARTED|Overall Study||12
462060|NCT00559377|1100864|P1|NOT COMPLETED|Overall Study||9
462061|NCT00559377|1100864|P1|COMPLETED|Overall Study||7
462062|NCT00559377|1100864|P1|STARTED|Overall Study||16
462063|NCT00559364|1100874|P2|NOT COMPLETED|Overall Study||0
462064|NCT00559364|1100875|P1|NOT COMPLETED|Overall Study||1
462065|NCT00559364|1100874|P2|COMPLETED|Overall Study||20
462066|NCT00559364|1100875|P1|COMPLETED|Overall Study||29
462067|NCT00559364|1100874|P2|STARTED|Overall Study||20
462068|NCT00559364|1100875|P1|STARTED|Overall Study||30
462069|NCT00559273|1100887|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
462070|NCT00559273|1100888|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
462071|NCT00559273|1100887|P2|COMPLETED|Evaluation Period (8 Weeks)||137
462072|NCT00559273|1100888|P1|COMPLETED|Evaluation Period (8 Weeks)||141
462073|NCT00559273|1100887|P2|STARTED|Evaluation Period (8 Weeks)||142
462074|NCT00559273|1100888|P1|STARTED|Evaluation Period (8 Weeks)||144
462075|NCT00559273|1100887|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
462076|NCT00559273|1100888|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
462077|NCT00559273|1100887|P2|COMPLETED|Correction Period (20 Weeks)||142
462078|NCT00559273|1100888|P1|COMPLETED|Correction Period (20 Weeks)||144
462079|NCT00559273|1100887|P2|Treated|Correction Period (20 Weeks)||154
462080|NCT00559273|1100888|P1|Treated|Correction Period (20 Weeks)||151
462081|NCT00559273|1100887|P2|STARTED|Correction Period (20 Weeks)||154
462082|NCT00559273|1100888|P1|STARTED|Correction Period (20 Weeks)||153
462083|NCT00559104|1100910|P2|NOT COMPLETED|Overall Study||0
462084|NCT00559104|1100911|P1|NOT COMPLETED|Overall Study||9
462085|NCT00559104|1100910|P2|COMPLETED|Overall Study||5
462086|NCT00559104|1100911|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
462087|NCT00559104|1100910|P2|STARTED|Overall Study||5
462088|NCT00559104|1100911|P1|STARTED|Overall Study||55
462089|NCT00559013|1100921|P1|NOT COMPLETED|Overall Study||0
462090|NCT00559013|1100921|P1|COMPLETED|Overall Study||38
462091|NCT00559013|1100921|P1|STARTED|Overall Study||38
462092|NCT00558896|1100932|P7|NOT COMPLETED|Overall Study||24
462093|NCT00558896|1100933|P6|NOT COMPLETED|Overall Study||52
462094|NCT00558896|1100934|P5|NOT COMPLETED|Overall Study||23
462095|NCT00558896|1100935|P4|NOT COMPLETED|Overall Study||12
462096|NCT00558896|1100936|P3|NOT COMPLETED|Overall Study||5
462097|NCT00558896|1100937|P2|NOT COMPLETED|Overall Study||7
462098|NCT00558896|1100938|P1|NOT COMPLETED|Overall Study||21
462099|NCT00558896|1100932|P7|COMPLETED|Overall Study||9
462100|NCT00558896|1100933|P6|COMPLETED|Overall Study||68
462101|NCT00558896|1100934|P5|COMPLETED|Overall Study||37
462102|NCT00558896|1100935|P4|COMPLETED|Overall Study||23
462103|NCT00558896|1100936|P3|COMPLETED|Overall Study||30
462104|NCT00558896|1100937|P2|COMPLETED|Overall Study||27
462105|NCT00558896|1100938|P1|COMPLETED|Overall Study||39
462106|NCT00558896|1100932|P7|STARTED|Overall Study||33
462107|NCT00558896|1100933|P6|STARTED|Overall Study||120
462108|NCT00558896|1100934|P5|STARTED|Overall Study||60
462109|NCT00558896|1100935|P4|STARTED|Overall Study||35
462110|NCT00558896|1100936|P3|STARTED|Overall Study||35
462111|NCT00558896|1100937|P2|STARTED|Overall Study||34
462112|NCT00558896|1100938|P1|STARTED|Overall Study||60
462113|NCT00558870|1100970|P2|NOT COMPLETED|Overall Study||0
462114|NCT00558870|1100971|P1|NOT COMPLETED|Overall Study||0
462115|NCT00558870|1100970|P2|COMPLETED|Overall Study||2
462116|NCT00558870|1100971|P1|COMPLETED|Overall Study||2
462117|NCT00558870|1100970|P2|STARTED|Overall Study||2
462118|NCT00558870|1100971|P1|STARTED|Overall Study||2
462119|NCT00558831|1100979|P1|NOT COMPLETED|Overall Study||1
462120|NCT00558831|1100979|P1|COMPLETED|Overall Study||10
462121|NCT00558831|1100979|P1|STARTED|Overall Study||11
462122|NCT00558792|1100988|P3|NOT COMPLETED|Overall Study||0
462123|NCT00558792|1100989|P2|NOT COMPLETED|Overall Study||0
462124|NCT00558792|1100990|P1|NOT COMPLETED|Overall Study||0
462125|NCT00558792|1100988|P3|COMPLETED|Overall Study||60
462126|NCT00558792|1100989|P2|COMPLETED|Overall Study||63
462127|NCT00558792|1100990|P1|COMPLETED|Overall Study||68
462128|NCT00558792|1100988|P3|STARTED|Overall Study||60
462129|NCT00558792|1100989|P2|STARTED|Overall Study||63
462130|NCT00558792|1100990|P1|STARTED|Overall Study||68
462131|NCT00558753|1101036|P2|NOT COMPLETED|Overall Study||7
462132|NCT00558753|1101037|P1|NOT COMPLETED|Overall Study||5
462133|NCT00558753|1101036|P2|COMPLETED|Overall Study||113
462134|NCT00558753|1101037|P1|COMPLETED|Overall Study||115
462135|NCT00558753|1101036|P2|STARTED|Overall Study||120
462136|NCT00558753|1101037|P1|STARTED|Overall Study||120
462137|NCT00558701|1101049|P2|NOT COMPLETED|Overall Study||4
462138|NCT00558701|1101050|P1|NOT COMPLETED|Overall Study||1
462139|NCT00558701|1101049|P2|COMPLETED|Overall Study||11
462140|NCT00558701|1101050|P1|COMPLETED|Overall Study||14
462141|NCT00558701|1101049|P2|STARTED|Overall Study||15
462142|NCT00558701|1101050|P1|STARTED|Overall Study||15
462143|NCT00558636|1101058|P2|NOT COMPLETED|Follow-up||7
462144|NCT00558636|1101059|P1|NOT COMPLETED|Follow-up||12
462145|NCT00558636|1101058|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
462146|NCT00558636|1101059|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
462147|NCT00558636|1101058|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
462148|NCT00558636|1101059|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
462149|NCT00558636|1101058|P2|NOT COMPLETED|Treatment||44
462150|NCT00558636|1101059|P1|NOT COMPLETED|Treatment||47
462151|NCT00558636|1101058|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
462152|NCT00558636|1101059|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
462153|NCT00558636|1101058|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
462154|NCT00558636|1101059|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
462155|NCT00558636|1101058|P2|STARTED|Treatment||44
462156|NCT00558636|1101059|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
462157|NCT00558571|1101081|P4|NOT COMPLETED|Overall Study||0
462158|NCT00558571|1101082|P3|NOT COMPLETED|Overall Study||0
462159|NCT00558571|1101083|P2|NOT COMPLETED|Overall Study||0
462160|NCT00558571|1101084|P1|NOT COMPLETED|Overall Study||0
462161|NCT00558571|1101081|P4|COMPLETED|Overall Study||30
462162|NCT00558571|1101082|P3|COMPLETED|Overall Study||16
462163|NCT00558571|1101083|P2|COMPLETED|Overall Study||16
462164|NCT00558571|1101084|P1|COMPLETED|Overall Study||16
462165|NCT00558571|1101081|P4|STARTED|Overall Study||30
462166|NCT00558571|1101082|P3|STARTED|Overall Study||16
462167|NCT00558571|1101083|P2|STARTED|Overall Study||16
462168|NCT00558571|1101084|P1|STARTED|Overall Study||16
462169|NCT00558558|1101159|P1|NOT COMPLETED|Overall Study||6
462170|NCT00558558|1101159|P1|COMPLETED|Overall Study||0
462171|NCT00558558|1101159|P1|STARTED|Overall Study||6
462172|NCT00558467|1101165|P2|NOT COMPLETED|Overall Study||4
462173|NCT00558467|1101166|P1|NOT COMPLETED|Overall Study||1
462174|NCT00558467|1101165|P2|COMPLETED|Overall Study||39
462175|NCT00558467|1101166|P1|COMPLETED|Overall Study||19
462176|NCT00558467|1101165|P2|STARTED|Overall Study||43
462177|NCT00558467|1101166|P1|STARTED|Overall Study||20
462178|NCT00558428|1101226|P4|NOT COMPLETED|Overall Study||11
462179|NCT00558428|1101227|P3|NOT COMPLETED|Overall Study||4
462180|NCT00558428|1101228|P2|NOT COMPLETED|Overall Study||24
462181|NCT00558428|1101229|P1|NOT COMPLETED|Overall Study||12
462182|NCT00558428|1101226|P4|COMPLETED|Overall Study||266
462183|NCT00558428|1101227|P3|COMPLETED|Overall Study||273
462184|NCT00558428|1101228|P2|COMPLETED|Overall Study||252
462185|NCT00558428|1101229|P1|COMPLETED|Overall Study||255
462186|NCT00558428|1101226|P4|STARTED|Overall Study||277
462187|NCT00558428|1101227|P3|STARTED|Overall Study||277
462188|NCT00558428|1101228|P2|STARTED|Overall Study||276
462189|NCT00558428|1101229|P1|STARTED|Overall Study||267
462190|NCT00558363|1101269|P2|NOT COMPLETED|Overall Study||36
462191|NCT00558363|1101270|P1|NOT COMPLETED|Overall Study||71
462192|NCT00558363|1101269|P2|COMPLETED|Overall Study||111
462193|NCT00558363|1101270|P1|COMPLETED|Overall Study||76
462194|NCT00558363|1101269|P2|STARTED|Overall Study||147
462195|NCT00558363|1101270|P1|STARTED|Overall Study||147
462196|NCT00558285|1101325|P5|NOT COMPLETED|Overall Study||4
462197|NCT00558285|1101326|P4|NOT COMPLETED|Overall Study||4
462198|NCT00558285|1101327|P3|NOT COMPLETED|Overall Study||5
462199|NCT00558285|1101328|P2|NOT COMPLETED|Overall Study||3
462200|NCT00558285|1101329|P1|NOT COMPLETED|Overall Study||6
462201|NCT00558285|1101325|P5|COMPLETED|Overall Study||49
462202|NCT00558285|1101326|P4|COMPLETED|Overall Study||48
462203|NCT00558285|1101327|P3|COMPLETED|Overall Study||46
462204|NCT00558285|1101328|P2|COMPLETED|Overall Study||48
462205|NCT00558285|1101329|P1|COMPLETED|Overall Study||44
462206|NCT00558285|1101325|P5|Safety: Received Study Drug|Overall Study||53
462207|NCT00558285|1101326|P4|Safety: Received Study Drug|Overall Study||51
462208|NCT00558285|1101327|P3|Safety: Received Study Drug|Overall Study||51
462209|NCT00558285|1101328|P2|Safety: Received Study Drug|Overall Study||51
462210|NCT00558285|1101329|P1|Safety: Received Study Drug|Overall Study||49
462211|NCT00558285|1101325|P5|STARTED|Overall Study||53
462212|NCT00558285|1101326|P4|STARTED|Overall Study||52
462213|NCT00558285|1101327|P3|STARTED|Overall Study||51
462214|NCT00558285|1101328|P2|STARTED|Overall Study||51
462215|NCT00558285|1101329|P1|STARTED|Overall Study||50
462216|NCT00558272|1101373|P2|NOT COMPLETED|Overall Study||2
462217|NCT00558272|1101374|P1|NOT COMPLETED|Overall Study||13
462218|NCT00558272|1101373|P2|COMPLETED|Overall Study|4-week treatment period|68
462219|NCT00558272|1101374|P1|COMPLETED|Overall Study|4-week treatment period|56
462220|NCT00558272|1101373|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
462221|NCT00558272|1101374|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
462222|NCT00558272|1101373|P2|STARTED|Overall Study|Randomised|70
462223|NCT00558272|1101374|P1|STARTED|Overall Study|Randomised|69
462224|NCT00558259|1101414|P2|NOT COMPLETED|Overall Study||99
462225|NCT00558259|1101415|P1|NOT COMPLETED|Overall Study||71
462226|NCT00558259|1101414|P2|COMPLETED|Overall Study|Completed treatment.|563
462227|NCT00558259|1101415|P1|COMPLETED|Overall Study|Completed treatment.|610
462228|NCT00558259|1101414|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
462229|NCT00558259|1101415|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
462230|NCT00558246|1101435|P1|NOT COMPLETED|Overall Study||0
462231|NCT00558246|1101435|P1|COMPLETED|Overall Study||79
462232|NCT00558246|1101435|P1|STARTED|Overall Study||79
462233|NCT00558103|1101455|P6|NOT COMPLETED|Monotherapy Extension Phase||9
462234|NCT00558103|1101456|P5|NOT COMPLETED|Monotherapy Extension Phase||0
462235|NCT00558103|1101457|P4|NOT COMPLETED|Monotherapy Extension Phase||0
462236|NCT00558103|1101458|P3|NOT COMPLETED|Monotherapy Extension Phase||0
462237|NCT00558103|1101459|P2|NOT COMPLETED|Monotherapy Extension Phase||0
462238|NCT00558103|1101460|P1|NOT COMPLETED|Monotherapy Extension Phase||0
462239|NCT00558103|1101455|P6|COMPLETED|Monotherapy Extension Phase||0
462240|NCT00558103|1101456|P5|COMPLETED|Monotherapy Extension Phase||0
462241|NCT00558103|1101457|P4|COMPLETED|Monotherapy Extension Phase||0
462242|NCT00558103|1101458|P3|COMPLETED|Monotherapy Extension Phase||0
462243|NCT00558103|1101459|P2|COMPLETED|Monotherapy Extension Phase||0
462244|NCT00558103|1101460|P1|COMPLETED|Monotherapy Extension Phase||0
462245|NCT00558103|1101455|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
462246|NCT00558103|1101456|P5|STARTED|Monotherapy Extension Phase||0
462247|NCT00558103|1101457|P4|STARTED|Monotherapy Extension Phase||0
462248|NCT00558103|1101458|P3|STARTED|Monotherapy Extension Phase||0
462249|NCT00558103|1101459|P2|STARTED|Monotherapy Extension Phase||0
462250|NCT00558103|1101460|P1|STARTED|Monotherapy Extension Phase||0
462251|NCT00558103|1101455|P6|NOT COMPLETED|Randomized Treatment Phase||0
462252|NCT00558103|1101456|P5|NOT COMPLETED|Randomized Treatment Phase||5
462253|NCT00558103|1101457|P4|NOT COMPLETED|Randomized Treatment Phase||2
462254|NCT00558103|1101458|P3|NOT COMPLETED|Randomized Treatment Phase||3
462255|NCT00558103|1101459|P2|NOT COMPLETED|Randomized Treatment Phase||4
462256|NCT00558103|1101460|P1|NOT COMPLETED|Randomized Treatment Phase||5
462257|NCT00558103|1101455|P6|COMPLETED|Randomized Treatment Phase||0
462258|NCT00558103|1101456|P5|COMPLETED|Randomized Treatment Phase||33
462259|NCT00558103|1101457|P4|COMPLETED|Randomized Treatment Phase||11
462260|NCT00558103|1101458|P3|COMPLETED|Randomized Treatment Phase||33
462261|NCT00558103|1101459|P2|COMPLETED|Randomized Treatment Phase||34
462262|NCT00558103|1101460|P1|COMPLETED|Randomized Treatment Phase||33
462263|NCT00558103|1101455|P6|STARTED|Randomized Treatment Phase||0
462264|NCT00558103|1101456|P5|STARTED|Randomized Treatment Phase||38
462265|NCT00558103|1101457|P4|STARTED|Randomized Treatment Phase||13
462266|NCT00558103|1101458|P3|STARTED|Randomized Treatment Phase||36
462267|NCT00558103|1101459|P2|STARTED|Randomized Treatment Phase||38
462268|NCT00558103|1101460|P1|STARTED|Randomized Treatment Phase||38
462269|NCT00558064|1101490|P2|NOT COMPLETED|Overall Study||5
462270|NCT00558064|1101491|P1|NOT COMPLETED|Overall Study||5
462271|NCT00558064|1101490|P2|COMPLETED|Overall Study||257
462272|NCT00558064|1101491|P1|COMPLETED|Overall Study||264
462273|NCT00558064|1101490|P2|STARTED|Overall Study||262
462274|NCT00558064|1101491|P1|STARTED|Overall Study||269
462275|NCT00558025|1101513|P2|NOT COMPLETED|Overall Study||3
462276|NCT00558025|1101514|P1|NOT COMPLETED|Overall Study||4
462277|NCT00558025|1101513|P2|COMPLETED|Overall Study||49
462278|NCT00558025|1101514|P1|COMPLETED|Overall Study||100
462279|NCT00558025|1101513|P2|STARTED|Overall Study||52
462280|NCT00558025|1101514|P1|STARTED|Overall Study||104
462281|NCT00558012|1101538|P2|NOT COMPLETED|Overall Study||18
462282|NCT00558012|1101539|P1|NOT COMPLETED|Overall Study||25
462283|NCT00558012|1101538|P2|COMPLETED|Overall Study||74
462284|NCT00558012|1101539|P1|COMPLETED|Overall Study||64
462285|NCT00558012|1101538|P2|STARTED|Overall Study||92
462286|NCT00558012|1101539|P1|STARTED|Overall Study||89
462287|NCT00557947|1101545|P1|NOT COMPLETED|Overall Study||0
462288|NCT00557947|1101545|P1|COMPLETED|Overall Study||83
462289|NCT00557947|1101545|P1|STARTED|Overall Study||83
462290|NCT00557856|1101561|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
462291|NCT00557856|1101562|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
462292|NCT00557856|1101563|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
462293|NCT00557856|1101564|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
462294|NCT00557856|1101565|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
462295|NCT00557856|1101566|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
462296|NCT00557856|1101567|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
462297|NCT00557856|1101568|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
462298|NCT00557856|1101569|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
462299|NCT00557856|1101561|P9|COMPLETED|Part 2: Exploratory Phase||0
462300|NCT00557856|1101562|P8|COMPLETED|Part 2: Exploratory Phase||0
462301|NCT00557856|1101563|P7|COMPLETED|Part 2: Exploratory Phase||0
462302|NCT00557856|1101564|P6|COMPLETED|Part 2: Exploratory Phase||0
462303|NCT00557856|1101565|P5|COMPLETED|Part 2: Exploratory Phase||0
462304|NCT00557856|1101566|P4|COMPLETED|Part 2: Exploratory Phase||0
462305|NCT00557856|1101567|P3|COMPLETED|Part 2: Exploratory Phase||0
462306|NCT00557856|1101568|P2|COMPLETED|Part 2: Exploratory Phase||0
462307|NCT00557856|1101569|P1|COMPLETED|Part 2: Exploratory Phase||0
462308|NCT00557856|1101561|P9|STARTED|Part 2: Exploratory Phase||24
462309|NCT00557856|1101562|P8|STARTED|Part 2: Exploratory Phase||0
462310|NCT00557856|1101563|P7|STARTED|Part 2: Exploratory Phase||0
462311|NCT00557856|1101564|P6|STARTED|Part 2: Exploratory Phase||0
462312|NCT00557856|1101565|P5|STARTED|Part 2: Exploratory Phase||0
462313|NCT00557856|1101566|P4|STARTED|Part 2: Exploratory Phase||0
462314|NCT00557856|1101567|P3|STARTED|Part 2: Exploratory Phase||0
462315|NCT00557856|1101568|P2|STARTED|Part 2: Exploratory Phase||0
462316|NCT00557856|1101569|P1|STARTED|Part 2: Exploratory Phase||0
462317|NCT00557856|1101561|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
462318|NCT00557856|1101562|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
462319|NCT00557856|1101563|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
462320|NCT00557856|1101564|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
462321|NCT00557856|1101565|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
462322|NCT00557856|1101566|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
462323|NCT00557856|1101567|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
462324|NCT00557856|1101568|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
462325|NCT00557856|1101569|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
462326|NCT00557856|1101561|P9|COMPLETED|Part 1: Dose Escalation Phase||0
462327|NCT00557856|1101562|P8|COMPLETED|Part 1: Dose Escalation Phase||0
462328|NCT00557856|1101563|P7|COMPLETED|Part 1: Dose Escalation Phase||0
462329|NCT00557856|1101564|P6|COMPLETED|Part 1: Dose Escalation Phase||0
462330|NCT00557856|1101565|P5|COMPLETED|Part 1: Dose Escalation Phase||0
462331|NCT00557856|1101566|P4|COMPLETED|Part 1: Dose Escalation Phase||0
462332|NCT00557856|1101567|P3|COMPLETED|Part 1: Dose Escalation Phase||0
462333|NCT00557856|1101568|P2|COMPLETED|Part 1: Dose Escalation Phase||0
462334|NCT00557856|1101569|P1|COMPLETED|Part 1: Dose Escalation Phase||0
462335|NCT00557856|1101561|P9|Treated|Part 1: Dose Escalation Phase||0
462336|NCT00557856|1101562|P8|Treated|Part 1: Dose Escalation Phase||6
462337|NCT00557856|1101563|P7|Treated|Part 1: Dose Escalation Phase||7
462338|NCT00557856|1101564|P6|Treated|Part 1: Dose Escalation Phase||8
462339|NCT00557856|1101565|P5|Treated|Part 1: Dose Escalation Phase||4
462340|NCT00557856|1101566|P4|Treated|Part 1: Dose Escalation Phase||3
462341|NCT00557856|1101567|P3|Treated|Part 1: Dose Escalation Phase||6
462342|NCT00557856|1101568|P2|Treated|Part 1: Dose Escalation Phase||5
462343|NCT00557856|1101569|P1|Treated|Part 1: Dose Escalation Phase||5
462344|NCT00557856|1101561|P9|STARTED|Part 1: Dose Escalation Phase||0
462345|NCT00557856|1101562|P8|STARTED|Part 1: Dose Escalation Phase||6
462346|NCT00557856|1101563|P7|STARTED|Part 1: Dose Escalation Phase||7
462347|NCT00557856|1101564|P6|STARTED|Part 1: Dose Escalation Phase||8
462348|NCT00557856|1101565|P5|STARTED|Part 1: Dose Escalation Phase||4
462349|NCT00557856|1101566|P4|STARTED|Part 1: Dose Escalation Phase||3
462350|NCT00557856|1101567|P3|STARTED|Part 1: Dose Escalation Phase||6
462351|NCT00557856|1101568|P2|STARTED|Part 1: Dose Escalation Phase||5
462352|NCT00557856|1101569|P1|STARTED|Part 1: Dose Escalation Phase||7
462353|NCT00557830|1101768|P3|NOT COMPLETED|Treatment Phase||0
462354|NCT00557830|1101769|P2|NOT COMPLETED|Treatment Phase||0
462355|NCT00557830|1101770|P1|NOT COMPLETED|Treatment Phase||0
462356|NCT00557830|1101768|P3|COMPLETED|Treatment Phase||2
462357|NCT00557830|1101769|P2|COMPLETED|Treatment Phase||4
462358|NCT00557830|1101770|P1|COMPLETED|Treatment Phase||0
462359|NCT00557830|1101768|P3|STARTED|Treatment Phase||2
462360|NCT00557830|1101769|P2|STARTED|Treatment Phase||4
462361|NCT00557830|1101770|P1|STARTED|Treatment Phase||0
462362|NCT00557830|1101768|P3|NOT COMPLETED|Screening Treatment Phase||0
462363|NCT00557830|1101769|P2|NOT COMPLETED|Screening Treatment Phase||0
462364|NCT00557830|1101770|P1|NOT COMPLETED|Screening Treatment Phase||6
462365|NCT00557830|1101768|P3|COMPLETED|Screening Treatment Phase||0
462366|NCT00557830|1101769|P2|COMPLETED|Screening Treatment Phase||0
462367|NCT00557830|1101770|P1|COMPLETED|Screening Treatment Phase||6
462368|NCT00557830|1101768|P3|STARTED|Screening Treatment Phase||0
462369|NCT00557830|1101769|P2|STARTED|Screening Treatment Phase||0
462370|NCT00557830|1101770|P1|STARTED|Screening Treatment Phase||12
462371|NCT00556712|1101792|P2|NOT COMPLETED|Overall Study||438
462372|NCT00556712|1101793|P1|NOT COMPLETED|Overall Study||451
462373|NCT00556712|1101792|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
462374|NCT00556712|1101793|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
462375|NCT00556712|1101792|P2|STARTED|Overall Study||438
462376|NCT00556712|1101793|P1|STARTED|Overall Study||451
462377|NCT00557622|1101871|P2|NOT COMPLETED|12-Week Treatment Phase||1
462378|NCT00557622|1101872|P1|NOT COMPLETED|12-Week Treatment Phase||0
462379|NCT00557622|1101871|P2|COMPLETED|12-Week Treatment Phase||1
462380|NCT00557622|1101872|P1|COMPLETED|12-Week Treatment Phase||1
462381|NCT00557622|1101871|P2|STARTED|12-Week Treatment Phase||2
462382|NCT00557622|1101872|P1|STARTED|12-Week Treatment Phase||1
462383|NCT00557622|1101871|P2|NOT COMPLETED|4-Week Run-in Phase||0
462384|NCT00557622|1101872|P1|NOT COMPLETED|4-Week Run-in Phase||2
462385|NCT00557622|1101871|P2|COMPLETED|4-Week Run-in Phase||0
462386|NCT00557622|1101872|P1|COMPLETED|4-Week Run-in Phase||3
462387|NCT00557622|1101871|P2|STARTED|4-Week Run-in Phase||0
462388|NCT00557622|1101872|P1|STARTED|4-Week Run-in Phase||5
462389|NCT00557505|1101901|P9|NOT COMPLETED|Overall Study||17
462390|NCT00557505|1101902|P8|NOT COMPLETED|Overall Study||5
462391|NCT00557505|1101903|P7|NOT COMPLETED|Overall Study||3
462392|NCT00557505|1101904|P6|NOT COMPLETED|Overall Study||3
462393|NCT00557505|1101905|P5|NOT COMPLETED|Overall Study||2
462394|NCT00557505|1101906|P4|NOT COMPLETED|Overall Study||3
462395|NCT00557505|1101907|P3|NOT COMPLETED|Overall Study||4
462396|NCT00557505|1101908|P2|NOT COMPLETED|Overall Study||3
462397|NCT00557505|1101909|P1|NOT COMPLETED|Overall Study||3
462398|NCT00557505|1101901|P9|COMPLETED|Overall Study||0
462399|NCT00557505|1101902|P8|COMPLETED|Overall Study||0
462400|NCT00557505|1101903|P7|COMPLETED|Overall Study||0
462401|NCT00557505|1101904|P6|COMPLETED|Overall Study||0
462402|NCT00557505|1101905|P5|COMPLETED|Overall Study||0
462403|NCT00557505|1101906|P4|COMPLETED|Overall Study||0
462404|NCT00557505|1101907|P3|COMPLETED|Overall Study||0
462405|NCT00557505|1101908|P2|COMPLETED|Overall Study||0
462406|NCT00557505|1101909|P1|COMPLETED|Overall Study||0
462407|NCT00557505|1101901|P9|STARTED|Overall Study||17
462408|NCT00557505|1101902|P8|STARTED|Overall Study||5
462409|NCT00557505|1101903|P7|STARTED|Overall Study||3
462410|NCT00557505|1101904|P6|STARTED|Overall Study||3
462411|NCT00557505|1101905|P5|STARTED|Overall Study||2
462412|NCT00557505|1101906|P4|STARTED|Overall Study||3
462413|NCT00557505|1101907|P3|STARTED|Overall Study||4
462414|NCT00557505|1101908|P2|STARTED|Overall Study||3
462415|NCT00557505|1101909|P1|STARTED|Overall Study||3
462416|NCT00557492|1102073|P1|NOT COMPLETED|Overall Study||1
462417|NCT00557492|1102073|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
462418|NCT00557492|1102073|P1|STARTED|Overall Study||59
462419|NCT00557466|1102091|P6|NOT COMPLETED|Overall Study||6
462420|NCT00557466|1102092|P5|NOT COMPLETED|Overall Study||3
462421|NCT00557466|1102093|P4|NOT COMPLETED|Overall Study||4
462422|NCT00557466|1102094|P3|NOT COMPLETED|Overall Study||6
462423|NCT00557466|1102095|P2|NOT COMPLETED|Overall Study||5
462424|NCT00557466|1102096|P1|NOT COMPLETED|Overall Study||4
462425|NCT00557466|1102091|P6|COMPLETED|Overall Study||85
462426|NCT00557466|1102092|P5|COMPLETED|Overall Study||87
462427|NCT00557466|1102093|P4|COMPLETED|Overall Study||92
462428|NCT00557466|1102094|P3|COMPLETED|Overall Study||95
462429|NCT00557466|1102095|P2|COMPLETED|Overall Study||87
462430|NCT00557466|1102096|P1|COMPLETED|Overall Study||94
462431|NCT00557466|1102091|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
462432|NCT00557466|1102092|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
462433|NCT00557466|1102093|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
462434|NCT00557466|1102094|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
462435|NCT00557466|1102095|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
462436|NCT00557466|1102096|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
462437|NCT00557466|1102091|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
462438|NCT00557466|1102092|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
462439|NCT00557466|1102093|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
462440|NCT00557466|1102094|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
462612|NCT00556478|1102500|P1|STARTED|Double-blind Phase||171
462441|NCT00557466|1102095|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
462442|NCT00557466|1102096|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
462443|NCT00557466|1102091|P6|STARTED|Overall Study||91
462444|NCT00557466|1102092|P5|STARTED|Overall Study||90
462445|NCT00557466|1102093|P4|STARTED|Overall Study||96
462446|NCT00557466|1102094|P3|STARTED|Overall Study||101
462447|NCT00557466|1102095|P2|STARTED|Overall Study||92
462448|NCT00557466|1102096|P1|STARTED|Overall Study||98
462449|NCT00557440|1102149|P3|NOT COMPLETED|Treatment Period 3||0
462450|NCT00557440|1102150|P2|NOT COMPLETED|Treatment Period 3||0
462451|NCT00557440|1102151|P1|NOT COMPLETED|Treatment Period 3||0
462452|NCT00557440|1102149|P3|COMPLETED|Treatment Period 3||12
462453|NCT00557440|1102150|P2|COMPLETED|Treatment Period 3||12
462454|NCT00557440|1102151|P1|COMPLETED|Treatment Period 3||12
462455|NCT00557440|1102149|P3|STARTED|Treatment Period 3||12
462456|NCT00557440|1102150|P2|STARTED|Treatment Period 3||12
462457|NCT00557440|1102151|P1|STARTED|Treatment Period 3||12
462458|NCT00557440|1102149|P3|NOT COMPLETED|Treatment Period 2||0
462459|NCT00557440|1102150|P2|NOT COMPLETED|Treatment Period 2||0
462460|NCT00557440|1102151|P1|NOT COMPLETED|Treatment Period 2||0
462461|NCT00557440|1102149|P3|COMPLETED|Treatment Period 2||12
462462|NCT00557440|1102150|P2|COMPLETED|Treatment Period 2||12
462463|NCT00557440|1102151|P1|COMPLETED|Treatment Period 2||12
462464|NCT00557440|1102149|P3|STARTED|Treatment Period 2||12
462465|NCT00557440|1102150|P2|STARTED|Treatment Period 2||12
462466|NCT00557440|1102151|P1|STARTED|Treatment Period 2||12
462467|NCT00557440|1102149|P3|NOT COMPLETED|Treatment Period 1||1
462468|NCT00557440|1102150|P2|NOT COMPLETED|Treatment Period 1||0
462469|NCT00557440|1102151|P1|NOT COMPLETED|Treatment Period 1||0
462470|NCT00557440|1102149|P3|COMPLETED|Treatment Period 1||12
462471|NCT00557440|1102150|P2|COMPLETED|Treatment Period 1||12
462472|NCT00557440|1102151|P1|COMPLETED|Treatment Period 1||12
462473|NCT00557440|1102149|P3|STARTED|Treatment Period 1||13
462474|NCT00557440|1102150|P2|STARTED|Treatment Period 1||12
462475|NCT00557440|1102151|P1|STARTED|Treatment Period 1||12
462476|NCT00557362|1102175|P4|NOT COMPLETED|Overall Study||3
462477|NCT00557362|1102176|P3|NOT COMPLETED|Overall Study||4
462478|NCT00557362|1102177|P2|NOT COMPLETED|Overall Study||2
462479|NCT00557362|1102178|P1|NOT COMPLETED|Overall Study||2
462480|NCT00557362|1102175|P4|COMPLETED|Overall Study||27
462481|NCT00557362|1102176|P3|COMPLETED|Overall Study||26
462482|NCT00557362|1102177|P2|COMPLETED|Overall Study||28
462483|NCT00557362|1102178|P1|COMPLETED|Overall Study||28
462484|NCT00557362|1102175|P4|STARTED|Overall Study||30
462485|NCT00557362|1102176|P3|STARTED|Overall Study||30
462486|NCT00557362|1102177|P2|STARTED|Overall Study||30
462487|NCT00557362|1102178|P1|STARTED|Overall Study||30
462488|NCT00557349|1102196|P2|NOT COMPLETED|Overall Study||5
462489|NCT00557349|1102197|P1|NOT COMPLETED|Overall Study||5
462490|NCT00557349|1102196|P2|COMPLETED|Overall Study||13
462491|NCT00557349|1102197|P1|COMPLETED|Overall Study||17
462492|NCT00557349|1102196|P2|STARTED|Overall Study||18
462493|NCT00557349|1102197|P1|STARTED|Overall Study|omeprazole/bicarb|22
462494|NCT00557323|1102205|P1|NOT COMPLETED|Overall Study||7
462495|NCT00557323|1102205|P1|COMPLETED|Overall Study||27
462496|NCT00557323|1102205|P1|STARTED|Overall Study||34
462497|NCT00557310|1102210|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
462498|NCT00557310|1102210|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
462499|NCT00557310|1102210|P1|STARTED|Extension Phase (18 - 24 Months)||30
462500|NCT00557310|1102210|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
462501|NCT00557310|1102210|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
462502|NCT00557310|1102210|P1|STARTED|Main Study (0 - 18 Months)||35
462503|NCT00557284|1102232|P2|NOT COMPLETED|Overall Study||0
462504|NCT00557284|1102233|P1|NOT COMPLETED|Overall Study||0
462505|NCT00557284|1102232|P2|COMPLETED|Overall Study||11
462506|NCT00557284|1102233|P1|COMPLETED|Overall Study||9
462507|NCT00557284|1102232|P2|STARTED|Overall Study||11
462508|NCT00557284|1102233|P1|STARTED|Overall Study||9
462509|NCT00557245|1102256|P3|NOT COMPLETED|Overall Study||12
462510|NCT00557245|1102257|P2|NOT COMPLETED|Overall Study||12
462511|NCT00557245|1102258|P1|NOT COMPLETED|Overall Study||12
462512|NCT00557245|1102256|P3|COMPLETED|Overall Study||1574
462513|NCT00557245|1102257|P2|COMPLETED|Overall Study||1571
462514|NCT00557245|1102258|P1|COMPLETED|Overall Study||1577
462515|NCT00557245|1102256|P3|STARTED|Overall Study||1586
462516|NCT00557245|1102257|P2|STARTED|Overall Study||1583
462517|NCT00557245|1102258|P1|STARTED|Overall Study||1589
462518|NCT00557076|1102298|P2|NOT COMPLETED|Overall Study||1
462519|NCT00557076|1102299|P1|NOT COMPLETED|Overall Study||0
462520|NCT00557076|1102298|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
462521|NCT00557076|1102299|P1|COMPLETED|Overall Study||8
462522|NCT00557076|1102298|P2|STARTED|Overall Study||8
462523|NCT00557076|1102299|P1|STARTED|Overall Study||8
462524|NCT00556998|1102307|P1|NOT COMPLETED|Voriconazole Oral||2
462525|NCT00556998|1102307|P1|COMPLETED|Voriconazole Oral||20
462526|NCT00556998|1102307|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
462527|NCT00556998|1102307|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
462613|NCT00556452|1102528|P3|NOT COMPLETED|Overall Study||0
462528|NCT00556998|1102307|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
462529|NCT00556998|1102307|P1|Treated|Voriconazole Intravenous (IV)||26
462530|NCT00556998|1102307|P1|STARTED|Voriconazole Intravenous (IV)||26
462531|NCT00556972|1102327|P1|NOT COMPLETED|Overall Study||0
462532|NCT00556972|1102327|P1|COMPLETED|Overall Study||4
462533|NCT00556972|1102327|P1|STARTED|Overall Study||4
462534|NCT00556946|1102334|P1|NOT COMPLETED|Overall Study||1
462535|NCT00556946|1102334|P1|COMPLETED|Overall Study||16
462536|NCT00556946|1102334|P1|STARTED|Overall Study||17
462537|NCT00556933|1102342|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
462538|NCT00556933|1102343|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
462539|NCT00556933|1102344|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
462540|NCT00556933|1102345|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
462541|NCT00556933|1102342|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
462542|NCT00556933|1102343|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
462543|NCT00556933|1102344|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
462544|NCT00556933|1102345|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
462545|NCT00556933|1102342|P4|STARTED|CNI Withdrawal vs. Minimization||43
462546|NCT00556933|1102343|P3|STARTED|CNI Withdrawal vs. Minimization||39
462547|NCT00556933|1102344|P2|STARTED|CNI Withdrawal vs. Minimization||37
462548|NCT00556933|1102345|P1|STARTED|CNI Withdrawal vs. Minimization||43
462549|NCT00556933|1102342|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
462550|NCT00556933|1102343|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
462551|NCT00556933|1102344|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
462552|NCT00556933|1102345|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
462553|NCT00556933|1102342|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
462554|NCT00556933|1102343|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
462555|NCT00556933|1102344|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
462556|NCT00556933|1102345|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
462557|NCT00556933|1102342|P4|STARTED|Single vs. Divided-dose rATG Induction||45
462558|NCT00556933|1102343|P3|STARTED|Single vs. Divided-dose rATG Induction||45
462559|NCT00556933|1102344|P2|STARTED|Single vs. Divided-dose rATG Induction||45
462560|NCT00556933|1102345|P1|STARTED|Single vs. Divided-dose rATG Induction||45
462561|NCT00556894|1102402|P3|NOT COMPLETED|Overall Study||19
462562|NCT00556894|1102403|P2|NOT COMPLETED|Overall Study||19
462563|NCT00556894|1102404|P1|NOT COMPLETED|Overall Study||16
462564|NCT00556894|1102402|P3|COMPLETED|Overall Study||65
462565|NCT00556894|1102403|P2|COMPLETED|Overall Study||68
462566|NCT00556894|1102404|P1|COMPLETED|Overall Study||66
462567|NCT00556894|1102402|P3|STARTED|Overall Study||84
462568|NCT00556894|1102403|P2|STARTED|Overall Study||87
462569|NCT00556894|1102404|P1|STARTED|Overall Study||82
462570|NCT00556673|1102414|P2|NOT COMPLETED|Overall Study||2
462571|NCT00556673|1102415|P1|NOT COMPLETED|Overall Study||3
462572|NCT00556673|1102414|P2|COMPLETED|Overall Study||13
462573|NCT00556673|1102415|P1|COMPLETED|Overall Study||13
462574|NCT00556673|1102414|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
462575|NCT00556673|1102415|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
462576|NCT00556673|1102414|P2|STARTED|Overall Study||15
462577|NCT00556673|1102415|P1|STARTED|Overall Study||16
462578|NCT00556543|1102451|P1|NOT COMPLETED|Overall Study||0
462579|NCT00556543|1102451|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
462580|NCT00556543|1102451|P1|STARTED|Overall Study||10
462581|NCT00556504|1102469|P2|NOT COMPLETED|Overall Study||9
462582|NCT00556504|1102470|P1|NOT COMPLETED|Overall Study||8
462583|NCT00556504|1102469|P2|COMPLETED|Overall Study||33
462584|NCT00556504|1102470|P1|COMPLETED|Overall Study||34
462585|NCT00556504|1102469|P2|Safety Population|Overall Study||42
462586|NCT00556504|1102470|P1|Safety Population|Overall Study||41
462587|NCT00556504|1102469|P2|Intend-to Treat Population|Overall Study||42
462588|NCT00556504|1102470|P1|Intend-to Treat Population|Overall Study||42
462589|NCT00556504|1102469|P2|STARTED|Overall Study||42
462590|NCT00556504|1102470|P1|STARTED|Overall Study||42
462591|NCT00556491|1102490|P2|NOT COMPLETED|Overall Study||1
462592|NCT00556491|1102491|P1|NOT COMPLETED|Overall Study||1
462593|NCT00556491|1102490|P2|COMPLETED|Overall Study||19
462594|NCT00556491|1102491|P1|COMPLETED|Overall Study||19
462595|NCT00556491|1102490|P2|STARTED|Overall Study||20
462596|NCT00556491|1102491|P1|STARTED|Overall Study|January 2008|20
462597|NCT00556478|1102499|P2|NOT COMPLETED|Open-Label Phase||10
462598|NCT00556478|1102500|P1|NOT COMPLETED|Open-Label Phase||14
462599|NCT00556478|1102499|P2|COMPLETED|Open-Label Phase||67
462600|NCT00556478|1102500|P1|COMPLETED|Open-Label Phase||132
462601|NCT00556478|1102499|P2|Treated in Open-label|Open-Label Phase||71
462602|NCT00556478|1102500|P1|Treated in Open-label|Open-Label Phase||142
462603|NCT00556478|1102499|P2|STARTED|Open-Label Phase||77
462604|NCT00556478|1102500|P1|STARTED|Open-Label Phase||146
462605|NCT00556478|1102499|P2|NOT COMPLETED|Double-blind Phase||8
462606|NCT00556478|1102500|P1|NOT COMPLETED|Double-blind Phase||21
462607|NCT00556478|1102499|P2|COMPLETED|Double-blind Phase||77
462608|NCT00556478|1102500|P1|COMPLETED|Double-blind Phase||150
462609|NCT00556478|1102499|P2|ITT|Double-blind Phase||82
462610|NCT00556478|1102500|P1|ITT|Double-blind Phase||167
462611|NCT00556478|1102499|P2|STARTED|Double-blind Phase||85
462614|NCT00556452|1102529|P2|NOT COMPLETED|Overall Study||0
462615|NCT00556452|1102530|P1|NOT COMPLETED|Overall Study||0
462616|NCT00556452|1102528|P3|COMPLETED|Overall Study||19
462617|NCT00556452|1102529|P2|COMPLETED|Overall Study||21
462618|NCT00556452|1102530|P1|COMPLETED|Overall Study||6
462619|NCT00556452|1102528|P3|STARTED|Overall Study||19
462620|NCT00556452|1102529|P2|STARTED|Overall Study||21
462621|NCT00556452|1102530|P1|STARTED|Overall Study||6
462622|NCT00556426|1102536|P1|NOT COMPLETED|Overall Study||9
462623|NCT00556426|1102536|P1|COMPLETED|Overall Study||91
462624|NCT00556426|1102536|P1|STARTED|Overall Study||100
462625|NCT00556400|1102546|P2|NOT COMPLETED|Overall Study||0
462626|NCT00556400|1102547|P1|NOT COMPLETED|Overall Study||0
462627|NCT00556400|1102546|P2|COMPLETED|Overall Study||0
462628|NCT00556400|1102547|P1|COMPLETED|Overall Study||1
462629|NCT00556400|1102546|P2|STARTED|Overall Study||0
462630|NCT00556400|1102547|P1|STARTED|Overall Study||1
462631|NCT00556374|1102558|P2|NOT COMPLETED|Overall Study||220
462632|NCT00556374|1102559|P1|NOT COMPLETED|Overall Study||247
462633|NCT00556374|1102558|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
462634|NCT00556374|1102559|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
462635|NCT00556374|1102558|P2|Received Study Drug|Overall Study||1700
462636|NCT00556374|1102559|P1|Received Study Drug|Overall Study||1699
462637|NCT00556374|1102558|P2|STARTED|Overall Study||1711
462638|NCT00556374|1102559|P1|STARTED|Overall Study||1709
462639|NCT00556322|1102577|P2|NOT COMPLETED|Overall Study||203
462640|NCT00556322|1102578|P1|NOT COMPLETED|Overall Study||221
462641|NCT00556322|1102577|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
462642|NCT00556322|1102578|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
462643|NCT00556322|1102577|P2|STARTED|Overall Study||203
462644|NCT00556322|1102578|P1|STARTED|Overall Study||221
462645|NCT00556166|1102626|P1|NOT COMPLETED|Overall Study||1
462646|NCT00556166|1102626|P1|COMPLETED|Overall Study||3
462647|NCT00556166|1102626|P1|STARTED|Overall Study||4
462648|NCT00556140|1102631|P1|NOT COMPLETED|Overall Study||3
462649|NCT00556140|1102631|P1|COMPLETED|Overall Study||13
462650|NCT00556140|1102631|P1|STARTED|Overall Study||16
462651|NCT00556075|1102639|P3|NOT COMPLETED|Overall Study||8
462652|NCT00556075|1102640|P2|NOT COMPLETED|Overall Study||9
462653|NCT00556075|1102641|P1|NOT COMPLETED|Overall Study||13
462654|NCT00556075|1102639|P3|COMPLETED|Overall Study||15
462655|NCT00556075|1102640|P2|COMPLETED|Overall Study||13
462656|NCT00556075|1102641|P1|COMPLETED|Overall Study||9
462657|NCT00556075|1102639|P3|STARTED|Overall Study||23
462658|NCT00556075|1102640|P2|STARTED|Overall Study||22
462659|NCT00556075|1102641|P1|STARTED|Overall Study||22
462660|NCT00556049|1102664|P1|NOT COMPLETED|Overall Study||0
462661|NCT00556049|1102664|P1|COMPLETED|Overall Study||72
462662|NCT00556049|1102664|P1|STARTED|Overall Study||72
462663|NCT00555997|1102671|P4|NOT COMPLETED|Phase 2 SPCD||3
462664|NCT00555997|1102672|P3|NOT COMPLETED|Phase 2 SPCD||7
462665|NCT00555997|1102673|P2|NOT COMPLETED|Phase 2 SPCD||0
462666|NCT00555997|1102674|P1|NOT COMPLETED|Phase 2 SPCD||0
462667|NCT00555997|1102671|P4|COMPLETED|Phase 2 SPCD||22
462668|NCT00555997|1102672|P3|COMPLETED|Phase 2 SPCD||31
462669|NCT00555997|1102673|P2|COMPLETED|Phase 2 SPCD||0
462670|NCT00555997|1102674|P1|COMPLETED|Phase 2 SPCD||0
462671|NCT00555997|1102671|P4|STARTED|Phase 2 SPCD||25
462672|NCT00555997|1102672|P3|STARTED|Phase 2 SPCD||38
462673|NCT00555997|1102673|P2|STARTED|Phase 2 SPCD||0
462674|NCT00555997|1102674|P1|STARTED|Phase 2 SPCD||0
462675|NCT00555997|1102671|P4|NOT COMPLETED|Phase 1 SPCD||0
462676|NCT00555997|1102672|P3|NOT COMPLETED|Phase 1 SPCD||0
462677|NCT00555997|1102673|P2|NOT COMPLETED|Phase 1 SPCD||15
462678|NCT00555997|1102674|P1|NOT COMPLETED|Phase 1 SPCD||12
462679|NCT00555997|1102671|P4|COMPLETED|Phase 1 SPCD||0
462680|NCT00555997|1102672|P3|COMPLETED|Phase 1 SPCD||0
462681|NCT00555997|1102673|P2|COMPLETED|Phase 1 SPCD||76
462682|NCT00555997|1102674|P1|COMPLETED|Phase 1 SPCD||17
462683|NCT00555997|1102671|P4|STARTED|Phase 1 SPCD||0
462684|NCT00555997|1102672|P3|STARTED|Phase 1 SPCD||0
462685|NCT00555997|1102673|P2|STARTED|Phase 1 SPCD||91
462686|NCT00555997|1102674|P1|STARTED|Phase 1 SPCD||29
462687|NCT00555906|1102693|P5|NOT COMPLETED|Phase 2||32
462688|NCT00555906|1102694|P4|NOT COMPLETED|Phase 2||0
462689|NCT00555906|1102695|P3|NOT COMPLETED|Phase 2||0
462690|NCT00555906|1102696|P2|NOT COMPLETED|Phase 2||0
462691|NCT00555906|1102697|P1|NOT COMPLETED|Phase 2||0
462692|NCT00555906|1102693|P5|COMPLETED|Phase 2||0
462693|NCT00555906|1102694|P4|COMPLETED|Phase 2||0
462694|NCT00555906|1102695|P3|COMPLETED|Phase 2||0
462695|NCT00555906|1102696|P2|COMPLETED|Phase 2||0
462696|NCT00555906|1102697|P1|COMPLETED|Phase 2||0
462697|NCT00555906|1102693|P5|Treated|Phase 2||30
462698|NCT00555906|1102694|P4|Treated|Phase 2||0
462699|NCT00555906|1102695|P3|Treated|Phase 2||0
462700|NCT00555906|1102696|P2|Treated|Phase 2||0
462701|NCT00555906|1102697|P1|Treated|Phase 2||0
462702|NCT00555906|1102693|P5|STARTED|Phase 2||32
462703|NCT00555906|1102694|P4|STARTED|Phase 2||0
462704|NCT00555906|1102695|P3|STARTED|Phase 2||0
462705|NCT00555906|1102696|P2|STARTED|Phase 2||0
462706|NCT00555906|1102697|P1|STARTED|Phase 2||0
462707|NCT00555906|1102693|P5|NOT COMPLETED|Phase 1||0
462708|NCT00555906|1102694|P4|NOT COMPLETED|Phase 1||5
462709|NCT00555906|1102695|P3|NOT COMPLETED|Phase 1||7
462710|NCT00555906|1102696|P2|NOT COMPLETED|Phase 1||6
462711|NCT00555906|1102697|P1|NOT COMPLETED|Phase 1||3
462712|NCT00555906|1102693|P5|COMPLETED|Phase 1||0
462713|NCT00555906|1102694|P4|COMPLETED|Phase 1||0
462714|NCT00555906|1102695|P3|COMPLETED|Phase 1||0
462715|NCT00555906|1102696|P2|COMPLETED|Phase 1||0
462716|NCT00555906|1102697|P1|COMPLETED|Phase 1||0
462717|NCT00555906|1102693|P5|STARTED|Phase 1||0
462718|NCT00555906|1102694|P4|STARTED|Phase 1||5
462719|NCT00555906|1102695|P3|STARTED|Phase 1||7
462720|NCT00555906|1102696|P2|STARTED|Phase 1||6
462721|NCT00555906|1102697|P1|STARTED|Phase 1||3
462722|NCT00555893|1102729|P2|NOT COMPLETED|Overall Study||0
462723|NCT00555893|1102730|P1|NOT COMPLETED|Overall Study||0
462724|NCT00555893|1102729|P2|COMPLETED|Overall Study||63
462725|NCT00555893|1102730|P1|COMPLETED|Overall Study||130
462726|NCT00555893|1102729|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
462727|NCT00555893|1102730|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
462728|NCT00555893|1102729|P2|STARTED|Overall Study||63
462729|NCT00555893|1102730|P1|STARTED|Overall Study||130
462730|NCT00555880|1102740|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
462731|NCT00555880|1102741|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
462732|NCT00555880|1102740|P2|COMPLETED|Treatment Period 2 (1 Day)||11
462733|NCT00555880|1102741|P1|COMPLETED|Treatment Period 2 (1 Day)||13
462734|NCT00555880|1102740|P2|STARTED|Treatment Period 2 (1 Day)||11
462735|NCT00555880|1102741|P1|STARTED|Treatment Period 2 (1 Day)||13
462736|NCT00555880|1102740|P2|NOT COMPLETED|Washout (1 Day)||0
462737|NCT00555880|1102741|P1|NOT COMPLETED|Washout (1 Day)||0
462738|NCT00555880|1102740|P2|COMPLETED|Washout (1 Day)||11
462739|NCT00555880|1102741|P1|COMPLETED|Washout (1 Day)||13
462740|NCT00555880|1102740|P2|STARTED|Washout (1 Day)||11
462741|NCT00555880|1102741|P1|STARTED|Washout (1 Day)||13
462742|NCT00555880|1102740|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
462743|NCT00555880|1102741|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
462744|NCT00555880|1102740|P2|COMPLETED|Treatment Period 1 (1 Day)||11
462745|NCT00555880|1102741|P1|COMPLETED|Treatment Period 1 (1 Day)||13
462746|NCT00555880|1102740|P2|STARTED|Treatment Period 1 (1 Day)||11
462747|NCT00555880|1102741|P1|STARTED|Treatment Period 1 (1 Day)||13
462748|NCT00555750|1102780|P2|NOT COMPLETED|Overall Study||0
462749|NCT00555750|1102781|P1|NOT COMPLETED|Overall Study||0
462750|NCT00555750|1102780|P2|COMPLETED|Overall Study||10
462751|NCT00555750|1102781|P1|COMPLETED|Overall Study||10
462752|NCT00555750|1102780|P2|STARTED|Overall Study||10
462753|NCT00555750|1102781|P1|STARTED|Overall Study||10
462754|NCT00555672|1102813|P2|NOT COMPLETED|Overall Study||10
462755|NCT00555672|1102814|P1|NOT COMPLETED|Overall Study||24
462756|NCT00555672|1102813|P2|COMPLETED|Overall Study||0
462757|NCT00555672|1102814|P1|COMPLETED|Overall Study||0
462758|NCT00555672|1102813|P2|STARTED|Overall Study||10
462759|NCT00555672|1102814|P1|STARTED|Overall Study||24
462760|NCT00555620|1102839|P6|NOT COMPLETED|Overall Study||22
462761|NCT00555620|1102840|P5|NOT COMPLETED|Overall Study||3
462762|NCT00555620|1102841|P4|NOT COMPLETED|Overall Study||23
462763|NCT00555620|1102842|P3|NOT COMPLETED|Overall Study||15
462764|NCT00555620|1102843|P2|NOT COMPLETED|Overall Study||7
462765|NCT00555620|1102844|P1|NOT COMPLETED|Overall Study||6
462766|NCT00555620|1102839|P6|COMPLETED|Overall Study||0
462767|NCT00555620|1102840|P5|COMPLETED|Overall Study||0
462768|NCT00555620|1102841|P4|COMPLETED|Overall Study||0
462769|NCT00555620|1102842|P3|COMPLETED|Overall Study||0
462770|NCT00555620|1102843|P2|COMPLETED|Overall Study||0
462771|NCT00555620|1102844|P1|COMPLETED|Overall Study||0
462772|NCT00555620|1102839|P6|STARTED|Overall Study||22
462773|NCT00555620|1102840|P5|STARTED|Overall Study||3
462774|NCT00555620|1102841|P4|STARTED|Overall Study||23
462775|NCT00555620|1102842|P3|STARTED|Overall Study||15
462776|NCT00555620|1102843|P2|STARTED|Overall Study||7
462777|NCT00555620|1102844|P1|STARTED|Overall Study||6
462778|NCT00555568|1102959|P3|NOT COMPLETED|Overall Study||16
462779|NCT00555568|1102960|P2|NOT COMPLETED|Overall Study||16
462780|NCT00555568|1102961|P1|NOT COMPLETED|Overall Study||26
462781|NCT00555568|1102959|P3|COMPLETED|Overall Study||84
462782|NCT00555568|1102960|P2|COMPLETED|Overall Study||82
462783|NCT00555568|1102961|P1|COMPLETED|Overall Study||74
462784|NCT00555568|1102959|P3|STARTED|Overall Study||100
462785|NCT00555568|1102960|P2|STARTED|Overall Study||98
462786|NCT00555568|1102961|P1|STARTED|Overall Study||100
462787|NCT00555477|1102983|P2|NOT COMPLETED|Overall Study||13
462788|NCT00555477|1102984|P1|NOT COMPLETED|Overall Study||2
462789|NCT00555477|1102983|P2|COMPLETED|Overall Study||32
462790|NCT00555477|1102984|P1|COMPLETED|Overall Study||12
462791|NCT00555477|1102983|P2|STARTED|Overall Study||45
462792|NCT00555477|1102984|P1|STARTED|Overall Study||14
462793|NCT00555464|1102991|P2|NOT COMPLETED|Overall Study||3
462794|NCT00555464|1102992|P1|NOT COMPLETED|Overall Study||0
462795|NCT00555464|1102991|P2|COMPLETED|Overall Study||1
462796|NCT00555464|1102992|P1|COMPLETED|Overall Study||4
462797|NCT00555464|1102991|P2|STARTED|Overall Study||4
462798|NCT00555464|1102992|P1|STARTED|Overall Study||4
462799|NCT00555438|1103000|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
462800|NCT00555438|1103000|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
462801|NCT00555438|1103000|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
462802|NCT00555438|1103000|P1|NOT COMPLETED|10 Days Post-operative||4
462803|NCT00555438|1103000|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
462804|NCT00555438|1103000|P1|STARTED|10 Days Post-operative||442
462805|NCT00555425|1103010|P2|NOT COMPLETED|Overall Study||19
462806|NCT00555425|1103011|P1|NOT COMPLETED|Overall Study||51
462807|NCT00555425|1103010|P2|COMPLETED|Overall Study||37
462808|NCT00555425|1103011|P1|COMPLETED|Overall Study||6
462809|NCT00555425|1103010|P2|STARTED|Overall Study||56
462810|NCT00555425|1103011|P1|STARTED|Overall Study||57
462811|NCT00555360|1103031|P2|NOT COMPLETED|Overall Study||36
462812|NCT00555360|1103032|P1|NOT COMPLETED|Overall Study||27
462813|NCT00555360|1103031|P2|COMPLETED|Overall Study||153
462814|NCT00555360|1103032|P1|COMPLETED|Overall Study||156
462815|NCT00555360|1103031|P2|STARTED|Overall Study||189
462816|NCT00555360|1103032|P1|STARTED|Overall Study||183
462817|NCT00555321|1103047|P5|NOT COMPLETED|Long-term Extension Phase||26
462818|NCT00555321|1103048|P4|NOT COMPLETED|Long-term Extension Phase||38
462819|NCT00555321|1103049|P3|NOT COMPLETED|Long-term Extension Phase||24
462820|NCT00555321|1103050|P2|NOT COMPLETED|Long-term Extension Phase||27
462821|NCT00555321|1103051|P1|NOT COMPLETED|Long-term Extension Phase||30
462822|NCT00555321|1103047|P5|COMPLETED|Long-term Extension Phase||0
462823|NCT00555321|1103048|P4|COMPLETED|Long-term Extension Phase||0
462824|NCT00555321|1103049|P3|COMPLETED|Long-term Extension Phase||0
462825|NCT00555321|1103050|P2|COMPLETED|Long-term Extension Phase||0
462826|NCT00555321|1103051|P1|COMPLETED|Long-term Extension Phase||0
462827|NCT00555321|1103047|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
462828|NCT00555321|1103048|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
462829|NCT00555321|1103049|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
462830|NCT00555321|1103050|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
462831|NCT00555321|1103051|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
462832|NCT00555321|1103047|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
462833|NCT00555321|1103048|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
462834|NCT00555321|1103049|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
462835|NCT00555321|1103050|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
462836|NCT00555321|1103051|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
462837|NCT00555321|1103047|P5|COMPLETED|Treatment Phase up to 12-months||32
462838|NCT00555321|1103048|P4|COMPLETED|Treatment Phase up to 12-months||46
462839|NCT00555321|1103049|P3|COMPLETED|Treatment Phase up to 12-months||26
462840|NCT00555321|1103050|P2|COMPLETED|Treatment Phase up to 12-months||29
462841|NCT00555321|1103051|P1|COMPLETED|Treatment Phase up to 12-months||31
462842|NCT00555321|1103047|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
462843|NCT00555321|1103048|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
462844|NCT00555321|1103049|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
462845|NCT00555321|1103050|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
462846|NCT00555321|1103051|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
462847|NCT00555321|1103047|P5|STARTED|Treatment Phase up to 12-months||54
462848|NCT00555321|1103048|P4|STARTED|Treatment Phase up to 12-months||53
462849|NCT00555321|1103049|P3|STARTED|Treatment Phase up to 12-months||50
462850|NCT00555321|1103050|P2|STARTED|Treatment Phase up to 12-months||51
462851|NCT00555321|1103051|P1|STARTED|Treatment Phase up to 12-months||52
462852|NCT00555217|1103355|P2|NOT COMPLETED|Overall Study||68
462853|NCT00555217|1103356|P1|NOT COMPLETED|Overall Study||75
462854|NCT00555217|1103355|P2|COMPLETED|Overall Study||656
462855|NCT00555217|1103356|P1|COMPLETED|Overall Study||649
462856|NCT00555217|1103355|P2|STARTED|Overall Study||724
462857|NCT00555217|1103356|P1|STARTED|Overall Study||724
462858|NCT00555152|1103368|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462859|NCT00555152|1103369|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462860|NCT00555152|1103370|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462861|NCT00555152|1103371|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462862|NCT00555152|1103368|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
462863|NCT00555152|1103369|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462864|NCT00555152|1103370|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
462865|NCT00555152|1103371|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462866|NCT00555152|1103368|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
462867|NCT00555152|1103369|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
462868|NCT00555152|1103370|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
462869|NCT00555152|1103371|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
462870|NCT00555152|1103368|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
462871|NCT00555152|1103369|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
462872|NCT00555152|1103370|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
462873|NCT00555152|1103371|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
462874|NCT00555152|1103368|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
462875|NCT00555152|1103369|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
462876|NCT00555152|1103370|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
462877|NCT00555152|1103371|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
462878|NCT00555152|1103368|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
462879|NCT00555152|1103369|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
462973|NCT00554372|1103583|P1|COMPLETED|Overall Study||14
462974|NCT00554372|1103582|P2|STARTED|Overall Study||16
462880|NCT00555152|1103370|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
462881|NCT00555152|1103371|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
462882|NCT00555061|1103393|P1|NOT COMPLETED|Overall Study||9
462883|NCT00555061|1103393|P1|COMPLETED|Overall Study||78
462884|NCT00555061|1103393|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
462885|NCT00555048|1103400|P1|NOT COMPLETED|Overall Study||0
462886|NCT00555048|1103400|P1|COMPLETED|Overall Study||1
462887|NCT00555048|1103400|P1|STARTED|Overall Study||1
462888|NCT00555009|1103412|P2|NOT COMPLETED|Overall Study||6
462889|NCT00555009|1103413|P1|NOT COMPLETED|Overall Study||2
462890|NCT00555009|1103412|P2|COMPLETED|Overall Study||0
462891|NCT00555009|1103413|P1|COMPLETED|Overall Study||2
462892|NCT00555009|1103412|P2|STARTED|Overall Study||6
462893|NCT00555009|1103413|P1|STARTED|Overall Study||4
462894|NCT00554996|1103435|P1|NOT COMPLETED|Overall Study||0
462895|NCT00554996|1103435|P1|COMPLETED|Overall Study||10
462896|NCT00554996|1103435|P1|STARTED|Overall Study||10
462897|NCT00554970|1103443|P4|NOT COMPLETED|Period 2||0
462898|NCT00554970|1103444|P3|NOT COMPLETED|Period 2||1
462899|NCT00554970|1103445|P2|NOT COMPLETED|Period 2||0
462900|NCT00554970|1103446|P1|NOT COMPLETED|Period 2||0
462901|NCT00554970|1103443|P4|COMPLETED|Period 2||8
462902|NCT00554970|1103444|P3|COMPLETED|Period 2||7
462903|NCT00554970|1103445|P2|COMPLETED|Period 2||8
462904|NCT00554970|1103446|P1|COMPLETED|Period 2||7
462905|NCT00554970|1103443|P4|STARTED|Period 2||8
462906|NCT00554970|1103444|P3|STARTED|Period 2||8
462907|NCT00554970|1103445|P2|STARTED|Period 2||8
462908|NCT00554970|1103446|P1|STARTED|Period 2||7
462909|NCT00554970|1103443|P4|NOT COMPLETED|Period 1||0
462910|NCT00554970|1103444|P3|NOT COMPLETED|Period 1||0
462911|NCT00554970|1103445|P2|NOT COMPLETED|Period 1||0
462912|NCT00554970|1103446|P1|NOT COMPLETED|Period 1||1
462913|NCT00554970|1103443|P4|COMPLETED|Period 1||8
462914|NCT00554970|1103444|P3|COMPLETED|Period 1||8
462915|NCT00554970|1103445|P2|COMPLETED|Period 1||8
462916|NCT00554970|1103446|P1|COMPLETED|Period 1||7
462917|NCT00554970|1103443|P4|STARTED|Period 1||8
462918|NCT00554970|1103444|P3|STARTED|Period 1||8
462919|NCT00554970|1103445|P2|STARTED|Period 1||8
462920|NCT00554970|1103446|P1|STARTED|Period 1||8
462921|NCT00554853|1103478|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
462922|NCT00554853|1103479|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
462923|NCT00554853|1103478|P2|COMPLETED|Crossover Arm (3 Months)||55
462924|NCT00554853|1103479|P1|COMPLETED|Crossover Arm (3 Months)||53
462925|NCT00554853|1103478|P2|STARTED|Crossover Arm (3 Months)||57
462926|NCT00554853|1103479|P1|STARTED|Crossover Arm (3 Months)||56
462927|NCT00554853|1103478|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
462928|NCT00554853|1103479|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
462929|NCT00554853|1103478|P2|COMPLETED|Washout Period (2 Weeks)||57
462930|NCT00554853|1103479|P1|COMPLETED|Washout Period (2 Weeks)||56
462931|NCT00554853|1103478|P2|STARTED|Washout Period (2 Weeks)||64
462932|NCT00554853|1103479|P1|STARTED|Washout Period (2 Weeks)||56
462933|NCT00554853|1103478|P2|NOT COMPLETED|First Arm of Study||7
462934|NCT00554853|1103479|P1|NOT COMPLETED|First Arm of Study||16
462935|NCT00554853|1103478|P2|COMPLETED|First Arm of Study||64
462936|NCT00554853|1103479|P1|COMPLETED|First Arm of Study||56
462937|NCT00554853|1103478|P2|STARTED|First Arm of Study||71
462938|NCT00554853|1103479|P1|STARTED|First Arm of Study||72
462939|NCT00554840|1103493|P2|NOT COMPLETED|Overall Study||1
462940|NCT00554840|1103494|P1|NOT COMPLETED|Overall Study||0
462941|NCT00554840|1103493|P2|COMPLETED|Overall Study||4
462942|NCT00554840|1103494|P1|COMPLETED|Overall Study||4
462943|NCT00554840|1103493|P2|STARTED|Overall Study||5
462944|NCT00554840|1103494|P1|STARTED|Overall Study||4
462945|NCT00554801|1103512|P2|NOT COMPLETED|Overall Study||0
462946|NCT00554801|1103513|P1|NOT COMPLETED|Overall Study||19
462947|NCT00554801|1103512|P2|COMPLETED|Overall Study||29
462948|NCT00554801|1103513|P1|COMPLETED|Overall Study||36
462949|NCT00554801|1103512|P2|STARTED|Overall Study||29
462950|NCT00554801|1103513|P1|STARTED|Overall Study||55
462951|NCT00554749|1103519|P1|NOT COMPLETED|Overall Study||0
462952|NCT00554749|1103519|P1|COMPLETED|Overall Study||7
462953|NCT00554749|1103519|P1|STARTED|Overall Study||7
462954|NCT00554671|1103526|P2|NOT COMPLETED|Overall Study||16
462955|NCT00554671|1103527|P1|NOT COMPLETED|Overall Study||20
462956|NCT00554671|1103526|P2|COMPLETED|Overall Study||117
462957|NCT00554671|1103527|P1|COMPLETED|Overall Study||97
462958|NCT00554671|1103526|P2|STARTED|Overall Study||133
462959|NCT00554671|1103527|P1|STARTED|Overall Study||117
462960|NCT00554619|1103535|P1|NOT COMPLETED|Overall Study||3
462961|NCT00554619|1103535|P1|COMPLETED|Overall Study||18
462962|NCT00554619|1103535|P1|STARTED|Overall Study||21
462963|NCT00554515|1103547|P1|NOT COMPLETED|Overall Study||118
462964|NCT00554515|1103547|P1|COMPLETED|Overall Study||5
462965|NCT00554515|1103547|P1|Treated|Overall Study||120
462966|NCT00554515|1103547|P1|STARTED|Overall Study||123
462967|NCT00554463|1103576|P1|NOT COMPLETED|Overall Study||0
462968|NCT00554463|1103576|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
462969|NCT00554463|1103576|P1|STARTED|Overall Study||5
462970|NCT00554372|1103582|P2|NOT COMPLETED|Overall Study||0
462971|NCT00554372|1103583|P1|NOT COMPLETED|Overall Study||0
462972|NCT00554372|1103582|P2|COMPLETED|Overall Study||16
462975|NCT00554372|1103583|P1|STARTED|Overall Study||14
462976|NCT00554294|1103597|P2|NOT COMPLETED|Overall Study||80
462977|NCT00554294|1103598|P1|NOT COMPLETED|Overall Study||160
462978|NCT00554294|1103597|P2|COMPLETED|Overall Study||1641
462979|NCT00554294|1103598|P1|COMPLETED|Overall Study||1309
462980|NCT00554294|1103597|P2|STARTED|Overall Study||1721
462981|NCT00554294|1103598|P1|STARTED|Overall Study||1469
462982|NCT00554229|1103604|P2|NOT COMPLETED|Overall Study||225
462983|NCT00554229|1103605|P1|NOT COMPLETED|Overall Study||226
462984|NCT00554229|1103604|P2|COMPLETED|Overall Study||70
462985|NCT00554229|1103605|P1|COMPLETED|Overall Study||73
462986|NCT00554229|1103604|P2|Patients Who Received Treatment|Overall Study||295
462987|NCT00554229|1103605|P1|Patients Who Received Treatment|Overall Study||298
462988|NCT00554229|1103604|P2|STARTED|Overall Study||295
462989|NCT00554229|1103605|P1|STARTED|Overall Study||299
462990|NCT00554216|1103630|P3|NOT COMPLETED|Overall Study||172
462991|NCT00554216|1103631|P2|NOT COMPLETED|Overall Study||94
462992|NCT00554216|1103632|P1|NOT COMPLETED|Overall Study||242
462993|NCT00554216|1103630|P3|COMPLETED|Overall Study||340
462994|NCT00554216|1103631|P2|COMPLETED|Overall Study||147
462995|NCT00554216|1103632|P1|COMPLETED|Overall Study||272
462996|NCT00554216|1103630|P3|STARTED|Overall Study||512
462997|NCT00554216|1103631|P2|STARTED|Overall Study||241
462998|NCT00554216|1103632|P1|STARTED|Overall Study||514
462999|NCT00554190|1103643|P1|NOT COMPLETED|Overall Study||10
463000|NCT00554190|1103643|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
463001|NCT00554190|1103643|P1|STARTED|Overall Study|29 subjects treated.|29
463002|NCT00554099|1103652|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
463003|NCT00554099|1103653|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
463004|NCT00554099|1103654|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
463005|NCT00554099|1103652|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
463006|NCT00554099|1103653|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
463007|NCT00554099|1103654|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
463008|NCT00554099|1103652|P3|STARTED|Non-Treatment Phase (9 Months)||27
463009|NCT00554099|1103653|P2|STARTED|Non-Treatment Phase (9 Months)||32
463010|NCT00554099|1103654|P1|STARTED|Non-Treatment Phase (9 Months)||29
463011|NCT00554099|1103652|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
463012|NCT00554099|1103653|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
463013|NCT00554099|1103654|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
463014|NCT00554099|1103652|P3|COMPLETED|Treatment Period (12 Weeks)||27
463015|NCT00554099|1103653|P2|COMPLETED|Treatment Period (12 Weeks)||32
463016|NCT00554099|1103654|P1|COMPLETED|Treatment Period (12 Weeks)||29
463017|NCT00554099|1103652|P3|STARTED|Treatment Period (12 Weeks)||36
463018|NCT00554099|1103653|P2|STARTED|Treatment Period (12 Weeks)||40
463019|NCT00554099|1103654|P1|STARTED|Treatment Period (12 Weeks)||41
463020|NCT00553969|1103687|P4|NOT COMPLETED|Overall Study||1
463021|NCT00553969|1103688|P3|NOT COMPLETED|Overall Study||1
463022|NCT00553969|1103689|P2|NOT COMPLETED|Overall Study||0
463023|NCT00553969|1103690|P1|NOT COMPLETED|Overall Study||8
463024|NCT00553969|1103687|P4|COMPLETED|Overall Study||23
463025|NCT00553969|1103688|P3|COMPLETED|Overall Study||21
463026|NCT00553969|1103689|P2|COMPLETED|Overall Study||24
463027|NCT00553969|1103690|P1|COMPLETED|Overall Study||23
463028|NCT00553969|1103687|P4|STARTED|Overall Study||24
463029|NCT00553969|1103688|P3|STARTED|Overall Study||22
463030|NCT00553969|1103689|P2|STARTED|Overall Study||24
463031|NCT00553969|1103690|P1|STARTED|Overall Study||31
463032|NCT00553839|1103700|P1|NOT COMPLETED|Overall Study||0
463033|NCT00553839|1103700|P1|COMPLETED|Overall Study||21
463034|NCT00553839|1103700|P1|STARTED|Overall Study||21
463035|NCT00553787|1103709|P3|NOT COMPLETED|Overall Study||262
463036|NCT00553787|1103710|P2|NOT COMPLETED|Overall Study||124
463037|NCT00553787|1103711|P1|NOT COMPLETED|Overall Study||378
463038|NCT00553787|1103709|P3|COMPLETED|Overall Study||733
463039|NCT00553787|1103710|P2|COMPLETED|Overall Study||374
463040|NCT00553787|1103711|P1|COMPLETED|Overall Study||616
463041|NCT00553787|1103709|P3|STARTED|Overall Study||995
463042|NCT00553787|1103710|P2|STARTED|Overall Study||498
463043|NCT00553787|1103711|P1|STARTED|Overall Study||994
463044|NCT00553735|1103722|P1|NOT COMPLETED|Overall Study||7
463045|NCT00553735|1103722|P1|COMPLETED|Overall Study||1
463046|NCT00553735|1103722|P1|STARTED|Overall Study||8
463047|NCT00553696|1103743|P4|NOT COMPLETED|Overall Study||1
463048|NCT00553696|1103744|P3|NOT COMPLETED|Overall Study||6
463049|NCT00553696|1103745|P2|NOT COMPLETED|Overall Study||16
463050|NCT00553696|1103746|P1|NOT COMPLETED|Overall Study||4
463051|NCT00553696|1103743|P4|COMPLETED|Overall Study||0
463052|NCT00553696|1103744|P3|COMPLETED|Overall Study||0
463053|NCT00553696|1103745|P2|COMPLETED|Overall Study||0
463054|NCT00553696|1103746|P1|COMPLETED|Overall Study||0
463055|NCT00553696|1103743|P4|STARTED|Overall Study||1
463056|NCT00553696|1103744|P3|STARTED|Overall Study||6
463057|NCT00553696|1103745|P2|STARTED|Overall Study||16
463058|NCT00553696|1103746|P1|STARTED|Overall Study||4
463059|NCT00553644|1103784|P1|NOT COMPLETED|Overall Study||28
463060|NCT00553644|1103784|P1|COMPLETED|Overall Study||25
463061|NCT00553644|1103784|P1|STARTED|Overall Study||53
463062|NCT00553631|1103790|P2|NOT COMPLETED|Overall Study||1
463063|NCT00553631|1103791|P1|NOT COMPLETED|Overall Study||1
463064|NCT00553631|1103790|P2|COMPLETED|Overall Study||16
463065|NCT00553631|1103791|P1|COMPLETED|Overall Study||16
463066|NCT00553631|1103790|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
463067|NCT00553631|1103791|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
463068|NCT00553605|1103813|P2|NOT COMPLETED|Overall Study||3
463069|NCT00553605|1103814|P1|NOT COMPLETED|Overall Study||4
463070|NCT00553605|1103813|P2|COMPLETED|Overall Study||161
463071|NCT00553605|1103814|P1|COMPLETED|Overall Study||172
463072|NCT00553605|1103813|P2|Treated|Overall Study||164
463073|NCT00553605|1103814|P1|Treated|Overall Study||174
463074|NCT00553605|1103813|P2|STARTED|Overall Study||164
463075|NCT00553605|1103814|P1|STARTED|Overall Study||176
463076|NCT00553514|1103843|P5|NOT COMPLETED|Overall Study||7
463077|NCT00553514|1103844|P4|NOT COMPLETED|Overall Study||7
463078|NCT00553514|1103845|P3|NOT COMPLETED|Overall Study||6
463079|NCT00553514|1103846|P2|NOT COMPLETED|Overall Study||8
463080|NCT00553514|1103847|P1|NOT COMPLETED|Overall Study||8
463081|NCT00553514|1103843|P5|COMPLETED|Overall Study||8
463082|NCT00553514|1103844|P4|COMPLETED|Overall Study||6
463083|NCT00553514|1103845|P3|COMPLETED|Overall Study||9
463084|NCT00553514|1103846|P2|COMPLETED|Overall Study||6
463085|NCT00553514|1103847|P1|COMPLETED|Overall Study||6
463086|NCT00553514|1103843|P5|STARTED|Overall Study||15
463087|NCT00553514|1103844|P4|STARTED|Overall Study||13
463088|NCT00553514|1103845|P3|STARTED|Overall Study||15
463089|NCT00553514|1103846|P2|STARTED|Overall Study||14
463090|NCT00553514|1103847|P1|STARTED|Overall Study||14
463091|NCT00553501|1103884|P1|NOT COMPLETED|Overall Study||4
463092|NCT00553501|1103884|P1|COMPLETED|Overall Study||55
463093|NCT00553501|1103884|P1|STARTED|Overall Study||59
463094|NCT00553475|1103893|P3|NOT COMPLETED|Overall Study||13
463095|NCT00553475|1103894|P2|NOT COMPLETED|Overall Study||20
463096|NCT00553475|1103895|P1|NOT COMPLETED|Overall Study||16
463097|NCT00553475|1103893|P3|COMPLETED|Overall Study||32
463098|NCT00553475|1103894|P2|COMPLETED|Overall Study||114
463099|NCT00553475|1103895|P1|COMPLETED|Overall Study||119
463100|NCT00553475|1103893|P3|STARTED|Overall Study||45
463101|NCT00553475|1103894|P2|STARTED|Overall Study||134
463102|NCT00553475|1103895|P1|STARTED|Overall Study||135
463103|NCT00553462|1104017|P1|NOT COMPLETED|Overall Study||14
463104|NCT00553462|1104017|P1|COMPLETED|Overall Study||61
463105|NCT00553462|1104017|P1|STARTED|Overall Study||75
463106|NCT00553436|1104023|P1|NOT COMPLETED|Overall Study||1
463107|NCT00553436|1104023|P1|COMPLETED|Overall Study|09 April 2009|6
463108|NCT00553436|1104023|P1|STARTED|Overall Study|20 August 2007|7
463109|NCT00553358|1104032|P3|NOT COMPLETED|Overall Study||60
463110|NCT00553358|1104033|P2|NOT COMPLETED|Overall Study||12
463111|NCT00553358|1104034|P1|NOT COMPLETED|Overall Study||53
463112|NCT00553358|1104032|P3|COMPLETED|Overall Study||92
463113|NCT00553358|1104033|P2|COMPLETED|Overall Study||137
463114|NCT00553358|1104034|P1|COMPLETED|Overall Study||101
463115|NCT00553358|1104032|P3|STARTED|Overall Study||152
463116|NCT00553358|1104033|P2|STARTED|Overall Study||149
463117|NCT00553358|1104034|P1|STARTED|Overall Study||154
463118|NCT00553332|1104060|P1|NOT COMPLETED|Overall Study||1
463119|NCT00553332|1104060|P1|COMPLETED|Overall Study|evaluable for response|28
463120|NCT00553332|1104060|P1|STARTED|Overall Study||29
463121|NCT00553319|1104072|P3|NOT COMPLETED|Overall Study||9
463122|NCT00553319|1104073|P2|NOT COMPLETED|Overall Study||10
463123|NCT00553319|1104074|P1|NOT COMPLETED|Overall Study||14
463124|NCT00553319|1104072|P3|COMPLETED|Overall Study||34
463125|NCT00553319|1104073|P2|COMPLETED|Overall Study||30
463126|NCT00553319|1104074|P1|COMPLETED|Overall Study||29
463127|NCT00553319|1104072|P3|STARTED|Overall Study||43
463128|NCT00553319|1104073|P2|STARTED|Overall Study||40
463129|NCT00553319|1104074|P1|STARTED|Overall Study||43
463130|NCT00553280|1104085|P1|NOT COMPLETED|Overall Study||26
463131|NCT00553280|1104085|P1|COMPLETED|Overall Study||97
463132|NCT00553280|1104085|P1|STARTED|Overall Study||123
463133|NCT00553267|1104097|P3|NOT COMPLETED|Overall Study||10
463134|NCT00553267|1104098|P2|NOT COMPLETED|Overall Study||18
463135|NCT00553267|1104099|P1|NOT COMPLETED|Overall Study||14
463136|NCT00553267|1104097|P3|COMPLETED|Overall Study||307
463137|NCT00553267|1104098|P2|COMPLETED|Overall Study||297
463138|NCT00553267|1104099|P1|COMPLETED|Overall Study||301
463139|NCT00553267|1104097|P3|STARTED|Overall Study||317
463140|NCT00553267|1104098|P2|STARTED|Overall Study||315
463141|NCT00553267|1104099|P1|STARTED|Overall Study||315
463142|NCT00553202|1104134|P1|NOT COMPLETED|Overall Study||68
463143|NCT00553202|1104134|P1|COMPLETED|Overall Study||90
463144|NCT00553202|1104134|P1|STARTED|Overall Study||158
463145|NCT00553150|1104144|P4|NOT COMPLETED|Overall Study||4
463146|NCT00553150|1104145|P3|NOT COMPLETED|Overall Study||0
463147|NCT00553150|1104146|P2|NOT COMPLETED|Overall Study||0
463148|NCT00553150|1104147|P1|NOT COMPLETED|Overall Study||0
463149|NCT00553150|1104144|P4|COMPLETED|Overall Study||100
463150|NCT00553150|1104145|P3|COMPLETED|Overall Study||6
463151|NCT00553150|1104146|P2|COMPLETED|Overall Study||6
463152|NCT00553150|1104147|P1|COMPLETED|Overall Study||6
463153|NCT00553150|1104144|P4|STARTED|Overall Study||104
463154|NCT00553150|1104145|P3|STARTED|Overall Study||6
463155|NCT00553150|1104146|P2|STARTED|Overall Study||6
463156|NCT00553150|1104147|P1|STARTED|Overall Study||6
463157|NCT00553098|1104159|P1|NOT COMPLETED|Overall Study||1
463158|NCT00553098|1104159|P1|COMPLETED|Overall Study||28
463159|NCT00553098|1104159|P1|STARTED|Overall Study||29
463160|NCT00552812|1104173|P1|NOT COMPLETED|Overall Study||20
463161|NCT00552812|1104173|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
463162|NCT00552812|1104173|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
463163|NCT00552786|1104181|P2|NOT COMPLETED|Second Intervention||0
463164|NCT00552786|1104182|P1|NOT COMPLETED|Second Intervention||0
463165|NCT00552786|1104181|P2|COMPLETED|Second Intervention||28
463166|NCT00552786|1104182|P1|COMPLETED|Second Intervention||25
463167|NCT00552786|1104181|P2|STARTED|Second Intervention||28
463168|NCT00552786|1104182|P1|STARTED|Second Intervention||25
463169|NCT00552786|1104181|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
463170|NCT00552786|1104182|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
463171|NCT00552786|1104181|P2|COMPLETED|Washout Period of 2 Weeks||28
463172|NCT00552786|1104182|P1|COMPLETED|Washout Period of 2 Weeks||25
463173|NCT00552786|1104181|P2|STARTED|Washout Period of 2 Weeks||28
463174|NCT00552786|1104182|P1|STARTED|Washout Period of 2 Weeks||25
463175|NCT00552786|1104181|P2|NOT COMPLETED|First Intervention||0
463176|NCT00552786|1104182|P1|NOT COMPLETED|First Intervention||0
463177|NCT00552786|1104181|P2|COMPLETED|First Intervention||28
463178|NCT00552786|1104182|P1|COMPLETED|First Intervention||25
463179|NCT00552786|1104181|P2|Medication and Hearing Evaluation|First Intervention||28
463180|NCT00552786|1104182|P1|Medication and Hearing Evaluation|First Intervention||25
463181|NCT00552786|1104181|P2|STARTED|First Intervention||28
463182|NCT00552786|1104182|P1|STARTED|First Intervention||25
463183|NCT00552760|1104192|P2|NOT COMPLETED|Overall Study||33
463184|NCT00552760|1104193|P1|NOT COMPLETED|Overall Study||26
463185|NCT00552760|1104192|P2|COMPLETED|Overall Study||8
463186|NCT00552760|1104193|P1|COMPLETED|Overall Study||16
463187|NCT00552760|1104192|P2|STARTED|Overall Study||41
463188|NCT00552760|1104193|P1|STARTED|Overall Study||42
463189|NCT00552695|1104209|P2|NOT COMPLETED|Overall Study||0
463190|NCT00552695|1104210|P1|NOT COMPLETED|Overall Study||0
463191|NCT00552695|1104209|P2|COMPLETED|Overall Study|September 2007|23
463192|NCT00552695|1104210|P1|COMPLETED|Overall Study|September 2007|22
463193|NCT00552695|1104209|P2|STARTED|Overall Study|August 2007|23
463194|NCT00552695|1104210|P1|STARTED|Overall Study|August 2007|22
463195|NCT00552669|1104220|P2|NOT COMPLETED|Overall Study||7
463196|NCT00552669|1104221|P1|NOT COMPLETED|Overall Study||3
463197|NCT00552669|1104220|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
463198|NCT00552669|1104221|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
463199|NCT00552669|1104220|P2|STARTED|Overall Study|patients|100
463200|NCT00552669|1104221|P1|STARTED|Overall Study|patients|100
463201|NCT00552578|1104233|P2|NOT COMPLETED|Overall Study||1
463202|NCT00552578|1104234|P1|NOT COMPLETED|Overall Study||1
463203|NCT00552578|1104233|P2|COMPLETED|Overall Study||5
463204|NCT00552578|1104234|P1|COMPLETED|Overall Study||5
463205|NCT00552578|1104233|P2|STARTED|Overall Study||6
463206|NCT00552578|1104234|P1|STARTED|Overall Study||6
463207|NCT00552513|1104246|P2|NOT COMPLETED|Overall Study||1
463208|NCT00552513|1104247|P1|NOT COMPLETED|Overall Study||5
463209|NCT00552513|1104246|P2|COMPLETED|Overall Study||1437
463210|NCT00552513|1104247|P1|COMPLETED|Overall Study||1588
463211|NCT00552513|1104246|P2|STARTED|Overall Study||1438
463212|NCT00552513|1104247|P1|STARTED|Overall Study||1593
463213|NCT00552448|1104259|P2|NOT COMPLETED|Overall Study||0
463214|NCT00552448|1104260|P1|NOT COMPLETED|Overall Study||1
463215|NCT00552448|1104259|P2|COMPLETED|Overall Study||16
463216|NCT00552448|1104260|P1|COMPLETED|Overall Study||19
463217|NCT00552448|1104259|P2|STARTED|Overall Study||16
463218|NCT00552448|1104260|P1|STARTED|Overall Study||20
463219|NCT00552422|1104272|P1|NOT COMPLETED|Overall Study||0
463220|NCT00552422|1104272|P1|COMPLETED|Overall Study||6
463221|NCT00552422|1104272|P1|STARTED|Overall Study||6
463222|NCT00552409|1104278|P2|NOT COMPLETED|Overall Study||2
463223|NCT00552409|1104279|P1|NOT COMPLETED|Overall Study||1
463224|NCT00552409|1104278|P2|COMPLETED|Overall Study||9
463225|NCT00552409|1104279|P1|COMPLETED|Overall Study||10
463226|NCT00552409|1104278|P2|STARTED|Overall Study||11
463227|NCT00552409|1104279|P1|STARTED|Overall Study||11
463228|NCT00552396|1104292|P7|NOT COMPLETED|Overall Study||9
463229|NCT00552396|1104293|P6|NOT COMPLETED|Overall Study||3
463230|NCT00552396|1104294|P5|NOT COMPLETED|Overall Study||3
463231|NCT00552396|1104295|P4|NOT COMPLETED|Overall Study||6
463232|NCT00552396|1104296|P3|NOT COMPLETED|Overall Study||3
463233|NCT00552396|1104297|P2|NOT COMPLETED|Overall Study||3
463234|NCT00552396|1104298|P1|NOT COMPLETED|Overall Study||3
463235|NCT00552396|1104292|P7|COMPLETED|Overall Study||1
463236|NCT00552396|1104293|P6|COMPLETED|Overall Study||0
463237|NCT00552396|1104294|P5|COMPLETED|Overall Study||0
463238|NCT00552396|1104295|P4|COMPLETED|Overall Study||0
463239|NCT00552396|1104296|P3|COMPLETED|Overall Study||0
463240|NCT00552396|1104297|P2|COMPLETED|Overall Study||0
463241|NCT00552396|1104298|P1|COMPLETED|Overall Study||1
463242|NCT00552396|1104292|P7|STARTED|Overall Study||10
463243|NCT00552396|1104293|P6|STARTED|Overall Study||3
463244|NCT00552396|1104294|P5|STARTED|Overall Study||3
463245|NCT00552396|1104295|P4|STARTED|Overall Study||6
463246|NCT00552396|1104296|P3|STARTED|Overall Study||3
463247|NCT00552396|1104297|P2|STARTED|Overall Study||3
463248|NCT00552396|1104298|P1|STARTED|Overall Study||4
463249|NCT00552344|1104335|P1|NOT COMPLETED|Overall Study||315
463250|NCT00552344|1104335|P1|COMPLETED|Overall Study||87
463251|NCT00552344|1104335|P1|STARTED|Overall Study||402
463252|NCT00552305|1104344|P1|NOT COMPLETED|Overall Study||250
463253|NCT00552305|1104344|P1|COMPLETED|Overall Study||120
463254|NCT00552305|1104344|P1|STARTED|Overall Study||370
463255|NCT00552279|1104354|P2|NOT COMPLETED|Overall Study||3
463256|NCT00552279|1104355|P1|NOT COMPLETED|Overall Study||14
463257|NCT00552279|1104354|P2|COMPLETED|Overall Study||398
463258|NCT00552279|1104355|P1|COMPLETED|Overall Study||389
463259|NCT00552279|1104354|P2|STARTED|Overall Study||401
463260|NCT00552279|1104355|P1|STARTED|Overall Study||403
463261|NCT00552240|1104381|P2|NOT COMPLETED|Overall Study||18
463262|NCT00552240|1104382|P1|NOT COMPLETED|Overall Study||24
463263|NCT00552240|1104381|P2|COMPLETED|Overall Study||59
463264|NCT00552240|1104382|P1|COMPLETED|Overall Study||51
463265|NCT00552240|1104381|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
463266|NCT00552240|1104382|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
463267|NCT00552188|1104484|P2|NOT COMPLETED|Overall Study||5
463268|NCT00552188|1104485|P1|NOT COMPLETED|Overall Study||2
463269|NCT00552188|1104484|P2|COMPLETED|Overall Study||21
463270|NCT00552188|1104485|P1|COMPLETED|Overall Study||24
463271|NCT00552188|1104484|P2|STARTED|Overall Study||26
463272|NCT00552188|1104485|P1|STARTED|Overall Study||26
463273|NCT00552175|1104496|P3|NOT COMPLETED|Overall Study||14
463274|NCT00552175|1104497|P2|NOT COMPLETED|Overall Study||13
463275|NCT00552175|1104498|P1|NOT COMPLETED|Overall Study||17
463276|NCT00552175|1104496|P3|COMPLETED|Overall Study||72
463277|NCT00552175|1104497|P2|COMPLETED|Overall Study||73
463278|NCT00552175|1104498|P1|COMPLETED|Overall Study||150
463279|NCT00552175|1104496|P3|Full Analysis Set Population|Overall Study||86
463280|NCT00552175|1104497|P2|Full Analysis Set Population|Overall Study||85
463281|NCT00552175|1104498|P1|Full Analysis Set Population|Overall Study||167
463282|NCT00552175|1104496|P3|STARTED|Overall Study||86
463283|NCT00552175|1104497|P2|STARTED|Overall Study||86
463284|NCT00552175|1104498|P1|STARTED|Overall Study||167
463285|NCT00552110|1104538|P5|NOT COMPLETED|Overall Study||9
463286|NCT00552110|1104539|P4|NOT COMPLETED|Overall Study||8
463287|NCT00552110|1104540|P3|NOT COMPLETED|Overall Study||2
463288|NCT00552110|1104541|P2|NOT COMPLETED|Overall Study||5
463289|NCT00552110|1104542|P1|NOT COMPLETED|Overall Study||4
463290|NCT00552110|1104538|P5|COMPLETED|Overall Study||133
463291|NCT00552110|1104539|P4|COMPLETED|Overall Study||133
463292|NCT00552110|1104540|P3|COMPLETED|Overall Study||137
463293|NCT00552110|1104541|P2|COMPLETED|Overall Study||134
463294|NCT00552110|1104542|P1|COMPLETED|Overall Study||142
463295|NCT00552110|1104538|P5|STARTED|Overall Study||142
463296|NCT00552110|1104539|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
463297|NCT00552110|1104540|P3|STARTED|Overall Study||139
463298|NCT00552110|1104541|P2|STARTED|Overall Study||139
463299|NCT00552110|1104542|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
463300|NCT00552084|1104561|P2|NOT COMPLETED|Overall Study||9
463301|NCT00552084|1104562|P1|NOT COMPLETED|Overall Study||8
463302|NCT00552084|1104561|P2|COMPLETED|Overall Study||55
463303|NCT00552084|1104562|P1|COMPLETED|Overall Study||118
463304|NCT00552084|1104561|P2|STARTED|Overall Study||64
463305|NCT00552084|1104562|P1|STARTED|Overall Study||126
463306|NCT00552058|1104570|P2|NOT COMPLETED|Overall Study||24
463307|NCT00552058|1104571|P1|NOT COMPLETED|Overall Study||16
463308|NCT00552058|1104570|P2|COMPLETED|Overall Study||192
463309|NCT00552058|1104571|P1|COMPLETED|Overall Study||207
463310|NCT00552058|1104570|P2|STARTED|Overall Study||216
463311|NCT00552058|1104571|P1|STARTED|Overall Study||223
463312|NCT00552032|1104611|P2|NOT COMPLETED|Overall Study||19
463313|NCT00552032|1104612|P1|NOT COMPLETED|Overall Study||17
463314|NCT00552032|1104611|P2|COMPLETED|Overall Study||47
463315|NCT00552032|1104612|P1|COMPLETED|Overall Study||49
463316|NCT00552032|1104611|P2|STARTED|Overall Study||66
463317|NCT00552032|1104612|P1|STARTED|Overall Study||66
463318|NCT00551759|1104656|P1|NOT COMPLETED|Overall Study||13
463319|NCT00551759|1104656|P1|COMPLETED|Overall Study||9
463320|NCT00551759|1104656|P1|Received Adjuvant Therapy|Overall Study||12
463321|NCT00551759|1104656|P1|Underwent Surgery|Overall Study||17
463322|NCT00551759|1104656|P1|Eligible and Began Treatment|Overall Study||21
463323|NCT00551759|1104656|P1|STARTED|Overall Study||22
463324|NCT00551746|1104662|P2|NOT COMPLETED|Overall Study||8
463325|NCT00551746|1104663|P1|NOT COMPLETED|Overall Study||11
463326|NCT00551746|1104662|P2|COMPLETED|Overall Study||26
463327|NCT00551746|1104663|P1|COMPLETED|Overall Study||25
463328|NCT00551746|1104662|P2|STARTED|Overall Study||34
463329|NCT00551746|1104663|P1|STARTED|Overall Study||36
463330|NCT00551707|1104674|P5|NOT COMPLETED|Overall Study||1
463331|NCT00551707|1104675|P4|NOT COMPLETED|Overall Study||4
463332|NCT00551707|1104676|P3|NOT COMPLETED|Overall Study||3
463333|NCT00551707|1104677|P2|NOT COMPLETED|Overall Study||6
463334|NCT00551707|1104678|P1|NOT COMPLETED|Overall Study||0
463335|NCT00551707|1104674|P5|COMPLETED|Overall Study||3
463336|NCT00551707|1104675|P4|COMPLETED|Overall Study||4
463337|NCT00551707|1104676|P3|COMPLETED|Overall Study||10
463338|NCT00551707|1104677|P2|COMPLETED|Overall Study||16
463339|NCT00551707|1104678|P1|COMPLETED|Overall Study||4
463340|NCT00551707|1104674|P5|STARTED|Overall Study||4
463341|NCT00551707|1104675|P4|STARTED|Overall Study||8
463342|NCT00551707|1104676|P3|STARTED|Overall Study||13
463343|NCT00551707|1104677|P2|STARTED|Overall Study||22
463344|NCT00551707|1104678|P1|STARTED|Overall Study||4
463345|NCT00551642|1104697|P2|NOT COMPLETED|Overall Study||63
463346|NCT00551642|1104698|P1|NOT COMPLETED|Overall Study||61
463347|NCT00551642|1104697|P2|COMPLETED|Overall Study||338
463348|NCT00551642|1104698|P1|COMPLETED|Overall Study||338
463349|NCT00551642|1104697|P2|STARTED|Overall Study||401
463350|NCT00551642|1104698|P1|STARTED|Overall Study||399
463351|NCT00551421|1104704|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
463352|NCT00551421|1104704|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
463353|NCT00551421|1104704|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
463354|NCT00551421|1104704|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
463355|NCT00551421|1104704|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
463356|NCT00551421|1104704|P1|STARTED|Original Protocol, Dose Level 1||3
463357|NCT00551369|1104711|P1|NOT COMPLETED|Overall Study||7
463358|NCT00551369|1104711|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
463359|NCT00551369|1104711|P1|STARTED|Overall Study||33
463360|NCT00551291|1104718|P1|NOT COMPLETED|Overall Study||1
463361|NCT00551291|1104718|P1|COMPLETED|Overall Study||9
463362|NCT00551291|1104718|P1|STARTED|Overall Study||10
463363|NCT00551213|1104726|P2|NOT COMPLETED|Overall Study||17
463364|NCT00551213|1104727|P1|NOT COMPLETED|Overall Study||50
463365|NCT00551213|1104726|P2|COMPLETED|Overall Study||0
463366|NCT00551213|1104727|P1|COMPLETED|Overall Study||0
463367|NCT00551213|1104726|P2|Treated|Overall Study||15
463368|NCT00551213|1104727|P1|Treated|Overall Study||49
463369|NCT00551213|1104726|P2|STARTED|Overall Study||17
463370|NCT00551213|1104727|P1|STARTED|Overall Study||50
463371|NCT00551200|1104743|P1|NOT COMPLETED|Overall Study||4
463372|NCT00551200|1104743|P1|COMPLETED|Overall Study||10
463373|NCT00551200|1104743|P1|STARTED|Overall Study||14
463374|NCT00551174|1104758|P2|NOT COMPLETED|Overall Study||6
463375|NCT00551174|1104759|P1|NOT COMPLETED|Overall Study||19
463376|NCT00551174|1104758|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
463377|NCT00551174|1104759|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
463378|NCT00551174|1104758|P2|STARTED|Overall Study||400
463379|NCT00551174|1104759|P1|STARTED|Overall Study||381
463380|NCT00551161|1104771|P1|NOT COMPLETED|Overall Study||1
463381|NCT00551161|1104771|P1|COMPLETED|Overall Study||11
463382|NCT00551161|1104771|P1|STARTED|Overall Study||12
463383|NCT00551135|1104779|P4|NOT COMPLETED|Overall Study||5
463384|NCT00551135|1104780|P3|NOT COMPLETED|Overall Study||5
463385|NCT00551135|1104781|P2|NOT COMPLETED|Overall Study||2
463386|NCT00551135|1104782|P1|NOT COMPLETED|Overall Study||5
463387|NCT00551135|1104779|P4|COMPLETED|Overall Study||103
463388|NCT00551135|1104780|P3|COMPLETED|Overall Study||98
463389|NCT00551135|1104781|P2|COMPLETED|Overall Study||104
463390|NCT00551135|1104782|P1|COMPLETED|Overall Study||103
463391|NCT00551135|1104779|P4|STARTED|Overall Study||108
463392|NCT00551135|1104780|P3|STARTED|Overall Study||103
463393|NCT00551135|1104781|P2|STARTED|Overall Study||106
463394|NCT00551135|1104782|P1|STARTED|Overall Study||108
463395|NCT00551070|1104896|P1|NOT COMPLETED|Overall Study||0
463396|NCT00551070|1104896|P1|COMPLETED|Overall Study||52
463397|NCT00551070|1104896|P1|STARTED|Overall Study||52
463398|NCT00551031|1104911|P5|NOT COMPLETED|Overall Study||1
463399|NCT00551031|1104912|P4|NOT COMPLETED|Overall Study||3
463400|NCT00551031|1104913|P3|NOT COMPLETED|Overall Study||2
463401|NCT00551031|1104914|P2|NOT COMPLETED|Overall Study||11
463402|NCT00551031|1104915|P1|NOT COMPLETED|Overall Study||2
463403|NCT00551031|1104911|P5|COMPLETED|Overall Study||185
463404|NCT00551031|1104912|P4|COMPLETED|Overall Study||317
463405|NCT00551031|1104913|P3|COMPLETED|Overall Study||317
463406|NCT00551031|1104914|P2|COMPLETED|Overall Study||625
463407|NCT00551031|1104915|P1|COMPLETED|Overall Study||635
463408|NCT00551031|1104911|P5|STARTED|Overall Study||186
463409|NCT00551031|1104912|P4|STARTED|Overall Study||320
463410|NCT00551031|1104913|P3|STARTED|Overall Study||319
463411|NCT00551031|1104914|P2|STARTED|Overall Study||636
463412|NCT00551031|1104915|P1|STARTED|Overall Study||637
463413|NCT00550953|1104944|P2|NOT COMPLETED|Overall Study||6
463414|NCT00550953|1104945|P1|NOT COMPLETED|Overall Study||6
463415|NCT00550953|1104944|P2|COMPLETED|Overall Study||152
463416|NCT00550953|1104945|P1|COMPLETED|Overall Study||150
463417|NCT00550953|1104944|P2|STARTED|Overall Study||158
463418|NCT00550953|1104945|P1|STARTED|Overall Study||156
463419|NCT00550862|1104969|P4|NOT COMPLETED|Overall Study||1
463420|NCT00550862|1104970|P3|NOT COMPLETED|Overall Study||16
463421|NCT00550862|1104971|P2|NOT COMPLETED|Overall Study||6
463422|NCT00550862|1104972|P1|NOT COMPLETED|Overall Study||6
463423|NCT00550862|1104969|P4|COMPLETED|Overall Study||37
463424|NCT00550862|1104970|P3|COMPLETED|Overall Study||25
463425|NCT00550862|1104971|P2|COMPLETED|Overall Study||42
463426|NCT00550862|1104972|P1|COMPLETED|Overall Study||32
463427|NCT00550862|1104969|P4|STARTED|Overall Study||38
463428|NCT00550862|1104970|P3|STARTED|Overall Study||41
463429|NCT00550862|1104971|P2|STARTED|Overall Study||48
463430|NCT00550862|1104972|P1|STARTED|Overall Study||38
463431|NCT00550836|1104992|P2|NOT COMPLETED|Overall Study||9
463432|NCT00550836|1104993|P1|NOT COMPLETED|Overall Study||3
463433|NCT00550836|1104992|P2|COMPLETED|Overall Study||46
463434|NCT00550836|1104993|P1|COMPLETED|Overall Study||46
463435|NCT00550836|1104992|P2|STARTED|Overall Study||55
463436|NCT00550836|1104993|P1|STARTED|Overall Study||49
463437|NCT00550771|1105009|P2|NOT COMPLETED|Overall Study||10
463438|NCT00550771|1105010|P1|NOT COMPLETED|Overall Study||17
463439|NCT00550771|1105009|P2|COMPLETED|Overall Study||50
463440|NCT00550771|1105010|P1|COMPLETED|Overall Study||104
463441|NCT00550771|1105009|P2|STARTED|Overall Study||60
463442|NCT00550771|1105010|P1|STARTED|Overall Study||121
463443|NCT00550745|1105024|P2|NOT COMPLETED|Overall Study||60
463444|NCT00550745|1105025|P1|NOT COMPLETED|Overall Study||87
463445|NCT00550745|1105024|P2|COMPLETED|Overall Study||5939
463446|NCT00550745|1105025|P1|COMPLETED|Overall Study||5913
463447|NCT00550745|1105024|P2|STARTED|Overall Study||5999
463448|NCT00550745|1105025|P1|STARTED|Overall Study||6000
463449|NCT00550732|1105033|P1|NOT COMPLETED|Overall Study||11
463450|NCT00550732|1105033|P1|COMPLETED|Overall Study||29
463451|NCT00550732|1105033|P1|STARTED|Overall Study||40
463452|NCT00550680|1105044|P1|NOT COMPLETED|Overall Study||56
463453|NCT00550680|1105044|P1|COMPLETED|Overall Study||152
463454|NCT00550680|1105044|P1|STARTED|Overall Study||208
463455|NCT00550654|1105053|P1|NOT COMPLETED|Overall Study||0
463456|NCT00550654|1105053|P1|COMPLETED|Overall Study||1
463457|NCT00550654|1105053|P1|STARTED|Overall Study||1
463458|NCT00550589|1105063|P1|NOT COMPLETED|Overall Study||0
463459|NCT00550589|1105063|P1|COMPLETED|Overall Study||33
463460|NCT00550589|1105063|P1|STARTED|Overall Study||33
463461|NCT00550550|1105076|P2|NOT COMPLETED|Overall Study||29
463462|NCT00550550|1105077|P1|NOT COMPLETED|Overall Study||34
463463|NCT00550550|1105076|P2|COMPLETED|Overall Study||140
463464|NCT00550550|1105077|P1|COMPLETED|Overall Study||142
463465|NCT00550550|1105076|P2|Number Treated|Overall Study||169
463466|NCT00550550|1105077|P1|Number Treated|Overall Study||175
463467|NCT00550550|1105076|P2|STARTED|Overall Study||169
463468|NCT00550550|1105077|P1|STARTED|Overall Study||176
463469|NCT00550537|1105089|P1|NOT COMPLETED|Overall Study||104
463470|NCT00550537|1105089|P1|COMPLETED|Overall Study||12
463471|NCT00550537|1105089|P1|STARTED|Overall Study||116
463472|NCT00550459|1105106|P2|NOT COMPLETED|Overall Study||3
463473|NCT00550459|1105107|P1|NOT COMPLETED|Overall Study||1
463474|NCT00550459|1105106|P2|COMPLETED|Overall Study||26
463475|NCT00550459|1105107|P1|COMPLETED|Overall Study||27
463476|NCT00550459|1105106|P2|STARTED|Overall Study||29
463477|NCT00550459|1105107|P1|STARTED|Overall Study||28
463478|NCT00550446|1105176|P11|NOT COMPLETED|Post Week 12||1
463479|NCT00550446|1105177|P10|NOT COMPLETED|Post Week 12||7
463480|NCT00550446|1105178|P9|NOT COMPLETED|Post Week 12||2
463481|NCT00550446|1105179|P8|NOT COMPLETED|Post Week 12||1
463482|NCT00550446|1105180|P7|NOT COMPLETED|Post Week 12||2
463483|NCT00550446|1105181|P6|NOT COMPLETED|Post Week 12||1
463484|NCT00550446|1105182|P5|NOT COMPLETED|Post Week 12||2
463485|NCT00550446|1105183|P4|NOT COMPLETED|Post Week 12||3
463486|NCT00550446|1105184|P3|NOT COMPLETED|Post Week 12||3
463487|NCT00550446|1105185|P2|NOT COMPLETED|Post Week 12||2
463488|NCT00550446|1105186|P1|NOT COMPLETED|Post Week 12||3
463489|NCT00550446|1105176|P11|COMPLETED|Post Week 12||24
463490|NCT00550446|1105177|P10|COMPLETED|Post Week 12||37
463491|NCT00550446|1105178|P9|COMPLETED|Post Week 12||15
463492|NCT00550446|1105179|P8|COMPLETED|Post Week 12||16
463493|NCT00550446|1105180|P7|COMPLETED|Post Week 12||19
463494|NCT00550446|1105181|P6|COMPLETED|Post Week 12||0
463495|NCT00550446|1105182|P5|COMPLETED|Post Week 12||52
463496|NCT00550446|1105183|P4|COMPLETED|Post Week 12||55
463497|NCT00550446|1105184|P3|COMPLETED|Post Week 12||43
463498|NCT00550446|1105185|P2|COMPLETED|Post Week 12||28
463499|NCT00550446|1105186|P1|COMPLETED|Post Week 12||24
463500|NCT00550446|1105176|P11|STARTED|Post Week 12||25
463501|NCT00550446|1105177|P10|STARTED|Post Week 12||44
463502|NCT00550446|1105178|P9|STARTED|Post Week 12||17
463503|NCT00550446|1105179|P8|STARTED|Post Week 12||17
463504|NCT00550446|1105180|P7|STARTED|Post Week 12||21
463505|NCT00550446|1105181|P6|STARTED|Post Week 12||1
463506|NCT00550446|1105182|P5|STARTED|Post Week 12||54
463507|NCT00550446|1105183|P4|STARTED|Post Week 12||58
463508|NCT00550446|1105184|P3|STARTED|Post Week 12||46
463509|NCT00550446|1105185|P2|STARTED|Post Week 12||30
463510|NCT00550446|1105186|P1|STARTED|Post Week 12||27
463511|NCT00550446|1105176|P11|NOT COMPLETED|Up To Week 12||0
463512|NCT00550446|1105177|P10|NOT COMPLETED|Up To Week 12||0
463513|NCT00550446|1105178|P9|NOT COMPLETED|Up To Week 12||0
463514|NCT00550446|1105179|P8|NOT COMPLETED|Up To Week 12||0
463515|NCT00550446|1105180|P7|NOT COMPLETED|Up To Week 12||13
463516|NCT00550446|1105181|P6|NOT COMPLETED|Up To Week 12||8
463517|NCT00550446|1105182|P5|NOT COMPLETED|Up To Week 12||3
463518|NCT00550446|1105183|P4|NOT COMPLETED|Up To Week 12||3
463519|NCT00550446|1105184|P3|NOT COMPLETED|Up To Week 12||4
463520|NCT00550446|1105185|P2|NOT COMPLETED|Up To Week 12||5
463521|NCT00550446|1105186|P1|NOT COMPLETED|Up To Week 12||10
463522|NCT00550446|1105176|P11|COMPLETED|Up To Week 12||0
463523|NCT00550446|1105177|P10|COMPLETED|Up To Week 12||0
463524|NCT00550446|1105178|P9|COMPLETED|Up To Week 12||0
463525|NCT00550446|1105179|P8|COMPLETED|Up To Week 12||0
463526|NCT00550446|1105180|P7|COMPLETED|Up To Week 12||46
463527|NCT00550446|1105181|P6|COMPLETED|Up To Week 12||45
463528|NCT00550446|1105182|P5|COMPLETED|Up To Week 12||54
463529|NCT00550446|1105183|P4|COMPLETED|Up To Week 12||58
463530|NCT00550446|1105184|P3|COMPLETED|Up To Week 12||46
463531|NCT00550446|1105185|P2|COMPLETED|Up To Week 12||47
463532|NCT00550446|1105186|P1|COMPLETED|Up To Week 12||44
463533|NCT00550446|1105176|P11|Treated|Up To Week 12||0
463534|NCT00550446|1105177|P10|Treated|Up To Week 12||0
463535|NCT00550446|1105178|P9|Treated|Up To Week 12||0
463536|NCT00550446|1105179|P8|Treated|Up To Week 12||0
463537|NCT00550446|1105180|P7|Treated|Up To Week 12||59
463538|NCT00550446|1105181|P6|Treated|Up To Week 12||53
463539|NCT00550446|1105182|P5|Treated|Up To Week 12||57
463540|NCT00550446|1105183|P4|Treated|Up To Week 12||61
463541|NCT00550446|1105184|P3|Treated|Up To Week 12||49
463542|NCT00550446|1105185|P2|Treated|Up To Week 12||51
463543|NCT00550446|1105186|P1|Treated|Up To Week 12||54
463544|NCT00550446|1105176|P11|STARTED|Up To Week 12||0
463545|NCT00550446|1105177|P10|STARTED|Up To Week 12||0
463546|NCT00550446|1105178|P9|STARTED|Up To Week 12||0
463547|NCT00550446|1105179|P8|STARTED|Up To Week 12||0
463548|NCT00550446|1105180|P7|STARTED|Up To Week 12||59
463549|NCT00550446|1105181|P6|STARTED|Up To Week 12||53
463550|NCT00550446|1105182|P5|STARTED|Up To Week 12||57
463551|NCT00550446|1105183|P4|STARTED|Up To Week 12||61
463552|NCT00550446|1105184|P3|STARTED|Up To Week 12||50
463553|NCT00550446|1105185|P2|STARTED|Up To Week 12||52
463554|NCT00550446|1105186|P1|STARTED|Up To Week 12||54
463555|NCT00550407|1105620|P3|NOT COMPLETED|26-Week Randomized Phase||24
463556|NCT00550407|1105621|P2|NOT COMPLETED|26-Week Randomized Phase||43
463557|NCT00550407|1105622|P1|NOT COMPLETED|26-Week Randomized Phase||0
463558|NCT00550407|1105620|P3|COMPLETED|26-Week Randomized Phase||21
463559|NCT00550407|1105621|P2|COMPLETED|26-Week Randomized Phase||15
463560|NCT00550407|1105622|P1|COMPLETED|26-Week Randomized Phase||0
463561|NCT00550407|1105620|P3|STARTED|26-Week Randomized Phase||45
463562|NCT00550407|1105621|P2|STARTED|26-Week Randomized Phase||58
463563|NCT00550407|1105622|P1|STARTED|26-Week Randomized Phase||0
463564|NCT00550407|1105620|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
463565|NCT00550407|1105621|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
463566|NCT00550407|1105622|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
463567|NCT00550407|1105620|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
463568|NCT00550407|1105621|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
463569|NCT00550407|1105622|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
463570|NCT00550407|1105620|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
463571|NCT00550407|1105621|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
463572|NCT00550407|1105622|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
463573|NCT00550394|1105657|P2|NOT COMPLETED|Overall Study||13
463574|NCT00550394|1105658|P1|NOT COMPLETED|Overall Study||12
463575|NCT00550394|1105657|P2|COMPLETED|Overall Study||5
463576|NCT00550394|1105658|P1|COMPLETED|Overall Study||9
463577|NCT00550394|1105657|P2|STARTED|Overall Study||18
463578|NCT00550394|1105658|P1|STARTED|Overall Study||21
463579|NCT00550368|1105672|P2|NOT COMPLETED|Overall Study||0
463580|NCT00550368|1105673|P1|NOT COMPLETED|Overall Study||0
463581|NCT00550368|1105672|P2|COMPLETED|Overall Study||19
463582|NCT00550368|1105673|P1|COMPLETED|Overall Study||26
463583|NCT00550368|1105672|P2|STARTED|Overall Study||19
463584|NCT00550368|1105673|P1|STARTED|Overall Study||26
463585|NCT00549601|1105684|P3|NOT COMPLETED|Received Study Drug||4
463586|NCT00549601|1105685|P2|NOT COMPLETED|Received Study Drug||11
463587|NCT00549601|1105686|P1|NOT COMPLETED|Received Study Drug||7
463588|NCT00549601|1105684|P3|COMPLETED|Received Study Drug||45
463589|NCT00549601|1105685|P2|COMPLETED|Received Study Drug||36
463590|NCT00549601|1105686|P1|COMPLETED|Received Study Drug||36
463591|NCT00549601|1105684|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
463592|NCT00549601|1105685|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
463593|NCT00549601|1105686|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
463594|NCT00549601|1105684|P3|NOT COMPLETED|Randomized||2
463595|NCT00549601|1105685|P2|NOT COMPLETED|Randomized||1
463596|NCT00549601|1105686|P1|NOT COMPLETED|Randomized||0
463597|NCT00549601|1105684|P3|COMPLETED|Randomized||49
463598|NCT00549601|1105685|P2|COMPLETED|Randomized||47
463599|NCT00549601|1105686|P1|COMPLETED|Randomized||43
463600|NCT00549601|1105684|P3|STARTED|Randomized||51
463601|NCT00549601|1105685|P2|STARTED|Randomized||48
463602|NCT00549601|1105686|P1|STARTED|Randomized||43
463603|NCT00549562|1105708|P1|NOT COMPLETED|Overall Study||2
463604|NCT00549562|1105708|P1|COMPLETED|Overall Study||23
463605|NCT00549562|1105708|P1|STARTED|Overall Study||25
463606|NCT00550277|1105716|P1|NOT COMPLETED|Overall Study||9
463607|NCT00550277|1105716|P1|COMPLETED|Overall Study||11
463608|NCT00550277|1105716|P1|STARTED|Overall Study||20
463609|NCT00550173|1105723|P3|NOT COMPLETED|Overall Study||73
463610|NCT00550173|1105724|P2|NOT COMPLETED|Overall Study||63
463611|NCT00550173|1105725|P1|NOT COMPLETED|Overall Study||72
463612|NCT00550173|1105723|P3|COMPLETED|Overall Study||11
463613|NCT00550173|1105724|P2|COMPLETED|Overall Study||19
463614|NCT00550173|1105725|P1|COMPLETED|Overall Study||9
463615|NCT00550173|1105723|P3|Not Discontinued at 18 Months|Overall Study||11
463616|NCT00550173|1105724|P2|Not Discontinued at 18 Months|Overall Study||19
463617|NCT00550173|1105725|P1|Not Discontinued at 18 Months|Overall Study||9
463618|NCT00550173|1105723|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
463619|NCT00550173|1105724|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
463702|NCT00549770|1105924|P5|Intent-to-treat Population|Overall Study||163
463620|NCT00550173|1105725|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
463621|NCT00550173|1105723|P3|STARTED|Overall Study||84
463622|NCT00550173|1105724|P2|STARTED|Overall Study||82
463623|NCT00550173|1105725|P1|STARTED|Overall Study||81
463624|NCT00550147|1105754|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
463625|NCT00550147|1105754|P1|COMPLETED|Quetiapine Addition Treatment Period||18
463626|NCT00550147|1105754|P1|STARTED|Quetiapine Addition Treatment Period||24
463627|NCT00550147|1105754|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
463628|NCT00550147|1105754|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
463629|NCT00550147|1105754|P1|STARTED|OROS Methylphenidate Monotherapy||30
463630|NCT00550043|1105777|P5|NOT COMPLETED|Overall Study||1
463631|NCT00550043|1105778|P4|NOT COMPLETED|Overall Study||2
463632|NCT00550043|1105779|P3|NOT COMPLETED|Overall Study||1
463633|NCT00550043|1105780|P2|NOT COMPLETED|Overall Study||3
463634|NCT00550043|1105781|P1|NOT COMPLETED|Overall Study||0
463635|NCT00550043|1105777|P5|COMPLETED|Overall Study||9
463636|NCT00550043|1105778|P4|COMPLETED|Overall Study||8
463637|NCT00550043|1105779|P3|COMPLETED|Overall Study||8
463638|NCT00550043|1105780|P2|COMPLETED|Overall Study||9
463639|NCT00550043|1105781|P1|COMPLETED|Overall Study||9
463640|NCT00550043|1105777|P5|STARTED|Overall Study||10
463641|NCT00550043|1105778|P4|STARTED|Overall Study||10
463642|NCT00550043|1105779|P3|STARTED|Overall Study||9
463643|NCT00550043|1105780|P2|STARTED|Overall Study||12
463644|NCT00550043|1105781|P1|STARTED|Overall Study||9
463645|NCT00549939|1105836|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
463646|NCT00549939|1105837|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
463647|NCT00549939|1105838|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
463648|NCT00549939|1105836|P3|COMPLETED|40-week Open Label Treatment Period||78
463649|NCT00549939|1105837|P2|COMPLETED|40-week Open Label Treatment Period||75
463650|NCT00549939|1105838|P1|COMPLETED|40-week Open Label Treatment Period||0
463651|NCT00549939|1105836|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
463652|NCT00549939|1105837|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
463653|NCT00549939|1105838|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
463654|NCT00549939|1105836|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
463655|NCT00549939|1105837|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
463656|NCT00549939|1105838|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
463657|NCT00549939|1105836|P3|COMPLETED|12-week Double Blind Treatment Period||56
463658|NCT00549939|1105837|P2|COMPLETED|12-week Double Blind Treatment Period||55
463659|NCT00549939|1105838|P1|COMPLETED|12-week Double Blind Treatment Period||56
463660|NCT00549939|1105836|P3|STARTED|12-week Double Blind Treatment Period||58
463661|NCT00549939|1105837|P2|STARTED|12-week Double Blind Treatment Period||57
463662|NCT00549939|1105838|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
463663|NCT00549900|1105865|P1|NOT COMPLETED|Overall Study||1
463664|NCT00549900|1105865|P1|COMPLETED|Overall Study||29
463665|NCT00549900|1105865|P1|STARTED|Overall Study||30
463666|NCT00549822|1105874|P1|NOT COMPLETED|Overall Study||0
463667|NCT00549822|1105874|P1|COMPLETED|Overall Study||3
463668|NCT00549822|1105874|P1|STARTED|Overall Study||3
463669|NCT00549783|1105882|P2|NOT COMPLETED|Overall Study||13
463670|NCT00549783|1105883|P1|NOT COMPLETED|Overall Study||8
463671|NCT00549783|1105882|P2|COMPLETED|Overall Study||122
463672|NCT00549783|1105883|P1|COMPLETED|Overall Study||131
463673|NCT00549783|1105882|P2|STARTED|Overall Study||135
463674|NCT00549783|1105883|P1|STARTED|Overall Study||139
463675|NCT00549770|1105921|P8|NOT COMPLETED|Overall Study||25
463676|NCT00549770|1105922|P7|NOT COMPLETED|Overall Study||14
463677|NCT00549770|1105923|P6|NOT COMPLETED|Overall Study||13
463678|NCT00549770|1105924|P5|NOT COMPLETED|Overall Study||17
463679|NCT00549770|1105925|P4|NOT COMPLETED|Overall Study||16
463680|NCT00549770|1105926|P3|NOT COMPLETED|Overall Study||10
463681|NCT00549770|1105927|P2|NOT COMPLETED|Overall Study||11
463682|NCT00549770|1105928|P1|NOT COMPLETED|Overall Study||7
463683|NCT00549770|1105921|P8|COMPLETED|Overall Study||148
463684|NCT00549770|1105922|P7|COMPLETED|Overall Study||151
463685|NCT00549770|1105923|P6|COMPLETED|Overall Study||151
463686|NCT00549770|1105924|P5|COMPLETED|Overall Study||149
463687|NCT00549770|1105925|P4|COMPLETED|Overall Study||147
463688|NCT00549770|1105926|P3|COMPLETED|Overall Study||162
463689|NCT00549770|1105927|P2|COMPLETED|Overall Study||158
463690|NCT00549770|1105928|P1|COMPLETED|Overall Study||149
463691|NCT00549770|1105921|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
463692|NCT00549770|1105922|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
463693|NCT00549770|1105923|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
463694|NCT00549770|1105924|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
463695|NCT00549770|1105925|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
463696|NCT00549770|1105926|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
463697|NCT00549770|1105927|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
463698|NCT00549770|1105928|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
463699|NCT00549770|1105921|P8|Intent-to-treat Population|Overall Study||172
463700|NCT00549770|1105922|P7|Intent-to-treat Population|Overall Study||164
463701|NCT00549770|1105923|P6|Intent-to-treat Population|Overall Study||163
463703|NCT00549770|1105925|P4|Intent-to-treat Population|Overall Study||163
463704|NCT00549770|1105926|P3|Intent-to-treat Population|Overall Study||170
463705|NCT00549770|1105927|P2|Intent-to-treat Population|Overall Study||168
463706|NCT00549770|1105928|P1|Intent-to-treat Population|Overall Study||154
463707|NCT00549770|1105921|P8|STARTED|Overall Study||173
463708|NCT00549770|1105922|P7|STARTED|Overall Study||165
463709|NCT00549770|1105923|P6|STARTED|Overall Study||164
463710|NCT00549770|1105924|P5|STARTED|Overall Study||166
463711|NCT00549770|1105925|P4|STARTED|Overall Study||163
463712|NCT00549770|1105926|P3|STARTED|Overall Study||172
463713|NCT00549770|1105927|P2|STARTED|Overall Study||169
463714|NCT00549770|1105928|P1|STARTED|Overall Study||156
463715|NCT00549757|1106012|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
463716|NCT00549757|1106013|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
463717|NCT00549757|1106012|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
463718|NCT00549757|1106013|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
463719|NCT00549757|1106012|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
463720|NCT00549757|1106013|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
463892|NCT00548340|1106498|P2|COMPLETED|Overall Study||98
463721|NCT00549757|1106012|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
463722|NCT00549757|1106013|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
463723|NCT00549757|1106012|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
463724|NCT00549757|1106013|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
463725|NCT00549757|1106012|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
463726|NCT00549757|1106013|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
463727|NCT00549757|1106012|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
463728|NCT00549757|1106013|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
463729|NCT00549757|1106012|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
463730|NCT00549757|1106013|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
463731|NCT00549718|1106075|P4|NOT COMPLETED|Overall Study||55
463732|NCT00549718|1106076|P3|NOT COMPLETED|Overall Study||39
463733|NCT00549718|1106077|P2|NOT COMPLETED|Overall Study||37
463734|NCT00549718|1106078|P1|NOT COMPLETED|Overall Study||41
463735|NCT00549718|1106075|P4|COMPLETED|Overall Study||73
463736|NCT00549718|1106076|P3|COMPLETED|Overall Study||85
463737|NCT00549718|1106077|P2|COMPLETED|Overall Study||86
463738|NCT00549718|1106078|P1|COMPLETED|Overall Study||84
463739|NCT00549718|1106075|P4|STARTED|Overall Study||128
463740|NCT00549718|1106076|P3|STARTED|Overall Study||124
463741|NCT00549718|1106077|P2|STARTED|Overall Study||123
463742|NCT00549718|1106078|P1|STARTED|Overall Study||125
463743|NCT00549640|1106094|P2|NOT COMPLETED|Overall Study||16
463744|NCT00549640|1106095|P1|NOT COMPLETED|Overall Study||18
463745|NCT00549640|1106094|P2|COMPLETED|Overall Study||24
463746|NCT00549640|1106095|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
463747|NCT00549640|1106094|P2|STARTED|Overall Study||40
463748|NCT00549640|1106095|P1|STARTED|Overall Study||40
463749|NCT00549549|1106109|P4|NOT COMPLETED|Overall Study||25
463750|NCT00549549|1106110|P3|NOT COMPLETED|Overall Study||17
463751|NCT00549549|1106111|P2|NOT COMPLETED|Overall Study||22
463752|NCT00549549|1106112|P1|NOT COMPLETED|Overall Study||24
463753|NCT00549549|1106109|P4|COMPLETED|Overall Study||78
463754|NCT00549549|1106110|P3|COMPLETED|Overall Study||82
463755|NCT00549549|1106111|P2|COMPLETED|Overall Study||77
463756|NCT00549549|1106112|P1|COMPLETED|Overall Study||77
463757|NCT00549549|1106109|P4|Treated|Overall Study||102
463758|NCT00549549|1106110|P3|Treated|Overall Study||98
463759|NCT00549549|1106111|P2|Treated|Overall Study||99
463760|NCT00549549|1106112|P1|Treated|Overall Study||101
463761|NCT00549549|1106109|P4|STARTED|Overall Study||103
463762|NCT00549549|1106110|P3|STARTED|Overall Study||99
463763|NCT00549549|1106111|P2|STARTED|Overall Study||99
463764|NCT00549549|1106112|P1|STARTED|Overall Study||101
463765|NCT00549393|1106180|P2|NOT COMPLETED|Period 3 (6 Months)||0
463766|NCT00549393|1106181|P1|NOT COMPLETED|Period 3 (6 Months)||0
463767|NCT00549393|1106180|P2|COMPLETED|Period 3 (6 Months)||1326
463768|NCT00549393|1106181|P1|COMPLETED|Period 3 (6 Months)||1103
463769|NCT00549393|1106180|P2|Per Protocol|Period 3 (6 Months)||1326
463770|NCT00549393|1106181|P1|Per Protocol|Period 3 (6 Months)||667
463771|NCT00549393|1106180|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
463772|NCT00549393|1106181|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
463773|NCT00549393|1106180|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
463774|NCT00549393|1106181|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
463775|NCT00549393|1106180|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
463776|NCT00549393|1106181|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
463777|NCT00549393|1106180|P2|STARTED|Period 2 Washout (2 Weeks)||0
463778|NCT00549393|1106181|P1|STARTED|Period 2 Washout (2 Weeks)||0
463779|NCT00549393|1106180|P2|NOT COMPLETED|Period 1 (6 Months)||0
463780|NCT00549393|1106181|P1|NOT COMPLETED|Period 1 (6 Months)||0
463781|NCT00549393|1106180|P2|COMPLETED|Period 1 (6 Months)||1199
463782|NCT00549393|1106181|P1|COMPLETED|Period 1 (6 Months)||1319
463783|NCT00549393|1106180|P2|Per Protocol|Period 1 (6 Months)||1199
463784|NCT00549393|1106181|P1|Per Protocol|Period 1 (6 Months)||880
463785|NCT00549393|1106180|P2|STARTED|Period 1 (6 Months)|ITT|1199
463786|NCT00549393|1106181|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
463787|NCT00549328|1106191|P1|NOT COMPLETED|Overall Study||14
463788|NCT00549328|1106191|P1|COMPLETED|Overall Study||0
463789|NCT00549328|1106191|P1|STARTED|Overall Study||14
463790|NCT00549302|1106202|P3|NOT COMPLETED|Open-Label||69
463791|NCT00549302|1106203|P2|NOT COMPLETED|Open-Label||0
463792|NCT00549302|1106204|P1|NOT COMPLETED|Open-Label||0
463793|NCT00549302|1106202|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
463794|NCT00549302|1106203|P2|COMPLETED|Open-Label||0
463795|NCT00549302|1106204|P1|COMPLETED|Open-Label||0
463796|NCT00549302|1106202|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
463797|NCT00549302|1106203|P2|STARTED|Open-Label||0
463798|NCT00549302|1106204|P1|STARTED|Open-Label||0
463799|NCT00549302|1106202|P3|NOT COMPLETED|Double-Blind||0
463800|NCT00549302|1106203|P2|NOT COMPLETED|Double-Blind||53
463801|NCT00549302|1106204|P1|NOT COMPLETED|Double-Blind||11
463802|NCT00549302|1106202|P3|COMPLETED|Double-Blind||0
463803|NCT00549302|1106203|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
463804|NCT00549302|1106204|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
463805|NCT00549302|1106202|P3|Received at Least One Dose of Study Drug|Double-Blind||0
463806|NCT00549302|1106203|P2|Received at Least One Dose of Study Drug|Double-Blind||294
463807|NCT00549302|1106204|P1|Received at Least One Dose of Study Drug|Double-Blind||63
463808|NCT00549302|1106202|P3|STARTED|Double-Blind||0
463809|NCT00549302|1106203|P2|STARTED|Double-Blind||294
463810|NCT00549302|1106204|P1|STARTED|Double-Blind||63
463811|NCT00549198|1106216|P2|NOT COMPLETED|Overall Study||63
463812|NCT00549198|1106217|P1|NOT COMPLETED|Overall Study||80
463813|NCT00549198|1106216|P2|COMPLETED|Overall Study||134
463814|NCT00549198|1106217|P1|COMPLETED|Overall Study||115
463815|NCT00549198|1106216|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
463816|NCT00549198|1106217|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
463817|NCT00549172|1106339|P2|NOT COMPLETED|Overall Study||0
463818|NCT00549172|1106340|P1|NOT COMPLETED|Overall Study||0
463819|NCT00549172|1106339|P2|COMPLETED|Overall Study||76
463820|NCT00549172|1106340|P1|COMPLETED|Overall Study||70
463821|NCT00549172|1106339|P2|STARTED|Overall Study||76
463822|NCT00549172|1106340|P1|STARTED|Overall Study||70
463823|NCT00549055|1106354|P1|NOT COMPLETED|Overall Study||35
463824|NCT00549055|1106354|P1|COMPLETED|Overall Study||3
463825|NCT00549055|1106354|P1|STARTED|Overall Study||38
463826|NCT00548886|1106364|P1|NOT COMPLETED|Overall Study||0
463827|NCT00548886|1106364|P1|COMPLETED|Overall Study||7
463828|NCT00548886|1106364|P1|STARTED|Overall Study||7
463829|NCT00548860|1106370|P2|NOT COMPLETED|Overall Study||175
463830|NCT00548860|1106371|P1|NOT COMPLETED|Overall Study||136
463831|NCT00548860|1106370|P2|COMPLETED|Overall Study||847
463832|NCT00548860|1106371|P1|COMPLETED|Overall Study||860
463833|NCT00548860|1106370|P2|STARTED|Overall Study||1022
463834|NCT00548860|1106371|P1|STARTED|Overall Study||996
463835|NCT00548847|1106377|P1|NOT COMPLETED|Overall Study||7
463836|NCT00548847|1106377|P1|COMPLETED|Overall Study||8
463837|NCT00548847|1106377|P1|STARTED|Overall Study||15
463838|NCT00548808|1106384|P2|NOT COMPLETED|Overall Study||26
463839|NCT00548808|1106385|P1|NOT COMPLETED|Overall Study||42
463840|NCT00548808|1106384|P2|COMPLETED|Overall Study||186
463841|NCT00548808|1106385|P1|COMPLETED|Overall Study||172
463842|NCT00548808|1106384|P2|Per-Protocol Set|Overall Study||184
463843|NCT00548808|1106385|P1|Per-Protocol Set|Overall Study||177
463844|NCT00548808|1106384|P2|Full Analysis Set|Overall Study||212
463845|NCT00548808|1106385|P1|Full Analysis Set|Overall Study||211
463846|NCT00548808|1106384|P2|STARTED|Overall Study||212
463847|NCT00548808|1106385|P1|STARTED|Overall Study||214
463848|NCT00548717|1106409|P2|NOT COMPLETED|Overall Study||2
463849|NCT00548717|1106410|P1|NOT COMPLETED|Overall Study||9
463850|NCT00548717|1106409|P2|COMPLETED|Overall Study||0
463851|NCT00548717|1106410|P1|COMPLETED|Overall Study||4
463852|NCT00548717|1106409|P2|STARTED|Overall Study||2
463853|NCT00548717|1106410|P1|STARTED|Overall Study||13
463854|NCT00548691|1106429|P2|NOT COMPLETED|Overall Study||9
463855|NCT00548691|1106430|P1|NOT COMPLETED|Overall Study||7
463856|NCT00548691|1106429|P2|COMPLETED|Overall Study||250
463857|NCT00548691|1106430|P1|COMPLETED|Overall Study||251
463858|NCT00548691|1106429|P2|STARTED|Overall Study||259
463859|NCT00548691|1106430|P1|STARTED|Overall Study||258
463860|NCT00548548|1106438|P2|NOT COMPLETED|Overall Study||366
463861|NCT00548548|1106439|P1|NOT COMPLETED|Overall Study||362
463862|NCT00548548|1106438|P2|COMPLETED|Overall Study||21
463863|NCT00548548|1106439|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
463864|NCT00548548|1106438|P2|Safety Population|Overall Study||381
463865|NCT00548548|1106439|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
463866|NCT00548548|1106438|P2|Treated|Overall Study||384
463867|NCT00548548|1106439|P1|Treated|Overall Study||383
463868|NCT00548548|1106438|P2|STARTED|Overall Study||387
463869|NCT00548548|1106439|P1|STARTED|Overall Study||387
463870|NCT00548431|1106459|P1|NOT COMPLETED|Overall Study||0
463871|NCT00548431|1106459|P1|COMPLETED|Overall Study||38
463872|NCT00548431|1106459|P1|STARTED|Overall Study||38
463873|NCT00548418|1106463|P1|NOT COMPLETED|Overall Study||0
463874|NCT00548418|1106463|P1|COMPLETED|Overall Study||27
463875|NCT00548418|1106463|P1|STARTED|Overall Study||27
463876|NCT00548405|1106474|P3|NOT COMPLETED|Overall Study||9
463877|NCT00548405|1106475|P2|NOT COMPLETED|Overall Study||20
463878|NCT00548405|1106476|P1|NOT COMPLETED|Overall Study||56
463879|NCT00548405|1106474|P3|COMPLETED|Overall Study||164
463880|NCT00548405|1106475|P2|COMPLETED|Overall Study||416
463881|NCT00548405|1106476|P1|COMPLETED|Overall Study||175
463882|NCT00548405|1106474|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
463883|NCT00548405|1106475|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
463884|NCT00548405|1106476|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
463885|NCT00548405|1106474|P3|STARTED|Overall Study|Randomized.|173
463886|NCT00548405|1106475|P2|STARTED|Overall Study|Randomized.|436
463887|NCT00548405|1106476|P1|STARTED|Overall Study|Randomized.|231
463888|NCT00548340|1106497|P3|NOT COMPLETED|Overall Study||9
463889|NCT00548340|1106498|P2|NOT COMPLETED|Overall Study||11
463890|NCT00548340|1106499|P1|NOT COMPLETED|Overall Study||8
463891|NCT00548340|1106497|P3|COMPLETED|Overall Study||95
463893|NCT00548340|1106499|P1|COMPLETED|Overall Study||101
463894|NCT00548340|1106497|P3|STARTED|Overall Study||104
463895|NCT00548340|1106498|P2|STARTED|Overall Study||109
463896|NCT00548340|1106499|P1|STARTED|Overall Study||109
463897|NCT00548327|1106518|P2|NOT COMPLETED|Overall Study||1
463898|NCT00548327|1106519|P1|NOT COMPLETED|Overall Study||0
463899|NCT00548327|1106518|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
463900|NCT00548327|1106519|P1|COMPLETED|Overall Study||6
463901|NCT00548327|1106518|P2|STARTED|Overall Study||5
463902|NCT00548327|1106519|P1|STARTED|Overall Study||6
463903|NCT00548262|1106537|P1|NOT COMPLETED|Overall Study||32
463904|NCT00548262|1106537|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
463905|NCT00548262|1106537|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
463906|NCT00548249|1106567|P5|NOT COMPLETED|Overall Study||21
463907|NCT00548249|1106568|P4|NOT COMPLETED|Overall Study||13
463908|NCT00548249|1106569|P3|NOT COMPLETED|Overall Study||20
463909|NCT00548249|1106570|P2|NOT COMPLETED|Overall Study||13
463910|NCT00548249|1106571|P1|NOT COMPLETED|Overall Study||16
463911|NCT00548249|1106567|P5|COMPLETED|Overall Study||7
463912|NCT00548249|1106568|P4|COMPLETED|Overall Study||9
463913|NCT00548249|1106569|P3|COMPLETED|Overall Study||9
463914|NCT00548249|1106570|P2|COMPLETED|Overall Study||13
463915|NCT00548249|1106571|P1|COMPLETED|Overall Study||10
463916|NCT00548249|1106567|P5|STARTED|Overall Study||28
463917|NCT00548249|1106568|P4|STARTED|Overall Study||22
463918|NCT00548249|1106569|P3|STARTED|Overall Study||29
463919|NCT00548249|1106570|P2|STARTED|Overall Study||26
463920|NCT00548249|1106571|P1|STARTED|Overall Study||26
463921|NCT00548184|1106608|P1|NOT COMPLETED|Overall Study||5
463922|NCT00548184|1106608|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
463923|NCT00548184|1106608|P1|STARTED|Overall Study||65
463924|NCT00548145|1106614|P2|NOT COMPLETED|Overall Study||4
463925|NCT00548145|1106615|P1|NOT COMPLETED|Overall Study||1
463926|NCT00548145|1106614|P2|COMPLETED|Overall Study||16
463927|NCT00548145|1106615|P1|COMPLETED|Overall Study||17
463928|NCT00548145|1106614|P2|STARTED|Overall Study||20
463929|NCT00548145|1106615|P1|STARTED|Overall Study||18
463930|NCT00548132|1106623|P2|NOT COMPLETED|Overall Study||0
463931|NCT00548132|1106624|P1|NOT COMPLETED|Overall Study||0
463932|NCT00548132|1106623|P2|COMPLETED|Overall Study||554
463933|NCT00548132|1106624|P1|COMPLETED|Overall Study||534
463934|NCT00548132|1106623|P2|Consented to Study|Overall Study||554
463935|NCT00548132|1106624|P1|Consented to Study|Overall Study||534
463936|NCT00548132|1106623|P2|STARTED|Overall Study||554
463937|NCT00548132|1106624|P1|STARTED|Overall Study||534
463938|NCT00548041|1106632|P1|NOT COMPLETED|Overall Study||0
463939|NCT00548041|1106632|P1|COMPLETED|Overall Study||100
463940|NCT00548041|1106632|P1|STARTED|Overall Study||100
463941|NCT00547911|1106640|P6|NOT COMPLETED|Overall Study||0
463942|NCT00547911|1106641|P5|NOT COMPLETED|Overall Study||0
463943|NCT00547911|1106642|P4|NOT COMPLETED|Overall Study||1
463944|NCT00547911|1106643|P3|NOT COMPLETED|Overall Study||0
463945|NCT00547911|1106644|P2|NOT COMPLETED|Overall Study||0
463946|NCT00547911|1106645|P1|NOT COMPLETED|Overall Study||0
463947|NCT00547911|1106640|P6|COMPLETED|Overall Study||3
463948|NCT00547911|1106641|P5|COMPLETED|Overall Study||3
463949|NCT00547911|1106642|P4|COMPLETED|Overall Study||1
463950|NCT00547911|1106643|P3|COMPLETED|Overall Study||2
463951|NCT00547911|1106644|P2|COMPLETED|Overall Study||2
463952|NCT00547911|1106645|P1|COMPLETED|Overall Study||2
463953|NCT00547911|1106640|P6|STARTED|Overall Study||3
463954|NCT00547911|1106641|P5|STARTED|Overall Study||3
463955|NCT00547911|1106642|P4|STARTED|Overall Study||2
463956|NCT00547911|1106643|P3|STARTED|Overall Study||2
463957|NCT00547911|1106644|P2|STARTED|Overall Study||2
463958|NCT00547911|1106645|P1|STARTED|Overall Study||2
463959|NCT00547703|1106676|P2|NOT COMPLETED|Overall Study||0
463960|NCT00547703|1106677|P1|NOT COMPLETED|Overall Study||1
463961|NCT00547703|1106676|P2|COMPLETED|Overall Study||1
463962|NCT00547703|1106677|P1|COMPLETED|Overall Study||3
463963|NCT00547703|1106676|P2|STARTED|Overall Study||1
463964|NCT00547703|1106677|P1|STARTED|Overall Study||4
463965|NCT00547638|1106685|P2|NOT COMPLETED|Overall Study||14
463966|NCT00547638|1106686|P1|NOT COMPLETED|Overall Study||24
463967|NCT00547638|1106685|P2|COMPLETED|Overall Study||59
463968|NCT00547638|1106686|P1|COMPLETED|Overall Study||119
463969|NCT00547638|1106685|P2|STARTED|Overall Study||73
463970|NCT00547638|1106686|P1|STARTED|Overall Study||143
463971|NCT00547534|1106702|P1|NOT COMPLETED|Overall Study||11
463972|NCT00547534|1106702|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
463973|NCT00547534|1106702|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
463974|NCT00547521|1106710|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
463975|NCT00547521|1106711|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
463976|NCT00547521|1106710|P2|COMPLETED|Long Term Extension (LTE) Study||59
463977|NCT00547521|1106711|P1|COMPLETED|Long Term Extension (LTE) Study||0
463978|NCT00547521|1106710|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
463979|NCT00547521|1106711|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
463980|NCT00547521|1106710|P2|NOT COMPLETED|Short Term Study (4 Months)||4
463981|NCT00547521|1106711|P1|NOT COMPLETED|Short Term Study (4 Months)||1
463982|NCT00547521|1106710|P2|COMPLETED|Short Term Study (4 Months)||45
463983|NCT00547521|1106711|P1|COMPLETED|Short Term Study (4 Months)||50
463984|NCT00547521|1106710|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
463985|NCT00547521|1106711|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
463986|NCT00547456|1106781|P1|NOT COMPLETED|Overall Study||0
463987|NCT00547456|1106781|P1|COMPLETED|Overall Study||20
463988|NCT00547456|1106781|P1|STARTED|Overall Study||20
463989|NCT00547365|1106785|P1|NOT COMPLETED|Overall Study||8
463990|NCT00547365|1106785|P1|COMPLETED|Overall Study||2
463991|NCT00547365|1106785|P1|STARTED|Overall Study||10
463992|NCT00547157|1106792|P2|NOT COMPLETED|Overall Study||23
463993|NCT00547157|1106793|P1|NOT COMPLETED|Overall Study||49
463994|NCT00547157|1106792|P2|COMPLETED|Overall Study||39
463995|NCT00547157|1106793|P1|COMPLETED|Overall Study||41
463996|NCT00547157|1106792|P2|STARTED|Overall Study||62
463997|NCT00547157|1106793|P1|STARTED|Overall Study||90
463998|NCT00547118|1106811|P2|NOT COMPLETED|Overall Study||2
463999|NCT00547118|1106812|P1|NOT COMPLETED|Overall Study||1
464000|NCT00547118|1106811|P2|COMPLETED|Overall Study||7
464001|NCT00547118|1106812|P1|COMPLETED|Overall Study||7
464002|NCT00547118|1106811|P2|STARTED|Overall Study||9
464003|NCT00547118|1106812|P1|STARTED|Overall Study||8
464004|NCT00546910|1106820|P2|NOT COMPLETED|Overall Study||11
464005|NCT00546910|1106821|P1|NOT COMPLETED|Overall Study||9
464006|NCT00546910|1106820|P2|COMPLETED|Overall Study||51
464007|NCT00546910|1106821|P1|COMPLETED|Overall Study||54
464008|NCT00546910|1106820|P2|STARTED|Overall Study||62
464009|NCT00546910|1106821|P1|STARTED|Overall Study||63
464010|NCT00546897|1106841|P2|NOT COMPLETED|Overall Study||0
464011|NCT00546897|1106842|P1|NOT COMPLETED|Overall Study||0
464012|NCT00546897|1106841|P2|COMPLETED|Overall Study||33
464013|NCT00546897|1106842|P1|COMPLETED|Overall Study||15
464014|NCT00546897|1106841|P2|STARTED|Overall Study||33
464015|NCT00546897|1106842|P1|STARTED|Overall Study||15
464016|NCT00546884|1106880|P2|NOT COMPLETED|Overall Study||0
464017|NCT00546884|1106881|P1|NOT COMPLETED|Overall Study||0
464018|NCT00546884|1106880|P2|COMPLETED|Overall Study||117
464019|NCT00546884|1106881|P1|COMPLETED|Overall Study||145
464020|NCT00546884|1106880|P2|STARTED|Overall Study||117
464021|NCT00546884|1106881|P1|STARTED|Overall Study||145
464022|NCT00546871|1106887|P2|NOT COMPLETED|Study Extension Period||1
464023|NCT00546871|1106888|P1|NOT COMPLETED|Study Extension Period||1
464024|NCT00546871|1106887|P2|COMPLETED|Study Extension Period||25
464025|NCT00546871|1106888|P1|COMPLETED|Study Extension Period||9
464026|NCT00546871|1106887|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
464027|NCT00546871|1106888|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
464028|NCT00546871|1106887|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
464029|NCT00546871|1106888|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
464030|NCT00546871|1106887|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
464031|NCT00546871|1106888|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
464032|NCT00546871|1106887|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
464033|NCT00546871|1106888|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
464034|NCT00546871|1106887|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
464035|NCT00546871|1106888|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
464036|NCT00546871|1106887|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
464037|NCT00546871|1106888|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
464038|NCT00546871|1106887|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
464039|NCT00546871|1106888|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
464040|NCT00546871|1106887|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
464041|NCT00546871|1106888|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
464042|NCT00546871|1106887|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
464043|NCT00546871|1106888|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
464044|NCT00546871|1106887|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
464045|NCT00546871|1106888|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
464046|NCT00546871|1106887|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
464047|NCT00546871|1106888|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
464048|NCT00546871|1106887|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
464049|NCT00546871|1106888|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
464050|NCT00546871|1106887|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
464051|NCT00546871|1106888|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
464052|NCT00546819|1106993|P2|NOT COMPLETED|Overall Study||6
464053|NCT00546819|1106994|P1|NOT COMPLETED|Overall Study||8
464054|NCT00546819|1106993|P2|COMPLETED|Overall Study||96
464055|NCT00546819|1106994|P1|COMPLETED|Overall Study||199
464056|NCT00546819|1106993|P2|VACCINATED|Overall Study||100
464057|NCT00546819|1106994|P1|VACCINATED|Overall Study||206
464058|NCT00546819|1106993|P2|STARTED|Overall Study||102
464059|NCT00546819|1106994|P1|STARTED|Overall Study||207
464060|NCT00546754|1107006|P2|NOT COMPLETED|Overall Study||49
464061|NCT00546754|1107007|P1|NOT COMPLETED|Overall Study||50
464062|NCT00546754|1107006|P2|COMPLETED|Overall Study||334
464063|NCT00546754|1107007|P1|COMPLETED|Overall Study||375
464064|NCT00546754|1107006|P2|Week 12|Overall Study||334
464065|NCT00546754|1107007|P1|Week 12|Overall Study||375
464066|NCT00546754|1107006|P2|Week 6|Overall Study||347
464067|NCT00546754|1107007|P1|Week 6|Overall Study||396
464068|NCT00546754|1107006|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
464069|NCT00546754|1107007|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
464070|NCT00546754|1107006|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
464071|NCT00546754|1107007|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
464072|NCT00546728|1107039|P2|NOT COMPLETED|Overall Study||0
464073|NCT00546728|1107040|P1|NOT COMPLETED|Overall Study||0
464074|NCT00546728|1107039|P2|COMPLETED|Overall Study||25
464075|NCT00546728|1107040|P1|COMPLETED|Overall Study||25
464076|NCT00546728|1107039|P2|STARTED|Overall Study||25
464077|NCT00546728|1107040|P1|STARTED|Overall Study||25
464078|NCT00546715|1107050|P4|NOT COMPLETED|Overall Study||0
464079|NCT00546715|1107051|P3|NOT COMPLETED|Overall Study||0
464080|NCT00546715|1107052|P2|NOT COMPLETED|Overall Study||1
464081|NCT00546715|1107053|P1|NOT COMPLETED|Overall Study||0
464082|NCT00546715|1107050|P4|COMPLETED|Overall Study||2
464083|NCT00546715|1107051|P3|COMPLETED|Overall Study||5
464084|NCT00546715|1107052|P2|COMPLETED|Overall Study||4
464085|NCT00546715|1107053|P1|COMPLETED|Overall Study||6
464086|NCT00546715|1107050|P4|STARTED|Overall Study||2
464087|NCT00546715|1107051|P3|STARTED|Overall Study||5
464088|NCT00546715|1107052|P2|STARTED|Overall Study||5
464089|NCT00546715|1107053|P1|STARTED|Overall Study||6
464090|NCT00546637|1107108|P2|NOT COMPLETED|Overall Study||49
464091|NCT00546637|1107109|P1|NOT COMPLETED|Overall Study||73
464092|NCT00546637|1107108|P2|COMPLETED|Overall Study||424
464093|NCT00546637|1107109|P1|COMPLETED|Overall Study||401
464094|NCT00546637|1107108|P2|Received Treatment|Overall Study||472
464095|NCT00546637|1107109|P1|Received Treatment|Overall Study||471
464096|NCT00546637|1107108|P2|STARTED|Overall Study||473
464097|NCT00546637|1107109|P1|STARTED|Overall Study||474
464098|NCT00546572|1107183|P2|NOT COMPLETED|Vax 2 / Year 1||2
464099|NCT00546572|1107184|P1|NOT COMPLETED|Vax 2 / Year 1||4
464100|NCT00546572|1107183|P2|COMPLETED|Vax 2 / Year 1||402
464101|NCT00546572|1107184|P1|COMPLETED|Vax 2 / Year 1||387
464102|NCT00546572|1107183|P2|Received Vax 2|Vax 2 / Year 1||404
464103|NCT00546572|1107184|P1|Received Vax 2|Vax 2 / Year 1||391
464104|NCT00546572|1107183|P2|STARTED|Vax 2 / Year 1||404
464105|NCT00546572|1107184|P1|STARTED|Vax 2 / Year 1||391
464106|NCT00546572|1107183|P2|NOT COMPLETED|Vax 1 / Year 0||70
464107|NCT00546572|1107184|P1|NOT COMPLETED|Vax 1 / Year 0||73
464108|NCT00546572|1107183|P2|COMPLETED|Vax 1 / Year 0||404
464109|NCT00546572|1107184|P1|COMPLETED|Vax 1 / Year 0||391
464110|NCT00546572|1107183|P2|Received Vax 1|Vax 1 / Year 0||473
464111|NCT00546572|1107184|P1|Received Vax 1|Vax 1 / Year 0||463
464112|NCT00546572|1107183|P2|STARTED|Vax 1 / Year 0||474
464113|NCT00546572|1107184|P1|STARTED|Vax 1 / Year 0||464
464114|NCT00546481|1107228|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
464115|NCT00546481|1107229|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
464116|NCT00546481|1107230|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
464117|NCT00546481|1107228|P3|COMPLETED|Maintenance Phase (CERA)||50
464118|NCT00546481|1107229|P2|COMPLETED|Maintenance Phase (CERA)||0
464119|NCT00546481|1107230|P1|COMPLETED|Maintenance Phase (CERA)||0
464120|NCT00546481|1107228|P3|STARTED|Maintenance Phase (CERA)||54
464121|NCT00546481|1107229|P2|STARTED|Maintenance Phase (CERA)||0
464122|NCT00546481|1107230|P1|STARTED|Maintenance Phase (CERA)||0
464123|NCT00546481|1107228|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
464124|NCT00546481|1107229|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
464125|NCT00546481|1107230|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
464126|NCT00546481|1107228|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
464127|NCT00546481|1107229|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
464128|NCT00546481|1107230|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
464129|NCT00546481|1107228|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
464130|NCT00546481|1107229|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
464131|NCT00546481|1107230|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
464132|NCT00546429|1107253|P1|NOT COMPLETED|Overall Study||30
464133|NCT00546429|1107253|P1|COMPLETED|Overall Study||32
464134|NCT00546429|1107253|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
464135|NCT00546377|1107257|P1|NOT COMPLETED|Overall Study||7
464136|NCT00546377|1107257|P1|COMPLETED|Overall Study||43
464137|NCT00546377|1107257|P1|STARTED|Overall Study||50
464138|NCT00546364|1107265|P3|NOT COMPLETED|Overall Study||17
464139|NCT00546364|1107266|P2|NOT COMPLETED|Overall Study||18
464140|NCT00546364|1107267|P1|NOT COMPLETED|Overall Study||17
464141|NCT00546364|1107265|P3|COMPLETED|Overall Study|Still on treatment|3
464142|NCT00546364|1107266|P2|COMPLETED|Overall Study|Still on treatment|4
464143|NCT00546364|1107267|P1|COMPLETED|Overall Study|Still on treatment|3
464144|NCT00546364|1107265|P3|Never Treated|Overall Study||0
464145|NCT00546364|1107266|P2|Never Treated|Overall Study||0
464146|NCT00546364|1107267|P1|Never Treated|Overall Study||0
464147|NCT00546364|1107265|P3|STARTED|Overall Study||20
464148|NCT00546364|1107266|P2|STARTED|Overall Study||22
464149|NCT00546364|1107267|P1|STARTED|Overall Study||20
464150|NCT00546351|1107302|P1|NOT COMPLETED|Overall Study||236
464151|NCT00546351|1107302|P1|COMPLETED|Overall Study||385
464152|NCT00546351|1107302|P1|STARTED|Overall Study||621
464153|NCT00546273|1107335|P5|NOT COMPLETED|IV||0
464154|NCT00546273|1107336|P4|NOT COMPLETED|IV||0
464155|NCT00546273|1107337|P3|NOT COMPLETED|IV||0
464156|NCT00546273|1107338|P2|NOT COMPLETED|IV||0
464157|NCT00546273|1107339|P1|NOT COMPLETED|IV||0
464158|NCT00546273|1107335|P5|COMPLETED|IV||2
464159|NCT00546273|1107336|P4|COMPLETED|IV||4
464160|NCT00546273|1107337|P3|COMPLETED|IV||0
464161|NCT00546273|1107338|P2|COMPLETED|IV||0
464162|NCT00546273|1107339|P1|COMPLETED|IV||0
464163|NCT00546273|1107335|P5|STARTED|IV||2
464164|NCT00546273|1107336|P4|STARTED|IV||4
464165|NCT00546273|1107337|P3|STARTED|IV||0
464166|NCT00546273|1107338|P2|STARTED|IV||0
464167|NCT00546273|1107339|P1|STARTED|IV||0
464168|NCT00546273|1107335|P5|NOT COMPLETED|III||0
464169|NCT00546273|1107336|P4|NOT COMPLETED|III||0
464170|NCT00546273|1107337|P3|NOT COMPLETED|III||0
464171|NCT00546273|1107338|P2|NOT COMPLETED|III||0
464172|NCT00546273|1107339|P1|NOT COMPLETED|III||0
464173|NCT00546273|1107335|P5|COMPLETED|III||2
464174|NCT00546273|1107336|P4|COMPLETED|III||0
464175|NCT00546273|1107337|P3|COMPLETED|III||4
464176|NCT00546273|1107338|P2|COMPLETED|III||0
464177|NCT00546273|1107339|P1|COMPLETED|III||0
464178|NCT00546273|1107335|P5|STARTED|III||2
464179|NCT00546273|1107336|P4|STARTED|III||0
464180|NCT00546273|1107337|P3|STARTED|III||4
464181|NCT00546273|1107338|P2|STARTED|III||0
464182|NCT00546273|1107339|P1|STARTED|III||0
464183|NCT00546273|1107335|P5|NOT COMPLETED|II||0
464184|NCT00546273|1107336|P4|NOT COMPLETED|II||0
464185|NCT00546273|1107337|P3|NOT COMPLETED|II||0
464186|NCT00546273|1107338|P2|NOT COMPLETED|II||0
464187|NCT00546273|1107339|P1|NOT COMPLETED|II||0
464188|NCT00546273|1107335|P5|COMPLETED|II||2
464189|NCT00546273|1107336|P4|COMPLETED|II||0
464190|NCT00546273|1107337|P3|COMPLETED|II||0
464191|NCT00546273|1107338|P2|COMPLETED|II||4
464192|NCT00546273|1107339|P1|COMPLETED|II||0
464193|NCT00546273|1107335|P5|STARTED|II||2
464194|NCT00546273|1107336|P4|STARTED|II||0
464195|NCT00546273|1107337|P3|STARTED|II||0
464196|NCT00546273|1107338|P2|STARTED|II||4
464197|NCT00546273|1107339|P1|STARTED|II||0
464198|NCT00546273|1107335|P5|NOT COMPLETED|I||0
464199|NCT00546273|1107336|P4|NOT COMPLETED|I||0
464200|NCT00546273|1107337|P3|NOT COMPLETED|I||0
464201|NCT00546273|1107338|P2|NOT COMPLETED|I||0
464202|NCT00546273|1107339|P1|NOT COMPLETED|I||0
464203|NCT00546273|1107335|P5|COMPLETED|I||2
464204|NCT00546273|1107336|P4|COMPLETED|I||0
464205|NCT00546273|1107337|P3|COMPLETED|I||0
464206|NCT00546273|1107338|P2|COMPLETED|I||0
464207|NCT00546273|1107339|P1|COMPLETED|I||4
464208|NCT00546273|1107335|P5|STARTED|I||2
464209|NCT00546273|1107336|P4|STARTED|I||0
464210|NCT00546273|1107337|P3|STARTED|I||0
464211|NCT00546273|1107338|P2|STARTED|I||0
464212|NCT00546273|1107339|P1|STARTED|I||4
464213|NCT00546260|1107348|P2|NOT COMPLETED|Overall Study||2
464214|NCT00546260|1107349|P1|NOT COMPLETED|Overall Study||8
464215|NCT00546260|1107348|P2|COMPLETED|Overall Study||32
464216|NCT00546260|1107349|P1|COMPLETED|Overall Study||28
464217|NCT00546260|1107348|P2|STARTED|Overall Study||34
464218|NCT00546260|1107349|P1|STARTED|Overall Study||36
464219|NCT00546156|1107361|P2|NOT COMPLETED|Overall Study||1
464220|NCT00546156|1107362|P1|NOT COMPLETED|Overall Study||14
464221|NCT00546156|1107361|P2|COMPLETED|Overall Study||19
464222|NCT00546156|1107362|P1|COMPLETED|Overall Study||70
464223|NCT00546156|1107361|P2|STARTED|Overall Study||20
464224|NCT00546156|1107362|P1|STARTED|Overall Study||84
464225|NCT00546117|1107371|P2|NOT COMPLETED|Overall Study||0
464226|NCT00546117|1107372|P1|NOT COMPLETED|Overall Study||4
464227|NCT00546117|1107371|P2|COMPLETED|Overall Study||7
464228|NCT00546117|1107372|P1|COMPLETED|Overall Study||5
464229|NCT00546117|1107371|P2|STARTED|Overall Study||7
464230|NCT00546117|1107372|P1|STARTED|Overall Study||9
464231|NCT00546104|1107380|P1|NOT COMPLETED|Overall Study||0
464232|NCT00546104|1107380|P1|COMPLETED|Overall Study||31
464233|NCT00546104|1107380|P1|STARTED|Overall Study||31
464234|NCT00546078|1107391|P2|NOT COMPLETED|Overall Study||7
464235|NCT00546078|1107392|P1|NOT COMPLETED|Overall Study||4
464236|NCT00546078|1107391|P2|COMPLETED|Overall Study||43
464237|NCT00546078|1107392|P1|COMPLETED|Overall Study||61
464238|NCT00546078|1107391|P2|Month 18|Overall Study||45
464239|NCT00546078|1107392|P1|Month 18|Overall Study||61
464240|NCT00546078|1107391|P2|STARTED|Overall Study||50
464241|NCT00546078|1107392|P1|STARTED|Overall Study||65
464242|NCT00546052|1107430|P1|NOT COMPLETED|Overall Study||227
464243|NCT00546052|1107430|P1|COMPLETED|Overall Study||1511
464244|NCT00546052|1107430|P1|Week 52|Overall Study||1511
464245|NCT00546052|1107430|P1|Week 32|Overall Study||1583
464246|NCT00546052|1107430|P1|Week 12|Overall Study||1650
464247|NCT00546052|1107430|P1|Week 8|Overall Study||1680
464248|NCT00546052|1107430|P1|Week 4|Overall Study||1714
464249|NCT00546052|1107430|P1|STARTED|Overall Study||1738
464250|NCT00546000|1107448|P1|NOT COMPLETED|Overall Study||4
464251|NCT00546000|1107448|P1|COMPLETED|Overall Study||52
464252|NCT00546000|1107448|P1|STARTED|Overall Study||56
464253|NCT00545974|1107455|P2|NOT COMPLETED|Overall Study||3
464254|NCT00545974|1107456|P1|NOT COMPLETED|Overall Study||2
464255|NCT00545974|1107455|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
464256|NCT00545974|1107456|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
464257|NCT00545974|1107455|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
464346|NCT00545623|1107660|P4|NOT COMPLETED|Overall Study||11
464258|NCT00545974|1107456|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
464259|NCT00545948|1107467|P3|NOT COMPLETED|Overall Study||7
464260|NCT00545948|1107468|P2|NOT COMPLETED|Overall Study||1
464261|NCT00545948|1107469|P1|NOT COMPLETED|Overall Study||1
464262|NCT00545948|1107467|P3|COMPLETED|Overall Study||0
464263|NCT00545948|1107468|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
464264|NCT00545948|1107469|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
464265|NCT00545948|1107467|P3|Assigned Treatment|Overall Study||0
464266|NCT00545948|1107468|P2|Assigned Treatment|Overall Study||15
464267|NCT00545948|1107469|P1|Assigned Treatment|Overall Study||9
464268|NCT00545948|1107467|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
464269|NCT00545948|1107468|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
464270|NCT00545948|1107469|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
464271|NCT00545844|1107479|P1|NOT COMPLETED|Overall Study||12
464272|NCT00545844|1107479|P1|COMPLETED|Overall Study||301
464273|NCT00545844|1107479|P1|STARTED|Overall Study||313
464274|NCT00545792|1107493|P1|NOT COMPLETED|Overall Study||1
464275|NCT00545792|1107493|P1|COMPLETED|Overall Study||20
464276|NCT00545792|1107493|P1|STARTED|Overall Study||21
464277|NCT00545779|1107498|P1|NOT COMPLETED|Overall Study||44
464278|NCT00545779|1107498|P1|COMPLETED|Overall Study||633
464279|NCT00545779|1107498|P1|STARTED|Overall Study||677
464280|NCT00545766|1107511|P1|NOT COMPLETED|Overall Study||5
464281|NCT00545766|1107511|P1|COMPLETED|Overall Study||36
464282|NCT00545766|1107511|P1|STARTED|Overall Study||41
464283|NCT00545753|1107518|P3|NOT COMPLETED|Overall Study||26
464284|NCT00545753|1107519|P2|NOT COMPLETED|Overall Study||5
464285|NCT00545753|1107520|P1|NOT COMPLETED|Overall Study||16
464286|NCT00545753|1107518|P3|COMPLETED|Overall Study||230
464287|NCT00545753|1107519|P2|COMPLETED|Overall Study||54
464288|NCT00545753|1107520|P1|COMPLETED|Overall Study||227
464289|NCT00545753|1107518|P3|STARTED|Overall Study||256
464290|NCT00545753|1107519|P2|STARTED|Overall Study||59
464291|NCT00545753|1107520|P1|STARTED|Overall Study||243
464292|NCT00545740|1107533|P4|NOT COMPLETED|Overall Study||71
464293|NCT00545740|1107534|P3|NOT COMPLETED|Overall Study||96
464294|NCT00545740|1107535|P2|NOT COMPLETED|Overall Study||83
464295|NCT00545740|1107536|P1|NOT COMPLETED|Overall Study||75
464296|NCT00545740|1107533|P4|COMPLETED|Overall Study||78
464297|NCT00545740|1107534|P3|COMPLETED|Overall Study||55
464298|NCT00545740|1107535|P2|COMPLETED|Overall Study||62
464299|NCT00545740|1107536|P1|COMPLETED|Overall Study||70
464300|NCT00545740|1107533|P4|STARTED|Overall Study||149
464301|NCT00545740|1107534|P3|STARTED|Overall Study||151
464302|NCT00545740|1107535|P2|STARTED|Overall Study||145
464303|NCT00545740|1107536|P1|STARTED|Overall Study||145
464304|NCT00545688|1107574|P4|NOT COMPLETED|Follow-Up Period||27
464305|NCT00545688|1107575|P3|NOT COMPLETED|Follow-Up Period||20
464306|NCT00545688|1107576|P2|NOT COMPLETED|Follow-Up Period||19
464307|NCT00545688|1107577|P1|NOT COMPLETED|Follow-Up Period||21
464308|NCT00545688|1107574|P4|COMPLETED|Follow-Up Period||60
464309|NCT00545688|1107575|P3|COMPLETED|Follow-Up Period||78
464310|NCT00545688|1107576|P2|COMPLETED|Follow-Up Period||83
464311|NCT00545688|1107577|P1|COMPLETED|Follow-Up Period||77
464312|NCT00545688|1107574|P4|STARTED|Follow-Up Period||87
464313|NCT00545688|1107575|P3|STARTED|Follow-Up Period||98
464314|NCT00545688|1107576|P2|STARTED|Follow-Up Period||102
464315|NCT00545688|1107577|P1|STARTED|Follow-Up Period||98
464316|NCT00545688|1107574|P4|NOT COMPLETED|Adjuvant Treatment Period||14
464317|NCT00545688|1107575|P3|NOT COMPLETED|Adjuvant Treatment Period||4
464318|NCT00545688|1107576|P2|NOT COMPLETED|Adjuvant Treatment Period||8
464319|NCT00545688|1107577|P1|NOT COMPLETED|Adjuvant Treatment Period||5
464320|NCT00545688|1107574|P4|COMPLETED|Adjuvant Treatment Period||74
464321|NCT00545688|1107575|P3|COMPLETED|Adjuvant Treatment Period||90
464322|NCT00545688|1107576|P2|COMPLETED|Adjuvant Treatment Period||94
464323|NCT00545688|1107577|P1|COMPLETED|Adjuvant Treatment Period||98
464324|NCT00545688|1107574|P4|STARTED|Adjuvant Treatment Period||88
464325|NCT00545688|1107575|P3|STARTED|Adjuvant Treatment Period||94
464326|NCT00545688|1107576|P2|STARTED|Adjuvant Treatment Period||102
464327|NCT00545688|1107577|P1|STARTED|Adjuvant Treatment Period||103
464328|NCT00545688|1107574|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
464329|NCT00545688|1107575|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
464330|NCT00545688|1107576|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
464331|NCT00545688|1107577|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
464332|NCT00545688|1107574|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
464333|NCT00545688|1107575|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
464334|NCT00545688|1107576|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
464335|NCT00545688|1107577|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
464336|NCT00545688|1107574|P4|STARTED|Neo-Adjuvant Treatment Period||94
464337|NCT00545688|1107575|P3|STARTED|Neo-Adjuvant Treatment Period||108
464338|NCT00545688|1107576|P2|STARTED|Neo-Adjuvant Treatment Period||107
464339|NCT00545688|1107577|P1|STARTED|Neo-Adjuvant Treatment Period||107
464340|NCT00545662|1107649|P2|NOT COMPLETED|Overall Study||79
464341|NCT00545662|1107650|P1|NOT COMPLETED|Overall Study||85
464342|NCT00545662|1107649|P2|COMPLETED|Overall Study||528
464343|NCT00545662|1107650|P1|COMPLETED|Overall Study||521
464344|NCT00545662|1107649|P2|STARTED|Overall Study||607
464345|NCT00545662|1107650|P1|STARTED|Overall Study||606
464347|NCT00545623|1107661|P3|NOT COMPLETED|Overall Study||13
464348|NCT00545623|1107662|P2|NOT COMPLETED|Overall Study||10
464349|NCT00545623|1107663|P1|NOT COMPLETED|Overall Study||7
464350|NCT00545623|1107660|P4|COMPLETED|Overall Study||23
464351|NCT00545623|1107661|P3|COMPLETED|Overall Study||20
464352|NCT00545623|1107662|P2|COMPLETED|Overall Study||21
464353|NCT00545623|1107663|P1|COMPLETED|Overall Study||25
464354|NCT00545623|1107660|P4|STARTED|Overall Study||34
464355|NCT00545623|1107661|P3|STARTED|Overall Study||33
464356|NCT00545623|1107662|P2|STARTED|Overall Study||31
464357|NCT00545623|1107663|P1|STARTED|Overall Study||32
464358|NCT00545584|1107676|P3|NOT COMPLETED|Overall Study||56
464359|NCT00545584|1107677|P2|NOT COMPLETED|Overall Study||80
464360|NCT00545584|1107678|P1|NOT COMPLETED|Overall Study||79
464361|NCT00545584|1107676|P3|COMPLETED|Overall Study||250
464362|NCT00545584|1107677|P2|COMPLETED|Overall Study||334
464363|NCT00545584|1107678|P1|COMPLETED|Overall Study||333
464364|NCT00545584|1107676|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
464365|NCT00545584|1107677|P2|STARTED|Overall Study||414
464366|NCT00545584|1107678|P1|STARTED|Overall Study||412
464367|NCT00545571|1107689|P1|NOT COMPLETED|Overall Study||67
464368|NCT00545571|1107689|P1|COMPLETED|Overall Study||53
464369|NCT00545571|1107689|P1|STARTED|Overall Study||120
464370|NCT00545506|1107704|P2|NOT COMPLETED|Overall Study||0
464371|NCT00545506|1107705|P1|NOT COMPLETED|Overall Study||0
464372|NCT00545506|1107704|P2|COMPLETED|Overall Study||3
464373|NCT00545506|1107705|P1|COMPLETED|Overall Study||3
464374|NCT00545506|1107704|P2|STARTED|Overall Study||3
464375|NCT00545506|1107705|P1|STARTED|Overall Study||3
464376|NCT00545441|1107713|P2|NOT COMPLETED|Overall Study||16
464377|NCT00545441|1107714|P1|NOT COMPLETED|Overall Study||18
464378|NCT00545441|1107713|P2|COMPLETED|Overall Study||26
464379|NCT00545441|1107714|P1|COMPLETED|Overall Study||26
464380|NCT00545441|1107713|P2|STARTED|Overall Study||42
464381|NCT00545441|1107714|P1|STARTED|Overall Study||44
464382|NCT00545402|1107722|P2|NOT COMPLETED|Overall Study||29
464383|NCT00545402|1107723|P1|NOT COMPLETED|Overall Study||34
464384|NCT00545402|1107722|P2|COMPLETED|Overall Study||61
464385|NCT00545402|1107723|P1|COMPLETED|Overall Study||56
464386|NCT00545402|1107722|P2|STARTED|Overall Study||90
464387|NCT00545402|1107723|P1|STARTED|Overall Study||90
464388|NCT00545363|1107741|P2|NOT COMPLETED|Overall Study||15
464389|NCT00545363|1107742|P1|NOT COMPLETED|Overall Study||19
464390|NCT00545363|1107741|P2|COMPLETED|Overall Study||343
464391|NCT00545363|1107742|P1|COMPLETED|Overall Study||339
464392|NCT00545363|1107741|P2|Treated|Overall Study||357
464393|NCT00545363|1107742|P1|Treated|Overall Study||354
464394|NCT00545363|1107741|P2|STARTED|Overall Study||358
464395|NCT00545363|1107742|P1|STARTED|Overall Study||358
464396|NCT00545298|1107757|P3|NOT COMPLETED|Overall Study||1
464397|NCT00545298|1107758|P2|NOT COMPLETED|Overall Study||0
464398|NCT00545298|1107759|P1|NOT COMPLETED|Overall Study||2
464399|NCT00545298|1107757|P3|COMPLETED|Overall Study||0
464400|NCT00545298|1107758|P2|COMPLETED|Overall Study||1
464401|NCT00545298|1107759|P1|COMPLETED|Overall Study||0
464402|NCT00545298|1107757|P3|STARTED|Overall Study||1
464403|NCT00545298|1107758|P2|STARTED|Overall Study||1
464404|NCT00545298|1107759|P1|STARTED|Overall Study||2
464405|NCT00545272|1107776|P6|NOT COMPLETED|Overall Study||3
464406|NCT00545272|1107777|P5|NOT COMPLETED|Overall Study||2
464407|NCT00545272|1107778|P4|NOT COMPLETED|Overall Study||1
464408|NCT00545272|1107779|P3|NOT COMPLETED|Overall Study||1
464409|NCT00545272|1107780|P2|NOT COMPLETED|Overall Study||1
464410|NCT00545272|1107781|P1|NOT COMPLETED|Overall Study||0
464411|NCT00545272|1107776|P6|COMPLETED|Overall Study||59
464412|NCT00545272|1107777|P5|COMPLETED|Overall Study||62
464413|NCT00545272|1107778|P4|COMPLETED|Overall Study||71
464414|NCT00545272|1107779|P3|COMPLETED|Overall Study||64
464415|NCT00545272|1107780|P2|COMPLETED|Overall Study||67
464416|NCT00545272|1107781|P1|COMPLETED|Overall Study||61
464417|NCT00545272|1107776|P6|STARTED|Overall Study||62
464418|NCT00545272|1107777|P5|STARTED|Overall Study||64
464419|NCT00545272|1107778|P4|STARTED|Overall Study||72
464420|NCT00545272|1107779|P3|STARTED|Overall Study||65
464421|NCT00545272|1107780|P2|STARTED|Overall Study||68
464422|NCT00545272|1107781|P1|STARTED|Overall Study||61
464423|NCT00545233|1107833|P2|NOT COMPLETED|Overall Study||35
464424|NCT00545233|1107834|P1|NOT COMPLETED|Overall Study||46
464425|NCT00545233|1107833|P2|COMPLETED|Overall Study||41
464426|NCT00545233|1107834|P1|COMPLETED|Overall Study||33
464427|NCT00545233|1107833|P2|Intent-to-Treat (ITT)|Overall Study||73
464428|NCT00545233|1107834|P1|Intent-to-Treat (ITT)|Overall Study||77
464429|NCT00545233|1107833|P2|Safety Set|Overall Study||75
464430|NCT00545233|1107834|P1|Safety Set|Overall Study||77
464431|NCT00545233|1107833|P2|STARTED|Overall Study||76
464432|NCT00545233|1107834|P1|STARTED|Overall Study||79
464433|NCT00545181|1107883|P2|NOT COMPLETED|Overall Study||0
464434|NCT00545181|1107884|P1|NOT COMPLETED|Overall Study||0
464435|NCT00545181|1107883|P2|COMPLETED|Overall Study||25
464436|NCT00545181|1107884|P1|COMPLETED|Overall Study||29
464437|NCT00545181|1107883|P2|STARTED|Overall Study||25
464438|NCT00545181|1107884|P1|STARTED|Overall Study||29
464439|NCT00545168|1107893|P3|NOT COMPLETED|Overall Study||21
464440|NCT00545168|1107894|P2|NOT COMPLETED|Overall Study||5
464441|NCT00545168|1107895|P1|NOT COMPLETED|Overall Study||16
464442|NCT00545168|1107893|P3|COMPLETED|Overall Study||193
464443|NCT00545168|1107894|P2|COMPLETED|Overall Study||58
464444|NCT00545168|1107895|P1|COMPLETED|Overall Study||187
464445|NCT00545168|1107893|P3|STARTED|Overall Study||214
464446|NCT00545168|1107894|P2|STARTED|Overall Study||63
464447|NCT00545168|1107895|P1|STARTED|Overall Study||203
464448|NCT00545155|1107904|P1|NOT COMPLETED|Overall Study||0
464449|NCT00545155|1107904|P1|COMPLETED|Overall Study||187
464450|NCT00545155|1107904|P1|STARTED|Overall Study||187
464451|NCT00545103|1107921|P4|NOT COMPLETED|Overall Study||70
464452|NCT00545103|1107922|P3|NOT COMPLETED|Overall Study||76
464453|NCT00545103|1107923|P2|NOT COMPLETED|Overall Study||78
464454|NCT00545103|1107924|P1|NOT COMPLETED|Overall Study||75
464455|NCT00545103|1107921|P4|COMPLETED|Overall Study||76
464456|NCT00545103|1107922|P3|COMPLETED|Overall Study||74
464457|NCT00545103|1107923|P2|COMPLETED|Overall Study||70
464458|NCT00545103|1107924|P1|COMPLETED|Overall Study||73
464459|NCT00545103|1107921|P4|STARTED|Overall Study||146
464460|NCT00545103|1107922|P3|STARTED|Overall Study||150
464461|NCT00545103|1107923|P2|STARTED|Overall Study||148
464462|NCT00545103|1107924|P1|STARTED|Overall Study||148
464463|NCT00545064|1107958|P1|NOT COMPLETED|Overall Study||8
464464|NCT00545064|1107958|P1|COMPLETED|Overall Study||170
464465|NCT00545064|1107958|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
464466|NCT00545064|1107958|P1|Visit 2 (Week 4)|Overall Study||169
464467|NCT00545064|1107958|P1|Visit 1 (Baseline)|Overall Study||178
464468|NCT00545064|1107958|P1|STARTED|Overall Study||178
464469|NCT00545051|1107969|P2|NOT COMPLETED|Overall Study||7
464470|NCT00545051|1107970|P1|NOT COMPLETED|Overall Study||9
464471|NCT00545051|1107969|P2|COMPLETED|Overall Study||65
464472|NCT00545051|1107970|P1|COMPLETED|Overall Study||59
464473|NCT00545051|1107969|P2|STARTED|Overall Study||72
464474|NCT00545051|1107970|P1|STARTED|Overall Study||68
464475|NCT00545025|1107986|P2|NOT COMPLETED|Overall Study||0
464476|NCT00545025|1107987|P1|NOT COMPLETED|Overall Study||0
464477|NCT00545025|1107986|P2|COMPLETED|Overall Study||83
464478|NCT00545025|1107987|P1|COMPLETED|Overall Study||160
464479|NCT00545025|1107986|P2|STARTED|Overall Study||83
464480|NCT00545025|1107987|P1|STARTED|Overall Study||160
464481|NCT00544908|1108007|P1|NOT COMPLETED|Overall Study||0
464482|NCT00544908|1108007|P1|COMPLETED|Overall Study||7
464483|NCT00544908|1108007|P1|STARTED|Overall Study||7
464484|NCT00544882|1108014|P3|NOT COMPLETED|Cycle 3: Follow-up||0
464485|NCT00544882|1108015|P2|NOT COMPLETED|Cycle 3: Follow-up||2
464486|NCT00544882|1108016|P1|NOT COMPLETED|Cycle 3: Follow-up||0
464487|NCT00544882|1108014|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
464488|NCT00544882|1108015|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
464489|NCT00544882|1108016|P1|COMPLETED|Cycle 3: Follow-up||0
464490|NCT00544882|1108014|P3|STARTED|Cycle 3: Follow-up||28
464491|NCT00544882|1108015|P2|STARTED|Cycle 3: Follow-up||28
464492|NCT00544882|1108016|P1|STARTED|Cycle 3: Follow-up||0
464493|NCT00544882|1108014|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
464494|NCT00544882|1108015|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
464495|NCT00544882|1108016|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
464496|NCT00544882|1108014|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
464497|NCT00544882|1108015|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
464498|NCT00544882|1108016|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
464499|NCT00544882|1108014|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
464500|NCT00544882|1108015|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
464501|NCT00544882|1108016|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
464502|NCT00544882|1108014|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
464503|NCT00544882|1108015|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
464504|NCT00544882|1108016|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
464505|NCT00544882|1108014|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
464506|NCT00544882|1108015|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
464507|NCT00544882|1108016|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
464508|NCT00544882|1108014|P3|COMPLETED|Cycle 1: Run-in Cycle||0
464509|NCT00544882|1108015|P2|COMPLETED|Cycle 1: Run-in Cycle||0
464510|NCT00544882|1108016|P1|COMPLETED|Cycle 1: Run-in Cycle||58
464511|NCT00544882|1108014|P3|STARTED|Cycle 1: Run-in Cycle||0
464512|NCT00544882|1108015|P2|STARTED|Cycle 1: Run-in Cycle||0
464513|NCT00544882|1108016|P1|STARTED|Cycle 1: Run-in Cycle||61
464514|NCT00544869|1108041|P3|NOT COMPLETED|Overall Study||0
464515|NCT00544869|1108042|P2|NOT COMPLETED|Overall Study||2
464516|NCT00544869|1108043|P1|NOT COMPLETED|Overall Study||12
464517|NCT00544869|1108041|P3|COMPLETED|Overall Study||2
464518|NCT00544869|1108042|P2|COMPLETED|Overall Study||12
464519|NCT00544869|1108043|P1|COMPLETED|Overall Study||24
464520|NCT00544869|1108041|P3|STARTED|Overall Study||2
464521|NCT00544869|1108042|P2|STARTED|Overall Study||14
464522|NCT00544869|1108043|P1|STARTED|Overall Study||36
464523|NCT00544817|1108051|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
464524|NCT00544817|1108051|P1|COMPLETED|Follow-up Systemic Therapy||9
464525|NCT00544817|1108051|P1|STARTED|Follow-up Systemic Therapy||28
464526|NCT00544817|1108051|P1|NOT COMPLETED|No Treatment Interval||12
464527|NCT00544817|1108051|P1|COMPLETED|No Treatment Interval||28
464528|NCT00544817|1108051|P1|STARTED|No Treatment Interval||40
464529|NCT00544817|1108051|P1|NOT COMPLETED|Combined Modality||7
464530|NCT00544817|1108051|P1|COMPLETED|Combined Modality||40
464531|NCT00544817|1108051|P1|STARTED|Combined Modality||47
464532|NCT00544778|1108057|P1|NOT COMPLETED|Overall Study||0
464533|NCT00544778|1108057|P1|COMPLETED|Overall Study||7
464534|NCT00544778|1108057|P1|STARTED|Overall Study||7
464535|NCT00544713|1108063|P2|NOT COMPLETED|Overall Study||5
464536|NCT00544713|1108064|P1|NOT COMPLETED|Overall Study||3
464537|NCT00544713|1108063|P2|COMPLETED|Overall Study||109
464538|NCT00544713|1108064|P1|COMPLETED|Overall Study||111
464539|NCT00544713|1108063|P2|STARTED|Overall Study||114
464540|NCT00544713|1108064|P1|STARTED|Overall Study||114
464541|NCT00544674|1108094|P1|NOT COMPLETED|Overall Study||1
464542|NCT00544674|1108094|P1|COMPLETED|Overall Study||4
464543|NCT00544674|1108094|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
464544|NCT00544648|1108100|P2|NOT COMPLETED|Overall Study||1
464545|NCT00544648|1108101|P1|NOT COMPLETED|Overall Study||3
464546|NCT00544648|1108100|P2|COMPLETED|Overall Study||1
464547|NCT00544648|1108101|P1|COMPLETED|Overall Study||8
464548|NCT00544648|1108100|P2|STARTED|Overall Study||2
464549|NCT00544648|1108101|P1|STARTED|Overall Study||11
464550|NCT00544557|1108115|P1|NOT COMPLETED|Overall Study||434
464551|NCT00544557|1108115|P1|COMPLETED|Overall Study||1251
464552|NCT00544557|1108115|P1|STARTED|Overall Study||1685
464553|NCT00544544|1108146|P1|NOT COMPLETED|Overall Study||3
464554|NCT00544544|1108146|P1|COMPLETED|Overall Study||11
464555|NCT00544544|1108146|P1|STARTED|Overall Study||14
464556|NCT00544440|1108150|P1|NOT COMPLETED|Overall Study||57
464557|NCT00544440|1108150|P1|COMPLETED|Overall Study||0
464558|NCT00544440|1108150|P1|STARTED|Overall Study||57
464559|NCT00544167|1108157|P1|NOT COMPLETED|Overall Study||29
464560|NCT00544167|1108157|P1|COMPLETED|Overall Study||16
464561|NCT00544167|1108157|P1|STARTED|Overall Study||45
464562|NCT00543296|1108161|P1|NOT COMPLETED|Overall Study||7
464563|NCT00543296|1108161|P1|COMPLETED|Overall Study||14
464564|NCT00543296|1108161|P1|STARTED|Overall Study||21
464565|NCT00543985|1108168|P1|NOT COMPLETED|Overall Study||4
464566|NCT00543985|1108168|P1|COMPLETED|Overall Study||32
464567|NCT00543985|1108168|P1|STARTED|Overall Study||36
464568|NCT00543855|1108179|P4|NOT COMPLETED|Overall Study||4
464569|NCT00543855|1108180|P3|NOT COMPLETED|Overall Study||6
464570|NCT00543855|1108181|P2|NOT COMPLETED|Overall Study||2
464571|NCT00543855|1108182|P1|NOT COMPLETED|Overall Study||4
464572|NCT00543855|1108179|P4|COMPLETED|Overall Study||30
464573|NCT00543855|1108180|P3|COMPLETED|Overall Study||31
464574|NCT00543855|1108181|P2|COMPLETED|Overall Study||31
464575|NCT00543855|1108182|P1|COMPLETED|Overall Study||31
464576|NCT00543855|1108179|P4|STARTED|Overall Study||34
464577|NCT00543855|1108180|P3|STARTED|Overall Study||37
464578|NCT00543855|1108181|P2|STARTED|Overall Study||33
464579|NCT00543855|1108182|P1|STARTED|Overall Study||35
464580|NCT00543803|1108204|P1|NOT COMPLETED|Overall Study||142
464581|NCT00543803|1108204|P1|COMPLETED|Overall Study||192
464582|NCT00543803|1108204|P1|STARTED|Overall Study||334
464583|NCT00543764|1108223|P2|NOT COMPLETED|Overall Study||0
464584|NCT00543764|1108224|P1|NOT COMPLETED|Overall Study||0
464585|NCT00543764|1108223|P2|COMPLETED|Overall Study||50
464586|NCT00543764|1108224|P1|COMPLETED|Overall Study||100
464587|NCT00543764|1108223|P2|STARTED|Overall Study||50
464588|NCT00543764|1108224|P1|STARTED|Overall Study||100
464589|NCT00543725|1108232|P2|NOT COMPLETED|Overall Study||74
464590|NCT00543725|1108233|P1|NOT COMPLETED|Overall Study||68
464591|NCT00543725|1108232|P2|COMPLETED|Overall Study||264
464592|NCT00543725|1108233|P1|COMPLETED|Overall Study||272
464593|NCT00543725|1108232|P2|STARTED|Overall Study||338
464594|NCT00543725|1108233|P1|STARTED|Overall Study||340
464595|NCT00543569|1108259|P4|NOT COMPLETED|Overall Study||9
464596|NCT00543569|1108260|P3|NOT COMPLETED|Overall Study||20
464597|NCT00543569|1108261|P2|NOT COMPLETED|Overall Study||8
464598|NCT00543569|1108262|P1|NOT COMPLETED|Overall Study||12
464599|NCT00543569|1108259|P4|COMPLETED|Overall Study||72
464600|NCT00543569|1108260|P3|COMPLETED|Overall Study||60
464601|NCT00543569|1108261|P2|COMPLETED|Overall Study||72
464602|NCT00543569|1108262|P1|COMPLETED|Overall Study||70
464603|NCT00543569|1108259|P4|Received Treatment|Overall Study||78
464604|NCT00543569|1108260|P3|Received Treatment|Overall Study||75
464605|NCT00543569|1108261|P2|Received Treatment|Overall Study||77
464606|NCT00543569|1108262|P1|Received Treatment|Overall Study||79
464607|NCT00543569|1108259|P4|STARTED|Overall Study||81
464608|NCT00543569|1108260|P3|STARTED|Overall Study||80
464609|NCT00543569|1108261|P2|STARTED|Overall Study||80
464610|NCT00543569|1108262|P1|STARTED|Overall Study||82
464611|NCT00543543|1108368|P4|NOT COMPLETED|Overall Study||1222
464612|NCT00543543|1108369|P3|NOT COMPLETED|Overall Study||14
464613|NCT00543543|1108370|P2|NOT COMPLETED|Overall Study||1252
464614|NCT00543543|1108371|P1|NOT COMPLETED|Overall Study||20
464615|NCT00543543|1108368|P4|COMPLETED|Overall Study|Follow-up was up to 54 months|5887
464616|NCT00543543|1108369|P3|COMPLETED|Overall Study|Follow-up was up to 7 months|296
464617|NCT00543543|1108370|P2|COMPLETED|Overall Study|Follow-up was up to 54 months|5854
464618|NCT00543543|1108371|P1|COMPLETED|Overall Study|Follow-up was up to 7 months|295
464619|NCT00543543|1108368|P4|Completed 3 Vaccinations|Overall Study||6934
464620|NCT00543543|1108369|P3|Completed 3 Vaccinations|Overall Study||297
464621|NCT00543543|1108370|P2|Completed 3 Vaccinations|Overall Study||6928
464622|NCT00543543|1108371|P1|Completed 3 Vaccinations|Overall Study||300
464623|NCT00543543|1108368|P4|STARTED|Overall Study||7109
464624|NCT00543543|1108369|P3|STARTED|Overall Study||310
464625|NCT00543543|1108370|P2|STARTED|Overall Study||7106
464626|NCT00543543|1108371|P1|STARTED|Overall Study||315
464627|NCT00543140|1108407|P1|NOT COMPLETED|Overall Study||72
464628|NCT00543140|1108407|P1|COMPLETED|Overall Study||231
464629|NCT00543140|1108407|P1|STARTED|Overall Study||303
464630|NCT00543101|1108417|P2|NOT COMPLETED|Overall Study||0
464631|NCT00543101|1108418|P1|NOT COMPLETED|Overall Study||0
464632|NCT00543101|1108417|P2|COMPLETED|Overall Study||12
464633|NCT00543101|1108418|P1|COMPLETED|Overall Study||12
464634|NCT00543101|1108417|P2|STARTED|Overall Study||12
464635|NCT00543101|1108418|P1|STARTED|Overall Study||12
464636|NCT00542997|1108430|P1|NOT COMPLETED|Efficacy Period||3
464637|NCT00542997|1108430|P1|COMPLETED|Efficacy Period||43
464638|NCT00542997|1108430|P1|STARTED|Efficacy Period||46
464639|NCT00542997|1108430|P1|NOT COMPLETED|Wash in / Wash Out Period||5
464640|NCT00542997|1108430|P1|COMPLETED|Wash in / Wash Out Period||46
464641|NCT00542997|1108430|P1|STARTED|Wash in / Wash Out Period||51
464642|NCT00542971|1108445|P1|NOT COMPLETED|Overall Study||0
464643|NCT00542971|1108445|P1|COMPLETED|Overall Study||75
464644|NCT00542971|1108445|P1|STARTED|Overall Study||75
464645|NCT00542880|1108452|P2|NOT COMPLETED|Period 3||2
464646|NCT00542880|1108453|P1|NOT COMPLETED|Period 3||0
464647|NCT00542880|1108452|P2|COMPLETED|Period 3||201
464648|NCT00542880|1108453|P1|COMPLETED|Period 3||204
464649|NCT00542880|1108452|P2|STARTED|Period 3||203
464650|NCT00542880|1108453|P1|STARTED|Period 3||204
464651|NCT00542880|1108452|P2|NOT COMPLETED|Period 2||10
464652|NCT00542880|1108453|P1|NOT COMPLETED|Period 2||7
464653|NCT00542880|1108452|P2|COMPLETED|Period 2||203
464654|NCT00542880|1108453|P1|COMPLETED|Period 2||204
464655|NCT00542880|1108452|P2|STARTED|Period 2||213
464656|NCT00542880|1108453|P1|STARTED|Period 2||211
464657|NCT00542880|1108452|P2|NOT COMPLETED|Period 1||12
464658|NCT00542880|1108453|P1|NOT COMPLETED|Period 1||6
464659|NCT00542880|1108452|P2|COMPLETED|Period 1||213
464660|NCT00542880|1108453|P1|COMPLETED|Period 1||211
464661|NCT00542880|1108452|P2|STARTED|Period 1||225
464662|NCT00542880|1108453|P1|STARTED|Period 1|This was a cross-over study|217
464663|NCT00542828|1108489|P1|NOT COMPLETED|Overall Study||13
464664|NCT00542828|1108489|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
464665|NCT00542828|1108489|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
464666|NCT00542815|1108507|P3|NOT COMPLETED|Overall Study||32
464667|NCT00542815|1108508|P2|NOT COMPLETED|Overall Study||32
464668|NCT00542815|1108509|P1|NOT COMPLETED|Overall Study||106
464669|NCT00542815|1108507|P3|COMPLETED|Overall Study||92
464670|NCT00542815|1108508|P2|COMPLETED|Overall Study||44
464671|NCT00542815|1108509|P1|COMPLETED|Overall Study||326
464672|NCT00542815|1108507|P3|STARTED|Overall Study||124
464673|NCT00542815|1108508|P2|STARTED|Overall Study||76
464674|NCT00542815|1108509|P1|STARTED|Overall Study||432
464675|NCT00542789|1108522|P2|NOT COMPLETED|Overall Study||78
464676|NCT00542789|1108523|P1|NOT COMPLETED|Overall Study||41
464677|NCT00542789|1108522|P2|COMPLETED|Overall Study||90
464678|NCT00542789|1108523|P1|COMPLETED|Overall Study||134
464679|NCT00542789|1108522|P2|STARTED|Overall Study|Randomised|168
464680|NCT00542789|1108523|P1|STARTED|Overall Study|Randomised|175
464681|NCT00542620|1108535|P2|NOT COMPLETED|Overall Study||0
464682|NCT00542620|1108536|P1|NOT COMPLETED|Overall Study||0
464683|NCT00542620|1108535|P2|COMPLETED|Overall Study||12
464684|NCT00542620|1108536|P1|COMPLETED|Overall Study||13
464685|NCT00542620|1108535|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
464686|NCT00542620|1108536|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
464687|NCT00542620|1108535|P2|STARTED|Overall Study||12
464688|NCT00542620|1108536|P1|STARTED|Overall Study||13
464689|NCT00542542|1108602|P2|NOT COMPLETED|Overall Study||0
464690|NCT00542542|1108603|P1|NOT COMPLETED|Overall Study||0
464691|NCT00542542|1108602|P2|COMPLETED|Overall Study||44
464692|NCT00542542|1108603|P1|COMPLETED|Overall Study||44
464693|NCT00542542|1108602|P2|STARTED|Overall Study||44
464694|NCT00542542|1108603|P1|STARTED|Overall Study||44
464695|NCT00542425|1108614|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
464696|NCT00542425|1108615|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
464697|NCT00542425|1108616|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
464698|NCT00542425|1108617|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
464699|NCT00542425|1108618|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
464700|NCT00542425|1108614|P5|COMPLETED|Extended 24 Weeks of Treatment||13
464701|NCT00542425|1108615|P4|COMPLETED|Extended 24 Weeks of Treatment||6
464702|NCT00542425|1108616|P3|COMPLETED|Extended 24 Weeks of Treatment||8
464703|NCT00542425|1108617|P2|COMPLETED|Extended 24 Weeks of Treatment||11
464704|NCT00542425|1108618|P1|COMPLETED|Extended 24 Weeks of Treatment||10
464705|NCT00542425|1108614|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
464706|NCT00542425|1108615|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
464707|NCT00542425|1108616|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
464708|NCT00542425|1108617|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
464805|NCT00541970|1108768|P4|STARTED|Month 48||239
464709|NCT00542425|1108618|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
464710|NCT00542425|1108614|P5|NOT COMPLETED|Initial 24 Weeks||6
464711|NCT00542425|1108615|P4|NOT COMPLETED|Initial 24 Weeks||11
464712|NCT00542425|1108616|P3|NOT COMPLETED|Initial 24 Weeks||7
464713|NCT00542425|1108617|P2|NOT COMPLETED|Initial 24 Weeks||10
464714|NCT00542425|1108618|P1|NOT COMPLETED|Initial 24 Weeks||4
464715|NCT00542425|1108614|P5|COMPLETED|Initial 24 Weeks||39
464716|NCT00542425|1108615|P4|COMPLETED|Initial 24 Weeks||34
464717|NCT00542425|1108616|P3|COMPLETED|Initial 24 Weeks||36
464718|NCT00542425|1108617|P2|COMPLETED|Initial 24 Weeks||33
464719|NCT00542425|1108618|P1|COMPLETED|Initial 24 Weeks||42
464720|NCT00542425|1108614|P5|STARTED|Initial 24 Weeks||45
464721|NCT00542425|1108615|P4|STARTED|Initial 24 Weeks||45
464722|NCT00542425|1108616|P3|STARTED|Initial 24 Weeks||43
464723|NCT00542425|1108617|P2|STARTED|Initial 24 Weeks||43
464724|NCT00542425|1108618|P1|STARTED|Initial 24 Weeks||46
464725|NCT00542386|1108656|P6|NOT COMPLETED|Overall Study||50
464726|NCT00542386|1108657|P5|NOT COMPLETED|Overall Study||40
464727|NCT00542386|1108658|P4|NOT COMPLETED|Overall Study||38
464728|NCT00542386|1108659|P3|NOT COMPLETED|Overall Study||33
464729|NCT00542386|1108660|P2|NOT COMPLETED|Overall Study||28
464730|NCT00542386|1108661|P1|NOT COMPLETED|Overall Study||43
464731|NCT00542386|1108656|P6|COMPLETED|Overall Study||82
464732|NCT00542386|1108657|P5|COMPLETED|Overall Study||62
464733|NCT00542386|1108658|P4|COMPLETED|Overall Study||65
464734|NCT00542386|1108659|P3|COMPLETED|Overall Study||66
464735|NCT00542386|1108660|P2|COMPLETED|Overall Study||74
464736|NCT00542386|1108661|P1|COMPLETED|Overall Study||61
464737|NCT00542386|1108656|P6|STARTED|Overall Study||132
464738|NCT00542386|1108657|P5|STARTED|Overall Study||102
464739|NCT00542386|1108658|P4|STARTED|Overall Study||103
464740|NCT00542386|1108659|P3|STARTED|Overall Study||99
464741|NCT00542386|1108660|P2|STARTED|Overall Study||102
464742|NCT00542386|1108661|P1|STARTED|Overall Study||104
464743|NCT00542321|1108683|P2|NOT COMPLETED|Overall Study||1
464744|NCT00542321|1108684|P1|NOT COMPLETED|Overall Study||0
464745|NCT00542321|1108683|P2|COMPLETED|Overall Study||7
464746|NCT00542321|1108684|P1|COMPLETED|Overall Study||8
464747|NCT00542321|1108683|P2|STARTED|Overall Study||8
464748|NCT00542321|1108684|P1|STARTED|Overall Study||8
464749|NCT00542308|1108698|P1|NOT COMPLETED|Overall Study||0
464750|NCT00542308|1108698|P1|COMPLETED|Overall Study||90
464751|NCT00542308|1108698|P1|STARTED|Overall Study||90
464752|NCT00542269|1108706|P3|NOT COMPLETED|Overall Study||6
464753|NCT00542269|1108707|P2|NOT COMPLETED|Overall Study||6
464754|NCT00542269|1108708|P1|NOT COMPLETED|Overall Study||13
464755|NCT00542269|1108706|P3|COMPLETED|Overall Study||51
464756|NCT00542269|1108707|P2|COMPLETED|Overall Study||54
464757|NCT00542269|1108708|P1|COMPLETED|Overall Study||48
464758|NCT00542269|1108706|P3|STARTED|Overall Study||57
464759|NCT00542269|1108707|P2|STARTED|Overall Study||60
464760|NCT00542269|1108708|P1|STARTED|Overall Study||61
464761|NCT00542178|1108743|P8|NOT COMPLETED|Overall Study||85
464762|NCT00542178|1108744|P7|NOT COMPLETED|Overall Study||87
464763|NCT00542178|1108745|P6|NOT COMPLETED|Overall Study||89
464764|NCT00542178|1108746|P5|NOT COMPLETED|Overall Study||64
464765|NCT00542178|1108747|P4|NOT COMPLETED|Overall Study||62
464766|NCT00542178|1108748|P3|NOT COMPLETED|Overall Study||74
464767|NCT00542178|1108749|P2|NOT COMPLETED|Overall Study||80
464768|NCT00542178|1108750|P1|NOT COMPLETED|Overall Study||75
464769|NCT00542178|1108743|P8|COMPLETED|Overall Study||381
464770|NCT00542178|1108744|P7|COMPLETED|Overall Study||406
464771|NCT00542178|1108745|P6|COMPLETED|Overall Study||406
464772|NCT00542178|1108746|P5|COMPLETED|Overall Study||400
464773|NCT00542178|1108747|P4|COMPLETED|Overall Study||308
464774|NCT00542178|1108748|P3|COMPLETED|Overall Study||308
464775|NCT00542178|1108749|P2|COMPLETED|Overall Study||332
464776|NCT00542178|1108750|P1|COMPLETED|Overall Study||315
464777|NCT00542178|1108743|P8|STARTED|Overall Study||466
464778|NCT00542178|1108744|P7|STARTED|Overall Study||493
464779|NCT00542178|1108745|P6|STARTED|Overall Study||495
464780|NCT00542178|1108746|P5|STARTED|Overall Study||464
464781|NCT00542178|1108747|P4|STARTED|Overall Study||370
464782|NCT00542178|1108748|P3|STARTED|Overall Study||382
464783|NCT00542178|1108749|P2|STARTED|Overall Study||412
464784|NCT00542178|1108750|P1|STARTED|Overall Study||390
464785|NCT00541970|1108768|P4|NOT COMPLETED|Month 60||72
464786|NCT00541970|1108769|P3|NOT COMPLETED|Month 60||82
464787|NCT00541970|1108770|P2|NOT COMPLETED|Month 60||77
464788|NCT00541970|1108771|P1|NOT COMPLETED|Month 60||78
464789|NCT00541970|1108768|P4|COMPLETED|Month 60||167
464790|NCT00541970|1108769|P3|COMPLETED|Month 60||158
464791|NCT00541970|1108770|P2|COMPLETED|Month 60||164
464792|NCT00541970|1108771|P1|COMPLETED|Month 60||162
464793|NCT00541970|1108768|P4|STARTED|Month 60||239
464794|NCT00541970|1108769|P3|STARTED|Month 60||240
464795|NCT00541970|1108770|P2|STARTED|Month 60||241
464796|NCT00541970|1108771|P1|STARTED|Month 60||240
464797|NCT00541970|1108768|P4|NOT COMPLETED|Month 48||75
464798|NCT00541970|1108769|P3|NOT COMPLETED|Month 48||73
464799|NCT00541970|1108770|P2|NOT COMPLETED|Month 48||73
464800|NCT00541970|1108771|P1|NOT COMPLETED|Month 48||71
464801|NCT00541970|1108768|P4|COMPLETED|Month 48||164
464802|NCT00541970|1108769|P3|COMPLETED|Month 48||167
464803|NCT00541970|1108770|P2|COMPLETED|Month 48||168
464804|NCT00541970|1108771|P1|COMPLETED|Month 48||169
464806|NCT00541970|1108769|P3|STARTED|Month 48||240
464807|NCT00541970|1108770|P2|STARTED|Month 48||241
464808|NCT00541970|1108771|P1|STARTED|Month 48||240
464809|NCT00541970|1108768|P4|NOT COMPLETED|Month 36||60
464810|NCT00541970|1108769|P3|NOT COMPLETED|Month 36||66
464811|NCT00541970|1108770|P2|NOT COMPLETED|Month 36||66
464812|NCT00541970|1108771|P1|NOT COMPLETED|Month 36||61
464813|NCT00541970|1108768|P4|COMPLETED|Month 36||179
464814|NCT00541970|1108769|P3|COMPLETED|Month 36||174
464815|NCT00541970|1108770|P2|COMPLETED|Month 36||175
464816|NCT00541970|1108771|P1|COMPLETED|Month 36||179
464817|NCT00541970|1108768|P4|STARTED|Month 36||239
464818|NCT00541970|1108769|P3|STARTED|Month 36||240
464819|NCT00541970|1108770|P2|STARTED|Month 36||241
464820|NCT00541970|1108771|P1|STARTED|Month 36||240
464821|NCT00541970|1108768|P4|NOT COMPLETED|Month 24||22
464822|NCT00541970|1108769|P3|NOT COMPLETED|Month 24||32
464823|NCT00541970|1108770|P2|NOT COMPLETED|Month 24||32
464824|NCT00541970|1108771|P1|NOT COMPLETED|Month 24||29
464825|NCT00541970|1108768|P4|COMPLETED|Month 24||217
464826|NCT00541970|1108769|P3|COMPLETED|Month 24||208
464827|NCT00541970|1108770|P2|COMPLETED|Month 24||209
464828|NCT00541970|1108771|P1|COMPLETED|Month 24||211
464829|NCT00541970|1108768|P4|STARTED|Month 24||239
464830|NCT00541970|1108769|P3|STARTED|Month 24||240
464831|NCT00541970|1108770|P2|STARTED|Month 24||241
464832|NCT00541970|1108771|P1|STARTED|Month 24||240
464833|NCT00541970|1108768|P4|NOT COMPLETED|Month 18||17
464834|NCT00541970|1108769|P3|NOT COMPLETED|Month 18||25
464835|NCT00541970|1108770|P2|NOT COMPLETED|Month 18||24
464836|NCT00541970|1108771|P1|NOT COMPLETED|Month 18||14
464837|NCT00541970|1108768|P4|COMPLETED|Month 18||222
464838|NCT00541970|1108769|P3|COMPLETED|Month 18||215
464839|NCT00541970|1108770|P2|COMPLETED|Month 18||217
464840|NCT00541970|1108771|P1|COMPLETED|Month 18||226
464841|NCT00541970|1108768|P4|STARTED|Month 18||239
464842|NCT00541970|1108769|P3|STARTED|Month 18||240
464843|NCT00541970|1108770|P2|STARTED|Month 18||241
464844|NCT00541970|1108771|P1|STARTED|Month 18||240
464845|NCT00541970|1108768|P4|NOT COMPLETED|Month 12||16
464846|NCT00541970|1108769|P3|NOT COMPLETED|Month 12||21
464847|NCT00541970|1108770|P2|NOT COMPLETED|Month 12||22
464848|NCT00541970|1108771|P1|NOT COMPLETED|Month 12||12
464849|NCT00541970|1108768|P4|COMPLETED|Month 12||223
464850|NCT00541970|1108769|P3|COMPLETED|Month 12||219
464851|NCT00541970|1108770|P2|COMPLETED|Month 12||219
464852|NCT00541970|1108771|P1|COMPLETED|Month 12||228
464853|NCT00541970|1108768|P4|STARTED|Month 12||239
464854|NCT00541970|1108769|P3|STARTED|Month 12||240
464855|NCT00541970|1108770|P2|STARTED|Month 12||241
464856|NCT00541970|1108771|P1|STARTED|Month 12||240
464857|NCT00541970|1108768|P4|NOT COMPLETED|Month 7||5
464858|NCT00541970|1108769|P3|NOT COMPLETED|Month 7||11
464859|NCT00541970|1108770|P2|NOT COMPLETED|Month 7||13
464860|NCT00541970|1108771|P1|NOT COMPLETED|Month 7||9
464861|NCT00541970|1108768|P4|COMPLETED|Month 7||234
464862|NCT00541970|1108769|P3|COMPLETED|Month 7||229
464863|NCT00541970|1108770|P2|COMPLETED|Month 7||228
464864|NCT00541970|1108771|P1|COMPLETED|Month 7||231
464865|NCT00541970|1108768|P4|STARTED|Month 7||239
464866|NCT00541970|1108769|P3|STARTED|Month 7||240
464867|NCT00541970|1108770|P2|STARTED|Month 7||241
464868|NCT00541970|1108771|P1|STARTED|Month 7||240
464869|NCT00541775|1108923|P3|NOT COMPLETED|Overall Study||8
464870|NCT00541775|1108924|P2|NOT COMPLETED|Overall Study||2
464871|NCT00541775|1108925|P1|NOT COMPLETED|Overall Study||9
464872|NCT00541775|1108923|P3|COMPLETED|Overall Study||84
464873|NCT00541775|1108924|P2|COMPLETED|Overall Study||85
464874|NCT00541775|1108925|P1|COMPLETED|Overall Study||85
464875|NCT00541775|1108923|P3|STARTED|Overall Study||92
464876|NCT00541775|1108924|P2|STARTED|Overall Study||87
464877|NCT00541775|1108925|P1|STARTED|Overall Study||94
464878|NCT00541671|1108941|P2|NOT COMPLETED|Overall Study||0
464879|NCT00541671|1108942|P1|NOT COMPLETED|Overall Study||0
464880|NCT00541671|1108941|P2|COMPLETED|Overall Study||12
464881|NCT00541671|1108942|P1|COMPLETED|Overall Study||13
464882|NCT00541671|1108941|P2|STARTED|Overall Study||12
464883|NCT00541671|1108942|P1|STARTED|Overall Study||13
464884|NCT00541658|1108951|P3|NOT COMPLETED|Overall Study||68
464885|NCT00541658|1108952|P2|NOT COMPLETED|Overall Study||73
464886|NCT00541658|1108953|P1|NOT COMPLETED|Overall Study||60
464887|NCT00541658|1108951|P3|COMPLETED|Overall Study||240
464888|NCT00541658|1108952|P2|COMPLETED|Overall Study||234
464889|NCT00541658|1108953|P1|COMPLETED|Overall Study||248
464890|NCT00541658|1108951|P3|ITT Population|Overall Study||308
464891|NCT00541658|1108952|P2|ITT Population|Overall Study||307
464892|NCT00541658|1108953|P1|ITT Population|Overall Study||307
464893|NCT00541658|1108951|P3|STARTED|Overall Study||308
464894|NCT00541658|1108952|P2|STARTED|Overall Study||307
464895|NCT00541658|1108953|P1|STARTED|Overall Study||308
464896|NCT00541593|1109110|P1|NOT COMPLETED|Overall Study||0
464897|NCT00541593|1109110|P1|COMPLETED|Overall Study||5
464898|NCT00541593|1109110|P1|STARTED|Overall Study||5
464899|NCT00541450|1109116|P2|NOT COMPLETED|Phase B||31
464900|NCT00541450|1109117|P1|NOT COMPLETED|Phase B||37
464901|NCT00541450|1109116|P2|COMPLETED|Phase B||200
464902|NCT00541450|1109117|P1|COMPLETED|Phase B||187
464903|NCT00541450|1109116|P2|STARTED|Phase B||231
464904|NCT00541450|1109117|P1|STARTED|Phase B||224
464905|NCT00541450|1109116|P2|NOT COMPLETED|Phase A||17
464906|NCT00541450|1109117|P1|NOT COMPLETED|Phase A||20
464907|NCT00541450|1109116|P2|COMPLETED|Phase A||231
464908|NCT00541450|1109117|P1|COMPLETED|Phase A||224
464909|NCT00541450|1109116|P2|STARTED|Phase A||248
464910|NCT00541450|1109117|P1|STARTED|Phase A||244
464911|NCT00541346|1109135|P1|NOT COMPLETED|Follow-up||1
464912|NCT00541346|1109135|P1|COMPLETED|Follow-up||15
464913|NCT00541346|1109135|P1|STARTED|Follow-up||16
464914|NCT00541346|1109135|P1|NOT COMPLETED|Baseline||0
464915|NCT00541346|1109135|P1|COMPLETED|Baseline||16
464916|NCT00541346|1109135|P1|STARTED|Baseline||16
464917|NCT00541307|1109149|P1|NOT COMPLETED|Overall Study||24
464918|NCT00541307|1109149|P1|COMPLETED|Overall Study||95
464919|NCT00541307|1109149|P1|STARTED|Overall Study||119
464920|NCT00541242|1109159|P2|NOT COMPLETED|Treatment Period 2||7
464921|NCT00541242|1109160|P1|NOT COMPLETED|Treatment Period 2||9
464922|NCT00541242|1109159|P2|COMPLETED|Treatment Period 2||266
464923|NCT00541242|1109160|P1|COMPLETED|Treatment Period 2||261
464924|NCT00541242|1109159|P2|STARTED|Treatment Period 2||273
464925|NCT00541242|1109160|P1|STARTED|Treatment Period 2||270
464926|NCT00541242|1109159|P2|NOT COMPLETED|Treatment Period 1||0
464927|NCT00541242|1109160|P1|NOT COMPLETED|Treatment Period 1||0
464928|NCT00541242|1109159|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
464929|NCT00541242|1109160|P1|COMPLETED|Treatment Period 1||0
464930|NCT00541242|1109159|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
464931|NCT00541242|1109160|P1|STARTED|Treatment Period 1||0
464932|NCT00541229|1109174|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
464933|NCT00541229|1109175|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
464934|NCT00541229|1109176|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
464935|NCT00541229|1109177|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
464936|NCT00541229|1109178|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
464937|NCT00541229|1109179|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
464938|NCT00541229|1109174|P6|COMPLETED|Treatment Period III (Week 11)||4
464939|NCT00541229|1109175|P5|COMPLETED|Treatment Period III (Week 11)||6
464940|NCT00541229|1109176|P4|COMPLETED|Treatment Period III (Week 11)||8
464941|NCT00541229|1109177|P3|COMPLETED|Treatment Period III (Week 11)||9
464942|NCT00541229|1109178|P2|COMPLETED|Treatment Period III (Week 11)||8
464943|NCT00541229|1109179|P1|COMPLETED|Treatment Period III (Week 11)||7
464944|NCT00541229|1109174|P6|STARTED|Treatment Period III (Week 11)||5
464945|NCT00541229|1109175|P5|STARTED|Treatment Period III (Week 11)||7
464946|NCT00541229|1109176|P4|STARTED|Treatment Period III (Week 11)||8
464947|NCT00541229|1109177|P3|STARTED|Treatment Period III (Week 11)||10
464948|NCT00541229|1109178|P2|STARTED|Treatment Period III (Week 11)||8
464949|NCT00541229|1109179|P1|STARTED|Treatment Period III (Week 11)||7
464950|NCT00541229|1109174|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
464951|NCT00541229|1109175|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
464952|NCT00541229|1109176|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
464953|NCT00541229|1109177|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
464954|NCT00541229|1109178|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
464955|NCT00541229|1109179|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
464956|NCT00541229|1109174|P6|COMPLETED|Washout Period II (Week 7-10)||5
464957|NCT00541229|1109175|P5|COMPLETED|Washout Period II (Week 7-10)||7
464958|NCT00541229|1109176|P4|COMPLETED|Washout Period II (Week 7-10)||8
464959|NCT00541229|1109177|P3|COMPLETED|Washout Period II (Week 7-10)||10
464960|NCT00541229|1109178|P2|COMPLETED|Washout Period II (Week 7-10)||8
464961|NCT00541229|1109179|P1|COMPLETED|Washout Period II (Week 7-10)||7
464962|NCT00541229|1109174|P6|STARTED|Washout Period II (Week 7-10)||8
464963|NCT00541229|1109175|P5|STARTED|Washout Period II (Week 7-10)||11
464964|NCT00541229|1109176|P4|STARTED|Washout Period II (Week 7-10)||12
464965|NCT00541229|1109177|P3|STARTED|Washout Period II (Week 7-10)||12
464966|NCT00541229|1109178|P2|STARTED|Washout Period II (Week 7-10)||12
464967|NCT00541229|1109179|P1|STARTED|Washout Period II (Week 7-10)||11
464968|NCT00541229|1109174|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
464969|NCT00541229|1109175|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
464970|NCT00541229|1109176|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
464971|NCT00541229|1109177|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
464972|NCT00541229|1109178|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
464973|NCT00541229|1109179|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
464974|NCT00541229|1109174|P6|COMPLETED|Treatment Period II (Week 6)||8
464975|NCT00541229|1109175|P5|COMPLETED|Treatment Period II (Week 6)||11
464976|NCT00541229|1109176|P4|COMPLETED|Treatment Period II (Week 6)||12
464977|NCT00541229|1109177|P3|COMPLETED|Treatment Period II (Week 6)||12
464978|NCT00541229|1109178|P2|COMPLETED|Treatment Period II (Week 6)||12
464979|NCT00541229|1109179|P1|COMPLETED|Treatment Period II (Week 6)||11
464980|NCT00541229|1109174|P6|STARTED|Treatment Period II (Week 6)||11
464981|NCT00541229|1109175|P5|STARTED|Treatment Period II (Week 6)||13
464982|NCT00541229|1109176|P4|STARTED|Treatment Period II (Week 6)||13
464983|NCT00541229|1109177|P3|STARTED|Treatment Period II (Week 6)||13
464984|NCT00541229|1109178|P2|STARTED|Treatment Period II (Week 6)||13
464985|NCT00541229|1109179|P1|STARTED|Treatment Period II (Week 6)||13
464986|NCT00541229|1109174|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
464987|NCT00541229|1109175|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
464988|NCT00541229|1109176|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
464989|NCT00541229|1109177|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
464990|NCT00541229|1109178|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
464991|NCT00541229|1109179|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
464992|NCT00541229|1109174|P6|COMPLETED|Washout Period I (Week 2-5)||11
464993|NCT00541229|1109175|P5|COMPLETED|Washout Period I (Week 2-5)||13
464994|NCT00541229|1109176|P4|COMPLETED|Washout Period I (Week 2-5)||13
464995|NCT00541229|1109177|P3|COMPLETED|Washout Period I (Week 2-5)||13
464996|NCT00541229|1109178|P2|COMPLETED|Washout Period I (Week 2-5)||13
464997|NCT00541229|1109179|P1|COMPLETED|Washout Period I (Week 2-5)||13
464998|NCT00541229|1109174|P6|STARTED|Washout Period I (Week 2-5)||16
464999|NCT00541229|1109175|P5|STARTED|Washout Period I (Week 2-5)||14
465000|NCT00541229|1109176|P4|STARTED|Washout Period I (Week 2-5)||17
465001|NCT00541229|1109177|P3|STARTED|Washout Period I (Week 2-5)||17
465002|NCT00541229|1109178|P2|STARTED|Washout Period I (Week 2-5)||15
465003|NCT00541229|1109179|P1|STARTED|Washout Period I (Week 2-5)||17
465004|NCT00541229|1109174|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
465005|NCT00541229|1109175|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
465006|NCT00541229|1109176|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
465007|NCT00541229|1109177|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
465008|NCT00541229|1109178|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
465009|NCT00541229|1109179|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
465010|NCT00541229|1109174|P6|COMPLETED|Treatment Period I (Week 1)||16
465011|NCT00541229|1109175|P5|COMPLETED|Treatment Period I (Week 1)||14
465012|NCT00541229|1109176|P4|COMPLETED|Treatment Period I (Week 1)||17
465013|NCT00541229|1109177|P3|COMPLETED|Treatment Period I (Week 1)||17
465014|NCT00541229|1109178|P2|COMPLETED|Treatment Period I (Week 1)||15
465015|NCT00541229|1109179|P1|COMPLETED|Treatment Period I (Week 1)||17
465016|NCT00541229|1109174|P6|STARTED|Treatment Period I (Week 1)||18
465017|NCT00541229|1109175|P5|STARTED|Treatment Period I (Week 1)||14
465018|NCT00541229|1109176|P4|STARTED|Treatment Period I (Week 1)||18
465019|NCT00541229|1109177|P3|STARTED|Treatment Period I (Week 1)||20
465020|NCT00541229|1109178|P2|STARTED|Treatment Period I (Week 1)||16
465021|NCT00541229|1109179|P1|STARTED|Treatment Period I (Week 1)||17
465022|NCT00541190|1109189|P2|NOT COMPLETED|Overall Study||0
465023|NCT00541190|1109190|P1|NOT COMPLETED|Overall Study||0
465024|NCT00541190|1109189|P2|COMPLETED|Overall Study||11
465025|NCT00541190|1109190|P1|COMPLETED|Overall Study||10
465026|NCT00541190|1109189|P2|STARTED|Overall Study||11
465027|NCT00541190|1109190|P1|STARTED|Overall Study||10
465028|NCT00541099|1109198|P1|NOT COMPLETED|Overall Study||3
465029|NCT00541099|1109198|P1|COMPLETED|Overall Study||8
465030|NCT00541099|1109198|P1|STARTED|Overall Study||11
465031|NCT00541034|1109202|P1|NOT COMPLETED|Overall Study||3
465032|NCT00541034|1109202|P1|COMPLETED|Overall Study||46
465033|NCT00541034|1109202|P1|STARTED|Overall Study||49
465034|NCT00540969|1109208|P2|NOT COMPLETED|Overall Study||0
465035|NCT00540969|1109209|P1|NOT COMPLETED|Overall Study||0
465036|NCT00540969|1109208|P2|COMPLETED|Overall Study||1
465037|NCT00540969|1109209|P1|COMPLETED|Overall Study||2
465038|NCT00540969|1109208|P2|STARTED|Overall Study||1
465039|NCT00540969|1109209|P1|STARTED|Overall Study||2
465040|NCT00540644|1109221|P2|NOT COMPLETED|Overall Study||9
465041|NCT00540644|1109222|P1|NOT COMPLETED|Overall Study||9
465042|NCT00540644|1109221|P2|COMPLETED|Overall Study||13
465043|NCT00540644|1109222|P1|COMPLETED|Overall Study||39
465044|NCT00540644|1109221|P2|STARTED|Overall Study||22
465045|NCT00540644|1109222|P1|STARTED|Overall Study||48
465046|NCT00540592|1109242|P10|NOT COMPLETED|Overall Study||2
465047|NCT00540592|1109243|P9|NOT COMPLETED|Overall Study||1
465048|NCT00540592|1109244|P8|NOT COMPLETED|Overall Study||1
465049|NCT00540592|1109245|P7|NOT COMPLETED|Overall Study||0
465050|NCT00540592|1109246|P6|NOT COMPLETED|Overall Study||0
465051|NCT00540592|1109247|P5|NOT COMPLETED|Overall Study||1
465052|NCT00540592|1109248|P4|NOT COMPLETED|Overall Study||1
465053|NCT00540592|1109249|P3|NOT COMPLETED|Overall Study||1
465054|NCT00540592|1109250|P2|NOT COMPLETED|Overall Study||1
465055|NCT00540592|1109251|P1|NOT COMPLETED|Overall Study||2
465056|NCT00540592|1109242|P10|COMPLETED|Overall Study||201
465057|NCT00540592|1109243|P9|COMPLETED|Overall Study||199
465058|NCT00540592|1109244|P8|COMPLETED|Overall Study||198
465059|NCT00540592|1109245|P7|COMPLETED|Overall Study||198
465060|NCT00540592|1109246|P6|COMPLETED|Overall Study||198
465061|NCT00540592|1109247|P5|COMPLETED|Overall Study||198
465062|NCT00540592|1109248|P4|COMPLETED|Overall Study||201
465063|NCT00540592|1109249|P3|COMPLETED|Overall Study||201
465064|NCT00540592|1109250|P2|COMPLETED|Overall Study||201
465065|NCT00540592|1109251|P1|COMPLETED|Overall Study||202
465066|NCT00540592|1109242|P10|Completed at Day 180|Overall Study||189
465067|NCT00540592|1109243|P9|Completed at Day 180|Overall Study||198
465068|NCT00540592|1109244|P8|Completed at Day 180|Overall Study||193
465069|NCT00540592|1109245|P7|Completed at Day 180|Overall Study||196
465070|NCT00540592|1109246|P6|Completed at Day 180|Overall Study||198
465071|NCT00540592|1109247|P5|Completed at Day 180|Overall Study||195
465072|NCT00540592|1109248|P4|Completed at Day 180|Overall Study||197
465073|NCT00540592|1109249|P3|Completed at Day 180|Overall Study||197
465074|NCT00540592|1109250|P2|Completed at Day 180|Overall Study||201
465075|NCT00540592|1109251|P1|Completed at Day 180|Overall Study||200
465076|NCT00540592|1109242|P10|STARTED|Overall Study||203
465077|NCT00540592|1109243|P9|STARTED|Overall Study||200
465078|NCT00540592|1109244|P8|STARTED|Overall Study||199
465079|NCT00540592|1109245|P7|STARTED|Overall Study||198
465080|NCT00540592|1109246|P6|STARTED|Overall Study||198
465081|NCT00540592|1109247|P5|STARTED|Overall Study||199
465082|NCT00540592|1109248|P4|STARTED|Overall Study||202
465083|NCT00540592|1109249|P3|STARTED|Overall Study||202
465084|NCT00540592|1109250|P2|STARTED|Overall Study||202
465085|NCT00540592|1109251|P1|STARTED|Overall Study||204
465086|NCT00540579|1109483|P1|NOT COMPLETED|Overall Study||0
465087|NCT00540579|1109483|P1|COMPLETED|Overall Study||23
465088|NCT00540579|1109483|P1|STARTED|Overall Study||23
465089|NCT00540514|1109490|P2|NOT COMPLETED|Overall Study||266
465090|NCT00540514|1109491|P1|NOT COMPLETED|Overall Study||246
465091|NCT00540514|1109490|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
465092|NCT00540514|1109491|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
465093|NCT00540514|1109490|P2|Biomarker Population|Overall Study||36
465094|NCT00540514|1109491|P1|Biomarker Population|Overall Study||35
465095|NCT00540514|1109490|P2|Treated|Overall Study||524
465096|NCT00540514|1109491|P1|Treated|Overall Study||514
465097|NCT00540514|1109490|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
465098|NCT00540514|1109491|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
465099|NCT00540449|1109523|P2|NOT COMPLETED|Overall Study||78
465100|NCT00540449|1109524|P1|NOT COMPLETED|Overall Study||84
465101|NCT00540449|1109523|P2|COMPLETED|Overall Study||266
465102|NCT00540449|1109524|P1|COMPLETED|Overall Study||262
465103|NCT00540449|1109523|P2|STARTED|Overall Study||344
465104|NCT00540449|1109524|P1|STARTED|Overall Study||346
465105|NCT00540436|1109546|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
465106|NCT00540436|1109546|P1|COMPLETED|Second 12-Week Treatment Period||21
465107|NCT00540436|1109546|P1|STARTED|Second 12-Week Treatment Period||22
465108|NCT00540436|1109546|P1|NOT COMPLETED|First 12-Week Treatment Period||3
465109|NCT00540436|1109546|P1|COMPLETED|First 12-Week Treatment Period||22
465110|NCT00540436|1109546|P1|STARTED|First 12-Week Treatment Period||25
465111|NCT00540423|1109561|P3|NOT COMPLETED|Open-Label Treatment Period||2
465112|NCT00540423|1109562|P2|NOT COMPLETED|Open-Label Treatment Period||0
465113|NCT00540423|1109563|P1|NOT COMPLETED|Open-Label Treatment Period||0
465114|NCT00540423|1109561|P3|COMPLETED|Open-Label Treatment Period||20
465115|NCT00540423|1109562|P2|COMPLETED|Open-Label Treatment Period||0
465116|NCT00540423|1109563|P1|COMPLETED|Open-Label Treatment Period||0
465117|NCT00540423|1109561|P3|STARTED|Open-Label Treatment Period||22
465118|NCT00540423|1109562|P2|STARTED|Open-Label Treatment Period||0
465119|NCT00540423|1109563|P1|STARTED|Open-Label Treatment Period||0
465120|NCT00540423|1109561|P3|NOT COMPLETED|Double-Blind Treatment Period||0
465121|NCT00540423|1109562|P2|NOT COMPLETED|Double-Blind Treatment Period||1
465122|NCT00540423|1109563|P1|NOT COMPLETED|Double-Blind Treatment Period||0
465123|NCT00540423|1109561|P3|COMPLETED|Double-Blind Treatment Period||0
465124|NCT00540423|1109562|P2|COMPLETED|Double-Blind Treatment Period||14
465125|NCT00540423|1109563|P1|COMPLETED|Double-Blind Treatment Period||8
465126|NCT00540423|1109561|P3|STARTED|Double-Blind Treatment Period||0
465127|NCT00540423|1109562|P2|STARTED|Double-Blind Treatment Period||15
465128|NCT00540423|1109563|P1|STARTED|Double-Blind Treatment Period||8
465129|NCT00540293|1109613|P1|NOT COMPLETED|Overall Study||35
465130|NCT00540293|1109613|P1|COMPLETED|Overall Study||390
465131|NCT00540293|1109613|P1|STARTED|Overall Study||425
465132|NCT00540228|1109661|P5|NOT COMPLETED|Overall Study||0
465133|NCT00540228|1109662|P4|NOT COMPLETED|Overall Study||0
465134|NCT00540228|1109663|P3|NOT COMPLETED|Overall Study||0
465135|NCT00540228|1109664|P2|NOT COMPLETED|Overall Study||1
465136|NCT00540228|1109665|P1|NOT COMPLETED|Overall Study||3
465137|NCT00540228|1109661|P5|COMPLETED|Overall Study||202
465138|NCT00540228|1109662|P4|COMPLETED|Overall Study||202
465139|NCT00540228|1109663|P3|COMPLETED|Overall Study||204
465140|NCT00540228|1109664|P2|COMPLETED|Overall Study||197
465141|NCT00540228|1109665|P1|COMPLETED|Overall Study||197
465142|NCT00540228|1109661|P5|STARTED|Overall Study||202
465143|NCT00540228|1109662|P4|STARTED|Overall Study||202
465144|NCT00540228|1109663|P3|STARTED|Overall Study||204
465145|NCT00540228|1109664|P2|STARTED|Overall Study||198
465146|NCT00540228|1109665|P1|STARTED|Overall Study||200
465147|NCT00540124|1109735|P3|NOT COMPLETED|Overall Study||1
465148|NCT00540124|1109736|P2|NOT COMPLETED|Overall Study||3
465149|NCT00540124|1109737|P1|NOT COMPLETED|Overall Study||4
465150|NCT00540124|1109735|P3|COMPLETED|Overall Study||48
465151|NCT00540124|1109736|P2|COMPLETED|Overall Study||48
465152|NCT00540124|1109737|P1|COMPLETED|Overall Study||47
465153|NCT00540124|1109735|P3|STARTED|Overall Study||49
465154|NCT00540124|1109736|P2|STARTED|Overall Study||51
465155|NCT00540124|1109737|P1|STARTED|Overall Study||51
465156|NCT00540046|1109783|P2|NOT COMPLETED|Overall Study||23
465157|NCT00540046|1109784|P1|NOT COMPLETED|Overall Study||33
465158|NCT00540046|1109783|P2|COMPLETED|Overall Study||88
465159|NCT00540046|1109784|P1|COMPLETED|Overall Study||71
465160|NCT00540046|1109783|P2|STARTED|Overall Study||111
465161|NCT00540046|1109784|P1|STARTED|Overall Study||104
465162|NCT00539994|1109795|P3|NOT COMPLETED|Overall Study||2
465163|NCT00539994|1109796|P2|NOT COMPLETED|Overall Study||1
465164|NCT00539994|1109797|P1|NOT COMPLETED|Overall Study||3
465165|NCT00539994|1109795|P3|COMPLETED|Overall Study||13
465166|NCT00539994|1109796|P2|COMPLETED|Overall Study||18
465167|NCT00539994|1109797|P1|COMPLETED|Overall Study||20
465168|NCT00539994|1109795|P3|STARTED|Overall Study||15
465169|NCT00539994|1109796|P2|STARTED|Overall Study||19
465170|NCT00539994|1109797|P1|STARTED|Overall Study||23
465171|NCT00539942|1109836|P2|NOT COMPLETED|Overall Study||0
465172|NCT00539942|1109837|P1|NOT COMPLETED|Overall Study||0
465173|NCT00539942|1109836|P2|COMPLETED|Overall Study||3
465174|NCT00539942|1109837|P1|COMPLETED|Overall Study||4
465175|NCT00539942|1109836|P2|STARTED|Overall Study||3
465176|NCT00539942|1109837|P1|STARTED|Overall Study||4
465177|NCT00539864|1109847|P2|NOT COMPLETED|Overall Study||2
465178|NCT00539864|1109848|P1|NOT COMPLETED|Overall Study||1
465179|NCT00539864|1109847|P2|COMPLETED|Overall Study||300
465180|NCT00539864|1109848|P1|COMPLETED|Overall Study||299
465181|NCT00539864|1109847|P2|STARTED|Overall Study||302
465182|NCT00539864|1109848|P1|STARTED|Overall Study||300
465183|NCT00539734|1109860|P1|NOT COMPLETED|Overall Study||1
465184|NCT00539734|1109860|P1|COMPLETED|Overall Study||25
465185|NCT00539734|1109860|P1|STARTED|Overall Study||26
465186|NCT00539695|1109865|P1|NOT COMPLETED|Overall Study||13
465187|NCT00539695|1109865|P1|COMPLETED|Overall Study||12
465188|NCT00539695|1109865|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
465189|NCT00539695|1109865|P1|STARTED|Overall Study||25
465190|NCT00539617|1109869|P1|NOT COMPLETED|Treatment Period||0
465191|NCT00539617|1109869|P1|COMPLETED|Treatment Period||3
465192|NCT00539617|1109869|P1|STARTED|Treatment Period||3
465193|NCT00539617|1109869|P1|NOT COMPLETED|Run-In Period||1
465194|NCT00539617|1109869|P1|COMPLETED|Run-In Period||3
465195|NCT00539617|1109869|P1|STARTED|Run-In Period||4
465196|NCT00539617|1109869|P1|NOT COMPLETED|Pre-screening Period||3
465197|NCT00539617|1109869|P1|COMPLETED|Pre-screening Period||4
465198|NCT00539617|1109869|P1|STARTED|Pre-screening Period||7
465199|NCT00539591|1109877|P3|NOT COMPLETED|Overall Study||3
465200|NCT00539591|1109878|P2|NOT COMPLETED|Overall Study||2
465201|NCT00539591|1109879|P1|NOT COMPLETED|Overall Study||5
465202|NCT00539591|1109877|P3|COMPLETED|Overall Study||1
465203|NCT00539591|1109878|P2|COMPLETED|Overall Study||0
465204|NCT00539591|1109879|P1|COMPLETED|Overall Study||18
465205|NCT00539591|1109877|P3|STARTED|Overall Study||4
465206|NCT00539591|1109878|P2|STARTED|Overall Study||2
465207|NCT00539591|1109879|P1|STARTED|Overall Study||23
465208|NCT00539539|1109989|P2|NOT COMPLETED|Overall Study||0
465209|NCT00539539|1109990|P1|NOT COMPLETED|Overall Study||0
465210|NCT00539539|1109989|P2|COMPLETED|Overall Study||771
465211|NCT00539539|1109990|P1|COMPLETED|Overall Study||815
465212|NCT00539539|1109989|P2|STARTED|Overall Study||771
465213|NCT00539539|1109990|P1|STARTED|Overall Study||815
465214|NCT00539526|1110013|P3|NOT COMPLETED|Overall Study||2
465215|NCT00539526|1110014|P2|NOT COMPLETED|Overall Study||2
465216|NCT00539526|1110015|P1|NOT COMPLETED|Overall Study||3
465217|NCT00539526|1110013|P3|COMPLETED|Overall Study||36
465218|NCT00539526|1110014|P2|COMPLETED|Overall Study||31
465219|NCT00539526|1110015|P1|COMPLETED|Overall Study||32
465220|NCT00539526|1110013|P3|STARTED|Overall Study||38
465221|NCT00539526|1110014|P2|STARTED|Overall Study||33
465222|NCT00539526|1110015|P1|STARTED|Overall Study||35
465223|NCT00539513|1110031|P2|NOT COMPLETED|Overall Study||2
465224|NCT00539513|1110032|P1|NOT COMPLETED|Overall Study||2
465225|NCT00539513|1110031|P2|COMPLETED|Overall Study||3
465226|NCT00539513|1110032|P1|COMPLETED|Overall Study||3
465227|NCT00539513|1110031|P2|Received Allocated Intervention|Overall Study||4
465228|NCT00539513|1110032|P1|Received Allocated Intervention|Overall Study||3
465229|NCT00539513|1110031|P2|STARTED|Overall Study||5
465230|NCT00539513|1110032|P1|STARTED|Overall Study||5
465231|NCT00539305|1110046|P2|NOT COMPLETED|Overall Study||2
465232|NCT00539305|1110047|P1|NOT COMPLETED|Overall Study||1
465233|NCT00539305|1110046|P2|COMPLETED|Overall Study||10
465234|NCT00539305|1110047|P1|COMPLETED|Overall Study||9
465235|NCT00539305|1110046|P2|STARTED|Overall Study||12
465236|NCT00539305|1110047|P1|STARTED|Overall Study||10
465237|NCT00539279|1110061|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
465238|NCT00539279|1110062|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
465239|NCT00539279|1110061|P2|COMPLETED|6-Month Follow-Up Assessment||22
465240|NCT00539279|1110062|P1|COMPLETED|6-Month Follow-Up Assessment||17
465241|NCT00539279|1110061|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
465242|NCT00539279|1110062|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
465243|NCT00539279|1110061|P2|NOT COMPLETED|Post-Treatment Assessment||9
465244|NCT00539279|1110062|P1|NOT COMPLETED|Post-Treatment Assessment||12
465245|NCT00539279|1110061|P2|COMPLETED|Post-Treatment Assessment||29
465246|NCT00539279|1110062|P1|COMPLETED|Post-Treatment Assessment||18
465247|NCT00539279|1110061|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
465248|NCT00539279|1110062|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
465249|NCT00539279|1110061|P2|NOT COMPLETED|Treatment||8
465250|NCT00539279|1110062|P1|NOT COMPLETED|Treatment||11
465251|NCT00539279|1110061|P2|COMPLETED|Treatment||38
465252|NCT00539279|1110062|P1|COMPLETED|Treatment||30
465253|NCT00539279|1110061|P2|STARTED|Treatment||46
465254|NCT00539279|1110062|P1|STARTED|Treatment||41
465255|NCT00539240|1110083|P3|NOT COMPLETED|Overall Study||15
465256|NCT00539240|1110084|P2|NOT COMPLETED|Overall Study||7
465257|NCT00539240|1110085|P1|NOT COMPLETED|Overall Study||6
465258|NCT00539240|1110083|P3|COMPLETED|Overall Study||39
465259|NCT00539240|1110084|P2|COMPLETED|Overall Study||48
465260|NCT00539240|1110085|P1|COMPLETED|Overall Study||53
465261|NCT00539240|1110083|P3|STARTED|Overall Study||54
465262|NCT00539240|1110084|P2|STARTED|Overall Study||55
465263|NCT00539240|1110085|P1|STARTED|Overall Study||59
465264|NCT00539188|1110104|P2|NOT COMPLETED|Overall Study||1
465265|NCT00539188|1110105|P1|NOT COMPLETED|Overall Study||3
465266|NCT00539188|1110104|P2|COMPLETED|Overall Study||1
465267|NCT00539188|1110105|P1|COMPLETED|Overall Study||1
465268|NCT00539188|1110104|P2|Received Allocated Intervention|Overall Study||2
465269|NCT00539188|1110105|P1|Received Allocated Intervention|Overall Study||3
465270|NCT00539188|1110104|P2|STARTED|Overall Study||2
465271|NCT00539188|1110105|P1|STARTED|Overall Study||4
465272|NCT00539110|1110119|P2|NOT COMPLETED|Overall Study||0
465273|NCT00539110|1110120|P1|NOT COMPLETED|Overall Study||0
465274|NCT00539110|1110119|P2|COMPLETED|Overall Study||5
465275|NCT00539110|1110120|P1|COMPLETED|Overall Study||5
465276|NCT00539110|1110119|P2|STARTED|Overall Study||5
465277|NCT00539110|1110120|P1|STARTED|Overall Study||5
465278|NCT00539032|1110128|P2|NOT COMPLETED|Overall Study||1
465279|NCT00539032|1110129|P1|NOT COMPLETED|Overall Study||2
465280|NCT00539032|1110128|P2|COMPLETED|Overall Study||84
465281|NCT00539032|1110129|P1|COMPLETED|Overall Study||151
465282|NCT00539032|1110128|P2|STARTED|Overall Study||85
465283|NCT00539032|1110129|P1|STARTED|Overall Study||153
465284|NCT00539006|1110143|P4|NOT COMPLETED|Post-Study||0
465285|NCT00539006|1110144|P3|NOT COMPLETED|Post-Study||0
465286|NCT00539006|1110145|P2|NOT COMPLETED|Post-Study||0
465287|NCT00539006|1110146|P1|NOT COMPLETED|Post-Study||0
465288|NCT00539006|1110143|P4|COMPLETED|Post-Study||81
465289|NCT00539006|1110144|P3|COMPLETED|Post-Study||77
465290|NCT00539006|1110145|P2|COMPLETED|Post-Study||83
465291|NCT00539006|1110146|P1|COMPLETED|Post-Study||75
465292|NCT00539006|1110143|P4|STARTED|Post-Study||81
465293|NCT00539006|1110144|P3|STARTED|Post-Study||77
465294|NCT00539006|1110145|P2|STARTED|Post-Study||83
465295|NCT00539006|1110146|P1|STARTED|Post-Study||75
465296|NCT00539006|1110143|P4|NOT COMPLETED|Treatment Period 2||0
465297|NCT00539006|1110144|P3|NOT COMPLETED|Treatment Period 2||0
465298|NCT00539006|1110145|P2|NOT COMPLETED|Treatment Period 2||1
465299|NCT00539006|1110146|P1|NOT COMPLETED|Treatment Period 2||1
465300|NCT00539006|1110143|P4|COMPLETED|Treatment Period 2||81
465301|NCT00539006|1110144|P3|COMPLETED|Treatment Period 2||77
465302|NCT00539006|1110145|P2|COMPLETED|Treatment Period 2||83
465303|NCT00539006|1110146|P1|COMPLETED|Treatment Period 2||75
465304|NCT00539006|1110143|P4|STARTED|Treatment Period 2||81
465305|NCT00539006|1110144|P3|STARTED|Treatment Period 2||77
465306|NCT00539006|1110145|P2|STARTED|Treatment Period 2||84
465307|NCT00539006|1110146|P1|STARTED|Treatment Period 2||76
465308|NCT00539006|1110143|P4|NOT COMPLETED|Washout||9
465309|NCT00539006|1110144|P3|NOT COMPLETED|Washout||16
465310|NCT00539006|1110145|P2|NOT COMPLETED|Washout||10
465311|NCT00539006|1110146|P1|NOT COMPLETED|Washout||20
465312|NCT00539006|1110143|P4|COMPLETED|Washout||81
465313|NCT00539006|1110144|P3|COMPLETED|Washout||77
465314|NCT00539006|1110145|P2|COMPLETED|Washout||84
465315|NCT00539006|1110146|P1|COMPLETED|Washout||76
465316|NCT00539006|1110143|P4|STARTED|Washout||90
465317|NCT00539006|1110144|P3|STARTED|Washout||93
465318|NCT00539006|1110145|P2|STARTED|Washout||94
465319|NCT00539006|1110146|P1|STARTED|Washout||96
465320|NCT00539006|1110143|P4|NOT COMPLETED|Treatment Period 1||1
465321|NCT00539006|1110144|P3|NOT COMPLETED|Treatment Period 1||2
465322|NCT00539006|1110145|P2|NOT COMPLETED|Treatment Period 1||0
465323|NCT00539006|1110146|P1|NOT COMPLETED|Treatment Period 1||0
465324|NCT00539006|1110143|P4|COMPLETED|Treatment Period 1||90
465325|NCT00539006|1110144|P3|COMPLETED|Treatment Period 1||93
465326|NCT00539006|1110145|P2|COMPLETED|Treatment Period 1||94
465327|NCT00539006|1110146|P1|COMPLETED|Treatment Period 1||96
465328|NCT00539006|1110143|P4|STARTED|Treatment Period 1||91
465329|NCT00539006|1110144|P3|STARTED|Treatment Period 1||95
465330|NCT00539006|1110145|P2|STARTED|Treatment Period 1||94
465331|NCT00539006|1110146|P1|STARTED|Treatment Period 1||96
465332|NCT00539006|1110143|P4|NOT COMPLETED|Pre-treatment||0
465333|NCT00539006|1110144|P3|NOT COMPLETED|Pre-treatment||0
465334|NCT00539006|1110145|P2|NOT COMPLETED|Pre-treatment||1
465335|NCT00539006|1110146|P1|NOT COMPLETED|Pre-treatment||0
465336|NCT00539006|1110143|P4|COMPLETED|Pre-treatment||91
465337|NCT00539006|1110144|P3|COMPLETED|Pre-treatment||95
465338|NCT00539006|1110145|P2|COMPLETED|Pre-treatment||94
465339|NCT00539006|1110146|P1|COMPLETED|Pre-treatment||96
465340|NCT00539006|1110143|P4|STARTED|Pre-treatment||91
465341|NCT00539006|1110144|P3|STARTED|Pre-treatment||95
465342|NCT00539006|1110145|P2|STARTED|Pre-treatment||95
465343|NCT00539006|1110146|P1|STARTED|Pre-treatment||96
465344|NCT00538915|1110176|P1|NOT COMPLETED|Overall Study||11
465345|NCT00538915|1110176|P1|COMPLETED|Overall Study||52
465346|NCT00538915|1110176|P1|STARTED|Overall Study||63
465347|NCT00538902|1110183|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
465348|NCT00538902|1110184|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
465349|NCT00538902|1110185|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
465350|NCT00538902|1110183|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
465351|NCT00538902|1110184|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
465352|NCT00538902|1110185|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
465353|NCT00538902|1110183|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
465354|NCT00538902|1110184|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
465355|NCT00538902|1110185|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
465356|NCT00538902|1110183|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
465357|NCT00538902|1110184|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
465358|NCT00538902|1110185|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
465359|NCT00538902|1110183|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
465360|NCT00538902|1110184|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
465361|NCT00538902|1110185|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
465362|NCT00538902|1110183|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
465363|NCT00538902|1110184|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
465364|NCT00538902|1110185|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
465365|NCT00538863|1110220|P1|NOT COMPLETED|Open-label Maintenance||106
465366|NCT00538863|1110220|P1|COMPLETED|Open-label Maintenance||163
465367|NCT00538863|1110220|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
465368|NCT00538863|1110220|P1|NOT COMPLETED|Open-label Titration||45
465369|NCT00538863|1110220|P1|COMPLETED|Open-label Titration||184
465370|NCT00538863|1110220|P1|STARTED|Open-label Titration||229
465371|NCT00538850|1110226|P3|NOT COMPLETED|Placebo - Double-blind||3
465372|NCT00538850|1110227|P2|NOT COMPLETED|Placebo - Double-blind||0
465373|NCT00538850|1110228|P1|NOT COMPLETED|Placebo - Double-blind||0
465374|NCT00538850|1110226|P3|COMPLETED|Placebo - Double-blind||95
465375|NCT00538850|1110227|P2|COMPLETED|Placebo - Double-blind||0
465376|NCT00538850|1110228|P1|COMPLETED|Placebo - Double-blind||0
465377|NCT00538850|1110226|P3|STARTED|Placebo - Double-blind||98
465378|NCT00538850|1110227|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
465379|NCT00538850|1110228|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
465380|NCT00538850|1110226|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
465381|NCT00538850|1110227|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
465382|NCT00538850|1110228|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
465383|NCT00538850|1110226|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
465384|NCT00538850|1110227|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
465385|NCT00538850|1110228|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
465386|NCT00538850|1110226|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
465387|NCT00538850|1110227|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
465388|NCT00538850|1110228|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
465389|NCT00538850|1110226|P3|NOT COMPLETED|Titration Period||0
465390|NCT00538850|1110227|P2|NOT COMPLETED|Titration Period||0
465391|NCT00538850|1110228|P1|NOT COMPLETED|Titration Period||32
465392|NCT00538850|1110226|P3|COMPLETED|Titration Period||0
465393|NCT00538850|1110227|P2|COMPLETED|Titration Period||0
465394|NCT00538850|1110228|P1|COMPLETED|Titration Period||98
465395|NCT00538850|1110226|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
465396|NCT00538850|1110227|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
465397|NCT00538850|1110228|P1|STARTED|Titration Period||130
465398|NCT00538824|1110240|P1|NOT COMPLETED|Overall Study||0
465399|NCT00538824|1110240|P1|COMPLETED|Overall Study||5
465400|NCT00538824|1110240|P1|Progression of Disease|Overall Study||2
465401|NCT00538824|1110240|P1|STARTED|Overall Study||5
465402|NCT00538785|1110246|P2|NOT COMPLETED|Overall Study||17
465403|NCT00538785|1110247|P1|NOT COMPLETED|Overall Study||19
465404|NCT00538785|1110246|P2|COMPLETED|Overall Study||595
465405|NCT00538785|1110247|P1|COMPLETED|Overall Study||604
465406|NCT00538785|1110246|P2|STARTED|Overall Study||612
465496|NCT00536913|1110578|P2|NOT COMPLETED|Overall Study||0
465497|NCT00536913|1110579|P1|NOT COMPLETED|Overall Study||0
465407|NCT00538785|1110247|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
465408|NCT00538642|1110270|P2|NOT COMPLETED|Overall Study||5
465409|NCT00538642|1110271|P1|NOT COMPLETED|Overall Study||1
465410|NCT00538642|1110270|P2|COMPLETED|Overall Study||9
465411|NCT00538642|1110271|P1|COMPLETED|Overall Study||9
465412|NCT00538642|1110270|P2|STARTED|Overall Study||14
465413|NCT00538642|1110271|P1|STARTED|Overall Study||10
465414|NCT00538629|1110311|P1|NOT COMPLETED|Overall Study||22
465415|NCT00538629|1110311|P1|COMPLETED|Overall Study||449
465416|NCT00538629|1110311|P1|STARTED|Overall Study||471
465417|NCT00538616|1110358|P2|NOT COMPLETED|Overall Study||0
465418|NCT00538616|1110359|P1|NOT COMPLETED|Overall Study||0
465419|NCT00538616|1110358|P2|COMPLETED|Overall Study||3
465420|NCT00538616|1110359|P1|COMPLETED|Overall Study||5
465421|NCT00538616|1110358|P2|STARTED|Overall Study||3
465422|NCT00538616|1110359|P1|STARTED|Overall Study||5
465423|NCT00538590|1110367|P2|NOT COMPLETED|Overall Study||0
465424|NCT00538590|1110368|P1|NOT COMPLETED|Overall Study||1
465425|NCT00538590|1110367|P2|COMPLETED|Overall Study||10
465426|NCT00538590|1110368|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
465427|NCT00538590|1110367|P2|STARTED|Overall Study||10
465428|NCT00538590|1110368|P1|STARTED|Overall Study||10
465429|NCT00538512|1110385|P3|NOT COMPLETED|Overall Study||13
465430|NCT00538512|1110386|P2|NOT COMPLETED|Overall Study||30
465431|NCT00538512|1110387|P1|NOT COMPLETED|Overall Study||27
465432|NCT00538512|1110385|P3|COMPLETED|Overall Study||312
465433|NCT00538512|1110386|P2|COMPLETED|Overall Study||783
465434|NCT00538512|1110387|P1|COMPLETED|Overall Study||787
465435|NCT00538512|1110385|P3|STARTED|Overall Study||325
465436|NCT00538512|1110386|P2|STARTED|Overall Study||813
465437|NCT00538512|1110387|P1|STARTED|Overall Study||814
465438|NCT00538473|1110397|P2|NOT COMPLETED|Overall Study||0
465439|NCT00538473|1110398|P1|NOT COMPLETED|Overall Study||1
465440|NCT00538473|1110397|P2|COMPLETED|Overall Study||35
465441|NCT00538473|1110398|P1|COMPLETED|Overall Study||32
465442|NCT00538473|1110397|P2|STARTED|Overall Study||35
465443|NCT00538473|1110398|P1|STARTED|Overall Study||33
465444|NCT00538434|1110434|P4|NOT COMPLETED|Overall Study||6
465445|NCT00538434|1110435|P3|NOT COMPLETED|Overall Study||7
465446|NCT00538434|1110436|P2|NOT COMPLETED|Overall Study||11
465447|NCT00538434|1110437|P1|NOT COMPLETED|Overall Study||9
465448|NCT00538434|1110434|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
465449|NCT00538434|1110435|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
465450|NCT00538434|1110436|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
465451|NCT00538434|1110437|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
465452|NCT00538434|1110434|P4|Intent-to-treat (ITT) Population|Overall Study||57
465453|NCT00538434|1110435|P3|Intent-to-treat (ITT) Population|Overall Study||57
465454|NCT00538434|1110436|P2|Intent-to-treat (ITT) Population|Overall Study||57
465455|NCT00538434|1110437|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
465456|NCT00538434|1110434|P4|STARTED|Overall Study||57
465457|NCT00538434|1110435|P3|STARTED|Overall Study||57
465458|NCT00538434|1110436|P2|STARTED|Overall Study||57
465459|NCT00538434|1110437|P1|STARTED|Overall Study||56
465460|NCT00538304|1110461|P2|NOT COMPLETED|Overall Study||5
465461|NCT00538304|1110462|P1|NOT COMPLETED|Overall Study||7
465462|NCT00538304|1110461|P2|COMPLETED|Overall Study||66
465463|NCT00538304|1110462|P1|COMPLETED|Overall Study||144
465464|NCT00538304|1110461|P2|STARTED|Overall Study||71
465465|NCT00538304|1110462|P1|STARTED|Overall Study||151
465466|NCT00538291|1110478|P1|NOT COMPLETED|Overall Study||3
465467|NCT00538291|1110478|P1|COMPLETED|Overall Study||10
465468|NCT00538291|1110478|P1|STARTED|Overall Study||13
465469|NCT00538213|1110485|P3|NOT COMPLETED|Overall Study||0
465470|NCT00538213|1110486|P2|NOT COMPLETED|Overall Study||0
465471|NCT00538213|1110487|P1|NOT COMPLETED|Overall Study||0
465472|NCT00538213|1110485|P3|COMPLETED|Overall Study||38
465473|NCT00538213|1110486|P2|COMPLETED|Overall Study||40
465474|NCT00538213|1110487|P1|COMPLETED|Overall Study||55
465475|NCT00538213|1110485|P3|STARTED|Overall Study||38
465476|NCT00538213|1110486|P2|STARTED|Overall Study||40
465477|NCT00538213|1110487|P1|STARTED|Overall Study||55
465478|NCT00537979|1110536|P2|NOT COMPLETED|Overall Study||20
465479|NCT00537979|1110537|P1|NOT COMPLETED|Overall Study||6
465480|NCT00537979|1110536|P2|COMPLETED|Overall Study||89
465481|NCT00537979|1110537|P1|COMPLETED|Overall Study||32
465482|NCT00537979|1110536|P2|STARTED|Overall Study||109
465483|NCT00537979|1110537|P1|STARTED|Overall Study||38
465484|NCT00537940|1110553|P2|NOT COMPLETED|Overall Study||179
465485|NCT00537940|1110554|P1|NOT COMPLETED|Overall Study||183
465486|NCT00537940|1110553|P2|COMPLETED|Overall Study||62
465487|NCT00537940|1110554|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
465488|NCT00537940|1110553|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
465489|NCT00537940|1110554|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
465490|NCT00537940|1110553|P2|Completed Maintenance Phase|Overall Study||172
465491|NCT00537940|1110554|P1|Completed Maintenance Phase|Overall Study||187
465492|NCT00537940|1110553|P2|Completed Titration Phase|Overall Study||210
465493|NCT00537940|1110554|P1|Completed Titration Phase|Overall Study||213
465494|NCT00537940|1110553|P2|STARTED|Overall Study||241
465495|NCT00537940|1110554|P1|STARTED|Overall Study||241
465498|NCT00536913|1110578|P2|COMPLETED|Overall Study||52
465499|NCT00536913|1110579|P1|COMPLETED|Overall Study||55
465500|NCT00536913|1110578|P2|STARTED|Overall Study||52
465501|NCT00536913|1110579|P1|STARTED|Overall Study||55
465502|NCT00536874|1110601|P1|NOT COMPLETED|Overall Study||4
465503|NCT00536874|1110601|P1|COMPLETED|Overall Study||35
465504|NCT00536874|1110601|P1|STARTED|Overall Study||39
465505|NCT00536809|1110611|P1|NOT COMPLETED|Phase II||2
465506|NCT00536809|1110611|P1|COMPLETED|Phase II||0
465507|NCT00536809|1110611|P1|STARTED|Phase II||2
465508|NCT00536809|1110611|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
465509|NCT00536809|1110611|P1|COMPLETED|Phase I (Dose-finding Phase)||10
465510|NCT00536809|1110611|P1|STARTED|Phase I (Dose-finding Phase)||10
465511|NCT00536744|1110634|P2|NOT COMPLETED|Overall Study||28
465512|NCT00536744|1110635|P1|NOT COMPLETED|Overall Study||29
465513|NCT00536744|1110634|P2|COMPLETED|Overall Study||71
465514|NCT00536744|1110635|P1|COMPLETED|Overall Study||78
465515|NCT00536744|1110634|P2|STARTED|Overall Study||99
465516|NCT00536744|1110635|P1|STARTED|Overall Study||107
465517|NCT00536731|1110644|P3|NOT COMPLETED|Overall Study||5
465518|NCT00536731|1110645|P2|NOT COMPLETED|Overall Study||5
465519|NCT00536731|1110646|P1|NOT COMPLETED|Overall Study||4
465520|NCT00536731|1110644|P3|COMPLETED|Overall Study||238
465521|NCT00536731|1110645|P2|COMPLETED|Overall Study||241
465522|NCT00536731|1110646|P1|COMPLETED|Overall Study||249
465523|NCT00536731|1110644|P3|STARTED|Overall Study||243
465524|NCT00536731|1110645|P2|STARTED|Overall Study||246
465525|NCT00536731|1110646|P1|STARTED|Overall Study||253
465526|NCT00537823|1110692|P2|NOT COMPLETED|Overall Study||0
465527|NCT00537823|1110693|P1|NOT COMPLETED|Overall Study||2
465528|NCT00537823|1110692|P2|COMPLETED|Overall Study||2
465529|NCT00537823|1110693|P1|COMPLETED|Overall Study||5
465530|NCT00537823|1110692|P2|STARTED|Overall Study||2
465531|NCT00537823|1110693|P1|STARTED|Overall Study||7
465532|NCT00537810|1110719|P4|NOT COMPLETED|Overall Study||4
465533|NCT00537810|1110720|P3|NOT COMPLETED|Overall Study||4
465534|NCT00537810|1110721|P2|NOT COMPLETED|Overall Study||13
465535|NCT00537810|1110722|P1|NOT COMPLETED|Overall Study||6
465536|NCT00537810|1110719|P4|COMPLETED|Overall Study||22
465537|NCT00537810|1110720|P3|COMPLETED|Overall Study||21
465538|NCT00537810|1110721|P2|COMPLETED|Overall Study||14
465539|NCT00537810|1110722|P1|COMPLETED|Overall Study||20
465540|NCT00537810|1110719|P4|STARTED|Overall Study||26
465541|NCT00537810|1110720|P3|STARTED|Overall Study||25
465542|NCT00537810|1110721|P2|STARTED|Overall Study||27
465543|NCT00537810|1110722|P1|STARTED|Overall Study||26
465544|NCT00537771|1110738|P2|NOT COMPLETED|Overall Study||61
465545|NCT00537771|1110739|P1|NOT COMPLETED|Overall Study||29
465546|NCT00537771|1110738|P2|COMPLETED|Overall Study||114
465547|NCT00537771|1110739|P1|COMPLETED|Overall Study||149
465548|NCT00537771|1110738|P2|STARTED|Overall Study||175
465549|NCT00537771|1110739|P1|STARTED|Overall Study||178
465550|NCT00537745|1110749|P1|NOT COMPLETED|Overall Study||5
465551|NCT00537745|1110749|P1|COMPLETED|Overall Study||9
465552|NCT00537745|1110749|P1|Began Intervention|Overall Study||11
465553|NCT00537745|1110749|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
465554|NCT00537680|1110757|P3|NOT COMPLETED|Overall Study||0
465555|NCT00537680|1110758|P2|NOT COMPLETED|Overall Study||2
465556|NCT00537680|1110759|P1|NOT COMPLETED|Overall Study||0
465557|NCT00537680|1110757|P3|COMPLETED|Overall Study||24
465558|NCT00537680|1110758|P2|COMPLETED|Overall Study||22
465559|NCT00537680|1110759|P1|COMPLETED|Overall Study||22
465560|NCT00537680|1110757|P3|STARTED|Overall Study||24
465561|NCT00537680|1110758|P2|STARTED|Overall Study||24
465562|NCT00537680|1110759|P1|STARTED|Overall Study||22
465563|NCT00537511|1110767|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
465564|NCT00537511|1110767|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
465565|NCT00537511|1110767|P1|STARTED|Maintenance Phase (Monotherapy)||8
465566|NCT00537511|1110767|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
465567|NCT00537511|1110767|P1|COMPLETED|Recovery Period (Monotherapy)||3
465568|NCT00537511|1110767|P1|STARTED|Recovery Period (Monotherapy)||11
465569|NCT00537511|1110767|P1|NOT COMPLETED|Extension Period (Combination)||6
465570|NCT00537511|1110767|P1|COMPLETED|Extension Period (Combination)||11
465571|NCT00537511|1110767|P1|STARTED|Extension Period (Combination)||17
465572|NCT00537511|1110767|P1|NOT COMPLETED|Treatment Period (Combination)||5
465573|NCT00537511|1110767|P1|COMPLETED|Treatment Period (Combination)||17
465574|NCT00537511|1110767|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
465575|NCT00537511|1110767|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
465576|NCT00537511|1110767|P1|STARTED|Treatment Period (Combination)||22
465577|NCT00537485|1110794|P2|NOT COMPLETED|Overall Study||10
465578|NCT00537485|1110795|P1|NOT COMPLETED|Overall Study||15
465579|NCT00537485|1110794|P2|COMPLETED|Overall Study||80
465580|NCT00537485|1110795|P1|COMPLETED|Overall Study||75
465581|NCT00537485|1110794|P2|STARTED|Overall Study||90
465582|NCT00537485|1110795|P1|STARTED|Overall Study||90
465583|NCT00537407|1110824|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
465584|NCT00537407|1110825|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
465585|NCT00537407|1110826|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
465586|NCT00537407|1110827|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
465587|NCT00537407|1110828|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
465588|NCT00537407|1110824|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
465589|NCT00537407|1110825|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
465590|NCT00537407|1110826|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
465591|NCT00537407|1110827|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
465592|NCT00537407|1110828|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
465593|NCT00537407|1110824|P5|STARTED|Part 2 Weeks 5-48 or 72||10
465594|NCT00537407|1110825|P4|STARTED|Part 2 Weeks 5-48 or 72||10
465595|NCT00537407|1110826|P3|STARTED|Part 2 Weeks 5-48 or 72||11
465596|NCT00537407|1110827|P2|STARTED|Part 2 Weeks 5-48 or 72||9
465597|NCT00537407|1110828|P1|STARTED|Part 2 Weeks 5-48 or 72||10
465598|NCT00537407|1110824|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
465599|NCT00537407|1110825|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
465600|NCT00537407|1110826|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
465601|NCT00537407|1110827|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
465602|NCT00537407|1110828|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
465603|NCT00537407|1110824|P5|COMPLETED|Part 1 Weeks 1-4||10
465604|NCT00537407|1110825|P4|COMPLETED|Part 1 Weeks 1-4||10
465605|NCT00537407|1110826|P3|COMPLETED|Part 1 Weeks 1-4||11
465606|NCT00537407|1110827|P2|COMPLETED|Part 1 Weeks 1-4||9
465607|NCT00537407|1110828|P1|COMPLETED|Part 1 Weeks 1-4||10
465608|NCT00537407|1110824|P5|STARTED|Part 1 Weeks 1-4||10
465609|NCT00537407|1110825|P4|STARTED|Part 1 Weeks 1-4||10
465610|NCT00537407|1110826|P3|STARTED|Part 1 Weeks 1-4||11
465611|NCT00537407|1110827|P2|STARTED|Part 1 Weeks 1-4||9
465612|NCT00537407|1110828|P1|STARTED|Part 1 Weeks 1-4||10
465613|NCT00537394|1110868|P3|NOT COMPLETED|2nd Year of Follow-up||6
465614|NCT00537394|1110869|P2|NOT COMPLETED|2nd Year of Follow-up||9
465615|NCT00537394|1110870|P1|NOT COMPLETED|2nd Year of Follow-up||11
465616|NCT00537394|1110868|P3|COMPLETED|2nd Year of Follow-up||44
465617|NCT00537394|1110869|P2|COMPLETED|2nd Year of Follow-up||159
465618|NCT00537394|1110870|P1|COMPLETED|2nd Year of Follow-up||158
465619|NCT00537394|1110868|P3|STARTED|2nd Year of Follow-up||50
465620|NCT00537394|1110869|P2|STARTED|2nd Year of Follow-up||168
465621|NCT00537394|1110870|P1|STARTED|2nd Year of Follow-up||169
465622|NCT00537394|1110868|P3|NOT COMPLETED|First Year of Follow-up||3
465623|NCT00537394|1110869|P2|NOT COMPLETED|First Year of Follow-up||11
465624|NCT00537394|1110870|P1|NOT COMPLETED|First Year of Follow-up||12
465625|NCT00537394|1110868|P3|COMPLETED|First Year of Follow-up||50
465626|NCT00537394|1110869|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
465627|NCT00537394|1110870|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
465628|NCT00537394|1110868|P3|STARTED|First Year of Follow-up||53
465629|NCT00537394|1110869|P2|STARTED|First Year of Follow-up||179
465630|NCT00537394|1110870|P1|STARTED|First Year of Follow-up||181
465631|NCT00537381|1110906|P2|NOT COMPLETED|Overall Study||62
465632|NCT00537381|1110907|P1|NOT COMPLETED|Overall Study||56
465633|NCT00537381|1110906|P2|COMPLETED|Overall Study||4
465634|NCT00537381|1110907|P1|COMPLETED|Overall Study||9
465635|NCT00537381|1110906|P2|STARTED|Overall Study||66
465636|NCT00537381|1110907|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
465637|NCT00537329|1110927|P1|NOT COMPLETED|Overall Study||26
465638|NCT00537329|1110927|P1|COMPLETED|Overall Study||17
465639|NCT00537329|1110927|P1|STARTED|Overall Study||43
465640|NCT00537316|1110947|P7|NOT COMPLETED|Part 2||2
465641|NCT00537316|1110948|P6|NOT COMPLETED|Part 2||4
465642|NCT00537316|1110949|P5|NOT COMPLETED|Part 2||1
465643|NCT00537316|1110950|P4|NOT COMPLETED|Part 2||3
465644|NCT00537316|1110951|P3|NOT COMPLETED|Part 2||32
465645|NCT00537316|1110952|P2|NOT COMPLETED|Part 2||9
465646|NCT00537316|1110953|P1|NOT COMPLETED|Part 2||26
465647|NCT00537316|1110947|P7|COMPLETED|Part 2||0
465648|NCT00537316|1110948|P6|COMPLETED|Part 2||0
465649|NCT00537316|1110949|P5|COMPLETED|Part 2||1
465650|NCT00537316|1110950|P4|COMPLETED|Part 2||2
465651|NCT00537316|1110951|P3|COMPLETED|Part 2||16
465652|NCT00537316|1110952|P2|COMPLETED|Part 2||1
465653|NCT00537316|1110953|P1|COMPLETED|Part 2||11
465654|NCT00537316|1110947|P7|STARTED|Part 2||2
465655|NCT00537316|1110948|P6|STARTED|Part 2||4
465656|NCT00537316|1110949|P5|STARTED|Part 2||2
465657|NCT00537316|1110950|P4|STARTED|Part 2||5
465658|NCT00537316|1110951|P3|STARTED|Part 2||48
465659|NCT00537316|1110952|P2|STARTED|Part 2||10
465660|NCT00537316|1110953|P1|STARTED|Part 2||37
465661|NCT00537316|1110947|P7|NOT COMPLETED|Part 1||0
465662|NCT00537316|1110948|P6|NOT COMPLETED|Part 1||0
465663|NCT00537316|1110949|P5|NOT COMPLETED|Part 1||0
465664|NCT00537316|1110950|P4|NOT COMPLETED|Part 1||0
465665|NCT00537316|1110951|P3|NOT COMPLETED|Part 1||17
465666|NCT00537316|1110952|P2|NOT COMPLETED|Part 1||27
465667|NCT00537316|1110953|P1|NOT COMPLETED|Part 1||14
465668|NCT00537316|1110947|P7|COMPLETED|Part 1||0
465669|NCT00537316|1110948|P6|COMPLETED|Part 1||0
465670|NCT00537316|1110949|P5|COMPLETED|Part 1||0
465671|NCT00537316|1110950|P4|COMPLETED|Part 1||0
465672|NCT00537316|1110951|P3|COMPLETED|Part 1||63
465673|NCT00537316|1110952|P2|COMPLETED|Part 1||53
465674|NCT00537316|1110953|P1|COMPLETED|Part 1||65
465675|NCT00537316|1110947|P7|STARTED|Part 1||0
465676|NCT00537316|1110948|P6|STARTED|Part 1||0
465677|NCT00537316|1110949|P5|STARTED|Part 1||0
465678|NCT00537316|1110950|P4|STARTED|Part 1||0
465679|NCT00537316|1110951|P3|STARTED|Part 1||80
465680|NCT00537316|1110952|P2|STARTED|Part 1||80
465681|NCT00537316|1110953|P1|STARTED|Part 1||79
465682|NCT00537303|1110980|P2|NOT COMPLETED|Overall Study||25
465683|NCT00537303|1110981|P1|NOT COMPLETED|Overall Study||26
465684|NCT00537303|1110980|P2|COMPLETED|Overall Study||125
465685|NCT00537303|1110981|P1|COMPLETED|Overall Study||120
465686|NCT00537303|1110980|P2|STARTED|Overall Study||150
465687|NCT00537303|1110981|P1|STARTED|Overall Study||146
465688|NCT00537277|1110997|P1|NOT COMPLETED|Overall Study||49
465689|NCT00537277|1110997|P1|COMPLETED|Overall Study||112
465690|NCT00537277|1110997|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
465691|NCT00537277|1110997|P1|STARTED|Overall Study||161
465692|NCT00537238|1111008|P2|NOT COMPLETED|Overall Study||173
465693|NCT00537238|1111009|P1|NOT COMPLETED|Overall Study||174
465694|NCT00537238|1111008|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
465695|NCT00537238|1111009|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
465696|NCT00537238|1111008|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
465697|NCT00537238|1111009|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
465698|NCT00537238|1111008|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
465699|NCT00537238|1111009|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
465700|NCT00537238|1111008|P2|Completed Titration Phase|Overall Study||236
465701|NCT00537238|1111009|P1|Completed Titration Phase|Overall Study||226
465702|NCT00537238|1111008|P2|STARTED|Overall Study||255
465703|NCT00537238|1111009|P1|STARTED|Overall Study||254
465704|NCT00537199|1111029|P1|NOT COMPLETED|Overall Study||1
465705|NCT00537199|1111029|P1|COMPLETED|Overall Study||0
465706|NCT00537199|1111029|P1|STARTED|Overall Study||1
465707|NCT00537095|1111035|P2|NOT COMPLETED|Overall Study||57
465708|NCT00537095|1111036|P1|NOT COMPLETED|Overall Study||51
465709|NCT00537095|1111035|P2|COMPLETED|Overall Study||16
465710|NCT00537095|1111036|P1|COMPLETED|Overall Study||21
465711|NCT00537095|1111035|P2|STARTED|Overall Study||73
465712|NCT00537095|1111036|P1|STARTED|Overall Study||72
465713|NCT00537082|1111051|P3|NOT COMPLETED|Overall Study||6
465714|NCT00537082|1111052|P2|NOT COMPLETED|Overall Study||9
465715|NCT00537082|1111053|P1|NOT COMPLETED|Overall Study||9
465716|NCT00537082|1111051|P3|COMPLETED|Overall Study||51
465717|NCT00537082|1111052|P2|COMPLETED|Overall Study||48
465718|NCT00537082|1111053|P1|COMPLETED|Overall Study||48
465719|NCT00537082|1111051|P3|STARTED|Overall Study||57
465720|NCT00537082|1111052|P2|STARTED|Overall Study||57
465721|NCT00537082|1111053|P1|STARTED|Overall Study||57
465722|NCT00537056|1111070|P1|NOT COMPLETED|12-month Follow-up||0
465723|NCT00537056|1111070|P1|COMPLETED|12-month Follow-up||17
465724|NCT00537056|1111070|P1|STARTED|12-month Follow-up||17
465725|NCT00537056|1111070|P1|NOT COMPLETED|Interim PET/CT||5
465726|NCT00537056|1111070|P1|COMPLETED|Interim PET/CT||12
465727|NCT00537056|1111070|P1|STARTED|Interim PET/CT||17
465728|NCT00537056|1111070|P1|NOT COMPLETED|Baseline PET/CT||0
465729|NCT00537056|1111070|P1|COMPLETED|Baseline PET/CT||17
465730|NCT00537056|1111070|P1|STARTED|Baseline PET/CT||17
465731|NCT00537030|1111082|P1|NOT COMPLETED|Overall Study||16
465732|NCT00537030|1111082|P1|COMPLETED|Overall Study||43
465733|NCT00537030|1111082|P1|STARTED|Overall Study||59
465734|NCT00537017|1111086|P1|NOT COMPLETED|Follow-up Phase||9
465735|NCT00537017|1111086|P1|COMPLETED|Follow-up Phase||126
465736|NCT00537017|1111086|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
465737|NCT00537017|1111086|P1|NOT COMPLETED|Treatment Phase||34
465738|NCT00537017|1111086|P1|COMPLETED|Treatment Phase||106
465739|NCT00537017|1111086|P1|STARTED|Treatment Phase||140
465740|NCT00536991|1111097|P1|NOT COMPLETED|Overall Study||13
465741|NCT00536991|1111097|P1|COMPLETED|Overall Study||38
465742|NCT00536991|1111097|P1|STARTED|Overall Study||51
465743|NCT00536978|1111104|P1|NOT COMPLETED|Overall Study||22
465744|NCT00536978|1111104|P1|COMPLETED|Overall Study||0
465745|NCT00536978|1111104|P1|STARTED|Overall Study||22
465746|NCT00536575|1111108|P1|NOT COMPLETED|Overall Study||2
465747|NCT00536575|1111108|P1|COMPLETED|Overall Study||11
465748|NCT00536575|1111108|P1|STARTED|Overall Study||13
465749|NCT00536510|1111114|P2|NOT COMPLETED|Overall Study||29
465750|NCT00536510|1111115|P1|NOT COMPLETED|Overall Study||82
465751|NCT00536510|1111114|P2|COMPLETED|Overall Study||295
465752|NCT00536510|1111115|P1|COMPLETED|Overall Study||240
465753|NCT00536510|1111114|P2|STARTED|Overall Study||324
465754|NCT00536510|1111115|P1|STARTED|Overall Study||322
465755|NCT00536484|1111125|P2|NOT COMPLETED|Overall Study||56
465756|NCT00536484|1111126|P1|NOT COMPLETED|Overall Study||60
465757|NCT00536484|1111125|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
465758|NCT00536484|1111126|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
465759|NCT00536484|1111125|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
465760|NCT00536484|1111126|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
465761|NCT00536471|1111160|P4|NOT COMPLETED|Overall Study||74
465762|NCT00536471|1111161|P3|NOT COMPLETED|Overall Study||139
465763|NCT00536471|1111162|P2|NOT COMPLETED|Overall Study||84
465764|NCT00536471|1111163|P1|NOT COMPLETED|Overall Study||156
465765|NCT00536471|1111160|P4|COMPLETED|Overall Study||57
465766|NCT00536471|1111161|P3|COMPLETED|Overall Study||122
465767|NCT00536471|1111162|P2|COMPLETED|Overall Study||43
465768|NCT00536471|1111163|P1|COMPLETED|Overall Study||101
465769|NCT00536471|1111160|P4|STARTED|Overall Study||131
465770|NCT00536471|1111161|P3|STARTED|Overall Study||261
465771|NCT00536471|1111162|P2|STARTED|Overall Study||127
465772|NCT00536471|1111163|P1|STARTED|Overall Study||257
465773|NCT00536380|1111408|P3|NOT COMPLETED|Overall Study||10
465774|NCT00536380|1111409|P2|NOT COMPLETED|Overall Study||9
465775|NCT00536380|1111410|P1|NOT COMPLETED|Overall Study||12
465776|NCT00536380|1111408|P3|COMPLETED|Overall Study||94
465777|NCT00536380|1111409|P2|COMPLETED|Overall Study||95
465778|NCT00536380|1111410|P1|COMPLETED|Overall Study||94
465779|NCT00536380|1111408|P3|STARTED|Overall Study||104
465780|NCT00536380|1111409|P2|STARTED|Overall Study||104
465781|NCT00536380|1111410|P1|STARTED|Overall Study||106
465782|NCT00536341|1111420|P2|NOT COMPLETED|Overall Study||11
465783|NCT00536341|1111421|P1|NOT COMPLETED|Overall Study||5
465784|NCT00536341|1111420|P2|COMPLETED|Overall Study||43
465785|NCT00536341|1111421|P1|COMPLETED|Overall Study||5
465786|NCT00536341|1111420|P2|STARTED|Overall Study||54
465787|NCT00536341|1111421|P1|STARTED|Overall Study||10
465788|NCT00536263|1111434|P3|NOT COMPLETED|Overall Study||21
465789|NCT00536263|1111435|P2|NOT COMPLETED|Overall Study||14
465790|NCT00536263|1111436|P1|NOT COMPLETED|Overall Study||11
465791|NCT00536263|1111434|P3|COMPLETED|Overall Study||204
465792|NCT00536263|1111435|P2|COMPLETED|Overall Study||207
465793|NCT00536263|1111436|P1|COMPLETED|Overall Study||214
465794|NCT00536263|1111434|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
465795|NCT00536263|1111435|P2|STARTED|Overall Study||221
465796|NCT00536263|1111436|P1|STARTED|Overall Study||225
465797|NCT00536198|1111476|P2|NOT COMPLETED|Overall Study||39
465798|NCT00536198|1111477|P1|NOT COMPLETED|Overall Study||37
465799|NCT00536198|1111476|P2|COMPLETED|Overall Study||88
465800|NCT00536198|1111477|P1|COMPLETED|Overall Study||88
465801|NCT00536198|1111476|P2|Cycle 6|Overall Study||88
465802|NCT00536198|1111477|P1|Cycle 6|Overall Study||88
465803|NCT00536198|1111476|P2|Cycle 5|Overall Study||85
465804|NCT00536198|1111477|P1|Cycle 5|Overall Study||88
465805|NCT00536198|1111476|P2|Cycle 4|Overall Study||98
465806|NCT00536198|1111477|P1|Cycle 4|Overall Study||95
465807|NCT00536198|1111476|P2|Cycle 3|Overall Study||101
465808|NCT00536198|1111477|P1|Cycle 3|Overall Study||100
465809|NCT00536198|1111476|P2|Cycle 2|Overall Study||112
465810|NCT00536198|1111477|P1|Cycle 2|Overall Study||104
465811|NCT00536198|1111476|P2|Cycle 1|Overall Study||123
465812|NCT00536198|1111477|P1|Cycle 1|Overall Study||110
465813|NCT00536198|1111476|P2|STARTED|Overall Study||127
465814|NCT00536198|1111477|P1|STARTED|Overall Study||125
465815|NCT00536172|1111507|P2|NOT COMPLETED|Overall Study||9
465816|NCT00536172|1111508|P1|NOT COMPLETED|Overall Study||14
465817|NCT00536172|1111507|P2|COMPLETED|Overall Study||65
465818|NCT00536172|1111508|P1|COMPLETED|Overall Study||60
465819|NCT00536172|1111507|P2|STARTED|Overall Study||74
465820|NCT00536172|1111508|P1|STARTED|Overall Study||74
465821|NCT00536120|1111516|P2|NOT COMPLETED|Overall Study||3
465822|NCT00536120|1111517|P1|NOT COMPLETED|Overall Study||6
465823|NCT00536120|1111516|P2|COMPLETED|Overall Study||27
465824|NCT00536120|1111517|P1|COMPLETED|Overall Study||24
465825|NCT00536120|1111516|P2|STARTED|Overall Study||30
465826|NCT00536120|1111517|P1|STARTED|Overall Study||30
465827|NCT00536107|1111531|P2|NOT COMPLETED|Overall Study||6
465828|NCT00536107|1111532|P1|NOT COMPLETED|Overall Study||8
465829|NCT00536107|1111531|P2|COMPLETED|Overall Study||0
465830|NCT00536107|1111532|P1|COMPLETED|Overall Study||0
465831|NCT00536107|1111531|P2|STARTED|Overall Study||6
465832|NCT00536107|1111532|P1|STARTED|Overall Study||8
465833|NCT00535938|1111542|P2|NOT COMPLETED|Overall Study||462
465834|NCT00535938|1111543|P1|NOT COMPLETED|Overall Study||391
465835|NCT00535938|1111542|P2|COMPLETED|Overall Study||404
465836|NCT00535938|1111543|P1|COMPLETED|Overall Study||115
465837|NCT00535938|1111542|P2|STARTED|Overall Study||866
465838|NCT00535938|1111543|P1|STARTED|Overall Study||506
465839|NCT00535873|1111579|P1|NOT COMPLETED|Overall Study||0
465840|NCT00535873|1111579|P1|COMPLETED|Overall Study||60
465841|NCT00535873|1111579|P1|STARTED|Overall Study||60
465842|NCT00535847|1111586|P3|NOT COMPLETED|Overall Study||2
465843|NCT00535847|1111587|P2|NOT COMPLETED|Overall Study||14
465844|NCT00535847|1111588|P1|NOT COMPLETED|Overall Study||22
465845|NCT00535847|1111586|P3|COMPLETED|Overall Study||0
465846|NCT00535847|1111587|P2|COMPLETED|Overall Study||20
465847|NCT00535847|1111588|P1|COMPLETED|Overall Study||59
465848|NCT00535847|1111586|P3|STARTED|Overall Study||2
465849|NCT00535847|1111587|P2|STARTED|Overall Study||34
465850|NCT00535847|1111588|P1|STARTED|Overall Study||81
465851|NCT00535821|1111614|P2|NOT COMPLETED|Overall Study||0
465852|NCT00535821|1111615|P1|NOT COMPLETED|Overall Study||0
465853|NCT00535821|1111614|P2|COMPLETED|Overall Study||3
465854|NCT00535821|1111615|P1|COMPLETED|Overall Study||2
465855|NCT00535821|1111614|P2|STARTED|Overall Study||3
465856|NCT00535821|1111615|P1|STARTED|Overall Study||2
465857|NCT00535782|1111623|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
465858|NCT00535782|1111624|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
465859|NCT00535782|1111625|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
465860|NCT00535782|1111623|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
465861|NCT00535782|1111624|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
465862|NCT00535782|1111625|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
465863|NCT00535782|1111623|P3|STARTED|Part 2: 80-Week Open-label Period||124
465864|NCT00535782|1111624|P2|STARTED|Part 2: 80-Week Open-label Period||0
465865|NCT00535782|1111625|P1|STARTED|Part 2: 80-Week Open-label Period||0
465866|NCT00535782|1111623|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
465867|NCT00535782|1111624|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
465868|NCT00535782|1111625|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
465869|NCT00535782|1111623|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
465870|NCT00535782|1111624|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
465871|NCT00535782|1111625|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
465872|NCT00535782|1111623|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
465873|NCT00535782|1111624|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
465874|NCT00535782|1111625|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
465875|NCT00535782|1111623|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
465876|NCT00535782|1111624|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
465877|NCT00535782|1111625|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
465878|NCT00535782|1111623|P3|STARTED|Part 1: 24-Week Double-blind Period||0
465879|NCT00535782|1111624|P2|STARTED|Part 1: 24-Week Double-blind Period||63
465880|NCT00535782|1111625|P1|STARTED|Part 1: 24-Week Double-blind Period||69
465881|NCT00535769|1111642|P2|NOT COMPLETED|Overall Study||0
465882|NCT00535769|1111643|P1|NOT COMPLETED|Overall Study||0
465883|NCT00535769|1111642|P2|COMPLETED|Overall Study||35
465884|NCT00535769|1111643|P1|COMPLETED|Overall Study||35
465885|NCT00535769|1111642|P2|STARTED|Overall Study||35
465886|NCT00535769|1111643|P1|STARTED|Overall Study||35
465887|NCT00535730|1111654|P2|NOT COMPLETED|Overall Study||7
465888|NCT00535730|1111655|P1|NOT COMPLETED|Overall Study||2
465889|NCT00535730|1111654|P2|COMPLETED|Overall Study||230
465890|NCT00535730|1111655|P1|COMPLETED|Overall Study||234
465891|NCT00535730|1111654|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
465892|NCT00535730|1111655|P1|STARTED|Overall Study||236
465893|NCT00535652|1111672|P1|NOT COMPLETED|Overall Study||3
465894|NCT00535652|1111672|P1|COMPLETED|Overall Study||20
465895|NCT00535652|1111672|P1|STARTED|Overall Study||23
465896|NCT00535587|1111680|P4|NOT COMPLETED|Overall Study||13
465897|NCT00535587|1111681|P3|NOT COMPLETED|Overall Study||8
465898|NCT00535587|1111682|P2|NOT COMPLETED|Overall Study||11
465899|NCT00535587|1111683|P1|NOT COMPLETED|Overall Study||10
465900|NCT00535587|1111680|P4|COMPLETED|Overall Study||41
465901|NCT00535587|1111681|P3|COMPLETED|Overall Study||39
465902|NCT00535587|1111682|P2|COMPLETED|Overall Study||42
465903|NCT00535587|1111683|P1|COMPLETED|Overall Study||43
465904|NCT00535587|1111680|P4|STARTED|Overall Study||54
465905|NCT00535587|1111681|P3|STARTED|Overall Study||47
465906|NCT00535587|1111682|P2|STARTED|Overall Study||53
465907|NCT00535587|1111683|P1|STARTED|Overall Study||53
465908|NCT00535496|1111693|P4|NOT COMPLETED|Overall Study||0
465909|NCT00535496|1111694|P3|NOT COMPLETED|Overall Study||0
465910|NCT00535496|1111695|P2|NOT COMPLETED|Overall Study||2
465911|NCT00535496|1111696|P1|NOT COMPLETED|Overall Study||0
465912|NCT00535496|1111693|P4|COMPLETED|Overall Study||31
465913|NCT00535496|1111694|P3|COMPLETED|Overall Study||30
465914|NCT00535496|1111695|P2|COMPLETED|Overall Study||13
465915|NCT00535496|1111696|P1|COMPLETED|Overall Study||15
465916|NCT00535496|1111693|P4|All-Subjects-Treated (AST) Group|Overall Study||31
465917|NCT00535496|1111694|P3|All-Subjects-Treated (AST) Group|Overall Study||30
465918|NCT00535496|1111695|P2|All-Subjects-Treated (AST) Group|Overall Study||14
465919|NCT00535496|1111696|P1|All-Subjects-Treated (AST) Group|Overall Study||15
465920|NCT00535496|1111693|P4|STARTED|Overall Study||31
465921|NCT00535496|1111694|P3|STARTED|Overall Study||30
465922|NCT00535496|1111695|P2|STARTED|Overall Study||15
465923|NCT00535496|1111696|P1|STARTED|Overall Study||15
465924|NCT00535405|1111716|P5|NOT COMPLETED|Overall Study||16
465925|NCT00535405|1111717|P4|NOT COMPLETED|Overall Study||22
465926|NCT00535405|1111718|P3|NOT COMPLETED|Overall Study||18
465927|NCT00535405|1111719|P2|NOT COMPLETED|Overall Study||26
465928|NCT00535405|1111720|P1|NOT COMPLETED|Overall Study||17
465929|NCT00535405|1111716|P5|COMPLETED|Overall Study||241
465930|NCT00535405|1111717|P4|COMPLETED|Overall Study||235
465931|NCT00535405|1111718|P3|COMPLETED|Overall Study||241
465932|NCT00535405|1111719|P2|COMPLETED|Overall Study||233
465933|NCT00535405|1111720|P1|COMPLETED|Overall Study||240
465934|NCT00535405|1111716|P5|STARTED|Overall Study||257
465935|NCT00535405|1111717|P4|STARTED|Overall Study||257
465936|NCT00535405|1111718|P3|STARTED|Overall Study||259
465937|NCT00535405|1111719|P2|STARTED|Overall Study||259
465938|NCT00535405|1111720|P1|STARTED|Overall Study||257
465939|NCT00535392|1111757|P1|NOT COMPLETED|Overall Study||0
465940|NCT00535392|1111757|P1|COMPLETED|Overall Study||33
465941|NCT00535392|1111757|P1|STARTED|Overall Study||33
465942|NCT00535301|1111765|P2|NOT COMPLETED|Overall Study||5
465943|NCT00535301|1111766|P1|NOT COMPLETED|Overall Study||5
465944|NCT00535301|1111765|P2|COMPLETED|Overall Study||33
465945|NCT00535301|1111766|P1|COMPLETED|Overall Study||33
465946|NCT00535301|1111765|P2|STARTED|Overall Study||38
465947|NCT00535301|1111766|P1|STARTED|Overall Study||38
465948|NCT00535288|1111781|P5|NOT COMPLETED|Overall Study||42
465949|NCT00535288|1111782|P4|NOT COMPLETED|Overall Study||29
465950|NCT00535288|1111783|P3|NOT COMPLETED|Overall Study||33
465951|NCT00535288|1111784|P2|NOT COMPLETED|Overall Study||32
465952|NCT00535288|1111785|P1|NOT COMPLETED|Overall Study||54
465953|NCT00535288|1111781|P5|COMPLETED|Overall Study||116
465954|NCT00535288|1111782|P4|COMPLETED|Overall Study||122
465955|NCT00535288|1111783|P3|COMPLETED|Overall Study||127
465956|NCT00535288|1111784|P2|COMPLETED|Overall Study||130
465957|NCT00535288|1111785|P1|COMPLETED|Overall Study||260
465958|NCT00535288|1111781|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
465959|NCT00535288|1111782|P4|STARTED|Overall Study||151
465960|NCT00535288|1111783|P3|STARTED|Overall Study||160
465961|NCT00535288|1111784|P2|STARTED|Overall Study||162
465962|NCT00535288|1111785|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
465963|NCT00535262|1111862|P1|NOT COMPLETED|Overall Study||3
465964|NCT00535262|1111862|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
465965|NCT00535262|1111862|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
465966|NCT00535223|1111868|P2|NOT COMPLETED|Overall Study||1
465967|NCT00535223|1111869|P1|NOT COMPLETED|Overall Study||4
465968|NCT00535223|1111868|P2|COMPLETED|Overall Study||39
465969|NCT00535223|1111869|P1|COMPLETED|Overall Study||37
465970|NCT00535223|1111868|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
465971|NCT00535223|1111869|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
465972|NCT00535145|1111877|P1|NOT COMPLETED|Phase II||15
465973|NCT00535145|1111877|P1|COMPLETED|Phase II||69
465974|NCT00535145|1111877|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
465975|NCT00535145|1111877|P1|NOT COMPLETED|Phase I||29
465976|NCT00535145|1111877|P1|COMPLETED|Phase I||85
465977|NCT00535145|1111877|P1|STARTED|Phase I||114
465978|NCT00535132|1111889|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
465979|NCT00535132|1111890|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
465980|NCT00535132|1111889|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
465981|NCT00535132|1111890|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
465982|NCT00535132|1111889|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
465983|NCT00535132|1111890|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
465984|NCT00535132|1111889|P2|NOT COMPLETED|Safety Analysis Set||2
465985|NCT00535132|1111890|P1|NOT COMPLETED|Safety Analysis Set||2
465986|NCT00535132|1111889|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
465987|NCT00535132|1111890|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
465988|NCT00535132|1111889|P2|STARTED|Safety Analysis Set||101
465989|NCT00535132|1111890|P1|STARTED|Safety Analysis Set||100
465990|NCT00535132|1111889|P2|NOT COMPLETED|Randomized Population||0
465991|NCT00535132|1111890|P1|NOT COMPLETED|Randomized Population||0
465992|NCT00535132|1111889|P2|COMPLETED|Randomized Population||101
465993|NCT00535132|1111890|P1|COMPLETED|Randomized Population||100
465994|NCT00535132|1111889|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
465995|NCT00535132|1111890|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
465996|NCT00535002|1111948|P8|NOT COMPLETED|Overall Study||0
465997|NCT00535002|1111949|P7|NOT COMPLETED|Overall Study||0
465998|NCT00535002|1111950|P6|NOT COMPLETED|Overall Study||0
465999|NCT00535002|1111951|P5|NOT COMPLETED|Overall Study||0
466000|NCT00535002|1111952|P4|NOT COMPLETED|Overall Study||0
466001|NCT00535002|1111953|P3|NOT COMPLETED|Overall Study||0
466002|NCT00535002|1111954|P2|NOT COMPLETED|Overall Study||0
466003|NCT00535002|1111955|P1|NOT COMPLETED|Overall Study||0
466004|NCT00535002|1111948|P8|COMPLETED|Overall Study||16
466005|NCT00535002|1111949|P7|COMPLETED|Overall Study||12
466006|NCT00535002|1111950|P6|COMPLETED|Overall Study||17
466007|NCT00535002|1111951|P5|COMPLETED|Overall Study||9
466008|NCT00535002|1111952|P4|COMPLETED|Overall Study||14
466009|NCT00535002|1111953|P3|COMPLETED|Overall Study||13
466010|NCT00535002|1111954|P2|COMPLETED|Overall Study||12
466011|NCT00535002|1111955|P1|COMPLETED|Overall Study||19
466012|NCT00535002|1111948|P8|STARTED|Overall Study||16
466013|NCT00535002|1111949|P7|STARTED|Overall Study||12
466014|NCT00535002|1111950|P6|STARTED|Overall Study||17
466015|NCT00535002|1111951|P5|STARTED|Overall Study||9
466016|NCT00535002|1111952|P4|STARTED|Overall Study||14
466017|NCT00535002|1111953|P3|STARTED|Overall Study||13
466018|NCT00535002|1111954|P2|STARTED|Overall Study||12
466019|NCT00535002|1111955|P1|STARTED|Overall Study||19
466020|NCT00534976|1111971|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
466021|NCT00534976|1111972|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
466022|NCT00534976|1111971|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
466023|NCT00534976|1111972|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
466024|NCT00534976|1111971|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
466025|NCT00534976|1111972|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
466026|NCT00534976|1111971|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
466027|NCT00534976|1111972|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
466028|NCT00534976|1111971|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
466029|NCT00534976|1111972|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
466030|NCT00534976|1111971|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
466031|NCT00534976|1111972|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
466032|NCT00534976|1111971|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
466033|NCT00534976|1111972|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
466034|NCT00534976|1111971|P2|COMPLETED|Period 1: Placebo Run-in||33
466035|NCT00534976|1111972|P1|COMPLETED|Period 1: Placebo Run-in||33
466036|NCT00534976|1111971|P2|STARTED|Period 1: Placebo Run-in||33
466037|NCT00534976|1111972|P1|STARTED|Period 1: Placebo Run-in||33
466038|NCT00534248|1111994|P2|NOT COMPLETED|Overall Study||673
466039|NCT00534248|1111995|P1|NOT COMPLETED|Overall Study||661
466040|NCT00534248|1111994|P2|COMPLETED|Overall Study||10555
466041|NCT00534248|1111995|P1|COMPLETED|Overall Study||10550
466042|NCT00534248|1111994|P2|VACCINATED|Overall Study||11210
466043|NCT00534248|1111995|P1|VACCINATED|Overall Study||11186
466044|NCT00534248|1111994|P2|STARTED|Overall Study||11228
466045|NCT00534248|1111995|P1|STARTED|Overall Study||11211
466046|NCT00534209|1112005|P1|NOT COMPLETED|Overall Study||0
466047|NCT00534209|1112005|P1|COMPLETED|Overall Study||1
466048|NCT00534209|1112005|P1|STARTED|Overall Study||1
466049|NCT00534105|1112011|P2|NOT COMPLETED|Overall Study||39
466050|NCT00534105|1112012|P1|NOT COMPLETED|Overall Study||23
466051|NCT00534105|1112011|P2|COMPLETED|Overall Study||20
466052|NCT00534105|1112012|P1|COMPLETED|Overall Study||24
466053|NCT00534105|1112011|P2|STARTED|Overall Study||59
466054|NCT00534105|1112012|P1|STARTED|Overall Study||47
466055|NCT00534092|1112026|P2|NOT COMPLETED|Overall Study||0
466056|NCT00534092|1112027|P1|NOT COMPLETED|Overall Study||2
466057|NCT00534092|1112026|P2|COMPLETED|Overall Study||14
466058|NCT00534092|1112027|P1|COMPLETED|Overall Study||53
466059|NCT00534092|1112026|P2|STARTED|Overall Study||14
466060|NCT00534092|1112027|P1|STARTED|Overall Study||55
466061|NCT00534937|1112052|P2|NOT COMPLETED|Overall Study||12
466062|NCT00534937|1112053|P1|NOT COMPLETED|Overall Study||8
466063|NCT00534937|1112052|P2|COMPLETED|Overall Study||35
466064|NCT00534937|1112053|P1|COMPLETED|Overall Study||34
466065|NCT00534937|1112052|P2|STARTED|Overall Study||47
466066|NCT00534937|1112053|P1|STARTED|Overall Study||42
466067|NCT00534833|1112067|P2|NOT COMPLETED|Overall Study||0
466068|NCT00534833|1112068|P1|NOT COMPLETED|Overall Study||0
466069|NCT00534833|1112067|P2|COMPLETED|Overall Study||180
466070|NCT00534833|1112068|P1|COMPLETED|Overall Study||182
466071|NCT00534833|1112067|P2|STARTED|Overall Study||180
466072|NCT00534833|1112068|P1|STARTED|Overall Study||182
466073|NCT00534794|1112080|P2|NOT COMPLETED|Overall Study||0
466074|NCT00534794|1112081|P1|NOT COMPLETED|Overall Study||0
466075|NCT00534794|1112080|P2|COMPLETED|Overall Study||39
466076|NCT00534794|1112081|P1|COMPLETED|Overall Study||40
466077|NCT00534794|1112080|P2|STARTED|Overall Study||39
466078|NCT00534794|1112081|P1|STARTED|Overall Study||40
466079|NCT00534638|1112091|P2|NOT COMPLETED|Overall Study||11791
466080|NCT00534638|1112092|P1|NOT COMPLETED|Overall Study||6491
466081|NCT00534638|1112091|P2|COMPLETED|Overall Study||5547
466082|NCT00534638|1112092|P1|COMPLETED|Overall Study||8346
466083|NCT00534638|1112091|P2|STARTED|Overall Study||17338
466084|NCT00534638|1112092|P1|STARTED|Overall Study||14837
466085|NCT00534599|1112127|P2|NOT COMPLETED|Overall Study||32
466086|NCT00534599|1112128|P1|NOT COMPLETED|Overall Study||57
466087|NCT00534599|1112127|P2|COMPLETED|Overall Study||168
466088|NCT00534599|1112128|P1|COMPLETED|Overall Study||152
466089|NCT00534599|1112127|P2|STARTED|Overall Study|Randomized|200
466090|NCT00534599|1112128|P1|STARTED|Overall Study|Randomized|209
466091|NCT00534495|1112164|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
466092|NCT00534495|1112165|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
466093|NCT00534495|1112166|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
466094|NCT00534495|1112164|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
466095|NCT00534495|1112165|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
466096|NCT00534495|1112166|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
466097|NCT00534495|1112164|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
466098|NCT00534495|1112165|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
466099|NCT00534495|1112166|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
466100|NCT00534495|1112164|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
466101|NCT00534495|1112165|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
466102|NCT00534495|1112166|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
466103|NCT00534495|1112164|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
466104|NCT00534495|1112165|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
466105|NCT00534495|1112166|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
466106|NCT00534495|1112164|P3|STARTED|All Active Treatment Phase Week 4-24||0
466107|NCT00534495|1112165|P2|STARTED|All Active Treatment Phase Week 4-24||34
466108|NCT00534495|1112166|P1|STARTED|All Active Treatment Phase Week 4-24||36
466109|NCT00534495|1112164|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
466110|NCT00534495|1112165|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
466111|NCT00534495|1112166|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
466112|NCT00534495|1112164|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
466113|NCT00534495|1112165|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
466114|NCT00534495|1112166|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
466115|NCT00534495|1112164|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
466116|NCT00534495|1112165|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
466117|NCT00534495|1112166|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
466118|NCT00534417|1112189|P1|NOT COMPLETED|Overall Study||0
466119|NCT00534417|1112189|P1|COMPLETED|Overall Study||41
466120|NCT00534417|1112189|P1|STARTED|Overall Study||41
466121|NCT00534404|1112204|P3|NOT COMPLETED|Overall Study||242
466122|NCT00534404|1112205|P2|NOT COMPLETED|Overall Study||143
466123|NCT00534404|1112206|P1|NOT COMPLETED|Overall Study||180
466124|NCT00534404|1112204|P3|COMPLETED|Overall Study||586
466125|NCT00534404|1112205|P2|COMPLETED|Overall Study||687
466126|NCT00534404|1112206|P1|COMPLETED|Overall Study||647
466127|NCT00534404|1112204|P3|3-month Follow up Completed|Overall Study||593
466128|NCT00534404|1112205|P2|3-month Follow up Completed|Overall Study||731
466129|NCT00534404|1112206|P1|3-month Follow up Completed|Overall Study||682
466130|NCT00534404|1112204|P3|1-month Follow up Completed|Overall Study||626
466131|NCT00534404|1112205|P2|1-month Follow up Completed|Overall Study||781
466132|NCT00534404|1112206|P1|1-month Follow up Completed|Overall Study||742
466133|NCT00534404|1112204|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
466134|NCT00534404|1112205|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
466135|NCT00534404|1112206|P1|Completed at Least 1 Counseling Call|Overall Study||813
466136|NCT00534404|1112204|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
466137|NCT00534404|1112205|P2|Completed Second NRT Order|Overall Study||789
466138|NCT00534404|1112206|P1|Completed Second NRT Order|Overall Study||640
466139|NCT00534404|1112204|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
466140|NCT00534404|1112205|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
466141|NCT00534404|1112206|P1|Completed First NRT Order|Overall Study||765
466142|NCT00534404|1112204|P3|Completed at Least 1 Online Session|Overall Study||658
466143|NCT00534404|1112205|P2|Completed at Least 1 Online Session|Overall Study||813
466144|NCT00534404|1112206|P1|Completed at Least 1 Online Session|Overall Study||781
466145|NCT00534404|1112204|P3|STARTED|Overall Study||828
466146|NCT00534404|1112205|P2|STARTED|Overall Study||830
466147|NCT00534404|1112206|P1|STARTED|Overall Study||827
466148|NCT00534365|1112222|P2|NOT COMPLETED|Overall Study||7
466149|NCT00534365|1112223|P1|NOT COMPLETED|Overall Study||0
466150|NCT00534365|1112222|P2|COMPLETED|Overall Study||129
466151|NCT00534365|1112223|P1|COMPLETED|Overall Study||127
466152|NCT00534365|1112222|P2|Included in Intent to Treat Analysis|Overall Study||136
466153|NCT00534365|1112223|P1|Included in Intent to Treat Analysis|Overall Study||127
466154|NCT00534365|1112222|P2|Follow up at 12 Months or More|Overall Study||128
466155|NCT00534365|1112223|P1|Follow up at 12 Months or More|Overall Study||119
466156|NCT00534365|1112222|P2|Any Follow up|Overall Study||135
466157|NCT00534365|1112223|P1|Any Follow up|Overall Study||126
466158|NCT00534365|1112222|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
466159|NCT00534365|1112223|P1|Received Procedure|Overall Study||127
466160|NCT00534365|1112222|P2|STARTED|Overall Study||136
466161|NCT00534365|1112223|P1|STARTED|Overall Study||127
466162|NCT00534352|1112237|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
466163|NCT00534352|1112237|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
466164|NCT00534352|1112237|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
466165|NCT00534352|1112237|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
466166|NCT00534352|1112237|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
466167|NCT00534352|1112237|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
466168|NCT00534352|1112237|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
466169|NCT00534352|1112237|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
466170|NCT00534352|1112237|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
466171|NCT00534352|1112237|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
466172|NCT00534352|1112237|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
466173|NCT00534352|1112237|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
466174|NCT00534313|1112281|P4|NOT COMPLETED|Long-term Period||33
466175|NCT00534313|1112282|P3|NOT COMPLETED|Long-term Period||43
466176|NCT00534313|1112283|P2|NOT COMPLETED|Long-term Period||34
466177|NCT00534313|1112284|P1|NOT COMPLETED|Long-term Period||37
466178|NCT00534313|1112281|P4|COMPLETED|Long-term Period||0
466179|NCT00534313|1112282|P3|COMPLETED|Long-term Period||0
466180|NCT00534313|1112283|P2|COMPLETED|Long-term Period||0
466181|NCT00534313|1112284|P1|COMPLETED|Long-term Period||0
466182|NCT00534313|1112281|P4|STARTED|Long-term Period||33
466183|NCT00534313|1112282|P3|STARTED|Long-term Period||43
466184|NCT00534313|1112283|P2|STARTED|Long-term Period||34
466185|NCT00534313|1112284|P1|STARTED|Long-term Period||37
466186|NCT00534313|1112281|P4|NOT COMPLETED|Short-term Period||9
466187|NCT00534313|1112282|P3|NOT COMPLETED|Short-term Period||2
466188|NCT00534313|1112283|P2|NOT COMPLETED|Short-term Period||6
466189|NCT00534313|1112284|P1|NOT COMPLETED|Short-term Period||6
466190|NCT00534313|1112281|P4|COMPLETED|Short-term Period|Completed the short-term study|33
466191|NCT00534313|1112282|P3|COMPLETED|Short-term Period|Completed the short-term study|43
466192|NCT00534313|1112283|P2|COMPLETED|Short-term Period|Completed the short-term study|34
466193|NCT00534313|1112284|P1|COMPLETED|Short-term Period|Completed the short-term study|37
466194|NCT00534313|1112281|P4|STARTED|Short-term Period||42
466195|NCT00534313|1112282|P3|STARTED|Short-term Period||45
466196|NCT00534313|1112283|P2|STARTED|Short-term Period||40
466197|NCT00534313|1112284|P1|STARTED|Short-term Period||43
466198|NCT00534001|1112379|P2|NOT COMPLETED|Overall Study||4
466199|NCT00534001|1112380|P1|NOT COMPLETED|Overall Study||5
466200|NCT00534001|1112379|P2|COMPLETED|Overall Study||43
466201|NCT00534001|1112380|P1|COMPLETED|Overall Study||43
466202|NCT00534001|1112379|P2|STARTED|Overall Study||47
466203|NCT00534001|1112380|P1|STARTED|Overall Study||48
466204|NCT00533949|1112392|P4|NOT COMPLETED|Overall Study||10
466205|NCT00533949|1112393|P3|NOT COMPLETED|Overall Study||10
466206|NCT00533949|1112394|P2|NOT COMPLETED|Overall Study||14
466207|NCT00533949|1112395|P1|NOT COMPLETED|Overall Study||15
466208|NCT00533949|1112392|P4|COMPLETED|Overall Study||100
466209|NCT00533949|1112393|P3|COMPLETED|Overall Study||137
466210|NCT00533949|1112394|P2|COMPLETED|Overall Study||107
466211|NCT00533949|1112395|P1|COMPLETED|Overall Study||151
466212|NCT00533949|1112392|P4|STARTED|Overall Study||110
466213|NCT00533949|1112393|P3|STARTED|Overall Study||147
466214|NCT00533949|1112394|P2|STARTED|Overall Study||121
466215|NCT00533949|1112395|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
466216|NCT00533897|1112426|P8|NOT COMPLETED|Long Term Extension (LTE)||25
466217|NCT00533897|1112427|P7|NOT COMPLETED|Long Term Extension (LTE)||13
466218|NCT00533897|1112428|P6|NOT COMPLETED|Long Term Extension (LTE)||0
466219|NCT00533897|1112429|P5|NOT COMPLETED|Long Term Extension (LTE)||0
466220|NCT00533897|1112430|P4|NOT COMPLETED|Long Term Extension (LTE)||0
466221|NCT00533897|1112431|P3|NOT COMPLETED|Long Term Extension (LTE)||0
466222|NCT00533897|1112432|P2|NOT COMPLETED|Long Term Extension (LTE)||0
466223|NCT00533897|1112433|P1|NOT COMPLETED|Long Term Extension (LTE)||0
466224|NCT00533897|1112426|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
466225|NCT00533897|1112427|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
466226|NCT00533897|1112428|P6|COMPLETED|Long Term Extension (LTE)||0
466227|NCT00533897|1112429|P5|COMPLETED|Long Term Extension (LTE)||0
466228|NCT00533897|1112430|P4|COMPLETED|Long Term Extension (LTE)||0
466229|NCT00533897|1112431|P3|COMPLETED|Long Term Extension (LTE)||0
466230|NCT00533897|1112432|P2|COMPLETED|Long Term Extension (LTE)||0
466231|NCT00533897|1112433|P1|COMPLETED|Long Term Extension (LTE)||0
466232|NCT00533897|1112426|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
466233|NCT00533897|1112427|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
466234|NCT00533897|1112428|P6|STARTED|Long Term Extension (LTE)||0
466235|NCT00533897|1112429|P5|STARTED|Long Term Extension (LTE)||0
466236|NCT00533897|1112430|P4|STARTED|Long Term Extension (LTE)||0
466237|NCT00533897|1112431|P3|STARTED|Long Term Extension (LTE)||0
466238|NCT00533897|1112432|P2|STARTED|Long Term Extension (LTE)||0
466239|NCT00533897|1112433|P1|STARTED|Long Term Extension (LTE)||0
466240|NCT00533897|1112426|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
466241|NCT00533897|1112427|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
466242|NCT00533897|1112428|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
466243|NCT00533897|1112429|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
466244|NCT00533897|1112430|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
466245|NCT00533897|1112431|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
466246|NCT00533897|1112432|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
466247|NCT00533897|1112433|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
466248|NCT00533897|1112426|P8|COMPLETED|Re-introduction (RI) Period 3||0
466249|NCT00533897|1112427|P7|COMPLETED|Re-introduction (RI) Period 3||0
466250|NCT00533897|1112428|P6|COMPLETED|Re-introduction (RI) Period 3||42
466251|NCT00533897|1112429|P5|COMPLETED|Re-introduction (RI) Period 3||35
466252|NCT00533897|1112430|P4|COMPLETED|Re-introduction (RI) Period 3||40
466253|NCT00533897|1112431|P3|COMPLETED|Re-introduction (RI) Period 3||0
466254|NCT00533897|1112432|P2|COMPLETED|Re-introduction (RI) Period 3||0
466255|NCT00533897|1112433|P1|COMPLETED|Re-introduction (RI) Period 3||0
466256|NCT00533897|1112426|P8|STARTED|Re-introduction (RI) Period 3||0
466257|NCT00533897|1112427|P7|STARTED|Re-introduction (RI) Period 3||0
466258|NCT00533897|1112428|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
466259|NCT00533897|1112429|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
466260|NCT00533897|1112430|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
466261|NCT00533897|1112431|P3|STARTED|Re-introduction (RI) Period 3||0
466262|NCT00533897|1112432|P2|STARTED|Re-introduction (RI) Period 3||0
466263|NCT00533897|1112433|P1|STARTED|Re-introduction (RI) Period 3||0
466264|NCT00533897|1112426|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466265|NCT00533897|1112427|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466266|NCT00533897|1112428|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466267|NCT00533897|1112429|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466268|NCT00533897|1112430|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466269|NCT00533897|1112431|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
466270|NCT00533897|1112432|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
466271|NCT00533897|1112433|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466272|NCT00533897|1112426|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466273|NCT00533897|1112427|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466274|NCT00533897|1112428|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466275|NCT00533897|1112429|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466276|NCT00533897|1112430|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466277|NCT00533897|1112431|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
466278|NCT00533897|1112432|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
466279|NCT00533897|1112433|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
466280|NCT00533897|1112426|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
466281|NCT00533897|1112427|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
466282|NCT00533897|1112428|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
466283|NCT00533897|1112429|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
466284|NCT00533897|1112430|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
466285|NCT00533897|1112431|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
466286|NCT00533897|1112432|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
466287|NCT00533897|1112433|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
466288|NCT00533897|1112426|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
466289|NCT00533897|1112427|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
466290|NCT00533897|1112428|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
466291|NCT00533897|1112429|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
466292|NCT00533897|1112430|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
466293|NCT00533897|1112431|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
466294|NCT00533897|1112432|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
466295|NCT00533897|1112433|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
466296|NCT00533897|1112426|P8|COMPLETED|Lead-in (LI) Period 1||0
466297|NCT00533897|1112427|P7|COMPLETED|Lead-in (LI) Period 1||0
466298|NCT00533897|1112428|P6|COMPLETED|Lead-in (LI) Period 1||0
466299|NCT00533897|1112429|P5|COMPLETED|Lead-in (LI) Period 1||0
466300|NCT00533897|1112430|P4|COMPLETED|Lead-in (LI) Period 1||0
466301|NCT00533897|1112431|P3|COMPLETED|Lead-in (LI) Period 1||0
466302|NCT00533897|1112432|P2|COMPLETED|Lead-in (LI) Period 1||0
466303|NCT00533897|1112433|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
466304|NCT00533897|1112426|P8|STARTED|Lead-in (LI) Period 1||0
466305|NCT00533897|1112427|P7|STARTED|Lead-in (LI) Period 1||0
466306|NCT00533897|1112428|P6|STARTED|Lead-in (LI) Period 1||0
466307|NCT00533897|1112429|P5|STARTED|Lead-in (LI) Period 1||0
466308|NCT00533897|1112430|P4|STARTED|Lead-in (LI) Period 1||0
466309|NCT00533897|1112431|P3|STARTED|Lead-in (LI) Period 1||0
466310|NCT00533897|1112432|P2|STARTED|Lead-in (LI) Period 1||0
466311|NCT00533897|1112433|P1|STARTED|Lead-in (LI) Period 1||167
466312|NCT00533702|1112573|P2|NOT COMPLETED|Overall Study||2
466313|NCT00533702|1112574|P1|NOT COMPLETED|Overall Study||5
466314|NCT00533702|1112573|P2|COMPLETED|Overall Study||50
466315|NCT00533702|1112574|P1|COMPLETED|Overall Study||49
466316|NCT00533702|1112573|P2|Received Any Quantity of Study Drug|Overall Study||50
466317|NCT00533702|1112574|P1|Received Any Quantity of Study Drug|Overall Study||52
466318|NCT00533702|1112573|P2|STARTED|Overall Study||52
466319|NCT00533702|1112574|P1|STARTED|Overall Study||54
466320|NCT00533546|1112598|P1|NOT COMPLETED|Overall Study||0
466321|NCT00533546|1112598|P1|COMPLETED|Overall Study||12
466322|NCT00533546|1112598|P1|STARTED|Overall Study||12
466323|NCT00533507|1112605|P1|NOT COMPLETED|Overall Study||1
466324|NCT00533507|1112605|P1|COMPLETED|Overall Study||229
466325|NCT00533507|1112605|P1|STARTED|Overall Study||230
466326|NCT00532948|1112627|P3|NOT COMPLETED|Overall Study||4
466327|NCT00532948|1112628|P2|NOT COMPLETED|Overall Study||5
466328|NCT00532948|1112629|P1|NOT COMPLETED|Overall Study||4
466329|NCT00532948|1112627|P3|COMPLETED|Overall Study||2
466330|NCT00532948|1112628|P2|COMPLETED|Overall Study||9
466331|NCT00532948|1112629|P1|COMPLETED|Overall Study||0
466332|NCT00532948|1112627|P3|STARTED|Overall Study||6
466333|NCT00532948|1112628|P2|STARTED|Overall Study||14
466334|NCT00532948|1112629|P1|STARTED|Overall Study||4
466335|NCT00532935|1112661|P2|NOT COMPLETED|Overall Study||52
466336|NCT00532935|1112662|P1|NOT COMPLETED|Overall Study||51
466337|NCT00532935|1112661|P2|COMPLETED|Overall Study||204
466338|NCT00532935|1112662|P1|COMPLETED|Overall Study||210
466339|NCT00532935|1112661|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
466340|NCT00532935|1112662|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
466341|NCT00533351|1112678|P2|NOT COMPLETED|Period 3||0
466342|NCT00533351|1112679|P1|NOT COMPLETED|Period 3||0
466343|NCT00533351|1112678|P2|COMPLETED|Period 3||0
466344|NCT00533351|1112679|P1|COMPLETED|Period 3||3
466345|NCT00533351|1112678|P2|STARTED|Period 3|No patients continued to Period 3|0
466346|NCT00533351|1112679|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
466347|NCT00533351|1112678|P2|NOT COMPLETED|Period 2||0
466348|NCT00533351|1112679|P1|NOT COMPLETED|Period 2||0
466349|NCT00533351|1112678|P2|COMPLETED|Period 2||1
466350|NCT00533351|1112679|P1|COMPLETED|Period 2||5
466351|NCT00533351|1112678|P2|STARTED|Period 2||1
466352|NCT00533351|1112679|P1|STARTED|Period 2||5
466353|NCT00533351|1112678|P2|NOT COMPLETED|Period 1||1
466354|NCT00533351|1112679|P1|NOT COMPLETED|Period 1||2
466355|NCT00533351|1112678|P2|COMPLETED|Period 1||1
466356|NCT00533351|1112679|P1|COMPLETED|Period 1||5
466357|NCT00533351|1112678|P2|STARTED|Period 1||2
466358|NCT00533351|1112679|P1|STARTED|Period 1||7
466359|NCT00533273|1112689|P2|NOT COMPLETED|Open-label||0
466360|NCT00533273|1112690|P1|NOT COMPLETED|Open-label||6
466361|NCT00533273|1112689|P2|COMPLETED|Open-label||0
466362|NCT00533273|1112690|P1|COMPLETED|Open-label||58
466363|NCT00533273|1112689|P2|STARTED|Open-label|no placebo - this phase was open label|0
466364|NCT00533273|1112690|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
466365|NCT00533273|1112689|P2|NOT COMPLETED|Double-blind||2
466366|NCT00533273|1112690|P1|NOT COMPLETED|Double-blind||0
466367|NCT00533273|1112689|P2|COMPLETED|Double-blind||19
466368|NCT00533273|1112690|P1|COMPLETED|Double-blind||45
466369|NCT00533273|1112689|P2|STARTED|Double-blind||21
466370|NCT00533273|1112690|P1|STARTED|Double-blind||45
466371|NCT00532883|1112700|P4|NOT COMPLETED|Overall Study||5
466372|NCT00532883|1112701|P3|NOT COMPLETED|Overall Study||4
466373|NCT00532883|1112702|P2|NOT COMPLETED|Overall Study||7
466374|NCT00532883|1112703|P1|NOT COMPLETED|Overall Study||6
466375|NCT00532883|1112700|P4|COMPLETED|Overall Study|Study terminated early.|6
466376|NCT00532883|1112701|P3|COMPLETED|Overall Study|Study terminated early.|6
466377|NCT00532883|1112702|P2|COMPLETED|Overall Study|Study terminated early.|5
466378|NCT00532883|1112703|P1|COMPLETED|Overall Study|Study terminated early.|5
466379|NCT00532883|1112700|P4|STARTED|Overall Study||11
466380|NCT00532883|1112701|P3|STARTED|Overall Study||10
466381|NCT00532883|1112702|P2|STARTED|Overall Study||12
466382|NCT00532883|1112703|P1|STARTED|Overall Study||11
466383|NCT00532779|1112716|P3|NOT COMPLETED|Overall Study||291
466384|NCT00532779|1112717|P2|NOT COMPLETED|Overall Study||287
466385|NCT00532779|1112718|P1|NOT COMPLETED|Overall Study||294
466386|NCT00532779|1112716|P3|COMPLETED|Overall Study||290
466387|NCT00532779|1112717|P2|COMPLETED|Overall Study||296
466388|NCT00532779|1112718|P1|COMPLETED|Overall Study||284
466389|NCT00532779|1112716|P3|STARTED|Overall Study||581
466390|NCT00532779|1112717|P2|STARTED|Overall Study||583
466391|NCT00532779|1112718|P1|STARTED|Overall Study||578
466392|NCT00532493|1112779|P2|NOT COMPLETED|Overall Study||29
466393|NCT00532493|1112780|P1|NOT COMPLETED|Overall Study||30
466394|NCT00532493|1112779|P2|COMPLETED|Overall Study||123
466395|NCT00532493|1112780|P1|COMPLETED|Overall Study||122
466396|NCT00532493|1112779|P2|STARTED|Overall Study||152
466397|NCT00532493|1112780|P1|STARTED|Overall Study||152
466398|NCT00532480|1112810|P1|NOT COMPLETED|Overall Study||3
466399|NCT00532480|1112810|P1|COMPLETED|Overall Study||7
466400|NCT00532480|1112810|P1|STARTED|Overall Study||10
466401|NCT00532441|1112814|P2|NOT COMPLETED|Overall Study||0
466402|NCT00532441|1112815|P1|NOT COMPLETED|Overall Study||1
466403|NCT00532441|1112814|P2|COMPLETED|Overall Study||11
466404|NCT00532441|1112815|P1|COMPLETED|Overall Study||13
466405|NCT00532441|1112814|P2|STARTED|Overall Study||11
466406|NCT00532441|1112815|P1|STARTED|Overall Study||14
466407|NCT00532298|1112830|P6|NOT COMPLETED|Overall Study||2
466408|NCT00532298|1112831|P5|NOT COMPLETED|Overall Study||1
466409|NCT00532298|1112832|P4|NOT COMPLETED|Overall Study||0
466410|NCT00532298|1112833|P3|NOT COMPLETED|Overall Study||1
466411|NCT00532298|1112834|P2|NOT COMPLETED|Overall Study||1
466412|NCT00532298|1112835|P1|NOT COMPLETED|Overall Study||2
466413|NCT00532298|1112830|P6|COMPLETED|Overall Study||261
466414|NCT00532298|1112831|P5|COMPLETED|Overall Study||267
466415|NCT00532298|1112832|P4|COMPLETED|Overall Study||264
466416|NCT00532298|1112833|P3|COMPLETED|Overall Study||263
466417|NCT00532298|1112834|P2|COMPLETED|Overall Study||265
466418|NCT00532298|1112835|P1|COMPLETED|Overall Study||267
466419|NCT00532298|1112830|P6|STARTED|Overall Study||263
466420|NCT00532298|1112831|P5|STARTED|Overall Study||268
466421|NCT00532298|1112832|P4|STARTED|Overall Study||264
466422|NCT00532298|1112833|P3|STARTED|Overall Study||264
466423|NCT00532298|1112834|P2|STARTED|Overall Study||266
466424|NCT00532298|1112835|P1|STARTED|Overall Study||269
466425|NCT00532259|1112915|P1|NOT COMPLETED|Overall Study||32
466426|NCT00532259|1112915|P1|COMPLETED|Overall Study||40
466427|NCT00532259|1112915|P1|STARTED|Overall Study||72
466428|NCT00532155|1112922|P2|NOT COMPLETED|Overall Study||456
466429|NCT00532155|1112923|P1|NOT COMPLETED|Overall Study||457
466430|NCT00532155|1112922|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
466431|NCT00532155|1112923|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
466432|NCT00532155|1112922|P2|SAFETY POPULATION|Overall Study||450
466433|NCT00532155|1112923|P1|SAFETY POPULATION|Overall Study||455
466434|NCT00532155|1112922|P2|STARTED|Overall Study||456
466435|NCT00532155|1112923|P1|STARTED|Overall Study||457
466436|NCT00532129|1112937|P1|NOT COMPLETED|Follow-up Period||65
466437|NCT00532129|1112937|P1|COMPLETED|Follow-up Period||33
466438|NCT00532129|1112937|P1|STARTED|Follow-up Period||98
466439|NCT00532129|1112937|P1|NOT COMPLETED|Treatment Period||49
466440|NCT00532129|1112937|P1|COMPLETED|Treatment Period||51
466441|NCT00532129|1112937|P1|STARTED|Treatment Period||100
466442|NCT00531960|1112957|P2|NOT COMPLETED|Overall Study||63
466443|NCT00531960|1112958|P1|NOT COMPLETED|Overall Study||61
466444|NCT00531960|1112957|P2|COMPLETED|Overall Study||0
466445|NCT00531960|1112958|P1|COMPLETED|Overall Study||0
466446|NCT00531960|1112957|P2|STARTED|Overall Study||63
466447|NCT00531960|1112958|P1|STARTED|Overall Study||61
466448|NCT00531947|1112976|P2|NOT COMPLETED|Overall Study||51
466449|NCT00531947|1112977|P1|NOT COMPLETED|Overall Study||42
466450|NCT00531947|1112976|P2|COMPLETED|Overall Study||101
466451|NCT00531947|1112977|P1|COMPLETED|Overall Study||114
466452|NCT00531947|1112976|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
466453|NCT00531947|1112977|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
466454|NCT00531934|1113021|P2|NOT COMPLETED|Overall Study||63
466455|NCT00531934|1113022|P1|NOT COMPLETED|Overall Study||66
466456|NCT00531934|1113021|P2|COMPLETED|Overall Study||11
466457|NCT00531934|1113022|P1|COMPLETED|Overall Study||7
466458|NCT00531934|1113021|P2|STARTED|Overall Study||74
466459|NCT00531934|1113022|P1|STARTED|Overall Study||73
466460|NCT00531843|1113092|P2|NOT COMPLETED|Overall Study||0
466461|NCT00531843|1113093|P1|NOT COMPLETED|Overall Study||0
466462|NCT00531843|1113092|P2|COMPLETED|Overall Study||6
466463|NCT00531843|1113093|P1|COMPLETED|Overall Study||81
466464|NCT00531843|1113092|P2|STARTED|Overall Study||6
466465|NCT00531843|1113093|P1|STARTED|Overall Study||81
466466|NCT00531817|1113105|P2|NOT COMPLETED|Entered Extended Treatment Period||57
466467|NCT00531817|1113106|P1|NOT COMPLETED|Entered Extended Treatment Period||137
466468|NCT00531817|1113105|P2|COMPLETED|Entered Extended Treatment Period||113
466469|NCT00531817|1113106|P1|COMPLETED|Entered Extended Treatment Period||206
466470|NCT00531817|1113105|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
466471|NCT00531817|1113106|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
466472|NCT00531817|1113105|P2|NOT COMPLETED|Randomized||34
466473|NCT00531817|1113106|P1|NOT COMPLETED|Randomized||59
466474|NCT00531817|1113105|P2|COMPLETED|Randomized||173
466475|NCT00531817|1113106|P1|COMPLETED|Randomized||353
466476|NCT00531817|1113105|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
466477|NCT00531817|1113106|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
466478|NCT00531817|1113105|P2|STARTED|Randomized||207
466479|NCT00531817|1113106|P1|STARTED|Randomized||412
466480|NCT00531752|1113137|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
466481|NCT00531752|1113138|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
466482|NCT00531752|1113139|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
466483|NCT00531752|1113140|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
466484|NCT00531752|1113137|P4|COMPLETED|Second Double-blind Intervention Period||11
466485|NCT00531752|1113138|P3|COMPLETED|Second Double-blind Intervention Period||9
466486|NCT00531752|1113139|P2|COMPLETED|Second Double-blind Intervention Period||11
466487|NCT00531752|1113140|P1|COMPLETED|Second Double-blind Intervention Period||9
466488|NCT00531752|1113137|P4|STARTED|Second Double-blind Intervention Period||13
466489|NCT00531752|1113138|P3|STARTED|Second Double-blind Intervention Period||9
466490|NCT00531752|1113139|P2|STARTED|Second Double-blind Intervention Period||13
466491|NCT00531752|1113140|P1|STARTED|Second Double-blind Intervention Period||11
466492|NCT00531752|1113137|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
466493|NCT00531752|1113138|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
466494|NCT00531752|1113139|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
466495|NCT00531752|1113140|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
466496|NCT00531752|1113137|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
466497|NCT00531752|1113138|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
466498|NCT00531752|1113139|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
466499|NCT00531752|1113140|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
466500|NCT00531752|1113137|P4|STARTED|Wash-out Period (at Least 7 Days)||13
466501|NCT00531752|1113138|P3|STARTED|Wash-out Period (at Least 7 Days)||9
466502|NCT00531752|1113139|P2|STARTED|Wash-out Period (at Least 7 Days)||13
466503|NCT00531752|1113140|P1|STARTED|Wash-out Period (at Least 7 Days)||11
466504|NCT00531752|1113137|P4|NOT COMPLETED|First Double-blind Intervention Period||3
466505|NCT00531752|1113138|P3|NOT COMPLETED|First Double-blind Intervention Period||7
466506|NCT00531752|1113139|P2|NOT COMPLETED|First Double-blind Intervention Period||4
466507|NCT00531752|1113140|P1|NOT COMPLETED|First Double-blind Intervention Period||6
466508|NCT00531752|1113137|P4|COMPLETED|First Double-blind Intervention Period||13
466509|NCT00531752|1113138|P3|COMPLETED|First Double-blind Intervention Period||9
466510|NCT00531752|1113139|P2|COMPLETED|First Double-blind Intervention Period||13
466511|NCT00531752|1113140|P1|COMPLETED|First Double-blind Intervention Period||11
466512|NCT00531752|1113137|P4|Treated|First Double-blind Intervention Period||16
466513|NCT00531752|1113138|P3|Treated|First Double-blind Intervention Period||16
466514|NCT00531752|1113139|P2|Treated|First Double-blind Intervention Period||17
466515|NCT00531752|1113140|P1|Treated|First Double-blind Intervention Period||16
466516|NCT00531752|1113137|P4|STARTED|First Double-blind Intervention Period||16
466517|NCT00531752|1113138|P3|STARTED|First Double-blind Intervention Period||16
466518|NCT00531752|1113139|P2|STARTED|First Double-blind Intervention Period||17
466519|NCT00531752|1113140|P1|STARTED|First Double-blind Intervention Period||17
466520|NCT00531661|1113219|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
466521|NCT00531661|1113220|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
466522|NCT00531661|1113219|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
466523|NCT00531661|1113220|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
466524|NCT00531661|1113219|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
466525|NCT00531661|1113220|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
466526|NCT00531661|1113219|P2|NOT COMPLETED|6 Months||26
466527|NCT00531661|1113220|P1|NOT COMPLETED|6 Months||26
466528|NCT00531661|1113219|P2|COMPLETED|6 Months||254
466529|NCT00531661|1113220|P1|COMPLETED|6 Months||244
466530|NCT00531661|1113219|P2|STARTED|6 Months||280
466531|NCT00531661|1113220|P1|STARTED|6 Months||270
466532|NCT00531518|1113242|P2|NOT COMPLETED|Overall Study||71
466533|NCT00531518|1113243|P1|NOT COMPLETED|Overall Study||32
466534|NCT00531518|1113242|P2|COMPLETED|Overall Study||134
466535|NCT00531518|1113243|P1|COMPLETED|Overall Study||55
466536|NCT00531518|1113242|P2|STARTED|Overall Study||205
466537|NCT00531518|1113243|P1|STARTED|Overall Study||87
466538|NCT00531479|1113251|P2|NOT COMPLETED|Overall Study||83
466539|NCT00531479|1113252|P1|NOT COMPLETED|Overall Study||76
466540|NCT00531479|1113251|P2|COMPLETED|Overall Study||146
466541|NCT00531479|1113252|P1|COMPLETED|Overall Study||154
466542|NCT00531479|1113251|P2|Treated|Overall Study||226
466543|NCT00531479|1113252|P1|Treated|Overall Study||228
466544|NCT00531479|1113251|P2|STARTED|Overall Study||229
466545|NCT00531479|1113252|P1|STARTED|Overall Study||230
466546|NCT00531453|1113272|P2|NOT COMPLETED|Overall Study||0
466547|NCT00531453|1113273|P1|NOT COMPLETED|Overall Study||0
466548|NCT00531453|1113272|P2|COMPLETED|Overall Study|10 April 2009|49
466549|NCT00531453|1113273|P1|COMPLETED|Overall Study|10 April 2009|49
466550|NCT00531453|1113272|P2|STARTED|Overall Study|02 October 2007|49
466551|NCT00531453|1113273|P1|STARTED|Overall Study|02 October 2007|49
466552|NCT00531427|1113283|P2|NOT COMPLETED|Overall Study||94
466553|NCT00531427|1113284|P1|NOT COMPLETED|Overall Study||73
466554|NCT00531427|1113283|P2|COMPLETED|Overall Study||191
466555|NCT00531427|1113284|P1|COMPLETED|Overall Study||209
466556|NCT00531427|1113283|P2|STARTED|Overall Study||285
466557|NCT00531427|1113284|P1|STARTED|Overall Study||282
466558|NCT00531284|1113312|P17|NOT COMPLETED|Overall Study||8
466559|NCT00531284|1113313|P16|NOT COMPLETED|Overall Study||12
466560|NCT00531284|1113314|P15|NOT COMPLETED|Overall Study||4
466561|NCT00531284|1113315|P14|NOT COMPLETED|Overall Study||3
466562|NCT00531284|1113316|P13|NOT COMPLETED|Overall Study||2
466563|NCT00531284|1113317|P12|NOT COMPLETED|Overall Study||24
466564|NCT00531284|1113318|P11|NOT COMPLETED|Overall Study||3
466565|NCT00531284|1113319|P10|NOT COMPLETED|Overall Study||4
466566|NCT00531284|1113320|P9|NOT COMPLETED|Overall Study||11
466567|NCT00531284|1113321|P8|NOT COMPLETED|Overall Study||10
466568|NCT00531284|1113322|P7|NOT COMPLETED|Overall Study||6
466569|NCT00531284|1113323|P6|NOT COMPLETED|Overall Study||7
466570|NCT00531284|1113324|P5|NOT COMPLETED|Overall Study||6
466571|NCT00531284|1113325|P4|NOT COMPLETED|Overall Study||63
466572|NCT00531284|1113326|P3|NOT COMPLETED|Overall Study||6
466573|NCT00531284|1113327|P2|NOT COMPLETED|Overall Study||4
466574|NCT00531284|1113328|P1|NOT COMPLETED|Overall Study||3
466575|NCT00531284|1113312|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466576|NCT00531284|1113313|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
466577|NCT00531284|1113314|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
466578|NCT00531284|1113315|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466579|NCT00531284|1113316|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466580|NCT00531284|1113317|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466581|NCT00531284|1113318|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466582|NCT00531284|1113319|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466583|NCT00531284|1113320|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466584|NCT00531284|1113321|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466585|NCT00531284|1113322|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466586|NCT00531284|1113323|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466587|NCT00531284|1113324|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
466588|NCT00531284|1113325|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
466589|NCT00531284|1113326|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
466590|NCT00531284|1113327|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
466591|NCT00531284|1113328|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
466592|NCT00531284|1113312|P17|STARTED|Overall Study||8
466593|NCT00531284|1113313|P16|STARTED|Overall Study||14
466594|NCT00531284|1113314|P15|STARTED|Overall Study||7
466595|NCT00531284|1113315|P14|STARTED|Overall Study||3
466596|NCT00531284|1113316|P13|STARTED|Overall Study||2
466597|NCT00531284|1113317|P12|STARTED|Overall Study||24
466598|NCT00531284|1113318|P11|STARTED|Overall Study||3
466599|NCT00531284|1113319|P10|STARTED|Overall Study||4
466600|NCT00531284|1113320|P9|STARTED|Overall Study||11
466601|NCT00531284|1113321|P8|STARTED|Overall Study||10
466602|NCT00531284|1113322|P7|STARTED|Overall Study||6
466603|NCT00531284|1113323|P6|STARTED|Overall Study||7
466604|NCT00531284|1113324|P5|STARTED|Overall Study||6
466605|NCT00531284|1113325|P4|STARTED|Overall Study||65
466606|NCT00531284|1113326|P3|STARTED|Overall Study||7
466607|NCT00531284|1113327|P2|STARTED|Overall Study||4
466608|NCT00531284|1113328|P1|STARTED|Overall Study||3
466609|NCT00531206|1113478|P1|NOT COMPLETED|Overall Study||20
466610|NCT00531206|1113478|P1|COMPLETED|Overall Study||45
466611|NCT00531206|1113478|P1|STARTED|Overall Study||65
466612|NCT00531050|1113508|P6|NOT COMPLETED|Part 2: Period 3||1
466613|NCT00531050|1113509|P5|NOT COMPLETED|Part 2: Period 3||0
466614|NCT00531050|1113510|P4|NOT COMPLETED|Part 2: Period 3||0
466615|NCT00531050|1113511|P3|NOT COMPLETED|Part 2: Period 3||0
466616|NCT00531050|1113512|P2|NOT COMPLETED|Part 2: Period 3||0
466617|NCT00531050|1113513|P1|NOT COMPLETED|Part 2: Period 3||1
466618|NCT00531050|1113508|P6|COMPLETED|Part 2: Period 3||3
466619|NCT00531050|1113509|P5|COMPLETED|Part 2: Period 3||4
466620|NCT00531050|1113510|P4|COMPLETED|Part 2: Period 3||4
466621|NCT00531050|1113511|P3|COMPLETED|Part 2: Period 3||4
466622|NCT00531050|1113512|P2|COMPLETED|Part 2: Period 3||4
466623|NCT00531050|1113513|P1|COMPLETED|Part 2: Period 3||2
466624|NCT00531050|1113508|P6|STARTED|Part 2: Period 3||4
466625|NCT00531050|1113509|P5|STARTED|Part 2: Period 3||4
466626|NCT00531050|1113510|P4|STARTED|Part 2: Period 3||4
466627|NCT00531050|1113511|P3|STARTED|Part 2: Period 3||4
466628|NCT00531050|1113512|P2|STARTED|Part 2: Period 3||4
466629|NCT00531050|1113513|P1|STARTED|Part 2: Period 3||3
466630|NCT00531050|1113508|P6|NOT COMPLETED|Part 2: Period 2||0
466631|NCT00531050|1113509|P5|NOT COMPLETED|Part 2: Period 2||0
466632|NCT00531050|1113510|P4|NOT COMPLETED|Part 2: Period 2||0
466633|NCT00531050|1113511|P3|NOT COMPLETED|Part 2: Period 2||0
466634|NCT00531050|1113512|P2|NOT COMPLETED|Part 2: Period 2||0
466635|NCT00531050|1113513|P1|NOT COMPLETED|Part 2: Period 2||0
466636|NCT00531050|1113508|P6|COMPLETED|Part 2: Period 2||4
466637|NCT00531050|1113509|P5|COMPLETED|Part 2: Period 2||4
466638|NCT00531050|1113510|P4|COMPLETED|Part 2: Period 2||4
466639|NCT00531050|1113511|P3|COMPLETED|Part 2: Period 2||4
466640|NCT00531050|1113512|P2|COMPLETED|Part 2: Period 2||4
466641|NCT00531050|1113513|P1|COMPLETED|Part 2: Period 2||3
466642|NCT00531050|1113508|P6|STARTED|Part 2: Period 2||4
466643|NCT00531050|1113509|P5|STARTED|Part 2: Period 2||4
466644|NCT00531050|1113510|P4|STARTED|Part 2: Period 2||4
466645|NCT00531050|1113511|P3|STARTED|Part 2: Period 2||4
466646|NCT00531050|1113512|P2|STARTED|Part 2: Period 2||4
466647|NCT00531050|1113513|P1|STARTED|Part 2: Period 2||3
466648|NCT00531050|1113508|P6|NOT COMPLETED|Part 2: Period 1||1
466649|NCT00531050|1113509|P5|NOT COMPLETED|Part 2: Period 1||0
466650|NCT00531050|1113510|P4|NOT COMPLETED|Part 2: Period 1||0
466651|NCT00531050|1113511|P3|NOT COMPLETED|Part 2: Period 1||0
466652|NCT00531050|1113512|P2|NOT COMPLETED|Part 2: Period 1||0
466653|NCT00531050|1113513|P1|NOT COMPLETED|Part 2: Period 1||0
466654|NCT00531050|1113508|P6|COMPLETED|Part 2: Period 1||4
466655|NCT00531050|1113509|P5|COMPLETED|Part 2: Period 1||4
466656|NCT00531050|1113510|P4|COMPLETED|Part 2: Period 1||4
466657|NCT00531050|1113511|P3|COMPLETED|Part 2: Period 1||4
466658|NCT00531050|1113512|P2|COMPLETED|Part 2: Period 1||4
466659|NCT00531050|1113513|P1|COMPLETED|Part 2: Period 1||3
466660|NCT00531050|1113508|P6|STARTED|Part 2: Period 1||5
466661|NCT00531050|1113509|P5|STARTED|Part 2: Period 1||4
466662|NCT00531050|1113510|P4|STARTED|Part 2: Period 1||4
466663|NCT00531050|1113511|P3|STARTED|Part 2: Period 1||4
466664|NCT00531050|1113512|P2|STARTED|Part 2: Period 1||4
466665|NCT00531050|1113513|P1|STARTED|Part 2: Period 1||3
466666|NCT00531050|1113508|P6|NOT COMPLETED|Part 1: Period 3||0
466667|NCT00531050|1113509|P5|NOT COMPLETED|Part 1: Period 3||0
466668|NCT00531050|1113510|P4|NOT COMPLETED|Part 1: Period 3||0
466669|NCT00531050|1113511|P3|NOT COMPLETED|Part 1: Period 3||0
466670|NCT00531050|1113512|P2|NOT COMPLETED|Part 1: Period 3||0
466671|NCT00531050|1113513|P1|NOT COMPLETED|Part 1: Period 3||1
466672|NCT00531050|1113508|P6|COMPLETED|Part 1: Period 3||5
466673|NCT00531050|1113509|P5|COMPLETED|Part 1: Period 3||4
466674|NCT00531050|1113510|P4|COMPLETED|Part 1: Period 3||4
466675|NCT00531050|1113511|P3|COMPLETED|Part 1: Period 3||4
466676|NCT00531050|1113512|P2|COMPLETED|Part 1: Period 3||4
466677|NCT00531050|1113513|P1|COMPLETED|Part 1: Period 3||3
466678|NCT00531050|1113508|P6|STARTED|Part 1: Period 3||5
466679|NCT00531050|1113509|P5|STARTED|Part 1: Period 3||4
466680|NCT00531050|1113510|P4|STARTED|Part 1: Period 3||4
466681|NCT00531050|1113511|P3|STARTED|Part 1: Period 3||4
466682|NCT00531050|1113512|P2|STARTED|Part 1: Period 3||4
466683|NCT00531050|1113513|P1|STARTED|Part 1: Period 3||4
466684|NCT00531050|1113508|P6|NOT COMPLETED|Part 1: Period 2||0
466685|NCT00531050|1113509|P5|NOT COMPLETED|Part 1: Period 2||0
466686|NCT00531050|1113510|P4|NOT COMPLETED|Part 1: Period 2||0
466687|NCT00531050|1113511|P3|NOT COMPLETED|Part 1: Period 2||0
466688|NCT00531050|1113512|P2|NOT COMPLETED|Part 1: Period 2||0
466689|NCT00531050|1113513|P1|NOT COMPLETED|Part 1: Period 2||0
466690|NCT00531050|1113508|P6|COMPLETED|Part 1: Period 2||5
466691|NCT00531050|1113509|P5|COMPLETED|Part 1: Period 2||4
466692|NCT00531050|1113510|P4|COMPLETED|Part 1: Period 2||4
466693|NCT00531050|1113511|P3|COMPLETED|Part 1: Period 2||4
466694|NCT00531050|1113512|P2|COMPLETED|Part 1: Period 2||4
466695|NCT00531050|1113513|P1|COMPLETED|Part 1: Period 2||4
466696|NCT00531050|1113508|P6|STARTED|Part 1: Period 2||5
466697|NCT00531050|1113509|P5|STARTED|Part 1: Period 2||4
466698|NCT00531050|1113510|P4|STARTED|Part 1: Period 2||4
466699|NCT00531050|1113511|P3|STARTED|Part 1: Period 2||4
466700|NCT00531050|1113512|P2|STARTED|Part 1: Period 2||4
466701|NCT00531050|1113513|P1|STARTED|Part 1: Period 2||4
466702|NCT00531050|1113508|P6|NOT COMPLETED|Part 1: Period 1||0
466703|NCT00531050|1113509|P5|NOT COMPLETED|Part 1: Period 1||0
466704|NCT00531050|1113510|P4|NOT COMPLETED|Part 1: Period 1||1
466705|NCT00531050|1113511|P3|NOT COMPLETED|Part 1: Period 1||0
466706|NCT00531050|1113512|P2|NOT COMPLETED|Part 1: Period 1||1
466707|NCT00531050|1113513|P1|NOT COMPLETED|Part 1: Period 1||0
466708|NCT00531050|1113508|P6|COMPLETED|Part 1: Period 1||5
466709|NCT00531050|1113509|P5|COMPLETED|Part 1: Period 1||4
466710|NCT00531050|1113510|P4|COMPLETED|Part 1: Period 1||4
466711|NCT00531050|1113511|P3|COMPLETED|Part 1: Period 1||4
466712|NCT00531050|1113512|P2|COMPLETED|Part 1: Period 1||4
466713|NCT00531050|1113513|P1|COMPLETED|Part 1: Period 1||4
466714|NCT00531050|1113508|P6|STARTED|Part 1: Period 1||5
466715|NCT00531050|1113509|P5|STARTED|Part 1: Period 1||4
466716|NCT00531050|1113510|P4|STARTED|Part 1: Period 1||5
466717|NCT00531050|1113511|P3|STARTED|Part 1: Period 1||4
466718|NCT00531050|1113512|P2|STARTED|Part 1: Period 1||5
466719|NCT00531050|1113513|P1|STARTED|Part 1: Period 1||4
466720|NCT00531011|1113542|P2|NOT COMPLETED|Overall Study||7
466721|NCT00531011|1113543|P1|NOT COMPLETED|Overall Study||4
466722|NCT00531011|1113542|P2|COMPLETED|Overall Study||90
466723|NCT00531011|1113543|P1|COMPLETED|Overall Study||99
466724|NCT00531011|1113542|P2|STARTED|Overall Study||97
466725|NCT00531011|1113543|P1|STARTED|Overall Study||103
466726|NCT00530946|1113589|P4|NOT COMPLETED|Overall Study||2
466727|NCT00530946|1113590|P3|NOT COMPLETED|Overall Study||1
466728|NCT00530946|1113591|P2|NOT COMPLETED|Overall Study||2
466729|NCT00530946|1113592|P1|NOT COMPLETED|Overall Study||2
466730|NCT00530946|1113589|P4|COMPLETED|Overall Study||38
466731|NCT00530946|1113590|P3|COMPLETED|Overall Study||40
466732|NCT00530946|1113591|P2|COMPLETED|Overall Study||39
466733|NCT00530946|1113592|P1|COMPLETED|Overall Study||41
466734|NCT00530946|1113589|P4|STARTED|Overall Study||40
466735|NCT00530946|1113590|P3|STARTED|Overall Study||41
466736|NCT00530946|1113591|P2|STARTED|Overall Study||41
466737|NCT00530946|1113592|P1|STARTED|Overall Study||43
466738|NCT00530920|1113645|P3|NOT COMPLETED|Overall Study||4
466739|NCT00530920|1113646|P2|NOT COMPLETED|Overall Study||2
466740|NCT00530920|1113647|P1|NOT COMPLETED|Overall Study||0
466741|NCT00530920|1113645|P3|COMPLETED|Overall Study||24
466742|NCT00530920|1113646|P2|COMPLETED|Overall Study||25
466743|NCT00530920|1113647|P1|COMPLETED|Overall Study||30
466744|NCT00530920|1113645|P3|STARTED|Overall Study||28
466745|NCT00530920|1113646|P2|STARTED|Overall Study||27
466746|NCT00530920|1113647|P1|STARTED|Overall Study||30
466747|NCT00530894|1113707|P4|NOT COMPLETED|Overall Study||94
466748|NCT00530894|1113708|P3|NOT COMPLETED|Overall Study||55
466749|NCT00530894|1113709|P2|NOT COMPLETED|Overall Study||115
466750|NCT00530894|1113710|P1|NOT COMPLETED|Overall Study||88
466751|NCT00530894|1113707|P4|COMPLETED|Overall Study||85
466752|NCT00530894|1113708|P3|COMPLETED|Overall Study||124
466753|NCT00530894|1113709|P2|COMPLETED|Overall Study||236
466754|NCT00530894|1113710|P1|COMPLETED|Overall Study||260
466755|NCT00530894|1113707|P4|STARTED|Overall Study||179
466756|NCT00530894|1113708|P3|STARTED|Overall Study||179
466757|NCT00530894|1113709|P2|STARTED|Overall Study||351
466758|NCT00530894|1113710|P1|STARTED|Overall Study||348
466759|NCT00530855|1113738|P1|NOT COMPLETED|Overall Study||112
466760|NCT00530855|1113738|P1|COMPLETED|Overall Study||210
466761|NCT00530855|1113738|P1|STARTED|Overall Study||322
466762|NCT00530842|1113747|P2|NOT COMPLETED|Period 2||9
466763|NCT00530842|1113748|P1|NOT COMPLETED|Period 2||8
466764|NCT00530842|1113747|P2|COMPLETED|Period 2||151
466765|NCT00530842|1113748|P1|COMPLETED|Period 2||149
466766|NCT00530842|1113747|P2|STARTED|Period 2||160
466767|NCT00530842|1113748|P1|STARTED|Period 2||157
466768|NCT00530842|1113747|P2|NOT COMPLETED|Period 1||11
466769|NCT00530842|1113748|P1|NOT COMPLETED|Period 1||14
466770|NCT00530842|1113747|P2|COMPLETED|Period 1||161
466771|NCT00530842|1113748|P1|COMPLETED|Period 1||158
466772|NCT00530842|1113747|P2|STARTED|Period 1||172
466773|NCT00530842|1113748|P1|STARTED|Period 1||172
466774|NCT00530842|1113747|P2|NOT COMPLETED|Overall Study||21
466775|NCT00530842|1113748|P1|NOT COMPLETED|Overall Study||23
466776|NCT00530842|1113747|P2|COMPLETED|Overall Study||151
466777|NCT00530842|1113748|P1|COMPLETED|Overall Study||149
466778|NCT00530842|1113747|P2|STARTED|Overall Study||172
466779|NCT00530842|1113748|P1|STARTED|Overall Study||172
466780|NCT00530816|1113875|P3|NOT COMPLETED|Overall Study||41
466781|NCT00530816|1113876|P2|NOT COMPLETED|Overall Study||42
466782|NCT00530816|1113877|P1|NOT COMPLETED|Overall Study||26
466783|NCT00530816|1113875|P3|COMPLETED|Overall Study||29
466784|NCT00530816|1113876|P2|COMPLETED|Overall Study||17
466785|NCT00530816|1113877|P1|COMPLETED|Overall Study||9
466786|NCT00530816|1113875|P3|STARTED|Overall Study||70
466787|NCT00530816|1113876|P2|STARTED|Overall Study||59
466788|NCT00530816|1113877|P1|STARTED|Overall Study||35
466789|NCT00530790|1113903|P1|NOT COMPLETED|Overall Study||5
466790|NCT00530790|1113903|P1|COMPLETED|Overall Study||30
466791|NCT00530790|1113903|P1|STARTED|Overall Study||35
466792|NCT00530777|1113925|P2|NOT COMPLETED|Overall Study||5
466793|NCT00530777|1113926|P1|NOT COMPLETED|Overall Study||7
466794|NCT00530777|1113925|P2|COMPLETED|Overall Study||69
466795|NCT00530777|1113926|P1|COMPLETED|Overall Study||67
466796|NCT00530777|1113925|P2|STARTED|Overall Study||74
466797|NCT00530777|1113926|P1|STARTED|Overall Study||74
466798|NCT00530764|1113938|P4|NOT COMPLETED|Overall Study||25
466799|NCT00530764|1113939|P3|NOT COMPLETED|Overall Study||20
466800|NCT00530764|1113940|P2|NOT COMPLETED|Overall Study||21
466801|NCT00530764|1113941|P1|NOT COMPLETED|Overall Study||31
466802|NCT00530764|1113938|P4|COMPLETED|Overall Study||66
466803|NCT00530764|1113939|P3|COMPLETED|Overall Study||71
466804|NCT00530764|1113940|P2|COMPLETED|Overall Study||67
466805|NCT00530764|1113941|P1|COMPLETED|Overall Study||59
466806|NCT00530764|1113938|P4|STARTED|Overall Study||91
466807|NCT00530764|1113939|P3|STARTED|Overall Study||91
466808|NCT00530764|1113940|P2|STARTED|Overall Study||88
466809|NCT00530764|1113941|P1|STARTED|Overall Study||90
466810|NCT00530712|1113983|P1|NOT COMPLETED|12 Month Follow-up Visit||24
466811|NCT00530712|1113983|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
466812|NCT00530712|1113983|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
466813|NCT00530712|1113983|P1|NOT COMPLETED|6 Month Follow-up Visit||12
466814|NCT00530712|1113983|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
466815|NCT00530712|1113983|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
466816|NCT00530712|1113983|P1|NOT COMPLETED|30 Day Follow-up Visit||7
466817|NCT00530712|1113983|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
466818|NCT00530712|1113983|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
466819|NCT00530712|1113983|P1|NOT COMPLETED|Enrollment||0
466820|NCT00530712|1113983|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
466821|NCT00530712|1113983|P1|STARTED|Enrollment|Total Enrolled Subjects|287
466822|NCT00530634|1113998|P1|NOT COMPLETED|Overall Study||0
466823|NCT00530634|1113998|P1|COMPLETED|Overall Study||3
466824|NCT00530634|1113998|P1|STARTED|Overall Study||3
466825|NCT00530504|1114002|P1|NOT COMPLETED|Overall Study||152
466826|NCT00530504|1114002|P1|COMPLETED|Overall Study||1348
466827|NCT00530504|1114002|P1|STARTED|Overall Study||1500
466828|NCT00530439|1114008|P2|NOT COMPLETED|Overall Study||26
466829|NCT00530439|1114009|P1|NOT COMPLETED|Overall Study||30
466830|NCT00530439|1114008|P2|COMPLETED|Overall Study||154
466831|NCT00530439|1114009|P1|COMPLETED|Overall Study||150
466832|NCT00530439|1114008|P2|STARTED|Overall Study||180
466833|NCT00530439|1114009|P1|STARTED|Overall Study||180
466834|NCT00530348|1114017|P2|NOT COMPLETED|Overall Study||19
466835|NCT00530348|1114018|P1|NOT COMPLETED|Overall Study||22
466836|NCT00530348|1114017|P2|COMPLETED|Overall Study||367
466837|NCT00530348|1114018|P1|COMPLETED|Overall Study||173
466838|NCT00530348|1114017|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
466839|NCT00530348|1114018|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
466840|NCT00530348|1114017|P2|STARTED|Overall Study|Randomized.|386
466841|NCT00530348|1114018|P1|STARTED|Overall Study|Randomized.|195
466842|NCT00530335|1114034|P1|NOT COMPLETED|Overall Study||6
466843|NCT00530335|1114034|P1|COMPLETED|Overall Study||39
466844|NCT00530335|1114034|P1|STARTED|Overall Study||45
466845|NCT00530270|1114051|P2|NOT COMPLETED|Overall Study||0
466846|NCT00530270|1114052|P1|NOT COMPLETED|Overall Study||1
466847|NCT00530270|1114051|P2|COMPLETED|Overall Study||6
466848|NCT00530270|1114052|P1|COMPLETED|Overall Study||5
466849|NCT00530270|1114051|P2|STARTED|Overall Study||6
466850|NCT00530270|1114052|P1|STARTED|Overall Study||6
466851|NCT00530257|1114066|P1|NOT COMPLETED|Overall Study||1
466852|NCT00530257|1114066|P1|COMPLETED|Overall Study||30
466853|NCT00530257|1114066|P1|STARTED|Overall Study||31
466854|NCT00530088|1114094|P1|NOT COMPLETED|Overall Study||10
466855|NCT00530088|1114094|P1|COMPLETED|Overall Study||20
466856|NCT00530088|1114094|P1|STARTED|Overall Study||30
466857|NCT00530075|1114099|P1|NOT COMPLETED|Overall Study||7
466858|NCT00530075|1114099|P1|COMPLETED|Overall Study||38
466859|NCT00530075|1114099|P1|STARTED|Overall Study||45
466860|NCT00530023|1114112|P2|NOT COMPLETED|Overall Study||1
466861|NCT00530023|1114113|P1|NOT COMPLETED|Overall Study||0
466862|NCT00530023|1114112|P2|COMPLETED|Overall Study||14
466863|NCT00530023|1114113|P1|COMPLETED|Overall Study||14
466864|NCT00530023|1114112|P2|STARTED|Overall Study||15
466865|NCT00530023|1114113|P1|STARTED|Overall Study||14
466866|NCT00529789|1114127|P1|NOT COMPLETED|Study Period IV||6
466867|NCT00529789|1114127|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
466868|NCT00529789|1114127|P1|STARTED|Study Period IV||48
466869|NCT00529789|1114127|P1|NOT COMPLETED|Study Period II/III||24
466870|NCT00529789|1114127|P1|COMPLETED|Study Period II/III||48
466871|NCT00529789|1114127|P1|STARTED|Study Period II/III||72
466872|NCT00529763|1114152|P3|NOT COMPLETED|Overall Study||7
466873|NCT00529763|1114153|P2|NOT COMPLETED|Overall Study||33
466874|NCT00529763|1114154|P1|NOT COMPLETED|Overall Study||10
466875|NCT00529763|1114152|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
466876|NCT00529763|1114153|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
466877|NCT00529763|1114154|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
466878|NCT00529763|1114152|P3|STARTED|Overall Study||59
466879|NCT00529763|1114153|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
466880|NCT00529763|1114154|P1|STARTED|Overall Study||25
466881|NCT00529659|1114192|P2|NOT COMPLETED|Overall Study||23
466882|NCT00529659|1114193|P1|NOT COMPLETED|Overall Study||11
466883|NCT00529659|1114192|P2|COMPLETED|Overall Study||66
466884|NCT00529659|1114193|P1|COMPLETED|Overall Study||70
466885|NCT00529659|1114192|P2|STARTED|Overall Study||89
466886|NCT00529659|1114193|P1|STARTED|Overall Study||81
466887|NCT00529633|1114211|P2|NOT COMPLETED|Overall Study||1
466888|NCT00529633|1114212|P1|NOT COMPLETED|Overall Study||1
466889|NCT00529633|1114211|P2|COMPLETED|Overall Study||1
466890|NCT00529633|1114212|P1|COMPLETED|Overall Study||1
466891|NCT00529633|1114211|P2|STARTED|Overall Study||2
466892|NCT00529633|1114212|P1|STARTED|Overall Study||2
466893|NCT00529568|1114224|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
466894|NCT00529568|1114225|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
466895|NCT00529568|1114226|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
466896|NCT00529568|1114224|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
466897|NCT00529568|1114225|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
466898|NCT00529568|1114226|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
466899|NCT00529568|1114224|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
466900|NCT00529568|1114225|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
466901|NCT00529568|1114226|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
466902|NCT00529568|1114224|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
466903|NCT00529568|1114225|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
466904|NCT00529568|1114226|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
466905|NCT00529568|1114224|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
466906|NCT00529568|1114225|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
466907|NCT00529568|1114226|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
466908|NCT00529568|1114224|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
466909|NCT00529568|1114225|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
466910|NCT00529568|1114226|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
466911|NCT00529555|1114277|P3|NOT COMPLETED|Overall Study||26
466912|NCT00529555|1114278|P2|NOT COMPLETED|Overall Study||30
466913|NCT00529555|1114279|P1|NOT COMPLETED|Overall Study||29
466914|NCT00529555|1114277|P3|COMPLETED|Overall Study||174
466915|NCT00529555|1114278|P2|COMPLETED|Overall Study||172
466916|NCT00529555|1114279|P1|COMPLETED|Overall Study||171
466917|NCT00529555|1114277|P3|STARTED|Overall Study||200
466918|NCT00529555|1114278|P2|STARTED|Overall Study||202
466919|NCT00529555|1114279|P1|STARTED|Overall Study||200
466920|NCT00529542|1114289|P2|NOT COMPLETED|Overall Study||1
466921|NCT00529542|1114290|P1|NOT COMPLETED|Overall Study||1
466922|NCT00529542|1114289|P2|COMPLETED|Overall Study||10
466923|NCT00529542|1114290|P1|COMPLETED|Overall Study||8
466924|NCT00529542|1114289|P2|STARTED|Overall Study||11
466925|NCT00529542|1114290|P1|STARTED|Overall Study||9
466926|NCT00529529|1114333|P3|NOT COMPLETED|Overall Study||31
466927|NCT00529529|1114334|P2|NOT COMPLETED|Overall Study||43
466928|NCT00529529|1114335|P1|NOT COMPLETED|Overall Study||43
466929|NCT00529529|1114333|P3|COMPLETED|Overall Study||238
466930|NCT00529529|1114334|P2|COMPLETED|Overall Study||225
466931|NCT00529529|1114335|P1|COMPLETED|Overall Study||225
466932|NCT00529529|1114333|P3|STARTED|Overall Study||269
466933|NCT00529529|1114334|P2|STARTED|Overall Study||268
466934|NCT00529529|1114335|P1|STARTED|Overall Study||268
466935|NCT00529516|1114394|P3|NOT COMPLETED|Overall Study||1
466936|NCT00529516|1114395|P2|NOT COMPLETED|Overall Study||2
466937|NCT00529516|1114396|P1|NOT COMPLETED|Overall Study||3
466938|NCT00529516|1114394|P3|COMPLETED|Overall Study||288
466939|NCT00529516|1114395|P2|COMPLETED|Overall Study||486
466940|NCT00529516|1114396|P1|COMPLETED|Overall Study||472
466941|NCT00529516|1114394|P3|STARTED|Overall Study||289
466942|NCT00529516|1114395|P2|STARTED|Overall Study||488
466943|NCT00529516|1114396|P1|STARTED|Overall Study||475
466944|NCT00529464|1114467|P3|NOT COMPLETED|Overall Study||0
466945|NCT00529464|1114468|P2|NOT COMPLETED|Overall Study||0
466946|NCT00529464|1114469|P1|NOT COMPLETED|Overall Study||0
466947|NCT00529464|1114467|P3|COMPLETED|Overall Study||0
466948|NCT00529464|1114468|P2|COMPLETED|Overall Study||0
466949|NCT00529464|1114469|P1|COMPLETED|Overall Study||0
466950|NCT00529464|1114467|P3|STARTED|Overall Study||0
466951|NCT00529464|1114468|P2|STARTED|Overall Study||0
466952|NCT00529464|1114469|P1|STARTED|Overall Study||0
466953|NCT00529451|1114481|P4|NOT COMPLETED|Overall Study||31
466954|NCT00529451|1114482|P3|NOT COMPLETED|Overall Study||40
466955|NCT00529451|1114483|P2|NOT COMPLETED|Overall Study||48
466956|NCT00529451|1114484|P1|NOT COMPLETED|Overall Study||37
466957|NCT00529451|1114481|P4|COMPLETED|Overall Study||299
466958|NCT00529451|1114482|P3|COMPLETED|Overall Study||292
466959|NCT00529451|1114483|P2|COMPLETED|Overall Study||275
466960|NCT00529451|1114484|P1|COMPLETED|Overall Study||294
466961|NCT00529451|1114481|P4|STARTED|Overall Study||330
466962|NCT00529451|1114482|P3|STARTED|Overall Study||332
466963|NCT00529451|1114483|P2|STARTED|Overall Study||323
466964|NCT00529451|1114484|P1|STARTED|Overall Study||331
466965|NCT00529399|1114511|P3|NOT COMPLETED|Overall Study||2
466966|NCT00529399|1114512|P2|NOT COMPLETED|Overall Study||1
466967|NCT00529399|1114513|P1|NOT COMPLETED|Overall Study||2
466968|NCT00529399|1114511|P3|COMPLETED|Overall Study||46
466969|NCT00529399|1114512|P2|COMPLETED|Overall Study||48
466970|NCT00529399|1114513|P1|COMPLETED|Overall Study||46
466971|NCT00529399|1114511|P3|STARTED|Overall Study||48
466972|NCT00529399|1114512|P2|STARTED|Overall Study||49
466973|NCT00529399|1114513|P1|STARTED|Overall Study||48
466974|NCT00529308|1114523|P2|NOT COMPLETED|Overall Study||1
466975|NCT00529308|1114524|P1|NOT COMPLETED|Overall Study||1
466976|NCT00529308|1114523|P2|COMPLETED|Overall Study||10
466977|NCT00529308|1114524|P1|COMPLETED|Overall Study||8
466978|NCT00529308|1114523|P2|STARTED|Overall Study||11
466979|NCT00529308|1114524|P1|STARTED|Overall Study||9
466980|NCT00529282|1114540|P2|NOT COMPLETED|Overall Study||0
466981|NCT00529282|1114541|P1|NOT COMPLETED|Overall Study||0
466982|NCT00529282|1114540|P2|COMPLETED|Overall Study||2
466983|NCT00529282|1114541|P1|COMPLETED|Overall Study||0
466984|NCT00529282|1114540|P2|STARTED|Overall Study||2
466985|NCT00529282|1114541|P1|STARTED|Overall Study||0
466986|NCT00529243|1114553|P1|NOT COMPLETED|Overall Study||3
466987|NCT00529243|1114553|P1|COMPLETED|Overall Study||49
466988|NCT00529243|1114553|P1|STARTED|Overall Study||52
466989|NCT00529217|1114558|P1|NOT COMPLETED|Overall Study||4
466990|NCT00529217|1114558|P1|COMPLETED|Overall Study||8
466991|NCT00529217|1114558|P1|STARTED|Overall Study||12
466992|NCT00529204|1114563|P1|NOT COMPLETED|Overall Study||0
466993|NCT00529204|1114563|P1|COMPLETED|Overall Study||1
466994|NCT00529204|1114563|P1|STARTED|Overall Study||1
466995|NCT00529191|1114571|P2|NOT COMPLETED|Overall Study||0
466996|NCT00529191|1114572|P1|NOT COMPLETED|Overall Study||3
466997|NCT00529191|1114571|P2|COMPLETED|Overall Study||13
466998|NCT00529191|1114572|P1|COMPLETED|Overall Study||24
466999|NCT00529191|1114571|P2|STARTED|Overall Study||13
467000|NCT00529191|1114572|P1|STARTED|Overall Study||27
467001|NCT00529152|1114594|P1|NOT COMPLETED|Overall Study||5
467002|NCT00529152|1114594|P1|COMPLETED|Overall Study||95
467003|NCT00529152|1114594|P1|STARTED|Overall Study||100
467004|NCT00529126|1114602|P4|NOT COMPLETED|Overall Study||0
467005|NCT00529126|1114603|P3|NOT COMPLETED|Overall Study||0
467006|NCT00529126|1114604|P2|NOT COMPLETED|Overall Study||0
467007|NCT00529126|1114605|P1|NOT COMPLETED|Overall Study||0
467008|NCT00529126|1114602|P4|COMPLETED|Overall Study||26
467009|NCT00529126|1114603|P3|COMPLETED|Overall Study||24
467010|NCT00529126|1114604|P2|COMPLETED|Overall Study||25
467011|NCT00529126|1114605|P1|COMPLETED|Overall Study||25
467012|NCT00529126|1114602|P4|STARTED|Overall Study||26
467013|NCT00529126|1114603|P3|STARTED|Overall Study||24
467014|NCT00529126|1114604|P2|STARTED|Overall Study||25
467015|NCT00529126|1114605|P1|STARTED|Overall Study||25
467016|NCT00529100|1114618|P2|NOT COMPLETED|Overall Study||9
467017|NCT00529100|1114619|P1|NOT COMPLETED|Overall Study||0
467018|NCT00529100|1114618|P2|COMPLETED|Overall Study||24
467019|NCT00529100|1114619|P1|COMPLETED|Overall Study||16
467020|NCT00529100|1114618|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
467021|NCT00529100|1114619|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
467022|NCT00529100|1114618|P2|STARTED|Overall Study||33
467023|NCT00529100|1114619|P1|STARTED|Overall Study||16
467024|NCT00529087|1114636|P3|NOT COMPLETED|Overall Study||16
467025|NCT00529087|1114637|P2|NOT COMPLETED|Overall Study||28
467026|NCT00529087|1114638|P1|NOT COMPLETED|Overall Study||28
467027|NCT00529087|1114636|P3|COMPLETED|Overall Study||146
467028|NCT00529087|1114637|P2|COMPLETED|Overall Study||120
467029|NCT00529087|1114638|P1|COMPLETED|Overall Study||122
467030|NCT00529087|1114636|P3|STARTED|Overall Study||162
467031|NCT00529087|1114637|P2|STARTED|Overall Study||148
467032|NCT00529087|1114638|P1|STARTED|Overall Study||150
467033|NCT00529035|1114702|P1|NOT COMPLETED|Overall Study||1
467034|NCT00529035|1114702|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
467035|NCT00529035|1114702|P1|STARTED|Overall Study|29 enrolled|29
467036|NCT00528957|1114715|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||40
467037|NCT00528957|1114716|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||34
467038|NCT00528957|1114715|P2|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
467039|NCT00528957|1114716|P1|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
467040|NCT00528957|1114715|P2|STARTED|Second Extension (Week 144 to Week 240)||40
467041|NCT00528957|1114716|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
467042|NCT00528957|1114715|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
467043|NCT00528957|1114716|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
467044|NCT00528957|1114715|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
467045|NCT00528957|1114716|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
467046|NCT00528957|1114715|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
467047|NCT00528957|1114716|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
467048|NCT00528957|1114715|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
467049|NCT00528957|1114716|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
467050|NCT00528957|1114715|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
467051|NCT00528957|1114716|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
467052|NCT00528957|1114715|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
467053|NCT00528957|1114716|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
467054|NCT00528931|1114759|P1|NOT COMPLETED|Overall Study||1
467055|NCT00528931|1114759|P1|COMPLETED|Overall Study||15
467056|NCT00528931|1114759|P1|STARTED|Overall Study||16
467057|NCT00528879|1114771|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
467058|NCT00528879|1114772|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
467059|NCT00528879|1114773|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
467060|NCT00528879|1114774|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
467061|NCT00528879|1114771|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
467062|NCT00528879|1114772|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
467063|NCT00528879|1114773|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
467064|NCT00528879|1114774|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
467065|NCT00528879|1114771|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
467066|NCT00528879|1114772|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
467067|NCT00528879|1114773|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
467068|NCT00528879|1114774|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
467069|NCT00528879|1114771|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
467070|NCT00528879|1114772|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
467071|NCT00528879|1114773|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
467072|NCT00528879|1114774|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
467073|NCT00528879|1114771|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
467074|NCT00528879|1114772|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
467075|NCT00528879|1114773|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
467076|NCT00528879|1114774|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
467248|NCT00526994|1115325|P1|COMPLETED|Overall Study||801
467077|NCT00528879|1114771|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
467078|NCT00528879|1114772|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
467079|NCT00528879|1114773|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
467080|NCT00528879|1114774|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
467081|NCT00528879|1114771|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
467082|NCT00528879|1114772|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
467083|NCT00528879|1114773|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
467084|NCT00528879|1114774|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
467085|NCT00528866|1114840|P1|NOT COMPLETED|Overall Study||6
467086|NCT00528866|1114840|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
467087|NCT00528866|1114840|P1|STARTED|Overall Study||80
467088|NCT00528840|1114852|P1|NOT COMPLETED|Overall Study||33
467089|NCT00528840|1114852|P1|COMPLETED|Overall Study||168
467090|NCT00528840|1114852|P1|STARTED|Overall Study||201
467091|NCT00528801|1114858|P2|NOT COMPLETED|Overall Study||11
467092|NCT00528801|1114859|P1|NOT COMPLETED|Overall Study||27
467093|NCT00528801|1114858|P2|COMPLETED|Overall Study||41
467094|NCT00528801|1114859|P1|COMPLETED|Overall Study||133
467095|NCT00528801|1114858|P2|STARTED|Overall Study||52
467096|NCT00528801|1114859|P1|STARTED|Overall Study||160
467097|NCT00528788|1114869|P1|NOT COMPLETED|Overall Study||4
467098|NCT00528788|1114869|P1|COMPLETED|Overall Study||20
467099|NCT00528788|1114869|P1|STARTED|Overall Study||24
467100|NCT00528775|1114873|P1|NOT COMPLETED|Overall Study||1
467101|NCT00528775|1114873|P1|COMPLETED|Overall Study||5
467102|NCT00528775|1114873|P1|STARTED|Overall Study||6
467103|NCT00528645|1114881|P1|NOT COMPLETED|Overall Study||3
467104|NCT00528645|1114881|P1|COMPLETED|Overall Study||20
467105|NCT00528645|1114881|P1|STARTED|Overall Study||23
467106|NCT00528606|1114887|P2|NOT COMPLETED|Overall Study||4
467107|NCT00528606|1114888|P1|NOT COMPLETED|Overall Study||13
467108|NCT00528606|1114887|P2|COMPLETED|Overall Study||100
467109|NCT00528606|1114888|P1|COMPLETED|Overall Study||191
467110|NCT00528606|1114887|P2|STARTED|Overall Study||104
467111|NCT00528606|1114888|P1|STARTED|Overall Study||204
467112|NCT00528567|1114896|P2|NOT COMPLETED|Overall Study||308
467113|NCT00528567|1114897|P1|NOT COMPLETED|Overall Study||431
467114|NCT00528567|1114896|P2|COMPLETED|Overall Study||982
467115|NCT00528567|1114897|P1|COMPLETED|Overall Study||870
467116|NCT00528567|1114896|P2|Safety Population|Overall Study||1271
467117|NCT00528567|1114897|P1|Safety Population|Overall Study||1288
467118|NCT00528567|1114896|P2|Intention to Treat|Overall Study||1290
467119|NCT00528567|1114897|P1|Intention to Treat|Overall Study||1301
467120|NCT00528567|1114896|P2|STARTED|Overall Study||1290
467121|NCT00528567|1114897|P1|STARTED|Overall Study||1301
467122|NCT00528541|1114937|P2|NOT COMPLETED|Overall Study||1
467123|NCT00528541|1114938|P1|NOT COMPLETED|Overall Study||2
467124|NCT00528541|1114937|P2|COMPLETED|Overall Study||69
467125|NCT00528541|1114938|P1|COMPLETED|Overall Study||73
467126|NCT00528541|1114937|P2|STARTED|Overall Study||70
467127|NCT00528541|1114938|P1|STARTED|Overall Study||75
467128|NCT00528528|1114964|P4|NOT COMPLETED|Overall Study||3
467129|NCT00528528|1114965|P3|NOT COMPLETED|Overall Study||3
467130|NCT00528528|1114966|P2|NOT COMPLETED|Overall Study||3
467131|NCT00528528|1114967|P1|NOT COMPLETED|Overall Study||3
467132|NCT00528528|1114964|P4|COMPLETED|Overall Study||36
467133|NCT00528528|1114965|P3|COMPLETED|Overall Study||37
467134|NCT00528528|1114966|P2|COMPLETED|Overall Study||39
467135|NCT00528528|1114967|P1|COMPLETED|Overall Study||37
467136|NCT00528528|1114964|P4|Ongoing at Time of Cut-off|Overall Study||0
467137|NCT00528528|1114965|P3|Ongoing at Time of Cut-off|Overall Study||1
467138|NCT00528528|1114966|P2|Ongoing at Time of Cut-off|Overall Study||0
467139|NCT00528528|1114967|P1|Ongoing at Time of Cut-off|Overall Study||0
467140|NCT00528528|1114964|P4|STARTED|Overall Study||39
467141|NCT00528528|1114965|P3|STARTED|Overall Study||40
467142|NCT00528528|1114966|P2|STARTED|Overall Study||42
467143|NCT00528528|1114967|P1|STARTED|Overall Study||40
467144|NCT00528450|1115001|P1|NOT COMPLETED|Overall Study||0
467145|NCT00528450|1115001|P1|COMPLETED|Overall Study||1
467146|NCT00528450|1115001|P1|STARTED|Overall Study||1
467147|NCT00528424|1115005|P1|NOT COMPLETED|Overall Study||29
467148|NCT00528424|1115005|P1|COMPLETED|Overall Study||257
467149|NCT00528424|1115005|P1|STARTED|Overall Study||286
467150|NCT00528411|1115012|P3|NOT COMPLETED|Overall Study||1
467151|NCT00528411|1115013|P2|NOT COMPLETED|Overall Study||3
467152|NCT00528411|1115014|P1|NOT COMPLETED|Overall Study||5
467153|NCT00528411|1115012|P3|COMPLETED|Overall Study||11
467154|NCT00528411|1115013|P2|COMPLETED|Overall Study||51
467155|NCT00528411|1115014|P1|COMPLETED|Overall Study||52
467156|NCT00528411|1115012|P3|STARTED|Overall Study||12
467157|NCT00528411|1115013|P2|STARTED|Overall Study||54
467158|NCT00528411|1115014|P1|STARTED|Overall Study||57
467159|NCT00528398|1115137|P1|NOT COMPLETED|Overall Study||0
467160|NCT00528398|1115137|P1|COMPLETED|Overall Study||111
467161|NCT00528398|1115137|P1|STARTED|Overall Study||111
467162|NCT00528372|1115151|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
467163|NCT00528372|1115152|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
467164|NCT00528372|1115153|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
467165|NCT00528372|1115154|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
467166|NCT00528372|1115155|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
467167|NCT00528372|1115156|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
467168|NCT00528372|1115157|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
467169|NCT00528372|1115158|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
467170|NCT00528372|1115159|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
467171|NCT00528372|1115151|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
467172|NCT00528372|1115152|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
467173|NCT00528372|1115153|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
467174|NCT00528372|1115154|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
467175|NCT00528372|1115155|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
467176|NCT00528372|1115156|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
467177|NCT00528372|1115157|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
467178|NCT00528372|1115158|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
467179|NCT00528372|1115159|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
467180|NCT00528372|1115151|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
467181|NCT00528372|1115152|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
467182|NCT00528372|1115153|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
467183|NCT00528372|1115154|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
467184|NCT00528372|1115155|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
467185|NCT00528372|1115156|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
467186|NCT00528372|1115157|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
467187|NCT00528372|1115158|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
467188|NCT00528372|1115159|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
467189|NCT00528372|1115151|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
467190|NCT00528372|1115152|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
467191|NCT00528372|1115153|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
467192|NCT00528372|1115154|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
467193|NCT00528372|1115155|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
467194|NCT00528372|1115156|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
467195|NCT00528372|1115157|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
467196|NCT00528372|1115158|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
467197|NCT00528372|1115159|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
467198|NCT00528372|1115151|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
467199|NCT00528372|1115152|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
467200|NCT00528372|1115153|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
467201|NCT00528372|1115154|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
467202|NCT00528372|1115155|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
467203|NCT00528372|1115156|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
467204|NCT00528372|1115157|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
467205|NCT00528372|1115158|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
467206|NCT00528372|1115159|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
467207|NCT00528372|1115151|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
467208|NCT00528372|1115152|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
467209|NCT00528372|1115153|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
467210|NCT00528372|1115154|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
467211|NCT00528372|1115155|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
467212|NCT00528372|1115156|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
467213|NCT00528372|1115157|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
467214|NCT00528372|1115158|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
467215|NCT00528372|1115159|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
467216|NCT00528268|1115273|P2|NOT COMPLETED|Overall Study||1
467217|NCT00528268|1115274|P1|NOT COMPLETED|Overall Study||1
467218|NCT00528268|1115273|P2|COMPLETED|Overall Study||7
467219|NCT00528268|1115274|P1|COMPLETED|Overall Study||5
467220|NCT00528268|1115273|P2|STARTED|Overall Study||8
467221|NCT00528268|1115274|P1|STARTED|Overall Study||6
467222|NCT00527124|1115282|P2|NOT COMPLETED|Overall Study||0
467223|NCT00527124|1115283|P1|NOT COMPLETED|Overall Study||0
467224|NCT00527124|1115282|P2|COMPLETED|Overall Study||28
467225|NCT00527124|1115283|P1|COMPLETED|Overall Study||29
467226|NCT00527124|1115282|P2|STARTED|Overall Study||28
467227|NCT00527124|1115283|P1|STARTED|Overall Study||29
467228|NCT00527111|1115291|P2|NOT COMPLETED|Overall Study||22
467229|NCT00527111|1115292|P1|NOT COMPLETED|Overall Study||20
467230|NCT00527111|1115291|P2|COMPLETED|Overall Study||47
467231|NCT00527111|1115292|P1|COMPLETED|Overall Study||50
467232|NCT00527111|1115291|P2|STARTED|Overall Study||69
467233|NCT00527111|1115292|P1|STARTED|Overall Study||70
467234|NCT00527098|1115308|P2|NOT COMPLETED|Overall Study||0
467235|NCT00527098|1115309|P1|NOT COMPLETED|Overall Study||0
467236|NCT00527098|1115308|P2|COMPLETED|Overall Study||83
467237|NCT00527098|1115309|P1|COMPLETED|Overall Study||36
467238|NCT00527098|1115308|P2|STARTED|Overall Study||83
467239|NCT00527098|1115309|P1|STARTED|Overall Study||36
467240|NCT00527072|1115314|P1|NOT COMPLETED|Overall Study||36
467241|NCT00527072|1115314|P1|COMPLETED|Overall Study||179
467242|NCT00527072|1115314|P1|STARTED|Overall Study||215
467243|NCT00526994|1115323|P3|NOT COMPLETED|Overall Study||107
467244|NCT00526994|1115324|P2|NOT COMPLETED|Overall Study||121
467245|NCT00526994|1115325|P1|NOT COMPLETED|Overall Study||108
467246|NCT00526994|1115323|P3|COMPLETED|Overall Study||791
467247|NCT00526994|1115324|P2|COMPLETED|Overall Study||772
467249|NCT00526994|1115323|P3|STARTED|Overall Study||898
467250|NCT00526994|1115324|P2|STARTED|Overall Study||893
467251|NCT00526994|1115325|P1|STARTED|Overall Study||909
467252|NCT00528190|1115344|P2|NOT COMPLETED|Overall Study||1
467253|NCT00528190|1115345|P1|NOT COMPLETED|Overall Study||0
467254|NCT00528190|1115344|P2|COMPLETED|Overall Study||16
467255|NCT00528190|1115345|P1|COMPLETED|Overall Study||18
467256|NCT00528190|1115344|P2|STARTED|Overall Study||17
467257|NCT00528190|1115345|P1|STARTED|Overall Study||18
467258|NCT00528112|1115353|P2|NOT COMPLETED|Extension Phase||157
467259|NCT00528112|1115354|P1|NOT COMPLETED|Extension Phase||0
467260|NCT00528112|1115353|P2|COMPLETED|Extension Phase||550
467261|NCT00528112|1115354|P1|COMPLETED|Extension Phase||0
467262|NCT00528112|1115353|P2|STARTED|Extension Phase||707
467263|NCT00528112|1115354|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
467264|NCT00528112|1115353|P2|NOT COMPLETED|Treatment up to 3 Years||583
467265|NCT00528112|1115354|P1|NOT COMPLETED|Treatment up to 3 Years||613
467266|NCT00528112|1115353|P2|COMPLETED|Treatment up to 3 Years||870
467267|NCT00528112|1115354|P1|COMPLETED|Treatment up to 3 Years||819
467268|NCT00528112|1115353|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
467269|NCT00528112|1115354|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
467270|NCT00528112|1115353|P2|STARTED|Treatment up to 3 Years||1453
467271|NCT00528112|1115354|P1|STARTED|Treatment up to 3 Years||1432
467272|NCT00528021|1115412|P4|NOT COMPLETED|Overall Study||9
467273|NCT00528021|1115413|P3|NOT COMPLETED|Overall Study||7
467274|NCT00528021|1115414|P2|NOT COMPLETED|Overall Study||13
467275|NCT00528021|1115415|P1|NOT COMPLETED|Overall Study||17
467276|NCT00528021|1115412|P4|COMPLETED|Overall Study||47
467277|NCT00528021|1115413|P3|COMPLETED|Overall Study||49
467278|NCT00528021|1115414|P2|COMPLETED|Overall Study||46
467279|NCT00528021|1115415|P1|COMPLETED|Overall Study||42
467280|NCT00528021|1115412|P4|STARTED|Overall Study||56
467281|NCT00528021|1115413|P3|STARTED|Overall Study||56
467282|NCT00528021|1115414|P2|STARTED|Overall Study||59
467283|NCT00528021|1115415|P1|STARTED|Overall Study||59
467284|NCT00527982|1115427|P2|NOT COMPLETED|Overall Study||0
467285|NCT00527982|1115428|P1|NOT COMPLETED|Overall Study||1
467286|NCT00527982|1115427|P2|COMPLETED|Overall Study||0
467287|NCT00527982|1115428|P1|COMPLETED|Overall Study||0
467288|NCT00527982|1115427|P2|STARTED|Overall Study||0
467289|NCT00527982|1115428|P1|STARTED|Overall Study||1
467290|NCT00527943|1115436|P2|NOT COMPLETED|Overall Study||146
467291|NCT00527943|1115437|P1|NOT COMPLETED|Overall Study||160
467292|NCT00527943|1115436|P2|COMPLETED|Overall Study||6327
467293|NCT00527943|1115437|P1|COMPLETED|Overall Study||6311
467294|NCT00527943|1115436|P2|Received Treatment|Overall Study||6446
467295|NCT00527943|1115437|P1|Received Treatment|Overall Study||6441
467296|NCT00527943|1115436|P2|STARTED|Overall Study||6473
467297|NCT00527943|1115437|P1|STARTED|Overall Study||6471
467298|NCT00527904|1115469|P1|NOT COMPLETED|Overall Study||96
467299|NCT00527904|1115469|P1|COMPLETED|Overall Study||143
467300|NCT00527904|1115469|P1|STARTED|Overall Study||239
467301|NCT00527878|1115473|P2|NOT COMPLETED|Intervention 2||0
467302|NCT00527878|1115474|P1|NOT COMPLETED|Intervention 2||0
467303|NCT00527878|1115473|P2|COMPLETED|Intervention 2||4
467304|NCT00527878|1115474|P1|COMPLETED|Intervention 2||5
467305|NCT00527878|1115473|P2|STARTED|Intervention 2||4
467306|NCT00527878|1115474|P1|STARTED|Intervention 2||5
467307|NCT00527878|1115473|P2|NOT COMPLETED|Intervention 1||3
467308|NCT00527878|1115474|P1|NOT COMPLETED|Intervention 1||2
467309|NCT00527878|1115473|P2|COMPLETED|Intervention 1||4
467310|NCT00527878|1115474|P1|COMPLETED|Intervention 1||5
467311|NCT00527878|1115473|P2|STARTED|Intervention 1||7
467312|NCT00527878|1115474|P1|STARTED|Intervention 1||7
467313|NCT00527826|1115488|P2|NOT COMPLETED|Overall Study||26
467314|NCT00527826|1115489|P1|NOT COMPLETED|Overall Study||21
467315|NCT00527826|1115488|P2|COMPLETED|Overall Study||80
467316|NCT00527826|1115489|P1|COMPLETED|Overall Study||87
467317|NCT00527826|1115488|P2|STARTED|Overall Study||106
467318|NCT00527826|1115489|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
467319|NCT00527787|1115538|P2|NOT COMPLETED|Overall Study||63
467320|NCT00527787|1115539|P1|NOT COMPLETED|Overall Study||38
467321|NCT00527787|1115538|P2|COMPLETED|Overall Study||153
467322|NCT00527787|1115539|P1|COMPLETED|Overall Study||180
467323|NCT00527787|1115538|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
467324|NCT00527787|1115539|P1|STARTED|Overall Study||218
467325|NCT00527748|1115561|P1|NOT COMPLETED|Overall Study||3
467326|NCT00527748|1115561|P1|COMPLETED|Overall Study||23
467327|NCT00527748|1115561|P1|STARTED|Overall Study||26
467328|NCT00527735|1115568|P3|NOT COMPLETED|Overall Study||107
467329|NCT00527735|1115569|P2|NOT COMPLETED|Overall Study||107
467330|NCT00527735|1115570|P1|NOT COMPLETED|Overall Study||108
467331|NCT00527735|1115568|P3|COMPLETED|Overall Study|Still on treatment|2
467332|NCT00527735|1115569|P2|COMPLETED|Overall Study|Still on treatment|2
467333|NCT00527735|1115570|P1|COMPLETED|Overall Study|Still on treatment|5
467334|NCT00527735|1115568|P3|STARTED|Overall Study|Treated|109
467335|NCT00527735|1115569|P2|STARTED|Overall Study|Treated|109
467336|NCT00527735|1115570|P1|STARTED|Overall Study|Treated|113
467337|NCT00527722|1115644|P2|NOT COMPLETED|Overall Study||0
467338|NCT00527722|1115645|P1|NOT COMPLETED|Overall Study||0
467339|NCT00527722|1115644|P2|COMPLETED|Overall Study||25
467340|NCT00527722|1115645|P1|COMPLETED|Overall Study||22
467341|NCT00527722|1115644|P2|STARTED|Overall Study||25
467342|NCT00527722|1115645|P1|STARTED|Overall Study||22
467343|NCT00527618|1115651|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
467344|NCT00527618|1115652|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
467345|NCT00527618|1115651|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
467346|NCT00527618|1115652|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
467347|NCT00527618|1115651|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
467348|NCT00527618|1115652|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
467349|NCT00527618|1115651|P2|NOT COMPLETED|Week 13-14 (Washout)||0
467350|NCT00527618|1115652|P1|NOT COMPLETED|Week 13-14 (Washout)||1
467351|NCT00527618|1115651|P2|COMPLETED|Week 13-14 (Washout)||16
467352|NCT00527618|1115652|P1|COMPLETED|Week 13-14 (Washout)||12
467353|NCT00527618|1115651|P2|STARTED|Week 13-14 (Washout)||16
467354|NCT00527618|1115652|P1|STARTED|Week 13-14 (Washout)||13
467355|NCT00527618|1115651|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
467356|NCT00527618|1115652|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
467357|NCT00527618|1115651|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
467358|NCT00527618|1115652|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
467359|NCT00527618|1115651|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
467360|NCT00527618|1115652|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
467361|NCT00527605|1115667|P2|NOT COMPLETED|Overall Study||11
467362|NCT00527605|1115668|P1|NOT COMPLETED|Overall Study||13
467363|NCT00527605|1115667|P2|COMPLETED|Overall Study||116
467364|NCT00527605|1115668|P1|COMPLETED|Overall Study||113
467365|NCT00527605|1115667|P2|STARTED|Overall Study||127
467366|NCT00527605|1115668|P1|STARTED|Overall Study||126
467367|NCT00527592|1115704|P1|NOT COMPLETED|Overall Study||0
467368|NCT00527592|1115704|P1|COMPLETED|Overall Study||54
467369|NCT00527592|1115704|P1|STARTED|Overall Study||54
467370|NCT00527566|1115710|P1|NOT COMPLETED|Overall Study||0
467371|NCT00527566|1115710|P1|COMPLETED|Overall Study||10
467372|NCT00527566|1115710|P1|STARTED|Overall Study||10
467373|NCT00527514|1115719|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
467374|NCT00527514|1115719|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
467375|NCT00527514|1115719|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
467376|NCT00527514|1115719|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
467377|NCT00527514|1115719|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
467378|NCT00527514|1115719|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
467379|NCT00527514|1115719|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
467380|NCT00527514|1115719|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
467381|NCT00527514|1115719|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
467382|NCT00527514|1115719|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
467383|NCT00527514|1115719|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
467384|NCT00527514|1115719|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
467385|NCT00527488|1115735|P4|NOT COMPLETED|Overall Study||0
467386|NCT00527488|1115736|P3|NOT COMPLETED|Overall Study||1
467387|NCT00527488|1115737|P2|NOT COMPLETED|Overall Study||1
467388|NCT00527488|1115738|P1|NOT COMPLETED|Overall Study||0
467389|NCT00527488|1115735|P4|COMPLETED|Overall Study||13
467390|NCT00527488|1115736|P3|COMPLETED|Overall Study||12
467391|NCT00527488|1115737|P2|COMPLETED|Overall Study||12
467392|NCT00527488|1115738|P1|COMPLETED|Overall Study||13
467393|NCT00527488|1115735|P4|STARTED|Overall Study||13
467394|NCT00527488|1115736|P3|STARTED|Overall Study||13
467395|NCT00527488|1115737|P2|STARTED|Overall Study||13
467396|NCT00527488|1115738|P1|STARTED|Overall Study||13
467397|NCT00527475|1115814|P2|NOT COMPLETED|Overall Study||1
467398|NCT00527475|1115815|P1|NOT COMPLETED|Overall Study||3
467399|NCT00527475|1115814|P2|COMPLETED|Overall Study||29
467400|NCT00527475|1115815|P1|COMPLETED|Overall Study||27
467401|NCT00527475|1115814|P2|STARTED|Overall Study||30
467402|NCT00527475|1115815|P1|STARTED|Overall Study||30
467403|NCT00527423|1115821|P1|NOT COMPLETED|Overall Study||37
467404|NCT00527423|1115821|P1|COMPLETED|Overall Study||120
467405|NCT00527423|1115821|P1|STARTED|Overall Study||157
467406|NCT00527397|1115827|P1|NOT COMPLETED|Overall Study||24
467407|NCT00527397|1115827|P1|COMPLETED|Overall Study||0
467408|NCT00527397|1115827|P1|STARTED|Overall Study||24
467409|NCT00527332|1115853|P2|NOT COMPLETED|Overall Study||9
467410|NCT00527332|1115854|P1|NOT COMPLETED|Overall Study||9
467411|NCT00527332|1115853|P2|COMPLETED|Overall Study||80
467412|NCT00527332|1115854|P1|COMPLETED|Overall Study||82
467413|NCT00527332|1115853|P2|STARTED|Overall Study||89
467414|NCT00527332|1115854|P1|STARTED|Overall Study||91
467415|NCT00527319|1115863|P3|NOT COMPLETED|Overall Study||6
467416|NCT00527319|1115864|P2|NOT COMPLETED|Overall Study||4
467417|NCT00527319|1115865|P1|NOT COMPLETED|Overall Study||6
467418|NCT00527319|1115863|P3|COMPLETED|Overall Study||7
467419|NCT00527319|1115864|P2|COMPLETED|Overall Study||8
467420|NCT00527319|1115865|P1|COMPLETED|Overall Study||6
467421|NCT00527319|1115863|P3|STARTED|Overall Study||13
467422|NCT00527319|1115864|P2|STARTED|Overall Study||12
467423|NCT00527319|1115865|P1|STARTED|Overall Study||12
467424|NCT00526890|1115876|P1|NOT COMPLETED|Overall Study||7
467425|NCT00526890|1115876|P1|COMPLETED|Overall Study||14
467426|NCT00526890|1115876|P1|STARTED|Overall Study||21
467427|NCT00526799|1115887|P2|NOT COMPLETED|Overall Study||1
467428|NCT00526799|1115888|P1|NOT COMPLETED|Overall Study||1
467429|NCT00526799|1115887|P2|COMPLETED|Overall Study||13
467430|NCT00526799|1115888|P1|COMPLETED|Overall Study||15
467431|NCT00526799|1115887|P2|STARTED|Overall Study||14
467432|NCT00526799|1115888|P1|STARTED|Overall Study||16
467433|NCT00526669|1115896|P2|NOT COMPLETED|Combined Treatment Phase||8
467434|NCT00526669|1115897|P1|NOT COMPLETED|Combined Treatment Phase||0
467435|NCT00526669|1115896|P2|COMPLETED|Combined Treatment Phase||59
467436|NCT00526669|1115897|P1|COMPLETED|Combined Treatment Phase||0
467437|NCT00526669|1115896|P2|STARTED|Combined Treatment Phase||67
467438|NCT00526669|1115897|P1|STARTED|Combined Treatment Phase||0
467439|NCT00526669|1115896|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
467440|NCT00526669|1115897|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
467441|NCT00526669|1115896|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
467442|NCT00526669|1115897|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
467443|NCT00526669|1115896|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
467444|NCT00526669|1115897|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
467445|NCT00526630|1115926|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
467446|NCT00526630|1115927|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
467447|NCT00526630|1115926|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
467448|NCT00526630|1115927|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
467449|NCT00526630|1115926|P2|STARTED|Second Intervention Period - 12 Weeks||8
467450|NCT00526630|1115927|P1|STARTED|Second Intervention Period - 12 Weeks||12
467451|NCT00526630|1115926|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
467452|NCT00526630|1115927|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
467453|NCT00526630|1115926|P2|COMPLETED|First Intervention Period - 12 Weeks||8
467454|NCT00526630|1115927|P1|COMPLETED|First Intervention Period - 12 Weeks||12
467455|NCT00526630|1115926|P2|STARTED|First Intervention Period - 12 Weeks||11
467456|NCT00526630|1115927|P1|STARTED|First Intervention Period - 12 Weeks||12
467457|NCT00526474|1115957|P2|NOT COMPLETED|Overall Study||272
467458|NCT00526474|1115958|P1|NOT COMPLETED|Overall Study||292
467459|NCT00526474|1115957|P2|COMPLETED|Overall Study||12953
467460|NCT00526474|1115958|P1|COMPLETED|Overall Study||12932
467461|NCT00526474|1115957|P2|Received Study Drug|Overall Study||13186
467462|NCT00526474|1115958|P1|Received Study Drug|Overall Study||13166
467463|NCT00526474|1115957|P2|STARTED|Overall Study||13225
467464|NCT00526474|1115958|P1|STARTED|Overall Study||13224
467465|NCT00526331|1116026|P1|NOT COMPLETED|Overall Study||55
467466|NCT00526331|1116026|P1|COMPLETED|Overall Study||0
467467|NCT00526331|1116026|P1|STARTED|Overall Study||55
467468|NCT00526292|1116030|P1|NOT COMPLETED|Overall Study||0
467469|NCT00526292|1116030|P1|COMPLETED|Overall Study||6
467470|NCT00526292|1116030|P1|STARTED|Overall Study||6
467471|NCT00526227|1116034|P1|NOT COMPLETED|Overall Study||2
467472|NCT00526227|1116034|P1|COMPLETED|Overall Study||79
467473|NCT00526227|1116034|P1|STARTED|Overall Study||81
467474|NCT00526188|1116039|P1|NOT COMPLETED|Overall Study||0
467475|NCT00526188|1116039|P1|COMPLETED|Overall Study||234
467476|NCT00526188|1116039|P1|STARTED|Overall Study||234
467477|NCT00526162|1116045|P1|NOT COMPLETED|Overall Study||3
467478|NCT00526162|1116045|P1|COMPLETED|Overall Study||80
467479|NCT00526162|1116045|P1|STARTED|Overall Study||83
467480|NCT00526123|1116052|P2|NOT COMPLETED|Overall Study||246
467481|NCT00526123|1116053|P1|NOT COMPLETED|Overall Study||264
467482|NCT00526123|1116052|P2|COMPLETED|Overall Study||50
467483|NCT00526123|1116053|P1|COMPLETED|Overall Study||39
467484|NCT00526123|1116052|P2|STARTED|Overall Study|Intent-to-Treat population|296
467485|NCT00526123|1116053|P1|STARTED|Overall Study|Intent-to-Treat population|303
467486|NCT00526110|1116075|P2|NOT COMPLETED|Overall Study||41
467487|NCT00526110|1116076|P1|NOT COMPLETED|Overall Study||2
467488|NCT00526110|1116075|P2|COMPLETED|Overall Study||4
467489|NCT00526110|1116076|P1|COMPLETED|Overall Study||51
467490|NCT00526110|1116075|P2|STARTED|Overall Study||45
467491|NCT00526110|1116076|P1|STARTED|Overall Study||53
467492|NCT00526097|1116085|P2|NOT COMPLETED|Overall Study||56
467493|NCT00526097|1116086|P1|NOT COMPLETED|Overall Study||15
467494|NCT00526097|1116085|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
467495|NCT00526097|1116086|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
467496|NCT00526097|1116085|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
467497|NCT00526097|1116086|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
467498|NCT00526058|1116264|P2|NOT COMPLETED|Period: Second Intervention||0
467499|NCT00526058|1116265|P1|NOT COMPLETED|Period: Second Intervention||0
467500|NCT00526058|1116264|P2|COMPLETED|Period: Second Intervention||9
467501|NCT00526058|1116265|P1|COMPLETED|Period: Second Intervention||9
467502|NCT00526058|1116264|P2|STARTED|Period: Second Intervention||9
467503|NCT00526058|1116265|P1|STARTED|Period: Second Intervention||9
467504|NCT00526058|1116264|P2|NOT COMPLETED|Period: First Intervention||0
467505|NCT00526058|1116265|P1|NOT COMPLETED|Period: First Intervention||0
467506|NCT00526058|1116264|P2|COMPLETED|Period: First Intervention||9
467507|NCT00526058|1116265|P1|COMPLETED|Period: First Intervention||9
467508|NCT00526058|1116264|P2|STARTED|Period: First Intervention||9
467509|NCT00526058|1116265|P1|STARTED|Period: First Intervention||9
467510|NCT00525915|1116273|P2|NOT COMPLETED|Overall Study||9
467511|NCT00525915|1116274|P1|NOT COMPLETED|Overall Study||8
467512|NCT00525915|1116273|P2|COMPLETED|Overall Study||54
467513|NCT00525915|1116274|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
467514|NCT00525915|1116273|P2|STARTED|Overall Study||63
467515|NCT00525915|1116274|P1|STARTED|Overall Study||63
467516|NCT00525902|1116280|P1|NOT COMPLETED|Overall Study||1
467517|NCT00525902|1116280|P1|COMPLETED|Overall Study||30
467518|NCT00525902|1116280|P1|50 Weeks|Overall Study||12
467519|NCT00525902|1116280|P1|10 Weeks|Overall Study||30
467520|NCT00525902|1116280|P1|STARTED|Overall Study||31
467521|NCT00525876|1116287|P2|NOT COMPLETED|Overall Study||0
467522|NCT00525876|1116288|P1|NOT COMPLETED|Overall Study||0
467523|NCT00525876|1116287|P2|COMPLETED|Overall Study||20
467524|NCT00525876|1116288|P1|COMPLETED|Overall Study||16
467525|NCT00525876|1116287|P2|STARTED|Overall Study||20
467526|NCT00525876|1116288|P1|STARTED|Overall Study||16
467527|NCT00525837|1116294|P1|NOT COMPLETED|Overall Study||4
467528|NCT00525837|1116294|P1|COMPLETED|Overall Study||14
467529|NCT00525837|1116294|P1|STARTED|Overall Study||18
467530|NCT00525824|1116302|P4|NOT COMPLETED|Overall Study||15
467531|NCT00525824|1116303|P3|NOT COMPLETED|Overall Study||19
467532|NCT00525824|1116304|P2|NOT COMPLETED|Overall Study||28
467533|NCT00525824|1116305|P1|NOT COMPLETED|Overall Study||19
467534|NCT00525824|1116302|P4|COMPLETED|Overall Study||188
467535|NCT00525824|1116303|P3|COMPLETED|Overall Study||183
467536|NCT00525824|1116304|P2|COMPLETED|Overall Study||186
467537|NCT00525824|1116305|P1|COMPLETED|Overall Study||195
467538|NCT00525824|1116302|P4|STARTED|Overall Study|Randomized population|203
467539|NCT00525824|1116303|P3|STARTED|Overall Study|Randomized population|202
467540|NCT00525824|1116304|P2|STARTED|Overall Study|Randomized population|214
467541|NCT00525824|1116305|P1|STARTED|Overall Study|Randomized population|214
467542|NCT00525798|1116369|P2|NOT COMPLETED|Overall Study||599
467543|NCT00525798|1116370|P1|NOT COMPLETED|Overall Study||756
467544|NCT00525798|1116369|P2|COMPLETED|Overall Study||1732
467545|NCT00525798|1116370|P1|COMPLETED|Overall Study||1578
467546|NCT00525798|1116369|P2|STARTED|Overall Study||2331
467547|NCT00525798|1116370|P1|STARTED|Overall Study||2334
467548|NCT00525733|1116380|P2|NOT COMPLETED|Overall Study||3
467549|NCT00525733|1116381|P1|NOT COMPLETED|Overall Study||3
467550|NCT00525733|1116380|P2|COMPLETED|Overall Study||23
467551|NCT00525733|1116381|P1|COMPLETED|Overall Study||11
467552|NCT00525733|1116380|P2|STARTED|Overall Study||26
467553|NCT00525733|1116381|P1|STARTED|Overall Study||14
467554|NCT00525629|1116389|P2|NOT COMPLETED|Overall Study||5
467555|NCT00525629|1116390|P1|NOT COMPLETED|Overall Study||5
467556|NCT00525629|1116389|P2|COMPLETED|Overall Study||15
467557|NCT00525629|1116390|P1|COMPLETED|Overall Study||15
467558|NCT00525629|1116389|P2|STARTED|Overall Study||20
467559|NCT00525629|1116390|P1|STARTED|Overall Study||20
467560|NCT00525603|1116396|P1|NOT COMPLETED|Overall Study||0
467561|NCT00525603|1116396|P1|COMPLETED|Overall Study||60
467562|NCT00525603|1116396|P1|STARTED|Overall Study||60
467563|NCT00525525|1116402|P2|NOT COMPLETED|Overall Study||0
467564|NCT00525525|1116403|P1|NOT COMPLETED|Overall Study||0
467565|NCT00525525|1116402|P2|COMPLETED|Overall Study||15
467566|NCT00525525|1116403|P1|COMPLETED|Overall Study||59
467567|NCT00525525|1116402|P2|STARTED|Overall Study||15
467568|NCT00525525|1116403|P1|STARTED|Overall Study||59
467569|NCT00525512|1116412|P4|NOT COMPLETED|Open-Label Phase||5
467570|NCT00525512|1116413|P3|NOT COMPLETED|Open-Label Phase||6
467571|NCT00525512|1116414|P2|NOT COMPLETED|Open-Label Phase||0
467572|NCT00525512|1116415|P1|NOT COMPLETED|Open-Label Phase||0
467573|NCT00525512|1116412|P4|COMPLETED|Open-Label Phase||189
467574|NCT00525512|1116413|P3|COMPLETED|Open-Label Phase||158
467575|NCT00525512|1116414|P2|COMPLETED|Open-Label Phase||0
467576|NCT00525512|1116415|P1|COMPLETED|Open-Label Phase||0
467577|NCT00525512|1116412|P4|STARTED|Open-Label Phase||194
467578|NCT00525512|1116413|P3|STARTED|Open-Label Phase||164
467579|NCT00525512|1116414|P2|STARTED|Open-Label Phase||0
467580|NCT00525512|1116415|P1|STARTED|Open-Label Phase||0
467581|NCT00525512|1116412|P4|NOT COMPLETED|Double-Blind Phase||0
467582|NCT00525512|1116413|P3|NOT COMPLETED|Double-Blind Phase||0
467583|NCT00525512|1116414|P2|NOT COMPLETED|Double-Blind Phase||66
467584|NCT00525512|1116415|P1|NOT COMPLETED|Double-Blind Phase||96
467585|NCT00525512|1116412|P4|COMPLETED|Double-Blind Phase||0
467586|NCT00525512|1116413|P3|COMPLETED|Double-Blind Phase||0
467587|NCT00525512|1116414|P2|COMPLETED|Double-Blind Phase||194
467588|NCT00525512|1116415|P1|COMPLETED|Double-Blind Phase||163
467589|NCT00525512|1116412|P4|STARTED|Double-Blind Phase||0
467590|NCT00525512|1116413|P3|STARTED|Double-Blind Phase||0
467591|NCT00525512|1116414|P2|STARTED|Double-Blind Phase||260
467592|NCT00525512|1116415|P1|STARTED|Double-Blind Phase||259
467593|NCT00525499|1116557|P4|NOT COMPLETED|Overall Study||7
467594|NCT00525499|1116558|P3|NOT COMPLETED|Overall Study||7
467595|NCT00525499|1116559|P2|NOT COMPLETED|Overall Study||7
467596|NCT00525499|1116560|P1|NOT COMPLETED|Overall Study||7
467597|NCT00525499|1116557|P4|COMPLETED|Overall Study||39
467598|NCT00525499|1116558|P3|COMPLETED|Overall Study||40
467599|NCT00525499|1116559|P2|COMPLETED|Overall Study||39
467600|NCT00525499|1116560|P1|COMPLETED|Overall Study||40
467601|NCT00525499|1116557|P4|STARTED|Overall Study||46
467602|NCT00525499|1116558|P3|STARTED|Overall Study||47
467603|NCT00525499|1116559|P2|STARTED|Overall Study||46
467604|NCT00525499|1116560|P1|STARTED|Overall Study||47
467605|NCT00525421|1116576|P2|NOT COMPLETED|Overall Study||0
467606|NCT00525421|1116577|P1|NOT COMPLETED|Overall Study||0
467607|NCT00525421|1116576|P2|COMPLETED|Overall Study||10
467608|NCT00525421|1116577|P1|COMPLETED|Overall Study||10
467609|NCT00525421|1116576|P2|STARTED|Overall Study||10
467610|NCT00525421|1116577|P1|STARTED|Overall Study|Enrollment started october 2007|10
467611|NCT00525265|1116587|P2|NOT COMPLETED|Overall Study||0
467612|NCT00525265|1116588|P1|NOT COMPLETED|Overall Study||1
467613|NCT00525265|1116587|P2|COMPLETED|Overall Study||10
467614|NCT00525265|1116588|P1|COMPLETED|Overall Study||9
467615|NCT00525265|1116587|P2|STARTED|Overall Study||10
467616|NCT00525265|1116588|P1|STARTED|Overall Study||10
467617|NCT00525174|1116596|P2|NOT COMPLETED|Overall Study||8
467618|NCT00525174|1116597|P1|NOT COMPLETED|Overall Study||9
467619|NCT00525174|1116596|P2|COMPLETED|Overall Study||81
467620|NCT00525174|1116597|P1|COMPLETED|Overall Study||88
467621|NCT00525174|1116596|P2|STARTED|Overall Study||89
467622|NCT00525174|1116597|P1|STARTED|Overall Study||97
467623|NCT00525161|1116645|P1|NOT COMPLETED|Overall Study||1
467624|NCT00525161|1116645|P1|COMPLETED|Overall Study||10
467625|NCT00525161|1116645|P1|STARTED|Overall Study||11
467626|NCT00525148|1116655|P4|NOT COMPLETED|Overall Study||61
467627|NCT00525148|1116656|P3|NOT COMPLETED|Overall Study||7
467628|NCT00525148|1116657|P2|NOT COMPLETED|Overall Study||38
467629|NCT00525148|1116658|P1|NOT COMPLETED|Overall Study||23
467630|NCT00525148|1116655|P4|COMPLETED|Overall Study||0
467631|NCT00525148|1116656|P3|COMPLETED|Overall Study||0
467632|NCT00525148|1116657|P2|COMPLETED|Overall Study||0
467633|NCT00525148|1116658|P1|COMPLETED|Overall Study||0
467634|NCT00525148|1116655|P4|STARTED|Overall Study|entered and treated|61
467635|NCT00525148|1116656|P3|STARTED|Overall Study|entered and treated|7
467636|NCT00525148|1116657|P2|STARTED|Overall Study|entered and treated|38
467637|NCT00525148|1116658|P1|STARTED|Overall Study|entered and treated|23
467638|NCT00525135|1116676|P1|NOT COMPLETED|Overall Study||0
467639|NCT00525135|1116676|P1|COMPLETED|Overall Study||5
467640|NCT00525135|1116676|P1|STARTED|Overall Study||5
467641|NCT00524940|1116684|P1|NOT COMPLETED|Overall Study||0
467642|NCT00524940|1116684|P1|COMPLETED|Overall Study||124
467643|NCT00524940|1116684|P1|STARTED|Overall Study||124
467644|NCT00524771|1116691|P2|NOT COMPLETED|Overall Study||585
467645|NCT00524771|1116692|P1|NOT COMPLETED|Overall Study||220
467646|NCT00524771|1116691|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
467647|NCT00524771|1116692|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
467648|NCT00524771|1116691|P2|STARTED|Overall Study||17016
467649|NCT00524771|1116692|P1|STARTED|Overall Study||17084
467650|NCT00524745|1116706|P4|NOT COMPLETED|Overall Study||22
467651|NCT00524745|1116707|P3|NOT COMPLETED|Overall Study||29
467652|NCT00524745|1116708|P2|NOT COMPLETED|Overall Study||13
467653|NCT00524745|1116709|P1|NOT COMPLETED|Overall Study||34
467654|NCT00524745|1116706|P4|COMPLETED|Overall Study||205
467655|NCT00524745|1116707|P3|COMPLETED|Overall Study||212
467656|NCT00524745|1116708|P2|COMPLETED|Overall Study||193
467657|NCT00524745|1116709|P1|COMPLETED|Overall Study||195
467658|NCT00524745|1116706|P4|STARTED|Overall Study||227
467659|NCT00524745|1116707|P3|STARTED|Overall Study||241
467660|NCT00524745|1116708|P2|STARTED|Overall Study||206
467661|NCT00524745|1116709|P1|STARTED|Overall Study||229
467662|NCT00524680|1116735|P4|NOT COMPLETED|Overall Study||6
467663|NCT00524680|1116736|P3|NOT COMPLETED|Overall Study||3
467664|NCT00524680|1116737|P2|NOT COMPLETED|Overall Study||1
467665|NCT00524680|1116738|P1|NOT COMPLETED|Overall Study||3
467666|NCT00524680|1116735|P4|COMPLETED|Overall Study||34
467667|NCT00524680|1116736|P3|COMPLETED|Overall Study||33
467668|NCT00524680|1116737|P2|COMPLETED|Overall Study||34
467669|NCT00524680|1116738|P1|COMPLETED|Overall Study||34
467670|NCT00524680|1116735|P4|STARTED|Overall Study||40
467671|NCT00524680|1116736|P3|STARTED|Overall Study||36
467672|NCT00524680|1116737|P2|STARTED|Overall Study||35
467673|NCT00524680|1116738|P1|STARTED|Overall Study||37
467674|NCT00524589|1116760|P1|NOT COMPLETED|Overall Study||18
467675|NCT00524589|1116760|P1|COMPLETED|Overall Study||0
467676|NCT00524589|1116760|P1|STARTED|Overall Study||18
467677|NCT00524576|1116766|P2|NOT COMPLETED|Overall Study||0
467678|NCT00524576|1116767|P1|NOT COMPLETED|Overall Study||0
467679|NCT00524576|1116766|P2|COMPLETED|Overall Study||47
467680|NCT00524576|1116767|P1|COMPLETED|Overall Study||97
467681|NCT00524576|1116766|P2|STARTED|Overall Study||47
467682|NCT00524576|1116767|P1|STARTED|Overall Study||97
467683|NCT00524537|1116785|P1|NOT COMPLETED|Overall Study||2574
467684|NCT00524537|1116785|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
467685|NCT00524537|1116785|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
467686|NCT00524537|1116785|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
467687|NCT00524537|1116785|P1|Discontinued|Overall Study|Discontinued from study|2811
467688|NCT00524537|1116785|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
467689|NCT00524511|1116801|P2|NOT COMPLETED|Overall Study||7
467690|NCT00524511|1116802|P1|NOT COMPLETED|Overall Study||4
467691|NCT00524511|1116801|P2|COMPLETED|Overall Study||61
467692|NCT00524511|1116802|P1|COMPLETED|Overall Study||64
467693|NCT00524511|1116801|P2|STARTED|Overall Study||68
467694|NCT00524511|1116802|P1|STARTED|Overall Study||68
467695|NCT00524485|1116810|P1|NOT COMPLETED|Overall Study||5
467696|NCT00524485|1116810|P1|COMPLETED|Overall Study||7
467697|NCT00524485|1116810|P1|STARTED|Overall Study||12
467698|NCT00524459|1116820|P1|NOT COMPLETED|Overall Study||2
467699|NCT00524459|1116820|P1|COMPLETED|Overall Study||4
467700|NCT00524459|1116820|P1|STARTED|Overall Study||6
467701|NCT00524420|1116830|P2|NOT COMPLETED|Overall Study||0
467702|NCT00524420|1116831|P1|NOT COMPLETED|Overall Study||1
467703|NCT00524420|1116830|P2|COMPLETED|Overall Study||11
467704|NCT00524420|1116831|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
467705|NCT00524420|1116830|P2|STARTED|Overall Study||11
467706|NCT00524420|1116831|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
467707|NCT00524394|1116843|P1|NOT COMPLETED|Overall Study||1
467708|NCT00524394|1116843|P1|COMPLETED|Overall Study||1
467709|NCT00524394|1116843|P1|STARTED|Overall Study||2
467710|NCT00524368|1116849|P2|NOT COMPLETED|Overall Study||48
467711|NCT00524368|1116850|P1|NOT COMPLETED|Overall Study||41
467712|NCT00524368|1116849|P2|COMPLETED|Overall Study||248
467713|NCT00524368|1116850|P1|COMPLETED|Overall Study||253
467714|NCT00524368|1116849|P2|STARTED|Overall Study||296
467715|NCT00524368|1116850|P1|STARTED|Overall Study||294
467716|NCT00524342|1116878|P1|NOT COMPLETED|Overall Study||0
467717|NCT00524342|1116878|P1|COMPLETED|Overall Study||7
467718|NCT00524342|1116878|P1|STARTED|Overall Study||7
467719|NCT00524316|1116883|P1|NOT COMPLETED|Overall Study||16
467720|NCT00524316|1116883|P1|COMPLETED|Overall Study||0
467721|NCT00524316|1116883|P1|STARTED|Overall Study||16
467722|NCT00524303|1116895|P3|NOT COMPLETED|Overall Study||18
467723|NCT00524303|1116896|P2|NOT COMPLETED|Overall Study||10
467724|NCT00524303|1116897|P1|NOT COMPLETED|Overall Study||12
467725|NCT00524303|1116895|P3|COMPLETED|Overall Study||15
467726|NCT00524303|1116896|P2|COMPLETED|Overall Study||24
467727|NCT00524303|1116897|P1|COMPLETED|Overall Study||21
467728|NCT00524303|1116895|P3|STARTED|Overall Study||33
467729|NCT00524303|1116896|P2|STARTED|Overall Study||34
467730|NCT00524303|1116897|P1|STARTED|Overall Study||33
467731|NCT00524264|1116927|P2|NOT COMPLETED|Overall Study||27
467732|NCT00524264|1116928|P1|NOT COMPLETED|Overall Study||20
467733|NCT00524264|1116927|P2|COMPLETED|Overall Study||57
467734|NCT00524264|1116928|P1|COMPLETED|Overall Study||144
467735|NCT00524264|1116927|P2|STARTED|Overall Study||84
467736|NCT00524264|1116928|P1|STARTED|Overall Study||164
467737|NCT00524225|1116940|P1|NOT COMPLETED|Overall Study||0
467738|NCT00524225|1116940|P1|COMPLETED|Overall Study||3
467739|NCT00524225|1116940|P1|STARTED|Overall Study||3
467740|NCT00524134|1116945|P1|NOT COMPLETED|Overall Study||2
467741|NCT00524134|1116945|P1|COMPLETED|Overall Study||4
467742|NCT00524134|1116945|P1|STARTED|Overall Study||6
467743|NCT00524121|1116952|P1|NOT COMPLETED|Overall Study||19
467744|NCT00524121|1116952|P1|COMPLETED|Overall Study||3
467745|NCT00524121|1116952|P1|STARTED|Overall Study||22
467746|NCT00524043|1116972|P3|NOT COMPLETED|Overall Study||31
467747|NCT00524043|1116973|P2|NOT COMPLETED|Overall Study||28
467748|NCT00524043|1116974|P1|NOT COMPLETED|Overall Study||30
467749|NCT00524043|1116972|P3|COMPLETED|Overall Study||35
467750|NCT00524043|1116973|P2|COMPLETED|Overall Study||42
467751|NCT00524043|1116974|P1|COMPLETED|Overall Study||34
467752|NCT00524043|1116972|P3|STARTED|Overall Study||66
467753|NCT00524043|1116973|P2|STARTED|Overall Study||70
467754|NCT00524043|1116974|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
467755|NCT00524030|1116996|P2|NOT COMPLETED|Overall Study||59
467756|NCT00524030|1116997|P1|NOT COMPLETED|Overall Study||17
467757|NCT00524030|1116996|P2|COMPLETED|Overall Study||70
467758|NCT00524030|1116997|P1|COMPLETED|Overall Study||15
467759|NCT00524030|1116996|P2|Completed Taper/Titration Phase|Overall Study||70
467760|NCT00524030|1116997|P1|Completed Taper/Titration Phase|Overall Study||15
467761|NCT00524030|1116996|P2|Completed Double-Blind Treatment Phase|Overall Study||70
467762|NCT00524030|1116997|P1|Completed Double-Blind Treatment Phase|Overall Study||15
467763|NCT00524030|1116996|P2|STARTED|Overall Study||129
467764|NCT00524030|1116997|P1|STARTED|Overall Study||32
467765|NCT00523991|1117015|P2|NOT COMPLETED|Overall Study||27
467766|NCT00523991|1117016|P1|NOT COMPLETED|Overall Study||21
467767|NCT00523991|1117015|P2|COMPLETED|Overall Study||211
467768|NCT00523991|1117016|P1|COMPLETED|Overall Study||198
467769|NCT00523991|1117015|P2|STARTED|Overall Study||238
467770|NCT00523991|1117016|P1|STARTED|Overall Study||219
467771|NCT00523978|1117296|P2|NOT COMPLETED|Overall Study||8
467772|NCT00523978|1117297|P1|NOT COMPLETED|Overall Study||9
467773|NCT00523978|1117296|P2|COMPLETED|Overall Study||79
467774|NCT00523978|1117297|P1|COMPLETED|Overall Study||162
467775|NCT00523978|1117296|P2|STARTED|Overall Study||87
467776|NCT00523978|1117297|P1|STARTED|Overall Study||171
467777|NCT00523939|1117311|P2|NOT COMPLETED|Overall Study||0
467778|NCT00523939|1117312|P1|NOT COMPLETED|Overall Study||0
467779|NCT00523939|1117311|P2|COMPLETED|Overall Study||2
467780|NCT00523939|1117312|P1|COMPLETED|Overall Study||2
467781|NCT00523939|1117311|P2|STARTED|Overall Study||2
467782|NCT00523939|1117312|P1|STARTED|Overall Study||2
467783|NCT00523848|1117319|P1|NOT COMPLETED|Overall Study||24
467784|NCT00523848|1117319|P1|COMPLETED|Overall Study||22
467785|NCT00523848|1117319|P1|Treated With Study Therapy|Overall Study||44
467786|NCT00523848|1117319|P1|STARTED|Overall Study||46
467787|NCT00523809|1117325|P1|NOT COMPLETED|Overall Study||0
467788|NCT00523809|1117325|P1|COMPLETED|Overall Study||5
467789|NCT00523809|1117325|P1|STARTED|Overall Study||5
467790|NCT00523744|1117329|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
467791|NCT00523744|1117329|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
467792|NCT00523744|1117329|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
467793|NCT00523744|1117329|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
467794|NCT00523744|1117329|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
467795|NCT00523744|1117329|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
467796|NCT00523744|1117329|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
467797|NCT00523744|1117329|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
467798|NCT00523744|1117329|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
467799|NCT00523718|1117348|P2|NOT COMPLETED|Overall Study||0
467800|NCT00523718|1117349|P1|NOT COMPLETED|Overall Study||3
467801|NCT00523718|1117348|P2|COMPLETED|Overall Study||18
467802|NCT00523718|1117349|P1|COMPLETED|Overall Study||17
467803|NCT00523718|1117348|P2|STARTED|Overall Study||18
467804|NCT00523718|1117349|P1|STARTED|Overall Study||20
467805|NCT00523705|1117363|P2|NOT COMPLETED|Overall Study||1
467806|NCT00523705|1117364|P1|NOT COMPLETED|Overall Study||0
467807|NCT00523705|1117363|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
467808|NCT00523705|1117364|P1|COMPLETED|Overall Study||7
467809|NCT00523705|1117363|P2|STARTED|Overall Study||4
467810|NCT00523705|1117364|P1|STARTED|Overall Study||7
467811|NCT00523640|1117376|P1|NOT COMPLETED|Overall Study||1
467812|NCT00523640|1117376|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
467813|NCT00523640|1117376|P1|STARTED|Overall Study||30
467814|NCT00523614|1117384|P2|NOT COMPLETED|Overall Study||0
467815|NCT00523614|1117385|P1|NOT COMPLETED|Overall Study||0
467816|NCT00523614|1117384|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
467817|NCT00523614|1117385|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
467818|NCT00523614|1117384|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
467819|NCT00523614|1117385|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
467820|NCT00523549|1117393|P2|NOT COMPLETED|Overall Study||16
467821|NCT00523549|1117394|P1|NOT COMPLETED|Overall Study||19
467822|NCT00523549|1117393|P2|COMPLETED|Overall Study||99
467823|NCT00523549|1117394|P1|COMPLETED|Overall Study||95
467824|NCT00523549|1117393|P2|STARTED|Overall Study||115
467825|NCT00523549|1117394|P1|STARTED|Overall Study||114
467826|NCT00523419|1117412|P1|NOT COMPLETED|Overall Study||32
467827|NCT00523419|1117412|P1|COMPLETED|Overall Study||0
467828|NCT00523419|1117412|P1|STARTED|Overall Study||32
467829|NCT00523367|1117422|P1|NOT COMPLETED|Overall Study||23
467830|NCT00523367|1117422|P1|COMPLETED|Overall Study||2
467831|NCT00523367|1117422|P1|STARTED|Overall Study||25
467832|NCT00523341|1117428|P2|NOT COMPLETED|Overall Study||1000
467833|NCT00523341|1117429|P1|NOT COMPLETED|Overall Study||924
467834|NCT00523341|1117428|P2|COMPLETED|Overall Study||1343
467835|NCT00523341|1117429|P1|COMPLETED|Overall Study||1283
467836|NCT00523341|1117428|P2|Received Treatment|Overall Study||2343
467837|NCT00523341|1117429|P1|Received Treatment|Overall Study||2206
467838|NCT00523341|1117428|P2|STARTED|Overall Study||2343
467839|NCT00523341|1117429|P1|STARTED|Overall Study||2207
467840|NCT00523237|1117529|P1|NOT COMPLETED|Overall Study||0
467841|NCT00523237|1117529|P1|COMPLETED|Overall Study||14
467842|NCT00523237|1117529|P1|STARTED|Overall Study||14
467843|NCT00522951|1117533|P2|NOT COMPLETED|Period 2||1
467844|NCT00522951|1117534|P1|NOT COMPLETED|Period 2||2
467845|NCT00522951|1117533|P2|COMPLETED|Period 2||75
467846|NCT00522951|1117534|P1|COMPLETED|Period 2||84
467847|NCT00522951|1117533|P2|Subjects Received Treatment|Period 2||75
467848|NCT00522951|1117534|P1|Subjects Received Treatment|Period 2||84
467849|NCT00522951|1117533|P2|STARTED|Period 2||76
467850|NCT00522951|1117534|P1|STARTED|Period 2||86
467851|NCT00522951|1117533|P2|NOT COMPLETED|Washout Period||2
467852|NCT00522951|1117534|P1|NOT COMPLETED|Washout Period||0
467853|NCT00522951|1117533|P2|COMPLETED|Washout Period||76
467854|NCT00522951|1117534|P1|COMPLETED|Washout Period||86
467855|NCT00522951|1117533|P2|STARTED|Washout Period||78
467856|NCT00522951|1117534|P1|STARTED|Washout Period||86
467857|NCT00522951|1117533|P2|NOT COMPLETED|Period 1||1
467858|NCT00522951|1117534|P1|NOT COMPLETED|Period 1||0
467859|NCT00522951|1117533|P2|COMPLETED|Period 1||78
467860|NCT00522951|1117534|P1|COMPLETED|Period 1||86
467861|NCT00522951|1117533|P2|Received Treatment|Period 1||78
467862|NCT00522951|1117534|P1|Received Treatment|Period 1||86
467863|NCT00522951|1117533|P2|STARTED|Period 1||79
467864|NCT00522951|1117534|P1|STARTED|Period 1||86
467865|NCT00522925|1117577|P3|NOT COMPLETED|Overall Study||2
467866|NCT00522925|1117578|P2|NOT COMPLETED|Overall Study||1
467867|NCT00522925|1117579|P1|NOT COMPLETED|Overall Study||8
467868|NCT00522925|1117577|P3|COMPLETED|Overall Study||36
467869|NCT00522925|1117578|P2|COMPLETED|Overall Study||38
467870|NCT00522925|1117579|P1|COMPLETED|Overall Study||28
467871|NCT00522925|1117577|P3|STARTED|Overall Study||38
467872|NCT00522925|1117578|P2|STARTED|Overall Study||39
467873|NCT00522925|1117579|P1|STARTED|Overall Study||36
467874|NCT00522873|1117589|P2|NOT COMPLETED|Overall Study||44
467875|NCT00522873|1117590|P1|NOT COMPLETED|Overall Study||96
467876|NCT00522873|1117589|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
467877|NCT00522873|1117590|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
467878|NCT00522873|1117589|P2|Received Treatment|Overall Study||172
467879|NCT00522873|1117590|P1|Received Treatment|Overall Study||489
467880|NCT00522873|1117589|P2|STARTED|Overall Study||172
467881|NCT00522873|1117590|P1|STARTED|Overall Study||490
467882|NCT00522795|1117599|P1|NOT COMPLETED|Overall Study||0
467883|NCT00522795|1117599|P1|COMPLETED|Overall Study||40
467884|NCT00522795|1117599|P1|STARTED|Overall Study||40
467885|NCT00522626|1117603|P1|NOT COMPLETED|Overall Study||7
467886|NCT00522626|1117603|P1|COMPLETED|Overall Study||12
467887|NCT00522626|1117603|P1|STARTED|Overall Study||19
467888|NCT00522457|1117607|P1|NOT COMPLETED|Overall Study||18
467889|NCT00522457|1117607|P1|COMPLETED|Overall Study||1
467890|NCT00522457|1117607|P1|STARTED|Overall Study||19
467891|NCT00522431|1117613|P1|NOT COMPLETED|Overall Study||11
467892|NCT00522431|1117613|P1|COMPLETED|Overall Study||138
467893|NCT00522431|1117613|P1|STARTED|Overall Study||149
467894|NCT00522418|1117620|P2|NOT COMPLETED|Overall Study||58
467895|NCT00522418|1117621|P1|NOT COMPLETED|Overall Study||57
467896|NCT00522418|1117620|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
467897|NCT00522418|1117621|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
467898|NCT00522418|1117620|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
467899|NCT00522418|1117621|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
467900|NCT00522418|1117620|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
467901|NCT00522418|1117621|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
467902|NCT00522418|1117620|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
467903|NCT00522418|1117621|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
467904|NCT00522418|1117620|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
467905|NCT00522418|1117621|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
467906|NCT00522418|1117620|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
467907|NCT00522418|1117621|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
467908|NCT00522418|1117620|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
467909|NCT00522418|1117621|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
467910|NCT00522418|1117620|P2|STARTED|Overall Study||63
467911|NCT00522418|1117621|P1|STARTED|Overall Study||59
467912|NCT00522392|1117669|P2|NOT COMPLETED|Overall Study||13
467913|NCT00522392|1117670|P1|NOT COMPLETED|Overall Study||8
467914|NCT00522392|1117669|P2|COMPLETED|Overall Study||12
467915|NCT00522392|1117670|P1|COMPLETED|Overall Study||15
467916|NCT00522392|1117669|P2|Pts w/ QOL Assessments Complete|Overall Study||8
467917|NCT00522392|1117670|P1|Pts w/ QOL Assessments Complete|Overall Study||12
467918|NCT00522392|1117669|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
467919|NCT00522392|1117670|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
467920|NCT00522392|1117669|P2|STARTED|Overall Study||25
467921|NCT00522392|1117670|P1|STARTED|Overall Study||23
467922|NCT00522379|1117687|P5|NOT COMPLETED|Overall Study||27
467923|NCT00522379|1117688|P4|NOT COMPLETED|Overall Study||14
467924|NCT00522379|1117689|P3|NOT COMPLETED|Overall Study||22
467925|NCT00522379|1117690|P2|NOT COMPLETED|Overall Study||23
467926|NCT00522379|1117691|P1|NOT COMPLETED|Overall Study||22
467927|NCT00522379|1117687|P5|COMPLETED|Overall Study||81
467928|NCT00522379|1117688|P4|COMPLETED|Overall Study||80
467929|NCT00522379|1117689|P3|COMPLETED|Overall Study||82
467930|NCT00522379|1117690|P2|COMPLETED|Overall Study||84
467931|NCT00522379|1117691|P1|COMPLETED|Overall Study||79
467932|NCT00522379|1117687|P5|STARTED|Overall Study||108
467933|NCT00522379|1117688|P4|STARTED|Overall Study||94
467934|NCT00522379|1117689|P3|STARTED|Overall Study||104
467935|NCT00522379|1117690|P2|STARTED|Overall Study||107
467936|NCT00522379|1117691|P1|STARTED|Overall Study||101
467937|NCT00522301|1117793|P1|NOT COMPLETED|Overall Study||6
467938|NCT00522301|1117793|P1|COMPLETED|Overall Study||0
467939|NCT00522301|1117793|P1|STARTED|Overall Study||6
467940|NCT00522275|1117797|P1|NOT COMPLETED|Overall Study||170
467941|NCT00522275|1117797|P1|COMPLETED|Overall Study||138
467942|NCT00522275|1117797|P1|STARTED|Overall Study||308
467943|NCT00522171|1117807|P2|NOT COMPLETED|Overall Study||0
467944|NCT00522171|1117808|P1|NOT COMPLETED|Overall Study||0
467945|NCT00522171|1117807|P2|COMPLETED|Overall Study||15
467946|NCT00522171|1117808|P1|COMPLETED|Overall Study||15
467947|NCT00522171|1117807|P2|STARTED|Overall Study||15
467948|NCT00522171|1117808|P1|STARTED|Overall Study||15
467949|NCT00522041|1117818|P2|NOT COMPLETED|Overall Study||12
467950|NCT00522041|1117819|P1|NOT COMPLETED|Overall Study||17
467951|NCT00522041|1117818|P2|COMPLETED|Overall Study||113
467952|NCT00522041|1117819|P1|COMPLETED|Overall Study||106
467953|NCT00522041|1117818|P2|Received Treatment|Overall Study||124
467954|NCT00522041|1117819|P1|Received Treatment|Overall Study||123
467955|NCT00522041|1117818|P2|STARTED|Overall Study||125
467956|NCT00522041|1117819|P1|STARTED|Overall Study||123
467957|NCT00521989|1117834|P5|NOT COMPLETED|Overall Study||23
467958|NCT00521989|1117835|P4|NOT COMPLETED|Overall Study||12
467959|NCT00521989|1117836|P3|NOT COMPLETED|Overall Study||16
467960|NCT00521989|1117837|P2|NOT COMPLETED|Overall Study||17
467961|NCT00521989|1117838|P1|NOT COMPLETED|Overall Study||20
467962|NCT00521989|1117834|P5|COMPLETED|Overall Study||35
467963|NCT00521989|1117835|P4|COMPLETED|Overall Study||42
467964|NCT00521989|1117836|P3|COMPLETED|Overall Study||41
467965|NCT00521989|1117837|P2|COMPLETED|Overall Study||37
467966|NCT00521989|1117838|P1|COMPLETED|Overall Study||36
467967|NCT00521989|1117834|P5|STARTED|Overall Study||58
467968|NCT00521989|1117835|P4|STARTED|Overall Study||54
467969|NCT00521989|1117836|P3|STARTED|Overall Study||57
467970|NCT00521989|1117837|P2|STARTED|Overall Study||54
467971|NCT00521989|1117838|P1|STARTED|Overall Study||56
467972|NCT00521976|1117850|P1|NOT COMPLETED|Overall Study||0
467973|NCT00521976|1117850|P1|COMPLETED|Overall Study||871
467974|NCT00521976|1117850|P1|STARTED|Overall Study||871
467975|NCT00521924|1117857|P2|NOT COMPLETED|Overall Study||4
467976|NCT00521924|1117858|P1|NOT COMPLETED|Overall Study||4
467977|NCT00521924|1117857|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
467978|NCT00521924|1117858|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
467979|NCT00521924|1117857|P2|STARTED|Overall Study|Subjects randomized|4
467980|NCT00521924|1117858|P1|STARTED|Overall Study|Subjects randomized|4
467981|NCT00521599|1117867|P3|NOT COMPLETED|Overall Study||36
467982|NCT00521599|1117868|P2|NOT COMPLETED|Overall Study||29
467983|NCT00521599|1117869|P1|NOT COMPLETED|Overall Study||25
467984|NCT00521599|1117867|P3|COMPLETED|Overall Study||100
467985|NCT00521599|1117868|P2|COMPLETED|Overall Study||239
467986|NCT00521599|1117869|P1|COMPLETED|Overall Study||243
467987|NCT00521599|1117867|P3|STARTED|Overall Study||136
467988|NCT00521599|1117868|P2|STARTED|Overall Study||268
467989|NCT00521599|1117869|P1|STARTED|Overall Study||268
467990|NCT00521586|1117880|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
467991|NCT00521586|1117881|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
467992|NCT00521586|1117880|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
467993|NCT00521586|1117881|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
467994|NCT00521586|1117880|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
467995|NCT00521586|1117881|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
467996|NCT00521586|1117880|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
467997|NCT00521586|1117881|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
467998|NCT00521586|1117880|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
467999|NCT00521586|1117881|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
468000|NCT00521586|1117880|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
468001|NCT00521586|1117881|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
468002|NCT00521586|1117880|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
468003|NCT00521586|1117881|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
468004|NCT00521586|1117880|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
468005|NCT00521586|1117881|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
468006|NCT00521586|1117880|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
468007|NCT00521586|1117881|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
468008|NCT00521586|1117880|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
468009|NCT00521586|1117881|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
468010|NCT00521586|1117880|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
468011|NCT00521586|1117881|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
468092|NCT00521053|1118083|P1|COMPLETED|Observation Phase||12
468093|NCT00521053|1118083|P1|STARTED|Observation Phase||80
468012|NCT00521586|1117880|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
468013|NCT00521586|1117881|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
468014|NCT00521586|1117880|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
468015|NCT00521586|1117881|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
468016|NCT00521586|1117880|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
468017|NCT00521586|1117881|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
468018|NCT00521586|1117880|P2|STARTED|Initial Vaccination (Year 0)||562
468019|NCT00521586|1117881|P1|STARTED|Initial Vaccination (Year 0)||554
468020|NCT00521456|1117941|P2|NOT COMPLETED|Overall Study||28
468021|NCT00521456|1117942|P1|NOT COMPLETED|Overall Study||13
468022|NCT00521456|1117941|P2|COMPLETED|Overall Study||59
468023|NCT00521456|1117942|P1|COMPLETED|Overall Study||163
468024|NCT00521456|1117941|P2|STARTED|Overall Study||87
468025|NCT00521456|1117942|P1|STARTED|Overall Study||176
468026|NCT00521365|1117954|P1|NOT COMPLETED|Overall Study||20
468027|NCT00521365|1117954|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
468028|NCT00521365|1117954|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
468029|NCT00521365|1117954|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
468116|NCT00520936|1118140|P7|NOT COMPLETED|Overall Study||4
468030|NCT00521365|1117954|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
468031|NCT00521365|1117954|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
468032|NCT00521352|1117973|P2|NOT COMPLETED|Overall Study||3
468033|NCT00521352|1117974|P1|NOT COMPLETED|Overall Study||1
468034|NCT00521352|1117973|P2|COMPLETED|Overall Study||10
468035|NCT00521352|1117974|P1|COMPLETED|Overall Study||11
468036|NCT00521352|1117973|P2|STARTED|Overall Study||13
468037|NCT00521352|1117974|P1|STARTED|Overall Study||12
468038|NCT00521339|1117984|P3|NOT COMPLETED|Observational Follow Up Phase||0
468039|NCT00521339|1117985|P2|NOT COMPLETED|Observational Follow Up Phase||0
468040|NCT00521339|1117986|P1|NOT COMPLETED|Observational Follow Up Phase||0
468041|NCT00521339|1117984|P3|COMPLETED|Observational Follow Up Phase||4
468042|NCT00521339|1117985|P2|COMPLETED|Observational Follow Up Phase||4
468043|NCT00521339|1117986|P1|COMPLETED|Observational Follow Up Phase||14
468044|NCT00521339|1117984|P3|STARTED|Observational Follow Up Phase||4
468045|NCT00521339|1117985|P2|STARTED|Observational Follow Up Phase||4
468046|NCT00521339|1117986|P1|STARTED|Observational Follow Up Phase||14
468047|NCT00521339|1117984|P3|NOT COMPLETED|Treatment Extension Phase||3
468048|NCT00521339|1117985|P2|NOT COMPLETED|Treatment Extension Phase||0
468049|NCT00521339|1117986|P1|NOT COMPLETED|Treatment Extension Phase||0
468050|NCT00521339|1117984|P3|COMPLETED|Treatment Extension Phase||4
468051|NCT00521339|1117985|P2|COMPLETED|Treatment Extension Phase||4
468052|NCT00521339|1117986|P1|COMPLETED|Treatment Extension Phase||0
468053|NCT00521339|1117984|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
468054|NCT00521339|1117985|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
468055|NCT00521339|1117986|P1|STARTED|Treatment Extension Phase||0
468056|NCT00521339|1117984|P3|NOT COMPLETED|Treatment Phase||0
468057|NCT00521339|1117985|P2|NOT COMPLETED|Treatment Phase||0
468058|NCT00521339|1117986|P1|NOT COMPLETED|Treatment Phase||12
468059|NCT00521339|1117984|P3|COMPLETED|Treatment Phase||0
468060|NCT00521339|1117985|P2|COMPLETED|Treatment Phase||0
468061|NCT00521339|1117986|P1|COMPLETED|Treatment Phase||19
468062|NCT00521339|1117984|P3|Received Apremilast|Treatment Phase||0
468063|NCT00521339|1117985|P2|Received Apremilast|Treatment Phase||0
468064|NCT00521339|1117986|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
468065|NCT00521339|1117984|P3|STARTED|Treatment Phase||0
468066|NCT00521339|1117985|P2|STARTED|Treatment Phase||0
468067|NCT00521339|1117986|P1|STARTED|Treatment Phase||31
468068|NCT00521144|1118054|P5|NOT COMPLETED|Overall Study||7
468069|NCT00521144|1118055|P4|NOT COMPLETED|Overall Study||1
468070|NCT00521144|1118056|P3|NOT COMPLETED|Overall Study||2
468071|NCT00521144|1118057|P2|NOT COMPLETED|Overall Study||3
468072|NCT00521144|1118058|P1|NOT COMPLETED|Overall Study||4
468073|NCT00521144|1118054|P5|COMPLETED|Overall Study||0
468074|NCT00521144|1118055|P4|COMPLETED|Overall Study||0
468075|NCT00521144|1118056|P3|COMPLETED|Overall Study||1
468076|NCT00521144|1118057|P2|COMPLETED|Overall Study||2
468077|NCT00521144|1118058|P1|COMPLETED|Overall Study||2
468078|NCT00521144|1118054|P5|STARTED|Overall Study||7
468079|NCT00521144|1118055|P4|STARTED|Overall Study||1
468080|NCT00521144|1118056|P3|STARTED|Overall Study||3
468081|NCT00521144|1118057|P2|STARTED|Overall Study||5
468082|NCT00521144|1118058|P1|STARTED|Overall Study||6
468083|NCT00521079|1118072|P2|NOT COMPLETED|Overall Study||5
468084|NCT00521079|1118073|P1|NOT COMPLETED|Overall Study||14
468085|NCT00521079|1118072|P2|COMPLETED|Overall Study||97
468086|NCT00521079|1118073|P1|COMPLETED|Overall Study||178
468087|NCT00521079|1118072|P2|Surgical Roll-In|Overall Study||5
468088|NCT00521079|1118073|P1|Surgical Roll-In|Overall Study||9
468089|NCT00521079|1118072|P2|STARTED|Overall Study||102
468090|NCT00521079|1118073|P1|STARTED|Overall Study||192
468091|NCT00521053|1118083|P1|NOT COMPLETED|Observation Phase||68
468094|NCT00521053|1118083|P1|NOT COMPLETED|Treatment Phase||0
468095|NCT00521053|1118083|P1|COMPLETED|Treatment Phase||80
468096|NCT00521053|1118083|P1|Received 4 Cycles of PV-10|Treatment Phase||3
468097|NCT00521053|1118083|P1|Received 3 Cycles of PV-10|Treatment Phase||16
468098|NCT00521053|1118083|P1|Received 2 Cycles of PV-10|Treatment Phase||26
468099|NCT00521053|1118083|P1|Received 1 Cycle of PV-10|Treatment Phase||35
468100|NCT00521053|1118083|P1|STARTED|Treatment Phase||80
468101|NCT00521014|1118093|P1|NOT COMPLETED|Overall Study||1
468102|NCT00521014|1118093|P1|COMPLETED|Overall Study||13
468103|NCT00521014|1118093|P1|STARTED|Overall Study||14
468104|NCT00521001|1118097|P1|NOT COMPLETED|Overall Study||1
468105|NCT00521001|1118097|P1|COMPLETED|Overall Study||48
468106|NCT00521001|1118097|P1|STARTED|Overall Study||49
468107|NCT00520975|1118106|P2|NOT COMPLETED|Overall Study||48
468108|NCT00520975|1118107|P1|NOT COMPLETED|Overall Study||48
468109|NCT00520975|1118106|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
468110|NCT00520975|1118107|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
468111|NCT00520975|1118106|P2|Treated and Reported Adverse Events Data|Overall Study||45
468112|NCT00520975|1118107|P1|Treated and Reported Adverse Events Data|Overall Study||47
468113|NCT00520975|1118106|P2|STARTED|Overall Study||48
468114|NCT00520975|1118107|P1|STARTED|Overall Study||48
468115|NCT00520936|1118139|P8|NOT COMPLETED|Overall Study||1
468117|NCT00520936|1118141|P6|NOT COMPLETED|Overall Study||0
468118|NCT00520936|1118142|P5|NOT COMPLETED|Overall Study||1
468119|NCT00520936|1118143|P4|NOT COMPLETED|Overall Study||0
468120|NCT00520936|1118144|P3|NOT COMPLETED|Overall Study||2
468121|NCT00520936|1118145|P2|NOT COMPLETED|Overall Study||4
468122|NCT00520936|1118146|P1|NOT COMPLETED|Overall Study||0
468123|NCT00520936|1118139|P8|COMPLETED|Overall Study||9
468124|NCT00520936|1118140|P7|COMPLETED|Overall Study||7
468125|NCT00520936|1118141|P6|COMPLETED|Overall Study||10
468126|NCT00520936|1118142|P5|COMPLETED|Overall Study||5
468127|NCT00520936|1118143|P4|COMPLETED|Overall Study||5
468128|NCT00520936|1118144|P3|COMPLETED|Overall Study||7
468129|NCT00520936|1118145|P2|COMPLETED|Overall Study||7
468130|NCT00520936|1118146|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
468131|NCT00520936|1118139|P8|STARTED|Overall Study||10
468132|NCT00520936|1118140|P7|STARTED|Overall Study||11
468133|NCT00520936|1118141|P6|STARTED|Overall Study||10
468134|NCT00520936|1118142|P5|STARTED|Overall Study||6
468135|NCT00520936|1118143|P4|STARTED|Overall Study||5
468136|NCT00520936|1118144|P3|STARTED|Overall Study||9
468137|NCT00520936|1118145|P2|STARTED|Overall Study||11
468138|NCT00520936|1118146|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
468139|NCT00520845|1118173|P1|NOT COMPLETED|Overall Study||22
468140|NCT00520845|1118173|P1|COMPLETED|Overall Study||1
468141|NCT00520845|1118173|P1|STARTED|Overall Study||23
468142|NCT00520767|1118181|P1|NOT COMPLETED|Overall Study||2
468143|NCT00520767|1118181|P1|COMPLETED|Overall Study||33
468144|NCT00520767|1118181|P1|STARTED|Overall Study||35
468145|NCT00520741|1118187|P2|NOT COMPLETED|Overall Study||125
468146|NCT00520741|1118188|P1|NOT COMPLETED|Overall Study||37
468147|NCT00520741|1118187|P2|COMPLETED|Overall Study||194
468148|NCT00520741|1118188|P1|COMPLETED|Overall Study||69
468149|NCT00520741|1118187|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
468150|NCT00520741|1118188|P1|STARTED|Overall Study||106
468151|NCT00520676|1118206|P2|NOT COMPLETED|Overall Study||103
468152|NCT00520676|1118207|P1|NOT COMPLETED|Overall Study||101
468153|NCT00520676|1118206|P2|COMPLETED|Overall Study||29
468154|NCT00520676|1118207|P1|COMPLETED|Overall Study||27
468155|NCT00520676|1118206|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
468156|NCT00520676|1118207|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
468157|NCT00520676|1118206|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
468158|NCT00520676|1118207|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
468159|NCT00520676|1118206|P2|STARTED|Overall Study||132
468160|NCT00520676|1118207|P1|STARTED|Overall Study||128
468161|NCT00520572|1118233|P6|NOT COMPLETED|Overall Study||2
468162|NCT00520572|1118234|P5|NOT COMPLETED|Overall Study||12
468163|NCT00520572|1118235|P4|NOT COMPLETED|Overall Study||14
468164|NCT00520572|1118236|P3|NOT COMPLETED|Overall Study||15
468165|NCT00520572|1118237|P2|NOT COMPLETED|Overall Study||14
468166|NCT00520572|1118238|P1|NOT COMPLETED|Overall Study||12
468167|NCT00520572|1118233|P6|COMPLETED|Overall Study|Participants completed the study.|62
468168|NCT00520572|1118234|P5|COMPLETED|Overall Study|Participants completed the study.|53
468169|NCT00520572|1118235|P4|COMPLETED|Overall Study|Participants completed the study.|50
468170|NCT00520572|1118236|P3|COMPLETED|Overall Study|Participants completed the study.|49
468171|NCT00520572|1118237|P2|COMPLETED|Overall Study|Participants completed the study.|50
468172|NCT00520572|1118238|P1|COMPLETED|Overall Study|Participants completed the study.|52
468173|NCT00520572|1118233|P6|STARTED|Overall Study|Participants randomised.|64
468174|NCT00520572|1118234|P5|STARTED|Overall Study|Participants randomised.|65
468175|NCT00520572|1118235|P4|STARTED|Overall Study|Participants randomised.|64
468176|NCT00520572|1118236|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
468177|NCT00520572|1118237|P2|STARTED|Overall Study|Participants randomised.|64
468268|NCT00519636|1118469|P1|STARTED|Post Study Period||69
468178|NCT00520572|1118238|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
468179|NCT00520546|1118276|P1|NOT COMPLETED|Overall Study||6
468180|NCT00520546|1118276|P1|COMPLETED|Overall Study||38
468181|NCT00520546|1118276|P1|STARTED|Overall Study||44
468182|NCT00519831|1118291|P1|NOT COMPLETED|Overall Study||3
468183|NCT00519831|1118291|P1|COMPLETED|Overall Study||13
468184|NCT00519831|1118291|P1|STARTED|Overall Study||16
468185|NCT00519818|1118298|P1|NOT COMPLETED|Overall Study||0
468186|NCT00519818|1118298|P1|COMPLETED|Overall Study||14
468187|NCT00519818|1118298|P1|STARTED|Overall Study||14
468188|NCT00519779|1118308|P2|NOT COMPLETED|Overall Study||1
468189|NCT00519779|1118309|P1|NOT COMPLETED|Overall Study||0
468190|NCT00519779|1118308|P2|COMPLETED|Overall Study||33
468191|NCT00519779|1118309|P1|COMPLETED|Overall Study||34
468192|NCT00519779|1118308|P2|STARTED|Overall Study||34
468193|NCT00519779|1118309|P1|STARTED|Overall Study||34
468194|NCT00520494|1118325|P1|NOT COMPLETED|Overall Study||1
468195|NCT00520494|1118325|P1|COMPLETED|Overall Study||17
468196|NCT00520494|1118325|P1|STARTED|Overall Study||18
468197|NCT00520468|1118348|P1|NOT COMPLETED|Overall Study||0
468198|NCT00520468|1118348|P1|COMPLETED|Overall Study||14
468199|NCT00520468|1118348|P1|STARTED|Overall Study||14
468200|NCT00520403|1118352|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
468201|NCT00520403|1118352|P1|COMPLETED|Bevacizumab Monotherapy||0
468202|NCT00520403|1118352|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
468203|NCT00520403|1118352|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
468204|NCT00520403|1118352|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
468205|NCT00520403|1118352|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
468206|NCT00520351|1118361|P2|NOT COMPLETED|Second Intervention||0
468207|NCT00520351|1118362|P1|NOT COMPLETED|Second Intervention||0
468208|NCT00520351|1118361|P2|COMPLETED|Second Intervention||14
468209|NCT00520351|1118362|P1|COMPLETED|Second Intervention||14
468210|NCT00520351|1118361|P2|STARTED|Second Intervention||14
468211|NCT00520351|1118362|P1|STARTED|Second Intervention||14
468212|NCT00520351|1118361|P2|NOT COMPLETED|First Intervention||1
468213|NCT00520351|1118362|P1|NOT COMPLETED|First Intervention||1
468214|NCT00520351|1118361|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
468215|NCT00520351|1118362|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
468216|NCT00520351|1118361|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
468217|NCT00520351|1118362|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
468218|NCT00520299|1118377|P3|NOT COMPLETED|Overall Study||6
468219|NCT00520299|1118378|P2|NOT COMPLETED|Overall Study||3
468220|NCT00520299|1118379|P1|NOT COMPLETED|Overall Study||0
468221|NCT00520299|1118377|P3|COMPLETED|Overall Study||13
468222|NCT00520299|1118378|P2|COMPLETED|Overall Study||3
468223|NCT00520299|1118379|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
468224|NCT00520299|1118377|P3|STARTED|Overall Study||19
468225|NCT00520299|1118378|P2|STARTED|Overall Study||6
468226|NCT00520299|1118379|P1|STARTED|Overall Study||6
468227|NCT00520286|1118410|P2|NOT COMPLETED|Overall Study||32
468228|NCT00520286|1118411|P1|NOT COMPLETED|Overall Study||66
468229|NCT00520286|1118410|P2|COMPLETED|Overall Study||36
468230|NCT00520286|1118411|P1|COMPLETED|Overall Study||76
468231|NCT00520286|1118410|P2|STARTED|Overall Study||68
468232|NCT00520286|1118411|P1|STARTED|Overall Study||142
468233|NCT00520234|1118421|P2|NOT COMPLETED|Overall Study||2
468234|NCT00520234|1118422|P1|NOT COMPLETED|Overall Study||1
468235|NCT00520234|1118421|P2|COMPLETED|Overall Study||102
468236|NCT00520234|1118422|P1|COMPLETED|Overall Study||117
468237|NCT00520234|1118421|P2|STARTED|Overall Study||104
468238|NCT00520234|1118422|P1|STARTED|Overall Study||118
468239|NCT00520013|1118435|P3|NOT COMPLETED|Overall Study||11
468240|NCT00520013|1118436|P2|NOT COMPLETED|Overall Study||15
468241|NCT00520013|1118437|P1|NOT COMPLETED|Overall Study||12
468242|NCT00520013|1118435|P3|COMPLETED|Overall Study||0
468243|NCT00520013|1118436|P2|COMPLETED|Overall Study||10
468244|NCT00520013|1118437|P1|COMPLETED|Overall Study||11
468245|NCT00520013|1118435|P3|Treated|Overall Study||11
468246|NCT00520013|1118436|P2|Treated|Overall Study||25
468247|NCT00520013|1118437|P1|Treated|Overall Study||23
468248|NCT00520013|1118435|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
468249|NCT00520013|1118436|P2|STARTED|Overall Study||25
468250|NCT00520013|1118437|P1|STARTED|Overall Study||23
468251|NCT00519896|1118447|P1|NOT COMPLETED|Overall Study||2
468252|NCT00519896|1118447|P1|COMPLETED|Overall Study||33
468253|NCT00519896|1118447|P1|STARTED|Overall Study||35
468254|NCT00519649|1118453|P1|NOT COMPLETED|Overall Study||1
468255|NCT00519649|1118453|P1|COMPLETED|Overall Study||299
468256|NCT00519649|1118453|P1|STARTED|Overall Study||300
468257|NCT00519636|1118466|P4|NOT COMPLETED|Post Study Period||1
468258|NCT00519636|1118467|P3|NOT COMPLETED|Post Study Period||0
468259|NCT00519636|1118468|P2|NOT COMPLETED|Post Study Period||0
468260|NCT00519636|1118469|P1|NOT COMPLETED|Post Study Period||0
468261|NCT00519636|1118466|P4|COMPLETED|Post Study Period||85
468262|NCT00519636|1118467|P3|COMPLETED|Post Study Period||74
468263|NCT00519636|1118468|P2|COMPLETED|Post Study Period||71
468264|NCT00519636|1118469|P1|COMPLETED|Post Study Period||69
468265|NCT00519636|1118466|P4|STARTED|Post Study Period||86
468266|NCT00519636|1118467|P3|STARTED|Post Study Period||74
468267|NCT00519636|1118468|P2|STARTED|Post Study Period||71
468269|NCT00519636|1118466|P4|NOT COMPLETED|Treatment Period 2||2
468270|NCT00519636|1118467|P3|NOT COMPLETED|Treatment Period 2||1
468271|NCT00519636|1118468|P2|NOT COMPLETED|Treatment Period 2||1
468272|NCT00519636|1118469|P1|NOT COMPLETED|Treatment Period 2||0
468273|NCT00519636|1118466|P4|COMPLETED|Treatment Period 2||86
468274|NCT00519636|1118467|P3|COMPLETED|Treatment Period 2||74
468275|NCT00519636|1118468|P2|COMPLETED|Treatment Period 2||71
468276|NCT00519636|1118469|P1|COMPLETED|Treatment Period 2||69
468277|NCT00519636|1118466|P4|STARTED|Treatment Period 2||88
468278|NCT00519636|1118467|P3|STARTED|Treatment Period 2||75
468279|NCT00519636|1118468|P2|STARTED|Treatment Period 2||72
468280|NCT00519636|1118469|P1|STARTED|Treatment Period 2||69
468281|NCT00519636|1118466|P4|NOT COMPLETED|Washout Period||5
468282|NCT00519636|1118467|P3|NOT COMPLETED|Washout Period||14
468283|NCT00519636|1118468|P2|NOT COMPLETED|Washout Period||14
468284|NCT00519636|1118469|P1|NOT COMPLETED|Washout Period||20
468285|NCT00519636|1118466|P4|COMPLETED|Washout Period||88
468286|NCT00519636|1118467|P3|COMPLETED|Washout Period||75
468287|NCT00519636|1118468|P2|COMPLETED|Washout Period||72
468288|NCT00519636|1118469|P1|COMPLETED|Washout Period||69
468289|NCT00519636|1118466|P4|STARTED|Washout Period||93
468290|NCT00519636|1118467|P3|STARTED|Washout Period||89
468291|NCT00519636|1118468|P2|STARTED|Washout Period||86
468292|NCT00519636|1118469|P1|STARTED|Washout Period||89
468293|NCT00519636|1118466|P4|NOT COMPLETED|Treatment Period 1||0
468294|NCT00519636|1118467|P3|NOT COMPLETED|Treatment Period 1||1
468295|NCT00519636|1118468|P2|NOT COMPLETED|Treatment Period 1||0
468296|NCT00519636|1118469|P1|NOT COMPLETED|Treatment Period 1||2
468297|NCT00519636|1118466|P4|COMPLETED|Treatment Period 1||93
468298|NCT00519636|1118467|P3|COMPLETED|Treatment Period 1||89
468299|NCT00519636|1118468|P2|COMPLETED|Treatment Period 1||86
468300|NCT00519636|1118469|P1|COMPLETED|Treatment Period 1||89
468301|NCT00519636|1118466|P4|STARTED|Treatment Period 1||93
468302|NCT00519636|1118467|P3|STARTED|Treatment Period 1||90
468303|NCT00519636|1118468|P2|STARTED|Treatment Period 1||86
468304|NCT00519636|1118469|P1|STARTED|Treatment Period 1||91
468305|NCT00519623|1118499|P1|NOT COMPLETED|Overall Study||1
468306|NCT00519623|1118499|P1|COMPLETED|Overall Study||8
468307|NCT00519623|1118499|P1|STARTED|Overall Study||9
468308|NCT00519532|1118504|P1|NOT COMPLETED|Overall Study||18
468309|NCT00519532|1118504|P1|COMPLETED|Overall Study||66
468310|NCT00519532|1118504|P1|STARTED|Overall Study||84
468311|NCT00519376|1118511|P16|NOT COMPLETED|Treatment Period 4||0
468312|NCT00519376|1118512|P15|NOT COMPLETED|Treatment Period 4||0
468313|NCT00519376|1118513|P14|NOT COMPLETED|Treatment Period 4||0
468314|NCT00519376|1118514|P13|NOT COMPLETED|Treatment Period 4||0
468315|NCT00519376|1118515|P12|NOT COMPLETED|Treatment Period 4||0
468316|NCT00519376|1118516|P11|NOT COMPLETED|Treatment Period 4||0
468317|NCT00519376|1118517|P10|NOT COMPLETED|Treatment Period 4||0
468318|NCT00519376|1118518|P9|NOT COMPLETED|Treatment Period 4||0
468319|NCT00519376|1118519|P8|NOT COMPLETED|Treatment Period 4||0
468320|NCT00519376|1118520|P7|NOT COMPLETED|Treatment Period 4||0
468321|NCT00519376|1118521|P6|NOT COMPLETED|Treatment Period 4||0
468322|NCT00519376|1118522|P5|NOT COMPLETED|Treatment Period 4||0
468323|NCT00519376|1118523|P4|NOT COMPLETED|Treatment Period 4||0
468324|NCT00519376|1118524|P3|NOT COMPLETED|Treatment Period 4||1
468325|NCT00519376|1118525|P2|NOT COMPLETED|Treatment Period 4||0
468326|NCT00519376|1118526|P1|NOT COMPLETED|Treatment Period 4||0
468327|NCT00519376|1118511|P16|COMPLETED|Treatment Period 4||1
468328|NCT00519376|1118512|P15|COMPLETED|Treatment Period 4||1
468329|NCT00519376|1118513|P14|COMPLETED|Treatment Period 4||1
468330|NCT00519376|1118514|P13|COMPLETED|Treatment Period 4||0
468331|NCT00519376|1118515|P12|COMPLETED|Treatment Period 4||1
468332|NCT00519376|1118516|P11|COMPLETED|Treatment Period 4||1
468333|NCT00519376|1118517|P10|COMPLETED|Treatment Period 4||1
468334|NCT00519376|1118518|P9|COMPLETED|Treatment Period 4||1
468335|NCT00519376|1118519|P8|COMPLETED|Treatment Period 4||1
468336|NCT00519376|1118520|P7|COMPLETED|Treatment Period 4||1
468337|NCT00519376|1118521|P6|COMPLETED|Treatment Period 4||1
468338|NCT00519376|1118522|P5|COMPLETED|Treatment Period 4||1
468339|NCT00519376|1118523|P4|COMPLETED|Treatment Period 4||2
468340|NCT00519376|1118524|P3|COMPLETED|Treatment Period 4||1
468341|NCT00519376|1118525|P2|COMPLETED|Treatment Period 4||2
468342|NCT00519376|1118526|P1|COMPLETED|Treatment Period 4||2
468343|NCT00519376|1118511|P16|STARTED|Treatment Period 4||1
468344|NCT00519376|1118512|P15|STARTED|Treatment Period 4||1
468345|NCT00519376|1118513|P14|STARTED|Treatment Period 4||1
468346|NCT00519376|1118514|P13|STARTED|Treatment Period 4||0
468347|NCT00519376|1118515|P12|STARTED|Treatment Period 4||1
468348|NCT00519376|1118516|P11|STARTED|Treatment Period 4||1
468349|NCT00519376|1118517|P10|STARTED|Treatment Period 4||1
468350|NCT00519376|1118518|P9|STARTED|Treatment Period 4||1
468351|NCT00519376|1118519|P8|STARTED|Treatment Period 4||1
468352|NCT00519376|1118520|P7|STARTED|Treatment Period 4||1
468353|NCT00519376|1118521|P6|STARTED|Treatment Period 4||1
468354|NCT00519376|1118522|P5|STARTED|Treatment Period 4||1
468355|NCT00519376|1118523|P4|STARTED|Treatment Period 4||2
468356|NCT00519376|1118524|P3|STARTED|Treatment Period 4||2
468357|NCT00519376|1118525|P2|STARTED|Treatment Period 4||2
468358|NCT00519376|1118526|P1|STARTED|Treatment Period 4||2
468359|NCT00519376|1118511|P16|NOT COMPLETED|Washout Period 3||0
468360|NCT00519376|1118512|P15|NOT COMPLETED|Washout Period 3||0
468361|NCT00519376|1118513|P14|NOT COMPLETED|Washout Period 3||0
468362|NCT00519376|1118514|P13|NOT COMPLETED|Washout Period 3||0
468363|NCT00519376|1118515|P12|NOT COMPLETED|Washout Period 3||0
468364|NCT00519376|1118516|P11|NOT COMPLETED|Washout Period 3||0
468365|NCT00519376|1118517|P10|NOT COMPLETED|Washout Period 3||0
468366|NCT00519376|1118518|P9|NOT COMPLETED|Washout Period 3||0
468367|NCT00519376|1118519|P8|NOT COMPLETED|Washout Period 3||0
468368|NCT00519376|1118520|P7|NOT COMPLETED|Washout Period 3||0
468369|NCT00519376|1118521|P6|NOT COMPLETED|Washout Period 3||0
468370|NCT00519376|1118522|P5|NOT COMPLETED|Washout Period 3||0
468371|NCT00519376|1118523|P4|NOT COMPLETED|Washout Period 3||0
468372|NCT00519376|1118524|P3|NOT COMPLETED|Washout Period 3||0
468373|NCT00519376|1118525|P2|NOT COMPLETED|Washout Period 3||0
468374|NCT00519376|1118526|P1|NOT COMPLETED|Washout Period 3||0
468375|NCT00519376|1118511|P16|COMPLETED|Washout Period 3||1
468376|NCT00519376|1118512|P15|COMPLETED|Washout Period 3||1
468377|NCT00519376|1118513|P14|COMPLETED|Washout Period 3||1
468378|NCT00519376|1118514|P13|COMPLETED|Washout Period 3||0
468379|NCT00519376|1118515|P12|COMPLETED|Washout Period 3||1
468380|NCT00519376|1118516|P11|COMPLETED|Washout Period 3||1
468381|NCT00519376|1118517|P10|COMPLETED|Washout Period 3||1
468382|NCT00519376|1118518|P9|COMPLETED|Washout Period 3||1
468383|NCT00519376|1118519|P8|COMPLETED|Washout Period 3||1
468384|NCT00519376|1118520|P7|COMPLETED|Washout Period 3||1
468385|NCT00519376|1118521|P6|COMPLETED|Washout Period 3||1
468386|NCT00519376|1118522|P5|COMPLETED|Washout Period 3||1
468387|NCT00519376|1118523|P4|COMPLETED|Washout Period 3||2
468388|NCT00519376|1118524|P3|COMPLETED|Washout Period 3||2
468389|NCT00519376|1118525|P2|COMPLETED|Washout Period 3||2
468390|NCT00519376|1118526|P1|COMPLETED|Washout Period 3||2
468391|NCT00519376|1118511|P16|STARTED|Washout Period 3||1
468392|NCT00519376|1118512|P15|STARTED|Washout Period 3||1
468393|NCT00519376|1118513|P14|STARTED|Washout Period 3||1
468394|NCT00519376|1118514|P13|STARTED|Washout Period 3||0
468395|NCT00519376|1118515|P12|STARTED|Washout Period 3||1
468396|NCT00519376|1118516|P11|STARTED|Washout Period 3||1
468397|NCT00519376|1118517|P10|STARTED|Washout Period 3||1
468398|NCT00519376|1118518|P9|STARTED|Washout Period 3||1
468399|NCT00519376|1118519|P8|STARTED|Washout Period 3||1
468400|NCT00519376|1118520|P7|STARTED|Washout Period 3||1
468401|NCT00519376|1118521|P6|STARTED|Washout Period 3||1
468402|NCT00519376|1118522|P5|STARTED|Washout Period 3||1
468403|NCT00519376|1118523|P4|STARTED|Washout Period 3||2
468404|NCT00519376|1118524|P3|STARTED|Washout Period 3||2
468405|NCT00519376|1118525|P2|STARTED|Washout Period 3||2
468406|NCT00519376|1118526|P1|STARTED|Washout Period 3||2
468407|NCT00519376|1118511|P16|NOT COMPLETED|Treatment Period 3||0
468408|NCT00519376|1118512|P15|NOT COMPLETED|Treatment Period 3||0
468409|NCT00519376|1118513|P14|NOT COMPLETED|Treatment Period 3||0
468410|NCT00519376|1118514|P13|NOT COMPLETED|Treatment Period 3||0
468411|NCT00519376|1118515|P12|NOT COMPLETED|Treatment Period 3||0
468412|NCT00519376|1118516|P11|NOT COMPLETED|Treatment Period 3||0
468413|NCT00519376|1118517|P10|NOT COMPLETED|Treatment Period 3||0
468414|NCT00519376|1118518|P9|NOT COMPLETED|Treatment Period 3||0
468415|NCT00519376|1118519|P8|NOT COMPLETED|Treatment Period 3||0
468416|NCT00519376|1118520|P7|NOT COMPLETED|Treatment Period 3||0
468417|NCT00519376|1118521|P6|NOT COMPLETED|Treatment Period 3||0
468418|NCT00519376|1118522|P5|NOT COMPLETED|Treatment Period 3||0
468419|NCT00519376|1118523|P4|NOT COMPLETED|Treatment Period 3||0
468420|NCT00519376|1118524|P3|NOT COMPLETED|Treatment Period 3||0
468421|NCT00519376|1118525|P2|NOT COMPLETED|Treatment Period 3||0
468422|NCT00519376|1118526|P1|NOT COMPLETED|Treatment Period 3||0
468423|NCT00519376|1118511|P16|COMPLETED|Treatment Period 3||1
468424|NCT00519376|1118512|P15|COMPLETED|Treatment Period 3||1
468425|NCT00519376|1118513|P14|COMPLETED|Treatment Period 3||1
468426|NCT00519376|1118514|P13|COMPLETED|Treatment Period 3||0
468427|NCT00519376|1118515|P12|COMPLETED|Treatment Period 3||1
468428|NCT00519376|1118516|P11|COMPLETED|Treatment Period 3||1
468429|NCT00519376|1118517|P10|COMPLETED|Treatment Period 3||1
468430|NCT00519376|1118518|P9|COMPLETED|Treatment Period 3||1
468431|NCT00519376|1118519|P8|COMPLETED|Treatment Period 3||1
468432|NCT00519376|1118520|P7|COMPLETED|Treatment Period 3||1
468433|NCT00519376|1118521|P6|COMPLETED|Treatment Period 3||1
468434|NCT00519376|1118522|P5|COMPLETED|Treatment Period 3||1
468435|NCT00519376|1118523|P4|COMPLETED|Treatment Period 3||2
468436|NCT00519376|1118524|P3|COMPLETED|Treatment Period 3||2
468437|NCT00519376|1118525|P2|COMPLETED|Treatment Period 3||2
468438|NCT00519376|1118526|P1|COMPLETED|Treatment Period 3||2
468439|NCT00519376|1118511|P16|STARTED|Treatment Period 3||1
468440|NCT00519376|1118512|P15|STARTED|Treatment Period 3||1
468441|NCT00519376|1118513|P14|STARTED|Treatment Period 3||1
468442|NCT00519376|1118514|P13|STARTED|Treatment Period 3||0
468443|NCT00519376|1118515|P12|STARTED|Treatment Period 3||1
468444|NCT00519376|1118516|P11|STARTED|Treatment Period 3||1
468445|NCT00519376|1118517|P10|STARTED|Treatment Period 3||1
468446|NCT00519376|1118518|P9|STARTED|Treatment Period 3||1
468447|NCT00519376|1118519|P8|STARTED|Treatment Period 3||1
468448|NCT00519376|1118520|P7|STARTED|Treatment Period 3||1
468449|NCT00519376|1118521|P6|STARTED|Treatment Period 3||1
468450|NCT00519376|1118522|P5|STARTED|Treatment Period 3||1
468451|NCT00519376|1118523|P4|STARTED|Treatment Period 3||2
468452|NCT00519376|1118524|P3|STARTED|Treatment Period 3||2
468453|NCT00519376|1118525|P2|STARTED|Treatment Period 3||2
468454|NCT00519376|1118526|P1|STARTED|Treatment Period 3||2
468455|NCT00519376|1118511|P16|NOT COMPLETED|Washout Period 2||0
468456|NCT00519376|1118512|P15|NOT COMPLETED|Washout Period 2||0
468457|NCT00519376|1118513|P14|NOT COMPLETED|Washout Period 2||0
468458|NCT00519376|1118514|P13|NOT COMPLETED|Washout Period 2||0
468459|NCT00519376|1118515|P12|NOT COMPLETED|Washout Period 2||0
468460|NCT00519376|1118516|P11|NOT COMPLETED|Washout Period 2||0
468461|NCT00519376|1118517|P10|NOT COMPLETED|Washout Period 2||0
468462|NCT00519376|1118518|P9|NOT COMPLETED|Washout Period 2||0
468463|NCT00519376|1118519|P8|NOT COMPLETED|Washout Period 2||0
468464|NCT00519376|1118520|P7|NOT COMPLETED|Washout Period 2||0
468465|NCT00519376|1118521|P6|NOT COMPLETED|Washout Period 2||0
468466|NCT00519376|1118522|P5|NOT COMPLETED|Washout Period 2||0
468467|NCT00519376|1118523|P4|NOT COMPLETED|Washout Period 2||0
468468|NCT00519376|1118524|P3|NOT COMPLETED|Washout Period 2||0
468469|NCT00519376|1118525|P2|NOT COMPLETED|Washout Period 2||0
468470|NCT00519376|1118526|P1|NOT COMPLETED|Washout Period 2||0
468471|NCT00519376|1118511|P16|COMPLETED|Washout Period 2||1
468472|NCT00519376|1118512|P15|COMPLETED|Washout Period 2||1
468473|NCT00519376|1118513|P14|COMPLETED|Washout Period 2||1
468474|NCT00519376|1118514|P13|COMPLETED|Washout Period 2||0
468475|NCT00519376|1118515|P12|COMPLETED|Washout Period 2||1
468476|NCT00519376|1118516|P11|COMPLETED|Washout Period 2||1
468477|NCT00519376|1118517|P10|COMPLETED|Washout Period 2||1
468478|NCT00519376|1118518|P9|COMPLETED|Washout Period 2||1
468479|NCT00519376|1118519|P8|COMPLETED|Washout Period 2||1
468480|NCT00519376|1118520|P7|COMPLETED|Washout Period 2||1
468481|NCT00519376|1118521|P6|COMPLETED|Washout Period 2||1
468482|NCT00519376|1118522|P5|COMPLETED|Washout Period 2||1
468483|NCT00519376|1118523|P4|COMPLETED|Washout Period 2||2
468484|NCT00519376|1118524|P3|COMPLETED|Washout Period 2||2
468485|NCT00519376|1118525|P2|COMPLETED|Washout Period 2||2
468486|NCT00519376|1118526|P1|COMPLETED|Washout Period 2||2
468487|NCT00519376|1118511|P16|STARTED|Washout Period 2||1
468488|NCT00519376|1118512|P15|STARTED|Washout Period 2||1
468489|NCT00519376|1118513|P14|STARTED|Washout Period 2||1
468490|NCT00519376|1118514|P13|STARTED|Washout Period 2||0
468491|NCT00519376|1118515|P12|STARTED|Washout Period 2||1
468492|NCT00519376|1118516|P11|STARTED|Washout Period 2||1
468493|NCT00519376|1118517|P10|STARTED|Washout Period 2||1
468494|NCT00519376|1118518|P9|STARTED|Washout Period 2||1
468495|NCT00519376|1118519|P8|STARTED|Washout Period 2||1
468496|NCT00519376|1118520|P7|STARTED|Washout Period 2||1
468497|NCT00519376|1118521|P6|STARTED|Washout Period 2||1
468498|NCT00519376|1118522|P5|STARTED|Washout Period 2||1
468499|NCT00519376|1118523|P4|STARTED|Washout Period 2||2
468500|NCT00519376|1118524|P3|STARTED|Washout Period 2||2
468501|NCT00519376|1118525|P2|STARTED|Washout Period 2||2
468502|NCT00519376|1118526|P1|STARTED|Washout Period 2||2
468503|NCT00519376|1118511|P16|NOT COMPLETED|Treatment Period 2||0
468504|NCT00519376|1118512|P15|NOT COMPLETED|Treatment Period 2||0
468505|NCT00519376|1118513|P14|NOT COMPLETED|Treatment Period 2||0
468506|NCT00519376|1118514|P13|NOT COMPLETED|Treatment Period 2||1
468507|NCT00519376|1118515|P12|NOT COMPLETED|Treatment Period 2||0
468508|NCT00519376|1118516|P11|NOT COMPLETED|Treatment Period 2||0
468509|NCT00519376|1118517|P10|NOT COMPLETED|Treatment Period 2||0
468510|NCT00519376|1118518|P9|NOT COMPLETED|Treatment Period 2||0
468511|NCT00519376|1118519|P8|NOT COMPLETED|Treatment Period 2||0
468512|NCT00519376|1118520|P7|NOT COMPLETED|Treatment Period 2||0
468513|NCT00519376|1118521|P6|NOT COMPLETED|Treatment Period 2||0
468514|NCT00519376|1118522|P5|NOT COMPLETED|Treatment Period 2||0
468515|NCT00519376|1118523|P4|NOT COMPLETED|Treatment Period 2||0
468516|NCT00519376|1118524|P3|NOT COMPLETED|Treatment Period 2||0
468517|NCT00519376|1118525|P2|NOT COMPLETED|Treatment Period 2||0
468518|NCT00519376|1118526|P1|NOT COMPLETED|Treatment Period 2||0
468519|NCT00519376|1118511|P16|COMPLETED|Treatment Period 2||1
468520|NCT00519376|1118512|P15|COMPLETED|Treatment Period 2||1
468521|NCT00519376|1118513|P14|COMPLETED|Treatment Period 2||1
468522|NCT00519376|1118514|P13|COMPLETED|Treatment Period 2||0
468523|NCT00519376|1118515|P12|COMPLETED|Treatment Period 2||1
468524|NCT00519376|1118516|P11|COMPLETED|Treatment Period 2||1
468525|NCT00519376|1118517|P10|COMPLETED|Treatment Period 2||1
468526|NCT00519376|1118518|P9|COMPLETED|Treatment Period 2||1
468527|NCT00519376|1118519|P8|COMPLETED|Treatment Period 2||1
468528|NCT00519376|1118520|P7|COMPLETED|Treatment Period 2||1
468529|NCT00519376|1118521|P6|COMPLETED|Treatment Period 2||1
468530|NCT00519376|1118522|P5|COMPLETED|Treatment Period 2||1
468531|NCT00519376|1118523|P4|COMPLETED|Treatment Period 2||2
468532|NCT00519376|1118524|P3|COMPLETED|Treatment Period 2||2
468533|NCT00519376|1118525|P2|COMPLETED|Treatment Period 2||2
468534|NCT00519376|1118526|P1|COMPLETED|Treatment Period 2||2
468535|NCT00519376|1118511|P16|STARTED|Treatment Period 2||1
468536|NCT00519376|1118512|P15|STARTED|Treatment Period 2||1
468537|NCT00519376|1118513|P14|STARTED|Treatment Period 2||1
468538|NCT00519376|1118514|P13|STARTED|Treatment Period 2||1
468539|NCT00519376|1118515|P12|STARTED|Treatment Period 2||1
468540|NCT00519376|1118516|P11|STARTED|Treatment Period 2||1
468541|NCT00519376|1118517|P10|STARTED|Treatment Period 2||1
468542|NCT00519376|1118518|P9|STARTED|Treatment Period 2||1
468543|NCT00519376|1118519|P8|STARTED|Treatment Period 2||1
468544|NCT00519376|1118520|P7|STARTED|Treatment Period 2||1
468545|NCT00519376|1118521|P6|STARTED|Treatment Period 2||1
468546|NCT00519376|1118522|P5|STARTED|Treatment Period 2||1
468547|NCT00519376|1118523|P4|STARTED|Treatment Period 2||2
468548|NCT00519376|1118524|P3|STARTED|Treatment Period 2||2
468549|NCT00519376|1118525|P2|STARTED|Treatment Period 2||2
468550|NCT00519376|1118526|P1|STARTED|Treatment Period 2||2
468551|NCT00519376|1118511|P16|NOT COMPLETED|Washout Period 1||0
468552|NCT00519376|1118512|P15|NOT COMPLETED|Washout Period 1||0
468553|NCT00519376|1118513|P14|NOT COMPLETED|Washout Period 1||0
468554|NCT00519376|1118514|P13|NOT COMPLETED|Washout Period 1||0
468555|NCT00519376|1118515|P12|NOT COMPLETED|Washout Period 1||0
468556|NCT00519376|1118516|P11|NOT COMPLETED|Washout Period 1||0
468557|NCT00519376|1118517|P10|NOT COMPLETED|Washout Period 1||0
468558|NCT00519376|1118518|P9|NOT COMPLETED|Washout Period 1||0
468559|NCT00519376|1118519|P8|NOT COMPLETED|Washout Period 1||0
468560|NCT00519376|1118520|P7|NOT COMPLETED|Washout Period 1||0
468561|NCT00519376|1118521|P6|NOT COMPLETED|Washout Period 1||0
468562|NCT00519376|1118522|P5|NOT COMPLETED|Washout Period 1||0
468563|NCT00519376|1118523|P4|NOT COMPLETED|Washout Period 1||0
468564|NCT00519376|1118524|P3|NOT COMPLETED|Washout Period 1||0
468565|NCT00519376|1118525|P2|NOT COMPLETED|Washout Period 1||0
468566|NCT00519376|1118526|P1|NOT COMPLETED|Washout Period 1||0
468567|NCT00519376|1118511|P16|COMPLETED|Washout Period 1||1
468568|NCT00519376|1118512|P15|COMPLETED|Washout Period 1||1
468569|NCT00519376|1118513|P14|COMPLETED|Washout Period 1||1
468570|NCT00519376|1118514|P13|COMPLETED|Washout Period 1||1
468571|NCT00519376|1118515|P12|COMPLETED|Washout Period 1||1
468572|NCT00519376|1118516|P11|COMPLETED|Washout Period 1||1
468573|NCT00519376|1118517|P10|COMPLETED|Washout Period 1||1
468574|NCT00519376|1118518|P9|COMPLETED|Washout Period 1||1
468575|NCT00519376|1118519|P8|COMPLETED|Washout Period 1||1
468576|NCT00519376|1118520|P7|COMPLETED|Washout Period 1||1
468577|NCT00519376|1118521|P6|COMPLETED|Washout Period 1||1
468578|NCT00519376|1118522|P5|COMPLETED|Washout Period 1||1
468579|NCT00519376|1118523|P4|COMPLETED|Washout Period 1||2
468580|NCT00519376|1118524|P3|COMPLETED|Washout Period 1||2
468581|NCT00519376|1118525|P2|COMPLETED|Washout Period 1||2
468582|NCT00519376|1118526|P1|COMPLETED|Washout Period 1||2
468583|NCT00519376|1118511|P16|STARTED|Washout Period 1||1
468584|NCT00519376|1118512|P15|STARTED|Washout Period 1||1
468585|NCT00519376|1118513|P14|STARTED|Washout Period 1||1
468586|NCT00519376|1118514|P13|STARTED|Washout Period 1||1
468587|NCT00519376|1118515|P12|STARTED|Washout Period 1||1
468588|NCT00519376|1118516|P11|STARTED|Washout Period 1||1
468589|NCT00519376|1118517|P10|STARTED|Washout Period 1||1
468590|NCT00519376|1118518|P9|STARTED|Washout Period 1||1
468591|NCT00519376|1118519|P8|STARTED|Washout Period 1||1
468592|NCT00519376|1118520|P7|STARTED|Washout Period 1||1
468593|NCT00519376|1118521|P6|STARTED|Washout Period 1||1
468594|NCT00519376|1118522|P5|STARTED|Washout Period 1||1
468595|NCT00519376|1118523|P4|STARTED|Washout Period 1||2
468596|NCT00519376|1118524|P3|STARTED|Washout Period 1||2
468597|NCT00519376|1118525|P2|STARTED|Washout Period 1||2
468598|NCT00519376|1118526|P1|STARTED|Washout Period 1||2
468599|NCT00519376|1118511|P16|NOT COMPLETED|Treatment Period 1||0
468600|NCT00519376|1118512|P15|NOT COMPLETED|Treatment Period 1||0
468601|NCT00519376|1118513|P14|NOT COMPLETED|Treatment Period 1||0
468602|NCT00519376|1118514|P13|NOT COMPLETED|Treatment Period 1||0
468603|NCT00519376|1118515|P12|NOT COMPLETED|Treatment Period 1||0
468604|NCT00519376|1118516|P11|NOT COMPLETED|Treatment Period 1||0
468605|NCT00519376|1118517|P10|NOT COMPLETED|Treatment Period 1||0
468606|NCT00519376|1118518|P9|NOT COMPLETED|Treatment Period 1||0
468607|NCT00519376|1118519|P8|NOT COMPLETED|Treatment Period 1||0
468608|NCT00519376|1118520|P7|NOT COMPLETED|Treatment Period 1||0
468609|NCT00519376|1118521|P6|NOT COMPLETED|Treatment Period 1||0
468610|NCT00519376|1118522|P5|NOT COMPLETED|Treatment Period 1||0
468611|NCT00519376|1118523|P4|NOT COMPLETED|Treatment Period 1||0
468612|NCT00519376|1118524|P3|NOT COMPLETED|Treatment Period 1||0
468613|NCT00519376|1118525|P2|NOT COMPLETED|Treatment Period 1||0
468614|NCT00519376|1118526|P1|NOT COMPLETED|Treatment Period 1||0
468615|NCT00519376|1118511|P16|COMPLETED|Treatment Period 1||1
468616|NCT00519376|1118512|P15|COMPLETED|Treatment Period 1||1
468617|NCT00519376|1118513|P14|COMPLETED|Treatment Period 1||1
468618|NCT00519376|1118514|P13|COMPLETED|Treatment Period 1||1
468619|NCT00519376|1118515|P12|COMPLETED|Treatment Period 1||1
468620|NCT00519376|1118516|P11|COMPLETED|Treatment Period 1||1
468621|NCT00519376|1118517|P10|COMPLETED|Treatment Period 1||1
468622|NCT00519376|1118518|P9|COMPLETED|Treatment Period 1||1
468623|NCT00519376|1118519|P8|COMPLETED|Treatment Period 1||1
468624|NCT00519376|1118520|P7|COMPLETED|Treatment Period 1||1
468625|NCT00519376|1118521|P6|COMPLETED|Treatment Period 1||1
468626|NCT00519376|1118522|P5|COMPLETED|Treatment Period 1||1
468627|NCT00519376|1118523|P4|COMPLETED|Treatment Period 1||2
468628|NCT00519376|1118524|P3|COMPLETED|Treatment Period 1||2
468629|NCT00519376|1118525|P2|COMPLETED|Treatment Period 1||2
468630|NCT00519376|1118526|P1|COMPLETED|Treatment Period 1||2
468631|NCT00519376|1118511|P16|STARTED|Treatment Period 1||1
468632|NCT00519376|1118512|P15|STARTED|Treatment Period 1||1
468633|NCT00519376|1118513|P14|STARTED|Treatment Period 1||1
468634|NCT00519376|1118514|P13|STARTED|Treatment Period 1||1
468635|NCT00519376|1118515|P12|STARTED|Treatment Period 1||1
468636|NCT00519376|1118516|P11|STARTED|Treatment Period 1||1
468637|NCT00519376|1118517|P10|STARTED|Treatment Period 1||1
468638|NCT00519376|1118518|P9|STARTED|Treatment Period 1||1
468639|NCT00519376|1118519|P8|STARTED|Treatment Period 1||1
468640|NCT00519376|1118520|P7|STARTED|Treatment Period 1||1
468641|NCT00519376|1118521|P6|STARTED|Treatment Period 1||1
468642|NCT00519376|1118522|P5|STARTED|Treatment Period 1||1
468643|NCT00519376|1118523|P4|STARTED|Treatment Period 1||2
468644|NCT00519376|1118524|P3|STARTED|Treatment Period 1||2
468645|NCT00519376|1118525|P2|STARTED|Treatment Period 1||2
468646|NCT00519376|1118526|P1|STARTED|Treatment Period 1||2
468647|NCT00519285|1118650|P2|NOT COMPLETED|Overall Study||612
468648|NCT00519285|1118651|P1|NOT COMPLETED|Overall Study||612
468649|NCT00519285|1118650|P2|COMPLETED|Overall Study||0
468650|NCT00519285|1118651|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
468651|NCT00519285|1118650|P2|Still Treated at Cut-off Date|Overall Study||2
468652|NCT00519285|1118651|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
468653|NCT00519285|1118650|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
468654|NCT00519285|1118651|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
468655|NCT00519285|1118650|P2|STARTED|Overall Study|Randomized|612
468656|NCT00519285|1118651|P1|STARTED|Overall Study|Randomized|612
468657|NCT00519194|1118677|P1|NOT COMPLETED|Overall Study||21
468658|NCT00519194|1118677|P1|COMPLETED|Overall Study||91
468659|NCT00519194|1118677|P1|STARTED|Overall Study||112
468660|NCT00519090|1118683|P2|NOT COMPLETED|Overall Study||0
468661|NCT00519090|1118684|P1|NOT COMPLETED|Overall Study||0
468662|NCT00519090|1118683|P2|COMPLETED|Overall Study||4
468663|NCT00519090|1118684|P1|COMPLETED|Overall Study||2
468664|NCT00519090|1118683|P2|STARTED|Overall Study||4
468665|NCT00519090|1118684|P1|STARTED|Overall Study||2
468666|NCT00519077|1118692|P1|NOT COMPLETED|Overall Study||8
468667|NCT00519077|1118692|P1|COMPLETED|Overall Study||36
468668|NCT00519077|1118692|P1|STARTED|Overall Study||44
468669|NCT00518986|1118699|P2|NOT COMPLETED|Overall Study||26
468670|NCT00518986|1118700|P1|NOT COMPLETED|Overall Study||26
468671|NCT00518986|1118699|P2|COMPLETED|Overall Study||98
468672|NCT00518986|1118700|P1|COMPLETED|Overall Study||99
468673|NCT00518986|1118699|P2|STARTED|Overall Study||124
468674|NCT00518986|1118700|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
468675|NCT00518882|1118826|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
468676|NCT00518882|1118827|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
468677|NCT00518882|1118826|P2|COMPLETED|Open-Label Extension, Week 26-78||138
468678|NCT00518882|1118827|P1|COMPLETED|Open-Label Extension, Week 26-78||161
468679|NCT00518882|1118826|P2|STARTED|Open-Label Extension, Week 26-78||187
468680|NCT00518882|1118827|P1|STARTED|Open-Label Extension, Week 26-78||202
468681|NCT00518882|1118826|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
468682|NCT00518882|1118827|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
468683|NCT00518882|1118826|P2|COMPLETED|Double-Blind, Week 0-26||187
468684|NCT00518882|1118827|P1|COMPLETED|Double-Blind, Week 0-26||202
468685|NCT00518882|1118826|P2|Randomised|Double-Blind, Week 0-26||231
468686|NCT00518882|1118827|P1|Randomised|Double-Blind, Week 0-26||233
468687|NCT00518882|1118826|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
468688|NCT00518882|1118827|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
468689|NCT00518713|1118945|P4|NOT COMPLETED|Overall Study||18
468690|NCT00518713|1118946|P3|NOT COMPLETED|Overall Study||18
468691|NCT00518713|1118947|P2|NOT COMPLETED|Overall Study||17
468692|NCT00518713|1118948|P1|NOT COMPLETED|Overall Study||8
468693|NCT00518713|1118945|P4|COMPLETED|Overall Study||41
468694|NCT00518713|1118946|P3|COMPLETED|Overall Study||41
468695|NCT00518713|1118947|P2|COMPLETED|Overall Study||45
468696|NCT00518713|1118948|P1|COMPLETED|Overall Study||50
468697|NCT00518713|1118945|P4|Modified Intent-to-Treat Population|Overall Study||57
468698|NCT00518713|1118946|P3|Modified Intent-to-Treat Population|Overall Study||49
468699|NCT00518713|1118947|P2|Modified Intent-to-Treat Population|Overall Study||58
468700|NCT00518713|1118948|P1|Modified Intent-to-Treat Population|Overall Study||53
468701|NCT00518713|1118945|P4|STARTED|Overall Study||59
468702|NCT00518713|1118946|P3|STARTED|Overall Study||59
468703|NCT00518713|1118947|P2|STARTED|Overall Study||62
468704|NCT00518713|1118948|P1|STARTED|Overall Study||58
468705|NCT00517699|1119006|P1|NOT COMPLETED|Overall Study||5
468706|NCT00517699|1119006|P1|COMPLETED|Overall Study||0
468707|NCT00517699|1119006|P1|STARTED|Overall Study||5
468708|NCT00517634|1119014|P6|NOT COMPLETED|Third Treatment Period||0
468709|NCT00517634|1119015|P5|NOT COMPLETED|Third Treatment Period||0
468710|NCT00517634|1119016|P4|NOT COMPLETED|Third Treatment Period||0
468711|NCT00517634|1119017|P3|NOT COMPLETED|Third Treatment Period||0
468712|NCT00517634|1119018|P2|NOT COMPLETED|Third Treatment Period||0
468713|NCT00517634|1119019|P1|NOT COMPLETED|Third Treatment Period||0
468714|NCT00517634|1119014|P6|COMPLETED|Third Treatment Period||4
468715|NCT00517634|1119015|P5|COMPLETED|Third Treatment Period||3
468716|NCT00517634|1119016|P4|COMPLETED|Third Treatment Period||3
468717|NCT00517634|1119017|P3|COMPLETED|Third Treatment Period||4
468718|NCT00517634|1119018|P2|COMPLETED|Third Treatment Period||4
468719|NCT00517634|1119019|P1|COMPLETED|Third Treatment Period||4
468720|NCT00517634|1119014|P6|STARTED|Third Treatment Period||4
468721|NCT00517634|1119015|P5|STARTED|Third Treatment Period||3
468722|NCT00517634|1119016|P4|STARTED|Third Treatment Period||3
468723|NCT00517634|1119017|P3|STARTED|Third Treatment Period||4
468724|NCT00517634|1119018|P2|STARTED|Third Treatment Period||4
468725|NCT00517634|1119019|P1|STARTED|Third Treatment Period||4
468726|NCT00517634|1119014|P6|NOT COMPLETED|Second Treatment Period||0
468727|NCT00517634|1119015|P5|NOT COMPLETED|Second Treatment Period||1
468728|NCT00517634|1119016|P4|NOT COMPLETED|Second Treatment Period||0
468729|NCT00517634|1119017|P3|NOT COMPLETED|Second Treatment Period||0
468730|NCT00517634|1119018|P2|NOT COMPLETED|Second Treatment Period||0
468731|NCT00517634|1119019|P1|NOT COMPLETED|Second Treatment Period||0
468732|NCT00517634|1119014|P6|COMPLETED|Second Treatment Period||4
468733|NCT00517634|1119015|P5|COMPLETED|Second Treatment Period||3
468734|NCT00517634|1119016|P4|COMPLETED|Second Treatment Period||3
468735|NCT00517634|1119017|P3|COMPLETED|Second Treatment Period||4
468736|NCT00517634|1119018|P2|COMPLETED|Second Treatment Period||4
468737|NCT00517634|1119019|P1|COMPLETED|Second Treatment Period||4
468738|NCT00517634|1119014|P6|STARTED|Second Treatment Period||4
468739|NCT00517634|1119015|P5|STARTED|Second Treatment Period||4
468740|NCT00517634|1119016|P4|STARTED|Second Treatment Period||3
468741|NCT00517634|1119017|P3|STARTED|Second Treatment Period||4
468742|NCT00517634|1119018|P2|STARTED|Second Treatment Period||4
468743|NCT00517634|1119019|P1|STARTED|Second Treatment Period||4
468744|NCT00517634|1119014|P6|NOT COMPLETED|First Treatment Period||0
468745|NCT00517634|1119015|P5|NOT COMPLETED|First Treatment Period||0
468746|NCT00517634|1119016|P4|NOT COMPLETED|First Treatment Period||0
468747|NCT00517634|1119017|P3|NOT COMPLETED|First Treatment Period||0
468748|NCT00517634|1119018|P2|NOT COMPLETED|First Treatment Period||0
468749|NCT00517634|1119019|P1|NOT COMPLETED|First Treatment Period||0
468750|NCT00517634|1119014|P6|COMPLETED|First Treatment Period||4
468751|NCT00517634|1119015|P5|COMPLETED|First Treatment Period||4
468752|NCT00517634|1119016|P4|COMPLETED|First Treatment Period||3
468753|NCT00517634|1119017|P3|COMPLETED|First Treatment Period||4
468754|NCT00517634|1119018|P2|COMPLETED|First Treatment Period||4
468755|NCT00517634|1119019|P1|COMPLETED|First Treatment Period||4
468756|NCT00517634|1119014|P6|STARTED|First Treatment Period||4
468757|NCT00517634|1119015|P5|STARTED|First Treatment Period||4
468758|NCT00517634|1119016|P4|STARTED|First Treatment Period||3
468759|NCT00517634|1119017|P3|STARTED|First Treatment Period||4
468760|NCT00517634|1119018|P2|STARTED|First Treatment Period||4
468761|NCT00517634|1119019|P1|STARTED|First Treatment Period||4
468762|NCT00518687|1119032|P2|NOT COMPLETED|Overall Study||1420
468763|NCT00518687|1119033|P1|NOT COMPLETED|Overall Study||1437
468764|NCT00518687|1119032|P2|COMPLETED|Overall Study||2585
468765|NCT00518687|1119033|P1|COMPLETED|Overall Study||2568
468766|NCT00518687|1119032|P2|Vaccinated|Overall Study||3982
468767|NCT00518687|1119033|P1|Vaccinated|Overall Study||3981
468768|NCT00518687|1119032|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
468769|NCT00518687|1119033|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
468770|NCT00518622|1119053|P8|NOT COMPLETED|Overall Study||0
468771|NCT00518622|1119054|P7|NOT COMPLETED|Overall Study||0
468772|NCT00518622|1119055|P6|NOT COMPLETED|Overall Study||0
468773|NCT00518622|1119056|P5|NOT COMPLETED|Overall Study||0
468774|NCT00518622|1119057|P4|NOT COMPLETED|Overall Study||0
468775|NCT00518622|1119058|P3|NOT COMPLETED|Overall Study||1
468776|NCT00518622|1119059|P2|NOT COMPLETED|Overall Study||1
468777|NCT00518622|1119060|P1|NOT COMPLETED|Overall Study||0
468778|NCT00518622|1119053|P8|COMPLETED|Overall Study||5
468779|NCT00518622|1119054|P7|COMPLETED|Overall Study||4
468780|NCT00518622|1119055|P6|COMPLETED|Overall Study||5
468781|NCT00518622|1119056|P5|COMPLETED|Overall Study||6
468782|NCT00518622|1119057|P4|COMPLETED|Overall Study||5
468783|NCT00518622|1119058|P3|COMPLETED|Overall Study||5
468784|NCT00518622|1119059|P2|COMPLETED|Overall Study||5
468785|NCT00518622|1119060|P1|COMPLETED|Overall Study||3
468786|NCT00518622|1119053|P8|Discontinued Therapy|Overall Study||0
468787|NCT00518622|1119054|P7|Discontinued Therapy|Overall Study||0
468788|NCT00518622|1119055|P6|Discontinued Therapy|Overall Study||0
468789|NCT00518622|1119056|P5|Discontinued Therapy|Overall Study||0
468790|NCT00518622|1119057|P4|Discontinued Therapy|Overall Study||0
468791|NCT00518622|1119058|P3|Discontinued Therapy|Overall Study||0
468792|NCT00518622|1119059|P2|Discontinued Therapy|Overall Study||1
468793|NCT00518622|1119060|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
468794|NCT00518622|1119053|P8|Completed Therapy|Overall Study||5
468795|NCT00518622|1119054|P7|Completed Therapy|Overall Study||4
468796|NCT00518622|1119055|P6|Completed Therapy|Overall Study||5
468797|NCT00518622|1119056|P5|Completed Therapy|Overall Study||6
468798|NCT00518622|1119057|P4|Completed Therapy|Overall Study||5
468799|NCT00518622|1119058|P3|Completed Therapy|Overall Study||6
468800|NCT00518622|1119059|P2|Completed Therapy|Overall Study||5
468801|NCT00518622|1119060|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
468802|NCT00518622|1119053|P8|STARTED|Overall Study||5
468803|NCT00518622|1119054|P7|STARTED|Overall Study||4
468804|NCT00518622|1119055|P6|STARTED|Overall Study||5
468805|NCT00518622|1119056|P5|STARTED|Overall Study||6
468806|NCT00518622|1119057|P4|STARTED|Overall Study||5
468807|NCT00518622|1119058|P3|STARTED|Overall Study||6
468808|NCT00518622|1119059|P2|STARTED|Overall Study||6
468809|NCT00518622|1119060|P1|STARTED|Overall Study||3
468810|NCT00518531|1119088|P2|NOT COMPLETED|Treatment Period 2||20
468811|NCT00518531|1119089|P1|NOT COMPLETED|Treatment Period 2||3
468812|NCT00518531|1119088|P2|COMPLETED|Treatment Period 2||95
468813|NCT00518531|1119089|P1|COMPLETED|Treatment Period 2||103
468814|NCT00518531|1119088|P2|Received Treatment|Treatment Period 2||110
468815|NCT00518531|1119089|P1|Received Treatment|Treatment Period 2||106
468816|NCT00518531|1119088|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
468817|NCT00518531|1119089|P1|STARTED|Treatment Period 2||106
468818|NCT00518531|1119088|P2|NOT COMPLETED|Treatment Period 1||12
468819|NCT00518531|1119089|P1|NOT COMPLETED|Treatment Period 1||18
468820|NCT00518531|1119088|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
468821|NCT00518531|1119089|P1|COMPLETED|Treatment Period 1||106
468822|NCT00518531|1119088|P2|Received Treatment|Treatment Period 1||124
468823|NCT00518531|1119089|P1|Received Treatment|Treatment Period 1||119
468824|NCT00518531|1119088|P2|STARTED|Treatment Period 1||126
468825|NCT00518531|1119089|P1|STARTED|Treatment Period 1||124
468826|NCT00518336|1119125|P2|NOT COMPLETED|Year 9||1
468827|NCT00518336|1119126|P1|NOT COMPLETED|Year 9||5
468828|NCT00518336|1119125|P2|COMPLETED|Year 9||212
468829|NCT00518336|1119126|P1|COMPLETED|Year 9||219
468830|NCT00518336|1119125|P2|STARTED|Year 9||213
468831|NCT00518336|1119126|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
468832|NCT00518336|1119125|P2|NOT COMPLETED|Year 8||2
468833|NCT00518336|1119126|P1|NOT COMPLETED|Year 8||1
468834|NCT00518336|1119125|P2|COMPLETED|Year 8||211
468835|NCT00518336|1119126|P1|COMPLETED|Year 8||222
468836|NCT00518336|1119125|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
468837|NCT00518336|1119126|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
468838|NCT00518336|1119125|P2|NOT COMPLETED|Year 7||3
468839|NCT00518336|1119126|P1|NOT COMPLETED|Year 7||2
468840|NCT00518336|1119125|P2|COMPLETED|Year 7||208
468841|NCT00518336|1119126|P1|COMPLETED|Year 7||220
468842|NCT00518336|1119125|P2|STARTED|Year 7||211
468843|NCT00518336|1119126|P1|STARTED|Year 7||222
468844|NCT00518323|1119292|P4|NOT COMPLETED|Overall Study||25
468845|NCT00518323|1119293|P3|NOT COMPLETED|Overall Study||11
468846|NCT00518323|1119294|P2|NOT COMPLETED|Overall Study||8
468847|NCT00518323|1119295|P1|NOT COMPLETED|Overall Study||19
468848|NCT00518323|1119292|P4|COMPLETED|Overall Study||26
468849|NCT00518323|1119293|P3|COMPLETED|Overall Study||37
468850|NCT00518323|1119294|P2|COMPLETED|Overall Study||40
468851|NCT00518323|1119295|P1|COMPLETED|Overall Study||35
468852|NCT00518323|1119292|P4|STARTED|Overall Study||51
468853|NCT00518323|1119293|P3|STARTED|Overall Study||48
468854|NCT00518323|1119294|P2|STARTED|Overall Study||48
468855|NCT00518323|1119295|P1|STARTED|Overall Study||54
468856|NCT00518284|1119325|P4|NOT COMPLETED|Overall Study||2
468857|NCT00518284|1119326|P3|NOT COMPLETED|Overall Study||1
468858|NCT00518284|1119327|P2|NOT COMPLETED|Overall Study||3
468859|NCT00518284|1119328|P1|NOT COMPLETED|Overall Study||0
468860|NCT00518284|1119325|P4|COMPLETED|Overall Study||0
468861|NCT00518284|1119326|P3|COMPLETED|Overall Study||0
468862|NCT00518284|1119327|P2|COMPLETED|Overall Study||0
468863|NCT00518284|1119328|P1|COMPLETED|Overall Study||0
468864|NCT00518284|1119325|P4|STARTED|Overall Study||2
468865|NCT00518284|1119326|P3|STARTED|Overall Study||1
468866|NCT00518284|1119327|P2|STARTED|Overall Study||3
468867|NCT00518284|1119328|P1|STARTED|Overall Study||0
468868|NCT00518180|1119385|P3|NOT COMPLETED|Overall Study||82
468869|NCT00518180|1119386|P2|NOT COMPLETED|Overall Study||69
468870|NCT00518180|1119387|P1|NOT COMPLETED|Overall Study||65
468871|NCT00518180|1119385|P3|COMPLETED|Overall Study||457
468872|NCT00518180|1119386|P2|COMPLETED|Overall Study||472
468873|NCT00518180|1119387|P1|COMPLETED|Overall Study||475
468874|NCT00518180|1119385|P3|STARTED|Overall Study||539
468875|NCT00518180|1119386|P2|STARTED|Overall Study||541
468876|NCT00518180|1119387|P1|STARTED|Overall Study||540
468877|NCT00518115|1119439|P10|NOT COMPLETED|Overall Study||15
468878|NCT00518115|1119440|P9|NOT COMPLETED|Overall Study||5
468879|NCT00518115|1119441|P8|NOT COMPLETED|Overall Study||15
468880|NCT00518115|1119442|P7|NOT COMPLETED|Overall Study||8
468881|NCT00518115|1119443|P6|NOT COMPLETED|Overall Study||15
468882|NCT00518115|1119444|P5|NOT COMPLETED|Overall Study||10
468883|NCT00518115|1119445|P4|NOT COMPLETED|Overall Study||11
468884|NCT00518115|1119446|P3|NOT COMPLETED|Overall Study||17
468885|NCT00518115|1119447|P2|NOT COMPLETED|Overall Study||6
468886|NCT00518115|1119448|P1|NOT COMPLETED|Overall Study||12
468887|NCT00518115|1119439|P10|COMPLETED|Overall Study||20
468888|NCT00518115|1119440|P9|COMPLETED|Overall Study||30
468889|NCT00518115|1119441|P8|COMPLETED|Overall Study||20
468890|NCT00518115|1119442|P7|COMPLETED|Overall Study||25
468891|NCT00518115|1119443|P6|COMPLETED|Overall Study||19
468892|NCT00518115|1119444|P5|COMPLETED|Overall Study||21
468893|NCT00518115|1119445|P4|COMPLETED|Overall Study||24
468894|NCT00518115|1119446|P3|COMPLETED|Overall Study||19
468895|NCT00518115|1119447|P2|COMPLETED|Overall Study||29
468896|NCT00518115|1119448|P1|COMPLETED|Overall Study||40
468982|NCT00517530|1119792|P1|Retreated Population|Overall Study||2
468897|NCT00518115|1119439|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
468898|NCT00518115|1119440|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
468899|NCT00518115|1119441|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
468900|NCT00518115|1119442|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
468901|NCT00518115|1119443|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
468902|NCT00518115|1119444|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
468903|NCT00518115|1119445|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
468904|NCT00518115|1119446|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
468905|NCT00518115|1119447|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
468906|NCT00518115|1119448|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
468907|NCT00518115|1119439|P10|STARTED|Overall Study||35
468908|NCT00518115|1119440|P9|STARTED|Overall Study||35
468909|NCT00518115|1119441|P8|STARTED|Overall Study||35
468910|NCT00518115|1119442|P7|STARTED|Overall Study||33
468911|NCT00518115|1119443|P6|STARTED|Overall Study||34
468912|NCT00518115|1119444|P5|STARTED|Overall Study||31
468913|NCT00518115|1119445|P4|STARTED|Overall Study||35
468914|NCT00518115|1119446|P3|STARTED|Overall Study||36
468915|NCT00518115|1119447|P2|STARTED|Overall Study||35
468916|NCT00518115|1119448|P1|STARTED|Overall Study||52
468917|NCT00518089|1119606|P2|NOT COMPLETED|Overall Study||31
468918|NCT00518089|1119607|P1|NOT COMPLETED|Overall Study||28
468919|NCT00518089|1119606|P2|COMPLETED|Overall Study||398
468920|NCT00518089|1119607|P1|COMPLETED|Overall Study||402
468921|NCT00518089|1119606|P2|STARTED|Overall Study||429
468922|NCT00518089|1119607|P1|STARTED|Overall Study||430
468923|NCT00518011|1119623|P2|NOT COMPLETED|Overall Study||8
468924|NCT00518011|1119624|P1|NOT COMPLETED|Overall Study||9
468925|NCT00518011|1119623|P2|COMPLETED|Overall Study||0
468926|NCT00518011|1119624|P1|COMPLETED|Overall Study||0
468927|NCT00518011|1119623|P2|STARTED|Overall Study||8
468928|NCT00518011|1119624|P1|STARTED|Overall Study||9
468929|NCT00517933|1119646|P2|NOT COMPLETED|Period 2||13
468930|NCT00517933|1119647|P1|NOT COMPLETED|Period 2||6
468931|NCT00517933|1119646|P2|COMPLETED|Period 2||70
468932|NCT00517933|1119647|P1|COMPLETED|Period 2||73
468933|NCT00517933|1119646|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
468934|NCT00517933|1119647|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
468935|NCT00517933|1119646|P2|NOT COMPLETED|Period 1||6
468936|NCT00517933|1119647|P1|NOT COMPLETED|Period 1||8
468937|NCT00517933|1119646|P2|COMPLETED|Period 1||85
468938|NCT00517933|1119647|P1|COMPLETED|Period 1||81
468939|NCT00517933|1119646|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
468940|NCT00517933|1119647|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
468941|NCT00517881|1119711|P1|NOT COMPLETED|Overall Study||5
468942|NCT00517881|1119711|P1|COMPLETED|Overall Study||24
468943|NCT00517881|1119711|P1|STARTED|Overall Study||29
468944|NCT00517829|1119723|P2|NOT COMPLETED|Overall Study||75
468945|NCT00517829|1119724|P1|NOT COMPLETED|Overall Study||75
468946|NCT00517829|1119723|P2|COMPLETED|Overall Study||0
468947|NCT00517829|1119724|P1|COMPLETED|Overall Study||0
468948|NCT00517829|1119723|P2|STARTED|Overall Study||75
468949|NCT00517829|1119724|P1|STARTED|Overall Study||75
468950|NCT00517751|1119738|P1|NOT COMPLETED|Overall Study||129
468951|NCT00517751|1119738|P1|COMPLETED|Overall Study||33
468952|NCT00517751|1119738|P1|STARTED|Overall Study||162
468953|NCT00517595|1119761|P1|NOT COMPLETED|Overall Study||0
468954|NCT00517595|1119761|P1|COMPLETED|Overall Study||48
468955|NCT00517595|1119761|P1|STARTED|Overall Study||48
468956|NCT00517556|1119772|P2|NOT COMPLETED|Overall Study||5
468957|NCT00517556|1119773|P1|NOT COMPLETED|Overall Study||4
468958|NCT00517556|1119772|P2|COMPLETED|Overall Study||14
468959|NCT00517556|1119773|P1|COMPLETED|Overall Study||15
468960|NCT00517556|1119772|P2|STARTED|Overall Study||19
468961|NCT00517556|1119773|P1|STARTED|Overall Study||19
468962|NCT00517530|1119786|P7|NOT COMPLETED|Overall Study||19
468963|NCT00517530|1119787|P6|NOT COMPLETED|Overall Study||19
468964|NCT00517530|1119788|P5|NOT COMPLETED|Overall Study||20
468965|NCT00517530|1119789|P4|NOT COMPLETED|Overall Study||21
468966|NCT00517530|1119790|P3|NOT COMPLETED|Overall Study||18
468967|NCT00517530|1119791|P2|NOT COMPLETED|Overall Study||13
468968|NCT00517530|1119792|P1|NOT COMPLETED|Overall Study||19
468969|NCT00517530|1119786|P7|COMPLETED|Overall Study||1
468970|NCT00517530|1119787|P6|COMPLETED|Overall Study||0
468971|NCT00517530|1119788|P5|COMPLETED|Overall Study||1
468972|NCT00517530|1119789|P4|COMPLETED|Overall Study||1
468973|NCT00517530|1119790|P3|COMPLETED|Overall Study||0
468974|NCT00517530|1119791|P2|COMPLETED|Overall Study||0
468975|NCT00517530|1119792|P1|COMPLETED|Overall Study||2
468976|NCT00517530|1119786|P7|Retreated Population|Overall Study||0
468977|NCT00517530|1119787|P6|Retreated Population|Overall Study||2
468978|NCT00517530|1119788|P5|Retreated Population|Overall Study||2
468979|NCT00517530|1119789|P4|Retreated Population|Overall Study||4
468980|NCT00517530|1119790|P3|Retreated Population|Overall Study||1
468981|NCT00517530|1119791|P2|Retreated Population|Overall Study||2
468983|NCT00517530|1119786|P7|Completed Follow-up|Overall Study||1
468984|NCT00517530|1119787|P6|Completed Follow-up|Overall Study||0
468985|NCT00517530|1119788|P5|Completed Follow-up|Overall Study||0
468986|NCT00517530|1119789|P4|Completed Follow-up|Overall Study||1
468987|NCT00517530|1119790|P3|Completed Follow-up|Overall Study||0
468988|NCT00517530|1119791|P2|Completed Follow-up|Overall Study||0
468989|NCT00517530|1119792|P1|Completed Follow-up|Overall Study||2
468990|NCT00517530|1119786|P7|Started Follow-up|Overall Study||19
468991|NCT00517530|1119787|P6|Started Follow-up|Overall Study||16
468992|NCT00517530|1119788|P5|Started Follow-up|Overall Study||17
468993|NCT00517530|1119789|P4|Started Follow-up|Overall Study||21
468994|NCT00517530|1119790|P3|Started Follow-up|Overall Study||17
468995|NCT00517530|1119791|P2|Started Follow-up|Overall Study||13
468996|NCT00517530|1119792|P1|Started Follow-up|Overall Study||20
468997|NCT00517530|1119786|P7|Completed Treatment|Overall Study||13
468998|NCT00517530|1119787|P6|Completed Treatment|Overall Study||9
468999|NCT00517530|1119788|P5|Completed Treatment|Overall Study||9
469000|NCT00517530|1119789|P4|Completed Treatment|Overall Study||18
469001|NCT00517530|1119790|P3|Completed Treatment|Overall Study||13
469002|NCT00517530|1119791|P2|Completed Treatment|Overall Study||13
469003|NCT00517530|1119792|P1|Completed Treatment|Overall Study||11
469004|NCT00517530|1119786|P7|STARTED|Overall Study||20
469005|NCT00517530|1119787|P6|STARTED|Overall Study||19
469006|NCT00517530|1119788|P5|STARTED|Overall Study||21
469007|NCT00517530|1119789|P4|STARTED|Overall Study||22
469008|NCT00517530|1119790|P3|STARTED|Overall Study||18
469009|NCT00517530|1119791|P2|STARTED|Overall Study||13
469010|NCT00517530|1119792|P1|STARTED|Overall Study||21
469011|NCT00517413|1119852|P1|NOT COMPLETED|Overall Study||61
469012|NCT00517413|1119852|P1|COMPLETED|Overall Study||102
469013|NCT00517413|1119852|P1|STARTED|Overall Study||163
469014|NCT00517361|1119873|P1|NOT COMPLETED|Overall Study||11
469015|NCT00517361|1119873|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
469016|NCT00517361|1119873|P1|STARTED|Overall Study||11
469017|NCT00517296|1119882|P2|NOT COMPLETED|Overall Study||0
469018|NCT00517296|1119883|P1|NOT COMPLETED|Overall Study||1
469019|NCT00517296|1119882|P2|COMPLETED|Overall Study||11
469020|NCT00517296|1119883|P1|COMPLETED|Overall Study||9
469021|NCT00517296|1119882|P2|STARTED|Overall Study||11
469022|NCT00517296|1119883|P1|STARTED|Overall Study||10
469023|NCT00517192|1119895|P2|NOT COMPLETED|Overall Study||20
469024|NCT00517192|1119896|P1|NOT COMPLETED|Overall Study||19
469025|NCT00517192|1119895|P2|COMPLETED|Overall Study||0
469026|NCT00517192|1119896|P1|COMPLETED|Overall Study||0
469027|NCT00517192|1119895|P2|STARTED|Overall Study||20
469028|NCT00517192|1119896|P1|STARTED|Overall Study||19
469029|NCT00517075|1119948|P4|NOT COMPLETED|Overall Study||0
469030|NCT00517075|1119949|P3|NOT COMPLETED|Overall Study||0
469031|NCT00517075|1119950|P2|NOT COMPLETED|Overall Study||0
469032|NCT00517075|1119951|P1|NOT COMPLETED|Overall Study||0
469033|NCT00517075|1119948|P4|COMPLETED|Overall Study||0
469034|NCT00517075|1119949|P3|COMPLETED|Overall Study||0
469035|NCT00517075|1119950|P2|COMPLETED|Overall Study||0
469036|NCT00517075|1119951|P1|COMPLETED|Overall Study||0
469037|NCT00517075|1119948|P4|STARTED|Overall Study||0
469038|NCT00517075|1119949|P3|STARTED|Overall Study||0
469039|NCT00517075|1119950|P2|STARTED|Overall Study||0
469040|NCT00517075|1119951|P1|STARTED|Overall Study||0
469041|NCT00517010|1119989|P1|NOT COMPLETED|Overall Study||1
469042|NCT00517010|1119989|P1|COMPLETED|Overall Study||5
469043|NCT00517010|1119989|P1|STARTED|Overall Study||6
469044|NCT00516919|1119994|P2|NOT COMPLETED|Overall Study||7
469045|NCT00516919|1119995|P1|NOT COMPLETED|Overall Study||10
469046|NCT00516919|1119994|P2|COMPLETED|Overall Study||32
469047|NCT00516919|1119995|P1|COMPLETED|Overall Study||30
469048|NCT00516919|1119994|P2|STARTED|Overall Study||39
469049|NCT00516919|1119995|P1|STARTED|Overall Study||40
469050|NCT00516906|1120003|P2|NOT COMPLETED|Overall Study||2
469051|NCT00516906|1120004|P1|NOT COMPLETED|Overall Study||6
469052|NCT00516906|1120003|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
469053|NCT00516906|1120004|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
469054|NCT00516906|1120003|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
469055|NCT00516906|1120004|P1|STARTED|Overall Study||36
469056|NCT00516893|1120014|P1|NOT COMPLETED|Overall Study||21
469057|NCT00516893|1120014|P1|COMPLETED|Overall Study||92
469058|NCT00516893|1120014|P1|Received Study Treatment|Overall Study||112
469059|NCT00516893|1120014|P1|STARTED|Overall Study||113
469060|NCT00516737|1120023|P2|NOT COMPLETED|Overall Study||8
469061|NCT00516737|1120024|P1|NOT COMPLETED|Overall Study||11
469062|NCT00516737|1120023|P2|COMPLETED|Overall Study||96
469063|NCT00516737|1120024|P1|COMPLETED|Overall Study||92
469064|NCT00516737|1120023|P2|STARTED|Overall Study||104
469065|NCT00516737|1120024|P1|STARTED|Overall Study||103
469066|NCT00516386|1120042|P1|NOT COMPLETED|Overall Study||6
469067|NCT00516386|1120042|P1|COMPLETED|Overall Study||10
469068|NCT00516386|1120042|P1|STARTED|Overall Study||16
469069|NCT00516321|1120049|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
469070|NCT00516321|1120050|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
469071|NCT00516321|1120051|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
469072|NCT00516321|1120049|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
469073|NCT00516321|1120050|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
469074|NCT00516321|1120051|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
469075|NCT00516321|1120049|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
469076|NCT00516321|1120050|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
469077|NCT00516321|1120051|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
469078|NCT00516321|1120049|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
469079|NCT00516321|1120050|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
469080|NCT00516321|1120051|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
469081|NCT00516321|1120049|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
469082|NCT00516321|1120050|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
469083|NCT00516321|1120051|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
469084|NCT00516321|1120049|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
469085|NCT00516321|1120050|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
469086|NCT00516321|1120051|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
469087|NCT00516295|1120102|P3|NOT COMPLETED|Overall Study||0
469088|NCT00516295|1120103|P2|NOT COMPLETED|Overall Study||0
469089|NCT00516295|1120104|P1|NOT COMPLETED|Overall Study||3
469090|NCT00516295|1120102|P3|COMPLETED|Overall Study||0
469091|NCT00516295|1120103|P2|COMPLETED|Overall Study||0
469092|NCT00516295|1120104|P1|COMPLETED|Overall Study||4
469093|NCT00516295|1120102|P3|STARTED|Overall Study||0
469094|NCT00516295|1120103|P2|STARTED|Overall Study||0
469095|NCT00516295|1120104|P1|STARTED|Overall Study||7
469096|NCT00516269|1120117|P2|NOT COMPLETED|Overall Study||3
469097|NCT00516269|1120118|P1|NOT COMPLETED|Overall Study||2
469098|NCT00516269|1120117|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
469099|NCT00516269|1120118|P1|COMPLETED|Overall Study|2 patients had an early termination|17
469100|NCT00516269|1120117|P2|STARTED|Overall Study||19
469101|NCT00516269|1120118|P1|STARTED|Overall Study||19
469102|NCT00516217|1120124|P1|NOT COMPLETED|Overall Study||0
469103|NCT00516217|1120124|P1|COMPLETED|Overall Study||29
469104|NCT00516217|1120124|P1|STARTED|Overall Study||29
469105|NCT00516165|1120130|P1|NOT COMPLETED|Overall Study||0
469106|NCT00516165|1120130|P1|COMPLETED|Overall Study||28
469107|NCT00516165|1120130|P1|STARTED|Overall Study||28
469108|NCT00516139|1120139|P1|NOT COMPLETED|Overall Study||38
469109|NCT00516139|1120139|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
469110|NCT00516139|1120139|P1|STARTED|Overall Study||122
469111|NCT00516074|1120170|P2|NOT COMPLETED|Overall Study||3
469112|NCT00516074|1120171|P1|NOT COMPLETED|Overall Study||6
469113|NCT00516074|1120170|P2|COMPLETED|Overall Study||23
469114|NCT00516074|1120171|P1|COMPLETED|Overall Study||22
469115|NCT00516074|1120170|P2|STARTED|Overall Study||26
469116|NCT00516074|1120171|P1|STARTED|Overall Study||28
469117|NCT00516048|1120189|P3|NOT COMPLETED|Overall Study||1
469118|NCT00516048|1120190|P2|NOT COMPLETED|Overall Study||2
469119|NCT00516048|1120191|P1|NOT COMPLETED|Overall Study||0
469120|NCT00516048|1120189|P3|COMPLETED|Overall Study||0
469121|NCT00516048|1120190|P2|COMPLETED|Overall Study||40
469122|NCT00516048|1120191|P1|COMPLETED|Overall Study||15
469123|NCT00516048|1120189|P3|STARTED|Overall Study||1
469124|NCT00516048|1120190|P2|STARTED|Overall Study||42
469125|NCT00516048|1120191|P1|STARTED|Overall Study||15
469126|NCT00515879|1120207|P2|NOT COMPLETED|Overall Study||20
469127|NCT00515879|1120208|P1|NOT COMPLETED|Overall Study||25
469128|NCT00515879|1120207|P2|COMPLETED|Overall Study||62
469129|NCT00515879|1120208|P1|COMPLETED|Overall Study||62
469130|NCT00515879|1120207|P2|STARTED|Overall Study||82
469131|NCT00515879|1120208|P1|STARTED|Overall Study||87
469132|NCT00515827|1120218|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
469133|NCT00515827|1120219|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
469134|NCT00515827|1120218|P2|COMPLETED|Second Intervention (12 Weeks)||25
469135|NCT00515827|1120219|P1|COMPLETED|Second Intervention (12 Weeks)||25
469136|NCT00515827|1120218|P2|STARTED|Second Intervention (12 Weeks)||25
469137|NCT00515827|1120219|P1|STARTED|Second Intervention (12 Weeks)||26
469138|NCT00515827|1120218|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
469139|NCT00515827|1120219|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
469140|NCT00515827|1120218|P2|COMPLETED|First Intervention (12 Weeks)||25
469141|NCT00515827|1120219|P1|COMPLETED|First Intervention (12 Weeks)||26
469142|NCT00515827|1120218|P2|STARTED|First Intervention (12 Weeks)||26
469143|NCT00515827|1120219|P1|STARTED|First Intervention (12 Weeks)||27
469144|NCT00515697|1120241|P1|NOT COMPLETED|Overall Study||0
469145|NCT00515697|1120241|P1|COMPLETED|Overall Study||39
469146|NCT00515697|1120241|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
469147|NCT00515697|1120241|P1|STARTED|Overall Study||39
469148|NCT00515671|1120254|P2|NOT COMPLETED|Overall Study||17
469149|NCT00515671|1120255|P1|NOT COMPLETED|Overall Study||17
469150|NCT00515671|1120254|P2|COMPLETED|Overall Study||41
469151|NCT00515671|1120255|P1|COMPLETED|Overall Study||43
469152|NCT00515671|1120254|P2|STARTED|Overall Study||58
469153|NCT00515671|1120255|P1|STARTED|Overall Study||60
469154|NCT00515619|1120263|P1|NOT COMPLETED|Overall Study||216
469155|NCT00515619|1120263|P1|COMPLETED|Overall Study||160
469156|NCT00515619|1120263|P1|Safety Set|Overall Study||376
469157|NCT00515619|1120263|P1|STARTED|Overall Study||376
469158|NCT00515541|1120275|P4|NOT COMPLETED|Overall Study||5
469159|NCT00515541|1120276|P3|NOT COMPLETED|Overall Study||0
469160|NCT00515541|1120277|P2|NOT COMPLETED|Overall Study||5
469161|NCT00515541|1120278|P1|NOT COMPLETED|Overall Study||0
469162|NCT00515541|1120275|P4|COMPLETED|Overall Study||6
469163|NCT00515541|1120276|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
469164|NCT00515541|1120277|P2|COMPLETED|Overall Study||7
469165|NCT00515541|1120278|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
469166|NCT00515541|1120275|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
469167|NCT00515541|1120276|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
469168|NCT00515541|1120277|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
469169|NCT00515541|1120278|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
469170|NCT00515541|1120275|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
469171|NCT00515541|1120276|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
469172|NCT00515541|1120277|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
469173|NCT00515541|1120278|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
469174|NCT00515541|1120275|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
469175|NCT00515541|1120276|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
469176|NCT00515541|1120277|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
469177|NCT00515541|1120278|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
469268|NCT00515502|1120310|P2|NOT COMPLETED|Treatment Period 3||0
469178|NCT00515541|1120275|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
469179|NCT00515541|1120276|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
469180|NCT00515541|1120277|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
469181|NCT00515541|1120278|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
469182|NCT00515541|1120275|P4|STARTED|Overall Study||11
469183|NCT00515541|1120276|P3|STARTED|Overall Study||10
469184|NCT00515541|1120277|P2|STARTED|Overall Study||12
469185|NCT00515541|1120278|P1|STARTED|Overall Study||10
469186|NCT00515502|1120300|P12|NOT COMPLETED|Treatment Period 4||0
469187|NCT00515502|1120301|P11|NOT COMPLETED|Treatment Period 4||0
469188|NCT00515502|1120302|P10|NOT COMPLETED|Treatment Period 4||0
469189|NCT00515502|1120303|P9|NOT COMPLETED|Treatment Period 4||0
469190|NCT00515502|1120304|P8|NOT COMPLETED|Treatment Period 4||0
469191|NCT00515502|1120305|P7|NOT COMPLETED|Treatment Period 4||0
469192|NCT00515502|1120306|P6|NOT COMPLETED|Treatment Period 4||0
469193|NCT00515502|1120307|P5|NOT COMPLETED|Treatment Period 4||0
469194|NCT00515502|1120308|P4|NOT COMPLETED|Treatment Period 4||0
469195|NCT00515502|1120309|P3|NOT COMPLETED|Treatment Period 4||0
469196|NCT00515502|1120310|P2|NOT COMPLETED|Treatment Period 4||0
469197|NCT00515502|1120311|P1|NOT COMPLETED|Treatment Period 4||0
469198|NCT00515502|1120300|P12|COMPLETED|Treatment Period 4||0
469199|NCT00515502|1120301|P11|COMPLETED|Treatment Period 4||1
469200|NCT00515502|1120302|P10|COMPLETED|Treatment Period 4||2
469201|NCT00515502|1120303|P9|COMPLETED|Treatment Period 4||0
469202|NCT00515502|1120304|P8|COMPLETED|Treatment Period 4||1
469203|NCT00515502|1120305|P7|COMPLETED|Treatment Period 4||1
469204|NCT00515502|1120306|P6|COMPLETED|Treatment Period 4||1
469205|NCT00515502|1120307|P5|COMPLETED|Treatment Period 4||3
469206|NCT00515502|1120308|P4|COMPLETED|Treatment Period 4||3
469207|NCT00515502|1120309|P3|COMPLETED|Treatment Period 4||4
469208|NCT00515502|1120310|P2|COMPLETED|Treatment Period 4||3
469209|NCT00515502|1120311|P1|COMPLETED|Treatment Period 4||1
469210|NCT00515502|1120300|P12|STARTED|Treatment Period 4||0
469211|NCT00515502|1120301|P11|STARTED|Treatment Period 4||1
469212|NCT00515502|1120302|P10|STARTED|Treatment Period 4||2
469213|NCT00515502|1120303|P9|STARTED|Treatment Period 4||0
469214|NCT00515502|1120304|P8|STARTED|Treatment Period 4||1
469215|NCT00515502|1120305|P7|STARTED|Treatment Period 4||1
469216|NCT00515502|1120306|P6|STARTED|Treatment Period 4||1
469217|NCT00515502|1120307|P5|STARTED|Treatment Period 4||3
469218|NCT00515502|1120308|P4|STARTED|Treatment Period 4||3
469219|NCT00515502|1120309|P3|STARTED|Treatment Period 4||4
469220|NCT00515502|1120310|P2|STARTED|Treatment Period 4||3
469221|NCT00515502|1120311|P1|STARTED|Treatment Period 4||1
469222|NCT00515502|1120300|P12|NOT COMPLETED|Washout Period 3||0
469223|NCT00515502|1120301|P11|NOT COMPLETED|Washout Period 3||0
469224|NCT00515502|1120302|P10|NOT COMPLETED|Washout Period 3||0
469225|NCT00515502|1120303|P9|NOT COMPLETED|Washout Period 3||0
469226|NCT00515502|1120304|P8|NOT COMPLETED|Washout Period 3||0
469227|NCT00515502|1120305|P7|NOT COMPLETED|Washout Period 3||0
469228|NCT00515502|1120306|P6|NOT COMPLETED|Washout Period 3||0
469229|NCT00515502|1120307|P5|NOT COMPLETED|Washout Period 3||0
469230|NCT00515502|1120308|P4|NOT COMPLETED|Washout Period 3||0
469231|NCT00515502|1120309|P3|NOT COMPLETED|Washout Period 3||0
469232|NCT00515502|1120310|P2|NOT COMPLETED|Washout Period 3||0
469233|NCT00515502|1120311|P1|NOT COMPLETED|Washout Period 3||0
469234|NCT00515502|1120300|P12|COMPLETED|Washout Period 3||0
469235|NCT00515502|1120301|P11|COMPLETED|Washout Period 3||1
469236|NCT00515502|1120302|P10|COMPLETED|Washout Period 3||2
469237|NCT00515502|1120303|P9|COMPLETED|Washout Period 3||0
469238|NCT00515502|1120304|P8|COMPLETED|Washout Period 3||1
469239|NCT00515502|1120305|P7|COMPLETED|Washout Period 3||1
469240|NCT00515502|1120306|P6|COMPLETED|Washout Period 3||1
469241|NCT00515502|1120307|P5|COMPLETED|Washout Period 3||3
469242|NCT00515502|1120308|P4|COMPLETED|Washout Period 3||3
469243|NCT00515502|1120309|P3|COMPLETED|Washout Period 3||4
469244|NCT00515502|1120310|P2|COMPLETED|Washout Period 3||3
469245|NCT00515502|1120311|P1|COMPLETED|Washout Period 3||1
469246|NCT00515502|1120300|P12|STARTED|Washout Period 3||0
469247|NCT00515502|1120301|P11|STARTED|Washout Period 3||1
469248|NCT00515502|1120302|P10|STARTED|Washout Period 3||2
469249|NCT00515502|1120303|P9|STARTED|Washout Period 3||0
469250|NCT00515502|1120304|P8|STARTED|Washout Period 3||1
469251|NCT00515502|1120305|P7|STARTED|Washout Period 3||1
469252|NCT00515502|1120306|P6|STARTED|Washout Period 3||1
469253|NCT00515502|1120307|P5|STARTED|Washout Period 3||3
469254|NCT00515502|1120308|P4|STARTED|Washout Period 3||3
469255|NCT00515502|1120309|P3|STARTED|Washout Period 3||4
469256|NCT00515502|1120310|P2|STARTED|Washout Period 3||3
469257|NCT00515502|1120311|P1|STARTED|Washout Period 3||1
469258|NCT00515502|1120300|P12|NOT COMPLETED|Treatment Period 3||0
469259|NCT00515502|1120301|P11|NOT COMPLETED|Treatment Period 3||0
469260|NCT00515502|1120302|P10|NOT COMPLETED|Treatment Period 3||0
469261|NCT00515502|1120303|P9|NOT COMPLETED|Treatment Period 3||0
469262|NCT00515502|1120304|P8|NOT COMPLETED|Treatment Period 3||0
469263|NCT00515502|1120305|P7|NOT COMPLETED|Treatment Period 3||0
469264|NCT00515502|1120306|P6|NOT COMPLETED|Treatment Period 3||0
469265|NCT00515502|1120307|P5|NOT COMPLETED|Treatment Period 3||0
469266|NCT00515502|1120308|P4|NOT COMPLETED|Treatment Period 3||0
469267|NCT00515502|1120309|P3|NOT COMPLETED|Treatment Period 3||0
469269|NCT00515502|1120311|P1|NOT COMPLETED|Treatment Period 3||0
469270|NCT00515502|1120300|P12|COMPLETED|Treatment Period 3||0
469271|NCT00515502|1120301|P11|COMPLETED|Treatment Period 3||1
469272|NCT00515502|1120302|P10|COMPLETED|Treatment Period 3||2
469273|NCT00515502|1120303|P9|COMPLETED|Treatment Period 3||0
469274|NCT00515502|1120304|P8|COMPLETED|Treatment Period 3||1
469275|NCT00515502|1120305|P7|COMPLETED|Treatment Period 3||1
469276|NCT00515502|1120306|P6|COMPLETED|Treatment Period 3||1
469277|NCT00515502|1120307|P5|COMPLETED|Treatment Period 3||3
469278|NCT00515502|1120308|P4|COMPLETED|Treatment Period 3||3
469279|NCT00515502|1120309|P3|COMPLETED|Treatment Period 3||4
469280|NCT00515502|1120310|P2|COMPLETED|Treatment Period 3||3
469281|NCT00515502|1120311|P1|COMPLETED|Treatment Period 3||1
469282|NCT00515502|1120300|P12|STARTED|Treatment Period 3||0
469283|NCT00515502|1120301|P11|STARTED|Treatment Period 3||1
469284|NCT00515502|1120302|P10|STARTED|Treatment Period 3||2
469285|NCT00515502|1120303|P9|STARTED|Treatment Period 3||0
469286|NCT00515502|1120304|P8|STARTED|Treatment Period 3||1
469287|NCT00515502|1120305|P7|STARTED|Treatment Period 3||1
469288|NCT00515502|1120306|P6|STARTED|Treatment Period 3||1
469289|NCT00515502|1120307|P5|STARTED|Treatment Period 3||3
469290|NCT00515502|1120308|P4|STARTED|Treatment Period 3||3
469291|NCT00515502|1120309|P3|STARTED|Treatment Period 3||4
469292|NCT00515502|1120310|P2|STARTED|Treatment Period 3||3
469293|NCT00515502|1120311|P1|STARTED|Treatment Period 3||1
469294|NCT00515502|1120300|P12|NOT COMPLETED|Washout Period 2||0
469295|NCT00515502|1120301|P11|NOT COMPLETED|Washout Period 2||0
469296|NCT00515502|1120302|P10|NOT COMPLETED|Washout Period 2||0
469297|NCT00515502|1120303|P9|NOT COMPLETED|Washout Period 2||0
469298|NCT00515502|1120304|P8|NOT COMPLETED|Washout Period 2||0
469299|NCT00515502|1120305|P7|NOT COMPLETED|Washout Period 2||0
469300|NCT00515502|1120306|P6|NOT COMPLETED|Washout Period 2||0
469301|NCT00515502|1120307|P5|NOT COMPLETED|Washout Period 2||0
469302|NCT00515502|1120308|P4|NOT COMPLETED|Washout Period 2||0
469303|NCT00515502|1120309|P3|NOT COMPLETED|Washout Period 2||0
469304|NCT00515502|1120310|P2|NOT COMPLETED|Washout Period 2||0
469305|NCT00515502|1120311|P1|NOT COMPLETED|Washout Period 2||0
469306|NCT00515502|1120300|P12|COMPLETED|Washout Period 2||0
469307|NCT00515502|1120301|P11|COMPLETED|Washout Period 2||1
469308|NCT00515502|1120302|P10|COMPLETED|Washout Period 2||2
469309|NCT00515502|1120303|P9|COMPLETED|Washout Period 2||0
469310|NCT00515502|1120304|P8|COMPLETED|Washout Period 2||1
469311|NCT00515502|1120305|P7|COMPLETED|Washout Period 2||1
469312|NCT00515502|1120306|P6|COMPLETED|Washout Period 2||1
469313|NCT00515502|1120307|P5|COMPLETED|Washout Period 2||3
469314|NCT00515502|1120308|P4|COMPLETED|Washout Period 2||3
469315|NCT00515502|1120309|P3|COMPLETED|Washout Period 2||4
469316|NCT00515502|1120310|P2|COMPLETED|Washout Period 2||3
469317|NCT00515502|1120311|P1|COMPLETED|Washout Period 2||1
469318|NCT00515502|1120300|P12|STARTED|Washout Period 2||0
469319|NCT00515502|1120301|P11|STARTED|Washout Period 2||1
469320|NCT00515502|1120302|P10|STARTED|Washout Period 2||2
469321|NCT00515502|1120303|P9|STARTED|Washout Period 2||0
469322|NCT00515502|1120304|P8|STARTED|Washout Period 2||1
469323|NCT00515502|1120305|P7|STARTED|Washout Period 2||1
469324|NCT00515502|1120306|P6|STARTED|Washout Period 2||1
469325|NCT00515502|1120307|P5|STARTED|Washout Period 2||3
469326|NCT00515502|1120308|P4|STARTED|Washout Period 2||3
469327|NCT00515502|1120309|P3|STARTED|Washout Period 2||4
469328|NCT00515502|1120310|P2|STARTED|Washout Period 2||3
469329|NCT00515502|1120311|P1|STARTED|Washout Period 2||1
469330|NCT00515502|1120300|P12|NOT COMPLETED|Treatment Period 2||0
469331|NCT00515502|1120301|P11|NOT COMPLETED|Treatment Period 2||0
469332|NCT00515502|1120302|P10|NOT COMPLETED|Treatment Period 2||0
469333|NCT00515502|1120303|P9|NOT COMPLETED|Treatment Period 2||0
469334|NCT00515502|1120304|P8|NOT COMPLETED|Treatment Period 2||0
469335|NCT00515502|1120305|P7|NOT COMPLETED|Treatment Period 2||0
469336|NCT00515502|1120306|P6|NOT COMPLETED|Treatment Period 2||0
469337|NCT00515502|1120307|P5|NOT COMPLETED|Treatment Period 2||0
469338|NCT00515502|1120308|P4|NOT COMPLETED|Treatment Period 2||0
469339|NCT00515502|1120309|P3|NOT COMPLETED|Treatment Period 2||0
469340|NCT00515502|1120310|P2|NOT COMPLETED|Treatment Period 2||1
469341|NCT00515502|1120311|P1|NOT COMPLETED|Treatment Period 2||0
469342|NCT00515502|1120300|P12|COMPLETED|Treatment Period 2||0
469343|NCT00515502|1120301|P11|COMPLETED|Treatment Period 2||1
469344|NCT00515502|1120302|P10|COMPLETED|Treatment Period 2||2
469345|NCT00515502|1120303|P9|COMPLETED|Treatment Period 2||0
469346|NCT00515502|1120304|P8|COMPLETED|Treatment Period 2||1
469347|NCT00515502|1120305|P7|COMPLETED|Treatment Period 2||1
469348|NCT00515502|1120306|P6|COMPLETED|Treatment Period 2||1
469349|NCT00515502|1120307|P5|COMPLETED|Treatment Period 2||3
469350|NCT00515502|1120308|P4|COMPLETED|Treatment Period 2||3
469351|NCT00515502|1120309|P3|COMPLETED|Treatment Period 2||4
469352|NCT00515502|1120310|P2|COMPLETED|Treatment Period 2||3
469353|NCT00515502|1120311|P1|COMPLETED|Treatment Period 2||1
469354|NCT00515502|1120300|P12|STARTED|Treatment Period 2||0
469355|NCT00515502|1120301|P11|STARTED|Treatment Period 2||1
469356|NCT00515502|1120302|P10|STARTED|Treatment Period 2||2
469357|NCT00515502|1120303|P9|STARTED|Treatment Period 2||0
469358|NCT00515502|1120304|P8|STARTED|Treatment Period 2||1
469359|NCT00515502|1120305|P7|STARTED|Treatment Period 2||1
469360|NCT00515502|1120306|P6|STARTED|Treatment Period 2||1
469361|NCT00515502|1120307|P5|STARTED|Treatment Period 2||3
469362|NCT00515502|1120308|P4|STARTED|Treatment Period 2||3
469363|NCT00515502|1120309|P3|STARTED|Treatment Period 2||4
469364|NCT00515502|1120310|P2|STARTED|Treatment Period 2||4
469365|NCT00515502|1120311|P1|STARTED|Treatment Period 2||1
469366|NCT00515502|1120300|P12|NOT COMPLETED|Washout Period 1||0
469367|NCT00515502|1120301|P11|NOT COMPLETED|Washout Period 1||0
469368|NCT00515502|1120302|P10|NOT COMPLETED|Washout Period 1||0
469369|NCT00515502|1120303|P9|NOT COMPLETED|Washout Period 1||0
469370|NCT00515502|1120304|P8|NOT COMPLETED|Washout Period 1||0
469371|NCT00515502|1120305|P7|NOT COMPLETED|Washout Period 1||0
469372|NCT00515502|1120306|P6|NOT COMPLETED|Washout Period 1||0
469373|NCT00515502|1120307|P5|NOT COMPLETED|Washout Period 1||0
469374|NCT00515502|1120308|P4|NOT COMPLETED|Washout Period 1||0
469375|NCT00515502|1120309|P3|NOT COMPLETED|Washout Period 1||0
469376|NCT00515502|1120310|P2|NOT COMPLETED|Washout Period 1||0
469377|NCT00515502|1120311|P1|NOT COMPLETED|Washout Period 1||0
469378|NCT00515502|1120300|P12|COMPLETED|Washout Period 1||0
469379|NCT00515502|1120301|P11|COMPLETED|Washout Period 1||1
469380|NCT00515502|1120302|P10|COMPLETED|Washout Period 1||2
469381|NCT00515502|1120303|P9|COMPLETED|Washout Period 1||0
469382|NCT00515502|1120304|P8|COMPLETED|Washout Period 1||1
469383|NCT00515502|1120305|P7|COMPLETED|Washout Period 1||1
469384|NCT00515502|1120306|P6|COMPLETED|Washout Period 1||1
469385|NCT00515502|1120307|P5|COMPLETED|Washout Period 1||3
469386|NCT00515502|1120308|P4|COMPLETED|Washout Period 1||3
469387|NCT00515502|1120309|P3|COMPLETED|Washout Period 1||4
469388|NCT00515502|1120310|P2|COMPLETED|Washout Period 1||4
469389|NCT00515502|1120311|P1|COMPLETED|Washout Period 1||1
469390|NCT00515502|1120300|P12|STARTED|Washout Period 1||0
469391|NCT00515502|1120301|P11|STARTED|Washout Period 1||1
469392|NCT00515502|1120302|P10|STARTED|Washout Period 1||2
469393|NCT00515502|1120303|P9|STARTED|Washout Period 1||0
469394|NCT00515502|1120304|P8|STARTED|Washout Period 1||1
469395|NCT00515502|1120305|P7|STARTED|Washout Period 1||1
469396|NCT00515502|1120306|P6|STARTED|Washout Period 1||1
469397|NCT00515502|1120307|P5|STARTED|Washout Period 1||3
469398|NCT00515502|1120308|P4|STARTED|Washout Period 1||3
469399|NCT00515502|1120309|P3|STARTED|Washout Period 1||4
469400|NCT00515502|1120310|P2|STARTED|Washout Period 1||4
469401|NCT00515502|1120311|P1|STARTED|Washout Period 1||1
469402|NCT00515502|1120300|P12|NOT COMPLETED|Treatment Period 1||1
469403|NCT00515502|1120301|P11|NOT COMPLETED|Treatment Period 1||0
469404|NCT00515502|1120302|P10|NOT COMPLETED|Treatment Period 1||0
469405|NCT00515502|1120303|P9|NOT COMPLETED|Treatment Period 1||1
469406|NCT00515502|1120304|P8|NOT COMPLETED|Treatment Period 1||0
469407|NCT00515502|1120305|P7|NOT COMPLETED|Treatment Period 1||1
469408|NCT00515502|1120306|P6|NOT COMPLETED|Treatment Period 1||0
469409|NCT00515502|1120307|P5|NOT COMPLETED|Treatment Period 1||0
469410|NCT00515502|1120308|P4|NOT COMPLETED|Treatment Period 1||0
469411|NCT00515502|1120309|P3|NOT COMPLETED|Treatment Period 1||0
469412|NCT00515502|1120310|P2|NOT COMPLETED|Treatment Period 1||0
469413|NCT00515502|1120311|P1|NOT COMPLETED|Treatment Period 1||0
469414|NCT00515502|1120300|P12|COMPLETED|Treatment Period 1||0
469415|NCT00515502|1120301|P11|COMPLETED|Treatment Period 1||1
469416|NCT00515502|1120302|P10|COMPLETED|Treatment Period 1||2
469417|NCT00515502|1120303|P9|COMPLETED|Treatment Period 1||0
469418|NCT00515502|1120304|P8|COMPLETED|Treatment Period 1||1
469419|NCT00515502|1120305|P7|COMPLETED|Treatment Period 1||1
469420|NCT00515502|1120306|P6|COMPLETED|Treatment Period 1||1
469421|NCT00515502|1120307|P5|COMPLETED|Treatment Period 1||3
469422|NCT00515502|1120308|P4|COMPLETED|Treatment Period 1||3
469423|NCT00515502|1120309|P3|COMPLETED|Treatment Period 1||4
469424|NCT00515502|1120310|P2|COMPLETED|Treatment Period 1||4
469425|NCT00515502|1120311|P1|COMPLETED|Treatment Period 1||1
469426|NCT00515502|1120300|P12|STARTED|Treatment Period 1||1
469427|NCT00515502|1120301|P11|STARTED|Treatment Period 1||1
469428|NCT00515502|1120302|P10|STARTED|Treatment Period 1||2
469429|NCT00515502|1120303|P9|STARTED|Treatment Period 1||1
469430|NCT00515502|1120304|P8|STARTED|Treatment Period 1||1
469431|NCT00515502|1120305|P7|STARTED|Treatment Period 1||2
469432|NCT00515502|1120306|P6|STARTED|Treatment Period 1||1
469433|NCT00515502|1120307|P5|STARTED|Treatment Period 1||3
469434|NCT00515502|1120308|P4|STARTED|Treatment Period 1||3
469435|NCT00515502|1120309|P3|STARTED|Treatment Period 1||4
469436|NCT00515502|1120310|P2|STARTED|Treatment Period 1||4
469437|NCT00515502|1120311|P1|STARTED|Treatment Period 1||1
469438|NCT00515463|1120471|P2|NOT COMPLETED|Overall Study||14
469439|NCT00515463|1120472|P1|NOT COMPLETED|Overall Study||14
469440|NCT00515463|1120471|P2|COMPLETED|Overall Study||142
469441|NCT00515463|1120472|P1|COMPLETED|Overall Study||141
469442|NCT00515463|1120471|P2|Received Study Medication|Overall Study||156
469443|NCT00515463|1120472|P1|Received Study Medication|Overall Study||154
469444|NCT00515463|1120471|P2|STARTED|Overall Study||156
469445|NCT00515463|1120472|P1|STARTED|Overall Study||155
469446|NCT00515437|1120626|P4|NOT COMPLETED|Overall Study||1
469447|NCT00515437|1120627|P3|NOT COMPLETED|Overall Study||0
469448|NCT00515437|1120628|P2|NOT COMPLETED|Overall Study||0
469449|NCT00515437|1120629|P1|NOT COMPLETED|Overall Study||0
469450|NCT00515437|1120626|P4|COMPLETED|Overall Study||14
469451|NCT00515437|1120627|P3|COMPLETED|Overall Study||13
469452|NCT00515437|1120628|P2|COMPLETED|Overall Study||12
469453|NCT00515437|1120629|P1|COMPLETED|Overall Study||14
469454|NCT00515437|1120626|P4|STARTED|Overall Study||15
469455|NCT00515437|1120627|P3|STARTED|Overall Study||13
469456|NCT00515437|1120628|P2|STARTED|Overall Study||12
469457|NCT00515437|1120629|P1|STARTED|Overall Study||14
469458|NCT00515216|1120651|P1|NOT COMPLETED|Overall Study||1
469459|NCT00515216|1120651|P1|COMPLETED|Overall Study||25
469460|NCT00515216|1120651|P1|STARTED|Overall Study||26
469461|NCT00515203|1120675|P2|NOT COMPLETED|Overall Study||0
469462|NCT00515203|1120676|P1|NOT COMPLETED|Overall Study||0
469463|NCT00515203|1120675|P2|COMPLETED|Overall Study||5
469464|NCT00515203|1120676|P1|COMPLETED|Overall Study||17
469465|NCT00515203|1120675|P2|STARTED|Overall Study||5
469466|NCT00515203|1120676|P1|STARTED|Overall Study||17
469467|NCT00515177|1120694|P2|NOT COMPLETED|Overall Study||1
469468|NCT00515177|1120695|P1|NOT COMPLETED|Overall Study||2
469469|NCT00515177|1120694|P2|COMPLETED|Overall Study||9
469470|NCT00515177|1120695|P1|COMPLETED|Overall Study||18
469471|NCT00515177|1120694|P2|STARTED|Overall Study||10
469472|NCT00515177|1120695|P1|STARTED|Overall Study||20
469473|NCT00515112|1120713|P2|NOT COMPLETED|Overall Study||3
469474|NCT00515112|1120714|P1|NOT COMPLETED|Overall Study||3
469475|NCT00515112|1120713|P2|COMPLETED|Overall Study||0
469476|NCT00515112|1120714|P1|COMPLETED|Overall Study||0
469477|NCT00515112|1120713|P2|STARTED|Overall Study||3
469478|NCT00515112|1120714|P1|STARTED|Overall Study||3
469479|NCT00515099|1120724|P2|NOT COMPLETED|Overall Study||4
469480|NCT00515099|1120725|P1|NOT COMPLETED|Overall Study||3
469481|NCT00515099|1120724|P2|COMPLETED|Overall Study||16
469482|NCT00515099|1120725|P1|COMPLETED|Overall Study||35
469483|NCT00515099|1120724|P2|STARTED|Overall Study||20
469484|NCT00515099|1120725|P1|STARTED|Overall Study||38
469485|NCT00515086|1120747|P4|NOT COMPLETED|Overall Study||6
469486|NCT00515086|1120748|P3|NOT COMPLETED|Overall Study||5
469487|NCT00515086|1120749|P2|NOT COMPLETED|Overall Study||6
469488|NCT00515086|1120750|P1|NOT COMPLETED|Overall Study||24
469489|NCT00515086|1120747|P4|COMPLETED|Overall Study||0
469490|NCT00515086|1120748|P3|COMPLETED|Overall Study||0
469491|NCT00515086|1120749|P2|COMPLETED|Overall Study||0
469492|NCT00515086|1120750|P1|COMPLETED|Overall Study||0
469493|NCT00515086|1120747|P4|STARTED|Overall Study||6
469494|NCT00515086|1120748|P3|STARTED|Overall Study||5
469495|NCT00515086|1120749|P2|STARTED|Overall Study||6
469496|NCT00515086|1120750|P1|STARTED|Overall Study||24
469497|NCT00515073|1120777|P1|NOT COMPLETED|Overall Study||2
469498|NCT00515073|1120777|P1|COMPLETED|Overall Study||28
469499|NCT00515073|1120777|P1|STARTED|Overall Study||30
469500|NCT00515034|1120785|P4|NOT COMPLETED|Overall Study||5
469501|NCT00515034|1120786|P3|NOT COMPLETED|Overall Study||8
469502|NCT00515034|1120787|P2|NOT COMPLETED|Overall Study||2
469503|NCT00515034|1120788|P1|NOT COMPLETED|Overall Study||8
469504|NCT00515034|1120785|P4|COMPLETED|Overall Study||15
469505|NCT00515034|1120786|P3|COMPLETED|Overall Study||54
469506|NCT00515034|1120787|P2|COMPLETED|Overall Study||13
469507|NCT00515034|1120788|P1|COMPLETED|Overall Study||41
469508|NCT00515034|1120785|P4|TREATED|Overall Study||19
469509|NCT00515034|1120786|P3|TREATED|Overall Study||61
469510|NCT00515034|1120787|P2|TREATED|Overall Study||15
469511|NCT00515034|1120788|P1|TREATED|Overall Study||48
469512|NCT00515034|1120785|P4|STARTED|Overall Study||20
469513|NCT00515034|1120786|P3|STARTED|Overall Study||62
469514|NCT00515034|1120787|P2|STARTED|Overall Study||15
469515|NCT00515034|1120788|P1|STARTED|Overall Study||49
469516|NCT00515008|1120808|P2|NOT COMPLETED|Overall Study||4
469517|NCT00515008|1120809|P1|NOT COMPLETED|Overall Study||3
469518|NCT00515008|1120808|P2|COMPLETED|Overall Study||29
469519|NCT00515008|1120809|P1|COMPLETED|Overall Study||30
469520|NCT00515008|1120808|P2|Completed 12 Week Evaluation|Overall Study||29
469521|NCT00515008|1120809|P1|Completed 12 Week Evaluation|Overall Study||32
469522|NCT00515008|1120808|P2|STARTED|Overall Study||33
469523|NCT00515008|1120809|P1|STARTED|Overall Study||33
469524|NCT00514943|1120833|P2|NOT COMPLETED|Stage 2||36
469525|NCT00514943|1120834|P1|NOT COMPLETED|Stage 2||32
469526|NCT00514943|1120833|P2|COMPLETED|Stage 2||0
469527|NCT00514943|1120834|P1|COMPLETED|Stage 2||0
469528|NCT00514943|1120833|P2|STARTED|Stage 2||36
469529|NCT00514943|1120834|P1|STARTED|Stage 2||32
469530|NCT00514943|1120833|P2|NOT COMPLETED|Stage 1||26
469531|NCT00514943|1120834|P1|NOT COMPLETED|Stage 1||30
469532|NCT00514943|1120833|P2|COMPLETED|Stage 1||36
469533|NCT00514943|1120834|P1|COMPLETED|Stage 1||32
469534|NCT00514943|1120833|P2|STARTED|Stage 1|2 randomized patients were not treated|62
469535|NCT00514943|1120834|P1|STARTED|Stage 1|1 randomized patient was not treated|62
469536|NCT00514917|1120892|P2|NOT COMPLETED|Overall Study||115
469537|NCT00514917|1120893|P1|NOT COMPLETED|Overall Study||126
469538|NCT00514917|1120892|P2|COMPLETED|Overall Study||91
469539|NCT00514917|1120893|P1|COMPLETED|Overall Study||81
469540|NCT00514917|1120892|P2|Testosterone-Specific Evaluable|Overall Study||124
469541|NCT00514917|1120893|P1|Testosterone-Specific Evaluable|Overall Study||122
469542|NCT00514917|1120892|P2|Completed Study Treatment|Overall Study||182
469543|NCT00514917|1120893|P1|Completed Study Treatment|Overall Study||170
469544|NCT00514917|1120892|P2|Treated|Overall Study||204
469545|NCT00514917|1120893|P1|Treated|Overall Study||196
469546|NCT00514917|1120892|P2|STARTED|Overall Study||206
469547|NCT00514917|1120893|P1|STARTED|Overall Study||207
469548|NCT00514852|1120921|P2|NOT COMPLETED|Overall Study||5
469549|NCT00514852|1120922|P1|NOT COMPLETED|Overall Study||5
469550|NCT00514852|1120921|P2|COMPLETED|Overall Study||154
469551|NCT00514852|1120922|P1|COMPLETED|Overall Study||152
469552|NCT00514852|1120921|P2|STARTED|Overall Study||159
469553|NCT00514852|1120922|P1|STARTED|Overall Study||157
469554|NCT00514813|1120950|P4|NOT COMPLETED|Overall Study||4
469555|NCT00514813|1120951|P3|NOT COMPLETED|Overall Study||47
469556|NCT00514813|1120952|P2|NOT COMPLETED|Overall Study||86
469557|NCT00514813|1120953|P1|NOT COMPLETED|Overall Study||15
469558|NCT00514813|1120950|P4|COMPLETED|Overall Study||0
469559|NCT00514813|1120951|P3|COMPLETED|Overall Study||0
469560|NCT00514813|1120952|P2|COMPLETED|Overall Study||0
469561|NCT00514813|1120953|P1|COMPLETED|Overall Study||0
469562|NCT00514813|1120950|P4|STARTED|Overall Study||4
469563|NCT00514813|1120951|P3|STARTED|Overall Study||47
469564|NCT00514813|1120952|P2|STARTED|Overall Study||86
469565|NCT00514813|1120953|P1|STARTED|Overall Study||15
469566|NCT00514735|1120973|P2|NOT COMPLETED|Overall Study||6
469567|NCT00514735|1120974|P1|NOT COMPLETED|Overall Study||14
469568|NCT00514735|1120973|P2|COMPLETED|Overall Study||66
469569|NCT00514735|1120974|P1|COMPLETED|Overall Study||124
469570|NCT00514735|1120973|P2|STARTED|Overall Study||72
469571|NCT00514735|1120974|P1|STARTED|Overall Study||138
469572|NCT00514709|1120994|P2|NOT COMPLETED|Overall Study||0
469573|NCT00514709|1120995|P1|NOT COMPLETED|Overall Study||0
469574|NCT00514709|1120994|P2|COMPLETED|Overall Study||613
469575|NCT00514709|1120995|P1|COMPLETED|Overall Study||1230
469576|NCT00514709|1120994|P2|STARTED|Overall Study||613
469577|NCT00514709|1120995|P1|STARTED|Overall Study||1230
469578|NCT00514683|1121010|P5|NOT COMPLETED|Overall Study||33
469579|NCT00514683|1121011|P4|NOT COMPLETED|Overall Study||14
469580|NCT00514683|1121012|P3|NOT COMPLETED|Overall Study||18
469581|NCT00514683|1121013|P2|NOT COMPLETED|Overall Study||25
469582|NCT00514683|1121014|P1|NOT COMPLETED|Overall Study||26
469583|NCT00514683|1121010|P5|COMPLETED|Overall Study||53
469584|NCT00514683|1121011|P4|COMPLETED|Overall Study||72
469585|NCT00514683|1121012|P3|COMPLETED|Overall Study||68
469586|NCT00514683|1121013|P2|COMPLETED|Overall Study||62
469587|NCT00514683|1121014|P1|COMPLETED|Overall Study||61
469588|NCT00514683|1121010|P5|STARTED|Overall Study|Randomised|86
469589|NCT00514683|1121011|P4|STARTED|Overall Study|Randomised|86
469590|NCT00514683|1121012|P3|STARTED|Overall Study|Randomised|86
469591|NCT00514683|1121013|P2|STARTED|Overall Study|Randomised|87
469592|NCT00514683|1121014|P1|STARTED|Overall Study|Randomised|87
469593|NCT00514592|1121205|P1|NOT COMPLETED|Overall Study||0
469594|NCT00514592|1121205|P1|COMPLETED|Overall Study||230
469595|NCT00514592|1121205|P1|STARTED|Overall Study||230
469596|NCT00514514|1121213|P3|NOT COMPLETED|Extension - 4 Years||21
469597|NCT00514514|1121214|P2|NOT COMPLETED|Extension - 4 Years||22
469598|NCT00514514|1121215|P1|NOT COMPLETED|Extension - 4 Years||37
469599|NCT00514514|1121213|P3|COMPLETED|Extension - 4 Years||113
469600|NCT00514514|1121214|P2|COMPLETED|Extension - 4 Years||117
469601|NCT00514514|1121215|P1|COMPLETED|Extension - 4 Years||108
469602|NCT00514514|1121213|P3|Non-randomized (Followed)|Extension - 4 Years||0
469603|NCT00514514|1121214|P2|Non-randomized (Followed)|Extension - 4 Years||0
469604|NCT00514514|1121215|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
469605|NCT00514514|1121213|P3|STARTED|Extension - 4 Years||134
469606|NCT00514514|1121214|P2|STARTED|Extension - 4 Years||139
469607|NCT00514514|1121215|P1|STARTED|Extension - 4 Years||145
469608|NCT00514514|1121213|P3|NOT COMPLETED|Randomized - 9 Month||38
469609|NCT00514514|1121214|P2|NOT COMPLETED|Randomized - 9 Month||61
469610|NCT00514514|1121215|P1|NOT COMPLETED|Randomized - 9 Month||39
469611|NCT00514514|1121213|P3|COMPLETED|Randomized - 9 Month||124
469612|NCT00514514|1121214|P2|COMPLETED|Randomized - 9 Month||110
469613|NCT00514514|1121215|P1|COMPLETED|Randomized - 9 Month||127
469614|NCT00514514|1121213|P3|Randomized - Received Treatment|Randomized - 9 Month||161
469615|NCT00514514|1121214|P2|Randomized - Received Treatment|Randomized - 9 Month||171
469616|NCT00514514|1121215|P1|Randomized - Received Treatment|Randomized - 9 Month||165
469617|NCT00514514|1121213|P3|STARTED|Randomized - 9 Month||162
469618|NCT00514514|1121214|P2|STARTED|Randomized - 9 Month||171
469619|NCT00514514|1121215|P1|STARTED|Randomized - 9 Month||166
469620|NCT00514514|1121213|P3|NOT COMPLETED|Pre-phase||0
469621|NCT00514514|1121214|P2|NOT COMPLETED|Pre-phase||0
469622|NCT00514514|1121215|P1|NOT COMPLETED|Pre-phase||303
469623|NCT00514514|1121213|P3|COMPLETED|Pre-phase||0
469624|NCT00514514|1121214|P2|COMPLETED|Pre-phase||0
469625|NCT00514514|1121215|P1|COMPLETED|Pre-phase||499
469626|NCT00514514|1121213|P3|STARTED|Pre-phase||0
469627|NCT00514514|1121214|P2|STARTED|Pre-phase||0
469628|NCT00514514|1121215|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
469629|NCT00514501|1121259|P1|NOT COMPLETED|Overall Study||3
469630|NCT00514501|1121259|P1|COMPLETED|Overall Study||507
469631|NCT00514501|1121259|P1|STARTED|Overall Study||510
469632|NCT00514215|1121265|P1|NOT COMPLETED|Overall Study||0
469633|NCT00514215|1121265|P1|COMPLETED|Overall Study||8
469634|NCT00514215|1121265|P1|STARTED|Overall Study||8
469635|NCT00514137|1121269|P1|NOT COMPLETED|Overall Study||0
469636|NCT00514137|1121269|P1|COMPLETED|Overall Study||13
469637|NCT00514137|1121269|P1|STARTED|Overall Study||13
469638|NCT00514020|1121276|P1|NOT COMPLETED|Overall Study||28
469639|NCT00514020|1121276|P1|COMPLETED|Overall Study||5
469730|NCT00513409|1121434|P2|NOT COMPLETED|Overall Study||6
469640|NCT00514020|1121276|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
469641|NCT00513799|1121284|P4|NOT COMPLETED|Four-Month Follow-Up||3
469642|NCT00513799|1121285|P3|NOT COMPLETED|Four-Month Follow-Up||7
469643|NCT00513799|1121286|P2|NOT COMPLETED|Four-Month Follow-Up||5
469644|NCT00513799|1121287|P1|NOT COMPLETED|Four-Month Follow-Up||0
469645|NCT00513799|1121284|P4|COMPLETED|Four-Month Follow-Up||51
469646|NCT00513799|1121285|P3|COMPLETED|Four-Month Follow-Up||57
469647|NCT00513799|1121286|P2|COMPLETED|Four-Month Follow-Up||57
469648|NCT00513799|1121287|P1|COMPLETED|Four-Month Follow-Up||64
469649|NCT00513799|1121284|P4|STARTED|Four-Month Follow-Up||54
469650|NCT00513799|1121285|P3|STARTED|Four-Month Follow-Up||64
469651|NCT00513799|1121286|P2|STARTED|Four-Month Follow-Up||62
469652|NCT00513799|1121287|P1|STARTED|Four-Month Follow-Up||64
469653|NCT00513799|1121284|P4|NOT COMPLETED|One-Month Follow-Up||21
469654|NCT00513799|1121285|P3|NOT COMPLETED|One-Month Follow-Up||11
469655|NCT00513799|1121286|P2|NOT COMPLETED|One-Month Follow-Up||13
469656|NCT00513799|1121287|P1|NOT COMPLETED|One-Month Follow-Up||11
469657|NCT00513799|1121284|P4|COMPLETED|One-Month Follow-Up||54
469658|NCT00513799|1121285|P3|COMPLETED|One-Month Follow-Up||64
469659|NCT00513799|1121286|P2|COMPLETED|One-Month Follow-Up||62
469660|NCT00513799|1121287|P1|COMPLETED|One-Month Follow-Up||64
469661|NCT00513799|1121284|P4|STARTED|One-Month Follow-Up||75
469662|NCT00513799|1121285|P3|STARTED|One-Month Follow-Up||75
469663|NCT00513799|1121286|P2|STARTED|One-Month Follow-Up||75
469664|NCT00513799|1121287|P1|STARTED|One-Month Follow-Up||75
469665|NCT00513708|1121308|P3|NOT COMPLETED|Overall Study||4
469666|NCT00513708|1121309|P2|NOT COMPLETED|Overall Study||4
469667|NCT00513708|1121310|P1|NOT COMPLETED|Overall Study||4
469668|NCT00513708|1121308|P3|COMPLETED|Overall Study||46
469669|NCT00513708|1121309|P2|COMPLETED|Overall Study||46
469670|NCT00513708|1121310|P1|COMPLETED|Overall Study||46
469671|NCT00513708|1121308|P3|STARTED|Overall Study||50
469672|NCT00513708|1121309|P2|STARTED|Overall Study||50
469673|NCT00513708|1121310|P1|STARTED|Overall Study||50
469674|NCT00513695|1121324|P1|NOT COMPLETED|Overall Study||5
469675|NCT00513695|1121324|P1|COMPLETED|Overall Study||63
469676|NCT00513695|1121324|P1|STARTED|Overall Study||68
469677|NCT00513682|1121333|P1|NOT COMPLETED|Treatment Phase||0
469678|NCT00513682|1121333|P1|COMPLETED|Treatment Phase||7
469679|NCT00513682|1121333|P1|STARTED|Treatment Phase||7
469680|NCT00513682|1121333|P1|NOT COMPLETED|Washout Phase||2
469681|NCT00513682|1121333|P1|COMPLETED|Washout Phase||7
469682|NCT00513682|1121333|P1|STARTED|Washout Phase||9
469683|NCT00513682|1121333|P1|NOT COMPLETED|Screening Phase||0
469684|NCT00513682|1121333|P1|COMPLETED|Screening Phase||9
469685|NCT00513682|1121333|P1|STARTED|Screening Phase||9
469686|NCT00513617|1121345|P3|NOT COMPLETED|Overall Study||8
469687|NCT00513617|1121346|P2|NOT COMPLETED|Overall Study||10
469688|NCT00513617|1121347|P1|NOT COMPLETED|Overall Study||11
469689|NCT00513617|1121345|P3|COMPLETED|Overall Study||30
469690|NCT00513617|1121346|P2|COMPLETED|Overall Study||25
469691|NCT00513617|1121347|P1|COMPLETED|Overall Study||25
469692|NCT00513617|1121345|P3|STARTED|Overall Study||38
469693|NCT00513617|1121346|P2|STARTED|Overall Study||35
469694|NCT00513617|1121347|P1|STARTED|Overall Study||36
469695|NCT00513604|1121363|P5|NOT COMPLETED|Overall Study||0
469696|NCT00513604|1121364|P4|NOT COMPLETED|Overall Study||0
469697|NCT00513604|1121365|P3|NOT COMPLETED|Overall Study||3
469698|NCT00513604|1121366|P2|NOT COMPLETED|Overall Study||3
469699|NCT00513604|1121367|P1|NOT COMPLETED|Overall Study||2
469700|NCT00513604|1121363|P5|COMPLETED|Overall Study||35
469701|NCT00513604|1121364|P4|COMPLETED|Overall Study||34
469702|NCT00513604|1121365|P3|COMPLETED|Overall Study||21
469703|NCT00513604|1121366|P2|COMPLETED|Overall Study||36
469704|NCT00513604|1121367|P1|COMPLETED|Overall Study||24
469705|NCT00513604|1121363|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
469706|NCT00513604|1121364|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
469793|NCT00512902|1121571|P1|COMPLETED|Overall Study||12
469707|NCT00513604|1121365|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
469708|NCT00513604|1121366|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
469709|NCT00513604|1121367|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
469710|NCT00513526|1121384|P1|NOT COMPLETED|Overall Study||17
469711|NCT00513526|1121384|P1|COMPLETED|Overall Study||92
469712|NCT00513526|1121384|P1|STARTED|Overall Study||109
469713|NCT00513500|1121401|P2|NOT COMPLETED|Overall Study||54
469714|NCT00513500|1121402|P1|NOT COMPLETED|Overall Study||41
469715|NCT00513500|1121401|P2|COMPLETED|Overall Study||2054
469716|NCT00513500|1121402|P1|COMPLETED|Overall Study||976
469717|NCT00513500|1121401|P2|STARTED|Overall Study||2108
469718|NCT00513500|1121402|P1|STARTED|Overall Study||1017
469719|NCT00513474|1121414|P2|NOT COMPLETED|Overall Study||9
469720|NCT00513474|1121415|P1|NOT COMPLETED|Overall Study||7
469721|NCT00513474|1121414|P2|COMPLETED|Overall Study||12
469722|NCT00513474|1121415|P1|COMPLETED|Overall Study||18
469723|NCT00513474|1121414|P2|Received Rasburicase Per Protocol|Overall Study||0
469724|NCT00513474|1121415|P1|Received Rasburicase Per Protocol|Overall Study||24
469725|NCT00513474|1121414|P2|STARTED|Overall Study||21
469726|NCT00513474|1121415|P1|STARTED|Overall Study||25
469727|NCT00513435|1121427|P1|NOT COMPLETED|Overall Study||0
469728|NCT00513435|1121427|P1|COMPLETED|Overall Study||9
469729|NCT00513435|1121427|P1|STARTED|Overall Study||9
469731|NCT00513409|1121435|P1|NOT COMPLETED|Overall Study||2
469732|NCT00513409|1121434|P2|COMPLETED|Overall Study||73
469733|NCT00513409|1121435|P1|COMPLETED|Overall Study||82
469734|NCT00513409|1121434|P2|STARTED|Overall Study||79
469735|NCT00513409|1121435|P1|STARTED|Overall Study||84
469736|NCT00513370|1121461|P1|NOT COMPLETED|Overall Study||24
469737|NCT00513370|1121461|P1|COMPLETED|Overall Study||179
469738|NCT00513370|1121461|P1|STARTED|Overall Study||203
469739|NCT00513357|1121491|P2|NOT COMPLETED|Overall Study||10
469740|NCT00513357|1121492|P1|NOT COMPLETED|Overall Study||15
469741|NCT00513357|1121491|P2|COMPLETED|Overall Study||25
469742|NCT00513357|1121492|P1|COMPLETED|Overall Study||23
469743|NCT00513357|1121491|P2|STARTED|Overall Study||35
469744|NCT00513357|1121492|P1|STARTED|Overall Study||38
469745|NCT00513344|1121498|P1|NOT COMPLETED|3rd Intervention 1 Day||0
469746|NCT00513344|1121498|P1|COMPLETED|3rd Intervention 1 Day||5
469747|NCT00513344|1121498|P1|STARTED|3rd Intervention 1 Day||5
469748|NCT00513344|1121498|P1|NOT COMPLETED|Washout Period 3 Days||0
469749|NCT00513344|1121498|P1|COMPLETED|Washout Period 3 Days||5
469750|NCT00513344|1121498|P1|STARTED|Washout Period 3 Days||5
469751|NCT00513344|1121498|P1|NOT COMPLETED|2nd Intervention 1 Day||0
469752|NCT00513344|1121498|P1|COMPLETED|2nd Intervention 1 Day||5
469753|NCT00513344|1121498|P1|STARTED|2nd Intervention 1 Day||5
469754|NCT00513344|1121498|P1|NOT COMPLETED|Washout Period 3 Days||0
469755|NCT00513344|1121498|P1|COMPLETED|Washout Period 3 Days||5
469756|NCT00513344|1121498|P1|STARTED|Washout Period 3 Days||5
469757|NCT00513344|1121498|P1|NOT COMPLETED|1st Intervention 1 Day||0
469758|NCT00513344|1121498|P1|COMPLETED|1st Intervention 1 Day||5
469759|NCT00513344|1121498|P1|STARTED|1st Intervention 1 Day||5
469760|NCT00513344|1121498|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
469761|NCT00513344|1121498|P1|COMPLETED|Diet Restriction (3 Days)||5
469762|NCT00513344|1121498|P1|STARTED|Diet Restriction (3 Days)||5
469763|NCT00513305|1121511|P2|NOT COMPLETED|Overall Study||27
469764|NCT00513305|1121512|P1|NOT COMPLETED|Overall Study||28
469765|NCT00513305|1121511|P2|COMPLETED|Overall Study||7
469766|NCT00513305|1121512|P1|COMPLETED|Overall Study||5
469767|NCT00513305|1121511|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
469768|NCT00513305|1121512|P1|STARTED|Overall Study||33
469769|NCT00513292|1121530|P2|NOT COMPLETED|Overall Study||0
469770|NCT00513292|1121531|P1|NOT COMPLETED|Overall Study||0
469771|NCT00513292|1121530|P2|COMPLETED|Overall Study||142
469772|NCT00513292|1121531|P1|COMPLETED|Overall Study||138
469773|NCT00513292|1121530|P2|STARTED|Overall Study||142
469774|NCT00513292|1121531|P1|STARTED|Overall Study||138
469775|NCT00513240|1121549|P2|NOT COMPLETED|Overall Study||7
469776|NCT00513240|1121550|P1|NOT COMPLETED|Overall Study||13
469777|NCT00513240|1121549|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
469778|NCT00513240|1121550|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
469779|NCT00513240|1121549|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
469780|NCT00513240|1121550|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
469781|NCT00513240|1121549|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
469782|NCT00513240|1121550|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
469783|NCT00513071|1121557|P1|NOT COMPLETED|Overall Study||5
469784|NCT00513071|1121557|P1|COMPLETED|Overall Study||23
469785|NCT00513071|1121557|P1|STARTED|Overall Study||28
469786|NCT00513019|1121564|P2|NOT COMPLETED|Overall Study||5
469787|NCT00513019|1121565|P1|NOT COMPLETED|Overall Study||5
469788|NCT00513019|1121564|P2|COMPLETED|Overall Study||13
469789|NCT00513019|1121565|P1|COMPLETED|Overall Study||12
469790|NCT00513019|1121564|P2|STARTED|Overall Study||18
469791|NCT00513019|1121565|P1|STARTED|Overall Study||17
469792|NCT00512902|1121571|P1|NOT COMPLETED|Overall Study||8
469794|NCT00512902|1121571|P1|STARTED|Overall Study||20
469795|NCT00512876|1121579|P1|NOT COMPLETED|Overall Study||4
469796|NCT00512876|1121579|P1|COMPLETED|Overall Study||20
469797|NCT00512876|1121579|P1|STARTED|Overall Study||24
469798|NCT00512798|1121586|P2|NOT COMPLETED|Overall Study||27
469799|NCT00512798|1121587|P1|NOT COMPLETED|Overall Study||19
469800|NCT00512798|1121586|P2|COMPLETED|Overall Study||1
469801|NCT00512798|1121587|P1|COMPLETED|Overall Study||0
469802|NCT00512798|1121586|P2|STARTED|Overall Study||28
469803|NCT00512798|1121587|P1|STARTED|Overall Study||19
469804|NCT00512252|1121599|P3|NOT COMPLETED|Overall Study||3
469805|NCT00512252|1121600|P2|NOT COMPLETED|Overall Study||0
469806|NCT00512252|1121601|P1|NOT COMPLETED|Overall Study||0
469807|NCT00512252|1121599|P3|COMPLETED|Overall Study||43
469808|NCT00512252|1121600|P2|COMPLETED|Overall Study||3
469809|NCT00512252|1121601|P1|COMPLETED|Overall Study||3
469810|NCT00512252|1121599|P3|STARTED|Overall Study||46
469811|NCT00512252|1121600|P2|STARTED|Overall Study||3
469812|NCT00512252|1121601|P1|STARTED|Overall Study||3
469813|NCT00512148|1121629|P1|NOT COMPLETED|Long Term Follow Up Period||6
469814|NCT00512148|1121629|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
469815|NCT00512148|1121629|P1|STARTED|Long Term Follow Up Period||6
469816|NCT00512148|1121629|P1|NOT COMPLETED|Primay Study Period||1
469817|NCT00512148|1121629|P1|COMPLETED|Primay Study Period||6
469818|NCT00512148|1121629|P1|STARTED|Primay Study Period||7
469819|NCT00512096|1121634|P1|NOT COMPLETED|Overall Study||7
469820|NCT00512096|1121634|P1|COMPLETED|Overall Study||23
469821|NCT00512096|1121634|P1|STARTED|Overall Study||30
469822|NCT00511914|1121640|P2|NOT COMPLETED|Overall Study||0
469823|NCT00511914|1121641|P1|NOT COMPLETED|Overall Study||0
469824|NCT00511914|1121640|P2|COMPLETED|Overall Study||67
469825|NCT00511914|1121641|P1|COMPLETED|Overall Study||68
469826|NCT00511914|1121640|P2|STARTED|Overall Study||67
469827|NCT00511914|1121641|P1|STARTED|Overall Study||68
469828|NCT00511901|1121657|P2|NOT COMPLETED|Overall Study||3
469829|NCT00511901|1121658|P1|NOT COMPLETED|Overall Study||1
469830|NCT00511901|1121657|P2|COMPLETED|Overall Study||8
469831|NCT00511901|1121658|P1|COMPLETED|Overall Study||10
469832|NCT00511901|1121657|P2|STARTED|Overall Study||11
469833|NCT00511901|1121658|P1|STARTED|Overall Study||11
469834|NCT00511862|1121681|P3|NOT COMPLETED|Overall Study||0
469835|NCT00511862|1121682|P2|NOT COMPLETED|Overall Study||0
469836|NCT00511862|1121683|P1|NOT COMPLETED|Overall Study||0
469837|NCT00511862|1121681|P3|COMPLETED|Overall Study||47
469838|NCT00511862|1121682|P2|COMPLETED|Overall Study||43
469839|NCT00511862|1121683|P1|COMPLETED|Overall Study||61
469840|NCT00511862|1121681|P3|STARTED|Overall Study||47
469841|NCT00511862|1121682|P2|STARTED|Overall Study||43
469842|NCT00511862|1121683|P1|STARTED|Overall Study||61
469843|NCT00511836|1121696|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
469844|NCT00511836|1121697|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
469845|NCT00511836|1121696|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
469846|NCT00511836|1121697|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
469847|NCT00511836|1121696|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
469848|NCT00511836|1121697|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
469849|NCT00511836|1121696|P2|NOT COMPLETED|Double-blind Period||0
469850|NCT00511836|1121697|P1|NOT COMPLETED|Double-blind Period||1
469851|NCT00511836|1121696|P2|COMPLETED|Double-blind Period||15
469852|NCT00511836|1121697|P1|COMPLETED|Double-blind Period||15
469853|NCT00511836|1121696|P2|STARTED|Double-blind Period||15
469854|NCT00511836|1121697|P1|STARTED|Double-blind Period||16
469855|NCT00511810|1121714|P2|NOT COMPLETED|Overall Study||5
469856|NCT00511810|1121715|P1|NOT COMPLETED|Overall Study||1
469857|NCT00511810|1121714|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
469858|NCT00511810|1121715|P1|COMPLETED|Overall Study||7
469859|NCT00511810|1121714|P2|STARTED|Overall Study||12
469860|NCT00511810|1121715|P1|STARTED|Overall Study||8
469861|NCT00511797|1121725|P4|NOT COMPLETED|Overall Study||15
469862|NCT00511797|1121726|P3|NOT COMPLETED|Overall Study||11
469863|NCT00511797|1121727|P2|NOT COMPLETED|Overall Study||8
469864|NCT00511797|1121728|P1|NOT COMPLETED|Overall Study||7
469865|NCT00511797|1121725|P4|COMPLETED|Overall Study||47
469866|NCT00511797|1121726|P3|COMPLETED|Overall Study||51
469867|NCT00511797|1121727|P2|COMPLETED|Overall Study||55
469868|NCT00511797|1121728|P1|COMPLETED|Overall Study||55
469869|NCT00511797|1121725|P4|Subjects Received Treatment|Overall Study|FAS|58
469870|NCT00511797|1121726|P3|Subjects Received Treatment|Overall Study|FAS|61
469871|NCT00511797|1121727|P2|Subjects Received Treatment|Overall Study|FAS|62
469872|NCT00511797|1121728|P1|Subjects Received Treatment|Overall Study|FAS|61
469873|NCT00511797|1121725|P4|Subjects Dispensed Drugs|Overall Study||59
469874|NCT00511797|1121726|P3|Subjects Dispensed Drugs|Overall Study||61
469875|NCT00511797|1121727|P2|Subjects Dispensed Drugs|Overall Study||63
469876|NCT00511797|1121728|P1|Subjects Dispensed Drugs|Overall Study||61
469877|NCT00511797|1121725|P4|STARTED|Overall Study||62
469878|NCT00511797|1121726|P3|STARTED|Overall Study||62
469879|NCT00511797|1121727|P2|STARTED|Overall Study||63
469880|NCT00511797|1121728|P1|STARTED|Overall Study||62
469881|NCT00511706|1121832|P2|NOT COMPLETED|Overall Study||5
469882|NCT00511706|1121833|P1|NOT COMPLETED|Overall Study||8
469883|NCT00511706|1121832|P2|COMPLETED|Overall Study||115
469884|NCT00511706|1121833|P1|COMPLETED|Overall Study||115
469885|NCT00511706|1121832|P2|STARTED|Overall Study||120
469886|NCT00511706|1121833|P1|STARTED|Overall Study||123
469887|NCT00511667|1121847|P2|NOT COMPLETED|Overall Study||3
469888|NCT00511667|1121848|P1|NOT COMPLETED|Overall Study||12
469889|NCT00511667|1121847|P2|COMPLETED|Overall Study||15
469890|NCT00511667|1121848|P1|COMPLETED|Overall Study||40
469891|NCT00511667|1121847|P2|STARTED|Overall Study||18
469892|NCT00511667|1121848|P1|STARTED|Overall Study||52
469893|NCT00511472|1121883|P2|NOT COMPLETED|Overall Study||6
469894|NCT00511472|1121884|P1|NOT COMPLETED|Overall Study||3
469895|NCT00511472|1121883|P2|COMPLETED|Overall Study||17
469896|NCT00511472|1121884|P1|COMPLETED|Overall Study||44
469897|NCT00511472|1121883|P2|STARTED|Overall Study||23
469898|NCT00511472|1121884|P1|STARTED|Overall Study||47
469899|NCT00511433|1121903|P2|NOT COMPLETED|Overall Study||1
469900|NCT00511433|1121904|P1|NOT COMPLETED|Overall Study||6
469901|NCT00511433|1121903|P2|COMPLETED|Overall Study||15
469902|NCT00511433|1121904|P1|COMPLETED|Overall Study||26
469903|NCT00511433|1121903|P2|STARTED|Overall Study||16
469904|NCT00511433|1121904|P1|STARTED|Overall Study||32
469905|NCT00511355|1121944|P2|NOT COMPLETED|Overall Study||9
469906|NCT00511355|1121945|P1|NOT COMPLETED|Overall Study||7
469907|NCT00511355|1121944|P2|COMPLETED|Overall Study||52
469908|NCT00511355|1121945|P1|COMPLETED|Overall Study||53
469909|NCT00511355|1121944|P2|STARTED|Overall Study||61
469910|NCT00511355|1121945|P1|STARTED|Overall Study||60
469911|NCT00511342|1122045|P2|NOT COMPLETED|Overall Study||22
469912|NCT00511342|1122046|P1|NOT COMPLETED|Overall Study||13
469913|NCT00511342|1122045|P2|COMPLETED|Overall Study||32
469914|NCT00511342|1122046|P1|COMPLETED|Overall Study||43
469915|NCT00511342|1122045|P2|STARTED|Overall Study||54
469916|NCT00511342|1122046|P1|STARTED|Overall Study||56
469917|NCT00511238|1122072|P2|NOT COMPLETED|Overall Study||226
469918|NCT00511238|1122073|P1|NOT COMPLETED|Overall Study||42
469919|NCT00511238|1122072|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
469920|NCT00511238|1122073|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
469921|NCT00511238|1122072|P2|STARTED|Overall Study||266
469922|NCT00511238|1122073|P1|STARTED|Overall Study||46
469923|NCT00511199|1122092|P2|NOT COMPLETED|Overall Study||125
469924|NCT00511199|1122093|P1|NOT COMPLETED|Overall Study||449
469925|NCT00511199|1122092|P2|COMPLETED|Overall Study||410
469926|NCT00511199|1122093|P1|COMPLETED|Overall Study||1142
469927|NCT00511199|1122092|P2|STARTED|Overall Study||535
469928|NCT00511199|1122093|P1|STARTED|Overall Study||1591
469929|NCT00511173|1122117|P1|NOT COMPLETED|Overall Study||0
469930|NCT00511173|1122117|P1|COMPLETED|Overall Study||102
469931|NCT00511173|1122117|P1|STARTED|Overall Study||102
469932|NCT00511147|1122122|P1|NOT COMPLETED|Overall Study||7
469933|NCT00511147|1122122|P1|COMPLETED|Overall Study||57
469934|NCT00511147|1122122|P1|STARTED|Overall Study||64
469935|NCT00511134|1122131|P2|NOT COMPLETED|Overall Study||2
469936|NCT00511134|1122132|P1|NOT COMPLETED|Overall Study||0
469937|NCT00511134|1122131|P2|COMPLETED|Overall Study||1
469938|NCT00511134|1122132|P1|COMPLETED|Overall Study||1
469939|NCT00511134|1122131|P2|STARTED|Overall Study||3
469940|NCT00511134|1122132|P1|STARTED|Overall Study||1
469941|NCT00511108|1122144|P4|NOT COMPLETED|Overall Study||5
469942|NCT00511108|1122145|P3|NOT COMPLETED|Overall Study||5
469943|NCT00511108|1122146|P2|NOT COMPLETED|Overall Study||2
469944|NCT00511108|1122147|P1|NOT COMPLETED|Overall Study||6
469945|NCT00511108|1122144|P4|COMPLETED|Overall Study||48
469946|NCT00511108|1122145|P3|COMPLETED|Overall Study||47
469947|NCT00511108|1122146|P2|COMPLETED|Overall Study||52
469948|NCT00511108|1122147|P1|COMPLETED|Overall Study||46
469949|NCT00511108|1122144|P4|STARTED|Overall Study||53
469950|NCT00511108|1122145|P3|STARTED|Overall Study||52
469951|NCT00511108|1122146|P2|STARTED|Overall Study||54
469952|NCT00511108|1122147|P1|STARTED|Overall Study||52
469953|NCT00511095|1122165|P1|NOT COMPLETED|Overall Study||11
469954|NCT00511095|1122165|P1|COMPLETED|Overall Study||196
469955|NCT00511095|1122165|P1|STARTED|Overall Study||207
469956|NCT00511004|1122174|P3|NOT COMPLETED|Overall Study||4
469957|NCT00511004|1122175|P2|NOT COMPLETED|Overall Study||0
469958|NCT00511004|1122176|P1|NOT COMPLETED|Overall Study||0
469959|NCT00511004|1122174|P3|COMPLETED|Overall Study||10
469960|NCT00511004|1122175|P2|COMPLETED|Overall Study||13
469961|NCT00511004|1122176|P1|COMPLETED|Overall Study||13
469962|NCT00511004|1122174|P3|STARTED|Overall Study||14
469963|NCT00511004|1122175|P2|STARTED|Overall Study||13
469964|NCT00511004|1122176|P1|STARTED|Overall Study||13
469965|NCT00510952|1122195|P2|NOT COMPLETED|Overall Study||16
469966|NCT00510952|1122196|P1|NOT COMPLETED|Overall Study||26
469967|NCT00510952|1122195|P2|COMPLETED|Overall Study||220
469968|NCT00510952|1122196|P1|COMPLETED|Overall Study||209
469969|NCT00510952|1122195|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
469970|NCT00510952|1122196|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
469971|NCT00510952|1122195|P2|STARTED|Overall Study||236
469972|NCT00510952|1122196|P1|STARTED|Overall Study||235
469973|NCT00510887|1122222|P1|NOT COMPLETED|Overall Study||1
469974|NCT00510887|1122222|P1|COMPLETED|Overall Study||11
469975|NCT00510887|1122222|P1|STARTED|Overall Study||12
469976|NCT00510874|1122238|P7|NOT COMPLETED|Overall Study||1
469977|NCT00510874|1122239|P6|NOT COMPLETED|Overall Study||0
469978|NCT00510874|1122240|P5|NOT COMPLETED|Overall Study||7
469979|NCT00510874|1122241|P4|NOT COMPLETED|Overall Study||3
469980|NCT00510874|1122242|P3|NOT COMPLETED|Overall Study||1
469981|NCT00510874|1122243|P2|NOT COMPLETED|Overall Study||4
469982|NCT00510874|1122244|P1|NOT COMPLETED|Overall Study||3
469983|NCT00510874|1122238|P7|COMPLETED|Overall Study|Upto Day 182|49
469984|NCT00510874|1122239|P6|COMPLETED|Overall Study|Upto Day 182|50
469985|NCT00510874|1122240|P5|COMPLETED|Overall Study|Upto Day 182|141
469986|NCT00510874|1122241|P4|COMPLETED|Overall Study|Upto Day 182|148
469987|NCT00510874|1122242|P3|COMPLETED|Overall Study|Upto Day 182|150
469988|NCT00510874|1122243|P2|COMPLETED|Overall Study|Upto Day 182|148
469989|NCT00510874|1122244|P1|COMPLETED|Overall Study|Upto Day 182|75
469990|NCT00510874|1122238|P7|STARTED|Overall Study||50
469991|NCT00510874|1122239|P6|STARTED|Overall Study||50
469992|NCT00510874|1122240|P5|STARTED|Overall Study||148
469993|NCT00510874|1122241|P4|STARTED|Overall Study||151
469994|NCT00510874|1122242|P3|STARTED|Overall Study||151
469995|NCT00510874|1122243|P2|STARTED|Overall Study||152
469996|NCT00510874|1122244|P1|STARTED|Overall Study||78
469997|NCT00510835|1122347|P3|NOT COMPLETED|Overall Study||2
469998|NCT00510835|1122348|P2|NOT COMPLETED|Overall Study||2
469999|NCT00510835|1122349|P1|NOT COMPLETED|Overall Study||6
470000|NCT00510835|1122347|P3|COMPLETED|Overall Study||456
470001|NCT00510835|1122348|P2|COMPLETED|Overall Study||446
470002|NCT00510835|1122349|P1|COMPLETED|Overall Study||439
470003|NCT00510835|1122347|P3|STARTED|Overall Study||458
470004|NCT00510835|1122348|P2|STARTED|Overall Study||448
470005|NCT00510835|1122349|P1|STARTED|Overall Study||445
470006|NCT00510809|1122360|P3|NOT COMPLETED|Overall Study||0
470007|NCT00510809|1122361|P2|NOT COMPLETED|Overall Study||0
470008|NCT00510809|1122362|P1|NOT COMPLETED|Overall Study||0
470009|NCT00510809|1122360|P3|COMPLETED|Overall Study||18
470010|NCT00510809|1122361|P2|COMPLETED|Overall Study||18
470011|NCT00510809|1122362|P1|COMPLETED|Overall Study||18
470012|NCT00510809|1122360|P3|STARTED|Overall Study||18
470013|NCT00510809|1122361|P2|STARTED|Overall Study||18
470014|NCT00510809|1122362|P1|STARTED|Overall Study||18
470015|NCT00510783|1122375|P2|NOT COMPLETED|Overall Study||29
470016|NCT00510783|1122376|P1|NOT COMPLETED|Overall Study||31
470017|NCT00510783|1122375|P2|COMPLETED|Overall Study||47
470018|NCT00510783|1122376|P1|COMPLETED|Overall Study||51
470019|NCT00510783|1122375|P2|STARTED|Overall Study||76
470020|NCT00510783|1122376|P1|STARTED|Overall Study||82
470021|NCT00510744|1122382|P1|NOT COMPLETED|Overall Study||0
470022|NCT00510744|1122382|P1|COMPLETED|Overall Study||5
470023|NCT00510744|1122382|P1|STARTED|Overall Study||5
470024|NCT00510692|1122388|P2|NOT COMPLETED|Overall Study||3
470025|NCT00510692|1122389|P1|NOT COMPLETED|Overall Study||2
470026|NCT00510692|1122388|P2|COMPLETED|Overall Study||26
470027|NCT00510692|1122389|P1|COMPLETED|Overall Study||27
470028|NCT00510692|1122388|P2|STARTED|Overall Study||29
470029|NCT00510692|1122389|P1|STARTED|Overall Study||29
470030|NCT00510653|1122403|P1|NOT COMPLETED|Overall Study||11
470031|NCT00510653|1122403|P1|COMPLETED|Overall Study||13
470032|NCT00510653|1122403|P1|STARTED|Overall Study||24
470033|NCT00510510|1122410|P3|NOT COMPLETED|Overall Study||17
470034|NCT00510510|1122411|P2|NOT COMPLETED|Overall Study||9
470035|NCT00510510|1122412|P1|NOT COMPLETED|Overall Study||5
470036|NCT00510510|1122410|P3|COMPLETED|Overall Study||74
470037|NCT00510510|1122411|P2|COMPLETED|Overall Study||89
470038|NCT00510510|1122412|P1|COMPLETED|Overall Study||87
470039|NCT00510510|1122410|P3|STARTED|Overall Study||91
470040|NCT00510510|1122411|P2|STARTED|Overall Study||98
470041|NCT00510510|1122412|P1|STARTED|Overall Study||92
470042|NCT00510497|1122423|P1|NOT COMPLETED|Overall Study||3
470043|NCT00510497|1122423|P1|COMPLETED|Overall Study||8
470044|NCT00510497|1122423|P1|STARTED|Overall Study||11
470045|NCT00510484|1122430|P2|NOT COMPLETED|Period 2||0
470046|NCT00510484|1122431|P1|NOT COMPLETED|Period 2||0
470047|NCT00510484|1122430|P2|COMPLETED|Period 2||15
470048|NCT00510484|1122431|P1|COMPLETED|Period 2||16
470049|NCT00510484|1122430|P2|STARTED|Period 2||15
470050|NCT00510484|1122431|P1|STARTED|Period 2||16
470051|NCT00510484|1122430|P2|NOT COMPLETED|Wash-out Period||1
470052|NCT00510484|1122431|P1|NOT COMPLETED|Wash-out Period||0
470053|NCT00510484|1122430|P2|COMPLETED|Wash-out Period||15
470054|NCT00510484|1122431|P1|COMPLETED|Wash-out Period||16
470055|NCT00510484|1122430|P2|STARTED|Wash-out Period||16
470056|NCT00510484|1122431|P1|STARTED|Wash-out Period||16
470057|NCT00510484|1122430|P2|NOT COMPLETED|Period 1||0
470058|NCT00510484|1122431|P1|NOT COMPLETED|Period 1||0
470059|NCT00510484|1122430|P2|COMPLETED|Period 1||16
470060|NCT00510484|1122431|P1|COMPLETED|Period 1||16
470061|NCT00510484|1122430|P2|STARTED|Period 1||16
470062|NCT00510484|1122431|P1|STARTED|Period 1||16
470063|NCT00510289|1122451|P1|NOT COMPLETED|Overall Study||12
470064|NCT00510289|1122451|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
470065|NCT00510289|1122451|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
470066|NCT00510289|1122451|P1|STARTED|Overall Study|All patients who consented|19
470067|NCT00510276|1122461|P2|NOT COMPLETED|Extension Open-Label Phase||48
470068|NCT00510276|1122462|P1|NOT COMPLETED|Extension Open-Label Phase||33
470069|NCT00510276|1122461|P2|COMPLETED|Extension Open-Label Phase||81
470070|NCT00510276|1122462|P1|COMPLETED|Extension Open-Label Phase||78
470071|NCT00510276|1122461|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
470072|NCT00510276|1122462|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
470073|NCT00510276|1122461|P2|NOT COMPLETED|Acute Double-Blind Phase||95
470074|NCT00510276|1122462|P1|NOT COMPLETED|Acute Double-Blind Phase||105
470075|NCT00510276|1122461|P2|COMPLETED|Acute Double-Blind Phase||130
470076|NCT00510276|1122462|P1|COMPLETED|Acute Double-Blind Phase||115
470077|NCT00510276|1122461|P2|STARTED|Acute Double-Blind Phase||225
470078|NCT00510276|1122462|P1|STARTED|Acute Double-Blind Phase||220
470079|NCT00510224|1122547|P1|NOT COMPLETED|Overall Study||3
470080|NCT00510224|1122547|P1|COMPLETED|Overall Study||10
470081|NCT00510224|1122547|P1|STARTED|Overall Study||13
470082|NCT00510146|1122556|P2|NOT COMPLETED|Open-Label Treatment||26
470083|NCT00510146|1122557|P1|NOT COMPLETED|Open-Label Treatment||71
470084|NCT00510146|1122556|P2|COMPLETED|Open-Label Treatment||96
470085|NCT00510146|1122557|P1|COMPLETED|Open-Label Treatment||196
470086|NCT00510146|1122556|P2|STARTED|Open-Label Treatment||122
470087|NCT00510146|1122557|P1|STARTED|Open-Label Treatment||267
470088|NCT00510146|1122556|P2|NOT COMPLETED|Double-Blind Treatment||49
470089|NCT00510146|1122557|P1|NOT COMPLETED|Double-Blind Treatment||76
470090|NCT00510146|1122556|P2|COMPLETED|Double-Blind Treatment||122
470091|NCT00510146|1122557|P1|COMPLETED|Double-Blind Treatment||267
470092|NCT00510146|1122556|P2|STARTED|Double-Blind Treatment||171
470093|NCT00510146|1122557|P1|STARTED|Double-Blind Treatment||343
470094|NCT00510068|1122646|P2|NOT COMPLETED|Open-label Period||0
470095|NCT00510068|1122647|P1|NOT COMPLETED|Open-label Period||225
470096|NCT00510068|1122646|P2|COMPLETED|Open-label Period||0
470097|NCT00510068|1122647|P1|COMPLETED|Open-label Period||0
470098|NCT00510068|1122646|P2|STARTED|Open-label Period||0
470099|NCT00510068|1122647|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
470100|NCT00510068|1122646|P2|NOT COMPLETED|Double-blind Period||203
470101|NCT00510068|1122647|P1|NOT COMPLETED|Double-blind Period||207
470102|NCT00510068|1122646|P2|COMPLETED|Double-blind Period||0
470103|NCT00510068|1122647|P1|COMPLETED|Double-blind Period||0
470104|NCT00510068|1122646|P2|Safety Population|Double-blind Period||203
470105|NCT00510068|1122647|P1|Safety Population|Double-blind Period||204
470106|NCT00510068|1122646|P2|STARTED|Double-blind Period||203
470107|NCT00510068|1122647|P1|STARTED|Double-blind Period||207
470108|NCT00509925|1122688|P2|NOT COMPLETED|Overall Study||1
470109|NCT00509925|1122689|P1|NOT COMPLETED|Overall Study||0
470110|NCT00509925|1122688|P2|COMPLETED|Overall Study||10
470111|NCT00509925|1122689|P1|COMPLETED|Overall Study||12
470112|NCT00509925|1122688|P2|STARTED|Overall Study||11
470113|NCT00509925|1122689|P1|STARTED|Overall Study||12
470114|NCT00509899|1122737|P8|NOT COMPLETED|Overall Study||1
470115|NCT00509899|1122738|P7|NOT COMPLETED|Overall Study||1
470116|NCT00509899|1122739|P6|NOT COMPLETED|Overall Study||10
470117|NCT00509899|1122740|P5|NOT COMPLETED|Overall Study||5
470118|NCT00509899|1122741|P4|NOT COMPLETED|Overall Study||4
470119|NCT00509899|1122742|P3|NOT COMPLETED|Overall Study||20
470120|NCT00509899|1122743|P2|NOT COMPLETED|Overall Study||9
470121|NCT00509899|1122744|P1|NOT COMPLETED|Overall Study||16
470122|NCT00509899|1122737|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
470123|NCT00509899|1122738|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
470124|NCT00509899|1122739|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
470125|NCT00509899|1122740|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
470126|NCT00509899|1122741|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
470127|NCT00509899|1122742|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
470128|NCT00509899|1122743|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
470129|NCT00509899|1122744|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
470130|NCT00509899|1122737|P8|STARTED|Overall Study||3
470131|NCT00509899|1122738|P7|STARTED|Overall Study||6
470132|NCT00509899|1122739|P6|STARTED|Overall Study||22
470133|NCT00509899|1122740|P5|STARTED|Overall Study||6
470134|NCT00509899|1122741|P4|STARTED|Overall Study||5
470135|NCT00509899|1122742|P3|STARTED|Overall Study||47
470136|NCT00509899|1122743|P2|STARTED|Overall Study||35
470137|NCT00509899|1122744|P1|STARTED|Overall Study||30
470138|NCT00509873|1122784|P2|NOT COMPLETED|Overall Study||15
470139|NCT00509873|1122785|P1|NOT COMPLETED|Overall Study||11
470140|NCT00509873|1122784|P2|COMPLETED|Overall Study||276
470141|NCT00509873|1122785|P1|COMPLETED|Overall Study||276
470142|NCT00509873|1122784|P2|STARTED|Overall Study||291
470143|NCT00509873|1122785|P1|STARTED|Overall Study||287
470144|NCT00509795|1122803|P4|NOT COMPLETED|Overall Study||27
470145|NCT00509795|1122804|P3|NOT COMPLETED|Overall Study||27
470146|NCT00509795|1122805|P2|NOT COMPLETED|Overall Study||11
470147|NCT00509795|1122806|P1|NOT COMPLETED|Overall Study||22
470148|NCT00509795|1122803|P4|COMPLETED|Overall Study||276
470149|NCT00509795|1122804|P3|COMPLETED|Overall Study||277
470150|NCT00509795|1122805|P2|COMPLETED|Overall Study||293
470151|NCT00509795|1122806|P1|COMPLETED|Overall Study||284
470152|NCT00509795|1122803|P4|Per Protocol Set (PPS) Population|Overall Study||265
470153|NCT00509795|1122804|P3|Per Protocol Set (PPS) Population|Overall Study||270
470154|NCT00509795|1122805|P2|Per Protocol Set (PPS) Population|Overall Study||285
470155|NCT00509795|1122806|P1|Per Protocol Set (PPS) Population|Overall Study||269
470156|NCT00509795|1122803|P4|Full Analysis Set (FAS) Population|Overall Study||301
470157|NCT00509795|1122804|P3|Full Analysis Set (FAS) Population|Overall Study||301
470158|NCT00509795|1122805|P2|Full Analysis Set (FAS) Population|Overall Study||304
470159|NCT00509795|1122806|P1|Full Analysis Set (FAS) Population|Overall Study||304
470160|NCT00509795|1122803|P4|Patients Received Treatment (SAF)|Overall Study||303
470161|NCT00509795|1122804|P3|Patients Received Treatment (SAF)|Overall Study||304
470162|NCT00509795|1122805|P2|Patients Received Treatment (SAF)|Overall Study||304
470163|NCT00509795|1122806|P1|Patients Received Treatment (SAF)|Overall Study||304
470164|NCT00509795|1122803|P4|STARTED|Overall Study||303
470165|NCT00509795|1122804|P3|STARTED|Overall Study||304
470166|NCT00509795|1122805|P2|STARTED|Overall Study||304
470167|NCT00509795|1122806|P1|STARTED|Overall Study||306
470168|NCT00509769|1122837|P1|NOT COMPLETED|Overall Study||91
470169|NCT00509769|1122837|P1|COMPLETED|Overall Study||21
470170|NCT00509769|1122837|P1|STARTED|Overall Study||112
470171|NCT00509600|1122846|P1|NOT COMPLETED|Overall Study||1
470172|NCT00509600|1122846|P1|COMPLETED|Overall Study||0
470173|NCT00509600|1122846|P1|STARTED|Overall Study||1
470174|NCT00509587|1122850|P1|NOT COMPLETED|Overall Study||0
470175|NCT00509587|1122850|P1|COMPLETED|Overall Study||21
470176|NCT00509587|1122850|P1|STARTED|Overall Study||21
470177|NCT00509496|1122860|P2|NOT COMPLETED|Overall Study||0
470178|NCT00509496|1122861|P1|NOT COMPLETED|Overall Study||0
470179|NCT00509496|1122860|P2|COMPLETED|Overall Study||2
470180|NCT00509496|1122861|P1|COMPLETED|Overall Study||19
470181|NCT00509496|1122860|P2|STARTED|Overall Study||2
470182|NCT00509496|1122861|P1|STARTED|Overall Study||19
470183|NCT00509366|1122874|P5|NOT COMPLETED|Overall Study||0
470184|NCT00509366|1122875|P4|NOT COMPLETED|Overall Study||0
470185|NCT00509366|1122876|P3|NOT COMPLETED|Overall Study||1
470186|NCT00509366|1122877|P2|NOT COMPLETED|Overall Study||1
470187|NCT00509366|1122878|P1|NOT COMPLETED|Overall Study||1
470188|NCT00509366|1122874|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
470189|NCT00509366|1122875|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
470190|NCT00509366|1122876|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
470191|NCT00509366|1122877|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
470192|NCT00509366|1122878|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
470193|NCT00509366|1122874|P5|Assigned Treatment|Overall Study||0
470194|NCT00509366|1122875|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
470195|NCT00509366|1122876|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
470196|NCT00509366|1122877|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
470197|NCT00509366|1122878|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
470198|NCT00509366|1122874|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
470199|NCT00509366|1122875|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
470200|NCT00509366|1122876|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
470201|NCT00509366|1122877|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
470202|NCT00509366|1122878|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
470203|NCT00509288|1122891|P2|NOT COMPLETED|Overall Study||0
470204|NCT00509288|1122892|P1|NOT COMPLETED|Overall Study||0
470205|NCT00509288|1122891|P2|COMPLETED|Overall Study||3
470206|NCT00509288|1122892|P1|COMPLETED|Overall Study||21
470207|NCT00509288|1122891|P2|STARTED|Overall Study||3
470208|NCT00509288|1122892|P1|STARTED|Overall Study||21
470209|NCT00509262|1122902|P2|NOT COMPLETED|Overall Study||42
470210|NCT00509262|1122903|P1|NOT COMPLETED|Overall Study||47
470211|NCT00509262|1122902|P2|COMPLETED|Overall Study||170
470212|NCT00509262|1122903|P1|COMPLETED|Overall Study||164
470213|NCT00509262|1122902|P2|STARTED|Overall Study||212
470214|NCT00509262|1122903|P1|STARTED|Overall Study||211
470215|NCT00509249|1122915|P1|NOT COMPLETED|Overall Study||0
470216|NCT00509249|1122915|P1|COMPLETED|Overall Study||18
470217|NCT00509249|1122915|P1|STARTED|Overall Study||18
470218|NCT00509236|1122921|P2|NOT COMPLETED|Overall Study||20
470219|NCT00509236|1122922|P1|NOT COMPLETED|Overall Study||17
470220|NCT00509236|1122921|P2|COMPLETED|Overall Study||45
470221|NCT00509236|1122922|P1|COMPLETED|Overall Study||47
470222|NCT00509236|1122921|P2|STARTED|Overall Study||65
470223|NCT00509236|1122922|P1|STARTED|Overall Study||64
470224|NCT00509223|1122937|P2|NOT COMPLETED|Overall Study||72
470225|NCT00509223|1122938|P1|NOT COMPLETED|Overall Study||88
470226|NCT00509223|1122937|P2|COMPLETED|Overall Study||137
470227|NCT00509223|1122938|P1|COMPLETED|Overall Study||119
470228|NCT00509223|1122937|P2|STARTED|Overall Study||209
470229|NCT00509223|1122938|P1|STARTED|Overall Study||207
470230|NCT00509197|1122946|P2|NOT COMPLETED|Overall Study||0
470231|NCT00509197|1122947|P1|NOT COMPLETED|Overall Study||0
470232|NCT00509197|1122946|P2|COMPLETED|Overall Study||6
470233|NCT00509197|1122947|P1|COMPLETED|Overall Study||6
470234|NCT00509197|1122946|P2|STARTED|Overall Study||6
470235|NCT00509197|1122947|P1|STARTED|Overall Study||6
470236|NCT00509106|1122961|P2|NOT COMPLETED|Overall Study||29
470237|NCT00509106|1122962|P1|NOT COMPLETED|Overall Study||31
470238|NCT00509106|1122961|P2|COMPLETED|Overall Study||278
470239|NCT00509106|1122962|P1|COMPLETED|Overall Study||284
470240|NCT00509106|1122961|P2|STARTED|Overall Study||307
470241|NCT00509106|1122962|P1|STARTED|Overall Study||315
470242|NCT00509067|1122970|P2|NOT COMPLETED|Overall Study||5
470243|NCT00509067|1122971|P1|NOT COMPLETED|Overall Study||4
470244|NCT00509067|1122970|P2|COMPLETED|Overall Study||19
470245|NCT00509067|1122971|P1|COMPLETED|Overall Study||15
470246|NCT00509067|1122970|P2|STARTED|Overall Study||24
470247|NCT00509067|1122971|P1|STARTED|Overall Study||19
470248|NCT00509041|1122977|P1|NOT COMPLETED|Overall Study||0
470249|NCT00509041|1122977|P1|COMPLETED|Overall Study||43
470250|NCT00509041|1122977|P1|STARTED|Overall Study||43
470251|NCT00509028|1122986|P2|NOT COMPLETED|Overall Study||7
470252|NCT00509028|1122987|P1|NOT COMPLETED|Overall Study||12
470253|NCT00509028|1122986|P2|COMPLETED|Overall Study||113
470254|NCT00509028|1122987|P1|COMPLETED|Overall Study||109
470255|NCT00509028|1122986|P2|STARTED|Overall Study||120
470256|NCT00509028|1122987|P1|STARTED|Overall Study||121
470257|NCT00508924|1123023|P4|NOT COMPLETED|Overall Study||1
470258|NCT00508924|1123024|P3|NOT COMPLETED|Overall Study||1
470259|NCT00508924|1123025|P2|NOT COMPLETED|Overall Study||0
470260|NCT00508924|1123026|P1|NOT COMPLETED|Overall Study||0
470261|NCT00508924|1123023|P4|COMPLETED|Overall Study||33
470262|NCT00508924|1123024|P3|COMPLETED|Overall Study||31
470263|NCT00508924|1123025|P2|COMPLETED|Overall Study||38
470264|NCT00508924|1123026|P1|COMPLETED|Overall Study||36
470265|NCT00508924|1123023|P4|STARTED|Overall Study||34
470266|NCT00508924|1123024|P3|STARTED|Overall Study||32
470267|NCT00508924|1123025|P2|STARTED|Overall Study||38
470268|NCT00508924|1123026|P1|STARTED|Overall Study||36
470269|NCT00508872|1123040|P1|NOT COMPLETED|Overall Study||2
470270|NCT00508872|1123040|P1|COMPLETED|Overall Study||0
470271|NCT00508872|1123040|P1|STARTED|Overall Study||2
470272|NCT00508820|1123046|P2|NOT COMPLETED|Overall Study||64
470273|NCT00508820|1123047|P1|NOT COMPLETED|Overall Study||55
470274|NCT00508820|1123046|P2|COMPLETED|Overall Study||175
470275|NCT00508820|1123047|P1|COMPLETED|Overall Study||113
470276|NCT00508820|1123046|P2|STARTED|Overall Study||239
470277|NCT00508820|1123047|P1|STARTED|Overall Study||168
470278|NCT00508755|1123057|P1|NOT COMPLETED|Overall Study||1
470279|NCT00508755|1123057|P1|COMPLETED|Overall Study||5
470280|NCT00508755|1123057|P1|STARTED|Overall Study||6
470281|NCT00508742|1123065|P2|NOT COMPLETED|Period 3: Toddler Dose||15
470282|NCT00508742|1123066|P1|NOT COMPLETED|Period 3: Toddler Dose||25
470283|NCT00508742|1123065|P2|COMPLETED|Period 3: Toddler Dose||863
470284|NCT00508742|1123066|P1|COMPLETED|Period 3: Toddler Dose||858
470285|NCT00508742|1123065|P2|STARTED|Period 3: Toddler Dose||878
470286|NCT00508742|1123066|P1|STARTED|Period 3: Toddler Dose||883
470287|NCT00508742|1123065|P2|NOT COMPLETED|Period 2: After Infant Series||11
470288|NCT00508742|1123066|P1|NOT COMPLETED|Period 2: After Infant Series||7
470289|NCT00508742|1123065|P2|COMPLETED|Period 2: After Infant Series||878
470290|NCT00508742|1123066|P1|COMPLETED|Period 2: After Infant Series||883
470291|NCT00508742|1123065|P2|STARTED|Period 2: After Infant Series||889
470292|NCT00508742|1123066|P1|STARTED|Period 2: After Infant Series||890
470293|NCT00508742|1123065|P2|NOT COMPLETED|Period 1: Infant Series||45
470294|NCT00508742|1123066|P1|NOT COMPLETED|Period 1: Infant Series||42
470295|NCT00508742|1123065|P2|COMPLETED|Period 1: Infant Series||889
470296|NCT00508742|1123066|P1|COMPLETED|Period 1: Infant Series||890
470297|NCT00508742|1123065|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
470298|NCT00508742|1123066|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
470299|NCT00508742|1123065|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
470300|NCT00508742|1123066|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
470301|NCT00508742|1123065|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
470302|NCT00508742|1123066|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
470303|NCT00508742|1123065|P2|STARTED|Period 1: Infant Series||934
470304|NCT00508742|1123066|P1|STARTED|Period 1: Infant Series||932
470305|NCT00508716|1123082|P2|NOT COMPLETED|Overall Study||0
470306|NCT00508716|1123083|P1|NOT COMPLETED|Overall Study||0
470307|NCT00508716|1123082|P2|COMPLETED|Overall Study||63
470308|NCT00508716|1123083|P1|COMPLETED|Overall Study||61
470309|NCT00508716|1123082|P2|STARTED|Overall Study||63
470310|NCT00508716|1123083|P1|STARTED|Overall Study||61
470311|NCT00508651|1123091|P2|NOT COMPLETED|Overall Study||2
470312|NCT00508651|1123092|P1|NOT COMPLETED|Overall Study||4
470313|NCT00508651|1123091|P2|COMPLETED|Overall Study||8
470314|NCT00508651|1123092|P1|COMPLETED|Overall Study||16
470315|NCT00508651|1123091|P2|STARTED|Overall Study||10
470316|NCT00508651|1123092|P1|STARTED|Overall Study||20
470317|NCT00508521|1123166|P1|NOT COMPLETED|Overall Study||0
470318|NCT00508521|1123166|P1|COMPLETED|Overall Study||4
470319|NCT00508521|1123166|P1|STARTED|Overall Study||4
470320|NCT00508482|1123173|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
470321|NCT00508482|1123174|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
470322|NCT00508482|1123175|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
470323|NCT00508482|1123173|P3|COMPLETED|at the 12th Week of Follow-up||98
470324|NCT00508482|1123174|P2|COMPLETED|at the 12th Week of Follow-up||96
470325|NCT00508482|1123175|P1|COMPLETED|at the 12th Week of Follow-up||196
470326|NCT00508482|1123173|P3|STARTED|at the 12th Week of Follow-up||98
470327|NCT00508482|1123174|P2|STARTED|at the 12th Week of Follow-up||96
470328|NCT00508482|1123175|P1|STARTED|at the 12th Week of Follow-up||196
470329|NCT00508482|1123173|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
470330|NCT00508482|1123174|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
470331|NCT00508482|1123175|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
470332|NCT00508482|1123173|P3|COMPLETED|at the 4th Week of Follow-up||98
470333|NCT00508482|1123174|P2|COMPLETED|at the 4th Week of Follow-up||96
470334|NCT00508482|1123175|P1|COMPLETED|at the 4th Week of Follow-up||196
470335|NCT00508482|1123173|P3|STARTED|at the 4th Week of Follow-up||99
470336|NCT00508482|1123174|P2|STARTED|at the 4th Week of Follow-up||102
470337|NCT00508482|1123175|P1|STARTED|at the 4th Week of Follow-up||216
470338|NCT00508482|1123173|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
470339|NCT00508482|1123174|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
470340|NCT00508482|1123175|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
470341|NCT00508482|1123173|P3|COMPLETED|Over 4 Weeks of Treatment||99
470342|NCT00508482|1123174|P2|COMPLETED|Over 4 Weeks of Treatment||102
470343|NCT00508482|1123175|P1|COMPLETED|Over 4 Weeks of Treatment||216
470344|NCT00508482|1123173|P3|STARTED|Over 4 Weeks of Treatment||119
470345|NCT00508482|1123174|P2|STARTED|Over 4 Weeks of Treatment||119
470346|NCT00508482|1123175|P1|STARTED|Over 4 Weeks of Treatment||237
470347|NCT00508469|1123212|P2|NOT COMPLETED|Overall Study||10
470348|NCT00508469|1123213|P1|NOT COMPLETED|Overall Study||17
470349|NCT00508469|1123212|P2|COMPLETED|Overall Study||40
470350|NCT00508469|1123213|P1|COMPLETED|Overall Study||35
470351|NCT00508469|1123212|P2|STARTED|Overall Study||50
470352|NCT00508469|1123213|P1|STARTED|Overall Study||52
470353|NCT00508404|1123219|P1|NOT COMPLETED|Overall Study||42
470354|NCT00508404|1123219|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
470355|NCT00508404|1123219|P1|STARTED|Overall Study||154
470356|NCT00508391|1123246|P2|NOT COMPLETED|Second Treatment||0
470357|NCT00508391|1123247|P1|NOT COMPLETED|Second Treatment||2
470358|NCT00508391|1123246|P2|COMPLETED|Second Treatment||59
470359|NCT00508391|1123247|P1|COMPLETED|Second Treatment||52
470360|NCT00508391|1123246|P2|STARTED|Second Treatment||59
470361|NCT00508391|1123247|P1|STARTED|Second Treatment||54
470362|NCT00508391|1123246|P2|NOT COMPLETED|First Treatment||3
470363|NCT00508391|1123247|P1|NOT COMPLETED|First Treatment||6
470364|NCT00508391|1123246|P2|COMPLETED|First Treatment||59
470365|NCT00508391|1123247|P1|COMPLETED|First Treatment||54
470366|NCT00508391|1123246|P2|STARTED|First Treatment||62
470367|NCT00508391|1123247|P1|STARTED|First Treatment||60
470368|NCT00508274|1123258|P1|NOT COMPLETED|Overall Study||2
470369|NCT00508274|1123258|P1|COMPLETED|Overall Study||50
470370|NCT00508274|1123258|P1|STARTED|Overall Study||52
470371|NCT00508157|1123269|P2|NOT COMPLETED|Overall Study||3
470372|NCT00508157|1123270|P1|NOT COMPLETED|Overall Study||2
470373|NCT00508157|1123269|P2|COMPLETED|Overall Study||23
470374|NCT00508157|1123270|P1|COMPLETED|Overall Study||24
470375|NCT00508157|1123269|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
470376|NCT00508157|1123270|P1|Safety Sample|Overall Study||26
470377|NCT00508157|1123269|P2|Randomized Sample|Overall Study||26
470378|NCT00508157|1123270|P1|Randomized Sample|Overall Study||26
470379|NCT00508157|1123269|P2|STARTED|Overall Study||26
470380|NCT00508157|1123270|P1|STARTED|Overall Study||26
470381|NCT00508144|1123292|P1|NOT COMPLETED|Overall Study||11
470382|NCT00508144|1123292|P1|COMPLETED|Overall Study||53
470383|NCT00508144|1123292|P1|STARTED|Overall Study||64
470384|NCT00508118|1123298|P2|NOT COMPLETED|Overall Study||0
470385|NCT00508118|1123299|P1|NOT COMPLETED|Overall Study||0
470386|NCT00508118|1123298|P2|COMPLETED|Overall Study||4
470387|NCT00508118|1123299|P1|COMPLETED|Overall Study||3
470388|NCT00508118|1123298|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
470389|NCT00508118|1123299|P1|STARTED|Overall Study||3
470390|NCT00508027|1123318|P1|NOT COMPLETED|Dose Level 3||0
470391|NCT00508027|1123318|P1|COMPLETED|Dose Level 3||2
470392|NCT00508027|1123318|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
470393|NCT00508027|1123318|P1|NOT COMPLETED|Dose Level 2||4
470394|NCT00508027|1123318|P1|COMPLETED|Dose Level 2||16
470395|NCT00508027|1123318|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
470396|NCT00508027|1123318|P1|NOT COMPLETED|Dose Level 1||8
470397|NCT00508027|1123318|P1|COMPLETED|Dose Level 1||12
470398|NCT00508027|1123318|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
470399|NCT00508001|1123359|P3|NOT COMPLETED|Overall Study||7
470400|NCT00508001|1123360|P2|NOT COMPLETED|Overall Study||12
470401|NCT00508001|1123361|P1|NOT COMPLETED|Overall Study||19
470402|NCT00508001|1123359|P3|COMPLETED|Overall Study||16
470403|NCT00508001|1123360|P2|COMPLETED|Overall Study||13
470404|NCT00508001|1123361|P1|COMPLETED|Overall Study||0
470405|NCT00508001|1123359|P3|Secondary Treatment Phase|Overall Study||16
470406|NCT00508001|1123360|P2|Secondary Treatment Phase|Overall Study||13
470407|NCT00508001|1123361|P1|Secondary Treatment Phase|Overall Study||0
470408|NCT00508001|1123359|P3|STARTED|Overall Study||23
470409|NCT00508001|1123360|P2|STARTED|Overall Study||25
470410|NCT00508001|1123361|P1|STARTED|Overall Study||19
470411|NCT00507819|1123378|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
470412|NCT00507819|1123379|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
470413|NCT00507819|1123378|P2|COMPLETED|Second Intervention (6 Weeks)||14
470414|NCT00507819|1123379|P1|COMPLETED|Second Intervention (6 Weeks)||13
470415|NCT00507819|1123378|P2|STARTED|Second Intervention (6 Weeks)||14
470416|NCT00507819|1123379|P1|STARTED|Second Intervention (6 Weeks)||13
470417|NCT00507819|1123378|P2|NOT COMPLETED|Washout (6 Weeks)||0
470418|NCT00507819|1123379|P1|NOT COMPLETED|Washout (6 Weeks)||1
470419|NCT00507819|1123378|P2|COMPLETED|Washout (6 Weeks)||14
470420|NCT00507819|1123379|P1|COMPLETED|Washout (6 Weeks)||13
470421|NCT00507819|1123378|P2|STARTED|Washout (6 Weeks)||14
470422|NCT00507819|1123379|P1|STARTED|Washout (6 Weeks)||14
470423|NCT00507819|1123378|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
470424|NCT00507819|1123379|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
470425|NCT00507819|1123378|P2|COMPLETED|First Intervention (6 Weeks)||14
470426|NCT00507819|1123379|P1|COMPLETED|First Intervention (6 Weeks)||14
470427|NCT00507819|1123378|P2|STARTED|First Intervention (6 Weeks)||14
470428|NCT00507819|1123379|P1|STARTED|First Intervention (6 Weeks)||14
470429|NCT00507767|1123391|P1|NOT COMPLETED|Overall Study||0
470430|NCT00507767|1123391|P1|COMPLETED|Overall Study||15
470431|NCT00507767|1123391|P1|STARTED|Overall Study||15
470432|NCT00507689|1123398|P2|NOT COMPLETED|Randomized Period||2
470433|NCT00507689|1123399|P1|NOT COMPLETED|Randomized Period||1
470434|NCT00507689|1123398|P2|COMPLETED|Randomized Period||16
470435|NCT00507689|1123399|P1|COMPLETED|Randomized Period||18
470436|NCT00507689|1123398|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
470437|NCT00507689|1123399|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
470438|NCT00507689|1123398|P2|NOT COMPLETED|Pre-Randomization Period||0
470439|NCT00507689|1123399|P1|NOT COMPLETED|Pre-Randomization Period||3
470440|NCT00507689|1123398|P2|COMPLETED|Pre-Randomization Period||0
470441|NCT00507689|1123399|P1|COMPLETED|Pre-Randomization Period||37
470442|NCT00507689|1123398|P2|STARTED|Pre-Randomization Period||0
470443|NCT00507689|1123399|P1|STARTED|Pre-Randomization Period||40
470444|NCT00507559|1123416|P1|NOT COMPLETED|Overall Study||71
470445|NCT00507559|1123416|P1|COMPLETED|Overall Study||84
470446|NCT00507559|1123416|P1|STARTED|Overall Study||155
470447|NCT00507546|1123431|P2|NOT COMPLETED|Overall Study||1
470448|NCT00507546|1123432|P1|NOT COMPLETED|Overall Study||2
470449|NCT00507546|1123431|P2|COMPLETED|Overall Study||3
470450|NCT00507546|1123432|P1|COMPLETED|Overall Study||2
470451|NCT00507546|1123431|P2|STARTED|Overall Study||4
470452|NCT00507546|1123432|P1|STARTED|Overall Study||4
470453|NCT00507507|1123442|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
470454|NCT00507507|1123443|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
470455|NCT00507507|1123442|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
470456|NCT00507507|1123443|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
470457|NCT00507507|1123442|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
470458|NCT00507507|1123443|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
470459|NCT00507507|1123442|P2|NOT COMPLETED|Treatment Period||53
470460|NCT00507507|1123443|P1|NOT COMPLETED|Treatment Period||52
470461|NCT00507507|1123442|P2|COMPLETED|Treatment Period||9
470462|NCT00507507|1123443|P1|COMPLETED|Treatment Period||12
470463|NCT00507507|1123442|P2|Completed 192 Weeks of Treatment|Treatment Period||52
470464|NCT00507507|1123443|P1|Completed 192 Weeks of Treatment|Treatment Period||52
470465|NCT00507507|1123442|P2|STARTED|Treatment Period||62
470466|NCT00507507|1123443|P1|STARTED|Treatment Period||64
470467|NCT00507455|1123478|P3|NOT COMPLETED|Overall Study||12
470468|NCT00507455|1123479|P2|NOT COMPLETED|Overall Study||6
470469|NCT00507455|1123480|P1|NOT COMPLETED|Overall Study||12
470470|NCT00507455|1123478|P3|COMPLETED|Overall Study||62
470471|NCT00507455|1123479|P2|COMPLETED|Overall Study||68
470472|NCT00507455|1123480|P1|COMPLETED|Overall Study||62
470473|NCT00507455|1123478|P3|STARTED|Overall Study||74
470474|NCT00507455|1123479|P2|STARTED|Overall Study||74
470475|NCT00507455|1123480|P1|STARTED|Overall Study||74
470476|NCT00507442|1123543|P4|NOT COMPLETED|Overall Study||5
470477|NCT00507442|1123544|P3|NOT COMPLETED|Overall Study||15
470478|NCT00507442|1123545|P2|NOT COMPLETED|Overall Study||27
470479|NCT00507442|1123546|P1|NOT COMPLETED|Overall Study||16
470480|NCT00507442|1123543|P4|COMPLETED|Overall Study||12
470481|NCT00507442|1123544|P3|COMPLETED|Overall Study||18
470482|NCT00507442|1123545|P2|COMPLETED|Overall Study||39
470483|NCT00507442|1123546|P1|COMPLETED|Overall Study||26
470484|NCT00507442|1123543|P4|STARTED|Overall Study||17
470485|NCT00507442|1123544|P3|STARTED|Overall Study||33
470486|NCT00507442|1123545|P2|STARTED|Overall Study||66
470487|NCT00507442|1123546|P1|STARTED|Overall Study||42
470488|NCT00507429|1123598|P2|NOT COMPLETED|Maintenance Phase||0
470489|NCT00507429|1123599|P1|NOT COMPLETED|Maintenance Phase||14
470490|NCT00507429|1123598|P2|COMPLETED|Maintenance Phase||0
470491|NCT00507429|1123599|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
470582|NCT00506883|1123762|P1|STARTED|Overall Study||52
470492|NCT00507429|1123598|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
470493|NCT00507429|1123599|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
470494|NCT00507429|1123598|P2|NOT COMPLETED|Treatment Phase||18
470495|NCT00507429|1123599|P1|NOT COMPLETED|Treatment Phase||37
470496|NCT00507429|1123598|P2|COMPLETED|Treatment Phase||7
470497|NCT00507429|1123599|P1|COMPLETED|Treatment Phase||18
470498|NCT00507429|1123598|P2|STARTED|Treatment Phase|Randomized|25
470499|NCT00507429|1123599|P1|STARTED|Treatment Phase|Randomized|55
470500|NCT00507416|1123610|P3|NOT COMPLETED|Overall Study||114
470501|NCT00507416|1123611|P2|NOT COMPLETED|Overall Study||125
470502|NCT00507416|1123612|P1|NOT COMPLETED|Overall Study||118
470503|NCT00507416|1123610|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
470504|NCT00507416|1123611|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
470505|NCT00507416|1123612|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
470506|NCT00507416|1123610|P3|Completed 8 Treatment Cycles|Overall Study||69
470507|NCT00507416|1123611|P2|Completed 8 Treatment Cycles|Overall Study||60
470508|NCT00507416|1123612|P1|Completed 8 Treatment Cycles|Overall Study||82
470509|NCT00507416|1123610|P3|Treated (Safety Population)|Overall Study||163
470510|NCT00507416|1123611|P2|Treated (Safety Population)|Overall Study||158
470511|NCT00507416|1123612|P1|Treated (Safety Population)|Overall Study||165
470512|NCT00507416|1123610|P3|STARTED|Overall Study||167
470513|NCT00507416|1123611|P2|STARTED|Overall Study||167
470514|NCT00507416|1123612|P1|STARTED|Overall Study||168
470515|NCT00507208|1123643|P2|NOT COMPLETED|Overall Study||0
470516|NCT00507208|1123644|P1|NOT COMPLETED|Overall Study||0
470517|NCT00507208|1123643|P2|COMPLETED|Overall Study||26
470518|NCT00507208|1123644|P1|COMPLETED|Overall Study||27
470519|NCT00507208|1123643|P2|Received Dynasplint in Crossover|Overall Study||3
470520|NCT00507208|1123644|P1|Received Dynasplint in Crossover|Overall Study||0
470521|NCT00507208|1123643|P2|STARTED|Overall Study||26
470522|NCT00507208|1123644|P1|STARTED|Overall Study||27
470523|NCT00503997|1123650|P1|NOT COMPLETED|Overall Study||8
470524|NCT00503997|1123650|P1|COMPLETED|Overall Study||34
470525|NCT00503997|1123650|P1|STARTED|Overall Study||42
470526|NCT00503984|1123656|P6|NOT COMPLETED|Overall Study||0
470527|NCT00503984|1123657|P5|NOT COMPLETED|Overall Study||1
470528|NCT00503984|1123658|P4|NOT COMPLETED|Overall Study||0
470529|NCT00503984|1123659|P3|NOT COMPLETED|Overall Study||0
470530|NCT00503984|1123660|P2|NOT COMPLETED|Overall Study||2
470531|NCT00503984|1123661|P1|NOT COMPLETED|Overall Study||0
470532|NCT00503984|1123656|P6|COMPLETED|Overall Study||1
470533|NCT00503984|1123657|P5|COMPLETED|Overall Study||5
470534|NCT00503984|1123658|P4|COMPLETED|Overall Study||6
470535|NCT00503984|1123659|P3|COMPLETED|Overall Study||3
470536|NCT00503984|1123660|P2|COMPLETED|Overall Study||1
470537|NCT00503984|1123661|P1|COMPLETED|Overall Study||3
470538|NCT00503984|1123656|P6|STARTED|Overall Study||1
470539|NCT00503984|1123657|P5|STARTED|Overall Study||6
470540|NCT00503984|1123658|P4|STARTED|Overall Study||6
470541|NCT00503984|1123659|P3|STARTED|Overall Study||3
470542|NCT00503984|1123660|P2|STARTED|Overall Study||3
470543|NCT00503984|1123661|P1|STARTED|Overall Study||3
470544|NCT00507130|1123691|P4|NOT COMPLETED|Overall Study||1
470545|NCT00507130|1123692|P3|NOT COMPLETED|Overall Study||1
470546|NCT00507130|1123693|P2|NOT COMPLETED|Overall Study||0
470547|NCT00507130|1123694|P1|NOT COMPLETED|Overall Study||1
470548|NCT00507130|1123691|P4|COMPLETED|Overall Study||8
470549|NCT00507130|1123692|P3|COMPLETED|Overall Study||8
470550|NCT00507130|1123693|P2|COMPLETED|Overall Study||9
470551|NCT00507130|1123694|P1|COMPLETED|Overall Study||8
470552|NCT00507130|1123691|P4|STARTED|Overall Study||9
470553|NCT00507130|1123692|P3|STARTED|Overall Study||9
470554|NCT00507130|1123693|P2|STARTED|Overall Study||9
470555|NCT00507130|1123694|P1|STARTED|Overall Study||9
470556|NCT00506948|1123736|P1|NOT COMPLETED|Overall Study||10
470557|NCT00506948|1123736|P1|COMPLETED|Overall Study||0
470558|NCT00506948|1123736|P1|STARTED|Overall Study||10
470559|NCT00506922|1123745|P5|NOT COMPLETED|Overall Study||1
470560|NCT00506922|1123746|P4|NOT COMPLETED|Overall Study||2
470561|NCT00506922|1123747|P3|NOT COMPLETED|Overall Study||0
470562|NCT00506922|1123748|P2|NOT COMPLETED|Overall Study||0
470563|NCT00506922|1123749|P1|NOT COMPLETED|Overall Study||0
470564|NCT00506922|1123745|P5|COMPLETED|Overall Study||10
470565|NCT00506922|1123746|P4|COMPLETED|Overall Study||61
470566|NCT00506922|1123747|P3|COMPLETED|Overall Study||29
470567|NCT00506922|1123748|P2|COMPLETED|Overall Study||10
470568|NCT00506922|1123749|P1|COMPLETED|Overall Study||37
470569|NCT00506922|1123745|P5|STARTED|Overall Study||11
470570|NCT00506922|1123746|P4|STARTED|Overall Study||63
470571|NCT00506922|1123747|P3|STARTED|Overall Study||29
470572|NCT00506922|1123748|P2|STARTED|Overall Study||10
470573|NCT00506922|1123749|P1|STARTED|Overall Study||37
470574|NCT00506883|1123760|P3|NOT COMPLETED|Overall Study||4
470575|NCT00506883|1123761|P2|NOT COMPLETED|Overall Study||3
470576|NCT00506883|1123762|P1|NOT COMPLETED|Overall Study||7
470577|NCT00506883|1123760|P3|COMPLETED|Overall Study||55
470578|NCT00506883|1123761|P2|COMPLETED|Overall Study||71
470579|NCT00506883|1123762|P1|COMPLETED|Overall Study||45
470580|NCT00506883|1123760|P3|STARTED|Overall Study||59
470581|NCT00506883|1123761|P2|STARTED|Overall Study||74
470583|NCT00506857|1123770|P1|NOT COMPLETED|Overall Study||0
470584|NCT00506857|1123770|P1|COMPLETED|Overall Study||80
470585|NCT00506857|1123770|P1|STARTED|Overall Study||80
470586|NCT00506831|1123775|P1|NOT COMPLETED|Overall Study||2
470587|NCT00506831|1123775|P1|COMPLETED|Overall Study||7
470588|NCT00506831|1123775|P1|STARTED|Overall Study||9
470589|NCT00506714|1123781|P2|NOT COMPLETED|Overall Study||0
470590|NCT00506714|1123782|P1|NOT COMPLETED|Overall Study||0
470591|NCT00506714|1123781|P2|COMPLETED|Overall Study||13
470592|NCT00506714|1123782|P1|COMPLETED|Overall Study||13
470593|NCT00506714|1123781|P2|STARTED|Overall Study||13
470594|NCT00506714|1123782|P1|STARTED|Overall Study||13
470595|NCT00506675|1123792|P2|NOT COMPLETED|Overall Study||0
470596|NCT00506675|1123793|P1|NOT COMPLETED|Overall Study||0
470597|NCT00506675|1123792|P2|COMPLETED|Overall Study||28
470598|NCT00506675|1123793|P1|COMPLETED|Overall Study||27
470599|NCT00506675|1123792|P2|STARTED|Overall Study||28
470600|NCT00506675|1123793|P1|STARTED|Overall Study||27
470601|NCT00506662|1123807|P2|NOT COMPLETED|Overall Study||28
470602|NCT00506662|1123808|P1|NOT COMPLETED|Overall Study||17
470603|NCT00506662|1123807|P2|COMPLETED|Overall Study||20
470604|NCT00506662|1123808|P1|COMPLETED|Overall Study||21
470605|NCT00506662|1123807|P2|STARTED|Overall Study||48
470606|NCT00506662|1123808|P1|STARTED|Overall Study||38
470607|NCT00506597|1123838|P1|NOT COMPLETED|Overall Study||0
470608|NCT00506597|1123838|P1|COMPLETED|Overall Study||33
470609|NCT00506597|1123838|P1|STARTED|Overall Study||33
470610|NCT00506493|1123842|P1|NOT COMPLETED|Overall Study||11
470611|NCT00506493|1123842|P1|COMPLETED|Overall Study||64
470612|NCT00506493|1123842|P1|STARTED|Overall Study||75
470613|NCT00506454|1123851|P2|NOT COMPLETED|Overall Study||1
470614|NCT00506454|1123852|P1|NOT COMPLETED|Overall Study||1
470615|NCT00506454|1123851|P2|COMPLETED|Overall Study||10
470616|NCT00506454|1123852|P1|COMPLETED|Overall Study||10
470617|NCT00506454|1123851|P2|STARTED|Overall Study||11
470618|NCT00506454|1123852|P1|STARTED|Overall Study||11
470619|NCT00506441|1123858|P2|NOT COMPLETED|Period 2; Double-blind Period||5
470620|NCT00506441|1123859|P1|NOT COMPLETED|Period 2; Double-blind Period||3
470621|NCT00506441|1123858|P2|COMPLETED|Period 2; Double-blind Period||79
470622|NCT00506441|1123859|P1|COMPLETED|Period 2; Double-blind Period||82
470623|NCT00506441|1123858|P2|STARTED|Period 2; Double-blind Period||84
470624|NCT00506441|1123859|P1|STARTED|Period 2; Double-blind Period||85
470625|NCT00506441|1123858|P2|NOT COMPLETED|Period 1; Open-label Period||0
470626|NCT00506441|1123859|P1|NOT COMPLETED|Period 1; Open-label Period||76
470627|NCT00506441|1123858|P2|COMPLETED|Period 1; Open-label Period||0
470628|NCT00506441|1123859|P1|COMPLETED|Period 1; Open-label Period||169
470629|NCT00506441|1123858|P2|STARTED|Period 1; Open-label Period||0
470630|NCT00506441|1123859|P1|STARTED|Period 1; Open-label Period||245
470631|NCT00506415|1123867|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
470632|NCT00506415|1123868|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
470633|NCT00506415|1123869|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
470634|NCT00506415|1123870|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
470635|NCT00506415|1123867|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
470636|NCT00506415|1123868|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
470637|NCT00506415|1123869|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
470638|NCT00506415|1123870|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
470639|NCT00506415|1123867|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
470640|NCT00506415|1123868|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
470641|NCT00506415|1123869|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
470642|NCT00506415|1123870|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
470643|NCT00506415|1123867|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
470644|NCT00506415|1123868|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
470645|NCT00506415|1123869|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
470646|NCT00506415|1123870|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
470647|NCT00506415|1123867|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
470648|NCT00506415|1123868|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
470649|NCT00506415|1123869|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
470650|NCT00506415|1123870|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
470651|NCT00506415|1123867|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
470652|NCT00506415|1123868|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
470653|NCT00506415|1123869|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
470654|NCT00506415|1123870|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
470655|NCT00506415|1123867|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
470656|NCT00506415|1123868|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
470657|NCT00506415|1123869|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
470658|NCT00506415|1123870|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
470659|NCT00506415|1123867|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
470660|NCT00506415|1123868|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
470661|NCT00506415|1123869|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
470662|NCT00506415|1123870|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
470663|NCT00506415|1123867|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
470664|NCT00506415|1123868|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
470665|NCT00506415|1123869|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
470666|NCT00506415|1123870|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
470667|NCT00506415|1123867|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
470668|NCT00506415|1123868|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
470669|NCT00506415|1123869|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
470670|NCT00506415|1123870|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
470671|NCT00506389|1123895|P3|NOT COMPLETED|Follow-up Period||0
470672|NCT00506389|1123896|P2|NOT COMPLETED|Follow-up Period||0
470673|NCT00506389|1123897|P1|NOT COMPLETED|Follow-up Period||0
470674|NCT00506389|1123895|P3|COMPLETED|Follow-up Period||136
470675|NCT00506389|1123896|P2|COMPLETED|Follow-up Period||138
470676|NCT00506389|1123897|P1|COMPLETED|Follow-up Period||139
470677|NCT00506389|1123895|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
470678|NCT00506389|1123896|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
470679|NCT00506389|1123897|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
470680|NCT00506389|1123895|P3|NOT COMPLETED|In-treatment Period||12
470681|NCT00506389|1123896|P2|NOT COMPLETED|In-treatment Period||15
470682|NCT00506389|1123897|P1|NOT COMPLETED|In-treatment Period||26
470683|NCT00506389|1123895|P3|COMPLETED|In-treatment Period||125
470684|NCT00506389|1123896|P2|COMPLETED|In-treatment Period||124
470685|NCT00506389|1123897|P1|COMPLETED|In-treatment Period||117
470686|NCT00506389|1123895|P3|All Participants Treated|In-treatment Period||136
470687|NCT00506389|1123896|P2|All Participants Treated|In-treatment Period||138
470688|NCT00506389|1123897|P1|All Participants Treated|In-treatment Period||139
470689|NCT00506389|1123895|P3|STARTED|In-treatment Period||137
470690|NCT00506389|1123896|P2|STARTED|In-treatment Period||139
470691|NCT00506389|1123897|P1|STARTED|In-treatment Period||143
470692|NCT00506285|1123916|P2|NOT COMPLETED|6-month Open Label Phase||12
470693|NCT00506285|1123917|P1|NOT COMPLETED|6-month Open Label Phase||10
470694|NCT00506285|1123916|P2|COMPLETED|6-month Open Label Phase||19
470695|NCT00506285|1123917|P1|COMPLETED|6-month Open Label Phase||10
470696|NCT00506285|1123916|P2|STARTED|6-month Open Label Phase||31
470697|NCT00506285|1123917|P1|STARTED|6-month Open Label Phase||20
470698|NCT00506285|1123916|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
470699|NCT00506285|1123917|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
470700|NCT00506285|1123916|P2|COMPLETED|Double Blind Cross-Over Phase||31
470701|NCT00506285|1123917|P1|COMPLETED|Double Blind Cross-Over Phase||20
470702|NCT00506285|1123916|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
470703|NCT00506285|1123917|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
470704|NCT00506285|1123916|P2|STARTED|Double Blind Cross-Over Phase||36
470705|NCT00506285|1123917|P1|STARTED|Double Blind Cross-Over Phase||29
470706|NCT00506285|1123916|P2|NOT COMPLETED|3 Week Screening Phase||10
470707|NCT00506285|1123917|P1|NOT COMPLETED|3 Week Screening Phase||17
470708|NCT00506285|1123916|P2|COMPLETED|3 Week Screening Phase||36
470709|NCT00506285|1123917|P1|COMPLETED|3 Week Screening Phase||29
470710|NCT00506285|1123916|P2|STARTED|3 Week Screening Phase||46
470711|NCT00506285|1123917|P1|STARTED|3 Week Screening Phase||46
470712|NCT00506155|1123925|P1|NOT COMPLETED|Overall Study||0
470713|NCT00506155|1123925|P1|COMPLETED|Overall Study||60
470714|NCT00506155|1123925|P1|STARTED|Overall Study||60
470715|NCT00506077|1123932|P2|NOT COMPLETED|Treatment Period 2||1
470716|NCT00506077|1123933|P1|NOT COMPLETED|Treatment Period 2||1
470717|NCT00506077|1123932|P2|COMPLETED|Treatment Period 2||23
470718|NCT00506077|1123933|P1|COMPLETED|Treatment Period 2||23
470719|NCT00506077|1123932|P2|STARTED|Treatment Period 2||24
470720|NCT00506077|1123933|P1|STARTED|Treatment Period 2||24
470721|NCT00506077|1123932|P2|NOT COMPLETED|Washout||0
470722|NCT00506077|1123933|P1|NOT COMPLETED|Washout||0
470723|NCT00506077|1123932|P2|COMPLETED|Washout||24
470724|NCT00506077|1123933|P1|COMPLETED|Washout||24
470725|NCT00506077|1123932|P2|STARTED|Washout||24
470726|NCT00506077|1123933|P1|STARTED|Washout||24
470727|NCT00506077|1123932|P2|NOT COMPLETED|Treatment Period 1||3
470728|NCT00506077|1123933|P1|NOT COMPLETED|Treatment Period 1||4
470729|NCT00506077|1123932|P2|COMPLETED|Treatment Period 1||24
470730|NCT00506077|1123933|P1|COMPLETED|Treatment Period 1||24
470731|NCT00506077|1123932|P2|STARTED|Treatment Period 1||27
470732|NCT00506077|1123933|P1|STARTED|Treatment Period 1||28
470733|NCT00506064|1123955|P2|NOT COMPLETED|Overall Study||0
470734|NCT00506064|1123956|P1|NOT COMPLETED|Overall Study||0
470735|NCT00506064|1123955|P2|COMPLETED|Overall Study||0
470736|NCT00506064|1123956|P1|COMPLETED|Overall Study||1
470737|NCT00506064|1123955|P2|STARTED|Overall Study||0
470738|NCT00506064|1123956|P1|STARTED|Overall Study||1
470739|NCT00506025|1123965|P3|NOT COMPLETED|Overall Study||0
470740|NCT00506025|1123966|P2|NOT COMPLETED|Overall Study||0
470741|NCT00506025|1123967|P1|NOT COMPLETED|Overall Study||0
470742|NCT00506025|1123965|P3|COMPLETED|Overall Study||8
470743|NCT00506025|1123966|P2|COMPLETED|Overall Study||9
470744|NCT00506025|1123967|P1|COMPLETED|Overall Study||10
470745|NCT00506025|1123965|P3|STARTED|Overall Study||8
470746|NCT00506025|1123966|P2|STARTED|Overall Study||9
470747|NCT00506025|1123967|P1|STARTED|Overall Study||10
470748|NCT00505934|1123975|P1|NOT COMPLETED|Overall Study||3
470749|NCT00505934|1123975|P1|COMPLETED|Overall Study||16
470750|NCT00505934|1123975|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
470751|NCT00505921|1123981|P1|NOT COMPLETED|Overall Study||9
470752|NCT00505921|1123981|P1|COMPLETED|Overall Study||18
470753|NCT00505921|1123981|P1|STARTED|Overall Study||27
470754|NCT00505895|1123987|P2|NOT COMPLETED|Overall Study||0
470755|NCT00505895|1123988|P1|NOT COMPLETED|Overall Study||0
470756|NCT00505895|1123987|P2|COMPLETED|Overall Study||23
470757|NCT00505895|1123988|P1|COMPLETED|Overall Study||27
470758|NCT00505895|1123987|P2|STARTED|Overall Study||23
470759|NCT00505895|1123988|P1|STARTED|Overall Study||27
470760|NCT00505778|1123998|P2|NOT COMPLETED|Overall Study||135
470761|NCT00505778|1123999|P1|NOT COMPLETED|Overall Study||134
470762|NCT00505778|1123998|P2|COMPLETED|Overall Study||378
470763|NCT00505778|1123999|P1|COMPLETED|Overall Study||380
470764|NCT00505778|1123998|P2|Intent to Treat (ITT) Population|Overall Study||511
470765|NCT00505778|1123999|P1|Intent to Treat (ITT) Population|Overall Study||512
470766|NCT00505778|1123998|P2|STARTED|Overall Study||513
470767|NCT00505778|1123999|P1|STARTED|Overall Study||514
470768|NCT00505765|1124018|P3|NOT COMPLETED|Overall Study||3
470769|NCT00505765|1124019|P2|NOT COMPLETED|Overall Study||3
470770|NCT00505765|1124020|P1|NOT COMPLETED|Overall Study||2
470771|NCT00505765|1124018|P3|COMPLETED|Overall Study||19
470772|NCT00505765|1124019|P2|COMPLETED|Overall Study||17
470773|NCT00505765|1124020|P1|COMPLETED|Overall Study||19
470774|NCT00505765|1124018|P3|Mid-Point Assessment|Overall Study||21
470775|NCT00505765|1124019|P2|Mid-Point Assessment|Overall Study||19
470776|NCT00505765|1124020|P1|Mid-Point Assessment|Overall Study||20
470777|NCT00505765|1124018|P3|STARTED|Overall Study||22
470778|NCT00505765|1124019|P2|STARTED|Overall Study||20
470779|NCT00505765|1124020|P1|STARTED|Overall Study||21
470780|NCT00505752|1124047|P4|NOT COMPLETED|Overall Study||6
470781|NCT00505752|1124048|P3|NOT COMPLETED|Overall Study||8
470782|NCT00505752|1124049|P2|NOT COMPLETED|Overall Study||9
470783|NCT00505752|1124050|P1|NOT COMPLETED|Overall Study||6
470784|NCT00505752|1124047|P4|COMPLETED|Overall Study||126
470785|NCT00505752|1124048|P3|COMPLETED|Overall Study||120
470786|NCT00505752|1124049|P2|COMPLETED|Overall Study||119
470787|NCT00505752|1124050|P1|COMPLETED|Overall Study||126
470788|NCT00505752|1124047|P4|STARTED|Overall Study||132
470789|NCT00505752|1124048|P3|STARTED|Overall Study||128
470790|NCT00505752|1124049|P2|STARTED|Overall Study||128
470791|NCT00505752|1124050|P1|STARTED|Overall Study||132
470792|NCT00505687|1124064|P1|NOT COMPLETED|Overall Study||95
470793|NCT00505687|1124064|P1|COMPLETED|Overall Study||91
470794|NCT00505687|1124064|P1|STARTED|Overall Study||186
470795|NCT00505661|1124070|P1|NOT COMPLETED|Overall Study||4
470796|NCT00505661|1124070|P1|COMPLETED|Overall Study||12
470797|NCT00505661|1124070|P1|STARTED|Overall Study||16
470798|NCT00505635|1124074|P1|NOT COMPLETED|Overall Study||0
470799|NCT00505635|1124074|P1|COMPLETED|Overall Study||5
470800|NCT00505635|1124074|P1|STARTED|Overall Study||5
470801|NCT00505622|1124081|P3|NOT COMPLETED|Overall Study||96
470802|NCT00505622|1124082|P2|NOT COMPLETED|Overall Study||108
470803|NCT00505622|1124083|P1|NOT COMPLETED|Overall Study||121
470804|NCT00505622|1124081|P3|COMPLETED|Overall Study||0
470805|NCT00505622|1124082|P2|COMPLETED|Overall Study||0
470806|NCT00505622|1124083|P1|COMPLETED|Overall Study||0
470807|NCT00505622|1124081|P3|STARTED|Overall Study||96
470808|NCT00505622|1124082|P2|STARTED|Overall Study||108
470809|NCT00505622|1124083|P1|STARTED|Overall Study||121
470810|NCT00505518|1124100|P1|NOT COMPLETED|Overall Study||0
470811|NCT00505518|1124100|P1|COMPLETED|Overall Study||9
470812|NCT00505518|1124100|P1|STARTED|Overall Study||9
470813|NCT00505414|1124108|P5|NOT COMPLETED|Maintenance Phase||0
470814|NCT00505414|1124109|P4|NOT COMPLETED|Maintenance Phase||0
470815|NCT00505414|1124110|P3|NOT COMPLETED|Maintenance Phase||8
470816|NCT00505414|1124111|P2|NOT COMPLETED|Maintenance Phase||5
470817|NCT00505414|1124112|P1|NOT COMPLETED|Maintenance Phase||6
470818|NCT00505414|1124108|P5|COMPLETED|Maintenance Phase||0
470819|NCT00505414|1124109|P4|COMPLETED|Maintenance Phase||0
470820|NCT00505414|1124110|P3|COMPLETED|Maintenance Phase||6
470821|NCT00505414|1124111|P2|COMPLETED|Maintenance Phase||10
470822|NCT00505414|1124112|P1|COMPLETED|Maintenance Phase||12
470823|NCT00505414|1124108|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
470824|NCT00505414|1124109|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
470825|NCT00505414|1124110|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
470826|NCT00505414|1124111|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
470827|NCT00505414|1124112|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
470828|NCT00505414|1124108|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
470829|NCT00505414|1124109|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
470830|NCT00505414|1124110|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
470831|NCT00505414|1124111|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
470832|NCT00505414|1124112|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
470833|NCT00505414|1124108|P5|NOT COMPLETED|Titration Phase||12
470834|NCT00505414|1124109|P4|NOT COMPLETED|Titration Phase||30
470835|NCT00505414|1124110|P3|NOT COMPLETED|Titration Phase||0
470836|NCT00505414|1124111|P2|NOT COMPLETED|Titration Phase||0
470837|NCT00505414|1124112|P1|NOT COMPLETED|Titration Phase||0
470838|NCT00505414|1124108|P5|COMPLETED|Titration Phase||19
470839|NCT00505414|1124109|P4|COMPLETED|Titration Phase||32
470840|NCT00505414|1124110|P3|COMPLETED|Titration Phase||0
470841|NCT00505414|1124111|P2|COMPLETED|Titration Phase||0
470842|NCT00505414|1124112|P1|COMPLETED|Titration Phase||0
470843|NCT00505414|1124108|P5|STARTED|Titration Phase||31
470844|NCT00505414|1124109|P4|STARTED|Titration Phase||62
470845|NCT00505414|1124110|P3|STARTED|Titration Phase||0
470846|NCT00505414|1124111|P2|STARTED|Titration Phase||0
470847|NCT00505414|1124112|P1|STARTED|Titration Phase||0
470848|NCT00505375|1124129|P2|NOT COMPLETED|Overall Study||5
470849|NCT00505375|1124130|P1|NOT COMPLETED|Overall Study||4
470850|NCT00505375|1124129|P2|COMPLETED|Overall Study||30
470851|NCT00505375|1124130|P1|COMPLETED|Overall Study||73
470852|NCT00505375|1124129|P2|STARTED|Overall Study||35
470853|NCT00505375|1124130|P1|STARTED|Overall Study||77
470854|NCT00505362|1124138|P2|NOT COMPLETED|Overall Study||0
470855|NCT00505362|1124139|P1|NOT COMPLETED|Overall Study||0
470856|NCT00505362|1124138|P2|COMPLETED|Overall Study||28
470857|NCT00505362|1124139|P1|COMPLETED|Overall Study||35
470858|NCT00505362|1124138|P2|STARTED|Overall Study||28
470859|NCT00505362|1124139|P1|STARTED|Overall Study||35
470860|NCT00505284|1124152|P5|NOT COMPLETED|Overall Study||33
470861|NCT00505284|1124153|P4|NOT COMPLETED|Overall Study||19
470862|NCT00505284|1124154|P3|NOT COMPLETED|Overall Study||12
470863|NCT00505284|1124155|P2|NOT COMPLETED|Overall Study||16
470864|NCT00505284|1124156|P1|NOT COMPLETED|Overall Study||10
470865|NCT00505284|1124152|P5|COMPLETED|Overall Study||37
470866|NCT00505284|1124153|P4|COMPLETED|Overall Study||49
470867|NCT00505284|1124154|P3|COMPLETED|Overall Study||57
470868|NCT00505284|1124155|P2|COMPLETED|Overall Study||56
470869|NCT00505284|1124156|P1|COMPLETED|Overall Study||63
470870|NCT00505284|1124152|P5|STARTED|Overall Study||70
470871|NCT00505284|1124153|P4|STARTED|Overall Study||68
470872|NCT00505284|1124154|P3|STARTED|Overall Study||69
470873|NCT00505284|1124155|P2|STARTED|Overall Study||72
470874|NCT00505284|1124156|P1|STARTED|Overall Study||73
470875|NCT00505076|1124226|P3|NOT COMPLETED|Overall Study||5
470876|NCT00505076|1124227|P2|NOT COMPLETED|Overall Study||2
470877|NCT00505076|1124228|P1|NOT COMPLETED|Overall Study||3
470878|NCT00505076|1124226|P3|COMPLETED|Overall Study||17
470879|NCT00505076|1124227|P2|COMPLETED|Overall Study||17
470880|NCT00505076|1124228|P1|COMPLETED|Overall Study||19
470881|NCT00505076|1124226|P3|STARTED|Overall Study||22
470882|NCT00505076|1124227|P2|STARTED|Overall Study||19
470883|NCT00505076|1124228|P1|STARTED|Overall Study||22
470884|NCT00504985|1124242|P1|NOT COMPLETED|Overall Study||0
470885|NCT00504985|1124242|P1|COMPLETED|Overall Study||14
470886|NCT00504985|1124242|P1|STARTED|Overall Study||14
470887|NCT00504894|1124248|P2|NOT COMPLETED|Overall Study||0
470888|NCT00504894|1124249|P1|NOT COMPLETED|Overall Study||0
470889|NCT00504894|1124248|P2|COMPLETED|Overall Study||18
470890|NCT00504894|1124249|P1|COMPLETED|Overall Study||17
470891|NCT00504894|1124248|P2|STARTED|Overall Study||18
470892|NCT00504894|1124249|P1|STARTED|Overall Study||17
470893|NCT00504881|1124257|P2|NOT COMPLETED|Overall Study||36
470894|NCT00504881|1124258|P1|NOT COMPLETED|Overall Study||10
470895|NCT00504881|1124257|P2|COMPLETED|Overall Study||323
470896|NCT00504881|1124258|P1|COMPLETED|Overall Study||111
470897|NCT00504881|1124257|P2|STARTED|Overall Study||359
470898|NCT00504881|1124258|P1|STARTED|Overall Study||121
470899|NCT00504777|1124308|P1|NOT COMPLETED|Overall Study||1
470900|NCT00504777|1124308|P1|COMPLETED|Overall Study||35
470901|NCT00504777|1124308|P1|STARTED|Overall Study||36
470902|NCT00504751|1124315|P1|NOT COMPLETED|Overall Study||0
470903|NCT00504751|1124315|P1|COMPLETED|Overall Study||15
470904|NCT00504751|1124315|P1|STARTED|Overall Study||15
470905|NCT00504725|1124321|P2|NOT COMPLETED|Overall Study||0
470906|NCT00504725|1124322|P1|NOT COMPLETED|Overall Study||1
470907|NCT00504725|1124321|P2|COMPLETED|Overall Study||20
470908|NCT00504725|1124322|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
470909|NCT00504725|1124321|P2|STARTED|Overall Study||20
470910|NCT00504725|1124322|P1|STARTED|Overall Study||21
470911|NCT00504660|1124334|P2|NOT COMPLETED|Overall Study||0
470912|NCT00504660|1124335|P1|NOT COMPLETED|Overall Study||0
470913|NCT00504660|1124334|P2|COMPLETED|Overall Study||43
470914|NCT00504660|1124335|P1|COMPLETED|Overall Study||31
470915|NCT00504660|1124334|P2|STARTED|Overall Study||43
470916|NCT00504660|1124335|P1|STARTED|Overall Study||31
470917|NCT00504595|1124345|P4|NOT COMPLETED|Overall Study||0
470918|NCT00504595|1124346|P3|NOT COMPLETED|Overall Study||2
470919|NCT00504595|1124347|P2|NOT COMPLETED|Overall Study||0
470920|NCT00504595|1124348|P1|NOT COMPLETED|Overall Study||1
470921|NCT00504595|1124345|P4|COMPLETED|Overall Study||10
470922|NCT00504595|1124346|P3|COMPLETED|Overall Study||8
470923|NCT00504595|1124347|P2|COMPLETED|Overall Study||10
470924|NCT00504595|1124348|P1|COMPLETED|Overall Study||49
470925|NCT00504595|1124345|P4|STARTED|Overall Study||10
470926|NCT00504595|1124346|P3|STARTED|Overall Study||10
470927|NCT00504595|1124347|P2|STARTED|Overall Study||10
470928|NCT00504595|1124348|P1|STARTED|Overall Study||50
470929|NCT00504556|1124365|P5|NOT COMPLETED|Overall Study||25
470930|NCT00504556|1124366|P4|NOT COMPLETED|Overall Study||128
470931|NCT00504556|1124367|P3|NOT COMPLETED|Overall Study||31
470932|NCT00504556|1124368|P2|NOT COMPLETED|Overall Study||38
470933|NCT00504556|1124369|P1|NOT COMPLETED|Overall Study||35
470934|NCT00504556|1124365|P5|COMPLETED|Overall Study||226
470935|NCT00504556|1124366|P4|COMPLETED|Overall Study||52
470936|NCT00504556|1124367|P3|COMPLETED|Overall Study||204
470937|NCT00504556|1124368|P2|COMPLETED|Overall Study||207
470938|NCT00504556|1124369|P1|COMPLETED|Overall Study||200
470939|NCT00504556|1124365|P5|Pharmacodynamic Analysis Set|Overall Study||244
470940|NCT00504556|1124366|P4|Pharmacodynamic Analysis Set|Overall Study||170
470941|NCT00504556|1124367|P3|Pharmacodynamic Analysis Set|Overall Study||228
470942|NCT00504556|1124368|P2|Pharmacodynamic Analysis Set|Overall Study||236
470943|NCT00504556|1124369|P1|Pharmacodynamic Analysis Set|Overall Study||230
470944|NCT00504556|1124365|P5|Per Protocol Analysis Set|Overall Study||250
470945|NCT00504556|1124366|P4|Per Protocol Analysis Set|Overall Study||180
470946|NCT00504556|1124367|P3|Per Protocol Analysis Set|Overall Study||234
470947|NCT00504556|1124368|P2|Per Protocol Analysis Set|Overall Study||243
470948|NCT00504556|1124369|P1|Per Protocol Analysis Set|Overall Study||235
470949|NCT00504556|1124365|P5|Safety Analysis Set|Overall Study||250
470950|NCT00504556|1124366|P4|Safety Analysis Set|Overall Study||180
470951|NCT00504556|1124367|P3|Safety Analysis Set|Overall Study||234
470952|NCT00504556|1124368|P2|Safety Analysis Set|Overall Study||244
470953|NCT00504556|1124369|P1|Safety Analysis Set|Overall Study||235
470954|NCT00504556|1124365|P5|STARTED|Overall Study||251
470955|NCT00504556|1124366|P4|STARTED|Overall Study||180
470956|NCT00504556|1124367|P3|STARTED|Overall Study||235
470957|NCT00504556|1124368|P2|STARTED|Overall Study||245
470958|NCT00504556|1124369|P1|STARTED|Overall Study||235
470959|NCT00504504|1124429|P1|NOT COMPLETED|Overall Study||0
470960|NCT00504504|1124429|P1|COMPLETED|Overall Study||82
470961|NCT00504504|1124429|P1|STARTED|Overall Study||82
470962|NCT00504426|1124437|P4|NOT COMPLETED|Overall Study||0
470963|NCT00504426|1124438|P3|NOT COMPLETED|Overall Study||4
470964|NCT00504426|1124439|P2|NOT COMPLETED|Overall Study||1
470965|NCT00504426|1124440|P1|NOT COMPLETED|Overall Study||3
470966|NCT00504426|1124437|P4|COMPLETED|Overall Study||24
470967|NCT00504426|1124438|P3|COMPLETED|Overall Study||18
470968|NCT00504426|1124439|P2|COMPLETED|Overall Study||22
470969|NCT00504426|1124440|P1|COMPLETED|Overall Study||29
470970|NCT00504426|1124437|P4|STARTED|Overall Study||24
470971|NCT00504426|1124438|P3|STARTED|Overall Study||22
470972|NCT00504426|1124439|P2|STARTED|Overall Study||23
470973|NCT00504426|1124440|P1|STARTED|Overall Study||32
470974|NCT00504257|1124454|P1|NOT COMPLETED|Overall Study||4
470975|NCT00504257|1124454|P1|COMPLETED|Overall Study||41
470976|NCT00504257|1124454|P1|STARTED|Overall Study||45
470977|NCT00504231|1124466|P4|NOT COMPLETED|Overall Study||0
470978|NCT00504231|1124467|P3|NOT COMPLETED|Overall Study||1
470979|NCT00504231|1124468|P2|NOT COMPLETED|Overall Study||0
470980|NCT00504231|1124469|P1|NOT COMPLETED|Overall Study||0
470981|NCT00504231|1124466|P4|COMPLETED|Overall Study||65
470982|NCT00504231|1124467|P3|COMPLETED|Overall Study||63
470983|NCT00504231|1124468|P2|COMPLETED|Overall Study||64
470984|NCT00504231|1124469|P1|COMPLETED|Overall Study||65
470985|NCT00504231|1124466|P4|STARTED|Overall Study||65
470986|NCT00504231|1124467|P3|STARTED|Overall Study||64
470987|NCT00504231|1124468|P2|STARTED|Overall Study||64
470988|NCT00504231|1124469|P1|STARTED|Overall Study||65
470989|NCT00504166|1124489|P2|NOT COMPLETED|Overall Study||14
470990|NCT00504166|1124490|P1|NOT COMPLETED|Overall Study||6
470991|NCT00504166|1124489|P2|COMPLETED|Overall Study||13
470992|NCT00504166|1124490|P1|COMPLETED|Overall Study||20
470993|NCT00504166|1124489|P2|STARTED|Overall Study||27
470994|NCT00504166|1124490|P1|STARTED|Overall Study||26
470995|NCT00504153|1124496|P1|NOT COMPLETED|Overall Study||6
470996|NCT00504153|1124496|P1|COMPLETED|Overall Study||13
470997|NCT00504153|1124496|P1|STARTED|Overall Study||19
470998|NCT00504075|1124504|P1|NOT COMPLETED|Overall Study||8
470999|NCT00504075|1124504|P1|COMPLETED|Overall Study||27
471000|NCT00504075|1124504|P1|STARTED|Overall Study||35
471001|NCT00503906|1124510|P1|NOT COMPLETED|Overall Study||1
471002|NCT00503906|1124510|P1|COMPLETED|Overall Study||29
471003|NCT00503906|1124510|P1|STARTED|Overall Study||30
471004|NCT00503841|1124519|P1|NOT COMPLETED|Overall Study||44
471005|NCT00503841|1124519|P1|COMPLETED|Overall Study||0
471006|NCT00503841|1124519|P1|STARTED|Overall Study||44
471007|NCT00503776|1124527|P4|NOT COMPLETED|Overall Study||2
471008|NCT00503776|1124528|P3|NOT COMPLETED|Overall Study||2
471009|NCT00503776|1124529|P2|NOT COMPLETED|Overall Study||0
471010|NCT00503776|1124530|P1|NOT COMPLETED|Overall Study||1
471011|NCT00503776|1124527|P4|COMPLETED|Overall Study||8
471012|NCT00503776|1124528|P3|COMPLETED|Overall Study||10
471013|NCT00503776|1124529|P2|COMPLETED|Overall Study||12
471014|NCT00503776|1124530|P1|COMPLETED|Overall Study||7
471015|NCT00503776|1124527|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
471016|NCT00503776|1124528|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
471017|NCT00503776|1124529|P2|STARTED|Overall Study||12
471018|NCT00503776|1124530|P1|STARTED|Overall Study||8
471019|NCT00503750|1124548|P1|NOT COMPLETED|Overall Study||0
471020|NCT00503750|1124548|P1|COMPLETED|Overall Study||27
471021|NCT00503750|1124548|P1|STARTED|Overall Study||27
471022|NCT00503698|1124555|P2|NOT COMPLETED|Overall Study||355
471023|NCT00503698|1124556|P1|NOT COMPLETED|Overall Study||357
471024|NCT00503698|1124555|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
471025|NCT00503698|1124556|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
471026|NCT00503698|1124555|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
471027|NCT00503698|1124556|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
471028|NCT00503698|1124555|P2|STARTED|Overall Study|Randomised|355
471029|NCT00503698|1124556|P1|STARTED|Overall Study|Randomised|357
471030|NCT00503425|1124570|P1|NOT COMPLETED|Overall Study||54
471031|NCT00503425|1124570|P1|COMPLETED|Overall Study||161
471032|NCT00503425|1124570|P1|STARTED|Overall Study||215
471033|NCT00503399|1124580|P2|NOT COMPLETED|Overall Study||8
471034|NCT00503399|1124581|P1|NOT COMPLETED|Overall Study||7
471035|NCT00503399|1124580|P2|COMPLETED|Overall Study||39
471036|NCT00503399|1124581|P1|COMPLETED|Overall Study||38
471037|NCT00503399|1124580|P2|STARTED|Overall Study||47
471038|NCT00503399|1124581|P1|STARTED|Overall Study||45
471039|NCT00503308|1124605|P2|NOT COMPLETED|Overall Study||1
471040|NCT00503308|1124606|P1|NOT COMPLETED|Overall Study||2
471041|NCT00503308|1124605|P2|COMPLETED|Overall Study||134
471042|NCT00503308|1124606|P1|COMPLETED|Overall Study||144
471043|NCT00503308|1124605|P2|STARTED|Overall Study||135
471044|NCT00503308|1124606|P1|STARTED|Overall Study||146
471045|NCT00503139|1124612|P1|NOT COMPLETED|Overall Study||8
471046|NCT00503139|1124612|P1|COMPLETED|Overall Study||676
471047|NCT00503139|1124612|P1|STARTED|Overall Study||684
471048|NCT00503113|1124626|P3|NOT COMPLETED|Overall Study||28
471049|NCT00503113|1124627|P2|NOT COMPLETED|Overall Study||28
471050|NCT00503113|1124628|P1|NOT COMPLETED|Overall Study||33
471051|NCT00503113|1124626|P3|COMPLETED|Overall Study||241
471052|NCT00503113|1124627|P2|COMPLETED|Overall Study||236
471053|NCT00503113|1124628|P1|COMPLETED|Overall Study||235
471054|NCT00503113|1124626|P3|Safety Population|Overall Study||267
471055|NCT00503113|1124627|P2|Safety Population|Overall Study||263
471056|NCT00503113|1124628|P1|Safety Population|Overall Study||263
471057|NCT00503113|1124626|P3|Per Protocol Population (PP)|Overall Study||241
471058|NCT00503113|1124627|P2|Per Protocol Population (PP)|Overall Study||243
471059|NCT00503113|1124628|P1|Per Protocol Population (PP)|Overall Study||246
471060|NCT00503113|1124626|P3|Intent to Treat Population (ITT)|Overall Study||268
471061|NCT00503113|1124627|P2|Intent to Treat Population (ITT)|Overall Study||261
471062|NCT00503113|1124628|P1|Intent to Treat Population (ITT)|Overall Study||262
471063|NCT00503113|1124626|P3|STARTED|Overall Study||269
471064|NCT00503113|1124627|P2|STARTED|Overall Study||264
471065|NCT00503113|1124628|P1|STARTED|Overall Study||268
471066|NCT00503009|1124660|P3|NOT COMPLETED|Overall Study||3
471067|NCT00503009|1124661|P2|NOT COMPLETED|Overall Study||2
471068|NCT00503009|1124662|P1|NOT COMPLETED|Overall Study||1
471069|NCT00503009|1124660|P3|COMPLETED|Overall Study||3
471070|NCT00503009|1124661|P2|COMPLETED|Overall Study||3
471071|NCT00503009|1124662|P1|COMPLETED|Overall Study||4
471072|NCT00503009|1124660|P3|STARTED|Overall Study||6
471073|NCT00503009|1124661|P2|STARTED|Overall Study||5
471074|NCT00503009|1124662|P1|STARTED|Overall Study||5
471075|NCT00502996|1124679|P1|NOT COMPLETED|Overall Study||44
471076|NCT00502996|1124679|P1|COMPLETED|Overall Study||188
471077|NCT00502996|1124679|P1|STARTED|Overall Study||232
471078|NCT00502944|1124705|P2|NOT COMPLETED|Overall Study||1766
471079|NCT00502944|1124706|P1|NOT COMPLETED|Overall Study||1064
471080|NCT00502944|1124705|P2|COMPLETED|Overall Study||643
471081|NCT00502944|1124706|P1|COMPLETED|Overall Study||1382
471082|NCT00502944|1124705|P2|STARTED|Overall Study||2409
471083|NCT00502944|1124706|P1|STARTED|Overall Study||2446
471084|NCT00502905|1124718|P1|NOT COMPLETED|Overall Study||0
471085|NCT00502905|1124718|P1|COMPLETED|Overall Study||196
471086|NCT00502905|1124718|P1|STARTED|Overall Study||196
471087|NCT00502853|1124722|P1|NOT COMPLETED|Overall Study||0
471088|NCT00502853|1124722|P1|COMPLETED|Overall Study||10
471089|NCT00502853|1124722|P1|STARTED|Overall Study||10
471090|NCT00502840|1124747|P1|NOT COMPLETED|Overall Study||100
471091|NCT00502840|1124747|P1|COMPLETED|Overall Study||93
471092|NCT00502840|1124747|P1|STARTED|Overall Study||193
471093|NCT00502801|1124775|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
471094|NCT00502801|1124775|P1|COMPLETED|End of Therapy to Test of Cure||121
471095|NCT00502801|1124775|P1|STARTED|End of Therapy to Test of Cure||129
471096|NCT00502801|1124775|P1|NOT COMPLETED|Treatment Period||54
471097|NCT00502801|1124775|P1|COMPLETED|Treatment Period||129
471098|NCT00502801|1124775|P1|STARTED|Treatment Period||183
471099|NCT00502775|1124783|P3|NOT COMPLETED|Overall Study||13
471100|NCT00502775|1124784|P2|NOT COMPLETED|Overall Study||15
471101|NCT00502775|1124785|P1|NOT COMPLETED|Overall Study||10
471102|NCT00502775|1124783|P3|COMPLETED|Overall Study||214
471103|NCT00502775|1124784|P2|COMPLETED|Overall Study||209
471104|NCT00502775|1124785|P1|COMPLETED|Overall Study||219
471105|NCT00502775|1124783|P3|STARTED|Overall Study||227
471106|NCT00502775|1124784|P2|STARTED|Overall Study||224
471107|NCT00502775|1124785|P1|STARTED|Overall Study||229
471108|NCT00502697|1124828|P2|NOT COMPLETED|Overall Study||12
471109|NCT00502697|1124829|P1|NOT COMPLETED|Overall Study||13
471110|NCT00502697|1124828|P2|COMPLETED|Overall Study||102
471111|NCT00502697|1124829|P1|COMPLETED|Overall Study||109
471112|NCT00502697|1124828|P2|STARTED|Overall Study||114
471113|NCT00502697|1124829|P1|STARTED|Overall Study||122
471114|NCT00502671|1124837|P1|NOT COMPLETED|Overall Study||77
471115|NCT00502671|1124837|P1|COMPLETED|Overall Study||151
471116|NCT00502671|1124837|P1|STARTED|Overall Study||228
471117|NCT00502593|1124854|P12|NOT COMPLETED|Overall Study||0
471118|NCT00502593|1124855|P11|NOT COMPLETED|Overall Study||2
471119|NCT00502593|1124856|P10|NOT COMPLETED|Overall Study||0
471120|NCT00502593|1124857|P9|NOT COMPLETED|Overall Study||6
471121|NCT00502593|1124858|P8|NOT COMPLETED|Overall Study||0
471122|NCT00502593|1124859|P7|NOT COMPLETED|Overall Study||5
471123|NCT00502593|1124860|P6|NOT COMPLETED|Overall Study||0
471124|NCT00502593|1124861|P5|NOT COMPLETED|Overall Study||4
471125|NCT00502593|1124862|P4|NOT COMPLETED|Overall Study||4
471126|NCT00502593|1124863|P3|NOT COMPLETED|Overall Study||10
471127|NCT00502593|1124864|P2|NOT COMPLETED|Overall Study||2
471128|NCT00502593|1124865|P1|NOT COMPLETED|Overall Study||3
471129|NCT00502593|1124854|P12|COMPLETED|Overall Study||18
471130|NCT00502593|1124855|P11|COMPLETED|Overall Study||47
471131|NCT00502593|1124856|P10|COMPLETED|Overall Study||17
471132|NCT00502593|1124857|P9|COMPLETED|Overall Study||43
471133|NCT00502593|1124858|P8|COMPLETED|Overall Study||17
471134|NCT00502593|1124859|P7|COMPLETED|Overall Study||44
471135|NCT00502593|1124860|P6|COMPLETED|Overall Study||17
471136|NCT00502593|1124861|P5|COMPLETED|Overall Study||47
471137|NCT00502593|1124862|P4|COMPLETED|Overall Study||14
471138|NCT00502593|1124863|P3|COMPLETED|Overall Study||41
471139|NCT00502593|1124864|P2|COMPLETED|Overall Study||16
471140|NCT00502593|1124865|P1|COMPLETED|Overall Study||48
471141|NCT00502593|1124854|P12|STARTED|Overall Study||18
471142|NCT00502593|1124855|P11|STARTED|Overall Study||49
471143|NCT00502593|1124856|P10|STARTED|Overall Study||17
471144|NCT00502593|1124857|P9|STARTED|Overall Study||49
471145|NCT00502593|1124858|P8|STARTED|Overall Study||17
471146|NCT00502593|1124859|P7|STARTED|Overall Study||49
471147|NCT00502593|1124860|P6|STARTED|Overall Study||17
471148|NCT00502593|1124861|P5|STARTED|Overall Study||51
471149|NCT00502593|1124862|P4|STARTED|Overall Study||18
471150|NCT00502593|1124863|P3|STARTED|Overall Study||51
471151|NCT00502593|1124864|P2|STARTED|Overall Study||18
471152|NCT00502593|1124865|P1|STARTED|Overall Study||51
471153|NCT00502320|1125381|P2|NOT COMPLETED|Overall Study||7
471154|NCT00502320|1125382|P1|NOT COMPLETED|Overall Study||6
471155|NCT00502320|1125381|P2|COMPLETED|Overall Study||18
471156|NCT00502320|1125382|P1|COMPLETED|Overall Study||19
471157|NCT00502320|1125381|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
471158|NCT00502320|1125382|P1|Screening Visit|Overall Study||25
471159|NCT00502320|1125381|P2|STARTED|Overall Study||25
471160|NCT00502320|1125382|P1|STARTED|Overall Study||25
471161|NCT00502242|1125394|P2|NOT COMPLETED|Overall Study||56
471162|NCT00502242|1125395|P1|NOT COMPLETED|Overall Study||51
471163|NCT00502242|1125394|P2|COMPLETED|Overall Study||84
471164|NCT00502242|1125395|P1|COMPLETED|Overall Study||104
471165|NCT00502242|1125394|P2|STARTED|Overall Study||140
471166|NCT00502242|1125395|P1|STARTED|Overall Study||155
471167|NCT00502216|1125448|P2|NOT COMPLETED|Overall Study||0
471168|NCT00502216|1125449|P1|NOT COMPLETED|Overall Study||0
471169|NCT00502216|1125448|P2|COMPLETED|Overall Study||19
471170|NCT00502216|1125449|P1|COMPLETED|Overall Study||21
471171|NCT00502216|1125448|P2|STARTED|Overall Study||19
471172|NCT00502216|1125449|P1|STARTED|Overall Study||21
471173|NCT00502203|1125455|P1|NOT COMPLETED|Overall Study||1
471174|NCT00502203|1125455|P1|COMPLETED|Overall Study||22
471175|NCT00502203|1125455|P1|STARTED|Overall Study||23
471176|NCT00501995|1125459|P1|NOT COMPLETED|Overall Study||1
471177|NCT00501995|1125459|P1|COMPLETED|Overall Study||5
471178|NCT00501995|1125459|P1|STARTED|Overall Study||6
471179|NCT00501969|1125464|P1|NOT COMPLETED|Overall Study||206
471180|NCT00501969|1125464|P1|COMPLETED|Overall Study||189
471181|NCT00501969|1125464|P1|STARTED|Overall Study||395
471182|NCT00501943|1125472|P2|NOT COMPLETED|Overall Study||3
471183|NCT00501943|1125473|P1|NOT COMPLETED|Overall Study||2
471184|NCT00501943|1125472|P2|COMPLETED|Overall Study||18
471185|NCT00501943|1125473|P1|COMPLETED|Overall Study||20
471186|NCT00501943|1125472|P2|STARTED|Overall Study||21
471187|NCT00501943|1125473|P1|STARTED|Overall Study||22
471188|NCT00501891|1125489|P1|NOT COMPLETED|Overall Study||0
471189|NCT00501891|1125489|P1|COMPLETED|Overall Study||32
471190|NCT00501891|1125489|P1|STARTED|Overall Study||32
471191|NCT00501852|1125496|P1|NOT COMPLETED|Overall Study||5
471192|NCT00501852|1125496|P1|COMPLETED|Overall Study||78
471193|NCT00501852|1125496|P1|Tiotropium|Overall Study||55
471194|NCT00501852|1125496|P1|Placebo|Overall Study||55
471195|NCT00501852|1125496|P1|NVA237 100µg|Overall Study||54
471196|NCT00501852|1125496|P1|NVA237 50µg|Overall Study||53
471197|NCT00501852|1125496|P1|NVA237 25µg|Overall Study||51
471198|NCT00501852|1125496|P1|NVA237 12.5µg|Overall Study||55
471199|NCT00501852|1125496|P1|STARTED|Overall Study||83
471200|NCT00501644|1125516|P1|NOT COMPLETED|Overall Study||5
471201|NCT00501644|1125516|P1|COMPLETED|Overall Study||54
471202|NCT00501644|1125516|P1|STARTED|Overall Study||59
471203|NCT00501631|1125522|P2|NOT COMPLETED|Part B (Open-label Period)||51
471204|NCT00501631|1125523|P1|NOT COMPLETED|Part B (Open-label Period)||53
471205|NCT00501631|1125522|P2|COMPLETED|Part B (Open-label Period)||48
471206|NCT00501631|1125523|P1|COMPLETED|Part B (Open-label Period)||37
471207|NCT00501631|1125522|P2|STARTED|Part B (Open-label Period)||99
471208|NCT00501631|1125523|P1|STARTED|Part B (Open-label Period)||90
471209|NCT00501631|1125522|P2|NOT COMPLETED|Part A (Double-blind Period)||49
471210|NCT00501631|1125523|P1|NOT COMPLETED|Part A (Double-blind Period)||62
471211|NCT00501631|1125522|P2|COMPLETED|Part A (Double-blind Period)||99
471212|NCT00501631|1125523|P1|COMPLETED|Part A (Double-blind Period)||90
471213|NCT00501631|1125522|P2|STARTED|Part A (Double-blind Period)||148
471214|NCT00501631|1125523|P1|STARTED|Part A (Double-blind Period)||152
471215|NCT00501592|1125532|P3|NOT COMPLETED|Overall Study||3
471216|NCT00501592|1125533|P2|NOT COMPLETED|Overall Study||5
471217|NCT00501592|1125534|P1|NOT COMPLETED|Overall Study||0
471218|NCT00501592|1125532|P3|COMPLETED|Overall Study||20
471219|NCT00501592|1125533|P2|COMPLETED|Overall Study||16
471220|NCT00501592|1125534|P1|COMPLETED|Overall Study||20
471221|NCT00501592|1125532|P3|STARTED|Overall Study||23
471222|NCT00501592|1125533|P2|STARTED|Overall Study||21
471223|NCT00501592|1125534|P1|STARTED|Overall Study||20
471224|NCT00501540|1125545|P1|NOT COMPLETED|Overall Study||5
471225|NCT00501540|1125545|P1|COMPLETED|Overall Study||10
471226|NCT00501540|1125545|P1|STARTED|Overall Study||15
471227|NCT00501345|1125551|P1|NOT COMPLETED|Overall Study||0
471228|NCT00501345|1125551|P1|COMPLETED|Overall Study||5
471229|NCT00501345|1125551|P1|STARTED|Overall Study||5
471230|NCT00501293|1125557|P2|NOT COMPLETED|Maintenance Period||28
471231|NCT00501293|1125558|P1|NOT COMPLETED|Maintenance Period||46
471232|NCT00501293|1125557|P2|COMPLETED|Maintenance Period||25
471233|NCT00501293|1125558|P1|COMPLETED|Maintenance Period||63
471234|NCT00501293|1125557|P2|STARTED|Maintenance Period||53
471235|NCT00501293|1125558|P1|STARTED|Maintenance Period||109
471236|NCT00501293|1125557|P2|NOT COMPLETED|Optimization Period||0
471237|NCT00501293|1125558|P1|NOT COMPLETED|Optimization Period||1
471238|NCT00501293|1125557|P2|COMPLETED|Optimization Period||53
471239|NCT00501293|1125558|P1|COMPLETED|Optimization Period||109
471240|NCT00501293|1125557|P2|STARTED|Optimization Period||53
471241|NCT00501293|1125558|P1|STARTED|Optimization Period||110
471242|NCT00501228|1125585|P1|NOT COMPLETED|Overall Study||1
471243|NCT00501228|1125585|P1|COMPLETED|Overall Study||1
471244|NCT00501228|1125585|P1|STARTED|Overall Study||2
471245|NCT00501085|1125589|P1|NOT COMPLETED|Overall Study||432
471246|NCT00501085|1125589|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
471247|NCT00501085|1125589|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
471248|NCT00501046|1125599|P2|NOT COMPLETED|Overall Study||294
471249|NCT00501046|1125600|P1|NOT COMPLETED|Overall Study||270
471250|NCT00501046|1125599|P2|COMPLETED|Overall Study||213
471251|NCT00501046|1125600|P1|COMPLETED|Overall Study||238
471252|NCT00501046|1125599|P2|STARTED|Overall Study||507
471253|NCT00501046|1125600|P1|STARTED|Overall Study||508
471254|NCT00501007|1125606|P2|NOT COMPLETED|Overall Study||25
471255|NCT00501007|1125607|P1|NOT COMPLETED|Overall Study||29
471256|NCT00501007|1125606|P2|COMPLETED|Overall Study||78
471257|NCT00501007|1125607|P1|COMPLETED|Overall Study||71
471258|NCT00501007|1125606|P2|STARTED|Overall Study||103
471259|NCT00501007|1125607|P1|STARTED|Overall Study||100
471260|NCT00500760|1125615|P2|NOT COMPLETED|Overall Study||24
471261|NCT00500760|1125616|P1|NOT COMPLETED|Overall Study||43
471262|NCT00500760|1125615|P2|COMPLETED|Overall Study||40
471263|NCT00500760|1125616|P1|COMPLETED|Overall Study||46
471264|NCT00500760|1125615|P2|Received Treatment|Overall Study||63
471265|NCT00500760|1125616|P1|Received Treatment|Overall Study||87
471266|NCT00500760|1125615|P2|STARTED|Overall Study||64
471267|NCT00500760|1125616|P1|STARTED|Overall Study||89
471268|NCT00500682|1125636|P2|NOT COMPLETED|Overall Study||287
471269|NCT00500682|1125637|P1|NOT COMPLETED|Overall Study||306
471270|NCT00500682|1125636|P2|COMPLETED|Overall Study||223
471271|NCT00500682|1125637|P1|COMPLETED|Overall Study||204
471272|NCT00500682|1125636|P2|STARTED|Overall Study||510
471273|NCT00500682|1125637|P1|STARTED|Overall Study||510
471274|NCT00500656|1125647|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
471275|NCT00500656|1125648|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
471276|NCT00500656|1125649|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
471277|NCT00500656|1125650|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
471278|NCT00500656|1125647|P4|COMPLETED|Open Label Extension (OLE) Phase||6
471279|NCT00500656|1125648|P3|COMPLETED|Open Label Extension (OLE) Phase||1
471280|NCT00500656|1125649|P2|COMPLETED|Open Label Extension (OLE) Phase||9
471281|NCT00500656|1125650|P1|COMPLETED|Open Label Extension (OLE) Phase||16
471282|NCT00500656|1125647|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
471283|NCT00500656|1125648|P3|STARTED|Open Label Extension (OLE) Phase||2
471284|NCT00500656|1125649|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
471285|NCT00500656|1125650|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
471286|NCT00500656|1125647|P4|NOT COMPLETED|Controlled Phase||8
471287|NCT00500656|1125648|P3|NOT COMPLETED|Controlled Phase||1
471288|NCT00500656|1125649|P2|NOT COMPLETED|Controlled Phase||10
471289|NCT00500656|1125650|P1|NOT COMPLETED|Controlled Phase||10
471290|NCT00500656|1125647|P4|COMPLETED|Controlled Phase||0
471291|NCT00500656|1125648|P3|COMPLETED|Controlled Phase||2
471292|NCT00500656|1125649|P2|COMPLETED|Controlled Phase||28
471293|NCT00500656|1125650|P1|COMPLETED|Controlled Phase||26
471294|NCT00500656|1125647|P4|STARTED|Controlled Phase||8
471295|NCT00500656|1125648|P3|STARTED|Controlled Phase||3
471296|NCT00500656|1125649|P2|STARTED|Controlled Phase||38
471297|NCT00500656|1125650|P1|STARTED|Controlled Phase||36
471298|NCT00500578|1125664|P2|NOT COMPLETED|Overall Study||0
471299|NCT00500578|1125665|P1|NOT COMPLETED|Overall Study||0
471300|NCT00500578|1125664|P2|COMPLETED|Overall Study|All completed|32
471301|NCT00500578|1125665|P1|COMPLETED|Overall Study|All completed|18
471302|NCT00500578|1125664|P2|STARTED|Overall Study||32
471303|NCT00500578|1125665|P1|STARTED|Overall Study||18
471304|NCT00500539|1125671|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
471305|NCT00500539|1125671|P1|COMPLETED|Follow-up Period (16 Weeks)||136
471306|NCT00500539|1125671|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
471307|NCT00500539|1125671|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
471308|NCT00500539|1125671|P1|COMPLETED|Treatment Period (24 Weeks)||140
471309|NCT00500539|1125671|P1|STARTED|Treatment Period (24 Weeks)||155
471310|NCT00500448|1125680|P2|NOT COMPLETED|Overall Study||0
471311|NCT00500448|1125681|P1|NOT COMPLETED|Overall Study||0
471312|NCT00500448|1125680|P2|COMPLETED|Overall Study||16
471313|NCT00500448|1125681|P1|COMPLETED|Overall Study||14
471314|NCT00500448|1125680|P2|STARTED|Overall Study||16
471315|NCT00500448|1125681|P1|STARTED|Overall Study||14
471316|NCT00500370|1125697|P2|NOT COMPLETED|Overall Study||34
471317|NCT00500370|1125698|P1|NOT COMPLETED|Overall Study||33
471318|NCT00500370|1125697|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
471319|NCT00500370|1125698|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
471320|NCT00500370|1125697|P2|Treatment Complete (Week 24)|Overall Study||54
471321|NCT00500370|1125698|P1|Treatment Complete (Week 24)|Overall Study||48
471322|NCT00500370|1125697|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
471323|NCT00500370|1125698|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
471324|NCT00500370|1125697|P2|STARTED|Overall Study||83
471325|NCT00500370|1125698|P1|STARTED|Overall Study||80
471326|NCT00500357|1125734|P1|NOT COMPLETED|Overall Study||1
471327|NCT00500357|1125734|P1|COMPLETED|Overall Study||104
471328|NCT00500357|1125734|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
471329|NCT00500357|1125734|P1|Received 13vPnC (Vax 3)|Overall Study||105
471330|NCT00500357|1125734|P1|STARTED|Overall Study||105
471331|NCT00500318|1125755|P2|NOT COMPLETED|Overall Study||17
471332|NCT00500318|1125756|P1|NOT COMPLETED|Overall Study||5
471333|NCT00500318|1125755|P2|COMPLETED|Overall Study||78
471334|NCT00500318|1125756|P1|COMPLETED|Overall Study||81
471335|NCT00500318|1125755|P2|STARTED|Overall Study||95
471336|NCT00500318|1125756|P1|STARTED|Overall Study||86
471337|NCT00500292|1125773|P3|NOT COMPLETED|Overall Study||27
471338|NCT00500292|1125774|P2|NOT COMPLETED|Overall Study||31
471339|NCT00500292|1125775|P1|NOT COMPLETED|Overall Study||25
471340|NCT00500292|1125773|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|10
471341|NCT00500292|1125774|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|4
471342|NCT00500292|1125775|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
471343|NCT00500292|1125773|P3|STARTED|Overall Study|randomised patients|37
471344|NCT00500292|1125774|P2|STARTED|Overall Study|randomised patients|35
471345|NCT00500292|1125775|P1|STARTED|Overall Study|randomised patients|32
471346|NCT00500266|1125783|P1|NOT COMPLETED|Overall Study||13
471347|NCT00500266|1125783|P1|COMPLETED|Overall Study||1040
471348|NCT00500266|1125783|P1|Treated|Overall Study||1049
471349|NCT00500266|1125783|P1|STARTED|Overall Study||1053
471350|NCT00500240|1125792|P2|NOT COMPLETED|Overall Study||0
471351|NCT00500240|1125793|P1|NOT COMPLETED|Overall Study||0
471352|NCT00500240|1125792|P2|COMPLETED|Overall Study||26
471353|NCT00500240|1125793|P1|COMPLETED|Overall Study||25
471354|NCT00500240|1125792|P2|STARTED|Overall Study||26
471355|NCT00500240|1125793|P1|STARTED|Overall Study||25
471356|NCT00500149|1125803|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
471357|NCT00500149|1125804|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
471358|NCT00500149|1125803|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
471359|NCT00500149|1125804|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
471360|NCT00500149|1125803|P2|STARTED|Second Intervention (Cross-over Phase)||57
471361|NCT00500149|1125804|P1|STARTED|Second Intervention (Cross-over Phase)||56
471362|NCT00500149|1125803|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
471363|NCT00500149|1125804|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
471364|NCT00500149|1125803|P2|COMPLETED|First Intervention (Cross-over Phase)||57
471365|NCT00500149|1125804|P1|COMPLETED|First Intervention (Cross-over Phase)||56
471366|NCT00500149|1125803|P2|STARTED|First Intervention (Cross-over Phase)||59
471367|NCT00500149|1125804|P1|STARTED|First Intervention (Cross-over Phase)||58
471368|NCT00500149|1125803|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
471369|NCT00500149|1125804|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
471370|NCT00500149|1125803|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
471371|NCT00500149|1125804|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
471372|NCT00500149|1125803|P2|STARTED|Enrolled (Dose-optimization Phase)||0
471373|NCT00500149|1125804|P1|STARTED|Enrolled (Dose-optimization Phase)||129
471374|NCT00500110|1125812|P1|NOT COMPLETED|Overall Study||3
471375|NCT00500110|1125812|P1|COMPLETED|Overall Study||36
471376|NCT00500110|1125812|P1|STARTED|Overall Study||39
471377|NCT00500071|1125816|P1|NOT COMPLETED|30-day Safety Follow-up||17
471378|NCT00500071|1125816|P1|COMPLETED|30-day Safety Follow-up||278
471379|NCT00500071|1125816|P1|STARTED|30-day Safety Follow-up||295
471380|NCT00500071|1125816|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
471381|NCT00500071|1125816|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
471475|NCT00499369|1125989|P3|STARTED|Overall Study||17
471382|NCT00500071|1125816|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
471383|NCT00500071|1125816|P1|NOT COMPLETED|Screening and Washout Phase||1
471384|NCT00500071|1125816|P1|COMPLETED|Screening and Washout Phase||317
471385|NCT00500071|1125816|P1|STARTED|Screening and Washout Phase||318
471386|NCT00499915|1125827|P2|NOT COMPLETED|Overall Study||6
471387|NCT00499915|1125828|P1|NOT COMPLETED|Overall Study||15
471388|NCT00499915|1125827|P2|COMPLETED|Overall Study||76
471389|NCT00499915|1125828|P1|COMPLETED|Overall Study||68
471390|NCT00499915|1125827|P2|STARTED|Overall Study||82
471391|NCT00499915|1125828|P1|STARTED|Overall Study||83
471392|NCT00499889|1125834|P1|NOT COMPLETED|Overall Study||1
471393|NCT00499889|1125834|P1|COMPLETED|Overall Study||41
471394|NCT00499889|1125834|P1|STARTED|Overall Study||42
471395|NCT00499863|1125842|P2|NOT COMPLETED|Overall Study||43
471396|NCT00499863|1125843|P1|NOT COMPLETED|Overall Study||50
471397|NCT00499863|1125842|P2|COMPLETED|Overall Study||29
471398|NCT00499863|1125843|P1|COMPLETED|Overall Study||95
471399|NCT00499863|1125842|P2|STARTED|Overall Study||72
471400|NCT00499863|1125843|P1|STARTED|Overall Study||145
471401|NCT00499694|1125871|P1|NOT COMPLETED|Overall Study||1
471402|NCT00499694|1125871|P1|COMPLETED|Overall Study||30
471403|NCT00499694|1125871|P1|STARTED|Overall Study||31
471404|NCT00499681|1125877|P2|NOT COMPLETED|Overall Study||2
471405|NCT00499681|1125878|P1|NOT COMPLETED|Overall Study||0
471406|NCT00499681|1125877|P2|COMPLETED|Overall Study||0
471407|NCT00499681|1125878|P1|COMPLETED|Overall Study||4
471408|NCT00499681|1125877|P2|STARTED|Overall Study||2
471409|NCT00499681|1125878|P1|STARTED|Overall Study||4
471410|NCT00499655|1125886|P2|NOT COMPLETED|Overall Study||0
471411|NCT00499655|1125887|P1|NOT COMPLETED|Overall Study||0
471412|NCT00499655|1125886|P2|COMPLETED|Overall Study||54
471413|NCT00499655|1125887|P1|COMPLETED|Overall Study||53
471414|NCT00499655|1125886|P2|STARTED|Overall Study||54
471415|NCT00499655|1125887|P1|STARTED|Overall Study||53
471416|NCT00499603|1125903|P2|NOT COMPLETED|Overall Study||1
471417|NCT00499603|1125904|P1|NOT COMPLETED|Overall Study||0
471418|NCT00499603|1125903|P2|COMPLETED|Overall Study||22
471419|NCT00499603|1125904|P1|COMPLETED|Overall Study||27
471420|NCT00499603|1125903|P2|STARTED|Overall Study||23
471421|NCT00499603|1125904|P1|STARTED|Overall Study||27
471422|NCT00499590|1125917|P3|NOT COMPLETED|Overall Study||113
471423|NCT00499590|1125918|P2|NOT COMPLETED|Overall Study||112
471424|NCT00499590|1125919|P1|NOT COMPLETED|Overall Study||113
471425|NCT00499590|1125917|P3|COMPLETED|Overall Study||0
471426|NCT00499590|1125918|P2|COMPLETED|Overall Study||0
471427|NCT00499590|1125919|P1|COMPLETED|Overall Study||0
471428|NCT00499590|1125917|P3|STARTED|Overall Study||113
471429|NCT00499590|1125918|P2|STARTED|Overall Study||112
471430|NCT00499590|1125919|P1|STARTED|Overall Study||113
471431|NCT00499486|1125930|P1|NOT COMPLETED|Overall Study||16
471432|NCT00499486|1125930|P1|COMPLETED|Overall Study||31
471433|NCT00499486|1125930|P1|STARTED|Overall Study||47
471434|NCT00499473|1125938|P2|NOT COMPLETED|Overall Study||0
471435|NCT00499473|1125939|P1|NOT COMPLETED|Overall Study||6
471436|NCT00499473|1125938|P2|COMPLETED|Overall Study||4
471437|NCT00499473|1125939|P1|COMPLETED|Overall Study|Patients evaluable|21
471438|NCT00499473|1125938|P2|STARTED|Overall Study||4
471439|NCT00499473|1125939|P1|STARTED|Overall Study||27
471440|NCT00499460|1125957|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
471441|NCT00499460|1125958|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
471442|NCT00499460|1125957|P2|COMPLETED|Intervention 2 (30 Days)||6
471443|NCT00499460|1125958|P1|COMPLETED|Intervention 2 (30 Days)||6
471444|NCT00499460|1125957|P2|STARTED|Intervention 2 (30 Days)||7
471445|NCT00499460|1125958|P1|STARTED|Intervention 2 (30 Days)||6
471446|NCT00499460|1125957|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
471447|NCT00499460|1125958|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
471448|NCT00499460|1125957|P2|COMPLETED|Intervention 1 (30 Days)||7
471449|NCT00499460|1125958|P1|COMPLETED|Intervention 1 (30 Days)||6
471450|NCT00499460|1125957|P2|STARTED|Intervention 1 (30 Days)||7
471451|NCT00499460|1125958|P1|STARTED|Intervention 1 (30 Days)||8
471452|NCT00499447|1125974|P1|NOT COMPLETED|Overall Study||0
471453|NCT00499447|1125974|P1|COMPLETED|Overall Study||13
471454|NCT00499447|1125974|P1|STARTED|Overall Study||13
471455|NCT00499408|1125978|P1|NOT COMPLETED|Overall Study||0
471456|NCT00499408|1125978|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
471457|NCT00499408|1125978|P1|STARTED|Overall Study||26
471458|NCT00499369|1125987|P5|NOT COMPLETED|Overall Study||12
471459|NCT00499369|1125988|P4|NOT COMPLETED|Overall Study||9
471460|NCT00499369|1125989|P3|NOT COMPLETED|Overall Study||17
471461|NCT00499369|1125990|P2|NOT COMPLETED|Overall Study||18
471462|NCT00499369|1125991|P1|NOT COMPLETED|Overall Study||16
471463|NCT00499369|1125987|P5|COMPLETED|Overall Study||0
471464|NCT00499369|1125988|P4|COMPLETED|Overall Study||0
471465|NCT00499369|1125989|P3|COMPLETED|Overall Study||0
471466|NCT00499369|1125990|P2|COMPLETED|Overall Study||0
471467|NCT00499369|1125991|P1|COMPLETED|Overall Study||0
471468|NCT00499369|1125987|P5|Eligible|Overall Study||12
471469|NCT00499369|1125988|P4|Eligible|Overall Study||8
471470|NCT00499369|1125989|P3|Eligible|Overall Study||16
471471|NCT00499369|1125990|P2|Eligible|Overall Study||16
471472|NCT00499369|1125991|P1|Eligible|Overall Study||14
471473|NCT00499369|1125987|P5|STARTED|Overall Study||12
471474|NCT00499369|1125988|P4|STARTED|Overall Study||9
471476|NCT00499369|1125990|P2|STARTED|Overall Study||18
471477|NCT00499369|1125991|P1|STARTED|Overall Study||16
471478|NCT00499343|1126020|P2|NOT COMPLETED|Overall Study||0
471479|NCT00499343|1126021|P1|NOT COMPLETED|Overall Study||0
471480|NCT00499343|1126020|P2|COMPLETED|Overall Study||43
471481|NCT00499343|1126021|P1|COMPLETED|Overall Study||41
471482|NCT00499343|1126020|P2|STARTED|Overall Study||43
471483|NCT00499343|1126021|P1|STARTED|Overall Study||41
471484|NCT00499252|1126027|P1|NOT COMPLETED|Overall Study||12
471485|NCT00499252|1126027|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
471486|NCT00499252|1126027|P1|STARTED|Overall Study||51
471487|NCT00499122|1126033|P1|NOT COMPLETED|Overall Study||2
471488|NCT00499122|1126033|P1|COMPLETED|Overall Study||39
471489|NCT00499122|1126033|P1|STARTED|Overall Study||41
471490|NCT00499109|1126040|P2|NOT COMPLETED|Overall Study||7
471491|NCT00499109|1126041|P1|NOT COMPLETED|Overall Study||18
471492|NCT00499109|1126040|P2|COMPLETED|Overall Study||85
471493|NCT00499109|1126041|P1|COMPLETED|Overall Study||165
471494|NCT00499109|1126040|P2|STARTED|Overall Study||92
471495|NCT00499109|1126041|P1|STARTED|Overall Study||183
471496|NCT00499096|1126056|P2|NOT COMPLETED|Overall Study||20
471497|NCT00499096|1126057|P1|NOT COMPLETED|Overall Study||23
471498|NCT00499096|1126056|P2|COMPLETED|Overall Study||40
471499|NCT00499096|1126057|P1|COMPLETED|Overall Study||35
471500|NCT00499096|1126056|P2|STARTED|Overall Study||60
471501|NCT00499096|1126057|P1|STARTED|Overall Study||58
471502|NCT00499031|1126075|P1|NOT COMPLETED|Overall Study||3
471503|NCT00499031|1126075|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
471504|NCT00499031|1126075|P1|STARTED|Overall Study|Total number participants enrolled on study|38
471505|NCT00498940|1126082|P2|NOT COMPLETED|Overall Study||0
471506|NCT00498940|1126083|P1|NOT COMPLETED|Overall Study||0
471507|NCT00498940|1126082|P2|COMPLETED|Overall Study||31
471508|NCT00498940|1126083|P1|COMPLETED|Overall Study||30
471509|NCT00498940|1126082|P2|STARTED|Overall Study||31
471510|NCT00498940|1126083|P1|STARTED|Overall Study||30
471511|NCT00498927|1126089|P1|NOT COMPLETED|Overall Study||0
471512|NCT00498927|1126089|P1|COMPLETED|Overall Study||47
471513|NCT00498927|1126089|P1|STARTED|Overall Study||47
471514|NCT00498797|1126096|P2|NOT COMPLETED|Overall Study||29
471515|NCT00498797|1126097|P1|NOT COMPLETED|Overall Study||38
471516|NCT00498797|1126096|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
471517|NCT00498797|1126097|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
471518|NCT00498797|1126096|P2|STARTED|Overall Study|randomised patients|43
471519|NCT00498797|1126097|P1|STARTED|Overall Study|randomised patients|43
471520|NCT00497770|1126109|P4|NOT COMPLETED|Overall Study||0
471521|NCT00497770|1126110|P3|NOT COMPLETED|Overall Study||0
471522|NCT00497770|1126111|P2|NOT COMPLETED|Overall Study||0
471523|NCT00497770|1126112|P1|NOT COMPLETED|Overall Study||0
471524|NCT00497770|1126109|P4|COMPLETED|Overall Study||28
471525|NCT00497770|1126110|P3|COMPLETED|Overall Study||37
471526|NCT00497770|1126111|P2|COMPLETED|Overall Study||65
471527|NCT00497770|1126112|P1|COMPLETED|Overall Study||304
471528|NCT00497770|1126109|P4|STARTED|Overall Study||28
471529|NCT00497770|1126110|P3|STARTED|Overall Study||37
471530|NCT00497770|1126111|P2|STARTED|Overall Study||65
471531|NCT00497770|1126112|P1|STARTED|Overall Study||304
471532|NCT00498706|1126164|P2|NOT COMPLETED|Overall Study||0
471533|NCT00498706|1126165|P1|NOT COMPLETED|Overall Study||0
471534|NCT00498706|1126164|P2|COMPLETED|Overall Study||162
471535|NCT00498706|1126165|P1|COMPLETED|Overall Study||163
471536|NCT00498706|1126164|P2|Post Treatment Week 18|Overall Study||162
471537|NCT00498706|1126165|P1|Post Treatment Week 18|Overall Study||163
471538|NCT00498706|1126164|P2|STARTED|Overall Study||162
471539|NCT00498706|1126165|P1|STARTED|Overall Study||163
471540|NCT00498628|1126179|P2|NOT COMPLETED|Overall Study||21
471541|NCT00498628|1126180|P1|NOT COMPLETED|Overall Study||15
471542|NCT00498628|1126179|P2|COMPLETED|Overall Study||92
471543|NCT00498628|1126180|P1|COMPLETED|Overall Study||90
471544|NCT00498628|1126179|P2|STARTED|Overall Study||113
471545|NCT00498628|1126180|P1|STARTED|Overall Study||105
471546|NCT00498615|1126186|P6|NOT COMPLETED|Placebo||0
471547|NCT00498615|1126187|P5|NOT COMPLETED|Placebo||0
471548|NCT00498615|1126188|P4|NOT COMPLETED|Placebo||0
471549|NCT00498615|1126189|P3|NOT COMPLETED|Placebo||0
471550|NCT00498615|1126190|P2|NOT COMPLETED|Placebo||0
471551|NCT00498615|1126191|P1|NOT COMPLETED|Placebo||0
471552|NCT00498615|1126186|P6|COMPLETED|Placebo||3
471553|NCT00498615|1126187|P5|COMPLETED|Placebo||3
471554|NCT00498615|1126188|P4|COMPLETED|Placebo||2
471555|NCT00498615|1126189|P3|COMPLETED|Placebo||3
471556|NCT00498615|1126190|P2|COMPLETED|Placebo||4
471557|NCT00498615|1126191|P1|COMPLETED|Placebo||2
471558|NCT00498615|1126186|P6|STARTED|Placebo||3
471559|NCT00498615|1126187|P5|STARTED|Placebo||3
471560|NCT00498615|1126188|P4|STARTED|Placebo||2
471561|NCT00498615|1126189|P3|STARTED|Placebo||3
471562|NCT00498615|1126190|P2|STARTED|Placebo||4
471563|NCT00498615|1126191|P1|STARTED|Placebo||2
471564|NCT00498615|1126186|P6|NOT COMPLETED|Fasudil 40mg||0
471565|NCT00498615|1126187|P5|NOT COMPLETED|Fasudil 40mg||0
471566|NCT00498615|1126188|P4|NOT COMPLETED|Fasudil 40mg||0
471567|NCT00498615|1126189|P3|NOT COMPLETED|Fasudil 40mg||0
471568|NCT00498615|1126190|P2|NOT COMPLETED|Fasudil 40mg||0
471569|NCT00498615|1126191|P1|NOT COMPLETED|Fasudil 40mg||0
471570|NCT00498615|1126186|P6|COMPLETED|Fasudil 40mg||3
471571|NCT00498615|1126187|P5|COMPLETED|Fasudil 40mg||3
471572|NCT00498615|1126188|P4|COMPLETED|Fasudil 40mg||2
471573|NCT00498615|1126189|P3|COMPLETED|Fasudil 40mg||3
471574|NCT00498615|1126190|P2|COMPLETED|Fasudil 40mg||4
471575|NCT00498615|1126191|P1|COMPLETED|Fasudil 40mg||2
471576|NCT00498615|1126186|P6|STARTED|Fasudil 40mg||3
471577|NCT00498615|1126187|P5|STARTED|Fasudil 40mg||3
471578|NCT00498615|1126188|P4|STARTED|Fasudil 40mg||2
471579|NCT00498615|1126189|P3|STARTED|Fasudil 40mg||3
471580|NCT00498615|1126190|P2|STARTED|Fasudil 40mg||4
471581|NCT00498615|1126191|P1|STARTED|Fasudil 40mg||2
471582|NCT00498615|1126186|P6|NOT COMPLETED|Fasudil 80mg||0
471583|NCT00498615|1126187|P5|NOT COMPLETED|Fasudil 80mg||0
471584|NCT00498615|1126188|P4|NOT COMPLETED|Fasudil 80mg||0
471585|NCT00498615|1126189|P3|NOT COMPLETED|Fasudil 80mg||0
471586|NCT00498615|1126190|P2|NOT COMPLETED|Fasudil 80mg||0
471587|NCT00498615|1126191|P1|NOT COMPLETED|Fasudil 80mg||0
471588|NCT00498615|1126186|P6|COMPLETED|Fasudil 80mg||3
471589|NCT00498615|1126187|P5|COMPLETED|Fasudil 80mg||3
471590|NCT00498615|1126188|P4|COMPLETED|Fasudil 80mg||2
471591|NCT00498615|1126189|P3|COMPLETED|Fasudil 80mg||3
471592|NCT00498615|1126190|P2|COMPLETED|Fasudil 80mg||4
471593|NCT00498615|1126191|P1|COMPLETED|Fasudil 80mg||2
471594|NCT00498615|1126186|P6|STARTED|Fasudil 80mg||3
471595|NCT00498615|1126187|P5|STARTED|Fasudil 80mg||3
471596|NCT00498615|1126188|P4|STARTED|Fasudil 80mg||2
471597|NCT00498615|1126189|P3|STARTED|Fasudil 80mg||3
471598|NCT00498615|1126190|P2|STARTED|Fasudil 80mg||4
471599|NCT00498615|1126191|P1|STARTED|Fasudil 80mg||2
471600|NCT00498602|1126212|P7|NOT COMPLETED|Overall Study||2
471601|NCT00498602|1126213|P6|NOT COMPLETED|Overall Study||13
471602|NCT00498602|1126214|P5|NOT COMPLETED|Overall Study||4
471603|NCT00498602|1126215|P4|NOT COMPLETED|Overall Study||5
471604|NCT00498602|1126216|P3|NOT COMPLETED|Overall Study||8
471605|NCT00498602|1126217|P2|NOT COMPLETED|Overall Study||10
471606|NCT00498602|1126218|P1|NOT COMPLETED|Overall Study||10
471607|NCT00498602|1126212|P7|COMPLETED|Overall Study||15
471608|NCT00498602|1126213|P6|COMPLETED|Overall Study||31
471609|NCT00498602|1126214|P5|COMPLETED|Overall Study||8
471610|NCT00498602|1126215|P4|COMPLETED|Overall Study||30
471611|NCT00498602|1126216|P3|COMPLETED|Overall Study||32
471612|NCT00498602|1126217|P2|COMPLETED|Overall Study||51
471613|NCT00498602|1126218|P1|COMPLETED|Overall Study||26
471614|NCT00498602|1126212|P7|Treated|Overall Study||17
471615|NCT00498602|1126213|P6|Treated|Overall Study||44
471616|NCT00498602|1126214|P5|Treated|Overall Study||12
471617|NCT00498602|1126215|P4|Treated|Overall Study||35
471618|NCT00498602|1126216|P3|Treated|Overall Study||40
471619|NCT00498602|1126217|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
471620|NCT00498602|1126218|P1|Treated|Overall Study||36
471621|NCT00498602|1126212|P7|STARTED|Overall Study||17
471622|NCT00498602|1126213|P6|STARTED|Overall Study||44
471623|NCT00498602|1126214|P5|STARTED|Overall Study||12
471624|NCT00498602|1126215|P4|STARTED|Overall Study||35
471625|NCT00498602|1126216|P3|STARTED|Overall Study||40
471626|NCT00498602|1126217|P2|STARTED|Overall Study||61
471627|NCT00498602|1126218|P1|STARTED|Overall Study||36
471628|NCT00498550|1126257|P2|NOT COMPLETED|Overall Study||1
471629|NCT00498550|1126258|P1|NOT COMPLETED|Overall Study||0
471630|NCT00498550|1126257|P2|COMPLETED|Overall Study||15
471631|NCT00498550|1126258|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
471632|NCT00498550|1126257|P2|STARTED|Overall Study||16
471633|NCT00498550|1126258|P1|STARTED|Overall Study||15
471634|NCT00498485|1126266|P2|NOT COMPLETED|Overall Study||5
471635|NCT00498485|1126267|P1|NOT COMPLETED|Overall Study||1
471636|NCT00498485|1126266|P2|COMPLETED|Overall Study||5
471637|NCT00498485|1126267|P1|COMPLETED|Overall Study||6
471638|NCT00498485|1126266|P2|STARTED|Overall Study||10
471639|NCT00498485|1126267|P1|STARTED|Overall Study||7
471640|NCT00498433|1126278|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
471641|NCT00498433|1126279|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
471642|NCT00498433|1126280|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
471643|NCT00498433|1126278|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
471644|NCT00498433|1126279|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
471645|NCT00498433|1126280|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
471646|NCT00498433|1126278|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
471647|NCT00498433|1126279|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
471648|NCT00498433|1126280|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
471649|NCT00498433|1126278|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
471650|NCT00498433|1126279|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
471651|NCT00498433|1126280|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
471652|NCT00498433|1126278|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
471653|NCT00498433|1126279|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
471654|NCT00498433|1126280|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
471655|NCT00498433|1126278|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
471656|NCT00498433|1126279|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
471657|NCT00498433|1126280|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
471658|NCT00498433|1126278|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471659|NCT00498433|1126279|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471660|NCT00498433|1126280|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471661|NCT00498433|1126278|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
471662|NCT00498433|1126279|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471663|NCT00498433|1126280|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471664|NCT00498433|1126278|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
471665|NCT00498433|1126279|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471666|NCT00498433|1126280|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
471667|NCT00498433|1126278|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471668|NCT00498433|1126279|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471669|NCT00498433|1126280|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471670|NCT00498433|1126278|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471671|NCT00498433|1126279|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
471672|NCT00498433|1126280|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471673|NCT00498433|1126278|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471674|NCT00498433|1126279|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
471675|NCT00498433|1126280|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
471676|NCT00498433|1126278|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471677|NCT00498433|1126279|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471678|NCT00498433|1126280|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471679|NCT00498433|1126278|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471680|NCT00498433|1126279|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471681|NCT00498433|1126280|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
471682|NCT00498433|1126278|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471683|NCT00498433|1126279|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
471684|NCT00498433|1126280|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
471685|NCT00498368|1126325|P2|NOT COMPLETED|Overall Study||2
471686|NCT00498368|1126326|P1|NOT COMPLETED|Overall Study||3
471687|NCT00498368|1126325|P2|COMPLETED|Overall Study||15
471688|NCT00498368|1126326|P1|COMPLETED|Overall Study||14
471689|NCT00498368|1126325|P2|STARTED|Overall Study||17
471690|NCT00498368|1126326|P1|STARTED|Overall Study||17
471691|NCT00498355|1126338|P1|NOT COMPLETED|Overall Study||1
471692|NCT00498355|1126338|P1|COMPLETED|Overall Study||6
471693|NCT00498355|1126338|P1|STARTED|Overall Study||7
471694|NCT00498186|1126342|P1|NOT COMPLETED|Overall Study||173
471695|NCT00498186|1126342|P1|COMPLETED|Overall Study||122
471696|NCT00498186|1126342|P1|STARTED|Overall Study||295
471697|NCT00497874|1126349|P2|NOT COMPLETED|Overall Study||116
471698|NCT00497874|1126350|P1|NOT COMPLETED|Overall Study||147
471699|NCT00497874|1126349|P2|COMPLETED|Overall Study||343
471700|NCT00497874|1126350|P1|COMPLETED|Overall Study||296
471701|NCT00497874|1126349|P2|STARTED|Overall Study||459
471702|NCT00497874|1126350|P1|STARTED|Overall Study||443
471703|NCT00497796|1126368|P2|NOT COMPLETED|Overall Study||59
471704|NCT00497796|1126369|P1|NOT COMPLETED|Overall Study||85
471705|NCT00497796|1126368|P2|COMPLETED|Overall Study||101
471706|NCT00497796|1126369|P1|COMPLETED|Overall Study||62
471707|NCT00497796|1126368|P2|STARTED|Overall Study||160
471708|NCT00497796|1126369|P1|STARTED|Overall Study||147
471709|NCT00497198|1126399|P2|NOT COMPLETED|Overall Study||5
471710|NCT00497198|1126400|P1|NOT COMPLETED|Overall Study||5
471711|NCT00497198|1126399|P2|COMPLETED|Overall Study||86
471712|NCT00497198|1126400|P1|COMPLETED|Overall Study||87
471713|NCT00497198|1126399|P2|STARTED|Overall Study||91
471714|NCT00497198|1126400|P1|STARTED|Overall Study||92
471715|NCT00497146|1126416|P2|NOT COMPLETED|Long-term Follow-up Period||6
471716|NCT00497146|1126417|P1|NOT COMPLETED|Long-term Follow-up Period||15
471717|NCT00497146|1126416|P2|COMPLETED|Long-term Follow-up Period||66
471718|NCT00497146|1126417|P1|COMPLETED|Long-term Follow-up Period||50
471719|NCT00497146|1126416|P2|STARTED|Long-term Follow-up Period||72
471720|NCT00497146|1126417|P1|STARTED|Long-term Follow-up Period||65
471721|NCT00497146|1126416|P2|NOT COMPLETED|Treatment Period||21
471722|NCT00497146|1126417|P1|NOT COMPLETED|Treatment Period||27
471723|NCT00497146|1126416|P2|COMPLETED|Treatment Period||91
471724|NCT00497146|1126417|P1|COMPLETED|Treatment Period||88
471725|NCT00497146|1126416|P2|STARTED|Treatment Period||112
471726|NCT00497146|1126417|P1|STARTED|Treatment Period||115
471727|NCT00497081|1126459|P2|NOT COMPLETED|Overall Study||2
471728|NCT00497081|1126460|P1|NOT COMPLETED|Overall Study||2
471729|NCT00497081|1126459|P2|COMPLETED|Overall Study||28
471730|NCT00497081|1126460|P1|COMPLETED|Overall Study||28
471731|NCT00497081|1126459|P2|STARTED|Overall Study||30
471732|NCT00497081|1126460|P1|STARTED|Overall Study||30
471733|NCT00497055|1126472|P2|NOT COMPLETED|Overall Study||5
471734|NCT00497055|1126473|P1|NOT COMPLETED|Overall Study||10
471735|NCT00497055|1126472|P2|COMPLETED|Overall Study||40
471736|NCT00497055|1126473|P1|COMPLETED|Overall Study||35
471737|NCT00497055|1126472|P2|STARTED|Overall Study||45
471738|NCT00497055|1126473|P1|STARTED|Overall Study||45
471739|NCT00496964|1126485|P2|NOT COMPLETED|Overall Study||1
471740|NCT00496964|1126486|P1|NOT COMPLETED|Overall Study||0
471741|NCT00496964|1126485|P2|COMPLETED|Overall Study||3
471742|NCT00496964|1126486|P1|COMPLETED|Overall Study||1
471743|NCT00496964|1126485|P2|STARTED|Overall Study||4
471744|NCT00496964|1126486|P1|STARTED|Overall Study||1
471745|NCT00496873|1126494|P1|NOT COMPLETED|Overall Study||7
471746|NCT00496873|1126494|P1|COMPLETED|Overall Study||78
471747|NCT00496873|1126494|P1|STARTED|Overall Study||85
471748|NCT00496860|1126503|P3|NOT COMPLETED|Overall Study||0
471749|NCT00496860|1126504|P2|NOT COMPLETED|Overall Study||1
471750|NCT00496860|1126505|P1|NOT COMPLETED|Overall Study||1
471751|NCT00496860|1126503|P3|COMPLETED|Overall Study||6
471752|NCT00496860|1126504|P2|COMPLETED|Overall Study||15
471753|NCT00496860|1126505|P1|COMPLETED|Overall Study||3
471754|NCT00496860|1126503|P3|STARTED|Overall Study||6
471755|NCT00496860|1126504|P2|STARTED|Overall Study||16
471756|NCT00496860|1126505|P1|STARTED|Overall Study||4
471757|NCT00496834|1126527|P2|NOT COMPLETED|Overall Study||13
471758|NCT00496834|1126528|P1|NOT COMPLETED|Overall Study||18
471759|NCT00496834|1126527|P2|COMPLETED|Overall Study||87
471760|NCT00496834|1126528|P1|COMPLETED|Overall Study||83
471761|NCT00496834|1126527|P2|STARTED|Overall Study||100
471762|NCT00496834|1126528|P1|STARTED|Overall Study||101
471763|NCT00496808|1126540|P1|NOT COMPLETED|Overall Study||0
471764|NCT00496808|1126540|P1|COMPLETED|Overall Study||69
471765|NCT00496808|1126540|P1|STARTED|Overall Study||69
471766|NCT00496782|1126547|P2|NOT COMPLETED|Overall Study||2
471767|NCT00496782|1126548|P1|NOT COMPLETED|Overall Study||1
471768|NCT00496782|1126547|P2|COMPLETED|Overall Study||5
471769|NCT00496782|1126548|P1|COMPLETED|Overall Study||8
471770|NCT00496782|1126547|P2|STARTED|Overall Study||7
471771|NCT00496782|1126548|P1|STARTED|Overall Study||9
471772|NCT00496769|1126582|P2|NOT COMPLETED|Overall Study||649
471773|NCT00496769|1126583|P1|NOT COMPLETED|Overall Study||558
471774|NCT00496769|1126582|P2|COMPLETED|Overall Study||2142
471775|NCT00496769|1126583|P1|COMPLETED|Overall Study||2249
471776|NCT00496769|1126582|P2|Received Treatment|Overall Study||2708
471777|NCT00496769|1126583|P1|Received Treatment|Overall Study||2798
471778|NCT00496769|1126582|P2|STARTED|Overall Study|Randomized|2791
471779|NCT00496769|1126583|P1|STARTED|Overall Study|Randomized|2807
471780|NCT00496730|1126607|P2|NOT COMPLETED|Overall Study||5
471781|NCT00496730|1126608|P1|NOT COMPLETED|Overall Study||6
471782|NCT00496730|1126607|P2|COMPLETED|Overall Study||121
471783|NCT00496730|1126608|P1|COMPLETED|Overall Study||124
471784|NCT00496730|1126607|P2|STARTED|Overall Study||126
471785|NCT00496730|1126608|P1|STARTED|Overall Study||130
471786|NCT00496626|1126620|P2|NOT COMPLETED|Overall Study||6
471787|NCT00496626|1126621|P1|NOT COMPLETED|Overall Study||6
471788|NCT00496626|1126620|P2|COMPLETED|Overall Study||292
471789|NCT00496626|1126621|P1|COMPLETED|Overall Study||296
471790|NCT00496626|1126620|P2|STARTED|Overall Study||298
471791|NCT00496626|1126621|P1|STARTED|Overall Study||302
471792|NCT00496483|1126633|P1|NOT COMPLETED|Overall Study||12
471793|NCT00496483|1126633|P1|COMPLETED|Overall Study||48
471794|NCT00496483|1126633|P1|Dosed|Overall Study||51
471795|NCT00496483|1126633|P1|STARTED|Overall Study||60
471796|NCT00496470|1126650|P2|NOT COMPLETED|Overall Study||29
471797|NCT00496470|1126651|P1|NOT COMPLETED|Overall Study||26
471798|NCT00496470|1126650|P2|COMPLETED|Overall Study||302
471799|NCT00496470|1126651|P1|COMPLETED|Overall Study||303
471800|NCT00496470|1126650|P2|Received Study Medication|Overall Study||330
471801|NCT00496470|1126651|P1|Received Study Medication|Overall Study||329
471802|NCT00496470|1126650|P2|STARTED|Overall Study||331
471803|NCT00496470|1126651|P1|STARTED|Overall Study||329
471804|NCT00496379|1126729|P1|NOT COMPLETED|Overall Study||0
471805|NCT00496379|1126729|P1|COMPLETED|Overall Study||15
471806|NCT00496379|1126729|P1|STARTED|Overall Study||15
471807|NCT00496366|1126737|P1|NOT COMPLETED|Overall Study||1
471808|NCT00496366|1126737|P1|COMPLETED|Overall Study||10
471809|NCT00496366|1126737|P1|STARTED|Overall Study||11
471810|NCT00496340|1126742|P1|NOT COMPLETED|Overall Study||0
471811|NCT00496340|1126742|P1|COMPLETED|Overall Study||42
471812|NCT00496340|1126742|P1|STARTED|Overall Study||42
471813|NCT00496262|1126755|P1|NOT COMPLETED|Overall Study||0
471814|NCT00496262|1126755|P1|COMPLETED|Overall Study||15
471815|NCT00496262|1126755|P1|STARTED|Overall Study||15
471816|NCT00496197|1126768|P1|NOT COMPLETED|Overall Study||122
471817|NCT00496197|1126768|P1|COMPLETED|Overall Study||160
471818|NCT00496197|1126768|P1|STARTED|Overall Study||282
471819|NCT00496080|1126795|P1|NOT COMPLETED|Overall Study||27
471820|NCT00496080|1126795|P1|COMPLETED|Overall Study||60
471821|NCT00496080|1126795|P1|STARTED|Overall Study||87
471822|NCT00496054|1126805|P1|NOT COMPLETED|Overall Study||8
471823|NCT00496054|1126805|P1|COMPLETED|Overall Study||102
471824|NCT00496054|1126805|P1|STARTED|Overall Study||110
471825|NCT00495820|1126834|P2|NOT COMPLETED|Overall Study||1
471826|NCT00495820|1126835|P1|NOT COMPLETED|Overall Study||1
471827|NCT00495820|1126834|P2|COMPLETED|Overall Study||29
471828|NCT00495820|1126835|P1|COMPLETED|Overall Study||29
471829|NCT00495820|1126834|P2|STARTED|Overall Study||30
471830|NCT00495820|1126835|P1|STARTED|Overall Study||30
471831|NCT00495794|1126847|P2|NOT COMPLETED|Overall Study||0
471832|NCT00495794|1126848|P1|NOT COMPLETED|Overall Study||522
471833|NCT00495794|1126847|P2|COMPLETED|Overall Study||2303
471834|NCT00495794|1126848|P1|COMPLETED|Overall Study||1797
471835|NCT00495794|1126847|P2|STARTED|Overall Study||2303
471836|NCT00495794|1126848|P1|STARTED|Overall Study||2319
471837|NCT00495755|1126858|P1|NOT COMPLETED|Overall Study||3
471838|NCT00495755|1126858|P1|COMPLETED|Overall Study||10
471839|NCT00495755|1126858|P1|STARTED|Overall Study||13
471840|NCT00495677|1126870|P7|NOT COMPLETED|Stage 2 (25 Days)||0
471841|NCT00495677|1126871|P6|NOT COMPLETED|Stage 2 (25 Days)||0
471842|NCT00495677|1126872|P5|NOT COMPLETED|Stage 2 (25 Days)||0
471843|NCT00495677|1126873|P4|NOT COMPLETED|Stage 2 (25 Days)||0
471844|NCT00495677|1126874|P3|NOT COMPLETED|Stage 2 (25 Days)||0
471845|NCT00495677|1126875|P2|NOT COMPLETED|Stage 2 (25 Days)||0
471846|NCT00495677|1126876|P1|NOT COMPLETED|Stage 2 (25 Days)||0
471847|NCT00495677|1126870|P7|COMPLETED|Stage 2 (25 Days)||7
471848|NCT00495677|1126871|P6|COMPLETED|Stage 2 (25 Days)||8
471849|NCT00495677|1126872|P5|COMPLETED|Stage 2 (25 Days)||8
471850|NCT00495677|1126873|P4|COMPLETED|Stage 2 (25 Days)||0
471851|NCT00495677|1126874|P3|COMPLETED|Stage 2 (25 Days)||0
471852|NCT00495677|1126875|P2|COMPLETED|Stage 2 (25 Days)||0
471853|NCT00495677|1126876|P1|COMPLETED|Stage 2 (25 Days)||0
471854|NCT00495677|1126870|P7|STARTED|Stage 2 (25 Days)||7
471855|NCT00495677|1126871|P6|STARTED|Stage 2 (25 Days)||8
471856|NCT00495677|1126872|P5|STARTED|Stage 2 (25 Days)||8
471857|NCT00495677|1126873|P4|STARTED|Stage 2 (25 Days)||0
471858|NCT00495677|1126874|P3|STARTED|Stage 2 (25 Days)||0
471859|NCT00495677|1126875|P2|STARTED|Stage 2 (25 Days)||0
471860|NCT00495677|1126876|P1|STARTED|Stage 2 (25 Days)||0
471861|NCT00495677|1126870|P7|NOT COMPLETED|Stage 1 (25 Days)||0
471862|NCT00495677|1126871|P6|NOT COMPLETED|Stage 1 (25 Days)||0
471863|NCT00495677|1126872|P5|NOT COMPLETED|Stage 1 (25 Days)||0
471864|NCT00495677|1126873|P4|NOT COMPLETED|Stage 1 (25 Days)||0
471865|NCT00495677|1126874|P3|NOT COMPLETED|Stage 1 (25 Days)||1
471866|NCT00495677|1126875|P2|NOT COMPLETED|Stage 1 (25 Days)||0
471867|NCT00495677|1126876|P1|NOT COMPLETED|Stage 1 (25 Days)||0
471868|NCT00495677|1126870|P7|COMPLETED|Stage 1 (25 Days)||0
471869|NCT00495677|1126871|P6|COMPLETED|Stage 1 (25 Days)||0
471870|NCT00495677|1126872|P5|COMPLETED|Stage 1 (25 Days)||0
471871|NCT00495677|1126873|P4|COMPLETED|Stage 1 (25 Days)||6
471872|NCT00495677|1126874|P3|COMPLETED|Stage 1 (25 Days)||5
471873|NCT00495677|1126875|P2|COMPLETED|Stage 1 (25 Days)||6
471874|NCT00495677|1126876|P1|COMPLETED|Stage 1 (25 Days)||2
471875|NCT00495677|1126870|P7|STARTED|Stage 1 (25 Days)||0
471876|NCT00495677|1126871|P6|STARTED|Stage 1 (25 Days)||0
471877|NCT00495677|1126872|P5|STARTED|Stage 1 (25 Days)||0
471878|NCT00495677|1126873|P4|STARTED|Stage 1 (25 Days)||6
471879|NCT00495677|1126874|P3|STARTED|Stage 1 (25 Days)||6
471880|NCT00495677|1126875|P2|STARTED|Stage 1 (25 Days)||6
471881|NCT00495677|1126876|P1|STARTED|Stage 1 (25 Days)||2
471882|NCT00495625|1126931|P1|NOT COMPLETED|Overall Study||10
471883|NCT00495625|1126931|P1|COMPLETED|Overall Study||23
471884|NCT00495625|1126931|P1|STARTED|Overall Study||33
471885|NCT00495612|1126942|P2|NOT COMPLETED|Overall Study||0
471886|NCT00495612|1126943|P1|NOT COMPLETED|Overall Study||4
471887|NCT00495612|1126942|P2|COMPLETED|Overall Study||33
471888|NCT00495612|1126943|P1|COMPLETED|Overall Study||32
471889|NCT00495612|1126942|P2|STARTED|Overall Study||33
471890|NCT00495612|1126943|P1|STARTED|Overall Study||36
471891|NCT00495586|1126961|P2|NOT COMPLETED|Overall Study||4
471892|NCT00495586|1126962|P1|NOT COMPLETED|Overall Study||4
471893|NCT00495586|1126961|P2|COMPLETED|Overall Study||158
471894|NCT00495586|1126962|P1|COMPLETED|Overall Study||152
471895|NCT00495586|1126961|P2|STARTED|Overall Study||162
471896|NCT00495586|1126962|P1|STARTED|Overall Study||156
471897|NCT00495495|1126970|P1|NOT COMPLETED|Overall Study||99
471898|NCT00495495|1126970|P1|COMPLETED|Overall Study||295
471899|NCT00495495|1126970|P1|STARTED|Overall Study||394
471900|NCT00495391|1126985|P2|NOT COMPLETED|Overall Study||21
471901|NCT00495391|1126986|P1|NOT COMPLETED|Overall Study||36
471902|NCT00495391|1126985|P2|COMPLETED|Overall Study||1
471903|NCT00495391|1126986|P1|COMPLETED|Overall Study||6
471904|NCT00495391|1126985|P2|From Baseline to End of Follow up|Overall Study||1
471905|NCT00495391|1126986|P1|From Baseline to End of Follow up|Overall Study||6
471906|NCT00495391|1126985|P2|From Baseline to End of Treatment|Overall Study||1
471907|NCT00495391|1126986|P1|From Baseline to End of Treatment|Overall Study||6
471908|NCT00495391|1126985|P2|From Baseline to Week 16|Overall Study||11
471909|NCT00495391|1126986|P1|From Baseline to Week 16|Overall Study||24
471910|NCT00495391|1126985|P2|From Baseline to Week 8|Overall Study||20
471911|NCT00495391|1126986|P1|From Baseline to Week 8|Overall Study||31
471912|NCT00495391|1126985|P2|STARTED|Overall Study||22
471913|NCT00495391|1126986|P1|STARTED|Overall Study||42
471914|NCT00495222|1127006|P1|NOT COMPLETED|Overall Study||0
471915|NCT00495222|1127006|P1|COMPLETED|Overall Study||9
471916|NCT00495222|1127006|P1|STARTED|Overall Study||9
471917|NCT00495157|1127012|P3|NOT COMPLETED|Overall Study||13
471918|NCT00495157|1127013|P2|NOT COMPLETED|Overall Study||23
471919|NCT00495157|1127014|P1|NOT COMPLETED|Overall Study||16
471920|NCT00495157|1127012|P3|COMPLETED|Overall Study||101
471921|NCT00495157|1127013|P2|COMPLETED|Overall Study||92
471922|NCT00495157|1127014|P1|COMPLETED|Overall Study||97
471923|NCT00495157|1127012|P3|STARTED|Overall Study||114
471924|NCT00495157|1127013|P2|STARTED|Overall Study||115
471925|NCT00495157|1127014|P1|STARTED|Overall Study||113
471926|NCT00495131|1127024|P2|NOT COMPLETED|Overall Study||6
471927|NCT00495131|1127025|P1|NOT COMPLETED|Overall Study||7
471928|NCT00495131|1127024|P2|COMPLETED|Overall Study||148
471929|NCT00495131|1127025|P1|COMPLETED|Overall Study||147
471930|NCT00495131|1127024|P2|STARTED|Overall Study||154
471931|NCT00495131|1127025|P1|STARTED|Overall Study||154
471932|NCT00495079|1127035|P1|NOT COMPLETED|Overall Study||0
471933|NCT00495079|1127035|P1|COMPLETED|Overall Study||65
471934|NCT00495079|1127035|P1|STARTED|Overall Study||65
471935|NCT00494975|1127044|P2|NOT COMPLETED|Overall Study||1
471936|NCT00494975|1127045|P1|NOT COMPLETED|Overall Study||2
471937|NCT00494975|1127044|P2|COMPLETED|Overall Study||10
471938|NCT00494975|1127045|P1|COMPLETED|Overall Study||8
471939|NCT00494975|1127044|P2|STARTED|Overall Study||11
471940|NCT00494975|1127045|P1|STARTED|Overall Study||10
471941|NCT00494871|1127053|P2|NOT COMPLETED|Follow-up (FU) Period||23
471942|NCT00494871|1127054|P1|NOT COMPLETED|Follow-up (FU) Period||29
471943|NCT00494871|1127053|P2|COMPLETED|Follow-up (FU) Period||616
471944|NCT00494871|1127054|P1|COMPLETED|Follow-up (FU) Period||610
471945|NCT00494871|1127053|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
471946|NCT00494871|1127054|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
471947|NCT00494871|1127053|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
471948|NCT00494871|1127054|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
471949|NCT00494871|1127053|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
471950|NCT00494871|1127054|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
471951|NCT00494871|1127053|P2|COMPLETED|Double-blind (DB) Treatment Period||468
471952|NCT00494871|1127054|P1|COMPLETED|Double-blind (DB) Treatment Period||480
471953|NCT00494871|1127053|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
471954|NCT00494871|1127054|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
471955|NCT00494871|1127053|P2|STARTED|Double-blind (DB) Treatment Period||640
471956|NCT00494871|1127054|P1|STARTED|Double-blind (DB) Treatment Period||640
471957|NCT00494806|1127086|P2|NOT COMPLETED|Overall Study||0
471958|NCT00494806|1127087|P1|NOT COMPLETED|Overall Study||0
471959|NCT00494806|1127086|P2|COMPLETED|Overall Study||32
471960|NCT00494806|1127087|P1|COMPLETED|Overall Study||34
471961|NCT00494806|1127086|P2|STARTED|Overall Study||32
471962|NCT00494806|1127087|P1|STARTED|Overall Study||34
471963|NCT00494780|1127095|P2|NOT COMPLETED|Overall Study||13
471964|NCT00494780|1127096|P1|NOT COMPLETED|Overall Study||11
471965|NCT00494780|1127095|P2|COMPLETED|Overall Study||17
471966|NCT00494780|1127096|P1|COMPLETED|Overall Study||18
471967|NCT00494780|1127095|P2|STARTED|Overall Study||30
471968|NCT00494780|1127096|P1|STARTED|Overall Study||29
471969|NCT00494676|1127134|P2|NOT COMPLETED|Second Intervention||1
471970|NCT00494676|1127135|P1|NOT COMPLETED|Second Intervention||1
471971|NCT00494676|1127134|P2|COMPLETED|Second Intervention||28
471972|NCT00494676|1127135|P1|COMPLETED|Second Intervention||33
471973|NCT00494676|1127134|P2|STARTED|Second Intervention||29
471974|NCT00494676|1127135|P1|STARTED|Second Intervention||34
471975|NCT00494676|1127134|P2|NOT COMPLETED|First Intervention||3
471976|NCT00494676|1127135|P1|NOT COMPLETED|First Intervention||1
471977|NCT00494676|1127134|P2|COMPLETED|First Intervention||29
471978|NCT00494676|1127135|P1|COMPLETED|First Intervention||34
471979|NCT00494676|1127134|P2|STARTED|First Intervention||32
471980|NCT00494676|1127135|P1|STARTED|First Intervention||35
471981|NCT00494676|1127134|P2|NOT COMPLETED|Allocation||4
471982|NCT00494676|1127135|P1|NOT COMPLETED|Allocation||2
471983|NCT00494676|1127134|P2|COMPLETED|Allocation||32
471984|NCT00494676|1127135|P1|COMPLETED|Allocation||35
471985|NCT00494676|1127134|P2|STARTED|Allocation||36
471986|NCT00494676|1127135|P1|STARTED|Allocation||37
471987|NCT00494585|1127142|P1|NOT COMPLETED|Overall Study||0
471988|NCT00494585|1127142|P1|COMPLETED|Overall Study||22
471989|NCT00494585|1127142|P1|STARTED|Overall Study||22
471990|NCT00494507|1127150|P4|NOT COMPLETED|Open-Label Phase||5
471991|NCT00494507|1127151|P3|NOT COMPLETED|Open-Label Phase||5
471992|NCT00494507|1127152|P2|NOT COMPLETED|Open-Label Phase||1
471993|NCT00494507|1127153|P1|NOT COMPLETED|Open-Label Phase||0
471994|NCT00494507|1127150|P4|COMPLETED|Open-Label Phase||14
471995|NCT00494507|1127151|P3|COMPLETED|Open-Label Phase||17
471996|NCT00494507|1127152|P2|COMPLETED|Open-Label Phase||7
471997|NCT00494507|1127153|P1|COMPLETED|Open-Label Phase||9
471998|NCT00494507|1127150|P4|STARTED|Open-Label Phase||19
471999|NCT00494507|1127151|P3|STARTED|Open-Label Phase||22
472000|NCT00494507|1127152|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
472001|NCT00494507|1127153|P1|STARTED|Open-Label Phase||9
472002|NCT00494507|1127150|P4|NOT COMPLETED|Double-Blind Phase||1
472003|NCT00494507|1127151|P3|NOT COMPLETED|Double-Blind Phase||2
472004|NCT00494507|1127152|P2|NOT COMPLETED|Double-Blind Phase||0
472005|NCT00494507|1127153|P1|NOT COMPLETED|Double-Blind Phase||3
472006|NCT00494507|1127150|P4|COMPLETED|Double-Blind Phase||19
472007|NCT00494507|1127151|P3|COMPLETED|Double-Blind Phase||22
472008|NCT00494507|1127152|P2|COMPLETED|Double-Blind Phase||9
472009|NCT00494507|1127153|P1|COMPLETED|Double-Blind Phase||9
472010|NCT00494507|1127150|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
472011|NCT00494507|1127151|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
472012|NCT00494507|1127152|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
472013|NCT00494507|1127153|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
472014|NCT00494507|1127150|P4|STARTED|Double-Blind Phase||20
472015|NCT00494507|1127151|P3|STARTED|Double-Blind Phase||24
472016|NCT00494507|1127152|P2|STARTED|Double-Blind Phase||9
472017|NCT00494507|1127153|P1|STARTED|Double-Blind Phase||12
472018|NCT00494494|1127203|P2|NOT COMPLETED|Overall Study||0
472019|NCT00494494|1127204|P1|NOT COMPLETED|Overall Study||0
472020|NCT00494494|1127203|P2|COMPLETED|Overall Study||39
472021|NCT00494494|1127204|P1|COMPLETED|Overall Study||40
472022|NCT00494494|1127203|P2|STARTED|Overall Study||39
472023|NCT00494494|1127204|P1|STARTED|Overall Study||40
472024|NCT00494481|1127220|P2|NOT COMPLETED|Overall Study||24
472025|NCT00494481|1127221|P1|NOT COMPLETED|Overall Study||29
472026|NCT00494481|1127220|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
472027|NCT00494481|1127221|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
472028|NCT00494481|1127220|P2|STARTED|Overall Study|randomised patients|29
472029|NCT00494481|1127221|P1|STARTED|Overall Study|randomised patients|35
472030|NCT00494442|1127229|P2|NOT COMPLETED|Overall Study||16
472031|NCT00494442|1127230|P1|NOT COMPLETED|Overall Study||17
472032|NCT00494442|1127229|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
472033|NCT00494442|1127230|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
472034|NCT00494442|1127229|P2|STARTED|Overall Study|Patients received treatment|33
472035|NCT00494442|1127230|P1|STARTED|Overall Study|Patients received treatment|24
472036|NCT00494299|1127246|P2|NOT COMPLETED|Overall Study||229
472037|NCT00494299|1127247|P1|NOT COMPLETED|Overall Study||229
472038|NCT00494299|1127246|P2|COMPLETED|Overall Study||0
472039|NCT00494299|1127247|P1|COMPLETED|Overall Study||0
472040|NCT00494299|1127246|P2|Received Treatment|Overall Study||227
472041|NCT00494299|1127247|P1|Received Treatment|Overall Study||229
472042|NCT00494299|1127246|P2|STARTED|Overall Study||229
472043|NCT00494299|1127247|P1|STARTED|Overall Study||229
472044|NCT00494234|1127259|P2|NOT COMPLETED|Overall Study||10
472045|NCT00494234|1127260|P1|NOT COMPLETED|Overall Study||15
472046|NCT00494234|1127259|P2|COMPLETED|Overall Study||17
472047|NCT00494234|1127260|P1|COMPLETED|Overall Study||12
472048|NCT00494234|1127259|P2|STARTED|Overall Study||27
472049|NCT00494234|1127260|P1|STARTED|Overall Study||27
472050|NCT00494221|1127279|P3|NOT COMPLETED|Overall Study||14
472051|NCT00494221|1127280|P2|NOT COMPLETED|Overall Study||11
472052|NCT00494221|1127281|P1|NOT COMPLETED|Overall Study||16
472053|NCT00494221|1127279|P3|COMPLETED|Overall Study||44
472054|NCT00494221|1127280|P2|COMPLETED|Overall Study||45
472055|NCT00494221|1127281|P1|COMPLETED|Overall Study||42
472056|NCT00494221|1127279|P3|STARTED|Overall Study||58
472057|NCT00494221|1127280|P2|STARTED|Overall Study||56
472058|NCT00494221|1127281|P1|STARTED|Overall Study||58
472059|NCT00494143|1127301|P6|NOT COMPLETED|Overall Study||0
472060|NCT00494143|1127302|P5|NOT COMPLETED|Overall Study||0
472061|NCT00494143|1127303|P4|NOT COMPLETED|Overall Study||0
472062|NCT00494143|1127304|P3|NOT COMPLETED|Overall Study||0
472063|NCT00494143|1127305|P2|NOT COMPLETED|Overall Study||0
472064|NCT00494143|1127306|P1|NOT COMPLETED|Overall Study||0
472065|NCT00494143|1127301|P6|COMPLETED|Overall Study||0
472066|NCT00494143|1127302|P5|COMPLETED|Overall Study||1
472067|NCT00494143|1127303|P4|COMPLETED|Overall Study||0
472068|NCT00494143|1127304|P3|COMPLETED|Overall Study||3
472069|NCT00494143|1127305|P2|COMPLETED|Overall Study||2
472070|NCT00494143|1127306|P1|COMPLETED|Overall Study||1
472071|NCT00494143|1127301|P6|STARTED|Overall Study||0
472072|NCT00494143|1127302|P5|STARTED|Overall Study||1
472073|NCT00494143|1127303|P4|STARTED|Overall Study||0
472074|NCT00494143|1127304|P3|STARTED|Overall Study||3
472075|NCT00494143|1127305|P2|STARTED|Overall Study||2
472076|NCT00494143|1127306|P1|STARTED|Overall Study||1
472077|NCT00494091|1127322|P2|NOT COMPLETED|Overall Study||76
472078|NCT00494091|1127323|P1|NOT COMPLETED|Overall Study||6
472079|NCT00494091|1127322|P2|COMPLETED|Overall Study||0
472080|NCT00494091|1127323|P1|COMPLETED|Overall Study||0
472081|NCT00494091|1127322|P2|STARTED|Overall Study||76
472082|NCT00494091|1127323|P1|STARTED|Overall Study||6
472083|NCT00494026|1127345|P1|NOT COMPLETED|Overall Study||4
472084|NCT00494026|1127345|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
472085|NCT00494026|1127345|P1|STARTED|Overall Study||4
472086|NCT00494013|1127355|P2|NOT COMPLETED|Overall Study||36
472087|NCT00494013|1127356|P1|NOT COMPLETED|Overall Study||30
472088|NCT00494013|1127355|P2|COMPLETED|Overall Study||183
472089|NCT00494013|1127356|P1|COMPLETED|Overall Study||193
472090|NCT00494013|1127355|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
472091|NCT00494013|1127356|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
472092|NCT00494013|1127355|P2|STARTED|Overall Study||219
472093|NCT00494013|1127356|P1|STARTED|Overall Study||223
472094|NCT00493974|1127386|P2|NOT COMPLETED|Overall Study||14
472095|NCT00493974|1127387|P1|NOT COMPLETED|Overall Study||13
472096|NCT00493974|1127386|P2|COMPLETED|Overall Study||45
472097|NCT00493974|1127387|P1|COMPLETED|Overall Study||47
472098|NCT00493974|1127386|P2|STARTED|Overall Study||59
472099|NCT00493974|1127387|P1|STARTED|Overall Study||60
472100|NCT00493805|1127405|P2|NOT COMPLETED|Overall Study||0
472101|NCT00493805|1127406|P1|NOT COMPLETED|Overall Study||0
472102|NCT00493805|1127405|P2|COMPLETED|Overall Study||42
472103|NCT00493805|1127406|P1|COMPLETED|Overall Study||17
472104|NCT00493805|1127405|P2|STARTED|Overall Study||42
472105|NCT00493805|1127406|P1|STARTED|Overall Study||17
472106|NCT00493779|1127414|P1|NOT COMPLETED|Overall Study||1
472107|NCT00493779|1127414|P1|COMPLETED|Overall Study|Completed follow-up phase|97
472108|NCT00493779|1127414|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
472109|NCT00493649|1127421|P1|NOT COMPLETED|Overall Study||82
472110|NCT00493649|1127421|P1|COMPLETED|Overall Study||411
472111|NCT00493649|1127421|P1|STARTED|Overall Study||493
472112|NCT00493636|1127434|P2|NOT COMPLETED|Overall Study||2
472113|NCT00493636|1127435|P1|NOT COMPLETED|Overall Study||2
472114|NCT00493636|1127434|P2|COMPLETED|Overall Study||77
472115|NCT00493636|1127435|P1|COMPLETED|Overall Study||79
472116|NCT00493636|1127434|P2|STARTED|Overall Study||79
472117|NCT00493636|1127435|P1|STARTED|Overall Study||81
472118|NCT00493454|1127449|P1|NOT COMPLETED|Overall Study||1
472119|NCT00493454|1127449|P1|COMPLETED|Overall Study||5
472120|NCT00493454|1127449|P1|STARTED|Overall Study||6
472121|NCT00493311|1127455|P2|NOT COMPLETED|Overall Study||2
472122|NCT00493311|1127456|P1|NOT COMPLETED|Overall Study||2
472123|NCT00493311|1127455|P2|COMPLETED|Overall Study||29
472124|NCT00493311|1127456|P1|COMPLETED|Overall Study||27
472125|NCT00493311|1127455|P2|STARTED|Overall Study||31
472126|NCT00493311|1127456|P1|STARTED|Overall Study||29
472127|NCT00493285|1127476|P6|NOT COMPLETED|Overall Study||0
472128|NCT00493285|1127477|P5|NOT COMPLETED|Overall Study||1
472129|NCT00493285|1127478|P4|NOT COMPLETED|Overall Study||0
472130|NCT00493285|1127479|P3|NOT COMPLETED|Overall Study||0
472131|NCT00493285|1127480|P2|NOT COMPLETED|Overall Study||0
472132|NCT00493285|1127481|P1|NOT COMPLETED|Overall Study||0
472133|NCT00493285|1127476|P6|COMPLETED|Overall Study||5
472134|NCT00493285|1127477|P5|COMPLETED|Overall Study||9
472135|NCT00493285|1127478|P4|COMPLETED|Overall Study||6
472136|NCT00493285|1127479|P3|COMPLETED|Overall Study||9
472137|NCT00493285|1127480|P2|COMPLETED|Overall Study||6
472138|NCT00493285|1127481|P1|COMPLETED|Overall Study||13
472139|NCT00493285|1127476|P6|STARTED|Overall Study||5
472140|NCT00493285|1127477|P5|STARTED|Overall Study||10
472141|NCT00493285|1127478|P4|STARTED|Overall Study||6
472142|NCT00493285|1127479|P3|STARTED|Overall Study||9
472143|NCT00493285|1127480|P2|STARTED|Overall Study||6
472144|NCT00493285|1127481|P1|STARTED|Overall Study||13
472145|NCT00493246|1127713|P8|NOT COMPLETED|Overall Study||0
472146|NCT00493246|1127714|P7|NOT COMPLETED|Overall Study||1
472147|NCT00493246|1127715|P6|NOT COMPLETED|Overall Study||1
472148|NCT00493246|1127716|P5|NOT COMPLETED|Overall Study||1
472149|NCT00493246|1127717|P4|NOT COMPLETED|Overall Study||0
472150|NCT00493246|1127718|P3|NOT COMPLETED|Overall Study||0
472151|NCT00493246|1127719|P2|NOT COMPLETED|Overall Study||0
472152|NCT00493246|1127720|P1|NOT COMPLETED|Overall Study||0
472153|NCT00493246|1127713|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
472154|NCT00493246|1127714|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
472155|NCT00493246|1127715|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
472156|NCT00493246|1127716|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
472157|NCT00493246|1127717|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
472158|NCT00493246|1127718|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
472159|NCT00493246|1127719|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
472160|NCT00493246|1127720|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
472161|NCT00493246|1127713|P8|STARTED|Overall Study|All subjects who were randomized.|10
472162|NCT00493246|1127714|P7|STARTED|Overall Study|All subjects who were randomized.|12
472163|NCT00493246|1127715|P6|STARTED|Overall Study|All subjects who were randomized.|16
472164|NCT00493246|1127716|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
472165|NCT00493246|1127717|P4|STARTED|Overall Study||13
472166|NCT00493246|1127718|P3|STARTED|Overall Study||12
472167|NCT00493246|1127719|P2|STARTED|Overall Study||1
472168|NCT00493246|1127720|P1|STARTED|Overall Study||2
472169|NCT00493220|1127784|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
472170|NCT00493220|1127785|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
472171|NCT00493220|1127786|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
472172|NCT00493220|1127787|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
472173|NCT00493220|1127788|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
472174|NCT00493220|1127789|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
472175|NCT00493220|1127784|P6|COMPLETED|Final 7-Day Safety Follow-up||5
472176|NCT00493220|1127785|P5|COMPLETED|Final 7-Day Safety Follow-up||5
472177|NCT00493220|1127786|P4|COMPLETED|Final 7-Day Safety Follow-up||5
472178|NCT00493220|1127787|P3|COMPLETED|Final 7-Day Safety Follow-up||5
472179|NCT00493220|1127788|P2|COMPLETED|Final 7-Day Safety Follow-up||5
472180|NCT00493220|1127789|P1|COMPLETED|Final 7-Day Safety Follow-up||4
472181|NCT00493220|1127784|P6|STARTED|Final 7-Day Safety Follow-up||5
472182|NCT00493220|1127785|P5|STARTED|Final 7-Day Safety Follow-up||5
472183|NCT00493220|1127786|P4|STARTED|Final 7-Day Safety Follow-up||5
472184|NCT00493220|1127787|P3|STARTED|Final 7-Day Safety Follow-up||5
472185|NCT00493220|1127788|P2|STARTED|Final 7-Day Safety Follow-up||5
472186|NCT00493220|1127789|P1|STARTED|Final 7-Day Safety Follow-up||4
472187|NCT00493220|1127784|P6|NOT COMPLETED|Third Intervention||0
472188|NCT00493220|1127785|P5|NOT COMPLETED|Third Intervention||0
472189|NCT00493220|1127786|P4|NOT COMPLETED|Third Intervention||0
472190|NCT00493220|1127787|P3|NOT COMPLETED|Third Intervention||0
472191|NCT00493220|1127788|P2|NOT COMPLETED|Third Intervention||0
472192|NCT00493220|1127789|P1|NOT COMPLETED|Third Intervention||1
472193|NCT00493220|1127784|P6|COMPLETED|Third Intervention||5
472194|NCT00493220|1127785|P5|COMPLETED|Third Intervention||5
472195|NCT00493220|1127786|P4|COMPLETED|Third Intervention||5
472196|NCT00493220|1127787|P3|COMPLETED|Third Intervention||5
472197|NCT00493220|1127788|P2|COMPLETED|Third Intervention||5
472198|NCT00493220|1127789|P1|COMPLETED|Third Intervention||4
472199|NCT00493220|1127784|P6|STARTED|Third Intervention||5
472200|NCT00493220|1127785|P5|STARTED|Third Intervention||5
472201|NCT00493220|1127786|P4|STARTED|Third Intervention||5
472202|NCT00493220|1127787|P3|STARTED|Third Intervention||5
472203|NCT00493220|1127788|P2|STARTED|Third Intervention||5
472204|NCT00493220|1127789|P1|STARTED|Third Intervention||5
472205|NCT00493220|1127784|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
472206|NCT00493220|1127785|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
472207|NCT00493220|1127786|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
472208|NCT00493220|1127787|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
472209|NCT00493220|1127788|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
472210|NCT00493220|1127789|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
472211|NCT00493220|1127784|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
472212|NCT00493220|1127785|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
472213|NCT00493220|1127786|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
472214|NCT00493220|1127787|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
472215|NCT00493220|1127788|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
472216|NCT00493220|1127789|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
472217|NCT00493220|1127784|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
472218|NCT00493220|1127785|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
472219|NCT00493220|1127786|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
472220|NCT00493220|1127787|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
472221|NCT00493220|1127788|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
472222|NCT00493220|1127789|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
472223|NCT00493220|1127784|P6|NOT COMPLETED|Second Intervention||0
472224|NCT00493220|1127785|P5|NOT COMPLETED|Second Intervention||0
472225|NCT00493220|1127786|P4|NOT COMPLETED|Second Intervention||0
472226|NCT00493220|1127787|P3|NOT COMPLETED|Second Intervention||0
472227|NCT00493220|1127788|P2|NOT COMPLETED|Second Intervention||0
472228|NCT00493220|1127789|P1|NOT COMPLETED|Second Intervention||0
472229|NCT00493220|1127784|P6|COMPLETED|Second Intervention||5
472230|NCT00493220|1127785|P5|COMPLETED|Second Intervention||5
472231|NCT00493220|1127786|P4|COMPLETED|Second Intervention||5
472232|NCT00493220|1127787|P3|COMPLETED|Second Intervention||5
472233|NCT00493220|1127788|P2|COMPLETED|Second Intervention||5
472234|NCT00493220|1127789|P1|COMPLETED|Second Intervention||5
472235|NCT00493220|1127784|P6|STARTED|Second Intervention||5
472236|NCT00493220|1127785|P5|STARTED|Second Intervention||5
472237|NCT00493220|1127786|P4|STARTED|Second Intervention||5
472238|NCT00493220|1127787|P3|STARTED|Second Intervention||5
472239|NCT00493220|1127788|P2|STARTED|Second Intervention||5
472240|NCT00493220|1127789|P1|STARTED|Second Intervention||5
472241|NCT00493220|1127784|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
472242|NCT00493220|1127785|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
472243|NCT00493220|1127786|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
472244|NCT00493220|1127787|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
472245|NCT00493220|1127788|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
472246|NCT00493220|1127789|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
472247|NCT00493220|1127784|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
472248|NCT00493220|1127785|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
472249|NCT00493220|1127786|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
472250|NCT00493220|1127787|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
472251|NCT00493220|1127788|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
472252|NCT00493220|1127789|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
472253|NCT00493220|1127784|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
472254|NCT00493220|1127785|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
472255|NCT00493220|1127786|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
472256|NCT00493220|1127787|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
472257|NCT00493220|1127788|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
472258|NCT00493220|1127789|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
472259|NCT00493220|1127784|P6|NOT COMPLETED|First Intervention||0
472260|NCT00493220|1127785|P5|NOT COMPLETED|First Intervention||0
472261|NCT00493220|1127786|P4|NOT COMPLETED|First Intervention||0
472262|NCT00493220|1127787|P3|NOT COMPLETED|First Intervention||0
472263|NCT00493220|1127788|P2|NOT COMPLETED|First Intervention||0
472264|NCT00493220|1127789|P1|NOT COMPLETED|First Intervention||0
472265|NCT00493220|1127784|P6|COMPLETED|First Intervention||5
472266|NCT00493220|1127785|P5|COMPLETED|First Intervention||5
472267|NCT00493220|1127786|P4|COMPLETED|First Intervention||5
472268|NCT00493220|1127787|P3|COMPLETED|First Intervention||5
472269|NCT00493220|1127788|P2|COMPLETED|First Intervention||5
472270|NCT00493220|1127789|P1|COMPLETED|First Intervention||5
472271|NCT00493220|1127784|P6|STARTED|First Intervention||5
472272|NCT00493220|1127785|P5|STARTED|First Intervention||5
472273|NCT00493220|1127786|P4|STARTED|First Intervention||5
472274|NCT00493220|1127787|P3|STARTED|First Intervention||5
472275|NCT00493220|1127788|P2|STARTED|First Intervention||5
472276|NCT00493220|1127789|P1|STARTED|First Intervention||5
472277|NCT00493181|1127806|P1|NOT COMPLETED|Overall Study||0
472278|NCT00493181|1127806|P1|COMPLETED|Overall Study||8
472279|NCT00493181|1127806|P1|STARTED|Overall Study||8
472280|NCT00493038|1127812|P2|NOT COMPLETED|Follow-up||0
472281|NCT00493038|1127813|P1|NOT COMPLETED|Follow-up||1
472282|NCT00493038|1127812|P2|COMPLETED|Follow-up||126
472283|NCT00493038|1127813|P1|COMPLETED|Follow-up||122
472284|NCT00493038|1127812|P2|STARTED|Follow-up||126
472285|NCT00493038|1127813|P1|STARTED|Follow-up||123
472286|NCT00493038|1127812|P2|NOT COMPLETED|Treatment||20
472287|NCT00493038|1127813|P1|NOT COMPLETED|Treatment||24
472288|NCT00493038|1127812|P2|COMPLETED|Treatment||126
472289|NCT00493038|1127813|P1|COMPLETED|Treatment||123
472290|NCT00493038|1127812|P2|Test-of-Cure Visit|Treatment||126
472291|NCT00493038|1127813|P1|Test-of-Cure Visit|Treatment||123
472292|NCT00493038|1127812|P2|Treated With Study Medication|Treatment||142
472293|NCT00493038|1127813|P1|Treated With Study Medication|Treatment||145
472294|NCT00493038|1127812|P2|Randomization|Treatment||146
472295|NCT00493038|1127813|P1|Randomization|Treatment||147
472296|NCT00493038|1127812|P2|STARTED|Treatment||146
472297|NCT00493038|1127813|P1|STARTED|Treatment||147
472298|NCT00493012|1127829|P2|NOT COMPLETED|Overall Study||17
472299|NCT00493012|1127830|P1|NOT COMPLETED|Overall Study||18
472300|NCT00493012|1127829|P2|COMPLETED|Overall Study||83
472301|NCT00493012|1127830|P1|COMPLETED|Overall Study||82
472302|NCT00493012|1127829|P2|STARTED|Overall Study||100
472303|NCT00493012|1127830|P1|STARTED|Overall Study||100
472304|NCT00492973|1127858|P2|NOT COMPLETED|Overall Study||1
472305|NCT00492973|1127859|P1|NOT COMPLETED|Overall Study||0
472306|NCT00492973|1127858|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
472307|NCT00492973|1127859|P1|COMPLETED|Overall Study||37
472308|NCT00492973|1127858|P2|STARTED|Overall Study||39
472309|NCT00492973|1127859|P1|STARTED|Overall Study||37
472310|NCT00492856|1127873|P4|NOT COMPLETED|Post-consolidation||1
472311|NCT00492856|1127874|P3|NOT COMPLETED|Post-consolidation||27
472312|NCT00492856|1127875|P2|NOT COMPLETED|Post-consolidation||12
472313|NCT00492856|1127876|P1|NOT COMPLETED|Post-consolidation||0
472314|NCT00492856|1127873|P4|COMPLETED|Post-consolidation||0
472315|NCT00492856|1127874|P3|COMPLETED|Post-consolidation||0
472316|NCT00492856|1127875|P2|COMPLETED|Post-consolidation||29
472317|NCT00492856|1127876|P1|COMPLETED|Post-consolidation||0
472318|NCT00492856|1127873|P4|STARTED|Post-consolidation||1
472319|NCT00492856|1127874|P3|STARTED|Post-consolidation||27
472320|NCT00492856|1127875|P2|STARTED|Post-consolidation||41
472321|NCT00492856|1127876|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
472322|NCT00492856|1127873|P4|NOT COMPLETED|Consolidation||0
472323|NCT00492856|1127874|P3|NOT COMPLETED|Consolidation||0
472324|NCT00492856|1127875|P2|NOT COMPLETED|Consolidation||0
472325|NCT00492856|1127876|P1|NOT COMPLETED|Consolidation||9
472326|NCT00492856|1127873|P4|COMPLETED|Consolidation||0
472327|NCT00492856|1127874|P3|COMPLETED|Consolidation||0
472328|NCT00492856|1127875|P2|COMPLETED|Consolidation||0
472329|NCT00492856|1127876|P1|COMPLETED|Consolidation||83
472330|NCT00492856|1127873|P4|STARTED|Consolidation||0
472331|NCT00492856|1127874|P3|STARTED|Consolidation||0
472332|NCT00492856|1127875|P2|STARTED|Consolidation||0
472333|NCT00492856|1127876|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
472334|NCT00492856|1127873|P4|NOT COMPLETED|Induction||0
472335|NCT00492856|1127874|P3|NOT COMPLETED|Induction||0
472336|NCT00492856|1127875|P2|NOT COMPLETED|Induction||0
472337|NCT00492856|1127876|P1|NOT COMPLETED|Induction||6
472338|NCT00492856|1127873|P4|COMPLETED|Induction||0
472339|NCT00492856|1127874|P3|COMPLETED|Induction||0
472340|NCT00492856|1127875|P2|COMPLETED|Induction||0
472341|NCT00492856|1127876|P1|COMPLETED|Induction||99
472342|NCT00492856|1127873|P4|STARTED|Induction||0
472343|NCT00492856|1127874|P3|STARTED|Induction||0
472344|NCT00492856|1127875|P2|STARTED|Induction||0
472345|NCT00492856|1127876|P1|STARTED|Induction||105
472346|NCT00492752|1127890|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
472347|NCT00492752|1127891|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
472348|NCT00492752|1127892|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
472349|NCT00492752|1127893|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
472350|NCT00492752|1127890|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
472351|NCT00492752|1127891|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
472352|NCT00492752|1127892|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
472353|NCT00492752|1127893|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
472354|NCT00492752|1127890|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
472355|NCT00492752|1127891|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
472356|NCT00492752|1127892|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
472357|NCT00492752|1127893|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
472358|NCT00492752|1127890|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
472359|NCT00492752|1127891|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
472360|NCT00492752|1127892|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
472361|NCT00492752|1127893|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
472362|NCT00492752|1127890|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
472363|NCT00492752|1127891|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
472364|NCT00492752|1127892|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
472365|NCT00492752|1127893|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
472366|NCT00492752|1127890|P4|NOT COMPLETED|Double Blind Treatment||0
472367|NCT00492752|1127891|P3|NOT COMPLETED|Double Blind Treatment||3
472368|NCT00492752|1127892|P2|NOT COMPLETED|Double Blind Treatment||0
472369|NCT00492752|1127893|P1|NOT COMPLETED|Double Blind Treatment||14
472370|NCT00492752|1127890|P4|COMPLETED|Double Blind Treatment||6
472371|NCT00492752|1127891|P3|COMPLETED|Double Blind Treatment||67
472372|NCT00492752|1127892|P2|COMPLETED|Double Blind Treatment||16
472373|NCT00492752|1127893|P1|COMPLETED|Double Blind Treatment||120
472374|NCT00492752|1127890|P4|Received Treatment|Double Blind Treatment|Safety Population|6
472375|NCT00492752|1127891|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
472376|NCT00492752|1127892|P2|Received Treatment|Double Blind Treatment|Safety Population|16
472377|NCT00492752|1127893|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
472378|NCT00492752|1127890|P4|STARTED|Double Blind Treatment||6
472379|NCT00492752|1127891|P3|STARTED|Double Blind Treatment||70
472380|NCT00492752|1127892|P2|STARTED|Double Blind Treatment||16
472381|NCT00492752|1127893|P1|STARTED|Double Blind Treatment||134
472382|NCT00492726|1127928|P2|NOT COMPLETED|Overall Study||36
472383|NCT00492726|1127929|P1|NOT COMPLETED|Overall Study||50
472384|NCT00492726|1127928|P2|COMPLETED|Overall Study||358
472385|NCT00492726|1127929|P1|COMPLETED|Overall Study||360
472386|NCT00492726|1127928|P2|End of Study|Overall Study||358
472387|NCT00492726|1127929|P1|End of Study|Overall Study||360
472388|NCT00492726|1127928|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
472389|NCT00492726|1127929|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
472390|NCT00492726|1127928|P2|STARTED|Overall Study||394
472391|NCT00492726|1127929|P1|STARTED|Overall Study||410
472392|NCT00492583|1127955|P2|NOT COMPLETED|Overall Study||0
472393|NCT00492583|1127956|P1|NOT COMPLETED|Overall Study||0
472394|NCT00492583|1127955|P2|COMPLETED|Overall Study||87
472395|NCT00492583|1127956|P1|COMPLETED|Overall Study||95
472396|NCT00492583|1127955|P2|STARTED|Overall Study||87
472397|NCT00492583|1127956|P1|STARTED|Overall Study||95
472398|NCT00492557|1127964|P2|NOT COMPLETED|Overall Study||23
472399|NCT00492557|1127965|P1|NOT COMPLETED|Overall Study||24
472400|NCT00492557|1127964|P2|COMPLETED|Overall Study||557
472401|NCT00492557|1127965|P1|COMPLETED|Overall Study||556
472402|NCT00492557|1127964|P2|Vaccinated Dose 2|Overall Study||558
472403|NCT00492557|1127965|P1|Vaccinated Dose 2|Overall Study||560
472404|NCT00492557|1127964|P2|Vaccinated Dose 1|Overall Study||575
472405|NCT00492557|1127965|P1|Vaccinated Dose 1|Overall Study||577
472406|NCT00492557|1127964|P2|STARTED|Overall Study||580
472407|NCT00492557|1127965|P1|STARTED|Overall Study||580
472408|NCT00492544|1127981|P1|NOT COMPLETED|Overall Study||0
472409|NCT00492544|1127981|P1|COMPLETED|Overall Study||100
472410|NCT00492544|1127981|P1|STARTED|Overall Study||100
472411|NCT00492531|1127995|P2|NOT COMPLETED|Overall Study||23
472412|NCT00492531|1127996|P1|NOT COMPLETED|Overall Study||22
472413|NCT00492531|1127995|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
472414|NCT00492531|1127996|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
472415|NCT00492531|1127995|P2|STARTED|Overall Study||37
472416|NCT00492531|1127996|P1|STARTED|Overall Study||37
472417|NCT00492401|1128008|P1|NOT COMPLETED|Overall Study||0
472418|NCT00492401|1128008|P1|COMPLETED|Overall Study||55
472419|NCT00492401|1128008|P1|STARTED|Overall Study||55
472420|NCT00492336|1128019|P2|NOT COMPLETED|Overall Study||6
472421|NCT00492336|1128020|P1|NOT COMPLETED|Overall Study||2
472422|NCT00492336|1128019|P2|COMPLETED|Overall Study||23
472423|NCT00492336|1128020|P1|COMPLETED|Overall Study||26
472424|NCT00492336|1128019|P2|STARTED|Overall Study||29
472425|NCT00492336|1128020|P1|STARTED|Overall Study||28
472426|NCT00492297|1128026|P1|NOT COMPLETED|Survival Only Follow-up||59
472427|NCT00492297|1128026|P1|COMPLETED|Survival Only Follow-up||0
472428|NCT00492297|1128026|P1|STARTED|Survival Only Follow-up||59
472429|NCT00492297|1128026|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
472430|NCT00492297|1128026|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
472431|NCT00492297|1128026|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
472432|NCT00492297|1128026|P1|NOT COMPLETED|Treatment||5
472433|NCT00492297|1128026|P1|COMPLETED|Treatment||78
472434|NCT00492297|1128026|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
472435|NCT00492297|1128026|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
472436|NCT00492297|1128026|P1|STARTED|Treatment||83
472437|NCT00492284|1128044|P4|NOT COMPLETED|Overall Study||10
472438|NCT00492284|1128045|P3|NOT COMPLETED|Overall Study||6
472439|NCT00492284|1128046|P2|NOT COMPLETED|Overall Study||4
472440|NCT00492284|1128047|P1|NOT COMPLETED|Overall Study||1
472441|NCT00492284|1128044|P4|COMPLETED|Overall Study||31
472442|NCT00492284|1128045|P3|COMPLETED|Overall Study||37
472443|NCT00492284|1128046|P2|COMPLETED|Overall Study||35
472444|NCT00492284|1128047|P1|COMPLETED|Overall Study||38
472445|NCT00492284|1128044|P4|STARTED|Overall Study||41
472446|NCT00492284|1128045|P3|STARTED|Overall Study||43
472447|NCT00492284|1128046|P2|STARTED|Overall Study||39
472448|NCT00492284|1128047|P1|STARTED|Overall Study||39
472449|NCT00492232|1128091|P2|NOT COMPLETED|Open-Label Treatment||0
472450|NCT00492232|1128092|P1|NOT COMPLETED|Open-Label Treatment||1
472451|NCT00492232|1128091|P2|COMPLETED|Open-Label Treatment||0
472452|NCT00492232|1128092|P1|COMPLETED|Open-Label Treatment||88
472453|NCT00492232|1128091|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
472454|NCT00492232|1128092|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
472455|NCT00492232|1128091|P2|NOT COMPLETED|Double-Blind Treatment||25
472456|NCT00492232|1128092|P1|NOT COMPLETED|Double-Blind Treatment||18
472457|NCT00492232|1128091|P2|COMPLETED|Double-Blind Treatment||45
472458|NCT00492232|1128092|P1|COMPLETED|Double-Blind Treatment||47
472459|NCT00492232|1128091|P2|STARTED|Double-Blind Treatment||70
472460|NCT00492232|1128092|P1|STARTED|Double-Blind Treatment||65
472461|NCT00492232|1128091|P2|NOT COMPLETED|Placebo Run-in||70
472462|NCT00492232|1128092|P1|NOT COMPLETED|Placebo Run-in||0
472463|NCT00492232|1128091|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
472464|NCT00492232|1128092|P1|COMPLETED|Placebo Run-in||0
472465|NCT00492232|1128091|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
472466|NCT00492232|1128092|P1|STARTED|Placebo Run-in||0
472467|NCT00492206|1128124|P1|NOT COMPLETED|Overall Study||0
472468|NCT00492206|1128124|P1|COMPLETED|Overall Study||40
472469|NCT00492206|1128124|P1|STARTED|Overall Study||40
472470|NCT00492089|1128133|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
472471|NCT00492089|1128134|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
472472|NCT00492089|1128133|P2|COMPLETED|Second Intervention (6 Weeks)||6
472473|NCT00492089|1128134|P1|COMPLETED|Second Intervention (6 Weeks)||5
472474|NCT00492089|1128133|P2|STARTED|Second Intervention (6 Weeks)||6
472475|NCT00492089|1128134|P1|STARTED|Second Intervention (6 Weeks)||5
472476|NCT00492089|1128133|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
472477|NCT00492089|1128134|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
472478|NCT00492089|1128133|P2|COMPLETED|First Intervention (6 Weeks)||6
472479|NCT00492089|1128134|P1|COMPLETED|First Intervention (6 Weeks)||5
472480|NCT00492089|1128133|P2|STARTED|First Intervention (6 Weeks)||6
472481|NCT00492089|1128134|P1|STARTED|First Intervention (6 Weeks)||5
472482|NCT00492063|1128144|P4|NOT COMPLETED|Overall Study||10
472483|NCT00492063|1128145|P3|NOT COMPLETED|Overall Study||11
472484|NCT00492063|1128146|P2|NOT COMPLETED|Overall Study||14
472485|NCT00492063|1128147|P1|NOT COMPLETED|Overall Study||10
472486|NCT00492063|1128144|P4|COMPLETED|Overall Study||666
472487|NCT00492063|1128145|P3|COMPLETED|Overall Study||667
472488|NCT00492063|1128146|P2|COMPLETED|Overall Study||634
472489|NCT00492063|1128147|P1|COMPLETED|Overall Study||642
472490|NCT00492063|1128144|P4|STARTED|Overall Study||676
472491|NCT00492063|1128145|P3|STARTED|Overall Study||678
472492|NCT00492063|1128146|P2|STARTED|Overall Study||648
472493|NCT00492063|1128147|P1|STARTED|Overall Study||652
472494|NCT00492024|1128171|P2|NOT COMPLETED|Follow up||2
472495|NCT00492024|1128172|P1|NOT COMPLETED|Follow up||1
472496|NCT00492024|1128171|P2|COMPLETED|Follow up||99
472497|NCT00492024|1128172|P1|COMPLETED|Follow up||221
472498|NCT00492024|1128171|P2|STARTED|Follow up||101
472499|NCT00492024|1128172|P1|STARTED|Follow up||222
472500|NCT00492024|1128171|P2|NOT COMPLETED|Treatment||22
472501|NCT00492024|1128172|P1|NOT COMPLETED|Treatment||29
472502|NCT00492024|1128171|P2|COMPLETED|Treatment||101
472503|NCT00492024|1128172|P1|COMPLETED|Treatment||222
472504|NCT00492024|1128171|P2|STARTED|Treatment||123
472505|NCT00492024|1128172|P1|STARTED|Treatment||251
472506|NCT00491894|1128188|P1|NOT COMPLETED|Overall Study||34
472507|NCT00491894|1128188|P1|COMPLETED|Overall Study||103
472508|NCT00491894|1128188|P1|STARTED|Overall Study||137
472509|NCT00491829|1128199|P3|NOT COMPLETED|Overall Study||75
472510|NCT00491829|1128200|P2|NOT COMPLETED|Overall Study||114
472511|NCT00491829|1128201|P1|NOT COMPLETED|Overall Study||95
472512|NCT00491829|1128199|P3|COMPLETED|Overall Study||243
472513|NCT00491829|1128200|P2|COMPLETED|Overall Study||202
472514|NCT00491829|1128201|P1|COMPLETED|Overall Study||216
472515|NCT00491829|1128199|P3|STARTED|Overall Study||318
472516|NCT00491829|1128200|P2|STARTED|Overall Study||316
472517|NCT00491829|1128201|P1|STARTED|Overall Study||311
472518|NCT00491764|1128215|P6|NOT COMPLETED|Overall Study||9
472519|NCT00491764|1128216|P5|NOT COMPLETED|Overall Study||3
472520|NCT00491764|1128217|P4|NOT COMPLETED|Overall Study||8
472521|NCT00491764|1128218|P3|NOT COMPLETED|Overall Study||8
472522|NCT00491764|1128219|P2|NOT COMPLETED|Overall Study||7
472523|NCT00491764|1128220|P1|NOT COMPLETED|Overall Study||5
472524|NCT00491764|1128215|P6|COMPLETED|Overall Study||27
472525|NCT00491764|1128216|P5|COMPLETED|Overall Study||33
472526|NCT00491764|1128217|P4|COMPLETED|Overall Study||28
472527|NCT00491764|1128218|P3|COMPLETED|Overall Study||28
472528|NCT00491764|1128219|P2|COMPLETED|Overall Study||30
472529|NCT00491764|1128220|P1|COMPLETED|Overall Study||32
472530|NCT00491764|1128215|P6|STARTED|Overall Study||36
472531|NCT00491764|1128216|P5|STARTED|Overall Study||36
472532|NCT00491764|1128217|P4|STARTED|Overall Study||36
472533|NCT00491764|1128218|P3|STARTED|Overall Study||36
472534|NCT00491764|1128219|P2|STARTED|Overall Study||37
472535|NCT00491764|1128220|P1|STARTED|Overall Study||37
472536|NCT00491738|1128248|P2|NOT COMPLETED|Overall Study||0
472537|NCT00491738|1128249|P1|NOT COMPLETED|Overall Study||0
472538|NCT00491738|1128248|P2|COMPLETED|Overall Study||9
472539|NCT00491738|1128249|P1|COMPLETED|Overall Study||7
472540|NCT00491738|1128248|P2|STARTED|Overall Study||9
472541|NCT00491738|1128249|P1|STARTED|Overall Study||7
472542|NCT00491608|1128253|P1|NOT COMPLETED|Overall Study||3
472543|NCT00491608|1128253|P1|COMPLETED|Overall Study||206
472544|NCT00491608|1128253|P1|STARTED|Overall Study|Participants who received treatment|209
472545|NCT00491556|1128264|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
472546|NCT00491556|1128265|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
472547|NCT00491556|1128264|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
472548|NCT00491556|1128265|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
472549|NCT00491556|1128264|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
472550|NCT00491556|1128265|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
472551|NCT00491556|1128264|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
472552|NCT00491556|1128265|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
472553|NCT00491556|1128264|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
472554|NCT00491556|1128265|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
472555|NCT00491556|1128264|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
472556|NCT00491556|1128265|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
472557|NCT00491556|1128264|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
472558|NCT00491556|1128265|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
472559|NCT00491530|1128324|P3|NOT COMPLETED|Overall Study||5
472560|NCT00491530|1128325|P2|NOT COMPLETED|Overall Study||6
472561|NCT00491530|1128326|P1|NOT COMPLETED|Overall Study||12
472562|NCT00491530|1128324|P3|COMPLETED|Overall Study||81
472563|NCT00491530|1128325|P2|COMPLETED|Overall Study||44
472564|NCT00491530|1128326|P1|COMPLETED|Overall Study||162
472565|NCT00491530|1128324|P3|STARTED|Overall Study||86
472566|NCT00491530|1128325|P2|STARTED|Overall Study||50
472567|NCT00491530|1128326|P1|STARTED|Overall Study||174
472568|NCT00491504|1128356|P4|NOT COMPLETED|Overall Study||4
472569|NCT00491504|1128357|P3|NOT COMPLETED|Overall Study||4
472570|NCT00491504|1128358|P2|NOT COMPLETED|Overall Study||1
472571|NCT00491504|1128359|P1|NOT COMPLETED|Overall Study||0
472572|NCT00491504|1128356|P4|COMPLETED|Overall Study||73
472573|NCT00491504|1128357|P3|COMPLETED|Overall Study||74
472574|NCT00491504|1128358|P2|COMPLETED|Overall Study||77
472575|NCT00491504|1128359|P1|COMPLETED|Overall Study||77
472576|NCT00491504|1128356|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
472577|NCT00491504|1128357|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
472578|NCT00491504|1128358|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
472579|NCT00491504|1128359|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
472580|NCT00491400|1128369|P2|NOT COMPLETED|Overall Study||4
472581|NCT00491400|1128370|P1|NOT COMPLETED|Overall Study||5
472582|NCT00491400|1128369|P2|COMPLETED|Overall Study||9
472583|NCT00491400|1128370|P1|COMPLETED|Overall Study||10
472584|NCT00491400|1128369|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
472585|NCT00491400|1128370|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
472586|NCT00491400|1128369|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
472587|NCT00491400|1128370|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
472588|NCT00491400|1128369|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
472589|NCT00491400|1128370|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
472590|NCT00491400|1128369|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
472591|NCT00491400|1128370|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
472592|NCT00491400|1128369|P2|STARTED|Overall Study||13
472593|NCT00491400|1128370|P1|STARTED|Overall Study||15
472594|NCT00491387|1128378|P1|NOT COMPLETED|Overall Study||0
472595|NCT00491387|1128378|P1|COMPLETED|Overall Study||24
472596|NCT00491387|1128378|P1|Study Enrollment|Overall Study||24
472597|NCT00491387|1128378|P1|STARTED|Overall Study||24
472598|NCT00491374|1128384|P2|NOT COMPLETED|Overall Study||0
472599|NCT00491374|1128385|P1|NOT COMPLETED|Overall Study||0
472600|NCT00491374|1128384|P2|COMPLETED|Overall Study||0
472601|NCT00491374|1128385|P1|COMPLETED|Overall Study||0
472602|NCT00491374|1128384|P2|STARTED|Overall Study||0
472603|NCT00491374|1128385|P1|STARTED|Overall Study||0
472604|NCT00491244|1128393|P2|NOT COMPLETED|Overall Study||20
472605|NCT00491244|1128394|P1|NOT COMPLETED|Overall Study||27
472606|NCT00491244|1128393|P2|COMPLETED|Overall Study||168
472607|NCT00491244|1128394|P1|COMPLETED|Overall Study||162
472608|NCT00491244|1128393|P2|STARTED|Overall Study||188
472609|NCT00491244|1128394|P1|STARTED|Overall Study||189
472610|NCT00491179|1128404|P2|NOT COMPLETED|Overall Study||2
472611|NCT00491179|1128405|P1|NOT COMPLETED|Overall Study||7
472612|NCT00491179|1128404|P2|COMPLETED|Overall Study||8
472613|NCT00491179|1128405|P1|COMPLETED|Overall Study||18
472614|NCT00491179|1128404|P2|STARTED|Overall Study||10
472615|NCT00491179|1128405|P1|STARTED|Overall Study||25
472616|NCT00491075|1128413|P1|NOT COMPLETED|Overall Study||2
472617|NCT00491075|1128413|P1|COMPLETED|Overall Study||14
472618|NCT00491075|1128413|P1|STARTED|Overall Study||16
472619|NCT00490971|1128419|P5|NOT COMPLETED|Maintenance||39
472620|NCT00490971|1128420|P4|NOT COMPLETED|Maintenance||53
472621|NCT00490971|1128421|P3|NOT COMPLETED|Maintenance||51
472622|NCT00490971|1128422|P2|NOT COMPLETED|Maintenance||0
472623|NCT00490971|1128423|P1|NOT COMPLETED|Maintenance||0
472624|NCT00490971|1128419|P5|COMPLETED|Maintenance||44
472625|NCT00490971|1128420|P4|COMPLETED|Maintenance||96
472626|NCT00490971|1128421|P3|COMPLETED|Maintenance||96
472627|NCT00490971|1128422|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
472628|NCT00490971|1128423|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
472629|NCT00490971|1128419|P5|STARTED|Maintenance||83
472630|NCT00490971|1128420|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
472631|NCT00490971|1128421|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
472632|NCT00490971|1128422|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
472633|NCT00490971|1128423|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
472634|NCT00490971|1128419|P5|NOT COMPLETED|Acute/Continuation||0
472635|NCT00490971|1128420|P4|NOT COMPLETED|Acute/Continuation||0
472636|NCT00490971|1128421|P3|NOT COMPLETED|Acute/Continuation||0
472637|NCT00490971|1128422|P2|NOT COMPLETED|Acute/Continuation||62
472638|NCT00490971|1128423|P1|NOT COMPLETED|Acute/Continuation||306
472639|NCT00490971|1128419|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
472640|NCT00490971|1128420|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
472641|NCT00490971|1128421|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
472642|NCT00490971|1128422|P2|COMPLETED|Acute/Continuation||86
472643|NCT00490971|1128423|P1|COMPLETED|Acute/Continuation||308
472644|NCT00490971|1128419|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
472645|NCT00490971|1128420|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
472646|NCT00490971|1128421|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
472647|NCT00490971|1128422|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
472648|NCT00490971|1128423|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
472649|NCT00490945|1128470|P5|NOT COMPLETED|Overall Study||0
472650|NCT00490945|1128471|P4|NOT COMPLETED|Overall Study||0
472651|NCT00490945|1128472|P3|NOT COMPLETED|Overall Study||0
472652|NCT00490945|1128473|P2|NOT COMPLETED|Overall Study||1
472653|NCT00490945|1128474|P1|NOT COMPLETED|Overall Study||0
472654|NCT00490945|1128470|P5|COMPLETED|Overall Study||7
472655|NCT00490945|1128471|P4|COMPLETED|Overall Study||7
472656|NCT00490945|1128472|P3|COMPLETED|Overall Study||8
472657|NCT00490945|1128473|P2|COMPLETED|Overall Study||8
472658|NCT00490945|1128474|P1|COMPLETED|Overall Study||8
472659|NCT00490945|1128470|P5|STARTED|Overall Study||7
472660|NCT00490945|1128471|P4|STARTED|Overall Study||7
472661|NCT00490945|1128472|P3|STARTED|Overall Study||8
472662|NCT00490945|1128473|P2|STARTED|Overall Study||9
472663|NCT00490945|1128474|P1|STARTED|Overall Study||8
472664|NCT00490919|1128510|P3|NOT COMPLETED|Double-blind Phase||84
472665|NCT00490919|1128511|P2|NOT COMPLETED|Double-blind Phase||86
472666|NCT00490919|1128512|P1|NOT COMPLETED|Double-blind Phase||0
472667|NCT00490919|1128510|P3|COMPLETED|Double-blind Phase||199
472668|NCT00490919|1128511|P2|COMPLETED|Double-blind Phase||170
472669|NCT00490919|1128512|P1|COMPLETED|Double-blind Phase||0
472670|NCT00490919|1128510|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
472671|NCT00490919|1128511|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
472672|NCT00490919|1128512|P1|STARTED|Double-blind Phase||0
472673|NCT00490919|1128510|P3|NOT COMPLETED|Open-label Run-in Period||0
472674|NCT00490919|1128511|P2|NOT COMPLETED|Open-label Run-in Period||0
472675|NCT00490919|1128512|P1|NOT COMPLETED|Open-label Run-in Period||483
472676|NCT00490919|1128510|P3|COMPLETED|Open-label Run-in Period||0
472677|NCT00490919|1128511|P2|COMPLETED|Open-label Run-in Period||0
472678|NCT00490919|1128512|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
472679|NCT00490919|1128510|P3|STARTED|Open-label Run-in Period||0
472680|NCT00490919|1128511|P2|STARTED|Open-label Run-in Period||0
472681|NCT00490919|1128512|P1|STARTED|Open-label Run-in Period||1024
472682|NCT00490841|1128523|P1|NOT COMPLETED|Overall Study||13
472683|NCT00490841|1128523|P1|COMPLETED|Overall Study||189
472684|NCT00490841|1128523|P1|STARTED|Overall Study||202
472685|NCT00490815|1128545|P2|NOT COMPLETED|Overall Study||9
472686|NCT00490815|1128546|P1|NOT COMPLETED|Overall Study||8
472687|NCT00490815|1128545|P2|COMPLETED|Overall Study||8
472688|NCT00490815|1128546|P1|COMPLETED|Overall Study||12
472689|NCT00490815|1128545|P2|STARTED|Overall Study||17
472690|NCT00490815|1128546|P1|STARTED|Overall Study||20
472691|NCT00490802|1128556|P2|NOT COMPLETED|Overall Study||2
472692|NCT00490802|1128557|P1|NOT COMPLETED|Overall Study||1
472693|NCT00490802|1128556|P2|COMPLETED|Overall Study||7
472694|NCT00490802|1128557|P1|COMPLETED|Overall Study||9
472695|NCT00490802|1128556|P2|STARTED|Overall Study||9
472696|NCT00490802|1128557|P1|STARTED|Overall Study||10
472697|NCT00490724|1128574|P3|NOT COMPLETED|Period II||3
472698|NCT00490724|1128575|P2|NOT COMPLETED|Period II||1
472699|NCT00490724|1128576|P1|NOT COMPLETED|Period II||3
472700|NCT00490724|1128574|P3|COMPLETED|Period II||16
472701|NCT00490724|1128575|P2|COMPLETED|Period II||19
472702|NCT00490724|1128576|P1|COMPLETED|Period II||18
472703|NCT00490724|1128574|P3|STARTED|Period II||19
472704|NCT00490724|1128575|P2|STARTED|Period II||20
472705|NCT00490724|1128576|P1|STARTED|Period II||21
472706|NCT00490724|1128574|P3|NOT COMPLETED|Period I||1
472707|NCT00490724|1128575|P2|NOT COMPLETED|Period I||0
472708|NCT00490724|1128576|P1|NOT COMPLETED|Period I||0
472709|NCT00490724|1128574|P3|COMPLETED|Period I||19
472710|NCT00490724|1128575|P2|COMPLETED|Period I||20
472711|NCT00490724|1128576|P1|COMPLETED|Period I||21
472712|NCT00490724|1128574|P3|STARTED|Period I||20
472713|NCT00490724|1128575|P2|STARTED|Period I||20
472714|NCT00490724|1128576|P1|STARTED|Period I||21
472715|NCT00490698|1128641|P1|NOT COMPLETED|Overall Study||10
472716|NCT00490698|1128641|P1|COMPLETED|Overall Study||1
472717|NCT00490698|1128641|P1|STARTED|Overall Study||11
472718|NCT00490646|1128647|P2|NOT COMPLETED|Overall Study||2
472719|NCT00490646|1128648|P1|NOT COMPLETED|Overall Study||2
472720|NCT00490646|1128647|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
472813|NCT00490009|1128906|P1|COMPLETED|Overall Study||9
472721|NCT00490646|1128648|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
472722|NCT00490646|1128647|P2|Treated|Overall Study||24
472723|NCT00490646|1128648|P1|Treated|Overall Study||24
472724|NCT00490646|1128647|P2|STARTED|Overall Study||25
472725|NCT00490646|1128648|P1|STARTED|Overall Study||25
472726|NCT00490555|1128672|P4|NOT COMPLETED|Overall Study||0
472727|NCT00490555|1128673|P3|NOT COMPLETED|Overall Study||2
472728|NCT00490555|1128674|P2|NOT COMPLETED|Overall Study||0
472729|NCT00490555|1128675|P1|NOT COMPLETED|Overall Study||0
472730|NCT00490555|1128672|P4|COMPLETED|Overall Study||7
472731|NCT00490555|1128673|P3|COMPLETED|Overall Study||7
472732|NCT00490555|1128674|P2|COMPLETED|Overall Study||8
472733|NCT00490555|1128675|P1|COMPLETED|Overall Study||8
472734|NCT00490555|1128672|P4|STARTED|Overall Study||7
472735|NCT00490555|1128673|P3|STARTED|Overall Study||9
472736|NCT00490555|1128674|P2|STARTED|Overall Study||8
472737|NCT00490555|1128675|P1|STARTED|Overall Study||8
472738|NCT00490542|1128703|P2|NOT COMPLETED|Overall Study||4
472739|NCT00490542|1128704|P1|NOT COMPLETED|Overall Study||7
472740|NCT00490542|1128703|P2|COMPLETED|Overall Study||31
472741|NCT00490542|1128704|P1|COMPLETED|Overall Study||31
472742|NCT00490542|1128703|P2|STARTED|Overall Study||35
472743|NCT00490542|1128704|P1|STARTED|Overall Study||38
472744|NCT00490490|1128710|P1|NOT COMPLETED|Completed Assessment for TTP||3
472745|NCT00490490|1128710|P1|COMPLETED|Completed Assessment for TTP||5
472746|NCT00490490|1128710|P1|STARTED|Completed Assessment for TTP||8
472747|NCT00490490|1128710|P1|NOT COMPLETED|Completed Assessment for CR||0
472748|NCT00490490|1128710|P1|COMPLETED|Completed Assessment for CR||8
472749|NCT00490490|1128710|P1|STARTED|Completed Assessment for CR||8
472750|NCT00490477|1128718|P2|NOT COMPLETED|Overall Study||0
472751|NCT00490477|1128719|P1|NOT COMPLETED|Overall Study||0
472752|NCT00490477|1128718|P2|COMPLETED|Overall Study||8
472753|NCT00490477|1128719|P1|COMPLETED|Overall Study||8
472754|NCT00490477|1128718|P2|STARTED|Overall Study||8
472755|NCT00490477|1128719|P1|STARTED|Overall Study||8
472756|NCT00490269|1128727|P2|NOT COMPLETED|Placebo Then Dronabinol||0
472757|NCT00490269|1128728|P1|NOT COMPLETED|Placebo Then Dronabinol||0
472758|NCT00490269|1128727|P2|COMPLETED|Placebo Then Dronabinol||6
472759|NCT00490269|1128728|P1|COMPLETED|Placebo Then Dronabinol||6
472760|NCT00490269|1128727|P2|STARTED|Placebo Then Dronabinol||6
472761|NCT00490269|1128728|P1|STARTED|Placebo Then Dronabinol||6
472762|NCT00490269|1128727|P2|NOT COMPLETED|Dronabinol Then Placebo||0
472763|NCT00490269|1128728|P1|NOT COMPLETED|Dronabinol Then Placebo||0
472764|NCT00490269|1128727|P2|COMPLETED|Dronabinol Then Placebo||6
472765|NCT00490269|1128728|P1|COMPLETED|Dronabinol Then Placebo||6
472766|NCT00490269|1128727|P2|STARTED|Dronabinol Then Placebo||6
472767|NCT00490269|1128728|P1|STARTED|Dronabinol Then Placebo||6
472768|NCT00490256|1128736|P2|NOT COMPLETED|Overall Study||0
472769|NCT00490256|1128737|P1|NOT COMPLETED|Overall Study||0
472770|NCT00490256|1128736|P2|COMPLETED|Overall Study||7
472771|NCT00490256|1128737|P1|COMPLETED|Overall Study||7
472772|NCT00490256|1128736|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
472773|NCT00490256|1128737|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
472774|NCT00490256|1128736|P2|STARTED|Overall Study||7
472775|NCT00490256|1128737|P1|STARTED|Overall Study||7
472776|NCT00490139|1128747|P4|NOT COMPLETED|Overall Study||307
472777|NCT00490139|1128748|P3|NOT COMPLETED|Overall Study||434
472778|NCT00490139|1128749|P2|NOT COMPLETED|Overall Study||275
472779|NCT00490139|1128750|P1|NOT COMPLETED|Overall Study||308
472780|NCT00490139|1128747|P4|COMPLETED|Overall Study||1790
472781|NCT00490139|1128748|P3|COMPLETED|Overall Study||1666
472782|NCT00490139|1128749|P2|COMPLETED|Overall Study||1816
472783|NCT00490139|1128750|P1|COMPLETED|Overall Study||1785
472784|NCT00490139|1128747|P4|STARTED|Overall Study||2097
472785|NCT00490139|1128748|P3|STARTED|Overall Study||2100
472786|NCT00490139|1128749|P2|STARTED|Overall Study||2091
472787|NCT00490139|1128750|P1|STARTED|Overall Study||2093
472788|NCT00490100|1128780|P1|NOT COMPLETED|Overall Study||3
472789|NCT00490100|1128780|P1|COMPLETED|Overall Study||3
472790|NCT00490100|1128780|P1|STARTED|Overall Study||6
472791|NCT00490061|1128785|P1|NOT COMPLETED|Overall Study||1
472792|NCT00490061|1128785|P1|COMPLETED|Overall Study||16
472793|NCT00490061|1128785|P1|STARTED|Overall Study||17
472794|NCT00490035|1128794|P4|NOT COMPLETED|Overall Study||6
472795|NCT00490035|1128795|P3|NOT COMPLETED|Overall Study||12
472796|NCT00490035|1128796|P2|NOT COMPLETED|Overall Study||6
472797|NCT00490035|1128797|P1|NOT COMPLETED|Overall Study||8
472798|NCT00490035|1128794|P4|COMPLETED|Overall Study||94
472799|NCT00490035|1128795|P3|COMPLETED|Overall Study||88
472800|NCT00490035|1128796|P2|COMPLETED|Overall Study||93
472801|NCT00490035|1128797|P1|COMPLETED|Overall Study||92
472802|NCT00490035|1128794|P4|STARTED|Overall Study||100
472803|NCT00490035|1128795|P3|STARTED|Overall Study||100
472804|NCT00490035|1128796|P2|STARTED|Overall Study||99
472805|NCT00490035|1128797|P1|STARTED|Overall Study||100
472806|NCT00490022|1128897|P2|NOT COMPLETED|Overall Study||3
472807|NCT00490022|1128898|P1|NOT COMPLETED|Overall Study||1
472808|NCT00490022|1128897|P2|COMPLETED|Overall Study||12
472809|NCT00490022|1128898|P1|COMPLETED|Overall Study||15
472810|NCT00490022|1128897|P2|STARTED|Overall Study||15
472811|NCT00490022|1128898|P1|STARTED|Overall Study||16
472812|NCT00490009|1128906|P1|NOT COMPLETED|Overall Study||0
472814|NCT00490009|1128906|P1|STARTED|Overall Study||9
472815|NCT00489970|1128914|P2|NOT COMPLETED|Persistence Year 5||0
472816|NCT00489970|1128915|P1|NOT COMPLETED|Persistence Year 5||0
472817|NCT00489970|1128914|P2|COMPLETED|Persistence Year 5||401
472818|NCT00489970|1128915|P1|COMPLETED|Persistence Year 5||856
472819|NCT00489970|1128914|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
472820|NCT00489970|1128915|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
472821|NCT00489970|1128914|P2|NOT COMPLETED|Persistence Year 3||0
472822|NCT00489970|1128915|P1|NOT COMPLETED|Persistence Year 3||0
472823|NCT00489970|1128914|P2|COMPLETED|Persistence Year 3||486
472824|NCT00489970|1128915|P1|COMPLETED|Persistence Year 3||1019
472825|NCT00489970|1128914|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
472826|NCT00489970|1128915|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
472827|NCT00489970|1128914|P2|NOT COMPLETED|Persistence Year 1||0
472828|NCT00489970|1128915|P1|NOT COMPLETED|Persistence Year 1||0
472829|NCT00489970|1128914|P2|COMPLETED|Persistence Year 1||523
472830|NCT00489970|1128915|P1|COMPLETED|Persistence Year 1||1069
472831|NCT00489970|1128914|P2|STARTED|Persistence Year 1||523
472832|NCT00489970|1128915|P1|STARTED|Persistence Year 1||1069
472833|NCT00489866|1128941|P2|NOT COMPLETED|Overall Study||0
472834|NCT00489866|1128942|P1|NOT COMPLETED|Overall Study||2
472835|NCT00489866|1128941|P2|COMPLETED|Overall Study||7
472836|NCT00489866|1128942|P1|COMPLETED|Overall Study||5
472837|NCT00489866|1128941|P2|STARTED|Overall Study||7
472838|NCT00489866|1128942|P1|STARTED|Overall Study||7
472839|NCT00489853|1128956|P3|NOT COMPLETED|Follow-up Period||0
472840|NCT00489853|1128957|P2|NOT COMPLETED|Follow-up Period||0
472841|NCT00489853|1128958|P1|NOT COMPLETED|Follow-up Period||0
472842|NCT00489853|1128956|P3|COMPLETED|Follow-up Period||33
472843|NCT00489853|1128957|P2|COMPLETED|Follow-up Period||29
472844|NCT00489853|1128958|P1|COMPLETED|Follow-up Period||29
472845|NCT00489853|1128956|P3|STARTED|Follow-up Period||33
472846|NCT00489853|1128957|P2|STARTED|Follow-up Period||29
472847|NCT00489853|1128958|P1|STARTED|Follow-up Period||29
472848|NCT00489853|1128956|P3|NOT COMPLETED|Treatment Period 3||0
472849|NCT00489853|1128957|P2|NOT COMPLETED|Treatment Period 3||1
472850|NCT00489853|1128958|P1|NOT COMPLETED|Treatment Period 3||0
472851|NCT00489853|1128956|P3|COMPLETED|Treatment Period 3||33
472852|NCT00489853|1128957|P2|COMPLETED|Treatment Period 3||29
472853|NCT00489853|1128958|P1|COMPLETED|Treatment Period 3||29
472854|NCT00489853|1128956|P3|STARTED|Treatment Period 3||33
472855|NCT00489853|1128957|P2|STARTED|Treatment Period 3||30
472856|NCT00489853|1128958|P1|STARTED|Treatment Period 3||29
472857|NCT00489853|1128956|P3|NOT COMPLETED|Wash-out Period 2||2
472858|NCT00489853|1128957|P2|NOT COMPLETED|Wash-out Period 2||3
472859|NCT00489853|1128958|P1|NOT COMPLETED|Wash-out Period 2||4
472860|NCT00489853|1128956|P3|COMPLETED|Wash-out Period 2||31
472861|NCT00489853|1128957|P2|COMPLETED|Wash-out Period 2||32
472862|NCT00489853|1128958|P1|COMPLETED|Wash-out Period 2||29
472863|NCT00489853|1128956|P3|STARTED|Wash-out Period 2||33
472864|NCT00489853|1128957|P2|STARTED|Wash-out Period 2||35
472865|NCT00489853|1128958|P1|STARTED|Wash-out Period 2||33
472866|NCT00489853|1128956|P3|NOT COMPLETED|Treatment Period 2||0
472867|NCT00489853|1128957|P2|NOT COMPLETED|Treatment Period 2||0
472868|NCT00489853|1128958|P1|NOT COMPLETED|Treatment Period 2||0
472869|NCT00489853|1128956|P3|COMPLETED|Treatment Period 2||33
472870|NCT00489853|1128957|P2|COMPLETED|Treatment Period 2||35
472871|NCT00489853|1128958|P1|COMPLETED|Treatment Period 2||33
472872|NCT00489853|1128956|P3|STARTED|Treatment Period 2||33
472873|NCT00489853|1128957|P2|STARTED|Treatment Period 2||35
472874|NCT00489853|1128958|P1|STARTED|Treatment Period 2||33
472875|NCT00489853|1128956|P3|NOT COMPLETED|Wash-out Period 1||6
472876|NCT00489853|1128957|P2|NOT COMPLETED|Wash-out Period 1||3
472877|NCT00489853|1128958|P1|NOT COMPLETED|Wash-out Period 1||1
472878|NCT00489853|1128956|P3|COMPLETED|Wash-out Period 1||32
472879|NCT00489853|1128957|P2|COMPLETED|Wash-out Period 1||34
472880|NCT00489853|1128958|P1|COMPLETED|Wash-out Period 1||35
472881|NCT00489853|1128956|P3|STARTED|Wash-out Period 1||38
472882|NCT00489853|1128957|P2|STARTED|Wash-out Period 1||37
472883|NCT00489853|1128958|P1|STARTED|Wash-out Period 1||36
472884|NCT00489853|1128956|P3|NOT COMPLETED|Treatment Period 1||0
472885|NCT00489853|1128957|P2|NOT COMPLETED|Treatment Period 1||0
472886|NCT00489853|1128958|P1|NOT COMPLETED|Treatment Period 1||0
472887|NCT00489853|1128956|P3|COMPLETED|Treatment Period 1||38
472888|NCT00489853|1128957|P2|COMPLETED|Treatment Period 1||37
472889|NCT00489853|1128958|P1|COMPLETED|Treatment Period 1||36
472890|NCT00489853|1128956|P3|STARTED|Treatment Period 1||38
472891|NCT00489853|1128957|P2|STARTED|Treatment Period 1||37
472892|NCT00489853|1128958|P1|STARTED|Treatment Period 1||36
472893|NCT00489736|1129055|P2|NOT COMPLETED|Overall Study||69
472894|NCT00489736|1129056|P1|NOT COMPLETED|Overall Study||96
472895|NCT00489736|1129055|P2|COMPLETED|Overall Study|completed study drug period|186
472896|NCT00489736|1129056|P1|COMPLETED|Overall Study|completed study drug period|153
472897|NCT00489736|1129055|P2|STARTED|Overall Study|Randomized and treated patients|255
472898|NCT00489736|1129056|P1|STARTED|Overall Study|Randomized and treated patients|249
472899|NCT00489554|1129066|P1|NOT COMPLETED|Overall Study||4
472900|NCT00489554|1129066|P1|COMPLETED|Overall Study||226
472901|NCT00489554|1129066|P1|STARTED|Overall Study||230
472902|NCT00489541|1129086|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
472903|NCT00489541|1129087|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
472904|NCT00489541|1129086|P2|COMPLETED|9-Month Angiographic Follow-up||108
472905|NCT00489541|1129087|P1|COMPLETED|9-Month Angiographic Follow-up||197
472906|NCT00489541|1129086|P2|STARTED|9-Month Angiographic Follow-up||125
472907|NCT00489541|1129087|P1|STARTED|9-Month Angiographic Follow-up||224
472908|NCT00489541|1129086|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
472909|NCT00489541|1129087|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
472910|NCT00489541|1129086|P2|COMPLETED|12-Month Clinical Follow-up||120
472911|NCT00489541|1129087|P1|COMPLETED|12-Month Clinical Follow-up||215
472912|NCT00489541|1129086|P2|STARTED|12-Month Clinical Follow-up||125
472913|NCT00489541|1129087|P1|STARTED|12-Month Clinical Follow-up||224
472914|NCT00489489|1129098|P3|NOT COMPLETED|Overall Study||3
472915|NCT00489489|1129099|P2|NOT COMPLETED|Overall Study||5
472916|NCT00489489|1129100|P1|NOT COMPLETED|Overall Study||3
472917|NCT00489489|1129098|P3|COMPLETED|Overall Study|completed treatment period|37
472918|NCT00489489|1129099|P2|COMPLETED|Overall Study|completed treatment period|32
472919|NCT00489489|1129100|P1|COMPLETED|Overall Study|completed treatment period|38
472920|NCT00489489|1129098|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
472921|NCT00489489|1129099|P2|Treated|Overall Study||36
472922|NCT00489489|1129100|P1|Treated|Overall Study||41
472923|NCT00489489|1129098|P3|STARTED|Overall Study|randomized|40
472924|NCT00489489|1129099|P2|STARTED|Overall Study|randomized|37
472925|NCT00489489|1129100|P1|STARTED|Overall Study|randomized|41
472926|NCT00489476|1129132|P4|NOT COMPLETED|Overall Study||0
472927|NCT00489476|1129133|P3|NOT COMPLETED|Overall Study||0
472928|NCT00489476|1129134|P2|NOT COMPLETED|Overall Study||1
472929|NCT00489476|1129135|P1|NOT COMPLETED|Overall Study||0
472930|NCT00489476|1129132|P4|COMPLETED|Overall Study||43
472931|NCT00489476|1129133|P3|COMPLETED|Overall Study||43
472932|NCT00489476|1129134|P2|COMPLETED|Overall Study||42
472933|NCT00489476|1129135|P1|COMPLETED|Overall Study||39
472934|NCT00489476|1129132|P4|STARTED|Overall Study||43
472935|NCT00489476|1129133|P3|STARTED|Overall Study||43
472936|NCT00489476|1129134|P2|STARTED|Overall Study||43
472937|NCT00489476|1129135|P1|STARTED|Overall Study||39
472938|NCT00489424|1129156|P3|NOT COMPLETED|Overall Study||5
472939|NCT00489424|1129157|P2|NOT COMPLETED|Overall Study||5
472940|NCT00489424|1129158|P1|NOT COMPLETED|Overall Study||4
472941|NCT00489424|1129156|P3|COMPLETED|Overall Study||257
472942|NCT00489424|1129157|P2|COMPLETED|Overall Study||259
472943|NCT00489424|1129158|P1|COMPLETED|Overall Study||263
472944|NCT00489424|1129156|P3|STARTED|Overall Study||262
472945|NCT00489424|1129157|P2|STARTED|Overall Study||264
472946|NCT00489424|1129158|P1|STARTED|Overall Study||267
472947|NCT00489411|1129189|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
472948|NCT00489411|1129190|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
472949|NCT00489411|1129189|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
472950|NCT00489411|1129190|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
472951|NCT00489411|1129189|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
472952|NCT00489411|1129190|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
472953|NCT00489411|1129189|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
472954|NCT00489411|1129190|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
472955|NCT00489411|1129189|P2|COMPLETED|Washout Period (Weeks 6-7)||93
472956|NCT00489411|1129190|P1|COMPLETED|Washout Period (Weeks 6-7)||85
472957|NCT00489411|1129189|P2|STARTED|Washout Period (Weeks 6-7)||94
472958|NCT00489411|1129190|P1|STARTED|Washout Period (Weeks 6-7)||87
472959|NCT00489411|1129189|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
472960|NCT00489411|1129190|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
472961|NCT00489411|1129189|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
472962|NCT00489411|1129190|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
472963|NCT00489411|1129189|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
472964|NCT00489411|1129190|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
472965|NCT00489359|1129204|P2|NOT COMPLETED|Overall Study||29
472966|NCT00489359|1129205|P1|NOT COMPLETED|Overall Study||7
472967|NCT00489359|1129204|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
472968|NCT00489359|1129205|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
472969|NCT00489359|1129204|P2|STARTED|Overall Study||66
472970|NCT00489359|1129205|P1|STARTED|Overall Study||20
472971|NCT00489268|1129233|P5|NOT COMPLETED|Overall Study||20
472972|NCT00489268|1129234|P4|NOT COMPLETED|Overall Study||0
472973|NCT00489268|1129235|P3|NOT COMPLETED|Overall Study||1
472974|NCT00489268|1129236|P2|NOT COMPLETED|Overall Study||0
472975|NCT00489268|1129237|P1|NOT COMPLETED|Overall Study||0
472976|NCT00489268|1129233|P5|COMPLETED|Overall Study||50
472977|NCT00489268|1129234|P4|COMPLETED|Overall Study||11
472978|NCT00489268|1129235|P3|COMPLETED|Overall Study||9
472979|NCT00489268|1129236|P2|COMPLETED|Overall Study||10
472980|NCT00489268|1129237|P1|COMPLETED|Overall Study||1
472981|NCT00489268|1129233|P5|STARTED|Overall Study||70
472982|NCT00489268|1129234|P4|STARTED|Overall Study||11
472983|NCT00489268|1129235|P3|STARTED|Overall Study||10
472984|NCT00489268|1129236|P2|STARTED|Overall Study||10
472985|NCT00489268|1129237|P1|STARTED|Overall Study||1
472986|NCT00489255|1129266|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
472987|NCT00489255|1129267|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
473147|NCT00488345|1129621|P3|STARTED|Overall Study||20
472988|NCT00489255|1129266|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
472989|NCT00489255|1129267|P1|COMPLETED|Period 3: Days 57 to 84||24
472990|NCT00489255|1129266|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
472991|NCT00489255|1129267|P1|STARTED|Period 3: Days 57 to 84||28
472992|NCT00489255|1129266|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
472993|NCT00489255|1129267|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
472994|NCT00489255|1129266|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
472995|NCT00489255|1129267|P1|COMPLETED|Period 2: Days 29 to 56||61
472996|NCT00489255|1129266|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
472997|NCT00489255|1129267|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
472998|NCT00489255|1129266|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
472999|NCT00489255|1129267|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
473000|NCT00489255|1129266|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
473001|NCT00489255|1129267|P1|STARTED|Period 2: Days 29 to 56||64
473002|NCT00489255|1129266|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
473003|NCT00489255|1129267|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
473004|NCT00489255|1129266|P2|COMPLETED|Period 1: Days 1 to 28||34
473005|NCT00489255|1129267|P1|COMPLETED|Period 1: Days 1 to 28||107
473006|NCT00489255|1129266|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
473007|NCT00489255|1129267|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
473008|NCT00489255|1129266|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
473009|NCT00489255|1129267|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
473010|NCT00489255|1129266|P2|STARTED|Period 1: Days 1 to 28||46
473011|NCT00489255|1129267|P1|STARTED|Period 1: Days 1 to 28||136
473012|NCT00489255|1129266|P2|NOT COMPLETED|Screening and Initial Randomization||3
473013|NCT00489255|1129267|P1|NOT COMPLETED|Screening and Initial Randomization||9
473014|NCT00489255|1129266|P2|COMPLETED|Screening and Initial Randomization||46
473015|NCT00489255|1129267|P1|COMPLETED|Screening and Initial Randomization||136
473016|NCT00489255|1129266|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
473017|NCT00489255|1129267|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
473018|NCT00489216|1129315|P1|NOT COMPLETED|Overall Study||1
473019|NCT00489216|1129315|P1|COMPLETED|Overall Study||1
473020|NCT00489216|1129315|P1|STARTED|Overall Study||2
473021|NCT00489086|1129324|P1|NOT COMPLETED|Overall Study||23
473022|NCT00489086|1129324|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
473023|NCT00489086|1129324|P1|STARTED|Overall Study||36
473024|NCT00488865|1129328|P1|NOT COMPLETED|Overall Study||0
473025|NCT00488865|1129328|P1|COMPLETED|Overall Study||100
473026|NCT00488865|1129328|P1|STARTED|Overall Study||100
473027|NCT00488826|1129337|P3|NOT COMPLETED|Overall Study||26
473028|NCT00488826|1129338|P2|NOT COMPLETED|Overall Study||52
473029|NCT00488826|1129339|P1|NOT COMPLETED|Overall Study||56
473030|NCT00488826|1129337|P3|COMPLETED|Overall Study||178
473031|NCT00488826|1129338|P2|COMPLETED|Overall Study||244
473032|NCT00488826|1129339|P1|COMPLETED|Overall Study||244
473033|NCT00488826|1129337|P3|STARTED|Overall Study||204
473034|NCT00488826|1129338|P2|STARTED|Overall Study||296
473035|NCT00488826|1129339|P1|STARTED|Overall Study||300
473036|NCT00488774|1129354|P4|NOT COMPLETED|Overall Study||3
473037|NCT00488774|1129355|P3|NOT COMPLETED|Overall Study||5
473038|NCT00488774|1129356|P2|NOT COMPLETED|Overall Study||5
473039|NCT00488774|1129357|P1|NOT COMPLETED|Overall Study||8
473040|NCT00488774|1129354|P4|COMPLETED|Overall Study||74
473041|NCT00488774|1129355|P3|COMPLETED|Overall Study||70
473042|NCT00488774|1129356|P2|COMPLETED|Overall Study||57
473043|NCT00488774|1129357|P1|COMPLETED|Overall Study||69
473044|NCT00488774|1129354|P4|STARTED|Overall Study||77
473045|NCT00488774|1129355|P3|STARTED|Overall Study||75
473046|NCT00488774|1129356|P2|STARTED|Overall Study||62
473047|NCT00488774|1129357|P1|STARTED|Overall Study||77
473048|NCT00488683|1129374|P3|NOT COMPLETED|Overall Study||2
473049|NCT00488683|1129375|P2|NOT COMPLETED|Overall Study||6
473050|NCT00488683|1129376|P1|NOT COMPLETED|Overall Study||12
473051|NCT00488683|1129374|P3|COMPLETED|Overall Study||52
473052|NCT00488683|1129375|P2|COMPLETED|Overall Study||48
473053|NCT00488683|1129376|P1|COMPLETED|Overall Study||96
473054|NCT00488683|1129374|P3|STARTED|Overall Study||54
473055|NCT00488683|1129375|P2|STARTED|Overall Study||54
473056|NCT00488683|1129376|P1|STARTED|Overall Study||108
473057|NCT00488644|1129435|P1|NOT COMPLETED|Overall Study||2
473058|NCT00488644|1129435|P1|COMPLETED|Overall Study||10
473059|NCT00488644|1129435|P1|STARTED|Overall Study||12
473060|NCT00488631|1129445|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
473061|NCT00488631|1129446|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
473062|NCT00488631|1129447|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
473063|NCT00488631|1129448|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
473064|NCT00488631|1129449|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
473065|NCT00488631|1129450|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
473066|NCT00488631|1129451|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
473067|NCT00488631|1129452|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
473068|NCT00488631|1129453|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
473069|NCT00488631|1129454|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
473070|NCT00488631|1129445|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
473071|NCT00488631|1129446|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
473072|NCT00488631|1129447|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
473073|NCT00488631|1129448|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
473074|NCT00488631|1129449|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
473075|NCT00488631|1129450|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
473076|NCT00488631|1129451|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
473077|NCT00488631|1129452|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
473078|NCT00488631|1129453|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
473079|NCT00488631|1129454|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
473080|NCT00488631|1129445|P10|STARTED|Open Label Study Extension (Week 54-228)||7
473081|NCT00488631|1129446|P9|STARTED|Open Label Study Extension (Week 54-228)||470
473082|NCT00488631|1129447|P8|STARTED|Open Label Study Extension (Week 54-228)||93
473083|NCT00488631|1129448|P7|STARTED|Open Label Study Extension (Week 54-228)||96
473084|NCT00488631|1129449|P6|STARTED|Open Label Study Extension (Week 54-228)||0
473085|NCT00488631|1129450|P5|STARTED|Open Label Study Extension (Week 54-228)||0
473086|NCT00488631|1129451|P4|STARTED|Open Label Study Extension (Week 54-228)||0
473087|NCT00488631|1129452|P3|STARTED|Open Label Study Extension (Week 54-228)||0
473088|NCT00488631|1129453|P2|STARTED|Open Label Study Extension (Week 54-228)||0
473089|NCT00488631|1129454|P1|STARTED|Open Label Study Extension (Week 54-228)||0
473090|NCT00488631|1129445|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
473091|NCT00488631|1129446|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
473092|NCT00488631|1129447|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
473093|NCT00488631|1129448|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
473094|NCT00488631|1129449|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
473095|NCT00488631|1129450|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
473096|NCT00488631|1129451|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
473097|NCT00488631|1129452|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
473098|NCT00488631|1129453|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
473099|NCT00488631|1129454|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
473100|NCT00488631|1129445|P10|COMPLETED|Double Blind Period (Week 0-54)||0
473101|NCT00488631|1129446|P9|COMPLETED|Double Blind Period (Week 0-54)||0
473102|NCT00488631|1129447|P8|COMPLETED|Double Blind Period (Week 0-54)||0
473103|NCT00488631|1129448|P7|COMPLETED|Double Blind Period (Week 0-54)||0
473104|NCT00488631|1129449|P6|COMPLETED|Double Blind Period (Week 0-54)||189
473105|NCT00488631|1129450|P5|COMPLETED|Double Blind Period (Week 0-54)||127
473106|NCT00488631|1129451|P4|COMPLETED|Double Blind Period (Week 0-54)||88
473107|NCT00488631|1129452|P3|COMPLETED|Double Blind Period (Week 0-54)||109
473108|NCT00488631|1129453|P2|COMPLETED|Double Blind Period (Week 0-54)||111
473109|NCT00488631|1129454|P1|COMPLETED|Double Blind Period (Week 0-54)||113
473110|NCT00488631|1129445|P10|STARTED|Double Blind Period (Week 0-54)||0
473111|NCT00488631|1129446|P9|STARTED|Double Blind Period (Week 0-54)||0
473112|NCT00488631|1129447|P8|STARTED|Double Blind Period (Week 0-54)||0
473113|NCT00488631|1129448|P7|STARTED|Double Blind Period (Week 0-54)||0
473114|NCT00488631|1129449|P6|STARTED|Double Blind Period (Week 0-54)||405
473115|NCT00488631|1129450|P5|STARTED|Double Blind Period (Week 0-54)||230
473116|NCT00488631|1129451|P4|STARTED|Double Blind Period (Week 0-54)||129
473117|NCT00488631|1129452|P3|STARTED|Double Blind Period (Week 0-54)||154
473118|NCT00488631|1129453|P2|STARTED|Double Blind Period (Week 0-54)||154
473119|NCT00488631|1129454|P1|STARTED|Double Blind Period (Week 0-54)||156
473120|NCT00488618|1129491|P2|NOT COMPLETED|Overall Study||43
473121|NCT00488618|1129492|P1|NOT COMPLETED|Overall Study||47
473122|NCT00488618|1129491|P2|COMPLETED|Overall Study||75
473123|NCT00488618|1129492|P1|COMPLETED|Overall Study||73
473124|NCT00488618|1129491|P2|Safety Population: Received Study Drug|Overall Study||118
473125|NCT00488618|1129492|P1|Safety Population: Received Study Drug|Overall Study||118
473126|NCT00488618|1129491|P2|STARTED|Overall Study||118
473127|NCT00488618|1129492|P1|STARTED|Overall Study||120
473128|NCT00488592|1129500|P1|NOT COMPLETED|Overall Study||3
473129|NCT00488592|1129500|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
473130|NCT00488592|1129500|P1|STARTED|Overall Study|10 subjects were accrued|10
473131|NCT00488514|1129504|P1|NOT COMPLETED|Overall Study||293
473132|NCT00488514|1129504|P1|COMPLETED|Overall Study||363
473133|NCT00488514|1129504|P1|STARTED|Overall Study||656
473134|NCT00488488|1129577|P1|NOT COMPLETED|Overall Study||268
473135|NCT00488488|1129577|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
473136|NCT00488488|1129577|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
473137|NCT00488488|1129577|P1|STARTED|Overall Study||1028
473138|NCT00488475|1129592|P1|NOT COMPLETED|Overall Study||1754
473139|NCT00488475|1129592|P1|COMPLETED|Overall Study||3191
473140|NCT00488475|1129592|P1|STARTED|Overall Study||4945
473141|NCT00488345|1129621|P3|NOT COMPLETED|Overall Study||3
473142|NCT00488345|1129622|P2|NOT COMPLETED|Overall Study||4
473143|NCT00488345|1129623|P1|NOT COMPLETED|Overall Study||0
473144|NCT00488345|1129621|P3|COMPLETED|Overall Study||17
473145|NCT00488345|1129622|P2|COMPLETED|Overall Study||17
473146|NCT00488345|1129623|P1|COMPLETED|Overall Study||17
473148|NCT00488345|1129622|P2|STARTED|Overall Study||21
473149|NCT00488345|1129623|P1|STARTED|Overall Study||17
473150|NCT00488319|1129649|P3|NOT COMPLETED|Overall Study||122
473151|NCT00488319|1129650|P2|NOT COMPLETED|Overall Study||43
473152|NCT00488319|1129651|P1|NOT COMPLETED|Overall Study||15
473153|NCT00488319|1129649|P3|COMPLETED|Overall Study||121
473154|NCT00488319|1129650|P2|COMPLETED|Overall Study||75
473155|NCT00488319|1129651|P1|COMPLETED|Overall Study||24
473156|NCT00488319|1129649|P3|STARTED|Overall Study||243
473157|NCT00488319|1129650|P2|STARTED|Overall Study||118
473158|NCT00488319|1129651|P1|STARTED|Overall Study||39
473159|NCT00488293|1129738|P2|NOT COMPLETED|Overall Study||30
473160|NCT00488293|1129739|P1|NOT COMPLETED|Overall Study||36
473161|NCT00488293|1129738|P2|COMPLETED|Overall Study||166
473162|NCT00488293|1129739|P1|COMPLETED|Overall Study||160
473163|NCT00488293|1129738|P2|STARTED|Overall Study||196
473164|NCT00488293|1129739|P1|STARTED|Overall Study||196
473165|NCT00488059|1129763|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
473166|NCT00488059|1129764|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
473167|NCT00488059|1129765|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
473168|NCT00488059|1129763|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
473169|NCT00488059|1129764|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
473170|NCT00488059|1129765|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
473171|NCT00488059|1129763|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
473172|NCT00488059|1129764|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
473173|NCT00488059|1129765|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
473174|NCT00488059|1129763|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
473175|NCT00488059|1129764|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
473176|NCT00488059|1129765|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
473177|NCT00488059|1129763|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
473178|NCT00488059|1129764|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
473179|NCT00488059|1129765|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
473180|NCT00488059|1129763|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
473181|NCT00488059|1129764|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
473182|NCT00488059|1129765|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
473183|NCT00488059|1129763|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
473184|NCT00488059|1129764|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
473185|NCT00488059|1129765|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
473186|NCT00488059|1129763|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
473187|NCT00488059|1129764|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
473188|NCT00488059|1129765|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
473189|NCT00488059|1129763|P3|STARTED|Phase I: ENF 90mg SC BID||0
473190|NCT00488059|1129764|P2|STARTED|Phase I: ENF 90mg SC BID||0
473191|NCT00488059|1129765|P1|STARTED|Phase I: ENF 90mg SC BID||29
473192|NCT00488033|1129784|P2|NOT COMPLETED|Overall Study||0
473193|NCT00488033|1129785|P1|NOT COMPLETED|Overall Study||1
473194|NCT00488033|1129784|P2|COMPLETED|Overall Study||452
473195|NCT00488033|1129785|P1|COMPLETED|Overall Study||447
473196|NCT00488033|1129784|P2|STARTED|Overall Study||452
473197|NCT00488033|1129785|P1|STARTED|Overall Study||448
473198|NCT00487981|1129801|P1|NOT COMPLETED|Overall Study||1
473199|NCT00487981|1129801|P1|COMPLETED|Overall Study||0
473200|NCT00487981|1129801|P1|STARTED|Overall Study||1
473201|NCT00487942|1129809|P4|NOT COMPLETED|Overall Study||2
473202|NCT00487942|1129810|P3|NOT COMPLETED|Overall Study||3
473203|NCT00487942|1129811|P2|NOT COMPLETED|Overall Study||3
473204|NCT00487942|1129812|P1|NOT COMPLETED|Overall Study||3
473205|NCT00487942|1129809|P4|COMPLETED|Overall Study||13
473206|NCT00487942|1129810|P3|COMPLETED|Overall Study||12
473207|NCT00487942|1129811|P2|COMPLETED|Overall Study||12
473208|NCT00487942|1129812|P1|COMPLETED|Overall Study||12
473209|NCT00487942|1129809|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
473210|NCT00487942|1129810|P3|STARTED|Overall Study||15
473211|NCT00487942|1129811|P2|STARTED|Overall Study||15
473212|NCT00487942|1129812|P1|STARTED|Overall Study||15
473213|NCT00487825|1130196|P2|NOT COMPLETED|Overall Study||5
473214|NCT00487825|1130197|P1|NOT COMPLETED|Overall Study||6
473215|NCT00487825|1130196|P2|COMPLETED|Overall Study||21
473216|NCT00487825|1130197|P1|COMPLETED|Overall Study||46
473217|NCT00487825|1130196|P2|STARTED|Overall Study||26
473218|NCT00487825|1130197|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
473219|NCT00487747|1130209|P1|NOT COMPLETED|Overall Study||11
473220|NCT00487747|1130209|P1|COMPLETED|Overall Study||7
473221|NCT00487747|1130209|P1|STARTED|Overall Study||18
473222|NCT00487721|1130220|P2|NOT COMPLETED|Overall Study||0
473223|NCT00487721|1130221|P1|NOT COMPLETED|Overall Study||0
473224|NCT00487721|1130220|P2|COMPLETED|Overall Study||6
473225|NCT00487721|1130221|P1|COMPLETED|Overall Study||6
473226|NCT00487721|1130220|P2|STARTED|Overall Study||6
473227|NCT00487721|1130221|P1|STARTED|Overall Study||6
473228|NCT00487695|1130226|P2|NOT COMPLETED|Second Procedure||3
473229|NCT00487695|1130227|P1|NOT COMPLETED|Second Procedure||1
473230|NCT00487695|1130226|P2|COMPLETED|Second Procedure||20
473231|NCT00487695|1130227|P1|COMPLETED|Second Procedure||19
473232|NCT00487695|1130226|P2|STARTED|Second Procedure||23
473233|NCT00487695|1130227|P1|STARTED|Second Procedure||20
473234|NCT00487695|1130226|P2|NOT COMPLETED|First Procedure||0
473235|NCT00487695|1130227|P1|NOT COMPLETED|First Procedure||3
473236|NCT00487695|1130226|P2|COMPLETED|First Procedure||23
473237|NCT00487695|1130227|P1|COMPLETED|First Procedure||20
473238|NCT00487695|1130226|P2|STARTED|First Procedure||23
473239|NCT00487695|1130227|P1|STARTED|First Procedure||23
473240|NCT00487669|1130243|P1|NOT COMPLETED|Overall Study||0
473241|NCT00487669|1130243|P1|COMPLETED|Overall Study||12
473242|NCT00487669|1130243|P1|STARTED|Overall Study||12
473243|NCT00487578|1130255|P2|NOT COMPLETED|Overall Study||4
473244|NCT00487578|1130256|P1|NOT COMPLETED|Overall Study||1
473245|NCT00487578|1130255|P2|COMPLETED|Overall Study||5
473246|NCT00487578|1130256|P1|COMPLETED|Overall Study||2
473247|NCT00487578|1130255|P2|STARTED|Overall Study||9
473248|NCT00487578|1130256|P1|STARTED|Overall Study||3
473249|NCT00487565|1130272|P1|NOT COMPLETED|Overall Study||28
473250|NCT00487565|1130272|P1|COMPLETED|Overall Study||182
473251|NCT00487565|1130272|P1|STARTED|Overall Study||210
473252|NCT00487552|1130276|P1|NOT COMPLETED|Overall Study||6
473253|NCT00487552|1130276|P1|COMPLETED|Overall Study||12
473254|NCT00487552|1130276|P1|STARTED|Overall Study||18
473255|NCT00487539|1130285|P4|NOT COMPLETED|Overall Study||4
473256|NCT00487539|1130286|P3|NOT COMPLETED|Overall Study||3
473257|NCT00487539|1130287|P2|NOT COMPLETED|Overall Study||3
473258|NCT00487539|1130288|P1|NOT COMPLETED|Overall Study||7
473259|NCT00487539|1130285|P4|COMPLETED|Overall Study||327
473260|NCT00487539|1130286|P3|COMPLETED|Overall Study||328
473261|NCT00487539|1130287|P2|COMPLETED|Overall Study||69
473262|NCT00487539|1130288|P1|COMPLETED|Overall Study||324
473263|NCT00487539|1130285|P4|STARTED|Overall Study||331
473264|NCT00487539|1130286|P3|STARTED|Overall Study||331
473265|NCT00487539|1130287|P2|STARTED|Overall Study||72
473266|NCT00487539|1130288|P1|STARTED|Overall Study||331
473267|NCT00487461|1130309|P3|NOT COMPLETED|Overall Study||4
473268|NCT00487461|1130310|P2|NOT COMPLETED|Overall Study||2
473269|NCT00487461|1130311|P1|NOT COMPLETED|Overall Study||0
473270|NCT00487461|1130309|P3|COMPLETED|Overall Study||7
473271|NCT00487461|1130310|P2|COMPLETED|Overall Study||10
473272|NCT00487461|1130311|P1|COMPLETED|Overall Study||2
473273|NCT00487461|1130309|P3|STARTED|Overall Study||11
473274|NCT00487461|1130310|P2|STARTED|Overall Study||12
473275|NCT00487461|1130311|P1|STARTED|Overall Study||2
473276|NCT00487435|1130322|P1|NOT COMPLETED|Overall Study||485
473277|NCT00487435|1130322|P1|COMPLETED|Overall Study||669
473278|NCT00487435|1130322|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
473279|NCT00487396|1130327|P1|NOT COMPLETED|Overall Study||3
473280|NCT00487396|1130327|P1|COMPLETED|Overall Study||95
473281|NCT00487396|1130327|P1|STARTED|Overall Study||98
473282|NCT00487279|1130335|P2|NOT COMPLETED|Overall Study||2
473283|NCT00487279|1130336|P1|NOT COMPLETED|Overall Study||1
473284|NCT00487279|1130335|P2|COMPLETED|Overall Study||35
473285|NCT00487279|1130336|P1|COMPLETED|Overall Study||43
473286|NCT00487279|1130335|P2|STARTED|Overall Study||37
473287|NCT00487279|1130336|P1|STARTED|Overall Study||44
473288|NCT00487240|1130346|P2|NOT COMPLETED|Overall Study||26
473289|NCT00487240|1130347|P1|NOT COMPLETED|Overall Study||31
473290|NCT00487240|1130346|P2|COMPLETED|Overall Study||166
473291|NCT00487240|1130347|P1|COMPLETED|Overall Study||164
473292|NCT00487240|1130346|P2|Full Analysis Set (ITT Population)|Overall Study||189
473293|NCT00487240|1130347|P1|Full Analysis Set (ITT Population)|Overall Study||192
473294|NCT00487240|1130346|P2|STARTED|Overall Study||192
473295|NCT00487240|1130347|P1|STARTED|Overall Study||195
473296|NCT00487188|1130375|P3|NOT COMPLETED|Maintenance Phase||1
473297|NCT00487188|1130376|P2|NOT COMPLETED|Maintenance Phase||0
473298|NCT00487188|1130377|P1|NOT COMPLETED|Maintenance Phase||3
473299|NCT00487188|1130375|P3|COMPLETED|Maintenance Phase||8
473300|NCT00487188|1130376|P2|COMPLETED|Maintenance Phase||8
473301|NCT00487188|1130377|P1|COMPLETED|Maintenance Phase||7
473302|NCT00487188|1130375|P3|STARTED|Maintenance Phase||9
473303|NCT00487188|1130376|P2|STARTED|Maintenance Phase||8
473304|NCT00487188|1130377|P1|STARTED|Maintenance Phase||10
473305|NCT00487188|1130375|P3|NOT COMPLETED|Induction Phase||0
473306|NCT00487188|1130376|P2|NOT COMPLETED|Induction Phase||7
473307|NCT00487188|1130377|P1|NOT COMPLETED|Induction Phase||9
473308|NCT00487188|1130375|P3|COMPLETED|Induction Phase||0
473309|NCT00487188|1130376|P2|COMPLETED|Induction Phase||9
473310|NCT00487188|1130377|P1|COMPLETED|Induction Phase||22
473311|NCT00487188|1130375|P3|Safety Population|Induction Phase||0
473312|NCT00487188|1130376|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
473313|NCT00487188|1130377|P1|Safety Population|Induction Phase||29
473314|NCT00487188|1130375|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
473315|NCT00487188|1130376|P2|STARTED|Induction Phase||16
473316|NCT00487188|1130377|P1|STARTED|Induction Phase||31
473317|NCT00487162|1130416|P2|NOT COMPLETED|Overall Study||5
473318|NCT00487162|1130417|P1|NOT COMPLETED|Overall Study||2
473319|NCT00487162|1130416|P2|COMPLETED|Overall Study||21
473320|NCT00487162|1130417|P1|COMPLETED|Overall Study||28
473321|NCT00487162|1130416|P2|STARTED|Overall Study||26
473322|NCT00487162|1130417|P1|STARTED|Overall Study||30
473323|NCT00487084|1130428|P3|NOT COMPLETED|Overall Study||5
473324|NCT00487084|1130429|P2|NOT COMPLETED|Overall Study||3
473325|NCT00487084|1130430|P1|NOT COMPLETED|Overall Study||4
473326|NCT00487084|1130428|P3|COMPLETED|Overall Study||28
473327|NCT00487084|1130429|P2|COMPLETED|Overall Study||30
473328|NCT00487084|1130430|P1|COMPLETED|Overall Study||29
473329|NCT00487084|1130428|P3|STARTED|Overall Study||33
473330|NCT00487084|1130429|P2|STARTED|Overall Study||33
473331|NCT00487084|1130430|P1|STARTED|Overall Study||33
473332|NCT00486954|1130451|P5|NOT COMPLETED|Randomized Part||14
473333|NCT00486954|1130452|P4|NOT COMPLETED|Randomized Part||20
473334|NCT00486954|1130453|P3|NOT COMPLETED|Randomized Part||0
473335|NCT00486954|1130454|P2|NOT COMPLETED|Randomized Part||0
473336|NCT00486954|1130455|P1|NOT COMPLETED|Randomized Part||0
473337|NCT00486954|1130451|P5|COMPLETED|Randomized Part||115
473338|NCT00486954|1130452|P4|COMPLETED|Randomized Part||112
473339|NCT00486954|1130453|P3|COMPLETED|Randomized Part||0
473340|NCT00486954|1130454|P2|COMPLETED|Randomized Part||0
473341|NCT00486954|1130455|P1|COMPLETED|Randomized Part||0
473342|NCT00486954|1130451|P5|STARTED|Randomized Part||129
473343|NCT00486954|1130452|P4|STARTED|Randomized Part||132
473344|NCT00486954|1130453|P3|STARTED|Randomized Part||0
473345|NCT00486954|1130454|P2|STARTED|Randomized Part||0
473346|NCT00486954|1130455|P1|STARTED|Randomized Part||0
473347|NCT00486954|1130451|P5|NOT COMPLETED|Pilot Part||0
473348|NCT00486954|1130452|P4|NOT COMPLETED|Pilot Part||0
473349|NCT00486954|1130453|P3|NOT COMPLETED|Pilot Part||6
473350|NCT00486954|1130454|P2|NOT COMPLETED|Pilot Part||0
473351|NCT00486954|1130455|P1|NOT COMPLETED|Pilot Part||6
473352|NCT00486954|1130451|P5|COMPLETED|Pilot Part||0
473353|NCT00486954|1130452|P4|COMPLETED|Pilot Part||0
473354|NCT00486954|1130453|P3|COMPLETED|Pilot Part||0
473355|NCT00486954|1130454|P2|COMPLETED|Pilot Part||0
473356|NCT00486954|1130455|P1|COMPLETED|Pilot Part||0
473357|NCT00486954|1130451|P5|STARTED|Pilot Part||0
473358|NCT00486954|1130452|P4|STARTED|Pilot Part||0
473359|NCT00486954|1130453|P3|STARTED|Pilot Part||6
473360|NCT00486954|1130454|P2|STARTED|Pilot Part||0
473361|NCT00486954|1130455|P1|STARTED|Pilot Part||6
473362|NCT00486902|1130553|P2|NOT COMPLETED|Overall Study||5
473363|NCT00486902|1130554|P1|NOT COMPLETED|Overall Study||9
473364|NCT00486902|1130553|P2|COMPLETED|Overall Study||89
473365|NCT00486902|1130554|P1|COMPLETED|Overall Study||85
473366|NCT00486902|1130553|P2|STARTED|Overall Study||94
473367|NCT00486902|1130554|P1|STARTED|Overall Study||94
473368|NCT00486863|1130576|P2|NOT COMPLETED|Overall Study||3
473369|NCT00486863|1130577|P1|NOT COMPLETED|Overall Study||1
473370|NCT00486863|1130576|P2|COMPLETED|Overall Study||183
473371|NCT00486863|1130577|P1|COMPLETED|Overall Study||183
473372|NCT00486863|1130576|P2|STARTED|Overall Study||186
473373|NCT00486863|1130577|P1|STARTED|Overall Study||184
473374|NCT00486837|1130621|P2|NOT COMPLETED|Overall Study||7
473375|NCT00486837|1130622|P1|NOT COMPLETED|Overall Study||9
473376|NCT00486837|1130621|P2|COMPLETED|Overall Study||28
473377|NCT00486837|1130622|P1|COMPLETED|Overall Study||28
473378|NCT00486837|1130621|P2|STARTED|Overall Study||35
473379|NCT00486837|1130622|P1|STARTED|Overall Study||37
473380|NCT00486811|1130641|P3|NOT COMPLETED|Overall Study||214
473381|NCT00486811|1130642|P2|NOT COMPLETED|Overall Study||141
473382|NCT00486811|1130643|P1|NOT COMPLETED|Overall Study||122
473383|NCT00486811|1130641|P3|COMPLETED|Overall Study||119
473384|NCT00486811|1130642|P2|COMPLETED|Overall Study||179
473385|NCT00486811|1130643|P1|COMPLETED|Overall Study||215
473386|NCT00486811|1130641|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
473387|NCT00486811|1130642|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
473388|NCT00486811|1130643|P1|STARTED|Overall Study||337
473389|NCT00486759|1130686|P2|NOT COMPLETED|Safety Follow-up||118
473390|NCT00486759|1130687|P1|NOT COMPLETED|Safety Follow-up||139
473391|NCT00486759|1130686|P2|COMPLETED|Safety Follow-up||142
473392|NCT00486759|1130687|P1|COMPLETED|Safety Follow-up||64
473393|NCT00486759|1130686|P2|STARTED|Safety Follow-up||260
473394|NCT00486759|1130687|P1|STARTED|Safety Follow-up||203
473395|NCT00486759|1130686|P2|NOT COMPLETED|Treatment||137
473396|NCT00486759|1130687|P1|NOT COMPLETED|Treatment||187
473397|NCT00486759|1130686|P2|COMPLETED|Treatment||260
473398|NCT00486759|1130687|P1|COMPLETED|Treatment||203
473399|NCT00486759|1130686|P2|STARTED|Treatment||397
473400|NCT00486759|1130687|P1|STARTED|Treatment||390
473401|NCT00486720|1130699|P2|NOT COMPLETED|Overall Study||12
473402|NCT00486720|1130700|P1|NOT COMPLETED|Overall Study||10
473403|NCT00486720|1130699|P2|COMPLETED|Overall Study||0
473404|NCT00486720|1130700|P1|COMPLETED|Overall Study||0
473405|NCT00486720|1130699|P2|STARTED|Overall Study||12
473406|NCT00486720|1130700|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
473407|NCT00486642|1130710|P2|NOT COMPLETED|Overall Study||0
473408|NCT00486642|1130711|P1|NOT COMPLETED|Overall Study||0
473409|NCT00486642|1130710|P2|COMPLETED|Overall Study||13
473410|NCT00486642|1130711|P1|COMPLETED|Overall Study||10
473411|NCT00486642|1130710|P2|STARTED|Overall Study||13
473412|NCT00486642|1130711|P1|STARTED|Overall Study||10
473413|NCT00486525|1130735|P2|NOT COMPLETED|Overall Study||13
473414|NCT00486525|1130736|P1|NOT COMPLETED|Overall Study||6
473415|NCT00486525|1130735|P2|COMPLETED|Overall Study||87
473416|NCT00486525|1130736|P1|COMPLETED|Overall Study||94
473417|NCT00486525|1130735|P2|STARTED|Overall Study||100
473418|NCT00486525|1130736|P1|STARTED|Overall Study||100
473419|NCT00486434|1130754|P2|NOT COMPLETED|Overall Study||134
473420|NCT00486434|1130755|P1|NOT COMPLETED|Overall Study||194
473421|NCT00486434|1130754|P2|COMPLETED|Overall Study||454
473422|NCT00486434|1130755|P1|COMPLETED|Overall Study||394
473423|NCT00486434|1130754|P2|STARTED|Overall Study||588
473424|NCT00486434|1130755|P1|STARTED|Overall Study||588
473425|NCT00486330|1130765|P1|NOT COMPLETED|Overall Study||2
473426|NCT00486330|1130765|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
473427|NCT00486330|1130765|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
473428|NCT00486291|1130771|P2|NOT COMPLETED|Overall Study||29
473429|NCT00486291|1130772|P1|NOT COMPLETED|Overall Study||16
473430|NCT00486291|1130771|P2|COMPLETED|Overall Study||76
473431|NCT00486291|1130772|P1|COMPLETED|Overall Study||89
473432|NCT00486291|1130771|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
473433|NCT00486291|1130772|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
473434|NCT00486278|1130780|P1|NOT COMPLETED|Overall Study||9
473435|NCT00486278|1130780|P1|COMPLETED|Overall Study||42
473436|NCT00486278|1130780|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
473437|NCT00486265|1130914|P1|NOT COMPLETED|Overall Study||9
473438|NCT00486265|1130914|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
473439|NCT00486265|1130914|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
473440|NCT00486252|1130918|P1|NOT COMPLETED|Overall Study||58
473441|NCT00486252|1130918|P1|COMPLETED|Overall Study||938
473442|NCT00486252|1130918|P1|STARTED|Overall Study||996
473443|NCT00486226|1130933|P1|NOT COMPLETED|Overall Study||13
473444|NCT00486226|1130933|P1|COMPLETED|Overall Study||92
473445|NCT00486226|1130933|P1|STARTED|Overall Study||105
473446|NCT00486044|1130943|P2|NOT COMPLETED|Overall Study||3
473447|NCT00486044|1130944|P1|NOT COMPLETED|Overall Study||2
473448|NCT00486044|1130943|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
473449|NCT00486044|1130944|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
473450|NCT00486044|1130943|P2|STARTED|Overall Study|23 in MRI sub-study|49
473451|NCT00486044|1130944|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
473452|NCT00486018|1130959|P3|NOT COMPLETED|Overall Study||6
473453|NCT00486018|1130960|P2|NOT COMPLETED|Overall Study||6
473454|NCT00486018|1130961|P1|NOT COMPLETED|Overall Study||9
473455|NCT00486018|1130959|P3|COMPLETED|Overall Study||125
473456|NCT00486018|1130960|P2|COMPLETED|Overall Study||128
473457|NCT00486018|1130961|P1|COMPLETED|Overall Study||123
473458|NCT00486018|1130959|P3|Received Drug (Safety Population)|Overall Study||130
473459|NCT00486018|1130960|P2|Received Drug (Safety Population)|Overall Study||134
473460|NCT00486018|1130961|P1|Received Drug (Safety Population)|Overall Study||131
473461|NCT00486018|1130959|P3|STARTED|Overall Study||131
473462|NCT00486018|1130960|P2|STARTED|Overall Study||134
473463|NCT00486018|1130961|P1|STARTED|Overall Study||132
473464|NCT00485953|1130989|P2|NOT COMPLETED|Overall Study||7
473465|NCT00485953|1130990|P1|NOT COMPLETED|Overall Study||7
473466|NCT00485953|1130989|P2|COMPLETED|Overall Study||47
473467|NCT00485953|1130990|P1|COMPLETED|Overall Study||48
473468|NCT00485953|1130989|P2|STARTED|Overall Study||54
473469|NCT00485953|1130990|P1|STARTED|Overall Study||55
473470|NCT00485836|1130999|P3|NOT COMPLETED|Overall Study||11
473471|NCT00485836|1131000|P2|NOT COMPLETED|Overall Study||3
473472|NCT00485836|1131001|P1|NOT COMPLETED|Overall Study||15
473473|NCT00485836|1130999|P3|COMPLETED|Overall Study||119
473474|NCT00485836|1131000|P2|COMPLETED|Overall Study||129
473475|NCT00485836|1131001|P1|COMPLETED|Overall Study||115
473476|NCT00485836|1130999|P3|Received Study Drug (Safety Population)|Overall Study||129
473477|NCT00485836|1131000|P2|Received Study Drug (Safety Population)|Overall Study||132
473478|NCT00485836|1131001|P1|Received Study Drug (Safety Population)|Overall Study||129
473479|NCT00485836|1130999|P3|STARTED|Overall Study||130
473480|NCT00485836|1131000|P2|STARTED|Overall Study||132
473481|NCT00485836|1131001|P1|STARTED|Overall Study||130
473482|NCT00485758|1131029|P2|NOT COMPLETED|Overall Study||65
473483|NCT00485758|1131030|P1|NOT COMPLETED|Overall Study||156
473484|NCT00485758|1131029|P2|COMPLETED|Overall Study||277
473485|NCT00485758|1131030|P1|COMPLETED|Overall Study||298
473486|NCT00485758|1131029|P2|STARTED|Overall Study||342
473487|NCT00485758|1131030|P1|STARTED|Overall Study||454
473488|NCT00485732|1131042|P2|NOT COMPLETED|Overall Study||9
473489|NCT00485732|1131043|P1|NOT COMPLETED|Overall Study||8
473490|NCT00485732|1131042|P2|COMPLETED|Overall Study||67
473491|NCT00485732|1131043|P1|COMPLETED|Overall Study||141
473492|NCT00485732|1131042|P2|STARTED|Overall Study||76
473493|NCT00485732|1131043|P1|STARTED|Overall Study||149
473494|NCT00485693|1131065|P2|NOT COMPLETED|Overall Study||0
473495|NCT00485693|1131066|P1|NOT COMPLETED|Overall Study||0
473496|NCT00485693|1131065|P2|COMPLETED|Overall Study||104
473497|NCT00485693|1131066|P1|COMPLETED|Overall Study||34
473498|NCT00485693|1131065|P2|STARTED|Overall Study||104
473499|NCT00485693|1131066|P1|STARTED|Overall Study||34
473500|NCT00485485|1131075|P1|NOT COMPLETED|Overall Study||0
473501|NCT00485485|1131075|P1|COMPLETED|Overall Study||7
473502|NCT00485485|1131075|P1|STARTED|Overall Study||7
473503|NCT00485472|1131081|P2|NOT COMPLETED|Overall Study||12
473504|NCT00485472|1131082|P1|NOT COMPLETED|Overall Study||16
473505|NCT00485472|1131081|P2|COMPLETED|Overall Study||64
473506|NCT00485472|1131082|P1|COMPLETED|Overall Study||57
473507|NCT00485472|1131081|P2|Entered Maintenance Phase|Overall Study||67
473508|NCT00485472|1131082|P1|Entered Maintenance Phase|Overall Study||65
473509|NCT00485472|1131081|P2|STARTED|Overall Study||76
473510|NCT00485472|1131082|P1|STARTED|Overall Study||73
473511|NCT00485433|1131108|P4|NOT COMPLETED|Overall Study||0
473512|NCT00485433|1131109|P3|NOT COMPLETED|Overall Study||0
473513|NCT00485433|1131110|P2|NOT COMPLETED|Overall Study||0
473514|NCT00485433|1131111|P1|NOT COMPLETED|Overall Study||0
473515|NCT00485433|1131108|P4|COMPLETED|Overall Study||25
473516|NCT00485433|1131109|P3|COMPLETED|Overall Study||24
473517|NCT00485433|1131110|P2|COMPLETED|Overall Study||25
473518|NCT00485433|1131111|P1|COMPLETED|Overall Study||24
473519|NCT00485433|1131108|P4|STARTED|Overall Study||25
473520|NCT00485433|1131109|P3|STARTED|Overall Study||24
473521|NCT00485433|1131110|P2|STARTED|Overall Study||25
473522|NCT00485433|1131111|P1|STARTED|Overall Study||24
473523|NCT00485303|1131119|P1|NOT COMPLETED|Overall Study||56
473524|NCT00485303|1131119|P1|COMPLETED|Overall Study||2
473525|NCT00485303|1131119|P1|STARTED|Overall Study||58
473526|NCT00485264|1131137|P6|NOT COMPLETED|Overall Study||0
473527|NCT00485264|1131138|P5|NOT COMPLETED|Overall Study||0
473528|NCT00485264|1131139|P4|NOT COMPLETED|Overall Study||10
473529|NCT00485264|1131140|P3|NOT COMPLETED|Overall Study||0
473530|NCT00485264|1131141|P2|NOT COMPLETED|Overall Study||1
473531|NCT00485264|1131142|P1|NOT COMPLETED|Overall Study||6
473532|NCT00485264|1131137|P6|COMPLETED|Overall Study|Not included in this interim analysis|0
473533|NCT00485264|1131138|P5|COMPLETED|Overall Study|Not included in this interim analysis|0
473534|NCT00485264|1131139|P4|COMPLETED|Overall Study|Completed week 48|11
473535|NCT00485264|1131140|P3|COMPLETED|Overall Study|Completed week 48|18
473536|NCT00485264|1131141|P2|COMPLETED|Overall Study|Completed week 48|15
473537|NCT00485264|1131142|P1|COMPLETED|Overall Study|Completed week 48|65
473538|NCT00485264|1131137|P6|Completed Week 24|Overall Study||0
473539|NCT00485264|1131138|P5|Completed Week 24|Overall Study||0
473540|NCT00485264|1131139|P4|Completed Week 24|Overall Study||21
473541|NCT00485264|1131140|P3|Completed Week 24|Overall Study||18
473542|NCT00485264|1131141|P2|Completed Week 24|Overall Study||16
473543|NCT00485264|1131142|P1|Completed Week 24|Overall Study||67
473544|NCT00485264|1131137|P6|STARTED|Overall Study|Not included in this interim analysis|0
473545|NCT00485264|1131138|P5|STARTED|Overall Study|Not included in this interim analysis|0
473546|NCT00485264|1131139|P4|STARTED|Overall Study||21
473547|NCT00485264|1131140|P3|STARTED|Overall Study||18
473548|NCT00485264|1131141|P2|STARTED|Overall Study||16
473549|NCT00485264|1131142|P1|STARTED|Overall Study||71
473550|NCT00485173|1131228|P2|NOT COMPLETED|Overall Study||64
473551|NCT00485173|1131229|P1|NOT COMPLETED|Overall Study||36
473552|NCT00485173|1131228|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
473553|NCT00485173|1131229|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
473554|NCT00485173|1131228|P2|STARTED|Overall Study||486
473555|NCT00485173|1131229|P1|STARTED|Overall Study||224
473556|NCT00485069|1131271|P2|NOT COMPLETED|Overall Study||12
473557|NCT00485069|1131272|P1|NOT COMPLETED|Overall Study||18
473558|NCT00485069|1131271|P2|COMPLETED|Overall Study||46
473559|NCT00485069|1131272|P1|COMPLETED|Overall Study||47
473560|NCT00485069|1131271|P2|STARTED|Overall Study||58
473561|NCT00485069|1131272|P1|STARTED|Overall Study||65
473562|NCT00484939|1131317|P2|NOT COMPLETED|Overall Study||140
473563|NCT00484939|1131318|P1|NOT COMPLETED|Overall Study||140
473564|NCT00484939|1131317|P2|COMPLETED|Overall Study||0
473565|NCT00484939|1131318|P1|COMPLETED|Overall Study||0
473566|NCT00484939|1131317|P2|STARTED|Overall Study||140
473567|NCT00484939|1131318|P1|STARTED|Overall Study||140
473568|NCT00484679|1131338|P1|NOT COMPLETED|Overall Study||3
473569|NCT00484679|1131338|P1|COMPLETED|Overall Study||15
473570|NCT00484679|1131338|P1|STARTED|Overall Study||18
473571|NCT00484419|1131345|P3|NOT COMPLETED|Overall Study||11
473572|NCT00484419|1131346|P2|NOT COMPLETED|Overall Study||5
473573|NCT00484419|1131347|P1|NOT COMPLETED|Overall Study||12
473574|NCT00484419|1131345|P3|COMPLETED|Overall Study||45
473575|NCT00484419|1131346|P2|COMPLETED|Overall Study||51
473576|NCT00484419|1131347|P1|COMPLETED|Overall Study||45
473577|NCT00484419|1131345|P3|STARTED|Overall Study||56
473578|NCT00484419|1131346|P2|STARTED|Overall Study||56
473579|NCT00484419|1131347|P1|STARTED|Overall Study||57
473580|NCT00484393|1131405|P2|NOT COMPLETED|Overall Study||0
473581|NCT00484393|1131406|P1|NOT COMPLETED|Overall Study||0
473582|NCT00484393|1131405|P2|COMPLETED|Overall Study||3
473583|NCT00484393|1131406|P1|COMPLETED|Overall Study||4
473584|NCT00484393|1131405|P2|STARTED|Overall Study||3
473585|NCT00484393|1131406|P1|STARTED|Overall Study||4
473586|NCT00484315|1131414|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
473587|NCT00484315|1131415|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
473588|NCT00484315|1131414|P2|COMPLETED|9-Month Angiographic Follow-up||61
473589|NCT00484315|1131415|P1|COMPLETED|9-Month Angiographic Follow-up||228
473590|NCT00484315|1131414|P2|STARTED|9-Month Angiographic Follow-up||74
473591|NCT00484315|1131415|P1|STARTED|9-Month Angiographic Follow-up||256
473592|NCT00484315|1131414|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
473593|NCT00484315|1131415|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
473594|NCT00484315|1131414|P2|COMPLETED|12-Month Clinical Follow-up||311
473595|NCT00484315|1131415|P1|COMPLETED|12-Month Clinical Follow-up||914
473596|NCT00484315|1131414|P2|STARTED|12-Month Clinical Follow-up||320
473597|NCT00484315|1131415|P1|STARTED|12-Month Clinical Follow-up||942
473598|NCT00484289|1131426|P3|NOT COMPLETED|Post Marketing Phase||0
473599|NCT00484289|1131427|P2|NOT COMPLETED|Post Marketing Phase||1
473600|NCT00484289|1131428|P1|NOT COMPLETED|Post Marketing Phase||0
473601|NCT00484289|1131426|P3|COMPLETED|Post Marketing Phase||10
473602|NCT00484289|1131427|P2|COMPLETED|Post Marketing Phase||141
473603|NCT00484289|1131428|P1|COMPLETED|Post Marketing Phase||10
473604|NCT00484289|1131426|P3|STARTED|Post Marketing Phase||10
473605|NCT00484289|1131427|P2|STARTED|Post Marketing Phase||142
473606|NCT00484289|1131428|P1|STARTED|Post Marketing Phase||10
473607|NCT00484289|1131426|P3|NOT COMPLETED|Long Term Phase||16
473608|NCT00484289|1131427|P2|NOT COMPLETED|Long Term Phase||36
473609|NCT00484289|1131428|P1|NOT COMPLETED|Long Term Phase||3
473610|NCT00484289|1131426|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
473611|NCT00484289|1131427|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
473612|NCT00484289|1131428|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
473613|NCT00484289|1131426|P3|STARTED|Long Term Phase||26
473614|NCT00484289|1131427|P2|STARTED|Long Term Phase||178
473615|NCT00484289|1131428|P1|STARTED|Long Term Phase||13
473616|NCT00484185|1131500|P1|NOT COMPLETED|Overall Study||71
473617|NCT00484185|1131500|P1|COMPLETED|Overall Study||112
473618|NCT00484185|1131500|P1|Treated|Overall Study||178
473619|NCT00484185|1131500|P1|STARTED|Overall Study||183
473620|NCT00484159|1131522|P3|NOT COMPLETED|Overall Study||0
473621|NCT00484159|1131523|P2|NOT COMPLETED|Overall Study||1
473622|NCT00484159|1131524|P1|NOT COMPLETED|Overall Study||1
473623|NCT00484159|1131522|P3|COMPLETED|Overall Study||51
473624|NCT00484159|1131523|P2|COMPLETED|Overall Study||49
473625|NCT00484159|1131524|P1|COMPLETED|Overall Study||49
473626|NCT00484159|1131522|P3|STARTED|Overall Study||51
473627|NCT00484159|1131523|P2|STARTED|Overall Study||50
473628|NCT00484159|1131524|P1|STARTED|Overall Study||50
473629|NCT00484094|1131535|P1|NOT COMPLETED|Overall Study||42
473630|NCT00484094|1131535|P1|COMPLETED|Overall Study||167
473631|NCT00484094|1131535|P1|STARTED|Overall Study||209
473632|NCT00483938|1131551|P7|NOT COMPLETED|Overall Study||40
473633|NCT00483938|1131552|P6|NOT COMPLETED|Overall Study||8
473634|NCT00483938|1131553|P5|NOT COMPLETED|Overall Study||2
473635|NCT00483938|1131554|P4|NOT COMPLETED|Overall Study||6
473636|NCT00483938|1131555|P3|NOT COMPLETED|Overall Study||0
473637|NCT00483938|1131556|P2|NOT COMPLETED|Overall Study||19
473638|NCT00483938|1131557|P1|NOT COMPLETED|Overall Study||5
473639|NCT00483938|1131551|P7|COMPLETED|Overall Study||0
473640|NCT00483938|1131552|P6|COMPLETED|Overall Study||18
473641|NCT00483938|1131553|P5|COMPLETED|Overall Study||23
473642|NCT00483938|1131554|P4|COMPLETED|Overall Study||25
473643|NCT00483938|1131555|P3|COMPLETED|Overall Study||30
473644|NCT00483938|1131556|P2|COMPLETED|Overall Study||24
473645|NCT00483938|1131557|P1|COMPLETED|Overall Study||36
473646|NCT00483938|1131551|P7|STARTED|Overall Study||40
473647|NCT00483938|1131552|P6|STARTED|Overall Study||26
473648|NCT00483938|1131553|P5|STARTED|Overall Study||25
473649|NCT00483938|1131554|P4|STARTED|Overall Study||31
473650|NCT00483938|1131555|P3|STARTED|Overall Study||30
473651|NCT00483938|1131556|P2|STARTED|Overall Study||43
473652|NCT00483938|1131557|P1|STARTED|Overall Study||41
473653|NCT00483756|1131581|P3|NOT COMPLETED|Overall Study||52
473654|NCT00483756|1131582|P2|NOT COMPLETED|Overall Study||50
473655|NCT00483756|1131583|P1|NOT COMPLETED|Overall Study||33
473656|NCT00483756|1131581|P3|COMPLETED|Overall Study||59
473657|NCT00483756|1131582|P2|COMPLETED|Overall Study||60
473658|NCT00483756|1131583|P1|COMPLETED|Overall Study||77
473659|NCT00483756|1131581|P3|Treated|Overall Study||107
473660|NCT00483756|1131582|P2|Treated|Overall Study||106
473661|NCT00483756|1131583|P1|Treated|Overall Study||109
473662|NCT00483756|1131581|P3|STARTED|Overall Study||111
473663|NCT00483756|1131582|P2|STARTED|Overall Study||110
473664|NCT00483756|1131583|P1|STARTED|Overall Study||110
473665|NCT00483717|1131647|P2|NOT COMPLETED|Overall Study||21
473666|NCT00483717|1131648|P1|NOT COMPLETED|Overall Study||24
473667|NCT00483717|1131647|P2|COMPLETED|Overall Study||65
473668|NCT00483717|1131648|P1|COMPLETED|Overall Study||63
473669|NCT00483717|1131647|P2|STARTED|Overall Study||86
473670|NCT00483717|1131648|P1|STARTED|Overall Study||87
473671|NCT00483704|1131671|P3|NOT COMPLETED|Treatment||156
473672|NCT00483704|1131672|P2|NOT COMPLETED|Treatment||129
473673|NCT00483704|1131673|P1|NOT COMPLETED|Treatment||129
473674|NCT00483704|1131671|P3|COMPLETED|Treatment||399
473675|NCT00483704|1131672|P2|COMPLETED|Treatment||420
473676|NCT00483704|1131673|P1|COMPLETED|Treatment||444
473677|NCT00483704|1131671|P3|STARTED|Treatment||555
473678|NCT00483704|1131672|P2|STARTED|Treatment||549
473679|NCT00483704|1131673|P1|STARTED|Treatment||573
473680|NCT00483704|1131671|P3|NOT COMPLETED|Randomization||91
473681|NCT00483704|1131672|P2|NOT COMPLETED|Randomization||96
473682|NCT00483704|1131673|P1|NOT COMPLETED|Randomization||71
473683|NCT00483704|1131671|P3|COMPLETED|Randomization||555
473684|NCT00483704|1131672|P2|COMPLETED|Randomization||549
473685|NCT00483704|1131673|P1|COMPLETED|Randomization||573
473686|NCT00483704|1131671|P3|STARTED|Randomization||646
473687|NCT00483704|1131672|P2|STARTED|Randomization||645
473688|NCT00483704|1131673|P1|STARTED|Randomization||644
473689|NCT00483652|1131719|P2|NOT COMPLETED|Post-study Follow-up||0
473690|NCT00483652|1131720|P1|NOT COMPLETED|Post-study Follow-up||0
473691|NCT00483652|1131719|P2|COMPLETED|Post-study Follow-up||114
473692|NCT00483652|1131720|P1|COMPLETED|Post-study Follow-up||113
473693|NCT00483652|1131719|P2|STARTED|Post-study Follow-up||114
473694|NCT00483652|1131720|P1|STARTED|Post-study Follow-up||113
473695|NCT00483652|1131719|P2|NOT COMPLETED|Double-blind Treatment Period||5
473696|NCT00483652|1131720|P1|NOT COMPLETED|Double-blind Treatment Period||7
473697|NCT00483652|1131719|P2|COMPLETED|Double-blind Treatment Period||114
473698|NCT00483652|1131720|P1|COMPLETED|Double-blind Treatment Period||113
473699|NCT00483652|1131719|P2|STARTED|Double-blind Treatment Period||119
473700|NCT00483652|1131720|P1|STARTED|Double-blind Treatment Period||120
473701|NCT00483574|1131730|P2|NOT COMPLETED|Overall Study||13
473702|NCT00483574|1131731|P1|NOT COMPLETED|Overall Study||102
473703|NCT00483574|1131730|P2|COMPLETED|Overall Study||308
473704|NCT00483574|1131731|P1|COMPLETED|Overall Study||951
473705|NCT00483574|1131730|P2|STARTED|Overall Study||321
473706|NCT00483574|1131731|P1|STARTED|Overall Study||1053
473707|NCT00483548|1131741|P2|NOT COMPLETED|Overall Study||46
473708|NCT00483548|1131742|P1|NOT COMPLETED|Overall Study||60
473709|NCT00483548|1131741|P2|COMPLETED|Overall Study||104
473710|NCT00483548|1131742|P1|COMPLETED|Overall Study||88
473711|NCT00483548|1131741|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
473712|NCT00483548|1131742|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
473713|NCT00483548|1131741|P2|STARTED|Overall Study||150
473714|NCT00483548|1131742|P1|STARTED|Overall Study||148
473715|NCT00483496|1131780|P1|NOT COMPLETED|Overall Study||1
473716|NCT00483496|1131780|P1|COMPLETED|Overall Study||15
473717|NCT00483496|1131780|P1|STARTED|Overall Study||16
473718|NCT00483405|1131791|P1|NOT COMPLETED|Overall Study||28
473719|NCT00483405|1131791|P1|COMPLETED|Overall Study||0
473720|NCT00483405|1131791|P1|STARTED|Overall Study||28
473721|NCT00483379|1131800|P2|NOT COMPLETED|Extension Period||0
473722|NCT00483379|1131801|P1|NOT COMPLETED|Extension Period||0
473723|NCT00483379|1131800|P2|COMPLETED|Extension Period||2
473724|NCT00483379|1131801|P1|COMPLETED|Extension Period||1
473725|NCT00483379|1131800|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
473726|NCT00483379|1131801|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
473727|NCT00483379|1131800|P2|NOT COMPLETED|Treatment Period||0
473728|NCT00483379|1131801|P1|NOT COMPLETED|Treatment Period||2
473729|NCT00483379|1131800|P2|COMPLETED|Treatment Period||7
473730|NCT00483379|1131801|P1|COMPLETED|Treatment Period||4
473731|NCT00483379|1131800|P2|STARTED|Treatment Period||7
473732|NCT00483379|1131801|P1|STARTED|Treatment Period||6
473736|NCT00483262|1131846|P2|NOT COMPLETED|Overall Study||0
473737|NCT00483262|1131847|P1|NOT COMPLETED|Overall Study||0
473738|NCT00483262|1131846|P2|COMPLETED|Overall Study||43
473739|NCT00483262|1131847|P1|COMPLETED|Overall Study||20
473740|NCT00483262|1131846|P2|STARTED|Overall Study||43
473741|NCT00483262|1131847|P1|STARTED|Overall Study||20
473742|NCT00483223|1131857|P1|NOT COMPLETED|Overall Study||0
473743|NCT00483223|1131857|P1|COMPLETED|Overall Study||86
473744|NCT00483223|1131857|P1|STARTED|Overall Study||86
473745|NCT00483184|1131867|P3|NOT COMPLETED|Overall Study||3
473746|NCT00483184|1131868|P2|NOT COMPLETED|Overall Study||4
473747|NCT00483184|1131869|P1|NOT COMPLETED|Overall Study||5
473748|NCT00483184|1131867|P3|COMPLETED|Overall Study||23
473749|NCT00483184|1131868|P2|COMPLETED|Overall Study||27
473750|NCT00483184|1131869|P1|COMPLETED|Overall Study||22
473751|NCT00483184|1131867|P3|STARTED|Overall Study||26
473752|NCT00483184|1131868|P2|STARTED|Overall Study||31
473753|NCT00483184|1131869|P1|STARTED|Overall Study||27
473754|NCT00483119|1131879|P2|NOT COMPLETED|Overall Study||1
473755|NCT00483119|1131880|P1|NOT COMPLETED|Overall Study||1
473756|NCT00483119|1131879|P2|COMPLETED|Overall Study||3
473757|NCT00483119|1131880|P1|COMPLETED|Overall Study||4
473758|NCT00483119|1131879|P2|STARTED|Overall Study||4
473759|NCT00483119|1131880|P1|STARTED|Overall Study||5
473760|NCT00483041|1131894|P2|NOT COMPLETED|Overall Study||1
473761|NCT00483041|1131895|P1|NOT COMPLETED|Overall Study||0
473762|NCT00483041|1131894|P2|COMPLETED|Overall Study||5
473763|NCT00483041|1131895|P1|COMPLETED|Overall Study||5
473764|NCT00483041|1131894|P2|STARTED|Overall Study||6
473765|NCT00483041|1131895|P1|STARTED|Overall Study||5
473766|NCT00483002|1131925|P1|NOT COMPLETED|Overall Study||2554
473767|NCT00483002|1131925|P1|COMPLETED|Overall Study||1165
473768|NCT00483002|1131925|P1|STARTED|Overall Study||3719
473769|NCT00482911|1131933|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
473770|NCT00482911|1131934|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
473771|NCT00482911|1131933|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
473772|NCT00482911|1131934|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
473773|NCT00482911|1131933|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
473774|NCT00482911|1131934|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
473775|NCT00482911|1131933|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
473776|NCT00482911|1131934|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
473777|NCT00482911|1131933|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
473778|NCT00482911|1131934|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
473779|NCT00482911|1131933|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
473780|NCT00482911|1131934|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
473781|NCT00482911|1131933|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
473782|NCT00482911|1131934|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
473783|NCT00482911|1131933|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
473784|NCT00482911|1131934|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
473785|NCT00482911|1131933|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
473786|NCT00482911|1131934|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
473787|NCT00482729|1131950|P2|NOT COMPLETED|Overall Study||218
473788|NCT00482729|1131951|P1|NOT COMPLETED|Overall Study||217
473789|NCT00482729|1131950|P2|COMPLETED|Overall Study||406
473790|NCT00482729|1131951|P1|COMPLETED|Overall Study||409
473791|NCT00482729|1131950|P2|Completed Phase B|Overall Study||406
473792|NCT00482729|1131951|P1|Completed Phase B|Overall Study||409
473793|NCT00482729|1131950|P2|Completed Phase A|Overall Study||482
473794|NCT00482729|1131951|P1|Completed Phase A|Overall Study||484
473795|NCT00482729|1131950|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
473796|NCT00482729|1131951|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
473797|NCT00482703|1131967|P2|NOT COMPLETED|Overall Study||0
473798|NCT00482703|1131968|P1|NOT COMPLETED|Overall Study||1
473799|NCT00482703|1131967|P2|COMPLETED|Overall Study||12
473800|NCT00482703|1131968|P1|COMPLETED|Overall Study||10
473801|NCT00482703|1131967|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
473802|NCT00482703|1131968|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
473803|NCT00482625|1132013|P1|NOT COMPLETED|Overall Study||0
473804|NCT00482625|1132013|P1|COMPLETED|Overall Study||6
473805|NCT00482625|1132013|P1|STARTED|Overall Study||6
473806|NCT00482612|1132026|P4|NOT COMPLETED|Follow-up Period||8
473807|NCT00482612|1132027|P3|NOT COMPLETED|Follow-up Period||22
473808|NCT00482612|1132028|P2|NOT COMPLETED|Follow-up Period||18
473809|NCT00482612|1132029|P1|NOT COMPLETED|Follow-up Period||14
473810|NCT00482612|1132026|P4|COMPLETED|Follow-up Period||127
473811|NCT00482612|1132027|P3|COMPLETED|Follow-up Period||106
473812|NCT00482612|1132028|P2|COMPLETED|Follow-up Period||107
473813|NCT00482612|1132029|P1|COMPLETED|Follow-up Period||123
473814|NCT00482612|1132026|P4|STARTED|Follow-up Period||135
473815|NCT00482612|1132027|P3|STARTED|Follow-up Period||128
473816|NCT00482612|1132028|P2|STARTED|Follow-up Period||125
473817|NCT00482612|1132029|P1|STARTED|Follow-up Period||137
473818|NCT00482612|1132026|P4|NOT COMPLETED|In-treatment Period||0
473819|NCT00482612|1132027|P3|NOT COMPLETED|In-treatment Period||1
473820|NCT00482612|1132028|P2|NOT COMPLETED|In-treatment Period||0
473821|NCT00482612|1132029|P1|NOT COMPLETED|In-treatment Period||0
473822|NCT00482612|1132026|P4|COMPLETED|In-treatment Period||135
473823|NCT00482612|1132027|P3|COMPLETED|In-treatment Period||128
473824|NCT00482612|1132028|P2|COMPLETED|In-treatment Period||125
473825|NCT00482612|1132029|P1|COMPLETED|In-treatment Period||137
473826|NCT00482612|1132026|P4|Treated|In-treatment Period||135
473827|NCT00482612|1132027|P3|Treated|In-treatment Period||128
473828|NCT00482612|1132028|P2|Treated|In-treatment Period||125
473829|NCT00482612|1132029|P1|Treated|In-treatment Period||137
473830|NCT00482612|1132026|P4|STARTED|In-treatment Period||135
473831|NCT00482612|1132027|P3|STARTED|In-treatment Period||129
473832|NCT00482612|1132028|P2|STARTED|In-treatment Period||125
473833|NCT00482612|1132029|P1|STARTED|In-treatment Period||137
473834|NCT00482547|1132057|P2|NOT COMPLETED|Overall Study||161
473835|NCT00482547|1132058|P1|NOT COMPLETED|Overall Study||173
473836|NCT00482547|1132057|P2|COMPLETED|Overall Study||428
473837|NCT00482547|1132058|P1|COMPLETED|Overall Study||426
473838|NCT00482547|1132057|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
473839|NCT00482547|1132058|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
473840|NCT00482547|1132057|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
473841|NCT00482547|1132058|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
473842|NCT00482547|1132057|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
473843|NCT00482547|1132058|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
473844|NCT00480636|1132078|P1|NOT COMPLETED|Overall Study||19
473845|NCT00480636|1132078|P1|COMPLETED|Overall Study||83
473846|NCT00480636|1132078|P1|STARTED|Overall Study||102
473847|NCT00482391|1132086|P1|NOT COMPLETED|Overall Study||3
473848|NCT00482391|1132086|P1|COMPLETED|Overall Study||92
473849|NCT00482391|1132086|P1|STARTED|Overall Study||95
473850|NCT00482274|1132091|P1|NOT COMPLETED|Overall Study||1
473851|NCT00482274|1132091|P1|COMPLETED|Overall Study||2
473852|NCT00482274|1132091|P1|STARTED|Overall Study||3
473853|NCT00482170|1132101|P2|NOT COMPLETED|Overall Study||20
473854|NCT00482170|1132102|P1|NOT COMPLETED|Overall Study||15
473855|NCT00482170|1132101|P2|COMPLETED|Overall Study||194
473856|NCT00482170|1132102|P1|COMPLETED|Overall Study||192
473857|NCT00482170|1132101|P2|Treated|Overall Study||211
473858|NCT00482170|1132102|P1|Treated|Overall Study||207
473859|NCT00482170|1132101|P2|STARTED|Overall Study||214
473860|NCT00482170|1132102|P1|STARTED|Overall Study||207
473861|NCT00482014|1132224|P4|NOT COMPLETED|Overall Study||23
473862|NCT00482014|1132225|P3|NOT COMPLETED|Overall Study||11
473863|NCT00482014|1132226|P2|NOT COMPLETED|Overall Study||6
473864|NCT00482014|1132227|P1|NOT COMPLETED|Overall Study||7
473865|NCT00482014|1132224|P4|COMPLETED|Overall Study||29
473866|NCT00482014|1132225|P3|COMPLETED|Overall Study||35
473867|NCT00482014|1132226|P2|COMPLETED|Overall Study||7
473868|NCT00482014|1132227|P1|COMPLETED|Overall Study||2
473869|NCT00482014|1132224|P4|STARTED|Overall Study||52
473870|NCT00482014|1132225|P3|STARTED|Overall Study||46
473871|NCT00482014|1132226|P2|STARTED|Overall Study||13
473872|NCT00482014|1132227|P1|STARTED|Overall Study||9
473873|NCT00481988|1132251|P2|NOT COMPLETED|Overall Study||1
473874|NCT00481988|1132252|P1|NOT COMPLETED|Overall Study||1
473875|NCT00481988|1132251|P2|COMPLETED|Overall Study||8
473876|NCT00481988|1132252|P1|COMPLETED|Overall Study||11
473877|NCT00481988|1132251|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
473878|NCT00481988|1132252|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
473879|NCT00481988|1132251|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
473880|NCT00481988|1132252|P1|STARTED|Overall Study||12
473881|NCT00481871|1132265|P5|NOT COMPLETED|Overall Study||0
473882|NCT00481871|1132266|P4|NOT COMPLETED|Overall Study||0
473883|NCT00481871|1132267|P3|NOT COMPLETED|Overall Study||1
473884|NCT00481871|1132268|P2|NOT COMPLETED|Overall Study||0
473885|NCT00481871|1132269|P1|NOT COMPLETED|Overall Study||0
473886|NCT00481871|1132265|P5|COMPLETED|Overall Study||34
473887|NCT00481871|1132266|P4|COMPLETED|Overall Study||38
473888|NCT00481871|1132267|P3|COMPLETED|Overall Study||17
473889|NCT00481871|1132268|P2|COMPLETED|Overall Study||10
473890|NCT00481871|1132269|P1|COMPLETED|Overall Study||7
473891|NCT00481871|1132265|P5|STARTED|Overall Study||34
473892|NCT00481871|1132266|P4|STARTED|Overall Study||38
473893|NCT00481871|1132267|P3|STARTED|Overall Study||18
473894|NCT00481871|1132268|P2|STARTED|Overall Study||10
473895|NCT00481871|1132269|P1|STARTED|Overall Study||7
473896|NCT00481845|1132285|P2|NOT COMPLETED|Overall Study||0
473897|NCT00481845|1132286|P1|NOT COMPLETED|Overall Study||0
473898|NCT00481845|1132285|P2|COMPLETED|Overall Study||0
473899|NCT00481845|1132286|P1|COMPLETED|Overall Study||1
473900|NCT00481845|1132285|P2|STARTED|Overall Study||0
473901|NCT00481845|1132286|P1|STARTED|Overall Study||1
473902|NCT00481767|1132296|P2|NOT COMPLETED|Overall Study||21
473903|NCT00481767|1132297|P1|NOT COMPLETED|Overall Study||32
473904|NCT00481767|1132296|P2|COMPLETED|Overall Study||205
473905|NCT00481767|1132297|P1|COMPLETED|Overall Study||418
473906|NCT00481767|1132296|P2|STARTED|Overall Study||226
473907|NCT00481767|1132297|P1|STARTED|Overall Study||450
473908|NCT00481676|1132329|P2|NOT COMPLETED|Overall Study||5
473909|NCT00481676|1132330|P1|NOT COMPLETED|Overall Study||2
473910|NCT00481676|1132329|P2|COMPLETED|Overall Study||17
473911|NCT00481676|1132330|P1|COMPLETED|Overall Study||25
473912|NCT00481676|1132329|P2|STARTED|Overall Study||22
473913|NCT00481676|1132330|P1|STARTED|Overall Study||27
473914|NCT00480532|1132356|P4|NOT COMPLETED|Overall Study||1
473915|NCT00480532|1132357|P3|NOT COMPLETED|Overall Study||4
473916|NCT00480532|1132358|P2|NOT COMPLETED|Overall Study||4
473917|NCT00480532|1132359|P1|NOT COMPLETED|Overall Study||2
473918|NCT00480532|1132356|P4|COMPLETED|Overall Study||31
473919|NCT00480532|1132357|P3|COMPLETED|Overall Study||29
473920|NCT00480532|1132358|P2|COMPLETED|Overall Study||29
473921|NCT00480532|1132359|P1|COMPLETED|Overall Study||31
473922|NCT00480532|1132356|P4|STARTED|Overall Study||32
473923|NCT00480532|1132357|P3|STARTED|Overall Study||33
473924|NCT00480532|1132358|P2|STARTED|Overall Study||33
473925|NCT00480532|1132359|P1|STARTED|Overall Study||33
473926|NCT00480493|1132379|P2|NOT COMPLETED|Overall Study||7
473927|NCT00480493|1132380|P1|NOT COMPLETED|Overall Study||2
473928|NCT00480493|1132379|P2|COMPLETED|Overall Study||21
473929|NCT00480493|1132380|P1|COMPLETED|Overall Study||30
473930|NCT00480493|1132379|P2|Randomized|Overall Study||28
473931|NCT00480493|1132380|P1|Randomized|Overall Study||32
473932|NCT00480493|1132379|P2|STARTED|Overall Study||28
473933|NCT00480493|1132380|P1|STARTED|Overall Study||32
473934|NCT00481507|1132392|P2|NOT COMPLETED|Overall Study||0
473935|NCT00481507|1132393|P1|NOT COMPLETED|Overall Study||0
473936|NCT00481507|1132392|P2|COMPLETED|Overall Study||61
473937|NCT00481507|1132393|P1|COMPLETED|Overall Study||64
473938|NCT00481507|1132392|P2|STARTED|Overall Study||61
473939|NCT00481507|1132393|P1|STARTED|Overall Study||64
473940|NCT00481351|1132401|P2|NOT COMPLETED|Overall Study||0
473941|NCT00481351|1132402|P1|NOT COMPLETED|Overall Study||0
473942|NCT00481351|1132401|P2|COMPLETED|Overall Study||12
473943|NCT00481351|1132402|P1|COMPLETED|Overall Study||13
473944|NCT00481351|1132401|P2|STARTED|Overall Study||12
473945|NCT00481351|1132402|P1|STARTED|Overall Study||13
473946|NCT00481247|1132418|P2|NOT COMPLETED|Overall Study||260
473947|NCT00481247|1132419|P1|NOT COMPLETED|Overall Study||259
473948|NCT00481247|1132418|P2|COMPLETED|Overall Study||0
473949|NCT00481247|1132419|P1|COMPLETED|Overall Study||0
473950|NCT00481247|1132418|P2|Received Treatment|Overall Study||258
473951|NCT00481247|1132419|P1|Received Treatment|Overall Study||258
473952|NCT00481247|1132418|P2|STARTED|Overall Study|Randomized|260
473953|NCT00481247|1132419|P1|STARTED|Overall Study|Randomized|259
473954|NCT00481195|1132443|P2|NOT COMPLETED|Overall Study||39
473955|NCT00481195|1132444|P1|NOT COMPLETED|Overall Study||39
473956|NCT00481195|1132443|P2|COMPLETED|Overall Study||90
473957|NCT00481195|1132444|P1|COMPLETED|Overall Study||89
473958|NCT00481195|1132443|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
473959|NCT00481195|1132444|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
473960|NCT00481078|1132530|P2|NOT COMPLETED|Overall Study||20
473961|NCT00481078|1132531|P1|NOT COMPLETED|Overall Study||42
473962|NCT00481078|1132530|P2|COMPLETED|Overall Study||12
473963|NCT00481078|1132531|P1|COMPLETED|Overall Study||20
473964|NCT00481078|1132530|P2|STARTED|Overall Study||32
473965|NCT00481078|1132531|P1|STARTED|Overall Study||62
473966|NCT00481065|1132549|P8|NOT COMPLETED|Overall Study||19
473967|NCT00481065|1132550|P7|NOT COMPLETED|Overall Study||16
473968|NCT00481065|1132551|P6|NOT COMPLETED|Overall Study||24
473969|NCT00481065|1132552|P5|NOT COMPLETED|Overall Study||23
473970|NCT00481065|1132553|P4|NOT COMPLETED|Overall Study||15
473971|NCT00481065|1132554|P3|NOT COMPLETED|Overall Study||19
473972|NCT00481065|1132555|P2|NOT COMPLETED|Overall Study||17
473973|NCT00481065|1132556|P1|NOT COMPLETED|Overall Study||22
473974|NCT00481065|1132549|P8|COMPLETED|Overall Study||30
473975|NCT00481065|1132550|P7|COMPLETED|Overall Study||34
473976|NCT00481065|1132551|P6|COMPLETED|Overall Study||27
473977|NCT00481065|1132552|P5|COMPLETED|Overall Study||28
473978|NCT00481065|1132553|P4|COMPLETED|Overall Study||37
473979|NCT00481065|1132554|P3|COMPLETED|Overall Study||32
473980|NCT00481065|1132555|P2|COMPLETED|Overall Study||33
473981|NCT00481065|1132556|P1|COMPLETED|Overall Study||29
473982|NCT00481065|1132549|P8|STARTED|Overall Study||49
473983|NCT00481065|1132550|P7|STARTED|Overall Study||50
473984|NCT00481065|1132551|P6|STARTED|Overall Study||51
473985|NCT00481065|1132552|P5|STARTED|Overall Study||51
473986|NCT00481065|1132553|P4|STARTED|Overall Study||52
473987|NCT00481065|1132554|P3|STARTED|Overall Study||51
473988|NCT00481065|1132555|P2|STARTED|Overall Study||50
473989|NCT00481065|1132556|P1|STARTED|Overall Study||51
473990|NCT00480987|1132642|P1|NOT COMPLETED|Overall Study||0
473991|NCT00480987|1132642|P1|COMPLETED|Overall Study||27
473992|NCT00480987|1132642|P1|STARTED|Overall Study||27
473993|NCT00480857|1132646|P1|NOT COMPLETED|Overall Study||2
473994|NCT00480857|1132646|P1|COMPLETED|Overall Study||17
473995|NCT00480857|1132646|P1|STARTED|Overall Study||19
473996|NCT00480779|1132653|P2|NOT COMPLETED|Overall Study||3
473997|NCT00480779|1132654|P1|NOT COMPLETED|Overall Study||2
473998|NCT00480779|1132653|P2|COMPLETED|Overall Study||19
473999|NCT00480779|1132654|P1|COMPLETED|Overall Study||24
474000|NCT00480779|1132653|P2|STARTED|Overall Study||22
474001|NCT00480779|1132654|P1|STARTED|Overall Study||26
474002|NCT00480740|1132681|P3|NOT COMPLETED|Overall Study||0
474003|NCT00480740|1132682|P2|NOT COMPLETED|Overall Study||0
474004|NCT00480740|1132683|P1|NOT COMPLETED|Overall Study||0
474005|NCT00480740|1132681|P3|COMPLETED|Overall Study||6
474006|NCT00480740|1132682|P2|COMPLETED|Overall Study||9
474007|NCT00480740|1132683|P1|COMPLETED|Overall Study||26
474008|NCT00480740|1132681|P3|STARTED|Overall Study||6
474009|NCT00480740|1132682|P2|STARTED|Overall Study||9
474010|NCT00480740|1132683|P1|STARTED|Overall Study||26
474011|NCT00480324|1132693|P2|NOT COMPLETED|Overall Study||16
474012|NCT00480324|1132694|P1|NOT COMPLETED|Overall Study||32
474013|NCT00480324|1132693|P2|COMPLETED|Overall Study||241
474014|NCT00480324|1132694|P1|COMPLETED|Overall Study||476
474015|NCT00480324|1132693|P2|STARTED|Overall Study||257
474016|NCT00480324|1132694|P1|STARTED|Overall Study||508
474017|NCT00479882|1132724|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
474018|NCT00479882|1132725|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
474019|NCT00479882|1132726|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
474020|NCT00479882|1132727|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
474021|NCT00479882|1132724|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
474022|NCT00479882|1132725|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
474023|NCT00479882|1132726|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
474024|NCT00479882|1132727|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
474025|NCT00479882|1132724|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
474026|NCT00479882|1132725|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
474027|NCT00479882|1132726|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
474028|NCT00479882|1132727|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
474029|NCT00479882|1132724|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
474030|NCT00479882|1132725|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
474031|NCT00479882|1132726|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
474032|NCT00479882|1132727|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
474033|NCT00479882|1132724|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
474034|NCT00479882|1132725|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
474035|NCT00479882|1132726|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
474036|NCT00479882|1132727|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
474037|NCT00479882|1132724|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
474038|NCT00479882|1132725|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
474039|NCT00479882|1132726|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
474040|NCT00479882|1132727|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
474041|NCT00479856|1132857|P1|NOT COMPLETED|Overall Study||3
474042|NCT00479856|1132857|P1|COMPLETED|Overall Study||6
474043|NCT00479856|1132857|P1|STARTED|Overall Study||9
474044|NCT00479765|1132866|P1|NOT COMPLETED|Overall Study||4
474045|NCT00479765|1132866|P1|COMPLETED|Overall Study||0
474046|NCT00479765|1132866|P1|STARTED|Overall Study||4
474047|NCT00479713|1132872|P2|NOT COMPLETED|Overall Study||9
474048|NCT00479713|1132873|P1|NOT COMPLETED|Overall Study||13
474049|NCT00479713|1132872|P2|COMPLETED|Overall Study||295
474050|NCT00479713|1132873|P1|COMPLETED|Overall Study||301
474051|NCT00479713|1132872|P2|STARTED|Overall Study||304
474052|NCT00479713|1132873|P1|STARTED|Overall Study||314
474053|NCT00479674|1132897|P1|NOT COMPLETED|Overall Study||41
474054|NCT00479674|1132897|P1|COMPLETED|Overall Study||0
474055|NCT00479674|1132897|P1|STARTED|Overall Study||41
474056|NCT00479557|1132912|P7|NOT COMPLETED|Overall Study||2
474057|NCT00479557|1132913|P6|NOT COMPLETED|Overall Study||13
474058|NCT00479557|1132914|P5|NOT COMPLETED|Overall Study||4
474059|NCT00479557|1132915|P4|NOT COMPLETED|Overall Study||5
474060|NCT00479557|1132916|P3|NOT COMPLETED|Overall Study||8
474061|NCT00479557|1132917|P2|NOT COMPLETED|Overall Study||10
474062|NCT00479557|1132918|P1|NOT COMPLETED|Overall Study||10
474063|NCT00479557|1132912|P7|COMPLETED|Overall Study||15
474064|NCT00479557|1132913|P6|COMPLETED|Overall Study||31
474065|NCT00479557|1132914|P5|COMPLETED|Overall Study||8
474066|NCT00479557|1132915|P4|COMPLETED|Overall Study||30
474067|NCT00479557|1132916|P3|COMPLETED|Overall Study||32
474068|NCT00479557|1132917|P2|COMPLETED|Overall Study||51
474069|NCT00479557|1132918|P1|COMPLETED|Overall Study||26
474070|NCT00479557|1132912|P7|Treated|Overall Study||17
474071|NCT00479557|1132913|P6|Treated|Overall Study||44
474072|NCT00479557|1132914|P5|Treated|Overall Study||12
474073|NCT00479557|1132915|P4|Treated|Overall Study||35
474074|NCT00479557|1132916|P3|Treated|Overall Study||40
474075|NCT00479557|1132917|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
474076|NCT00479557|1132918|P1|Treated|Overall Study||36
474077|NCT00479557|1132912|P7|STARTED|Overall Study||17
474078|NCT00479557|1132913|P6|STARTED|Overall Study||44
474079|NCT00479557|1132914|P5|STARTED|Overall Study||12
474080|NCT00479557|1132915|P4|STARTED|Overall Study||35
474081|NCT00479557|1132916|P3|STARTED|Overall Study||40
474082|NCT00479557|1132917|P2|STARTED|Overall Study||61
474083|NCT00479557|1132918|P1|STARTED|Overall Study||36
474084|NCT00479466|1132961|P6|NOT COMPLETED|Overall Study||4
474085|NCT00479466|1132962|P5|NOT COMPLETED|Overall Study||8
474086|NCT00479466|1132963|P4|NOT COMPLETED|Overall Study||3
474087|NCT00479466|1132964|P3|NOT COMPLETED|Overall Study||3
474088|NCT00479466|1132965|P2|NOT COMPLETED|Overall Study||8
474089|NCT00479466|1132966|P1|NOT COMPLETED|Overall Study||13
474090|NCT00479466|1132961|P6|COMPLETED|Overall Study||53
474091|NCT00479466|1132962|P5|COMPLETED|Overall Study||48
474092|NCT00479466|1132963|P4|COMPLETED|Overall Study||55
474093|NCT00479466|1132964|P3|COMPLETED|Overall Study||54
474094|NCT00479466|1132965|P2|COMPLETED|Overall Study||49
474095|NCT00479466|1132966|P1|COMPLETED|Overall Study||44
474096|NCT00479466|1132961|P6|STARTED|Overall Study||57
474097|NCT00479466|1132962|P5|STARTED|Overall Study||56
474098|NCT00479466|1132963|P4|STARTED|Overall Study||58
474099|NCT00479466|1132964|P3|STARTED|Overall Study||57
474100|NCT00479466|1132965|P2|STARTED|Overall Study||57
474101|NCT00479466|1132966|P1|STARTED|Overall Study||57
474102|NCT00479401|1132995|P3|NOT COMPLETED|Overall Study||12
474103|NCT00479401|1132996|P2|NOT COMPLETED|Overall Study||37
474104|NCT00479401|1132997|P1|NOT COMPLETED|Overall Study||49
474105|NCT00479401|1132995|P3|COMPLETED|Overall Study||91
474106|NCT00479401|1132996|P2|COMPLETED|Overall Study||176
474107|NCT00479401|1132997|P1|COMPLETED|Overall Study||174
474108|NCT00479401|1132995|P3|STARTED|Overall Study||103
474109|NCT00479401|1132996|P2|STARTED|Overall Study||213
474110|NCT00479401|1132997|P1|STARTED|Overall Study||223
474111|NCT00479388|1133052|P2|NOT COMPLETED|Overall Study||73
474112|NCT00479388|1133053|P1|NOT COMPLETED|Overall Study||132
474113|NCT00479388|1133052|P2|COMPLETED|Overall Study||537
474114|NCT00479388|1133053|P1|COMPLETED|Overall Study||474
474115|NCT00479388|1133052|P2|STARTED|Overall Study||610
474116|NCT00479388|1133053|P1|STARTED|Overall Study||606
474117|NCT00479336|1133067|P4|NOT COMPLETED|Overall Study||5
474118|NCT00479336|1133068|P3|NOT COMPLETED|Overall Study||1
474119|NCT00479336|1133069|P2|NOT COMPLETED|Overall Study||6
474120|NCT00479336|1133070|P1|NOT COMPLETED|Overall Study||4
474121|NCT00479336|1133067|P4|COMPLETED|Overall Study||21
474122|NCT00479336|1133068|P3|COMPLETED|Overall Study||24
474123|NCT00479336|1133069|P2|COMPLETED|Overall Study||20
474124|NCT00479336|1133070|P1|COMPLETED|Overall Study||23
474125|NCT00479336|1133067|P4|STARTED|Overall Study||26
474126|NCT00479336|1133068|P3|STARTED|Overall Study||25
474127|NCT00479336|1133069|P2|STARTED|Overall Study||26
474128|NCT00479336|1133070|P1|STARTED|Overall Study||27
474129|NCT00479258|1133086|P2|NOT COMPLETED|Overall Study||0
474130|NCT00479258|1133087|P1|NOT COMPLETED|Overall Study||0
474131|NCT00479258|1133086|P2|COMPLETED|Overall Study||0
474132|NCT00479258|1133087|P1|COMPLETED|Overall Study||0
474133|NCT00479258|1133086|P2|STARTED|Overall Study||0
474134|NCT00479258|1133087|P1|STARTED|Overall Study||0
474135|NCT00479232|1133093|P6|NOT COMPLETED|Overall Study||30
474136|NCT00479232|1133094|P5|NOT COMPLETED|Overall Study||4
474137|NCT00479232|1133095|P4|NOT COMPLETED|Overall Study||3
474138|NCT00479232|1133096|P3|NOT COMPLETED|Overall Study||28
474139|NCT00479232|1133097|P2|NOT COMPLETED|Overall Study||3
474140|NCT00479232|1133098|P1|NOT COMPLETED|Overall Study||3
474141|NCT00479232|1133093|P6|COMPLETED|Overall Study||0
474142|NCT00479232|1133094|P5|COMPLETED|Overall Study||0
474143|NCT00479232|1133095|P4|COMPLETED|Overall Study||0
474144|NCT00479232|1133096|P3|COMPLETED|Overall Study||0
474145|NCT00479232|1133097|P2|COMPLETED|Overall Study||0
474146|NCT00479232|1133098|P1|COMPLETED|Overall Study||0
474147|NCT00479232|1133093|P6|STARTED|Overall Study||30
474148|NCT00479232|1133094|P5|STARTED|Overall Study||4
474149|NCT00479232|1133095|P4|STARTED|Overall Study||3
474150|NCT00479232|1133096|P3|STARTED|Overall Study||28
474151|NCT00479232|1133097|P2|STARTED|Overall Study||3
474152|NCT00479232|1133098|P1|STARTED|Overall Study||3
474153|NCT00479154|1133118|P2|NOT COMPLETED|Overall Study||0
474154|NCT00479154|1133119|P1|NOT COMPLETED|Overall Study||0
474155|NCT00479154|1133118|P2|COMPLETED|Overall Study||3
474156|NCT00479154|1133119|P1|COMPLETED|Overall Study||3
474157|NCT00479154|1133118|P2|STARTED|Overall Study||3
474158|NCT00479154|1133119|P1|STARTED|Overall Study||3
474159|NCT00479089|1133127|P2|NOT COMPLETED|Overall Study||0
474160|NCT00479089|1133128|P1|NOT COMPLETED|Overall Study||0
474161|NCT00479089|1133127|P2|COMPLETED|Overall Study||25
474162|NCT00479089|1133128|P1|COMPLETED|Overall Study||25
474163|NCT00479089|1133127|P2|STARTED|Overall Study||25
474164|NCT00479089|1133128|P1|STARTED|Overall Study||25
474165|NCT00479037|1133140|P2|NOT COMPLETED|Overall Study||6
474166|NCT00479037|1133141|P1|NOT COMPLETED|Overall Study||3
474167|NCT00479037|1133140|P2|COMPLETED|Overall Study||34
474168|NCT00479037|1133141|P1|COMPLETED|Overall Study||38
474169|NCT00479037|1133140|P2|STARTED|Overall Study||40
474170|NCT00479037|1133141|P1|STARTED|Overall Study||41
474171|NCT00478881|1133153|P2|NOT COMPLETED|Overall Study||22
474172|NCT00478881|1133154|P1|NOT COMPLETED|Overall Study||39
474173|NCT00478881|1133153|P2|COMPLETED|Overall Study||176
474174|NCT00478881|1133154|P1|COMPLETED|Overall Study||160
474175|NCT00478881|1133153|P2|Received Medication|Overall Study||198
474176|NCT00478881|1133154|P1|Received Medication|Overall Study||198
474177|NCT00478881|1133153|P2|STARTED|Overall Study||198
474178|NCT00478881|1133154|P1|STARTED|Overall Study||199
474179|NCT00478777|1133178|P1|NOT COMPLETED|Overall Study||77
474180|NCT00478777|1133178|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
474181|NCT00478777|1133178|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
474182|NCT00478777|1133178|P1|STARTED|Overall Study||150
474183|NCT00478673|1133185|P1|NOT COMPLETED|12-Months Post-Procedure||64
474184|NCT00478673|1133185|P1|COMPLETED|12-Months Post-Procedure||231
474185|NCT00478673|1133185|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
474186|NCT00478673|1133185|P1|NOT COMPLETED|30-Days Post-Procedure||10
474187|NCT00478673|1133185|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
474188|NCT00478673|1133185|P1|STARTED|30-Days Post-Procedure||298
474189|NCT00478647|1133190|P1|NOT COMPLETED|Overall Study||2
474190|NCT00478647|1133190|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
474191|NCT00478647|1133190|P1|STARTED|Overall Study||40
474192|NCT00478608|1133198|P1|NOT COMPLETED|Overall Study||20
474193|NCT00478608|1133198|P1|COMPLETED|Overall Study||59
474194|NCT00478608|1133198|P1|STARTED|Overall Study||79
474195|NCT00478569|1133206|P1|NOT COMPLETED|Overall Study||409
474196|NCT00478569|1133206|P1|COMPLETED|Overall Study||761
474197|NCT00478569|1133206|P1|STARTED|Overall Study||1170
474198|NCT00478556|1133222|P2|NOT COMPLETED|Overall Study||0
474199|NCT00478556|1133223|P1|NOT COMPLETED|Overall Study||0
474200|NCT00478556|1133222|P2|COMPLETED|Overall Study||149
474201|NCT00478556|1133223|P1|COMPLETED|Overall Study||151
474202|NCT00478556|1133222|P2|STARTED|Overall Study||149
474203|NCT00478556|1133223|P1|STARTED|Overall Study||151
474204|NCT00478257|1133233|P2|NOT COMPLETED|Overall Study||3
474205|NCT00478257|1133234|P1|NOT COMPLETED|Overall Study||8
474206|NCT00478257|1133233|P2|COMPLETED|Overall Study||13
474207|NCT00478257|1133234|P1|COMPLETED|Overall Study||15
474208|NCT00478257|1133233|P2|STARTED|Overall Study||16
474209|NCT00478257|1133234|P1|STARTED|Overall Study||23
474210|NCT00478244|1133240|P1|NOT COMPLETED|Overall Study||1
474211|NCT00478244|1133240|P1|COMPLETED|Overall Study||6
474212|NCT00478244|1133240|P1|STARTED|Overall Study||7
474213|NCT00478231|1133253|P1|NOT COMPLETED|Overall Study||84
474214|NCT00478231|1133253|P1|COMPLETED|Overall Study||125
474215|NCT00478231|1133253|P1|Treated|Overall Study||206
474216|NCT00478231|1133253|P1|STARTED|Overall Study||209
474217|NCT00478218|1133274|P2|NOT COMPLETED|Overall Study||0
474218|NCT00478218|1133275|P1|NOT COMPLETED|Overall Study||0
474219|NCT00478218|1133274|P2|COMPLETED|Overall Study||19
474220|NCT00478218|1133275|P1|COMPLETED|Overall Study||34
474221|NCT00478218|1133274|P2|STARTED|Overall Study||19
474222|NCT00478218|1133275|P1|STARTED|Overall Study||34
474223|NCT00478205|1133289|P2|NOT COMPLETED|Overall Study||87
474224|NCT00478205|1133290|P1|NOT COMPLETED|Overall Study||296
474225|NCT00478205|1133289|P2|COMPLETED|Overall Study||399
474226|NCT00478205|1133290|P1|COMPLETED|Overall Study||685
474227|NCT00478205|1133289|P2|STARTED|Overall Study||486
474228|NCT00478205|1133290|P1|STARTED|Overall Study||981
474229|NCT00478192|1133305|P3|NOT COMPLETED|Overall Study||2
474230|NCT00478192|1133306|P2|NOT COMPLETED|Overall Study||5
474231|NCT00478192|1133307|P1|NOT COMPLETED|Overall Study||4
474232|NCT00478192|1133305|P3|COMPLETED|Overall Study||8
474233|NCT00478192|1133306|P2|COMPLETED|Overall Study||15
474234|NCT00478192|1133307|P1|COMPLETED|Overall Study||16
474235|NCT00478192|1133305|P3|End of Treatment|Overall Study||8
474236|NCT00478192|1133306|P2|End of Treatment|Overall Study||16
474237|NCT00478192|1133307|P1|End of Treatment|Overall Study||18
474238|NCT00478192|1133305|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
474239|NCT00478192|1133306|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
474240|NCT00478192|1133307|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
474241|NCT00478192|1133305|P3|STARTED|Overall Study||10
474242|NCT00478192|1133306|P2|STARTED|Overall Study||20
474243|NCT00478192|1133307|P1|STARTED|Overall Study||20
474244|NCT00478140|1133334|P1|NOT COMPLETED|Overall Study||3
474245|NCT00478140|1133334|P1|COMPLETED|Overall Study||1
474246|NCT00478140|1133334|P1|STARTED|Overall Study||4
474247|NCT00478036|1133341|P3|NOT COMPLETED|Overall Study||0
474248|NCT00478036|1133342|P2|NOT COMPLETED|Overall Study||0
474249|NCT00478036|1133343|P1|NOT COMPLETED|Overall Study||0
474250|NCT00478036|1133341|P3|COMPLETED|Overall Study||14
474251|NCT00478036|1133342|P2|COMPLETED|Overall Study||7
474252|NCT00478036|1133343|P1|COMPLETED|Overall Study||10
474253|NCT00478036|1133341|P3|STARTED|Overall Study||14
474254|NCT00478036|1133342|P2|STARTED|Overall Study||7
474255|NCT00478036|1133343|P1|STARTED|Overall Study||10
474256|NCT00478023|1133356|P5|NOT COMPLETED|Overall Study||55
474257|NCT00478023|1133357|P4|NOT COMPLETED|Overall Study||30
474258|NCT00478023|1133358|P3|NOT COMPLETED|Overall Study||20
474259|NCT00478023|1133359|P2|NOT COMPLETED|Overall Study||24
474260|NCT00478023|1133360|P1|NOT COMPLETED|Overall Study||35
474261|NCT00478023|1133356|P5|COMPLETED|Overall Study||114
474262|NCT00478023|1133357|P4|COMPLETED|Overall Study||146
474263|NCT00478023|1133358|P3|COMPLETED|Overall Study||151
474264|NCT00478023|1133359|P2|COMPLETED|Overall Study||144
474265|NCT00478023|1133360|P1|COMPLETED|Overall Study||135
474266|NCT00478023|1133356|P5|STARTED|Overall Study||169
474267|NCT00478023|1133357|P4|STARTED|Overall Study||176
474268|NCT00478023|1133358|P3|STARTED|Overall Study||171
474269|NCT00478023|1133359|P2|STARTED|Overall Study||168
474270|NCT00478023|1133360|P1|STARTED|Overall Study||170
474271|NCT00477971|1133379|P2|NOT COMPLETED|Overall Study||6
474272|NCT00477971|1133380|P1|NOT COMPLETED|Overall Study||17
474273|NCT00477971|1133379|P2|COMPLETED|Overall Study||49
474274|NCT00477971|1133380|P1|COMPLETED|Overall Study||17
474275|NCT00477971|1133379|P2|STARTED|Overall Study||55
474276|NCT00477971|1133380|P1|STARTED|Overall Study||34
474277|NCT00477750|1133392|P1|NOT COMPLETED|Overall Study||11
474278|NCT00477750|1133392|P1|COMPLETED|Overall Study||15
474279|NCT00477750|1133392|P1|STARTED|Overall Study||26
474280|NCT00477685|1133396|P1|NOT COMPLETED|Overall Study||0
474281|NCT00477685|1133396|P1|COMPLETED|Overall Study||10
474282|NCT00477685|1133396|P1|STARTED|Overall Study||10
474283|NCT00477672|1133404|P3|NOT COMPLETED|Overall Study||16
474284|NCT00477672|1133405|P2|NOT COMPLETED|Overall Study||16
474285|NCT00477672|1133406|P1|NOT COMPLETED|Overall Study||7
474286|NCT00477672|1133404|P3|COMPLETED|Overall Study||83
474287|NCT00477672|1133405|P2|COMPLETED|Overall Study||85
474288|NCT00477672|1133406|P1|COMPLETED|Overall Study||91
474289|NCT00477672|1133404|P3|STARTED|Overall Study||99
474290|NCT00477672|1133405|P2|STARTED|Overall Study||101
474291|NCT00477672|1133406|P1|STARTED|Overall Study||98
474292|NCT00477633|1133417|P1|NOT COMPLETED|Overall Study||709
474293|NCT00477633|1133417|P1|COMPLETED|Overall Study||991
474294|NCT00477633|1133417|P1|STARTED|Overall Study||1700
474295|NCT00477607|1133425|P2|NOT COMPLETED|Overall Study||7
474296|NCT00477607|1133426|P1|NOT COMPLETED|Overall Study||7
474297|NCT00477607|1133425|P2|COMPLETED|Overall Study||13
474298|NCT00477607|1133426|P1|COMPLETED|Overall Study||12
474299|NCT00477607|1133425|P2|STARTED|Overall Study||20
474300|NCT00477607|1133426|P1|STARTED|Overall Study||19
474301|NCT00477594|1133438|P2|NOT COMPLETED|Follow-up Period||1
474302|NCT00477594|1133439|P1|NOT COMPLETED|Follow-up Period||3
474303|NCT00477594|1133438|P2|COMPLETED|Follow-up Period||4
474304|NCT00477594|1133439|P1|COMPLETED|Follow-up Period||13
474305|NCT00477594|1133438|P2|STARTED|Follow-up Period||5
474306|NCT00477594|1133439|P1|STARTED|Follow-up Period||16
474307|NCT00477594|1133438|P2|NOT COMPLETED|Year 3||0
474308|NCT00477594|1133439|P1|NOT COMPLETED|Year 3||2
474309|NCT00477594|1133438|P2|COMPLETED|Year 3||0
474310|NCT00477594|1133439|P1|COMPLETED|Year 3||2
474311|NCT00477594|1133438|P2|STARTED|Year 3||0
474312|NCT00477594|1133439|P1|STARTED|Year 3||4
474313|NCT00477594|1133438|P2|NOT COMPLETED|Year 1 and Year 2||4
474314|NCT00477594|1133439|P1|NOT COMPLETED|Year 1 and Year 2||9
474315|NCT00477594|1133438|P2|COMPLETED|Year 1 and Year 2||1
474316|NCT00477594|1133439|P1|COMPLETED|Year 1 and Year 2||7
474317|NCT00477594|1133438|P2|STARTED|Year 1 and Year 2||5
474318|NCT00477594|1133439|P1|STARTED|Year 1 and Year 2||16
474319|NCT00477490|1133500|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
474320|NCT00477490|1133501|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
474321|NCT00477490|1133502|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
474322|NCT00477490|1133503|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
474323|NCT00477490|1133504|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
474324|NCT00477490|1133505|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
474325|NCT00477490|1133506|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
474326|NCT00477490|1133507|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
474327|NCT00477490|1133508|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
474328|NCT00477490|1133500|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
474329|NCT00477490|1133501|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
474330|NCT00477490|1133502|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
474331|NCT00477490|1133503|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
474332|NCT00477490|1133504|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
474333|NCT00477490|1133505|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
474334|NCT00477490|1133506|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
474335|NCT00477490|1133507|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
474336|NCT00477490|1133508|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
474337|NCT00477490|1133500|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
474338|NCT00477490|1133501|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
474339|NCT00477490|1133502|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
474340|NCT00477490|1133503|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
474341|NCT00477490|1133504|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
474342|NCT00477490|1133505|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
474343|NCT00477490|1133506|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
474344|NCT00477490|1133507|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
474345|NCT00477490|1133508|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
474346|NCT00477490|1133500|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
474347|NCT00477490|1133501|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
474348|NCT00477490|1133502|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
474349|NCT00477490|1133503|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
474350|NCT00477490|1133504|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
474351|NCT00477490|1133505|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
474352|NCT00477490|1133506|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
474353|NCT00477490|1133507|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
474354|NCT00477490|1133508|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
474355|NCT00477490|1133500|P9|COMPLETED|Part I: 4 Week Efficacy||0
474356|NCT00477490|1133501|P8|COMPLETED|Part I: 4 Week Efficacy||0
474357|NCT00477490|1133502|P7|COMPLETED|Part I: 4 Week Efficacy||0
474358|NCT00477490|1133503|P6|COMPLETED|Part I: 4 Week Efficacy||0
474359|NCT00477490|1133504|P5|COMPLETED|Part I: 4 Week Efficacy||135
474360|NCT00477490|1133505|P4|COMPLETED|Part I: 4 Week Efficacy||138
474361|NCT00477490|1133506|P3|COMPLETED|Part I: 4 Week Efficacy||148
474362|NCT00477490|1133507|P2|COMPLETED|Part I: 4 Week Efficacy||144
474363|NCT00477490|1133508|P1|COMPLETED|Part I: 4 Week Efficacy||145
474364|NCT00477490|1133500|P9|ITT Population|Part I: 4 Week Efficacy||0
474365|NCT00477490|1133501|P8|ITT Population|Part I: 4 Week Efficacy||0
474366|NCT00477490|1133502|P7|ITT Population|Part I: 4 Week Efficacy||0
474367|NCT00477490|1133503|P6|ITT Population|Part I: 4 Week Efficacy||0
474368|NCT00477490|1133504|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
474369|NCT00477490|1133505|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
474370|NCT00477490|1133506|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
474371|NCT00477490|1133507|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
474372|NCT00477490|1133508|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
474373|NCT00477490|1133500|P9|STARTED|Part I: 4 Week Efficacy||0
474374|NCT00477490|1133501|P8|STARTED|Part I: 4 Week Efficacy||0
474375|NCT00477490|1133502|P7|STARTED|Part I: 4 Week Efficacy||0
474376|NCT00477490|1133503|P6|STARTED|Part I: 4 Week Efficacy||0
474377|NCT00477490|1133504|P5|STARTED|Part I: 4 Week Efficacy||160
474378|NCT00477490|1133505|P4|STARTED|Part I: 4 Week Efficacy||158
474379|NCT00477490|1133506|P3|STARTED|Part I: 4 Week Efficacy||158
474380|NCT00477490|1133507|P2|STARTED|Part I: 4 Week Efficacy||163
474381|NCT00477490|1133508|P1|STARTED|Part I: 4 Week Efficacy||160
474382|NCT00477464|1133592|P1|NOT COMPLETED|Overall Study||51
474383|NCT00477464|1133592|P1|COMPLETED|Overall Study||0
474384|NCT00477464|1133592|P1|STARTED|Overall Study||51
474385|NCT00477451|1133619|P4|NOT COMPLETED|Overall Study||0
474386|NCT00477451|1133620|P3|NOT COMPLETED|Overall Study||0
474387|NCT00477451|1133621|P2|NOT COMPLETED|Overall Study||0
474388|NCT00477451|1133622|P1|NOT COMPLETED|Overall Study||0
474389|NCT00477451|1133619|P4|COMPLETED|Overall Study||2
474390|NCT00477451|1133620|P3|COMPLETED|Overall Study||7
474391|NCT00477451|1133621|P2|COMPLETED|Overall Study||20
474392|NCT00477451|1133622|P1|COMPLETED|Overall Study||20
474393|NCT00477451|1133619|P4|STARTED|Overall Study||2
474394|NCT00477451|1133620|P3|STARTED|Overall Study||7
474395|NCT00477451|1133621|P2|STARTED|Overall Study||20
474396|NCT00477451|1133622|P1|STARTED|Overall Study||20
474397|NCT00477386|1133636|P2|NOT COMPLETED|Overall Study||17
474398|NCT00477386|1133637|P1|NOT COMPLETED|Overall Study||11
474399|NCT00477386|1133636|P2|COMPLETED|Overall Study||0
474400|NCT00477386|1133637|P1|COMPLETED|Overall Study||0
474401|NCT00477386|1133636|P2|STARTED|Overall Study||17
474402|NCT00477386|1133637|P1|STARTED|Overall Study||11
474403|NCT00477334|1133647|P2|NOT COMPLETED|Overall Study||76
474404|NCT00477334|1133648|P1|NOT COMPLETED|Overall Study||170
474405|NCT00477334|1133647|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
474406|NCT00477334|1133648|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
474407|NCT00477334|1133647|P2|Modified Intent to Treat Population|Overall Study||78
474408|NCT00477334|1133648|P1|Modified Intent to Treat Population|Overall Study||152
474409|NCT00477334|1133647|P2|Participants Completing First Recurrence|Overall Study||92
474410|NCT00477334|1133648|P1|Participants Completing First Recurrence|Overall Study||187
474411|NCT00477334|1133647|P2|Intent to Treat Population|Overall Study||98
474412|NCT00477334|1133648|P1|Intent to Treat Population|Overall Study||201
474413|NCT00477334|1133647|P2|Randomized and Took Study Drug|Overall Study||98
474414|NCT00477334|1133648|P1|Randomized and Took Study Drug|Overall Study||206
474415|NCT00477334|1133647|P2|STARTED|Overall Study||151
474416|NCT00477334|1133648|P1|STARTED|Overall Study||312
474417|NCT00477295|1133674|P2|NOT COMPLETED|Overall Study||109
474418|NCT00477295|1133675|P1|NOT COMPLETED|Overall Study||121
474419|NCT00477295|1133674|P2|COMPLETED|Overall Study||192
474420|NCT00477295|1133675|P1|COMPLETED|Overall Study||161
474421|NCT00477295|1133674|P2|STARTED|Overall Study||301
474422|NCT00477295|1133675|P1|STARTED|Overall Study||282
474423|NCT00477269|1133703|P3|NOT COMPLETED|Open Label Extension||13
474424|NCT00477269|1133704|P2|NOT COMPLETED|Open Label Extension||0
474425|NCT00477269|1133705|P1|NOT COMPLETED|Open Label Extension||0
474426|NCT00477269|1133703|P3|COMPLETED|Open Label Extension||9
474427|NCT00477269|1133704|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
474428|NCT00477269|1133705|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
474429|NCT00477269|1133703|P3|STARTED|Open Label Extension||22
474430|NCT00477269|1133704|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
474431|NCT00477269|1133705|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
474432|NCT00477269|1133703|P3|NOT COMPLETED|Core Study||0
474433|NCT00477269|1133704|P2|NOT COMPLETED|Core Study||8
474434|NCT00477269|1133705|P1|NOT COMPLETED|Core Study||9
474435|NCT00477269|1133703|P3|COMPLETED|Core Study||0
474436|NCT00477269|1133704|P2|COMPLETED|Core Study||23
474437|NCT00477269|1133705|P1|COMPLETED|Core Study||19
474438|NCT00477269|1133703|P3|STARTED|Core Study||0
474439|NCT00477269|1133704|P2|STARTED|Core Study||31
474440|NCT00477269|1133705|P1|STARTED|Core Study||28
474441|NCT00477230|1133759|P2|NOT COMPLETED|Overall Study||31
474442|NCT00477230|1133760|P1|NOT COMPLETED|Overall Study||20
474443|NCT00477230|1133759|P2|COMPLETED|Overall Study||1
474444|NCT00477230|1133760|P1|COMPLETED|Overall Study||12
474445|NCT00477230|1133759|P2|STARTED|Overall Study||32
474446|NCT00477230|1133760|P1|STARTED|Overall Study||32
474447|NCT00477204|1133768|P2|NOT COMPLETED|Overall Study||0
474448|NCT00477204|1133769|P1|NOT COMPLETED|Overall Study||0
474449|NCT00477204|1133768|P2|COMPLETED|Overall Study||5
474450|NCT00477204|1133769|P1|COMPLETED|Overall Study||4
474451|NCT00477204|1133768|P2|STARTED|Overall Study||5
474452|NCT00477204|1133769|P1|STARTED|Overall Study||4
474453|NCT00477191|1133775|P1|NOT COMPLETED|Overall Study||5
474454|NCT00477191|1133775|P1|COMPLETED|Overall Study||13
474455|NCT00477191|1133775|P1|STARTED|Overall Study||18
474456|NCT00477165|1133784|P2|NOT COMPLETED|Overall Study||2
474457|NCT00477165|1133785|P1|NOT COMPLETED|Overall Study||7
474458|NCT00477165|1133784|P2|COMPLETED|Overall Study||25
474459|NCT00477165|1133785|P1|COMPLETED|Overall Study||20
474460|NCT00477165|1133784|P2|STARTED|Overall Study||27
474461|NCT00477165|1133785|P1|STARTED|Overall Study||27
474462|NCT00477152|1133797|P1|NOT COMPLETED|Overall Study||3
474463|NCT00477152|1133797|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
474464|NCT00477152|1133797|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
474465|NCT00476957|1133806|P2|NOT COMPLETED|Overall Study||193
474466|NCT00476957|1133807|P1|NOT COMPLETED|Overall Study||176
474467|NCT00476957|1133806|P2|COMPLETED|Overall Study||4159
474468|NCT00476957|1133807|P1|COMPLETED|Overall Study||4181
474469|NCT00476957|1133806|P2|STARTED|Overall Study||4352
474470|NCT00476957|1133807|P1|STARTED|Overall Study||4357
474471|NCT00476827|1133821|P6|NOT COMPLETED|Overall Study||0
474472|NCT00476827|1133822|P5|NOT COMPLETED|Overall Study||0
474473|NCT00476827|1133823|P4|NOT COMPLETED|Overall Study||0
474474|NCT00476827|1133824|P3|NOT COMPLETED|Overall Study||0
474475|NCT00476827|1133825|P2|NOT COMPLETED|Overall Study||0
474476|NCT00476827|1133826|P1|NOT COMPLETED|Overall Study||0
474477|NCT00476827|1133821|P6|COMPLETED|Overall Study||2
474478|NCT00476827|1133822|P5|COMPLETED|Overall Study||2
474479|NCT00476827|1133823|P4|COMPLETED|Overall Study||0
474480|NCT00476827|1133824|P3|COMPLETED|Overall Study||1
474481|NCT00476827|1133825|P2|COMPLETED|Overall Study||0
474482|NCT00476827|1133826|P1|COMPLETED|Overall Study||3
474483|NCT00476827|1133821|P6|STARTED|Overall Study||2
474484|NCT00476827|1133822|P5|STARTED|Overall Study||2
474485|NCT00476827|1133823|P4|STARTED|Overall Study||0
474486|NCT00476827|1133824|P3|STARTED|Overall Study||1
474487|NCT00476827|1133825|P2|STARTED|Overall Study||0
474488|NCT00476827|1133826|P1|STARTED|Overall Study||3
474489|NCT00476788|1133856|P1|NOT COMPLETED|Overall Study||3
474490|NCT00476788|1133856|P1|COMPLETED|Overall Study||11
474491|NCT00476788|1133856|P1|STARTED|Overall Study||14
474492|NCT00476645|1133861|P1|NOT COMPLETED|Overall Study||0
474493|NCT00476645|1133861|P1|COMPLETED|Overall Study||10
474494|NCT00476645|1133861|P1|STARTED|Overall Study||10
474495|NCT00476593|1133871|P4|NOT COMPLETED|Overall Study||22
474496|NCT00476593|1133872|P3|NOT COMPLETED|Overall Study||8
474497|NCT00476593|1133873|P2|NOT COMPLETED|Overall Study||2
474498|NCT00476593|1133874|P1|NOT COMPLETED|Overall Study||10
474499|NCT00476593|1133871|P4|COMPLETED|Overall Study||107
474500|NCT00476593|1133872|P3|COMPLETED|Overall Study||30
474501|NCT00476593|1133873|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
474502|NCT00476593|1133874|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
474503|NCT00476593|1133871|P4|STARTED|Overall Study||129
474504|NCT00476593|1133872|P3|STARTED|Overall Study||38
474505|NCT00476593|1133873|P2|STARTED|Overall Study||19
474506|NCT00476593|1133874|P1|STARTED|Overall Study||32
474507|NCT00476476|1133886|P2|NOT COMPLETED|Overall Study||24
474508|NCT00476476|1133887|P1|NOT COMPLETED|Overall Study||2
474509|NCT00476476|1133886|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
474510|NCT00476476|1133887|P1|COMPLETED|Overall Study||15
474511|NCT00476476|1133886|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
474512|NCT00476476|1133887|P1|Response Evaluable|Overall Study||17
474513|NCT00476476|1133886|P2|STARTED|Overall Study||24
474514|NCT00476476|1133887|P1|STARTED|Overall Study||17
474515|NCT00476242|1133894|P2|NOT COMPLETED|Overall Study||16
474516|NCT00476242|1133895|P1|NOT COMPLETED|Overall Study||8
474517|NCT00476242|1133894|P2|COMPLETED|Overall Study||12
474518|NCT00476242|1133895|P1|COMPLETED|Overall Study||19
474519|NCT00476242|1133894|P2|STARTED|Overall Study||28
474520|NCT00476242|1133895|P1|STARTED|Overall Study||27
474521|NCT00476229|1133903|P1|NOT COMPLETED|Overall Study||1
474522|NCT00476229|1133903|P1|COMPLETED|Overall Study||19
474523|NCT00476229|1133903|P1|STARTED|Overall Study||20
474524|NCT00476151|1133909|P2|NOT COMPLETED|Overall Study||7
474525|NCT00476151|1133910|P1|NOT COMPLETED|Overall Study||3
474526|NCT00476151|1133909|P2|COMPLETED|Overall Study||107
474527|NCT00476151|1133910|P1|COMPLETED|Overall Study||109
474528|NCT00476151|1133909|P2|STARTED|Overall Study||114
474529|NCT00476151|1133910|P1|STARTED|Overall Study||112
474530|NCT00476086|1133916|P1|NOT COMPLETED|Overall Study||5
474531|NCT00476086|1133916|P1|COMPLETED|Overall Study||15
474532|NCT00476086|1133916|P1|Received Radiation|Overall Study||15
474533|NCT00476086|1133916|P1|Received Chemotherapy|Overall Study||19
474534|NCT00476086|1133916|P1|STARTED|Overall Study||20
474535|NCT00476021|1133924|P2|NOT COMPLETED|Overall Study||0
474536|NCT00476021|1133925|P1|NOT COMPLETED|Overall Study||0
474537|NCT00476021|1133924|P2|COMPLETED|Overall Study||51
474538|NCT00476021|1133925|P1|COMPLETED|Overall Study||51
474539|NCT00476021|1133924|P2|STARTED|Overall Study||51
474540|NCT00476021|1133925|P1|STARTED|Overall Study||51
474541|NCT00476008|1133941|P2|NOT COMPLETED|Overall Study||8
474542|NCT00476008|1133942|P1|NOT COMPLETED|Overall Study||9
474543|NCT00476008|1133941|P2|COMPLETED|Overall Study||13
474544|NCT00476008|1133942|P1|COMPLETED|Overall Study||13
474545|NCT00476008|1133941|P2|6 Month Testing|Overall Study||14
474546|NCT00476008|1133942|P1|6 Month Testing|Overall Study||15
474547|NCT00476008|1133941|P2|STARTED|Overall Study||21
474548|NCT00476008|1133942|P1|STARTED|Overall Study||22
474549|NCT00475904|1133969|P3|NOT COMPLETED|Overall Study||4
474550|NCT00475904|1133970|P2|NOT COMPLETED|Overall Study||13
474551|NCT00475904|1133971|P1|NOT COMPLETED|Overall Study||15
474552|NCT00475904|1133969|P3|COMPLETED|Overall Study||72
474553|NCT00475904|1133970|P2|COMPLETED|Overall Study||131
474554|NCT00475904|1133971|P1|COMPLETED|Overall Study||125
474555|NCT00475904|1133969|P3|STARTED|Overall Study||76
474556|NCT00475904|1133970|P2|STARTED|Overall Study||144
474557|NCT00475904|1133971|P1|STARTED|Overall Study||140
474558|NCT00475878|1133984|P2|NOT COMPLETED|Overall Study||0
474559|NCT00475878|1133985|P1|NOT COMPLETED|Overall Study||0
474560|NCT00475878|1133984|P2|COMPLETED|Overall Study||72
474561|NCT00475878|1133985|P1|COMPLETED|Overall Study||75
474562|NCT00475878|1133984|P2|STARTED|Overall Study||72
474563|NCT00475878|1133985|P1|STARTED|Overall Study||75
474564|NCT00475865|1133996|P3|NOT COMPLETED|Overall Study||6
474565|NCT00475865|1133997|P2|NOT COMPLETED|Overall Study||5
474566|NCT00475865|1133998|P1|NOT COMPLETED|Overall Study||2
474567|NCT00475865|1133996|P3|COMPLETED|Overall Study|completed treatment period|34
474568|NCT00475865|1133997|P2|COMPLETED|Overall Study|completed treatment period|37
474569|NCT00475865|1133998|P1|COMPLETED|Overall Study||39
474570|NCT00475865|1133996|P3|Treated|Overall Study||40
474571|NCT00475865|1133997|P2|Treated|Overall Study||42
474572|NCT00475865|1133998|P1|Treated|Overall Study|completed treatment period|41
474573|NCT00475865|1133996|P3|STARTED|Overall Study|randomized|40
474574|NCT00475865|1133997|P2|STARTED|Overall Study|randomized|42
474575|NCT00475865|1133998|P1|STARTED|Overall Study|randomized|41
474576|NCT00475852|1134028|P2|NOT COMPLETED|Overall Study||548
474577|NCT00475852|1134029|P1|NOT COMPLETED|Overall Study||517
474578|NCT00475852|1134028|P2|COMPLETED|Overall Study||3029
474579|NCT00475852|1134029|P1|COMPLETED|Overall Study||3047
474580|NCT00475852|1134028|P2|STARTED|Overall Study||3577
474581|NCT00475852|1134029|P1|STARTED|Overall Study||3564
474582|NCT00475787|1134059|P2|NOT COMPLETED|Overall Study||7
474583|NCT00475787|1134060|P1|NOT COMPLETED|Overall Study||8
474584|NCT00475787|1134059|P2|COMPLETED|Overall Study||60
474585|NCT00475787|1134060|P1|COMPLETED|Overall Study||61
474586|NCT00475787|1134059|P2|STARTED|Overall Study||67
474587|NCT00475787|1134060|P1|STARTED|Overall Study||69
474588|NCT00475735|1134080|P6|NOT COMPLETED|Treatment Period 2||1
474589|NCT00475735|1134081|P5|NOT COMPLETED|Treatment Period 2||1
474590|NCT00475735|1134082|P4|NOT COMPLETED|Treatment Period 2||2
474591|NCT00475735|1134083|P3|NOT COMPLETED|Treatment Period 2||0
474592|NCT00475735|1134084|P2|NOT COMPLETED|Treatment Period 2||1
474593|NCT00475735|1134085|P1|NOT COMPLETED|Treatment Period 2||0
474594|NCT00475735|1134080|P6|COMPLETED|Treatment Period 2||13
474595|NCT00475735|1134081|P5|COMPLETED|Treatment Period 2||15
474596|NCT00475735|1134082|P4|COMPLETED|Treatment Period 2||4
474597|NCT00475735|1134083|P3|COMPLETED|Treatment Period 2||7
474598|NCT00475735|1134084|P2|COMPLETED|Treatment Period 2||9
474599|NCT00475735|1134085|P1|COMPLETED|Treatment Period 2||10
474600|NCT00475735|1134080|P6|STARTED|Treatment Period 2||14
474601|NCT00475735|1134081|P5|STARTED|Treatment Period 2||16
474602|NCT00475735|1134082|P4|STARTED|Treatment Period 2||6
474603|NCT00475735|1134083|P3|STARTED|Treatment Period 2||7
474604|NCT00475735|1134084|P2|STARTED|Treatment Period 2||10
474605|NCT00475735|1134085|P1|STARTED|Treatment Period 2||10
474606|NCT00475735|1134080|P6|NOT COMPLETED|Treatment Washout||0
474607|NCT00475735|1134081|P5|NOT COMPLETED|Treatment Washout||0
474608|NCT00475735|1134082|P4|NOT COMPLETED|Treatment Washout||0
474609|NCT00475735|1134083|P3|NOT COMPLETED|Treatment Washout||0
474610|NCT00475735|1134084|P2|NOT COMPLETED|Treatment Washout||2
474611|NCT00475735|1134085|P1|NOT COMPLETED|Treatment Washout||0
474612|NCT00475735|1134080|P6|COMPLETED|Treatment Washout||14
474613|NCT00475735|1134081|P5|COMPLETED|Treatment Washout||16
474614|NCT00475735|1134082|P4|COMPLETED|Treatment Washout||6
474615|NCT00475735|1134083|P3|COMPLETED|Treatment Washout||7
474616|NCT00475735|1134084|P2|COMPLETED|Treatment Washout||10
474617|NCT00475735|1134085|P1|COMPLETED|Treatment Washout||10
474618|NCT00475735|1134080|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
474619|NCT00475735|1134081|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
474620|NCT00475735|1134082|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
474621|NCT00475735|1134083|P3|STARTED|Treatment Washout||7
474622|NCT00475735|1134084|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
474623|NCT00475735|1134085|P1|STARTED|Treatment Washout||10
474624|NCT00475735|1134080|P6|NOT COMPLETED|Treatment Period 1||3
474625|NCT00475735|1134081|P5|NOT COMPLETED|Treatment Period 1||2
474626|NCT00475735|1134082|P4|NOT COMPLETED|Treatment Period 1||2
474627|NCT00475735|1134083|P3|NOT COMPLETED|Treatment Period 1||0
474628|NCT00475735|1134084|P2|NOT COMPLETED|Treatment Period 1||2
474629|NCT00475735|1134085|P1|NOT COMPLETED|Treatment Period 1||4
474630|NCT00475735|1134080|P6|COMPLETED|Treatment Period 1||12
474631|NCT00475735|1134081|P5|COMPLETED|Treatment Period 1||14
474632|NCT00475735|1134082|P4|COMPLETED|Treatment Period 1||5
474633|NCT00475735|1134083|P3|COMPLETED|Treatment Period 1||7
474634|NCT00475735|1134084|P2|COMPLETED|Treatment Period 1||11
474635|NCT00475735|1134085|P1|COMPLETED|Treatment Period 1||10
474636|NCT00475735|1134080|P6|STARTED|Treatment Period 1||15
474637|NCT00475735|1134081|P5|STARTED|Treatment Period 1||16
474638|NCT00475735|1134082|P4|STARTED|Treatment Period 1||7
474639|NCT00475735|1134083|P3|STARTED|Treatment Period 1||7
474640|NCT00475735|1134084|P2|STARTED|Treatment Period 1||13
474641|NCT00475735|1134085|P1|STARTED|Treatment Period 1||14
474642|NCT00475722|1134098|P2|NOT COMPLETED|Overall Study||12
474643|NCT00475722|1134099|P1|NOT COMPLETED|Overall Study||15
474644|NCT00475722|1134098|P2|COMPLETED|Overall Study||47
474645|NCT00475722|1134099|P1|COMPLETED|Overall Study||46
474646|NCT00475722|1134098|P2|STARTED|Overall Study||59
474647|NCT00475722|1134099|P1|STARTED|Overall Study||61
474648|NCT00475709|1134105|P1|NOT COMPLETED|Overall Study||76
474649|NCT00475709|1134105|P1|COMPLETED|Overall Study||946
474650|NCT00475709|1134105|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
474651|NCT00475709|1134105|P1|STARTED|Overall Study||1022
474652|NCT00475670|1134113|P2|NOT COMPLETED|Overall Study||41
474653|NCT00475670|1134114|P1|NOT COMPLETED|Overall Study||3
474654|NCT00475670|1134113|P2|COMPLETED|Overall Study||0
474655|NCT00475670|1134114|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
474656|NCT00475670|1134113|P2|STARTED|Overall Study||41
474657|NCT00475670|1134114|P1|STARTED|Overall Study||3
474658|NCT00475657|1134138|P1|NOT COMPLETED|Overall Study||4
474659|NCT00475657|1134138|P1|COMPLETED|Overall Study||1
474660|NCT00475657|1134138|P1|STARTED|Overall Study||5
474661|NCT00475501|1134150|P4|NOT COMPLETED|Overall Study||4
474662|NCT00475501|1134151|P3|NOT COMPLETED|Overall Study||4
474663|NCT00475501|1134152|P2|NOT COMPLETED|Overall Study||5
474664|NCT00475501|1134153|P1|NOT COMPLETED|Overall Study||7
474665|NCT00475501|1134150|P4|COMPLETED|Overall Study||12
474666|NCT00475501|1134151|P3|COMPLETED|Overall Study||13
474667|NCT00475501|1134152|P2|COMPLETED|Overall Study||8
474668|NCT00475501|1134153|P1|COMPLETED|Overall Study||7
474669|NCT00475501|1134150|P4|STARTED|Overall Study||16
474670|NCT00475501|1134151|P3|STARTED|Overall Study||17
474671|NCT00475501|1134152|P2|STARTED|Overall Study||13
474672|NCT00475501|1134153|P1|STARTED|Overall Study||14
474673|NCT00475423|1134203|P1|NOT COMPLETED|Overall Study||32
474674|NCT00475423|1134203|P1|COMPLETED|Overall Study||90
474675|NCT00475423|1134203|P1|STARTED|Overall Study||122
474676|NCT00475332|1134224|P1|NOT COMPLETED|Overall Study||0
474677|NCT00475332|1134224|P1|COMPLETED|Overall Study||2
474678|NCT00475332|1134224|P1|STARTED|Overall Study||2
474679|NCT00475319|1134232|P3|NOT COMPLETED|Overall Study||4
474680|NCT00475319|1134233|P2|NOT COMPLETED|Overall Study||1
474681|NCT00475319|1134234|P1|NOT COMPLETED|Overall Study||2
474682|NCT00475319|1134232|P3|COMPLETED|Overall Study||99
474683|NCT00475319|1134233|P2|COMPLETED|Overall Study||101
474684|NCT00475319|1134234|P1|COMPLETED|Overall Study||101
474685|NCT00475319|1134232|P3|STARTED|Overall Study||103
474686|NCT00475319|1134233|P2|STARTED|Overall Study||102
474687|NCT00475319|1134234|P1|STARTED|Overall Study||103
474688|NCT00475306|1134249|P4|NOT COMPLETED|Overall Study||1
474689|NCT00475306|1134250|P3|NOT COMPLETED|Overall Study||0
474690|NCT00475306|1134251|P2|NOT COMPLETED|Overall Study||1
474691|NCT00475306|1134252|P1|NOT COMPLETED|Overall Study||1
474692|NCT00475306|1134249|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
474693|NCT00475306|1134250|P3|COMPLETED|Overall Study||72
474694|NCT00475306|1134251|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
474695|NCT00475306|1134252|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
474696|NCT00475306|1134249|P4|STARTED|Overall Study||72
474697|NCT00475306|1134250|P3|STARTED|Overall Study||72
474698|NCT00475306|1134251|P2|STARTED|Overall Study||72
474699|NCT00475306|1134252|P1|STARTED|Overall Study||73
474700|NCT00475241|1134268|P2|NOT COMPLETED|Overall Study||3
474701|NCT00475241|1134269|P1|NOT COMPLETED|Overall Study||7
474702|NCT00475241|1134268|P2|COMPLETED|Overall Study||15
474703|NCT00475241|1134269|P1|COMPLETED|Overall Study||11
474704|NCT00475241|1134268|P2|STARTED|Overall Study||18
474705|NCT00475241|1134269|P1|STARTED|Overall Study||18
474706|NCT00475228|1134277|P2|NOT COMPLETED|Overall Study||17
474707|NCT00475228|1134278|P1|NOT COMPLETED|Overall Study||17
474708|NCT00475228|1134277|P2|COMPLETED|Overall Study||27
474709|NCT00475228|1134278|P1|COMPLETED|Overall Study||27
474710|NCT00475228|1134277|P2|STARTED|Overall Study||44
474711|NCT00475228|1134278|P1|STARTED|Overall Study||44
474712|NCT00475176|1134288|P1|NOT COMPLETED|Overall Study||4
474713|NCT00475176|1134288|P1|COMPLETED|Overall Study||20
474714|NCT00475176|1134288|P1|STARTED|Overall Study||24
474715|NCT00475150|1134295|P2|NOT COMPLETED|Overall Study||0
474716|NCT00475150|1134296|P1|NOT COMPLETED|Overall Study||0
474717|NCT00475150|1134295|P2|COMPLETED|Overall Study||16
474718|NCT00475150|1134296|P1|COMPLETED|Overall Study||23
474719|NCT00475150|1134295|P2|STARTED|Overall Study||16
474720|NCT00475150|1134296|P1|STARTED|Overall Study||23
474721|NCT00475085|1134313|P4|NOT COMPLETED|Overall Study||20
474722|NCT00475085|1134314|P3|NOT COMPLETED|Overall Study||19
474723|NCT00475085|1134315|P2|NOT COMPLETED|Overall Study||20
474724|NCT00475085|1134316|P1|NOT COMPLETED|Overall Study||18
474725|NCT00475085|1134313|P4|COMPLETED|Overall Study||234
474726|NCT00475085|1134314|P3|COMPLETED|Overall Study||241
474727|NCT00475085|1134315|P2|COMPLETED|Overall Study||234
474728|NCT00475085|1134316|P1|COMPLETED|Overall Study||235
474729|NCT00475085|1134313|P4|STARTED|Overall Study||254
474730|NCT00475085|1134314|P3|STARTED|Overall Study||260
474731|NCT00475085|1134315|P2|STARTED|Overall Study||254
474732|NCT00475085|1134316|P1|STARTED|Overall Study||253
474733|NCT00475033|1134328|P2|NOT COMPLETED|Toddler Dose||0
474734|NCT00475033|1134329|P1|NOT COMPLETED|Toddler Dose||4
474735|NCT00475033|1134328|P2|COMPLETED|Toddler Dose||282
474736|NCT00475033|1134329|P1|COMPLETED|Toddler Dose||283
474737|NCT00475033|1134328|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
474738|NCT00475033|1134329|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
474739|NCT00475033|1134328|P2|NOT COMPLETED|After the Infant Series||8
474740|NCT00475033|1134329|P1|NOT COMPLETED|After the Infant Series||6
474741|NCT00475033|1134328|P2|COMPLETED|After the Infant Series||282
474742|NCT00475033|1134329|P1|COMPLETED|After the Infant Series||287
474743|NCT00475033|1134328|P2|Withdrawn After Infant Series|After the Infant Series||8
474744|NCT00475033|1134329|P1|Withdrawn After Infant Series|After the Infant Series||6
474745|NCT00475033|1134328|P2|STARTED|After the Infant Series||290
474746|NCT00475033|1134329|P1|STARTED|After the Infant Series||293
474747|NCT00475033|1134328|P2|NOT COMPLETED|Infant Series||13
474748|NCT00475033|1134329|P1|NOT COMPLETED|Infant Series||7
474749|NCT00475033|1134328|P2|COMPLETED|Infant Series||290
474750|NCT00475033|1134329|P1|COMPLETED|Infant Series||293
474751|NCT00475033|1134328|P2|Vaccinated Dose 3|Infant Series||294
474752|NCT00475033|1134329|P1|Vaccinated Dose 3|Infant Series||293
474753|NCT00475033|1134328|P2|Vaccinated Dose 2|Infant Series||296
474754|NCT00475033|1134329|P1|Vaccinated Dose 2|Infant Series||297
474755|NCT00475033|1134328|P2|Vaccinated Dose 1|Infant Series||303
474756|NCT00475033|1134329|P1|Vaccinated Dose 1|Infant Series||300
474757|NCT00475033|1134328|P2|STARTED|Infant Series||303
474758|NCT00475033|1134329|P1|STARTED|Infant Series||300
474759|NCT00474994|1134377|P1|NOT COMPLETED|Overall Study||5
474760|NCT00474994|1134377|P1|COMPLETED|Overall Study||48
474761|NCT00474994|1134377|P1|STARTED|Overall Study||53
474762|NCT00474968|1134383|P2|NOT COMPLETED|Overall Study||16
474763|NCT00474968|1134384|P1|NOT COMPLETED|Overall Study||18
474764|NCT00474968|1134383|P2|COMPLETED|Overall Study||355
474765|NCT00474968|1134384|P1|COMPLETED|Overall Study||348
474766|NCT00474968|1134383|P2|STARTED|Overall Study||371
474767|NCT00474968|1134384|P1|STARTED|Overall Study||366
474768|NCT00474955|1134394|P1|NOT COMPLETED|Overall Study||8
474769|NCT00474955|1134394|P1|COMPLETED|Overall Study||19
474770|NCT00474955|1134394|P1|STARTED|Overall Study||27
474771|NCT00474929|1134410|P5|NOT COMPLETED|Overall Study||0
474772|NCT00474929|1134411|P4|NOT COMPLETED|Overall Study||2
474773|NCT00474929|1134412|P3|NOT COMPLETED|Overall Study||2
474774|NCT00474929|1134413|P2|NOT COMPLETED|Overall Study||1
474775|NCT00474929|1134414|P1|NOT COMPLETED|Overall Study||0
474776|NCT00474929|1134410|P5|COMPLETED|Overall Study||77
474777|NCT00474929|1134411|P4|COMPLETED|Overall Study||5
474778|NCT00474929|1134412|P3|COMPLETED|Overall Study||5
474779|NCT00474929|1134413|P2|COMPLETED|Overall Study||5
474780|NCT00474929|1134414|P1|COMPLETED|Overall Study||6
474781|NCT00474929|1134410|P5|STARTED|Overall Study||77
474782|NCT00474929|1134411|P4|STARTED|Overall Study||7
474783|NCT00474929|1134412|P3|STARTED|Overall Study||7
474784|NCT00474929|1134413|P2|STARTED|Overall Study||6
474785|NCT00474929|1134414|P1|STARTED|Overall Study||6
474786|NCT00474903|1134431|P3|NOT COMPLETED|Overall Study||2
474787|NCT00474903|1134432|P2|NOT COMPLETED|Overall Study||5
474788|NCT00474903|1134433|P1|NOT COMPLETED|Overall Study||1
474789|NCT00474903|1134431|P3|COMPLETED|Overall Study||43
474790|NCT00474903|1134432|P2|COMPLETED|Overall Study||42
474791|NCT00474903|1134433|P1|COMPLETED|Overall Study||29
474792|NCT00474903|1134431|P3|STARTED|Overall Study||45
474793|NCT00474903|1134432|P2|STARTED|Overall Study||47
474794|NCT00474903|1134433|P1|STARTED|Overall Study||30
474795|NCT00474851|1134446|P2|NOT COMPLETED|Overall Study||11
474796|NCT00474851|1134447|P1|NOT COMPLETED|Overall Study||8
474797|NCT00474851|1134446|P2|COMPLETED|Overall Study||16
474798|NCT00474851|1134447|P1|COMPLETED|Overall Study||18
474799|NCT00474851|1134446|P2|Completed Baseline|Overall Study||26
474800|NCT00474851|1134447|P1|Completed Baseline|Overall Study||25
474801|NCT00474851|1134446|P2|STARTED|Overall Study||27
474802|NCT00474851|1134447|P1|STARTED|Overall Study||26
474803|NCT00474812|1134455|P1|NOT COMPLETED|Overall Study||7
474804|NCT00474812|1134455|P1|COMPLETED|Overall Study||44
474805|NCT00474812|1134455|P1|STARTED|Overall Study||51
474806|NCT00474786|1134465|P2|NOT COMPLETED|Overall Study||253
474807|NCT00474786|1134466|P1|NOT COMPLETED|Overall Study||259
474808|NCT00474786|1134465|P2|COMPLETED|Overall Study||0
474809|NCT00474786|1134466|P1|COMPLETED|Overall Study||0
474810|NCT00474786|1134465|P2|STARTED|Overall Study||253
474811|NCT00474786|1134466|P1|STARTED|Overall Study||259
474812|NCT00474760|1134491|P7|NOT COMPLETED|Overall Study||10
474813|NCT00474760|1134492|P6|NOT COMPLETED|Overall Study||29
474814|NCT00474760|1134493|P5|NOT COMPLETED|Overall Study||12
474815|NCT00474760|1134494|P4|NOT COMPLETED|Overall Study||3
474816|NCT00474760|1134495|P3|NOT COMPLETED|Overall Study||3
474817|NCT00474760|1134496|P2|NOT COMPLETED|Overall Study||3
474818|NCT00474760|1134497|P1|NOT COMPLETED|Overall Study||3
474819|NCT00474760|1134491|P7|COMPLETED|Overall Study||1
474820|NCT00474760|1134492|P6|COMPLETED|Overall Study||0
474821|NCT00474760|1134493|P5|COMPLETED|Overall Study||1
474822|NCT00474760|1134494|P4|COMPLETED|Overall Study||0
474823|NCT00474760|1134495|P3|COMPLETED|Overall Study||0
474824|NCT00474760|1134496|P2|COMPLETED|Overall Study||0
474825|NCT00474760|1134497|P1|COMPLETED|Overall Study||0
474826|NCT00474760|1134491|P7|STARTED|Overall Study||11
474827|NCT00474760|1134492|P6|STARTED|Overall Study||29
474828|NCT00474760|1134493|P5|STARTED|Overall Study||13
474829|NCT00474760|1134494|P4|STARTED|Overall Study||3
474830|NCT00474760|1134495|P3|STARTED|Overall Study||3
474831|NCT00474760|1134496|P2|STARTED|Overall Study||3
474832|NCT00474760|1134497|P1|STARTED|Overall Study||3
474833|NCT00474708|1134604|P2|NOT COMPLETED|Overall Study||25
474834|NCT00474708|1134605|P1|NOT COMPLETED|Overall Study||57
474835|NCT00474708|1134604|P2|COMPLETED|Overall Study||342
474836|NCT00474708|1134605|P1|COMPLETED|Overall Study||734
474837|NCT00474708|1134604|P2|STARTED|Overall Study||367
474838|NCT00474708|1134605|P1|STARTED|Overall Study||791
474839|NCT00474630|1134615|P2|NOT COMPLETED|Overall Study||70
474840|NCT00474630|1134616|P1|NOT COMPLETED|Overall Study||160
474841|NCT00474630|1134615|P2|COMPLETED|Overall Study||100
474842|NCT00474630|1134616|P1|COMPLETED|Overall Study||175
474843|NCT00474630|1134615|P2|STARTED|Overall Study||170
474844|NCT00474630|1134616|P1|STARTED|Overall Study||335
474845|NCT00474539|1134672|P2|NOT COMPLETED|Toddler Dose||0
474846|NCT00474539|1134673|P1|NOT COMPLETED|Toddler Dose||1
474847|NCT00474539|1134672|P2|COMPLETED|Toddler Dose||220
474848|NCT00474539|1134673|P1|COMPLETED|Toddler Dose||208
474849|NCT00474539|1134672|P2|STARTED|Toddler Dose||220
474850|NCT00474539|1134673|P1|STARTED|Toddler Dose||209
474851|NCT00474539|1134672|P2|NOT COMPLETED|After Infant Series||0
474852|NCT00474539|1134673|P1|NOT COMPLETED|After Infant Series||4
474853|NCT00474539|1134672|P2|COMPLETED|After Infant Series||220
474854|NCT00474539|1134673|P1|COMPLETED|After Infant Series||209
474855|NCT00474539|1134672|P2|STARTED|After Infant Series||220
474856|NCT00474539|1134673|P1|STARTED|After Infant Series||213
474857|NCT00474539|1134672|P2|NOT COMPLETED|Infant Series||6
474858|NCT00474539|1134673|P1|NOT COMPLETED|Infant Series||10
474859|NCT00474539|1134672|P2|COMPLETED|Infant Series||220
474860|NCT00474539|1134673|P1|COMPLETED|Infant Series||213
474861|NCT00474539|1134672|P2|Vaccinated Dose 3|Infant Series||221
474862|NCT00474539|1134673|P1|Vaccinated Dose 3|Infant Series||214
474863|NCT00474539|1134672|P2|Vaccinated Dose 2|Infant Series||222
474864|NCT00474539|1134673|P1|Vaccinated Dose 2|Infant Series||217
474865|NCT00474539|1134672|P2|Vaccinated Dose 1|Infant Series||226
474866|NCT00474539|1134673|P1|Vaccinated Dose 1|Infant Series||218
474867|NCT00474539|1134672|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
474868|NCT00474539|1134673|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
474869|NCT00474526|1134738|P17|NOT COMPLETED|Overall Study||9
474870|NCT00474526|1134739|P16|NOT COMPLETED|Overall Study||18
474871|NCT00474526|1134740|P15|NOT COMPLETED|Overall Study||77
474872|NCT00474526|1134741|P14|NOT COMPLETED|Overall Study||156
474873|NCT00474526|1134742|P13|NOT COMPLETED|Overall Study||15
474874|NCT00474526|1134743|P12|NOT COMPLETED|Overall Study||11
474875|NCT00474526|1134744|P11|NOT COMPLETED|Overall Study||10
474876|NCT00474526|1134745|P10|NOT COMPLETED|Overall Study||27
474877|NCT00474526|1134746|P9|NOT COMPLETED|Overall Study||6
474878|NCT00474526|1134747|P8|NOT COMPLETED|Overall Study||6
474879|NCT00474526|1134748|P7|NOT COMPLETED|Overall Study||25
474880|NCT00474526|1134749|P6|NOT COMPLETED|Overall Study||16
474881|NCT00474526|1134750|P5|NOT COMPLETED|Overall Study||68
474882|NCT00474526|1134751|P4|NOT COMPLETED|Overall Study||119
474883|NCT00474526|1134752|P3|NOT COMPLETED|Overall Study||49
474884|NCT00474526|1134753|P2|NOT COMPLETED|Overall Study||46
474885|NCT00474526|1134754|P1|NOT COMPLETED|Overall Study||33
474886|NCT00474526|1134738|P17|COMPLETED|Overall Study||174
474887|NCT00474526|1134739|P16|COMPLETED|Overall Study||152
474888|NCT00474526|1134740|P15|COMPLETED|Overall Study||281
474889|NCT00474526|1134741|P14|COMPLETED|Overall Study||1270
474890|NCT00474526|1134742|P13|COMPLETED|Overall Study||135
474891|NCT00474526|1134743|P12|COMPLETED|Overall Study||139
474892|NCT00474526|1134744|P11|COMPLETED|Overall Study||141
474893|NCT00474526|1134745|P10|COMPLETED|Overall Study||121
474894|NCT00474526|1134746|P9|COMPLETED|Overall Study||144
474895|NCT00474526|1134747|P8|COMPLETED|Overall Study||145
474896|NCT00474526|1134748|P7|COMPLETED|Overall Study||178
474897|NCT00474526|1134749|P6|COMPLETED|Overall Study||54
474898|NCT00474526|1134750|P5|COMPLETED|Overall Study||8
474899|NCT00474526|1134751|P4|COMPLETED|Overall Study||561
474900|NCT00474526|1134752|P3|COMPLETED|Overall Study||110
474901|NCT00474526|1134753|P2|COMPLETED|Overall Study||120
474902|NCT00474526|1134754|P1|COMPLETED|Overall Study||121
474903|NCT00474526|1134738|P17|STARTED|Overall Study||183
474904|NCT00474526|1134739|P16|STARTED|Overall Study||170
474905|NCT00474526|1134740|P15|STARTED|Overall Study||358
474906|NCT00474526|1134741|P14|STARTED|Overall Study||1426
474907|NCT00474526|1134742|P13|STARTED|Overall Study||150
474908|NCT00474526|1134743|P12|STARTED|Overall Study||150
474909|NCT00474526|1134744|P11|STARTED|Overall Study||151
474910|NCT00474526|1134745|P10|STARTED|Overall Study||148
474911|NCT00474526|1134746|P9|STARTED|Overall Study||150
474912|NCT00474526|1134747|P8|STARTED|Overall Study||151
474913|NCT00474526|1134748|P7|STARTED|Overall Study||203
474914|NCT00474526|1134749|P6|STARTED|Overall Study||70
474915|NCT00474526|1134750|P5|STARTED|Overall Study||76
474916|NCT00474526|1134751|P4|STARTED|Overall Study||680
474917|NCT00474526|1134752|P3|STARTED|Overall Study||159
474918|NCT00474526|1134753|P2|STARTED|Overall Study||166
474919|NCT00474526|1134754|P1|STARTED|Overall Study||154
474920|NCT00474487|1134919|P4|NOT COMPLETED|Overall Study||0
474921|NCT00474487|1134920|P3|NOT COMPLETED|Overall Study||14
474922|NCT00474487|1134921|P2|NOT COMPLETED|Overall Study||2
474923|NCT00474487|1134922|P1|NOT COMPLETED|Overall Study||30
474924|NCT00474487|1134919|P4|COMPLETED|Overall Study||109
474925|NCT00474487|1134920|P3|COMPLETED|Overall Study||885
474926|NCT00474487|1134921|P2|COMPLETED|Overall Study||215
474927|NCT00474487|1134922|P1|COMPLETED|Overall Study||1576
474928|NCT00474487|1134919|P4|STARTED|Overall Study||109
474929|NCT00474487|1134920|P3|STARTED|Overall Study||899
474930|NCT00474487|1134921|P2|STARTED|Overall Study||217
474931|NCT00474487|1134922|P1|STARTED|Overall Study||1606
474932|NCT00474383|1134942|P2|NOT COMPLETED|Extension||5
474933|NCT00474383|1134943|P1|NOT COMPLETED|Extension||0
474934|NCT00474383|1134942|P2|COMPLETED|Extension||0
474935|NCT00474383|1134943|P1|COMPLETED|Extension||0
474936|NCT00474383|1134942|P2|STARTED|Extension||5
474937|NCT00474383|1134943|P1|STARTED|Extension||0
474938|NCT00474383|1134942|P2|NOT COMPLETED|Between Main Study and Extension||0
474939|NCT00474383|1134943|P1|NOT COMPLETED|Between Main Study and Extension||6
474940|NCT00474383|1134942|P2|COMPLETED|Between Main Study and Extension||0
474941|NCT00474383|1134943|P1|COMPLETED|Between Main Study and Extension||5
474942|NCT00474383|1134942|P2|STARTED|Between Main Study and Extension||0
474943|NCT00474383|1134943|P1|STARTED|Between Main Study and Extension||11
474944|NCT00474383|1134942|P2|NOT COMPLETED|Main Study||0
474945|NCT00474383|1134943|P1|NOT COMPLETED|Main Study||36
474946|NCT00474383|1134942|P2|COMPLETED|Main Study||0
474947|NCT00474383|1134943|P1|COMPLETED|Main Study||11
474948|NCT00474383|1134942|P2|STARTED|Main Study||0
474949|NCT00474383|1134943|P1|STARTED|Main Study||47
474950|NCT00474240|1134960|P6|NOT COMPLETED|Overall Study||18
474951|NCT00474240|1134961|P5|NOT COMPLETED|Overall Study||8
474952|NCT00474240|1134962|P4|NOT COMPLETED|Overall Study||16
474953|NCT00474240|1134963|P3|NOT COMPLETED|Overall Study||9
474954|NCT00474240|1134964|P2|NOT COMPLETED|Overall Study||1
474955|NCT00474240|1134965|P1|NOT COMPLETED|Overall Study||1
474956|NCT00474240|1134960|P6|COMPLETED|Overall Study||8
474957|NCT00474240|1134961|P5|COMPLETED|Overall Study||18
474958|NCT00474240|1134962|P4|COMPLETED|Overall Study||10
474959|NCT00474240|1134963|P3|COMPLETED|Overall Study||17
474960|NCT00474240|1134964|P2|COMPLETED|Overall Study||25
474961|NCT00474240|1134965|P1|COMPLETED|Overall Study||26
474962|NCT00474240|1134960|P6|STARTED|Overall Study||26
474963|NCT00474240|1134961|P5|STARTED|Overall Study||26
474964|NCT00474240|1134962|P4|STARTED|Overall Study||26
474965|NCT00474240|1134963|P3|STARTED|Overall Study||26
474966|NCT00474240|1134964|P2|STARTED|Overall Study||26
474967|NCT00474240|1134965|P1|STARTED|Overall Study||27
474968|NCT00474201|1134985|P1|NOT COMPLETED|Overall Study||0
474969|NCT00474201|1134985|P1|COMPLETED|Overall Study||15
474970|NCT00474201|1134985|P1|STARTED|Overall Study||15
474971|NCT00474188|1134990|P1|NOT COMPLETED|Overall Study||6
474972|NCT00474188|1134990|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
474973|NCT00474188|1134990|P1|STARTED|Overall Study||26
474974|NCT00474175|1135000|P3|NOT COMPLETED|Overall Study||4
474975|NCT00474175|1135001|P2|NOT COMPLETED|Overall Study||7
474976|NCT00474175|1135002|P1|NOT COMPLETED|Overall Study||1
474977|NCT00474175|1135000|P3|COMPLETED|Overall Study||225
474978|NCT00474175|1135001|P2|COMPLETED|Overall Study||226
474979|NCT00474175|1135002|P1|COMPLETED|Overall Study||114
474980|NCT00474175|1135000|P3|Treated|Overall Study||228
474981|NCT00474175|1135001|P2|Treated|Overall Study||233
474982|NCT00474175|1135002|P1|Treated|Overall Study||115
474983|NCT00474175|1135000|P3|STARTED|Overall Study||229
474984|NCT00474175|1135001|P2|STARTED|Overall Study||233
474985|NCT00474175|1135002|P1|STARTED|Overall Study||115
474986|NCT00474123|1135039|P2|NOT COMPLETED|Overall Study||0
474987|NCT00474123|1135040|P1|NOT COMPLETED|Overall Study||0
474988|NCT00474123|1135039|P2|COMPLETED|Overall Study||40
474989|NCT00474123|1135040|P1|COMPLETED|Overall Study||38
474990|NCT00474123|1135039|P2|STARTED|Overall Study||40
474991|NCT00474123|1135040|P1|STARTED|Overall Study||38
474992|NCT00474058|1135066|P2|NOT COMPLETED|Overall Study||17
474993|NCT00474058|1135067|P1|NOT COMPLETED|Overall Study||24
474994|NCT00474058|1135066|P2|COMPLETED|Overall Study||80
474995|NCT00474058|1135067|P1|COMPLETED|Overall Study||166
474996|NCT00474058|1135066|P2|STARTED|Overall Study||97
474997|NCT00474058|1135067|P1|STARTED|Overall Study||190
474998|NCT00474045|1135081|P2|NOT COMPLETED|Overall Study||101
474999|NCT00474045|1135082|P1|NOT COMPLETED|Overall Study||106
475000|NCT00474045|1135081|P2|COMPLETED|Overall Study||136
475001|NCT00474045|1135082|P1|COMPLETED|Overall Study||127
475002|NCT00474045|1135081|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
475003|NCT00474045|1135082|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
475004|NCT00474045|1135081|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
475005|NCT00474045|1135082|P1|Exposed-Pregnant Subjects|Overall Study||152
475006|NCT00474045|1135081|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
475007|NCT00474045|1135082|P1|Exposed-All Subjects|Overall Study||233
475008|NCT00474045|1135081|P2|STARTED|Overall Study||237
475009|NCT00474045|1135082|P1|STARTED|Overall Study||233
475010|NCT00473889|1135182|P2|NOT COMPLETED|Overall Study||64
475011|NCT00473889|1135183|P1|NOT COMPLETED|Overall Study||83
475012|NCT00473889|1135182|P2|COMPLETED|Overall Study||63
475013|NCT00473889|1135183|P1|COMPLETED|Overall Study||43
475014|NCT00473889|1135182|P2|STARTED|Overall Study||127
475015|NCT00473889|1135183|P1|STARTED|Overall Study||126
475016|NCT00473876|1135195|P2|NOT COMPLETED|Overall Study||1
475017|NCT00473876|1135196|P1|NOT COMPLETED|Overall Study||3
475018|NCT00473876|1135195|P2|COMPLETED|Overall Study||22
475019|NCT00473876|1135196|P1|COMPLETED|Overall Study||36
475020|NCT00473876|1135195|P2|STARTED|Overall Study||23
475021|NCT00473876|1135196|P1|STARTED|Overall Study||39
475022|NCT00473837|1135206|P2|NOT COMPLETED|Overall Study||3
475023|NCT00473837|1135207|P1|NOT COMPLETED|Overall Study||1
475024|NCT00473837|1135206|P2|COMPLETED|Overall Study||43
475025|NCT00473837|1135207|P1|COMPLETED|Overall Study||49
475026|NCT00473837|1135206|P2|STARTED|Overall Study||46
475027|NCT00473837|1135207|P1|STARTED|Overall Study||50
475028|NCT00473824|1135215|P2|NOT COMPLETED|Overall Study||0
475029|NCT00473824|1135216|P1|NOT COMPLETED|Overall Study||5
475030|NCT00473824|1135215|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
475031|NCT00473824|1135216|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
475032|NCT00473824|1135215|P2|STARTED|Overall Study||2
475033|NCT00473824|1135216|P1|STARTED|Overall Study||5
475034|NCT00473746|1135227|P5|NOT COMPLETED|Period 2 (Phase 2)||27
475035|NCT00473746|1135228|P4|NOT COMPLETED|Period 2 (Phase 2)||0
475036|NCT00473746|1135229|P3|NOT COMPLETED|Period 2 (Phase 2)||0
475037|NCT00473746|1135230|P2|NOT COMPLETED|Period 2 (Phase 2)||0
475038|NCT00473746|1135231|P1|NOT COMPLETED|Period 2 (Phase 2)||0
475039|NCT00473746|1135227|P5|COMPLETED|Period 2 (Phase 2)||6
475040|NCT00473746|1135228|P4|COMPLETED|Period 2 (Phase 2)||0
475041|NCT00473746|1135229|P3|COMPLETED|Period 2 (Phase 2)||0
475042|NCT00473746|1135230|P2|COMPLETED|Period 2 (Phase 2)||0
475043|NCT00473746|1135231|P1|COMPLETED|Period 2 (Phase 2)||0
475044|NCT00473746|1135227|P5|STARTED|Period 2 (Phase 2)||33
475045|NCT00473746|1135228|P4|STARTED|Period 2 (Phase 2)||0
475046|NCT00473746|1135229|P3|STARTED|Period 2 (Phase 2)||0
475047|NCT00473746|1135230|P2|STARTED|Period 2 (Phase 2)||0
475048|NCT00473746|1135231|P1|STARTED|Period 2 (Phase 2)||0
475049|NCT00473746|1135227|P5|NOT COMPLETED|Period 1 (Phase 1)||0
475050|NCT00473746|1135228|P4|NOT COMPLETED|Period 1 (Phase 1)||10
475051|NCT00473746|1135229|P3|NOT COMPLETED|Period 1 (Phase 1)||6
475052|NCT00473746|1135230|P2|NOT COMPLETED|Period 1 (Phase 1)||9
475053|NCT00473746|1135231|P1|NOT COMPLETED|Period 1 (Phase 1)||6
475054|NCT00473746|1135227|P5|COMPLETED|Period 1 (Phase 1)||0
475055|NCT00473746|1135228|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
475056|NCT00473746|1135229|P3|COMPLETED|Period 1 (Phase 1)||0
475057|NCT00473746|1135230|P2|COMPLETED|Period 1 (Phase 1)||0
475058|NCT00473746|1135231|P1|COMPLETED|Period 1 (Phase 1)||0
475059|NCT00473746|1135227|P5|STARTED|Period 1 (Phase 1)||0
475060|NCT00473746|1135228|P4|STARTED|Period 1 (Phase 1)||12
475061|NCT00473746|1135229|P3|STARTED|Period 1 (Phase 1)||6
475062|NCT00473746|1135230|P2|STARTED|Period 1 (Phase 1)||9
475063|NCT00473746|1135231|P1|STARTED|Period 1 (Phase 1)||6
475064|NCT00473655|1135279|P3|NOT COMPLETED|Overall Study||8
475065|NCT00473655|1135280|P2|NOT COMPLETED|Overall Study||5
475066|NCT00473655|1135281|P1|NOT COMPLETED|Overall Study||9
475067|NCT00473655|1135279|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
475068|NCT00473655|1135280|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
475069|NCT00473655|1135281|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
475070|NCT00473655|1135279|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
475071|NCT00473655|1135280|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
475072|NCT00473655|1135281|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
475073|NCT00473642|1135316|P3|NOT COMPLETED|Overall Study||2
475074|NCT00473642|1135317|P2|NOT COMPLETED|Overall Study||1
475075|NCT00473642|1135318|P1|NOT COMPLETED|Overall Study||2
475076|NCT00473642|1135316|P3|COMPLETED|Overall Study||8
475077|NCT00473642|1135317|P2|COMPLETED|Overall Study||10
475078|NCT00473642|1135318|P1|COMPLETED|Overall Study||8
475079|NCT00473642|1135316|P3|STARTED|Overall Study||10
475080|NCT00473642|1135317|P2|STARTED|Overall Study||11
475081|NCT00473642|1135318|P1|STARTED|Overall Study||10
475082|NCT00473590|1135328|P2|NOT COMPLETED|Overall Study||38
475083|NCT00473590|1135329|P1|NOT COMPLETED|Overall Study||45
475084|NCT00473590|1135328|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
475085|NCT00473590|1135329|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
475086|NCT00473590|1135328|P2|Safety Population|Overall Study||50
475087|NCT00473590|1135329|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
475088|NCT00473590|1135328|P2|Treated|Overall Study||48
475089|NCT00473590|1135329|P1|Treated|Overall Study||52
475090|NCT00473590|1135328|P2|STARTED|Overall Study||49
475091|NCT00473590|1135329|P1|STARTED|Overall Study||53
475092|NCT00473564|1135345|P1|NOT COMPLETED|Overall Study||23
475093|NCT00473564|1135345|P1|COMPLETED|Overall Study||147
475094|NCT00473564|1135345|P1|STARTED|Overall Study||170
475095|NCT00473512|1135355|P5|NOT COMPLETED|Period 2 (Phase 2)||2
475096|NCT00473512|1135356|P4|NOT COMPLETED|Period 2 (Phase 2)||23
475097|NCT00473512|1135357|P3|NOT COMPLETED|Period 2 (Phase 2)||2
475098|NCT00473512|1135358|P2|NOT COMPLETED|Period 2 (Phase 2)||2
475099|NCT00473512|1135359|P1|NOT COMPLETED|Period 2 (Phase 2)||1
475100|NCT00473512|1135355|P5|COMPLETED|Period 2 (Phase 2)||0
475101|NCT00473512|1135356|P4|COMPLETED|Period 2 (Phase 2)||0
475102|NCT00473512|1135357|P3|COMPLETED|Period 2 (Phase 2)||0
475103|NCT00473512|1135358|P2|COMPLETED|Period 2 (Phase 2)||0
475104|NCT00473512|1135359|P1|COMPLETED|Period 2 (Phase 2)||0
475105|NCT00473512|1135355|P5|STARTED|Period 2 (Phase 2)||2
475106|NCT00473512|1135356|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
475107|NCT00473512|1135357|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
475108|NCT00473512|1135358|P2|STARTED|Period 2 (Phase 2)||2
475109|NCT00473512|1135359|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
475110|NCT00473512|1135355|P5|NOT COMPLETED|Period 1 (Phase 1)||1
475111|NCT00473512|1135356|P4|NOT COMPLETED|Period 1 (Phase 1)||17
475112|NCT00473512|1135357|P3|NOT COMPLETED|Period 1 (Phase 1)||0
475113|NCT00473512|1135358|P2|NOT COMPLETED|Period 1 (Phase 1)||1
475114|NCT00473512|1135359|P1|NOT COMPLETED|Period 1 (Phase 1)||1
475115|NCT00473512|1135355|P5|COMPLETED|Period 1 (Phase 1)||2
475116|NCT00473512|1135356|P4|COMPLETED|Period 1 (Phase 1)||25
475117|NCT00473512|1135357|P3|COMPLETED|Period 1 (Phase 1)||3
475118|NCT00473512|1135358|P2|COMPLETED|Period 1 (Phase 1)||2
475119|NCT00473512|1135359|P1|COMPLETED|Period 1 (Phase 1)||2
475120|NCT00473512|1135355|P5|STARTED|Period 1 (Phase 1)||3
475121|NCT00473512|1135356|P4|STARTED|Period 1 (Phase 1)||42
475122|NCT00473512|1135357|P3|STARTED|Period 1 (Phase 1)||3
475123|NCT00473512|1135358|P2|STARTED|Period 1 (Phase 1)||3
475124|NCT00473512|1135359|P1|STARTED|Period 1 (Phase 1)||3
475125|NCT00473434|1135417|P1|NOT COMPLETED|Overall Study||32
475126|NCT00473434|1135417|P1|COMPLETED|Overall Study||32
475127|NCT00473434|1135417|P1|STARTED|Overall Study||64
475128|NCT00473382|1135482|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
475129|NCT00473382|1135483|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
475130|NCT00473382|1135484|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
475131|NCT00473382|1135482|P3|COMPLETED|Open-label Extension Through Month 60||2
475132|NCT00473382|1135483|P2|COMPLETED|Open-label Extension Through Month 60||1
475133|NCT00473382|1135484|P1|COMPLETED|Open-label Extension Through Month 60||2
475134|NCT00473382|1135482|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
475135|NCT00473382|1135483|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
475136|NCT00473382|1135484|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
475137|NCT00473382|1135482|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
475138|NCT00473382|1135483|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
475139|NCT00473382|1135484|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
475140|NCT00473382|1135482|P3|COMPLETED|Open-label Extension Through Month 48||37
475141|NCT00473382|1135483|P2|COMPLETED|Open-label Extension Through Month 48||42
475142|NCT00473382|1135484|P1|COMPLETED|Open-label Extension Through Month 48||38
475143|NCT00473382|1135482|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
475144|NCT00473382|1135483|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
475145|NCT00473382|1135484|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
475146|NCT00473382|1135482|P3|NOT COMPLETED|Core Study||29
475147|NCT00473382|1135483|P2|NOT COMPLETED|Core Study||27
475148|NCT00473382|1135484|P1|NOT COMPLETED|Core Study||28
475149|NCT00473382|1135482|P3|COMPLETED|Core Study||98
475150|NCT00473382|1135483|P2|COMPLETED|Core Study||98
475151|NCT00473382|1135484|P1|COMPLETED|Core Study||102
475152|NCT00473382|1135482|P3|STARTED|Core Study||127
475153|NCT00473382|1135483|P2|STARTED|Core Study||125
475154|NCT00473382|1135484|P1|STARTED|Core Study||130
475155|NCT00473330|1135542|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
475156|NCT00473330|1135543|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
475157|NCT00473330|1135544|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
475158|NCT00473330|1135542|P3|COMPLETED|Open-label Extension Through Month 60||0
475159|NCT00473330|1135543|P2|COMPLETED|Open-label Extension Through Month 60||1
475160|NCT00473330|1135544|P1|COMPLETED|Open-label Extension Through Month 60||1
475161|NCT00473330|1135542|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
475162|NCT00473330|1135543|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
475163|NCT00473330|1135544|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
475164|NCT00473330|1135542|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
475165|NCT00473330|1135543|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
475166|NCT00473330|1135544|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
475167|NCT00473330|1135542|P3|COMPLETED|Open-label Extension Through Month 48||50
475168|NCT00473330|1135543|P2|COMPLETED|Open-label Extension Through Month 48||59
475169|NCT00473330|1135544|P1|COMPLETED|Open-label Extension Through Month 48||63
475170|NCT00473330|1135542|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
475171|NCT00473330|1135543|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
475172|NCT00473330|1135544|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
475173|NCT00473330|1135542|P3|NOT COMPLETED|Core Study||41
475174|NCT00473330|1135543|P2|NOT COMPLETED|Core Study||25
475175|NCT00473330|1135544|P1|NOT COMPLETED|Core Study||27
475176|NCT00473330|1135542|P3|COMPLETED|Core Study||86
475177|NCT00473330|1135543|P2|COMPLETED|Core Study||100
475178|NCT00473330|1135544|P1|COMPLETED|Core Study||98
475179|NCT00473330|1135542|P3|STARTED|Core Study||127
475180|NCT00473330|1135543|P2|STARTED|Core Study||125
475181|NCT00473330|1135544|P1|STARTED|Core Study||125
475182|NCT00473265|1135599|P1|NOT COMPLETED|Overall Study||20
475183|NCT00473265|1135599|P1|COMPLETED|Overall Study||48
475184|NCT00473265|1135599|P1|STARTED|Overall Study||68
475185|NCT00473083|1135611|P3|NOT COMPLETED|Overall Study||0
475186|NCT00473083|1135612|P2|NOT COMPLETED|Overall Study||0
475187|NCT00473083|1135613|P1|NOT COMPLETED|Overall Study||1
475188|NCT00473083|1135611|P3|COMPLETED|Overall Study||50
475189|NCT00473083|1135612|P2|COMPLETED|Overall Study||50
475190|NCT00473083|1135613|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
475191|NCT00473083|1135611|P3|STARTED|Overall Study||50
475192|NCT00473083|1135612|P2|STARTED|Overall Study||50
475193|NCT00473083|1135613|P1|STARTED|Overall Study||50
475194|NCT00472849|1135641|P2|NOT COMPLETED|Overall Study||0
475195|NCT00472849|1135642|P1|NOT COMPLETED|Overall Study||0
475196|NCT00472849|1135641|P2|COMPLETED|Overall Study||78
475197|NCT00472849|1135642|P1|COMPLETED|Overall Study||12
475198|NCT00472849|1135641|P2|STARTED|Overall Study||78
475199|NCT00472849|1135642|P1|STARTED|Overall Study||12
475200|NCT00472797|1135650|P2|NOT COMPLETED|Overall Study||1
475201|NCT00472797|1135651|P1|NOT COMPLETED|Overall Study||4
475202|NCT00472797|1135650|P2|COMPLETED|Overall Study||112
475203|NCT00472797|1135651|P1|COMPLETED|Overall Study||115
475204|NCT00472797|1135650|P2|STARTED|Overall Study||113
475205|NCT00472797|1135651|P1|STARTED|Overall Study||119
475206|NCT00472732|1135677|P2|NOT COMPLETED|Overall Study||0
475207|NCT00472732|1135678|P1|NOT COMPLETED|Overall Study||0
475208|NCT00472732|1135677|P2|COMPLETED|Overall Study||22
475209|NCT00472732|1135678|P1|COMPLETED|Overall Study||24
475210|NCT00472732|1135677|P2|STARTED|Overall Study||22
475211|NCT00472732|1135678|P1|STARTED|Overall Study||24
475212|NCT00472641|1135688|P1|NOT COMPLETED|Overall Study||7
475213|NCT00472641|1135688|P1|COMPLETED|Overall Study||18
475214|NCT00472641|1135688|P1|STARTED|Overall Study||25
475215|NCT00472576|1135695|P2|NOT COMPLETED|Second Intervention||0
475216|NCT00472576|1135696|P1|NOT COMPLETED|Second Intervention||0
475217|NCT00472576|1135695|P2|COMPLETED|Second Intervention||3
475218|NCT00472576|1135696|P1|COMPLETED|Second Intervention||2
475219|NCT00472576|1135695|P2|STARTED|Second Intervention||3
475220|NCT00472576|1135696|P1|STARTED|Second Intervention||2
475221|NCT00472576|1135695|P2|NOT COMPLETED|First Intervention||0
475222|NCT00472576|1135696|P1|NOT COMPLETED|First Intervention||0
475223|NCT00472576|1135695|P2|COMPLETED|First Intervention||3
475224|NCT00472576|1135696|P1|COMPLETED|First Intervention||2
475225|NCT00472576|1135695|P2|STARTED|First Intervention||3
475226|NCT00472576|1135696|P1|STARTED|First Intervention||2
475227|NCT00472056|1135708|P4|NOT COMPLETED|Overall Study||0
475228|NCT00472056|1135709|P3|NOT COMPLETED|Overall Study||0
475229|NCT00472056|1135710|P2|NOT COMPLETED|Overall Study||0
475230|NCT00472056|1135711|P1|NOT COMPLETED|Overall Study||0
475231|NCT00472056|1135708|P4|COMPLETED|Overall Study||17
475232|NCT00472056|1135709|P3|COMPLETED|Overall Study||32
475233|NCT00472056|1135710|P2|COMPLETED|Overall Study||19
475234|NCT00472056|1135711|P1|COMPLETED|Overall Study||25
475235|NCT00472056|1135708|P4|STARTED|Overall Study||17
475236|NCT00472056|1135709|P3|STARTED|Overall Study||32
475237|NCT00472056|1135710|P2|STARTED|Overall Study||19
475238|NCT00472056|1135711|P1|STARTED|Overall Study||25
475239|NCT00472030|1135721|P2|NOT COMPLETED|Overall Study||0
475240|NCT00472030|1135722|P1|NOT COMPLETED|Overall Study||1
475241|NCT00472030|1135721|P2|COMPLETED|Overall Study||0
475242|NCT00472030|1135722|P1|COMPLETED|Overall Study||1
475243|NCT00472030|1135721|P2|STARTED|Overall Study||0
475244|NCT00472030|1135722|P1|STARTED|Overall Study||2
475245|NCT00472446|1135742|P4|NOT COMPLETED|Overall Study||6
475246|NCT00472446|1135743|P3|NOT COMPLETED|Overall Study||7
475247|NCT00472446|1135744|P2|NOT COMPLETED|Overall Study||6
475248|NCT00472446|1135745|P1|NOT COMPLETED|Overall Study||5
475249|NCT00472446|1135742|P4|COMPLETED|Overall Study||39
475250|NCT00472446|1135743|P3|COMPLETED|Overall Study||38
475251|NCT00472446|1135744|P2|COMPLETED|Overall Study||41
475252|NCT00472446|1135745|P1|COMPLETED|Overall Study||41
475253|NCT00472446|1135742|P4|STARTED|Overall Study||45
475254|NCT00472446|1135743|P3|STARTED|Overall Study||45
475255|NCT00472446|1135744|P2|STARTED|Overall Study||47
475256|NCT00472446|1135745|P1|STARTED|Overall Study||46
475257|NCT00472420|1135775|P1|NOT COMPLETED|Follow-up Period||17
475258|NCT00472420|1135775|P1|COMPLETED|Follow-up Period||15
475259|NCT00472420|1135775|P1|STARTED|Follow-up Period||32
475260|NCT00472420|1135775|P1|NOT COMPLETED|Induction Treatment Period||16
475261|NCT00472420|1135775|P1|COMPLETED|Induction Treatment Period||32
475262|NCT00472420|1135775|P1|STARTED|Induction Treatment Period||48
475263|NCT00472303|1135783|P3|NOT COMPLETED|Maintenance Phase||17
475264|NCT00472303|1135784|P2|NOT COMPLETED|Maintenance Phase||16
475265|NCT00472303|1135785|P1|NOT COMPLETED|Maintenance Phase||17
475266|NCT00472303|1135783|P3|COMPLETED|Maintenance Phase||95
475267|NCT00472303|1135784|P2|COMPLETED|Maintenance Phase||93
475268|NCT00472303|1135785|P1|COMPLETED|Maintenance Phase||89
475269|NCT00472303|1135783|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
475270|NCT00472303|1135784|P2|STARTED|Maintenance Phase||109
475271|NCT00472303|1135785|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
475272|NCT00472303|1135783|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
475273|NCT00472303|1135784|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
475274|NCT00472303|1135785|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
475275|NCT00472303|1135783|P3|COMPLETED|Discontinuations After Titration Phase||0
475276|NCT00472303|1135784|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
475277|NCT00472303|1135785|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
475278|NCT00472303|1135783|P3|STARTED|Discontinuations After Titration Phase||0
475279|NCT00472303|1135784|P2|STARTED|Discontinuations After Titration Phase||129
475280|NCT00472303|1135785|P1|STARTED|Discontinuations After Titration Phase||279
475281|NCT00472303|1135783|P3|NOT COMPLETED|Titration Phase||0
475282|NCT00472303|1135784|P2|NOT COMPLETED|Titration Phase||29
475283|NCT00472303|1135785|P1|NOT COMPLETED|Titration Phase||59
475284|NCT00472303|1135783|P3|COMPLETED|Titration Phase||0
475285|NCT00472303|1135784|P2|COMPLETED|Titration Phase||129
475286|NCT00472303|1135785|P1|COMPLETED|Titration Phase||279
475287|NCT00472303|1135783|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
475288|NCT00472303|1135784|P2|STARTED|Titration Phase||158
475289|NCT00472303|1135785|P1|STARTED|Titration Phase||338
475290|NCT00472290|1135848|P1|NOT COMPLETED|Overall Study||72
475291|NCT00472290|1135848|P1|COMPLETED|Overall Study||0
475292|NCT00472290|1135848|P1|STARTED|Overall Study||72
475293|NCT00472199|1135860|P2|NOT COMPLETED|Overall Study||60
475294|NCT00472199|1135861|P1|NOT COMPLETED|Overall Study||35
475295|NCT00472199|1135860|P2|COMPLETED|Overall Study||103
475296|NCT00472199|1135861|P1|COMPLETED|Overall Study||131
475297|NCT00472199|1135860|P2|STARTED|Overall Study||163
475298|NCT00472199|1135861|P1|STARTED|Overall Study||166
475299|NCT00472082|1135927|P1|NOT COMPLETED|Overall Study||5
475300|NCT00472082|1135927|P1|COMPLETED|Overall Study||0
475301|NCT00472082|1135927|P1|STARTED|Overall Study||5
475302|NCT00471822|1135932|P1|NOT COMPLETED|Overall Study||2
475303|NCT00471822|1135932|P1|COMPLETED|Overall Study||9705
475304|NCT00471822|1135932|P1|Treated|Overall Study||9705
475305|NCT00471822|1135932|P1|STARTED|Overall Study||9707
475306|NCT00471718|1135940|P1|NOT COMPLETED|Overall Study||27
475307|NCT00471718|1135940|P1|COMPLETED|Overall Study||0
475308|NCT00471718|1135940|P1|STARTED|Overall Study||27
475309|NCT00471705|1135952|P3|NOT COMPLETED|Overall Study||15
475310|NCT00471705|1135953|P2|NOT COMPLETED|Overall Study||22
475311|NCT00471705|1135954|P1|NOT COMPLETED|Overall Study||24
475312|NCT00471705|1135952|P3|COMPLETED|Overall Study||134
475313|NCT00471705|1135953|P2|COMPLETED|Overall Study||121
475314|NCT00471705|1135954|P1|COMPLETED|Overall Study||121
475315|NCT00471705|1135952|P3|STARTED|Overall Study||149
475316|NCT00471705|1135953|P2|STARTED|Overall Study||143
475317|NCT00471705|1135954|P1|STARTED|Overall Study||145
475318|NCT00471536|1135968|P1|NOT COMPLETED|Overall Study||1
475319|NCT00471536|1135968|P1|COMPLETED|Overall Study||18
475320|NCT00471536|1135968|P1|STARTED|Overall Study||19
475321|NCT00471497|1135980|P3|NOT COMPLETED|Overall Study||40
475322|NCT00471497|1135981|P2|NOT COMPLETED|Overall Study||35
475323|NCT00471497|1135982|P1|NOT COMPLETED|Overall Study||46
475324|NCT00471497|1135980|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
475325|NCT00471497|1135981|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
475326|NCT00471497|1135982|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
475327|NCT00471497|1135980|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
475328|NCT00471497|1135981|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
475329|NCT00471497|1135982|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
475330|NCT00471497|1135980|P3|STARTED|Overall Study||281
475331|NCT00471497|1135981|P2|STARTED|Overall Study||282
475332|NCT00471497|1135982|P1|STARTED|Overall Study||283
475333|NCT00471445|1135992|P2|NOT COMPLETED|Overall Study||2
475334|NCT00471445|1135993|P1|NOT COMPLETED|Overall Study||2
475335|NCT00471445|1135992|P2|COMPLETED|Overall Study||231
475336|NCT00471445|1135993|P1|COMPLETED|Overall Study||227
475337|NCT00471445|1135992|P2|STARTED|Overall Study||233
475338|NCT00471445|1135993|P1|STARTED|Overall Study||229
475339|NCT00471380|1135999|P2|NOT COMPLETED|Third Intervention||2
475340|NCT00471380|1136000|P1|NOT COMPLETED|Third Intervention||1
475341|NCT00471380|1135999|P2|COMPLETED|Third Intervention||14
475342|NCT00471380|1136000|P1|COMPLETED|Third Intervention||17
475343|NCT00471380|1135999|P2|STARTED|Third Intervention||16
475344|NCT00471380|1136000|P1|STARTED|Third Intervention||18
475345|NCT00471380|1135999|P2|NOT COMPLETED|Second Intervention||4
475346|NCT00471380|1136000|P1|NOT COMPLETED|Second Intervention||0
475347|NCT00471380|1135999|P2|COMPLETED|Second Intervention||16
475348|NCT00471380|1136000|P1|COMPLETED|Second Intervention||18
475349|NCT00471380|1135999|P2|STARTED|Second Intervention||20
475350|NCT00471380|1136000|P1|STARTED|Second Intervention||18
475351|NCT00471380|1135999|P2|NOT COMPLETED|First Intervention||4
475352|NCT00471380|1136000|P1|NOT COMPLETED|First Intervention||4
475353|NCT00471380|1135999|P2|COMPLETED|First Intervention||20
475354|NCT00471380|1136000|P1|COMPLETED|First Intervention||18
475355|NCT00471380|1135999|P2|STARTED|First Intervention||24
475356|NCT00471380|1136000|P1|STARTED|First Intervention||22
475357|NCT00471354|1136006|P1|NOT COMPLETED|Overall Study||52
475358|NCT00471354|1136006|P1|COMPLETED|Overall Study||176
475359|NCT00471354|1136006|P1|STARTED|Overall Study||228
475360|NCT00471328|1136018|P2|NOT COMPLETED|Extension Phase||67
475361|NCT00471328|1136019|P1|NOT COMPLETED|Extension Phase||41
475362|NCT00471328|1136018|P2|COMPLETED|Extension Phase||0
475363|NCT00471328|1136019|P1|COMPLETED|Extension Phase||0
475364|NCT00471328|1136018|P2|Started:CrossOver During Extension|Extension Phase||10
475365|NCT00471328|1136019|P1|Started:CrossOver During Extension|Extension Phase||0
475366|NCT00471328|1136018|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
475367|NCT00471328|1136019|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
475368|NCT00471328|1136018|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
475369|NCT00471328|1136019|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
475370|NCT00471328|1136018|P2|STARTED|Extension Phase||67
475371|NCT00471328|1136019|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
475372|NCT00471328|1136018|P2|NOT COMPLETED|Core Phase||67
475373|NCT00471328|1136019|P1|NOT COMPLETED|Core Phase||107
475374|NCT00471328|1136018|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
475375|NCT00471328|1136019|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
475376|NCT00471328|1136018|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
475377|NCT00471328|1136019|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
475378|NCT00471328|1136018|P2|STARTED|Core Phase||83
475379|NCT00471328|1136019|P1|STARTED|Core Phase||165
475380|NCT00471315|1136038|P1|NOT COMPLETED|Overall Study||8
475381|NCT00471315|1136038|P1|COMPLETED|Overall Study||10
475382|NCT00471315|1136038|P1|STARTED|Overall Study||18
475383|NCT00471276|1136043|P1|NOT COMPLETED|Overall Study||83
475384|NCT00471276|1136043|P1|COMPLETED|Overall Study||0
475385|NCT00471276|1136043|P1|STARTED|Overall Study||83
475386|NCT00471146|1136068|P2|NOT COMPLETED|Overall Study||174
475387|NCT00471146|1136069|P1|NOT COMPLETED|Overall Study||172
475388|NCT00471146|1136068|P2|COMPLETED|Overall Study||142
475389|NCT00471146|1136069|P1|COMPLETED|Overall Study||142
475390|NCT00471146|1136068|P2|Treated|Overall Study||308
475391|NCT00471146|1136069|P1|Treated|Overall Study||305
475392|NCT00471146|1136068|P2|STARTED|Overall Study||316
475393|NCT00471146|1136069|P1|STARTED|Overall Study||314
475394|NCT00471107|1136094|P3|NOT COMPLETED|Overall Study||3
475395|NCT00471107|1136095|P2|NOT COMPLETED|Overall Study||1
475396|NCT00471107|1136096|P1|NOT COMPLETED|Overall Study||3
475397|NCT00471107|1136094|P3|COMPLETED|Overall Study||12
475398|NCT00471107|1136095|P2|COMPLETED|Overall Study||14
475399|NCT00471107|1136096|P1|COMPLETED|Overall Study||12
475400|NCT00471107|1136094|P3|STARTED|Overall Study||15
475401|NCT00471107|1136095|P2|STARTED|Overall Study||15
475402|NCT00471107|1136096|P1|STARTED|Overall Study||15
475403|NCT00471068|1136106|P2|NOT COMPLETED|Overall Study||1
475404|NCT00471068|1136107|P1|NOT COMPLETED|Overall Study||1
475405|NCT00471068|1136106|P2|COMPLETED|Overall Study||24
475406|NCT00471068|1136107|P1|COMPLETED|Overall Study||20
475407|NCT00471068|1136106|P2|STARTED|Overall Study||25
475408|NCT00471068|1136107|P1|STARTED|Overall Study||21
475409|NCT00470847|1136113|P1|NOT COMPLETED|Overall Study||1
475410|NCT00470847|1136113|P1|COMPLETED|Overall Study||34
475411|NCT00470847|1136113|P1|STARTED|Overall Study||35
475412|NCT00470834|1136126|P2|NOT COMPLETED|Extension Period (24 Months)||23
475413|NCT00470834|1136127|P1|NOT COMPLETED|Extension Period (24 Months)||15
475414|NCT00470834|1136126|P2|COMPLETED|Extension Period (24 Months)||7
475415|NCT00470834|1136127|P1|COMPLETED|Extension Period (24 Months)||11
475416|NCT00470834|1136126|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
475417|NCT00470834|1136127|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
475418|NCT00470834|1136126|P2|NOT COMPLETED|Treatment Period (18 Months)||31
475419|NCT00470834|1136127|P1|NOT COMPLETED|Treatment Period (18 Months)||38
475420|NCT00470834|1136126|P2|COMPLETED|Treatment Period (18 Months)||31
475421|NCT00470834|1136127|P1|COMPLETED|Treatment Period (18 Months)||27
475422|NCT00470834|1136126|P2|STARTED|Treatment Period (18 Months)||62
475423|NCT00470834|1136127|P1|STARTED|Treatment Period (18 Months)||65
475424|NCT00470626|1136141|P1|NOT COMPLETED|Overall Study||17
475425|NCT00470626|1136141|P1|COMPLETED|Overall Study||112
475426|NCT00470626|1136141|P1|STARTED|Overall Study||129
475427|NCT00470600|1136149|P2|NOT COMPLETED|Overall Study||0
475428|NCT00470600|1136150|P1|NOT COMPLETED|Overall Study||0
475429|NCT00470600|1136149|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
475430|NCT00470600|1136150|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
475431|NCT00470600|1136149|P2|STARTED|Overall Study||99
475432|NCT00470600|1136150|P1|STARTED|Overall Study||86
475433|NCT00470548|1136162|P4|NOT COMPLETED|Overall Study||0
475434|NCT00470548|1136163|P3|NOT COMPLETED|Overall Study||0
475435|NCT00470548|1136164|P2|NOT COMPLETED|Overall Study||0
475436|NCT00470548|1136165|P1|NOT COMPLETED|Overall Study||0
475437|NCT00470548|1136162|P4|COMPLETED|Overall Study||37
475438|NCT00470548|1136163|P3|COMPLETED|Overall Study||6
475439|NCT00470548|1136164|P2|COMPLETED|Overall Study||3
475440|NCT00470548|1136165|P1|COMPLETED|Overall Study||3
475441|NCT00470548|1136162|P4|STARTED|Overall Study||37
475442|NCT00470548|1136163|P3|STARTED|Overall Study||6
475443|NCT00470548|1136164|P2|STARTED|Overall Study||3
475444|NCT00470548|1136165|P1|STARTED|Overall Study||3
475445|NCT00470535|1136183|P1|NOT COMPLETED|Overall Study||18
475446|NCT00470535|1136183|P1|COMPLETED|Overall Study||0
475447|NCT00470535|1136183|P1|STARTED|Overall Study||18
475448|NCT00470470|1136192|P1|NOT COMPLETED|Overall Study||5
475449|NCT00470470|1136192|P1|COMPLETED|Overall Study||25
475450|NCT00470470|1136192|P1|STARTED|Overall Study||30
475451|NCT00470418|1136199|P2|NOT COMPLETED|Overall Study||0
475452|NCT00470418|1136200|P1|NOT COMPLETED|Overall Study||1
475453|NCT00470418|1136199|P2|COMPLETED|Overall Study||3
475454|NCT00470418|1136200|P1|COMPLETED|Overall Study||6
475455|NCT00470418|1136199|P2|STARTED|Overall Study||3
475456|NCT00470418|1136200|P1|STARTED|Overall Study||7
475457|NCT00470392|1136210|P2|NOT COMPLETED|Overall Study||0
475458|NCT00470392|1136211|P1|NOT COMPLETED|Overall Study||0
475459|NCT00470392|1136210|P2|COMPLETED|Overall Study||2
475460|NCT00470392|1136211|P1|COMPLETED|Overall Study||7
475461|NCT00470392|1136210|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
475462|NCT00470392|1136211|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
475463|NCT00470301|1136221|P1|NOT COMPLETED|Overall Study||5
475464|NCT00470301|1136221|P1|COMPLETED|Overall Study||55
475465|NCT00470301|1136221|P1|STARTED|Overall Study||60
475466|NCT00470275|1136225|P1|NOT COMPLETED|Overall Study||10
475467|NCT00470275|1136225|P1|COMPLETED|Overall Study||0
475468|NCT00470275|1136225|P1|STARTED|Overall Study||10
475469|NCT00470262|1136231|P2|NOT COMPLETED|Overall Study||0
475470|NCT00470262|1136232|P1|NOT COMPLETED|Overall Study||2
475471|NCT00470262|1136231|P2|COMPLETED|Overall Study||12
475472|NCT00470262|1136232|P1|COMPLETED|Overall Study||13
475473|NCT00470262|1136231|P2|STARTED|Overall Study||12
475474|NCT00470262|1136232|P1|STARTED|Overall Study||15
475475|NCT00470184|1136240|P1|NOT COMPLETED|Overall Study||22
475476|NCT00470184|1136240|P1|COMPLETED|Overall Study||19
475477|NCT00470184|1136240|P1|Treated With Study Therapy|Overall Study||36
475478|NCT00470184|1136240|P1|STARTED|Overall Study||41
475479|NCT00470158|1136252|P5|NOT COMPLETED|Overall Study||6
475480|NCT00470158|1136253|P4|NOT COMPLETED|Overall Study||5
475481|NCT00470158|1136254|P3|NOT COMPLETED|Overall Study||8
475482|NCT00470158|1136255|P2|NOT COMPLETED|Overall Study||8
475483|NCT00470158|1136256|P1|NOT COMPLETED|Overall Study||8
475484|NCT00470158|1136252|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
475485|NCT00470158|1136253|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
475486|NCT00470158|1136254|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
475487|NCT00470158|1136255|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
475488|NCT00470158|1136256|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
475489|NCT00470158|1136252|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
475490|NCT00470158|1136253|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
475491|NCT00470158|1136254|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
475492|NCT00470158|1136255|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
475493|NCT00470158|1136256|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
475494|NCT00470106|1136272|P4|NOT COMPLETED|Overall Study||2
475495|NCT00470106|1136273|P3|NOT COMPLETED|Overall Study||7
475496|NCT00470106|1136274|P2|NOT COMPLETED|Overall Study||5
475497|NCT00470106|1136275|P1|NOT COMPLETED|Overall Study||3
475498|NCT00470106|1136272|P4|COMPLETED|Overall Study||19
475499|NCT00470106|1136273|P3|COMPLETED|Overall Study||14
475500|NCT00470106|1136274|P2|COMPLETED|Overall Study||19
475501|NCT00470106|1136275|P1|COMPLETED|Overall Study||16
475502|NCT00470106|1136272|P4|STARTED|Overall Study||21
475503|NCT00470106|1136273|P3|STARTED|Overall Study||21
475504|NCT00470106|1136274|P2|STARTED|Overall Study||24
475505|NCT00470106|1136275|P1|STARTED|Overall Study||19
475506|NCT00470067|1136289|P1|NOT COMPLETED|Overall Study||7
475507|NCT00470067|1136289|P1|COMPLETED|Overall Study||2
475508|NCT00470067|1136289|P1|STARTED|Overall Study||9
475509|NCT00470054|1136293|P1|NOT COMPLETED|Overall Study||1
475510|NCT00470054|1136293|P1|COMPLETED|Overall Study||43
475511|NCT00470054|1136293|P1|STARTED|Overall Study||44
475512|NCT00469898|1136301|P1|NOT COMPLETED|Overall Study||25
475513|NCT00469898|1136301|P1|COMPLETED|Overall Study||25
475514|NCT00469898|1136301|P1|STARTED|Overall Study||50
475515|NCT00469859|1136310|P2|NOT COMPLETED|Overall Study||2
475516|NCT00469859|1136311|P1|NOT COMPLETED|Overall Study||0
475517|NCT00469859|1136310|P2|COMPLETED|Overall Study||6
475518|NCT00469859|1136311|P1|COMPLETED|Overall Study||6
475519|NCT00469859|1136310|P2|STARTED|Overall Study||8
475520|NCT00469859|1136311|P1|STARTED|Overall Study||6
475521|NCT00469833|1136319|P1|NOT COMPLETED|Overall Study||2
475522|NCT00469833|1136319|P1|COMPLETED|Overall Study||15
475523|NCT00469833|1136319|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
475524|NCT00469508|1136331|P2|NOT COMPLETED|Overall Study||24
475525|NCT00469508|1136332|P1|NOT COMPLETED|Overall Study||20
475526|NCT00469508|1136331|P2|COMPLETED|Overall Study||13
475527|NCT00469508|1136332|P1|COMPLETED|Overall Study||14
475528|NCT00469508|1136331|P2|STARTED|Overall Study||37
475529|NCT00469508|1136332|P1|STARTED|Overall Study||34
475530|NCT00469456|1136346|P2|NOT COMPLETED|Overall Study||4
475531|NCT00469456|1136347|P1|NOT COMPLETED|Overall Study||9
475532|NCT00469456|1136346|P2|COMPLETED|Overall Study||131
475533|NCT00469456|1136347|P1|COMPLETED|Overall Study||120
475534|NCT00469456|1136346|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
475535|NCT00469456|1136347|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
475536|NCT00469391|1136357|P2|NOT COMPLETED|Overall Study||5
475537|NCT00469391|1136358|P1|NOT COMPLETED|Overall Study||14
475538|NCT00469391|1136357|P2|COMPLETED|Overall Study||24
475539|NCT00469391|1136358|P1|COMPLETED|Overall Study||13
475540|NCT00469391|1136357|P2|Patient Preference|Overall Study||1
475541|NCT00469391|1136358|P1|Patient Preference|Overall Study||0
475542|NCT00469391|1136357|P2|Lost to Follow up|Overall Study||1
475543|NCT00469391|1136358|P1|Lost to Follow up|Overall Study||0
475544|NCT00469391|1136357|P2|Adverse Event|Overall Study||0
475545|NCT00469391|1136358|P1|Adverse Event|Overall Study||8
475546|NCT00469391|1136357|P2|Unsuccessful Implant Procedure|Overall Study||0
475547|NCT00469391|1136358|P1|Unsuccessful Implant Procedure|Overall Study||4
475548|NCT00469391|1136357|P2|Discontinued Prior to Procedure|Overall Study||3
475549|NCT00469391|1136358|P1|Discontinued Prior to Procedure|Overall Study||2
475550|NCT00469391|1136357|P2|STARTED|Overall Study||29
475551|NCT00469391|1136358|P1|STARTED|Overall Study||27
475552|NCT00469274|1136366|P2|NOT COMPLETED|Overall Study||0
475553|NCT00469274|1136367|P1|NOT COMPLETED|Overall Study||0
475554|NCT00469274|1136366|P2|COMPLETED|Overall Study||42
475555|NCT00469274|1136367|P1|COMPLETED|Overall Study||44
475556|NCT00469274|1136366|P2|STARTED|Overall Study||42
475557|NCT00469274|1136367|P1|STARTED|Overall Study||44
475558|NCT00469209|1136376|P3|NOT COMPLETED|Overall Study||1
475559|NCT00469209|1136377|P2|NOT COMPLETED|Overall Study||0
475560|NCT00469209|1136378|P1|NOT COMPLETED|Overall Study||1
475561|NCT00469209|1136376|P3|COMPLETED|Overall Study||19
475562|NCT00469209|1136377|P2|COMPLETED|Overall Study||20
475563|NCT00469209|1136378|P1|COMPLETED|Overall Study||19
475564|NCT00469209|1136376|P3|STARTED|Overall Study||20
475565|NCT00469209|1136377|P2|STARTED|Overall Study||20
475566|NCT00469209|1136378|P1|STARTED|Overall Study||20
475567|NCT00469092|1136388|P2|NOT COMPLETED|Overall Study||21
475568|NCT00469092|1136389|P1|NOT COMPLETED|Overall Study||26
475569|NCT00469092|1136388|P2|COMPLETED|Overall Study||220
475570|NCT00469092|1136389|P1|COMPLETED|Overall Study||213
475571|NCT00469092|1136388|P2|Exposed to Study Drug|Overall Study||238
475572|NCT00469092|1136389|P1|Exposed to Study Drug|Overall Study||231
475573|NCT00469092|1136388|P2|STARTED|Overall Study||241
475574|NCT00469092|1136389|P1|STARTED|Overall Study||239
475575|NCT00469079|1136408|P3|NOT COMPLETED|Overall Study||19
475576|NCT00469079|1136409|P2|NOT COMPLETED|Overall Study||22
475577|NCT00469079|1136410|P1|NOT COMPLETED|Overall Study||9
475578|NCT00469079|1136408|P3|COMPLETED|Overall Study||32
475579|NCT00469079|1136409|P2|COMPLETED|Overall Study||30
475580|NCT00469079|1136410|P1|COMPLETED|Overall Study||18
475581|NCT00469079|1136408|P3|STARTED|Overall Study||51
475582|NCT00469079|1136409|P2|STARTED|Overall Study||52
475583|NCT00469079|1136410|P1|STARTED|Overall Study||27
475584|NCT00468910|1136429|P2|NOT COMPLETED|Overall Study||3
475585|NCT00468910|1136430|P1|NOT COMPLETED|Overall Study||4
475586|NCT00468910|1136429|P2|COMPLETED|Overall Study||36
475587|NCT00468910|1136430|P1|COMPLETED|Overall Study||36
475588|NCT00468910|1136429|P2|Follow-up|Overall Study||36
475589|NCT00468910|1136430|P1|Follow-up|Overall Study||36
475590|NCT00468910|1136429|P2|Post-Treatment Biopsy|Overall Study||36
475591|NCT00468910|1136430|P1|Post-Treatment Biopsy|Overall Study||36
475592|NCT00468910|1136429|P2|Treatment|Overall Study||36
475593|NCT00468910|1136430|P1|Treatment|Overall Study||36
475594|NCT00468910|1136429|P2|Randomization|Overall Study||39
475595|NCT00468910|1136430|P1|Randomization|Overall Study||40
475596|NCT00468910|1136429|P2|STARTED|Overall Study||39
475597|NCT00468910|1136430|P1|STARTED|Overall Study||40
475598|NCT00468858|1136449|P3|NOT COMPLETED|Overall Study||14
475599|NCT00468858|1136450|P2|NOT COMPLETED|Overall Study||10
475600|NCT00468858|1136451|P1|NOT COMPLETED|Overall Study||9
475601|NCT00468858|1136449|P3|COMPLETED|Overall Study||199
475602|NCT00468858|1136450|P2|COMPLETED|Overall Study||202
475603|NCT00468858|1136451|P1|COMPLETED|Overall Study||202
475604|NCT00468858|1136449|P3|STARTED|Overall Study||213
475605|NCT00468858|1136450|P2|STARTED|Overall Study||212
475606|NCT00468858|1136451|P1|STARTED|Overall Study||211
475607|NCT00468845|1136572|P3|NOT COMPLETED|Overall Study||30
475608|NCT00468845|1136573|P2|NOT COMPLETED|Overall Study||34
475609|NCT00468845|1136574|P1|NOT COMPLETED|Overall Study||21
475610|NCT00468845|1136572|P3|COMPLETED|Overall Study||139
475611|NCT00468845|1136573|P2|COMPLETED|Overall Study||136
475612|NCT00468845|1136574|P1|COMPLETED|Overall Study||141
475613|NCT00468845|1136572|P3|Received Treatment|Overall Study||167
475614|NCT00468845|1136573|P2|Received Treatment|Overall Study||166
475615|NCT00468845|1136574|P1|Received Treatment|Overall Study||161
475616|NCT00468845|1136572|P3|STARTED|Overall Study||169
475617|NCT00468845|1136573|P2|STARTED|Overall Study||170
475618|NCT00468845|1136574|P1|STARTED|Overall Study||162
475619|NCT00468819|1136711|P3|NOT COMPLETED|Overall Study||2
475620|NCT00468819|1136712|P2|NOT COMPLETED|Overall Study||0
475621|NCT00468819|1136713|P1|NOT COMPLETED|Overall Study||6
475622|NCT00468819|1136711|P3|COMPLETED|Overall Study||46
475623|NCT00468819|1136712|P2|COMPLETED|Overall Study||44
475624|NCT00468819|1136713|P1|COMPLETED|Overall Study||42
475625|NCT00468819|1136711|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
475626|NCT00468819|1136712|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
475627|NCT00468819|1136713|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
475628|NCT00468819|1136711|P3|STARTED|Overall Study|Enrolled participants|48
475629|NCT00468819|1136712|P2|STARTED|Overall Study|Enrolled participants|44
475630|NCT00468819|1136713|P1|STARTED|Overall Study|Enrolled participants|48
475631|NCT00468728|1136793|P2|NOT COMPLETED|Follow-up||31
475632|NCT00468728|1136794|P1|NOT COMPLETED|Follow-up||34
475633|NCT00468728|1136793|P2|COMPLETED|Follow-up||222
475634|NCT00468728|1136794|P1|COMPLETED|Follow-up||222
475635|NCT00468728|1136793|P2|STARTED|Follow-up||253
475636|NCT00468728|1136794|P1|STARTED|Follow-up||256
475637|NCT00468728|1136793|P2|NOT COMPLETED|Treatment||11
475638|NCT00468728|1136794|P1|NOT COMPLETED|Treatment||4
475639|NCT00468728|1136793|P2|COMPLETED|Treatment||253
475640|NCT00468728|1136794|P1|COMPLETED|Treatment||256
475641|NCT00468728|1136793|P2|STARTED|Treatment||264
475642|NCT00468728|1136794|P1|STARTED|Treatment||260
475643|NCT00468728|1136793|P2|NOT COMPLETED|Enrollment||7
475644|NCT00468728|1136794|P1|NOT COMPLETED|Enrollment||4
475645|NCT00468728|1136793|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
475646|NCT00468728|1136794|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
475647|NCT00468728|1136793|P2|STARTED|Enrollment||271
475648|NCT00468728|1136794|P1|STARTED|Enrollment||264
475649|NCT00468676|1136806|P2|NOT COMPLETED|Overall Study||12
475650|NCT00468676|1136807|P1|NOT COMPLETED|Overall Study||16
475651|NCT00468676|1136806|P2|COMPLETED|Overall Study||94
475652|NCT00468676|1136807|P1|COMPLETED|Overall Study||92
475653|NCT00468676|1136806|P2|STARTED|Overall Study||106
475654|NCT00468676|1136807|P1|STARTED|Overall Study||108
475655|NCT00468650|1136824|P1|NOT COMPLETED|Overall Study||7
475656|NCT00468650|1136824|P1|COMPLETED|Overall Study||110
475657|NCT00468650|1136824|P1|STARTED|Overall Study||117
475658|NCT00468585|1136872|P4|NOT COMPLETED|Overall Study||1
475659|NCT00468585|1136873|P3|NOT COMPLETED|Overall Study||5
475660|NCT00468585|1136874|P2|NOT COMPLETED|Overall Study||0
475661|NCT00468585|1136875|P1|NOT COMPLETED|Overall Study||1
475662|NCT00468585|1136872|P4|COMPLETED|Overall Study||5
475663|NCT00468585|1136873|P3|COMPLETED|Overall Study||45
475664|NCT00468585|1136874|P2|COMPLETED|Overall Study||3
475665|NCT00468585|1136875|P1|COMPLETED|Overall Study||3
475666|NCT00468585|1136872|P4|STARTED|Overall Study||6
475667|NCT00468585|1136873|P3|STARTED|Overall Study||50
475668|NCT00468585|1136874|P2|STARTED|Overall Study||3
475669|NCT00468585|1136875|P1|STARTED|Overall Study||4
475670|NCT00468559|1136887|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
475671|NCT00468559|1136888|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
475672|NCT00468559|1136889|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
475673|NCT00468559|1136887|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
475674|NCT00468559|1136888|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
475675|NCT00468559|1136889|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
475676|NCT00468559|1136887|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
475677|NCT00468559|1136888|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
475678|NCT00468559|1136889|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
475679|NCT00468559|1136887|P3|NOT COMPLETED|Open-label Treatment Phase||0
475680|NCT00468559|1136888|P2|NOT COMPLETED|Open-label Treatment Phase||0
475681|NCT00468559|1136889|P1|NOT COMPLETED|Open-label Treatment Phase||18
475682|NCT00468559|1136887|P3|COMPLETED|Open-label Treatment Phase||0
475683|NCT00468559|1136888|P2|COMPLETED|Open-label Treatment Phase||0
475684|NCT00468559|1136889|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
475685|NCT00468559|1136887|P3|STARTED|Open-label Treatment Phase||0
475686|NCT00468559|1136888|P2|STARTED|Open-label Treatment Phase||0
475687|NCT00468559|1136889|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
475688|NCT00468546|1136917|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
475689|NCT00468546|1136918|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
475690|NCT00468546|1136917|P2|COMPLETED|Week 24 to Week 104 Analysis||83
475691|NCT00468546|1136918|P1|COMPLETED|Week 24 to Week 104 Analysis||103
475692|NCT00468546|1136917|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
475693|NCT00468546|1136918|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
475694|NCT00468546|1136917|P2|NOT COMPLETED|Week 24 Analysis||55
475695|NCT00468546|1136918|P1|NOT COMPLETED|Week 24 Analysis||97
475696|NCT00468546|1136917|P2|COMPLETED|Week 24 Analysis||253
475697|NCT00468546|1136918|P1|COMPLETED|Week 24 Analysis||111
475698|NCT00468546|1136917|P2|STARTED|Week 24 Analysis||308
475699|NCT00468546|1136918|P1|STARTED|Week 24 Analysis||208
475700|NCT00468481|1136948|P2|NOT COMPLETED|Overall Study||24
475701|NCT00468481|1136949|P1|NOT COMPLETED|Overall Study||88
475702|NCT00468481|1136948|P2|COMPLETED|Overall Study||70
475703|NCT00468481|1136949|P1|COMPLETED|Overall Study||203
475704|NCT00468481|1136948|P2|Subjects Treated|Overall Study||94
475705|NCT00468481|1136949|P1|Subjects Treated|Overall Study||285
475706|NCT00468481|1136948|P2|STARTED|Overall Study||94
475707|NCT00468481|1136949|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
475708|NCT00468312|1137049|P2|NOT COMPLETED|Overall Study||5
475709|NCT00468312|1137050|P1|NOT COMPLETED|Overall Study||4
475710|NCT00468312|1137049|P2|COMPLETED|Overall Study||204
475711|NCT00468312|1137050|P1|COMPLETED|Overall Study||216
475712|NCT00468312|1137049|P2|STARTED|Overall Study||209
475713|NCT00468312|1137050|P1|STARTED|Overall Study||220
475714|NCT00468299|1137066|P2|NOT COMPLETED|Overall Study||1
475715|NCT00468299|1137067|P1|NOT COMPLETED|Overall Study||0
475716|NCT00468299|1137066|P2|COMPLETED|Overall Study||7
475717|NCT00468299|1137067|P1|COMPLETED|Overall Study||9
475718|NCT00468299|1137066|P2|STARTED|Overall Study||8
475719|NCT00468299|1137067|P1|STARTED|Overall Study||9
475720|NCT00468286|1137077|P2|NOT COMPLETED|Overall Study||12
475721|NCT00468286|1137078|P1|NOT COMPLETED|Overall Study||7
475722|NCT00468286|1137077|P2|COMPLETED|Overall Study||54
475723|NCT00468286|1137078|P1|COMPLETED|Overall Study||60
475724|NCT00468286|1137077|P2|STARTED|Overall Study||66
475725|NCT00468286|1137078|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
475726|NCT00468208|1137100|P1|NOT COMPLETED|Overall Study||0
475727|NCT00468208|1137100|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
475728|NCT00468208|1137100|P1|STARTED|Overall Study||20
475729|NCT00468143|1137108|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
475730|NCT00468143|1137109|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
475731|NCT00468143|1137108|P2|COMPLETED|Second Intervention (3 Weeks)||24
475732|NCT00468143|1137109|P1|COMPLETED|Second Intervention (3 Weeks)||25
475733|NCT00468143|1137108|P2|STARTED|Second Intervention (3 Weeks)||27
475734|NCT00468143|1137109|P1|STARTED|Second Intervention (3 Weeks)||28
475735|NCT00468143|1137108|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
475736|NCT00468143|1137109|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
475737|NCT00468143|1137108|P2|COMPLETED|First Intervention (3 Weeks)||27
475738|NCT00468143|1137109|P1|COMPLETED|First Intervention (3 Weeks)||28
475739|NCT00468143|1137108|P2|STARTED|First Intervention (3 Weeks)||31
475740|NCT00468143|1137109|P1|STARTED|First Intervention (3 Weeks)||31
475741|NCT00468104|1137123|P2|NOT COMPLETED|Second Intervention||4
475742|NCT00468104|1137124|P1|NOT COMPLETED|Second Intervention||5
475743|NCT00468104|1137123|P2|COMPLETED|Second Intervention||37
475744|NCT00468104|1137124|P1|COMPLETED|Second Intervention||3
475745|NCT00468104|1137123|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
475746|NCT00468104|1137124|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
475747|NCT00468104|1137123|P2|NOT COMPLETED|First Intervention||1
475748|NCT00468104|1137124|P1|NOT COMPLETED|First Intervention||9
475749|NCT00468104|1137123|P2|COMPLETED|First Intervention||45
475750|NCT00468104|1137124|P1|COMPLETED|First Intervention||45
475751|NCT00468104|1137123|P2|STARTED|First Intervention||46
475752|NCT00468104|1137124|P1|STARTED|First Intervention||54
475753|NCT00468052|1137141|P2|NOT COMPLETED|Overall Study||8
475754|NCT00468052|1137142|P1|NOT COMPLETED|Overall Study||7
475755|NCT00468052|1137141|P2|COMPLETED|Overall Study||61
475756|NCT00468052|1137142|P1|COMPLETED|Overall Study||61
475757|NCT00468052|1137141|P2|Target Enrollment|Overall Study||70
475758|NCT00468052|1137142|P1|Target Enrollment|Overall Study||70
475759|NCT00468052|1137141|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
475760|NCT00468052|1137142|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
475761|NCT00467961|1137160|P1|NOT COMPLETED|Overall Study||7
475762|NCT00467961|1137160|P1|COMPLETED|Overall Study||24
475763|NCT00467961|1137160|P1|STARTED|Overall Study||31
475764|NCT00467896|1137164|P1|NOT COMPLETED|Overall Study||51
475765|NCT00467896|1137164|P1|COMPLETED|Overall Study||11
475766|NCT00467896|1137164|P1|STARTED|Overall Study||62
475767|NCT00467870|1137190|P6|NOT COMPLETED|Overall Study||2
475768|NCT00467870|1137191|P5|NOT COMPLETED|Overall Study||37
475769|NCT00467870|1137192|P4|NOT COMPLETED|Overall Study||33
475770|NCT00467870|1137193|P3|NOT COMPLETED|Overall Study||4
475771|NCT00467870|1137194|P2|NOT COMPLETED|Overall Study||43
475772|NCT00467870|1137195|P1|NOT COMPLETED|Overall Study||45
475773|NCT00467870|1137190|P6|COMPLETED|Overall Study||21
475774|NCT00467870|1137191|P5|COMPLETED|Overall Study||93
475775|NCT00467870|1137192|P4|COMPLETED|Overall Study||79
475776|NCT00467870|1137193|P3|COMPLETED|Overall Study||18
475777|NCT00467870|1137194|P2|COMPLETED|Overall Study||74
475778|NCT00467870|1137195|P1|COMPLETED|Overall Study||75
475779|NCT00467870|1137190|P6|STARTED|Overall Study||23
475780|NCT00467870|1137191|P5|STARTED|Overall Study||130
475781|NCT00467870|1137192|P4|STARTED|Overall Study||112
475782|NCT00467870|1137193|P3|STARTED|Overall Study||22
475783|NCT00467870|1137194|P2|STARTED|Overall Study||117
475784|NCT00467870|1137195|P1|STARTED|Overall Study||120
475785|NCT00467857|1137238|P2|NOT COMPLETED|Overall Study||8
475786|NCT00467857|1137239|P1|NOT COMPLETED|Overall Study||3
475787|NCT00467857|1137238|P2|COMPLETED|Overall Study||139
475788|NCT00467857|1137239|P1|COMPLETED|Overall Study||143
475789|NCT00467857|1137238|P2|STARTED|Overall Study||147
475790|NCT00467857|1137239|P1|STARTED|Overall Study||146
475791|NCT00467844|1137274|P3|NOT COMPLETED|Overall Study||14
475792|NCT00467844|1137275|P2|NOT COMPLETED|Overall Study||20
475793|NCT00467844|1137276|P1|NOT COMPLETED|Overall Study||19
475794|NCT00467844|1137274|P3|COMPLETED|Overall Study||38
475795|NCT00467844|1137275|P2|COMPLETED|Overall Study||34
475796|NCT00467844|1137276|P1|COMPLETED|Overall Study||34
475797|NCT00467844|1137274|P3|STARTED|Overall Study||52
475798|NCT00467844|1137275|P2|STARTED|Overall Study||54
475799|NCT00467844|1137276|P1|STARTED|Overall Study||53
475800|NCT00467831|1137287|P1|NOT COMPLETED|Overall Study||3
475801|NCT00467831|1137287|P1|COMPLETED|Overall Study||0
475802|NCT00467831|1137287|P1|STARTED|Overall Study||3
475803|NCT00467779|1137306|P15|NOT COMPLETED|Stage 3||17
475804|NCT00467779|1137307|P14|NOT COMPLETED|Stage 3||0
475805|NCT00467779|1137308|P13|NOT COMPLETED|Stage 3||0
475806|NCT00467779|1137309|P12|NOT COMPLETED|Stage 3||0
475807|NCT00467779|1137310|P11|NOT COMPLETED|Stage 3||0
475808|NCT00467779|1137311|P10|NOT COMPLETED|Stage 3||0
475809|NCT00467779|1137312|P9|NOT COMPLETED|Stage 3||0
475810|NCT00467779|1137313|P8|NOT COMPLETED|Stage 3||0
475811|NCT00467779|1137314|P7|NOT COMPLETED|Stage 3||0
475812|NCT00467779|1137315|P6|NOT COMPLETED|Stage 3||0
475813|NCT00467779|1137316|P5|NOT COMPLETED|Stage 3||0
475814|NCT00467779|1137317|P4|NOT COMPLETED|Stage 3||0
475815|NCT00467779|1137318|P3|NOT COMPLETED|Stage 3||0
475816|NCT00467779|1137319|P2|NOT COMPLETED|Stage 3||0
475817|NCT00467779|1137320|P1|NOT COMPLETED|Stage 3||0
475818|NCT00467779|1137306|P15|COMPLETED|Stage 3||3
475819|NCT00467779|1137307|P14|COMPLETED|Stage 3||0
475820|NCT00467779|1137308|P13|COMPLETED|Stage 3||0
475821|NCT00467779|1137309|P12|COMPLETED|Stage 3||0
475822|NCT00467779|1137310|P11|COMPLETED|Stage 3||0
475823|NCT00467779|1137311|P10|COMPLETED|Stage 3||0
475824|NCT00467779|1137312|P9|COMPLETED|Stage 3||0
475825|NCT00467779|1137313|P8|COMPLETED|Stage 3||0
475826|NCT00467779|1137314|P7|COMPLETED|Stage 3||0
475827|NCT00467779|1137315|P6|COMPLETED|Stage 3||0
475828|NCT00467779|1137316|P5|COMPLETED|Stage 3||0
475829|NCT00467779|1137317|P4|COMPLETED|Stage 3||0
475830|NCT00467779|1137318|P3|COMPLETED|Stage 3||0
475831|NCT00467779|1137319|P2|COMPLETED|Stage 3||0
475832|NCT00467779|1137320|P1|COMPLETED|Stage 3||0
475833|NCT00467779|1137306|P15|STARTED|Stage 3||20
475834|NCT00467779|1137307|P14|STARTED|Stage 3||0
475835|NCT00467779|1137308|P13|STARTED|Stage 3||0
475836|NCT00467779|1137309|P12|STARTED|Stage 3||0
475837|NCT00467779|1137310|P11|STARTED|Stage 3||0
475838|NCT00467779|1137311|P10|STARTED|Stage 3||0
475839|NCT00467779|1137312|P9|STARTED|Stage 3||0
475840|NCT00467779|1137313|P8|STARTED|Stage 3||0
475841|NCT00467779|1137314|P7|STARTED|Stage 3||0
475842|NCT00467779|1137315|P6|STARTED|Stage 3||0
475843|NCT00467779|1137316|P5|STARTED|Stage 3||0
475844|NCT00467779|1137317|P4|STARTED|Stage 3||0
475845|NCT00467779|1137318|P3|STARTED|Stage 3||0
475846|NCT00467779|1137319|P2|STARTED|Stage 3||0
475847|NCT00467779|1137320|P1|STARTED|Stage 3||0
475848|NCT00467779|1137306|P15|NOT COMPLETED|Stage 2A||0
475849|NCT00467779|1137307|P14|NOT COMPLETED|Stage 2A||21
475850|NCT00467779|1137308|P13|NOT COMPLETED|Stage 2A||0
475851|NCT00467779|1137309|P12|NOT COMPLETED|Stage 2A||0
475852|NCT00467779|1137310|P11|NOT COMPLETED|Stage 2A||0
475853|NCT00467779|1137311|P10|NOT COMPLETED|Stage 2A||0
475854|NCT00467779|1137312|P9|NOT COMPLETED|Stage 2A||0
475855|NCT00467779|1137313|P8|NOT COMPLETED|Stage 2A||0
475856|NCT00467779|1137314|P7|NOT COMPLETED|Stage 2A||0
475857|NCT00467779|1137315|P6|NOT COMPLETED|Stage 2A||0
475858|NCT00467779|1137316|P5|NOT COMPLETED|Stage 2A||0
475859|NCT00467779|1137317|P4|NOT COMPLETED|Stage 2A||0
475860|NCT00467779|1137318|P3|NOT COMPLETED|Stage 2A||0
475861|NCT00467779|1137319|P2|NOT COMPLETED|Stage 2A||0
475862|NCT00467779|1137320|P1|NOT COMPLETED|Stage 2A||0
475863|NCT00467779|1137306|P15|COMPLETED|Stage 2A||0
475864|NCT00467779|1137307|P14|COMPLETED|Stage 2A||1
475865|NCT00467779|1137308|P13|COMPLETED|Stage 2A||0
475866|NCT00467779|1137309|P12|COMPLETED|Stage 2A||0
475867|NCT00467779|1137310|P11|COMPLETED|Stage 2A||0
475868|NCT00467779|1137311|P10|COMPLETED|Stage 2A||0
475869|NCT00467779|1137312|P9|COMPLETED|Stage 2A||0
475870|NCT00467779|1137313|P8|COMPLETED|Stage 2A||0
475871|NCT00467779|1137314|P7|COMPLETED|Stage 2A||0
475872|NCT00467779|1137315|P6|COMPLETED|Stage 2A||0
475873|NCT00467779|1137316|P5|COMPLETED|Stage 2A||0
475874|NCT00467779|1137317|P4|COMPLETED|Stage 2A||0
475875|NCT00467779|1137318|P3|COMPLETED|Stage 2A||0
475876|NCT00467779|1137319|P2|COMPLETED|Stage 2A||0
475877|NCT00467779|1137320|P1|COMPLETED|Stage 2A||0
475878|NCT00467779|1137306|P15|STARTED|Stage 2A||0
475879|NCT00467779|1137307|P14|STARTED|Stage 2A||22
475880|NCT00467779|1137308|P13|STARTED|Stage 2A||0
475881|NCT00467779|1137309|P12|STARTED|Stage 2A||0
475882|NCT00467779|1137310|P11|STARTED|Stage 2A||0
475883|NCT00467779|1137311|P10|STARTED|Stage 2A||0
475884|NCT00467779|1137312|P9|STARTED|Stage 2A||0
475885|NCT00467779|1137313|P8|STARTED|Stage 2A||0
475886|NCT00467779|1137314|P7|STARTED|Stage 2A||0
475887|NCT00467779|1137315|P6|STARTED|Stage 2A||0
475888|NCT00467779|1137316|P5|STARTED|Stage 2A||0
475889|NCT00467779|1137317|P4|STARTED|Stage 2A||0
475890|NCT00467779|1137318|P3|STARTED|Stage 2A||0
475891|NCT00467779|1137319|P2|STARTED|Stage 2A||0
475892|NCT00467779|1137320|P1|STARTED|Stage 2A||0
475893|NCT00467779|1137306|P15|NOT COMPLETED|Stage 2||0
475894|NCT00467779|1137307|P14|NOT COMPLETED|Stage 2||0
475895|NCT00467779|1137308|P13|NOT COMPLETED|Stage 2||0
475896|NCT00467779|1137309|P12|NOT COMPLETED|Stage 2||0
475897|NCT00467779|1137310|P11|NOT COMPLETED|Stage 2||0
475898|NCT00467779|1137311|P10|NOT COMPLETED|Stage 2||0
475899|NCT00467779|1137312|P9|NOT COMPLETED|Stage 2||21
475900|NCT00467779|1137313|P8|NOT COMPLETED|Stage 2||0
475901|NCT00467779|1137314|P7|NOT COMPLETED|Stage 2||0
475902|NCT00467779|1137315|P6|NOT COMPLETED|Stage 2||0
475903|NCT00467779|1137316|P5|NOT COMPLETED|Stage 2||0
475904|NCT00467779|1137317|P4|NOT COMPLETED|Stage 2||0
475905|NCT00467779|1137318|P3|NOT COMPLETED|Stage 2||0
475906|NCT00467779|1137319|P2|NOT COMPLETED|Stage 2||0
475907|NCT00467779|1137320|P1|NOT COMPLETED|Stage 2||0
475908|NCT00467779|1137306|P15|COMPLETED|Stage 2||0
475909|NCT00467779|1137307|P14|COMPLETED|Stage 2||0
475910|NCT00467779|1137308|P13|COMPLETED|Stage 2||0
475911|NCT00467779|1137309|P12|COMPLETED|Stage 2||0
475912|NCT00467779|1137310|P11|COMPLETED|Stage 2||0
475913|NCT00467779|1137311|P10|COMPLETED|Stage 2||0
475914|NCT00467779|1137312|P9|COMPLETED|Stage 2||0
475915|NCT00467779|1137313|P8|COMPLETED|Stage 2||0
475916|NCT00467779|1137314|P7|COMPLETED|Stage 2||0
475917|NCT00467779|1137315|P6|COMPLETED|Stage 2||0
475918|NCT00467779|1137316|P5|COMPLETED|Stage 2||0
475919|NCT00467779|1137317|P4|COMPLETED|Stage 2||0
475920|NCT00467779|1137318|P3|COMPLETED|Stage 2||0
475921|NCT00467779|1137319|P2|COMPLETED|Stage 2||0
475922|NCT00467779|1137320|P1|COMPLETED|Stage 2||0
475923|NCT00467779|1137306|P15|STARTED|Stage 2||0
475924|NCT00467779|1137307|P14|STARTED|Stage 2||0
475925|NCT00467779|1137308|P13|STARTED|Stage 2||0
475926|NCT00467779|1137309|P12|STARTED|Stage 2||0
475927|NCT00467779|1137310|P11|STARTED|Stage 2||0
475928|NCT00467779|1137311|P10|STARTED|Stage 2||0
475929|NCT00467779|1137312|P9|STARTED|Stage 2||21
475930|NCT00467779|1137313|P8|STARTED|Stage 2||0
475931|NCT00467779|1137314|P7|STARTED|Stage 2||0
475932|NCT00467779|1137315|P6|STARTED|Stage 2||0
475933|NCT00467779|1137316|P5|STARTED|Stage 2||0
475934|NCT00467779|1137317|P4|STARTED|Stage 2||0
475935|NCT00467779|1137318|P3|STARTED|Stage 2||0
475936|NCT00467779|1137319|P2|STARTED|Stage 2||0
475937|NCT00467779|1137320|P1|STARTED|Stage 2||0
475938|NCT00467779|1137306|P15|NOT COMPLETED|Stage 1A||0
475939|NCT00467779|1137307|P14|NOT COMPLETED|Stage 1A||0
475940|NCT00467779|1137308|P13|NOT COMPLETED|Stage 1A||6
475941|NCT00467779|1137309|P12|NOT COMPLETED|Stage 1A||8
475942|NCT00467779|1137310|P11|NOT COMPLETED|Stage 1A||3
475943|NCT00467779|1137311|P10|NOT COMPLETED|Stage 1A||3
475944|NCT00467779|1137312|P9|NOT COMPLETED|Stage 1A||0
475945|NCT00467779|1137313|P8|NOT COMPLETED|Stage 1A||0
475946|NCT00467779|1137314|P7|NOT COMPLETED|Stage 1A||0
475947|NCT00467779|1137315|P6|NOT COMPLETED|Stage 1A||0
475948|NCT00467779|1137316|P5|NOT COMPLETED|Stage 1A||0
475949|NCT00467779|1137317|P4|NOT COMPLETED|Stage 1A||0
475950|NCT00467779|1137318|P3|NOT COMPLETED|Stage 1A||0
475951|NCT00467779|1137319|P2|NOT COMPLETED|Stage 1A||0
475952|NCT00467779|1137320|P1|NOT COMPLETED|Stage 1A||0
475953|NCT00467779|1137306|P15|COMPLETED|Stage 1A||0
475954|NCT00467779|1137307|P14|COMPLETED|Stage 1A||0
475955|NCT00467779|1137308|P13|COMPLETED|Stage 1A||0
475956|NCT00467779|1137309|P12|COMPLETED|Stage 1A||0
475957|NCT00467779|1137310|P11|COMPLETED|Stage 1A||0
475958|NCT00467779|1137311|P10|COMPLETED|Stage 1A||0
475959|NCT00467779|1137312|P9|COMPLETED|Stage 1A||0
475960|NCT00467779|1137313|P8|COMPLETED|Stage 1A||0
475961|NCT00467779|1137314|P7|COMPLETED|Stage 1A||0
475962|NCT00467779|1137315|P6|COMPLETED|Stage 1A||0
475963|NCT00467779|1137316|P5|COMPLETED|Stage 1A||0
475964|NCT00467779|1137317|P4|COMPLETED|Stage 1A||0
475965|NCT00467779|1137318|P3|COMPLETED|Stage 1A||0
475966|NCT00467779|1137319|P2|COMPLETED|Stage 1A||0
475967|NCT00467779|1137320|P1|COMPLETED|Stage 1A||0
475968|NCT00467779|1137306|P15|STARTED|Stage 1A||0
475969|NCT00467779|1137307|P14|STARTED|Stage 1A||0
475970|NCT00467779|1137308|P13|STARTED|Stage 1A||6
475971|NCT00467779|1137309|P12|STARTED|Stage 1A||8
475972|NCT00467779|1137310|P11|STARTED|Stage 1A||3
475973|NCT00467779|1137311|P10|STARTED|Stage 1A||3
475974|NCT00467779|1137312|P9|STARTED|Stage 1A||0
475975|NCT00467779|1137313|P8|STARTED|Stage 1A||0
475976|NCT00467779|1137314|P7|STARTED|Stage 1A||0
475977|NCT00467779|1137315|P6|STARTED|Stage 1A||0
475978|NCT00467779|1137316|P5|STARTED|Stage 1A||0
475979|NCT00467779|1137317|P4|STARTED|Stage 1A||0
475980|NCT00467779|1137318|P3|STARTED|Stage 1A||0
475981|NCT00467779|1137319|P2|STARTED|Stage 1A||0
475982|NCT00467779|1137320|P1|STARTED|Stage 1A||0
475983|NCT00467779|1137306|P15|NOT COMPLETED|Stage 1||0
475984|NCT00467779|1137307|P14|NOT COMPLETED|Stage 1||0
475985|NCT00467779|1137308|P13|NOT COMPLETED|Stage 1||0
475986|NCT00467779|1137309|P12|NOT COMPLETED|Stage 1||0
475987|NCT00467779|1137310|P11|NOT COMPLETED|Stage 1||0
475988|NCT00467779|1137311|P10|NOT COMPLETED|Stage 1||0
475989|NCT00467779|1137312|P9|NOT COMPLETED|Stage 1||0
475990|NCT00467779|1137313|P8|NOT COMPLETED|Stage 1||7
475991|NCT00467779|1137314|P7|NOT COMPLETED|Stage 1||7
475992|NCT00467779|1137315|P6|NOT COMPLETED|Stage 1||5
475993|NCT00467779|1137316|P5|NOT COMPLETED|Stage 1||3
475994|NCT00467779|1137317|P4|NOT COMPLETED|Stage 1||3
475995|NCT00467779|1137318|P3|NOT COMPLETED|Stage 1||3
475996|NCT00467779|1137319|P2|NOT COMPLETED|Stage 1||3
475997|NCT00467779|1137320|P1|NOT COMPLETED|Stage 1||4
475998|NCT00467779|1137306|P15|COMPLETED|Stage 1||0
475999|NCT00467779|1137307|P14|COMPLETED|Stage 1||0
476000|NCT00467779|1137308|P13|COMPLETED|Stage 1||0
476001|NCT00467779|1137309|P12|COMPLETED|Stage 1||0
476002|NCT00467779|1137310|P11|COMPLETED|Stage 1||0
476003|NCT00467779|1137311|P10|COMPLETED|Stage 1||0
476004|NCT00467779|1137312|P9|COMPLETED|Stage 1||0
476005|NCT00467779|1137313|P8|COMPLETED|Stage 1||0
476006|NCT00467779|1137314|P7|COMPLETED|Stage 1||0
476007|NCT00467779|1137315|P6|COMPLETED|Stage 1||1
476008|NCT00467779|1137316|P5|COMPLETED|Stage 1||0
476009|NCT00467779|1137317|P4|COMPLETED|Stage 1||0
476010|NCT00467779|1137318|P3|COMPLETED|Stage 1||0
476011|NCT00467779|1137319|P2|COMPLETED|Stage 1||0
476012|NCT00467779|1137320|P1|COMPLETED|Stage 1||0
476013|NCT00467779|1137306|P15|STARTED|Stage 1||0
476014|NCT00467779|1137307|P14|STARTED|Stage 1||0
476015|NCT00467779|1137308|P13|STARTED|Stage 1||0
476016|NCT00467779|1137309|P12|STARTED|Stage 1||0
476017|NCT00467779|1137310|P11|STARTED|Stage 1||0
476018|NCT00467779|1137311|P10|STARTED|Stage 1||0
476019|NCT00467779|1137312|P9|STARTED|Stage 1||0
476020|NCT00467779|1137313|P8|STARTED|Stage 1||7
476021|NCT00467779|1137314|P7|STARTED|Stage 1||7
476022|NCT00467779|1137315|P6|STARTED|Stage 1||6
476023|NCT00467779|1137316|P5|STARTED|Stage 1||3
476024|NCT00467779|1137317|P4|STARTED|Stage 1||3
476025|NCT00467779|1137318|P3|STARTED|Stage 1||3
476026|NCT00467779|1137319|P2|STARTED|Stage 1||3
476027|NCT00467779|1137320|P1|STARTED|Stage 1||4
476028|NCT00467753|1137494|P2|NOT COMPLETED|Overall Study||2
476029|NCT00467753|1137495|P1|NOT COMPLETED|Overall Study||3
476030|NCT00467753|1137494|P2|COMPLETED|Overall Study||0
476031|NCT00467753|1137495|P1|COMPLETED|Overall Study||0
476032|NCT00467753|1137494|P2|STARTED|Overall Study||2
476033|NCT00467753|1137495|P1|STARTED|Overall Study||3
476034|NCT00467740|1137506|P5|NOT COMPLETED|Overall Study||0
476035|NCT00467740|1137507|P4|NOT COMPLETED|Overall Study||1
476036|NCT00467740|1137508|P3|NOT COMPLETED|Overall Study||2
476037|NCT00467740|1137509|P2|NOT COMPLETED|Overall Study||3
476038|NCT00467740|1137510|P1|NOT COMPLETED|Overall Study||1
476039|NCT00467740|1137506|P5|COMPLETED|Overall Study||61
476040|NCT00467740|1137507|P4|COMPLETED|Overall Study||59
476041|NCT00467740|1137508|P3|COMPLETED|Overall Study||58
476042|NCT00467740|1137509|P2|COMPLETED|Overall Study||58
476043|NCT00467740|1137510|P1|COMPLETED|Overall Study||53
476044|NCT00467740|1137506|P5|STARTED|Overall Study||61
476045|NCT00467740|1137507|P4|STARTED|Overall Study||60
476046|NCT00467740|1137508|P3|STARTED|Overall Study||60
476047|NCT00467740|1137509|P2|STARTED|Overall Study||61
476048|NCT00467740|1137510|P1|STARTED|Overall Study||54
476049|NCT00467649|1137699|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
476050|NCT00467649|1137700|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
476051|NCT00467649|1137701|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
476052|NCT00467649|1137702|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
476053|NCT00467649|1137703|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
476054|NCT00467649|1137704|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
476055|NCT00467649|1137699|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
476056|NCT00467649|1137700|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
476057|NCT00467649|1137701|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
476058|NCT00467649|1137702|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
476059|NCT00467649|1137703|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
476060|NCT00467649|1137704|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
476061|NCT00467649|1137699|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
476062|NCT00467649|1137700|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
476063|NCT00467649|1137701|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
476064|NCT00467649|1137702|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
476065|NCT00467649|1137703|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
476066|NCT00467649|1137704|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
476067|NCT00467649|1137699|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
476068|NCT00467649|1137700|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
476069|NCT00467649|1137701|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
476070|NCT00467649|1137702|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
476071|NCT00467649|1137703|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
476072|NCT00467649|1137704|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
476073|NCT00467649|1137699|P6|COMPLETED|Phase 1 (Randomized Population)||0
476074|NCT00467649|1137700|P5|COMPLETED|Phase 1 (Randomized Population)||0
476075|NCT00467649|1137701|P4|COMPLETED|Phase 1 (Randomized Population)||0
476076|NCT00467649|1137702|P3|COMPLETED|Phase 1 (Randomized Population)||0
476077|NCT00467649|1137703|P2|COMPLETED|Phase 1 (Randomized Population)||50
476078|NCT00467649|1137704|P1|COMPLETED|Phase 1 (Randomized Population)||48
476079|NCT00467649|1137699|P6|Intent to Treat|Phase 1 (Randomized Population)||0
476080|NCT00467649|1137700|P5|Intent to Treat|Phase 1 (Randomized Population)||0
476081|NCT00467649|1137701|P4|Intent to Treat|Phase 1 (Randomized Population)||0
476082|NCT00467649|1137702|P3|Intent to Treat|Phase 1 (Randomized Population)||0
476083|NCT00467649|1137703|P2|Intent to Treat|Phase 1 (Randomized Population)||56
476084|NCT00467649|1137704|P1|Intent to Treat|Phase 1 (Randomized Population)||56
476085|NCT00467649|1137699|P6|STARTED|Phase 1 (Randomized Population)||0
476086|NCT00467649|1137700|P5|STARTED|Phase 1 (Randomized Population)||0
476087|NCT00467649|1137701|P4|STARTED|Phase 1 (Randomized Population)||0
476088|NCT00467649|1137702|P3|STARTED|Phase 1 (Randomized Population)||0
476089|NCT00467649|1137703|P2|STARTED|Phase 1 (Randomized Population)||56
476090|NCT00467649|1137704|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
476091|NCT00467610|1137744|P1|NOT COMPLETED|Overall Study||1
476092|NCT00467610|1137744|P1|COMPLETED|Overall Study||5
476093|NCT00467610|1137744|P1|STARTED|Overall Study||6
476094|NCT00467597|1137755|P2|NOT COMPLETED|Overall Study||0
476095|NCT00467597|1137756|P1|NOT COMPLETED|Overall Study||2
476096|NCT00467597|1137755|P2|COMPLETED|Overall Study||6
476097|NCT00467597|1137756|P1|COMPLETED|Overall Study||24
476098|NCT00467597|1137755|P2|STARTED|Overall Study||6
476099|NCT00467597|1137756|P1|STARTED|Overall Study||26
476100|NCT00467584|1137769|P3|NOT COMPLETED|Overall Study||1
476101|NCT00467584|1137770|P2|NOT COMPLETED|Overall Study||5
476102|NCT00467584|1137771|P1|NOT COMPLETED|Overall Study||4
476103|NCT00467584|1137769|P3|COMPLETED|Overall Study||20
476104|NCT00467584|1137770|P2|COMPLETED|Overall Study||15
476105|NCT00467584|1137771|P1|COMPLETED|Overall Study||17
476106|NCT00467584|1137769|P3|STARTED|Overall Study||21
476107|NCT00467584|1137770|P2|STARTED|Overall Study||20
476108|NCT00467584|1137771|P1|STARTED|Overall Study||21
476109|NCT00467558|1137781|P2|NOT COMPLETED|Overall Study||0
476110|NCT00467558|1137782|P1|NOT COMPLETED|Overall Study||2
476111|NCT00467558|1137781|P2|COMPLETED|Overall Study||3
476112|NCT00467558|1137782|P1|COMPLETED|Overall Study||2
476113|NCT00467558|1137781|P2|STARTED|Overall Study||3
476114|NCT00467558|1137782|P1|STARTED|Overall Study||4
476115|NCT00467519|1137792|P2|NOT COMPLETED|Overall Study||23
476116|NCT00467519|1137793|P1|NOT COMPLETED|Overall Study||14
476117|NCT00467519|1137792|P2|COMPLETED|Overall Study||488
476118|NCT00467519|1137793|P1|COMPLETED|Overall Study||517
476119|NCT00467519|1137792|P2|STARTED|Overall Study||511
476120|NCT00467519|1137793|P1|STARTED|Overall Study||531
476121|NCT00467389|1137809|P2|NOT COMPLETED|Overall Study||0
476122|NCT00467389|1137810|P1|NOT COMPLETED|Overall Study||0
476123|NCT00467389|1137809|P2|COMPLETED|Overall Study||6
476124|NCT00467389|1137810|P1|COMPLETED|Overall Study||6
476125|NCT00467389|1137809|P2|STARTED|Overall Study||6
476126|NCT00467389|1137810|P1|STARTED|Overall Study||6
476127|NCT00467363|1137822|P2|NOT COMPLETED|Overall Study||70
476128|NCT00467363|1137823|P1|NOT COMPLETED|Overall Study||80
476129|NCT00467363|1137822|P2|COMPLETED|Overall Study||543
476130|NCT00467363|1137823|P1|COMPLETED|Overall Study||535
476131|NCT00467363|1137822|P2|STARTED|Overall Study||613
476132|NCT00467363|1137823|P1|STARTED|Overall Study||615
476133|NCT00467285|1137859|P2|NOT COMPLETED|Overall Study||4
476134|NCT00467285|1137860|P1|NOT COMPLETED|Overall Study||4
476135|NCT00467285|1137859|P2|COMPLETED|Overall Study||60
476136|NCT00467285|1137860|P1|COMPLETED|Overall Study||28
476137|NCT00467285|1137859|P2|STARTED|Overall Study||64
476138|NCT00467285|1137860|P1|STARTED|Overall Study||32
476139|NCT00467259|1137880|P2|NOT COMPLETED|Overall Study||242
476140|NCT00467259|1137881|P1|NOT COMPLETED|Overall Study||75
476141|NCT00467259|1137880|P2|COMPLETED|Overall Study||778
476142|NCT00467259|1137881|P1|COMPLETED|Overall Study||176
476143|NCT00467259|1137880|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
476144|NCT00467259|1137881|P1|ITT Population|Overall Study||251
476145|NCT00467259|1137880|P2|STARTED|Overall Study||1020
476146|NCT00467259|1137881|P1|STARTED|Overall Study||251
476147|NCT00467077|1137891|P1|NOT COMPLETED|Overall Study||0
476148|NCT00467077|1137891|P1|COMPLETED|Overall Study||21
476149|NCT00467077|1137891|P1|STARTED|Overall Study||21
476150|NCT00467051|1137898|P1|NOT COMPLETED|Overall Study||2
476151|NCT00467051|1137898|P1|COMPLETED|Overall Study||18
476152|NCT00467051|1137898|P1|STARTED|Overall Study||20
476153|NCT00467038|1137904|P2|NOT COMPLETED|Overall Study||0
476154|NCT00467038|1137905|P1|NOT COMPLETED|Overall Study||0
476155|NCT00467038|1137904|P2|COMPLETED|Overall Study||11
476156|NCT00467038|1137905|P1|COMPLETED|Overall Study||11
476157|NCT00467038|1137904|P2|STARTED|Overall Study||11
476158|NCT00467038|1137905|P1|STARTED|Overall Study||11
476159|NCT00466947|1137915|P2|NOT COMPLETED|Study End Analysis Period||2534
476160|NCT00466947|1137916|P1|NOT COMPLETED|Study End Analysis Period||2496
476161|NCT00466947|1137915|P2|COMPLETED|Study End Analysis Period||9265
476162|NCT00466947|1137916|P1|COMPLETED|Study End Analysis Period||9302
476163|NCT00466947|1137915|P2|STARTED|Study End Analysis Period||11799
476164|NCT00466947|1137916|P1|STARTED|Study End Analysis Period||11798
476165|NCT00466947|1137915|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
476166|NCT00466947|1137916|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
476167|NCT00466947|1137915|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
476168|NCT00466947|1137916|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
476169|NCT00466947|1137915|P2|Ongoing|Primary Outcome Analysis Period||11863
476170|NCT00466947|1137916|P1|Ongoing|Primary Outcome Analysis Period||11875
476171|NCT00466947|1137915|P2|STARTED|Primary Outcome Analysis Period||11863
476172|NCT00466947|1137916|P1|STARTED|Primary Outcome Analysis Period||11875
476173|NCT00466882|1138038|P1|NOT COMPLETED|Overall Study||0
476174|NCT00466882|1138038|P1|COMPLETED|Overall Study||3
476175|NCT00466882|1138038|P1|STARTED|Overall Study||3
476176|NCT00466817|1138044|P2|NOT COMPLETED|Overall Study||4
476177|NCT00466817|1138045|P1|NOT COMPLETED|Overall Study||5
476178|NCT00466817|1138044|P2|COMPLETED|Overall Study||43
476179|NCT00466817|1138045|P1|COMPLETED|Overall Study||44
476180|NCT00466817|1138044|P2|STARTED|Overall Study||47
476181|NCT00466817|1138045|P1|STARTED|Overall Study||49
476182|NCT00466687|1138098|P1|NOT COMPLETED|Overall Study||34
476183|NCT00466687|1138098|P1|COMPLETED|Overall Study||0
476184|NCT00466687|1138098|P1|STARTED|Overall Study||34
476185|NCT00465647|1138109|P4|NOT COMPLETED|Overall Study||13
476186|NCT00465647|1138110|P3|NOT COMPLETED|Overall Study||11
476187|NCT00465647|1138111|P2|NOT COMPLETED|Overall Study||8
476188|NCT00465647|1138112|P1|NOT COMPLETED|Overall Study||13
476189|NCT00465647|1138109|P4|COMPLETED|Overall Study||12
476190|NCT00465647|1138110|P3|COMPLETED|Overall Study||18
476191|NCT00465647|1138111|P2|COMPLETED|Overall Study||15
476192|NCT00465647|1138112|P1|COMPLETED|Overall Study||26
476193|NCT00465647|1138109|P4|STARTED|Overall Study||25
476194|NCT00465647|1138110|P3|STARTED|Overall Study||29
476195|NCT00465647|1138111|P2|STARTED|Overall Study||23
476196|NCT00465647|1138112|P1|STARTED|Overall Study||39
476197|NCT00466505|1138135|P1|NOT COMPLETED|Overall Study||17
476198|NCT00466505|1138135|P1|COMPLETED|Overall Study||0
476199|NCT00466505|1138135|P1|STARTED|Overall Study||17
476200|NCT00466323|1138149|P2|NOT COMPLETED|Overall Study||23
476201|NCT00466323|1138150|P1|NOT COMPLETED|Overall Study||28
476202|NCT00466323|1138149|P2|COMPLETED|Overall Study||92
476203|NCT00466323|1138150|P1|COMPLETED|Overall Study||89
476204|NCT00466323|1138149|P2|STARTED|Overall Study||115
476205|NCT00466323|1138150|P1|STARTED|Overall Study||117
476206|NCT00466310|1138165|P3|NOT COMPLETED|Overall Study||0
476207|NCT00466310|1138166|P2|NOT COMPLETED|Overall Study||0
476208|NCT00466310|1138167|P1|NOT COMPLETED|Overall Study||0
476209|NCT00466310|1138165|P3|COMPLETED|Overall Study||31
476210|NCT00466310|1138166|P2|COMPLETED|Overall Study||20
476211|NCT00466310|1138167|P1|COMPLETED|Overall Study||20
476212|NCT00466310|1138165|P3|STARTED|Overall Study||31
476213|NCT00466310|1138166|P2|STARTED|Overall Study||20
476214|NCT00466310|1138167|P1|STARTED|Overall Study||20
476215|NCT00466206|1138175|P1|NOT COMPLETED|Overall Study||0
476216|NCT00466206|1138175|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
476217|NCT00466206|1138175|P1|STARTED|Overall Study||10
476218|NCT00466193|1138185|P2|NOT COMPLETED|Overall Study||8
476219|NCT00466193|1138186|P1|NOT COMPLETED|Overall Study||12
476220|NCT00466193|1138185|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
476221|NCT00466193|1138186|P1|COMPLETED|Overall Study||138
476222|NCT00466193|1138185|P2|STARTED|Overall Study||145
476223|NCT00466193|1138186|P1|STARTED|Overall Study||150
476224|NCT00466167|1138213|P3|NOT COMPLETED|Overall Study||21
476225|NCT00466167|1138214|P2|NOT COMPLETED|Overall Study||12
476226|NCT00466167|1138215|P1|NOT COMPLETED|Overall Study||20
476227|NCT00466167|1138213|P3|COMPLETED|Overall Study||157
476228|NCT00466167|1138214|P2|COMPLETED|Overall Study||163
476229|NCT00466167|1138215|P1|COMPLETED|Overall Study||145
476230|NCT00466167|1138213|P3|STARTED|Overall Study||178
476231|NCT00466167|1138214|P2|STARTED|Overall Study||175
476232|NCT00466167|1138215|P1|STARTED|Overall Study||165
476233|NCT00465998|1138271|P1|NOT COMPLETED|Overall Study||0
476234|NCT00465998|1138271|P1|COMPLETED|Overall Study||275
476235|NCT00465998|1138271|P1|STARTED|Overall Study||275
476236|NCT00465985|1138276|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
476237|NCT00465985|1138277|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
476238|NCT00465985|1138276|P2|COMPLETED|Part III - Open-label Treatment Period||0
476239|NCT00465985|1138277|P1|COMPLETED|Part III - Open-label Treatment Period||29
476240|NCT00465985|1138276|P2|STARTED|Part III - Open-label Treatment Period||0
476241|NCT00465985|1138277|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
476242|NCT00465985|1138276|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
476243|NCT00465985|1138277|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
476244|NCT00465985|1138276|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
476245|NCT00465985|1138277|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
476246|NCT00465985|1138276|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
476247|NCT00465985|1138277|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
476248|NCT00465985|1138276|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
476249|NCT00465985|1138277|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
476250|NCT00465985|1138276|P2|COMPLETED|Part I - Open-label Treatment Period||0
476251|NCT00465985|1138277|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
476252|NCT00465985|1138276|P2|STARTED|Part I - Open-label Treatment Period||0
476253|NCT00465985|1138277|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
476254|NCT00465972|1138300|P2|NOT COMPLETED|Overall Study||1
476255|NCT00465972|1138301|P1|NOT COMPLETED|Overall Study||2
476256|NCT00465972|1138300|P2|COMPLETED|Overall Study||23
476257|NCT00465972|1138301|P1|COMPLETED|Overall Study||18
476258|NCT00465972|1138300|P2|STARTED|Overall Study||24
476259|NCT00465972|1138301|P1|STARTED|Overall Study||20
476260|NCT00465894|1138311|P2|NOT COMPLETED|Overall Study||3
476261|NCT00465894|1138312|P1|NOT COMPLETED|Overall Study||5
476262|NCT00465894|1138311|P2|COMPLETED|Overall Study||25
476263|NCT00465894|1138312|P1|COMPLETED|Overall Study||25
476264|NCT00465894|1138311|P2|STARTED|Overall Study||28
476265|NCT00465894|1138312|P1|STARTED|Overall Study||30
476266|NCT00465816|1138321|P3|NOT COMPLETED|Overall Study||2
476267|NCT00465816|1138322|P2|NOT COMPLETED|Overall Study||0
476268|NCT00465816|1138323|P1|NOT COMPLETED|Overall Study||0
476269|NCT00465816|1138321|P3|COMPLETED|Overall Study||120
476270|NCT00465816|1138322|P2|COMPLETED|Overall Study||122
476271|NCT00465816|1138323|P1|COMPLETED|Overall Study||367
476272|NCT00465816|1138321|P3|STARTED|Overall Study||122
476273|NCT00465816|1138322|P2|STARTED|Overall Study||122
476274|NCT00465816|1138323|P1|STARTED|Overall Study||367
476275|NCT00465738|1138405|P2|NOT COMPLETED|Overall Study||6
476276|NCT00465738|1138406|P1|NOT COMPLETED|Overall Study||6
476277|NCT00465738|1138405|P2|COMPLETED|Overall Study||89
476278|NCT00465738|1138406|P1|COMPLETED|Overall Study||91
476279|NCT00465738|1138405|P2|STARTED|Overall Study||95
476280|NCT00465738|1138406|P1|STARTED|Overall Study||97
476281|NCT00465569|1138498|P2|NOT COMPLETED|Overall Study||0
476282|NCT00465569|1138499|P1|NOT COMPLETED|Overall Study||1
476283|NCT00465569|1138498|P2|COMPLETED|Overall Study||7
476284|NCT00465569|1138499|P1|COMPLETED|Overall Study||12
476285|NCT00465569|1138498|P2|STARTED|Overall Study||7
476286|NCT00465569|1138499|P1|STARTED|Overall Study||13
476287|NCT00465530|1138511|P2|NOT COMPLETED|Overall Study||4
476288|NCT00465530|1138512|P1|NOT COMPLETED|Overall Study||2
476289|NCT00465530|1138511|P2|COMPLETED|Overall Study||15
476290|NCT00465530|1138512|P1|COMPLETED|Overall Study||19
476291|NCT00465530|1138511|P2|STARTED|Overall Study||19
476292|NCT00465530|1138512|P1|STARTED|Overall Study||21
476293|NCT00465361|1138522|P1|NOT COMPLETED|Post-Intervention Assessment||0
476294|NCT00465361|1138522|P1|COMPLETED|Post-Intervention Assessment||3
476295|NCT00465361|1138522|P1|STARTED|Post-Intervention Assessment||3
476296|NCT00465361|1138522|P1|NOT COMPLETED|Baseline Assessment||4
476297|NCT00465361|1138522|P1|COMPLETED|Baseline Assessment||3
476298|NCT00465361|1138522|P1|STARTED|Baseline Assessment||7
476299|NCT00465179|1138526|P1|NOT COMPLETED|Overall Study||53
476300|NCT00465179|1138526|P1|COMPLETED|Overall Study||4
476301|NCT00465179|1138526|P1|STARTED|Overall Study||57
476302|NCT00465101|1138532|P1|NOT COMPLETED|Overall Study||59
476303|NCT00465101|1138532|P1|COMPLETED|Overall Study||91
476304|NCT00465101|1138532|P1|STARTED|Overall Study||150
476305|NCT00465088|1138567|P2|NOT COMPLETED|Overall Study||9
476306|NCT00465088|1138568|P1|NOT COMPLETED|Overall Study||32
476307|NCT00465088|1138567|P2|COMPLETED|Overall Study||70
476308|NCT00465088|1138568|P1|COMPLETED|Overall Study||82
476309|NCT00465088|1138567|P2|STARTED|Overall Study||79
476310|NCT00465088|1138568|P1|STARTED|Overall Study|For both arms, started means treated.|114
476311|NCT00464945|1138602|P2|NOT COMPLETED|Toddler Dose||1
476312|NCT00464945|1138603|P1|NOT COMPLETED|Toddler Dose||0
476313|NCT00464945|1138602|P2|COMPLETED|Toddler Dose||130
476314|NCT00464945|1138603|P1|COMPLETED|Toddler Dose||131
476315|NCT00464945|1138602|P2|STARTED|Toddler Dose||131
476316|NCT00464945|1138603|P1|STARTED|Toddler Dose||131
476317|NCT00464945|1138602|P2|NOT COMPLETED|After Infant Series||2
476318|NCT00464945|1138603|P1|NOT COMPLETED|After Infant Series||0
476319|NCT00464945|1138602|P2|COMPLETED|After Infant Series||131
476320|NCT00464945|1138603|P1|COMPLETED|After Infant Series||131
476321|NCT00464945|1138602|P2|STARTED|After Infant Series||133
476322|NCT00464945|1138603|P1|STARTED|After Infant Series||131
476323|NCT00464945|1138602|P2|NOT COMPLETED|Infant Series||1
476324|NCT00464945|1138603|P1|NOT COMPLETED|Infant Series||4
476325|NCT00464945|1138602|P2|COMPLETED|Infant Series||133
476326|NCT00464945|1138603|P1|COMPLETED|Infant Series||131
476327|NCT00464945|1138602|P2|Vaccinated Dose 3|Infant Series||133
476328|NCT00464945|1138603|P1|Vaccinated Dose 3|Infant Series||132
476329|NCT00464945|1138602|P2|Vaccinated Dose 2|Infant Series||133
476330|NCT00464945|1138603|P1|Vaccinated Dose 2|Infant Series||132
476331|NCT00464945|1138602|P2|Vaccinated Dose 1|Infant Series||134
476332|NCT00464945|1138603|P1|Vaccinated Dose 1|Infant Series||134
476333|NCT00464945|1138602|P2|STARTED|Infant Series||134
476334|NCT00464945|1138603|P1|STARTED|Infant Series||135
476335|NCT00464737|1138634|P3|NOT COMPLETED|Overall Study||55
476336|NCT00464737|1138635|P2|NOT COMPLETED|Overall Study||32
476337|NCT00464737|1138636|P1|NOT COMPLETED|Overall Study||32
476338|NCT00464737|1138634|P3|COMPLETED|Overall Study||19
476339|NCT00464737|1138635|P2|COMPLETED|Overall Study||42
476340|NCT00464737|1138636|P1|COMPLETED|Overall Study||50
476341|NCT00464737|1138634|P3|STARTED|Overall Study||74
476342|NCT00464737|1138635|P2|STARTED|Overall Study||74
476343|NCT00464737|1138636|P1|STARTED|Overall Study||82
476344|NCT00464711|1138683|P1|NOT COMPLETED|Overall Study||15
476345|NCT00464711|1138683|P1|COMPLETED|Overall Study||25
476346|NCT00464711|1138683|P1|STARTED|Overall Study||40
476347|NCT00464698|1138687|P1|NOT COMPLETED|Period 3: 120mg||2
476348|NCT00464698|1138687|P1|COMPLETED|Period 3: 120mg||12
476349|NCT00464698|1138687|P1|STARTED|Period 3: 120mg||14
476350|NCT00464698|1138687|P1|NOT COMPLETED|Period 2: 60 mg||0
476351|NCT00464698|1138687|P1|COMPLETED|Period 2: 60 mg||17
476352|NCT00464698|1138687|P1|STARTED|Period 2: 60 mg||17
476353|NCT00464698|1138687|P1|NOT COMPLETED|Period 1: 30 mg||3
476354|NCT00464698|1138687|P1|COMPLETED|Period 1: 30 mg||17
476355|NCT00464698|1138687|P1|STARTED|Period 1: 30 mg||20
476356|NCT00464685|1138699|P2|NOT COMPLETED|Overall Study||33
476357|NCT00464685|1138700|P1|NOT COMPLETED|Overall Study||23
476358|NCT00464685|1138699|P2|COMPLETED|Overall Study||94
476359|NCT00464685|1138700|P1|COMPLETED|Overall Study||103
476360|NCT00464685|1138699|P2|STARTED|Overall Study||127
476361|NCT00464685|1138700|P1|STARTED|Overall Study||126
476362|NCT00464672|1138716|P6|NOT COMPLETED|Overall Study||4
476363|NCT00464672|1138717|P5|NOT COMPLETED|Overall Study||10
476364|NCT00464672|1138718|P4|NOT COMPLETED|Overall Study||1
476365|NCT00464672|1138719|P3|NOT COMPLETED|Overall Study||0
476366|NCT00464672|1138720|P2|NOT COMPLETED|Overall Study||10
476367|NCT00464672|1138721|P1|NOT COMPLETED|Overall Study||25
476368|NCT00464672|1138716|P6|COMPLETED|Overall Study||195
476369|NCT00464672|1138717|P5|COMPLETED|Overall Study||392
476370|NCT00464672|1138718|P4|COMPLETED|Overall Study||199
476371|NCT00464672|1138719|P3|COMPLETED|Overall Study||400
476372|NCT00464672|1138720|P2|COMPLETED|Overall Study||222
476373|NCT00464672|1138721|P1|COMPLETED|Overall Study||435
476374|NCT00464672|1138716|P6|STARTED|Overall Study||199
476375|NCT00464672|1138717|P5|STARTED|Overall Study||402
476376|NCT00464672|1138718|P4|STARTED|Overall Study||200
476377|NCT00464672|1138719|P3|STARTED|Overall Study||400
476378|NCT00464672|1138720|P2|STARTED|Overall Study||232
476379|NCT00464672|1138721|P1|STARTED|Overall Study||460
476380|NCT00464646|1138793|P2|NOT COMPLETED|Overall Study||0
476381|NCT00464646|1138794|P1|NOT COMPLETED|Overall Study||0
476382|NCT00464646|1138793|P2|COMPLETED|Overall Study||29
476383|NCT00464646|1138794|P1|COMPLETED|Overall Study||76
476384|NCT00464646|1138793|P2|STARTED|Overall Study||29
476385|NCT00464646|1138794|P1|STARTED|Overall Study||76
476386|NCT00464542|1138800|P1|NOT COMPLETED|Post-treatment||0
476387|NCT00464542|1138800|P1|COMPLETED|Post-treatment||10
476388|NCT00464542|1138800|P1|STARTED|Post-treatment||10
476389|NCT00464542|1138800|P1|NOT COMPLETED|Pre-treatment||2
476390|NCT00464542|1138800|P1|COMPLETED|Pre-treatment||10
476391|NCT00464542|1138800|P1|STARTED|Pre-treatment||12
476392|NCT00464490|1138807|P2|NOT COMPLETED|Overall Study||11
476393|NCT00464490|1138808|P1|NOT COMPLETED|Overall Study||11
476394|NCT00464490|1138807|P2|COMPLETED|Overall Study||10
476395|NCT00464490|1138808|P1|COMPLETED|Overall Study||10
476396|NCT00464490|1138807|P2|STARTED|Overall Study||21
476397|NCT00464490|1138808|P1|STARTED|Overall Study||21
476398|NCT00464464|1138816|P2|NOT COMPLETED|Overall Study||3
476399|NCT00464464|1138817|P1|NOT COMPLETED|Overall Study||5
476400|NCT00464464|1138816|P2|COMPLETED|Overall Study||36
476401|NCT00464464|1138817|P1|COMPLETED|Overall Study||36
476402|NCT00464464|1138816|P2|STARTED|Overall Study||39
476403|NCT00464464|1138817|P1|STARTED|Overall Study||41
476404|NCT00464438|1138831|P2|NOT COMPLETED|Overall Study||6
476405|NCT00464438|1138832|P1|NOT COMPLETED|Overall Study||2
476406|NCT00464438|1138831|P2|COMPLETED|Overall Study||80
476407|NCT00464438|1138832|P1|COMPLETED|Overall Study||83
476408|NCT00464438|1138831|P2|STARTED|Overall Study||86
476409|NCT00464438|1138832|P1|STARTED|Overall Study||85
476410|NCT00464334|1138855|P11|NOT COMPLETED|Overall Study||4
476411|NCT00464334|1138856|P10|NOT COMPLETED|Overall Study||1
476412|NCT00464334|1138857|P9|NOT COMPLETED|Overall Study||6
476413|NCT00464334|1138858|P8|NOT COMPLETED|Overall Study||1
476414|NCT00464334|1138859|P7|NOT COMPLETED|Overall Study||3
476415|NCT00464334|1138860|P6|NOT COMPLETED|Overall Study||4
476416|NCT00464334|1138861|P5|NOT COMPLETED|Overall Study||4
476417|NCT00464334|1138862|P4|NOT COMPLETED|Overall Study||4
476418|NCT00464334|1138863|P3|NOT COMPLETED|Overall Study||5
476419|NCT00464334|1138864|P2|NOT COMPLETED|Overall Study||8
476420|NCT00464334|1138865|P1|NOT COMPLETED|Overall Study||1
476421|NCT00464334|1138855|P11|COMPLETED|Overall Study||4
476422|NCT00464334|1138856|P10|COMPLETED|Overall Study||4
476423|NCT00464334|1138857|P9|COMPLETED|Overall Study||2
476424|NCT00464334|1138858|P8|COMPLETED|Overall Study||7
476425|NCT00464334|1138859|P7|COMPLETED|Overall Study||6
476426|NCT00464334|1138860|P6|COMPLETED|Overall Study||3
476427|NCT00464334|1138861|P5|COMPLETED|Overall Study||3
476428|NCT00464334|1138862|P4|COMPLETED|Overall Study||4
476429|NCT00464334|1138863|P3|COMPLETED|Overall Study||3
476430|NCT00464334|1138864|P2|COMPLETED|Overall Study||5
476431|NCT00464334|1138865|P1|COMPLETED|Overall Study||4
476432|NCT00464334|1138855|P11|STARTED|Overall Study||8
476433|NCT00464334|1138856|P10|STARTED|Overall Study||5
476434|NCT00464334|1138857|P9|STARTED|Overall Study||8
476435|NCT00464334|1138858|P8|STARTED|Overall Study||8
476436|NCT00464334|1138859|P7|STARTED|Overall Study||9
476437|NCT00464334|1138860|P6|STARTED|Overall Study||7
476438|NCT00464334|1138861|P5|STARTED|Overall Study||7
476439|NCT00464334|1138862|P4|STARTED|Overall Study||8
476440|NCT00464334|1138863|P3|STARTED|Overall Study||8
476441|NCT00464334|1138864|P2|STARTED|Overall Study||13
476442|NCT00464334|1138865|P1|STARTED|Overall Study||5
476443|NCT00464308|1138925|P3|NOT COMPLETED|Overall Study||59
476444|NCT00464308|1138926|P2|NOT COMPLETED|Overall Study||63
476445|NCT00464308|1138927|P1|NOT COMPLETED|Overall Study||69
476446|NCT00464308|1138925|P3|COMPLETED|Overall Study||400
476447|NCT00464308|1138926|P2|COMPLETED|Overall Study||406
476448|NCT00464308|1138927|P1|COMPLETED|Overall Study||395
476449|NCT00464308|1138925|P3|STARTED|Overall Study||459
476450|NCT00464308|1138926|P2|STARTED|Overall Study||469
476451|NCT00464308|1138927|P1|STARTED|Overall Study||464
476452|NCT00464269|1138957|P4|NOT COMPLETED|Overall Study||9
476453|NCT00464269|1138958|P3|NOT COMPLETED|Overall Study||7
476454|NCT00464269|1138959|P2|NOT COMPLETED|Overall Study||17
476455|NCT00464269|1138960|P1|NOT COMPLETED|Overall Study||6
476456|NCT00464269|1138957|P4|COMPLETED|Overall Study||93
476457|NCT00464269|1138958|P3|COMPLETED|Overall Study||93
476458|NCT00464269|1138959|P2|COMPLETED|Overall Study||82
476459|NCT00464269|1138960|P1|COMPLETED|Overall Study||93
476460|NCT00464269|1138957|P4|STARTED|Overall Study||102
476461|NCT00464269|1138958|P3|STARTED|Overall Study||100
476462|NCT00464269|1138959|P2|STARTED|Overall Study||99
476463|NCT00464269|1138960|P1|STARTED|Overall Study||99
476464|NCT00464204|1139060|P2|NOT COMPLETED|Overall Study||32
476465|NCT00464204|1139061|P1|NOT COMPLETED|Overall Study||49
476466|NCT00464204|1139060|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
476467|NCT00464204|1139061|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
476468|NCT00464204|1139060|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
476469|NCT00464204|1139061|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
476470|NCT00464204|1139060|P2|Day 90 Follow-up Performed|Overall Study||74
476471|NCT00464204|1139061|P1|Day 90 Follow-up Performed|Overall Study||69
476472|NCT00464204|1139060|P2|Day 30 Follow-up Performed|Overall Study||83
476473|NCT00464204|1139061|P1|Day 30 Follow-up Performed|Overall Study||89
476474|NCT00464204|1139060|P2|Completed Treatment|Overall Study||83
476475|NCT00464204|1139061|P1|Completed Treatment|Overall Study||81
476476|NCT00464204|1139060|P2|STARTED|Overall Study||96
476477|NCT00464204|1139061|P1|STARTED|Overall Study||100
476478|NCT00464087|1139098|P3|NOT COMPLETED|Overall Study||29
476479|NCT00464087|1139099|P2|NOT COMPLETED|Overall Study||0
476480|NCT00464087|1139100|P1|NOT COMPLETED|Overall Study||0
476481|NCT00464087|1139098|P3|COMPLETED|Overall Study||0
476482|NCT00464087|1139099|P2|COMPLETED|Overall Study||51
476483|NCT00464087|1139100|P1|COMPLETED|Overall Study||49
476484|NCT00464087|1139098|P3|STARTED|Overall Study||29
476485|NCT00464087|1139099|P2|STARTED|Overall Study||51
476486|NCT00464087|1139100|P1|STARTED|Overall Study||49
476487|NCT00463866|1139118|P2|NOT COMPLETED|Overall Study||340
476488|NCT00463866|1139119|P1|NOT COMPLETED|Overall Study||309
476489|NCT00463866|1139118|P2|COMPLETED|Overall Study||3705
476490|NCT00463866|1139119|P1|COMPLETED|Overall Study||3699
476491|NCT00463866|1139118|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
476492|NCT00463866|1139119|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
476493|NCT00463840|1139139|P1|NOT COMPLETED|Overall Study||12
476494|NCT00463840|1139139|P1|COMPLETED|Overall Study||12
476495|NCT00463840|1139139|P1|STARTED|Overall Study||24
476496|NCT00463801|1139143|P1|NOT COMPLETED|Overall Study||13
476497|NCT00463801|1139143|P1|COMPLETED|Overall Study||39
476498|NCT00463801|1139143|P1|STARTED|Overall Study||52
476499|NCT00463788|1139149|P2|NOT COMPLETED|Overall Study||54
476500|NCT00463788|1139150|P1|NOT COMPLETED|Overall Study||109
476501|NCT00463788|1139149|P2|COMPLETED|Overall Study||4
476502|NCT00463788|1139150|P1|COMPLETED|Overall Study||6
476503|NCT00463788|1139149|P2|Treated|Overall Study||57
476504|NCT00463788|1139150|P1|Treated|Overall Study||114
476505|NCT00463788|1139149|P2|STARTED|Overall Study||58
476506|NCT00463788|1139150|P1|STARTED|Overall Study||115
476507|NCT00463606|1139168|P3|NOT COMPLETED|Overall Study||20
476508|NCT00463606|1139169|P2|NOT COMPLETED|Overall Study||34
476509|NCT00463606|1139170|P1|NOT COMPLETED|Overall Study||41
476510|NCT00463606|1139168|P3|COMPLETED|Overall Study||231
476511|NCT00463606|1139169|P2|COMPLETED|Overall Study||220
476512|NCT00463606|1139170|P1|COMPLETED|Overall Study||212
476513|NCT00463606|1139168|P3|STARTED|Overall Study||251
476514|NCT00463606|1139169|P2|STARTED|Overall Study||254
476515|NCT00463606|1139170|P1|STARTED|Overall Study||253
476516|NCT00463580|1139195|P2|NOT COMPLETED|Overall Study||2
476517|NCT00463580|1139196|P1|NOT COMPLETED|Overall Study||3
476518|NCT00463580|1139195|P2|COMPLETED|Overall Study||28
476519|NCT00463580|1139196|P1|COMPLETED|Overall Study||27
476520|NCT00463580|1139195|P2|STARTED|Overall Study||30
476521|NCT00463580|1139196|P1|STARTED|Overall Study||30
476522|NCT00463567|1139211|P7|NOT COMPLETED|Overall Study||11
476523|NCT00463567|1139212|P6|NOT COMPLETED|Overall Study||21
476524|NCT00463567|1139213|P5|NOT COMPLETED|Overall Study||23
476525|NCT00463567|1139214|P4|NOT COMPLETED|Overall Study||131
476526|NCT00463567|1139215|P3|NOT COMPLETED|Overall Study||89
476527|NCT00463567|1139216|P2|NOT COMPLETED|Overall Study||77
476528|NCT00463567|1139217|P1|NOT COMPLETED|Overall Study||95
476529|NCT00463567|1139211|P7|COMPLETED|Overall Study||112
476530|NCT00463567|1139212|P6|COMPLETED|Overall Study||102
476531|NCT00463567|1139213|P5|COMPLETED|Overall Study||107
476532|NCT00463567|1139214|P4|COMPLETED|Overall Study||294
476533|NCT00463567|1139215|P3|COMPLETED|Overall Study||331
476534|NCT00463567|1139216|P2|COMPLETED|Overall Study||341
476535|NCT00463567|1139217|P1|COMPLETED|Overall Study||325
476536|NCT00463567|1139211|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
476537|NCT00463567|1139212|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
476538|NCT00463567|1139213|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
476539|NCT00463567|1139214|P4|Safety Population: Received Study Drug|Overall Study||418
476540|NCT00463567|1139215|P3|Safety Population: Received Study Drug|Overall Study||415
476541|NCT00463567|1139216|P2|Safety Population: Received Study Drug|Overall Study||416
476632|NCT00462917|1139562|P2|COMPLETED|Overall Study||65
476542|NCT00463567|1139217|P1|Safety Population: Received Study Drug|Overall Study||416
476543|NCT00463567|1139211|P7|STARTED|Overall Study||123
476544|NCT00463567|1139212|P6|STARTED|Overall Study||123
476545|NCT00463567|1139213|P5|STARTED|Overall Study||130
476546|NCT00463567|1139214|P4|STARTED|Overall Study||425
476547|NCT00463567|1139215|P3|STARTED|Overall Study||420
476548|NCT00463567|1139216|P2|STARTED|Overall Study||418
476549|NCT00463567|1139217|P1|STARTED|Overall Study|Randomized Participants|420
476550|NCT00463437|1139252|P4|NOT COMPLETED|Overall Study||7
476551|NCT00463437|1139253|P3|NOT COMPLETED|Overall Study||6
476552|NCT00463437|1139254|P2|NOT COMPLETED|Overall Study||11
476553|NCT00463437|1139255|P1|NOT COMPLETED|Overall Study||4
476554|NCT00463437|1139252|P4|COMPLETED|Overall Study||350
476555|NCT00463437|1139253|P3|COMPLETED|Overall Study||352
476556|NCT00463437|1139254|P2|COMPLETED|Overall Study||352
476557|NCT00463437|1139255|P1|COMPLETED|Overall Study||355
476558|NCT00463437|1139252|P4|STARTED|Overall Study||357
476559|NCT00463437|1139253|P3|STARTED|Overall Study||358
476560|NCT00463437|1139254|P2|STARTED|Overall Study||363
476561|NCT00463437|1139255|P1|STARTED|Overall Study||359
476562|NCT00463385|1139321|P4|NOT COMPLETED|Overall Study||22
476563|NCT00463385|1139322|P3|NOT COMPLETED|Overall Study||22
476564|NCT00463385|1139323|P2|NOT COMPLETED|Overall Study||22
476565|NCT00463385|1139324|P1|NOT COMPLETED|Overall Study||22
476566|NCT00463385|1139321|P4|COMPLETED|Overall Study||0
476567|NCT00463385|1139322|P3|COMPLETED|Overall Study||0
476568|NCT00463385|1139323|P2|COMPLETED|Overall Study||0
476569|NCT00463385|1139324|P1|COMPLETED|Overall Study||0
476570|NCT00463385|1139321|P4|Treated|Overall Study||22
476571|NCT00463385|1139322|P3|Treated|Overall Study||19
476572|NCT00463385|1139323|P2|Treated|Overall Study||22
476573|NCT00463385|1139324|P1|Treated|Overall Study||22
476574|NCT00463385|1139321|P4|STARTED|Overall Study||22
476575|NCT00463385|1139322|P3|STARTED|Overall Study||22
476576|NCT00463385|1139323|P2|STARTED|Overall Study||22
476577|NCT00463385|1139324|P1|STARTED|Overall Study||22
476578|NCT00463346|1139376|P2|NOT COMPLETED|Overall Study||3
476579|NCT00463346|1139377|P1|NOT COMPLETED|Overall Study||3
476580|NCT00463346|1139376|P2|COMPLETED|Overall Study||8
476581|NCT00463346|1139377|P1|COMPLETED|Overall Study||9
476582|NCT00463346|1139376|P2|STARTED|Overall Study||11
476583|NCT00463346|1139377|P1|STARTED|Overall Study||12
476584|NCT00463229|1139387|P2|NOT COMPLETED|Overall Study||10
476585|NCT00463229|1139388|P1|NOT COMPLETED|Overall Study||9
476586|NCT00463229|1139387|P2|COMPLETED|Overall Study||39
476587|NCT00463229|1139388|P1|COMPLETED|Overall Study||43
476588|NCT00463229|1139387|P2|STARTED|Overall Study||49
476589|NCT00463229|1139388|P1|STARTED|Overall Study||52
476590|NCT00463047|1139394|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
476591|NCT00463047|1139395|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
476592|NCT00463047|1139394|P2|COMPLETED|Double-Blind Treatment Period 2||88
476593|NCT00463047|1139395|P1|COMPLETED|Double-Blind Treatment Period 2||92
476594|NCT00463047|1139394|P2|STARTED|Double-Blind Treatment Period 2||90
476595|NCT00463047|1139395|P1|STARTED|Double-Blind Treatment Period 2||93
476596|NCT00463047|1139394|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
476597|NCT00463047|1139395|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
476598|NCT00463047|1139394|P2|COMPLETED|Double-Blind Treatment Period 1||90
476599|NCT00463047|1139395|P1|COMPLETED|Double-Blind Treatment Period 1||93
476600|NCT00463047|1139394|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
476601|NCT00463047|1139395|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
476602|NCT00463047|1139394|P2|NOT COMPLETED|Titration Period 2||23
476603|NCT00463047|1139395|P1|NOT COMPLETED|Titration Period 2||30
476604|NCT00463047|1139394|P2|COMPLETED|Titration Period 2||98
476605|NCT00463047|1139395|P1|COMPLETED|Titration Period 2||93
476606|NCT00463047|1139394|P2|STARTED|Titration Period 2||121
476607|NCT00463047|1139395|P1|STARTED|Titration Period 2||123
476608|NCT00463047|1139394|P2|NOT COMPLETED|Titration Period 1||39
476609|NCT00463047|1139395|P1|NOT COMPLETED|Titration Period 1||37
476610|NCT00463047|1139394|P2|COMPLETED|Titration Period 1||121
476611|NCT00463047|1139395|P1|COMPLETED|Titration Period 1||123
476612|NCT00463047|1139394|P2|STARTED|Titration Period 1||160
476613|NCT00463047|1139395|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
476614|NCT00462982|1139480|P1|NOT COMPLETED|Overall Study||3
476615|NCT00462982|1139480|P1|COMPLETED|Overall Study||5
476616|NCT00462982|1139480|P1|STARTED|Overall Study||8
476617|NCT00462943|1139487|P3|NOT COMPLETED|Overall Study||23
476618|NCT00462943|1139488|P2|NOT COMPLETED|Overall Study||30
476619|NCT00462943|1139489|P1|NOT COMPLETED|Overall Study||45
476620|NCT00462943|1139487|P3|COMPLETED|Overall Study||0
476621|NCT00462943|1139488|P2|COMPLETED|Overall Study||1
476622|NCT00462943|1139489|P1|COMPLETED|Overall Study||1
476623|NCT00462943|1139487|P3|STARTED|Overall Study||23
476624|NCT00462943|1139488|P2|STARTED|Overall Study||31
476625|NCT00462943|1139489|P1|STARTED|Overall Study||46
476626|NCT00462917|1139560|P4|NOT COMPLETED|Overall Study||11
476627|NCT00462917|1139561|P3|NOT COMPLETED|Overall Study||12
476628|NCT00462917|1139562|P2|NOT COMPLETED|Overall Study||10
476629|NCT00462917|1139563|P1|NOT COMPLETED|Overall Study||10
476630|NCT00462917|1139560|P4|COMPLETED|Overall Study||66
476631|NCT00462917|1139561|P3|COMPLETED|Overall Study||54
476633|NCT00462917|1139563|P1|COMPLETED|Overall Study||62
476634|NCT00462917|1139560|P4|Completed 6 Month Follow-up|Overall Study||66
476635|NCT00462917|1139561|P3|Completed 6 Month Follow-up|Overall Study||55
476636|NCT00462917|1139562|P2|Completed 6 Month Follow-up|Overall Study||68
476637|NCT00462917|1139563|P1|Completed 6 Month Follow-up|Overall Study||63
476638|NCT00462917|1139560|P4|Completed 6 Week Follow-up|Overall Study||68
476639|NCT00462917|1139561|P3|Completed 6 Week Follow-up|Overall Study||55
476640|NCT00462917|1139562|P2|Completed 6 Week Follow-up|Overall Study||70
476641|NCT00462917|1139563|P1|Completed 6 Week Follow-up|Overall Study||63
476642|NCT00462917|1139560|P4|Received Risk Information|Overall Study||68
476643|NCT00462917|1139561|P3|Received Risk Information|Overall Study||55
476644|NCT00462917|1139562|P2|Received Risk Information|Overall Study||70
476645|NCT00462917|1139563|P1|Received Risk Information|Overall Study||64
476646|NCT00462917|1139560|P4|Met With Genetic Counselor|Overall Study||71
476647|NCT00462917|1139561|P3|Met With Genetic Counselor|Overall Study||56
476648|NCT00462917|1139562|P2|Met With Genetic Counselor|Overall Study||71
476649|NCT00462917|1139563|P1|Met With Genetic Counselor|Overall Study||66
476650|NCT00462917|1139560|P4|STARTED|Overall Study||77
476651|NCT00462917|1139561|P3|STARTED|Overall Study||66
476652|NCT00462917|1139562|P2|STARTED|Overall Study||75
476653|NCT00462917|1139563|P1|STARTED|Overall Study||72
476654|NCT00462865|1139581|P1|NOT COMPLETED|Overall Study||1
476655|NCT00462865|1139581|P1|COMPLETED|Overall Study||17
476656|NCT00462865|1139581|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
476657|NCT00462839|1139587|P2|NOT COMPLETED|Viewed Second||0
476658|NCT00462839|1139588|P1|NOT COMPLETED|Viewed Second||0
476659|NCT00462839|1139587|P2|COMPLETED|Viewed Second||53
476660|NCT00462839|1139588|P1|COMPLETED|Viewed Second||53
476661|NCT00462839|1139587|P2|STARTED|Viewed Second||53
476662|NCT00462839|1139588|P1|STARTED|Viewed Second||53
476663|NCT00462839|1139587|P2|NOT COMPLETED|Viewed First||0
476664|NCT00462839|1139588|P1|NOT COMPLETED|Viewed First||0
476665|NCT00462839|1139587|P2|COMPLETED|Viewed First||53
476666|NCT00462839|1139588|P1|COMPLETED|Viewed First||53
476667|NCT00462839|1139587|P2|STARTED|Viewed First||53
476668|NCT00462839|1139588|P1|STARTED|Viewed First||53
476669|NCT00462826|1139600|P1|NOT COMPLETED|Overall Study||5
476670|NCT00462826|1139600|P1|COMPLETED|Overall Study||44
476671|NCT00462826|1139600|P1|STARTED|Overall Study||49
476672|NCT00462748|1139607|P3|NOT COMPLETED|Overall Study||11
476673|NCT00462748|1139608|P2|NOT COMPLETED|Overall Study||11
476674|NCT00462748|1139609|P1|NOT COMPLETED|Overall Study||12
476675|NCT00462748|1139607|P3|COMPLETED|Overall Study||251
476676|NCT00462748|1139608|P2|COMPLETED|Overall Study||252
476677|NCT00462748|1139609|P1|COMPLETED|Overall Study||249
476678|NCT00462748|1139607|P3|STARTED|Overall Study||262
476679|NCT00462748|1139608|P2|STARTED|Overall Study||263
476680|NCT00462748|1139609|P1|STARTED|Overall Study||261
476681|NCT00462722|1139620|P3|NOT COMPLETED|Overall Study||12
476682|NCT00462722|1139621|P2|NOT COMPLETED|Overall Study||4
476683|NCT00462722|1139622|P1|NOT COMPLETED|Overall Study||13
476684|NCT00462722|1139620|P3|COMPLETED|Overall Study||42
476685|NCT00462722|1139621|P2|COMPLETED|Overall Study||51
476686|NCT00462722|1139622|P1|COMPLETED|Overall Study||37
476687|NCT00462722|1139620|P3|STARTED|Overall Study||54
476688|NCT00462722|1139621|P2|STARTED|Overall Study||55
476689|NCT00462722|1139622|P1|STARTED|Overall Study||50
476690|NCT00462709|1139654|P1|NOT COMPLETED|Overall Study||67
476691|NCT00462709|1139654|P1|COMPLETED|Overall Study||79
476692|NCT00462709|1139654|P1|STARTED|Overall Study||146
476693|NCT00462670|1139663|P2|NOT COMPLETED|Overall Study||7
476694|NCT00462670|1139664|P1|NOT COMPLETED|Overall Study||5
476695|NCT00462670|1139663|P2|COMPLETED|Overall Study||46
476696|NCT00462670|1139664|P1|COMPLETED|Overall Study||52
476697|NCT00462670|1139663|P2|STARTED|Overall Study||53
476698|NCT00462670|1139664|P1|STARTED|Overall Study||57
476699|NCT00462644|1139674|P2|NOT COMPLETED|Overall Study||0
476700|NCT00462644|1139675|P1|NOT COMPLETED|Overall Study||0
476701|NCT00462644|1139674|P2|COMPLETED|Overall Study||12
476702|NCT00462644|1139675|P1|COMPLETED|Overall Study||18
476703|NCT00462644|1139674|P2|STARTED|Overall Study||12
476704|NCT00462644|1139675|P1|STARTED|Overall Study||18
476705|NCT00462605|1139693|P1|NOT COMPLETED|Overall Study||14
476706|NCT00462605|1139693|P1|COMPLETED|Overall Study||10
476707|NCT00462605|1139693|P1|STARTED|Overall Study||24
476708|NCT00462501|1139697|P1|NOT COMPLETED|Overall Study||5
476709|NCT00462501|1139697|P1|COMPLETED|Overall Study||30
476710|NCT00462501|1139697|P1|STARTED|Overall Study||35
476711|NCT00462462|1139703|P2|NOT COMPLETED|Overall Study||1
476712|NCT00462462|1139704|P1|NOT COMPLETED|Overall Study||0
476713|NCT00462462|1139703|P2|COMPLETED|Overall Study||13
476714|NCT00462462|1139704|P1|COMPLETED|Overall Study||17
476715|NCT00462462|1139703|P2|STARTED|Overall Study||14
476716|NCT00462462|1139704|P1|STARTED|Overall Study||17
476717|NCT00462449|1139714|P2|NOT COMPLETED|Overall Study||0
476718|NCT00462449|1139715|P1|NOT COMPLETED|Overall Study||0
476719|NCT00462449|1139714|P2|COMPLETED|Overall Study||10
476720|NCT00462449|1139715|P1|COMPLETED|Overall Study||13
476721|NCT00462449|1139714|P2|STARTED|Overall Study||10
476722|NCT00462449|1139715|P1|STARTED|Overall Study||13
476723|NCT00462423|1139725|P1|NOT COMPLETED|Overall Study||0
476724|NCT00462423|1139725|P1|COMPLETED|Overall Study||50
476725|NCT00462423|1139725|P1|STARTED|Overall Study||50
476726|NCT00462384|1139732|P1|NOT COMPLETED|Overall Study||9
476727|NCT00462384|1139732|P1|COMPLETED|Overall Study||30
476728|NCT00462384|1139732|P1|STARTED|Overall Study||39
476729|NCT00462345|1139740|P1|NOT COMPLETED|Overall Study||3
476730|NCT00462345|1139740|P1|COMPLETED|Overall Study||37
476731|NCT00462345|1139740|P1|Completed First Course|Overall Study||38
476732|NCT00462345|1139740|P1|STARTED|Overall Study||40
476733|NCT00462332|1139764|P2|NOT COMPLETED|Overall Study||0
476734|NCT00462332|1139765|P1|NOT COMPLETED|Overall Study||0
476735|NCT00462332|1139764|P2|COMPLETED|Overall Study||41
476736|NCT00462332|1139765|P1|COMPLETED|Overall Study||45
476737|NCT00462332|1139764|P2|STARTED|Overall Study||41
476738|NCT00462332|1139765|P1|STARTED|Overall Study||45
476739|NCT00462306|1139775|P2|NOT COMPLETED|Overall Study||13
476740|NCT00462306|1139776|P1|NOT COMPLETED|Overall Study||0
476741|NCT00462306|1139775|P2|COMPLETED|Overall Study||490
476742|NCT00462306|1139776|P1|COMPLETED|Overall Study||4074
476743|NCT00462306|1139775|P2|STARTED|Overall Study||503
476744|NCT00462306|1139776|P1|STARTED|Overall Study||4074
476745|NCT00462280|1139788|P4|NOT COMPLETED|Overall Study||3
476746|NCT00462280|1139789|P3|NOT COMPLETED|Overall Study||0
476747|NCT00462280|1139790|P2|NOT COMPLETED|Overall Study||7
476748|NCT00462280|1139791|P1|NOT COMPLETED|Overall Study||10
476749|NCT00462280|1139788|P4|COMPLETED|Overall Study||4
476750|NCT00462280|1139789|P3|COMPLETED|Overall Study||7
476751|NCT00462280|1139790|P2|COMPLETED|Overall Study||25
476752|NCT00462280|1139791|P1|COMPLETED|Overall Study||24
476753|NCT00462280|1139788|P4|STARTED|Overall Study||7
476754|NCT00462280|1139789|P3|STARTED|Overall Study||7
476755|NCT00462280|1139790|P2|STARTED|Overall Study||32
476756|NCT00462280|1139791|P1|STARTED|Overall Study||34
476757|NCT00462228|1139851|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
476758|NCT00462228|1139851|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
476759|NCT00462228|1139851|P1|STARTED|No Treatment (Washout) 4 Weeks||11
476760|NCT00462228|1139851|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
476761|NCT00462228|1139851|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
476762|NCT00462228|1139851|P1|STARTED|Placebo or Memantine 12 Weeks||11
476763|NCT00462228|1139851|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
476764|NCT00462228|1139851|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
476765|NCT00462228|1139851|P1|STARTED|No Treatment (Washout) 4 Weeks||11
476766|NCT00462228|1139851|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
476767|NCT00462228|1139851|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
476768|NCT00462228|1139851|P1|STARTED|Memantine or Placebo 12 Weeks||11
476769|NCT00462072|1139875|P3|NOT COMPLETED|Week 10||0
476770|NCT00462072|1139876|P2|NOT COMPLETED|Week 10||0
476771|NCT00462072|1139877|P1|NOT COMPLETED|Week 10||0
476772|NCT00462072|1139875|P3|COMPLETED|Week 10||9
476773|NCT00462072|1139876|P2|COMPLETED|Week 10||12
476774|NCT00462072|1139877|P1|COMPLETED|Week 10||10
476775|NCT00462072|1139875|P3|STARTED|Week 10||9
476776|NCT00462072|1139876|P2|STARTED|Week 10||12
476777|NCT00462072|1139877|P1|STARTED|Week 10||10
476778|NCT00462072|1139875|P3|NOT COMPLETED|Baseline (Week 0)||0
476779|NCT00462072|1139876|P2|NOT COMPLETED|Baseline (Week 0)||0
476780|NCT00462072|1139877|P1|NOT COMPLETED|Baseline (Week 0)||0
476781|NCT00462072|1139875|P3|COMPLETED|Baseline (Week 0)||9
476782|NCT00462072|1139876|P2|COMPLETED|Baseline (Week 0)||12
476783|NCT00462072|1139877|P1|COMPLETED|Baseline (Week 0)||10
476784|NCT00462072|1139875|P3|STARTED|Baseline (Week 0)||9
476785|NCT00462072|1139876|P2|STARTED|Baseline (Week 0)||12
476786|NCT00462072|1139877|P1|STARTED|Baseline (Week 0)||10
476787|NCT00462020|1139893|P2|NOT COMPLETED|Overall Study||0
476788|NCT00462020|1139894|P1|NOT COMPLETED|Overall Study||0
476789|NCT00462020|1139893|P2|COMPLETED|Overall Study||50
476790|NCT00462020|1139894|P1|COMPLETED|Overall Study||52
476791|NCT00462020|1139893|P2|STARTED|Overall Study||50
476792|NCT00462020|1139894|P1|STARTED|Overall Study||52
476793|NCT00461981|1139902|P2|NOT COMPLETED|Overall Study||9
476794|NCT00461981|1139903|P1|NOT COMPLETED|Overall Study||11
476795|NCT00461981|1139902|P2|COMPLETED|Overall Study||42
476796|NCT00461981|1139903|P1|COMPLETED|Overall Study||39
476797|NCT00461981|1139902|P2|STARTED|Overall Study||51
476798|NCT00461981|1139903|P1|STARTED|Overall Study||50
476799|NCT00461851|1140013|P1|NOT COMPLETED|Overall Study||2
476800|NCT00461851|1140013|P1|COMPLETED|Overall Study||17
476801|NCT00461851|1140013|P1|STARTED|Overall Study||19
476802|NCT00461786|1140017|P1|NOT COMPLETED|Overall Study||3
476803|NCT00461786|1140017|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
476804|NCT00461786|1140017|P1|STARTED|Overall Study||51
476805|NCT00461734|1140027|P2|NOT COMPLETED|Overall Study||60
476806|NCT00461734|1140028|P1|NOT COMPLETED|Overall Study||58
476807|NCT00461734|1140027|P2|COMPLETED|Overall Study||60
476808|NCT00461734|1140028|P1|COMPLETED|Overall Study||62
476809|NCT00461734|1140027|P2|STARTED|Overall Study||120
476810|NCT00461734|1140028|P1|STARTED|Overall Study||120
476811|NCT00461708|1140062|P2|NOT COMPLETED|Overall Study||38
476812|NCT00461708|1140063|P1|NOT COMPLETED|Overall Study||115
476813|NCT00461708|1140062|P2|COMPLETED|Overall Study||0
476814|NCT00461708|1140063|P1|COMPLETED|Overall Study||0
476815|NCT00461708|1140062|P2|STARTED|Overall Study||38
476816|NCT00461708|1140063|P1|STARTED|Overall Study||115
476817|NCT00461682|1140089|P1|NOT COMPLETED|Overall Study||1
476818|NCT00461682|1140089|P1|COMPLETED|Overall Study||0
476819|NCT00461682|1140089|P1|STARTED|Overall Study||1
476820|NCT00461630|1140117|P2|NOT COMPLETED|Overall Study||827
476821|NCT00461630|1140118|P1|NOT COMPLETED|Overall Study||906
476822|NCT00461630|1140117|P2|COMPLETED|Overall Study||12008
476823|NCT00461630|1140118|P1|COMPLETED|Overall Study||11932
476824|NCT00461630|1140117|P2|STARTED|Overall Study||12835
476825|NCT00461630|1140118|P1|STARTED|Overall Study||12838
476826|NCT00461513|1140134|P2|NOT COMPLETED|Overall Study||27
476827|NCT00461513|1140135|P1|NOT COMPLETED|Overall Study||28
476828|NCT00461513|1140134|P2|COMPLETED|Overall Study||172
476829|NCT00461513|1140135|P1|COMPLETED|Overall Study||165
476830|NCT00461513|1140134|P2|STARTED|Overall Study||199
476831|NCT00461513|1140135|P1|STARTED|Overall Study||193
476832|NCT00461500|1140143|P2|NOT COMPLETED|Overall Study||6
476833|NCT00461500|1140144|P1|NOT COMPLETED|Overall Study||7
476834|NCT00461500|1140143|P2|COMPLETED|Overall Study||38
476835|NCT00461500|1140144|P1|COMPLETED|Overall Study||30
476836|NCT00461500|1140143|P2|STARTED|Overall Study||44
476837|NCT00461500|1140144|P1|STARTED|Overall Study||37
476838|NCT00461331|1140174|P2|NOT COMPLETED|Intervention 2||0
476839|NCT00461331|1140175|P1|NOT COMPLETED|Intervention 2||0
476840|NCT00461331|1140174|P2|COMPLETED|Intervention 2||10
476841|NCT00461331|1140175|P1|COMPLETED|Intervention 2||10
476842|NCT00461331|1140174|P2|STARTED|Intervention 2||10
476843|NCT00461331|1140175|P1|STARTED|Intervention 2||10
476844|NCT00461331|1140174|P2|NOT COMPLETED|Washout||0
476845|NCT00461331|1140175|P1|NOT COMPLETED|Washout||0
476846|NCT00461331|1140174|P2|COMPLETED|Washout||10
476847|NCT00461331|1140175|P1|COMPLETED|Washout||10
476848|NCT00461331|1140174|P2|STARTED|Washout||10
476849|NCT00461331|1140175|P1|STARTED|Washout||10
476850|NCT00461331|1140174|P2|NOT COMPLETED|Intervention 1||0
476851|NCT00461331|1140175|P1|NOT COMPLETED|Intervention 1||0
476852|NCT00461331|1140174|P2|COMPLETED|Intervention 1||10
476853|NCT00461331|1140175|P1|COMPLETED|Intervention 1||10
476854|NCT00461331|1140174|P2|STARTED|Intervention 1||10
476855|NCT00461331|1140175|P1|STARTED|Intervention 1||10
476856|NCT00461305|1140187|P2|NOT COMPLETED|Continued Treatment||0
476857|NCT00461305|1140188|P1|NOT COMPLETED|Continued Treatment||95
476858|NCT00461305|1140187|P2|COMPLETED|Continued Treatment||0
476859|NCT00461305|1140188|P1|COMPLETED|Continued Treatment||254
476860|NCT00461305|1140187|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
476861|NCT00461305|1140188|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
476862|NCT00461305|1140187|P2|NOT COMPLETED|Treatment||9
476863|NCT00461305|1140188|P1|NOT COMPLETED|Treatment||101
476864|NCT00461305|1140187|P2|COMPLETED|Treatment||56
476865|NCT00461305|1140188|P1|COMPLETED|Treatment||254
476866|NCT00461305|1140187|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
476867|NCT00461305|1140188|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
476868|NCT00461305|1140187|P2|Subjects Dispensed Drugs|Treatment||65
476869|NCT00461305|1140188|P1|Subjects Dispensed Drugs|Treatment||350
476870|NCT00461305|1140187|P2|STARTED|Treatment|Enrolled|65
476871|NCT00461305|1140188|P1|STARTED|Treatment|Enrolled|355
476872|NCT00461292|1140251|P3|NOT COMPLETED|Treatment Cycle 2||0
476873|NCT00461292|1140252|P2|NOT COMPLETED|Treatment Cycle 2||2
476874|NCT00461292|1140253|P1|NOT COMPLETED|Treatment Cycle 2||5
476875|NCT00461292|1140251|P3|COMPLETED|Treatment Cycle 2||0
476876|NCT00461292|1140252|P2|COMPLETED|Treatment Cycle 2||72
476877|NCT00461292|1140253|P1|COMPLETED|Treatment Cycle 2||58
476878|NCT00461292|1140251|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
476879|NCT00461292|1140252|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
476880|NCT00461292|1140253|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
476881|NCT00461292|1140251|P3|NOT COMPLETED|Treatment Cycle 1||11
476882|NCT00461292|1140252|P2|NOT COMPLETED|Treatment Cycle 1||12
476883|NCT00461292|1140253|P1|NOT COMPLETED|Treatment Cycle 1||15
476884|NCT00461292|1140251|P3|COMPLETED|Treatment Cycle 1||81
476885|NCT00461292|1140252|P2|COMPLETED|Treatment Cycle 1||80
476886|NCT00461292|1140253|P1|COMPLETED|Treatment Cycle 1||76
476887|NCT00461292|1140251|P3|STARTED|Treatment Cycle 1||92
476888|NCT00461292|1140252|P2|STARTED|Treatment Cycle 1||92
476889|NCT00461292|1140253|P1|STARTED|Treatment Cycle 1||91
476890|NCT00461253|1140272|P2|NOT COMPLETED|Overall Study||19798
476891|NCT00461253|1140273|P1|NOT COMPLETED|Overall Study||4980
476892|NCT00461253|1140272|P2|COMPLETED|Overall Study|Analyzed controls|20452
476893|NCT00461253|1140273|P1|COMPLETED|Overall Study|Analyzed cases|5113
476894|NCT00461253|1140272|P2|STARTED|Overall Study|Identified controls|40250
476895|NCT00461253|1140273|P1|STARTED|Overall Study|Identified cases|10093
476896|NCT00461175|1140281|P2|NOT COMPLETED|Overall Study||365
476897|NCT00461175|1140282|P1|NOT COMPLETED|Overall Study||522
476898|NCT00461175|1140281|P2|COMPLETED|Overall Study||18370
476899|NCT00461175|1140282|P1|COMPLETED|Overall Study||43078
476900|NCT00461175|1140281|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
476901|NCT00461175|1140282|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
476902|NCT00461123|1140292|P2|NOT COMPLETED|Overall Study||6
476903|NCT00461123|1140293|P1|NOT COMPLETED|Overall Study||6
476904|NCT00461123|1140292|P2|COMPLETED|Overall Study||19
476905|NCT00461123|1140293|P1|COMPLETED|Overall Study||19
476906|NCT00461123|1140292|P2|STARTED|Overall Study||25
476907|NCT00461123|1140293|P1|STARTED|Overall Study||25
476908|NCT00461097|1140309|P2|NOT COMPLETED|Overall Study||0
476909|NCT00461097|1140310|P1|NOT COMPLETED|Overall Study||0
476910|NCT00461097|1140309|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
476911|NCT00461097|1140310|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
476912|NCT00461097|1140309|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
476913|NCT00461097|1140310|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
476914|NCT00461097|1140309|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
476915|NCT00461097|1140310|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
476916|NCT00461097|1140309|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
476917|NCT00461097|1140310|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
476918|NCT00461097|1140309|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
476919|NCT00461097|1140310|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
476920|NCT00461097|1140309|P2|STARTED|Overall Study||15
476921|NCT00461097|1140310|P1|STARTED|Overall Study||40
476922|NCT00461032|1140328|P2|NOT COMPLETED|Overall Study||44
476923|NCT00461032|1140329|P1|NOT COMPLETED|Overall Study||37
476924|NCT00461032|1140328|P2|COMPLETED|Overall Study||536
476925|NCT00461032|1140329|P1|COMPLETED|Overall Study||545
476926|NCT00461032|1140328|P2|STARTED|Overall Study||580
476927|NCT00461032|1140329|P1|STARTED|Overall Study||582
476928|NCT00460993|1140343|P2|NOT COMPLETED|Phase 2 (6 Days)||0
476929|NCT00460993|1140344|P1|NOT COMPLETED|Phase 2 (6 Days)||0
476930|NCT00460993|1140343|P2|COMPLETED|Phase 2 (6 Days)||17
476931|NCT00460993|1140344|P1|COMPLETED|Phase 2 (6 Days)||14
476932|NCT00460993|1140343|P2|STARTED|Phase 2 (6 Days)||17
476933|NCT00460993|1140344|P1|STARTED|Phase 2 (6 Days)||14
476934|NCT00460993|1140343|P2|NOT COMPLETED|Phase 1 (6 Days)||0
476935|NCT00460993|1140344|P1|NOT COMPLETED|Phase 1 (6 Days)||0
476936|NCT00460993|1140343|P2|COMPLETED|Phase 1 (6 Days)||17
476937|NCT00460993|1140344|P1|COMPLETED|Phase 1 (6 Days)||14
476938|NCT00460993|1140343|P2|STARTED|Phase 1 (6 Days)||17
476939|NCT00460993|1140344|P1|STARTED|Phase 1 (6 Days)||14
476940|NCT00460811|1140355|P5|NOT COMPLETED|Overall Study||20
476941|NCT00460811|1140356|P4|NOT COMPLETED|Overall Study||18
476942|NCT00460811|1140357|P3|NOT COMPLETED|Overall Study||14
476943|NCT00460811|1140358|P2|NOT COMPLETED|Overall Study||15
476944|NCT00460811|1140359|P1|NOT COMPLETED|Overall Study||16
476945|NCT00460811|1140355|P5|COMPLETED|Overall Study||65
476946|NCT00460811|1140356|P4|COMPLETED|Overall Study||71
476947|NCT00460811|1140357|P3|COMPLETED|Overall Study||71
476948|NCT00460811|1140358|P2|COMPLETED|Overall Study||67
476949|NCT00460811|1140359|P1|COMPLETED|Overall Study||63
476950|NCT00460811|1140355|P5|STARTED|Overall Study||85
476951|NCT00460811|1140356|P4|STARTED|Overall Study||89
476952|NCT00460811|1140357|P3|STARTED|Overall Study||85
476953|NCT00460811|1140358|P2|STARTED|Overall Study||82
476954|NCT00460811|1140359|P1|STARTED|Overall Study||79
476955|NCT00460798|1140401|P1|NOT COMPLETED|Overall Study||340
476956|NCT00460798|1140401|P1|COMPLETED|Overall Study||108
476957|NCT00460798|1140401|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
476958|NCT00460798|1140401|P1|STARTED|Overall Study||448
476959|NCT00460746|1140409|P1|NOT COMPLETED|Overall Study||2
476960|NCT00460746|1140409|P1|COMPLETED|Overall Study||8
476961|NCT00460746|1140409|P1|STARTED|Overall Study||10
476962|NCT00460655|1140424|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
476963|NCT00460655|1140425|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
476964|NCT00460655|1140426|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
476965|NCT00460655|1140427|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
476966|NCT00460655|1140424|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
476967|NCT00460655|1140425|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
476968|NCT00460655|1140426|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
476969|NCT00460655|1140427|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
476970|NCT00460655|1140424|P4|STARTED|Open-Label Phase (36 Weeks)||61
476971|NCT00460655|1140425|P3|STARTED|Open-Label Phase (36 Weeks)||52
476972|NCT00460655|1140426|P2|STARTED|Open-Label Phase (36 Weeks)||0
476973|NCT00460655|1140427|P1|STARTED|Open-Label Phase (36 Weeks)||0
476974|NCT00460655|1140424|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
476975|NCT00460655|1140425|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
476976|NCT00460655|1140426|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
476977|NCT00460655|1140427|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
476978|NCT00460655|1140424|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
476979|NCT00460655|1140425|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
476980|NCT00460655|1140426|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
476981|NCT00460655|1140427|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
476982|NCT00460655|1140424|P4|STARTED|Double-Blind Phase (12 Weeks)||0
476983|NCT00460655|1140425|P3|STARTED|Double-Blind Phase (12 Weeks)||0
476984|NCT00460655|1140426|P2|STARTED|Double-Blind Phase (12 Weeks)||62
476985|NCT00460655|1140427|P1|STARTED|Double-Blind Phase (12 Weeks)||58
476986|NCT00460603|1140471|P12|NOT COMPLETED|Phase 2||41
476987|NCT00460603|1140472|P11|NOT COMPLETED|Phase 2||43
476988|NCT00460603|1140473|P10|NOT COMPLETED|Phase 2||42
476989|NCT00460603|1140474|P9|NOT COMPLETED|Phase 2||0
476990|NCT00460603|1140475|P8|NOT COMPLETED|Phase 2||0
476991|NCT00460603|1140476|P7|NOT COMPLETED|Phase 2||0
476992|NCT00460603|1140477|P6|NOT COMPLETED|Phase 2||0
476993|NCT00460603|1140478|P5|NOT COMPLETED|Phase 2||0
476994|NCT00460603|1140479|P4|NOT COMPLETED|Phase 2||0
476995|NCT00460603|1140480|P3|NOT COMPLETED|Phase 2||0
476996|NCT00460603|1140481|P2|NOT COMPLETED|Phase 2||0
476997|NCT00460603|1140482|P1|NOT COMPLETED|Phase 2||0
476998|NCT00460603|1140471|P12|COMPLETED|Phase 2||0
476999|NCT00460603|1140472|P11|COMPLETED|Phase 2||0
477000|NCT00460603|1140473|P10|COMPLETED|Phase 2||0
477001|NCT00460603|1140474|P9|COMPLETED|Phase 2||0
477002|NCT00460603|1140475|P8|COMPLETED|Phase 2||0
477003|NCT00460603|1140476|P7|COMPLETED|Phase 2||0
477004|NCT00460603|1140477|P6|COMPLETED|Phase 2||0
477005|NCT00460603|1140478|P5|COMPLETED|Phase 2||0
477006|NCT00460603|1140479|P4|COMPLETED|Phase 2||0
477007|NCT00460603|1140480|P3|COMPLETED|Phase 2||0
477008|NCT00460603|1140481|P2|COMPLETED|Phase 2||0
477009|NCT00460603|1140482|P1|COMPLETED|Phase 2||0
477010|NCT00460603|1140471|P12|Treated|Phase 2||41
477011|NCT00460603|1140472|P11|Treated|Phase 2||43
477012|NCT00460603|1140473|P10|Treated|Phase 2||39
477013|NCT00460603|1140474|P9|Treated|Phase 2||0
477014|NCT00460603|1140475|P8|Treated|Phase 2||0
477015|NCT00460603|1140476|P7|Treated|Phase 2||0
477016|NCT00460603|1140477|P6|Treated|Phase 2||0
477017|NCT00460603|1140478|P5|Treated|Phase 2||0
477018|NCT00460603|1140479|P4|Treated|Phase 2||0
477019|NCT00460603|1140480|P3|Treated|Phase 2||0
477020|NCT00460603|1140481|P2|Treated|Phase 2||0
477021|NCT00460603|1140482|P1|Treated|Phase 2||0
477022|NCT00460603|1140471|P12|STARTED|Phase 2||41
477023|NCT00460603|1140472|P11|STARTED|Phase 2||43
477024|NCT00460603|1140473|P10|STARTED|Phase 2||42
477025|NCT00460603|1140474|P9|STARTED|Phase 2||0
477026|NCT00460603|1140475|P8|STARTED|Phase 2||0
477027|NCT00460603|1140476|P7|STARTED|Phase 2||0
477028|NCT00460603|1140477|P6|STARTED|Phase 2||0
477029|NCT00460603|1140478|P5|STARTED|Phase 2||0
477030|NCT00460603|1140479|P4|STARTED|Phase 2||0
477031|NCT00460603|1140480|P3|STARTED|Phase 2||0
477032|NCT00460603|1140481|P2|STARTED|Phase 2||0
477033|NCT00460603|1140482|P1|STARTED|Phase 2||0
477034|NCT00460603|1140471|P12|NOT COMPLETED|Phase 1||0
477035|NCT00460603|1140472|P11|NOT COMPLETED|Phase 1||0
477036|NCT00460603|1140473|P10|NOT COMPLETED|Phase 1||0
477037|NCT00460603|1140474|P9|NOT COMPLETED|Phase 1||18
477038|NCT00460603|1140475|P8|NOT COMPLETED|Phase 1||3
477039|NCT00460603|1140476|P7|NOT COMPLETED|Phase 1||6
477040|NCT00460603|1140477|P6|NOT COMPLETED|Phase 1||4
477041|NCT00460603|1140478|P5|NOT COMPLETED|Phase 1||6
477042|NCT00460603|1140479|P4|NOT COMPLETED|Phase 1||8
477043|NCT00460603|1140480|P3|NOT COMPLETED|Phase 1||4
477044|NCT00460603|1140481|P2|NOT COMPLETED|Phase 1||6
477045|NCT00460603|1140482|P1|NOT COMPLETED|Phase 1||6
477046|NCT00460603|1140471|P12|COMPLETED|Phase 1||0
477047|NCT00460603|1140472|P11|COMPLETED|Phase 1||0
477048|NCT00460603|1140473|P10|COMPLETED|Phase 1||0
477049|NCT00460603|1140474|P9|COMPLETED|Phase 1||0
477050|NCT00460603|1140475|P8|COMPLETED|Phase 1||0
477051|NCT00460603|1140476|P7|COMPLETED|Phase 1||0
477052|NCT00460603|1140477|P6|COMPLETED|Phase 1||0
477053|NCT00460603|1140478|P5|COMPLETED|Phase 1||0
477054|NCT00460603|1140479|P4|COMPLETED|Phase 1||0
477055|NCT00460603|1140480|P3|COMPLETED|Phase 1||0
477056|NCT00460603|1140481|P2|COMPLETED|Phase 1||0
477057|NCT00460603|1140482|P1|COMPLETED|Phase 1||0
477058|NCT00460603|1140471|P12|STARTED|Phase 1||0
477059|NCT00460603|1140472|P11|STARTED|Phase 1||0
477060|NCT00460603|1140473|P10|STARTED|Phase 1||0
477061|NCT00460603|1140474|P9|STARTED|Phase 1||18
477062|NCT00460603|1140475|P8|STARTED|Phase 1||3
477063|NCT00460603|1140476|P7|STARTED|Phase 1||6
477064|NCT00460603|1140477|P6|STARTED|Phase 1||4
477065|NCT00460603|1140478|P5|STARTED|Phase 1||6
477066|NCT00460603|1140479|P4|STARTED|Phase 1||8
477067|NCT00460603|1140480|P3|STARTED|Phase 1||4
477068|NCT00460603|1140481|P2|STARTED|Phase 1||6
477069|NCT00460603|1140482|P1|STARTED|Phase 1||6
477070|NCT00460577|1140576|P2|NOT COMPLETED|Overall Study||6
477071|NCT00460577|1140577|P1|NOT COMPLETED|Overall Study||2
477072|NCT00460577|1140576|P2|COMPLETED|Overall Study||24
477073|NCT00460577|1140577|P1|COMPLETED|Overall Study||28
477074|NCT00460577|1140576|P2|STARTED|Overall Study||30
477075|NCT00460577|1140577|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
477076|NCT00460564|1140595|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
477077|NCT00460564|1140596|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
477078|NCT00460564|1140597|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
477079|NCT00460564|1140598|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
477080|NCT00460564|1140599|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
477081|NCT00460564|1140600|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
477082|NCT00460564|1140601|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
477083|NCT00460564|1140602|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
477084|NCT00460564|1140595|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
477085|NCT00460564|1140596|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
477086|NCT00460564|1140597|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
477087|NCT00460564|1140598|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
477088|NCT00460564|1140599|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
477089|NCT00460564|1140600|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
477090|NCT00460564|1140601|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
477091|NCT00460564|1140602|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
477092|NCT00460564|1140595|P8|STARTED|Open-Label Phase (36 Weeks)||11
477093|NCT00460564|1140596|P7|STARTED|Open-Label Phase (36 Weeks)||21
477094|NCT00460564|1140597|P6|STARTED|Open-Label Phase (36 Weeks)||25
477095|NCT00460564|1140598|P5|STARTED|Open-Label Phase (36 Weeks)||47
477096|NCT00460564|1140599|P4|STARTED|Open-Label Phase (36 Weeks)||0
477097|NCT00460564|1140600|P3|STARTED|Open-Label Phase (36 Weeks)||0
477098|NCT00460564|1140601|P2|STARTED|Open-Label Phase (36 Weeks)||0
477099|NCT00460564|1140602|P1|STARTED|Open-Label Phase (36 Weeks)||0
477100|NCT00460564|1140595|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
477101|NCT00460564|1140596|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
477102|NCT00460564|1140597|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
477103|NCT00460564|1140598|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
477104|NCT00460564|1140599|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
477105|NCT00460564|1140600|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
477106|NCT00460564|1140601|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
477107|NCT00460564|1140602|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
477108|NCT00460564|1140595|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
477109|NCT00460564|1140596|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
477110|NCT00460564|1140597|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
477111|NCT00460564|1140598|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
477112|NCT00460564|1140599|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
477113|NCT00460564|1140600|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
477114|NCT00460564|1140601|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
477115|NCT00460564|1140602|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
477116|NCT00460564|1140595|P8|STARTED|Double-Blind Phase (12 Weeks)||0
477117|NCT00460564|1140596|P7|STARTED|Double-Blind Phase (12 Weeks)||0
477118|NCT00460564|1140597|P6|STARTED|Double-Blind Phase (12 Weeks)||0
477119|NCT00460564|1140598|P5|STARTED|Double-Blind Phase (12 Weeks)||0
477120|NCT00460564|1140599|P4|STARTED|Double-Blind Phase (12 Weeks)||11
477121|NCT00460564|1140600|P3|STARTED|Double-Blind Phase (12 Weeks)||21
477122|NCT00460564|1140601|P2|STARTED|Double-Blind Phase (12 Weeks)||26
477123|NCT00460564|1140602|P1|STARTED|Double-Blind Phase (12 Weeks)||51
477124|NCT00460551|1140696|P1|NOT COMPLETED|Overall Study||0
477125|NCT00460551|1140696|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
477126|NCT00460551|1140696|P1|STARTED|Overall Study||13
477127|NCT00460525|1140703|P2|NOT COMPLETED|Overall Study||5
477128|NCT00460525|1140704|P1|NOT COMPLETED|Overall Study||11
477129|NCT00460525|1140703|P2|COMPLETED|Overall Study||194
477130|NCT00460525|1140704|P1|COMPLETED|Overall Study||190
477131|NCT00460525|1140703|P2|STARTED|Overall Study||199
477132|NCT00460525|1140704|P1|STARTED|Overall Study||201
477133|NCT00460421|1140747|P3|NOT COMPLETED|Overall Study||0
477134|NCT00460421|1140748|P2|NOT COMPLETED|Overall Study||0
477135|NCT00460421|1140749|P1|NOT COMPLETED|Overall Study||0
477136|NCT00460421|1140747|P3|COMPLETED|Overall Study||9
477137|NCT00460421|1140748|P2|COMPLETED|Overall Study||9
477138|NCT00460421|1140749|P1|COMPLETED|Overall Study||9
477139|NCT00460421|1140747|P3|STARTED|Overall Study||9
477140|NCT00460421|1140748|P2|STARTED|Overall Study||9
477141|NCT00460421|1140749|P1|STARTED|Overall Study||9
477142|NCT00460408|1140797|P4|NOT COMPLETED|Overall Study||0
477143|NCT00460408|1140798|P3|NOT COMPLETED|Overall Study||6
477144|NCT00460408|1140799|P2|NOT COMPLETED|Overall Study||3
477145|NCT00460408|1140800|P1|NOT COMPLETED|Overall Study||67
477146|NCT00460408|1140797|P4|COMPLETED|Overall Study||7
477147|NCT00460408|1140798|P3|COMPLETED|Overall Study||69
477148|NCT00460408|1140799|P2|COMPLETED|Overall Study||13
477149|NCT00460408|1140800|P1|COMPLETED|Overall Study||336
477150|NCT00460408|1140797|P4|STARTED|Overall Study||7
477151|NCT00460408|1140798|P3|STARTED|Overall Study||75
477152|NCT00460408|1140799|P2|STARTED|Overall Study||16
477153|NCT00460408|1140800|P1|STARTED|Overall Study||403
477154|NCT00460265|1140837|P2|NOT COMPLETED|Overall Study||89
477155|NCT00460265|1140838|P1|NOT COMPLETED|Overall Study||85
477156|NCT00460265|1140837|P2|COMPLETED|Overall Study|Completed study=death|241
477157|NCT00460265|1140838|P1|COMPLETED|Overall Study|Completed study=death|243
477158|NCT00460265|1140837|P2|Received Study Medication|Overall Study||325
477159|NCT00460265|1140838|P1|Received Study Medication|Overall Study||325
477160|NCT00460265|1140837|P2|Randomized While Alive|Overall Study||330
477161|NCT00460265|1140838|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
477162|NCT00460265|1140837|P2|STARTED|Overall Study||330
477163|NCT00460265|1140838|P1|STARTED|Overall Study||328
477164|NCT00460239|1140854|P9|NOT COMPLETED|Overall Study||0
477165|NCT00460239|1140855|P8|NOT COMPLETED|Overall Study||0
477166|NCT00460239|1140856|P7|NOT COMPLETED|Overall Study||0
477167|NCT00460239|1140857|P6|NOT COMPLETED|Overall Study||3
477168|NCT00460239|1140858|P5|NOT COMPLETED|Overall Study||0
477169|NCT00460239|1140859|P4|NOT COMPLETED|Overall Study||0
477170|NCT00460239|1140860|P3|NOT COMPLETED|Overall Study||0
477171|NCT00460239|1140861|P2|NOT COMPLETED|Overall Study||1
477172|NCT00460239|1140862|P1|NOT COMPLETED|Overall Study||0
477173|NCT00460239|1140854|P9|COMPLETED|Overall Study||1
477174|NCT00460239|1140855|P8|COMPLETED|Overall Study||1
477175|NCT00460239|1140856|P7|COMPLETED|Overall Study||1
477176|NCT00460239|1140857|P6|COMPLETED|Overall Study||1
477177|NCT00460239|1140858|P5|COMPLETED|Overall Study||1
477178|NCT00460239|1140859|P4|COMPLETED|Overall Study||0
477179|NCT00460239|1140860|P3|COMPLETED|Overall Study||1
477180|NCT00460239|1140861|P2|COMPLETED|Overall Study||2
477181|NCT00460239|1140862|P1|COMPLETED|Overall Study||0
477182|NCT00460239|1140854|P9|STARTED|Overall Study||1
477183|NCT00460239|1140855|P8|STARTED|Overall Study||1
477184|NCT00460239|1140856|P7|STARTED|Overall Study||1
477185|NCT00460239|1140857|P6|STARTED|Overall Study||4
477186|NCT00460239|1140858|P5|STARTED|Overall Study||1
477187|NCT00460239|1140859|P4|STARTED|Overall Study||0
477188|NCT00460239|1140860|P3|STARTED|Overall Study||1
477189|NCT00460239|1140861|P2|STARTED|Overall Study||3
477190|NCT00460239|1140862|P1|STARTED|Overall Study||0
477191|NCT00460109|1140931|P1|NOT COMPLETED|Overall Study||1
477192|NCT00460109|1140931|P1|COMPLETED|Overall Study||23
477193|NCT00460109|1140931|P1|STARTED|Overall Study||24
477194|NCT00460031|1140939|P1|NOT COMPLETED|Overall Study||11
477195|NCT00460031|1140939|P1|COMPLETED|Overall Study||23
477196|NCT00460031|1140939|P1|STARTED|Overall Study||34
477197|NCT00459979|1140947|P1|NOT COMPLETED|Overall Study||2
477198|NCT00459979|1140947|P1|COMPLETED|Overall Study||28
477199|NCT00459979|1140947|P1|STARTED|Overall Study||30
477200|NCT00459953|1140959|P2|NOT COMPLETED|Overall Study||1
477201|NCT00459953|1140960|P1|NOT COMPLETED|Overall Study||1
477202|NCT00459953|1140959|P2|COMPLETED|Overall Study||70
477203|NCT00459953|1140960|P1|COMPLETED|Overall Study||71
477204|NCT00459953|1140959|P2|STARTED|Overall Study||71
477205|NCT00459953|1140960|P1|STARTED|Overall Study||72
477206|NCT00459875|1140966|P1|NOT COMPLETED|Overall Study||3
477207|NCT00459875|1140966|P1|COMPLETED|Overall Study||21
477208|NCT00459875|1140966|P1|STARTED|Overall Study||24
477209|NCT00459862|1140970|P1|NOT COMPLETED|Overall Study||0
477210|NCT00459862|1140970|P1|COMPLETED|Overall Study||34
477211|NCT00459862|1140970|P1|STARTED|Overall Study||34
477212|NCT00459810|1140979|P1|NOT COMPLETED|Overall Study||0
477213|NCT00459810|1140979|P1|COMPLETED|Overall Study||21
477214|NCT00459810|1140979|P1|STARTED|Overall Study||21
477215|NCT00459732|1140989|P2|NOT COMPLETED|Overall Study||3
477216|NCT00459732|1140990|P1|NOT COMPLETED|Overall Study||4
477217|NCT00459732|1140989|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
477218|NCT00459732|1140990|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
477219|NCT00459732|1140989|P2|STARTED|Overall Study||17
477220|NCT00459732|1140990|P1|STARTED|Overall Study||23
477221|NCT00459706|1141002|P2|NOT COMPLETED|Overall Study||21
477222|NCT00459706|1141003|P1|NOT COMPLETED|Overall Study||26
477223|NCT00459706|1141002|P2|COMPLETED|Overall Study||294
477224|NCT00459706|1141003|P1|COMPLETED|Overall Study||299
477225|NCT00459706|1141002|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
477226|NCT00459706|1141003|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
477227|NCT00459706|1141002|P2|STARTED|Overall Study||315
477228|NCT00459706|1141003|P1|STARTED|Overall Study||325
477229|NCT00459667|1141146|P3|NOT COMPLETED|Overall Study||20
477230|NCT00459667|1141147|P2|NOT COMPLETED|Overall Study||47
477231|NCT00459667|1141148|P1|NOT COMPLETED|Overall Study||38
477232|NCT00459667|1141146|P3|COMPLETED|Overall Study||161
477233|NCT00459667|1141147|P2|COMPLETED|Overall Study||600
477234|NCT00459667|1141148|P1|COMPLETED|Overall Study||554
477235|NCT00459667|1141146|P3|Started Treatment|Overall Study||180
477236|NCT00459667|1141147|P2|Started Treatment|Overall Study||644
477237|NCT00459667|1141148|P1|Started Treatment|Overall Study||586
477238|NCT00459667|1141146|P3|Study Medication Dispensed|Overall Study||180
477239|NCT00459667|1141147|P2|Study Medication Dispensed|Overall Study||645
477240|NCT00459667|1141148|P1|Study Medication Dispensed|Overall Study||586
477241|NCT00459667|1141146|P3|STARTED|Overall Study||181
477242|NCT00459667|1141147|P2|STARTED|Overall Study||647
477243|NCT00459667|1141148|P1|STARTED|Overall Study||592
477244|NCT00459537|1141170|P2|NOT COMPLETED|Overall Study||76
477245|NCT00459537|1141171|P1|NOT COMPLETED|Overall Study||66
477246|NCT00459537|1141170|P2|COMPLETED|Overall Study||446
477247|NCT00459537|1141171|P1|COMPLETED|Overall Study||441
477248|NCT00459537|1141170|P2|Safety Population|Overall Study||512
477249|NCT00459537|1141171|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
477250|NCT00459537|1141170|P2|STARTED|Overall Study||522
477251|NCT00459537|1141171|P1|STARTED|Overall Study||507
477252|NCT00459381|1141185|P1|NOT COMPLETED|Overall Study||0
477253|NCT00459381|1141185|P1|COMPLETED|Overall Study||35
477254|NCT00459381|1141185|P1|STARTED|Overall Study||35
477255|NCT00459368|1141197|P2|NOT COMPLETED|Overall Study||329
477256|NCT00459368|1141198|P1|NOT COMPLETED|Overall Study||295
477257|NCT00459368|1141197|P2|COMPLETED|Overall Study||1034
477258|NCT00459368|1141198|P1|COMPLETED|Overall Study||1040
477259|NCT00459368|1141197|P2|STARTED|Overall Study||1363
477260|NCT00459368|1141198|P1|STARTED|Overall Study||1335
477261|NCT00459355|1141206|P2|NOT COMPLETED|Overall Study||18
477262|NCT00459355|1141207|P1|NOT COMPLETED|Overall Study||20
477263|NCT00459355|1141206|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
477264|NCT00459355|1141207|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
477265|NCT00459355|1141206|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
477266|NCT00459355|1141207|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
477267|NCT00459342|1141219|P1|NOT COMPLETED|Overall Study||1
477268|NCT00459342|1141219|P1|COMPLETED|Overall Study||34
477269|NCT00459342|1141219|P1|STARTED|Overall Study||35
477270|NCT00459316|1141228|P3|NOT COMPLETED|Step 3||1
477271|NCT00459316|1141229|P2|NOT COMPLETED|Step 3||0
477272|NCT00459316|1141230|P1|NOT COMPLETED|Step 3||3
477273|NCT00459316|1141228|P3|COMPLETED|Step 3||39
477274|NCT00459316|1141229|P2|COMPLETED|Step 3||0
477275|NCT00459316|1141230|P1|COMPLETED|Step 3||149
477276|NCT00459316|1141228|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
477277|NCT00459316|1141229|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
477278|NCT00459316|1141230|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
477279|NCT00459316|1141228|P3|NOT COMPLETED|Steps 1 & 2||2
477280|NCT00459316|1141229|P2|NOT COMPLETED|Steps 1 & 2||7
477281|NCT00459316|1141230|P1|NOT COMPLETED|Steps 1 & 2||21
477282|NCT00459316|1141228|P3|COMPLETED|Steps 1 & 2||57
477283|NCT00459316|1141229|P2|COMPLETED|Steps 1 & 2||32
477284|NCT00459316|1141230|P1|COMPLETED|Steps 1 & 2||259
477285|NCT00459316|1141228|P3|STARTED|Steps 1 & 2||59
477286|NCT00459316|1141229|P2|STARTED|Steps 1 & 2||39
477287|NCT00459316|1141230|P1|STARTED|Steps 1 & 2||280
477288|NCT00459303|1141284|P1|NOT COMPLETED|Overall Study||0
477289|NCT00459303|1141284|P1|COMPLETED|Overall Study||20
477290|NCT00459303|1141284|P1|STARTED|Overall Study||20
477291|NCT00459290|1141295|P1|NOT COMPLETED|Overall Study||5
477292|NCT00459290|1141295|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
477293|NCT00459290|1141295|P1|STARTED|Overall Study||24
477294|NCT00459186|1141309|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
477295|NCT00459186|1141309|P1|COMPLETED|Combination RAD001 + Docetaxel||15
477296|NCT00459186|1141309|P1|STARTED|Combination RAD001 + Docetaxel||15
477297|NCT00459186|1141309|P1|NOT COMPLETED|PET Imaging and Assessment||3
477298|NCT00459186|1141309|P1|COMPLETED|PET Imaging and Assessment||15
477299|NCT00459186|1141309|P1|STARTED|PET Imaging and Assessment||18
477300|NCT00459186|1141309|P1|NOT COMPLETED|Single Agent RAD001||1
477301|NCT00459186|1141309|P1|COMPLETED|Single Agent RAD001||18
477302|NCT00459186|1141309|P1|STARTED|Single Agent RAD001||19
477303|NCT00459134|1141316|P2|NOT COMPLETED|Overall Study||25
477304|NCT00459134|1141317|P1|NOT COMPLETED|Overall Study||23
477305|NCT00459134|1141316|P2|COMPLETED|Overall Study||67
477306|NCT00459134|1141317|P1|COMPLETED|Overall Study||71
477307|NCT00459134|1141316|P2|STARTED|Overall Study||92
477308|NCT00459134|1141317|P1|STARTED|Overall Study||94
477309|NCT00459121|1141325|P1|NOT COMPLETED|Overall Study||0
477310|NCT00459121|1141325|P1|COMPLETED|Overall Study||2
477311|NCT00459121|1141325|P1|STARTED|Overall Study||2
477312|NCT00459108|1141329|P1|NOT COMPLETED|Overall Study||11
477313|NCT00459108|1141329|P1|COMPLETED|Overall Study||14
477314|NCT00459108|1141329|P1|STARTED|Overall Study||25
477315|NCT00459056|1141336|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
477316|NCT00459056|1141337|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
477317|NCT00459056|1141336|P2|COMPLETED|Second Intervention (Final Three Months)||14
477318|NCT00459056|1141337|P1|COMPLETED|Second Intervention (Final Three Months)||9
477319|NCT00459056|1141336|P2|STARTED|Second Intervention (Final Three Months)||14
477320|NCT00459056|1141337|P1|STARTED|Second Intervention (Final Three Months)||9
477321|NCT00459056|1141336|P2|NOT COMPLETED|Washout (1 Month)||0
477322|NCT00459056|1141337|P1|NOT COMPLETED|Washout (1 Month)||0
477323|NCT00459056|1141336|P2|COMPLETED|Washout (1 Month)||14
477324|NCT00459056|1141337|P1|COMPLETED|Washout (1 Month)||9
477325|NCT00459056|1141336|P2|STARTED|Washout (1 Month)||14
477326|NCT00459056|1141337|P1|STARTED|Washout (1 Month)||9
477327|NCT00459056|1141336|P2|NOT COMPLETED|First Intervention (First Three Months)||1
477328|NCT00459056|1141337|P1|NOT COMPLETED|First Intervention (First Three Months)||1
477329|NCT00459056|1141336|P2|COMPLETED|First Intervention (First Three Months)||14
477330|NCT00459056|1141337|P1|COMPLETED|First Intervention (First Three Months)||9
477331|NCT00459056|1141336|P2|STARTED|First Intervention (First Three Months)||15
477332|NCT00459056|1141337|P1|STARTED|First Intervention (First Three Months)||10
477333|NCT00459043|1141345|P2|NOT COMPLETED|Overall Study||0
477334|NCT00459043|1141346|P1|NOT COMPLETED|Overall Study||1
477335|NCT00459043|1141345|P2|COMPLETED|Overall Study||15
477336|NCT00459043|1141346|P1|COMPLETED|Overall Study||14
477337|NCT00459043|1141345|P2|STARTED|Overall Study||15
477338|NCT00459043|1141346|P1|STARTED|Overall Study||15
477339|NCT00458952|1141358|P2|NOT COMPLETED|Overall Study||5
477340|NCT00458952|1141359|P1|NOT COMPLETED|Overall Study||2
477341|NCT00458952|1141358|P2|COMPLETED|Overall Study||9
477342|NCT00458952|1141359|P1|COMPLETED|Overall Study||5
477343|NCT00458952|1141358|P2|STARTED|Overall Study||14
477344|NCT00458952|1141359|P1|STARTED|Overall Study||7
477345|NCT00458822|1141363|P1|NOT COMPLETED|Overall Study||0
477346|NCT00458822|1141363|P1|COMPLETED|Overall Study||40
477347|NCT00458822|1141363|P1|STARTED|Overall Study||40
477348|NCT00458705|1141367|P1|NOT COMPLETED|Overall Study||5
477349|NCT00458705|1141367|P1|COMPLETED|Overall Study||40
477350|NCT00458705|1141367|P1|STARTED|Overall Study||45
477351|NCT00458536|1141371|P1|NOT COMPLETED|Overall Study||19
477352|NCT00458536|1141371|P1|COMPLETED|Overall Study||19
477353|NCT00458536|1141371|P1|STARTED|Overall Study||38
477354|NCT00458406|1141377|P2|NOT COMPLETED|Month 3||0
477355|NCT00458406|1141378|P1|NOT COMPLETED|Month 3||0
477356|NCT00458406|1141377|P2|COMPLETED|Month 3||13
477357|NCT00458406|1141378|P1|COMPLETED|Month 3||43
477358|NCT00458406|1141377|P2|STARTED|Month 3||13
477359|NCT00458406|1141378|P1|STARTED|Month 3||43
477360|NCT00458406|1141377|P2|NOT COMPLETED|Month 1||0
477361|NCT00458406|1141378|P1|NOT COMPLETED|Month 1||0
477362|NCT00458406|1141377|P2|COMPLETED|Month 1||13
477363|NCT00458406|1141378|P1|COMPLETED|Month 1||43
477364|NCT00458406|1141377|P2|STARTED|Month 1||13
477365|NCT00458406|1141378|P1|STARTED|Month 1||43
477366|NCT00458302|1141398|P2|NOT COMPLETED|Overall Study||24
477367|NCT00458302|1141399|P1|NOT COMPLETED|Overall Study||20
477368|NCT00458302|1141398|P2|COMPLETED|Overall Study||103
477369|NCT00458302|1141399|P1|COMPLETED|Overall Study||109
477370|NCT00458302|1141398|P2|STARTED|Overall Study||127
477371|NCT00458302|1141399|P1|STARTED|Overall Study||129
477372|NCT00458237|1141433|P3|NOT COMPLETED|Overall Study||0
477373|NCT00458237|1141434|P2|NOT COMPLETED|Overall Study||0
477374|NCT00458237|1141435|P1|NOT COMPLETED|Overall Study||0
477375|NCT00458237|1141433|P3|COMPLETED|Overall Study||5
477376|NCT00458237|1141434|P2|COMPLETED|Overall Study||3
477377|NCT00458237|1141435|P1|COMPLETED|Overall Study||3
477378|NCT00458237|1141433|P3|STARTED|Overall Study||5
477379|NCT00458237|1141434|P2|STARTED|Overall Study||3
477380|NCT00458237|1141435|P1|STARTED|Overall Study||3
477381|NCT00458211|1141444|P1|NOT COMPLETED|Overall Study||16
477560|NCT00456625|1141841|P1|COMPLETED|Overall Study||76
477382|NCT00458211|1141444|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
477383|NCT00458211|1141444|P1|STARTED|Overall Study||40
477384|NCT00457977|1141457|P2|NOT COMPLETED|Overall Study||25
477385|NCT00457977|1141458|P1|NOT COMPLETED|Overall Study||28
477386|NCT00457977|1141457|P2|COMPLETED|Overall Study||66
477387|NCT00457977|1141458|P1|COMPLETED|Overall Study||62
477388|NCT00457977|1141457|P2|2-Year|Overall Study||66
477389|NCT00457977|1141458|P1|2-Year|Overall Study||62
477390|NCT00457977|1141457|P2|1-Year|Overall Study||76
477391|NCT00457977|1141458|P1|1-Year|Overall Study||69
477392|NCT00457977|1141457|P2|1-Month|Overall Study||87
477393|NCT00457977|1141458|P1|1-Month|Overall Study||88
477394|NCT00457977|1141457|P2|STARTED|Overall Study||91
477395|NCT00457977|1141458|P1|STARTED|Overall Study||90
477396|NCT00457951|1141469|P3|NOT COMPLETED|Overall Study||12
477397|NCT00457951|1141470|P2|NOT COMPLETED|Overall Study||16
477398|NCT00457951|1141471|P1|NOT COMPLETED|Overall Study||0
477399|NCT00457951|1141469|P3|COMPLETED|Overall Study||60
477400|NCT00457951|1141470|P2|COMPLETED|Overall Study||50
477401|NCT00457951|1141471|P1|COMPLETED|Overall Study||13
477402|NCT00457951|1141469|P3|STARTED|Overall Study||72
477403|NCT00457951|1141470|P2|STARTED|Overall Study||66
477404|NCT00457951|1141471|P1|STARTED|Overall Study||13
477405|NCT00457821|1141486|P8|NOT COMPLETED|Part 2||1
477406|NCT00457821|1141487|P7|NOT COMPLETED|Part 2||0
477407|NCT00457821|1141488|P6|NOT COMPLETED|Part 2||0
477408|NCT00457821|1141489|P5|NOT COMPLETED|Part 2||0
477409|NCT00457821|1141490|P4|NOT COMPLETED|Part 2||0
477410|NCT00457821|1141491|P3|NOT COMPLETED|Part 2||0
477411|NCT00457821|1141492|P2|NOT COMPLETED|Part 2||0
477412|NCT00457821|1141493|P1|NOT COMPLETED|Part 2||0
477413|NCT00457821|1141486|P8|COMPLETED|Part 2||4
477414|NCT00457821|1141487|P7|COMPLETED|Part 2||7
477415|NCT00457821|1141488|P6|COMPLETED|Part 2||8
477416|NCT00457821|1141489|P5|COMPLETED|Part 2||0
477417|NCT00457821|1141490|P4|COMPLETED|Part 2||0
477418|NCT00457821|1141491|P3|COMPLETED|Part 2||0
477419|NCT00457821|1141492|P2|COMPLETED|Part 2||0
477420|NCT00457821|1141493|P1|COMPLETED|Part 2||0
477421|NCT00457821|1141486|P8|Completed Study Drug Treatment|Part 2||4
477422|NCT00457821|1141487|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
477423|NCT00457821|1141488|P6|Completed Study Drug Treatment|Part 2||8
477424|NCT00457821|1141489|P5|Completed Study Drug Treatment|Part 2||0
477425|NCT00457821|1141490|P4|Completed Study Drug Treatment|Part 2||0
477426|NCT00457821|1141491|P3|Completed Study Drug Treatment|Part 2||0
477427|NCT00457821|1141492|P2|Completed Study Drug Treatment|Part 2||0
477428|NCT00457821|1141493|P1|Completed Study Drug Treatment|Part 2||0
477429|NCT00457821|1141486|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
477430|NCT00457821|1141487|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
477431|NCT00457821|1141488|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
477432|NCT00457821|1141489|P5|STARTED|Part 2|Arm in Part 1 only|0
477433|NCT00457821|1141490|P4|STARTED|Part 2|Arm in Part 1 only|0
477434|NCT00457821|1141491|P3|STARTED|Part 2|Arm in Part 1 only|0
477435|NCT00457821|1141492|P2|STARTED|Part 2|Arm in Part 1 only|0
477436|NCT00457821|1141493|P1|STARTED|Part 2|Arm in Part 1 only|0
477437|NCT00457821|1141486|P8|NOT COMPLETED|Part 1||0
477438|NCT00457821|1141487|P7|NOT COMPLETED|Part 1||0
477439|NCT00457821|1141488|P6|NOT COMPLETED|Part 1||0
477440|NCT00457821|1141489|P5|NOT COMPLETED|Part 1||0
477441|NCT00457821|1141490|P4|NOT COMPLETED|Part 1||0
477442|NCT00457821|1141491|P3|NOT COMPLETED|Part 1||1
477443|NCT00457821|1141492|P2|NOT COMPLETED|Part 1||0
477444|NCT00457821|1141493|P1|NOT COMPLETED|Part 1||0
477445|NCT00457821|1141486|P8|COMPLETED|Part 1||0
477446|NCT00457821|1141487|P7|COMPLETED|Part 1||0
477447|NCT00457821|1141488|P6|COMPLETED|Part 1||0
477448|NCT00457821|1141489|P5|COMPLETED|Part 1||4
477449|NCT00457821|1141490|P4|COMPLETED|Part 1||4
477450|NCT00457821|1141491|P3|COMPLETED|Part 1||4
477451|NCT00457821|1141492|P2|COMPLETED|Part 1||4
477452|NCT00457821|1141493|P1|COMPLETED|Part 1||4
477453|NCT00457821|1141486|P8|STARTED|Part 1|Arm in Part 2 only|0
477454|NCT00457821|1141487|P7|STARTED|Part 1|Arm in Part 2 only|0
477455|NCT00457821|1141488|P6|STARTED|Part 1|Arm in Part 2 only|0
477456|NCT00457821|1141489|P5|STARTED|Part 1|Number of subjects randomized|4
477457|NCT00457821|1141490|P4|STARTED|Part 1|Number of subjects randomized|4
477458|NCT00457821|1141491|P3|STARTED|Part 1|Number of subjects randomized|5
477459|NCT00457821|1141492|P2|STARTED|Part 1|Number of subjects randomized|4
477460|NCT00457821|1141493|P1|STARTED|Part 1|Number of subjects randomized|4
477461|NCT00457795|1141522|P1|NOT COMPLETED|Overall Study||0
477462|NCT00457795|1141522|P1|COMPLETED|Overall Study||15
477463|NCT00457795|1141522|P1|STARTED|Overall Study||15
477464|NCT00457743|1141532|P3|NOT COMPLETED|Overall Study||3
477465|NCT00457743|1141533|P2|NOT COMPLETED|Overall Study||27
477466|NCT00457743|1141534|P1|NOT COMPLETED|Overall Study||3
477467|NCT00457743|1141532|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
477468|NCT00457743|1141533|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
477469|NCT00457743|1141534|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
477470|NCT00457743|1141532|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
477471|NCT00457743|1141533|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
477472|NCT00457743|1141534|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
477473|NCT00457743|1141532|P3|Completed Phase 1|Overall Study||3
477474|NCT00457743|1141533|P2|Completed Phase 1|Overall Study||6
477475|NCT00457743|1141534|P1|Completed Phase 1|Overall Study||3
477476|NCT00457743|1141532|P3|Enrolled in Phase 1|Overall Study||3
477477|NCT00457743|1141533|P2|Enrolled in Phase 1|Overall Study||6
477478|NCT00457743|1141534|P1|Enrolled in Phase 1|Overall Study||3
477479|NCT00457743|1141532|P3|STARTED|Overall Study|Overall study|3
477480|NCT00457743|1141533|P2|STARTED|Overall Study|Overall study|30
477481|NCT00457743|1141534|P1|STARTED|Overall Study|Overall study|3
477482|NCT00457730|1141578|P2|NOT COMPLETED|Overall Study||1
477483|NCT00457730|1141579|P1|NOT COMPLETED|Overall Study||4
477484|NCT00457730|1141578|P2|COMPLETED|Overall Study||19
477485|NCT00457730|1141579|P1|COMPLETED|Overall Study||14
477486|NCT00457730|1141578|P2|STARTED|Overall Study||20
477487|NCT00457730|1141579|P1|STARTED|Overall Study||18
477488|NCT00457691|1141591|P2|NOT COMPLETED|Overall Study||382
477489|NCT00457691|1141592|P1|NOT COMPLETED|Overall Study||386
477490|NCT00457691|1141591|P2|COMPLETED|Overall Study||0
477491|NCT00457691|1141592|P1|COMPLETED|Overall Study||0
477492|NCT00457691|1141591|P2|STARTED|Overall Study||382
477493|NCT00457691|1141592|P1|STARTED|Overall Study||386
477494|NCT00457418|1141612|P1|NOT COMPLETED|Post PK Maintenance||28
477495|NCT00457418|1141612|P1|COMPLETED|Post PK Maintenance||3
477496|NCT00457418|1141612|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
477497|NCT00457418|1141612|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
477498|NCT00457418|1141612|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
477499|NCT00457418|1141612|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
477500|NCT00457392|1141624|P2|NOT COMPLETED|Overall Study||480
477501|NCT00457392|1141625|P1|NOT COMPLETED|Overall Study||480
477502|NCT00457392|1141624|P2|COMPLETED|Overall Study||0
477503|NCT00457392|1141625|P1|COMPLETED|Overall Study||0
477504|NCT00457392|1141624|P2|Treated|Overall Study||477
477505|NCT00457392|1141625|P1|Treated|Overall Study||473
477506|NCT00457392|1141624|P2|STARTED|Overall Study||480
477507|NCT00457392|1141625|P1|STARTED|Overall Study||480
477508|NCT00457301|1141643|P2|NOT COMPLETED|Overall Study||24
477509|NCT00457301|1141644|P1|NOT COMPLETED|Overall Study||23
477510|NCT00457301|1141643|P2|COMPLETED|Overall Study||84
477511|NCT00457301|1141644|P1|COMPLETED|Overall Study||82
477512|NCT00457301|1141643|P2|STARTED|Overall Study||108
477513|NCT00457301|1141644|P1|STARTED|Overall Study||105
477514|NCT00457249|1141658|P2|NOT COMPLETED|Overall Study||2
477515|NCT00457249|1141659|P1|NOT COMPLETED|Overall Study||12
477516|NCT00457249|1141658|P2|COMPLETED|Overall Study||389
477517|NCT00457249|1141659|P1|COMPLETED|Overall Study||1158
477518|NCT00457249|1141658|P2|STARTED|Overall Study||391
477519|NCT00457249|1141659|P1|STARTED|Overall Study||1170
477520|NCT00457197|1141673|P2|NOT COMPLETED|Overall Study||1
477521|NCT00457197|1141674|P1|NOT COMPLETED|Overall Study||1
477522|NCT00457197|1141673|P2|COMPLETED|Overall Study||44
477523|NCT00457197|1141674|P1|COMPLETED|Overall Study||44
477524|NCT00457197|1141673|P2|STARTED|Overall Study||45
477525|NCT00457197|1141674|P1|STARTED|Overall Study||45
477526|NCT00457015|1141698|P2|NOT COMPLETED|Overall Study||1
477527|NCT00457015|1141699|P1|NOT COMPLETED|Overall Study||0
477528|NCT00457015|1141698|P2|COMPLETED|Overall Study||47
477529|NCT00457015|1141699|P1|COMPLETED|Overall Study||48
477530|NCT00457015|1141698|P2|STARTED|Overall Study||48
477531|NCT00457015|1141699|P1|STARTED|Overall Study||48
477532|NCT00457002|1141715|P2|NOT COMPLETED|Overall Study||757
477533|NCT00457002|1141716|P1|NOT COMPLETED|Overall Study||813
477534|NCT00457002|1141715|P2|COMPLETED|Overall Study||2516
477535|NCT00457002|1141716|P1|COMPLETED|Overall Study||2442
477536|NCT00457002|1141715|P2|STARTED|Overall Study||3273
477537|NCT00457002|1141716|P1|STARTED|Overall Study||3255
477538|NCT00456989|1141784|P1|NOT COMPLETED|Overall Study||0
477539|NCT00456989|1141784|P1|COMPLETED|Overall Study||39
477540|NCT00456989|1141784|P1|STARTED|Overall Study||39
477541|NCT00456846|1141790|P2|NOT COMPLETED|Overall Study||28
477542|NCT00456846|1141791|P1|NOT COMPLETED|Overall Study||16
477543|NCT00456846|1141790|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
477544|NCT00456846|1141791|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
477545|NCT00456846|1141790|P2|STARTED|Overall Study||76
477546|NCT00456846|1141791|P1|STARTED|Overall Study||47
477547|NCT00456807|1141813|P2|NOT COMPLETED|Overall Study||0
477548|NCT00456807|1141814|P1|NOT COMPLETED|Overall Study||1
477549|NCT00456807|1141813|P2|COMPLETED|Overall Study||47
477550|NCT00456807|1141814|P1|COMPLETED|Overall Study||52
477551|NCT00456807|1141813|P2|STARTED|Overall Study||47
477552|NCT00456807|1141814|P1|STARTED|Overall Study||53
477553|NCT00456755|1141832|P2|NOT COMPLETED|Overall Study||1
477554|NCT00456755|1141833|P1|NOT COMPLETED|Overall Study||2
477555|NCT00456755|1141832|P2|COMPLETED|Overall Study||62
477556|NCT00456755|1141833|P1|COMPLETED|Overall Study||61
477557|NCT00456755|1141832|P2|STARTED|Overall Study||63
477558|NCT00456755|1141833|P1|STARTED|Overall Study||63
477559|NCT00456625|1141841|P1|NOT COMPLETED|Overall Study||0
477561|NCT00456625|1141841|P1|STARTED|Overall Study||76
477562|NCT00456612|1141847|P1|NOT COMPLETED|Overall Study||3
477563|NCT00456612|1141847|P1|COMPLETED|Overall Study||1
477564|NCT00456612|1141847|P1|STARTED|Overall Study||4
477565|NCT00456599|1141852|P1|NOT COMPLETED|Overall Study||3
477566|NCT00456599|1141852|P1|COMPLETED|Overall Study||68
477567|NCT00456599|1141852|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
477568|NCT00456599|1141852|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
477569|NCT00456599|1141852|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
477570|NCT00456599|1141852|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
477571|NCT00456599|1141852|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
477572|NCT00456599|1141852|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
477573|NCT00456599|1141852|P1|STARTED|Overall Study||71
477574|NCT00456547|1141860|P2|NOT COMPLETED|Overall Study||0
477575|NCT00456547|1141861|P1|NOT COMPLETED|Overall Study||0
477576|NCT00456547|1141860|P2|COMPLETED|Overall Study||12
477577|NCT00456547|1141861|P1|COMPLETED|Overall Study||12
477578|NCT00456547|1141860|P2|STARTED|Overall Study||12
477579|NCT00456547|1141861|P1|STARTED|Overall Study||12
477580|NCT00456521|1141875|P2|NOT COMPLETED|Overall Study||84
477581|NCT00456521|1141876|P1|NOT COMPLETED|Overall Study||249
477582|NCT00456521|1141875|P2|COMPLETED|Overall Study||118
477583|NCT00456521|1141876|P1|COMPLETED|Overall Study||342
477584|NCT00456521|1141875|P2|STARTED|Overall Study||202
477585|NCT00456521|1141876|P1|STARTED|Overall Study||591
477586|NCT00456508|1141916|P1|NOT COMPLETED|Overall Study||0
477587|NCT00456508|1141916|P1|COMPLETED|Overall Study||147
477588|NCT00456508|1141916|P1|STARTED|Overall Study||147
477589|NCT00456495|1141922|P1|NOT COMPLETED|Overall Study||2
477590|NCT00456495|1141922|P1|COMPLETED|Overall Study||3
477591|NCT00456495|1141922|P1|STARTED|Overall Study||5
477592|NCT00456261|1141928|P2|NOT COMPLETED|Maintenance Therapy||0
477593|NCT00456261|1141929|P1|NOT COMPLETED|Maintenance Therapy||0
477594|NCT00456261|1141928|P2|COMPLETED|Maintenance Therapy||29
477595|NCT00456261|1141929|P1|COMPLETED|Maintenance Therapy||3
477596|NCT00456261|1141928|P2|STARTED|Maintenance Therapy||29
477597|NCT00456261|1141929|P1|STARTED|Maintenance Therapy||3
477598|NCT00456261|1141928|P2|NOT COMPLETED|Combination Therapy||26
477599|NCT00456261|1141929|P1|NOT COMPLETED|Combination Therapy||52
477600|NCT00456261|1141928|P2|COMPLETED|Combination Therapy||29
477601|NCT00456261|1141929|P1|COMPLETED|Combination Therapy||3
477602|NCT00456261|1141928|P2|STARTED|Combination Therapy||55
477603|NCT00456261|1141929|P1|STARTED|Combination Therapy||55
477604|NCT00456014|1141939|P1|NOT COMPLETED|Tricyclic Phase||3
477605|NCT00456014|1141939|P1|COMPLETED|Tricyclic Phase||1
477606|NCT00456014|1141939|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
477607|NCT00456014|1141939|P1|NOT COMPLETED|SSRI Phase||9
477608|NCT00456014|1141939|P1|COMPLETED|SSRI Phase||28
477609|NCT00456014|1141939|P1|STARTED|SSRI Phase||37
477610|NCT00455975|1141947|P2|NOT COMPLETED|Overall Study||21
477611|NCT00455975|1141948|P1|NOT COMPLETED|Overall Study||18
477612|NCT00455975|1141947|P2|COMPLETED|Overall Study||40
477613|NCT00455975|1141948|P1|COMPLETED|Overall Study||40
477614|NCT00455975|1141947|P2|STARTED|Overall Study||61
477615|NCT00455975|1141948|P1|STARTED|Overall Study||58
477616|NCT00455962|1141962|P2|NOT COMPLETED|Overall Study||2
477617|NCT00455962|1141963|P1|NOT COMPLETED|Overall Study||5
477618|NCT00455962|1141962|P2|COMPLETED|Overall Study||13
477619|NCT00455962|1141963|P1|COMPLETED|Overall Study||10
477620|NCT00455962|1141962|P2|STARTED|Overall Study||15
477621|NCT00455962|1141963|P1|STARTED|Overall Study||15
477622|NCT00454909|1141972|P3|NOT COMPLETED|Overall Study||2
477623|NCT00454909|1141973|P2|NOT COMPLETED|Overall Study||3
477624|NCT00454909|1141974|P1|NOT COMPLETED|Overall Study||7
477625|NCT00454909|1141972|P3|COMPLETED|Overall Study||86
477626|NCT00454909|1141973|P2|COMPLETED|Overall Study||194
477627|NCT00454909|1141974|P1|COMPLETED|Overall Study||580
477628|NCT00454909|1141972|P3|STARTED|Overall Study||88
477629|NCT00454909|1141973|P2|STARTED|Overall Study||197
477630|NCT00454909|1141974|P1|STARTED|Overall Study||587
477631|NCT00454857|1142012|P1|NOT COMPLETED|Overall Study||54
477632|NCT00454857|1142012|P1|COMPLETED|Overall Study||272
477633|NCT00454857|1142012|P1|Completed ≥1 Observational Study Visit|Overall Study||319
477634|NCT00454857|1142012|P1|Completed Retrospective Chart Review|Overall Study||324
477635|NCT00454857|1142012|P1|STARTED|Overall Study||326
477636|NCT00454818|1142037|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
477637|NCT00454818|1142038|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
477638|NCT00454818|1142039|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
477639|NCT00454818|1142040|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
477640|NCT00454818|1142041|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
477641|NCT00454818|1142037|P5|COMPLETED|Phase 2: Randomized Double-blind||10
477642|NCT00454818|1142038|P4|COMPLETED|Phase 2: Randomized Double-blind||8
477643|NCT00454818|1142039|P3|COMPLETED|Phase 2: Randomized Double-blind||5
477644|NCT00454818|1142040|P2|COMPLETED|Phase 2: Randomized Double-blind||6
477645|NCT00454818|1142041|P1|COMPLETED|Phase 2: Randomized Double-blind||0
477646|NCT00454818|1142037|P5|STARTED|Phase 2: Randomized Double-blind||14
477647|NCT00454818|1142038|P4|STARTED|Phase 2: Randomized Double-blind||9
477648|NCT00454818|1142039|P3|STARTED|Phase 2: Randomized Double-blind||8
477649|NCT00454818|1142040|P2|STARTED|Phase 2: Randomized Double-blind||8
477650|NCT00454818|1142041|P1|STARTED|Phase 2: Randomized Double-blind||0
477651|NCT00454818|1142037|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
477652|NCT00454818|1142038|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
477653|NCT00454818|1142039|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
477654|NCT00454818|1142040|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
477655|NCT00454818|1142041|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
477656|NCT00454818|1142037|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
477657|NCT00454818|1142038|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
477658|NCT00454818|1142039|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
477659|NCT00454818|1142040|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
477660|NCT00454818|1142041|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
477661|NCT00454818|1142037|P5|STARTED|Phase I: Open-label Dose-escalation||0
477662|NCT00454818|1142038|P4|STARTED|Phase I: Open-label Dose-escalation||3
477663|NCT00454818|1142039|P3|STARTED|Phase I: Open-label Dose-escalation||3
477664|NCT00454818|1142040|P2|STARTED|Phase I: Open-label Dose-escalation||3
477665|NCT00454818|1142041|P1|STARTED|Phase I: Open-label Dose-escalation||3
477666|NCT00454805|1142120|P2|NOT COMPLETED|Overall Study||23
477667|NCT00454805|1142121|P1|NOT COMPLETED|Overall Study||26
477668|NCT00454805|1142120|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
477669|NCT00454805|1142121|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
477670|NCT00454805|1142120|P2|STARTED|Overall Study|Randomised|31
477671|NCT00454805|1142121|P1|STARTED|Overall Study|Randomised|31
477672|NCT00454779|1142137|P2|NOT COMPLETED|Second-line Treatment Phase||3
477673|NCT00454779|1142138|P1|NOT COMPLETED|Second-line Treatment Phase||0
477674|NCT00454779|1142137|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
477675|NCT00454779|1142138|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
477676|NCT00454779|1142137|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
477677|NCT00454779|1142138|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
477678|NCT00454779|1142137|P2|NOT COMPLETED|First-line Treatment Phase||8
477679|NCT00454779|1142138|P1|NOT COMPLETED|First-line Treatment Phase||5
477680|NCT00454779|1142137|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
477681|NCT00454779|1142138|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
477682|NCT00454779|1142137|P2|Received Study Medication|First-line Treatment Phase||55
477683|NCT00454779|1142138|P1|Received Study Medication|First-line Treatment Phase||56
477684|NCT00454779|1142137|P2|STARTED|First-line Treatment Phase||57
477685|NCT00454779|1142138|P1|STARTED|First-line Treatment Phase||56
477686|NCT00455858|1142166|P1|NOT COMPLETED|Overall Study||6
477687|NCT00455858|1142166|P1|COMPLETED|Overall Study||81
477688|NCT00455858|1142166|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
477689|NCT00455702|1142176|P2|NOT COMPLETED|Overall Study||3
477690|NCT00455702|1142177|P1|NOT COMPLETED|Overall Study||3
477691|NCT00455702|1142176|P2|COMPLETED|Overall Study||16
477692|NCT00455702|1142177|P1|COMPLETED|Overall Study||16
477693|NCT00455702|1142176|P2|STARTED|Overall Study||19
477694|NCT00455702|1142177|P1|STARTED|Overall Study||19
477695|NCT00455663|1142188|P3|NOT COMPLETED|Overall Study||3
477696|NCT00455663|1142189|P2|NOT COMPLETED|Overall Study||4
477697|NCT00455663|1142190|P1|NOT COMPLETED|Overall Study||3
477698|NCT00455663|1142188|P3|COMPLETED|Overall Study||29
477699|NCT00455663|1142189|P2|COMPLETED|Overall Study||32
477700|NCT00455663|1142190|P1|COMPLETED|Overall Study||34
477701|NCT00455663|1142188|P3|STARTED|Overall Study||32
477702|NCT00455663|1142189|P2|STARTED|Overall Study||36
477703|NCT00455663|1142190|P1|STARTED|Overall Study||37
477704|NCT00455650|1142209|P6|NOT COMPLETED|Week 3||0
477705|NCT00455650|1142210|P5|NOT COMPLETED|Week 3||0
477706|NCT00455650|1142211|P4|NOT COMPLETED|Week 3||0
477707|NCT00455650|1142212|P3|NOT COMPLETED|Week 3||0
477708|NCT00455650|1142213|P2|NOT COMPLETED|Week 3||0
477709|NCT00455650|1142214|P1|NOT COMPLETED|Week 3||0
477710|NCT00455650|1142209|P6|COMPLETED|Week 3||13
477711|NCT00455650|1142210|P5|COMPLETED|Week 3||14
477712|NCT00455650|1142211|P4|COMPLETED|Week 3||14
477713|NCT00455650|1142212|P3|COMPLETED|Week 3||10
477714|NCT00455650|1142213|P2|COMPLETED|Week 3||10
477715|NCT00455650|1142214|P1|COMPLETED|Week 3||10
477716|NCT00455650|1142209|P6|STARTED|Week 3||13
477717|NCT00455650|1142210|P5|STARTED|Week 3||14
477718|NCT00455650|1142211|P4|STARTED|Week 3||14
477719|NCT00455650|1142212|P3|STARTED|Week 3||10
477720|NCT00455650|1142213|P2|STARTED|Week 3||10
477721|NCT00455650|1142214|P1|STARTED|Week 3||10
477722|NCT00455650|1142209|P6|NOT COMPLETED|Week 2||0
477723|NCT00455650|1142210|P5|NOT COMPLETED|Week 2||0
477724|NCT00455650|1142211|P4|NOT COMPLETED|Week 2||0
477725|NCT00455650|1142212|P3|NOT COMPLETED|Week 2||0
477726|NCT00455650|1142213|P2|NOT COMPLETED|Week 2||0
477727|NCT00455650|1142214|P1|NOT COMPLETED|Week 2||0
477728|NCT00455650|1142209|P6|COMPLETED|Week 2||13
477729|NCT00455650|1142210|P5|COMPLETED|Week 2||14
477730|NCT00455650|1142211|P4|COMPLETED|Week 2||14
477731|NCT00455650|1142212|P3|COMPLETED|Week 2||10
477732|NCT00455650|1142213|P2|COMPLETED|Week 2||10
477733|NCT00455650|1142214|P1|COMPLETED|Week 2||10
477734|NCT00455650|1142209|P6|STARTED|Week 2||13
477735|NCT00455650|1142210|P5|STARTED|Week 2||14
477736|NCT00455650|1142211|P4|STARTED|Week 2||14
477737|NCT00455650|1142212|P3|STARTED|Week 2||10
477738|NCT00455650|1142213|P2|STARTED|Week 2||10
477739|NCT00455650|1142214|P1|STARTED|Week 2||10
477740|NCT00455650|1142209|P6|NOT COMPLETED|Week 1||0
477741|NCT00455650|1142210|P5|NOT COMPLETED|Week 1||0
477742|NCT00455650|1142211|P4|NOT COMPLETED|Week 1||0
477743|NCT00455650|1142212|P3|NOT COMPLETED|Week 1||0
477744|NCT00455650|1142213|P2|NOT COMPLETED|Week 1||0
477745|NCT00455650|1142214|P1|NOT COMPLETED|Week 1||0
477746|NCT00455650|1142209|P6|COMPLETED|Week 1||13
477747|NCT00455650|1142210|P5|COMPLETED|Week 1||14
477748|NCT00455650|1142211|P4|COMPLETED|Week 1||14
477749|NCT00455650|1142212|P3|COMPLETED|Week 1||10
477750|NCT00455650|1142213|P2|COMPLETED|Week 1||10
477751|NCT00455650|1142214|P1|COMPLETED|Week 1||10
477752|NCT00455650|1142209|P6|STARTED|Week 1||13
477753|NCT00455650|1142210|P5|STARTED|Week 1||14
477754|NCT00455650|1142211|P4|STARTED|Week 1||14
477755|NCT00455650|1142212|P3|STARTED|Week 1||10
477756|NCT00455650|1142213|P2|STARTED|Week 1||10
477757|NCT00455650|1142214|P1|STARTED|Week 1||10
477758|NCT00455533|1142244|P3|NOT COMPLETED|Period Two: Randomized Period||6
477759|NCT00455533|1142245|P2|NOT COMPLETED|Period Two: Randomized Period||6
477760|NCT00455533|1142246|P1|NOT COMPLETED|Period Two: Randomized Period||0
477761|NCT00455533|1142244|P3|COMPLETED|Period Two: Randomized Period||138
477762|NCT00455533|1142245|P2|COMPLETED|Period Two: Randomized Period||139
477763|NCT00455533|1142246|P1|COMPLETED|Period Two: Randomized Period||0
477764|NCT00455533|1142244|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
477765|NCT00455533|1142245|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
477766|NCT00455533|1142246|P1|STARTED|Period Two: Randomized Period||0
477767|NCT00455533|1142244|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
477768|NCT00455533|1142245|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
477769|NCT00455533|1142246|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
477770|NCT00455533|1142244|P3|COMPLETED|Period One: Initial Chemotherapy||0
477771|NCT00455533|1142245|P2|COMPLETED|Period One: Initial Chemotherapy||0
477772|NCT00455533|1142246|P1|COMPLETED|Period One: Initial Chemotherapy||295
477773|NCT00455533|1142244|P3|STARTED|Period One: Initial Chemotherapy||0
477774|NCT00455533|1142245|P2|STARTED|Period One: Initial Chemotherapy||0
477775|NCT00455533|1142246|P1|STARTED|Period One: Initial Chemotherapy||313
477776|NCT00455520|1142295|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
477777|NCT00455520|1142296|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
477778|NCT00455520|1142295|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
477779|NCT00455520|1142296|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
477780|NCT00455520|1142295|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
477781|NCT00455520|1142296|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
477782|NCT00455520|1142295|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
477783|NCT00455520|1142296|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
477784|NCT00455520|1142295|P2|COMPLETED|Open Label Tapentadol Extended Release||0
477785|NCT00455520|1142296|P1|COMPLETED|Open Label Tapentadol Extended Release||395
477786|NCT00455520|1142295|P2|STARTED|Open Label Tapentadol Extended Release||0
477787|NCT00455520|1142296|P1|STARTED|Open Label Tapentadol Extended Release||591
477788|NCT00455455|1142312|P2|NOT COMPLETED|Second Intervention||0
477789|NCT00455455|1142313|P1|NOT COMPLETED|Second Intervention||0
477790|NCT00455455|1142312|P2|COMPLETED|Second Intervention||24
477791|NCT00455455|1142313|P1|COMPLETED|Second Intervention||24
477792|NCT00455455|1142312|P2|STARTED|Second Intervention||24
477793|NCT00455455|1142313|P1|STARTED|Second Intervention||24
477794|NCT00455455|1142312|P2|NOT COMPLETED|Washout||0
477795|NCT00455455|1142313|P1|NOT COMPLETED|Washout||1
477796|NCT00455455|1142312|P2|COMPLETED|Washout||24
477797|NCT00455455|1142313|P1|COMPLETED|Washout||24
477798|NCT00455455|1142312|P2|STARTED|Washout||24
477799|NCT00455455|1142313|P1|STARTED|Washout||25
477800|NCT00455455|1142312|P2|NOT COMPLETED|First Intervention||0
477801|NCT00455455|1142313|P1|NOT COMPLETED|First Intervention||0
477802|NCT00455455|1142312|P2|COMPLETED|First Intervention||24
477803|NCT00455455|1142313|P1|COMPLETED|First Intervention||25
477804|NCT00455455|1142312|P2|STARTED|First Intervention||24
477805|NCT00455455|1142313|P1|STARTED|First Intervention||25
477806|NCT00455455|1142312|P2|NOT COMPLETED|Washout||1
477807|NCT00455455|1142313|P1|NOT COMPLETED|Washout||0
477808|NCT00455455|1142312|P2|COMPLETED|Washout||24
477809|NCT00455455|1142313|P1|COMPLETED|Washout||25
477810|NCT00455455|1142312|P2|STARTED|Washout||25
477811|NCT00455455|1142313|P1|STARTED|Washout||25
477812|NCT00455429|1142333|P4|NOT COMPLETED|Overall Study||14
477813|NCT00455429|1142334|P3|NOT COMPLETED|Overall Study||1
477814|NCT00455429|1142335|P2|NOT COMPLETED|Overall Study||5
477815|NCT00455429|1142336|P1|NOT COMPLETED|Overall Study||2
477816|NCT00455429|1142333|P4|COMPLETED|Overall Study||20
477817|NCT00455429|1142334|P3|COMPLETED|Overall Study||16
477818|NCT00455429|1142335|P2|COMPLETED|Overall Study||10
477819|NCT00455429|1142336|P1|COMPLETED|Overall Study||16
477820|NCT00455429|1142333|P4|Treated|Overall Study||32
477821|NCT00455429|1142334|P3|Treated|Overall Study||17
477822|NCT00455429|1142335|P2|Treated|Overall Study||15
477823|NCT00455429|1142336|P1|Treated|Overall Study||18
477824|NCT00455429|1142333|P4|STARTED|Overall Study||34
477825|NCT00455429|1142334|P3|STARTED|Overall Study||17
477826|NCT00455429|1142335|P2|STARTED|Overall Study||15
477827|NCT00455429|1142336|P1|STARTED|Overall Study||18
477828|NCT00455312|1142395|P2|NOT COMPLETED|Overall Study||1
477829|NCT00455312|1142396|P1|NOT COMPLETED|Overall Study||0
477830|NCT00455312|1142395|P2|COMPLETED|Overall Study||20
477831|NCT00455312|1142396|P1|COMPLETED|Overall Study||15
477832|NCT00455312|1142395|P2|STARTED|Overall Study||21
477833|NCT00455312|1142396|P1|STARTED|Overall Study||15
477834|NCT00455195|1142422|P2|NOT COMPLETED|Extension Study AGLU03206||0
477835|NCT00455195|1142423|P1|NOT COMPLETED|Extension Study AGLU03206||0
477836|NCT00455195|1142422|P2|COMPLETED|Extension Study AGLU03206||26
477837|NCT00455195|1142423|P1|COMPLETED|Extension Study AGLU03206||55
477838|NCT00455195|1142422|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
477839|NCT00455195|1142423|P1|STARTED|Extension Study AGLU03206||55
477840|NCT00455195|1142422|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
477841|NCT00455195|1142423|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
477842|NCT00455195|1142422|P2|COMPLETED|Double-blind Study AGLU02704||26
477843|NCT00455195|1142423|P1|COMPLETED|Double-blind Study AGLU02704||55
477844|NCT00455195|1142422|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
477845|NCT00455195|1142423|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
477846|NCT00455013|1142440|P3|NOT COMPLETED|Long Term Extension (LTE)||7
477847|NCT00455013|1142441|P2|NOT COMPLETED|Long Term Extension (LTE)||3
477848|NCT00455013|1142442|P1|NOT COMPLETED|Long Term Extension (LTE)||2
477849|NCT00455013|1142440|P3|COMPLETED|Long Term Extension (LTE)||20
477850|NCT00455013|1142441|P2|COMPLETED|Long Term Extension (LTE)||16
477851|NCT00455013|1142442|P1|COMPLETED|Long Term Extension (LTE)||25
477852|NCT00455013|1142440|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
477853|NCT00455013|1142441|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
477854|NCT00455013|1142442|P1|STARTED|Long Term Extension (LTE)||27
477855|NCT00455013|1142440|P3|NOT COMPLETED|Short Term Period||2
477856|NCT00455013|1142441|P2|NOT COMPLETED|Short Term Period||5
477857|NCT00455013|1142442|P1|NOT COMPLETED|Short Term Period||6
477858|NCT00455013|1142440|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
477859|NCT00455013|1142441|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
477860|NCT00455013|1142442|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
477861|NCT00455013|1142440|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
477862|NCT00455013|1142441|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
477863|NCT00455013|1142442|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
477864|NCT00454987|1142510|P3|NOT COMPLETED|Year 4||0
477865|NCT00454987|1142511|P2|NOT COMPLETED|Year 4||0
477866|NCT00454987|1142512|P1|NOT COMPLETED|Year 4||0
477867|NCT00454987|1142510|P3|COMPLETED|Year 4||0
477868|NCT00454987|1142511|P2|COMPLETED|Year 4||62
477869|NCT00454987|1142512|P1|COMPLETED|Year 4||206
477870|NCT00454987|1142510|P3|STARTED|Year 4||0
477871|NCT00454987|1142511|P2|STARTED|Year 4||62
477872|NCT00454987|1142512|P1|STARTED|Year 4||206
477873|NCT00454987|1142510|P3|NOT COMPLETED|Year 2||0
477874|NCT00454987|1142511|P2|NOT COMPLETED|Year 2||0
477875|NCT00454987|1142512|P1|NOT COMPLETED|Year 2||0
477876|NCT00454987|1142510|P3|COMPLETED|Year 2||74
477877|NCT00454987|1142511|P2|COMPLETED|Year 2||77
477878|NCT00454987|1142512|P1|COMPLETED|Year 2||235
477879|NCT00454987|1142510|P3|STARTED|Year 2||74
477880|NCT00454987|1142511|P2|STARTED|Year 2||77
477881|NCT00454987|1142512|P1|STARTED|Year 2||235
477882|NCT00454987|1142510|P3|NOT COMPLETED|Year 1||0
477883|NCT00454987|1142511|P2|NOT COMPLETED|Year 1||0
477884|NCT00454987|1142512|P1|NOT COMPLETED|Year 1||0
477885|NCT00454987|1142510|P3|COMPLETED|Year 1||0
477886|NCT00454987|1142511|P2|COMPLETED|Year 1||67
477887|NCT00454987|1142512|P1|COMPLETED|Year 1||221
477888|NCT00454987|1142510|P3|STARTED|Year 1||0
477889|NCT00454987|1142511|P2|STARTED|Year 1||67
477890|NCT00454987|1142512|P1|STARTED|Year 1||221
477891|NCT00454987|1142510|P3|NOT COMPLETED|Booster Period||0
477892|NCT00454987|1142511|P2|NOT COMPLETED|Booster Period||1
477893|NCT00454987|1142512|P1|NOT COMPLETED|Booster Period||2
477894|NCT00454987|1142510|P3|COMPLETED|Booster Period||0
477895|NCT00454987|1142511|P2|COMPLETED|Booster Period||116
477896|NCT00454987|1142512|P1|COMPLETED|Booster Period||357
477897|NCT00454987|1142510|P3|STARTED|Booster Period||0
477898|NCT00454987|1142511|P2|STARTED|Booster Period||117
477899|NCT00454987|1142512|P1|STARTED|Booster Period||359
477900|NCT00454649|1142593|P10|NOT COMPLETED|Overall Study||5
477901|NCT00454649|1142594|P9|NOT COMPLETED|Overall Study||20
477902|NCT00454649|1142595|P8|NOT COMPLETED|Overall Study||19
477903|NCT00454649|1142596|P7|NOT COMPLETED|Overall Study||9
477904|NCT00454649|1142597|P6|NOT COMPLETED|Overall Study||7
477905|NCT00454649|1142598|P5|NOT COMPLETED|Overall Study||1
477906|NCT00454649|1142599|P4|NOT COMPLETED|Overall Study||6
477907|NCT00454649|1142600|P3|NOT COMPLETED|Overall Study||19
477908|NCT00454649|1142601|P2|NOT COMPLETED|Overall Study||4
477909|NCT00454649|1142602|P1|NOT COMPLETED|Overall Study||3
477910|NCT00454649|1142593|P10|COMPLETED|Overall Study||1
477911|NCT00454649|1142594|P9|COMPLETED|Overall Study||1
477912|NCT00454649|1142595|P8|COMPLETED|Overall Study||0
477913|NCT00454649|1142596|P7|COMPLETED|Overall Study||0
477914|NCT00454649|1142597|P6|COMPLETED|Overall Study||0
477915|NCT00454649|1142598|P5|COMPLETED|Overall Study||0
477916|NCT00454649|1142599|P4|COMPLETED|Overall Study||1
477917|NCT00454649|1142600|P3|COMPLETED|Overall Study||1
477918|NCT00454649|1142601|P2|COMPLETED|Overall Study||1
477919|NCT00454649|1142602|P1|COMPLETED|Overall Study||0
477920|NCT00454649|1142593|P10|STARTED|Overall Study||6
477921|NCT00454649|1142594|P9|STARTED|Overall Study||21
477922|NCT00454649|1142595|P8|STARTED|Overall Study||19
477923|NCT00454649|1142596|P7|STARTED|Overall Study||9
477924|NCT00454649|1142597|P6|STARTED|Overall Study||7
477925|NCT00454649|1142598|P5|STARTED|Overall Study||1
477926|NCT00454649|1142599|P4|STARTED|Overall Study||7
477927|NCT00454649|1142600|P3|STARTED|Overall Study||20
477928|NCT00454649|1142601|P2|STARTED|Overall Study||5
477929|NCT00454649|1142602|P1|STARTED|Overall Study||3
477930|NCT00454636|1142731|P4|NOT COMPLETED|Overall Study||32
477931|NCT00454636|1142732|P3|NOT COMPLETED|Overall Study||20
477932|NCT00454636|1142733|P2|NOT COMPLETED|Overall Study||23
477933|NCT00454636|1142734|P1|NOT COMPLETED|Overall Study||31
477934|NCT00454636|1142731|P4|COMPLETED|Overall Study||26
477935|NCT00454636|1142732|P3|COMPLETED|Overall Study||7
477936|NCT00454636|1142733|P2|COMPLETED|Overall Study||9
477937|NCT00454636|1142734|P1|COMPLETED|Overall Study||10
477938|NCT00454636|1142731|P4|STARTED|Overall Study||58
477939|NCT00454636|1142732|P3|STARTED|Overall Study||27
477940|NCT00454636|1142733|P2|STARTED|Overall Study||32
477941|NCT00454636|1142734|P1|STARTED|Overall Study||41
477942|NCT00454584|1142767|P6|NOT COMPLETED|After Controlled Period||32
477943|NCT00454584|1142768|P5|NOT COMPLETED|After Controlled Period||12
477944|NCT00454584|1142769|P4|NOT COMPLETED|After Controlled Period||26
477945|NCT00454584|1142770|P3|NOT COMPLETED|After Controlled Period||0
477946|NCT00454584|1142771|P2|NOT COMPLETED|After Controlled Period||0
477947|NCT00454584|1142772|P1|NOT COMPLETED|After Controlled Period||0
477948|NCT00454584|1142767|P6|COMPLETED|After Controlled Period||310
477949|NCT00454584|1142768|P5|COMPLETED|After Controlled Period||189
477950|NCT00454584|1142769|P4|COMPLETED|After Controlled Period||310
477951|NCT00454584|1142770|P3|COMPLETED|After Controlled Period||0
477952|NCT00454584|1142771|P2|COMPLETED|After Controlled Period||0
477953|NCT00454584|1142772|P1|COMPLETED|After Controlled Period||0
477954|NCT00454584|1142767|P6|STARTED|After Controlled Period||342
477955|NCT00454584|1142768|P5|STARTED|After Controlled Period||201
477956|NCT00454584|1142769|P4|STARTED|After Controlled Period||336
477957|NCT00454584|1142770|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
477958|NCT00454584|1142771|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
477959|NCT00454584|1142772|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
477960|NCT00454584|1142767|P6|NOT COMPLETED|Controlled Period||0
477961|NCT00454584|1142768|P5|NOT COMPLETED|Controlled Period||0
477962|NCT00454584|1142769|P4|NOT COMPLETED|Controlled Period||0
477963|NCT00454584|1142770|P3|NOT COMPLETED|Controlled Period||5
477964|NCT00454584|1142771|P2|NOT COMPLETED|Controlled Period||8
477965|NCT00454584|1142772|P1|NOT COMPLETED|Controlled Period||11
477966|NCT00454584|1142767|P6|COMPLETED|Controlled Period||0
477967|NCT00454584|1142768|P5|COMPLETED|Controlled Period||0
477968|NCT00454584|1142769|P4|COMPLETED|Controlled Period||0
477969|NCT00454584|1142770|P3|COMPLETED|Controlled Period||342
477970|NCT00454584|1142771|P2|COMPLETED|Controlled Period||201
477971|NCT00454584|1142772|P1|COMPLETED|Controlled Period||336
477972|NCT00454584|1142767|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
477973|NCT00454584|1142768|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
477974|NCT00454584|1142769|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
477975|NCT00454584|1142770|P3|STARTED|Controlled Period||347
477976|NCT00454584|1142771|P2|STARTED|Controlled Period||209
477977|NCT00454584|1142772|P1|STARTED|Controlled Period||347
477978|NCT00454571|1142794|P2|NOT COMPLETED|Overall Study||6
477979|NCT00454571|1142795|P1|NOT COMPLETED|Overall Study||13
477980|NCT00454571|1142794|P2|COMPLETED|Overall Study||13
477981|NCT00454571|1142795|P1|COMPLETED|Overall Study||5
477982|NCT00454571|1142794|P2|STARTED|Overall Study||19
477983|NCT00454571|1142795|P1|STARTED|Overall Study||18
477984|NCT00454532|1142807|P4|NOT COMPLETED|Overall Study||0
477985|NCT00454532|1142808|P3|NOT COMPLETED|Overall Study||0
477986|NCT00454532|1142809|P2|NOT COMPLETED|Overall Study||0
477987|NCT00454532|1142810|P1|NOT COMPLETED|Overall Study||0
477988|NCT00454532|1142807|P4|COMPLETED|Overall Study||7
477989|NCT00454532|1142808|P3|COMPLETED|Overall Study||3
477990|NCT00454532|1142809|P2|COMPLETED|Overall Study||6
477991|NCT00454532|1142810|P1|COMPLETED|Overall Study||11
477992|NCT00454532|1142807|P4|STARTED|Overall Study||7
477993|NCT00454532|1142808|P3|STARTED|Overall Study||3
477994|NCT00454532|1142809|P2|STARTED|Overall Study||6
477995|NCT00454532|1142810|P1|STARTED|Overall Study||11
477996|NCT00454363|1142830|P2|NOT COMPLETED|Overall Study||2
477997|NCT00454363|1142831|P1|NOT COMPLETED|Overall Study||5
477998|NCT00454363|1142830|P2|COMPLETED|Overall Study||29
477999|NCT00454363|1142831|P1|COMPLETED|Overall Study||15
478000|NCT00454363|1142830|P2|STARTED|Overall Study||31
478001|NCT00454363|1142831|P1|STARTED|Overall Study||20
478002|NCT00454324|1142840|P2|NOT COMPLETED|Overall Study||0
478003|NCT00454324|1142841|P1|NOT COMPLETED|Overall Study||0
478004|NCT00454324|1142840|P2|COMPLETED|Overall Study||13
478005|NCT00454324|1142841|P1|COMPLETED|Overall Study||14
478006|NCT00454324|1142840|P2|STARTED|Overall Study||13
478007|NCT00454324|1142841|P1|STARTED|Overall Study||14
478008|NCT00454246|1142856|P3|NOT COMPLETED|Overall Study||9
478009|NCT00454246|1142857|P2|NOT COMPLETED|Overall Study||29
478010|NCT00454246|1142858|P1|NOT COMPLETED|Overall Study||73
478011|NCT00454246|1142856|P3|COMPLETED|Overall Study||0
478012|NCT00454246|1142857|P2|COMPLETED|Overall Study||0
478013|NCT00454246|1142858|P1|COMPLETED|Overall Study||0
478014|NCT00454246|1142856|P3|STARTED|Overall Study||9
478015|NCT00454246|1142857|P2|STARTED|Overall Study||29
478016|NCT00454246|1142858|P1|STARTED|Overall Study||73
478017|NCT00454207|1142874|P2|NOT COMPLETED|Overall Study||2
478018|NCT00454207|1142875|P1|NOT COMPLETED|Overall Study||4
478019|NCT00454207|1142874|P2|COMPLETED|Overall Study||21
478020|NCT00454207|1142875|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
478021|NCT00454207|1142874|P2|STARTED|Overall Study||23
478022|NCT00454207|1142875|P1|STARTED|Overall Study||21
478023|NCT00454194|1142920|P2|NOT COMPLETED|Overall Study||14
478024|NCT00454194|1142921|P1|NOT COMPLETED|Overall Study||22
478025|NCT00454194|1142920|P2|COMPLETED|Overall Study||37
478026|NCT00454194|1142921|P1|COMPLETED|Overall Study||25
478027|NCT00454194|1142920|P2|STARTED|Overall Study||51
478028|NCT00454194|1142921|P1|STARTED|Overall Study||47
478029|NCT00454181|1142939|P2|NOT COMPLETED|Overall Study||3
478030|NCT00454181|1142940|P1|NOT COMPLETED|Overall Study||15
478031|NCT00454181|1142939|P2|COMPLETED|Overall Study||11
478032|NCT00454181|1142940|P1|COMPLETED|Overall Study||30
478033|NCT00454181|1142939|P2|STARTED|Overall Study||14
478034|NCT00454181|1142940|P1|STARTED|Overall Study||45
478035|NCT00454142|1142956|P1|NOT COMPLETED|Overall Study||1
478036|NCT00454142|1142956|P1|COMPLETED|Overall Study||32
478037|NCT00454142|1142956|P1|STARTED|Overall Study||33
478038|NCT00454116|1142974|P3|NOT COMPLETED|Overall Study||28
478039|NCT00454116|1142975|P2|NOT COMPLETED|Overall Study||29
478040|NCT00454116|1142976|P1|NOT COMPLETED|Overall Study||27
478041|NCT00454116|1142974|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
478042|NCT00454116|1142975|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
478043|NCT00454116|1142976|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
478044|NCT00454116|1142974|P3|STARTED|Overall Study|randomised patients|35
478045|NCT00454116|1142975|P2|STARTED|Overall Study|randomised patients|36
478046|NCT00454116|1142976|P1|STARTED|Overall Study|randomised patients|35
478047|NCT00454051|1142986|P2|NOT COMPLETED|Overall Study||3
478048|NCT00454051|1142987|P1|NOT COMPLETED|Overall Study||3
478049|NCT00454051|1142986|P2|COMPLETED|Overall Study||8
478050|NCT00454051|1142987|P1|COMPLETED|Overall Study||17
478051|NCT00454051|1142986|P2|STARTED|Overall Study||11
478052|NCT00454051|1142987|P1|STARTED|Overall Study||20
478053|NCT00453999|1143020|P3|NOT COMPLETED|Overall Study||3
478054|NCT00453999|1143021|P2|NOT COMPLETED|Overall Study||5
478055|NCT00453999|1143022|P1|NOT COMPLETED|Overall Study||5
478056|NCT00453999|1143020|P3|COMPLETED|Overall Study||43
478057|NCT00453999|1143021|P2|COMPLETED|Overall Study||41
478058|NCT00453999|1143022|P1|COMPLETED|Overall Study||40
478059|NCT00453999|1143020|P3|STARTED|Overall Study||46
478060|NCT00453999|1143021|P2|STARTED|Overall Study||46
478061|NCT00453999|1143022|P1|STARTED|Overall Study||45
478062|NCT00453986|1143050|P5|NOT COMPLETED|Overall Study||0
478063|NCT00453986|1143051|P4|NOT COMPLETED|Overall Study||2
478064|NCT00453986|1143052|P3|NOT COMPLETED|Overall Study||6
478065|NCT00453986|1143053|P2|NOT COMPLETED|Overall Study||5
478066|NCT00453986|1143054|P1|NOT COMPLETED|Overall Study||6
478067|NCT00453986|1143050|P5|COMPLETED|Overall Study||105
478068|NCT00453986|1143051|P4|COMPLETED|Overall Study||310
478069|NCT00453986|1143052|P3|COMPLETED|Overall Study||307
478070|NCT00453986|1143053|P2|COMPLETED|Overall Study||306
478071|NCT00453986|1143054|P1|COMPLETED|Overall Study||305
478072|NCT00453986|1143050|P5|STARTED|Overall Study||105
478073|NCT00453986|1143051|P4|STARTED|Overall Study||312
478074|NCT00453986|1143052|P3|STARTED|Overall Study||313
478075|NCT00453986|1143053|P2|STARTED|Overall Study||311
478076|NCT00453986|1143054|P1|STARTED|Overall Study||311
478077|NCT00453973|1143149|P2|NOT COMPLETED|Overall Study||48
478078|NCT00453973|1143150|P1|NOT COMPLETED|Overall Study||51
478079|NCT00453973|1143149|P2|COMPLETED|Overall Study||15
478080|NCT00453973|1143150|P1|COMPLETED|Overall Study||0
478081|NCT00453973|1143149|P2|STARTED|Overall Study||63
478082|NCT00453973|1143150|P1|STARTED|Overall Study||51
478083|NCT00453388|1143160|P4|NOT COMPLETED|Overall Study||0
478084|NCT00453388|1143161|P3|NOT COMPLETED|Overall Study||0
478085|NCT00453388|1143162|P2|NOT COMPLETED|Overall Study||0
478086|NCT00453388|1143163|P1|NOT COMPLETED|Overall Study||0
478087|NCT00453388|1143160|P4|COMPLETED|Overall Study||0
478088|NCT00453388|1143161|P3|COMPLETED|Overall Study||1
478089|NCT00453388|1143162|P2|COMPLETED|Overall Study||5
478090|NCT00453388|1143163|P1|COMPLETED|Overall Study||0
478091|NCT00453388|1143160|P4|STARTED|Overall Study||0
478092|NCT00453388|1143161|P3|STARTED|Overall Study||1
478093|NCT00453388|1143162|P2|STARTED|Overall Study||5
478094|NCT00453388|1143163|P1|STARTED|Overall Study||0
478095|NCT00453362|1143185|P1|NOT COMPLETED|Overall Study||87
478096|NCT00453362|1143185|P1|COMPLETED|Overall Study||1
478097|NCT00453362|1143185|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
478098|NCT00453362|1143185|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
478099|NCT00453362|1143185|P1|Treated With Erlotinib|Overall Study||74
478100|NCT00453362|1143185|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
478101|NCT00453349|1143211|P2|NOT COMPLETED|Completed Study||34
478102|NCT00453349|1143212|P1|NOT COMPLETED|Completed Study||27
478103|NCT00453349|1143211|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
478104|NCT00453349|1143212|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
478105|NCT00453349|1143211|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
478106|NCT00453349|1143212|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
478107|NCT00453349|1143211|P2|STARTED|Completed Study||232
478108|NCT00453349|1143212|P1|STARTED|Completed Study||228
478109|NCT00453349|1143211|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
478110|NCT00453349|1143212|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
478111|NCT00453349|1143211|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
478112|NCT00453349|1143212|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
478113|NCT00453349|1143211|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
478114|NCT00453349|1143212|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
478115|NCT00453349|1143211|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
478116|NCT00453349|1143212|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
478117|NCT00453349|1143211|P2|NOT COMPLETED|Randomized||23
478118|NCT00453349|1143212|P1|NOT COMPLETED|Randomized||25
478119|NCT00453349|1143211|P2|COMPLETED|Randomized||209
478120|NCT00453349|1143212|P1|COMPLETED|Randomized||203
478121|NCT00453349|1143211|P2|STARTED|Randomized||232
478122|NCT00453349|1143212|P1|STARTED|Randomized||228
478123|NCT00453336|1143238|P1|NOT COMPLETED|Overall Study||0
478124|NCT00453336|1143238|P1|COMPLETED|Overall Study||45
478125|NCT00453336|1143238|P1|STARTED|Overall Study||45
478126|NCT00453310|1143243|P1|NOT COMPLETED|Overall Study||10
478127|NCT00453310|1143243|P1|COMPLETED|Overall Study||0
478128|NCT00453310|1143243|P1|STARTED|Overall Study||10
478129|NCT00453206|1143247|P1|NOT COMPLETED|Overall Study||1
478130|NCT00453206|1143247|P1|COMPLETED|Overall Study||65
478131|NCT00453206|1143247|P1|STARTED|Overall Study||66
478132|NCT00453193|1143251|P1|NOT COMPLETED|Overall Study||0
478133|NCT00453193|1143251|P1|COMPLETED|Overall Study||24
478134|NCT00453193|1143251|P1|STARTED|Overall Study||24
478135|NCT00453180|1143257|P2|NOT COMPLETED|Overall Study||3
478136|NCT00453180|1143258|P1|NOT COMPLETED|Overall Study||3
478137|NCT00453180|1143257|P2|COMPLETED|Overall Study||12
478138|NCT00453180|1143258|P1|COMPLETED|Overall Study||13
478139|NCT00453180|1143257|P2|STARTED|Overall Study||15
478140|NCT00453180|1143258|P1|STARTED|Overall Study||16
478141|NCT00453154|1143277|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
478142|NCT00453154|1143278|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
478143|NCT00453154|1143279|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
478144|NCT00453154|1143280|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
478145|NCT00453154|1143277|P4|COMPLETED|Open Label Sunitinib Crossover||0
478146|NCT00453154|1143278|P3|COMPLETED|Open Label Sunitinib Crossover||18
478147|NCT00453154|1143279|P2|COMPLETED|Open Label Sunitinib Crossover||0
478148|NCT00453154|1143280|P1|COMPLETED|Open Label Sunitinib Crossover||0
478149|NCT00453154|1143277|P4|STARTED|Open Label Sunitinib Crossover||0
478150|NCT00453154|1143278|P3|STARTED|Open Label Sunitinib Crossover||18
478151|NCT00453154|1143279|P2|STARTED|Open Label Sunitinib Crossover||0
478152|NCT00453154|1143280|P1|STARTED|Open Label Sunitinib Crossover||0
478153|NCT00453154|1143277|P4|NOT COMPLETED|Double BIind Maintenance||49
478154|NCT00453154|1143278|P3|NOT COMPLETED|Double BIind Maintenance||46
478155|NCT00453154|1143279|P2|NOT COMPLETED|Double BIind Maintenance||0
478156|NCT00453154|1143280|P1|NOT COMPLETED|Double BIind Maintenance||0
478157|NCT00453154|1143277|P4|COMPLETED|Double BIind Maintenance||0
478158|NCT00453154|1143278|P3|COMPLETED|Double BIind Maintenance||0
478159|NCT00453154|1143279|P2|COMPLETED|Double BIind Maintenance||0
478160|NCT00453154|1143280|P1|COMPLETED|Double BIind Maintenance||0
478161|NCT00453154|1143277|P4|STARTED|Double BIind Maintenance||49
478162|NCT00453154|1143278|P3|STARTED|Double BIind Maintenance||46
478163|NCT00453154|1143279|P2|STARTED|Double BIind Maintenance||0
478164|NCT00453154|1143280|P1|STARTED|Double BIind Maintenance||0
478165|NCT00453154|1143277|P4|NOT COMPLETED|Combination Chemotherapy||0
478166|NCT00453154|1143278|P3|NOT COMPLETED|Combination Chemotherapy||0
478167|NCT00453154|1143279|P2|NOT COMPLETED|Combination Chemotherapy||49
478168|NCT00453154|1143280|P1|NOT COMPLETED|Combination Chemotherapy||0
478169|NCT00453154|1143277|P4|COMPLETED|Combination Chemotherapy||0
478170|NCT00453154|1143278|P3|COMPLETED|Combination Chemotherapy||0
478171|NCT00453154|1143279|P2|COMPLETED|Combination Chemotherapy||95
478172|NCT00453154|1143280|P1|COMPLETED|Combination Chemotherapy||12
478173|NCT00453154|1143277|P4|STARTED|Combination Chemotherapy||0
478174|NCT00453154|1143278|P3|STARTED|Combination Chemotherapy||0
478175|NCT00453154|1143279|P2|STARTED|Combination Chemotherapy||144
478176|NCT00453154|1143280|P1|STARTED|Combination Chemotherapy||12
478177|NCT00453102|1143293|P1|NOT COMPLETED|Overall Study||2
478178|NCT00453102|1143293|P1|COMPLETED|Overall Study||16
478179|NCT00453102|1143293|P1|STARTED|Overall Study||18
478180|NCT00453063|1143304|P2|NOT COMPLETED|Overall Study||3
478181|NCT00453063|1143305|P1|NOT COMPLETED|Overall Study||3
478182|NCT00453063|1143304|P2|COMPLETED|Overall Study||212
478183|NCT00453063|1143305|P1|COMPLETED|Overall Study||208
478184|NCT00453063|1143304|P2|STARTED|Overall Study||215
478185|NCT00453063|1143305|P1|STARTED|Overall Study||211
478186|NCT00452868|1143319|P1|NOT COMPLETED|Overall Study||2
478187|NCT00452868|1143319|P1|COMPLETED|Overall Study||11
478188|NCT00452868|1143319|P1|STARTED|Overall Study||13
478189|NCT00452790|1143325|P2|NOT COMPLETED|Toddler Dose||2
478190|NCT00452790|1143326|P1|NOT COMPLETED|Toddler Dose||0
478191|NCT00452790|1143325|P2|COMPLETED|Toddler Dose||198
478192|NCT00452790|1143326|P1|COMPLETED|Toddler Dose||198
478193|NCT00452790|1143325|P2|STARTED|Toddler Dose||200
478194|NCT00452790|1143326|P1|STARTED|Toddler Dose||198
478195|NCT00452790|1143325|P2|NOT COMPLETED|After Infant Series||14
478196|NCT00452790|1143326|P1|NOT COMPLETED|After Infant Series||21
478197|NCT00452790|1143325|P2|COMPLETED|After Infant Series||200
478198|NCT00452790|1143326|P1|COMPLETED|After Infant Series||198
478199|NCT00452790|1143325|P2|STARTED|After Infant Series||214
478200|NCT00452790|1143326|P1|STARTED|After Infant Series||219
478201|NCT00452790|1143325|P2|NOT COMPLETED|Infant Series||141
478202|NCT00452790|1143326|P1|NOT COMPLETED|Infant Series||135
478203|NCT00452790|1143325|P2|COMPLETED|Infant Series||214
478204|NCT00452790|1143326|P1|COMPLETED|Infant Series||219
478205|NCT00452790|1143325|P2|Vaccinated Dose 3|Infant Series||218
478206|NCT00452790|1143326|P1|Vaccinated Dose 3|Infant Series||221
478207|NCT00452790|1143325|P2|Vaccinated Dose 2|Infant Series||300
478208|NCT00452790|1143326|P1|Vaccinated Dose 2|Infant Series||300
478209|NCT00452790|1143325|P2|Vaccinated Dose 1|Infant Series||353
478210|NCT00452790|1143326|P1|Vaccinated Dose 1|Infant Series||353
478211|NCT00452790|1143325|P2|STARTED|Infant Series||355
478212|NCT00452790|1143326|P1|STARTED|Infant Series||354
478213|NCT00452699|1143362|P2|NOT COMPLETED|Overall Study||73
478214|NCT00452699|1143363|P1|NOT COMPLETED|Overall Study||81
478215|NCT00452699|1143362|P2|COMPLETED|Overall Study||242
478216|NCT00452699|1143363|P1|COMPLETED|Overall Study||225
478217|NCT00452699|1143362|P2|STARTED|Overall Study||315
478218|NCT00452699|1143363|P1|STARTED|Overall Study||306
478219|NCT00452673|1143379|P5|NOT COMPLETED|Dose Expansion Period||21
478220|NCT00452673|1143380|P4|NOT COMPLETED|Dose Expansion Period||0
478221|NCT00452673|1143381|P3|NOT COMPLETED|Dose Expansion Period||0
478222|NCT00452673|1143382|P2|NOT COMPLETED|Dose Expansion Period||0
478223|NCT00452673|1143383|P1|NOT COMPLETED|Dose Expansion Period||0
478224|NCT00452673|1143379|P5|COMPLETED|Dose Expansion Period||0
478225|NCT00452673|1143380|P4|COMPLETED|Dose Expansion Period||0
478226|NCT00452673|1143381|P3|COMPLETED|Dose Expansion Period||0
478227|NCT00452673|1143382|P2|COMPLETED|Dose Expansion Period||0
478228|NCT00452673|1143383|P1|COMPLETED|Dose Expansion Period||0
478229|NCT00452673|1143379|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
478230|NCT00452673|1143380|P4|STARTED|Dose Expansion Period||0
478231|NCT00452673|1143381|P3|STARTED|Dose Expansion Period||0
478232|NCT00452673|1143382|P2|STARTED|Dose Expansion Period||0
478233|NCT00452673|1143383|P1|STARTED|Dose Expansion Period||0
478234|NCT00452673|1143379|P5|NOT COMPLETED|Dose Escalation Period||0
478235|NCT00452673|1143380|P4|NOT COMPLETED|Dose Escalation Period||9
478236|NCT00452673|1143381|P3|NOT COMPLETED|Dose Escalation Period||6
478237|NCT00452673|1143382|P2|NOT COMPLETED|Dose Escalation Period||9
478238|NCT00452673|1143383|P1|NOT COMPLETED|Dose Escalation Period||7
478239|NCT00452673|1143379|P5|COMPLETED|Dose Escalation Period||0
478240|NCT00452673|1143380|P4|COMPLETED|Dose Escalation Period||0
478241|NCT00452673|1143381|P3|COMPLETED|Dose Escalation Period||0
478242|NCT00452673|1143382|P2|COMPLETED|Dose Escalation Period||0
478243|NCT00452673|1143383|P1|COMPLETED|Dose Escalation Period||0
478244|NCT00452673|1143379|P5|STARTED|Dose Escalation Period||0
478245|NCT00452673|1143380|P4|STARTED|Dose Escalation Period||9
478246|NCT00452673|1143381|P3|STARTED|Dose Escalation Period||6
478247|NCT00452673|1143382|P2|STARTED|Dose Escalation Period||9
478248|NCT00452673|1143383|P1|STARTED|Dose Escalation Period||7
478249|NCT00452543|1143415|P2|NOT COMPLETED|Overall Study||6
478250|NCT00452543|1143416|P1|NOT COMPLETED|Overall Study||5
478251|NCT00452543|1143415|P2|COMPLETED|Overall Study||5
478252|NCT00452543|1143416|P1|COMPLETED|Overall Study||7
478253|NCT00452543|1143415|P2|STARTED|Overall Study||11
478254|NCT00452543|1143416|P1|STARTED|Overall Study||12
478255|NCT00452530|1143430|P2|NOT COMPLETED|Overall Study||136
478256|NCT00452530|1143431|P1|NOT COMPLETED|Overall Study||136
478257|NCT00452530|1143430|P2|COMPLETED|Overall Study||1393
478258|NCT00452530|1143431|P1|COMPLETED|Overall Study||1392
478259|NCT00452530|1143430|P2|Primary Participants|Overall Study||997
478260|NCT00452530|1143431|P1|Primary Participants|Overall Study||976
478261|NCT00452530|1143430|P2|Evaluable Participants|Overall Study||921
478262|NCT00452530|1143431|P1|Evaluable Participants|Overall Study||907
478263|NCT00452530|1143430|P2|Received Treatment|Overall Study||1508
478264|NCT00452530|1143431|P1|Received Treatment|Overall Study||1501
478265|NCT00452530|1143430|P2|STARTED|Overall Study|Randomized|1529
478266|NCT00452530|1143431|P1|STARTED|Overall Study|Randomized|1528
478267|NCT00452452|1143452|P3|NOT COMPLETED|Overall Study||1
478268|NCT00452452|1143453|P2|NOT COMPLETED|Overall Study||0
478269|NCT00452452|1143454|P1|NOT COMPLETED|Overall Study||2
478270|NCT00452452|1143452|P3|COMPLETED|Overall Study||152
478271|NCT00452452|1143453|P2|COMPLETED|Overall Study||112
478272|NCT00452452|1143454|P1|COMPLETED|Overall Study||88
478273|NCT00452452|1143452|P3|Vaccinated Dose 3|Overall Study||0
478274|NCT00452452|1143453|P2|Vaccinated Dose 3|Overall Study||0
478275|NCT00452452|1143454|P1|Vaccinated Dose 3|Overall Study||89
478276|NCT00452452|1143452|P3|Vaccinated Dose 2|Overall Study||0
478277|NCT00452452|1143453|P2|Vaccinated Dose 2|Overall Study||112
478278|NCT00452452|1143454|P1|Vaccinated Dose 2|Overall Study||90
478279|NCT00452452|1143452|P3|Vaccinated Dose 1|Overall Study||152
478280|NCT00452452|1143453|P2|Vaccinated Dose 1|Overall Study||112
478281|NCT00452452|1143454|P1|Vaccinated Dose 1|Overall Study||90
478282|NCT00452452|1143452|P3|STARTED|Overall Study||153
478283|NCT00452452|1143453|P2|STARTED|Overall Study||112
478284|NCT00452452|1143454|P1|STARTED|Overall Study||90
478285|NCT00452426|1143479|P2|NOT COMPLETED|Overall Study||11
478286|NCT00452426|1143480|P1|NOT COMPLETED|Overall Study||7
478287|NCT00452426|1143479|P2|COMPLETED|Overall Study||493
478288|NCT00452426|1143480|P1|COMPLETED|Overall Study||489
478289|NCT00452426|1143479|P2|STARTED|Overall Study||504
478290|NCT00452426|1143480|P1|STARTED|Overall Study||496
478291|NCT00452400|1143499|P5|NOT COMPLETED|Overall Study||3
478292|NCT00452400|1143500|P4|NOT COMPLETED|Overall Study||1
478293|NCT00452400|1143501|P3|NOT COMPLETED|Overall Study||7
478294|NCT00452400|1143502|P2|NOT COMPLETED|Overall Study||1
478295|NCT00452400|1143503|P1|NOT COMPLETED|Overall Study||5
478296|NCT00452400|1143499|P5|COMPLETED|Overall Study||76
478297|NCT00452400|1143500|P4|COMPLETED|Overall Study||85
478298|NCT00452400|1143501|P3|COMPLETED|Overall Study||73
478299|NCT00452400|1143502|P2|COMPLETED|Overall Study||80
478300|NCT00452400|1143503|P1|COMPLETED|Overall Study||74
478301|NCT00452400|1143499|P5|STARTED|Overall Study||79
478302|NCT00452400|1143500|P4|STARTED|Overall Study||86
478303|NCT00452400|1143501|P3|STARTED|Overall Study||80
478304|NCT00452400|1143502|P2|STARTED|Overall Study||81
478305|NCT00452400|1143503|P1|STARTED|Overall Study||79
478306|NCT00452387|1143675|P1|NOT COMPLETED|Overall Study||0
478307|NCT00452387|1143675|P1|COMPLETED|Overall Study||22
478308|NCT00452387|1143675|P1|STARTED|Overall Study||22
478309|NCT00452374|1143683|P1|NOT COMPLETED|Overall Study||0
478310|NCT00452374|1143683|P1|COMPLETED|Overall Study||48
478311|NCT00452374|1143683|P1|STARTED|Overall Study||48
478312|NCT00452361|1143690|P2|NOT COMPLETED|Overall Study||10
478313|NCT00452361|1143691|P1|NOT COMPLETED|Overall Study||21
478314|NCT00452361|1143690|P2|COMPLETED|Overall Study||0
478315|NCT00452361|1143691|P1|COMPLETED|Overall Study||0
478316|NCT00452361|1143690|P2|STARTED|Overall Study||10
478317|NCT00452361|1143691|P1|STARTED|Overall Study||21
478318|NCT00452348|1143735|P2|NOT COMPLETED|Overall Study||84
478319|NCT00452348|1143736|P1|NOT COMPLETED|Overall Study||79
478320|NCT00452348|1143735|P2|COMPLETED|Overall Study||234
478321|NCT00452348|1143736|P1|COMPLETED|Overall Study||231
478322|NCT00452348|1143735|P2|STARTED|Overall Study||318
478323|NCT00452348|1143736|P1|STARTED|Overall Study||310
478324|NCT00452335|1143751|P3|NOT COMPLETED|Overall Study||9
478325|NCT00452335|1143752|P2|NOT COMPLETED|Overall Study||4
478326|NCT00452335|1143753|P1|NOT COMPLETED|Overall Study||2
478327|NCT00452335|1143751|P3|COMPLETED|Overall Study||23
478328|NCT00452335|1143752|P2|COMPLETED|Overall Study||61
478329|NCT00452335|1143753|P1|COMPLETED|Overall Study||25
478330|NCT00452335|1143751|P3|STARTED|Overall Study||32
478331|NCT00452335|1143752|P2|STARTED|Overall Study||65
478332|NCT00452335|1143753|P1|STARTED|Overall Study||27
478333|NCT00452114|1143790|P2|NOT COMPLETED|Overall Study||3
478334|NCT00452114|1143791|P1|NOT COMPLETED|Overall Study||3
478335|NCT00452114|1143790|P2|COMPLETED|Overall Study||10
478336|NCT00452114|1143791|P1|COMPLETED|Overall Study||12
478337|NCT00452114|1143790|P2|STARTED|Overall Study||13
478338|NCT00452114|1143791|P1|STARTED|Overall Study||15
478339|NCT00451958|1143801|P5|NOT COMPLETED|CS21A (NCT00451958)||0
478340|NCT00451958|1143802|P4|NOT COMPLETED|CS21A (NCT00451958)||39
478341|NCT00451958|1143803|P3|NOT COMPLETED|CS21A (NCT00451958)||42
478342|NCT00451958|1143804|P2|NOT COMPLETED|CS21A (NCT00451958)||77
478343|NCT00451958|1143805|P1|NOT COMPLETED|CS21A (NCT00451958)||65
478344|NCT00451958|1143801|P5|COMPLETED|CS21A (NCT00451958)||0
478345|NCT00451958|1143802|P4|COMPLETED|CS21A (NCT00451958)||27
478346|NCT00451958|1143803|P3|COMPLETED|CS21A (NCT00451958)||27
478347|NCT00451958|1143804|P2|COMPLETED|CS21A (NCT00451958)||49
478348|NCT00451958|1143805|P1|COMPLETED|CS21A (NCT00451958)||60
478349|NCT00451958|1143801|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
478350|NCT00451958|1143802|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
478351|NCT00451958|1143803|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
478352|NCT00451958|1143804|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
478353|NCT00451958|1143805|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
478354|NCT00451958|1143801|P5|NOT COMPLETED|CS21 (NCT00295750)||32
478355|NCT00451958|1143802|P4|NOT COMPLETED|CS21 (NCT00295750)||0
478356|NCT00451958|1143803|P3|NOT COMPLETED|CS21 (NCT00295750)||0
478357|NCT00451958|1143804|P2|NOT COMPLETED|CS21 (NCT00295750)||43
478358|NCT00451958|1143805|P1|NOT COMPLETED|CS21 (NCT00295750)||41
478359|NCT00451958|1143801|P5|COMPLETED|CS21 (NCT00295750)||172
478360|NCT00451958|1143802|P4|COMPLETED|CS21 (NCT00295750)||0
478361|NCT00451958|1143803|P3|COMPLETED|CS21 (NCT00295750)||0
478362|NCT00451958|1143804|P2|COMPLETED|CS21 (NCT00295750)||163
478363|NCT00451958|1143805|P1|COMPLETED|CS21 (NCT00295750)||169
478364|NCT00451958|1143801|P5|STARTED|CS21 (NCT00295750)||204
478365|NCT00451958|1143802|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
478366|NCT00451958|1143803|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
478367|NCT00451958|1143804|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
478368|NCT00451958|1143805|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
478369|NCT00450866|1143835|P2|NOT COMPLETED|Overall Study||3
478370|NCT00450866|1143836|P1|NOT COMPLETED|Overall Study||7
478371|NCT00450866|1143835|P2|COMPLETED|Overall Study||7
478372|NCT00450866|1143836|P1|COMPLETED|Overall Study||38
478373|NCT00450866|1143835|P2|STARTED|Overall Study||10
478374|NCT00450866|1143836|P1|STARTED|Overall Study||45
478375|NCT00450801|1143846|P1|NOT COMPLETED|Overall Study||1
478376|NCT00450801|1143846|P1|COMPLETED|Overall Study||21
478377|NCT00450801|1143846|P1|STARTED|Overall Study||22
478378|NCT00450749|1143860|P3|NOT COMPLETED|Overall Study||2
478379|NCT00450749|1143861|P2|NOT COMPLETED|Overall Study||1
478380|NCT00450749|1143862|P1|NOT COMPLETED|Overall Study||0
478381|NCT00450749|1143860|P3|COMPLETED|Overall Study||2
478382|NCT00450749|1143861|P2|COMPLETED|Overall Study||2
478383|NCT00450749|1143862|P1|COMPLETED|Overall Study||3
478384|NCT00450749|1143860|P3|STARTED|Overall Study||4
478385|NCT00450749|1143861|P2|STARTED|Overall Study||3
478386|NCT00450749|1143862|P1|STARTED|Overall Study||3
478387|NCT00450723|1143870|P1|NOT COMPLETED|Overall Study||5
478388|NCT00450723|1143870|P1|COMPLETED|Overall Study||34
478389|NCT00450723|1143870|P1|STARTED|Overall Study||39
478390|NCT00451906|1143876|P1|NOT COMPLETED|Overall Study||2239
478391|NCT00451906|1143876|P1|COMPLETED|Overall Study||13
478392|NCT00451906|1143876|P1|STARTED|Overall Study||2252
478393|NCT00451698|1143886|P2|NOT COMPLETED|Overall Study||0
478394|NCT00451698|1143887|P1|NOT COMPLETED|Overall Study||0
478395|NCT00451698|1143886|P2|COMPLETED|Overall Study||6
478396|NCT00451698|1143887|P1|COMPLETED|Overall Study||3
478397|NCT00451698|1143886|P2|STARTED|Overall Study||6
478398|NCT00451698|1143887|P1|STARTED|Overall Study||3
478399|NCT00451451|1143899|P4|NOT COMPLETED|Overall Study||58
478400|NCT00451451|1143900|P3|NOT COMPLETED|Overall Study||72
478401|NCT00451451|1143901|P2|NOT COMPLETED|Overall Study||75
478402|NCT00451451|1143902|P1|NOT COMPLETED|Overall Study||85
478403|NCT00451451|1143899|P4|COMPLETED|Overall Study||292
478404|NCT00451451|1143900|P3|COMPLETED|Overall Study||273
478405|NCT00451451|1143901|P2|COMPLETED|Overall Study||284
478406|NCT00451451|1143902|P1|COMPLETED|Overall Study||278
478407|NCT00451451|1143899|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
478408|NCT00451451|1143900|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
478409|NCT00451451|1143901|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
478410|NCT00451451|1143902|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
478411|NCT00451282|1143931|P2|NOT COMPLETED|Overall Study||5
478412|NCT00451282|1143932|P1|NOT COMPLETED|Overall Study||6
478413|NCT00451282|1143931|P2|COMPLETED|Overall Study||34
478414|NCT00451282|1143932|P1|COMPLETED|Overall Study||40
478415|NCT00451282|1143931|P2|STARTED|Overall Study||39
478416|NCT00451282|1143932|P1|STARTED|Overall Study||46
478417|NCT00451204|1143946|P2|NOT COMPLETED|Overall Study||20
478418|NCT00451204|1143947|P1|NOT COMPLETED|Overall Study||22
478419|NCT00451204|1143946|P2|COMPLETED|Overall Study||56
478420|NCT00451204|1143947|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
478421|NCT00451204|1143946|P2|STARTED|Overall Study||76
478422|NCT00451204|1143947|P1|STARTED|Overall Study||82
478423|NCT00451191|1143965|P2|NOT COMPLETED|Overall Study||11
478424|NCT00451191|1143966|P1|NOT COMPLETED|Overall Study||15
478425|NCT00451191|1143965|P2|COMPLETED|Overall Study||55
478426|NCT00451191|1143966|P1|COMPLETED|Overall Study||53
478427|NCT00451191|1143965|P2|STARTED|Overall Study||66
478428|NCT00451191|1143966|P1|STARTED|Overall Study||68
478429|NCT00451048|1143972|P1|NOT COMPLETED|Overall Study||0
478430|NCT00451048|1143972|P1|COMPLETED|Overall Study||10
478431|NCT00451048|1143972|P1|STARTED|Overall Study||10
478432|NCT00450983|1143976|P1|NOT COMPLETED|Overall Study||0
478433|NCT00450983|1143976|P1|COMPLETED|Overall Study||1
478434|NCT00450983|1143976|P1|STARTED|Overall Study||1
478435|NCT00450658|1143990|P2|NOT COMPLETED|Overall Study||90
478436|NCT00450658|1143991|P1|NOT COMPLETED|Overall Study||143
478437|NCT00450658|1143990|P2|COMPLETED|Overall Study||122
478438|NCT00450658|1143991|P1|COMPLETED|Overall Study||272
478439|NCT00450658|1143990|P2|STARTED|Overall Study||212
478440|NCT00450658|1143991|P1|STARTED|Overall Study||415
478441|NCT00450619|1144005|P2|NOT COMPLETED|Overall Study||1
478442|NCT00450619|1144006|P1|NOT COMPLETED|Overall Study||4
478443|NCT00450619|1144005|P2|COMPLETED|Overall Study||21
478444|NCT00450619|1144006|P1|COMPLETED|Overall Study||18
478445|NCT00450619|1144005|P2|STARTED|Overall Study||22
478446|NCT00450619|1144006|P1|STARTED|Overall Study||22
478447|NCT00450580|1144032|P2|NOT COMPLETED|Overall Study||16
478448|NCT00450580|1144033|P1|NOT COMPLETED|Overall Study||16
478449|NCT00450580|1144032|P2|COMPLETED|Overall Study||90
478450|NCT00450580|1144033|P1|COMPLETED|Overall Study||90
478451|NCT00450580|1144032|P2|STARTED|Overall Study||106
478452|NCT00450580|1144033|P1|STARTED|Overall Study||106
478453|NCT00450450|1144053|P2|NOT COMPLETED|Overall Study||3
478454|NCT00450450|1144054|P1|NOT COMPLETED|Overall Study||5
478455|NCT00450450|1144053|P2|COMPLETED|Overall Study||11
478456|NCT00450450|1144054|P1|COMPLETED|Overall Study||8
478457|NCT00450450|1144053|P2|STARTED|Overall Study||14
478458|NCT00450450|1144054|P1|STARTED|Overall Study||13
478459|NCT00450437|1144078|P4|NOT COMPLETED|Overall Study||11
478460|NCT00450437|1144079|P3|NOT COMPLETED|Overall Study||24
478461|NCT00450437|1144080|P2|NOT COMPLETED|Overall Study||16
478462|NCT00450437|1144081|P1|NOT COMPLETED|Overall Study||46
478463|NCT00450437|1144078|P4|COMPLETED|Overall Study||325
478464|NCT00450437|1144079|P3|COMPLETED|Overall Study||999
478465|NCT00450437|1144080|P2|COMPLETED|Overall Study||524
478466|NCT00450437|1144081|P1|COMPLETED|Overall Study||1594
478467|NCT00450437|1144078|P4|STARTED|Overall Study||336
478468|NCT00450437|1144079|P3|STARTED|Overall Study||1023
478469|NCT00450437|1144080|P2|STARTED|Overall Study||540
478470|NCT00450437|1144081|P1|STARTED|Overall Study||1640
478471|NCT00450424|1144105|P2|NOT COMPLETED|Overall Study||11
478472|NCT00450424|1144106|P1|NOT COMPLETED|Overall Study||20
478473|NCT00450424|1144105|P2|COMPLETED|Overall Study||106
478474|NCT00450424|1144106|P1|COMPLETED|Overall Study||102
478475|NCT00450424|1144105|P2|STARTED|Overall Study||117
478476|NCT00450424|1144106|P1|STARTED|Overall Study||122
478477|NCT00450372|1144112|P1|NOT COMPLETED|Overall Study||1
478478|NCT00450372|1144112|P1|COMPLETED|Overall Study||37
478479|NCT00450372|1144112|P1|STARTED|Overall Study||38
478480|NCT00450333|1144125|P4|NOT COMPLETED|Overall Study||28
478481|NCT00450333|1144126|P3|NOT COMPLETED|Overall Study||25
478482|NCT00450333|1144127|P2|NOT COMPLETED|Overall Study||63
478483|NCT00450333|1144128|P1|NOT COMPLETED|Overall Study||54
478484|NCT00450333|1144125|P4|COMPLETED|Overall Study||74
478485|NCT00450333|1144126|P3|COMPLETED|Overall Study||75
478486|NCT00450333|1144127|P2|COMPLETED|Overall Study||44
478487|NCT00450333|1144128|P1|COMPLETED|Overall Study||44
478488|NCT00450333|1144125|P4|STARTED|Overall Study||102
478489|NCT00450333|1144126|P3|STARTED|Overall Study||100
478490|NCT00450333|1144127|P2|STARTED|Overall Study||107
478491|NCT00450333|1144128|P1|STARTED|Overall Study||98
478492|NCT00450294|1144146|P1|NOT COMPLETED|Overall Study||0
478493|NCT00450294|1144146|P1|COMPLETED|Overall Study||10
478494|NCT00450294|1144146|P1|STARTED|Overall Study||10
478495|NCT00450255|1144151|P1|NOT COMPLETED|Overall Study||1
478496|NCT00450255|1144151|P1|COMPLETED|Overall Study||40
478497|NCT00450255|1144151|P1|STARTED|Overall Study||41
478498|NCT00450242|1144159|P2|NOT COMPLETED|Overall Study||1
478499|NCT00450242|1144160|P1|NOT COMPLETED|Overall Study||3
478500|NCT00450242|1144159|P2|COMPLETED|Overall Study||6
478501|NCT00450242|1144160|P1|COMPLETED|Overall Study||4
478502|NCT00450242|1144159|P2|STARTED|Overall Study||7
478503|NCT00450242|1144160|P1|STARTED|Overall Study||7
478504|NCT00450216|1144174|P2|NOT COMPLETED|Overall Study||129
478505|NCT00450216|1144175|P1|NOT COMPLETED|Overall Study||174
478506|NCT00450216|1144174|P2|COMPLETED|Overall Study||170
478507|NCT00450216|1144175|P1|COMPLETED|Overall Study||433
478508|NCT00450216|1144174|P2|STARTED|Overall Study||299
478509|NCT00450216|1144175|P1|STARTED|Overall Study||607
478510|NCT00450112|1144189|P2|NOT COMPLETED|Overall Study||6
478511|NCT00450112|1144190|P1|NOT COMPLETED|Overall Study||13
478512|NCT00450112|1144189|P2|COMPLETED|Overall Study||71
478513|NCT00450112|1144190|P1|COMPLETED|Overall Study||112
478514|NCT00450112|1144189|P2|Analyzed Participants|Overall Study||74
478515|NCT00450112|1144190|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
478516|NCT00450112|1144189|P2|Received Injection|Overall Study||74
478517|NCT00450112|1144190|P1|Received Injection|Overall Study||125
478518|NCT00450112|1144189|P2|STARTED|Overall Study||77
478519|NCT00450112|1144190|P1|STARTED|Overall Study||125
478520|NCT00450073|1144215|P3|NOT COMPLETED|Overall Study||1
478521|NCT00450073|1144216|P2|NOT COMPLETED|Overall Study||0
478522|NCT00450073|1144217|P1|NOT COMPLETED|Overall Study||1
478523|NCT00450073|1144215|P3|COMPLETED|Overall Study||9
478524|NCT00450073|1144216|P2|COMPLETED|Overall Study||10
478525|NCT00450073|1144217|P1|COMPLETED|Overall Study||9
478526|NCT00450073|1144215|P3|STARTED|Overall Study||10
478527|NCT00450073|1144216|P2|STARTED|Overall Study||10
478528|NCT00450073|1144217|P1|STARTED|Overall Study||10
478529|NCT00449956|1144228|P3|NOT COMPLETED|Overall Study||9
478530|NCT00449956|1144229|P2|NOT COMPLETED|Overall Study||4
478531|NCT00449956|1144230|P1|NOT COMPLETED|Overall Study||10
478532|NCT00449956|1144228|P3|COMPLETED|Overall Study||184
478533|NCT00449956|1144229|P2|COMPLETED|Overall Study||88
478534|NCT00449956|1144230|P1|COMPLETED|Overall Study||179
478535|NCT00449956|1144228|P3|STARTED|Overall Study||193
478536|NCT00449956|1144229|P2|STARTED|Overall Study||92
478537|NCT00449956|1144230|P1|STARTED|Overall Study||189
478538|NCT00449930|1144246|P2|NOT COMPLETED|Overall Study||75
478539|NCT00449930|1144247|P1|NOT COMPLETED|Overall Study||61
478540|NCT00449930|1144246|P2|COMPLETED|Overall Study||447
478541|NCT00449930|1144247|P1|COMPLETED|Overall Study||467
478542|NCT00449930|1144246|P2|STARTED|Overall Study||522
478543|NCT00449930|1144247|P1|STARTED|Overall Study||528
478544|NCT00449865|1144263|P2|NOT COMPLETED|Overall Study||534
478545|NCT00449865|1144264|P1|NOT COMPLETED|Overall Study||522
478546|NCT00449865|1144263|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
478547|NCT00449865|1144264|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
478548|NCT00449865|1144263|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
478549|NCT00449865|1144264|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
478550|NCT00449865|1144263|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
478551|NCT00449865|1144264|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
478552|NCT00449865|1144263|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
478553|NCT00449865|1144264|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
478554|NCT00449865|1144263|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
478555|NCT00449865|1144264|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
478556|NCT00449865|1144263|P2|STARTED|Overall Study||874
478557|NCT00449865|1144264|P1|STARTED|Overall Study||867
478558|NCT00449787|1144272|P2|NOT COMPLETED|Overall Study||100
478559|NCT00449787|1144273|P1|NOT COMPLETED|Overall Study||105
478560|NCT00449787|1144272|P2|COMPLETED|Overall Study||98
478561|NCT00449787|1144273|P1|COMPLETED|Overall Study||98
478562|NCT00449787|1144272|P2|STARTED|Overall Study||198
478563|NCT00449787|1144273|P1|STARTED|Overall Study||203
478564|NCT00449748|1144283|P1|NOT COMPLETED|Overall Study||0
478565|NCT00449748|1144283|P1|COMPLETED|Overall Study||10
478566|NCT00449748|1144283|P1|STARTED|Overall Study||10
478567|NCT00449696|1144289|P2|NOT COMPLETED|Overall Study||9
478568|NCT00449696|1144290|P1|NOT COMPLETED|Overall Study||20
478569|NCT00449696|1144289|P2|COMPLETED|Overall Study||119
478570|NCT00449696|1144290|P1|COMPLETED|Overall Study||231
478571|NCT00449696|1144289|P2|Analyzed Participants|Overall Study||128
478572|NCT00449696|1144290|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
478573|NCT00449696|1144289|P2|Received Injection|Overall Study||128
478574|NCT00449696|1144290|P1|Received Injection|Overall Study||249
478575|NCT00449696|1144289|P2|STARTED|Overall Study||128
478576|NCT00449696|1144290|P1|STARTED|Overall Study||251
478577|NCT00449644|1144316|P4|NOT COMPLETED|Overall Study||32
478578|NCT00449644|1144317|P3|NOT COMPLETED|Overall Study||29
478579|NCT00449644|1144318|P2|NOT COMPLETED|Overall Study||13
478580|NCT00449644|1144319|P1|NOT COMPLETED|Overall Study||10
478581|NCT00449644|1144316|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
478582|NCT00449644|1144317|P3|COMPLETED|Overall Study||50
478583|NCT00449644|1144318|P2|COMPLETED|Overall Study||11
478584|NCT00449644|1144319|P1|COMPLETED|Overall Study||13
478585|NCT00449644|1144316|P4|Rollover|Overall Study||1
478586|NCT00449644|1144317|P3|Rollover|Overall Study||0
478587|NCT00449644|1144318|P2|Rollover|Overall Study||0
478588|NCT00449644|1144319|P1|Rollover|Overall Study||0
478589|NCT00449644|1144316|P4|STARTED|Overall Study||81
478590|NCT00449644|1144317|P3|STARTED|Overall Study||79
478591|NCT00449644|1144318|P2|STARTED|Overall Study||24
478592|NCT00449644|1144319|P1|STARTED|Overall Study||23
478593|NCT00449540|1144339|P3|NOT COMPLETED|Treatment Phase||17
478594|NCT00449540|1144340|P2|NOT COMPLETED|Treatment Phase||20
478595|NCT00449540|1144341|P1|NOT COMPLETED|Treatment Phase||0
478596|NCT00449540|1144339|P3|COMPLETED|Treatment Phase||82
478597|NCT00449540|1144340|P2|COMPLETED|Treatment Phase||82
478598|NCT00449540|1144341|P1|COMPLETED|Treatment Phase||0
478599|NCT00449540|1144339|P3|STARTED|Treatment Phase||99
478600|NCT00449540|1144340|P2|STARTED|Treatment Phase||102
478601|NCT00449540|1144341|P1|STARTED|Treatment Phase||0
478602|NCT00449540|1144339|P3|NOT COMPLETED|Pretreatment Phase||0
478603|NCT00449540|1144340|P2|NOT COMPLETED|Pretreatment Phase||0
478604|NCT00449540|1144341|P1|NOT COMPLETED|Pretreatment Phase||66
478605|NCT00449540|1144339|P3|COMPLETED|Pretreatment Phase||0
478606|NCT00449540|1144340|P2|COMPLETED|Pretreatment Phase||0
478607|NCT00449540|1144341|P1|COMPLETED|Pretreatment Phase||201
478608|NCT00449540|1144339|P3|STARTED|Pretreatment Phase||0
478609|NCT00449540|1144340|P2|STARTED|Pretreatment Phase||0
478610|NCT00449540|1144341|P1|STARTED|Pretreatment Phase||267
478611|NCT00449176|1144358|P3|NOT COMPLETED|Overall Study||167
478612|NCT00449176|1144359|P2|NOT COMPLETED|Overall Study||195
478613|NCT00449176|1144360|P1|NOT COMPLETED|Overall Study||152
478614|NCT00449176|1144358|P3|COMPLETED|Overall Study||152
478615|NCT00449176|1144359|P2|COMPLETED|Overall Study||133
478616|NCT00449176|1144360|P1|COMPLETED|Overall Study||166
478617|NCT00449176|1144358|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
478618|NCT00449176|1144359|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
478619|NCT00449176|1144360|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
478620|NCT00449163|1144386|P1|NOT COMPLETED|Overall Study||3
478621|NCT00449163|1144386|P1|COMPLETED|Overall Study||22
478622|NCT00449163|1144386|P1|STARTED|Overall Study||25
478623|NCT00449150|1144396|P3|NOT COMPLETED|Overall Study||47
478624|NCT00449150|1144397|P2|NOT COMPLETED|Overall Study||53
478625|NCT00449150|1144398|P1|NOT COMPLETED|Overall Study||46
478626|NCT00449150|1144396|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
478627|NCT00449150|1144397|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
478628|NCT00449150|1144398|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
478629|NCT00449150|1144396|P3|STARTED|Overall Study||218
478630|NCT00449150|1144397|P2|STARTED|Overall Study||230
478631|NCT00449150|1144398|P1|STARTED|Overall Study||219
478632|NCT00449072|1144408|P2|NOT COMPLETED|Overall Study||42
478633|NCT00449072|1144409|P1|NOT COMPLETED|Overall Study||41
478634|NCT00449072|1144408|P2|COMPLETED|Overall Study||109
478635|NCT00449072|1144409|P1|COMPLETED|Overall Study||107
478636|NCT00449072|1144408|P2|STARTED|Overall Study||151
478637|NCT00449072|1144409|P1|STARTED|Overall Study||148
478638|NCT00449046|1144433|P1|NOT COMPLETED|Overall Study||0
478639|NCT00449046|1144433|P1|COMPLETED|Overall Study||40
478640|NCT00449046|1144433|P1|STARTED|Overall Study||40
478641|NCT00449033|1144446|P2|NOT COMPLETED|Follow-up Period||434
478642|NCT00449033|1144447|P1|NOT COMPLETED|Follow-up Period||425
478643|NCT00449033|1144446|P2|COMPLETED|Follow-up Period||0
478644|NCT00449033|1144447|P1|COMPLETED|Follow-up Period||0
478645|NCT00449033|1144446|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
478646|NCT00449033|1144447|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
478647|NCT00449033|1144446|P2|NOT COMPLETED|Treatment Period||452
478648|NCT00449033|1144447|P1|NOT COMPLETED|Treatment Period||452
478649|NCT00449033|1144446|P2|COMPLETED|Treatment Period||0
478650|NCT00449033|1144447|P1|COMPLETED|Treatment Period||0
478651|NCT00449033|1144446|P2|Received Treatment|Treatment Period||449
478652|NCT00449033|1144447|P1|Received Treatment|Treatment Period||452
478653|NCT00449033|1144446|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
478654|NCT00449033|1144447|P1|STARTED|Treatment Period||452
478655|NCT00448916|1144485|P4|NOT COMPLETED|Overall Study||6
478656|NCT00448916|1144486|P3|NOT COMPLETED|Overall Study||6
478657|NCT00448916|1144487|P2|NOT COMPLETED|Overall Study||6
478658|NCT00448916|1144488|P1|NOT COMPLETED|Overall Study||7
478659|NCT00448916|1144485|P4|COMPLETED|Overall Study||5
478660|NCT00448916|1144486|P3|COMPLETED|Overall Study||6
478661|NCT00448916|1144487|P2|COMPLETED|Overall Study||9
478662|NCT00448916|1144488|P1|COMPLETED|Overall Study||9
478663|NCT00448916|1144485|P4|STARTED|Overall Study||11
478664|NCT00448916|1144486|P3|STARTED|Overall Study||12
478665|NCT00448916|1144487|P2|STARTED|Overall Study||15
478666|NCT00448916|1144488|P1|STARTED|Overall Study||16
478667|NCT00448864|1144562|P3|NOT COMPLETED|Overall Study||1
478668|NCT00448864|1144563|P2|NOT COMPLETED|Overall Study||5
478669|NCT00448864|1144564|P1|NOT COMPLETED|Overall Study||5
478670|NCT00448864|1144562|P3|COMPLETED|Overall Study||18
478671|NCT00448864|1144563|P2|COMPLETED|Overall Study||24
478672|NCT00448864|1144564|P1|COMPLETED|Overall Study||22
478673|NCT00448864|1144562|P3|Completed Post-operative Period|Overall Study||18
478674|NCT00448864|1144563|P2|Completed Post-operative Period|Overall Study||25
478675|NCT00448864|1144564|P1|Completed Post-operative Period|Overall Study||26
478676|NCT00448864|1144562|P3|Started Post-operative Period|Overall Study||18
478677|NCT00448864|1144563|P2|Started Post-operative Period|Overall Study||25
478678|NCT00448864|1144564|P1|Started Post-operative Period|Overall Study||26
478679|NCT00448864|1144562|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
478680|NCT00448864|1144563|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
478681|NCT00448864|1144564|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
478682|NCT00448864|1144562|P3|STARTED|Overall Study||19
478683|NCT00448864|1144563|P2|STARTED|Overall Study||29
478684|NCT00448864|1144564|P1|STARTED|Overall Study||27
478685|NCT00448760|1144580|P1|NOT COMPLETED|Overall Study||3
478686|NCT00448760|1144580|P1|COMPLETED|Overall Study||26
478687|NCT00448760|1144580|P1|STARTED|Overall Study||29
478688|NCT00448708|1144589|P2|NOT COMPLETED|Overall Study||31
478689|NCT00448708|1144590|P1|NOT COMPLETED|Overall Study||35
478690|NCT00448708|1144589|P2|COMPLETED|Overall Study||79
478691|NCT00448708|1144590|P1|COMPLETED|Overall Study||77
478692|NCT00448708|1144589|P2|STARTED|Overall Study||110
478693|NCT00448708|1144590|P1|STARTED|Overall Study||112
478694|NCT00448682|1144598|P1|NOT COMPLETED|Overall Study||0
478695|NCT00448682|1144598|P1|COMPLETED|Overall Study||25
478696|NCT00448682|1144598|P1|STARTED|Overall Study||25
478697|NCT00448630|1144604|P1|NOT COMPLETED|Overall Study||27
478698|NCT00448630|1144604|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
478699|NCT00448630|1144604|P1|STARTED|Overall Study||328
478700|NCT00448591|1144649|P1|NOT COMPLETED|Overall Study||2296
478701|NCT00448591|1144649|P1|COMPLETED|Overall Study||0
478702|NCT00448591|1144649|P1|STARTED|Overall Study||2296
478703|NCT00448539|1144660|P2|NOT COMPLETED|Overall Study||152
478704|NCT00448539|1144661|P1|NOT COMPLETED|Overall Study||134
478705|NCT00448539|1144660|P2|COMPLETED|Overall Study||0
478706|NCT00448539|1144661|P1|COMPLETED|Overall Study||0
478707|NCT00448539|1144660|P2|STARTED|Overall Study||152
478708|NCT00448539|1144661|P1|STARTED|Overall Study||134
478709|NCT00448448|1144669|P2|NOT COMPLETED|Overall Study||41
478710|NCT00448448|1144670|P1|NOT COMPLETED|Overall Study||100
478711|NCT00448448|1144669|P2|COMPLETED|Overall Study||96
478712|NCT00448448|1144670|P1|COMPLETED|Overall Study||146
478713|NCT00448448|1144669|P2|STARTED|Overall Study||137
478714|NCT00448448|1144670|P1|STARTED|Overall Study||246
478715|NCT00448435|1144676|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
478716|NCT00448435|1144677|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
478717|NCT00448435|1144676|P2|COMPLETED|Extension Period - 20 Weeks||0
478718|NCT00448435|1144677|P1|COMPLETED|Extension Period - 20 Weeks||50
478719|NCT00448435|1144676|P2|STARTED|Extension Period - 20 Weeks||0
478720|NCT00448435|1144677|P1|STARTED|Extension Period - 20 Weeks||50
478721|NCT00448435|1144676|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
478722|NCT00448435|1144677|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
478723|NCT00448435|1144676|P2|COMPLETED|Treatment Period II - 4 Weeks||25
478724|NCT00448435|1144677|P1|COMPLETED|Treatment Period II - 4 Weeks||25
478725|NCT00448435|1144676|P2|STARTED|Treatment Period II - 4 Weeks||25
478726|NCT00448435|1144677|P1|STARTED|Treatment Period II - 4 Weeks||25
478727|NCT00448435|1144676|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
478728|NCT00448435|1144677|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
478729|NCT00448435|1144676|P2|COMPLETED|Washout Period - 2 Weeks||25
478730|NCT00448435|1144677|P1|COMPLETED|Washout Period - 2 Weeks||25
478731|NCT00448435|1144676|P2|STARTED|Washout Period - 2 Weeks||25
478732|NCT00448435|1144677|P1|STARTED|Washout Period - 2 Weeks||26
478733|NCT00448435|1144676|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
478734|NCT00448435|1144677|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
478735|NCT00448435|1144676|P2|COMPLETED|Treatment Period I - 4 Weeks||25
478736|NCT00448435|1144677|P1|COMPLETED|Treatment Period I - 4 Weeks||26
478737|NCT00448435|1144676|P2|STARTED|Treatment Period I - 4 Weeks||25
478738|NCT00448435|1144677|P1|STARTED|Treatment Period I - 4 Weeks||26
478739|NCT00448344|1144705|P2|NOT COMPLETED|Overall Study||36
478740|NCT00448344|1144706|P1|NOT COMPLETED|Overall Study||30
478741|NCT00448344|1144705|P2|COMPLETED|Overall Study||200
478742|NCT00448344|1144706|P1|COMPLETED|Overall Study||205
478743|NCT00448344|1144705|P2|STARTED|Overall Study||236
478744|NCT00448344|1144706|P1|STARTED|Overall Study||235
478745|NCT00448279|1144716|P2|NOT COMPLETED|Overall Study||29
478746|NCT00448279|1144717|P1|NOT COMPLETED|Overall Study||29
478747|NCT00448279|1144716|P2|COMPLETED|Overall Study||0
478748|NCT00448279|1144717|P1|COMPLETED|Overall Study||0
478749|NCT00448279|1144716|P2|STARTED|Overall Study||29
478750|NCT00448279|1144717|P1|STARTED|Overall Study||29
478751|NCT00448227|1144733|P1|NOT COMPLETED|Overall Study||0
478752|NCT00448227|1144733|P1|COMPLETED|Overall Study||18
478753|NCT00448227|1144733|P1|STARTED|Overall Study||18
478754|NCT00448201|1144760|P1|NOT COMPLETED|Overall Study||0
478755|NCT00448201|1144760|P1|COMPLETED|Overall Study||71
478756|NCT00448201|1144760|P1|STARTED|Overall Study||71
478757|NCT00448175|1144771|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
478758|NCT00448175|1144772|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
478759|NCT00448175|1144771|P2|COMPLETED|Continued PTNS Through 12 Months||0
478760|NCT00448175|1144772|P1|COMPLETED|Continued PTNS Through 12 Months||25
478761|NCT00448175|1144771|P2|STARTED|Continued PTNS Through 12 Months||0
478762|NCT00448175|1144772|P1|STARTED|Continued PTNS Through 12 Months||35
478763|NCT00448175|1144771|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
478764|NCT00448175|1144772|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
478765|NCT00448175|1144771|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
478766|NCT00448175|1144772|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
478767|NCT00448175|1144771|P2|STARTED|12 Weeks PTNS vs. Drug||50
478768|NCT00448175|1144772|P1|STARTED|12 Weeks PTNS vs. Drug||50
478769|NCT00448136|1144780|P2|NOT COMPLETED|Overall Study||8
478770|NCT00448136|1144781|P1|NOT COMPLETED|Overall Study||4
478771|NCT00448136|1144780|P2|COMPLETED|Overall Study||41
478772|NCT00448136|1144781|P1|COMPLETED|Overall Study||30
478773|NCT00448136|1144780|P2|STARTED|Overall Study||49
478774|NCT00448136|1144781|P1|STARTED|Overall Study||34
478775|NCT00448123|1144819|P2|NOT COMPLETED|Overall Study||12
478776|NCT00448123|1144820|P1|NOT COMPLETED|Overall Study||15
478777|NCT00448123|1144819|P2|COMPLETED|Overall Study||53
478778|NCT00448123|1144820|P1|COMPLETED|Overall Study||47
478779|NCT00448123|1144819|P2|STARTED|Overall Study||65
478780|NCT00448123|1144820|P1|STARTED|Overall Study||62
478781|NCT00448019|1144830|P1|NOT COMPLETED|Overall Study||7
478782|NCT00448019|1144830|P1|COMPLETED|Overall Study||57
478783|NCT00448019|1144830|P1|STARTED|Overall Study||64
478784|NCT00447902|1144838|P2|NOT COMPLETED|Overall Study||6
478785|NCT00447902|1144839|P1|NOT COMPLETED|Overall Study||4
478786|NCT00447902|1144838|P2|COMPLETED|Overall Study||0
478787|NCT00447902|1144839|P1|COMPLETED|Overall Study||1
478788|NCT00447902|1144838|P2|STARTED|Overall Study||6
478789|NCT00447902|1144839|P1|STARTED|Overall Study||5
478790|NCT00447603|1144879|P3|NOT COMPLETED|Filter Period||15
478791|NCT00447603|1144880|P2|NOT COMPLETED|Filter Period||4
478792|NCT00447603|1144881|P1|NOT COMPLETED|Filter Period||0
478793|NCT00447603|1144879|P3|COMPLETED|Filter Period||0
478794|NCT00447603|1144880|P2|COMPLETED|Filter Period||0
478795|NCT00447603|1144881|P1|COMPLETED|Filter Period||0
478796|NCT00447603|1144879|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
478797|NCT00447603|1144880|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
478798|NCT00447603|1144881|P1|STARTED|Filter Period||0
478799|NCT00447603|1144879|P3|NOT COMPLETED|Screening||0
478800|NCT00447603|1144880|P2|NOT COMPLETED|Screening||0
478801|NCT00447603|1144881|P1|NOT COMPLETED|Screening||21
478802|NCT00447603|1144879|P3|COMPLETED|Screening||0
478803|NCT00447603|1144880|P2|COMPLETED|Screening||0
478804|NCT00447603|1144881|P1|COMPLETED|Screening||19
478805|NCT00447603|1144879|P3|STARTED|Screening||0
478806|NCT00447603|1144880|P2|STARTED|Screening||0
478807|NCT00447603|1144881|P1|STARTED|Screening||40
478808|NCT00447590|1144901|P1|NOT COMPLETED|Overall Study||60
478809|NCT00447590|1144901|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
478810|NCT00447590|1144901|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
478811|NCT00447499|1144910|P1|NOT COMPLETED|Overall Study||7
478812|NCT00447499|1144910|P1|COMPLETED|Overall Study||52
478813|NCT00447499|1144910|P1|STARTED|Overall Study||59
478814|NCT00447421|1144920|P1|NOT COMPLETED|Overall Study||6
478815|NCT00447421|1144920|P1|COMPLETED|Overall Study||3
478816|NCT00447421|1144920|P1|STARTED|Overall Study||9
478817|NCT00447382|1144932|P2|NOT COMPLETED|Overall Study||6
478818|NCT00447382|1144933|P1|NOT COMPLETED|Overall Study||6
478819|NCT00447382|1144932|P2|COMPLETED|Overall Study||160
478820|NCT00447382|1144933|P1|COMPLETED|Overall Study||158
478821|NCT00447382|1144932|P2|STARTED|Overall Study||166
478822|NCT00447382|1144933|P1|STARTED|Overall Study||164
478823|NCT00447330|1144985|P1|NOT COMPLETED|Overall Study||2
478824|NCT00447330|1144985|P1|COMPLETED|Overall Study||58
478825|NCT00447330|1144985|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
478826|NCT00447278|1144994|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
478827|NCT00447278|1144995|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
478828|NCT00447278|1144994|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
478829|NCT00447278|1144995|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
478830|NCT00447278|1144994|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
478831|NCT00447278|1144995|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
478832|NCT00447278|1144994|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
478833|NCT00447278|1144995|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
478834|NCT00447278|1144994|P2|COMPLETED|Period II (6 Month Open-Label)||171
478835|NCT00447278|1144995|P1|COMPLETED|Period II (6 Month Open-Label)||157
478836|NCT00447278|1144994|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
478837|NCT00447278|1144995|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
478838|NCT00447278|1144994|P2|STARTED|Period II (6 Month Open-Label)||200
478839|NCT00447278|1144995|P1|STARTED|Period II (6 Month Open-Label)||199
478840|NCT00447265|1145016|P2|NOT COMPLETED|Overall Study||0
478841|NCT00447265|1145017|P1|NOT COMPLETED|Overall Study||1
478842|NCT00447265|1145016|P2|COMPLETED|Overall Study||0
478843|NCT00447265|1145017|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
478844|NCT00447265|1145016|P2|STARTED|Overall Study||0
478845|NCT00447265|1145017|P1|STARTED|Overall Study||1
478846|NCT00447226|1145030|P2|NOT COMPLETED|Double-blind Phase||3
478847|NCT00447226|1145031|P1|NOT COMPLETED|Double-blind Phase||4
478848|NCT00447226|1145030|P2|COMPLETED|Double-blind Phase||0
478849|NCT00447226|1145031|P1|COMPLETED|Double-blind Phase||0
478850|NCT00447226|1145030|P2|STARTED|Double-blind Phase||3
478851|NCT00447226|1145031|P1|STARTED|Double-blind Phase||4
478852|NCT00447226|1145030|P2|NOT COMPLETED|12-Week Open-label Phase||25
478853|NCT00447226|1145031|P1|NOT COMPLETED|12-Week Open-label Phase||0
478854|NCT00447226|1145030|P2|COMPLETED|12-Week Open-label Phase||7
478855|NCT00447226|1145031|P1|COMPLETED|12-Week Open-label Phase||0
478856|NCT00447226|1145030|P2|STARTED|12-Week Open-label Phase||32
478857|NCT00447226|1145031|P1|STARTED|12-Week Open-label Phase||0
478858|NCT00447122|1145049|P1|NOT COMPLETED|Overall Study||2
478859|NCT00447122|1145049|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
478860|NCT00447122|1145049|P1|STARTED|Overall Study||31
478861|NCT00447057|1145057|P4|NOT COMPLETED|Overall Study||26
478862|NCT00447057|1145058|P3|NOT COMPLETED|Overall Study||19
478863|NCT00447057|1145059|P2|NOT COMPLETED|Overall Study||73
478864|NCT00447057|1145060|P1|NOT COMPLETED|Overall Study||83
478865|NCT00447057|1145057|P4|COMPLETED|Overall Study||0
478866|NCT00447057|1145058|P3|COMPLETED|Overall Study||0
478867|NCT00447057|1145059|P2|COMPLETED|Overall Study||3
478868|NCT00447057|1145060|P1|COMPLETED|Overall Study||0
478869|NCT00447057|1145057|P4|STARTED|Overall Study||26
478870|NCT00447057|1145058|P3|STARTED|Overall Study||19
478871|NCT00447057|1145059|P2|STARTED|Overall Study||76
478872|NCT00447057|1145060|P1|STARTED|Overall Study||83
478873|NCT00447005|1145078|P1|NOT COMPLETED|Overall Study||12
478874|NCT00447005|1145078|P1|COMPLETED|Overall Study||0
478875|NCT00447005|1145078|P1|STARTED|Overall Study||12
478876|NCT00446992|1145092|P1|NOT COMPLETED|Overall Study||16
478877|NCT00446992|1145092|P1|COMPLETED|Overall Study|Intervention Completion|14
478878|NCT00446992|1145092|P1|STARTED|Overall Study|Beginning of Intervention|30
478879|NCT00446849|1145104|P1|NOT COMPLETED|Maintenance Phase||70
478880|NCT00446849|1145104|P1|COMPLETED|Maintenance Phase||138
478881|NCT00446849|1145104|P1|STARTED|Maintenance Phase||208
478882|NCT00446849|1145104|P1|NOT COMPLETED|Acute Phase||82
478883|NCT00446849|1145104|P1|COMPLETED|Acute Phase||56
478884|NCT00446849|1145104|P1|STARTED|Acute Phase||138
478885|NCT00446797|1145116|P2|NOT COMPLETED|Overall Study||12
478886|NCT00446797|1145117|P1|NOT COMPLETED|Overall Study||8
478887|NCT00446797|1145116|P2|COMPLETED|Overall Study||125
478888|NCT00446797|1145117|P1|COMPLETED|Overall Study||133
478889|NCT00446797|1145116|P2|STARTED|Overall Study||137
478890|NCT00446797|1145117|P1|STARTED|Overall Study||141
478891|NCT00446654|1145163|P2|NOT COMPLETED|Overall Study||0
478892|NCT00446654|1145164|P1|NOT COMPLETED|Overall Study||2
478893|NCT00446654|1145163|P2|COMPLETED|Overall Study||22
478894|NCT00446654|1145164|P1|COMPLETED|Overall Study||19
478895|NCT00446654|1145163|P2|STARTED|Overall Study||22
478896|NCT00446654|1145164|P1|STARTED|Overall Study||21
478897|NCT00446641|1145172|P2|NOT COMPLETED|Overall Study||10
478898|NCT00446641|1145173|P1|NOT COMPLETED|Overall Study||17
478899|NCT00446641|1145172|P2|COMPLETED|Overall Study||109
478900|NCT00446641|1145173|P1|COMPLETED|Overall Study||108
478901|NCT00446641|1145172|P2|STARTED|Overall Study||119
478902|NCT00446641|1145173|P1|STARTED|Overall Study||125
478903|NCT00446563|1145193|P2|NOT COMPLETED|Overall Study||9
478904|NCT00446563|1145194|P1|NOT COMPLETED|Overall Study||7
478905|NCT00446563|1145193|P2|COMPLETED|Overall Study||38
478906|NCT00446563|1145194|P1|COMPLETED|Overall Study||36
478907|NCT00446563|1145193|P2|STARTED|Overall Study||47
478908|NCT00446563|1145194|P1|STARTED|Overall Study||43
478909|NCT00446511|1145232|P4|NOT COMPLETED|Overall Study||6
478910|NCT00446511|1145233|P3|NOT COMPLETED|Overall Study||7
478911|NCT00446511|1145234|P2|NOT COMPLETED|Overall Study||2
478912|NCT00446511|1145235|P1|NOT COMPLETED|Overall Study||10
478913|NCT00446511|1145232|P4|COMPLETED|Overall Study||103
478914|NCT00446511|1145233|P3|COMPLETED|Overall Study||96
478915|NCT00446511|1145234|P2|COMPLETED|Overall Study||15
478916|NCT00446511|1145235|P1|COMPLETED|Overall Study||11
478917|NCT00446511|1145232|P4|STARTED|Overall Study||109
478918|NCT00446511|1145233|P3|STARTED|Overall Study||103
478919|NCT00446511|1145234|P2|STARTED|Overall Study||17
478920|NCT00446511|1145235|P1|STARTED|Overall Study||21
478921|NCT00446459|1145259|P1|NOT COMPLETED|12 Months||18
478922|NCT00446459|1145259|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
478923|NCT00446459|1145259|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
478924|NCT00446459|1145259|P1|NOT COMPLETED|8 Months||12
478925|NCT00446459|1145259|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
478926|NCT00446459|1145259|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
478927|NCT00446446|1145267|P1|NOT COMPLETED|Overall Study||24
478928|NCT00446446|1145267|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
478929|NCT00446446|1145267|P1|STARTED|Overall Study||52
478930|NCT00446290|1145278|P1|NOT COMPLETED|Overall Study||0
478931|NCT00446290|1145278|P1|COMPLETED|Overall Study||21
478932|NCT00446290|1145278|P1|STARTED|Overall Study||21
478933|NCT00446264|1145282|P1|NOT COMPLETED|Overall Study||0
478934|NCT00446264|1145282|P1|COMPLETED|Overall Study||14
478935|NCT00446264|1145282|P1|STARTED|Overall Study||14
478936|NCT00446251|1145291|P1|NOT COMPLETED|Overall Study||5
478937|NCT00446251|1145291|P1|COMPLETED|Overall Study||9
478938|NCT00446251|1145291|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
478939|NCT00446199|1145301|P4|NOT COMPLETED|Overall Study||30
478940|NCT00446199|1145302|P3|NOT COMPLETED|Overall Study||27
478941|NCT00446199|1145303|P2|NOT COMPLETED|Overall Study||20
478942|NCT00446199|1145304|P1|NOT COMPLETED|Overall Study||23
478943|NCT00446199|1145301|P4|COMPLETED|Overall Study||153
478944|NCT00446199|1145302|P3|COMPLETED|Overall Study||158
478945|NCT00446199|1145303|P2|COMPLETED|Overall Study||164
478946|NCT00446199|1145304|P1|COMPLETED|Overall Study||160
478947|NCT00446199|1145301|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
478948|NCT00446199|1145302|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
478949|NCT00446199|1145303|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
478950|NCT00446199|1145304|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
478951|NCT00446199|1145301|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
478952|NCT00446199|1145302|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
478953|NCT00446199|1145303|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
478954|NCT00446199|1145304|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
478955|NCT00446199|1145301|P4|STARTED|Overall Study||183
478956|NCT00446199|1145302|P3|STARTED|Overall Study||185
478957|NCT00446199|1145303|P2|STARTED|Overall Study||184
478958|NCT00446199|1145304|P1|STARTED|Overall Study||183
478959|NCT00446147|1145384|P2|NOT COMPLETED|Overall Study||14
478960|NCT00446147|1145385|P1|NOT COMPLETED|Overall Study||15
478961|NCT00446147|1145384|P2|COMPLETED|Overall Study||180
478962|NCT00446147|1145385|P1|COMPLETED|Overall Study||180
478963|NCT00446147|1145384|P2|STARTED|Overall Study||194
478964|NCT00446147|1145385|P1|STARTED|Overall Study||195
478965|NCT00446134|1145397|P4|NOT COMPLETED|Overall Study||45
478966|NCT00446134|1145398|P3|NOT COMPLETED|Overall Study||43
478967|NCT00446134|1145399|P2|NOT COMPLETED|Overall Study||45
478968|NCT00446134|1145400|P1|NOT COMPLETED|Overall Study||34
478969|NCT00446134|1145397|P4|COMPLETED|Overall Study||25
478970|NCT00446134|1145398|P3|COMPLETED|Overall Study||26
478971|NCT00446134|1145399|P2|COMPLETED|Overall Study||25
478972|NCT00446134|1145400|P1|COMPLETED|Overall Study||35
478973|NCT00446134|1145397|P4|STARTED|Overall Study||70
478974|NCT00446134|1145398|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
478975|NCT00446134|1145399|P2|STARTED|Overall Study||70
478976|NCT00446134|1145400|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
478977|NCT00446095|1145427|P5|NOT COMPLETED|Phase I (28 Days)||3
478978|NCT00446095|1145428|P4|NOT COMPLETED|Phase I (28 Days)||1
478979|NCT00446095|1145429|P3|NOT COMPLETED|Phase I (28 Days)||0
478980|NCT00446095|1145430|P2|NOT COMPLETED|Phase I (28 Days)||0
478981|NCT00446095|1145431|P1|NOT COMPLETED|Phase I (28 Days)||0
478982|NCT00446095|1145427|P5|COMPLETED|Phase I (28 Days)||4
478983|NCT00446095|1145428|P4|COMPLETED|Phase I (28 Days)||5
478984|NCT00446095|1145429|P3|COMPLETED|Phase I (28 Days)||0
478985|NCT00446095|1145430|P2|COMPLETED|Phase I (28 Days)||0
478986|NCT00446095|1145431|P1|COMPLETED|Phase I (28 Days)||0
478987|NCT00446095|1145427|P5|STARTED|Phase I (28 Days)||7
478988|NCT00446095|1145428|P4|STARTED|Phase I (28 Days)||6
478989|NCT00446095|1145429|P3|STARTED|Phase I (28 Days)||0
478990|NCT00446095|1145430|P2|STARTED|Phase I (28 Days)||0
478991|NCT00446095|1145431|P1|STARTED|Phase I (28 Days)||0
478992|NCT00446095|1145427|P5|NOT COMPLETED|Phase II (8 Weeks)||0
478993|NCT00446095|1145428|P4|NOT COMPLETED|Phase II (8 Weeks)||0
478994|NCT00446095|1145429|P3|NOT COMPLETED|Phase II (8 Weeks)||3
478995|NCT00446095|1145430|P2|NOT COMPLETED|Phase II (8 Weeks)||3
478996|NCT00446095|1145431|P1|NOT COMPLETED|Phase II (8 Weeks)||12
478997|NCT00446095|1145427|P5|COMPLETED|Phase II (8 Weeks)||0
478998|NCT00446095|1145428|P4|COMPLETED|Phase II (8 Weeks)||0
478999|NCT00446095|1145429|P3|COMPLETED|Phase II (8 Weeks)||21
479000|NCT00446095|1145430|P2|COMPLETED|Phase II (8 Weeks)||18
479001|NCT00446095|1145431|P1|COMPLETED|Phase II (8 Weeks)||11
479002|NCT00446095|1145427|P5|STARTED|Phase II (8 Weeks)||0
479003|NCT00446095|1145428|P4|STARTED|Phase II (8 Weeks)||0
479004|NCT00446095|1145429|P3|STARTED|Phase II (8 Weeks)||24
479005|NCT00446095|1145430|P2|STARTED|Phase II (8 Weeks)||21
479006|NCT00446095|1145431|P1|STARTED|Phase II (8 Weeks)||23
479007|NCT00446030|1145454|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
479008|NCT00446030|1145455|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
479009|NCT00446030|1145454|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
479010|NCT00446030|1145455|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
479011|NCT00446030|1145454|P2|STARTED|FOLLOW-UP (up to 2-years)||34
479012|NCT00446030|1145455|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
479013|NCT00446030|1145454|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
479014|NCT00446030|1145455|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
479015|NCT00446030|1145454|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
479016|NCT00446030|1145455|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
479017|NCT00446030|1145454|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
479018|NCT00446030|1145455|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
479019|NCT00446030|1145454|P2|STARTED|TREATMENT (up to 52 Weeks)||34
479020|NCT00446030|1145455|P1|STARTED|TREATMENT (up to 52 Weeks)||93
479021|NCT00445939|1145466|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
479022|NCT00445939|1145467|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
479023|NCT00445939|1145468|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
479024|NCT00445939|1145469|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
479025|NCT00445939|1145466|P4|COMPLETED|Period B - Week 4 - Week 8||20
479026|NCT00445939|1145467|P3|COMPLETED|Period B - Week 4 - Week 8||0
479027|NCT00445939|1145468|P2|COMPLETED|Period B - Week 4 - Week 8||0
479028|NCT00445939|1145469|P1|COMPLETED|Period B - Week 4 - Week 8||14
479029|NCT00445939|1145466|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
479030|NCT00445939|1145467|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
479031|NCT00445939|1145468|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
479032|NCT00445939|1145469|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
479033|NCT00445939|1145466|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
479034|NCT00445939|1145467|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
479035|NCT00445939|1145468|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
479036|NCT00445939|1145469|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
479037|NCT00445939|1145466|P4|COMPLETED|Period A - Week 0 - Week 4||0
479038|NCT00445939|1145467|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
479039|NCT00445939|1145468|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
479040|NCT00445939|1145469|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
479041|NCT00445939|1145466|P4|STARTED|Period A - Week 0 - Week 4||0
479042|NCT00445939|1145467|P3|STARTED|Period A - Week 0 - Week 4||23
479043|NCT00445939|1145468|P2|STARTED|Period A - Week 0 - Week 4||34
479044|NCT00445939|1145469|P1|STARTED|Period A - Week 0 - Week 4||33
479045|NCT00445848|1145492|P1|NOT COMPLETED|Overall Study||85
479046|NCT00445848|1145492|P1|COMPLETED|Overall Study||0
479047|NCT00445848|1145492|P1|STARTED|Overall Study||85
479048|NCT00445770|1145502|P3|NOT COMPLETED|Overall Study||31
479049|NCT00445770|1145503|P2|NOT COMPLETED|Overall Study||35
479050|NCT00445770|1145504|P1|NOT COMPLETED|Overall Study||53
479051|NCT00445770|1145502|P3|COMPLETED|Overall Study||151
479052|NCT00445770|1145503|P2|COMPLETED|Overall Study||157
479053|NCT00445770|1145504|P1|COMPLETED|Overall Study||123
479054|NCT00445770|1145502|P3|STARTED|Overall Study||182
479055|NCT00445770|1145503|P2|STARTED|Overall Study||192
479056|NCT00445770|1145504|P1|STARTED|Overall Study||176
479057|NCT00445705|1145575|P4|NOT COMPLETED|Overall Study||14
479058|NCT00445705|1145576|P3|NOT COMPLETED|Overall Study||11
479059|NCT00445705|1145577|P2|NOT COMPLETED|Overall Study||11
479060|NCT00445705|1145578|P1|NOT COMPLETED|Overall Study||9
479061|NCT00445705|1145575|P4|COMPLETED|Overall Study||39
479062|NCT00445705|1145576|P3|COMPLETED|Overall Study||41
479063|NCT00445705|1145577|P2|COMPLETED|Overall Study||42
479064|NCT00445705|1145578|P1|COMPLETED|Overall Study||44
479065|NCT00445705|1145575|P4|STARTED|Overall Study||53
479066|NCT00445705|1145576|P3|STARTED|Overall Study||52
479067|NCT00445705|1145577|P2|STARTED|Overall Study||53
479068|NCT00445705|1145578|P1|STARTED|Overall Study||53
479069|NCT00445679|1145604|P4|NOT COMPLETED|Overall Study||47
479070|NCT00445679|1145605|P3|NOT COMPLETED|Overall Study||66
479071|NCT00445679|1145606|P2|NOT COMPLETED|Overall Study||46
479072|NCT00445679|1145607|P1|NOT COMPLETED|Overall Study||48
479073|NCT00445679|1145604|P4|COMPLETED|Overall Study||149
479074|NCT00445679|1145605|P3|COMPLETED|Overall Study||139
479075|NCT00445679|1145606|P2|COMPLETED|Overall Study||157
479076|NCT00445679|1145607|P1|COMPLETED|Overall Study||155
479077|NCT00445679|1145604|P4|STARTED|Overall Study||196
479078|NCT00445679|1145605|P3|STARTED|Overall Study||205
479079|NCT00445679|1145606|P2|STARTED|Overall Study||203
479080|NCT00445679|1145607|P1|STARTED|Overall Study||203
479081|NCT00445588|1145641|P1|NOT COMPLETED|Overall Study||0
479082|NCT00445588|1145641|P1|COMPLETED|Overall Study||56
479083|NCT00445588|1145641|P1|STARTED|Overall Study||56
479084|NCT00445549|1145646|P1|NOT COMPLETED|Overall Study||12
479085|NCT00445549|1145646|P1|COMPLETED|Overall Study||0
479086|NCT00445549|1145646|P1|STARTED|Overall Study||12
479087|NCT00445484|1145653|P2|NOT COMPLETED|Overall Study||1
479088|NCT00445484|1145654|P1|NOT COMPLETED|Overall Study||4
479089|NCT00445484|1145653|P2|COMPLETED|Overall Study||10
479090|NCT00445484|1145654|P1|COMPLETED|Overall Study||7
479091|NCT00445484|1145653|P2|STARTED|Overall Study||11
479092|NCT00445484|1145654|P1|STARTED|Overall Study||11
479093|NCT00445432|1145669|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
479094|NCT00445432|1145670|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
479095|NCT00445432|1145671|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
479096|NCT00445432|1145672|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
479097|NCT00445432|1145669|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
479098|NCT00445432|1145670|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
479099|NCT00445432|1145671|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
479100|NCT00445432|1145672|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
479101|NCT00445432|1145669|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
479102|NCT00445432|1145670|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
479103|NCT00445432|1145671|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
479104|NCT00445432|1145672|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
479105|NCT00445432|1145669|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
479106|NCT00445432|1145670|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
479107|NCT00445432|1145671|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
479108|NCT00445432|1145672|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
479109|NCT00445432|1145669|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
479110|NCT00445432|1145670|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
479111|NCT00445432|1145671|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
479112|NCT00445432|1145672|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
479113|NCT00445432|1145669|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
479114|NCT00445432|1145670|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
479115|NCT00445432|1145671|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
479116|NCT00445432|1145672|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
479117|NCT00445341|1145705|P1|NOT COMPLETED|Overall Study||2
479118|NCT00445341|1145705|P1|COMPLETED|Overall Study||26
479119|NCT00445341|1145705|P1|STARTED|Overall Study||28
479120|NCT00445328|1145712|P2|NOT COMPLETED|Overall Study||6
479121|NCT00445328|1145713|P1|NOT COMPLETED|Overall Study||3
479122|NCT00445328|1145712|P2|COMPLETED|Overall Study||36
479123|NCT00445328|1145713|P1|COMPLETED|Overall Study||39
479124|NCT00445328|1145712|P2|Received Treatment|Overall Study||42
479125|NCT00445328|1145713|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
479126|NCT00445328|1145712|P2|STARTED|Overall Study||42
479127|NCT00445328|1145713|P1|STARTED|Overall Study||42
479128|NCT00445315|1145736|P5|NOT COMPLETED|Overall Study||0
479129|NCT00445315|1145737|P4|NOT COMPLETED|Overall Study||0
479130|NCT00445315|1145738|P3|NOT COMPLETED|Overall Study||0
479131|NCT00445315|1145739|P2|NOT COMPLETED|Overall Study||0
479132|NCT00445315|1145740|P1|NOT COMPLETED|Overall Study||0
479133|NCT00445315|1145736|P5|COMPLETED|Overall Study||8
479134|NCT00445315|1145737|P4|COMPLETED|Overall Study||6
479135|NCT00445315|1145738|P3|COMPLETED|Overall Study||6
479136|NCT00445315|1145739|P2|COMPLETED|Overall Study||6
479137|NCT00445315|1145740|P1|COMPLETED|Overall Study||6
479138|NCT00445315|1145736|P5|STARTED|Overall Study||8
479139|NCT00445315|1145737|P4|STARTED|Overall Study||6
479140|NCT00445315|1145738|P3|STARTED|Overall Study||6
479141|NCT00445315|1145739|P2|STARTED|Overall Study||6
479142|NCT00445315|1145740|P1|STARTED|Overall Study||6
479143|NCT00445302|1145834|P4|NOT COMPLETED|Overall Study||0
479144|NCT00445302|1145835|P3|NOT COMPLETED|Overall Study||0
479145|NCT00445302|1145836|P2|NOT COMPLETED|Overall Study||0
479146|NCT00445302|1145837|P1|NOT COMPLETED|Overall Study||0
479147|NCT00445302|1145834|P4|COMPLETED|Overall Study||6
479148|NCT00445302|1145835|P3|COMPLETED|Overall Study||6
479149|NCT00445302|1145836|P2|COMPLETED|Overall Study||5
479150|NCT00445302|1145837|P1|COMPLETED|Overall Study||6
479151|NCT00445302|1145834|P4|STARTED|Overall Study||6
479152|NCT00445302|1145835|P3|STARTED|Overall Study||6
479153|NCT00445302|1145836|P2|STARTED|Overall Study||5
479154|NCT00445302|1145837|P1|STARTED|Overall Study||6
479155|NCT00445263|1145865|P2|NOT COMPLETED|Overall Study||1
479156|NCT00445263|1145866|P1|NOT COMPLETED|Overall Study||0
479157|NCT00445263|1145865|P2|COMPLETED|Overall Study||86
479158|NCT00445263|1145866|P1|COMPLETED|Overall Study||83
479159|NCT00445263|1145865|P2|STARTED|Overall Study||87
479160|NCT00445263|1145866|P1|STARTED|Overall Study||83
479161|NCT00445224|1145874|P2|NOT COMPLETED|Combined Exercises||0
479162|NCT00445224|1145875|P1|NOT COMPLETED|Combined Exercises||0
479163|NCT00445224|1145874|P2|COMPLETED|Combined Exercises||13
479164|NCT00445224|1145875|P1|COMPLETED|Combined Exercises||13
479165|NCT00445224|1145874|P2|STARTED|Combined Exercises||13
479166|NCT00445224|1145875|P1|STARTED|Combined Exercises||13
479167|NCT00445224|1145874|P2|NOT COMPLETED|Specific Exercises||3
479168|NCT00445224|1145875|P1|NOT COMPLETED|Specific Exercises||4
479169|NCT00445224|1145874|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
479170|NCT00445224|1145875|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
479171|NCT00445224|1145874|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
479172|NCT00445224|1145875|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
479173|NCT00445224|1145874|P2|Baseline|Specific Exercises||16
479174|NCT00445224|1145875|P1|Baseline|Specific Exercises||17
479175|NCT00445224|1145874|P2|STARTED|Specific Exercises||16
479176|NCT00445224|1145875|P1|STARTED|Specific Exercises||17
479177|NCT00445211|1145887|P2|NOT COMPLETED|Overall Study||0
479178|NCT00445211|1145888|P1|NOT COMPLETED|Overall Study||0
479179|NCT00445211|1145887|P2|COMPLETED|Overall Study||23
479180|NCT00445211|1145888|P1|COMPLETED|Overall Study||23
479181|NCT00445211|1145887|P2|STARTED|Overall Study||23
479182|NCT00445211|1145888|P1|STARTED|Overall Study||23
479183|NCT00445146|1145902|P1|NOT COMPLETED|Overall Study||119
479184|NCT00445146|1145902|P1|COMPLETED|Overall Study||73
479185|NCT00445146|1145902|P1|STARTED|Overall Study||192
479186|NCT00445003|1145924|P3|NOT COMPLETED|Overall Study||4
479187|NCT00445003|1145925|P2|NOT COMPLETED|Overall Study||10
479188|NCT00445003|1145926|P1|NOT COMPLETED|Overall Study||5
479189|NCT00445003|1145924|P3|COMPLETED|Overall Study||105
479190|NCT00445003|1145925|P2|COMPLETED|Overall Study||103
479191|NCT00445003|1145926|P1|COMPLETED|Overall Study||118
479192|NCT00445003|1145924|P3|STARTED|Overall Study||109
479193|NCT00445003|1145925|P2|STARTED|Overall Study||113
479194|NCT00445003|1145926|P1|STARTED|Overall Study||123
479195|NCT00444951|1145958|P3|NOT COMPLETED|Overall Study||3
479196|NCT00444951|1145959|P2|NOT COMPLETED|Overall Study||6
479197|NCT00444951|1145960|P1|NOT COMPLETED|Overall Study||5
479198|NCT00444951|1145958|P3|COMPLETED|Overall Study||160
479199|NCT00444951|1145959|P2|COMPLETED|Overall Study||136
479200|NCT00444951|1145960|P1|COMPLETED|Overall Study||140
479201|NCT00444951|1145958|P3|STARTED|Overall Study||163
479202|NCT00444951|1145959|P2|STARTED|Overall Study||142
479203|NCT00444951|1145960|P1|STARTED|Overall Study||145
479204|NCT00444925|1145977|P3|NOT COMPLETED|Double-blind Treatment Period||81
479205|NCT00444925|1145978|P2|NOT COMPLETED|Double-blind Treatment Period||56
479206|NCT00444925|1145979|P1|NOT COMPLETED|Double-blind Treatment Period||30
479207|NCT00444925|1145977|P3|COMPLETED|Double-blind Treatment Period||598
479208|NCT00444925|1145978|P2|COMPLETED|Double-blind Treatment Period||628
479209|NCT00444925|1145979|P1|COMPLETED|Double-blind Treatment Period||304
479210|NCT00444925|1145977|P3|STARTED|Double-blind Treatment Period||679
479211|NCT00444925|1145978|P2|STARTED|Double-blind Treatment Period||684
479212|NCT00444925|1145979|P1|STARTED|Double-blind Treatment Period||334
479213|NCT00444925|1145977|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
479214|NCT00444925|1145978|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
479215|NCT00444925|1145979|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
479216|NCT00444925|1145977|P3|COMPLETED|Randomized to Double-blind Treatment||679
479217|NCT00444925|1145978|P2|COMPLETED|Randomized to Double-blind Treatment||684
479218|NCT00444925|1145979|P1|COMPLETED|Randomized to Double-blind Treatment||334
479219|NCT00444925|1145977|P3|STARTED|Randomized to Double-blind Treatment||685
479220|NCT00444925|1145978|P2|STARTED|Randomized to Double-blind Treatment||690
479221|NCT00444925|1145979|P1|STARTED|Randomized to Double-blind Treatment||337
479222|NCT00444925|1145977|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
479223|NCT00444925|1145978|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
479224|NCT00444925|1145979|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
479225|NCT00444925|1145977|P3|COMPLETED|Single-blind Placebo Run-In Period||0
479226|NCT00444925|1145978|P2|COMPLETED|Single-blind Placebo Run-In Period||0
479227|NCT00444925|1145979|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
479228|NCT00444925|1145977|P3|STARTED|Single-blind Placebo Run-In Period||0
479229|NCT00444925|1145978|P2|STARTED|Single-blind Placebo Run-In Period||0
479230|NCT00444925|1145979|P1|STARTED|Single-blind Placebo Run-In Period||2446
479231|NCT00444912|1146043|P2|NOT COMPLETED|Overall Study||2
479232|NCT00444912|1146044|P1|NOT COMPLETED|Overall Study||3
479233|NCT00444912|1146043|P2|COMPLETED|Overall Study||13
479234|NCT00444912|1146044|P1|COMPLETED|Overall Study||12
479235|NCT00444912|1146043|P2|Received Transplant|Overall Study||14
479236|NCT00444912|1146044|P1|Received Transplant|Overall Study||14
479237|NCT00444912|1146043|P2|Received Plerixafor|Overall Study||15
479238|NCT00444912|1146044|P1|Received Plerixafor|Overall Study||15
479239|NCT00444912|1146043|P2|STARTED|Overall Study||15
479240|NCT00444912|1146044|P1|STARTED|Overall Study||15
479241|NCT00444795|1146072|P1|NOT COMPLETED|Overall Study||3
479242|NCT00444795|1146072|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
479243|NCT00444795|1146072|P1|STARTED|Overall Study||620
479244|NCT00444626|1146077|P1|NOT COMPLETED|Repeat Treatment Period||0
479245|NCT00444626|1146077|P1|COMPLETED|Repeat Treatment Period||105
479246|NCT00444626|1146077|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
479247|NCT00444626|1146077|P1|NOT COMPLETED|Initial Treatment Period||12
479248|NCT00444626|1146077|P1|COMPLETED|Initial Treatment Period||128
479249|NCT00444626|1146077|P1|STARTED|Initial Treatment Period||140
479250|NCT00444600|1146107|P4|NOT COMPLETED|Overall Study||10
479251|NCT00444600|1146108|P3|NOT COMPLETED|Overall Study||10
479252|NCT00444600|1146109|P2|NOT COMPLETED|Overall Study||16
479253|NCT00444600|1146110|P1|NOT COMPLETED|Overall Study||19
479254|NCT00444600|1146107|P4|COMPLETED|Overall Study|Number of eyes|176
479255|NCT00444600|1146108|P3|COMPLETED|Overall Study|Number of eyes|178
479256|NCT00444600|1146109|P2|COMPLETED|Overall Study|Number of eyes|171
479257|NCT00444600|1146110|P1|COMPLETED|Overall Study|Number of eyes|274
479258|NCT00444600|1146107|P4|STARTED|Overall Study|Number of eyes|186
479259|NCT00444600|1146108|P3|STARTED|Overall Study|Number of eyes|188
479260|NCT00444600|1146109|P2|STARTED|Overall Study|Number of eyes|187
479261|NCT00444600|1146110|P1|STARTED|Overall Study|Number of eyes|293
479262|NCT00444587|1146202|P2|NOT COMPLETED|Overall Study||15
479263|NCT00444587|1146203|P1|NOT COMPLETED|Overall Study||83
479264|NCT00444587|1146202|P2|COMPLETED|Overall Study||1
479265|NCT00444587|1146203|P1|COMPLETED|Overall Study||10
479266|NCT00444587|1146202|P2|STARTED|Overall Study||16
479267|NCT00444587|1146203|P1|STARTED|Overall Study||93
479268|NCT00444535|1146224|P1|NOT COMPLETED|Overall Study||24
479269|NCT00444535|1146224|P1|COMPLETED|Overall Study||28
479270|NCT00444535|1146224|P1|STARTED|Overall Study||52
479271|NCT00444457|1146235|P4|NOT COMPLETED|Toddler Dose||8
479272|NCT00444457|1146236|P3|NOT COMPLETED|Toddler Dose||4
479273|NCT00444457|1146237|P2|NOT COMPLETED|Toddler Dose||6
479274|NCT00444457|1146238|P1|NOT COMPLETED|Toddler Dose||7
479275|NCT00444457|1146235|P4|COMPLETED|Toddler Dose||200
479276|NCT00444457|1146236|P3|COMPLETED|Toddler Dose||404
479277|NCT00444457|1146237|P2|COMPLETED|Toddler Dose||391
479278|NCT00444457|1146238|P1|COMPLETED|Toddler Dose||408
479279|NCT00444457|1146235|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
479280|NCT00444457|1146236|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
479281|NCT00444457|1146237|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
479282|NCT00444457|1146238|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
479283|NCT00444457|1146235|P4|NOT COMPLETED|After Infant Series||10
479284|NCT00444457|1146236|P3|NOT COMPLETED|After Infant Series||19
479285|NCT00444457|1146237|P2|NOT COMPLETED|After Infant Series||30
479286|NCT00444457|1146238|P1|NOT COMPLETED|After Infant Series||20
479287|NCT00444457|1146235|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
479288|NCT00444457|1146236|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
479289|NCT00444457|1146237|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
479290|NCT00444457|1146238|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
479291|NCT00444457|1146235|P4|STARTED|After Infant Series||218
479292|NCT00444457|1146236|P3|STARTED|After Infant Series||427
479293|NCT00444457|1146237|P2|STARTED|After Infant Series||427
479294|NCT00444457|1146238|P1|STARTED|After Infant Series||435
479295|NCT00444457|1146235|P4|NOT COMPLETED|Infant Series||28
479296|NCT00444457|1146236|P3|NOT COMPLETED|Infant Series||61
479297|NCT00444457|1146237|P2|NOT COMPLETED|Infant Series||61
479298|NCT00444457|1146238|P1|NOT COMPLETED|Infant Series||54
479299|NCT00444457|1146235|P4|COMPLETED|Infant Series||218
479300|NCT00444457|1146236|P3|COMPLETED|Infant Series||428
479301|NCT00444457|1146237|P2|COMPLETED|Infant Series||427
479302|NCT00444457|1146238|P1|COMPLETED|Infant Series||435
479303|NCT00444457|1146235|P4|Vaccinated Dose 3|Infant Series||225
479304|NCT00444457|1146236|P3|Vaccinated Dose 3|Infant Series||438
479305|NCT00444457|1146237|P2|Vaccinated Dose 3|Infant Series||435
479306|NCT00444457|1146238|P1|Vaccinated Dose 3|Infant Series||442
479307|NCT00444457|1146235|P4|Vaccinated Dose 2|Infant Series||228
479308|NCT00444457|1146236|P3|Vaccinated Dose 2|Infant Series||455
479309|NCT00444457|1146237|P2|Vaccinated Dose 2|Infant Series||447
479310|NCT00444457|1146238|P1|Vaccinated Dose 2|Infant Series||455
479311|NCT00444457|1146235|P4|Vaccinated Dose 1|Infant Series||244
479312|NCT00444457|1146236|P3|Vaccinated Dose 1|Infant Series||485
479313|NCT00444457|1146237|P2|Vaccinated Dose 1|Infant Series||484
479314|NCT00444457|1146238|P1|Vaccinated Dose 1|Infant Series||486
479315|NCT00444457|1146235|P4|STARTED|Infant Series||246
479316|NCT00444457|1146236|P3|STARTED|Infant Series||489
479317|NCT00444457|1146237|P2|STARTED|Infant Series||488
479318|NCT00444457|1146238|P1|STARTED|Infant Series||489
479319|NCT00444275|1146303|P5|NOT COMPLETED|Maintenance Treatment Phase||179
479320|NCT00444275|1146304|P4|NOT COMPLETED|Maintenance Treatment Phase||133
479321|NCT00444275|1146305|P3|NOT COMPLETED|Maintenance Treatment Phase||161
479322|NCT00444275|1146306|P2|NOT COMPLETED|Maintenance Treatment Phase||0
479323|NCT00444275|1146307|P1|NOT COMPLETED|Maintenance Treatment Phase||0
479324|NCT00444275|1146303|P5|COMPLETED|Maintenance Treatment Phase||701
479325|NCT00444275|1146304|P4|COMPLETED|Maintenance Treatment Phase||764
479326|NCT00444275|1146305|P3|COMPLETED|Maintenance Treatment Phase||747
479327|NCT00444275|1146306|P2|COMPLETED|Maintenance Treatment Phase||0
479328|NCT00444275|1146307|P1|COMPLETED|Maintenance Treatment Phase||0
479329|NCT00444275|1146303|P5|STARTED|Maintenance Treatment Phase||880
479330|NCT00444275|1146304|P4|STARTED|Maintenance Treatment Phase||897
479331|NCT00444275|1146305|P3|STARTED|Maintenance Treatment Phase||908
479332|NCT00444275|1146306|P2|STARTED|Maintenance Treatment Phase||0
479333|NCT00444275|1146307|P1|STARTED|Maintenance Treatment Phase||0
479334|NCT00444275|1146303|P5|NOT COMPLETED|Initial Treatment Phase||0
479335|NCT00444275|1146304|P4|NOT COMPLETED|Initial Treatment Phase||0
479336|NCT00444275|1146305|P3|NOT COMPLETED|Initial Treatment Phase||0
479337|NCT00444275|1146306|P2|NOT COMPLETED|Initial Treatment Phase||96
479338|NCT00444275|1146307|P1|NOT COMPLETED|Initial Treatment Phase||248
479339|NCT00444275|1146303|P5|COMPLETED|Initial Treatment Phase||0
479340|NCT00444275|1146304|P4|COMPLETED|Initial Treatment Phase||0
479341|NCT00444275|1146305|P3|COMPLETED|Initial Treatment Phase||0
479342|NCT00444275|1146306|P2|COMPLETED|Initial Treatment Phase||777
479343|NCT00444275|1146307|P1|COMPLETED|Initial Treatment Phase||1908
479344|NCT00444275|1146303|P5|STARTED|Initial Treatment Phase||0
479345|NCT00444275|1146304|P4|STARTED|Initial Treatment Phase||0
479346|NCT00444275|1146305|P3|STARTED|Initial Treatment Phase||0
479347|NCT00444275|1146306|P2|STARTED|Initial Treatment Phase||873
479348|NCT00444275|1146307|P1|STARTED|Initial Treatment Phase||2156
479349|NCT00444145|1146357|P1|NOT COMPLETED|Overall Study||19
479350|NCT00444145|1146357|P1|COMPLETED|Overall Study||19
479351|NCT00444145|1146357|P1|STARTED|Overall Study||38
479352|NCT00444106|1146364|P3|NOT COMPLETED|Overall Study||1
479353|NCT00444106|1146365|P2|NOT COMPLETED|Overall Study||1
479354|NCT00444106|1146366|P1|NOT COMPLETED|Overall Study||2
479355|NCT00444106|1146364|P3|COMPLETED|Overall Study||52
479356|NCT00444106|1146365|P2|COMPLETED|Overall Study||52
479357|NCT00444106|1146366|P1|COMPLETED|Overall Study||157
479358|NCT00444106|1146364|P3|Completed Treatment Period|Overall Study||53
479359|NCT00444106|1146365|P2|Completed Treatment Period|Overall Study||53
479360|NCT00444106|1146366|P1|Completed Treatment Period|Overall Study||159
479361|NCT00444106|1146364|P3|STARTED|Overall Study||53
479362|NCT00444106|1146365|P2|STARTED|Overall Study||53
479363|NCT00444106|1146366|P1|STARTED|Overall Study||159
479364|NCT00444067|1146383|P2|NOT COMPLETED|Overall Study||1
479365|NCT00444067|1146384|P1|NOT COMPLETED|Overall Study||0
479366|NCT00444067|1146383|P2|COMPLETED|Overall Study||23
479367|NCT00444067|1146384|P1|COMPLETED|Overall Study||74
479368|NCT00444067|1146383|P2|STARTED|Overall Study||24
479369|NCT00444067|1146384|P1|STARTED|Overall Study||74
479370|NCT00443898|1146398|P4|NOT COMPLETED|Overall Study||18
479371|NCT00443898|1146399|P3|NOT COMPLETED|Overall Study||29
479372|NCT00443898|1146400|P2|NOT COMPLETED|Overall Study||25
479373|NCT00443898|1146401|P1|NOT COMPLETED|Overall Study||24
479374|NCT00443898|1146398|P4|COMPLETED|Overall Study||110
479375|NCT00443898|1146399|P3|COMPLETED|Overall Study||107
479376|NCT00443898|1146400|P2|COMPLETED|Overall Study||103
479377|NCT00443898|1146401|P1|COMPLETED|Overall Study||102
479378|NCT00443898|1146398|P4|STARTED|Overall Study||128
479379|NCT00443898|1146399|P3|STARTED|Overall Study||136
479380|NCT00443898|1146400|P2|STARTED|Overall Study||128
479381|NCT00443898|1146401|P1|STARTED|Overall Study||126
479382|NCT00443872|1146423|P1|NOT COMPLETED|Overall Study||17
479383|NCT00443872|1146423|P1|COMPLETED|Overall Study||60
479384|NCT00443872|1146423|P1|STARTED|Overall Study||77
479385|NCT00443820|1146440|P4|NOT COMPLETED|Overall Study||17
479386|NCT00443820|1146441|P3|NOT COMPLETED|Overall Study||18
479387|NCT00443820|1146442|P2|NOT COMPLETED|Overall Study||19
479388|NCT00443820|1146443|P1|NOT COMPLETED|Overall Study||21
479389|NCT00443820|1146440|P4|COMPLETED|Overall Study||111
479390|NCT00443820|1146441|P3|COMPLETED|Overall Study||117
479391|NCT00443820|1146442|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
479392|NCT00443820|1146443|P1|COMPLETED|Overall Study||112
479393|NCT00443820|1146440|P4|Safety Population|Overall Study||126
479394|NCT00443820|1146441|P3|Safety Population|Overall Study||134
479395|NCT00443820|1146442|P2|Safety Population|Overall Study||129
479396|NCT00443820|1146443|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
479397|NCT00443820|1146440|P4|STARTED|Overall Study||128
479398|NCT00443820|1146441|P3|STARTED|Overall Study||135
479399|NCT00443820|1146442|P2|STARTED|Overall Study||130
479400|NCT00443820|1146443|P1|STARTED|Overall Study||133
479401|NCT00443781|1146465|P1|NOT COMPLETED|Overall Study||25
479402|NCT00443781|1146465|P1|COMPLETED|Overall Study||37
479403|NCT00443781|1146465|P1|STARTED|Overall Study||62
479404|NCT00443755|1146471|P2|NOT COMPLETED|Overall Study||1
479405|NCT00443755|1146472|P1|NOT COMPLETED|Overall Study||2
479406|NCT00443755|1146471|P2|COMPLETED|Overall Study||13
479407|NCT00443755|1146472|P1|COMPLETED|Overall Study||12
479408|NCT00443755|1146471|P2|STARTED|Overall Study||14
479409|NCT00443755|1146472|P1|STARTED|Overall Study||14
479410|NCT00443729|1146506|P2|NOT COMPLETED|Overall Study||7
479411|NCT00443729|1146507|P1|NOT COMPLETED|Overall Study||10
479412|NCT00443729|1146506|P2|COMPLETED|Overall Study||172
479413|NCT00443729|1146507|P1|COMPLETED|Overall Study||166
479414|NCT00443729|1146506|P2|Treated|Overall Study||178
479415|NCT00443729|1146507|P1|Treated|Overall Study||176
479416|NCT00443729|1146506|P2|STARTED|Overall Study||179
479417|NCT00443729|1146507|P1|STARTED|Overall Study||176
479418|NCT00443703|1146555|P2|NOT COMPLETED|Overall Study||18
479419|NCT00443703|1146556|P1|NOT COMPLETED|Overall Study||28
479420|NCT00443703|1146555|P2|COMPLETED|Overall Study||157
479421|NCT00443703|1146556|P1|COMPLETED|Overall Study||149
479422|NCT00443703|1146555|P2|Treated|Overall Study||174
479423|NCT00443703|1146556|P1|Treated|Overall Study||174
479424|NCT00443703|1146555|P2|STARTED|Overall Study||175
479425|NCT00443703|1146556|P1|STARTED|Overall Study||177
479426|NCT00443651|1146608|P2|NOT COMPLETED|Overall Study||58
479427|NCT00443651|1146609|P1|NOT COMPLETED|Overall Study||95
479428|NCT00443651|1146608|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
479429|NCT00443651|1146609|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
479430|NCT00443651|1146608|P2|Week 48|Overall Study||134
479431|NCT00443651|1146609|P1|Week 48|Overall Study||338
479432|NCT00443651|1146608|P2|Week 24|Overall Study||160
479433|NCT00443651|1146609|P1|Week 24|Overall Study||376
479434|NCT00443651|1146608|P2|STARTED|Overall Study||176
479435|NCT00443651|1146609|P1|STARTED|Overall Study||401
479436|NCT00443599|1146629|P2|NOT COMPLETED|Overall Study||3
479437|NCT00443599|1146630|P1|NOT COMPLETED|Overall Study||6
479438|NCT00443599|1146629|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
479439|NCT00443599|1146630|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
479440|NCT00443599|1146629|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
479441|NCT00443599|1146630|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
479442|NCT00443560|1146664|P2|NOT COMPLETED|Overall Study||30
479443|NCT00443560|1146665|P1|NOT COMPLETED|Overall Study||60
479444|NCT00443560|1146664|P2|COMPLETED|Overall Study||1051
479445|NCT00443560|1146665|P1|COMPLETED|Overall Study||1021
479446|NCT00443560|1146664|P2|STARTED|Overall Study||1081
479447|NCT00443560|1146665|P1|STARTED|Overall Study||1081
479448|NCT00443534|1146675|P1|NOT COMPLETED|Overall Study||123
479449|NCT00443534|1146675|P1|COMPLETED|Overall Study||0
479450|NCT00443534|1146675|P1|Treated|Overall Study||122
479451|NCT00443534|1146675|P1|STARTED|Overall Study||123
479452|NCT00443456|1146682|P1|NOT COMPLETED|Overall Study||18
479453|NCT00443456|1146682|P1|COMPLETED|Overall Study||116
479454|NCT00443456|1146682|P1|STARTED|Overall Study||134
479455|NCT00443430|1146717|P2|NOT COMPLETED|Overall Study||4
479456|NCT00443430|1146718|P1|NOT COMPLETED|Overall Study||4
479457|NCT00443430|1146717|P2|COMPLETED|Overall Study||38
479458|NCT00443430|1146718|P1|COMPLETED|Overall Study||39
479459|NCT00443430|1146717|P2|STARTED|Overall Study||42
479460|NCT00443430|1146718|P1|STARTED|Overall Study||43
479461|NCT00443352|1146728|P1|NOT COMPLETED|Overall Study||5
479462|NCT00443352|1146728|P1|COMPLETED|Overall Study||22
479463|NCT00443352|1146728|P1|STARTED|Overall Study||27
479464|NCT00443261|1146732|P1|NOT COMPLETED|Overall Study||1
479465|NCT00443261|1146732|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
479466|NCT00443261|1146732|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
479467|NCT00443261|1146732|P1|STARTED|Overall Study||1
479468|NCT00443209|1146738|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
479469|NCT00443209|1146739|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
479470|NCT00443209|1146738|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
479471|NCT00443209|1146739|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
479472|NCT00443209|1146738|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
479473|NCT00443209|1146739|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
479474|NCT00443209|1146738|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
479475|NCT00443209|1146739|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
479476|NCT00443209|1146738|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
479477|NCT00443209|1146739|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
479478|NCT00443209|1146738|P2|Treated|Months 1 to 12 Treatment Period||313
479479|NCT00443209|1146739|P1|Treated|Months 1 to 12 Treatment Period||641
479480|NCT00443209|1146738|P2|STARTED|Months 1 to 12 Treatment Period||356
479481|NCT00443209|1146739|P1|STARTED|Months 1 to 12 Treatment Period||712
479482|NCT00443118|1146756|P3|NOT COMPLETED|Overall Study||0
479483|NCT00443118|1146757|P2|NOT COMPLETED|Overall Study||1
479484|NCT00443118|1146758|P1|NOT COMPLETED|Overall Study||4
479485|NCT00443118|1146756|P3|COMPLETED|Overall Study||226
479486|NCT00443118|1146757|P2|COMPLETED|Overall Study||290
479487|NCT00443118|1146758|P1|COMPLETED|Overall Study||511
479488|NCT00443118|1146756|P3|STARTED|Overall Study||226
479489|NCT00443118|1146757|P2|STARTED|Overall Study||291
479490|NCT00443118|1146758|P1|STARTED|Overall Study||515
479491|NCT00443053|1146804|P2|NOT COMPLETED|Overall Study||33
479492|NCT00443053|1146805|P1|NOT COMPLETED|Overall Study||21
479493|NCT00443053|1146804|P2|COMPLETED|Overall Study||1467
479494|NCT00443053|1146805|P1|COMPLETED|Overall Study||1481
479495|NCT00443053|1146804|P2|STARTED|Overall Study||1500
479496|NCT00443053|1146805|P1|STARTED|Overall Study||1502
479497|NCT00443040|1146826|P3|NOT COMPLETED|Overall Study||1
479498|NCT00443040|1146827|P2|NOT COMPLETED|Overall Study||0
479499|NCT00443040|1146828|P1|NOT COMPLETED|Overall Study||4
479500|NCT00443040|1146826|P3|COMPLETED|Overall Study||9
479501|NCT00443040|1146827|P2|COMPLETED|Overall Study||11
479502|NCT00443040|1146828|P1|COMPLETED|Overall Study||10
479503|NCT00443040|1146826|P3|STARTED|Overall Study||10
479504|NCT00443040|1146827|P2|STARTED|Overall Study||11
479505|NCT00443040|1146828|P1|STARTED|Overall Study||14
479506|NCT00442962|1146836|P1|NOT COMPLETED|Overall Study||8
479507|NCT00442962|1146836|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
479508|NCT00442962|1146836|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
479509|NCT00442962|1146836|P1|STARTED|Overall Study||54
479510|NCT00442936|1146854|P4|NOT COMPLETED|Overall Study||1
479511|NCT00442936|1146855|P3|NOT COMPLETED|Overall Study||1
479512|NCT00442936|1146856|P2|NOT COMPLETED|Overall Study||0
479513|NCT00442936|1146857|P1|NOT COMPLETED|Overall Study||1
479514|NCT00442936|1146854|P4|COMPLETED|Overall Study||347
479515|NCT00442936|1146855|P3|COMPLETED|Overall Study||344
479516|NCT00442936|1146856|P2|COMPLETED|Overall Study||354
479517|NCT00442936|1146857|P1|COMPLETED|Overall Study||332
479518|NCT00442936|1146854|P4|STARTED|Overall Study||348
479519|NCT00442936|1146855|P3|STARTED|Overall Study||345
479520|NCT00442936|1146856|P2|STARTED|Overall Study||354
479521|NCT00442936|1146857|P1|STARTED|Overall Study||333
479522|NCT00442897|1146905|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
479523|NCT00442897|1146906|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
479524|NCT00442897|1146905|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
479525|NCT00442897|1146906|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
479526|NCT00442897|1146905|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
479527|NCT00442897|1146906|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
479528|NCT00442897|1146905|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
479529|NCT00442897|1146906|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
479530|NCT00442897|1146905|P2|COMPLETED|Base Study (12 Week Follow-up)||99
479531|NCT00442897|1146906|P1|COMPLETED|Base Study (12 Week Follow-up)||101
479532|NCT00442897|1146905|P2|STARTED|Base Study (12 Week Follow-up)||111
479533|NCT00442897|1146906|P1|STARTED|Base Study (12 Week Follow-up)||118
479534|NCT00442702|1146916|P2|NOT COMPLETED|Evaluation Period||4
479535|NCT00442702|1146917|P1|NOT COMPLETED|Evaluation Period||5
479536|NCT00442702|1146916|P2|COMPLETED|Evaluation Period||107
479537|NCT00442702|1146917|P1|COMPLETED|Evaluation Period||97
479538|NCT00442702|1146916|P2|STARTED|Evaluation Period||111
479539|NCT00442702|1146917|P1|STARTED|Evaluation Period||102
479540|NCT00442702|1146916|P2|NOT COMPLETED|Titration Period||3
479541|NCT00442702|1146917|P1|NOT COMPLETED|Titration Period||12
479542|NCT00442702|1146916|P2|COMPLETED|Titration Period||111
479543|NCT00442702|1146917|P1|COMPLETED|Titration Period||102
479544|NCT00442702|1146916|P2|Safety Population|Titration Period||113
479545|NCT00442702|1146917|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
479546|NCT00442702|1146916|P2|STARTED|Titration Period||114
479547|NCT00442702|1146917|P1|STARTED|Titration Period||114
479548|NCT00442689|1146932|P3|NOT COMPLETED|Overall Study||9
479549|NCT00442689|1146933|P2|NOT COMPLETED|Overall Study||11
479550|NCT00442689|1146934|P1|NOT COMPLETED|Overall Study||10
479551|NCT00442689|1146932|P3|COMPLETED|Overall Study||13
479552|NCT00442689|1146933|P2|COMPLETED|Overall Study||13
479553|NCT00442689|1146934|P1|COMPLETED|Overall Study||11
479554|NCT00442689|1146932|P3|STARTED|Overall Study||22
479555|NCT00442689|1146933|P2|STARTED|Overall Study||24
479556|NCT00442689|1146934|P1|STARTED|Overall Study||21
479557|NCT00442611|1146962|P2|NOT COMPLETED|Overall Study||0
479558|NCT00442611|1146963|P1|NOT COMPLETED|Overall Study||1
479559|NCT00442611|1146962|P2|COMPLETED|Overall Study||3
479560|NCT00442611|1146963|P1|COMPLETED|Overall Study||6
479561|NCT00442611|1146962|P2|STARTED|Overall Study||3
479562|NCT00442611|1146963|P1|STARTED|Overall Study||7
479563|NCT00442598|1146976|P3|NOT COMPLETED|Overall Study||0
479564|NCT00442598|1146977|P2|NOT COMPLETED|Overall Study||8
479565|NCT00442598|1146978|P1|NOT COMPLETED|Overall Study||6
479566|NCT00442598|1146976|P3|COMPLETED|Overall Study||0
479567|NCT00442598|1146977|P2|COMPLETED|Overall Study||2
479568|NCT00442598|1146978|P1|COMPLETED|Overall Study||1
479569|NCT00442598|1146976|P3|Two Cycles|Overall Study||0
479570|NCT00442598|1146977|P2|Two Cycles|Overall Study||6
479571|NCT00442598|1146978|P1|Two Cycles|Overall Study||5
479572|NCT00442598|1146976|P3|STARTED|Overall Study||0
479573|NCT00442598|1146977|P2|STARTED|Overall Study||10
479574|NCT00442598|1146978|P1|STARTED|Overall Study||7
479575|NCT00442572|1146996|P2|NOT COMPLETED|Overall Study||3
479576|NCT00442572|1146997|P1|NOT COMPLETED|Overall Study||8
479577|NCT00442572|1146996|P2|COMPLETED|Overall Study||1
479578|NCT00442572|1146997|P1|COMPLETED|Overall Study||9
479579|NCT00442572|1146996|P2|STARTED|Overall Study||4
479580|NCT00442572|1146997|P1|STARTED|Overall Study||17
479581|NCT00442559|1147037|P2|NOT COMPLETED|Overall Study||35
479582|NCT00442559|1147038|P1|NOT COMPLETED|Overall Study||34
479583|NCT00442559|1147037|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
479584|NCT00442559|1147038|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
479585|NCT00442559|1147037|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
479586|NCT00442559|1147038|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
479587|NCT00442559|1147037|P2|STARTED|Overall Study||91
479588|NCT00442559|1147038|P1|STARTED|Overall Study||100
479589|NCT00442546|1147053|P3|NOT COMPLETED|Overall Study||33
479590|NCT00442546|1147054|P2|NOT COMPLETED|Overall Study||37
479591|NCT00442546|1147055|P1|NOT COMPLETED|Overall Study||26
479592|NCT00442546|1147053|P3|COMPLETED|Overall Study||71
479593|NCT00442546|1147054|P2|COMPLETED|Overall Study||63
479594|NCT00442546|1147055|P1|COMPLETED|Overall Study||77
479595|NCT00442546|1147053|P3|Received Treatment|Overall Study||98
479596|NCT00442546|1147054|P2|Received Treatment|Overall Study||96
479597|NCT00442546|1147055|P1|Received Treatment|Overall Study||98
479598|NCT00442546|1147053|P3|STARTED|Overall Study||104
479599|NCT00442546|1147054|P2|STARTED|Overall Study||100
479600|NCT00442546|1147055|P1|STARTED|Overall Study||103
479601|NCT00442507|1147177|P1|NOT COMPLETED|Overall Study||0
479602|NCT00442507|1147177|P1|COMPLETED|Overall Study||6
479603|NCT00442507|1147177|P1|STARTED|Overall Study||6
479604|NCT00442468|1147184|P1|NOT COMPLETED|Overall Study||183
479605|NCT00442468|1147184|P1|COMPLETED|Overall Study||1100
479606|NCT00442468|1147184|P1|STARTED|Overall Study||1283
479607|NCT00442416|1147214|P2|NOT COMPLETED|Overall Study||39
479608|NCT00442416|1147215|P1|NOT COMPLETED|Overall Study||37
479609|NCT00442416|1147214|P2|COMPLETED|Overall Study||2
479610|NCT00442416|1147215|P1|COMPLETED|Overall Study||2
479611|NCT00442416|1147214|P2|STARTED|Overall Study||41
479612|NCT00442416|1147215|P1|STARTED|Overall Study||39
479613|NCT00442364|1147248|P1|NOT COMPLETED|Overall Study||0
479614|NCT00442364|1147248|P1|COMPLETED|Overall Study||60
479615|NCT00442364|1147248|P1|STARTED|Overall Study||60
479616|NCT00442351|1147254|P2|NOT COMPLETED|Overall Study||6
479617|NCT00442351|1147255|P1|NOT COMPLETED|Overall Study||7
479618|NCT00442351|1147254|P2|COMPLETED|Overall Study||3
479619|NCT00442351|1147255|P1|COMPLETED|Overall Study||10
479620|NCT00442351|1147254|P2|STARTED|Overall Study||9
479621|NCT00442351|1147255|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
479622|NCT00442338|1147264|P3|NOT COMPLETED|Overall Study||0
479623|NCT00442338|1147265|P2|NOT COMPLETED|Overall Study||0
479624|NCT00442338|1147266|P1|NOT COMPLETED|Overall Study||0
479625|NCT00442338|1147264|P3|COMPLETED|Overall Study||31
479626|NCT00442338|1147265|P2|COMPLETED|Overall Study||30
479627|NCT00442338|1147266|P1|COMPLETED|Overall Study||30
479628|NCT00442338|1147264|P3|STARTED|Overall Study||31
479629|NCT00442338|1147265|P2|STARTED|Overall Study||30
479630|NCT00442338|1147266|P1|STARTED|Overall Study||30
479631|NCT00442286|1147277|P2|NOT COMPLETED|Overall Study||2
479632|NCT00442286|1147278|P1|NOT COMPLETED|Overall Study||7
479633|NCT00442286|1147277|P2|COMPLETED|Overall Study||82
479634|NCT00442286|1147278|P1|COMPLETED|Overall Study||174
479635|NCT00442286|1147277|P2|12 Months|Overall Study||82
479636|NCT00442286|1147278|P1|12 Months|Overall Study||174
479637|NCT00442286|1147277|P2|6 Months|Overall Study||83
479638|NCT00442286|1147278|P1|6 Months|Overall Study||177
479639|NCT00442286|1147277|P2|STARTED|Overall Study||84
479640|NCT00442286|1147278|P1|STARTED|Overall Study||181
479641|NCT00442169|1147295|P6|NOT COMPLETED|Part 2||0
479642|NCT00442169|1147296|P5|NOT COMPLETED|Part 2||0
479643|NCT00442169|1147297|P4|NOT COMPLETED|Part 2||0
479644|NCT00442169|1147298|P3|NOT COMPLETED|Part 2||0
479645|NCT00442169|1147299|P2|NOT COMPLETED|Part 2||0
479646|NCT00442169|1147300|P1|NOT COMPLETED|Part 2||0
479647|NCT00442169|1147295|P6|COMPLETED|Part 2||57
479648|NCT00442169|1147296|P5|COMPLETED|Part 2||25
479649|NCT00442169|1147297|P4|COMPLETED|Part 2||0
479650|NCT00442169|1147298|P3|COMPLETED|Part 2||0
479651|NCT00442169|1147299|P2|COMPLETED|Part 2||0
479652|NCT00442169|1147300|P1|COMPLETED|Part 2||0
479653|NCT00442169|1147295|P6|STARTED|Part 2||57
479654|NCT00442169|1147296|P5|STARTED|Part 2||25
479655|NCT00442169|1147297|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
479656|NCT00442169|1147298|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
479657|NCT00442169|1147299|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
479658|NCT00442169|1147300|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
479659|NCT00442169|1147295|P6|NOT COMPLETED|Part 1||0
479660|NCT00442169|1147296|P5|NOT COMPLETED|Part 1||0
479661|NCT00442169|1147297|P4|NOT COMPLETED|Part 1||0
479662|NCT00442169|1147298|P3|NOT COMPLETED|Part 1||0
479663|NCT00442169|1147299|P2|NOT COMPLETED|Part 1||0
479664|NCT00442169|1147300|P1|NOT COMPLETED|Part 1||0
479665|NCT00442169|1147295|P6|COMPLETED|Part 1||0
479666|NCT00442169|1147296|P5|COMPLETED|Part 1||0
479667|NCT00442169|1147297|P4|COMPLETED|Part 1||31
479668|NCT00442169|1147298|P3|COMPLETED|Part 1||40
479669|NCT00442169|1147299|P2|COMPLETED|Part 1||24
479670|NCT00442169|1147300|P1|COMPLETED|Part 1||17
479671|NCT00442169|1147295|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
479672|NCT00442169|1147296|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
479673|NCT00442169|1147297|P4|STARTED|Part 1||31
479674|NCT00442169|1147298|P3|STARTED|Part 1||40
479675|NCT00442169|1147299|P2|STARTED|Part 1||24
479676|NCT00442169|1147300|P1|STARTED|Part 1||17
479677|NCT00442117|1147340|P2|NOT COMPLETED|Overall Study||38
479678|NCT00442117|1147341|P1|NOT COMPLETED|Overall Study||38
479679|NCT00442117|1147340|P2|COMPLETED|Overall Study||49
479680|NCT00442117|1147341|P1|COMPLETED|Overall Study||47
479681|NCT00442117|1147340|P2|STARTED|Overall Study||87
479682|NCT00442117|1147341|P1|STARTED|Overall Study||85
479683|NCT00442013|1147355|P2|NOT COMPLETED|Overall Study||17
479684|NCT00442013|1147356|P1|NOT COMPLETED|Overall Study||26
479685|NCT00442013|1147355|P2|COMPLETED|Overall Study||132
479686|NCT00442013|1147356|P1|COMPLETED|Overall Study||131
479687|NCT00442013|1147355|P2|STARTED|Overall Study||149
479688|NCT00442013|1147356|P1|STARTED|Overall Study||157
479689|NCT00441974|1147372|P1|NOT COMPLETED|Overall Study||128
479690|NCT00441974|1147372|P1|COMPLETED|Overall Study||1342
479691|NCT00441974|1147372|P1|STARTED|Overall Study||1470
479692|NCT00441792|1147388|P2|NOT COMPLETED|Overall Study||2
479693|NCT00441792|1147389|P1|NOT COMPLETED|Overall Study||0
479694|NCT00441792|1147388|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
479695|NCT00441792|1147389|P1|COMPLETED|Overall Study||59
479696|NCT00441792|1147388|P2|STARTED|Overall Study||63
479697|NCT00441792|1147389|P1|STARTED|Overall Study||59
479698|NCT00441766|1147401|P4|NOT COMPLETED|Overall Study||6
479699|NCT00441766|1147402|P3|NOT COMPLETED|Overall Study||9
479700|NCT00441766|1147403|P2|NOT COMPLETED|Overall Study||7
479701|NCT00441766|1147404|P1|NOT COMPLETED|Overall Study||14
479702|NCT00441766|1147401|P4|COMPLETED|Overall Study||48
479703|NCT00441766|1147402|P3|COMPLETED|Overall Study||44
479704|NCT00441766|1147403|P2|COMPLETED|Overall Study||46
479705|NCT00441766|1147404|P1|COMPLETED|Overall Study||39
479706|NCT00441766|1147401|P4|STARTED|Overall Study||54
479707|NCT00441766|1147402|P3|STARTED|Overall Study||53
479708|NCT00441766|1147403|P2|STARTED|Overall Study||53
479709|NCT00441766|1147404|P1|STARTED|Overall Study||53
479710|NCT00441727|1147429|P3|NOT COMPLETED|Overall Study||168
479711|NCT00441727|1147430|P2|NOT COMPLETED|Overall Study||118
479712|NCT00441727|1147431|P1|NOT COMPLETED|Overall Study||106
479713|NCT00441727|1147429|P3|COMPLETED|Overall Study|ITT/randomised|637
479714|NCT00441727|1147430|P2|COMPLETED|Overall Study|ITT/randomised|686
479715|NCT00441727|1147431|P1|COMPLETED|Overall Study|ITT/randomised|711
479716|NCT00441727|1147429|P3|STARTED|Overall Study|ITT/randomised|805
479717|NCT00441727|1147430|P2|STARTED|Overall Study|ITT/randomised|804
479718|NCT00441727|1147431|P1|STARTED|Overall Study|ITT/randomised|817
479719|NCT00441701|1147464|P10|NOT COMPLETED|Overall Study||0
479720|NCT00441701|1147465|P9|NOT COMPLETED|Overall Study||0
479721|NCT00441701|1147466|P8|NOT COMPLETED|Overall Study||0
479722|NCT00441701|1147467|P7|NOT COMPLETED|Overall Study||0
479723|NCT00441701|1147468|P6|NOT COMPLETED|Overall Study||3
479724|NCT00441701|1147469|P5|NOT COMPLETED|Overall Study||2
479725|NCT00441701|1147470|P4|NOT COMPLETED|Overall Study||3
479726|NCT00441701|1147471|P3|NOT COMPLETED|Overall Study||4
479727|NCT00441701|1147472|P2|NOT COMPLETED|Overall Study||4
479728|NCT00441701|1147473|P1|NOT COMPLETED|Overall Study||5
479729|NCT00441701|1147464|P10|COMPLETED|Overall Study||0
479730|NCT00441701|1147465|P9|COMPLETED|Overall Study||0
479731|NCT00441701|1147466|P8|COMPLETED|Overall Study||0
479732|NCT00441701|1147467|P7|COMPLETED|Overall Study||0
479733|NCT00441701|1147468|P6|COMPLETED|Overall Study||8
479734|NCT00441701|1147469|P5|COMPLETED|Overall Study||20
479735|NCT00441701|1147470|P4|COMPLETED|Overall Study||8
479736|NCT00441701|1147471|P3|COMPLETED|Overall Study||18
479737|NCT00441701|1147472|P2|COMPLETED|Overall Study||7
479738|NCT00441701|1147473|P1|COMPLETED|Overall Study||17
479739|NCT00441701|1147464|P10|STARTED|Overall Study||0
479740|NCT00441701|1147465|P9|STARTED|Overall Study||0
479741|NCT00441701|1147466|P8|STARTED|Overall Study||0
479742|NCT00441701|1147467|P7|STARTED|Overall Study||0
479743|NCT00441701|1147468|P6|STARTED|Overall Study||11
479744|NCT00441701|1147469|P5|STARTED|Overall Study||22
479745|NCT00441701|1147470|P4|STARTED|Overall Study||11
479746|NCT00441701|1147471|P3|STARTED|Overall Study||22
479747|NCT00441701|1147472|P2|STARTED|Overall Study||11
479748|NCT00441701|1147473|P1|STARTED|Overall Study||22
479749|NCT00441584|1147555|P1|NOT COMPLETED|Overall Study||105
479750|NCT00441584|1147555|P1|COMPLETED|Overall Study||12
479751|NCT00441584|1147555|P1|STARTED|Overall Study||117
479752|NCT00441558|1147559|P1|NOT COMPLETED|Overall Study||1056
479753|NCT00441558|1147559|P1|COMPLETED|Overall Study||667
479754|NCT00441558|1147559|P1|STARTED|Overall Study||1723
479755|NCT00441545|1147563|P2|NOT COMPLETED|Second Intervention||7
479756|NCT00441545|1147564|P1|NOT COMPLETED|Second Intervention||12
479757|NCT00441545|1147563|P2|COMPLETED|Second Intervention||68
479758|NCT00441545|1147564|P1|COMPLETED|Second Intervention||65
479759|NCT00441545|1147563|P2|STARTED|Second Intervention||75
479760|NCT00441545|1147564|P1|STARTED|Second Intervention||77
479761|NCT00441545|1147563|P2|NOT COMPLETED|Washout||0
479762|NCT00441545|1147564|P1|NOT COMPLETED|Washout||0
479763|NCT00441545|1147563|P2|COMPLETED|Washout||75
479764|NCT00441545|1147564|P1|COMPLETED|Washout||77
479765|NCT00441545|1147563|P2|STARTED|Washout||75
479766|NCT00441545|1147564|P1|STARTED|Washout||77
479767|NCT00441545|1147563|P2|NOT COMPLETED|First Intervention||12
479768|NCT00441545|1147564|P1|NOT COMPLETED|First Intervention||18
479769|NCT00441545|1147563|P2|COMPLETED|First Intervention||75
479770|NCT00441545|1147564|P1|COMPLETED|First Intervention||77
479771|NCT00441545|1147563|P2|STARTED|First Intervention||87
479772|NCT00441545|1147564|P1|STARTED|First Intervention||95
479773|NCT00441480|1147578|P2|NOT COMPLETED|Overall Study||4
479774|NCT00441480|1147579|P1|NOT COMPLETED|Overall Study||3
479775|NCT00441480|1147578|P2|COMPLETED|Overall Study||41
479776|NCT00441480|1147579|P1|COMPLETED|Overall Study||43
479777|NCT00441480|1147578|P2|STARTED|Overall Study||45
479778|NCT00441480|1147579|P1|STARTED|Overall Study||46
479779|NCT00441467|1147611|P1|NOT COMPLETED|Overall Study||18
479780|NCT00441467|1147611|P1|COMPLETED|Overall Study||4
479781|NCT00441467|1147611|P1|4 Cycles|Overall Study||7
479782|NCT00441467|1147611|P1|2 Cycles|Overall Study||17
479783|NCT00441467|1147611|P1|STARTED|Overall Study||22
479784|NCT00441441|1147619|P2|NOT COMPLETED|Overall Study||14
479785|NCT00441441|1147620|P1|NOT COMPLETED|Overall Study||11
479786|NCT00441441|1147619|P2|COMPLETED|Overall Study||163
479787|NCT00441441|1147620|P1|COMPLETED|Overall Study||162
479788|NCT00441441|1147619|P2|STARTED|Overall Study||177
479789|NCT00441441|1147620|P1|STARTED|Overall Study||173
479790|NCT00441363|1147680|P2|NOT COMPLETED|Overall Study||15
479791|NCT00441363|1147681|P1|NOT COMPLETED|Overall Study||17
479792|NCT00441363|1147680|P2|COMPLETED|Overall Study||19
479793|NCT00441363|1147681|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
479794|NCT00441363|1147680|P2|STARTED|Overall Study||34
479795|NCT00441363|1147681|P1|STARTED|Overall Study||32
479796|NCT00441337|1147693|P4|NOT COMPLETED|Overall Study||21
479797|NCT00441337|1147694|P3|NOT COMPLETED|Overall Study||6
479798|NCT00441337|1147695|P2|NOT COMPLETED|Overall Study||6
479799|NCT00441337|1147696|P1|NOT COMPLETED|Overall Study||6
479800|NCT00441337|1147693|P4|COMPLETED|Overall Study||0
479801|NCT00441337|1147694|P3|COMPLETED|Overall Study||0
479802|NCT00441337|1147695|P2|COMPLETED|Overall Study||0
479803|NCT00441337|1147696|P1|COMPLETED|Overall Study||0
479804|NCT00441337|1147693|P4|STARTED|Overall Study||21
479805|NCT00441337|1147694|P3|STARTED|Overall Study||6
479806|NCT00441337|1147695|P2|STARTED|Overall Study||6
479807|NCT00441337|1147696|P1|STARTED|Overall Study||6
479808|NCT00441285|1147779|P5|NOT COMPLETED|Overall Study||0
479809|NCT00441285|1147780|P4|NOT COMPLETED|Overall Study||0
479810|NCT00441285|1147781|P3|NOT COMPLETED|Overall Study||0
479811|NCT00441285|1147782|P2|NOT COMPLETED|Overall Study||0
479812|NCT00441285|1147783|P1|NOT COMPLETED|Overall Study||0
479813|NCT00441285|1147779|P5|COMPLETED|Overall Study||43
479814|NCT00441285|1147780|P4|COMPLETED|Overall Study||40
479815|NCT00441285|1147781|P3|COMPLETED|Overall Study||41
479816|NCT00441285|1147782|P2|COMPLETED|Overall Study||16
479817|NCT00441285|1147783|P1|COMPLETED|Overall Study||16
479818|NCT00441285|1147779|P5|STARTED|Overall Study||43
479819|NCT00441285|1147780|P4|STARTED|Overall Study||40
479820|NCT00441285|1147781|P3|STARTED|Overall Study||41
479821|NCT00441285|1147782|P2|STARTED|Overall Study||16
479822|NCT00441285|1147783|P1|STARTED|Overall Study||16
479823|NCT00441272|1147809|P2|NOT COMPLETED|Overall Study||25
479824|NCT00441272|1147810|P1|NOT COMPLETED|Overall Study||25
479825|NCT00441272|1147809|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
479826|NCT00441272|1147810|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
479827|NCT00441272|1147809|P2|STARTED|Overall Study||25
479828|NCT00441272|1147810|P1|STARTED|Overall Study||25
479829|NCT00441259|1147818|P2|NOT COMPLETED|Overall Study||0
479830|NCT00441259|1147819|P1|NOT COMPLETED|Overall Study||0
479831|NCT00441259|1147818|P2|COMPLETED|Overall Study||48
479832|NCT00441259|1147819|P1|COMPLETED|Overall Study||48
479833|NCT00441259|1147818|P2|STARTED|Overall Study||48
479834|NCT00441259|1147819|P1|STARTED|Overall Study||48
479835|NCT00441168|1147837|P2|NOT COMPLETED|Follow-up Period||9
479836|NCT00441168|1147838|P1|NOT COMPLETED|Follow-up Period||12
479837|NCT00441168|1147837|P2|COMPLETED|Follow-up Period||4
479838|NCT00441168|1147838|P1|COMPLETED|Follow-up Period||5
479839|NCT00441168|1147837|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
479840|NCT00441168|1147838|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
479841|NCT00441168|1147837|P2|NOT COMPLETED|Treatment Period||6
479842|NCT00441168|1147838|P1|NOT COMPLETED|Treatment Period||11
479843|NCT00441168|1147837|P2|COMPLETED|Treatment Period||7
479844|NCT00441168|1147838|P1|COMPLETED|Treatment Period||6
479845|NCT00441168|1147837|P2|TREATED|Treatment Period||13
479846|NCT00441168|1147838|P1|TREATED|Treatment Period||16
479847|NCT00441168|1147837|P2|STARTED|Treatment Period||13
479848|NCT00441168|1147838|P1|STARTED|Treatment Period||17
479849|NCT00441142|1147852|P4|NOT COMPLETED|Overall Study||68
479850|NCT00441142|1147853|P3|NOT COMPLETED|Overall Study||22
479851|NCT00441142|1147854|P2|NOT COMPLETED|Overall Study||7
479852|NCT00441142|1147855|P1|NOT COMPLETED|Overall Study||6
479853|NCT00441142|1147852|P4|COMPLETED|Overall Study||1
479854|NCT00441142|1147853|P3|COMPLETED|Overall Study||7
479855|NCT00441142|1147854|P2|COMPLETED|Overall Study||0
479856|NCT00441142|1147855|P1|COMPLETED|Overall Study||0
479857|NCT00441142|1147852|P4|STARTED|Overall Study||69
479858|NCT00441142|1147853|P3|STARTED|Overall Study||29
479859|NCT00441142|1147854|P2|STARTED|Overall Study||7
479860|NCT00441142|1147855|P1|STARTED|Overall Study||6
479861|NCT00441116|1147873|P2|NOT COMPLETED|Overall Study||2
479862|NCT00441116|1147874|P1|NOT COMPLETED|Overall Study||3
479863|NCT00441116|1147873|P2|COMPLETED|Overall Study||75
479864|NCT00441116|1147874|P1|COMPLETED|Overall Study||73
479865|NCT00441116|1147873|P2|STARTED|Overall Study||77
479866|NCT00441116|1147874|P1|STARTED|Overall Study||76
479867|NCT00441103|1147942|P2|NOT COMPLETED|Overall Study||4
479868|NCT00441103|1147943|P1|NOT COMPLETED|Overall Study||11
479869|NCT00441103|1147942|P2|COMPLETED|Overall Study||56
479870|NCT00441103|1147943|P1|COMPLETED|Overall Study||109
479871|NCT00441103|1147942|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
479872|NCT00441103|1147943|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
479873|NCT00441064|1147956|P2|NOT COMPLETED|Overall Study||7
479874|NCT00441064|1147957|P1|NOT COMPLETED|Overall Study||10
479875|NCT00441064|1147956|P2|COMPLETED|Overall Study||56
479876|NCT00441064|1147957|P1|COMPLETED|Overall Study||59
479877|NCT00441064|1147956|P2|Intent-to-treat (ITT) Population|Overall Study||57
479878|NCT00441064|1147957|P1|Intent-to-treat (ITT) Population|Overall Study||61
479879|NCT00441064|1147956|P2|Safety Population (SP)|Overall Study||63
479880|NCT00441064|1147957|P1|Safety Population (SP)|Overall Study||69
479881|NCT00441064|1147956|P2|STARTED|Overall Study||63
479882|NCT00441064|1147957|P1|STARTED|Overall Study||69
479883|NCT00441012|1147969|P2|NOT COMPLETED|Overall Study||13
479884|NCT00441012|1147970|P1|NOT COMPLETED|Overall Study||18
479885|NCT00441012|1147969|P2|COMPLETED|Overall Study||263
479886|NCT00441012|1147970|P1|COMPLETED|Overall Study||252
479887|NCT00441012|1147969|P2|Vaccination Visit 3|Overall Study||269
479888|NCT00441012|1147970|P1|Vaccination Visit 3|Overall Study||265
479889|NCT00441012|1147969|P2|Vaccination Visit 2|Overall Study||272
479890|NCT00441012|1147970|P1|Vaccination Visit 2|Overall Study||267
479891|NCT00441012|1147969|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
479892|NCT00441012|1147970|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
479893|NCT00441012|1147969|P2|STARTED|Overall Study||276
479894|NCT00441012|1147970|P1|STARTED|Overall Study||270
479895|NCT00440947|1147984|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
479896|NCT00440947|1147985|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
479897|NCT00440947|1147986|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
479898|NCT00440947|1147987|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
479899|NCT00440947|1147988|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
479900|NCT00440947|1147984|P5|COMPLETED|Optional 60-Week Extension Phase||154
479901|NCT00440947|1147985|P4|COMPLETED|Optional 60-Week Extension Phase||160
479902|NCT00440947|1147986|P3|COMPLETED|Optional 60-Week Extension Phase||0
479903|NCT00440947|1147987|P2|COMPLETED|Optional 60-Week Extension Phase||0
479904|NCT00440947|1147988|P1|COMPLETED|Optional 60-Week Extension Phase||0
479905|NCT00440947|1147984|P5|STARTED|Optional 60-Week Extension Phase||180
479906|NCT00440947|1147985|P4|STARTED|Optional 60-Week Extension Phase||189
479907|NCT00440947|1147986|P3|STARTED|Optional 60-Week Extension Phase||0
479908|NCT00440947|1147987|P2|STARTED|Optional 60-Week Extension Phase||0
479909|NCT00440947|1147988|P1|STARTED|Optional 60-Week Extension Phase||0
479910|NCT00440947|1147984|P5|NOT COMPLETED|48-Week Randomization Phase||0
479911|NCT00440947|1147985|P4|NOT COMPLETED|48-Week Randomization Phase||0
479912|NCT00440947|1147986|P3|NOT COMPLETED|48-Week Randomization Phase||24
479913|NCT00440947|1147987|P2|NOT COMPLETED|48-Week Randomization Phase||16
479914|NCT00440947|1147988|P1|NOT COMPLETED|48-Week Randomization Phase||0
479915|NCT00440947|1147984|P5|COMPLETED|48-Week Randomization Phase||0
479916|NCT00440947|1147985|P4|COMPLETED|48-Week Randomization Phase||0
479917|NCT00440947|1147986|P3|COMPLETED|48-Week Randomization Phase||185
479918|NCT00440947|1147987|P2|COMPLETED|48-Week Randomization Phase||194
479919|NCT00440947|1147988|P1|COMPLETED|48-Week Randomization Phase||0
479920|NCT00440947|1147984|P5|STARTED|48-Week Randomization Phase||0
479921|NCT00440947|1147985|P4|STARTED|48-Week Randomization Phase||0
479922|NCT00440947|1147986|P3|STARTED|48-Week Randomization Phase||209
479923|NCT00440947|1147987|P2|STARTED|48-Week Randomization Phase||210
479924|NCT00440947|1147988|P1|STARTED|48-Week Randomization Phase||0
479925|NCT00440947|1147984|P5|NOT COMPLETED|36-Week Induction Phase||0
479926|NCT00440947|1147985|P4|NOT COMPLETED|36-Week Induction Phase||0
479927|NCT00440947|1147986|P3|NOT COMPLETED|36-Week Induction Phase||0
479928|NCT00440947|1147987|P2|NOT COMPLETED|36-Week Induction Phase||0
479929|NCT00440947|1147988|P1|NOT COMPLETED|36-Week Induction Phase||73
479930|NCT00440947|1147984|P5|COMPLETED|36-Week Induction Phase||0
479931|NCT00440947|1147985|P4|COMPLETED|36-Week Induction Phase||0
479932|NCT00440947|1147986|P3|COMPLETED|36-Week Induction Phase||0
479933|NCT00440947|1147987|P2|COMPLETED|36-Week Induction Phase||0
479934|NCT00440947|1147988|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
479935|NCT00440947|1147984|P5|STARTED|36-Week Induction Phase||0
479936|NCT00440947|1147985|P4|STARTED|36-Week Induction Phase||0
479937|NCT00440947|1147986|P3|STARTED|36-Week Induction Phase||0
479938|NCT00440947|1147987|P2|STARTED|36-Week Induction Phase||0
479939|NCT00440947|1147988|P1|STARTED|36-Week Induction Phase||515
479940|NCT00440830|1148043|P4|NOT COMPLETED|Overall Study||0
479941|NCT00440830|1148044|P3|NOT COMPLETED|Overall Study||0
479942|NCT00440830|1148045|P2|NOT COMPLETED|Overall Study||0
479943|NCT00440830|1148046|P1|NOT COMPLETED|Overall Study||0
479944|NCT00440830|1148043|P4|COMPLETED|Overall Study||10
479945|NCT00440830|1148044|P3|COMPLETED|Overall Study||30
479946|NCT00440830|1148045|P2|COMPLETED|Overall Study||8
479947|NCT00440830|1148046|P1|COMPLETED|Overall Study||20
479948|NCT00440830|1148043|P4|STARTED|Overall Study||10
479949|NCT00440830|1148044|P3|STARTED|Overall Study||30
479950|NCT00440830|1148045|P2|STARTED|Overall Study||8
479951|NCT00440830|1148046|P1|STARTED|Overall Study||20
479952|NCT00440700|1148063|P3|NOT COMPLETED|Overall Study||4
479953|NCT00440700|1148064|P2|NOT COMPLETED|Overall Study||8
479954|NCT00440700|1148065|P1|NOT COMPLETED|Overall Study||8
479955|NCT00440700|1148063|P3|COMPLETED|Overall Study||120
479956|NCT00440700|1148064|P2|COMPLETED|Overall Study||110
479957|NCT00440700|1148065|P1|COMPLETED|Overall Study||114
479958|NCT00440700|1148063|P3|STARTED|Overall Study||124
479959|NCT00440700|1148064|P2|STARTED|Overall Study||118
479960|NCT00440700|1148065|P1|STARTED|Overall Study||122
479961|NCT00440557|1148088|P3|NOT COMPLETED|Overall Study||35
479962|NCT00440557|1148089|P2|NOT COMPLETED|Overall Study||29
479963|NCT00440557|1148090|P1|NOT COMPLETED|Overall Study||25
479964|NCT00440557|1148088|P3|COMPLETED|Overall Study||90
479965|NCT00440557|1148089|P2|COMPLETED|Overall Study||96
479966|NCT00440557|1148090|P1|COMPLETED|Overall Study||98
479967|NCT00440557|1148088|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
479968|NCT00440557|1148089|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
479969|NCT00440557|1148090|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
479970|NCT00440531|1148122|P3|NOT COMPLETED|Overall Study||7
479971|NCT00440531|1148123|P2|NOT COMPLETED|Overall Study||5
479972|NCT00440531|1148124|P1|NOT COMPLETED|Overall Study||10
479973|NCT00440531|1148122|P3|COMPLETED|Overall Study||165
479974|NCT00440531|1148123|P2|COMPLETED|Overall Study||178
479975|NCT00440531|1148124|P1|COMPLETED|Overall Study||175
479976|NCT00440531|1148122|P3|Vaccination 3|Overall Study||166
479977|NCT00440531|1148123|P2|Vaccination 3|Overall Study||178
479978|NCT00440531|1148124|P1|Vaccination 3|Overall Study||176
479979|NCT00440531|1148122|P3|Vaccination 2|Overall Study||171
479980|NCT00440531|1148123|P2|Vaccination 2|Overall Study||182
479981|NCT00440531|1148124|P1|Vaccination 2|Overall Study||181
479982|NCT00440531|1148122|P3|Vaccination 1|Overall Study||172
479983|NCT00440531|1148123|P2|Vaccination 1|Overall Study||183
479984|NCT00440531|1148124|P1|Vaccination 1|Overall Study||183
479985|NCT00440531|1148122|P3|STARTED|Overall Study||172
479986|NCT00440531|1148123|P2|STARTED|Overall Study||183
479987|NCT00440531|1148124|P1|STARTED|Overall Study||185
479988|NCT00440518|1148141|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
479989|NCT00440518|1148142|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
479990|NCT00440518|1148143|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
479991|NCT00440518|1148141|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
479992|NCT00440518|1148142|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
479993|NCT00440518|1148143|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
479994|NCT00440518|1148141|P3|STARTED|Maintenance and Safety Follow-up Periods||70
479995|NCT00440518|1148142|P2|STARTED|Maintenance and Safety Follow-up Periods||63
479996|NCT00440518|1148143|P1|STARTED|Maintenance and Safety Follow-up Periods||59
479997|NCT00440518|1148141|P3|NOT COMPLETED|Randomized /Titration Period||4
479998|NCT00440518|1148142|P2|NOT COMPLETED|Randomized /Titration Period||9
479999|NCT00440518|1148143|P1|NOT COMPLETED|Randomized /Titration Period||13
480000|NCT00440518|1148141|P3|COMPLETED|Randomized /Titration Period||70
480001|NCT00440518|1148142|P2|COMPLETED|Randomized /Titration Period||63
480002|NCT00440518|1148143|P1|COMPLETED|Randomized /Titration Period||59
480003|NCT00440518|1148141|P3|STARTED|Randomized /Titration Period||74
480004|NCT00440518|1148142|P2|STARTED|Randomized /Titration Period||72
480005|NCT00440518|1148143|P1|STARTED|Randomized /Titration Period||72
480006|NCT00440505|1148163|P6|NOT COMPLETED|Third Intervention||0
480007|NCT00440505|1148164|P5|NOT COMPLETED|Third Intervention||0
480008|NCT00440505|1148165|P4|NOT COMPLETED|Third Intervention||1
480009|NCT00440505|1148166|P3|NOT COMPLETED|Third Intervention||0
480010|NCT00440505|1148167|P2|NOT COMPLETED|Third Intervention||0
480011|NCT00440505|1148168|P1|NOT COMPLETED|Third Intervention||0
480012|NCT00440505|1148163|P6|COMPLETED|Third Intervention||5
480013|NCT00440505|1148164|P5|COMPLETED|Third Intervention||5
480014|NCT00440505|1148165|P4|COMPLETED|Third Intervention||1
480015|NCT00440505|1148166|P3|COMPLETED|Third Intervention||1
480016|NCT00440505|1148167|P2|COMPLETED|Third Intervention||2
480017|NCT00440505|1148168|P1|COMPLETED|Third Intervention||5
480018|NCT00440505|1148163|P6|STARTED|Third Intervention||5
480019|NCT00440505|1148164|P5|STARTED|Third Intervention||5
480020|NCT00440505|1148165|P4|STARTED|Third Intervention||2
480021|NCT00440505|1148166|P3|STARTED|Third Intervention||1
480022|NCT00440505|1148167|P2|STARTED|Third Intervention||2
480023|NCT00440505|1148168|P1|STARTED|Third Intervention||5
480024|NCT00440505|1148163|P6|NOT COMPLETED|Second Intervention||0
480025|NCT00440505|1148164|P5|NOT COMPLETED|Second Intervention||0
480026|NCT00440505|1148165|P4|NOT COMPLETED|Second Intervention||0
480027|NCT00440505|1148166|P3|NOT COMPLETED|Second Intervention||0
480028|NCT00440505|1148167|P2|NOT COMPLETED|Second Intervention||0
480029|NCT00440505|1148168|P1|NOT COMPLETED|Second Intervention||0
480030|NCT00440505|1148163|P6|COMPLETED|Second Intervention||5
480031|NCT00440505|1148164|P5|COMPLETED|Second Intervention||5
480032|NCT00440505|1148165|P4|COMPLETED|Second Intervention||2
480033|NCT00440505|1148166|P3|COMPLETED|Second Intervention||1
480034|NCT00440505|1148167|P2|COMPLETED|Second Intervention||2
480035|NCT00440505|1148168|P1|COMPLETED|Second Intervention||5
480036|NCT00440505|1148163|P6|STARTED|Second Intervention||5
480037|NCT00440505|1148164|P5|STARTED|Second Intervention||5
480038|NCT00440505|1148165|P4|STARTED|Second Intervention||2
480039|NCT00440505|1148166|P3|STARTED|Second Intervention||1
480040|NCT00440505|1148167|P2|STARTED|Second Intervention||2
480041|NCT00440505|1148168|P1|STARTED|Second Intervention||5
480042|NCT00440505|1148163|P6|NOT COMPLETED|First Intervention||0
480043|NCT00440505|1148164|P5|NOT COMPLETED|First Intervention||0
480044|NCT00440505|1148165|P4|NOT COMPLETED|First Intervention||0
480045|NCT00440505|1148166|P3|NOT COMPLETED|First Intervention||0
480046|NCT00440505|1148167|P2|NOT COMPLETED|First Intervention||0
480047|NCT00440505|1148168|P1|NOT COMPLETED|First Intervention||0
480048|NCT00440505|1148163|P6|COMPLETED|First Intervention||5
480049|NCT00440505|1148164|P5|COMPLETED|First Intervention||5
480050|NCT00440505|1148165|P4|COMPLETED|First Intervention||2
480051|NCT00440505|1148166|P3|COMPLETED|First Intervention||1
480052|NCT00440505|1148167|P2|COMPLETED|First Intervention||2
480053|NCT00440505|1148168|P1|COMPLETED|First Intervention||5
480054|NCT00440505|1148163|P6|STARTED|First Intervention||5
480055|NCT00440505|1148164|P5|STARTED|First Intervention||5
480056|NCT00440505|1148165|P4|STARTED|First Intervention||2
480057|NCT00440505|1148166|P3|STARTED|First Intervention||1
480058|NCT00440505|1148167|P2|STARTED|First Intervention||2
480059|NCT00440505|1148168|P1|STARTED|First Intervention||5
480060|NCT00440466|1148188|P3|NOT COMPLETED|Overall Study||41
480061|NCT00440466|1148189|P2|NOT COMPLETED|Overall Study||15
480062|NCT00440466|1148190|P1|NOT COMPLETED|Overall Study||13
480063|NCT00440466|1148188|P3|COMPLETED|Overall Study||174
480064|NCT00440466|1148189|P2|COMPLETED|Overall Study||92
480065|NCT00440466|1148190|P1|COMPLETED|Overall Study||95
480066|NCT00440466|1148188|P3|STARTED|Overall Study||215
480067|NCT00440466|1148189|P2|STARTED|Overall Study||107
480068|NCT00440466|1148190|P1|STARTED|Overall Study||108
480069|NCT00440401|1148224|P2|NOT COMPLETED|Overall Study||6
480070|NCT00440401|1148225|P1|NOT COMPLETED|Overall Study||4
480071|NCT00440401|1148224|P2|COMPLETED|Overall Study||54
480072|NCT00440401|1148225|P1|COMPLETED|Overall Study||55
480073|NCT00440401|1148224|P2|STARTED|Overall Study||60
480074|NCT00440401|1148225|P1|STARTED|Overall Study||59
480075|NCT00440310|1148235|P2|NOT COMPLETED|Overall Study||30
480076|NCT00440310|1148236|P1|NOT COMPLETED|Overall Study||28
480077|NCT00440310|1148235|P2|COMPLETED|Overall Study||209
480078|NCT00440310|1148236|P1|COMPLETED|Overall Study||216
480079|NCT00440310|1148235|P2|Treated|Overall Study||232
480080|NCT00440310|1148236|P1|Treated|Overall Study||222
480081|NCT00440310|1148235|P2|STARTED|Overall Study||239
480082|NCT00440310|1148236|P1|STARTED|Overall Study||244
480083|NCT00440297|1148244|P2|NOT COMPLETED|Overall Study||18
480084|NCT00440297|1148245|P1|NOT COMPLETED|Overall Study||23
480085|NCT00440297|1148244|P2|COMPLETED|Overall Study||120
480086|NCT00440297|1148245|P1|COMPLETED|Overall Study||116
480087|NCT00440297|1148244|P2|Vaccination Visit 4|Overall Study||122
480088|NCT00440297|1148245|P1|Vaccination Visit 4|Overall Study||116
480089|NCT00440297|1148244|P2|Vaccination Visit 3|Overall Study||125
480090|NCT00440297|1148245|P1|Vaccination Visit 3|Overall Study||124
480091|NCT00440297|1148244|P2|Vaccination Visit 2|Overall Study||134
480092|NCT00440297|1148245|P1|Vaccination Visit 2|Overall Study||136
480093|NCT00440297|1148244|P2|Vaccination Visit 1|Overall Study||138
480094|NCT00440297|1148245|P1|Vaccination Visit 1|Overall Study||138
480095|NCT00440297|1148244|P2|STARTED|Overall Study||138
480096|NCT00440297|1148245|P1|STARTED|Overall Study||139
480097|NCT00440271|1148261|P2|NOT COMPLETED|Overall Study||15
480098|NCT00440271|1148262|P1|NOT COMPLETED|Overall Study||12
480099|NCT00440271|1148261|P2|COMPLETED|Overall Study||3
480100|NCT00440271|1148262|P1|COMPLETED|Overall Study||3
480101|NCT00440271|1148261|P2|STARTED|Overall Study||18
480102|NCT00440271|1148262|P1|STARTED|Overall Study||15
480103|NCT00440232|1148296|P2|NOT COMPLETED|Overall Study||4
480104|NCT00440232|1148297|P1|NOT COMPLETED|Overall Study||3
480105|NCT00440232|1148296|P2|COMPLETED|Overall Study||34
480106|NCT00440232|1148297|P1|COMPLETED|Overall Study||33
480107|NCT00440232|1148296|P2|STARTED|Overall Study||38
480108|NCT00440232|1148297|P1|STARTED|Overall Study||36
480109|NCT00440193|1148307|P2|NOT COMPLETED|Observational Period||38
480110|NCT00440193|1148308|P1|NOT COMPLETED|Observational Period||45
480111|NCT00440193|1148307|P2|COMPLETED|Observational Period||1369
480112|NCT00440193|1148308|P1|COMPLETED|Observational Period||1380
480113|NCT00440193|1148307|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
480114|NCT00440193|1148308|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
480115|NCT00440193|1148307|P2|NOT COMPLETED|Treatment Period||351
480116|NCT00440193|1148308|P1|NOT COMPLETED|Treatment Period||305
480117|NCT00440193|1148307|P2|COMPLETED|Treatment Period||1367
480118|NCT00440193|1148308|P1|COMPLETED|Treatment Period||1426
480119|NCT00440193|1148307|P2|Participants Received Treatment|Treatment Period||1711
480120|NCT00440193|1148308|P1|Participants Received Treatment|Treatment Period||1718
480121|NCT00440193|1148307|P2|STARTED|Treatment Period||1718
480122|NCT00440193|1148308|P1|STARTED|Treatment Period||1731
480123|NCT00440180|1148344|P2|NOT COMPLETED|Overall Study||0
480124|NCT00440180|1148345|P1|NOT COMPLETED|Overall Study||0
480125|NCT00440180|1148344|P2|COMPLETED|Overall Study||10
480126|NCT00440180|1148345|P1|COMPLETED|Overall Study||10
480127|NCT00440180|1148344|P2|STARTED|Overall Study||10
480128|NCT00440180|1148345|P1|STARTED|Overall Study||10
480129|NCT00440115|1148354|P3|NOT COMPLETED|Overall Study||6
480130|NCT00440115|1148355|P2|NOT COMPLETED|Overall Study||11
480131|NCT00440115|1148356|P1|NOT COMPLETED|Overall Study||7
480132|NCT00440115|1148354|P3|COMPLETED|Overall Study||244
480133|NCT00440115|1148355|P2|COMPLETED|Overall Study||238
480134|NCT00440115|1148356|P1|COMPLETED|Overall Study||244
480135|NCT00440115|1148354|P3|STARTED|Overall Study||250
480136|NCT00440115|1148355|P2|STARTED|Overall Study||249
480137|NCT00440115|1148356|P1|STARTED|Overall Study||251
480138|NCT00440050|1148372|P2|NOT COMPLETED|Overall Study||67
480139|NCT00440050|1148373|P1|NOT COMPLETED|Overall Study||40
480140|NCT00440050|1148372|P2|COMPLETED|Overall Study||171
480141|NCT00440050|1148373|P1|COMPLETED|Overall Study||124
480142|NCT00440050|1148372|P2|STARTED|Overall Study||238
480143|NCT00440050|1148373|P1|STARTED|Overall Study||164
480144|NCT00440011|1148387|P2|NOT COMPLETED|Overall Study||3
480145|NCT00440011|1148388|P1|NOT COMPLETED|Overall Study||4
480146|NCT00440011|1148387|P2|COMPLETED|Overall Study||132
480147|NCT00440011|1148388|P1|COMPLETED|Overall Study||127
480148|NCT00440011|1148387|P2|STARTED|Overall Study||135
480149|NCT00440011|1148388|P1|STARTED|Overall Study||131
480150|NCT00439946|1148396|P1|NOT COMPLETED|Overall Study||0
480151|NCT00439946|1148396|P1|COMPLETED|Overall Study||8
480152|NCT00439946|1148396|P1|STARTED|Overall Study||8
480153|NCT00439777|1148415|P2|NOT COMPLETED|Observational Period||41
480154|NCT00439777|1148416|P1|NOT COMPLETED|Observational Period||41
480155|NCT00439777|1148415|P2|COMPLETED|Observational Period||2156
480156|NCT00439777|1148416|P1|COMPLETED|Observational Period||2165
480157|NCT00439777|1148415|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
480158|NCT00439777|1148416|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
480159|NCT00439777|1148415|P2|NOT COMPLETED|Treatment Period||459
480160|NCT00439777|1148416|P1|NOT COMPLETED|Treatment Period||419
480161|NCT00439777|1148415|P2|COMPLETED|Treatment Period||1954
480162|NCT00439777|1148416|P1|COMPLETED|Treatment Period||2001
480163|NCT00439777|1148415|P2|Participants Received Treatment|Treatment Period||2405
480164|NCT00439777|1148416|P1|Participants Received Treatment|Treatment Period||2412
480165|NCT00439777|1148415|P2|STARTED|Treatment Period||2413
480166|NCT00439777|1148416|P1|STARTED|Treatment Period||2420
480167|NCT00439738|1148454|P2|NOT COMPLETED|Overall Study||28
480168|NCT00439738|1148455|P1|NOT COMPLETED|Overall Study||36
480169|NCT00439738|1148454|P2|COMPLETED|Overall Study||178
480170|NCT00439738|1148455|P1|COMPLETED|Overall Study||170
480171|NCT00439738|1148454|P2|STARTED|Overall Study||206
480172|NCT00439738|1148455|P1|STARTED|Overall Study||206
480173|NCT00439725|1148473|P2|NOT COMPLETED|Observational Period||7
480174|NCT00439725|1148474|P1|NOT COMPLETED|Observational Period||8
480175|NCT00439725|1148473|P2|COMPLETED|Observational Period||553
480176|NCT00439725|1148474|P1|COMPLETED|Observational Period||569
480177|NCT00439725|1148473|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
480178|NCT00439725|1148474|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
480179|NCT00439725|1148473|P2|NOT COMPLETED|Treatment Period||246
480180|NCT00439725|1148474|P1|NOT COMPLETED|Treatment Period||236
480181|NCT00439725|1148473|P2|COMPLETED|Treatment Period||349
480182|NCT00439725|1148474|P1|COMPLETED|Treatment Period||366
480183|NCT00439725|1148473|P2|Participants Received Treatment|Treatment Period|Safety population|590
480184|NCT00439725|1148474|P1|Participants Received Treatment|Treatment Period|Safety population|598
480185|NCT00439725|1148473|P2|STARTED|Treatment Period||595
480186|NCT00439725|1148474|P1|STARTED|Treatment Period||602
480187|NCT00439647|1148520|P2|NOT COMPLETED|Overall Study||71
480188|NCT00439647|1148521|P1|NOT COMPLETED|Overall Study||58
480189|NCT00439647|1148520|P2|COMPLETED|Overall Study||540
480190|NCT00439647|1148521|P1|COMPLETED|Overall Study||530
480191|NCT00439647|1148520|P2|Modified Intent to Treat (mITT)|Overall Study||574
480192|NCT00439647|1148521|P1|Modified Intent to Treat (mITT)|Overall Study||553
480193|NCT00439647|1148520|P2|STARTED|Overall Study||611
480279|NCT00439218|1148731|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
480194|NCT00439647|1148521|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
480195|NCT00439608|1148553|P1|NOT COMPLETED|Overall Study||0
480196|NCT00439608|1148553|P1|COMPLETED|Overall Study||60
480197|NCT00439608|1148553|P1|STARTED|Overall Study||60
480198|NCT00439569|1148557|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
480199|NCT00439569|1148557|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
480200|NCT00439569|1148557|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
480201|NCT00439569|1148557|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
480202|NCT00439569|1148557|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
480203|NCT00439569|1148557|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
480204|NCT00439517|1148570|P2|NOT COMPLETED|Overall Study||0
480205|NCT00439517|1148571|P1|NOT COMPLETED|Overall Study||2
480206|NCT00439517|1148570|P2|COMPLETED|Overall Study||150
480207|NCT00439517|1148571|P1|COMPLETED|Overall Study||150
480208|NCT00439517|1148570|P2|STARTED|Overall Study||150
480209|NCT00439517|1148571|P1|STARTED|Overall Study||152
480210|NCT00439413|1148595|P2|NOT COMPLETED|Overall Study||37
480211|NCT00439413|1148596|P1|NOT COMPLETED|Overall Study||31
480212|NCT00439413|1148595|P2|COMPLETED|Overall Study||88
480213|NCT00439413|1148596|P1|COMPLETED|Overall Study||90
480214|NCT00439413|1148595|P2|STARTED|Overall Study||125
480215|NCT00439413|1148596|P1|STARTED|Overall Study||121
480216|NCT00439335|1148606|P2|NOT COMPLETED|Overall Study||0
480217|NCT00439335|1148607|P1|NOT COMPLETED|Overall Study||2
480218|NCT00439335|1148606|P2|COMPLETED|Overall Study||114
480219|NCT00439335|1148607|P1|COMPLETED|Overall Study||111
480220|NCT00439335|1148606|P2|STARTED|Overall Study||114
480221|NCT00439335|1148607|P1|STARTED|Overall Study||113
480222|NCT00439309|1148639|P2|NOT COMPLETED|Follow-Up||2
480223|NCT00439309|1148640|P1|NOT COMPLETED|Follow-Up||3
480224|NCT00439309|1148639|P2|COMPLETED|Follow-Up||13
480225|NCT00439309|1148640|P1|COMPLETED|Follow-Up||51
480226|NCT00439309|1148639|P2|STARTED|Follow-Up||15
480227|NCT00439309|1148640|P1|STARTED|Follow-Up||54
480228|NCT00439309|1148639|P2|NOT COMPLETED|Treatment||0
480229|NCT00439309|1148640|P1|NOT COMPLETED|Treatment||0
480230|NCT00439309|1148639|P2|COMPLETED|Treatment||15
480231|NCT00439309|1148640|P1|COMPLETED|Treatment||54
480232|NCT00439309|1148639|P2|STARTED|Treatment||15
480233|NCT00439309|1148640|P1|STARTED|Treatment||54
480234|NCT00439270|1148659|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
480235|NCT00439270|1148660|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
480236|NCT00439270|1148661|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
480237|NCT00439270|1148662|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
480238|NCT00439270|1148663|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
480239|NCT00439270|1148659|P5|COMPLETED|Phase 2 (51.6 Months)||0
480240|NCT00439270|1148660|P4|COMPLETED|Phase 2 (51.6 Months)||0
480241|NCT00439270|1148661|P3|COMPLETED|Phase 2 (51.6 Months)||0
480242|NCT00439270|1148662|P2|COMPLETED|Phase 2 (51.6 Months)||0
480243|NCT00439270|1148663|P1|COMPLETED|Phase 2 (51.6 Months)||0
480244|NCT00439270|1148659|P5|STARTED|Phase 2 (51.6 Months)||0
480245|NCT00439270|1148660|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
480246|NCT00439270|1148661|P3|STARTED|Phase 2 (51.6 Months)||0
480247|NCT00439270|1148662|P2|STARTED|Phase 2 (51.6 Months)||0
480248|NCT00439270|1148663|P1|STARTED|Phase 2 (51.6 Months)||0
480249|NCT00439270|1148659|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
480250|NCT00439270|1148660|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
480251|NCT00439270|1148661|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
480252|NCT00439270|1148662|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
480253|NCT00439270|1148663|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
480254|NCT00439270|1148659|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
480255|NCT00439270|1148660|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
480256|NCT00439270|1148661|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
480257|NCT00439270|1148662|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
480258|NCT00439270|1148663|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
480259|NCT00439270|1148659|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
480260|NCT00439270|1148660|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
480261|NCT00439270|1148661|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
480262|NCT00439270|1148662|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
480263|NCT00439270|1148663|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
480264|NCT00439244|1148705|P3|NOT COMPLETED|Overall Study||7
480265|NCT00439244|1148706|P2|NOT COMPLETED|Overall Study||6
480266|NCT00439244|1148707|P1|NOT COMPLETED|Overall Study||11
480267|NCT00439244|1148705|P3|COMPLETED|Overall Study||131
480268|NCT00439244|1148706|P2|COMPLETED|Overall Study||131
480269|NCT00439244|1148707|P1|COMPLETED|Overall Study||126
480270|NCT00439244|1148705|P3|Safety Population|Overall Study||137
480271|NCT00439244|1148706|P2|Safety Population|Overall Study||137
480272|NCT00439244|1148707|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
480273|NCT00439244|1148705|P3|STARTED|Overall Study||138
480274|NCT00439244|1148706|P2|STARTED|Overall Study||137
480275|NCT00439244|1148707|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
480276|NCT00439231|1148727|P1|NOT COMPLETED|Overall Study||28
480277|NCT00439231|1148727|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
480278|NCT00439231|1148727|P1|STARTED|Overall Study||33
480280|NCT00439218|1148731|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
480281|NCT00439218|1148731|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
480282|NCT00439218|1148731|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
480283|NCT00439218|1148731|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
480284|NCT00439218|1148731|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
480285|NCT00439179|1148746|P4|NOT COMPLETED|Overall Study||0
480286|NCT00439179|1148747|P3|NOT COMPLETED|Overall Study||0
480287|NCT00439179|1148748|P2|NOT COMPLETED|Overall Study||2
480288|NCT00439179|1148749|P1|NOT COMPLETED|Overall Study||0
480289|NCT00439179|1148746|P4|COMPLETED|Overall Study||5
480290|NCT00439179|1148747|P3|COMPLETED|Overall Study||6
480291|NCT00439179|1148748|P2|COMPLETED|Overall Study||11
480292|NCT00439179|1148749|P1|COMPLETED|Overall Study||3
480293|NCT00439179|1148746|P4|STARTED|Overall Study|2 with biliry|5
480294|NCT00439179|1148747|P3|STARTED|Overall Study|2 with biliary|6
480295|NCT00439179|1148748|P2|STARTED|Overall Study|2 with biliary|13
480296|NCT00439179|1148749|P1|STARTED|Overall Study|1 with biliary|3
480297|NCT00439140|1148766|P3|NOT COMPLETED|Treatment Cycle 2||0
480298|NCT00439140|1148767|P2|NOT COMPLETED|Treatment Cycle 2||1
480299|NCT00439140|1148768|P1|NOT COMPLETED|Treatment Cycle 2||2
480300|NCT00439140|1148766|P3|COMPLETED|Treatment Cycle 2||0
480301|NCT00439140|1148767|P2|COMPLETED|Treatment Cycle 2||6
480302|NCT00439140|1148768|P1|COMPLETED|Treatment Cycle 2||11
480303|NCT00439140|1148766|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
480304|NCT00439140|1148767|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
480305|NCT00439140|1148768|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
480306|NCT00439140|1148766|P3|NOT COMPLETED|Treatment Cycle 1||1
480307|NCT00439140|1148767|P2|NOT COMPLETED|Treatment Cycle 1||4
480308|NCT00439140|1148768|P1|NOT COMPLETED|Treatment Cycle 1||1
480309|NCT00439140|1148766|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
480310|NCT00439140|1148767|P2|COMPLETED|Treatment Cycle 1||10
480311|NCT00439140|1148768|P1|COMPLETED|Treatment Cycle 1||14
480312|NCT00439140|1148766|P3|STARTED|Treatment Cycle 1||12
480313|NCT00439140|1148767|P2|STARTED|Treatment Cycle 1||14
480314|NCT00439140|1148768|P1|STARTED|Treatment Cycle 1||15
480315|NCT00438971|1148797|P1|NOT COMPLETED|Overall Study||2
480316|NCT00438971|1148797|P1|COMPLETED|Overall Study||15
480317|NCT00438971|1148797|P1|STARTED|Overall Study||17
480318|NCT00438932|1148812|P4|NOT COMPLETED|Overall Study||0
480319|NCT00438932|1148813|P3|NOT COMPLETED|Overall Study||0
480320|NCT00438932|1148814|P2|NOT COMPLETED|Overall Study||0
480321|NCT00438932|1148815|P1|NOT COMPLETED|Overall Study||0
480322|NCT00438932|1148812|P4|COMPLETED|Overall Study||4
480323|NCT00438932|1148813|P3|COMPLETED|Overall Study||4
480324|NCT00438932|1148814|P2|COMPLETED|Overall Study||4
480325|NCT00438932|1148815|P1|COMPLETED|Overall Study||4
480326|NCT00438932|1148812|P4|STARTED|Overall Study||4
480327|NCT00438932|1148813|P3|STARTED|Overall Study||4
480328|NCT00438932|1148814|P2|STARTED|Overall Study||4
480329|NCT00438932|1148815|P1|STARTED|Overall Study||4
480330|NCT00438880|1148831|P2|NOT COMPLETED|Overall Study||0
480331|NCT00438880|1148832|P1|NOT COMPLETED|Overall Study||0
480332|NCT00438880|1148831|P2|COMPLETED|Overall Study||8
480333|NCT00438880|1148832|P1|COMPLETED|Overall Study||30
480334|NCT00438880|1148831|P2|STARTED|Overall Study||8
480335|NCT00438880|1148832|P1|STARTED|Overall Study||30
480336|NCT00438854|1148844|P1|NOT COMPLETED|Overall Study||0
480337|NCT00438854|1148844|P1|COMPLETED|Overall Study||15
480338|NCT00438854|1148844|P1|STARTED|Overall Study||15
480339|NCT00438815|1148848|P1|NOT COMPLETED|Overall Study||70
480340|NCT00438815|1148848|P1|COMPLETED|Overall Study||43
480341|NCT00438815|1148848|P1|STARTED|Overall Study||113
480342|NCT00437983|1148860|P2|NOT COMPLETED|Overall Study||13
480343|NCT00437983|1148861|P1|NOT COMPLETED|Overall Study||13
480344|NCT00437983|1148860|P2|COMPLETED|Overall Study||65
480345|NCT00437983|1148861|P1|COMPLETED|Overall Study||66
480346|NCT00437983|1148860|P2|STARTED|Overall Study||78
480347|NCT00437983|1148861|P1|STARTED|Overall Study||79
480348|NCT00438750|1148873|P2|NOT COMPLETED|Overall Study||9
480349|NCT00438750|1148874|P1|NOT COMPLETED|Overall Study||9
480350|NCT00438750|1148873|P2|COMPLETED|Overall Study||37
480351|NCT00438750|1148874|P1|COMPLETED|Overall Study||39
480352|NCT00438750|1148873|P2|STARTED|Overall Study||46
480353|NCT00438750|1148874|P1|STARTED|Overall Study||48
480354|NCT00438672|1148894|P2|NOT COMPLETED|Overall Study||9
480355|NCT00438672|1148895|P1|NOT COMPLETED|Overall Study||7
480356|NCT00438672|1148894|P2|COMPLETED|Overall Study||24
480357|NCT00438672|1148895|P1|COMPLETED|Overall Study||24
480358|NCT00438672|1148894|P2|STARTED|Overall Study||33
480359|NCT00438672|1148895|P1|STARTED|Overall Study||31
480360|NCT00438659|1148905|P2|NOT COMPLETED|Overall Study||4
480361|NCT00438659|1148906|P1|NOT COMPLETED|Overall Study||6
480362|NCT00438659|1148905|P2|COMPLETED|Overall Study||82
480363|NCT00438659|1148906|P1|COMPLETED|Overall Study||84
480364|NCT00438659|1148905|P2|STARTED|Overall Study||86
480365|NCT00438659|1148906|P1|STARTED|Overall Study||90
480366|NCT00438490|1148930|P2|NOT COMPLETED|Overall Study||0
480367|NCT00438490|1148931|P1|NOT COMPLETED|Overall Study||0
480368|NCT00438490|1148930|P2|COMPLETED|Overall Study||9
480369|NCT00438490|1148931|P1|COMPLETED|Overall Study||12
480370|NCT00438490|1148930|P2|STARTED|Overall Study||9
480371|NCT00438490|1148931|P1|STARTED|Overall Study||12
480372|NCT00438464|1148939|P2|NOT COMPLETED|Overall Study||7
480373|NCT00438464|1148940|P1|NOT COMPLETED|Overall Study||14
480374|NCT00438464|1148939|P2|COMPLETED|Overall Study||94
480375|NCT00438464|1148940|P1|COMPLETED|Overall Study||89
480376|NCT00438464|1148939|P2|Received Assigned Intervention|Overall Study||94
480377|NCT00438464|1148940|P1|Received Assigned Intervention|Overall Study||89
480378|NCT00438464|1148939|P2|STARTED|Overall Study||101
480379|NCT00438464|1148940|P1|STARTED|Overall Study||103
480380|NCT00438451|1148995|P3|NOT COMPLETED|Overall Study||53
480381|NCT00438451|1148996|P2|NOT COMPLETED|Overall Study||66
480382|NCT00438451|1148997|P1|NOT COMPLETED|Overall Study||47
480383|NCT00438451|1148995|P3|COMPLETED|Overall Study||65
480384|NCT00438451|1148996|P2|COMPLETED|Overall Study||55
480385|NCT00438451|1148997|P1|COMPLETED|Overall Study||75
480386|NCT00438451|1148995|P3|Maintenance Phase (Week 7-58)|Overall Study||93
480387|NCT00438451|1148996|P2|Maintenance Phase (Week 7-58)|Overall Study||89
480388|NCT00438451|1148997|P1|Maintenance Phase (Week 7-58)|Overall Study||93
480389|NCT00438451|1148995|P3|ITT Population|Overall Study||117
480390|NCT00438451|1148996|P2|ITT Population|Overall Study||120
480391|NCT00438451|1148997|P1|ITT Population|Overall Study||122
480392|NCT00438451|1148995|P3|Safety Population|Overall Study||117
480393|NCT00438451|1148996|P2|Safety Population|Overall Study||121
480394|NCT00438451|1148997|P1|Safety Population|Overall Study||122
480395|NCT00438451|1148995|P3|STARTED|Overall Study||118
480396|NCT00438451|1148996|P2|STARTED|Overall Study||121
480397|NCT00438451|1148997|P1|STARTED|Overall Study||122
480398|NCT00438399|1149041|P6|NOT COMPLETED|Overall Study||6
480399|NCT00438399|1149042|P5|NOT COMPLETED|Overall Study||3
480400|NCT00438399|1149043|P4|NOT COMPLETED|Overall Study||4
480401|NCT00438399|1149044|P3|NOT COMPLETED|Overall Study||7
480402|NCT00438399|1149045|P2|NOT COMPLETED|Overall Study||8
480403|NCT00438399|1149046|P1|NOT COMPLETED|Overall Study||8
480404|NCT00438399|1149041|P6|COMPLETED|Overall Study||31
480405|NCT00438399|1149042|P5|COMPLETED|Overall Study||30
480406|NCT00438399|1149043|P4|COMPLETED|Overall Study||32
480407|NCT00438399|1149044|P3|COMPLETED|Overall Study||28
480408|NCT00438399|1149045|P2|COMPLETED|Overall Study||32
480409|NCT00438399|1149046|P1|COMPLETED|Overall Study||30
480410|NCT00438399|1149041|P6|TREATED & ANALYZED|Overall Study||31
480411|NCT00438399|1149042|P5|TREATED & ANALYZED|Overall Study||30
480412|NCT00438399|1149043|P4|TREATED & ANALYZED|Overall Study||32
480413|NCT00438399|1149044|P3|TREATED & ANALYZED|Overall Study||28
480414|NCT00438399|1149045|P2|TREATED & ANALYZED|Overall Study||32
480415|NCT00438399|1149046|P1|TREATED & ANALYZED|Overall Study||30
480416|NCT00438399|1149041|P6|STARTED|Overall Study||37
480417|NCT00438399|1149042|P5|STARTED|Overall Study||33
480418|NCT00438399|1149043|P4|STARTED|Overall Study||36
480419|NCT00438399|1149044|P3|STARTED|Overall Study||35
480420|NCT00438399|1149045|P2|STARTED|Overall Study||40
480421|NCT00438399|1149046|P1|STARTED|Overall Study||38
480422|NCT00438360|1149057|P2|NOT COMPLETED|Overall Study||43
480423|NCT00438360|1149058|P1|NOT COMPLETED|Overall Study||72
480424|NCT00438360|1149057|P2|COMPLETED|Overall Study||38
480425|NCT00438360|1149058|P1|COMPLETED|Overall Study||90
480426|NCT00438360|1149057|P2|Intention to Treat (ITT) Population|Overall Study||79
480427|NCT00438360|1149058|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
480428|NCT00438360|1149057|P2|STARTED|Overall Study||81
480429|NCT00438360|1149058|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
480430|NCT00438204|1149072|P1|NOT COMPLETED|Overall Study||0
480431|NCT00438204|1149072|P1|COMPLETED|Overall Study||39
480432|NCT00438204|1149072|P1|STARTED|Overall Study||39
480433|NCT00438100|1149078|P2|NOT COMPLETED|Overall Study||4
480434|NCT00438100|1149079|P1|NOT COMPLETED|Overall Study||2
480435|NCT00438100|1149078|P2|COMPLETED|Overall Study||65
480436|NCT00438100|1149079|P1|COMPLETED|Overall Study||71
480437|NCT00438100|1149078|P2|STARTED|Overall Study||69
480438|NCT00438100|1149079|P1|STARTED|Overall Study||73
480439|NCT00437645|1149087|P2|NOT COMPLETED|Overall Study||115
480440|NCT00437645|1149088|P1|NOT COMPLETED|Overall Study||35
480441|NCT00437645|1149087|P2|COMPLETED|Overall Study||476
480442|NCT00437645|1149088|P1|COMPLETED|Overall Study||557
480443|NCT00437645|1149087|P2|STARTED|Overall Study||591
480444|NCT00437645|1149088|P1|STARTED|Overall Study||592
480445|NCT00437489|1149104|P2|NOT COMPLETED|Overall Study||22
480446|NCT00437489|1149105|P1|NOT COMPLETED|Overall Study||23
480447|NCT00437489|1149104|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
480448|NCT00437489|1149105|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
480449|NCT00437489|1149104|P2|STARTED|Overall Study||24
480450|NCT00437489|1149105|P1|STARTED|Overall Study||25
480451|NCT00437398|1149117|P1|NOT COMPLETED|Overall Study||0
480452|NCT00437398|1149117|P1|COMPLETED|Overall Study||2
480453|NCT00437398|1149117|P1|STARTED|Overall Study||2
480454|NCT00437281|1149142|P20|NOT COMPLETED|Overall Study||1
480455|NCT00437281|1149143|P19|NOT COMPLETED|Overall Study||1
480456|NCT00437281|1149144|P18|NOT COMPLETED|Overall Study||0
480457|NCT00437281|1149145|P17|NOT COMPLETED|Overall Study||0
480458|NCT00437281|1149146|P16|NOT COMPLETED|Overall Study||0
480459|NCT00437281|1149147|P15|NOT COMPLETED|Overall Study||1
480460|NCT00437281|1149148|P14|NOT COMPLETED|Overall Study||1
480461|NCT00437281|1149149|P13|NOT COMPLETED|Overall Study||0
480462|NCT00437281|1149150|P12|NOT COMPLETED|Overall Study||0
480463|NCT00437281|1149151|P11|NOT COMPLETED|Overall Study||0
480464|NCT00437281|1149152|P10|NOT COMPLETED|Overall Study||1
480465|NCT00437281|1149153|P9|NOT COMPLETED|Overall Study||0
480466|NCT00437281|1149154|P8|NOT COMPLETED|Overall Study||0
480467|NCT00437281|1149155|P7|NOT COMPLETED|Overall Study||0
480468|NCT00437281|1149156|P6|NOT COMPLETED|Overall Study||1
480469|NCT00437281|1149157|P5|NOT COMPLETED|Overall Study||0
480470|NCT00437281|1149158|P4|NOT COMPLETED|Overall Study||1
480471|NCT00437281|1149159|P3|NOT COMPLETED|Overall Study||0
480472|NCT00437281|1149160|P2|NOT COMPLETED|Overall Study||0
480473|NCT00437281|1149161|P1|NOT COMPLETED|Overall Study||0
480474|NCT00437281|1149142|P20|COMPLETED|Overall Study||2
480475|NCT00437281|1149143|P19|COMPLETED|Overall Study||1
480476|NCT00437281|1149144|P18|COMPLETED|Overall Study||4
480477|NCT00437281|1149145|P17|COMPLETED|Overall Study||3
480478|NCT00437281|1149146|P16|COMPLETED|Overall Study||3
480479|NCT00437281|1149147|P15|COMPLETED|Overall Study||4
480480|NCT00437281|1149148|P14|COMPLETED|Overall Study||2
480481|NCT00437281|1149149|P13|COMPLETED|Overall Study||2
480482|NCT00437281|1149150|P12|COMPLETED|Overall Study||3
480483|NCT00437281|1149151|P11|COMPLETED|Overall Study||3
480484|NCT00437281|1149152|P10|COMPLETED|Overall Study||4
480485|NCT00437281|1149153|P9|COMPLETED|Overall Study||3
480486|NCT00437281|1149154|P8|COMPLETED|Overall Study||3
480487|NCT00437281|1149155|P7|COMPLETED|Overall Study||3
480488|NCT00437281|1149156|P6|COMPLETED|Overall Study||3
480489|NCT00437281|1149157|P5|COMPLETED|Overall Study||4
480490|NCT00437281|1149158|P4|COMPLETED|Overall Study||2
480491|NCT00437281|1149159|P3|COMPLETED|Overall Study||3
480492|NCT00437281|1149160|P2|COMPLETED|Overall Study||3
480493|NCT00437281|1149161|P1|COMPLETED|Overall Study||3
480494|NCT00437281|1149142|P20|STARTED|Overall Study||3
480495|NCT00437281|1149143|P19|STARTED|Overall Study||2
480496|NCT00437281|1149144|P18|STARTED|Overall Study||4
480497|NCT00437281|1149145|P17|STARTED|Overall Study||3
480498|NCT00437281|1149146|P16|STARTED|Overall Study||3
480499|NCT00437281|1149147|P15|STARTED|Overall Study||5
480500|NCT00437281|1149148|P14|STARTED|Overall Study||3
480501|NCT00437281|1149149|P13|STARTED|Overall Study||2
480502|NCT00437281|1149150|P12|STARTED|Overall Study||3
480503|NCT00437281|1149151|P11|STARTED|Overall Study||3
480504|NCT00437281|1149152|P10|STARTED|Overall Study||5
480505|NCT00437281|1149153|P9|STARTED|Overall Study||3
480506|NCT00437281|1149154|P8|STARTED|Overall Study||3
480507|NCT00437281|1149155|P7|STARTED|Overall Study||3
480508|NCT00437281|1149156|P6|STARTED|Overall Study||4
480509|NCT00437281|1149157|P5|STARTED|Overall Study||4
480510|NCT00437281|1149158|P4|STARTED|Overall Study||3
480511|NCT00437281|1149159|P3|STARTED|Overall Study||3
480512|NCT00437281|1149160|P2|STARTED|Overall Study||3
480513|NCT00437281|1149161|P1|STARTED|Overall Study||3
480514|NCT00437203|1149465|P10|NOT COMPLETED|Overall Study||4
480515|NCT00437203|1149466|P9|NOT COMPLETED|Overall Study||3
480516|NCT00437203|1149467|P8|NOT COMPLETED|Overall Study||3
480517|NCT00437203|1149468|P7|NOT COMPLETED|Overall Study||7
480518|NCT00437203|1149469|P6|NOT COMPLETED|Overall Study||3
480519|NCT00437203|1149470|P5|NOT COMPLETED|Overall Study||3
480520|NCT00437203|1149471|P4|NOT COMPLETED|Overall Study||3
480521|NCT00437203|1149472|P3|NOT COMPLETED|Overall Study||3
480522|NCT00437203|1149473|P2|NOT COMPLETED|Overall Study||8
480523|NCT00437203|1149474|P1|NOT COMPLETED|Overall Study||6
480524|NCT00437203|1149465|P10|COMPLETED|Overall Study||0
480525|NCT00437203|1149466|P9|COMPLETED|Overall Study||0
480526|NCT00437203|1149467|P8|COMPLETED|Overall Study||0
480527|NCT00437203|1149468|P7|COMPLETED|Overall Study||0
480528|NCT00437203|1149469|P6|COMPLETED|Overall Study||0
480529|NCT00437203|1149470|P5|COMPLETED|Overall Study||0
480530|NCT00437203|1149471|P4|COMPLETED|Overall Study||0
480531|NCT00437203|1149472|P3|COMPLETED|Overall Study||0
480532|NCT00437203|1149473|P2|COMPLETED|Overall Study||0
480533|NCT00437203|1149474|P1|COMPLETED|Overall Study||0
480534|NCT00437203|1149465|P10|STARTED|Overall Study||4
480535|NCT00437203|1149466|P9|STARTED|Overall Study||3
480536|NCT00437203|1149467|P8|STARTED|Overall Study||3
480537|NCT00437203|1149468|P7|STARTED|Overall Study||7
480538|NCT00437203|1149469|P6|STARTED|Overall Study||3
480539|NCT00437203|1149470|P5|STARTED|Overall Study||3
480540|NCT00437203|1149471|P4|STARTED|Overall Study||3
480541|NCT00437203|1149472|P3|STARTED|Overall Study||3
480542|NCT00437203|1149473|P2|STARTED|Overall Study||8
480543|NCT00437203|1149474|P1|STARTED|Overall Study||6
480544|NCT00437125|1149578|P1|NOT COMPLETED|Overall Study||32
480545|NCT00437125|1149578|P1|COMPLETED|Overall Study||119
480546|NCT00437125|1149578|P1|STARTED|Overall Study||151
480547|NCT00437073|1149599|P2|NOT COMPLETED|Overall Study||1
480548|NCT00437073|1149600|P1|NOT COMPLETED|Overall Study||1
480549|NCT00437073|1149599|P2|COMPLETED|Overall Study||8
480550|NCT00437073|1149600|P1|COMPLETED|Overall Study||12
480551|NCT00437073|1149599|P2|STARTED|Overall Study||9
480552|NCT00437073|1149600|P1|STARTED|Overall Study||13
480553|NCT00437034|1149628|P1|NOT COMPLETED|Overall Study||6
480554|NCT00437034|1149628|P1|COMPLETED|Overall Study||0
480555|NCT00437034|1149628|P1|STARTED|Overall Study||6
480556|NCT00436982|1149634|P2|NOT COMPLETED|Overall Study||5
480557|NCT00436982|1149635|P1|NOT COMPLETED|Overall Study||5
480558|NCT00436982|1149634|P2|COMPLETED|Overall Study||25
480559|NCT00436982|1149635|P1|COMPLETED|Overall Study||25
480560|NCT00436982|1149634|P2|STARTED|Overall Study||30
480561|NCT00436982|1149635|P1|STARTED|Overall Study||30
480562|NCT00436969|1149643|P2|NOT COMPLETED|Overall Study||52
480563|NCT00436969|1149644|P1|NOT COMPLETED|Overall Study||22
480564|NCT00436969|1149643|P2|COMPLETED|Overall Study||134
480565|NCT00436969|1149644|P1|COMPLETED|Overall Study||66
480566|NCT00436969|1149643|P2|Randomized But Not Treated|Overall Study||3
480567|NCT00436969|1149644|P1|Randomized But Not Treated|Overall Study||1
480568|NCT00436969|1149643|P2|STARTED|Overall Study||186
480569|NCT00436969|1149644|P1|STARTED|Overall Study||88
480570|NCT00436956|1149692|P2|NOT COMPLETED|Overall Study||0
480571|NCT00436956|1149693|P1|NOT COMPLETED|Overall Study||1
480572|NCT00436956|1149692|P2|COMPLETED|Overall Study||23
480573|NCT00436956|1149693|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
480574|NCT00436956|1149692|P2|STARTED|Overall Study||23
480575|NCT00436956|1149693|P1|STARTED|Overall Study||36
480576|NCT00436917|1149702|P1|NOT COMPLETED|Overall Study||54
480577|NCT00436917|1149702|P1|COMPLETED|Overall Study||0
480578|NCT00436917|1149702|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
480579|NCT00436904|1149706|P1|NOT COMPLETED|Overall Study||0
480580|NCT00436904|1149706|P1|COMPLETED|Overall Study||30
480581|NCT00436904|1149706|P1|STARTED|Overall Study||30
480582|NCT00436852|1149717|P2|NOT COMPLETED|Overall Study||45
480583|NCT00436852|1149718|P1|NOT COMPLETED|Overall Study||35
480584|NCT00436852|1149717|P2|COMPLETED|Overall Study||2
480585|NCT00436852|1149718|P1|COMPLETED|Overall Study||10
480586|NCT00436852|1149717|P2|STARTED|Overall Study||47
480587|NCT00436852|1149718|P1|STARTED|Overall Study||45
480588|NCT00436826|1149728|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
480589|NCT00436826|1149729|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
480590|NCT00436826|1149730|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
480591|NCT00436826|1149731|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
480592|NCT00436826|1149732|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
480593|NCT00436826|1149733|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
480594|NCT00436826|1149728|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
480595|NCT00436826|1149729|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
480596|NCT00436826|1149730|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
480597|NCT00436826|1149731|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
480598|NCT00436826|1149732|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
480599|NCT00436826|1149733|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
480600|NCT00436826|1149728|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
480601|NCT00436826|1149729|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
480602|NCT00436826|1149730|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
480603|NCT00436826|1149731|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
480604|NCT00436826|1149732|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
480605|NCT00436826|1149733|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
480606|NCT00436826|1149728|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
480607|NCT00436826|1149729|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
480608|NCT00436826|1149730|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
480609|NCT00436826|1149731|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
480610|NCT00436826|1149732|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
480611|NCT00436826|1149733|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
480612|NCT00436826|1149728|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
480613|NCT00436826|1149729|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
480614|NCT00436826|1149730|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
480615|NCT00436826|1149731|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
480616|NCT00436826|1149732|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
480617|NCT00436826|1149733|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
480618|NCT00436826|1149728|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
480619|NCT00436826|1149729|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
480620|NCT00436826|1149730|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
480621|NCT00436826|1149731|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
480622|NCT00436826|1149732|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
480623|NCT00436826|1149733|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
480624|NCT00436826|1149728|P6|NOT COMPLETED|Double Blind Period||0
480625|NCT00436826|1149729|P5|NOT COMPLETED|Double Blind Period||0
480626|NCT00436826|1149730|P4|NOT COMPLETED|Double Blind Period||0
480627|NCT00436826|1149731|P3|NOT COMPLETED|Double Blind Period||0
480628|NCT00436826|1149732|P2|NOT COMPLETED|Double Blind Period||11
480629|NCT00436826|1149733|P1|NOT COMPLETED|Double Blind Period||13
480630|NCT00436826|1149728|P6|COMPLETED|Double Blind Period||0
480631|NCT00436826|1149729|P5|COMPLETED|Double Blind Period||0
480632|NCT00436826|1149730|P4|COMPLETED|Double Blind Period||0
480633|NCT00436826|1149731|P3|COMPLETED|Double Blind Period||0
480634|NCT00436826|1149732|P2|COMPLETED|Double Blind Period||37
480635|NCT00436826|1149733|P1|COMPLETED|Double Blind Period||111
480636|NCT00436826|1149728|P6|STARTED|Double Blind Period||0
480637|NCT00436826|1149729|P5|STARTED|Double Blind Period||0
480638|NCT00436826|1149730|P4|STARTED|Double Blind Period||0
480639|NCT00436826|1149731|P3|STARTED|Double Blind Period||0
480640|NCT00436826|1149732|P2|STARTED|Double Blind Period||48
480641|NCT00436826|1149733|P1|STARTED|Double Blind Period||124
480642|NCT00436748|1149755|P2|NOT COMPLETED|Overall Study||12
480643|NCT00436748|1149756|P1|NOT COMPLETED|Overall Study||11
480644|NCT00436748|1149755|P2|COMPLETED|Overall Study||45
480645|NCT00436748|1149756|P1|COMPLETED|Overall Study||48
480646|NCT00436748|1149755|P2|Received Treatment|Overall Study||56
480647|NCT00436748|1149756|P1|Received Treatment|Overall Study||58
480648|NCT00436748|1149755|P2|STARTED|Overall Study||57
480649|NCT00436748|1149756|P1|STARTED|Overall Study||59
480650|NCT00436644|1149790|P1|NOT COMPLETED|Overall Study||3
480651|NCT00436644|1149790|P1|COMPLETED|Overall Study||15
480652|NCT00436644|1149790|P1|STARTED|Overall Study||18
480653|NCT00436618|1149800|P3|NOT COMPLETED|Overall Study||61
480654|NCT00436618|1149801|P2|NOT COMPLETED|Overall Study||27
480655|NCT00436618|1149802|P1|NOT COMPLETED|Overall Study||30
480656|NCT00436618|1149800|P3|COMPLETED|Overall Study||46
480657|NCT00436618|1149801|P2|COMPLETED|Overall Study||28
480658|NCT00436618|1149802|P1|COMPLETED|Overall Study||84
480659|NCT00436618|1149800|P3|STARTED|Overall Study||107
480660|NCT00436618|1149801|P2|STARTED|Overall Study||55
480661|NCT00436618|1149802|P1|STARTED|Overall Study||114
480662|NCT00436605|1149819|P1|NOT COMPLETED|Overall Study||3
480663|NCT00436605|1149819|P1|COMPLETED|Overall Study||36
480664|NCT00436605|1149819|P1|STARTED|Overall Study||39
480665|NCT00436566|1149824|P1|NOT COMPLETED|Overall Study||3
480666|NCT00436566|1149824|P1|COMPLETED|Overall Study||109
480667|NCT00436566|1149824|P1|STARTED|Overall Study||112
480668|NCT00436553|1149831|P3|NOT COMPLETED|Overall Study||10
480669|NCT00436553|1149832|P2|NOT COMPLETED|Overall Study||12
480670|NCT00436553|1149833|P1|NOT COMPLETED|Overall Study||13
480671|NCT00436553|1149831|P3|COMPLETED|Overall Study||102
480672|NCT00436553|1149832|P2|COMPLETED|Overall Study||93
480673|NCT00436553|1149833|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
480674|NCT00436553|1149831|P3|STARTED|Overall Study||112
480675|NCT00436553|1149832|P2|STARTED|Overall Study||105
480676|NCT00436553|1149833|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
480677|NCT00436501|1149854|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
480678|NCT00436501|1149855|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
480679|NCT00436501|1149854|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
480680|NCT00436501|1149855|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
480681|NCT00436501|1149854|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
480682|NCT00436501|1149855|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
480683|NCT00436501|1149854|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
480684|NCT00436501|1149855|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
480685|NCT00436501|1149854|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
480686|NCT00436501|1149855|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
480687|NCT00436501|1149854|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
480688|NCT00436501|1149855|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
480689|NCT00436501|1149854|P2|NOT COMPLETED|Complete Study Participation||0
480690|NCT00436501|1149855|P1|NOT COMPLETED|Complete Study Participation||0
480691|NCT00436501|1149854|P2|COMPLETED|Complete Study Participation||49
480692|NCT00436501|1149855|P1|COMPLETED|Complete Study Participation||9
480693|NCT00436501|1149854|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
480694|NCT00436501|1149855|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
480695|NCT00436436|1149866|P1|NOT COMPLETED|Overall Study||12
480696|NCT00436436|1149866|P1|COMPLETED|Overall Study||0
480697|NCT00436436|1149866|P1|STARTED|Overall Study||12
480698|NCT00436345|1149877|P2|NOT COMPLETED|Overall Study||0
480699|NCT00436345|1149878|P1|NOT COMPLETED|Overall Study||3
480700|NCT00436345|1149877|P2|COMPLETED|Overall Study||18
480701|NCT00436345|1149878|P1|COMPLETED|Overall Study||18
480702|NCT00436345|1149877|P2|STARTED|Overall Study||18
480703|NCT00436345|1149878|P1|STARTED|Overall Study||21
480704|NCT00436332|1149931|P1|NOT COMPLETED|Overall Study||83
480705|NCT00436332|1149931|P1|COMPLETED|Overall Study||1
480706|NCT00436332|1149931|P1|Eligible and Began Protocol Therapy|Overall Study||79
480707|NCT00436332|1149931|P1|Eligible|Overall Study||82
480708|NCT00436332|1149931|P1|STARTED|Overall Study||84
480709|NCT00436215|1149938|P1|NOT COMPLETED|Overall Study||4
480710|NCT00436215|1149938|P1|COMPLETED|Overall Study||51
480711|NCT00436215|1149938|P1|STARTED|Overall Study||55
480712|NCT00436163|1149944|P1|NOT COMPLETED|Overall Study||3
480713|NCT00436163|1149944|P1|COMPLETED|Overall Study||36
480714|NCT00436163|1149944|P1|STARTED|Overall Study||39
480715|NCT00436046|1149958|P3|NOT COMPLETED|Overall Study||0
480716|NCT00436046|1149959|P2|NOT COMPLETED|Overall Study||0
480717|NCT00436046|1149960|P1|NOT COMPLETED|Overall Study||0
480718|NCT00436046|1149958|P3|COMPLETED|Overall Study||31
480719|NCT00436046|1149959|P2|COMPLETED|Overall Study||32
480720|NCT00436046|1149960|P1|COMPLETED|Overall Study||32
480721|NCT00436046|1149958|P3|STARTED|Overall Study||31
480722|NCT00436046|1149959|P2|STARTED|Overall Study||32
480723|NCT00436046|1149960|P1|STARTED|Overall Study||32
480724|NCT00436007|1149992|P3|NOT COMPLETED|Overall Study||23
480725|NCT00436007|1149993|P2|NOT COMPLETED|Overall Study||14
480726|NCT00436007|1149994|P1|NOT COMPLETED|Overall Study||19
480727|NCT00436007|1149992|P3|COMPLETED|Overall Study||148
480728|NCT00436007|1149993|P2|COMPLETED|Overall Study||156
480729|NCT00436007|1149994|P1|COMPLETED|Overall Study||151
480730|NCT00436007|1149992|P3|STARTED|Overall Study||171
480731|NCT00436007|1149993|P2|STARTED|Overall Study||170
480732|NCT00436007|1149994|P1|STARTED|Overall Study||170
480733|NCT00435994|1150042|P3|NOT COMPLETED|Overall Study||0
480734|NCT00435994|1150043|P2|NOT COMPLETED|Overall Study||0
480735|NCT00435994|1150044|P1|NOT COMPLETED|Overall Study||7
480736|NCT00435994|1150042|P3|COMPLETED|Overall Study||12
480737|NCT00435994|1150043|P2|COMPLETED|Overall Study||25
480738|NCT00435994|1150044|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
480739|NCT00435994|1150042|P3|STARTED|Overall Study||12
480740|NCT00435994|1150043|P2|STARTED|Overall Study||25
480741|NCT00435994|1150044|P1|STARTED|Overall Study||22
480742|NCT00435929|1150055|P2|NOT COMPLETED|Overall Study||0
480743|NCT00435929|1150056|P1|NOT COMPLETED|Overall Study||0
480744|NCT00435929|1150055|P2|COMPLETED|Overall Study||9
480745|NCT00435929|1150056|P1|COMPLETED|Overall Study||7
480746|NCT00435929|1150055|P2|STARTED|Overall Study||9
480747|NCT00435929|1150056|P1|STARTED|Overall Study||7
480748|NCT00435825|1150086|P4|NOT COMPLETED|Overall Study||16
480749|NCT00435825|1150087|P3|NOT COMPLETED|Overall Study||11
480750|NCT00435825|1150088|P2|NOT COMPLETED|Overall Study||12
480751|NCT00435825|1150089|P1|NOT COMPLETED|Overall Study||18
480752|NCT00435825|1150086|P4|COMPLETED|Overall Study||120
480753|NCT00435825|1150087|P3|COMPLETED|Overall Study||127
480754|NCT00435825|1150088|P2|COMPLETED|Overall Study||124
480755|NCT00435825|1150089|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
480756|NCT00435825|1150086|P4|Completed 48 Weeks Treatment|Overall Study||117
480757|NCT00435825|1150087|P3|Completed 48 Weeks Treatment|Overall Study||124
480758|NCT00435825|1150088|P2|Completed 48 Weeks Treatment|Overall Study||0
480759|NCT00435825|1150089|P1|Completed 48 Weeks Treatment|Overall Study||0
480760|NCT00435825|1150086|P4|Completed 24 Weeks Treatment|Overall Study||131
480761|NCT00435825|1150087|P3|Completed 24 Weeks Treatment|Overall Study||134
480762|NCT00435825|1150088|P2|Completed 24 Weeks Treatment|Overall Study||126
480763|NCT00435825|1150089|P1|Completed 24 Weeks Treatment|Overall Study||128
480764|NCT00435825|1150086|P4|Entered Follow-up|Overall Study||133
480765|NCT00435825|1150087|P3|Entered Follow-up|Overall Study||135
480766|NCT00435825|1150088|P2|Entered Follow-up|Overall Study||132
480767|NCT00435825|1150089|P1|Entered Follow-up|Overall Study||140
480768|NCT00435825|1150086|P4|Received Study Drug|Overall Study||136
480769|NCT00435825|1150087|P3|Received Study Drug|Overall Study||136
480770|NCT00435825|1150088|P2|Received Study Drug|Overall Study||136
480771|NCT00435825|1150089|P1|Received Study Drug|Overall Study||140
480772|NCT00435825|1150086|P4|STARTED|Overall Study||136
480773|NCT00435825|1150087|P3|STARTED|Overall Study||138
480774|NCT00435825|1150088|P2|STARTED|Overall Study||136
480775|NCT00435825|1150089|P1|STARTED|Overall Study||141
480776|NCT00435591|1150147|P4|NOT COMPLETED|Overall Study||11
480777|NCT00435591|1150148|P3|NOT COMPLETED|Overall Study||5
480778|NCT00435591|1150149|P2|NOT COMPLETED|Overall Study||4
480779|NCT00435591|1150150|P1|NOT COMPLETED|Overall Study||7
480780|NCT00435591|1150147|P4|COMPLETED|Overall Study||19
480781|NCT00435591|1150148|P3|COMPLETED|Overall Study||25
480782|NCT00435591|1150149|P2|COMPLETED|Overall Study||27
480783|NCT00435591|1150150|P1|COMPLETED|Overall Study||23
480784|NCT00435591|1150147|P4|End of Treatment|Overall Study||23
480785|NCT00435591|1150148|P3|End of Treatment|Overall Study||27
480786|NCT00435591|1150149|P2|End of Treatment|Overall Study||27
480787|NCT00435591|1150150|P1|End of Treatment|Overall Study||25
480788|NCT00435591|1150147|P4|Full Analysis Set|Overall Study||29
480789|NCT00435591|1150148|P3|Full Analysis Set|Overall Study||30
480790|NCT00435591|1150149|P2|Full Analysis Set|Overall Study||29
480791|NCT00435591|1150150|P1|Full Analysis Set|Overall Study||28
480792|NCT00435591|1150147|P4|Safety Analysis Set|Overall Study||29
480793|NCT00435591|1150148|P3|Safety Analysis Set|Overall Study||30
480794|NCT00435591|1150149|P2|Safety Analysis Set|Overall Study||30
480795|NCT00435591|1150150|P1|Safety Analysis Set|Overall Study||28
480796|NCT00435591|1150147|P4|STARTED|Overall Study||30
480797|NCT00435591|1150148|P3|STARTED|Overall Study||30
480798|NCT00435591|1150149|P2|STARTED|Overall Study||31
480799|NCT00435591|1150150|P1|STARTED|Overall Study||30
480800|NCT00435539|1150180|P5|NOT COMPLETED|Overall Study||0
480801|NCT00435539|1150181|P4|NOT COMPLETED|Overall Study||0
480802|NCT00435539|1150182|P3|NOT COMPLETED|Overall Study||0
480803|NCT00435539|1150183|P2|NOT COMPLETED|Overall Study||0
480804|NCT00435539|1150184|P1|NOT COMPLETED|Overall Study||0
480805|NCT00435539|1150180|P5|COMPLETED|Overall Study||12
480806|NCT00435539|1150181|P4|COMPLETED|Overall Study||12
480807|NCT00435539|1150182|P3|COMPLETED|Overall Study||11
480808|NCT00435539|1150183|P2|COMPLETED|Overall Study||13
480809|NCT00435539|1150184|P1|COMPLETED|Overall Study||12
480810|NCT00435539|1150180|P5|STARTED|Overall Study||12
480811|NCT00435539|1150181|P4|STARTED|Overall Study||12
480812|NCT00435539|1150182|P3|STARTED|Overall Study||11
480813|NCT00435539|1150183|P2|STARTED|Overall Study||13
480814|NCT00435539|1150184|P1|STARTED|Overall Study||12
480815|NCT00435487|1150201|P2|NOT COMPLETED|Overall Study||15
480816|NCT00435487|1150202|P1|NOT COMPLETED|Overall Study||12
480817|NCT00435487|1150201|P2|COMPLETED|Overall Study||71
480818|NCT00435487|1150202|P1|COMPLETED|Overall Study||76
480819|NCT00435487|1150201|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
480820|NCT00435487|1150202|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
480821|NCT00435487|1150201|P2|STARTED|Overall Study||86
480822|NCT00435487|1150202|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
480823|NCT00435409|1150220|P3|NOT COMPLETED|Overall Study||78
480824|NCT00435409|1150221|P2|NOT COMPLETED|Overall Study||143
480825|NCT00435409|1150222|P1|NOT COMPLETED|Overall Study||221
480826|NCT00435409|1150220|P3|COMPLETED|Overall Study||0
480827|NCT00435409|1150221|P2|COMPLETED|Overall Study||0
480828|NCT00435409|1150222|P1|COMPLETED|Overall Study||0
480829|NCT00435409|1150220|P3|Treated|Overall Study||78
480830|NCT00435409|1150221|P2|Treated|Overall Study||139
480831|NCT00435409|1150222|P1|Treated|Overall Study||217
480832|NCT00435409|1150220|P3|STARTED|Overall Study||78
480833|NCT00435409|1150221|P2|STARTED|Overall Study||143
480834|NCT00435409|1150222|P1|STARTED|Overall Study||221
480835|NCT00435370|1150244|P2|NOT COMPLETED|Overall Study||20
480836|NCT00435370|1150245|P1|NOT COMPLETED|Overall Study||22
480837|NCT00435370|1150244|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
480838|NCT00435370|1150245|P1|COMPLETED|Overall Study||68
480839|NCT00435370|1150244|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
480840|NCT00435370|1150245|P1|STARTED|Overall Study||90
480841|NCT00435188|1150253|P2|NOT COMPLETED|Overall Study||23
480842|NCT00435188|1150254|P1|NOT COMPLETED|Overall Study||22
480843|NCT00435188|1150253|P2|COMPLETED|Overall Study||176
480844|NCT00435188|1150254|P1|COMPLETED|Overall Study||177
480845|NCT00435188|1150253|P2|STARTED|Overall Study||199
480846|NCT00435188|1150254|P1|STARTED|Overall Study||199
480847|NCT00435162|1150297|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
480848|NCT00435162|1150298|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
480849|NCT00435162|1150299|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
480850|NCT00435162|1150300|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
480851|NCT00435162|1150301|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
480852|NCT00435162|1150302|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
480853|NCT00435162|1150297|P6|COMPLETED|Period 2 (2 Weeks)||15
480854|NCT00435162|1150298|P5|COMPLETED|Period 2 (2 Weeks)||15
480855|NCT00435162|1150299|P4|COMPLETED|Period 2 (2 Weeks)||8
480856|NCT00435162|1150300|P3|COMPLETED|Period 2 (2 Weeks)||6
480857|NCT00435162|1150301|P2|COMPLETED|Period 2 (2 Weeks)||14
480858|NCT00435162|1150302|P1|COMPLETED|Period 2 (2 Weeks)||15
480859|NCT00435162|1150297|P6|STARTED|Period 2 (2 Weeks)||15
480860|NCT00435162|1150298|P5|STARTED|Period 2 (2 Weeks)||15
480861|NCT00435162|1150299|P4|STARTED|Period 2 (2 Weeks)||8
480862|NCT00435162|1150300|P3|STARTED|Period 2 (2 Weeks)||6
480863|NCT00435162|1150301|P2|STARTED|Period 2 (2 Weeks)||15
480864|NCT00435162|1150302|P1|STARTED|Period 2 (2 Weeks)||15
480865|NCT00435162|1150297|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
480866|NCT00435162|1150298|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
480867|NCT00435162|1150299|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
480868|NCT00435162|1150300|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
480869|NCT00435162|1150301|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
480870|NCT00435162|1150302|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
480871|NCT00435162|1150297|P6|COMPLETED|Period 1 (6 Weeks)||15
480872|NCT00435162|1150298|P5|COMPLETED|Period 1 (6 Weeks)||15
480873|NCT00435162|1150299|P4|COMPLETED|Period 1 (6 Weeks)||8
480874|NCT00435162|1150300|P3|COMPLETED|Period 1 (6 Weeks)||6
480875|NCT00435162|1150301|P2|COMPLETED|Period 1 (6 Weeks)||15
480876|NCT00435162|1150302|P1|COMPLETED|Period 1 (6 Weeks)||15
480877|NCT00435162|1150297|P6|STARTED|Period 1 (6 Weeks)||15
480878|NCT00435162|1150298|P5|STARTED|Period 1 (6 Weeks)||15
480879|NCT00435162|1150299|P4|STARTED|Period 1 (6 Weeks)||8
480880|NCT00435162|1150300|P3|STARTED|Period 1 (6 Weeks)||6
480881|NCT00435162|1150301|P2|STARTED|Period 1 (6 Weeks)||15
480882|NCT00435162|1150302|P1|STARTED|Period 1 (6 Weeks)||15
480883|NCT00435045|1150322|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
480884|NCT00435045|1150323|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
480885|NCT00435045|1150322|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
480886|NCT00435045|1150323|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
480887|NCT00435045|1150322|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
480888|NCT00435045|1150323|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
480889|NCT00435045|1150322|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
480890|NCT00435045|1150323|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
480891|NCT00435045|1150322|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
480892|NCT00435045|1150323|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
480893|NCT00435045|1150322|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
480894|NCT00435045|1150323|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
480895|NCT00435045|1150322|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
480896|NCT00435045|1150323|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
480897|NCT00435045|1150322|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
480898|NCT00435045|1150323|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
480899|NCT00435045|1150322|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
480900|NCT00435045|1150323|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
480901|NCT00435019|1150379|P2|NOT COMPLETED|Overall Study||10
480902|NCT00435019|1150380|P1|NOT COMPLETED|Overall Study||13
480903|NCT00435019|1150379|P2|COMPLETED|Overall Study||161
480904|NCT00435019|1150380|P1|COMPLETED|Overall Study||164
480905|NCT00435019|1150379|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
480906|NCT00435019|1150380|P1|Exposed to Study Drug|Overall Study||177
480907|NCT00435019|1150379|P2|STARTED|Overall Study|Randomised|171
480908|NCT00435019|1150380|P1|STARTED|Overall Study|Randomised|177
480909|NCT00434993|1150392|P2|NOT COMPLETED|Overall Study||0
480910|NCT00434993|1150393|P1|NOT COMPLETED|Overall Study||0
480911|NCT00434993|1150392|P2|COMPLETED|Overall Study||130
480912|NCT00434993|1150393|P1|COMPLETED|Overall Study||152
480913|NCT00434993|1150392|P2|STARTED|Overall Study||130
480914|NCT00434993|1150393|P1|STARTED|Overall Study||152
480915|NCT00434967|1150421|P4|NOT COMPLETED|Overall Study||14
480916|NCT00434967|1150422|P3|NOT COMPLETED|Overall Study||9
480917|NCT00434967|1150423|P2|NOT COMPLETED|Overall Study||8
480918|NCT00434967|1150424|P1|NOT COMPLETED|Overall Study||7
480919|NCT00434967|1150421|P4|COMPLETED|Overall Study||478
480920|NCT00434967|1150422|P3|COMPLETED|Overall Study||461
480921|NCT00434967|1150423|P2|COMPLETED|Overall Study||457
480922|NCT00434967|1150424|P1|COMPLETED|Overall Study||90
480923|NCT00434967|1150421|P4|STARTED|Overall Study||492
480924|NCT00434967|1150422|P3|STARTED|Overall Study||470
480925|NCT00434967|1150423|P2|STARTED|Overall Study||465
480926|NCT00434967|1150424|P1|STARTED|Overall Study||97
480927|NCT00434954|1150444|P2|NOT COMPLETED|Overall Study||71
480928|NCT00434954|1150445|P1|NOT COMPLETED|Overall Study||82
480929|NCT00434954|1150444|P2|COMPLETED|Overall Study||175
480930|NCT00434954|1150445|P1|COMPLETED|Overall Study||166
480931|NCT00434954|1150444|P2|Completed - Previous Treatment MET + SU|Overall Study||38
480932|NCT00434954|1150445|P1|Completed - Previous Treatment MET + SU|Overall Study||31
480933|NCT00434954|1150444|P2|Completed - Previous Treatment MET Only|Overall Study||137
480934|NCT00434954|1150445|P1|Completed - Previous Treatment MET Only|Overall Study||135
480935|NCT00434954|1150444|P2|FAS - Previous Treatment MET + SU|Overall Study||60
480936|NCT00434954|1150445|P1|FAS - Previous Treatment MET + SU|Overall Study||66
480937|NCT00434954|1150444|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
480938|NCT00434954|1150445|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
480939|NCT00434954|1150444|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
480940|NCT00434954|1150445|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
480941|NCT00434954|1150444|P2|Started - Previous Treatment MET + SU|Overall Study||65
480942|NCT00434954|1150445|P1|Started - Previous Treatment MET + SU|Overall Study||66
480943|NCT00434954|1150444|P2|Started - Previous Treatment MET Only|Overall Study||181
480944|NCT00434954|1150445|P1|Started - Previous Treatment MET Only|Overall Study||182
480945|NCT00434954|1150444|P2|STARTED|Overall Study||246
480946|NCT00434954|1150445|P1|STARTED|Overall Study||248
480947|NCT00434876|1150475|P2|NOT COMPLETED|Overall Study||1
480948|NCT00434876|1150476|P1|NOT COMPLETED|Overall Study||1
480949|NCT00434876|1150475|P2|COMPLETED|Overall Study||10
480950|NCT00434876|1150476|P1|COMPLETED|Overall Study||10
480951|NCT00434876|1150475|P2|STARTED|Overall Study||11
480952|NCT00434876|1150476|P1|STARTED|Overall Study||11
480953|NCT00434759|1150490|P2|NOT COMPLETED|Overall Study||5
480954|NCT00434759|1150491|P1|NOT COMPLETED|Overall Study||24
480955|NCT00434759|1150490|P2|COMPLETED|Overall Study||38
480956|NCT00434759|1150491|P1|COMPLETED|Overall Study||22
480957|NCT00434759|1150490|P2|STARTED|Overall Study||43
480958|NCT00434759|1150491|P1|STARTED|Overall Study||46
480959|NCT00434642|1150507|P2|NOT COMPLETED|Open-label Treatment Phase||11
480960|NCT00434642|1150508|P1|NOT COMPLETED|Open-label Treatment Phase||0
480961|NCT00434642|1150507|P2|COMPLETED|Open-label Treatment Phase||1
480962|NCT00434642|1150508|P1|COMPLETED|Open-label Treatment Phase||0
480963|NCT00434642|1150507|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
480964|NCT00434642|1150508|P1|STARTED|Open-label Treatment Phase||0
480965|NCT00434642|1150507|P2|NOT COMPLETED|Blinded Treatment Phase||229
480966|NCT00434642|1150508|P1|NOT COMPLETED|Blinded Treatment Phase||242
480967|NCT00434642|1150507|P2|COMPLETED|Blinded Treatment Phase||13
480968|NCT00434642|1150508|P1|COMPLETED|Blinded Treatment Phase||0
480969|NCT00434642|1150507|P2|STARTED|Blinded Treatment Phase||242
480970|NCT00434642|1150508|P1|STARTED|Blinded Treatment Phase||242
480971|NCT00434590|1150526|P2|NOT COMPLETED|Overall Study||5
480972|NCT00434590|1150527|P1|NOT COMPLETED|Overall Study||5
480973|NCT00434590|1150526|P2|COMPLETED|Overall Study||0
480974|NCT00434590|1150527|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
480975|NCT00434590|1150526|P2|STARTED|Overall Study||5
480976|NCT00434590|1150527|P1|STARTED|Overall Study||5
480977|NCT00434434|1150536|P3|NOT COMPLETED|Overall Study||1
480978|NCT00434434|1150537|P2|NOT COMPLETED|Overall Study||0
480979|NCT00434434|1150538|P1|NOT COMPLETED|Overall Study||2
480980|NCT00434434|1150536|P3|COMPLETED|Overall Study||13
480981|NCT00434434|1150537|P2|COMPLETED|Overall Study||24
480982|NCT00434434|1150538|P1|COMPLETED|Overall Study||21
480983|NCT00434434|1150536|P3|STARTED|Overall Study||14
480984|NCT00434434|1150537|P2|STARTED|Overall Study||24
480985|NCT00434434|1150538|P1|STARTED|Overall Study||23
480986|NCT00434421|1150549|P1|NOT COMPLETED|Overall Study||2
480987|NCT00434421|1150549|P1|COMPLETED|Overall Study||26
480988|NCT00434421|1150549|P1|STARTED|Overall Study||28
480989|NCT00434356|1150555|P2|NOT COMPLETED|Overall Study||23
480990|NCT00434356|1150556|P1|NOT COMPLETED|Overall Study||23
480991|NCT00434356|1150555|P2|COMPLETED|Overall Study||0
480992|NCT00434356|1150556|P1|COMPLETED|Overall Study||0
480993|NCT00434356|1150555|P2|STARTED|Overall Study||23
480994|NCT00434356|1150556|P1|STARTED|Overall Study||23
480995|NCT00434330|1150577|P6|NOT COMPLETED|Overall Study||1
480996|NCT00434330|1150578|P5|NOT COMPLETED|Overall Study||1
480997|NCT00434330|1150579|P4|NOT COMPLETED|Overall Study||2
480998|NCT00434330|1150580|P3|NOT COMPLETED|Overall Study||3
480999|NCT00434330|1150581|P2|NOT COMPLETED|Overall Study||0
481000|NCT00434330|1150582|P1|NOT COMPLETED|Overall Study||1
481001|NCT00434330|1150577|P6|COMPLETED|Overall Study||14
481002|NCT00434330|1150578|P5|COMPLETED|Overall Study||14
481003|NCT00434330|1150579|P4|COMPLETED|Overall Study||13
481004|NCT00434330|1150580|P3|COMPLETED|Overall Study||13
481005|NCT00434330|1150581|P2|COMPLETED|Overall Study||15
481006|NCT00434330|1150582|P1|COMPLETED|Overall Study||14
481007|NCT00434330|1150577|P6|STARTED|Overall Study||15
481008|NCT00434330|1150578|P5|STARTED|Overall Study||15
481009|NCT00434330|1150579|P4|STARTED|Overall Study||15
481010|NCT00434330|1150580|P3|STARTED|Overall Study||16
481011|NCT00434330|1150581|P2|STARTED|Overall Study||15
481012|NCT00434330|1150582|P1|STARTED|Overall Study||15
481013|NCT00434304|1150614|P1|NOT COMPLETED|Overall Study||20
481014|NCT00434304|1150614|P1|COMPLETED|Overall Study||42
481015|NCT00434304|1150614|P1|STARTED|Overall Study||62
481016|NCT00434278|1150652|P2|NOT COMPLETED|Overall Study||0
481017|NCT00434278|1150653|P1|NOT COMPLETED|Overall Study||2
481018|NCT00434278|1150652|P2|COMPLETED|Overall Study||13
481019|NCT00434278|1150653|P1|COMPLETED|Overall Study||12
481020|NCT00434278|1150652|P2|STARTED|Overall Study||13
481021|NCT00434278|1150653|P1|STARTED|Overall Study||14
481022|NCT00434252|1150663|P2|NOT COMPLETED|Overall Study||131
481023|NCT00434252|1150664|P1|NOT COMPLETED|Overall Study||64
481024|NCT00434252|1150663|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
481025|NCT00434252|1150664|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
481026|NCT00434252|1150663|P2|Treated|Overall Study||143
481027|NCT00434252|1150664|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
481028|NCT00434252|1150663|P2|STARTED|Overall Study||143
481029|NCT00434252|1150664|P1|STARTED|Overall Study||71
481030|NCT00434226|1150686|P2|NOT COMPLETED|Overall Study||26
481031|NCT00434226|1150687|P1|NOT COMPLETED|Overall Study||30
481032|NCT00434226|1150686|P2|COMPLETED|Overall Study||0
481033|NCT00434226|1150687|P1|COMPLETED|Overall Study||0
481034|NCT00434226|1150686|P2|STARTED|Overall Study||26
481035|NCT00434226|1150687|P1|STARTED|Overall Study||30
481036|NCT00434213|1150698|P1|NOT COMPLETED|Overall Study||49
481037|NCT00434213|1150698|P1|COMPLETED|Overall Study||260
481038|NCT00434213|1150698|P1|STARTED|Overall Study||309
481039|NCT00434161|1150706|P3|NOT COMPLETED|Overall Study||11
481040|NCT00434161|1150707|P2|NOT COMPLETED|Overall Study||3
481041|NCT00434161|1150708|P1|NOT COMPLETED|Overall Study||10
481042|NCT00434161|1150706|P3|COMPLETED|Overall Study||104
481043|NCT00434161|1150707|P2|COMPLETED|Overall Study||54
481044|NCT00434161|1150708|P1|COMPLETED|Overall Study||99
481045|NCT00434161|1150706|P3|STARTED|Overall Study||115
481046|NCT00434161|1150707|P2|STARTED|Overall Study||57
481047|NCT00434161|1150708|P1|STARTED|Overall Study||109
481048|NCT00434148|1150752|P2|NOT COMPLETED|Overall Study||73
481049|NCT00434148|1150753|P1|NOT COMPLETED|Overall Study||69
481050|NCT00434148|1150752|P2|COMPLETED|Overall Study||7
481051|NCT00434148|1150753|P1|COMPLETED|Overall Study||13
481052|NCT00434148|1150752|P2|Completed Month 12; Entered Extension|Overall Study||32
481053|NCT00434148|1150753|P1|Completed Month 12; Entered Extension|Overall Study||26
481054|NCT00434148|1150752|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
481055|NCT00434148|1150753|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
481056|NCT00434148|1150752|P2|Completed Month 12|Overall Study||39
481057|NCT00434148|1150753|P1|Completed Month 12|Overall Study||39
481058|NCT00434148|1150752|P2|STARTED|Overall Study||80
481059|NCT00434148|1150753|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
481060|NCT00434122|1150789|P2|NOT COMPLETED|Overall Study||7
481061|NCT00434122|1150790|P1|NOT COMPLETED|Overall Study||6
481062|NCT00434122|1150789|P2|COMPLETED|Overall Study||36
481063|NCT00434122|1150790|P1|COMPLETED|Overall Study||36
481064|NCT00434122|1150789|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
481065|NCT00434122|1150790|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
481066|NCT00434122|1150789|P2|STARTED|Overall Study|Randomised|43
481067|NCT00434122|1150790|P1|STARTED|Overall Study|Randomised|42
481068|NCT00434109|1150799|P1|NOT COMPLETED|Overall Study||18
481069|NCT00434109|1150799|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
481070|NCT00434109|1150799|P1|STARTED|Overall Study||39
481071|NCT00434057|1150808|P1|NOT COMPLETED|Overall Study||1
481072|NCT00434057|1150808|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
481073|NCT00434057|1150808|P1|STARTED|Overall Study||1383
481074|NCT00434018|1150814|P2|NOT COMPLETED|Overall Study||12
481075|NCT00434018|1150815|P1|NOT COMPLETED|Overall Study||17
481076|NCT00434018|1150814|P2|COMPLETED|Overall Study||57
481077|NCT00434018|1150815|P1|COMPLETED|Overall Study||52
481078|NCT00434018|1150814|P2|STARTED|Overall Study||69
481079|NCT00434018|1150815|P1|STARTED|Overall Study||69
481080|NCT00433914|1150833|P2|NOT COMPLETED|Overall Study||3
481081|NCT00433914|1150834|P1|NOT COMPLETED|Overall Study||0
481082|NCT00433914|1150833|P2|COMPLETED|Overall Study||27
481083|NCT00433914|1150834|P1|COMPLETED|Overall Study||30
481084|NCT00433914|1150833|P2|STARTED|Overall Study||30
481085|NCT00433914|1150834|P1|STARTED|Overall Study||30
481086|NCT00433836|1150854|P2|NOT COMPLETED|Overall Study||6
481087|NCT00433836|1150855|P1|NOT COMPLETED|Overall Study||13
481088|NCT00433836|1150854|P2|COMPLETED|Overall Study||143
481089|NCT00433836|1150855|P1|COMPLETED|Overall Study||138
481090|NCT00433836|1150854|P2|STARTED|Overall Study||149
481091|NCT00433836|1150855|P1|STARTED|Overall Study||151
481092|NCT00433771|1150867|P1|NOT COMPLETED|Overall Study||19
481093|NCT00433771|1150867|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
481094|NCT00433771|1150867|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
481095|NCT00433745|1150883|P1|NOT COMPLETED|Overall Study||0
481096|NCT00433745|1150883|P1|COMPLETED|Overall Study||4
481097|NCT00433745|1150883|P1|STARTED|Overall Study||4
481098|NCT00433654|1150890|P2|NOT COMPLETED|Overall Study||5
481099|NCT00433654|1150891|P1|NOT COMPLETED|Overall Study||15
481100|NCT00433654|1150890|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
481101|NCT00433654|1150891|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
481102|NCT00433654|1150890|P2|STARTED|Overall Study||206
481103|NCT00433654|1150891|P1|STARTED|Overall Study||258
481104|NCT00433537|1150922|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
481105|NCT00433537|1150923|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
481106|NCT00433537|1150924|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
481107|NCT00433537|1150922|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
481108|NCT00433537|1150923|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
481109|NCT00433537|1150924|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
481110|NCT00433537|1150922|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
481111|NCT00433537|1150923|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
481112|NCT00433537|1150924|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
481113|NCT00433537|1150922|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
481114|NCT00433537|1150923|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
481115|NCT00433537|1150924|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
481116|NCT00433537|1150922|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
481117|NCT00433537|1150923|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
481118|NCT00433537|1150924|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
481119|NCT00433537|1150922|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
481120|NCT00433537|1150923|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
481121|NCT00433537|1150924|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
481122|NCT00433537|1150922|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
481123|NCT00433537|1150923|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
481124|NCT00433537|1150924|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
481125|NCT00433537|1150922|P3|STARTED|Step 1 - VcR-CVAD Induction||10
481126|NCT00433537|1150923|P2|STARTED|Step 1 - VcR-CVAD Induction||22
481127|NCT00433537|1150924|P1|STARTED|Step 1 - VcR-CVAD Induction||45
481128|NCT00433446|1150933|P1|NOT COMPLETED|Overall Study||61
481129|NCT00433446|1150933|P1|COMPLETED|Overall Study||1
481130|NCT00433446|1150933|P1|Eligible and Began Protocol Therapy|Overall Study||53
481131|NCT00433446|1150933|P1|Eligible|Overall Study||53
481132|NCT00433446|1150933|P1|STARTED|Overall Study||62
481133|NCT00433381|1150943|P2|NOT COMPLETED|Overall Study||3
481134|NCT00433381|1150944|P1|NOT COMPLETED|Overall Study||5
481135|NCT00433381|1150943|P2|COMPLETED|Overall Study||57
481136|NCT00433381|1150944|P1|COMPLETED|Overall Study|Evaluated for 6-month progression-free survival. (Applies to both arms).|58
481137|NCT00433381|1150943|P2|STARTED|Overall Study||60
481138|NCT00433381|1150944|P1|STARTED|Overall Study||63
481139|NCT00433329|1150950|P1|NOT COMPLETED|Overall Study||21
481140|NCT00433329|1150950|P1|COMPLETED|Overall Study||79
481141|NCT00433329|1150950|P1|STARTED|Overall Study||100
481142|NCT00433290|1150956|P2|NOT COMPLETED|Overall Study||17
481143|NCT00433290|1150957|P1|NOT COMPLETED|Overall Study||35
481144|NCT00433290|1150956|P2|COMPLETED|Overall Study||111
481145|NCT00433290|1150957|P1|COMPLETED|Overall Study||93
481146|NCT00433290|1150956|P2|STARTED|Overall Study||128
481147|NCT00433290|1150957|P1|STARTED|Overall Study||128
481148|NCT00433199|1151026|P2|NOT COMPLETED|Open-Label Period||34
481149|NCT00433199|1151027|P1|NOT COMPLETED|Open-Label Period||0
481150|NCT00433199|1151026|P2|COMPLETED|Open-Label Period||185
481151|NCT00433199|1151027|P1|COMPLETED|Open-Label Period||0
481152|NCT00433199|1151026|P2|STARTED|Open-Label Period||219
481153|NCT00433199|1151027|P1|STARTED|Open-Label Period||0
481154|NCT00433199|1151026|P2|NOT COMPLETED|Double-Blind Period||66
481155|NCT00433199|1151027|P1|NOT COMPLETED|Double-Blind Period||12
481156|NCT00433199|1151026|P2|COMPLETED|Double-Blind Period||168
481157|NCT00433199|1151027|P1|COMPLETED|Double-Blind Period||28
481158|NCT00433199|1151026|P2|STARTED|Double-Blind Period||234
481159|NCT00433199|1151027|P1|STARTED|Double-Blind Period||40
481160|NCT00433160|1151047|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
481161|NCT00433160|1151048|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
481162|NCT00433160|1151047|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
481163|NCT00433160|1151048|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
481164|NCT00433160|1151047|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
481165|NCT00433160|1151048|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
481166|NCT00433160|1151047|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
481167|NCT00433160|1151048|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
481168|NCT00433160|1151047|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
481169|NCT00433160|1151048|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
481170|NCT00433160|1151047|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
481171|NCT00433160|1151048|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
481172|NCT00433160|1151047|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
481173|NCT00433160|1151048|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
481174|NCT00433160|1151047|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
481175|NCT00433160|1151048|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
481176|NCT00433160|1151047|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
481177|NCT00433160|1151048|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
481178|NCT00433160|1151047|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
481179|NCT00433160|1151048|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
481180|NCT00433160|1151047|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
481181|NCT00433160|1151048|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
481182|NCT00433160|1151047|P2|STARTED|52-Week Double-Blind (DB) Period||70
481183|NCT00433160|1151048|P1|STARTED|52-Week Double-Blind (DB) Period||137
481184|NCT00433017|1151098|P2|NOT COMPLETED|Overall Study||101
481185|NCT00433017|1151099|P1|NOT COMPLETED|Overall Study||96
481186|NCT00433017|1151098|P2|COMPLETED|Overall Study||32
481187|NCT00433017|1151099|P1|COMPLETED|Overall Study||26
481188|NCT00433017|1151098|P2|Completed 12 Month Phase|Overall Study||126
481189|NCT00433017|1151099|P1|Completed 12 Month Phase|Overall Study||114
481190|NCT00433017|1151098|P2|STARTED|Overall Study||133
481191|NCT00433017|1151099|P1|STARTED|Overall Study||122
481192|NCT00432991|1151115|P2|NOT COMPLETED|Overall Study||12
481193|NCT00432991|1151116|P1|NOT COMPLETED|Overall Study||7
481194|NCT00432991|1151115|P2|COMPLETED|Overall Study||19
481195|NCT00432991|1151116|P1|COMPLETED|Overall Study||15
481196|NCT00432991|1151115|P2|STARTED|Overall Study||31
481197|NCT00432991|1151116|P1|STARTED|Overall Study||22
481198|NCT00432835|1151128|P2|NOT COMPLETED|Overall Study||7
481199|NCT00432835|1151129|P1|NOT COMPLETED|Overall Study||6
481200|NCT00432835|1151128|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
481201|NCT00432835|1151129|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
481202|NCT00432835|1151128|P2|Completed 2nd Intervention|Overall Study||23
481203|NCT00432835|1151129|P1|Completed 2nd Intervention|Overall Study||22
481204|NCT00432835|1151128|P2|Completed 1st Intervention|Overall Study||23
481205|NCT00432835|1151129|P1|Completed 1st Intervention|Overall Study||22
481206|NCT00432835|1151128|P2|STARTED|Overall Study||30
481207|NCT00432835|1151129|P1|STARTED|Overall Study||28
481208|NCT00432809|1151142|P3|NOT COMPLETED|2 Year Sub-study||1
481209|NCT00432809|1151143|P2|NOT COMPLETED|2 Year Sub-study||2
481210|NCT00432809|1151144|P1|NOT COMPLETED|2 Year Sub-study||3
481211|NCT00432809|1151142|P3|COMPLETED|2 Year Sub-study||19
481212|NCT00432809|1151143|P2|COMPLETED|2 Year Sub-study||18
481213|NCT00432809|1151144|P1|COMPLETED|2 Year Sub-study||17
481214|NCT00432809|1151142|P3|STARTED|2 Year Sub-study||20
481215|NCT00432809|1151143|P2|STARTED|2 Year Sub-study||20
481216|NCT00432809|1151144|P1|STARTED|2 Year Sub-study||20
481217|NCT00432809|1151142|P3|NOT COMPLETED|1 Year Follow-up||1
481218|NCT00432809|1151143|P2|NOT COMPLETED|1 Year Follow-up||0
481219|NCT00432809|1151144|P1|NOT COMPLETED|1 Year Follow-up||9
481220|NCT00432809|1151142|P3|COMPLETED|1 Year Follow-up||49
481221|NCT00432809|1151143|P2|COMPLETED|1 Year Follow-up||50
481222|NCT00432809|1151144|P1|COMPLETED|1 Year Follow-up||41
481223|NCT00432809|1151142|P3|STARTED|1 Year Follow-up||50
481224|NCT00432809|1151143|P2|STARTED|1 Year Follow-up||50
481225|NCT00432809|1151144|P1|STARTED|1 Year Follow-up||50
481226|NCT00432744|1151217|P2|NOT COMPLETED|Months 7 - 12||1
481227|NCT00432744|1151218|P1|NOT COMPLETED|Months 7 - 12||1
481228|NCT00432744|1151217|P2|COMPLETED|Months 7 - 12||7
481229|NCT00432744|1151218|P1|COMPLETED|Months 7 - 12||6
481230|NCT00432744|1151217|P2|STARTED|Months 7 - 12||8
481231|NCT00432744|1151218|P1|STARTED|Months 7 - 12||7
481232|NCT00432744|1151217|P2|NOT COMPLETED|Months 0-6||4
481233|NCT00432744|1151218|P1|NOT COMPLETED|Months 0-6||5
481234|NCT00432744|1151217|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
481235|NCT00432744|1151218|P1|COMPLETED|Months 0-6||7
481236|NCT00432744|1151217|P2|STARTED|Months 0-6||12
481237|NCT00432744|1151218|P1|STARTED|Months 0-6||12
481238|NCT00432666|1151230|P2|NOT COMPLETED|Open-Label Extension Period||0
481239|NCT00432666|1151231|P1|NOT COMPLETED|Open-Label Extension Period||25
481240|NCT00432666|1151230|P2|COMPLETED|Open-Label Extension Period||0
481241|NCT00432666|1151231|P1|COMPLETED|Open-Label Extension Period||120
481242|NCT00432666|1151230|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
481243|NCT00432666|1151231|P1|STARTED|Open-Label Extension Period||145
481244|NCT00432666|1151230|P2|NOT COMPLETED|Main Period||1
481245|NCT00432666|1151231|P1|NOT COMPLETED|Main Period||2
481246|NCT00432666|1151230|P2|COMPLETED|Main Period||74
481247|NCT00432666|1151231|P1|COMPLETED|Main Period||71
481248|NCT00432666|1151230|P2|STARTED|Main Period||75
481249|NCT00432666|1151231|P1|STARTED|Main Period||73
481250|NCT00432601|1151395|P2|NOT COMPLETED|Time 2 to Time 3||22
481251|NCT00432601|1151396|P1|NOT COMPLETED|Time 2 to Time 3||19
481252|NCT00432601|1151395|P2|COMPLETED|Time 2 to Time 3||122
481253|NCT00432601|1151396|P1|COMPLETED|Time 2 to Time 3||122
481254|NCT00432601|1151395|P2|STARTED|Time 2 to Time 3||144
481255|NCT00432601|1151396|P1|STARTED|Time 2 to Time 3||141
481256|NCT00432601|1151395|P2|NOT COMPLETED|Time 1 to Time 2||368
481257|NCT00432601|1151396|P1|NOT COMPLETED|Time 1 to Time 2||369
481258|NCT00432601|1151395|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
481259|NCT00432601|1151396|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
481260|NCT00432601|1151395|P2|STARTED|Time 1 to Time 2||512
481261|NCT00432601|1151396|P1|STARTED|Time 1 to Time 2||510
481262|NCT00432562|1151404|P2|NOT COMPLETED|Overall Study||0
481263|NCT00432562|1151405|P1|NOT COMPLETED|Overall Study||3
481264|NCT00432562|1151404|P2|COMPLETED|Overall Study||15
481265|NCT00432562|1151405|P1|COMPLETED|Overall Study||13
481266|NCT00432562|1151404|P2|STARTED|Overall Study||15
481267|NCT00432562|1151405|P1|STARTED|Overall Study||16
481268|NCT00432458|1151431|P2|NOT COMPLETED|Overall Study||1
481269|NCT00432458|1151432|P1|NOT COMPLETED|Overall Study||5
481270|NCT00432458|1151431|P2|COMPLETED|Overall Study||32
481271|NCT00432458|1151432|P1|COMPLETED|Overall Study||30
481272|NCT00432458|1151431|P2|STARTED|Overall Study||33
481273|NCT00432458|1151432|P1|STARTED|Overall Study||35
481274|NCT00432445|1151450|P1|NOT COMPLETED|Overall Study||0
481275|NCT00432445|1151450|P1|COMPLETED|Overall Study||2
481276|NCT00432445|1151450|P1|STARTED|Overall Study||2
481277|NCT00432341|1151456|P2|NOT COMPLETED|Overall Study||0
481278|NCT00432341|1151457|P1|NOT COMPLETED|Overall Study||0
481279|NCT00432341|1151456|P2|COMPLETED|Overall Study||30
481280|NCT00432341|1151457|P1|COMPLETED|Overall Study||24
481281|NCT00432341|1151456|P2|STARTED|Overall Study||30
481282|NCT00432341|1151457|P1|STARTED|Overall Study||24
481283|NCT00432276|1151483|P2|NOT COMPLETED|Overall Study||156
481284|NCT00432276|1151484|P1|NOT COMPLETED|Overall Study||121
481285|NCT00432276|1151483|P2|COMPLETED|Overall Study||243
481286|NCT00432276|1151484|P1|COMPLETED|Overall Study||283
481287|NCT00432276|1151483|P2|Per Protocol Set|Overall Study||306
481288|NCT00432276|1151484|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
481289|NCT00432276|1151483|P2|STARTED|Overall Study||399
481290|NCT00432276|1151484|P1|STARTED|Overall Study||404
481291|NCT00432237|1151574|P4|NOT COMPLETED|Overall Study||124
481292|NCT00432237|1151575|P3|NOT COMPLETED|Overall Study||109
481293|NCT00432237|1151576|P2|NOT COMPLETED|Overall Study||101
481294|NCT00432237|1151577|P1|NOT COMPLETED|Overall Study||67
481295|NCT00432237|1151574|P4|COMPLETED|Overall Study||366
481296|NCT00432237|1151575|P3|COMPLETED|Overall Study||375
481297|NCT00432237|1151576|P2|COMPLETED|Overall Study||384
481298|NCT00432237|1151577|P1|COMPLETED|Overall Study||177
481299|NCT00432237|1151574|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
481300|NCT00432237|1151575|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
481301|NCT00432237|1151576|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
481302|NCT00432237|1151577|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
481303|NCT00432237|1151574|P4|Completed--With Data|Overall Study||365
481304|NCT00432237|1151575|P3|Completed--With Data|Overall Study||370
481305|NCT00432237|1151576|P2|Completed--With Data|Overall Study||381
481306|NCT00432237|1151577|P1|Completed--With Data|Overall Study||176
481307|NCT00432237|1151574|P4|STARTED|Overall Study||490
481308|NCT00432237|1151575|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
481309|NCT00432237|1151576|P2|STARTED|Overall Study||485
481310|NCT00432237|1151577|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
481311|NCT00432159|1151620|P5|NOT COMPLETED|Overall Study||10
481312|NCT00432159|1151621|P4|NOT COMPLETED|Overall Study||5
481313|NCT00432159|1151622|P3|NOT COMPLETED|Overall Study||4
481314|NCT00432159|1151623|P2|NOT COMPLETED|Overall Study||30
481315|NCT00432159|1151624|P1|NOT COMPLETED|Overall Study||22
481316|NCT00432159|1151620|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
481317|NCT00432159|1151621|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
481318|NCT00432159|1151622|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
481319|NCT00432159|1151623|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
481320|NCT00432159|1151624|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
481321|NCT00432159|1151620|P5|STARTED|Overall Study||89
481322|NCT00432159|1151621|P4|STARTED|Overall Study||20
481323|NCT00432159|1151622|P3|STARTED|Overall Study||39
481324|NCT00432159|1151623|P2|STARTED|Overall Study||167
481325|NCT00432159|1151624|P1|STARTED|Overall Study||185
481326|NCT00431964|1151730|P2|NOT COMPLETED|Overall Study||8
481327|NCT00431964|1151731|P1|NOT COMPLETED|Overall Study||6
481328|NCT00431964|1151730|P2|COMPLETED|Overall Study||124
481329|NCT00431964|1151731|P1|COMPLETED|Overall Study||125
481330|NCT00431964|1151730|P2|Withdrew From Study|Overall Study||5
481331|NCT00431964|1151731|P1|Withdrew From Study|Overall Study||6
481332|NCT00431964|1151730|P2|Did Not Receive Drug|Overall Study||3
481333|NCT00431964|1151731|P1|Did Not Receive Drug|Overall Study||0
481334|NCT00431964|1151730|P2|Randomized/Received Drug|Overall Study||129
481335|NCT00431964|1151731|P1|Randomized/Received Drug|Overall Study||131
481336|NCT00431964|1151730|P2|STARTED|Overall Study||132
481337|NCT00431964|1151731|P1|STARTED|Overall Study||131
481338|NCT00431951|1151741|P4|NOT COMPLETED|Overall Study||2
481339|NCT00431951|1151742|P3|NOT COMPLETED|Overall Study||2
481340|NCT00431951|1151743|P2|NOT COMPLETED|Overall Study||2
481341|NCT00431951|1151744|P1|NOT COMPLETED|Overall Study||1
481342|NCT00431951|1151741|P4|COMPLETED|Overall Study||4
481343|NCT00431951|1151742|P3|COMPLETED|Overall Study||6
481344|NCT00431951|1151743|P2|COMPLETED|Overall Study||6
481345|NCT00431951|1151744|P1|COMPLETED|Overall Study||7
481346|NCT00431951|1151741|P4|STARTED|Overall Study||6
481347|NCT00431951|1151742|P3|STARTED|Overall Study||8
481348|NCT00431951|1151743|P2|STARTED|Overall Study||8
481349|NCT00431951|1151744|P1|STARTED|Overall Study||8
481350|NCT00431847|1151806|P5|NOT COMPLETED|Overall Study||1
481351|NCT00431847|1151807|P4|NOT COMPLETED|Overall Study||14
481352|NCT00431847|1151808|P3|NOT COMPLETED|Overall Study||4
481353|NCT00431847|1151809|P2|NOT COMPLETED|Overall Study||3
481354|NCT00431847|1151810|P1|NOT COMPLETED|Overall Study||6
481355|NCT00431847|1151806|P5|COMPLETED|Overall Study||0
481356|NCT00431847|1151807|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
481357|NCT00431847|1151808|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
481358|NCT00431847|1151809|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
481359|NCT00431847|1151810|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
481360|NCT00431847|1151806|P5|STARTED|Overall Study||1
481361|NCT00431847|1151807|P4|STARTED|Overall Study||184
481362|NCT00431847|1151808|P3|STARTED|Overall Study||24
481363|NCT00431847|1151809|P2|STARTED|Overall Study||45
481364|NCT00431847|1151810|P1|STARTED|Overall Study||132
481365|NCT00431834|1151884|P1|NOT COMPLETED|Overall Study||13
481366|NCT00431834|1151884|P1|COMPLETED|Overall Study||62
481367|NCT00431834|1151884|P1|STARTED|Overall Study||75
481368|NCT00431626|1151893|P2|NOT COMPLETED|Overall Study||0
481369|NCT00431626|1151894|P1|NOT COMPLETED|Overall Study||0
481370|NCT00431626|1151893|P2|COMPLETED|Overall Study||0
481371|NCT00431626|1151894|P1|COMPLETED|Overall Study||4
481372|NCT00431626|1151893|P2|STARTED|Overall Study||0
481373|NCT00431626|1151894|P1|STARTED|Overall Study||4
481374|NCT00431496|1151900|P1|NOT COMPLETED|Overall Study||11
481375|NCT00431496|1151900|P1|COMPLETED|Overall Study||60
481376|NCT00431496|1151900|P1|STARTED|Overall Study||71
481377|NCT00431444|1151911|P2|NOT COMPLETED|Overall Study||7
481378|NCT00431444|1151912|P1|NOT COMPLETED|Overall Study||5
481379|NCT00431444|1151911|P2|COMPLETED|Overall Study||46
481380|NCT00431444|1151912|P1|COMPLETED|Overall Study||51
481381|NCT00431444|1151911|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
481382|NCT00431444|1151912|P1|STARTED|Overall Study||56
481383|NCT00431184|1151938|P2|NOT COMPLETED|Second Intervention (Day 2)||0
481384|NCT00431184|1151939|P1|NOT COMPLETED|Second Intervention (Day 2)||0
481385|NCT00431184|1151938|P2|COMPLETED|Second Intervention (Day 2)||9
481386|NCT00431184|1151939|P1|COMPLETED|Second Intervention (Day 2)||10
481387|NCT00431184|1151938|P2|STARTED|Second Intervention (Day 2)||9
481388|NCT00431184|1151939|P1|STARTED|Second Intervention (Day 2)||10
481389|NCT00431184|1151938|P2|NOT COMPLETED|1st Intervention (Day 1)||0
481390|NCT00431184|1151939|P1|NOT COMPLETED|1st Intervention (Day 1)||0
481391|NCT00431184|1151938|P2|COMPLETED|1st Intervention (Day 1)||9
481392|NCT00431184|1151939|P1|COMPLETED|1st Intervention (Day 1)||10
481393|NCT00431184|1151938|P2|STARTED|1st Intervention (Day 1)||9
481394|NCT00431184|1151939|P1|STARTED|1st Intervention (Day 1)||10
481395|NCT00431132|1151947|P1|NOT COMPLETED|Overall Study||44
481396|NCT00431132|1151947|P1|COMPLETED|Overall Study||292
481397|NCT00431132|1151947|P1|STARTED|Overall Study||336
481398|NCT00431067|1151952|P1|NOT COMPLETED|Overall Study||41
481399|NCT00431067|1151952|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
481400|NCT00431067|1151952|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
481401|NCT00431041|1151962|P2|NOT COMPLETED|Overall Study||24
481402|NCT00431041|1151963|P1|NOT COMPLETED|Overall Study||16
481403|NCT00431041|1151962|P2|COMPLETED|Overall Study||40
481404|NCT00431041|1151963|P1|COMPLETED|Overall Study||52
481405|NCT00431041|1151962|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
481406|NCT00431041|1151963|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
481407|NCT00430950|1151977|P2|NOT COMPLETED|Overall Study||13
481408|NCT00430950|1151978|P1|NOT COMPLETED|Overall Study||13
481409|NCT00430950|1151977|P2|COMPLETED|Overall Study||495
481410|NCT00430950|1151978|P1|COMPLETED|Overall Study||489
481411|NCT00430950|1151977|P2|STARTED|Overall Study||508
481412|NCT00430950|1151978|P1|STARTED|Overall Study||502
481413|NCT00430937|1151994|P2|NOT COMPLETED|Overall Study||28
481414|NCT00430937|1151995|P1|NOT COMPLETED|Overall Study||27
481415|NCT00430937|1151994|P2|COMPLETED|Overall Study||64
481416|NCT00430937|1151995|P1|COMPLETED|Overall Study||70
481417|NCT00430937|1151994|P2|STARTED|Overall Study||92
481418|NCT00430937|1151995|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
481419|NCT00430781|1152006|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
481420|NCT00430781|1152007|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
481421|NCT00430781|1152008|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
481422|NCT00430781|1152006|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
481423|NCT00430781|1152007|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
481424|NCT00430781|1152008|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
481425|NCT00430781|1152006|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
481426|NCT00430781|1152007|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
481427|NCT00430781|1152008|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
481428|NCT00430781|1152006|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
481429|NCT00430781|1152007|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
481430|NCT00430781|1152008|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
481431|NCT00430781|1152006|P3|COMPLETED|Final Analysis; 31 July 2008||26
481432|NCT00430781|1152007|P2|COMPLETED|Final Analysis; 31 July 2008||39
481433|NCT00430781|1152008|P1|COMPLETED|Final Analysis; 31 July 2008||0
481434|NCT00430781|1152006|P3|Ongoing|Final Analysis; 31 July 2008||32
481435|NCT00430781|1152007|P2|Ongoing|Final Analysis; 31 July 2008||29
481436|NCT00430781|1152008|P1|Ongoing|Final Analysis; 31 July 2008||0
481437|NCT00430781|1152006|P3|STARTED|Final Analysis; 31 July 2008||74
481438|NCT00430781|1152007|P2|STARTED|Final Analysis; 31 July 2008||78
481439|NCT00430781|1152008|P1|STARTED|Final Analysis; 31 July 2008||0
481440|NCT00430781|1152006|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
481441|NCT00430781|1152007|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
481442|NCT00430781|1152008|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
481443|NCT00430781|1152006|P3|COMPLETED|Interim Analysis; 11 February 2008||0
481444|NCT00430781|1152007|P2|COMPLETED|Interim Analysis; 11 February 2008||0
481445|NCT00430781|1152008|P1|COMPLETED|Interim Analysis; 11 February 2008||0
481446|NCT00430781|1152006|P3|Ongoing|Interim Analysis; 11 February 2008||25
481447|NCT00430781|1152007|P2|Ongoing|Interim Analysis; 11 February 2008||20
481448|NCT00430781|1152008|P1|Ongoing|Interim Analysis; 11 February 2008||23
481449|NCT00430781|1152006|P3|STARTED|Interim Analysis; 11 February 2008||60
481450|NCT00430781|1152007|P2|STARTED|Interim Analysis; 11 February 2008||58
481451|NCT00430781|1152008|P1|STARTED|Interim Analysis; 11 February 2008||59
481452|NCT00430768|1152034|P3|NOT COMPLETED|Overall Study||0
481453|NCT00430768|1152035|P2|NOT COMPLETED|Overall Study||0
481454|NCT00430768|1152036|P1|NOT COMPLETED|Overall Study||0
481455|NCT00430768|1152034|P3|COMPLETED|Overall Study||3
481456|NCT00430768|1152035|P2|COMPLETED|Overall Study||3
481457|NCT00430768|1152036|P1|COMPLETED|Overall Study||3
481458|NCT00430768|1152034|P3|STARTED|Overall Study||3
481459|NCT00430768|1152035|P2|STARTED|Overall Study||3
481460|NCT00430768|1152036|P1|STARTED|Overall Study||3
481461|NCT00430755|1152050|P1|NOT COMPLETED|Overall Study||53
481462|NCT00430755|1152050|P1|COMPLETED|Overall Study||45
481463|NCT00430755|1152050|P1|STARTED|Overall Study||98
481464|NCT00430716|1152057|P3|NOT COMPLETED|Open Label Phase||7
481465|NCT00430716|1152058|P2|NOT COMPLETED|Open Label Phase||7
481466|NCT00430716|1152059|P1|NOT COMPLETED|Open Label Phase||9
481467|NCT00430716|1152057|P3|COMPLETED|Open Label Phase||32
481468|NCT00430716|1152058|P2|COMPLETED|Open Label Phase||31
481469|NCT00430716|1152059|P1|COMPLETED|Open Label Phase||27
481470|NCT00430716|1152057|P3|STARTED|Open Label Phase||39
481471|NCT00430716|1152058|P2|STARTED|Open Label Phase||38
481472|NCT00430716|1152059|P1|STARTED|Open Label Phase||36
481473|NCT00430716|1152057|P3|NOT COMPLETED|Double Blind Phase||6
481474|NCT00430716|1152058|P2|NOT COMPLETED|Double Blind Phase||5
481475|NCT00430716|1152059|P1|NOT COMPLETED|Double Blind Phase||6
481476|NCT00430716|1152057|P3|COMPLETED|Double Blind Phase||39
481477|NCT00430716|1152058|P2|COMPLETED|Double Blind Phase||38
481478|NCT00430716|1152059|P1|COMPLETED|Double Blind Phase||36
481479|NCT00430716|1152057|P3|Treated|Double Blind Phase||45
481480|NCT00430716|1152058|P2|Treated|Double Blind Phase||43
481481|NCT00430716|1152059|P1|Treated|Double Blind Phase||41
481482|NCT00430716|1152057|P3|STARTED|Double Blind Phase||45
481483|NCT00430716|1152058|P2|STARTED|Double Blind Phase||43
481484|NCT00430716|1152059|P1|STARTED|Double Blind Phase||42
481485|NCT00430677|1152091|P3|NOT COMPLETED|Long-term Extension Period||63
481486|NCT00430677|1152092|P2|NOT COMPLETED|Long-term Extension Period||58
481487|NCT00430677|1152093|P1|NOT COMPLETED|Long-term Extension Period||60
481488|NCT00430677|1152091|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
481489|NCT00430677|1152092|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
481490|NCT00430677|1152093|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
481491|NCT00430677|1152091|P3|STARTED|Long-term Extension Period||74
481492|NCT00430677|1152092|P2|STARTED|Long-term Extension Period||67
481493|NCT00430677|1152093|P1|STARTED|Long-term Extension Period||70
481494|NCT00430677|1152091|P3|NOT COMPLETED|Short-term Period||22
481495|NCT00430677|1152092|P2|NOT COMPLETED|Short-term Period||25
481496|NCT00430677|1152093|P1|NOT COMPLETED|Short-term Period||23
481497|NCT00430677|1152091|P3|COMPLETED|Short-term Period|Completed the short-term period|78
481498|NCT00430677|1152092|P2|COMPLETED|Short-term Period|Completed the short-term period|74
481499|NCT00430677|1152093|P1|COMPLETED|Short-term Period|Completed the short-term period|76
481500|NCT00430677|1152091|P3|STARTED|Short-term Period||100
481501|NCT00430677|1152092|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
481502|NCT00430677|1152093|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
481503|NCT00430638|1152216|P2|NOT COMPLETED|Overall Study||48
481504|NCT00430638|1152217|P1|NOT COMPLETED|Overall Study||78
481505|NCT00430638|1152216|P2|COMPLETED|Overall Study||92
481506|NCT00430638|1152217|P1|COMPLETED|Overall Study||60
481507|NCT00430638|1152216|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
481508|NCT00430638|1152217|P1|STARTED|Overall Study||138
481509|NCT00430625|1152235|P2|NOT COMPLETED|Overall Study||0
481510|NCT00430625|1152236|P1|NOT COMPLETED|Overall Study||0
481511|NCT00430625|1152235|P2|COMPLETED|Overall Study||12
481512|NCT00430625|1152236|P1|COMPLETED|Overall Study||13
481513|NCT00430625|1152235|P2|STARTED|Overall Study||12
481514|NCT00430625|1152236|P1|STARTED|Overall Study||13
481515|NCT00430508|1152256|P4|NOT COMPLETED|Overall Study||5
481516|NCT00430508|1152257|P3|NOT COMPLETED|Overall Study||13
481517|NCT00430508|1152258|P2|NOT COMPLETED|Overall Study||6
481518|NCT00430508|1152259|P1|NOT COMPLETED|Overall Study||3
481519|NCT00430508|1152256|P4|COMPLETED|Overall Study||269
481520|NCT00430508|1152257|P3|COMPLETED|Overall Study||266
481521|NCT00430508|1152258|P2|COMPLETED|Overall Study||272
481522|NCT00430508|1152259|P1|COMPLETED|Overall Study||137
481523|NCT00430508|1152256|P4|STARTED|Overall Study||274
481524|NCT00430508|1152257|P3|STARTED|Overall Study||279
481525|NCT00430508|1152258|P2|STARTED|Overall Study||278
481526|NCT00430508|1152259|P1|STARTED|Overall Study||140
481527|NCT00430495|1152297|P4|NOT COMPLETED|Overall Study||4
481528|NCT00430495|1152298|P3|NOT COMPLETED|Overall Study||13
481529|NCT00430495|1152299|P2|NOT COMPLETED|Overall Study||7
481530|NCT00430495|1152300|P1|NOT COMPLETED|Overall Study||14
481531|NCT00430495|1152297|P4|COMPLETED|Overall Study||60
481532|NCT00430495|1152298|P3|COMPLETED|Overall Study||49
481533|NCT00430495|1152299|P2|COMPLETED|Overall Study||59
481534|NCT00430495|1152300|P1|COMPLETED|Overall Study||50
481535|NCT00430495|1152297|P4|Treated|Overall Study||64
481536|NCT00430495|1152298|P3|Treated|Overall Study||62
481537|NCT00430495|1152299|P2|Treated|Overall Study||66
481538|NCT00430495|1152300|P1|Treated|Overall Study||62
481539|NCT00430495|1152297|P4|STARTED|Overall Study||64
481540|NCT00430495|1152298|P3|STARTED|Overall Study||62
481541|NCT00430495|1152299|P2|STARTED|Overall Study||66
481542|NCT00430495|1152300|P1|STARTED|Overall Study||64
481543|NCT00430352|1152338|P1|NOT COMPLETED|Overall Study||138
481544|NCT00430352|1152338|P1|COMPLETED|Overall Study||407
481545|NCT00430352|1152338|P1|STARTED|Overall Study||545
481546|NCT00430300|1152356|P4|NOT COMPLETED|Overall Study||2
481547|NCT00430300|1152357|P3|NOT COMPLETED|Overall Study||6
481548|NCT00430300|1152358|P2|NOT COMPLETED|Overall Study||2
481549|NCT00430300|1152359|P1|NOT COMPLETED|Overall Study||2
481550|NCT00430300|1152356|P4|COMPLETED|Overall Study||15
481551|NCT00430300|1152357|P3|COMPLETED|Overall Study||29
481552|NCT00430300|1152358|P2|COMPLETED|Overall Study||16
481553|NCT00430300|1152359|P1|COMPLETED|Overall Study||15
481554|NCT00430300|1152356|P4|STARTED|Overall Study||17
481555|NCT00430300|1152357|P3|STARTED|Overall Study||35
481556|NCT00430300|1152358|P2|STARTED|Overall Study||18
481557|NCT00430300|1152359|P1|STARTED|Overall Study||17
481558|NCT00430248|1152464|P3|NOT COMPLETED|Overall Study||135
481559|NCT00430248|1152465|P2|NOT COMPLETED|Overall Study||158
481560|NCT00430248|1152466|P1|NOT COMPLETED|Overall Study||125
481561|NCT00430248|1152464|P3|COMPLETED|Overall Study||621
481562|NCT00430248|1152465|P2|COMPLETED|Overall Study||598
481563|NCT00430248|1152466|P1|COMPLETED|Overall Study||632
481564|NCT00430248|1152464|P3|STARTED|Overall Study||756
481565|NCT00430248|1152465|P2|STARTED|Overall Study||756
481566|NCT00430248|1152466|P1|STARTED|Overall Study||757
481567|NCT00430092|1152525|P3|NOT COMPLETED|Overall Study||57
481568|NCT00430092|1152526|P2|NOT COMPLETED|Overall Study||4
481569|NCT00430092|1152527|P1|NOT COMPLETED|Overall Study||6
481570|NCT00430092|1152525|P3|COMPLETED|Overall Study||56
481571|NCT00430092|1152526|P2|COMPLETED|Overall Study||48
481572|NCT00430092|1152527|P1|COMPLETED|Overall Study||48
481573|NCT00430092|1152525|P3|STARTED|Overall Study||113
481574|NCT00430092|1152526|P2|STARTED|Overall Study||52
481575|NCT00430092|1152527|P1|STARTED|Overall Study||54
481576|NCT00430027|1152532|P1|NOT COMPLETED|Overall Study||8
481577|NCT00430027|1152532|P1|COMPLETED|Overall Study||0
481578|NCT00430027|1152532|P1|STARTED|Overall Study||8
481579|NCT00429949|1152536|P1|NOT COMPLETED|Overall Study||0
481580|NCT00429949|1152536|P1|COMPLETED|Overall Study||21
481581|NCT00429949|1152536|P1|STARTED|Overall Study||21
481582|NCT00429923|1152549|P3|NOT COMPLETED|Overall Study||39
481583|NCT00429923|1152550|P2|NOT COMPLETED|Overall Study||4
481584|NCT00429923|1152551|P1|NOT COMPLETED|Overall Study||5
481585|NCT00429923|1152549|P3|COMPLETED|Overall Study||68
481586|NCT00429923|1152550|P2|COMPLETED|Overall Study||51
481587|NCT00429923|1152551|P1|COMPLETED|Overall Study||52
481588|NCT00429923|1152549|P3|STARTED|Overall Study||107
481589|NCT00429923|1152550|P2|STARTED|Overall Study||55
481590|NCT00429923|1152551|P1|STARTED|Overall Study||57
481591|NCT00429793|1152556|P1|NOT COMPLETED|Overall Study||6
481592|NCT00429793|1152556|P1|COMPLETED|Overall Study||54
481593|NCT00429793|1152556|P1|STARTED|Overall Study||60
481594|NCT00429702|1152565|P2|NOT COMPLETED|Overall Study||0
481595|NCT00429702|1152566|P1|NOT COMPLETED|Overall Study||0
481596|NCT00429702|1152565|P2|COMPLETED|Overall Study||4
481597|NCT00429702|1152566|P1|COMPLETED|Overall Study||3
481598|NCT00429702|1152565|P2|STARTED|Overall Study||4
481599|NCT00429702|1152566|P1|STARTED|Overall Study||3
481600|NCT00429663|1152576|P2|NOT COMPLETED|Overall Study||39
481601|NCT00429663|1152577|P1|NOT COMPLETED|Overall Study||36
481602|NCT00429663|1152576|P2|COMPLETED|Overall Study||41
481603|NCT00429663|1152577|P1|COMPLETED|Overall Study||40
481604|NCT00429663|1152576|P2|STARTED|Overall Study||80
481605|NCT00429663|1152577|P1|STARTED|Overall Study||76
481606|NCT00429572|1152591|P1|NOT COMPLETED|Overall Study||1
481607|NCT00429572|1152591|P1|COMPLETED|Overall Study||18
481608|NCT00429572|1152591|P1|STARTED|Overall Study||19
481609|NCT00429507|1152599|P1|NOT COMPLETED|Overall Study||0
481610|NCT00429507|1152599|P1|COMPLETED|Overall Study||12
481611|NCT00429507|1152599|P1|STARTED|Overall Study||12
481612|NCT00429494|1152603|P1|NOT COMPLETED|Overall Study||15
481613|NCT00429494|1152603|P1|COMPLETED|Overall Study||44
481614|NCT00429494|1152603|P1|STARTED|Overall Study||59
481615|NCT00429416|1152607|P1|NOT COMPLETED|Overall Study||1
481616|NCT00429416|1152607|P1|COMPLETED|Overall Study||13
481617|NCT00429416|1152607|P1|STARTED|Overall Study||14
481618|NCT00429403|1152617|P2|NOT COMPLETED|Overall Study||0
481619|NCT00429403|1152618|P1|NOT COMPLETED|Overall Study||0
481620|NCT00429403|1152617|P2|COMPLETED|Overall Study||0
481621|NCT00429403|1152618|P1|COMPLETED|Overall Study||1
481622|NCT00429403|1152617|P2|STARTED|Overall Study||0
481623|NCT00429403|1152618|P1|STARTED|Overall Study||1
481624|NCT00429364|1152626|P2|NOT COMPLETED|Overall Study||33
481625|NCT00429364|1152627|P1|NOT COMPLETED|Overall Study||32
481626|NCT00429364|1152626|P2|COMPLETED|Overall Study||272
481627|NCT00429364|1152627|P1|COMPLETED|Overall Study||271
481628|NCT00429364|1152626|P2|STARTED|Overall Study||305
481629|NCT00429364|1152627|P1|STARTED|Overall Study||303
481630|NCT00429299|1152686|P3|NOT COMPLETED|Overall Study||4
481631|NCT00429299|1152687|P2|NOT COMPLETED|Overall Study||7
481632|NCT00429299|1152688|P1|NOT COMPLETED|Overall Study||4
481633|NCT00429299|1152686|P3|COMPLETED|Overall Study||42
481634|NCT00429299|1152687|P2|COMPLETED|Overall Study||32
481635|NCT00429299|1152688|P1|COMPLETED|Overall Study||32
481636|NCT00429299|1152686|P3|STARTED|Overall Study||46
481637|NCT00429299|1152687|P2|STARTED|Overall Study||39
481638|NCT00429299|1152688|P1|STARTED|Overall Study||36
481639|NCT00429273|1152720|P3|NOT COMPLETED|Overall Study||9
481640|NCT00429273|1152721|P2|NOT COMPLETED|Overall Study||8
481641|NCT00429273|1152722|P1|NOT COMPLETED|Overall Study||8
481642|NCT00429273|1152720|P3|COMPLETED|Overall Study||61
481643|NCT00429273|1152721|P2|COMPLETED|Overall Study||61
481644|NCT00429273|1152722|P1|COMPLETED|Overall Study||60
481645|NCT00429273|1152720|P3|STARTED|Overall Study||70
481646|NCT00429273|1152721|P2|STARTED|Overall Study||69
481647|NCT00429273|1152722|P1|STARTED|Overall Study||68
481648|NCT00429182|1152730|P1|NOT COMPLETED|Overall Study||7
481649|NCT00429182|1152730|P1|COMPLETED|Overall Study||25
481650|NCT00429182|1152730|P1|STARTED|Overall Study||32
481651|NCT00429169|1152737|P2|NOT COMPLETED|Overall Study||2
481652|NCT00429169|1152738|P1|NOT COMPLETED|Overall Study||2
481653|NCT00429169|1152737|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
481654|NCT00429169|1152738|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
481655|NCT00429169|1152737|P2|STARTED|Overall Study||40
481656|NCT00429169|1152738|P1|STARTED|Overall Study||38
481657|NCT00429143|1152748|P1|NOT COMPLETED|Overall Study||0
481658|NCT00429143|1152748|P1|COMPLETED|Overall Study||27
481659|NCT00429143|1152748|P1|STARTED|Overall Study||27
481660|NCT00429104|1152756|P1|NOT COMPLETED|Overall Study||1
481661|NCT00429104|1152756|P1|COMPLETED|Overall Study||17
481662|NCT00429104|1152756|P1|STARTED|Overall Study||18
481663|NCT00429026|1152761|P1|NOT COMPLETED|Overall Study||40
481664|NCT00429026|1152761|P1|COMPLETED|Overall Study||0
481665|NCT00429026|1152761|P1|STARTED|Overall Study||40
481666|NCT00428974|1152769|P4|NOT COMPLETED|Overall Study||3
481667|NCT00428974|1152770|P3|NOT COMPLETED|Overall Study||1
481668|NCT00428974|1152771|P2|NOT COMPLETED|Overall Study||0
481669|NCT00428974|1152772|P1|NOT COMPLETED|Overall Study||8
481670|NCT00428974|1152769|P4|COMPLETED|Overall Study||16
481671|NCT00428974|1152770|P3|COMPLETED|Overall Study||14
481672|NCT00428974|1152771|P2|COMPLETED|Overall Study||17
481673|NCT00428974|1152772|P1|COMPLETED|Overall Study||17
481674|NCT00428974|1152769|P4|STARTED|Overall Study||19
481675|NCT00428974|1152770|P3|STARTED|Overall Study||15
481676|NCT00428974|1152771|P2|STARTED|Overall Study||17
481677|NCT00428974|1152772|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
481678|NCT00428922|1152786|P1|NOT COMPLETED|Overall Study||0
481679|NCT00428922|1152786|P1|COMPLETED|Overall Study||26
481680|NCT00428922|1152786|P1|STARTED|Overall Study||26
481681|NCT00428844|1152796|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
481682|NCT00428844|1152797|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
481683|NCT00428844|1152798|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
481684|NCT00428844|1152796|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
481685|NCT00428844|1152797|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
481686|NCT00428844|1152798|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
481687|NCT00428844|1152796|P3|STARTED|Completed Test of Cure (TOC) Visit||19
481688|NCT00428844|1152797|P2|STARTED|Completed Test of Cure (TOC) Visit||18
481689|NCT00428844|1152798|P1|STARTED|Completed Test of Cure (TOC) Visit||23
481690|NCT00428844|1152796|P3|NOT COMPLETED|Completed Study Drug Treatment||7
481691|NCT00428844|1152797|P2|NOT COMPLETED|Completed Study Drug Treatment||6
481692|NCT00428844|1152798|P1|NOT COMPLETED|Completed Study Drug Treatment||2
481693|NCT00428844|1152796|P3|COMPLETED|Completed Study Drug Treatment||19
481694|NCT00428844|1152797|P2|COMPLETED|Completed Study Drug Treatment||18
481695|NCT00428844|1152798|P1|COMPLETED|Completed Study Drug Treatment||23
481696|NCT00428844|1152796|P3|Received First Dose|Completed Study Drug Treatment||25
481697|NCT00428844|1152797|P2|Received First Dose|Completed Study Drug Treatment||24
481698|NCT00428844|1152798|P1|Received First Dose|Completed Study Drug Treatment||25
481699|NCT00428844|1152796|P3|STARTED|Completed Study Drug Treatment||26
481700|NCT00428844|1152797|P2|STARTED|Completed Study Drug Treatment||24
481701|NCT00428844|1152798|P1|STARTED|Completed Study Drug Treatment||25
481702|NCT00428792|1152821|P2|NOT COMPLETED|Overall Study||4
481703|NCT00428792|1152822|P1|NOT COMPLETED|Overall Study||1
481704|NCT00428792|1152821|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
481705|NCT00428792|1152822|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
481706|NCT00428792|1152821|P2|STARTED|Overall Study||70
481707|NCT00428792|1152822|P1|STARTED|Overall Study||80
481708|NCT00428597|1152848|P2|NOT COMPLETED|Overall Study||85
481709|NCT00428597|1152849|P1|NOT COMPLETED|Overall Study||86
481710|NCT00428597|1152848|P2|COMPLETED|Overall Study||0
481711|NCT00428597|1152849|P1|COMPLETED|Overall Study||0
481712|NCT00428597|1152848|P2|Received Treatment|Overall Study||82
481713|NCT00428597|1152849|P1|Received Treatment|Overall Study||83
481714|NCT00428597|1152848|P2|STARTED|Overall Study||85
481715|NCT00428597|1152849|P1|STARTED|Overall Study||86
481716|NCT00428584|1152891|P2|NOT COMPLETED|Extension Phase||29
481717|NCT00428584|1152892|P1|NOT COMPLETED|Extension Phase||21
481718|NCT00428584|1152891|P2|COMPLETED|Extension Phase||34
481719|NCT00428584|1152892|P1|COMPLETED|Extension Phase||35
481720|NCT00428584|1152891|P2|STARTED|Extension Phase||63
481721|NCT00428584|1152892|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
481722|NCT00428584|1152891|P2|NOT COMPLETED|Comparative Phase||1
481723|NCT00428584|1152892|P1|NOT COMPLETED|Comparative Phase||9
481724|NCT00428584|1152891|P2|COMPLETED|Comparative Phase||63
481725|NCT00428584|1152892|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
481726|NCT00428584|1152891|P2|STARTED|Comparative Phase||64
481727|NCT00428584|1152892|P1|STARTED|Comparative Phase||65
481728|NCT00428441|1152916|P1|NOT COMPLETED|Overall Study||1
481729|NCT00428441|1152916|P1|COMPLETED|Overall Study||74
481730|NCT00428441|1152916|P1|STARTED|Overall Study||75
481731|NCT00428389|1152922|P2|NOT COMPLETED|Extension Phase||26
481732|NCT00428389|1152923|P1|NOT COMPLETED|Extension Phase||32
481733|NCT00428389|1152922|P2|COMPLETED|Extension Phase||91
481734|NCT00428389|1152923|P1|COMPLETED|Extension Phase||85
481735|NCT00428389|1152922|P2|STARTED|Extension Phase||117
481736|NCT00428389|1152923|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
481737|NCT00428389|1152922|P2|NOT COMPLETED|Core Phase||11
481738|NCT00428389|1152923|P1|NOT COMPLETED|Core Phase||11
481739|NCT00428389|1152922|P2|COMPLETED|Core Phase||120
481740|NCT00428389|1152923|P1|COMPLETED|Core Phase||120
481741|NCT00428389|1152922|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
481742|NCT00428389|1152923|P1|Intent-to-treat Population|Core Phase||131
481743|NCT00428389|1152922|P2|STARTED|Core Phase||131
481744|NCT00428389|1152923|P1|STARTED|Core Phase||131
481745|NCT00428298|1152943|P2|NOT COMPLETED|Overall Study||11
481746|NCT00428298|1152944|P1|NOT COMPLETED|Overall Study||14
481747|NCT00428298|1152943|P2|COMPLETED|Overall Study||19
481748|NCT00428298|1152944|P1|COMPLETED|Overall Study||16
481749|NCT00428298|1152943|P2|Second RBANS at Study Exit|Overall Study||3
481750|NCT00428298|1152944|P1|Second RBANS at Study Exit|Overall Study||3
481751|NCT00428298|1152943|P2|STARTED|Overall Study||30
481752|NCT00428298|1152944|P1|STARTED|Overall Study||30
481753|NCT00428246|1152957|P3|NOT COMPLETED|Overall Study||1
481754|NCT00428246|1152958|P2|NOT COMPLETED|Overall Study||0
481755|NCT00428246|1152959|P1|NOT COMPLETED|Overall Study||1
481756|NCT00428246|1152957|P3|COMPLETED|Overall Study||7
481757|NCT00428246|1152958|P2|COMPLETED|Overall Study||8
481758|NCT00428246|1152959|P1|COMPLETED|Overall Study||7
481759|NCT00428246|1152957|P3|STARTED|Overall Study||8
481760|NCT00428246|1152958|P2|STARTED|Overall Study||8
481761|NCT00428246|1152959|P1|STARTED|Overall Study||8
481762|NCT00428220|1152967|P1|NOT COMPLETED|Overall Study||223
481763|NCT00428220|1152967|P1|COMPLETED|Overall Study||0
481764|NCT00428220|1152967|P1|STARTED|Overall Study||223
481765|NCT00428207|1152983|P2|NOT COMPLETED|Overall Study||0
481766|NCT00428207|1152984|P1|NOT COMPLETED|Overall Study||0
481767|NCT00428207|1152983|P2|COMPLETED|Overall Study||2
481768|NCT00428207|1152984|P1|COMPLETED|Overall Study||2
481769|NCT00428207|1152983|P2|STARTED|Overall Study||2
481770|NCT00428207|1152984|P1|STARTED|Overall Study||2
481771|NCT00428116|1152992|P2|NOT COMPLETED|Overall Study||0
481772|NCT00428116|1152993|P1|NOT COMPLETED|Overall Study||3
481773|NCT00428116|1152992|P2|COMPLETED|Overall Study||21
481774|NCT00428116|1152993|P1|COMPLETED|Overall Study||18
481775|NCT00428116|1152992|P2|STARTED|Overall Study||21
481776|NCT00428116|1152993|P1|STARTED|Overall Study||21
481777|NCT00428090|1153005|P4|NOT COMPLETED|Overall Study||28
481778|NCT00428090|1153006|P3|NOT COMPLETED|Overall Study||38
481779|NCT00428090|1153007|P2|NOT COMPLETED|Overall Study||31
481780|NCT00428090|1153008|P1|NOT COMPLETED|Overall Study||34
481781|NCT00428090|1153005|P4|COMPLETED|Overall Study||55
481782|NCT00428090|1153006|P3|COMPLETED|Overall Study||127
481783|NCT00428090|1153007|P2|COMPLETED|Overall Study||135
481784|NCT00428090|1153008|P1|COMPLETED|Overall Study||131
481785|NCT00428090|1153005|P4|STARTED|Overall Study||83
481786|NCT00428090|1153006|P3|STARTED|Overall Study||165
481787|NCT00428090|1153007|P2|STARTED|Overall Study||166
481788|NCT00428090|1153008|P1|STARTED|Overall Study||165
481789|NCT00428077|1153122|P1|NOT COMPLETED|Overall Study||0
481790|NCT00428077|1153122|P1|COMPLETED|Overall Study||4
481791|NCT00428077|1153122|P1|STARTED|Overall Study||4
481792|NCT00427999|1153126|P1|NOT COMPLETED|Overall Study||32
481793|NCT00427999|1153126|P1|COMPLETED|Overall Study||33
481794|NCT00427999|1153126|P1|Extension Follow-up|Overall Study||19
481795|NCT00427999|1153126|P1|Intent to Treat (ITT)|Overall Study||61
481796|NCT00427999|1153126|P1|STARTED|Overall Study||65
481797|NCT00427973|1153135|P1|NOT COMPLETED|Overall Study||0
481798|NCT00427973|1153135|P1|COMPLETED|Overall Study||17
481799|NCT00427973|1153135|P1|STARTED|Overall Study||17
481800|NCT00427960|1153144|P2|NOT COMPLETED|Overall Study||4
481801|NCT00427960|1153145|P1|NOT COMPLETED|Overall Study||2
481802|NCT00427960|1153144|P2|COMPLETED|Overall Study||21
481803|NCT00427960|1153145|P1|COMPLETED|Overall Study||28
481804|NCT00427960|1153144|P2|STARTED|Overall Study||25
481805|NCT00427960|1153145|P1|STARTED|Overall Study||30
481806|NCT00427934|1153183|P4|NOT COMPLETED|Overall Study||15
481807|NCT00427934|1153184|P3|NOT COMPLETED|Overall Study||23
481808|NCT00427934|1153185|P2|NOT COMPLETED|Overall Study||0
481809|NCT00427934|1153186|P1|NOT COMPLETED|Overall Study||1
481810|NCT00427934|1153183|P4|COMPLETED|Overall Study||19
481811|NCT00427934|1153184|P3|COMPLETED|Overall Study||55
481812|NCT00427934|1153185|P2|COMPLETED|Overall Study||8
481813|NCT00427934|1153186|P1|COMPLETED|Overall Study||7
481814|NCT00427934|1153183|P4|Treated|Overall Study||33
481815|NCT00427934|1153184|P3|Treated|Overall Study||77
481816|NCT00427934|1153185|P2|Treated|Overall Study||8
481817|NCT00427934|1153186|P1|Treated|Overall Study||8
481818|NCT00427934|1153183|P4|STARTED|Overall Study||34
481819|NCT00427934|1153184|P3|STARTED|Overall Study||78
481820|NCT00427934|1153185|P2|STARTED|Overall Study||8
481821|NCT00427934|1153186|P1|STARTED|Overall Study||8
481822|NCT00427921|1153254|P1|NOT COMPLETED|Overall Study||50
481823|NCT00427921|1153254|P1|COMPLETED|Overall Study||254
481824|NCT00427921|1153254|P1|STARTED|Overall Study||304
481825|NCT00427895|1153277|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
481826|NCT00427895|1153278|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
481827|NCT00427895|1153279|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
481828|NCT00427895|1153280|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
481829|NCT00427895|1153281|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
481830|NCT00427895|1153282|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
481831|NCT00427895|1153283|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
481832|NCT00427895|1153284|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
481833|NCT00427895|1153277|P8|COMPLETED|Vax 2/Year 3 to 4||212
481834|NCT00427895|1153278|P7|COMPLETED|Vax 2/Year 3 to 4||189
481835|NCT00427895|1153279|P6|COMPLETED|Vax 2/Year 3 to 4||108
481836|NCT00427895|1153280|P5|COMPLETED|Vax 2/Year 3 to 4||107
481837|NCT00427895|1153281|P4|COMPLETED|Vax 2/Year 3 to 4||0
481838|NCT00427895|1153282|P3|COMPLETED|Vax 2/Year 3 to 4||0
481839|NCT00427895|1153283|P2|COMPLETED|Vax 2/Year 3 to 4||0
481840|NCT00427895|1153284|P1|COMPLETED|Vax 2/Year 3 to 4||0
481841|NCT00427895|1153277|P8|STARTED|Vax 2/Year 3 to 4||214
481842|NCT00427895|1153278|P7|STARTED|Vax 2/Year 3 to 4||189
481843|NCT00427895|1153279|P6|STARTED|Vax 2/Year 3 to 4||108
481844|NCT00427895|1153280|P5|STARTED|Vax 2/Year 3 to 4||108
481845|NCT00427895|1153281|P4|STARTED|Vax 2/Year 3 to 4||0
481846|NCT00427895|1153282|P3|STARTED|Vax 2/Year 3 to 4||0
481847|NCT00427895|1153283|P2|STARTED|Vax 2/Year 3 to 4||0
481848|NCT00427895|1153284|P1|STARTED|Vax 2/Year 3 to 4||0
481849|NCT00427895|1153277|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481850|NCT00427895|1153278|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481851|NCT00427895|1153279|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481852|NCT00427895|1153280|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481853|NCT00427895|1153281|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
481854|NCT00427895|1153282|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
481855|NCT00427895|1153283|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
481856|NCT00427895|1153284|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
481857|NCT00427895|1153277|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481858|NCT00427895|1153278|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481859|NCT00427895|1153279|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481860|NCT00427895|1153280|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481861|NCT00427895|1153281|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
481862|NCT00427895|1153282|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
481863|NCT00427895|1153283|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
481864|NCT00427895|1153284|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
481865|NCT00427895|1153277|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
481866|NCT00427895|1153278|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
481867|NCT00427895|1153279|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
481868|NCT00427895|1153280|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
481869|NCT00427895|1153281|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
481870|NCT00427895|1153282|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
481871|NCT00427895|1153283|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
481872|NCT00427895|1153284|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
481873|NCT00427895|1153277|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
481874|NCT00427895|1153278|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
481875|NCT00427895|1153279|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
481876|NCT00427895|1153280|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
481877|NCT00427895|1153281|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
481878|NCT00427895|1153282|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
481879|NCT00427895|1153283|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
481880|NCT00427895|1153284|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
481881|NCT00427895|1153277|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
481882|NCT00427895|1153278|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
481883|NCT00427895|1153279|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
481884|NCT00427895|1153280|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
481885|NCT00427895|1153281|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
481886|NCT00427895|1153282|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
481887|NCT00427895|1153283|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
481888|NCT00427895|1153284|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
481889|NCT00427895|1153277|P8|STARTED|Vax 1/Year 1 Follow-up||0
481890|NCT00427895|1153278|P7|STARTED|Vax 1/Year 1 Follow-up||0
481891|NCT00427895|1153279|P6|STARTED|Vax 1/Year 1 Follow-up||0
481892|NCT00427895|1153280|P5|STARTED|Vax 1/Year 1 Follow-up||0
481893|NCT00427895|1153281|P4|STARTED|Vax 1/Year 1 Follow-up||502
481894|NCT00427895|1153282|P3|STARTED|Vax 1/Year 1 Follow-up||392
481895|NCT00427895|1153283|P2|STARTED|Vax 1/Year 1 Follow-up||411
481896|NCT00427895|1153284|P1|STARTED|Vax 1/Year 1 Follow-up||411
481897|NCT00427895|1153277|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481898|NCT00427895|1153278|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481899|NCT00427895|1153279|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481900|NCT00427895|1153280|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481901|NCT00427895|1153281|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
481902|NCT00427895|1153282|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481903|NCT00427895|1153283|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481904|NCT00427895|1153284|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
481905|NCT00427895|1153277|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
481906|NCT00427895|1153278|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
481907|NCT00427895|1153279|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
481908|NCT00427895|1153280|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
481909|NCT00427895|1153281|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
481910|NCT00427895|1153282|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
481911|NCT00427895|1153283|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
481912|NCT00427895|1153284|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
481913|NCT00427895|1153277|P8|STARTED|Between 6-Month Follow-up - Year 1||0
481914|NCT00427895|1153278|P7|STARTED|Between 6-Month Follow-up - Year 1||0
481915|NCT00427895|1153279|P6|STARTED|Between 6-Month Follow-up - Year 1||0
481916|NCT00427895|1153280|P5|STARTED|Between 6-Month Follow-up - Year 1||0
481917|NCT00427895|1153281|P4|STARTED|Between 6-Month Follow-up - Year 1||854
481918|NCT00427895|1153282|P3|STARTED|Between 6-Month Follow-up - Year 1||392
481919|NCT00427895|1153283|P2|STARTED|Between 6-Month Follow-up - Year 1||411
481920|NCT00427895|1153284|P1|STARTED|Between 6-Month Follow-up - Year 1||411
481921|NCT00427895|1153277|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481922|NCT00427895|1153278|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481923|NCT00427895|1153279|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481924|NCT00427895|1153280|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481925|NCT00427895|1153281|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
481926|NCT00427895|1153282|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
481927|NCT00427895|1153283|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
481928|NCT00427895|1153284|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
481929|NCT00427895|1153277|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481930|NCT00427895|1153278|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481931|NCT00427895|1153279|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481932|NCT00427895|1153280|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
481933|NCT00427895|1153281|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
481934|NCT00427895|1153282|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
481935|NCT00427895|1153283|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
481936|NCT00427895|1153284|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
481937|NCT00427895|1153277|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
481938|NCT00427895|1153278|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
481939|NCT00427895|1153279|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
481940|NCT00427895|1153280|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
481941|NCT00427895|1153281|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
481942|NCT00427895|1153282|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
481943|NCT00427895|1153283|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
481944|NCT00427895|1153284|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
481945|NCT00427895|1153277|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
481946|NCT00427895|1153278|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
481947|NCT00427895|1153279|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
481948|NCT00427895|1153280|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
481949|NCT00427895|1153281|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
481950|NCT00427895|1153282|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
481951|NCT00427895|1153283|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
481952|NCT00427895|1153284|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
481953|NCT00427804|1153341|P2|NOT COMPLETED|Overall Study||0
481954|NCT00427804|1153342|P1|NOT COMPLETED|Overall Study||0
481955|NCT00427804|1153341|P2|COMPLETED|Overall Study||5
481956|NCT00427804|1153342|P1|COMPLETED|Overall Study||4
481957|NCT00427804|1153341|P2|STARTED|Overall Study||5
481958|NCT00427804|1153342|P1|STARTED|Overall Study||4
481959|NCT00427791|1153350|P2|NOT COMPLETED|Overall Study||0
481960|NCT00427791|1153351|P1|NOT COMPLETED|Overall Study||0
481961|NCT00427791|1153350|P2|COMPLETED|Overall Study||13
481962|NCT00427791|1153351|P1|COMPLETED|Overall Study||10
481963|NCT00427791|1153350|P2|STARTED|Overall Study||13
481964|NCT00427791|1153351|P1|STARTED|Overall Study||10
481965|NCT00427765|1153359|P1|NOT COMPLETED|Overall Study||0
481966|NCT00427765|1153359|P1|COMPLETED|Overall Study||164
481967|NCT00427765|1153359|P1|STARTED|Overall Study||164
481968|NCT00427700|1153365|P2|NOT COMPLETED|Overall Study||11
481969|NCT00427700|1153366|P1|NOT COMPLETED|Overall Study||3
481970|NCT00427700|1153365|P2|COMPLETED|Overall Study||31
481971|NCT00427700|1153366|P1|COMPLETED|Overall Study||37
481972|NCT00427700|1153365|P2|STARTED|Overall Study||42
481973|NCT00427700|1153366|P1|STARTED|Overall Study||40
481974|NCT00427661|1153374|P1|NOT COMPLETED|Overall Study||0
481975|NCT00427661|1153374|P1|COMPLETED|Overall Study||8
481976|NCT00427661|1153374|P1|STARTED|Overall Study||8
481977|NCT00427635|1153382|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
481978|NCT00427635|1153383|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
481979|NCT00427635|1153382|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
481980|NCT00427635|1153383|P1|COMPLETED|Study Completion to Safety Follow-up||25
481981|NCT00427635|1153382|P2|STARTED|Study Completion to Safety Follow-up||26
481982|NCT00427635|1153383|P1|STARTED|Study Completion to Safety Follow-up||25
481983|NCT00427635|1153382|P2|NOT COMPLETED|Treatment Phase||0
481984|NCT00427635|1153383|P1|NOT COMPLETED|Treatment Phase||1
481985|NCT00427635|1153382|P2|COMPLETED|Treatment Phase|ITT population|26
481986|NCT00427635|1153383|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
481987|NCT00427635|1153382|P2|STARTED|Treatment Phase|Randomised|26
481988|NCT00427635|1153383|P1|STARTED|Treatment Phase|Randomised|26
481989|NCT00427557|1153411|P1|NOT COMPLETED|Overall Study||0
481990|NCT00427557|1153411|P1|COMPLETED|Overall Study||30
481991|NCT00427557|1153411|P1|STARTED|Overall Study||30
481992|NCT00427349|1153415|P1|NOT COMPLETED|Overall Study||46
481993|NCT00427349|1153415|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
481994|NCT00427349|1153415|P1|Eligible and Treated|Overall Study||44
481995|NCT00427349|1153415|P1|Treated|Overall Study||45
481996|NCT00427349|1153415|P1|Eligible|Overall Study||45
481997|NCT00427349|1153415|P1|STARTED|Overall Study||46
481998|NCT00427336|1153421|P1|NOT COMPLETED|Overall Study||0
481999|NCT00427336|1153421|P1|COMPLETED|Overall Study||9
482000|NCT00427336|1153421|P1|STARTED|Overall Study||9
482001|NCT00427037|1153427|P2|NOT COMPLETED|Overall Study||7
482002|NCT00427037|1153428|P1|NOT COMPLETED|Overall Study||7
482003|NCT00427037|1153427|P2|COMPLETED|Overall Study||10
482004|NCT00427037|1153428|P1|COMPLETED|Overall Study||10
482005|NCT00427037|1153427|P2|STARTED|Overall Study||17
482006|NCT00427037|1153428|P1|STARTED|Overall Study||17
482007|NCT00427011|1153436|P1|NOT COMPLETED|Overall Study||25
482008|NCT00427011|1153436|P1|COMPLETED|Overall Study||0
482009|NCT00427011|1153436|P1|STARTED|Overall Study||25
482010|NCT00426855|1153447|P1|NOT COMPLETED|Overall Study||0
482011|NCT00426855|1153447|P1|COMPLETED|Overall Study||12
482012|NCT00426855|1153447|P1|STARTED|Overall Study||12
482013|NCT00426842|1153451|P1|NOT COMPLETED|Overall Study||1
482014|NCT00426842|1153451|P1|COMPLETED|Overall Study||10
482015|NCT00426842|1153451|P1|STARTED|Overall Study||11
482016|NCT00426764|1153457|P1|NOT COMPLETED|Overall Study||98
482017|NCT00426764|1153457|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
482018|NCT00426764|1153457|P1|Received 6 or More Treatment Cycles|Overall Study||36
482019|NCT00426764|1153457|P1|Received 4 or More Treatment Cycles|Overall Study||50
482020|NCT00426764|1153457|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
482021|NCT00426764|1153457|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
482022|NCT00426751|1153473|P2|NOT COMPLETED|Overall Study||20
482023|NCT00426751|1153474|P1|NOT COMPLETED|Overall Study||22
482024|NCT00426751|1153473|P2|COMPLETED|Overall Study||183
482025|NCT00426751|1153474|P1|COMPLETED|Overall Study||204
482026|NCT00426751|1153473|P2|STARTED|Overall Study||203
482027|NCT00426751|1153474|P1|STARTED|Overall Study||226
482028|NCT00426660|1153518|P1|NOT COMPLETED|Overall Study||131
482029|NCT00426660|1153518|P1|COMPLETED|Overall Study||916
482030|NCT00426660|1153518|P1|Safety Analysis Set|Overall Study||1032
482031|NCT00426660|1153518|P1|Treated|Overall Study||1032
482032|NCT00426660|1153518|P1|STARTED|Overall Study||1047
482033|NCT00426556|1153549|P4|NOT COMPLETED|Phase II - Extension Phase||23
482034|NCT00426556|1153550|P3|NOT COMPLETED|Phase II - Extension Phase||0
482035|NCT00426556|1153551|P2|NOT COMPLETED|Phase II - Extension Phase||0
482036|NCT00426556|1153552|P1|NOT COMPLETED|Phase II - Extension Phase||0
482037|NCT00426556|1153549|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
482038|NCT00426556|1153550|P3|COMPLETED|Phase II - Extension Phase||0
482039|NCT00426556|1153551|P2|COMPLETED|Phase II - Extension Phase||0
482040|NCT00426556|1153552|P1|COMPLETED|Phase II - Extension Phase||0
482041|NCT00426556|1153549|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
482042|NCT00426556|1153550|P3|STARTED|Phase II - Extension Phase||0
482043|NCT00426556|1153551|P2|STARTED|Phase II - Extension Phase||0
482044|NCT00426556|1153552|P1|STARTED|Phase II - Extension Phase||0
482045|NCT00426556|1153549|P4|NOT COMPLETED|Phase II - Core Phase||27
482046|NCT00426556|1153550|P3|NOT COMPLETED|Phase II - Core Phase||0
482047|NCT00426556|1153551|P2|NOT COMPLETED|Phase II - Core Phase||0
482048|NCT00426556|1153552|P1|NOT COMPLETED|Phase II - Core Phase||0
482049|NCT00426556|1153549|P4|COMPLETED|Phase II - Core Phase||28
482050|NCT00426556|1153550|P3|COMPLETED|Phase II - Core Phase||0
482051|NCT00426556|1153551|P2|COMPLETED|Phase II - Core Phase||0
482052|NCT00426556|1153552|P1|COMPLETED|Phase II - Core Phase||0
482053|NCT00426556|1153549|P4|STARTED|Phase II - Core Phase||55
482054|NCT00426556|1153550|P3|STARTED|Phase II - Core Phase||0
482055|NCT00426556|1153551|P2|STARTED|Phase II - Core Phase||0
482056|NCT00426556|1153552|P1|STARTED|Phase II - Core Phase||0
482057|NCT00426556|1153549|P4|NOT COMPLETED|Phase I - Extension Phase||0
482058|NCT00426556|1153550|P3|NOT COMPLETED|Phase I - Extension Phase||7
482059|NCT00426556|1153551|P2|NOT COMPLETED|Phase I - Extension Phase||6
482060|NCT00426556|1153552|P1|NOT COMPLETED|Phase I - Extension Phase||5
482061|NCT00426556|1153549|P4|COMPLETED|Phase I - Extension Phase||0
482062|NCT00426556|1153550|P3|COMPLETED|Phase I - Extension Phase||0
482063|NCT00426556|1153551|P2|COMPLETED|Phase I - Extension Phase||1
482064|NCT00426556|1153552|P1|COMPLETED|Phase I - Extension Phase||0
482065|NCT00426556|1153549|P4|STARTED|Phase I - Extension Phase||0
482066|NCT00426556|1153550|P3|STARTED|Phase I - Extension Phase||7
482067|NCT00426556|1153551|P2|STARTED|Phase I - Extension Phase||7
482068|NCT00426556|1153552|P1|STARTED|Phase I - Extension Phase||5
482069|NCT00426556|1153549|P4|NOT COMPLETED|Phase I - Core Phase||0
482070|NCT00426556|1153550|P3|NOT COMPLETED|Phase I - Core Phase||3
482071|NCT00426556|1153551|P2|NOT COMPLETED|Phase I - Core Phase||10
482072|NCT00426556|1153552|P1|NOT COMPLETED|Phase I - Core Phase||1
482073|NCT00426556|1153549|P4|COMPLETED|Phase I - Core Phase||0
482074|NCT00426556|1153550|P3|COMPLETED|Phase I - Core Phase||7
482075|NCT00426556|1153551|P2|COMPLETED|Phase I - Core Phase||7
482076|NCT00426556|1153552|P1|COMPLETED|Phase I - Core Phase||5
482077|NCT00426556|1153549|P4|STARTED|Phase I - Core Phase||0
482078|NCT00426556|1153550|P3|STARTED|Phase I - Core Phase||10
482079|NCT00426556|1153551|P2|STARTED|Phase I - Core Phase||17
482080|NCT00426556|1153552|P1|STARTED|Phase I - Core Phase||6
482081|NCT00426361|1153577|P3|NOT COMPLETED|Overall Study||5
482082|NCT00426361|1153578|P2|NOT COMPLETED|Overall Study||5
482083|NCT00426361|1153579|P1|NOT COMPLETED|Overall Study||4
482084|NCT00426361|1153577|P3|COMPLETED|Overall Study||243
482085|NCT00426361|1153578|P2|COMPLETED|Overall Study||250
482086|NCT00426361|1153579|P1|COMPLETED|Overall Study||244
482087|NCT00426361|1153577|P3|STARTED|Overall Study||248
482088|NCT00426361|1153578|P2|STARTED|Overall Study||255
482089|NCT00426361|1153579|P1|STARTED|Overall Study||248
482090|NCT00426283|1153631|P2|NOT COMPLETED|Overall Study||1
482091|NCT00426283|1153632|P1|NOT COMPLETED|Overall Study||5
482092|NCT00426283|1153631|P2|COMPLETED|Overall Study||13
482093|NCT00426283|1153632|P1|COMPLETED|Overall Study||23
482094|NCT00426283|1153631|P2|STARTED|Overall Study||14
482095|NCT00426283|1153632|P1|STARTED|Overall Study||28
482096|NCT00426270|1153638|P1|NOT COMPLETED|Overall Study||6
482097|NCT00426270|1153638|P1|COMPLETED|Overall Study||110
482098|NCT00426270|1153638|P1|STARTED|Overall Study||116
482099|NCT00426231|1153648|P2|NOT COMPLETED|Overall Study||12
482100|NCT00426231|1153649|P1|NOT COMPLETED|Overall Study||9
482101|NCT00426231|1153648|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
482102|NCT00426231|1153649|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
482103|NCT00426231|1153648|P2|STARTED|Overall Study||37
482104|NCT00426231|1153649|P1|STARTED|Overall Study||36
482105|NCT00426153|1153659|P2|NOT COMPLETED|Overall Study||0
482106|NCT00426153|1153660|P1|NOT COMPLETED|Overall Study||0
482107|NCT00426153|1153659|P2|COMPLETED|Overall Study||14
482108|NCT00426153|1153660|P1|COMPLETED|Overall Study||28
482109|NCT00426153|1153659|P2|STARTED|Overall Study||14
482110|NCT00426153|1153660|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
482111|NCT00426127|1153672|P1|NOT COMPLETED|Overall Study||2
482112|NCT00426127|1153672|P1|COMPLETED|Overall Study||0
482113|NCT00426127|1153672|P1|STARTED|Overall Study||2
482114|NCT00425113|1153680|P2|NOT COMPLETED|Overall Study||2
482115|NCT00425113|1153681|P1|NOT COMPLETED|Overall Study||2
482116|NCT00425113|1153680|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
482117|NCT00425113|1153681|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
482118|NCT00425113|1153680|P2|Exposed to Study Drug|Overall Study||17
482119|NCT00425113|1153681|P1|Exposed to Study Drug|Overall Study||16
482120|NCT00425113|1153680|P2|STARTED|Overall Study||18
482121|NCT00425113|1153681|P1|STARTED|Overall Study||17
482122|NCT00425100|1153689|P1|NOT COMPLETED|Overall Study||53
482123|NCT00425100|1153689|P1|COMPLETED|Overall Study||463
482124|NCT00425100|1153689|P1|STARTED|Overall Study||516
482125|NCT00425061|1153733|P7|NOT COMPLETED|Overall Study||19
482126|NCT00425061|1153734|P6|NOT COMPLETED|Overall Study||4
482127|NCT00425061|1153735|P5|NOT COMPLETED|Overall Study||26
482128|NCT00425061|1153736|P4|NOT COMPLETED|Overall Study||2
482129|NCT00425061|1153737|P3|NOT COMPLETED|Overall Study||0
482130|NCT00425061|1153738|P2|NOT COMPLETED|Overall Study||2
482131|NCT00425061|1153739|P1|NOT COMPLETED|Overall Study||2
482132|NCT00425061|1153733|P7|COMPLETED|Overall Study||26
482133|NCT00425061|1153734|P6|COMPLETED|Overall Study||0
482134|NCT00425061|1153735|P5|COMPLETED|Overall Study||19
482135|NCT00425061|1153736|P4|COMPLETED|Overall Study||14
482136|NCT00425061|1153737|P3|COMPLETED|Overall Study||16
482137|NCT00425061|1153738|P2|COMPLETED|Overall Study||15
482138|NCT00425061|1153739|P1|COMPLETED|Overall Study||14
482139|NCT00425061|1153733|P7|STARTED|Overall Study||45
482140|NCT00425061|1153734|P6|STARTED|Overall Study||4
482141|NCT00425061|1153735|P5|STARTED|Overall Study||45
482142|NCT00425061|1153736|P4|STARTED|Overall Study||16
482143|NCT00425061|1153737|P3|STARTED|Overall Study||16
482144|NCT00425061|1153738|P2|STARTED|Overall Study||17
482145|NCT00425061|1153739|P1|STARTED|Overall Study||16
482146|NCT00425945|1153857|P2|NOT COMPLETED|Overall Study||5
482147|NCT00425945|1153858|P1|NOT COMPLETED|Overall Study||4
482148|NCT00425945|1153857|P2|COMPLETED|Overall Study||61
482149|NCT00425945|1153858|P1|COMPLETED|Overall Study||60
482150|NCT00425945|1153857|P2|STARTED|Overall Study||66
482151|NCT00425945|1153858|P1|STARTED|Overall Study||64
482152|NCT00425854|1153896|P2|NOT COMPLETED|Overall Study||21
482153|NCT00425854|1153897|P1|NOT COMPLETED|Overall Study||29
482154|NCT00425854|1153896|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
482155|NCT00425854|1153897|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
482156|NCT00425854|1153896|P2|STARTED|Overall Study|Treated|21
482157|NCT00425854|1153897|P1|STARTED|Overall Study|Treated|29
482158|NCT00425750|1153918|P1|NOT COMPLETED|Overall Study||25
482159|NCT00425750|1153918|P1|COMPLETED|Overall Study||0
482160|NCT00425750|1153918|P1|STARTED|Overall Study||25
482161|NCT00425698|1153926|P2|NOT COMPLETED|Overall Study||2
482162|NCT00425698|1153927|P1|NOT COMPLETED|Overall Study||3
482163|NCT00425698|1153926|P2|COMPLETED|Overall Study||42
482164|NCT00425698|1153927|P1|COMPLETED|Overall Study||41
482165|NCT00425698|1153926|P2|STARTED|Overall Study||44
482166|NCT00425698|1153927|P1|STARTED|Overall Study||44
482167|NCT00425607|1153933|P1|NOT COMPLETED|Overall Study||2
482168|NCT00425607|1153933|P1|COMPLETED|Overall Study||27
482169|NCT00425607|1153933|P1|Received Treatment|Overall Study||28
482170|NCT00425607|1153933|P1|STARTED|Overall Study||29
482171|NCT00425503|1153937|P1|NOT COMPLETED|Overall Study||3
482172|NCT00425503|1153937|P1|COMPLETED|Overall Study||37
482173|NCT00425503|1153937|P1|STARTED|Overall Study||40
482174|NCT00425438|1153943|P2|NOT COMPLETED|Overall Study||27
482175|NCT00425438|1153944|P1|NOT COMPLETED|Overall Study||25
482176|NCT00425438|1153943|P2|COMPLETED|Overall Study||0
482177|NCT00425438|1153944|P1|COMPLETED|Overall Study||0
482178|NCT00425438|1153943|P2|STARTED|Overall Study||27
482179|NCT00425438|1153944|P1|STARTED|Overall Study||25
482180|NCT00425386|1153960|P1|NOT COMPLETED|Overall Study||3
482181|NCT00425386|1153960|P1|COMPLETED|Overall Study||43
482182|NCT00425386|1153960|P1|STARTED|Overall Study||46
482183|NCT00425373|1153978|P9|NOT COMPLETED|Overall Study||18
482184|NCT00425373|1153979|P8|NOT COMPLETED|Overall Study||10
482185|NCT00425373|1153980|P7|NOT COMPLETED|Overall Study||7
482186|NCT00425373|1153981|P6|NOT COMPLETED|Overall Study||9
482187|NCT00425373|1153982|P5|NOT COMPLETED|Overall Study||10
482188|NCT00425373|1153983|P4|NOT COMPLETED|Overall Study||2
482189|NCT00425373|1153984|P3|NOT COMPLETED|Overall Study||3
482190|NCT00425373|1153985|P2|NOT COMPLETED|Overall Study||3
482191|NCT00425373|1153986|P1|NOT COMPLETED|Overall Study||5
482192|NCT00425373|1153978|P9|COMPLETED|Overall Study||148
482193|NCT00425373|1153979|P8|COMPLETED|Overall Study||151
482194|NCT00425373|1153980|P7|COMPLETED|Overall Study||154
482195|NCT00425373|1153981|P6|COMPLETED|Overall Study||154
482196|NCT00425373|1153982|P5|COMPLETED|Overall Study||159
482197|NCT00425373|1153983|P4|COMPLETED|Overall Study||160
482198|NCT00425373|1153984|P3|COMPLETED|Overall Study||157
482199|NCT00425373|1153985|P2|COMPLETED|Overall Study||164
482200|NCT00425373|1153986|P1|COMPLETED|Overall Study||154
482201|NCT00425373|1153978|P9|STARTED|Overall Study||166
482202|NCT00425373|1153979|P8|STARTED|Overall Study||161
482203|NCT00425373|1153980|P7|STARTED|Overall Study||161
482204|NCT00425373|1153981|P6|STARTED|Overall Study||163
482205|NCT00425373|1153982|P5|STARTED|Overall Study||169
482206|NCT00425373|1153983|P4|STARTED|Overall Study||162
482207|NCT00425373|1153984|P3|STARTED|Overall Study||160
482208|NCT00425373|1153985|P2|STARTED|Overall Study||167
482209|NCT00425373|1153986|P1|STARTED|Overall Study||159
482210|NCT00425308|1154044|P2|NOT COMPLETED|Overall Study||1
482211|NCT00425308|1154045|P1|NOT COMPLETED|Overall Study||4
482212|NCT00425308|1154044|P2|COMPLETED|Overall Study||14
482213|NCT00425308|1154045|P1|COMPLETED|Overall Study||11
482214|NCT00425308|1154044|P2|STARTED|Overall Study||15
482215|NCT00425308|1154045|P1|STARTED|Overall Study||15
482216|NCT00425269|1154075|P2|NOT COMPLETED|Overall Study||20
482217|NCT00425269|1154076|P1|NOT COMPLETED|Overall Study||19
482218|NCT00425269|1154075|P2|COMPLETED|Overall Study||77
482219|NCT00425269|1154076|P1|COMPLETED|Overall Study||82
482220|NCT00425269|1154075|P2|STARTED|Overall Study||97
482221|NCT00425269|1154076|P1|STARTED|Overall Study||101
482222|NCT00424827|1154152|P1|NOT COMPLETED|Overall Study||1
482223|NCT00424827|1154152|P1|COMPLETED|Overall Study||10
482224|NCT00424827|1154152|P1|STARTED|Overall Study||11
482225|NCT00424775|1154160|P2|NOT COMPLETED|Overall Study||0
482226|NCT00424775|1154161|P1|NOT COMPLETED|Overall Study||3
482227|NCT00424775|1154160|P2|COMPLETED|Overall Study||0
482228|NCT00424775|1154161|P1|COMPLETED|Overall Study||0
482229|NCT00424775|1154160|P2|STARTED|Overall Study||0
482230|NCT00424775|1154161|P1|STARTED|Overall Study||3
482231|NCT00424762|1154171|P2|NOT COMPLETED|Overall Study||22
482232|NCT00424762|1154172|P1|NOT COMPLETED|Overall Study||20
482233|NCT00424762|1154171|P2|COMPLETED|Overall Study||54
482234|NCT00424762|1154172|P1|COMPLETED|Overall Study||54
482235|NCT00424762|1154171|P2|STARTED|Overall Study||76
482236|NCT00424762|1154172|P1|STARTED|Overall Study||74
482237|NCT00424749|1154182|P1|NOT COMPLETED|Overall Study||1
482238|NCT00424749|1154182|P1|COMPLETED|Overall Study||3
482239|NCT00424749|1154182|P1|STARTED|Overall Study||4
482240|NCT00424645|1154189|P2|NOT COMPLETED|Overall Study||0
482241|NCT00424645|1154190|P1|NOT COMPLETED|Overall Study||1
482242|NCT00424645|1154189|P2|COMPLETED|Overall Study||0
482243|NCT00424645|1154190|P1|COMPLETED|Overall Study||2
482244|NCT00424645|1154189|P2|STARTED|Overall Study||0
482245|NCT00424645|1154190|P1|STARTED|Overall Study||3
482246|NCT00424632|1154198|P10|NOT COMPLETED|Overall Study||6
482247|NCT00424632|1154199|P9|NOT COMPLETED|Overall Study||16
482248|NCT00424632|1154200|P8|NOT COMPLETED|Overall Study||3
482249|NCT00424632|1154201|P7|NOT COMPLETED|Overall Study||7
482250|NCT00424632|1154202|P6|NOT COMPLETED|Overall Study||15
482251|NCT00424632|1154203|P5|NOT COMPLETED|Overall Study||3
482252|NCT00424632|1154204|P4|NOT COMPLETED|Overall Study||4
482253|NCT00424632|1154205|P3|NOT COMPLETED|Overall Study||1
482254|NCT00424632|1154206|P2|NOT COMPLETED|Overall Study||1
482255|NCT00424632|1154207|P1|NOT COMPLETED|Overall Study||1
482256|NCT00424632|1154198|P10|COMPLETED|Overall Study||0
482257|NCT00424632|1154199|P9|COMPLETED|Overall Study||0
482258|NCT00424632|1154200|P8|COMPLETED|Overall Study||0
482259|NCT00424632|1154201|P7|COMPLETED|Overall Study||0
482260|NCT00424632|1154202|P6|COMPLETED|Overall Study||0
482261|NCT00424632|1154203|P5|COMPLETED|Overall Study||0
482262|NCT00424632|1154204|P4|COMPLETED|Overall Study||0
482263|NCT00424632|1154205|P3|COMPLETED|Overall Study||0
482264|NCT00424632|1154206|P2|COMPLETED|Overall Study||0
482265|NCT00424632|1154207|P1|COMPLETED|Overall Study||0
482266|NCT00424632|1154198|P10|STARTED|Overall Study||6
482267|NCT00424632|1154199|P9|STARTED|Overall Study||16
482268|NCT00424632|1154200|P8|STARTED|Overall Study||3
482269|NCT00424632|1154201|P7|STARTED|Overall Study||7
482270|NCT00424632|1154202|P6|STARTED|Overall Study||15
482271|NCT00424632|1154203|P5|STARTED|Overall Study||3
482272|NCT00424632|1154204|P4|STARTED|Overall Study||4
482273|NCT00424632|1154205|P3|STARTED|Overall Study||1
482274|NCT00424632|1154206|P2|STARTED|Overall Study||1
482275|NCT00424632|1154207|P1|STARTED|Overall Study||1
482276|NCT00424619|1154341|P3|NOT COMPLETED|3 Month||0
482277|NCT00424619|1154342|P2|NOT COMPLETED|3 Month||0
482278|NCT00424619|1154343|P1|NOT COMPLETED|3 Month||0
482279|NCT00424619|1154341|P3|COMPLETED|3 Month||17
482280|NCT00424619|1154342|P2|COMPLETED|3 Month||18
482281|NCT00424619|1154343|P1|COMPLETED|3 Month||12
482282|NCT00424619|1154341|P3|STARTED|3 Month||17
482283|NCT00424619|1154342|P2|STARTED|3 Month||18
482284|NCT00424619|1154343|P1|STARTED|3 Month||12
482285|NCT00424619|1154341|P3|NOT COMPLETED|4 Week||0
482286|NCT00424619|1154342|P2|NOT COMPLETED|4 Week||0
482287|NCT00424619|1154343|P1|NOT COMPLETED|4 Week||0
482288|NCT00424619|1154341|P3|COMPLETED|4 Week||17
482289|NCT00424619|1154342|P2|COMPLETED|4 Week||17
482290|NCT00424619|1154343|P1|COMPLETED|4 Week||18
482291|NCT00424619|1154341|P3|STARTED|4 Week||17
482292|NCT00424619|1154342|P2|STARTED|4 Week||17
482293|NCT00424619|1154343|P1|STARTED|4 Week||18
482294|NCT00424619|1154341|P3|NOT COMPLETED|Baseline||1
482295|NCT00424619|1154342|P2|NOT COMPLETED|Baseline||0
482296|NCT00424619|1154343|P1|NOT COMPLETED|Baseline||0
482297|NCT00424619|1154341|P3|COMPLETED|Baseline||20
482298|NCT00424619|1154342|P2|COMPLETED|Baseline||22
482299|NCT00424619|1154343|P1|COMPLETED|Baseline||22
482300|NCT00424619|1154341|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
482301|NCT00424619|1154342|P2|STARTED|Baseline||22
482302|NCT00424619|1154343|P1|STARTED|Baseline||22
482303|NCT00424593|1154377|P2|NOT COMPLETED|Dose-Blind Extension Period||0
482304|NCT00424593|1154378|P1|NOT COMPLETED|Dose-Blind Extension Period||64
482305|NCT00424593|1154377|P2|COMPLETED|Dose-Blind Extension Period||0
482306|NCT00424593|1154378|P1|COMPLETED|Dose-Blind Extension Period||117
482307|NCT00424593|1154377|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
482308|NCT00424593|1154378|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
482309|NCT00424593|1154377|P2|NOT COMPLETED|Acute Double-Blind Period||23
482310|NCT00424593|1154378|P1|NOT COMPLETED|Acute Double-Blind Period||31
482311|NCT00424593|1154377|P2|COMPLETED|Acute Double-Blind Period||98
482312|NCT00424593|1154378|P1|COMPLETED|Acute Double-Blind Period||84
482313|NCT00424593|1154377|P2|STARTED|Acute Double-Blind Period||121
482314|NCT00424593|1154378|P1|STARTED|Acute Double-Blind Period||115
482315|NCT00424554|1154424|P2|NOT COMPLETED|Overall Study||0
482316|NCT00424554|1154425|P1|NOT COMPLETED|Overall Study||0
482317|NCT00424554|1154424|P2|COMPLETED|Overall Study||6
482318|NCT00424554|1154425|P1|COMPLETED|Overall Study||34
482319|NCT00424554|1154424|P2|STARTED|Overall Study||6
482320|NCT00424554|1154425|P1|STARTED|Overall Study||34
482321|NCT00424528|1154442|P3|NOT COMPLETED|Overall Study||4
482322|NCT00424528|1154443|P2|NOT COMPLETED|Overall Study||4
482323|NCT00424528|1154444|P1|NOT COMPLETED|Overall Study||5
482324|NCT00424528|1154442|P3|COMPLETED|Overall Study||74
482325|NCT00424528|1154443|P2|COMPLETED|Overall Study||76
482326|NCT00424528|1154444|P1|COMPLETED|Overall Study||71
482327|NCT00424528|1154442|P3|STARTED|Overall Study||78
482328|NCT00424528|1154443|P2|STARTED|Overall Study||80
482329|NCT00424528|1154444|P1|STARTED|Overall Study||76
482330|NCT00424515|1154499|P2|NOT COMPLETED|Overall Study||13
482331|NCT00424515|1154500|P1|NOT COMPLETED|Overall Study||11
482332|NCT00424515|1154499|P2|COMPLETED|Overall Study||0
482333|NCT00424515|1154500|P1|COMPLETED|Overall Study||0
482334|NCT00424515|1154499|P2|STARTED|Overall Study||13
482335|NCT00424515|1154500|P1|STARTED|Overall Study||11
482336|NCT00424502|1154510|P1|NOT COMPLETED|Overall Study||0
482337|NCT00424502|1154510|P1|COMPLETED|Overall Study||20
482338|NCT00424502|1154510|P1|STARTED|Overall Study||20
482339|NCT00424476|1154522|P3|NOT COMPLETED|Overall Study||49
482340|NCT00424476|1154523|P2|NOT COMPLETED|Overall Study||48
482341|NCT00424476|1154524|P1|NOT COMPLETED|Overall Study||61
482342|NCT00424476|1154522|P3|COMPLETED|Overall Study||241
482343|NCT00424476|1154523|P2|COMPLETED|Overall Study||240
482344|NCT00424476|1154524|P1|COMPLETED|Overall Study||226
482345|NCT00424476|1154522|P3|STARTED|Overall Study||290
482346|NCT00424476|1154523|P2|STARTED|Overall Study||288
482347|NCT00424476|1154524|P1|STARTED|Overall Study||287
482348|NCT00424398|1154550|P3|NOT COMPLETED|Overall Study||0
482349|NCT00424398|1154551|P2|NOT COMPLETED|Overall Study||1
482350|NCT00424398|1154552|P1|NOT COMPLETED|Overall Study||3
482351|NCT00424398|1154550|P3|COMPLETED|Overall Study||36
482352|NCT00424398|1154551|P2|COMPLETED|Overall Study||35
482353|NCT00424398|1154552|P1|COMPLETED|Overall Study||32
482354|NCT00424398|1154550|P3|STARTED|Overall Study||36
482355|NCT00424398|1154551|P2|STARTED|Overall Study||36
482356|NCT00424398|1154552|P1|STARTED|Overall Study||35
482357|NCT00424385|1154596|P1|NOT COMPLETED|Cohort 1||1
482358|NCT00424385|1154596|P1|COMPLETED|Cohort 1||4
482359|NCT00424385|1154596|P1|STARTED|Cohort 1||5
482360|NCT00424385|1154596|P1|NOT COMPLETED|Cohort 0||6
482361|NCT00424385|1154596|P1|COMPLETED|Cohort 0||6
482362|NCT00424385|1154596|P1|STARTED|Cohort 0||12
482363|NCT00424372|1154603|P1|NOT COMPLETED|Overall Study||31
482364|NCT00424372|1154603|P1|COMPLETED|Overall Study||95
482365|NCT00424372|1154603|P1|STARTED|Overall Study||126
482366|NCT00424346|1154615|P4|NOT COMPLETED|Extension Phase||55
482367|NCT00424346|1154616|P3|NOT COMPLETED|Extension Phase||55
482368|NCT00424346|1154617|P2|NOT COMPLETED|Extension Phase||102
482369|NCT00424346|1154618|P1|NOT COMPLETED|Extension Phase||0
482370|NCT00424346|1154615|P4|COMPLETED|Extension Phase||3
482371|NCT00424346|1154616|P3|COMPLETED|Extension Phase||4
482372|NCT00424346|1154617|P2|COMPLETED|Extension Phase||8
482373|NCT00424346|1154618|P1|COMPLETED|Extension Phase||0
482374|NCT00424346|1154615|P4|STARTED|Extension Phase||58
482375|NCT00424346|1154616|P3|STARTED|Extension Phase||59
482376|NCT00424346|1154617|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
482377|NCT00424346|1154618|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
482378|NCT00424346|1154615|P4|NOT COMPLETED|Core Study||7
482379|NCT00424346|1154616|P3|NOT COMPLETED|Core Study||4
482380|NCT00424346|1154617|P2|NOT COMPLETED|Core Study||8
482381|NCT00424346|1154618|P1|NOT COMPLETED|Core Study||9
482382|NCT00424346|1154615|P4|COMPLETED|Core Study||63
482383|NCT00424346|1154616|P3|COMPLETED|Core Study||65
482384|NCT00424346|1154617|P2|COMPLETED|Core Study||56
482385|NCT00424346|1154618|P1|COMPLETED|Core Study||62
482386|NCT00424346|1154615|P4|STARTED|Core Study||70
482387|NCT00424346|1154616|P3|STARTED|Core Study||69
482388|NCT00424346|1154617|P2|STARTED|Core Study||64
482389|NCT00424346|1154618|P1|STARTED|Core Study||71
482390|NCT00424294|1154733|P2|NOT COMPLETED|Overall Study||15
482391|NCT00424294|1154734|P1|NOT COMPLETED|Overall Study||8
482392|NCT00424294|1154733|P2|COMPLETED|Overall Study||19
482393|NCT00424294|1154734|P1|COMPLETED|Overall Study||28
482394|NCT00424294|1154733|P2|Treated|Overall Study||34
482395|NCT00424294|1154734|P1|Treated|Overall Study||35
482396|NCT00424294|1154733|P2|STARTED|Overall Study||34
482397|NCT00424294|1154734|P1|STARTED|Overall Study||36
482398|NCT00424268|1154784|P2|NOT COMPLETED|Overall Study||39
482399|NCT00424268|1154785|P1|NOT COMPLETED|Overall Study||62
482400|NCT00424268|1154784|P2|COMPLETED|Overall Study||333
482401|NCT00424268|1154785|P1|COMPLETED|Overall Study||309
482402|NCT00424268|1154784|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
482403|NCT00424268|1154785|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
482404|NCT00424255|1154801|P2|NOT COMPLETED|Overall Study||346
482405|NCT00424255|1154802|P1|NOT COMPLETED|Overall Study||342
482406|NCT00424255|1154801|P2|COMPLETED|Overall Study||0
482407|NCT00424255|1154802|P1|COMPLETED|Overall Study||0
482408|NCT00424255|1154801|P2|STARTED|Overall Study||346
482409|NCT00424255|1154802|P1|STARTED|Overall Study||342
482410|NCT00424190|1154850|P2|NOT COMPLETED|Overall Study||30
482411|NCT00424190|1154851|P1|NOT COMPLETED|Overall Study||22
482412|NCT00424190|1154850|P2|COMPLETED|Overall Study||317
482413|NCT00424190|1154851|P1|COMPLETED|Overall Study||329
482414|NCT00424190|1154850|P2|STARTED|Overall Study||347
482415|NCT00424190|1154851|P1|STARTED|Overall Study||351
482416|NCT00424177|1154857|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
482417|NCT00424177|1154857|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
482418|NCT00424177|1154857|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
482419|NCT00424177|1154857|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
482420|NCT00424177|1154857|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
482421|NCT00424177|1154857|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
482422|NCT00424177|1154857|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
482423|NCT00424177|1154857|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
482424|NCT00424177|1154857|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
482425|NCT00424047|1154886|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
482426|NCT00424047|1154887|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
482427|NCT00424047|1154886|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
482428|NCT00424047|1154887|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
482429|NCT00424047|1154886|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
482430|NCT00424047|1154887|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
482431|NCT00424047|1154886|P2|NOT COMPLETED|On Study at Time of Unblinding||167
482432|NCT00424047|1154887|P1|NOT COMPLETED|On Study at Time of Unblinding||155
482433|NCT00424047|1154886|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
482434|NCT00424047|1154887|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
482435|NCT00424047|1154886|P2|STARTED|On Study at Time of Unblinding||175
482436|NCT00424047|1154887|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
482437|NCT00424047|1154886|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
482438|NCT00424047|1154887|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
482439|NCT00424047|1154886|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
482440|NCT00424047|1154887|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
482441|NCT00424047|1154886|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
482442|NCT00424047|1154887|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
482443|NCT00424047|1154886|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
482444|NCT00424047|1154887|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
482445|NCT00424047|1154886|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
482446|NCT00424047|1154887|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
482447|NCT00424021|1154919|P4|NOT COMPLETED|AMB-220-E Study Period||10
482448|NCT00424021|1154920|P3|NOT COMPLETED|AMB-220-E Study Period||5
482449|NCT00424021|1154921|P2|NOT COMPLETED|AMB-220-E Study Period||2
482450|NCT00424021|1154922|P1|NOT COMPLETED|AMB-220-E Study Period||1
482451|NCT00424021|1154919|P4|COMPLETED|AMB-220-E Study Period||16
482452|NCT00424021|1154920|P3|COMPLETED|AMB-220-E Study Period||14
482453|NCT00424021|1154921|P2|COMPLETED|AMB-220-E Study Period||5
482454|NCT00424021|1154922|P1|COMPLETED|AMB-220-E Study Period||1
482455|NCT00424021|1154919|P4|STARTED|AMB-220-E Study Period||26
482456|NCT00424021|1154920|P3|STARTED|AMB-220-E Study Period||19
482457|NCT00424021|1154921|P2|STARTED|AMB-220-E Study Period||7
482458|NCT00424021|1154922|P1|STARTED|AMB-220-E Study Period||2
482459|NCT00424021|1154919|P4|NOT COMPLETED|NCT00046319 Study Period||1
482460|NCT00424021|1154920|P3|NOT COMPLETED|NCT00046319 Study Period||1
482461|NCT00424021|1154921|P2|NOT COMPLETED|NCT00046319 Study Period||3
482462|NCT00424021|1154922|P1|NOT COMPLETED|NCT00046319 Study Period||1
482463|NCT00424021|1154919|P4|COMPLETED|NCT00046319 Study Period||12
482464|NCT00424021|1154920|P3|COMPLETED|NCT00046319 Study Period||15
482465|NCT00424021|1154921|P2|COMPLETED|NCT00046319 Study Period||16
482466|NCT00424021|1154922|P1|COMPLETED|NCT00046319 Study Period||15
482467|NCT00424021|1154919|P4|STARTED|NCT00046319 Study Period||13
482468|NCT00424021|1154920|P3|STARTED|NCT00046319 Study Period||16
482469|NCT00424021|1154921|P2|STARTED|NCT00046319 Study Period||19
482470|NCT00424021|1154922|P1|STARTED|NCT00046319 Study Period||16
482471|NCT00424008|1154965|P2|NOT COMPLETED|Overall Study||335
482472|NCT00424008|1154966|P1|NOT COMPLETED|Overall Study||349
482473|NCT00424008|1154965|P2|COMPLETED|Overall Study||16
482474|NCT00424008|1154966|P1|COMPLETED|Overall Study||22
482475|NCT00424008|1154965|P2|STARTED|Overall Study||351
482476|NCT00424008|1154966|P1|STARTED|Overall Study||371
482477|NCT00423917|1154979|P1|NOT COMPLETED|Overall Study||3
482478|NCT00423917|1154979|P1|COMPLETED|Overall Study||33
482479|NCT00423917|1154979|P1|STARTED|Overall Study||36
482480|NCT00423891|1154992|P3|NOT COMPLETED|Post-Dosing Follow Up||1
482481|NCT00423891|1154993|P2|NOT COMPLETED|Post-Dosing Follow Up||17
482482|NCT00423891|1154994|P1|NOT COMPLETED|Post-Dosing Follow Up||2
482483|NCT00423891|1154992|P3|COMPLETED|Post-Dosing Follow Up||0
482484|NCT00423891|1154993|P2|COMPLETED|Post-Dosing Follow Up||1
482485|NCT00423891|1154994|P1|COMPLETED|Post-Dosing Follow Up||20
482486|NCT00423891|1154992|P3|STARTED|Post-Dosing Follow Up||1
482487|NCT00423891|1154993|P2|STARTED|Post-Dosing Follow Up|1 participant completed treatment but did not enter post dosing follow up period: Withdrew Consent.|18
482488|NCT00423891|1154994|P1|STARTED|Post-Dosing Follow Up||22
482489|NCT00423891|1154992|P3|NOT COMPLETED|Treatment||4
482490|NCT00423891|1154993|P2|NOT COMPLETED|Treatment||0
482491|NCT00423891|1154994|P1|NOT COMPLETED|Treatment||2
482492|NCT00423891|1154992|P3|COMPLETED|Treatment||1
482493|NCT00423891|1154993|P2|COMPLETED|Treatment||19
482494|NCT00423891|1154994|P1|COMPLETED|Treatment||22
482495|NCT00423891|1154992|P3|STARTED|Treatment||5
482496|NCT00423891|1154993|P2|STARTED|Treatment||19
482497|NCT00423891|1154994|P1|STARTED|Treatment||24
482498|NCT00423891|1154992|P3|NOT COMPLETED|Enrolled||3
482499|NCT00423891|1154993|P2|NOT COMPLETED|Enrolled||2
482500|NCT00423891|1154994|P1|NOT COMPLETED|Enrolled||11
482501|NCT00423891|1154992|P3|COMPLETED|Enrolled||5
482502|NCT00423891|1154993|P2|COMPLETED|Enrolled||19
482503|NCT00423891|1154994|P1|COMPLETED|Enrolled||24
482504|NCT00423891|1154992|P3|STARTED|Enrolled||8
482505|NCT00423891|1154993|P2|STARTED|Enrolled||21
482506|NCT00423891|1154994|P1|STARTED|Enrolled||35
482507|NCT00423878|1155063|P2|NOT COMPLETED|Overall Study||8
482508|NCT00423878|1155064|P1|NOT COMPLETED|Overall Study||20
482509|NCT00423878|1155063|P2|COMPLETED|Overall Study||98
482510|NCT00423878|1155064|P1|COMPLETED|Overall Study||89
482511|NCT00423878|1155063|P2|STARTED|Overall Study||106
482512|NCT00423878|1155064|P1|STARTED|Overall Study||109
482513|NCT00423852|1155072|P1|NOT COMPLETED|Overall Study||3
482514|NCT00423852|1155072|P1|COMPLETED|Overall Study||23
482515|NCT00423852|1155072|P1|STARTED|Overall Study||26
482516|NCT00423813|1155080|P3|NOT COMPLETED|Overall Study||74
482517|NCT00423813|1155081|P2|NOT COMPLETED|Overall Study||66
482518|NCT00423813|1155082|P1|NOT COMPLETED|Overall Study||57
482519|NCT00423813|1155080|P3|COMPLETED|Overall Study||116
482520|NCT00423813|1155081|P2|COMPLETED|Overall Study||129
482521|NCT00423813|1155082|P1|COMPLETED|Overall Study||131
482522|NCT00423813|1155080|P3|Treated|Overall Study||189
482523|NCT00423813|1155081|P2|Treated|Overall Study||194
482524|NCT00423813|1155082|P1|Treated|Overall Study||188
482525|NCT00423813|1155080|P3|STARTED|Overall Study||190
482526|NCT00423813|1155081|P2|STARTED|Overall Study||195
482527|NCT00423813|1155082|P1|STARTED|Overall Study||188
482528|NCT00423800|1155092|P2|NOT COMPLETED|Overall Study||1
482529|NCT00423800|1155093|P1|NOT COMPLETED|Overall Study||0
482530|NCT00423800|1155092|P2|COMPLETED|Overall Study||1
482531|NCT00423800|1155093|P1|COMPLETED|Overall Study||3
482532|NCT00423800|1155092|P2|STARTED|Overall Study||2
482533|NCT00423800|1155093|P1|STARTED|Overall Study||3
482534|NCT00423735|1155105|P3|NOT COMPLETED|Overall Study||0
482535|NCT00423735|1155106|P2|NOT COMPLETED|Overall Study||6
482536|NCT00423735|1155107|P1|NOT COMPLETED|Overall Study||8
482537|NCT00423735|1155105|P3|COMPLETED|Overall Study||0
482538|NCT00423735|1155106|P2|COMPLETED|Overall Study||29
482539|NCT00423735|1155107|P1|COMPLETED|Overall Study||21
482540|NCT00423735|1155105|P3|STARTED|Overall Study||0
482541|NCT00423735|1155106|P2|STARTED|Overall Study||35
482542|NCT00423735|1155107|P1|STARTED|Overall Study||29
482543|NCT00423722|1155130|P2|NOT COMPLETED|Overall Study||13
482544|NCT00423722|1155131|P1|NOT COMPLETED|Overall Study||14
482545|NCT00423722|1155130|P2|COMPLETED|Overall Study||53
482546|NCT00423722|1155131|P1|COMPLETED|Overall Study||49
482547|NCT00423722|1155130|P2|STARTED|Overall Study||66
482548|NCT00423722|1155131|P1|STARTED|Overall Study||63
482549|NCT00423683|1155153|P2|NOT COMPLETED|Overall Study||0
482550|NCT00423683|1155154|P1|NOT COMPLETED|Overall Study||1
482551|NCT00423683|1155153|P2|COMPLETED|Overall Study||33
482552|NCT00423683|1155154|P1|COMPLETED|Overall Study||30
482553|NCT00423683|1155153|P2|STARTED|Overall Study||33
482554|NCT00423683|1155154|P1|STARTED|Overall Study||31
482555|NCT00423670|1155173|P8|NOT COMPLETED|Follow-up Period||3
482556|NCT00423670|1155174|P7|NOT COMPLETED|Follow-up Period||9
482557|NCT00423670|1155175|P6|NOT COMPLETED|Follow-up Period||0
482558|NCT00423670|1155176|P5|NOT COMPLETED|Follow-up Period||2
482559|NCT00423670|1155177|P4|NOT COMPLETED|Follow-up Period||5
482560|NCT00423670|1155178|P3|NOT COMPLETED|Follow-up Period||11
482561|NCT00423670|1155179|P2|NOT COMPLETED|Follow-up Period||16
482562|NCT00423670|1155180|P1|NOT COMPLETED|Follow-up Period||3
482563|NCT00423670|1155173|P8|COMPLETED|Follow-up Period||32
482564|NCT00423670|1155174|P7|COMPLETED|Follow-up Period||41
482565|NCT00423670|1155175|P6|COMPLETED|Follow-up Period||14
482566|NCT00423670|1155176|P5|COMPLETED|Follow-up Period||89
482567|NCT00423670|1155177|P4|COMPLETED|Follow-up Period||91
482568|NCT00423670|1155178|P3|COMPLETED|Follow-up Period||85
482569|NCT00423670|1155179|P2|COMPLETED|Follow-up Period||84
482570|NCT00423670|1155180|P1|COMPLETED|Follow-up Period||94
482571|NCT00423670|1155173|P8|STARTED|Follow-up Period||35
482572|NCT00423670|1155174|P7|STARTED|Follow-up Period||50
482573|NCT00423670|1155175|P6|STARTED|Follow-up Period||14
482574|NCT00423670|1155176|P5|STARTED|Follow-up Period||91
482575|NCT00423670|1155177|P4|STARTED|Follow-up Period||96
482576|NCT00423670|1155178|P3|STARTED|Follow-up Period||96
482577|NCT00423670|1155179|P2|STARTED|Follow-up Period||100
482578|NCT00423670|1155180|P1|STARTED|Follow-up Period||97
482579|NCT00423670|1155173|P8|NOT COMPLETED|Treatment Period||21
482580|NCT00423670|1155174|P7|NOT COMPLETED|Treatment Period||31
482581|NCT00423670|1155175|P6|NOT COMPLETED|Treatment Period||8
482582|NCT00423670|1155176|P5|NOT COMPLETED|Treatment Period||27
482583|NCT00423670|1155177|P4|NOT COMPLETED|Treatment Period||40
482584|NCT00423670|1155178|P3|NOT COMPLETED|Treatment Period||27
482585|NCT00423670|1155179|P2|NOT COMPLETED|Treatment Period||30
482586|NCT00423670|1155180|P1|NOT COMPLETED|Treatment Period||52
482587|NCT00423670|1155173|P8|COMPLETED|Treatment Period||15
482588|NCT00423670|1155174|P7|COMPLETED|Treatment Period||28
482589|NCT00423670|1155175|P6|COMPLETED|Treatment Period||8
482590|NCT00423670|1155176|P5|COMPLETED|Treatment Period||76
482591|NCT00423670|1155177|P4|COMPLETED|Treatment Period||63
482592|NCT00423670|1155178|P3|COMPLETED|Treatment Period||76
482593|NCT00423670|1155179|P2|COMPLETED|Treatment Period||77
482594|NCT00423670|1155180|P1|COMPLETED|Treatment Period||52
482595|NCT00423670|1155173|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
482596|NCT00423670|1155174|P7|STARTED|Treatment Period||59
482597|NCT00423670|1155175|P6|STARTED|Treatment Period||16
482598|NCT00423670|1155176|P5|STARTED|Treatment Period||103
482599|NCT00423670|1155177|P4|STARTED|Treatment Period||103
482600|NCT00423670|1155178|P3|STARTED|Treatment Period||103
482601|NCT00423670|1155179|P2|STARTED|Treatment Period||107
482602|NCT00423670|1155180|P1|STARTED|Treatment Period||104
482603|NCT00423657|1155238|P2|NOT COMPLETED|Overall Study||25
482604|NCT00423657|1155239|P1|NOT COMPLETED|Overall Study||26
482605|NCT00423657|1155238|P2|COMPLETED|Overall Study||313
482606|NCT00423657|1155239|P1|COMPLETED|Overall Study||316
482607|NCT00423657|1155238|P2|STARTED|Overall Study||338
482608|NCT00423657|1155239|P1|STARTED|Overall Study||342
482609|NCT00423605|1155245|P1|NOT COMPLETED|Overall Study||241
482610|NCT00423605|1155245|P1|COMPLETED|Overall Study||319
482611|NCT00423605|1155245|P1|STARTED|Overall Study||560
482612|NCT00423592|1155249|P1|NOT COMPLETED|Overall Study||7
482613|NCT00423592|1155249|P1|COMPLETED|Overall Study|Completed study|29
482614|NCT00423592|1155249|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
482615|NCT00423592|1155249|P1|STARTED|Overall Study|Enrolled|36
482616|NCT00423579|1155270|P2|NOT COMPLETED|Overall Study||4
482617|NCT00423579|1155271|P1|NOT COMPLETED|Overall Study||4
482618|NCT00423579|1155270|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
482619|NCT00423579|1155271|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
482620|NCT00423579|1155270|P2|STARTED|Overall Study||60
482621|NCT00423579|1155271|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
482622|NCT00423488|1155279|P2|NOT COMPLETED|Overall Study||1
482623|NCT00423488|1155280|P1|NOT COMPLETED|Overall Study||5
482624|NCT00423488|1155279|P2|COMPLETED|Overall Study||50
482625|NCT00423488|1155280|P1|COMPLETED|Overall Study||37
482626|NCT00423488|1155279|P2|STARTED|Overall Study||51
482627|NCT00423488|1155280|P1|STARTED|Overall Study||42
482628|NCT00423449|1155286|P5|NOT COMPLETED|Overall Study||7
482629|NCT00423449|1155287|P4|NOT COMPLETED|Overall Study||22
482630|NCT00423449|1155288|P3|NOT COMPLETED|Overall Study||15
482631|NCT00423449|1155289|P2|NOT COMPLETED|Overall Study||4
482632|NCT00423449|1155290|P1|NOT COMPLETED|Overall Study||3
482633|NCT00423449|1155286|P5|COMPLETED|Overall Study||0
482634|NCT00423449|1155287|P4|COMPLETED|Overall Study||5
482635|NCT00423449|1155288|P3|COMPLETED|Overall Study||2
482636|NCT00423449|1155289|P2|COMPLETED|Overall Study||2
482637|NCT00423449|1155290|P1|COMPLETED|Overall Study||1
482638|NCT00423449|1155286|P5|STARTED|Overall Study||7
482639|NCT00423449|1155287|P4|STARTED|Overall Study||27
482640|NCT00423449|1155288|P3|STARTED|Overall Study||17
482641|NCT00423449|1155289|P2|STARTED|Overall Study||6
482642|NCT00423449|1155290|P1|STARTED|Overall Study||4
482643|NCT00423436|1155315|P2|NOT COMPLETED|Overall Study||0
482644|NCT00423436|1155316|P1|NOT COMPLETED|Overall Study||0
482645|NCT00423436|1155315|P2|COMPLETED|Overall Study||33
482646|NCT00423436|1155316|P1|COMPLETED|Overall Study||35
482647|NCT00423436|1155315|P2|STARTED|Overall Study||33
482648|NCT00423436|1155316|P1|STARTED|Overall Study||35
482649|NCT00423358|1155324|P2|NOT COMPLETED|Overall Study||0
482650|NCT00423358|1155325|P1|NOT COMPLETED|Overall Study||0
482651|NCT00423358|1155324|P2|COMPLETED|Overall Study||11
482652|NCT00423358|1155325|P1|COMPLETED|Overall Study||11
482653|NCT00423358|1155324|P2|STARTED|Overall Study||11
482654|NCT00423358|1155325|P1|STARTED|Overall Study||11
482655|NCT00423332|1155337|P2|NOT COMPLETED|Overall Study||7
482656|NCT00423332|1155338|P1|NOT COMPLETED|Overall Study||9
482657|NCT00423332|1155337|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
482658|NCT00423332|1155338|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
482659|NCT00423332|1155337|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
482660|NCT00423332|1155338|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
482661|NCT00423332|1155337|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
482662|NCT00423332|1155338|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
482663|NCT00423332|1155337|P2|STARTED|Overall Study|Number randomised|18
482664|NCT00423332|1155338|P1|STARTED|Overall Study|Randomised|53
482665|NCT00423319|1155357|P2|NOT COMPLETED|Overall Study||252
482666|NCT00423319|1155358|P1|NOT COMPLETED|Overall Study||224
482667|NCT00423319|1155357|P2|COMPLETED|Overall Study||2447
482668|NCT00423319|1155358|P1|COMPLETED|Overall Study||2484
482669|NCT00423319|1155357|P2|Participants Who Received Treatment|Overall Study||2659
482670|NCT00423319|1155358|P1|Participants Who Received Treatment|Overall Study||2673
482671|NCT00423319|1155357|P2|STARTED|Overall Study|Randomized|2699
482672|NCT00423319|1155358|P1|STARTED|Overall Study|Randomized|2708
482673|NCT00423293|1155390|P1|NOT COMPLETED|Overall Study||11
482674|NCT00423293|1155390|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
482675|NCT00423293|1155390|P1|STARTED|Overall Study||63
482676|NCT00423267|1155396|P2|NOT COMPLETED|Period B||0
482677|NCT00423267|1155397|P1|NOT COMPLETED|Period B||0
482678|NCT00423267|1155396|P2|COMPLETED|Period B||0
482679|NCT00423267|1155397|P1|COMPLETED|Period B||12
482680|NCT00423267|1155396|P2|STARTED|Period B||0
482681|NCT00423267|1155397|P1|STARTED|Period B||12
482682|NCT00423267|1155396|P2|NOT COMPLETED|Period A||1
482683|NCT00423267|1155397|P1|NOT COMPLETED|Period A||2
482684|NCT00423267|1155396|P2|COMPLETED|Period A||6
482685|NCT00423267|1155397|P1|COMPLETED|Period A||7
482686|NCT00423267|1155396|P2|STARTED|Period A||7
482687|NCT00423267|1155397|P1|STARTED|Period A||9
482688|NCT00423189|1155417|P3|NOT COMPLETED|Overall Study||0
482689|NCT00423189|1155418|P2|NOT COMPLETED|Overall Study||1
482690|NCT00423189|1155419|P1|NOT COMPLETED|Overall Study||0
482691|NCT00423189|1155417|P3|COMPLETED|Overall Study||2
482692|NCT00423189|1155418|P2|COMPLETED|Overall Study||2
482693|NCT00423189|1155419|P1|COMPLETED|Overall Study||2
482694|NCT00423189|1155417|P3|STARTED|Overall Study||2
482695|NCT00423189|1155418|P2|STARTED|Overall Study||3
482696|NCT00423189|1155419|P1|STARTED|Overall Study||2
482697|NCT00423176|1155441|P2|NOT COMPLETED|Overall Study||29
482698|NCT00423176|1155442|P1|NOT COMPLETED|Overall Study||16
482699|NCT00423176|1155441|P2|COMPLETED|Overall Study||94
482700|NCT00423176|1155442|P1|COMPLETED|Overall Study||98
482701|NCT00423176|1155441|P2|STARTED|Overall Study||123
482702|NCT00423176|1155442|P1|STARTED|Overall Study||114
482703|NCT00423150|1155450|P1|NOT COMPLETED|Overall Study||86
482704|NCT00423150|1155450|P1|COMPLETED|Overall Study||0
482705|NCT00423150|1155450|P1|STARTED|Overall Study||86
482706|NCT00423098|1155456|P2|NOT COMPLETED|Overall Study||4
482707|NCT00423098|1155457|P1|NOT COMPLETED|Overall Study||3
482708|NCT00423098|1155456|P2|COMPLETED|Overall Study||35
482709|NCT00423098|1155457|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
482710|NCT00423098|1155456|P2|STARTED|Overall Study||39
482711|NCT00423098|1155457|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
482712|NCT00423085|1155484|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
482713|NCT00423085|1155485|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
482714|NCT00423085|1155486|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
482715|NCT00423085|1155487|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
482716|NCT00423085|1155484|P4|COMPLETED|52-Week Open-Label Extension Phase||474
482717|NCT00423085|1155485|P3|COMPLETED|52-Week Open-Label Extension Phase||0
482718|NCT00423085|1155486|P2|COMPLETED|52-Week Open-Label Extension Phase||0
482719|NCT00423085|1155487|P1|COMPLETED|52-Week Open-Label Extension Phase||0
482720|NCT00423085|1155484|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
482721|NCT00423085|1155485|P3|STARTED|52-Week Open-Label Extension Phase||0
482722|NCT00423085|1155486|P2|STARTED|52-Week Open-Label Extension Phase||0
482723|NCT00423085|1155487|P1|STARTED|52-Week Open-Label Extension Phase||0
482724|NCT00423085|1155484|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
482725|NCT00423085|1155485|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
482726|NCT00423085|1155486|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
482727|NCT00423085|1155487|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
482728|NCT00423085|1155484|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
482729|NCT00423085|1155485|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
482730|NCT00423085|1155486|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
482731|NCT00423085|1155487|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
482732|NCT00423085|1155484|P4|STARTED|24-Week Double-Blind Treatment Phase||0
482733|NCT00423085|1155485|P3|STARTED|24-Week Double-Blind Treatment Phase||287
482734|NCT00423085|1155486|P2|STARTED|24-Week Double-Blind Treatment Phase||284
482735|NCT00423085|1155487|P1|STARTED|24-Week Double-Blind Treatment Phase||288
482736|NCT00423046|1155516|P2|NOT COMPLETED|Overall Study||345
482737|NCT00423046|1155517|P1|NOT COMPLETED|Overall Study||340
482738|NCT00423046|1155516|P2|COMPLETED|Overall Study|Completed until Month 60|208
482739|NCT00423046|1155517|P1|COMPLETED|Overall Study|Completed until Month 60|213
482740|NCT00423046|1155516|P2|STARTED|Overall Study||553
482741|NCT00423046|1155517|P1|STARTED|Overall Study||553
482742|NCT00422942|1155583|P1|NOT COMPLETED|Overall Study||3
482743|NCT00422942|1155583|P1|COMPLETED|Overall Study||0
482744|NCT00422942|1155583|P1|STARTED|Overall Study||3
482745|NCT00422903|1155602|P2|NOT COMPLETED|Overall Study||5
482746|NCT00422903|1155603|P1|NOT COMPLETED|Overall Study||4
482747|NCT00422903|1155602|P2|COMPLETED|Overall Study||38
482748|NCT00422903|1155603|P1|COMPLETED|Overall Study||45
482749|NCT00422903|1155602|P2|STARTED|Overall Study||43
482750|NCT00422903|1155603|P1|STARTED|Overall Study||49
482751|NCT00421733|1155630|P3|NOT COMPLETED|Overall Study||20
482752|NCT00421733|1155631|P2|NOT COMPLETED|Overall Study||26
482753|NCT00421733|1155632|P1|NOT COMPLETED|Overall Study||15
482754|NCT00421733|1155630|P3|COMPLETED|Overall Study||73
482755|NCT00421733|1155631|P2|COMPLETED|Overall Study||69
482756|NCT00421733|1155632|P1|COMPLETED|Overall Study||78
482757|NCT00421733|1155630|P3|STARTED|Overall Study||93
482758|NCT00421733|1155631|P2|STARTED|Overall Study||95
482759|NCT00421733|1155632|P1|STARTED|Overall Study||93
482760|NCT00422734|1155652|P2|NOT COMPLETED|Overall Study||21
482761|NCT00422734|1155653|P1|NOT COMPLETED|Overall Study||14
482762|NCT00422734|1155652|P2|COMPLETED|Overall Study||243
482763|NCT00422734|1155653|P1|COMPLETED|Overall Study||64
482764|NCT00422734|1155652|P2|STARTED|Overall Study||264
482765|NCT00422734|1155653|P1|STARTED|Overall Study||78
482766|NCT00422695|1155687|P2|NOT COMPLETED|Overall Study||0
482767|NCT00422695|1155688|P1|NOT COMPLETED|Overall Study||0
482768|NCT00422695|1155687|P2|COMPLETED|Overall Study||38
482769|NCT00422695|1155688|P1|COMPLETED|Overall Study||105
482770|NCT00422695|1155687|P2|STARTED|Overall Study||38
482771|NCT00422695|1155688|P1|STARTED|Overall Study||105
482772|NCT00422669|1155699|P3|NOT COMPLETED|Overall Study||7
482773|NCT00422669|1155700|P2|NOT COMPLETED|Overall Study||100
482774|NCT00422669|1155701|P1|NOT COMPLETED|Overall Study||98
482775|NCT00422669|1155699|P3|COMPLETED|Overall Study||0
482776|NCT00422669|1155700|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
482777|NCT00422669|1155701|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
482778|NCT00422669|1155699|P3|STARTED|Overall Study||7
482779|NCT00422669|1155700|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
482780|NCT00422669|1155701|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
482781|NCT00422656|1155722|P1|NOT COMPLETED|Overall Study||0
482782|NCT00422656|1155722|P1|COMPLETED|Overall Study||37
482783|NCT00422656|1155722|P1|STARTED|Overall Study||37
482784|NCT00422513|1155728|P2|NOT COMPLETED|Overall Study||106
482785|NCT00422513|1155729|P1|NOT COMPLETED|Overall Study||107
482786|NCT00422513|1155728|P2|COMPLETED|Overall Study||24
482787|NCT00422513|1155729|P1|COMPLETED|Overall Study||23
482788|NCT00422513|1155728|P2|STARTED|Overall Study||130
482789|NCT00422513|1155729|P1|STARTED|Overall Study||130
482790|NCT00422448|1155741|P1|NOT COMPLETED|Overall Study||0
482791|NCT00422448|1155741|P1|COMPLETED|Overall Study||43
482792|NCT00422448|1155741|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
482793|NCT00422422|1155746|P1|NOT COMPLETED|Overall Study||10
482794|NCT00422422|1155746|P1|COMPLETED|Overall Study||90
482795|NCT00422422|1155746|P1|STARTED|Overall Study||100
482796|NCT00422383|1155763|P5|NOT COMPLETED|Overall Study||3
482797|NCT00422383|1155764|P4|NOT COMPLETED|Overall Study||2
482798|NCT00422383|1155765|P3|NOT COMPLETED|Overall Study||4
482799|NCT00422383|1155766|P2|NOT COMPLETED|Overall Study||14
482800|NCT00422383|1155767|P1|NOT COMPLETED|Overall Study||15
482801|NCT00422383|1155763|P5|COMPLETED|Overall Study||22
482802|NCT00422383|1155764|P4|COMPLETED|Overall Study||4
482803|NCT00422383|1155765|P3|COMPLETED|Overall Study||89
482804|NCT00422383|1155766|P2|COMPLETED|Overall Study||106
482805|NCT00422383|1155767|P1|COMPLETED|Overall Study||119
482806|NCT00422383|1155763|P5|STARTED|Overall Study||25
482807|NCT00422383|1155764|P4|STARTED|Overall Study||6
482808|NCT00422383|1155765|P3|STARTED|Overall Study||93
482809|NCT00422383|1155766|P2|STARTED|Overall Study||120
482810|NCT00422383|1155767|P1|STARTED|Overall Study||134
482811|NCT00422292|1155910|P4|NOT COMPLETED|Overall Study||24
482812|NCT00422292|1155911|P3|NOT COMPLETED|Overall Study||22
482813|NCT00422292|1155912|P2|NOT COMPLETED|Overall Study||66
482814|NCT00422292|1155913|P1|NOT COMPLETED|Overall Study||18
482815|NCT00422292|1155910|P4|COMPLETED|Overall Study||452
482816|NCT00422292|1155911|P3|COMPLETED|Overall Study||224
482817|NCT00422292|1155912|P2|COMPLETED|Overall Study||598
482818|NCT00422292|1155913|P1|COMPLETED|Overall Study||239
482819|NCT00422292|1155910|P4|STARTED|Overall Study||476
482820|NCT00422292|1155911|P3|STARTED|Overall Study||246
482821|NCT00422292|1155912|P2|STARTED|Overall Study||664
482822|NCT00422292|1155913|P1|STARTED|Overall Study||257
482823|NCT00422279|1155941|P2|NOT COMPLETED|Overall Study||0
482824|NCT00422279|1155942|P1|NOT COMPLETED|Overall Study||0
482825|NCT00422279|1155941|P2|COMPLETED|Overall Study||2
482826|NCT00422279|1155942|P1|COMPLETED|Overall Study||2
482827|NCT00422279|1155941|P2|24 Month After Loading Period|Overall Study||2
482828|NCT00422279|1155942|P1|24 Month After Loading Period|Overall Study||2
482829|NCT00422279|1155941|P2|STARTED|Overall Study||2
482830|NCT00422279|1155942|P1|STARTED|Overall Study||2
482831|NCT00422227|1155952|P2|NOT COMPLETED|Overall Study||15
482832|NCT00422227|1155953|P1|NOT COMPLETED|Overall Study||4
482833|NCT00422227|1155952|P2|COMPLETED|Overall Study||88
482834|NCT00422227|1155953|P1|COMPLETED|Overall Study||193
482835|NCT00422227|1155952|P2|STARTED|Overall Study||103
482836|NCT00422227|1155953|P1|STARTED|Overall Study||197
482837|NCT00422201|1155977|P1|NOT COMPLETED|Overall Study||11
482838|NCT00422201|1155977|P1|COMPLETED|Overall Study||7
482839|NCT00422201|1155977|P1|STARTED|Overall Study||18
482840|NCT00422162|1155983|P2|NOT COMPLETED|Overall Study||30
482841|NCT00422162|1155984|P1|NOT COMPLETED|Overall Study||24
482842|NCT00422162|1155983|P2|COMPLETED|Overall Study||142
482843|NCT00422162|1155984|P1|COMPLETED|Overall Study||143
482844|NCT00422162|1155983|P2|Received Treatment|Overall Study||171
482845|NCT00422162|1155984|P1|Received Treatment|Overall Study||167
482846|NCT00422162|1155983|P2|STARTED|Overall Study||172
482847|NCT00422162|1155984|P1|STARTED|Overall Study||167
482848|NCT00422097|1156044|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482849|NCT00422097|1156045|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482850|NCT00422097|1156046|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482851|NCT00422097|1156047|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482852|NCT00422097|1156048|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482853|NCT00422097|1156049|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482854|NCT00422097|1156050|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482855|NCT00422097|1156051|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
482856|NCT00422097|1156044|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
482857|NCT00422097|1156045|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
482858|NCT00422097|1156046|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
482859|NCT00422097|1156047|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
482860|NCT00422097|1156048|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
482861|NCT00422097|1156049|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
482862|NCT00422097|1156050|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
482863|NCT00422097|1156051|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
482864|NCT00422097|1156044|P8|STARTED|Ixabepilone With Famotidine or Food||7
482865|NCT00422097|1156045|P7|STARTED|Ixabepilone With Famotidine or Food||8
482866|NCT00422097|1156046|P6|STARTED|Ixabepilone With Famotidine or Food||0
482867|NCT00422097|1156047|P5|STARTED|Ixabepilone With Famotidine or Food||0
482868|NCT00422097|1156048|P4|STARTED|Ixabepilone With Famotidine or Food||0
482869|NCT00422097|1156049|P3|STARTED|Ixabepilone With Famotidine or Food||0
482870|NCT00422097|1156050|P2|STARTED|Ixabepilone With Famotidine or Food||0
482871|NCT00422097|1156051|P1|STARTED|Ixabepilone With Famotidine or Food||0
482872|NCT00422097|1156044|P8|NOT COMPLETED|Dose Level 6||0
482873|NCT00422097|1156045|P7|NOT COMPLETED|Dose Level 6||0
482874|NCT00422097|1156046|P6|NOT COMPLETED|Dose Level 6||0
482875|NCT00422097|1156047|P5|NOT COMPLETED|Dose Level 6||0
482876|NCT00422097|1156048|P4|NOT COMPLETED|Dose Level 6||0
482877|NCT00422097|1156049|P3|NOT COMPLETED|Dose Level 6||0
482878|NCT00422097|1156050|P2|NOT COMPLETED|Dose Level 6||0
482879|NCT00422097|1156051|P1|NOT COMPLETED|Dose Level 6||0
482880|NCT00422097|1156044|P8|COMPLETED|Dose Level 6||0
482881|NCT00422097|1156045|P7|COMPLETED|Dose Level 6||0
482882|NCT00422097|1156046|P6|COMPLETED|Dose Level 6||6
482883|NCT00422097|1156047|P5|COMPLETED|Dose Level 6||0
482884|NCT00422097|1156048|P4|COMPLETED|Dose Level 6||0
482885|NCT00422097|1156049|P3|COMPLETED|Dose Level 6||0
482886|NCT00422097|1156050|P2|COMPLETED|Dose Level 6||0
482887|NCT00422097|1156051|P1|COMPLETED|Dose Level 6||0
482888|NCT00422097|1156044|P8|STARTED|Dose Level 6||0
482889|NCT00422097|1156045|P7|STARTED|Dose Level 6||0
482890|NCT00422097|1156046|P6|STARTED|Dose Level 6||6
482891|NCT00422097|1156047|P5|STARTED|Dose Level 6||0
482892|NCT00422097|1156048|P4|STARTED|Dose Level 6||0
482893|NCT00422097|1156049|P3|STARTED|Dose Level 6||0
482894|NCT00422097|1156050|P2|STARTED|Dose Level 6||0
482895|NCT00422097|1156051|P1|STARTED|Dose Level 6||0
482896|NCT00422097|1156044|P8|NOT COMPLETED|Dose Level 5||0
482897|NCT00422097|1156045|P7|NOT COMPLETED|Dose Level 5||0
482898|NCT00422097|1156046|P6|NOT COMPLETED|Dose Level 5||0
482899|NCT00422097|1156047|P5|NOT COMPLETED|Dose Level 5||0
482900|NCT00422097|1156048|P4|NOT COMPLETED|Dose Level 5||0
482901|NCT00422097|1156049|P3|NOT COMPLETED|Dose Level 5||0
482902|NCT00422097|1156050|P2|NOT COMPLETED|Dose Level 5||0
482903|NCT00422097|1156051|P1|NOT COMPLETED|Dose Level 5||0
482904|NCT00422097|1156044|P8|COMPLETED|Dose Level 5||0
482905|NCT00422097|1156045|P7|COMPLETED|Dose Level 5||0
482906|NCT00422097|1156046|P6|COMPLETED|Dose Level 5||0
482907|NCT00422097|1156047|P5|COMPLETED|Dose Level 5||23
482908|NCT00422097|1156048|P4|COMPLETED|Dose Level 5||0
482909|NCT00422097|1156049|P3|COMPLETED|Dose Level 5||0
482910|NCT00422097|1156050|P2|COMPLETED|Dose Level 5||0
482911|NCT00422097|1156051|P1|COMPLETED|Dose Level 5||0
482912|NCT00422097|1156044|P8|STARTED|Dose Level 5||0
482913|NCT00422097|1156045|P7|STARTED|Dose Level 5||0
482914|NCT00422097|1156046|P6|STARTED|Dose Level 5||0
482915|NCT00422097|1156047|P5|STARTED|Dose Level 5||23
482916|NCT00422097|1156048|P4|STARTED|Dose Level 5||0
482917|NCT00422097|1156049|P3|STARTED|Dose Level 5||0
482918|NCT00422097|1156050|P2|STARTED|Dose Level 5||0
482919|NCT00422097|1156051|P1|STARTED|Dose Level 5||0
482920|NCT00422097|1156044|P8|NOT COMPLETED|Dose Level 4||0
482921|NCT00422097|1156045|P7|NOT COMPLETED|Dose Level 4||0
482922|NCT00422097|1156046|P6|NOT COMPLETED|Dose Level 4||0
482923|NCT00422097|1156047|P5|NOT COMPLETED|Dose Level 4||0
482924|NCT00422097|1156048|P4|NOT COMPLETED|Dose Level 4||0
482925|NCT00422097|1156049|P3|NOT COMPLETED|Dose Level 4||0
482926|NCT00422097|1156050|P2|NOT COMPLETED|Dose Level 4||0
482927|NCT00422097|1156051|P1|NOT COMPLETED|Dose Level 4||0
482928|NCT00422097|1156044|P8|COMPLETED|Dose Level 4||0
482929|NCT00422097|1156045|P7|COMPLETED|Dose Level 4||0
482930|NCT00422097|1156046|P6|COMPLETED|Dose Level 4||0
482931|NCT00422097|1156047|P5|COMPLETED|Dose Level 4||0
482932|NCT00422097|1156048|P4|COMPLETED|Dose Level 4||3
482933|NCT00422097|1156049|P3|COMPLETED|Dose Level 4||0
482934|NCT00422097|1156050|P2|COMPLETED|Dose Level 4||0
482935|NCT00422097|1156051|P1|COMPLETED|Dose Level 4||0
482936|NCT00422097|1156044|P8|STARTED|Dose Level 4||0
482937|NCT00422097|1156045|P7|STARTED|Dose Level 4||0
482938|NCT00422097|1156046|P6|STARTED|Dose Level 4||0
482939|NCT00422097|1156047|P5|STARTED|Dose Level 4||0
482940|NCT00422097|1156048|P4|STARTED|Dose Level 4||3
482941|NCT00422097|1156049|P3|STARTED|Dose Level 4||0
482942|NCT00422097|1156050|P2|STARTED|Dose Level 4||0
482943|NCT00422097|1156051|P1|STARTED|Dose Level 4||0
482944|NCT00422097|1156044|P8|NOT COMPLETED|Dose Level 3||0
482945|NCT00422097|1156045|P7|NOT COMPLETED|Dose Level 3||0
482946|NCT00422097|1156046|P6|NOT COMPLETED|Dose Level 3||0
482947|NCT00422097|1156047|P5|NOT COMPLETED|Dose Level 3||0
482948|NCT00422097|1156048|P4|NOT COMPLETED|Dose Level 3||0
482949|NCT00422097|1156049|P3|NOT COMPLETED|Dose Level 3||0
482950|NCT00422097|1156050|P2|NOT COMPLETED|Dose Level 3||0
482951|NCT00422097|1156051|P1|NOT COMPLETED|Dose Level 3||0
482952|NCT00422097|1156044|P8|COMPLETED|Dose Level 3||0
482953|NCT00422097|1156045|P7|COMPLETED|Dose Level 3||0
482954|NCT00422097|1156046|P6|COMPLETED|Dose Level 3||0
482955|NCT00422097|1156047|P5|COMPLETED|Dose Level 3||0
482956|NCT00422097|1156048|P4|COMPLETED|Dose Level 3||0
482957|NCT00422097|1156049|P3|COMPLETED|Dose Level 3||3
482958|NCT00422097|1156050|P2|COMPLETED|Dose Level 3||0
482959|NCT00422097|1156051|P1|COMPLETED|Dose Level 3||0
482960|NCT00422097|1156044|P8|STARTED|Dose Level 3||0
482961|NCT00422097|1156045|P7|STARTED|Dose Level 3||0
482962|NCT00422097|1156046|P6|STARTED|Dose Level 3||0
482963|NCT00422097|1156047|P5|STARTED|Dose Level 3||0
482964|NCT00422097|1156048|P4|STARTED|Dose Level 3||0
482965|NCT00422097|1156049|P3|STARTED|Dose Level 3||3
482966|NCT00422097|1156050|P2|STARTED|Dose Level 3||0
482967|NCT00422097|1156051|P1|STARTED|Dose Level 3||0
482968|NCT00422097|1156044|P8|NOT COMPLETED|Dose Level 2||0
482969|NCT00422097|1156045|P7|NOT COMPLETED|Dose Level 2||0
482970|NCT00422097|1156046|P6|NOT COMPLETED|Dose Level 2||0
482971|NCT00422097|1156047|P5|NOT COMPLETED|Dose Level 2||0
482972|NCT00422097|1156048|P4|NOT COMPLETED|Dose Level 2||0
482973|NCT00422097|1156049|P3|NOT COMPLETED|Dose Level 2||0
482974|NCT00422097|1156050|P2|NOT COMPLETED|Dose Level 2||1
482975|NCT00422097|1156051|P1|NOT COMPLETED|Dose Level 2||0
482976|NCT00422097|1156044|P8|COMPLETED|Dose Level 2||0
482977|NCT00422097|1156045|P7|COMPLETED|Dose Level 2||0
482978|NCT00422097|1156046|P6|COMPLETED|Dose Level 2||0
482979|NCT00422097|1156047|P5|COMPLETED|Dose Level 2||0
482980|NCT00422097|1156048|P4|COMPLETED|Dose Level 2||0
482981|NCT00422097|1156049|P3|COMPLETED|Dose Level 2||0
482982|NCT00422097|1156050|P2|COMPLETED|Dose Level 2||5
482983|NCT00422097|1156051|P1|COMPLETED|Dose Level 2||0
482984|NCT00422097|1156044|P8|STARTED|Dose Level 2||0
482985|NCT00422097|1156045|P7|STARTED|Dose Level 2||0
482986|NCT00422097|1156046|P6|STARTED|Dose Level 2||0
482987|NCT00422097|1156047|P5|STARTED|Dose Level 2||0
482988|NCT00422097|1156048|P4|STARTED|Dose Level 2||0
482989|NCT00422097|1156049|P3|STARTED|Dose Level 2||0
482990|NCT00422097|1156050|P2|STARTED|Dose Level 2||6
482991|NCT00422097|1156051|P1|STARTED|Dose Level 2||0
482992|NCT00422097|1156044|P8|NOT COMPLETED|Dose Level 1||0
482993|NCT00422097|1156045|P7|NOT COMPLETED|Dose Level 1||0
482994|NCT00422097|1156046|P6|NOT COMPLETED|Dose Level 1||0
482995|NCT00422097|1156047|P5|NOT COMPLETED|Dose Level 1||0
482996|NCT00422097|1156048|P4|NOT COMPLETED|Dose Level 1||0
482997|NCT00422097|1156049|P3|NOT COMPLETED|Dose Level 1||0
482998|NCT00422097|1156050|P2|NOT COMPLETED|Dose Level 1||0
482999|NCT00422097|1156051|P1|NOT COMPLETED|Dose Level 1||0
483000|NCT00422097|1156044|P8|COMPLETED|Dose Level 1||0
483001|NCT00422097|1156045|P7|COMPLETED|Dose Level 1||0
483002|NCT00422097|1156046|P6|COMPLETED|Dose Level 1||0
483003|NCT00422097|1156047|P5|COMPLETED|Dose Level 1||0
483004|NCT00422097|1156048|P4|COMPLETED|Dose Level 1||0
483005|NCT00422097|1156049|P3|COMPLETED|Dose Level 1||0
483006|NCT00422097|1156050|P2|COMPLETED|Dose Level 1||0
483007|NCT00422097|1156051|P1|COMPLETED|Dose Level 1||3
483008|NCT00422097|1156044|P8|STARTED|Dose Level 1||0
483009|NCT00422097|1156045|P7|STARTED|Dose Level 1||0
483010|NCT00422097|1156046|P6|STARTED|Dose Level 1||0
483011|NCT00422097|1156047|P5|STARTED|Dose Level 1||0
483012|NCT00422097|1156048|P4|STARTED|Dose Level 1||0
483013|NCT00422097|1156049|P3|STARTED|Dose Level 1||0
483014|NCT00422097|1156050|P2|STARTED|Dose Level 1||0
483015|NCT00422097|1156051|P1|STARTED|Dose Level 1||3
483016|NCT00422058|1156116|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
483017|NCT00422058|1156117|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
483018|NCT00422058|1156118|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
483019|NCT00422058|1156119|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
483020|NCT00422058|1156120|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
483021|NCT00422058|1156121|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
483022|NCT00422058|1156116|P6|COMPLETED|Open-Label Extension, Week 20-104||45
483023|NCT00422058|1156117|P5|COMPLETED|Open-Label Extension, Week 20-104||47
483024|NCT00422058|1156118|P4|COMPLETED|Open-Label Extension, Week 20-104||45
483025|NCT00422058|1156119|P3|COMPLETED|Open-Label Extension, Week 20-104||38
483026|NCT00422058|1156120|P2|COMPLETED|Open-Label Extension, Week 20-104||46
483027|NCT00422058|1156121|P1|COMPLETED|Open-Label Extension, Week 20-104||47
483028|NCT00422058|1156116|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
483029|NCT00422058|1156117|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
483030|NCT00422058|1156118|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
483031|NCT00422058|1156119|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
483032|NCT00422058|1156120|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
483033|NCT00422058|1156121|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
483034|NCT00422058|1156116|P6|STARTED|Open-Label Extension, Week 20-104||79
483035|NCT00422058|1156117|P5|STARTED|Open-Label Extension, Week 20-104||82
483036|NCT00422058|1156118|P4|STARTED|Open-Label Extension, Week 20-104||73
483037|NCT00422058|1156119|P3|STARTED|Open-Label Extension, Week 20-104||74
483038|NCT00422058|1156120|P2|STARTED|Open-Label Extension, Week 20-104||85
483039|NCT00422058|1156121|P1|STARTED|Open-Label Extension, Week 20-104||79
483040|NCT00422058|1156116|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
483041|NCT00422058|1156117|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
483042|NCT00422058|1156118|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
483043|NCT00422058|1156119|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
483044|NCT00422058|1156120|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
483045|NCT00422058|1156121|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
483046|NCT00422058|1156116|P6|COMPLETED|Double-Blind, Week 0-20||79
483047|NCT00422058|1156117|P5|COMPLETED|Double-Blind, Week 0-20||82
483048|NCT00422058|1156118|P4|COMPLETED|Double-Blind, Week 0-20||73
483049|NCT00422058|1156119|P3|COMPLETED|Double-Blind, Week 0-20||74
483050|NCT00422058|1156120|P2|COMPLETED|Double-Blind, Week 0-20||85
483051|NCT00422058|1156121|P1|COMPLETED|Double-Blind, Week 0-20||79
483052|NCT00422058|1156116|P6|STARTED|Double-Blind, Week 0-20||95
483053|NCT00422058|1156117|P5|STARTED|Double-Blind, Week 0-20||93
483054|NCT00422058|1156118|P4|STARTED|Double-Blind, Week 0-20||93
483055|NCT00422058|1156119|P3|STARTED|Double-Blind, Week 0-20||90
483056|NCT00422058|1156120|P2|STARTED|Double-Blind, Week 0-20||95
483057|NCT00422058|1156121|P1|STARTED|Double-Blind, Week 0-20||98
483058|NCT00422032|1156251|P2|NOT COMPLETED|Overall Study||0
483059|NCT00422032|1156252|P1|NOT COMPLETED|Overall Study||0
483060|NCT00422032|1156251|P2|COMPLETED|Overall Study||21
483061|NCT00422032|1156252|P1|COMPLETED|Overall Study||37
483062|NCT00422032|1156251|P2|STARTED|Overall Study||21
483063|NCT00422032|1156252|P1|STARTED|Overall Study||37
483064|NCT00421993|1156262|P4|NOT COMPLETED|Overall Study||57
483065|NCT00421993|1156263|P3|NOT COMPLETED|Overall Study||52
483066|NCT00421993|1156264|P2|NOT COMPLETED|Overall Study||49
483067|NCT00421993|1156265|P1|NOT COMPLETED|Overall Study||53
483068|NCT00421993|1156262|P4|COMPLETED|Overall Study||361
483069|NCT00421993|1156263|P3|COMPLETED|Overall Study||363
483070|NCT00421993|1156264|P2|COMPLETED|Overall Study||369
483071|NCT00421993|1156265|P1|COMPLETED|Overall Study||366
483072|NCT00421993|1156262|P4|STARTED|Overall Study||418
483073|NCT00421993|1156263|P3|STARTED|Overall Study||415
483074|NCT00421993|1156264|P2|STARTED|Overall Study||418
483075|NCT00421993|1156265|P1|STARTED|Overall Study||419
483076|NCT00421954|1156295|P1|NOT COMPLETED|Overall Study||0
483077|NCT00421954|1156295|P1|COMPLETED|Overall Study||0
483078|NCT00421954|1156295|P1|STARTED|Overall Study||0
483079|NCT00421928|1156302|P3|NOT COMPLETED|Overall Study||134
483080|NCT00421928|1156303|P2|NOT COMPLETED|Overall Study||224
483081|NCT00421928|1156304|P1|NOT COMPLETED|Overall Study||163
483082|NCT00421928|1156302|P3|COMPLETED|Overall Study||203
483083|NCT00421928|1156303|P2|COMPLETED|Overall Study||118
483084|NCT00421928|1156304|P1|COMPLETED|Overall Study||181
483085|NCT00421928|1156302|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
483086|NCT00421928|1156303|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
483087|NCT00421928|1156304|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
483088|NCT00421889|1156339|P9|NOT COMPLETED|Overall Study||11
483089|NCT00421889|1156340|P8|NOT COMPLETED|Overall Study||2
483090|NCT00421889|1156341|P7|NOT COMPLETED|Overall Study||4
483091|NCT00421889|1156342|P6|NOT COMPLETED|Overall Study||35
483092|NCT00421889|1156343|P5|NOT COMPLETED|Overall Study||6
483093|NCT00421889|1156344|P4|NOT COMPLETED|Overall Study||4
483094|NCT00421889|1156345|P3|NOT COMPLETED|Overall Study||3
483095|NCT00421889|1156346|P2|NOT COMPLETED|Overall Study||5
483096|NCT00421889|1156347|P1|NOT COMPLETED|Overall Study||5
483097|NCT00421889|1156339|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
483098|NCT00421889|1156340|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
483099|NCT00421889|1156341|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
483100|NCT00421889|1156342|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
483101|NCT00421889|1156343|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
483102|NCT00421889|1156344|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
483103|NCT00421889|1156345|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
483104|NCT00421889|1156346|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
483105|NCT00421889|1156347|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
483106|NCT00421889|1156339|P9|STARTED|Overall Study||15
483107|NCT00421889|1156340|P8|STARTED|Overall Study||3
483108|NCT00421889|1156341|P7|STARTED|Overall Study||4
483109|NCT00421889|1156342|P6|STARTED|Overall Study||35
483110|NCT00421889|1156343|P5|STARTED|Overall Study||6
483111|NCT00421889|1156344|P4|STARTED|Overall Study||4
483112|NCT00421889|1156345|P3|STARTED|Overall Study||3
483113|NCT00421889|1156346|P2|STARTED|Overall Study||5
483114|NCT00421889|1156347|P1|STARTED|Overall Study||5
483115|NCT00421603|1156391|P2|NOT COMPLETED|Overall Study||12
483116|NCT00421603|1156392|P1|NOT COMPLETED|Overall Study||11
483117|NCT00421603|1156391|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
483118|NCT00421603|1156392|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
483119|NCT00421603|1156391|P2|STARTED|Overall Study||42
483120|NCT00421603|1156392|P1|STARTED|Overall Study||39
483121|NCT00421408|1156400|P2|NOT COMPLETED|Overall Study||45
483122|NCT00421408|1156401|P1|NOT COMPLETED|Overall Study||42
483123|NCT00421408|1156400|P2|COMPLETED|Overall Study||61
483124|NCT00421408|1156401|P1|COMPLETED|Overall Study||60
483125|NCT00421408|1156400|P2|STARTED|Overall Study||106
483126|NCT00421408|1156401|P1|STARTED|Overall Study||102
483127|NCT00421343|1156419|P1|NOT COMPLETED|Overall Study||6
483128|NCT00421343|1156419|P1|COMPLETED|Overall Study||23
483129|NCT00421343|1156419|P1|STARTED|Overall Study||29
483130|NCT00421174|1156425|P2|NOT COMPLETED|Overall Study||1
483131|NCT00421174|1156426|P1|NOT COMPLETED|Overall Study||2
483132|NCT00421174|1156425|P2|COMPLETED|Overall Study||18
483133|NCT00421174|1156426|P1|COMPLETED|Overall Study||16
483134|NCT00421174|1156425|P2|STARTED|Overall Study||19
483135|NCT00421174|1156426|P1|STARTED|Overall Study||18
483136|NCT00420992|1156456|P2|NOT COMPLETED|Maintenance Phase||75
483137|NCT00420992|1156457|P1|NOT COMPLETED|Maintenance Phase||61
483138|NCT00420992|1156456|P2|COMPLETED|Maintenance Phase||98
483139|NCT00420992|1156457|P1|COMPLETED|Maintenance Phase||110
483140|NCT00420992|1156456|P2|STARTED|Maintenance Phase||173
483141|NCT00420992|1156457|P1|STARTED|Maintenance Phase||171
483142|NCT00420992|1156456|P2|NOT COMPLETED|Titration Phase||0
483143|NCT00420992|1156457|P1|NOT COMPLETED|Titration Phase||203
483144|NCT00420992|1156456|P2|COMPLETED|Titration Phase||0
483145|NCT00420992|1156457|P1|COMPLETED|Titration Phase||344
483146|NCT00420992|1156456|P2|STARTED|Titration Phase||0
483147|NCT00420992|1156457|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
483148|NCT00420927|1156471|P7|NOT COMPLETED|Period 2||53
483149|NCT00420927|1156472|P6|NOT COMPLETED|Period 2||15
483150|NCT00420927|1156473|P5|NOT COMPLETED|Period 2||43
483151|NCT00420927|1156474|P4|NOT COMPLETED|Period 2||10
483152|NCT00420927|1156475|P3|NOT COMPLETED|Period 2||13
483153|NCT00420927|1156476|P2|NOT COMPLETED|Period 2||0
483154|NCT00420927|1156477|P1|NOT COMPLETED|Period 2||0
483155|NCT00420927|1156471|P7|COMPLETED|Period 2||295
483156|NCT00420927|1156472|P6|COMPLETED|Period 2||97
483157|NCT00420927|1156473|P5|COMPLETED|Period 2||216
483158|NCT00420927|1156474|P4|COMPLETED|Period 2||95
483159|NCT00420927|1156475|P3|COMPLETED|Period 2||89
483160|NCT00420927|1156476|P2|COMPLETED|Period 2||0
483161|NCT00420927|1156477|P1|COMPLETED|Period 2||0
483162|NCT00420927|1156471|P7|STARTED|Period 2||348
483163|NCT00420927|1156472|P6|STARTED|Period 2||112
483164|NCT00420927|1156473|P5|STARTED|Period 2||259
483165|NCT00420927|1156474|P4|STARTED|Period 2||105
483166|NCT00420927|1156475|P3|STARTED|Period 2||102
483167|NCT00420927|1156476|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
483168|NCT00420927|1156477|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
483169|NCT00420927|1156471|P7|NOT COMPLETED|Period 1||0
483170|NCT00420927|1156472|P6|NOT COMPLETED|Period 1||0
483171|NCT00420927|1156473|P5|NOT COMPLETED|Period 1||0
483172|NCT00420927|1156474|P4|NOT COMPLETED|Period 1||0
483173|NCT00420927|1156475|P3|NOT COMPLETED|Period 1||0
483174|NCT00420927|1156476|P2|NOT COMPLETED|Period 1||57
483175|NCT00420927|1156477|P1|NOT COMPLETED|Period 1||49
483176|NCT00420927|1156471|P7|COMPLETED|Period 1||0
483177|NCT00420927|1156472|P6|COMPLETED|Period 1||0
483178|NCT00420927|1156473|P5|COMPLETED|Period 1||0
483179|NCT00420927|1156474|P4|COMPLETED|Period 1||0
483180|NCT00420927|1156475|P3|COMPLETED|Period 1||0
483181|NCT00420927|1156476|P2|COMPLETED|Period 1||460
483182|NCT00420927|1156477|P1|COMPLETED|Period 1||466
483183|NCT00420927|1156471|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
483184|NCT00420927|1156472|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
483185|NCT00420927|1156473|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
483186|NCT00420927|1156474|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
483187|NCT00420927|1156475|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
483188|NCT00420927|1156476|P2|STARTED|Period 1||517
483189|NCT00420927|1156477|P1|STARTED|Period 1||515
483190|NCT00420849|1156581|P1|NOT COMPLETED|Overall Study||331
483191|NCT00420849|1156581|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
483192|NCT00420849|1156581|P1|STARTED|Overall Study||587
483193|NCT00420784|1156650|P4|NOT COMPLETED|Overall Study||78
483194|NCT00420784|1156651|P3|NOT COMPLETED|Overall Study||53
483195|NCT00420784|1156652|P2|NOT COMPLETED|Overall Study||58
483196|NCT00420784|1156653|P1|NOT COMPLETED|Overall Study||29
483197|NCT00420784|1156650|P4|COMPLETED|Overall Study||36
483198|NCT00420784|1156651|P3|COMPLETED|Overall Study||58
483199|NCT00420784|1156652|P2|COMPLETED|Overall Study||55
483200|NCT00420784|1156653|P1|COMPLETED|Overall Study||86
483201|NCT00420784|1156650|P4|STARTED|Overall Study||114
483202|NCT00420784|1156651|P3|STARTED|Overall Study||111
483203|NCT00420784|1156652|P2|STARTED|Overall Study||113
483204|NCT00420784|1156653|P1|STARTED|Overall Study||115
483205|NCT00420745|1156682|P2|NOT COMPLETED|Overall Study||6
483206|NCT00420745|1156683|P1|NOT COMPLETED|Overall Study||15
483207|NCT00420745|1156682|P2|COMPLETED|Overall Study||333
483208|NCT00420745|1156683|P1|COMPLETED|Overall Study||655
483209|NCT00420745|1156682|P2|STARTED|Overall Study||339
483210|NCT00420745|1156683|P1|STARTED|Overall Study||670
483211|NCT00420017|1156701|P2|NOT COMPLETED|Overall Study||0
483212|NCT00420017|1156702|P1|NOT COMPLETED|Overall Study||2
483213|NCT00420017|1156701|P2|COMPLETED|Overall Study||40
483214|NCT00420017|1156702|P1|COMPLETED|Overall Study|40 completed analysis|38
483215|NCT00420017|1156701|P2|STARTED|Overall Study||40
483216|NCT00420017|1156702|P1|STARTED|Overall Study||40
483217|NCT00420628|1156716|P2|NOT COMPLETED|Overall Study||4
483218|NCT00420628|1156717|P1|NOT COMPLETED|Overall Study||9
483219|NCT00420628|1156716|P2|COMPLETED|Overall Study||32
483220|NCT00420628|1156717|P1|COMPLETED|Overall Study||63
483221|NCT00420628|1156716|P2|STARTED|Overall Study||36
483222|NCT00420628|1156717|P1|STARTED|Overall Study||72
483223|NCT00420511|1156733|P2|NOT COMPLETED|Overall Study||1
483224|NCT00420511|1156734|P1|NOT COMPLETED|Overall Study||2
483225|NCT00420511|1156733|P2|COMPLETED|Overall Study||10
483226|NCT00420511|1156734|P1|COMPLETED|Overall Study||8
483227|NCT00420511|1156733|P2|STARTED|Overall Study||11
483228|NCT00420511|1156734|P1|STARTED|Overall Study||10
483229|NCT00420459|1156744|P1|NOT COMPLETED|Overall Study||0
483230|NCT00420459|1156744|P1|COMPLETED|Overall Study||12
483231|NCT00420459|1156744|P1|STARTED|Overall Study||12
483232|NCT00420420|1156755|P2|NOT COMPLETED|Overall Study||4
483233|NCT00420420|1156756|P1|NOT COMPLETED|Overall Study||8
483234|NCT00420420|1156755|P2|COMPLETED|Overall Study||67
483235|NCT00420420|1156756|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
483236|NCT00420420|1156755|P2|STARTED|Overall Study|Number of patients randomized.|71
483237|NCT00420420|1156756|P1|STARTED|Overall Study|Number of patients randomized.|73
483238|NCT00420407|1156774|P2|NOT COMPLETED|Overall Study||6
483239|NCT00420407|1156775|P1|NOT COMPLETED|Overall Study||4
483240|NCT00420407|1156774|P2|COMPLETED|Overall Study||34
483241|NCT00420407|1156775|P1|COMPLETED|Overall Study||37
483242|NCT00420407|1156774|P2|STARTED|Overall Study||40
483243|NCT00420407|1156775|P1|STARTED|Overall Study||41
483244|NCT00420342|1156784|P3|NOT COMPLETED|Overall Study||1
483245|NCT00420342|1156785|P2|NOT COMPLETED|Overall Study||2
483246|NCT00420342|1156786|P1|NOT COMPLETED|Overall Study||1
483247|NCT00420342|1156784|P3|COMPLETED|Overall Study||28
483248|NCT00420342|1156785|P2|COMPLETED|Overall Study||31
483249|NCT00420342|1156786|P1|COMPLETED|Overall Study||29
483250|NCT00420342|1156784|P3|Received Treatment|Overall Study||29
483251|NCT00420342|1156785|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
483340|NCT00419744|1157263|P3|NOT COMPLETED|Overall Study||133
483252|NCT00420342|1156786|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
483253|NCT00420342|1156784|P3|STARTED|Overall Study||29
483254|NCT00420342|1156785|P2|STARTED|Overall Study||33
483255|NCT00420342|1156786|P1|STARTED|Overall Study||30
483256|NCT00420316|1156829|P2|NOT COMPLETED|Overall Study||9
483257|NCT00420316|1156830|P1|NOT COMPLETED|Overall Study||12
483258|NCT00420316|1156829|P2|COMPLETED|Overall Study||522
483259|NCT00420316|1156830|P1|COMPLETED|Overall Study||1070
483260|NCT00420316|1156829|P2|STARTED|Overall Study||531
483261|NCT00420316|1156830|P1|STARTED|Overall Study||1082
483262|NCT00420303|1156854|P2|NOT COMPLETED|Overall Study||4
483263|NCT00420303|1156855|P1|NOT COMPLETED|Overall Study||1
483264|NCT00420303|1156854|P2|COMPLETED|Overall Study||8
483265|NCT00420303|1156855|P1|COMPLETED|Overall Study||11
483266|NCT00420303|1156854|P2|STARTED|Overall Study||12
483267|NCT00420303|1156855|P1|STARTED|Overall Study||12
483268|NCT00420290|1156867|P2|NOT COMPLETED|Overall Study||4
483269|NCT00420290|1156868|P1|NOT COMPLETED|Overall Study||4
483270|NCT00420290|1156867|P2|COMPLETED|Overall Study||7
483271|NCT00420290|1156868|P1|COMPLETED|Overall Study||7
483272|NCT00420290|1156867|P2|STARTED|Overall Study||11
483273|NCT00420290|1156868|P1|STARTED|Overall Study||11
483274|NCT00420238|1156884|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
483275|NCT00420238|1156885|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
483276|NCT00420238|1156884|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
483277|NCT00420238|1156885|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
483278|NCT00420238|1156884|P2|STARTED|12 Week Open-Label Treatment Period 2||39
483279|NCT00420238|1156885|P1|STARTED|12 Week Open-Label Treatment Period 2||38
483280|NCT00420238|1156884|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
483281|NCT00420238|1156885|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
483282|NCT00420238|1156884|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
483283|NCT00420238|1156885|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
483284|NCT00420238|1156884|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
483285|NCT00420238|1156885|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
483286|NCT00420212|1157024|P3|NOT COMPLETED|Overall Study||96
483287|NCT00420212|1157025|P2|NOT COMPLETED|Overall Study||95
483288|NCT00420212|1157026|P1|NOT COMPLETED|Overall Study||91
483289|NCT00420212|1157024|P3|COMPLETED|Overall Study||320
483290|NCT00420212|1157025|P2|COMPLETED|Overall Study||315
483291|NCT00420212|1157026|P1|COMPLETED|Overall Study||317
483292|NCT00420212|1157024|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
483293|NCT00420212|1157025|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
483294|NCT00420212|1157026|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
483295|NCT00420199|1157052|P2|NOT COMPLETED|Overall Study||0
483296|NCT00420199|1157053|P1|NOT COMPLETED|Overall Study||1
483297|NCT00420199|1157052|P2|COMPLETED|Overall Study||23
483298|NCT00420199|1157053|P1|COMPLETED|Overall Study||26
483299|NCT00420199|1157052|P2|STARTED|Overall Study||23
483300|NCT00420199|1157053|P1|STARTED|Overall Study||27
483301|NCT00420147|1157108|P2|NOT COMPLETED|Overall Study||0
483302|NCT00420147|1157109|P1|NOT COMPLETED|Overall Study||0
483303|NCT00420147|1157108|P2|COMPLETED|Overall Study||19
483304|NCT00420147|1157109|P1|COMPLETED|Overall Study||19
483305|NCT00420147|1157108|P2|STARTED|Overall Study||19
483306|NCT00420147|1157109|P1|STARTED|Overall Study||19
483307|NCT00420095|1157119|P2|NOT COMPLETED|Overall Study||1
483308|NCT00420095|1157120|P1|NOT COMPLETED|Overall Study||3
483309|NCT00420095|1157119|P2|COMPLETED|Overall Study||59
483310|NCT00420095|1157120|P1|COMPLETED|Overall Study||54
483311|NCT00420095|1157119|P2|STARTED|Overall Study||60
483312|NCT00420095|1157120|P1|STARTED|Overall Study||57
483313|NCT00420056|1157138|P1|NOT COMPLETED|Overall Study||17
483314|NCT00420056|1157138|P1|COMPLETED|Overall Study||0
483315|NCT00420056|1157138|P1|STARTED|Overall Study||17
483316|NCT00419952|1157162|P2|NOT COMPLETED|Overall Study||125
483317|NCT00419952|1157163|P1|NOT COMPLETED|Overall Study||149
483318|NCT00419952|1157162|P2|COMPLETED|Overall Study||240
483319|NCT00419952|1157163|P1|COMPLETED|Overall Study||228
483320|NCT00419952|1157162|P2|STARTED|Overall Study||365
483321|NCT00419952|1157163|P1|STARTED|Overall Study||377
483322|NCT00419926|1157197|P2|NOT COMPLETED|Overall Study||10
483323|NCT00419926|1157198|P1|NOT COMPLETED|Overall Study||14
483324|NCT00419926|1157197|P2|COMPLETED|Overall Study||148
483325|NCT00419926|1157198|P1|COMPLETED|Overall Study||141
483326|NCT00419926|1157197|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
483327|NCT00419926|1157198|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
483328|NCT00419770|1157214|P2|NOT COMPLETED|Overall Study||1
483329|NCT00419770|1157215|P1|NOT COMPLETED|Overall Study||5
483330|NCT00419770|1157214|P2|COMPLETED|Overall Study||8
483331|NCT00419770|1157215|P1|COMPLETED|Overall Study||6
483332|NCT00419770|1157214|P2|STARTED|Overall Study||9
483333|NCT00419770|1157215|P1|STARTED|Overall Study||11
483334|NCT00419757|1157223|P2|NOT COMPLETED|Overall Study||21
483335|NCT00419757|1157224|P1|NOT COMPLETED|Overall Study||18
483336|NCT00419757|1157223|P2|COMPLETED|Overall Study|Randomized patients|102
483337|NCT00419757|1157224|P1|COMPLETED|Overall Study|Randomized patients|109
483338|NCT00419757|1157223|P2|STARTED|Overall Study|Randomized patients|123
483339|NCT00419757|1157224|P1|STARTED|Overall Study|Randomized patients|127
483341|NCT00419744|1157264|P2|NOT COMPLETED|Overall Study||118
483342|NCT00419744|1157265|P1|NOT COMPLETED|Overall Study||117
483343|NCT00419744|1157263|P3|COMPLETED|Overall Study||271
483344|NCT00419744|1157264|P2|COMPLETED|Overall Study||290
483345|NCT00419744|1157265|P1|COMPLETED|Overall Study||290
483346|NCT00419744|1157263|P3|STARTED|Overall Study||404
483347|NCT00419744|1157264|P2|STARTED|Overall Study||408
483348|NCT00419744|1157265|P1|STARTED|Overall Study||407
483349|NCT00419445|1157297|P3|NOT COMPLETED|Overall Study||1
483350|NCT00419445|1157298|P2|NOT COMPLETED|Overall Study||2
483351|NCT00419445|1157299|P1|NOT COMPLETED|Overall Study||1
483352|NCT00419445|1157297|P3|COMPLETED|Overall Study||7
483353|NCT00419445|1157298|P2|COMPLETED|Overall Study||14
483354|NCT00419445|1157299|P1|COMPLETED|Overall Study||7
483355|NCT00419445|1157297|P3|STARTED|Overall Study||8
483356|NCT00419445|1157298|P2|STARTED|Overall Study||16
483357|NCT00419445|1157299|P1|STARTED|Overall Study||8
483358|NCT00419393|1157307|P1|NOT COMPLETED|Overall Study||24
483359|NCT00419393|1157307|P1|COMPLETED|Overall Study||166
483360|NCT00419393|1157307|P1|STARTED|Overall Study|One subject did not receive medication|190
483361|NCT00419380|1157317|P2|NOT COMPLETED|Overall Study||10
483362|NCT00419380|1157318|P1|NOT COMPLETED|Overall Study||1
483363|NCT00419380|1157317|P2|COMPLETED|Overall Study||12
483364|NCT00419380|1157318|P1|COMPLETED|Overall Study||18
483365|NCT00419380|1157317|P2|STARTED|Overall Study||22
483366|NCT00419380|1157318|P1|STARTED|Overall Study||19
483367|NCT00419341|1157326|P1|NOT COMPLETED|Efficacy Period||10
483368|NCT00419341|1157326|P1|COMPLETED|Efficacy Period||28
483369|NCT00419341|1157326|P1|STARTED|Efficacy Period||38
483370|NCT00419341|1157326|P1|NOT COMPLETED|Wash in/Wash Out Period||11
483371|NCT00419341|1157326|P1|COMPLETED|Wash in/Wash Out Period||38
483372|NCT00419341|1157326|P1|STARTED|Wash in/Wash Out Period||49
483373|NCT00419315|1157349|P2|NOT COMPLETED|Overall Study||0
483374|NCT00419315|1157350|P1|NOT COMPLETED|Overall Study||0
483375|NCT00419315|1157349|P2|COMPLETED|Overall Study||78
483376|NCT00419315|1157350|P1|COMPLETED|Overall Study||85
483377|NCT00419315|1157349|P2|STARTED|Overall Study||78
483378|NCT00419315|1157350|P1|STARTED|Overall Study||85
483379|NCT00419263|1157361|P3|NOT COMPLETED|Overall Study||3
483380|NCT00419263|1157362|P2|NOT COMPLETED|Overall Study||2
483381|NCT00419263|1157363|P1|NOT COMPLETED|Overall Study||3
483382|NCT00419263|1157361|P3|COMPLETED|Overall Study||112
483383|NCT00419263|1157362|P2|COMPLETED|Overall Study||112
483384|NCT00419263|1157363|P1|COMPLETED|Overall Study||112
483385|NCT00419263|1157361|P3|STARTED|Overall Study||115
483386|NCT00419263|1157362|P2|STARTED|Overall Study||114
483387|NCT00419263|1157363|P1|STARTED|Overall Study||115
483388|NCT00419159|1157392|P2|NOT COMPLETED|Overall Study||100
483389|NCT00419159|1157393|P1|NOT COMPLETED|Overall Study||99
483390|NCT00419159|1157392|P2|COMPLETED|Overall Study||0
483391|NCT00419159|1157393|P1|COMPLETED|Overall Study||0
483392|NCT00419159|1157392|P2|STARTED|Overall Study||100
483393|NCT00419159|1157393|P1|STARTED|Overall Study|Full Analysis Set|99
483394|NCT00419120|1157407|P1|NOT COMPLETED|Long Term Follow up Period||10
483395|NCT00419120|1157407|P1|COMPLETED|Long Term Follow up Period||0
483396|NCT00419120|1157407|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
483397|NCT00419120|1157407|P1|NOT COMPLETED|Primary Study Period||0
483398|NCT00419120|1157407|P1|COMPLETED|Primary Study Period||10
483399|NCT00419120|1157407|P1|STARTED|Primary Study Period||10
483400|NCT00419094|1157414|P2|NOT COMPLETED|Overall Study||30
483401|NCT00419094|1157415|P1|NOT COMPLETED|Overall Study||7
483402|NCT00419094|1157414|P2|COMPLETED|Overall Study||141
483403|NCT00419094|1157415|P1|COMPLETED|Overall Study||50
483404|NCT00419094|1157414|P2|STARTED|Overall Study||171
483405|NCT00419094|1157415|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
483406|NCT00417976|1157427|P1|NOT COMPLETED|Overall Study||3
483407|NCT00417976|1157427|P1|COMPLETED|Overall Study||39
483408|NCT00417976|1157427|P1|STARTED|Overall Study||42
483409|NCT00417963|1157432|P1|NOT COMPLETED|Overall Study||41
483410|NCT00417963|1157432|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
483411|NCT00417963|1157432|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
483412|NCT00419003|1157451|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
483413|NCT00419003|1157452|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
483414|NCT00419003|1157451|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
483415|NCT00419003|1157452|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
483416|NCT00419003|1157451|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
483417|NCT00419003|1157452|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
483418|NCT00419003|1157451|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
483419|NCT00419003|1157452|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
483420|NCT00419003|1157451|P2|COMPLETED|Phase I, Ketamine Infusion||7
483421|NCT00419003|1157452|P1|COMPLETED|Phase I, Ketamine Infusion||7
483422|NCT00419003|1157451|P2|STARTED|Phase I, Ketamine Infusion||13
483423|NCT00419003|1157452|P1|STARTED|Phase I, Ketamine Infusion||13
483424|NCT00418977|1157463|P2|NOT COMPLETED|Overall Study||3
483425|NCT00418977|1157464|P1|NOT COMPLETED|Overall Study||3
483426|NCT00418977|1157463|P2|COMPLETED|Overall Study||13
483427|NCT00418977|1157464|P1|COMPLETED|Overall Study||40
483428|NCT00418977|1157463|P2|STARTED|Overall Study||16
483429|NCT00418977|1157464|P1|STARTED|Overall Study||43
483430|NCT00418964|1157481|P3|NOT COMPLETED|Overall Study||6
483431|NCT00418964|1157482|P2|NOT COMPLETED|Overall Study||3
483432|NCT00418964|1157483|P1|NOT COMPLETED|Overall Study||1
483433|NCT00418964|1157481|P3|COMPLETED|Overall Study||14
483434|NCT00418964|1157482|P2|COMPLETED|Overall Study||17
483435|NCT00418964|1157483|P1|COMPLETED|Overall Study||21
483436|NCT00418964|1157481|P3|STARTED|Overall Study||20
483437|NCT00418964|1157482|P2|STARTED|Overall Study||20
483438|NCT00418964|1157483|P1|STARTED|Overall Study||22
483439|NCT00418951|1157494|P3|NOT COMPLETED|Overall Study||0
483440|NCT00418951|1157495|P2|NOT COMPLETED|Overall Study||0
483441|NCT00418951|1157496|P1|NOT COMPLETED|Overall Study||0
483442|NCT00418951|1157494|P3|COMPLETED|Overall Study||40
483443|NCT00418951|1157495|P2|COMPLETED|Overall Study||33
483444|NCT00418951|1157496|P1|COMPLETED|Overall Study||39
483445|NCT00418951|1157494|P3|STARTED|Overall Study||40
483446|NCT00418951|1157495|P2|STARTED|Overall Study||33
483447|NCT00418951|1157496|P1|STARTED|Overall Study||39
483448|NCT00418938|1157506|P2|NOT COMPLETED|Overall Study||23
483449|NCT00418938|1157507|P1|NOT COMPLETED|Overall Study||24
483450|NCT00418938|1157506|P2|COMPLETED|Overall Study||108
483451|NCT00418938|1157507|P1|COMPLETED|Overall Study||109
483452|NCT00418938|1157506|P2|STARTED|Overall Study||131
483453|NCT00418938|1157507|P1|STARTED|Overall Study||133
483454|NCT00418886|1157527|P2|NOT COMPLETED|Overall Study||255
483455|NCT00418886|1157528|P1|NOT COMPLETED|Overall Study||226
483456|NCT00418886|1157527|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
483457|NCT00418886|1157528|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
483458|NCT00418886|1157527|P2|STARTED|Overall Study|randomised patients|278
483459|NCT00418886|1157528|P1|STARTED|Overall Study|randomised patients|256
483460|NCT00418834|1157554|P2|NOT COMPLETED|Overall Study||20
483461|NCT00418834|1157555|P1|NOT COMPLETED|Overall Study||23
483462|NCT00418834|1157554|P2|COMPLETED|Overall Study||507
483463|NCT00418834|1157555|P1|COMPLETED|Overall Study||503
483464|NCT00418834|1157554|P2|STARTED|Overall Study||527
483465|NCT00418834|1157555|P1|STARTED|Overall Study||526
483466|NCT00418717|1157615|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
483467|NCT00418717|1157615|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
483468|NCT00418717|1157615|P1|STARTED|Treatment Period B - Weeks 5-12||41
483469|NCT00418717|1157615|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
483470|NCT00418717|1157615|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
483471|NCT00418717|1157615|P1|STARTED|Treatment Period A - Weeks 1-4||42
483472|NCT00418691|1157623|P3|NOT COMPLETED|Overall Study||5
483473|NCT00418691|1157624|P2|NOT COMPLETED|Overall Study||2
483474|NCT00418691|1157625|P1|NOT COMPLETED|Overall Study||2
483475|NCT00418691|1157623|P3|COMPLETED|Overall Study||5
483476|NCT00418691|1157624|P2|COMPLETED|Overall Study||10
483477|NCT00418691|1157625|P1|COMPLETED|Overall Study||9
483478|NCT00418691|1157623|P3|STARTED|Overall Study||10
483479|NCT00418691|1157624|P2|STARTED|Overall Study||12
483480|NCT00418691|1157625|P1|STARTED|Overall Study||11
483481|NCT00418665|1157636|P3|NOT COMPLETED|Treatment Extension||2
483482|NCT00418665|1157637|P2|NOT COMPLETED|Treatment Extension||4
483483|NCT00418665|1157638|P1|NOT COMPLETED|Treatment Extension||6
483484|NCT00418665|1157636|P3|COMPLETED|Treatment Extension||7
483485|NCT00418665|1157637|P2|COMPLETED|Treatment Extension||4
483486|NCT00418665|1157638|P1|COMPLETED|Treatment Extension||1
483487|NCT00418665|1157636|P3|STARTED|Treatment Extension||9
483488|NCT00418665|1157637|P2|STARTED|Treatment Extension||8
483489|NCT00418665|1157638|P1|STARTED|Treatment Extension||7
483490|NCT00418665|1157636|P3|NOT COMPLETED|Treatment Period||4
483491|NCT00418665|1157637|P2|NOT COMPLETED|Treatment Period||6
483492|NCT00418665|1157638|P1|NOT COMPLETED|Treatment Period||5
483493|NCT00418665|1157636|P3|COMPLETED|Treatment Period||9
483494|NCT00418665|1157637|P2|COMPLETED|Treatment Period||8
483495|NCT00418665|1157638|P1|COMPLETED|Treatment Period||7
483496|NCT00418665|1157636|P3|Received Study Medication|Treatment Period||13
483497|NCT00418665|1157637|P2|Received Study Medication|Treatment Period||13
483498|NCT00418665|1157638|P1|Received Study Medication|Treatment Period||11
483499|NCT00418665|1157636|P3|STARTED|Treatment Period||13
483500|NCT00418665|1157637|P2|STARTED|Treatment Period||14
483501|NCT00418665|1157638|P1|STARTED|Treatment Period||12
483502|NCT00418574|1157657|P2|NOT COMPLETED|Overall Study||23
483503|NCT00418574|1157658|P1|NOT COMPLETED|Overall Study||48
483504|NCT00418574|1157657|P2|COMPLETED|Overall Study||272
483505|NCT00418574|1157658|P1|COMPLETED|Overall Study||545
483506|NCT00418574|1157657|P2|TREATED|Overall Study||294
483507|NCT00418574|1157658|P1|TREATED|Overall Study||592
483508|NCT00418574|1157657|P2|STARTED|Overall Study||295
483509|NCT00418574|1157658|P1|STARTED|Overall Study||593
483510|NCT00418561|1157672|P3|NOT COMPLETED|Overall Study||0
483511|NCT00418561|1157673|P2|NOT COMPLETED|Overall Study||1
483512|NCT00418561|1157674|P1|NOT COMPLETED|Overall Study||0
483513|NCT00418561|1157672|P3|COMPLETED|Overall Study||4
483514|NCT00418561|1157673|P2|COMPLETED|Overall Study||4
483515|NCT00418561|1157674|P1|COMPLETED|Overall Study||4
483516|NCT00418561|1157672|P3|STARTED|Overall Study||4
483517|NCT00418561|1157673|P2|STARTED|Overall Study||5
483518|NCT00418561|1157674|P1|STARTED|Overall Study||4
483519|NCT00418522|1157744|P2|NOT COMPLETED|Overall Study||42
483520|NCT00418522|1157745|P1|NOT COMPLETED|Overall Study||83
483521|NCT00418522|1157744|P2|COMPLETED|Overall Study||152
483522|NCT00418522|1157745|P1|COMPLETED|Overall Study||136
483523|NCT00418522|1157744|P2|Received Treatment|Overall Study||190
483524|NCT00418522|1157745|P1|Received Treatment|Overall Study||212
483525|NCT00418522|1157744|P2|STARTED|Overall Study||194
483526|NCT00418522|1157745|P1|STARTED|Overall Study||219
483527|NCT00418379|1157792|P3|NOT COMPLETED|Year 5||3
483528|NCT00418379|1157793|P2|NOT COMPLETED|Year 5||5
483529|NCT00418379|1157794|P1|NOT COMPLETED|Year 5||2
483530|NCT00418379|1157792|P3|COMPLETED|Year 5||131
483531|NCT00418379|1157793|P2|COMPLETED|Year 5||115
483532|NCT00418379|1157794|P1|COMPLETED|Year 5||126
483533|NCT00418379|1157792|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
483534|NCT00418379|1157793|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
483535|NCT00418379|1157794|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
483536|NCT00418379|1157792|P3|NOT COMPLETED|Year 4||2
483537|NCT00418379|1157793|P2|NOT COMPLETED|Year 4||5
483538|NCT00418379|1157794|P1|NOT COMPLETED|Year 4||3
483539|NCT00418379|1157792|P3|COMPLETED|Year 4||154
483540|NCT00418379|1157793|P2|COMPLETED|Year 4||136
483541|NCT00418379|1157794|P1|COMPLETED|Year 4||142
483542|NCT00418379|1157792|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
483809|NCT00415532|1158320|P1|COMPLETED|Treatment Period||60
483543|NCT00418379|1157793|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
483544|NCT00418379|1157794|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
483545|NCT00418379|1157792|P3|NOT COMPLETED|Year 3||3
483546|NCT00418379|1157793|P2|NOT COMPLETED|Year 3||2
483547|NCT00418379|1157794|P1|NOT COMPLETED|Year 3||3
483548|NCT00418379|1157792|P3|COMPLETED|Year 3||163
483549|NCT00418379|1157793|P2|COMPLETED|Year 3||146
483550|NCT00418379|1157794|P1|COMPLETED|Year 3||148
483551|NCT00418379|1157792|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
483552|NCT00418379|1157793|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
483553|NCT00418379|1157794|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
483554|NCT00418379|1157792|P3|NOT COMPLETED|Year 2||10
483555|NCT00418379|1157793|P2|NOT COMPLETED|Year 2||4
483556|NCT00418379|1157794|P1|NOT COMPLETED|Year 2||8
483557|NCT00418379|1157792|P3|COMPLETED|Year 2||172
483558|NCT00418379|1157793|P2|COMPLETED|Year 2||155
483559|NCT00418379|1157794|P1|COMPLETED|Year 2||159
483560|NCT00418379|1157792|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
483561|NCT00418379|1157793|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
483562|NCT00418379|1157794|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
483563|NCT00418379|1157792|P3|NOT COMPLETED|Year 1||15
483564|NCT00418379|1157793|P2|NOT COMPLETED|Year 1||28
483565|NCT00418379|1157794|P1|NOT COMPLETED|Year 1||18
483566|NCT00418379|1157792|P3|COMPLETED|Year 1||204
483567|NCT00418379|1157793|P2|COMPLETED|Year 1||179
483568|NCT00418379|1157794|P1|COMPLETED|Year 1||189
483569|NCT00418379|1157792|P3|STARTED|Year 1||219
483570|NCT00418379|1157793|P2|STARTED|Year 1||207
483571|NCT00418379|1157794|P1|STARTED|Year 1||207
483572|NCT00418314|1157804|P2|NOT COMPLETED|Overall Study||2
483573|NCT00418314|1157805|P1|NOT COMPLETED|Overall Study||1
483574|NCT00418314|1157804|P2|COMPLETED|Overall Study||828
483575|NCT00418314|1157805|P1|COMPLETED|Overall Study||816
483576|NCT00418314|1157804|P2|STARTED|Overall Study||830
483577|NCT00418314|1157805|P1|STARTED|Overall Study||817
483578|NCT00418184|1157817|P2|NOT COMPLETED|Open-label Phase||5
483579|NCT00418184|1157818|P1|NOT COMPLETED|Open-label Phase||5
483580|NCT00418184|1157817|P2|COMPLETED|Open-label Phase|5 dropped out|43
483581|NCT00418184|1157818|P1|COMPLETED|Open-label Phase|5 dropped out|97
483582|NCT00418184|1157817|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
483583|NCT00418184|1157818|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
483584|NCT00418184|1157817|P2|NOT COMPLETED|Double-blind Phase||11
483585|NCT00418184|1157818|P1|NOT COMPLETED|Double-blind Phase||27
483586|NCT00418184|1157817|P2|COMPLETED|Double-blind Phase||52
483587|NCT00418184|1157818|P1|COMPLETED|Double-blind Phase||110
483588|NCT00418184|1157817|P2|STARTED|Double-blind Phase||63
483589|NCT00418184|1157818|P1|STARTED|Double-blind Phase||137
483590|NCT00418145|1157826|P1|NOT COMPLETED|Overall Study||6
483591|NCT00418145|1157826|P1|COMPLETED|Overall Study||10
483592|NCT00418145|1157826|P1|STARTED|Overall Study||16
483593|NCT00418093|1157838|P1|NOT COMPLETED|Overall Study||0
483594|NCT00418093|1157838|P1|COMPLETED|Overall Study||19
483595|NCT00418093|1157838|P1|Completed Study|Overall Study||19
483596|NCT00418093|1157838|P1|STARTED|Overall Study||19
483597|NCT00418015|1157849|P4|NOT COMPLETED|Overall Study||0
483598|NCT00418015|1157850|P3|NOT COMPLETED|Overall Study||0
483599|NCT00418015|1157851|P2|NOT COMPLETED|Overall Study||0
483600|NCT00418015|1157852|P1|NOT COMPLETED|Overall Study||0
483601|NCT00418015|1157849|P4|COMPLETED|Overall Study||25
483602|NCT00418015|1157850|P3|COMPLETED|Overall Study||78
483603|NCT00418015|1157851|P2|COMPLETED|Overall Study||46
483604|NCT00418015|1157852|P1|COMPLETED|Overall Study||144
483605|NCT00418015|1157849|P4|STARTED|Overall Study||25
483606|NCT00418015|1157850|P3|STARTED|Overall Study||78
483607|NCT00418015|1157851|P2|STARTED|Overall Study||46
483608|NCT00418015|1157852|P1|STARTED|Overall Study||144
483609|NCT00417989|1157880|P2|NOT COMPLETED|Overall Study||22
483610|NCT00417989|1157881|P1|NOT COMPLETED|Overall Study||20
483611|NCT00417989|1157880|P2|COMPLETED|Overall Study||219
483612|NCT00417989|1157881|P1|COMPLETED|Overall Study||224
483613|NCT00417989|1157880|P2|STARTED|Overall Study||241
483614|NCT00417989|1157881|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
483615|NCT00417885|1157901|P1|NOT COMPLETED|Overall Study||6
483616|NCT00417885|1157901|P1|COMPLETED|Overall Study||0
483617|NCT00417885|1157901|P1|STARTED|Overall Study||6
483618|NCT00417612|1157912|P2|NOT COMPLETED|Overall Study||3
483619|NCT00417612|1157913|P1|NOT COMPLETED|Overall Study||3
483620|NCT00417612|1157912|P2|COMPLETED|Overall Study||8
483621|NCT00417612|1157913|P1|COMPLETED|Overall Study||19
483622|NCT00417612|1157912|P2|STARTED|Overall Study||11
483623|NCT00417612|1157913|P1|STARTED|Overall Study||22
483624|NCT00417482|1157939|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
483625|NCT00417482|1157940|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
483626|NCT00417482|1157941|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
483627|NCT00417482|1157939|P3|COMPLETED|Phase B 2nd 16 Weeks||10
483628|NCT00417482|1157940|P2|COMPLETED|Phase B 2nd 16 Weeks||14
483629|NCT00417482|1157941|P1|COMPLETED|Phase B 2nd 16 Weeks||10
483888|NCT00414700|1158473|P1|STARTED|Overall Study||57
483630|NCT00417482|1157939|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
483631|NCT00417482|1157940|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
483632|NCT00417482|1157941|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
483633|NCT00417482|1157939|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
483634|NCT00417482|1157940|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
483635|NCT00417482|1157941|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
483636|NCT00417482|1157939|P3|COMPLETED|Phase B 1st 16 Weeks||13
483637|NCT00417482|1157940|P2|COMPLETED|Phase B 1st 16 Weeks||27
483638|NCT00417482|1157941|P1|COMPLETED|Phase B 1st 16 Weeks||13
483639|NCT00417482|1157939|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
483640|NCT00417482|1157940|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
483641|NCT00417482|1157941|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
483642|NCT00417417|1157967|P2|NOT COMPLETED|Overall Study||0
483643|NCT00417417|1157968|P1|NOT COMPLETED|Overall Study||0
483644|NCT00417417|1157967|P2|COMPLETED|Overall Study||6
483645|NCT00417417|1157968|P1|COMPLETED|Overall Study||4
483646|NCT00417417|1157967|P2|STARTED|Overall Study||6
483647|NCT00417417|1157968|P1|STARTED|Overall Study||4
483648|NCT00417274|1157976|P1|NOT COMPLETED|Overall Study||0
483649|NCT00417274|1157976|P1|COMPLETED|Overall Study||31
483650|NCT00417274|1157976|P1|STARTED|Overall Study||31
483651|NCT00417248|1157980|P1|NOT COMPLETED|Overall Study||8
483652|NCT00417248|1157980|P1|COMPLETED|Overall Study||0
483653|NCT00417248|1157980|P1|STARTED|Overall Study||8
483654|NCT00417170|1157987|P2|NOT COMPLETED|Overall Study||3
483655|NCT00417170|1157988|P1|NOT COMPLETED|Overall Study||2
483656|NCT00417170|1157987|P2|COMPLETED|Overall Study||22
483657|NCT00417170|1157988|P1|COMPLETED|Overall Study||21
483658|NCT00417170|1157987|P2|Pharmacodynamics Population|Overall Study||23
483659|NCT00417170|1157988|P1|Pharmacodynamics Population|Overall Study||21
483660|NCT00417170|1157987|P2|STARTED|Overall Study||25
483661|NCT00417170|1157988|P1|STARTED|Overall Study|"Started indicates Safety population."|23
483662|NCT00417079|1158004|P2|NOT COMPLETED|Overall Study||273
483663|NCT00417079|1158005|P1|NOT COMPLETED|Overall Study||331
483664|NCT00417079|1158004|P2|COMPLETED|Overall Study|Randomized patients|105
483665|NCT00417079|1158005|P1|COMPLETED|Overall Study|Randomized patients|46
483666|NCT00417079|1158004|P2|STARTED|Overall Study|Randomized patients|378
483667|NCT00417079|1158005|P1|STARTED|Overall Study|Randomized patients|377
483668|NCT00417027|1158028|P3|NOT COMPLETED|Overall Study||5
483669|NCT00417027|1158029|P2|NOT COMPLETED|Overall Study||5
483670|NCT00417027|1158030|P1|NOT COMPLETED|Overall Study||0
483671|NCT00417027|1158028|P3|COMPLETED|Overall Study||54
483672|NCT00417027|1158029|P2|COMPLETED|Overall Study||60
483673|NCT00417027|1158030|P1|COMPLETED|Overall Study||66
483674|NCT00417027|1158028|P3|STARTED|Overall Study||59
483675|NCT00417027|1158029|P2|STARTED|Overall Study||65
483676|NCT00417027|1158030|P1|STARTED|Overall Study||66
483677|NCT00416884|1158056|P1|NOT COMPLETED|Overall Study||1
483678|NCT00416884|1158056|P1|COMPLETED|Overall Study||0
483679|NCT00416884|1158056|P1|STARTED|Overall Study||1
483680|NCT00416793|1158060|P1|NOT COMPLETED|Overall Study||0
483681|NCT00416793|1158060|P1|COMPLETED|Overall Study||9
483682|NCT00416793|1158060|P1|STARTED|Overall Study||9
483683|NCT00416624|1158068|P4|NOT COMPLETED|Overall Study||17
483684|NCT00416624|1158069|P3|NOT COMPLETED|Overall Study||18
483685|NCT00416624|1158070|P2|NOT COMPLETED|Overall Study||27
483686|NCT00416624|1158071|P1|NOT COMPLETED|Overall Study||22
483687|NCT00416624|1158068|P4|COMPLETED|Overall Study||40
483688|NCT00416624|1158069|P3|COMPLETED|Overall Study||40
483689|NCT00416624|1158070|P2|COMPLETED|Overall Study||33
483690|NCT00416624|1158071|P1|COMPLETED|Overall Study||39
483691|NCT00416624|1158068|P4|STARTED|Overall Study||57
483692|NCT00416624|1158069|P3|STARTED|Overall Study||58
483693|NCT00416624|1158070|P2|STARTED|Overall Study||60
483694|NCT00416624|1158071|P1|STARTED|Overall Study||61
483695|NCT00416598|1158125|P1|NOT COMPLETED|Decitabine Maintenance||72
483696|NCT00416598|1158125|P1|COMPLETED|Decitabine Maintenance||62
483697|NCT00416598|1158125|P1|STARTED|Decitabine Maintenance||134
483698|NCT00416598|1158125|P1|NOT COMPLETED|Induction & Intensification||412
483699|NCT00416598|1158125|P1|COMPLETED|Induction & Intensification||134
483700|NCT00416598|1158125|P1|STARTED|Induction & Intensification||546
483701|NCT00416572|1158133|P3|NOT COMPLETED|Overall Study||8
483702|NCT00416572|1158134|P2|NOT COMPLETED|Overall Study||7
483703|NCT00416572|1158135|P1|NOT COMPLETED|Overall Study||13
483704|NCT00416572|1158133|P3|COMPLETED|Overall Study||76
483705|NCT00416572|1158134|P2|COMPLETED|Overall Study||78
483706|NCT00416572|1158135|P1|COMPLETED|Overall Study||70
483707|NCT00416572|1158133|P3|STARTED|Overall Study||84
483708|NCT00416572|1158134|P2|STARTED|Overall Study||85
483709|NCT00416572|1158135|P1|STARTED|Overall Study||83
483710|NCT00416520|1158151|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
483711|NCT00416520|1158152|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
483712|NCT00416520|1158153|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
483713|NCT00416520|1158154|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
483714|NCT00416520|1158151|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
483715|NCT00416520|1158152|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
483716|NCT00416520|1158153|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
483717|NCT00416520|1158154|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
483718|NCT00416520|1158151|P4|STARTED|Placebo-controlled Withdrawal Period||54
483719|NCT00416520|1158152|P3|STARTED|Placebo-controlled Withdrawal Period||50
483720|NCT00416520|1158153|P2|STARTED|Placebo-controlled Withdrawal Period||0
483721|NCT00416520|1158154|P1|STARTED|Placebo-controlled Withdrawal Period||0
483722|NCT00416520|1158151|P4|NOT COMPLETED|Open-label Period||0
483723|NCT00416520|1158152|P3|NOT COMPLETED|Open-label Period||0
483724|NCT00416520|1158153|P2|NOT COMPLETED|Open-label Period||32
483725|NCT00416520|1158154|P1|NOT COMPLETED|Open-label Period||60
483726|NCT00416520|1158151|P4|COMPLETED|Open-label Period||0
483727|NCT00416520|1158152|P3|COMPLETED|Open-label Period||0
483728|NCT00416520|1158153|P2|COMPLETED|Open-label Period||139
483729|NCT00416520|1158154|P1|COMPLETED|Open-label Period||105
483730|NCT00416520|1158151|P4|STARTED|Open-label Period||0
483731|NCT00416520|1158152|P3|STARTED|Open-label Period||0
483732|NCT00416520|1158153|P2|STARTED|Open-label Period||171
483733|NCT00416520|1158154|P1|STARTED|Open-label Period||165
483734|NCT00416494|1158166|P2|NOT COMPLETED|Overall Study||0
483735|NCT00416494|1158167|P1|NOT COMPLETED|Overall Study||0
483736|NCT00416494|1158166|P2|COMPLETED|Overall Study||31
483737|NCT00416494|1158167|P1|COMPLETED|Overall Study||19
483738|NCT00416494|1158166|P2|STARTED|Overall Study||31
483739|NCT00416494|1158167|P1|STARTED|Overall Study||19
483740|NCT00416455|1158183|P2|NOT COMPLETED|Overall Study||8
483741|NCT00416455|1158184|P1|NOT COMPLETED|Overall Study||16
483742|NCT00416455|1158183|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
483743|NCT00416455|1158184|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
483744|NCT00416455|1158183|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
483745|NCT00416455|1158184|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
483746|NCT00416195|1158198|P2|NOT COMPLETED|Overall Study||4
483747|NCT00416195|1158199|P1|NOT COMPLETED|Overall Study||2
483748|NCT00416195|1158198|P2|COMPLETED|Overall Study||34
483749|NCT00416195|1158199|P1|COMPLETED|Overall Study||8
483750|NCT00416195|1158198|P2|STARTED|Overall Study||38
483751|NCT00416195|1158199|P1|STARTED|Overall Study||10
483752|NCT00416182|1158209|P2|NOT COMPLETED|Overall Study||2
483753|NCT00416182|1158210|P1|NOT COMPLETED|Overall Study||3
483754|NCT00416182|1158209|P2|COMPLETED|Overall Study||6
483755|NCT00416182|1158210|P1|COMPLETED|Overall Study||5
483756|NCT00416182|1158209|P2|STARTED|Overall Study||8
483757|NCT00416182|1158210|P1|STARTED|Overall Study||8
483758|NCT00416078|1158224|P2|NOT COMPLETED|Overall Study||8
483759|NCT00416078|1158225|P1|NOT COMPLETED|Overall Study||11
483760|NCT00416078|1158224|P2|COMPLETED|Overall Study||16
483761|NCT00416078|1158225|P1|COMPLETED|Overall Study||18
483762|NCT00416078|1158224|P2|STARTED|Overall Study||24
483763|NCT00416078|1158225|P1|STARTED|Overall Study||29
483764|NCT00415909|1158241|P1|NOT COMPLETED|Overall Study||3
483765|NCT00415909|1158241|P1|COMPLETED|Overall Study||0
483766|NCT00415909|1158241|P1|STARTED|Overall Study||3
483767|NCT00415870|1158247|P2|NOT COMPLETED|Overall Study||7
483768|NCT00415870|1158248|P1|NOT COMPLETED|Overall Study||6
483769|NCT00415870|1158247|P2|COMPLETED|Overall Study||26
483770|NCT00415870|1158248|P1|COMPLETED|Overall Study||26
483771|NCT00415870|1158247|P2|STARTED|Overall Study||33
483772|NCT00415870|1158248|P1|STARTED|Overall Study||32
483773|NCT00415857|1158256|P2|NOT COMPLETED|Overall Study||0
483774|NCT00415857|1158257|P1|NOT COMPLETED|Overall Study||0
483775|NCT00415857|1158256|P2|COMPLETED|Overall Study||3
483776|NCT00415857|1158257|P1|COMPLETED|Overall Study||2
483777|NCT00415857|1158256|P2|STARTED|Overall Study||3
483778|NCT00415857|1158257|P1|STARTED|Overall Study||2
483779|NCT00415623|1158267|P2|NOT COMPLETED|Overall Study||5
483780|NCT00415623|1158268|P1|NOT COMPLETED|Overall Study||5
483781|NCT00415623|1158267|P2|COMPLETED|Overall Study||146
483782|NCT00415623|1158268|P1|COMPLETED|Overall Study||149
483783|NCT00415623|1158267|P2|STARTED|Overall Study||151
483784|NCT00415623|1158268|P1|STARTED|Overall Study||154
483785|NCT00415610|1158295|P3|NOT COMPLETED|Overall Study||5
483786|NCT00415610|1158296|P2|NOT COMPLETED|Overall Study||2
483787|NCT00415610|1158297|P1|NOT COMPLETED|Overall Study||3
483788|NCT00415610|1158295|P3|COMPLETED|Overall Study||17
483789|NCT00415610|1158296|P2|COMPLETED|Overall Study||18
483790|NCT00415610|1158297|P1|COMPLETED|Overall Study||15
483791|NCT00415610|1158295|P3|STARTED|Overall Study||22
483792|NCT00415610|1158296|P2|STARTED|Overall Study||20
483793|NCT00415610|1158297|P1|STARTED|Overall Study||18
483794|NCT00415597|1158311|P1|NOT COMPLETED|Treatment||305
483795|NCT00415597|1158311|P1|COMPLETED|Treatment||160
483796|NCT00415597|1158311|P1|STARTED|Treatment||465
483797|NCT00415597|1158311|P1|NOT COMPLETED|Enrollment||2
483798|NCT00415597|1158311|P1|COMPLETED|Enrollment||465
483799|NCT00415597|1158311|P1|STARTED|Enrollment||467
483800|NCT00415532|1158319|P2|NOT COMPLETED|Safety Follow Up Period||12
483801|NCT00415532|1158320|P1|NOT COMPLETED|Safety Follow Up Period||9
483802|NCT00415532|1158319|P2|COMPLETED|Safety Follow Up Period||18
483803|NCT00415532|1158320|P1|COMPLETED|Safety Follow Up Period||34
483804|NCT00415532|1158319|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
483805|NCT00415532|1158320|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
483806|NCT00415532|1158319|P2|NOT COMPLETED|Treatment Period||15
483807|NCT00415532|1158320|P1|NOT COMPLETED|Treatment Period||17
483808|NCT00415532|1158319|P2|COMPLETED|Treatment Period||142
483810|NCT00415532|1158319|P2|Switched to Romiplostim Group|Treatment Period||0
483811|NCT00415532|1158320|P1|Switched to Romiplostim Group|Treatment Period||2
483812|NCT00415532|1158319|P2|Received Treatment|Treatment Period||154
483813|NCT00415532|1158320|P1|Received Treatment|Treatment Period||75
483814|NCT00415532|1158319|P2|STARTED|Treatment Period||157
483815|NCT00415532|1158320|P1|STARTED|Treatment Period||77
483816|NCT00415506|1158342|P2|NOT COMPLETED|Overall Study||1
483817|NCT00415506|1158343|P1|NOT COMPLETED|Overall Study||3
483818|NCT00415506|1158342|P2|COMPLETED|Overall Study||9
483819|NCT00415506|1158343|P1|COMPLETED|Overall Study||9
483820|NCT00415506|1158342|P2|STARTED|Overall Study||10
483821|NCT00415506|1158343|P1|STARTED|Overall Study||12
483822|NCT00415493|1158353|P2|NOT COMPLETED|Overall Study||0
483823|NCT00415493|1158354|P1|NOT COMPLETED|Overall Study||0
483824|NCT00415493|1158353|P2|COMPLETED|Overall Study||12
483825|NCT00415493|1158354|P1|COMPLETED|Overall Study||12
483826|NCT00415493|1158353|P2|STARTED|Overall Study||12
483827|NCT00415493|1158354|P1|STARTED|Overall Study||12
483828|NCT00415194|1158362|P2|NOT COMPLETED|Overall Study||342
483829|NCT00415194|1158363|P1|NOT COMPLETED|Overall Study||328
483830|NCT00415194|1158362|P2|COMPLETED|Overall Study||55
483831|NCT00415194|1158363|P1|COMPLETED|Overall Study||70
483832|NCT00415194|1158362|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
483833|NCT00415194|1158363|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
483834|NCT00415194|1158362|P2|STARTED|Overall Study||397
483835|NCT00415194|1158363|P1|STARTED|Overall Study||398
483836|NCT00415168|1158379|P1|NOT COMPLETED|Overall Study||52
483837|NCT00415168|1158379|P1|COMPLETED|Overall Study||1
483838|NCT00415168|1158379|P1|Completed Treatment|Overall Study||15
483839|NCT00415168|1158379|P1|STARTED|Overall Study||53
483840|NCT00415051|1158389|P1|NOT COMPLETED|Overall Study||1
483841|NCT00415051|1158389|P1|COMPLETED|Overall Study||19
483842|NCT00415051|1158389|P1|STARTED|Overall Study||20
483843|NCT00414973|1158400|P4|NOT COMPLETED|Overall Study||0
483844|NCT00414973|1158401|P3|NOT COMPLETED|Overall Study||3
483845|NCT00414973|1158402|P2|NOT COMPLETED|Overall Study||10
483846|NCT00414973|1158403|P1|NOT COMPLETED|Overall Study||28
483847|NCT00414973|1158400|P4|COMPLETED|Overall Study||11
483848|NCT00414973|1158401|P3|COMPLETED|Overall Study||21
483849|NCT00414973|1158402|P2|COMPLETED|Overall Study||99
483850|NCT00414973|1158403|P1|COMPLETED|Overall Study||190
483851|NCT00414973|1158400|P4|STARTED|Overall Study||11
483852|NCT00414973|1158401|P3|STARTED|Overall Study||24
483853|NCT00414973|1158402|P2|STARTED|Overall Study||109
483854|NCT00414973|1158403|P1|STARTED|Overall Study||218
483855|NCT00414908|1158423|P2|NOT COMPLETED|Overall Study||1
483856|NCT00414908|1158424|P1|NOT COMPLETED|Overall Study||1
483857|NCT00414908|1158423|P2|COMPLETED|Overall Study||28
483858|NCT00414908|1158424|P1|COMPLETED|Overall Study||24
483859|NCT00414908|1158423|P2|STARTED|Overall Study||29
483860|NCT00414908|1158424|P1|STARTED|Overall Study||25
483861|NCT00414817|1158448|P2|NOT COMPLETED|Overall Study||3016
483862|NCT00414817|1158449|P1|NOT COMPLETED|Overall Study||3130
483863|NCT00414817|1158448|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
483864|NCT00414817|1158449|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
483865|NCT00414817|1158448|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
483866|NCT00414817|1158449|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
483867|NCT00414817|1158448|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
483868|NCT00414817|1158449|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
483869|NCT00414817|1158448|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
483870|NCT00414817|1158449|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
483960|NCT00414453|1158623|P1|STARTED|Overall Study||19
483961|NCT00414440|1158671|P2|NOT COMPLETED|Extension Period||140
483871|NCT00414817|1158448|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
483872|NCT00414817|1158449|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
483873|NCT00414817|1158448|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
483874|NCT00414817|1158449|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
483875|NCT00414817|1158448|P2|STARTED|Overall Study||7031
483876|NCT00414817|1158449|P1|STARTED|Overall Study||7033
483877|NCT00414726|1158461|P2|NOT COMPLETED|Overall Study||1
483878|NCT00414726|1158462|P1|NOT COMPLETED|Overall Study||0
483879|NCT00414726|1158461|P2|COMPLETED|Overall Study||41
483880|NCT00414726|1158462|P1|COMPLETED|Overall Study||43
483881|NCT00414726|1158461|P2|STARTED|Overall Study||42
483882|NCT00414726|1158462|P1|STARTED|Overall Study||43
483883|NCT00414700|1158472|P2|NOT COMPLETED|Overall Study||3
483884|NCT00414700|1158473|P1|NOT COMPLETED|Overall Study||6
483885|NCT00414700|1158472|P2|COMPLETED|Overall Study||58
483886|NCT00414700|1158473|P1|COMPLETED|Overall Study||51
483887|NCT00414700|1158472|P2|STARTED|Overall Study||61
483889|NCT00414661|1158497|P4|NOT COMPLETED|Overall Study||3
483890|NCT00414661|1158498|P3|NOT COMPLETED|Overall Study||2
483891|NCT00414661|1158499|P2|NOT COMPLETED|Overall Study||14
483892|NCT00414661|1158500|P1|NOT COMPLETED|Overall Study||14
483893|NCT00414661|1158497|P4|COMPLETED|Overall Study||0
483894|NCT00414661|1158498|P3|COMPLETED|Overall Study||20
483895|NCT00414661|1158499|P2|COMPLETED|Overall Study||75
483896|NCT00414661|1158500|P1|COMPLETED|Overall Study||34
483897|NCT00414661|1158497|P4|STARTED|Overall Study||3
483898|NCT00414661|1158498|P3|STARTED|Overall Study||22
483899|NCT00414661|1158499|P2|STARTED|Overall Study||89
483900|NCT00414661|1158500|P1|STARTED|Overall Study||48
483901|NCT00414635|1158524|P2|NOT COMPLETED|Overall Study||2
483902|NCT00414635|1158525|P1|NOT COMPLETED|Overall Study||5
483903|NCT00414635|1158524|P2|COMPLETED|Overall Study||28
483904|NCT00414635|1158525|P1|COMPLETED|Overall Study||25
483905|NCT00414635|1158524|P2|STARTED|Overall Study||30
483906|NCT00414635|1158525|P1|STARTED|Overall Study||30
483907|NCT00414609|1158545|P3|NOT COMPLETED|Extension Study||57
483908|NCT00414609|1158546|P2|NOT COMPLETED|Extension Study||0
483909|NCT00414609|1158547|P1|NOT COMPLETED|Extension Study||0
483910|NCT00414609|1158545|P3|COMPLETED|Extension Study||365
483911|NCT00414609|1158546|P2|COMPLETED|Extension Study||0
483912|NCT00414609|1158547|P1|COMPLETED|Extension Study||0
483913|NCT00414609|1158545|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
483914|NCT00414609|1158546|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
483915|NCT00414609|1158547|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
483916|NCT00414609|1158545|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
483917|NCT00414609|1158546|P2|STARTED|Extension Study||0
483918|NCT00414609|1158547|P1|STARTED|Extension Study||0
483919|NCT00414609|1158545|P3|NOT COMPLETED|Core Study||0
483920|NCT00414609|1158546|P2|NOT COMPLETED|Core Study||45
483921|NCT00414609|1158547|P1|NOT COMPLETED|Core Study||34
483922|NCT00414609|1158545|P3|COMPLETED|Core Study||0
483923|NCT00414609|1158546|P2|COMPLETED|Core Study||378
483924|NCT00414609|1158547|P1|COMPLETED|Core Study||363
483925|NCT00414609|1158545|P3|Echocardiogram Evaluable Set|Core Study||0
483926|NCT00414609|1158546|P2|Echocardiogram Evaluable Set|Core Study||343
483927|NCT00414609|1158547|P1|Echocardiogram Evaluable Set|Core Study||330
483928|NCT00414609|1158545|P3|Received Study Drug|Core Study||0
483929|NCT00414609|1158546|P2|Received Study Drug|Core Study||422
483930|NCT00414609|1158547|P1|Received Study Drug|Core Study||397
483931|NCT00414609|1158545|P3|STARTED|Core Study||0
483932|NCT00414609|1158546|P2|STARTED|Core Study||423
483933|NCT00414609|1158547|P1|STARTED|Core Study||397
483934|NCT00414596|1158570|P1|NOT COMPLETED|Overall Study||2
483935|NCT00414596|1158570|P1|COMPLETED|Overall Study|April 2007|18
483936|NCT00414596|1158570|P1|STARTED|Overall Study|December 2006|20
483937|NCT00414544|1158579|P1|NOT COMPLETED|Overall Study||14
483938|NCT00414544|1158579|P1|COMPLETED|Overall Study||131
483939|NCT00414544|1158579|P1|STARTED|Overall Study||145
483940|NCT00414518|1158587|P2|NOT COMPLETED|Overall Study||0
483941|NCT00414518|1158588|P1|NOT COMPLETED|Overall Study||0
483942|NCT00414518|1158587|P2|COMPLETED|Overall Study||9
483943|NCT00414518|1158588|P1|COMPLETED|Overall Study||7
483944|NCT00414518|1158587|P2|STARTED|Overall Study||9
483945|NCT00414518|1158588|P1|STARTED|Overall Study||7
483946|NCT00414466|1158602|P4|NOT COMPLETED|Overall Study||1
483947|NCT00414466|1158603|P3|NOT COMPLETED|Overall Study||1
483948|NCT00414466|1158604|P2|NOT COMPLETED|Overall Study||0
483949|NCT00414466|1158605|P1|NOT COMPLETED|Overall Study||2
483950|NCT00414466|1158602|P4|COMPLETED|Overall Study||42
483951|NCT00414466|1158603|P3|COMPLETED|Overall Study||40
483952|NCT00414466|1158604|P2|COMPLETED|Overall Study||42
483953|NCT00414466|1158605|P1|COMPLETED|Overall Study||42
483954|NCT00414466|1158602|P4|STARTED|Overall Study||43
483955|NCT00414466|1158603|P3|STARTED|Overall Study||41
483956|NCT00414466|1158604|P2|STARTED|Overall Study||42
483957|NCT00414466|1158605|P1|STARTED|Overall Study||44
483958|NCT00414453|1158623|P1|NOT COMPLETED|Overall Study||16
483959|NCT00414453|1158623|P1|COMPLETED|Overall Study||3
483962|NCT00414440|1158672|P1|NOT COMPLETED|Extension Period||150
483963|NCT00414440|1158671|P2|COMPLETED|Extension Period|Extension|77
483964|NCT00414440|1158672|P1|COMPLETED|Extension Period|Extension|64
483965|NCT00414440|1158671|P2|STARTED|Extension Period|Extension|217
483966|NCT00414440|1158672|P1|STARTED|Extension Period|Extension|214
483967|NCT00414440|1158671|P2|NOT COMPLETED|Core Period||32
483968|NCT00414440|1158672|P1|NOT COMPLETED|Core Period||70
483969|NCT00414440|1158671|P2|COMPLETED|Core Period|Core period|185
483970|NCT00414440|1158672|P1|COMPLETED|Core Period|Core period|144
483971|NCT00414440|1158671|P2|STARTED|Core Period|Core period|217
483972|NCT00414440|1158672|P1|STARTED|Core Period|Core period|214
483973|NCT00414388|1158686|P1|NOT COMPLETED|Overall Study||1
483974|NCT00414388|1158686|P1|COMPLETED|Overall Study||21
483975|NCT00414388|1158686|P1|STARTED|Overall Study||22
483976|NCT00414310|1158694|P2|NOT COMPLETED|Overall Study||0
483977|NCT00414310|1158695|P1|NOT COMPLETED|Overall Study||1
483978|NCT00414310|1158694|P2|COMPLETED|Overall Study||79
483979|NCT00414310|1158695|P1|COMPLETED|Overall Study||70
483980|NCT00414310|1158694|P2|STARTED|Overall Study||79
483981|NCT00414310|1158695|P1|STARTED|Overall Study||71
483982|NCT00414206|1158704|P3|NOT COMPLETED|Overall Study||55
483983|NCT00414206|1158705|P2|NOT COMPLETED|Overall Study||56
483984|NCT00414206|1158706|P1|NOT COMPLETED|Overall Study||58
483985|NCT00414206|1158704|P3|COMPLETED|Overall Study||59
483986|NCT00414206|1158705|P2|COMPLETED|Overall Study||58
483987|NCT00414206|1158706|P1|COMPLETED|Overall Study||57
483988|NCT00414206|1158704|P3|STARTED|Overall Study||114
483989|NCT00414206|1158705|P2|STARTED|Overall Study||114
483990|NCT00414206|1158706|P1|STARTED|Overall Study||115
483991|NCT00414167|1158716|P2|NOT COMPLETED|Overall Study||3
483992|NCT00414167|1158717|P1|NOT COMPLETED|Overall Study||4
483993|NCT00414167|1158716|P2|COMPLETED|Overall Study||27
483994|NCT00414167|1158717|P1|COMPLETED|Overall Study||27
483995|NCT00414167|1158716|P2|STARTED|Overall Study||30
483996|NCT00414167|1158717|P1|STARTED|Overall Study||31
483997|NCT00414050|1158729|P4|NOT COMPLETED|Overall Study||8
483998|NCT00414050|1158730|P3|NOT COMPLETED|Overall Study||6
483999|NCT00414050|1158731|P2|NOT COMPLETED|Overall Study||8
484000|NCT00414050|1158732|P1|NOT COMPLETED|Overall Study||9
484001|NCT00414050|1158729|P4|COMPLETED|Overall Study||423
484002|NCT00414050|1158730|P3|COMPLETED|Overall Study||423
484003|NCT00414050|1158731|P2|COMPLETED|Overall Study||419
484004|NCT00414050|1158732|P1|COMPLETED|Overall Study||422
484005|NCT00414050|1158729|P4|Received Vaccination 3|Overall Study||424
484006|NCT00414050|1158730|P3|Received Vaccination 3|Overall Study||425
484007|NCT00414050|1158731|P2|Received Vaccination 3|Overall Study||419
484008|NCT00414050|1158732|P1|Received Vaccination 3|Overall Study||424
484009|NCT00414050|1158729|P4|Received Vaccination 2|Overall Study||425
484010|NCT00414050|1158730|P3|Received Vaccination 2|Overall Study||425
484011|NCT00414050|1158731|P2|Received Vaccination 2|Overall Study||421
484012|NCT00414050|1158732|P1|Received Vaccination 2|Overall Study||425
484013|NCT00414050|1158729|P4|Received Vaccination 1|Overall Study||431
484014|NCT00414050|1158730|P3|Received Vaccination 1|Overall Study||429
484015|NCT00414050|1158731|P2|Received Vaccination 1|Overall Study||426
484016|NCT00414050|1158732|P1|Received Vaccination 1|Overall Study||431
484017|NCT00414050|1158729|P4|STARTED|Overall Study||431
484018|NCT00414050|1158730|P3|STARTED|Overall Study||429
484019|NCT00414050|1158731|P2|STARTED|Overall Study||427
484020|NCT00414050|1158732|P1|STARTED|Overall Study||431
484021|NCT00414011|1158746|P1|NOT COMPLETED|Overall Study||5
484022|NCT00414011|1158746|P1|COMPLETED|Overall Study||35
484023|NCT00414011|1158746|P1|STARTED|Overall Study||40
484024|NCT00413972|1158755|P4|NOT COMPLETED|Overall Study||3
484025|NCT00413972|1158756|P3|NOT COMPLETED|Overall Study||10
484026|NCT00413972|1158757|P2|NOT COMPLETED|Overall Study||8
484027|NCT00413972|1158758|P1|NOT COMPLETED|Overall Study||7
484028|NCT00413972|1158755|P4|COMPLETED|Overall Study||95
484029|NCT00413972|1158756|P3|COMPLETED|Overall Study||88
484030|NCT00413972|1158757|P2|COMPLETED|Overall Study||90
484031|NCT00413972|1158758|P1|COMPLETED|Overall Study||91
484032|NCT00413972|1158755|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
484033|NCT00413972|1158756|P3|STARTED|Overall Study||98
484034|NCT00413972|1158757|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
484035|NCT00413972|1158758|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
484036|NCT00413959|1158768|P1|NOT COMPLETED|Overall Study||1
484037|NCT00413959|1158768|P1|COMPLETED|Overall Study||11
484038|NCT00413959|1158768|P1|STARTED|Overall Study||12
484039|NCT00413920|1158775|P2|NOT COMPLETED|Overall Study||28
484040|NCT00413920|1158776|P1|NOT COMPLETED|Overall Study||28
484041|NCT00413920|1158775|P2|COMPLETED|Overall Study||82
484042|NCT00413920|1158776|P1|COMPLETED|Overall Study||84
484043|NCT00413920|1158775|P2|STARTED|Overall Study||110
484044|NCT00413920|1158776|P1|STARTED|Overall Study||112
484045|NCT00413894|1158791|P1|NOT COMPLETED|Overall Study||80
484046|NCT00413894|1158791|P1|COMPLETED|Overall Study||344
484047|NCT00413894|1158791|P1|STARTED|Overall Study||424
484048|NCT00413660|1158813|P11|NOT COMPLETED|Post Week 12||1
484049|NCT00413660|1158814|P10|NOT COMPLETED|Post Week 12||1
484050|NCT00413660|1158815|P9|NOT COMPLETED|Post Week 12||0
484051|NCT00413660|1158816|P8|NOT COMPLETED|Post Week 12||0
484052|NCT00413660|1158817|P7|NOT COMPLETED|Post Week 12||3
484053|NCT00413660|1158818|P6|NOT COMPLETED|Post Week 12||3
484054|NCT00413660|1158819|P5|NOT COMPLETED|Post Week 12||6
484055|NCT00413660|1158820|P4|NOT COMPLETED|Post Week 12||1
484056|NCT00413660|1158821|P3|NOT COMPLETED|Post Week 12||8
484057|NCT00413660|1158822|P2|NOT COMPLETED|Post Week 12||4
484058|NCT00413660|1158823|P1|NOT COMPLETED|Post Week 12||3
484059|NCT00413660|1158813|P11|COMPLETED|Post Week 12||17
484060|NCT00413660|1158814|P10|COMPLETED|Post Week 12||12
484061|NCT00413660|1158815|P9|COMPLETED|Post Week 12||13
484062|NCT00413660|1158816|P8|COMPLETED|Post Week 12||21
484063|NCT00413660|1158817|P7|COMPLETED|Post Week 12||37
484064|NCT00413660|1158818|P6|COMPLETED|Post Week 12||54
484065|NCT00413660|1158819|P5|COMPLETED|Post Week 12||60
484066|NCT00413660|1158820|P4|COMPLETED|Post Week 12||66
484067|NCT00413660|1158821|P3|COMPLETED|Post Week 12||56
484068|NCT00413660|1158822|P2|COMPLETED|Post Week 12||44
484069|NCT00413660|1158823|P1|COMPLETED|Post Week 12||40
484070|NCT00413660|1158813|P11|STARTED|Post Week 12||18
484071|NCT00413660|1158814|P10|STARTED|Post Week 12||13
484072|NCT00413660|1158815|P9|STARTED|Post Week 12||13
484073|NCT00413660|1158816|P8|STARTED|Post Week 12||21
484074|NCT00413660|1158817|P7|STARTED|Post Week 12||40
484075|NCT00413660|1158818|P6|STARTED|Post Week 12||57
484076|NCT00413660|1158819|P5|STARTED|Post Week 12||66
484077|NCT00413660|1158820|P4|STARTED|Post Week 12||67
484078|NCT00413660|1158821|P3|STARTED|Post Week 12||64
484079|NCT00413660|1158822|P2|STARTED|Post Week 12||48
484080|NCT00413660|1158823|P1|STARTED|Post Week 12||43
484081|NCT00413660|1158813|P11|NOT COMPLETED|Up To Week 12||0
484082|NCT00413660|1158814|P10|NOT COMPLETED|Up To Week 12||0
484083|NCT00413660|1158815|P9|NOT COMPLETED|Up To Week 12||0
484084|NCT00413660|1158816|P8|NOT COMPLETED|Up To Week 12||0
484085|NCT00413660|1158817|P7|NOT COMPLETED|Up To Week 12||11
484086|NCT00413660|1158818|P6|NOT COMPLETED|Up To Week 12||10
484087|NCT00413660|1158819|P5|NOT COMPLETED|Up To Week 12||9
484088|NCT00413660|1158820|P4|NOT COMPLETED|Up To Week 12||8
484089|NCT00413660|1158821|P3|NOT COMPLETED|Up To Week 12||7
484090|NCT00413660|1158822|P2|NOT COMPLETED|Up To Week 12||7
484091|NCT00413660|1158823|P1|NOT COMPLETED|Up To Week 12||7
484092|NCT00413660|1158813|P11|COMPLETED|Up To Week 12||0
484093|NCT00413660|1158814|P10|COMPLETED|Up To Week 12||0
484094|NCT00413660|1158815|P9|COMPLETED|Up To Week 12||0
484095|NCT00413660|1158816|P8|COMPLETED|Up To Week 12||0
484096|NCT00413660|1158817|P7|COMPLETED|Up To Week 12||58
484097|NCT00413660|1158818|P6|COMPLETED|Up To Week 12||70
484098|NCT00413660|1158819|P5|COMPLETED|Up To Week 12||66
484099|NCT00413660|1158820|P4|COMPLETED|Up To Week 12||67
484100|NCT00413660|1158821|P3|COMPLETED|Up To Week 12||64
484101|NCT00413660|1158822|P2|COMPLETED|Up To Week 12||61
484102|NCT00413660|1158823|P1|COMPLETED|Up To Week 12||64
484103|NCT00413660|1158813|P11|Treated|Up To Week 12||0
484104|NCT00413660|1158814|P10|Treated|Up To Week 12||0
484105|NCT00413660|1158815|P9|Treated|Up To Week 12||0
484106|NCT00413660|1158816|P8|Treated|Up To Week 12||0
484107|NCT00413660|1158817|P7|Treated|Up To Week 12||69
484108|NCT00413660|1158818|P6|Treated|Up To Week 12||80
484109|NCT00413660|1158819|P5|Treated|Up To Week 12||75
484110|NCT00413660|1158820|P4|Treated|Up To Week 12||74
484111|NCT00413660|1158821|P3|Treated|Up To Week 12||71
484112|NCT00413660|1158822|P2|Treated|Up To Week 12||68
484113|NCT00413660|1158823|P1|Treated|Up To Week 12||70
484114|NCT00413660|1158813|P11|STARTED|Up To Week 12||0
484115|NCT00413660|1158814|P10|STARTED|Up To Week 12||0
484116|NCT00413660|1158815|P9|STARTED|Up To Week 12||0
484117|NCT00413660|1158816|P8|STARTED|Up To Week 12||0
484118|NCT00413660|1158817|P7|STARTED|Up To Week 12||69
484119|NCT00413660|1158818|P6|STARTED|Up To Week 12||80
484120|NCT00413660|1158819|P5|STARTED|Up To Week 12||75
484121|NCT00413660|1158820|P4|STARTED|Up To Week 12||75
484122|NCT00413660|1158821|P3|STARTED|Up To Week 12||71
484123|NCT00413660|1158822|P2|STARTED|Up To Week 12||68
484124|NCT00413660|1158823|P1|STARTED|Up To Week 12||71
484125|NCT00413634|1159171|P2|NOT COMPLETED|Overall Study||0
484126|NCT00413634|1159172|P1|NOT COMPLETED|Overall Study||0
484127|NCT00413634|1159171|P2|COMPLETED|Overall Study||12
484128|NCT00413634|1159172|P1|COMPLETED|Overall Study||12
484129|NCT00413634|1159171|P2|STARTED|Overall Study||12
484130|NCT00413634|1159172|P1|STARTED|Overall Study||12
484131|NCT00413582|1159210|P2|NOT COMPLETED|Overall Study||0
484132|NCT00413582|1159211|P1|NOT COMPLETED|Overall Study||0
484133|NCT00413582|1159210|P2|COMPLETED|Overall Study|all enrolled completed|55
484134|NCT00413582|1159211|P1|COMPLETED|Overall Study|all enrolled completed|55
484135|NCT00413582|1159210|P2|Completion of Study|Overall Study|all enrolled completed|55
484136|NCT00413582|1159211|P1|Completion of Study|Overall Study|all enrolled completed|55
484137|NCT00413582|1159210|P2|STARTED|Overall Study|all enrolled completed|55
484138|NCT00413582|1159211|P1|STARTED|Overall Study|all enrolled completed|55
484139|NCT00413478|1159219|P1|NOT COMPLETED|Overall Study||0
484140|NCT00413478|1159219|P1|COMPLETED|Overall Study||9
484141|NCT00413478|1159219|P1|STARTED|Overall Study||9
484142|NCT00413413|1159226|P3|NOT COMPLETED|Double-Blind||18
484143|NCT00413413|1159227|P2|NOT COMPLETED|Double-Blind||14
484144|NCT00413413|1159228|P1|NOT COMPLETED|Double-Blind||15
484145|NCT00413413|1159226|P3|COMPLETED|Double-Blind||285
484146|NCT00413413|1159227|P2|COMPLETED|Double-Blind||293
484147|NCT00413413|1159228|P1|COMPLETED|Double-Blind||293
484148|NCT00413413|1159226|P3|STARTED|Double-Blind||303
484149|NCT00413413|1159227|P2|STARTED|Double-Blind||307
484150|NCT00413413|1159228|P1|STARTED|Double-Blind||308
484151|NCT00413413|1159226|P3|NOT COMPLETED|Single-Blind||0
484152|NCT00413413|1159227|P2|NOT COMPLETED|Single-Blind||216
484153|NCT00413413|1159228|P1|NOT COMPLETED|Single-Blind||0
484154|NCT00413413|1159226|P3|COMPLETED|Single-Blind||0
484155|NCT00413413|1159227|P2|COMPLETED|Single-Blind||918
484156|NCT00413413|1159228|P1|COMPLETED|Single-Blind||0
484157|NCT00413413|1159226|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
484158|NCT00413413|1159227|P2|STARTED|Single-Blind||1134
484159|NCT00413413|1159228|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
484160|NCT00413400|1159250|P2|NOT COMPLETED|Overall Study||4
484161|NCT00413400|1159251|P1|NOT COMPLETED|Overall Study||2
484162|NCT00413400|1159250|P2|COMPLETED|Overall Study||12
484163|NCT00413400|1159251|P1|COMPLETED|Overall Study||22
484164|NCT00413400|1159250|P2|3 Month Visit|Overall Study||12
484165|NCT00413400|1159251|P1|3 Month Visit|Overall Study||22
484166|NCT00413400|1159250|P2|STARTED|Overall Study||16
484167|NCT00413400|1159251|P1|STARTED|Overall Study||24
484168|NCT00413374|1159279|P1|NOT COMPLETED|Overall Study||6
484169|NCT00413374|1159279|P1|COMPLETED|Overall Study||34
484170|NCT00413374|1159279|P1|STARTED|Overall Study||40
484171|NCT00413335|1159286|P2|NOT COMPLETED|Overall Study||0
484172|NCT00413335|1159287|P1|NOT COMPLETED|Overall Study||0
484173|NCT00413335|1159286|P2|COMPLETED|Overall Study||9
484174|NCT00413335|1159287|P1|COMPLETED|Overall Study||12
484175|NCT00413335|1159286|P2|STARTED|Overall Study||9
484176|NCT00413335|1159287|P1|STARTED|Overall Study||12
484177|NCT00413283|1159305|P4|NOT COMPLETED|Overall Study||4
484178|NCT00413283|1159306|P3|NOT COMPLETED|Overall Study||2
484179|NCT00413283|1159307|P2|NOT COMPLETED|Overall Study||3
484180|NCT00413283|1159308|P1|NOT COMPLETED|Overall Study||1
484181|NCT00413283|1159305|P4|COMPLETED|Overall Study||13
484182|NCT00413283|1159306|P3|COMPLETED|Overall Study||16
484183|NCT00413283|1159307|P2|COMPLETED|Overall Study||13
484184|NCT00413283|1159308|P1|COMPLETED|Overall Study||11
484185|NCT00413283|1159305|P4|Received Study Drug|Overall Study||16
484186|NCT00413283|1159306|P3|Received Study Drug|Overall Study||18
484187|NCT00413283|1159307|P2|Received Study Drug|Overall Study||16
484188|NCT00413283|1159308|P1|Received Study Drug|Overall Study||12
484189|NCT00413283|1159305|P4|STARTED|Overall Study||17
484190|NCT00413283|1159306|P3|STARTED|Overall Study||18
484191|NCT00413283|1159307|P2|STARTED|Overall Study||16
484192|NCT00413283|1159308|P1|STARTED|Overall Study||12
484193|NCT00413244|1159340|P2|NOT COMPLETED|Overall Study||1
484194|NCT00413244|1159341|P1|NOT COMPLETED|Overall Study||10
484195|NCT00413244|1159340|P2|COMPLETED|Overall Study||19
484196|NCT00413244|1159341|P1|COMPLETED|Overall Study||21
484197|NCT00413244|1159340|P2|STARTED|Overall Study||20
484198|NCT00413244|1159341|P1|STARTED|Overall Study||31
484199|NCT00413231|1159369|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
484200|NCT00413231|1159369|P1|COMPLETED|365-day to 60-month Post Treatment||93
484201|NCT00413231|1159369|P1|STARTED|365-day to 60-month Post Treatment||139
484202|NCT00413231|1159369|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
484203|NCT00413231|1159369|P1|COMPLETED|30-day to 365-day Post Treatment||139
484204|NCT00413231|1159369|P1|STARTED|30-day to 365-day Post Treatment||152
484205|NCT00413231|1159369|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
484206|NCT00413231|1159369|P1|COMPLETED|0 to 30-day Post Treatment||152
484207|NCT00413231|1159369|P1|STARTED|0 to 30-day Post Treatment||160
484208|NCT00413192|1159403|P4|NOT COMPLETED|Overall Study||32
484209|NCT00413192|1159404|P3|NOT COMPLETED|Overall Study||19
484210|NCT00413192|1159405|P2|NOT COMPLETED|Overall Study||40
484211|NCT00413192|1159406|P1|NOT COMPLETED|Overall Study||37
484212|NCT00413192|1159403|P4|COMPLETED|Overall Study||0
484213|NCT00413192|1159404|P3|COMPLETED|Overall Study||0
484214|NCT00413192|1159405|P2|COMPLETED|Overall Study||0
484215|NCT00413192|1159406|P1|COMPLETED|Overall Study||0
484216|NCT00413192|1159403|P4|STARTED|Overall Study||32
484217|NCT00413192|1159404|P3|STARTED|Overall Study||19
484218|NCT00413192|1159405|P2|STARTED|Overall Study||40
484219|NCT00413192|1159406|P1|STARTED|Overall Study||37
484220|NCT00413153|1159446|P2|NOT COMPLETED|Overall Study||1
484221|NCT00413153|1159447|P1|NOT COMPLETED|Overall Study||2
484222|NCT00413153|1159446|P2|COMPLETED|Overall Study||7
484223|NCT00413153|1159447|P1|COMPLETED|Overall Study||5
484224|NCT00413153|1159446|P2|STARTED|Overall Study||8
484225|NCT00413153|1159447|P1|STARTED|Overall Study||7
484226|NCT00413062|1159471|P2|NOT COMPLETED|Overall Study||210
484227|NCT00413062|1159472|P1|NOT COMPLETED|Overall Study||678
484228|NCT00413062|1159471|P2|COMPLETED|Overall Study||344
484229|NCT00413062|1159472|P1|COMPLETED|Overall Study||988
484230|NCT00413062|1159471|P2|STARTED|Overall Study||554
484231|NCT00413062|1159472|P1|STARTED|Overall Study||1666
484232|NCT00413049|1159498|P2|NOT COMPLETED|Overall Study||18
484233|NCT00413049|1159499|P1|NOT COMPLETED|Overall Study||24
484234|NCT00413049|1159498|P2|COMPLETED|Overall Study||331
484235|NCT00413049|1159499|P1|COMPLETED|Overall Study||325
484236|NCT00413049|1159498|P2|STARTED|Overall Study||349
484237|NCT00413049|1159499|P1|STARTED|Overall Study||349
484238|NCT00413036|1159515|P1|NOT COMPLETED|Overall Study||217
484327|NCT00412542|1159767|P2|COMPLETED|Overall Study||42
484239|NCT00413036|1159515|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
484240|NCT00413036|1159515|P1|STARTED|Overall Study||217
484241|NCT00413010|1159525|P2|NOT COMPLETED|Overall Study||63
484242|NCT00413010|1159526|P1|NOT COMPLETED|Overall Study||72
484243|NCT00413010|1159525|P2|COMPLETED|Overall Study||113
484244|NCT00413010|1159526|P1|COMPLETED|Overall Study||108
484245|NCT00413010|1159525|P2|STARTED|Overall Study||176
484246|NCT00413010|1159526|P1|STARTED|Overall Study||180
484247|NCT00412984|1159548|P2|NOT COMPLETED|Overall Study||2493
484248|NCT00412984|1159549|P1|NOT COMPLETED|Overall Study||2310
484249|NCT00412984|1159548|P2|COMPLETED|Overall Study||6588
484250|NCT00412984|1159549|P1|COMPLETED|Overall Study||6810
484251|NCT00412984|1159548|P2|STARTED|Overall Study|Randomized participants|9081
484252|NCT00412984|1159549|P1|STARTED|Overall Study|Randomized participants|9120
484253|NCT00412971|1159593|P2|NOT COMPLETED|Overall Study||10
484254|NCT00412971|1159594|P1|NOT COMPLETED|Overall Study||30
484255|NCT00412971|1159593|P2|COMPLETED|Overall Study||108
484256|NCT00412971|1159594|P1|COMPLETED|Overall Study||85
484257|NCT00412971|1159593|P2|STARTED|Overall Study||118
484258|NCT00412971|1159594|P1|STARTED|Overall Study||115
484259|NCT00412958|1159607|P4|NOT COMPLETED|Overall Study||1
484260|NCT00412958|1159608|P3|NOT COMPLETED|Overall Study||0
484261|NCT00412958|1159609|P2|NOT COMPLETED|Overall Study||4
484262|NCT00412958|1159610|P1|NOT COMPLETED|Overall Study||3
484263|NCT00412958|1159607|P4|COMPLETED|Overall Study||30
484264|NCT00412958|1159608|P3|COMPLETED|Overall Study||32
484265|NCT00412958|1159609|P2|COMPLETED|Overall Study||29
484266|NCT00412958|1159610|P1|COMPLETED|Overall Study||26
484267|NCT00412958|1159607|P4|STARTED|Overall Study||31
484268|NCT00412958|1159608|P3|STARTED|Overall Study||32
484269|NCT00412958|1159609|P2|STARTED|Overall Study||33
484270|NCT00412958|1159610|P1|STARTED|Overall Study||29
484271|NCT00412932|1159620|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
484272|NCT00412932|1159620|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
484273|NCT00412932|1159620|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
484274|NCT00412932|1159620|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
484275|NCT00412932|1159620|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
484276|NCT00412932|1159620|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
484277|NCT00412932|1159620|P1|NOT COMPLETED|Olmesartan 40 mg||8
484278|NCT00412932|1159620|P1|COMPLETED|Olmesartan 40 mg||161
484279|NCT00412932|1159620|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
484280|NCT00412932|1159620|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
484281|NCT00412932|1159620|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
484282|NCT00412932|1159620|P1|STARTED|Olmesartan (Olm) 20 mg||178
484283|NCT00412893|1159631|P2|NOT COMPLETED|Overall Study||144
484284|NCT00412893|1159632|P1|NOT COMPLETED|Overall Study||145
484285|NCT00412893|1159631|P2|COMPLETED|Overall Study|Defined as completed treatment|120
484286|NCT00412893|1159632|P1|COMPLETED|Overall Study|Defined as completed treatment|118
484287|NCT00412893|1159631|P2|Received Treatment|Overall Study||258
484288|NCT00412893|1159632|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
484289|NCT00412893|1159631|P2|STARTED|Overall Study||264
484290|NCT00412893|1159632|P1|STARTED|Overall Study||263
484291|NCT00412867|1159658|P1|NOT COMPLETED|Overall Study||0
484292|NCT00412867|1159658|P1|COMPLETED|Overall Study||58
484293|NCT00412867|1159658|P1|STARTED|Overall Study||58
484294|NCT00412854|1159667|P2|NOT COMPLETED|Overall Study||16
484295|NCT00412854|1159668|P1|NOT COMPLETED|Overall Study||14
484296|NCT00412854|1159667|P2|COMPLETED|Overall Study||314
484297|NCT00412854|1159668|P1|COMPLETED|Overall Study||316
484298|NCT00412854|1159667|P2|STARTED|Overall Study||330
484299|NCT00412854|1159668|P1|STARTED|Overall Study||330
484300|NCT00412841|1159696|P2|NOT COMPLETED|Overall Study||5
484301|NCT00412841|1159697|P1|NOT COMPLETED|Overall Study||10
484302|NCT00412841|1159696|P2|COMPLETED|Overall Study||16
484303|NCT00412841|1159697|P1|COMPLETED|Overall Study||12
484304|NCT00412841|1159696|P2|STARTED|Overall Study||21
484305|NCT00412841|1159697|P1|STARTED|Overall Study||22
484306|NCT00412750|1159708|P3|NOT COMPLETED|Overall Study||23
484307|NCT00412750|1159709|P2|NOT COMPLETED|Overall Study||21
484308|NCT00412750|1159710|P1|NOT COMPLETED|Overall Study||31
484309|NCT00412750|1159708|P3|COMPLETED|Overall Study||31
484310|NCT00412750|1159709|P2|COMPLETED|Overall Study||34
484311|NCT00412750|1159710|P1|COMPLETED|Overall Study||19
484312|NCT00412750|1159708|P3|STARTED|Overall Study||54
484313|NCT00412750|1159709|P2|STARTED|Overall Study||55
484314|NCT00412750|1159710|P1|STARTED|Overall Study||50
484315|NCT00412737|1159735|P2|NOT COMPLETED|Overall Study||6
484316|NCT00412737|1159736|P1|NOT COMPLETED|Overall Study||16
484317|NCT00412737|1159735|P2|COMPLETED|Overall Study||232
484318|NCT00412737|1159736|P1|COMPLETED|Overall Study||221
484319|NCT00412737|1159735|P2|STARTED|Overall Study||238
484320|NCT00412737|1159736|P1|STARTED|Overall Study||237
484321|NCT00412607|1159754|P1|NOT COMPLETED|Overall Study||104
484322|NCT00412607|1159754|P1|COMPLETED|Overall Study||145
484323|NCT00412607|1159754|P1|Started Study Catheter|Overall Study||233
484324|NCT00412607|1159754|P1|STARTED|Overall Study||249
484325|NCT00412542|1159767|P2|NOT COMPLETED|Overall Study||3
484326|NCT00412542|1159768|P1|NOT COMPLETED|Overall Study||0
484328|NCT00412542|1159768|P1|COMPLETED|Overall Study||33
484329|NCT00412542|1159767|P2|STARTED|Overall Study||45
484330|NCT00412542|1159768|P1|STARTED|Overall Study||33
484331|NCT00412529|1159774|P2|NOT COMPLETED|Overall Study||0
484332|NCT00412529|1159775|P1|NOT COMPLETED|Overall Study||0
484333|NCT00412529|1159774|P2|COMPLETED|Overall Study||21
484334|NCT00412529|1159775|P1|COMPLETED|Overall Study||23
484335|NCT00412529|1159774|P2|STARTED|Overall Study||21
484336|NCT00412529|1159775|P1|STARTED|Overall Study||23
484337|NCT00412516|1159798|P3|NOT COMPLETED|Overall Study||0
484338|NCT00412516|1159799|P2|NOT COMPLETED|Overall Study||0
484339|NCT00412516|1159800|P1|NOT COMPLETED|Overall Study||0
484340|NCT00412516|1159798|P3|COMPLETED|Overall Study||214
484341|NCT00412516|1159799|P2|COMPLETED|Overall Study||212
484342|NCT00412516|1159800|P1|COMPLETED|Overall Study||93
484343|NCT00412516|1159798|P3|STARTED|Overall Study||214
484344|NCT00412516|1159799|P2|STARTED|Overall Study||212
484345|NCT00412516|1159800|P1|STARTED|Overall Study||93
484346|NCT00412464|1159817|P1|NOT COMPLETED|Overall Study||0
484347|NCT00412464|1159817|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
484348|NCT00412464|1159817|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
484349|NCT00412451|1159829|P4|NOT COMPLETED|Overall Study||2
484350|NCT00412451|1159830|P3|NOT COMPLETED|Overall Study||1
484351|NCT00412451|1159831|P2|NOT COMPLETED|Overall Study||0
484352|NCT00412451|1159832|P1|NOT COMPLETED|Overall Study||0
484353|NCT00412451|1159829|P4|COMPLETED|Overall Study||11
484354|NCT00412451|1159830|P3|COMPLETED|Overall Study||14
484355|NCT00412451|1159831|P2|COMPLETED|Overall Study||15
484356|NCT00412451|1159832|P1|COMPLETED|Overall Study||8
484357|NCT00412451|1159829|P4|STARTED|Overall Study||13
484358|NCT00412451|1159830|P3|STARTED|Overall Study||15
484359|NCT00412451|1159831|P2|STARTED|Overall Study||15
484360|NCT00412451|1159832|P1|STARTED|Overall Study||8
484361|NCT00412425|1159844|P2|NOT COMPLETED|Overall Study||0
484362|NCT00412425|1159845|P1|NOT COMPLETED|Overall Study||0
484363|NCT00412425|1159844|P2|COMPLETED|Overall Study||15
484364|NCT00412425|1159845|P1|COMPLETED|Overall Study||15
484365|NCT00412425|1159844|P2|STARTED|Overall Study||15
484366|NCT00412425|1159845|P1|STARTED|Overall Study||15
484367|NCT00412373|1159853|P2|NOT COMPLETED|Overall Study||77
484368|NCT00412373|1159854|P1|NOT COMPLETED|Overall Study||41
484369|NCT00412373|1159853|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
484370|NCT00412373|1159854|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
484371|NCT00412373|1159853|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
484372|NCT00412373|1159854|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
484373|NCT00412360|1159896|P2|NOT COMPLETED|Overall Study||3
484374|NCT00412360|1159897|P1|NOT COMPLETED|Overall Study||1
484375|NCT00412360|1159896|P2|COMPLETED|Overall Study||108
484376|NCT00412360|1159897|P1|COMPLETED|Overall Study||112
484377|NCT00412360|1159896|P2|STARTED|Overall Study||111
484378|NCT00412360|1159897|P1|STARTED|Overall Study||113
484379|NCT00412243|1159921|P1|NOT COMPLETED|Overall Study||0
484380|NCT00412243|1159921|P1|COMPLETED|Overall Study||50
484381|NCT00412243|1159921|P1|STARTED|Overall Study||50
484382|NCT00412217|1159927|P2|NOT COMPLETED|Overall Study||48
484383|NCT00412217|1159928|P1|NOT COMPLETED|Overall Study||46
484384|NCT00412217|1159927|P2|COMPLETED|Overall Study||0
484385|NCT00412217|1159928|P1|COMPLETED|Overall Study||0
484386|NCT00412217|1159927|P2|STARTED|Overall Study||48
484387|NCT00412217|1159928|P1|STARTED|Overall Study||46
484388|NCT00412113|1159942|P2|NOT COMPLETED|Overall Study||15
484389|NCT00412113|1159943|P1|NOT COMPLETED|Overall Study||12
484390|NCT00412113|1159942|P2|COMPLETED|Overall Study|15-April-2008|107
484391|NCT00412113|1159943|P1|COMPLETED|Overall Study|15-April-2008|111
484392|NCT00412113|1159942|P2|Received Treatment|Overall Study||122
484393|NCT00412113|1159943|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
484394|NCT00412113|1159942|P2|STARTED|Overall Study|15-January-2007|122
484395|NCT00412113|1159943|P1|STARTED|Overall Study|15-January-2007|123
484396|NCT00412087|1159997|P2|NOT COMPLETED|Overall Study||65
484397|NCT00412087|1159998|P1|NOT COMPLETED|Overall Study||62
484398|NCT00412087|1159997|P2|COMPLETED|Overall Study||66
484399|NCT00412087|1159998|P1|COMPLETED|Overall Study||72
484400|NCT00412087|1159997|P2|STARTED|Overall Study||131
484401|NCT00412087|1159998|P1|STARTED|Overall Study||134
484402|NCT00412074|1160009|P3|NOT COMPLETED|Overall Study||67
484403|NCT00412074|1160010|P2|NOT COMPLETED|Overall Study||22
484404|NCT00412074|1160011|P1|NOT COMPLETED|Overall Study||77
484405|NCT00412074|1160009|P3|COMPLETED|Overall Study||128
484406|NCT00412074|1160010|P2|COMPLETED|Overall Study||44
484407|NCT00412074|1160011|P1|COMPLETED|Overall Study||122
484408|NCT00412074|1160009|P3|STARTED|Overall Study||195
484409|NCT00412074|1160010|P2|STARTED|Overall Study||66
484410|NCT00412074|1160011|P1|STARTED|Overall Study||199
484411|NCT00412061|1160027|P2|NOT COMPLETED|Open Label Phase||170
484412|NCT00412061|1160028|P1|NOT COMPLETED|Open Label Phase||0
484413|NCT00412061|1160027|P2|COMPLETED|Open Label Phase||0
484414|NCT00412061|1160028|P1|COMPLETED|Open Label Phase||0
484415|NCT00412061|1160027|P2|STARTED|Open Label Phase||170
484416|NCT00412061|1160028|P1|STARTED|Open Label Phase||0
484417|NCT00412061|1160027|P2|NOT COMPLETED|Double Blind Phase||213
484418|NCT00412061|1160028|P1|NOT COMPLETED|Double Blind Phase||216
484419|NCT00412061|1160027|P2|COMPLETED|Double Blind Phase||0
484420|NCT00412061|1160028|P1|COMPLETED|Double Blind Phase||0
484421|NCT00412061|1160027|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
484422|NCT00412061|1160028|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
484423|NCT00412061|1160027|P2|STARTED|Double Blind Phase||213
484424|NCT00412061|1160028|P1|STARTED|Double Blind Phase||216
484425|NCT00411788|1160046|P1|NOT COMPLETED|Overall Study||2
484426|NCT00411788|1160046|P1|COMPLETED|Overall Study||9
484427|NCT00411788|1160046|P1|STARTED|Overall Study||11
484428|NCT00411762|1160055|P1|NOT COMPLETED|Overall Study||5
484429|NCT00411762|1160055|P1|COMPLETED|Overall Study||20
484430|NCT00411762|1160055|P1|STARTED|Overall Study||25
484431|NCT00411749|1160062|P2|NOT COMPLETED|Overall Study||0
484432|NCT00411749|1160063|P1|NOT COMPLETED|Overall Study||0
484433|NCT00411749|1160062|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
484434|NCT00411749|1160063|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
484435|NCT00411749|1160062|P2|Vaccinated|Overall Study||25
484436|NCT00411749|1160063|P1|Vaccinated|Overall Study||82
484437|NCT00411749|1160062|P2|STARTED|Overall Study||25
484438|NCT00411749|1160063|P1|STARTED|Overall Study||82
484439|NCT00411671|1160079|P1|NOT COMPLETED|Overall Study||20
484440|NCT00411671|1160079|P1|COMPLETED|Overall Study||85
484441|NCT00411671|1160079|P1|STARTED|Overall Study||105
484442|NCT00411645|1160087|P2|NOT COMPLETED|Overall Study||164
484443|NCT00411645|1160088|P1|NOT COMPLETED|Overall Study||81
484444|NCT00411645|1160087|P2|COMPLETED|Overall Study||290
484445|NCT00411645|1160088|P1|COMPLETED|Overall Study||146
484446|NCT00411645|1160087|P2|STARTED|Overall Study||454
484447|NCT00411645|1160088|P1|STARTED|Overall Study||227
484448|NCT00411619|1160112|P1|NOT COMPLETED|Overall Study||6
484449|NCT00411619|1160112|P1|COMPLETED|Overall Study||22
484450|NCT00411619|1160112|P1|STARTED|Overall Study||28
484451|NCT00411554|1160119|P2|NOT COMPLETED|Overall Study||9
484452|NCT00411554|1160120|P1|NOT COMPLETED|Overall Study||8
484453|NCT00411554|1160119|P2|COMPLETED|Overall Study||147
484454|NCT00411554|1160120|P1|COMPLETED|Overall Study||155
484455|NCT00411554|1160119|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
484456|NCT00411554|1160120|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
484457|NCT00411463|1160132|P2|NOT COMPLETED|Overall Study||3
484458|NCT00411463|1160133|P1|NOT COMPLETED|Overall Study||3
484459|NCT00411463|1160132|P2|COMPLETED|Overall Study||8
484460|NCT00411463|1160133|P1|COMPLETED|Overall Study||11
484461|NCT00411463|1160132|P2|STARTED|Overall Study||11
484462|NCT00411463|1160133|P1|STARTED|Overall Study||14
484463|NCT00411450|1160146|P1|NOT COMPLETED|Overall Study||3
484464|NCT00411450|1160146|P1|COMPLETED|Overall Study|Ended second-line treatment|113
484465|NCT00411450|1160146|P1|Received Treatment|Overall Study||115
484466|NCT00411450|1160146|P1|STARTED|Overall Study||116
484467|NCT00411411|1160174|P2|NOT COMPLETED|Overall Study||0
484468|NCT00411411|1160175|P1|NOT COMPLETED|Overall Study||0
484469|NCT00411411|1160174|P2|COMPLETED|Overall Study||25
484470|NCT00411411|1160175|P1|COMPLETED|Overall Study||24
484471|NCT00411411|1160174|P2|STARTED|Overall Study||25
484472|NCT00411411|1160175|P1|STARTED|Overall Study||24
484473|NCT00411398|1160183|P1|NOT COMPLETED|Overall Study||5
484474|NCT00411398|1160183|P1|COMPLETED|Overall Study||10
484475|NCT00411398|1160183|P1|STARTED|Overall Study||15
484476|NCT00411216|1160189|P2|NOT COMPLETED|Overall Study||2
484477|NCT00411216|1160190|P1|NOT COMPLETED|Overall Study||0
484478|NCT00411216|1160189|P2|COMPLETED|Overall Study||8
484479|NCT00411216|1160190|P1|COMPLETED|Overall Study||13
484480|NCT00411216|1160189|P2|STARTED|Overall Study||10
484481|NCT00411216|1160190|P1|STARTED|Overall Study||13
484482|NCT00411151|1160196|P1|NOT COMPLETED|Overall Study||47
484483|NCT00411151|1160196|P1|COMPLETED|Overall Study||5
484484|NCT00411151|1160196|P1|STARTED|Overall Study||52
484485|NCT00410904|1160208|P2|NOT COMPLETED|Overall Study||0
484486|NCT00410904|1160209|P1|NOT COMPLETED|Overall Study||0
484487|NCT00410904|1160208|P2|COMPLETED|Overall Study||20
484488|NCT00410904|1160209|P1|COMPLETED|Overall Study||40
484489|NCT00410904|1160208|P2|STARTED|Overall Study||20
484490|NCT00410904|1160209|P1|STARTED|Overall Study||40
484491|NCT00410891|1160215|P1|NOT COMPLETED|Overall Study||0
484492|NCT00410891|1160215|P1|COMPLETED|Overall Study||129
484493|NCT00410891|1160215|P1|STARTED|Overall Study||129
484494|NCT00410826|1160221|P2|NOT COMPLETED|Overall Study||4
484495|NCT00410826|1160222|P1|NOT COMPLETED|Overall Study||9
484496|NCT00410826|1160221|P2|COMPLETED|Overall Study||95
484497|NCT00410826|1160222|P1|COMPLETED|Overall Study||96
484498|NCT00410826|1160221|P2|STARTED|Overall Study||99
484499|NCT00410826|1160222|P1|STARTED|Overall Study||105
484500|NCT00410761|1160232|P2|NOT COMPLETED|Overall Study||72
484501|NCT00410761|1160233|P1|NOT COMPLETED|Overall Study||120
484502|NCT00410761|1160232|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
484503|NCT00410761|1160233|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
484504|NCT00410761|1160232|P2|STARTED|Overall Study|randomised patients|100
484505|NCT00410761|1160233|P1|STARTED|Overall Study|randomised patients|231
484506|NCT00410514|1160256|P3|NOT COMPLETED|Overall Study||7
484507|NCT00410514|1160257|P2|NOT COMPLETED|Overall Study||3
484508|NCT00410514|1160258|P1|NOT COMPLETED|Overall Study||2
484509|NCT00410514|1160256|P3|COMPLETED|Overall Study||58
484510|NCT00410514|1160257|P2|COMPLETED|Overall Study||67
484511|NCT00410514|1160258|P1|COMPLETED|Overall Study||63
484512|NCT00410514|1160256|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
484513|NCT00410514|1160257|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
484514|NCT00410514|1160258|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
484515|NCT00410514|1160256|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
484516|NCT00410514|1160257|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
484517|NCT00410514|1160258|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
484518|NCT00410514|1160256|P3|STARTED|Overall Study||65
484519|NCT00410514|1160257|P2|STARTED|Overall Study||70
484520|NCT00410514|1160258|P1|STARTED|Overall Study||65
484521|NCT00410488|1160319|P2|NOT COMPLETED|Overall Study||0
484522|NCT00410488|1160320|P1|NOT COMPLETED|Overall Study||0
484523|NCT00410488|1160319|P2|COMPLETED|Overall Study||34
484524|NCT00410488|1160320|P1|COMPLETED|Overall Study||16
484525|NCT00410488|1160319|P2|STARTED|Overall Study||34
484526|NCT00410488|1160320|P1|STARTED|Overall Study||16
484527|NCT00410410|1160331|P9|NOT COMPLETED|Open-Label Period (OL)||349
484528|NCT00410410|1160332|P8|NOT COMPLETED|Open-Label Period (OL)||0
484529|NCT00410410|1160333|P7|NOT COMPLETED|Open-Label Period (OL)||0
484530|NCT00410410|1160334|P6|NOT COMPLETED|Open-Label Period (OL)||0
484531|NCT00410410|1160335|P5|NOT COMPLETED|Open-Label Period (OL)||0
484532|NCT00410410|1160336|P4|NOT COMPLETED|Open-Label Period (OL)||0
484533|NCT00410410|1160337|P3|NOT COMPLETED|Open-Label Period (OL)||0
484534|NCT00410410|1160338|P2|NOT COMPLETED|Open-Label Period (OL)||0
484535|NCT00410410|1160339|P1|NOT COMPLETED|Open-Label Period (OL)||0
484536|NCT00410410|1160331|P9|COMPLETED|Open-Label Period (OL)||0
484537|NCT00410410|1160332|P8|COMPLETED|Open-Label Period (OL)||0
484538|NCT00410410|1160333|P7|COMPLETED|Open-Label Period (OL)||0
484539|NCT00410410|1160334|P6|COMPLETED|Open-Label Period (OL)||0
484540|NCT00410410|1160335|P5|COMPLETED|Open-Label Period (OL)||0
484541|NCT00410410|1160336|P4|COMPLETED|Open-Label Period (OL)||0
484542|NCT00410410|1160337|P3|COMPLETED|Open-Label Period (OL)||0
484543|NCT00410410|1160338|P2|COMPLETED|Open-Label Period (OL)||0
484544|NCT00410410|1160339|P1|COMPLETED|Open-Label Period (OL)||0
484545|NCT00410410|1160331|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
484546|NCT00410410|1160332|P8|STARTED|Open-Label Period (OL)||0
484547|NCT00410410|1160333|P7|STARTED|Open-Label Period (OL)||0
484548|NCT00410410|1160334|P6|STARTED|Open-Label Period (OL)||0
484549|NCT00410410|1160335|P5|STARTED|Open-Label Period (OL)||0
484550|NCT00410410|1160336|P4|STARTED|Open-Label Period (OL)||0
484551|NCT00410410|1160337|P3|STARTED|Open-Label Period (OL)||0
484552|NCT00410410|1160338|P2|STARTED|Open-Label Period (OL)||0
484553|NCT00410410|1160339|P1|STARTED|Open-Label Period (OL)||0
484554|NCT00410410|1160331|P9|NOT COMPLETED|Maintenance Period (MP)||0
484555|NCT00410410|1160332|P8|NOT COMPLETED|Maintenance Period (MP)||55
484556|NCT00410410|1160333|P7|NOT COMPLETED|Maintenance Period (MP)||50
484557|NCT00410410|1160334|P6|NOT COMPLETED|Maintenance Period (MP)||0
484558|NCT00410410|1160335|P5|NOT COMPLETED|Maintenance Period (MP)||0
484559|NCT00410410|1160336|P4|NOT COMPLETED|Maintenance Period (MP)||0
484560|NCT00410410|1160337|P3|NOT COMPLETED|Maintenance Period (MP)||0
484561|NCT00410410|1160338|P2|NOT COMPLETED|Maintenance Period (MP)||0
484562|NCT00410410|1160339|P1|NOT COMPLETED|Maintenance Period (MP)||0
484563|NCT00410410|1160331|P9|COMPLETED|Maintenance Period (MP)||0
484564|NCT00410410|1160332|P8|COMPLETED|Maintenance Period (MP)||11
484565|NCT00410410|1160333|P7|COMPLETED|Maintenance Period (MP)||15
484566|NCT00410410|1160334|P6|COMPLETED|Maintenance Period (MP)||0
484567|NCT00410410|1160335|P5|COMPLETED|Maintenance Period (MP)||0
484568|NCT00410410|1160336|P4|COMPLETED|Maintenance Period (MP)||0
484569|NCT00410410|1160337|P3|COMPLETED|Maintenance Period (MP)||0
484570|NCT00410410|1160338|P2|COMPLETED|Maintenance Period (MP)||0
484571|NCT00410410|1160339|P1|COMPLETED|Maintenance Period (MP)||0
484572|NCT00410410|1160331|P9|STARTED|Maintenance Period (MP)||0
484573|NCT00410410|1160332|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
484574|NCT00410410|1160333|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
484575|NCT00410410|1160334|P6|STARTED|Maintenance Period (MP)||0
484576|NCT00410410|1160335|P5|STARTED|Maintenance Period (MP)||0
484577|NCT00410410|1160336|P4|STARTED|Maintenance Period (MP)||0
484578|NCT00410410|1160337|P3|STARTED|Maintenance Period (MP)||0
484579|NCT00410410|1160338|P2|STARTED|Maintenance Period (MP)||0
484580|NCT00410410|1160339|P1|STARTED|Maintenance Period (MP)||0
484581|NCT00410410|1160331|P9|NOT COMPLETED|Induction Period (IP)||0
484582|NCT00410410|1160332|P8|NOT COMPLETED|Induction Period (IP)||0
484583|NCT00410410|1160333|P7|NOT COMPLETED|Induction Period (IP)||0
484584|NCT00410410|1160334|P6|NOT COMPLETED|Induction Period (IP)||29
484585|NCT00410410|1160335|P5|NOT COMPLETED|Induction Period (IP)||32
484586|NCT00410410|1160336|P4|NOT COMPLETED|Induction Period (IP)||20
484587|NCT00410410|1160337|P3|NOT COMPLETED|Induction Period (IP)||17
484588|NCT00410410|1160338|P2|NOT COMPLETED|Induction Period (IP)||35
484589|NCT00410410|1160339|P1|NOT COMPLETED|Induction Period (IP)||35
484590|NCT00410410|1160331|P9|COMPLETED|Induction Period (IP)||0
484591|NCT00410410|1160332|P8|COMPLETED|Induction Period (IP)||0
484592|NCT00410410|1160333|P7|COMPLETED|Induction Period (IP)||0
484593|NCT00410410|1160334|P6|COMPLETED|Induction Period (IP)||21
484594|NCT00410410|1160335|P5|COMPLETED|Induction Period (IP)||19
484595|NCT00410410|1160336|P4|COMPLETED|Induction Period (IP)||120
484596|NCT00410410|1160337|P3|COMPLETED|Induction Period (IP)||53
484597|NCT00410410|1160338|P2|COMPLETED|Induction Period (IP)||104
484598|NCT00410410|1160339|P1|COMPLETED|Induction Period (IP)||106
484599|NCT00410410|1160331|P9|STARTED|Induction Period (IP)||0
484600|NCT00410410|1160332|P8|STARTED|Induction Period (IP)||0
484601|NCT00410410|1160333|P7|STARTED|Induction Period (IP)||0
484602|NCT00410410|1160334|P6|STARTED|Induction Period (IP)||50
484603|NCT00410410|1160335|P5|STARTED|Induction Period (IP)||51
484604|NCT00410410|1160336|P4|STARTED|Induction Period (IP)||140
484605|NCT00410410|1160337|P3|STARTED|Induction Period (IP)||70
484606|NCT00410410|1160338|P2|STARTED|Induction Period (IP)||139
484607|NCT00410410|1160339|P1|STARTED|Induction Period (IP)||141
484608|NCT00410384|1160500|P3|NOT COMPLETED|Overall Study||82
484609|NCT00410384|1160501|P2|NOT COMPLETED|Overall Study||72
484610|NCT00410384|1160502|P1|NOT COMPLETED|Overall Study||89
484611|NCT00410384|1160500|P3|COMPLETED|Overall Study||191
484612|NCT00410384|1160501|P2|COMPLETED|Overall Study||199
484613|NCT00410384|1160502|P1|COMPLETED|Overall Study||186
484614|NCT00410384|1160500|P3|STARTED|Overall Study||273
484615|NCT00410384|1160501|P2|STARTED|Overall Study||271
484616|NCT00410384|1160502|P1|STARTED|Overall Study||275
484617|NCT00410280|1160530|P2|NOT COMPLETED|Overall Study||0
484618|NCT00410280|1160531|P1|NOT COMPLETED|Overall Study||0
484619|NCT00410280|1160530|P2|COMPLETED|Overall Study||13
484620|NCT00410280|1160531|P1|COMPLETED|Overall Study||14
484621|NCT00410280|1160530|P2|STARTED|Overall Study||13
484622|NCT00410280|1160531|P1|STARTED|Overall Study||14
484623|NCT00410202|1160575|P3|NOT COMPLETED|Off-treatment Follow up||12
484624|NCT00410202|1160576|P2|NOT COMPLETED|Off-treatment Follow up||8
484625|NCT00410202|1160577|P1|NOT COMPLETED|Off-treatment Follow up||14
484626|NCT00410202|1160575|P3|COMPLETED|Off-treatment Follow up||2
484627|NCT00410202|1160576|P2|COMPLETED|Off-treatment Follow up||0
484628|NCT00410202|1160577|P1|COMPLETED|Off-treatment Follow up||1
484629|NCT00410202|1160575|P3|STARTED|Off-treatment Follow up||14
484630|NCT00410202|1160576|P2|STARTED|Off-treatment Follow up||8
484631|NCT00410202|1160577|P1|STARTED|Off-treatment Follow up||15
484632|NCT00410202|1160575|P3|NOT COMPLETED|On-Treatment||71
484633|NCT00410202|1160576|P2|NOT COMPLETED|On-Treatment||79
484634|NCT00410202|1160577|P1|NOT COMPLETED|On-Treatment||75
484635|NCT00410202|1160575|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
484636|NCT00410202|1160576|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
484637|NCT00410202|1160577|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
484638|NCT00410202|1160575|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
484639|NCT00410202|1160576|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
484640|NCT00410202|1160577|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
484641|NCT00410202|1160575|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
484642|NCT00410202|1160576|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
484643|NCT00410202|1160577|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
484644|NCT00410202|1160575|P3|STARTED|On-Treatment||137
484645|NCT00410202|1160576|P2|STARTED|On-Treatment||140
484646|NCT00410202|1160577|P1|STARTED|On-Treatment||138
484647|NCT00410189|1160657|P1|NOT COMPLETED|Overall Study||0
484648|NCT00410189|1160657|P1|COMPLETED|Overall Study||54
484649|NCT00410189|1160657|P1|STARTED|Overall Study||54
484650|NCT00410163|1160664|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
484651|NCT00410163|1160665|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
484652|NCT00410163|1160664|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
484653|NCT00410163|1160665|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
484654|NCT00410163|1160664|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
484655|NCT00410163|1160665|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
484656|NCT00410163|1160664|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
484657|NCT00410163|1160665|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
484658|NCT00410163|1160664|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
484659|NCT00410163|1160665|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
484660|NCT00410163|1160664|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
484661|NCT00410163|1160665|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
484662|NCT00410150|1160709|P2|NOT COMPLETED|Overall Study||3
484663|NCT00410150|1160710|P1|NOT COMPLETED|Overall Study||2
484664|NCT00410150|1160709|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
484665|NCT00410150|1160710|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
484666|NCT00410150|1160709|P2|STARTED|Overall Study||20
484667|NCT00410150|1160710|P1|STARTED|Overall Study||22
484668|NCT00410124|1160718|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
484669|NCT00410124|1160719|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
484670|NCT00410124|1160718|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
484671|NCT00410124|1160719|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
484672|NCT00410124|1160718|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
484673|NCT00410124|1160719|P1|STARTED|Extension Phase - Open Label (45 Months)||67
484674|NCT00410124|1160718|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
484675|NCT00410124|1160719|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
484676|NCT00410124|1160718|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
484677|NCT00410124|1160719|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
484678|NCT00410124|1160718|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
484679|NCT00410124|1160719|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
484680|NCT00410124|1160718|P2|Ongoing|Core Phase Double Blind (15 Months)||4
484681|NCT00410124|1160719|P1|Ongoing|Core Phase Double Blind (15 Months)||13
484682|NCT00410124|1160718|P2|STARTED|Core Phase Double Blind (15 Months)||139
484683|NCT00410124|1160719|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
484684|NCT00410072|1160750|P2|NOT COMPLETED|After Week 48 to Week 96||11
484685|NCT00410072|1160751|P1|NOT COMPLETED|After Week 48 to Week 96||6
484686|NCT00410072|1160750|P2|COMPLETED|After Week 48 to Week 96||174
484687|NCT00410072|1160751|P1|COMPLETED|After Week 48 to Week 96||170
484688|NCT00410072|1160750|P2|STARTED|After Week 48 to Week 96||185
484689|NCT00410072|1160751|P1|STARTED|After Week 48 to Week 96||176
484690|NCT00410072|1160750|P2|NOT COMPLETED|Day 1 to Week 48||12
484691|NCT00410072|1160751|P1|NOT COMPLETED|Day 1 to Week 48||6
484692|NCT00410072|1160750|P2|COMPLETED|Day 1 to Week 48||185
484693|NCT00410072|1160751|P1|COMPLETED|Day 1 to Week 48||176
484694|NCT00410072|1160750|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
484695|NCT00410072|1160751|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
484696|NCT00410046|1160787|P1|NOT COMPLETED|Overall Study||5
484697|NCT00410046|1160787|P1|COMPLETED|Overall Study||79
484698|NCT00410046|1160787|P1|STARTED|Overall Study||84
484699|NCT00409838|1160818|P2|NOT COMPLETED|Long-term Extension Period||0
484700|NCT00409838|1160819|P1|NOT COMPLETED|Long-term Extension Period||18
484701|NCT00409838|1160818|P2|COMPLETED|Long-term Extension Period||0
484702|NCT00409838|1160819|P1|COMPLETED|Long-term Extension Period||87
484703|NCT00409838|1160818|P2|STARTED|Long-term Extension Period||0
484704|NCT00409838|1160819|P1|STARTED|Long-term Extension Period||105
484705|NCT00409838|1160818|P2|NOT COMPLETED|Short-term Period||5
484706|NCT00409838|1160819|P1|NOT COMPLETED|Short-term Period||3
484707|NCT00409838|1160818|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
484708|NCT00409838|1160819|P1|COMPLETED|Short-term Period||53
484709|NCT00409838|1160818|P2|Treated (Baseline) Population|Short-term Period||57
484710|NCT00409838|1160819|P1|Treated (Baseline) Population|Short-term Period||55
484711|NCT00409838|1160818|P2|STARTED|Short-term Period|Randomized|57
484712|NCT00409838|1160819|P1|STARTED|Short-term Period|Randomized|56
484713|NCT00409825|1160880|P1|NOT COMPLETED|Overall Study||0
484714|NCT00409825|1160880|P1|COMPLETED|Overall Study||61
484715|NCT00409825|1160880|P1|STARTED|Overall Study||61
484716|NCT00409786|1160884|P1|NOT COMPLETED|Overall Study||3
484717|NCT00409786|1160884|P1|COMPLETED|Overall Study||47
484718|NCT00409786|1160884|P1|STARTED|Overall Study||50
484719|NCT00409773|1160893|P5|NOT COMPLETED|Overall Study||10
484720|NCT00409773|1160894|P4|NOT COMPLETED|Overall Study||12
484721|NCT00409773|1160895|P3|NOT COMPLETED|Overall Study||9
484722|NCT00409773|1160896|P2|NOT COMPLETED|Overall Study||7
484723|NCT00409773|1160897|P1|NOT COMPLETED|Overall Study||9
484724|NCT00409773|1160893|P5|COMPLETED|Overall Study||218
484725|NCT00409773|1160894|P4|COMPLETED|Overall Study||216
484726|NCT00409773|1160895|P3|COMPLETED|Overall Study||220
484727|NCT00409773|1160896|P2|COMPLETED|Overall Study||222
484728|NCT00409773|1160897|P1|COMPLETED|Overall Study||220
484729|NCT00409773|1160893|P5|STARTED|Overall Study||228
484730|NCT00409773|1160894|P4|STARTED|Overall Study||228
484731|NCT00409773|1160895|P3|STARTED|Overall Study||229
484732|NCT00409773|1160896|P2|STARTED|Overall Study||229
484733|NCT00409773|1160897|P1|STARTED|Overall Study||229
484734|NCT00409747|1160979|P1|NOT COMPLETED|Overall Study||1
484735|NCT00409747|1160979|P1|COMPLETED|Overall Study||10
484736|NCT00409747|1160979|P1|STARTED|Overall Study||11
484737|NCT00409708|1160986|P2|NOT COMPLETED|Washout||10
484738|NCT00409708|1160987|P1|NOT COMPLETED|Washout||21
484739|NCT00409708|1160986|P2|COMPLETED|Washout||29
484740|NCT00409708|1160987|P1|COMPLETED|Washout||17
484741|NCT00409708|1160986|P2|STARTED|Washout||39
484742|NCT00409708|1160987|P1|STARTED|Washout||38
484743|NCT00409708|1160986|P2|NOT COMPLETED|Treatment||17
484744|NCT00409708|1160987|P1|NOT COMPLETED|Treatment||15
484745|NCT00409708|1160986|P2|COMPLETED|Treatment||39
484746|NCT00409708|1160987|P1|COMPLETED|Treatment||38
484747|NCT00409708|1160986|P2|STARTED|Treatment||56
484748|NCT00409708|1160987|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
484749|NCT00409682|1161008|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
484750|NCT00409682|1161009|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
484751|NCT00409682|1161010|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
484752|NCT00409682|1161008|P3|COMPLETED|EOW Double-blind Maintenance Period||66
484753|NCT00409682|1161009|P2|COMPLETED|EOW Double-blind Maintenance Period||58
484754|NCT00409682|1161010|P1|COMPLETED|EOW Double-blind Maintenance Period||0
484755|NCT00409682|1161008|P3|STARTED|EOW Double-blind Maintenance Period||93
484756|NCT00409682|1161009|P2|STARTED|EOW Double-blind Maintenance Period||95
484757|NCT00409682|1161010|P1|STARTED|EOW Double-blind Maintenance Period||0
484758|NCT00409682|1161008|P3|NOT COMPLETED|Open-label Induction Period||0
484759|NCT00409682|1161009|P2|NOT COMPLETED|Open-label Induction Period||0
484760|NCT00409682|1161010|P1|NOT COMPLETED|Open-label Induction Period||4
484761|NCT00409682|1161008|P3|COMPLETED|Open-label Induction Period||0
484762|NCT00409682|1161009|P2|COMPLETED|Open-label Induction Period||0
484763|NCT00409682|1161010|P1|COMPLETED|Open-label Induction Period||188
484764|NCT00409682|1161008|P3|STARTED|Open-label Induction Period||0
484765|NCT00409682|1161009|P2|STARTED|Open-label Induction Period||0
484766|NCT00409682|1161010|P1|STARTED|Open-label Induction Period||192
484767|NCT00409617|1161027|P1|NOT COMPLETED|Overall Study||160
484768|NCT00409617|1161027|P1|COMPLETED|Overall Study||785
484769|NCT00409617|1161027|P1|STARTED|Overall Study||945
484770|NCT00409578|1161043|P4|NOT COMPLETED|Overall Study||67
484771|NCT00409578|1161044|P3|NOT COMPLETED|Overall Study||54
484772|NCT00409578|1161045|P2|NOT COMPLETED|Overall Study||70
484773|NCT00409578|1161046|P1|NOT COMPLETED|Overall Study||52
484774|NCT00409578|1161043|P4|COMPLETED|Overall Study||214
484775|NCT00409578|1161044|P3|COMPLETED|Overall Study||215
484776|NCT00409578|1161045|P2|COMPLETED|Overall Study||201
484777|NCT00409578|1161046|P1|COMPLETED|Overall Study||228
484778|NCT00409578|1161043|P4|STARTED|Overall Study||281
484779|NCT00409578|1161044|P3|STARTED|Overall Study||269
484780|NCT00409578|1161045|P2|STARTED|Overall Study||271
484781|NCT00409578|1161046|P1|STARTED|Overall Study||280
484782|NCT00409565|1161068|P1|NOT COMPLETED|Overall Study||1
484783|NCT00409565|1161068|P1|COMPLETED|Overall Study||45
484784|NCT00409565|1161068|P1|Overall Response Rate|Overall Study||7
484785|NCT00409565|1161068|P1|STARTED|Overall Study||46
484786|NCT00409539|1161081|P5|NOT COMPLETED|Overall Study||25
484787|NCT00409539|1161082|P4|NOT COMPLETED|Overall Study||12
484788|NCT00409539|1161083|P3|NOT COMPLETED|Overall Study||14
484789|NCT00409539|1161084|P2|NOT COMPLETED|Overall Study||11
484790|NCT00409539|1161085|P1|NOT COMPLETED|Overall Study||11
484791|NCT00409539|1161081|P5|COMPLETED|Overall Study||85
484792|NCT00409539|1161082|P4|COMPLETED|Overall Study||97
484793|NCT00409539|1161083|P3|COMPLETED|Overall Study||95
484794|NCT00409539|1161084|P2|COMPLETED|Overall Study||100
484795|NCT00409539|1161085|P1|COMPLETED|Overall Study||100
484796|NCT00409539|1161081|P5|STARTED|Overall Study||110
484797|NCT00409539|1161082|P4|STARTED|Overall Study||109
484798|NCT00409539|1161083|P3|STARTED|Overall Study||109
484799|NCT00409539|1161084|P2|STARTED|Overall Study||111
484800|NCT00409539|1161085|P1|STARTED|Overall Study||111
484801|NCT00409409|1161104|P2|NOT COMPLETED|Overall Study||4
484802|NCT00409409|1161105|P1|NOT COMPLETED|Overall Study||8
484803|NCT00409409|1161104|P2|COMPLETED|Overall Study||135
484804|NCT00409409|1161105|P1|COMPLETED|Overall Study||131
484805|NCT00409409|1161104|P2|STARTED|Overall Study||139
484806|NCT00409409|1161105|P1|STARTED|Overall Study||139
484807|NCT00409344|1161113|P2|NOT COMPLETED|Overall Study||0
484808|NCT00409344|1161114|P1|NOT COMPLETED|Overall Study||0
484809|NCT00409344|1161113|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
484810|NCT00409344|1161114|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
484811|NCT00409344|1161113|P2|STARTED|Overall Study|No participants enrolled|0
484812|NCT00409344|1161114|P1|STARTED|Overall Study|No participants enrolled|0
484813|NCT00409331|1161132|P1|NOT COMPLETED|Overall Study||1
484814|NCT00409331|1161132|P1|COMPLETED|Overall Study||0
484815|NCT00409331|1161132|P1|STARTED|Overall Study||1
484816|NCT00409292|1161136|P1|NOT COMPLETED|Overall Study||0
484817|NCT00409292|1161136|P1|COMPLETED|Overall Study||33
484818|NCT00409292|1161136|P1|STARTED|Overall Study||33
484819|NCT00409240|1161145|P2|NOT COMPLETED|Overall Study||1
484820|NCT00409240|1161146|P1|NOT COMPLETED|Overall Study||3
484821|NCT00409240|1161145|P2|COMPLETED|Overall Study||49
484822|NCT00409240|1161146|P1|COMPLETED|Overall Study||50
484823|NCT00409240|1161145|P2|STARTED|Overall Study||50
484824|NCT00409240|1161146|P1|STARTED|Overall Study||53
484825|NCT00409188|1161154|P2|NOT COMPLETED|Overall Study||175
484826|NCT00409188|1161155|P1|NOT COMPLETED|Overall Study||383
484827|NCT00409188|1161154|P2|COMPLETED|Overall Study||332
484828|NCT00409188|1161155|P1|COMPLETED|Overall Study||623
484829|NCT00409188|1161154|P2|STARTED|Overall Study||507
484830|NCT00409188|1161155|P1|STARTED|Overall Study||1006
484831|NCT00409175|1161171|P2|NOT COMPLETED|Overall Study||19
484832|NCT00409175|1161172|P1|NOT COMPLETED|Overall Study||18
484833|NCT00409175|1161171|P2|COMPLETED|Overall Study||44
484834|NCT00409175|1161172|P1|COMPLETED|Overall Study||47
484835|NCT00409175|1161171|P2|STARTED|Overall Study||63
484836|NCT00409175|1161172|P1|STARTED|Overall Study||65
484837|NCT00409006|1161198|P2|NOT COMPLETED|Overall Study||12
484838|NCT00409006|1161199|P1|NOT COMPLETED|Overall Study||20
484839|NCT00409006|1161198|P2|COMPLETED|Overall Study||19
484840|NCT00409006|1161199|P1|COMPLETED|Overall Study||19
484841|NCT00409006|1161198|P2|STARTED|Overall Study||31
484842|NCT00409006|1161199|P1|STARTED|Overall Study||39
484843|NCT00408993|1161215|P2|NOT COMPLETED|Overall Study||17
484844|NCT00408993|1161216|P1|NOT COMPLETED|Overall Study||19
484845|NCT00408993|1161215|P2|COMPLETED|Overall Study||92
484846|NCT00408993|1161216|P1|COMPLETED|Overall Study||87
484847|NCT00408993|1161215|P2|STARTED|Overall Study||109
484848|NCT00408993|1161216|P1|STARTED|Overall Study||106
484849|NCT00408928|1161248|P1|NOT COMPLETED|Overall Study||3
484850|NCT00408928|1161248|P1|COMPLETED|Overall Study||8
484851|NCT00408928|1161248|P1|STARTED|Overall Study||11
484852|NCT00408902|1161253|P1|NOT COMPLETED|Overall Study||10
484853|NCT00408902|1161253|P1|COMPLETED|Overall Study||0
484854|NCT00408902|1161253|P1|STARTED|Overall Study||10
484855|NCT00408876|1161262|P4|NOT COMPLETED|Overall Study||35
484856|NCT00408876|1161263|P3|NOT COMPLETED|Overall Study||50
484857|NCT00408876|1161264|P2|NOT COMPLETED|Overall Study||36
484858|NCT00408876|1161265|P1|NOT COMPLETED|Overall Study||16
484859|NCT00408876|1161262|P4|COMPLETED|Overall Study||82
484860|NCT00408876|1161263|P3|COMPLETED|Overall Study||62
484861|NCT00408876|1161264|P2|COMPLETED|Overall Study||80
484862|NCT00408876|1161265|P1|COMPLETED|Overall Study||43
484863|NCT00408876|1161262|P4|STARTED|Overall Study||117
484864|NCT00408876|1161263|P3|STARTED|Overall Study||112
484865|NCT00408876|1161264|P2|STARTED|Overall Study||116
484866|NCT00408876|1161265|P1|STARTED|Overall Study||59
484867|NCT00408694|1161515|P1|NOT COMPLETED|Overall Study||2
484868|NCT00408694|1161515|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
484869|NCT00408694|1161515|P1|STARTED|Overall Study||46
484870|NCT00408681|1161519|P1|NOT COMPLETED|Overall Study||9
484871|NCT00408681|1161519|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
484872|NCT00408681|1161519|P1|STARTED|Overall Study||20
484873|NCT00408629|1161538|P2|NOT COMPLETED|Overall Study||125
484874|NCT00408629|1161539|P1|NOT COMPLETED|Overall Study||97
484875|NCT00408629|1161538|P2|COMPLETED|Overall Study||135
484876|NCT00408629|1161539|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
484877|NCT00408629|1161538|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
484878|NCT00408629|1161539|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
484879|NCT00408499|1161578|P5|NOT COMPLETED|Phase II- MTD Expansion||20
484880|NCT00408499|1161579|P4|NOT COMPLETED|Phase II- MTD Expansion||0
484881|NCT00408499|1161580|P3|NOT COMPLETED|Phase II- MTD Expansion||0
484882|NCT00408499|1161581|P2|NOT COMPLETED|Phase II- MTD Expansion||0
484883|NCT00408499|1161582|P1|NOT COMPLETED|Phase II- MTD Expansion||0
484884|NCT00408499|1161578|P5|COMPLETED|Phase II- MTD Expansion||24
484885|NCT00408499|1161579|P4|COMPLETED|Phase II- MTD Expansion||0
484886|NCT00408499|1161580|P3|COMPLETED|Phase II- MTD Expansion||0
484887|NCT00408499|1161581|P2|COMPLETED|Phase II- MTD Expansion||0
484888|NCT00408499|1161582|P1|COMPLETED|Phase II- MTD Expansion||0
484889|NCT00408499|1161578|P5|STARTED|Phase II- MTD Expansion||44
484890|NCT00408499|1161579|P4|STARTED|Phase II- MTD Expansion||0
484891|NCT00408499|1161580|P3|STARTED|Phase II- MTD Expansion||0
484892|NCT00408499|1161581|P2|STARTED|Phase II- MTD Expansion||0
484893|NCT00408499|1161582|P1|STARTED|Phase II- MTD Expansion||0
484894|NCT00408499|1161578|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
484895|NCT00408499|1161579|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
484896|NCT00408499|1161580|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
484897|NCT00408499|1161581|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
484898|NCT00408499|1161582|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
484899|NCT00408499|1161578|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
484900|NCT00408499|1161579|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
484901|NCT00408499|1161580|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
484902|NCT00408499|1161581|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
484903|NCT00408499|1161582|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
484904|NCT00408499|1161578|P5|STARTED|Phase 1: Dose Levels 1-4||0
484905|NCT00408499|1161579|P4|STARTED|Phase 1: Dose Levels 1-4||6
484906|NCT00408499|1161580|P3|STARTED|Phase 1: Dose Levels 1-4||3
484907|NCT00408499|1161581|P2|STARTED|Phase 1: Dose Levels 1-4||7
484908|NCT00408499|1161582|P1|STARTED|Phase 1: Dose Levels 1-4||4
484909|NCT00408460|1161591|P1|NOT COMPLETED|Overall Study||0
484910|NCT00408460|1161591|P1|COMPLETED|Overall Study||34
484911|NCT00408460|1161591|P1|STARTED|Overall Study||34
484912|NCT00408421|1161599|P3|NOT COMPLETED|Treatment Re-Randomization||5
484913|NCT00408421|1161600|P2|NOT COMPLETED|Treatment Re-Randomization||7
484914|NCT00408421|1161601|P1|NOT COMPLETED|Treatment Re-Randomization||7
484915|NCT00408421|1161599|P3|COMPLETED|Treatment Re-Randomization||38
484916|NCT00408421|1161600|P2|COMPLETED|Treatment Re-Randomization||39
484917|NCT00408421|1161601|P1|COMPLETED|Treatment Re-Randomization||96
484918|NCT00408421|1161599|P3|STARTED|Treatment Re-Randomization||43
484919|NCT00408421|1161600|P2|STARTED|Treatment Re-Randomization||46
484920|NCT00408421|1161601|P1|STARTED|Treatment Re-Randomization||103
484921|NCT00408421|1161599|P3|NOT COMPLETED|Treatment Initial Randomization||0
484922|NCT00408421|1161600|P2|NOT COMPLETED|Treatment Initial Randomization||22
484923|NCT00408421|1161601|P1|NOT COMPLETED|Treatment Initial Randomization||17
484924|NCT00408421|1161599|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
484925|NCT00408421|1161600|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
485097|NCT00406653|1162065|P2|NOT COMPLETED|Induction Period||34
484926|NCT00408421|1161601|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
484927|NCT00408421|1161599|P3|STARTED|Treatment Initial Randomization||0
484928|NCT00408421|1161600|P2|STARTED|Treatment Initial Randomization||111
484929|NCT00408421|1161601|P1|STARTED|Treatment Initial Randomization||120
484930|NCT00408317|1161675|P2|NOT COMPLETED|Second Intervention Period||2
484931|NCT00408317|1161676|P1|NOT COMPLETED|Second Intervention Period||2
484932|NCT00408317|1161675|P2|COMPLETED|Second Intervention Period||14
484933|NCT00408317|1161676|P1|COMPLETED|Second Intervention Period||12
484934|NCT00408317|1161675|P2|STARTED|Second Intervention Period||16
484935|NCT00408317|1161676|P1|STARTED|Second Intervention Period||14
484936|NCT00408317|1161675|P2|NOT COMPLETED|First Intervention Period||1
484937|NCT00408317|1161676|P1|NOT COMPLETED|First Intervention Period||0
484938|NCT00408317|1161675|P2|COMPLETED|First Intervention Period||16
484939|NCT00408317|1161676|P1|COMPLETED|First Intervention Period||14
484940|NCT00408317|1161675|P2|STARTED|First Intervention Period||17
484941|NCT00408317|1161676|P1|STARTED|First Intervention Period||14
484942|NCT00408200|1161690|P2|NOT COMPLETED|Overall Study||0
484943|NCT00408200|1161691|P1|NOT COMPLETED|Overall Study||0
484944|NCT00408200|1161690|P2|COMPLETED|Overall Study||53
484945|NCT00408200|1161691|P1|COMPLETED|Overall Study||57
484946|NCT00408200|1161690|P2|STARTED|Overall Study||53
484947|NCT00408200|1161691|P1|STARTED|Overall Study||57
484948|NCT00408070|1161699|P1|NOT COMPLETED|Overall Study||0
484949|NCT00408070|1161699|P1|COMPLETED|Overall Study||5
484950|NCT00408070|1161699|P1|STARTED|Overall Study||5
484951|NCT00407966|1161703|P1|NOT COMPLETED|Overall Study||0
484952|NCT00407966|1161703|P1|COMPLETED|Overall Study||45
484953|NCT00407966|1161703|P1|CR|Overall Study||30
484954|NCT00407966|1161703|P1|STARTED|Overall Study||45
484955|NCT00407797|1161707|P1|NOT COMPLETED|Overall Study||18
484956|NCT00407797|1161707|P1|COMPLETED|Overall Study||118
484957|NCT00407797|1161707|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
484958|NCT00407797|1161707|P1|STARTED|Overall Study||136
484959|NCT00407745|1161724|P2|NOT COMPLETED|Overall Study||17
484960|NCT00407745|1161725|P1|NOT COMPLETED|Overall Study||19
484961|NCT00407745|1161724|P2|COMPLETED|Overall Study||91
484962|NCT00407745|1161725|P1|COMPLETED|Overall Study||93
484963|NCT00407745|1161724|P2|Treated|Overall Study||107
484964|NCT00407745|1161725|P1|Treated|Overall Study||112
484965|NCT00407745|1161724|P2|STARTED|Overall Study||108
484966|NCT00407745|1161725|P1|STARTED|Overall Study||112
484967|NCT00407654|1161797|P1|NOT COMPLETED|Overall Study||0
484968|NCT00407654|1161797|P1|COMPLETED|Overall Study||75
484969|NCT00407654|1161797|P1|STARTED|Overall Study||75
484970|NCT00407563|1161809|P1|NOT COMPLETED|Overall Study||1
484971|NCT00407563|1161809|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
484972|NCT00407563|1161809|P1|STARTED|Overall Study||48
484973|NCT00407550|1161819|P2|NOT COMPLETED|Overall Study||4
484974|NCT00407550|1161820|P1|NOT COMPLETED|Overall Study||3
484975|NCT00407550|1161819|P2|COMPLETED|Overall Study||5
484976|NCT00407550|1161820|P1|COMPLETED|Overall Study||7
484977|NCT00407550|1161819|P2|STARTED|Overall Study||9
484978|NCT00407550|1161820|P1|STARTED|Overall Study||10
484979|NCT00407537|1161828|P2|NOT COMPLETED|Overall Study||44
484980|NCT00407537|1161829|P1|NOT COMPLETED|Overall Study||93
484981|NCT00407537|1161828|P2|COMPLETED|Overall Study||638
484982|NCT00407537|1161829|P1|COMPLETED|Overall Study||686
484983|NCT00407537|1161828|P2|Eligible for Efficacy Analysis|Overall Study||657
484984|NCT00407537|1161829|P1|Eligible for Efficacy Analysis|Overall Study||760
484985|NCT00407537|1161828|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
484986|NCT00407537|1161829|P1|STARTED|Overall Study||779
484987|NCT00407511|1161877|P1|NOT COMPLETED|Overall Study||22
484988|NCT00407511|1161877|P1|COMPLETED|Overall Study||99
484989|NCT00407511|1161877|P1|STARTED|Overall Study||121
484990|NCT00407485|1161891|P1|NOT COMPLETED|Overall Study||0
484991|NCT00407485|1161891|P1|COMPLETED|Overall Study||22
484992|NCT00407485|1161891|P1|STARTED|Overall Study||22
484993|NCT00407381|1161899|P3|NOT COMPLETED|Overall Study||2
484994|NCT00407381|1161900|P2|NOT COMPLETED|Overall Study||4
484995|NCT00407381|1161901|P1|NOT COMPLETED|Overall Study||3
484996|NCT00407381|1161899|P3|COMPLETED|Overall Study||40
484997|NCT00407381|1161900|P2|COMPLETED|Overall Study||38
484998|NCT00407381|1161901|P1|COMPLETED|Overall Study||39
484999|NCT00407381|1161899|P3|STARTED|Overall Study||42
485000|NCT00407381|1161900|P2|STARTED|Overall Study||42
485001|NCT00407381|1161901|P1|STARTED|Overall Study||42
485002|NCT00407355|1161911|P2|NOT COMPLETED|Overall Study||11
485003|NCT00407355|1161912|P1|NOT COMPLETED|Overall Study||10
485004|NCT00407355|1161911|P2|COMPLETED|Overall Study||9
485005|NCT00407355|1161912|P1|COMPLETED|Overall Study||10
485006|NCT00407355|1161911|P2|STARTED|Overall Study||20
485007|NCT00407355|1161912|P1|STARTED|Overall Study||20
485008|NCT00407030|1161923|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
485009|NCT00407030|1161924|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
485010|NCT00407030|1161925|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
485011|NCT00407030|1161923|P3|COMPLETED|Extension Period - up to 68 Weeks||0
485012|NCT00407030|1161924|P2|COMPLETED|Extension Period - up to 68 Weeks||74
485013|NCT00407030|1161925|P1|COMPLETED|Extension Period - up to 68 Weeks||84
485098|NCT00406653|1162066|P1|NOT COMPLETED|Induction Period||15
485014|NCT00407030|1161923|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
485015|NCT00407030|1161924|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
485016|NCT00407030|1161925|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
485017|NCT00407030|1161923|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
485018|NCT00407030|1161924|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
485019|NCT00407030|1161925|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
485020|NCT00407030|1161923|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
485021|NCT00407030|1161924|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
485022|NCT00407030|1161925|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
485023|NCT00407030|1161923|P3|STARTED|Main Period - 8 to 20 Weeks||74
485024|NCT00407030|1161924|P2|STARTED|Main Period - 8 to 20 Weeks||78
485025|NCT00407030|1161925|P1|STARTED|Main Period - 8 to 20 Weeks||81
485026|NCT00406848|1161953|P2|NOT COMPLETED|Overall Study||54
485027|NCT00406848|1161954|P1|NOT COMPLETED|Overall Study||93
485028|NCT00406848|1161953|P2|COMPLETED|Overall Study||67
485029|NCT00406848|1161954|P1|COMPLETED|Overall Study||156
485030|NCT00406848|1161953|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
485031|NCT00406848|1161954|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
485032|NCT00406783|1162018|P2|NOT COMPLETED|Overall Study||15
485033|NCT00406783|1162019|P1|NOT COMPLETED|Overall Study||14
485034|NCT00406783|1162018|P2|COMPLETED|Overall Study||256
485035|NCT00406783|1162019|P1|COMPLETED|Overall Study||262
485036|NCT00406783|1162018|P2|STARTED|Overall Study||271
485037|NCT00406783|1162019|P1|STARTED|Overall Study||276
485038|NCT00406718|1162034|P3|NOT COMPLETED|Overall Study||8
485039|NCT00406718|1162035|P2|NOT COMPLETED|Overall Study||14
485040|NCT00406718|1162036|P1|NOT COMPLETED|Overall Study||4
485041|NCT00406718|1162034|P3|COMPLETED|Overall Study||39
485042|NCT00406718|1162035|P2|COMPLETED|Overall Study||34
485043|NCT00406718|1162036|P1|COMPLETED|Overall Study||43
485044|NCT00406718|1162034|P3|STARTED|Overall Study||47
485045|NCT00406718|1162035|P2|STARTED|Overall Study||48
485046|NCT00406718|1162036|P1|STARTED|Overall Study||47
485047|NCT00406692|1162050|P1|NOT COMPLETED|Overall Study||7
485048|NCT00406692|1162050|P1|COMPLETED|Overall Study||9
485049|NCT00406692|1162050|P1|STARTED|Overall Study||16
485050|NCT00406653|1162060|P7|NOT COMPLETED|Open-Label Period||324
485051|NCT00406653|1162061|P6|NOT COMPLETED|Open-Label Period||0
485052|NCT00406653|1162062|P5|NOT COMPLETED|Open-Label Period||0
485053|NCT00406653|1162063|P4|NOT COMPLETED|Open-Label Period||0
485054|NCT00406653|1162064|P3|NOT COMPLETED|Open-Label Period||0
485055|NCT00406653|1162065|P2|NOT COMPLETED|Open-Label Period||0
485056|NCT00406653|1162066|P1|NOT COMPLETED|Open-Label Period||0
485057|NCT00406653|1162060|P7|COMPLETED|Open-Label Period||0
485058|NCT00406653|1162061|P6|COMPLETED|Open-Label Period||0
485059|NCT00406653|1162062|P5|COMPLETED|Open-Label Period||0
485060|NCT00406653|1162063|P4|COMPLETED|Open-Label Period||0
485061|NCT00406653|1162064|P3|COMPLETED|Open-Label Period||0
485062|NCT00406653|1162065|P2|COMPLETED|Open-Label Period||0
485063|NCT00406653|1162066|P1|COMPLETED|Open-Label Period||0
485064|NCT00406653|1162060|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
485065|NCT00406653|1162061|P6|STARTED|Open-Label Period||0
485066|NCT00406653|1162062|P5|STARTED|Open-Label Period||0
485067|NCT00406653|1162063|P4|STARTED|Open-Label Period||0
485068|NCT00406653|1162064|P3|STARTED|Open-Label Period||0
485069|NCT00406653|1162065|P2|STARTED|Open-Label Period||0
485070|NCT00406653|1162066|P1|STARTED|Open-Label Period||0
485071|NCT00406653|1162060|P7|NOT COMPLETED|Maintenance Period||0
485072|NCT00406653|1162061|P6|NOT COMPLETED|Maintenance Period||36
485073|NCT00406653|1162062|P5|NOT COMPLETED|Maintenance Period||30
485074|NCT00406653|1162063|P4|NOT COMPLETED|Maintenance Period||0
485075|NCT00406653|1162064|P3|NOT COMPLETED|Maintenance Period||0
485076|NCT00406653|1162065|P2|NOT COMPLETED|Maintenance Period||0
485077|NCT00406653|1162066|P1|NOT COMPLETED|Maintenance Period||0
485078|NCT00406653|1162060|P7|COMPLETED|Maintenance Period||0
485079|NCT00406653|1162061|P6|COMPLETED|Maintenance Period||10
485080|NCT00406653|1162062|P5|COMPLETED|Maintenance Period||14
485081|NCT00406653|1162063|P4|COMPLETED|Maintenance Period||0
485082|NCT00406653|1162064|P3|COMPLETED|Maintenance Period||0
485083|NCT00406653|1162065|P2|COMPLETED|Maintenance Period||0
485084|NCT00406653|1162066|P1|COMPLETED|Maintenance Period||0
485085|NCT00406653|1162060|P7|STARTED|Maintenance Period||0
485086|NCT00406653|1162061|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
485087|NCT00406653|1162062|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
485088|NCT00406653|1162063|P4|STARTED|Maintenance Period||0
485089|NCT00406653|1162064|P3|STARTED|Maintenance Period||0
485090|NCT00406653|1162065|P2|STARTED|Maintenance Period||0
485091|NCT00406653|1162066|P1|STARTED|Maintenance Period||0
485092|NCT00406653|1162060|P7|NOT COMPLETED|Induction Period||0
485093|NCT00406653|1162061|P6|NOT COMPLETED|Induction Period||0
485094|NCT00406653|1162062|P5|NOT COMPLETED|Induction Period||0
485095|NCT00406653|1162063|P4|NOT COMPLETED|Induction Period||26
485096|NCT00406653|1162064|P3|NOT COMPLETED|Induction Period||18
485099|NCT00406653|1162060|P7|COMPLETED|Induction Period||0
485100|NCT00406653|1162061|P6|COMPLETED|Induction Period||0
485101|NCT00406653|1162062|P5|COMPLETED|Induction Period||0
485102|NCT00406653|1162063|P4|COMPLETED|Induction Period||102
485103|NCT00406653|1162064|P3|COMPLETED|Induction Period||112
485104|NCT00406653|1162065|P2|COMPLETED|Induction Period||94
485105|NCT00406653|1162066|P1|COMPLETED|Induction Period||50
485106|NCT00406653|1162060|P7|STARTED|Induction Period||0
485107|NCT00406653|1162061|P6|STARTED|Induction Period||0
485108|NCT00406653|1162062|P5|STARTED|Induction Period||0
485109|NCT00406653|1162063|P4|STARTED|Induction Period||128
485110|NCT00406653|1162064|P3|STARTED|Induction Period||130
485111|NCT00406653|1162065|P2|STARTED|Induction Period||128
485112|NCT00406653|1162066|P1|STARTED|Induction Period||65
485113|NCT00406640|1162147|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
485114|NCT00406640|1162148|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
485115|NCT00406640|1162147|P2|COMPLETED|OL Extension Phase for Non-Responders||36
485116|NCT00406640|1162148|P1|COMPLETED|OL Extension Phase for Non-Responders||47
485117|NCT00406640|1162147|P2|STARTED|OL Extension Phase for Non-Responders||60
485118|NCT00406640|1162148|P1|STARTED|OL Extension Phase for Non-Responders||69
485119|NCT00406640|1162147|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
485120|NCT00406640|1162148|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
485121|NCT00406640|1162147|P2|COMPLETED|DB Continuation Phase for Responders||151
485122|NCT00406640|1162148|P1|COMPLETED|DB Continuation Phase for Responders||139
485123|NCT00406640|1162147|P2|STARTED|DB Continuation Phase for Responders||188
485124|NCT00406640|1162148|P1|STARTED|DB Continuation Phase for Responders||172
485125|NCT00406640|1162147|P2|NOT COMPLETED|Acute Phase||43
485126|NCT00406640|1162148|P1|NOT COMPLETED|Acute Phase||51
485127|NCT00406640|1162147|P2|COMPLETED|Acute Phase||256
485128|NCT00406640|1162148|P1|COMPLETED|Acute Phase||245
485129|NCT00406640|1162147|P2|STARTED|Acute Phase||299
485130|NCT00406640|1162148|P1|STARTED|Acute Phase||296
485131|NCT00406393|1162180|P2|NOT COMPLETED|Overall Study||1
485132|NCT00406393|1162181|P1|NOT COMPLETED|Overall Study||2
485133|NCT00406393|1162180|P2|COMPLETED|Overall Study||152
485134|NCT00406393|1162181|P1|COMPLETED|Overall Study||149
485135|NCT00406393|1162180|P2|STARTED|Overall Study||153
485136|NCT00406393|1162181|P1|STARTED|Overall Study||151
485137|NCT00406367|1162211|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
485138|NCT00406367|1162212|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
485139|NCT00406367|1162211|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
485140|NCT00406367|1162212|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
485141|NCT00406367|1162211|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
485142|NCT00406367|1162212|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
485143|NCT00406367|1162211|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
485144|NCT00406367|1162212|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
485145|NCT00406367|1162211|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
485146|NCT00406367|1162212|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
485147|NCT00406367|1162211|P2|STARTED|Main Period - 6 to 20 Weeks||34
485148|NCT00406367|1162212|P1|STARTED|Main Period - 6 to 20 Weeks||75
485149|NCT00406354|1162227|P3|NOT COMPLETED|All Randomized and Treated Patients||22
485150|NCT00406354|1162228|P2|NOT COMPLETED|All Randomized and Treated Patients||13
485151|NCT00406354|1162229|P1|NOT COMPLETED|All Randomized and Treated Patients||16
485152|NCT00406354|1162227|P3|COMPLETED|All Randomized and Treated Patients||37
485153|NCT00406354|1162228|P2|COMPLETED|All Randomized and Treated Patients||48
485154|NCT00406354|1162229|P1|COMPLETED|All Randomized and Treated Patients||44
485155|NCT00406354|1162227|P3|STARTED|All Randomized and Treated Patients||59
485156|NCT00406354|1162228|P2|STARTED|All Randomized and Treated Patients||61
485157|NCT00406354|1162229|P1|STARTED|All Randomized and Treated Patients||60
485158|NCT00406354|1162227|P3|NOT COMPLETED|All Randomized Patients||1
485159|NCT00406354|1162228|P2|NOT COMPLETED|All Randomized Patients||0
485160|NCT00406354|1162229|P1|NOT COMPLETED|All Randomized Patients||0
485161|NCT00406354|1162227|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
485162|NCT00406354|1162228|P2|COMPLETED|All Randomized Patients||61
485163|NCT00406354|1162229|P1|COMPLETED|All Randomized Patients||60
485164|NCT00406354|1162227|P3|STARTED|All Randomized Patients||60
485165|NCT00406354|1162228|P2|STARTED|All Randomized Patients||61
485166|NCT00406354|1162229|P1|STARTED|All Randomized Patients||60
485167|NCT00406315|1162300|P1|NOT COMPLETED|Overall Study||141
485168|NCT00406315|1162300|P1|COMPLETED|Overall Study||100
485169|NCT00406315|1162300|P1|STARTED|Overall Study|Started = Treated|241
485170|NCT00406276|1162318|P1|NOT COMPLETED|Overall Study||4
485171|NCT00406276|1162318|P1|COMPLETED|Overall Study||24
485172|NCT00406276|1162318|P1|STARTED|Overall Study||28
485173|NCT00405067|1162326|P3|NOT COMPLETED|Overall Study||5
485174|NCT00405067|1162327|P2|NOT COMPLETED|Overall Study||9
485175|NCT00405067|1162328|P1|NOT COMPLETED|Overall Study||4
485176|NCT00405067|1162326|P3|COMPLETED|Overall Study||24
485177|NCT00405067|1162327|P2|COMPLETED|Overall Study||19
485178|NCT00405067|1162328|P1|COMPLETED|Overall Study||24
485179|NCT00405067|1162326|P3|STARTED|Overall Study||29
485180|NCT00405067|1162327|P2|STARTED|Overall Study||28
485181|NCT00405067|1162328|P1|STARTED|Overall Study||28
485182|NCT00406133|1162367|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
485183|NCT00406133|1162368|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
485184|NCT00406133|1162369|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
485185|NCT00406133|1162370|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
485186|NCT00406133|1162367|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
485187|NCT00406133|1162368|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
485188|NCT00406133|1162369|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
485189|NCT00406133|1162370|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
485190|NCT00406133|1162367|P4|STARTED|Phase 2 (Second 26 Week Period)||60
485191|NCT00406133|1162368|P3|STARTED|Phase 2 (Second 26 Week Period)||67
485192|NCT00406133|1162369|P2|STARTED|Phase 2 (Second 26 Week Period)||155
485193|NCT00406133|1162370|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
485194|NCT00406133|1162367|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
485195|NCT00406133|1162368|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
485196|NCT00406133|1162369|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
485197|NCT00406133|1162370|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
485198|NCT00406133|1162367|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
485199|NCT00406133|1162368|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
485200|NCT00406133|1162369|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
485201|NCT00406133|1162370|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
485202|NCT00406133|1162367|P4|STARTED|Phase 1 (First 26 Week Period)||62
485203|NCT00406133|1162368|P3|STARTED|Phase 1 (First 26 Week Period)||67
485204|NCT00406133|1162369|P2|STARTED|Phase 1 (First 26 Week Period)||157
485205|NCT00406133|1162370|P1|STARTED|Phase 1 (First 26 Week Period)||165
485206|NCT00406107|1162434|P2|NOT COMPLETED|Overall Study||1
485207|NCT00406107|1162435|P1|NOT COMPLETED|Overall Study||1
485208|NCT00406107|1162434|P2|COMPLETED|Overall Study||4
485209|NCT00406107|1162435|P1|COMPLETED|Overall Study||14
485210|NCT00406107|1162434|P2|STARTED|Overall Study||5
485211|NCT00406107|1162435|P1|STARTED|Overall Study||15
485212|NCT00406029|1162450|P5|NOT COMPLETED|Overall Study||8
485213|NCT00406029|1162451|P4|NOT COMPLETED|Overall Study||17
485214|NCT00406029|1162452|P3|NOT COMPLETED|Overall Study||10
485215|NCT00406029|1162453|P2|NOT COMPLETED|Overall Study||8
485216|NCT00406029|1162454|P1|NOT COMPLETED|Overall Study||16
485217|NCT00406029|1162450|P5|COMPLETED|Overall Study||41
485218|NCT00406029|1162451|P4|COMPLETED|Overall Study||40
485219|NCT00406029|1162452|P3|COMPLETED|Overall Study||39
485220|NCT00406029|1162453|P2|COMPLETED|Overall Study||41
485221|NCT00406029|1162454|P1|COMPLETED|Overall Study||33
485222|NCT00406029|1162450|P5|Treated|Overall Study||47
485223|NCT00406029|1162451|P4|Treated|Overall Study||54
485224|NCT00406029|1162452|P3|Treated|Overall Study||47
485225|NCT00406029|1162453|P2|Treated|Overall Study||49
485226|NCT00406029|1162454|P1|Treated|Overall Study||49
485227|NCT00406029|1162450|P5|STARTED|Overall Study||49
485228|NCT00406029|1162451|P4|STARTED|Overall Study||57
485229|NCT00406029|1162452|P3|STARTED|Overall Study||49
485230|NCT00406029|1162453|P2|STARTED|Overall Study||49
485231|NCT00406029|1162454|P1|STARTED|Overall Study||49
485232|NCT00405964|1162558|P2|NOT COMPLETED|Overall Study||95
485233|NCT00405964|1162559|P1|NOT COMPLETED|Overall Study||59
485234|NCT00405964|1162558|P2|COMPLETED|Overall Study||261
485235|NCT00405964|1162559|P1|COMPLETED|Overall Study||301
485236|NCT00405964|1162558|P2|STARTED|Overall Study||356
485237|NCT00405964|1162559|P1|STARTED|Overall Study||360
485238|NCT00405938|1162571|P2|NOT COMPLETED|Overall Study||0
485239|NCT00405938|1162572|P1|NOT COMPLETED|Overall Study||0
485240|NCT00405938|1162571|P2|COMPLETED|Overall Study||41
485241|NCT00405938|1162572|P1|COMPLETED|Overall Study||38
485242|NCT00405938|1162571|P2|STARTED|Overall Study||41
485243|NCT00405938|1162572|P1|STARTED|Overall Study||38
485244|NCT00405912|1162581|P3|NOT COMPLETED|Overall Study||16
485245|NCT00405912|1162582|P2|NOT COMPLETED|Overall Study||19
485246|NCT00405912|1162583|P1|NOT COMPLETED|Overall Study||16
485247|NCT00405912|1162581|P3|COMPLETED|Overall Study||23
485248|NCT00405912|1162582|P2|COMPLETED|Overall Study||21
485249|NCT00405912|1162583|P1|COMPLETED|Overall Study||23
485250|NCT00405912|1162581|P3|STARTED|Overall Study||39
485251|NCT00405912|1162582|P2|STARTED|Overall Study||40
485252|NCT00405912|1162583|P1|STARTED|Overall Study||39
485253|NCT00405821|1162596|P2|NOT COMPLETED|Overall Study||22
485254|NCT00405821|1162597|P1|NOT COMPLETED|Overall Study||22
485255|NCT00405821|1162596|P2|COMPLETED|Overall Study||198
485256|NCT00405821|1162597|P1|COMPLETED|Overall Study||198
485257|NCT00405821|1162596|P2|STARTED|Overall Study||220
485258|NCT00405821|1162597|P1|STARTED|Overall Study||220
485259|NCT00405756|1162610|P3|NOT COMPLETED|Follow-up||88
485260|NCT00405756|1162611|P2|NOT COMPLETED|Follow-up||90
485261|NCT00405756|1162612|P1|NOT COMPLETED|Follow-up||75
485262|NCT00405756|1162610|P3|COMPLETED|Follow-up||0
485263|NCT00405756|1162611|P2|COMPLETED|Follow-up||0
485264|NCT00405756|1162612|P1|COMPLETED|Follow-up||0
485265|NCT00405756|1162610|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
485266|NCT00405756|1162611|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
485267|NCT00405756|1162612|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
485268|NCT00405756|1162610|P3|NOT COMPLETED|Open-label Extension||72
485269|NCT00405756|1162611|P2|NOT COMPLETED|Open-label Extension||47
485270|NCT00405756|1162612|P1|NOT COMPLETED|Open-label Extension||19
485271|NCT00405756|1162610|P3|COMPLETED|Open-label Extension||0
485272|NCT00405756|1162611|P2|COMPLETED|Open-label Extension||0
485273|NCT00405756|1162612|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
485274|NCT00405756|1162610|P3|STARTED|Open-label Extension||72
485275|NCT00405756|1162611|P2|STARTED|Open-label Extension||47
485276|NCT00405756|1162612|P1|STARTED|Open-label Extension||19
485277|NCT00405756|1162610|P3|NOT COMPLETED|Double-blind Treatment||154
485278|NCT00405756|1162611|P2|NOT COMPLETED|Double-blind Treatment||153
485279|NCT00405756|1162612|P1|NOT COMPLETED|Double-blind Treatment||152
485280|NCT00405756|1162610|P3|COMPLETED|Double-blind Treatment||0
485281|NCT00405756|1162611|P2|COMPLETED|Double-blind Treatment||0
485282|NCT00405756|1162612|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
485283|NCT00405756|1162610|P3|Safety Population|Double-blind Treatment||153
485284|NCT00405756|1162611|P2|Safety Population|Double-blind Treatment||152
485285|NCT00405756|1162612|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
485286|NCT00405756|1162610|P3|STARTED|Double-blind Treatment||154
485287|NCT00405756|1162611|P2|STARTED|Double-blind Treatment||153
485288|NCT00405756|1162612|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
485289|NCT00405704|1162702|P2|NOT COMPLETED|Overall Study||46
485290|NCT00405704|1162703|P1|NOT COMPLETED|Overall Study||41
485291|NCT00405704|1162702|P2|COMPLETED|Overall Study||259
485292|NCT00405704|1162703|P1|COMPLETED|Overall Study||261
485293|NCT00405704|1162702|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
485294|NCT00405704|1162703|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
485295|NCT00405704|1162702|P2|Recurrent UTI With E. Coli|Overall Study||57
485296|NCT00405704|1162703|P1|Recurrent UTI With E. Coli|Overall Study||30
485297|NCT00405704|1162702|P2|Outcome Stool Assessed|Overall Study||210
485298|NCT00405704|1162703|P1|Outcome Stool Assessed|Overall Study||203
485299|NCT00405704|1162702|P2|Completed Assessments for New Scarring|Overall Study||227
485300|NCT00405704|1162703|P1|Completed Assessments for New Scarring|Overall Study||220
485301|NCT00405704|1162702|P2|Completed Outcome Renal Scan|Overall Study||235
485302|NCT00405704|1162703|P1|Completed Outcome Renal Scan|Overall Study||227
485303|NCT00405704|1162702|P2|STARTED|Overall Study||305
485304|NCT00405704|1162703|P1|STARTED|Overall Study||302
485305|NCT00405652|1162723|P1|NOT COMPLETED|Overall Study||4
485306|NCT00405652|1162723|P1|COMPLETED|Overall Study||30
485307|NCT00405652|1162723|P1|STARTED|Overall Study||34
485308|NCT00405639|1162730|P2|NOT COMPLETED|Overall Study||0
485309|NCT00405639|1162731|P1|NOT COMPLETED|Overall Study||3
485310|NCT00405639|1162730|P2|COMPLETED|Overall Study||12
485311|NCT00405639|1162731|P1|COMPLETED|Overall Study||22
485312|NCT00405639|1162730|P2|STARTED|Overall Study||12
485313|NCT00405639|1162731|P1|STARTED|Overall Study||25
485314|NCT00405548|1162745|P2|NOT COMPLETED|Overall Study||1
485315|NCT00405548|1162746|P1|NOT COMPLETED|Overall Study||4
485316|NCT00405548|1162745|P2|COMPLETED|Overall Study||12
485317|NCT00405548|1162746|P1|COMPLETED|Overall Study||24
485318|NCT00405548|1162745|P2|STARTED|Overall Study||13
485319|NCT00405548|1162746|P1|STARTED|Overall Study||28
485320|NCT00405509|1162760|P2|NOT COMPLETED|Overall Study||0
485321|NCT00405509|1162761|P1|NOT COMPLETED|Overall Study||0
485322|NCT00405509|1162760|P2|COMPLETED|Overall Study||22
485323|NCT00405509|1162761|P1|COMPLETED|Overall Study||11
485324|NCT00405509|1162760|P2|STARTED|Overall Study||22
485325|NCT00405509|1162761|P1|STARTED|Overall Study||11
485326|NCT00405288|1162777|P2|NOT COMPLETED|Overall Study||0
485327|NCT00405288|1162778|P1|NOT COMPLETED|Overall Study||0
485328|NCT00405288|1162777|P2|COMPLETED|Overall Study||204
485329|NCT00405288|1162778|P1|COMPLETED|Overall Study||204
485330|NCT00405288|1162777|P2|STARTED|Overall Study||204
485331|NCT00405288|1162778|P1|STARTED|Overall Study||204
485332|NCT00405275|1162808|P2|NOT COMPLETED|Overall Study||19
485333|NCT00405275|1162809|P1|NOT COMPLETED|Overall Study||23
485334|NCT00405275|1162808|P2|COMPLETED|Overall Study||156
485335|NCT00405275|1162809|P1|COMPLETED|Overall Study||155
485336|NCT00405275|1162808|P2|24 Week (Switch)|Overall Study||44
485337|NCT00405275|1162809|P1|24 Week (Switch)|Overall Study||44
485338|NCT00405275|1162808|P2|24 Week (no Switch)|Overall Study||121
485339|NCT00405275|1162809|P1|24 Week (no Switch)|Overall Study||119
485340|NCT00405275|1162808|P2|24 Weeks (Total)|Overall Study||165
485341|NCT00405275|1162809|P1|24 Weeks (Total)|Overall Study||163
485342|NCT00405275|1162808|P2|STARTED|Overall Study||175
485343|NCT00405275|1162809|P1|STARTED|Overall Study||178
485344|NCT00404924|1162817|P2|NOT COMPLETED|Overall Study||306
485345|NCT00404924|1162818|P1|NOT COMPLETED|Overall Study||603
485346|NCT00404924|1162817|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
485347|NCT00404924|1162818|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
485348|NCT00404924|1162817|P2|STARTED|Overall Study|randomised patients|307
485349|NCT00404924|1162818|P1|STARTED|Overall Study|randomised patients|617
485350|NCT00404820|1162836|P2|NOT COMPLETED|Overall Study||24
485351|NCT00404820|1162837|P1|NOT COMPLETED|Overall Study||19
485352|NCT00404820|1162836|P2|COMPLETED|Overall Study||172
485353|NCT00404820|1162837|P1|COMPLETED|Overall Study||389
485354|NCT00404820|1162836|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
485355|NCT00404820|1162837|P1|Started Treatment|Overall Study||408
485356|NCT00404820|1162836|P2|STARTED|Overall Study||196
485357|NCT00404820|1162837|P1|STARTED|Overall Study||408
485358|NCT00404651|1162859|P4|NOT COMPLETED|Overall Study||21
485359|NCT00404651|1162860|P3|NOT COMPLETED|Overall Study||45
485360|NCT00404651|1162861|P2|NOT COMPLETED|Overall Study||28
485361|NCT00404651|1162862|P1|NOT COMPLETED|Overall Study||39
485362|NCT00404651|1162859|P4|COMPLETED|Overall Study||146
485363|NCT00404651|1162860|P3|COMPLETED|Overall Study||294
485364|NCT00404651|1162861|P2|COMPLETED|Overall Study||315
485365|NCT00404651|1162862|P1|COMPLETED|Overall Study||301
485366|NCT00404651|1162859|P4|STARTED|Overall Study||167
485367|NCT00404651|1162860|P3|STARTED|Overall Study||339
485368|NCT00404651|1162861|P2|STARTED|Overall Study||343
485369|NCT00404651|1162862|P1|STARTED|Overall Study||340
485370|NCT00404547|1162890|P2|NOT COMPLETED|Overall Study||25
485371|NCT00404547|1162891|P1|NOT COMPLETED|Overall Study||90
485372|NCT00404547|1162890|P2|COMPLETED|Overall Study||334
485373|NCT00404547|1162891|P1|COMPLETED|Overall Study||672
485374|NCT00404547|1162890|P2|STARTED|Overall Study||359
485375|NCT00404547|1162891|P1|STARTED|Overall Study||762
485376|NCT00404495|1162901|P2|NOT COMPLETED|Overall Study||11
485377|NCT00404495|1162902|P1|NOT COMPLETED|Overall Study||44
485378|NCT00404495|1162901|P2|COMPLETED|Overall Study||6
485379|NCT00404495|1162902|P1|COMPLETED|Overall Study||22
485380|NCT00404495|1162901|P2|STARTED|Overall Study||17
485381|NCT00404495|1162902|P1|STARTED|Overall Study||66
485382|NCT00404352|1162921|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
485383|NCT00404352|1162922|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
485384|NCT00404352|1162923|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
485385|NCT00404352|1162924|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
485386|NCT00404352|1162925|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
485387|NCT00404352|1162926|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
485388|NCT00404352|1162927|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
485389|NCT00404352|1162928|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
485390|NCT00404352|1162929|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
485391|NCT00404352|1162921|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
485392|NCT00404352|1162922|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
485393|NCT00404352|1162923|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
485394|NCT00404352|1162924|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
485395|NCT00404352|1162925|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
485396|NCT00404352|1162926|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
485397|NCT00404352|1162927|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
485398|NCT00404352|1162928|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
485399|NCT00404352|1162929|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
485400|NCT00404352|1162921|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
485401|NCT00404352|1162922|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
485402|NCT00404352|1162923|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
485403|NCT00404352|1162924|P6|STARTED|Open Label Extension (up to 36 Months)||0
485404|NCT00404352|1162925|P5|STARTED|Open Label Extension (up to 36 Months)||0
485405|NCT00404352|1162926|P4|STARTED|Open Label Extension (up to 36 Months)||0
485406|NCT00404352|1162927|P3|STARTED|Open Label Extension (up to 36 Months)||0
485407|NCT00404352|1162928|P2|STARTED|Open Label Extension (up to 36 Months)||0
485408|NCT00404352|1162929|P1|STARTED|Open Label Extension (up to 36 Months)||0
485409|NCT00404352|1162921|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
485410|NCT00404352|1162922|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
485411|NCT00404352|1162923|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
485412|NCT00404352|1162924|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
485413|NCT00404352|1162925|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
485414|NCT00404352|1162926|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
485415|NCT00404352|1162927|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
485416|NCT00404352|1162928|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
485417|NCT00404352|1162929|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
485418|NCT00404352|1162921|P9|COMPLETED|Open Label (up to 24 Month)||0
485419|NCT00404352|1162922|P8|COMPLETED|Open Label (up to 24 Month)||0
485420|NCT00404352|1162923|P7|COMPLETED|Open Label (up to 24 Month)||0
485421|NCT00404352|1162924|P6|COMPLETED|Open Label (up to 24 Month)||52
485422|NCT00404352|1162925|P5|COMPLETED|Open Label (up to 24 Month)||28
485423|NCT00404352|1162926|P4|COMPLETED|Open Label (up to 24 Month)||28
485424|NCT00404352|1162927|P3|COMPLETED|Open Label (up to 24 Month)||0
485425|NCT00404352|1162928|P2|COMPLETED|Open Label (up to 24 Month)||0
485426|NCT00404352|1162929|P1|COMPLETED|Open Label (up to 24 Month)||0
485427|NCT00404352|1162921|P9|STARTED|Open Label (up to 24 Month)||0
485428|NCT00404352|1162922|P8|STARTED|Open Label (up to 24 Month)||0
485429|NCT00404352|1162923|P7|STARTED|Open Label (up to 24 Month)||0
485430|NCT00404352|1162924|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
485431|NCT00404352|1162925|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
485432|NCT00404352|1162926|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
485433|NCT00404352|1162927|P3|STARTED|Open Label (up to 24 Month)||0
485434|NCT00404352|1162928|P2|STARTED|Open Label (up to 24 Month)||0
485435|NCT00404352|1162929|P1|STARTED|Open Label (up to 24 Month)||0
485436|NCT00404352|1162921|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
485437|NCT00404352|1162922|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
485438|NCT00404352|1162923|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
485439|NCT00404352|1162924|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
485440|NCT00404352|1162925|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
485441|NCT00404352|1162926|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
485442|NCT00404352|1162927|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
485443|NCT00404352|1162928|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
485444|NCT00404352|1162929|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
485445|NCT00404352|1162921|P9|COMPLETED|Double Blind (up to 24 Month)||0
485446|NCT00404352|1162922|P8|COMPLETED|Double Blind (up to 24 Month)||0
485447|NCT00404352|1162923|P7|COMPLETED|Double Blind (up to 24 Month)||0
485448|NCT00404352|1162924|P6|COMPLETED|Double Blind (up to 24 Month)||0
485449|NCT00404352|1162925|P5|COMPLETED|Double Blind (up to 24 Month)||0
485450|NCT00404352|1162926|P4|COMPLETED|Double Blind (up to 24 Month)||0
485451|NCT00404352|1162927|P3|COMPLETED|Double Blind (up to 24 Month)||92
485452|NCT00404352|1162928|P2|COMPLETED|Double Blind (up to 24 Month)||128
485453|NCT00404352|1162929|P1|COMPLETED|Double Blind (up to 24 Month)||119
485454|NCT00404352|1162921|P9|Treated|Double Blind (up to 24 Month)||0
485455|NCT00404352|1162922|P8|Treated|Double Blind (up to 24 Month)||0
485456|NCT00404352|1162923|P7|Treated|Double Blind (up to 24 Month)||0
485457|NCT00404352|1162924|P6|Treated|Double Blind (up to 24 Month)||0
485458|NCT00404352|1162925|P5|Treated|Double Blind (up to 24 Month)||0
485459|NCT00404352|1162926|P4|Treated|Double Blind (up to 24 Month)||0
485460|NCT00404352|1162927|P3|Treated|Double Blind (up to 24 Month)||171
485461|NCT00404352|1162928|P2|Treated|Double Blind (up to 24 Month)||173
485462|NCT00404352|1162929|P1|Treated|Double Blind (up to 24 Month)||171
485463|NCT00404352|1162921|P9|STARTED|Double Blind (up to 24 Month)||0
485464|NCT00404352|1162922|P8|STARTED|Double Blind (up to 24 Month)||0
485465|NCT00404352|1162923|P7|STARTED|Double Blind (up to 24 Month)||0
485466|NCT00404352|1162924|P6|STARTED|Double Blind (up to 24 Month)||0
485467|NCT00404352|1162925|P5|STARTED|Double Blind (up to 24 Month)||0
485468|NCT00404352|1162926|P4|STARTED|Double Blind (up to 24 Month)||0
485469|NCT00404352|1162927|P3|STARTED|Double Blind (up to 24 Month)||171
485470|NCT00404352|1162928|P2|STARTED|Double Blind (up to 24 Month)||175
485471|NCT00404352|1162929|P1|STARTED|Double Blind (up to 24 Month)||171
485472|NCT00404248|1162964|P9|NOT COMPLETED|Overall Study||0
485473|NCT00404248|1162965|P8|NOT COMPLETED|Overall Study||0
485474|NCT00404248|1162966|P7|NOT COMPLETED|Overall Study||0
485475|NCT00404248|1162967|P6|NOT COMPLETED|Overall Study||0
485476|NCT00404248|1162968|P5|NOT COMPLETED|Overall Study||0
485477|NCT00404248|1162969|P4|NOT COMPLETED|Overall Study||0
485478|NCT00404248|1162970|P3|NOT COMPLETED|Overall Study||0
485479|NCT00404248|1162971|P2|NOT COMPLETED|Overall Study||1
485480|NCT00404248|1162972|P1|NOT COMPLETED|Overall Study||0
485481|NCT00404248|1162964|P9|COMPLETED|Overall Study||3
485482|NCT00404248|1162965|P8|COMPLETED|Overall Study||6
485483|NCT00404248|1162966|P7|COMPLETED|Overall Study||6
485484|NCT00404248|1162967|P6|COMPLETED|Overall Study||3
485485|NCT00404248|1162968|P5|COMPLETED|Overall Study||3
485486|NCT00404248|1162969|P4|COMPLETED|Overall Study||2
485487|NCT00404248|1162970|P3|COMPLETED|Overall Study||5
485488|NCT00404248|1162971|P2|COMPLETED|Overall Study||3
485489|NCT00404248|1162972|P1|COMPLETED|Overall Study||3
485490|NCT00404248|1162964|P9|STARTED|Overall Study||3
485491|NCT00404248|1162965|P8|STARTED|Overall Study||6
485492|NCT00404248|1162966|P7|STARTED|Overall Study||6
485493|NCT00404248|1162967|P6|STARTED|Overall Study||3
485494|NCT00404248|1162968|P5|STARTED|Overall Study||3
485495|NCT00404248|1162969|P4|STARTED|Overall Study||2
485496|NCT00404248|1162970|P3|STARTED|Overall Study||5
485497|NCT00404248|1162971|P2|STARTED|Overall Study||4
485498|NCT00404248|1162972|P1|STARTED|Overall Study||3
485499|NCT00404092|1163007|P4|NOT COMPLETED|Overall Study||0
485500|NCT00404092|1163008|P3|NOT COMPLETED|Overall Study||1
485501|NCT00404092|1163009|P2|NOT COMPLETED|Overall Study||0
485502|NCT00404092|1163010|P1|NOT COMPLETED|Overall Study||1
485503|NCT00404092|1163007|P4|COMPLETED|Overall Study||20
485504|NCT00404092|1163008|P3|COMPLETED|Overall Study||8
485505|NCT00404092|1163009|P2|COMPLETED|Overall Study||8
485506|NCT00404092|1163010|P1|COMPLETED|Overall Study||8
485507|NCT00404092|1163007|P4|STARTED|Overall Study||20
485508|NCT00404092|1163008|P3|STARTED|Overall Study||9
485509|NCT00404092|1163009|P2|STARTED|Overall Study||8
485510|NCT00404092|1163010|P1|STARTED|Overall Study||9
485511|NCT00404079|1163026|P2|NOT COMPLETED|Overall Study||20
485512|NCT00404079|1163027|P1|NOT COMPLETED|Overall Study||22
485513|NCT00404079|1163026|P2|COMPLETED|Overall Study||105
485514|NCT00404079|1163027|P1|COMPLETED|Overall Study||103
485515|NCT00404079|1163026|P2|STARTED|Overall Study||125
485516|NCT00404079|1163027|P1|STARTED|Overall Study||125
485517|NCT00403845|1163033|P4|NOT COMPLETED|Treatment Period 4||0
485518|NCT00403845|1163034|P3|NOT COMPLETED|Treatment Period 4||0
485519|NCT00403845|1163035|P2|NOT COMPLETED|Treatment Period 4||0
485520|NCT00403845|1163036|P1|NOT COMPLETED|Treatment Period 4||0
485521|NCT00403845|1163033|P4|COMPLETED|Treatment Period 4||11
485522|NCT00403845|1163034|P3|COMPLETED|Treatment Period 4||11
485523|NCT00403845|1163035|P2|COMPLETED|Treatment Period 4||13
485524|NCT00403845|1163036|P1|COMPLETED|Treatment Period 4||10
485525|NCT00403845|1163033|P4|STARTED|Treatment Period 4||11
485526|NCT00403845|1163034|P3|STARTED|Treatment Period 4||11
485527|NCT00403845|1163035|P2|STARTED|Treatment Period 4||13
485528|NCT00403845|1163036|P1|STARTED|Treatment Period 4||10
485529|NCT00403845|1163033|P4|NOT COMPLETED|Treatment Period 3||2
485530|NCT00403845|1163034|P3|NOT COMPLETED|Treatment Period 3||0
485531|NCT00403845|1163035|P2|NOT COMPLETED|Treatment Period 3||0
485532|NCT00403845|1163036|P1|NOT COMPLETED|Treatment Period 3||0
485533|NCT00403845|1163033|P4|COMPLETED|Treatment Period 3||11
485534|NCT00403845|1163034|P3|COMPLETED|Treatment Period 3||11
485535|NCT00403845|1163035|P2|COMPLETED|Treatment Period 3||13
485536|NCT00403845|1163036|P1|COMPLETED|Treatment Period 3||10
485537|NCT00403845|1163033|P4|STARTED|Treatment Period 3||13
485538|NCT00403845|1163034|P3|STARTED|Treatment Period 3||11
485539|NCT00403845|1163035|P2|STARTED|Treatment Period 3||13
485540|NCT00403845|1163036|P1|STARTED|Treatment Period 3||10
485541|NCT00403845|1163033|P4|NOT COMPLETED|Treatment Period 2||0
485542|NCT00403845|1163034|P3|NOT COMPLETED|Treatment Period 2||0
485543|NCT00403845|1163035|P2|NOT COMPLETED|Treatment Period 2||0
485544|NCT00403845|1163036|P1|NOT COMPLETED|Treatment Period 2||1
485545|NCT00403845|1163033|P4|COMPLETED|Treatment Period 2||13
485546|NCT00403845|1163034|P3|COMPLETED|Treatment Period 2||11
485547|NCT00403845|1163035|P2|COMPLETED|Treatment Period 2||13
485548|NCT00403845|1163036|P1|COMPLETED|Treatment Period 2||10
485549|NCT00403845|1163033|P4|STARTED|Treatment Period 2||13
485550|NCT00403845|1163034|P3|STARTED|Treatment Period 2||11
485551|NCT00403845|1163035|P2|STARTED|Treatment Period 2||13
485552|NCT00403845|1163036|P1|STARTED|Treatment Period 2||11
485553|NCT00403845|1163033|P4|NOT COMPLETED|Treatment Period 1||1
485554|NCT00403845|1163034|P3|NOT COMPLETED|Treatment Period 1||0
485555|NCT00403845|1163035|P2|NOT COMPLETED|Treatment Period 1||0
485556|NCT00403845|1163036|P1|NOT COMPLETED|Treatment Period 1||1
485557|NCT00403845|1163033|P4|COMPLETED|Treatment Period 1||13
485558|NCT00403845|1163034|P3|COMPLETED|Treatment Period 1||11
485559|NCT00403845|1163035|P2|COMPLETED|Treatment Period 1||13
485560|NCT00403845|1163036|P1|COMPLETED|Treatment Period 1||11
485561|NCT00403845|1163033|P4|STARTED|Treatment Period 1||14
485562|NCT00403845|1163034|P3|STARTED|Treatment Period 1||11
485563|NCT00403845|1163035|P2|STARTED|Treatment Period 1||13
485564|NCT00403845|1163036|P1|STARTED|Treatment Period 1||12
485565|NCT00403767|1163060|P2|NOT COMPLETED|Overall Study||2468
485566|NCT00403767|1163061|P1|NOT COMPLETED|Overall Study||2520
485567|NCT00403767|1163060|P2|COMPLETED|Overall Study||4657
485568|NCT00403767|1163061|P1|COMPLETED|Overall Study||4591
485569|NCT00403767|1163060|P2|STARTED|Overall Study||7125
485570|NCT00403767|1163061|P1|STARTED|Overall Study||7111
485571|NCT00403754|1163085|P4|NOT COMPLETED|Open Label: Salmeterol||0
485572|NCT00403754|1163086|P3|NOT COMPLETED|Open Label: Salmeterol||0
485573|NCT00403754|1163087|P2|NOT COMPLETED|Open Label: Salmeterol||0
485574|NCT00403754|1163088|P1|NOT COMPLETED|Open Label: Salmeterol||0
485575|NCT00403754|1163085|P4|COMPLETED|Open Label: Salmeterol||11
485576|NCT00403754|1163086|P3|COMPLETED|Open Label: Salmeterol||8
485577|NCT00403754|1163087|P2|COMPLETED|Open Label: Salmeterol||9
485578|NCT00403754|1163088|P1|COMPLETED|Open Label: Salmeterol||11
485579|NCT00403754|1163085|P4|STARTED|Open Label: Salmeterol||11
485580|NCT00403754|1163086|P3|STARTED|Open Label: Salmeterol||8
485581|NCT00403754|1163087|P2|STARTED|Open Label: Salmeterol||9
485582|NCT00403754|1163088|P1|STARTED|Open Label: Salmeterol||11
485583|NCT00403754|1163085|P4|NOT COMPLETED|Core Treatment Period 4||0
485584|NCT00403754|1163086|P3|NOT COMPLETED|Core Treatment Period 4||0
485585|NCT00403754|1163087|P2|NOT COMPLETED|Core Treatment Period 4||0
485586|NCT00403754|1163088|P1|NOT COMPLETED|Core Treatment Period 4||0
485587|NCT00403754|1163085|P4|COMPLETED|Core Treatment Period 4||11
485588|NCT00403754|1163086|P3|COMPLETED|Core Treatment Period 4||8
485589|NCT00403754|1163087|P2|COMPLETED|Core Treatment Period 4||9
485590|NCT00403754|1163088|P1|COMPLETED|Core Treatment Period 4||11
485591|NCT00403754|1163085|P4|STARTED|Core Treatment Period 4||11
485592|NCT00403754|1163086|P3|STARTED|Core Treatment Period 4||8
485593|NCT00403754|1163087|P2|STARTED|Core Treatment Period 4||9
485594|NCT00403754|1163088|P1|STARTED|Core Treatment Period 4||11
485595|NCT00403754|1163085|P4|NOT COMPLETED|Core Treatment Period 3||0
485596|NCT00403754|1163086|P3|NOT COMPLETED|Core Treatment Period 3||0
485597|NCT00403754|1163087|P2|NOT COMPLETED|Core Treatment Period 3||0
485598|NCT00403754|1163088|P1|NOT COMPLETED|Core Treatment Period 3||0
485599|NCT00403754|1163085|P4|COMPLETED|Core Treatment Period 3||11
485600|NCT00403754|1163086|P3|COMPLETED|Core Treatment Period 3||8
485601|NCT00403754|1163087|P2|COMPLETED|Core Treatment Period 3||9
485602|NCT00403754|1163088|P1|COMPLETED|Core Treatment Period 3||11
485603|NCT00403754|1163085|P4|STARTED|Core Treatment Period 3||11
485604|NCT00403754|1163086|P3|STARTED|Core Treatment Period 3||8
485605|NCT00403754|1163087|P2|STARTED|Core Treatment Period 3||9
485606|NCT00403754|1163088|P1|STARTED|Core Treatment Period 3||11
485607|NCT00403754|1163085|P4|NOT COMPLETED|Core Treatment Period 2||0
485608|NCT00403754|1163086|P3|NOT COMPLETED|Core Treatment Period 2||1
485609|NCT00403754|1163087|P2|NOT COMPLETED|Core Treatment Period 2||0
485610|NCT00403754|1163088|P1|NOT COMPLETED|Core Treatment Period 2||0
485611|NCT00403754|1163085|P4|COMPLETED|Core Treatment Period 2||11
485612|NCT00403754|1163086|P3|COMPLETED|Core Treatment Period 2||8
485613|NCT00403754|1163087|P2|COMPLETED|Core Treatment Period 2||9
485614|NCT00403754|1163088|P1|COMPLETED|Core Treatment Period 2||11
485615|NCT00403754|1163085|P4|STARTED|Core Treatment Period 2||11
485616|NCT00403754|1163086|P3|STARTED|Core Treatment Period 2||9
485617|NCT00403754|1163087|P2|STARTED|Core Treatment Period 2||9
485618|NCT00403754|1163088|P1|STARTED|Core Treatment Period 2||11
485619|NCT00403754|1163085|P4|NOT COMPLETED|Core Treatment Period 1||0
485620|NCT00403754|1163086|P3|NOT COMPLETED|Core Treatment Period 1||0
485621|NCT00403754|1163087|P2|NOT COMPLETED|Core Treatment Period 1||1
485622|NCT00403754|1163088|P1|NOT COMPLETED|Core Treatment Period 1||0
485623|NCT00403754|1163085|P4|COMPLETED|Core Treatment Period 1||11
485624|NCT00403754|1163086|P3|COMPLETED|Core Treatment Period 1||9
485625|NCT00403754|1163087|P2|COMPLETED|Core Treatment Period 1||9
485626|NCT00403754|1163088|P1|COMPLETED|Core Treatment Period 1||11
485627|NCT00403754|1163085|P4|STARTED|Core Treatment Period 1||11
485628|NCT00403754|1163086|P3|STARTED|Core Treatment Period 1||9
485629|NCT00403754|1163087|P2|STARTED|Core Treatment Period 1||10
485630|NCT00403754|1163088|P1|STARTED|Core Treatment Period 1||11
485631|NCT00403585|1163115|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
485632|NCT00403585|1163115|P1|COMPLETED|Open-Label Phase; Extension Study||74
485633|NCT00403585|1163115|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
485634|NCT00403585|1163115|P1|NOT COMPLETED|Initial Treatment Phase||2
485635|NCT00403585|1163115|P1|COMPLETED|Initial Treatment Phase||102
485636|NCT00403585|1163115|P1|STARTED|Initial Treatment Phase||104
485637|NCT00403546|1163126|P3|NOT COMPLETED|Randomized Trial||16
485638|NCT00403546|1163127|P2|NOT COMPLETED|Randomized Trial||17
485639|NCT00403546|1163128|P1|NOT COMPLETED|Randomized Trial||0
485640|NCT00403546|1163126|P3|COMPLETED|Randomized Trial||21
485641|NCT00403546|1163127|P2|COMPLETED|Randomized Trial||21
485642|NCT00403546|1163128|P1|COMPLETED|Randomized Trial||0
485643|NCT00403546|1163126|P3|STARTED|Randomized Trial||37
485644|NCT00403546|1163127|P2|STARTED|Randomized Trial||38
485645|NCT00403546|1163128|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
485646|NCT00403546|1163126|P3|NOT COMPLETED|Screening Phase||0
485647|NCT00403546|1163127|P2|NOT COMPLETED|Screening Phase||0
485648|NCT00403546|1163128|P1|NOT COMPLETED|Screening Phase||28
485649|NCT00403546|1163126|P3|COMPLETED|Screening Phase||0
485650|NCT00403546|1163127|P2|COMPLETED|Screening Phase||0
485651|NCT00403546|1163128|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
485652|NCT00403546|1163126|P3|STARTED|Screening Phase||0
485653|NCT00403546|1163127|P2|STARTED|Screening Phase||0
485654|NCT00403546|1163128|P1|STARTED|Screening Phase||103
485655|NCT00403546|1163126|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
485656|NCT00403546|1163127|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
485657|NCT00403546|1163128|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
485658|NCT00403546|1163126|P3|COMPLETED|Signed Informed Consent/Open-Label||0
485659|NCT00403546|1163127|P2|COMPLETED|Signed Informed Consent/Open-Label||0
485660|NCT00403546|1163128|P1|COMPLETED|Signed Informed Consent/Open-Label||103
485661|NCT00403546|1163126|P3|STARTED|Signed Informed Consent/Open-Label||0
485662|NCT00403546|1163127|P2|STARTED|Signed Informed Consent/Open-Label||0
485663|NCT00403546|1163128|P1|STARTED|Signed Informed Consent/Open-Label||131
485664|NCT00403481|1163168|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
485665|NCT00403481|1163168|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
485666|NCT00403481|1163168|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
485667|NCT00403481|1163168|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
485668|NCT00403481|1163168|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
485669|NCT00403481|1163168|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
485670|NCT00403481|1163168|P1|NOT COMPLETED|Olm 40 mg||5
485671|NCT00403481|1163168|P1|COMPLETED|Olm 40 mg||177
485672|NCT00403481|1163168|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
485673|NCT00403481|1163168|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
485674|NCT00403481|1163168|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
485675|NCT00403481|1163168|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
485676|NCT00403455|1163183|P1|NOT COMPLETED|Overall Study||1
485677|NCT00403455|1163183|P1|COMPLETED|Overall Study||37
485678|NCT00403455|1163183|P1|STARTED|Overall Study||38
485679|NCT00403403|1163189|P2|NOT COMPLETED|Overall Study||0
485680|NCT00403403|1163190|P1|NOT COMPLETED|Overall Study||0
485681|NCT00403403|1163189|P2|COMPLETED|Overall Study||52
485682|NCT00403403|1163190|P1|COMPLETED|Overall Study||50
485683|NCT00403403|1163189|P2|Safety-Evaluable Patients|Overall Study||51
485684|NCT00403403|1163190|P1|Safety-Evaluable Patients|Overall Study||47
485685|NCT00403403|1163189|P2|STARTED|Overall Study||52
485686|NCT00403403|1163190|P1|STARTED|Overall Study||50
485687|NCT00403273|1163206|P2|NOT COMPLETED|Overall Study||4
485688|NCT00403273|1163207|P1|NOT COMPLETED|Overall Study||3
485689|NCT00403273|1163206|P2|COMPLETED|Overall Study||25
485690|NCT00403273|1163207|P1|COMPLETED|Overall Study||22
485691|NCT00403273|1163206|P2|STARTED|Overall Study||29
485692|NCT00403273|1163207|P1|STARTED|Overall Study||25
485693|NCT00403234|1163237|P4|NOT COMPLETED|Overall Study||0
485694|NCT00403234|1163238|P3|NOT COMPLETED|Overall Study||1
485695|NCT00403234|1163239|P2|NOT COMPLETED|Overall Study||1
485696|NCT00403234|1163240|P1|NOT COMPLETED|Overall Study||1
485697|NCT00403234|1163237|P4|COMPLETED|Overall Study||2
485698|NCT00403234|1163238|P3|COMPLETED|Overall Study||2
485699|NCT00403234|1163239|P2|COMPLETED|Overall Study||2
485700|NCT00403234|1163240|P1|COMPLETED|Overall Study||1
485701|NCT00403234|1163237|P4|STARTED|Overall Study||2
485702|NCT00403234|1163238|P3|STARTED|Overall Study||3
485703|NCT00403234|1163239|P2|STARTED|Overall Study||3
485704|NCT00403234|1163240|P1|STARTED|Overall Study||2
485705|NCT00403130|1163250|P1|NOT COMPLETED|Overall Study||5
485706|NCT00403130|1163250|P1|COMPLETED|Overall Study||26
485707|NCT00403130|1163250|P1|STARTED|Overall Study||31
485708|NCT00402987|1163261|P4|NOT COMPLETED|Overall Study||0
485709|NCT00402987|1163262|P3|NOT COMPLETED|Overall Study||1
485710|NCT00402987|1163263|P2|NOT COMPLETED|Overall Study||0
485711|NCT00402987|1163264|P1|NOT COMPLETED|Overall Study||0
485712|NCT00402987|1163261|P4|COMPLETED|Overall Study||89
485713|NCT00402987|1163262|P3|COMPLETED|Overall Study||44
485714|NCT00402987|1163263|P2|COMPLETED|Overall Study||45
485715|NCT00402987|1163264|P1|COMPLETED|Overall Study||90
485716|NCT00402987|1163261|P4|STARTED|Overall Study||89
485717|NCT00402987|1163262|P3|STARTED|Overall Study||45
485718|NCT00402987|1163263|P2|STARTED|Overall Study||45
485719|NCT00402987|1163264|P1|STARTED|Overall Study||90
485720|NCT00402896|1163426|P1|NOT COMPLETED|Overall Study||0
485721|NCT00402896|1163426|P1|COMPLETED|Overall Study||20
485722|NCT00402896|1163426|P1|STARTED|Overall Study||20
485723|NCT00402883|1163430|P1|NOT COMPLETED|Maintenance Therapy||0
485724|NCT00402883|1163430|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
485725|NCT00402883|1163430|P1|STARTED|Maintenance Therapy||5
485726|NCT00402883|1163430|P1|NOT COMPLETED|Consolidation Therapy||0
485727|NCT00402883|1163430|P1|COMPLETED|Consolidation Therapy||5
485728|NCT00402883|1163430|P1|STARTED|Consolidation Therapy||5
485729|NCT00402883|1163430|P1|NOT COMPLETED|Induction Therapy||0
485730|NCT00402883|1163430|P1|COMPLETED|Induction Therapy||5
485731|NCT00402883|1163430|P1|STARTED|Induction Therapy||5
485732|NCT00402740|1163434|P1|NOT COMPLETED|Overall Study||80
485733|NCT00402740|1163434|P1|COMPLETED|Overall Study||242
485734|NCT00402740|1163434|P1|STARTED|Overall Study||322
485735|NCT00402727|1163446|P2|NOT COMPLETED|Overall Study||34
485736|NCT00402727|1163447|P1|NOT COMPLETED|Overall Study||42
485737|NCT00402727|1163446|P2|COMPLETED|Overall Study||347
485738|NCT00402727|1163447|P1|COMPLETED|Overall Study||390
485739|NCT00402727|1163446|P2|Achieving Test Of Cure (TOC)|Overall Study||347
485740|NCT00402727|1163447|P1|Achieving Test Of Cure (TOC)|Overall Study||390
485741|NCT00402727|1163446|P2|Achieving End Of Treatment (EOT)|Overall Study||355
485742|NCT00402727|1163447|P1|Achieving End Of Treatment (EOT)|Overall Study||408
485743|NCT00402727|1163446|P2|STARTED|Overall Study||381
485744|NCT00402727|1163447|P1|STARTED|Overall Study||432
485745|NCT00402714|1163477|P2|NOT COMPLETED|Overall Study||0
485746|NCT00402714|1163478|P1|NOT COMPLETED|Overall Study||0
485747|NCT00402714|1163477|P2|COMPLETED|Overall Study||11
485748|NCT00402714|1163478|P1|COMPLETED|Overall Study||3
485749|NCT00402714|1163477|P2|STARTED|Overall Study||11
485750|NCT00402714|1163478|P1|STARTED|Overall Study||3
485751|NCT00402688|1163489|P3|NOT COMPLETED|Overall Study||15
485752|NCT00402688|1163490|P2|NOT COMPLETED|Overall Study||16
485753|NCT00402688|1163491|P1|NOT COMPLETED|Overall Study||21
485754|NCT00402688|1163489|P3|COMPLETED|Overall Study||65
485755|NCT00402688|1163490|P2|COMPLETED|Overall Study||65
485756|NCT00402688|1163491|P1|COMPLETED|Overall Study||60
485757|NCT00402688|1163489|P3|STARTED|Overall Study||80
485758|NCT00402688|1163490|P2|STARTED|Overall Study||81
485759|NCT00402688|1163491|P1|STARTED|Overall Study||81
485760|NCT00402649|1163514|P1|NOT COMPLETED|Overall Study||2
485761|NCT00402649|1163514|P1|COMPLETED|Overall Study||33
485762|NCT00402649|1163514|P1|STARTED|Overall Study||35
485763|NCT00402597|1163529|P5|NOT COMPLETED|Overall Study||124
485764|NCT00402597|1163530|P4|NOT COMPLETED|Overall Study||74
485765|NCT00402597|1163531|P3|NOT COMPLETED|Overall Study||212
485766|NCT00402597|1163532|P2|NOT COMPLETED|Overall Study||46
485767|NCT00402597|1163533|P1|NOT COMPLETED|Overall Study||191
485768|NCT00402597|1163529|P5|COMPLETED|Overall Study||479
485769|NCT00402597|1163530|P4|COMPLETED|Overall Study||279
485770|NCT00402597|1163531|P3|COMPLETED|Overall Study||834
485771|NCT00402597|1163532|P2|COMPLETED|Overall Study||261
485772|NCT00402597|1163533|P1|COMPLETED|Overall Study||962
485773|NCT00402597|1163529|P5|STARTED|Overall Study||603
485774|NCT00402597|1163530|P4|STARTED|Overall Study||353
485775|NCT00402597|1163531|P3|STARTED|Overall Study||1046
485776|NCT00402597|1163532|P2|STARTED|Overall Study||307
485777|NCT00402597|1163533|P1|STARTED|Overall Study||1153
485778|NCT00402363|1163574|P4|NOT COMPLETED|Overall Study||10
485779|NCT00402363|1163575|P3|NOT COMPLETED|Overall Study||6
485780|NCT00402363|1163576|P2|NOT COMPLETED|Overall Study||30
485781|NCT00402363|1163577|P1|NOT COMPLETED|Overall Study||33
485782|NCT00402363|1163574|P4|COMPLETED|Overall Study||45
485783|NCT00402363|1163575|P3|COMPLETED|Overall Study||60
485784|NCT00402363|1163576|P2|COMPLETED|Overall Study||246
485785|NCT00402363|1163577|P1|COMPLETED|Overall Study||233
485786|NCT00402363|1163574|P4|STARTED|Overall Study||55
485787|NCT00402363|1163575|P3|STARTED|Overall Study||66
485788|NCT00402363|1163576|P2|STARTED|Overall Study||276
485789|NCT00402363|1163577|P1|STARTED|Overall Study||266
485790|NCT00402337|1163640|P5|NOT COMPLETED|Overall Study||8
485791|NCT00402337|1163641|P4|NOT COMPLETED|Overall Study||12
485792|NCT00402337|1163642|P3|NOT COMPLETED|Overall Study||4
485793|NCT00402337|1163643|P2|NOT COMPLETED|Overall Study||6
485794|NCT00402337|1163644|P1|NOT COMPLETED|Overall Study||5
485795|NCT00402337|1163640|P5|COMPLETED|Overall Study||61
485796|NCT00402337|1163641|P4|COMPLETED|Overall Study||51
485797|NCT00402337|1163642|P3|COMPLETED|Overall Study||58
485798|NCT00402337|1163643|P2|COMPLETED|Overall Study||51
485799|NCT00402337|1163644|P1|COMPLETED|Overall Study||54
485800|NCT00402337|1163640|P5|STARTED|Overall Study||69
485801|NCT00402337|1163641|P4|STARTED|Overall Study||63
485802|NCT00402337|1163642|P3|STARTED|Overall Study||62
485803|NCT00402337|1163643|P2|STARTED|Overall Study||57
485804|NCT00402337|1163644|P1|STARTED|Overall Study||59
485805|NCT00402324|1163683|P2|NOT COMPLETED|Overall Study||41
485806|NCT00402324|1163684|P1|NOT COMPLETED|Overall Study||43
485807|NCT00402324|1163683|P2|COMPLETED|Overall Study||60
485808|NCT00402324|1163684|P1|COMPLETED|Overall Study||58
485809|NCT00402324|1163683|P2|STARTED|Overall Study||101
485810|NCT00402324|1163684|P1|STARTED|Overall Study||101
485811|NCT00402285|1163717|P3|NOT COMPLETED|Overall Study||2
485812|NCT00402285|1163718|P2|NOT COMPLETED|Overall Study||6
485813|NCT00402285|1163719|P1|NOT COMPLETED|Overall Study||7
485814|NCT00402285|1163717|P3|COMPLETED|Overall Study||26
485815|NCT00402285|1163718|P2|COMPLETED|Overall Study||21
485816|NCT00402285|1163719|P1|COMPLETED|Overall Study||22
485817|NCT00402285|1163717|P3|STARTED|Overall Study||28
485818|NCT00402285|1163718|P2|STARTED|Overall Study||27
485819|NCT00402285|1163719|P1|STARTED|Overall Study||29
485820|NCT00402246|1163727|P2|NOT COMPLETED|Overall Study||234
485821|NCT00402246|1163728|P1|NOT COMPLETED|Overall Study||220
485822|NCT00402246|1163727|P2|COMPLETED|Overall Study||749
485823|NCT00402246|1163728|P1|COMPLETED|Overall Study||794
485824|NCT00402246|1163727|P2|STARTED|Overall Study||983
485825|NCT00402246|1163728|P1|STARTED|Overall Study||1014
485826|NCT00402233|1163762|P4|NOT COMPLETED|Overall Study||11
485827|NCT00402233|1163763|P3|NOT COMPLETED|Overall Study||11
485828|NCT00402233|1163764|P2|NOT COMPLETED|Overall Study||10
485829|NCT00402233|1163765|P1|NOT COMPLETED|Overall Study||5
485830|NCT00402233|1163762|P4|COMPLETED|Overall Study||62
485831|NCT00402233|1163763|P3|COMPLETED|Overall Study||70
485832|NCT00402233|1163764|P2|COMPLETED|Overall Study||70
485833|NCT00402233|1163765|P1|COMPLETED|Overall Study||72
485834|NCT00402233|1163762|P4|STARTED|Overall Study||73
485835|NCT00402233|1163763|P3|STARTED|Overall Study||81
485836|NCT00402233|1163764|P2|STARTED|Overall Study||80
485837|NCT00402233|1163765|P1|STARTED|Overall Study||77
485838|NCT00402194|1163789|P2|NOT COMPLETED|Overall Study||0
485839|NCT00402194|1163790|P1|NOT COMPLETED|Overall Study||0
485840|NCT00402194|1163789|P2|COMPLETED|Overall Study||8
485841|NCT00402194|1163790|P1|COMPLETED|Overall Study||9
485842|NCT00402194|1163789|P2|STARTED|Overall Study||8
485843|NCT00402194|1163790|P1|STARTED|Overall Study||9
485844|NCT00402168|1163800|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
485845|NCT00402168|1163801|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
485846|NCT00402168|1163800|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
485847|NCT00402168|1163801|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
485848|NCT00402168|1163800|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
485849|NCT00402168|1163801|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
485850|NCT00402168|1163800|P2|NOT COMPLETED|Long Term (LT)||17
485851|NCT00402168|1163801|P1|NOT COMPLETED|Long Term (LT)||11
485852|NCT00402168|1163800|P2|COMPLETED|Long Term (LT)||64
485853|NCT00402168|1163801|P1|COMPLETED|Long Term (LT)||70
485854|NCT00402168|1163800|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
485855|NCT00402168|1163801|P1|STARTED|Long Term (LT)||81
485856|NCT00402168|1163800|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
485857|NCT00402168|1163801|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
485858|NCT00402168|1163800|P2|COMPLETED|Treatment (up to 12 Months)||86
485859|NCT00402168|1163801|P1|COMPLETED|Treatment (up to 12 Months)||81
485860|NCT00402168|1163800|P2|STARTED|Treatment (up to 12 Months)||88
485861|NCT00402168|1163801|P1|STARTED|Treatment (up to 12 Months)||83
485862|NCT00402168|1163800|P2|NOT COMPLETED|Randomized||1
485863|NCT00402168|1163801|P1|NOT COMPLETED|Randomized||1
485864|NCT00402168|1163800|P2|COMPLETED|Randomized||88
485865|NCT00402168|1163801|P1|COMPLETED|Randomized||83
485866|NCT00402168|1163800|P2|STARTED|Randomized||89
485867|NCT00402168|1163801|P1|STARTED|Randomized||84
485868|NCT00402103|1163858|P2|NOT COMPLETED|Overall Study||13
485869|NCT00402103|1163859|P1|NOT COMPLETED|Overall Study||91
485870|NCT00402103|1163858|P2|COMPLETED|Overall Study||73
485871|NCT00402103|1163859|P1|COMPLETED|Overall Study||379
485872|NCT00402103|1163858|P2|STARTED|Overall Study||86
485873|NCT00402103|1163859|P1|STARTED|Overall Study||470
485874|NCT00402051|1163875|P2|NOT COMPLETED|Overall Study||35
485875|NCT00402051|1163876|P1|NOT COMPLETED|Overall Study||38
485876|NCT00402051|1163875|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
485877|NCT00402051|1163876|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
485878|NCT00402051|1163875|P2|Received Treatment|Overall Study||65
485879|NCT00402051|1163876|P1|Received Treatment|Overall Study||65
485880|NCT00402051|1163875|P2|STARTED|Overall Study||67
485881|NCT00402051|1163876|P1|STARTED|Overall Study||66
485882|NCT00402025|1163893|P3|NOT COMPLETED|Overall Study||10
485883|NCT00402025|1163894|P2|NOT COMPLETED|Overall Study||3
485884|NCT00402025|1163895|P1|NOT COMPLETED|Overall Study||2
485885|NCT00402025|1163893|P3|COMPLETED|Overall Study||0
485886|NCT00402025|1163894|P2|COMPLETED|Overall Study||1
485887|NCT00402025|1163895|P1|COMPLETED|Overall Study||1
485888|NCT00402025|1163893|P3|STARTED|Overall Study||10
485889|NCT00402025|1163894|P2|STARTED|Overall Study||4
485890|NCT00402025|1163895|P1|STARTED|Overall Study||3
485891|NCT00401973|1163921|P3|NOT COMPLETED|Overall Study||23
485892|NCT00401973|1163922|P2|NOT COMPLETED|Overall Study||26
485893|NCT00401973|1163923|P1|NOT COMPLETED|Overall Study||11
485894|NCT00401973|1163921|P3|COMPLETED|Overall Study||50
485895|NCT00401973|1163922|P2|COMPLETED|Overall Study||50
485896|NCT00401973|1163923|P1|COMPLETED|Overall Study||39
485897|NCT00401973|1163921|P3|STARTED|Overall Study||73
485898|NCT00401973|1163922|P2|STARTED|Overall Study||76
485899|NCT00401973|1163923|P1|STARTED|Overall Study||50
485900|NCT00401960|1163962|P2|NOT COMPLETED|Overall Study||0
485901|NCT00401960|1163963|P1|NOT COMPLETED|Overall Study||5
485902|NCT00401960|1163962|P2|COMPLETED|Overall Study||1
485903|NCT00401960|1163963|P1|COMPLETED|Overall Study||0
485904|NCT00401960|1163962|P2|STARTED|Overall Study||1
485905|NCT00401960|1163963|P1|STARTED|Overall Study||5
485906|NCT00401882|1163973|P2|NOT COMPLETED|Overall Study||0
485907|NCT00401882|1163974|P1|NOT COMPLETED|Overall Study||0
485908|NCT00401882|1163973|P2|COMPLETED|Overall Study||5
485909|NCT00401882|1163974|P1|COMPLETED|Overall Study||2
485910|NCT00401882|1163973|P2|STARTED|Overall Study||5
485911|NCT00401882|1163974|P1|STARTED|Overall Study||2
485912|NCT00401843|1163993|P3|NOT COMPLETED|Overall Study||142
485913|NCT00401843|1163994|P2|NOT COMPLETED|Overall Study||144
485914|NCT00401843|1163995|P1|NOT COMPLETED|Overall Study||21
485915|NCT00401843|1163993|P3|COMPLETED|Overall Study||0
485916|NCT00401843|1163994|P2|COMPLETED|Overall Study||0
485917|NCT00401843|1163995|P1|COMPLETED|Overall Study||0
485918|NCT00401843|1163993|P3|Treated|Overall Study||139
485919|NCT00401843|1163994|P2|Treated|Overall Study||142
485920|NCT00401843|1163995|P1|Treated|Overall Study||21
485921|NCT00401843|1163993|P3|STARTED|Overall Study||142
485922|NCT00401843|1163994|P2|STARTED|Overall Study||144
485923|NCT00401843|1163995|P1|STARTED|Overall Study||21
485924|NCT00401830|1164013|P2|NOT COMPLETED|Overall Study||32
485925|NCT00401830|1164014|P1|NOT COMPLETED|Overall Study||31
485926|NCT00401830|1164013|P2|COMPLETED|Overall Study||46
485927|NCT00401830|1164014|P1|COMPLETED|Overall Study||50
485928|NCT00401830|1164013|P2|STARTED|Overall Study||78
485929|NCT00401830|1164014|P1|STARTED|Overall Study||81
485930|NCT00401778|1164049|P3|NOT COMPLETED|Overall Study||1
485931|NCT00401778|1164050|P2|NOT COMPLETED|Overall Study||1
485932|NCT00401778|1164051|P1|NOT COMPLETED|Overall Study||1
485933|NCT00401778|1164049|P3|COMPLETED|Overall Study||10
485934|NCT00401778|1164050|P2|COMPLETED|Overall Study||11
485935|NCT00401778|1164051|P1|COMPLETED|Overall Study||9
485936|NCT00401778|1164049|P3|STARTED|Overall Study||11
485937|NCT00401778|1164050|P2|STARTED|Overall Study||12
485938|NCT00401778|1164051|P1|STARTED|Overall Study||10
485939|NCT00401752|1164065|P2|NOT COMPLETED|Overall Study||18
485940|NCT00401752|1164066|P1|NOT COMPLETED|Overall Study||10
485941|NCT00401752|1164065|P2|COMPLETED|Overall Study||94
485942|NCT00401752|1164066|P1|COMPLETED|Overall Study||97
485943|NCT00401752|1164065|P2|Patients Included in Per-Protocol Popula|Overall Study||99
485944|NCT00401752|1164066|P1|Patients Included in Per-Protocol Popula|Overall Study||100
485945|NCT00401752|1164065|P2|Patients Included in Safety Population|Overall Study||110
485946|NCT00401752|1164066|P1|Patients Included in Safety Population|Overall Study||107
485947|NCT00401752|1164065|P2|Patients Included in ITT Population|Overall Study||111
485948|NCT00401752|1164066|P1|Patients Included in ITT Population|Overall Study||106
485949|NCT00401752|1164065|P2|Number of Patients Received Treatment|Overall Study||111
485950|NCT00401752|1164066|P1|Number of Patients Received Treatment|Overall Study||107
485951|NCT00401752|1164065|P2|STARTED|Overall Study||112
485952|NCT00401752|1164066|P1|STARTED|Overall Study||107
485953|NCT00401726|1164084|P2|NOT COMPLETED|Overall Study||112
485954|NCT00401726|1164085|P1|NOT COMPLETED|Overall Study||97
485955|NCT00401726|1164084|P2|COMPLETED|Overall Study||156
485956|NCT00401726|1164085|P1|COMPLETED|Overall Study||172
485957|NCT00401726|1164084|P2|STARTED|Overall Study||268
485958|NCT00401726|1164085|P1|STARTED|Overall Study||269
485959|NCT00401622|1164107|P2|NOT COMPLETED|Overall Study||43
485960|NCT00401622|1164108|P1|NOT COMPLETED|Overall Study||34
485961|NCT00401622|1164107|P2|COMPLETED|Overall Study||117
485962|NCT00401622|1164108|P1|COMPLETED|Overall Study||126
485963|NCT00401622|1164107|P2|STARTED|Overall Study||160
485964|NCT00401622|1164108|P1|STARTED|Overall Study||160
485965|NCT00401544|1164120|P4|NOT COMPLETED|Overall Study||16
485966|NCT00401544|1164121|P3|NOT COMPLETED|Overall Study||12
485967|NCT00401544|1164122|P2|NOT COMPLETED|Overall Study||18
485968|NCT00401544|1164123|P1|NOT COMPLETED|Overall Study||18
485969|NCT00401544|1164120|P4|COMPLETED|Overall Study||44
485970|NCT00401544|1164121|P3|COMPLETED|Overall Study||48
485971|NCT00401544|1164122|P2|COMPLETED|Overall Study||44
485972|NCT00401544|1164123|P1|COMPLETED|Overall Study||38
485973|NCT00401544|1164120|P4|STARTED|Overall Study|Randomized and treated|60
485974|NCT00401544|1164121|P3|STARTED|Overall Study|Randomized and treated|60
485975|NCT00401544|1164122|P2|STARTED|Overall Study|Randomized and treated|62
485976|NCT00401544|1164123|P1|STARTED|Overall Study|Randomized and treated|56
485977|NCT00401531|1164163|P2|NOT COMPLETED|Overall Study||10
485978|NCT00401531|1164164|P1|NOT COMPLETED|Overall Study||9
485979|NCT00401531|1164163|P2|COMPLETED|Overall Study||196
485980|NCT00401531|1164164|P1|COMPLETED|Overall Study||197
485981|NCT00401531|1164163|P2|STARTED|Overall Study||206
485982|NCT00401531|1164164|P1|STARTED|Overall Study||206
485983|NCT00401414|1164183|P3|NOT COMPLETED|Overall Study||0
485984|NCT00401414|1164184|P2|NOT COMPLETED|Overall Study||0
485985|NCT00401414|1164185|P1|NOT COMPLETED|Overall Study||0
485986|NCT00401414|1164183|P3|COMPLETED|Overall Study||79
485987|NCT00401414|1164184|P2|COMPLETED|Overall Study||147
485988|NCT00401414|1164185|P1|COMPLETED|Overall Study||118
485989|NCT00401414|1164183|P3|STARTED|Overall Study||79
485990|NCT00401414|1164184|P2|STARTED|Overall Study||147
485991|NCT00401414|1164185|P1|STARTED|Overall Study||118
485992|NCT00401401|1164209|P4|NOT COMPLETED|Overall Study||3
485993|NCT00401401|1164210|P3|NOT COMPLETED|Overall Study||1
485994|NCT00401401|1164211|P2|NOT COMPLETED|Overall Study||0
485995|NCT00401401|1164212|P1|NOT COMPLETED|Overall Study||0
485996|NCT00401401|1164209|P4|COMPLETED|Overall Study||9
485997|NCT00401401|1164210|P3|COMPLETED|Overall Study||5
485998|NCT00401401|1164211|P2|COMPLETED|Overall Study||6
485999|NCT00401401|1164212|P1|COMPLETED|Overall Study||6
486000|NCT00401401|1164209|P4|STARTED|Overall Study||12
486001|NCT00401401|1164210|P3|STARTED|Overall Study||6
486002|NCT00401401|1164211|P2|STARTED|Overall Study||6
486003|NCT00401401|1164212|P1|STARTED|Overall Study||6
486004|NCT00401258|1164234|P1|NOT COMPLETED|Overall Study||7
486005|NCT00401258|1164234|P1|COMPLETED|Overall Study||8
486006|NCT00401258|1164234|P1|STARTED|Overall Study||15
486007|NCT00401245|1164242|P8|NOT COMPLETED|Double Blind Tapering Phase||7
486008|NCT00401245|1164243|P7|NOT COMPLETED|Double Blind Tapering Phase||7
486009|NCT00401245|1164244|P6|NOT COMPLETED|Double Blind Tapering Phase||4
486010|NCT00401245|1164245|P5|NOT COMPLETED|Double Blind Tapering Phase||4
486011|NCT00401245|1164246|P4|NOT COMPLETED|Double Blind Tapering Phase||0
486012|NCT00401245|1164247|P3|NOT COMPLETED|Double Blind Tapering Phase||0
486013|NCT00401245|1164248|P2|NOT COMPLETED|Double Blind Tapering Phase||0
486014|NCT00401245|1164249|P1|NOT COMPLETED|Double Blind Tapering Phase||0
486015|NCT00401245|1164242|P8|COMPLETED|Double Blind Tapering Phase||95
486016|NCT00401245|1164243|P7|COMPLETED|Double Blind Tapering Phase||80
486017|NCT00401245|1164244|P6|COMPLETED|Double Blind Tapering Phase||90
486018|NCT00401245|1164245|P5|COMPLETED|Double Blind Tapering Phase||97
486019|NCT00401245|1164246|P4|COMPLETED|Double Blind Tapering Phase||0
486020|NCT00401245|1164247|P3|COMPLETED|Double Blind Tapering Phase||0
486021|NCT00401245|1164248|P2|COMPLETED|Double Blind Tapering Phase||0
486022|NCT00401245|1164249|P1|COMPLETED|Double Blind Tapering Phase||0
486023|NCT00401245|1164242|P8|STARTED|Double Blind Tapering Phase||102
486024|NCT00401245|1164243|P7|STARTED|Double Blind Tapering Phase||87
486025|NCT00401245|1164244|P6|STARTED|Double Blind Tapering Phase||94
486026|NCT00401245|1164245|P5|STARTED|Double Blind Tapering Phase||101
486027|NCT00401245|1164246|P4|STARTED|Double Blind Tapering Phase||0
486028|NCT00401245|1164247|P3|STARTED|Double Blind Tapering Phase||0
486029|NCT00401245|1164248|P2|STARTED|Double Blind Tapering Phase||0
486030|NCT00401245|1164249|P1|STARTED|Double Blind Tapering Phase||0
486031|NCT00401245|1164242|P8|NOT COMPLETED|Open Label Phase||0
486032|NCT00401245|1164243|P7|NOT COMPLETED|Open Label Phase||0
486033|NCT00401245|1164244|P6|NOT COMPLETED|Open Label Phase||0
486034|NCT00401245|1164245|P5|NOT COMPLETED|Open Label Phase||0
486035|NCT00401245|1164246|P4|NOT COMPLETED|Open Label Phase||21
486036|NCT00401245|1164247|P3|NOT COMPLETED|Open Label Phase||23
486037|NCT00401245|1164248|P2|NOT COMPLETED|Open Label Phase||35
486038|NCT00401245|1164249|P1|NOT COMPLETED|Open Label Phase||21
486039|NCT00401245|1164242|P8|COMPLETED|Open Label Phase||0
486040|NCT00401245|1164243|P7|COMPLETED|Open Label Phase||0
486041|NCT00401245|1164244|P6|COMPLETED|Open Label Phase||0
486042|NCT00401245|1164245|P5|COMPLETED|Open Label Phase||0
486043|NCT00401245|1164246|P4|COMPLETED|Open Label Phase||84
486044|NCT00401245|1164247|P3|COMPLETED|Open Label Phase||95
486045|NCT00401245|1164248|P2|COMPLETED|Open Label Phase||81
486046|NCT00401245|1164249|P1|COMPLETED|Open Label Phase||101
486047|NCT00401245|1164242|P8|STARTED|Open Label Phase||0
486048|NCT00401245|1164243|P7|STARTED|Open Label Phase||0
486049|NCT00401245|1164244|P6|STARTED|Open Label Phase||0
486050|NCT00401245|1164245|P5|STARTED|Open Label Phase||0
486051|NCT00401245|1164246|P4|STARTED|Open Label Phase||105
486052|NCT00401245|1164247|P3|STARTED|Open Label Phase||118
486053|NCT00401245|1164248|P2|STARTED|Open Label Phase||116
486054|NCT00401245|1164249|P1|STARTED|Open Label Phase||122
486055|NCT00401245|1164242|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
486056|NCT00401245|1164243|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
486057|NCT00401245|1164244|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
486058|NCT00401245|1164245|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
486059|NCT00401245|1164246|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
486060|NCT00401245|1164247|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
486061|NCT00401245|1164248|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
486062|NCT00401245|1164249|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
486063|NCT00401245|1164242|P8|COMPLETED|Between Titration and Open Label Phase||0
486064|NCT00401245|1164243|P7|COMPLETED|Between Titration and Open Label Phase||0
486065|NCT00401245|1164244|P6|COMPLETED|Between Titration and Open Label Phase||0
486066|NCT00401245|1164245|P5|COMPLETED|Between Titration and Open Label Phase||0
486067|NCT00401245|1164246|P4|COMPLETED|Between Titration and Open Label Phase||105
486068|NCT00401245|1164247|P3|COMPLETED|Between Titration and Open Label Phase||118
486069|NCT00401245|1164248|P2|COMPLETED|Between Titration and Open Label Phase||116
486070|NCT00401245|1164249|P1|COMPLETED|Between Titration and Open Label Phase||122
486071|NCT00401245|1164242|P8|STARTED|Between Titration and Open Label Phase||0
486072|NCT00401245|1164243|P7|STARTED|Between Titration and Open Label Phase||0
486073|NCT00401245|1164244|P6|STARTED|Between Titration and Open Label Phase||0
486074|NCT00401245|1164245|P5|STARTED|Between Titration and Open Label Phase||0
486075|NCT00401245|1164246|P4|STARTED|Between Titration and Open Label Phase||107
486076|NCT00401245|1164247|P3|STARTED|Between Titration and Open Label Phase||118
486077|NCT00401245|1164248|P2|STARTED|Between Titration and Open Label Phase||118
486078|NCT00401245|1164249|P1|STARTED|Between Titration and Open Label Phase||122
486079|NCT00401245|1164242|P8|NOT COMPLETED|Double Blind Titration Phase||0
486080|NCT00401245|1164243|P7|NOT COMPLETED|Double Blind Titration Phase||0
486081|NCT00401245|1164244|P6|NOT COMPLETED|Double Blind Titration Phase||0
486082|NCT00401245|1164245|P5|NOT COMPLETED|Double Blind Titration Phase||0
486083|NCT00401245|1164246|P4|NOT COMPLETED|Double Blind Titration Phase||15
486084|NCT00401245|1164247|P3|NOT COMPLETED|Double Blind Titration Phase||6
486085|NCT00401245|1164248|P2|NOT COMPLETED|Double Blind Titration Phase||3
486086|NCT00401245|1164249|P1|NOT COMPLETED|Double Blind Titration Phase||4
486087|NCT00401245|1164242|P8|COMPLETED|Double Blind Titration Phase||0
486088|NCT00401245|1164243|P7|COMPLETED|Double Blind Titration Phase||0
486089|NCT00401245|1164244|P6|COMPLETED|Double Blind Titration Phase||0
486090|NCT00401245|1164245|P5|COMPLETED|Double Blind Titration Phase||0
486091|NCT00401245|1164246|P4|COMPLETED|Double Blind Titration Phase||107
486092|NCT00401245|1164247|P3|COMPLETED|Double Blind Titration Phase||118
486093|NCT00401245|1164248|P2|COMPLETED|Double Blind Titration Phase||118
486094|NCT00401245|1164249|P1|COMPLETED|Double Blind Titration Phase||122
486095|NCT00401245|1164242|P8|STARTED|Double Blind Titration Phase||0
486096|NCT00401245|1164243|P7|STARTED|Double Blind Titration Phase||0
486097|NCT00401245|1164244|P6|STARTED|Double Blind Titration Phase||0
486098|NCT00401245|1164245|P5|STARTED|Double Blind Titration Phase||0
486099|NCT00401245|1164246|P4|STARTED|Double Blind Titration Phase||122
486100|NCT00401245|1164247|P3|STARTED|Double Blind Titration Phase||124
486101|NCT00401245|1164248|P2|STARTED|Double Blind Titration Phase||121
486102|NCT00401245|1164249|P1|STARTED|Double Blind Titration Phase||126
486103|NCT00401193|1164317|P3|NOT COMPLETED|Overall Study||6
486104|NCT00401193|1164318|P2|NOT COMPLETED|Overall Study||11
486105|NCT00401193|1164319|P1|NOT COMPLETED|Overall Study||15
486106|NCT00401193|1164317|P3|COMPLETED|Overall Study||63
486107|NCT00401193|1164318|P2|COMPLETED|Overall Study||106
486108|NCT00401193|1164319|P1|COMPLETED|Overall Study||103
486109|NCT00401193|1164317|P3|Modified Intent to Treat Population|Overall Study||67
486110|NCT00401193|1164318|P2|Modified Intent to Treat Population|Overall Study||115
486111|NCT00401193|1164319|P1|Modified Intent to Treat Population|Overall Study||112
486112|NCT00401193|1164317|P3|Intent to Treat Population|Overall Study||67
486113|NCT00401193|1164318|P2|Intent to Treat Population|Overall Study||115
486114|NCT00401193|1164319|P1|Intent to Treat Population|Overall Study||115
486115|NCT00401193|1164317|P3|STARTED|Overall Study||69
486116|NCT00401193|1164318|P2|STARTED|Overall Study||117
486117|NCT00401193|1164319|P1|STARTED|Overall Study||118
486118|NCT00401102|1164333|P1|NOT COMPLETED|Overall Study||7
486119|NCT00401102|1164333|P1|COMPLETED|Overall Study||5
486120|NCT00401102|1164333|P1|STARTED|Overall Study||12
486121|NCT00400946|1164342|P5|NOT COMPLETED|Overall Study||38
486122|NCT00400946|1164343|P4|NOT COMPLETED|Overall Study||47
486123|NCT00400946|1164344|P3|NOT COMPLETED|Overall Study||2
486124|NCT00400946|1164345|P2|NOT COMPLETED|Overall Study||11
486125|NCT00400946|1164346|P1|NOT COMPLETED|Overall Study||14
486126|NCT00400946|1164342|P5|COMPLETED|Overall Study||206
486127|NCT00400946|1164343|P4|COMPLETED|Overall Study||4
486128|NCT00400946|1164344|P3|COMPLETED|Overall Study||40
486129|NCT00400946|1164345|P2|COMPLETED|Overall Study||221
486130|NCT00400946|1164346|P1|COMPLETED|Overall Study||217
486131|NCT00400946|1164342|P5|Eligible and Treated|Overall Study||243
486132|NCT00400946|1164343|P4|Eligible and Treated|Overall Study||46
486133|NCT00400946|1164344|P3|Eligible and Treated|Overall Study||42
486134|NCT00400946|1164345|P2|Eligible and Treated|Overall Study||232
486135|NCT00400946|1164346|P1|Eligible and Treated|Overall Study||231
486136|NCT00400946|1164342|P5|Evaluable for Day 32 MRD|Overall Study||168
486137|NCT00400946|1164343|P4|Evaluable for Day 32 MRD|Overall Study||12
486138|NCT00400946|1164344|P3|Evaluable for Day 32 MRD|Overall Study||33
486139|NCT00400946|1164345|P2|Evaluable for Day 32 MRD|Overall Study||167
486140|NCT00400946|1164346|P1|Evaluable for Day 32 MRD|Overall Study||166
486141|NCT00400946|1164342|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
486142|NCT00400946|1164343|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
486143|NCT00400946|1164344|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
486144|NCT00400946|1164345|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
486145|NCT00400946|1164346|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
486146|NCT00400946|1164342|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
486147|NCT00400946|1164343|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
486148|NCT00400946|1164344|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
486149|NCT00400946|1164345|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
486150|NCT00400946|1164346|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
486151|NCT00400946|1164342|P5|STARTED|Overall Study||244
486152|NCT00400946|1164343|P4|STARTED|Overall Study||51
486153|NCT00400946|1164344|P3|STARTED|Overall Study||42
486154|NCT00400946|1164345|P2|STARTED|Overall Study||232
486155|NCT00400946|1164346|P1|STARTED|Overall Study||231
486156|NCT00400881|1164374|P2|NOT COMPLETED|Overall Study||0
486157|NCT00400881|1164375|P1|NOT COMPLETED|Overall Study||0
486158|NCT00400881|1164374|P2|COMPLETED|Overall Study||60
486159|NCT00400881|1164375|P1|COMPLETED|Overall Study||62
486160|NCT00400881|1164374|P2|STARTED|Overall Study||60
486161|NCT00400881|1164375|P1|STARTED|Overall Study||62
486162|NCT00400829|1164383|P1|NOT COMPLETED|Overall Study||0
486163|NCT00400829|1164383|P1|COMPLETED|Overall Study||66
486164|NCT00400829|1164383|P1|STARTED|Overall Study||66
486165|NCT00400803|1164389|P1|NOT COMPLETED|Overall Study||0
486166|NCT00400803|1164389|P1|COMPLETED|Overall Study||35
486167|NCT00400803|1164389|P1|STARTED|Overall Study||35
486168|NCT00400764|1164405|P5|NOT COMPLETED|Phase II||11
486169|NCT00400764|1164406|P4|NOT COMPLETED|Phase II||26
486170|NCT00400764|1164407|P3|NOT COMPLETED|Phase II||23
486171|NCT00400764|1164408|P2|NOT COMPLETED|Phase II||0
486172|NCT00400764|1164409|P1|NOT COMPLETED|Phase II||0
486173|NCT00400764|1164405|P5|COMPLETED|Phase II||0
486174|NCT00400764|1164406|P4|COMPLETED|Phase II||0
486175|NCT00400764|1164407|P3|COMPLETED|Phase II||0
486176|NCT00400764|1164408|P2|COMPLETED|Phase II||0
486177|NCT00400764|1164409|P1|COMPLETED|Phase II||0
486178|NCT00400764|1164405|P5|Treated|Phase II||11
486179|NCT00400764|1164406|P4|Treated|Phase II||26
486180|NCT00400764|1164407|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
486181|NCT00400764|1164408|P2|Treated|Phase II||0
486182|NCT00400764|1164409|P1|Treated|Phase II||0
486183|NCT00400764|1164405|P5|STARTED|Phase II||11
486184|NCT00400764|1164406|P4|STARTED|Phase II||26
486185|NCT00400764|1164407|P3|STARTED|Phase II||23
486186|NCT00400764|1164408|P2|STARTED|Phase II||0
486187|NCT00400764|1164409|P1|STARTED|Phase II||0
486188|NCT00400764|1164405|P5|NOT COMPLETED|Phase Ib||0
486189|NCT00400764|1164406|P4|NOT COMPLETED|Phase Ib||0
486190|NCT00400764|1164407|P3|NOT COMPLETED|Phase Ib||0
486191|NCT00400764|1164408|P2|NOT COMPLETED|Phase Ib||4
486192|NCT00400764|1164409|P1|NOT COMPLETED|Phase Ib||6
486193|NCT00400764|1164405|P5|COMPLETED|Phase Ib||0
486194|NCT00400764|1164406|P4|COMPLETED|Phase Ib||0
486195|NCT00400764|1164407|P3|COMPLETED|Phase Ib||0
486196|NCT00400764|1164408|P2|COMPLETED|Phase Ib||2
486197|NCT00400764|1164409|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
486198|NCT00400764|1164405|P5|Treated|Phase Ib||0
486199|NCT00400764|1164406|P4|Treated|Phase Ib||0
486200|NCT00400764|1164407|P3|Treated|Phase Ib||0
486201|NCT00400764|1164408|P2|Treated|Phase Ib||6
486202|NCT00400764|1164409|P1|Treated|Phase Ib||6
486203|NCT00400764|1164405|P5|STARTED|Phase Ib||0
486204|NCT00400764|1164406|P4|STARTED|Phase Ib||0
486205|NCT00400764|1164407|P3|STARTED|Phase Ib||0
486206|NCT00400764|1164408|P2|STARTED|Phase Ib||6
486207|NCT00400764|1164409|P1|STARTED|Phase Ib||6
486208|NCT00400712|1164462|P2|NOT COMPLETED|Overall Study||16
486209|NCT00400712|1164463|P1|NOT COMPLETED|Overall Study||17
486210|NCT00400712|1164462|P2|COMPLETED|Overall Study||35
486211|NCT00400712|1164463|P1|COMPLETED|Overall Study||35
486212|NCT00400712|1164462|P2|STARTED|Overall Study||51
486213|NCT00400712|1164463|P1|STARTED|Overall Study||52
486214|NCT00400686|1164481|P1|NOT COMPLETED|Overall Study||0
486215|NCT00400686|1164481|P1|COMPLETED|Overall Study||31
486216|NCT00400686|1164481|P1|STARTED|Overall Study||31
486217|NCT00400634|1164489|P2|NOT COMPLETED|Overall Study||1
486218|NCT00400634|1164490|P1|NOT COMPLETED|Overall Study||4
486219|NCT00400634|1164489|P2|COMPLETED|Overall Study||19
486220|NCT00400634|1164490|P1|COMPLETED|Overall Study||34
486221|NCT00400634|1164489|P2|STARTED|Overall Study||20
486222|NCT00400634|1164490|P1|STARTED|Overall Study||38
486223|NCT00400569|1164498|P1|NOT COMPLETED|Overall Study||1
486224|NCT00400569|1164498|P1|COMPLETED|Overall Study||47
486225|NCT00400569|1164498|P1|STARTED|Overall Study||48
486226|NCT00400400|1164511|P2|NOT COMPLETED|Overall Study||15
486227|NCT00400400|1164512|P1|NOT COMPLETED|Overall Study||14
486228|NCT00400400|1164511|P2|COMPLETED|Overall Study||185
486229|NCT00400400|1164512|P1|COMPLETED|Overall Study||186
486230|NCT00400400|1164511|P2|Intent-to-Treat Population|Overall Study||197
486231|NCT00400400|1164512|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
486232|NCT00400400|1164511|P2|STARTED|Overall Study||200
486233|NCT00400400|1164512|P1|STARTED|Overall Study||200
486234|NCT00400205|1164530|P1|NOT COMPLETED|Overall Study||5
486235|NCT00400205|1164530|P1|COMPLETED|Overall Study||9
486236|NCT00400205|1164530|P1|STARTED|Overall Study||14
486237|NCT00400179|1164536|P2|NOT COMPLETED|Overall Study||18
486238|NCT00400179|1164537|P1|NOT COMPLETED|Overall Study||6
486239|NCT00400179|1164536|P2|COMPLETED|Overall Study||508
486240|NCT00400179|1164537|P1|COMPLETED|Overall Study|Received Treatment|521
486241|NCT00400179|1164536|P2|STARTED|Overall Study||526
486242|NCT00400179|1164537|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
486243|NCT00400153|1164554|P3|NOT COMPLETED|Overall Study||61
486244|NCT00400153|1164555|P2|NOT COMPLETED|Overall Study||55
486245|NCT00400153|1164556|P1|NOT COMPLETED|Overall Study||48
486246|NCT00400153|1164554|P3|COMPLETED|Overall Study||422
486247|NCT00400153|1164555|P2|COMPLETED|Overall Study||436
486248|NCT00400153|1164556|P1|COMPLETED|Overall Study||438
486249|NCT00400153|1164554|P3|STARTED|Overall Study||483
486250|NCT00400153|1164555|P2|STARTED|Overall Study||491
486251|NCT00400153|1164556|P1|STARTED|Overall Study||486
486252|NCT00399893|1164803|P2|NOT COMPLETED|Overall Study||0
486253|NCT00399893|1164804|P1|NOT COMPLETED|Overall Study||1
486254|NCT00399893|1164803|P2|COMPLETED|Overall Study||3
486255|NCT00399893|1164804|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
486256|NCT00399893|1164803|P2|STARTED|Overall Study||3
486257|NCT00399893|1164804|P1|STARTED|Overall Study||2
486258|NCT00399763|1164832|P2|NOT COMPLETED|Overall Study||3
486259|NCT00399763|1164833|P1|NOT COMPLETED|Overall Study||2
486260|NCT00399763|1164832|P2|COMPLETED|Overall Study||32
486261|NCT00399763|1164833|P1|COMPLETED|Overall Study||33
486262|NCT00399763|1164832|P2|STARTED|Overall Study||35
486263|NCT00399763|1164833|P1|STARTED|Overall Study||35
486264|NCT00399568|1164845|P2|NOT COMPLETED|Overall Study||9
486265|NCT00399568|1164846|P1|NOT COMPLETED|Overall Study||12
486266|NCT00399568|1164845|P2|COMPLETED|Overall Study||156
486267|NCT00399568|1164846|P1|COMPLETED|Overall Study||154
486268|NCT00399568|1164845|P2|STARTED|Overall Study||165
486269|NCT00399568|1164846|P1|STARTED|Overall Study||166
486270|NCT00399542|1164860|P2|NOT COMPLETED|Overall Study||43
486271|NCT00399542|1164861|P1|NOT COMPLETED|Overall Study||84
486272|NCT00399542|1164860|P2|COMPLETED|Overall Study||151
486273|NCT00399542|1164861|P1|COMPLETED|Overall Study||303
486274|NCT00399542|1164860|P2|STARTED|Overall Study||194
486275|NCT00399542|1164861|P1|STARTED|Overall Study||387
486276|NCT00399516|1164923|P1|NOT COMPLETED|Overall Study||2
486277|NCT00399516|1164923|P1|COMPLETED|Overall Study||19
486278|NCT00399516|1164923|P1|STARTED|Overall Study||21
486279|NCT00399360|1164931|P4|NOT COMPLETED|Overall Study||6
486280|NCT00399360|1164932|P3|NOT COMPLETED|Overall Study||3
486281|NCT00399360|1164933|P2|NOT COMPLETED|Overall Study||3
486282|NCT00399360|1164934|P1|NOT COMPLETED|Overall Study||2
486283|NCT00399360|1164931|P4|COMPLETED|Overall Study||9
486284|NCT00399360|1164932|P3|COMPLETED|Overall Study||10
486285|NCT00399360|1164933|P2|COMPLETED|Overall Study||8
486286|NCT00399360|1164934|P1|COMPLETED|Overall Study||9
486287|NCT00399360|1164931|P4|STARTED|Overall Study||15
486288|NCT00399360|1164932|P3|STARTED|Overall Study||13
486289|NCT00399360|1164933|P2|STARTED|Overall Study||11
486290|NCT00399360|1164934|P1|STARTED|Overall Study||11
486291|NCT00399308|1164983|P3|NOT COMPLETED|Overall Study||1
486292|NCT00399308|1164984|P2|NOT COMPLETED|Overall Study||0
486293|NCT00399308|1164985|P1|NOT COMPLETED|Overall Study||0
486294|NCT00399308|1164983|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
486295|NCT00399308|1164984|P2|COMPLETED|Overall Study||15
486296|NCT00399308|1164985|P1|COMPLETED|Overall Study||13
486297|NCT00399308|1164983|P3|STARTED|Overall Study||12
486298|NCT00399308|1164984|P2|STARTED|Overall Study||15
486299|NCT00399308|1164985|P1|STARTED|Overall Study||13
486300|NCT00399035|1165005|P3|NOT COMPLETED|Overall Study||252
486301|NCT00399035|1165006|P2|NOT COMPLETED|Overall Study||158
486302|NCT00399035|1165007|P1|NOT COMPLETED|Overall Study||313
486303|NCT00399035|1165005|P3|COMPLETED|Overall Study||106
486304|NCT00399035|1165006|P2|COMPLETED|Overall Study||58
486305|NCT00399035|1165007|P1|COMPLETED|Overall Study||189
486306|NCT00399035|1165005|P3|STARTED|Overall Study||358
486307|NCT00399035|1165006|P2|STARTED|Overall Study||216
486308|NCT00399035|1165007|P1|STARTED|Overall Study||502
486309|NCT00398983|1165028|P2|NOT COMPLETED|Overall Study||0
486310|NCT00398983|1165029|P1|NOT COMPLETED|Overall Study||0
486311|NCT00398983|1165028|P2|COMPLETED|Overall Study||25
486312|NCT00398983|1165029|P1|COMPLETED|Overall Study||20
486313|NCT00398983|1165028|P2|STARTED|Overall Study||25
486314|NCT00398983|1165029|P1|STARTED|Overall Study||20
486315|NCT00398918|1165035|P1|NOT COMPLETED|Overall Study||0
486316|NCT00398918|1165035|P1|COMPLETED|Overall Study||10
486317|NCT00398918|1165035|P1|STARTED|Overall Study||10
486318|NCT00398632|1165040|P1|NOT COMPLETED|Overall Study||2
486319|NCT00398632|1165040|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
486320|NCT00398632|1165040|P1|STARTED|Overall Study||6
486321|NCT00398411|1165046|P2|NOT COMPLETED|Overall Study||1
486322|NCT00398411|1165047|P1|NOT COMPLETED|Overall Study||0
486323|NCT00398411|1165046|P2|COMPLETED|Overall Study||31
486324|NCT00398411|1165047|P1|COMPLETED|Overall Study||34
486325|NCT00398411|1165046|P2|STARTED|Overall Study||32
486326|NCT00398411|1165047|P1|STARTED|Overall Study||34
486327|NCT00398398|1165063|P1|NOT COMPLETED|Overall Study||0
486328|NCT00398398|1165063|P1|COMPLETED|Overall Study||44
486329|NCT00398398|1165063|P1|STARTED|Overall Study||44
486330|NCT00398320|1165070|P1|NOT COMPLETED|Overall Study||6
486331|NCT00398320|1165070|P1|COMPLETED|Overall Study||34
486332|NCT00398320|1165070|P1|STARTED|Overall Study||40
486333|NCT00398216|1165083|P5|NOT COMPLETED|Overall Study||15
486334|NCT00398216|1165084|P4|NOT COMPLETED|Overall Study||22
486335|NCT00398216|1165085|P3|NOT COMPLETED|Overall Study||21
486336|NCT00398216|1165086|P2|NOT COMPLETED|Overall Study||19
486337|NCT00398216|1165087|P1|NOT COMPLETED|Overall Study||11
486338|NCT00398216|1165083|P5|COMPLETED|Overall Study||157
486339|NCT00398216|1165084|P4|COMPLETED|Overall Study||155
486340|NCT00398216|1165085|P3|COMPLETED|Overall Study||164
486341|NCT00398216|1165086|P2|COMPLETED|Overall Study||151
486342|NCT00398216|1165087|P1|COMPLETED|Overall Study||181
486343|NCT00398216|1165083|P5|STARTED|Overall Study||172
486344|NCT00398216|1165084|P4|STARTED|Overall Study||177
486345|NCT00398216|1165085|P3|STARTED|Overall Study||185
486346|NCT00398216|1165086|P2|STARTED|Overall Study||170
486347|NCT00398216|1165087|P1|STARTED|Overall Study||192
486348|NCT00398138|1165114|P1|NOT COMPLETED|Overall Study||2
486349|NCT00398138|1165114|P1|COMPLETED|Overall Study||10
486350|NCT00398138|1165114|P1|STARTED|Overall Study||12
486351|NCT00398112|1165119|P1|NOT COMPLETED|Overall Study||18
486352|NCT00398112|1165119|P1|COMPLETED|Overall Study||0
486353|NCT00398112|1165119|P1|STARTED|Overall Study||18
486354|NCT00398086|1165130|P3|NOT COMPLETED|Overall Study||2
486355|NCT00398086|1165131|P2|NOT COMPLETED|Overall Study||23
486356|NCT00398086|1165132|P1|NOT COMPLETED|Overall Study||9
486357|NCT00398086|1165130|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
486358|NCT00398086|1165131|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
486359|NCT00398086|1165132|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
486360|NCT00398086|1165130|P3|Phase 1, Dose Escalation Population|Overall Study||3
486361|NCT00398086|1165131|P2|Phase 1, Dose Escalation Population|Overall Study||7
486362|NCT00398086|1165132|P1|Phase 1, Dose Escalation Population|Overall Study||20
486363|NCT00398086|1165130|P3|STARTED|Overall Study||3
486364|NCT00398086|1165131|P2|STARTED|Overall Study||44
486365|NCT00398086|1165132|P1|STARTED|Overall Study||20
486366|NCT00398073|1165166|P2|NOT COMPLETED|Overall Study||0
486367|NCT00398073|1165167|P1|NOT COMPLETED|Overall Study||1
486368|NCT00398073|1165166|P2|COMPLETED|Overall Study||17
486369|NCT00398073|1165167|P1|COMPLETED|Overall Study||17
486370|NCT00398073|1165166|P2|STARTED|Overall Study||17
486371|NCT00398073|1165167|P1|STARTED|Overall Study||18
486372|NCT00398047|1165177|P1|NOT COMPLETED|Overall Study||3
486373|NCT00398047|1165177|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
486374|NCT00398047|1165177|P1|STARTED|Overall Study||3
486375|NCT00397982|1165187|P1|NOT COMPLETED|Overall Study||4
486376|NCT00397982|1165187|P1|COMPLETED|Overall Study||13
486377|NCT00397982|1165187|P1|STARTED|Overall Study||17
486378|NCT00397930|1165198|P2|NOT COMPLETED|Overall Study||51
486379|NCT00397930|1165199|P1|NOT COMPLETED|Overall Study||38
486380|NCT00397930|1165198|P2|COMPLETED|Overall Study||153
486381|NCT00397930|1165199|P1|COMPLETED|Overall Study||168
486382|NCT00397930|1165198|P2|STARTED|Overall Study||204
486383|NCT00397930|1165199|P1|STARTED|Overall Study||206
486384|NCT00397904|1165205|P1|NOT COMPLETED|Overall Study||0
486385|NCT00397904|1165205|P1|COMPLETED|Overall Study||16
486386|NCT00397904|1165205|P1|STARTED|Overall Study||16
486387|NCT00397891|1165214|P5|NOT COMPLETED|Overall Study||1
486388|NCT00397891|1165215|P4|NOT COMPLETED|Overall Study||0
486389|NCT00397891|1165216|P3|NOT COMPLETED|Overall Study||0
486390|NCT00397891|1165217|P2|NOT COMPLETED|Overall Study||0
486391|NCT00397891|1165218|P1|NOT COMPLETED|Overall Study||1
486392|NCT00397891|1165214|P5|COMPLETED|Overall Study||7
486393|NCT00397891|1165215|P4|COMPLETED|Overall Study||6
486394|NCT00397891|1165216|P3|COMPLETED|Overall Study||6
486395|NCT00397891|1165217|P2|COMPLETED|Overall Study||6
486396|NCT00397891|1165218|P1|COMPLETED|Overall Study||5
486397|NCT00397891|1165214|P5|STARTED|Overall Study||8
486398|NCT00397891|1165215|P4|STARTED|Overall Study||6
486399|NCT00397891|1165216|P3|STARTED|Overall Study||6
486400|NCT00397891|1165217|P2|STARTED|Overall Study||6
486401|NCT00397891|1165218|P1|STARTED|Overall Study||6
486402|NCT00397878|1165316|P1|NOT COMPLETED|Overall Study||0
486403|NCT00397878|1165316|P1|COMPLETED|Overall Study||10
486404|NCT00397878|1165316|P1|STARTED|Overall Study||10
486405|NCT00397839|1165322|P2|NOT COMPLETED|Overall Study||18
486406|NCT00397839|1165323|P1|NOT COMPLETED|Overall Study||7
486407|NCT00397839|1165322|P2|COMPLETED|Overall Study||69
486408|NCT00397839|1165323|P1|COMPLETED|Overall Study||41
486409|NCT00397839|1165322|P2|STARTED|Overall Study||87
486410|NCT00397839|1165323|P1|STARTED|Overall Study||48
486411|NCT00397631|1165339|P2|NOT COMPLETED|Overall Study||44
486412|NCT00397631|1165340|P1|NOT COMPLETED|Overall Study||30
486413|NCT00397631|1165339|P2|COMPLETED|Overall Study||215
486414|NCT00397631|1165340|P1|COMPLETED|Overall Study||231
486415|NCT00397631|1165339|P2|STARTED|Overall Study||259
486416|NCT00397631|1165340|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
486417|NCT00397540|1165352|P2|NOT COMPLETED|Overall Study||0
486418|NCT00397540|1165353|P1|NOT COMPLETED|Overall Study||1
486419|NCT00397540|1165352|P2|COMPLETED|Overall Study||85
486420|NCT00397540|1165353|P1|COMPLETED|Overall Study||59
486421|NCT00397540|1165352|P2|STARTED|Overall Study||85
486422|NCT00397540|1165353|P1|STARTED|Overall Study||60
486423|NCT00397514|1165359|P1|NOT COMPLETED|Overall Study||9
486424|NCT00397514|1165359|P1|COMPLETED|Overall Study||25
486425|NCT00397514|1165359|P1|STARTED|Overall Study||34
486426|NCT00397488|1165369|P1|NOT COMPLETED|Overall Study||7
486427|NCT00397488|1165369|P1|COMPLETED|Overall Study||71
486428|NCT00397488|1165369|P1|STARTED|Overall Study||78
486429|NCT00397462|1165376|P3|NOT COMPLETED|Overall Study||0
486430|NCT00397462|1165377|P2|NOT COMPLETED|Overall Study||0
486431|NCT00397462|1165378|P1|NOT COMPLETED|Overall Study||0
486432|NCT00397462|1165376|P3|COMPLETED|Overall Study||15
486433|NCT00397462|1165377|P2|COMPLETED|Overall Study||13
486434|NCT00397462|1165378|P1|COMPLETED|Overall Study||16
486435|NCT00397462|1165376|P3|STARTED|Overall Study||15
486436|NCT00397462|1165377|P2|STARTED|Overall Study||13
486437|NCT00397462|1165378|P1|STARTED|Overall Study||16
486438|NCT00397254|1165389|P2|NOT COMPLETED|Overall Study||2
486439|NCT00397254|1165390|P1|NOT COMPLETED|Overall Study||2
486440|NCT00397254|1165389|P2|COMPLETED|Overall Study||74
486441|NCT00397254|1165390|P1|COMPLETED|Overall Study||77
486442|NCT00397254|1165389|P2|STARTED|Overall Study||76
486443|NCT00397254|1165390|P1|STARTED|Overall Study||79
486444|NCT00397215|1165412|P4|NOT COMPLETED|Month 24 (Day 720)||0
486445|NCT00397215|1165413|P3|NOT COMPLETED|Month 24 (Day 720)||0
486446|NCT00397215|1165414|P2|NOT COMPLETED|Month 24 (Day 720)||0
486447|NCT00397215|1165415|P1|NOT COMPLETED|Month 24 (Day 720)||0
486448|NCT00397215|1165412|P4|COMPLETED|Month 24 (Day 720)||36
486449|NCT00397215|1165413|P3|COMPLETED|Month 24 (Day 720)||117
486450|NCT00397215|1165414|P2|COMPLETED|Month 24 (Day 720)||45
486451|NCT00397215|1165415|P1|COMPLETED|Month 24 (Day 720)||122
486452|NCT00397215|1165412|P4|STARTED|Month 24 (Day 720)||36
486453|NCT00397215|1165413|P3|STARTED|Month 24 (Day 720)||117
486454|NCT00397215|1165414|P2|STARTED|Month 24 (Day 720)||45
486455|NCT00397215|1165415|P1|STARTED|Month 24 (Day 720)||122
486456|NCT00397215|1165412|P4|NOT COMPLETED|Month 12 (Day 360)||0
486457|NCT00397215|1165413|P3|NOT COMPLETED|Month 12 (Day 360)||0
486458|NCT00397215|1165414|P2|NOT COMPLETED|Month 12 (Day 360)||0
486459|NCT00397215|1165415|P1|NOT COMPLETED|Month 12 (Day 360)||0
486460|NCT00397215|1165412|P4|COMPLETED|Month 12 (Day 360)||42
486461|NCT00397215|1165413|P3|COMPLETED|Month 12 (Day 360)||125
486462|NCT00397215|1165414|P2|COMPLETED|Month 12 (Day 360)||48
486463|NCT00397215|1165415|P1|COMPLETED|Month 12 (Day 360)||130
486464|NCT00397215|1165412|P4|STARTED|Month 12 (Day 360)||42
486465|NCT00397215|1165413|P3|STARTED|Month 12 (Day 360)||125
486466|NCT00397215|1165414|P2|STARTED|Month 12 (Day 360)||48
486467|NCT00397215|1165415|P1|STARTED|Month 12 (Day 360)||130
486468|NCT00397215|1165412|P4|NOT COMPLETED|Month 6 (Day 180)||0
486469|NCT00397215|1165413|P3|NOT COMPLETED|Month 6 (Day 180)||5
486470|NCT00397215|1165414|P2|NOT COMPLETED|Month 6 (Day 180)||3
486471|NCT00397215|1165415|P1|NOT COMPLETED|Month 6 (Day 180)||2
486472|NCT00397215|1165412|P4|COMPLETED|Month 6 (Day 180)||51
486473|NCT00397215|1165413|P3|COMPLETED|Month 6 (Day 180)||153
486474|NCT00397215|1165414|P2|COMPLETED|Month 6 (Day 180)||55
486475|NCT00397215|1165415|P1|COMPLETED|Month 6 (Day 180)||162
486476|NCT00397215|1165412|P4|STARTED|Month 6 (Day 180)||51
486477|NCT00397215|1165413|P3|STARTED|Month 6 (Day 180)||158
486478|NCT00397215|1165414|P2|STARTED|Month 6 (Day 180)||58
486479|NCT00397215|1165415|P1|STARTED|Month 6 (Day 180)||164
486480|NCT00397215|1165412|P4|NOT COMPLETED|Month 0 (Day 0)||4
486481|NCT00397215|1165413|P3|NOT COMPLETED|Month 0 (Day 0)||6
486482|NCT00397215|1165414|P2|NOT COMPLETED|Month 0 (Day 0)||5
486483|NCT00397215|1165415|P1|NOT COMPLETED|Month 0 (Day 0)||7
486484|NCT00397215|1165412|P4|COMPLETED|Month 0 (Day 0)||48
486485|NCT00397215|1165413|P3|COMPLETED|Month 0 (Day 0)||153
486486|NCT00397215|1165414|P2|COMPLETED|Month 0 (Day 0)||56
486487|NCT00397215|1165415|P1|COMPLETED|Month 0 (Day 0)||158
486488|NCT00397215|1165412|P4|STARTED|Month 0 (Day 0)||52
486489|NCT00397215|1165413|P3|STARTED|Month 0 (Day 0)||159
486490|NCT00397215|1165414|P2|STARTED|Month 0 (Day 0)||61
486491|NCT00397215|1165415|P1|STARTED|Month 0 (Day 0)||165
486492|NCT00397189|1165551|P2|NOT COMPLETED|Extension Period||43
486493|NCT00397189|1165552|P1|NOT COMPLETED|Extension Period||113
486494|NCT00397189|1165551|P2|COMPLETED|Extension Period||134
486495|NCT00397189|1165552|P1|COMPLETED|Extension Period||421
486496|NCT00397189|1165551|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
486497|NCT00397189|1165552|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
486498|NCT00397189|1165551|P2|NOT COMPLETED|3 Weeks Period||22
486499|NCT00397189|1165552|P1|NOT COMPLETED|3 Weeks Period||21
486500|NCT00397189|1165551|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
486501|NCT00397189|1165552|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
486502|NCT00397189|1165551|P2|STARTED|3 Weeks Period||395
486503|NCT00397189|1165552|P1|STARTED|3 Weeks Period||394
486504|NCT00397150|1165560|P2|NOT COMPLETED|Overall Study||145
486505|NCT00397150|1165561|P1|NOT COMPLETED|Overall Study||135
486506|NCT00397150|1165560|P2|COMPLETED|Overall Study||1111
486507|NCT00397150|1165561|P1|COMPLETED|Overall Study||1188
486508|NCT00397150|1165560|P2|STARTED|Overall Study||1256
486509|NCT00397150|1165561|P1|STARTED|Overall Study||1323
486510|NCT00397033|1165576|P3|NOT COMPLETED|Overall Study||23
486511|NCT00397033|1165577|P2|NOT COMPLETED|Overall Study||37
486512|NCT00397033|1165578|P1|NOT COMPLETED|Overall Study||44
486513|NCT00397033|1165576|P3|COMPLETED|Overall Study||77
486514|NCT00397033|1165577|P2|COMPLETED|Overall Study||72
486515|NCT00397033|1165578|P1|COMPLETED|Overall Study||63
486516|NCT00397033|1165576|P3|ITT Population|Overall Study||98
486517|NCT00397033|1165577|P2|ITT Population|Overall Study||105
486518|NCT00397033|1165578|P1|ITT Population|Overall Study||107
486519|NCT00397033|1165576|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
486520|NCT00397033|1165577|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
486521|NCT00397033|1165578|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
486522|NCT00397033|1165576|P3|STARTED|Overall Study||100
486523|NCT00397033|1165577|P2|STARTED|Overall Study||109
486524|NCT00397033|1165578|P1|STARTED|Overall Study||107
486525|NCT00396981|1165639|P2|NOT COMPLETED|Overall Study||9
486526|NCT00396981|1165640|P1|NOT COMPLETED|Overall Study||15
486527|NCT00396981|1165639|P2|COMPLETED|Overall Study||306
486528|NCT00396981|1165640|P1|COMPLETED|Overall Study||296
486529|NCT00396981|1165639|P2|STARTED|Overall Study||315
486530|NCT00396981|1165640|P1|STARTED|Overall Study||311
486531|NCT00396877|1165660|P2|NOT COMPLETED|Overall Study||8
486532|NCT00396877|1165661|P1|NOT COMPLETED|Overall Study||6
486533|NCT00396877|1165660|P2|COMPLETED|Overall Study|Completed follow-up|459
486534|NCT00396877|1165661|P1|COMPLETED|Overall Study|Completed follow-up|433
486535|NCT00396877|1165660|P2|Completed Treatment|Overall Study||352
486536|NCT00396877|1165661|P1|Completed Treatment|Overall Study||356
486537|NCT00396877|1165660|P2|Treated|Overall Study||464
486538|NCT00396877|1165661|P1|Treated|Overall Study||436
486539|NCT00396877|1165660|P2|STARTED|Overall Study|Randomized|467
486540|NCT00396877|1165661|P1|STARTED|Overall Study|Randomized|439
486541|NCT00396812|1165671|P1|NOT COMPLETED|Overall Study||1
486542|NCT00396812|1165671|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
486543|NCT00396812|1165671|P1|STARTED|Overall Study||4
486544|NCT00396656|1165683|P2|NOT COMPLETED|Second Treatment Period||1
486545|NCT00396656|1165684|P1|NOT COMPLETED|Second Treatment Period||0
486546|NCT00396656|1165683|P2|COMPLETED|Second Treatment Period||12
486547|NCT00396656|1165684|P1|COMPLETED|Second Treatment Period||15
486548|NCT00396656|1165683|P2|STARTED|Second Treatment Period||13
486549|NCT00396656|1165684|P1|STARTED|Second Treatment Period||15
486550|NCT00396656|1165683|P2|NOT COMPLETED|First Treatment Period||2
486551|NCT00396656|1165684|P1|NOT COMPLETED|First Treatment Period||0
486552|NCT00396656|1165683|P2|COMPLETED|First Treatment Period||13
486553|NCT00396656|1165684|P1|COMPLETED|First Treatment Period||15
486554|NCT00396656|1165683|P2|STARTED|First Treatment Period||15
486555|NCT00396656|1165684|P1|STARTED|First Treatment Period||15
486556|NCT00396630|1165702|P2|NOT COMPLETED|Overall Study||5
486557|NCT00396630|1165703|P1|NOT COMPLETED|Overall Study||5
486558|NCT00396630|1165702|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
486559|NCT00396630|1165703|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
486560|NCT00396630|1165702|P2|STARTED|Overall Study||100
486561|NCT00396630|1165703|P1|STARTED|Overall Study||100
486562|NCT00396591|1165720|P1|NOT COMPLETED|Overall Study||16
486563|NCT00396591|1165720|P1|COMPLETED|Overall Study||0
486564|NCT00396591|1165720|P1|STARTED|Overall Study||16
486565|NCT00396565|1165733|P3|NOT COMPLETED|Overall Study||17
486566|NCT00396565|1165734|P2|NOT COMPLETED|Overall Study||91
486567|NCT00396565|1165735|P1|NOT COMPLETED|Overall Study||48
486568|NCT00396565|1165733|P3|COMPLETED|Overall Study||30
486569|NCT00396565|1165734|P2|COMPLETED|Overall Study||47
486570|NCT00396565|1165735|P1|COMPLETED|Overall Study||88
486571|NCT00396565|1165733|P3|STARTED|Overall Study||47
486572|NCT00396565|1165734|P2|STARTED|Overall Study||138
486573|NCT00396565|1165735|P1|STARTED|Overall Study||136
486574|NCT00396409|1165760|P2|NOT COMPLETED|Period 2 - 2008||2
486575|NCT00396409|1165761|P1|NOT COMPLETED|Period 2 - 2008||7
486576|NCT00396409|1165760|P2|COMPLETED|Period 2 - 2008||53
486577|NCT00396409|1165761|P1|COMPLETED|Period 2 - 2008||52
486578|NCT00396409|1165760|P2|STARTED|Period 2 - 2008||55
486579|NCT00396409|1165761|P1|STARTED|Period 2 - 2008||59
486580|NCT00396409|1165760|P2|NOT COMPLETED|Between Period 1 and Period 2||2
486581|NCT00396409|1165761|P1|NOT COMPLETED|Between Period 1 and Period 2||3
486582|NCT00396409|1165760|P2|COMPLETED|Between Period 1 and Period 2||55
486583|NCT00396409|1165761|P1|COMPLETED|Between Period 1 and Period 2||59
486584|NCT00396409|1165760|P2|STARTED|Between Period 1 and Period 2||57
486585|NCT00396409|1165761|P1|STARTED|Between Period 1 and Period 2||62
486586|NCT00396409|1165760|P2|NOT COMPLETED|Period 1 - 2007||6
486587|NCT00396409|1165761|P1|NOT COMPLETED|Period 1 - 2007||3
486588|NCT00396409|1165760|P2|COMPLETED|Period 1 - 2007||57
486589|NCT00396409|1165761|P1|COMPLETED|Period 1 - 2007||62
486590|NCT00396409|1165760|P2|STARTED|Period 1 - 2007||63
486591|NCT00396409|1165761|P1|STARTED|Period 1 - 2007||65
486592|NCT00396383|1165791|P1|NOT COMPLETED|Overall Study||3
486593|NCT00396383|1165791|P1|COMPLETED|Overall Study||6
486594|NCT00396383|1165791|P1|STARTED|Overall Study||9
486595|NCT00396331|1165804|P1|NOT COMPLETED|Overall Study||32
486596|NCT00396331|1165804|P1|COMPLETED|Overall Study||68
486597|NCT00396331|1165804|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
486598|NCT00396331|1165804|P1|Number of Participants Treated|Overall Study||100
486599|NCT00396331|1165804|P1|STARTED|Overall Study||100
486600|NCT00396318|1165857|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
486601|NCT00396318|1165857|P1|COMPLETED|7-Day Post-Treatment Contact||240
486602|NCT00396318|1165857|P1|STARTED|7-Day Post-Treatment Contact||241
486603|NCT00396318|1165857|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
486604|NCT00396318|1165857|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
486605|NCT00396318|1165857|P1|STARTED|48- to 96-Hour Follow-Up Period||246
486606|NCT00396318|1165857|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
486607|NCT00396318|1165857|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
486608|NCT00396318|1165857|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
486609|NCT00396292|1165870|P2|NOT COMPLETED|Overall Study||16
486610|NCT00396292|1165871|P1|NOT COMPLETED|Overall Study||9
486611|NCT00396292|1165870|P2|COMPLETED|Overall Study||162
486612|NCT00396292|1165871|P1|COMPLETED|Overall Study||165
486613|NCT00396292|1165870|P2|STARTED|Overall Study||178
486614|NCT00396292|1165871|P1|STARTED|Overall Study||174
486615|NCT00396279|1165877|P1|NOT COMPLETED|Overall Study||30
486616|NCT00396279|1165877|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
486617|NCT00396279|1165877|P1|STARTED|Overall Study||37
486618|NCT00396266|1165888|P2|NOT COMPLETED|Overall Study||0
486619|NCT00396266|1165889|P1|NOT COMPLETED|Overall Study||0
486620|NCT00396266|1165888|P2|COMPLETED|Overall Study||14
486621|NCT00396266|1165889|P1|COMPLETED|Overall Study||8
486622|NCT00396266|1165888|P2|STARTED|Overall Study||14
486623|NCT00396266|1165889|P1|STARTED|Overall Study||8
486624|NCT00396253|1165910|P1|NOT COMPLETED|Overall Study||13
486625|NCT00396253|1165910|P1|COMPLETED|Overall Study||210
486626|NCT00396253|1165910|P1|STARTED|Overall Study||223
486627|NCT00396201|1165922|P1|NOT COMPLETED|Follow-up Period||0
486628|NCT00396201|1165922|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
486629|NCT00396201|1165922|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
486630|NCT00396201|1165922|P1|NOT COMPLETED|Treatment Period||0
486631|NCT00396201|1165922|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
486632|NCT00396201|1165922|P1|STARTED|Treatment Period||22
486633|NCT00396162|1165941|P2|NOT COMPLETED|Overall Study||3
486634|NCT00396162|1165942|P1|NOT COMPLETED|Overall Study||2
486635|NCT00396162|1165941|P2|COMPLETED|Overall Study||35
486636|NCT00396162|1165942|P1|COMPLETED|Overall Study||37
486637|NCT00396162|1165941|P2|STARTED|Overall Study||38
486638|NCT00396162|1165942|P1|STARTED|Overall Study||39
486639|NCT00396136|1165954|P1|NOT COMPLETED|Overall Study||125
486640|NCT00396136|1165954|P1|COMPLETED|Overall Study||96
486641|NCT00396136|1165954|P1|STARTED|Overall Study||221
486642|NCT00396097|1165961|P2|NOT COMPLETED|Overall Study||46
486643|NCT00396097|1165962|P1|NOT COMPLETED|Overall Study||26
486644|NCT00396097|1165961|P2|COMPLETED|Overall Study||156
486645|NCT00396097|1165962|P1|COMPLETED|Overall Study||88
486646|NCT00396097|1165961|P2|STARTED|Overall Study||202
486647|NCT00396097|1165962|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
486648|NCT00396084|1165990|P6|NOT COMPLETED|Overall Study||2
486649|NCT00396084|1165991|P5|NOT COMPLETED|Overall Study||1
486650|NCT00396084|1165992|P4|NOT COMPLETED|Overall Study||1
486651|NCT00396084|1165993|P3|NOT COMPLETED|Overall Study||0
486652|NCT00396084|1165994|P2|NOT COMPLETED|Overall Study||0
486653|NCT00396084|1165995|P1|NOT COMPLETED|Overall Study||0
486654|NCT00396084|1165990|P6|COMPLETED|Overall Study||18
486655|NCT00396084|1165991|P5|COMPLETED|Overall Study||9
486656|NCT00396084|1165992|P4|COMPLETED|Overall Study||9
486657|NCT00396084|1165993|P3|COMPLETED|Overall Study||10
486658|NCT00396084|1165994|P2|COMPLETED|Overall Study||10
486659|NCT00396084|1165995|P1|COMPLETED|Overall Study||10
486660|NCT00396084|1165990|P6|STARTED|Overall Study||20
486661|NCT00396084|1165991|P5|STARTED|Overall Study||10
486662|NCT00396084|1165992|P4|STARTED|Overall Study||10
486663|NCT00396084|1165993|P3|STARTED|Overall Study||10
486664|NCT00396084|1165994|P2|STARTED|Overall Study||10
486665|NCT00396084|1165995|P1|STARTED|Overall Study||10
486666|NCT00396032|1166070|P2|NOT COMPLETED|Overall Study||5
486667|NCT00396032|1166071|P1|NOT COMPLETED|Overall Study||4
486668|NCT00396032|1166070|P2|COMPLETED|Overall Study||71
486669|NCT00396032|1166071|P1|COMPLETED|Overall Study||70
486670|NCT00396032|1166070|P2|STARTED|Overall Study||76
486671|NCT00396032|1166071|P1|STARTED|Overall Study||74
486672|NCT00396006|1166085|P1|NOT COMPLETED|Overall Study||0
486673|NCT00396006|1166085|P1|COMPLETED|Overall Study||13
486674|NCT00396006|1166085|P1|STARTED|Overall Study||13
486675|NCT00395993|1166102|P2|NOT COMPLETED|Overall Study||19
486676|NCT00395993|1166103|P1|NOT COMPLETED|Overall Study||35
486677|NCT00395993|1166102|P2|COMPLETED|Overall Study||212
486678|NCT00395993|1166103|P1|COMPLETED|Overall Study||211
486679|NCT00395993|1166102|P2|STARTED|Overall Study||231
486680|NCT00395993|1166103|P1|STARTED|Overall Study||246
486681|NCT00395967|1166109|P1|NOT COMPLETED|Follow-up Period||2
486682|NCT00395967|1166109|P1|COMPLETED|Follow-up Period||3
486683|NCT00395967|1166109|P1|STARTED|Follow-up Period|Participants who had transplants.|5
486684|NCT00395967|1166109|P1|NOT COMPLETED|Treatment Period||1
486685|NCT00395967|1166109|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
486686|NCT00395967|1166109|P1|STARTED|Treatment Period||5
486687|NCT00395876|1166120|P2|NOT COMPLETED|Overall Study||0
486688|NCT00395876|1166121|P1|NOT COMPLETED|Overall Study||3
486689|NCT00395876|1166120|P2|COMPLETED|Overall Study||50
486690|NCT00395876|1166121|P1|COMPLETED|Overall Study||47
486691|NCT00395876|1166120|P2|STARTED|Overall Study||50
486692|NCT00395876|1166121|P1|STARTED|Overall Study||50
486693|NCT00395863|1166149|P2|NOT COMPLETED|Overall Study||3
486694|NCT00395863|1166150|P1|NOT COMPLETED|Overall Study||2
486695|NCT00395863|1166149|P2|COMPLETED|Overall Study||20
486696|NCT00395863|1166150|P1|COMPLETED|Overall Study||21
486697|NCT00395863|1166149|P2|STARTED|Overall Study||23
486698|NCT00395863|1166150|P1|STARTED|Overall Study||23
486699|NCT00395850|1166185|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
486700|NCT00395850|1166186|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
486701|NCT00395850|1166187|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
486702|NCT00395850|1166188|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
486703|NCT00395850|1166185|P4|COMPLETED|Disulfiram/Placebo Treatment||8
486704|NCT00395850|1166186|P3|COMPLETED|Disulfiram/Placebo Treatment||5
486705|NCT00395850|1166187|P2|COMPLETED|Disulfiram/Placebo Treatment||9
486706|NCT00395850|1166188|P1|COMPLETED|Disulfiram/Placebo Treatment||11
486707|NCT00395850|1166185|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
486708|NCT00395850|1166186|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
486709|NCT00395850|1166187|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
486710|NCT00395850|1166188|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
486711|NCT00395850|1166185|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
486712|NCT00395850|1166186|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
486713|NCT00395850|1166187|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
486714|NCT00395850|1166188|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
486715|NCT00395850|1166185|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
486716|NCT00395850|1166186|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
486717|NCT00395850|1166187|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
486718|NCT00395850|1166188|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
486719|NCT00395850|1166185|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
486720|NCT00395850|1166186|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
486721|NCT00395850|1166187|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
486722|NCT00395850|1166188|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
486723|NCT00395850|1166185|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
486724|NCT00395850|1166186|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
486725|NCT00395850|1166187|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
486726|NCT00395850|1166188|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
486727|NCT00395850|1166185|P4|COMPLETED|Pre-randomization Baseline/Induction||0
486728|NCT00395850|1166186|P3|COMPLETED|Pre-randomization Baseline/Induction||0
486729|NCT00395850|1166187|P2|COMPLETED|Pre-randomization Baseline/Induction||0
486730|NCT00395850|1166188|P1|COMPLETED|Pre-randomization Baseline/Induction||107
486731|NCT00395850|1166185|P4|STARTED|Pre-randomization Baseline/Induction||0
486732|NCT00395850|1166186|P3|STARTED|Pre-randomization Baseline/Induction||0
486733|NCT00395850|1166187|P2|STARTED|Pre-randomization Baseline/Induction||0
486734|NCT00395850|1166188|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
486735|NCT00395746|1166205|P3|NOT COMPLETED|Overall Study||22
486736|NCT00395746|1166206|P2|NOT COMPLETED|Overall Study||4
486737|NCT00395746|1166207|P1|NOT COMPLETED|Overall Study||10
486738|NCT00395746|1166205|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
486739|NCT00395746|1166206|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
486740|NCT00395746|1166207|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
486741|NCT00395746|1166205|P3|STARTED|Overall Study|Exposed to study drug|88
486742|NCT00395746|1166206|P2|STARTED|Overall Study|Exposed to study drug|88
486743|NCT00395746|1166207|P1|STARTED|Overall Study|Exposed to study drug|88
486744|NCT00395733|1166253|P2|NOT COMPLETED|Period 2||5
486745|NCT00395733|1166254|P1|NOT COMPLETED|Period 2||2
486746|NCT00395733|1166253|P2|COMPLETED|Period 2||37
486747|NCT00395733|1166254|P1|COMPLETED|Period 2||39
486748|NCT00395733|1166253|P2|STARTED|Period 2||42
486749|NCT00395733|1166254|P1|STARTED|Period 2||41
486750|NCT00395733|1166253|P2|NOT COMPLETED|Period 1||0
486751|NCT00395733|1166254|P1|NOT COMPLETED|Period 1||0
486752|NCT00395733|1166253|P2|COMPLETED|Period 1||42
486753|NCT00395733|1166254|P1|COMPLETED|Period 1||41
486754|NCT00395733|1166253|P2|STARTED|Period 1||42
486755|NCT00395733|1166254|P1|STARTED|Period 1||41
486756|NCT00395694|1166278|P2|NOT COMPLETED|Continuation Phase||13
486757|NCT00395694|1166279|P1|NOT COMPLETED|Continuation Phase||15
486758|NCT00395694|1166278|P2|COMPLETED|Continuation Phase||35
486759|NCT00395694|1166279|P1|COMPLETED|Continuation Phase||34
486760|NCT00395694|1166278|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
486761|NCT00395694|1166279|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
486762|NCT00395694|1166278|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
486763|NCT00395694|1166279|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
486764|NCT00395694|1166278|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
486765|NCT00395694|1166279|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
486766|NCT00395694|1166278|P2|STARTED|Escalation Phase + Maintenance Phase||51
486767|NCT00395694|1166279|P1|STARTED|Escalation Phase + Maintenance Phase||51
486768|NCT00395642|1166310|P1|NOT COMPLETED|Overall Study||13
486769|NCT00395642|1166310|P1|COMPLETED|Overall Study||53
486770|NCT00395642|1166310|P1|STARTED|Overall Study||66
486771|NCT00395629|1166317|P3|NOT COMPLETED|Extension Study||3
486772|NCT00395629|1166318|P2|NOT COMPLETED|Extension Study||0
486773|NCT00395629|1166319|P1|NOT COMPLETED|Extension Study||0
486774|NCT00395629|1166317|P3|COMPLETED|Extension Study||8
486775|NCT00395629|1166318|P2|COMPLETED|Extension Study||6
486776|NCT00395629|1166319|P1|COMPLETED|Extension Study||9
486777|NCT00395629|1166317|P3|STARTED|Extension Study||11
486778|NCT00395629|1166318|P2|STARTED|Extension Study||6
486779|NCT00395629|1166319|P1|STARTED|Extension Study||9
486780|NCT00395629|1166317|P3|NOT COMPLETED|Core Study||7
486781|NCT00395629|1166318|P2|NOT COMPLETED|Core Study||4
486782|NCT00395629|1166319|P1|NOT COMPLETED|Core Study||1
486783|NCT00395629|1166317|P3|COMPLETED|Core Study||16
486784|NCT00395629|1166318|P2|COMPLETED|Core Study||11
486785|NCT00395629|1166319|P1|COMPLETED|Core Study||10
486786|NCT00395629|1166317|P3|STARTED|Core Study||23
486787|NCT00395629|1166318|P2|STARTED|Core Study||15
486788|NCT00395629|1166319|P1|STARTED|Core Study||11
486789|NCT00395512|1166337|P4|NOT COMPLETED|Overall Study||38
486790|NCT00395512|1166338|P3|NOT COMPLETED|Overall Study||28
486791|NCT00395512|1166339|P2|NOT COMPLETED|Overall Study||37
486792|NCT00395512|1166340|P1|NOT COMPLETED|Overall Study||38
486793|NCT00395512|1166337|P4|COMPLETED|Overall Study||126
486794|NCT00395512|1166338|P3|COMPLETED|Overall Study||136
486795|NCT00395512|1166339|P2|COMPLETED|Overall Study||126
486796|NCT00395512|1166340|P1|COMPLETED|Overall Study||126
486797|NCT00395512|1166337|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
486798|NCT00395512|1166338|P3|Safety Set|Overall Study||164
486799|NCT00395512|1166339|P2|Safety Set|Overall Study||163
486800|NCT00395512|1166340|P1|Safety Set|Overall Study||164
486801|NCT00395512|1166337|P4|STARTED|Overall Study||164
486802|NCT00395512|1166338|P3|STARTED|Overall Study||164
486803|NCT00395512|1166339|P2|STARTED|Overall Study||163
486804|NCT00395512|1166340|P1|STARTED|Overall Study||164
486805|NCT00395486|1166512|P2|NOT COMPLETED|Overall Study||5
486806|NCT00395486|1166513|P1|NOT COMPLETED|Overall Study||6
486807|NCT00395486|1166512|P2|COMPLETED|Overall Study|Completed subjects|121
486808|NCT00395486|1166513|P1|COMPLETED|Overall Study|Completed subjects|126
486809|NCT00395486|1166512|P2|STARTED|Overall Study|Randomized subjects|126
486810|NCT00395486|1166513|P1|STARTED|Overall Study|Randomized subjects|132
486811|NCT00395460|1166543|P2|NOT COMPLETED|Overall Study||0
486812|NCT00395460|1166544|P1|NOT COMPLETED|Overall Study||1
486813|NCT00395460|1166543|P2|COMPLETED|Overall Study||75
486814|NCT00395460|1166544|P1|COMPLETED|Overall Study||71
486815|NCT00395460|1166543|P2|Received Treatment|Overall Study||75
486816|NCT00395460|1166544|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
486817|NCT00395460|1166543|P2|STARTED|Overall Study||75
486818|NCT00395460|1166544|P1|STARTED|Overall Study||72
486819|NCT00395447|1166568|P2|NOT COMPLETED|Overall Study||111
486820|NCT00395447|1166569|P1|NOT COMPLETED|Overall Study||121
486821|NCT00395447|1166568|P2|COMPLETED|Overall Study||602
486822|NCT00395447|1166569|P1|COMPLETED|Overall Study||910
486823|NCT00395447|1166568|P2|STARTED|Overall Study||713
486824|NCT00395447|1166569|P1|STARTED|Overall Study||1031
486825|NCT00395343|1166577|P2|NOT COMPLETED|Overall Study||36
486826|NCT00395343|1166578|P1|NOT COMPLETED|Overall Study||41
486827|NCT00395343|1166577|P2|COMPLETED|Overall Study||283
486828|NCT00395343|1166578|P1|COMPLETED|Overall Study||281
486829|NCT00395343|1166577|P2|STARTED|Overall Study||319
486830|NCT00395343|1166578|P1|STARTED|Overall Study||322
486831|NCT00395304|1166596|P6|NOT COMPLETED|Treatment Period 3||1
486832|NCT00395304|1166597|P5|NOT COMPLETED|Treatment Period 3||0
486833|NCT00395304|1166598|P4|NOT COMPLETED|Treatment Period 3||2
486834|NCT00395304|1166599|P3|NOT COMPLETED|Treatment Period 3||0
486835|NCT00395304|1166600|P2|NOT COMPLETED|Treatment Period 3||2
486836|NCT00395304|1166601|P1|NOT COMPLETED|Treatment Period 3||1
486837|NCT00395304|1166596|P6|COMPLETED|Treatment Period 3||27
486838|NCT00395304|1166597|P5|COMPLETED|Treatment Period 3||27
486839|NCT00395304|1166598|P4|COMPLETED|Treatment Period 3||25
486840|NCT00395304|1166599|P3|COMPLETED|Treatment Period 3||29
486841|NCT00395304|1166600|P2|COMPLETED|Treatment Period 3||20
486842|NCT00395304|1166601|P1|COMPLETED|Treatment Period 3||29
486843|NCT00395304|1166596|P6|STARTED|Treatment Period 3||28
486844|NCT00395304|1166597|P5|STARTED|Treatment Period 3||27
486845|NCT00395304|1166598|P4|STARTED|Treatment Period 3||27
486846|NCT00395304|1166599|P3|STARTED|Treatment Period 3||29
486847|NCT00395304|1166600|P2|STARTED|Treatment Period 3||22
486848|NCT00395304|1166601|P1|STARTED|Treatment Period 3||30
486849|NCT00395304|1166596|P6|NOT COMPLETED|Treatment Period 2||2
486850|NCT00395304|1166597|P5|NOT COMPLETED|Treatment Period 2||0
486851|NCT00395304|1166598|P4|NOT COMPLETED|Treatment Period 2||1
486852|NCT00395304|1166599|P3|NOT COMPLETED|Treatment Period 2||1
486853|NCT00395304|1166600|P2|NOT COMPLETED|Treatment Period 2||4
486854|NCT00395304|1166601|P1|NOT COMPLETED|Treatment Period 2||0
486855|NCT00395304|1166596|P6|COMPLETED|Treatment Period 2||28
486856|NCT00395304|1166597|P5|COMPLETED|Treatment Period 2||27
486857|NCT00395304|1166598|P4|COMPLETED|Treatment Period 2||27
486858|NCT00395304|1166599|P3|COMPLETED|Treatment Period 2||29
486859|NCT00395304|1166600|P2|COMPLETED|Treatment Period 2||22
486860|NCT00395304|1166601|P1|COMPLETED|Treatment Period 2||30
486861|NCT00395304|1166596|P6|STARTED|Treatment Period 2||30
486862|NCT00395304|1166597|P5|STARTED|Treatment Period 2||27
486863|NCT00395304|1166598|P4|STARTED|Treatment Period 2||28
486864|NCT00395304|1166599|P3|STARTED|Treatment Period 2||30
486865|NCT00395304|1166600|P2|STARTED|Treatment Period 2||26
486866|NCT00395304|1166601|P1|STARTED|Treatment Period 2||30
486867|NCT00395304|1166596|P6|NOT COMPLETED|Treatment Period 1||2
486868|NCT00395304|1166597|P5|NOT COMPLETED|Treatment Period 1||1
486869|NCT00395304|1166598|P4|NOT COMPLETED|Treatment Period 1||3
486870|NCT00395304|1166599|P3|NOT COMPLETED|Treatment Period 1||0
486871|NCT00395304|1166600|P2|NOT COMPLETED|Treatment Period 1||4
486872|NCT00395304|1166601|P1|NOT COMPLETED|Treatment Period 1||1
486873|NCT00395304|1166596|P6|COMPLETED|Treatment Period 1||30
486874|NCT00395304|1166597|P5|COMPLETED|Treatment Period 1||27
486875|NCT00395304|1166598|P4|COMPLETED|Treatment Period 1||28
486876|NCT00395304|1166599|P3|COMPLETED|Treatment Period 1||30
486877|NCT00395304|1166600|P2|COMPLETED|Treatment Period 1||26
486878|NCT00395304|1166601|P1|COMPLETED|Treatment Period 1||30
486879|NCT00395304|1166596|P6|STARTED|Treatment Period 1||32
486880|NCT00395304|1166597|P5|STARTED|Treatment Period 1||28
486881|NCT00395304|1166598|P4|STARTED|Treatment Period 1||31
486882|NCT00395304|1166599|P3|STARTED|Treatment Period 1||30
486883|NCT00395304|1166600|P2|STARTED|Treatment Period 1||30
486884|NCT00395304|1166601|P1|STARTED|Treatment Period 1||31
486885|NCT00395291|1166605|P2|NOT COMPLETED|Second Intervention||0
486886|NCT00395291|1166606|P1|NOT COMPLETED|Second Intervention||0
486887|NCT00395291|1166605|P2|COMPLETED|Second Intervention||9
486888|NCT00395291|1166606|P1|COMPLETED|Second Intervention||13
486889|NCT00395291|1166605|P2|STARTED|Second Intervention||9
486890|NCT00395291|1166606|P1|STARTED|Second Intervention||13
486891|NCT00395291|1166605|P2|NOT COMPLETED|Washout Period for 30 Days||0
486892|NCT00395291|1166606|P1|NOT COMPLETED|Washout Period for 30 Days||2
486893|NCT00395291|1166605|P2|COMPLETED|Washout Period for 30 Days||9
486894|NCT00395291|1166606|P1|COMPLETED|Washout Period for 30 Days||13
486895|NCT00395291|1166605|P2|STARTED|Washout Period for 30 Days||9
486896|NCT00395291|1166606|P1|STARTED|Washout Period for 30 Days||15
486897|NCT00395291|1166605|P2|NOT COMPLETED|First Intervention||0
486898|NCT00395291|1166606|P1|NOT COMPLETED|First Intervention||2
486899|NCT00395291|1166605|P2|COMPLETED|First Intervention||9
486900|NCT00395291|1166606|P1|COMPLETED|First Intervention||15
486901|NCT00395291|1166605|P2|STARTED|First Intervention||9
486902|NCT00395291|1166606|P1|STARTED|First Intervention||17
486903|NCT00395226|1166638|P2|NOT COMPLETED|Overall Study||5
486904|NCT00395226|1166639|P1|NOT COMPLETED|Overall Study||4
486905|NCT00395226|1166638|P2|COMPLETED|Overall Study||22
486906|NCT00395226|1166639|P1|COMPLETED|Overall Study||22
486907|NCT00395226|1166638|P2|STARTED|Overall Study||27
486908|NCT00395226|1166639|P1|STARTED|Overall Study||26
486909|NCT00395161|1166647|P2|NOT COMPLETED|Overall Study||0
486910|NCT00395161|1166648|P1|NOT COMPLETED|Overall Study||0
486911|NCT00395161|1166647|P2|COMPLETED|Overall Study||144
486912|NCT00395161|1166648|P1|COMPLETED|Overall Study||149
486913|NCT00395161|1166647|P2|STARTED|Overall Study||144
486914|NCT00395161|1166648|P1|STARTED|Overall Study||149
486915|NCT00395135|1166664|P5|NOT COMPLETED|Year 2||190
486916|NCT00395135|1166665|P4|NOT COMPLETED|Year 2||88
486917|NCT00395135|1166666|P3|NOT COMPLETED|Year 2||147
486918|NCT00395135|1166667|P2|NOT COMPLETED|Year 2||0
486919|NCT00395135|1166668|P1|NOT COMPLETED|Year 2||0
486920|NCT00395135|1166664|P5|COMPLETED|Year 2||507
486921|NCT00395135|1166665|P4|COMPLETED|Year 2||195
486922|NCT00395135|1166666|P3|COMPLETED|Year 2||426
486923|NCT00395135|1166667|P2|COMPLETED|Year 2||0
486924|NCT00395135|1166668|P1|COMPLETED|Year 2||0
486925|NCT00395135|1166664|P5|STARTED|Year 2||697
486926|NCT00395135|1166665|P4|STARTED|Year 2||283
486927|NCT00395135|1166666|P3|STARTED|Year 2||573
486928|NCT00395135|1166667|P2|STARTED|Year 2||0
486929|NCT00395135|1166668|P1|STARTED|Year 2||0
486930|NCT00395135|1166664|P5|NOT COMPLETED|Year 1||0
486931|NCT00395135|1166665|P4|NOT COMPLETED|Year 1||0
486932|NCT00395135|1166666|P3|NOT COMPLETED|Year 1||0
486933|NCT00395135|1166667|P2|NOT COMPLETED|Year 1||871
486934|NCT00395135|1166668|P1|NOT COMPLETED|Year 1||712
486935|NCT00395135|1166664|P5|COMPLETED|Year 1||0
486936|NCT00395135|1166665|P4|COMPLETED|Year 1||0
486937|NCT00395135|1166666|P3|COMPLETED|Year 1||0
486938|NCT00395135|1166667|P2|COMPLETED|Year 1||716
486939|NCT00395135|1166668|P1|COMPLETED|Year 1||883
486940|NCT00395135|1166664|P5|STARTED|Year 1||0
486941|NCT00395135|1166665|P4|STARTED|Year 1||0
486942|NCT00395135|1166666|P3|STARTED|Year 1||0
486943|NCT00395135|1166667|P2|STARTED|Year 1||1587
486944|NCT00395135|1166668|P1|STARTED|Year 1||1595
486945|NCT00395083|1166686|P2|NOT COMPLETED|Overall Study||8
486946|NCT00395083|1166687|P1|NOT COMPLETED|Overall Study||10
486947|NCT00395083|1166686|P2|COMPLETED|Overall Study||201
486948|NCT00395083|1166687|P1|COMPLETED|Overall Study||207
486949|NCT00395083|1166686|P2|STARTED|Overall Study||209
486950|NCT00395083|1166687|P1|STARTED|Overall Study||217
486951|NCT00395057|1166703|P4|NOT COMPLETED|Overall Study||33
486952|NCT00395057|1166704|P3|NOT COMPLETED|Overall Study||33
486953|NCT00395057|1166705|P2|NOT COMPLETED|Overall Study||34
486954|NCT00395057|1166706|P1|NOT COMPLETED|Overall Study||32
486955|NCT00395057|1166703|P4|COMPLETED|Overall Study||1
486956|NCT00395057|1166704|P3|COMPLETED|Overall Study||2
486957|NCT00395057|1166705|P2|COMPLETED|Overall Study||1
486958|NCT00395057|1166706|P1|COMPLETED|Overall Study||2
486959|NCT00395057|1166703|P4|STARTED|Overall Study||34
486960|NCT00395057|1166704|P3|STARTED|Overall Study||35
486961|NCT00395057|1166705|P2|STARTED|Overall Study||35
486962|NCT00395057|1166706|P1|STARTED|Overall Study||34
486963|NCT00395044|1166734|P2|NOT COMPLETED|Overall Study||14
486964|NCT00395044|1166735|P1|NOT COMPLETED|Overall Study||18
486965|NCT00395044|1166734|P2|COMPLETED|Overall Study||11
486966|NCT00395044|1166735|P1|COMPLETED|Overall Study||7
486967|NCT00395044|1166734|P2|STARTED|Overall Study||25
486968|NCT00395044|1166735|P1|STARTED|Overall Study||25
486969|NCT00395018|1166753|P1|NOT COMPLETED|Off-Treatment Follow-up||4
486970|NCT00395018|1166753|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
486971|NCT00395018|1166753|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
486972|NCT00395018|1166753|P1|NOT COMPLETED|On-Treatment||10
486973|NCT00395018|1166753|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
486974|NCT00395018|1166753|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
486975|NCT00395018|1166753|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
486976|NCT00395018|1166753|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
486977|NCT00394953|1166774|P2|NOT COMPLETED|Second Treatment Period||74
486978|NCT00394953|1166775|P1|NOT COMPLETED|Second Treatment Period||29
486979|NCT00394953|1166774|P2|COMPLETED|Second Treatment Period||148
486980|NCT00394953|1166775|P1|COMPLETED|Second Treatment Period||187
486981|NCT00394953|1166774|P2|STARTED|Second Treatment Period||222
486982|NCT00394953|1166775|P1|STARTED|Second Treatment Period||216
486983|NCT00394953|1166774|P2|NOT COMPLETED|First Treatment Period||22
486984|NCT00394953|1166775|P1|NOT COMPLETED|First Treatment Period||29
486985|NCT00394953|1166774|P2|COMPLETED|First Treatment Period||222
486986|NCT00394953|1166775|P1|COMPLETED|First Treatment Period||216
486987|NCT00394953|1166774|P2|STARTED|First Treatment Period||244
486988|NCT00394953|1166775|P1|STARTED|First Treatment Period||245
486989|NCT00394914|1166793|P3|NOT COMPLETED|Treatment Period||6
486990|NCT00394914|1166794|P2|NOT COMPLETED|Treatment Period||10
486991|NCT00394914|1166795|P1|NOT COMPLETED|Treatment Period||0
486992|NCT00394914|1166793|P3|COMPLETED|Treatment Period||151
486993|NCT00394914|1166794|P2|COMPLETED|Treatment Period||144
486994|NCT00394914|1166795|P1|COMPLETED|Treatment Period||0
486995|NCT00394914|1166793|P3|STARTED|Treatment Period||157
486996|NCT00394914|1166794|P2|STARTED|Treatment Period||154
486997|NCT00394914|1166795|P1|STARTED|Treatment Period||0
486998|NCT00394914|1166793|P3|NOT COMPLETED|Pre-exposure Period||0
486999|NCT00394914|1166794|P2|NOT COMPLETED|Pre-exposure Period||0
487000|NCT00394914|1166795|P1|NOT COMPLETED|Pre-exposure Period||0
487001|NCT00394914|1166793|P3|COMPLETED|Pre-exposure Period||0
487002|NCT00394914|1166794|P2|COMPLETED|Pre-exposure Period||0
487003|NCT00394914|1166795|P1|COMPLETED|Pre-exposure Period||311
487004|NCT00394914|1166793|P3|STARTED|Pre-exposure Period||0
487005|NCT00394914|1166794|P2|STARTED|Pre-exposure Period||0
487006|NCT00394914|1166795|P1|STARTED|Pre-exposure Period||311
487007|NCT00394914|1166793|P3|NOT COMPLETED|Screening Period||0
487008|NCT00394914|1166794|P2|NOT COMPLETED|Screening Period||0
487009|NCT00394914|1166795|P1|NOT COMPLETED|Screening Period||0
487010|NCT00394914|1166793|P3|COMPLETED|Screening Period||0
487011|NCT00394914|1166794|P2|COMPLETED|Screening Period||0
487012|NCT00394914|1166795|P1|COMPLETED|Screening Period||311
487013|NCT00394914|1166793|P3|STARTED|Screening Period||0
487014|NCT00394914|1166794|P2|STARTED|Screening Period||0
487015|NCT00394914|1166795|P1|STARTED|Screening Period||311
487016|NCT00394901|1166823|P4|NOT COMPLETED|Double-blind Phase||27
487017|NCT00394901|1166824|P3|NOT COMPLETED|Double-blind Phase||18
487018|NCT00394901|1166825|P2|NOT COMPLETED|Double-blind Phase||14
487019|NCT00394901|1166826|P1|NOT COMPLETED|Double-blind Phase||15
487020|NCT00394901|1166823|P4|COMPLETED|Double-blind Phase||70
487021|NCT00394901|1166824|P3|COMPLETED|Double-blind Phase||71
487022|NCT00394901|1166825|P2|COMPLETED|Double-blind Phase||73
487023|NCT00394901|1166826|P1|COMPLETED|Double-blind Phase||83
487024|NCT00394901|1166823|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
487025|NCT00394901|1166824|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
487026|NCT00394901|1166825|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
487027|NCT00394901|1166826|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
487028|NCT00394901|1166823|P4|NOT COMPLETED|Baseline Phase||0
487029|NCT00394901|1166824|P3|NOT COMPLETED|Baseline Phase||1
487030|NCT00394901|1166825|P2|NOT COMPLETED|Baseline Phase||0
487031|NCT00394901|1166826|P1|NOT COMPLETED|Baseline Phase||0
487032|NCT00394901|1166823|P4|COMPLETED|Baseline Phase||97
487033|NCT00394901|1166824|P3|COMPLETED|Baseline Phase||89
487034|NCT00394901|1166825|P2|COMPLETED|Baseline Phase||87
487035|NCT00394901|1166826|P1|COMPLETED|Baseline Phase||98
487036|NCT00394901|1166823|P4|STARTED|Baseline Phase|Subjects randomized|97
487037|NCT00394901|1166824|P3|STARTED|Baseline Phase|Subjects randomized|90
487038|NCT00394901|1166825|P2|STARTED|Baseline Phase|Subjects randomized|87
487039|NCT00394901|1166826|P1|STARTED|Baseline Phase|Subjects randomized|98
487040|NCT00394888|1167054|P3|NOT COMPLETED|Overall Study||0
487041|NCT00394888|1167055|P2|NOT COMPLETED|Overall Study||0
487042|NCT00394888|1167056|P1|NOT COMPLETED|Overall Study||0
487043|NCT00394888|1167054|P3|COMPLETED|Overall Study||201
487044|NCT00394888|1167055|P2|COMPLETED|Overall Study||48
487045|NCT00394888|1167056|P1|COMPLETED|Overall Study||108
487046|NCT00394888|1167054|P3|STARTED|Overall Study||201
487047|NCT00394888|1167055|P2|STARTED|Overall Study||48
487048|NCT00394888|1167056|P1|STARTED|Overall Study||108
487049|NCT00394836|1167069|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
487050|NCT00394836|1167070|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
487051|NCT00394836|1167069|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
487052|NCT00394836|1167070|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
487053|NCT00394836|1167069|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
487054|NCT00394836|1167070|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
487055|NCT00394836|1167069|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
487056|NCT00394836|1167070|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
487057|NCT00394836|1167069|P2|COMPLETED|Teatment or Follow-up Phase||8
487058|NCT00394836|1167070|P1|COMPLETED|Teatment or Follow-up Phase||2
487059|NCT00394836|1167069|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
487060|NCT00394836|1167070|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
487061|NCT00394836|1167069|P2|STARTED|Teatment or Follow-up Phase||86
487062|NCT00394836|1167070|P1|STARTED|Teatment or Follow-up Phase||30
487063|NCT00394771|1167116|P4|NOT COMPLETED|Overall Study||39
487064|NCT00394771|1167117|P3|NOT COMPLETED|Overall Study||47
487065|NCT00394771|1167118|P2|NOT COMPLETED|Overall Study||34
487066|NCT00394771|1167119|P1|NOT COMPLETED|Overall Study||41
487067|NCT00394771|1167116|P4|COMPLETED|Overall Study||109
487068|NCT00394771|1167117|P3|COMPLETED|Overall Study||96
487069|NCT00394771|1167118|P2|COMPLETED|Overall Study||102
487070|NCT00394771|1167119|P1|COMPLETED|Overall Study||99
487071|NCT00394771|1167116|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
487072|NCT00394771|1167117|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
487073|NCT00394771|1167118|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
487074|NCT00394771|1167119|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
487075|NCT00394771|1167116|P4|STARTED|Overall Study|Safety population of treated participants|148
487076|NCT00394771|1167117|P3|STARTED|Overall Study|Safety population of treated participants|143
487077|NCT00394771|1167118|P2|STARTED|Overall Study|Safety population of treated participants|136
487078|NCT00394771|1167119|P1|STARTED|Overall Study|Safety population of treated participants|140
487079|NCT00394706|1167189|P8|NOT COMPLETED|Overall Study||0
487080|NCT00394706|1167190|P7|NOT COMPLETED|Overall Study||3
487081|NCT00394706|1167191|P6|NOT COMPLETED|Overall Study||7
487082|NCT00394706|1167192|P5|NOT COMPLETED|Overall Study||2
487083|NCT00394706|1167193|P4|NOT COMPLETED|Overall Study||1
487084|NCT00394706|1167194|P3|NOT COMPLETED|Overall Study||9
487085|NCT00394706|1167195|P2|NOT COMPLETED|Overall Study||2
487086|NCT00394706|1167196|P1|NOT COMPLETED|Overall Study||4
487087|NCT00394706|1167189|P8|COMPLETED|Overall Study||851
487088|NCT00394706|1167190|P7|COMPLETED|Overall Study||926
487089|NCT00394706|1167191|P6|COMPLETED|Overall Study||1377
487090|NCT00394706|1167192|P5|COMPLETED|Overall Study||1634
487091|NCT00394706|1167193|P4|COMPLETED|Overall Study||1632
487092|NCT00394706|1167194|P3|COMPLETED|Overall Study||1615
487093|NCT00394706|1167195|P2|COMPLETED|Overall Study||1860
487094|NCT00394706|1167196|P1|COMPLETED|Overall Study||1815
487095|NCT00394706|1167189|P8|STARTED|Overall Study||851
487096|NCT00394706|1167190|P7|STARTED|Overall Study||929
487097|NCT00394706|1167191|P6|STARTED|Overall Study||1384
487098|NCT00394706|1167192|P5|STARTED|Overall Study||1636
487099|NCT00394706|1167193|P4|STARTED|Overall Study||1633
487100|NCT00394706|1167194|P3|STARTED|Overall Study||1624
487101|NCT00394706|1167195|P2|STARTED|Overall Study||1862
487102|NCT00394706|1167196|P1|STARTED|Overall Study||1819
487103|NCT00394654|1167216|P2|NOT COMPLETED|Overall Study||0
487104|NCT00394654|1167217|P1|NOT COMPLETED|Overall Study||2
487105|NCT00394654|1167216|P2|COMPLETED|Overall Study||15
487106|NCT00394654|1167217|P1|COMPLETED|Overall Study||13
487107|NCT00394654|1167216|P2|STARTED|Overall Study||15
487108|NCT00394654|1167217|P1|STARTED|Overall Study||15
487109|NCT00394589|1167282|P3|NOT COMPLETED|Overall Study||7
487110|NCT00394589|1167283|P2|NOT COMPLETED|Overall Study||3
487111|NCT00394589|1167284|P1|NOT COMPLETED|Overall Study||8
487112|NCT00394589|1167282|P3|COMPLETED|Overall Study||11
487113|NCT00394589|1167283|P2|COMPLETED|Overall Study||8
487114|NCT00394589|1167284|P1|COMPLETED|Overall Study||6
487115|NCT00394589|1167282|P3|STARTED|Overall Study||18
487116|NCT00394589|1167283|P2|STARTED|Overall Study||11
487117|NCT00394589|1167284|P1|STARTED|Overall Study||14
487118|NCT00394524|1167294|P2|NOT COMPLETED|Overall Study||10
487119|NCT00394524|1167295|P1|NOT COMPLETED|Overall Study||11
487120|NCT00394524|1167294|P2|COMPLETED|Overall Study||68
487121|NCT00394524|1167295|P1|COMPLETED|Overall Study||68
487122|NCT00394524|1167294|P2|STARTED|Overall Study||78
487123|NCT00394524|1167295|P1|STARTED|Overall Study||79
487124|NCT00394472|1167307|P2|NOT COMPLETED|Overall Study||11
487125|NCT00394472|1167308|P1|NOT COMPLETED|Overall Study||9
487126|NCT00394472|1167307|P2|COMPLETED|Overall Study||111
487127|NCT00394472|1167308|P1|COMPLETED|Overall Study||113
487128|NCT00394472|1167307|P2|STARTED|Overall Study||122
487129|NCT00394472|1167308|P1|STARTED|Overall Study||122
487130|NCT00394433|1167316|P1|NOT COMPLETED|Overall Study||3
487131|NCT00394433|1167316|P1|COMPLETED|Overall Study||35
487132|NCT00394433|1167316|P1|Evaluable and Treated|Overall Study||35
487133|NCT00394433|1167316|P1|STARTED|Overall Study||38
487134|NCT00394355|1167327|P4|NOT COMPLETED|Overall Study||31
487135|NCT00394355|1167328|P3|NOT COMPLETED|Overall Study||38
487136|NCT00394355|1167329|P2|NOT COMPLETED|Overall Study||34
487137|NCT00394355|1167330|P1|NOT COMPLETED|Overall Study||35
487138|NCT00394355|1167327|P4|COMPLETED|Overall Study||111
487139|NCT00394355|1167328|P3|COMPLETED|Overall Study||109
487140|NCT00394355|1167329|P2|COMPLETED|Overall Study||103
487141|NCT00394355|1167330|P1|COMPLETED|Overall Study||105
487142|NCT00394355|1167327|P4|STARTED|Overall Study||142
487143|NCT00394355|1167328|P3|STARTED|Overall Study||147
487144|NCT00394355|1167329|P2|STARTED|Overall Study||137
487145|NCT00394355|1167330|P1|STARTED|Overall Study||140
487146|NCT00394329|1167356|P4|NOT COMPLETED|Overall Study||24
487147|NCT00394329|1167357|P3|NOT COMPLETED|Overall Study||13
487148|NCT00394329|1167358|P2|NOT COMPLETED|Overall Study||9
487149|NCT00394329|1167359|P1|NOT COMPLETED|Overall Study||8
487150|NCT00394329|1167356|P4|COMPLETED|Overall Study||50
487151|NCT00394329|1167357|P3|COMPLETED|Overall Study||58
487152|NCT00394329|1167358|P2|COMPLETED|Overall Study||63
487153|NCT00394329|1167359|P1|COMPLETED|Overall Study||63
487154|NCT00394329|1167356|P4|STARTED|Overall Study||74
487155|NCT00394329|1167357|P3|STARTED|Overall Study||71
487156|NCT00394329|1167358|P2|STARTED|Overall Study||72
487157|NCT00394329|1167359|P1|STARTED|Overall Study||71
487158|NCT00394277|1167373|P4|NOT COMPLETED|Overall Study||125
487159|NCT00394277|1167374|P3|NOT COMPLETED|Overall Study||120
487160|NCT00394277|1167375|P2|NOT COMPLETED|Overall Study||60
487161|NCT00394277|1167376|P1|NOT COMPLETED|Overall Study||58
487162|NCT00394277|1167373|P4|COMPLETED|Overall Study||266
487163|NCT00394277|1167374|P3|COMPLETED|Overall Study||273
487164|NCT00394277|1167375|P2|COMPLETED|Overall Study||136
487165|NCT00394277|1167376|P1|COMPLETED|Overall Study||137
487166|NCT00394277|1167373|P4|STARTED|Overall Study||391
487167|NCT00394277|1167374|P3|STARTED|Overall Study||393
487168|NCT00394277|1167375|P2|STARTED|Overall Study||196
487169|NCT00394277|1167376|P1|STARTED|Overall Study||195
487170|NCT00394251|1167400|P2|NOT COMPLETED|Overall Study||38
487171|NCT00394251|1167401|P1|NOT COMPLETED|Overall Study||37
487172|NCT00394251|1167400|P2|COMPLETED|Overall Study||61
487173|NCT00394251|1167401|P1|COMPLETED|Overall Study||61
487174|NCT00394251|1167400|P2|At Least One Dose of Taxane|Overall Study||93
487175|NCT00394251|1167401|P1|At Least One Dose of Taxane|Overall Study||93
487176|NCT00394251|1167400|P2|STARTED|Overall Study||99
487177|NCT00394251|1167401|P1|STARTED|Overall Study||98
487178|NCT00394212|1167429|P2|NOT COMPLETED|Overall Study||1
487179|NCT00394212|1167430|P1|NOT COMPLETED|Overall Study||7
487180|NCT00394212|1167429|P2|COMPLETED|Overall Study||26
487181|NCT00394212|1167430|P1|COMPLETED|Overall Study||43
487182|NCT00394212|1167429|P2|6 Month Follow-up|Overall Study||26
487183|NCT00394212|1167430|P1|6 Month Follow-up|Overall Study||43
487184|NCT00394212|1167429|P2|3 Month Follow-up|Overall Study||26
487185|NCT00394212|1167430|P1|3 Month Follow-up|Overall Study||45
487186|NCT00394212|1167429|P2|6 Week Follow-up|Overall Study||26
487187|NCT00394212|1167430|P1|6 Week Follow-up|Overall Study||45
487188|NCT00394212|1167429|P2|STARTED|Overall Study||27
487189|NCT00394212|1167430|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
487190|NCT00394095|1167444|P2|NOT COMPLETED|Overall Study||0
487191|NCT00394095|1167445|P1|NOT COMPLETED|Overall Study||1
487192|NCT00394095|1167444|P2|COMPLETED|Overall Study||14
487193|NCT00394095|1167445|P1|COMPLETED|Overall Study||16
487194|NCT00394095|1167444|P2|Screened|Overall Study||14
487195|NCT00394095|1167445|P1|Screened|Overall Study||17
487196|NCT00394095|1167444|P2|STARTED|Overall Study||14
487197|NCT00394095|1167445|P1|STARTED|Overall Study||17
487198|NCT00394082|1167453|P1|NOT COMPLETED|Overall Study||26
487199|NCT00394082|1167453|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
487200|NCT00394082|1167453|P1|At Least One Response Assessment|Overall Study||43
487201|NCT00394082|1167453|P1|STARTED|Overall Study||50
487202|NCT00393939|1167464|P2|NOT COMPLETED|Overall Study||297
487203|NCT00393939|1167465|P1|NOT COMPLETED|Overall Study||296
487204|NCT00393939|1167464|P2|COMPLETED|Overall Study||0
487205|NCT00393939|1167465|P1|COMPLETED|Overall Study||0
487206|NCT00393939|1167464|P2|Treated|Overall Study||293
487207|NCT00393939|1167465|P1|Treated|Overall Study||295
487208|NCT00393939|1167464|P2|STARTED|Overall Study||297
487209|NCT00393939|1167465|P1|STARTED|Overall Study||296
487210|NCT00393913|1167483|P1|NOT COMPLETED|CPAP Withdrawal||0
487211|NCT00393913|1167483|P1|COMPLETED|CPAP Withdrawal||42
487212|NCT00393913|1167483|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
487213|NCT00393913|1167483|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
487214|NCT00393913|1167483|P1|NOT COMPLETED|CPAP||7
487215|NCT00393913|1167483|P1|COMPLETED|CPAP||93
487216|NCT00393913|1167483|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
487217|NCT00393913|1167483|P1|NOT COMPLETED|Initial Assessment||37
487218|NCT00393913|1167483|P1|COMPLETED|Initial Assessment||107
487219|NCT00393913|1167483|P1|STARTED|Initial Assessment||144
487220|NCT00393887|1167491|P2|NOT COMPLETED|Overall Study||9
487221|NCT00393887|1167492|P1|NOT COMPLETED|Overall Study||16
487222|NCT00393887|1167491|P2|COMPLETED|Overall Study||41
487223|NCT00393887|1167492|P1|COMPLETED|Overall Study||34
487224|NCT00393887|1167491|P2|1 Year|Overall Study||50
487225|NCT00393887|1167492|P1|1 Year|Overall Study||45
487226|NCT00393887|1167491|P2|STARTED|Overall Study||50
487227|NCT00393887|1167492|P1|STARTED|Overall Study||50
487228|NCT00393874|1167501|P3|NOT COMPLETED|Overall Study||2
487229|NCT00393874|1167502|P2|NOT COMPLETED|Overall Study||4
487230|NCT00393874|1167503|P1|NOT COMPLETED|Overall Study||3
487231|NCT00393874|1167501|P3|COMPLETED|Overall Study||13
487232|NCT00393874|1167502|P2|COMPLETED|Overall Study||13
487233|NCT00393874|1167503|P1|COMPLETED|Overall Study||15
487234|NCT00393874|1167501|P3|STARTED|Overall Study||15
487235|NCT00393874|1167502|P2|STARTED|Overall Study||17
487236|NCT00393874|1167503|P1|STARTED|Overall Study||18
487237|NCT00393861|1167520|P1|NOT COMPLETED|Overall Study||26
487238|NCT00393861|1167520|P1|COMPLETED|Overall Study||3
487239|NCT00393861|1167520|P1|STARTED|Overall Study||29
487240|NCT00393848|1167531|P4|NOT COMPLETED|Overall Study||1
487241|NCT00393848|1167532|P3|NOT COMPLETED|Overall Study||2
487242|NCT00393848|1167533|P2|NOT COMPLETED|Overall Study||0
487243|NCT00393848|1167534|P1|NOT COMPLETED|Overall Study||0
487244|NCT00393848|1167531|P4|COMPLETED|Overall Study||8
487245|NCT00393848|1167532|P3|COMPLETED|Overall Study||4
487246|NCT00393848|1167533|P2|COMPLETED|Overall Study||9
487247|NCT00393848|1167534|P1|COMPLETED|Overall Study||16
487248|NCT00393848|1167531|P4|STARTED|Overall Study||9
487249|NCT00393848|1167532|P3|STARTED|Overall Study||6
487250|NCT00393848|1167533|P2|STARTED|Overall Study||9
487251|NCT00393848|1167534|P1|STARTED|Overall Study||16
487252|NCT00393796|1167548|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
487253|NCT00393796|1167549|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
487254|NCT00393796|1167548|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
487255|NCT00393796|1167549|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
487256|NCT00393796|1167548|P2|STARTED|Open Label Period - Placebo to SUTENT||16
487257|NCT00393796|1167549|P1|STARTED|Open Label Period - Placebo to SUTENT||0
487258|NCT00393796|1167548|P2|NOT COMPLETED|Double Blind Period||0
487259|NCT00393796|1167549|P1|NOT COMPLETED|Double Blind Period||0
487260|NCT00393796|1167548|P2|COMPLETED|Double Blind Period||28
487261|NCT00393796|1167549|P1|COMPLETED|Double Blind Period||26
487262|NCT00393796|1167548|P2|STARTED|Double Blind Period||28
487263|NCT00393796|1167549|P1|STARTED|Double Blind Period||26
487264|NCT00393718|1167557|P2|NOT COMPLETED|Overall Study||22
487265|NCT00393718|1167558|P1|NOT COMPLETED|Overall Study||43
487266|NCT00393718|1167557|P2|COMPLETED|Overall Study||110
487267|NCT00393718|1167558|P1|COMPLETED|Overall Study||225
487268|NCT00393718|1167557|P2|STARTED|Overall Study||132
487269|NCT00393718|1167558|P1|STARTED|Overall Study||268
487270|NCT00393705|1167590|P2|NOT COMPLETED|Overall Study||23
487271|NCT00393705|1167591|P1|NOT COMPLETED|Overall Study||23
487272|NCT00393705|1167590|P2|COMPLETED|Overall Study||128
487273|NCT00393705|1167591|P1|COMPLETED|Overall Study||128
487274|NCT00393705|1167590|P2|Received at Least One Dose of Study Drug|Overall Study||139
487275|NCT00393705|1167591|P1|Received at Least One Dose of Study Drug|Overall Study||139
487276|NCT00393705|1167590|P2|STARTED|Overall Study||151
487277|NCT00393705|1167591|P1|STARTED|Overall Study||151
487278|NCT00393523|1167620|P5|NOT COMPLETED|Overall Study||1
487279|NCT00393523|1167621|P4|NOT COMPLETED|Overall Study||6
487280|NCT00393523|1167622|P3|NOT COMPLETED|Overall Study||4
487281|NCT00393523|1167623|P2|NOT COMPLETED|Overall Study||9
487282|NCT00393523|1167624|P1|NOT COMPLETED|Overall Study||12
487283|NCT00393523|1167620|P5|COMPLETED|Overall Study||19
487284|NCT00393523|1167621|P4|COMPLETED|Overall Study||348
487285|NCT00393523|1167622|P3|COMPLETED|Overall Study||349
487286|NCT00393523|1167623|P2|COMPLETED|Overall Study||366
487287|NCT00393523|1167624|P1|COMPLETED|Overall Study||364
487288|NCT00393523|1167620|P5|Vaccination Visit 1|Overall Study||20
487289|NCT00393523|1167621|P4|Vaccination Visit 1|Overall Study||352
487290|NCT00393523|1167622|P3|Vaccination Visit 1|Overall Study||349
487291|NCT00393523|1167623|P2|Vaccination Visit 1|Overall Study||375
487292|NCT00393523|1167624|P1|Vaccination Visit 1|Overall Study||374
487293|NCT00393523|1167620|P5|STARTED|Overall Study||20
487294|NCT00393523|1167621|P4|STARTED|Overall Study||354
487295|NCT00393523|1167622|P3|STARTED|Overall Study||353
487296|NCT00393523|1167623|P2|STARTED|Overall Study||375
487297|NCT00393523|1167624|P1|STARTED|Overall Study||376
487298|NCT00393510|1167641|P2|NOT COMPLETED|Overall Study||9
487299|NCT00393510|1167642|P1|NOT COMPLETED|Overall Study||3
487300|NCT00393510|1167641|P2|COMPLETED|Overall Study||31
487301|NCT00393510|1167642|P1|COMPLETED|Overall Study||37
487302|NCT00393510|1167641|P2|STARTED|Overall Study||40
487303|NCT00393510|1167642|P1|STARTED|Overall Study||40
487304|NCT00393484|1167654|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
487305|NCT00393484|1167655|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
487306|NCT00393484|1167654|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
487307|NCT00393484|1167655|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
487308|NCT00393484|1167654|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
487309|NCT00393484|1167655|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
487310|NCT00393484|1167654|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
487311|NCT00393484|1167655|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
487312|NCT00393484|1167654|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
487313|NCT00393484|1167655|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
487314|NCT00393484|1167654|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
487315|NCT00393484|1167655|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
487316|NCT00393484|1167654|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
487317|NCT00393484|1167655|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
487318|NCT00393484|1167654|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
487319|NCT00393484|1167655|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
487320|NCT00393484|1167654|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
487321|NCT00393484|1167655|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
487322|NCT00393458|1167691|P4|NOT COMPLETED|Overall Study||137
487323|NCT00393458|1167692|P3|NOT COMPLETED|Overall Study||112
487324|NCT00393458|1167693|P2|NOT COMPLETED|Overall Study||102
487325|NCT00393458|1167694|P1|NOT COMPLETED|Overall Study||99
487326|NCT00393458|1167691|P4|COMPLETED|Overall Study||295
487327|NCT00393458|1167692|P3|COMPLETED|Overall Study||323
487328|NCT00393458|1167693|P2|COMPLETED|Overall Study||326
487329|NCT00393458|1167694|P1|COMPLETED|Overall Study||338
487330|NCT00393458|1167691|P4|Exposed to Study Medication or Placebo|Overall Study||432
487331|NCT00393458|1167692|P3|Exposed to Study Medication or Placebo|Overall Study||434
487332|NCT00393458|1167693|P2|Exposed to Study Medication or Placebo|Overall Study||425
487333|NCT00393458|1167694|P1|Exposed to Study Medication or Placebo|Overall Study||437
487334|NCT00393458|1167691|P4|STARTED|Overall Study||432
487335|NCT00393458|1167692|P3|STARTED|Overall Study||435
487336|NCT00393458|1167693|P2|STARTED|Overall Study||428
487337|NCT00393458|1167694|P1|STARTED|Overall Study||437
487338|NCT00393380|1167708|P1|NOT COMPLETED|Overall Study||0
487339|NCT00393380|1167708|P1|COMPLETED|Overall Study||13
487340|NCT00393380|1167708|P1|STARTED|Overall Study||13
487341|NCT00393367|1167721|P2|NOT COMPLETED|Overall Study||7
487342|NCT00393367|1167722|P1|NOT COMPLETED|Overall Study||2
487343|NCT00393367|1167721|P2|COMPLETED|Overall Study||81
487344|NCT00393367|1167722|P1|COMPLETED|Overall Study||89
487345|NCT00393367|1167721|P2|STARTED|Overall Study||88
487346|NCT00393367|1167722|P1|STARTED|Overall Study||91
487347|NCT00393094|1167750|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
487348|NCT00393094|1167750|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
487349|NCT00393094|1167750|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
487350|NCT00393094|1167750|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
487351|NCT00393094|1167750|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
487352|NCT00393094|1167750|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
487353|NCT00393068|1167757|P1|NOT COMPLETED|Overall Study||18
487354|NCT00393068|1167757|P1|COMPLETED|Overall Study||44
487355|NCT00393068|1167757|P1|STARTED|Overall Study||62
487356|NCT00393042|1167761|P2|NOT COMPLETED|Second Intervetion||8
487357|NCT00393042|1167762|P1|NOT COMPLETED|Second Intervetion||2
487358|NCT00393042|1167761|P2|COMPLETED|Second Intervetion||19
487359|NCT00393042|1167762|P1|COMPLETED|Second Intervetion||24
487360|NCT00393042|1167761|P2|Completed 25/30 mg Dosage|Second Intervetion||20
487361|NCT00393042|1167762|P1|Completed 25/30 mg Dosage|Second Intervetion||24
487362|NCT00393042|1167761|P2|Completed the 20mg Dosage|Second Intervetion||21
487363|NCT00393042|1167762|P1|Completed the 20mg Dosage|Second Intervetion||24
487364|NCT00393042|1167761|P2|Completed 10 mg Dosage|Second Intervetion||24
487365|NCT00393042|1167762|P1|Completed 10 mg Dosage|Second Intervetion||26
487366|NCT00393042|1167761|P2|Completed Placebo Dosage|Second Intervetion||21
487367|NCT00393042|1167762|P1|Completed Placebo Dosage|Second Intervetion||25
487368|NCT00393042|1167761|P2|STARTED|Second Intervetion||27
487369|NCT00393042|1167762|P1|STARTED|Second Intervetion||26
487370|NCT00393042|1167761|P2|NOT COMPLETED|First Intervention||6
487371|NCT00393042|1167762|P1|NOT COMPLETED|First Intervention||5
487372|NCT00393042|1167761|P2|COMPLETED|First Intervention||27
487373|NCT00393042|1167762|P1|COMPLETED|First Intervention||26
487374|NCT00393042|1167761|P2|Completed 25/30mg Dosage|First Intervention||27
487375|NCT00393042|1167762|P1|Completed 25/30mg Dosage|First Intervention||27
487376|NCT00393042|1167761|P2|Completed 20 mg Dosage|First Intervention||28
487377|NCT00393042|1167762|P1|Completed 20 mg Dosage|First Intervention||26
487378|NCT00393042|1167761|P2|Completed 10mg Dosage|First Intervention||29
487379|NCT00393042|1167762|P1|Completed 10mg Dosage|First Intervention||29
487380|NCT00393042|1167761|P2|Completed the Placebo Dosage|First Intervention||29
487381|NCT00393042|1167762|P1|Completed the Placebo Dosage|First Intervention||27
487382|NCT00393042|1167761|P2|STARTED|First Intervention||33
487383|NCT00393042|1167762|P1|STARTED|First Intervention||31
487384|NCT00393029|1167834|P2|NOT COMPLETED|Overall Study||1
487385|NCT00393029|1167835|P1|NOT COMPLETED|Overall Study||0
487386|NCT00393029|1167834|P2|COMPLETED|Overall Study||9
487387|NCT00393029|1167835|P1|COMPLETED|Overall Study||2
487388|NCT00393029|1167834|P2|STARTED|Overall Study||10
487389|NCT00393029|1167835|P1|STARTED|Overall Study||2
487390|NCT00392925|1167848|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
487391|NCT00392925|1167849|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
487392|NCT00392925|1167850|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
487393|NCT00392925|1167851|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
487394|NCT00392925|1167848|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
487395|NCT00392925|1167849|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
487396|NCT00392925|1167850|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
487397|NCT00392925|1167851|P1|COMPLETED|Randomization to Treatment Group Period||0
487398|NCT00392925|1167848|P4|STARTED|Randomization to Treatment Group Period||56
487399|NCT00392925|1167849|P3|STARTED|Randomization to Treatment Group Period||56
487400|NCT00392925|1167850|P2|STARTED|Randomization to Treatment Group Period||27
487401|NCT00392925|1167851|P1|STARTED|Randomization to Treatment Group Period||0
487402|NCT00392925|1167848|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
487403|NCT00392925|1167849|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
487404|NCT00392925|1167850|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
487405|NCT00392925|1167851|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
487406|NCT00392925|1167848|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
487407|NCT00392925|1167849|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
487408|NCT00392925|1167850|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
487409|NCT00392925|1167851|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
487410|NCT00392925|1167848|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
487411|NCT00392925|1167849|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
487412|NCT00392925|1167850|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
487413|NCT00392925|1167851|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
487414|NCT00392860|1167939|P3|NOT COMPLETED|Overall Study||0
487415|NCT00392860|1167940|P2|NOT COMPLETED|Overall Study||0
487416|NCT00392860|1167941|P1|NOT COMPLETED|Overall Study||0
487417|NCT00392860|1167939|P3|COMPLETED|Overall Study||1
487418|NCT00392860|1167940|P2|COMPLETED|Overall Study||0
487419|NCT00392860|1167941|P1|COMPLETED|Overall Study||3
487420|NCT00392860|1167939|P3|STARTED|Overall Study||1
487421|NCT00392860|1167940|P2|STARTED|Overall Study||0
487422|NCT00392860|1167941|P1|STARTED|Overall Study||3
487423|NCT00392834|1167949|P2|NOT COMPLETED|Overall Study||0
487424|NCT00392834|1167950|P1|NOT COMPLETED|Overall Study||0
487425|NCT00392834|1167949|P2|COMPLETED|Overall Study||32
487426|NCT00392834|1167950|P1|COMPLETED|Overall Study||2
487427|NCT00392834|1167949|P2|STARTED|Overall Study||32
487428|NCT00392834|1167950|P1|STARTED|Overall Study||2
487429|NCT00392821|1167956|P1|NOT COMPLETED|Overall Study||19
487430|NCT00392821|1167956|P1|COMPLETED|Overall Study||59
487431|NCT00392821|1167956|P1|STARTED|Overall Study||78
487432|NCT00392808|1167965|P4|NOT COMPLETED|Overall Study||4
487433|NCT00392808|1167966|P3|NOT COMPLETED|Overall Study||2
487434|NCT00392808|1167967|P2|NOT COMPLETED|Overall Study||3
487435|NCT00392808|1167968|P1|NOT COMPLETED|Overall Study||6
487436|NCT00392808|1167965|P4|COMPLETED|Overall Study||100
487437|NCT00392808|1167966|P3|COMPLETED|Overall Study||107
487438|NCT00392808|1167967|P2|COMPLETED|Overall Study||86
487439|NCT00392808|1167968|P1|COMPLETED|Overall Study||81
487440|NCT00392808|1167965|P4|STARTED|Overall Study||104
487441|NCT00392808|1167966|P3|STARTED|Overall Study||109
487442|NCT00392808|1167967|P2|STARTED|Overall Study||89
487443|NCT00392808|1167968|P1|STARTED|Overall Study||87
487444|NCT00392782|1167982|P1|NOT COMPLETED|Overall Study||0
487445|NCT00392782|1167982|P1|COMPLETED|Overall Study||24
487446|NCT00392782|1167982|P1|STARTED|Overall Study||24
487447|NCT00392769|1167992|P1|NOT COMPLETED|Overall Study||10
487448|NCT00392769|1167992|P1|COMPLETED|Overall Study||23
487449|NCT00392769|1167992|P1|STARTED|Overall Study||33
487450|NCT00392704|1167996|P1|NOT COMPLETED|Combined Modality Therapy||5
487451|NCT00392704|1167996|P1|COMPLETED|Combined Modality Therapy||49
487452|NCT00392704|1167996|P1|STARTED|Combined Modality Therapy||54
487453|NCT00392704|1167996|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
487454|NCT00392704|1167996|P1|COMPLETED|Neoadjuvant Chemotherapy||54
487455|NCT00392704|1167996|P1|STARTED|Neoadjuvant Chemotherapy||60
487456|NCT00392678|1168005|P4|NOT COMPLETED|Overall Study||1
487457|NCT00392678|1168006|P3|NOT COMPLETED|Overall Study||2
487458|NCT00392678|1168007|P2|NOT COMPLETED|Overall Study||1
487459|NCT00392678|1168008|P1|NOT COMPLETED|Overall Study||0
487460|NCT00392678|1168005|P4|COMPLETED|Overall Study||26
487461|NCT00392678|1168006|P3|COMPLETED|Overall Study||25
487462|NCT00392678|1168007|P2|COMPLETED|Overall Study||26
487463|NCT00392678|1168008|P1|COMPLETED|Overall Study||27
487464|NCT00392678|1168005|P4|STARTED|Overall Study||27
487465|NCT00392678|1168006|P3|STARTED|Overall Study||27
487466|NCT00392678|1168007|P2|STARTED|Overall Study||27
487467|NCT00392678|1168008|P1|STARTED|Overall Study||27
487468|NCT00392665|1168044|P2|NOT COMPLETED|Overall Study||15
487469|NCT00392665|1168045|P1|NOT COMPLETED|Overall Study||17
487470|NCT00392665|1168044|P2|COMPLETED|Overall Study||3
487471|NCT00392665|1168045|P1|COMPLETED|Overall Study||1
487472|NCT00392665|1168044|P2|STARTED|Overall Study||18
487473|NCT00392665|1168045|P1|STARTED|Overall Study||18
487474|NCT00392496|1168057|P1|NOT COMPLETED|Overall Study||0
487475|NCT00392496|1168057|P1|COMPLETED|Overall Study||19
487476|NCT00392496|1168057|P1|STARTED|Overall Study||19
487477|NCT00392444|1168061|P1|NOT COMPLETED|Overall Study||0
487478|NCT00392444|1168061|P1|COMPLETED|Overall Study||39
487479|NCT00392444|1168061|P1|STARTED|Overall Study||39
487480|NCT00392392|1168065|P1|NOT COMPLETED|Overall Study||20
487481|NCT00392392|1168065|P1|COMPLETED|Overall Study||9
487482|NCT00392392|1168065|P1|STARTED|Overall Study||29
487483|NCT00392379|1168071|P2|NOT COMPLETED|Overall Study||38
487484|NCT00392379|1168072|P1|NOT COMPLETED|Overall Study||22
487485|NCT00392379|1168071|P2|COMPLETED|Overall Study|Medication period|96
487486|NCT00392379|1168072|P1|COMPLETED|Overall Study|Medication period|114
487487|NCT00392379|1168071|P2|STARTED|Overall Study|Medication period|134
487488|NCT00392379|1168072|P1|STARTED|Overall Study|Medication period|136
487489|NCT00392288|1168085|P3|NOT COMPLETED|Overall Study||17
487490|NCT00392288|1168086|P2|NOT COMPLETED|Overall Study||22
487491|NCT00392288|1168087|P1|NOT COMPLETED|Overall Study||32
487492|NCT00392288|1168085|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
487493|NCT00392288|1168086|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
487494|NCT00392288|1168087|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
487495|NCT00392288|1168085|P3|Treatment Period|Overall Study||175
487496|NCT00392288|1168086|P2|Treatment Period|Overall Study||174
487497|NCT00392288|1168087|P1|Treatment Period|Overall Study||172
487498|NCT00392288|1168085|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
487499|NCT00392288|1168086|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
487500|NCT00392288|1168087|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
487501|NCT00392236|1168103|P2|NOT COMPLETED|Overall Study||6
487502|NCT00392236|1168104|P1|NOT COMPLETED|Overall Study||12
487503|NCT00392236|1168103|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
487504|NCT00392236|1168104|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
487505|NCT00392236|1168103|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
487506|NCT00392236|1168104|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
487507|NCT00392223|1168112|P2|NOT COMPLETED|Overall Study||13
487508|NCT00392223|1168113|P1|NOT COMPLETED|Overall Study||9
487509|NCT00392223|1168112|P2|COMPLETED|Overall Study||47
487510|NCT00392223|1168113|P1|COMPLETED|Overall Study||49
487511|NCT00392223|1168112|P2|STARTED|Overall Study||60
487512|NCT00392223|1168113|P1|STARTED|Overall Study||58
487513|NCT00392210|1168131|P2|NOT COMPLETED|Second Voiding Trial||0
487514|NCT00392210|1168132|P1|NOT COMPLETED|Second Voiding Trial||0
487515|NCT00392210|1168131|P2|COMPLETED|Second Voiding Trial||31
487516|NCT00392210|1168132|P1|COMPLETED|Second Voiding Trial||34
487517|NCT00392210|1168131|P2|STARTED|Second Voiding Trial||31
487518|NCT00392210|1168132|P1|STARTED|Second Voiding Trial||34
487519|NCT00392210|1168131|P2|NOT COMPLETED|First Voiding Trial||2
487520|NCT00392210|1168132|P1|NOT COMPLETED|First Voiding Trial||2
487521|NCT00392210|1168131|P2|COMPLETED|First Voiding Trial||31
487522|NCT00392210|1168132|P1|COMPLETED|First Voiding Trial||34
487523|NCT00392210|1168131|P2|STARTED|First Voiding Trial||33
487524|NCT00392210|1168132|P1|STARTED|First Voiding Trial||36
487525|NCT00392197|1168140|P2|NOT COMPLETED|Overall Study||30
487526|NCT00392197|1168141|P1|NOT COMPLETED|Overall Study||21
487527|NCT00392197|1168140|P2|COMPLETED|Overall Study||33
487528|NCT00392197|1168141|P1|COMPLETED|Overall Study||27
487529|NCT00392197|1168140|P2|STARTED|Overall Study||63
487530|NCT00392197|1168141|P1|STARTED|Overall Study||48
487531|NCT00392171|1168149|P1|NOT COMPLETED|Overall Study||105
487532|NCT00392171|1168149|P1|COMPLETED|Overall Study||15
487533|NCT00392171|1168149|P1|STARTED|Overall Study||120
487534|NCT00391989|1168153|P1|NOT COMPLETED|Overall Study||2
487535|NCT00391989|1168153|P1|COMPLETED|Overall Study||53
487536|NCT00391989|1168153|P1|STARTED|Overall Study||55
487537|NCT00391976|1168160|P3|NOT COMPLETED|Overall Study||35
487538|NCT00391976|1168161|P2|NOT COMPLETED|Overall Study||25
487539|NCT00391976|1168162|P1|NOT COMPLETED|Overall Study||27
487540|NCT00391976|1168160|P3|COMPLETED|Overall Study||0
487541|NCT00391976|1168161|P2|COMPLETED|Overall Study||18
487542|NCT00391976|1168162|P1|COMPLETED|Overall Study||18
487543|NCT00391976|1168160|P3|Safety Population|Overall Study||35
487544|NCT00391976|1168161|P2|Safety Population|Overall Study||43
487545|NCT00391976|1168162|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
487546|NCT00391976|1168160|P3|Randomized|Overall Study||0
487547|NCT00391976|1168161|P2|Randomized|Overall Study||43
487548|NCT00391976|1168162|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
487549|NCT00391976|1168160|P3|STARTED|Overall Study||35
487550|NCT00391976|1168161|P2|STARTED|Overall Study||43
487551|NCT00391976|1168162|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
487552|NCT00391898|1168186|P2|NOT COMPLETED|Overall Study||10
487553|NCT00391898|1168187|P1|NOT COMPLETED|Overall Study||11
487554|NCT00391898|1168186|P2|COMPLETED|Overall Study||39
487555|NCT00391898|1168187|P1|COMPLETED|Overall Study||35
487556|NCT00391898|1168186|P2|STARTED|Overall Study||49
487557|NCT00391898|1168187|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
487558|NCT00391872|1168207|P2|NOT COMPLETED|Overall Study||255
487559|NCT00391872|1168208|P1|NOT COMPLETED|Overall Study||307
487560|NCT00391872|1168207|P2|COMPLETED|Overall Study||9036
487561|NCT00391872|1168208|P1|COMPLETED|Overall Study||9026
487562|NCT00391872|1168207|P2|STARTED|Overall Study||9291
487563|NCT00391872|1168208|P1|STARTED|Overall Study||9333
487564|NCT00391846|1168246|P2|NOT COMPLETED|Overall Study||7
487565|NCT00391846|1168247|P1|NOT COMPLETED|Overall Study||8
487566|NCT00391846|1168246|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
487567|NCT00391846|1168247|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
487658|NCT00391274|1168525|P2|COMPLETED|Overall Study||47
487568|NCT00391846|1168246|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
487569|NCT00391846|1168247|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
487570|NCT00391807|1168267|P1|NOT COMPLETED|Overall Study||715
487571|NCT00391807|1168267|P1|COMPLETED|Overall Study||968
487572|NCT00391807|1168267|P1|STARTED|Overall Study||1683
487573|NCT00391768|1168294|P7|NOT COMPLETED|Overall Study||4
487574|NCT00391768|1168295|P6|NOT COMPLETED|Overall Study||3
487575|NCT00391768|1168296|P5|NOT COMPLETED|Overall Study||2
487576|NCT00391768|1168297|P4|NOT COMPLETED|Overall Study||1
487577|NCT00391768|1168298|P3|NOT COMPLETED|Overall Study||1
487578|NCT00391768|1168299|P2|NOT COMPLETED|Overall Study||0
487579|NCT00391768|1168300|P1|NOT COMPLETED|Overall Study||0
487580|NCT00391768|1168294|P7|COMPLETED|Overall Study||19
487581|NCT00391768|1168295|P6|COMPLETED|Overall Study||7
487582|NCT00391768|1168296|P5|COMPLETED|Overall Study||22
487583|NCT00391768|1168297|P4|COMPLETED|Overall Study||7
487584|NCT00391768|1168298|P3|COMPLETED|Overall Study||6
487585|NCT00391768|1168299|P2|COMPLETED|Overall Study||3
487586|NCT00391768|1168300|P1|COMPLETED|Overall Study||12
487587|NCT00391768|1168294|P7|STARTED|Overall Study||23
487588|NCT00391768|1168295|P6|STARTED|Overall Study||10
487589|NCT00391768|1168296|P5|STARTED|Overall Study||24
487590|NCT00391768|1168297|P4|STARTED|Overall Study||8
487591|NCT00391768|1168298|P3|STARTED|Overall Study||7
487592|NCT00391768|1168299|P2|STARTED|Overall Study||3
487593|NCT00391768|1168300|P1|STARTED|Overall Study||12
487594|NCT00391716|1168368|P3|NOT COMPLETED|Overall Study||19
487595|NCT00391716|1168369|P2|NOT COMPLETED|Overall Study||19
487596|NCT00391716|1168370|P1|NOT COMPLETED|Overall Study||27
487597|NCT00391716|1168368|P3|COMPLETED|Overall Study||30
487598|NCT00391716|1168369|P2|COMPLETED|Overall Study||28
487599|NCT00391716|1168370|P1|COMPLETED|Overall Study||27
487600|NCT00391716|1168368|P3|STARTED|Overall Study||49
487601|NCT00391716|1168369|P2|STARTED|Overall Study||47
487602|NCT00391716|1168370|P1|STARTED|Overall Study||54
487603|NCT00391625|1168387|P1|NOT COMPLETED|Month 84||0
487604|NCT00391625|1168387|P1|COMPLETED|Month 84||8
487605|NCT00391625|1168387|P1|STARTED|Month 84||8
487606|NCT00391625|1168387|P1|NOT COMPLETED|Month 50||1
487607|NCT00391625|1168387|P1|COMPLETED|Month 50||8
487608|NCT00391625|1168387|P1|STARTED|Month 50||9
487609|NCT00391625|1168387|P1|NOT COMPLETED|Month 14||1
487610|NCT00391625|1168387|P1|COMPLETED|Month 14||9
487611|NCT00391625|1168387|P1|STARTED|Month 14||10
487612|NCT00391625|1168387|P1|NOT COMPLETED|Baseline||0
487613|NCT00391625|1168387|P1|COMPLETED|Baseline||10
487614|NCT00391625|1168387|P1|STARTED|Baseline||10
487615|NCT00391599|1168429|P2|NOT COMPLETED|Overall Study||0
487616|NCT00391599|1168430|P1|NOT COMPLETED|Overall Study||0
487617|NCT00391599|1168429|P2|COMPLETED|Overall Study||65
487618|NCT00391599|1168430|P1|COMPLETED|Overall Study||65
487619|NCT00391599|1168429|P2|STARTED|Overall Study||65
487620|NCT00391599|1168430|P1|STARTED|Overall Study||65
487621|NCT00391586|1168440|P1|NOT COMPLETED|Overall Study||24
487622|NCT00391586|1168440|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
487623|NCT00391586|1168440|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
487624|NCT00391586|1168440|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
487625|NCT00391586|1168440|P1|STARTED|Overall Study||45
487626|NCT00391469|1168449|P2|NOT COMPLETED|Overall Study||0
487627|NCT00391469|1168450|P1|NOT COMPLETED|Overall Study||0
487628|NCT00391469|1168449|P2|COMPLETED|Overall Study||671
487629|NCT00391469|1168450|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
487630|NCT00391469|1168449|P2|STARTED|Overall Study||671
487631|NCT00391469|1168450|P1|STARTED|Overall Study||688
487632|NCT00391443|1168464|P2|NOT COMPLETED|Overall Study||0
487633|NCT00391443|1168465|P1|NOT COMPLETED|Overall Study||0
487634|NCT00391443|1168464|P2|COMPLETED|Overall Study||407
487635|NCT00391443|1168465|P1|COMPLETED|Overall Study||209
487636|NCT00391443|1168464|P2|STARTED|Overall Study||407
487637|NCT00391443|1168465|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
487638|NCT00391391|1168477|P4|NOT COMPLETED|Overall Study||19
487639|NCT00391391|1168478|P3|NOT COMPLETED|Overall Study||23
487640|NCT00391391|1168479|P2|NOT COMPLETED|Overall Study||10
487641|NCT00391391|1168480|P1|NOT COMPLETED|Overall Study||9
487642|NCT00391391|1168477|P4|COMPLETED|Overall Study||145
487643|NCT00391391|1168478|P3|COMPLETED|Overall Study||138
487644|NCT00391391|1168479|P2|COMPLETED|Overall Study||87
487645|NCT00391391|1168480|P1|COMPLETED|Overall Study||89
487646|NCT00391391|1168477|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
487647|NCT00391391|1168478|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
487648|NCT00391391|1168479|P2|STARTED|Overall Study||97
487649|NCT00391391|1168480|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
487650|NCT00391365|1168512|P2|NOT COMPLETED|Overall Study||19
487651|NCT00391365|1168513|P1|NOT COMPLETED|Overall Study||25
487652|NCT00391365|1168512|P2|COMPLETED|Overall Study||151
487653|NCT00391365|1168513|P1|COMPLETED|Overall Study||78
487654|NCT00391365|1168512|P2|STARTED|Overall Study||170
487655|NCT00391365|1168513|P1|STARTED|Overall Study||103
487656|NCT00391274|1168525|P2|NOT COMPLETED|Overall Study||57
487657|NCT00391274|1168526|P1|NOT COMPLETED|Overall Study||61
487659|NCT00391274|1168526|P1|COMPLETED|Overall Study||46
487660|NCT00391274|1168525|P2|Received at Least One Dose of Study Drug|Overall Study||102
487661|NCT00391274|1168526|P1|Received at Least One Dose of Study Drug|Overall Study||106
487662|NCT00391274|1168525|P2|STARTED|Overall Study||104
487663|NCT00391274|1168526|P1|STARTED|Overall Study||107
487664|NCT00391222|1168545|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
487665|NCT00391222|1168546|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
487666|NCT00391222|1168547|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
487667|NCT00391222|1168548|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
487668|NCT00391222|1168545|P4|COMPLETED|Period III (Double-Blind Treatment)||0
487669|NCT00391222|1168546|P3|COMPLETED|Period III (Double-Blind Treatment)||108
487670|NCT00391222|1168547|P2|COMPLETED|Period III (Double-Blind Treatment)||113
487671|NCT00391222|1168548|P1|COMPLETED|Period III (Double-Blind Treatment)||104
487672|NCT00391222|1168545|P4|STARTED|Period III (Double-Blind Treatment)||0
487673|NCT00391222|1168546|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
487756|NCT00390689|1168817|P3|STARTED|Overall Study||53
487674|NCT00391222|1168547|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
487675|NCT00391222|1168548|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
487676|NCT00391222|1168545|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
487677|NCT00391222|1168546|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
487678|NCT00391222|1168547|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
487679|NCT00391222|1168548|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
487680|NCT00391222|1168545|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
487681|NCT00391222|1168546|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
487682|NCT00391222|1168547|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
487683|NCT00391222|1168548|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
487684|NCT00391222|1168545|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
487685|NCT00391222|1168546|P3|STARTED|Period II (Open-label Risperidone LAI)||0
487686|NCT00391222|1168547|P2|STARTED|Period II (Open-label Risperidone LAI)||0
487687|NCT00391222|1168548|P1|STARTED|Period II (Open-label Risperidone LAI)||0
487688|NCT00391092|1168574|P2|NOT COMPLETED|Overall Study||216
487689|NCT00391092|1168575|P1|NOT COMPLETED|Overall Study||208
487690|NCT00391092|1168574|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
487691|NCT00391092|1168575|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
487692|NCT00391092|1168574|P2|Received Treatment|Overall Study||215
487693|NCT00391092|1168575|P1|Received Treatment|Overall Study||206
487694|NCT00391092|1168574|P2|STARTED|Overall Study||216
487695|NCT00391092|1168575|P1|STARTED|Overall Study||208
487696|NCT00391079|1168595|P2|NOT COMPLETED|Overall Study||16
487697|NCT00391079|1168596|P1|NOT COMPLETED|Overall Study||26
487698|NCT00391079|1168595|P2|COMPLETED|Overall Study||156
487699|NCT00391079|1168596|P1|COMPLETED|Overall Study||141
487700|NCT00391079|1168595|P2|STARTED|Overall Study||172
487701|NCT00391079|1168596|P1|STARTED|Overall Study||167
487702|NCT00391053|1168618|P4|NOT COMPLETED|Overall Study||10
487703|NCT00391053|1168619|P3|NOT COMPLETED|Overall Study||2
487704|NCT00391053|1168620|P2|NOT COMPLETED|Overall Study||1
487705|NCT00391053|1168621|P1|NOT COMPLETED|Overall Study||9
487706|NCT00391053|1168618|P4|COMPLETED|Overall Study||1252
487707|NCT00391053|1168619|P3|COMPLETED|Overall Study||868
487708|NCT00391053|1168620|P2|COMPLETED|Overall Study||847
487709|NCT00391053|1168621|P1|COMPLETED|Overall Study||848
487710|NCT00391053|1168618|P4|STARTED|Overall Study||1262
487711|NCT00391053|1168619|P3|STARTED|Overall Study||870
487712|NCT00391053|1168620|P2|STARTED|Overall Study||848
487713|NCT00391053|1168621|P1|STARTED|Overall Study||857
487714|NCT00391027|1168645|P2|NOT COMPLETED|Overall Study||12
487715|NCT00391027|1168646|P1|NOT COMPLETED|Overall Study||25
487716|NCT00391027|1168645|P2|COMPLETED|Overall Study||110
487717|NCT00391027|1168646|P1|COMPLETED|Overall Study||110
487718|NCT00391027|1168645|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
487719|NCT00391027|1168646|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
487720|NCT00390884|1168686|P2|NOT COMPLETED|Overall Study||2
487721|NCT00390884|1168687|P1|NOT COMPLETED|Overall Study||2
487722|NCT00390884|1168686|P2|COMPLETED|Overall Study||55
487723|NCT00390884|1168687|P1|COMPLETED|Overall Study||114
487724|NCT00390884|1168686|P2|STARTED|Overall Study||57
487725|NCT00390884|1168687|P1|STARTED|Overall Study||116
487726|NCT00390858|1168699|P2|NOT COMPLETED|Overall Study||7
487727|NCT00390858|1168700|P1|NOT COMPLETED|Overall Study||9
487728|NCT00390858|1168699|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
487729|NCT00390858|1168700|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
487730|NCT00390858|1168699|P2|Completed Core & Entered Extension Study|Overall Study||20
487731|NCT00390858|1168700|P1|Completed Core & Entered Extension Study|Overall Study||19
487732|NCT00390858|1168699|P2|STARTED|Overall Study|20 Participants started the Core Study|20
487733|NCT00390858|1168700|P1|STARTED|Overall Study|20 participants started the Core Study|20
487734|NCT00390806|1168714|P2|NOT COMPLETED|Overall Study||32
487735|NCT00390806|1168715|P1|NOT COMPLETED|Overall Study||30
487736|NCT00390806|1168714|P2|COMPLETED|Overall Study||204
487737|NCT00390806|1168715|P1|COMPLETED|Overall Study||206
487738|NCT00390806|1168714|P2|Ongoing|Overall Study||2
487739|NCT00390806|1168715|P1|Ongoing|Overall Study||4
487740|NCT00390806|1168714|P2|STARTED|Overall Study||236
487741|NCT00390806|1168715|P1|STARTED|Overall Study||236
487742|NCT00390780|1168783|P2|NOT COMPLETED|Overall Study||27
487743|NCT00390780|1168784|P1|NOT COMPLETED|Overall Study||23
487744|NCT00390780|1168783|P2|COMPLETED|Overall Study||260
487745|NCT00390780|1168784|P1|COMPLETED|Overall Study||268
487746|NCT00390780|1168783|P2|Treatment|Overall Study||287
487747|NCT00390780|1168784|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
487748|NCT00390780|1168783|P2|STARTED|Overall Study||287
487749|NCT00390780|1168784|P1|STARTED|Overall Study||291
487750|NCT00390689|1168817|P3|NOT COMPLETED|Overall Study||3
487751|NCT00390689|1168818|P2|NOT COMPLETED|Overall Study||5
487752|NCT00390689|1168819|P1|NOT COMPLETED|Overall Study||5
487753|NCT00390689|1168817|P3|COMPLETED|Overall Study||50
487754|NCT00390689|1168818|P2|COMPLETED|Overall Study||48
487755|NCT00390689|1168819|P1|COMPLETED|Overall Study||43
487757|NCT00390689|1168818|P2|STARTED|Overall Study||53
487758|NCT00390689|1168819|P1|STARTED|Overall Study||48
487759|NCT00390611|1168879|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
487760|NCT00390611|1168880|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
487761|NCT00390611|1168879|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
487762|NCT00390611|1168880|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
487763|NCT00390611|1168879|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
487764|NCT00390611|1168880|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
487765|NCT00390611|1168879|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
487766|NCT00390611|1168880|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
487767|NCT00390611|1168879|P2|COMPLETED|6 Cycles of Study Treatment||37
487768|NCT00390611|1168880|P1|COMPLETED|6 Cycles of Study Treatment||34
487769|NCT00390611|1168879|P2|STARTED|6 Cycles of Study Treatment||42
487770|NCT00390611|1168880|P1|STARTED|6 Cycles of Study Treatment||43
487771|NCT00390572|1168894|P2|NOT COMPLETED|Overall Study||5
487772|NCT00390572|1168895|P1|NOT COMPLETED|Overall Study||8
487773|NCT00390572|1168894|P2|COMPLETED|Overall Study||64
487774|NCT00390572|1168895|P1|COMPLETED|Overall Study||60
487775|NCT00390572|1168894|P2|STARTED|Overall Study||69
487776|NCT00390572|1168895|P1|STARTED|Overall Study||68
487777|NCT00390559|1168909|P1|NOT COMPLETED|Overall Study||44
487778|NCT00390559|1168909|P1|COMPLETED|Overall Study||80
487779|NCT00390559|1168909|P1|ActiveP/PlaceboC|Overall Study||90
487780|NCT00390559|1168909|P1|PlaceboP/PlaceboC|Overall Study||93
487781|NCT00390559|1168909|P1|ActiveP/ActiveC|Overall Study||87
487782|NCT00390559|1168909|P1|Received PlaceboP/Active C|Overall Study||93
487783|NCT00390559|1168909|P1|STARTED|Overall Study||124
487784|NCT00390546|1168921|P2|NOT COMPLETED|Overall Study||5
487785|NCT00390546|1168922|P1|NOT COMPLETED|Overall Study||6
487786|NCT00390546|1168921|P2|COMPLETED|Overall Study||34
487787|NCT00390546|1168922|P1|COMPLETED|Overall Study||27
487788|NCT00390546|1168921|P2|STARTED|Overall Study||39
487789|NCT00390546|1168922|P1|STARTED|Overall Study||33
487790|NCT00390468|1168932|P1|NOT COMPLETED|Overall Study||3
487791|NCT00390468|1168932|P1|COMPLETED|Overall Study||15
487792|NCT00390468|1168932|P1|STARTED|Overall Study||18
487799|NCT00390416|1168957|P1|NOT COMPLETED|Overall Study||4
487800|NCT00390416|1168957|P1|COMPLETED|Overall Study||44
487801|NCT00390416|1168957|P1|STARTED|Overall Study||48
487802|NCT00390364|1168963|P1|NOT COMPLETED|Overall Study||0
487803|NCT00390364|1168963|P1|COMPLETED|Overall Study||1
487804|NCT00390364|1168963|P1|STARTED|Overall Study||1
487805|NCT00390234|1168967|P1|NOT COMPLETED|Overall Study||0
487806|NCT00390234|1168967|P1|COMPLETED|Overall Study||63
487807|NCT00390234|1168967|P1|STARTED|Overall Study||63
487808|NCT00390221|1168978|P3|NOT COMPLETED|Overall Study||15
487809|NCT00390221|1168979|P2|NOT COMPLETED|Overall Study||20
487810|NCT00390221|1168980|P1|NOT COMPLETED|Overall Study||18
487811|NCT00390221|1168978|P3|COMPLETED|Overall Study||194
487812|NCT00390221|1168979|P2|COMPLETED|Overall Study||188
487813|NCT00390221|1168980|P1|COMPLETED|Overall Study||186
487814|NCT00390221|1168978|P3|STARTED|Overall Study||209
487815|NCT00390221|1168979|P2|STARTED|Overall Study||208
487816|NCT00390221|1168980|P1|STARTED|Overall Study||204
487817|NCT00390182|1169001|P1|NOT COMPLETED|Overall Study||5
487818|NCT00390182|1169001|P1|COMPLETED|Overall Study||33
487819|NCT00390182|1169001|P1|STARTED|Overall Study||38
487820|NCT00389974|1169007|P1|NOT COMPLETED|Overall Study||0
487821|NCT00389974|1169007|P1|COMPLETED|Overall Study||19
487822|NCT00389974|1169007|P1|STARTED|Overall Study||19
487823|NCT00389857|1169013|P2|NOT COMPLETED|Overall Study||0
487824|NCT00389857|1169014|P1|NOT COMPLETED|Overall Study||0
487825|NCT00389857|1169013|P2|COMPLETED|Overall Study||17
487826|NCT00389857|1169014|P1|COMPLETED|Overall Study||14
487827|NCT00389857|1169013|P2|STARTED|Overall Study||17
487828|NCT00389857|1169014|P1|STARTED|Overall Study||14
487829|NCT00389831|1169026|P2|NOT COMPLETED|Overall Study||7
487830|NCT00389831|1169027|P1|NOT COMPLETED|Overall Study||0
487831|NCT00389831|1169026|P2|COMPLETED|Overall Study||27
487832|NCT00389831|1169027|P1|COMPLETED|Overall Study||10
487833|NCT00389831|1169026|P2|STARTED|Overall Study||34
487834|NCT00389831|1169027|P1|STARTED|Overall Study||10
487835|NCT00389818|1169053|P1|NOT COMPLETED|Overall Study||3
487836|NCT00389818|1169053|P1|COMPLETED|Overall Study||40
487837|NCT00389818|1169053|P1|STARTED|Overall Study||43
487838|NCT00389597|1169061|P4|NOT COMPLETED|Overall Study||6
487839|NCT00389597|1169062|P3|NOT COMPLETED|Overall Study||4
487840|NCT00389597|1169063|P2|NOT COMPLETED|Overall Study||6
487841|NCT00389597|1169064|P1|NOT COMPLETED|Overall Study||8
487842|NCT00389597|1169061|P4|COMPLETED|Overall Study||99
487843|NCT00389597|1169062|P3|COMPLETED|Overall Study||221
487844|NCT00389597|1169063|P2|COMPLETED|Overall Study||75
487845|NCT00389597|1169064|P1|COMPLETED|Overall Study||156
487846|NCT00389597|1169061|P4|24 mo|Overall Study||99
487847|NCT00389597|1169062|P3|24 mo|Overall Study||221
487848|NCT00389597|1169063|P2|24 mo|Overall Study||75
487849|NCT00389597|1169064|P1|24 mo|Overall Study||156
487850|NCT00389597|1169061|P4|STARTED|Overall Study||105
487851|NCT00389597|1169062|P3|STARTED|Overall Study||225
487852|NCT00389597|1169063|P2|STARTED|Overall Study||81
487853|NCT00389597|1169064|P1|STARTED|Overall Study||164
487854|NCT00389532|1169076|P2|NOT COMPLETED|Overall Study||0
487855|NCT00389532|1169077|P1|NOT COMPLETED|Overall Study||0
487856|NCT00389532|1169076|P2|COMPLETED|Overall Study||56
487857|NCT00389532|1169077|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
487858|NCT00389532|1169076|P2|STARTED|Overall Study||56
487859|NCT00389532|1169077|P1|STARTED|Overall Study||60
487860|NCT00389519|1169089|P4|NOT COMPLETED|Treated||4
487861|NCT00389519|1169090|P3|NOT COMPLETED|Treated||0
487862|NCT00389519|1169091|P2|NOT COMPLETED|Treated||1
487863|NCT00389519|1169092|P1|NOT COMPLETED|Treated||2
487864|NCT00389519|1169089|P4|COMPLETED|Treated||76
487865|NCT00389519|1169090|P3|COMPLETED|Treated||40
487866|NCT00389519|1169091|P2|COMPLETED|Treated||40
487867|NCT00389519|1169092|P1|COMPLETED|Treated||79
487868|NCT00389519|1169089|P4|STARTED|Treated||80
487869|NCT00389519|1169090|P3|STARTED|Treated||40
487870|NCT00389519|1169091|P2|STARTED|Treated||41
487871|NCT00389519|1169092|P1|STARTED|Treated||81
487872|NCT00389519|1169089|P4|NOT COMPLETED|Randomized||0
487873|NCT00389519|1169090|P3|NOT COMPLETED|Randomized||0
487874|NCT00389519|1169091|P2|NOT COMPLETED|Randomized||0
487875|NCT00389519|1169092|P1|NOT COMPLETED|Randomized||2
487876|NCT00389519|1169089|P4|COMPLETED|Randomized||80
487877|NCT00389519|1169090|P3|COMPLETED|Randomized||40
487878|NCT00389519|1169091|P2|COMPLETED|Randomized||41
487879|NCT00389519|1169092|P1|COMPLETED|Randomized||81
487880|NCT00389519|1169089|P4|STARTED|Randomized||80
487881|NCT00389519|1169090|P3|STARTED|Randomized||40
487882|NCT00389519|1169091|P2|STARTED|Randomized||41
487883|NCT00389519|1169092|P1|STARTED|Randomized||83
487884|NCT00389519|1169089|P4|NOT COMPLETED|Placebo Run-In||0
487885|NCT00389519|1169090|P3|NOT COMPLETED|Placebo Run-In||0
487886|NCT00389519|1169091|P2|NOT COMPLETED|Placebo Run-In||0
487887|NCT00389519|1169092|P1|NOT COMPLETED|Placebo Run-In||178
487888|NCT00389519|1169089|P4|COMPLETED|Placebo Run-In||0
487889|NCT00389519|1169090|P3|COMPLETED|Placebo Run-In||0
487890|NCT00389519|1169091|P2|COMPLETED|Placebo Run-In||0
487891|NCT00389519|1169092|P1|COMPLETED|Placebo Run-In||244
487892|NCT00389519|1169089|P4|STARTED|Placebo Run-In||0
487893|NCT00389519|1169090|P3|STARTED|Placebo Run-In||0
487894|NCT00389519|1169091|P2|STARTED|Placebo Run-In||0
487895|NCT00389519|1169092|P1|STARTED|Placebo Run-In||422
487896|NCT00389493|1169121|P3|NOT COMPLETED|Overall Study||3
487897|NCT00389493|1169122|P2|NOT COMPLETED|Overall Study||8
487898|NCT00389493|1169123|P1|NOT COMPLETED|Overall Study||3
487899|NCT00389493|1169121|P3|COMPLETED|Overall Study||17
487900|NCT00389493|1169122|P2|COMPLETED|Overall Study||32
487901|NCT00389493|1169123|P1|COMPLETED|Overall Study||37
487902|NCT00389493|1169121|P3|STARTED|Overall Study||20
487903|NCT00389493|1169122|P2|STARTED|Overall Study||40
487904|NCT00389493|1169123|P1|STARTED|Overall Study||40
487905|NCT00389467|1169147|P4|NOT COMPLETED|Overall Study||0
487906|NCT00389467|1169148|P3|NOT COMPLETED|Overall Study||0
487907|NCT00389467|1169149|P2|NOT COMPLETED|Overall Study||0
487908|NCT00389467|1169150|P1|NOT COMPLETED|Overall Study||0
487909|NCT00389467|1169147|P4|COMPLETED|Overall Study||20
487910|NCT00389467|1169148|P3|COMPLETED|Overall Study||30
487911|NCT00389467|1169149|P2|COMPLETED|Overall Study||34
487912|NCT00389467|1169150|P1|COMPLETED|Overall Study||34
487913|NCT00389467|1169147|P4|STARTED|Overall Study||20
487914|NCT00389467|1169148|P3|STARTED|Overall Study||30
487915|NCT00389467|1169149|P2|STARTED|Overall Study||34
487916|NCT00389467|1169150|P1|STARTED|Overall Study||34
487917|NCT00389441|1169169|P1|NOT COMPLETED|Overall Study||52
487918|NCT00389441|1169169|P1|COMPLETED|Overall Study||0
487919|NCT00389441|1169169|P1|STARTED|Overall Study||52
487920|NCT00389324|1169178|P1|NOT COMPLETED|Subcutaneous Phase||7
487921|NCT00389324|1169178|P1|COMPLETED|Subcutaneous Phase||25
487922|NCT00389324|1169178|P1|STARTED|Subcutaneous Phase||32
487923|NCT00389324|1169178|P1|NOT COMPLETED|Intravenous Phase||0
487924|NCT00389324|1169178|P1|COMPLETED|Intravenous Phase||32
487925|NCT00389324|1169178|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
487926|NCT00389324|1169178|P1|NOT COMPLETED|Run-In Phase||3
487927|NCT00389324|1169178|P1|COMPLETED|Run-In Phase||18
487928|NCT00389324|1169178|P1|STARTED|Run-In Phase||21
487929|NCT00389207|1169188|P3|NOT COMPLETED|Overall Study||41
487930|NCT00389207|1169189|P2|NOT COMPLETED|Overall Study||72
487931|NCT00389207|1169190|P1|NOT COMPLETED|Overall Study||63
487932|NCT00389207|1169188|P3|COMPLETED|Overall Study||152
487933|NCT00389207|1169189|P2|COMPLETED|Overall Study||116
487934|NCT00389207|1169190|P1|COMPLETED|Overall Study||125
487935|NCT00389207|1169188|P3|STARTED|Overall Study||193
487936|NCT00389207|1169189|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
487937|NCT00389207|1169190|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
487938|NCT00389168|1169294|P2|NOT COMPLETED|Overall Study||5
487939|NCT00389168|1169295|P1|NOT COMPLETED|Overall Study||9
487940|NCT00389168|1169294|P2|COMPLETED|Overall Study||53
487941|NCT00389168|1169295|P1|COMPLETED|Overall Study||47
487942|NCT00389168|1169294|P2|STARTED|Overall Study||58
487943|NCT00389168|1169295|P1|STARTED|Overall Study||56
487944|NCT00389064|1169313|P2|NOT COMPLETED|Overall Study||59
487945|NCT00389064|1169314|P1|NOT COMPLETED|Overall Study||45
487946|NCT00389064|1169313|P2|COMPLETED|Overall Study||168
487947|NCT00389064|1169314|P1|COMPLETED|Overall Study||178
487948|NCT00389064|1169313|P2|STARTED|Overall Study||227
487949|NCT00389064|1169314|P1|STARTED|Overall Study||223
487950|NCT00388973|1169342|P2|NOT COMPLETED|Overall Study||58
487951|NCT00388973|1169343|P1|NOT COMPLETED|Overall Study||56
487952|NCT00388973|1169342|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
487953|NCT00388973|1169343|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
487954|NCT00388973|1169342|P2|Completed Study|Overall Study||114
487955|NCT00388973|1169343|P1|Completed Study|Overall Study||110
487956|NCT00388973|1169342|P2|STARTED|Overall Study|Randomized|172
487957|NCT00388973|1169343|P1|STARTED|Overall Study|Randomized|166
487958|NCT00388947|1169363|P1|NOT COMPLETED|Overall Study||47
487959|NCT00388947|1169363|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
487960|NCT00388947|1169363|P1|STARTED|Overall Study||1590
487961|NCT00388804|1169370|P2|NOT COMPLETED|Overall Study||0
487962|NCT00388804|1169371|P1|NOT COMPLETED|Overall Study||0
487963|NCT00388804|1169370|P2|COMPLETED|Overall Study||21
487964|NCT00388804|1169371|P1|COMPLETED|Overall Study||17
487965|NCT00388804|1169370|P2|STARTED|Overall Study||21
487966|NCT00388804|1169371|P1|STARTED|Overall Study||17
487967|NCT00388726|1169379|P2|NOT COMPLETED|Overall Study||244
487968|NCT00388726|1169380|P1|NOT COMPLETED|Overall Study||484
487969|NCT00388726|1169379|P2|COMPLETED|Overall Study||10
487970|NCT00388726|1169380|P1|COMPLETED|Overall Study||24
487971|NCT00388726|1169379|P2|STARTED|Overall Study||254
487972|NCT00388726|1169380|P1|STARTED|Overall Study||508
487973|NCT00388583|1169394|P2|NOT COMPLETED|Overall Study||4
487974|NCT00388583|1169395|P1|NOT COMPLETED|Overall Study||6
487975|NCT00388583|1169394|P2|COMPLETED|Overall Study||406
487976|NCT00388583|1169395|P1|COMPLETED|Overall Study||401
487977|NCT00388583|1169394|P2|STARTED|Overall Study||410
487978|NCT00388583|1169395|P1|STARTED|Overall Study||407
487979|NCT00388505|1169409|P2|NOT COMPLETED|Overall Study||38
487980|NCT00388505|1169410|P1|NOT COMPLETED|Overall Study||83
487981|NCT00388505|1169409|P2|COMPLETED|Overall Study||171
487982|NCT00388505|1169410|P1|COMPLETED|Overall Study||225
487983|NCT00388505|1169409|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
487984|NCT00388505|1169410|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
487985|NCT00388362|1169432|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
487986|NCT00388362|1169432|P1|COMPLETED|Remained on Study Median of 514 Days||21
487987|NCT00388362|1169432|P1|STARTED|Remained on Study Median of 514 Days||23
487988|NCT00388362|1169432|P1|NOT COMPLETED|Enrolled||13
487989|NCT00388362|1169432|P1|COMPLETED|Enrolled||23
487990|NCT00388362|1169432|P1|STARTED|Enrolled||36
487991|NCT00388349|1169437|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
487992|NCT00388349|1169438|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
487993|NCT00388349|1169437|P2|COMPLETED|Phase 2 Dose Expansion||0
487994|NCT00388349|1169438|P1|COMPLETED|Phase 2 Dose Expansion||139
487995|NCT00388349|1169437|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
487996|NCT00388349|1169438|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
487997|NCT00388349|1169437|P2|NOT COMPLETED|Phase I Dose Escalation||3
487998|NCT00388349|1169438|P1|NOT COMPLETED|Phase I Dose Escalation||0
487999|NCT00388349|1169437|P2|COMPLETED|Phase I Dose Escalation||1
488000|NCT00388349|1169438|P1|COMPLETED|Phase I Dose Escalation||3
488001|NCT00388349|1169437|P2|STARTED|Phase I Dose Escalation||4
488002|NCT00388349|1169438|P1|STARTED|Phase I Dose Escalation||3
488003|NCT00388154|1169447|P1|NOT COMPLETED|Overall Study||1
488004|NCT00388154|1169447|P1|COMPLETED|Overall Study||20
488005|NCT00388154|1169447|P1|STARTED|Overall Study||21
488006|NCT00388037|1169452|P1|NOT COMPLETED|Overall Study||1
488007|NCT00388037|1169452|P1|COMPLETED|Overall Study||30
488008|NCT00388037|1169452|P1|STARTED|Overall Study||31
488009|NCT00387959|1169456|P1|NOT COMPLETED|Overall Study||1
488010|NCT00387959|1169456|P1|COMPLETED|Overall Study||16
488011|NCT00387959|1169456|P1|STARTED|Overall Study||17
488012|NCT00387894|1169460|P1|NOT COMPLETED|Overall Study||1
488013|NCT00387894|1169460|P1|COMPLETED|Overall Study||5
488014|NCT00387894|1169460|P1|STARTED|Overall Study||6
488015|NCT00387881|1169467|P2|NOT COMPLETED|Overall Study||102
488016|NCT00387881|1169468|P1|NOT COMPLETED|Overall Study||89
488017|NCT00387881|1169467|P2|COMPLETED|Overall Study||243
488018|NCT00387881|1169468|P1|COMPLETED|Overall Study||245
488019|NCT00387881|1169467|P2|STARTED|Overall Study||345
488020|NCT00387881|1169468|P1|STARTED|Overall Study||334
488021|NCT00387829|1169492|P2|NOT COMPLETED|Intent-to-treat Population||30
488022|NCT00387829|1169493|P1|NOT COMPLETED|Intent-to-treat Population||38
488023|NCT00387829|1169492|P2|COMPLETED|Intent-to-treat Population||136
488024|NCT00387829|1169493|P1|COMPLETED|Intent-to-treat Population||139
488025|NCT00387829|1169492|P2|STARTED|Intent-to-treat Population||166
488026|NCT00387829|1169493|P1|STARTED|Intent-to-treat Population||177
488027|NCT00387829|1169492|P2|NOT COMPLETED|Safety Population||33
488028|NCT00387829|1169493|P1|NOT COMPLETED|Safety Population||39
488029|NCT00387829|1169492|P2|COMPLETED|Safety Population||136
488030|NCT00387829|1169493|P1|COMPLETED|Safety Population||139
488031|NCT00387829|1169492|P2|STARTED|Safety Population||169
488032|NCT00387829|1169493|P1|STARTED|Safety Population||178
488033|NCT00387790|1169501|P1|NOT COMPLETED|Overall Study||14
488034|NCT00387790|1169501|P1|COMPLETED|Overall Study||50
488035|NCT00387790|1169501|P1|STARTED|Overall Study||64
488036|NCT00387764|1169505|P1|NOT COMPLETED|Overall Study||31
488037|NCT00387764|1169505|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
488038|NCT00387764|1169505|P1|STARTED|Overall Study||80
488039|NCT00387751|1169523|P1|NOT COMPLETED|Overall Study||0
488040|NCT00387751|1169523|P1|COMPLETED|Overall Study||14
488041|NCT00387751|1169523|P1|STARTED|Overall Study||14
488042|NCT00387725|1169531|P4|NOT COMPLETED|Overall Study||2
488043|NCT00387725|1169532|P3|NOT COMPLETED|Overall Study||2
488044|NCT00387725|1169533|P2|NOT COMPLETED|Overall Study||1
488045|NCT00387725|1169534|P1|NOT COMPLETED|Overall Study||1
488046|NCT00387725|1169531|P4|COMPLETED|Overall Study||43
488047|NCT00387725|1169532|P3|COMPLETED|Overall Study||43
488048|NCT00387725|1169533|P2|COMPLETED|Overall Study||15
488049|NCT00387725|1169534|P1|COMPLETED|Overall Study||20
488050|NCT00387725|1169531|P4|STARTED|Overall Study||45
488051|NCT00387725|1169532|P3|STARTED|Overall Study||45
488052|NCT00387725|1169533|P2|STARTED|Overall Study||16
488053|NCT00387725|1169534|P1|STARTED|Overall Study||21
488054|NCT00387673|1169552|P3|NOT COMPLETED|Overall Study||0
488055|NCT00387673|1169553|P2|NOT COMPLETED|Overall Study||0
488056|NCT00387673|1169554|P1|NOT COMPLETED|Overall Study||0
488057|NCT00387673|1169552|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
488058|NCT00387673|1169553|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
488059|NCT00387673|1169554|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
488060|NCT00387673|1169552|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
488061|NCT00387673|1169553|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
488062|NCT00387673|1169554|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
488063|NCT00387660|1169562|P2|NOT COMPLETED|Overall Study||0
488064|NCT00387660|1169563|P1|NOT COMPLETED|Overall Study||0
488065|NCT00387660|1169562|P2|COMPLETED|Overall Study||40
488066|NCT00387660|1169563|P1|COMPLETED|Overall Study||40
488067|NCT00387660|1169562|P2|STARTED|Overall Study||40
488068|NCT00387660|1169563|P1|STARTED|Overall Study||40
488069|NCT00387647|1169573|P1|NOT COMPLETED|Overall Study||18
488070|NCT00387647|1169573|P1|COMPLETED|Overall Study||6
488071|NCT00387647|1169573|P1|STARTED|Overall Study||24
488072|NCT00387621|1169582|P2|NOT COMPLETED|Second Intervention||0
488073|NCT00387621|1169583|P1|NOT COMPLETED|Second Intervention||0
488074|NCT00387621|1169582|P2|COMPLETED|Second Intervention||29
488075|NCT00387621|1169583|P1|COMPLETED|Second Intervention||29
488076|NCT00387621|1169582|P2|STARTED|Second Intervention||29
488077|NCT00387621|1169583|P1|STARTED|Second Intervention||29
488078|NCT00387621|1169582|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
488079|NCT00387621|1169583|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
488080|NCT00387621|1169582|P2|COMPLETED|Washout Period of 2 Weeks||29
488081|NCT00387621|1169583|P1|COMPLETED|Washout Period of 2 Weeks||29
488082|NCT00387621|1169582|P2|STARTED|Washout Period of 2 Weeks||29
488083|NCT00387621|1169583|P1|STARTED|Washout Period of 2 Weeks||29
488084|NCT00387621|1169582|P2|NOT COMPLETED|First Intervention||0
488085|NCT00387621|1169583|P1|NOT COMPLETED|First Intervention||0
488086|NCT00387621|1169582|P2|COMPLETED|First Intervention||29
488087|NCT00387621|1169583|P1|COMPLETED|First Intervention||29
488088|NCT00387621|1169582|P2|STARTED|First Intervention||29
488089|NCT00387621|1169583|P1|STARTED|First Intervention||29
488090|NCT00387426|1169613|P1|NOT COMPLETED|Overall Study||14
488091|NCT00387426|1169613|P1|COMPLETED|Overall Study||0
488092|NCT00387426|1169613|P1|STARTED|Overall Study||14
488093|NCT00387348|1169620|P3|NOT COMPLETED|Overall Study||4
488094|NCT00387348|1169621|P2|NOT COMPLETED|Overall Study||3
488095|NCT00387348|1169622|P1|NOT COMPLETED|Overall Study||3
488096|NCT00387348|1169620|P3|COMPLETED|Overall Study||7
488097|NCT00387348|1169621|P2|COMPLETED|Overall Study||2
488098|NCT00387348|1169622|P1|COMPLETED|Overall Study||5
488099|NCT00387348|1169620|P3|STARTED|Overall Study||11
488100|NCT00387348|1169621|P2|STARTED|Overall Study||5
488101|NCT00387348|1169622|P1|STARTED|Overall Study||8
488102|NCT00387335|1169638|P2|NOT COMPLETED|Overall Study||0
488103|NCT00387335|1169639|P1|NOT COMPLETED|Overall Study||0
488104|NCT00387335|1169638|P2|COMPLETED|Overall Study||7
488105|NCT00387335|1169639|P1|COMPLETED|Overall Study||15
488106|NCT00387335|1169638|P2|STARTED|Overall Study||7
488107|NCT00387335|1169639|P1|STARTED|Overall Study||15
488108|NCT00387153|1169651|P1|NOT COMPLETED|Overall Study||8
488109|NCT00387153|1169651|P1|COMPLETED|Overall Study||0
488110|NCT00387153|1169651|P1|STARTED|Overall Study||8
488111|NCT00387127|1169657|P2|NOT COMPLETED|Overall Study||34
488112|NCT00387127|1169658|P1|NOT COMPLETED|Overall Study||33
488113|NCT00387127|1169657|P2|COMPLETED|Overall Study||0
488114|NCT00387127|1169658|P1|COMPLETED|Overall Study||0
488115|NCT00387127|1169657|P2|STARTED|Overall Study||34
488116|NCT00387127|1169658|P1|STARTED|Overall Study||33
488117|NCT00387088|1169700|P2|NOT COMPLETED|Overall Study||373
488118|NCT00387088|1169701|P1|NOT COMPLETED|Overall Study||318
488119|NCT00387088|1169700|P2|COMPLETED|Overall Study||1629
488120|NCT00387088|1169701|P1|COMPLETED|Overall Study||1671
488121|NCT00387088|1169700|P2|STARTED|Overall Study||2002
488122|NCT00387088|1169701|P1|STARTED|Overall Study||1989
488123|NCT00387036|1169745|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
488124|NCT00387036|1169746|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
488125|NCT00387036|1169745|P2|COMPLETED|2-Week Crossover Second Intervention||6
488126|NCT00387036|1169746|P1|COMPLETED|2-Week Crossover Second Intervention||6
488127|NCT00387036|1169745|P2|STARTED|2-Week Crossover Second Intervention||6
488128|NCT00387036|1169746|P1|STARTED|2-Week Crossover Second Intervention||6
488129|NCT00387036|1169745|P2|NOT COMPLETED|2-Week Placebo Washout||0
488130|NCT00387036|1169746|P1|NOT COMPLETED|2-Week Placebo Washout||0
488131|NCT00387036|1169745|P2|COMPLETED|2-Week Placebo Washout||6
488132|NCT00387036|1169746|P1|COMPLETED|2-Week Placebo Washout||6
488133|NCT00387036|1169745|P2|STARTED|2-Week Placebo Washout||6
488134|NCT00387036|1169746|P1|STARTED|2-Week Placebo Washout||6
488135|NCT00387036|1169745|P2|NOT COMPLETED|2-Week First Intervention||0
488136|NCT00387036|1169746|P1|NOT COMPLETED|2-Week First Intervention||0
488137|NCT00387036|1169745|P2|COMPLETED|2-Week First Intervention||6
488138|NCT00387036|1169746|P1|COMPLETED|2-Week First Intervention||6
488139|NCT00387036|1169745|P2|STARTED|2-Week First Intervention||6
488140|NCT00387036|1169746|P1|STARTED|2-Week First Intervention||6
488141|NCT00387023|1169754|P1|NOT COMPLETED|Overall Study||0
488142|NCT00387023|1169754|P1|COMPLETED|Overall Study||12
488143|NCT00387023|1169754|P1|STARTED|Overall Study||12
488144|NCT00387010|1169758|P1|NOT COMPLETED|Treatment Period||11
488145|NCT00387010|1169758|P1|COMPLETED|Treatment Period||169
488146|NCT00387010|1169758|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
488147|NCT00387010|1169758|P1|STARTED|Treatment Period||180
488148|NCT00387010|1169758|P1|NOT COMPLETED|Dose Titration Period||38
488149|NCT00387010|1169758|P1|COMPLETED|Dose Titration Period||180
488150|NCT00387010|1169758|P1|STARTED|Dose Titration Period||218
488151|NCT00386880|1169779|P2|NOT COMPLETED|Overall Study||0
488152|NCT00386880|1169780|P1|NOT COMPLETED|Overall Study||0
488153|NCT00386880|1169779|P2|COMPLETED|Overall Study||8
488154|NCT00386880|1169780|P1|COMPLETED|Overall Study||30
488155|NCT00386880|1169779|P2|STARTED|Overall Study||8
488156|NCT00386880|1169780|P1|STARTED|Overall Study||30
488157|NCT00386776|1169785|P1|NOT COMPLETED|Overall Study||8
488158|NCT00386776|1169785|P1|COMPLETED|Overall Study||32
488159|NCT00386776|1169785|P1|STARTED|Overall Study||40
488160|NCT00386607|1169795|P2|NOT COMPLETED|Extension||17
488161|NCT00386607|1169796|P1|NOT COMPLETED|Extension||0
488162|NCT00386607|1169795|P2|COMPLETED|Extension||145
488163|NCT00386607|1169796|P1|COMPLETED|Extension||0
488164|NCT00386607|1169795|P2|STARTED|Extension||162
488165|NCT00386607|1169796|P1|STARTED|Extension||0
488166|NCT00386607|1169795|P2|NOT COMPLETED|Core||0
488167|NCT00386607|1169796|P1|NOT COMPLETED|Core||115
488168|NCT00386607|1169795|P2|COMPLETED|Core||0
488169|NCT00386607|1169796|P1|COMPLETED|Core||486
488170|NCT00386607|1169795|P2|STARTED|Core||0
488171|NCT00386607|1169796|P1|STARTED|Core||601
488172|NCT00386477|1169814|P2|NOT COMPLETED|Overall Study||0
488173|NCT00386477|1169815|P1|NOT COMPLETED|Overall Study||0
488174|NCT00386477|1169814|P2|COMPLETED|Overall Study||145
488175|NCT00386477|1169815|P1|COMPLETED|Overall Study||155
488176|NCT00386477|1169814|P2|STARTED|Overall Study||145
488177|NCT00386477|1169815|P1|STARTED|Overall Study||155
488178|NCT00386425|1169824|P3|NOT COMPLETED|Overall Study||0
488179|NCT00386425|1169825|P2|NOT COMPLETED|Overall Study||1
488180|NCT00386425|1169826|P1|NOT COMPLETED|Overall Study||3
488181|NCT00386425|1169824|P3|COMPLETED|Overall Study||53
488182|NCT00386425|1169825|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
488183|NCT00386425|1169826|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
488184|NCT00386425|1169824|P3|Received Study Drug|Overall Study||53
488185|NCT00386425|1169825|P2|Received Study Drug|Overall Study||206
488186|NCT00386425|1169826|P1|Received Study Drug|Overall Study||227
488187|NCT00386425|1169824|P3|STARTED|Overall Study||53
488188|NCT00386425|1169825|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
488189|NCT00386425|1169826|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
488190|NCT00386360|1169852|P2|NOT COMPLETED|Overall Study||17
488191|NCT00386360|1169853|P1|NOT COMPLETED|Overall Study||9
488192|NCT00386360|1169852|P2|COMPLETED|Overall Study||95
488193|NCT00386360|1169853|P1|COMPLETED|Overall Study||40
488194|NCT00386360|1169852|P2|Primary Efficacy|Overall Study||77
488195|NCT00386360|1169853|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
488196|NCT00386360|1169852|P2|Intent to Treat Population (ITT)|Overall Study||110
488197|NCT00386360|1169853|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
488198|NCT00386360|1169852|P2|STARTED|Overall Study||112
488199|NCT00386360|1169853|P1|STARTED|Overall Study||49
488200|NCT00386334|1169887|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
488201|NCT00386334|1169888|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
488202|NCT00386334|1169887|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
488203|NCT00386334|1169888|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
488204|NCT00386334|1169887|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
488205|NCT00386334|1169888|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
488206|NCT00386334|1169887|P2|NOT COMPLETED|Double Blind Period||47
488207|NCT00386334|1169888|P1|NOT COMPLETED|Double Blind Period||46
488208|NCT00386334|1169887|P2|COMPLETED|Double Blind Period||147
488209|NCT00386334|1169888|P1|COMPLETED|Double Blind Period||148
488210|NCT00386334|1169887|P2|STARTED|Double Blind Period||194
488211|NCT00386334|1169888|P1|STARTED|Double Blind Period||194
488212|NCT00386308|1170032|P2|NOT COMPLETED|Overall Study||19
488213|NCT00386308|1170033|P1|NOT COMPLETED|Overall Study||29
488214|NCT00386308|1170032|P2|COMPLETED|Overall Study||54
488215|NCT00386308|1170033|P1|COMPLETED|Overall Study||94
488216|NCT00386308|1170032|P2|Modified Intent to Treat Population|Overall Study||72
488217|NCT00386308|1170033|P1|Modified Intent to Treat Population|Overall Study||115
488218|NCT00386308|1170032|P2|Intent to Treat Population|Overall Study||72
488219|NCT00386308|1170033|P1|Intent to Treat Population|Overall Study||117
488220|NCT00386308|1170032|P2|STARTED|Overall Study||73
488221|NCT00386308|1170033|P1|STARTED|Overall Study||123
488222|NCT00386256|1170049|P4|NOT COMPLETED|Overall Study||0
488223|NCT00386256|1170050|P3|NOT COMPLETED|Overall Study||0
488224|NCT00386256|1170051|P2|NOT COMPLETED|Overall Study||0
488225|NCT00386256|1170052|P1|NOT COMPLETED|Overall Study||0
488226|NCT00386256|1170049|P4|COMPLETED|Overall Study||3
488227|NCT00386256|1170050|P3|COMPLETED|Overall Study||4
488228|NCT00386256|1170051|P2|COMPLETED|Overall Study||15
488229|NCT00386256|1170052|P1|COMPLETED|Overall Study||16
488230|NCT00386256|1170049|P4|STARTED|Overall Study||3
488231|NCT00386256|1170050|P3|STARTED|Overall Study||4
488232|NCT00386256|1170051|P2|STARTED|Overall Study||15
488233|NCT00386256|1170052|P1|STARTED|Overall Study||16
488234|NCT00386243|1170068|P2|NOT COMPLETED|Overall Study||13
488235|NCT00386243|1170069|P1|NOT COMPLETED|Overall Study||7
488236|NCT00386243|1170068|P2|COMPLETED|Overall Study||108
488237|NCT00386243|1170069|P1|COMPLETED|Overall Study||114
488238|NCT00386243|1170068|P2|STARTED|Overall Study||121
488239|NCT00386243|1170069|P1|STARTED|Overall Study||121
488240|NCT00386152|1170080|P3|NOT COMPLETED|Overall Study||33
488241|NCT00386152|1170081|P2|NOT COMPLETED|Overall Study||40
488242|NCT00386152|1170082|P1|NOT COMPLETED|Overall Study||44
488243|NCT00386152|1170080|P3|COMPLETED|Overall Study||42
488244|NCT00386152|1170081|P2|COMPLETED|Overall Study||37
488245|NCT00386152|1170082|P1|COMPLETED|Overall Study||31
488246|NCT00386152|1170080|P3|STARTED|Overall Study|number of subjects treated|75
488247|NCT00386152|1170081|P2|STARTED|Overall Study|number of subjects treated|77
488248|NCT00386152|1170082|P1|STARTED|Overall Study|number of subjects treated|75
488249|NCT00386100|1170101|P2|NOT COMPLETED|Overall Study||131
488250|NCT00386100|1170102|P1|NOT COMPLETED|Overall Study||154
488251|NCT00386100|1170101|P2|COMPLETED|Overall Study||217
488252|NCT00386100|1170102|P1|COMPLETED|Overall Study||186
488253|NCT00386100|1170101|P2|STARTED|Overall Study||348
488254|NCT00386100|1170102|P1|STARTED|Overall Study||340
488255|NCT00386022|1170166|P2|NOT COMPLETED|Plus Estrogen||1
488256|NCT00386022|1170167|P1|NOT COMPLETED|Plus Estrogen||2
488257|NCT00386022|1170166|P2|COMPLETED|Plus Estrogen||8
488258|NCT00386022|1170167|P1|COMPLETED|Plus Estrogen||8
488259|NCT00386022|1170166|P2|All Doses GnRH|Plus Estrogen||8
488260|NCT00386022|1170167|P1|All Doses GnRH|Plus Estrogen||8
488261|NCT00386022|1170166|P2|Estrogen Patch|Plus Estrogen||9
488262|NCT00386022|1170167|P1|Estrogen Patch|Plus Estrogen||8
488263|NCT00386022|1170166|P2|STARTED|Plus Estrogen||9
488264|NCT00386022|1170167|P1|STARTED|Plus Estrogen||10
488265|NCT00386022|1170166|P2|NOT COMPLETED|Baseline||0
488266|NCT00386022|1170167|P1|NOT COMPLETED|Baseline||0
488267|NCT00386022|1170166|P2|COMPLETED|Baseline||9
488268|NCT00386022|1170167|P1|COMPLETED|Baseline||10
488269|NCT00386022|1170166|P2|All Doses of GnRH|Baseline||9
488270|NCT00386022|1170167|P1|All Doses of GnRH|Baseline||10
488271|NCT00386022|1170166|P2|STARTED|Baseline||9
488272|NCT00386022|1170167|P1|STARTED|Baseline||10
488273|NCT00386009|1170177|P2|NOT COMPLETED|Overall Study||10
488274|NCT00386009|1170178|P1|NOT COMPLETED|Overall Study||9
488275|NCT00386009|1170177|P2|COMPLETED|Overall Study||89
488276|NCT00386009|1170178|P1|COMPLETED|Overall Study||92
488277|NCT00386009|1170177|P2|STARTED|Overall Study||99
488278|NCT00386009|1170178|P1|STARTED|Overall Study||101
488279|NCT00385996|1170216|P1|NOT COMPLETED|Overall Study||0
488280|NCT00385996|1170216|P1|COMPLETED|Overall Study||22
488281|NCT00385996|1170216|P1|STARTED|Overall Study||22
488282|NCT00385944|1170223|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
488283|NCT00385944|1170224|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
488284|NCT00385944|1170225|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
488285|NCT00385944|1170223|P3|COMPLETED|2nd Maintenance Dose Period||0
488286|NCT00385944|1170224|P2|COMPLETED|2nd Maintenance Dose Period||19
488287|NCT00385944|1170225|P1|COMPLETED|2nd Maintenance Dose Period||22
488288|NCT00385944|1170223|P3|STARTED|2nd Maintenance Dose Period||0
488289|NCT00385944|1170224|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
488290|NCT00385944|1170225|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
488291|NCT00385944|1170223|P3|NOT COMPLETED|1st Maintenance Dose Period||0
488292|NCT00385944|1170224|P2|NOT COMPLETED|1st Maintenance Dose Period||1
488293|NCT00385944|1170225|P1|NOT COMPLETED|1st Maintenance Dose Period||4
488294|NCT00385944|1170223|P3|COMPLETED|1st Maintenance Dose Period||0
488295|NCT00385944|1170224|P2|COMPLETED|1st Maintenance Dose Period||24
488296|NCT00385944|1170225|P1|COMPLETED|1st Maintenance Dose Period||25
488297|NCT00385944|1170223|P3|STARTED|1st Maintenance Dose Period||0
488298|NCT00385944|1170224|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
488299|NCT00385944|1170225|P1|STARTED|1st Maintenance Dose Period||29
488300|NCT00385944|1170223|P3|NOT COMPLETED|Loading Dose||0
488301|NCT00385944|1170224|P2|NOT COMPLETED|Loading Dose||0
488302|NCT00385944|1170225|P1|NOT COMPLETED|Loading Dose||0
488303|NCT00385944|1170223|P3|COMPLETED|Loading Dose||56
488304|NCT00385944|1170224|P2|COMPLETED|Loading Dose||0
488305|NCT00385944|1170225|P1|COMPLETED|Loading Dose||0
488306|NCT00385944|1170223|P3|STARTED|Loading Dose||56
488307|NCT00385944|1170224|P2|STARTED|Loading Dose||0
488308|NCT00385944|1170225|P1|STARTED|Loading Dose||0
488309|NCT00385918|1170268|P3|NOT COMPLETED|Intervention Phase After Randomization||0
488310|NCT00385918|1170269|P2|NOT COMPLETED|Intervention Phase After Randomization||0
488311|NCT00385918|1170270|P1|NOT COMPLETED|Intervention Phase After Randomization||3
488312|NCT00385918|1170268|P3|COMPLETED|Intervention Phase After Randomization||0
488313|NCT00385918|1170269|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
488314|NCT00385918|1170270|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
488315|NCT00385918|1170268|P3|STARTED|Intervention Phase After Randomization||0
488316|NCT00385918|1170269|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
488317|NCT00385918|1170270|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
488318|NCT00385918|1170268|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
488319|NCT00385918|1170269|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
488320|NCT00385918|1170270|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
488321|NCT00385918|1170268|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
488322|NCT00385918|1170269|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
488323|NCT00385918|1170270|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
488324|NCT00385918|1170268|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
488325|NCT00385918|1170269|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
488326|NCT00385918|1170270|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
488327|NCT00385918|1170268|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
488328|NCT00385918|1170269|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
488329|NCT00385918|1170270|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
488330|NCT00385918|1170268|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
488331|NCT00385918|1170269|P2|STARTED|Feasibility & Baseline Measurement Phase||0
488332|NCT00385918|1170270|P1|STARTED|Feasibility & Baseline Measurement Phase||0
488333|NCT00385840|1170294|P2|NOT COMPLETED|Overall Study||14
488334|NCT00385840|1170295|P1|NOT COMPLETED|Overall Study||4
488335|NCT00385840|1170294|P2|COMPLETED|Overall Study||531
488336|NCT00385840|1170295|P1|COMPLETED|Overall Study||129
488337|NCT00385840|1170294|P2|STARTED|Overall Study||545
488338|NCT00385840|1170295|P1|STARTED|Overall Study||133
488339|NCT00385827|1170318|P3|NOT COMPLETED|Part 2||48
488340|NCT00385827|1170319|P2|NOT COMPLETED|Part 2||33
488341|NCT00385827|1170320|P1|NOT COMPLETED|Part 2||0
488342|NCT00385827|1170318|P3|COMPLETED|Part 2||0
488343|NCT00385827|1170319|P2|COMPLETED|Part 2||16
488344|NCT00385827|1170320|P1|COMPLETED|Part 2||0
488345|NCT00385827|1170318|P3|Treated|Part 2||46
488346|NCT00385827|1170319|P2|Treated|Part 2||47
488347|NCT00385827|1170320|P1|Treated|Part 2||0
488348|NCT00385827|1170318|P3|STARTED|Part 2||48
488349|NCT00385827|1170319|P2|STARTED|Part 2||49
488350|NCT00385827|1170320|P1|STARTED|Part 2||0
488351|NCT00385827|1170318|P3|NOT COMPLETED|Part 1||0
488352|NCT00385827|1170319|P2|NOT COMPLETED|Part 1||0
488353|NCT00385827|1170320|P1|NOT COMPLETED|Part 1||9
488354|NCT00385827|1170318|P3|COMPLETED|Part 1||0
488355|NCT00385827|1170319|P2|COMPLETED|Part 1||0
488356|NCT00385827|1170320|P1|COMPLETED|Part 1||0
488357|NCT00385827|1170318|P3|Treated|Part 1||0
488358|NCT00385827|1170319|P2|Treated|Part 1||0
488359|NCT00385827|1170320|P1|Treated|Part 1||9
488360|NCT00385827|1170318|P3|STARTED|Part 1||0
488361|NCT00385827|1170319|P2|STARTED|Part 1||0
488362|NCT00385827|1170320|P1|STARTED|Part 1||9
488363|NCT00385801|1170342|P2|NOT COMPLETED|Overall Study||8
488364|NCT00385801|1170343|P1|NOT COMPLETED|Overall Study||9
488365|NCT00385801|1170342|P2|COMPLETED|Overall Study||8
488366|NCT00385801|1170343|P1|COMPLETED|Overall Study||6
488367|NCT00385801|1170342|P2|STARTED|Overall Study||16
488368|NCT00385801|1170343|P1|STARTED|Overall Study||15
488369|NCT00385736|1170358|P3|NOT COMPLETED|Safety Analysis Set||80
488370|NCT00385736|1170359|P2|NOT COMPLETED|Safety Analysis Set||44
488371|NCT00385736|1170360|P1|NOT COMPLETED|Safety Analysis Set||70
488372|NCT00385736|1170358|P3|COMPLETED|Safety Analysis Set||143
488373|NCT00385736|1170359|P2|COMPLETED|Safety Analysis Set||86
488374|NCT00385736|1170360|P1|COMPLETED|Safety Analysis Set||153
488375|NCT00385736|1170358|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
488376|NCT00385736|1170359|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
488377|NCT00385736|1170360|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
488378|NCT00385736|1170358|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
488379|NCT00385736|1170359|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
488380|NCT00385736|1170360|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
488381|NCT00385736|1170358|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
488382|NCT00385736|1170359|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
488383|NCT00385736|1170360|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
488384|NCT00385736|1170358|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
488385|NCT00385736|1170359|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
488386|NCT00385736|1170360|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
488387|NCT00385736|1170358|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
488388|NCT00385736|1170359|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
488389|NCT00385736|1170360|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
488390|NCT00385736|1170358|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
488391|NCT00385736|1170359|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
488392|NCT00385736|1170360|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
488393|NCT00385736|1170358|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
488394|NCT00385736|1170359|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
488395|NCT00385736|1170360|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
488396|NCT00385723|1170405|P3|NOT COMPLETED|Overall Study||2
488397|NCT00385723|1170406|P2|NOT COMPLETED|Overall Study||1
488398|NCT00385723|1170407|P1|NOT COMPLETED|Overall Study||2
488399|NCT00385723|1170405|P3|COMPLETED|Overall Study||44
488400|NCT00385723|1170406|P2|COMPLETED|Overall Study||45
488401|NCT00385723|1170407|P1|COMPLETED|Overall Study||44
488402|NCT00385723|1170405|P3|STARTED|Overall Study||46
488403|NCT00385723|1170406|P2|STARTED|Overall Study||46
488404|NCT00385723|1170407|P1|STARTED|Overall Study||46
488405|NCT00385684|1170421|P2|NOT COMPLETED|PHASE B||0
488406|NCT00385684|1170422|P1|NOT COMPLETED|PHASE B||0
488407|NCT00385684|1170421|P2|COMPLETED|PHASE B||3
488408|NCT00385684|1170422|P1|COMPLETED|PHASE B||5
488409|NCT00385684|1170421|P2|STARTED|PHASE B||3
488410|NCT00385684|1170422|P1|STARTED|PHASE B||5
488411|NCT00385684|1170421|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
488412|NCT00385684|1170422|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
488413|NCT00385684|1170421|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
488414|NCT00385684|1170422|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
488415|NCT00385684|1170421|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
488416|NCT00385684|1170422|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
488417|NCT00385684|1170421|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
488418|NCT00385684|1170422|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
488419|NCT00385684|1170421|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
488420|NCT00385684|1170422|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
488421|NCT00385684|1170421|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
488422|NCT00385684|1170422|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
488423|NCT00385671|1170431|P3|NOT COMPLETED|Overall Study||36
488424|NCT00385671|1170432|P2|NOT COMPLETED|Overall Study||51
488425|NCT00385671|1170433|P1|NOT COMPLETED|Overall Study||38
488426|NCT00385671|1170431|P3|COMPLETED|Overall Study||99
488427|NCT00385671|1170432|P2|COMPLETED|Overall Study||87
488428|NCT00385671|1170433|P1|COMPLETED|Overall Study||96
488429|NCT00385671|1170431|P3|STARTED|Overall Study||135
488430|NCT00385671|1170432|P2|STARTED|Overall Study||138
488431|NCT00385671|1170433|P1|STARTED|Overall Study||134
488432|NCT00385593|1170589|P2|NOT COMPLETED|Overall Study||37
488433|NCT00385593|1170590|P1|NOT COMPLETED|Overall Study||58
488434|NCT00385593|1170589|P2|COMPLETED|Overall Study||289
488435|NCT00385593|1170590|P1|COMPLETED|Overall Study||270
488436|NCT00385593|1170589|P2|STARTED|Overall Study||326
488437|NCT00385593|1170590|P1|STARTED|Overall Study||328
488438|NCT00385580|1170608|P2|NOT COMPLETED|Overall Study||0
488439|NCT00385580|1170609|P1|NOT COMPLETED|Overall Study||0
488440|NCT00385580|1170608|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
488441|NCT00385580|1170609|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
488442|NCT00385580|1170608|P2|STARTED|Overall Study|Number of participants treated.|47
488443|NCT00385580|1170609|P1|STARTED|Overall Study|Number of participants treated.|48
488444|NCT00385541|1170700|P2|NOT COMPLETED|Overall Study||1
488445|NCT00385541|1170701|P1|NOT COMPLETED|Overall Study||0
488446|NCT00385541|1170700|P2|COMPLETED|Overall Study||24
488447|NCT00385541|1170701|P1|COMPLETED|Overall Study||25
488448|NCT00385541|1170700|P2|STARTED|Overall Study||25
488449|NCT00385541|1170701|P1|STARTED|Overall Study||25
488450|NCT00385515|1170717|P2|NOT COMPLETED|Overall Study||3
488451|NCT00385515|1170718|P1|NOT COMPLETED|Overall Study||4
488452|NCT00385515|1170717|P2|COMPLETED|Overall Study||21
488453|NCT00385515|1170718|P1|COMPLETED|Overall Study||53
488454|NCT00385515|1170717|P2|STARTED|Overall Study||24
488455|NCT00385515|1170718|P1|STARTED|Overall Study||57
488456|NCT00385268|1170726|P2|NOT COMPLETED|Overall Study||8
488457|NCT00385268|1170727|P1|NOT COMPLETED|Overall Study||16
488458|NCT00385268|1170726|P2|COMPLETED|Overall Study||18
488459|NCT00385268|1170727|P1|COMPLETED|Overall Study||18
488460|NCT00385268|1170726|P2|STARTED|Overall Study||26
488461|NCT00385268|1170727|P1|STARTED|Overall Study||34
488462|NCT00385216|1170733|P2|NOT COMPLETED|Second Intervention||0
488463|NCT00385216|1170734|P1|NOT COMPLETED|Second Intervention||0
488464|NCT00385216|1170733|P2|COMPLETED|Second Intervention||9
488465|NCT00385216|1170734|P1|COMPLETED|Second Intervention||11
488466|NCT00385216|1170733|P2|STARTED|Second Intervention||9
488467|NCT00385216|1170734|P1|STARTED|Second Intervention||11
488468|NCT00385216|1170733|P2|NOT COMPLETED|First Intervention||0
488469|NCT00385216|1170734|P1|NOT COMPLETED|First Intervention||0
488470|NCT00385216|1170733|P2|COMPLETED|First Intervention||9
488471|NCT00385216|1170734|P1|COMPLETED|First Intervention||11
488472|NCT00385216|1170733|P2|STARTED|First Intervention||9
488473|NCT00385216|1170734|P1|STARTED|First Intervention||11
488474|NCT00385203|1170748|P2|NOT COMPLETED|Overall Study||7
488475|NCT00385203|1170749|P1|NOT COMPLETED|Overall Study||26
488476|NCT00385203|1170748|P2|COMPLETED|Overall Study||3
488477|NCT00385203|1170749|P1|COMPLETED|Overall Study||0
488478|NCT00385203|1170748|P2|STARTED|Overall Study||10
488479|NCT00385203|1170749|P1|STARTED|Overall Study||26
488480|NCT00385138|1170769|P2|NOT COMPLETED|Overall Study||28
488481|NCT00385138|1170770|P1|NOT COMPLETED|Overall Study||30
488482|NCT00385138|1170769|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
488483|NCT00385138|1170770|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
488484|NCT00385138|1170769|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
488485|NCT00385138|1170770|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
488486|NCT00385138|1170769|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
488487|NCT00385138|1170770|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
488488|NCT00385138|1170769|P2|Intent-to-treat (ITT)|Overall Study||2669
488489|NCT00385138|1170770|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
488490|NCT00385138|1170769|P2|STARTED|Overall Study||2669
488491|NCT00385138|1170770|P1|STARTED|Overall Study||2695
488492|NCT00384956|1170814|P1|NOT COMPLETED|Overall Study||3
488493|NCT00384956|1170814|P1|COMPLETED|Overall Study||22
488494|NCT00384956|1170814|P1|STARTED|Overall Study||25
488495|NCT00384930|1170831|P5|NOT COMPLETED|Overall Study||47
488496|NCT00384930|1170832|P4|NOT COMPLETED|Overall Study||41
488497|NCT00384930|1170833|P3|NOT COMPLETED|Overall Study||30
488498|NCT00384930|1170834|P2|NOT COMPLETED|Overall Study||27
488499|NCT00384930|1170835|P1|NOT COMPLETED|Overall Study||27
488500|NCT00384930|1170831|P5|COMPLETED|Overall Study||162
488501|NCT00384930|1170832|P4|COMPLETED|Overall Study||175
488502|NCT00384930|1170833|P3|COMPLETED|Overall Study||182
488503|NCT00384930|1170834|P2|COMPLETED|Overall Study||182
488504|NCT00384930|1170835|P1|COMPLETED|Overall Study||185
488505|NCT00384930|1170831|P5|Received Double-Blind Study Drug|Overall Study||209
488506|NCT00384930|1170832|P4|Received Double-Blind Study Drug|Overall Study||216
488507|NCT00384930|1170833|P3|Received Double-Blind Study Drug|Overall Study||212
488508|NCT00384930|1170834|P2|Received Double-Blind Study Drug|Overall Study||208
488509|NCT00384930|1170835|P1|Received Double-Blind Study Drug|Overall Study||211
488510|NCT00384930|1170831|P5|STARTED|Overall Study||209
488511|NCT00384930|1170832|P4|STARTED|Overall Study||216
488512|NCT00384930|1170833|P3|STARTED|Overall Study||212
488513|NCT00384930|1170834|P2|STARTED|Overall Study||209
488514|NCT00384930|1170835|P1|STARTED|Overall Study||212
488515|NCT00384813|1170891|P2|NOT COMPLETED|Overall Study||0
488516|NCT00384813|1170892|P1|NOT COMPLETED|Overall Study||2
488517|NCT00384813|1170891|P2|COMPLETED|Overall Study||20
488518|NCT00384813|1170892|P1|COMPLETED|Overall Study||21
488519|NCT00384813|1170891|P2|STARTED|Overall Study||20
488520|NCT00384813|1170892|P1|STARTED|Overall Study||23
488521|NCT00384748|1170900|P2|NOT COMPLETED|Overall Study||0
488522|NCT00384748|1170901|P1|NOT COMPLETED|Overall Study||0
488523|NCT00384748|1170900|P2|COMPLETED|Overall Study||23
488524|NCT00384748|1170901|P1|COMPLETED|Overall Study||25
488525|NCT00384748|1170900|P2|STARTED|Overall Study||23
488526|NCT00384748|1170901|P1|STARTED|Overall Study||25
488527|NCT00384670|1170907|P1|NOT COMPLETED|Overall Study||0
488528|NCT00384670|1170907|P1|COMPLETED|Overall Study||7
488529|NCT00384670|1170907|P1|STARTED|Overall Study||7
488530|NCT00384397|1170920|P3|NOT COMPLETED|Overall Study||33
488531|NCT00384397|1170921|P2|NOT COMPLETED|Overall Study||46
488532|NCT00384397|1170922|P1|NOT COMPLETED|Overall Study||32
488533|NCT00384397|1170920|P3|COMPLETED|Overall Study||385
488534|NCT00384397|1170921|P2|COMPLETED|Overall Study||247
488535|NCT00384397|1170922|P1|COMPLETED|Overall Study||375
488536|NCT00384397|1170920|P3|STARTED|Overall Study||418
488537|NCT00384397|1170921|P2|STARTED|Overall Study||293
488538|NCT00384397|1170922|P1|STARTED|Overall Study||407
488539|NCT00384293|1170941|P3|NOT COMPLETED|Post-randomization Period||219
488540|NCT00384293|1170942|P2|NOT COMPLETED|Post-randomization Period||214
488541|NCT00384293|1170943|P1|NOT COMPLETED|Post-randomization Period||0
488542|NCT00384293|1170941|P3|COMPLETED|Post-randomization Period||0
488543|NCT00384293|1170942|P2|COMPLETED|Post-randomization Period||0
488544|NCT00384293|1170943|P1|COMPLETED|Post-randomization Period||0
488545|NCT00384293|1170941|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
488546|NCT00384293|1170942|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
488547|NCT00384293|1170943|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
488548|NCT00384293|1170941|P3|STARTED|Post-randomization Period||219
488549|NCT00384293|1170942|P2|STARTED|Post-randomization Period||214
488550|NCT00384293|1170943|P1|STARTED|Post-randomization Period||0
488551|NCT00384293|1170941|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
488552|NCT00384293|1170942|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
488553|NCT00384293|1170943|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
488554|NCT00384293|1170941|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
488555|NCT00384293|1170942|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
488556|NCT00384293|1170943|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
488557|NCT00384293|1170941|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
488558|NCT00384293|1170942|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
488559|NCT00384293|1170943|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
488560|NCT00384293|1170941|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
488561|NCT00384293|1170942|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
488562|NCT00384293|1170943|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
488563|NCT00384293|1170941|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
488564|NCT00384293|1170942|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
488565|NCT00384293|1170943|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
488566|NCT00384241|1170956|P2|NOT COMPLETED|Overall Study||0
488567|NCT00384241|1170957|P1|NOT COMPLETED|Overall Study||0
488568|NCT00384241|1170956|P2|COMPLETED|Overall Study||599
488569|NCT00384241|1170957|P1|COMPLETED|Overall Study||500
488570|NCT00384241|1170956|P2|STARTED|Overall Study||599
488571|NCT00384241|1170957|P1|STARTED|Overall Study||500
488572|NCT00384189|1170967|P4|NOT COMPLETED|Overall Study||40
488573|NCT00384189|1170968|P3|NOT COMPLETED|Overall Study||58
488574|NCT00384189|1170969|P2|NOT COMPLETED|Overall Study||57
488575|NCT00384189|1170970|P1|NOT COMPLETED|Overall Study||50
488576|NCT00384189|1170967|P4|COMPLETED|Overall Study||110
488577|NCT00384189|1170968|P3|COMPLETED|Overall Study||255
488578|NCT00384189|1170969|P2|COMPLETED|Overall Study||255
488579|NCT00384189|1170970|P1|COMPLETED|Overall Study||255
488580|NCT00384189|1170967|P4|Actual Treatment Received|Overall Study||146
488581|NCT00384189|1170968|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
488582|NCT00384189|1170969|P2|Actual Treatment Received|Overall Study||312
488583|NCT00384189|1170970|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
488584|NCT00384189|1170967|P4|Randomized, Not Treated|Overall Study||4
488585|NCT00384189|1170968|P3|Randomized, Not Treated|Overall Study||2
488586|NCT00384189|1170969|P2|Randomized, Not Treated|Overall Study||0
488587|NCT00384189|1170970|P1|Randomized, Not Treated|Overall Study||1
488588|NCT00384189|1170967|P4|STARTED|Overall Study||150
488589|NCT00384189|1170968|P3|STARTED|Overall Study||313
488590|NCT00384189|1170969|P2|STARTED|Overall Study||312
488591|NCT00384189|1170970|P1|STARTED|Overall Study||305
488592|NCT00384176|1171031|P3|NOT COMPLETED|Overall Study||132
488593|NCT00384176|1171032|P2|NOT COMPLETED|Overall Study||319
488594|NCT00384176|1171033|P1|NOT COMPLETED|Overall Study||312
488595|NCT00384176|1171031|P3|COMPLETED|Overall Study||60
488596|NCT00384176|1171032|P2|COMPLETED|Overall Study||394
488597|NCT00384176|1171033|P1|COMPLETED|Overall Study||397
488598|NCT00384176|1171031|P3|STARTED|Overall Study||192
488599|NCT00384176|1171032|P2|STARTED|Overall Study||713
488600|NCT00384176|1171033|P1|STARTED|Overall Study||709
488601|NCT00384085|1171059|P3|NOT COMPLETED|Overall Study||56
488602|NCT00384085|1171060|P2|NOT COMPLETED|Overall Study||46
488603|NCT00384085|1171061|P1|NOT COMPLETED|Overall Study||39
488604|NCT00384085|1171059|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
488605|NCT00384085|1171060|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
488606|NCT00384085|1171061|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
488607|NCT00384085|1171059|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
488608|NCT00384085|1171060|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
488609|NCT00384085|1171061|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
488610|NCT00384085|1171059|P3|Treated (Safety Population)|Overall Study||194
488611|NCT00384085|1171060|P2|Treated (Safety Population)|Overall Study||194
488612|NCT00384085|1171061|P1|Treated (Safety Population)|Overall Study||194
488613|NCT00384085|1171059|P3|Intent-To-Treat (ITT)|Overall Study||197
488614|NCT00384085|1171060|P2|Intent-To-Treat (ITT)|Overall Study||196
488615|NCT00384085|1171061|P1|Intent-To-Treat (ITT)|Overall Study||195
488616|NCT00384085|1171059|P3|STARTED|Overall Study|Randomized|197
488617|NCT00384085|1171060|P2|STARTED|Overall Study|Randomized|196
488618|NCT00384085|1171061|P1|STARTED|Overall Study|Randomized|195
488619|NCT00384059|1171087|P2|NOT COMPLETED|Toddler Dose||2
488620|NCT00384059|1171088|P1|NOT COMPLETED|Toddler Dose||1
488621|NCT00384059|1171087|P2|COMPLETED|Toddler Dose||120
488622|NCT00384059|1171088|P1|COMPLETED|Toddler Dose||130
488623|NCT00384059|1171087|P2|STARTED|Toddler Dose||122
488624|NCT00384059|1171088|P1|STARTED|Toddler Dose||131
488625|NCT00384059|1171087|P2|NOT COMPLETED|After Infant Series||10
488626|NCT00384059|1171088|P1|NOT COMPLETED|After Infant Series||4
488627|NCT00384059|1171087|P2|COMPLETED|After Infant Series||122
488628|NCT00384059|1171088|P1|COMPLETED|After Infant Series||131
488629|NCT00384059|1171087|P2|STARTED|After Infant Series||132
488630|NCT00384059|1171088|P1|STARTED|After Infant Series||135
488631|NCT00384059|1171087|P2|NOT COMPLETED|Infant Series||13
488632|NCT00384059|1171088|P1|NOT COMPLETED|Infant Series||6
488633|NCT00384059|1171087|P2|COMPLETED|Infant Series||132
488634|NCT00384059|1171088|P1|COMPLETED|Infant Series||135
488635|NCT00384059|1171087|P2|Vaccinated Dose 2|Infant Series||135
488636|NCT00384059|1171088|P1|Vaccinated Dose 2|Infant Series||136
488637|NCT00384059|1171087|P2|Vaccinated Dose 1|Infant Series||139
488638|NCT00384059|1171088|P1|Vaccinated Dose 1|Infant Series||139
488639|NCT00384059|1171087|P2|STARTED|Infant Series||145
488640|NCT00384059|1171088|P1|STARTED|Infant Series||141
488641|NCT00384033|1171138|P4|NOT COMPLETED|Overall Study||40
488642|NCT00384033|1171139|P3|NOT COMPLETED|Overall Study||43
488643|NCT00384033|1171140|P2|NOT COMPLETED|Overall Study||35
488644|NCT00384033|1171141|P1|NOT COMPLETED|Overall Study||41
488645|NCT00384033|1171138|P4|COMPLETED|Overall Study||119
488646|NCT00384033|1171139|P3|COMPLETED|Overall Study||117
488647|NCT00384033|1171140|P2|COMPLETED|Overall Study||120
488648|NCT00384033|1171141|P1|COMPLETED|Overall Study||123
488649|NCT00384033|1171138|P4|Treated|Overall Study||157
488650|NCT00384033|1171139|P3|Treated|Overall Study||150
488651|NCT00384033|1171140|P2|Treated|Overall Study||148
488652|NCT00384033|1171141|P1|Treated|Overall Study||161
488653|NCT00384033|1171138|P4|STARTED|Overall Study||159
488654|NCT00384033|1171139|P3|STARTED|Overall Study||160
488655|NCT00384033|1171140|P2|STARTED|Overall Study||155
488656|NCT00384033|1171141|P1|STARTED|Overall Study||164
488657|NCT00383942|1171185|P2|NOT COMPLETED|Overall Study||0
488658|NCT00383942|1171186|P1|NOT COMPLETED|Overall Study||0
488659|NCT00383942|1171185|P2|COMPLETED|Overall Study||40
488660|NCT00383942|1171186|P1|COMPLETED|Overall Study||40
488661|NCT00383942|1171185|P2|STARTED|Overall Study||40
488662|NCT00383942|1171186|P1|STARTED|Overall Study||40
488663|NCT00383786|1171194|P2|NOT COMPLETED|Overall Study||12
488664|NCT00383786|1171195|P1|NOT COMPLETED|Overall Study||4
488665|NCT00383786|1171194|P2|COMPLETED|Overall Study||13
488666|NCT00383786|1171195|P1|COMPLETED|Overall Study||18
488667|NCT00383786|1171194|P2|STARTED|Overall Study||25
488668|NCT00383786|1171195|P1|STARTED|Overall Study||22
488669|NCT00383760|1171201|P1|NOT COMPLETED|Overall Study||0
488670|NCT00383760|1171201|P1|COMPLETED|Overall Study||15
488671|NCT00383760|1171201|P1|STARTED|Overall Study||15
488672|NCT00383747|1171217|P4|NOT COMPLETED|Visit 2||0
488673|NCT00383747|1171218|P3|NOT COMPLETED|Visit 2||0
488674|NCT00383747|1171219|P2|NOT COMPLETED|Visit 2||0
488675|NCT00383747|1171220|P1|NOT COMPLETED|Visit 2||0
488676|NCT00383747|1171217|P4|COMPLETED|Visit 2||16
488677|NCT00383747|1171218|P3|COMPLETED|Visit 2||16
488678|NCT00383747|1171219|P2|COMPLETED|Visit 2||14
488679|NCT00383747|1171220|P1|COMPLETED|Visit 2||14
488680|NCT00383747|1171217|P4|STARTED|Visit 2||16
488681|NCT00383747|1171218|P3|STARTED|Visit 2||16
488682|NCT00383747|1171219|P2|STARTED|Visit 2||14
488683|NCT00383747|1171220|P1|STARTED|Visit 2||14
488684|NCT00383747|1171217|P4|NOT COMPLETED|Visit 1||0
488685|NCT00383747|1171218|P3|NOT COMPLETED|Visit 1||0
488686|NCT00383747|1171219|P2|NOT COMPLETED|Visit 1||0
488687|NCT00383747|1171220|P1|NOT COMPLETED|Visit 1||0
488688|NCT00383747|1171217|P4|COMPLETED|Visit 1||16
488689|NCT00383747|1171218|P3|COMPLETED|Visit 1||16
488690|NCT00383747|1171219|P2|COMPLETED|Visit 1||14
488691|NCT00383747|1171220|P1|COMPLETED|Visit 1||14
488692|NCT00383747|1171217|P4|STARTED|Visit 1||16
488693|NCT00383747|1171218|P3|STARTED|Visit 1||16
488694|NCT00383747|1171219|P2|STARTED|Visit 1||14
488695|NCT00383747|1171220|P1|STARTED|Visit 1||14
488696|NCT00383721|1171245|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
488697|NCT00383721|1171246|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
488698|NCT00383721|1171247|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
488699|NCT00383721|1171248|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
488700|NCT00383721|1171249|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
488701|NCT00383721|1171245|P5|COMPLETED|26-Week Treatment Safety Extension||8
488702|NCT00383721|1171246|P4|COMPLETED|26-Week Treatment Safety Extension||131
488703|NCT00383721|1171247|P3|COMPLETED|26-Week Treatment Safety Extension||126
488704|NCT00383721|1171248|P2|COMPLETED|26-Week Treatment Safety Extension||136
488705|NCT00383721|1171249|P1|COMPLETED|26-Week Treatment Safety Extension||126
488706|NCT00383721|1171245|P5|STARTED|26-Week Treatment Safety Extension||8
488707|NCT00383721|1171246|P4|STARTED|26-Week Treatment Safety Extension||148
488708|NCT00383721|1171247|P3|STARTED|26-Week Treatment Safety Extension||149
488709|NCT00383721|1171248|P2|STARTED|26-Week Treatment Safety Extension||153
488710|NCT00383721|1171249|P1|STARTED|26-Week Treatment Safety Extension||145
488711|NCT00383721|1171245|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
488712|NCT00383721|1171246|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
488713|NCT00383721|1171247|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
488714|NCT00383721|1171248|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
488715|NCT00383721|1171249|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
488716|NCT00383721|1171245|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
488717|NCT00383721|1171246|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
488718|NCT00383721|1171247|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
488719|NCT00383721|1171248|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
488720|NCT00383721|1171249|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
488721|NCT00383721|1171245|P5|STARTED|26-Week Double-Blind Treatment Period||236
488722|NCT00383721|1171246|P4|STARTED|26-Week Double-Blind Treatment Period||243
488723|NCT00383721|1171247|P3|STARTED|26-Week Double-Blind Treatment Period||253
488724|NCT00383721|1171248|P2|STARTED|26-Week Double-Blind Treatment Period||239
488725|NCT00383721|1171249|P1|STARTED|26-Week Double-Blind Treatment Period||225
488726|NCT00383643|1171289|P3|NOT COMPLETED|Overall Study||1
488727|NCT00383643|1171290|P2|NOT COMPLETED|Overall Study||1
488728|NCT00383643|1171291|P1|NOT COMPLETED|Overall Study||1
488729|NCT00383643|1171289|P3|COMPLETED|Overall Study||13
488730|NCT00383643|1171290|P2|COMPLETED|Overall Study||15
488731|NCT00383643|1171291|P1|COMPLETED|Overall Study||17
488732|NCT00383643|1171289|P3|STARTED|Overall Study||14
488733|NCT00383643|1171290|P2|STARTED|Overall Study||16
488734|NCT00383643|1171291|P1|STARTED|Overall Study||18
488735|NCT00383565|1171311|P1|NOT COMPLETED|Overall Study||0
488736|NCT00383565|1171311|P1|COMPLETED|Overall Study||9
488737|NCT00383565|1171311|P1|STARTED|Overall Study||9
488738|NCT00383552|1171321|P4|NOT COMPLETED|Overall Study||72
488739|NCT00383552|1171322|P3|NOT COMPLETED|Overall Study||61
488740|NCT00383552|1171323|P2|NOT COMPLETED|Overall Study||41
488741|NCT00383552|1171324|P1|NOT COMPLETED|Overall Study||36
488742|NCT00383552|1171321|P4|COMPLETED|Overall Study||116
488743|NCT00383552|1171322|P3|COMPLETED|Overall Study||127
488744|NCT00383552|1171323|P2|COMPLETED|Overall Study||147
488745|NCT00383552|1171324|P1|COMPLETED|Overall Study||146
488746|NCT00383552|1171321|P4|STARTED|Overall Study||188
488747|NCT00383552|1171322|P3|STARTED|Overall Study||188
488748|NCT00383552|1171323|P2|STARTED|Overall Study||188
488749|NCT00383552|1171324|P1|STARTED|Overall Study||182
488750|NCT00383500|1171366|P3|NOT COMPLETED|Overall Study||2
488751|NCT00383500|1171367|P2|NOT COMPLETED|Overall Study||3
488752|NCT00383500|1171368|P1|NOT COMPLETED|Overall Study||8
488753|NCT00383500|1171366|P3|COMPLETED|Overall Study||22
488754|NCT00383500|1171367|P2|COMPLETED|Overall Study||21
488755|NCT00383500|1171368|P1|COMPLETED|Overall Study||19
488756|NCT00383500|1171366|P3|STARTED|Overall Study||24
488757|NCT00383500|1171367|P2|STARTED|Overall Study||24
488758|NCT00383500|1171368|P1|STARTED|Overall Study||27
488759|NCT00383435|1171384|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
488760|NCT00383435|1171385|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
488761|NCT00383435|1171386|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
488762|NCT00383435|1171387|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
488763|NCT00383435|1171388|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
488764|NCT00383435|1171384|P5|COMPLETED|26-Week Treatment Safety Extension||10
488765|NCT00383435|1171385|P4|COMPLETED|26-Week Treatment Safety Extension||116
488766|NCT00383435|1171386|P3|COMPLETED|26-Week Treatment Safety Extension||108
488767|NCT00383435|1171387|P2|COMPLETED|26-Week Treatment Safety Extension||121
488768|NCT00383435|1171388|P1|COMPLETED|26-Week Treatment Safety Extension||117
488769|NCT00383435|1171384|P5|STARTED|26-Week Treatment Safety Extension||13
488770|NCT00383435|1171385|P4|STARTED|26-Week Treatment Safety Extension||131
488771|NCT00383435|1171386|P3|STARTED|26-Week Treatment Safety Extension||124
488772|NCT00383435|1171387|P2|STARTED|26-Week Treatment Safety Extension||130
488773|NCT00383435|1171388|P1|STARTED|26-Week Treatment Safety Extension||131
488774|NCT00383435|1171384|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
488775|NCT00383435|1171385|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
488776|NCT00383435|1171386|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
488777|NCT00383435|1171387|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
488778|NCT00383435|1171388|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
488779|NCT00383435|1171384|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
488780|NCT00383435|1171385|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
488781|NCT00383435|1171386|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
488782|NCT00383435|1171387|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
488783|NCT00383435|1171388|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
488784|NCT00383435|1171384|P5|STARTED|26-Week Double-Blind Treatment Period||212
488785|NCT00383435|1171385|P4|STARTED|26-Week Double-Blind Treatment Period||209
488786|NCT00383435|1171386|P3|STARTED|26-Week Double-Blind Treatment Period||210
488787|NCT00383435|1171387|P2|STARTED|26-Week Double-Blind Treatment Period||207
488788|NCT00383435|1171388|P1|STARTED|26-Week Double-Blind Treatment Period||217
488789|NCT00383331|1171427|P2|NOT COMPLETED|Overall Study||1
488790|NCT00383331|1171428|P1|NOT COMPLETED|Overall Study||0
488791|NCT00383331|1171427|P2|COMPLETED|Overall Study||8
488792|NCT00383331|1171428|P1|COMPLETED|Overall Study||10
488793|NCT00383331|1171427|P2|STARTED|Overall Study||9
488794|NCT00383331|1171428|P1|STARTED|Overall Study||10
488795|NCT00383266|1171444|P1|NOT COMPLETED|Overall Study||0
488796|NCT00383266|1171444|P1|COMPLETED|Overall Study||9
488797|NCT00383266|1171444|P1|STARTED|Overall Study||9
488798|NCT00383240|1171457|P4|NOT COMPLETED|Overall Study||77
488799|NCT00383240|1171458|P3|NOT COMPLETED|Overall Study||85
488800|NCT00383240|1171459|P2|NOT COMPLETED|Overall Study||33
488801|NCT00383240|1171460|P1|NOT COMPLETED|Overall Study||35
488802|NCT00383240|1171457|P4|COMPLETED|Overall Study||119
488803|NCT00383240|1171458|P3|COMPLETED|Overall Study||117
488804|NCT00383240|1171459|P2|COMPLETED|Overall Study||159
488805|NCT00383240|1171460|P1|COMPLETED|Overall Study||156
488806|NCT00383240|1171457|P4|STARTED|Overall Study||196
488807|NCT00383240|1171458|P3|STARTED|Overall Study||202
488808|NCT00383240|1171459|P2|STARTED|Overall Study||192
488809|NCT00383240|1171460|P1|STARTED|Overall Study||191
488810|NCT00383162|1171491|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
488811|NCT00383162|1171492|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
488812|NCT00383162|1171491|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
488813|NCT00383162|1171492|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
488814|NCT00383162|1171491|P2|STARTED|Migraine Attack 2 (Period 2)||73
488815|NCT00383162|1171492|P1|STARTED|Migraine Attack 2 (Period 2)||67
488816|NCT00383162|1171491|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
488817|NCT00383162|1171492|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
488818|NCT00383162|1171491|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
488819|NCT00383162|1171492|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
488820|NCT00383162|1171491|P2|STARTED|Migraine Attack 1 (Period 1)||86
488821|NCT00383162|1171492|P1|STARTED|Migraine Attack 1 (Period 1)||87
488822|NCT00383149|1171534|P1|NOT COMPLETED|Overall Study||54
488823|NCT00383149|1171534|P1|COMPLETED|Overall Study||0
488824|NCT00383149|1171534|P1|STARTED|Overall Study||54
488825|NCT00383123|1171553|P2|NOT COMPLETED|Overall Study||86
488826|NCT00383123|1171554|P1|NOT COMPLETED|Overall Study||111
488827|NCT00383123|1171553|P2|COMPLETED|Overall Study||1124
488828|NCT00383123|1171554|P1|COMPLETED|Overall Study||2004
488829|NCT00383123|1171553|P2|STARTED|Overall Study||1210
488830|NCT00383123|1171554|P1|STARTED|Overall Study||2115
488831|NCT00383110|1171576|P2|NOT COMPLETED|Overall Study||0
488832|NCT00383110|1171577|P1|NOT COMPLETED|Overall Study||0
488833|NCT00383110|1171576|P2|COMPLETED|Overall Study||150
488834|NCT00383110|1171577|P1|COMPLETED|Overall Study||150
488835|NCT00383110|1171576|P2|STARTED|Overall Study||150
488836|NCT00383110|1171577|P1|STARTED|Overall Study||150
488837|NCT00383084|1171595|P2|NOT COMPLETED|Overall Study||10
488838|NCT00383084|1171596|P1|NOT COMPLETED|Overall Study||12
488839|NCT00383084|1171595|P2|COMPLETED|Overall Study||28
488840|NCT00383084|1171596|P1|COMPLETED|Overall Study||34
488841|NCT00383084|1171595|P2|STARTED|Overall Study||38
488842|NCT00383084|1171596|P1|STARTED|Overall Study||46
488843|NCT00383071|1171612|P4|NOT COMPLETED|Overall Study||3
488844|NCT00383071|1171613|P3|NOT COMPLETED|Overall Study||7
488845|NCT00383071|1171614|P2|NOT COMPLETED|Overall Study||4
488846|NCT00383071|1171615|P1|NOT COMPLETED|Overall Study||0
488847|NCT00383071|1171612|P4|COMPLETED|Overall Study||22
488848|NCT00383071|1171613|P3|COMPLETED|Overall Study||44
488849|NCT00383071|1171614|P2|COMPLETED|Overall Study||21
488850|NCT00383071|1171615|P1|COMPLETED|Overall Study||25
488851|NCT00383071|1171612|P4|STARTED|Overall Study||25
488852|NCT00383071|1171613|P3|STARTED|Overall Study||51
488853|NCT00383071|1171614|P2|STARTED|Overall Study||25
488854|NCT00383071|1171615|P1|STARTED|Overall Study||25
488855|NCT00383019|1171627|P2|NOT COMPLETED|Overall Study||2
488856|NCT00383019|1171628|P1|NOT COMPLETED|Overall Study||5
488857|NCT00383019|1171627|P2|COMPLETED|Overall Study||143
488858|NCT00383019|1171628|P1|COMPLETED|Overall Study||139
488859|NCT00383019|1171627|P2|STARTED|Overall Study||145
488860|NCT00383019|1171628|P1|STARTED|Overall Study||144
488861|NCT00382993|1171650|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
488862|NCT00382993|1171651|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
488863|NCT00382993|1171650|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
488864|NCT00382993|1171651|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
488865|NCT00382993|1171650|P2|STARTED|Migraine Attack 2 (Period 2)||67
488866|NCT00382993|1171651|P1|STARTED|Migraine Attack 2 (Period 2)||70
488867|NCT00382993|1171650|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
488868|NCT00382993|1171651|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
488869|NCT00382993|1171650|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
488870|NCT00382993|1171651|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
488871|NCT00382993|1171650|P2|STARTED|Migraine Attack 1 (Period 1)||85
488872|NCT00382993|1171651|P1|STARTED|Migraine Attack 1 (Period 1)||84
488873|NCT00382967|1171695|P2|NOT COMPLETED|Overall Study||1
488874|NCT00382967|1171696|P1|NOT COMPLETED|Overall Study||1
488875|NCT00382967|1171695|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
488876|NCT00382967|1171696|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
488877|NCT00382967|1171695|P2|STARTED|Overall Study||138
488878|NCT00382967|1171696|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
488879|NCT00382928|1171706|P2|NOT COMPLETED|Overall Study||0
488880|NCT00382928|1171707|P1|NOT COMPLETED|Overall Study||0
488881|NCT00382928|1171706|P2|COMPLETED|Overall Study||95
488882|NCT00382928|1171707|P1|COMPLETED|Overall Study||97
488883|NCT00382928|1171706|P2|STARTED|Overall Study||95
488884|NCT00382928|1171707|P1|STARTED|Overall Study||97
488885|NCT00382863|1171721|P2|NOT COMPLETED|Overall Study||36
488886|NCT00382863|1171722|P1|NOT COMPLETED|Overall Study||15
488887|NCT00382863|1171721|P2|COMPLETED|Overall Study||78
488888|NCT00382863|1171722|P1|COMPLETED|Overall Study||81
488889|NCT00382863|1171721|P2|STARTED|Overall Study||114
488890|NCT00382863|1171722|P1|STARTED|Overall Study||96
488891|NCT00382785|1171778|P2|NOT COMPLETED|Overall Study||0
488892|NCT00382785|1171779|P1|NOT COMPLETED|Overall Study||0
488893|NCT00382785|1171778|P2|COMPLETED|Overall Study||26
488894|NCT00382785|1171779|P1|COMPLETED|Overall Study||25
488895|NCT00382785|1171778|P2|STARTED|Overall Study||26
488896|NCT00382785|1171779|P1|STARTED|Overall Study||25
488897|NCT00382733|1171789|P5|NOT COMPLETED|Overall Study||0
488898|NCT00382733|1171790|P4|NOT COMPLETED|Overall Study||0
488899|NCT00382733|1171791|P3|NOT COMPLETED|Overall Study||0
488900|NCT00382733|1171792|P2|NOT COMPLETED|Overall Study||1
488901|NCT00382733|1171793|P1|NOT COMPLETED|Overall Study||0
488902|NCT00382733|1171789|P5|COMPLETED|Overall Study||2
488903|NCT00382733|1171790|P4|COMPLETED|Overall Study||14
488904|NCT00382733|1171791|P3|COMPLETED|Overall Study||3
488905|NCT00382733|1171792|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
488906|NCT00382733|1171793|P1|COMPLETED|Overall Study||3
488907|NCT00382733|1171789|P5|STARTED|Overall Study||2
488908|NCT00382733|1171790|P4|STARTED|Overall Study||14
488909|NCT00382733|1171791|P3|STARTED|Overall Study||3
488910|NCT00382733|1171792|P2|STARTED|Overall Study||4
488911|NCT00382733|1171793|P1|STARTED|Overall Study||3
488912|NCT00382720|1171814|P3|NOT COMPLETED|Overall Study||86
488913|NCT00382720|1171815|P2|NOT COMPLETED|Overall Study||89
488914|NCT00382720|1171816|P1|NOT COMPLETED|Overall Study||79
488915|NCT00382720|1171814|P3|COMPLETED|Overall Study||0
488916|NCT00382720|1171815|P2|COMPLETED|Overall Study||0
488917|NCT00382720|1171816|P1|COMPLETED|Overall Study||0
488918|NCT00382720|1171814|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
488919|NCT00382720|1171815|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
488920|NCT00382720|1171816|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
488921|NCT00382720|1171814|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
488922|NCT00382720|1171815|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
488923|NCT00382720|1171816|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
488924|NCT00382720|1171814|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
488925|NCT00382720|1171815|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
488926|NCT00382720|1171816|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
488927|NCT00382720|1171814|P3|STARTED|Overall Study||86
488928|NCT00382720|1171815|P2|STARTED|Overall Study||89
488929|NCT00382720|1171816|P1|STARTED|Overall Study||79
488930|NCT00382590|1171832|P2|NOT COMPLETED|Overall Study||0
488931|NCT00382590|1171833|P1|NOT COMPLETED|Overall Study||0
488932|NCT00382590|1171832|P2|COMPLETED|Overall Study||6
488933|NCT00382590|1171833|P1|COMPLETED|Overall Study||4
488934|NCT00382590|1171832|P2|STARTED|Overall Study||6
488935|NCT00382590|1171833|P1|STARTED|Overall Study||4
488936|NCT00382408|1171841|P2|NOT COMPLETED|Overall Study||54
488937|NCT00382408|1171842|P1|NOT COMPLETED|Overall Study||144
488938|NCT00382408|1171841|P2|COMPLETED|Overall Study||955
488939|NCT00382408|1171842|P1|COMPLETED|Overall Study||2887
488940|NCT00382408|1171841|P2|STARTED|Overall Study||1009
488941|NCT00382408|1171842|P1|STARTED|Overall Study||3031
488942|NCT00382291|1171869|P3|NOT COMPLETED|Overall Study||8
488943|NCT00382291|1171870|P2|NOT COMPLETED|Overall Study||7
488944|NCT00382291|1171871|P1|NOT COMPLETED|Overall Study||4
488945|NCT00382291|1171869|P3|COMPLETED|Overall Study||13
488946|NCT00382291|1171870|P2|COMPLETED|Overall Study||10
488947|NCT00382291|1171871|P1|COMPLETED|Overall Study||14
488948|NCT00382291|1171869|P3|STARTED|Overall Study||21
488949|NCT00382291|1171870|P2|STARTED|Overall Study||17
488950|NCT00382291|1171871|P1|STARTED|Overall Study||18
488951|NCT00382174|1171884|P3|NOT COMPLETED|Overall Study||21
488952|NCT00382174|1171885|P2|NOT COMPLETED|Overall Study||17
488953|NCT00382174|1171886|P1|NOT COMPLETED|Overall Study||4
488954|NCT00382174|1171884|P3|COMPLETED|Overall Study||51
488955|NCT00382174|1171885|P2|COMPLETED|Overall Study||37
488956|NCT00382174|1171886|P1|COMPLETED|Overall Study||14
488957|NCT00382174|1171884|P3|STARTED|Overall Study||72
488958|NCT00382174|1171885|P2|STARTED|Overall Study||54
488959|NCT00382174|1171886|P1|STARTED|Overall Study||18
488960|NCT00382148|1171899|P2|NOT COMPLETED|Overall Study||0
488961|NCT00382148|1171900|P1|NOT COMPLETED|Overall Study||1
488962|NCT00382148|1171899|P2|COMPLETED|Overall Study||7
488963|NCT00382148|1171900|P1|COMPLETED|Overall Study||3
488964|NCT00382148|1171899|P2|STARTED|Overall Study||7
488965|NCT00382148|1171900|P1|STARTED|Overall Study||4
488966|NCT00382109|1171914|P2|NOT COMPLETED|Overall Study||4
488967|NCT00382109|1171915|P1|NOT COMPLETED|Overall Study||12
488968|NCT00382109|1171914|P2|COMPLETED|Overall Study||66
488969|NCT00382109|1171915|P1|COMPLETED|Overall Study||64
488970|NCT00382109|1171914|P2|STARTED|Overall Study||70
488971|NCT00382109|1171915|P1|STARTED|Overall Study||76
488972|NCT00382031|1171937|P2|NOT COMPLETED|Overall Study||0
488973|NCT00382031|1171938|P1|NOT COMPLETED|Overall Study||0
488974|NCT00382031|1171937|P2|COMPLETED|Overall Study||95
488975|NCT00382031|1171938|P1|COMPLETED|Overall Study||191
488976|NCT00382031|1171937|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
489070|NCT00381628|1172132|P4|STARTED|Overall Study||14
488977|NCT00382031|1171938|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
488978|NCT00382018|1171954|P4|NOT COMPLETED|Overall Study||59
488979|NCT00382018|1171955|P3|NOT COMPLETED|Overall Study||64
488980|NCT00382018|1171956|P2|NOT COMPLETED|Overall Study||165
488981|NCT00382018|1171957|P1|NOT COMPLETED|Overall Study||0
488982|NCT00382018|1171954|P4|COMPLETED|Overall Study||0
488983|NCT00382018|1171955|P3|COMPLETED|Overall Study||0
488984|NCT00382018|1171956|P2|COMPLETED|Overall Study||0
488985|NCT00382018|1171957|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
488986|NCT00382018|1171954|P4|STARTED|Overall Study||59
488987|NCT00382018|1171955|P3|STARTED|Overall Study||64
488988|NCT00382018|1171956|P2|STARTED|Overall Study||165
488989|NCT00382018|1171957|P1|STARTED|Overall Study||276
488990|NCT00381940|1171975|P1|NOT COMPLETED|Overall Study||5
488991|NCT00381940|1171975|P1|COMPLETED|Overall Study||21
488992|NCT00381940|1171975|P1|STARTED|Overall Study||26
488993|NCT00381888|1171979|P1|NOT COMPLETED|Overall Study||17
488994|NCT00381888|1171979|P1|COMPLETED|Overall Study||27
488995|NCT00381888|1171979|P1|STARTED|Overall Study||44
488996|NCT00381862|1171984|P1|NOT COMPLETED|Overall Study||10
488997|NCT00381862|1171984|P1|COMPLETED|Overall Study||44
488998|NCT00381862|1171984|P1|STARTED|Overall Study||54
488999|NCT00381849|1171990|P2|NOT COMPLETED|Open-label||0
489000|NCT00381849|1171991|P1|NOT COMPLETED|Open-label||0
489001|NCT00381849|1171990|P2|COMPLETED|Open-label||9
489002|NCT00381849|1171991|P1|COMPLETED|Open-label||10
489003|NCT00381849|1171990|P2|STARTED|Open-label||9
489004|NCT00381849|1171991|P1|STARTED|Open-label||10
489005|NCT00381849|1171990|P2|NOT COMPLETED|Second Intervention||0
489006|NCT00381849|1171991|P1|NOT COMPLETED|Second Intervention||0
489007|NCT00381849|1171990|P2|COMPLETED|Second Intervention||9
489008|NCT00381849|1171991|P1|COMPLETED|Second Intervention||10
489009|NCT00381849|1171990|P2|STARTED|Second Intervention||9
489010|NCT00381849|1171991|P1|STARTED|Second Intervention||10
489011|NCT00381849|1171990|P2|NOT COMPLETED|Wash Out||1
489012|NCT00381849|1171991|P1|NOT COMPLETED|Wash Out||0
489013|NCT00381849|1171990|P2|COMPLETED|Wash Out||9
489014|NCT00381849|1171991|P1|COMPLETED|Wash Out||10
489015|NCT00381849|1171990|P2|STARTED|Wash Out||10
489016|NCT00381849|1171991|P1|STARTED|Wash Out||10
489017|NCT00381849|1171990|P2|NOT COMPLETED|First Intervention||0
489018|NCT00381849|1171991|P1|NOT COMPLETED|First Intervention||0
489019|NCT00381849|1171990|P2|COMPLETED|First Intervention||10
489020|NCT00381849|1171991|P1|COMPLETED|First Intervention||10
489021|NCT00381849|1171990|P2|STARTED|First Intervention||10
489022|NCT00381849|1171991|P1|STARTED|First Intervention||10
489023|NCT00381810|1172009|P1|NOT COMPLETED|B Cell Follow-up||7
489024|NCT00381810|1172009|P1|COMPLETED|B Cell Follow-up||0
489025|NCT00381810|1172009|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
489026|NCT00381810|1172009|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
489027|NCT00381810|1172009|P1|COMPLETED|Treatment and Safety Follow-up||16
489028|NCT00381810|1172009|P1|STARTED|Treatment and Safety Follow-up||31
489029|NCT00381797|1172018|P5|NOT COMPLETED|Overall Study||2
489030|NCT00381797|1172019|P4|NOT COMPLETED|Overall Study||1
489031|NCT00381797|1172020|P3|NOT COMPLETED|Overall Study||0
489032|NCT00381797|1172021|P2|NOT COMPLETED|Overall Study||1
489033|NCT00381797|1172022|P1|NOT COMPLETED|Overall Study||1
489034|NCT00381797|1172018|P5|COMPLETED|Overall Study||35
489035|NCT00381797|1172019|P4|COMPLETED|Overall Study||14
489036|NCT00381797|1172020|P3|COMPLETED|Overall Study||10
489037|NCT00381797|1172021|P2|COMPLETED|Overall Study||16
489038|NCT00381797|1172022|P1|COMPLETED|Overall Study||17
489039|NCT00381797|1172018|P5|STARTED|Overall Study||37
489040|NCT00381797|1172019|P4|STARTED|Overall Study||15
489041|NCT00381797|1172020|P3|STARTED|Overall Study||10
489042|NCT00381797|1172021|P2|STARTED|Overall Study||17
489043|NCT00381797|1172022|P1|STARTED|Overall Study||18
489044|NCT00381706|1172078|P3|NOT COMPLETED|Overall Study||1
489045|NCT00381706|1172079|P2|NOT COMPLETED|Overall Study||2
489046|NCT00381706|1172080|P1|NOT COMPLETED|Overall Study||7
489047|NCT00381706|1172078|P3|COMPLETED|Overall Study||79
489048|NCT00381706|1172079|P2|COMPLETED|Overall Study||81
489049|NCT00381706|1172080|P1|COMPLETED|Overall Study||75
489050|NCT00381706|1172078|P3|STARTED|Overall Study||80
489051|NCT00381706|1172079|P2|STARTED|Overall Study||83
489052|NCT00381706|1172080|P1|STARTED|Overall Study||82
489053|NCT00381693|1172103|P1|NOT COMPLETED|Overall Study||8
489054|NCT00381693|1172103|P1|COMPLETED|Overall Study||2
489055|NCT00381693|1172103|P1|STARTED|Overall Study||10
489056|NCT00381680|1172112|P2|NOT COMPLETED|Overall Study||50
489057|NCT00381680|1172113|P1|NOT COMPLETED|Overall Study||125
489058|NCT00381680|1172112|P2|COMPLETED|Overall Study||19
489059|NCT00381680|1172113|P1|COMPLETED|Overall Study||81
489060|NCT00381680|1172112|P2|STARTED|Overall Study||69
489061|NCT00381680|1172113|P1|STARTED|Overall Study||206
489062|NCT00381628|1172132|P4|NOT COMPLETED|Overall Study||0
489063|NCT00381628|1172133|P3|NOT COMPLETED|Overall Study||0
489064|NCT00381628|1172134|P2|NOT COMPLETED|Overall Study||0
489065|NCT00381628|1172135|P1|NOT COMPLETED|Overall Study||0
489066|NCT00381628|1172132|P4|COMPLETED|Overall Study||14
489067|NCT00381628|1172133|P3|COMPLETED|Overall Study||0
489068|NCT00381628|1172134|P2|COMPLETED|Overall Study||27
489069|NCT00381628|1172135|P1|COMPLETED|Overall Study||18
489071|NCT00381628|1172133|P3|STARTED|Overall Study||0
489072|NCT00381628|1172134|P2|STARTED|Overall Study||27
489073|NCT00381628|1172135|P1|STARTED|Overall Study||18
489074|NCT00381615|1172149|P4|NOT COMPLETED|Overall Study||2
489075|NCT00381615|1172150|P3|NOT COMPLETED|Overall Study||1
489076|NCT00381615|1172151|P2|NOT COMPLETED|Overall Study||5
489077|NCT00381615|1172152|P1|NOT COMPLETED|Overall Study||4
489078|NCT00381615|1172149|P4|COMPLETED|Overall Study||22
489079|NCT00381615|1172150|P3|COMPLETED|Overall Study||24
489080|NCT00381615|1172151|P2|COMPLETED|Overall Study||45
489081|NCT00381615|1172152|P1|COMPLETED|Overall Study||44
489082|NCT00381615|1172149|P4|STARTED|Overall Study||24
489083|NCT00381615|1172150|P3|STARTED|Overall Study||25
489084|NCT00381615|1172151|P2|STARTED|Overall Study||50
489085|NCT00381615|1172152|P1|STARTED|Overall Study||48
489086|NCT00381550|1172202|P1|NOT COMPLETED|Overall Study||0
489087|NCT00381550|1172202|P1|COMPLETED|Overall Study||35
489088|NCT00381550|1172202|P1|STARTED|Overall Study||35
489089|NCT00380081|1172213|P6|NOT COMPLETED|Overall Study||1
489090|NCT00380081|1172214|P5|NOT COMPLETED|Overall Study||1
489091|NCT00380081|1172215|P4|NOT COMPLETED|Overall Study||0
489092|NCT00380081|1172216|P3|NOT COMPLETED|Overall Study||0
489093|NCT00380081|1172217|P2|NOT COMPLETED|Overall Study||0
489094|NCT00380081|1172218|P1|NOT COMPLETED|Overall Study||0
489095|NCT00380081|1172213|P6|COMPLETED|Overall Study||13
489096|NCT00380081|1172214|P5|COMPLETED|Overall Study||12
489097|NCT00380081|1172215|P4|COMPLETED|Overall Study||15
489098|NCT00380081|1172216|P3|COMPLETED|Overall Study||13
489099|NCT00380081|1172217|P2|COMPLETED|Overall Study||13
489100|NCT00380081|1172218|P1|COMPLETED|Overall Study||14
489101|NCT00380081|1172213|P6|STARTED|Overall Study||14
489102|NCT00380081|1172214|P5|STARTED|Overall Study||13
489103|NCT00380081|1172215|P4|STARTED|Overall Study||15
489104|NCT00380081|1172216|P3|STARTED|Overall Study||13
489105|NCT00380081|1172217|P2|STARTED|Overall Study||13
489106|NCT00380081|1172218|P1|STARTED|Overall Study||14
489107|NCT00380068|1172268|P1|NOT COMPLETED|Overall Study||69
489108|NCT00380068|1172268|P1|COMPLETED|Overall Study||155
489109|NCT00380068|1172268|P1|STARTED|Overall Study||224
489110|NCT00381485|1172291|P4|NOT COMPLETED|Double-Blind Treatment Period||33
489111|NCT00381485|1172292|P3|NOT COMPLETED|Double-Blind Treatment Period||25
489112|NCT00381485|1172293|P2|NOT COMPLETED|Double-Blind Treatment Period||27
489113|NCT00381485|1172294|P1|NOT COMPLETED|Double-Blind Treatment Period||0
489114|NCT00381485|1172291|P4|COMPLETED|Double-Blind Treatment Period||207
489115|NCT00381485|1172292|P3|COMPLETED|Double-Blind Treatment Period||208
489116|NCT00381485|1172293|P2|COMPLETED|Double-Blind Treatment Period||228
489117|NCT00381485|1172294|P1|COMPLETED|Double-Blind Treatment Period||0
489118|NCT00381485|1172291|P4|STARTED|Double-Blind Treatment Period||240
489119|NCT00381485|1172292|P3|STARTED|Double-Blind Treatment Period||233
489120|NCT00381485|1172293|P2|STARTED|Double-Blind Treatment Period||255
489121|NCT00381485|1172294|P1|STARTED|Double-Blind Treatment Period||0
489122|NCT00381485|1172291|P4|NOT COMPLETED|Open-Label Run-In Period||0
489123|NCT00381485|1172292|P3|NOT COMPLETED|Open-Label Run-In Period||0
489124|NCT00381485|1172293|P2|NOT COMPLETED|Open-Label Run-In Period||0
489125|NCT00381485|1172294|P1|NOT COMPLETED|Open-Label Run-In Period||106
489126|NCT00381485|1172291|P4|COMPLETED|Open-Label Run-In Period||0
489127|NCT00381485|1172292|P3|COMPLETED|Open-Label Run-In Period||0
489128|NCT00381485|1172293|P2|COMPLETED|Open-Label Run-In Period||0
489129|NCT00381485|1172294|P1|COMPLETED|Open-Label Run-In Period||728
489130|NCT00381485|1172291|P4|STARTED|Open-Label Run-In Period||0
489131|NCT00381485|1172292|P3|STARTED|Open-Label Run-In Period||0
489132|NCT00381485|1172293|P2|STARTED|Open-Label Run-In Period||0
489133|NCT00381485|1172294|P1|STARTED|Open-Label Run-In Period||834
489134|NCT00381381|1172312|P1|NOT COMPLETED|Overall Study||64
489135|NCT00381381|1172312|P1|COMPLETED|Overall Study||135
489136|NCT00381381|1172312|P1|STARTED|Overall Study||199
489137|NCT00381303|1172321|P2|NOT COMPLETED|Overall Study||33
489138|NCT00381303|1172322|P1|NOT COMPLETED|Overall Study||94
489139|NCT00381303|1172321|P2|COMPLETED|Overall Study||109
489140|NCT00381303|1172322|P1|COMPLETED|Overall Study||193
489141|NCT00381303|1172321|P2|STARTED|Overall Study||142
489142|NCT00381303|1172322|P1|STARTED|Overall Study||287
489143|NCT00381238|1172382|P1|NOT COMPLETED|Overall Study||12
489144|NCT00381238|1172382|P1|COMPLETED|Overall Study||21
489145|NCT00381238|1172382|P1|STARTED|Overall Study||33
489146|NCT00381095|1172398|P2|NOT COMPLETED|Overall Study||21
489147|NCT00381095|1172399|P1|NOT COMPLETED|Overall Study||13
489148|NCT00381095|1172398|P2|COMPLETED|Overall Study||59
489149|NCT00381095|1172399|P1|COMPLETED|Overall Study||59
489150|NCT00381095|1172398|P2|STARTED|Overall Study||80
489151|NCT00381095|1172399|P1|STARTED|Overall Study||72
489152|NCT00381043|1172431|P2|NOT COMPLETED|Overall Study||8
489153|NCT00381043|1172432|P1|NOT COMPLETED|Overall Study||12
489154|NCT00381043|1172431|P2|COMPLETED|Overall Study||41
489155|NCT00381043|1172432|P1|COMPLETED|Overall Study||39
489156|NCT00381043|1172431|P2|STARTED|Overall Study||49
489157|NCT00381043|1172432|P1|STARTED|Overall Study||51
489158|NCT00381004|1172450|P1|NOT COMPLETED|Overall Study||0
489159|NCT00381004|1172450|P1|COMPLETED|Overall Study||60
489160|NCT00381004|1172450|P1|STARTED|Overall Study||60
489161|NCT00380978|1172458|P2|NOT COMPLETED|Overall Study||10
489162|NCT00380978|1172459|P1|NOT COMPLETED|Overall Study||2
489163|NCT00380978|1172458|P2|COMPLETED|Overall Study||400
489164|NCT00380978|1172459|P1|COMPLETED|Overall Study||406
489165|NCT00380978|1172458|P2|STARTED|Overall Study||410
489166|NCT00380978|1172459|P1|STARTED|Overall Study||408
489167|NCT00380874|1172481|P2|NOT COMPLETED|Overall Study||10
489168|NCT00380874|1172482|P1|NOT COMPLETED|Overall Study||13
489169|NCT00380874|1172481|P2|COMPLETED|Overall Study||19
489170|NCT00380874|1172482|P1|COMPLETED|Overall Study||19
489171|NCT00380874|1172481|P2|STARTED|Overall Study||29
489172|NCT00380874|1172482|P1|STARTED|Overall Study||32
489173|NCT00380861|1172500|P2|NOT COMPLETED|Overall Study||17
489174|NCT00380861|1172501|P1|NOT COMPLETED|Overall Study||18
489175|NCT00380861|1172500|P2|COMPLETED|Overall Study||74
489176|NCT00380861|1172501|P1|COMPLETED|Overall Study||75
489177|NCT00380861|1172500|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
489178|NCT00380861|1172501|P1|STARTED|Overall Study||93
489179|NCT00379912|1172509|P2|NOT COMPLETED|Overall Study||0
489180|NCT00379912|1172510|P1|NOT COMPLETED|Overall Study||1
489181|NCT00379912|1172509|P2|COMPLETED|Overall Study||8
489182|NCT00379912|1172510|P1|COMPLETED|Overall Study||6
489183|NCT00379912|1172509|P2|STARTED|Overall Study||8
489184|NCT00379912|1172510|P1|STARTED|Overall Study||7
489185|NCT00379899|1172530|P2|NOT COMPLETED|Overall Study||40
489186|NCT00379899|1172531|P1|NOT COMPLETED|Overall Study||40
489187|NCT00379899|1172530|P2|COMPLETED|Overall Study||140
489188|NCT00379899|1172531|P1|COMPLETED|Overall Study||140
489189|NCT00379899|1172530|P2|STARTED|Overall Study||180
489190|NCT00379899|1172531|P1|STARTED|Overall Study||180
489191|NCT00380718|1172559|P1|NOT COMPLETED|Overall Study||18
489192|NCT00380718|1172559|P1|COMPLETED|Overall Study||15
489193|NCT00380718|1172559|P1|Received Escalated Dose in Cycle 2|Overall Study||25
489194|NCT00380718|1172559|P1|Received at Least One Dose of Study Drug|Overall Study||33
489195|NCT00380718|1172559|P1|STARTED|Overall Study||33
489196|NCT00380692|1172571|P2|NOT COMPLETED|Study Period III - Open Label||12
489197|NCT00380692|1172572|P1|NOT COMPLETED|Study Period III - Open Label||6
489198|NCT00380692|1172571|P2|COMPLETED|Study Period III - Open Label||34
489199|NCT00380692|1172572|P1|COMPLETED|Study Period III - Open Label||36
489200|NCT00380692|1172571|P2|STARTED|Study Period III - Open Label||46
489201|NCT00380692|1172572|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
489202|NCT00380692|1172571|P2|NOT COMPLETED|Study Period II - Double Blind||3
489203|NCT00380692|1172572|P1|NOT COMPLETED|Study Period II - Double Blind||5
489204|NCT00380692|1172571|P2|COMPLETED|Study Period II - Double Blind||46
489205|NCT00380692|1172572|P1|COMPLETED|Study Period II - Double Blind||43
489206|NCT00380692|1172571|P2|STARTED|Study Period II - Double Blind||49
489207|NCT00380692|1172572|P1|STARTED|Study Period II - Double Blind||48
489208|NCT00380588|1172620|P2|NOT COMPLETED|Overall Study||40
489209|NCT00380588|1172621|P1|NOT COMPLETED|Overall Study||39
489210|NCT00380588|1172620|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
489211|NCT00380588|1172621|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
489212|NCT00380588|1172620|P2|Received at Least One Dose of Study Drug|Overall Study||42
489213|NCT00380588|1172621|P1|Received at Least One Dose of Study Drug|Overall Study||41
489214|NCT00380588|1172620|P2|STARTED|Overall Study||42
489215|NCT00380588|1172621|P1|STARTED|Overall Study||42
489216|NCT00380367|1172633|P1|NOT COMPLETED|Overall Study||2
489217|NCT00380367|1172633|P1|COMPLETED|Overall Study||108
489218|NCT00380367|1172633|P1|STARTED|Overall Study||110
489219|NCT00380250|1172640|P2|NOT COMPLETED|Overall Study||55
489220|NCT00380250|1172641|P1|NOT COMPLETED|Overall Study||99
489221|NCT00380250|1172640|P2|COMPLETED|Overall Study||139
489222|NCT00380250|1172641|P1|COMPLETED|Overall Study||297
489223|NCT00380250|1172640|P2|STARTED|Overall Study||194
489224|NCT00380250|1172641|P1|STARTED|Overall Study||396
489225|NCT00379834|1172703|P1|NOT COMPLETED|Overall Study||2
489226|NCT00379834|1172703|P1|COMPLETED|Overall Study||8
489227|NCT00379834|1172703|P1|STARTED|Overall Study||10
489228|NCT00379821|1172711|P4|NOT COMPLETED|Overall Study||79
489229|NCT00379821|1172712|P3|NOT COMPLETED|Overall Study||67
489230|NCT00379821|1172713|P2|NOT COMPLETED|Overall Study||89
489231|NCT00379821|1172714|P1|NOT COMPLETED|Overall Study||73
489232|NCT00379821|1172711|P4|COMPLETED|Overall Study||81
489233|NCT00379821|1172712|P3|COMPLETED|Overall Study||93
489234|NCT00379821|1172713|P2|COMPLETED|Overall Study||71
489235|NCT00379821|1172714|P1|COMPLETED|Overall Study||87
489236|NCT00379821|1172711|P4|STARTED|Overall Study||160
489237|NCT00379821|1172712|P3|STARTED|Overall Study||160
489238|NCT00379821|1172713|P2|STARTED|Overall Study||160
489239|NCT00379821|1172714|P1|STARTED|Overall Study||160
489240|NCT00379808|1172855|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
489241|NCT00379808|1172856|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
489242|NCT00379808|1172855|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
489243|NCT00379808|1172856|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
489244|NCT00379808|1172855|P2|STARTED|Intervention Period 2 (4 Weeks)||11
489245|NCT00379808|1172856|P1|STARTED|Intervention Period 2 (4 Weeks)||11
489246|NCT00379808|1172855|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
489247|NCT00379808|1172856|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
489248|NCT00379808|1172855|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
489249|NCT00379808|1172856|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
489250|NCT00379808|1172855|P2|STARTED|Intervention Period 1 (4 Weeks)||11
489251|NCT00379808|1172856|P1|STARTED|Intervention Period 1 (4 Weeks)||11
489252|NCT00379795|1172877|P5|NOT COMPLETED|Overall Study||49
489253|NCT00379795|1172878|P4|NOT COMPLETED|Overall Study||68
489254|NCT00379795|1172879|P3|NOT COMPLETED|Overall Study||93
489255|NCT00379795|1172880|P2|NOT COMPLETED|Overall Study||51
489256|NCT00379795|1172881|P1|NOT COMPLETED|Overall Study||476
489257|NCT00379795|1172877|P5|COMPLETED|Overall Study||14
489258|NCT00379795|1172878|P4|COMPLETED|Overall Study||6
489259|NCT00379795|1172879|P3|COMPLETED|Overall Study||23
489260|NCT00379795|1172880|P2|COMPLETED|Overall Study||23
489261|NCT00379795|1172881|P1|COMPLETED|Overall Study||50
489262|NCT00379795|1172877|P5|Received Ranibizumab in Extension Study|Overall Study||0
489263|NCT00379795|1172878|P4|Received Ranibizumab in Extension Study|Overall Study||55
489264|NCT00379795|1172879|P3|Received Ranibizumab in Extension Study|Overall Study||113
489265|NCT00379795|1172880|P2|Received Ranibizumab in Extension Study|Overall Study||41
489266|NCT00379795|1172881|P1|Received Ranibizumab in Extension Study|Overall Study||377
489267|NCT00379795|1172877|P5|STARTED|Overall Study||63
489268|NCT00379795|1172878|P4|STARTED|Overall Study||74
489269|NCT00379795|1172879|P3|STARTED|Overall Study||116
489270|NCT00379795|1172880|P2|STARTED|Overall Study||74
489271|NCT00379795|1172881|P1|STARTED|Overall Study||526
489272|NCT00379769|1172911|P6|NOT COMPLETED|Observational Follow-up||148
489273|NCT00379769|1172912|P5|NOT COMPLETED|Observational Follow-up||149
489274|NCT00379769|1172913|P4|NOT COMPLETED|Observational Follow-up||0
489275|NCT00379769|1172914|P3|NOT COMPLETED|Observational Follow-up||0
489276|NCT00379769|1172915|P2|NOT COMPLETED|Observational Follow-up||0
489277|NCT00379769|1172916|P1|NOT COMPLETED|Observational Follow-up||0
489278|NCT00379769|1172911|P6|COMPLETED|Observational Follow-up||1102
489279|NCT00379769|1172912|P5|COMPLETED|Observational Follow-up||1131
489280|NCT00379769|1172913|P4|COMPLETED|Observational Follow-up||0
489281|NCT00379769|1172914|P3|COMPLETED|Observational Follow-up||0
489282|NCT00379769|1172915|P2|COMPLETED|Observational Follow-up||0
489283|NCT00379769|1172916|P1|COMPLETED|Observational Follow-up||0
489284|NCT00379769|1172911|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
489285|NCT00379769|1172912|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
489286|NCT00379769|1172913|P4|STARTED|Observational Follow-up||0
489287|NCT00379769|1172914|P3|STARTED|Observational Follow-up||0
489288|NCT00379769|1172915|P2|STARTED|Observational Follow-up||0
489289|NCT00379769|1172916|P1|STARTED|Observational Follow-up||0
489290|NCT00379769|1172911|P6|NOT COMPLETED|Main Study||0
489291|NCT00379769|1172912|P5|NOT COMPLETED|Main Study||0
489292|NCT00379769|1172913|P4|NOT COMPLETED|Main Study||230
489293|NCT00379769|1172914|P3|NOT COMPLETED|Main Study||207
489294|NCT00379769|1172915|P2|NOT COMPLETED|Main Study||199
489295|NCT00379769|1172916|P1|NOT COMPLETED|Main Study||178
489296|NCT00379769|1172911|P6|COMPLETED|Main Study||0
489297|NCT00379769|1172912|P5|COMPLETED|Main Study||0
489298|NCT00379769|1172913|P4|COMPLETED|Main Study||892
489299|NCT00379769|1172914|P3|COMPLETED|Main Study||896
489300|NCT00379769|1172915|P2|COMPLETED|Main Study||906
489301|NCT00379769|1172916|P1|COMPLETED|Main Study||939
489302|NCT00379769|1172911|P6|STARTED|Main Study||0
489303|NCT00379769|1172912|P5|STARTED|Main Study||0
489304|NCT00379769|1172913|P4|STARTED|Main Study||1122
489305|NCT00379769|1172914|P3|STARTED|Main Study||1103
489306|NCT00379769|1172915|P2|STARTED|Main Study||1105
489307|NCT00379769|1172916|P1|STARTED|Main Study||1117
489308|NCT00379639|1173075|P5|NOT COMPLETED|Overall Study||6
489309|NCT00379639|1173076|P4|NOT COMPLETED|Overall Study||6
489310|NCT00379639|1173077|P3|NOT COMPLETED|Overall Study||9
489311|NCT00379639|1173078|P2|NOT COMPLETED|Overall Study||5
489312|NCT00379639|1173079|P1|NOT COMPLETED|Overall Study||3
489313|NCT00379639|1173075|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
489314|NCT00379639|1173076|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
489315|NCT00379639|1173077|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
489316|NCT00379639|1173078|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
489317|NCT00379639|1173079|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
489318|NCT00379639|1173075|P5|Completed 6 Cycles of Therapy|Overall Study||0
489319|NCT00379639|1173076|P4|Completed 6 Cycles of Therapy|Overall Study||0
489320|NCT00379639|1173077|P3|Completed 6 Cycles of Therapy|Overall Study||1
489321|NCT00379639|1173078|P2|Completed 6 Cycles of Therapy|Overall Study||2
489322|NCT00379639|1173079|P1|Completed 6 Cycles of Therapy|Overall Study||4
489323|NCT00379639|1173075|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
489324|NCT00379639|1173076|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
489325|NCT00379639|1173077|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
489326|NCT00379639|1173078|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
489327|NCT00379639|1173079|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
489328|NCT00379639|1173075|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
489329|NCT00379639|1173076|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
489330|NCT00379639|1173077|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
489331|NCT00379639|1173078|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
489332|NCT00379639|1173079|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
489333|NCT00379587|1173101|P1|NOT COMPLETED|Overall Study||2
489334|NCT00379587|1173101|P1|COMPLETED|Overall Study||63
489335|NCT00379587|1173101|P1|STARTED|Overall Study||65
489336|NCT00379574|1173108|P1|NOT COMPLETED|Overall Study||0
489337|NCT00379574|1173108|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
489338|NCT00379574|1173108|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
489339|NCT00379353|1173115|P2|NOT COMPLETED|Overall Study||6
489340|NCT00379353|1173116|P1|NOT COMPLETED|Overall Study||11
489341|NCT00379353|1173115|P2|COMPLETED|Overall Study||9
489342|NCT00379353|1173116|P1|COMPLETED|Overall Study||5
489343|NCT00379353|1173115|P2|STARTED|Overall Study||15
489344|NCT00379353|1173116|P1|STARTED|Overall Study||16
489345|NCT00379340|1173151|P5|NOT COMPLETED|Overall Study||14
489346|NCT00379340|1173152|P4|NOT COMPLETED|Overall Study||13
489347|NCT00379340|1173153|P3|NOT COMPLETED|Overall Study||2
489348|NCT00379340|1173154|P2|NOT COMPLETED|Overall Study||3
489349|NCT00379340|1173155|P1|NOT COMPLETED|Overall Study||13
489350|NCT00379340|1173151|P5|COMPLETED|Overall Study||9
489351|NCT00379340|1173152|P4|COMPLETED|Overall Study||37
489352|NCT00379340|1173153|P3|COMPLETED|Overall Study||50
489353|NCT00379340|1173154|P2|COMPLETED|Overall Study||132
489354|NCT00379340|1173155|P1|COMPLETED|Overall Study||107
489355|NCT00379340|1173151|P5|STARTED|Overall Study||23
489356|NCT00379340|1173152|P4|STARTED|Overall Study||50
489357|NCT00379340|1173153|P3|STARTED|Overall Study||52
489358|NCT00379340|1173154|P2|STARTED|Overall Study||135
489359|NCT00379340|1173155|P1|STARTED|Overall Study||120
489360|NCT00379288|1173172|P4|NOT COMPLETED|Overall Study||8
489361|NCT00379288|1173173|P3|NOT COMPLETED|Overall Study||10
489362|NCT00379288|1173174|P2|NOT COMPLETED|Overall Study||22
489363|NCT00379288|1173175|P1|NOT COMPLETED|Overall Study||19
489364|NCT00379288|1173172|P4|COMPLETED|Overall Study||57
489365|NCT00379288|1173173|P3|COMPLETED|Overall Study||58
489366|NCT00379288|1173174|P2|COMPLETED|Overall Study||108
489367|NCT00379288|1173175|P1|COMPLETED|Overall Study||122
489368|NCT00379288|1173172|P4|STARTED|Overall Study||65
489369|NCT00379288|1173173|P3|STARTED|Overall Study||68
489370|NCT00379288|1173174|P2|STARTED|Overall Study||130
489371|NCT00379288|1173175|P1|STARTED|Overall Study||141
489372|NCT00379236|1173187|P3|NOT COMPLETED|Open-label Extension||55
489373|NCT00379236|1173188|P2|NOT COMPLETED|Open-label Extension||0
489374|NCT00379236|1173189|P1|NOT COMPLETED|Open-label Extension||0
489375|NCT00379236|1173187|P3|COMPLETED|Open-label Extension||378
489376|NCT00379236|1173188|P2|COMPLETED|Open-label Extension||0
489377|NCT00379236|1173189|P1|COMPLETED|Open-label Extension||0
489378|NCT00379236|1173187|P3|STARTED|Open-label Extension||433
489379|NCT00379236|1173188|P2|STARTED|Open-label Extension||0
489380|NCT00379236|1173189|P1|STARTED|Open-label Extension||0
489381|NCT00379236|1173187|P3|NOT COMPLETED|Double-blind||0
489382|NCT00379236|1173188|P2|NOT COMPLETED|Double-blind||36
489383|NCT00379236|1173189|P1|NOT COMPLETED|Double-blind||36
489384|NCT00379236|1173187|P3|COMPLETED|Double-blind||0
489385|NCT00379236|1173188|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
489386|NCT00379236|1173189|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
489387|NCT00379236|1173187|P3|STARTED|Double-blind||0
489388|NCT00379236|1173188|P2|STARTED|Double-blind||295
489389|NCT00379236|1173189|P1|STARTED|Double-blind||293
489390|NCT00379210|1173234|P2|NOT COMPLETED|Overall Study||7
489391|NCT00379210|1173235|P1|NOT COMPLETED|Overall Study||10
489392|NCT00379210|1173234|P2|COMPLETED|Overall Study||23
489393|NCT00379210|1173235|P1|COMPLETED|Overall Study||20
489394|NCT00379210|1173234|P2|STARTED|Overall Study||30
489395|NCT00379210|1173235|P1|STARTED|Overall Study||30
489396|NCT00379197|1173241|P1|NOT COMPLETED|Overall Study||5
489397|NCT00379197|1173241|P1|COMPLETED|Overall Study||8
489398|NCT00379197|1173241|P1|STARTED|Overall Study||13
489399|NCT00379080|1173249|P3|NOT COMPLETED|Overall Study||0
489400|NCT00379080|1173250|P2|NOT COMPLETED|Overall Study||4
489401|NCT00379080|1173251|P1|NOT COMPLETED|Overall Study||0
489402|NCT00379080|1173249|P3|COMPLETED|Overall Study||31
489403|NCT00379080|1173250|P2|COMPLETED|Overall Study||15
489404|NCT00379080|1173251|P1|COMPLETED|Overall Study||6
489405|NCT00379080|1173249|P3|STARTED|Overall Study||31
489406|NCT00379080|1173250|P2|STARTED|Overall Study||19
489407|NCT00379080|1173251|P1|STARTED|Overall Study||6
489408|NCT00378898|1173296|P2|NOT COMPLETED|Overall Study||6
489409|NCT00378898|1173297|P1|NOT COMPLETED|Overall Study||11
489410|NCT00378898|1173296|P2|COMPLETED|Overall Study||11
489411|NCT00378898|1173297|P1|COMPLETED|Overall Study||11
489412|NCT00378898|1173296|P2|STARTED|Overall Study||17
489413|NCT00378898|1173297|P1|STARTED|Overall Study||22
489434|NCT00378599|1173334|P1|NOT COMPLETED|Overall Study||52
489435|NCT00378599|1173334|P1|COMPLETED|Overall Study||73
489436|NCT00378599|1173334|P1|STARTED|Overall Study||125
489437|NCT00378573|1173338|P1|NOT COMPLETED|Follow-up||14
489438|NCT00378573|1173338|P1|COMPLETED|Follow-up||3
489439|NCT00378573|1173338|P1|STARTED|Follow-up||17
489440|NCT00378573|1173338|P1|NOT COMPLETED|Treatment Period||17
489441|NCT00378573|1173338|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
489442|NCT00378573|1173338|P1|STARTED|Treatment Period||17
489443|NCT00378560|1173346|P2|NOT COMPLETED|Overall Study||58
489444|NCT00378560|1173347|P1|NOT COMPLETED|Overall Study||56
489445|NCT00378560|1173346|P2|COMPLETED|Overall Study||454
489446|NCT00378560|1173347|P1|COMPLETED|Overall Study||453
489447|NCT00378560|1173346|P2|Vaccinated|Overall Study||512
489448|NCT00378560|1173347|P1|Vaccinated|Overall Study||509
489449|NCT00378560|1173346|P2|STARTED|Overall Study||512
489450|NCT00378560|1173347|P1|STARTED|Overall Study||509
489451|NCT00378534|1173361|P1|NOT COMPLETED|Overall Study||60
489452|NCT00378534|1173361|P1|COMPLETED|Overall Study|Transplantation Recipients|55
489453|NCT00378534|1173361|P1|STARTED|Overall Study||115
489454|NCT00378508|1173367|P2|NOT COMPLETED|Overall Study||3
489455|NCT00378508|1173368|P1|NOT COMPLETED|Overall Study||2
489456|NCT00378508|1173367|P2|COMPLETED|Overall Study||31
489457|NCT00378508|1173368|P1|COMPLETED|Overall Study||27
489458|NCT00378508|1173367|P2|Received Intervention/Placebo|Overall Study||31
489459|NCT00378508|1173368|P1|Received Intervention/Placebo|Overall Study||28
489460|NCT00378508|1173367|P2|Randomized|Overall Study||34
489461|NCT00378508|1173368|P1|Randomized|Overall Study||29
489462|NCT00378508|1173367|P2|STARTED|Overall Study||34
489463|NCT00378508|1173368|P1|STARTED|Overall Study||29
489464|NCT00378378|1173387|P3|NOT COMPLETED|Overall Study||2
489465|NCT00378378|1173388|P2|NOT COMPLETED|Overall Study||1
489466|NCT00378378|1173389|P1|NOT COMPLETED|Overall Study||0
489467|NCT00378378|1173387|P3|COMPLETED|Overall Study||24
489468|NCT00378378|1173388|P2|COMPLETED|Overall Study||49
489469|NCT00378378|1173389|P1|COMPLETED|Overall Study||51
489470|NCT00378378|1173387|P3|STARTED|Overall Study||26
489471|NCT00378378|1173388|P2|STARTED|Overall Study||50
489472|NCT00378378|1173389|P1|STARTED|Overall Study||51
489473|NCT00378352|1173402|P6|NOT COMPLETED|Efficacy Phase||7
489474|NCT00378352|1173403|P5|NOT COMPLETED|Efficacy Phase||11
489475|NCT00378352|1173404|P4|NOT COMPLETED|Efficacy Phase||0
489476|NCT00378352|1173405|P3|NOT COMPLETED|Efficacy Phase||0
489477|NCT00378352|1173406|P2|NOT COMPLETED|Efficacy Phase||0
489478|NCT00378352|1173407|P1|NOT COMPLETED|Efficacy Phase||0
489479|NCT00378352|1173402|P6|COMPLETED|Efficacy Phase||59
489480|NCT00378352|1173403|P5|COMPLETED|Efficacy Phase||54
489481|NCT00378352|1173404|P4|COMPLETED|Efficacy Phase||0
489482|NCT00378352|1173405|P3|COMPLETED|Efficacy Phase||0
489483|NCT00378352|1173406|P2|COMPLETED|Efficacy Phase||0
489484|NCT00378352|1173407|P1|COMPLETED|Efficacy Phase||0
489485|NCT00378352|1173402|P6|Safety Analysis|Efficacy Phase||64
489486|NCT00378352|1173403|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
489487|NCT00378352|1173404|P4|Safety Analysis|Efficacy Phase||0
489488|NCT00378352|1173405|P3|Safety Analysis|Efficacy Phase||0
489489|NCT00378352|1173406|P2|Safety Analysis|Efficacy Phase||0
489490|NCT00378352|1173407|P1|Safety Analysis|Efficacy Phase||0
489491|NCT00378352|1173402|P6|STARTED|Efficacy Phase||66
489492|NCT00378352|1173403|P5|STARTED|Efficacy Phase||65
489493|NCT00378352|1173404|P4|STARTED|Efficacy Phase||0
489494|NCT00378352|1173405|P3|STARTED|Efficacy Phase||0
489495|NCT00378352|1173406|P2|STARTED|Efficacy Phase||0
489496|NCT00378352|1173407|P1|STARTED|Efficacy Phase||0
489497|NCT00378352|1173402|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
489498|NCT00378352|1173403|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
489499|NCT00378352|1173404|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
489500|NCT00378352|1173405|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
489501|NCT00378352|1173406|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
489502|NCT00378352|1173407|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
489503|NCT00378352|1173402|P6|COMPLETED|Dose Escalation 60,000 Units||0
489504|NCT00378352|1173403|P5|COMPLETED|Dose Escalation 60,000 Units||0
489505|NCT00378352|1173404|P4|COMPLETED|Dose Escalation 60,000 Units||10
489506|NCT00378352|1173405|P3|COMPLETED|Dose Escalation 60,000 Units||17
489507|NCT00378352|1173406|P2|COMPLETED|Dose Escalation 60,000 Units||0
489508|NCT00378352|1173407|P1|COMPLETED|Dose Escalation 60,000 Units||0
489509|NCT00378352|1173402|P6|Safety Analysis|Dose Escalation 60,000 Units||0
489510|NCT00378352|1173403|P5|Safety Analysis|Dose Escalation 60,000 Units||0
489511|NCT00378352|1173404|P4|Safety Analysis|Dose Escalation 60,000 Units||11
489512|NCT00378352|1173405|P3|Safety Analysis|Dose Escalation 60,000 Units||19
489513|NCT00378352|1173406|P2|Safety Analysis|Dose Escalation 60,000 Units||0
489514|NCT00378352|1173407|P1|Safety Analysis|Dose Escalation 60,000 Units||0
489515|NCT00378352|1173402|P6|STARTED|Dose Escalation 60,000 Units||0
489516|NCT00378352|1173403|P5|STARTED|Dose Escalation 60,000 Units||0
489517|NCT00378352|1173404|P4|STARTED|Dose Escalation 60,000 Units||11
489518|NCT00378352|1173405|P3|STARTED|Dose Escalation 60,000 Units||20
489519|NCT00378352|1173406|P2|STARTED|Dose Escalation 60,000 Units||0
489520|NCT00378352|1173407|P1|STARTED|Dose Escalation 60,000 Units||0
489521|NCT00378352|1173402|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
489522|NCT00378352|1173403|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
489523|NCT00378352|1173404|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
489524|NCT00378352|1173405|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
489525|NCT00378352|1173406|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
489526|NCT00378352|1173407|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
489527|NCT00378352|1173402|P6|COMPLETED|Dose Escalation 30,000 Units||0
489528|NCT00378352|1173403|P5|COMPLETED|Dose Escalation 30,000 Units||0
489529|NCT00378352|1173404|P4|COMPLETED|Dose Escalation 30,000 Units||9
489530|NCT00378352|1173405|P3|COMPLETED|Dose Escalation 30,000 Units||0
489531|NCT00378352|1173406|P2|COMPLETED|Dose Escalation 30,000 Units||16
489532|NCT00378352|1173407|P1|COMPLETED|Dose Escalation 30,000 Units||0
489533|NCT00378352|1173402|P6|Safety Analysis|Dose Escalation 30,000 Units||0
489534|NCT00378352|1173403|P5|Safety Analysis|Dose Escalation 30,000 Units||0
489535|NCT00378352|1173404|P4|Safety Analysis|Dose Escalation 30,000 Units||11
489536|NCT00378352|1173405|P3|Safety Analysis|Dose Escalation 30,000 Units||0
489537|NCT00378352|1173406|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
489538|NCT00378352|1173407|P1|Safety Analysis|Dose Escalation 30,000 Units||0
489539|NCT00378352|1173402|P6|STARTED|Dose Escalation 30,000 Units||0
489540|NCT00378352|1173403|P5|STARTED|Dose Escalation 30,000 Units||0
489541|NCT00378352|1173404|P4|STARTED|Dose Escalation 30,000 Units||11
489542|NCT00378352|1173405|P3|STARTED|Dose Escalation 30,000 Units||0
489543|NCT00378352|1173406|P2|STARTED|Dose Escalation 30,000 Units||19
489544|NCT00378352|1173407|P1|STARTED|Dose Escalation 30,000 Units||0
489545|NCT00378352|1173402|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
489546|NCT00378352|1173403|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
489547|NCT00378352|1173404|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
489548|NCT00378352|1173405|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
489549|NCT00378352|1173406|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
489550|NCT00378352|1173407|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
489551|NCT00378352|1173402|P6|COMPLETED|Dose Escalation 15,000 Units||0
489552|NCT00378352|1173403|P5|COMPLETED|Dose Escalation 15,000 Units||0
489553|NCT00378352|1173404|P4|COMPLETED|Dose Escalation 15,000 Units||10
489554|NCT00378352|1173405|P3|COMPLETED|Dose Escalation 15,000 Units||0
489555|NCT00378352|1173406|P2|COMPLETED|Dose Escalation 15,000 Units||0
489556|NCT00378352|1173407|P1|COMPLETED|Dose Escalation 15,000 Units||15
489640|NCT00377741|1173613|P2|COMPLETED|Overall Study||15
489557|NCT00378352|1173402|P6|Safety Analysis|Dose Escalation 15,000 Units||0
489558|NCT00378352|1173403|P5|Safety Analysis|Dose Escalation 15,000 Units||0
489559|NCT00378352|1173404|P4|Safety Analysis|Dose Escalation 15,000 Units||11
489560|NCT00378352|1173405|P3|Safety Analysis|Dose Escalation 15,000 Units||0
489561|NCT00378352|1173406|P2|Safety Analysis|Dose Escalation 15,000 Units||0
489562|NCT00378352|1173407|P1|Safety Analysis|Dose Escalation 15,000 Units||19
489563|NCT00378352|1173402|P6|STARTED|Dose Escalation 15,000 Units||0
489564|NCT00378352|1173403|P5|STARTED|Dose Escalation 15,000 Units||0
489565|NCT00378352|1173404|P4|STARTED|Dose Escalation 15,000 Units||11
489566|NCT00378352|1173405|P3|STARTED|Dose Escalation 15,000 Units||0
489567|NCT00378352|1173406|P2|STARTED|Dose Escalation 15,000 Units||0
489568|NCT00378352|1173407|P1|STARTED|Dose Escalation 15,000 Units||20
489569|NCT00378326|1173429|P1|NOT COMPLETED|Overall Study||0
489570|NCT00378326|1173429|P1|COMPLETED|Overall Study||26
489571|NCT00378326|1173429|P1|STARTED|Overall Study||26
489572|NCT00378209|1173435|P1|NOT COMPLETED|Overall Study||22
489573|NCT00378209|1173435|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
489574|NCT00378209|1173435|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
489575|NCT00378105|1173445|P2|NOT COMPLETED|Overall Study||30
489576|NCT00378105|1173446|P1|NOT COMPLETED|Overall Study||20
489577|NCT00378105|1173445|P2|COMPLETED|Overall Study||5
489578|NCT00378105|1173446|P1|COMPLETED|Overall Study||11
489579|NCT00378105|1173445|P2|STARTED|Overall Study||35
489580|NCT00378105|1173446|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
489581|NCT00378079|1173458|P3|NOT COMPLETED|Overall Study||0
489582|NCT00378079|1173459|P2|NOT COMPLETED|Overall Study||1
489583|NCT00378079|1173460|P1|NOT COMPLETED|Overall Study||6
489584|NCT00378079|1173458|P3|COMPLETED|Overall Study||71
489585|NCT00378079|1173459|P2|COMPLETED|Overall Study||69
489586|NCT00378079|1173460|P1|COMPLETED|Overall Study||64
489587|NCT00378079|1173458|P3|STARTED|Overall Study||71
489588|NCT00378079|1173459|P2|STARTED|Overall Study||70
489589|NCT00378079|1173460|P1|STARTED|Overall Study||70
489590|NCT00378014|1173482|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
489591|NCT00378014|1173483|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
489592|NCT00378014|1173482|P2|COMPLETED|Extension (Month 12 to Month 59)||26
489593|NCT00378014|1173483|P1|COMPLETED|Extension (Month 12 to Month 59)||27
489594|NCT00378014|1173482|P2|STARTED|Extension (Month 12 to Month 59)||40
489595|NCT00378014|1173483|P1|STARTED|Extension (Month 12 to Month 59)||41
489596|NCT00378014|1173482|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
489597|NCT00378014|1173483|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
489598|NCT00378014|1173482|P2|COMPLETED|Core (Randomization to Month 11)||90
489599|NCT00378014|1173483|P1|COMPLETED|Core (Randomization to Month 11)||87
489600|NCT00378014|1173482|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
489601|NCT00378014|1173483|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
489602|NCT00378014|1173482|P2|STARTED|Core (Randomization to Month 11)||102
489603|NCT00378014|1173483|P1|STARTED|Core (Randomization to Month 11)||101
489604|NCT00377962|1173509|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
489605|NCT00377962|1173510|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
489606|NCT00377962|1173509|P2|COMPLETED|Extension Study: 12-24 Months||123
489607|NCT00377962|1173510|P1|COMPLETED|Extension Study: 12-24 Months||98
489608|NCT00377962|1173509|P2|STARTED|Extension Study: 12-24 Months||127
489609|NCT00377962|1173510|P1|STARTED|Extension Study: 12-24 Months||108
489610|NCT00377962|1173509|P2|NOT COMPLETED|Core Study: 0-12 Months||9
489611|NCT00377962|1173510|P1|NOT COMPLETED|Core Study: 0-12 Months||28
489612|NCT00377962|1173509|P2|COMPLETED|Core Study: 0-12 Months||133
489613|NCT00377962|1173510|P1|COMPLETED|Core Study: 0-12 Months||112
489614|NCT00377962|1173509|P2|STARTED|Core Study: 0-12 Months||142
489615|NCT00377962|1173510|P1|STARTED|Core Study: 0-12 Months||140
489616|NCT00377858|1173546|P2|NOT COMPLETED|Overall Study||27
489617|NCT00377858|1173547|P1|NOT COMPLETED|Overall Study||31
489618|NCT00377858|1173546|P2|COMPLETED|Overall Study||215
489619|NCT00377858|1173547|P1|COMPLETED|Overall Study||211
489620|NCT00377858|1173546|P2|Had at Least One Post-Baseline Value|Overall Study||240
489621|NCT00377858|1173547|P1|Had at Least One Post-Baseline Value|Overall Study||239
489622|NCT00377858|1173546|P2|STARTED|Overall Study||242
489623|NCT00377858|1173547|P1|STARTED|Overall Study||242
489624|NCT00377832|1173577|P2|NOT COMPLETED|Overall Study||0
489625|NCT00377832|1173578|P1|NOT COMPLETED|Overall Study||0
489626|NCT00377832|1173577|P2|COMPLETED|Overall Study||6
489627|NCT00377832|1173578|P1|COMPLETED|Overall Study||7
489628|NCT00377832|1173577|P2|STARTED|Overall Study||6
489629|NCT00377832|1173578|P1|STARTED|Overall Study||7
489630|NCT00377819|1173600|P2|NOT COMPLETED|Overall Study||10
489631|NCT00377819|1173601|P1|NOT COMPLETED|Overall Study||13
489632|NCT00377819|1173600|P2|COMPLETED|Overall Study||243
489633|NCT00377819|1173601|P1|COMPLETED|Overall Study||238
489634|NCT00377819|1173600|P2|Received Study Medication|Overall Study||253
489635|NCT00377819|1173601|P1|Received Study Medication|Overall Study||249
489636|NCT00377819|1173600|P2|STARTED|Overall Study||253
489637|NCT00377819|1173601|P1|STARTED|Overall Study||251
489638|NCT00377741|1173613|P2|NOT COMPLETED|Overall Study||0
489639|NCT00377741|1173614|P1|NOT COMPLETED|Overall Study||0
489641|NCT00377741|1173614|P1|COMPLETED|Overall Study||16
489642|NCT00377741|1173613|P2|STARTED|Overall Study||15
489643|NCT00377741|1173614|P1|STARTED|Overall Study||16
489644|NCT00377676|1173630|P2|NOT COMPLETED|Overall Study||322
489645|NCT00377676|1173631|P1|NOT COMPLETED|Overall Study||961
489646|NCT00377676|1173630|P2|COMPLETED|Overall Study||694
489647|NCT00377676|1173631|P1|COMPLETED|Overall Study||1093
489648|NCT00377676|1173630|P2|STARTED|Overall Study||1016
489649|NCT00377676|1173631|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
489650|NCT00377637|1173647|P4|NOT COMPLETED|Maintenance Phase||57
489651|NCT00377637|1173648|P3|NOT COMPLETED|Maintenance Phase||43
489652|NCT00377637|1173649|P2|NOT COMPLETED|Maintenance Phase||0
489653|NCT00377637|1173650|P1|NOT COMPLETED|Maintenance Phase||0
489654|NCT00377637|1173647|P4|COMPLETED|Maintenance Phase||54
489655|NCT00377637|1173648|P3|COMPLETED|Maintenance Phase||73
489656|NCT00377637|1173649|P2|COMPLETED|Maintenance Phase||0
489657|NCT00377637|1173650|P1|COMPLETED|Maintenance Phase||0
489658|NCT00377637|1173647|P4|STARTED|Maintenance Phase||111
489659|NCT00377637|1173648|P3|STARTED|Maintenance Phase||116
489660|NCT00377637|1173649|P2|STARTED|Maintenance Phase||0
489661|NCT00377637|1173650|P1|STARTED|Maintenance Phase||0
489662|NCT00377637|1173647|P4|NOT COMPLETED|Induction Phase||0
489663|NCT00377637|1173648|P3|NOT COMPLETED|Induction Phase||0
489664|NCT00377637|1173649|P2|NOT COMPLETED|Induction Phase||35
489665|NCT00377637|1173650|P1|NOT COMPLETED|Induction Phase||29
489666|NCT00377637|1173647|P4|COMPLETED|Induction Phase||0
489667|NCT00377637|1173648|P3|COMPLETED|Induction Phase||0
489668|NCT00377637|1173649|P2|COMPLETED|Induction Phase||150
489669|NCT00377637|1173650|P1|COMPLETED|Induction Phase||156
489670|NCT00377637|1173647|P4|Safety Population|Induction Phase||0
489671|NCT00377637|1173648|P3|Safety Population|Induction Phase||0
489672|NCT00377637|1173649|P2|Safety Population|Induction Phase||184
489673|NCT00377637|1173650|P1|Safety Population|Induction Phase||180
489674|NCT00377637|1173647|P4|STARTED|Induction Phase||0
489675|NCT00377637|1173648|P3|STARTED|Induction Phase||0
489676|NCT00377637|1173649|P2|STARTED|Induction Phase|Intent-To-Treat|185
489677|NCT00377637|1173650|P1|STARTED|Induction Phase|Intent-To-Treat|185
489678|NCT00377572|1173686|P2|NOT COMPLETED|Overall Study||54
489679|NCT00377572|1173687|P1|NOT COMPLETED|Overall Study||53
489680|NCT00377572|1173686|P2|COMPLETED|Overall Study||157
489681|NCT00377572|1173687|P1|COMPLETED|Overall Study||155
489682|NCT00377572|1173686|P2|STARTED|Overall Study||211
489683|NCT00377572|1173687|P1|STARTED|Overall Study||208
489684|NCT00377520|1173725|P1|NOT COMPLETED|Overall Study||1
489685|NCT00377520|1173725|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
489686|NCT00377520|1173725|P1|STARTED|Overall Study||27
489687|NCT00377455|1173730|P1|NOT COMPLETED|Overall Study||1
489688|NCT00377455|1173730|P1|COMPLETED|Overall Study||4
489689|NCT00377455|1173730|P1|STARTED|Overall Study||5
489690|NCT00377429|1173734|P1|NOT COMPLETED|Overall Study||15
489691|NCT00377429|1173734|P1|COMPLETED|Overall Study|Completed main study|32
489692|NCT00377429|1173734|P1|STARTED|Overall Study|Treated|47
489693|NCT00377403|1173745|P2|NOT COMPLETED|Overall Study||7
489694|NCT00377403|1173746|P1|NOT COMPLETED|Overall Study||4
489695|NCT00377403|1173745|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
489696|NCT00377403|1173746|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
489697|NCT00377403|1173745|P2|Day 28 Assessment|Overall Study||77
489698|NCT00377403|1173746|P1|Day 28 Assessment|Overall Study||82
489699|NCT00377403|1173745|P2|Day 10 Assessment|Overall Study||71
489700|NCT00377403|1173746|P1|Day 10 Assessment|Overall Study||81
489701|NCT00377403|1173745|P2|Day 7 Assessment|Overall Study||75
489702|NCT00377403|1173746|P1|Day 7 Assessment|Overall Study||80
489703|NCT00377403|1173745|P2|Day -3 Assessment|Overall Study||74
489704|NCT00377403|1173746|P1|Day -3 Assessment|Overall Study||81
489705|NCT00377403|1173745|P2|STARTED|Overall Study||81
489706|NCT00377403|1173746|P1|STARTED|Overall Study||85
489707|NCT00377364|1173754|P2|NOT COMPLETED|Overall Study||0
489708|NCT00377364|1173755|P1|NOT COMPLETED|Overall Study||2
489709|NCT00377364|1173754|P2|COMPLETED|Overall Study||14
489710|NCT00377364|1173755|P1|COMPLETED|Overall Study||14
489711|NCT00377364|1173754|P2|STARTED|Overall Study||14
489712|NCT00377364|1173755|P1|STARTED|Overall Study||16
489713|NCT00377312|1173781|P2|NOT COMPLETED|Overall Study||1
489714|NCT00377312|1173782|P1|NOT COMPLETED|Overall Study||1
489715|NCT00377312|1173781|P2|COMPLETED|Overall Study||4
489716|NCT00377312|1173782|P1|COMPLETED|Overall Study||5
489717|NCT00377312|1173781|P2|STARTED|Overall Study||5
489718|NCT00377312|1173782|P1|STARTED|Overall Study||6
489719|NCT00377299|1173814|P2|NOT COMPLETED|Overall Study||24
489720|NCT00377299|1173815|P1|NOT COMPLETED|Overall Study||19
489721|NCT00377299|1173814|P2|COMPLETED|Overall Study||4
489722|NCT00377299|1173815|P1|COMPLETED|Overall Study||13
489723|NCT00377299|1173814|P2|STARTED|Overall Study||28
489724|NCT00377299|1173815|P1|STARTED|Overall Study||32
489725|NCT00377260|1173831|P2|NOT COMPLETED|Overall Study||5
489726|NCT00377260|1173832|P1|NOT COMPLETED|Overall Study||2
489727|NCT00377260|1173831|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
489728|NCT00377260|1173832|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
489729|NCT00377260|1173831|P2|STARTED|Overall Study||147
489730|NCT00377260|1173832|P1|STARTED|Overall Study||144
489731|NCT00377234|1173886|P2|NOT COMPLETED|Overall Study||31
489732|NCT00377234|1173887|P1|NOT COMPLETED|Overall Study||34
489733|NCT00377234|1173886|P2|COMPLETED|Overall Study||145
489734|NCT00377234|1173887|P1|COMPLETED|Overall Study||146
489735|NCT00377234|1173886|P2|Safety Analysis Set: Risedronate|Overall Study||174
489736|NCT00377234|1173887|P1|Safety Analysis Set: Risedronate|Overall Study||153
489737|NCT00377234|1173886|P2|Safety Analysis Set: Ibandronate|Overall Study||150
489738|NCT00377234|1173887|P1|Safety Analysis Set: Ibandronate|Overall Study||177
489739|NCT00377234|1173886|P2|Safety Analysis Set: Period 2|Overall Study||150
489740|NCT00377234|1173887|P1|Safety Analysis Set: Period 2|Overall Study||153
489741|NCT00377234|1173886|P2|Safety Analysis Set: Period 1|Overall Study||174
489742|NCT00377234|1173887|P1|Safety Analysis Set: Period 1|Overall Study||177
489743|NCT00377234|1173886|P2|Received Treatment|Overall Study||174
489744|NCT00377234|1173887|P1|Received Treatment|Overall Study||177
489745|NCT00377234|1173886|P2|Did Not Receive Study Treatment|Overall Study||2
489746|NCT00377234|1173887|P1|Did Not Receive Study Treatment|Overall Study||3
489747|NCT00377234|1173886|P2|Randomized|Overall Study||176
489748|NCT00377234|1173887|P1|Randomized|Overall Study||180
489749|NCT00377234|1173886|P2|STARTED|Overall Study||176
489750|NCT00377234|1173887|P1|STARTED|Overall Study||180
489751|NCT00376961|1173903|P2|NOT COMPLETED|Maintenance||23
489752|NCT00376961|1173904|P1|NOT COMPLETED|Maintenance||0
489753|NCT00376961|1173903|P2|COMPLETED|Maintenance||27
489754|NCT00376961|1173904|P1|COMPLETED|Maintenance||0
489755|NCT00376961|1173903|P2|Eligible|Maintenance||47
489756|NCT00376961|1173904|P1|Eligible|Maintenance||0
489757|NCT00376961|1173903|P2|STARTED|Maintenance||50
489758|NCT00376961|1173904|P1|STARTED|Maintenance||0
489759|NCT00376961|1173903|P2|NOT COMPLETED|Initial Registration||0
489760|NCT00376961|1173904|P1|NOT COMPLETED|Initial Registration||7
489761|NCT00376961|1173903|P2|COMPLETED|Initial Registration||0
489762|NCT00376961|1173904|P1|COMPLETED|Initial Registration||61
489763|NCT00376961|1173903|P2|Eligible|Initial Registration||0
489764|NCT00376961|1173904|P1|Eligible|Initial Registration||65
489765|NCT00376961|1173903|P2|STARTED|Initial Registration||0
489766|NCT00376961|1173904|P1|STARTED|Initial Registration||68
489767|NCT00376948|1173913|P1|NOT COMPLETED|Overall Study||0
489768|NCT00376948|1173913|P1|COMPLETED|Overall Study||20
489769|NCT00376948|1173913|P1|STARTED|Overall Study||20
489770|NCT00376935|1173922|P4|NOT COMPLETED|Overall Study||0
489771|NCT00376935|1173923|P3|NOT COMPLETED|Overall Study||0
489772|NCT00376935|1173924|P2|NOT COMPLETED|Overall Study||0
489773|NCT00376935|1173925|P1|NOT COMPLETED|Overall Study||0
489774|NCT00376935|1173922|P4|COMPLETED|Overall Study||24
489775|NCT00376935|1173923|P3|COMPLETED|Overall Study||25
489776|NCT00376935|1173924|P2|COMPLETED|Overall Study||25
489777|NCT00376935|1173925|P1|COMPLETED|Overall Study||25
489778|NCT00376935|1173922|P4|STARTED|Overall Study||24
489779|NCT00376935|1173923|P3|STARTED|Overall Study||25
489780|NCT00376935|1173924|P2|STARTED|Overall Study||25
489781|NCT00376935|1173925|P1|STARTED|Overall Study||25
489782|NCT00376805|1173963|P1|NOT COMPLETED|Overall Study||0
489783|NCT00376805|1173963|P1|COMPLETED|Overall Study||6
489784|NCT00376805|1173963|P1|STARTED|Overall Study||6
489785|NCT00376688|1173970|P1|NOT COMPLETED|Overall Study||4
489786|NCT00376688|1173970|P1|COMPLETED|Overall Study||27
489787|NCT00376688|1173970|P1|STARTED|Overall Study||31
489788|NCT00376675|1173976|P2|NOT COMPLETED|Overall Study||14
489789|NCT00376675|1173977|P1|NOT COMPLETED|Overall Study||20
489790|NCT00376675|1173976|P2|COMPLETED|Overall Study||56
489791|NCT00376675|1173977|P1|COMPLETED|Overall Study||49
489792|NCT00376675|1173976|P2|STARTED|Overall Study||70
489793|NCT00376675|1173977|P1|STARTED|Overall Study||69
489794|NCT00375518|1174001|P2|NOT COMPLETED|Overall Study||17
489795|NCT00375518|1174002|P1|NOT COMPLETED|Overall Study||8
489796|NCT00375518|1174001|P2|COMPLETED|Overall Study||65
489797|NCT00375518|1174002|P1|COMPLETED|Overall Study||72
489798|NCT00375518|1174001|P2|STARTED|Overall Study||82
489799|NCT00375518|1174002|P1|STARTED|Overall Study||80
489800|NCT00376558|1174010|P2|NOT COMPLETED|Overall Study||0
489801|NCT00376558|1174011|P1|NOT COMPLETED|Overall Study||0
489802|NCT00376558|1174010|P2|COMPLETED|Overall Study||25
489803|NCT00376558|1174011|P1|COMPLETED|Overall Study||25
489804|NCT00376558|1174010|P2|STARTED|Overall Study||25
489805|NCT00376558|1174011|P1|STARTED|Overall Study||25
489806|NCT00376532|1174020|P2|NOT COMPLETED|Overall Study||6
489807|NCT00376532|1174021|P1|NOT COMPLETED|Overall Study||6
489808|NCT00376532|1174020|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
489809|NCT00376532|1174021|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
489810|NCT00376532|1174020|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
489811|NCT00376532|1174021|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
489812|NCT00376506|1174031|P2|NOT COMPLETED|Overall Study||2
489813|NCT00376506|1174032|P1|NOT COMPLETED|Overall Study||0
489814|NCT00376506|1174031|P2|COMPLETED|Overall Study||4
489815|NCT00376506|1174032|P1|COMPLETED|Overall Study||4
489816|NCT00376506|1174031|P2|STARTED|Overall Study||6
489817|NCT00376506|1174032|P1|STARTED|Overall Study||4
489818|NCT00376363|1174050|P2|NOT COMPLETED|Overall Study||46
489819|NCT00376363|1174051|P1|NOT COMPLETED|Overall Study||56
489820|NCT00376363|1174050|P2|COMPLETED|Overall Study||87
489821|NCT00376363|1174051|P1|COMPLETED|Overall Study||87
489822|NCT00376363|1174050|P2|STARTED|Overall Study||133
489823|NCT00376363|1174051|P1|STARTED|Overall Study||143
489824|NCT00376259|1174063|P2|NOT COMPLETED|Overall Study||21
489825|NCT00376259|1174064|P1|NOT COMPLETED|Overall Study||22
489826|NCT00376259|1174063|P2|COMPLETED|Overall Study||0
489827|NCT00376259|1174064|P1|COMPLETED|Overall Study||0
489828|NCT00376259|1174063|P2|Received Study Drug|Overall Study||21
489829|NCT00376259|1174064|P1|Received Study Drug|Overall Study||21
489830|NCT00376259|1174063|P2|STARTED|Overall Study||21
489831|NCT00376259|1174064|P1|STARTED|Overall Study||22
489832|NCT00376220|1174078|P2|NOT COMPLETED|Overall Study||12
489833|NCT00376220|1174079|P1|NOT COMPLETED|Overall Study||10
489834|NCT00376220|1174078|P2|COMPLETED|Overall Study||35
489835|NCT00376220|1174079|P1|COMPLETED|Overall Study||37
489836|NCT00376220|1174078|P2|STARTED|Overall Study||47
489837|NCT00376220|1174079|P1|STARTED|Overall Study||47
489838|NCT00376168|1174087|P2|NOT COMPLETED|Overall Study||1
489839|NCT00376168|1174088|P1|NOT COMPLETED|Overall Study||2
489840|NCT00376168|1174087|P2|COMPLETED|Overall Study||15
489841|NCT00376168|1174088|P1|COMPLETED|Overall Study||14
489842|NCT00376168|1174087|P2|STARTED|Overall Study|One patient randomized but not treated|16
489843|NCT00376168|1174088|P1|STARTED|Overall Study||16
489844|NCT00375999|1174102|P1|NOT COMPLETED|Overall Study||2
489845|NCT00375999|1174102|P1|COMPLETED|Overall Study||32
489846|NCT00375999|1174102|P1|STARTED|Overall Study||34
489847|NCT00375973|1174108|P2|NOT COMPLETED|Overall Study||2
489848|NCT00375973|1174109|P1|NOT COMPLETED|Overall Study||10
489849|NCT00375973|1174108|P2|COMPLETED|Overall Study||28
489850|NCT00375973|1174109|P1|COMPLETED|Overall Study||20
489851|NCT00375973|1174108|P2|STARTED|Overall Study||30
489852|NCT00375973|1174109|P1|STARTED|Overall Study||30
489853|NCT00375934|1174129|P2|NOT COMPLETED|Overall Study||6
489854|NCT00375934|1174130|P1|NOT COMPLETED|Overall Study||3
489855|NCT00375934|1174129|P2|COMPLETED|Overall Study||95
489856|NCT00375934|1174130|P1|COMPLETED|Overall Study||96
489857|NCT00375934|1174129|P2|STARTED|Overall Study||101
489858|NCT00375934|1174130|P1|STARTED|Overall Study||99
489859|NCT00375752|1174158|P2|NOT COMPLETED|Overall Study||15
489860|NCT00375752|1174159|P1|NOT COMPLETED|Overall Study||12
489861|NCT00375752|1174158|P2|COMPLETED|Overall Study||74
489862|NCT00375752|1174159|P1|COMPLETED|Overall Study||67
489863|NCT00375752|1174158|P2|STARTED|Overall Study||89
489864|NCT00375752|1174159|P1|STARTED|Overall Study||79
489865|NCT00375713|1174173|P2|NOT COMPLETED|Overall Study||23
489866|NCT00375713|1174174|P1|NOT COMPLETED|Overall Study||20
489867|NCT00375713|1174173|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
489868|NCT00375713|1174174|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
489869|NCT00375713|1174173|P2|STARTED|Overall Study|Randomized population (N=234).|234
489870|NCT00375713|1174174|P1|STARTED|Overall Study|Randomized population (N=232).|232
489871|NCT00375505|1174188|P2|NOT COMPLETED|Overall Study||2
489872|NCT00375505|1174189|P1|NOT COMPLETED|Overall Study||1
489873|NCT00375505|1174188|P2|COMPLETED|Overall Study||32
489874|NCT00375505|1174189|P1|COMPLETED|Overall Study||35
489875|NCT00375505|1174188|P2|STARTED|Overall Study||34
489876|NCT00375505|1174189|P1|STARTED|Overall Study||36
489877|NCT00375492|1174233|P2|NOT COMPLETED|Overall Study||26
489878|NCT00375492|1174234|P1|NOT COMPLETED|Overall Study||26
489879|NCT00375492|1174233|P2|COMPLETED|Overall Study||72
489880|NCT00375492|1174234|P1|COMPLETED|Overall Study||70
489881|NCT00375492|1174233|P2|STARTED|Overall Study||98
489882|NCT00375492|1174234|P1|STARTED|Overall Study||96
489883|NCT00375427|1174264|P2|NOT COMPLETED|Overall Study||74
489884|NCT00375427|1174265|P1|NOT COMPLETED|Overall Study||60
489885|NCT00375427|1174264|P2|COMPLETED|Overall Study||142
489886|NCT00375427|1174265|P1|COMPLETED|Overall Study||149
489887|NCT00375427|1174264|P2|STARTED|Overall Study||216
489888|NCT00375427|1174265|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
489889|NCT00375219|1174290|P3|NOT COMPLETED|Overall Study||21
489890|NCT00375219|1174291|P2|NOT COMPLETED|Overall Study||20
489891|NCT00375219|1174292|P1|NOT COMPLETED|Overall Study||59
489892|NCT00375219|1174290|P3|COMPLETED|Overall Study||0
489893|NCT00375219|1174291|P2|COMPLETED|Overall Study||0
489894|NCT00375219|1174292|P1|COMPLETED|Overall Study||3
489895|NCT00375219|1174290|P3|STARTED|Overall Study||21
489896|NCT00375219|1174291|P2|STARTED|Overall Study||20
489897|NCT00375219|1174292|P1|STARTED|Overall Study||62
489898|NCT00374907|1174360|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
489899|NCT00374907|1174361|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
489900|NCT00374907|1174360|P2|COMPLETED|116-Week Short-term + Long-term Period||2
489901|NCT00374907|1174361|P1|COMPLETED|116-Week Short-term + Long-term Period||7
489902|NCT00374907|1174360|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
489903|NCT00374907|1174361|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
489904|NCT00374907|1174360|P2|STARTED|116-Week Short-term + Long-term Period||16
489905|NCT00374907|1174361|P1|STARTED|116-Week Short-term + Long-term Period||20
489906|NCT00374907|1174360|P2|NOT COMPLETED|12-Week Short-term Period||1
489907|NCT00374907|1174361|P1|NOT COMPLETED|12-Week Short-term Period||3
489908|NCT00374907|1174360|P2|COMPLETED|12-Week Short-term Period||15
489909|NCT00374907|1174361|P1|COMPLETED|12-Week Short-term Period||17
489910|NCT00374907|1174360|P2|STARTED|12-Week Short-term Period||16
489911|NCT00374907|1174361|P1|STARTED|12-Week Short-term Period||20
489912|NCT00374868|1174373|P1|NOT COMPLETED|Overall Study||36
489913|NCT00374868|1174373|P1|COMPLETED|Overall Study||2
489914|NCT00374868|1174373|P1|STARTED|Overall Study||38
489915|NCT00374842|1174387|P3|NOT COMPLETED|Overall Study||0
489916|NCT00374842|1174388|P2|NOT COMPLETED|Overall Study||0
489917|NCT00374842|1174389|P1|NOT COMPLETED|Overall Study||0
489918|NCT00374842|1174387|P3|COMPLETED|Overall Study||100
489919|NCT00374842|1174388|P2|COMPLETED|Overall Study||100
489920|NCT00374842|1174389|P1|COMPLETED|Overall Study||100
489921|NCT00374842|1174387|P3|STARTED|Overall Study||100
489922|NCT00374842|1174388|P2|STARTED|Overall Study||100
489923|NCT00374842|1174389|P1|STARTED|Overall Study||100
489924|NCT00374803|1174420|P2|NOT COMPLETED|Overall Study||0
489925|NCT00374803|1174421|P1|NOT COMPLETED|Overall Study||0
489926|NCT00374803|1174420|P2|COMPLETED|Overall Study||23
489927|NCT00374803|1174421|P1|COMPLETED|Overall Study||22
489928|NCT00374803|1174420|P2|STARTED|Overall Study||23
489929|NCT00374803|1174421|P1|STARTED|Overall Study||22
489930|NCT00374543|1174437|P2|NOT COMPLETED|Overall Study||0
489931|NCT00374543|1174438|P1|NOT COMPLETED|Overall Study||0
489932|NCT00374543|1174437|P2|COMPLETED|Overall Study||1
489933|NCT00374543|1174438|P1|COMPLETED|Overall Study||2
489934|NCT00374543|1174437|P2|STARTED|Overall Study||1
489935|NCT00374543|1174438|P1|STARTED|Overall Study||2
489936|NCT00374335|1174444|P1|NOT COMPLETED|Overall Study||0
489937|NCT00374335|1174444|P1|COMPLETED|Overall Study||261
489938|NCT00374335|1174444|P1|STARTED|Overall Study||261
489939|NCT00374322|1174451|P2|NOT COMPLETED|Overall Study||1304
489940|NCT00374322|1174452|P1|NOT COMPLETED|Overall Study||1257
489941|NCT00374322|1174451|P2|COMPLETED|Overall Study||278
489942|NCT00374322|1174452|P1|COMPLETED|Overall Study||322
489943|NCT00374322|1174451|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
489944|NCT00374322|1174452|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
489945|NCT00374322|1174451|P2|STARTED|Overall Study||1582
489946|NCT00374322|1174452|P1|STARTED|Overall Study||1579
489947|NCT00374244|1174490|P2|NOT COMPLETED|Overall Study||0
489948|NCT00374244|1174491|P1|NOT COMPLETED|Overall Study||0
489949|NCT00374244|1174490|P2|COMPLETED|Overall Study||14
489950|NCT00374244|1174491|P1|COMPLETED|Overall Study||14
489951|NCT00374244|1174490|P2|STARTED|Overall Study||14
489952|NCT00374244|1174491|P1|STARTED|Overall Study||14
489953|NCT00374231|1174537|P1|NOT COMPLETED|Overall Study||0
489954|NCT00374231|1174537|P1|COMPLETED|Overall Study||40
489955|NCT00374231|1174537|P1|STARTED|Overall Study||40
489956|NCT00374140|1174543|P1|NOT COMPLETED|Overall Study||2
489957|NCT00374140|1174543|P1|COMPLETED|Overall Study||38
489958|NCT00374140|1174543|P1|STARTED|Overall Study||40
489959|NCT00374088|1174549|P2|NOT COMPLETED|Overall Study||1
489960|NCT00374088|1174550|P1|NOT COMPLETED|Overall Study||1
489961|NCT00374088|1174549|P2|COMPLETED|Overall Study||10
489962|NCT00374088|1174550|P1|COMPLETED|Overall Study||9
489963|NCT00374088|1174549|P2|STARTED|Overall Study||11
489964|NCT00374088|1174550|P1|STARTED|Overall Study||10
489965|NCT00373958|1174562|P2|NOT COMPLETED|Toddler Dose||38
489966|NCT00373958|1174563|P1|NOT COMPLETED|Toddler Dose||30
489967|NCT00373958|1174562|P2|COMPLETED|Toddler Dose||252
489968|NCT00373958|1174563|P1|COMPLETED|Toddler Dose||264
489969|NCT00373958|1174562|P2|Vaccinated Toddler Dose|Toddler Dose||265
489970|NCT00373958|1174563|P1|Vaccinated Toddler Dose|Toddler Dose||272
489971|NCT00373958|1174562|P2|Withdrawn After Infant Series|Toddler Dose||25
489972|NCT00373958|1174563|P1|Withdrawn After Infant Series|Toddler Dose||22
489973|NCT00373958|1174562|P2|STARTED|Toddler Dose||290
489974|NCT00373958|1174563|P1|STARTED|Toddler Dose||294
489975|NCT00373958|1174562|P2|NOT COMPLETED|Infant Series||42
489976|NCT00373958|1174563|P1|NOT COMPLETED|Infant Series||40
489977|NCT00373958|1174562|P2|COMPLETED|Infant Series||290
489978|NCT00373958|1174563|P1|COMPLETED|Infant Series||294
489979|NCT00373958|1174562|P2|Vaccinated Dose 3|Infant Series||300
489980|NCT00373958|1174563|P1|Vaccinated Dose 3|Infant Series||298
489981|NCT00373958|1174562|P2|Vaccinated Dose 2|Infant Series||305
489982|NCT00373958|1174563|P1|Vaccinated Dose 2|Infant Series||309
489983|NCT00373958|1174562|P2|Vaccinated Dose 1|Infant Series||331
489984|NCT00373958|1174563|P1|Vaccinated Dose 1|Infant Series||332
489985|NCT00373958|1174562|P2|STARTED|Infant Series||332
489986|NCT00373958|1174563|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
489987|NCT00373698|1174613|P2|NOT COMPLETED|Overall Study||0
489988|NCT00373698|1174614|P1|NOT COMPLETED|Overall Study||11
489989|NCT00373698|1174613|P2|COMPLETED|Overall Study||99
489990|NCT00373698|1174614|P1|COMPLETED|Overall Study||85
489991|NCT00373698|1174613|P2|STARTED|Overall Study||99
489992|NCT00373698|1174614|P1|STARTED|Overall Study||96
489993|NCT00373685|1174628|P2|NOT COMPLETED|Overall Study||1421
489994|NCT00373685|1174629|P1|NOT COMPLETED|Overall Study||1439
489995|NCT00373685|1174628|P2|COMPLETED|Overall Study||2611
489996|NCT00373685|1174629|P1|COMPLETED|Overall Study||2596
489997|NCT00373685|1174628|P2|Treated|Overall Study||3955
489998|NCT00373685|1174629|P1|Treated|Overall Study||3984
489999|NCT00373685|1174628|P2|STARTED|Overall Study||4032
490000|NCT00373685|1174629|P1|STARTED|Overall Study||4035
490001|NCT00373529|1174663|P1|NOT COMPLETED|Overall Study||108
490088|NCT00373295|1174778|P3|COMPLETED|Intervention 1 (8 Days)||1
490002|NCT00373529|1174663|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
490003|NCT00373529|1174663|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
490004|NCT00373529|1174663|P1|STARTED|Overall Study||116
490005|NCT00373490|1174675|P2|NOT COMPLETED|Overall Study||6
490006|NCT00373490|1174676|P1|NOT COMPLETED|Overall Study||9
490007|NCT00373490|1174675|P2|COMPLETED|Overall Study||0
490008|NCT00373490|1174676|P1|COMPLETED|Overall Study||1
490009|NCT00373490|1174675|P2|STARTED|Overall Study||6
490010|NCT00373490|1174676|P1|STARTED|Overall Study||10
490011|NCT00373425|1174699|P5|NOT COMPLETED|Overall Study||72
490012|NCT00373425|1174700|P4|NOT COMPLETED|Overall Study||11
490013|NCT00373425|1174701|P3|NOT COMPLETED|Overall Study||134
490014|NCT00373425|1174702|P2|NOT COMPLETED|Overall Study||153
490015|NCT00373425|1174703|P1|NOT COMPLETED|Overall Study||370
490016|NCT00373425|1174699|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
490017|NCT00373425|1174700|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
490018|NCT00373425|1174701|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
490019|NCT00373425|1174702|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
490020|NCT00373425|1174703|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
490021|NCT00373425|1174699|P5|Received Treatment|Overall Study||132
490022|NCT00373425|1174700|P4|Received Treatment|Overall Study||7
490023|NCT00373425|1174701|P3|Received Treatment|Overall Study||134
490024|NCT00373425|1174702|P2|Received Treatment|Overall Study||342
490025|NCT00373425|1174703|P1|Received Treatment|Overall Study||612
490026|NCT00373425|1174699|P5|STARTED|Overall Study||132
490027|NCT00373425|1174700|P4|STARTED|Overall Study||11
490028|NCT00373425|1174701|P3|STARTED|Overall Study||134
490029|NCT00373425|1174702|P2|STARTED|Overall Study||350
490030|NCT00373425|1174703|P1|STARTED|Overall Study||623
490031|NCT00373360|1174728|P1|NOT COMPLETED|Overall Study||0
490032|NCT00373360|1174728|P1|COMPLETED|Overall Study||10
490033|NCT00373360|1174728|P1|STARTED|Overall Study||10
490034|NCT00373334|1174759|P3|NOT COMPLETED|Overall Study||13
490035|NCT00373334|1174760|P2|NOT COMPLETED|Overall Study||18
490036|NCT00373334|1174761|P1|NOT COMPLETED|Overall Study||10
490037|NCT00373334|1174759|P3|COMPLETED|Overall Study||32
490038|NCT00373334|1174760|P2|COMPLETED|Overall Study||32
490039|NCT00373334|1174761|P1|COMPLETED|Overall Study||33
490040|NCT00373334|1174759|P3|STARTED|Overall Study||45
490041|NCT00373334|1174760|P2|STARTED|Overall Study||50
490042|NCT00373334|1174761|P1|STARTED|Overall Study||43
490043|NCT00373295|1174775|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
490044|NCT00373295|1174776|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
490045|NCT00373295|1174777|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
490046|NCT00373295|1174778|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
490047|NCT00373295|1174779|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
490048|NCT00373295|1174780|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
490049|NCT00373295|1174775|P6|COMPLETED|Intervention 3 (8 Days)||2
490050|NCT00373295|1174776|P5|COMPLETED|Intervention 3 (8 Days)||2
490051|NCT00373295|1174777|P4|COMPLETED|Intervention 3 (8 Days)||2
490052|NCT00373295|1174778|P3|COMPLETED|Intervention 3 (8 Days)||1
490053|NCT00373295|1174779|P2|COMPLETED|Intervention 3 (8 Days)||1
490054|NCT00373295|1174780|P1|COMPLETED|Intervention 3 (8 Days)||2
490055|NCT00373295|1174775|P6|STARTED|Intervention 3 (8 Days)||2
490056|NCT00373295|1174776|P5|STARTED|Intervention 3 (8 Days)||2
490057|NCT00373295|1174777|P4|STARTED|Intervention 3 (8 Days)||2
490058|NCT00373295|1174778|P3|STARTED|Intervention 3 (8 Days)||1
490059|NCT00373295|1174779|P2|STARTED|Intervention 3 (8 Days)||1
490060|NCT00373295|1174780|P1|STARTED|Intervention 3 (8 Days)||2
490061|NCT00373295|1174775|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
490062|NCT00373295|1174776|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
490063|NCT00373295|1174777|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
490064|NCT00373295|1174778|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
490065|NCT00373295|1174779|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
490066|NCT00373295|1174780|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
490067|NCT00373295|1174775|P6|COMPLETED|Intervention 2 (8 Days)||2
490068|NCT00373295|1174776|P5|COMPLETED|Intervention 2 (8 Days)||2
490069|NCT00373295|1174777|P4|COMPLETED|Intervention 2 (8 Days)||2
490070|NCT00373295|1174778|P3|COMPLETED|Intervention 2 (8 Days)||1
490071|NCT00373295|1174779|P2|COMPLETED|Intervention 2 (8 Days)||1
490072|NCT00373295|1174780|P1|COMPLETED|Intervention 2 (8 Days)||2
490073|NCT00373295|1174775|P6|STARTED|Intervention 2 (8 Days)||2
490074|NCT00373295|1174776|P5|STARTED|Intervention 2 (8 Days)||2
490075|NCT00373295|1174777|P4|STARTED|Intervention 2 (8 Days)||2
490076|NCT00373295|1174778|P3|STARTED|Intervention 2 (8 Days)||1
490077|NCT00373295|1174779|P2|STARTED|Intervention 2 (8 Days)||1
490078|NCT00373295|1174780|P1|STARTED|Intervention 2 (8 Days)||2
490079|NCT00373295|1174775|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
490080|NCT00373295|1174776|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
490081|NCT00373295|1174777|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
490082|NCT00373295|1174778|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
490083|NCT00373295|1174779|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
490084|NCT00373295|1174780|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
490085|NCT00373295|1174775|P6|COMPLETED|Intervention 1 (8 Days)||2
490086|NCT00373295|1174776|P5|COMPLETED|Intervention 1 (8 Days)||2
490087|NCT00373295|1174777|P4|COMPLETED|Intervention 1 (8 Days)||2
490089|NCT00373295|1174779|P2|COMPLETED|Intervention 1 (8 Days)||1
490090|NCT00373295|1174780|P1|COMPLETED|Intervention 1 (8 Days)||2
490091|NCT00373295|1174775|P6|STARTED|Intervention 1 (8 Days)||2
490092|NCT00373295|1174776|P5|STARTED|Intervention 1 (8 Days)||3
490093|NCT00373295|1174777|P4|STARTED|Intervention 1 (8 Days)||2
490094|NCT00373295|1174778|P3|STARTED|Intervention 1 (8 Days)||1
490095|NCT00373295|1174779|P2|STARTED|Intervention 1 (8 Days)||3
490096|NCT00373295|1174780|P1|STARTED|Intervention 1 (8 Days)||2
490097|NCT00373269|1174790|P2|NOT COMPLETED|Overall Study||0
490098|NCT00373269|1174791|P1|NOT COMPLETED|Overall Study||0
490099|NCT00373269|1174790|P2|COMPLETED|Overall Study||10
490100|NCT00373269|1174791|P1|COMPLETED|Overall Study||11
490101|NCT00373269|1174790|P2|STARTED|Overall Study||10
490102|NCT00373269|1174791|P1|STARTED|Overall Study||11
490103|NCT00373256|1174801|P2|NOT COMPLETED|Overall Study||247
490104|NCT00373256|1174802|P1|NOT COMPLETED|Overall Study||241
490105|NCT00373256|1174801|P2|COMPLETED|Overall Study||0
490106|NCT00373256|1174802|P1|COMPLETED|Overall Study||0
490107|NCT00373256|1174801|P2|Treated|Overall Study||236
490108|NCT00373256|1174802|P1|Treated|Overall Study||235
490109|NCT00373256|1174801|P2|STARTED|Overall Study||247
490110|NCT00373256|1174802|P1|STARTED|Overall Study||241
490111|NCT00373113|1174828|P2|NOT COMPLETED|Overall Study||244
490112|NCT00373113|1174829|P1|NOT COMPLETED|Overall Study||238
490113|NCT00373113|1174828|P2|COMPLETED|Overall Study||0
490114|NCT00373113|1174829|P1|COMPLETED|Overall Study||0
490115|NCT00373113|1174828|P2|Received Treatment|Overall Study||240
490116|NCT00373113|1174829|P1|Received Treatment|Overall Study||238
490117|NCT00373113|1174828|P2|STARTED|Overall Study||244
490118|NCT00373113|1174829|P1|STARTED|Overall Study||238
490119|NCT00372996|1174851|P4|NOT COMPLETED|Overall Study||20
490120|NCT00372996|1174852|P3|NOT COMPLETED|Overall Study||28
490121|NCT00372996|1174853|P2|NOT COMPLETED|Overall Study||14
490122|NCT00372996|1174854|P1|NOT COMPLETED|Overall Study||37
490123|NCT00372996|1174851|P4|COMPLETED|Overall Study||23
490124|NCT00372996|1174852|P3|COMPLETED|Overall Study||33
490125|NCT00372996|1174853|P2|COMPLETED|Overall Study||22
490126|NCT00372996|1174854|P1|COMPLETED|Overall Study||42
490127|NCT00372996|1174851|P4|STARTED|Overall Study||43
490128|NCT00372996|1174852|P3|STARTED|Overall Study||61
490129|NCT00372996|1174853|P2|STARTED|Overall Study||36
490130|NCT00372996|1174854|P1|STARTED|Overall Study||79
490131|NCT00372970|1174880|P2|NOT COMPLETED|Overall Study||0
490132|NCT00372970|1174881|P1|NOT COMPLETED|Overall Study||0
490133|NCT00372970|1174880|P2|COMPLETED|Overall Study||16
490134|NCT00372970|1174881|P1|COMPLETED|Overall Study||16
490135|NCT00372970|1174880|P2|STARTED|Overall Study||16
490136|NCT00372970|1174881|P1|STARTED|Overall Study||16
490137|NCT00372775|1174887|P1|NOT COMPLETED|Overall Study||63
490138|NCT00372775|1174887|P1|COMPLETED|Overall Study||3
490139|NCT00372775|1174887|P1|Received Treatment|Overall Study||64
490140|NCT00372775|1174887|P1|STARTED|Overall Study||66
490141|NCT00372697|1174909|P2|NOT COMPLETED|Overall Study||1
490142|NCT00372697|1174910|P1|NOT COMPLETED|Overall Study||1
490143|NCT00372697|1174909|P2|COMPLETED|Overall Study||11
490144|NCT00372697|1174910|P1|COMPLETED|Overall Study||15
490145|NCT00372697|1174909|P2|STARTED|Overall Study||12
490146|NCT00372697|1174910|P1|STARTED|Overall Study||16
490147|NCT00372619|1174935|P7|NOT COMPLETED|Overall Study||0
490148|NCT00372619|1174936|P6|NOT COMPLETED|Overall Study||3
490149|NCT00372619|1174937|P5|NOT COMPLETED|Overall Study||0
490150|NCT00372619|1174938|P4|NOT COMPLETED|Overall Study||0
490151|NCT00372619|1174939|P3|NOT COMPLETED|Overall Study||0
490152|NCT00372619|1174940|P2|NOT COMPLETED|Overall Study||0
490153|NCT00372619|1174941|P1|NOT COMPLETED|Overall Study||0
490154|NCT00372619|1174935|P7|COMPLETED|Overall Study||2
490155|NCT00372619|1174936|P6|COMPLETED|Overall Study||39
490156|NCT00372619|1174937|P5|COMPLETED|Overall Study||7
490157|NCT00372619|1174938|P4|COMPLETED|Overall Study||10
490158|NCT00372619|1174939|P3|COMPLETED|Overall Study||3
490159|NCT00372619|1174940|P2|COMPLETED|Overall Study||2
490160|NCT00372619|1174941|P1|COMPLETED|Overall Study||8
490161|NCT00372619|1174935|P7|STARTED|Overall Study||2
490162|NCT00372619|1174936|P6|STARTED|Overall Study||42
490163|NCT00372619|1174937|P5|STARTED|Overall Study||7
490164|NCT00372619|1174938|P4|STARTED|Overall Study||10
490165|NCT00372619|1174939|P3|STARTED|Overall Study||3
490166|NCT00372619|1174940|P2|STARTED|Overall Study||2
490167|NCT00372619|1174941|P1|STARTED|Overall Study||8
490168|NCT00372593|1174974|P3|NOT COMPLETED|Overall Study||4
490169|NCT00372593|1174975|P2|NOT COMPLETED|Overall Study||198
490170|NCT00372593|1174976|P1|NOT COMPLETED|Overall Study||204
490171|NCT00372593|1174974|P3|COMPLETED|Overall Study||3
490172|NCT00372593|1174975|P2|COMPLETED|Overall Study||334
490173|NCT00372593|1174976|P1|COMPLETED|Overall Study||327
490174|NCT00372593|1174974|P3|STARTED|Overall Study||7
490175|NCT00372593|1174975|P2|STARTED|Overall Study||532
490176|NCT00372593|1174976|P1|STARTED|Overall Study||531
490177|NCT00372567|1175005|P3|NOT COMPLETED|Phase 3 Study||12
490178|NCT00372567|1175006|P2|NOT COMPLETED|Phase 3 Study||26
490179|NCT00372567|1175007|P1|NOT COMPLETED|Phase 3 Study||31
490180|NCT00372567|1175005|P3|COMPLETED|Phase 3 Study||0
490181|NCT00372567|1175006|P2|COMPLETED|Phase 3 Study||0
490182|NCT00372567|1175007|P1|COMPLETED|Phase 3 Study||0
490183|NCT00372567|1175005|P3|Received Treatment|Phase 3 Study||12
490184|NCT00372567|1175006|P2|Received Treatment|Phase 3 Study||25
490185|NCT00372567|1175007|P1|Received Treatment|Phase 3 Study||31
490186|NCT00372567|1175005|P3|STARTED|Phase 3 Study||12
490187|NCT00372567|1175006|P2|STARTED|Phase 3 Study||26
490188|NCT00372567|1175007|P1|STARTED|Phase 3 Study||31
490189|NCT00372567|1175005|P3|NOT COMPLETED|Phase 1 Sub-study||0
490190|NCT00372567|1175006|P2|NOT COMPLETED|Phase 1 Sub-study||0
490191|NCT00372567|1175007|P1|NOT COMPLETED|Phase 1 Sub-study||0
490192|NCT00372567|1175005|P3|COMPLETED|Phase 1 Sub-study||12
490193|NCT00372567|1175006|P2|COMPLETED|Phase 1 Sub-study||0
490194|NCT00372567|1175007|P1|COMPLETED|Phase 1 Sub-study||0
490195|NCT00372567|1175005|P3|STARTED|Phase 1 Sub-study||12
490196|NCT00372567|1175006|P2|STARTED|Phase 1 Sub-study||0
490197|NCT00372567|1175007|P1|STARTED|Phase 1 Sub-study||0
490198|NCT00372528|1175035|P1|NOT COMPLETED|Overall Study||21
490199|NCT00372528|1175035|P1|COMPLETED|Overall Study||0
490200|NCT00372528|1175035|P1|STARTED|Overall Study||21
490201|NCT00372489|1175040|P1|NOT COMPLETED|Overall Study||79
490202|NCT00372489|1175040|P1|COMPLETED|Overall Study||2
490203|NCT00372489|1175040|P1|STARTED|Overall Study||81
490204|NCT00372424|1175044|P1|NOT COMPLETED|Overall Study||26
490205|NCT00372424|1175044|P1|COMPLETED|Overall Study||0
490206|NCT00372424|1175044|P1|Treated|Overall Study||25
490207|NCT00372424|1175044|P1|STARTED|Overall Study||26
490208|NCT00372411|1175058|P3|NOT COMPLETED|Overall Study||3
490209|NCT00372411|1175059|P2|NOT COMPLETED|Overall Study||8
490210|NCT00372411|1175060|P1|NOT COMPLETED|Overall Study||5
490211|NCT00372411|1175058|P3|COMPLETED|Overall Study||25
490212|NCT00372411|1175059|P2|COMPLETED|Overall Study||42
490213|NCT00372411|1175060|P1|COMPLETED|Overall Study||44
490214|NCT00372411|1175058|P3|STARTED|Overall Study||28
490215|NCT00372411|1175059|P2|STARTED|Overall Study||50
490216|NCT00372411|1175060|P1|STARTED|Overall Study||49
490217|NCT00372385|1175084|P4|NOT COMPLETED|Overall Study||8
490218|NCT00372385|1175085|P3|NOT COMPLETED|Overall Study||10
490219|NCT00372385|1175086|P2|NOT COMPLETED|Overall Study||20
490220|NCT00372385|1175087|P1|NOT COMPLETED|Overall Study||33
490221|NCT00372385|1175084|P4|COMPLETED|Overall Study||70
490222|NCT00372385|1175085|P3|COMPLETED|Overall Study||72
490223|NCT00372385|1175086|P2|COMPLETED|Overall Study||61
490224|NCT00372385|1175087|P1|COMPLETED|Overall Study||49
490225|NCT00372385|1175084|P4|STARTED|Overall Study||78
490226|NCT00372385|1175085|P3|STARTED|Overall Study||82
490227|NCT00372385|1175086|P2|STARTED|Overall Study||81
490228|NCT00372385|1175087|P1|STARTED|Overall Study||82
490229|NCT00372060|1175116|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
490230|NCT00372060|1175117|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
490231|NCT00372060|1175116|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
490232|NCT00372060|1175117|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
490233|NCT00372060|1175116|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
490234|NCT00372060|1175117|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
490235|NCT00372060|1175116|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
490236|NCT00372060|1175117|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
490237|NCT00372060|1175116|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
490238|NCT00372060|1175117|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
490239|NCT00372060|1175116|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
490240|NCT00372060|1175117|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
490241|NCT00371865|1175132|P2|NOT COMPLETED|Overall Study||14
490242|NCT00371865|1175133|P1|NOT COMPLETED|Overall Study||15
490243|NCT00371865|1175132|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
490244|NCT00371865|1175133|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
490245|NCT00371865|1175132|P2|STARTED|Overall Study||57
490246|NCT00371865|1175133|P1|STARTED|Overall Study||57
490247|NCT00371839|1175150|P3|NOT COMPLETED|Overall Study||2
490248|NCT00371839|1175151|P2|NOT COMPLETED|Overall Study||7
490249|NCT00371839|1175152|P1|NOT COMPLETED|Overall Study||17
490250|NCT00371839|1175150|P3|COMPLETED|Overall Study||7
490251|NCT00371839|1175151|P2|COMPLETED|Overall Study||13
490252|NCT00371839|1175152|P1|COMPLETED|Overall Study||32
490253|NCT00371839|1175150|P3|STARTED|Overall Study||9
490254|NCT00371839|1175151|P2|STARTED|Overall Study||20
490255|NCT00371839|1175152|P1|STARTED|Overall Study||49
490256|NCT00371826|1175161|P3|NOT COMPLETED|Extension Phase (24 Months)||2
490257|NCT00371826|1175162|P2|NOT COMPLETED|Extension Phase (24 Months)||10
490258|NCT00371826|1175163|P1|NOT COMPLETED|Extension Phase (24 Months)||5
490259|NCT00371826|1175161|P3|COMPLETED|Extension Phase (24 Months)||3
490260|NCT00371826|1175162|P2|COMPLETED|Extension Phase (24 Months)||29
490261|NCT00371826|1175163|P1|COMPLETED|Extension Phase (24 Months)||18
490262|NCT00371826|1175161|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
490263|NCT00371826|1175162|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
490264|NCT00371826|1175163|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
490265|NCT00371826|1175161|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
490266|NCT00371826|1175162|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
490267|NCT00371826|1175163|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
490268|NCT00371826|1175161|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
490269|NCT00371826|1175162|P2|STARTED|Extension Phase (24 Months)||39
490270|NCT00371826|1175163|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
490271|NCT00371826|1175161|P3|NOT COMPLETED|Core Phase (12 Months)||24
490272|NCT00371826|1175162|P2|NOT COMPLETED|Core Phase (12 Months)||8
490273|NCT00371826|1175163|P1|NOT COMPLETED|Core Phase (12 Months)||24
490274|NCT00371826|1175161|P3|COMPLETED|Core Phase (12 Months)||6
490275|NCT00371826|1175162|P2|COMPLETED|Core Phase (12 Months)||39
490276|NCT00371826|1175163|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
490277|NCT00371826|1175161|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
490278|NCT00371826|1175162|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
490279|NCT00371826|1175163|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
490280|NCT00371826|1175161|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
490281|NCT00371826|1175162|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
490282|NCT00371826|1175163|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
490283|NCT00371826|1175161|P3|STARTED|Core Phase (12 Months)||30
490284|NCT00371826|1175162|P2|STARTED|Core Phase (12 Months)||47
490285|NCT00371826|1175163|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
490286|NCT00371787|1175287|P2|NOT COMPLETED|Overall Study||1
490287|NCT00371787|1175288|P1|NOT COMPLETED|Overall Study||3
490288|NCT00371787|1175287|P2|COMPLETED|Overall Study||11
490289|NCT00371787|1175288|P1|COMPLETED|Overall Study||23
490290|NCT00371787|1175287|P2|STARTED|Overall Study||12
490291|NCT00371787|1175288|P1|STARTED|Overall Study||26
490292|NCT00371761|1175302|P2|NOT COMPLETED|Overall Study||10
490293|NCT00371761|1175303|P1|NOT COMPLETED|Overall Study||8
490294|NCT00371761|1175302|P2|COMPLETED|Overall Study||2
490295|NCT00371761|1175303|P1|COMPLETED|Overall Study||5
490296|NCT00371761|1175302|P2|STARTED|Overall Study||12
490297|NCT00371761|1175303|P1|STARTED|Overall Study||13
490298|NCT00371683|1175311|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
490299|NCT00371683|1175312|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
490300|NCT00371683|1175311|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
490301|NCT00371683|1175312|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
490302|NCT00371683|1175311|P2|STARTED|Follow-Up Period - Randomized Patients||1533
490303|NCT00371683|1175312|P1|STARTED|Follow-Up Period - Randomized Patients||1553
490304|NCT00371683|1175311|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
490305|NCT00371683|1175312|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
490306|NCT00371683|1175311|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
490307|NCT00371683|1175312|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
490308|NCT00371683|1175311|P2|STARTED|DB Treatment Period-Randomized Patients||1596
490309|NCT00371683|1175312|P1|STARTED|DB Treatment Period-Randomized Patients||1599
490310|NCT00371644|1175366|P2|NOT COMPLETED|Overall Study||13
490311|NCT00371644|1175367|P1|NOT COMPLETED|Overall Study||28
490312|NCT00371644|1175366|P2|COMPLETED|Overall Study||44
490313|NCT00371644|1175367|P1|COMPLETED|Overall Study||44
490314|NCT00371644|1175366|P2|STARTED|Overall Study||57
490315|NCT00371644|1175367|P1|STARTED|Overall Study||72
490316|NCT00371631|1175373|P1|NOT COMPLETED|Overall Study||0
490317|NCT00371631|1175373|P1|COMPLETED|Overall Study||13
490318|NCT00371631|1175373|P1|STARTED|Overall Study||13
490319|NCT00371566|1175380|P2|NOT COMPLETED|Follow Up Phase||7
490320|NCT00371566|1175381|P1|NOT COMPLETED|Follow Up Phase||3
490321|NCT00371566|1175380|P2|COMPLETED|Follow Up Phase||58
490322|NCT00371566|1175381|P1|COMPLETED|Follow Up Phase||28
490323|NCT00371566|1175380|P2|STARTED|Follow Up Phase||65
490324|NCT00371566|1175381|P1|STARTED|Follow Up Phase||31
490325|NCT00371566|1175380|P2|NOT COMPLETED|Chemoradiation Phase||3
490326|NCT00371566|1175381|P1|NOT COMPLETED|Chemoradiation Phase||5
490327|NCT00371566|1175380|P2|COMPLETED|Chemoradiation Phase||65
490328|NCT00371566|1175381|P1|COMPLETED|Chemoradiation Phase||31
490329|NCT00371566|1175380|P2|STARTED|Chemoradiation Phase||68
490330|NCT00371566|1175381|P1|STARTED|Chemoradiation Phase||36
490331|NCT00371566|1175380|P2|NOT COMPLETED|Treatment Phase||3
490332|NCT00371566|1175381|P1|NOT COMPLETED|Treatment Phase||0
490333|NCT00371566|1175380|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
490334|NCT00371566|1175381|P1|COMPLETED|Treatment Phase||36
490335|NCT00371566|1175380|P2|STARTED|Treatment Phase||71
490336|NCT00371566|1175381|P1|STARTED|Treatment Phase||36
490337|NCT00371540|1175453|P2|NOT COMPLETED|Overall Study||9
490338|NCT00371540|1175454|P1|NOT COMPLETED|Overall Study||10
490339|NCT00371540|1175453|P2|COMPLETED|Overall Study||87
490340|NCT00371540|1175454|P1|COMPLETED|Overall Study||102
490341|NCT00371540|1175453|P2|STARTED|Overall Study||96
490342|NCT00371540|1175454|P1|STARTED|Overall Study||112
490343|NCT00371462|1175466|P2|NOT COMPLETED|Overall Study||8
490344|NCT00371462|1175467|P1|NOT COMPLETED|Overall Study||8
490345|NCT00371462|1175466|P2|COMPLETED|Overall Study||27
490346|NCT00371462|1175467|P1|COMPLETED|Overall Study||27
490347|NCT00371462|1175466|P2|STARTED|Overall Study||35
490348|NCT00371462|1175467|P1|STARTED|Overall Study||35
490349|NCT00371449|1175473|P1|NOT COMPLETED|Overall Study||0
490350|NCT00371449|1175473|P1|COMPLETED|Overall Study||120
490351|NCT00371449|1175473|P1|STARTED|Overall Study||120
490352|NCT00371436|1175484|P2|NOT COMPLETED|Overall Study||21
490353|NCT00371436|1175485|P1|NOT COMPLETED|Overall Study||34
490354|NCT00371436|1175484|P2|COMPLETED|Overall Study||68
490355|NCT00371436|1175485|P1|COMPLETED|Overall Study||58
490356|NCT00371436|1175484|P2|STARTED|Overall Study||89
490357|NCT00371436|1175485|P1|STARTED|Overall Study||92
490358|NCT00371397|1175491|P12|NOT COMPLETED|Session 3||0
490359|NCT00371397|1175492|P11|NOT COMPLETED|Session 3||0
490360|NCT00371397|1175493|P10|NOT COMPLETED|Session 3||0
490361|NCT00371397|1175494|P9|NOT COMPLETED|Session 3||0
490362|NCT00371397|1175495|P8|NOT COMPLETED|Session 3||0
490363|NCT00371397|1175496|P7|NOT COMPLETED|Session 3||0
490364|NCT00371397|1175497|P6|NOT COMPLETED|Session 3||0
490365|NCT00371397|1175498|P5|NOT COMPLETED|Session 3||0
490366|NCT00371397|1175499|P4|NOT COMPLETED|Session 3||0
490367|NCT00371397|1175500|P3|NOT COMPLETED|Session 3||0
490368|NCT00371397|1175501|P2|NOT COMPLETED|Session 3||0
490369|NCT00371397|1175502|P1|NOT COMPLETED|Session 3||0
490370|NCT00371397|1175491|P12|COMPLETED|Session 3||2
490371|NCT00371397|1175492|P11|COMPLETED|Session 3||4
490372|NCT00371397|1175493|P10|COMPLETED|Session 3||5
490373|NCT00371397|1175494|P9|COMPLETED|Session 3||6
490374|NCT00371397|1175495|P8|COMPLETED|Session 3||4
490375|NCT00371397|1175496|P7|COMPLETED|Session 3||4
490376|NCT00371397|1175497|P6|COMPLETED|Session 3||4
490377|NCT00371397|1175498|P5|COMPLETED|Session 3||3
490378|NCT00371397|1175499|P4|COMPLETED|Session 3||2
490379|NCT00371397|1175500|P3|COMPLETED|Session 3||5
490380|NCT00371397|1175501|P2|COMPLETED|Session 3||7
490381|NCT00371397|1175502|P1|COMPLETED|Session 3||4
490382|NCT00371397|1175491|P12|STARTED|Session 3||2
490383|NCT00371397|1175492|P11|STARTED|Session 3||4
490384|NCT00371397|1175493|P10|STARTED|Session 3||5
490385|NCT00371397|1175494|P9|STARTED|Session 3||6
490386|NCT00371397|1175495|P8|STARTED|Session 3||4
490387|NCT00371397|1175496|P7|STARTED|Session 3||4
490388|NCT00371397|1175497|P6|STARTED|Session 3||4
490389|NCT00371397|1175498|P5|STARTED|Session 3||3
490390|NCT00371397|1175499|P4|STARTED|Session 3||2
490391|NCT00371397|1175500|P3|STARTED|Session 3||5
490392|NCT00371397|1175501|P2|STARTED|Session 3||7
490393|NCT00371397|1175502|P1|STARTED|Session 3||4
490394|NCT00371397|1175491|P12|NOT COMPLETED|Session 2||0
490395|NCT00371397|1175492|P11|NOT COMPLETED|Session 2||0
490396|NCT00371397|1175493|P10|NOT COMPLETED|Session 2||0
490397|NCT00371397|1175494|P9|NOT COMPLETED|Session 2||0
490398|NCT00371397|1175495|P8|NOT COMPLETED|Session 2||0
490399|NCT00371397|1175496|P7|NOT COMPLETED|Session 2||0
490400|NCT00371397|1175497|P6|NOT COMPLETED|Session 2||0
490401|NCT00371397|1175498|P5|NOT COMPLETED|Session 2||0
490402|NCT00371397|1175499|P4|NOT COMPLETED|Session 2||0
490403|NCT00371397|1175500|P3|NOT COMPLETED|Session 2||0
490404|NCT00371397|1175501|P2|NOT COMPLETED|Session 2||0
490405|NCT00371397|1175502|P1|NOT COMPLETED|Session 2||0
490406|NCT00371397|1175491|P12|COMPLETED|Session 2||2
490407|NCT00371397|1175492|P11|COMPLETED|Session 2||4
490408|NCT00371397|1175493|P10|COMPLETED|Session 2||5
490409|NCT00371397|1175494|P9|COMPLETED|Session 2||6
490410|NCT00371397|1175495|P8|COMPLETED|Session 2||4
490411|NCT00371397|1175496|P7|COMPLETED|Session 2||4
490412|NCT00371397|1175497|P6|COMPLETED|Session 2||4
490413|NCT00371397|1175498|P5|COMPLETED|Session 2||3
490414|NCT00371397|1175499|P4|COMPLETED|Session 2||2
490415|NCT00371397|1175500|P3|COMPLETED|Session 2||5
490416|NCT00371397|1175501|P2|COMPLETED|Session 2||7
490417|NCT00371397|1175502|P1|COMPLETED|Session 2||4
490418|NCT00371397|1175491|P12|STARTED|Session 2||2
490419|NCT00371397|1175492|P11|STARTED|Session 2||4
490420|NCT00371397|1175493|P10|STARTED|Session 2||5
490421|NCT00371397|1175494|P9|STARTED|Session 2||6
490422|NCT00371397|1175495|P8|STARTED|Session 2||4
490423|NCT00371397|1175496|P7|STARTED|Session 2||4
490424|NCT00371397|1175497|P6|STARTED|Session 2||4
490425|NCT00371397|1175498|P5|STARTED|Session 2||3
490426|NCT00371397|1175499|P4|STARTED|Session 2||2
490427|NCT00371397|1175500|P3|STARTED|Session 2||5
490428|NCT00371397|1175501|P2|STARTED|Session 2||7
490429|NCT00371397|1175502|P1|STARTED|Session 2||4
490430|NCT00371397|1175491|P12|NOT COMPLETED|Session 1||0
490431|NCT00371397|1175492|P11|NOT COMPLETED|Session 1||0
490432|NCT00371397|1175493|P10|NOT COMPLETED|Session 1||0
490433|NCT00371397|1175494|P9|NOT COMPLETED|Session 1||0
490434|NCT00371397|1175495|P8|NOT COMPLETED|Session 1||1
490435|NCT00371397|1175496|P7|NOT COMPLETED|Session 1||0
490436|NCT00371397|1175497|P6|NOT COMPLETED|Session 1||0
490437|NCT00371397|1175498|P5|NOT COMPLETED|Session 1||0
490438|NCT00371397|1175499|P4|NOT COMPLETED|Session 1||0
490439|NCT00371397|1175500|P3|NOT COMPLETED|Session 1||0
490440|NCT00371397|1175501|P2|NOT COMPLETED|Session 1||0
490441|NCT00371397|1175502|P1|NOT COMPLETED|Session 1||1
490442|NCT00371397|1175491|P12|COMPLETED|Session 1||2
490443|NCT00371397|1175492|P11|COMPLETED|Session 1||4
490444|NCT00371397|1175493|P10|COMPLETED|Session 1||5
490445|NCT00371397|1175494|P9|COMPLETED|Session 1||6
490446|NCT00371397|1175495|P8|COMPLETED|Session 1||4
490447|NCT00371397|1175496|P7|COMPLETED|Session 1||4
490448|NCT00371397|1175497|P6|COMPLETED|Session 1||4
490449|NCT00371397|1175498|P5|COMPLETED|Session 1||3
490450|NCT00371397|1175499|P4|COMPLETED|Session 1||2
490451|NCT00371397|1175500|P3|COMPLETED|Session 1||5
490452|NCT00371397|1175501|P2|COMPLETED|Session 1||7
490453|NCT00371397|1175502|P1|COMPLETED|Session 1||4
490454|NCT00371397|1175491|P12|STARTED|Session 1||2
490455|NCT00371397|1175492|P11|STARTED|Session 1||4
490456|NCT00371397|1175493|P10|STARTED|Session 1||5
490457|NCT00371397|1175494|P9|STARTED|Session 1||6
490458|NCT00371397|1175495|P8|STARTED|Session 1||5
490459|NCT00371397|1175496|P7|STARTED|Session 1||4
490460|NCT00371397|1175497|P6|STARTED|Session 1||4
490461|NCT00371397|1175498|P5|STARTED|Session 1||3
490462|NCT00371397|1175499|P4|STARTED|Session 1||2
490463|NCT00371397|1175500|P3|STARTED|Session 1||5
490464|NCT00371397|1175501|P2|STARTED|Session 1||7
490465|NCT00371397|1175502|P1|STARTED|Session 1||5
490466|NCT00371345|1175510|P2|NOT COMPLETED|Overall Study||46
490467|NCT00371345|1175511|P1|NOT COMPLETED|Overall Study||24
490468|NCT00371345|1175510|P2|COMPLETED|Overall Study||0
490469|NCT00371345|1175511|P1|COMPLETED|Overall Study||0
490470|NCT00371345|1175510|P2|STARTED|Overall Study||46
490471|NCT00371345|1175511|P1|STARTED|Overall Study||24
490472|NCT00371293|1175571|P3|NOT COMPLETED|Overall Study||16
490473|NCT00371293|1175572|P2|NOT COMPLETED|Overall Study||19
490474|NCT00371293|1175573|P1|NOT COMPLETED|Overall Study||10
490475|NCT00371293|1175571|P3|COMPLETED|Overall Study||46
490476|NCT00371293|1175572|P2|COMPLETED|Overall Study||42
490477|NCT00371293|1175573|P1|COMPLETED|Overall Study||48
490478|NCT00371293|1175571|P3|STARTED|Overall Study||62
490479|NCT00371293|1175572|P2|STARTED|Overall Study||61
490480|NCT00371293|1175573|P1|STARTED|Overall Study||58
490481|NCT00371267|1175595|P2|NOT COMPLETED|Overall Study||18
490482|NCT00371267|1175596|P1|NOT COMPLETED|Overall Study||9
490483|NCT00371267|1175595|P2|COMPLETED|Overall Study||32
490484|NCT00371267|1175596|P1|COMPLETED|Overall Study||39
490485|NCT00371267|1175595|P2|STARTED|Overall Study||50
490486|NCT00371267|1175596|P1|STARTED|Overall Study||48
490487|NCT00371254|1175612|P2|NOT COMPLETED|Overall Study||21
490488|NCT00371254|1175613|P1|NOT COMPLETED|Overall Study||23
490489|NCT00371254|1175612|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
490490|NCT00371254|1175613|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
490491|NCT00371254|1175612|P2|STARTED|Overall Study|Number of participants treated|21
490492|NCT00371254|1175613|P1|STARTED|Overall Study|Number of participants treated|23
490493|NCT00371176|1175665|P2|NOT COMPLETED|Overall Study||8
490494|NCT00371176|1175666|P1|NOT COMPLETED|Overall Study||5
490495|NCT00371176|1175665|P2|COMPLETED|Overall Study||5
490496|NCT00371176|1175666|P1|COMPLETED|Overall Study||8
490497|NCT00371176|1175665|P2|Completed Treatment|Overall Study||9
490498|NCT00371176|1175666|P1|Completed Treatment|Overall Study||10
490499|NCT00371176|1175665|P2|STARTED|Overall Study||13
490500|NCT00371176|1175666|P1|STARTED|Overall Study||13
490501|NCT00371150|1175696|P2|NOT COMPLETED|Overall Study||2
490502|NCT00371150|1175697|P1|NOT COMPLETED|Overall Study||3
490503|NCT00371150|1175696|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
490504|NCT00371150|1175697|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
490505|NCT00371150|1175696|P2|Discontinued at or After Week 48 Visit|Overall Study||1
490506|NCT00371150|1175697|P1|Discontinued at or After Week 48 Visit|Overall Study||2
490507|NCT00371150|1175696|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
490508|NCT00371150|1175697|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
490509|NCT00371150|1175696|P2|STARTED|Overall Study||6
490510|NCT00371150|1175697|P1|STARTED|Overall Study||40
490511|NCT00371137|1175732|P3|NOT COMPLETED|Overall Study||79
490512|NCT00371137|1175733|P2|NOT COMPLETED|Overall Study||63
490513|NCT00371137|1175734|P1|NOT COMPLETED|Overall Study||72
490514|NCT00371137|1175732|P3|COMPLETED|Overall Study||104
490515|NCT00371137|1175733|P2|COMPLETED|Overall Study||119
490516|NCT00371137|1175734|P1|COMPLETED|Overall Study||111
490517|NCT00371137|1175732|P3|Treated|Overall Study||182
490518|NCT00371137|1175733|P2|Treated|Overall Study||182
490519|NCT00371137|1175734|P1|Treated|Overall Study||183
490520|NCT00371137|1175732|P3|STARTED|Overall Study||183
490521|NCT00371137|1175733|P2|STARTED|Overall Study||182
490522|NCT00371137|1175734|P1|STARTED|Overall Study||183
490523|NCT00370994|1175744|P2|NOT COMPLETED|Overall Study||0
490524|NCT00370994|1175745|P1|NOT COMPLETED|Overall Study||0
490525|NCT00370994|1175744|P2|COMPLETED|Overall Study||60
490526|NCT00370994|1175745|P1|COMPLETED|Overall Study||60
490527|NCT00370994|1175744|P2|STARTED|Overall Study||60
490528|NCT00370994|1175745|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
490529|NCT00370838|1175755|P2|NOT COMPLETED|Taper||0
490530|NCT00370838|1175756|P1|NOT COMPLETED|Taper||0
490531|NCT00370838|1175755|P2|COMPLETED|Taper||3
490532|NCT00370838|1175756|P1|COMPLETED|Taper||7
490533|NCT00370838|1175755|P2|STARTED|Taper||3
490534|NCT00370838|1175756|P1|STARTED|Taper||7
490535|NCT00370838|1175755|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
490536|NCT00370838|1175756|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
490537|NCT00370838|1175755|P2|COMPLETED|Period 2 (Days 65-107)||3
490538|NCT00370838|1175756|P1|COMPLETED|Period 2 (Days 65-107)||7
490539|NCT00370838|1175755|P2|STARTED|Period 2 (Days 65-107)||3
490540|NCT00370838|1175756|P1|STARTED|Period 2 (Days 65-107)||7
490541|NCT00370838|1175755|P2|NOT COMPLETED|Washout (Days 51-64)||0
490542|NCT00370838|1175756|P1|NOT COMPLETED|Washout (Days 51-64)||0
490543|NCT00370838|1175755|P2|COMPLETED|Washout (Days 51-64)||3
490544|NCT00370838|1175756|P1|COMPLETED|Washout (Days 51-64)||7
490545|NCT00370838|1175755|P2|STARTED|Washout (Days 51-64)||3
490546|NCT00370838|1175756|P1|STARTED|Washout (Days 51-64)||7
490547|NCT00370838|1175755|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
490548|NCT00370838|1175756|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
490549|NCT00370838|1175755|P2|COMPLETED|Period 1 (Days 8-50)||3
490550|NCT00370838|1175756|P1|COMPLETED|Period 1 (Days 8-50)||7
490551|NCT00370838|1175755|P2|STARTED|Period 1 (Days 8-50)||3
490552|NCT00370838|1175756|P1|STARTED|Period 1 (Days 8-50)||7
490553|NCT00370682|1175777|P3|NOT COMPLETED|Overall Study||1
490554|NCT00370682|1175778|P2|NOT COMPLETED|Overall Study||3
490555|NCT00370682|1175779|P1|NOT COMPLETED|Overall Study||0
490556|NCT00370682|1175777|P3|COMPLETED|Overall Study||39
490557|NCT00370682|1175778|P2|COMPLETED|Overall Study||37
490558|NCT00370682|1175779|P1|COMPLETED|Overall Study||40
490559|NCT00370682|1175777|P3|STARTED|Overall Study||40
490560|NCT00370682|1175778|P2|STARTED|Overall Study||40
490561|NCT00370682|1175779|P1|STARTED|Overall Study||40
490562|NCT00370552|1175821|P3|NOT COMPLETED|Overall Study||32
490563|NCT00370552|1175822|P2|NOT COMPLETED|Overall Study||45
490564|NCT00370552|1175823|P1|NOT COMPLETED|Overall Study||46
490565|NCT00370552|1175821|P3|COMPLETED|Overall Study||0
490566|NCT00370552|1175822|P2|COMPLETED|Overall Study||0
490567|NCT00370552|1175823|P1|COMPLETED|Overall Study||0
490568|NCT00370552|1175821|P3|STARTED|Overall Study|Randomized|32
490569|NCT00370552|1175822|P2|STARTED|Overall Study|Randomized|45
490570|NCT00370552|1175823|P1|STARTED|Overall Study|Randomized|46
490571|NCT00370331|1175863|P2|NOT COMPLETED|Overall Study||23
490572|NCT00370331|1175864|P1|NOT COMPLETED|Overall Study||7
490573|NCT00370331|1175863|P2|COMPLETED|Overall Study||112
490574|NCT00370331|1175864|P1|COMPLETED|Overall Study||55
490575|NCT00370331|1175863|P2|STARTED|Overall Study||135
490576|NCT00370331|1175864|P1|STARTED|Overall Study||62
490577|NCT00370292|1175890|P1|NOT COMPLETED|Overall Study||13
490578|NCT00370292|1175890|P1|COMPLETED|Overall Study||6
490579|NCT00370292|1175890|P1|STARTED|Overall Study||19
490580|NCT00370149|1175903|P2|NOT COMPLETED|Overall Study||19
490581|NCT00370149|1175904|P1|NOT COMPLETED|Overall Study||19
490582|NCT00370149|1175903|P2|COMPLETED|Overall Study||142
490583|NCT00370149|1175904|P1|COMPLETED|Overall Study||146
490584|NCT00370149|1175903|P2|STARTED|Overall Study||161
490585|NCT00370149|1175904|P1|STARTED|Overall Study||165
490586|NCT00370071|1175914|P1|NOT COMPLETED|Overall Study||2
490587|NCT00370071|1175914|P1|COMPLETED|Overall Study||37
490588|NCT00370071|1175914|P1|STARTED|Overall Study||39
490589|NCT00370032|1175931|P2|NOT COMPLETED|Follow-up Period||0
490590|NCT00370032|1175932|P1|NOT COMPLETED|Follow-up Period||1
490591|NCT00370032|1175931|P2|COMPLETED|Follow-up Period||22
490592|NCT00370032|1175932|P1|COMPLETED|Follow-up Period||22
490593|NCT00370032|1175931|P2|STARTED|Follow-up Period||22
490594|NCT00370032|1175932|P1|STARTED|Follow-up Period||23
490595|NCT00370032|1175931|P2|NOT COMPLETED|Treatment Period 2||0
490596|NCT00370032|1175932|P1|NOT COMPLETED|Treatment Period 2||0
490597|NCT00370032|1175931|P2|COMPLETED|Treatment Period 2||22
490598|NCT00370032|1175932|P1|COMPLETED|Treatment Period 2||23
490599|NCT00370032|1175931|P2|STARTED|Treatment Period 2||22
490600|NCT00370032|1175932|P1|STARTED|Treatment Period 2||23
490601|NCT00370032|1175931|P2|NOT COMPLETED|Washout Period||2
490602|NCT00370032|1175932|P1|NOT COMPLETED|Washout Period||1
490603|NCT00370032|1175931|P2|COMPLETED|Washout Period||22
490604|NCT00370032|1175932|P1|COMPLETED|Washout Period||23
490605|NCT00370032|1175931|P2|STARTED|Washout Period||24
490606|NCT00370032|1175932|P1|STARTED|Washout Period||24
490607|NCT00370032|1175931|P2|NOT COMPLETED|Treatment Period 1||1
490608|NCT00370032|1175932|P1|NOT COMPLETED|Treatment Period 1||0
490609|NCT00370032|1175931|P2|COMPLETED|Treatment Period 1||24
490610|NCT00370032|1175932|P1|COMPLETED|Treatment Period 1||24
490611|NCT00370032|1175931|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
490612|NCT00370032|1175932|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
490613|NCT00369967|1175952|P2|NOT COMPLETED|Overall Study||12
490614|NCT00369967|1175953|P1|NOT COMPLETED|Overall Study||23
490615|NCT00369967|1175952|P2|COMPLETED|Overall Study||5
490616|NCT00369967|1175953|P1|COMPLETED|Overall Study||8
490617|NCT00369967|1175952|P2|STARTED|Overall Study||17
490618|NCT00369967|1175953|P1|STARTED|Overall Study||31
490619|NCT00369941|1175971|P2|NOT COMPLETED|Overall Study||100
490620|NCT00369941|1175972|P1|NOT COMPLETED|Overall Study||72
490621|NCT00369941|1175971|P2|COMPLETED|Overall Study||184
490622|NCT00369941|1175972|P1|COMPLETED|Overall Study||210
490623|NCT00369941|1175971|P2|Treated|Overall Study||282
490624|NCT00369941|1175972|P1|Treated|Overall Study||281
490625|NCT00369941|1175971|P2|STARTED|Overall Study||284
490626|NCT00369941|1175972|P1|STARTED|Overall Study||282
490627|NCT00369928|1176125|P3|NOT COMPLETED|Overall Study||20
490628|NCT00369928|1176126|P2|NOT COMPLETED|Overall Study||16
490629|NCT00369928|1176127|P1|NOT COMPLETED|Overall Study||8
490630|NCT00369928|1176125|P3|COMPLETED|Overall Study||66
490631|NCT00369928|1176126|P2|COMPLETED|Overall Study||69
490632|NCT00369928|1176127|P1|COMPLETED|Overall Study||77
490633|NCT00369928|1176125|P3|STARTED|Overall Study||86
490634|NCT00369928|1176126|P2|STARTED|Overall Study||85
490635|NCT00369928|1176127|P1|STARTED|Overall Study||85
490636|NCT00369915|1176137|P2|NOT COMPLETED|Overall Study||3
490637|NCT00369915|1176138|P1|NOT COMPLETED|Overall Study||6
490638|NCT00369915|1176137|P2|COMPLETED|Overall Study||4
490639|NCT00369915|1176138|P1|COMPLETED|Overall Study||4
490640|NCT00369915|1176137|P2|STARTED|Overall Study||7
490641|NCT00369915|1176138|P1|STARTED|Overall Study||10
490642|NCT00369824|1176152|P6|NOT COMPLETED|Overall Study||11
490643|NCT00369824|1176153|P5|NOT COMPLETED|Overall Study||18
490644|NCT00369824|1176154|P4|NOT COMPLETED|Overall Study||15
490645|NCT00369824|1176155|P3|NOT COMPLETED|Overall Study||12
490646|NCT00369824|1176156|P2|NOT COMPLETED|Overall Study||19
490647|NCT00369824|1176157|P1|NOT COMPLETED|Overall Study||15
490648|NCT00369824|1176152|P6|COMPLETED|Overall Study||204
490649|NCT00369824|1176153|P5|COMPLETED|Overall Study||196
490650|NCT00369824|1176154|P4|COMPLETED|Overall Study||199
490651|NCT00369824|1176155|P3|COMPLETED|Overall Study||202
490652|NCT00369824|1176156|P2|COMPLETED|Overall Study||195
490653|NCT00369824|1176157|P1|COMPLETED|Overall Study||197
490654|NCT00369824|1176152|P6|STARTED|Overall Study||215
490655|NCT00369824|1176153|P5|STARTED|Overall Study||214
490656|NCT00369824|1176154|P4|STARTED|Overall Study||214
490657|NCT00369824|1176155|P3|STARTED|Overall Study||214
490658|NCT00369824|1176156|P2|STARTED|Overall Study||214
490659|NCT00369824|1176157|P1|STARTED|Overall Study||212
490660|NCT00369785|1176257|P2|NOT COMPLETED|Overall Study||25
490661|NCT00369785|1176258|P1|NOT COMPLETED|Overall Study||27
490662|NCT00369785|1176257|P2|COMPLETED|Overall Study||74
490663|NCT00369785|1176258|P1|COMPLETED|Overall Study||72
490664|NCT00369785|1176257|P2|STARTED|Overall Study||99
490665|NCT00369785|1176258|P1|STARTED|Overall Study||99
490666|NCT00369746|1176268|P2|NOT COMPLETED|Overall Study||0
490667|NCT00369746|1176269|P1|NOT COMPLETED|Overall Study||0
490668|NCT00369746|1176268|P2|COMPLETED|Overall Study||536
490669|NCT00369746|1176269|P1|COMPLETED|Overall Study||138
490670|NCT00369746|1176268|P2|STARTED|Overall Study||536
490671|NCT00369746|1176269|P1|STARTED|Overall Study||138
490672|NCT00369681|1176279|P1|NOT COMPLETED|Overall Study||1
490673|NCT00369681|1176279|P1|COMPLETED|Overall Study||49
490674|NCT00369681|1176279|P1|STARTED|Overall Study||50
490675|NCT00369668|1176288|P3|NOT COMPLETED|Overall Study||7
490676|NCT00369668|1176289|P2|NOT COMPLETED|Overall Study||5
490677|NCT00369668|1176290|P1|NOT COMPLETED|Overall Study||4
490678|NCT00369668|1176288|P3|COMPLETED|Overall Study||3
490679|NCT00369668|1176289|P2|COMPLETED|Overall Study||5
490680|NCT00369668|1176290|P1|COMPLETED|Overall Study||6
490681|NCT00369668|1176288|P3|STARTED|Overall Study||10
490682|NCT00369668|1176289|P2|STARTED|Overall Study||10
490683|NCT00369668|1176290|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
490684|NCT00369655|1176304|P1|NOT COMPLETED|Overall Study||2
490685|NCT00369655|1176304|P1|COMPLETED|Overall Study||19
490686|NCT00369655|1176304|P1|STARTED|Overall Study||21
490687|NCT00369590|1176315|P2|NOT COMPLETED|Overall Study||0
490688|NCT00369590|1176316|P1|NOT COMPLETED|Overall Study||0
490689|NCT00369590|1176315|P2|COMPLETED|Overall Study||42
490690|NCT00369590|1176316|P1|COMPLETED|Overall Study||16
490691|NCT00369590|1176315|P2|STARTED|Overall Study||42
490692|NCT00369590|1176316|P1|STARTED|Overall Study||16
490693|NCT00369564|1176333|P2|NOT COMPLETED|Overall Study||23
490694|NCT00369564|1176334|P1|NOT COMPLETED|Overall Study||43
490695|NCT00369564|1176333|P2|COMPLETED|Overall Study||100
490696|NCT00369564|1176334|P1|COMPLETED|Overall Study||84
490697|NCT00369564|1176333|P2|STARTED|Overall Study||123
490698|NCT00369564|1176334|P1|STARTED|Overall Study||127
490699|NCT00369512|1176340|P1|NOT COMPLETED|Overall Study||0
490700|NCT00369512|1176340|P1|COMPLETED|Overall Study||15
490701|NCT00369512|1176340|P1|STARTED|Overall Study||15
490702|NCT00369486|1176351|P5|NOT COMPLETED|34-Week Visit||3
490703|NCT00369486|1176352|P4|NOT COMPLETED|34-Week Visit||3
490704|NCT00369486|1176353|P3|NOT COMPLETED|34-Week Visit||1
490705|NCT00369486|1176354|P2|NOT COMPLETED|34-Week Visit||1
490706|NCT00369486|1176355|P1|NOT COMPLETED|34-Week Visit||0
490707|NCT00369486|1176351|P5|COMPLETED|34-Week Visit|Number of eyes|22
490708|NCT00369486|1176352|P4|COMPLETED|34-Week Visit|Number of eyes|19
490709|NCT00369486|1176353|P3|COMPLETED|34-Week Visit|Number of eyes|22
490710|NCT00369486|1176354|P2|COMPLETED|34-Week Visit|Number of eyes|20
490711|NCT00369486|1176355|P1|COMPLETED|34-Week Visit|Number of eyes|38
490712|NCT00369486|1176351|P5|STARTED|34-Week Visit|Number of eyes that|25
490713|NCT00369486|1176352|P4|STARTED|34-Week Visit|Number of eyes|22
490714|NCT00369486|1176353|P3|STARTED|34-Week Visit|Number of eyes|23
490715|NCT00369486|1176354|P2|STARTED|34-Week Visit|Number of eyes|21
490716|NCT00369486|1176355|P1|STARTED|34-Week Visit|Number of eyes|38
490717|NCT00369486|1176351|P5|NOT COMPLETED|17-Week Visit||1
490718|NCT00369486|1176352|P4|NOT COMPLETED|17-Week Visit||1
490719|NCT00369486|1176353|P3|NOT COMPLETED|17-Week Visit||1
490720|NCT00369486|1176354|P2|NOT COMPLETED|17-Week Visit||0
490721|NCT00369486|1176355|P1|NOT COMPLETED|17-Week Visit||0
490722|NCT00369486|1176351|P5|COMPLETED|17-Week Visit|Number of eyes|24
490723|NCT00369486|1176352|P4|COMPLETED|17-Week Visit|Number of eyes|21
490724|NCT00369486|1176353|P3|COMPLETED|17-Week Visit|Number of eyes|22
490725|NCT00369486|1176354|P2|COMPLETED|17-Week Visit|Number of eyes|21
490726|NCT00369486|1176355|P1|COMPLETED|17-Week Visit|Number of eyes|38
490727|NCT00369486|1176351|P5|STARTED|17-Week Visit|Number of eyes|25
490728|NCT00369486|1176352|P4|STARTED|17-Week Visit|Number of eyes|22
490729|NCT00369486|1176353|P3|STARTED|17-Week Visit|Number of eyes|23
490730|NCT00369486|1176354|P2|STARTED|17-Week Visit|Number of eyes|21
490731|NCT00369486|1176355|P1|STARTED|17-Week Visit|Number of eyes|38
490732|NCT00369486|1176351|P5|NOT COMPLETED|8-Week Visit||1
490733|NCT00369486|1176352|P4|NOT COMPLETED|8-Week Visit||1
490734|NCT00369486|1176353|P3|NOT COMPLETED|8-Week Visit||0
490735|NCT00369486|1176354|P2|NOT COMPLETED|8-Week Visit||1
490736|NCT00369486|1176355|P1|NOT COMPLETED|8-Week Visit||0
490737|NCT00369486|1176351|P5|COMPLETED|8-Week Visit|Number of eyes|24
490738|NCT00369486|1176352|P4|COMPLETED|8-Week Visit|Number of eyes|21
490739|NCT00369486|1176353|P3|COMPLETED|8-Week Visit|Number of eyes|22
490740|NCT00369486|1176354|P2|COMPLETED|8-Week Visit|Number of eyes|20
490741|NCT00369486|1176355|P1|COMPLETED|8-Week Visit|Number of eyes|38
490742|NCT00369486|1176351|P5|STARTED|8-Week Visit|Number of eyes|25
490743|NCT00369486|1176352|P4|STARTED|8-Week Visit|Number of eyes|22
490744|NCT00369486|1176353|P3|STARTED|8-Week Visit|Number of eyes|22
490745|NCT00369486|1176354|P2|STARTED|8-Week Visit|Number of eyes|21
490746|NCT00369486|1176355|P1|STARTED|8-Week Visit|Number of eyes|38
490747|NCT00369486|1176351|P5|NOT COMPLETED|4-Week Visit||1
490748|NCT00369486|1176352|P4|NOT COMPLETED|4-Week Visit||2
490749|NCT00369486|1176353|P3|NOT COMPLETED|4-Week Visit||1
490750|NCT00369486|1176354|P2|NOT COMPLETED|4-Week Visit||2
490751|NCT00369486|1176355|P1|NOT COMPLETED|4-Week Visit||2
490752|NCT00369486|1176351|P5|COMPLETED|4-Week Visit|Number of eyes|24
490753|NCT00369486|1176352|P4|COMPLETED|4-Week Visit|Number of eyes|20
490754|NCT00369486|1176353|P3|COMPLETED|4-Week Visit|Number of eyes|22
490755|NCT00369486|1176354|P2|COMPLETED|4-Week Visit|Number of eyes;|19
490756|NCT00369486|1176355|P1|COMPLETED|4-Week Visit|Number of eyes|36
490757|NCT00369486|1176351|P5|STARTED|4-Week Visit|Number of eyes|25
490758|NCT00369486|1176352|P4|STARTED|4-Week Visit|Number of eyes|22
490759|NCT00369486|1176353|P3|STARTED|4-Week Visit|Number of eyes|23
490760|NCT00369486|1176354|P2|STARTED|4-Week Visit|Number of eyes|21
490761|NCT00369486|1176355|P1|STARTED|4-Week Visit|Number of eyes|38
490762|NCT00369382|1176394|P2|NOT COMPLETED|Overall Study||3
490763|NCT00369382|1176395|P1|NOT COMPLETED|Overall Study||10
490764|NCT00369382|1176394|P2|COMPLETED|Overall Study||54
490765|NCT00369382|1176395|P1|COMPLETED|Overall Study||49
490766|NCT00369382|1176394|P2|Completed Assigned Treatment Regimen|Overall Study||33
490767|NCT00369382|1176395|P1|Completed Assigned Treatment Regimen|Overall Study||48
490768|NCT00369382|1176394|P2|Received Treatment|Overall Study||57
490769|NCT00369382|1176395|P1|Received Treatment|Overall Study||57
490770|NCT00369382|1176394|P2|STARTED|Overall Study||57
490771|NCT00369382|1176395|P1|STARTED|Overall Study||59
490772|NCT00369343|1176428|P2|NOT COMPLETED|Open-label Phase||30
490773|NCT00369343|1176429|P1|NOT COMPLETED|Open-label Phase||57
490774|NCT00369343|1176428|P2|COMPLETED|Open-label Phase||79
490775|NCT00369343|1176429|P1|COMPLETED|Open-label Phase||155
490776|NCT00369343|1176428|P2|STARTED|Open-label Phase||109
490777|NCT00369343|1176429|P1|STARTED|Open-label Phase||212
490778|NCT00369343|1176428|P2|NOT COMPLETED|Double-blind Phase||16
490779|NCT00369343|1176429|P1|NOT COMPLETED|Double-blind Phase||44
490780|NCT00369343|1176428|P2|COMPLETED|Double-blind Phase||109
490781|NCT00369343|1176429|P1|COMPLETED|Double-blind Phase||212
490782|NCT00369343|1176428|P2|STARTED|Double-blind Phase||125
490783|NCT00369343|1176429|P1|STARTED|Double-blind Phase||256
490784|NCT00369317|1176462|P1|NOT COMPLETED|Overall Study||20
490785|NCT00369317|1176462|P1|COMPLETED|Overall Study||185
490786|NCT00369317|1176462|P1|STARTED|Overall Study||205
490787|NCT00369278|1176469|P2|NOT COMPLETED|Overall Study||21
490788|NCT00369278|1176470|P1|NOT COMPLETED|Overall Study||24
490789|NCT00369278|1176469|P2|COMPLETED|Overall Study||44
490790|NCT00369278|1176470|P1|COMPLETED|Overall Study||39
490791|NCT00369278|1176469|P2|STARTED|Overall Study||65
490792|NCT00369278|1176470|P1|STARTED|Overall Study||63
490793|NCT00369265|1176486|P2|NOT COMPLETED|Overall Study||7
490794|NCT00369265|1176487|P1|NOT COMPLETED|Overall Study||4
490795|NCT00369265|1176486|P2|COMPLETED|Overall Study||0
490796|NCT00369265|1176487|P1|COMPLETED|Overall Study||0
490797|NCT00369265|1176486|P2|STARTED|Overall Study||7
490798|NCT00369265|1176487|P1|STARTED|Overall Study||4
490799|NCT00369226|1176495|P2|NOT COMPLETED|Phase II (45 Days)||0
490800|NCT00369226|1176496|P1|NOT COMPLETED|Phase II (45 Days)||0
490801|NCT00369226|1176495|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
490802|NCT00369226|1176496|P1|COMPLETED|Phase II (45 Days)||0
490803|NCT00369226|1176495|P2|STARTED|Phase II (45 Days)||32
490804|NCT00369226|1176496|P1|STARTED|Phase II (45 Days)||0
490805|NCT00369226|1176495|P2|NOT COMPLETED|Phase I (45 Days)||0
490806|NCT00369226|1176496|P1|NOT COMPLETED|Phase I (45 Days)||0
490807|NCT00369226|1176495|P2|COMPLETED|Phase I (45 Days)||0
490808|NCT00369226|1176496|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
490809|NCT00369226|1176495|P2|STARTED|Phase I (45 Days)||0
490810|NCT00369226|1176496|P1|STARTED|Phase I (45 Days)||13
490811|NCT00369161|1176508|P2|NOT COMPLETED|Overall Study||24
490812|NCT00369161|1176509|P1|NOT COMPLETED|Overall Study||27
490813|NCT00369161|1176508|P2|COMPLETED|Overall Study||95
490814|NCT00369161|1176509|P1|COMPLETED|Overall Study||82
490815|NCT00369161|1176508|P2|Intention to Treat (ITT)|Overall Study||117
490816|NCT00369161|1176509|P1|Intention to Treat (ITT)|Overall Study||107
490817|NCT00369161|1176508|P2|STARTED|Overall Study||119
490818|NCT00369161|1176509|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
490819|NCT00369122|1176519|P1|NOT COMPLETED|Overall Study||11
490820|NCT00369122|1176519|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
490821|NCT00369122|1176519|P1|STARTED|Overall Study||60
490822|NCT00368992|1176523|P1|NOT COMPLETED|Overall Study||110
490823|NCT00368992|1176523|P1|COMPLETED|Overall Study||0
490824|NCT00368992|1176523|P1|STARTED|Overall Study||110
490825|NCT00368979|1176532|P2|NOT COMPLETED|Overall Study||30
490826|NCT00368979|1176533|P1|NOT COMPLETED|Overall Study||25
490827|NCT00368979|1176532|P2|COMPLETED|Overall Study||163
490828|NCT00368979|1176533|P1|COMPLETED|Overall Study||160
490829|NCT00368979|1176532|P2|STARTED|Overall Study||193
490830|NCT00368979|1176533|P1|STARTED|Overall Study||185
490831|NCT00368966|1176549|P2|NOT COMPLETED|Toddler Dose||3
490832|NCT00368966|1176550|P1|NOT COMPLETED|Toddler Dose||1
490833|NCT00368966|1176549|P2|COMPLETED|Toddler Dose||286
490834|NCT00368966|1176550|P1|COMPLETED|Toddler Dose||292
490835|NCT00368966|1176549|P2|STARTED|Toddler Dose||289
490836|NCT00368966|1176550|P1|STARTED|Toddler Dose||293
490837|NCT00368966|1176549|P2|NOT COMPLETED|After Infant||5
490838|NCT00368966|1176550|P1|NOT COMPLETED|After Infant||6
490839|NCT00368966|1176549|P2|COMPLETED|After Infant||289
490840|NCT00368966|1176550|P1|COMPLETED|After Infant||293
490841|NCT00368966|1176549|P2|STARTED|After Infant||294
490842|NCT00368966|1176550|P1|STARTED|After Infant||299
490843|NCT00368966|1176549|P2|NOT COMPLETED|Infant Series||10
490844|NCT00368966|1176550|P1|NOT COMPLETED|Infant Series||16
490845|NCT00368966|1176549|P2|COMPLETED|Infant Series||294
490846|NCT00368966|1176550|P1|COMPLETED|Infant Series||299
490847|NCT00368966|1176549|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
490848|NCT00368966|1176550|P1|Vaccinated Dose 3|Infant Series||301
490849|NCT00368966|1176549|P2|Vaccinated Dose 2|Infant Series||298
490850|NCT00368966|1176550|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
490851|NCT00368966|1176549|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
490852|NCT00368966|1176550|P1|Vaccinated Dose 1|Infant Series||314
490853|NCT00368966|1176549|P2|STARTED|Infant Series||304
490854|NCT00368966|1176550|P1|STARTED|Infant Series||315
490855|NCT00368927|1176606|P2|NOT COMPLETED|Overall Study||3
490856|NCT00368927|1176607|P1|NOT COMPLETED|Overall Study||5
490857|NCT00368927|1176606|P2|COMPLETED|Overall Study||27
490858|NCT00368927|1176607|P1|COMPLETED|Overall Study||26
490859|NCT00368927|1176606|P2|STARTED|Overall Study||30
490860|NCT00368927|1176607|P1|STARTED|Overall Study||31
490861|NCT00368875|1176615|P2|NOT COMPLETED|Overall Study||48
490862|NCT00368875|1176616|P1|NOT COMPLETED|Overall Study||6
490863|NCT00368875|1176615|P2|COMPLETED|Overall Study||0
490864|NCT00368875|1176616|P1|COMPLETED|Overall Study||0
490865|NCT00368875|1176615|P2|STARTED|Overall Study||48
490866|NCT00368875|1176616|P1|STARTED|Overall Study||6
490867|NCT00368849|1176624|P2|NOT COMPLETED|Overall Study||2
490868|NCT00368849|1176625|P1|NOT COMPLETED|Overall Study||0
490869|NCT00368849|1176624|P2|COMPLETED|Overall Study||8
490870|NCT00368849|1176625|P1|COMPLETED|Overall Study||10
490871|NCT00368849|1176624|P2|STARTED|Overall Study||10
490872|NCT00368849|1176625|P1|STARTED|Overall Study||10
490873|NCT00368745|1176641|P2|NOT COMPLETED|Double-blind Treatment Period||31
490874|NCT00368745|1176642|P1|NOT COMPLETED|Double-blind Treatment Period||26
490875|NCT00368745|1176641|P2|COMPLETED|Double-blind Treatment Period||19
490876|NCT00368745|1176642|P1|COMPLETED|Double-blind Treatment Period||30
490877|NCT00368745|1176641|P2|STARTED|Double-blind Treatment Period||50
490878|NCT00368745|1176642|P1|STARTED|Double-blind Treatment Period||56
490879|NCT00368745|1176641|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
490880|NCT00368745|1176642|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
490881|NCT00368745|1176641|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
490882|NCT00368745|1176642|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
490883|NCT00368745|1176641|P2|STARTED|Randomized to Double-blind Treatment||51
490884|NCT00368745|1176642|P1|STARTED|Randomized to Double-blind Treatment||57
490885|NCT00368641|1176674|P2|NOT COMPLETED|Overall Study||6
490886|NCT00368641|1176675|P1|NOT COMPLETED|Overall Study||6
490887|NCT00368641|1176674|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
490888|NCT00368641|1176675|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
490889|NCT00368641|1176674|P2|STARTED|Overall Study||6
490890|NCT00368641|1176675|P1|STARTED|Overall Study||6
490891|NCT00368550|1176683|P2|NOT COMPLETED|Overall Study||23
490892|NCT00368550|1176684|P1|NOT COMPLETED|Overall Study||28
490893|NCT00368550|1176683|P2|COMPLETED|Overall Study||48
490894|NCT00368550|1176684|P1|COMPLETED|Overall Study||35
490895|NCT00368550|1176683|P2|STARTED|Overall Study||71
490896|NCT00368550|1176684|P1|STARTED|Overall Study||63
490897|NCT00368537|1176696|P2|NOT COMPLETED|Baseline Participants||24
490898|NCT00368537|1176697|P1|NOT COMPLETED|Baseline Participants||24
490899|NCT00368537|1176696|P2|COMPLETED|Baseline Participants||239
490900|NCT00368537|1176697|P1|COMPLETED|Baseline Participants||244
490901|NCT00368537|1176696|P2|STARTED|Baseline Participants||263
490902|NCT00368537|1176697|P1|STARTED|Baseline Participants||268
490903|NCT00368537|1176696|P2|NOT COMPLETED|Randomization||6
490904|NCT00368537|1176697|P1|NOT COMPLETED|Randomization||13
490905|NCT00368537|1176696|P2|COMPLETED|Randomization||263
490906|NCT00368537|1176697|P1|COMPLETED|Randomization||268
490907|NCT00368537|1176696|P2|STARTED|Randomization||269
490908|NCT00368537|1176697|P1|STARTED|Randomization||281
490909|NCT00368472|1176711|P1|NOT COMPLETED|Overall Study||105
490910|NCT00368472|1176711|P1|COMPLETED|Overall Study||33
490911|NCT00368472|1176711|P1|STARTED|Overall Study||138
490912|NCT00368459|1176719|P2|NOT COMPLETED|Overall Study||1
490913|NCT00368459|1176720|P1|NOT COMPLETED|Overall Study||2
490914|NCT00368459|1176719|P2|COMPLETED|Overall Study||20
490915|NCT00368459|1176720|P1|COMPLETED|Overall Study||19
490916|NCT00368459|1176719|P2|STARTED|Overall Study||21
490917|NCT00368459|1176720|P1|STARTED|Overall Study||21
490918|NCT00367679|1176744|P1|NOT COMPLETED|Overall Study||0
490919|NCT00367679|1176744|P1|COMPLETED|Overall Study||35
490920|NCT00367679|1176744|P1|STARTED|Overall Study||35
490921|NCT00368316|1176763|P2|NOT COMPLETED|Overall Study||46
490922|NCT00368316|1176764|P1|NOT COMPLETED|Overall Study||42
490923|NCT00368316|1176763|P2|COMPLETED|Overall Study||1319
490924|NCT00368316|1176764|P1|COMPLETED|Overall Study||1392
490925|NCT00368316|1176763|P2|STARTED|Overall Study||1365
490926|NCT00368316|1176764|P1|STARTED|Overall Study||1434
490927|NCT00368290|1176776|P2|NOT COMPLETED|Overall Study||10
490928|NCT00368290|1176777|P1|NOT COMPLETED|Overall Study||13
490929|NCT00368290|1176776|P2|COMPLETED|Overall Study||37
490930|NCT00368290|1176777|P1|COMPLETED|Overall Study||34
490931|NCT00368290|1176776|P2|STARTED|Overall Study||47
490932|NCT00368290|1176777|P1|STARTED|Overall Study||47
490933|NCT00368277|1176787|P2|NOT COMPLETED|Overall Study||108
490934|NCT00368277|1176788|P1|NOT COMPLETED|Overall Study||113
490935|NCT00368277|1176787|P2|COMPLETED|Overall Study||336
490936|NCT00368277|1176788|P1|COMPLETED|Overall Study||344
490937|NCT00368277|1176787|P2|STARTED|Overall Study||444
490938|NCT00368277|1176788|P1|STARTED|Overall Study||457
490939|NCT00368251|1176803|P3|NOT COMPLETED|Overall Study||1
490940|NCT00368251|1176804|P2|NOT COMPLETED|Overall Study||0
490941|NCT00368251|1176805|P1|NOT COMPLETED|Overall Study||1
490942|NCT00368251|1176803|P3|COMPLETED|Overall Study||17
490943|NCT00368251|1176804|P2|COMPLETED|Overall Study||20
490944|NCT00368251|1176805|P1|COMPLETED|Overall Study||17
490945|NCT00368251|1176803|P3|STARTED|Overall Study||18
490946|NCT00368251|1176804|P2|STARTED|Overall Study||20
490947|NCT00368251|1176805|P1|STARTED|Overall Study||18
490948|NCT00368108|1176828|P3|NOT COMPLETED|Overall Study||68
490949|NCT00368108|1176829|P2|NOT COMPLETED|Overall Study||53
490950|NCT00368108|1176830|P1|NOT COMPLETED|Overall Study||64
490951|NCT00368108|1176828|P3|COMPLETED|Overall Study||182
490952|NCT00368108|1176829|P2|COMPLETED|Overall Study||198
490953|NCT00368108|1176830|P1|COMPLETED|Overall Study||187
490954|NCT00368108|1176828|P3|STARTED|Overall Study||250
490955|NCT00368108|1176829|P2|STARTED|Overall Study||251
490956|NCT00368108|1176830|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
490957|NCT00368069|1176849|P2|NOT COMPLETED|Overall Study||7
490958|NCT00368069|1176850|P1|NOT COMPLETED|Overall Study||8
490959|NCT00368069|1176849|P2|COMPLETED|Overall Study||72
490960|NCT00368069|1176850|P1|COMPLETED|Overall Study||71
490961|NCT00368069|1176849|P2|STARTED|Overall Study||79
490962|NCT00368069|1176850|P1|STARTED|Overall Study||79
490963|NCT00367991|1176868|P2|NOT COMPLETED|Overall Study||2
490964|NCT00367991|1176869|P1|NOT COMPLETED|Overall Study||2
490965|NCT00367991|1176868|P2|COMPLETED|Overall Study||13
490966|NCT00367991|1176869|P1|COMPLETED|Overall Study||27
490967|NCT00367991|1176868|P2|STARTED|Overall Study||15
490968|NCT00367991|1176869|P1|STARTED|Overall Study||29
490969|NCT00367835|1176877|P2|NOT COMPLETED|Overall Study||31
490970|NCT00367835|1176878|P1|NOT COMPLETED|Overall Study||29
490971|NCT00367835|1176877|P2|COMPLETED|Overall Study||48
490972|NCT00367835|1176878|P1|COMPLETED|Overall Study||109
490973|NCT00367835|1176877|P2|STARTED|Overall Study||79
490974|NCT00367835|1176878|P1|STARTED|Overall Study||138
490975|NCT00367770|1176904|P1|NOT COMPLETED|Overall Study||2
490976|NCT00367770|1176904|P1|COMPLETED|Overall Study||35
490977|NCT00367770|1176904|P1|STARTED|Overall Study||37
490978|NCT00367744|1176912|P2|NOT COMPLETED|Overall Study||5
490979|NCT00367744|1176913|P1|NOT COMPLETED|Overall Study||4
490980|NCT00367744|1176912|P2|COMPLETED|Overall Study||32
490981|NCT00367744|1176913|P1|COMPLETED|Overall Study||30
490982|NCT00367744|1176912|P2|STARTED|Overall Study||37
490983|NCT00367744|1176913|P1|STARTED|Overall Study||34
490984|NCT00367640|1176925|P4|NOT COMPLETED|Overall Study||10
490985|NCT00367640|1176926|P3|NOT COMPLETED|Overall Study||19
490986|NCT00367640|1176927|P2|NOT COMPLETED|Overall Study||22
490987|NCT00367640|1176928|P1|NOT COMPLETED|Overall Study||18
490988|NCT00367640|1176925|P4|COMPLETED|Overall Study||146
490989|NCT00367640|1176926|P3|COMPLETED|Overall Study||141
490990|NCT00367640|1176927|P2|COMPLETED|Overall Study||133
490991|NCT00367640|1176928|P1|COMPLETED|Overall Study||139
490992|NCT00367640|1176925|P4|STARTED|Overall Study||156
490993|NCT00367640|1176926|P3|STARTED|Overall Study||160
490994|NCT00367640|1176927|P2|STARTED|Overall Study||155
490995|NCT00367640|1176928|P1|STARTED|Overall Study||157
490996|NCT00367601|1176938|P1|NOT COMPLETED|Overall Study||0
490997|NCT00367601|1176938|P1|COMPLETED|Overall Study||25
490998|NCT00367601|1176938|P1|STARTED|Overall Study||25
490999|NCT00367484|1176944|P1|NOT COMPLETED|Overall Study||17
491000|NCT00367484|1176944|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
491001|NCT00367484|1176944|P1|STARTED|Overall Study||460
491002|NCT00367432|1176948|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
491003|NCT00367432|1176949|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
491004|NCT00367432|1176948|P2|COMPLETED|Second Period (up to 54 Months)||69
491005|NCT00367432|1176949|P1|COMPLETED|Second Period (up to 54 Months)||188
491006|NCT00367432|1176948|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
491007|NCT00367432|1176949|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
491008|NCT00367432|1176948|P2|NOT COMPLETED|First Period (16 Weeks)||0
491009|NCT00367432|1176949|P1|NOT COMPLETED|First Period (16 Weeks)||38
491010|NCT00367432|1176948|P2|COMPLETED|First Period (16 Weeks)||0
491011|NCT00367432|1176949|P1|COMPLETED|First Period (16 Weeks)||275
491012|NCT00367432|1176948|P2|STARTED|First Period (16 Weeks)||0
491013|NCT00367432|1176949|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
491014|NCT00367380|1176964|P3|NOT COMPLETED|Overall Study||0
491015|NCT00367380|1176965|P2|NOT COMPLETED|Overall Study||0
491016|NCT00367380|1176966|P1|NOT COMPLETED|Overall Study||0
491017|NCT00367380|1176964|P3|COMPLETED|Overall Study||6
491018|NCT00367380|1176965|P2|COMPLETED|Overall Study||6
491019|NCT00367380|1176966|P1|COMPLETED|Overall Study||6
491020|NCT00367380|1176964|P3|STARTED|Overall Study||6
491021|NCT00367380|1176965|P2|STARTED|Overall Study||6
491022|NCT00367380|1176966|P1|STARTED|Overall Study||6
491023|NCT00367341|1176976|P2|NOT COMPLETED|Overall Study||0
491024|NCT00367341|1176977|P1|NOT COMPLETED|Overall Study||2
491025|NCT00367341|1176976|P2|COMPLETED|Overall Study||40
491026|NCT00367341|1176977|P1|COMPLETED|Overall Study||40
491027|NCT00367341|1176976|P2|STARTED|Overall Study||40
491028|NCT00367341|1176977|P1|STARTED|Overall Study||42
491029|NCT00367237|1176987|P2|NOT COMPLETED|Overall Study||11
491030|NCT00367237|1176988|P1|NOT COMPLETED|Overall Study||10
491031|NCT00367237|1176987|P2|COMPLETED|Overall Study||47
491032|NCT00367237|1176988|P1|COMPLETED|Overall Study||47
491033|NCT00367237|1176987|P2|STARTED|Overall Study|Number of subjects randomized|58
491034|NCT00367237|1176988|P1|STARTED|Overall Study|Number of subjects randomized|57
491035|NCT00367133|1176997|P3|NOT COMPLETED|3 Years||18
491036|NCT00367133|1176998|P2|NOT COMPLETED|3 Years||23
491037|NCT00367133|1176999|P1|NOT COMPLETED|3 Years||28
491038|NCT00367133|1176997|P3|COMPLETED|3 Years||98
491039|NCT00367133|1176998|P2|COMPLETED|3 Years||93
491040|NCT00367133|1176999|P1|COMPLETED|3 Years||115
491041|NCT00367133|1176997|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
491042|NCT00367133|1176998|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
491043|NCT00367133|1176999|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
491044|NCT00367133|1176997|P3|NOT COMPLETED|2 Years||49
491045|NCT00367133|1176998|P2|NOT COMPLETED|2 Years||36
491046|NCT00367133|1176999|P1|NOT COMPLETED|2 Years||58
491047|NCT00367133|1176997|P3|COMPLETED|2 Years||205
491048|NCT00367133|1176998|P2|COMPLETED|2 Years||220
491049|NCT00367133|1176999|P1|COMPLETED|2 Years||272
491050|NCT00367133|1176997|P3|STARTED|2 Years|Number of Eyes|254
491051|NCT00367133|1176998|P2|STARTED|2 Years|Number of Eyes|256
491052|NCT00367133|1176999|P1|STARTED|2 Years|Number of Eyes|330
491053|NCT00367055|1177051|P2|NOT COMPLETED|Overall Study||11
491054|NCT00367055|1177052|P1|NOT COMPLETED|Overall Study||11
491055|NCT00367055|1177051|P2|COMPLETED|Overall Study||30
491056|NCT00367055|1177052|P1|COMPLETED|Overall Study||32
491057|NCT00367055|1177051|P2|STARTED|Overall Study||41
491058|NCT00367055|1177052|P1|STARTED|Overall Study||43
491059|NCT00366899|1177068|P2|NOT COMPLETED|Toddler Dose||1
491060|NCT00366899|1177069|P1|NOT COMPLETED|Toddler Dose||2
491061|NCT00366899|1177068|P2|COMPLETED|Toddler Dose||281
491062|NCT00366899|1177069|P1|COMPLETED|Toddler Dose||285
491063|NCT00366899|1177068|P2|STARTED|Toddler Dose||282
491064|NCT00366899|1177069|P1|STARTED|Toddler Dose||287
491065|NCT00366899|1177068|P2|NOT COMPLETED|After Infant Series||9
491066|NCT00366899|1177069|P1|NOT COMPLETED|After Infant Series||7
491067|NCT00366899|1177068|P2|COMPLETED|After Infant Series||282
491068|NCT00366899|1177069|P1|COMPLETED|After Infant Series||287
491069|NCT00366899|1177068|P2|STARTED|After Infant Series||291
491070|NCT00366899|1177069|P1|STARTED|After Infant Series||294
491071|NCT00366899|1177068|P2|NOT COMPLETED|Infant Series||12
491072|NCT00366899|1177069|P1|NOT COMPLETED|Infant Series||9
491073|NCT00366899|1177068|P2|COMPLETED|Infant Series||291
491074|NCT00366899|1177069|P1|COMPLETED|Infant Series||294
491075|NCT00366899|1177068|P2|Vaccinated Dose 2|Infant Series||293
491076|NCT00366899|1177069|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
491077|NCT00366899|1177068|P2|Vaccinated Dose 1|Infant Series||302
491078|NCT00366899|1177069|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
491079|NCT00366899|1177068|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
491080|NCT00366899|1177069|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
491081|NCT00366678|1177129|P3|NOT COMPLETED|Toddler Dose||0
491082|NCT00366678|1177130|P2|NOT COMPLETED|Toddler Dose||1
491083|NCT00366678|1177131|P1|NOT COMPLETED|Toddler Dose||5
491084|NCT00366678|1177129|P3|COMPLETED|Toddler Dose||137
491085|NCT00366678|1177130|P2|COMPLETED|Toddler Dose||151
491086|NCT00366678|1177131|P1|COMPLETED|Toddler Dose||268
491087|NCT00366678|1177129|P3|STARTED|Toddler Dose||137
491088|NCT00366678|1177130|P2|STARTED|Toddler Dose||152
491089|NCT00366678|1177131|P1|STARTED|Toddler Dose||273
491090|NCT00366678|1177129|P3|NOT COMPLETED|After Infant||0
491091|NCT00366678|1177130|P2|NOT COMPLETED|After Infant||10
491092|NCT00366678|1177131|P1|NOT COMPLETED|After Infant||17
491093|NCT00366678|1177129|P3|COMPLETED|After Infant||0
491094|NCT00366678|1177130|P2|COMPLETED|After Infant||289
491095|NCT00366678|1177131|P1|COMPLETED|After Infant||273
491096|NCT00366678|1177129|P3|STARTED|After Infant||0
491097|NCT00366678|1177130|P2|STARTED|After Infant||299
491098|NCT00366678|1177131|P1|STARTED|After Infant||290
491099|NCT00366678|1177129|P3|NOT COMPLETED|Infant Series||0
491100|NCT00366678|1177130|P2|NOT COMPLETED|Infant Series||10
491101|NCT00366678|1177131|P1|NOT COMPLETED|Infant Series||14
491102|NCT00366678|1177129|P3|COMPLETED|Infant Series||0
491103|NCT00366678|1177130|P2|COMPLETED|Infant Series||299
491104|NCT00366678|1177131|P1|COMPLETED|Infant Series||290
491105|NCT00366678|1177129|P3|Vaccinated Dose 3|Infant Series||0
491106|NCT00366678|1177130|P2|Vaccinated Dose 3|Infant Series||302
491107|NCT00366678|1177131|P1|Vaccinated Dose 3|Infant Series||291
491108|NCT00366678|1177129|P3|Vaccinated Dose 2|Infant Series||0
491109|NCT00366678|1177130|P2|Vaccinated Dose 2|Infant Series||304
491110|NCT00366678|1177131|P1|Vaccinated Dose 2|Infant Series||295
491111|NCT00366678|1177129|P3|Vaccinated Dose 1|Infant Series||0
491112|NCT00366678|1177130|P2|Vaccinated Dose 1|Infant Series||309
491113|NCT00366678|1177131|P1|Vaccinated Dose 1|Infant Series||302
491114|NCT00366678|1177129|P3|STARTED|Infant Series||0
491115|NCT00366678|1177130|P2|STARTED|Infant Series||309
491116|NCT00366678|1177131|P1|STARTED|Infant Series||304
491117|NCT00366626|1177198|P2|NOT COMPLETED|Overall Study||0
491118|NCT00366626|1177199|P1|NOT COMPLETED|Overall Study||0
491119|NCT00366626|1177198|P2|COMPLETED|Overall Study||45
491120|NCT00366626|1177199|P1|COMPLETED|Overall Study||38
491121|NCT00366626|1177198|P2|STARTED|Overall Study||45
491122|NCT00366626|1177199|P1|STARTED|Overall Study||38
491123|NCT00365872|1177214|P3|NOT COMPLETED|Overall Study||0
491124|NCT00365872|1177215|P2|NOT COMPLETED|Overall Study||0
491125|NCT00365872|1177216|P1|NOT COMPLETED|Overall Study||0
491126|NCT00365872|1177214|P3|COMPLETED|Overall Study||6
491127|NCT00365872|1177215|P2|COMPLETED|Overall Study||6
491128|NCT00365872|1177216|P1|COMPLETED|Overall Study||5
491129|NCT00365872|1177214|P3|STARTED|Overall Study||6
491130|NCT00365872|1177215|P2|STARTED|Overall Study||6
491131|NCT00365872|1177216|P1|STARTED|Overall Study||5
491132|NCT00365859|1177229|P4|NOT COMPLETED|Overall Study||131
491133|NCT00365859|1177230|P3|NOT COMPLETED|Overall Study||67
491134|NCT00365859|1177231|P2|NOT COMPLETED|Overall Study||33
491135|NCT00365859|1177232|P1|NOT COMPLETED|Overall Study||31
491136|NCT00365859|1177229|P4|COMPLETED|Overall Study||199
491137|NCT00365859|1177230|P3|COMPLETED|Overall Study||107
491138|NCT00365859|1177231|P2|COMPLETED|Overall Study||37
491139|NCT00365859|1177232|P1|COMPLETED|Overall Study||55
491140|NCT00365859|1177229|P4|Efficacy Population|Overall Study||322
491227|NCT00365716|1177349|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
491141|NCT00365859|1177230|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
491142|NCT00365859|1177231|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
491143|NCT00365859|1177232|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
491144|NCT00365859|1177229|P4|Safety Population|Overall Study||330
491145|NCT00365859|1177230|P3|Safety Population|Overall Study||174
491146|NCT00365859|1177231|P2|Safety Population|Overall Study||70
491147|NCT00365859|1177232|P1|Safety Population|Overall Study||86
491148|NCT00365859|1177229|P4|STARTED|Overall Study||330
491149|NCT00365859|1177230|P3|STARTED|Overall Study||174
491150|NCT00365859|1177231|P2|STARTED|Overall Study||70
491151|NCT00365859|1177232|P1|STARTED|Overall Study||86
491152|NCT00365846|1177321|P1|NOT COMPLETED|Overall Study||1
491153|NCT00365846|1177321|P1|COMPLETED|Overall Study||28
491154|NCT00365846|1177321|P1|STARTED|Overall Study||29
491155|NCT00365768|1177332|P2|NOT COMPLETED|Overall Study||0
491156|NCT00365768|1177333|P1|NOT COMPLETED|Overall Study||0
491157|NCT00365768|1177332|P2|COMPLETED|Overall Study||25
491158|NCT00365768|1177333|P1|COMPLETED|Overall Study||24
491159|NCT00365768|1177332|P2|STARTED|Overall Study||25
491160|NCT00365768|1177333|P1|STARTED|Overall Study||24
491161|NCT00365716|1177346|P7|NOT COMPLETED|Extension 2||10
491162|NCT00365716|1177347|P6|NOT COMPLETED|Extension 2||0
491163|NCT00365716|1177348|P5|NOT COMPLETED|Extension 2||0
491164|NCT00365716|1177349|P4|NOT COMPLETED|Extension 2||0
491165|NCT00365716|1177350|P3|NOT COMPLETED|Extension 2||0
491166|NCT00365716|1177351|P2|NOT COMPLETED|Extension 2||0
491167|NCT00365716|1177352|P1|NOT COMPLETED|Extension 2||0
491168|NCT00365716|1177346|P7|COMPLETED|Extension 2||7
491169|NCT00365716|1177347|P6|COMPLETED|Extension 2||0
491170|NCT00365716|1177348|P5|COMPLETED|Extension 2||0
491171|NCT00365716|1177349|P4|COMPLETED|Extension 2||0
491172|NCT00365716|1177350|P3|COMPLETED|Extension 2||0
491173|NCT00365716|1177351|P2|COMPLETED|Extension 2||0
491174|NCT00365716|1177352|P1|COMPLETED|Extension 2||0
491175|NCT00365716|1177346|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
491176|NCT00365716|1177347|P6|STARTED|Extension 2||0
491177|NCT00365716|1177348|P5|STARTED|Extension 2||0
491178|NCT00365716|1177349|P4|STARTED|Extension 2||0
491179|NCT00365716|1177350|P3|STARTED|Extension 2||0
491180|NCT00365716|1177351|P2|STARTED|Extension 2||0
491181|NCT00365716|1177352|P1|STARTED|Extension 2||0
491182|NCT00365716|1177346|P7|NOT COMPLETED|Extension 1||0
491183|NCT00365716|1177347|P6|NOT COMPLETED|Extension 1||22
491184|NCT00365716|1177348|P5|NOT COMPLETED|Extension 1||0
491185|NCT00365716|1177349|P4|NOT COMPLETED|Extension 1||0
491186|NCT00365716|1177350|P3|NOT COMPLETED|Extension 1||0
491187|NCT00365716|1177351|P2|NOT COMPLETED|Extension 1||0
491188|NCT00365716|1177352|P1|NOT COMPLETED|Extension 1||0
491189|NCT00365716|1177346|P7|COMPLETED|Extension 1||0
491190|NCT00365716|1177347|P6|COMPLETED|Extension 1||219
491191|NCT00365716|1177348|P5|COMPLETED|Extension 1||0
491192|NCT00365716|1177349|P4|COMPLETED|Extension 1||0
491193|NCT00365716|1177350|P3|COMPLETED|Extension 1||0
491194|NCT00365716|1177351|P2|COMPLETED|Extension 1||0
491195|NCT00365716|1177352|P1|COMPLETED|Extension 1||0
491196|NCT00365716|1177346|P7|STARTED|Extension 1||0
491197|NCT00365716|1177347|P6|STARTED|Extension 1||241
491198|NCT00365716|1177348|P5|STARTED|Extension 1||0
491199|NCT00365716|1177349|P4|STARTED|Extension 1||0
491200|NCT00365716|1177350|P3|STARTED|Extension 1||0
491201|NCT00365716|1177351|P2|STARTED|Extension 1||0
491202|NCT00365716|1177352|P1|STARTED|Extension 1||0
491203|NCT00365716|1177346|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
491204|NCT00365716|1177347|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
491205|NCT00365716|1177348|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
491206|NCT00365716|1177349|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
491207|NCT00365716|1177350|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
491208|NCT00365716|1177351|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
491209|NCT00365716|1177352|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
491210|NCT00365716|1177346|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
491211|NCT00365716|1177347|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
491212|NCT00365716|1177348|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
491213|NCT00365716|1177349|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
491214|NCT00365716|1177350|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
491215|NCT00365716|1177351|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
491216|NCT00365716|1177352|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
491217|NCT00365716|1177346|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
491218|NCT00365716|1177347|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
491219|NCT00365716|1177348|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
491220|NCT00365716|1177349|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
491221|NCT00365716|1177350|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
491222|NCT00365716|1177351|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
491223|NCT00365716|1177352|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
491224|NCT00365716|1177346|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
491225|NCT00365716|1177347|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
491226|NCT00365716|1177348|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
491228|NCT00365716|1177350|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
491229|NCT00365716|1177351|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
491230|NCT00365716|1177352|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
491231|NCT00365716|1177346|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
491232|NCT00365716|1177347|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
491233|NCT00365716|1177348|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
491234|NCT00365716|1177349|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
491235|NCT00365716|1177350|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
491236|NCT00365716|1177351|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
491237|NCT00365716|1177352|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
491238|NCT00365716|1177346|P7|STARTED|Base Study (Day 1 to Month 7)||0
491239|NCT00365716|1177347|P6|STARTED|Base Study (Day 1 to Month 7)||0
491240|NCT00365716|1177348|P5|STARTED|Base Study (Day 1 to Month 7)||146
491241|NCT00365716|1177349|P4|STARTED|Base Study (Day 1 to Month 7)||146
491242|NCT00365716|1177350|P3|STARTED|Base Study (Day 1 to Month 7)||292
491243|NCT00365716|1177351|P2|STARTED|Base Study (Day 1 to Month 7)||284
491244|NCT00365716|1177352|P1|STARTED|Base Study (Day 1 to Month 7)||290
491245|NCT00366548|1177369|P2|NOT COMPLETED|Toddler Dose||0
491246|NCT00366548|1177370|P1|NOT COMPLETED|Toddler Dose||0
491247|NCT00366548|1177369|P2|COMPLETED|Toddler Dose||244
491248|NCT00366548|1177370|P1|COMPLETED|Toddler Dose||240
491249|NCT00366548|1177369|P2|STARTED|Toddler Dose||244
491250|NCT00366548|1177370|P1|STARTED|Toddler Dose||240
491251|NCT00366548|1177369|P2|NOT COMPLETED|After Infant Series||1
491252|NCT00366548|1177370|P1|NOT COMPLETED|After Infant Series||6
491253|NCT00366548|1177369|P2|COMPLETED|After Infant Series||244
491254|NCT00366548|1177370|P1|COMPLETED|After Infant Series||240
491255|NCT00366548|1177369|P2|STARTED|After Infant Series||245
491256|NCT00366548|1177370|P1|STARTED|After Infant Series||246
491257|NCT00366548|1177369|P2|NOT COMPLETED|Infant Series||5
491258|NCT00366548|1177370|P1|NOT COMPLETED|Infant Series||4
491259|NCT00366548|1177369|P2|COMPLETED|Infant Series||245
491260|NCT00366548|1177370|P1|COMPLETED|Infant Series||246
491261|NCT00366548|1177369|P2|Vaccinated Dose 3|Infant Series||247
491262|NCT00366548|1177370|P1|Vaccinated Dose 3|Infant Series||246
491263|NCT00366548|1177369|P2|Vaccinated Dose 2|Infant Series||249
491264|NCT00366548|1177370|P1|Vaccinated Dose 2|Infant Series||246
491265|NCT00366548|1177369|P2|Vaccinated Dose 1|Infant Series||250
491266|NCT00366548|1177370|P1|Vaccinated Dose 1|Infant Series||250
491267|NCT00366548|1177369|P2|STARTED|Infant Series||250
491268|NCT00366548|1177370|P1|STARTED|Infant Series||250
491269|NCT00366457|1177404|P1|NOT COMPLETED|Overall Study||2
491270|NCT00366457|1177404|P1|COMPLETED|Overall Study||30
491271|NCT00366457|1177404|P1|STARTED|Overall Study||32
491272|NCT00366444|1177413|P2|NOT COMPLETED|Overall Study||2
491273|NCT00366444|1177414|P1|NOT COMPLETED|Overall Study||1
491274|NCT00366444|1177413|P2|COMPLETED|Overall Study||97
491275|NCT00366444|1177414|P1|COMPLETED|Overall Study||101
491276|NCT00366444|1177413|P2|STARTED|Overall Study||99
491277|NCT00366444|1177414|P1|STARTED|Overall Study||102
491278|NCT00366340|1177442|P2|NOT COMPLETED|Toddler Dose||1
491279|NCT00366340|1177443|P1|NOT COMPLETED|Toddler Dose||1
491280|NCT00366340|1177442|P2|COMPLETED|Toddler Dose||286
491281|NCT00366340|1177443|P1|COMPLETED|Toddler Dose||289
491282|NCT00366340|1177442|P2|STARTED|Toddler Dose||287
491283|NCT00366340|1177443|P1|STARTED|Toddler Dose||290
491284|NCT00366340|1177442|P2|NOT COMPLETED|After the Infant Series||6
491285|NCT00366340|1177443|P1|NOT COMPLETED|After the Infant Series||3
491286|NCT00366340|1177442|P2|COMPLETED|After the Infant Series||287
491287|NCT00366340|1177443|P1|COMPLETED|After the Infant Series||290
491288|NCT00366340|1177442|P2|STARTED|After the Infant Series||293
491289|NCT00366340|1177443|P1|STARTED|After the Infant Series||293
491290|NCT00366340|1177442|P2|NOT COMPLETED|Infant Series||10
491291|NCT00366340|1177443|P1|NOT COMPLETED|Infant Series||8
491292|NCT00366340|1177442|P2|COMPLETED|Infant Series||293
491293|NCT00366340|1177443|P1|COMPLETED|Infant Series||293
491294|NCT00366340|1177442|P2|Vaccinated Dose 3|Infant Series||293
491295|NCT00366340|1177443|P1|Vaccinated Dose 3|Infant Series||294
491296|NCT00366340|1177442|P2|Vaccinated Dose 2|Infant Series||297
491297|NCT00366340|1177443|P1|Vaccinated Dose 2|Infant Series||296
491298|NCT00366340|1177442|P2|Vaccinated Dose 1|Infant Series||303
491299|NCT00366340|1177443|P1|Vaccinated Dose 1|Infant Series||300
491300|NCT00366340|1177442|P2|STARTED|Infant Series||303
491301|NCT00366340|1177443|P1|STARTED|Infant Series||301
491302|NCT00366301|1177501|P4|NOT COMPLETED|Overall Study||8
491303|NCT00366301|1177502|P3|NOT COMPLETED|Overall Study||4
491304|NCT00366301|1177503|P2|NOT COMPLETED|Overall Study||6
491305|NCT00366301|1177504|P1|NOT COMPLETED|Overall Study||8
491306|NCT00366301|1177501|P4|COMPLETED|Overall Study||116
491307|NCT00366301|1177502|P3|COMPLETED|Overall Study||122
491308|NCT00366301|1177503|P2|COMPLETED|Overall Study||120
491309|NCT00366301|1177504|P1|COMPLETED|Overall Study||116
491310|NCT00366301|1177501|P4|Either 6W or 14W CRP Obtained|Overall Study||119
491311|NCT00366301|1177502|P3|Either 6W or 14W CRP Obtained|Overall Study||124
491312|NCT00366301|1177503|P2|Either 6W or 14W CRP Obtained|Overall Study||124
491313|NCT00366301|1177504|P1|Either 6W or 14W CRP Obtained|Overall Study||120
491314|NCT00366301|1177501|P4|STARTED|Overall Study||124
491315|NCT00366301|1177502|P3|STARTED|Overall Study||126
491316|NCT00366301|1177503|P2|STARTED|Overall Study||126
491317|NCT00366301|1177504|P1|STARTED|Overall Study||124
491318|NCT00366275|1177514|P1|NOT COMPLETED|Overall Study||6
491319|NCT00366275|1177514|P1|COMPLETED|Overall Study||58
491320|NCT00366275|1177514|P1|STARTED|Overall Study||64
491321|NCT00366249|1177520|P2|NOT COMPLETED|Overall Study||78
491322|NCT00366249|1177521|P1|NOT COMPLETED|Overall Study||131
491323|NCT00366249|1177520|P2|COMPLETED|Overall Study||430
491324|NCT00366249|1177521|P1|COMPLETED|Overall Study||422
491325|NCT00366249|1177520|P2|STARTED|Overall Study||508
491326|NCT00366249|1177521|P1|STARTED|Overall Study||553
491327|NCT00366106|1177535|P1|NOT COMPLETED|Overall Study||0
491328|NCT00366106|1177535|P1|COMPLETED|Overall Study||32
491329|NCT00366106|1177535|P1|STARTED|Overall Study||32
491330|NCT00366028|1177544|P2|NOT COMPLETED|Overall Study||0
491331|NCT00366028|1177545|P1|NOT COMPLETED|Overall Study||0
491332|NCT00366028|1177544|P2|COMPLETED|Overall Study||735
491333|NCT00366028|1177545|P1|COMPLETED|Overall Study||889
491334|NCT00366028|1177544|P2|STARTED|Overall Study||735
491335|NCT00366028|1177545|P1|STARTED|Overall Study||889
491336|NCT00365976|1177555|P2|NOT COMPLETED|Overall Study||5
491337|NCT00365976|1177556|P1|NOT COMPLETED|Overall Study||1
491338|NCT00365976|1177555|P2|COMPLETED|Overall Study||20
491339|NCT00365976|1177556|P1|COMPLETED|Overall Study||32
491340|NCT00365976|1177555|P2|STARTED|Overall Study||25
491341|NCT00365976|1177556|P1|STARTED|Overall Study||33
491342|NCT00365599|1177584|P1|NOT COMPLETED|Overall Study||0
491343|NCT00365599|1177584|P1|COMPLETED|Overall Study||43
491344|NCT00365599|1177584|P1|STARTED|Overall Study||43
491345|NCT00365547|1177590|P1|NOT COMPLETED|Overall Study||3
491346|NCT00365547|1177590|P1|COMPLETED|Overall Study||43
491347|NCT00365547|1177590|P1|STARTED|Overall Study||46
491348|NCT00365508|1177600|P2|NOT COMPLETED|Overall Study||154
491349|NCT00365508|1177601|P1|NOT COMPLETED|Overall Study||139
491350|NCT00365508|1177600|P2|COMPLETED|Overall Study||167
491351|NCT00365508|1177601|P1|COMPLETED|Overall Study||182
491352|NCT00365508|1177600|P2|STARTED|Overall Study||321
491353|NCT00365508|1177601|P1|STARTED|Overall Study||321
491354|NCT00365456|1177609|P2|NOT COMPLETED|Trial Period III (12 Months)||5
491355|NCT00365456|1177610|P1|NOT COMPLETED|Trial Period III (12 Months)||18
491356|NCT00365456|1177609|P2|COMPLETED|Trial Period III (12 Months)||127
491357|NCT00365456|1177610|P1|COMPLETED|Trial Period III (12 Months)||118
491358|NCT00365456|1177609|P2|STARTED|Trial Period III (12 Months)||132
491359|NCT00365456|1177610|P1|STARTED|Trial Period III (12 Months)||136
491360|NCT00365456|1177609|P2|NOT COMPLETED|Trial Period II (12 Months)||14
491361|NCT00365456|1177610|P1|NOT COMPLETED|Trial Period II (12 Months)||0
491362|NCT00365456|1177609|P2|COMPLETED|Trial Period II (12 Months)||268
491363|NCT00365456|1177610|P1|COMPLETED|Trial Period II (12 Months)||0
491364|NCT00365456|1177609|P2|STARTED|Trial Period II (12 Months)||282
491365|NCT00365456|1177610|P1|STARTED|Trial Period II (12 Months)||0
491366|NCT00365456|1177609|P2|NOT COMPLETED|Trial Period I (12 Months)||0
491367|NCT00365456|1177610|P1|NOT COMPLETED|Trial Period I (12 Months)||125
491368|NCT00365456|1177609|P2|COMPLETED|Trial Period I (12 Months)||0
491369|NCT00365456|1177610|P1|COMPLETED|Trial Period I (12 Months)||282
491370|NCT00365456|1177609|P2|STARTED|Trial Period I (12 Months)||0
491371|NCT00365456|1177610|P1|STARTED|Trial Period I (12 Months)||407
491372|NCT00365417|1177616|P1|NOT COMPLETED|Overall Study||0
491373|NCT00365417|1177616|P1|COMPLETED|Overall Study||45
491374|NCT00365417|1177616|P1|STARTED|Overall Study||45
491375|NCT00365391|1177622|P1|NOT COMPLETED|Overall Study||0
491376|NCT00365391|1177622|P1|COMPLETED|Overall Study||27
491377|NCT00365391|1177622|P1|STARTED|Overall Study||27
491378|NCT00365378|1177632|P3|NOT COMPLETED|Extension||197
491379|NCT00365378|1177633|P2|NOT COMPLETED|Extension||0
491380|NCT00365378|1177634|P1|NOT COMPLETED|Extension||0
491381|NCT00365378|1177632|P3|COMPLETED|Extension||203
491382|NCT00365378|1177633|P2|COMPLETED|Extension||0
491383|NCT00365378|1177634|P1|COMPLETED|Extension||0
491384|NCT00365378|1177632|P3|STARTED|Extension||400
491385|NCT00365378|1177633|P2|STARTED|Extension||0
491386|NCT00365378|1177634|P1|STARTED|Extension||0
491387|NCT00365378|1177632|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
491388|NCT00365378|1177633|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
491389|NCT00365378|1177634|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
491390|NCT00365378|1177632|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
491391|NCT00365378|1177633|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
491392|NCT00365378|1177634|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
491393|NCT00365378|1177632|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
491394|NCT00365378|1177633|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
491395|NCT00365378|1177634|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
491396|NCT00365378|1177632|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
491397|NCT00365378|1177633|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
491398|NCT00365378|1177634|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
491399|NCT00365378|1177632|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
491400|NCT00365378|1177633|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
491401|NCT00365378|1177634|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
491402|NCT00365378|1177632|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
491403|NCT00365378|1177633|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
491404|NCT00365378|1177634|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
491405|NCT00365378|1177632|P3|STARTED|Vaccination (Day 1 to Month 7)||0
491406|NCT00365378|1177633|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
491407|NCT00365378|1177634|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
491408|NCT00365365|1177648|P3|NOT COMPLETED|Overall Study||15
491409|NCT00365365|1177649|P2|NOT COMPLETED|Overall Study||36
491410|NCT00365365|1177650|P1|NOT COMPLETED|Overall Study||34
491411|NCT00365365|1177648|P3|COMPLETED|Overall Study||44
491412|NCT00365365|1177649|P2|COMPLETED|Overall Study||41
491413|NCT00365365|1177650|P1|COMPLETED|Overall Study||44
491414|NCT00365365|1177648|P3|COMPLETED TREATMENT|Overall Study||45
491415|NCT00365365|1177649|P2|COMPLETED TREATMENT|Overall Study||36
491416|NCT00365365|1177650|P1|COMPLETED TREATMENT|Overall Study||38
491417|NCT00365365|1177648|P3|TREATED (SAFETY POPULATION)|Overall Study||59
491418|NCT00365365|1177649|P2|TREATED (SAFETY POPULATION)|Overall Study||75
491419|NCT00365365|1177650|P1|TREATED (SAFETY POPULATION)|Overall Study||78
491420|NCT00365365|1177648|P3|STARTED|Overall Study||59
491421|NCT00365365|1177649|P2|STARTED|Overall Study||77
491422|NCT00365365|1177650|P1|STARTED|Overall Study||78
491423|NCT00365352|1177667|P3|NOT COMPLETED|Overall Study||15
491424|NCT00365352|1177668|P2|NOT COMPLETED|Overall Study||11
491425|NCT00365352|1177669|P1|NOT COMPLETED|Overall Study||20
491426|NCT00365352|1177667|P3|COMPLETED|Overall Study||98
491427|NCT00365352|1177668|P2|COMPLETED|Overall Study||104
491428|NCT00365352|1177669|P1|COMPLETED|Overall Study||77
491429|NCT00365352|1177667|P3|Modified Intent-to-Treat Population|Overall Study||111
491430|NCT00365352|1177668|P2|Modified Intent-to-Treat Population|Overall Study||114
491431|NCT00365352|1177669|P1|Modified Intent-to-Treat Population|Overall Study||96
491432|NCT00365352|1177667|P3|Safety Population|Overall Study||111
491433|NCT00365352|1177668|P2|Safety Population|Overall Study||115
491434|NCT00365352|1177669|P1|Safety Population|Overall Study||96
491435|NCT00365352|1177667|P3|STARTED|Overall Study||113
491436|NCT00365352|1177668|P2|STARTED|Overall Study||115
491437|NCT00365352|1177669|P1|STARTED|Overall Study||97
491438|NCT00365300|1177753|P2|NOT COMPLETED|Double-blind Phase||9
491439|NCT00365300|1177754|P1|NOT COMPLETED|Double-blind Phase||11
491440|NCT00365300|1177753|P2|COMPLETED|Double-blind Phase||45
491441|NCT00365300|1177754|P1|COMPLETED|Double-blind Phase||43
491442|NCT00365300|1177753|P2|STARTED|Double-blind Phase||54
491443|NCT00365300|1177754|P1|STARTED|Double-blind Phase||54
491444|NCT00365300|1177753|P2|NOT COMPLETED|Open-label Phase||0
491445|NCT00365300|1177754|P1|NOT COMPLETED|Open-label Phase||22
491446|NCT00365300|1177753|P2|COMPLETED|Open-label Phase||0
491447|NCT00365300|1177754|P1|COMPLETED|Open-label Phase||107
491448|NCT00365300|1177753|P2|STARTED|Open-label Phase||0
491449|NCT00365300|1177754|P1|STARTED|Open-label Phase||129
491450|NCT00365274|1177763|P1|NOT COMPLETED|Overall Study||0
491451|NCT00365274|1177763|P1|COMPLETED|Overall Study||6
491452|NCT00365274|1177763|P1|STARTED|Overall Study||6
491453|NCT00365261|1177769|P2|NOT COMPLETED|Overall Study||3
491454|NCT00365261|1177770|P1|NOT COMPLETED|Overall Study||3
491455|NCT00365261|1177769|P2|COMPLETED|Overall Study||19
491456|NCT00365261|1177770|P1|COMPLETED|Overall Study||20
491457|NCT00365261|1177769|P2|STARTED|Overall Study||22
491458|NCT00365261|1177770|P1|STARTED|Overall Study||23
491459|NCT00365209|1177780|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
491460|NCT00365209|1177780|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
491461|NCT00365209|1177780|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
491462|NCT00365209|1177780|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
491463|NCT00365209|1177780|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
491464|NCT00365209|1177780|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
491465|NCT00365144|1177809|P1|NOT COMPLETED|Overall Study||0
491466|NCT00365144|1177809|P1|COMPLETED|Overall Study||36
491467|NCT00365144|1177809|P1|STARTED|Overall Study||36
491468|NCT00365105|1177817|P2|NOT COMPLETED|Overall Study||4
491469|NCT00365105|1177818|P1|NOT COMPLETED|Overall Study||6
491470|NCT00365105|1177817|P2|COMPLETED|Overall Study||128
491471|NCT00365105|1177818|P1|COMPLETED|Overall Study||123
491472|NCT00365105|1177817|P2|STARTED|Overall Study||132
491473|NCT00365105|1177818|P1|STARTED|Overall Study||129
491474|NCT00365053|1177824|P1|NOT COMPLETED|Overall Study||0
491475|NCT00365053|1177824|P1|COMPLETED|Overall Study||13
491476|NCT00365053|1177824|P1|STARTED|Overall Study||13
491477|NCT00364949|1177832|P2|NOT COMPLETED|Overall Study||0
491478|NCT00364949|1177833|P1|NOT COMPLETED|Overall Study||0
491479|NCT00364949|1177832|P2|COMPLETED|Overall Study||39
491480|NCT00364949|1177833|P1|COMPLETED|Overall Study||31
491481|NCT00364949|1177832|P2|STARTED|Overall Study||39
491482|NCT00364949|1177833|P1|STARTED|Overall Study||31
491483|NCT00364923|1177851|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
491484|NCT00364923|1177851|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
491485|NCT00364923|1177851|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
491486|NCT00364923|1177851|P1|NOT COMPLETED|Treatment With Pralatrexate||4
491487|NCT00364923|1177851|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
491488|NCT00364923|1177851|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
491489|NCT00364858|1177860|P2|NOT COMPLETED|Overall Study||22
491490|NCT00364858|1177861|P1|NOT COMPLETED|Overall Study||7
491491|NCT00364858|1177860|P2|COMPLETED|Overall Study||40
491492|NCT00364858|1177861|P1|COMPLETED|Overall Study||26
491493|NCT00364858|1177860|P2|STARTED|Overall Study||62
491494|NCT00364858|1177861|P1|STARTED|Overall Study||33
491495|NCT00364845|1177876|P2|NOT COMPLETED|Overall Study||11
491496|NCT00364845|1177877|P1|NOT COMPLETED|Overall Study||11
491497|NCT00364845|1177876|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
491498|NCT00364845|1177877|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
491499|NCT00364845|1177876|P2|STARTED|Overall Study||23
491500|NCT00364845|1177877|P1|STARTED|Overall Study||28
491501|NCT00364832|1177898|P12|NOT COMPLETED|Extension Year 2||3
491502|NCT00364832|1177899|P11|NOT COMPLETED|Extension Year 2||5
491503|NCT00364832|1177900|P10|NOT COMPLETED|Extension Year 2||5
491504|NCT00364832|1177901|P9|NOT COMPLETED|Extension Year 2||0
491505|NCT00364832|1177902|P8|NOT COMPLETED|Extension Year 2||0
491506|NCT00364832|1177903|P7|NOT COMPLETED|Extension Year 2||0
491507|NCT00364832|1177904|P6|NOT COMPLETED|Extension Year 2||0
491508|NCT00364832|1177905|P5|NOT COMPLETED|Extension Year 2||0
491509|NCT00364832|1177906|P4|NOT COMPLETED|Extension Year 2||0
491510|NCT00364832|1177907|P3|NOT COMPLETED|Extension Year 2||0
491511|NCT00364832|1177908|P2|NOT COMPLETED|Extension Year 2||0
491512|NCT00364832|1177909|P1|NOT COMPLETED|Extension Year 2||0
491513|NCT00364832|1177898|P12|COMPLETED|Extension Year 2||11
491514|NCT00364832|1177899|P11|COMPLETED|Extension Year 2||9
491515|NCT00364832|1177900|P10|COMPLETED|Extension Year 2||9
491516|NCT00364832|1177901|P9|COMPLETED|Extension Year 2||0
491517|NCT00364832|1177902|P8|COMPLETED|Extension Year 2||0
491518|NCT00364832|1177903|P7|COMPLETED|Extension Year 2||0
491519|NCT00364832|1177904|P6|COMPLETED|Extension Year 2||0
491520|NCT00364832|1177905|P5|COMPLETED|Extension Year 2||0
491521|NCT00364832|1177906|P4|COMPLETED|Extension Year 2||0
491522|NCT00364832|1177907|P3|COMPLETED|Extension Year 2||0
491523|NCT00364832|1177908|P2|COMPLETED|Extension Year 2||0
491524|NCT00364832|1177909|P1|COMPLETED|Extension Year 2||0
491525|NCT00364832|1177898|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
491526|NCT00364832|1177899|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
491527|NCT00364832|1177900|P10|STARTED|Extension Year 2||14
491528|NCT00364832|1177901|P9|STARTED|Extension Year 2||0
491529|NCT00364832|1177902|P8|STARTED|Extension Year 2||0
491530|NCT00364832|1177903|P7|STARTED|Extension Year 2||0
491531|NCT00364832|1177904|P6|STARTED|Extension Year 2||0
491532|NCT00364832|1177905|P5|STARTED|Extension Year 2||0
491533|NCT00364832|1177906|P4|STARTED|Extension Year 2||0
491534|NCT00364832|1177907|P3|STARTED|Extension Year 2||0
491535|NCT00364832|1177908|P2|STARTED|Extension Year 2||0
491536|NCT00364832|1177909|P1|STARTED|Extension Year 2||0
491537|NCT00364832|1177898|P12|NOT COMPLETED|Extension Year 1||10
491538|NCT00364832|1177899|P11|NOT COMPLETED|Extension Year 1||2
491539|NCT00364832|1177900|P10|NOT COMPLETED|Extension Year 1||4
491540|NCT00364832|1177901|P9|NOT COMPLETED|Extension Year 1||0
491541|NCT00364832|1177902|P8|NOT COMPLETED|Extension Year 1||0
491542|NCT00364832|1177903|P7|NOT COMPLETED|Extension Year 1||0
491543|NCT00364832|1177904|P6|NOT COMPLETED|Extension Year 1||0
491544|NCT00364832|1177905|P5|NOT COMPLETED|Extension Year 1||0
491545|NCT00364832|1177906|P4|NOT COMPLETED|Extension Year 1||0
491546|NCT00364832|1177907|P3|NOT COMPLETED|Extension Year 1||0
491547|NCT00364832|1177908|P2|NOT COMPLETED|Extension Year 1||0
491548|NCT00364832|1177909|P1|NOT COMPLETED|Extension Year 1||0
491549|NCT00364832|1177898|P12|COMPLETED|Extension Year 1||17
491550|NCT00364832|1177899|P11|COMPLETED|Extension Year 1||15
491551|NCT00364832|1177900|P10|COMPLETED|Extension Year 1||14
491552|NCT00364832|1177901|P9|COMPLETED|Extension Year 1||0
491553|NCT00364832|1177902|P8|COMPLETED|Extension Year 1||0
491554|NCT00364832|1177903|P7|COMPLETED|Extension Year 1||0
491555|NCT00364832|1177904|P6|COMPLETED|Extension Year 1||0
491556|NCT00364832|1177905|P5|COMPLETED|Extension Year 1||0
491557|NCT00364832|1177906|P4|COMPLETED|Extension Year 1||0
491558|NCT00364832|1177907|P3|COMPLETED|Extension Year 1||0
491559|NCT00364832|1177908|P2|COMPLETED|Extension Year 1||0
491560|NCT00364832|1177909|P1|COMPLETED|Extension Year 1||0
491561|NCT00364832|1177898|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
491562|NCT00364832|1177899|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
491563|NCT00364832|1177900|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
491564|NCT00364832|1177901|P9|STARTED|Extension Year 1||0
491565|NCT00364832|1177902|P8|STARTED|Extension Year 1||0
491566|NCT00364832|1177903|P7|STARTED|Extension Year 1||0
491567|NCT00364832|1177904|P6|STARTED|Extension Year 1||0
491568|NCT00364832|1177905|P5|STARTED|Extension Year 1||0
491569|NCT00364832|1177906|P4|STARTED|Extension Year 1||0
491570|NCT00364832|1177907|P3|STARTED|Extension Year 1||0
491571|NCT00364832|1177908|P2|STARTED|Extension Year 1||0
491572|NCT00364832|1177909|P1|STARTED|Extension Year 1||0
491573|NCT00364832|1177898|P12|NOT COMPLETED|Core Period||0
491574|NCT00364832|1177899|P11|NOT COMPLETED|Core Period||0
491575|NCT00364832|1177900|P10|NOT COMPLETED|Core Period||0
491576|NCT00364832|1177901|P9|NOT COMPLETED|Core Period||0
491577|NCT00364832|1177902|P8|NOT COMPLETED|Core Period||1
491578|NCT00364832|1177903|P7|NOT COMPLETED|Core Period||4
491579|NCT00364832|1177904|P6|NOT COMPLETED|Core Period||0
491580|NCT00364832|1177905|P5|NOT COMPLETED|Core Period||0
491581|NCT00364832|1177906|P4|NOT COMPLETED|Core Period||1
491582|NCT00364832|1177907|P3|NOT COMPLETED|Core Period||1
491583|NCT00364832|1177908|P2|NOT COMPLETED|Core Period||2
491584|NCT00364832|1177909|P1|NOT COMPLETED|Core Period||2
491585|NCT00364832|1177898|P12|COMPLETED|Core Period||0
491586|NCT00364832|1177899|P11|COMPLETED|Core Period||0
491587|NCT00364832|1177900|P10|COMPLETED|Core Period||0
491588|NCT00364832|1177901|P9|COMPLETED|Core Period||16
491589|NCT00364832|1177902|P8|COMPLETED|Core Period||14
491590|NCT00364832|1177903|P7|COMPLETED|Core Period||12
491591|NCT00364832|1177904|P6|COMPLETED|Core Period||12
491592|NCT00364832|1177905|P5|COMPLETED|Core Period||16
491593|NCT00364832|1177906|P4|COMPLETED|Core Period||15
491594|NCT00364832|1177907|P3|COMPLETED|Core Period||14
491595|NCT00364832|1177908|P2|COMPLETED|Core Period||13
491596|NCT00364832|1177909|P1|COMPLETED|Core Period||14
491597|NCT00364832|1177898|P12|STARTED|Core Period||0
491598|NCT00364832|1177899|P11|STARTED|Core Period||0
491599|NCT00364832|1177900|P10|STARTED|Core Period||0
491600|NCT00364832|1177901|P9|STARTED|Core Period||16
491601|NCT00364832|1177902|P8|STARTED|Core Period||15
491602|NCT00364832|1177903|P7|STARTED|Core Period||16
491603|NCT00364832|1177904|P6|STARTED|Core Period||12
491604|NCT00364832|1177905|P5|STARTED|Core Period||16
491605|NCT00364832|1177906|P4|STARTED|Core Period||16
491606|NCT00364832|1177907|P3|STARTED|Core Period||15
491607|NCT00364832|1177908|P2|STARTED|Core Period||15
491608|NCT00364832|1177909|P1|STARTED|Core Period||16
491609|NCT00364819|1177962|P1|NOT COMPLETED|Overall Study||0
491610|NCT00364819|1177962|P1|COMPLETED|Overall Study||6
491611|NCT00364819|1177962|P1|STARTED|Overall Study||6
491612|NCT00364793|1177974|P4|NOT COMPLETED|Overall Study||3
491613|NCT00364793|1177975|P3|NOT COMPLETED|Overall Study||4
491614|NCT00364793|1177976|P2|NOT COMPLETED|Overall Study||5
491615|NCT00364793|1177977|P1|NOT COMPLETED|Overall Study||8
491616|NCT00364793|1177974|P4|COMPLETED|Overall Study||5
491617|NCT00364793|1177975|P3|COMPLETED|Overall Study||0
491618|NCT00364793|1177976|P2|COMPLETED|Overall Study||5
491619|NCT00364793|1177977|P1|COMPLETED|Overall Study||7
491620|NCT00364793|1177974|P4|STARTED|Overall Study||8
491621|NCT00364793|1177975|P3|STARTED|Overall Study||4
491622|NCT00364793|1177976|P2|STARTED|Overall Study||10
491623|NCT00364793|1177977|P1|STARTED|Overall Study||15
491624|NCT00364611|1178113|P2|NOT COMPLETED|Overall Study||21
491625|NCT00364611|1178114|P1|NOT COMPLETED|Overall Study||51
491626|NCT00364611|1178113|P2|COMPLETED|Overall Study||0
491627|NCT00364611|1178114|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
491628|NCT00364611|1178113|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
491629|NCT00364611|1178114|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
491630|NCT00364611|1178113|P2|STARTED|Overall Study||21
491631|NCT00364611|1178114|P1|STARTED|Overall Study||52
491632|NCT00364533|1178137|P5|NOT COMPLETED|Overall Study||51
491633|NCT00364533|1178138|P4|NOT COMPLETED|Overall Study||31
491634|NCT00364533|1178139|P3|NOT COMPLETED|Overall Study||45
491635|NCT00364533|1178140|P2|NOT COMPLETED|Overall Study||40
491636|NCT00364533|1178141|P1|NOT COMPLETED|Overall Study||42
491637|NCT00364533|1178137|P5|COMPLETED|Overall Study||24
491638|NCT00364533|1178138|P4|COMPLETED|Overall Study||36
491639|NCT00364533|1178139|P3|COMPLETED|Overall Study||30
491640|NCT00364533|1178140|P2|COMPLETED|Overall Study||31
491641|NCT00364533|1178141|P1|COMPLETED|Overall Study||35
491642|NCT00364533|1178137|P5|STARTED|Overall Study||75
491643|NCT00364533|1178138|P4|STARTED|Overall Study||67
491644|NCT00364533|1178139|P3|STARTED|Overall Study||75
491645|NCT00364533|1178140|P2|STARTED|Overall Study||71
491646|NCT00364533|1178141|P1|STARTED|Overall Study||77
491647|NCT00364377|1178165|P2|NOT COMPLETED|Overall Study||0
491648|NCT00364377|1178166|P1|NOT COMPLETED|Overall Study||0
491649|NCT00364377|1178165|P2|COMPLETED|Overall Study||11
491650|NCT00364377|1178166|P1|COMPLETED|Overall Study||11
491651|NCT00364377|1178165|P2|STARTED|Overall Study||11
491652|NCT00364377|1178166|P1|STARTED|Overall Study||11
491653|NCT00364351|1178174|P2|NOT COMPLETED|Overall Study||583
491654|NCT00364351|1178175|P1|NOT COMPLETED|Overall Study||592
491655|NCT00364351|1178174|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|34
491656|NCT00364351|1178175|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|31
491657|NCT00364351|1178174|P2|STARTED|Overall Study|randomised patients|617
491658|NCT00364351|1178175|P1|STARTED|Overall Study|randomised patients|623
491659|NCT00364286|1178193|P1|NOT COMPLETED|Overall Study||0
491660|NCT00364286|1178193|P1|COMPLETED|Overall Study||17
491661|NCT00364286|1178193|P1|STARTED|Overall Study||17
491662|NCT00364182|1178200|P3|NOT COMPLETED|Fourth Intervention||0
491663|NCT00364182|1178201|P2|NOT COMPLETED|Fourth Intervention||0
491664|NCT00364182|1178202|P1|NOT COMPLETED|Fourth Intervention||0
491665|NCT00364182|1178200|P3|COMPLETED|Fourth Intervention||22
491666|NCT00364182|1178201|P2|COMPLETED|Fourth Intervention||19
491667|NCT00364182|1178202|P1|COMPLETED|Fourth Intervention||0
491668|NCT00364182|1178200|P3|STARTED|Fourth Intervention||22
491669|NCT00364182|1178201|P2|STARTED|Fourth Intervention||19
491670|NCT00364182|1178202|P1|STARTED|Fourth Intervention||0
491671|NCT00364182|1178200|P3|NOT COMPLETED|Third Intervention||1
491672|NCT00364182|1178201|P2|NOT COMPLETED|Third Intervention||1
491673|NCT00364182|1178202|P1|NOT COMPLETED|Third Intervention||0
491674|NCT00364182|1178200|P3|COMPLETED|Third Intervention||22
491675|NCT00364182|1178201|P2|COMPLETED|Third Intervention||19
491676|NCT00364182|1178202|P1|COMPLETED|Third Intervention||0
491677|NCT00364182|1178200|P3|STARTED|Third Intervention||23
491678|NCT00364182|1178201|P2|STARTED|Third Intervention||20
491679|NCT00364182|1178202|P1|STARTED|Third Intervention||0
491680|NCT00364182|1178200|P3|NOT COMPLETED|Second Intervention||2
491681|NCT00364182|1178201|P2|NOT COMPLETED|Second Intervention||2
491682|NCT00364182|1178202|P1|NOT COMPLETED|Second Intervention||0
491683|NCT00364182|1178200|P3|COMPLETED|Second Intervention||23
491684|NCT00364182|1178201|P2|COMPLETED|Second Intervention||20
491685|NCT00364182|1178202|P1|COMPLETED|Second Intervention||0
491686|NCT00364182|1178200|P3|Randomized|Second Intervention||25
491687|NCT00364182|1178201|P2|Randomized|Second Intervention||22
491688|NCT00364182|1178202|P1|Randomized|Second Intervention||0
491689|NCT00364182|1178200|P3|STARTED|Second Intervention||25
491690|NCT00364182|1178201|P2|STARTED|Second Intervention||22
491691|NCT00364182|1178202|P1|STARTED|Second Intervention||0
491692|NCT00364182|1178200|P3|NOT COMPLETED|First Intervention||0
491693|NCT00364182|1178201|P2|NOT COMPLETED|First Intervention||0
491694|NCT00364182|1178202|P1|NOT COMPLETED|First Intervention||3
491695|NCT00364182|1178200|P3|COMPLETED|First Intervention||25
491696|NCT00364182|1178201|P2|COMPLETED|First Intervention||22
491697|NCT00364182|1178202|P1|COMPLETED|First Intervention||0
491698|NCT00364182|1178200|P3|STARTED|First Intervention||25
491699|NCT00364182|1178201|P2|STARTED|First Intervention||22
491700|NCT00364182|1178202|P1|STARTED|First Intervention||3
491701|NCT00364156|1178236|P2|NOT COMPLETED|Overall Study||81
491702|NCT00364156|1178237|P1|NOT COMPLETED|Overall Study||79
491703|NCT00364156|1178236|P2|COMPLETED|Overall Study||205
491704|NCT00364156|1178237|P1|COMPLETED|Overall Study||203
491705|NCT00364156|1178236|P2|STARTED|Overall Study||286
491706|NCT00364156|1178237|P1|STARTED|Overall Study||282
491707|NCT00364130|1178245|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
491708|NCT00364130|1178246|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
491709|NCT00364130|1178245|P2|COMPLETED|Post Intervention Follow-up Period||50
491710|NCT00364130|1178246|P1|COMPLETED|Post Intervention Follow-up Period||55
491711|NCT00364130|1178245|P2|STARTED|Post Intervention Follow-up Period||61
491712|NCT00364130|1178246|P1|STARTED|Post Intervention Follow-up Period||60
491713|NCT00364130|1178245|P2|NOT COMPLETED|Intervention Period||8
491714|NCT00364130|1178246|P1|NOT COMPLETED|Intervention Period||9
491715|NCT00364130|1178245|P2|COMPLETED|Intervention Period||61
491716|NCT00364130|1178246|P1|COMPLETED|Intervention Period||60
491717|NCT00364130|1178245|P2|STARTED|Intervention Period||69
491718|NCT00364130|1178246|P1|STARTED|Intervention Period||69
491719|NCT00364013|1178268|P2|NOT COMPLETED|Overall Study||95
491720|NCT00364013|1178269|P1|NOT COMPLETED|Overall Study||101
491721|NCT00364013|1178268|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
491722|NCT00364013|1178269|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
491723|NCT00364013|1178268|P2|Received Study Drug|Overall Study||583
491724|NCT00364013|1178269|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
491725|NCT00364013|1178268|P2|STARTED|Overall Study||590
491726|NCT00364013|1178269|P1|STARTED|Overall Study||593
491727|NCT00363896|1178297|P2|NOT COMPLETED|Overall Study||47
491728|NCT00363896|1178298|P1|NOT COMPLETED|Overall Study||89
491729|NCT00363896|1178297|P2|COMPLETED|Overall Study||169
491730|NCT00363896|1178298|P1|COMPLETED|Overall Study||538
491731|NCT00363896|1178297|P2|STARTED|Overall Study||216
491732|NCT00363896|1178298|P1|STARTED|Overall Study||627
491733|NCT00363883|1178310|P1|NOT COMPLETED|Overall Study||0
491734|NCT00363883|1178310|P1|COMPLETED|Overall Study||14
491735|NCT00363883|1178310|P1|STARTED|Overall Study||14
491736|NCT00363805|1178319|P3|NOT COMPLETED|Overall Study||3
491737|NCT00363805|1178320|P2|NOT COMPLETED|Overall Study||6
491738|NCT00363805|1178321|P1|NOT COMPLETED|Overall Study||4
491739|NCT00363805|1178319|P3|COMPLETED|Overall Study||70
491740|NCT00363805|1178320|P2|COMPLETED|Overall Study||57
491741|NCT00363805|1178321|P1|COMPLETED|Overall Study||38
491742|NCT00363805|1178319|P3|STARTED|Overall Study||73
491743|NCT00363805|1178320|P2|STARTED|Overall Study||63
491744|NCT00363805|1178321|P1|STARTED|Overall Study||42
491745|NCT00363779|1178332|P1|NOT COMPLETED|Overall Study||0
491746|NCT00363779|1178332|P1|COMPLETED|Overall Study||5
491747|NCT00363779|1178332|P1|STARTED|Overall Study||5
491748|NCT00363675|1178337|P1|NOT COMPLETED|Overall Study||0
491749|NCT00363675|1178337|P1|COMPLETED|Overall Study||3
491750|NCT00363675|1178337|P1|Completed Testing|Overall Study||3
491751|NCT00363675|1178337|P1|STARTED|Overall Study||3
491752|NCT00363545|1178346|P2|NOT COMPLETED|Overall Study||57
491753|NCT00363545|1178347|P1|NOT COMPLETED|Overall Study||44
491754|NCT00363545|1178346|P2|COMPLETED|Overall Study||581
491755|NCT00363545|1178347|P1|COMPLETED|Overall Study||592
491756|NCT00363545|1178346|P2|STARTED|Overall Study||638
491757|NCT00363545|1178347|P1|STARTED|Overall Study||636
491758|NCT00363467|1178365|P1|NOT COMPLETED|Overall Study||1
491759|NCT00363467|1178365|P1|COMPLETED|Overall Study||2
491760|NCT00363467|1178365|P1|STARTED|Overall Study||3
491761|NCT00363415|1178375|P2|NOT COMPLETED|Overall Study||249
491762|NCT00363415|1178376|P1|NOT COMPLETED|Overall Study||361
491763|NCT00363415|1178375|P2|COMPLETED|Overall Study||206
491764|NCT00363415|1178376|P1|COMPLETED|Overall Study||92
491765|NCT00363415|1178375|P2|Received at Least One Dose of Study Drug|Overall Study||447
491766|NCT00363415|1178376|P1|Received at Least One Dose of Study Drug|Overall Study||433
491767|NCT00363415|1178375|P2|STARTED|Overall Study||455
491768|NCT00363415|1178376|P1|STARTED|Overall Study||453
491769|NCT00363311|1178394|P2|NOT COMPLETED|Overall Study||45
491770|NCT00363311|1178395|P1|NOT COMPLETED|Overall Study||76
491771|NCT00363311|1178394|P2|COMPLETED|Overall Study||102
491772|NCT00363311|1178395|P1|COMPLETED|Overall Study||79
491773|NCT00363311|1178394|P2|STARTED|Overall Study||147
491774|NCT00363311|1178395|P1|STARTED|Overall Study||155
491775|NCT00363298|1178461|P2|NOT COMPLETED|4-week Study Continuation Phase||0
491776|NCT00363298|1178462|P1|NOT COMPLETED|4-week Study Continuation Phase||1
491777|NCT00363298|1178461|P2|COMPLETED|4-week Study Continuation Phase||7
491778|NCT00363298|1178462|P1|COMPLETED|4-week Study Continuation Phase||5
491779|NCT00363298|1178461|P2|STARTED|4-week Study Continuation Phase||7
491780|NCT00363298|1178462|P1|STARTED|4-week Study Continuation Phase||6
491781|NCT00363298|1178461|P2|NOT COMPLETED|First Study Week||5
491782|NCT00363298|1178462|P1|NOT COMPLETED|First Study Week||6
491783|NCT00363298|1178461|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
491784|NCT00363298|1178462|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
491785|NCT00363298|1178461|P2|STARTED|First Study Week||12
491786|NCT00363298|1178462|P1|STARTED|First Study Week||12
491787|NCT00363246|1178470|P1|NOT COMPLETED|Overall Study||97
491788|NCT00363246|1178470|P1|COMPLETED|Overall Study||669
491789|NCT00363246|1178470|P1|STARTED|Overall Study||766
491790|NCT00363168|1178477|P2|NOT COMPLETED|Overall Study||0
491791|NCT00363168|1178478|P1|NOT COMPLETED|Overall Study||0
491792|NCT00363168|1178477|P2|COMPLETED|Overall Study||2
491793|NCT00363168|1178478|P1|COMPLETED|Overall Study||5
491794|NCT00363168|1178477|P2|STARTED|Overall Study||2
491795|NCT00363168|1178478|P1|STARTED|Overall Study||5
491796|NCT00363142|1178488|P2|NOT COMPLETED|Overall Study||3
491797|NCT00363142|1178489|P1|NOT COMPLETED|Overall Study||7
491798|NCT00363142|1178488|P2|COMPLETED|Overall Study||66
491799|NCT00363142|1178489|P1|COMPLETED|Overall Study||133
491800|NCT00363142|1178488|P2|STARTED|Overall Study||69
491801|NCT00363142|1178489|P1|STARTED|Overall Study||140
491802|NCT00363129|1178518|P2|NOT COMPLETED|Overall Study||33
491803|NCT00363129|1178519|P1|NOT COMPLETED|Overall Study||29
491804|NCT00363129|1178518|P2|COMPLETED|Overall Study||60
491805|NCT00363129|1178519|P1|COMPLETED|Overall Study||67
491806|NCT00363129|1178518|P2|STARTED|Overall Study||93
491807|NCT00363129|1178519|P1|STARTED|Overall Study||96
491808|NCT00363077|1178535|P2|NOT COMPLETED|Overall Study||0
491809|NCT00363077|1178536|P1|NOT COMPLETED|Overall Study||0
491810|NCT00363077|1178535|P2|COMPLETED|Overall Study||75
491811|NCT00363077|1178536|P1|COMPLETED|Overall Study||75
491812|NCT00363077|1178535|P2|STARTED|Overall Study||75
491813|NCT00363077|1178536|P1|STARTED|Overall Study||75
491814|NCT00363051|1178562|P2|NOT COMPLETED|Overall Study||22
491815|NCT00363051|1178563|P1|NOT COMPLETED|Overall Study||38
491816|NCT00363051|1178562|P2|COMPLETED|Overall Study||23
491817|NCT00363051|1178563|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
491818|NCT00363051|1178562|P2|STARTED|Overall Study||45
491819|NCT00363051|1178563|P1|STARTED|Overall Study||115
491820|NCT00363038|1178580|P1|NOT COMPLETED|Overall Study||0
491821|NCT00363038|1178580|P1|COMPLETED|Overall Study||16
491822|NCT00363038|1178580|P1|STARTED|Overall Study||16
491823|NCT00362882|1178586|P2|NOT COMPLETED|Overall Study||0
491824|NCT00362882|1178587|P1|NOT COMPLETED|Overall Study||0
491825|NCT00362882|1178586|P2|COMPLETED|Overall Study||41
491826|NCT00362882|1178587|P1|COMPLETED|Overall Study||40
491827|NCT00362882|1178586|P2|STARTED|Overall Study||41
491828|NCT00362882|1178587|P1|STARTED|Overall Study||40
491829|NCT00362817|1178597|P1|NOT COMPLETED|Overall Study||0
491830|NCT00362817|1178597|P1|COMPLETED|Overall Study||17
491831|NCT00362817|1178597|P1|STARTED|Overall Study||17
491832|NCT00362648|1178610|P4|NOT COMPLETED|Overall Study||11
491833|NCT00362648|1178611|P3|NOT COMPLETED|Overall Study||9
491834|NCT00362648|1178612|P2|NOT COMPLETED|Overall Study||134
491835|NCT00362648|1178613|P1|NOT COMPLETED|Overall Study||126
491836|NCT00362648|1178610|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
491837|NCT00362648|1178611|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
491838|NCT00362648|1178612|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
491839|NCT00362648|1178613|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
491840|NCT00362648|1178610|P4|Vaccinated at Visit 3|Overall Study||1007
491841|NCT00362648|1178611|P3|Vaccinated at Visit 3|Overall Study||1009
491842|NCT00362648|1178612|P2|Vaccinated at Visit 3|Overall Study||2612
491843|NCT00362648|1178613|P1|Vaccinated at Visit 3|Overall Study||2613
491844|NCT00362648|1178610|P4|Vaccinated at Visit 2|Overall Study||1009
491845|NCT00362648|1178611|P3|Vaccinated at Visit 2|Overall Study||1013
491846|NCT00362648|1178612|P2|Vaccinated at Visit 2|Overall Study||2666
491847|NCT00362648|1178613|P1|Vaccinated at Visit 2|Overall Study||2657
491848|NCT00362648|1178610|P4|Vaccinated at Visit 1|Overall Study||1018
491849|NCT00362648|1178611|P3|Vaccinated at Visit 1|Overall Study||1018
491850|NCT00362648|1178612|P2|Vaccinated at Visit 1|Overall Study||2735
491851|NCT00362648|1178613|P1|Vaccinated at Visit 1|Overall Study||2733
491852|NCT00362648|1178610|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
491853|NCT00362648|1178611|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
491854|NCT00362648|1178612|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
491855|NCT00362648|1178613|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
491856|NCT00362609|1178631|P2|NOT COMPLETED|Overall Study||2
491857|NCT00362609|1178632|P1|NOT COMPLETED|Overall Study||0
491858|NCT00362609|1178631|P2|COMPLETED|Overall Study||38
491859|NCT00362609|1178632|P1|COMPLETED|Overall Study||19
491860|NCT00362609|1178631|P2|STARTED|Overall Study||40
491861|NCT00362609|1178632|P1|STARTED|Overall Study||19
491862|NCT00362466|1178646|P2|NOT COMPLETED|Overall Study||0
491863|NCT00362466|1178647|P1|NOT COMPLETED|Overall Study||0
491864|NCT00362466|1178646|P2|COMPLETED|Overall Study||1
491865|NCT00362466|1178647|P1|COMPLETED|Overall Study||2
491866|NCT00362466|1178646|P2|STARTED|Overall Study||1
491867|NCT00362466|1178647|P1|STARTED|Overall Study||2
491868|NCT00362453|1178669|P2|NOT COMPLETED|Overall Study||0
491869|NCT00362453|1178670|P1|NOT COMPLETED|Overall Study||0
491870|NCT00362453|1178669|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
491871|NCT00362453|1178670|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
491872|NCT00362453|1178669|P2|STARTED|Overall Study||20
491873|NCT00362453|1178670|P1|STARTED|Overall Study||20
491874|NCT00362440|1178702|P2|NOT COMPLETED|Overall Study||1
491875|NCT00362440|1178703|P1|NOT COMPLETED|Overall Study||2
491876|NCT00362440|1178702|P2|COMPLETED|Overall Study||3
491877|NCT00362440|1178703|P1|COMPLETED|Overall Study||3
491878|NCT00362440|1178702|P2|STARTED|Overall Study||4
491879|NCT00362440|1178703|P1|STARTED|Overall Study||5
491880|NCT00362414|1178713|P1|NOT COMPLETED|Overall Study||3
491881|NCT00362414|1178713|P1|COMPLETED|Overall Study||12
491882|NCT00362414|1178713|P1|STARTED|Overall Study||15
491883|NCT00362401|1178733|P3|NOT COMPLETED|Overall Study||0
491884|NCT00362401|1178734|P2|NOT COMPLETED|Overall Study||0
491885|NCT00362401|1178735|P1|NOT COMPLETED|Overall Study||0
491886|NCT00362401|1178733|P3|COMPLETED|Overall Study||40
491887|NCT00362401|1178734|P2|COMPLETED|Overall Study||29
491888|NCT00362401|1178735|P1|COMPLETED|Overall Study||15
491889|NCT00362401|1178733|P3|STARTED|Overall Study||40
491890|NCT00362401|1178734|P2|STARTED|Overall Study||29
491891|NCT00362401|1178735|P1|STARTED|Overall Study||15
491892|NCT00362375|1178742|P2|NOT COMPLETED|Overall Study||35
491893|NCT00362375|1178743|P1|NOT COMPLETED|Overall Study||40
491894|NCT00362375|1178742|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
491895|NCT00362375|1178743|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
491896|NCT00362375|1178742|P2|STARTED|Overall Study|Number eligible and randomized|152
491897|NCT00362375|1178743|P1|STARTED|Overall Study|Number eligible and randomized|161
491898|NCT00362336|1178760|P3|NOT COMPLETED|Overall Study||3
491899|NCT00362336|1178761|P2|NOT COMPLETED|Overall Study||7
491900|NCT00362336|1178762|P1|NOT COMPLETED|Overall Study||10
491901|NCT00362336|1178760|P3|COMPLETED|Overall Study||134
491902|NCT00362336|1178761|P2|COMPLETED|Overall Study||235
491903|NCT00362336|1178762|P1|COMPLETED|Overall Study||233
491904|NCT00362336|1178760|P3|STARTED|Overall Study||137
491905|NCT00362336|1178761|P2|STARTED|Overall Study||242
491906|NCT00362336|1178762|P1|STARTED|Overall Study||243
491907|NCT00362297|1178790|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
491908|NCT00362297|1178791|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
491909|NCT00362297|1178790|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
491910|NCT00362297|1178791|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
491911|NCT00362297|1178790|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
491912|NCT00362297|1178791|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
491913|NCT00362297|1178790|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
491914|NCT00362297|1178791|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
491915|NCT00362297|1178790|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
491916|NCT00362297|1178791|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
491917|NCT00362297|1178790|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
491918|NCT00362297|1178791|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
491919|NCT00362232|1178799|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
491920|NCT00362232|1178800|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
491921|NCT00362232|1178799|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
491922|NCT00362232|1178800|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
491923|NCT00362232|1178799|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
491924|NCT00362232|1178800|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
491925|NCT00362232|1178799|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
491926|NCT00362232|1178800|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
491927|NCT00362232|1178799|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
491928|NCT00362232|1178800|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
491929|NCT00362232|1178799|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
491930|NCT00362232|1178800|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
491931|NCT00362232|1178799|P2|STARTED|Treatment (12 +/- 2 Days)||1564
491932|NCT00362232|1178800|P1|STARTED|Treatment (12 +/- 2 Days)||1584
491933|NCT00362180|1178845|P9|NOT COMPLETED|20 Week Safety Follow-up||0
491934|NCT00362180|1178846|P8|NOT COMPLETED|20 Week Safety Follow-up||0
491935|NCT00362180|1178847|P7|NOT COMPLETED|20 Week Safety Follow-up||0
491936|NCT00362180|1178848|P6|NOT COMPLETED|20 Week Safety Follow-up||0
491937|NCT00362180|1178849|P5|NOT COMPLETED|20 Week Safety Follow-up||0
491938|NCT00362180|1178850|P4|NOT COMPLETED|20 Week Safety Follow-up||0
491939|NCT00362180|1178851|P3|NOT COMPLETED|20 Week Safety Follow-up||0
491940|NCT00362180|1178852|P2|NOT COMPLETED|20 Week Safety Follow-up||0
491941|NCT00362180|1178853|P1|NOT COMPLETED|20 Week Safety Follow-up||0
491942|NCT00362180|1178845|P9|COMPLETED|20 Week Safety Follow-up||1
491943|NCT00362180|1178846|P8|COMPLETED|20 Week Safety Follow-up||3
491944|NCT00362180|1178847|P7|COMPLETED|20 Week Safety Follow-up||0
491945|NCT00362180|1178848|P6|COMPLETED|20 Week Safety Follow-up||9
491946|NCT00362180|1178849|P5|COMPLETED|20 Week Safety Follow-up||11
491947|NCT00362180|1178850|P4|COMPLETED|20 Week Safety Follow-up||0
491948|NCT00362180|1178851|P3|COMPLETED|20 Week Safety Follow-up||1
491949|NCT00362180|1178852|P2|COMPLETED|20 Week Safety Follow-up||2
491950|NCT00362180|1178853|P1|COMPLETED|20 Week Safety Follow-up||3
491951|NCT00362180|1178845|P9|STARTED|20 Week Safety Follow-up||1
491952|NCT00362180|1178846|P8|STARTED|20 Week Safety Follow-up||3
491953|NCT00362180|1178847|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
491954|NCT00362180|1178848|P6|STARTED|20 Week Safety Follow-up||9
491955|NCT00362180|1178849|P5|STARTED|20 Week Safety Follow-up||11
491956|NCT00362180|1178850|P4|STARTED|20 Week Safety Follow-up||0
491957|NCT00362180|1178851|P3|STARTED|20 Week Safety Follow-up||1
491958|NCT00362180|1178852|P2|STARTED|20 Week Safety Follow-up||2
491959|NCT00362180|1178853|P1|STARTED|20 Week Safety Follow-up||3
491960|NCT00362180|1178845|P9|NOT COMPLETED|Treated Period||0
491961|NCT00362180|1178846|P8|NOT COMPLETED|Treated Period||1
491962|NCT00362180|1178847|P7|NOT COMPLETED|Treated Period||0
491963|NCT00362180|1178848|P6|NOT COMPLETED|Treated Period||1
491964|NCT00362180|1178849|P5|NOT COMPLETED|Treated Period||0
491965|NCT00362180|1178850|P4|NOT COMPLETED|Treated Period||0
491966|NCT00362180|1178851|P3|NOT COMPLETED|Treated Period||0
491967|NCT00362180|1178852|P2|NOT COMPLETED|Treated Period||0
491968|NCT00362180|1178853|P1|NOT COMPLETED|Treated Period||1
491969|NCT00362180|1178845|P9|COMPLETED|Treated Period||1
491970|NCT00362180|1178846|P8|COMPLETED|Treated Period||2
491971|NCT00362180|1178847|P7|COMPLETED|Treated Period||6
491972|NCT00362180|1178848|P6|COMPLETED|Treated Period||9
491973|NCT00362180|1178849|P5|COMPLETED|Treated Period||11
491974|NCT00362180|1178850|P4|COMPLETED|Treated Period||0
491975|NCT00362180|1178851|P3|COMPLETED|Treated Period||1
491976|NCT00362180|1178852|P2|COMPLETED|Treated Period||2
491977|NCT00362180|1178853|P1|COMPLETED|Treated Period||3
491978|NCT00362180|1178845|P9|STARTED|Treated Period||1
491979|NCT00362180|1178846|P8|STARTED|Treated Period||3
491980|NCT00362180|1178847|P7|STARTED|Treated Period||6
491981|NCT00362180|1178848|P6|STARTED|Treated Period||10
491982|NCT00362180|1178849|P5|STARTED|Treated Period||11
491983|NCT00362180|1178850|P4|STARTED|Treated Period||0
491984|NCT00362180|1178851|P3|STARTED|Treated Period||1
491985|NCT00362180|1178852|P2|STARTED|Treated Period||2
491986|NCT00362180|1178853|P1|STARTED|Treated Period||4
491987|NCT00362128|1178914|P1|NOT COMPLETED|Overall Study||0
491988|NCT00362128|1178914|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
491989|NCT00362128|1178914|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
491990|NCT00362115|1178925|P7|NOT COMPLETED|Overall Study||12
491991|NCT00362115|1178926|P6|NOT COMPLETED|Overall Study||7
491992|NCT00362115|1178927|P5|NOT COMPLETED|Overall Study||7
491993|NCT00362115|1178928|P4|NOT COMPLETED|Overall Study||4
491994|NCT00362115|1178929|P3|NOT COMPLETED|Overall Study||7
491995|NCT00362115|1178930|P2|NOT COMPLETED|Overall Study||6
491996|NCT00362115|1178931|P1|NOT COMPLETED|Overall Study||2
491997|NCT00362115|1178925|P7|COMPLETED|Overall Study||52
491998|NCT00362115|1178926|P6|COMPLETED|Overall Study||57
491999|NCT00362115|1178927|P5|COMPLETED|Overall Study||57
492000|NCT00362115|1178928|P4|COMPLETED|Overall Study||59
492001|NCT00362115|1178929|P3|COMPLETED|Overall Study||57
492002|NCT00362115|1178930|P2|COMPLETED|Overall Study||59
492003|NCT00362115|1178931|P1|COMPLETED|Overall Study||63
492004|NCT00362115|1178925|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
492005|NCT00362115|1178926|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
492006|NCT00362115|1178927|P5|STARTED|Overall Study||64
492007|NCT00362115|1178928|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
492008|NCT00362115|1178929|P3|STARTED|Overall Study||64
492009|NCT00362115|1178930|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
492010|NCT00362115|1178931|P1|STARTED|Overall Study||65
492011|NCT00361972|1179082|P2|NOT COMPLETED|Overall Study||0
492012|NCT00361972|1179083|P1|NOT COMPLETED|Overall Study||0
492013|NCT00361972|1179082|P2|COMPLETED|Overall Study||9
492014|NCT00361972|1179083|P1|COMPLETED|Overall Study||8
492015|NCT00361972|1179082|P2|STARTED|Overall Study||9
492016|NCT00361972|1179083|P1|STARTED|Overall Study||8
492017|NCT00361634|1179091|P1|NOT COMPLETED|Overall Study||2
492018|NCT00361634|1179091|P1|COMPLETED|Overall Study||12
492019|NCT00361634|1179091|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
492020|NCT00361634|1179091|P1|STARTED|Overall Study||14
492021|NCT00361595|1179109|P1|NOT COMPLETED|Overall Study||0
492022|NCT00361595|1179109|P1|COMPLETED|Overall Study||35
492023|NCT00361595|1179109|P1|STARTED|Overall Study||35
492024|NCT00361569|1179120|P4|NOT COMPLETED|Overall Study||21
492025|NCT00361569|1179121|P3|NOT COMPLETED|Overall Study||18
492026|NCT00361569|1179122|P2|NOT COMPLETED|Overall Study||11
492027|NCT00361569|1179123|P1|NOT COMPLETED|Overall Study||12
492028|NCT00361569|1179120|P4|COMPLETED|Overall Study||135
492029|NCT00361569|1179121|P3|COMPLETED|Overall Study||137
492030|NCT00361569|1179122|P2|COMPLETED|Overall Study||150
492031|NCT00361569|1179123|P1|COMPLETED|Overall Study||138
492032|NCT00361569|1179120|P4|STARTED|Overall Study||156
492033|NCT00361569|1179121|P3|STARTED|Overall Study||155
492034|NCT00361569|1179122|P2|STARTED|Overall Study||161
492035|NCT00361569|1179123|P1|STARTED|Overall Study||150
492036|NCT00361504|1179147|P2|NOT COMPLETED|Overall Study||145
492037|NCT00361504|1179148|P1|NOT COMPLETED|Overall Study||481
492038|NCT00361504|1179147|P2|COMPLETED|Overall Study||78
492039|NCT00361504|1179148|P1|COMPLETED|Overall Study||413
492040|NCT00361504|1179147|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
492041|NCT00361504|1179148|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
492042|NCT00361439|1179158|P2|NOT COMPLETED|Overall Study||0
492043|NCT00361439|1179159|P1|NOT COMPLETED|Overall Study||0
492044|NCT00361439|1179158|P2|COMPLETED|Overall Study||9
492045|NCT00361439|1179159|P1|COMPLETED|Overall Study||8
492046|NCT00361439|1179158|P2|STARTED|Overall Study||9
492047|NCT00361439|1179159|P1|STARTED|Overall Study||8
492048|NCT00361374|1179174|P3|NOT COMPLETED|Overall Study||12
492049|NCT00361374|1179175|P2|NOT COMPLETED|Overall Study||15
492050|NCT00361374|1179176|P1|NOT COMPLETED|Overall Study||15
492051|NCT00361374|1179174|P3|COMPLETED|Overall Study||53
492052|NCT00361374|1179175|P2|COMPLETED|Overall Study||50
492053|NCT00361374|1179176|P1|COMPLETED|Overall Study||51
492054|NCT00361374|1179174|P3|STARTED|Overall Study||65
492055|NCT00361374|1179175|P2|STARTED|Overall Study||65
492056|NCT00361374|1179176|P1|STARTED|Overall Study||66
492057|NCT00361335|1179189|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
492058|NCT00361335|1179190|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
492059|NCT00361335|1179191|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
492060|NCT00361335|1179192|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
492061|NCT00361335|1179193|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
492062|NCT00361335|1179194|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
492063|NCT00361335|1179195|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
492064|NCT00361335|1179189|P7|COMPLETED|SC Period: Week E0 to Week E24||164
492065|NCT00361335|1179190|P6|COMPLETED|SC Period: Week E0 to Week E24||23
492066|NCT00361335|1179191|P5|COMPLETED|SC Period: Week E0 to Week E24||3
492067|NCT00361335|1179192|P4|COMPLETED|SC Period: Week E0 to Week E24||59
492068|NCT00361335|1179193|P3|COMPLETED|SC Period: Week E0 to Week E24||99
492069|NCT00361335|1179194|P2|COMPLETED|SC Period: Week E0 to Week E24||56
492070|NCT00361335|1179195|P1|COMPLETED|SC Period: Week E0 to Week E24||80
492071|NCT00361335|1179189|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
492072|NCT00361335|1179190|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
492073|NCT00361335|1179191|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
492074|NCT00361335|1179192|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
492075|NCT00361335|1179193|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
492076|NCT00361335|1179194|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
492077|NCT00361335|1179195|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
492078|NCT00361335|1179189|P7|NOT COMPLETED|IV Period: Baseline to E0||0
492079|NCT00361335|1179190|P6|NOT COMPLETED|IV Period: Baseline to E0||0
492080|NCT00361335|1179191|P5|NOT COMPLETED|IV Period: Baseline to E0||24
492081|NCT00361335|1179192|P4|NOT COMPLETED|IV Period: Baseline to E0||27
492082|NCT00361335|1179193|P3|NOT COMPLETED|IV Period: Baseline to E0||21
492083|NCT00361335|1179194|P2|NOT COMPLETED|IV Period: Baseline to E0||29
492084|NCT00361335|1179195|P1|NOT COMPLETED|IV Period: Baseline to E0||20
492085|NCT00361335|1179189|P7|COMPLETED|IV Period: Baseline to E0||0
492086|NCT00361335|1179190|P6|COMPLETED|IV Period: Baseline to E0||0
492087|NCT00361335|1179191|P5|COMPLETED|IV Period: Baseline to E0||105
492088|NCT00361335|1179192|P4|COMPLETED|IV Period: Baseline to E0||102
492089|NCT00361335|1179193|P3|COMPLETED|IV Period: Baseline to E0||107
492090|NCT00361335|1179194|P2|COMPLETED|IV Period: Baseline to E0||99
492091|NCT00361335|1179195|P1|COMPLETED|IV Period: Baseline to E0||109
492092|NCT00361335|1179189|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
492093|NCT00361335|1179190|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
492094|NCT00361335|1179191|P5|STARTED|IV Period: Baseline to E0||129
492095|NCT00361335|1179192|P4|STARTED|IV Period: Baseline to E0||129
492096|NCT00361335|1179193|P3|STARTED|IV Period: Baseline to E0||128
492097|NCT00361335|1179194|P2|STARTED|IV Period: Baseline to E0||128
492098|NCT00361335|1179195|P1|STARTED|IV Period: Baseline to E0||129
492099|NCT00361283|1179239|P1|NOT COMPLETED|Overall Study||27
492100|NCT00361283|1179239|P1|COMPLETED|Overall Study||81
492101|NCT00361283|1179239|P1|STARTED|Overall Study||108
492102|NCT00361270|1179247|P4|NOT COMPLETED|Overall Study||13
492103|NCT00361270|1179248|P3|NOT COMPLETED|Overall Study||10
492104|NCT00361270|1179249|P2|NOT COMPLETED|Overall Study||14
492105|NCT00361270|1179250|P1|NOT COMPLETED|Overall Study||24
492106|NCT00361270|1179247|P4|COMPLETED|Overall Study||25
492107|NCT00361270|1179248|P3|COMPLETED|Overall Study||25
492108|NCT00361270|1179249|P2|COMPLETED|Overall Study||25
492109|NCT00361270|1179250|P1|COMPLETED|Overall Study||25
492110|NCT00361270|1179247|P4|STARTED|Overall Study||38
492111|NCT00361270|1179248|P3|STARTED|Overall Study||35
492112|NCT00361270|1179249|P2|STARTED|Overall Study||39
492113|NCT00361270|1179250|P1|STARTED|Overall Study||49
492114|NCT00361257|1179270|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
492115|NCT00361257|1179271|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
492116|NCT00361257|1179270|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
492117|NCT00361257|1179271|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
492118|NCT00361257|1179270|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
492119|NCT00361257|1179271|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
492120|NCT00361257|1179270|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
492121|NCT00361257|1179271|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
492122|NCT00361257|1179270|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
492123|NCT00361257|1179271|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
492124|NCT00361257|1179270|P2|STARTED|Step 1: Minocycline vs. Placebo||55
492125|NCT00361257|1179271|P1|STARTED|Step 1: Minocycline vs. Placebo||52
492126|NCT00361231|1179323|P1|NOT COMPLETED|Overall Study||34
492127|NCT00361231|1179323|P1|COMPLETED|Overall Study||1
492128|NCT00361231|1179323|P1|STARTED|Overall Study||35
492129|NCT00361218|1179328|P1|NOT COMPLETED|Overall Study||23
492130|NCT00361218|1179328|P1|COMPLETED|Overall Study||30
492131|NCT00361218|1179328|P1|Completed Baseline Assessment|Overall Study||47
492132|NCT00361218|1179328|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
492133|NCT00361140|1179335|P3|NOT COMPLETED|Overall Study||0
492134|NCT00361140|1179336|P2|NOT COMPLETED|Overall Study||0
492135|NCT00361140|1179337|P1|NOT COMPLETED|Overall Study||0
492136|NCT00361140|1179335|P3|COMPLETED|Overall Study||3
492137|NCT00361140|1179336|P2|COMPLETED|Overall Study||29
492138|NCT00361140|1179337|P1|COMPLETED|Overall Study||40
492139|NCT00361140|1179335|P3|STARTED|Overall Study||3
492140|NCT00361140|1179336|P2|STARTED|Overall Study||29
492141|NCT00361140|1179337|P1|STARTED|Overall Study||40
492142|NCT00360971|1179350|P2|NOT COMPLETED|Overall Study||0
492143|NCT00360971|1179351|P1|NOT COMPLETED|Overall Study||0
492144|NCT00360971|1179350|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
492145|NCT00360971|1179351|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
492146|NCT00360971|1179350|P2|STARTED|Overall Study||11
492147|NCT00360971|1179351|P1|STARTED|Overall Study||10
492148|NCT00360828|1179357|P1|NOT COMPLETED|Overall Study||1
492149|NCT00360828|1179357|P1|COMPLETED|Overall Study||9
492150|NCT00360828|1179357|P1|STARTED|Overall Study||10
492151|NCT00360724|1179367|P2|NOT COMPLETED|Overall Study||4
492152|NCT00360724|1179368|P1|NOT COMPLETED|Overall Study||4
492153|NCT00360724|1179367|P2|COMPLETED|Overall Study||28
492154|NCT00360724|1179368|P1|COMPLETED|Overall Study||29
492155|NCT00360724|1179367|P2|STARTED|Overall Study||32
492156|NCT00360724|1179368|P1|STARTED|Overall Study||33
492157|NCT00360698|1179392|P2|NOT COMPLETED|Treatment Period||1
492158|NCT00360698|1179393|P1|NOT COMPLETED|Treatment Period||1
492159|NCT00360698|1179392|P2|COMPLETED|Treatment Period||56
492160|NCT00360698|1179393|P1|COMPLETED|Treatment Period||48
492161|NCT00360698|1179392|P2|STARTED|Treatment Period||57
492162|NCT00360698|1179393|P1|STARTED|Treatment Period||49
492163|NCT00360698|1179392|P2|NOT COMPLETED|Run-In||10
492164|NCT00360698|1179393|P1|NOT COMPLETED|Run-In||0
492165|NCT00360698|1179392|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
492166|NCT00360698|1179393|P1|COMPLETED|Run-In||0
492167|NCT00360698|1179392|P2|STARTED|Run-In||135
492168|NCT00360698|1179393|P1|STARTED|Run-In||0
492169|NCT00360685|1179421|P2|NOT COMPLETED|Overall Study||0
492170|NCT00360685|1179422|P1|NOT COMPLETED|Overall Study||0
492171|NCT00360685|1179421|P2|COMPLETED|Overall Study||42
492172|NCT00360685|1179422|P1|COMPLETED|Overall Study||47
492173|NCT00360685|1179421|P2|STARTED|Overall Study||42
492174|NCT00360685|1179422|P1|STARTED|Overall Study||47
492175|NCT00360672|1179432|P1|NOT COMPLETED|Overall Study||0
492176|NCT00360672|1179432|P1|COMPLETED|Overall Study||27
492177|NCT00360672|1179432|P1|STARTED|Overall Study||27
492178|NCT00360568|1179438|P2|NOT COMPLETED|Overall Study||5
492179|NCT00360568|1179439|P1|NOT COMPLETED|Overall Study||2
492180|NCT00360568|1179438|P2|COMPLETED|Overall Study||24
492181|NCT00360568|1179439|P1|COMPLETED|Overall Study||31
492182|NCT00360568|1179438|P2|STARTED|Overall Study||29
492183|NCT00360568|1179439|P1|STARTED|Overall Study||33
492184|NCT00360555|1179550|P4|NOT COMPLETED|Overall Study||112
492185|NCT00360555|1179551|P3|NOT COMPLETED|Overall Study||145
492186|NCT00360555|1179552|P2|NOT COMPLETED|Overall Study||134
492187|NCT00360555|1179553|P1|NOT COMPLETED|Overall Study||122
492188|NCT00360555|1179550|P4|COMPLETED|Overall Study||287
492189|NCT00360555|1179551|P3|COMPLETED|Overall Study||251
492190|NCT00360555|1179552|P2|COMPLETED|Overall Study||259
492191|NCT00360555|1179553|P1|COMPLETED|Overall Study||274
492192|NCT00360555|1179550|P4|STARTED|Overall Study||399
492193|NCT00360555|1179551|P3|STARTED|Overall Study||396
492194|NCT00360555|1179552|P2|STARTED|Overall Study||393
492195|NCT00360555|1179553|P1|STARTED|Overall Study||396
492196|NCT00360529|1179570|P3|NOT COMPLETED|Overall Study||91
492197|NCT00360529|1179571|P2|NOT COMPLETED|Overall Study||65
492198|NCT00360529|1179572|P1|NOT COMPLETED|Overall Study||61
492199|NCT00360529|1179570|P3|COMPLETED|Overall Study||199
492200|NCT00360529|1179571|P2|COMPLETED|Overall Study||230
492201|NCT00360529|1179572|P1|COMPLETED|Overall Study||234
492202|NCT00360529|1179570|P3|STARTED|Overall Study||290
492203|NCT00360529|1179571|P2|STARTED|Overall Study||295
492204|NCT00360529|1179572|P1|STARTED|Overall Study||295
492205|NCT00360490|1179600|P2|NOT COMPLETED|Overall Study||11
492206|NCT00360490|1179601|P1|NOT COMPLETED|Overall Study||9
492207|NCT00360490|1179600|P2|COMPLETED|Overall Study||72
492208|NCT00360490|1179601|P1|COMPLETED|Overall Study||73
492209|NCT00360490|1179600|P2|STARTED|Overall Study||83
492210|NCT00360490|1179601|P1|STARTED|Overall Study||82
492211|NCT00360412|1179636|P2|NOT COMPLETED|Overall Study||662
492212|NCT00360412|1179637|P1|NOT COMPLETED|Overall Study||333
492213|NCT00360412|1179636|P2|COMPLETED|Overall Study||2
492214|NCT00360412|1179637|P1|COMPLETED|Overall Study||0
492215|NCT00360412|1179636|P2|STARTED|Overall Study||664
492216|NCT00360412|1179637|P1|STARTED|Overall Study||333
492217|NCT00360399|1179652|P3|NOT COMPLETED|Overall Study||46
492218|NCT00360399|1179653|P2|NOT COMPLETED|Overall Study||36
492219|NCT00360399|1179654|P1|NOT COMPLETED|Overall Study||28
492220|NCT00360399|1179652|P3|COMPLETED|Overall Study||69
492221|NCT00360399|1179653|P2|COMPLETED|Overall Study||79
492222|NCT00360399|1179654|P1|COMPLETED|Overall Study||86
492223|NCT00360399|1179652|P3|Had Post-randomization Assessment|Overall Study||105
492224|NCT00360399|1179653|P2|Had Post-randomization Assessment|Overall Study||106
492225|NCT00360399|1179654|P1|Had Post-randomization Assessment|Overall Study||105
492226|NCT00360399|1179652|P3|STARTED|Overall Study||115
492227|NCT00360399|1179653|P2|STARTED|Overall Study||115
492228|NCT00360399|1179654|P1|STARTED|Overall Study||114
492229|NCT00360360|1179677|P1|NOT COMPLETED|Overall Study||6
492230|NCT00360360|1179677|P1|COMPLETED|Overall Study||54
492231|NCT00360360|1179677|P1|STARTED|Overall Study||60
492232|NCT00360334|1179684|P2|NOT COMPLETED|Overall Study||13
492233|NCT00360334|1179685|P1|NOT COMPLETED|Overall Study||19
492234|NCT00360334|1179684|P2|COMPLETED|Overall Study||104
492235|NCT00360334|1179685|P1|COMPLETED|Overall Study||99
492236|NCT00360334|1179684|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
492237|NCT00360334|1179685|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
492238|NCT00360334|1179684|P2|STARTED|Overall Study||117
492239|NCT00360334|1179685|P1|STARTED|Overall Study||118
492240|NCT00360308|1179748|P3|NOT COMPLETED|Overall Study||88
492241|NCT00360308|1179749|P2|NOT COMPLETED|Overall Study||79
492242|NCT00360308|1179750|P1|NOT COMPLETED|Overall Study||76
492243|NCT00360308|1179748|P3|COMPLETED|Overall Study||154
492244|NCT00360308|1179749|P2|COMPLETED|Overall Study||155
492245|NCT00360308|1179750|P1|COMPLETED|Overall Study||171
492246|NCT00360308|1179748|P3|STARTED|Overall Study||242
492247|NCT00360308|1179749|P2|STARTED|Overall Study||234
492248|NCT00360308|1179750|P1|STARTED|Overall Study||247
492249|NCT00360282|1179767|P4|NOT COMPLETED|Second Intervention||0
492250|NCT00360282|1179768|P3|NOT COMPLETED|Second Intervention||0
492251|NCT00360282|1179769|P2|NOT COMPLETED|Second Intervention||1
492252|NCT00360282|1179770|P1|NOT COMPLETED|Second Intervention||0
492253|NCT00360282|1179767|P4|COMPLETED|Second Intervention||6
492254|NCT00360282|1179768|P3|COMPLETED|Second Intervention||6
492255|NCT00360282|1179769|P2|COMPLETED|Second Intervention||7
492256|NCT00360282|1179770|P1|COMPLETED|Second Intervention||6
492257|NCT00360282|1179767|P4|STARTED|Second Intervention||6
492258|NCT00360282|1179768|P3|STARTED|Second Intervention||6
492259|NCT00360282|1179769|P2|STARTED|Second Intervention||8
492260|NCT00360282|1179770|P1|STARTED|Second Intervention||6
492261|NCT00360282|1179767|P4|NOT COMPLETED|Washout 1-3 Weeks||0
492262|NCT00360282|1179768|P3|NOT COMPLETED|Washout 1-3 Weeks||1
492263|NCT00360282|1179769|P2|NOT COMPLETED|Washout 1-3 Weeks||0
492264|NCT00360282|1179770|P1|NOT COMPLETED|Washout 1-3 Weeks||0
492265|NCT00360282|1179767|P4|COMPLETED|Washout 1-3 Weeks||6
492266|NCT00360282|1179768|P3|COMPLETED|Washout 1-3 Weeks||6
492267|NCT00360282|1179769|P2|COMPLETED|Washout 1-3 Weeks||8
492268|NCT00360282|1179770|P1|COMPLETED|Washout 1-3 Weeks||6
492269|NCT00360282|1179767|P4|STARTED|Washout 1-3 Weeks||6
492270|NCT00360282|1179768|P3|STARTED|Washout 1-3 Weeks||7
492271|NCT00360282|1179769|P2|STARTED|Washout 1-3 Weeks||8
492272|NCT00360282|1179770|P1|STARTED|Washout 1-3 Weeks||6
492273|NCT00360282|1179767|P4|NOT COMPLETED|First Intervention||0
492274|NCT00360282|1179768|P3|NOT COMPLETED|First Intervention||0
492275|NCT00360282|1179769|P2|NOT COMPLETED|First Intervention||0
492276|NCT00360282|1179770|P1|NOT COMPLETED|First Intervention||0
492277|NCT00360282|1179767|P4|COMPLETED|First Intervention||6
492278|NCT00360282|1179768|P3|COMPLETED|First Intervention||7
492279|NCT00360282|1179769|P2|COMPLETED|First Intervention||8
492280|NCT00360282|1179770|P1|COMPLETED|First Intervention||6
492281|NCT00360282|1179767|P4|STARTED|First Intervention||6
492282|NCT00360282|1179768|P3|STARTED|First Intervention||7
492283|NCT00360282|1179769|P2|STARTED|First Intervention||8
492284|NCT00360282|1179770|P1|STARTED|First Intervention||6
492285|NCT00360269|1179782|P2|NOT COMPLETED|Overall Study||12
492286|NCT00360269|1179783|P1|NOT COMPLETED|Overall Study||10
492287|NCT00360269|1179782|P2|COMPLETED|Overall Study||7
492288|NCT00360269|1179783|P1|COMPLETED|Overall Study||9
492289|NCT00360269|1179782|P2|STARTED|Overall Study||19
492290|NCT00360269|1179783|P1|STARTED|Overall Study||19
492291|NCT00360243|1179801|P4|NOT COMPLETED|Overall Study||125
492292|NCT00360243|1179802|P3|NOT COMPLETED|Overall Study||156
492293|NCT00360243|1179803|P2|NOT COMPLETED|Overall Study||120
492294|NCT00360243|1179804|P1|NOT COMPLETED|Overall Study||102
492295|NCT00360243|1179801|P4|COMPLETED|Overall Study||224
492296|NCT00360243|1179802|P3|COMPLETED|Overall Study||180
492297|NCT00360243|1179803|P2|COMPLETED|Overall Study||243
492298|NCT00360243|1179804|P1|COMPLETED|Overall Study||235
492299|NCT00360243|1179801|P4|STARTED|Overall Study||349
492300|NCT00360243|1179802|P3|STARTED|Overall Study||336
492301|NCT00360243|1179803|P2|STARTED|Overall Study||363
492302|NCT00360243|1179804|P1|STARTED|Overall Study||337
492303|NCT00360126|1179818|P1|NOT COMPLETED|Overall Study||0
492304|NCT00360126|1179818|P1|COMPLETED|Overall Study||11
492305|NCT00360126|1179818|P1|STARTED|Overall Study||11
492306|NCT00360009|1179825|P3|NOT COMPLETED|Overall Study||3
492307|NCT00360009|1179826|P2|NOT COMPLETED|Overall Study||4
492308|NCT00360009|1179827|P1|NOT COMPLETED|Overall Study||0
492309|NCT00360009|1179825|P3|COMPLETED|Overall Study||23
492310|NCT00360009|1179826|P2|COMPLETED|Overall Study||22
492311|NCT00360009|1179827|P1|COMPLETED|Overall Study||10
492312|NCT00360009|1179825|P3|STARTED|Overall Study||26
492313|NCT00360009|1179826|P2|STARTED|Overall Study||26
492314|NCT00360009|1179827|P1|STARTED|Overall Study||10
492315|NCT00359983|1179868|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
492316|NCT00359983|1179869|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
492317|NCT00359983|1179870|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
492318|NCT00359983|1179868|P3|COMPLETED|Year 5 Persistence Follow-up||42
492319|NCT00359983|1179869|P2|COMPLETED|Year 5 Persistence Follow-up||44
492320|NCT00359983|1179870|P1|COMPLETED|Year 5 Persistence Follow-up||95
492321|NCT00359983|1179868|P3|STARTED|Year 5 Persistence Follow-up||42
492322|NCT00359983|1179869|P2|STARTED|Year 5 Persistence Follow-up||44
492323|NCT00359983|1179870|P1|STARTED|Year 5 Persistence Follow-up||95
492324|NCT00359983|1179868|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
492325|NCT00359983|1179869|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
492326|NCT00359983|1179870|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
492327|NCT00359983|1179868|P3|COMPLETED|Year 3 Persistence Follow-up||51
492328|NCT00359983|1179869|P2|COMPLETED|Year 3 Persistence Follow-up||47
492329|NCT00359983|1179870|P1|COMPLETED|Year 3 Persistence Follow-up||103
492330|NCT00359983|1179868|P3|STARTED|Year 3 Persistence Follow-up||51
492331|NCT00359983|1179869|P2|STARTED|Year 3 Persistence Follow-up||47
492332|NCT00359983|1179870|P1|STARTED|Year 3 Persistence Follow-up||103
492333|NCT00359983|1179868|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
492334|NCT00359983|1179869|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
492335|NCT00359983|1179870|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
492336|NCT00359983|1179868|P3|COMPLETED|Year 1 Persistence Follow-up||62
492337|NCT00359983|1179869|P2|COMPLETED|Year 1 Persistence Follow-up||70
492338|NCT00359983|1179870|P1|COMPLETED|Year 1 Persistence Follow-up||138
492339|NCT00359983|1179868|P3|STARTED|Year 1 Persistence Follow-up||62
492340|NCT00359983|1179869|P2|STARTED|Year 1 Persistence Follow-up||70
492341|NCT00359983|1179870|P1|STARTED|Year 1 Persistence Follow-up||138
492342|NCT00359944|1179905|P3|NOT COMPLETED|Overall Study||19
492343|NCT00359944|1179906|P2|NOT COMPLETED|Overall Study||19
492344|NCT00359944|1179907|P1|NOT COMPLETED|Overall Study||16
492345|NCT00359944|1179905|P3|COMPLETED|Overall Study||38
492346|NCT00359944|1179906|P2|COMPLETED|Overall Study||28
492347|NCT00359944|1179907|P1|COMPLETED|Overall Study||34
492348|NCT00359944|1179905|P3|STARTED|Overall Study||57
492349|NCT00359944|1179906|P2|STARTED|Overall Study||47
492350|NCT00359944|1179907|P1|STARTED|Overall Study||50
492351|NCT00359801|1179923|P2|NOT COMPLETED|Overall Study||220
492352|NCT00359801|1179924|P1|NOT COMPLETED|Overall Study||305
492353|NCT00359801|1179923|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
492354|NCT00359801|1179924|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
492355|NCT00359801|1179923|P2|STARTED|Overall Study||989
492356|NCT00359801|1179924|P1|STARTED|Overall Study||987
492357|NCT00359788|1179958|P2|NOT COMPLETED|Overall Study||17
492358|NCT00359788|1179959|P1|NOT COMPLETED|Overall Study||23
492359|NCT00359788|1179958|P2|COMPLETED|Overall Study||159
492360|NCT00359788|1179959|P1|COMPLETED|Overall Study||150
492361|NCT00359788|1179958|P2|STARTED|Overall Study||176
492362|NCT00359788|1179959|P1|STARTED|Overall Study||173
492363|NCT00359762|1180193|P5|NOT COMPLETED|Period I||0
492364|NCT00359762|1180194|P4|NOT COMPLETED|Period I||0
492365|NCT00359762|1180195|P3|NOT COMPLETED|Period I||0
492366|NCT00359762|1180196|P2|NOT COMPLETED|Period I||0
492367|NCT00359762|1180197|P1|NOT COMPLETED|Period I||0
492368|NCT00359762|1180193|P5|COMPLETED|Period I||0
492369|NCT00359762|1180194|P4|COMPLETED|Period I||0
492370|NCT00359762|1180195|P3|COMPLETED|Period I||0
492371|NCT00359762|1180196|P2|COMPLETED|Period I||0
492372|NCT00359762|1180197|P1|COMPLETED|Period I||0
492373|NCT00359762|1180193|P5|STARTED|Period I||0
492374|NCT00359762|1180194|P4|STARTED|Period I||0
492375|NCT00359762|1180195|P3|STARTED|Period I||0
492376|NCT00359762|1180196|P2|STARTED|Period I||0
492377|NCT00359762|1180197|P1|STARTED|Period I||0
492378|NCT00359762|1180193|P5|NOT COMPLETED|Period III||0
492379|NCT00359762|1180194|P4|NOT COMPLETED|Period III||65
492380|NCT00359762|1180195|P3|NOT COMPLETED|Period III||30
492381|NCT00359762|1180196|P2|NOT COMPLETED|Period III||29
492382|NCT00359762|1180197|P1|NOT COMPLETED|Period III||0
492383|NCT00359762|1180193|P5|COMPLETED|Period III||0
492384|NCT00359762|1180194|P4|COMPLETED|Period III||101
492385|NCT00359762|1180195|P3|COMPLETED|Period III||47
492386|NCT00359762|1180196|P2|COMPLETED|Period III||48
492387|NCT00359762|1180197|P1|COMPLETED|Period III||0
492388|NCT00359762|1180193|P5|Extension ITT Efficacy Population|Period III||0
492389|NCT00359762|1180194|P4|Extension ITT Efficacy Population|Period III||164
492390|NCT00359762|1180195|P3|Extension ITT Efficacy Population|Period III||75
492391|NCT00359762|1180196|P2|Extension ITT Efficacy Population|Period III||73
492392|NCT00359762|1180197|P1|Extension ITT Efficacy Population|Period III||0
492393|NCT00359762|1180193|P5|Extension ITT Safety Population|Period III||0
492394|NCT00359762|1180194|P4|Extension ITT Safety Population|Period III||166
492395|NCT00359762|1180195|P3|Extension ITT Safety Population|Period III||76
492396|NCT00359762|1180196|P2|Extension ITT Safety Population|Period III||74
492397|NCT00359762|1180197|P1|Extension ITT Safety Population|Period III||0
492398|NCT00359762|1180193|P5|STARTED|Period III||0
492399|NCT00359762|1180194|P4|STARTED|Period III||166
492400|NCT00359762|1180195|P3|STARTED|Period III||77
492401|NCT00359762|1180196|P2|STARTED|Period III||77
492402|NCT00359762|1180197|P1|STARTED|Period III||0
492403|NCT00359762|1180193|P5|NOT COMPLETED|Period II||174
492404|NCT00359762|1180194|P4|NOT COMPLETED|Period II||0
492405|NCT00359762|1180195|P3|NOT COMPLETED|Period II||0
492406|NCT00359762|1180196|P2|NOT COMPLETED|Period II||0
492407|NCT00359762|1180197|P1|NOT COMPLETED|Period II||128
492408|NCT00359762|1180193|P5|COMPLETED|Period II||341
492409|NCT00359762|1180194|P4|COMPLETED|Period II||0
492410|NCT00359762|1180195|P3|COMPLETED|Period II||0
492411|NCT00359762|1180196|P2|COMPLETED|Period II||0
492412|NCT00359762|1180197|P1|COMPLETED|Period II||386
492413|NCT00359762|1180193|P5|Without Treatment Failure|Period II||138
492414|NCT00359762|1180194|P4|Without Treatment Failure|Period II||0
492415|NCT00359762|1180195|P3|Without Treatment Failure|Period II||0
492416|NCT00359762|1180196|P2|Without Treatment Failure|Period II||0
492417|NCT00359762|1180197|P1|Without Treatment Failure|Period II||124
492418|NCT00359762|1180193|P5|Met Primary Endpoint|Period II||203
492419|NCT00359762|1180194|P4|Met Primary Endpoint|Period II||0
492420|NCT00359762|1180195|P3|Met Primary Endpoint|Period II||0
492421|NCT00359762|1180196|P2|Met Primary Endpoint|Period II||0
492422|NCT00359762|1180197|P1|Met Primary Endpoint|Period II||262
492423|NCT00359762|1180193|P5|ITT Efficacy Population|Period II||490
492424|NCT00359762|1180194|P4|ITT Efficacy Population|Period II||0
492425|NCT00359762|1180195|P3|ITT Efficacy Population|Period II||0
492426|NCT00359762|1180196|P2|ITT Efficacy Population|Period II||0
492427|NCT00359762|1180197|P1|ITT Efficacy Population|Period II||487
492428|NCT00359762|1180193|P5|Intent to Treat (ITT) Safety Population|Period II||511
492429|NCT00359762|1180194|P4|Intent to Treat (ITT) Safety Population|Period II||0
492430|NCT00359762|1180195|P3|Intent to Treat (ITT) Safety Population|Period II||0
492431|NCT00359762|1180196|P2|Intent to Treat (ITT) Safety Population|Period II||0
492432|NCT00359762|1180197|P1|Intent to Treat (ITT) Safety Population|Period II||508
492433|NCT00359762|1180193|P5|STARTED|Period II||515
492434|NCT00359762|1180194|P4|STARTED|Period II||0
492435|NCT00359762|1180195|P3|STARTED|Period II||0
492436|NCT00359762|1180196|P2|STARTED|Period II||0
492437|NCT00359762|1180197|P1|STARTED|Period II||514
492438|NCT00359736|1180260|P2|NOT COMPLETED|Overall Study||0
492439|NCT00359736|1180261|P1|NOT COMPLETED|Overall Study||0
492440|NCT00359736|1180260|P2|COMPLETED|Overall Study||15
492441|NCT00359736|1180261|P1|COMPLETED|Overall Study||14
492442|NCT00359736|1180260|P2|STARTED|Overall Study||15
492443|NCT00359736|1180261|P1|STARTED|Overall Study||14
492444|NCT00359632|1180271|P2|NOT COMPLETED|Overall Study||0
492445|NCT00359632|1180272|P1|NOT COMPLETED|Overall Study||4
492446|NCT00359632|1180271|P2|COMPLETED|Overall Study||9
492447|NCT00359632|1180272|P1|COMPLETED|Overall Study||20
492448|NCT00359632|1180271|P2|STARTED|Overall Study||9
492449|NCT00359632|1180272|P1|STARTED|Overall Study||24
492450|NCT00359619|1180286|P7|NOT COMPLETED|Overall Study||4
492451|NCT00359619|1180287|P6|NOT COMPLETED|Overall Study||5
492452|NCT00359619|1180288|P5|NOT COMPLETED|Overall Study||3
492453|NCT00359619|1180289|P4|NOT COMPLETED|Overall Study||3
492454|NCT00359619|1180290|P3|NOT COMPLETED|Overall Study||7
492455|NCT00359619|1180291|P2|NOT COMPLETED|Overall Study||5
492456|NCT00359619|1180292|P1|NOT COMPLETED|Overall Study||8
492457|NCT00359619|1180286|P7|COMPLETED|Overall Study||46
492458|NCT00359619|1180287|P6|COMPLETED|Overall Study||45
492459|NCT00359619|1180288|P5|COMPLETED|Overall Study||45
492460|NCT00359619|1180289|P4|COMPLETED|Overall Study||45
492461|NCT00359619|1180290|P3|COMPLETED|Overall Study||42
492462|NCT00359619|1180291|P2|COMPLETED|Overall Study||45
492463|NCT00359619|1180292|P1|COMPLETED|Overall Study||80
492464|NCT00359619|1180286|P7|STARTED|Overall Study||50
492465|NCT00359619|1180287|P6|STARTED|Overall Study||50
492466|NCT00359619|1180288|P5|STARTED|Overall Study||48
492467|NCT00359619|1180289|P4|STARTED|Overall Study||48
492468|NCT00359619|1180290|P3|STARTED|Overall Study||49
492469|NCT00359619|1180291|P2|STARTED|Overall Study||50
492470|NCT00359619|1180292|P1|STARTED|Overall Study||88
492471|NCT00359424|1180422|P2|NOT COMPLETED|Overall Study||67
492472|NCT00359424|1180423|P1|NOT COMPLETED|Overall Study||130
492473|NCT00359424|1180422|P2|COMPLETED|Overall Study||155
492474|NCT00359424|1180423|P1|COMPLETED|Overall Study||304
492475|NCT00359424|1180422|P2|270 Day Follow up|Overall Study||159
492476|NCT00359424|1180423|P1|270 Day Follow up|Overall Study||313
492477|NCT00359424|1180422|P2|180 Day Follow up|Overall Study||167
492478|NCT00359424|1180423|P1|180 Day Follow up|Overall Study||325
492479|NCT00359424|1180422|P2|90 Day Follow up|Overall Study||172
492480|NCT00359424|1180423|P1|90 Day Follow up|Overall Study||343
492481|NCT00359424|1180422|P2|STARTED|Overall Study||222
492482|NCT00359424|1180423|P1|STARTED|Overall Study||434
492483|NCT00359281|1180462|P9|NOT COMPLETED|Overall Study||0
492484|NCT00359281|1180463|P8|NOT COMPLETED|Overall Study||0
492485|NCT00359281|1180464|P7|NOT COMPLETED|Overall Study||2
492486|NCT00359281|1180465|P6|NOT COMPLETED|Overall Study||0
492487|NCT00359281|1180466|P5|NOT COMPLETED|Overall Study||0
492488|NCT00359281|1180467|P4|NOT COMPLETED|Overall Study||0
492489|NCT00359281|1180468|P3|NOT COMPLETED|Overall Study||0
492490|NCT00359281|1180469|P2|NOT COMPLETED|Overall Study||0
492491|NCT00359281|1180470|P1|NOT COMPLETED|Overall Study||1
492492|NCT00359281|1180462|P9|COMPLETED|Overall Study||20
492493|NCT00359281|1180463|P8|COMPLETED|Overall Study||15
492494|NCT00359281|1180464|P7|COMPLETED|Overall Study||16
492495|NCT00359281|1180465|P6|COMPLETED|Overall Study||15
492496|NCT00359281|1180466|P5|COMPLETED|Overall Study||10
492497|NCT00359281|1180467|P4|COMPLETED|Overall Study||10
492498|NCT00359281|1180468|P3|COMPLETED|Overall Study||10
492499|NCT00359281|1180469|P2|COMPLETED|Overall Study||15
492500|NCT00359281|1180470|P1|COMPLETED|Overall Study||15
492501|NCT00359281|1180462|P9|STARTED|Overall Study||20
492502|NCT00359281|1180463|P8|STARTED|Overall Study||15
492503|NCT00359281|1180464|P7|STARTED|Overall Study||18
492504|NCT00359281|1180465|P6|STARTED|Overall Study||15
492505|NCT00359281|1180466|P5|STARTED|Overall Study||10
492506|NCT00359281|1180467|P4|STARTED|Overall Study||10
492507|NCT00359281|1180468|P3|STARTED|Overall Study||10
492508|NCT00359281|1180469|P2|STARTED|Overall Study||15
492509|NCT00359281|1180470|P1|STARTED|Overall Study||16
492510|NCT00359216|1180502|P2|NOT COMPLETED|Overall Study||1
492511|NCT00359216|1180503|P1|NOT COMPLETED|Overall Study||0
492512|NCT00359216|1180502|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
492513|NCT00359216|1180503|P1|COMPLETED|Overall Study||20
492514|NCT00359216|1180502|P2|STARTED|Overall Study||10
492515|NCT00359216|1180503|P1|STARTED|Overall Study||20
492516|NCT00359203|1180511|P2|NOT COMPLETED|Overall Study||0
492517|NCT00359203|1180512|P1|NOT COMPLETED|Overall Study||0
492518|NCT00359203|1180511|P2|COMPLETED|Overall Study||38
492519|NCT00359203|1180512|P1|COMPLETED|Overall Study||39
492520|NCT00359203|1180511|P2|STARTED|Overall Study||38
492521|NCT00359203|1180512|P1|STARTED|Overall Study||39
492522|NCT00359138|1180521|P3|NOT COMPLETED|Overall Study||0
492523|NCT00359138|1180522|P2|NOT COMPLETED|Overall Study||0
492524|NCT00359138|1180523|P1|NOT COMPLETED|Overall Study||0
492525|NCT00359138|1180521|P3|COMPLETED|Overall Study||12
492526|NCT00359138|1180522|P2|COMPLETED|Overall Study||12
492527|NCT00359138|1180523|P1|COMPLETED|Overall Study||12
492528|NCT00359138|1180521|P3|STARTED|Overall Study||12
492529|NCT00359138|1180522|P2|STARTED|Overall Study||12
492530|NCT00359138|1180523|P1|STARTED|Overall Study||12
492531|NCT00359021|1180533|P2|NOT COMPLETED|Overall Study||52
492532|NCT00359021|1180534|P1|NOT COMPLETED|Overall Study||81
492533|NCT00359021|1180533|P2|COMPLETED|Overall Study||195
492534|NCT00359021|1180534|P1|COMPLETED|Overall Study||175
492535|NCT00359021|1180533|P2|STARTED|Overall Study||247
492536|NCT00359021|1180534|P1|STARTED|Overall Study||256
492537|NCT00358956|1180546|P1|NOT COMPLETED|Overall Study||8
492538|NCT00358956|1180546|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
492539|NCT00358956|1180546|P1|STARTED|Overall Study||19
492540|NCT00358917|1180558|P2|NOT COMPLETED|Overall Study||69
492541|NCT00358917|1180559|P1|NOT COMPLETED|Overall Study||66
492542|NCT00358917|1180558|P2|COMPLETED|Overall Study||230
492543|NCT00358917|1180559|P1|COMPLETED|Overall Study||234
492544|NCT00358917|1180558|P2|STARTED|Overall Study||299
492545|NCT00358917|1180559|P1|STARTED|Overall Study||300
492546|NCT00358150|1180573|P1|NOT COMPLETED|Overall Study||7
492547|NCT00358150|1180573|P1|COMPLETED|Overall Study||19
492548|NCT00358150|1180573|P1|STARTED|Overall Study||26
492549|NCT00358826|1180599|P8|NOT COMPLETED|MDCT Substudy||0
492550|NCT00358826|1180600|P7|NOT COMPLETED|MDCT Substudy||0
492551|NCT00358826|1180601|P6|NOT COMPLETED|MDCT Substudy||2
492552|NCT00358826|1180602|P5|NOT COMPLETED|MDCT Substudy||1
492553|NCT00358826|1180603|P4|NOT COMPLETED|MDCT Substudy||0
492554|NCT00358826|1180604|P3|NOT COMPLETED|MDCT Substudy||0
492555|NCT00358826|1180605|P2|NOT COMPLETED|MDCT Substudy||0
492556|NCT00358826|1180606|P1|NOT COMPLETED|MDCT Substudy||0
492557|NCT00358826|1180599|P8|COMPLETED|MDCT Substudy||27
492558|NCT00358826|1180600|P7|COMPLETED|MDCT Substudy||19
492559|NCT00358826|1180601|P6|COMPLETED|MDCT Substudy||20
492560|NCT00358826|1180602|P5|COMPLETED|MDCT Substudy||24
492561|NCT00358826|1180603|P4|COMPLETED|MDCT Substudy||0
492562|NCT00358826|1180604|P3|COMPLETED|MDCT Substudy||0
492563|NCT00358826|1180605|P2|COMPLETED|MDCT Substudy||0
492564|NCT00358826|1180606|P1|COMPLETED|MDCT Substudy||0
492565|NCT00358826|1180599|P8|STARTED|MDCT Substudy||27
492566|NCT00358826|1180600|P7|STARTED|MDCT Substudy||19
492567|NCT00358826|1180601|P6|STARTED|MDCT Substudy||22
492568|NCT00358826|1180602|P5|STARTED|MDCT Substudy||25
492569|NCT00358826|1180603|P4|STARTED|MDCT Substudy||0
492570|NCT00358826|1180604|P3|STARTED|MDCT Substudy||0
492571|NCT00358826|1180605|P2|STARTED|MDCT Substudy||0
492572|NCT00358826|1180606|P1|STARTED|MDCT Substudy||0
492573|NCT00358826|1180599|P8|NOT COMPLETED|Core Study||0
492574|NCT00358826|1180600|P7|NOT COMPLETED|Core Study||0
492575|NCT00358826|1180601|P6|NOT COMPLETED|Core Study||0
492576|NCT00358826|1180602|P5|NOT COMPLETED|Core Study||0
492577|NCT00358826|1180603|P4|NOT COMPLETED|Core Study||2
492578|NCT00358826|1180604|P3|NOT COMPLETED|Core Study||2
492579|NCT00358826|1180605|P2|NOT COMPLETED|Core Study||5
492580|NCT00358826|1180606|P1|NOT COMPLETED|Core Study||3
492581|NCT00358826|1180599|P8|COMPLETED|Core Study||0
492582|NCT00358826|1180600|P7|COMPLETED|Core Study||0
492583|NCT00358826|1180601|P6|COMPLETED|Core Study||0
492584|NCT00358826|1180602|P5|COMPLETED|Core Study||0
492585|NCT00358826|1180603|P4|COMPLETED|Core Study||50
492586|NCT00358826|1180604|P3|COMPLETED|Core Study||42
492587|NCT00358826|1180605|P2|COMPLETED|Core Study||41
492588|NCT00358826|1180606|P1|COMPLETED|Core Study||46
492589|NCT00358826|1180599|P8|STARTED|Core Study||0
492590|NCT00358826|1180600|P7|STARTED|Core Study||0
492591|NCT00358826|1180601|P6|STARTED|Core Study||0
492592|NCT00358826|1180602|P5|STARTED|Core Study||0
492593|NCT00358826|1180603|P4|STARTED|Core Study||52
492594|NCT00358826|1180604|P3|STARTED|Core Study||44
492595|NCT00358826|1180605|P2|STARTED|Core Study||46
492596|NCT00358826|1180606|P1|STARTED|Core Study||49
492597|NCT00358735|1180642|P2|NOT COMPLETED|Overall Study||17
492598|NCT00358735|1180643|P1|NOT COMPLETED|Overall Study||8
492599|NCT00358735|1180642|P2|COMPLETED|Overall Study|Efficacy|190
492600|NCT00358735|1180643|P1|COMPLETED|Overall Study|Efficacy|196
492601|NCT00358735|1180642|P2|Not Completed Safety|Overall Study||13
492602|NCT00358735|1180643|P1|Not Completed Safety|Overall Study||6
492603|NCT00358735|1180642|P2|Completed Safety|Overall Study||194
492604|NCT00358735|1180643|P1|Completed Safety|Overall Study||198
492605|NCT00358735|1180642|P2|STARTED|Overall Study||207
492606|NCT00358735|1180643|P1|STARTED|Overall Study||204
492607|NCT00358670|1180673|P2|NOT COMPLETED|Overall Study||219
492608|NCT00358670|1180674|P1|NOT COMPLETED|Overall Study||222
492609|NCT00358670|1180673|P2|COMPLETED|Overall Study||0
492610|NCT00358670|1180674|P1|COMPLETED|Overall Study||0
492611|NCT00358670|1180673|P2|STARTED|Overall Study||219
492612|NCT00358670|1180674|P1|STARTED|Overall Study||222
492613|NCT00358644|1180688|P1|NOT COMPLETED|Overall Study||50
492614|NCT00358644|1180688|P1|COMPLETED|Overall Study||5
492615|NCT00358644|1180688|P1|STARTED|Overall Study||55
492616|NCT00358579|1180694|P2|NOT COMPLETED|Overall Study||0
492617|NCT00358579|1180695|P1|NOT COMPLETED|Overall Study||0
492618|NCT00358579|1180694|P2|COMPLETED|Overall Study||374
492619|NCT00358579|1180695|P1|COMPLETED|Overall Study||353
492620|NCT00358579|1180694|P2|STARTED|Overall Study||374
492621|NCT00358579|1180695|P1|STARTED|Overall Study||353
492622|NCT00358527|1180711|P2|NOT COMPLETED|Overall Study||3
492623|NCT00358527|1180712|P1|NOT COMPLETED|Overall Study||13
492624|NCT00358527|1180711|P2|COMPLETED|Overall Study||131
492625|NCT00358527|1180712|P1|COMPLETED|Overall Study||254
492626|NCT00358527|1180711|P2|STARTED|Overall Study||134
492627|NCT00358527|1180712|P1|STARTED|Overall Study||267
492628|NCT00358501|1180722|P2|NOT COMPLETED|Overall Study||0
492629|NCT00358501|1180723|P1|NOT COMPLETED|Overall Study||0
492630|NCT00358501|1180722|P2|COMPLETED|Overall Study||32
492631|NCT00358501|1180723|P1|COMPLETED|Overall Study||102
492632|NCT00358501|1180722|P2|STARTED|Overall Study||32
492633|NCT00358501|1180723|P1|STARTED|Overall Study||102
492634|NCT00358462|1180738|P2|NOT COMPLETED|Overall Study||64
492635|NCT00358462|1180739|P1|NOT COMPLETED|Overall Study||59
492636|NCT00358462|1180738|P2|COMPLETED|Overall Study||238
492637|NCT00358462|1180739|P1|COMPLETED|Overall Study||245
492638|NCT00358462|1180738|P2|STARTED|Overall Study||302
492639|NCT00358462|1180739|P1|STARTED|Overall Study||304
492640|NCT00358449|1180750|P3|NOT COMPLETED|Overall Study||2
492641|NCT00358449|1180751|P2|NOT COMPLETED|Overall Study||1
492642|NCT00358449|1180752|P1|NOT COMPLETED|Overall Study||4
492643|NCT00358449|1180750|P3|COMPLETED|Overall Study||18
492644|NCT00358449|1180751|P2|COMPLETED|Overall Study||19
492645|NCT00358449|1180752|P1|COMPLETED|Overall Study||15
492646|NCT00358449|1180750|P3|STARTED|Overall Study||20
492647|NCT00358449|1180751|P2|STARTED|Overall Study||20
492648|NCT00358449|1180752|P1|STARTED|Overall Study||19
492649|NCT00358436|1180855|P2|NOT COMPLETED|Overall Study||86
492650|NCT00358436|1180856|P1|NOT COMPLETED|Overall Study||154
492651|NCT00358436|1180855|P2|COMPLETED|Overall Study||118
492652|NCT00358436|1180856|P1|COMPLETED|Overall Study||446
492653|NCT00358436|1180855|P2|STARTED|Overall Study||204
492654|NCT00358436|1180856|P1|STARTED|Overall Study||600
492655|NCT00358332|1180872|P4|NOT COMPLETED|Overall Study||0
492656|NCT00358332|1180873|P3|NOT COMPLETED|Overall Study||1
492657|NCT00358332|1180874|P2|NOT COMPLETED|Overall Study||3
492658|NCT00358332|1180875|P1|NOT COMPLETED|Overall Study||0
492659|NCT00358332|1180872|P4|COMPLETED|Overall Study||25
492660|NCT00358332|1180873|P3|COMPLETED|Overall Study||29
492661|NCT00358332|1180874|P2|COMPLETED|Overall Study||27
492662|NCT00358332|1180875|P1|COMPLETED|Overall Study||15
492663|NCT00358332|1180872|P4|STARTED|Overall Study||25
492664|NCT00358332|1180873|P3|STARTED|Overall Study||30
492665|NCT00358332|1180874|P2|STARTED|Overall Study||30
492666|NCT00358332|1180875|P1|STARTED|Overall Study||15
492667|NCT00358215|1180927|P2|NOT COMPLETED|Overall Study||652
492668|NCT00358215|1180928|P1|NOT COMPLETED|Overall Study||679
492669|NCT00358215|1180927|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
492670|NCT00358215|1180928|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
492671|NCT00358215|1180927|P2|Received Investigational Product|Overall Study||1133
492672|NCT00358215|1180928|P1|Received Investigational Product|Overall Study||1140
492673|NCT00358215|1180927|P2|STARTED|Overall Study||1136
492674|NCT00358215|1180928|P1|STARTED|Overall Study||1142
492675|NCT00358007|1180942|P1|NOT COMPLETED|Overall Study||2
492676|NCT00358007|1180942|P1|COMPLETED|Overall Study||28
492677|NCT00358007|1180942|P1|STARTED|Overall Study||30
492678|NCT00357994|1180949|P2|NOT COMPLETED|Overall Study||3
492679|NCT00357994|1180950|P1|NOT COMPLETED|Overall Study||2
492680|NCT00357994|1180949|P2|COMPLETED|Overall Study||31
492681|NCT00357994|1180950|P1|COMPLETED|Overall Study||35
492682|NCT00357994|1180949|P2|STARTED|Overall Study||34
492683|NCT00357994|1180950|P1|STARTED|Overall Study||37
492684|NCT00357968|1181004|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
492685|NCT00357968|1181005|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
492686|NCT00357968|1181004|P2|COMPLETED|Crossover Maintenance Dose Phase||55
492687|NCT00357968|1181005|P1|COMPLETED|Crossover Maintenance Dose Phase||54
492688|NCT00357968|1181004|P2|STARTED|Crossover Maintenance Dose Phase||55
492689|NCT00357968|1181005|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
492690|NCT00357968|1181004|P2|NOT COMPLETED|First Maintenance Dose Phase||44
492691|NCT00357968|1181005|P1|NOT COMPLETED|First Maintenance Dose Phase||48
492692|NCT00357968|1181004|P2|COMPLETED|First Maintenance Dose Phase||55
492693|NCT00357968|1181005|P1|COMPLETED|First Maintenance Dose Phase||54
492694|NCT00357968|1181004|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
492695|NCT00357968|1181005|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
492696|NCT00357968|1181004|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
492697|NCT00357968|1181005|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
492698|NCT00357968|1181004|P2|Received Loading Dose|First Maintenance Dose Phase||99
492699|NCT00357968|1181005|P1|Received Loading Dose|First Maintenance Dose Phase||102
492700|NCT00357968|1181004|P2|STARTED|First Maintenance Dose Phase||99
492701|NCT00357968|1181005|P1|STARTED|First Maintenance Dose Phase||102
492702|NCT00357955|1181049|P2|NOT COMPLETED|Overall Study||3
492703|NCT00357955|1181050|P1|NOT COMPLETED|Overall Study||6
492704|NCT00357955|1181049|P2|COMPLETED|Overall Study||51
492705|NCT00357955|1181050|P1|COMPLETED|Overall Study||58
492706|NCT00357955|1181049|P2|STARTED|Overall Study||54
492707|NCT00357955|1181050|P1|STARTED|Overall Study||64
492708|NCT00357903|1181058|P2|NOT COMPLETED|Overall Study||43
492709|NCT00357903|1181059|P1|NOT COMPLETED|Overall Study||363
492710|NCT00357903|1181058|P2|COMPLETED|Overall Study||15
492711|NCT00357903|1181059|P1|COMPLETED|Overall Study||218
492712|NCT00357903|1181058|P2|STARTED|Overall Study||58
492713|NCT00357903|1181059|P1|STARTED|Overall Study||581
492714|NCT00357877|1181099|P2|NOT COMPLETED|Overall Study||30
492715|NCT00357877|1181100|P1|NOT COMPLETED|Overall Study||26
492716|NCT00357877|1181099|P2|COMPLETED|Overall Study||460
492717|NCT00357877|1181100|P1|COMPLETED|Overall Study||467
492718|NCT00357877|1181099|P2|STARTED|Overall Study||490
492719|NCT00357877|1181100|P1|STARTED|Overall Study||493
492720|NCT00357760|1181114|P2|NOT COMPLETED|Overall Study||35
492721|NCT00357760|1181115|P1|NOT COMPLETED|Overall Study||59
492722|NCT00357760|1181114|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
492723|NCT00357760|1181115|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
492724|NCT00357760|1181114|P2|Patients Who Undergo Dose Escalation|Overall Study||16
492725|NCT00357760|1181115|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
492726|NCT00357760|1181114|P2|Eligible and Treated Patients|Overall Study||32
492727|NCT00357760|1181115|P1|Eligible and Treated Patients|Overall Study||57
492728|NCT00357760|1181114|P2|Patients Who Started Treatment|Overall Study||34
492729|NCT00357760|1181115|P1|Patients Who Started Treatment|Overall Study||57
492730|NCT00357760|1181114|P2|STARTED|Overall Study||35
492731|NCT00357760|1181115|P1|STARTED|Overall Study||59
492732|NCT00357734|1181125|P1|NOT COMPLETED|Overall Study||4
492733|NCT00357734|1181125|P1|COMPLETED|Overall Study||10
492734|NCT00357734|1181125|P1|Patient Received 500 mg of ZD1839|Overall Study||1
492735|NCT00357734|1181125|P1|Patients Received 250 mg of ZD1839|Overall Study||13
492736|NCT00357734|1181125|P1|STARTED|Overall Study||14
492737|NCT00357656|1181136|P2|NOT COMPLETED|Overall Study||3
492738|NCT00357656|1181137|P1|NOT COMPLETED|Overall Study||0
492739|NCT00357656|1181136|P2|COMPLETED|Overall Study||29
492740|NCT00357656|1181137|P1|COMPLETED|Overall Study||31
492741|NCT00357656|1181136|P2|STARTED|Overall Study||32
492742|NCT00357656|1181137|P1|STARTED|Overall Study||31
492743|NCT00357552|1181188|P1|NOT COMPLETED|Weeks 24 to 104||5
492744|NCT00357552|1181188|P1|COMPLETED|Weeks 24 to 104||117
492745|NCT00357552|1181188|P1|STARTED|Weeks 24 to 104||122
492746|NCT00357552|1181188|P1|NOT COMPLETED|Weeks 0 to 24||1
492747|NCT00357552|1181188|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
492748|NCT00357552|1181188|P1|STARTED|Weeks 0 to 24||123
492749|NCT00357552|1181188|P1|NOT COMPLETED|Screening||84
492750|NCT00357552|1181188|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
492751|NCT00357552|1181188|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
492752|NCT00357500|1181203|P1|NOT COMPLETED|Overall Study||77
492753|NCT00357500|1181203|P1|COMPLETED|Overall Study||24
492754|NCT00357500|1181203|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
492755|NCT00357500|1181203|P1|STARTED|Overall Study||101
492756|NCT00357396|1181212|P2|NOT COMPLETED|Overall Study||0
492757|NCT00357396|1181213|P1|NOT COMPLETED|Overall Study||1
492758|NCT00357396|1181212|P2|COMPLETED|Overall Study||4
492759|NCT00357396|1181213|P1|COMPLETED|Overall Study||5
492760|NCT00357396|1181212|P2|STARTED|Overall Study||4
492761|NCT00357396|1181213|P1|STARTED|Overall Study||6
492762|NCT00357370|1181221|P3|NOT COMPLETED|Cohort 2||2
492763|NCT00357370|1181222|P2|NOT COMPLETED|Cohort 2||7
492764|NCT00357370|1181223|P1|NOT COMPLETED|Cohort 2||2
492765|NCT00357370|1181221|P3|COMPLETED|Cohort 2||22
492766|NCT00357370|1181222|P2|COMPLETED|Cohort 2||16
492767|NCT00357370|1181223|P1|COMPLETED|Cohort 2||22
492768|NCT00357370|1181221|P3|STARTED|Cohort 2||24
492769|NCT00357370|1181222|P2|STARTED|Cohort 2||23
492770|NCT00357370|1181223|P1|STARTED|Cohort 2||24
492771|NCT00357370|1181221|P3|NOT COMPLETED|Cohort 1||0
492772|NCT00357370|1181222|P2|NOT COMPLETED|Cohort 1||0
492773|NCT00357370|1181223|P1|NOT COMPLETED|Cohort 1||0
492774|NCT00357370|1181221|P3|COMPLETED|Cohort 1||0
492775|NCT00357370|1181222|P2|COMPLETED|Cohort 1||0
492776|NCT00357370|1181223|P1|COMPLETED|Cohort 1||4
492777|NCT00357370|1181221|P3|STARTED|Cohort 1||0
492778|NCT00357370|1181222|P2|STARTED|Cohort 1||0
492779|NCT00357370|1181223|P1|STARTED|Cohort 1||4
492780|NCT00357331|1181248|P2|NOT COMPLETED|Overall Study||0
492781|NCT00357331|1181249|P1|NOT COMPLETED|Overall Study||0
492782|NCT00357331|1181248|P2|COMPLETED|Overall Study||41
492783|NCT00357331|1181249|P1|COMPLETED|Overall Study||42
492784|NCT00357331|1181248|P2|STARTED|Overall Study||41
492785|NCT00357331|1181249|P1|STARTED|Overall Study||42
492786|NCT00357162|1181259|P1|NOT COMPLETED|Overall Study||0
492787|NCT00357162|1181259|P1|COMPLETED|Overall Study||21
492788|NCT00357162|1181259|P1|STARTED|Overall Study||21
492789|NCT00357110|1181269|P2|NOT COMPLETED|Overall Study||5
492790|NCT00357110|1181270|P1|NOT COMPLETED|Overall Study||5
492791|NCT00357110|1181269|P2|COMPLETED|Overall Study||2
492792|NCT00357110|1181270|P1|COMPLETED|Overall Study||1
492793|NCT00357110|1181269|P2|STARTED|Overall Study||7
492794|NCT00357110|1181270|P1|STARTED|Overall Study||6
492795|NCT00357097|1181278|P2|NOT COMPLETED|Overall Study||29
492796|NCT00357097|1181279|P1|NOT COMPLETED|Overall Study||54
492797|NCT00357097|1181278|P2|COMPLETED|Overall Study||38
492798|NCT00357097|1181279|P1|COMPLETED|Overall Study||145
492799|NCT00357097|1181278|P2|STARTED|Overall Study||67
492800|NCT00357097|1181279|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
492801|NCT00357032|1181323|P1|NOT COMPLETED|Overall Study||0
492802|NCT00357032|1181323|P1|COMPLETED|Overall Study||12
492803|NCT00357032|1181323|P1|STARTED|Overall Study||12
492804|NCT00357006|1181331|P3|NOT COMPLETED|Overall Study||3
492805|NCT00357006|1181332|P2|NOT COMPLETED|Overall Study||5
492806|NCT00357006|1181333|P1|NOT COMPLETED|Overall Study||2
492807|NCT00357006|1181331|P3|COMPLETED|Overall Study||59
492808|NCT00357006|1181332|P2|COMPLETED|Overall Study||51
492809|NCT00357006|1181333|P1|COMPLETED|Overall Study||60
492810|NCT00357006|1181331|P3|STARTED|Overall Study||62
492811|NCT00357006|1181332|P2|STARTED|Overall Study||56
492812|NCT00357006|1181333|P1|STARTED|Overall Study||62
492813|NCT00356915|1181344|P3|NOT COMPLETED|Overall Study||42
492814|NCT00356915|1181345|P2|NOT COMPLETED|Overall Study||94
492815|NCT00356915|1181346|P1|NOT COMPLETED|Overall Study||76
492816|NCT00356915|1181344|P3|COMPLETED|Overall Study||156
492817|NCT00356915|1181345|P2|COMPLETED|Overall Study||496
492818|NCT00356915|1181346|P1|COMPLETED|Overall Study||517
492819|NCT00356915|1181344|P3|STARTED|Overall Study||198
492820|NCT00356915|1181345|P2|STARTED|Overall Study||590
492821|NCT00356915|1181346|P1|STARTED|Overall Study||593
492822|NCT00356889|1181363|P1|NOT COMPLETED|Overall Study||3
492823|NCT00356889|1181363|P1|COMPLETED|Overall Study||53
492824|NCT00356889|1181363|P1|STARTED|Overall Study||56
492825|NCT00356863|1181372|P2|NOT COMPLETED|Overall Study||75
492826|NCT00356863|1181373|P1|NOT COMPLETED|Overall Study||92
492827|NCT00356863|1181372|P2|COMPLETED|Overall Study||445
492828|NCT00356863|1181373|P1|COMPLETED|Overall Study||412
492829|NCT00356863|1181372|P2|STARTED|Overall Study||520
492830|NCT00356863|1181373|P1|STARTED|Overall Study||504
492831|NCT00356811|1181399|P1|NOT COMPLETED|Overall Study||49
492832|NCT00356811|1181399|P1|COMPLETED|Overall Study||8
492833|NCT00356811|1181399|P1|STARTED|Overall Study||57
492834|NCT00356590|1181412|P1|NOT COMPLETED|Overall Study||274
492835|NCT00356590|1181412|P1|COMPLETED|Overall Study||194
492836|NCT00356590|1181412|P1|STARTED|Overall Study||468
492837|NCT00356525|1181448|P4|NOT COMPLETED|Overall Study||9
492838|NCT00356525|1181449|P3|NOT COMPLETED|Overall Study||7
492839|NCT00356525|1181450|P2|NOT COMPLETED|Overall Study||11
492840|NCT00356525|1181451|P1|NOT COMPLETED|Overall Study||14
492841|NCT00356525|1181448|P4|COMPLETED|Overall Study||0
492842|NCT00356525|1181449|P3|COMPLETED|Overall Study||0
492843|NCT00356525|1181450|P2|COMPLETED|Overall Study||0
492844|NCT00356525|1181451|P1|COMPLETED|Overall Study||0
492845|NCT00356525|1181448|P4|STARTED|Overall Study||9
492846|NCT00356525|1181449|P3|STARTED|Overall Study||7
492847|NCT00356525|1181450|P2|STARTED|Overall Study||11
492848|NCT00356525|1181451|P1|STARTED|Overall Study||14
492849|NCT00356421|1181479|P2|NOT COMPLETED|Overall Study||17
492850|NCT00356421|1181480|P1|NOT COMPLETED|Overall Study||32
492851|NCT00356421|1181479|P2|COMPLETED|Overall Study||3
492852|NCT00356421|1181480|P1|COMPLETED|Overall Study||6
492853|NCT00356421|1181479|P2|STARTED|Overall Study||20
492854|NCT00356421|1181480|P1|STARTED|Overall Study||38
492855|NCT00356408|1181520|P1|NOT COMPLETED|Overall Study||60
492856|NCT00356408|1181520|P1|COMPLETED|Overall Study||43
492857|NCT00356408|1181520|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
492858|NCT00356304|1181537|P2|NOT COMPLETED|Overall Study||4
492859|NCT00356304|1181538|P1|NOT COMPLETED|Overall Study||2
492860|NCT00356304|1181537|P2|COMPLETED|Overall Study||20
492861|NCT00356304|1181538|P1|COMPLETED|Overall Study||24
492862|NCT00356304|1181537|P2|STARTED|Overall Study||24
492863|NCT00356304|1181538|P1|STARTED|Overall Study||26
492864|NCT00356278|1181549|P3|NOT COMPLETED|Overall Study||19
492865|NCT00356278|1181550|P2|NOT COMPLETED|Overall Study||15
492866|NCT00356278|1181551|P1|NOT COMPLETED|Overall Study||25
492867|NCT00356278|1181549|P3|COMPLETED|Overall Study||34
492868|NCT00356278|1181550|P2|COMPLETED|Overall Study||35
492869|NCT00356278|1181551|P1|COMPLETED|Overall Study||28
492870|NCT00356278|1181549|P3|STARTED|Overall Study||53
492871|NCT00356278|1181550|P2|STARTED|Overall Study||50
492872|NCT00356278|1181551|P1|STARTED|Overall Study||53
492873|NCT00356200|1181588|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
492874|NCT00356200|1181589|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
492875|NCT00356200|1181588|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
492876|NCT00356200|1181589|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
492877|NCT00356200|1181588|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
492878|NCT00356200|1181589|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
492879|NCT00356200|1181588|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
492880|NCT00356200|1181589|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
492881|NCT00356200|1181588|P2|COMPLETED|Cohort 1: 10 ug/ml||0
492882|NCT00356200|1181589|P1|COMPLETED|Cohort 1: 10 ug/ml||4
492883|NCT00356200|1181588|P2|STARTED|Cohort 1: 10 ug/ml||0
492884|NCT00356200|1181589|P1|STARTED|Cohort 1: 10 ug/ml||5
492885|NCT00356148|1181603|P2|NOT COMPLETED|Overall Study||1
492886|NCT00356148|1181604|P1|NOT COMPLETED|Overall Study||2
492887|NCT00356148|1181603|P2|COMPLETED|Overall Study||182
492888|NCT00356148|1181604|P1|COMPLETED|Overall Study||187
492889|NCT00356148|1181603|P2|STARTED|Overall Study||183
492890|NCT00356148|1181604|P1|STARTED|Overall Study||189
492891|NCT00356135|1181615|P3|NOT COMPLETED|Overall Study||5
492892|NCT00356135|1181616|P2|NOT COMPLETED|Overall Study||2
492893|NCT00356135|1181617|P1|NOT COMPLETED|Overall Study||4
492894|NCT00356135|1181615|P3|COMPLETED|Overall Study||39
492895|NCT00356135|1181616|P2|COMPLETED|Overall Study||46
492896|NCT00356135|1181617|P1|COMPLETED|Overall Study||43
492897|NCT00356135|1181615|P3|STARTED|Overall Study||44
492898|NCT00356135|1181616|P2|STARTED|Overall Study||48
492899|NCT00356135|1181617|P1|STARTED|Overall Study||47
492900|NCT00356122|1181639|P1|NOT COMPLETED|FOLLOW-UP||41
492901|NCT00356122|1181639|P1|COMPLETED|FOLLOW-UP||12
492902|NCT00356122|1181639|P1|STARTED|FOLLOW-UP||53
492903|NCT00356122|1181639|P1|NOT COMPLETED|TREATMENT||45
492904|NCT00356122|1181639|P1|COMPLETED|TREATMENT||8
492905|NCT00356122|1181639|P1|STARTED|TREATMENT||53
492906|NCT00356057|1181650|P3|NOT COMPLETED|Overall Study||12
492907|NCT00356057|1181651|P2|NOT COMPLETED|Overall Study||14
492908|NCT00356057|1181652|P1|NOT COMPLETED|Overall Study||13
492909|NCT00356057|1181650|P3|COMPLETED|Overall Study||22
492910|NCT00356057|1181651|P2|COMPLETED|Overall Study||47
492911|NCT00356057|1181652|P1|COMPLETED|Overall Study||45
492912|NCT00356057|1181650|P3|IMPLANTED|Overall Study||25
492913|NCT00356057|1181651|P2|IMPLANTED|Overall Study||52
492914|NCT00356057|1181652|P1|IMPLANTED|Overall Study||49
492915|NCT00356057|1181650|P3|STARTED|Overall Study||34
492916|NCT00356057|1181651|P2|STARTED|Overall Study||61
492917|NCT00356057|1181652|P1|STARTED|Overall Study||58
492918|NCT00356031|1181658|P1|NOT COMPLETED|Overall Study||0
492919|NCT00356031|1181658|P1|COMPLETED|Overall Study||20
492920|NCT00356031|1181658|P1|STARTED|Overall Study||20
492921|NCT00355914|1181669|P2|NOT COMPLETED|Overall Study||0
492922|NCT00355914|1181670|P1|NOT COMPLETED|Overall Study||0
492923|NCT00355914|1181669|P2|COMPLETED|Overall Study||60
492924|NCT00355914|1181670|P1|COMPLETED|Overall Study||60
492925|NCT00355914|1181669|P2|STARTED|Overall Study||60
492926|NCT00355914|1181670|P1|STARTED|Overall Study||60
492927|NCT00355797|1181681|P3|NOT COMPLETED|Overall Study||142
492928|NCT00355797|1181682|P2|NOT COMPLETED|Overall Study||148
492929|NCT00355797|1181683|P1|NOT COMPLETED|Overall Study||240
492930|NCT00355797|1181681|P3|COMPLETED|Overall Study||239
492931|NCT00355797|1181682|P2|COMPLETED|Overall Study||221
492932|NCT00355797|1181683|P1|COMPLETED|Overall Study||501
492933|NCT00355797|1181681|P3|STARTED|Overall Study||381
492934|NCT00355797|1181682|P2|STARTED|Overall Study||369
492935|NCT00355797|1181683|P1|STARTED|Overall Study||741
492936|NCT00355784|1181715|P3|NOT COMPLETED|Overall Study||2
492937|NCT00355784|1181716|P2|NOT COMPLETED|Overall Study||0
492938|NCT00355784|1181717|P1|NOT COMPLETED|Overall Study||0
492939|NCT00355784|1181715|P3|COMPLETED|Overall Study||5
492940|NCT00355784|1181716|P2|COMPLETED|Overall Study||8
492941|NCT00355784|1181717|P1|COMPLETED|Overall Study||9
492942|NCT00355784|1181715|P3|STARTED|Overall Study||7
492943|NCT00355784|1181716|P2|STARTED|Overall Study||8
492944|NCT00355784|1181717|P1|STARTED|Overall Study||9
492945|NCT00355706|1181751|P2|NOT COMPLETED|Overall Study||0
492946|NCT00355706|1181752|P1|NOT COMPLETED|Overall Study||0
492947|NCT00355706|1181751|P2|COMPLETED|Overall Study||50
492948|NCT00355706|1181752|P1|COMPLETED|Overall Study||50
492949|NCT00355706|1181751|P2|STARTED|Overall Study||50
492950|NCT00355706|1181752|P1|STARTED|Overall Study||50
492951|NCT00355615|1181766|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
492952|NCT00355615|1181767|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
492953|NCT00355615|1181768|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
492954|NCT00355615|1181769|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
492955|NCT00355615|1181770|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
492956|NCT00355615|1181766|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
492957|NCT00355615|1181767|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
492958|NCT00355615|1181768|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
492959|NCT00355615|1181769|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
492960|NCT00355615|1181770|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
492961|NCT00355615|1181766|P5|STARTED|40-week Rosuvastatin Open Label Period||173
492962|NCT00355615|1181767|P4|STARTED|40-week Rosuvastatin Open Label Period||0
492963|NCT00355615|1181768|P3|STARTED|40-week Rosuvastatin Open Label Period||0
492964|NCT00355615|1181769|P2|STARTED|40-week Rosuvastatin Open Label Period||0
492965|NCT00355615|1181770|P1|STARTED|40-week Rosuvastatin Open Label Period||0
492966|NCT00355615|1181766|P5|NOT COMPLETED|Randomized Double Blind Period||0
492967|NCT00355615|1181767|P4|NOT COMPLETED|Randomized Double Blind Period||1
492968|NCT00355615|1181768|P3|NOT COMPLETED|Randomized Double Blind Period||1
492969|NCT00355615|1181769|P2|NOT COMPLETED|Randomized Double Blind Period||0
492970|NCT00355615|1181770|P1|NOT COMPLETED|Randomized Double Blind Period||1
492971|NCT00355615|1181766|P5|COMPLETED|Randomized Double Blind Period||0
492972|NCT00355615|1181767|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
492973|NCT00355615|1181768|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
492974|NCT00355615|1181769|P2|COMPLETED|Randomized Double Blind Period||44
492975|NCT00355615|1181770|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
492976|NCT00355615|1181766|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
492977|NCT00355615|1181767|P4|STARTED|Randomized Double Blind Period||46
492978|NCT00355615|1181768|P3|STARTED|Randomized Double Blind Period||45
492979|NCT00355615|1181769|P2|STARTED|Randomized Double Blind Period||44
492980|NCT00355615|1181770|P1|STARTED|Randomized Double Blind Period||42
492981|NCT00355472|1181829|P1|NOT COMPLETED|Overall Study||1
492982|NCT00355472|1181829|P1|COMPLETED|Overall Study||15
492983|NCT00355472|1181829|P1|STARTED|Overall Study||16
492984|NCT00355394|1181856|P2|NOT COMPLETED|Overall Study||0
492985|NCT00355394|1181857|P1|NOT COMPLETED|Overall Study||0
492986|NCT00355394|1181856|P2|COMPLETED|Overall Study||16
492987|NCT00355394|1181857|P1|COMPLETED|Overall Study||15
492988|NCT00355394|1181856|P2|STARTED|Overall Study||16
492989|NCT00355394|1181857|P1|STARTED|Overall Study||15
492990|NCT00355368|1181875|P2|NOT COMPLETED|Overall Study||9
492991|NCT00355368|1181876|P1|NOT COMPLETED|Overall Study||10
492992|NCT00355368|1181875|P2|COMPLETED|Overall Study||201
492993|NCT00355368|1181876|P1|COMPLETED|Overall Study||200
492994|NCT00355368|1181875|P2|STARTED|Overall Study||210
492995|NCT00355368|1181876|P1|STARTED|Overall Study||210
492996|NCT00355147|1181890|P2|NOT COMPLETED|Overall Study||20
492997|NCT00355147|1181891|P1|NOT COMPLETED|Overall Study||18
492998|NCT00355147|1181890|P2|COMPLETED|Overall Study||67
492999|NCT00355147|1181891|P1|COMPLETED|Overall Study||69
493000|NCT00355147|1181890|P2|STARTED|Overall Study||87
493001|NCT00355147|1181891|P1|STARTED|Overall Study||87
493002|NCT00355134|1181910|P5|NOT COMPLETED|Extension Phase||19
493003|NCT00355134|1181911|P4|NOT COMPLETED|Extension Phase||16
493004|NCT00355134|1181912|P3|NOT COMPLETED|Extension Phase||0
493005|NCT00355134|1181913|P2|NOT COMPLETED|Extension Phase||37
493006|NCT00355134|1181914|P1|NOT COMPLETED|Extension Phase||31
493007|NCT00355134|1181910|P5|COMPLETED|Extension Phase||88
493008|NCT00355134|1181911|P4|COMPLETED|Extension Phase||89
493009|NCT00355134|1181912|P3|COMPLETED|Extension Phase||0
493010|NCT00355134|1181913|P2|COMPLETED|Extension Phase||180
493011|NCT00355134|1181914|P1|COMPLETED|Extension Phase||172
493012|NCT00355134|1181910|P5|STARTED|Extension Phase||107
493013|NCT00355134|1181911|P4|STARTED|Extension Phase||105
493014|NCT00355134|1181912|P3|STARTED|Extension Phase||0
493015|NCT00355134|1181913|P2|STARTED|Extension Phase||217
493016|NCT00355134|1181914|P1|STARTED|Extension Phase||203
493017|NCT00355134|1181910|P5|NOT COMPLETED|Core Phase||0
493018|NCT00355134|1181911|P4|NOT COMPLETED|Core Phase||0
493019|NCT00355134|1181912|P3|NOT COMPLETED|Core Phase||100
493020|NCT00355134|1181913|P2|NOT COMPLETED|Core Phase||86
493021|NCT00355134|1181914|P1|NOT COMPLETED|Core Phase||119
493022|NCT00355134|1181910|P5|COMPLETED|Core Phase||0
493023|NCT00355134|1181911|P4|COMPLETED|Core Phase||0
493024|NCT00355134|1181912|P3|COMPLETED|Core Phase||255
493025|NCT00355134|1181913|P2|COMPLETED|Core Phase||272
493026|NCT00355134|1181914|P1|COMPLETED|Core Phase||251
493027|NCT00355134|1181910|P5|STARTED|Core Phase||0
493028|NCT00355134|1181911|P4|STARTED|Core Phase||0
493029|NCT00355134|1181912|P3|STARTED|Core Phase||355
493030|NCT00355134|1181913|P2|STARTED|Core Phase||358
493031|NCT00355134|1181914|P1|STARTED|Core Phase||370
493032|NCT00355121|1181957|P3|NOT COMPLETED|Overall Study||5
493033|NCT00355121|1181958|P2|NOT COMPLETED|Overall Study||29
493034|NCT00355121|1181959|P1|NOT COMPLETED|Overall Study||21
493035|NCT00355121|1181957|P3|COMPLETED|Overall Study||170
493036|NCT00355121|1181958|P2|COMPLETED|Overall Study||324
493037|NCT00355121|1181959|P1|COMPLETED|Overall Study||332
493038|NCT00355121|1181957|P3|STARTED|Overall Study||175
493039|NCT00355121|1181958|P2|STARTED|Overall Study||353
493040|NCT00355121|1181959|P1|STARTED|Overall Study||353
493041|NCT00355082|1181990|P3|NOT COMPLETED|Continuation Phase||3
493042|NCT00355082|1181991|P2|NOT COMPLETED|Continuation Phase||0
493043|NCT00355082|1181992|P1|NOT COMPLETED|Continuation Phase||24
493044|NCT00355082|1181990|P3|COMPLETED|Continuation Phase||8
493045|NCT00355082|1181991|P2|COMPLETED|Continuation Phase||0
493046|NCT00355082|1181992|P1|COMPLETED|Continuation Phase||160
493047|NCT00355082|1181990|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
493048|NCT00355082|1181991|P2|STARTED|Continuation Phase||0
493049|NCT00355082|1181992|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
493311|NCT00352534|1182461|P1|COMPLETED|Initial Staging||203
493050|NCT00355082|1181990|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
493051|NCT00355082|1181991|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
493052|NCT00355082|1181992|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
493053|NCT00355082|1181990|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
493054|NCT00355082|1181991|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
493055|NCT00355082|1181992|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
493056|NCT00355082|1181990|P3|STARTED|Double-Blind (DB) Treatment Phase||0
493057|NCT00355082|1181991|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
493058|NCT00355082|1181992|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
493059|NCT00355030|1182014|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
493060|NCT00355030|1182015|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
493061|NCT00355030|1182014|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
493062|NCT00355030|1182015|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
493063|NCT00355030|1182014|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
493064|NCT00355030|1182015|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
493065|NCT00355030|1182014|P2|NOT COMPLETED|Study Period 1 Treatment||44
493066|NCT00355030|1182015|P1|NOT COMPLETED|Study Period 1 Treatment||45
493067|NCT00355030|1182014|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
493068|NCT00355030|1182015|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
493069|NCT00355030|1182014|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
493070|NCT00355030|1182015|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
493071|NCT00355030|1182014|P2|STARTED|Study Period 1 Treatment||45
493072|NCT00355030|1182015|P1|STARTED|Study Period 1 Treatment||46
493073|NCT00354978|1182037|P1|NOT COMPLETED|Overall Study||0
493074|NCT00354978|1182037|P1|COMPLETED|Overall Study||43
493075|NCT00354978|1182037|P1|STARTED|Overall Study||43
493076|NCT00354913|1182041|P1|NOT COMPLETED|Overall Study||0
493077|NCT00354913|1182041|P1|COMPLETED|Overall Study||21
493078|NCT00354913|1182041|P1|STARTED|Overall Study||21
493079|NCT00354887|1182048|P1|NOT COMPLETED|Overall Study||1
493080|NCT00354887|1182048|P1|COMPLETED|Overall Study||29
493081|NCT00354887|1182048|P1|STARTED|Overall Study||30
493082|NCT00354770|1182054|P2|NOT COMPLETED|Overall Study||3
493083|NCT00354770|1182055|P1|NOT COMPLETED|Overall Study||3
493084|NCT00354770|1182054|P2|COMPLETED|Overall Study||22
493085|NCT00354770|1182055|P1|COMPLETED|Overall Study||22
493086|NCT00354770|1182054|P2|STARTED|Overall Study||25
493087|NCT00354770|1182055|P1|STARTED|Overall Study||25
493088|NCT00354744|1182061|P1|NOT COMPLETED|Overall Study||42
493089|NCT00354744|1182061|P1|COMPLETED|Overall Study||67
493090|NCT00354744|1182061|P1|STARTED|Overall Study||109
493091|NCT00354679|1182066|P1|NOT COMPLETED|Overall Study||1
493092|NCT00354679|1182066|P1|COMPLETED|Overall Study||33
493093|NCT00354679|1182066|P1|STARTED|Overall Study||34
493094|NCT00354640|1182070|P1|NOT COMPLETED|Overall Study||0
493095|NCT00354640|1182070|P1|COMPLETED|Overall Study||11
493096|NCT00354640|1182070|P1|STARTED|Overall Study||11
493097|NCT00354601|1182075|P1|NOT COMPLETED|Overall Study||2
493098|NCT00354601|1182075|P1|COMPLETED|Overall Study||0
493099|NCT00354601|1182075|P1|STARTED|Overall Study||2
493100|NCT00354484|1182084|P2|NOT COMPLETED|Overall Study||3
493101|NCT00354484|1182085|P1|NOT COMPLETED|Overall Study||4
493102|NCT00354484|1182084|P2|COMPLETED|Overall Study||144
493103|NCT00354484|1182085|P1|COMPLETED|Overall Study||138
493104|NCT00354484|1182084|P2|STARTED|Overall Study||147
493105|NCT00354484|1182085|P1|STARTED|Overall Study||142
493106|NCT00354432|1182095|P4|NOT COMPLETED|Overall Study||10
493107|NCT00354432|1182096|P3|NOT COMPLETED|Overall Study||10
493108|NCT00354432|1182097|P2|NOT COMPLETED|Overall Study||8
493109|NCT00354432|1182098|P1|NOT COMPLETED|Overall Study||6
493110|NCT00354432|1182095|P4|COMPLETED|Overall Study||20
493111|NCT00354432|1182096|P3|COMPLETED|Overall Study||20
493112|NCT00354432|1182097|P2|COMPLETED|Overall Study||22
493113|NCT00354432|1182098|P1|COMPLETED|Overall Study||24
493114|NCT00354432|1182095|P4|STARTED|Overall Study||30
493115|NCT00354432|1182096|P3|STARTED|Overall Study||30
493116|NCT00354432|1182097|P2|STARTED|Overall Study||30
493117|NCT00354432|1182098|P1|STARTED|Overall Study||30
493118|NCT00354341|1182114|P2|NOT COMPLETED|Overall Study||7
493119|NCT00354341|1182115|P1|NOT COMPLETED|Overall Study||3
493120|NCT00354341|1182114|P2|COMPLETED|Overall Study||75
493121|NCT00354341|1182115|P1|COMPLETED|Overall Study||85
493122|NCT00354341|1182114|P2|STARTED|Overall Study||82
493123|NCT00354341|1182115|P1|STARTED|Overall Study||88
493124|NCT00354172|1182131|P1|NOT COMPLETED|Overall Study||1
493125|NCT00354172|1182131|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
493126|NCT00354172|1182131|P1|STARTED|Overall Study||16
493127|NCT00354159|1182151|P2|NOT COMPLETED|Long-term Follow-up||176
493128|NCT00354159|1182152|P1|NOT COMPLETED|Long-term Follow-up||180
493129|NCT00354159|1182151|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
493130|NCT00354159|1182152|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
493312|NCT00352534|1182455|P7|STARTED|Initial Staging||0
493131|NCT00354159|1182151|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
493132|NCT00354159|1182152|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
493133|NCT00354159|1182151|P2|NOT COMPLETED|Randomized Study Period||22
493134|NCT00354159|1182152|P1|NOT COMPLETED|Randomized Study Period||22
493135|NCT00354159|1182151|P2|COMPLETED|Randomized Study Period||176
493136|NCT00354159|1182152|P1|COMPLETED|Randomized Study Period||180
493137|NCT00354159|1182151|P2|STARTED|Randomized Study Period||198
493138|NCT00354159|1182152|P1|STARTED|Randomized Study Period||202
493139|NCT00354107|1182195|P1|NOT COMPLETED|Overall Study||5
493140|NCT00354107|1182195|P1|COMPLETED|Overall Study||0
493141|NCT00354107|1182195|P1|STARTED|Overall Study||5
493142|NCT00354029|1182201|P2|NOT COMPLETED|Overall Study||2
493143|NCT00354029|1182202|P1|NOT COMPLETED|Overall Study||4
493144|NCT00354029|1182201|P2|COMPLETED|Overall Study||38
493145|NCT00354029|1182202|P1|COMPLETED|Overall Study||39
493146|NCT00354029|1182201|P2|STARTED|Overall Study||40
493147|NCT00354029|1182202|P1|STARTED|Overall Study||43
493148|NCT00353977|1182208|P1|NOT COMPLETED|Overall Study||0
493149|NCT00353977|1182208|P1|COMPLETED|Overall Study||38
493150|NCT00353977|1182208|P1|STARTED|Overall Study||38
493151|NCT00353873|1182214|P2|NOT COMPLETED|Overall Study||3
493152|NCT00353873|1182215|P1|NOT COMPLETED|Overall Study||6
493153|NCT00353873|1182214|P2|COMPLETED|Overall Study||147
493154|NCT00353873|1182215|P1|COMPLETED|Overall Study||147
493155|NCT00353873|1182214|P2|STARTED|Overall Study||150
493156|NCT00353873|1182215|P1|STARTED|Overall Study||153
493157|NCT00353795|1182227|P1|NOT COMPLETED|Overall Study||0
493158|NCT00353795|1182227|P1|COMPLETED|Overall Study||179
493159|NCT00353795|1182227|P1|STARTED|Overall Study||179
493160|NCT00353704|1182233|P2|NOT COMPLETED|Overall Study||1
493161|NCT00353704|1182234|P1|NOT COMPLETED|Overall Study||3
493162|NCT00353704|1182233|P2|COMPLETED|Overall Study||24
493163|NCT00353704|1182234|P1|COMPLETED|Overall Study||22
493164|NCT00353704|1182233|P2|STARTED|Overall Study||25
493165|NCT00353704|1182234|P1|STARTED|Overall Study||25
493166|NCT00353652|1182248|P6|NOT COMPLETED|Overall Study||5
493167|NCT00353652|1182249|P5|NOT COMPLETED|Overall Study||5
493168|NCT00353652|1182250|P4|NOT COMPLETED|Overall Study||0
493169|NCT00353652|1182251|P3|NOT COMPLETED|Overall Study||0
493170|NCT00353652|1182252|P2|NOT COMPLETED|Overall Study||0
493171|NCT00353652|1182253|P1|NOT COMPLETED|Overall Study||0
493172|NCT00353652|1182248|P6|COMPLETED|Overall Study||18
493173|NCT00353652|1182249|P5|COMPLETED|Overall Study||18
493174|NCT00353652|1182250|P4|COMPLETED|Overall Study||7
493175|NCT00353652|1182251|P3|COMPLETED|Overall Study||17
493176|NCT00353652|1182252|P2|COMPLETED|Overall Study||17
493177|NCT00353652|1182253|P1|COMPLETED|Overall Study||17
493178|NCT00353652|1182248|P6|STARTED|Overall Study||23
493179|NCT00353652|1182249|P5|STARTED|Overall Study||23
493180|NCT00353652|1182250|P4|STARTED|Overall Study||7
493181|NCT00353652|1182251|P3|STARTED|Overall Study||17
493182|NCT00353652|1182252|P2|STARTED|Overall Study||17
493183|NCT00353652|1182253|P1|STARTED|Overall Study||17
493184|NCT00353496|1182269|P2|NOT COMPLETED|Overall Study||17
493185|NCT00353496|1182270|P1|NOT COMPLETED|Overall Study||16
493186|NCT00353496|1182269|P2|COMPLETED|Overall Study||86
493187|NCT00353496|1182270|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
493188|NCT00353496|1182269|P2|STARTED|Overall Study||103
493189|NCT00353496|1182270|P1|STARTED|Overall Study||101
493190|NCT00353431|1182287|P2|NOT COMPLETED|Overall Study||0
493191|NCT00353431|1182288|P1|NOT COMPLETED|Overall Study||0
493192|NCT00353431|1182287|P2|COMPLETED|Overall Study||67
493193|NCT00353431|1182288|P1|COMPLETED|Overall Study||63
493194|NCT00353431|1182287|P2|STARTED|Overall Study||67
493195|NCT00353431|1182288|P1|STARTED|Overall Study||63
493196|NCT00353418|1182304|P2|NOT COMPLETED|Overall Study||158
493197|NCT00353418|1182305|P1|NOT COMPLETED|Overall Study||83
493198|NCT00353418|1182304|P2|COMPLETED|Overall Study||119
493199|NCT00353418|1182305|P1|COMPLETED|Overall Study||55
493200|NCT00353418|1182304|P2|STARTED|Overall Study||277
493201|NCT00353418|1182305|P1|STARTED|Overall Study||138
493202|NCT00353366|1182323|P1|NOT COMPLETED|Overall Study||143
493203|NCT00353366|1182323|P1|COMPLETED|Overall Study||1289
493204|NCT00353366|1182323|P1|STARTED|Overall Study||1432
493205|NCT00353301|1182330|P1|NOT COMPLETED|Overall Study||0
493206|NCT00353301|1182330|P1|COMPLETED|Overall Study||25
493207|NCT00353301|1182330|P1|STARTED|Overall Study||25
493208|NCT00353275|1182337|P2|NOT COMPLETED|Overall Study||0
493209|NCT00353275|1182338|P1|NOT COMPLETED|Overall Study||0
493210|NCT00353275|1182337|P2|COMPLETED|Overall Study||3
493211|NCT00353275|1182338|P1|COMPLETED|Overall Study||2
493212|NCT00353275|1182337|P2|STARTED|Overall Study||3
493213|NCT00353275|1182338|P1|STARTED|Overall Study||2
493214|NCT00353262|1182344|P1|NOT COMPLETED|Overall Study||29
493215|NCT00353262|1182344|P1|COMPLETED|Overall Study||7
493216|NCT00353262|1182344|P1|STARTED|Overall Study||36
493217|NCT00353119|1182363|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
493218|NCT00353119|1182364|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
493219|NCT00353119|1182363|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
493220|NCT00353119|1182364|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
493221|NCT00353119|1182363|P2|STARTED|Second Intervention Week 12 to Week 28||10
493222|NCT00353119|1182364|P1|STARTED|Second Intervention Week 12 to Week 28||5
493223|NCT00353119|1182363|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
493224|NCT00353119|1182364|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
493225|NCT00353119|1182363|P2|COMPLETED|First Intervention Day 0 to Week 12||10
493226|NCT00353119|1182364|P1|COMPLETED|First Intervention Day 0 to Week 12||5
493227|NCT00353119|1182363|P2|STARTED|First Intervention Day 0 to Week 12||10
493228|NCT00353119|1182364|P1|STARTED|First Intervention Day 0 to Week 12||5
493229|NCT00352911|1182376|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
493230|NCT00352911|1182377|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
493231|NCT00352911|1182376|P2|COMPLETED|300mg Twice Daily (14 Days)||3
493232|NCT00352911|1182377|P1|COMPLETED|300mg Twice Daily (14 Days)||15
493233|NCT00352911|1182376|P2|STARTED|300mg Twice Daily (14 Days)||3
493234|NCT00352911|1182377|P1|STARTED|300mg Twice Daily (14 Days)||16
493235|NCT00352911|1182376|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
493236|NCT00352911|1182377|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
493237|NCT00352911|1182376|P2|COMPLETED|150mg Twice Daily (14 Days)||3
493238|NCT00352911|1182377|P1|COMPLETED|150mg Twice Daily (14 Days)||16
493239|NCT00352911|1182376|P2|STARTED|150mg Twice Daily (14 Days)||3
493240|NCT00352911|1182377|P1|STARTED|150mg Twice Daily (14 Days)||16
493241|NCT00352885|1182385|P2|NOT COMPLETED|Overall Study||8
493242|NCT00352885|1182386|P1|NOT COMPLETED|Overall Study||5
493243|NCT00352885|1182385|P2|COMPLETED|Overall Study||3
493244|NCT00352885|1182386|P1|COMPLETED|Overall Study||4
493245|NCT00352885|1182385|P2|STARTED|Overall Study||11
493246|NCT00352885|1182386|P1|STARTED|Overall Study||9
493247|NCT00352846|1182394|P2|NOT COMPLETED|Overall Study||13
493248|NCT00352846|1182395|P1|NOT COMPLETED|Overall Study||8
493249|NCT00352846|1182394|P2|COMPLETED|Overall Study||24
493250|NCT00352846|1182395|P1|COMPLETED|Overall Study||29
493251|NCT00352846|1182394|P2|STARTED|Overall Study||37
493252|NCT00352846|1182395|P1|STARTED|Overall Study||37
493253|NCT00352781|1182401|P1|NOT COMPLETED|Overall Study||883
493254|NCT00352781|1182401|P1|COMPLETED|Overall Study||884
493255|NCT00352781|1182401|P1|STARTED|Overall Study||1767
493256|NCT00352755|1182406|P1|NOT COMPLETED|Overall Study||2
493257|NCT00352755|1182406|P1|COMPLETED|Overall Study||16
493258|NCT00352755|1182406|P1|STARTED|Overall Study||18
493259|NCT00352690|1182416|P2|NOT COMPLETED|Overall Study||0
493260|NCT00352690|1182417|P1|NOT COMPLETED|Overall Study||2
493261|NCT00352690|1182416|P2|COMPLETED|Overall Study||0
493262|NCT00352690|1182417|P1|COMPLETED|Overall Study||8
493263|NCT00352690|1182416|P2|STARTED|Overall Study||0
493264|NCT00352690|1182417|P1|STARTED|Overall Study||10
493265|NCT00352664|1182437|P2|NOT COMPLETED|Overall Study||0
493266|NCT00352664|1182438|P1|NOT COMPLETED|Overall Study||7
493267|NCT00352664|1182437|P2|COMPLETED|Overall Study||0
493268|NCT00352664|1182438|P1|COMPLETED|Overall Study||20
493269|NCT00352664|1182437|P2|STARTED|Overall Study||0
493270|NCT00352664|1182438|P1|STARTED|Overall Study||27
493271|NCT00352612|1182446|P2|NOT COMPLETED|Overall Study||0
493272|NCT00352612|1182447|P1|NOT COMPLETED|Overall Study||0
493273|NCT00352612|1182446|P2|COMPLETED|Overall Study||100
493274|NCT00352612|1182447|P1|COMPLETED|Overall Study||100
493275|NCT00352612|1182446|P2|STARTED|Overall Study||100
493276|NCT00352612|1182447|P1|STARTED|Overall Study||100
493277|NCT00352534|1182455|P7|NOT COMPLETED|Final Risk Group Assignment||39
493278|NCT00352534|1182456|P6|NOT COMPLETED|Final Risk Group Assignment||45
493279|NCT00352534|1182457|P5|NOT COMPLETED|Final Risk Group Assignment||1
493280|NCT00352534|1182458|P4|NOT COMPLETED|Final Risk Group Assignment||3
493281|NCT00352534|1182459|P3|NOT COMPLETED|Final Risk Group Assignment||3
493282|NCT00352534|1182460|P2|NOT COMPLETED|Final Risk Group Assignment||0
493283|NCT00352534|1182461|P1|NOT COMPLETED|Final Risk Group Assignment||0
493284|NCT00352534|1182455|P7|COMPLETED|Final Risk Group Assignment||1
493285|NCT00352534|1182456|P6|COMPLETED|Final Risk Group Assignment||503
493286|NCT00352534|1182457|P5|COMPLETED|Final Risk Group Assignment||31
493287|NCT00352534|1182458|P4|COMPLETED|Final Risk Group Assignment||49
493288|NCT00352534|1182459|P3|COMPLETED|Final Risk Group Assignment||116
493289|NCT00352534|1182460|P2|COMPLETED|Final Risk Group Assignment||0
493290|NCT00352534|1182461|P1|COMPLETED|Final Risk Group Assignment||0
493291|NCT00352534|1182455|P7|STARTED|Final Risk Group Assignment||40
493292|NCT00352534|1182456|P6|STARTED|Final Risk Group Assignment||548
493293|NCT00352534|1182457|P5|STARTED|Final Risk Group Assignment||32
493294|NCT00352534|1182458|P4|STARTED|Final Risk Group Assignment||52
493295|NCT00352534|1182459|P3|STARTED|Final Risk Group Assignment||119
493296|NCT00352534|1182460|P2|STARTED|Final Risk Group Assignment||0
493297|NCT00352534|1182461|P1|STARTED|Final Risk Group Assignment||0
493298|NCT00352534|1182455|P7|NOT COMPLETED|Initial Staging||0
493299|NCT00352534|1182456|P6|NOT COMPLETED|Initial Staging||0
493300|NCT00352534|1182457|P5|NOT COMPLETED|Initial Staging||0
493301|NCT00352534|1182458|P4|NOT COMPLETED|Initial Staging||0
493302|NCT00352534|1182459|P3|NOT COMPLETED|Initial Staging||0
493303|NCT00352534|1182460|P2|NOT COMPLETED|Initial Staging||9
493304|NCT00352534|1182461|P1|NOT COMPLETED|Initial Staging||8
493305|NCT00352534|1182455|P7|COMPLETED|Initial Staging||0
493306|NCT00352534|1182456|P6|COMPLETED|Initial Staging||0
493307|NCT00352534|1182457|P5|COMPLETED|Initial Staging||0
493308|NCT00352534|1182458|P4|COMPLETED|Initial Staging||0
493309|NCT00352534|1182459|P3|COMPLETED|Initial Staging||0
493310|NCT00352534|1182460|P2|COMPLETED|Initial Staging||588
493313|NCT00352534|1182456|P6|STARTED|Initial Staging||0
493314|NCT00352534|1182457|P5|STARTED|Initial Staging||0
493315|NCT00352534|1182458|P4|STARTED|Initial Staging||0
493316|NCT00352534|1182459|P3|STARTED|Initial Staging||0
493317|NCT00352534|1182460|P2|STARTED|Initial Staging||597
493318|NCT00352534|1182461|P1|STARTED|Initial Staging||211
493319|NCT00352417|1182478|P2|NOT COMPLETED|Overall Study||5
493320|NCT00352417|1182479|P1|NOT COMPLETED|Overall Study||5
493321|NCT00352417|1182478|P2|COMPLETED|Overall Study||21
493322|NCT00352417|1182479|P1|COMPLETED|Overall Study||19
493323|NCT00352417|1182478|P2|STARTED|Overall Study||26
493324|NCT00352417|1182479|P1|STARTED|Overall Study||24
493325|NCT00352365|1182493|P1|NOT COMPLETED|Maintenance Therapy||12
493326|NCT00352365|1182493|P1|COMPLETED|Maintenance Therapy||0
493327|NCT00352365|1182493|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
493328|NCT00352365|1182493|P1|STARTED|Maintenance Therapy||12
493329|NCT00352365|1182493|P1|NOT COMPLETED|Induction Therapy||27
493330|NCT00352365|1182493|P1|COMPLETED|Induction Therapy||14
493331|NCT00352365|1182493|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
493332|NCT00352365|1182493|P1|Eligible|Induction Therapy||38
493333|NCT00352365|1182493|P1|STARTED|Induction Therapy||41
493334|NCT00352118|1182503|P1|NOT COMPLETED|Overall Study||4
493335|NCT00352118|1182503|P1|COMPLETED|Overall Study||0
493336|NCT00352118|1182503|P1|STARTED|Overall Study||4
493337|NCT00352105|1182513|P1|NOT COMPLETED|Overall Study||40
493338|NCT00352105|1182513|P1|COMPLETED|Overall Study||20
493339|NCT00352105|1182513|P1|STARTED|Overall Study||60
493340|NCT00352053|1182524|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
493341|NCT00352053|1182525|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
493342|NCT00352053|1182524|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
493343|NCT00352053|1182525|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
493344|NCT00352053|1182524|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
493345|NCT00352053|1182525|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
493346|NCT00352053|1182524|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
493347|NCT00352053|1182525|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
493348|NCT00352053|1182524|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
493349|NCT00352053|1182525|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
493350|NCT00352053|1182524|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
493351|NCT00352053|1182525|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
493352|NCT00352053|1182524|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
493353|NCT00352053|1182525|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
493354|NCT00352053|1182524|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
493355|NCT00352053|1182525|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
493356|NCT00352053|1182524|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
493357|NCT00352053|1182525|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
493447|NCT00350792|1183178|P1|STARTED|Overall Study||62
493358|NCT00352053|1182524|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
493359|NCT00352053|1182525|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
493360|NCT00352053|1182524|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
493361|NCT00352053|1182525|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
493362|NCT00352053|1182524|P2|STARTED|Double-Blind Phase (Through Week 48)||42
493363|NCT00352053|1182525|P1|STARTED|Double-Blind Phase (Through Week 48)||45
493364|NCT00352027|1182692|P1|NOT COMPLETED|Overall Study||3
493365|NCT00352027|1182692|P1|COMPLETED|Overall Study||77
493366|NCT00352027|1182692|P1|STARTED|Overall Study||80
493367|NCT00351936|1182961|P1|NOT COMPLETED|Overall Study||0
493368|NCT00351936|1182961|P1|COMPLETED|Overall Study||15
493369|NCT00351936|1182961|P1|STARTED|Overall Study||15
493370|NCT00351741|1182980|P2|NOT COMPLETED|Overall Study||0
493371|NCT00351741|1182981|P1|NOT COMPLETED|Overall Study||0
493372|NCT00351741|1182980|P2|COMPLETED|Overall Study||31
493373|NCT00351741|1182981|P1|COMPLETED|Overall Study||31
493374|NCT00351741|1182980|P2|STARTED|Overall Study||31
493375|NCT00351741|1182981|P1|STARTED|Overall Study||31
493376|NCT00351533|1183001|P2|NOT COMPLETED|Overall Study||5
493377|NCT00351533|1183002|P1|NOT COMPLETED|Overall Study||2
493378|NCT00351533|1183001|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
493379|NCT00351533|1183002|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
493380|NCT00351533|1183001|P2|STARTED|Overall Study||49
493381|NCT00351533|1183002|P1|STARTED|Overall Study||41
493382|NCT00351468|1183062|P1|NOT COMPLETED|Overall Study||167
493383|NCT00351468|1183062|P1|COMPLETED|Overall Study||135
493384|NCT00351468|1183062|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
493385|NCT00351468|1183062|P1|Subjects From TRA108057 Repeat|Overall Study||43
493386|NCT00351468|1183062|P1|Subjects From TRA102537 Raise|Overall Study||146
493387|NCT00351468|1183062|P1|Subjects From TRA100773B|Overall Study||61
493388|NCT00351468|1183062|P1|Subjects From TRA100773A|Overall Study||51
493389|NCT00351468|1183062|P1|STARTED|Overall Study||302
493390|NCT00351416|1183079|P2|NOT COMPLETED|Overall Study||0
493391|NCT00351416|1183080|P1|NOT COMPLETED|Overall Study||0
493392|NCT00351416|1183079|P2|COMPLETED|Overall Study||9
493393|NCT00351416|1183080|P1|COMPLETED|Overall Study||6
493394|NCT00351416|1183079|P2|STARTED|Overall Study||9
493395|NCT00351416|1183080|P1|STARTED|Overall Study||6
493396|NCT00351377|1183086|P1|NOT COMPLETED|Overall Study||7
493397|NCT00351377|1183086|P1|COMPLETED|Overall Study||104
493398|NCT00351377|1183086|P1|STARTED|Overall Study||111
493399|NCT00351351|1183100|P2|NOT COMPLETED|Overall Study||4
493400|NCT00351351|1183101|P1|NOT COMPLETED|Overall Study||9
493401|NCT00351351|1183100|P2|COMPLETED|Overall Study||32
493402|NCT00351351|1183101|P1|COMPLETED|Overall Study||25
493403|NCT00351351|1183100|P2|STARTED|Overall Study||36
493404|NCT00351351|1183101|P1|STARTED|Overall Study||34
493405|NCT00351299|1183109|P2|NOT COMPLETED|Overall Study||0
493406|NCT00351299|1183110|P1|NOT COMPLETED|Overall Study||0
493407|NCT00351299|1183109|P2|COMPLETED|Overall Study||28
493408|NCT00351299|1183110|P1|COMPLETED|Overall Study||25
493409|NCT00351299|1183109|P2|STARTED|Overall Study||28
493410|NCT00351299|1183110|P1|STARTED|Overall Study||25
493411|NCT00351273|1183127|P3|NOT COMPLETED|Overall Study||5
493412|NCT00351273|1183128|P2|NOT COMPLETED|Overall Study||2
493413|NCT00351273|1183129|P1|NOT COMPLETED|Overall Study||1
493414|NCT00351273|1183127|P3|COMPLETED|Overall Study||10
493415|NCT00351273|1183128|P2|COMPLETED|Overall Study||10
493416|NCT00351273|1183129|P1|COMPLETED|Overall Study||14
493417|NCT00351273|1183127|P3|STARTED|Overall Study||15
493418|NCT00351273|1183128|P2|STARTED|Overall Study||12
493419|NCT00351273|1183129|P1|STARTED|Overall Study||15
493420|NCT00351039|1183137|P1|NOT COMPLETED|Overall Study||0
493421|NCT00351039|1183137|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
493422|NCT00351039|1183137|P1|STARTED|Overall Study||8
493423|NCT00351000|1183146|P1|NOT COMPLETED|Overall Study||3
493424|NCT00351000|1183146|P1|COMPLETED|Overall Study||21
493425|NCT00351000|1183146|P1|STARTED|Overall Study||24
493426|NCT00350870|1183157|P4|NOT COMPLETED|Overall Study||15
493427|NCT00350870|1183158|P3|NOT COMPLETED|Overall Study||16
493428|NCT00350870|1183159|P2|NOT COMPLETED|Overall Study||17
493429|NCT00350870|1183160|P1|NOT COMPLETED|Overall Study||22
493430|NCT00350870|1183157|P4|COMPLETED|Overall Study||7
493431|NCT00350870|1183158|P3|COMPLETED|Overall Study||6
493432|NCT00350870|1183159|P2|COMPLETED|Overall Study||11
493433|NCT00350870|1183160|P1|COMPLETED|Overall Study||5
493434|NCT00350870|1183157|P4|Had at Least 1 Day of Med|Overall Study||19
493435|NCT00350870|1183158|P3|Had at Least 1 Day of Med|Overall Study||18
493436|NCT00350870|1183159|P2|Had at Least 1 Day of Med|Overall Study||24
493437|NCT00350870|1183160|P1|Had at Least 1 Day of Med|Overall Study||19
493438|NCT00350870|1183157|P4|STARTED|Overall Study||22
493439|NCT00350870|1183158|P3|STARTED|Overall Study||22
493440|NCT00350870|1183159|P2|STARTED|Overall Study||28
493441|NCT00350870|1183160|P1|STARTED|Overall Study||27
493442|NCT00350844|1183174|P1|NOT COMPLETED|Overall Study||1
493443|NCT00350844|1183174|P1|COMPLETED|Overall Study||5
493444|NCT00350844|1183174|P1|STARTED|Overall Study||6
493445|NCT00350792|1183178|P1|NOT COMPLETED|Overall Study||33
493446|NCT00350792|1183178|P1|COMPLETED|Overall Study||29
493448|NCT00350779|1183188|P2|NOT COMPLETED|Overall Study||21
493449|NCT00350779|1183189|P1|NOT COMPLETED|Overall Study||22
493450|NCT00350779|1183188|P2|COMPLETED|Overall Study||71
493451|NCT00350779|1183189|P1|COMPLETED|Overall Study||148
493452|NCT00350779|1183188|P2|STARTED|Overall Study||92
493453|NCT00350779|1183189|P1|STARTED|Overall Study||170
493454|NCT00350727|1183210|P3|NOT COMPLETED|Phase II||22
493455|NCT00350727|1183211|P2|NOT COMPLETED|Phase II||19
493456|NCT00350727|1183212|P1|NOT COMPLETED|Phase II||0
493457|NCT00350727|1183210|P3|COMPLETED|Phase II||0
493458|NCT00350727|1183211|P2|COMPLETED|Phase II||0
493459|NCT00350727|1183212|P1|COMPLETED|Phase II||0
493460|NCT00350727|1183210|P3|STARTED|Phase II||22
493461|NCT00350727|1183211|P2|STARTED|Phase II||19
493462|NCT00350727|1183212|P1|STARTED|Phase II||0
493463|NCT00350727|1183210|P3|NOT COMPLETED|Phase I: Dose Escalation||0
493464|NCT00350727|1183211|P2|NOT COMPLETED|Phase I: Dose Escalation||0
493465|NCT00350727|1183212|P1|NOT COMPLETED|Phase I: Dose Escalation||34
493466|NCT00350727|1183210|P3|COMPLETED|Phase I: Dose Escalation||0
493467|NCT00350727|1183211|P2|COMPLETED|Phase I: Dose Escalation||0
493468|NCT00350727|1183212|P1|COMPLETED|Phase I: Dose Escalation||0
493469|NCT00350727|1183210|P3|STARTED|Phase I: Dose Escalation||0
493470|NCT00350727|1183211|P2|STARTED|Phase I: Dose Escalation||0
493471|NCT00350727|1183212|P1|STARTED|Phase I: Dose Escalation||34
493472|NCT00350636|1183356|P2|NOT COMPLETED|Overall Study||45
493473|NCT00350636|1183357|P1|NOT COMPLETED|Overall Study||43
493474|NCT00350636|1183356|P2|COMPLETED|Overall Study||355
493475|NCT00350636|1183357|P1|COMPLETED|Overall Study||346
493476|NCT00350636|1183356|P2|STARTED|Overall Study||400
493477|NCT00350636|1183357|P1|STARTED|Overall Study||389
493478|NCT00350623|1183376|P3|NOT COMPLETED|Overall Study||6
493479|NCT00350623|1183377|P2|NOT COMPLETED|Overall Study||4
493480|NCT00350623|1183378|P1|NOT COMPLETED|Overall Study||8
493481|NCT00350623|1183376|P3|COMPLETED|Overall Study||62
493482|NCT00350623|1183377|P2|COMPLETED|Overall Study||67
493483|NCT00350623|1183378|P1|COMPLETED|Overall Study||63
493484|NCT00350623|1183376|P3|STARTED|Overall Study||68
493485|NCT00350623|1183377|P2|STARTED|Overall Study||71
493486|NCT00350623|1183378|P1|STARTED|Overall Study||71
493487|NCT00350532|1183388|P2|NOT COMPLETED|Overall Study||0
493488|NCT00350532|1183389|P1|NOT COMPLETED|Overall Study||0
493489|NCT00350532|1183388|P2|COMPLETED|Overall Study||19
493490|NCT00350532|1183389|P1|COMPLETED|Overall Study||24
493491|NCT00350532|1183388|P2|STARTED|Overall Study||19
493492|NCT00350532|1183389|P1|STARTED|Overall Study||24
493493|NCT00350519|1183397|P2|NOT COMPLETED|Overall Study||6
493494|NCT00350519|1183398|P1|NOT COMPLETED|Overall Study||4
493495|NCT00350519|1183397|P2|COMPLETED|Overall Study||13
493496|NCT00350519|1183398|P1|COMPLETED|Overall Study||14
493497|NCT00350519|1183397|P2|STARTED|Overall Study||19
493498|NCT00350519|1183398|P1|STARTED|Overall Study||18
493499|NCT00350402|1183412|P2|NOT COMPLETED|Overall Study||1
493500|NCT00350402|1183413|P1|NOT COMPLETED|Overall Study||1
493501|NCT00350402|1183412|P2|COMPLETED|Overall Study||20
493502|NCT00350402|1183413|P1|COMPLETED|Overall Study||20
493503|NCT00350402|1183412|P2|STARTED|Overall Study||21
493504|NCT00350402|1183413|P1|STARTED|Overall Study||21
493505|NCT00350363|1183425|P1|NOT COMPLETED|Overall Study||0
493506|NCT00350363|1183425|P1|COMPLETED|Overall Study||60
493507|NCT00350363|1183425|P1|STARTED|Overall Study||60
493508|NCT00350272|1183431|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
493509|NCT00350272|1183432|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
493510|NCT00350272|1183431|P2|COMPLETED|Open-Label 84 Week Treatment||27
493511|NCT00350272|1183432|P1|COMPLETED|Open-Label 84 Week Treatment||21
493512|NCT00350272|1183431|P2|STARTED|Open-Label 84 Week Treatment||35
493513|NCT00350272|1183432|P1|STARTED|Open-Label 84 Week Treatment||30
493514|NCT00350272|1183431|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
493515|NCT00350272|1183432|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
493516|NCT00350272|1183431|P2|COMPLETED|Blinded 12 Week Treatment||35
493517|NCT00350272|1183432|P1|COMPLETED|Blinded 12 Week Treatment||30
493518|NCT00350272|1183431|P2|STARTED|Blinded 12 Week Treatment||37
493519|NCT00350272|1183432|P1|STARTED|Blinded 12 Week Treatment||39
493520|NCT00350220|1183442|P2|NOT COMPLETED|Overall Study||0
493521|NCT00350220|1183443|P1|NOT COMPLETED|Overall Study||0
493522|NCT00350220|1183442|P2|COMPLETED|Overall Study||30
493523|NCT00350220|1183443|P1|COMPLETED|Overall Study||30
493524|NCT00350220|1183442|P2|STARTED|Overall Study||30
493525|NCT00350220|1183443|P1|STARTED|Overall Study||30
493526|NCT00350207|1183454|P3|NOT COMPLETED|Overall Study||7
493527|NCT00350207|1183455|P2|NOT COMPLETED|Overall Study||6
493528|NCT00350207|1183456|P1|NOT COMPLETED|Overall Study||8
493529|NCT00350207|1183454|P3|COMPLETED|Overall Study||119
493530|NCT00350207|1183455|P2|COMPLETED|Overall Study||128
493531|NCT00350207|1183456|P1|COMPLETED|Overall Study||120
493532|NCT00350207|1183454|P3|STARTED|Overall Study||126
493533|NCT00350207|1183455|P2|STARTED|Overall Study||134
493534|NCT00350207|1183456|P1|STARTED|Overall Study||128
493535|NCT00350142|1183650|P1|NOT COMPLETED|Overall Study||0
493536|NCT00350142|1183650|P1|COMPLETED|Overall Study||20
493537|NCT00350142|1183650|P1|STARTED|Overall Study||20
493538|NCT00350025|1183657|P2|NOT COMPLETED|Overall Study||2
493539|NCT00350025|1183658|P1|NOT COMPLETED|Overall Study||0
493540|NCT00350025|1183657|P2|COMPLETED|Overall Study||28
493541|NCT00350025|1183658|P1|COMPLETED|Overall Study||11
493542|NCT00350025|1183657|P2|STARTED|Overall Study||30
493543|NCT00350025|1183658|P1|STARTED|Overall Study||11
493544|NCT00349921|1183670|P4|NOT COMPLETED|Second Spinal Injection||0
493545|NCT00349921|1183671|P3|NOT COMPLETED|Second Spinal Injection||0
493546|NCT00349921|1183672|P2|NOT COMPLETED|Second Spinal Injection||0
493547|NCT00349921|1183673|P1|NOT COMPLETED|Second Spinal Injection||0
493548|NCT00349921|1183670|P4|COMPLETED|Second Spinal Injection||1
493549|NCT00349921|1183671|P3|COMPLETED|Second Spinal Injection||0
493550|NCT00349921|1183672|P2|COMPLETED|Second Spinal Injection||10
493551|NCT00349921|1183673|P1|COMPLETED|Second Spinal Injection||9
493552|NCT00349921|1183670|P4|STARTED|Second Spinal Injection||1
493553|NCT00349921|1183671|P3|STARTED|Second Spinal Injection||0
493554|NCT00349921|1183672|P2|STARTED|Second Spinal Injection||10
493555|NCT00349921|1183673|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
493556|NCT00349921|1183670|P4|NOT COMPLETED|First Spinal Injection||0
493557|NCT00349921|1183671|P3|NOT COMPLETED|First Spinal Injection||1
493558|NCT00349921|1183672|P2|NOT COMPLETED|First Spinal Injection||0
493559|NCT00349921|1183673|P1|NOT COMPLETED|First Spinal Injection||1
493560|NCT00349921|1183670|P4|COMPLETED|First Spinal Injection||1
493561|NCT00349921|1183671|P3|COMPLETED|First Spinal Injection||0
493562|NCT00349921|1183672|P2|COMPLETED|First Spinal Injection||10
493563|NCT00349921|1183673|P1|COMPLETED|First Spinal Injection||9
493564|NCT00349921|1183670|P4|STARTED|First Spinal Injection||1
493565|NCT00349921|1183671|P3|STARTED|First Spinal Injection||1
493566|NCT00349921|1183672|P2|STARTED|First Spinal Injection||10
493567|NCT00349921|1183673|P1|STARTED|First Spinal Injection||10
493568|NCT00349908|1183684|P2|NOT COMPLETED|Overall Study||4
493569|NCT00349908|1183685|P1|NOT COMPLETED|Overall Study||0
493570|NCT00349908|1183684|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
493571|NCT00349908|1183685|P1|COMPLETED|Overall Study||10
493572|NCT00349908|1183684|P2|STARTED|Overall Study||10
493573|NCT00349908|1183685|P1|STARTED|Overall Study||10
493574|NCT00349752|1183705|P2|NOT COMPLETED|Overall Study||64
493575|NCT00349752|1183706|P1|NOT COMPLETED|Overall Study||59
493576|NCT00349752|1183705|P2|COMPLETED|Overall Study||23
493577|NCT00349752|1183706|P1|COMPLETED|Overall Study||28
493578|NCT00349752|1183705|P2|STARTED|Overall Study||87
493579|NCT00349752|1183706|P1|STARTED|Overall Study||87
493580|NCT00349622|1183734|P2|NOT COMPLETED|Overall Study||96
493581|NCT00349622|1183735|P1|NOT COMPLETED|Overall Study||178
493582|NCT00349622|1183734|P2|COMPLETED|Overall Study||77
493583|NCT00349622|1183735|P1|COMPLETED|Overall Study||162
493584|NCT00349622|1183734|P2|STARTED|Overall Study||173
493585|NCT00349622|1183735|P1|STARTED|Overall Study||340
493586|NCT00349466|1183753|P2|NOT COMPLETED|Overall Study||3
493587|NCT00349466|1183754|P1|NOT COMPLETED|Overall Study||9
493588|NCT00349466|1183753|P2|COMPLETED|Overall Study||35
493589|NCT00349466|1183754|P1|COMPLETED|Overall Study||33
493590|NCT00349466|1183753|P2|STARTED|Overall Study||38
493591|NCT00349466|1183754|P1|STARTED|Overall Study||42
493592|NCT00349388|1183762|P2|NOT COMPLETED|Overall Study||0
493593|NCT00349388|1183763|P1|NOT COMPLETED|Overall Study||0
493594|NCT00349388|1183762|P2|COMPLETED|Overall Study||1
493595|NCT00349388|1183763|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
493596|NCT00349388|1183762|P2|STARTED|Overall Study||1
493597|NCT00349388|1183763|P1|STARTED|Overall Study|no patients enrolled|0
493598|NCT00349349|1183772|P3|NOT COMPLETED|Overall Study||6
493599|NCT00349349|1183773|P2|NOT COMPLETED|Overall Study||62
493600|NCT00349349|1183774|P1|NOT COMPLETED|Overall Study||53
493601|NCT00349349|1183772|P3|COMPLETED|Overall Study||10
493602|NCT00349349|1183773|P2|COMPLETED|Overall Study||50
493603|NCT00349349|1183774|P1|COMPLETED|Overall Study||42
493604|NCT00349349|1183772|P3|STARTED|Overall Study||16
493605|NCT00349349|1183773|P2|STARTED|Overall Study||112
493606|NCT00349349|1183774|P1|STARTED|Overall Study||95
493607|NCT00349336|1183840|P2|NOT COMPLETED|Overall Study||14
493608|NCT00349336|1183841|P1|NOT COMPLETED|Overall Study||13
493609|NCT00349336|1183840|P2|COMPLETED|Overall Study||18
493610|NCT00349336|1183841|P1|COMPLETED|Overall Study||19
493611|NCT00349336|1183840|P2|STARTED|Overall Study||32
493612|NCT00349336|1183841|P1|STARTED|Overall Study||32
493613|NCT00348933|1183863|P1|NOT COMPLETED|Overall Study||25
493614|NCT00348933|1183863|P1|COMPLETED|Overall Study||65
493615|NCT00348933|1183863|P1|STARTED|Overall Study||90
493616|NCT00348881|1183871|P2|NOT COMPLETED|Overall Study||12
493617|NCT00348881|1183872|P1|NOT COMPLETED|Overall Study||17
493618|NCT00348881|1183871|P2|COMPLETED|Overall Study||697
493619|NCT00348881|1183872|P1|COMPLETED|Overall Study||1407
493620|NCT00348881|1183871|P2|STARTED|Overall Study||709
493621|NCT00348881|1183872|P1|STARTED|Overall Study||1424
493622|NCT00348816|1183884|P1|NOT COMPLETED|Overall Study||1
493623|NCT00348816|1183884|P1|COMPLETED|Overall Study||19
493624|NCT00348816|1183884|P1|STARTED|Overall Study||20
493625|NCT00348790|1183888|P1|NOT COMPLETED|Completed Treatment||25
493626|NCT00348790|1183888|P1|COMPLETED|Completed Treatment||0
493627|NCT00348790|1183888|P1|STARTED|Completed Treatment||25
493628|NCT00348790|1183888|P1|NOT COMPLETED|Began Treatment||0
493629|NCT00348790|1183888|P1|COMPLETED|Began Treatment||25
493630|NCT00348790|1183888|P1|STARTED|Began Treatment||25
493631|NCT00348686|1183893|P1|NOT COMPLETED|Overall Study||66
493632|NCT00348686|1183893|P1|COMPLETED|Overall Study||249
493633|NCT00348686|1183893|P1|STARTED|Overall Study||315
493634|NCT00348673|1183910|P9|NOT COMPLETED|Stage 2||0
493635|NCT00348673|1183911|P8|NOT COMPLETED|Stage 2||0
493636|NCT00348673|1183912|P7|NOT COMPLETED|Stage 2||0
493637|NCT00348673|1183913|P6|NOT COMPLETED|Stage 2||0
493638|NCT00348673|1183914|P5|NOT COMPLETED|Stage 2||0
493639|NCT00348673|1183915|P4|NOT COMPLETED|Stage 2||0
493640|NCT00348673|1183916|P3|NOT COMPLETED|Stage 2||0
493641|NCT00348673|1183917|P2|NOT COMPLETED|Stage 2||0
493642|NCT00348673|1183918|P1|NOT COMPLETED|Stage 2||0
493643|NCT00348673|1183910|P9|COMPLETED|Stage 2||2
493644|NCT00348673|1183911|P8|COMPLETED|Stage 2||6
493645|NCT00348673|1183912|P7|COMPLETED|Stage 2||6
493646|NCT00348673|1183913|P6|COMPLETED|Stage 2||6
493647|NCT00348673|1183914|P5|COMPLETED|Stage 2||0
493648|NCT00348673|1183915|P4|COMPLETED|Stage 2||0
493649|NCT00348673|1183916|P3|COMPLETED|Stage 2||0
493650|NCT00348673|1183917|P2|COMPLETED|Stage 2||0
493651|NCT00348673|1183918|P1|COMPLETED|Stage 2||0
493652|NCT00348673|1183910|P9|STARTED|Stage 2||2
493653|NCT00348673|1183911|P8|STARTED|Stage 2||6
493654|NCT00348673|1183912|P7|STARTED|Stage 2||6
493655|NCT00348673|1183913|P6|STARTED|Stage 2||6
493656|NCT00348673|1183914|P5|STARTED|Stage 2||0
493657|NCT00348673|1183915|P4|STARTED|Stage 2||0
493658|NCT00348673|1183916|P3|STARTED|Stage 2||0
493659|NCT00348673|1183917|P2|STARTED|Stage 2||0
493660|NCT00348673|1183918|P1|STARTED|Stage 2||0
493661|NCT00348673|1183910|P9|NOT COMPLETED|Stage 1||0
493662|NCT00348673|1183911|P8|NOT COMPLETED|Stage 1||0
493663|NCT00348673|1183912|P7|NOT COMPLETED|Stage 1||0
493664|NCT00348673|1183913|P6|NOT COMPLETED|Stage 1||0
493665|NCT00348673|1183914|P5|NOT COMPLETED|Stage 1||0
493666|NCT00348673|1183915|P4|NOT COMPLETED|Stage 1||0
493667|NCT00348673|1183916|P3|NOT COMPLETED|Stage 1||1
493668|NCT00348673|1183917|P2|NOT COMPLETED|Stage 1||0
493669|NCT00348673|1183918|P1|NOT COMPLETED|Stage 1||0
493670|NCT00348673|1183910|P9|COMPLETED|Stage 1||0
493671|NCT00348673|1183911|P8|COMPLETED|Stage 1||0
493672|NCT00348673|1183912|P7|COMPLETED|Stage 1||0
493673|NCT00348673|1183913|P6|COMPLETED|Stage 1||0
493674|NCT00348673|1183914|P5|COMPLETED|Stage 1||4
493675|NCT00348673|1183915|P4|COMPLETED|Stage 1||6
493676|NCT00348673|1183916|P3|COMPLETED|Stage 1||6
493677|NCT00348673|1183917|P2|COMPLETED|Stage 1||6
493678|NCT00348673|1183918|P1|COMPLETED|Stage 1||6
493679|NCT00348673|1183910|P9|Treated|Stage 1||0
493680|NCT00348673|1183911|P8|Treated|Stage 1||0
493681|NCT00348673|1183912|P7|Treated|Stage 1||0
493682|NCT00348673|1183913|P6|Treated|Stage 1||0
493683|NCT00348673|1183914|P5|Treated|Stage 1||4
493684|NCT00348673|1183915|P4|Treated|Stage 1||6
493685|NCT00348673|1183916|P3|Treated|Stage 1||6
493686|NCT00348673|1183917|P2|Treated|Stage 1||6
493687|NCT00348673|1183918|P1|Treated|Stage 1||6
493688|NCT00348673|1183910|P9|STARTED|Stage 1||0
493689|NCT00348673|1183911|P8|STARTED|Stage 1||0
493690|NCT00348673|1183912|P7|STARTED|Stage 1||0
493691|NCT00348673|1183913|P6|STARTED|Stage 1||0
493692|NCT00348673|1183914|P5|STARTED|Stage 1||4
493693|NCT00348673|1183915|P4|STARTED|Stage 1||6
493694|NCT00348673|1183916|P3|STARTED|Stage 1||7
493695|NCT00348673|1183917|P2|STARTED|Stage 1||6
493696|NCT00348673|1183918|P1|STARTED|Stage 1||6
493697|NCT00348556|1183965|P1|NOT COMPLETED|Overall Study||1
493698|NCT00348556|1183965|P1|COMPLETED|Overall Study||3
493699|NCT00348556|1183965|P1|STARTED|Overall Study||4
493700|NCT00348374|1183972|P2|NOT COMPLETED|Overall Study||32
493701|NCT00348374|1183973|P1|NOT COMPLETED|Overall Study||19
493702|NCT00348374|1183972|P2|COMPLETED|Overall Study||71
493703|NCT00348374|1183973|P1|COMPLETED|Overall Study||69
493704|NCT00348374|1183972|P2|Received Study Treatment|Overall Study||96
493705|NCT00348374|1183973|P1|Received Study Treatment|Overall Study||88
493706|NCT00348374|1183972|P2|STARTED|Overall Study||103
493707|NCT00348374|1183973|P1|STARTED|Overall Study||88
493708|NCT00348348|1184020|P2|NOT COMPLETED|Overall Study||27
493709|NCT00348348|1184021|P1|NOT COMPLETED|Overall Study||25
493710|NCT00348348|1184020|P2|COMPLETED|Overall Study||555
493711|NCT00348348|1184021|P1|COMPLETED|Overall Study||554
493712|NCT00348348|1184020|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
493713|NCT00348348|1184021|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
493714|NCT00348283|1184035|P2|NOT COMPLETED|Open Label||34
493715|NCT00348283|1184036|P1|NOT COMPLETED|Open Label||0
493716|NCT00348283|1184035|P2|COMPLETED|Open Label||66
493717|NCT00348283|1184036|P1|COMPLETED|Open Label||0
493718|NCT00348283|1184035|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
493719|NCT00348283|1184036|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
493720|NCT00348283|1184035|P2|NOT COMPLETED|Double Blind||10
493721|NCT00348283|1184036|P1|NOT COMPLETED|Double Blind||5
493722|NCT00348283|1184035|P2|COMPLETED|Double Blind||54
493723|NCT00348283|1184036|P1|COMPLETED|Double Blind||60
493724|NCT00348283|1184035|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
493725|NCT00348283|1184036|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
493726|NCT00348283|1184035|P2|NOT COMPLETED|Induction||6
493727|NCT00348283|1184036|P1|NOT COMPLETED|Induction||0
493728|NCT00348283|1184035|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
493729|NCT00348283|1184036|P1|COMPLETED|Induction||0
493730|NCT00348283|1184035|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
493731|NCT00348283|1184036|P1|STARTED|Induction||0
493732|NCT00347958|1184052|P1|NOT COMPLETED|Overall Study||4
493733|NCT00347958|1184052|P1|COMPLETED|Overall Study||540
493734|NCT00347958|1184052|P1|STARTED|Overall Study||544
493735|NCT00347932|1184061|P2|NOT COMPLETED|Overall Study||52
493736|NCT00347932|1184062|P1|NOT COMPLETED|Overall Study||31
493737|NCT00347932|1184061|P2|COMPLETED|Overall Study||430
493738|NCT00347932|1184062|P1|COMPLETED|Overall Study||444
493739|NCT00347932|1184061|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
493740|NCT00347932|1184062|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
493741|NCT00347919|1184077|P3|NOT COMPLETED|Overall Study||38
493742|NCT00347919|1184078|P2|NOT COMPLETED|Overall Study||76
493743|NCT00347919|1184079|P1|NOT COMPLETED|Overall Study||71
493744|NCT00347919|1184077|P3|COMPLETED|Overall Study||2
493745|NCT00347919|1184078|P2|COMPLETED|Overall Study||0
493746|NCT00347919|1184079|P1|COMPLETED|Overall Study||2
493747|NCT00347919|1184077|P3|STARTED|Overall Study|Safety Population|40
493748|NCT00347919|1184078|P2|STARTED|Overall Study|Safety Population|76
493749|NCT00347919|1184079|P1|STARTED|Overall Study|Safety Population|73
493750|NCT00347438|1184099|P1|NOT COMPLETED|Overall Study||2
493751|NCT00347438|1184099|P1|COMPLETED|Overall Study||16
493752|NCT00347438|1184099|P1|STARTED|Overall Study||18
493753|NCT00347360|1184121|P15|NOT COMPLETED|Overall Study||4
493754|NCT00347360|1184122|P14|NOT COMPLETED|Overall Study||8
493755|NCT00347360|1184123|P13|NOT COMPLETED|Overall Study||10
493756|NCT00347360|1184124|P12|NOT COMPLETED|Overall Study||6
493757|NCT00347360|1184125|P11|NOT COMPLETED|Overall Study||5
493758|NCT00347360|1184126|P10|NOT COMPLETED|Overall Study||9
493759|NCT00347360|1184127|P9|NOT COMPLETED|Overall Study||6
493760|NCT00347360|1184128|P8|NOT COMPLETED|Overall Study||3
493761|NCT00347360|1184129|P7|NOT COMPLETED|Overall Study||7
493762|NCT00347360|1184130|P6|NOT COMPLETED|Overall Study||8
493763|NCT00347360|1184131|P5|NOT COMPLETED|Overall Study||5
493764|NCT00347360|1184132|P4|NOT COMPLETED|Overall Study||13
493765|NCT00347360|1184133|P3|NOT COMPLETED|Overall Study||6
493766|NCT00347360|1184134|P2|NOT COMPLETED|Overall Study||8
493767|NCT00347360|1184135|P1|NOT COMPLETED|Overall Study||5
493768|NCT00347360|1184121|P15|COMPLETED|Overall Study||39
493769|NCT00347360|1184122|P14|COMPLETED|Overall Study||36
493770|NCT00347360|1184123|P13|COMPLETED|Overall Study||34
493771|NCT00347360|1184124|P12|COMPLETED|Overall Study||37
493772|NCT00347360|1184125|P11|COMPLETED|Overall Study||39
493773|NCT00347360|1184126|P10|COMPLETED|Overall Study||35
493774|NCT00347360|1184127|P9|COMPLETED|Overall Study||38
493775|NCT00347360|1184128|P8|COMPLETED|Overall Study||40
493776|NCT00347360|1184129|P7|COMPLETED|Overall Study||37
493777|NCT00347360|1184130|P6|COMPLETED|Overall Study||36
493778|NCT00347360|1184131|P5|COMPLETED|Overall Study||39
493779|NCT00347360|1184132|P4|COMPLETED|Overall Study||30
493780|NCT00347360|1184133|P3|COMPLETED|Overall Study||37
493781|NCT00347360|1184134|P2|COMPLETED|Overall Study||35
493782|NCT00347360|1184135|P1|COMPLETED|Overall Study||39
493783|NCT00347360|1184121|P15|STARTED|Overall Study||43
493784|NCT00347360|1184122|P14|STARTED|Overall Study||44
493785|NCT00347360|1184123|P13|STARTED|Overall Study||44
493786|NCT00347360|1184124|P12|STARTED|Overall Study||43
493787|NCT00347360|1184125|P11|STARTED|Overall Study||44
493788|NCT00347360|1184126|P10|STARTED|Overall Study||44
493789|NCT00347360|1184127|P9|STARTED|Overall Study||44
493790|NCT00347360|1184128|P8|STARTED|Overall Study||43
493791|NCT00347360|1184129|P7|STARTED|Overall Study||44
493792|NCT00347360|1184130|P6|STARTED|Overall Study||44
493793|NCT00347360|1184131|P5|STARTED|Overall Study||44
493794|NCT00347360|1184132|P4|STARTED|Overall Study||43
493795|NCT00347360|1184133|P3|STARTED|Overall Study||43
493796|NCT00347360|1184134|P2|STARTED|Overall Study||43
493797|NCT00347360|1184135|P1|STARTED|Overall Study||44
493798|NCT00347308|1184317|P1|NOT COMPLETED|Overall Study||0
493799|NCT00347308|1184317|P1|COMPLETED|Overall Study||40
493800|NCT00347308|1184317|P1|STARTED|Overall Study||40
493801|NCT00347269|1184323|P2|NOT COMPLETED|Overall Study||106
493802|NCT00347269|1184324|P1|NOT COMPLETED|Overall Study||94
493803|NCT00347269|1184323|P2|COMPLETED|Overall Study||395
493804|NCT00347269|1184324|P1|COMPLETED|Overall Study||409
493805|NCT00347269|1184323|P2|STARTED|Overall Study||501
493806|NCT00347269|1184324|P1|STARTED|Overall Study||503
493807|NCT00347022|1184332|P2|NOT COMPLETED|Overall Study||5
493808|NCT00347022|1184333|P1|NOT COMPLETED|Overall Study||12
493809|NCT00347022|1184332|P2|COMPLETED|Overall Study||66
493810|NCT00347022|1184333|P1|COMPLETED|Overall Study||62
493811|NCT00347022|1184332|P2|STARTED|Overall Study||71
493812|NCT00347022|1184333|P1|STARTED|Overall Study||74
493813|NCT00347009|1184339|P1|NOT COMPLETED|Overall Study||27
493814|NCT00347009|1184339|P1|COMPLETED|Overall Study||128
493815|NCT00347009|1184339|P1|STARTED|Overall Study||155
493816|NCT00346697|1184358|P2|NOT COMPLETED|Overall Study||1
493817|NCT00346697|1184359|P1|NOT COMPLETED|Overall Study||0
493818|NCT00346697|1184358|P2|COMPLETED|Overall Study||23
493819|NCT00346697|1184359|P1|COMPLETED|Overall Study||24
493820|NCT00346697|1184358|P2|STARTED|Overall Study||24
493821|NCT00346697|1184359|P1|STARTED|Overall Study||24
493822|NCT00346632|1184395|P10|NOT COMPLETED|Overall Study||3
493823|NCT00346632|1184396|P9|NOT COMPLETED|Overall Study||4
493824|NCT00346632|1184397|P8|NOT COMPLETED|Overall Study||4
493825|NCT00346632|1184398|P7|NOT COMPLETED|Overall Study||5
493826|NCT00346632|1184399|P6|NOT COMPLETED|Overall Study||2
493827|NCT00346632|1184400|P5|NOT COMPLETED|Overall Study||4
493828|NCT00346632|1184401|P4|NOT COMPLETED|Overall Study||3
493829|NCT00346632|1184402|P3|NOT COMPLETED|Overall Study||6
493830|NCT00346632|1184403|P2|NOT COMPLETED|Overall Study||3
493831|NCT00346632|1184404|P1|NOT COMPLETED|Overall Study||3
493832|NCT00346632|1184395|P10|COMPLETED|Overall Study||0
493833|NCT00346632|1184396|P9|COMPLETED|Overall Study||0
493834|NCT00346632|1184397|P8|COMPLETED|Overall Study||0
493835|NCT00346632|1184398|P7|COMPLETED|Overall Study||0
493836|NCT00346632|1184399|P6|COMPLETED|Overall Study||0
493837|NCT00346632|1184400|P5|COMPLETED|Overall Study||0
493838|NCT00346632|1184401|P4|COMPLETED|Overall Study||0
493839|NCT00346632|1184402|P3|COMPLETED|Overall Study||0
493840|NCT00346632|1184403|P2|COMPLETED|Overall Study||0
493841|NCT00346632|1184404|P1|COMPLETED|Overall Study||0
493842|NCT00346632|1184395|P10|STARTED|Overall Study||3
493843|NCT00346632|1184396|P9|STARTED|Overall Study||4
493844|NCT00346632|1184397|P8|STARTED|Overall Study||4
493845|NCT00346632|1184398|P7|STARTED|Overall Study||5
493846|NCT00346632|1184399|P6|STARTED|Overall Study||2
493847|NCT00346632|1184400|P5|STARTED|Overall Study||4
493848|NCT00346632|1184401|P4|STARTED|Overall Study||3
493849|NCT00346632|1184402|P3|STARTED|Overall Study||6
493850|NCT00346632|1184403|P2|STARTED|Overall Study||3
493851|NCT00346632|1184404|P1|STARTED|Overall Study||3
493852|NCT00346476|1184547|P1|NOT COMPLETED|Overall Study||0
493853|NCT00346476|1184547|P1|COMPLETED|Overall Study||1250
493854|NCT00346476|1184547|P1|STARTED|Overall Study||1250
493855|NCT00346398|1184554|P2|NOT COMPLETED|Overall Study||2
493856|NCT00346398|1184555|P1|NOT COMPLETED|Overall Study||3
493857|NCT00346398|1184554|P2|COMPLETED|Overall Study||24
493858|NCT00346398|1184555|P1|COMPLETED|Overall Study||22
493859|NCT00346398|1184554|P2|STARTED|Overall Study||26
493860|NCT00346398|1184555|P1|STARTED|Overall Study||25
493861|NCT00346333|1184567|P2|NOT COMPLETED|Overall Study||8
493862|NCT00346333|1184568|P1|NOT COMPLETED|Overall Study||5
493863|NCT00346333|1184567|P2|COMPLETED|Overall Study||111
493864|NCT00346333|1184568|P1|COMPLETED|Overall Study||116
493865|NCT00346333|1184567|P2|STARTED|Overall Study||119
493866|NCT00346333|1184568|P1|STARTED|Overall Study||121
493867|NCT00346268|1184584|P2|NOT COMPLETED|Overall Study||3
493868|NCT00346268|1184585|P1|NOT COMPLETED|Overall Study||2
493869|NCT00346268|1184584|P2|COMPLETED|Overall Study||50
493870|NCT00346268|1184585|P1|COMPLETED|Overall Study||50
493871|NCT00346268|1184584|P2|STARTED|Overall Study||53
493872|NCT00346268|1184585|P1|STARTED|Overall Study||52
493873|NCT00346216|1184620|P3|NOT COMPLETED|Overall Study||2348
493874|NCT00346216|1184621|P2|NOT COMPLETED|Overall Study||2460
493875|NCT00346216|1184622|P1|NOT COMPLETED|Overall Study||2408
493876|NCT00346216|1184620|P3|COMPLETED|Overall Study||5621
493877|NCT00346216|1184621|P2|COMPLETED|Overall Study||5580
493878|NCT00346216|1184622|P1|COMPLETED|Overall Study||5664
493879|NCT00346216|1184620|P3|STARTED|Overall Study||7969
493880|NCT00346216|1184621|P2|STARTED|Overall Study||8040
493881|NCT00346216|1184622|P1|STARTED|Overall Study||8072
493882|NCT00346151|1184639|P1|NOT COMPLETED|Overall Study||3
493883|NCT00346151|1184639|P1|COMPLETED|Overall Study||2
493884|NCT00346151|1184639|P1|STARTED|Overall Study||5
493885|NCT00346034|1184657|P1|NOT COMPLETED|Overall Study||57
493886|NCT00346034|1184657|P1|COMPLETED|Overall Study||300
493887|NCT00346034|1184657|P1|STARTED|Overall Study||357
493888|NCT00345878|1184664|P2|NOT COMPLETED|Overall Study||1
493889|NCT00345878|1184665|P1|NOT COMPLETED|Overall Study||4
493890|NCT00345878|1184664|P2|COMPLETED|Overall Study||135
493891|NCT00345878|1184665|P1|COMPLETED|Overall Study||131
493892|NCT00345878|1184664|P2|STARTED|Overall Study||136
493893|NCT00345878|1184665|P1|STARTED|Overall Study||135
493894|NCT00345839|1184683|P2|NOT COMPLETED|Overall Study||159
493895|NCT00345839|1184684|P1|NOT COMPLETED|Overall Study||149
493896|NCT00345839|1184683|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
493897|NCT00345839|1184684|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
493898|NCT00345839|1184683|P2|STARTED|Overall Study|Randomized to placebo|1935
493899|NCT00345839|1184684|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
493900|NCT00345683|1184710|P2|NOT COMPLETED|Overall Study||9
493901|NCT00345683|1184711|P1|NOT COMPLETED|Overall Study||25
493902|NCT00345683|1184710|P2|COMPLETED|Overall Study||1001
493903|NCT00345683|1184711|P1|COMPLETED|Overall Study||2985
493904|NCT00345683|1184710|P2|STARTED|Overall Study||1010
493905|NCT00345683|1184711|P1|STARTED|Overall Study||3010
493906|NCT00345631|1184734|P3|NOT COMPLETED|Overall Study||6
493907|NCT00345631|1184735|P2|NOT COMPLETED|Overall Study||8
493908|NCT00345631|1184736|P1|NOT COMPLETED|Overall Study||4
493909|NCT00345631|1184734|P3|COMPLETED|Overall Study||128
493910|NCT00345631|1184735|P2|COMPLETED|Overall Study||259
493911|NCT00345631|1184736|P1|COMPLETED|Overall Study||83
493912|NCT00345631|1184734|P3|STARTED|Overall Study||134
493913|NCT00345631|1184735|P2|STARTED|Overall Study||267
493914|NCT00345631|1184736|P1|STARTED|Overall Study||87
493915|NCT00345605|1184768|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
493916|NCT00345605|1184769|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
493917|NCT00345605|1184768|P2|COMPLETED|Arm 2, Opposite Treatment||6
493918|NCT00345605|1184769|P1|COMPLETED|Arm 2, Opposite Treatment||5
493919|NCT00345605|1184768|P2|STARTED|Arm 2, Opposite Treatment||6
493920|NCT00345605|1184769|P1|STARTED|Arm 2, Opposite Treatment||6
493921|NCT00345605|1184768|P2|NOT COMPLETED|Crossover Wash-out||0
493922|NCT00345605|1184769|P1|NOT COMPLETED|Crossover Wash-out||0
493923|NCT00345605|1184768|P2|COMPLETED|Crossover Wash-out||6
493924|NCT00345605|1184769|P1|COMPLETED|Crossover Wash-out||6
493925|NCT00345605|1184768|P2|STARTED|Crossover Wash-out||6
493926|NCT00345605|1184769|P1|STARTED|Crossover Wash-out||6
493927|NCT00345605|1184768|P2|NOT COMPLETED|Interval||0
493928|NCT00345605|1184769|P1|NOT COMPLETED|Interval||0
493929|NCT00345605|1184768|P2|COMPLETED|Interval||6
493930|NCT00345605|1184769|P1|COMPLETED|Interval||6
493931|NCT00345605|1184768|P2|STARTED|Interval||6
493932|NCT00345605|1184769|P1|STARTED|Interval||6
493933|NCT00345605|1184768|P2|NOT COMPLETED|Arm 1||1
493934|NCT00345605|1184769|P1|NOT COMPLETED|Arm 1||0
493935|NCT00345605|1184768|P2|COMPLETED|Arm 1||5
493936|NCT00345605|1184769|P1|COMPLETED|Arm 1||6
493937|NCT00345605|1184768|P2|STARTED|Arm 1||6
493938|NCT00345605|1184769|P1|STARTED|Arm 1||6
493939|NCT00345605|1184768|P2|NOT COMPLETED|Initial Washout||0
493940|NCT00345605|1184769|P1|NOT COMPLETED|Initial Washout||0
493941|NCT00345605|1184768|P2|COMPLETED|Initial Washout||6
493942|NCT00345605|1184769|P1|COMPLETED|Initial Washout||6
493943|NCT00345605|1184768|P2|STARTED|Initial Washout||6
493944|NCT00345605|1184769|P1|STARTED|Initial Washout||6
493945|NCT00345592|1184789|P2|NOT COMPLETED|Overall Study||24
493946|NCT00345592|1184790|P1|NOT COMPLETED|Overall Study||25
493947|NCT00345592|1184789|P2|COMPLETED|Overall Study||173
493948|NCT00345592|1184790|P1|COMPLETED|Overall Study||174
493949|NCT00345592|1184789|P2|STARTED|Overall Study||197
493950|NCT00345592|1184790|P1|STARTED|Overall Study||199
493951|NCT00345579|1184798|P2|NOT COMPLETED|Overall Study||65
493952|NCT00345579|1184799|P1|NOT COMPLETED|Overall Study||164
493953|NCT00345579|1184798|P2|COMPLETED|Overall Study||1048
493954|NCT00345579|1184799|P1|COMPLETED|Overall Study||3114
493955|NCT00345579|1184798|P2|STARTED|Overall Study||1113
493956|NCT00345579|1184799|P1|STARTED|Overall Study||3278
493957|NCT00345540|1184819|P1|NOT COMPLETED|Overall Study||1
493958|NCT00345540|1184819|P1|COMPLETED|Overall Study||15
493959|NCT00345540|1184819|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
493960|NCT00345397|1184825|P1|NOT COMPLETED|Overall Study||1
493961|NCT00345397|1184825|P1|COMPLETED|Overall Study||6
493962|NCT00345397|1184825|P1|STARTED|Overall Study||7
493963|NCT00345384|1184832|P2|NOT COMPLETED|Overall Study||0
493964|NCT00345384|1184833|P1|NOT COMPLETED|Overall Study||0
493965|NCT00345384|1184832|P2|COMPLETED|Overall Study||19
493966|NCT00345384|1184833|P1|COMPLETED|Overall Study||19
493967|NCT00345384|1184832|P2|STARTED|Overall Study||19
493968|NCT00345384|1184833|P1|STARTED|Overall Study||19
493969|NCT00345371|1184843|P2|NOT COMPLETED|Overall Study||33
493970|NCT00345371|1184844|P1|NOT COMPLETED|Overall Study||30
493971|NCT00345371|1184843|P2|COMPLETED|Overall Study||38
493972|NCT00345371|1184844|P1|COMPLETED|Overall Study||39
493973|NCT00345371|1184843|P2|STARTED|Overall Study||71
493974|NCT00345371|1184844|P1|STARTED|Overall Study||69
493975|NCT00345293|1184852|P2|NOT COMPLETED|Overall Study||0
493976|NCT00345293|1184853|P1|NOT COMPLETED|Overall Study||2
493977|NCT00345293|1184852|P2|COMPLETED|Overall Study||3
493978|NCT00345293|1184853|P1|COMPLETED|Overall Study||8
493979|NCT00345293|1184852|P2|STARTED|Overall Study||3
493980|NCT00345293|1184853|P1|STARTED|Overall Study||10
493981|NCT00345254|1184862|P2|NOT COMPLETED|Overall Study||0
493982|NCT00345254|1184863|P1|NOT COMPLETED|Overall Study||0
493983|NCT00345254|1184862|P2|COMPLETED|Overall Study||30
493984|NCT00345254|1184863|P1|COMPLETED|Overall Study||30
493985|NCT00345254|1184862|P2|STARTED|Overall Study||30
493986|NCT00345254|1184863|P1|STARTED|Overall Study||30
493987|NCT00345176|1184873|P4|NOT COMPLETED|Overall Study||10
493988|NCT00345176|1184874|P3|NOT COMPLETED|Overall Study||6
493989|NCT00345176|1184875|P2|NOT COMPLETED|Overall Study||6
493990|NCT00345176|1184876|P1|NOT COMPLETED|Overall Study||5
493991|NCT00345176|1184873|P4|COMPLETED|Overall Study||1069
493992|NCT00345176|1184874|P3|COMPLETED|Overall Study||1062
493993|NCT00345176|1184875|P2|COMPLETED|Overall Study||1038
493994|NCT00345176|1184876|P1|COMPLETED|Overall Study||1007
493995|NCT00345176|1184873|P4|STARTED|Overall Study||1079
493996|NCT00345176|1184874|P3|STARTED|Overall Study||1068
493997|NCT00345176|1184875|P2|STARTED|Overall Study||1044
493998|NCT00345176|1184876|P1|STARTED|Overall Study||1012
493999|NCT00345046|1184899|P3|NOT COMPLETED|Overall Study||2
494000|NCT00345046|1184900|P2|NOT COMPLETED|Overall Study||1
494001|NCT00345046|1184901|P1|NOT COMPLETED|Overall Study||1
494002|NCT00345046|1184899|P3|COMPLETED|Overall Study||14
494003|NCT00345046|1184900|P2|COMPLETED|Overall Study||21
494004|NCT00345046|1184901|P1|COMPLETED|Overall Study||17
494005|NCT00345046|1184899|P3|STARTED|Overall Study||16
494006|NCT00345046|1184900|P2|STARTED|Overall Study||22
494007|NCT00345046|1184901|P1|STARTED|Overall Study||18
494008|NCT00345033|1184911|P2|NOT COMPLETED|Overall Study||4
494009|NCT00345033|1184912|P1|NOT COMPLETED|Overall Study||4
494010|NCT00345033|1184911|P2|COMPLETED|Overall Study||14
494011|NCT00345033|1184912|P1|COMPLETED|Overall Study||16
494012|NCT00345033|1184911|P2|STARTED|Overall Study||18
494013|NCT00345033|1184912|P1|STARTED|Overall Study||20
494014|NCT00344968|1184931|P3|NOT COMPLETED|Overall Study||116
494015|NCT00344968|1184932|P2|NOT COMPLETED|Overall Study||102
494016|NCT00344968|1184933|P1|NOT COMPLETED|Overall Study||59
494017|NCT00344968|1184931|P3|COMPLETED|Overall Study||279
494018|NCT00344968|1184932|P2|COMPLETED|Overall Study||274
494019|NCT00344968|1184933|P1|COMPLETED|Overall Study||126
494020|NCT00344968|1184931|P3|STARTED|Overall Study||395
494021|NCT00344968|1184932|P2|STARTED|Overall Study||376
494022|NCT00344968|1184933|P1|STARTED|Overall Study||185
494023|NCT00344773|1184944|P1|NOT COMPLETED|Overall Study||21
494024|NCT00344773|1184944|P1|COMPLETED|Overall Study||25
494025|NCT00344773|1184944|P1|STARTED|Overall Study||46
494026|NCT00344682|1184952|P2|NOT COMPLETED|Overall Study||1
494027|NCT00344682|1184953|P1|NOT COMPLETED|Overall Study||4
494028|NCT00344682|1184952|P2|COMPLETED|Overall Study||14
494029|NCT00344682|1184953|P1|COMPLETED|Overall Study||12
494030|NCT00344682|1184952|P2|STARTED|Overall Study||15
494031|NCT00344682|1184953|P1|STARTED|Overall Study||16
494032|NCT00344500|1184967|P3|NOT COMPLETED|Overall Study||2
494033|NCT00344500|1184968|P2|NOT COMPLETED|Overall Study||35
494034|NCT00344500|1184969|P1|NOT COMPLETED|Overall Study||23
494035|NCT00344500|1184967|P3|COMPLETED|Overall Study||12
494036|NCT00344500|1184968|P2|COMPLETED|Overall Study||25
494037|NCT00344500|1184969|P1|COMPLETED|Overall Study||25
494038|NCT00344500|1184967|P3|STARTED|Overall Study||14
494039|NCT00344500|1184968|P2|STARTED|Overall Study||60
494040|NCT00344500|1184969|P1|STARTED|Overall Study||48
494041|NCT00344487|1184980|P1|NOT COMPLETED|Overall Study||1
494042|NCT00344487|1184980|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
494043|NCT00344487|1184980|P1|STARTED|Overall Study||3
494044|NCT00344448|1184986|P2|NOT COMPLETED|Open Label||1
494045|NCT00344448|1184987|P1|NOT COMPLETED|Open Label||2
494046|NCT00344448|1184986|P2|COMPLETED|Open Label||2
494047|NCT00344448|1184987|P1|COMPLETED|Open Label||2
494048|NCT00344448|1184986|P2|STARTED|Open Label||3
494049|NCT00344448|1184987|P1|STARTED|Open Label||4
494050|NCT00344448|1184986|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
494051|NCT00344448|1184987|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
494052|NCT00344448|1184986|P2|COMPLETED|Double Blind, Placebo Controlled||3
494053|NCT00344448|1184987|P1|COMPLETED|Double Blind, Placebo Controlled||4
494054|NCT00344448|1184986|P2|STARTED|Double Blind, Placebo Controlled||3
494055|NCT00344448|1184987|P1|STARTED|Double Blind, Placebo Controlled||6
494056|NCT00344448|1184986|P2|NOT COMPLETED|Screening||1
494057|NCT00344448|1184987|P1|NOT COMPLETED|Screening||0
494058|NCT00344448|1184986|P2|COMPLETED|Screening||3
494059|NCT00344448|1184987|P1|COMPLETED|Screening||6
494060|NCT00344448|1184986|P2|STARTED|Screening||4
494061|NCT00344448|1184987|P1|STARTED|Screening|No randomization during the screening phase|6
494062|NCT00344370|1184995|P2|NOT COMPLETED|Overall Study||3
494063|NCT00344370|1184996|P1|NOT COMPLETED|Overall Study||15
494064|NCT00344370|1184995|P2|COMPLETED|Overall Study||68
494065|NCT00344370|1184996|P1|COMPLETED|Overall Study||128
494066|NCT00344370|1184995|P2|STARTED|Overall Study||71
494067|NCT00344370|1184996|P1|STARTED|Overall Study||143
494068|NCT00344305|1185006|P2|NOT COMPLETED|Overall Study||1
494069|NCT00344305|1185007|P1|NOT COMPLETED|Overall Study||2
494070|NCT00344305|1185006|P2|COMPLETED|Overall Study||99
494071|NCT00344305|1185007|P1|COMPLETED|Overall Study||98
494072|NCT00344305|1185006|P2|STARTED|Overall Study||100
494073|NCT00344305|1185007|P1|STARTED|Overall Study||100
494074|NCT00344175|1185038|P2|NOT COMPLETED|Overall Study||10
494075|NCT00344175|1185039|P1|NOT COMPLETED|Overall Study||12
494076|NCT00344175|1185038|P2|COMPLETED|Overall Study||47
494077|NCT00344175|1185039|P1|COMPLETED|Overall Study||109
494078|NCT00344175|1185038|P2|STARTED|Overall Study||57
494079|NCT00344175|1185039|P1|STARTED|Overall Study||121
494080|NCT00344032|1185051|P2|NOT COMPLETED|Overall Study||10
494081|NCT00344032|1185052|P1|NOT COMPLETED|Overall Study||14
494082|NCT00344032|1185051|P2|COMPLETED|Overall Study||168
494083|NCT00344032|1185052|P1|COMPLETED|Overall Study||162
494084|NCT00344032|1185051|P2|STARTED|Overall Study||178
494085|NCT00344032|1185052|P1|STARTED|Overall Study||176
494086|NCT00343915|1185070|P2|NOT COMPLETED|Month 66 Follow-up||0
494087|NCT00343915|1185071|P1|NOT COMPLETED|Month 66 Follow-up||0
494088|NCT00343915|1185070|P2|COMPLETED|Month 66 Follow-up||76
494089|NCT00343915|1185071|P1|COMPLETED|Month 66 Follow-up||158
494090|NCT00343915|1185070|P2|STARTED|Month 66 Follow-up||76
494091|NCT00343915|1185071|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
494092|NCT00343915|1185070|P2|NOT COMPLETED|Month 54 Follow-up||0
494093|NCT00343915|1185071|P1|NOT COMPLETED|Month 54 Follow-up||0
494094|NCT00343915|1185070|P2|COMPLETED|Month 54 Follow-up||79
494095|NCT00343915|1185071|P1|COMPLETED|Month 54 Follow-up||166
494096|NCT00343915|1185070|P2|STARTED|Month 54 Follow-up||79
494097|NCT00343915|1185071|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
494098|NCT00343915|1185070|P2|NOT COMPLETED|Month 42 Follow-up||0
494099|NCT00343915|1185071|P1|NOT COMPLETED|Month 42 Follow-up||0
494100|NCT00343915|1185070|P2|COMPLETED|Month 42 Follow-up||84
494101|NCT00343915|1185071|P1|COMPLETED|Month 42 Follow-up||174
494102|NCT00343915|1185070|P2|STARTED|Month 42 Follow-up||84
494103|NCT00343915|1185071|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
494104|NCT00343915|1185070|P2|NOT COMPLETED|Month 30 Follow-up||0
494105|NCT00343915|1185071|P1|NOT COMPLETED|Month 30 Follow-up||0
494106|NCT00343915|1185070|P2|COMPLETED|Month 30 Follow-up||88
494107|NCT00343915|1185071|P1|COMPLETED|Month 30 Follow-up||179
494108|NCT00343915|1185070|P2|STARTED|Month 30 Follow-up||88
494109|NCT00343915|1185071|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
494110|NCT00343915|1185070|P2|NOT COMPLETED|Primary Study||3
494111|NCT00343915|1185071|P1|NOT COMPLETED|Primary Study||4
494112|NCT00343915|1185070|P2|COMPLETED|Primary Study||123
494113|NCT00343915|1185071|P1|COMPLETED|Primary Study||254
494114|NCT00343915|1185070|P2|STARTED|Primary Study||126
494115|NCT00343915|1185071|P1|STARTED|Primary Study||258
494116|NCT00343889|1185097|P2|NOT COMPLETED|Overall Study||1
494117|NCT00343889|1185098|P1|NOT COMPLETED|Overall Study||3
494118|NCT00343889|1185097|P2|COMPLETED|Overall Study||188
494119|NCT00343889|1185098|P1|COMPLETED|Overall Study||187
494120|NCT00343889|1185097|P2|STARTED|Overall Study||189
494121|NCT00343889|1185098|P1|STARTED|Overall Study||190
494122|NCT00343785|1185114|P1|NOT COMPLETED|Overall Study||0
494123|NCT00343785|1185114|P1|COMPLETED|Overall Study||21
494124|NCT00343785|1185114|P1|STARTED|Overall Study||21
494125|NCT00343564|1185131|P11|NOT COMPLETED|Overall Study||0
494126|NCT00343564|1185132|P10|NOT COMPLETED|Overall Study||0
494127|NCT00343564|1185133|P9|NOT COMPLETED|Overall Study||0
494128|NCT00343564|1185134|P8|NOT COMPLETED|Overall Study||0
494129|NCT00343564|1185135|P7|NOT COMPLETED|Overall Study||0
494130|NCT00343564|1185136|P6|NOT COMPLETED|Overall Study||0
494131|NCT00343564|1185137|P5|NOT COMPLETED|Overall Study||0
494132|NCT00343564|1185138|P4|NOT COMPLETED|Overall Study||0
494133|NCT00343564|1185139|P3|NOT COMPLETED|Overall Study||0
494134|NCT00343564|1185140|P2|NOT COMPLETED|Overall Study||0
494135|NCT00343564|1185141|P1|NOT COMPLETED|Overall Study||0
494136|NCT00343564|1185131|P11|COMPLETED|Overall Study||8
494137|NCT00343564|1185132|P10|COMPLETED|Overall Study||8
494138|NCT00343564|1185133|P9|COMPLETED|Overall Study||3
494139|NCT00343564|1185134|P8|COMPLETED|Overall Study||3
494140|NCT00343564|1185135|P7|COMPLETED|Overall Study||4
494141|NCT00343564|1185136|P6|COMPLETED|Overall Study||9
494142|NCT00343564|1185137|P5|COMPLETED|Overall Study||10
494143|NCT00343564|1185138|P4|COMPLETED|Overall Study||7
494144|NCT00343564|1185139|P3|COMPLETED|Overall Study||3
494145|NCT00343564|1185140|P2|COMPLETED|Overall Study||7
494146|NCT00343564|1185141|P1|COMPLETED|Overall Study||6
494147|NCT00343564|1185131|P11|STARTED|Overall Study||8
494148|NCT00343564|1185132|P10|STARTED|Overall Study||8
494149|NCT00343564|1185133|P9|STARTED|Overall Study||3
494150|NCT00343564|1185134|P8|STARTED|Overall Study||3
494151|NCT00343564|1185135|P7|STARTED|Overall Study||4
494152|NCT00343564|1185136|P6|STARTED|Overall Study||9
494153|NCT00343564|1185137|P5|STARTED|Overall Study||10
494154|NCT00343564|1185138|P4|STARTED|Overall Study||7
494155|NCT00343564|1185139|P3|STARTED|Overall Study||3
494156|NCT00343564|1185140|P2|STARTED|Overall Study||7
494157|NCT00343564|1185141|P1|STARTED|Overall Study||6
494158|NCT00343512|1185156|P1|NOT COMPLETED|Overall Study||2
494159|NCT00343512|1185156|P1|COMPLETED|Overall Study||32
494160|NCT00343512|1185156|P1|STARTED|Overall Study||34
494161|NCT00343460|1185168|P3|NOT COMPLETED|Cycle 2 - 4||0
494162|NCT00343460|1185169|P2|NOT COMPLETED|Cycle 2 - 4||50
494163|NCT00343460|1185170|P1|NOT COMPLETED|Cycle 2 - 4||56
494164|NCT00343460|1185168|P3|COMPLETED|Cycle 2 - 4||0
494165|NCT00343460|1185169|P2|COMPLETED|Cycle 2 - 4||515
494166|NCT00343460|1185170|P1|COMPLETED|Cycle 2 - 4||528
494167|NCT00343460|1185168|P3|STARTED|Cycle 2 - 4||0
494168|NCT00343460|1185169|P2|STARTED|Cycle 2 - 4||565
494169|NCT00343460|1185170|P1|STARTED|Cycle 2 - 4||584
494170|NCT00343460|1185168|P3|NOT COMPLETED|Cycle 1||18
494171|NCT00343460|1185169|P2|NOT COMPLETED|Cycle 1||22
494172|NCT00343460|1185170|P1|NOT COMPLETED|Cycle 1||22
494173|NCT00343460|1185168|P3|COMPLETED|Cycle 1||454
494174|NCT00343460|1185169|P2|COMPLETED|Cycle 1||459
494175|NCT00343460|1185170|P1|COMPLETED|Cycle 1||453
494176|NCT00343460|1185168|P3|STARTED|Cycle 1||472
494177|NCT00343460|1185169|P2|STARTED|Cycle 1||481
494178|NCT00343460|1185170|P1|STARTED|Cycle 1||475
494179|NCT00343382|1185244|P3|NOT COMPLETED|Overall Study||17
494180|NCT00343382|1185245|P2|NOT COMPLETED|Overall Study||14
494181|NCT00343382|1185246|P1|NOT COMPLETED|Overall Study||4
494182|NCT00343382|1185244|P3|COMPLETED|Overall Study||49
494183|NCT00343382|1185245|P2|COMPLETED|Overall Study||51
494184|NCT00343382|1185246|P1|COMPLETED|Overall Study||60
494185|NCT00343382|1185244|P3|STARTED|Overall Study||66
494186|NCT00343382|1185245|P2|STARTED|Overall Study||65
494187|NCT00343382|1185246|P1|STARTED|Overall Study||64
494188|NCT00343291|1185265|P2|NOT COMPLETED|Overall Study||56
494189|NCT00343291|1185266|P1|NOT COMPLETED|Overall Study||57
494190|NCT00343291|1185265|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
494191|NCT00343291|1185266|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
494192|NCT00343291|1185265|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
494193|NCT00343291|1185266|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
494194|NCT00343291|1185265|P2|STARTED|Overall Study||61
494195|NCT00343291|1185266|P1|STARTED|Overall Study||60
494196|NCT00343252|1185282|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
494197|NCT00343252|1185283|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
494198|NCT00343252|1185282|P2|COMPLETED|18 Months (All Treated Participants)||269
494199|NCT00343252|1185283|P1|COMPLETED|18 Months (All Treated Participants)||259
494200|NCT00343252|1185282|P2|STARTED|18 Months (All Treated Participants)||350
494201|NCT00343252|1185283|P1|STARTED|18 Months (All Treated Participants)||360
494202|NCT00343252|1185282|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
494203|NCT00343252|1185283|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
494204|NCT00343252|1185282|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
494205|NCT00343252|1185283|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
494206|NCT00343252|1185282|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
494207|NCT00343252|1185283|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
494208|NCT00343252|1185282|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
494209|NCT00343252|1185283|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
494210|NCT00343252|1185282|P2|COMPLETED|6 Months (All Treated Participants)||306
494211|NCT00343252|1185283|P1|COMPLETED|6 Months (All Treated Participants)||304
494212|NCT00343252|1185282|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
494213|NCT00343252|1185283|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
494214|NCT00343252|1185282|P2|NOT COMPLETED|All Randomized Participants||82
494215|NCT00343252|1185283|P1|NOT COMPLETED|All Randomized Participants||102
494216|NCT00343252|1185282|P2|COMPLETED|All Randomized Participants||269
494217|NCT00343252|1185283|P1|COMPLETED|All Randomized Participants||259
494218|NCT00343252|1185282|P2|STARTED|All Randomized Participants||351
494219|NCT00343252|1185283|P1|STARTED|All Randomized Participants||361
494220|NCT00343083|1185329|P1|NOT COMPLETED|Overall Study||21
494221|NCT00343083|1185329|P1|COMPLETED|Overall Study||22
494222|NCT00343083|1185329|P1|STARTED|Overall Study||43
494223|NCT00343044|1185338|P1|NOT COMPLETED|Overall Study||0
494224|NCT00343044|1185338|P1|COMPLETED|Overall Study||40
494225|NCT00343044|1185338|P1|STARTED|Overall Study||40
494226|NCT00342628|1185348|P3|NOT COMPLETED|Overall Study||19
494227|NCT00342628|1185349|P2|NOT COMPLETED|Overall Study||21
494228|NCT00342628|1185350|P1|NOT COMPLETED|Overall Study||20
494229|NCT00342628|1185348|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
494230|NCT00342628|1185349|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
494231|NCT00342628|1185350|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
494232|NCT00342628|1185348|P3|STARTED|Overall Study||100
494233|NCT00342628|1185349|P2|STARTED|Overall Study||101
494234|NCT00342628|1185350|P1|STARTED|Overall Study||100
494235|NCT00342563|1185371|P4|NOT COMPLETED|Overall Study||6
494236|NCT00342563|1185372|P3|NOT COMPLETED|Overall Study||14
494237|NCT00342563|1185373|P2|NOT COMPLETED|Overall Study||8
494238|NCT00342563|1185374|P1|NOT COMPLETED|Overall Study||6
494239|NCT00342563|1185371|P4|COMPLETED|Overall Study||22
494240|NCT00342563|1185372|P3|COMPLETED|Overall Study||26
494241|NCT00342563|1185373|P2|COMPLETED|Overall Study||19
494242|NCT00342563|1185374|P1|COMPLETED|Overall Study||35
494243|NCT00342563|1185371|P4|STARTED|Overall Study||28
494244|NCT00342563|1185372|P3|STARTED|Overall Study||40
494245|NCT00342563|1185373|P2|STARTED|Overall Study||27
494246|NCT00342563|1185374|P1|STARTED|Overall Study||41
494247|NCT00342355|1185394|P4|NOT COMPLETED|Overall Study||0
494248|NCT00342355|1185395|P3|NOT COMPLETED|Overall Study||0
494249|NCT00342355|1185396|P2|NOT COMPLETED|Overall Study||0
494250|NCT00342355|1185397|P1|NOT COMPLETED|Overall Study||0
494251|NCT00342355|1185394|P4|COMPLETED|Overall Study||443
494252|NCT00342355|1185395|P3|COMPLETED|Overall Study||444
494253|NCT00342355|1185396|P2|COMPLETED|Overall Study||440
494254|NCT00342355|1185397|P1|COMPLETED|Overall Study||444
494255|NCT00342355|1185394|P4|STARTED|Overall Study||443
494256|NCT00342355|1185395|P3|STARTED|Overall Study||444
494257|NCT00342355|1185396|P2|STARTED|Overall Study||440
494258|NCT00342355|1185397|P1|STARTED|Overall Study||444
494259|NCT00340834|1185416|P5|NOT COMPLETED|Extension Phase of Study||44
494260|NCT00340834|1185417|P4|NOT COMPLETED|Extension Phase of Study||53
494261|NCT00340834|1185418|P3|NOT COMPLETED|Extension Phase of Study||0
494262|NCT00340834|1185419|P2|NOT COMPLETED|Extension Phase of Study||76
494263|NCT00340834|1185420|P1|NOT COMPLETED|Extension Phase of Study||85
494264|NCT00340834|1185416|P5|COMPLETED|Extension Phase of Study||123
494265|NCT00340834|1185417|P4|COMPLETED|Extension Phase of Study||123
494266|NCT00340834|1185418|P3|COMPLETED|Extension Phase of Study||0
494267|NCT00340834|1185419|P2|COMPLETED|Extension Phase of Study||281
494268|NCT00340834|1185420|P1|COMPLETED|Extension Phase of Study||245
494269|NCT00340834|1185416|P5|Received Study Drug|Extension Phase of Study||167
494270|NCT00340834|1185417|P4|Received Study Drug|Extension Phase of Study||174
494271|NCT00340834|1185418|P3|Received Study Drug|Extension Phase of Study||0
494272|NCT00340834|1185419|P2|Received Study Drug|Extension Phase of Study||356
494273|NCT00340834|1185420|P1|Received Study Drug|Extension Phase of Study||330
494274|NCT00340834|1185416|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
494275|NCT00340834|1185417|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
494276|NCT00340834|1185418|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
494277|NCT00340834|1185419|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
494278|NCT00340834|1185420|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
494279|NCT00340834|1185416|P5|NOT COMPLETED|Core Phase of Study||0
494280|NCT00340834|1185417|P4|NOT COMPLETED|Core Phase of Study||0
494281|NCT00340834|1185418|P3|NOT COMPLETED|Core Phase of Study||49
494282|NCT00340834|1185419|P2|NOT COMPLETED|Core Phase of Study||33
494283|NCT00340834|1185420|P1|NOT COMPLETED|Core Phase of Study||57
494284|NCT00340834|1185416|P5|COMPLETED|Core Phase of Study||0
494285|NCT00340834|1185417|P4|COMPLETED|Core Phase of Study||0
494286|NCT00340834|1185418|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
494287|NCT00340834|1185419|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
494288|NCT00340834|1185420|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
494289|NCT00340834|1185416|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
494290|NCT00340834|1185417|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
494291|NCT00340834|1185418|P3|STARTED|Core Phase of Study||435
494292|NCT00340834|1185419|P2|STARTED|Core Phase of Study||431
494293|NCT00340834|1185420|P1|STARTED|Core Phase of Study||426
494294|NCT00340704|1185454|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
494295|NCT00340704|1185455|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
494296|NCT00340704|1185456|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
494297|NCT00340704|1185457|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
494298|NCT00340704|1185458|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
494299|NCT00340704|1185459|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
494300|NCT00340704|1185460|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494301|NCT00340704|1185461|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494302|NCT00340704|1185462|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494303|NCT00340704|1185454|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494304|NCT00340704|1185455|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
494305|NCT00340704|1185456|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
494306|NCT00340704|1185457|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
494307|NCT00340704|1185458|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
494308|NCT00340704|1185459|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
494309|NCT00340704|1185460|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494310|NCT00340704|1185461|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494311|NCT00340704|1185462|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
494312|NCT00340704|1185454|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
494313|NCT00340704|1185455|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
494314|NCT00340704|1185456|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
494315|NCT00340704|1185457|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
494316|NCT00340704|1185458|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
494317|NCT00340704|1185459|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
494318|NCT00340704|1185460|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
494319|NCT00340704|1185461|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
494320|NCT00340704|1185462|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
494321|NCT00340704|1185454|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
494322|NCT00340704|1185455|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
494323|NCT00340704|1185456|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
494324|NCT00340704|1185457|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
494325|NCT00340704|1185458|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
494326|NCT00340704|1185459|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
494327|NCT00340704|1185460|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
494328|NCT00340704|1185461|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
494329|NCT00340704|1185462|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
494330|NCT00340704|1185454|P9|NOT COMPLETED|PK Study||0
494331|NCT00340704|1185455|P8|NOT COMPLETED|PK Study||0
494332|NCT00340704|1185456|P7|NOT COMPLETED|PK Study||0
494333|NCT00340704|1185457|P6|NOT COMPLETED|PK Study||0
494334|NCT00340704|1185458|P5|NOT COMPLETED|PK Study||0
494335|NCT00340704|1185459|P4|NOT COMPLETED|PK Study||0
494336|NCT00340704|1185460|P3|NOT COMPLETED|PK Study||1
494337|NCT00340704|1185461|P2|NOT COMPLETED|PK Study||1
494338|NCT00340704|1185462|P1|NOT COMPLETED|PK Study||0
494339|NCT00340704|1185454|P9|COMPLETED|PK Study||0
494340|NCT00340704|1185455|P8|COMPLETED|PK Study||0
494341|NCT00340704|1185456|P7|COMPLETED|PK Study||0
494342|NCT00340704|1185457|P6|COMPLETED|PK Study||0
494343|NCT00340704|1185458|P5|COMPLETED|PK Study||0
494344|NCT00340704|1185459|P4|COMPLETED|PK Study||0
494345|NCT00340704|1185460|P3|COMPLETED|PK Study||10
494346|NCT00340704|1185461|P2|COMPLETED|PK Study||9
494347|NCT00340704|1185462|P1|COMPLETED|PK Study||10
494348|NCT00340704|1185454|P9|STARTED|PK Study||0
494349|NCT00340704|1185455|P8|STARTED|PK Study||0
494350|NCT00340704|1185456|P7|STARTED|PK Study||0
494351|NCT00340704|1185457|P6|STARTED|PK Study||0
494352|NCT00340704|1185458|P5|STARTED|PK Study||0
494353|NCT00340704|1185459|P4|STARTED|PK Study||0
494354|NCT00340704|1185460|P3|STARTED|PK Study||11
494355|NCT00340704|1185461|P2|STARTED|PK Study||10
494356|NCT00340704|1185462|P1|STARTED|PK Study||10
494357|NCT00340678|1185568|P4|NOT COMPLETED|Overall Study||0
494358|NCT00340678|1185569|P3|NOT COMPLETED|Overall Study||0
494359|NCT00340678|1185570|P2|NOT COMPLETED|Overall Study||0
494360|NCT00340678|1185571|P1|NOT COMPLETED|Overall Study||1
494361|NCT00340678|1185568|P4|COMPLETED|Overall Study||39
494362|NCT00340678|1185569|P3|COMPLETED|Overall Study||39
494363|NCT00340678|1185570|P2|COMPLETED|Overall Study||46
494364|NCT00340678|1185571|P1|COMPLETED|Overall Study||45
494365|NCT00340678|1185568|P4|STARTED|Overall Study||39
494366|NCT00340678|1185569|P3|STARTED|Overall Study||39
494367|NCT00340678|1185570|P2|STARTED|Overall Study||46
494368|NCT00340678|1185571|P1|STARTED|Overall Study||46
494369|NCT00340379|1185585|P2|NOT COMPLETED|Overall Study||9
494370|NCT00340379|1185586|P1|NOT COMPLETED|Overall Study||8
494371|NCT00340379|1185585|P2|COMPLETED|Overall Study||28
494372|NCT00340379|1185586|P1|COMPLETED|Overall Study||27
494373|NCT00340379|1185585|P2|STARTED|Overall Study||37
494374|NCT00340379|1185586|P1|STARTED|Overall Study||35
494375|NCT00339183|1185598|P2|NOT COMPLETED|Overall Study||105
494376|NCT00339183|1185599|P1|NOT COMPLETED|Overall Study||121
494377|NCT00339183|1185598|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
494378|NCT00339183|1185599|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
494379|NCT00339183|1185598|P2|Received Study Drug|Overall Study||593
494380|NCT00339183|1185599|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
494381|NCT00339183|1185598|P2|STARTED|Overall Study||595
494382|NCT00339183|1185599|P1|STARTED|Overall Study||591
494383|NCT00339144|1185628|P3|NOT COMPLETED|Overall Study||4
494384|NCT00339144|1185629|P2|NOT COMPLETED|Overall Study||3
494385|NCT00339144|1185630|P1|NOT COMPLETED|Overall Study||9
494386|NCT00339144|1185628|P3|COMPLETED|Overall Study||0
494387|NCT00339144|1185629|P2|COMPLETED|Overall Study||0
494388|NCT00339144|1185630|P1|COMPLETED|Overall Study||0
494389|NCT00339144|1185628|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
494390|NCT00339144|1185629|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
494391|NCT00339144|1185630|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
494392|NCT00339833|1185714|P2|NOT COMPLETED|Overall Study||8
494393|NCT00339833|1185715|P1|NOT COMPLETED|Overall Study||6
494394|NCT00339833|1185714|P2|COMPLETED|Overall Study||18
494395|NCT00339833|1185715|P1|COMPLETED|Overall Study||22
494396|NCT00339833|1185714|P2|STARTED|Overall Study||26
494397|NCT00339833|1185715|P1|STARTED|Overall Study||28
494398|NCT00339079|1185727|P4|NOT COMPLETED|Overall Study||24
494399|NCT00339079|1185728|P3|NOT COMPLETED|Overall Study||18
494400|NCT00339079|1185729|P2|NOT COMPLETED|Overall Study||23
494401|NCT00339079|1185730|P1|NOT COMPLETED|Overall Study||33
494402|NCT00339079|1185727|P4|COMPLETED|Overall Study||29
494403|NCT00339079|1185728|P3|COMPLETED|Overall Study||27
494404|NCT00339079|1185729|P2|COMPLETED|Overall Study||21
494405|NCT00339079|1185730|P1|COMPLETED|Overall Study||20
494406|NCT00339079|1185727|P4|STARTED|Overall Study||53
494407|NCT00339079|1185728|P3|STARTED|Overall Study||45
494408|NCT00339079|1185729|P2|STARTED|Overall Study||44
494409|NCT00339079|1185730|P1|STARTED|Overall Study||53
494410|NCT00339040|1185746|P2|NOT COMPLETED|Stage II||2
494411|NCT00339040|1185747|P1|NOT COMPLETED|Stage II||10
494412|NCT00339040|1185746|P2|COMPLETED|Stage II||27
494413|NCT00339040|1185747|P1|COMPLETED|Stage II||84
494414|NCT00339040|1185746|P2|Vaccination 6 at Week 120|Stage II||27
494415|NCT00339040|1185747|P1|Vaccination 6 at Week 120|Stage II||0
494416|NCT00339040|1185746|P2|Vaccination 5 at Week 104|Stage II||28
494417|NCT00339040|1185747|P1|Vaccination 5 at Week 104|Stage II||0
494418|NCT00339040|1185746|P2|Vaccination 4 at Week 96|Stage II||29
494419|NCT00339040|1185747|P1|Vaccination 4 at Week 96|Stage II||84
494420|NCT00339040|1185746|P2|STARTED|Stage II||29
494421|NCT00339040|1185747|P1|STARTED|Stage II||94
494422|NCT00339040|1185746|P2|NOT COMPLETED|Stage I||1
494423|NCT00339040|1185747|P1|NOT COMPLETED|Stage I||2
494424|NCT00339040|1185746|P2|COMPLETED|Stage I||29
494425|NCT00339040|1185747|P1|COMPLETED|Stage I||94
494426|NCT00339040|1185746|P2|Vaccination 3 at Week 24|Stage I||30
494427|NCT00339040|1185747|P1|Vaccination 3 at Week 24|Stage I||94
494428|NCT00339040|1185746|P2|Vaccination 2 at Week 8|Stage I||30
494429|NCT00339040|1185747|P1|Vaccination 2 at Week 8|Stage I||95
494430|NCT00339040|1185746|P2|Vaccination 1 at Week 0|Stage I||30
494431|NCT00339040|1185747|P1|Vaccination 1 at Week 0|Stage I||96
494432|NCT00339040|1185746|P2|STARTED|Stage I||30
494433|NCT00339040|1185747|P1|STARTED|Stage I||96
494434|NCT00338988|1185765|P1|NOT COMPLETED|Overall Study||1
494435|NCT00338988|1185765|P1|COMPLETED|Overall Study||43
494436|NCT00338988|1185765|P1|STARTED|Overall Study||44
494437|NCT00338962|1185774|P4|NOT COMPLETED|Overall Study||3
494438|NCT00338962|1185775|P3|NOT COMPLETED|Overall Study||6
494439|NCT00338962|1185776|P2|NOT COMPLETED|Overall Study||4
494440|NCT00338962|1185777|P1|NOT COMPLETED|Overall Study||8
494441|NCT00338962|1185774|P4|COMPLETED|Overall Study||21
494442|NCT00338962|1185775|P3|COMPLETED|Overall Study||16
494443|NCT00338962|1185776|P2|COMPLETED|Overall Study||16
494444|NCT00338962|1185777|P1|COMPLETED|Overall Study||14
494445|NCT00338962|1185774|P4|STARTED|Overall Study||24
494446|NCT00338962|1185775|P3|STARTED|Overall Study||22
494447|NCT00338962|1185776|P2|STARTED|Overall Study||20
494448|NCT00338962|1185777|P1|STARTED|Overall Study||22
494449|NCT00338884|1185799|P1|NOT COMPLETED|Overall Study||78
494450|NCT00338884|1185799|P1|COMPLETED|Overall Study||42
494451|NCT00338884|1185799|P1|Received Treatment|Overall Study||119
494452|NCT00338884|1185799|P1|STARTED|Overall Study||120
494453|NCT00338741|1185833|P2|NOT COMPLETED|Overall Study||0
494454|NCT00338741|1185834|P1|NOT COMPLETED|Overall Study||2
494455|NCT00338741|1185833|P2|COMPLETED|Overall Study||2
494456|NCT00338741|1185834|P1|COMPLETED|Overall Study||32
494457|NCT00338741|1185833|P2|STARTED|Overall Study||2
494458|NCT00338741|1185834|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
494459|NCT00338598|1185844|P2|NOT COMPLETED|Overall Study||2
494460|NCT00338598|1185845|P1|NOT COMPLETED|Overall Study||0
494461|NCT00338598|1185844|P2|COMPLETED|Overall Study||8
494462|NCT00338598|1185845|P1|COMPLETED|Overall Study||10
494463|NCT00338598|1185844|P2|STARTED|Overall Study||10
494464|NCT00338598|1185845|P1|STARTED|Overall Study||10
494465|NCT00338455|1185865|P2|NOT COMPLETED|Overall Study||1
494466|NCT00338455|1185866|P1|NOT COMPLETED|Overall Study||3
494467|NCT00338455|1185865|P2|COMPLETED|Overall Study||6
494468|NCT00338455|1185866|P1|COMPLETED|Overall Study||6
494469|NCT00338455|1185865|P2|Administered Study Drug|Overall Study||7
494470|NCT00338455|1185866|P1|Administered Study Drug|Overall Study||8
494471|NCT00338455|1185865|P2|STARTED|Overall Study||7
494472|NCT00338455|1185866|P1|STARTED|Overall Study||9
494473|NCT00338286|1185880|P2|NOT COMPLETED|Overall Study||370
494474|NCT00338286|1185881|P1|NOT COMPLETED|Overall Study||393
494475|NCT00338286|1185880|P2|COMPLETED|Overall Study||680
494476|NCT00338286|1185881|P1|COMPLETED|Overall Study||655
494477|NCT00338286|1185880|P2|STARTED|Overall Study||1050
494478|NCT00338286|1185881|P1|STARTED|Overall Study||1048
494479|NCT00338104|1185898|P3|NOT COMPLETED|Overall Study||3
494480|NCT00338104|1185899|P2|NOT COMPLETED|Overall Study||1
494481|NCT00338104|1185900|P1|NOT COMPLETED|Overall Study||2
494482|NCT00338104|1185898|P3|COMPLETED|Overall Study||22
494483|NCT00338104|1185899|P2|COMPLETED|Overall Study||24
494484|NCT00338104|1185900|P1|COMPLETED|Overall Study||23
494485|NCT00338104|1185898|P3|STARTED|Overall Study||25
494486|NCT00338104|1185899|P2|STARTED|Overall Study||25
494487|NCT00338104|1185900|P1|STARTED|Overall Study||25
494488|NCT00338039|1185911|P1|NOT COMPLETED|Overall Study||0
494489|NCT00338039|1185911|P1|COMPLETED|Overall Study||69
494490|NCT00338039|1185911|P1|STARTED|Overall Study||69
494491|NCT00337987|1185916|P1|NOT COMPLETED|Overall Study||0
494492|NCT00337987|1185916|P1|COMPLETED|Overall Study||49
494493|NCT00337987|1185916|P1|STARTED|Overall Study||49
494494|NCT00337935|1185923|P2|NOT COMPLETED|Overall Study||27
494495|NCT00337935|1185924|P1|NOT COMPLETED|Overall Study||10
494496|NCT00337935|1185923|P2|COMPLETED|Overall Study||91
494497|NCT00337935|1185924|P1|COMPLETED|Overall Study||29
494498|NCT00337935|1185923|P2|STARTED|Overall Study||118
494499|NCT00337935|1185924|P1|STARTED|Overall Study||39
494500|NCT00337818|1185937|P3|NOT COMPLETED|Overall Study||107
494501|NCT00337818|1185938|P2|NOT COMPLETED|Overall Study||91
494502|NCT00337818|1185939|P1|NOT COMPLETED|Overall Study||289
494503|NCT00337818|1185937|P3|COMPLETED|Overall Study||51
494504|NCT00337818|1185938|P2|COMPLETED|Overall Study||63
494505|NCT00337818|1185939|P1|COMPLETED|Overall Study||169
494506|NCT00337818|1185937|P3|STARTED|Overall Study||158
494507|NCT00337818|1185938|P2|STARTED|Overall Study||154
494508|NCT00337818|1185939|P1|STARTED|Overall Study||458
494509|NCT00337779|1185961|P2|NOT COMPLETED|Overall Study||79
494510|NCT00337779|1185962|P1|NOT COMPLETED|Overall Study||52
494511|NCT00337779|1185961|P2|COMPLETED|Overall Study||490
494512|NCT00337779|1185962|P1|COMPLETED|Overall Study||534
494513|NCT00337779|1185961|P2|STARTED|Overall Study||569
494514|NCT00337779|1185962|P1|STARTED|Overall Study||586
494515|NCT00337727|1185974|P2|NOT COMPLETED|Overall Study||12
494516|NCT00337727|1185975|P1|NOT COMPLETED|Overall Study||18
494517|NCT00337727|1185974|P2|COMPLETED|Overall Study||406
494518|NCT00337727|1185975|P1|COMPLETED|Overall Study||412
494519|NCT00337727|1185974|P2|STARTED|Overall Study||418
494520|NCT00337727|1185975|P1|STARTED|Overall Study||430
494521|NCT00337675|1185986|P3|NOT COMPLETED|Overall Study||99
494522|NCT00337675|1185987|P2|NOT COMPLETED|Overall Study||103
494523|NCT00337675|1185988|P1|NOT COMPLETED|Overall Study||97
494524|NCT00337675|1185986|P3|COMPLETED|Overall Study||492
494525|NCT00337675|1185987|P2|COMPLETED|Overall Study||488
494526|NCT00337675|1185988|P1|COMPLETED|Overall Study||492
494527|NCT00337675|1185986|P3|STARTED|Overall Study||591
494528|NCT00337675|1185987|P2|STARTED|Overall Study||591
494529|NCT00337675|1185988|P1|STARTED|Overall Study||589
494530|NCT00337662|1186005|P4|NOT COMPLETED|Study Period III||0
494531|NCT00337662|1186006|P3|NOT COMPLETED|Study Period III||44
494532|NCT00337662|1186007|P2|NOT COMPLETED|Study Period III||58
494533|NCT00337662|1186008|P1|NOT COMPLETED|Study Period III||60
494534|NCT00337662|1186005|P4|COMPLETED|Study Period III||0
494535|NCT00337662|1186006|P3|COMPLETED|Study Period III||100
494536|NCT00337662|1186007|P2|COMPLETED|Study Period III||134
494537|NCT00337662|1186008|P1|COMPLETED|Study Period III||126
494538|NCT00337662|1186005|P4|STARTED|Study Period III||0
494539|NCT00337662|1186006|P3|STARTED|Study Period III||144
494540|NCT00337662|1186007|P2|STARTED|Study Period III||192
494541|NCT00337662|1186008|P1|STARTED|Study Period III||186
494542|NCT00337662|1186005|P4|NOT COMPLETED|Study Period II||106
494543|NCT00337662|1186006|P3|NOT COMPLETED|Study Period II||0
494544|NCT00337662|1186007|P2|NOT COMPLETED|Study Period II||0
494545|NCT00337662|1186008|P1|NOT COMPLETED|Study Period II||0
494546|NCT00337662|1186005|P4|COMPLETED|Study Period II||522
494547|NCT00337662|1186006|P3|COMPLETED|Study Period II||0
494548|NCT00337662|1186007|P2|COMPLETED|Study Period II||0
494549|NCT00337662|1186008|P1|COMPLETED|Study Period II||0
494550|NCT00337662|1186005|P4|STARTED|Study Period II||628
494551|NCT00337662|1186006|P3|STARTED|Study Period II||0
494552|NCT00337662|1186007|P2|STARTED|Study Period II||0
494553|NCT00337662|1186008|P1|STARTED|Study Period II||0
494554|NCT00337610|1186062|P2|NOT COMPLETED|Overall Study||14
494555|NCT00337610|1186063|P1|NOT COMPLETED|Overall Study||17
494556|NCT00337610|1186062|P2|COMPLETED|Overall Study||80
494557|NCT00337610|1186063|P1|COMPLETED|Overall Study||79
494558|NCT00337610|1186062|P2|Completed Week 18|Overall Study||82
494559|NCT00337610|1186063|P1|Completed Week 18|Overall Study||89
494560|NCT00337610|1186062|P2|STARTED|Overall Study||94
494561|NCT00337610|1186063|P1|STARTED|Overall Study||96
494562|NCT00337571|1186079|P4|NOT COMPLETED|Overall Study||7
494563|NCT00337571|1186080|P3|NOT COMPLETED|Overall Study||10
494564|NCT00337571|1186081|P2|NOT COMPLETED|Overall Study||9
494565|NCT00337571|1186082|P1|NOT COMPLETED|Overall Study||14
494566|NCT00337571|1186079|P4|COMPLETED|Overall Study||47
494567|NCT00337571|1186080|P3|COMPLETED|Overall Study||49
494568|NCT00337571|1186081|P2|COMPLETED|Overall Study||44
494569|NCT00337571|1186082|P1|COMPLETED|Overall Study||38
494570|NCT00337571|1186079|P4|STARTED|Overall Study||54
494571|NCT00337571|1186080|P3|STARTED|Overall Study||59
494572|NCT00337571|1186081|P2|STARTED|Overall Study||53
494573|NCT00337571|1186082|P1|STARTED|Overall Study||52
494574|NCT00337467|1186120|P1|NOT COMPLETED|Overall Study||10
494575|NCT00337467|1186120|P1|COMPLETED|Overall Study||51
494658|NCT00336973|1186281|P1|COMPLETED|Overall Study||33
494576|NCT00337467|1186120|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
494577|NCT00337467|1186120|P1|STARTED|Overall Study||61
494578|NCT00337428|1186139|P2|NOT COMPLETED|Overall Study||3
494579|NCT00337428|1186140|P1|NOT COMPLETED|Overall Study||4
494580|NCT00337428|1186139|P2|COMPLETED|Overall Study||421
494581|NCT00337428|1186140|P1|COMPLETED|Overall Study||415
494582|NCT00337428|1186139|P2|STARTED|Overall Study||424
494583|NCT00337428|1186140|P1|STARTED|Overall Study||419
494584|NCT00337350|1186180|P2|NOT COMPLETED|Overall Study||1
494585|NCT00337350|1186181|P1|NOT COMPLETED|Overall Study||1
494586|NCT00337350|1186180|P2|COMPLETED|Overall Study||10
494587|NCT00337350|1186181|P1|COMPLETED|Overall Study||8
494588|NCT00337350|1186180|P2|STARTED|Overall Study||11
494589|NCT00337350|1186181|P1|STARTED|Overall Study||9
494590|NCT00337285|1186191|P1|NOT COMPLETED|Overall Study||158
494591|NCT00337285|1186191|P1|COMPLETED|Overall Study||191
494592|NCT00337285|1186191|P1|STARTED|Overall Study||349
494593|NCT00337272|1186199|P2|NOT COMPLETED|Withdrawal Period||1
494594|NCT00337272|1186200|P1|NOT COMPLETED|Withdrawal Period||0
494595|NCT00337272|1186199|P2|COMPLETED|Withdrawal Period||6
494596|NCT00337272|1186200|P1|COMPLETED|Withdrawal Period||6
494597|NCT00337272|1186199|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
494598|NCT00337272|1186200|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
494599|NCT00337272|1186199|P2|NOT COMPLETED|Treatment Period||2
494600|NCT00337272|1186200|P1|NOT COMPLETED|Treatment Period||1
494601|NCT00337272|1186199|P2|COMPLETED|Treatment Period||7
494602|NCT00337272|1186200|P1|COMPLETED|Treatment Period||6
494603|NCT00337272|1186199|P2|Randomization|Treatment Period||9
494604|NCT00337272|1186200|P1|Randomization|Treatment Period||7
494605|NCT00337272|1186199|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
494606|NCT00337272|1186200|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
494607|NCT00337272|1186199|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
494608|NCT00337272|1186200|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
494609|NCT00337272|1186199|P2|COMPLETED|Screening Period (Pre-randomization)||0
494610|NCT00337272|1186200|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
494611|NCT00337272|1186199|P2|STARTED|Screening Period (Pre-randomization)||0
494612|NCT00337272|1186200|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
494613|NCT00337207|1186220|P1|NOT COMPLETED|Overall Study||3
494614|NCT00337207|1186220|P1|COMPLETED|Overall Study||52
494615|NCT00337207|1186220|P1|STARTED|Overall Study||55
494616|NCT00337194|1186226|P2|NOT COMPLETED|Overall Study||4
494617|NCT00337194|1186227|P1|NOT COMPLETED|Overall Study||12
494618|NCT00337194|1186226|P2|COMPLETED|Overall Study||3
494619|NCT00337194|1186227|P1|COMPLETED|Overall Study||11
494620|NCT00337194|1186226|P2|STARTED|Overall Study||7
494621|NCT00337194|1186227|P1|STARTED|Overall Study||23
494622|NCT00337168|1186242|P1|NOT COMPLETED|Overall Study||8
494623|NCT00337168|1186242|P1|COMPLETED|Overall Study||29
494624|NCT00337168|1186242|P1|Eligible and Treated|Overall Study||36
494625|NCT00337168|1186242|P1|Eligible|Overall Study||37
494626|NCT00337168|1186242|P1|STARTED|Overall Study||37
494627|NCT00337129|1186249|P1|NOT COMPLETED|Overall Study||40
494628|NCT00337129|1186249|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
494629|NCT00337129|1186249|P1|STARTED|Overall Study||40
494630|NCT00337103|1186258|P2|NOT COMPLETED|Overall Study||543
494631|NCT00337103|1186259|P1|NOT COMPLETED|Overall Study||549
494632|NCT00337103|1186258|P2|COMPLETED|Overall Study||5
494633|NCT00337103|1186259|P1|COMPLETED|Overall Study||5
494634|NCT00337103|1186258|P2|STARTED|Overall Study||548
494635|NCT00337103|1186259|P1|STARTED|Overall Study||554
494636|NCT00337077|1186270|P3|NOT COMPLETED|Overall Study||25
494637|NCT00337077|1186271|P2|NOT COMPLETED|Overall Study||53
494638|NCT00337077|1186272|P1|NOT COMPLETED|Overall Study||43
494639|NCT00337077|1186270|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
494640|NCT00337077|1186271|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
494641|NCT00337077|1186272|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
494642|NCT00337077|1186270|P3|Patients With Measurable Disease|Overall Study||13
494643|NCT00337077|1186271|P2|Patients With Measurable Disease|Overall Study||38
494644|NCT00337077|1186272|P1|Patients With Measurable Disease|Overall Study||26
494645|NCT00337077|1186270|P3|Eligible and Treated|Overall Study||24
494646|NCT00337077|1186271|P2|Eligible and Treated|Overall Study||51
494647|NCT00337077|1186272|P1|Eligible and Treated|Overall Study||41
494648|NCT00337077|1186270|P3|Toxicity Assessed|Overall Study||25
494649|NCT00337077|1186271|P2|Toxicity Assessed|Overall Study||51
494650|NCT00337077|1186272|P1|Toxicity Assessed|Overall Study||42
494651|NCT00337077|1186270|P3|Treated|Overall Study||25
494652|NCT00337077|1186271|P2|Treated|Overall Study||52
494653|NCT00337077|1186272|P1|Treated|Overall Study||42
494654|NCT00337077|1186270|P3|STARTED|Overall Study||25
494655|NCT00337077|1186271|P2|STARTED|Overall Study||53
494656|NCT00337077|1186272|P1|STARTED|Overall Study||43
494657|NCT00336973|1186281|P1|NOT COMPLETED|Overall Study||33
494659|NCT00336973|1186281|P1|STARTED|Overall Study||66
494660|NCT00336895|1186287|P1|NOT COMPLETED|Overall Study||4
494661|NCT00336895|1186287|P1|COMPLETED|Overall Study||26
494662|NCT00336895|1186287|P1|STARTED|Overall Study||30
494663|NCT00336856|1186293|P1|NOT COMPLETED|Overall Study||4
494664|NCT00336856|1186293|P1|COMPLETED|Overall Study||31
494665|NCT00336856|1186293|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
494666|NCT00336817|1186301|P2|NOT COMPLETED|Overall Study||2
494667|NCT00336817|1186302|P1|NOT COMPLETED|Overall Study||1
494668|NCT00336817|1186301|P2|COMPLETED|Overall Study||13
494669|NCT00336817|1186302|P1|COMPLETED|Overall Study||14
494670|NCT00336817|1186301|P2|STARTED|Overall Study||15
494671|NCT00336817|1186302|P1|STARTED|Overall Study||15
494672|NCT00336700|1186332|P1|NOT COMPLETED|Overall Study||0
494673|NCT00336700|1186332|P1|COMPLETED|Overall Study||25
494674|NCT00336700|1186332|P1|STARTED|Overall Study||25
494675|NCT00336583|1186341|P1|NOT COMPLETED|Overall Study||2
494676|NCT00336583|1186341|P1|COMPLETED|Overall Study||25
494677|NCT00336583|1186341|P1|STARTED|Overall Study||27
494678|NCT00336544|1186348|P2|NOT COMPLETED|Overall Study||22
494679|NCT00336544|1186349|P1|NOT COMPLETED|Overall Study||19
494680|NCT00336544|1186348|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
494681|NCT00336544|1186349|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
494682|NCT00336544|1186348|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
494683|NCT00336544|1186349|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
494684|NCT00336505|1186363|P2|NOT COMPLETED|Overall Study||27
494685|NCT00336505|1186364|P1|NOT COMPLETED|Overall Study||37
494686|NCT00336505|1186363|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
494687|NCT00336505|1186364|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
494688|NCT00336505|1186363|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
494689|NCT00336505|1186364|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
494690|NCT00336492|1186379|P3|NOT COMPLETED|Overall Study||11
494691|NCT00336492|1186380|P2|NOT COMPLETED|Overall Study||4
494692|NCT00336492|1186381|P1|NOT COMPLETED|Overall Study||15
494693|NCT00336492|1186379|P3|COMPLETED|Overall Study||12
494694|NCT00336492|1186380|P2|COMPLETED|Overall Study||18
494695|NCT00336492|1186381|P1|COMPLETED|Overall Study||0
494696|NCT00336492|1186379|P3|STARTED|Overall Study||23
494697|NCT00336492|1186380|P2|STARTED|Overall Study||22
494698|NCT00336492|1186381|P1|STARTED|Overall Study||15
494699|NCT00336479|1186393|P4|NOT COMPLETED|Overall Study||4
494700|NCT00336479|1186394|P3|NOT COMPLETED|Overall Study||26
494701|NCT00336479|1186395|P2|NOT COMPLETED|Overall Study||25
494702|NCT00336479|1186396|P1|NOT COMPLETED|Overall Study||37
494703|NCT00336479|1186393|P4|COMPLETED|Overall Study||13
494704|NCT00336479|1186394|P3|COMPLETED|Overall Study||53
494705|NCT00336479|1186395|P2|COMPLETED|Overall Study||54
494706|NCT00336479|1186396|P1|COMPLETED|Overall Study||38
494707|NCT00336479|1186393|P4|STARTED|Overall Study||17
494708|NCT00336479|1186394|P3|STARTED|Overall Study||79
494709|NCT00336479|1186395|P2|STARTED|Overall Study||79
494710|NCT00336479|1186396|P1|STARTED|Overall Study||75
494711|NCT00336323|1186424|P5|NOT COMPLETED|Overall Study||3
494712|NCT00336323|1186425|P4|NOT COMPLETED|Overall Study||0
494713|NCT00336323|1186426|P3|NOT COMPLETED|Overall Study||1
494714|NCT00336323|1186427|P2|NOT COMPLETED|Overall Study||1
494715|NCT00336323|1186428|P1|NOT COMPLETED|Overall Study||0
494716|NCT00336323|1186424|P5|COMPLETED|Overall Study||19
494717|NCT00336323|1186425|P4|COMPLETED|Overall Study||22
494718|NCT00336323|1186426|P3|COMPLETED|Overall Study||23
494719|NCT00336323|1186427|P2|COMPLETED|Overall Study||21
494720|NCT00336323|1186428|P1|COMPLETED|Overall Study||19
494721|NCT00336323|1186424|P5|24 Week Visit|Overall Study||19
494722|NCT00336323|1186425|P4|24 Week Visit|Overall Study||22
494723|NCT00336323|1186426|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
494724|NCT00336323|1186427|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
494725|NCT00336323|1186428|P1|24 Week Visit|Overall Study||18
494726|NCT00336323|1186424|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
494727|NCT00336323|1186425|P4|18 Week Visit|Overall Study||21
494728|NCT00336323|1186426|P3|18 Week Visit|Overall Study||23
494729|NCT00336323|1186427|P2|18 Week Visit|Overall Study||22
494730|NCT00336323|1186428|P1|18 Week Visit|Overall Study||19
494731|NCT00336323|1186424|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
494732|NCT00336323|1186425|P4|12 Week Visit|Overall Study||22
494733|NCT00336323|1186426|P3|12 Week Visit|Overall Study||24
494734|NCT00336323|1186427|P2|12 Week Visit|Overall Study||21
494735|NCT00336323|1186428|P1|12 Week Visit|Overall Study||19
494736|NCT00336323|1186424|P5|9 Week Visit|Overall Study||19
494737|NCT00336323|1186425|P4|9 Week Visit|Overall Study||21
494738|NCT00336323|1186426|P3|9 Week Visit|Overall Study||23
494739|NCT00336323|1186427|P2|9 Week Visit|Overall Study||21
494740|NCT00336323|1186428|P1|9 Week Visit|Overall Study||18
494741|NCT00336323|1186424|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
494742|NCT00336323|1186425|P4|6 Week Visit|Overall Study||22
494743|NCT00336323|1186426|P3|6 Week Visit|Overall Study||24
494744|NCT00336323|1186427|P2|6 Week Visit|Overall Study||22
494745|NCT00336323|1186428|P1|6 Week Visit|Overall Study||18
494746|NCT00336323|1186424|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
494747|NCT00336323|1186425|P4|3 Week Visit|Overall Study||22
494748|NCT00336323|1186426|P3|3 Week Visit|Overall Study||24
494749|NCT00336323|1186427|P2|3 Week Visit|Overall Study||21
494750|NCT00336323|1186428|P1|3 Week Visit|Overall Study||18
494751|NCT00336323|1186424|P5|STARTED|Overall Study||22
494752|NCT00336323|1186425|P4|STARTED|Overall Study||22
494753|NCT00336323|1186426|P3|STARTED|Overall Study||24
494754|NCT00336323|1186427|P2|STARTED|Overall Study||22
494755|NCT00336323|1186428|P1|STARTED|Overall Study||19
494756|NCT00336284|1186485|P2|NOT COMPLETED|Overall Study||151
494757|NCT00336284|1186486|P1|NOT COMPLETED|Overall Study||236
494758|NCT00336284|1186485|P2|COMPLETED|Overall Study||322
494759|NCT00336284|1186486|P1|COMPLETED|Overall Study||741
494760|NCT00336284|1186485|P2|STARTED|Overall Study||473
494761|NCT00336284|1186486|P1|STARTED|Overall Study||977
494762|NCT00336232|1186498|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
494763|NCT00336232|1186498|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
494764|NCT00336232|1186498|P1|STARTED|High Vitamin K (500mcg Daily)||42
494765|NCT00336232|1186498|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
494766|NCT00336232|1186498|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
494767|NCT00336232|1186498|P1|STARTED|Low Vitamin K (10mcg Daily)||42
494768|NCT00336232|1186498|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
494769|NCT00336232|1186498|P1|COMPLETED|Baseline (200mcg Daily)||42
494770|NCT00336232|1186498|P1|STARTED|Baseline (200mcg Daily)||59
494771|NCT00335959|1186502|P1|NOT COMPLETED|Overall Study||3
494772|NCT00335959|1186502|P1|COMPLETED|Overall Study||4
494773|NCT00335959|1186502|P1|Eligible and Began Protocol Therapy|Overall Study||6
494774|NCT00335959|1186502|P1|Eligible|Overall Study||6
494775|NCT00335959|1186502|P1|STARTED|Overall Study||7
494776|NCT00335777|1186507|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
494777|NCT00335777|1186507|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
494778|NCT00335777|1186507|P1|STARTED|Treated 2 Headaches Per Protocol||35
494779|NCT00335777|1186507|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
494780|NCT00335777|1186507|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
494781|NCT00335777|1186507|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
494782|NCT00335725|1186514|P2|NOT COMPLETED|Overall Study||5
494783|NCT00335725|1186515|P1|NOT COMPLETED|Overall Study||4
494784|NCT00335725|1186514|P2|COMPLETED|Overall Study||71
494785|NCT00335725|1186515|P1|COMPLETED|Overall Study||71
494786|NCT00335725|1186514|P2|STARTED|Overall Study||76
494787|NCT00335725|1186515|P1|STARTED|Overall Study||75
494788|NCT00335556|1186529|P6|NOT COMPLETED|Overall Study||1
494789|NCT00335556|1186530|P5|NOT COMPLETED|Overall Study||1
494790|NCT00335556|1186531|P4|NOT COMPLETED|Overall Study||5
494791|NCT00335556|1186532|P3|NOT COMPLETED|Overall Study||5
494792|NCT00335556|1186533|P2|NOT COMPLETED|Overall Study||34
494793|NCT00335556|1186534|P1|NOT COMPLETED|Overall Study||2
494794|NCT00335556|1186529|P6|COMPLETED|Overall Study||29
494795|NCT00335556|1186530|P5|COMPLETED|Overall Study||77
494796|NCT00335556|1186531|P4|COMPLETED|Overall Study||5
494797|NCT00335556|1186532|P3|COMPLETED|Overall Study||2
494798|NCT00335556|1186533|P2|COMPLETED|Overall Study||64
494799|NCT00335556|1186534|P1|COMPLETED|Overall Study||66
494800|NCT00335556|1186529|P6|STARTED|Overall Study||30
494801|NCT00335556|1186530|P5|STARTED|Overall Study||78
494802|NCT00335556|1186531|P4|STARTED|Overall Study||10
494803|NCT00335556|1186532|P3|STARTED|Overall Study||7
494804|NCT00335556|1186533|P2|STARTED|Overall Study||98
494805|NCT00335556|1186534|P1|STARTED|Overall Study||68
494806|NCT00335517|1186555|P1|NOT COMPLETED|Overall Study||2
494807|NCT00335517|1186555|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
494808|NCT00335517|1186555|P1|STARTED|Overall Study||100
494809|NCT00335504|1186563|P4|NOT COMPLETED|Overall Study||0
494810|NCT00335504|1186564|P3|NOT COMPLETED|Overall Study||0
494811|NCT00335504|1186565|P2|NOT COMPLETED|Overall Study||0
494812|NCT00335504|1186566|P1|NOT COMPLETED|Overall Study||0
494813|NCT00335504|1186563|P4|COMPLETED|Overall Study||22
494814|NCT00335504|1186564|P3|COMPLETED|Overall Study||20
494815|NCT00335504|1186565|P2|COMPLETED|Overall Study||21
494816|NCT00335504|1186566|P1|COMPLETED|Overall Study||22
494817|NCT00335504|1186563|P4|STARTED|Overall Study||22
494818|NCT00335504|1186564|P3|STARTED|Overall Study||20
494819|NCT00335504|1186565|P2|STARTED|Overall Study||21
494820|NCT00335504|1186566|P1|STARTED|Overall Study||22
494821|NCT00335478|1186588|P1|NOT COMPLETED|Overall Study||24
494822|NCT00335478|1186588|P1|COMPLETED|Overall Study||30
494823|NCT00335478|1186588|P1|STARTED|Overall Study||54
494824|NCT00335452|1186596|P4|NOT COMPLETED|Overall Study||131
494825|NCT00335452|1186597|P3|NOT COMPLETED|Overall Study||159
494826|NCT00335452|1186598|P2|NOT COMPLETED|Overall Study||147
494827|NCT00335452|1186599|P1|NOT COMPLETED|Overall Study||158
494828|NCT00335452|1186596|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
494829|NCT00335452|1186597|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
494830|NCT00335452|1186598|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
494831|NCT00335452|1186599|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
494832|NCT00335452|1186596|P4|TREATED WITH ASA|Overall Study||6247
494833|NCT00335452|1186597|P3|TREATED WITH ASA|Overall Study||6261
494834|NCT00335452|1186598|P2|TREATED WITH ASA|Overall Study||6251
494835|NCT00335452|1186599|P1|TREATED WITH ASA|Overall Study||6302
494836|NCT00335452|1186596|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
494837|NCT00335452|1186597|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
494838|NCT00335452|1186598|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
494839|NCT00335452|1186599|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
494840|NCT00335452|1186596|P4|STARTED|Overall Study|Randomized|6253
494841|NCT00335452|1186597|P3|STARTED|Overall Study|Randomized|6267
494842|NCT00335452|1186598|P2|STARTED|Overall Study|Randomized|6254
494843|NCT00335452|1186599|P1|STARTED|Overall Study|Randomized|6312
494844|NCT00335322|1186624|P3|NOT COMPLETED|Overall Study||2
494845|NCT00335322|1186625|P2|NOT COMPLETED|Overall Study||2
494846|NCT00335322|1186626|P1|NOT COMPLETED|Overall Study||1
494847|NCT00335322|1186624|P3|COMPLETED|Overall Study||103
494848|NCT00335322|1186625|P2|COMPLETED|Overall Study||105
494849|NCT00335322|1186626|P1|COMPLETED|Overall Study||114
494850|NCT00335322|1186624|P3|STARTED|Overall Study||105
494851|NCT00335322|1186625|P2|STARTED|Overall Study||107
494852|NCT00335322|1186626|P1|STARTED|Overall Study||115
494853|NCT00335283|1186636|P2|NOT COMPLETED|Overall Study||5
494854|NCT00335283|1186637|P1|NOT COMPLETED|Overall Study||6
494855|NCT00335283|1186636|P2|COMPLETED|Overall Study||34
494856|NCT00335283|1186637|P1|COMPLETED|Overall Study||30
494857|NCT00335283|1186636|P2|STARTED|Overall Study||39
494858|NCT00335283|1186637|P1|STARTED|Overall Study||36
494859|NCT00335257|1186652|P3|NOT COMPLETED|Overall Study||0
494860|NCT00335257|1186653|P2|NOT COMPLETED|Overall Study||0
494861|NCT00335257|1186654|P1|NOT COMPLETED|Overall Study||0
494862|NCT00335257|1186652|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
494863|NCT00335257|1186653|P2|COMPLETED|Overall Study||9377
494864|NCT00335257|1186654|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
494865|NCT00335257|1186652|P3|STARTED|Overall Study||60190
494866|NCT00335257|1186653|P2|STARTED|Overall Study||9377
494867|NCT00335257|1186654|P1|STARTED|Overall Study||15542
494868|NCT00335153|1186671|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
494869|NCT00335153|1186671|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
494870|NCT00335153|1186671|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
494871|NCT00335153|1186671|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
494872|NCT00335153|1186671|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
494873|NCT00335153|1186671|P1|STARTED|Nasojejunal (NJ) Test Period||354
494874|NCT00334958|1186710|P2|NOT COMPLETED|Overall Study||24
494875|NCT00334958|1186711|P1|NOT COMPLETED|Overall Study||37
494876|NCT00334958|1186710|P2|COMPLETED|Overall Study||156
494877|NCT00334958|1186711|P1|COMPLETED|Overall Study||139
494878|NCT00334958|1186710|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
494879|NCT00334958|1186711|P1|STARTED|Overall Study||176
494880|NCT00334893|1186725|P2|NOT COMPLETED|Overall Study||0
494881|NCT00334893|1186726|P1|NOT COMPLETED|Overall Study||1
494882|NCT00334893|1186725|P2|COMPLETED|Overall Study||37
494883|NCT00334893|1186726|P1|COMPLETED|Overall Study||36
494884|NCT00334893|1186725|P2|STARTED|Overall Study||37
494885|NCT00334893|1186726|P1|STARTED|Overall Study||37
494886|NCT00334815|1186734|P2|NOT COMPLETED|Overall Study||10
494887|NCT00334815|1186735|P1|NOT COMPLETED|Overall Study||7
494888|NCT00334815|1186734|P2|COMPLETED|Overall Study||3
494889|NCT00334815|1186735|P1|COMPLETED|Overall Study||9
494890|NCT00334815|1186734|P2|STARTED|Overall Study||13
494891|NCT00334815|1186735|P1|STARTED|Overall Study||16
494892|NCT00334802|1186749|P2|NOT COMPLETED|Overall Study||40
494893|NCT00334802|1186750|P1|NOT COMPLETED|Overall Study||6
494894|NCT00334802|1186749|P2|COMPLETED|Overall Study||16
494895|NCT00334802|1186750|P1|COMPLETED|Overall Study||0
494896|NCT00334802|1186749|P2|STARTED|Overall Study||56
494897|NCT00334802|1186750|P1|STARTED|Overall Study||6
494898|NCT00334633|1186770|P3|NOT COMPLETED|Overall Study||82
494899|NCT00334633|1186771|P2|NOT COMPLETED|Overall Study||82
494900|NCT00334633|1186772|P1|NOT COMPLETED|Overall Study||80
494901|NCT00334633|1186770|P3|COMPLETED|Overall Study||114
494902|NCT00334633|1186771|P2|COMPLETED|Overall Study||118
494903|NCT00334633|1186772|P1|COMPLETED|Overall Study||117
494904|NCT00334633|1186770|P3|STARTED|Overall Study||196
494905|NCT00334633|1186771|P2|STARTED|Overall Study||200
494906|NCT00334633|1186772|P1|STARTED|Overall Study||197
494907|NCT00334542|1186780|P1|NOT COMPLETED|Overall Study||5
494908|NCT00334542|1186780|P1|COMPLETED|Overall Study||45
494909|NCT00334542|1186780|P1|STARTED|Overall Study||50
494910|NCT00334295|1186785|P1|NOT COMPLETED|Overall Study||5
494911|NCT00334295|1186785|P1|COMPLETED|Overall Study||30
494912|NCT00334295|1186785|P1|STARTED|Overall Study||35
494913|NCT00334282|1186795|P2|NOT COMPLETED|Overall Study||108
494914|NCT00334282|1186796|P1|NOT COMPLETED|Overall Study||222
494915|NCT00334282|1186795|P2|COMPLETED|Overall Study||37
494916|NCT00334282|1186796|P1|COMPLETED|Overall Study||68
494917|NCT00334282|1186795|P2|STARTED|Overall Study||145
494918|NCT00334282|1186796|P1|STARTED|Overall Study||290
494919|NCT00334204|1186819|P1|NOT COMPLETED|Overall Study||2
494920|NCT00334204|1186819|P1|COMPLETED|Overall Study||56
494921|NCT00334204|1186819|P1|STARTED|Overall Study||58
494922|NCT00334113|1186827|P2|NOT COMPLETED|Overall Study||3
494923|NCT00334113|1186828|P1|NOT COMPLETED|Overall Study||2
494924|NCT00334113|1186827|P2|COMPLETED|Overall Study||31
494925|NCT00334113|1186828|P1|COMPLETED|Overall Study||30
494926|NCT00334113|1186827|P2|STARTED|Overall Study||34
494927|NCT00334113|1186828|P1|STARTED|Overall Study||32
494928|NCT00334074|1186834|P1|NOT COMPLETED|Overall Study||0
494929|NCT00334074|1186834|P1|COMPLETED|Overall Study||30
494930|NCT00334074|1186834|P1|STARTED|Overall Study||30
494931|NCT00334061|1186839|P1|NOT COMPLETED|Overall Study||0
494932|NCT00334061|1186839|P1|COMPLETED|Overall Study|November 2007|125
494933|NCT00334061|1186839|P1|STARTED|Overall Study|June 2006|125
494934|NCT00333983|1186851|P3|NOT COMPLETED|Overall Study||2
494935|NCT00333983|1186852|P2|NOT COMPLETED|Overall Study||5
494936|NCT00333983|1186853|P1|NOT COMPLETED|Overall Study||3
494937|NCT00333983|1186851|P3|COMPLETED|Overall Study||19
494938|NCT00333983|1186852|P2|COMPLETED|Overall Study||16
494939|NCT00333983|1186853|P1|COMPLETED|Overall Study||17
494940|NCT00333983|1186851|P3|STARTED|Overall Study||21
494941|NCT00333983|1186852|P2|STARTED|Overall Study||21
494942|NCT00333983|1186853|P1|STARTED|Overall Study||20
494943|NCT00333970|1186863|P2|NOT COMPLETED|Overall Study||7
494944|NCT00333970|1186864|P1|NOT COMPLETED|Overall Study||13
494945|NCT00333970|1186863|P2|COMPLETED|Overall Study||18
494946|NCT00333970|1186864|P1|COMPLETED|Overall Study||37
494947|NCT00333970|1186863|P2|STARTED|Overall Study||25
494948|NCT00333970|1186864|P1|STARTED|Overall Study||50
494949|NCT00333879|1186870|P1|NOT COMPLETED|Overall Study||0
494950|NCT00333879|1186870|P1|COMPLETED|Overall Study||4
494951|NCT00333879|1186870|P1|STARTED|Overall Study||4
494952|NCT00333866|1186879|P4|NOT COMPLETED|Overall Study||66
494953|NCT00333866|1186880|P3|NOT COMPLETED|Overall Study||51
494954|NCT00333866|1186881|P2|NOT COMPLETED|Overall Study||64
494955|NCT00333866|1186882|P1|NOT COMPLETED|Overall Study||48
494956|NCT00333866|1186879|P4|COMPLETED|Overall Study||121
494957|NCT00333866|1186880|P3|COMPLETED|Overall Study||133
494958|NCT00333866|1186881|P2|COMPLETED|Overall Study||123
494959|NCT00333866|1186882|P1|COMPLETED|Overall Study||141
494960|NCT00333866|1186879|P4|TREATED|Overall Study||186
494961|NCT00333866|1186880|P3|TREATED|Overall Study||182
494962|NCT00333866|1186881|P2|TREATED|Overall Study||184
494963|NCT00333866|1186882|P1|TREATED|Overall Study||184
494964|NCT00333866|1186879|P4|STARTED|Overall Study||187
494965|NCT00333866|1186880|P3|STARTED|Overall Study||184
494966|NCT00333866|1186881|P2|STARTED|Overall Study||187
494967|NCT00333866|1186882|P1|STARTED|Overall Study||189
494968|NCT00333840|1186942|P4|NOT COMPLETED|Second-line Treatment Period||188
494969|NCT00333840|1186943|P3|NOT COMPLETED|Second-line Treatment Period||14
494970|NCT00333840|1186944|P2|NOT COMPLETED|Second-line Treatment Period||0
494971|NCT00333840|1186945|P1|NOT COMPLETED|Second-line Treatment Period||0
494972|NCT00333840|1186942|P4|COMPLETED|Second-line Treatment Period||175
494973|NCT00333840|1186943|P3|COMPLETED|Second-line Treatment Period||0
494974|NCT00333840|1186944|P2|COMPLETED|Second-line Treatment Period||0
494975|NCT00333840|1186945|P1|COMPLETED|Second-line Treatment Period||0
494976|NCT00333840|1186942|P4|STARTED|Second-line Treatment Period||363
494977|NCT00333840|1186943|P3|STARTED|Second-line Treatment Period||14
494978|NCT00333840|1186944|P2|STARTED|Second-line Treatment Period||0
494979|NCT00333840|1186945|P1|STARTED|Second-line Treatment Period||0
494980|NCT00333840|1186942|P4|NOT COMPLETED|First-line Treatment Period||0
494981|NCT00333840|1186943|P3|NOT COMPLETED|First-line Treatment Period||0
494982|NCT00333840|1186944|P2|NOT COMPLETED|First-line Treatment Period||546
494983|NCT00333840|1186945|P1|NOT COMPLETED|First-line Treatment Period||286
494984|NCT00333840|1186942|P4|COMPLETED|First-line Treatment Period||0
494985|NCT00333840|1186943|P3|COMPLETED|First-line Treatment Period||0
494986|NCT00333840|1186944|P2|COMPLETED|First-line Treatment Period||7
494987|NCT00333840|1186945|P1|COMPLETED|First-line Treatment Period||267
494988|NCT00333840|1186942|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
494989|NCT00333840|1186943|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
494990|NCT00333840|1186944|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
494991|NCT00333840|1186945|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
494992|NCT00333840|1186942|P4|STARTED|First-line Treatment Period||0
494993|NCT00333840|1186943|P3|STARTED|First-line Treatment Period||0
494994|NCT00333840|1186944|P2|STARTED|First-line Treatment Period||553
494995|NCT00333840|1186945|P1|STARTED|First-line Treatment Period||553
494996|NCT00333814|1186973|P3|NOT COMPLETED|Overall Study||5
494997|NCT00333814|1186974|P2|NOT COMPLETED|Overall Study||4
494998|NCT00333814|1186975|P1|NOT COMPLETED|Overall Study||3
494999|NCT00333814|1186973|P3|COMPLETED|Overall Study||71
495000|NCT00333814|1186974|P2|COMPLETED|Overall Study||73
495001|NCT00333814|1186975|P1|COMPLETED|Overall Study||73
495002|NCT00333814|1186973|P3|STARTED|Overall Study||76
495003|NCT00333814|1186974|P2|STARTED|Overall Study||77
495004|NCT00333814|1186975|P1|STARTED|Overall Study||76
495005|NCT00333801|1186991|P2|NOT COMPLETED|Overall Study||6
495006|NCT00333801|1186992|P1|NOT COMPLETED|Overall Study||8
495007|NCT00333801|1186991|P2|COMPLETED|Overall Study||36
495008|NCT00333801|1186992|P1|COMPLETED|Overall Study||35
495009|NCT00333801|1186991|P2|STARTED|Overall Study||42
495010|NCT00333801|1186992|P1|STARTED|Overall Study||43
495011|NCT00333788|1187010|P1|NOT COMPLETED|Overall Study||162
495012|NCT00333788|1187010|P1|COMPLETED|Overall Study||71
495013|NCT00333788|1187010|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
495014|NCT00333775|1187040|P3|NOT COMPLETED|Overall Study||247
495015|NCT00333775|1187041|P2|NOT COMPLETED|Overall Study||248
495016|NCT00333775|1187042|P1|NOT COMPLETED|Overall Study||241
495017|NCT00333775|1187040|P3|COMPLETED|Overall Study||0
495018|NCT00333775|1187041|P2|COMPLETED|Overall Study||0
495019|NCT00333775|1187042|P1|COMPLETED|Overall Study||0
495020|NCT00333775|1187040|P3|Received Treatment|Overall Study||245
495021|NCT00333775|1187041|P2|Received Treatment|Overall Study||247
495022|NCT00333775|1187042|P1|Received Treatment|Overall Study||238
495023|NCT00333775|1187040|P3|STARTED|Overall Study||247
495024|NCT00333775|1187041|P2|STARTED|Overall Study||248
495025|NCT00333775|1187042|P1|STARTED|Overall Study||241
495026|NCT00333762|1187062|P1|NOT COMPLETED|Overall Study||4
495027|NCT00333762|1187062|P1|COMPLETED|Overall Study||0
495028|NCT00333762|1187062|P1|STARTED|Overall Study||4
495029|NCT00333710|1187069|P3|NOT COMPLETED|Overall Study||1
495030|NCT00333710|1187070|P2|NOT COMPLETED|Overall Study||4
495031|NCT00333710|1187071|P1|NOT COMPLETED|Overall Study||11
495032|NCT00333710|1187069|P3|COMPLETED|Overall Study||15
495033|NCT00333710|1187070|P2|COMPLETED|Overall Study||14
495034|NCT00333710|1187071|P1|COMPLETED|Overall Study||8
495035|NCT00333710|1187069|P3|STARTED|Overall Study||16
495036|NCT00333710|1187070|P2|STARTED|Overall Study||18
495037|NCT00333710|1187071|P1|STARTED|Overall Study||19
495038|NCT00333619|1187081|P2|NOT COMPLETED|Overall Study||10
495039|NCT00333619|1187082|P1|NOT COMPLETED|Overall Study||21
495040|NCT00333619|1187081|P2|COMPLETED|Overall Study||99
495041|NCT00333619|1187082|P1|COMPLETED|Overall Study||89
495042|NCT00333619|1187081|P2|3-month Follow-up|Overall Study||105
495043|NCT00333619|1187082|P1|3-month Follow-up|Overall Study||101
495044|NCT00333619|1187081|P2|Post-treatment|Overall Study||109
495045|NCT00333619|1187082|P1|Post-treatment|Overall Study||109
495046|NCT00333619|1187081|P2|STARTED|Overall Study||109
495047|NCT00333619|1187082|P1|STARTED|Overall Study||110
495048|NCT00333437|1187090|P1|NOT COMPLETED|Overall Study||0
495049|NCT00333437|1187090|P1|COMPLETED|Overall Study||7
495050|NCT00333437|1187090|P1|STARTED|Overall Study||7
495051|NCT00333359|1187100|P2|NOT COMPLETED|Overall Study||122
495052|NCT00333359|1187101|P1|NOT COMPLETED|Overall Study||73
495053|NCT00333359|1187100|P2|COMPLETED|Overall Study||260
495054|NCT00333359|1187101|P1|COMPLETED|Overall Study||126
495055|NCT00333359|1187100|P2|STARTED|Overall Study||382
495056|NCT00333359|1187101|P1|STARTED|Overall Study||199
495057|NCT00333229|1187144|P2|NOT COMPLETED|Overall Study||1
495058|NCT00333229|1187145|P1|NOT COMPLETED|Overall Study||0
495059|NCT00333229|1187144|P2|COMPLETED|Overall Study||4
495060|NCT00333229|1187145|P1|COMPLETED|Overall Study||6
495061|NCT00333229|1187144|P2|STARTED|Overall Study||5
495062|NCT00333229|1187145|P1|STARTED|Overall Study||6
495063|NCT00333138|1187162|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
495064|NCT00333138|1187163|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
495065|NCT00333138|1187164|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
495066|NCT00333138|1187162|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
495067|NCT00333138|1187163|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
495068|NCT00333138|1187164|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
495069|NCT00333138|1187162|P3|STARTED|Extension Study (Month6 to End of Study)||80
495070|NCT00333138|1187163|P2|STARTED|Extension Study (Month6 to End of Study)||87
495071|NCT00333138|1187164|P1|STARTED|Extension Study (Month6 to End of Study)||83
495072|NCT00333138|1187162|P3|NOT COMPLETED|Core Study (6 Months)||12
495073|NCT00333138|1187163|P2|NOT COMPLETED|Core Study (6 Months)||6
495074|NCT00333138|1187164|P1|NOT COMPLETED|Core Study (6 Months)||7
495075|NCT00333138|1187162|P3|COMPLETED|Core Study (6 Months)||82
495076|NCT00333138|1187163|P2|COMPLETED|Core Study (6 Months)||88
495077|NCT00333138|1187164|P1|COMPLETED|Core Study (6 Months)||86
495078|NCT00333138|1187162|P3|STARTED|Core Study (6 Months)||94
495079|NCT00333138|1187163|P2|STARTED|Core Study (6 Months)||94
495080|NCT00333138|1187164|P1|STARTED|Core Study (6 Months)||93
495081|NCT00332839|1187203|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
495082|NCT00332839|1187204|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
495083|NCT00332839|1187203|P2|COMPLETED|Follow-up (Months 12 - 60)||31
495084|NCT00332839|1187204|P1|COMPLETED|Follow-up (Months 12 - 60)||29
495085|NCT00332839|1187203|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
495086|NCT00332839|1187204|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
495087|NCT00332839|1187203|P2|NOT COMPLETED|Core (Months 0 - 12)||18
495088|NCT00332839|1187204|P1|NOT COMPLETED|Core (Months 0 - 12)||10
495089|NCT00332839|1187203|P2|COMPLETED|Core (Months 0 - 12)||28
495090|NCT00332839|1187204|P1|COMPLETED|Core (Months 0 - 12)||37
495091|NCT00332839|1187203|P2|Safety Set|Core (Months 0 - 12)||46
495092|NCT00332839|1187204|P1|Safety Set|Core (Months 0 - 12)||47
495093|NCT00332839|1187203|P2|STARTED|Core (Months 0 - 12)||46
495094|NCT00332839|1187204|P1|STARTED|Core (Months 0 - 12)||47
495095|NCT00332722|1187224|P2|NOT COMPLETED|Overall Study||0
495096|NCT00332722|1187225|P1|NOT COMPLETED|Overall Study||0
495097|NCT00332722|1187224|P2|COMPLETED|Overall Study||60
495098|NCT00332722|1187225|P1|COMPLETED|Overall Study||60
495099|NCT00332722|1187224|P2|STARTED|Overall Study||60
495100|NCT00332722|1187225|P1|STARTED|Overall Study||60
495101|NCT00332709|1187235|P2|NOT COMPLETED|Overall Study||20
495102|NCT00332709|1187236|P1|NOT COMPLETED|Overall Study||16
495103|NCT00332709|1187235|P2|COMPLETED|Overall Study||21
495104|NCT00332709|1187236|P1|COMPLETED|Overall Study||24
495105|NCT00332709|1187235|P2|STARTED|Overall Study||41
495106|NCT00332709|1187236|P1|STARTED|Overall Study||40
495107|NCT00332696|1187260|P2|NOT COMPLETED|Overall Study||30
495108|NCT00332696|1187261|P1|NOT COMPLETED|Overall Study||30
495109|NCT00332696|1187260|P2|COMPLETED|Overall Study||2
495110|NCT00332696|1187261|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
495111|NCT00332696|1187260|P2|Completed Day 14 Visit|Overall Study||15
495112|NCT00332696|1187261|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
495113|NCT00332696|1187260|P2|STARTED|Overall Study||32
495114|NCT00332696|1187261|P1|STARTED|Overall Study||32
495115|NCT00332644|1187293|P6|NOT COMPLETED|Overall Study||15
495116|NCT00332644|1187294|P5|NOT COMPLETED|Overall Study||12
495117|NCT00332644|1187295|P4|NOT COMPLETED|Overall Study||20
495118|NCT00332644|1187296|P3|NOT COMPLETED|Overall Study||9
495119|NCT00332644|1187297|P2|NOT COMPLETED|Overall Study||22
495120|NCT00332644|1187298|P1|NOT COMPLETED|Overall Study||12
495121|NCT00332644|1187293|P6|COMPLETED|Overall Study||174
495122|NCT00332644|1187294|P5|COMPLETED|Overall Study||250
495123|NCT00332644|1187295|P4|COMPLETED|Overall Study||244
495124|NCT00332644|1187296|P3|COMPLETED|Overall Study||258
495125|NCT00332644|1187297|P2|COMPLETED|Overall Study||238
495126|NCT00332644|1187298|P1|COMPLETED|Overall Study||250
495127|NCT00332644|1187293|P6|STARTED|Overall Study||189
495128|NCT00332644|1187294|P5|STARTED|Overall Study||262
495129|NCT00332644|1187295|P4|STARTED|Overall Study||264
495130|NCT00332644|1187296|P3|STARTED|Overall Study||267
495131|NCT00332644|1187297|P2|STARTED|Overall Study||260
495132|NCT00332644|1187298|P1|STARTED|Overall Study||262
495133|NCT00332605|1187315|P3|NOT COMPLETED|Overall Study||8
495134|NCT00332605|1187316|P2|NOT COMPLETED|Overall Study||2
495135|NCT00332605|1187317|P1|NOT COMPLETED|Overall Study||2
495136|NCT00332605|1187315|P3|COMPLETED|Overall Study||9
495137|NCT00332605|1187316|P2|COMPLETED|Overall Study||12
495138|NCT00332605|1187317|P1|COMPLETED|Overall Study||12
495139|NCT00332605|1187315|P3|STARTED|Overall Study||17
495140|NCT00332605|1187316|P2|STARTED|Overall Study||14
495141|NCT00332605|1187317|P1|STARTED|Overall Study||14
495142|NCT00332579|1187327|P2|NOT COMPLETED|Overall Study||1
495143|NCT00332579|1187328|P1|NOT COMPLETED|Overall Study||1
495144|NCT00332579|1187327|P2|COMPLETED|Overall Study||12
495145|NCT00332579|1187328|P1|COMPLETED|Overall Study||11
495146|NCT00332579|1187327|P2|STARTED|Overall Study||13
495147|NCT00332579|1187328|P1|STARTED|Overall Study||12
495148|NCT00332488|1187337|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
495149|NCT00332488|1187338|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
495150|NCT00332488|1187339|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
495151|NCT00332488|1187337|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
495152|NCT00332488|1187338|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
495153|NCT00332488|1187339|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
495154|NCT00332488|1187337|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
495155|NCT00332488|1187338|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
495156|NCT00332488|1187339|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
495157|NCT00332488|1187337|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
495158|NCT00332488|1187338|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
495159|NCT00332488|1187339|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
495160|NCT00332488|1187337|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
495161|NCT00332488|1187338|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
495162|NCT00332488|1187339|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
495163|NCT00332488|1187337|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
495164|NCT00332488|1187338|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
495165|NCT00332488|1187339|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
495166|NCT00332462|1187351|P1|NOT COMPLETED|Overall Study||16
495167|NCT00332462|1187351|P1|COMPLETED|Overall Study||18
495168|NCT00332462|1187351|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
495169|NCT00332462|1187351|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
495170|NCT00332462|1187351|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
495171|NCT00332332|1187358|P1|NOT COMPLETED|Overall Study||68
495172|NCT00332332|1187358|P1|COMPLETED|Overall Study||178
495173|NCT00332332|1187358|P1|Received Study Medication|Overall Study||230
495174|NCT00332332|1187358|P1|STARTED|Overall Study||246
495175|NCT00332241|1187367|P2|NOT COMPLETED|Overall Study||8
495176|NCT00332241|1187368|P1|NOT COMPLETED|Overall Study||15
495177|NCT00332241|1187367|P2|COMPLETED|Overall Study||39
495178|NCT00332241|1187368|P1|COMPLETED|Overall Study||36
495179|NCT00332241|1187367|P2|STARTED|Overall Study||47
495180|NCT00332241|1187368|P1|STARTED|Overall Study||51
495181|NCT00332189|1187388|P1|NOT COMPLETED|Overall Study||21
495182|NCT00332189|1187388|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
495183|NCT00332189|1187388|P1|STARTED|Overall Study||111
495184|NCT00332163|1187395|P2|NOT COMPLETED|Overall Study||0
495185|NCT00332163|1187396|P1|NOT COMPLETED|Overall Study||0
495186|NCT00332163|1187395|P2|COMPLETED|Overall Study||47
495187|NCT00332163|1187396|P1|COMPLETED|Overall Study||48
495188|NCT00332163|1187395|P2|Received Treatment|Overall Study||47
495189|NCT00332163|1187396|P1|Received Treatment|Overall Study||48
495190|NCT00332163|1187395|P2|STARTED|Overall Study||47
495191|NCT00332163|1187396|P1|STARTED|Overall Study||48
495192|NCT00331864|1187430|P2|NOT COMPLETED|Overall Study||4
495193|NCT00331864|1187431|P1|NOT COMPLETED|Overall Study||58
495194|NCT00331864|1187430|P2|COMPLETED|Overall Study||14
495195|NCT00331864|1187431|P1|COMPLETED|Overall Study||455
495196|NCT00331864|1187430|P2|STARTED|Overall Study||18
495197|NCT00331864|1187431|P1|STARTED|Overall Study||513
495198|NCT00331799|1187450|P1|NOT COMPLETED|Overall Study||3
495199|NCT00331799|1187450|P1|COMPLETED|Overall Study||15
495200|NCT00331799|1187450|P1|STARTED|Overall Study||18
495201|NCT00331773|1187456|P2|NOT COMPLETED|Overall Study||7
495202|NCT00331773|1187457|P1|NOT COMPLETED|Overall Study||16
495203|NCT00331773|1187456|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
495204|NCT00331773|1187457|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
495205|NCT00331773|1187456|P2|STARTED|Overall Study||557
495206|NCT00331773|1187457|P1|STARTED|Overall Study||558
495207|NCT00331760|1187485|P2|NOT COMPLETED|Overall Study||8
495208|NCT00331760|1187486|P1|NOT COMPLETED|Overall Study||15
495209|NCT00331760|1187485|P2|COMPLETED|Overall Study||40
495210|NCT00331760|1187486|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
495211|NCT00331760|1187485|P2|STARTED|Overall Study||48
495212|NCT00331760|1187486|P1|STARTED|Overall Study||58
495213|NCT00331682|1187492|P1|NOT COMPLETED|Overall Study||1
495214|NCT00331682|1187492|P1|COMPLETED|Overall Study||9
495215|NCT00331682|1187492|P1|STARTED|Overall Study||10
495216|NCT00331422|1187498|P1|NOT COMPLETED|Overall Study||5
495217|NCT00331422|1187498|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
495218|NCT00331422|1187498|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
495219|NCT00331409|1187507|P1|NOT COMPLETED|Overall Study||4
495220|NCT00331409|1187507|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
495221|NCT00331409|1187507|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
495222|NCT00331006|1187514|P1|NOT COMPLETED|Follow-Up Phase II||3
495223|NCT00331006|1187514|P1|COMPLETED|Follow-Up Phase II||11
495224|NCT00331006|1187514|P1|STARTED|Follow-Up Phase II||14
495225|NCT00331006|1187514|P1|NOT COMPLETED|Follow-Up Phase I||1
495226|NCT00331006|1187514|P1|COMPLETED|Follow-Up Phase I||14
495227|NCT00331006|1187514|P1|STARTED|Follow-Up Phase I||15
495228|NCT00331006|1187514|P1|NOT COMPLETED|Treatment Phase||1
495229|NCT00331006|1187514|P1|COMPLETED|Treatment Phase||15
495230|NCT00331006|1187514|P1|STARTED|Treatment Phase||16
495231|NCT00331006|1187514|P1|NOT COMPLETED|Screening Phase||7
495326|NCT00329849|1187744|P1|STARTED|Overall Study||950
495232|NCT00331006|1187514|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
495233|NCT00331006|1187514|P1|STARTED|Screening Phase||23
495234|NCT00330967|1187527|P2|NOT COMPLETED|Overall Study||14
495235|NCT00330967|1187528|P1|NOT COMPLETED|Overall Study||0
495236|NCT00330967|1187527|P2|COMPLETED|Overall Study||11
495237|NCT00330967|1187528|P1|COMPLETED|Overall Study||0
495238|NCT00330967|1187527|P2|STARTED|Overall Study||25
495239|NCT00330967|1187528|P1|STARTED|Overall Study||0
495240|NCT00330928|1187539|P1|NOT COMPLETED|Overall Study||17
495241|NCT00330928|1187539|P1|COMPLETED|Overall Study||89
495242|NCT00330928|1187539|P1|1 Year Phone Contact|Overall Study||89
495243|NCT00330928|1187539|P1|7 Day Phone Contact|Overall Study||99
495244|NCT00330928|1187539|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
495245|NCT00330915|1187544|P1|NOT COMPLETED|Overall Study||0
495246|NCT00330915|1187544|P1|COMPLETED|Overall Study||37
495247|NCT00330915|1187544|P1|STARTED|Overall Study||37
495248|NCT00330876|1187551|P2|NOT COMPLETED|Overall Study||13
495249|NCT00330876|1187552|P1|NOT COMPLETED|Overall Study||71
495250|NCT00330876|1187551|P2|COMPLETED|Overall Study||77
495251|NCT00330876|1187552|P1|COMPLETED|Overall Study||378
495252|NCT00330876|1187551|P2|STARTED|Overall Study||90
495253|NCT00330876|1187552|P1|STARTED|Overall Study||449
495254|NCT00330759|1187562|P2|NOT COMPLETED|Overall Study||706
495255|NCT00330759|1187563|P1|NOT COMPLETED|Overall Study||712
495256|NCT00330759|1187562|P2|COMPLETED|Overall Study||180
495257|NCT00330759|1187563|P1|COMPLETED|Overall Study||178
495258|NCT00330759|1187562|P2|Received Investigational Product|Overall Study||878
495259|NCT00330759|1187563|P1|Received Investigational Product|Overall Study||878
495260|NCT00330759|1187562|P2|STARTED|Overall Study||886
495261|NCT00330759|1187563|P1|STARTED|Overall Study||890
495262|NCT00330733|1187575|P2|NOT COMPLETED|Overall Study||5
495263|NCT00330733|1187576|P1|NOT COMPLETED|Overall Study||7
495264|NCT00330733|1187575|P2|COMPLETED|Overall Study||29
495265|NCT00330733|1187576|P1|COMPLETED|Overall Study||30
495266|NCT00330733|1187575|P2|Received Study Medication|Overall Study||34
495267|NCT00330733|1187576|P1|Received Study Medication|Overall Study||36
495268|NCT00330733|1187575|P2|STARTED|Overall Study||34
495269|NCT00330733|1187576|P1|STARTED|Overall Study||37
495270|NCT00330681|1187584|P2|NOT COMPLETED|Overall Study||14
495271|NCT00330681|1187585|P1|NOT COMPLETED|Overall Study||9
495272|NCT00330681|1187584|P2|COMPLETED|Overall Study||90
495273|NCT00330681|1187585|P1|COMPLETED|Overall Study||93
495274|NCT00330681|1187584|P2|STARTED|Overall Study||104
495275|NCT00330681|1187585|P1|STARTED|Overall Study||102
495276|NCT00330668|1187607|P1|NOT COMPLETED|Overall Study||114
495277|NCT00330668|1187607|P1|COMPLETED|Overall Study||0
495278|NCT00330668|1187607|P1|STARTED|Overall Study||114
495279|NCT00330616|1187614|P1|NOT COMPLETED|Overall Study||21
495280|NCT00330616|1187614|P1|COMPLETED|Overall Study||14
495281|NCT00330616|1187614|P1|STARTED|Overall Study||35
495282|NCT00330564|1187633|P1|NOT COMPLETED|Overall Study||0
495283|NCT00330564|1187633|P1|COMPLETED|Overall Study||15
495284|NCT00330564|1187633|P1|STARTED|Overall Study||15
495285|NCT00330460|1187640|P2|NOT COMPLETED|Overall Study||33
495286|NCT00330460|1187641|P1|NOT COMPLETED|Overall Study||42
495287|NCT00330460|1187640|P2|COMPLETED|Overall Study||561
495288|NCT00330460|1187641|P1|COMPLETED|Overall Study||553
495289|NCT00330460|1187640|P2|STARTED|Overall Study||594
495290|NCT00330460|1187641|P1|STARTED|Overall Study||595
495291|NCT00330421|1187655|P2|NOT COMPLETED|Overall Study||0
495292|NCT00330421|1187656|P1|NOT COMPLETED|Overall Study||0
495293|NCT00330421|1187655|P2|COMPLETED|Overall Study||0
495294|NCT00330421|1187656|P1|COMPLETED|Overall Study||15
495295|NCT00330421|1187655|P2|STARTED|Overall Study||0
495296|NCT00330421|1187656|P1|STARTED|Overall Study||15
495297|NCT00330382|1187662|P2|NOT COMPLETED|Overall Study||17
495298|NCT00330382|1187663|P1|NOT COMPLETED|Overall Study||24
495299|NCT00330382|1187662|P2|COMPLETED|Overall Study||48
495300|NCT00330382|1187663|P1|COMPLETED|Overall Study||43
495301|NCT00330382|1187662|P2|STARTED|Overall Study||65
495302|NCT00330382|1187663|P1|STARTED|Overall Study||67
495303|NCT00330174|1187686|P2|NOT COMPLETED|Overall Study||19
495304|NCT00330174|1187687|P1|NOT COMPLETED|Overall Study||22
495305|NCT00330174|1187686|P2|COMPLETED|Overall Study||26
495306|NCT00330174|1187687|P1|COMPLETED|Overall Study||23
495307|NCT00330174|1187686|P2|STARTED|Overall Study||45
495308|NCT00330174|1187687|P1|STARTED|Overall Study||45
495309|NCT00330161|1187699|P1|NOT COMPLETED|Overall Study||0
495310|NCT00330161|1187699|P1|COMPLETED|Overall Study||29
495311|NCT00330161|1187699|P1|STARTED|Overall Study||29
495312|NCT00329901|1187711|P3|NOT COMPLETED|Overall Study||4
495313|NCT00329901|1187712|P2|NOT COMPLETED|Overall Study||5
495314|NCT00329901|1187713|P1|NOT COMPLETED|Overall Study||9
495315|NCT00329901|1187711|P3|COMPLETED|Overall Study||353
495316|NCT00329901|1187712|P2|COMPLETED|Overall Study||349
495317|NCT00329901|1187713|P1|COMPLETED|Overall Study||352
495318|NCT00329901|1187711|P3|STARTED|Overall Study||357
495319|NCT00329901|1187712|P2|STARTED|Overall Study||354
495320|NCT00329901|1187713|P1|STARTED|Overall Study||361
495321|NCT00329849|1187743|P2|NOT COMPLETED|Overall Study||4
495322|NCT00329849|1187744|P1|NOT COMPLETED|Overall Study||6
495323|NCT00329849|1187743|P2|COMPLETED|Overall Study||546
495324|NCT00329849|1187744|P1|COMPLETED|Overall Study||944
495325|NCT00329849|1187743|P2|STARTED|Overall Study||550
495327|NCT00329836|1187764|P1|NOT COMPLETED|Overall Study||0
495328|NCT00329836|1187764|P1|COMPLETED|Overall Study||41
495329|NCT00329836|1187764|P1|STARTED|Overall Study||41
495330|NCT00329784|1187772|P4|NOT COMPLETED|Overall Study||0
495331|NCT00329784|1187773|P3|NOT COMPLETED|Overall Study||0
495332|NCT00329784|1187774|P2|NOT COMPLETED|Overall Study||5
495333|NCT00329784|1187775|P1|NOT COMPLETED|Overall Study||5
495334|NCT00329784|1187772|P4|COMPLETED|Overall Study||47
495335|NCT00329784|1187773|P3|COMPLETED|Overall Study||51
495336|NCT00329784|1187774|P2|COMPLETED|Overall Study||267
495337|NCT00329784|1187775|P1|COMPLETED|Overall Study||265
495338|NCT00329784|1187772|P4|STARTED|Overall Study||47
495339|NCT00329784|1187773|P3|STARTED|Overall Study||51
495340|NCT00329784|1187774|P2|STARTED|Overall Study||272
495341|NCT00329784|1187775|P1|STARTED|Overall Study||270
495342|NCT00329771|1187797|P1|NOT COMPLETED|Overall Study||3
495343|NCT00329771|1187797|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
495344|NCT00329771|1187797|P1|STARTED|Overall Study||28
495345|NCT00329745|1187803|P2|NOT COMPLETED|Overall Study||102
495346|NCT00329745|1187804|P1|NOT COMPLETED|Overall Study||87
495347|NCT00329745|1187803|P2|COMPLETED|Overall Study||4226
495348|NCT00329745|1187804|P1|COMPLETED|Overall Study||4272
495349|NCT00329745|1187803|P2|STARTED|Overall Study||4328
495350|NCT00329745|1187804|P1|STARTED|Overall Study||4359
495351|NCT00329732|1187814|P2|NOT COMPLETED|Overall Study||0
495352|NCT00329732|1187815|P1|NOT COMPLETED|Overall Study||0
495353|NCT00329732|1187814|P2|COMPLETED|Overall Study||0
495354|NCT00329732|1187815|P1|COMPLETED|Overall Study||2
495355|NCT00329732|1187814|P2|STARTED|Overall Study||0
495356|NCT00329732|1187815|P1|STARTED|Overall Study||2
495357|NCT00329719|1187824|P4|NOT COMPLETED|Overall Study||1
495358|NCT00329719|1187825|P3|NOT COMPLETED|Overall Study||0
495359|NCT00329719|1187826|P2|NOT COMPLETED|Overall Study||0
495360|NCT00329719|1187827|P1|NOT COMPLETED|Overall Study||0
495361|NCT00329719|1187824|P4|COMPLETED|Overall Study||44
495362|NCT00329719|1187825|P3|COMPLETED|Overall Study||9
495363|NCT00329719|1187826|P2|COMPLETED|Overall Study||49
495364|NCT00329719|1187827|P1|COMPLETED|Overall Study||12
495365|NCT00329719|1187824|P4|STARTED|Overall Study||45
495366|NCT00329719|1187825|P3|STARTED|Overall Study||9
495367|NCT00329719|1187826|P2|STARTED|Overall Study||49
495368|NCT00329719|1187827|P1|STARTED|Overall Study||12
495369|NCT00329641|1187849|P1|NOT COMPLETED|Overall Study||6
495370|NCT00329641|1187849|P1|COMPLETED|Overall Study||19
495371|NCT00329641|1187849|P1|Eligible and Received Treatment|Overall Study||24
495372|NCT00329641|1187849|P1|Eligible|Overall Study||25
495373|NCT00329641|1187849|P1|STARTED|Overall Study||25
495374|NCT00329602|1187858|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
495375|NCT00329602|1187859|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
495376|NCT00329602|1187860|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
495377|NCT00329602|1187858|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
495378|NCT00329602|1187859|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
495379|NCT00329602|1187860|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
495380|NCT00329602|1187858|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
495381|NCT00329602|1187859|P2|STARTED|40-Week Open-Label Treatment Phase||0
495382|NCT00329602|1187860|P1|STARTED|40-Week Open-Label Treatment Phase||0
495383|NCT00329602|1187858|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
495384|NCT00329602|1187859|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
495385|NCT00329602|1187860|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
495386|NCT00329602|1187858|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
495387|NCT00329602|1187859|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
495388|NCT00329602|1187860|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
495389|NCT00329602|1187858|P3|STARTED|26-Week Double-Blind Treatment Phase||0
495390|NCT00329602|1187859|P2|STARTED|26-Week Double-Blind Treatment Phase||197
495391|NCT00329602|1187860|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
495392|NCT00329550|1187898|P3|NOT COMPLETED|Overall Study||4
495393|NCT00329550|1187899|P2|NOT COMPLETED|Overall Study||4
495394|NCT00329550|1187900|P1|NOT COMPLETED|Overall Study||4
495395|NCT00329550|1187898|P3|COMPLETED|Overall Study||12
495396|NCT00329550|1187899|P2|COMPLETED|Overall Study||11
495397|NCT00329550|1187900|P1|COMPLETED|Overall Study||5
495398|NCT00329550|1187898|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
495399|NCT00329550|1187899|P2|STARTED|Overall Study||15
495400|NCT00329550|1187900|P1|STARTED|Overall Study||9
495401|NCT00329524|1188147|P1|NOT COMPLETED|Overall Study||0
495402|NCT00329524|1188147|P1|COMPLETED|Overall Study||5
495403|NCT00329524|1188147|P1|STARTED|Overall Study||5
495404|NCT00329433|1188155|P2|NOT COMPLETED|Overall Study||0
495405|NCT00329433|1188156|P1|NOT COMPLETED|Overall Study||0
495406|NCT00329433|1188155|P2|COMPLETED|Overall Study||59
495407|NCT00329433|1188156|P1|COMPLETED|Overall Study||61
495408|NCT00329433|1188155|P2|STARTED|Overall Study||59
495409|NCT00329433|1188156|P1|STARTED|Overall Study||61
495410|NCT00329420|1188165|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
495411|NCT00329420|1188166|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
495412|NCT00329420|1188167|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
495413|NCT00329420|1188165|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
495414|NCT00329420|1188166|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
495415|NCT00329420|1188167|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
495416|NCT00329420|1188165|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
495417|NCT00329420|1188166|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
495418|NCT00329420|1188167|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
495419|NCT00329420|1188165|P3|NOT COMPLETED|Re-induction Phase||8
495420|NCT00329420|1188166|P2|NOT COMPLETED|Re-induction Phase||6
495421|NCT00329420|1188167|P1|NOT COMPLETED|Re-induction Phase||6
495422|NCT00329420|1188165|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
495423|NCT00329420|1188166|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
495424|NCT00329420|1188167|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
495425|NCT00329420|1188165|P3|STARTED|Re-induction Phase||15
495426|NCT00329420|1188166|P2|STARTED|Re-induction Phase||13
495427|NCT00329420|1188167|P1|STARTED|Re-induction Phase||18
495428|NCT00329407|1188546|P1|NOT COMPLETED|Overall Study||1
495429|NCT00329407|1188546|P1|COMPLETED|Overall Study||9
495430|NCT00329407|1188546|P1|STARTED|Overall Study||10
495431|NCT00329238|1188553|P2|NOT COMPLETED|Overall Study||281
495432|NCT00329238|1188554|P1|NOT COMPLETED|Overall Study||276
495433|NCT00329238|1188553|P2|COMPLETED|Overall Study||1145
495434|NCT00329238|1188554|P1|COMPLETED|Overall Study||1154
495435|NCT00329238|1188553|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
495436|NCT00329238|1188554|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
495437|NCT00329160|1188590|P1|NOT COMPLETED|Overall Study||88
495438|NCT00329160|1188590|P1|COMPLETED|Overall Study||126
495439|NCT00329160|1188590|P1|Treatment Period|Overall Study||214
495440|NCT00329160|1188590|P1|Observation Period|Overall Study||214
495441|NCT00329160|1188590|P1|STARTED|Overall Study||214
495442|NCT00329108|1188599|P2|NOT COMPLETED|Overall Study||12
495443|NCT00329108|1188600|P1|NOT COMPLETED|Overall Study||10
495444|NCT00329108|1188599|P2|COMPLETED|Overall Study||2
495445|NCT00329108|1188600|P1|COMPLETED|Overall Study||5
495446|NCT00329108|1188599|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
495447|NCT00329108|1188600|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
495448|NCT00329030|1188608|P2|NOT COMPLETED|Overall Study||6
495449|NCT00329030|1188609|P1|NOT COMPLETED|Overall Study||8
495450|NCT00329030|1188608|P2|COMPLETED|Overall Study||107
495451|NCT00329030|1188609|P1|COMPLETED|Overall Study||103
495452|NCT00329030|1188608|P2|STARTED|Overall Study||113
495453|NCT00329030|1188609|P1|STARTED|Overall Study||111
495454|NCT00328926|1188640|P3|NOT COMPLETED|Overall Study||2
495455|NCT00328926|1188641|P2|NOT COMPLETED|Overall Study||3
495456|NCT00328926|1188642|P1|NOT COMPLETED|Overall Study||2
495457|NCT00328926|1188640|P3|COMPLETED|Overall Study||1
495458|NCT00328926|1188641|P2|COMPLETED|Overall Study||0
495459|NCT00328926|1188642|P1|COMPLETED|Overall Study||3
495460|NCT00328926|1188640|P3|STARTED|Overall Study||3
495461|NCT00328926|1188641|P2|STARTED|Overall Study||3
495462|NCT00328926|1188642|P1|STARTED|Overall Study||5
495463|NCT00328861|1188658|P2|NOT COMPLETED|Overall Study||0
495464|NCT00328861|1188659|P1|NOT COMPLETED|Overall Study||0
495465|NCT00328861|1188658|P2|COMPLETED|Overall Study||1
495466|NCT00328861|1188659|P1|COMPLETED|Overall Study||7
495467|NCT00328861|1188658|P2|STARTED|Overall Study||1
495468|NCT00328861|1188659|P1|STARTED|Overall Study||7
495469|NCT00328783|1188667|P1|NOT COMPLETED|Overall Study||26
495470|NCT00328783|1188667|P1|COMPLETED|Overall Study||86
495471|NCT00328783|1188667|P1|STARTED|Overall Study||112
495472|NCT00328770|1188672|P1|NOT COMPLETED|Overall Study||0
495473|NCT00328770|1188672|P1|COMPLETED|Overall Study||70
495474|NCT00328770|1188672|P1|STARTED|Overall Study||70
495475|NCT00328627|1188690|P12|NOT COMPLETED|Overall Study||16
495476|NCT00328627|1188691|P11|NOT COMPLETED|Overall Study||18
495477|NCT00328627|1188692|P10|NOT COMPLETED|Overall Study||32
495478|NCT00328627|1188693|P9|NOT COMPLETED|Overall Study||17
495479|NCT00328627|1188694|P8|NOT COMPLETED|Overall Study||14
495480|NCT00328627|1188695|P7|NOT COMPLETED|Overall Study||35
495481|NCT00328627|1188696|P6|NOT COMPLETED|Overall Study||20
495482|NCT00328627|1188697|P5|NOT COMPLETED|Overall Study||15
495483|NCT00328627|1188698|P4|NOT COMPLETED|Overall Study||37
495484|NCT00328627|1188699|P3|NOT COMPLETED|Overall Study||28
495485|NCT00328627|1188700|P2|NOT COMPLETED|Overall Study||31
495486|NCT00328627|1188701|P1|NOT COMPLETED|Overall Study||59
495487|NCT00328627|1188690|P12|COMPLETED|Overall Study||114
495488|NCT00328627|1188691|P11|COMPLETED|Overall Study||112
495489|NCT00328627|1188692|P10|COMPLETED|Overall Study||97
495490|NCT00328627|1188693|P9|COMPLETED|Overall Study||113
495491|NCT00328627|1188694|P8|COMPLETED|Overall Study||116
495492|NCT00328627|1188695|P7|COMPLETED|Overall Study||94
495493|NCT00328627|1188696|P6|COMPLETED|Overall Study||110
495494|NCT00328627|1188697|P5|COMPLETED|Overall Study||115
495495|NCT00328627|1188698|P4|COMPLETED|Overall Study||93
495496|NCT00328627|1188699|P3|COMPLETED|Overall Study||101
495497|NCT00328627|1188700|P2|COMPLETED|Overall Study||97
495498|NCT00328627|1188701|P1|COMPLETED|Overall Study||70
495499|NCT00328627|1188690|P12|Safety Set|Overall Study||130
495500|NCT00328627|1188691|P11|Safety Set|Overall Study||130
495501|NCT00328627|1188692|P10|Safety Set|Overall Study||129
495502|NCT00328627|1188693|P9|Safety Set|Overall Study||130
495503|NCT00328627|1188694|P8|Safety Set|Overall Study||130
495504|NCT00328627|1188695|P7|Safety Set|Overall Study||129
495505|NCT00328627|1188696|P6|Safety Set|Overall Study||130
495506|NCT00328627|1188697|P5|Safety Set|Overall Study||130
495507|NCT00328627|1188698|P4|Safety Set|Overall Study||129
495508|NCT00328627|1188699|P3|Safety Set|Overall Study||129
495509|NCT00328627|1188700|P2|Safety Set|Overall Study||128
495510|NCT00328627|1188701|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
495511|NCT00328627|1188690|P12|STARTED|Overall Study||130
495512|NCT00328627|1188691|P11|STARTED|Overall Study||130
495513|NCT00328627|1188692|P10|STARTED|Overall Study||129
495514|NCT00328627|1188693|P9|STARTED|Overall Study||130
495515|NCT00328627|1188694|P8|STARTED|Overall Study||130
495516|NCT00328627|1188695|P7|STARTED|Overall Study||129
495517|NCT00328627|1188696|P6|STARTED|Overall Study||130
495518|NCT00328627|1188697|P5|STARTED|Overall Study||130
495519|NCT00328627|1188698|P4|STARTED|Overall Study||130
495520|NCT00328627|1188699|P3|STARTED|Overall Study||129
495521|NCT00328627|1188700|P2|STARTED|Overall Study||128
495522|NCT00328627|1188701|P1|STARTED|Overall Study||129
495523|NCT00328614|1190224|P6|NOT COMPLETED|Overall Study||1
495524|NCT00328614|1190225|P5|NOT COMPLETED|Overall Study||1
495525|NCT00328614|1190226|P4|NOT COMPLETED|Overall Study||1
495526|NCT00328614|1190227|P3|NOT COMPLETED|Overall Study||0
495527|NCT00328614|1190228|P2|NOT COMPLETED|Overall Study||0
495528|NCT00328614|1190229|P1|NOT COMPLETED|Overall Study||0
495529|NCT00328614|1190224|P6|COMPLETED|Overall Study||5
495530|NCT00328614|1190225|P5|COMPLETED|Overall Study||5
495531|NCT00328614|1190226|P4|COMPLETED|Overall Study||5
495532|NCT00328614|1190227|P3|COMPLETED|Overall Study||6
495533|NCT00328614|1190228|P2|COMPLETED|Overall Study||4
495534|NCT00328614|1190229|P1|COMPLETED|Overall Study||4
495535|NCT00328614|1190224|P6|STARTED|Overall Study||6
495536|NCT00328614|1190225|P5|STARTED|Overall Study||6
495537|NCT00328614|1190226|P4|STARTED|Overall Study||6
495538|NCT00328614|1190227|P3|STARTED|Overall Study||6
495539|NCT00328614|1190228|P2|STARTED|Overall Study||4
495540|NCT00328614|1190229|P1|STARTED|Overall Study||4
495541|NCT00328562|1190238|P1|NOT COMPLETED|Overall Study||1
495542|NCT00328562|1190238|P1|COMPLETED|Overall Study||12
495543|NCT00328562|1190238|P1|STARTED|Overall Study||13
495544|NCT00328510|1190247|P2|NOT COMPLETED|Overall Study||4
495545|NCT00328510|1190248|P1|NOT COMPLETED|Overall Study||10
495546|NCT00328510|1190247|P2|COMPLETED|Overall Study||37
495547|NCT00328510|1190248|P1|COMPLETED|Overall Study||32
495548|NCT00328510|1190247|P2|STARTED|Overall Study||41
495549|NCT00328510|1190248|P1|STARTED|Overall Study||42
495550|NCT00328263|1190256|P2|NOT COMPLETED|Overall Study||4
495551|NCT00328263|1190257|P1|NOT COMPLETED|Overall Study||3
495552|NCT00328263|1190256|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
495553|NCT00328263|1190257|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
495554|NCT00328263|1190256|P2|STARTED|Overall Study||221
495555|NCT00328263|1190257|P1|STARTED|Overall Study||216
495556|NCT00328198|1190263|P1|NOT COMPLETED|Follow-up||35
495557|NCT00328198|1190263|P1|COMPLETED|Follow-up||43
495558|NCT00328198|1190263|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
495559|NCT00328198|1190263|P1|NOT COMPLETED|Treatment||38
495560|NCT00328198|1190263|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
495561|NCT00328198|1190263|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
495562|NCT00328172|1190278|P5|NOT COMPLETED|Overall Study||5
495563|NCT00328172|1190279|P4|NOT COMPLETED|Overall Study||13
495564|NCT00328172|1190280|P3|NOT COMPLETED|Overall Study||10
495565|NCT00328172|1190281|P2|NOT COMPLETED|Overall Study||14
495566|NCT00328172|1190282|P1|NOT COMPLETED|Overall Study||22
495567|NCT00328172|1190278|P5|COMPLETED|Overall Study||60
495568|NCT00328172|1190279|P4|COMPLETED|Overall Study||42
495569|NCT00328172|1190280|P3|COMPLETED|Overall Study||47
495570|NCT00328172|1190281|P2|COMPLETED|Overall Study||44
495571|NCT00328172|1190282|P1|COMPLETED|Overall Study||45
495572|NCT00328172|1190278|P5|STARTED|Overall Study||65
495573|NCT00328172|1190279|P4|STARTED|Overall Study||55
495574|NCT00328172|1190280|P3|STARTED|Overall Study||57
495575|NCT00328172|1190281|P2|STARTED|Overall Study||58
495576|NCT00328172|1190282|P1|STARTED|Overall Study||67
495577|NCT00328094|1190306|P2|NOT COMPLETED|Overall Study||3
495578|NCT00328094|1190307|P1|NOT COMPLETED|Overall Study||3
495579|NCT00328094|1190306|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
495580|NCT00328094|1190307|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
495581|NCT00328094|1190306|P2|STARTED|Overall Study||125
495582|NCT00328094|1190307|P1|STARTED|Overall Study||117
495583|NCT00328042|1190317|P2|NOT COMPLETED|Overall Study||2
495584|NCT00328042|1190318|P1|NOT COMPLETED|Overall Study||0
495585|NCT00328042|1190317|P2|COMPLETED|Overall Study||63
495586|NCT00328042|1190318|P1|COMPLETED|Overall Study||69
495587|NCT00328042|1190317|P2|STARTED|Overall Study||65
495588|NCT00328042|1190318|P1|STARTED|Overall Study||69
495589|NCT00327717|1190328|P2|NOT COMPLETED|Overall Study||14
495590|NCT00327717|1190329|P1|NOT COMPLETED|Overall Study||9
495591|NCT00327717|1190328|P2|COMPLETED|Overall Study||106
495592|NCT00327717|1190329|P1|COMPLETED|Overall Study||111
495593|NCT00327717|1190328|P2|STARTED|Overall Study||120
495594|NCT00327717|1190329|P1|STARTED|Overall Study||120
495595|NCT00327470|1190355|P2|NOT COMPLETED|Overall Study||63
495596|NCT00327470|1190356|P1|NOT COMPLETED|Overall Study||29
495597|NCT00327470|1190355|P2|COMPLETED|Overall Study||118
495598|NCT00327470|1190356|P1|COMPLETED|Overall Study||78
495599|NCT00327470|1190355|P2|Treated|Overall Study||179
495600|NCT00327470|1190356|P1|Treated|Overall Study||107
495601|NCT00327470|1190355|P2|STARTED|Overall Study||181
495602|NCT00327470|1190356|P1|STARTED|Overall Study||107
495603|NCT00327444|1190376|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
495604|NCT00327444|1190377|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
495605|NCT00327444|1190376|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
495606|NCT00327444|1190377|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
495607|NCT00327444|1190376|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
495608|NCT00327444|1190377|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
495609|NCT00327444|1190376|P2|STARTED|Open Label Treatment (OL) Period||10
495610|NCT00327444|1190377|P1|STARTED|Open Label Treatment (OL) Period||11
495611|NCT00327444|1190376|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
495612|NCT00327444|1190377|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
495613|NCT00327444|1190376|P2|COMPLETED|Double Blind Treatment (DB) Period||0
495614|NCT00327444|1190377|P1|COMPLETED|Double Blind Treatment (DB) Period||0
495615|NCT00327444|1190376|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
495616|NCT00327444|1190377|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
495617|NCT00327444|1190376|P2|STARTED|Double Blind Treatment (DB) Period||29
495618|NCT00327444|1190377|P1|STARTED|Double Blind Treatment (DB) Period||26
495619|NCT00327392|1190389|P1|NOT COMPLETED|Overall Study||0
495620|NCT00327392|1190389|P1|COMPLETED|Overall Study||123
495621|NCT00327392|1190389|P1|STARTED|Overall Study||123
495622|NCT00327340|1190395|P2|NOT COMPLETED|Overall Study||30
495623|NCT00327340|1190396|P1|NOT COMPLETED|Overall Study||15
495624|NCT00327340|1190395|P2|COMPLETED|Overall Study||16
495625|NCT00327340|1190396|P1|COMPLETED|Overall Study||8
495626|NCT00327340|1190395|P2|STARTED|Overall Study||46
495627|NCT00327340|1190396|P1|STARTED|Overall Study||23
495628|NCT00327171|1190410|P2|NOT COMPLETED|Overall Study||109
495629|NCT00327171|1190411|P1|NOT COMPLETED|Overall Study||108
495630|NCT00327171|1190410|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
495631|NCT00327171|1190411|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
495632|NCT00327171|1190410|P2|STARTED|Overall Study||109
495633|NCT00327171|1190411|P1|STARTED|Overall Study||109
495634|NCT00327015|1190443|P4|NOT COMPLETED|Overall Study||109
495635|NCT00327015|1190444|P3|NOT COMPLETED|Overall Study||126
495636|NCT00327015|1190445|P2|NOT COMPLETED|Overall Study||92
495637|NCT00327015|1190446|P1|NOT COMPLETED|Overall Study||91
495638|NCT00327015|1190443|P4|COMPLETED|Overall Study||219
495639|NCT00327015|1190444|P3|COMPLETED|Overall Study||209
495640|NCT00327015|1190445|P2|COMPLETED|Overall Study||231
495641|NCT00327015|1190446|P1|COMPLETED|Overall Study||229
495642|NCT00327015|1190443|P4|Completed Study Without Being Rescued|Overall Study||144
495643|NCT00327015|1190444|P3|Completed Study Without Being Rescued|Overall Study||113
495644|NCT00327015|1190445|P2|Completed Study Without Being Rescued|Overall Study||177
495645|NCT00327015|1190446|P1|Completed Study Without Being Rescued|Overall Study||179
495646|NCT00327015|1190443|P4|STARTED|Overall Study||328
495647|NCT00327015|1190444|P3|STARTED|Overall Study||335
495648|NCT00327015|1190445|P2|STARTED|Overall Study||323
495649|NCT00327015|1190446|P1|STARTED|Overall Study||320
495650|NCT00326963|1190488|P1|NOT COMPLETED|Overall Study||33
495651|NCT00326963|1190488|P1|COMPLETED|Overall Study||107
495652|NCT00326963|1190488|P1|STARTED|Overall Study||140
495653|NCT00326950|1190508|P1|NOT COMPLETED|Overall Study||1
495654|NCT00326950|1190508|P1|COMPLETED|Overall Study||14
495655|NCT00326950|1190508|P1|STARTED|Overall Study||15
495656|NCT00326911|1190515|P2|NOT COMPLETED|Overall Study||2
495657|NCT00326911|1190516|P1|NOT COMPLETED|Overall Study||1
495658|NCT00326911|1190515|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
495659|NCT00326911|1190516|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
495660|NCT00326911|1190515|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
495661|NCT00326911|1190516|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
495662|NCT00326898|1190569|P3|NOT COMPLETED|Overall Study||203
495663|NCT00326898|1190570|P2|NOT COMPLETED|Overall Study||343
495664|NCT00326898|1190571|P1|NOT COMPLETED|Overall Study||351
495665|NCT00326898|1190569|P3|COMPLETED|Overall Study||444
495666|NCT00326898|1190570|P2|COMPLETED|Overall Study||306
495667|NCT00326898|1190571|P1|COMPLETED|Overall Study||296
495668|NCT00326898|1190569|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
495669|NCT00326898|1190570|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
495670|NCT00326898|1190571|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
495671|NCT00326898|1190569|P3|Patients With Clear Cell Histology|Overall Study||540
495672|NCT00326898|1190570|P2|Patients With Clear Cell Histology|Overall Study||540
495673|NCT00326898|1190571|P1|Patients With Clear Cell Histology|Overall Study||542
495674|NCT00326898|1190569|P3|Patients With Toxicity Data|Overall Study||626
495675|NCT00326898|1190570|P2|Patients With Toxicity Data|Overall Study||628
495676|NCT00326898|1190571|P1|Patients With Toxicity Data|Overall Study||625
495677|NCT00326898|1190569|P3|STARTED|Overall Study||647
495678|NCT00326898|1190570|P2|STARTED|Overall Study||649
495679|NCT00326898|1190571|P1|STARTED|Overall Study||647
495680|NCT00326885|1190588|P1|NOT COMPLETED|Overall Study||7
495681|NCT00326885|1190588|P1|COMPLETED|Overall Study||25
495682|NCT00326885|1190588|P1|STARTED|Overall Study||32
495683|NCT00326872|1190597|P1|NOT COMPLETED|Overall Study||0
495684|NCT00326872|1190597|P1|COMPLETED|Overall Study||26
495685|NCT00326872|1190597|P1|STARTED|Overall Study||26
495686|NCT00326781|1190608|P2|NOT COMPLETED|Overall Study||32
495687|NCT00326781|1190609|P1|NOT COMPLETED|Overall Study||42
495688|NCT00326781|1190608|P2|COMPLETED|Overall Study||298
495689|NCT00326781|1190609|P1|COMPLETED|Overall Study||302
495690|NCT00326781|1190608|P2|STARTED|Overall Study||330
495691|NCT00326781|1190609|P1|STARTED|Overall Study||344
495692|NCT00326716|1190619|P4|NOT COMPLETED|Infants||0
495693|NCT00326716|1190620|P3|NOT COMPLETED|Infants||0
495694|NCT00326716|1190621|P2|NOT COMPLETED|Infants||0
495695|NCT00326716|1190622|P1|NOT COMPLETED|Infants||0
495696|NCT00326716|1190619|P4|COMPLETED|Infants||20
495697|NCT00326716|1190620|P3|COMPLETED|Infants||20
495698|NCT00326716|1190621|P2|COMPLETED|Infants||0
495699|NCT00326716|1190622|P1|COMPLETED|Infants||0
495700|NCT00326716|1190619|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
495701|NCT00326716|1190620|P3|STARTED|Infants|All infants were followed.|20
495702|NCT00326716|1190621|P2|STARTED|Infants||0
495703|NCT00326716|1190622|P1|STARTED|Infants||0
495704|NCT00326716|1190619|P4|NOT COMPLETED|Pre-Natal Mothers||0
495705|NCT00326716|1190620|P3|NOT COMPLETED|Pre-Natal Mothers||0
495706|NCT00326716|1190621|P2|NOT COMPLETED|Pre-Natal Mothers||2
495707|NCT00326716|1190622|P1|NOT COMPLETED|Pre-Natal Mothers||1
495708|NCT00326716|1190619|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
495709|NCT00326716|1190620|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
495710|NCT00326716|1190621|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
495711|NCT00326716|1190622|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
495712|NCT00326716|1190619|P4|STARTED|Pre-Natal Mothers||0
495713|NCT00326716|1190620|P3|STARTED|Pre-Natal Mothers||0
495714|NCT00326716|1190621|P2|STARTED|Pre-Natal Mothers||21
495715|NCT00326716|1190622|P1|STARTED|Pre-Natal Mothers||20
495716|NCT00326612|1190694|P2|NOT COMPLETED|Overall Study||137
495717|NCT00326612|1190695|P1|NOT COMPLETED|Overall Study||129
495718|NCT00326612|1190694|P2|COMPLETED|Overall Study||42
495719|NCT00326612|1190695|P1|COMPLETED|Overall Study||50
495720|NCT00326612|1190694|P2|STARTED|Overall Study||179
495721|NCT00326612|1190695|P1|STARTED|Overall Study||179
495722|NCT00326599|1190717|P4|NOT COMPLETED|Overall Study||19
495723|NCT00326599|1190718|P3|NOT COMPLETED|Overall Study||53
495724|NCT00326599|1190719|P2|NOT COMPLETED|Overall Study||1
495725|NCT00326599|1190720|P1|NOT COMPLETED|Overall Study||6
495726|NCT00326599|1190717|P4|COMPLETED|Overall Study||10
495727|NCT00326599|1190718|P3|COMPLETED|Overall Study||5
495728|NCT00326599|1190719|P2|COMPLETED|Overall Study||2
495729|NCT00326599|1190720|P1|COMPLETED|Overall Study||0
495730|NCT00326599|1190717|P4|STARTED|Overall Study||29
495731|NCT00326599|1190718|P3|STARTED|Overall Study||58
495732|NCT00326599|1190719|P2|STARTED|Overall Study||3
495733|NCT00326599|1190720|P1|STARTED|Overall Study||6
495734|NCT00326495|1190739|P1|NOT COMPLETED|Overall Study||5
495735|NCT00326495|1190739|P1|COMPLETED|Overall Study||46
495736|NCT00326495|1190739|P1|STARTED|Overall Study||51
495737|NCT00326417|1190746|P4|NOT COMPLETED|Overall Study||3
495738|NCT00326417|1190747|P3|NOT COMPLETED|Overall Study||1
495739|NCT00326417|1190748|P2|NOT COMPLETED|Overall Study||0
495740|NCT00326417|1190749|P1|NOT COMPLETED|Overall Study||14
495741|NCT00326417|1190746|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
495742|NCT00326417|1190747|P3|COMPLETED|Overall Study||38
495743|NCT00326417|1190748|P2|COMPLETED|Overall Study||41
495744|NCT00326417|1190749|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
495745|NCT00326417|1190746|P4|Phase II|Overall Study||0
495746|NCT00326417|1190747|P3|Phase II|Overall Study||33
495747|NCT00326417|1190748|P2|Phase II|Overall Study||35
495748|NCT00326417|1190749|P1|Phase II|Overall Study||8
495749|NCT00326417|1190746|P4|Phase I|Overall Study||3
495750|NCT00326417|1190747|P3|Phase I|Overall Study||6
495751|NCT00326417|1190748|P2|Phase I|Overall Study||6
495752|NCT00326417|1190749|P1|Phase I|Overall Study||6
495753|NCT00326417|1190746|P4|STARTED|Overall Study||3
495754|NCT00326417|1190747|P3|STARTED|Overall Study||39
495755|NCT00326417|1190748|P2|STARTED|Overall Study||41
495756|NCT00326417|1190749|P1|STARTED|Overall Study||14
495757|NCT00326196|1190767|P2|NOT COMPLETED|Overall Study||0
495758|NCT00326196|1190768|P1|NOT COMPLETED|Overall Study||0
495759|NCT00326196|1190767|P2|COMPLETED|Overall Study||97
495760|NCT00326196|1190768|P1|COMPLETED|Overall Study||101
495761|NCT00326196|1190767|P2|STARTED|Overall Study||97
495762|NCT00326196|1190768|P1|STARTED|Overall Study||101
495763|NCT00326183|1190776|P2|NOT COMPLETED|Overall Study||83
495764|NCT00326183|1190777|P1|NOT COMPLETED|Overall Study||200
495765|NCT00326183|1190776|P2|COMPLETED|Overall Study||264
495766|NCT00326183|1190777|P1|COMPLETED|Overall Study||1253
495767|NCT00326183|1190776|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
495768|NCT00326183|1190777|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
495769|NCT00326183|1190776|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
495770|NCT00326183|1190777|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
495771|NCT00326183|1190776|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
495772|NCT00326183|1190777|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
495773|NCT00326183|1190776|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
495774|NCT00326183|1190777|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
495775|NCT00326183|1190776|P2|STARTED|Overall Study||347
495776|NCT00326183|1190777|P1|STARTED|Overall Study||1453
495777|NCT00326170|1190803|P1|NOT COMPLETED|Overall Study||0
495778|NCT00326170|1190803|P1|COMPLETED|Overall Study||34
495779|NCT00326170|1190803|P1|STARTED|Overall Study||34
495780|NCT00326118|1190809|P2|NOT COMPLETED|Year 5 Follow up||0
495781|NCT00326118|1190810|P1|NOT COMPLETED|Year 5 Follow up||0
495782|NCT00326118|1190809|P2|COMPLETED|Year 5 Follow up||78
495783|NCT00326118|1190810|P1|COMPLETED|Year 5 Follow up||217
495784|NCT00326118|1190809|P2|STARTED|Year 5 Follow up||78
495785|NCT00326118|1190810|P1|STARTED|Year 5 Follow up||217
495786|NCT00326118|1190809|P2|NOT COMPLETED|Year 4 Follow-up||0
495787|NCT00326118|1190810|P1|NOT COMPLETED|Year 4 Follow-up||0
495788|NCT00326118|1190809|P2|COMPLETED|Year 4 Follow-up||80
495789|NCT00326118|1190810|P1|COMPLETED|Year 4 Follow-up||228
495790|NCT00326118|1190809|P2|STARTED|Year 4 Follow-up||80
495791|NCT00326118|1190810|P1|STARTED|Year 4 Follow-up||228
495792|NCT00326118|1190809|P2|NOT COMPLETED|Year 3 Follow-up||0
495793|NCT00326118|1190810|P1|NOT COMPLETED|Year 3 Follow-up||0
495794|NCT00326118|1190809|P2|COMPLETED|Year 3 Follow-up||89
495795|NCT00326118|1190810|P1|COMPLETED|Year 3 Follow-up||256
495796|NCT00326118|1190809|P2|STARTED|Year 3 Follow-up||89
495797|NCT00326118|1190810|P1|STARTED|Year 3 Follow-up||256
495798|NCT00326118|1190809|P2|NOT COMPLETED|Year 2 Follow-up||0
495799|NCT00326118|1190810|P1|NOT COMPLETED|Year 2 Follow-up||0
495800|NCT00326118|1190809|P2|COMPLETED|Year 2 Follow-up||92
495801|NCT00326118|1190810|P1|COMPLETED|Year 2 Follow-up||270
495802|NCT00326118|1190809|P2|STARTED|Year 2 Follow-up||92
495803|NCT00326118|1190810|P1|STARTED|Year 2 Follow-up||270
495804|NCT00326118|1190809|P2|NOT COMPLETED|Year 1 Follow-up||0
495805|NCT00326118|1190810|P1|NOT COMPLETED|Year 1 Follow-up||0
495806|NCT00326118|1190809|P2|COMPLETED|Year 1 Follow-up||100
495807|NCT00326118|1190810|P1|COMPLETED|Year 1 Follow-up||295
495808|NCT00326118|1190809|P2|STARTED|Year 1 Follow-up||100
495809|NCT00326118|1190810|P1|STARTED|Year 1 Follow-up||295
495810|NCT00326118|1190809|P2|NOT COMPLETED|Active Phase||1
495811|NCT00326118|1190810|P1|NOT COMPLETED|Active Phase||4
495812|NCT00326118|1190809|P2|COMPLETED|Active Phase||108
495813|NCT00326118|1190810|P1|COMPLETED|Active Phase||320
495814|NCT00326118|1190809|P2|STARTED|Active Phase||109
495815|NCT00326118|1190810|P1|STARTED|Active Phase||324
495816|NCT00326001|1190846|P2|NOT COMPLETED|Overall Study||8
495817|NCT00326001|1190847|P1|NOT COMPLETED|Overall Study||7
495818|NCT00326001|1190846|P2|COMPLETED|Overall Study||219
495819|NCT00326001|1190847|P1|COMPLETED|Overall Study||229
495820|NCT00326001|1190846|P2|STARTED|Overall Study||227
495821|NCT00326001|1190847|P1|STARTED|Overall Study||236
495822|NCT00325897|1190861|P2|NOT COMPLETED|Overall Study||13
495823|NCT00325897|1190862|P1|NOT COMPLETED|Overall Study||12
495824|NCT00325897|1190861|P2|COMPLETED|Overall Study||559
495825|NCT00325897|1190862|P1|COMPLETED|Overall Study||558
495826|NCT00325897|1190861|P2|STARTED|Overall Study||572
495827|NCT00325897|1190862|P1|STARTED|Overall Study||570
495828|NCT00325819|1190882|P2|NOT COMPLETED|Overall Study||13
495829|NCT00325819|1190883|P1|NOT COMPLETED|Overall Study||9
495830|NCT00325819|1190882|P2|COMPLETED|Overall Study||176
495831|NCT00325819|1190883|P1|COMPLETED|Overall Study||176
495832|NCT00325819|1190882|P2|STARTED|Overall Study||189
495833|NCT00325819|1190883|P1|STARTED|Overall Study||185
495834|NCT00325780|1190903|P1|NOT COMPLETED|Overall Study||155
495835|NCT00325780|1190903|P1|COMPLETED|Overall Study||1200
495836|NCT00325780|1190903|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
495837|NCT00325780|1190903|P1|STARTED|Overall Study||1355
495838|NCT00325754|1190910|P2|NOT COMPLETED|Overall Study||1
495839|NCT00325754|1190911|P1|NOT COMPLETED|Overall Study||4
495840|NCT00325754|1190910|P2|COMPLETED|Overall Study||10
495841|NCT00325754|1190911|P1|COMPLETED|Overall Study||7
495842|NCT00325754|1190910|P2|STARTED|Overall Study||11
495843|NCT00325754|1190911|P1|STARTED|Overall Study||11
495844|NCT00325598|1190927|P2|NOT COMPLETED|Overall Study||0
495845|NCT00325598|1190928|P1|NOT COMPLETED|Overall Study||0
495846|NCT00325598|1190927|P2|COMPLETED|Overall Study||50
495847|NCT00325598|1190928|P1|COMPLETED|Overall Study||50
495848|NCT00325598|1190927|P2|STARTED|Overall Study||50
495849|NCT00325598|1190928|P1|STARTED|Overall Study||50
495850|NCT00325468|1190943|P5|NOT COMPLETED|Overall Study||8
495851|NCT00325468|1190944|P4|NOT COMPLETED|Overall Study||34
495852|NCT00325468|1190945|P3|NOT COMPLETED|Overall Study||4
495853|NCT00325468|1190946|P2|NOT COMPLETED|Overall Study||5
495854|NCT00325468|1190947|P1|NOT COMPLETED|Overall Study||11
495855|NCT00325468|1190943|P5|COMPLETED|Overall Study||14
495856|NCT00325468|1190944|P4|COMPLETED|Overall Study||90
495857|NCT00325468|1190945|P3|COMPLETED|Overall Study||10
495858|NCT00325468|1190946|P2|COMPLETED|Overall Study||12
495859|NCT00325468|1190947|P1|COMPLETED|Overall Study||12
495860|NCT00325468|1190943|P5|STARTED|Overall Study||22
495861|NCT00325468|1190944|P4|STARTED|Overall Study||124
495862|NCT00325468|1190945|P3|STARTED|Overall Study||14
495863|NCT00325468|1190946|P2|STARTED|Overall Study||17
495864|NCT00325468|1190947|P1|STARTED|Overall Study||23
495865|NCT00325442|1190982|P2|NOT COMPLETED|Overall Study||21
495866|NCT00325442|1190983|P1|NOT COMPLETED|Overall Study||9
495867|NCT00325442|1190982|P2|COMPLETED|Overall Study||153
495868|NCT00325442|1190983|P1|COMPLETED|Overall Study||167
495869|NCT00325442|1190982|P2|STARTED|Overall Study||174
495870|NCT00325442|1190983|P1|STARTED|Overall Study||176
495871|NCT00325416|1191030|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
495872|NCT00325416|1191031|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
495873|NCT00325416|1191030|P2|COMPLETED|Phase II: Treatment at MTD||40
495874|NCT00325416|1191031|P1|COMPLETED|Phase II: Treatment at MTD||78
495875|NCT00325416|1191030|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
495876|NCT00325416|1191031|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
495877|NCT00325416|1191030|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
495878|NCT00325416|1191031|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
495879|NCT00325416|1191030|P2|STARTED|Phase II: Treatment at MTD||42
495880|NCT00325416|1191031|P1|STARTED|Phase II: Treatment at MTD||78
495881|NCT00325416|1191030|P2|NOT COMPLETED|Phase I: Dose Escalation||16
495882|NCT00325416|1191031|P1|NOT COMPLETED|Phase I: Dose Escalation||22
495883|NCT00325416|1191030|P2|COMPLETED|Phase I: Dose Escalation||44
495884|NCT00325416|1191031|P1|COMPLETED|Phase I: Dose Escalation||48
495885|NCT00325416|1191030|P2|STARTED|Phase I: Dose Escalation||60
495886|NCT00325416|1191031|P1|STARTED|Phase I: Dose Escalation||70
495887|NCT00325403|1191045|P2|NOT COMPLETED|Overall Study||51
495888|NCT00325403|1191046|P1|NOT COMPLETED|Overall Study||18
495889|NCT00325403|1191045|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
495890|NCT00325403|1191046|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
495891|NCT00325403|1191045|P2|STARTED|Overall Study||233
495892|NCT00325403|1191046|P1|STARTED|Overall Study||116
495893|NCT00325234|1191084|P2|NOT COMPLETED|Overall Study||66
495894|NCT00325234|1191085|P1|NOT COMPLETED|Overall Study||69
495895|NCT00325234|1191084|P2|COMPLETED|Overall Study||0
495896|NCT00325234|1191085|P1|COMPLETED|Overall Study||0
495897|NCT00325234|1191084|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
495898|NCT00325234|1191085|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
495899|NCT00325234|1191084|P2|STARTED|Overall Study||66
495900|NCT00325234|1191085|P1|STARTED|Overall Study||69
495901|NCT00325195|1191104|P3|NOT COMPLETED|Received Intervention: ITT Population||4
495902|NCT00325195|1191105|P2|NOT COMPLETED|Received Intervention: ITT Population||25
495903|NCT00325195|1191106|P1|NOT COMPLETED|Received Intervention: ITT Population||26
495904|NCT00325195|1191104|P3|COMPLETED|Received Intervention: ITT Population||39
495905|NCT00325195|1191105|P2|COMPLETED|Received Intervention: ITT Population||59
495906|NCT00325195|1191106|P1|COMPLETED|Received Intervention: ITT Population||59
495907|NCT00325195|1191104|P3|STARTED|Received Intervention: ITT Population||43
495908|NCT00325195|1191105|P2|STARTED|Received Intervention: ITT Population||84
495909|NCT00325195|1191106|P1|STARTED|Received Intervention: ITT Population||85
495910|NCT00325195|1191104|P3|NOT COMPLETED|Randomized||3
495911|NCT00325195|1191105|P2|NOT COMPLETED|Randomized||5
495912|NCT00325195|1191106|P1|NOT COMPLETED|Randomized||5
495913|NCT00325195|1191104|P3|COMPLETED|Randomized||43
495914|NCT00325195|1191105|P2|COMPLETED|Randomized||84
495915|NCT00325195|1191106|P1|COMPLETED|Randomized||85
495916|NCT00325195|1191104|P3|STARTED|Randomized||46
495917|NCT00325195|1191105|P2|STARTED|Randomized||89
495918|NCT00325195|1191106|P1|STARTED|Randomized||90
495919|NCT00325156|1191129|P1|NOT COMPLETED|Overall Study||112
495920|NCT00325156|1191129|P1|COMPLETED|Overall Study||2478
495921|NCT00325156|1191129|P1|STARTED|Overall Study||2590
495922|NCT00325143|1191136|P1|NOT COMPLETED|Overall Study||26
495923|NCT00325143|1191136|P1|COMPLETED|Overall Study||676
495924|NCT00325143|1191136|P1|STARTED|Overall Study||702
495925|NCT00325130|1191145|P2|NOT COMPLETED|Overall Study||30
495926|NCT00325130|1191146|P1|NOT COMPLETED|Overall Study||19
495927|NCT00325130|1191145|P2|COMPLETED|Overall Study||494
495928|NCT00325130|1191146|P1|COMPLETED|Overall Study||499
495929|NCT00325130|1191145|P2|STARTED|Overall Study||524
495930|NCT00325130|1191146|P1|STARTED|Overall Study||518
495931|NCT00325078|1191189|P3|NOT COMPLETED|Overall Study||2
495932|NCT00325078|1191190|P2|NOT COMPLETED|Overall Study||5
495933|NCT00325078|1191191|P1|NOT COMPLETED|Overall Study||5
495934|NCT00325078|1191189|P3|COMPLETED|Overall Study||23
495935|NCT00325078|1191190|P2|COMPLETED|Overall Study||2
495936|NCT00325078|1191191|P1|COMPLETED|Overall Study||3
495937|NCT00325078|1191189|P3|STARTED|Overall Study||25
495938|NCT00325078|1191190|P2|STARTED|Overall Study||7
495939|NCT00325078|1191191|P1|STARTED|Overall Study||8
495940|NCT00325039|1191203|P2|NOT COMPLETED|Overall Study||14
495941|NCT00325039|1191204|P1|NOT COMPLETED|Overall Study||18
495942|NCT00325039|1191203|P2|COMPLETED|Overall Study||285
495943|NCT00325039|1191204|P1|COMPLETED|Overall Study||280
495944|NCT00325039|1191203|P2|STARTED|Overall Study||299
495945|NCT00325039|1191204|P1|STARTED|Overall Study||298
495946|NCT00324961|1191218|P1|NOT COMPLETED|Overall Study||43
495947|NCT00324961|1191218|P1|COMPLETED|Overall Study||490
495948|NCT00324961|1191218|P1|STARTED|Overall Study||533
495949|NCT00324896|1191233|P2|NOT COMPLETED|Overall Study||8
495950|NCT00324896|1191234|P1|NOT COMPLETED|Overall Study||3
495951|NCT00324896|1191233|P2|COMPLETED|Overall Study||7
495952|NCT00324896|1191234|P1|COMPLETED|Overall Study||12
495953|NCT00324896|1191233|P2|STARTED|Overall Study||15
495954|NCT00324896|1191234|P1|STARTED|Overall Study||15
495955|NCT00324870|1191242|P1|NOT COMPLETED|Overall Study||0
495956|NCT00324870|1191242|P1|COMPLETED|Overall Study||37
495957|NCT00324870|1191242|P1|STARTED|Overall Study||37
495958|NCT00324857|1191250|P4|NOT COMPLETED|Overall Study||5
495959|NCT00324857|1191251|P3|NOT COMPLETED|Overall Study||7
495960|NCT00324857|1191252|P2|NOT COMPLETED|Overall Study||6
495961|NCT00324857|1191253|P1|NOT COMPLETED|Overall Study||6
495962|NCT00324857|1191250|P4|COMPLETED|Overall Study||158
495963|NCT00324857|1191251|P3|COMPLETED|Overall Study||158
495964|NCT00324857|1191252|P2|COMPLETED|Overall Study||162
495965|NCT00324857|1191253|P1|COMPLETED|Overall Study||161
495966|NCT00324857|1191250|P4|STARTED|Overall Study||163
495967|NCT00324857|1191251|P3|STARTED|Overall Study||165
495968|NCT00324857|1191252|P2|STARTED|Overall Study||168
495969|NCT00324857|1191253|P1|STARTED|Overall Study||167
495970|NCT00324740|1191263|P3|NOT COMPLETED|Overall Study||1
495971|NCT00324740|1191264|P2|NOT COMPLETED|Overall Study||0
495972|NCT00324740|1191265|P1|NOT COMPLETED|Overall Study||1
495973|NCT00324740|1191263|P3|COMPLETED|Overall Study||3
495974|NCT00324740|1191264|P2|COMPLETED|Overall Study||3
495975|NCT00324740|1191265|P1|COMPLETED|Overall Study||6
495976|NCT00324740|1191263|P3|STARTED|Overall Study||4
495977|NCT00324740|1191264|P2|STARTED|Overall Study||3
495978|NCT00324740|1191265|P1|STARTED|Overall Study||7
495979|NCT00324701|1191274|P2|NOT COMPLETED|Overall Study||17
495980|NCT00324701|1191275|P1|NOT COMPLETED|Overall Study||20
495981|NCT00324701|1191274|P2|COMPLETED|Overall Study||104
495982|NCT00324701|1191275|P1|COMPLETED|Overall Study||100
495983|NCT00324701|1191274|P2|Week 8 Assessment|Overall Study||107
495984|NCT00324701|1191275|P1|Week 8 Assessment|Overall Study||108
495985|NCT00324701|1191274|P2|STARTED|Overall Study||121
495986|NCT00324701|1191275|P1|STARTED|Overall Study||120
495987|NCT00324675|1191285|P2|NOT COMPLETED|Overall Study||0
495988|NCT00324675|1191286|P1|NOT COMPLETED|Overall Study||1
495989|NCT00324675|1191285|P2|COMPLETED|Overall Study||14
495990|NCT00324675|1191286|P1|COMPLETED|Overall Study||13
495991|NCT00324675|1191285|P2|STARTED|Overall Study||14
495992|NCT00324675|1191286|P1|STARTED|Overall Study||14
495993|NCT00324649|1191294|P2|NOT COMPLETED|Overall Study||5
495994|NCT00324649|1191295|P1|NOT COMPLETED|Overall Study||2
495995|NCT00324649|1191294|P2|COMPLETED|Overall Study||36
495996|NCT00324649|1191295|P1|COMPLETED|Overall Study||37
495997|NCT00324649|1191294|P2|STARTED|Overall Study||41
495998|NCT00324649|1191295|P1|STARTED|Overall Study||39
495999|NCT00324415|1191335|P1|NOT COMPLETED|Overall Study||0
496000|NCT00324415|1191335|P1|COMPLETED|Overall Study||45
496001|NCT00324415|1191335|P1|STARTED|Overall Study||45
496002|NCT00324350|1191350|P2|NOT COMPLETED|Overall Study||0
496003|NCT00324350|1191351|P1|NOT COMPLETED|Overall Study||0
496004|NCT00324350|1191350|P2|COMPLETED|Overall Study||3632
496005|NCT00324350|1191351|P1|COMPLETED|Overall Study||3655
496006|NCT00324350|1191350|P2|Falls Follow-Up|Overall Study||3418
496007|NCT00324350|1191351|P1|Falls Follow-Up|Overall Study||3364
496008|NCT00324350|1191350|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
496009|NCT00324350|1191351|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
496010|NCT00324350|1191350|P2|STARTED|Overall Study||3632
496011|NCT00324350|1191351|P1|STARTED|Overall Study||3655
496012|NCT00324272|1191365|P4|NOT COMPLETED|Overall Study||0
496013|NCT00324272|1191366|P3|NOT COMPLETED|Overall Study||0
496014|NCT00324272|1191367|P2|NOT COMPLETED|Overall Study||0
496015|NCT00324272|1191368|P1|NOT COMPLETED|Overall Study||0
496016|NCT00324272|1191365|P4|COMPLETED|Overall Study||18
496017|NCT00324272|1191366|P3|COMPLETED|Overall Study||18
496018|NCT00324272|1191367|P2|COMPLETED|Overall Study||20
496019|NCT00324272|1191368|P1|COMPLETED|Overall Study||18
496020|NCT00324272|1191365|P4|STARTED|Overall Study||18
496021|NCT00324272|1191366|P3|STARTED|Overall Study||18
496022|NCT00324272|1191367|P2|STARTED|Overall Study||20
496023|NCT00324272|1191368|P1|STARTED|Overall Study||18
496024|NCT00324259|1191404|P2|NOT COMPLETED|Overall Study||0
496025|NCT00324259|1191405|P1|NOT COMPLETED|Overall Study||0
496026|NCT00324259|1191404|P2|COMPLETED|Overall Study||32
496027|NCT00324259|1191405|P1|COMPLETED|Overall Study||34
496028|NCT00324259|1191404|P2|STARTED|Overall Study||32
496029|NCT00324259|1191405|P1|STARTED|Overall Study||34
496030|NCT00324233|1191426|P2|NOT COMPLETED|Second Period||7
496031|NCT00324233|1191427|P1|NOT COMPLETED|Second Period||5
496032|NCT00324233|1191426|P2|COMPLETED|Second Period||11
496033|NCT00324233|1191427|P1|COMPLETED|Second Period||12
496034|NCT00324233|1191426|P2|STARTED|Second Period||18
496035|NCT00324233|1191427|P1|STARTED|Second Period||17
496036|NCT00324233|1191426|P2|NOT COMPLETED|First Period||0
496037|NCT00324233|1191427|P1|NOT COMPLETED|First Period||1
496038|NCT00324233|1191426|P2|COMPLETED|First Period||18
496039|NCT00324233|1191427|P1|COMPLETED|First Period||17
496040|NCT00324233|1191426|P2|STARTED|First Period||18
496041|NCT00324233|1191427|P1|STARTED|First Period||18
496042|NCT00324168|1191435|P2|NOT COMPLETED|Overall Study||30
496043|NCT00324168|1191436|P1|NOT COMPLETED|Overall Study||28
496044|NCT00324168|1191435|P2|COMPLETED|Overall Study||220
496045|NCT00324168|1191436|P1|COMPLETED|Overall Study||222
496046|NCT00324168|1191435|P2|STARTED|Overall Study||250
496047|NCT00324168|1191436|P1|STARTED|Overall Study||250
496048|NCT00324155|1191464|P2|NOT COMPLETED|Follow-up Phase||6
496049|NCT00324155|1191465|P1|NOT COMPLETED|Follow-up Phase||11
496050|NCT00324155|1191464|P2|COMPLETED|Follow-up Phase||245
496051|NCT00324155|1191465|P1|COMPLETED|Follow-up Phase||236
496052|NCT00324155|1191464|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
496053|NCT00324155|1191465|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
496054|NCT00324155|1191464|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
496055|NCT00324155|1191465|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
496056|NCT00324155|1191464|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
496057|NCT00324155|1191465|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
496058|NCT00324155|1191464|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
496059|NCT00324155|1191465|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
496060|NCT00324155|1191464|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
496061|NCT00324155|1191465|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
496062|NCT00324155|1191464|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
496063|NCT00324155|1191465|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
496064|NCT00324155|1191464|P2|STARTED|Received Treatment in Induction Phase||251
496065|NCT00324155|1191465|P1|STARTED|Received Treatment in Induction Phase||247
496066|NCT00324155|1191464|P2|NOT COMPLETED|Enrolled and Randomized||1
496067|NCT00324155|1191465|P1|NOT COMPLETED|Enrolled and Randomized||3
496068|NCT00324155|1191464|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
496069|NCT00324155|1191465|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
496070|NCT00324155|1191464|P2|STARTED|Enrolled and Randomized||252
496071|NCT00324155|1191465|P1|STARTED|Enrolled and Randomized||250
496072|NCT00324116|1191495|P1|NOT COMPLETED|Overall Study||32
496073|NCT00324116|1191495|P1|COMPLETED|Overall Study||49
496074|NCT00324116|1191495|P1|STARTED|Overall Study|subjects received treatment|81
496075|NCT00324038|1191507|P2|NOT COMPLETED|Overall Study||51
496076|NCT00324038|1191508|P1|NOT COMPLETED|Overall Study||49
496077|NCT00324038|1191507|P2|COMPLETED|Overall Study||58
496078|NCT00324038|1191508|P1|COMPLETED|Overall Study||61
496079|NCT00324038|1191507|P2|STARTED|Overall Study||109
496080|NCT00324038|1191508|P1|STARTED|Overall Study||110
496081|NCT00323882|1191519|P5|NOT COMPLETED|Overall Study||32
496082|NCT00323882|1191520|P4|NOT COMPLETED|Overall Study||7
496083|NCT00323882|1191521|P3|NOT COMPLETED|Overall Study||13
496084|NCT00323882|1191522|P2|NOT COMPLETED|Overall Study||6
496085|NCT00323882|1191523|P1|NOT COMPLETED|Overall Study||8
496086|NCT00323882|1191519|P5|COMPLETED|Overall Study||2
496087|NCT00323882|1191520|P4|COMPLETED|Overall Study||0
496088|NCT00323882|1191521|P3|COMPLETED|Overall Study||3
496089|NCT00323882|1191522|P2|COMPLETED|Overall Study||0
496090|NCT00323882|1191523|P1|COMPLETED|Overall Study||0
496091|NCT00323882|1191519|P5|STARTED|Overall Study||34
496092|NCT00323882|1191520|P4|STARTED|Overall Study||7
496093|NCT00323882|1191521|P3|STARTED|Overall Study||16
496094|NCT00323882|1191522|P2|STARTED|Overall Study||6
496095|NCT00323882|1191523|P1|STARTED|Overall Study||8
496096|NCT00323869|1191594|P1|NOT COMPLETED|Overall Study||1
496097|NCT00323869|1191594|P1|COMPLETED|Overall Study||47
496098|NCT00323869|1191594|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
496099|NCT00323869|1191594|P1|STARTED|Overall Study|Enrollment|48
496100|NCT00323739|1191606|P1|NOT COMPLETED|Overall Study||0
496101|NCT00323739|1191606|P1|COMPLETED|Overall Study||80
496102|NCT00323739|1191606|P1|STARTED|Overall Study||80
496103|NCT00323635|1191613|P2|NOT COMPLETED|Overall Study||0
496104|NCT00323635|1191614|P1|NOT COMPLETED|Overall Study||0
496105|NCT00323635|1191613|P2|COMPLETED|Overall Study||9
496106|NCT00323635|1191614|P1|COMPLETED|Overall Study||10
496107|NCT00323635|1191613|P2|STARTED|Overall Study||9
496108|NCT00323635|1191614|P1|STARTED|Overall Study||10
496109|NCT00323622|1191638|P8|NOT COMPLETED|Overall Study||15
496110|NCT00323622|1191639|P7|NOT COMPLETED|Overall Study||5
496111|NCT00323622|1191640|P6|NOT COMPLETED|Overall Study||74
496112|NCT00323622|1191641|P5|NOT COMPLETED|Overall Study||39
496113|NCT00323622|1191642|P4|NOT COMPLETED|Overall Study||12
496114|NCT00323622|1191643|P3|NOT COMPLETED|Overall Study||4
496115|NCT00323622|1191644|P2|NOT COMPLETED|Overall Study||92
496116|NCT00323622|1191645|P1|NOT COMPLETED|Overall Study||31
496117|NCT00323622|1191638|P8|COMPLETED|Overall Study||125
496118|NCT00323622|1191639|P7|COMPLETED|Overall Study||38
496119|NCT00323622|1191640|P6|COMPLETED|Overall Study||454
496120|NCT00323622|1191641|P5|COMPLETED|Overall Study||120
496121|NCT00323622|1191642|P4|COMPLETED|Overall Study||122
496122|NCT00323622|1191643|P3|COMPLETED|Overall Study||38
496123|NCT00323622|1191644|P2|COMPLETED|Overall Study||423
496124|NCT00323622|1191645|P1|COMPLETED|Overall Study||145
496125|NCT00323622|1191638|P8|STARTED|Overall Study||140
496126|NCT00323622|1191639|P7|STARTED|Overall Study||43
496127|NCT00323622|1191640|P6|STARTED|Overall Study||528
496128|NCT00323622|1191641|P5|STARTED|Overall Study||159
496129|NCT00323622|1191642|P4|STARTED|Overall Study||134
496130|NCT00323622|1191643|P3|STARTED|Overall Study||42
496131|NCT00323622|1191644|P2|STARTED|Overall Study||515
496132|NCT00323622|1191645|P1|STARTED|Overall Study||176
496133|NCT00323609|1191687|P4|NOT COMPLETED|Overall Study||15
496134|NCT00323609|1191688|P3|NOT COMPLETED|Overall Study||8
496135|NCT00323609|1191689|P2|NOT COMPLETED|Overall Study||99
496136|NCT00323609|1191690|P1|NOT COMPLETED|Overall Study||91
496137|NCT00323609|1191687|P4|COMPLETED|Overall Study||0
496138|NCT00323609|1191688|P3|COMPLETED|Overall Study||0
496139|NCT00323609|1191689|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
496140|NCT00323609|1191690|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
496141|NCT00323609|1191687|P4|STARTED|Overall Study||15
496142|NCT00323609|1191688|P3|STARTED|Overall Study||8
496143|NCT00323609|1191689|P2|STARTED|Overall Study||190
496144|NCT00323609|1191690|P1|STARTED|Overall Study||191
496145|NCT00323557|1191726|P2|NOT COMPLETED|Overall Study||0
496146|NCT00323557|1191727|P1|NOT COMPLETED|Overall Study||1
496147|NCT00323557|1191726|P2|COMPLETED|Overall Study||7
496148|NCT00323557|1191727|P1|COMPLETED|Overall Study||24
496149|NCT00323557|1191726|P2|STARTED|Overall Study||7
496150|NCT00323557|1191727|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
496151|NCT00323492|1191736|P3|NOT COMPLETED|Study Phase 2||1
496152|NCT00323492|1191737|P2|NOT COMPLETED|Study Phase 2||1
496153|NCT00323492|1191738|P1|NOT COMPLETED|Study Phase 2||4
496154|NCT00323492|1191736|P3|COMPLETED|Study Phase 2||24
496155|NCT00323492|1191737|P2|COMPLETED|Study Phase 2||17
496156|NCT00323492|1191738|P1|COMPLETED|Study Phase 2||40
496157|NCT00323492|1191736|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
496158|NCT00323492|1191737|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
496159|NCT00323492|1191738|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
496160|NCT00323492|1191736|P3|NOT COMPLETED|Study Phase 1||0
496161|NCT00323492|1191737|P2|NOT COMPLETED|Study Phase 1||0
496162|NCT00323492|1191738|P1|NOT COMPLETED|Study Phase 1||2
496163|NCT00323492|1191736|P3|COMPLETED|Study Phase 1||0
496164|NCT00323492|1191737|P2|COMPLETED|Study Phase 1||45
496165|NCT00323492|1191738|P1|COMPLETED|Study Phase 1||45
496166|NCT00323492|1191736|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
496167|NCT00323492|1191737|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
496168|NCT00323492|1191738|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
496169|NCT00323492|1191736|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
496170|NCT00323492|1191737|P2|STARTED|Study Phase 1||45
496171|NCT00323492|1191738|P1|STARTED|Study Phase 1||47
496172|NCT00323479|1191769|P1|NOT COMPLETED|Overall Study||8
496173|NCT00323479|1191769|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
496174|NCT00323479|1191769|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
496175|NCT00323479|1191769|P1|STARTED|Overall Study||114
496176|NCT00323427|1191780|P2|NOT COMPLETED|Overall Study||23
496177|NCT00323427|1191781|P1|NOT COMPLETED|Overall Study||31
496178|NCT00323427|1191780|P2|COMPLETED|Overall Study||43
496179|NCT00323427|1191781|P1|COMPLETED|Overall Study||38
496180|NCT00323427|1191780|P2|STARTED|Overall Study||66
496181|NCT00323427|1191781|P1|STARTED|Overall Study||69
496182|NCT00323362|1191791|P1|NOT COMPLETED|Overall Study||0
496183|NCT00323362|1191791|P1|COMPLETED|Overall Study||17
496184|NCT00323362|1191791|P1|STARTED|Overall Study||17
496185|NCT00323310|1191797|P1|NOT COMPLETED|Overall Study||3
496186|NCT00323310|1191797|P1|COMPLETED|Overall Study||89
496187|NCT00323310|1191797|P1|STARTED|Overall Study||92
496188|NCT00323297|1191812|P2|NOT COMPLETED|Part B (Open-label)||12
496189|NCT00323297|1191813|P1|NOT COMPLETED|Part B (Open-label)||9
496190|NCT00323297|1191812|P2|COMPLETED|Part B (Open-label)||31
496191|NCT00323297|1191813|P1|COMPLETED|Part B (Open-label)||39
496192|NCT00323297|1191812|P2|STARTED|Part B (Open-label)||43
496193|NCT00323297|1191813|P1|STARTED|Part B (Open-label)||48
496194|NCT00323297|1191812|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
496195|NCT00323297|1191813|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
496196|NCT00323297|1191812|P2|COMPLETED|Part A (Double Blind Randomized)||43
496197|NCT00323297|1191813|P1|COMPLETED|Part A (Double Blind Randomized)||48
496198|NCT00323297|1191812|P2|STARTED|Part A (Double Blind Randomized)||50
496199|NCT00323297|1191813|P1|STARTED|Part A (Double Blind Randomized)||53
496200|NCT00323284|1191831|P2|NOT COMPLETED|24 Months Follow-up||22
496201|NCT00323284|1191832|P1|NOT COMPLETED|24 Months Follow-up||18
496202|NCT00323284|1191831|P2|COMPLETED|24 Months Follow-up||101
496203|NCT00323284|1191832|P1|COMPLETED|24 Months Follow-up||98
496204|NCT00323284|1191831|P2|STARTED|24 Months Follow-up||123
496205|NCT00323284|1191832|P1|STARTED|24 Months Follow-up||116
496206|NCT00323284|1191831|P2|NOT COMPLETED|12 Months Follow-up||9
496207|NCT00323284|1191832|P1|NOT COMPLETED|12 Months Follow-up||5
496208|NCT00323284|1191831|P2|COMPLETED|12 Months Follow-up||114
496209|NCT00323284|1191832|P1|COMPLETED|12 Months Follow-up||111
496210|NCT00323284|1191831|P2|STARTED|12 Months Follow-up||123
496211|NCT00323284|1191832|P1|STARTED|12 Months Follow-up||116
496212|NCT00323271|1191842|P2|NOT COMPLETED|Overall Study||3
496213|NCT00323271|1191843|P1|NOT COMPLETED|Overall Study||2
496214|NCT00323271|1191842|P2|COMPLETED|Overall Study||9
496215|NCT00323271|1191843|P1|COMPLETED|Overall Study||11
496216|NCT00323271|1191842|P2|STARTED|Overall Study||12
496217|NCT00323271|1191843|P1|STARTED|Overall Study||13
496218|NCT00323258|1191853|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
496219|NCT00323258|1191854|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
496220|NCT00323258|1191853|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
496221|NCT00323258|1191854|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
496222|NCT00323258|1191853|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
496223|NCT00323258|1191854|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
496224|NCT00323258|1191853|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
496225|NCT00323258|1191854|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
496226|NCT00323258|1191853|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
496227|NCT00323258|1191854|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
496228|NCT00323258|1191853|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
496229|NCT00323258|1191854|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
496230|NCT00323193|1191870|P2|NOT COMPLETED|Overall Study||15
496231|NCT00323193|1191871|P1|NOT COMPLETED|Overall Study||23
496232|NCT00323193|1191870|P2|COMPLETED|Overall Study||41
496233|NCT00323193|1191871|P1|COMPLETED|Overall Study||30
496234|NCT00323193|1191870|P2|STARTED|Overall Study||56
496235|NCT00323193|1191871|P1|STARTED|Overall Study||53
496236|NCT00323115|1191879|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
496237|NCT00323115|1191879|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
496238|NCT00323115|1191879|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
496239|NCT00323115|1191879|P1|NOT COMPLETED|Vaccine Administration||1
496240|NCT00323115|1191879|P1|COMPLETED|Vaccine Administration||10
496241|NCT00323115|1191879|P1|STARTED|Vaccine Administration||11
496242|NCT00323037|1191886|P2|NOT COMPLETED|Overall Study||27
496243|NCT00323037|1191887|P1|NOT COMPLETED|Overall Study||33
496244|NCT00323037|1191886|P2|COMPLETED|Overall Study||126
496245|NCT00323037|1191887|P1|COMPLETED|Overall Study||132
496246|NCT00323037|1191886|P2|STARTED|Overall Study|Number randomized|153
496247|NCT00323037|1191887|P1|STARTED|Overall Study|Number randomized|165
496248|NCT00322881|1191891|P1|NOT COMPLETED|Overall Study||5
496249|NCT00322881|1191891|P1|COMPLETED|Overall Study||7
496250|NCT00322881|1191891|P1|STARTED|Overall Study||12
496251|NCT00322855|1191895|P1|NOT COMPLETED|Overall Study||0
496252|NCT00322855|1191895|P1|COMPLETED|Overall Study||1
496253|NCT00322855|1191895|P1|STARTED|Overall Study||1
496254|NCT00322842|1191901|P2|NOT COMPLETED|Overall Study||2
496255|NCT00322842|1191902|P1|NOT COMPLETED|Overall Study||2
496256|NCT00322842|1191901|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
496257|NCT00322842|1191902|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
496258|NCT00322842|1191901|P2|STARTED|Overall Study||31
496259|NCT00322842|1191902|P1|STARTED|Overall Study||4
496260|NCT00322777|1191929|P2|NOT COMPLETED|Overall Study||0
496261|NCT00322777|1191930|P1|NOT COMPLETED|Overall Study||0
496262|NCT00322777|1191929|P2|COMPLETED|Overall Study||45
496263|NCT00322777|1191930|P1|COMPLETED|Overall Study||39
496264|NCT00322777|1191929|P2|Data Collection at Week 24|Overall Study||45
496265|NCT00322777|1191930|P1|Data Collection at Week 24|Overall Study||39
496266|NCT00322777|1191929|P2|Data Collection at Week 16|Overall Study||45
496267|NCT00322777|1191930|P1|Data Collection at Week 16|Overall Study||39
496268|NCT00322777|1191929|P2|Data Collection at Week 8|Overall Study||45
496269|NCT00322777|1191930|P1|Data Collection at Week 8|Overall Study||39
496270|NCT00322777|1191929|P2|"Data Collection at BASELINE|"|Overall Study||45
496271|NCT00322777|1191930|P1|"Data Collection at BASELINE|"|Overall Study||39
496272|NCT00322777|1191929|P2|STARTED|Overall Study||45
496273|NCT00322777|1191930|P1|STARTED|Overall Study||39
496274|NCT00322712|1191940|P1|NOT COMPLETED|Overall Study||1
496275|NCT00322712|1191940|P1|COMPLETED|Overall Study||11
496276|NCT00322712|1191940|P1|STARTED|Overall Study||12
496277|NCT00322621|1191944|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
496278|NCT00322621|1191945|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
496279|NCT00322621|1191946|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
496280|NCT00322621|1191944|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
496281|NCT00322621|1191945|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
496282|NCT00322621|1191946|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
496283|NCT00322621|1191944|P3|STARTED|Period III - Maintenance / Rescue Phase||69
496284|NCT00322621|1191945|P2|STARTED|Period III - Maintenance / Rescue Phase||115
496285|NCT00322621|1191946|P1|STARTED|Period III - Maintenance / Rescue Phase||0
496286|NCT00322621|1191944|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
496287|NCT00322621|1191945|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
496288|NCT00322621|1191946|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
496289|NCT00322621|1191944|P3|COMPLETED|Period II - Acute Therapy Phase||0
496290|NCT00322621|1191945|P2|COMPLETED|Period II - Acute Therapy Phase||0
496291|NCT00322621|1191946|P1|COMPLETED|Period II - Acute Therapy Phase||184
496292|NCT00322621|1191944|P3|STARTED|Period II - Acute Therapy Phase||0
496293|NCT00322621|1191945|P2|STARTED|Period II - Acute Therapy Phase||0
496294|NCT00322621|1191946|P1|STARTED|Period II - Acute Therapy Phase||216
496295|NCT00322556|1191998|P1|NOT COMPLETED|Overall Study||12
496296|NCT00322556|1191998|P1|COMPLETED|Overall Study||43
496297|NCT00322556|1191998|P1|STARTED|Overall Study||55
496298|NCT00322491|1192014|P2|NOT COMPLETED|Overall Study||2
496299|NCT00322491|1192015|P1|NOT COMPLETED|Overall Study||2
496300|NCT00322491|1192014|P2|COMPLETED|Overall Study||24
496301|NCT00322491|1192015|P1|COMPLETED|Overall Study||21
496302|NCT00322491|1192014|P2|STARTED|Overall Study||26
496303|NCT00322491|1192015|P1|STARTED|Overall Study||23
496304|NCT00322465|1192041|P4|NOT COMPLETED|Overall Study||26
496305|NCT00322465|1192042|P3|NOT COMPLETED|Overall Study||26
496306|NCT00322465|1192043|P2|NOT COMPLETED|Overall Study||24
496307|NCT00322465|1192044|P1|NOT COMPLETED|Overall Study||20
496308|NCT00322465|1192041|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
496309|NCT00322465|1192042|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
496310|NCT00322465|1192043|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
496311|NCT00322465|1192044|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
496312|NCT00322465|1192041|P4|STARTED|Overall Study|Randomized|79
496313|NCT00322465|1192042|P3|STARTED|Overall Study|Randomized|77
496314|NCT00322465|1192043|P2|STARTED|Overall Study|Randomized|73
496315|NCT00322465|1192044|P1|STARTED|Overall Study|Randomized|76
496316|NCT00322452|1192105|P2|NOT COMPLETED|Overall Study||276
496317|NCT00322452|1192106|P1|NOT COMPLETED|Overall Study||247
496318|NCT00322452|1192105|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
496319|NCT00322452|1192106|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
496320|NCT00322452|1192105|P2|STARTED|Overall Study|Number of patients randomized|608
496321|NCT00322452|1192106|P1|STARTED|Overall Study|Number of patients randomized|609
496322|NCT00322439|1192142|P1|NOT COMPLETED|Overall Study||1056
496323|NCT00322439|1192142|P1|COMPLETED|Overall Study||1455
496324|NCT00322439|1192142|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
496325|NCT00322439|1192142|P1|STARTED|Overall Study||2511
496326|NCT00322387|1192157|P2|NOT COMPLETED|Follow-up Period||3
496327|NCT00322387|1192158|P1|NOT COMPLETED|Follow-up Period||2
496328|NCT00322387|1192157|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
496329|NCT00322387|1192158|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
496330|NCT00322387|1192157|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
496331|NCT00322387|1192158|P1|STARTED|Follow-up Period|Participants who had transplants|14
496332|NCT00322387|1192157|P2|NOT COMPLETED|Treatment Period||1
496333|NCT00322387|1192158|P1|NOT COMPLETED|Treatment Period||0
496334|NCT00322387|1192157|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
496335|NCT00322387|1192158|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
496336|NCT00322387|1192157|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
496337|NCT00322387|1192158|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
496338|NCT00322374|1192192|P4|NOT COMPLETED|Second Escalation||0
496339|NCT00322374|1192193|P3|NOT COMPLETED|Second Escalation||6
496340|NCT00322374|1192194|P2|NOT COMPLETED|Second Escalation||0
496341|NCT00322374|1192195|P1|NOT COMPLETED|Second Escalation||0
496342|NCT00322374|1192192|P4|COMPLETED|Second Escalation||0
496343|NCT00322374|1192193|P3|COMPLETED|Second Escalation||0
496344|NCT00322374|1192194|P2|COMPLETED|Second Escalation||0
496345|NCT00322374|1192195|P1|COMPLETED|Second Escalation||0
496346|NCT00322374|1192192|P4|STARTED|Second Escalation||0
496347|NCT00322374|1192193|P3|STARTED|Second Escalation||6
496348|NCT00322374|1192194|P2|STARTED|Second Escalation||0
496349|NCT00322374|1192195|P1|STARTED|Second Escalation||0
496350|NCT00322374|1192192|P4|NOT COMPLETED|First Escalation||0
496351|NCT00322374|1192193|P3|NOT COMPLETED|First Escalation||0
496352|NCT00322374|1192194|P2|NOT COMPLETED|First Escalation||30
496353|NCT00322374|1192195|P1|NOT COMPLETED|First Escalation||0
496354|NCT00322374|1192192|P4|COMPLETED|First Escalation||0
496355|NCT00322374|1192193|P3|COMPLETED|First Escalation||0
496356|NCT00322374|1192194|P2|COMPLETED|First Escalation||0
496357|NCT00322374|1192195|P1|COMPLETED|First Escalation||0
496358|NCT00322374|1192192|P4|STARTED|First Escalation||0
496359|NCT00322374|1192193|P3|STARTED|First Escalation||0
496360|NCT00322374|1192194|P2|STARTED|First Escalation||30
496361|NCT00322374|1192195|P1|STARTED|First Escalation||0
496362|NCT00322374|1192192|P4|NOT COMPLETED|Starting Dose||0
496363|NCT00322374|1192193|P3|NOT COMPLETED|Starting Dose||0
496364|NCT00322374|1192194|P2|NOT COMPLETED|Starting Dose||0
496365|NCT00322374|1192195|P1|NOT COMPLETED|Starting Dose||6
496366|NCT00322374|1192192|P4|COMPLETED|Starting Dose||0
496367|NCT00322374|1192193|P3|COMPLETED|Starting Dose||0
496368|NCT00322374|1192194|P2|COMPLETED|Starting Dose||0
496369|NCT00322374|1192195|P1|COMPLETED|Starting Dose||0
496370|NCT00322374|1192192|P4|STARTED|Starting Dose||0
496371|NCT00322374|1192193|P3|STARTED|Starting Dose||0
496372|NCT00322374|1192194|P2|STARTED|Starting Dose||0
496373|NCT00322374|1192195|P1|STARTED|Starting Dose||6
496374|NCT00322374|1192192|P4|NOT COMPLETED|Enrollment||0
496375|NCT00322374|1192193|P3|NOT COMPLETED|Enrollment||0
496376|NCT00322374|1192194|P2|NOT COMPLETED|Enrollment||0
496377|NCT00322374|1192195|P1|NOT COMPLETED|Enrollment||0
496378|NCT00322374|1192192|P4|COMPLETED|Enrollment||42
496379|NCT00322374|1192193|P3|COMPLETED|Enrollment||0
496380|NCT00322374|1192194|P2|COMPLETED|Enrollment||0
496381|NCT00322374|1192195|P1|COMPLETED|Enrollment||0
496382|NCT00322374|1192192|P4|STARTED|Enrollment||42
496383|NCT00322374|1192193|P3|STARTED|Enrollment||0
496384|NCT00322374|1192194|P2|STARTED|Enrollment||0
496385|NCT00322374|1192195|P1|STARTED|Enrollment||0
496386|NCT00322348|1192245|P2|NOT COMPLETED|Overall Study||33
496387|NCT00322348|1192246|P1|NOT COMPLETED|Overall Study||37
496388|NCT00322348|1192245|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
496389|NCT00322348|1192246|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
496390|NCT00322348|1192245|P2|Received Study Treatment|Overall Study||48
496391|NCT00322348|1192246|P1|Received Study Treatment|Overall Study||50
496392|NCT00322348|1192245|P2|STARTED|Overall Study||49
496393|NCT00322348|1192246|P1|STARTED|Overall Study||49
496394|NCT00322335|1192265|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
496395|NCT00322335|1192266|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
496396|NCT00322335|1192267|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
496397|NCT00322335|1192265|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
496398|NCT00322335|1192266|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
496399|NCT00322335|1192267|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
496400|NCT00322335|1192265|P3|STARTED|Subjects 66 Months After Booster Dose||53
496401|NCT00322335|1192266|P2|STARTED|Subjects 66 Months After Booster Dose||104
496402|NCT00322335|1192267|P1|STARTED|Subjects 66 Months After Booster Dose||48
496403|NCT00322335|1192265|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
496404|NCT00322335|1192266|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
496405|NCT00322335|1192267|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
496406|NCT00322335|1192265|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
496407|NCT00322335|1192266|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
496408|NCT00322335|1192267|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
496409|NCT00322335|1192265|P3|STARTED|Subjects 54 Months After Booster Dose||56
496410|NCT00322335|1192266|P2|STARTED|Subjects 54 Months After Booster Dose||108
496495|NCT00321906|1192460|P1|COMPLETED|Overall Study||48
496411|NCT00322335|1192267|P1|STARTED|Subjects 54 Months After Booster Dose||50
496412|NCT00322335|1192265|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
496413|NCT00322335|1192266|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
496414|NCT00322335|1192267|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
496415|NCT00322335|1192265|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
496416|NCT00322335|1192266|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
496417|NCT00322335|1192267|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
496418|NCT00322335|1192265|P3|STARTED|Subjects 42 Months After Booster Dose||56
496419|NCT00322335|1192266|P2|STARTED|Subjects 42 Months After Booster Dose||113
496420|NCT00322335|1192267|P1|STARTED|Subjects 42 Months After Booster Dose||51
496421|NCT00322335|1192265|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
496422|NCT00322335|1192266|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
496423|NCT00322335|1192267|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
496424|NCT00322335|1192265|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
496425|NCT00322335|1192266|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
496426|NCT00322335|1192267|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
496427|NCT00322335|1192265|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
496428|NCT00322335|1192266|P2|STARTED|Subjects 30 Months After Booster Dose||119
496429|NCT00322335|1192267|P1|STARTED|Subjects 30 Months After Booster Dose||54
496430|NCT00322335|1192265|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
496431|NCT00322335|1192266|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
496432|NCT00322335|1192267|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
496433|NCT00322335|1192265|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
496434|NCT00322335|1192266|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
496435|NCT00322335|1192267|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
496436|NCT00322335|1192265|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
496437|NCT00322335|1192266|P2|STARTED|Subjects 18 Months After Booster Dose||123
496438|NCT00322335|1192267|P1|STARTED|Subjects 18 Months After Booster Dose||58
496439|NCT00322309|1192307|P2|NOT COMPLETED|Overall Study||4
496440|NCT00322309|1192308|P1|NOT COMPLETED|Overall Study||2
496441|NCT00322309|1192307|P2|COMPLETED|Overall Study||9
496442|NCT00322309|1192308|P1|COMPLETED|Overall Study||9
496443|NCT00322309|1192307|P2|STARTED|Overall Study||13
496444|NCT00322309|1192308|P1|STARTED|Overall Study||11
496445|NCT00322231|1192324|P2|NOT COMPLETED|Period 2||0
496446|NCT00322231|1192325|P1|NOT COMPLETED|Period 2||0
496447|NCT00322231|1192324|P2|COMPLETED|Period 2||49
496448|NCT00322231|1192325|P1|COMPLETED|Period 2||51
496449|NCT00322231|1192324|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
496450|NCT00322231|1192325|P1|STARTED|Period 2||51
496451|NCT00322231|1192324|P2|NOT COMPLETED|Period 1||0
496452|NCT00322231|1192325|P1|NOT COMPLETED|Period 1||0
496453|NCT00322231|1192324|P2|COMPLETED|Period 1||50
496454|NCT00322231|1192325|P1|COMPLETED|Period 1||51
496455|NCT00322231|1192324|P2|STARTED|Period 1||50
496456|NCT00322231|1192325|P1|STARTED|Period 1||51
496457|NCT00322153|1192337|P2|NOT COMPLETED|Overall Study||69
496458|NCT00322153|1192338|P1|NOT COMPLETED|Overall Study||63
496459|NCT00322153|1192337|P2|COMPLETED|Overall Study||273
496460|NCT00322153|1192338|P1|COMPLETED|Overall Study||272
496461|NCT00322153|1192337|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
496462|NCT00322153|1192338|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
496463|NCT00322153|1192337|P2|STARTED|Overall Study|Randomized to Memantine ER|342
496464|NCT00322153|1192338|P1|STARTED|Overall Study|Randomized to placebo|335
496465|NCT00322101|1192350|P2|NOT COMPLETED|Overall Study||0
496466|NCT00322101|1192351|P1|NOT COMPLETED|Overall Study||0
496467|NCT00322101|1192350|P2|COMPLETED|Overall Study||11
496468|NCT00322101|1192351|P1|COMPLETED|Overall Study||14
496469|NCT00322101|1192350|P2|STARTED|Overall Study||11
496470|NCT00322101|1192351|P1|STARTED|Overall Study||14
496471|NCT00321984|1192370|P3|NOT COMPLETED|Overall Study||26
496472|NCT00321984|1192371|P2|NOT COMPLETED|Overall Study||21
496473|NCT00321984|1192372|P1|NOT COMPLETED|Overall Study||27
496474|NCT00321984|1192370|P3|COMPLETED|Overall Study||289
496475|NCT00321984|1192371|P2|COMPLETED|Overall Study||294
496476|NCT00321984|1192372|P1|COMPLETED|Overall Study||290
496477|NCT00321984|1192370|P3|STARTED|Overall Study||315
496478|NCT00321984|1192371|P2|STARTED|Overall Study||315
496479|NCT00321984|1192372|P1|STARTED|Overall Study||317
496480|NCT00321932|1192391|P2|NOT COMPLETED|Overall Study||21
496481|NCT00321932|1192392|P1|NOT COMPLETED|Overall Study||10
496482|NCT00321932|1192391|P2|COMPLETED|Overall Study||11
496483|NCT00321932|1192392|P1|COMPLETED|Overall Study||19
496484|NCT00321932|1192391|P2|STARTED|Overall Study||32
496485|NCT00321932|1192392|P1|STARTED|Overall Study||29
496486|NCT00321919|1192416|P2|NOT COMPLETED|Overall Study||52
496487|NCT00321919|1192417|P1|NOT COMPLETED|Overall Study||75
496488|NCT00321919|1192416|P2|COMPLETED|Overall Study||250
496489|NCT00321919|1192417|P1|COMPLETED|Overall Study||226
496490|NCT00321919|1192416|P2|STARTED|Overall Study||302
496491|NCT00321919|1192417|P1|STARTED|Overall Study||301
496492|NCT00321906|1192459|P2|NOT COMPLETED|Overall Study||56
496493|NCT00321906|1192460|P1|NOT COMPLETED|Overall Study||46
496494|NCT00321906|1192459|P2|COMPLETED|Overall Study||31
496496|NCT00321906|1192459|P2|STARTED|Overall Study||87
496497|NCT00321906|1192460|P1|STARTED|Overall Study||94
496498|NCT00321893|1192482|P2|NOT COMPLETED|Overall Study||14
496499|NCT00321893|1192483|P1|NOT COMPLETED|Overall Study||24
496500|NCT00321893|1192482|P2|COMPLETED|Overall Study||87
496501|NCT00321893|1192483|P1|COMPLETED|Overall Study||77
496502|NCT00321893|1192482|P2|STARTED|Overall Study||101
496503|NCT00321893|1192483|P1|STARTED|Overall Study||101
496504|NCT00321854|1192497|P2|NOT COMPLETED|Overall Study||82
496505|NCT00321854|1192498|P1|NOT COMPLETED|Overall Study||63
496506|NCT00321854|1192497|P2|COMPLETED|Overall Study||192
496507|NCT00321854|1192498|P1|COMPLETED|Overall Study||198
496508|NCT00321854|1192497|P2|STARTED|Overall Study||274
496509|NCT00321854|1192498|P1|STARTED|Overall Study||261
496510|NCT00321828|1192616|P1|NOT COMPLETED|Overall Study||4
496511|NCT00321828|1192616|P1|COMPLETED|Overall Study||86
496512|NCT00321828|1192616|P1|STARTED|Overall Study||90
496513|NCT00321789|1192622|P2|NOT COMPLETED|Overall Study||16
496514|NCT00321789|1192623|P1|NOT COMPLETED|Overall Study||15
496515|NCT00321789|1192622|P2|COMPLETED|Overall Study||112
496516|NCT00321789|1192623|P1|COMPLETED|Overall Study||112
496517|NCT00321789|1192622|P2|STARTED|Overall Study||128
496518|NCT00321789|1192623|P1|STARTED|Overall Study||127
496519|NCT00321763|1192655|P4|NOT COMPLETED|Overall Study||5
496520|NCT00321763|1192656|P3|NOT COMPLETED|Overall Study||6
496521|NCT00321763|1192657|P2|NOT COMPLETED|Overall Study||2
496522|NCT00321763|1192658|P1|NOT COMPLETED|Overall Study||6
496523|NCT00321763|1192655|P4|COMPLETED|Overall Study||565
496524|NCT00321763|1192656|P3|COMPLETED|Overall Study||848
496525|NCT00321763|1192657|P2|COMPLETED|Overall Study||848
496526|NCT00321763|1192658|P1|COMPLETED|Overall Study||844
496527|NCT00321763|1192655|P4|STARTED|Overall Study||570
496528|NCT00321763|1192656|P3|STARTED|Overall Study||854
496529|NCT00321763|1192657|P2|STARTED|Overall Study||850
496530|NCT00321763|1192658|P1|STARTED|Overall Study||850
496531|NCT00321737|1192718|P3|NOT COMPLETED|Overall Study||54
496532|NCT00321737|1192719|P2|NOT COMPLETED|Overall Study||48
496533|NCT00321737|1192720|P1|NOT COMPLETED|Overall Study||122
496534|NCT00321737|1192718|P3|COMPLETED|Overall Study||104
496535|NCT00321737|1192719|P2|COMPLETED|Overall Study||92
496536|NCT00321737|1192720|P1|COMPLETED|Overall Study||25
496537|NCT00321737|1192718|P3|STARTED|Overall Study||158
496538|NCT00321737|1192719|P2|STARTED|Overall Study||140
496539|NCT00321737|1192720|P1|STARTED|Overall Study||147
496540|NCT00321711|1192748|P5|NOT COMPLETED|Part B||5
496541|NCT00321711|1192749|P4|NOT COMPLETED|Part B||6
496542|NCT00321711|1192750|P3|NOT COMPLETED|Part B||0
496543|NCT00321711|1192751|P2|NOT COMPLETED|Part B||0
496544|NCT00321711|1192752|P1|NOT COMPLETED|Part B||0
496545|NCT00321711|1192748|P5|COMPLETED|Part B||10
496546|NCT00321711|1192749|P4|COMPLETED|Part B||8
496547|NCT00321711|1192750|P3|COMPLETED|Part B||0
496548|NCT00321711|1192751|P2|COMPLETED|Part B||0
496549|NCT00321711|1192752|P1|COMPLETED|Part B||0
496550|NCT00321711|1192748|P5|STARTED|Part B||15
496551|NCT00321711|1192749|P4|STARTED|Part B||14
496552|NCT00321711|1192750|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
496553|NCT00321711|1192751|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
496554|NCT00321711|1192752|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
496555|NCT00321711|1192748|P5|NOT COMPLETED|Part A||0
496556|NCT00321711|1192749|P4|NOT COMPLETED|Part A||0
496557|NCT00321711|1192750|P3|NOT COMPLETED|Part A||11
496558|NCT00321711|1192751|P2|NOT COMPLETED|Part A||10
496559|NCT00321711|1192752|P1|NOT COMPLETED|Part A||5
496560|NCT00321711|1192748|P5|COMPLETED|Part A||0
496561|NCT00321711|1192749|P4|COMPLETED|Part A||0
496562|NCT00321711|1192750|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
496563|NCT00321711|1192751|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
496564|NCT00321711|1192752|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
496565|NCT00321711|1192748|P5|STARTED|Part A||0
496566|NCT00321711|1192749|P4|STARTED|Part A||0
496567|NCT00321711|1192750|P3|STARTED|Part A||14
496568|NCT00321711|1192751|P2|STARTED|Part A||13
496569|NCT00321711|1192752|P1|STARTED|Part A||13
496570|NCT00321698|1192784|P5|NOT COMPLETED|Phase II, MTD Dose||0
496571|NCT00321698|1192785|P4|NOT COMPLETED|Phase II, MTD Dose||0
496572|NCT00321698|1192786|P3|NOT COMPLETED|Phase II, MTD Dose||0
496573|NCT00321698|1192787|P2|NOT COMPLETED|Phase II, MTD Dose||0
496574|NCT00321698|1192788|P1|NOT COMPLETED|Phase II, MTD Dose||0
496575|NCT00321698|1192784|P5|COMPLETED|Phase II, MTD Dose||13
496576|NCT00321698|1192785|P4|COMPLETED|Phase II, MTD Dose||0
496577|NCT00321698|1192786|P3|COMPLETED|Phase II, MTD Dose||0
496578|NCT00321698|1192787|P2|COMPLETED|Phase II, MTD Dose||0
496579|NCT00321698|1192788|P1|COMPLETED|Phase II, MTD Dose||0
496580|NCT00321698|1192784|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
496581|NCT00321698|1192785|P4|STARTED|Phase II, MTD Dose||0
496582|NCT00321698|1192786|P3|STARTED|Phase II, MTD Dose||0
496583|NCT00321698|1192787|P2|STARTED|Phase II, MTD Dose||0
496584|NCT00321698|1192788|P1|STARTED|Phase II, MTD Dose||0
496585|NCT00321698|1192784|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
496586|NCT00321698|1192785|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
496587|NCT00321698|1192786|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
496588|NCT00321698|1192787|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
496589|NCT00321698|1192788|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
496590|NCT00321698|1192784|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
496591|NCT00321698|1192785|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
496592|NCT00321698|1192786|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
496593|NCT00321698|1192787|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
496594|NCT00321698|1192788|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
496595|NCT00321698|1192784|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
496596|NCT00321698|1192785|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
496597|NCT00321698|1192786|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
496598|NCT00321698|1192787|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
496599|NCT00321698|1192788|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
496600|NCT00321685|1192802|P1|NOT COMPLETED|Overall Study||39
496601|NCT00321685|1192802|P1|COMPLETED|Overall Study||18
496602|NCT00321685|1192802|P1|Eligible and Treated|Overall Study||53
496603|NCT00321685|1192802|P1|Started Protocol Therapy|Overall Study||55
496604|NCT00321685|1192802|P1|Eligible|Overall Study||55
496605|NCT00321685|1192802|P1|STARTED|Overall Study||57
496606|NCT00321672|1192814|P4|NOT COMPLETED|Overall Study||2
496607|NCT00321672|1192815|P3|NOT COMPLETED|Overall Study||11
496608|NCT00321672|1192816|P2|NOT COMPLETED|Overall Study||8
496609|NCT00321672|1192817|P1|NOT COMPLETED|Overall Study||12
496610|NCT00321672|1192814|P4|COMPLETED|Overall Study||71
496611|NCT00321672|1192815|P3|COMPLETED|Overall Study||156
496612|NCT00321672|1192816|P2|COMPLETED|Overall Study||81
496613|NCT00321672|1192817|P1|COMPLETED|Overall Study||153
496614|NCT00321672|1192814|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
496615|NCT00321672|1192815|P3|STARTED|Overall Study||167
496616|NCT00321672|1192816|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
496617|NCT00321672|1192817|P1|STARTED|Overall Study||165
496618|NCT00321646|1192843|P1|NOT COMPLETED|Prostatectomy||0
496619|NCT00321646|1192843|P1|COMPLETED|Prostatectomy||37
496620|NCT00321646|1192843|P1|STARTED|Prostatectomy||37
496621|NCT00321646|1192843|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
496622|NCT00321646|1192843|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
496623|NCT00321646|1192843|P1|STARTED|Neoadjuvant Chemotherapy||42
496624|NCT00321620|1192850|P2|NOT COMPLETED|Overall Study||722
496625|NCT00321620|1192851|P1|NOT COMPLETED|Overall Study||743
496626|NCT00321620|1192850|P2|COMPLETED|Overall Study||228
496627|NCT00321620|1192851|P1|COMPLETED|Overall Study||208
496628|NCT00321620|1192850|P2|Received Investigational Product|Overall Study||942
496629|NCT00321620|1192851|P1|Received Investigational Product|Overall Study||946
496630|NCT00321620|1192850|P2|STARTED|Overall Study||950
496631|NCT00321620|1192851|P1|STARTED|Overall Study||951
496632|NCT00321464|1192863|P2|NOT COMPLETED|Overall Study||558
496633|NCT00321464|1192864|P1|NOT COMPLETED|Overall Study||559
496634|NCT00321464|1192863|P2|COMPLETED|Overall Study||468
496635|NCT00321464|1192864|P1|COMPLETED|Overall Study||461
496636|NCT00321464|1192863|P2|Received Investigational Product|Overall Study||1019
496637|NCT00321464|1192864|P1|Received Investigational Product|Overall Study||1014
496638|NCT00321464|1192863|P2|STARTED|Overall Study||1026
496639|NCT00321464|1192864|P1|STARTED|Overall Study||1020
496640|NCT00321373|1192877|P3|NOT COMPLETED|Overall Study||3
496641|NCT00321373|1192878|P2|NOT COMPLETED|Overall Study||0
496642|NCT00321373|1192879|P1|NOT COMPLETED|Overall Study||2
496643|NCT00321373|1192877|P3|COMPLETED|Overall Study||404
496644|NCT00321373|1192878|P2|COMPLETED|Overall Study||406
496645|NCT00321373|1192879|P1|COMPLETED|Overall Study||405
496646|NCT00321373|1192877|P3|STARTED|Overall Study||407
496647|NCT00321373|1192878|P2|STARTED|Overall Study||406
496648|NCT00321373|1192879|P1|STARTED|Overall Study||407
496649|NCT00321321|1192902|P1|NOT COMPLETED|Overall Study||0
496650|NCT00321321|1192902|P1|COMPLETED|Overall Study||12
496651|NCT00321321|1192902|P1|STARTED|Overall Study||12
496652|NCT00321269|1192908|P2|NOT COMPLETED|Overall Study||6
496653|NCT00321269|1192909|P1|NOT COMPLETED|Overall Study||8
496654|NCT00321269|1192908|P2|COMPLETED|Overall Study||68
496655|NCT00321269|1192909|P1|COMPLETED|Overall Study||66
496656|NCT00321269|1192908|P2|STARTED|Overall Study||74
496657|NCT00321269|1192909|P1|STARTED|Overall Study||74
496658|NCT00319982|1192919|P2|NOT COMPLETED|Overall Study||0
496659|NCT00319982|1192920|P1|NOT COMPLETED|Overall Study||1
496660|NCT00319982|1192919|P2|COMPLETED|Overall Study||20
496661|NCT00319982|1192920|P1|COMPLETED|Overall Study||18
496662|NCT00319982|1192919|P2|STARTED|Overall Study||20
496663|NCT00319982|1192920|P1|STARTED|Overall Study||19
496664|NCT00320801|1192940|P4|NOT COMPLETED|Extension Phase||48
496665|NCT00320801|1192941|P3|NOT COMPLETED|Extension Phase||0
496666|NCT00320801|1192942|P2|NOT COMPLETED|Extension Phase||0
496667|NCT00320801|1192943|P1|NOT COMPLETED|Extension Phase||0
496668|NCT00320801|1192940|P4|COMPLETED|Extension Phase||7
496669|NCT00320801|1192941|P3|COMPLETED|Extension Phase||0
496670|NCT00320801|1192942|P2|COMPLETED|Extension Phase||0
496671|NCT00320801|1192943|P1|COMPLETED|Extension Phase||0
496672|NCT00320801|1192940|P4|STARTED|Extension Phase||55
496673|NCT00320801|1192941|P3|STARTED|Extension Phase||0
496674|NCT00320801|1192942|P2|STARTED|Extension Phase||0
496675|NCT00320801|1192943|P1|STARTED|Extension Phase||0
496676|NCT00320801|1192940|P4|NOT COMPLETED|Double-blind Phase||0
496677|NCT00320801|1192941|P3|NOT COMPLETED|Double-blind Phase||14
496678|NCT00320801|1192942|P2|NOT COMPLETED|Double-blind Phase||11
496679|NCT00320801|1192943|P1|NOT COMPLETED|Double-blind Phase||0
496680|NCT00320801|1192940|P4|COMPLETED|Double-blind Phase||0
496681|NCT00320801|1192941|P3|COMPLETED|Double-blind Phase||35
496682|NCT00320801|1192942|P2|COMPLETED|Double-blind Phase||36
496683|NCT00320801|1192943|P1|COMPLETED|Double-blind Phase||0
496684|NCT00320801|1192940|P4|STARTED|Double-blind Phase||0
496685|NCT00320801|1192941|P3|STARTED|Double-blind Phase||49
496686|NCT00320801|1192942|P2|STARTED|Double-blind Phase||47
496687|NCT00320801|1192943|P1|STARTED|Double-blind Phase||0
496688|NCT00320801|1192940|P4|NOT COMPLETED|Open-label Run-in Period||0
496689|NCT00320801|1192941|P3|NOT COMPLETED|Open-label Run-in Period||0
496690|NCT00320801|1192942|P2|NOT COMPLETED|Open-label Run-in Period||0
496691|NCT00320801|1192943|P1|NOT COMPLETED|Open-label Run-in Period||92
496692|NCT00320801|1192940|P4|COMPLETED|Open-label Run-in Period||0
496693|NCT00320801|1192941|P3|COMPLETED|Open-label Run-in Period||0
496694|NCT00320801|1192942|P2|COMPLETED|Open-label Run-in Period||0
496695|NCT00320801|1192943|P1|COMPLETED|Open-label Run-in Period||96
496696|NCT00320801|1192940|P4|STARTED|Open-label Run-in Period||0
496697|NCT00320801|1192941|P3|STARTED|Open-label Run-in Period||0
496698|NCT00320801|1192942|P2|STARTED|Open-label Run-in Period||0
496699|NCT00320801|1192943|P1|STARTED|Open-label Run-in Period||188
496700|NCT00320788|1192958|P5|NOT COMPLETED|Overall Study||5
496701|NCT00320788|1192959|P4|NOT COMPLETED|Overall Study||5
496702|NCT00320788|1192960|P3|NOT COMPLETED|Overall Study||3
496703|NCT00320788|1192961|P2|NOT COMPLETED|Overall Study||6
496704|NCT00320788|1192962|P1|NOT COMPLETED|Overall Study||6
496705|NCT00320788|1192958|P5|COMPLETED|Overall Study||26
496706|NCT00320788|1192959|P4|COMPLETED|Overall Study||27
496707|NCT00320788|1192960|P3|COMPLETED|Overall Study||29
496708|NCT00320788|1192961|P2|COMPLETED|Overall Study||26
496709|NCT00320788|1192962|P1|COMPLETED|Overall Study||26
496710|NCT00320788|1192958|P5|Participants Received Treatment (SAF)|Overall Study||31
496711|NCT00320788|1192959|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
496712|NCT00320788|1192960|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
496713|NCT00320788|1192961|P2|Participants Received Treatment (SAF)|Overall Study||32
496714|NCT00320788|1192962|P1|Participants Received Treatment (SAF)|Overall Study||32
496715|NCT00320788|1192958|P5|STARTED|Overall Study||31
496716|NCT00320788|1192959|P4|STARTED|Overall Study|Participants Randomized|32
496717|NCT00320788|1192960|P3|STARTED|Overall Study||32
496718|NCT00320788|1192961|P2|STARTED|Overall Study||32
496719|NCT00320788|1192962|P1|STARTED|Overall Study||32
496720|NCT00320749|1193005|P3|NOT COMPLETED|Overall Study||9
496721|NCT00320749|1193006|P2|NOT COMPLETED|Overall Study||2
496722|NCT00320749|1193007|P1|NOT COMPLETED|Overall Study||0
496723|NCT00320749|1193005|P3|COMPLETED|Overall Study||1
496724|NCT00320749|1193006|P2|COMPLETED|Overall Study||6
496725|NCT00320749|1193007|P1|COMPLETED|Overall Study||3
496726|NCT00320749|1193005|P3|STARTED|Overall Study||10
496727|NCT00320749|1193006|P2|STARTED|Overall Study||8
496728|NCT00320749|1193007|P1|STARTED|Overall Study||3
496729|NCT00320710|1193016|P3|NOT COMPLETED|Overall Study||5
496730|NCT00320710|1193017|P2|NOT COMPLETED|Overall Study||76
496731|NCT00320710|1193018|P1|NOT COMPLETED|Overall Study||94
496732|NCT00320710|1193016|P3|COMPLETED|Overall Study||8
496733|NCT00320710|1193017|P2|COMPLETED|Overall Study||127
496734|NCT00320710|1193018|P1|COMPLETED|Overall Study||106
496735|NCT00320710|1193016|P3|Treated (Safety Set)|Overall Study||13
496736|NCT00320710|1193017|P2|Treated (Safety Set)|Overall Study||202
496737|NCT00320710|1193018|P1|Treated (Safety Set)|Overall Study||198
496738|NCT00320710|1193016|P3|STARTED|Overall Study||13
496739|NCT00320710|1193017|P2|STARTED|Overall Study||203
496740|NCT00320710|1193018|P1|STARTED|Overall Study||200
496741|NCT00320671|1193041|P2|NOT COMPLETED|Overall Study||38
496742|NCT00320671|1193042|P1|NOT COMPLETED|Overall Study||33
496743|NCT00320671|1193041|P2|COMPLETED|Overall Study||58
496744|NCT00320671|1193042|P1|COMPLETED|Overall Study||69
496745|NCT00320671|1193041|P2|STARTED|Overall Study||96
496746|NCT00320671|1193042|P1|STARTED|Overall Study||102
496747|NCT00320606|1193048|P1|NOT COMPLETED|Overall Study||14
496748|NCT00320606|1193048|P1|COMPLETED|Overall Study|2 discontinued early, 12 ongoing in study|6
496749|NCT00320606|1193048|P1|STARTED|Overall Study||20
496750|NCT00320593|1193054|P2|NOT COMPLETED|Overall Study||1
496751|NCT00320593|1193055|P1|NOT COMPLETED|Overall Study||7
496752|NCT00320593|1193054|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
496753|NCT00320593|1193055|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
496754|NCT00320593|1193054|P2|STARTED|Overall Study||59
496755|NCT00320593|1193055|P1|STARTED|Overall Study||59
496756|NCT00320541|1193079|P2|NOT COMPLETED|Overall Study||57
496757|NCT00320541|1193080|P1|NOT COMPLETED|Overall Study||50
496758|NCT00320541|1193079|P2|COMPLETED|Overall Study||36
496759|NCT00320541|1193080|P1|COMPLETED|Overall Study||44
496760|NCT00320541|1193079|P2|STARTED|Overall Study||93
496761|NCT00320541|1193080|P1|STARTED|Overall Study||94
496762|NCT00320528|1193107|P3|NOT COMPLETED|Study Period III||106
496763|NCT00320528|1193108|P2|NOT COMPLETED|Study Period III||31
496764|NCT00320528|1193109|P1|NOT COMPLETED|Study Period III||87
496765|NCT00320528|1193107|P3|COMPLETED|Study Period III||2
496766|NCT00320528|1193108|P2|COMPLETED|Study Period III||0
496767|NCT00320528|1193109|P1|COMPLETED|Study Period III||0
496768|NCT00320528|1193107|P3|STARTED|Study Period III||108
496769|NCT00320528|1193108|P2|STARTED|Study Period III||31
496770|NCT00320528|1193109|P1|STARTED|Study Period III||87
496771|NCT00320528|1193107|P3|NOT COMPLETED|Study Period II||22
496772|NCT00320528|1193108|P2|NOT COMPLETED|Study Period II||10
496773|NCT00320528|1193109|P1|NOT COMPLETED|Study Period II||11
496774|NCT00320528|1193107|P3|COMPLETED|Study Period II||108
496775|NCT00320528|1193108|P2|COMPLETED|Study Period II||31
496776|NCT00320528|1193109|P1|COMPLETED|Study Period II||87
496777|NCT00320528|1193107|P3|Received at Least One Dose of Study Drug|Study Period II||128
496778|NCT00320528|1193108|P2|Received at Least One Dose of Study Drug|Study Period II||38
496779|NCT00320528|1193109|P1|Received at Least One Dose of Study Drug|Study Period II||97
496780|NCT00320528|1193107|P3|STARTED|Study Period II||130
496781|NCT00320528|1193108|P2|STARTED|Study Period II||41
496782|NCT00320528|1193109|P1|STARTED|Study Period II||98
496783|NCT00320515|1193144|P1|NOT COMPLETED|Overall Study||49
496784|NCT00320515|1193144|P1|COMPLETED|Overall Study||20
496785|NCT00320515|1193144|P1|STARTED|Overall Study||69
496786|NCT00320489|1193153|P2|NOT COMPLETED|Overall Study||136
496787|NCT00320489|1193154|P1|NOT COMPLETED|Overall Study||145
496788|NCT00320489|1193153|P2|COMPLETED|Overall Study||124
496789|NCT00320489|1193154|P1|COMPLETED|Overall Study||119
496790|NCT00320489|1193153|P2|STARTED|Overall Study||260
496791|NCT00320489|1193154|P1|STARTED|Overall Study||264
496792|NCT00320411|1193210|P1|NOT COMPLETED|Overall Study||4
496793|NCT00320411|1193210|P1|COMPLETED|Overall Study||58
496794|NCT00320411|1193210|P1|STARTED|Overall Study||62
496795|NCT00320385|1193233|P2|NOT COMPLETED|Overall Study||22
496796|NCT00320385|1193234|P1|NOT COMPLETED|Overall Study||18
496797|NCT00320385|1193233|P2|COMPLETED|Overall Study||126
496798|NCT00320385|1193234|P1|COMPLETED|Overall Study||130
496799|NCT00320385|1193233|P2|STARTED|Overall Study||148
496800|NCT00320385|1193234|P1|STARTED|Overall Study||148
496801|NCT00320372|1193257|P2|NOT COMPLETED|Overall Study||163
496802|NCT00320372|1193258|P1|NOT COMPLETED|Overall Study||195
496803|NCT00320372|1193257|P2|COMPLETED|Overall Study||138
496804|NCT00320372|1193258|P1|COMPLETED|Overall Study||299
496805|NCT00320372|1193257|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
496806|NCT00320372|1193258|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
496807|NCT00320372|1193257|P2|VNS Therapy D-23 Original|Overall Study||0
496808|NCT00320372|1193258|P1|VNS Therapy D-23 Original|Overall Study||335
496809|NCT00320372|1193257|P2|STARTED|Overall Study||301
496810|NCT00320372|1193258|P1|STARTED|Overall Study||494
496811|NCT00320281|1193285|P2|NOT COMPLETED|Overall Study||0
496812|NCT00320281|1193286|P1|NOT COMPLETED|Overall Study||0
496813|NCT00320281|1193285|P2|COMPLETED|Overall Study||9
496814|NCT00320281|1193286|P1|COMPLETED|Overall Study||10
496815|NCT00320281|1193285|P2|STARTED|Overall Study||9
496816|NCT00320281|1193286|P1|STARTED|Overall Study||10
496817|NCT00320255|1193298|P6|NOT COMPLETED|Overall Study||0
496818|NCT00320255|1193299|P5|NOT COMPLETED|Overall Study||0
496819|NCT00320255|1193300|P4|NOT COMPLETED|Overall Study||8
496820|NCT00320255|1193301|P3|NOT COMPLETED|Overall Study||6
496821|NCT00320255|1193302|P2|NOT COMPLETED|Overall Study||7
496822|NCT00320255|1193303|P1|NOT COMPLETED|Overall Study||11
496823|NCT00320255|1193298|P6|COMPLETED|Overall Study||3
496824|NCT00320255|1193299|P5|COMPLETED|Overall Study||2
496825|NCT00320255|1193300|P4|COMPLETED|Overall Study||25
496826|NCT00320255|1193301|P3|COMPLETED|Overall Study||24
496827|NCT00320255|1193302|P2|COMPLETED|Overall Study||25
496828|NCT00320255|1193303|P1|COMPLETED|Overall Study||19
496829|NCT00320255|1193298|P6|Received Treatment|Overall Study||3
496830|NCT00320255|1193299|P5|Received Treatment|Overall Study||2
496831|NCT00320255|1193300|P4|Received Treatment|Overall Study||32
496832|NCT00320255|1193301|P3|Received Treatment|Overall Study||29
496833|NCT00320255|1193302|P2|Received Treatment|Overall Study||32
496834|NCT00320255|1193303|P1|Received Treatment|Overall Study||29
496835|NCT00320255|1193298|P6|STARTED|Overall Study||3
496836|NCT00320255|1193299|P5|STARTED|Overall Study||2
496837|NCT00320255|1193300|P4|STARTED|Overall Study||33
496838|NCT00320255|1193301|P3|STARTED|Overall Study||30
496839|NCT00320255|1193302|P2|STARTED|Overall Study||32
496840|NCT00320255|1193303|P1|STARTED|Overall Study||30
496841|NCT00320216|1193388|P5|NOT COMPLETED|Overall Study||6
496842|NCT00320216|1193389|P4|NOT COMPLETED|Overall Study||3
496843|NCT00320216|1193390|P3|NOT COMPLETED|Overall Study||6
496844|NCT00320216|1193391|P2|NOT COMPLETED|Overall Study||10
496845|NCT00320216|1193392|P1|NOT COMPLETED|Overall Study||16
496846|NCT00320216|1193388|P5|COMPLETED|Overall Study||58
496847|NCT00320216|1193389|P4|COMPLETED|Overall Study||61
496848|NCT00320216|1193390|P3|COMPLETED|Overall Study||58
496849|NCT00320216|1193391|P2|COMPLETED|Overall Study||54
496850|NCT00320216|1193392|P1|COMPLETED|Overall Study||48
496851|NCT00320216|1193388|P5|STARTED|Overall Study||64
496852|NCT00320216|1193389|P4|STARTED|Overall Study||64
496853|NCT00320216|1193390|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
496854|NCT00320216|1193391|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
496855|NCT00320216|1193392|P1|STARTED|Overall Study||64
496945|NCT00319046|1193634|P1|COMPLETED|Overall Study||34
496856|NCT00320190|1193426|P2|NOT COMPLETED|Long-term (12-month) Extension||2
496857|NCT00320190|1193427|P1|NOT COMPLETED|Long-term (12-month) Extension||9
496858|NCT00320190|1193426|P2|COMPLETED|Long-term (12-month) Extension||1
496859|NCT00320190|1193427|P1|COMPLETED|Long-term (12-month) Extension||2
496860|NCT00320190|1193426|P2|STARTED|Long-term (12-month) Extension||3
496861|NCT00320190|1193427|P1|STARTED|Long-term (12-month) Extension||11
496862|NCT00320190|1193426|P2|NOT COMPLETED|First 12 Months||10
496863|NCT00320190|1193427|P1|NOT COMPLETED|First 12 Months||8
496864|NCT00320190|1193426|P2|COMPLETED|First 12 Months||3
496865|NCT00320190|1193427|P1|COMPLETED|First 12 Months||11
496866|NCT00320190|1193426|P2|STARTED|First 12 Months||13
496867|NCT00320190|1193427|P1|STARTED|First 12 Months||19
496868|NCT00320112|1193447|P2|NOT COMPLETED|Overall Study||5
496869|NCT00320112|1193448|P1|NOT COMPLETED|Overall Study||8
496870|NCT00320112|1193447|P2|COMPLETED|Overall Study||114
496871|NCT00320112|1193448|P1|COMPLETED|Overall Study||117
496872|NCT00320112|1193447|P2|STARTED|Overall Study||119
496873|NCT00320112|1193448|P1|STARTED|Overall Study||125
496874|NCT00319748|1193460|P1|NOT COMPLETED|Overall Study||0
496875|NCT00319748|1193460|P1|COMPLETED|Overall Study||13
496876|NCT00319748|1193460|P1|STARTED|Overall Study||13
496877|NCT00319735|1193470|P1|NOT COMPLETED|Overall Study||2
496878|NCT00319735|1193470|P1|COMPLETED|Overall Study||39
496879|NCT00319735|1193470|P1|STARTED|Overall Study||41
496880|NCT00319696|1193483|P1|NOT COMPLETED|Overall Study||60
496881|NCT00319696|1193483|P1|COMPLETED|Overall Study||56
496882|NCT00319696|1193483|P1|STARTED|Overall Study||116
496883|NCT00319644|1193509|P2|NOT COMPLETED|Overall Study||0
496884|NCT00319644|1193510|P1|NOT COMPLETED|Overall Study||0
496885|NCT00319644|1193509|P2|COMPLETED|Overall Study||16
496886|NCT00319644|1193510|P1|COMPLETED|Overall Study||21
496887|NCT00319644|1193509|P2|STARTED|Overall Study||16
496888|NCT00319644|1193510|P1|STARTED|Overall Study||21
496889|NCT00319592|1193520|P2|NOT COMPLETED|Overall Study||1
496890|NCT00319592|1193521|P1|NOT COMPLETED|Overall Study||1
496891|NCT00319592|1193520|P2|COMPLETED|Overall Study||29
496892|NCT00319592|1193521|P1|COMPLETED|Overall Study||29
496893|NCT00319592|1193520|P2|STARTED|Overall Study||30
496894|NCT00319592|1193521|P1|STARTED|Overall Study||30
496895|NCT00319553|1193537|P2|NOT COMPLETED|Overall Study||4
496896|NCT00319553|1193538|P1|NOT COMPLETED|Overall Study||4
496897|NCT00319553|1193537|P2|COMPLETED|Overall Study||317
496898|NCT00319553|1193538|P1|COMPLETED|Overall Study||319
496899|NCT00319553|1193537|P2|STARTED|Overall Study||321
496900|NCT00319553|1193538|P1|STARTED|Overall Study||323
496901|NCT00319501|1193552|P2|NOT COMPLETED|Open-label Extension Period||0
496902|NCT00319501|1193553|P1|NOT COMPLETED|Open-label Extension Period||51
496903|NCT00319501|1193552|P2|COMPLETED|Open-label Extension Period||0
496904|NCT00319501|1193553|P1|COMPLETED|Open-label Extension Period||0
496905|NCT00319501|1193552|P2|Received Treatment|Open-label Extension Period||0
496906|NCT00319501|1193553|P1|Received Treatment|Open-label Extension Period||33
496907|NCT00319501|1193552|P2|STARTED|Open-label Extension Period||0
496908|NCT00319501|1193553|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
496909|NCT00319501|1193552|P2|NOT COMPLETED|Open-label Period||0
496910|NCT00319501|1193553|P1|NOT COMPLETED|Open-label Period||116
496911|NCT00319501|1193552|P2|COMPLETED|Open-label Period||0
496912|NCT00319501|1193553|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
496913|NCT00319501|1193552|P2|Received Treatment|Open-label Period||0
496914|NCT00319501|1193553|P1|Received Treatment|Open-label Period||128
496915|NCT00319501|1193552|P2|STARTED|Open-label Period||0
496916|NCT00319501|1193553|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
496917|NCT00319501|1193552|P2|NOT COMPLETED|Double-blind Period||32
496918|NCT00319501|1193553|P1|NOT COMPLETED|Double-blind Period||43
496919|NCT00319501|1193552|P2|COMPLETED|Double-blind Period||78
496920|NCT00319501|1193553|P1|COMPLETED|Double-blind Period||81
496921|NCT00319501|1193552|P2|Received Treatment|Double-blind Period||81
496922|NCT00319501|1193553|P1|Received Treatment|Double-blind Period||82
496923|NCT00319501|1193552|P2|STARTED|Double-blind Period|Randomized participants|110
496924|NCT00319501|1193553|P1|STARTED|Double-blind Period|Randomized participants|124
496925|NCT00319449|1193579|P2|NOT COMPLETED|Overall Study||0
496926|NCT00319449|1193580|P1|NOT COMPLETED|Overall Study||2
496927|NCT00319449|1193579|P2|COMPLETED|Overall Study||12
496928|NCT00319449|1193580|P1|COMPLETED|Overall Study||8
496929|NCT00319449|1193579|P2|STARTED|Overall Study||12
496930|NCT00319449|1193580|P1|STARTED|Overall Study||10
496931|NCT00319436|1193592|P2|NOT COMPLETED|Overall Study||7
496932|NCT00319436|1193593|P1|NOT COMPLETED|Overall Study||6
496933|NCT00319436|1193592|P2|COMPLETED|Overall Study||17
496934|NCT00319436|1193593|P1|COMPLETED|Overall Study||17
496935|NCT00319436|1193592|P2|STARTED|Overall Study||24
496936|NCT00319436|1193593|P1|STARTED|Overall Study||23
496937|NCT00319254|1193611|P1|NOT COMPLETED|Overall Study||54
496938|NCT00319254|1193611|P1|COMPLETED|Overall Study||21
496939|NCT00319254|1193611|P1|Treated|Overall Study||73
496940|NCT00319254|1193611|P1|STARTED|Overall Study||75
496941|NCT00319111|1193624|P1|NOT COMPLETED|Overall Study||47
496942|NCT00319111|1193624|P1|COMPLETED|Overall Study||104
496943|NCT00319111|1193624|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
496944|NCT00319046|1193634|P1|NOT COMPLETED|Overall Study||8
496946|NCT00319046|1193634|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
496947|NCT00319020|1193643|P2|NOT COMPLETED|Overall Study||13
496948|NCT00319020|1193644|P1|NOT COMPLETED|Overall Study||7
496949|NCT00319020|1193643|P2|COMPLETED|Overall Study||8
496950|NCT00319020|1193644|P1|COMPLETED|Overall Study||8
496951|NCT00319020|1193643|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
496952|NCT00319020|1193644|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
496953|NCT00319020|1193643|P2|STARTED|Overall Study||21
496954|NCT00319020|1193644|P1|STARTED|Overall Study||15
496955|NCT00318929|1193673|P1|NOT COMPLETED|Overall Study||0
496956|NCT00318929|1193673|P1|COMPLETED|Overall Study||14
496957|NCT00318929|1193673|P1|STARTED|Overall Study||14
496958|NCT00318812|1193679|P2|NOT COMPLETED|Overall Study||0
496959|NCT00318812|1193680|P1|NOT COMPLETED|Overall Study||0
496960|NCT00318812|1193679|P2|COMPLETED|Overall Study||22
496961|NCT00318812|1193680|P1|COMPLETED|Overall Study||18
496962|NCT00318812|1193679|P2|STARTED|Overall Study||22
496963|NCT00318812|1193680|P1|STARTED|Overall Study||18
496964|NCT00318708|1193692|P2|NOT COMPLETED|Overall Study||5
496965|NCT00318708|1193693|P1|NOT COMPLETED|Overall Study||8
496966|NCT00318708|1193692|P2|COMPLETED|Overall Study||40
496967|NCT00318708|1193693|P1|COMPLETED|Overall Study||39
496968|NCT00318708|1193692|P2|8-week Milestone|Overall Study||42
496969|NCT00318708|1193693|P1|8-week Milestone|Overall Study||42
496970|NCT00318708|1193692|P2|STARTED|Overall Study||45
496971|NCT00318708|1193693|P1|STARTED|Overall Study||47
496972|NCT00318656|1193701|P2|NOT COMPLETED|Overall Study||2
496973|NCT00318656|1193702|P1|NOT COMPLETED|Overall Study||0
496974|NCT00318656|1193701|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
496975|NCT00318656|1193702|P1|COMPLETED|Overall Study||12
496976|NCT00318656|1193701|P2|STARTED|Overall Study||11
496977|NCT00318656|1193702|P1|STARTED|Overall Study||12
496978|NCT00318591|1193740|P2|NOT COMPLETED|Overall Study||45
496979|NCT00318591|1193741|P1|NOT COMPLETED|Overall Study||60
496980|NCT00318591|1193740|P2|COMPLETED|Overall Study||69
496981|NCT00318591|1193741|P1|COMPLETED|Overall Study||45
496982|NCT00318591|1193740|P2|STARTED|Overall Study||114
496983|NCT00318591|1193741|P1|STARTED|Overall Study||105
496984|NCT00318565|1193759|P1|NOT COMPLETED|Overall Study||24
496985|NCT00318565|1193759|P1|COMPLETED|Overall Study||267
496986|NCT00318565|1193759|P1|STARTED|Overall Study||291
496987|NCT00318474|1193766|P2|NOT COMPLETED|Overall Study||17
496988|NCT00318474|1193767|P1|NOT COMPLETED|Overall Study||18
496989|NCT00318474|1193766|P2|COMPLETED|Overall Study||10
496990|NCT00318474|1193767|P1|COMPLETED|Overall Study||7
496991|NCT00318474|1193766|P2|STARTED|Overall Study||27
496992|NCT00318474|1193767|P1|STARTED|Overall Study||25
496993|NCT00318461|1193778|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
496994|NCT00318461|1193779|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
496995|NCT00318461|1193780|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
496996|NCT00318461|1193781|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
496997|NCT00318461|1193782|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
496998|NCT00318461|1193778|P5|COMPLETED|Open-Label Extension, 18 Months||113
496999|NCT00318461|1193779|P4|COMPLETED|Open-Label Extension, 18 Months||31
497000|NCT00318461|1193780|P3|COMPLETED|Open-Label Extension, 18 Months||118
497001|NCT00318461|1193781|P2|COMPLETED|Open-Label Extension, 18 Months||137
497002|NCT00318461|1193782|P1|COMPLETED|Open-Label Extension, 18 Months||130
497003|NCT00318461|1193778|P5|STARTED|Open-Label Extension, 18 Months||210
497004|NCT00318461|1193779|P4|STARTED|Open-Label Extension, 18 Months||74
497005|NCT00318461|1193780|P3|STARTED|Open-Label Extension, 18 Months||191
497006|NCT00318461|1193781|P2|STARTED|Open-Label Extension, 18 Months||197
497007|NCT00318461|1193782|P1|STARTED|Open-Label Extension, 18 Months||208
497008|NCT00318461|1193778|P5|NOT COMPLETED|Double-Blind, 6 Months||34
497009|NCT00318461|1193779|P4|NOT COMPLETED|Double-Blind, 6 Months||48
497010|NCT00318461|1193780|P3|NOT COMPLETED|Double-Blind, 6 Months||51
497011|NCT00318461|1193781|P2|NOT COMPLETED|Double-Blind, 6 Months||44
497012|NCT00318461|1193782|P1|NOT COMPLETED|Double-Blind, 6 Months||34
497013|NCT00318461|1193778|P5|COMPLETED|Double-Blind, 6 Months||210
497014|NCT00318461|1193779|P4|COMPLETED|Double-Blind, 6 Months||74
497015|NCT00318461|1193780|P3|COMPLETED|Double-Blind, 6 Months||191
497016|NCT00318461|1193781|P2|COMPLETED|Double-Blind, 6 Months||197
497017|NCT00318461|1193782|P1|COMPLETED|Double-Blind, 6 Months||208
497018|NCT00318461|1193778|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
497019|NCT00318461|1193779|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
497020|NCT00318461|1193780|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
497021|NCT00318461|1193781|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
497022|NCT00318461|1193782|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
497023|NCT00318461|1193778|P5|STARTED|Double-Blind, 6 Months|Randomised|244
497024|NCT00318461|1193779|P4|STARTED|Double-Blind, 6 Months|Randomised|122
497025|NCT00318461|1193780|P3|STARTED|Double-Blind, 6 Months|Randomised|242
497026|NCT00318461|1193781|P2|STARTED|Double-Blind, 6 Months|Randomised|241
497027|NCT00318461|1193782|P1|STARTED|Double-Blind, 6 Months|Randomised|242
497028|NCT00318409|1193861|P2|NOT COMPLETED|Overall Study||1
497029|NCT00318409|1193862|P1|NOT COMPLETED|Overall Study||2
497030|NCT00318409|1193861|P2|COMPLETED|Overall Study||9
497031|NCT00318409|1193862|P1|COMPLETED|Overall Study||18
497032|NCT00318409|1193861|P2|STARTED|Overall Study||10
497033|NCT00318409|1193862|P1|STARTED|Overall Study||20
497034|NCT00318370|1193881|P3|NOT COMPLETED|Period 3||33
497035|NCT00318370|1193882|P2|NOT COMPLETED|Period 3||0
497036|NCT00318370|1193883|P1|NOT COMPLETED|Period 3||0
497037|NCT00318370|1193881|P3|COMPLETED|Period 3||3
497038|NCT00318370|1193882|P2|COMPLETED|Period 3||0
497039|NCT00318370|1193883|P1|COMPLETED|Period 3||0
497040|NCT00318370|1193881|P3|STARTED|Period 3||36
497041|NCT00318370|1193882|P2|STARTED|Period 3||0
497042|NCT00318370|1193883|P1|STARTED|Period 3||0
497043|NCT00318370|1193881|P3|NOT COMPLETED|Period 2||0
497044|NCT00318370|1193882|P2|NOT COMPLETED|Period 2||11
497045|NCT00318370|1193883|P1|NOT COMPLETED|Period 2||0
497046|NCT00318370|1193881|P3|COMPLETED|Period 2||0
497047|NCT00318370|1193882|P2|COMPLETED|Period 2||36
497048|NCT00318370|1193883|P1|COMPLETED|Period 2||0
497049|NCT00318370|1193881|P3|STARTED|Period 2||0
497050|NCT00318370|1193882|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
497051|NCT00318370|1193883|P1|STARTED|Period 2||0
497052|NCT00318370|1193881|P3|NOT COMPLETED|Period 1||0
497053|NCT00318370|1193882|P2|NOT COMPLETED|Period 1||0
497054|NCT00318370|1193883|P1|NOT COMPLETED|Period 1||7
497055|NCT00318370|1193881|P3|COMPLETED|Period 1||0
497056|NCT00318370|1193882|P2|COMPLETED|Period 1||0
497057|NCT00318370|1193883|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
497058|NCT00318370|1193881|P3|STARTED|Period 1||0
497059|NCT00318370|1193882|P2|STARTED|Period 1||0
497060|NCT00318370|1193883|P1|STARTED|Period 1||28
497061|NCT00317239|1193895|P2|NOT COMPLETED|Overall Study||19
497062|NCT00317239|1193896|P1|NOT COMPLETED|Overall Study||13
497063|NCT00317239|1193895|P2|COMPLETED|Overall Study||84
497064|NCT00317239|1193896|P1|COMPLETED|Overall Study||134
497065|NCT00317239|1193895|P2|STARTED|Overall Study||103
497066|NCT00317239|1193896|P1|STARTED|Overall Study||147
497067|NCT00317226|1193902|P1|NOT COMPLETED|Overall Study||23
497068|NCT00317226|1193902|P1|COMPLETED|Overall Study||104
497069|NCT00317226|1193902|P1|STARTED|Overall Study||127
497070|NCT00318292|1193908|P2|NOT COMPLETED|Overall Study||0
497071|NCT00318292|1193909|P1|NOT COMPLETED|Overall Study||0
497072|NCT00318292|1193908|P2|COMPLETED|Overall Study||45
497073|NCT00318292|1193909|P1|COMPLETED|Overall Study||45
497074|NCT00318292|1193908|P2|STARTED|Overall Study||45
497075|NCT00318292|1193909|P1|STARTED|Overall Study||45
497076|NCT00318136|1193915|P1|NOT COMPLETED|Overall Study||45
497077|NCT00318136|1193915|P1|COMPLETED|Overall Study||2
497078|NCT00318136|1193915|P1|STARTED|Overall Study||47
497079|NCT00317941|1193924|P3|NOT COMPLETED|Overall Study||8
497080|NCT00317941|1193925|P2|NOT COMPLETED|Overall Study||5
497081|NCT00317941|1193926|P1|NOT COMPLETED|Overall Study||7
497082|NCT00317941|1193924|P3|COMPLETED|Overall Study||60
497083|NCT00317941|1193925|P2|COMPLETED|Overall Study||74
497084|NCT00317941|1193926|P1|COMPLETED|Overall Study||66
497085|NCT00317941|1193924|P3|Fulfilled Requirements PP Population|Overall Study||63
497086|NCT00317941|1193925|P2|Fulfilled Requirements PP Population|Overall Study||76
497087|NCT00317941|1193926|P1|Fulfilled Requirements PP Population|Overall Study||66
497088|NCT00317941|1193924|P3|Fulfilled Requirement Safety Population|Overall Study||65
497089|NCT00317941|1193925|P2|Fulfilled Requirement Safety Population|Overall Study||77
497090|NCT00317941|1193926|P1|Fulfilled Requirement Safety Population|Overall Study||73
497091|NCT00317941|1193924|P3|Participants Received Treatment|Overall Study||68
497092|NCT00317941|1193925|P2|Participants Received Treatment|Overall Study||79
497093|NCT00317941|1193926|P1|Participants Received Treatment|Overall Study||73
497094|NCT00317941|1193924|P3|STARTED|Overall Study||68
497095|NCT00317941|1193925|P2|STARTED|Overall Study||79
497096|NCT00317941|1193926|P1|STARTED|Overall Study||73
497097|NCT00317720|1193967|P2|NOT COMPLETED|Overall Study||0
497098|NCT00317720|1193968|P1|NOT COMPLETED|Overall Study||0
497099|NCT00317720|1193967|P2|COMPLETED|Overall Study||7
497100|NCT00317720|1193968|P1|COMPLETED|Overall Study||40
497101|NCT00317720|1193967|P2|STARTED|Overall Study||7
497102|NCT00317720|1193968|P1|STARTED|Overall Study||40
497103|NCT00317642|1193975|P2|NOT COMPLETED|Overall Study||135
497104|NCT00317642|1193976|P1|NOT COMPLETED|Overall Study||122
497105|NCT00317642|1193975|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
497106|NCT00317642|1193976|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
497107|NCT00317642|1193975|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
497108|NCT00317642|1193976|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
497109|NCT00317642|1193975|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
497110|NCT00317642|1193976|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
497111|NCT00317642|1193975|P2|STARTED|Overall Study||163
497112|NCT00317642|1193976|P1|STARTED|Overall Study||163
497113|NCT00317109|1194051|P2|NOT COMPLETED|Overall Study||0
497114|NCT00317109|1194052|P1|NOT COMPLETED|Overall Study||3
497115|NCT00317109|1194051|P2|COMPLETED|Overall Study||84
497116|NCT00317109|1194052|P1|COMPLETED|Overall Study||81
497117|NCT00317109|1194051|P2|STARTED|Overall Study||84
497118|NCT00317109|1194052|P1|STARTED|Overall Study||84
497119|NCT00317044|1194089|P3|NOT COMPLETED|Overall Study||45
497120|NCT00317044|1194090|P2|NOT COMPLETED|Overall Study||40
497121|NCT00317044|1194091|P1|NOT COMPLETED|Overall Study||48
497122|NCT00317044|1194089|P3|COMPLETED|Overall Study||283
497123|NCT00317044|1194090|P2|COMPLETED|Overall Study||273
497124|NCT00317044|1194091|P1|COMPLETED|Overall Study||272
497125|NCT00317044|1194089|P3|STARTED|Overall Study||328
497126|NCT00317044|1194090|P2|STARTED|Overall Study||313
497127|NCT00317044|1194091|P1|STARTED|Overall Study||320
497128|NCT00316914|1194137|P2|NOT COMPLETED|Overall Study||36
497129|NCT00316914|1194138|P1|NOT COMPLETED|Overall Study||33
497130|NCT00316914|1194137|P2|COMPLETED|Overall Study||16
497131|NCT00316914|1194138|P1|COMPLETED|Overall Study||17
497132|NCT00316914|1194137|P2|STARTED|Overall Study||52
497133|NCT00316914|1194138|P1|STARTED|Overall Study||50
497134|NCT00316888|1194168|P2|NOT COMPLETED|Overall Study||8
497135|NCT00316888|1194169|P1|NOT COMPLETED|Overall Study||6
497136|NCT00316888|1194168|P2|COMPLETED|Overall Study||27
497137|NCT00316888|1194169|P1|COMPLETED|Overall Study||22
497138|NCT00316888|1194168|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
497139|NCT00316888|1194169|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
497140|NCT00316888|1194168|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
497141|NCT00316888|1194169|P1|Started Induction Chemotherapy|Overall Study||28
497142|NCT00316888|1194168|P2|Treated|Overall Study||34
497143|NCT00316888|1194169|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
497144|NCT00316888|1194168|P2|Eligible|Overall Study||35
497145|NCT00316888|1194169|P1|Eligible|Overall Study||28
497146|NCT00316888|1194168|P2|STARTED|Overall Study||35
497147|NCT00316888|1194169|P1|STARTED|Overall Study||28
497148|NCT00316862|1194183|P1|NOT COMPLETED|Overall Study||0
497149|NCT00316862|1194183|P1|COMPLETED|Overall Study||82
497150|NCT00316862|1194183|P1|STARTED|Overall Study||82
497151|NCT00316719|1194191|P2|NOT COMPLETED|Overall Study||6
497152|NCT00316719|1194192|P1|NOT COMPLETED|Overall Study||2
497153|NCT00316719|1194191|P2|COMPLETED|Overall Study||47
497154|NCT00316719|1194192|P1|COMPLETED|Overall Study||50
497155|NCT00316719|1194191|P2|STARTED|Overall Study||53
497156|NCT00316719|1194192|P1|STARTED|Overall Study||52
497157|NCT00316706|1194218|P2|NOT COMPLETED|Overall Study||48
497158|NCT00316706|1194219|P1|NOT COMPLETED|Overall Study||38
497159|NCT00316706|1194218|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
497160|NCT00316706|1194219|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
497161|NCT00316706|1194218|P2|STARTED|Overall Study||619
497162|NCT00316706|1194219|P1|STARTED|Overall Study||626
497163|NCT00316693|1194235|P2|NOT COMPLETED|Overall Study||85
497164|NCT00316693|1194236|P1|NOT COMPLETED|Overall Study||77
497165|NCT00316693|1194235|P2|COMPLETED|Overall Study||436
497166|NCT00316693|1194236|P1|COMPLETED|Overall Study||442
497167|NCT00316693|1194235|P2|STARTED|Overall Study||521
497168|NCT00316693|1194236|P1|STARTED|Overall Study||519
497169|NCT00316355|1194278|P2|NOT COMPLETED|Overall Study||7
497170|NCT00316355|1194279|P1|NOT COMPLETED|Overall Study||5
497171|NCT00316355|1194278|P2|COMPLETED|Overall Study||12
497172|NCT00316355|1194279|P1|COMPLETED|Overall Study||10
497173|NCT00316355|1194278|P2|Started Treatment|Overall Study||18
497174|NCT00316355|1194279|P1|Started Treatment|Overall Study||12
497175|NCT00316355|1194278|P2|STARTED|Overall Study||19
497176|NCT00316355|1194279|P1|STARTED|Overall Study||15
497177|NCT00316303|1194289|P2|NOT COMPLETED|Overall Study||16
497178|NCT00316303|1194290|P1|NOT COMPLETED|Overall Study||11
497179|NCT00316303|1194289|P2|COMPLETED|Overall Study||102
497180|NCT00316303|1194290|P1|COMPLETED|Overall Study||107
497181|NCT00316303|1194289|P2|STARTED|Overall Study||118
497182|NCT00316303|1194290|P1|STARTED|Overall Study||118
497183|NCT00316277|1194306|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
497184|NCT00316277|1194307|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
497185|NCT00316277|1194306|P2|COMPLETED|Phase 2 (24 Weeks)||161
497186|NCT00316277|1194307|P1|COMPLETED|Phase 2 (24 Weeks)||161
497187|NCT00316277|1194306|P2|STARTED|Phase 2 (24 Weeks)||180
497188|NCT00316277|1194307|P1|STARTED|Phase 2 (24 Weeks)||180
497189|NCT00316277|1194306|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
497190|NCT00316277|1194307|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
497191|NCT00316277|1194306|P2|COMPLETED|Phase 1 (12 Weeks)||24
497192|NCT00316277|1194307|P1|COMPLETED|Phase 1 (12 Weeks)||19
497193|NCT00316277|1194306|P2|STARTED|Phase 1 (12 Weeks)||324
497194|NCT00316277|1194307|P1|STARTED|Phase 1 (12 Weeks)||329
497195|NCT00316264|1194328|P3|NOT COMPLETED|Overall Study||6
497196|NCT00316264|1194329|P2|NOT COMPLETED|Overall Study||7
497197|NCT00316264|1194330|P1|NOT COMPLETED|Overall Study||6
497198|NCT00316264|1194328|P3|COMPLETED|Overall Study||87
497199|NCT00316264|1194329|P2|COMPLETED|Overall Study||77
497200|NCT00316264|1194330|P1|COMPLETED|Overall Study||77
497201|NCT00316264|1194328|P3|STARTED|Overall Study||93
497202|NCT00316264|1194329|P2|STARTED|Overall Study||84
497203|NCT00316264|1194330|P1|STARTED|Overall Study||83
497204|NCT00316225|1194398|P1|NOT COMPLETED|Overall Study||25
497205|NCT00316225|1194398|P1|COMPLETED|Overall Study||6
497206|NCT00316225|1194398|P1|STARTED|Overall Study||31
497207|NCT00316199|1194407|P1|NOT COMPLETED|Overall Study||12
497208|NCT00316199|1194407|P1|COMPLETED|Overall Study||48
497209|NCT00316199|1194407|P1|STARTED|Overall Study||60
497210|NCT00316186|1194415|P1|NOT COMPLETED|Overall Study||12
497211|NCT00316186|1194415|P1|COMPLETED|Overall Study||21
497212|NCT00316186|1194415|P1|STARTED|Overall Study||33
497213|NCT00316173|1194429|P2|NOT COMPLETED|Treatment Phase||42
497214|NCT00316173|1194430|P1|NOT COMPLETED|Treatment Phase||0
497215|NCT00316173|1194429|P2|COMPLETED|Treatment Phase||13
497216|NCT00316173|1194430|P1|COMPLETED|Treatment Phase||0
497217|NCT00316173|1194429|P2|STARTED|Treatment Phase||55
497218|NCT00316173|1194430|P1|STARTED|Treatment Phase||0
497219|NCT00316173|1194429|P2|NOT COMPLETED|Run-in Phase||0
497220|NCT00316173|1194430|P1|NOT COMPLETED|Run-in Phase||7
497221|NCT00316173|1194429|P2|COMPLETED|Run-in Phase||0
497222|NCT00316173|1194430|P1|COMPLETED|Run-in Phase||15
497223|NCT00316173|1194429|P2|STARTED|Run-in Phase||0
497224|NCT00316173|1194430|P1|STARTED|Run-in Phase||22
497225|NCT00316121|1194443|P2|NOT COMPLETED|Overall Study||9
497226|NCT00316121|1194444|P1|NOT COMPLETED|Overall Study||22
497227|NCT00316121|1194443|P2|COMPLETED|Overall Study||37
497228|NCT00316121|1194444|P1|COMPLETED|Overall Study||70
497229|NCT00316121|1194443|P2|STARTED|Overall Study||46
497230|NCT00316121|1194444|P1|STARTED|Overall Study||92
497231|NCT00316082|1194455|P5|NOT COMPLETED|Overall Study||26
497232|NCT00316082|1194456|P4|NOT COMPLETED|Overall Study||26
497233|NCT00316082|1194457|P3|NOT COMPLETED|Overall Study||27
497234|NCT00316082|1194458|P2|NOT COMPLETED|Overall Study||22
497235|NCT00316082|1194459|P1|NOT COMPLETED|Overall Study||33
497236|NCT00316082|1194455|P5|COMPLETED|Overall Study||48
497237|NCT00316082|1194456|P4|COMPLETED|Overall Study||46
497238|NCT00316082|1194457|P3|COMPLETED|Overall Study||44
497239|NCT00316082|1194458|P2|COMPLETED|Overall Study||52
497240|NCT00316082|1194459|P1|COMPLETED|Overall Study||41
497241|NCT00316082|1194455|P5|Completed Study Without Being Rescued|Overall Study||31
497242|NCT00316082|1194456|P4|Completed Study Without Being Rescued|Overall Study||27
497243|NCT00316082|1194457|P3|Completed Study Without Being Rescued|Overall Study||29
497244|NCT00316082|1194458|P2|Completed Study Without Being Rescued|Overall Study||35
497245|NCT00316082|1194459|P1|Completed Study Without Being Rescued|Overall Study||25
497246|NCT00316082|1194455|P5|STARTED|Overall Study||74
497247|NCT00316082|1194456|P4|STARTED|Overall Study||72
497248|NCT00316082|1194457|P3|STARTED|Overall Study||71
497249|NCT00316082|1194458|P2|STARTED|Overall Study||74
497250|NCT00316082|1194459|P1|STARTED|Overall Study||74
497251|NCT00316017|1194490|P3|NOT COMPLETED|Overall Study||19
497252|NCT00316017|1194491|P2|NOT COMPLETED|Overall Study||13
497253|NCT00316017|1194492|P1|NOT COMPLETED|Overall Study||11
497254|NCT00316017|1194490|P3|COMPLETED|Overall Study||376
497255|NCT00316017|1194491|P2|COMPLETED|Overall Study||256
497256|NCT00316017|1194492|P1|COMPLETED|Overall Study||220
497257|NCT00316017|1194490|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
497258|NCT00316017|1194491|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
497348|NCT00315328|1194832|P2|5 Week Visit|Overall Study||89
497259|NCT00316017|1194492|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
497260|NCT00316004|1194566|P3|NOT COMPLETED|Overall Study||21
497261|NCT00316004|1194567|P2|NOT COMPLETED|Overall Study||14
497262|NCT00316004|1194568|P1|NOT COMPLETED|Overall Study||14
497263|NCT00316004|1194566|P3|COMPLETED|Overall Study||582
497264|NCT00316004|1194567|P2|COMPLETED|Overall Study||341
497265|NCT00316004|1194568|P1|COMPLETED|Overall Study||359
497266|NCT00316004|1194566|P3|STARTED|Overall Study||603
497267|NCT00316004|1194567|P2|STARTED|Overall Study||355
497268|NCT00316004|1194568|P1|STARTED|Overall Study||373
497269|NCT00315939|1194623|P2|NOT COMPLETED|Admission 3 (3 Months)||2
497270|NCT00315939|1194624|P1|NOT COMPLETED|Admission 3 (3 Months)||4
497271|NCT00315939|1194623|P2|COMPLETED|Admission 3 (3 Months)||49
497272|NCT00315939|1194624|P1|COMPLETED|Admission 3 (3 Months)||48
497273|NCT00315939|1194623|P2|STARTED|Admission 3 (3 Months)||51
497274|NCT00315939|1194624|P1|STARTED|Admission 3 (3 Months)||52
497275|NCT00315939|1194623|P2|NOT COMPLETED|Admission 2 (3 Months)||4
497276|NCT00315939|1194624|P1|NOT COMPLETED|Admission 2 (3 Months)||4
497277|NCT00315939|1194623|P2|COMPLETED|Admission 2 (3 Months)||51
497278|NCT00315939|1194624|P1|COMPLETED|Admission 2 (3 Months)||52
497279|NCT00315939|1194623|P2|STARTED|Admission 2 (3 Months)||55
497280|NCT00315939|1194624|P1|STARTED|Admission 2 (3 Months)||56
497281|NCT00315939|1194623|P2|NOT COMPLETED|Admission 1 (3 Months)||6
497282|NCT00315939|1194624|P1|NOT COMPLETED|Admission 1 (3 Months)||3
497283|NCT00315939|1194623|P2|COMPLETED|Admission 1 (3 Months)||55
497284|NCT00315939|1194624|P1|COMPLETED|Admission 1 (3 Months)||56
497285|NCT00315939|1194623|P2|STARTED|Admission 1 (3 Months)||61
497286|NCT00315939|1194624|P1|STARTED|Admission 1 (3 Months)||59
497287|NCT00315822|1194632|P2|NOT COMPLETED|Overall Study||0
497288|NCT00315822|1194633|P1|NOT COMPLETED|Overall Study||0
497289|NCT00315822|1194632|P2|COMPLETED|Overall Study||202
497290|NCT00315822|1194633|P1|COMPLETED|Overall Study||198
497291|NCT00315822|1194632|P2|STARTED|Overall Study||202
497292|NCT00315822|1194633|P1|STARTED|Overall Study||198
497293|NCT00315731|1194639|P1|NOT COMPLETED|Overall Study||6
497294|NCT00315731|1194639|P1|COMPLETED|Overall Study||9
497295|NCT00315731|1194639|P1|STARTED|Overall Study||15
497296|NCT00315705|1194667|P1|NOT COMPLETED|Phase 2||25
497297|NCT00315705|1194667|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
497298|NCT00315705|1194667|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
497299|NCT00315705|1194667|P1|NOT COMPLETED|Phase 1||25
497300|NCT00315705|1194667|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
497301|NCT00315705|1194667|P1|STARTED|Phase 1||25
497302|NCT00315627|1194704|P1|NOT COMPLETED|Overall Study||0
497303|NCT00315627|1194704|P1|COMPLETED|Overall Study||3
497304|NCT00315627|1194704|P1|STARTED|Overall Study||3
497305|NCT00315614|1194712|P1|NOT COMPLETED|Overall Study||0
497306|NCT00315614|1194712|P1|COMPLETED|Overall Study||3
497307|NCT00315614|1194712|P1|STARTED|Overall Study||3
497308|NCT00315588|1194719|P1|NOT COMPLETED|Overall Study||0
497309|NCT00315588|1194719|P1|COMPLETED|Overall Study||7
497310|NCT00315588|1194719|P1|STARTED|Overall Study||7
497311|NCT00315458|1194728|P4|NOT COMPLETED|Overall Study||29
497312|NCT00315458|1194729|P3|NOT COMPLETED|Overall Study||52
497313|NCT00315458|1194730|P2|NOT COMPLETED|Overall Study||12
497314|NCT00315458|1194731|P1|NOT COMPLETED|Overall Study||3
497315|NCT00315458|1194728|P4|COMPLETED|Overall Study||10
497316|NCT00315458|1194729|P3|COMPLETED|Overall Study||107
497317|NCT00315458|1194730|P2|COMPLETED|Overall Study||44
497318|NCT00315458|1194731|P1|COMPLETED|Overall Study||48
497319|NCT00315458|1194728|P4|STARTED|Overall Study||39
497320|NCT00315458|1194729|P3|STARTED|Overall Study||159
497321|NCT00315458|1194730|P2|STARTED|Overall Study||56
497322|NCT00315458|1194731|P1|STARTED|Overall Study||51
497323|NCT00315445|1194744|P3|NOT COMPLETED|Overall Study||24
497324|NCT00315445|1194745|P2|NOT COMPLETED|Overall Study||16
497325|NCT00315445|1194746|P1|NOT COMPLETED|Overall Study||27
497326|NCT00315445|1194744|P3|COMPLETED|Overall Study||22
497327|NCT00315445|1194745|P2|COMPLETED|Overall Study||27
497328|NCT00315445|1194746|P1|COMPLETED|Overall Study||18
497329|NCT00315445|1194744|P3|STARTED|Overall Study||46
497330|NCT00315445|1194745|P2|STARTED|Overall Study||43
497331|NCT00315445|1194746|P1|STARTED|Overall Study||45
497332|NCT00315341|1194819|P2|NOT COMPLETED|Overall Study||138
497333|NCT00315341|1194820|P1|NOT COMPLETED|Overall Study||400
497334|NCT00315341|1194819|P2|COMPLETED|Overall Study||391
497335|NCT00315341|1194820|P1|COMPLETED|Overall Study||340
497336|NCT00315341|1194819|P2|STARTED|Overall Study||529
497337|NCT00315341|1194820|P1|STARTED|Overall Study||740
497338|NCT00315328|1194830|P4|NOT COMPLETED|Overall Study||2
497339|NCT00315328|1194831|P3|NOT COMPLETED|Overall Study||5
497340|NCT00315328|1194832|P2|NOT COMPLETED|Overall Study||7
497341|NCT00315328|1194833|P1|NOT COMPLETED|Overall Study||14
497342|NCT00315328|1194830|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
497343|NCT00315328|1194831|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
497344|NCT00315328|1194832|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
497345|NCT00315328|1194833|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
497346|NCT00315328|1194830|P4|5 Week Visit|Overall Study||19
497347|NCT00315328|1194831|P3|5 Week Visit|Overall Study||17
497349|NCT00315328|1194833|P1|5 Week Visit|Overall Study||91
497350|NCT00315328|1194830|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
497351|NCT00315328|1194831|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
497352|NCT00315328|1194832|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
497353|NCT00315328|1194833|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
497354|NCT00315302|1194903|P4|NOT COMPLETED|Overall Study||3
497355|NCT00315302|1194904|P3|NOT COMPLETED|Overall Study||2
497356|NCT00315302|1194905|P2|NOT COMPLETED|Overall Study||2
497357|NCT00315302|1194906|P1|NOT COMPLETED|Overall Study||6
497358|NCT00315302|1194903|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
497359|NCT00315302|1194904|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
497360|NCT00315302|1194905|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
497361|NCT00315302|1194906|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
497362|NCT00315302|1194903|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
497363|NCT00315302|1194904|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
497364|NCT00315302|1194905|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
497365|NCT00315302|1194906|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
497366|NCT00315302|1194903|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
497367|NCT00315302|1194904|P3|18 Week Primary Outcome Visit|Overall Study||24
497368|NCT00315302|1194905|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
497369|NCT00315302|1194906|P1|18 Week Primary Outcome Visit|Overall Study||84
497370|NCT00315302|1194903|P4|10 Week Visit|Overall Study||29
497371|NCT00315302|1194904|P3|10 Week Visit|Overall Study||24
497372|NCT00315302|1194905|P2|10 Week Visit|Overall Study||85
497373|NCT00315302|1194906|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
497374|NCT00315302|1194903|P4|5 Week Visit|Overall Study||30
497375|NCT00315302|1194904|P3|5 Week Visit|Overall Study||26
497376|NCT00315302|1194905|P2|5 Week Visit|Overall Study||86
497377|NCT00315302|1194906|P1|5 Week Visit|Overall Study||85
497378|NCT00315302|1194903|P4|STARTED|Overall Study||34
497379|NCT00315302|1194904|P3|STARTED|Overall Study||26
497380|NCT00315302|1194905|P2|STARTED|Overall Study||90
497381|NCT00315302|1194906|P1|STARTED|Overall Study||90
497382|NCT00315146|1194952|P4|NOT COMPLETED|Overall Study||0
497383|NCT00315146|1194953|P3|NOT COMPLETED|Overall Study||2
497384|NCT00315146|1194954|P2|NOT COMPLETED|Overall Study||3
497385|NCT00315146|1194955|P1|NOT COMPLETED|Overall Study||2
497386|NCT00315146|1194952|P4|COMPLETED|Overall Study||22
497387|NCT00315146|1194953|P3|COMPLETED|Overall Study||20
497388|NCT00315146|1194954|P2|COMPLETED|Overall Study||19
497389|NCT00315146|1194955|P1|COMPLETED|Overall Study||20
497390|NCT00315146|1194952|P4|STARTED|Overall Study||22
497391|NCT00315146|1194953|P3|STARTED|Overall Study||22
497392|NCT00315146|1194954|P2|STARTED|Overall Study||22
497393|NCT00315146|1194955|P1|STARTED|Overall Study||22
497394|NCT00315120|1194973|P4|NOT COMPLETED|Overall Study||0
497395|NCT00315120|1194974|P3|NOT COMPLETED|Overall Study||0
497396|NCT00315120|1194975|P2|NOT COMPLETED|Overall Study||0
497397|NCT00315120|1194976|P1|NOT COMPLETED|Overall Study||0
497398|NCT00315120|1194973|P4|COMPLETED|Overall Study||107
497399|NCT00315120|1194974|P3|COMPLETED|Overall Study||115
497400|NCT00315120|1194975|P2|COMPLETED|Overall Study||118
497401|NCT00315120|1194976|P1|COMPLETED|Overall Study||115
497402|NCT00315120|1194973|P4|STARTED|Overall Study||107
497403|NCT00315120|1194974|P3|STARTED|Overall Study||115
497404|NCT00315120|1194975|P2|STARTED|Overall Study||118
497405|NCT00315120|1194976|P1|STARTED|Overall Study||115
497406|NCT00315055|1195036|P2|NOT COMPLETED|Overall Study||5
497407|NCT00315055|1195037|P1|NOT COMPLETED|Overall Study||3
497408|NCT00315055|1195036|P2|COMPLETED|Overall Study||150
497409|NCT00315055|1195037|P1|COMPLETED|Overall Study||152
497410|NCT00315055|1195036|P2|STARTED|Overall Study||155
497411|NCT00315055|1195037|P1|STARTED|Overall Study||155
497412|NCT00314951|1195055|P2|NOT COMPLETED|Follow-up||34
497413|NCT00314951|1195056|P1|NOT COMPLETED|Follow-up||44
497414|NCT00314951|1195055|P2|COMPLETED|Follow-up||255
497415|NCT00314951|1195056|P1|COMPLETED|Follow-up||263
497416|NCT00314951|1195055|P2|STARTED|Follow-up||289
497417|NCT00314951|1195056|P1|STARTED|Follow-up||307
497418|NCT00314951|1195055|P2|NOT COMPLETED|Treatment||11
497419|NCT00314951|1195056|P1|NOT COMPLETED|Treatment||16
497420|NCT00314951|1195055|P2|COMPLETED|Treatment||289
497421|NCT00314951|1195056|P1|COMPLETED|Treatment||307
497422|NCT00314951|1195055|P2|STARTED|Treatment||300
497423|NCT00314951|1195056|P1|STARTED|Treatment||323
497424|NCT00314951|1195055|P2|NOT COMPLETED|Enrollment||6
497425|NCT00314951|1195056|P1|NOT COMPLETED|Enrollment||0
497426|NCT00314951|1195055|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
497427|NCT00314951|1195056|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
497428|NCT00314951|1195055|P2|STARTED|Enrollment||306
497429|NCT00314951|1195056|P1|STARTED|Enrollment||323
497430|NCT00314808|1195066|P1|NOT COMPLETED|Overall Study||8
497431|NCT00314808|1195066|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
497432|NCT00314808|1195066|P1|STARTED|Overall Study||33
497433|NCT00314574|1195076|P2|NOT COMPLETED|Overall Study||83
497434|NCT00314574|1195077|P1|NOT COMPLETED|Overall Study||94
497435|NCT00314574|1195076|P2|COMPLETED|Overall Study||344
497436|NCT00314574|1195077|P1|COMPLETED|Overall Study||329
497437|NCT00314574|1195076|P2|Safety Population|Overall Study||428
497438|NCT00314574|1195077|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
497439|NCT00314574|1195076|P2|Received at Least One Dose of Study Drug|Overall Study||427
497440|NCT00314574|1195077|P1|Received at Least One Dose of Study Drug|Overall Study||421
497441|NCT00314574|1195076|P2|STARTED|Overall Study||427
497442|NCT00314574|1195077|P1|STARTED|Overall Study||423
497443|NCT00314366|1195093|P2|NOT COMPLETED|Overall Study||0
497444|NCT00314366|1195094|P1|NOT COMPLETED|Overall Study||1
497445|NCT00314366|1195093|P2|COMPLETED|Overall Study||10
497446|NCT00314366|1195094|P1|COMPLETED|Overall Study||10
497447|NCT00314366|1195093|P2|STARTED|Overall Study||10
497448|NCT00314366|1195094|P1|STARTED|Overall Study||11
497449|NCT00314353|1195124|P2|NOT COMPLETED|Follow-up||0
497450|NCT00314353|1195125|P1|NOT COMPLETED|Follow-up||0
497451|NCT00314353|1195124|P2|COMPLETED|Follow-up||0
497452|NCT00314353|1195125|P1|COMPLETED|Follow-up||3
497453|NCT00314353|1195124|P2|STARTED|Follow-up||0
497454|NCT00314353|1195125|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
497455|NCT00314353|1195124|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
497456|NCT00314353|1195125|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
497457|NCT00314353|1195124|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
497458|NCT00314353|1195125|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
497459|NCT00314353|1195124|P2|STARTED|Protocol Therapy (8 Cycles)||3
497460|NCT00314353|1195125|P1|STARTED|Protocol Therapy (8 Cycles)||4
497461|NCT00314340|1195131|P1|NOT COMPLETED|Overall Study||1
497462|NCT00314340|1195131|P1|COMPLETED|Overall Study||11
497463|NCT00314340|1195131|P1|Placebo|Overall Study||12
497464|NCT00314340|1195131|P1|Hydrocodone Plus APAP|Overall Study||12
497465|NCT00314340|1195131|P1|ER Morphine|Overall Study||11
497466|NCT00314340|1195131|P1|STARTED|Overall Study||12
497467|NCT00314327|1195137|P1|NOT COMPLETED|Overall Study||1
497468|NCT00314327|1195137|P1|COMPLETED|Overall Study||0
497469|NCT00314327|1195137|P1|STARTED|Overall Study||1
497470|NCT00314262|1195141|P1|NOT COMPLETED|Overall Study||5
497471|NCT00314262|1195141|P1|COMPLETED|Overall Study||7
497472|NCT00314262|1195141|P1|STARTED|Overall Study||12
497473|NCT00314249|1195149|P2|NOT COMPLETED|Overall Study||163
497474|NCT00314249|1195150|P1|NOT COMPLETED|Overall Study||152
497475|NCT00314249|1195149|P2|COMPLETED|Overall Study||353
497476|NCT00314249|1195150|P1|COMPLETED|Overall Study||357
497477|NCT00314249|1195149|P2|STARTED|Overall Study||516
497478|NCT00314249|1195150|P1|STARTED|Overall Study||509
497479|NCT00314236|1195168|P2|NOT COMPLETED|Overall Study||2
497480|NCT00314236|1195169|P1|NOT COMPLETED|Overall Study||0
497481|NCT00314236|1195168|P2|COMPLETED|Overall Study||37
497482|NCT00314236|1195169|P1|COMPLETED|Overall Study||41
497483|NCT00314236|1195168|P2|STARTED|Overall Study||39
497484|NCT00314236|1195169|P1|STARTED|Overall Study||41
497485|NCT00314145|1195183|P2|NOT COMPLETED|Overall Study||29
497486|NCT00314145|1195184|P1|NOT COMPLETED|Overall Study||21
497487|NCT00314145|1195183|P2|COMPLETED|Overall Study||381
497488|NCT00314145|1195184|P1|COMPLETED|Overall Study||389
497489|NCT00314145|1195183|P2|STARTED|Overall Study||410
497490|NCT00314145|1195184|P1|STARTED|Overall Study||410
497491|NCT00314132|1195198|P2|NOT COMPLETED|Overall Study||18
497492|NCT00314132|1195199|P1|NOT COMPLETED|Overall Study||8
497493|NCT00314132|1195198|P2|COMPLETED|Overall Study||1583
497494|NCT00314132|1195199|P1|COMPLETED|Overall Study||395
497495|NCT00314132|1195198|P2|STARTED|Overall Study||1601
497496|NCT00314132|1195199|P1|STARTED|Overall Study||403
497497|NCT00314106|1195209|P2|NOT COMPLETED|Overall Study||0
497498|NCT00314106|1195210|P1|NOT COMPLETED|Overall Study||0
497499|NCT00314106|1195209|P2|COMPLETED|Overall Study||8
497500|NCT00314106|1195210|P1|COMPLETED|Overall Study||18
497501|NCT00314106|1195209|P2|STARTED|Overall Study||8
497502|NCT00314106|1195210|P1|STARTED|Overall Study||18
497503|NCT00313911|1195220|P2|NOT COMPLETED|Overall Study||41
497504|NCT00313911|1195221|P1|NOT COMPLETED|Overall Study||94
497505|NCT00313911|1195220|P2|COMPLETED|Overall Study||670
497506|NCT00313911|1195221|P1|COMPLETED|Overall Study||1328
497507|NCT00313911|1195220|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
497508|NCT00313911|1195221|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
497509|NCT00313846|1195235|P2|NOT COMPLETED|Overall Study||11
497510|NCT00313846|1195236|P1|NOT COMPLETED|Overall Study||5
497511|NCT00313846|1195235|P2|COMPLETED|Overall Study||153
497512|NCT00313846|1195236|P1|COMPLETED|Overall Study||157
497513|NCT00313846|1195235|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
497514|NCT00313846|1195236|P1|STARTED|Overall Study||162
497515|NCT00313820|1195247|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
497516|NCT00313820|1195248|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
497517|NCT00313820|1195247|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
497518|NCT00313820|1195248|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
497519|NCT00313820|1195247|P2|STARTED|Pregabalin or Placebo Treatment Period||109
497520|NCT00313820|1195248|P1|STARTED|Pregabalin or Placebo Treatment Period||110
497521|NCT00313820|1195247|P2|NOT COMPLETED|Assigned to Treatment||0
497522|NCT00313820|1195248|P1|NOT COMPLETED|Assigned to Treatment||1
497523|NCT00313820|1195247|P2|COMPLETED|Assigned to Treatment||109
497524|NCT00313820|1195248|P1|COMPLETED|Assigned to Treatment||110
497525|NCT00313820|1195247|P2|STARTED|Assigned to Treatment||109
497526|NCT00313820|1195248|P1|STARTED|Assigned to Treatment||111
497527|NCT00313781|1195286|P3|NOT COMPLETED|After Crossover||27
497528|NCT00313781|1195287|P2|NOT COMPLETED|After Crossover||0
497529|NCT00313781|1195288|P1|NOT COMPLETED|After Crossover||0
497530|NCT00313781|1195286|P3|COMPLETED|After Crossover||10
497531|NCT00313781|1195287|P2|COMPLETED|After Crossover||0
497532|NCT00313781|1195288|P1|COMPLETED|After Crossover||0
497533|NCT00313781|1195286|P3|STARTED|After Crossover||37
497534|NCT00313781|1195287|P2|STARTED|After Crossover||0
497535|NCT00313781|1195288|P1|STARTED|After Crossover||0
497536|NCT00313781|1195286|P3|NOT COMPLETED|Before Crossover||0
497537|NCT00313781|1195287|P2|NOT COMPLETED|Before Crossover||79
497538|NCT00313781|1195288|P1|NOT COMPLETED|Before Crossover||75
497539|NCT00313781|1195286|P3|COMPLETED|Before Crossover||0
497540|NCT00313781|1195287|P2|COMPLETED|Before Crossover||23
497541|NCT00313781|1195288|P1|COMPLETED|Before Crossover||27
497542|NCT00313781|1195286|P3|Treated|Before Crossover||0
497543|NCT00313781|1195287|P2|Treated|Before Crossover||102
497544|NCT00313781|1195288|P1|Treated|Before Crossover||97
497545|NCT00313781|1195286|P3|STARTED|Before Crossover||0
497546|NCT00313781|1195287|P2|STARTED|Before Crossover||102
497547|NCT00313781|1195288|P1|STARTED|Before Crossover||102
497548|NCT00313716|1195328|P6|NOT COMPLETED|Overall Study||13
497549|NCT00313716|1195329|P5|NOT COMPLETED|Overall Study||6
497550|NCT00313716|1195330|P4|NOT COMPLETED|Overall Study||4
497551|NCT00313716|1195331|P3|NOT COMPLETED|Overall Study||12
497552|NCT00313716|1195332|P2|NOT COMPLETED|Overall Study||8
497553|NCT00313716|1195333|P1|NOT COMPLETED|Overall Study||5
497554|NCT00313716|1195328|P6|COMPLETED|Overall Study||35
497555|NCT00313716|1195329|P5|COMPLETED|Overall Study||27
497556|NCT00313716|1195330|P4|COMPLETED|Overall Study||16
497557|NCT00313716|1195331|P3|COMPLETED|Overall Study||38
497558|NCT00313716|1195332|P2|COMPLETED|Overall Study||23
497559|NCT00313716|1195333|P1|COMPLETED|Overall Study||13
497560|NCT00313716|1195328|P6|STARTED|Overall Study||48
497561|NCT00313716|1195329|P5|STARTED|Overall Study||33
497562|NCT00313716|1195330|P4|STARTED|Overall Study||20
497563|NCT00313716|1195331|P3|STARTED|Overall Study||50
497564|NCT00313716|1195332|P2|STARTED|Overall Study||31
497565|NCT00313716|1195333|P1|STARTED|Overall Study||18
497566|NCT00313703|1195360|P4|NOT COMPLETED|Overall Study||12
497567|NCT00313703|1195361|P3|NOT COMPLETED|Overall Study||5
497568|NCT00313703|1195362|P2|NOT COMPLETED|Overall Study||2
497569|NCT00313703|1195363|P1|NOT COMPLETED|Overall Study||11
497570|NCT00313703|1195360|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
497571|NCT00313703|1195361|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
497572|NCT00313703|1195362|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
497573|NCT00313703|1195363|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
497574|NCT00313703|1195360|P4|STARTED|Overall Study||12
497575|NCT00313703|1195361|P3|STARTED|Overall Study||77
497576|NCT00313703|1195362|P2|STARTED|Overall Study||34
497577|NCT00313703|1195363|P1|STARTED|Overall Study||186
497578|NCT00313612|1195379|P2|NOT COMPLETED|Overall Study||1
497579|NCT00313612|1195380|P1|NOT COMPLETED|Overall Study||0
497580|NCT00313612|1195379|P2|COMPLETED|Overall Study||19
497581|NCT00313612|1195380|P1|COMPLETED|Overall Study||19
497582|NCT00313612|1195379|P2|STARTED|Overall Study||20
497583|NCT00313612|1195380|P1|STARTED|Overall Study||19
497584|NCT00313586|1195392|P4|NOT COMPLETED|Overall Study||23
497585|NCT00313586|1195393|P3|NOT COMPLETED|Overall Study||24
497586|NCT00313586|1195394|P2|NOT COMPLETED|Overall Study||70
497587|NCT00313586|1195395|P1|NOT COMPLETED|Overall Study||70
497588|NCT00313586|1195392|P4|COMPLETED|Overall Study||0
497589|NCT00313586|1195393|P3|COMPLETED|Overall Study||0
497590|NCT00313586|1195394|P2|COMPLETED|Overall Study||5
497591|NCT00313586|1195395|P1|COMPLETED|Overall Study||5
497592|NCT00313586|1195392|P4|Treated|Overall Study||23
497593|NCT00313586|1195393|P3|Treated|Overall Study||24
497594|NCT00313586|1195394|P2|Treated|Overall Study||75
497595|NCT00313586|1195395|P1|Treated|Overall Study||74
497596|NCT00313586|1195392|P4|STARTED|Overall Study||23
497597|NCT00313586|1195393|P3|STARTED|Overall Study||24
497598|NCT00313586|1195394|P2|STARTED|Overall Study||75
497599|NCT00313586|1195395|P1|STARTED|Overall Study||75
497600|NCT00313443|1195403|P1|NOT COMPLETED|Overall Study||0
497601|NCT00313443|1195403|P1|COMPLETED|Overall Study||30
497602|NCT00313443|1195403|P1|STARTED|Overall Study||30
497603|NCT00313313|1195414|P3|NOT COMPLETED|Overall Study||82
497604|NCT00313313|1195415|P2|NOT COMPLETED|Overall Study||66
497605|NCT00313313|1195416|P1|NOT COMPLETED|Overall Study||63
497606|NCT00313313|1195414|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
497607|NCT00313313|1195415|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
497608|NCT00313313|1195416|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
497609|NCT00313313|1195414|P3|STARTED|Overall Study||267
497610|NCT00313313|1195415|P2|STARTED|Overall Study||253
497611|NCT00313313|1195416|P1|STARTED|Overall Study||248
497612|NCT00313300|1195438|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
497613|NCT00313300|1195439|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
497614|NCT00313300|1195440|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
497615|NCT00313300|1195441|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
497616|NCT00313300|1195442|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
497617|NCT00313300|1195438|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
497618|NCT00313300|1195439|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
497619|NCT00313300|1195440|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
497620|NCT00313300|1195441|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
497621|NCT00313300|1195442|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
497622|NCT00313300|1195438|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
497623|NCT00313300|1195439|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
497624|NCT00313300|1195440|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
497625|NCT00313300|1195441|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
497626|NCT00313300|1195442|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
497627|NCT00313300|1195438|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
497628|NCT00313300|1195439|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
497629|NCT00313300|1195440|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
497630|NCT00313300|1195441|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
497631|NCT00313300|1195442|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
497632|NCT00313300|1195438|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
497633|NCT00313300|1195439|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
497634|NCT00313300|1195440|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
497635|NCT00313300|1195441|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
497636|NCT00313300|1195442|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
497637|NCT00313300|1195438|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
497638|NCT00313300|1195439|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
497639|NCT00313300|1195440|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
497640|NCT00313300|1195441|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
497641|NCT00313300|1195442|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
497642|NCT00313300|1195438|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
497643|NCT00313300|1195439|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
497644|NCT00313300|1195440|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
497645|NCT00313300|1195441|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
497646|NCT00313300|1195442|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
497647|NCT00313300|1195438|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
497648|NCT00313300|1195439|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
497649|NCT00313300|1195440|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
497650|NCT00313300|1195441|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
497651|NCT00313300|1195442|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
497652|NCT00313300|1195438|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
497653|NCT00313300|1195439|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
497654|NCT00313300|1195440|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
497655|NCT00313300|1195441|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
497656|NCT00313300|1195442|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
497657|NCT00313300|1195438|P5|STARTED|Randomized in Phase B (26 Weeks)||221
497658|NCT00313300|1195439|P4|STARTED|Randomized in Phase B (26 Weeks)||248
497659|NCT00313300|1195440|P3|STARTED|Randomized in Phase B (26 Weeks)||134
497660|NCT00313300|1195441|P2|STARTED|Randomized in Phase B (26 Weeks)||138
497661|NCT00313300|1195442|P1|STARTED|Randomized in Phase B (26 Weeks)||427
497662|NCT00313300|1195438|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
497663|NCT00313300|1195439|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
497664|NCT00313300|1195440|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
497665|NCT00313300|1195441|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
497666|NCT00313300|1195442|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
497667|NCT00313300|1195438|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
497668|NCT00313300|1195439|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
497669|NCT00313300|1195440|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
497670|NCT00313300|1195441|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
497671|NCT00313300|1195442|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
497672|NCT00313300|1195438|P5|STARTED|Randomized in Phase A (26 Weeks)||0
497673|NCT00313300|1195439|P4|STARTED|Randomized in Phase A (26 Weeks)||0
497674|NCT00313300|1195440|P3|STARTED|Randomized in Phase A (26 Weeks)||184
497675|NCT00313300|1195441|P2|STARTED|Randomized in Phase A (26 Weeks)||179
497676|NCT00313300|1195442|P1|STARTED|Randomized in Phase A (26 Weeks)||184
497677|NCT00313209|1195494|P2|NOT COMPLETED|Overall Study||82
497678|NCT00313209|1195495|P1|NOT COMPLETED|Overall Study||107
497679|NCT00313209|1195494|P2|COMPLETED|Overall Study||385
497680|NCT00313209|1195495|P1|COMPLETED|Overall Study||359
497681|NCT00313209|1195494|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
497773|NCT00312221|1195827|P4|COMPLETED|Double-blind Phase||63
497682|NCT00313209|1195495|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
497683|NCT00313170|1195512|P3|NOT COMPLETED|Overall Study||32
497684|NCT00313170|1195513|P2|NOT COMPLETED|Overall Study||35
497685|NCT00313170|1195514|P1|NOT COMPLETED|Overall Study||36
497686|NCT00313170|1195512|P3|COMPLETED|Overall Study||14
497687|NCT00313170|1195513|P2|COMPLETED|Overall Study||16
497688|NCT00313170|1195514|P1|COMPLETED|Overall Study||11
497689|NCT00313170|1195512|P3|STARTED|Overall Study||46
497690|NCT00313170|1195513|P2|STARTED|Overall Study||51
497691|NCT00313170|1195514|P1|STARTED|Overall Study||47
497692|NCT00313144|1195530|P1|NOT COMPLETED|Overall Study||110
497693|NCT00313144|1195530|P1|COMPLETED|Overall Study||17
497694|NCT00313144|1195530|P1|STARTED|Overall Study||127
497695|NCT00313014|1195617|P3|NOT COMPLETED|Overall Study||61
497696|NCT00313014|1195618|P2|NOT COMPLETED|Overall Study||73
497697|NCT00313014|1195619|P1|NOT COMPLETED|Overall Study||93
497698|NCT00313014|1195617|P3|COMPLETED|Overall Study||159
497699|NCT00313014|1195618|P2|COMPLETED|Overall Study||146
497700|NCT00313014|1195619|P1|COMPLETED|Overall Study||128
497701|NCT00313014|1195617|P3|STARTED|Overall Study||220
497702|NCT00313014|1195618|P2|STARTED|Overall Study||219
497703|NCT00313014|1195619|P1|STARTED|Overall Study||221
497704|NCT00312923|1195639|P2|NOT COMPLETED|Overall Study||6
497705|NCT00312923|1195640|P1|NOT COMPLETED|Overall Study||9
497706|NCT00312923|1195639|P2|COMPLETED|Overall Study||20
497707|NCT00312923|1195640|P1|COMPLETED|Overall Study||19
497708|NCT00312923|1195639|P2|STARTED|Overall Study||26
497709|NCT00312923|1195640|P1|STARTED|Overall Study||28
497710|NCT00312884|1195650|P2|NOT COMPLETED|Overall Study||12
497711|NCT00312884|1195651|P1|NOT COMPLETED|Overall Study||17
497712|NCT00312884|1195650|P2|COMPLETED|Overall Study||79
497713|NCT00312884|1195651|P1|COMPLETED|Overall Study||74
497714|NCT00312884|1195650|P2|STARTED|Overall Study||91
497715|NCT00312884|1195651|P1|STARTED|Overall Study||91
497716|NCT00312858|1195665|P2|NOT COMPLETED|Overall Study||93
497717|NCT00312858|1195666|P1|NOT COMPLETED|Overall Study||68
497718|NCT00312858|1195665|P2|COMPLETED|Overall Study||230
497719|NCT00312858|1195666|P1|COMPLETED|Overall Study||262
497720|NCT00312858|1195665|P2|Visit 4|Overall Study||240
497721|NCT00312858|1195666|P1|Visit 4|Overall Study||262
497722|NCT00312858|1195665|P2|Visit 3|Overall Study||261
497723|NCT00312858|1195666|P1|Visit 3|Overall Study||273
497724|NCT00312858|1195665|P2|Visit 2|Overall Study||294
497725|NCT00312858|1195666|P1|Visit 2|Overall Study||305
497726|NCT00312858|1195665|P2|Visit 1|Overall Study||323
497727|NCT00312858|1195666|P1|Visit 1|Overall Study||330
497728|NCT00312858|1195665|P2|STARTED|Overall Study||323
497729|NCT00312858|1195666|P1|STARTED|Overall Study||330
497730|NCT00312845|1195720|P2|NOT COMPLETED|Overall Study||95
497731|NCT00312845|1195721|P1|NOT COMPLETED|Overall Study||99
497732|NCT00312845|1195720|P2|COMPLETED|Overall Study||245
497733|NCT00312845|1195721|P1|COMPLETED|Overall Study||237
497734|NCT00312845|1195720|P2|STARTED|Overall Study||340
497735|NCT00312845|1195721|P1|STARTED|Overall Study||336
497736|NCT00312728|1195729|P1|NOT COMPLETED|Overall Study||110
497737|NCT00312728|1195729|P1|COMPLETED|Overall Study||5
497738|NCT00312728|1195729|P1|STARTED|Overall Study||115
497739|NCT00312572|1195740|P2|NOT COMPLETED|Overall Study||21
497740|NCT00312572|1195741|P1|NOT COMPLETED|Overall Study||16
497741|NCT00312572|1195740|P2|COMPLETED|Overall Study||82
497742|NCT00312572|1195741|P1|COMPLETED|Overall Study||85
497743|NCT00312572|1195740|P2|STARTED|Overall Study||103
497744|NCT00312572|1195741|P1|STARTED|Overall Study||101
497745|NCT00312494|1195752|P3|NOT COMPLETED|Overall Study||43
497746|NCT00312494|1195753|P2|NOT COMPLETED|Overall Study||58
497747|NCT00312494|1195754|P1|NOT COMPLETED|Overall Study||71
497748|NCT00312494|1195752|P3|COMPLETED|Overall Study||179
497749|NCT00312494|1195753|P2|COMPLETED|Overall Study||168
497750|NCT00312494|1195754|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
497751|NCT00312494|1195752|P3|Received Study Treatment|Overall Study||217
497752|NCT00312494|1195753|P2|Received Study Treatment|Overall Study||216
497753|NCT00312494|1195754|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
497754|NCT00312494|1195752|P3|STARTED|Overall Study||222
497755|NCT00312494|1195753|P2|STARTED|Overall Study||226
497756|NCT00312494|1195754|P1|STARTED|Overall Study||232
497757|NCT00312377|1195788|P2|NOT COMPLETED|Overall Study||668
497758|NCT00312377|1195789|P1|NOT COMPLETED|Overall Study||644
497759|NCT00312377|1195788|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
497760|NCT00312377|1195789|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
497761|NCT00312377|1195788|P2|STARTED|Overall Study|randomised patients|697
497762|NCT00312377|1195789|P1|STARTED|Overall Study|randomised patients|694
497763|NCT00312338|1195813|P2|NOT COMPLETED|Overall Study||3
497764|NCT00312338|1195814|P1|NOT COMPLETED|Overall Study||22
497765|NCT00312338|1195813|P2|COMPLETED|Overall Study||54
497766|NCT00312338|1195814|P1|COMPLETED|Overall Study||83
497767|NCT00312338|1195813|P2|STARTED|Overall Study||57
497768|NCT00312338|1195814|P1|STARTED|Overall Study||105
497769|NCT00312221|1195827|P4|NOT COMPLETED|Double-blind Phase||70
497770|NCT00312221|1195828|P3|NOT COMPLETED|Double-blind Phase||72
497771|NCT00312221|1195829|P2|NOT COMPLETED|Double-blind Phase||59
497772|NCT00312221|1195830|P1|NOT COMPLETED|Double-blind Phase||0
497774|NCT00312221|1195828|P3|COMPLETED|Double-blind Phase||77
497775|NCT00312221|1195829|P2|COMPLETED|Double-blind Phase||77
497776|NCT00312221|1195830|P1|COMPLETED|Double-blind Phase||0
497777|NCT00312221|1195827|P4|STARTED|Double-blind Phase||133
497778|NCT00312221|1195828|P3|STARTED|Double-blind Phase||149
497779|NCT00312221|1195829|P2|STARTED|Double-blind Phase||136
497780|NCT00312221|1195830|P1|STARTED|Double-blind Phase||0
497781|NCT00312221|1195827|P4|NOT COMPLETED|Open-label Run-in Period||0
497782|NCT00312221|1195828|P3|NOT COMPLETED|Open-label Run-in Period||0
497783|NCT00312221|1195829|P2|NOT COMPLETED|Open-label Run-in Period||0
497784|NCT00312221|1195830|P1|NOT COMPLETED|Open-label Run-in Period||234
497785|NCT00312221|1195827|P4|COMPLETED|Open-label Run-in Period||0
497786|NCT00312221|1195828|P3|COMPLETED|Open-label Run-in Period||0
497787|NCT00312221|1195829|P2|COMPLETED|Open-label Run-in Period||0
497788|NCT00312221|1195830|P1|COMPLETED|Open-label Run-in Period||418
497789|NCT00312221|1195827|P4|STARTED|Open-label Run-in Period||0
497790|NCT00312221|1195828|P3|STARTED|Open-label Run-in Period||0
497791|NCT00312221|1195829|P2|STARTED|Open-label Run-in Period||0
497792|NCT00312221|1195830|P1|STARTED|Open-label Run-in Period||652
497793|NCT00312208|1195850|P2|NOT COMPLETED|Overall Study||123
497794|NCT00312208|1195851|P1|NOT COMPLETED|Overall Study||172
497795|NCT00312208|1195850|P2|COMPLETED|Overall Study||1526
497796|NCT00312208|1195851|P1|COMPLETED|Overall Study||1477
497797|NCT00312208|1195850|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
497798|NCT00312208|1195851|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
497799|NCT00312195|1195861|P2|NOT COMPLETED|Overall Study||6
497800|NCT00312195|1195862|P1|NOT COMPLETED|Overall Study||6
497801|NCT00312195|1195861|P2|COMPLETED|Overall Study||123
497802|NCT00312195|1195862|P1|COMPLETED|Overall Study||132
497803|NCT00312195|1195861|P2|STARTED|Overall Study||129
497804|NCT00312195|1195862|P1|STARTED|Overall Study||138
497805|NCT00311766|1195878|P2|NOT COMPLETED|Overall Study||5
497806|NCT00311766|1195879|P1|NOT COMPLETED|Overall Study||0
497807|NCT00311766|1195878|P2|COMPLETED|Overall Study||17
497808|NCT00311766|1195879|P1|COMPLETED|Overall Study||8
497809|NCT00311766|1195878|P2|STARTED|Overall Study||22
497810|NCT00311766|1195879|P1|STARTED|Overall Study||8
497811|NCT00311584|1195889|P2|NOT COMPLETED|Overall Study||23
497812|NCT00311584|1195890|P1|NOT COMPLETED|Overall Study||20
497813|NCT00311584|1195889|P2|COMPLETED|Overall Study||7
497814|NCT00311584|1195890|P1|COMPLETED|Overall Study||9
497815|NCT00311584|1195889|P2|STARTED|Overall Study||30
497816|NCT00311584|1195890|P1|STARTED|Overall Study||29
497817|NCT00311402|1195898|P2|NOT COMPLETED|Overall Study||177
497818|NCT00311402|1195899|P1|NOT COMPLETED|Overall Study||210
497819|NCT00311402|1195898|P2|COMPLETED|Overall Study||462
497820|NCT00311402|1195899|P1|COMPLETED|Overall Study||445
497821|NCT00311402|1195898|P2|STARTED|Overall Study||639
497822|NCT00311402|1195899|P1|STARTED|Overall Study||655
497823|NCT00311376|1195926|P3|NOT COMPLETED|Treatment Cycle 2||0
497824|NCT00311376|1195927|P2|NOT COMPLETED|Treatment Cycle 2||13
497825|NCT00311376|1195928|P1|NOT COMPLETED|Treatment Cycle 2||9
497826|NCT00311376|1195926|P3|COMPLETED|Treatment Cycle 2||0
497827|NCT00311376|1195927|P2|COMPLETED|Treatment Cycle 2||112
497828|NCT00311376|1195928|P1|COMPLETED|Treatment Cycle 2||106
497829|NCT00311376|1195926|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
497830|NCT00311376|1195927|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
497831|NCT00311376|1195928|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
497832|NCT00311376|1195926|P3|NOT COMPLETED|Treatment Cycle 1||17
497833|NCT00311376|1195927|P2|NOT COMPLETED|Treatment Cycle 1||17
497834|NCT00311376|1195928|P1|NOT COMPLETED|Treatment Cycle 1||27
497835|NCT00311376|1195926|P3|COMPLETED|Treatment Cycle 1||132
497836|NCT00311376|1195927|P2|COMPLETED|Treatment Cycle 1||118
497837|NCT00311376|1195928|P1|COMPLETED|Treatment Cycle 1||105
497838|NCT00311376|1195926|P3|STARTED|Treatment Cycle 1||149
497839|NCT00311376|1195927|P2|STARTED|Treatment Cycle 1||135
497840|NCT00311376|1195928|P1|STARTED|Treatment Cycle 1||132
497841|NCT00311363|1195948|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
497842|NCT00311363|1195949|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
497843|NCT00311363|1195950|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
497844|NCT00311363|1195948|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
497845|NCT00311363|1195949|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
497846|NCT00311363|1195950|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
497847|NCT00311363|1195948|P3|STARTED|12-Week Double-Blind Treatment Period||96
497848|NCT00311363|1195949|P2|STARTED|12-Week Double-Blind Treatment Period||98
497849|NCT00311363|1195950|P1|STARTED|12-Week Double-Blind Treatment Period||0
497850|NCT00311363|1195948|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
497851|NCT00311363|1195949|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
497852|NCT00311363|1195950|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
497853|NCT00311363|1195948|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
497854|NCT00311363|1195949|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
497855|NCT00311363|1195950|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
497856|NCT00311363|1195948|P3|STARTED|24-Week Single-Blind Treatment Period||0
497857|NCT00311363|1195949|P2|STARTED|24-Week Single-Blind Treatment Period||0
497858|NCT00311363|1195950|P1|STARTED|24-Week Single-Blind Treatment Period||327
497859|NCT00311311|1196010|P2|NOT COMPLETED|Overall Study||9
497860|NCT00311311|1196011|P1|NOT COMPLETED|Overall Study||8
497861|NCT00311311|1196010|P2|COMPLETED|Overall Study||26
497862|NCT00311311|1196011|P1|COMPLETED|Overall Study||29
497863|NCT00311311|1196010|P2|STARTED|Overall Study||35
497864|NCT00311311|1196011|P1|STARTED|Overall Study||37
497865|NCT00311181|1196061|P1|NOT COMPLETED|Overall Study||96
497866|NCT00311181|1196061|P1|COMPLETED|Overall Study||121
497867|NCT00311181|1196061|P1|STARTED|Overall Study||217
497868|NCT00311155|1196067|P1|NOT COMPLETED|Overall Study||93
497869|NCT00311155|1196067|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
497870|NCT00311155|1196067|P1|STARTED|Overall Study||694
497871|NCT00310856|1196079|P3|NOT COMPLETED|Overall Study||8
497872|NCT00310856|1196080|P2|NOT COMPLETED|Overall Study||5
497873|NCT00310856|1196081|P1|NOT COMPLETED|Overall Study||5
497874|NCT00310856|1196079|P3|COMPLETED|Overall Study||42
497875|NCT00310856|1196080|P2|COMPLETED|Overall Study||56
497876|NCT00310856|1196081|P1|COMPLETED|Overall Study||59
497877|NCT00310856|1196079|P3|STARTED|Overall Study||50
497878|NCT00310856|1196080|P2|STARTED|Overall Study||61
497879|NCT00310856|1196081|P1|STARTED|Overall Study||64
497880|NCT00310817|1196105|P4|NOT COMPLETED|Overall Study||8
497881|NCT00310817|1196106|P3|NOT COMPLETED|Overall Study||8
497882|NCT00310817|1196107|P2|NOT COMPLETED|Overall Study||8
497883|NCT00310817|1196108|P1|NOT COMPLETED|Overall Study||11
497884|NCT00310817|1196105|P4|COMPLETED|Overall Study||74
497885|NCT00310817|1196106|P3|COMPLETED|Overall Study||120
497886|NCT00310817|1196107|P2|COMPLETED|Overall Study||198
497887|NCT00310817|1196108|P1|COMPLETED|Overall Study||196
497888|NCT00310817|1196105|P4|STARTED|Overall Study||82
497889|NCT00310817|1196106|P3|STARTED|Overall Study||128
497890|NCT00310817|1196107|P2|STARTED|Overall Study||206
497891|NCT00310817|1196108|P1|STARTED|Overall Study||207
497892|NCT00310804|1196196|P2|NOT COMPLETED|Overall Study||0
497893|NCT00310804|1196197|P1|NOT COMPLETED|Overall Study||5
497894|NCT00310804|1196196|P2|COMPLETED|Overall Study||171
497895|NCT00310804|1196197|P1|COMPLETED|Overall Study||1024
497896|NCT00310804|1196196|P2|STARTED|Overall Study||171
497897|NCT00310804|1196197|P1|STARTED|Overall Study||1029
497898|NCT00310791|1196232|P2|NOT COMPLETED|Overall Study||10
497899|NCT00310791|1196233|P1|NOT COMPLETED|Overall Study||10
497900|NCT00310791|1196232|P2|COMPLETED|Overall Study||30
497901|NCT00310791|1196233|P1|COMPLETED|Overall Study||30
497902|NCT00310791|1196232|P2|STARTED|Overall Study||40
497903|NCT00310791|1196233|P1|STARTED|Overall Study||40
497904|NCT00310466|1196241|P2|NOT COMPLETED|Overall Study||12
497905|NCT00310466|1196242|P1|NOT COMPLETED|Overall Study||18
497906|NCT00310466|1196241|P2|COMPLETED|Overall Study||101
497907|NCT00310466|1196242|P1|COMPLETED|Overall Study||95
497908|NCT00310466|1196241|P2|STARTED|Overall Study||113
497909|NCT00310466|1196242|P1|STARTED|Overall Study||113
497910|NCT00310440|1196256|P2|NOT COMPLETED|Overall Study||13
497911|NCT00310440|1196257|P1|NOT COMPLETED|Overall Study||26
497912|NCT00310440|1196256|P2|COMPLETED|Overall Study||141
497913|NCT00310440|1196257|P1|COMPLETED|Overall Study||139
497914|NCT00310440|1196256|P2|STARTED|Overall Study||154
497915|NCT00310440|1196257|P1|STARTED|Overall Study||165
497916|NCT00310427|1196283|P2|NOT COMPLETED|Overall Study||1
497917|NCT00310427|1196284|P1|NOT COMPLETED|Overall Study||2
497918|NCT00310427|1196283|P2|COMPLETED|Overall Study||25
497919|NCT00310427|1196284|P1|COMPLETED|Overall Study||25
497920|NCT00310427|1196283|P2|STARTED|Overall Study||26
497921|NCT00310427|1196284|P1|STARTED|Overall Study||27
497922|NCT00310401|1196306|P2|NOT COMPLETED|Overall Study||0
497923|NCT00310401|1196307|P1|NOT COMPLETED|Overall Study||0
497924|NCT00310401|1196306|P2|COMPLETED|Overall Study||246
497925|NCT00310401|1196307|P1|COMPLETED|Overall Study||260
497926|NCT00310401|1196306|P2|STARTED|Overall Study||246
497927|NCT00310401|1196307|P1|STARTED|Overall Study||260
497928|NCT00310375|1196315|P2|NOT COMPLETED|Overall Study||68
497929|NCT00310375|1196316|P1|NOT COMPLETED|Overall Study||91
497930|NCT00310375|1196315|P2|COMPLETED|Overall Study||11
497931|NCT00310375|1196316|P1|COMPLETED|Overall Study||11
497932|NCT00310375|1196315|P2|STARTED|Overall Study||79
497933|NCT00310375|1196316|P1|STARTED|Overall Study||102
497934|NCT00310362|1196357|P3|NOT COMPLETED|Overall Study||0
497935|NCT00310362|1196358|P2|NOT COMPLETED|Overall Study||0
497936|NCT00310362|1196359|P1|NOT COMPLETED|Overall Study||0
497937|NCT00310362|1196357|P3|COMPLETED|Overall Study||1206
497938|NCT00310362|1196358|P2|COMPLETED|Overall Study||1205
497939|NCT00310362|1196359|P1|COMPLETED|Overall Study||1199
497940|NCT00310362|1196357|P3|STARTED|Overall Study||1206
497941|NCT00310362|1196358|P2|STARTED|Overall Study||1205
497942|NCT00310362|1196359|P1|STARTED|Overall Study||1199
497943|NCT00310310|1196369|P2|NOT COMPLETED|Overall Study||20
497944|NCT00310310|1196370|P1|NOT COMPLETED|Overall Study||30
497945|NCT00310310|1196369|P2|COMPLETED|Overall Study||100
497946|NCT00310310|1196370|P1|COMPLETED|Overall Study||90
497947|NCT00310310|1196369|P2|STARTED|Overall Study||120
497948|NCT00310310|1196370|P1|STARTED|Overall Study||120
497949|NCT00310076|1196394|P1|NOT COMPLETED|Overall Study||3
497950|NCT00310076|1196394|P1|COMPLETED|Overall Study||26
497951|NCT00310076|1196394|P1|STARTED|Overall Study||29
497952|NCT00309985|1196400|P2|NOT COMPLETED|Overall Study||1
497953|NCT00309985|1196401|P1|NOT COMPLETED|Overall Study||62
497954|NCT00309985|1196400|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
497955|NCT00309985|1196401|P1|COMPLETED|Overall Study||335
497956|NCT00309985|1196400|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
497957|NCT00309985|1196401|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
497958|NCT00309985|1196400|P2|Toxicity Analysis|Overall Study||392
497959|NCT00309985|1196401|P1|Toxicity Analysis|Overall Study||390
497960|NCT00309985|1196400|P2|STARTED|Overall Study||393
497961|NCT00309985|1196401|P1|STARTED|Overall Study||397
497962|NCT00309946|1196417|P1|NOT COMPLETED|Overall Study||1
497963|NCT00309946|1196417|P1|COMPLETED|Overall Study||50
497964|NCT00309946|1196417|P1|STARTED|Overall Study||51
497965|NCT00309907|1196423|P1|NOT COMPLETED|Overall Study||20
497966|NCT00309907|1196423|P1|COMPLETED|Overall Study||19
497967|NCT00309907|1196423|P1|STARTED|Overall Study||39
497968|NCT00309777|1196431|P4|NOT COMPLETED|Overall Study||4
497969|NCT00309777|1196432|P3|NOT COMPLETED|Overall Study||19
497970|NCT00309777|1196433|P2|NOT COMPLETED|Overall Study||9
497971|NCT00309777|1196434|P1|NOT COMPLETED|Overall Study||23
497972|NCT00309777|1196431|P4|COMPLETED|Overall Study||107
497973|NCT00309777|1196432|P3|COMPLETED|Overall Study||304
497974|NCT00309777|1196433|P2|COMPLETED|Overall Study||99
497975|NCT00309777|1196434|P1|COMPLETED|Overall Study||292
497976|NCT00309777|1196431|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
497977|NCT00309777|1196432|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
497978|NCT00309777|1196433|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
497979|NCT00309777|1196434|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
497980|NCT00309777|1196431|P4|STARTED|Overall Study||111
497981|NCT00309777|1196432|P3|STARTED|Overall Study||323
497982|NCT00309777|1196433|P2|STARTED|Overall Study||108
497983|NCT00309777|1196434|P1|STARTED|Overall Study||315
497984|NCT00309751|1196450|P2|NOT COMPLETED|Overall Study||15
497985|NCT00309751|1196451|P1|NOT COMPLETED|Overall Study||31
497986|NCT00309751|1196450|P2|COMPLETED|Overall Study||124
497987|NCT00309751|1196451|P1|COMPLETED|Overall Study||248
497988|NCT00309751|1196450|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
497989|NCT00309751|1196451|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
497990|NCT00309751|1196450|P2|STARTED|Overall Study||139
497991|NCT00309751|1196451|P1|STARTED|Overall Study||279
497992|NCT00309738|1196461|P2|NOT COMPLETED|Overall Study||12
497993|NCT00309738|1196462|P1|NOT COMPLETED|Overall Study||13
497994|NCT00309738|1196461|P2|COMPLETED|Overall Study||107
497995|NCT00309738|1196462|P1|COMPLETED|Overall Study||223
497996|NCT00309738|1196461|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
497997|NCT00309738|1196462|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
497998|NCT00309738|1196461|P2|STARTED|Overall Study||119
497999|NCT00309738|1196462|P1|STARTED|Overall Study||236
498000|NCT00309608|1196475|P5|NOT COMPLETED|Overall Study||4
498001|NCT00309608|1196476|P4|NOT COMPLETED|Overall Study||6
498002|NCT00309608|1196477|P3|NOT COMPLETED|Overall Study||10
498003|NCT00309608|1196478|P2|NOT COMPLETED|Overall Study||13
498004|NCT00309608|1196479|P1|NOT COMPLETED|Overall Study||14
498005|NCT00309608|1196475|P5|COMPLETED|Overall Study||61
498006|NCT00309608|1196476|P4|COMPLETED|Overall Study||60
498007|NCT00309608|1196477|P3|COMPLETED|Overall Study||56
498008|NCT00309608|1196478|P2|COMPLETED|Overall Study||52
498009|NCT00309608|1196479|P1|COMPLETED|Overall Study||57
498010|NCT00309608|1196475|P5|STARTED|Overall Study||65
498011|NCT00309608|1196476|P4|STARTED|Overall Study||66
498012|NCT00309608|1196477|P3|STARTED|Overall Study||66
498013|NCT00309608|1196478|P2|STARTED|Overall Study||65
498014|NCT00309608|1196479|P1|STARTED|Overall Study||71
498015|NCT00309465|1196506|P6|NOT COMPLETED|Overall Study||0
498016|NCT00309465|1196507|P5|NOT COMPLETED|Overall Study||0
498017|NCT00309465|1196508|P4|NOT COMPLETED|Overall Study||1
498018|NCT00309465|1196509|P3|NOT COMPLETED|Overall Study||0
498019|NCT00309465|1196510|P2|NOT COMPLETED|Overall Study||0
498020|NCT00309465|1196511|P1|NOT COMPLETED|Overall Study||0
498021|NCT00309465|1196506|P6|COMPLETED|Overall Study||76
498022|NCT00309465|1196507|P5|COMPLETED|Overall Study||76
498023|NCT00309465|1196508|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
498024|NCT00309465|1196509|P3|COMPLETED|Overall Study||58
498025|NCT00309465|1196510|P2|COMPLETED|Overall Study||58
498026|NCT00309465|1196511|P1|COMPLETED|Overall Study||58
498027|NCT00309465|1196506|P6|STARTED|Overall Study||76
498028|NCT00309465|1196507|P5|STARTED|Overall Study||76
498029|NCT00309465|1196508|P4|STARTED|Overall Study||76
498030|NCT00309465|1196509|P3|STARTED|Overall Study||58
498031|NCT00309465|1196510|P2|STARTED|Overall Study||58
498032|NCT00309465|1196511|P1|STARTED|Overall Study||58
498033|NCT00309452|1196527|P2|NOT COMPLETED|Overall Study||0
498034|NCT00309452|1196528|P1|NOT COMPLETED|Overall Study||3
498035|NCT00309452|1196527|P2|COMPLETED|Overall Study||60
498036|NCT00309452|1196528|P1|COMPLETED|Overall Study||57
498037|NCT00309452|1196527|P2|STARTED|Overall Study||60
498038|NCT00309452|1196528|P1|STARTED|Overall Study||60
498039|NCT00309387|1196556|P2|NOT COMPLETED|Overall Study||159
498040|NCT00309387|1196557|P1|NOT COMPLETED|Overall Study||142
498041|NCT00309387|1196556|P2|COMPLETED|Overall Study||351
498042|NCT00309387|1196557|P1|COMPLETED|Overall Study||368
498043|NCT00309387|1196556|P2|STARTED|Overall Study||510
498044|NCT00309387|1196557|P1|STARTED|Overall Study||510
498045|NCT00309244|1196575|P2|NOT COMPLETED|Overall Study||97
498046|NCT00309244|1196576|P1|NOT COMPLETED|Overall Study||118
498047|NCT00309244|1196575|P2|COMPLETED|Overall Study||246
498048|NCT00309244|1196576|P1|COMPLETED|Overall Study||216
498049|NCT00309244|1196575|P2|STARTED|Overall Study||343
498050|NCT00309244|1196576|P1|STARTED|Overall Study||334
498051|NCT00308997|1196598|P2|NOT COMPLETED|Overall Study||1
498052|NCT00308997|1196599|P1|NOT COMPLETED|Overall Study||1
498053|NCT00308997|1196598|P2|COMPLETED|Overall Study||28
498054|NCT00308997|1196599|P1|COMPLETED|Overall Study||55
498055|NCT00308997|1196598|P2|STARTED|Overall Study||29
498056|NCT00308997|1196599|P1|STARTED|Overall Study||56
498057|NCT00308737|1196618|P3|NOT COMPLETED|Overall Study||37
498058|NCT00308737|1196619|P2|NOT COMPLETED|Overall Study||289
498059|NCT00308737|1196620|P1|NOT COMPLETED|Overall Study||463
498060|NCT00308737|1196618|P3|COMPLETED|Overall Study||127
498061|NCT00308737|1196619|P2|COMPLETED|Overall Study||662
498062|NCT00308737|1196620|P1|COMPLETED|Overall Study||475
498063|NCT00308737|1196618|P3|STARTED|Overall Study||164
498064|NCT00308737|1196619|P2|STARTED|Overall Study||951
498065|NCT00308737|1196620|P1|STARTED|Overall Study||938
498066|NCT00308711|1196660|P3|NOT COMPLETED|Overall Study||5
498067|NCT00308711|1196661|P2|NOT COMPLETED|Overall Study||4
498068|NCT00308711|1196662|P1|NOT COMPLETED|Overall Study||2
498069|NCT00308711|1196660|P3|COMPLETED|Overall Study||431
498070|NCT00308711|1196661|P2|COMPLETED|Overall Study||440
498071|NCT00308711|1196662|P1|COMPLETED|Overall Study||426
498072|NCT00308711|1196660|P3|STARTED|Overall Study||436
498073|NCT00308711|1196661|P2|STARTED|Overall Study||444
498074|NCT00308711|1196662|P1|STARTED|Overall Study||428
498075|NCT00308620|1196697|P3|NOT COMPLETED|Overall Study||1
498076|NCT00308620|1196698|P2|NOT COMPLETED|Overall Study||1
498077|NCT00308620|1196699|P1|NOT COMPLETED|Overall Study||1
498078|NCT00308620|1196697|P3|COMPLETED|Overall Study||5
498079|NCT00308620|1196698|P2|COMPLETED|Overall Study||3
498080|NCT00308620|1196699|P1|COMPLETED|Overall Study||2
498081|NCT00308620|1196697|P3|STARTED|Overall Study||6
498082|NCT00308620|1196698|P2|STARTED|Overall Study||4
498083|NCT00308620|1196699|P1|STARTED|Overall Study||3
498084|NCT00308581|1196708|P3|NOT COMPLETED|Randomized Maintenance Phase||0
498085|NCT00308581|1196709|P2|NOT COMPLETED|Randomized Maintenance Phase||103
498086|NCT00308581|1196710|P1|NOT COMPLETED|Randomized Maintenance Phase||105
498087|NCT00308581|1196708|P3|COMPLETED|Randomized Maintenance Phase||0
498088|NCT00308581|1196709|P2|COMPLETED|Randomized Maintenance Phase||83
498089|NCT00308581|1196710|P1|COMPLETED|Randomized Maintenance Phase||82
498090|NCT00308581|1196708|P3|STARTED|Randomized Maintenance Phase||0
498091|NCT00308581|1196709|P2|STARTED|Randomized Maintenance Phase||186
498092|NCT00308581|1196710|P1|STARTED|Randomized Maintenance Phase||187
498093|NCT00308581|1196708|P3|NOT COMPLETED|Induction Phase||166
498094|NCT00308581|1196709|P2|NOT COMPLETED|Induction Phase||0
498095|NCT00308581|1196710|P1|NOT COMPLETED|Induction Phase||0
498096|NCT00308581|1196708|P3|COMPLETED|Induction Phase||373
498097|NCT00308581|1196709|P2|COMPLETED|Induction Phase|Not applicable in this period|0
498098|NCT00308581|1196710|P1|COMPLETED|Induction Phase|Not applicable in this period|0
498099|NCT00308581|1196708|P3|STARTED|Induction Phase||539
498100|NCT00308581|1196709|P2|STARTED|Induction Phase|Not applicable in this period|0
498101|NCT00308581|1196710|P1|STARTED|Induction Phase|Not applicable in this period|0
498102|NCT00308555|1196836|P2|NOT COMPLETED|Overall Study||0
498103|NCT00308555|1196837|P1|NOT COMPLETED|Overall Study||3
498104|NCT00308555|1196836|P2|COMPLETED|Overall Study||11
498105|NCT00308555|1196837|P1|COMPLETED|Overall Study||10
498106|NCT00308555|1196836|P2|STARTED|Overall Study||11
498107|NCT00308555|1196837|P1|STARTED|Overall Study||13
498108|NCT00308516|1196845|P2|NOT COMPLETED|Overall Study||21
498109|NCT00308516|1196846|P1|NOT COMPLETED|Overall Study||29
498110|NCT00308516|1196845|P2|COMPLETED|Overall Study||10
498111|NCT00308516|1196846|P1|COMPLETED|Overall Study||6
498112|NCT00308516|1196845|P2|STARTED|Overall Study||31
498113|NCT00308516|1196846|P1|STARTED|Overall Study||35
498114|NCT00308308|1196854|P2|NOT COMPLETED|Overall Study||68
498115|NCT00308308|1196855|P1|NOT COMPLETED|Overall Study||103
498116|NCT00308308|1196854|P2|COMPLETED|Overall Study||220
498117|NCT00308308|1196855|P1|COMPLETED|Overall Study||198
498118|NCT00308308|1196854|P2|STARTED|Overall Study||288
498119|NCT00308308|1196855|P1|STARTED|Overall Study||301
498120|NCT00308230|1196878|P3|NOT COMPLETED|Overall Study||0
498121|NCT00308230|1196879|P2|NOT COMPLETED|Overall Study||0
498122|NCT00308230|1196880|P1|NOT COMPLETED|Overall Study||0
498123|NCT00308230|1196878|P3|COMPLETED|Overall Study||20
498124|NCT00308230|1196879|P2|COMPLETED|Overall Study||8
498125|NCT00308230|1196880|P1|COMPLETED|Overall Study||6
498126|NCT00308230|1196878|P3|STARTED|Overall Study||20
498127|NCT00308230|1196879|P2|STARTED|Overall Study||8
498128|NCT00308230|1196880|P1|STARTED|Overall Study||6
498129|NCT00308139|1196890|P2|NOT COMPLETED|Overall Study||87
498130|NCT00308139|1196891|P1|NOT COMPLETED|Overall Study||94
498131|NCT00308139|1196890|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
498132|NCT00308139|1196891|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
498133|NCT00308139|1196890|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
498134|NCT00308139|1196891|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
498135|NCT00308139|1196890|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
498136|NCT00308139|1196891|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
498137|NCT00308139|1196890|P2|Pharmacokinetics Population|Overall Study||0
498138|NCT00308139|1196891|P1|Pharmacokinetics Population|Overall Study||129
498139|NCT00308139|1196890|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
498140|NCT00308139|1196891|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
498141|NCT00308139|1196890|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
498142|NCT00308139|1196891|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
498143|NCT00308139|1196890|P2|STARTED|Overall Study||151
498144|NCT00308139|1196891|P1|STARTED|Overall Study||152
498145|NCT00308113|1196965|P4|NOT COMPLETED|Overall Study||1
498146|NCT00308113|1196966|P3|NOT COMPLETED|Overall Study||0
498147|NCT00308113|1196967|P2|NOT COMPLETED|Overall Study||0
498148|NCT00308113|1196968|P1|NOT COMPLETED|Overall Study||0
498149|NCT00308113|1196965|P4|COMPLETED|Overall Study||1
498150|NCT00308113|1196966|P3|COMPLETED|Overall Study||1
498151|NCT00308113|1196967|P2|COMPLETED|Overall Study||0
498152|NCT00308113|1196968|P1|COMPLETED|Overall Study||0
498153|NCT00308113|1196965|P4|STARTED|Overall Study||2
498154|NCT00308113|1196966|P3|STARTED|Overall Study||1
498155|NCT00308113|1196967|P2|STARTED|Overall Study||0
498156|NCT00308113|1196968|P1|STARTED|Overall Study||0
498157|NCT00308087|1196988|P2|NOT COMPLETED|Overall Study||37
498158|NCT00308087|1196989|P1|NOT COMPLETED|Overall Study||36
498159|NCT00308087|1196988|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
498160|NCT00308087|1196989|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
498161|NCT00308087|1196988|P2|STARTED|Overall Study||38
498162|NCT00308087|1196989|P1|STARTED|Overall Study||37
498163|NCT00308074|1197005|P1|NOT COMPLETED|Overall Study||1
498164|NCT00308074|1197005|P1|COMPLETED|Overall Study||13
498165|NCT00308074|1197005|P1|STARTED|Overall Study||14
498166|NCT00307931|1197012|P1|NOT COMPLETED|Overall Study||1
498167|NCT00307931|1197012|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
498168|NCT00307931|1197012|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
498169|NCT00307801|1197029|P2|NOT COMPLETED|Overall Study||17
498170|NCT00307801|1197030|P1|NOT COMPLETED|Overall Study||32
498171|NCT00307801|1197029|P2|COMPLETED|Overall Study||65
498172|NCT00307801|1197030|P1|COMPLETED|Overall Study||117
498173|NCT00307801|1197029|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
498174|NCT00307801|1197030|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
498175|NCT00307801|1197029|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
498176|NCT00307801|1197030|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
498177|NCT00307801|1197029|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
498178|NCT00307801|1197030|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
498179|NCT00307801|1197029|P2|Subjects Received Treatment|Overall Study||81
498180|NCT00307801|1197030|P1|Subjects Received Treatment|Overall Study||145
498181|NCT00307801|1197029|P2|STARTED|Overall Study||82
498182|NCT00307801|1197030|P1|STARTED|Overall Study||149
498183|NCT00307736|1197142|P4|NOT COMPLETED|Overall Study||3
498184|NCT00307736|1197143|P3|NOT COMPLETED|Overall Study||3
498185|NCT00307736|1197144|P2|NOT COMPLETED|Overall Study||0
498186|NCT00307736|1197145|P1|NOT COMPLETED|Overall Study||0
498187|NCT00307736|1197142|P4|COMPLETED|Overall Study||20
498188|NCT00307736|1197143|P3|COMPLETED|Overall Study||0
498189|NCT00307736|1197144|P2|COMPLETED|Overall Study||3
498190|NCT00307736|1197145|P1|COMPLETED|Overall Study||3
498191|NCT00307736|1197142|P4|STARTED|Overall Study||23
498192|NCT00307736|1197143|P3|STARTED|Overall Study||3
498193|NCT00307736|1197144|P2|STARTED|Overall Study||3
498194|NCT00307736|1197145|P1|STARTED|Overall Study||3
498195|NCT00307684|1197156|P3|NOT COMPLETED|Double Blind Phase||0
498196|NCT00307684|1197157|P2|NOT COMPLETED|Double Blind Phase||5
498197|NCT00307684|1197158|P1|NOT COMPLETED|Double Blind Phase||2
498198|NCT00307684|1197156|P3|COMPLETED|Double Blind Phase||0
498199|NCT00307684|1197157|P2|COMPLETED|Double Blind Phase||17
498200|NCT00307684|1197158|P1|COMPLETED|Double Blind Phase||21
498201|NCT00307684|1197156|P3|STARTED|Double Blind Phase||0
498202|NCT00307684|1197157|P2|STARTED|Double Blind Phase||22
498203|NCT00307684|1197158|P1|STARTED|Double Blind Phase||23
498204|NCT00307684|1197156|P3|NOT COMPLETED|Open Label Phase||56
498205|NCT00307684|1197157|P2|NOT COMPLETED|Open Label Phase||0
498206|NCT00307684|1197158|P1|NOT COMPLETED|Open Label Phase||0
498207|NCT00307684|1197156|P3|COMPLETED|Open Label Phase||99
498208|NCT00307684|1197157|P2|COMPLETED|Open Label Phase||0
498209|NCT00307684|1197158|P1|COMPLETED|Open Label Phase||0
498210|NCT00307684|1197156|P3|STARTED|Open Label Phase|1 screening failure|155
498211|NCT00307684|1197157|P2|STARTED|Open Label Phase||0
498212|NCT00307684|1197158|P1|STARTED|Open Label Phase||0
498213|NCT00307489|1197186|P2|NOT COMPLETED|Week 48 Through Week 168||6
498214|NCT00307489|1197187|P1|NOT COMPLETED|Week 48 Through Week 168||6
498215|NCT00307489|1197186|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
498216|NCT00307489|1197187|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
498217|NCT00307489|1197186|P2|STARTED|Week 48 Through Week 168||50
498218|NCT00307489|1197187|P1|STARTED|Week 48 Through Week 168||52
498219|NCT00307489|1197186|P2|NOT COMPLETED|Baseline Through Week 48||2
498220|NCT00307489|1197187|P1|NOT COMPLETED|Baseline Through Week 48||1
498221|NCT00307489|1197186|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
498222|NCT00307489|1197187|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
498223|NCT00307489|1197186|P2|STARTED|Baseline Through Week 48||52
498224|NCT00307489|1197187|P1|STARTED|Baseline Through Week 48||53
498225|NCT00307437|1197232|P7|NOT COMPLETED|After Controlled Period||113
498226|NCT00307437|1197233|P6|NOT COMPLETED|After Controlled Period||122
498227|NCT00307437|1197234|P5|NOT COMPLETED|After Controlled Period||55
498228|NCT00307437|1197235|P4|NOT COMPLETED|After Controlled Period||58
498229|NCT00307437|1197236|P3|NOT COMPLETED|After Controlled Period||0
498230|NCT00307437|1197237|P2|NOT COMPLETED|After Controlled Period||0
498231|NCT00307437|1197238|P1|NOT COMPLETED|After Controlled Period||0
498232|NCT00307437|1197232|P7|COMPLETED|After Controlled Period||289
498233|NCT00307437|1197233|P6|COMPLETED|After Controlled Period||281
498234|NCT00307437|1197234|P5|COMPLETED|After Controlled Period||140
498235|NCT00307437|1197235|P4|COMPLETED|After Controlled Period||139
498236|NCT00307437|1197236|P3|COMPLETED|After Controlled Period||0
498237|NCT00307437|1197237|P2|COMPLETED|After Controlled Period||0
498238|NCT00307437|1197238|P1|COMPLETED|After Controlled Period||0
498239|NCT00307437|1197232|P7|STARTED|After Controlled Period||402
498240|NCT00307437|1197233|P6|STARTED|After Controlled Period||403
498241|NCT00307437|1197234|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
498242|NCT00307437|1197235|P4|STARTED|After Controlled Period||197
498243|NCT00307437|1197236|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
498244|NCT00307437|1197237|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
498245|NCT00307437|1197238|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
498246|NCT00307437|1197232|P7|NOT COMPLETED|Controlled Period||0
498247|NCT00307437|1197233|P6|NOT COMPLETED|Controlled Period||0
498248|NCT00307437|1197234|P5|NOT COMPLETED|Controlled Period||0
498249|NCT00307437|1197235|P4|NOT COMPLETED|Controlled Period||0
498250|NCT00307437|1197236|P3|NOT COMPLETED|Controlled Period||9
498251|NCT00307437|1197237|P2|NOT COMPLETED|Controlled Period||6
498252|NCT00307437|1197238|P1|NOT COMPLETED|Controlled Period||16
498253|NCT00307437|1197232|P7|COMPLETED|Controlled Period||0
498254|NCT00307437|1197233|P6|COMPLETED|Controlled Period||0
498255|NCT00307437|1197234|P5|COMPLETED|Controlled Period||0
498256|NCT00307437|1197235|P4|COMPLETED|Controlled Period||0
498257|NCT00307437|1197236|P3|COMPLETED|Controlled Period||402
498258|NCT00307437|1197237|P2|COMPLETED|Controlled Period||403
498259|NCT00307437|1197238|P1|COMPLETED|Controlled Period||394
498260|NCT00307437|1197232|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
498261|NCT00307437|1197233|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
498262|NCT00307437|1197234|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
498263|NCT00307437|1197235|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
498264|NCT00307437|1197236|P3|STARTED|Controlled Period||411
498265|NCT00307437|1197237|P2|STARTED|Controlled Period||409
498266|NCT00307437|1197238|P1|STARTED|Controlled Period||410
498267|NCT00307333|1197264|P2|NOT COMPLETED|Overall Study||3
498268|NCT00307333|1197265|P1|NOT COMPLETED|Overall Study||11
498269|NCT00307333|1197264|P2|COMPLETED|Overall Study||1489
498270|NCT00307333|1197265|P1|COMPLETED|Overall Study||1500
498271|NCT00307333|1197264|P2|STARTED|Overall Study||1492
498272|NCT00307333|1197265|P1|STARTED|Overall Study||1511
498273|NCT00307294|1197277|P1|NOT COMPLETED|Overall Study||30
498274|NCT00307294|1197277|P1|COMPLETED|Overall Study||9
498275|NCT00307294|1197277|P1|STARTED|Overall Study||39
498276|NCT00307164|1197283|P2|NOT COMPLETED|Overall Study||14
498277|NCT00307164|1197284|P1|NOT COMPLETED|Overall Study||15
498278|NCT00307164|1197283|P2|COMPLETED|Overall Study||68
498279|NCT00307164|1197284|P1|COMPLETED|Overall Study||68
498280|NCT00307164|1197283|P2|STARTED|Overall Study||82
498281|NCT00307164|1197284|P1|STARTED|Overall Study||83
498282|NCT00307151|1197324|P4|NOT COMPLETED|Overall Study||11
498283|NCT00307151|1197325|P3|NOT COMPLETED|Overall Study||20
498284|NCT00307151|1197326|P2|NOT COMPLETED|Overall Study||7
498285|NCT00307151|1197327|P1|NOT COMPLETED|Overall Study||11
498286|NCT00307151|1197324|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
498287|NCT00307151|1197325|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
498288|NCT00307151|1197326|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
498289|NCT00307151|1197327|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
498290|NCT00307151|1197324|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
498291|NCT00307151|1197325|P3|STARTED|Overall Study||147
498292|NCT00307151|1197326|P2|STARTED|Overall Study||82
498293|NCT00307151|1197327|P1|STARTED|Overall Study||82
498294|NCT00307125|1197371|P3|NOT COMPLETED|Pilot Phase||1
498295|NCT00307125|1197372|P2|NOT COMPLETED|Pilot Phase||2
498296|NCT00307125|1197373|P1|NOT COMPLETED|Pilot Phase||0
498297|NCT00307125|1197371|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
498298|NCT00307125|1197372|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
498299|NCT00307125|1197373|P1|COMPLETED|Pilot Phase||0
498300|NCT00307125|1197371|P3|STARTED|Pilot Phase||7
498301|NCT00307125|1197372|P2|STARTED|Pilot Phase||15
498302|NCT00307125|1197373|P1|STARTED|Pilot Phase||0
498303|NCT00307125|1197371|P3|NOT COMPLETED|Screening Phase||0
498304|NCT00307125|1197372|P2|NOT COMPLETED|Screening Phase||0
498305|NCT00307125|1197373|P1|NOT COMPLETED|Screening Phase||454
498306|NCT00307125|1197371|P3|COMPLETED|Screening Phase||0
498307|NCT00307125|1197372|P2|COMPLETED|Screening Phase||0
498308|NCT00307125|1197373|P1|COMPLETED|Screening Phase||303
498309|NCT00307125|1197371|P3|STARTED|Screening Phase||0
498310|NCT00307125|1197372|P2|STARTED|Screening Phase||0
498311|NCT00307125|1197373|P1|STARTED|Screening Phase||757
498312|NCT00307086|1197395|P1|NOT COMPLETED|Overall Study||5
498313|NCT00307086|1197395|P1|COMPLETED|Overall Study||25
498314|NCT00307086|1197395|P1|STARTED|Overall Study||30
498315|NCT00307047|1197401|P2|NOT COMPLETED|Overall Study||49
498316|NCT00307047|1197402|P1|NOT COMPLETED|Overall Study||69
498317|NCT00307047|1197401|P2|COMPLETED|Overall Study||1180
498318|NCT00307047|1197402|P1|COMPLETED|Overall Study||2389
498319|NCT00307047|1197401|P2|STARTED|Overall Study||1229
498320|NCT00307047|1197402|P1|STARTED|Overall Study||2458
498321|NCT00307034|1197540|P2|NOT COMPLETED|Overall Study||7
498322|NCT00307034|1197541|P1|NOT COMPLETED|Overall Study||2
498323|NCT00307034|1197540|P2|COMPLETED|Overall Study||169
498324|NCT00307034|1197541|P1|COMPLETED|Overall Study||173
498325|NCT00307034|1197540|P2|STARTED|Overall Study||176
498326|NCT00307034|1197541|P1|STARTED|Overall Study||175
498327|NCT00306917|1197581|P2|NOT COMPLETED|Overall Study||109
498328|NCT00306917|1197582|P1|NOT COMPLETED|Overall Study||108
498329|NCT00306917|1197581|P2|COMPLETED|Overall Study||15
498330|NCT00306917|1197582|P1|COMPLETED|Overall Study||13
498331|NCT00306917|1197581|P2|60 Month Follow up|Overall Study||15
498332|NCT00306917|1197582|P1|60 Month Follow up|Overall Study||13
498333|NCT00306917|1197581|P2|48 Month Follow up|Overall Study||22
498334|NCT00306917|1197582|P1|48 Month Follow up|Overall Study||29
498335|NCT00306917|1197581|P2|36 Month Follow up|Overall Study||42
498336|NCT00306917|1197582|P1|36 Month Follow up|Overall Study||56
498337|NCT00306917|1197581|P2|24 Month Follow up|Overall Study||71
498338|NCT00306917|1197582|P1|24 Month Follow up|Overall Study||60
498339|NCT00306917|1197581|P2|12 Month Follow|Overall Study||94
498340|NCT00306917|1197582|P1|12 Month Follow|Overall Study||86
498341|NCT00306917|1197581|P2|Postoperative to 6 Month Follow up|Overall Study||100
498342|NCT00306917|1197582|P1|Postoperative to 6 Month Follow up|Overall Study||93
498343|NCT00306917|1197581|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
498344|NCT00306917|1197582|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
498345|NCT00306891|1197592|P4|NOT COMPLETED|Part B||17
498346|NCT00306891|1197593|P3|NOT COMPLETED|Part B||11
498347|NCT00306891|1197594|P2|NOT COMPLETED|Part B||0
498348|NCT00306891|1197595|P1|NOT COMPLETED|Part B||0
498349|NCT00306891|1197592|P4|COMPLETED|Part B||14
498350|NCT00306891|1197593|P3|COMPLETED|Part B||5
498351|NCT00306891|1197594|P2|COMPLETED|Part B||0
498352|NCT00306891|1197595|P1|COMPLETED|Part B||0
498353|NCT00306891|1197592|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
498354|NCT00306891|1197593|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
498355|NCT00306891|1197594|P2|STARTED|Part B||0
498356|NCT00306891|1197595|P1|STARTED|Part B||0
498357|NCT00306891|1197592|P4|NOT COMPLETED|Part A||0
498358|NCT00306891|1197593|P3|NOT COMPLETED|Part A||0
498359|NCT00306891|1197594|P2|NOT COMPLETED|Part A||6
498360|NCT00306891|1197595|P1|NOT COMPLETED|Part A||5
498361|NCT00306891|1197592|P4|COMPLETED|Part A||0
498362|NCT00306891|1197593|P3|COMPLETED|Part A||0
498363|NCT00306891|1197594|P2|COMPLETED|Part A||16
498364|NCT00306891|1197595|P1|COMPLETED|Part A||18
498365|NCT00306891|1197592|P4|STARTED|Part A||0
498366|NCT00306891|1197593|P3|STARTED|Part A||0
498367|NCT00306891|1197594|P2|STARTED|Part A||22
498368|NCT00306891|1197595|P1|STARTED|Part A||23
498369|NCT00306852|1197618|P2|NOT COMPLETED|Overall Study||38
498370|NCT00306852|1197619|P1|NOT COMPLETED|Overall Study||29
498371|NCT00306852|1197618|P2|COMPLETED|Overall Study||69
498372|NCT00306852|1197619|P1|COMPLETED|Overall Study||76
498373|NCT00306852|1197618|P2|STARTED|Overall Study||107
498374|NCT00306852|1197619|P1|STARTED|Overall Study||105
498375|NCT00306787|1197637|P2|NOT COMPLETED|Overall Study||241
498376|NCT00306787|1197638|P1|NOT COMPLETED|Overall Study||234
498377|NCT00306787|1197637|P2|COMPLETED|Overall Study||359
498378|NCT00306787|1197638|P1|COMPLETED|Overall Study||345
498379|NCT00306787|1197637|P2|Intent to Treat (ITT) Population|Overall Study||381
498380|NCT00306787|1197638|P1|Intent to Treat (ITT) Population|Overall Study||370
498381|NCT00306787|1197637|P2|Received Study Drug (Safety Population)|Overall Study||385
498382|NCT00306787|1197638|P1|Received Study Drug (Safety Population)|Overall Study||371
498383|NCT00306787|1197637|P2|STARTED|Overall Study||600
498384|NCT00306787|1197638|P1|STARTED|Overall Study||579
498385|NCT00306670|1197656|P2|NOT COMPLETED|Overall Study||2
498386|NCT00306670|1197657|P1|NOT COMPLETED|Overall Study||0
498387|NCT00306670|1197656|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
498388|NCT00306670|1197657|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
498389|NCT00306670|1197656|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
498390|NCT00306670|1197657|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
498391|NCT00306592|1197663|P2|NOT COMPLETED|Overall Study||58
498392|NCT00306592|1197664|P1|NOT COMPLETED|Overall Study||31
498393|NCT00306592|1197663|P2|COMPLETED|Overall Study||632
498394|NCT00306592|1197664|P1|COMPLETED|Overall Study||373
498395|NCT00306592|1197663|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
498396|NCT00306592|1197664|P1|Entered 101-MS-321 Extension Study|Overall Study||22
498397|NCT00306592|1197663|P2|Completed at 48 Weeks|Overall Study||632
498398|NCT00306592|1197664|P1|Completed at 48 Weeks|Overall Study||81
498399|NCT00306592|1197663|P2|Completed Between 24 and 48 Weeks|Overall Study||0
498400|NCT00306592|1197664|P1|Completed Between 24 and 48 Weeks|Overall Study||85
498401|NCT00306592|1197663|P2|Completed at 24 Weeks|Overall Study||0
498402|NCT00306592|1197664|P1|Completed at 24 Weeks|Overall Study||207
498403|NCT00306592|1197663|P2|STARTED|Overall Study||690
498404|NCT00306592|1197664|P1|STARTED|Overall Study||404
498405|NCT00306527|1197674|P4|NOT COMPLETED|Overall Study||6
498406|NCT00306527|1197675|P3|NOT COMPLETED|Overall Study||5
498407|NCT00306527|1197676|P2|NOT COMPLETED|Overall Study||7
498408|NCT00306527|1197677|P1|NOT COMPLETED|Overall Study||6
498409|NCT00306527|1197674|P4|COMPLETED|Overall Study||590
498410|NCT00306527|1197675|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
498411|NCT00306527|1197676|P2|COMPLETED|Overall Study||527
498412|NCT00306527|1197677|P1|COMPLETED|Overall Study||527
498413|NCT00306527|1197674|P4|STARTED|Overall Study||596
498414|NCT00306527|1197675|P3|STARTED|Overall Study||572
498415|NCT00306527|1197676|P2|STARTED|Overall Study||534
498416|NCT00306527|1197677|P1|STARTED|Overall Study||533
498417|NCT00306488|1197731|P2|NOT COMPLETED|Overall Study||1
498418|NCT00306488|1197732|P1|NOT COMPLETED|Overall Study||1
498419|NCT00306488|1197731|P2|COMPLETED|Overall Study||10
498420|NCT00306488|1197732|P1|COMPLETED|Overall Study||10
498421|NCT00306488|1197731|P2|STARTED|Overall Study||11
498422|NCT00306488|1197732|P1|STARTED|Overall Study||11
498423|NCT00306384|1197746|P3|NOT COMPLETED|Overall Study||277
498424|NCT00306384|1197747|P2|NOT COMPLETED|Overall Study||508
498425|NCT00306384|1197748|P1|NOT COMPLETED|Overall Study||542
498426|NCT00306384|1197746|P3|COMPLETED|Overall Study||251
498427|NCT00306384|1197747|P2|COMPLETED|Overall Study||891
498428|NCT00306384|1197748|P1|COMPLETED|Overall Study||854
498429|NCT00306384|1197746|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
498430|NCT00306384|1197747|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
498431|NCT00306384|1197748|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
498432|NCT00306384|1197746|P3|STARTED|Overall Study||528
498433|NCT00306384|1197747|P2|STARTED|Overall Study||1399
498434|NCT00306384|1197748|P1|STARTED|Overall Study||1396
498435|NCT00306202|1197783|P3|NOT COMPLETED|Overall Study||0
498436|NCT00306202|1197784|P2|NOT COMPLETED|Overall Study||1
498437|NCT00306202|1197785|P1|NOT COMPLETED|Overall Study||6
498438|NCT00306202|1197783|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
498439|NCT00306202|1197784|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
498440|NCT00306202|1197785|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
498441|NCT00306202|1197783|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
498442|NCT00306202|1197784|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
498443|NCT00306202|1197785|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
498444|NCT00306189|1197945|P4|NOT COMPLETED|Overall Study||5
498445|NCT00306189|1197946|P3|NOT COMPLETED|Overall Study||11
498446|NCT00306189|1197947|P2|NOT COMPLETED|Overall Study||6
498447|NCT00306189|1197948|P1|NOT COMPLETED|Overall Study||9
498448|NCT00306189|1197945|P4|COMPLETED|Overall Study||52
498449|NCT00306189|1197946|P3|COMPLETED|Overall Study||45
498450|NCT00306189|1197947|P2|COMPLETED|Overall Study||50
498451|NCT00306189|1197948|P1|COMPLETED|Overall Study||48
498452|NCT00306189|1197945|P4|STARTED|Overall Study||57
498453|NCT00306189|1197946|P3|STARTED|Overall Study||56
498454|NCT00306189|1197947|P2|STARTED|Overall Study||56
498455|NCT00306189|1197948|P1|STARTED|Overall Study||57
498456|NCT00306163|1197960|P2|NOT COMPLETED|Overall Study||0
498457|NCT00306163|1197961|P1|NOT COMPLETED|Overall Study||0
498458|NCT00306163|1197960|P2|COMPLETED|Overall Study||18
498459|NCT00306163|1197961|P1|COMPLETED|Overall Study||19
498460|NCT00306163|1197960|P2|STARTED|Overall Study||18
498461|NCT00306163|1197961|P1|STARTED|Overall Study||19
498462|NCT00305942|1197967|P1|NOT COMPLETED|Overall Study||38
498463|NCT00305942|1197967|P1|COMPLETED|Overall Study||23
498464|NCT00305942|1197967|P1|STARTED|Overall Study||61
498465|NCT00305877|1197975|P2|NOT COMPLETED|Overall Study||34
498466|NCT00305877|1197976|P1|NOT COMPLETED|Overall Study||24
498467|NCT00305877|1197975|P2|COMPLETED|Overall Study||34
498468|NCT00305877|1197976|P1|COMPLETED|Overall Study||45
498469|NCT00305877|1197975|P2|Included in Efficacy Analysis|Overall Study||62
498470|NCT00305877|1197976|P1|Included in Efficacy Analysis|Overall Study||65
498471|NCT00305877|1197975|P2|Eligible|Overall Study||66
498472|NCT00305877|1197976|P1|Eligible|Overall Study||66
498473|NCT00305877|1197975|P2|Treated|Overall Study||63
498474|NCT00305877|1197976|P1|Treated|Overall Study||67
498475|NCT00305877|1197975|P2|STARTED|Overall Study||68
498476|NCT00305877|1197976|P1|STARTED|Overall Study||69
498477|NCT00305864|1197990|P4|NOT COMPLETED|Overall Study||13
498478|NCT00305864|1197991|P3|NOT COMPLETED|Overall Study||1
498479|NCT00305864|1197992|P2|NOT COMPLETED|Overall Study||1
498480|NCT00305864|1197993|P1|NOT COMPLETED|Overall Study||0
498481|NCT00305864|1197990|P4|COMPLETED|Overall Study||81
498482|NCT00305864|1197991|P3|COMPLETED|Overall Study||6
498483|NCT00305864|1197992|P2|COMPLETED|Overall Study||9
498484|NCT00305864|1197993|P1|COMPLETED|Overall Study||7
498485|NCT00305864|1197990|P4|STARTED|Overall Study||94
498486|NCT00305864|1197991|P3|STARTED|Overall Study||7
498487|NCT00305864|1197992|P2|STARTED|Overall Study||10
498488|NCT00305864|1197993|P1|STARTED|Overall Study||7
498489|NCT00305773|1198005|P2|NOT COMPLETED|Overall Study||18
498490|NCT00305773|1198006|P1|NOT COMPLETED|Overall Study||14
498491|NCT00305773|1198005|P2|COMPLETED|Overall Study||4
498492|NCT00305773|1198006|P1|COMPLETED|Overall Study||1
498493|NCT00305773|1198005|P2|STARTED|Overall Study||22
498494|NCT00305773|1198006|P1|STARTED|Overall Study||15
498495|NCT00305760|1198020|P1|NOT COMPLETED|Overall Study||47
498496|NCT00305760|1198020|P1|COMPLETED|Overall Study||13
498497|NCT00305760|1198020|P1|STARTED|Overall Study||60
498498|NCT00305643|1198026|P2|NOT COMPLETED|Overall Study||0
498499|NCT00305643|1198027|P1|NOT COMPLETED|Overall Study||0
498500|NCT00305643|1198026|P2|COMPLETED|Overall Study||5
498501|NCT00305643|1198027|P1|COMPLETED|Overall Study||6
498502|NCT00305643|1198026|P2|STARTED|Overall Study||5
498503|NCT00305643|1198027|P1|STARTED|Overall Study||6
498504|NCT00305604|1198037|P2|NOT COMPLETED|Overall Study||47
498505|NCT00305604|1198038|P1|NOT COMPLETED|Overall Study||32
498506|NCT00305604|1198037|P2|COMPLETED|Overall Study||57
498507|NCT00305604|1198038|P1|COMPLETED|Overall Study||70
498508|NCT00305604|1198037|P2|STARTED|Overall Study||104
498509|NCT00305604|1198038|P1|STARTED|Overall Study||102
498510|NCT00305578|1198052|P2|NOT COMPLETED|Overall Study||2
498511|NCT00305578|1198053|P1|NOT COMPLETED|Overall Study||3
498512|NCT00305578|1198052|P2|COMPLETED|Overall Study||12
498513|NCT00305578|1198053|P1|COMPLETED|Overall Study||12
498514|NCT00305578|1198052|P2|STARTED|Overall Study||14
498515|NCT00305578|1198053|P1|STARTED|Overall Study||15
498516|NCT00305565|1198062|P3|NOT COMPLETED|Overall Study (ITT Population)||5
498517|NCT00305565|1198063|P2|NOT COMPLETED|Overall Study (ITT Population)||11
498518|NCT00305565|1198064|P1|NOT COMPLETED|Overall Study (ITT Population)||13
498519|NCT00305565|1198062|P3|COMPLETED|Overall Study (ITT Population)||102
498520|NCT00305565|1198063|P2|COMPLETED|Overall Study (ITT Population)||90
498521|NCT00305565|1198064|P1|COMPLETED|Overall Study (ITT Population)||89
498522|NCT00305565|1198062|P3|STARTED|Overall Study (ITT Population)||107
498523|NCT00305565|1198063|P2|STARTED|Overall Study (ITT Population)||101
498524|NCT00305565|1198064|P1|STARTED|Overall Study (ITT Population)||102
498525|NCT00305565|1198062|P3|NOT COMPLETED|Overall Study (Safety Population)||7
498526|NCT00305565|1198063|P2|NOT COMPLETED|Overall Study (Safety Population)||12
498527|NCT00305565|1198064|P1|NOT COMPLETED|Overall Study (Safety Population)||14
498528|NCT00305565|1198062|P3|COMPLETED|Overall Study (Safety Population)||106
498529|NCT00305565|1198063|P2|COMPLETED|Overall Study (Safety Population)||95
498530|NCT00305565|1198064|P1|COMPLETED|Overall Study (Safety Population)||97
498531|NCT00305565|1198062|P3|STARTED|Overall Study (Safety Population)||113
498532|NCT00305565|1198063|P2|STARTED|Overall Study (Safety Population)||107
498533|NCT00305565|1198064|P1|STARTED|Overall Study (Safety Population)||111
498534|NCT00305448|1198182|P3|NOT COMPLETED|Overall Study||33
498535|NCT00305448|1198183|P2|NOT COMPLETED|Overall Study||34
498536|NCT00305448|1198184|P1|NOT COMPLETED|Overall Study||31
498537|NCT00305448|1198182|P3|COMPLETED|Overall Study||14
498538|NCT00305448|1198183|P2|COMPLETED|Overall Study||17
498539|NCT00305448|1198184|P1|COMPLETED|Overall Study||14
498540|NCT00305448|1198182|P3|STARTED|Overall Study||47
498541|NCT00305448|1198183|P2|STARTED|Overall Study||51
498542|NCT00305448|1198184|P1|STARTED|Overall Study||45
498543|NCT00305344|1198200|P1|NOT COMPLETED|Overall Study||0
498544|NCT00305344|1198200|P1|COMPLETED|Overall Study||23
498545|NCT00305344|1198200|P1|STARTED|Overall Study||23
498546|NCT00305253|1198206|P2|NOT COMPLETED|Overall Study||1
498547|NCT00305253|1198207|P1|NOT COMPLETED|Overall Study||0
498548|NCT00305253|1198206|P2|COMPLETED|Overall Study||558
498549|NCT00305253|1198207|P1|COMPLETED|Overall Study||432
498550|NCT00305253|1198206|P2|STARTED|Overall Study||559
498551|NCT00305253|1198207|P1|STARTED|Overall Study||432
498552|NCT00305227|1198219|P2|NOT COMPLETED|Overall Study||6
498553|NCT00305227|1198220|P1|NOT COMPLETED|Overall Study||7
498554|NCT00305227|1198219|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
498555|NCT00305227|1198220|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
498556|NCT00305227|1198219|P2|STARTED|Overall Study||50
498557|NCT00305227|1198220|P1|STARTED|Overall Study||50
498558|NCT00305162|1198228|P2|NOT COMPLETED|1 Year Follow-up Period||65
498559|NCT00305162|1198229|P1|NOT COMPLETED|1 Year Follow-up Period||55
498560|NCT00305162|1198228|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
498561|NCT00305162|1198229|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
498562|NCT00305162|1198228|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
498563|NCT00305162|1198229|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
498564|NCT00305162|1198228|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
498565|NCT00305162|1198229|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
498566|NCT00305162|1198228|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
498567|NCT00305162|1198229|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
498568|NCT00305162|1198228|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
498569|NCT00305162|1198229|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
498570|NCT00305162|1198228|P2|STARTED|1 Year Follow-up Period||4447
498571|NCT00305162|1198229|P1|STARTED|1 Year Follow-up Period||4435
498572|NCT00305162|1198228|P2|NOT COMPLETED|30-day Follow-up Period||63
498573|NCT00305162|1198229|P1|NOT COMPLETED|30-day Follow-up Period||62
498574|NCT00305162|1198228|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
498575|NCT00305162|1198229|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
498576|NCT00305162|1198228|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
498577|NCT00305162|1198229|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
498578|NCT00305162|1198228|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
498579|NCT00305162|1198229|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
498580|NCT00305162|1198228|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
498581|NCT00305162|1198229|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
498582|NCT00305162|1198228|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
498583|NCT00305162|1198229|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
498584|NCT00305162|1198228|P2|STARTED|30-day Follow-up Period||4447
498585|NCT00305162|1198229|P1|STARTED|30-day Follow-up Period||4435
498586|NCT00305162|1198228|P2|NOT COMPLETED|48 Hour Follow-up Period||16
498587|NCT00305162|1198229|P1|NOT COMPLETED|48 Hour Follow-up Period||20
498588|NCT00305162|1198228|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
498589|NCT00305162|1198229|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
498590|NCT00305162|1198228|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
498591|NCT00305162|1198229|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
498592|NCT00305162|1198228|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
498593|NCT00305162|1198229|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
498594|NCT00305162|1198228|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
498595|NCT00305162|1198229|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
498596|NCT00305162|1198228|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
498597|NCT00305162|1198229|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
498598|NCT00305162|1198228|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
498599|NCT00305162|1198229|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
498600|NCT00305162|1198228|P2|STARTED|48 Hour Follow-up Period||4447
498601|NCT00305162|1198229|P1|STARTED|48 Hour Follow-up Period||4435
498602|NCT00304954|1198271|P4|NOT COMPLETED|Overall Study||0
498603|NCT00304954|1198272|P3|NOT COMPLETED|Overall Study||1
498604|NCT00304954|1198273|P2|NOT COMPLETED|Overall Study||0
498605|NCT00304954|1198274|P1|NOT COMPLETED|Overall Study||1
498606|NCT00304954|1198271|P4|COMPLETED|Overall Study||3
498607|NCT00304954|1198272|P3|COMPLETED|Overall Study||2
498608|NCT00304954|1198273|P2|COMPLETED|Overall Study||3
498609|NCT00304954|1198274|P1|COMPLETED|Overall Study||3
498610|NCT00304954|1198271|P4|STARTED|Overall Study||3
498611|NCT00304954|1198272|P3|STARTED|Overall Study||3
498612|NCT00304954|1198273|P2|STARTED|Overall Study||3
498613|NCT00304954|1198274|P1|STARTED|Overall Study||4
498614|NCT00304915|1198294|P2|NOT COMPLETED|Overall Study||16
498615|NCT00304915|1198295|P1|NOT COMPLETED|Overall Study||18
498616|NCT00304915|1198294|P2|COMPLETED|Overall Study||110
498617|NCT00304915|1198295|P1|COMPLETED|Overall Study||105
498618|NCT00304915|1198294|P2|STARTED|Overall Study||126
498619|NCT00304915|1198295|P1|STARTED|Overall Study||123
498620|NCT00304746|1198303|P2|NOT COMPLETED|Overall Study||0
498621|NCT00304746|1198304|P1|NOT COMPLETED|Overall Study||0
498622|NCT00304746|1198303|P2|COMPLETED|Overall Study||50
498623|NCT00304746|1198304|P1|COMPLETED|Overall Study||50
498624|NCT00304746|1198303|P2|STARTED|Overall Study||50
498625|NCT00304746|1198304|P1|STARTED|Overall Study||50
498626|NCT00304707|1198314|P2|NOT COMPLETED|Overall Study||6
498627|NCT00304707|1198315|P1|NOT COMPLETED|Overall Study||7
498628|NCT00304707|1198314|P2|COMPLETED|Overall Study||64
498629|NCT00304707|1198315|P1|COMPLETED|Overall Study||66
498630|NCT00304707|1198314|P2|STARTED|Overall Study||70
498631|NCT00304707|1198315|P1|STARTED|Overall Study||73
498632|NCT00304265|1198323|P2|NOT COMPLETED|Overall Study||0
498633|NCT00304265|1198324|P1|NOT COMPLETED|Overall Study||0
498634|NCT00304265|1198323|P2|COMPLETED|Overall Study||98
498635|NCT00304265|1198324|P1|COMPLETED|Overall Study||117
498636|NCT00304265|1198323|P2|STARTED|Overall Study||98
498637|NCT00304265|1198324|P1|STARTED|Overall Study||117
498638|NCT00304187|1198332|P2|NOT COMPLETED|Overall Study||1
498639|NCT00304187|1198333|P1|NOT COMPLETED|Overall Study||2
498640|NCT00304187|1198332|P2|COMPLETED|Overall Study||13
498641|NCT00304187|1198333|P1|COMPLETED|Overall Study||13
498642|NCT00304187|1198332|P2|STARTED|Overall Study||14
498643|NCT00304187|1198333|P1|STARTED|Overall Study||15
498644|NCT00304161|1198341|P2|NOT COMPLETED|Overall Study||6
498645|NCT00304161|1198342|P1|NOT COMPLETED|Overall Study||6
498646|NCT00304161|1198341|P2|COMPLETED|Overall Study||21
498647|NCT00304161|1198342|P1|COMPLETED|Overall Study||22
498648|NCT00304161|1198341|P2|STARTED|Overall Study||27
498649|NCT00304161|1198342|P1|STARTED|Overall Study||28
498650|NCT00304096|1198352|P2|NOT COMPLETED|Overall Study||0
498651|NCT00304096|1198353|P1|NOT COMPLETED|Overall Study||0
498652|NCT00304096|1198352|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
498653|NCT00304096|1198353|P1|COMPLETED|Overall Study||6
498654|NCT00304096|1198352|P2|STARTED|Overall Study||5
498655|NCT00304096|1198353|P1|STARTED|Overall Study||6
498656|NCT00304070|1198364|P3|NOT COMPLETED|Overall Study||12
498657|NCT00304070|1198365|P2|NOT COMPLETED|Overall Study||7
498658|NCT00304070|1198366|P1|NOT COMPLETED|Overall Study||3
498659|NCT00304070|1198364|P3|COMPLETED|Overall Study||27
498660|NCT00304070|1198365|P2|COMPLETED|Overall Study||8
498661|NCT00304070|1198366|P1|COMPLETED|Overall Study||21
498662|NCT00304070|1198364|P3|STARTED|Overall Study||39
498663|NCT00304070|1198365|P2|STARTED|Overall Study||15
498664|NCT00304070|1198366|P1|STARTED|Overall Study||24
498665|NCT00304031|1198381|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
498666|NCT00304031|1198382|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
498667|NCT00304031|1198383|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
498668|NCT00304031|1198381|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
498669|NCT00304031|1198382|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
498670|NCT00304031|1198383|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
498671|NCT00304031|1198381|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
498672|NCT00304031|1198382|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
498673|NCT00304031|1198383|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
498674|NCT00304031|1198381|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
498675|NCT00304031|1198382|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
498676|NCT00304031|1198383|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
498677|NCT00304031|1198381|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
498678|NCT00304031|1198382|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
498679|NCT00304031|1198383|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
498680|NCT00304031|1198381|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
498681|NCT00304031|1198382|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
498682|NCT00304031|1198383|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
498683|NCT00304031|1198381|P3|NOT COMPLETED|Registration||0
498684|NCT00304031|1198382|P2|NOT COMPLETED|Registration||0
498685|NCT00304031|1198383|P1|NOT COMPLETED|Registration||48
498686|NCT00304031|1198381|P3|COMPLETED|Registration||0
498687|NCT00304031|1198382|P2|COMPLETED|Registration||0
498688|NCT00304031|1198383|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
498689|NCT00304031|1198381|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
498690|NCT00304031|1198382|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
498691|NCT00304031|1198383|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
498692|NCT00303979|1198393|P3|NOT COMPLETED|Single Time Point (18 Month)||0
498693|NCT00303979|1198394|P2|NOT COMPLETED|Single Time Point (18 Month)||0
498694|NCT00303979|1198395|P1|NOT COMPLETED|Single Time Point (18 Month)||0
498695|NCT00303979|1198393|P3|COMPLETED|Single Time Point (18 Month)||9641
498696|NCT00303979|1198394|P2|COMPLETED|Single Time Point (18 Month)||0
498697|NCT00303979|1198395|P1|COMPLETED|Single Time Point (18 Month)||0
498698|NCT00303979|1198393|P3|STARTED|Single Time Point (18 Month)||9641
498699|NCT00303979|1198394|P2|STARTED|Single Time Point (18 Month)||0
498700|NCT00303979|1198395|P1|STARTED|Single Time Point (18 Month)||0
498701|NCT00303979|1198393|P3|NOT COMPLETED|Single Time Point (6 Month)||0
498702|NCT00303979|1198394|P2|NOT COMPLETED|Single Time Point (6 Month)||0
498703|NCT00303979|1198395|P1|NOT COMPLETED|Single Time Point (6 Month)||0
498704|NCT00303979|1198393|P3|COMPLETED|Single Time Point (6 Month)||0
498705|NCT00303979|1198394|P2|COMPLETED|Single Time Point (6 Month)||9992
498706|NCT00303979|1198395|P1|COMPLETED|Single Time Point (6 Month)||0
498707|NCT00303979|1198393|P3|STARTED|Single Time Point (6 Month)||0
498708|NCT00303979|1198394|P2|STARTED|Single Time Point (6 Month)||9992
498709|NCT00303979|1198395|P1|STARTED|Single Time Point (6 Month)||0
498710|NCT00303979|1198393|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
498711|NCT00303979|1198394|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
498712|NCT00303979|1198395|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
498713|NCT00303979|1198393|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
498714|NCT00303979|1198394|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
498715|NCT00303979|1198395|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
498716|NCT00303979|1198393|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
498717|NCT00303979|1198394|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
498718|NCT00303979|1198395|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
498719|NCT00303966|1198405|P1|NOT COMPLETED|Overall Study||0
498720|NCT00303966|1198405|P1|COMPLETED|Overall Study||5
498721|NCT00303966|1198405|P1|STARTED|Overall Study||5
498722|NCT00303953|1198414|P1|NOT COMPLETED|Overall Study||19
498723|NCT00303953|1198414|P1|COMPLETED|Overall Study||3
498724|NCT00303953|1198414|P1|Eligible and Treated|Overall Study||20
498725|NCT00303953|1198414|P1|Eligible|Overall Study||21
498726|NCT00303953|1198414|P1|STARTED|Overall Study||22
498727|NCT00303901|1198420|P1|NOT COMPLETED|Overall Study||0
498728|NCT00303901|1198420|P1|COMPLETED|Overall Study||40
498729|NCT00303901|1198420|P1|STARTED|Overall Study||40
498730|NCT00303862|1198425|P1|NOT COMPLETED|Overall Study||0
498731|NCT00303862|1198425|P1|COMPLETED|Overall Study||10
498732|NCT00303862|1198425|P1|STARTED|Overall Study||10
498733|NCT00303823|1198434|P2|NOT COMPLETED|Overall Study||10
498734|NCT00303823|1198435|P1|NOT COMPLETED|Overall Study||15
498735|NCT00303823|1198434|P2|COMPLETED|Overall Study||38
498736|NCT00303823|1198435|P1|COMPLETED|Overall Study||35
498737|NCT00303823|1198434|P2|STARTED|Overall Study||48
498738|NCT00303823|1198435|P1|STARTED|Overall Study||50
498739|NCT00303667|1198449|P2|NOT COMPLETED|Overall Study||4
498740|NCT00303667|1198450|P1|NOT COMPLETED|Overall Study||0
498741|NCT00303667|1198449|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
498742|NCT00303667|1198450|P1|COMPLETED|Overall Study||8
498743|NCT00303667|1198449|P2|STARTED|Overall Study||39
498744|NCT00303667|1198450|P1|STARTED|Overall Study||8
498745|NCT00303628|1198474|P2|NOT COMPLETED|Overall Study||73
498746|NCT00303628|1198475|P1|NOT COMPLETED|Overall Study||50
498747|NCT00303628|1198474|P2|COMPLETED|Overall Study||106
498748|NCT00303628|1198475|P1|COMPLETED|Overall Study||126
498749|NCT00303628|1198474|P2|Treated|Overall Study||174
498750|NCT00303628|1198475|P1|Treated|Overall Study||173
498751|NCT00303628|1198474|P2|Eligible|Overall Study||177
498752|NCT00303628|1198475|P1|Eligible|Overall Study||171
498753|NCT00303628|1198474|P2|STARTED|Overall Study||179
498754|NCT00303628|1198475|P1|STARTED|Overall Study||176
498755|NCT00303602|1198493|P2|NOT COMPLETED|Overall Study||15
498756|NCT00303602|1198494|P1|NOT COMPLETED|Overall Study||19
498757|NCT00303602|1198493|P2|COMPLETED|Overall Study||50
498758|NCT00303602|1198494|P1|COMPLETED|Overall Study||65
498759|NCT00303602|1198493|P2|STARTED|Overall Study||65
498760|NCT00303602|1198494|P1|STARTED|Overall Study||84
498761|NCT00303511|1198534|P1|NOT COMPLETED|Overall Study||0
498762|NCT00303511|1198534|P1|COMPLETED|Overall Study||10
498763|NCT00303511|1198534|P1|STARTED|Overall Study||10
498764|NCT00303485|1198540|P2|NOT COMPLETED|Overall Study||2
498765|NCT00303485|1198541|P1|NOT COMPLETED|Overall Study||1
498766|NCT00303485|1198540|P2|COMPLETED|Overall Study||15
498767|NCT00303485|1198541|P1|COMPLETED|Overall Study||48
498768|NCT00303485|1198540|P2|STARTED|Overall Study||17
498769|NCT00303485|1198541|P1|STARTED|Overall Study||49
498770|NCT00303472|1198572|P7|NOT COMPLETED|Treatment Extension (Optional)||0
498771|NCT00303472|1198573|P6|NOT COMPLETED|Treatment Extension (Optional)||1
498772|NCT00303472|1198574|P5|NOT COMPLETED|Treatment Extension (Optional)||4
498773|NCT00303472|1198575|P4|NOT COMPLETED|Treatment Extension (Optional)||8
498774|NCT00303472|1198576|P3|NOT COMPLETED|Treatment Extension (Optional)||9
498775|NCT00303472|1198577|P2|NOT COMPLETED|Treatment Extension (Optional)||6
498776|NCT00303472|1198578|P1|NOT COMPLETED|Treatment Extension (Optional)||5
498777|NCT00303472|1198572|P7|COMPLETED|Treatment Extension (Optional)||1
498778|NCT00303472|1198573|P6|COMPLETED|Treatment Extension (Optional)||4
498779|NCT00303472|1198574|P5|COMPLETED|Treatment Extension (Optional)||1
498780|NCT00303472|1198575|P4|COMPLETED|Treatment Extension (Optional)||5
498781|NCT00303472|1198576|P3|COMPLETED|Treatment Extension (Optional)||2
498782|NCT00303472|1198577|P2|COMPLETED|Treatment Extension (Optional)||5
498783|NCT00303472|1198578|P1|COMPLETED|Treatment Extension (Optional)||1
498784|NCT00303472|1198572|P7|STARTED|Treatment Extension (Optional)||1
498785|NCT00303472|1198573|P6|STARTED|Treatment Extension (Optional)||5
498786|NCT00303472|1198574|P5|STARTED|Treatment Extension (Optional)||5
498787|NCT00303472|1198575|P4|STARTED|Treatment Extension (Optional)||13
498788|NCT00303472|1198576|P3|STARTED|Treatment Extension (Optional)||11
498789|NCT00303472|1198577|P2|STARTED|Treatment Extension (Optional)||11
498790|NCT00303472|1198578|P1|STARTED|Treatment Extension (Optional)||6
498791|NCT00303472|1198572|P7|NOT COMPLETED|Treatment Period||2
498792|NCT00303472|1198573|P6|NOT COMPLETED|Treatment Period||1
498793|NCT00303472|1198574|P5|NOT COMPLETED|Treatment Period||3
498794|NCT00303472|1198575|P4|NOT COMPLETED|Treatment Period||2
498795|NCT00303472|1198576|P3|NOT COMPLETED|Treatment Period||0
498796|NCT00303472|1198577|P2|NOT COMPLETED|Treatment Period||0
498797|NCT00303472|1198578|P1|NOT COMPLETED|Treatment Period||0
498798|NCT00303472|1198572|P7|COMPLETED|Treatment Period||3
498799|NCT00303472|1198573|P6|COMPLETED|Treatment Period||11
498800|NCT00303472|1198574|P5|COMPLETED|Treatment Period||8
498801|NCT00303472|1198575|P4|COMPLETED|Treatment Period||14
498802|NCT00303472|1198576|P3|COMPLETED|Treatment Period||11
498803|NCT00303472|1198577|P2|COMPLETED|Treatment Period||11
498804|NCT00303472|1198578|P1|COMPLETED|Treatment Period||6
498805|NCT00303472|1198572|P7|STARTED|Treatment Period||5
498806|NCT00303472|1198573|P6|STARTED|Treatment Period||12
498807|NCT00303472|1198574|P5|STARTED|Treatment Period||11
498808|NCT00303472|1198575|P4|STARTED|Treatment Period||16
498809|NCT00303472|1198576|P3|STARTED|Treatment Period||11
498810|NCT00303472|1198577|P2|STARTED|Treatment Period||11
498811|NCT00303472|1198578|P1|STARTED|Treatment Period||6
498812|NCT00303459|1198638|P2|NOT COMPLETED|Overall Study||89
498813|NCT00303459|1198639|P1|NOT COMPLETED|Overall Study||83
498814|NCT00303459|1198638|P2|COMPLETED|Overall Study||86
498815|NCT00303459|1198639|P1|COMPLETED|Overall Study||76
498816|NCT00303459|1198638|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
498817|NCT00303459|1198639|P1|STARTED|Overall Study||159
498818|NCT00303446|1198665|P2|NOT COMPLETED|Overall Study||4
498819|NCT00303446|1198666|P1|NOT COMPLETED|Overall Study||2
498820|NCT00303446|1198665|P2|COMPLETED|Overall Study||21
498821|NCT00303446|1198666|P1|COMPLETED|Overall Study||23
498822|NCT00303446|1198665|P2|STARTED|Overall Study||25
498823|NCT00303446|1198666|P1|STARTED|Overall Study||25
498824|NCT00303329|1198702|P2|NOT COMPLETED|Overall Study||62
498825|NCT00303329|1198703|P1|NOT COMPLETED|Overall Study||35
498826|NCT00303329|1198702|P2|COMPLETED|Overall Study||37
498827|NCT00303329|1198703|P1|COMPLETED|Overall Study||50
498828|NCT00303329|1198702|P2|STARTED|Overall Study||99
498829|NCT00303329|1198703|P1|STARTED|Overall Study||85
498830|NCT00303316|1198717|P2|NOT COMPLETED|Overall Study||3
498831|NCT00303316|1198718|P1|NOT COMPLETED|Overall Study||2
498832|NCT00303316|1198717|P2|COMPLETED|Overall Study||223
498833|NCT00303316|1198718|P1|COMPLETED|Overall Study||230
498834|NCT00303316|1198717|P2|STARTED|Overall Study||226
498835|NCT00303316|1198718|P1|STARTED|Overall Study||232
498836|NCT00303186|1198730|P1|NOT COMPLETED|Overall Study||52
498837|NCT00303186|1198730|P1|COMPLETED|Overall Study||55
498838|NCT00303186|1198730|P1|STARTED|Overall Study||107
498839|NCT00303108|1198764|P3|NOT COMPLETED|Overall Study||16
498840|NCT00303108|1198765|P2|NOT COMPLETED|Overall Study||9
498841|NCT00303108|1198766|P1|NOT COMPLETED|Overall Study||12
498842|NCT00303108|1198764|P3|COMPLETED|Overall Study||31
498843|NCT00303108|1198765|P2|COMPLETED|Overall Study||37
498844|NCT00303108|1198766|P1|COMPLETED|Overall Study||31
498845|NCT00303108|1198764|P3|STARTED|Overall Study||47
498846|NCT00303108|1198765|P2|STARTED|Overall Study||46
498847|NCT00303108|1198766|P1|STARTED|Overall Study||43
498848|NCT00303069|1198786|P4|NOT COMPLETED|Overall Study||2
498849|NCT00303069|1198787|P3|NOT COMPLETED|Overall Study||1
498850|NCT00303069|1198788|P2|NOT COMPLETED|Overall Study||0
498851|NCT00303069|1198789|P1|NOT COMPLETED|Overall Study||2
498852|NCT00303069|1198786|P4|COMPLETED|Overall Study||29
498853|NCT00303069|1198787|P3|COMPLETED|Overall Study||33
498854|NCT00303069|1198788|P2|COMPLETED|Overall Study||28
498855|NCT00303069|1198789|P1|COMPLETED|Overall Study||29
498856|NCT00303069|1198786|P4|STARTED|Overall Study||31
498857|NCT00303069|1198787|P3|STARTED|Overall Study||34
498858|NCT00303069|1198788|P2|STARTED|Overall Study||28
498859|NCT00303069|1198789|P1|STARTED|Overall Study||31
498860|NCT00302952|1198809|P2|NOT COMPLETED|Overall Study||5
498861|NCT00302952|1198810|P1|NOT COMPLETED|Overall Study||3
498862|NCT00302952|1198809|P2|COMPLETED|Overall Study||25
498863|NCT00302952|1198810|P1|COMPLETED|Overall Study||31
498864|NCT00302952|1198809|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
498865|NCT00302952|1198810|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
498866|NCT00302952|1198809|P2|Started Intent-to-Treat (ITT)|Overall Study||30
498867|NCT00302952|1198810|P1|Started Intent-to-Treat (ITT)|Overall Study||34
498868|NCT00302952|1198809|P2|STARTED|Overall Study||30
498869|NCT00302952|1198810|P1|STARTED|Overall Study||34
498870|NCT00302848|1198847|P3|NOT COMPLETED|Overall Study||579
498871|NCT00302848|1198848|P2|NOT COMPLETED|Overall Study||419
498872|NCT00302848|1198849|P1|NOT COMPLETED|Overall Study||401
498873|NCT00302848|1198847|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
498874|NCT00302848|1198848|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
498875|NCT00302848|1198849|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
498876|NCT00302848|1198847|P3|STARTED|Overall Study||26341
498877|NCT00302848|1198848|P2|STARTED|Overall Study||15428
498878|NCT00302848|1198849|P1|STARTED|Overall Study||16534
498879|NCT00302718|1198860|P4|NOT COMPLETED|Overall Study||2
498880|NCT00302718|1198861|P3|NOT COMPLETED|Overall Study||2
498881|NCT00302718|1198862|P2|NOT COMPLETED|Overall Study||1
498882|NCT00302718|1198863|P1|NOT COMPLETED|Overall Study||1
498883|NCT00302718|1198860|P4|COMPLETED|Overall Study||19
498884|NCT00302718|1198861|P3|COMPLETED|Overall Study||19
498885|NCT00302718|1198862|P2|COMPLETED|Overall Study||20
498886|NCT00302718|1198863|P1|COMPLETED|Overall Study||19
498887|NCT00302718|1198860|P4|STARTED|Overall Study||21
498888|NCT00302718|1198861|P3|STARTED|Overall Study||21
498889|NCT00302718|1198862|P2|STARTED|Overall Study||21
498890|NCT00302718|1198863|P1|STARTED|Overall Study||20
498891|NCT00302458|1198895|P1|NOT COMPLETED|Overall Study||3
498892|NCT00302458|1198895|P1|COMPLETED|Overall Study||26
498893|NCT00302458|1198895|P1|STARTED|Overall Study||29
498894|NCT00302328|1198906|P3|NOT COMPLETED|Overall Study||0
498895|NCT00302328|1198907|P2|NOT COMPLETED|Overall Study||1
498896|NCT00302328|1198908|P1|NOT COMPLETED|Overall Study||0
498897|NCT00302328|1198906|P3|COMPLETED|Overall Study||18
498898|NCT00302328|1198907|P2|COMPLETED|Overall Study|developed cancer during the study|34
498899|NCT00302328|1198908|P1|COMPLETED|Overall Study||25
498900|NCT00302328|1198906|P3|STARTED|Overall Study||18
498901|NCT00302328|1198907|P2|STARTED|Overall Study||35
498902|NCT00302328|1198908|P1|STARTED|Overall Study||25
498903|NCT00302211|1198925|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
498904|NCT00302211|1198926|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
498905|NCT00302211|1198927|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
498906|NCT00302211|1198928|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
498907|NCT00302211|1198929|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
498908|NCT00302211|1198925|P5|COMPLETED|Open Label-Patients From Double-Blind||24
498909|NCT00302211|1198926|P4|COMPLETED|Open Label-Patients From Double-Blind||18
498910|NCT00302211|1198927|P3|COMPLETED|Open Label-Patients From Double-Blind||0
498911|NCT00302211|1198928|P2|COMPLETED|Open Label-Patients From Double-Blind||0
498912|NCT00302211|1198929|P1|COMPLETED|Open Label-Patients From Double-Blind||0
499000|NCT00301418|1199079|P1|COMPLETED|Overall Study||11
498913|NCT00302211|1198925|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
498914|NCT00302211|1198926|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
498915|NCT00302211|1198927|P3|STARTED|Open Label-Patients From Double-Blind||0
498916|NCT00302211|1198928|P2|STARTED|Open Label-Patients From Double-Blind||0
498917|NCT00302211|1198929|P1|STARTED|Open Label-Patients From Double-Blind||0
498918|NCT00302211|1198925|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
498919|NCT00302211|1198926|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
498920|NCT00302211|1198927|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
498921|NCT00302211|1198928|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
498922|NCT00302211|1198929|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
498923|NCT00302211|1198925|P5|COMPLETED|Double Blind Period (New Patients)||0
498924|NCT00302211|1198926|P4|COMPLETED|Double Blind Period (New Patients)||0
498925|NCT00302211|1198927|P3|COMPLETED|Double Blind Period (New Patients)||10
498926|NCT00302211|1198928|P2|COMPLETED|Double Blind Period (New Patients)||25
498927|NCT00302211|1198929|P1|COMPLETED|Double Blind Period (New Patients)||23
498928|NCT00302211|1198925|P5|STARTED|Double Blind Period (New Patients)||0
498929|NCT00302211|1198926|P4|STARTED|Double Blind Period (New Patients)||0
498930|NCT00302211|1198927|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
498931|NCT00302211|1198928|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
498932|NCT00302211|1198929|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
498933|NCT00302159|1198941|P1|NOT COMPLETED|Overall Study||2
498934|NCT00302159|1198941|P1|COMPLETED|Overall Study||41
498935|NCT00302159|1198941|P1|STARTED|Overall Study||43
498936|NCT00302133|1198952|P2|NOT COMPLETED|Overall Study||4
498937|NCT00302133|1198953|P1|NOT COMPLETED|Overall Study||4
498938|NCT00302133|1198952|P2|COMPLETED|Overall Study||5
498939|NCT00302133|1198953|P1|COMPLETED|Overall Study||5
498940|NCT00302133|1198952|P2|STARTED|Overall Study||9
498941|NCT00302133|1198953|P1|STARTED|Overall Study||9
498942|NCT00302107|1198963|P2|NOT COMPLETED|Overall Study||9
498943|NCT00302107|1198964|P1|NOT COMPLETED|Overall Study||8
498944|NCT00302107|1198963|P2|COMPLETED|Overall Study||30
498945|NCT00302107|1198964|P1|COMPLETED|Overall Study||31
498946|NCT00302107|1198963|P2|STARTED|Overall Study||39
498947|NCT00302107|1198964|P1|STARTED|Overall Study||39
498948|NCT00302081|1198973|P3|NOT COMPLETED|Overall Study||52
498949|NCT00302081|1198974|P2|NOT COMPLETED|Overall Study||43
498950|NCT00302081|1198975|P1|NOT COMPLETED|Overall Study||56
498951|NCT00302081|1198973|P3|COMPLETED|Overall Study||178
498952|NCT00302081|1198974|P2|COMPLETED|Overall Study||186
498953|NCT00302081|1198975|P1|COMPLETED|Overall Study||181
498954|NCT00302081|1198973|P3|STARTED|Overall Study||230
498955|NCT00302081|1198974|P2|STARTED|Overall Study||229
498956|NCT00302081|1198975|P1|STARTED|Overall Study||237
498957|NCT00302068|1198986|P3|NOT COMPLETED|Overall Study||1
498958|NCT00302068|1198987|P2|NOT COMPLETED|Overall Study||4
498959|NCT00302068|1198988|P1|NOT COMPLETED|Overall Study||1
498960|NCT00302068|1198986|P3|COMPLETED|Overall Study||23
498961|NCT00302068|1198987|P2|COMPLETED|Overall Study||36
498962|NCT00302068|1198988|P1|COMPLETED|Overall Study||36
498963|NCT00302068|1198986|P3|STARTED|Overall Study||24
498964|NCT00302068|1198987|P2|STARTED|Overall Study||40
498965|NCT00302068|1198988|P1|STARTED|Overall Study||37
498966|NCT00302055|1199016|P2|NOT COMPLETED|Overall Study||13
498967|NCT00302055|1199017|P1|NOT COMPLETED|Overall Study||9
498968|NCT00302055|1199016|P2|COMPLETED|Overall Study||36
498969|NCT00302055|1199017|P1|COMPLETED|Overall Study||14
498970|NCT00302055|1199016|P2|STARTED|Overall Study||49
498971|NCT00302055|1199017|P1|STARTED|Overall Study||23
498972|NCT00302042|1199025|P2|NOT COMPLETED|Overall Study||8
498973|NCT00302042|1199026|P1|NOT COMPLETED|Overall Study||7
498974|NCT00302042|1199025|P2|COMPLETED|Overall Study||38
498975|NCT00302042|1199026|P1|COMPLETED|Overall Study||39
498976|NCT00302042|1199025|P2|STARTED|Overall Study||46
498977|NCT00302042|1199026|P1|STARTED|Overall Study||46
498978|NCT00302003|1199032|P1|NOT COMPLETED|Overall Study||80
498979|NCT00302003|1199032|P1|COMPLETED|Overall Study||207
498980|NCT00302003|1199032|P1|STARTED|Overall Study||287
498981|NCT00301964|1199039|P1|NOT COMPLETED|Overall Study||4
498982|NCT00301964|1199039|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
498983|NCT00301964|1199039|P1|STARTED|Overall Study||56
498984|NCT00301873|1199044|P1|NOT COMPLETED|Overall Study||0
498985|NCT00301873|1199044|P1|COMPLETED|Overall Study||59
498986|NCT00301873|1199044|P1|STARTED|Overall Study||59
498987|NCT00301834|1199050|P1|NOT COMPLETED|Overall Study||1
498988|NCT00301834|1199050|P1|COMPLETED|Overall Study||34
498989|NCT00301834|1199050|P1|STARTED|Overall Study||35
498990|NCT00301821|1199059|P1|NOT COMPLETED|Overall Study||26
498991|NCT00301821|1199059|P1|COMPLETED|Overall Study||81
498992|NCT00301821|1199059|P1|STARTED|Overall Study||107
498993|NCT00301808|1199066|P1|NOT COMPLETED|Overall Study||12
498994|NCT00301808|1199066|P1|COMPLETED|Overall Study||17
498995|NCT00301808|1199066|P1|STARTED|Overall Study||29
498996|NCT00301756|1199070|P1|NOT COMPLETED|Overall Study||0
498997|NCT00301756|1199070|P1|COMPLETED|Overall Study||32
498998|NCT00301756|1199070|P1|STARTED|Overall Study||32
498999|NCT00301418|1199079|P1|NOT COMPLETED|Overall Study||0
499001|NCT00301418|1199079|P1|STARTED|Overall Study||11
499002|NCT00301366|1199085|P1|NOT COMPLETED|Overall Study||1
499003|NCT00301366|1199085|P1|COMPLETED|Overall Study||37
499004|NCT00301366|1199085|P1|STARTED|Overall Study||38
499005|NCT00301262|1199091|P2|NOT COMPLETED|Open Label Phase (OL)||2
499006|NCT00301262|1199092|P1|NOT COMPLETED|Open Label Phase (OL)||4
499007|NCT00301262|1199091|P2|COMPLETED|Open Label Phase (OL)||67
499008|NCT00301262|1199092|P1|COMPLETED|Open Label Phase (OL)||79
499009|NCT00301262|1199091|P2|STARTED|Open Label Phase (OL)||69
499010|NCT00301262|1199092|P1|STARTED|Open Label Phase (OL)||83
499011|NCT00301262|1199091|P2|NOT COMPLETED|Double Blind Phase (DB)||13
499012|NCT00301262|1199092|P1|NOT COMPLETED|Double Blind Phase (DB)||10
499013|NCT00301262|1199091|P2|COMPLETED|Double Blind Phase (DB)||69
499014|NCT00301262|1199092|P1|COMPLETED|Double Blind Phase (DB)||84
499015|NCT00301262|1199091|P2|STARTED|Double Blind Phase (DB)||82
499016|NCT00301262|1199092|P1|STARTED|Double Blind Phase (DB)||94
499017|NCT00301080|1199250|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499018|NCT00301080|1199251|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499019|NCT00301080|1199252|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499020|NCT00301080|1199253|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499021|NCT00301080|1199254|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499022|NCT00301080|1199250|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499023|NCT00301080|1199251|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499024|NCT00301080|1199252|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499025|NCT00301080|1199253|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499026|NCT00301080|1199254|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
499027|NCT00301080|1199250|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
499028|NCT00301080|1199251|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
499029|NCT00301080|1199252|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
499030|NCT00301080|1199253|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
499031|NCT00301080|1199254|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
499032|NCT00301080|1199250|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499033|NCT00301080|1199251|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499034|NCT00301080|1199252|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499035|NCT00301080|1199253|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499036|NCT00301080|1199254|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
499037|NCT00301080|1199250|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499038|NCT00301080|1199251|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499039|NCT00301080|1199252|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
499040|NCT00301080|1199253|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
499041|NCT00301080|1199254|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
499042|NCT00301080|1199250|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
499043|NCT00301080|1199251|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
499044|NCT00301080|1199252|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
499045|NCT00301080|1199253|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
499046|NCT00301080|1199254|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
499047|NCT00301080|1199250|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
499048|NCT00301080|1199251|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
499049|NCT00301080|1199252|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
499050|NCT00301080|1199253|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
499051|NCT00301080|1199254|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
499052|NCT00301080|1199250|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
499053|NCT00301080|1199251|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
499054|NCT00301080|1199252|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
499055|NCT00301080|1199253|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
499056|NCT00301080|1199254|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
499057|NCT00301028|1199283|P1|NOT COMPLETED|Overall Study||0
499058|NCT00301028|1199283|P1|COMPLETED|Overall Study||47
499059|NCT00301028|1199283|P1|STARTED|Overall Study||47
499060|NCT00300885|1199289|P2|NOT COMPLETED|Follow-up||195
499061|NCT00300885|1199290|P1|NOT COMPLETED|Follow-up||178
499062|NCT00300885|1199289|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
499063|NCT00300885|1199290|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
499064|NCT00300885|1199289|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
499065|NCT00300885|1199290|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
499066|NCT00300885|1199289|P2|NOT COMPLETED|Treatment||374
499067|NCT00300885|1199290|P1|NOT COMPLETED|Treatment||373
499068|NCT00300885|1199289|P2|COMPLETED|Treatment||88
499069|NCT00300885|1199290|P1|COMPLETED|Treatment||91
499070|NCT00300885|1199289|P2|Received Treatment|Treatment||459
499071|NCT00300885|1199290|P1|Received Treatment|Treatment||463
499072|NCT00300885|1199289|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
499073|NCT00300885|1199290|P1|STARTED|Treatment||464
499074|NCT00300755|1199309|P3|NOT COMPLETED|Overall Study||2
499075|NCT00300755|1199310|P2|NOT COMPLETED|Overall Study||4
499076|NCT00300755|1199311|P1|NOT COMPLETED|Overall Study||1
499077|NCT00300755|1199309|P3|COMPLETED|Overall Study||19
499078|NCT00300755|1199310|P2|COMPLETED|Overall Study||17
499079|NCT00300755|1199311|P1|COMPLETED|Overall Study||17
499080|NCT00300755|1199309|P3|STARTED|Overall Study||21
499081|NCT00300755|1199310|P2|STARTED|Overall Study||21
499082|NCT00300755|1199311|P1|STARTED|Overall Study||18
499083|NCT00300742|1199328|P1|NOT COMPLETED|Overall Study||2
499084|NCT00300742|1199328|P1|COMPLETED|Overall Study||3
499085|NCT00300742|1199328|P1|STARTED|Overall Study||5
499086|NCT00300677|1199336|P1|NOT COMPLETED|Overall Study||0
499087|NCT00300677|1199336|P1|COMPLETED|Overall Study||12
499088|NCT00300677|1199336|P1|STARTED|Overall Study||12
499089|NCT00300495|1199345|P2|NOT COMPLETED|Overall Study||1
499090|NCT00300495|1199346|P1|NOT COMPLETED|Overall Study||4
499091|NCT00300495|1199345|P2|COMPLETED|Overall Study||8
499092|NCT00300495|1199346|P1|COMPLETED|Overall Study||6
499093|NCT00300495|1199345|P2|STARTED|Overall Study||9
499094|NCT00300495|1199346|P1|STARTED|Overall Study||10
499095|NCT00300482|1199360|P6|NOT COMPLETED|Overall Study||16
499096|NCT00300482|1199361|P5|NOT COMPLETED|Overall Study||23
499097|NCT00300482|1199362|P4|NOT COMPLETED|Overall Study||24
499098|NCT00300482|1199363|P3|NOT COMPLETED|Overall Study||51
499099|NCT00300482|1199364|P2|NOT COMPLETED|Overall Study||41
499100|NCT00300482|1199365|P1|NOT COMPLETED|Overall Study||41
499101|NCT00300482|1199360|P6|COMPLETED|Overall Study||115
499102|NCT00300482|1199361|P5|COMPLETED|Overall Study||243
499103|NCT00300482|1199362|P4|COMPLETED|Overall Study||237
499104|NCT00300482|1199363|P3|COMPLETED|Overall Study||208
499105|NCT00300482|1199364|P2|COMPLETED|Overall Study||220
499106|NCT00300482|1199365|P1|COMPLETED|Overall Study||220
499107|NCT00300482|1199360|P6|STARTED|Overall Study||131
499108|NCT00300482|1199361|P5|STARTED|Overall Study||266
499109|NCT00300482|1199362|P4|STARTED|Overall Study||261
499110|NCT00300482|1199363|P3|STARTED|Overall Study||259
499111|NCT00300482|1199364|P2|STARTED|Overall Study||261
499112|NCT00300482|1199365|P1|STARTED|Overall Study|"For all arms, started means treated."|261
499113|NCT00300469|1199427|P6|NOT COMPLETED|Overall Study||9
499114|NCT00300469|1199428|P5|NOT COMPLETED|Overall Study||14
499115|NCT00300469|1199429|P4|NOT COMPLETED|Overall Study||9
499116|NCT00300469|1199430|P3|NOT COMPLETED|Overall Study||17
499117|NCT00300469|1199431|P2|NOT COMPLETED|Overall Study||21
499118|NCT00300469|1199432|P1|NOT COMPLETED|Overall Study||21
499119|NCT00300469|1199427|P6|COMPLETED|Overall Study||46
499120|NCT00300469|1199428|P5|COMPLETED|Overall Study||95
499121|NCT00300469|1199429|P4|COMPLETED|Overall Study||104
499122|NCT00300469|1199430|P3|COMPLETED|Overall Study||95
499123|NCT00300469|1199431|P2|COMPLETED|Overall Study||89
499124|NCT00300469|1199432|P1|COMPLETED|Overall Study||89
499125|NCT00300469|1199427|P6|STARTED|Overall Study||55
499126|NCT00300469|1199428|P5|STARTED|Overall Study||109
499127|NCT00300469|1199429|P4|STARTED|Overall Study||113
499128|NCT00300469|1199430|P3|STARTED|Overall Study||112
499129|NCT00300469|1199431|P2|STARTED|Overall Study||110
499130|NCT00300469|1199432|P1|STARTED|Overall Study|"For all arms, started means treated."|110
499131|NCT00300456|1199494|P6|NOT COMPLETED|Overall Study||11
499132|NCT00300456|1199495|P5|NOT COMPLETED|Overall Study||17
499133|NCT00300456|1199496|P4|NOT COMPLETED|Overall Study||14
499134|NCT00300456|1199497|P3|NOT COMPLETED|Overall Study||21
499135|NCT00300456|1199498|P2|NOT COMPLETED|Overall Study||16
499136|NCT00300456|1199499|P1|NOT COMPLETED|Overall Study||16
499137|NCT00300456|1199494|P6|COMPLETED|Overall Study||48
499138|NCT00300456|1199495|P5|COMPLETED|Overall Study||99
499139|NCT00300456|1199496|P4|COMPLETED|Overall Study||105
499140|NCT00300456|1199497|P3|COMPLETED|Overall Study||98
499141|NCT00300456|1199498|P2|COMPLETED|Overall Study||102
499142|NCT00300456|1199499|P1|COMPLETED|Overall Study||103
499143|NCT00300456|1199494|P6|STARTED|Overall Study||59
499144|NCT00300456|1199495|P5|STARTED|Overall Study||116
499145|NCT00300456|1199496|P4|STARTED|Overall Study||119
499146|NCT00300456|1199497|P3|STARTED|Overall Study||119
499147|NCT00300456|1199498|P2|STARTED|Overall Study||118
499148|NCT00300456|1199499|P1|STARTED|Overall Study|"For all arms, started means treated."|119
499149|NCT00300430|1199558|P3|NOT COMPLETED|Overall Study||151
499150|NCT00300430|1199559|P2|NOT COMPLETED|Overall Study||169
499151|NCT00300430|1199560|P1|NOT COMPLETED|Overall Study||367
499152|NCT00300430|1199558|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
499153|NCT00300430|1199559|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
499154|NCT00300430|1199560|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
499155|NCT00300430|1199558|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
499156|NCT00300430|1199559|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
499157|NCT00300430|1199560|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
499158|NCT00300274|1199595|P3|NOT COMPLETED|Overall Study||45
499159|NCT00300274|1199596|P2|NOT COMPLETED|Overall Study||27
499160|NCT00300274|1199597|P1|NOT COMPLETED|Overall Study||46
499161|NCT00300274|1199595|P3|COMPLETED|Overall Study||226
499162|NCT00300274|1199596|P2|COMPLETED|Overall Study||141
499163|NCT00300274|1199597|P1|COMPLETED|Overall Study||236
499164|NCT00300274|1199595|P3|Completed 12 Month|Overall Study||248
499165|NCT00300274|1199596|P2|Completed 12 Month|Overall Study||149
499166|NCT00300274|1199597|P1|Completed 12 Month|Overall Study||250
499167|NCT00300274|1199595|P3|STARTED|Overall Study||271
499168|NCT00300274|1199596|P2|STARTED|Overall Study||168
499169|NCT00300274|1199597|P1|STARTED|Overall Study||282
499170|NCT00300235|1199637|P5|NOT COMPLETED|Overall Study||0
499171|NCT00300235|1199638|P4|NOT COMPLETED|Overall Study||0
499172|NCT00300235|1199639|P3|NOT COMPLETED|Overall Study||0
499173|NCT00300235|1199640|P2|NOT COMPLETED|Overall Study||0
499174|NCT00300235|1199641|P1|NOT COMPLETED|Overall Study||0
499175|NCT00300235|1199637|P5|COMPLETED|Overall Study||251
499176|NCT00300235|1199638|P4|COMPLETED|Overall Study||362
499177|NCT00300235|1199639|P3|COMPLETED|Overall Study||398
499178|NCT00300235|1199640|P2|COMPLETED|Overall Study||240
499179|NCT00300235|1199641|P1|COMPLETED|Overall Study||208
499180|NCT00300235|1199637|P5|STARTED|Overall Study||251
499181|NCT00300235|1199638|P4|STARTED|Overall Study||362
499182|NCT00300235|1199639|P3|STARTED|Overall Study||398
499183|NCT00300235|1199640|P2|STARTED|Overall Study||240
499184|NCT00300235|1199641|P1|STARTED|Overall Study||208
499185|NCT00299975|1199656|P3|NOT COMPLETED|Overall Study||8
499186|NCT00299975|1199657|P2|NOT COMPLETED|Overall Study||1
499187|NCT00299975|1199658|P1|NOT COMPLETED|Overall Study||3
499188|NCT00299975|1199656|P3|COMPLETED|Overall Study||25
499189|NCT00299975|1199657|P2|COMPLETED|Overall Study||31
499190|NCT00299975|1199658|P1|COMPLETED|Overall Study||29
499191|NCT00299975|1199656|P3|Received Allocated Intervention|Overall Study||32
499192|NCT00299975|1199657|P2|Received Allocated Intervention|Overall Study||32
499193|NCT00299975|1199658|P1|Received Allocated Intervention|Overall Study||32
499194|NCT00299975|1199656|P3|STARTED|Overall Study||33
499195|NCT00299975|1199657|P2|STARTED|Overall Study||32
499196|NCT00299975|1199658|P1|STARTED|Overall Study||32
499197|NCT00299741|1199708|P1|NOT COMPLETED|Overall Study||0
499198|NCT00299741|1199708|P1|COMPLETED|Overall Study||36
499199|NCT00299741|1199708|P1|STARTED|Overall Study||36
499200|NCT00299702|1199715|P2|NOT COMPLETED|Overall Study||50
499201|NCT00299702|1199716|P1|NOT COMPLETED|Overall Study||53
499202|NCT00299702|1199715|P2|COMPLETED|Overall Study||126
499203|NCT00299702|1199716|P1|COMPLETED|Overall Study||126
499204|NCT00299702|1199715|P2|STARTED|Overall Study||176
499205|NCT00299702|1199716|P1|STARTED|Overall Study||179
499206|NCT00299689|1199724|P1|NOT COMPLETED|Overall Study||0
499207|NCT00299689|1199724|P1|COMPLETED|Overall Study||69
499208|NCT00299689|1199724|P1|STARTED|Overall Study||69
499209|NCT00299546|1199731|P3|NOT COMPLETED|Overall Study||86
499210|NCT00299546|1199732|P2|NOT COMPLETED|Overall Study||92
499211|NCT00299546|1199733|P1|NOT COMPLETED|Overall Study||100
499212|NCT00299546|1199731|P3|COMPLETED|Overall Study||67
499213|NCT00299546|1199732|P2|COMPLETED|Overall Study||61
499214|NCT00299546|1199733|P1|COMPLETED|Overall Study||55
499215|NCT00299546|1199731|P3|STARTED|Overall Study||153
499216|NCT00299546|1199732|P2|STARTED|Overall Study||153
499217|NCT00299546|1199733|P1|STARTED|Overall Study||155
499218|NCT00299416|1199758|P1|NOT COMPLETED|Overall Study||0
499219|NCT00299416|1199758|P1|COMPLETED|Overall Study||30
499220|NCT00299416|1199758|P1|STARTED|Overall Study||30
499221|NCT00299221|1199766|P2|NOT COMPLETED|Overall Study||0
499222|NCT00299221|1199767|P1|NOT COMPLETED|Overall Study||0
499223|NCT00299221|1199766|P2|COMPLETED|Overall Study||71
499224|NCT00299221|1199767|P1|COMPLETED|Overall Study||79
499225|NCT00299221|1199766|P2|STARTED|Overall Study||71
499226|NCT00299221|1199767|P1|STARTED|Overall Study||79
499227|NCT00299156|1199784|P3|NOT COMPLETED|Period 2 (Randomized)||0
499228|NCT00299156|1199785|P2|NOT COMPLETED|Period 2 (Randomized)||1
499229|NCT00299156|1199786|P1|NOT COMPLETED|Period 2 (Randomized)||0
499230|NCT00299156|1199784|P3|COMPLETED|Period 2 (Randomized)||16
499231|NCT00299156|1199785|P2|COMPLETED|Period 2 (Randomized)||16
499232|NCT00299156|1199786|P1|COMPLETED|Period 2 (Randomized)||0
499233|NCT00299156|1199784|P3|STARTED|Period 2 (Randomized)||16
499234|NCT00299156|1199785|P2|STARTED|Period 2 (Randomized)||17
499235|NCT00299156|1199786|P1|STARTED|Period 2 (Randomized)||0
499236|NCT00299156|1199784|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
499237|NCT00299156|1199785|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
499238|NCT00299156|1199786|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
499239|NCT00299156|1199784|P3|COMPLETED|Period 1 (Non-Randomized)||0
499240|NCT00299156|1199785|P2|COMPLETED|Period 1 (Non-Randomized)||0
499241|NCT00299156|1199786|P1|COMPLETED|Period 1 (Non-Randomized)||32
499242|NCT00299156|1199784|P3|STARTED|Period 1 (Non-Randomized)||0
499243|NCT00299156|1199785|P2|STARTED|Period 1 (Non-Randomized)||0
499244|NCT00299156|1199786|P1|STARTED|Period 1 (Non-Randomized)||32
499245|NCT00299130|1199797|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
499246|NCT00299130|1199798|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
499247|NCT00299130|1199799|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
499248|NCT00299130|1199797|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
499249|NCT00299130|1199798|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
499250|NCT00299130|1199799|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
499251|NCT00299130|1199797|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
499252|NCT00299130|1199798|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
499253|NCT00299130|1199799|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
499254|NCT00299130|1199797|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
499255|NCT00299130|1199798|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
499256|NCT00299130|1199799|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
499257|NCT00299130|1199797|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
499258|NCT00299130|1199798|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
499259|NCT00299130|1199799|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
499260|NCT00299130|1199797|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
499261|NCT00299130|1199798|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
499262|NCT00299130|1199799|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
499263|NCT00299130|1199797|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
499264|NCT00299130|1199798|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
499265|NCT00299130|1199799|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
499266|NCT00299130|1199797|P3|COMPLETED|Treatment Period (up to 5 Years)||121
499267|NCT00299130|1199798|P2|COMPLETED|Treatment Period (up to 5 Years)||125
499268|NCT00299130|1199799|P1|COMPLETED|Treatment Period (up to 5 Years)||119
499269|NCT00299130|1199797|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
499270|NCT00299130|1199798|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
499271|NCT00299130|1199799|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
499272|NCT00299130|1199797|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
499273|NCT00299130|1199798|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
499274|NCT00299130|1199799|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
499275|NCT00299130|1199797|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
499276|NCT00299130|1199798|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
499277|NCT00299130|1199799|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
499278|NCT00299130|1199797|P3|Treated|Treatment Period (up to 5 Years)||170
499279|NCT00299130|1199798|P2|Treated|Treatment Period (up to 5 Years)||167
499280|NCT00299130|1199799|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
499281|NCT00299130|1199797|P3|STARTED|Treatment Period (up to 5 Years)||171
499282|NCT00299130|1199798|P2|STARTED|Treatment Period (up to 5 Years)||168
499283|NCT00299130|1199799|P1|STARTED|Treatment Period (up to 5 Years)||172
499284|NCT00299104|1199904|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
499285|NCT00299104|1199905|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
499286|NCT00299104|1199906|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
499287|NCT00299104|1199904|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
499288|NCT00299104|1199905|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
499289|NCT00299104|1199906|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
499290|NCT00299104|1199904|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
499291|NCT00299104|1199905|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
499292|NCT00299104|1199906|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
499293|NCT00299104|1199904|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
499294|NCT00299104|1199905|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
499295|NCT00299104|1199906|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
499296|NCT00299104|1199904|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
499297|NCT00299104|1199905|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
499298|NCT00299104|1199906|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
499299|NCT00299104|1199904|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
499300|NCT00299104|1199905|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
499301|NCT00299104|1199906|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
499302|NCT00299104|1199904|P3|NOT COMPLETED|Treatment Period||172
499303|NCT00299104|1199905|P2|NOT COMPLETED|Treatment Period||175
499304|NCT00299104|1199906|P1|NOT COMPLETED|Treatment Period||189
499305|NCT00299104|1199904|P3|COMPLETED|Treatment Period||80
499306|NCT00299104|1199905|P2|COMPLETED|Treatment Period||77
499307|NCT00299104|1199906|P1|COMPLETED|Treatment Period|Completed Week 152|62
499308|NCT00299104|1199904|P3|Completed Week 104|Treatment Period||216
499309|NCT00299104|1199905|P2|Completed Week 104|Treatment Period||213
499310|NCT00299104|1199906|P1|Completed Week 104|Treatment Period||178
499311|NCT00299104|1199904|P3|Completed Week 52|Treatment Period||232
499312|NCT00299104|1199905|P2|Completed Week 52|Treatment Period||227
499313|NCT00299104|1199906|P1|Completed Week 52|Treatment Period||213
499314|NCT00299104|1199904|P3|Completed Week 24|Treatment Period||241
499315|NCT00299104|1199905|P2|Completed Week 24|Treatment Period||240
499316|NCT00299104|1199906|P1|Completed Week 24|Treatment Period||227
499317|NCT00299104|1199904|P3|Safety/ITT: Received Study Drug|Treatment Period||250
499318|NCT00299104|1199905|P2|Safety/ITT: Received Study Drug|Treatment Period||249
499319|NCT00299104|1199906|P1|Safety/ITT: Received Study Drug|Treatment Period||249
499320|NCT00299104|1199904|P3|STARTED|Treatment Period||252
499321|NCT00299104|1199905|P2|STARTED|Treatment Period||252
499322|NCT00299104|1199906|P1|STARTED|Treatment Period||251
499323|NCT00299000|1200003|P2|NOT COMPLETED|Overall Study||0
499324|NCT00299000|1200004|P1|NOT COMPLETED|Overall Study||0
499325|NCT00299000|1200003|P2|COMPLETED|Overall Study||2
499326|NCT00299000|1200004|P1|COMPLETED|Overall Study||2
499327|NCT00299000|1200003|P2|STARTED|Overall Study||2
499328|NCT00299000|1200004|P1|STARTED|Overall Study||2
499329|NCT00298766|1200016|P1|NOT COMPLETED|Overall Study||46
499330|NCT00298766|1200016|P1|COMPLETED|Overall Study||24
499331|NCT00298766|1200016|P1|STARTED|Overall Study||70
499332|NCT00298610|1200025|P1|NOT COMPLETED|Overall Study||0
499333|NCT00298610|1200025|P1|COMPLETED|Overall Study||30
499334|NCT00298610|1200025|P1|STARTED|Overall Study||30
499335|NCT00298558|1200039|P4|NOT COMPLETED|10th Annual (A10)||163
499336|NCT00298558|1200040|P3|NOT COMPLETED|10th Annual (A10)||171
499337|NCT00298558|1200041|P2|NOT COMPLETED|10th Annual (A10)||153
499338|NCT00298558|1200042|P1|NOT COMPLETED|10th Annual (A10)||172
499339|NCT00298558|1200039|P4|COMPLETED|10th Annual (A10)||285
499340|NCT00298558|1200040|P3|COMPLETED|10th Annual (A10)||319
499341|NCT00298558|1200041|P2|COMPLETED|10th Annual (A10)||316
499342|NCT00298558|1200042|P1|COMPLETED|10th Annual (A10)||300
499343|NCT00298558|1200039|P4|STARTED|10th Annual (A10)||448
499344|NCT00298558|1200040|P3|STARTED|10th Annual (A10)||490
499345|NCT00298558|1200041|P2|STARTED|10th Annual (A10)||469
499346|NCT00298558|1200042|P1|STARTED|10th Annual (A10)||472
499347|NCT00298558|1200039|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
499348|NCT00298558|1200040|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
499349|NCT00298558|1200041|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
499350|NCT00298558|1200042|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
499351|NCT00298558|1200039|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
499352|NCT00298558|1200040|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
499353|NCT00298558|1200041|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
499354|NCT00298558|1200042|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
499355|NCT00298558|1200039|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
499356|NCT00298558|1200040|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
499357|NCT00298558|1200041|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
499358|NCT00298558|1200042|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
499359|NCT00298558|1200039|P4|NOT COMPLETED|3rd Annual Booster||0
499360|NCT00298558|1200040|P3|NOT COMPLETED|3rd Annual Booster||140
499361|NCT00298558|1200041|P2|NOT COMPLETED|3rd Annual Booster||128
499362|NCT00298558|1200042|P1|NOT COMPLETED|3rd Annual Booster||122
499363|NCT00298558|1200039|P4|COMPLETED|3rd Annual Booster||0
499364|NCT00298558|1200040|P3|COMPLETED|3rd Annual Booster||230
499365|NCT00298558|1200041|P2|COMPLETED|3rd Annual Booster||243
499366|NCT00298558|1200042|P1|COMPLETED|3rd Annual Booster||250
499367|NCT00298558|1200039|P4|STARTED|3rd Annual Booster||0
499368|NCT00298558|1200040|P3|STARTED|3rd Annual Booster||370
499369|NCT00298558|1200041|P2|STARTED|3rd Annual Booster||371
499370|NCT00298558|1200042|P1|STARTED|3rd Annual Booster||372
499371|NCT00298558|1200039|P4|NOT COMPLETED|2nd Annual (A2)||32
499372|NCT00298558|1200040|P3|NOT COMPLETED|2nd Annual (A2)||27
499373|NCT00298558|1200041|P2|NOT COMPLETED|2nd Annual (A2)||11
499374|NCT00298558|1200042|P1|NOT COMPLETED|2nd Annual (A2)||22
499375|NCT00298558|1200039|P4|COMPLETED|2nd Annual (A2)||552
499376|NCT00298558|1200040|P3|COMPLETED|2nd Annual (A2)||574
499377|NCT00298558|1200041|P2|COMPLETED|2nd Annual (A2)||555
499378|NCT00298558|1200042|P1|COMPLETED|2nd Annual (A2)||563
499379|NCT00298558|1200039|P4|STARTED|2nd Annual (A2)||584
499380|NCT00298558|1200040|P3|STARTED|2nd Annual (A2)||601
499381|NCT00298558|1200041|P2|STARTED|2nd Annual (A2)||566
499382|NCT00298558|1200042|P1|STARTED|2nd Annual (A2)||585
499383|NCT00298558|1200039|P4|NOT COMPLETED|1st Annual (A1)||55
499384|NCT00298558|1200040|P3|NOT COMPLETED|1st Annual (A1)||52
499385|NCT00298558|1200041|P2|NOT COMPLETED|1st Annual (A1)||63
499386|NCT00298558|1200042|P1|NOT COMPLETED|1st Annual (A1)||55
499387|NCT00298558|1200039|P4|COMPLETED|1st Annual (A1)||584
499388|NCT00298558|1200040|P3|COMPLETED|1st Annual (A1)||601
499389|NCT00298558|1200041|P2|COMPLETED|1st Annual (A1)||566
499390|NCT00298558|1200042|P1|COMPLETED|1st Annual (A1)||585
499391|NCT00298558|1200039|P4|STARTED|1st Annual (A1)||639
499392|NCT00298558|1200040|P3|STARTED|1st Annual (A1)||653
499393|NCT00298558|1200041|P2|STARTED|1st Annual (A1)||629
499394|NCT00298558|1200042|P1|STARTED|1st Annual (A1)||640
499395|NCT00298558|1200039|P4|NOT COMPLETED|Booster||0
499396|NCT00298558|1200040|P3|NOT COMPLETED|Booster||75
499397|NCT00298558|1200041|P2|NOT COMPLETED|Booster||70
499398|NCT00298558|1200042|P1|NOT COMPLETED|Booster||89
499399|NCT00298558|1200039|P4|COMPLETED|Booster||0
499400|NCT00298558|1200040|P3|COMPLETED|Booster||295
499401|NCT00298558|1200041|P2|COMPLETED|Booster||301
499402|NCT00298558|1200042|P1|COMPLETED|Booster||283
499403|NCT00298558|1200039|P4|STARTED|Booster||0
499404|NCT00298558|1200040|P3|STARTED|Booster||370
499405|NCT00298558|1200041|P2|STARTED|Booster||371
499406|NCT00298558|1200042|P1|STARTED|Booster||372
499407|NCT00298558|1200039|P4|NOT COMPLETED|Immediate Post Test||65
499408|NCT00298558|1200040|P3|NOT COMPLETED|Immediate Post Test||59
499409|NCT00298558|1200041|P2|NOT COMPLETED|Immediate Post Test||76
499410|NCT00298558|1200042|P1|NOT COMPLETED|Immediate Post Test||71
499411|NCT00298558|1200039|P4|COMPLETED|Immediate Post Test||639
499412|NCT00298558|1200040|P3|COMPLETED|Immediate Post Test||653
499413|NCT00298558|1200041|P2|COMPLETED|Immediate Post Test||629
499414|NCT00298558|1200042|P1|COMPLETED|Immediate Post Test||640
499415|NCT00298558|1200039|P4|STARTED|Immediate Post Test||704
499416|NCT00298558|1200040|P3|STARTED|Immediate Post Test||712
499417|NCT00298558|1200041|P2|STARTED|Immediate Post Test||705
499418|NCT00298558|1200042|P1|STARTED|Immediate Post Test||711
499419|NCT00298558|1200039|P4|NOT COMPLETED|Intervention||419
499420|NCT00298558|1200040|P3|NOT COMPLETED|Intervention||75
499421|NCT00298558|1200041|P2|NOT COMPLETED|Intervention||78
499422|NCT00298558|1200042|P1|NOT COMPLETED|Intervention||91
499423|NCT00298558|1200039|P4|COMPLETED|Intervention||285
499424|NCT00298558|1200040|P3|COMPLETED|Intervention||637
499425|NCT00298558|1200041|P2|COMPLETED|Intervention||627
499426|NCT00298558|1200042|P1|COMPLETED|Intervention||620
499427|NCT00298558|1200039|P4|STARTED|Intervention||704
499428|NCT00298558|1200040|P3|STARTED|Intervention||712
499429|NCT00298558|1200041|P2|STARTED|Intervention||705
499430|NCT00298558|1200042|P1|STARTED|Intervention||711
499431|NCT00298558|1200039|P4|NOT COMPLETED|Baseline||0
499432|NCT00298558|1200040|P3|NOT COMPLETED|Baseline||0
499433|NCT00298558|1200041|P2|NOT COMPLETED|Baseline||0
499434|NCT00298558|1200042|P1|NOT COMPLETED|Baseline||0
499435|NCT00298558|1200039|P4|COMPLETED|Baseline||704
499436|NCT00298558|1200040|P3|COMPLETED|Baseline||712
499437|NCT00298558|1200041|P2|COMPLETED|Baseline||705
499438|NCT00298558|1200042|P1|COMPLETED|Baseline||711
499439|NCT00298558|1200039|P4|STARTED|Baseline||704
499440|NCT00298558|1200040|P3|STARTED|Baseline||712
499441|NCT00298558|1200041|P2|STARTED|Baseline||705
499442|NCT00298558|1200042|P1|STARTED|Baseline||711
499443|NCT00298363|1200075|P3|NOT COMPLETED|Overall Study||6
499444|NCT00298363|1200076|P2|NOT COMPLETED|Overall Study||8
499445|NCT00298363|1200077|P1|NOT COMPLETED|Overall Study||17
499446|NCT00298363|1200075|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
499447|NCT00298363|1200076|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
499448|NCT00298363|1200077|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
499449|NCT00298363|1200075|P3|STARTED|Overall Study||22
499450|NCT00298363|1200076|P2|STARTED|Overall Study||45
499451|NCT00298363|1200077|P1|STARTED|Overall Study||45
499452|NCT00298272|1200235|P2|NOT COMPLETED|Safety Follow-up Phase||4
499453|NCT00298272|1200236|P1|NOT COMPLETED|Safety Follow-up Phase||4
499454|NCT00298272|1200235|P2|COMPLETED|Safety Follow-up Phase||13
499455|NCT00298272|1200236|P1|COMPLETED|Safety Follow-up Phase||18
499456|NCT00298272|1200235|P2|STARTED|Safety Follow-up Phase||17
499457|NCT00298272|1200236|P1|STARTED|Safety Follow-up Phase||22
499458|NCT00298272|1200235|P2|NOT COMPLETED|Open Label Retreatment Phase||4
499459|NCT00298272|1200236|P1|NOT COMPLETED|Open Label Retreatment Phase||9
499460|NCT00298272|1200235|P2|COMPLETED|Open Label Retreatment Phase||12
499461|NCT00298272|1200236|P1|COMPLETED|Open Label Retreatment Phase||13
499462|NCT00298272|1200235|P2|Completed to Week 56|Open Label Retreatment Phase||12
499463|NCT00298272|1200236|P1|Completed to Week 56|Open Label Retreatment Phase||13
499464|NCT00298272|1200235|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
499465|NCT00298272|1200236|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
499466|NCT00298272|1200235|P2|STARTED|Open Label Retreatment Phase||16
499467|NCT00298272|1200236|P1|STARTED|Open Label Retreatment Phase||22
499468|NCT00298272|1200235|P2|NOT COMPLETED|Double-blind Phase||0
499469|NCT00298272|1200236|P1|NOT COMPLETED|Double-blind Phase||8
499470|NCT00298272|1200235|P2|COMPLETED|Double-blind Phase||18
499471|NCT00298272|1200236|P1|COMPLETED|Double-blind Phase||28
499472|NCT00298272|1200235|P2|Completed to Week 56|Double-blind Phase||3
499473|NCT00298272|1200236|P1|Completed to Week 56|Double-blind Phase||8
499474|NCT00298272|1200235|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
499475|NCT00298272|1200236|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
499476|NCT00298272|1200235|P2|Safety Population|Double-blind Phase||18
499477|NCT00298272|1200236|P1|Safety Population|Double-blind Phase|received treatment|33
499478|NCT00298272|1200235|P2|STARTED|Double-blind Phase||18
499479|NCT00298272|1200236|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
499480|NCT00298233|1200259|P4|NOT COMPLETED|Overall Study||0
499481|NCT00298233|1200260|P3|NOT COMPLETED|Overall Study||0
499482|NCT00298233|1200261|P2|NOT COMPLETED|Overall Study||0
499483|NCT00298233|1200262|P1|NOT COMPLETED|Overall Study||0
499484|NCT00298233|1200259|P4|COMPLETED|Overall Study||124
499485|NCT00298233|1200260|P3|COMPLETED|Overall Study||122
499486|NCT00298233|1200261|P2|COMPLETED|Overall Study||41
499487|NCT00298233|1200262|P1|COMPLETED|Overall Study||39
499488|NCT00298233|1200259|P4|STARTED|Overall Study||124
499489|NCT00298233|1200260|P3|STARTED|Overall Study||122
499490|NCT00298233|1200261|P2|STARTED|Overall Study||41
499491|NCT00298233|1200262|P1|STARTED|Overall Study||39
499492|NCT00298155|1200281|P3|NOT COMPLETED|Overall Study||0
499493|NCT00298155|1200282|P2|NOT COMPLETED|Overall Study||0
499494|NCT00298155|1200283|P1|NOT COMPLETED|Overall Study||0
499495|NCT00298155|1200281|P3|COMPLETED|Overall Study||13
499496|NCT00298155|1200282|P2|COMPLETED|Overall Study||10
499497|NCT00298155|1200283|P1|COMPLETED|Overall Study||12
499498|NCT00298155|1200281|P3|STARTED|Overall Study||13
499499|NCT00298155|1200282|P2|STARTED|Overall Study||10
499500|NCT00298155|1200283|P1|STARTED|Overall Study||12
499501|NCT00298090|1200294|P1|NOT COMPLETED|Overall Study||18
499502|NCT00298090|1200294|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
499503|NCT00298090|1200294|P1|STARTED|Overall Study||47
499504|NCT00297830|1200301|P3|NOT COMPLETED|12 Month Visit||0
499505|NCT00297830|1200302|P2|NOT COMPLETED|12 Month Visit||6
499506|NCT00297830|1200303|P1|NOT COMPLETED|12 Month Visit||1
499507|NCT00297830|1200301|P3|COMPLETED|12 Month Visit||24
499508|NCT00297830|1200302|P2|COMPLETED|12 Month Visit||35
499509|NCT00297830|1200303|P1|COMPLETED|12 Month Visit||37
499510|NCT00297830|1200301|P3|STARTED|12 Month Visit||24
499511|NCT00297830|1200302|P2|STARTED|12 Month Visit||41
499512|NCT00297830|1200303|P1|STARTED|12 Month Visit||38
499513|NCT00297830|1200301|P3|NOT COMPLETED|6 Month Visit||3
499514|NCT00297830|1200302|P2|NOT COMPLETED|6 Month Visit||2
499515|NCT00297830|1200303|P1|NOT COMPLETED|6 Month Visit||3
499516|NCT00297830|1200301|P3|COMPLETED|6 Month Visit||24
499517|NCT00297830|1200302|P2|COMPLETED|6 Month Visit||41
499518|NCT00297830|1200303|P1|COMPLETED|6 Month Visit||38
499519|NCT00297830|1200301|P3|STARTED|6 Month Visit||27
499520|NCT00297830|1200302|P2|STARTED|6 Month Visit||43
499521|NCT00297830|1200303|P1|STARTED|6 Month Visit||41
499522|NCT00297830|1200301|P3|NOT COMPLETED|Baseline||0
499523|NCT00297830|1200302|P2|NOT COMPLETED|Baseline||0
499524|NCT00297830|1200303|P1|NOT COMPLETED|Baseline||0
499525|NCT00297830|1200301|P3|COMPLETED|Baseline||27
499526|NCT00297830|1200302|P2|COMPLETED|Baseline||43
499527|NCT00297830|1200303|P1|COMPLETED|Baseline||41
499528|NCT00297830|1200301|P3|STARTED|Baseline||27
499529|NCT00297830|1200302|P2|STARTED|Baseline||43
499530|NCT00297830|1200303|P1|STARTED|Baseline||41
499531|NCT00297778|1200322|P2|NOT COMPLETED|Overall Study||20
499532|NCT00297778|1200323|P1|NOT COMPLETED|Overall Study||19
499533|NCT00297778|1200322|P2|COMPLETED|Overall Study||124
499534|NCT00297778|1200323|P1|COMPLETED|Overall Study||133
499535|NCT00297778|1200322|P2|STARTED|Overall Study||144
499536|NCT00297778|1200323|P1|STARTED|Overall Study||152
499537|NCT00297648|1200357|P1|NOT COMPLETED|Overall Study||36
499538|NCT00297648|1200357|P1|COMPLETED|Overall Study||53
499539|NCT00297648|1200357|P1|STARTED|Overall Study||89
499540|NCT00297596|1200396|P1|NOT COMPLETED|Overall Study||0
499541|NCT00297596|1200396|P1|COMPLETED|Overall Study||25
499542|NCT00297596|1200396|P1|STARTED|Overall Study||25
499543|NCT00297492|1200403|P3|NOT COMPLETED|6 Month Follow-up||27
499544|NCT00297492|1200404|P2|NOT COMPLETED|6 Month Follow-up||49
499545|NCT00297492|1200405|P1|NOT COMPLETED|6 Month Follow-up||63
499546|NCT00297492|1200403|P3|COMPLETED|6 Month Follow-up||118
499547|NCT00297492|1200404|P2|COMPLETED|6 Month Follow-up||237
499548|NCT00297492|1200405|P1|COMPLETED|6 Month Follow-up||227
499549|NCT00297492|1200403|P3|STARTED|6 Month Follow-up||145
499550|NCT00297492|1200404|P2|STARTED|6 Month Follow-up||286
499551|NCT00297492|1200405|P1|STARTED|6 Month Follow-up||290
499552|NCT00297492|1200403|P3|NOT COMPLETED|Set Quit Date||5
499553|NCT00297492|1200404|P2|NOT COMPLETED|Set Quit Date||13
499554|NCT00297492|1200405|P1|NOT COMPLETED|Set Quit Date||7
499555|NCT00297492|1200403|P3|COMPLETED|Set Quit Date||145
499556|NCT00297492|1200404|P2|COMPLETED|Set Quit Date||286
499557|NCT00297492|1200405|P1|COMPLETED|Set Quit Date||290
499558|NCT00297492|1200403|P3|STARTED|Set Quit Date||150
499559|NCT00297492|1200404|P2|STARTED|Set Quit Date||299
499560|NCT00297492|1200405|P1|STARTED|Set Quit Date||297
499561|NCT00297427|1200415|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
499562|NCT00297427|1200416|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
499563|NCT00297427|1200415|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
499564|NCT00297427|1200416|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
499565|NCT00297427|1200415|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
499566|NCT00297427|1200416|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
499567|NCT00297427|1200415|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
499568|NCT00297427|1200416|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
499569|NCT00297427|1200415|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
499570|NCT00297427|1200416|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
499571|NCT00297427|1200415|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
499572|NCT00297427|1200416|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
499573|NCT00297427|1200415|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
499574|NCT00297427|1200416|P1|STARTED|Phase 2: Optional Crossover for Sham||54
499575|NCT00297427|1200415|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
499576|NCT00297427|1200416|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
499577|NCT00297427|1200415|P2|COMPLETED|Phase 1: Initial Intervention||54
499578|NCT00297427|1200416|P1|COMPLETED|Phase 1: Initial Intervention||56
499579|NCT00297427|1200415|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
499580|NCT00297427|1200416|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
499581|NCT00297258|1200457|P1|NOT COMPLETED|Overall Study||142
499582|NCT00297258|1200457|P1|COMPLETED|Overall Study||0
499583|NCT00297258|1200457|P1|STARTED|Overall Study||142
499584|NCT00297232|1200476|P1|NOT COMPLETED|Overall Study||605
499585|NCT00297232|1200476|P1|COMPLETED|Overall Study||489
499586|NCT00297232|1200476|P1|STARTED|Overall Study||1094
499587|NCT00297167|1200482|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
499588|NCT00297167|1200483|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
499589|NCT00297167|1200484|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
499590|NCT00297167|1200482|P3|COMPLETED|Open-label Dose Normalization Period 2||31
499671|NCT00296517|1200596|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
499591|NCT00297167|1200483|P2|COMPLETED|Open-label Dose Normalization Period 2||0
499592|NCT00297167|1200484|P1|COMPLETED|Open-label Dose Normalization Period 2||0
499593|NCT00297167|1200482|P3|STARTED|Open-label Dose Normalization Period 2||31
499594|NCT00297167|1200483|P2|STARTED|Open-label Dose Normalization Period 2||0
499595|NCT00297167|1200484|P1|STARTED|Open-label Dose Normalization Period 2||0
499596|NCT00297167|1200482|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
499597|NCT00297167|1200483|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
499598|NCT00297167|1200484|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
499599|NCT00297167|1200482|P3|COMPLETED|Second Double-blind Intervention Period||0
499600|NCT00297167|1200483|P2|COMPLETED|Second Double-blind Intervention Period||15
499601|NCT00297167|1200484|P1|COMPLETED|Second Double-blind Intervention Period||16
499602|NCT00297167|1200482|P3|STARTED|Second Double-blind Intervention Period||0
499603|NCT00297167|1200483|P2|STARTED|Second Double-blind Intervention Period||15
499604|NCT00297167|1200484|P1|STARTED|Second Double-blind Intervention Period||17
499605|NCT00297167|1200482|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
499606|NCT00297167|1200483|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
499607|NCT00297167|1200484|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
499608|NCT00297167|1200482|P3|COMPLETED|Open-label Dose Normalization Period 1||32
499609|NCT00297167|1200483|P2|COMPLETED|Open-label Dose Normalization Period 1||0
499610|NCT00297167|1200484|P1|COMPLETED|Open-label Dose Normalization Period 1||0
499611|NCT00297167|1200482|P3|STARTED|Open-label Dose Normalization Period 1||33
499612|NCT00297167|1200483|P2|STARTED|Open-label Dose Normalization Period 1||0
499613|NCT00297167|1200484|P1|STARTED|Open-label Dose Normalization Period 1||0
499614|NCT00297167|1200482|P3|NOT COMPLETED|First Double-blind Intervention Period||0
499615|NCT00297167|1200483|P2|NOT COMPLETED|First Double-blind Intervention Period||0
499616|NCT00297167|1200484|P1|NOT COMPLETED|First Double-blind Intervention Period||0
499617|NCT00297167|1200482|P3|COMPLETED|First Double-blind Intervention Period||0
499618|NCT00297167|1200483|P2|COMPLETED|First Double-blind Intervention Period||16
499619|NCT00297167|1200484|P1|COMPLETED|First Double-blind Intervention Period||17
499620|NCT00297167|1200482|P3|STARTED|First Double-blind Intervention Period||0
499621|NCT00297167|1200483|P2|STARTED|First Double-blind Intervention Period||16
499622|NCT00297167|1200484|P1|STARTED|First Double-blind Intervention Period||17
499623|NCT00297115|1200510|P2|NOT COMPLETED|Overall Study||246
499624|NCT00297115|1200511|P1|NOT COMPLETED|Overall Study||245
499625|NCT00297115|1200510|P2|COMPLETED|Overall Study||550
499626|NCT00297115|1200511|P1|COMPLETED|Overall Study||527
499627|NCT00297115|1200510|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
499628|NCT00297115|1200511|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
499629|NCT00297102|1200529|P2|NOT COMPLETED|Overall Study||233
499630|NCT00297102|1200530|P1|NOT COMPLETED|Overall Study||263
499631|NCT00297102|1200529|P2|COMPLETED|Overall Study||525
499632|NCT00297102|1200530|P1|COMPLETED|Overall Study||502
499633|NCT00297102|1200529|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
499634|NCT00297102|1200530|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
499635|NCT00297037|1200548|P2|NOT COMPLETED|Overall Study||0
499636|NCT00297037|1200549|P1|NOT COMPLETED|Overall Study||2
499637|NCT00297037|1200548|P2|COMPLETED|Overall Study||11
499638|NCT00297037|1200549|P1|COMPLETED|Overall Study||8
499639|NCT00297037|1200548|P2|STARTED|Overall Study||11
499640|NCT00297037|1200549|P1|STARTED|Overall Study||10
499641|NCT00296816|1200561|P1|NOT COMPLETED|Overall Study||74
499642|NCT00296816|1200561|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
499643|NCT00296816|1200561|P1|STARTED|Overall Study||132
499644|NCT00296647|1200578|P5|NOT COMPLETED|Overall Study||20
499645|NCT00296647|1200579|P4|NOT COMPLETED|Overall Study||17
499646|NCT00296647|1200580|P3|NOT COMPLETED|Overall Study||34
499647|NCT00296647|1200581|P2|NOT COMPLETED|Overall Study||28
499648|NCT00296647|1200582|P1|NOT COMPLETED|Overall Study||32
499649|NCT00296647|1200578|P5|COMPLETED|Overall Study||248
499650|NCT00296647|1200579|P4|COMPLETED|Overall Study||262
499651|NCT00296647|1200580|P3|COMPLETED|Overall Study||222
499652|NCT00296647|1200581|P2|COMPLETED|Overall Study||233
499653|NCT00296647|1200582|P1|COMPLETED|Overall Study||250
499654|NCT00296647|1200578|P5|STARTED|Overall Study||268
499655|NCT00296647|1200579|P4|STARTED|Overall Study||279
499656|NCT00296647|1200580|P3|STARTED|Overall Study||256
499657|NCT00296647|1200581|P2|STARTED|Overall Study||261
499658|NCT00296647|1200582|P1|STARTED|Overall Study||282
499659|NCT00296517|1200596|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
499660|NCT00296517|1200597|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
499661|NCT00296517|1200596|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
499662|NCT00296517|1200597|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
499663|NCT00296517|1200596|P2|STARTED|Dose Level 3 - Weeks 3-12||161
499664|NCT00296517|1200597|P1|STARTED|Dose Level 3 - Weeks 3-12||157
499665|NCT00296517|1200596|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
499666|NCT00296517|1200597|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
499667|NCT00296517|1200596|P2|COMPLETED|Dose Level 2 - Week 2||161
499668|NCT00296517|1200597|P1|COMPLETED|Dose Level 2 - Week 2||157
499669|NCT00296517|1200596|P2|STARTED|Dose Level 2 - Week 2||166
499670|NCT00296517|1200597|P1|STARTED|Dose Level 2 - Week 2||159
499672|NCT00296517|1200597|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
499673|NCT00296517|1200596|P2|COMPLETED|Dose Level 1 - Week 1||166
499674|NCT00296517|1200597|P1|COMPLETED|Dose Level 1 - Week 1||159
499675|NCT00296517|1200596|P2|STARTED|Dose Level 1 - Week 1||166
499676|NCT00296517|1200597|P1|STARTED|Dose Level 1 - Week 1||159
499677|NCT00296504|1200633|P9|NOT COMPLETED|Final Analysis||21
499678|NCT00296504|1200634|P8|NOT COMPLETED|Final Analysis||0
499679|NCT00296504|1200635|P7|NOT COMPLETED|Final Analysis||0
499680|NCT00296504|1200636|P6|NOT COMPLETED|Final Analysis||0
499681|NCT00296504|1200637|P5|NOT COMPLETED|Final Analysis||0
499682|NCT00296504|1200638|P4|NOT COMPLETED|Final Analysis||0
499683|NCT00296504|1200639|P3|NOT COMPLETED|Final Analysis||0
499684|NCT00296504|1200640|P2|NOT COMPLETED|Final Analysis||0
499685|NCT00296504|1200641|P1|NOT COMPLETED|Final Analysis||0
499686|NCT00296504|1200633|P9|COMPLETED|Final Analysis||90
499687|NCT00296504|1200634|P8|COMPLETED|Final Analysis||0
499688|NCT00296504|1200635|P7|COMPLETED|Final Analysis||0
499689|NCT00296504|1200636|P6|COMPLETED|Final Analysis||0
499690|NCT00296504|1200637|P5|COMPLETED|Final Analysis||0
499691|NCT00296504|1200638|P4|COMPLETED|Final Analysis||0
499692|NCT00296504|1200639|P3|COMPLETED|Final Analysis||0
499693|NCT00296504|1200640|P2|COMPLETED|Final Analysis||0
499694|NCT00296504|1200641|P1|COMPLETED|Final Analysis||0
499695|NCT00296504|1200633|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
499696|NCT00296504|1200634|P8|STARTED|Final Analysis||0
499697|NCT00296504|1200635|P7|STARTED|Final Analysis||0
499698|NCT00296504|1200636|P6|STARTED|Final Analysis||0
499699|NCT00296504|1200637|P5|STARTED|Final Analysis||0
499700|NCT00296504|1200638|P4|STARTED|Final Analysis||0
499701|NCT00296504|1200639|P3|STARTED|Final Analysis||0
499702|NCT00296504|1200640|P2|STARTED|Final Analysis||0
499703|NCT00296504|1200641|P1|STARTED|Final Analysis||0
499704|NCT00296504|1200633|P9|NOT COMPLETED|Interim Analysis||0
499705|NCT00296504|1200634|P8|NOT COMPLETED|Interim Analysis||49
499706|NCT00296504|1200635|P7|NOT COMPLETED|Interim Analysis||74
499707|NCT00296504|1200636|P6|NOT COMPLETED|Interim Analysis||37
499708|NCT00296504|1200637|P5|NOT COMPLETED|Interim Analysis||37
499709|NCT00296504|1200638|P4|NOT COMPLETED|Interim Analysis||43
499710|NCT00296504|1200639|P3|NOT COMPLETED|Interim Analysis||105
499711|NCT00296504|1200640|P2|NOT COMPLETED|Interim Analysis||18
499712|NCT00296504|1200641|P1|NOT COMPLETED|Interim Analysis||76
499713|NCT00296504|1200633|P9|COMPLETED|Interim Analysis||0
499714|NCT00296504|1200634|P8|COMPLETED|Interim Analysis||37
499715|NCT00296504|1200635|P7|COMPLETED|Interim Analysis||30
499716|NCT00296504|1200636|P6|COMPLETED|Interim Analysis||41
499717|NCT00296504|1200637|P5|COMPLETED|Interim Analysis||36
499718|NCT00296504|1200638|P4|COMPLETED|Interim Analysis||11
499719|NCT00296504|1200639|P3|COMPLETED|Interim Analysis||116
499720|NCT00296504|1200640|P2|COMPLETED|Interim Analysis||0
499721|NCT00296504|1200641|P1|COMPLETED|Interim Analysis||43
499722|NCT00296504|1200633|P9|Ongoing|Interim Analysis||0
499723|NCT00296504|1200634|P8|Ongoing|Interim Analysis||1
499724|NCT00296504|1200635|P7|Ongoing|Interim Analysis||30
499725|NCT00296504|1200636|P6|Ongoing|Interim Analysis||0
499726|NCT00296504|1200637|P5|Ongoing|Interim Analysis||0
499727|NCT00296504|1200638|P4|Ongoing|Interim Analysis||22
499728|NCT00296504|1200639|P3|Ongoing|Interim Analysis||16
499729|NCT00296504|1200640|P2|Ongoing|Interim Analysis||12
499730|NCT00296504|1200641|P1|Ongoing|Interim Analysis||32
499731|NCT00296504|1200633|P9|STARTED|Interim Analysis||0
499732|NCT00296504|1200634|P8|STARTED|Interim Analysis||86
499733|NCT00296504|1200635|P7|STARTED|Interim Analysis||104
499734|NCT00296504|1200636|P6|STARTED|Interim Analysis||78
499735|NCT00296504|1200637|P5|STARTED|Interim Analysis||73
499736|NCT00296504|1200638|P4|STARTED|Interim Analysis||54
499737|NCT00296504|1200639|P3|STARTED|Interim Analysis||221
499738|NCT00296504|1200640|P2|STARTED|Interim Analysis||18
499739|NCT00296504|1200641|P1|STARTED|Interim Analysis||119
499740|NCT00296491|1200734|P4|NOT COMPLETED|Overall Study||43
499741|NCT00296491|1200735|P3|NOT COMPLETED|Overall Study||43
499742|NCT00296491|1200736|P2|NOT COMPLETED|Overall Study||53
499743|NCT00296491|1200737|P1|NOT COMPLETED|Overall Study||42
499744|NCT00296491|1200734|P4|COMPLETED|Overall Study||138
499745|NCT00296491|1200735|P3|COMPLETED|Overall Study||137
499746|NCT00296491|1200736|P2|COMPLETED|Overall Study||129
499747|NCT00296491|1200737|P1|COMPLETED|Overall Study||140
499748|NCT00296491|1200734|P4|STARTED|Overall Study||181
499749|NCT00296491|1200735|P3|STARTED|Overall Study||180
499750|NCT00296491|1200736|P2|STARTED|Overall Study||182
499751|NCT00296491|1200737|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
499752|NCT00296400|1200766|P3|NOT COMPLETED|Overall Study||13
499753|NCT00296400|1200767|P2|NOT COMPLETED|Overall Study||18
499754|NCT00296400|1200768|P1|NOT COMPLETED|Overall Study||17
499755|NCT00296400|1200766|P3|COMPLETED|Overall Study||67
499756|NCT00296400|1200767|P2|COMPLETED|Overall Study||69
499757|NCT00296400|1200768|P1|COMPLETED|Overall Study||53
499758|NCT00296400|1200766|P3|STARTED|Overall Study||80
499759|NCT00296400|1200767|P2|STARTED|Overall Study||87
499760|NCT00296400|1200768|P1|STARTED|Overall Study||70
499761|NCT00296374|1200992|P3|NOT COMPLETED|Overall Study||29
499762|NCT00296374|1200993|P2|NOT COMPLETED|Overall Study||23
499763|NCT00296374|1200994|P1|NOT COMPLETED|Overall Study||25
499764|NCT00296374|1200992|P3|COMPLETED|Overall Study||82
499765|NCT00296374|1200993|P2|COMPLETED|Overall Study||101
499766|NCT00296374|1200994|P1|COMPLETED|Overall Study||93
499767|NCT00296374|1200992|P3|STARTED|Overall Study||111
499768|NCT00296374|1200993|P2|STARTED|Overall Study||124
499769|NCT00296374|1200994|P1|STARTED|Overall Study||118
499770|NCT00296335|1201217|P2|NOT COMPLETED|Overall Study||122
499771|NCT00296335|1201218|P1|NOT COMPLETED|Overall Study||30
499772|NCT00296335|1201217|P2|COMPLETED|Overall Study||309
499773|NCT00296335|1201218|P1|COMPLETED|Overall Study||394
499774|NCT00296335|1201217|P2|STARTED|Overall Study||431
499775|NCT00296335|1201218|P1|STARTED|Overall Study||424
499776|NCT00296322|1201230|P2|NOT COMPLETED|Overall Study||79
499777|NCT00296322|1201231|P1|NOT COMPLETED|Overall Study||21
499778|NCT00296322|1201230|P2|COMPLETED|Overall Study||184
499779|NCT00296322|1201231|P1|COMPLETED|Overall Study||237
499780|NCT00296322|1201230|P2|STARTED|Overall Study||263
499781|NCT00296322|1201231|P1|STARTED|Overall Study||258
499782|NCT00296244|1201243|P2|NOT COMPLETED|Overall Study||1
499783|NCT00296244|1201244|P1|NOT COMPLETED|Overall Study||0
499784|NCT00296244|1201243|P2|COMPLETED|Overall Study||19
499785|NCT00296244|1201244|P1|COMPLETED|Overall Study||20
499786|NCT00296244|1201243|P2|STARTED|Overall Study||20
499787|NCT00296244|1201244|P1|STARTED|Overall Study||20
499788|NCT00296231|1201260|P1|NOT COMPLETED|Overall Study||0
499789|NCT00296231|1201260|P1|COMPLETED|Overall Study||14
499790|NCT00296231|1201260|P1|STARTED|Overall Study||14
499791|NCT00296192|1201270|P5|NOT COMPLETED|Overall Study||0
499792|NCT00296192|1201271|P4|NOT COMPLETED|Overall Study||0
499793|NCT00296192|1201272|P3|NOT COMPLETED|Overall Study||0
499794|NCT00296192|1201273|P2|NOT COMPLETED|Overall Study||0
499795|NCT00296192|1201274|P1|NOT COMPLETED|Overall Study||0
499796|NCT00296192|1201270|P5|COMPLETED|Overall Study||16
499797|NCT00296192|1201271|P4|COMPLETED|Overall Study||17
499798|NCT00296192|1201272|P3|COMPLETED|Overall Study||16
499799|NCT00296192|1201273|P2|COMPLETED|Overall Study||16
499800|NCT00296192|1201274|P1|COMPLETED|Overall Study||17
499801|NCT00296192|1201270|P5|STARTED|Overall Study||16
499802|NCT00296192|1201271|P4|STARTED|Overall Study||17
499803|NCT00296192|1201272|P3|STARTED|Overall Study||16
499804|NCT00296192|1201273|P2|STARTED|Overall Study||16
499805|NCT00296192|1201274|P1|STARTED|Overall Study||17
499806|NCT00296036|1201308|P6|NOT COMPLETED|Overall Study||4
499807|NCT00296036|1201309|P5|NOT COMPLETED|Overall Study||2
499808|NCT00296036|1201310|P4|NOT COMPLETED|Overall Study||1
499809|NCT00296036|1201311|P3|NOT COMPLETED|Overall Study||2
499810|NCT00296036|1201312|P2|NOT COMPLETED|Overall Study||0
499811|NCT00296036|1201313|P1|NOT COMPLETED|Overall Study||1
499812|NCT00296036|1201308|P6|COMPLETED|Overall Study||28
499813|NCT00296036|1201309|P5|COMPLETED|Overall Study||31
499814|NCT00296036|1201310|P4|COMPLETED|Overall Study||16
499815|NCT00296036|1201311|P3|COMPLETED|Overall Study||16
499816|NCT00296036|1201312|P2|COMPLETED|Overall Study||18
499817|NCT00296036|1201313|P1|COMPLETED|Overall Study||18
499818|NCT00296036|1201308|P6|STARTED|Overall Study||32
499819|NCT00296036|1201309|P5|STARTED|Overall Study||33
499820|NCT00296036|1201310|P4|STARTED|Overall Study||17
499821|NCT00296036|1201311|P3|STARTED|Overall Study||18
499822|NCT00296036|1201312|P2|STARTED|Overall Study||18
499823|NCT00296036|1201313|P1|STARTED|Overall Study||19
499824|NCT00295880|1201339|P1|NOT COMPLETED|Overall Study||2
499825|NCT00295880|1201339|P1|COMPLETED|Overall Study||10
499826|NCT00295880|1201339|P1|STARTED|Overall Study||12
499827|NCT00295854|1201353|P3|NOT COMPLETED|Overall Study||15
499828|NCT00295854|1201354|P2|NOT COMPLETED|Overall Study||21
499829|NCT00295854|1201355|P1|NOT COMPLETED|Overall Study||18
499830|NCT00295854|1201353|P3|COMPLETED|Overall Study||87
499831|NCT00295854|1201354|P2|COMPLETED|Overall Study||87
499832|NCT00295854|1201355|P1|COMPLETED|Overall Study||77
499833|NCT00295854|1201353|P3|ITT Population (N=296)|Overall Study||99
499834|NCT00295854|1201354|P2|ITT Population (N=296)|Overall Study||105
499835|NCT00295854|1201355|P1|ITT Population (N=296)|Overall Study||92
499836|NCT00295854|1201353|P3|Safety Population (N=304)|Overall Study||101
499837|NCT00295854|1201354|P2|Safety Population (N=304)|Overall Study||108
499838|NCT00295854|1201355|P1|Safety Population (N=304)|Overall Study||95
499839|NCT00295854|1201353|P3|STARTED|Overall Study||102
499840|NCT00295854|1201354|P2|STARTED|Overall Study||108
499841|NCT00295854|1201355|P1|STARTED|Overall Study||95
499842|NCT00295750|1201369|P3|NOT COMPLETED|Overall Study||32
499843|NCT00295750|1201370|P2|NOT COMPLETED|Overall Study||41
499844|NCT00295750|1201371|P1|NOT COMPLETED|Overall Study||43
499845|NCT00295750|1201369|P3|COMPLETED|Overall Study||172
499846|NCT00295750|1201370|P2|COMPLETED|Overall Study||169
499847|NCT00295750|1201371|P1|COMPLETED|Overall Study||163
499848|NCT00295750|1201369|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
499849|NCT00295750|1201370|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
499850|NCT00295750|1201371|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
499851|NCT00295750|1201369|P3|STARTED|Overall Study|randomized|204
499852|NCT00295750|1201370|P2|STARTED|Overall Study|randomized|210
499853|NCT00295750|1201371|P1|STARTED|Overall Study|randomized|206
499854|NCT00295633|1201406|P3|NOT COMPLETED|Overall Study||76
499855|NCT00295633|1201407|P2|NOT COMPLETED|Overall Study||67
499856|NCT00295633|1201408|P1|NOT COMPLETED|Overall Study||62
499857|NCT00295633|1201406|P3|COMPLETED|Overall Study||108
499858|NCT00295633|1201407|P2|COMPLETED|Overall Study||119
499859|NCT00295633|1201408|P1|COMPLETED|Overall Study||133
499860|NCT00295633|1201406|P3|Completed Study Without Being Rescued|Overall Study||51
499861|NCT00295633|1201407|P2|Completed Study Without Being Rescued|Overall Study||82
499862|NCT00295633|1201408|P1|Completed Study Without Being Rescued|Overall Study||88
499863|NCT00295633|1201406|P3|STARTED|Overall Study||184
499864|NCT00295633|1201407|P2|STARTED|Overall Study||186
499865|NCT00295633|1201408|P1|STARTED|Overall Study||195
499866|NCT00295503|1201425|P1|NOT COMPLETED|Overall Study||0
499867|NCT00295503|1201425|P1|COMPLETED|Overall Study||53
499868|NCT00295503|1201425|P1|STARTED|Overall Study||53
499869|NCT00295490|1201435|P4|NOT COMPLETED|Overall Study||5
499870|NCT00295490|1201436|P3|NOT COMPLETED|Overall Study||4
499871|NCT00295490|1201437|P2|NOT COMPLETED|Overall Study||4
499872|NCT00295490|1201438|P1|NOT COMPLETED|Overall Study||1
499873|NCT00295490|1201435|P4|COMPLETED|Overall Study||12
499874|NCT00295490|1201436|P3|COMPLETED|Overall Study||12
499875|NCT00295490|1201437|P2|COMPLETED|Overall Study||15
499876|NCT00295490|1201438|P1|COMPLETED|Overall Study||14
499877|NCT00295490|1201435|P4|STARTED|Overall Study||17
499878|NCT00295490|1201436|P3|STARTED|Overall Study||16
499879|NCT00295490|1201437|P2|STARTED|Overall Study||19
499880|NCT00295490|1201438|P1|STARTED|Overall Study||15
499881|NCT00295061|1201478|P2|NOT COMPLETED|Overall Study||0
499882|NCT00295061|1201479|P1|NOT COMPLETED|Overall Study||0
499883|NCT00295061|1201478|P2|COMPLETED|Overall Study||12
499884|NCT00295061|1201479|P1|COMPLETED|Overall Study||12
499885|NCT00295061|1201478|P2|STARTED|Overall Study||12
499886|NCT00295061|1201479|P1|STARTED|Overall Study||12
499887|NCT00295009|1201491|P6|NOT COMPLETED|Overall Study||269
499888|NCT00295009|1201492|P5|NOT COMPLETED|Overall Study||58
499889|NCT00295009|1201493|P4|NOT COMPLETED|Overall Study||25
499890|NCT00295009|1201494|P3|NOT COMPLETED|Overall Study||12
499891|NCT00295009|1201495|P2|NOT COMPLETED|Overall Study||49
499892|NCT00295009|1201496|P1|NOT COMPLETED|Overall Study||41
499893|NCT00295009|1201491|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
499894|NCT00295009|1201492|P5|COMPLETED|Overall Study|Completed 60 month visit|116
499895|NCT00295009|1201493|P4|COMPLETED|Overall Study|Completed 60 month visit|57
499896|NCT00295009|1201494|P3|COMPLETED|Overall Study|Completed 60 month visit|39
499897|NCT00295009|1201495|P2|COMPLETED|Overall Study|Completed 60 month visit|134
499898|NCT00295009|1201496|P1|COMPLETED|Overall Study|Completed 60 month visit|52
499899|NCT00295009|1201491|P6|Completed 24 Month Analysis|Overall Study||198
499900|NCT00295009|1201492|P5|Completed 24 Month Analysis|Overall Study||133
499901|NCT00295009|1201493|P4|Completed 24 Month Analysis|Overall Study||60
499902|NCT00295009|1201494|P3|Completed 24 Month Analysis|Overall Study||45
499903|NCT00295009|1201495|P2|Completed 24 Month Analysis|Overall Study||148
499904|NCT00295009|1201496|P1|Completed 24 Month Analysis|Overall Study||71
499905|NCT00295009|1201491|P6|Treated|Overall Study||259
499906|NCT00295009|1201492|P5|Treated|Overall Study||165
499907|NCT00295009|1201493|P4|Treated|Overall Study||72
499908|NCT00295009|1201494|P3|Treated|Overall Study||50
499909|NCT00295009|1201495|P2|Treated|Overall Study||162
499910|NCT00295009|1201496|P1|Treated|Overall Study||80
499911|NCT00295009|1201491|P6|STARTED|Overall Study||269
499912|NCT00295009|1201492|P5|STARTED|Overall Study||174
499913|NCT00295009|1201493|P4|STARTED|Overall Study||82
499914|NCT00295009|1201494|P3|STARTED|Overall Study||51
499915|NCT00295009|1201495|P2|STARTED|Overall Study||183
499916|NCT00295009|1201496|P1|STARTED|Overall Study||93
499917|NCT00292370|1201519|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
499918|NCT00292370|1201520|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
499919|NCT00292370|1201521|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
499920|NCT00292370|1201519|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
499921|NCT00292370|1201520|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
499922|NCT00292370|1201521|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
499923|NCT00292370|1201519|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
499924|NCT00292370|1201520|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
499925|NCT00292370|1201521|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
499926|NCT00292370|1201519|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
499927|NCT00292370|1201520|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
499928|NCT00292370|1201521|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
499929|NCT00292370|1201519|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
499930|NCT00292370|1201520|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
499931|NCT00292370|1201521|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
499932|NCT00292370|1201519|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
499933|NCT00292370|1201520|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
499934|NCT00292370|1201521|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
499935|NCT00294762|1201530|P2|NOT COMPLETED|Overall Study||3
499936|NCT00294762|1201531|P1|NOT COMPLETED|Overall Study||3
499937|NCT00294762|1201530|P2|COMPLETED|Overall Study||68
499938|NCT00294762|1201531|P1|COMPLETED|Overall Study||69
499939|NCT00294762|1201530|P2|STARTED|Overall Study||71
499940|NCT00294762|1201531|P1|STARTED|Overall Study||72
499941|NCT00294723|1201550|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
499942|NCT00294723|1201551|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
499943|NCT00294723|1201552|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
499944|NCT00294723|1201550|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
499945|NCT00294723|1201551|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
499946|NCT00294723|1201552|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
499947|NCT00294723|1201550|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
499948|NCT00294723|1201551|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
499949|NCT00294723|1201552|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
499950|NCT00294723|1201550|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
499951|NCT00294723|1201551|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
499952|NCT00294723|1201552|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
499953|NCT00294723|1201550|P3|COMPLETED|Open-Label Extension 52 Weeks||97
499954|NCT00294723|1201551|P2|COMPLETED|Open-Label Extension 52 Weeks||110
499955|NCT00294723|1201552|P1|COMPLETED|Open-Label Extension 52 Weeks||114
499956|NCT00294723|1201550|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
499957|NCT00294723|1201551|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
499958|NCT00294723|1201552|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
499959|NCT00294723|1201550|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
499960|NCT00294723|1201551|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
499961|NCT00294723|1201552|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
499962|NCT00294723|1201550|P3|COMPLETED|Double-Blind Period 52 Weeks||152
499963|NCT00294723|1201551|P2|COMPLETED|Double-Blind Period 52 Weeks||162
499964|NCT00294723|1201552|P1|COMPLETED|Double-Blind Period 52 Weeks||173
499965|NCT00294723|1201550|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
499966|NCT00294723|1201551|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
499967|NCT00294723|1201552|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
499968|NCT00294723|1201550|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
499969|NCT00294723|1201551|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
499970|NCT00294723|1201552|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
499971|NCT00294684|1201613|P2|NOT COMPLETED|Overall Study||8
499972|NCT00294684|1201614|P1|NOT COMPLETED|Overall Study||5
499973|NCT00294684|1201613|P2|COMPLETED|Overall Study||62
499974|NCT00294684|1201614|P1|COMPLETED|Overall Study||65
499975|NCT00294684|1201613|P2|STARTED|Overall Study||70
499976|NCT00294684|1201614|P1|STARTED|Overall Study||70
499977|NCT00294671|1201654|P2|NOT COMPLETED|Overall Study||40
499978|NCT00294671|1201655|P1|NOT COMPLETED|Overall Study||27
499979|NCT00294671|1201654|P2|COMPLETED|Overall Study||26
499980|NCT00294671|1201655|P1|COMPLETED|Overall Study||37
499981|NCT00294671|1201654|P2|STARTED|Overall Study||66
499982|NCT00294671|1201655|P1|STARTED|Overall Study||64
499983|NCT00294658|1201671|P2|NOT COMPLETED|Overall Study||9
499984|NCT00294658|1201672|P1|NOT COMPLETED|Overall Study||6
499985|NCT00294658|1201671|P2|COMPLETED|Overall Study||51
499986|NCT00294658|1201672|P1|COMPLETED|Overall Study||60
499987|NCT00294658|1201671|P2|STARTED|Overall Study||60
499988|NCT00294658|1201672|P1|STARTED|Overall Study||66
499989|NCT00294645|1201736|P2|NOT COMPLETED|Overall Study||92
499990|NCT00294645|1201737|P1|NOT COMPLETED|Overall Study||48
499991|NCT00294645|1201736|P2|COMPLETED|Overall Study||510
499992|NCT00294645|1201737|P1|COMPLETED|Overall Study||247
499993|NCT00294645|1201736|P2|STARTED|Overall Study||602
499994|NCT00294645|1201737|P1|STARTED|Overall Study||295
499995|NCT00294515|1201771|P2|NOT COMPLETED|Overall Study||28
499996|NCT00294515|1201772|P1|NOT COMPLETED|Overall Study||34
499997|NCT00294515|1201771|P2|COMPLETED|Overall Study||132
499998|NCT00294515|1201772|P1|COMPLETED|Overall Study||132
499999|NCT00294515|1201771|P2|STARTED|Overall Study|Randomized|160
500000|NCT00294515|1201772|P1|STARTED|Overall Study|Randomized|166
500001|NCT00294398|1201788|P2|NOT COMPLETED|Overall Study||26
500002|NCT00294398|1201789|P1|NOT COMPLETED|Overall Study||21
500003|NCT00294398|1201788|P2|COMPLETED|Overall Study||48
500004|NCT00294398|1201789|P1|COMPLETED|Overall Study||57
500005|NCT00294398|1201788|P2|STARTED|Overall Study||74
500006|NCT00294398|1201789|P1|STARTED|Overall Study||78
500007|NCT00294060|1201797|P1|NOT COMPLETED|Overall Study||1173
500008|NCT00294060|1201797|P1|COMPLETED|Overall Study||840
500009|NCT00294060|1201797|P1|STARTED|Overall Study||2013
500010|NCT00294047|1201805|P2|NOT COMPLETED|Month 84||989
500011|NCT00294047|1201806|P1|NOT COMPLETED|Month 84||973
500012|NCT00294047|1201805|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
500013|NCT00294047|1201806|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
500014|NCT00294047|1201805|P2|STARTED|Month 84||2870
500015|NCT00294047|1201806|P1|STARTED|Month 84||2877
500016|NCT00294047|1201805|P2|NOT COMPLETED|Month 48||433
500017|NCT00294047|1201806|P1|NOT COMPLETED|Month 48||425
500018|NCT00294047|1201805|P2|COMPLETED|Month 48||2438
500019|NCT00294047|1201806|P1|COMPLETED|Month 48||2456
500020|NCT00294047|1201805|P2|Participated up to Month 48|Month 48||2281
500021|NCT00294047|1201806|P1|Participated up to Month 48|Month 48||2305
500022|NCT00294047|1201805|P2|STARTED|Month 48||2871
500023|NCT00294047|1201806|P1|STARTED|Month 48||2881
500024|NCT00292318|1201910|P2|NOT COMPLETED|Overall Study||1
500025|NCT00292318|1201911|P1|NOT COMPLETED|Overall Study||2
500026|NCT00292318|1201910|P2|COMPLETED|Overall Study||2
500027|NCT00292318|1201911|P1|COMPLETED|Overall Study||2
500028|NCT00292318|1201910|P2|STARTED|Overall Study||3
500029|NCT00292318|1201911|P1|STARTED|Overall Study||4
500030|NCT00293813|1201922|P3|NOT COMPLETED|Overall Study||8
500031|NCT00293813|1201923|P2|NOT COMPLETED|Overall Study||9
500032|NCT00293813|1201924|P1|NOT COMPLETED|Overall Study||13
500033|NCT00293813|1201922|P3|COMPLETED|Overall Study||74
500034|NCT00293813|1201923|P2|COMPLETED|Overall Study||74
500035|NCT00293813|1201924|P1|COMPLETED|Overall Study||69
500036|NCT00293813|1201922|P3|STARTED|Overall Study||82
500037|NCT00293813|1201923|P2|STARTED|Overall Study||83
500038|NCT00293813|1201924|P1|STARTED|Overall Study||82
500039|NCT00293722|1201935|P1|NOT COMPLETED|Overall Study||427
500040|NCT00293722|1201935|P1|COMPLETED|Overall Study||864
500041|NCT00293722|1201935|P1|STARTED|Overall Study||1291
500042|NCT00293709|1201949|P1|NOT COMPLETED|Overall Study||47
500043|NCT00293709|1201949|P1|COMPLETED|Overall Study||102
500044|NCT00293709|1201949|P1|STARTED|Overall Study||149
500045|NCT00293579|1201963|P1|NOT COMPLETED|Overall Study||1
500046|NCT00293579|1201963|P1|COMPLETED|Overall Study||4
500047|NCT00293579|1201963|P1|STARTED|Overall Study||5
500048|NCT00293540|1201972|P2|NOT COMPLETED|Overall Study||8
500049|NCT00293540|1201973|P1|NOT COMPLETED|Overall Study||7
500050|NCT00293540|1201972|P2|COMPLETED|Overall Study||119
500051|NCT00293540|1201973|P1|COMPLETED|Overall Study||115
500052|NCT00293540|1201972|P2|STARTED|Overall Study||127
500053|NCT00293540|1201973|P1|STARTED|Overall Study||122
500054|NCT00293462|1201982|P3|NOT COMPLETED|Overall Study||10
500055|NCT00293462|1201983|P2|NOT COMPLETED|Overall Study||8
500056|NCT00293462|1201984|P1|NOT COMPLETED|Overall Study||7
500057|NCT00293462|1201982|P3|COMPLETED|Overall Study||21
500058|NCT00293462|1201983|P2|COMPLETED|Overall Study||21
500059|NCT00293462|1201984|P1|COMPLETED|Overall Study||24
500060|NCT00293462|1201982|P3|STARTED|Overall Study||31
500061|NCT00293462|1201983|P2|STARTED|Overall Study||29
500062|NCT00293462|1201984|P1|STARTED|Overall Study||31
500063|NCT00293384|1202003|P1|NOT COMPLETED|Overall Study||5
500064|NCT00293384|1202003|P1|COMPLETED|Overall Study||35
500065|NCT00293384|1202003|P1|STARTED|Overall Study||40
500066|NCT00293293|1202012|P2|NOT COMPLETED|Overall Study||2
500067|NCT00293293|1202013|P1|NOT COMPLETED|Overall Study||2
500068|NCT00293293|1202012|P2|COMPLETED|Overall Study||21
500069|NCT00293293|1202013|P1|COMPLETED|Overall Study||18
500070|NCT00293293|1202012|P2|STARTED|Overall Study||23
500071|NCT00293293|1202013|P1|STARTED|Overall Study||20
500072|NCT00293267|1202041|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
500073|NCT00293267|1202042|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
500074|NCT00293267|1202041|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
500075|NCT00293267|1202042|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
500076|NCT00293267|1202041|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
500077|NCT00293267|1202042|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
500078|NCT00293267|1202041|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
500079|NCT00293267|1202042|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
500080|NCT00293267|1202041|P2|COMPLETED|Extension - Open-Label Week 157-240||26
500081|NCT00293267|1202042|P1|COMPLETED|Extension - Open-Label Week 157-240||111
500082|NCT00293267|1202041|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
500083|NCT00293267|1202042|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
500084|NCT00293267|1202041|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
500085|NCT00293267|1202042|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
500086|NCT00293267|1202041|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
500087|NCT00293267|1202042|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
500088|NCT00293267|1202041|P2|STARTED|Extension - Double-Blind Week 49-156||50
500089|NCT00293267|1202042|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
500090|NCT00293267|1202041|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
500091|NCT00293267|1202042|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
500092|NCT00293267|1202041|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
500093|NCT00293267|1202042|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
500094|NCT00293267|1202041|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
500095|NCT00293267|1202042|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
500096|NCT00293267|1202041|P2|Treated|Primary Study - Double-Blind Week 0-48||118
500097|NCT00293267|1202042|P1|Treated|Primary Study - Double-Blind Week 0-48||232
500098|NCT00293267|1202041|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
500099|NCT00293267|1202042|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
500100|NCT00293254|1202082|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
500101|NCT00293254|1202083|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
500102|NCT00293254|1202082|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
500103|NCT00293254|1202083|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
500104|NCT00293254|1202082|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
500105|NCT00293254|1202083|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
500106|NCT00293254|1202082|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
500107|NCT00293254|1202083|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
500108|NCT00293254|1202082|P2|COMPLETED|Extension - Open-Label Week 157-240||18
500109|NCT00293254|1202083|P1|COMPLETED|Extension - Open-Label Week 157-240||110
500110|NCT00293254|1202082|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
500111|NCT00293254|1202083|P1|STARTED|Extension - Open-Label Week 157-240||120
500112|NCT00293254|1202082|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
500113|NCT00293254|1202083|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
500114|NCT00293254|1202082|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
500115|NCT00293254|1202083|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
500116|NCT00293254|1202082|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
500117|NCT00293254|1202083|P1|STARTED|Extension - Double-Blind Week 49-156||177
500118|NCT00293254|1202082|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
500119|NCT00293254|1202083|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
500120|NCT00293254|1202082|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
500121|NCT00293254|1202083|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
500122|NCT00293254|1202082|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
500123|NCT00293254|1202083|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
500124|NCT00293254|1202082|P2|Treated|Primary Study - Double-Blind Week 0-48||119
500125|NCT00293254|1202083|P1|Treated|Primary Study - Double-Blind Week 0-48||230
500126|NCT00293254|1202082|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
500127|NCT00293254|1202083|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
500128|NCT00293241|1202123|P2|NOT COMPLETED|Overall Study||41
500129|NCT00293241|1202124|P1|NOT COMPLETED|Overall Study||36
500130|NCT00293241|1202123|P2|COMPLETED|Overall Study||265
500131|NCT00293241|1202124|P1|COMPLETED|Overall Study||263
500132|NCT00293241|1202123|P2|STARTED|Overall Study||306
500133|NCT00293241|1202124|P1|STARTED|Overall Study||299
500134|NCT00292227|1202168|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
500135|NCT00292227|1202169|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
500136|NCT00292227|1202170|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
500137|NCT00292227|1202168|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
500138|NCT00292227|1202169|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
500139|NCT00292227|1202170|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
500140|NCT00292227|1202168|P3|STARTED|Cross-over Period 2 (Day 39)||30
500141|NCT00292227|1202169|P2|STARTED|Cross-over Period 2 (Day 39)||31
500142|NCT00292227|1202170|P1|STARTED|Cross-over Period 2 (Day 39)||65
500143|NCT00292227|1202168|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
500144|NCT00292227|1202169|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
500145|NCT00292227|1202170|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
500146|NCT00292227|1202168|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
500147|NCT00292227|1202169|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
500148|NCT00292227|1202170|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
500149|NCT00292227|1202168|P3|STARTED|Cross-over Period 1 (Day 32)||30
500150|NCT00292227|1202169|P2|STARTED|Cross-over Period 1 (Day 32)||31
500151|NCT00292227|1202170|P1|STARTED|Cross-over Period 1 (Day 32)||65
500152|NCT00292227|1202168|P3|NOT COMPLETED|Patch Period||3
500153|NCT00292227|1202169|P2|NOT COMPLETED|Patch Period||0
500154|NCT00292227|1202170|P1|NOT COMPLETED|Patch Period||1
500155|NCT00292227|1202168|P3|COMPLETED|Patch Period||30
500156|NCT00292227|1202169|P2|COMPLETED|Patch Period||31
500157|NCT00292227|1202170|P1|COMPLETED|Patch Period||65
500158|NCT00292227|1202168|P3|STARTED|Patch Period||33
500159|NCT00292227|1202169|P2|STARTED|Patch Period||31
500160|NCT00292227|1202170|P1|STARTED|Patch Period||66
500161|NCT00292188|1202252|P3|NOT COMPLETED|Double-Blind||29
500162|NCT00292188|1202253|P2|NOT COMPLETED|Double-Blind||31
500163|NCT00292188|1202254|P1|NOT COMPLETED|Double-Blind||0
500164|NCT00292188|1202252|P3|COMPLETED|Double-Blind||98
500165|NCT00292188|1202253|P2|COMPLETED|Double-Blind||96
500166|NCT00292188|1202254|P1|COMPLETED|Double-Blind||0
500167|NCT00292188|1202252|P3|STARTED|Double-Blind||127
500168|NCT00292188|1202253|P2|STARTED|Double-Blind||127
500169|NCT00292188|1202254|P1|STARTED|Double-Blind||0
500170|NCT00292188|1202252|P3|NOT COMPLETED|Single-Blind||0
500171|NCT00292188|1202253|P2|NOT COMPLETED|Single-Blind||0
500172|NCT00292188|1202254|P1|NOT COMPLETED|Single-Blind||114
500173|NCT00292188|1202252|P3|COMPLETED|Single-Blind||0
500174|NCT00292188|1202253|P2|COMPLETED|Single-Blind||0
500175|NCT00292188|1202254|P1|COMPLETED|Single-Blind||254
500176|NCT00292188|1202252|P3|Received Treatment|Single-Blind||0
500177|NCT00292188|1202253|P2|Received Treatment|Single-Blind||0
500178|NCT00292188|1202254|P1|Received Treatment|Single-Blind||367
500179|NCT00292188|1202252|P3|STARTED|Single-Blind||0
500180|NCT00292188|1202253|P2|STARTED|Single-Blind||0
500181|NCT00292188|1202254|P1|STARTED|Single-Blind||368
500182|NCT00292162|1202315|P2|NOT COMPLETED|Overall Study||2
500183|NCT00292162|1202316|P1|NOT COMPLETED|Overall Study||1
500184|NCT00292162|1202315|P2|COMPLETED|Overall Study||20
500185|NCT00292162|1202316|P1|COMPLETED|Overall Study||18
500186|NCT00292162|1202315|P2|STARTED|Overall Study||22
500187|NCT00292162|1202316|P1|STARTED|Overall Study||19
500188|NCT00293059|1202334|P2|NOT COMPLETED|Overall Study||19
500189|NCT00293059|1202335|P1|NOT COMPLETED|Overall Study||35
500190|NCT00293059|1202334|P2|COMPLETED|Overall Study||51
500191|NCT00293059|1202335|P1|COMPLETED|Overall Study||85
500192|NCT00293059|1202334|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
500193|NCT00293059|1202335|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
500194|NCT00293059|1202334|P2|Cycle 3/Treatment Day 84|Overall Study||55
500195|NCT00293059|1202335|P1|Cycle 3/Treatment Day 84|Overall Study||100
500196|NCT00293059|1202334|P2|Cycle 1/Treatment Day 28|Overall Study||64
500197|NCT00293059|1202335|P1|Cycle 1/Treatment Day 28|Overall Study||115
500198|NCT00293059|1202334|P2|Subjects Received Treatment|Overall Study||66
500199|NCT00293059|1202335|P1|Subjects Received Treatment|Overall Study||119
500200|NCT00293059|1202334|P2|STARTED|Overall Study||70
500201|NCT00293059|1202335|P1|STARTED|Overall Study||120
500202|NCT00293020|1202447|P1|NOT COMPLETED|Overall Study||162
500203|NCT00293020|1202447|P1|COMPLETED|Overall Study||82
500204|NCT00293020|1202447|P1|STARTED|Overall Study||244
500205|NCT00292981|1202451|P1|NOT COMPLETED|Overall Study||39
500206|NCT00292981|1202451|P1|COMPLETED|Overall Study||18
500207|NCT00292981|1202451|P1|STARTED|Overall Study||57
500208|NCT00292591|1202461|P3|NOT COMPLETED|Overall Study||58
500209|NCT00292591|1202462|P2|NOT COMPLETED|Overall Study||56
500210|NCT00292591|1202463|P1|NOT COMPLETED|Overall Study||64
500211|NCT00292591|1202461|P3|COMPLETED|Overall Study||110
500212|NCT00292591|1202462|P2|COMPLETED|Overall Study||111
500213|NCT00292591|1202463|P1|COMPLETED|Overall Study||102
500214|NCT00292591|1202461|P3|STARTED|Overall Study||168
500215|NCT00292591|1202462|P2|STARTED|Overall Study||167
500216|NCT00292591|1202463|P1|STARTED|Overall Study||166
500217|NCT00292461|1202473|P2|NOT COMPLETED|Overall Study||6
500218|NCT00292461|1202474|P1|NOT COMPLETED|Overall Study||10
500219|NCT00292461|1202473|P2|COMPLETED|Overall Study||24
500220|NCT00292461|1202474|P1|COMPLETED|Overall Study||24
500221|NCT00292461|1202473|P2|STARTED|Overall Study||30
500222|NCT00292461|1202474|P1|STARTED|Overall Study||34
500223|NCT00291876|1202486|P1|NOT COMPLETED|Overall Study||0
500224|NCT00291876|1202486|P1|COMPLETED|Overall Study||135
500225|NCT00291876|1202486|P1|STARTED|Overall Study||135
500226|NCT00291694|1202500|P2|NOT COMPLETED|Overall Study||5
500227|NCT00291694|1202501|P1|NOT COMPLETED|Overall Study||3
500228|NCT00291694|1202500|P2|COMPLETED|Overall Study||43
500229|NCT00291694|1202501|P1|COMPLETED|Overall Study||21
500230|NCT00291694|1202500|P2|STARTED|Overall Study||48
500231|NCT00291694|1202501|P1|STARTED|Overall Study||24
500232|NCT00291655|1202515|P1|NOT COMPLETED|Overall Study||15
500233|NCT00291655|1202515|P1|COMPLETED|Overall Study||115
500234|NCT00291655|1202515|P1|STARTED|Overall Study||130
500235|NCT00291577|1202520|P1|NOT COMPLETED|Overall Study||21
500236|NCT00291577|1202520|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
500237|NCT00291577|1202520|P1|STARTED|Overall Study||22
500238|NCT00291551|1202539|P1|NOT COMPLETED|Overall Study||13
500239|NCT00291551|1202539|P1|COMPLETED|Overall Study||26
500240|NCT00291551|1202539|P1|STARTED|Overall Study||39
500241|NCT00291330|1202556|P2|NOT COMPLETED|Overall Study||97
500242|NCT00291330|1202557|P1|NOT COMPLETED|Overall Study||101
500243|NCT00291330|1202556|P2|COMPLETED|Overall Study|Completed planned observation time|1169
500244|NCT00291330|1202557|P1|COMPLETED|Overall Study|Completed planned observation time|1172
500245|NCT00291330|1202556|P2|STARTED|Overall Study|Started Treatment|1266
500246|NCT00291330|1202557|P1|STARTED|Overall Study|Started Treatment|1273
500247|NCT00291317|1202579|P1|NOT COMPLETED|Overall Study||0
500248|NCT00291317|1202579|P1|COMPLETED|Overall Study||6
500249|NCT00291317|1202579|P1|STARTED|Overall Study||6
500250|NCT00291226|1202586|P2|NOT COMPLETED|Overall Study||1
500251|NCT00291226|1202587|P1|NOT COMPLETED|Overall Study||1
500252|NCT00291226|1202586|P2|COMPLETED|Overall Study||3
500253|NCT00291226|1202587|P1|COMPLETED|Overall Study||3
500254|NCT00291226|1202586|P2|STARTED|Overall Study||4
500255|NCT00291226|1202587|P1|STARTED|Overall Study||4
500256|NCT00291187|1202599|P4|NOT COMPLETED|Overall Study||0
500257|NCT00291187|1202600|P3|NOT COMPLETED|Overall Study||1
500258|NCT00291187|1202601|P2|NOT COMPLETED|Overall Study||0
500259|NCT00291187|1202602|P1|NOT COMPLETED|Overall Study||0
500260|NCT00291187|1202599|P4|COMPLETED|Overall Study||106
500261|NCT00291187|1202600|P3|COMPLETED|Overall Study||102
500262|NCT00291187|1202601|P2|COMPLETED|Overall Study||100
500263|NCT00291187|1202602|P1|COMPLETED|Overall Study||103
500264|NCT00291187|1202599|P4|STARTED|Overall Study||106
500265|NCT00291187|1202600|P3|STARTED|Overall Study||103
500266|NCT00291187|1202601|P2|STARTED|Overall Study||100
500267|NCT00291187|1202602|P1|STARTED|Overall Study||103
500268|NCT00291161|1202628|P4|NOT COMPLETED|Overall Study||65
500269|NCT00291161|1202629|P3|NOT COMPLETED|Overall Study||93
500270|NCT00291161|1202630|P2|NOT COMPLETED|Overall Study||58
500271|NCT00291161|1202631|P1|NOT COMPLETED|Overall Study||81
500272|NCT00291161|1202628|P4|COMPLETED|Overall Study||122
500273|NCT00291161|1202629|P3|COMPLETED|Overall Study||206
500274|NCT00291161|1202630|P2|COMPLETED|Overall Study||134
500275|NCT00291161|1202631|P1|COMPLETED|Overall Study||235
500276|NCT00291161|1202628|P4|STARTED|Overall Study||187
500277|NCT00291161|1202629|P3|STARTED|Overall Study||299
500278|NCT00291161|1202630|P2|STARTED|Overall Study||192
500279|NCT00291161|1202631|P1|STARTED|Overall Study||316
500280|NCT00291135|1202639|P1|NOT COMPLETED|Overall Study||0
500281|NCT00291135|1202639|P1|COMPLETED|Overall Study||42
500282|NCT00291135|1202639|P1|STARTED|Overall Study||42
500283|NCT00291018|1202646|P3|NOT COMPLETED|Overall Study||43
500284|NCT00291018|1202647|P2|NOT COMPLETED|Overall Study||42
500285|NCT00291018|1202648|P1|NOT COMPLETED|Overall Study||25
500286|NCT00291018|1202646|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
500287|NCT00291018|1202647|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
500288|NCT00291018|1202648|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
500289|NCT00291018|1202646|P3|Evaluated at 24 Months|Overall Study||105
500290|NCT00291018|1202647|P2|Evaluated at 24 Months|Overall Study||92
500291|NCT00291018|1202648|P1|Evaluated at 24 Months|Overall Study||99
500292|NCT00291018|1202646|P3|STARTED|Overall Study|Started =Subjects Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated|136
500293|NCT00291018|1202647|P2|STARTED|Overall Study|Started = Subjects Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated|106
500294|NCT00291018|1202648|P1|STARTED|Overall Study|Started = Subjects Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated|103
500295|NCT00290888|1202688|P2|NOT COMPLETED|Overall Study||1
500296|NCT00290888|1202689|P1|NOT COMPLETED|Overall Study||3
500297|NCT00290888|1202688|P2|COMPLETED|Overall Study||44
500298|NCT00290888|1202689|P1|COMPLETED|Overall Study||38
500299|NCT00290888|1202688|P2|STARTED|Overall Study||45
500300|NCT00290888|1202689|P1|STARTED|Overall Study||41
500301|NCT00290810|1202697|P1|NOT COMPLETED|Overall Study||0
500302|NCT00290810|1202697|P1|COMPLETED|Overall Study||12
500303|NCT00290810|1202697|P1|STARTED|Overall Study||12
500304|NCT00290771|1202706|P2|NOT COMPLETED|Overall Study||97
500305|NCT00290771|1202707|P1|NOT COMPLETED|Overall Study||127
500306|NCT00290771|1202706|P2|COMPLETED|Overall Study||3
500307|NCT00290771|1202707|P1|COMPLETED|Overall Study||4
500308|NCT00290771|1202706|P2|STARTED|Overall Study||100
500309|NCT00290771|1202707|P1|STARTED|Overall Study||131
500310|NCT00290758|1202731|P2|NOT COMPLETED|Post Intervention rFNA||5
500311|NCT00290758|1202732|P1|NOT COMPLETED|Post Intervention rFNA||6
500312|NCT00290758|1202731|P2|COMPLETED|Post Intervention rFNA||49
500313|NCT00290758|1202732|P1|COMPLETED|Post Intervention rFNA||49
500314|NCT00290758|1202731|P2|STARTED|Post Intervention rFNA||54
500315|NCT00290758|1202732|P1|STARTED|Post Intervention rFNA||55
500316|NCT00290758|1202731|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
500317|NCT00290758|1202732|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
500318|NCT00290758|1202731|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
500319|NCT00290758|1202732|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
500320|NCT00290758|1202731|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
500321|NCT00290758|1202732|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
500322|NCT00290758|1202731|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
500323|NCT00290758|1202732|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
500324|NCT00290758|1202731|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
500325|NCT00290758|1202732|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
500326|NCT00290758|1202731|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
500327|NCT00290758|1202732|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
500328|NCT00290758|1202731|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
500329|NCT00290758|1202732|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
500330|NCT00290732|1202754|P5|NOT COMPLETED|Overall Study||0
500331|NCT00290732|1202755|P4|NOT COMPLETED|Overall Study||0
500332|NCT00290732|1202756|P3|NOT COMPLETED|Overall Study||1
500333|NCT00290732|1202757|P2|NOT COMPLETED|Overall Study||1
500334|NCT00290732|1202758|P1|NOT COMPLETED|Overall Study||0
500335|NCT00290732|1202754|P5|COMPLETED|Overall Study||3
500336|NCT00290732|1202755|P4|COMPLETED|Overall Study||6
500337|NCT00290732|1202756|P3|COMPLETED|Overall Study||3
500338|NCT00290732|1202757|P2|COMPLETED|Overall Study||3
500339|NCT00290732|1202758|P1|COMPLETED|Overall Study||3
500340|NCT00290732|1202754|P5|STARTED|Overall Study||3
500341|NCT00290732|1202755|P4|STARTED|Overall Study||6
500342|NCT00290732|1202756|P3|STARTED|Overall Study||4
500343|NCT00290732|1202757|P2|STARTED|Overall Study||4
500344|NCT00290732|1202758|P1|STARTED|Overall Study||3
500345|NCT00290693|1202776|P1|NOT COMPLETED|Overall Study||0
500346|NCT00290693|1202776|P1|COMPLETED|Overall Study||24
500347|NCT00290693|1202776|P1|STARTED|Overall Study||24
500348|NCT00290654|1202781|P1|NOT COMPLETED|Overall Study||0
500349|NCT00290654|1202781|P1|COMPLETED|Overall Study||41
500350|NCT00290654|1202781|P1|STARTED|Overall Study||41
500351|NCT00290615|1202792|P1|NOT COMPLETED|Overall Study||0
500352|NCT00290615|1202792|P1|COMPLETED|Overall Study||30
500353|NCT00290615|1202792|P1|STARTED|Overall Study||30
500354|NCT00290537|1202799|P2|NOT COMPLETED|Overall Study||0
500355|NCT00290537|1202800|P1|NOT COMPLETED|Overall Study||0
500356|NCT00290537|1202799|P2|COMPLETED|Overall Study||0
500357|NCT00290537|1202800|P1|COMPLETED|Overall Study||4
500358|NCT00290537|1202799|P2|STARTED|Overall Study||0
500359|NCT00290537|1202800|P1|STARTED|Overall Study||4
500360|NCT00290472|1202808|P3|NOT COMPLETED|Overall Study||0
500361|NCT00290472|1202809|P2|NOT COMPLETED|Overall Study||0
500362|NCT00290472|1202810|P1|NOT COMPLETED|Overall Study||0
500363|NCT00290472|1202808|P3|COMPLETED|Overall Study||18
500364|NCT00290472|1202809|P2|COMPLETED|Overall Study||39
500365|NCT00290472|1202810|P1|COMPLETED|Overall Study||32
500366|NCT00290472|1202808|P3|STARTED|Overall Study||18
500367|NCT00290472|1202809|P2|STARTED|Overall Study||39
500368|NCT00290472|1202810|P1|STARTED|Overall Study||32
500369|NCT00290407|1202822|P1|NOT COMPLETED|Overall Study||0
500370|NCT00290407|1202822|P1|COMPLETED|Overall Study||2
500371|NCT00290407|1202822|P1|STARTED|Overall Study||2
500372|NCT00290329|1202829|P3|NOT COMPLETED|Overall Study||0
500373|NCT00290329|1202830|P2|NOT COMPLETED|Overall Study||0
500374|NCT00290329|1202831|P1|NOT COMPLETED|Overall Study||0
500375|NCT00290329|1202829|P3|COMPLETED|Overall Study||61
500376|NCT00290329|1202830|P2|COMPLETED|Overall Study||86
500377|NCT00290329|1202831|P1|COMPLETED|Overall Study||102
500378|NCT00290329|1202829|P3|STARTED|Overall Study||61
500379|NCT00290329|1202830|P2|STARTED|Overall Study||86
500380|NCT00290329|1202831|P1|STARTED|Overall Study||102
500381|NCT00290290|1202853|P2|NOT COMPLETED|Overall Study||18
500382|NCT00290290|1202854|P1|NOT COMPLETED|Overall Study||18
500383|NCT00290290|1202853|P2|COMPLETED|Overall Study||391
500384|NCT00290290|1202854|P1|COMPLETED|Overall Study||422
500385|NCT00290290|1202853|P2|STARTED|Overall Study||409
500386|NCT00290290|1202854|P1|STARTED|Overall Study||440
500387|NCT00290251|1202860|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
500388|NCT00290251|1202861|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
500389|NCT00290251|1202862|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
500390|NCT00290251|1202860|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
500391|NCT00290251|1202861|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
500392|NCT00290251|1202862|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
500393|NCT00290251|1202860|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
500394|NCT00290251|1202861|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
500395|NCT00290251|1202862|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
500396|NCT00290251|1202860|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
500397|NCT00290251|1202861|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
500398|NCT00290251|1202862|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
500399|NCT00290251|1202860|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
500400|NCT00290251|1202861|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
500401|NCT00290251|1202862|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
500402|NCT00290251|1202860|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
500403|NCT00290251|1202861|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
500486|NCT00289913|1203002|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
500404|NCT00290251|1202862|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
500405|NCT00290251|1202860|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
500406|NCT00290251|1202861|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
500407|NCT00290251|1202862|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
500408|NCT00290251|1202860|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
500409|NCT00290251|1202861|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
500410|NCT00290251|1202862|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
500411|NCT00290251|1202860|P3|STARTED|Treatment 1 (Months 1 - 3)||14
500412|NCT00290251|1202861|P2|STARTED|Treatment 1 (Months 1 - 3)||14
500413|NCT00290251|1202862|P1|STARTED|Treatment 1 (Months 1 - 3)||14
500414|NCT00290238|1202874|P2|NOT COMPLETED|Overall Study||41
500415|NCT00290238|1202875|P1|NOT COMPLETED|Overall Study||42
500416|NCT00290238|1202874|P2|COMPLETED|Overall Study||24
500417|NCT00290238|1202875|P1|COMPLETED|Overall Study||15
500418|NCT00290238|1202874|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
500419|NCT00290238|1202875|P1|STARTED|Overall Study||57
500420|NCT00290199|1202885|P2|NOT COMPLETED|Overall Study||0
500421|NCT00290199|1202886|P1|NOT COMPLETED|Overall Study||0
500422|NCT00290199|1202885|P2|COMPLETED|Overall Study||82
500423|NCT00290199|1202886|P1|COMPLETED|Overall Study||87
500424|NCT00290199|1202885|P2|STARTED|Overall Study||82
500425|NCT00290199|1202886|P1|STARTED|Overall Study||87
500426|NCT00290186|1202900|P2|NOT COMPLETED|Overall Study||5
500427|NCT00290186|1202901|P1|NOT COMPLETED|Overall Study||5
500428|NCT00290186|1202900|P2|COMPLETED|Overall Study||19
500429|NCT00290186|1202901|P1|COMPLETED|Overall Study||20
500430|NCT00290186|1202900|P2|Completed 6-month Followup Assessments|Overall Study||19
500431|NCT00290186|1202901|P1|Completed 6-month Followup Assessments|Overall Study||20
500432|NCT00290186|1202900|P2|Completed 3-month Followup Assessments|Overall Study||21
500433|NCT00290186|1202901|P1|Completed 3-month Followup Assessments|Overall Study||20
500434|NCT00290186|1202900|P2|Completed Post-treatment Assessments|Overall Study||22
500435|NCT00290186|1202901|P1|Completed Post-treatment Assessments|Overall Study||24
500436|NCT00290186|1202900|P2|Completed 8 Weeks of Treatment|Overall Study||22
500437|NCT00290186|1202901|P1|Completed 8 Weeks of Treatment|Overall Study||24
500438|NCT00290186|1202900|P2|Completed Baseline Assessments|Overall Study||24
500439|NCT00290186|1202901|P1|Completed Baseline Assessments|Overall Study||25
500440|NCT00290186|1202900|P2|STARTED|Overall Study||24
500441|NCT00290186|1202901|P1|STARTED|Overall Study||25
500442|NCT00290147|1202941|P2|NOT COMPLETED|Overall Study||0
500443|NCT00290147|1202942|P1|NOT COMPLETED|Overall Study||0
500444|NCT00290147|1202941|P2|COMPLETED|Overall Study||12
500445|NCT00290147|1202942|P1|COMPLETED|Overall Study||10
500446|NCT00290147|1202941|P2|STARTED|Overall Study||12
500447|NCT00290147|1202942|P1|STARTED|Overall Study||10
500448|NCT00289991|1202952|P2|NOT COMPLETED|Overall Study||80
500449|NCT00289991|1202953|P1|NOT COMPLETED|Overall Study||58
500450|NCT00289991|1202952|P2|COMPLETED|Overall Study||175
500451|NCT00289991|1202953|P1|COMPLETED|Overall Study||176
500452|NCT00289991|1202952|P2|STARTED|Overall Study||255
500453|NCT00289991|1202953|P1|STARTED|Overall Study||234
500454|NCT00289978|1202978|P3|NOT COMPLETED|Overall Study||86
500455|NCT00289978|1202979|P2|NOT COMPLETED|Overall Study||56
500456|NCT00289978|1202980|P1|NOT COMPLETED|Overall Study||97
500457|NCT00289978|1202978|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
500458|NCT00289978|1202979|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
500459|NCT00289978|1202980|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
500460|NCT00289978|1202978|P3|STARTED|Overall Study||418
500461|NCT00289978|1202979|P2|STARTED|Overall Study||425
500462|NCT00289978|1202980|P1|STARTED|Overall Study||429
500463|NCT00289913|1202999|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
500464|NCT00289913|1203000|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
500465|NCT00289913|1203001|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
500466|NCT00289913|1203002|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
500467|NCT00289913|1203003|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
500468|NCT00289913|1202999|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
500469|NCT00289913|1203000|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
500470|NCT00289913|1203001|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
500471|NCT00289913|1203002|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
500472|NCT00289913|1203003|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
500473|NCT00289913|1202999|P5|STARTED|Visit 4 (Stage I and Stage II)||597
500474|NCT00289913|1203000|P4|STARTED|Visit 4 (Stage I and Stage II)||131
500475|NCT00289913|1203001|P3|STARTED|Visit 4 (Stage I and Stage II)||138
500476|NCT00289913|1203002|P2|STARTED|Visit 4 (Stage I and Stage II)||106
500477|NCT00289913|1203003|P1|STARTED|Visit 4 (Stage I and Stage II)||122
500478|NCT00289913|1202999|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
500479|NCT00289913|1203000|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
500480|NCT00289913|1203001|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
500481|NCT00289913|1203002|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
500482|NCT00289913|1203003|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
500483|NCT00289913|1202999|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
500484|NCT00289913|1203000|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
500485|NCT00289913|1203001|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
500487|NCT00289913|1203003|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
500488|NCT00289913|1202999|P5|STARTED|Visit 3 (Stage I and Stage II)||605
500489|NCT00289913|1203000|P4|STARTED|Visit 3 (Stage I and Stage II)||135
500490|NCT00289913|1203001|P3|STARTED|Visit 3 (Stage I and Stage II)||140
500491|NCT00289913|1203002|P2|STARTED|Visit 3 (Stage I and Stage II)||114
500492|NCT00289913|1203003|P1|STARTED|Visit 3 (Stage I and Stage II)||131
500493|NCT00289913|1202999|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
500494|NCT00289913|1203000|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
500495|NCT00289913|1203001|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
500496|NCT00289913|1203002|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
500497|NCT00289913|1203003|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
500498|NCT00289913|1202999|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
500499|NCT00289913|1203000|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
500500|NCT00289913|1203001|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
500501|NCT00289913|1203002|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
500502|NCT00289913|1203003|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
500503|NCT00289913|1202999|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
500504|NCT00289913|1203000|P4|STARTED|Visit 2 (Stage I and Stage II)||141
500505|NCT00289913|1203001|P3|STARTED|Visit 2 (Stage I and Stage II)||150
500506|NCT00289913|1203002|P2|STARTED|Visit 2 (Stage I and Stage II)||135
500507|NCT00289913|1203003|P1|STARTED|Visit 2 (Stage I and Stage II)||146
500508|NCT00289913|1202999|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
500509|NCT00289913|1203000|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
500510|NCT00289913|1203001|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
500511|NCT00289913|1203002|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
500512|NCT00289913|1203003|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
500513|NCT00289913|1202999|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
500514|NCT00289913|1203000|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
500515|NCT00289913|1203001|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
500516|NCT00289913|1203002|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
500517|NCT00289913|1203003|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
500518|NCT00289913|1202999|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
500519|NCT00289913|1203000|P4|STARTED|Visit 1 (Stage I and Stage II)||152
500520|NCT00289913|1203001|P3|STARTED|Visit 1 (Stage I and Stage II)||159
500521|NCT00289913|1203002|P2|STARTED|Visit 1 (Stage I and Stage II)||151
500522|NCT00289913|1203003|P1|STARTED|Visit 1 (Stage I and Stage II)||155
500523|NCT00289900|1203034|P6|NOT COMPLETED|Overall Study||61
500524|NCT00289900|1203035|P5|NOT COMPLETED|Overall Study||45
500525|NCT00289900|1203036|P4|NOT COMPLETED|Overall Study||59
500526|NCT00289900|1203037|P3|NOT COMPLETED|Overall Study||33
500527|NCT00289900|1203038|P2|NOT COMPLETED|Overall Study||120
500528|NCT00289900|1203039|P1|NOT COMPLETED|Overall Study||68
500529|NCT00289900|1203034|P6|COMPLETED|Overall Study||372
500530|NCT00289900|1203035|P5|COMPLETED|Overall Study||392
500531|NCT00289900|1203036|P4|COMPLETED|Overall Study||380
500532|NCT00289900|1203037|P3|COMPLETED|Overall Study||265
500533|NCT00289900|1203038|P2|COMPLETED|Overall Study||316
500534|NCT00289900|1203039|P1|COMPLETED|Overall Study||229
500535|NCT00289900|1203034|P6|Treated|Overall Study||433
500536|NCT00289900|1203035|P5|Treated|Overall Study||437
500537|NCT00289900|1203036|P4|Treated|Overall Study||439
500538|NCT00289900|1203037|P3|Treated|Overall Study||298
500539|NCT00289900|1203038|P2|Treated|Overall Study||435
500540|NCT00289900|1203039|P1|Treated|Overall Study||297
500541|NCT00289900|1203034|P6|STARTED|Overall Study||433
500542|NCT00289900|1203035|P5|STARTED|Overall Study||437
500543|NCT00289900|1203036|P4|STARTED|Overall Study||439
500544|NCT00289900|1203037|P3|STARTED|Overall Study||298
500545|NCT00289900|1203038|P2|STARTED|Overall Study||436
500546|NCT00289900|1203039|P1|STARTED|Overall Study||297
500547|NCT00289887|1203143|P2|NOT COMPLETED|Overall Study||29
500548|NCT00289887|1203144|P1|NOT COMPLETED|Overall Study||22
500549|NCT00289887|1203143|P2|COMPLETED|Overall Study||105
500550|NCT00289887|1203144|P1|COMPLETED|Overall Study||105
500551|NCT00289887|1203143|P2|STARTED|Overall Study||134
500552|NCT00289887|1203144|P1|STARTED|Overall Study||127
500553|NCT00289874|1203162|P2|NOT COMPLETED|Overall Study||8
500554|NCT00289874|1203163|P1|NOT COMPLETED|Overall Study||6
500555|NCT00289874|1203162|P2|COMPLETED|Overall Study||210
500556|NCT00289874|1203163|P1|COMPLETED|Overall Study||197
500557|NCT00289874|1203162|P2|STARTED|Overall Study||218
500558|NCT00289874|1203163|P1|STARTED|Overall Study||203
500559|NCT00289848|1203173|P2|NOT COMPLETED|Overall Study||45
500560|NCT00289848|1203174|P1|NOT COMPLETED|Overall Study||46
500561|NCT00289848|1203173|P2|COMPLETED|Overall Study||133
500562|NCT00289848|1203174|P1|COMPLETED|Overall Study||306
500563|NCT00289848|1203173|P2|STARTED|Overall Study||178
500564|NCT00289848|1203174|P1|STARTED|Overall Study||352
500565|NCT00289783|1203186|P2|NOT COMPLETED|Fourth Dose Phase||24
500566|NCT00289783|1203187|P1|NOT COMPLETED|Fourth Dose Phase||87
500567|NCT00289783|1203186|P2|COMPLETED|Fourth Dose Phase||899
500568|NCT00289783|1203187|P1|COMPLETED|Fourth Dose Phase||2682
500569|NCT00289783|1203186|P2|STARTED|Fourth Dose Phase||923
500570|NCT00289783|1203187|P1|STARTED|Fourth Dose Phase||2769
500571|NCT00289783|1203186|P2|NOT COMPLETED|Primary Phase||83
500572|NCT00289783|1203187|P1|NOT COMPLETED|Primary Phase||248
500573|NCT00289783|1203186|P2|COMPLETED|Primary Phase||961
500574|NCT00289783|1203187|P1|COMPLETED|Primary Phase||2888
500575|NCT00289783|1203186|P2|STARTED|Primary Phase||1044
500576|NCT00289783|1203187|P1|STARTED|Primary Phase||3136
500577|NCT00289770|1203365|P1|NOT COMPLETED|Year 15||1
500578|NCT00289770|1203365|P1|COMPLETED|Year 15||49
500579|NCT00289770|1203365|P1|STARTED|Year 15||50
500580|NCT00289770|1203365|P1|NOT COMPLETED|Year 14||0
500581|NCT00289770|1203365|P1|COMPLETED|Year 14||43
500582|NCT00289770|1203365|P1|STARTED|Year 14||43
500583|NCT00289770|1203365|P1|NOT COMPLETED|Year 13||0
500584|NCT00289770|1203365|P1|COMPLETED|Year 13||37
500585|NCT00289770|1203365|P1|STARTED|Year 13||37
500586|NCT00289770|1203365|P1|NOT COMPLETED|Year 12||0
500587|NCT00289770|1203365|P1|COMPLETED|Year 12||40
500588|NCT00289770|1203365|P1|STARTED|Year 12||40
500589|NCT00289770|1203365|P1|NOT COMPLETED|Year 11||0
500590|NCT00289770|1203365|P1|COMPLETED|Year 11||37
500591|NCT00289770|1203365|P1|STARTED|Year 11||37
500592|NCT00289757|1203377|P1|NOT COMPLETED|Overall Study||0
500593|NCT00289757|1203377|P1|COMPLETED|Overall Study||78
500594|NCT00289757|1203377|P1|STARTED|Overall Study||78
500595|NCT00289744|1203388|P3|NOT COMPLETED|Additional Dose Phase||0
500596|NCT00289744|1203389|P2|NOT COMPLETED|Additional Dose Phase||0
500597|NCT00289744|1203390|P1|NOT COMPLETED|Additional Dose Phase||0
500598|NCT00289744|1203388|P3|COMPLETED|Additional Dose Phase||6
500599|NCT00289744|1203389|P2|COMPLETED|Additional Dose Phase||19
500600|NCT00289744|1203390|P1|COMPLETED|Additional Dose Phase||0
500601|NCT00289744|1203388|P3|STARTED|Additional Dose Phase||6
500602|NCT00289744|1203389|P2|STARTED|Additional Dose Phase||19
500603|NCT00289744|1203390|P1|STARTED|Additional Dose Phase||0
500604|NCT00289744|1203388|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
500605|NCT00289744|1203389|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
500606|NCT00289744|1203390|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
500607|NCT00289744|1203388|P3|COMPLETED|Year 10 Long-term Follow-up||0
500608|NCT00289744|1203389|P2|COMPLETED|Year 10 Long-term Follow-up||0
500609|NCT00289744|1203390|P1|COMPLETED|Year 10 Long-term Follow-up||171
500610|NCT00289744|1203388|P3|STARTED|Year 10 Long-term Follow-up||0
500611|NCT00289744|1203389|P2|STARTED|Year 10 Long-term Follow-up||0
500612|NCT00289744|1203390|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
500613|NCT00289744|1203388|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
500614|NCT00289744|1203389|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
500615|NCT00289744|1203390|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
500616|NCT00289744|1203388|P3|COMPLETED|Year 9 Long-term Follow-up||0
500617|NCT00289744|1203389|P2|COMPLETED|Year 9 Long-term Follow-up||0
500618|NCT00289744|1203390|P1|COMPLETED|Year 9 Long-term Follow-up||173
500619|NCT00289744|1203388|P3|STARTED|Year 9 Long-term Follow-up||0
500620|NCT00289744|1203389|P2|STARTED|Year 9 Long-term Follow-up||0
500621|NCT00289744|1203390|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
500622|NCT00289744|1203388|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
500623|NCT00289744|1203389|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
500624|NCT00289744|1203390|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
500625|NCT00289744|1203388|P3|COMPLETED|Year 8 Long-term Follow-up||0
500626|NCT00289744|1203389|P2|COMPLETED|Year 8 Long-term Follow-up||0
500627|NCT00289744|1203390|P1|COMPLETED|Year 8 Long-term Follow-up||174
500628|NCT00289744|1203388|P3|STARTED|Year 8 Long-term Follow-up||0
500629|NCT00289744|1203389|P2|STARTED|Year 8 Long-term Follow-up||0
500630|NCT00289744|1203390|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
500631|NCT00289744|1203388|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
500632|NCT00289744|1203389|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
500633|NCT00289744|1203390|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
500634|NCT00289744|1203388|P3|COMPLETED|Year 7 Long-term Follow-up||0
500635|NCT00289744|1203389|P2|COMPLETED|Year 7 Long-term Follow-up||0
500636|NCT00289744|1203390|P1|COMPLETED|Year 7 Long-term Follow-up||175
500637|NCT00289744|1203388|P3|STARTED|Year 7 Long-term Follow-up||0
500638|NCT00289744|1203389|P2|STARTED|Year 7 Long-term Follow-up||0
500639|NCT00289744|1203390|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
500640|NCT00289744|1203388|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
500641|NCT00289744|1203389|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
500642|NCT00289744|1203390|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
500643|NCT00289744|1203388|P3|COMPLETED|Year 6 Long-term Follow-up||0
500644|NCT00289744|1203389|P2|COMPLETED|Year 6 Long-term Follow-up||0
500645|NCT00289744|1203390|P1|COMPLETED|Year 6 Long-term Follow-up||178
500646|NCT00289744|1203388|P3|STARTED|Year 6 Long-term Follow-up||0
500647|NCT00289744|1203389|P2|STARTED|Year 6 Long-term Follow-up||0
500648|NCT00289744|1203390|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
500649|NCT00289718|1203408|P1|NOT COMPLETED|Overall Study||0
500650|NCT00289718|1203408|P1|COMPLETED|Overall Study||51
500651|NCT00289718|1203408|P1|STARTED|Overall Study||51
500652|NCT00289536|1203420|P3|NOT COMPLETED|Period 3||1
500653|NCT00289536|1203421|P2|NOT COMPLETED|Period 3||0
500654|NCT00289536|1203422|P1|NOT COMPLETED|Period 3||0
500655|NCT00289536|1203420|P3|COMPLETED|Period 3||9
500656|NCT00289536|1203421|P2|COMPLETED|Period 3||9
500657|NCT00289536|1203422|P1|COMPLETED|Period 3||7
500658|NCT00289536|1203420|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
500659|NCT00289536|1203421|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
500660|NCT00289536|1203422|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
500661|NCT00289536|1203420|P3|NOT COMPLETED|Period 2||0
500662|NCT00289536|1203421|P2|NOT COMPLETED|Period 2||0
500663|NCT00289536|1203422|P1|NOT COMPLETED|Period 2||0
500664|NCT00289536|1203420|P3|COMPLETED|Period 2||7
500665|NCT00289536|1203421|P2|COMPLETED|Period 2||9
500666|NCT00289536|1203422|P1|COMPLETED|Period 2||10
500667|NCT00289536|1203420|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
500668|NCT00289536|1203421|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
500669|NCT00289536|1203422|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
500670|NCT00289536|1203420|P3|NOT COMPLETED|Period 1||0
500671|NCT00289536|1203421|P2|NOT COMPLETED|Period 1||0
500672|NCT00289536|1203422|P1|NOT COMPLETED|Period 1||0
500673|NCT00289536|1203420|P3|COMPLETED|Period 1||9
500674|NCT00289536|1203421|P2|COMPLETED|Period 1||8
500675|NCT00289536|1203422|P1|COMPLETED|Period 1||9
500676|NCT00289536|1203420|P3|STARTED|Period 1||9
500677|NCT00289536|1203421|P2|STARTED|Period 1||8
500678|NCT00289536|1203422|P1|STARTED|Period 1||9
500679|NCT00289471|1203461|P1|NOT COMPLETED|Overall Study||0
500680|NCT00289471|1203461|P1|COMPLETED|Overall Study||630
500681|NCT00289471|1203461|P1|STARTED|Overall Study||630
500682|NCT00289458|1203468|P3|NOT COMPLETED|Overall Study||6
500683|NCT00289458|1203469|P2|NOT COMPLETED|Overall Study||6
500684|NCT00289458|1203470|P1|NOT COMPLETED|Overall Study||6
500685|NCT00289458|1203468|P3|COMPLETED|Overall Study||22
500686|NCT00289458|1203469|P2|COMPLETED|Overall Study||20
500687|NCT00289458|1203470|P1|COMPLETED|Overall Study||19
500688|NCT00289458|1203468|P3|STARTED|Overall Study||28
500689|NCT00289458|1203469|P2|STARTED|Overall Study||26
500690|NCT00289458|1203470|P1|STARTED|Overall Study||25
500691|NCT00289341|1203495|P2|NOT COMPLETED|Overall Study||0
500692|NCT00289341|1203496|P1|NOT COMPLETED|Overall Study||0
500693|NCT00289341|1203495|P2|COMPLETED|Overall Study||12
500694|NCT00289341|1203496|P1|COMPLETED|Overall Study||12
500695|NCT00289341|1203495|P2|STARTED|Overall Study||12
500696|NCT00289341|1203496|P1|STARTED|Overall Study||12
500697|NCT00289289|1203509|P3|NOT COMPLETED|Overall Study||49
500698|NCT00289289|1203510|P2|NOT COMPLETED|Overall Study||10
500699|NCT00289289|1203511|P1|NOT COMPLETED|Overall Study||19
500700|NCT00289289|1203509|P3|COMPLETED|Overall Study||95
500701|NCT00289289|1203510|P2|COMPLETED|Overall Study||114
500702|NCT00289289|1203511|P1|COMPLETED|Overall Study||113
500703|NCT00289289|1203509|P3|STARTED|Overall Study||144
500704|NCT00289289|1203510|P2|STARTED|Overall Study||124
500705|NCT00289289|1203511|P1|STARTED|Overall Study||132
500706|NCT00289276|1203526|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
500707|NCT00289276|1203527|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
500708|NCT00289276|1203526|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
500709|NCT00289276|1203527|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
500710|NCT00289276|1203526|P2|STARTED|Second Part of FAST Study (Expansion)||109
500711|NCT00289276|1203527|P1|STARTED|Second Part of FAST Study (Expansion)||0
500712|NCT00289276|1203526|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
500713|NCT00289276|1203527|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
500714|NCT00289276|1203526|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
500715|NCT00289276|1203527|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
500716|NCT00289276|1203526|P2|STARTED|First Part of FAST Study (Pivotal)||0
500717|NCT00289276|1203527|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
500718|NCT00289211|1203542|P3|NOT COMPLETED|Overall Study||10
500719|NCT00289211|1203543|P2|NOT COMPLETED|Overall Study||1
500720|NCT00289211|1203544|P1|NOT COMPLETED|Overall Study||0
500721|NCT00289211|1203542|P3|COMPLETED|Overall Study||2
500722|NCT00289211|1203543|P2|COMPLETED|Overall Study||34
500723|NCT00289211|1203544|P1|COMPLETED|Overall Study||36
500724|NCT00289211|1203542|P3|STARTED|Overall Study||12
500725|NCT00289211|1203543|P2|STARTED|Overall Study||35
500726|NCT00289211|1203544|P1|STARTED|Overall Study||36
500727|NCT00289185|1203562|P2|NOT COMPLETED|Overall Study||26
500728|NCT00289185|1203563|P1|NOT COMPLETED|Overall Study||28
500729|NCT00289185|1203562|P2|COMPLETED|Overall Study||144
500730|NCT00289185|1203563|P1|COMPLETED|Overall Study||142
500731|NCT00289185|1203562|P2|STARTED|Overall Study||170
500732|NCT00289185|1203563|P1|STARTED|Overall Study||170
500733|NCT00289133|1203610|P2|NOT COMPLETED|Overall Study||298
500734|NCT00289133|1203611|P1|NOT COMPLETED|Overall Study||272
500735|NCT00289133|1203610|P2|COMPLETED|Overall Study||179
500736|NCT00289133|1203611|P1|COMPLETED|Overall Study||189
500737|NCT00289133|1203610|P2|STARTED|Overall Study||477
500738|NCT00289133|1203611|P1|STARTED|Overall Study||461
500739|NCT00289120|1203633|P1|NOT COMPLETED|Overall Study||0
500740|NCT00289120|1203633|P1|COMPLETED|Overall Study||13
500741|NCT00289120|1203633|P1|STARTED|Overall Study||13
500742|NCT00289107|1203651|P2|NOT COMPLETED|Overall Study||44
500743|NCT00289107|1203652|P1|NOT COMPLETED|Overall Study||53
500744|NCT00289107|1203651|P2|COMPLETED|Overall Study||28
500745|NCT00289107|1203652|P1|COMPLETED|Overall Study||24
500746|NCT00289107|1203651|P2|STARTED|Overall Study||72
500747|NCT00289107|1203652|P1|STARTED|Overall Study||77
500748|NCT00289094|1203660|P2|NOT COMPLETED|Overall Study||47
500749|NCT00289094|1203661|P1|NOT COMPLETED|Overall Study||47
500750|NCT00289094|1203660|P2|COMPLETED|Overall Study||2
500751|NCT00289094|1203661|P1|COMPLETED|Overall Study||3
500752|NCT00289094|1203660|P2|STARTED|Overall Study||49
500753|NCT00289094|1203661|P1|STARTED|Overall Study||50
500754|NCT00289016|1203667|P1|NOT COMPLETED|Overall Study||37
500755|NCT00289016|1203667|P1|COMPLETED|Overall Study||13
500756|NCT00289016|1203667|P1|STARTED|Overall Study||50
500757|NCT00288912|1203679|P3|NOT COMPLETED|Overall Study||28
500758|NCT00288912|1203680|P2|NOT COMPLETED|Overall Study||17
500759|NCT00288912|1203681|P1|NOT COMPLETED|Overall Study||17
500760|NCT00288912|1203679|P3|COMPLETED|Overall Study||146
500761|NCT00288912|1203680|P2|COMPLETED|Overall Study||157
500762|NCT00288912|1203681|P1|COMPLETED|Overall Study||158
500763|NCT00288912|1203679|P3|STARTED|Overall Study||174
500764|NCT00288912|1203680|P2|STARTED|Overall Study||174
500765|NCT00288912|1203681|P1|STARTED|Overall Study||175
500766|NCT00288886|1203700|P2|NOT COMPLETED|Overall Study||11
500767|NCT00288886|1203701|P1|NOT COMPLETED|Overall Study||11
500768|NCT00288886|1203700|P2|COMPLETED|Overall Study||81
500769|NCT00288886|1203701|P1|COMPLETED|Overall Study||80
500770|NCT00288886|1203700|P2|12-month Follow Up|Overall Study||81
500771|NCT00288886|1203701|P1|12-month Follow Up|Overall Study||80
500772|NCT00288886|1203700|P2|6-month Follow Up|Overall Study||84
500773|NCT00288886|1203701|P1|6-month Follow Up|Overall Study||85
500774|NCT00288886|1203700|P2|3-month Follow Up|Overall Study||85
500775|NCT00288886|1203701|P1|3-month Follow Up|Overall Study||82
500776|NCT00288886|1203700|P2|STARTED|Overall Study||92
500777|NCT00288886|1203701|P1|STARTED|Overall Study||91
500778|NCT00288860|1203721|P2|NOT COMPLETED|Overall Study||97
500779|NCT00288860|1203722|P1|NOT COMPLETED|Overall Study||102
500780|NCT00288860|1203721|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
500781|NCT00288860|1203722|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
500782|NCT00288860|1203721|P2|Completed 12 Month fu Survey|Overall Study||281
500783|NCT00288860|1203722|P1|Completed 12 Month fu Survey|Overall Study||257
500784|NCT00288860|1203721|P2|Completed 4 Month fu Survey|Overall Study||299
500785|NCT00288860|1203722|P1|Completed 4 Month fu Survey|Overall Study||275
500786|NCT00288860|1203721|P2|Completed Intake Survey|Overall Study||417
500787|NCT00288860|1203722|P1|Completed Intake Survey|Overall Study||408
500788|NCT00288860|1203721|P2|STARTED|Overall Study||425
500789|NCT00288860|1203722|P1|STARTED|Overall Study||412
500790|NCT00288704|1203735|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
500791|NCT00288704|1203736|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
500792|NCT00288704|1203737|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
500793|NCT00288704|1203735|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
500794|NCT00288704|1203736|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
500795|NCT00288704|1203737|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
500796|NCT00288704|1203735|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
500797|NCT00288704|1203736|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
500798|NCT00288704|1203737|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
500799|NCT00288704|1203735|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
500800|NCT00288704|1203736|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
500801|NCT00288704|1203737|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
500802|NCT00288704|1203735|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
500803|NCT00288704|1203736|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
500804|NCT00288704|1203737|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
500805|NCT00288704|1203735|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
500806|NCT00288704|1203736|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
500807|NCT00288704|1203737|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
500808|NCT00288704|1203735|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
500809|NCT00288704|1203736|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
500810|NCT00288704|1203737|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
500811|NCT00288704|1203735|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
500812|NCT00288704|1203736|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
500813|NCT00288704|1203737|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
500814|NCT00288704|1203735|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
500815|NCT00288704|1203736|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
500816|NCT00288704|1203737|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
500817|NCT00288639|1203764|P1|NOT COMPLETED|Overall Study||12
500818|NCT00288639|1203764|P1|COMPLETED|Overall Study||86
500819|NCT00288639|1203764|P1|STARTED|Overall Study||98
500820|NCT00288626|1203781|P1|NOT COMPLETED|Overall Study||7
500821|NCT00288626|1203781|P1|COMPLETED|Overall Study||17
500822|NCT00288626|1203781|P1|STARTED|Overall Study||24
500823|NCT00288600|1203806|P2|NOT COMPLETED|Overall Study||0
500824|NCT00288600|1203807|P1|NOT COMPLETED|Overall Study||0
500825|NCT00288600|1203806|P2|COMPLETED|Overall Study||46
500826|NCT00288600|1203807|P1|COMPLETED|Overall Study||46
500827|NCT00288600|1203806|P2|STARTED|Overall Study||46
500828|NCT00288600|1203807|P1|STARTED|Overall Study||46
500829|NCT00288587|1203815|P2|NOT COMPLETED|Overall Study||10
500830|NCT00288587|1203816|P1|NOT COMPLETED|Overall Study||5
500831|NCT00288587|1203815|P2|COMPLETED|Overall Study||7
500832|NCT00288587|1203816|P1|COMPLETED|Overall Study||14
500833|NCT00288587|1203815|P2|STARTED|Overall Study||17
500834|NCT00288587|1203816|P1|STARTED|Overall Study||19
500835|NCT00288574|1203832|P2|NOT COMPLETED|Overall Study||0
500836|NCT00288574|1203833|P1|NOT COMPLETED|Overall Study||0
500837|NCT00288574|1203832|P2|COMPLETED|Overall Study||44
500838|NCT00288574|1203833|P1|COMPLETED|Overall Study||49
500839|NCT00288574|1203832|P2|STARTED|Overall Study||44
500840|NCT00288574|1203833|P1|STARTED|Overall Study||49
500841|NCT00288509|1203839|P1|NOT COMPLETED|Treatment Cycle 4||8
500842|NCT00288509|1203839|P1|COMPLETED|Treatment Cycle 4||80
500843|NCT00288509|1203839|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
500844|NCT00288509|1203839|P1|NOT COMPLETED|Treatment Cycle 3||5
500845|NCT00288509|1203839|P1|COMPLETED|Treatment Cycle 3||91
500846|NCT00288509|1203839|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
500847|NCT00288509|1203839|P1|NOT COMPLETED|Treatment Cycle 2||3
500848|NCT00288509|1203839|P1|COMPLETED|Treatment Cycle 2||97
500849|NCT00288509|1203839|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
500850|NCT00288509|1203839|P1|NOT COMPLETED|Treatment Cycle 1||6
500851|NCT00288509|1203839|P1|COMPLETED|Treatment Cycle 1||102
500852|NCT00288509|1203839|P1|STARTED|Treatment Cycle 1||108
500853|NCT00288080|1203848|P2|NOT COMPLETED|Overall Study||23
500854|NCT00288080|1203849|P1|NOT COMPLETED|Overall Study||26
500855|NCT00288080|1203848|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
500856|NCT00288080|1203849|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
500857|NCT00288080|1203848|P2|STARTED|Overall Study||305
500858|NCT00288080|1203849|P1|STARTED|Overall Study||307
500859|NCT00288067|1203865|P1|NOT COMPLETED|Overall Study||0
500860|NCT00288067|1203865|P1|COMPLETED|Overall Study||32
500861|NCT00288067|1203865|P1|STARTED|Overall Study||32
500862|NCT00288054|1203871|P1|NOT COMPLETED|Overall Study||24
500863|NCT00288054|1203871|P1|COMPLETED|Overall Study||0
500864|NCT00288054|1203871|P1|STARTED|Overall Study||24
500865|NCT00287872|1203879|P1|NOT COMPLETED|Overall Study||0
500866|NCT00287872|1203879|P1|COMPLETED|Overall Study||30
500867|NCT00287872|1203879|P1|STARTED|Overall Study||30
500868|NCT00287729|1203886|P2|NOT COMPLETED|Overall Study||31
500869|NCT00287729|1203887|P1|NOT COMPLETED|Overall Study||34
500870|NCT00287729|1203886|P2|COMPLETED|Overall Study||142
500871|NCT00287729|1203887|P1|COMPLETED|Overall Study||137
500872|NCT00287729|1203886|P2|STARTED|Overall Study||173
500873|NCT00287729|1203887|P1|STARTED|Overall Study||171
500874|NCT00287716|1203910|P3|NOT COMPLETED|Overall Study||31
500875|NCT00287716|1203911|P2|NOT COMPLETED|Overall Study||17
500876|NCT00287716|1203912|P1|NOT COMPLETED|Overall Study||38
500877|NCT00287716|1203910|P3|COMPLETED|Overall Study||143
500878|NCT00287716|1203911|P2|COMPLETED|Overall Study||70
500879|NCT00287716|1203912|P1|COMPLETED|Overall Study||136
500880|NCT00287716|1203910|P3|STARTED|Overall Study||174
500881|NCT00287716|1203911|P2|STARTED|Overall Study||87
500882|NCT00287716|1203912|P1|STARTED|Overall Study||174
500883|NCT00287365|1203941|P1|NOT COMPLETED|Overall Study||13
500884|NCT00287365|1203941|P1|COMPLETED|Overall Study||12
500885|NCT00287365|1203941|P1|STARTED|Overall Study||25
500886|NCT00287339|1203950|P2|NOT COMPLETED|Overall Study||0
500887|NCT00287339|1203951|P1|NOT COMPLETED|Overall Study||0
500888|NCT00287339|1203950|P2|COMPLETED|Overall Study||18
500889|NCT00287339|1203951|P1|COMPLETED|Overall Study||22
500890|NCT00287339|1203950|P2|STARTED|Overall Study||18
500891|NCT00287339|1203951|P1|STARTED|Overall Study||22
500892|NCT00287222|1203957|P1|NOT COMPLETED|Overall Study||0
500893|NCT00287222|1203957|P1|COMPLETED|Overall Study||21
500894|NCT00287222|1203957|P1|STARTED|Overall Study||21
500895|NCT00287079|1203963|P2|NOT COMPLETED|Overall Study||1
500896|NCT00287079|1203964|P1|NOT COMPLETED|Overall Study||22
500897|NCT00287079|1203963|P2|COMPLETED|Overall Study||2
500898|NCT00287079|1203964|P1|COMPLETED|Overall Study||10
500899|NCT00287079|1203963|P2|STARTED|Overall Study||3
500900|NCT00287079|1203964|P1|STARTED|Overall Study||32
500901|NCT00287053|1203976|P2|NOT COMPLETED|Overall Study||1
500902|NCT00287053|1203977|P1|NOT COMPLETED|Overall Study||4
500903|NCT00287053|1203976|P2|COMPLETED|Overall Study||26
500904|NCT00287053|1203977|P1|COMPLETED|Overall Study||26
500905|NCT00287053|1203976|P2|STARTED|Overall Study||27
500906|NCT00287053|1203977|P1|STARTED|Overall Study||30
500907|NCT00286754|1203986|P3|NOT COMPLETED|Overall Study||10
500908|NCT00286754|1203987|P2|NOT COMPLETED|Overall Study||18
500909|NCT00286754|1203988|P1|NOT COMPLETED|Overall Study||20
500910|NCT00286754|1203986|P3|COMPLETED|Overall Study||170
500911|NCT00286754|1203987|P2|COMPLETED|Overall Study||159
500912|NCT00286754|1203988|P1|COMPLETED|Overall Study||156
500913|NCT00286754|1203986|P3|STARTED|Overall Study||180
500914|NCT00286754|1203987|P2|STARTED|Overall Study||177
500915|NCT00286754|1203988|P1|STARTED|Overall Study||176
500916|NCT00286741|1204022|P2|NOT COMPLETED|Overall Study||17
500917|NCT00286741|1204023|P1|NOT COMPLETED|Overall Study||11
500918|NCT00286741|1204022|P2|COMPLETED|Overall Study||89
500919|NCT00286741|1204023|P1|COMPLETED|Overall Study||122
500920|NCT00286741|1204022|P2|STARTED|Overall Study||106
500921|NCT00286741|1204023|P1|STARTED|Overall Study||133
500922|NCT00286728|1204033|P2|NOT COMPLETED|Overall Study||29
500923|NCT00286728|1204034|P1|NOT COMPLETED|Overall Study||36
500924|NCT00286728|1204033|P2|COMPLETED|Overall Study||116
500925|NCT00286728|1204034|P1|COMPLETED|Overall Study||106
500926|NCT00286728|1204033|P2|STARTED|Overall Study||145
500927|NCT00286728|1204034|P1|STARTED|Overall Study||142
500928|NCT00286494|1204043|P3|NOT COMPLETED|Overall Study||39
500929|NCT00286494|1204044|P2|NOT COMPLETED|Overall Study||44
500930|NCT00286494|1204045|P1|NOT COMPLETED|Overall Study||26
500931|NCT00286494|1204043|P3|COMPLETED|Overall Study||160
500932|NCT00286494|1204044|P2|COMPLETED|Overall Study||153
500933|NCT00286494|1204045|P1|COMPLETED|Overall Study||71
500934|NCT00286494|1204043|P3|STARTED|Overall Study||199
500935|NCT00286494|1204044|P2|STARTED|Overall Study||197
500936|NCT00286494|1204045|P1|STARTED|Overall Study||97
500937|NCT00286468|1204206|P3|NOT COMPLETED|Overall Study||50
500938|NCT00286468|1204207|P2|NOT COMPLETED|Overall Study||50
500939|NCT00286468|1204208|P1|NOT COMPLETED|Overall Study||37
500940|NCT00286468|1204206|P3|COMPLETED|Overall Study||148
500941|NCT00286468|1204207|P2|COMPLETED|Overall Study||153
500942|NCT00286468|1204208|P1|COMPLETED|Overall Study||62
500943|NCT00286468|1204206|P3|STARTED|Overall Study||198
500944|NCT00286468|1204207|P2|STARTED|Overall Study||203
500945|NCT00286468|1204208|P1|STARTED|Overall Study||99
500946|NCT00286455|1204369|P3|NOT COMPLETED|Overall Study||24
500947|NCT00286455|1204370|P2|NOT COMPLETED|Overall Study||28
500948|NCT00286455|1204371|P1|NOT COMPLETED|Overall Study||25
500949|NCT00286455|1204369|P3|COMPLETED|Overall Study||107
500950|NCT00286455|1204370|P2|COMPLETED|Overall Study||105
500951|NCT00286455|1204371|P1|COMPLETED|Overall Study||40
500952|NCT00286455|1204369|P3|STARTED|Overall Study||131
500953|NCT00286455|1204370|P2|STARTED|Overall Study||133
500954|NCT00286455|1204371|P1|STARTED|Overall Study||65
500955|NCT00286442|1204550|P3|NOT COMPLETED|Overall Study||32
500956|NCT00286442|1204551|P2|NOT COMPLETED|Overall Study||45
500957|NCT00286442|1204552|P1|NOT COMPLETED|Overall Study||37
500958|NCT00286442|1204550|P3|COMPLETED|Overall Study||72
500959|NCT00286442|1204551|P2|COMPLETED|Overall Study||165
500960|NCT00286442|1204552|P1|COMPLETED|Overall Study||176
500961|NCT00286442|1204550|P3|STARTED|Overall Study||104
500962|NCT00286442|1204551|P2|STARTED|Overall Study||210
500963|NCT00286442|1204552|P1|STARTED|Overall Study||213
500964|NCT00286429|1204713|P3|NOT COMPLETED|Overall Study||52
500965|NCT00286429|1204714|P2|NOT COMPLETED|Overall Study||48
500966|NCT00286429|1204715|P1|NOT COMPLETED|Overall Study||75
500967|NCT00286429|1204713|P3|COMPLETED|Overall Study||77
500968|NCT00286429|1204714|P2|COMPLETED|Overall Study||83
500969|NCT00286429|1204715|P1|COMPLETED|Overall Study||55
500970|NCT00286429|1204713|P3|STARTED|Overall Study||129
500971|NCT00286429|1204714|P2|STARTED|Overall Study||131
500972|NCT00286429|1204715|P1|STARTED|Overall Study||130
500973|NCT00286325|1204819|P1|NOT COMPLETED|Overall Study||0
500974|NCT00286325|1204819|P1|COMPLETED|Overall Study||8
500975|NCT00286325|1204819|P1|STARTED|Overall Study||8
500976|NCT00286182|1204829|P2|NOT COMPLETED|Overall Study||3
500977|NCT00286182|1204830|P1|NOT COMPLETED|Overall Study||5
500978|NCT00286182|1204829|P2|COMPLETED|Overall Study||25
500979|NCT00286182|1204830|P1|COMPLETED|Overall Study||23
500980|NCT00286182|1204829|P2|STARTED|Overall Study||28
500981|NCT00286182|1204830|P1|STARTED|Overall Study||28
500982|NCT00286156|1204839|P3|NOT COMPLETED|Overall Study||1
500983|NCT00286156|1204840|P2|NOT COMPLETED|Overall Study||1
500984|NCT00286156|1204841|P1|NOT COMPLETED|Overall Study||2
500985|NCT00286156|1204839|P3|COMPLETED|Overall Study||9
500986|NCT00286156|1204840|P2|COMPLETED|Overall Study||9
500987|NCT00286156|1204841|P1|COMPLETED|Overall Study||8
500988|NCT00286156|1204839|P3|STARTED|Overall Study||10
500989|NCT00286156|1204840|P2|STARTED|Overall Study||10
500990|NCT00286156|1204841|P1|STARTED|Overall Study||10
500991|NCT00286091|1204854|P2|NOT COMPLETED|Open-label Treatment Phase||71
500992|NCT00286091|1204855|P1|NOT COMPLETED|Open-label Treatment Phase||77
500993|NCT00286091|1204854|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
500994|NCT00286091|1204855|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
500995|NCT00286091|1204854|P2|Received Treatment|Open-label Treatment Phase||101
500996|NCT00286091|1204855|P1|Received Treatment|Open-label Treatment Phase||109
500997|NCT00286091|1204854|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
500998|NCT00286091|1204855|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
500999|NCT00286091|1204854|P2|NOT COMPLETED|Double-blind Treatment Phase||593
501000|NCT00286091|1204855|P1|NOT COMPLETED|Double-blind Treatment Phase||584
501001|NCT00286091|1204854|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
501002|NCT00286091|1204855|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
501003|NCT00286091|1204854|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
501004|NCT00286091|1204855|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
501005|NCT00286091|1204854|P2|Received Treatment|Double-blind Treatment Phase||716
501006|NCT00286091|1204855|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
501007|NCT00286091|1204854|P2|STARTED|Double-blind Treatment Phase||716
501008|NCT00286091|1204855|P1|STARTED|Double-blind Treatment Phase||716
501009|NCT00286078|1204869|P2|NOT COMPLETED|Overall Study||34
501010|NCT00286078|1204870|P1|NOT COMPLETED|Overall Study||32
501011|NCT00286078|1204869|P2|COMPLETED|Overall Study||34
501012|NCT00286078|1204870|P1|COMPLETED|Overall Study||40
501013|NCT00286078|1204869|P2|12 Weeks|Overall Study||62
501014|NCT00286078|1204870|P1|12 Weeks|Overall Study||63
501015|NCT00286078|1204869|P2|STARTED|Overall Study||68
501016|NCT00286078|1204870|P1|STARTED|Overall Study||72
501017|NCT00285246|1204878|P1|NOT COMPLETED|Overall Study||48
501018|NCT00285246|1204878|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
501019|NCT00285246|1204878|P1|STARTED|Overall Study||838
501020|NCT00285207|1204887|P2|NOT COMPLETED|Overall Study||6
501021|NCT00285207|1204888|P1|NOT COMPLETED|Overall Study||9
501022|NCT00285207|1204887|P2|COMPLETED|Overall Study||71
501023|NCT00285207|1204888|P1|COMPLETED|Overall Study||61
501024|NCT00285207|1204887|P2|Treated|Overall Study||75
501025|NCT00285207|1204888|P1|Treated|Overall Study||63
501026|NCT00285207|1204887|P2|STARTED|Overall Study||77
501027|NCT00285207|1204888|P1|STARTED|Overall Study||70
501028|NCT00282867|1204897|P3|NOT COMPLETED|Overall Study||0
501029|NCT00282867|1204898|P2|NOT COMPLETED|Overall Study||1
501030|NCT00282867|1204899|P1|NOT COMPLETED|Overall Study||1
501031|NCT00282867|1204897|P3|COMPLETED|Overall Study||25
501032|NCT00282867|1204898|P2|COMPLETED|Overall Study||24
501033|NCT00282867|1204899|P1|COMPLETED|Overall Study||23
501034|NCT00282867|1204897|P3|STARTED|Overall Study||25
501035|NCT00282867|1204898|P2|STARTED|Overall Study||25
501036|NCT00282867|1204899|P1|STARTED|Overall Study||24
501037|NCT00282828|1204916|P3|NOT COMPLETED|Overall Study||9
501038|NCT00282828|1204917|P2|NOT COMPLETED|Overall Study||12
501039|NCT00282828|1204918|P1|NOT COMPLETED|Overall Study||6
501040|NCT00282828|1204916|P3|COMPLETED|Overall Study||50
501041|NCT00282828|1204917|P2|COMPLETED|Overall Study||47
501042|NCT00282828|1204918|P1|COMPLETED|Overall Study||57
501043|NCT00282828|1204916|P3|STARTED|Overall Study||59
501044|NCT00282828|1204917|P2|STARTED|Overall Study||59
501045|NCT00282828|1204918|P1|STARTED|Overall Study||63
501046|NCT00282815|1204931|P2|NOT COMPLETED|Overall Study||6
501047|NCT00282815|1204932|P1|NOT COMPLETED|Overall Study||7
501048|NCT00282815|1204931|P2|COMPLETED|Overall Study||11
501049|NCT00282815|1204932|P1|COMPLETED|Overall Study||8
501050|NCT00282815|1204931|P2|STARTED|Overall Study||17
501051|NCT00282815|1204932|P1|STARTED|Overall Study||15
501052|NCT00285857|1204941|P1|NOT COMPLETED|Overall Study||4
501053|NCT00285857|1204941|P1|COMPLETED|Overall Study||26
501054|NCT00285857|1204941|P1|STARTED|Overall Study||30
501055|NCT00285818|1204954|P2|NOT COMPLETED|Overall Study||2
501056|NCT00285818|1204955|P1|NOT COMPLETED|Overall Study||4
501057|NCT00285818|1204954|P2|COMPLETED|Overall Study||3
501058|NCT00285818|1204955|P1|COMPLETED|Overall Study||2
501059|NCT00285818|1204954|P2|STARTED|Overall Study||5
501060|NCT00285818|1204955|P1|STARTED|Overall Study||6
501061|NCT00285779|1204963|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
501062|NCT00285779|1204964|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
501063|NCT00285779|1204963|P2|COMPLETED|Follow-up Period (wk 24-32)||10
501064|NCT00285779|1204964|P1|COMPLETED|Follow-up Period (wk 24-32)||8
501065|NCT00285779|1204963|P2|STARTED|Follow-up Period (wk 24-32)||10
501066|NCT00285779|1204964|P1|STARTED|Follow-up Period (wk 24-32)||9
501067|NCT00285779|1204963|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
501068|NCT00285779|1204964|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
501069|NCT00285779|1204963|P2|COMPLETED|Open Label Period (wk 12-24)||10
501070|NCT00285779|1204964|P1|COMPLETED|Open Label Period (wk 12-24)||9
501071|NCT00285779|1204963|P2|STARTED|Open Label Period (wk 12-24)||12
501072|NCT00285779|1204964|P1|STARTED|Open Label Period (wk 12-24)||11
501073|NCT00285779|1204963|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
501074|NCT00285779|1204964|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
501075|NCT00285779|1204963|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
501076|NCT00285779|1204964|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
501077|NCT00285779|1204963|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
501078|NCT00285779|1204964|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
501079|NCT00285584|1204972|P2|NOT COMPLETED|Month 9||3
501080|NCT00285584|1204973|P1|NOT COMPLETED|Month 9||1
501081|NCT00285584|1204972|P2|COMPLETED|Month 9||14
501082|NCT00285584|1204973|P1|COMPLETED|Month 9||15
501083|NCT00285584|1204972|P2|STARTED|Month 9||17
501084|NCT00285584|1204973|P1|STARTED|Month 9||16
501085|NCT00285584|1204972|P2|NOT COMPLETED|Month 6||1
501086|NCT00285584|1204973|P1|NOT COMPLETED|Month 6||0
501087|NCT00285584|1204972|P2|COMPLETED|Month 6||17
501088|NCT00285584|1204973|P1|COMPLETED|Month 6||16
501089|NCT00285584|1204972|P2|STARTED|Month 6||18
501090|NCT00285584|1204973|P1|STARTED|Month 6||16
501091|NCT00285584|1204972|P2|NOT COMPLETED|Month 3||3
501092|NCT00285584|1204973|P1|NOT COMPLETED|Month 3||4
501093|NCT00285584|1204972|P2|COMPLETED|Month 3||18
501094|NCT00285584|1204973|P1|COMPLETED|Month 3||16
501095|NCT00285584|1204972|P2|STARTED|Month 3||21
501096|NCT00285584|1204973|P1|STARTED|Month 3||20
501097|NCT00285584|1204972|P2|NOT COMPLETED|Enrollment (Month 0)||0
501098|NCT00285584|1204973|P1|NOT COMPLETED|Enrollment (Month 0)||0
501099|NCT00285584|1204972|P2|COMPLETED|Enrollment (Month 0)||21
501100|NCT00285584|1204973|P1|COMPLETED|Enrollment (Month 0)||20
501101|NCT00285584|1204972|P2|STARTED|Enrollment (Month 0)||21
501102|NCT00285584|1204973|P1|STARTED|Enrollment (Month 0)||20
501103|NCT00285467|1204987|P2|NOT COMPLETED|Overall Study||0
501104|NCT00285467|1204988|P1|NOT COMPLETED|Overall Study||0
501105|NCT00285467|1204987|P2|COMPLETED|Overall Study||22
501106|NCT00285467|1204988|P1|COMPLETED|Overall Study||25
501107|NCT00285467|1204987|P2|STARTED|Overall Study||22
501108|NCT00285467|1204988|P1|STARTED|Overall Study||25
501109|NCT00285012|1204998|P2|NOT COMPLETED|Received Study Tx||94
501110|NCT00285012|1204999|P1|NOT COMPLETED|Received Study Tx||72
501111|NCT00285012|1204998|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
501112|NCT00285012|1204999|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
501113|NCT00285012|1204998|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
501114|NCT00285012|1204999|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
501115|NCT00285012|1204998|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
501116|NCT00285012|1204999|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
501117|NCT00285012|1204998|P2|STARTED|Received Study Tx||251
501118|NCT00285012|1204999|P1|STARTED|Received Study Tx||248
501119|NCT00285012|1204998|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
501120|NCT00285012|1204999|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
501121|NCT00285012|1204998|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
501122|NCT00285012|1204999|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
501123|NCT00285012|1204998|P2|STARTED|Assigned to Study Treatment (Tx)||254
501124|NCT00285012|1204999|P1|STARTED|Assigned to Study Treatment (Tx)||250
501125|NCT00284934|1205025|P2|NOT COMPLETED|Overall Study||3
501126|NCT00284934|1205026|P1|NOT COMPLETED|Overall Study||4
501127|NCT00284934|1205025|P2|COMPLETED|Overall Study||43
501128|NCT00284934|1205026|P1|COMPLETED|Overall Study||44
501129|NCT00284934|1205025|P2|Intent-to-treat Population (ITT)|Overall Study||45
501130|NCT00284934|1205026|P1|Intent-to-treat Population (ITT)|Overall Study||47
501131|NCT00284934|1205025|P2|STARTED|Overall Study||46
501132|NCT00284934|1205026|P1|STARTED|Overall Study||48
501133|NCT00284856|1205041|P3|NOT COMPLETED|Overall Study||60
501134|NCT00284856|1205042|P2|NOT COMPLETED|Overall Study||50
501135|NCT00284856|1205043|P1|NOT COMPLETED|Overall Study||51
501136|NCT00284856|1205041|P3|COMPLETED|Overall Study||276
501137|NCT00284856|1205042|P2|COMPLETED|Overall Study||286
501138|NCT00284856|1205043|P1|COMPLETED|Overall Study||296
501139|NCT00284856|1205041|P3|STARTED|Overall Study||336
501140|NCT00284856|1205042|P2|STARTED|Overall Study||336
501141|NCT00284856|1205043|P1|STARTED|Overall Study||347
501142|NCT00284739|1205059|P2|NOT COMPLETED|Overall Study||0
501143|NCT00284739|1205060|P1|NOT COMPLETED|Overall Study||0
501144|NCT00284739|1205059|P2|COMPLETED|Overall Study||9
501145|NCT00284739|1205060|P1|COMPLETED|Overall Study||11
501146|NCT00284739|1205059|P2|STARTED|Overall Study||9
501147|NCT00284739|1205060|P1|STARTED|Overall Study||11
501148|NCT00283296|1205070|P1|NOT COMPLETED|Overall Study||5
501149|NCT00283296|1205070|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
501150|NCT00283296|1205070|P1|STARTED|Overall Study||14
501151|NCT00283244|1205079|P3|NOT COMPLETED|Overall Study||51
501152|NCT00283244|1205080|P2|NOT COMPLETED|Overall Study||51
501153|NCT00283244|1205081|P1|NOT COMPLETED|Overall Study||18
501154|NCT00283244|1205079|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
501155|NCT00283244|1205080|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
501156|NCT00283244|1205081|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
501157|NCT00283244|1205079|P3|STARTED|Overall Study||51
501158|NCT00283244|1205080|P2|STARTED|Overall Study||51
501159|NCT00283244|1205081|P1|STARTED|Overall Study||44
501160|NCT00283075|1205101|P2|NOT COMPLETED|Overall Study||0
501161|NCT00283075|1205102|P1|NOT COMPLETED|Overall Study||0
501162|NCT00283075|1205101|P2|COMPLETED|Overall Study||6
501163|NCT00283075|1205102|P1|COMPLETED|Overall Study||25
501164|NCT00283075|1205101|P2|STARTED|Overall Study||6
501165|NCT00283075|1205102|P1|STARTED|Overall Study||25
501166|NCT00283062|1205117|P4|NOT COMPLETED|Overall Study||49
501167|NCT00283062|1205118|P3|NOT COMPLETED|Overall Study||41
501168|NCT00283062|1205119|P2|NOT COMPLETED|Overall Study||7
501169|NCT00283062|1205120|P1|NOT COMPLETED|Overall Study||12
501170|NCT00283062|1205117|P4|COMPLETED|Overall Study||13
501171|NCT00283062|1205118|P3|COMPLETED|Overall Study||15
501172|NCT00283062|1205119|P2|COMPLETED|Overall Study||48
501173|NCT00283062|1205120|P1|COMPLETED|Overall Study||43
501174|NCT00283062|1205117|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
501175|NCT00283062|1205118|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
501176|NCT00283062|1205119|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
501177|NCT00283062|1205120|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
501178|NCT00283062|1205117|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
501179|NCT00283062|1205118|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
501180|NCT00283062|1205119|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
501181|NCT00283062|1205120|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
501182|NCT00283062|1205117|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
501183|NCT00283062|1205118|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
501184|NCT00283062|1205119|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
501185|NCT00283062|1205120|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
501186|NCT00283062|1205117|P4|STARTED|Overall Study||62
501187|NCT00283062|1205118|P3|STARTED|Overall Study||56
501188|NCT00283062|1205119|P2|STARTED|Overall Study||55
501189|NCT00283062|1205120|P1|STARTED|Overall Study||55
501190|NCT00283049|1205153|P3|NOT COMPLETED|Overall Study||54
501191|NCT00283049|1205154|P2|NOT COMPLETED|Overall Study||45
501192|NCT00283049|1205155|P1|NOT COMPLETED|Overall Study||58
501193|NCT00283049|1205153|P3|COMPLETED|Overall Study||76
501194|NCT00283049|1205154|P2|COMPLETED|Overall Study||83
501195|NCT00283049|1205155|P1|COMPLETED|Overall Study||70
501196|NCT00283049|1205153|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
501197|NCT00283049|1205154|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
501198|NCT00283049|1205155|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
501199|NCT00284557|1205183|P2|NOT COMPLETED|Overall Study||13
501200|NCT00284557|1205184|P1|NOT COMPLETED|Overall Study||9
501201|NCT00284557|1205183|P2|COMPLETED|Overall Study||50
501202|NCT00284557|1205184|P1|COMPLETED|Overall Study||58
501203|NCT00284557|1205183|P2|STARTED|Overall Study||63
501204|NCT00284557|1205184|P1|STARTED|Overall Study||67
501205|NCT00284518|1205196|P4|NOT COMPLETED|Overall Study||33
501206|NCT00284518|1205197|P3|NOT COMPLETED|Overall Study||28
501207|NCT00284518|1205198|P2|NOT COMPLETED|Overall Study||28
501208|NCT00284518|1205199|P1|NOT COMPLETED|Overall Study||26
501209|NCT00284518|1205196|P4|COMPLETED|Overall Study||61
501210|NCT00284518|1205197|P3|COMPLETED|Overall Study||67
501211|NCT00284518|1205198|P2|COMPLETED|Overall Study||66
501212|NCT00284518|1205199|P1|COMPLETED|Overall Study||71
501213|NCT00284518|1205196|P4|STARTED|Overall Study||94
501214|NCT00284518|1205197|P3|STARTED|Overall Study||95
501215|NCT00284518|1205198|P2|STARTED|Overall Study||94
501216|NCT00284518|1205199|P1|STARTED|Overall Study||97
501217|NCT00282984|1205239|P2|NOT COMPLETED|Overall Study||61
501218|NCT00282984|1205240|P1|NOT COMPLETED|Overall Study||51
501219|NCT00282984|1205239|P2|COMPLETED|Overall Study||289
501220|NCT00282984|1205240|P1|COMPLETED|Overall Study||302
501221|NCT00282984|1205239|P2|STARTED|Overall Study||350
501222|NCT00282984|1205240|P1|STARTED|Overall Study||353
501223|NCT00282971|1205266|P2|NOT COMPLETED|Overall Study||22
501224|NCT00282971|1205267|P1|NOT COMPLETED|Overall Study||34
501225|NCT00282971|1205266|P2|COMPLETED|Overall Study||149
501226|NCT00282971|1205267|P1|COMPLETED|Overall Study||146
501227|NCT00282971|1205266|P2|STARTED|Overall Study||171
501228|NCT00282971|1205267|P1|STARTED|Overall Study||180
501229|NCT00282919|1205277|P1|NOT COMPLETED|Overall Study||7
501230|NCT00282919|1205277|P1|COMPLETED|Overall Study||103
501231|NCT00282919|1205277|P1|STARTED|Overall Study||110
501232|NCT00284180|1205291|P2|NOT COMPLETED|Overall Study||4
501233|NCT00284180|1205292|P1|NOT COMPLETED|Overall Study||0
501234|NCT00284180|1205291|P2|COMPLETED|Overall Study||17
501235|NCT00284180|1205292|P1|COMPLETED|Overall Study||11
501236|NCT00284180|1205291|P2|STARTED|Overall Study||21
501237|NCT00284180|1205292|P1|STARTED|Overall Study||11
501238|NCT00284154|1205298|P1|NOT COMPLETED|Overall Study||42
501239|NCT00284154|1205298|P1|COMPLETED|Overall Study||9
501240|NCT00284154|1205298|P1|STARTED|Overall Study||51
501241|NCT00284141|1205305|P1|NOT COMPLETED|Overall Study||98
501242|NCT00284141|1205305|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
501243|NCT00284141|1205305|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
501244|NCT00284141|1205305|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
501245|NCT00284141|1205305|P1|STARTED|Overall Study||98
501246|NCT00284089|1205328|P4|NOT COMPLETED|Extension Phase||12
501247|NCT00284089|1205329|P3|NOT COMPLETED|Extension Phase||6
501248|NCT00284089|1205330|P2|NOT COMPLETED|Extension Phase||0
501249|NCT00284089|1205331|P1|NOT COMPLETED|Extension Phase||2
501250|NCT00284089|1205328|P4|COMPLETED|Extension Phase||21
501251|NCT00284089|1205329|P3|COMPLETED|Extension Phase||22
501252|NCT00284089|1205330|P2|COMPLETED|Extension Phase||6
501253|NCT00284089|1205331|P1|COMPLETED|Extension Phase||1
501254|NCT00284089|1205328|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
501255|NCT00284089|1205329|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
501256|NCT00284089|1205330|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
501257|NCT00284089|1205331|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
501258|NCT00284089|1205328|P4|NOT COMPLETED|Multiple Dose Phase||4
501259|NCT00284089|1205329|P3|NOT COMPLETED|Multiple Dose Phase||4
501260|NCT00284089|1205330|P2|NOT COMPLETED|Multiple Dose Phase||0
501261|NCT00284089|1205331|P1|NOT COMPLETED|Multiple Dose Phase||1
501262|NCT00284089|1205328|P4|COMPLETED|Multiple Dose Phase||37
501263|NCT00284089|1205329|P3|COMPLETED|Multiple Dose Phase||31
501264|NCT00284089|1205330|P2|COMPLETED|Multiple Dose Phase||6
501265|NCT00284089|1205331|P1|COMPLETED|Multiple Dose Phase||4
501266|NCT00284089|1205328|P4|STARTED|Multiple Dose Phase||41
501267|NCT00284089|1205329|P3|STARTED|Multiple Dose Phase||35
501268|NCT00284089|1205330|P2|STARTED|Multiple Dose Phase||6
501269|NCT00284089|1205331|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
501270|NCT00284089|1205328|P4|NOT COMPLETED|Single Dose Phase||0
501271|NCT00284089|1205329|P3|NOT COMPLETED|Single Dose Phase||0
501272|NCT00284089|1205330|P2|NOT COMPLETED|Single Dose Phase||0
501273|NCT00284089|1205331|P1|NOT COMPLETED|Single Dose Phase||0
501274|NCT00284089|1205328|P4|COMPLETED|Single Dose Phase||0
501275|NCT00284089|1205329|P3|COMPLETED|Single Dose Phase||0
501276|NCT00284089|1205330|P2|COMPLETED|Single Dose Phase||6
501277|NCT00284089|1205331|P1|COMPLETED|Single Dose Phase||6
501278|NCT00284089|1205328|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
501279|NCT00284089|1205329|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
501280|NCT00284089|1205330|P2|STARTED|Single Dose Phase||6
501281|NCT00284089|1205331|P1|STARTED|Single Dose Phase||6
501282|NCT00284050|1205360|P3|NOT COMPLETED|Overall Study||9
501283|NCT00284050|1205361|P2|NOT COMPLETED|Overall Study||5
501284|NCT00284050|1205362|P1|NOT COMPLETED|Overall Study||5
501285|NCT00284050|1205360|P3|COMPLETED|Overall Study||40
501286|NCT00284050|1205361|P2|COMPLETED|Overall Study||46
501287|NCT00284050|1205362|P1|COMPLETED|Overall Study||46
501288|NCT00284050|1205360|P3|STARTED|Overall Study||49
501289|NCT00284050|1205361|P2|STARTED|Overall Study||51
501290|NCT00284050|1205362|P1|STARTED|Overall Study||51
501291|NCT00283868|1205378|P2|NOT COMPLETED|Overall Study||8
501292|NCT00283868|1205379|P1|NOT COMPLETED|Overall Study||7
501293|NCT00283868|1205378|P2|COMPLETED|Overall Study||103
501294|NCT00283868|1205379|P1|COMPLETED|Overall Study||104
501295|NCT00283868|1205378|P2|STARTED|Overall Study||111
501296|NCT00283868|1205379|P1|STARTED|Overall Study||111
501297|NCT00283842|1205396|P5|NOT COMPLETED|Overall Study||15
501298|NCT00283842|1205397|P4|NOT COMPLETED|Overall Study||27
501299|NCT00283842|1205398|P3|NOT COMPLETED|Overall Study||31
501300|NCT00283842|1205399|P2|NOT COMPLETED|Overall Study||18
501301|NCT00283842|1205400|P1|NOT COMPLETED|Overall Study||12
501302|NCT00283842|1205396|P5|COMPLETED|Overall Study||75
501303|NCT00283842|1205397|P4|COMPLETED|Overall Study||42
501304|NCT00283842|1205398|P3|COMPLETED|Overall Study||68
501305|NCT00283842|1205399|P2|COMPLETED|Overall Study||69
501306|NCT00283842|1205400|P1|COMPLETED|Overall Study||51
501307|NCT00283842|1205396|P5|STARTED|Overall Study||90
501308|NCT00283842|1205397|P4|STARTED|Overall Study||69
501309|NCT00283842|1205398|P3|STARTED|Overall Study||99
501310|NCT00283842|1205399|P2|STARTED|Overall Study||87
501311|NCT00283842|1205400|P1|STARTED|Overall Study||63
501312|NCT00283816|1205419|P2|NOT COMPLETED|Overall Study||2
501313|NCT00283816|1205420|P1|NOT COMPLETED|Overall Study||2
501314|NCT00283816|1205419|P2|COMPLETED|Overall Study||16
501315|NCT00283816|1205420|P1|COMPLETED|Overall Study||16
501316|NCT00283816|1205419|P2|STARTED|Overall Study||18
501317|NCT00283816|1205420|P1|STARTED|Overall Study||18
501318|NCT00283712|1205434|P2|NOT COMPLETED|Overall Study||1
501319|NCT00283712|1205435|P1|NOT COMPLETED|Overall Study||0
501320|NCT00283712|1205434|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
501321|NCT00283712|1205435|P1|COMPLETED|Overall Study||10
501322|NCT00283712|1205434|P2|Per-Protocol Sample|Overall Study||7
501323|NCT00283712|1205435|P1|Per-Protocol Sample|Overall Study||6
501324|NCT00283712|1205434|P2|Safety Sample|Overall Study||10
501325|NCT00283712|1205435|P1|Safety Sample|Overall Study||10
501326|NCT00283712|1205434|P2|Intent-to-treat Sample|Overall Study||10
501327|NCT00283712|1205435|P1|Intent-to-treat Sample|Overall Study||10
501328|NCT00283712|1205434|P2|STARTED|Overall Study||10
501329|NCT00283712|1205435|P1|STARTED|Overall Study||10
501330|NCT00283686|1205473|P4|NOT COMPLETED|Overall Study||32
501331|NCT00283686|1205474|P3|NOT COMPLETED|Overall Study||33
501332|NCT00283686|1205475|P2|NOT COMPLETED|Overall Study||41
501333|NCT00283686|1205476|P1|NOT COMPLETED|Overall Study||29
501334|NCT00283686|1205473|P4|COMPLETED|Overall Study||109
501335|NCT00283686|1205474|P3|COMPLETED|Overall Study||111
501336|NCT00283686|1205475|P2|COMPLETED|Overall Study||92
501337|NCT00283686|1205476|P1|COMPLETED|Overall Study||111
501338|NCT00283686|1205473|P4|STARTED|Overall Study||141
501339|NCT00283686|1205474|P3|STARTED|Overall Study||144
501340|NCT00283686|1205475|P2|STARTED|Overall Study||133
501341|NCT00283686|1205476|P1|STARTED|Overall Study||140
501342|NCT00283595|1205520|P2|NOT COMPLETED|Overall Study||2
501343|NCT00283595|1205521|P1|NOT COMPLETED|Overall Study||1
501344|NCT00283595|1205520|P2|COMPLETED|Overall Study||9
501345|NCT00283595|1205521|P1|COMPLETED|Overall Study||9
501346|NCT00283595|1205520|P2|STARTED|Overall Study||11
501347|NCT00283595|1205521|P1|STARTED|Overall Study||10
501348|NCT00283439|1205533|P4|NOT COMPLETED|Overall Study||9
501349|NCT00283439|1205534|P3|NOT COMPLETED|Overall Study||11
501350|NCT00283439|1205535|P2|NOT COMPLETED|Overall Study||11
501351|NCT00283439|1205536|P1|NOT COMPLETED|Overall Study||8
501352|NCT00283439|1205533|P4|COMPLETED|Overall Study||0
501353|NCT00283439|1205534|P3|COMPLETED|Overall Study||0
501354|NCT00283439|1205535|P2|COMPLETED|Overall Study||0
501355|NCT00283439|1205536|P1|COMPLETED|Overall Study||0
501356|NCT00283439|1205533|P4|STARTED|Overall Study||9
501357|NCT00283439|1205534|P3|STARTED|Overall Study||11
501358|NCT00283439|1205535|P2|STARTED|Overall Study||11
501359|NCT00283439|1205536|P1|STARTED|Overall Study||8
501360|NCT00283400|1205562|P4|NOT COMPLETED|Overall Study||0
501361|NCT00283400|1205563|P3|NOT COMPLETED|Overall Study||1
501362|NCT00283400|1205564|P2|NOT COMPLETED|Overall Study||1
501363|NCT00283400|1205565|P1|NOT COMPLETED|Overall Study||2
501364|NCT00283400|1205562|P4|COMPLETED|Overall Study||0
501365|NCT00283400|1205563|P3|COMPLETED|Overall Study||6
501366|NCT00283400|1205564|P2|COMPLETED|Overall Study||19
501367|NCT00283400|1205565|P1|COMPLETED|Overall Study||18
501368|NCT00283400|1205562|P4|STARTED|Overall Study||0
501369|NCT00283400|1205563|P3|STARTED|Overall Study||7
501370|NCT00283400|1205564|P2|STARTED|Overall Study||20
501371|NCT00283400|1205565|P1|STARTED|Overall Study||20
501372|NCT00283387|1205583|P2|NOT COMPLETED|Second Intervention||0
501373|NCT00283387|1205584|P1|NOT COMPLETED|Second Intervention||0
501374|NCT00283387|1205583|P2|COMPLETED|Second Intervention||5
501375|NCT00283387|1205584|P1|COMPLETED|Second Intervention||5
501376|NCT00283387|1205583|P2|STARTED|Second Intervention||5
501377|NCT00283387|1205584|P1|STARTED|Second Intervention||5
501378|NCT00283387|1205583|P2|NOT COMPLETED|Washout Period of 2 Months||0
501379|NCT00283387|1205584|P1|NOT COMPLETED|Washout Period of 2 Months||0
501380|NCT00283387|1205583|P2|COMPLETED|Washout Period of 2 Months||5
501381|NCT00283387|1205584|P1|COMPLETED|Washout Period of 2 Months||5
501382|NCT00283387|1205583|P2|STARTED|Washout Period of 2 Months||5
501383|NCT00283387|1205584|P1|STARTED|Washout Period of 2 Months||5
501384|NCT00283387|1205583|P2|NOT COMPLETED|First Intervention||2
501385|NCT00283387|1205584|P1|NOT COMPLETED|First Intervention||1
501386|NCT00283387|1205583|P2|COMPLETED|First Intervention||5
501387|NCT00283387|1205584|P1|COMPLETED|First Intervention||5
501388|NCT00283387|1205583|P2|STARTED|First Intervention||7
501389|NCT00283387|1205584|P1|STARTED|First Intervention||6
501390|NCT00282672|1205594|P4|NOT COMPLETED|5 Year: Follow up||5
501391|NCT00282672|1205595|P3|NOT COMPLETED|5 Year: Follow up||0
501392|NCT00282672|1205596|P2|NOT COMPLETED|5 Year: Follow up||5
501393|NCT00282672|1205597|P1|NOT COMPLETED|5 Year: Follow up||1
501394|NCT00282672|1205594|P4|COMPLETED|5 Year: Follow up||20
501395|NCT00282672|1205595|P3|COMPLETED|5 Year: Follow up||12
501396|NCT00282672|1205596|P2|COMPLETED|5 Year: Follow up||27
501397|NCT00282672|1205597|P1|COMPLETED|5 Year: Follow up||14
501398|NCT00282672|1205594|P4|STARTED|5 Year: Follow up|11 withdrew|25
501399|NCT00282672|1205595|P3|STARTED|5 Year: Follow up|3 withdrew|12
501400|NCT00282672|1205596|P2|STARTED|5 Year: Follow up|7 withdrew|32
501401|NCT00282672|1205597|P1|STARTED|5 Year: Follow up|1 withdrew|15
501402|NCT00282672|1205594|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
501403|NCT00282672|1205595|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
501404|NCT00282672|1205596|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
501405|NCT00282672|1205597|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
501406|NCT00282672|1205594|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
501407|NCT00282672|1205595|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
501408|NCT00282672|1205596|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
501409|NCT00282672|1205597|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
501410|NCT00282672|1205594|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
501411|NCT00282672|1205595|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
501412|NCT00282672|1205596|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
501413|NCT00282672|1205597|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
501414|NCT00282672|1205594|P4|NOT COMPLETED|1 Year||4
501415|NCT00282672|1205595|P3|NOT COMPLETED|1 Year||1
501416|NCT00282672|1205596|P2|NOT COMPLETED|1 Year||2
501417|NCT00282672|1205597|P1|NOT COMPLETED|1 Year||3
501418|NCT00282672|1205594|P4|COMPLETED|1 Year||38
501419|NCT00282672|1205595|P3|COMPLETED|1 Year||20
501420|NCT00282672|1205596|P2|COMPLETED|1 Year||40
501421|NCT00282672|1205597|P1|COMPLETED|1 Year||19
501422|NCT00282672|1205594|P4|STARTED|1 Year||42
501423|NCT00282672|1205595|P3|STARTED|1 Year||21
501424|NCT00282672|1205596|P2|STARTED|1 Year||42
501425|NCT00282672|1205597|P1|STARTED|1 Year||22
501426|NCT00282568|1205643|P1|NOT COMPLETED|Extended Treatment Period||24
501427|NCT00282568|1205643|P1|COMPLETED|Extended Treatment Period||42
501428|NCT00282568|1205643|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
501429|NCT00282568|1205643|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
501430|NCT00282568|1205643|P1|COMPLETED|Pharmacokinetic Treatment Period||67
501431|NCT00282568|1205643|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
501432|NCT00282568|1205643|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
501433|NCT00282568|1205643|P1|STARTED|Pharmacokinetic Treatment Period||70
501434|NCT00282464|1205669|P2|NOT COMPLETED|Overall Study||62
501435|NCT00282464|1205670|P1|NOT COMPLETED|Overall Study||73
501436|NCT00282464|1205669|P2|COMPLETED|Overall Study||134
501437|NCT00282464|1205670|P1|COMPLETED|Overall Study||112
501438|NCT00282464|1205669|P2|STARTED|Overall Study||196
501439|NCT00282464|1205670|P1|STARTED|Overall Study||185
501440|NCT00282438|1205720|P2|NOT COMPLETED|Overall Study||1
501441|NCT00282438|1205721|P1|NOT COMPLETED|Overall Study||1
501442|NCT00282438|1205720|P2|COMPLETED|Overall Study||0
501443|NCT00282438|1205721|P1|COMPLETED|Overall Study||0
501444|NCT00282438|1205720|P2|STARTED|Overall Study||1
501445|NCT00282438|1205721|P1|STARTED|Overall Study||1
501446|NCT00282347|1205729|P2|NOT COMPLETED|B Cell Follow-up Period||0
501447|NCT00282347|1205730|P1|NOT COMPLETED|B Cell Follow-up Period||5
501448|NCT00282347|1205729|P2|COMPLETED|B Cell Follow-up Period||4
501449|NCT00282347|1205730|P1|COMPLETED|B Cell Follow-up Period||15
501450|NCT00282347|1205729|P2|STARTED|B Cell Follow-up Period||4
501451|NCT00282347|1205730|P1|STARTED|B Cell Follow-up Period||20
501452|NCT00282347|1205729|P2|NOT COMPLETED|Safety Follow-up Period||6
501453|NCT00282347|1205730|P1|NOT COMPLETED|Safety Follow-up Period||3
501454|NCT00282347|1205729|P2|COMPLETED|Safety Follow-up Period||57
501455|NCT00282347|1205730|P1|COMPLETED|Safety Follow-up Period||64
501456|NCT00282347|1205729|P2|STARTED|Safety Follow-up Period||63
501457|NCT00282347|1205730|P1|STARTED|Safety Follow-up Period||67
501458|NCT00282347|1205729|P2|NOT COMPLETED|Treatment Period||9
501459|NCT00282347|1205730|P1|NOT COMPLETED|Treatment Period||5
501460|NCT00282347|1205729|P2|COMPLETED|Treatment Period||63
501461|NCT00282347|1205730|P1|COMPLETED|Treatment Period||67
501462|NCT00282347|1205729|P2|STARTED|Treatment Period||72
501463|NCT00282347|1205730|P1|STARTED|Treatment Period||72
501464|NCT00282334|1205756|P2|NOT COMPLETED|Overall Study||5
501465|NCT00282334|1205757|P1|NOT COMPLETED|Overall Study||8
501466|NCT00282334|1205756|P2|COMPLETED|Overall Study||118
501467|NCT00282334|1205757|P1|COMPLETED|Overall Study||105
501468|NCT00282334|1205756|P2|STARTED|Overall Study||123
501469|NCT00282334|1205757|P1|STARTED|Overall Study||113
501470|NCT00282308|1205765|P3|NOT COMPLETED|Safety Follow-up Period||19
501471|NCT00282308|1205766|P2|NOT COMPLETED|Safety Follow-up Period||0
501472|NCT00282308|1205767|P1|NOT COMPLETED|Safety Follow-up Period||0
501473|NCT00282308|1205765|P3|COMPLETED|Safety Follow-up Period||81
501474|NCT00282308|1205766|P2|COMPLETED|Safety Follow-up Period||0
501475|NCT00282308|1205767|P1|COMPLETED|Safety Follow-up Period||0
501476|NCT00282308|1205765|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
501477|NCT00282308|1205766|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
501478|NCT00282308|1205767|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
501479|NCT00282308|1205765|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
501480|NCT00282308|1205766|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
501481|NCT00282308|1205767|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
501482|NCT00282308|1205765|P3|COMPLETED|Optional Extension Re-treatment Period||72
501483|NCT00282308|1205766|P2|COMPLETED|Optional Extension Re-treatment Period||0
501484|NCT00282308|1205767|P1|COMPLETED|Optional Extension Re-treatment Period||0
501485|NCT00282308|1205765|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
501486|NCT00282308|1205766|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
501487|NCT00282308|1205767|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
501488|NCT00282308|1205765|P3|NOT COMPLETED|Treatment Period||0
501489|NCT00282308|1205766|P2|NOT COMPLETED|Treatment Period||6
501490|NCT00282308|1205767|P1|NOT COMPLETED|Treatment Period||4
501491|NCT00282308|1205765|P3|COMPLETED|Treatment Period||0
501492|NCT00282308|1205766|P2|COMPLETED|Treatment Period||28
501493|NCT00282308|1205767|P1|COMPLETED|Treatment Period||65
501494|NCT00282308|1205765|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
501495|NCT00282308|1205766|P2|STARTED|Treatment Period||34
501496|NCT00282308|1205767|P1|STARTED|Treatment Period||69
501497|NCT00282295|1205797|P3|NOT COMPLETED|Overall Study||8
501498|NCT00282295|1205798|P2|NOT COMPLETED|Overall Study||17
501499|NCT00282295|1205799|P1|NOT COMPLETED|Overall Study||3
501500|NCT00282295|1205797|P3|COMPLETED|Overall Study||441
501501|NCT00282295|1205798|P2|COMPLETED|Overall Study||429
501502|NCT00282295|1205799|P1|COMPLETED|Overall Study||443
501503|NCT00282295|1205797|P3|STARTED|Overall Study||449
501504|NCT00282295|1205798|P2|STARTED|Overall Study||446
501505|NCT00282295|1205799|P1|STARTED|Overall Study||446
501506|NCT00282282|1205848|P1|NOT COMPLETED|Overall Study||0
501507|NCT00282282|1205848|P1|COMPLETED|Overall Study||29
501508|NCT00282282|1205848|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
501509|NCT00282256|1205854|P1|NOT COMPLETED|Extension Treatment Period||2
501510|NCT00282256|1205854|P1|COMPLETED|Extension Treatment Period||16
501511|NCT00282256|1205854|P1|STARTED|Extension Treatment Period||18
501512|NCT00282256|1205854|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
501513|NCT00282256|1205854|P1|COMPLETED|Pharmacokinetic Treatment Period||18
501514|NCT00282256|1205854|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
501515|NCT00282256|1205854|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
501516|NCT00282256|1205854|P1|STARTED|Pharmacokinetic Treatment Period||19
501517|NCT00282243|1205875|P1|NOT COMPLETED|Extension Treatment Period||22
501518|NCT00282243|1205875|P1|COMPLETED|Extension Treatment Period||43
501519|NCT00282243|1205875|P1|STARTED|Extension Treatment Period||65
501520|NCT00282243|1205875|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
501521|NCT00282243|1205875|P1|COMPLETED|Pharmacokinetic Treatment Period||65
501522|NCT00282243|1205875|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
501523|NCT00282243|1205875|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
501524|NCT00282243|1205875|P1|STARTED|Pharmacokinetic Treatment Period||70
501525|NCT00282152|1205901|P2|NOT COMPLETED|Overall Study||0
501526|NCT00282152|1205902|P1|NOT COMPLETED|Overall Study||1
501527|NCT00282152|1205901|P2|COMPLETED|Overall Study||15
501528|NCT00282152|1205902|P1|COMPLETED|Overall Study||14
501529|NCT00282152|1205901|P2|STARTED|Overall Study||15
501530|NCT00282152|1205902|P1|STARTED|Overall Study||15
501531|NCT00282113|1205923|P3|NOT COMPLETED|Overall Study||0
501532|NCT00282113|1205924|P2|NOT COMPLETED|Overall Study||0
501533|NCT00282113|1205925|P1|NOT COMPLETED|Overall Study||1
501534|NCT00282113|1205923|P3|COMPLETED|Overall Study||29
501535|NCT00282113|1205924|P2|COMPLETED|Overall Study||30
501536|NCT00282113|1205925|P1|COMPLETED|Overall Study||30
501537|NCT00282113|1205923|P3|STARTED|Overall Study||29
501538|NCT00282113|1205924|P2|STARTED|Overall Study||30
501539|NCT00282113|1205925|P1|STARTED|Overall Study||31
501540|NCT00282087|1205939|P1|NOT COMPLETED|Overall Study||1
501541|NCT00282087|1205939|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
501542|NCT00282087|1205939|P1|STARTED|Overall Study||47
501543|NCT00282048|1205952|P1|NOT COMPLETED|Overall Study||62
501544|NCT00282048|1205952|P1|COMPLETED|Overall Study||0
501545|NCT00282048|1205952|P1|STARTED|Overall Study||62
501546|NCT00281957|1205966|P2|NOT COMPLETED|Overall Study||42
501547|NCT00281957|1205967|P1|NOT COMPLETED|Overall Study||67
501548|NCT00281957|1205966|P2|COMPLETED|Overall Study||0
501549|NCT00281957|1205967|P1|COMPLETED|Overall Study||0
501550|NCT00281957|1205966|P2|Eligible and Received Treatment|Overall Study||39
501551|NCT00281957|1205967|P1|Eligible and Received Treatment|Overall Study||63
501552|NCT00281957|1205966|P2|Eligible|Overall Study||40
501553|NCT00281957|1205967|P1|Eligible|Overall Study||66
501554|NCT00281957|1205966|P2|STARTED|Overall Study||42
501555|NCT00281957|1205967|P1|STARTED|Overall Study||67
501556|NCT00281918|1205981|P2|NOT COMPLETED|Overall Study||108
501557|NCT00281918|1205982|P1|NOT COMPLETED|Overall Study||142
501558|NCT00281918|1205981|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
501559|NCT00281918|1205982|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
501560|NCT00281918|1205981|P2|Safety Population; Received Study Drug|Overall Study||402
501561|NCT00281918|1205982|P1|Safety Population; Received Study Drug|Overall Study||398
501562|NCT00281918|1205981|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
501563|NCT00281918|1205982|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
501564|NCT00281879|1206016|P8|NOT COMPLETED|Overall Study||1
501565|NCT00281879|1206017|P7|NOT COMPLETED|Overall Study||0
501566|NCT00281879|1206018|P6|NOT COMPLETED|Overall Study||9
501567|NCT00281879|1206019|P5|NOT COMPLETED|Overall Study||6
501568|NCT00281879|1206020|P4|NOT COMPLETED|Overall Study||0
501569|NCT00281879|1206021|P3|NOT COMPLETED|Overall Study||20
501570|NCT00281879|1206022|P2|NOT COMPLETED|Overall Study||36
501571|NCT00281879|1206023|P1|NOT COMPLETED|Overall Study||128
501572|NCT00281879|1206016|P8|COMPLETED|Overall Study||0
501573|NCT00281879|1206017|P7|COMPLETED|Overall Study||0
501574|NCT00281879|1206018|P6|COMPLETED|Overall Study||0
501575|NCT00281879|1206019|P5|COMPLETED|Overall Study||0
501576|NCT00281879|1206020|P4|COMPLETED|Overall Study||0
501577|NCT00281879|1206021|P3|COMPLETED|Overall Study||0
501578|NCT00281879|1206022|P2|COMPLETED|Overall Study||0
501579|NCT00281879|1206023|P1|COMPLETED|Overall Study||0
501580|NCT00281879|1206016|P8|STARTED|Overall Study||1
501581|NCT00281879|1206017|P7|STARTED|Overall Study||0
501582|NCT00281879|1206018|P6|STARTED|Overall Study||9
501583|NCT00281879|1206019|P5|STARTED|Overall Study||6
501584|NCT00281879|1206020|P4|STARTED|Overall Study||0
501585|NCT00281879|1206021|P3|STARTED|Overall Study||20
501586|NCT00281879|1206022|P2|STARTED|Overall Study||36
501587|NCT00281879|1206023|P1|STARTED|Overall Study||128
501588|NCT00281840|1206041|P1|NOT COMPLETED|Overall Study||25
501589|NCT00281840|1206041|P1|COMPLETED|Overall Study||5
501590|NCT00281840|1206041|P1|STARTED|Overall Study||30
501591|NCT00281827|1206046|P1|NOT COMPLETED|Overall Study||0
501592|NCT00281827|1206046|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
501593|NCT00281827|1206046|P1|STARTED|Overall Study||22
501594|NCT00281697|1206057|P2|NOT COMPLETED|Overall Study||197
501595|NCT00281697|1206058|P1|NOT COMPLETED|Overall Study||401
501596|NCT00281697|1206057|P2|COMPLETED|Overall Study||28
501597|NCT00281697|1206058|P1|COMPLETED|Overall Study||58
501598|NCT00281697|1206057|P2|STARTED|Overall Study||225
501599|NCT00281697|1206058|P1|STARTED|Overall Study||459
501600|NCT00281658|1206076|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
501601|NCT00281658|1206077|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
501602|NCT00281658|1206078|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
501603|NCT00281658|1206076|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
501604|NCT00281658|1206077|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
501605|NCT00281658|1206078|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
501606|NCT00281658|1206076|P3|STARTED|Open-label Monotherapy Extension Phase||149
501607|NCT00281658|1206077|P2|STARTED|Open-label Monotherapy Extension Phase||0
501608|NCT00281658|1206078|P1|STARTED|Open-label Monotherapy Extension Phase||0
501609|NCT00281658|1206076|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
501610|NCT00281658|1206077|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
501611|NCT00281658|1206078|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
501612|NCT00281658|1206076|P3|COMPLETED|Double-blind, Randomized Phase||0
501613|NCT00281658|1206077|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
501614|NCT00281658|1206078|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
501615|NCT00281658|1206076|P3|STARTED|Double-blind, Randomized Phase||0
501616|NCT00281658|1206077|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
501617|NCT00281658|1206078|P1|STARTED|Double-blind, Randomized Phase||222
501618|NCT00281632|1206095|P1|NOT COMPLETED|Overall Study||36
501619|NCT00281632|1206095|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
501620|NCT00281632|1206095|P1|STARTED|Overall Study||36
501621|NCT00281580|1206137|P16|NOT COMPLETED|Overall Study||13
501622|NCT00281580|1206138|P15|NOT COMPLETED|Overall Study||7
501623|NCT00281580|1206139|P14|NOT COMPLETED|Overall Study||7
501624|NCT00281580|1206140|P13|NOT COMPLETED|Overall Study||13
501625|NCT00281580|1206141|P12|NOT COMPLETED|Overall Study||10
501626|NCT00281580|1206142|P11|NOT COMPLETED|Overall Study||4
501627|NCT00281580|1206143|P10|NOT COMPLETED|Overall Study||12
501628|NCT00281580|1206144|P9|NOT COMPLETED|Overall Study||8
501629|NCT00281580|1206145|P8|NOT COMPLETED|Overall Study||1
501630|NCT00281580|1206146|P7|NOT COMPLETED|Overall Study||5
501631|NCT00281580|1206147|P6|NOT COMPLETED|Overall Study||3
501632|NCT00281580|1206148|P5|NOT COMPLETED|Overall Study||4
501633|NCT00281580|1206149|P4|NOT COMPLETED|Overall Study||17
501634|NCT00281580|1206150|P3|NOT COMPLETED|Overall Study||5
501635|NCT00281580|1206151|P2|NOT COMPLETED|Overall Study||1
501636|NCT00281580|1206152|P1|NOT COMPLETED|Overall Study||7
501637|NCT00281580|1206137|P16|COMPLETED|Overall Study||116
501638|NCT00281580|1206138|P15|COMPLETED|Overall Study||133
501639|NCT00281580|1206139|P14|COMPLETED|Overall Study||43
501640|NCT00281580|1206140|P13|COMPLETED|Overall Study||129
501641|NCT00281580|1206141|P12|COMPLETED|Overall Study||136
501642|NCT00281580|1206142|P11|COMPLETED|Overall Study||44
501643|NCT00281580|1206143|P10|COMPLETED|Overall Study||117
501644|NCT00281580|1206144|P9|COMPLETED|Overall Study||135
501645|NCT00281580|1206145|P8|COMPLETED|Overall Study||46
501646|NCT00281580|1206146|P7|COMPLETED|Overall Study||39
501647|NCT00281580|1206147|P6|COMPLETED|Overall Study||43
501648|NCT00281580|1206148|P5|COMPLETED|Overall Study||40
501649|NCT00281580|1206149|P4|COMPLETED|Overall Study||118
501650|NCT00281580|1206150|P3|COMPLETED|Overall Study||125
501651|NCT00281580|1206151|P2|COMPLETED|Overall Study||41
501652|NCT00281580|1206152|P1|COMPLETED|Overall Study||39
501653|NCT00281580|1206137|P16|STARTED|Overall Study||129
501654|NCT00281580|1206138|P15|STARTED|Overall Study||140
501655|NCT00281580|1206139|P14|STARTED|Overall Study||50
501656|NCT00281580|1206140|P13|STARTED|Overall Study||142
501657|NCT00281580|1206141|P12|STARTED|Overall Study||146
501658|NCT00281580|1206142|P11|STARTED|Overall Study||48
501659|NCT00281580|1206143|P10|STARTED|Overall Study||129
501660|NCT00281580|1206144|P9|STARTED|Overall Study||143
501661|NCT00281580|1206145|P8|STARTED|Overall Study||47
501662|NCT00281580|1206146|P7|STARTED|Overall Study||44
501663|NCT00281580|1206147|P6|STARTED|Overall Study||46
501664|NCT00281580|1206148|P5|STARTED|Overall Study||44
501665|NCT00281580|1206149|P4|STARTED|Overall Study||135
501666|NCT00281580|1206150|P3|STARTED|Overall Study||130
501667|NCT00281580|1206151|P2|STARTED|Overall Study||42
501668|NCT00281580|1206152|P1|STARTED|Overall Study||46
501669|NCT00281528|1206499|P3|NOT COMPLETED|Overall Study||79
501670|NCT00281528|1206500|P2|NOT COMPLETED|Overall Study||54
501671|NCT00281528|1206501|P1|NOT COMPLETED|Overall Study||75
501672|NCT00281528|1206499|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
501673|NCT00281528|1206500|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
501674|NCT00281528|1206501|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
501675|NCT00281528|1206499|P3|STARTED|Overall Study||79
501676|NCT00281528|1206500|P2|STARTED|Overall Study||54
501677|NCT00281528|1206501|P1|STARTED|Overall Study||75
501678|NCT00281463|1206545|P1|NOT COMPLETED|Overall Study||0
501679|NCT00281463|1206545|P1|COMPLETED|Overall Study||45
501680|NCT00281463|1206545|P1|STARTED|Overall Study||45
501681|NCT00281320|1206552|P2|NOT COMPLETED|Overall Study||21
501682|NCT00281320|1206553|P1|NOT COMPLETED|Overall Study||25
501683|NCT00281320|1206552|P2|COMPLETED|Overall Study||40
501684|NCT00281320|1206553|P1|COMPLETED|Overall Study||36
501685|NCT00281320|1206552|P2|STARTED|Overall Study||61
501686|NCT00281320|1206553|P1|STARTED|Overall Study||61
501687|NCT00281099|1206575|P2|NOT COMPLETED|Overall Study||222
501688|NCT00281099|1206576|P1|NOT COMPLETED|Overall Study||205
501689|NCT00281099|1206575|P2|COMPLETED|Overall Study||296
501690|NCT00281099|1206576|P1|COMPLETED|Overall Study||308
501691|NCT00281099|1206575|P2|STARTED|Overall Study||518
501692|NCT00281099|1206576|P1|STARTED|Overall Study||513
501693|NCT00281021|1206617|P1|NOT COMPLETED|Overall Study||2
501694|NCT00281021|1206617|P1|COMPLETED|Overall Study||24
501695|NCT00281021|1206617|P1|STARTED|Overall Study||26
501696|NCT00280917|1206625|P4|NOT COMPLETED|Overall Study||2
501697|NCT00280917|1206626|P3|NOT COMPLETED|Overall Study||6
501698|NCT00280917|1206627|P2|NOT COMPLETED|Overall Study||6
501699|NCT00280917|1206628|P1|NOT COMPLETED|Overall Study||2
501700|NCT00280917|1206625|P4|COMPLETED|Overall Study||61
501701|NCT00280917|1206626|P3|COMPLETED|Overall Study||57
501702|NCT00280917|1206627|P2|COMPLETED|Overall Study||57
501703|NCT00280917|1206628|P1|COMPLETED|Overall Study||63
501704|NCT00280917|1206625|P4|STARTED|Overall Study||63
501705|NCT00280917|1206626|P3|STARTED|Overall Study||63
501706|NCT00280917|1206627|P2|STARTED|Overall Study||63
501707|NCT00280917|1206628|P1|STARTED|Overall Study||65
501708|NCT00280904|1206638|P1|NOT COMPLETED|Overall Study||0
501709|NCT00280904|1206638|P1|COMPLETED|Overall Study||433
501710|NCT00280904|1206638|P1|STARTED|Overall Study||433
501711|NCT00280826|1206643|P1|NOT COMPLETED|Overall Study||0
501712|NCT00280826|1206643|P1|COMPLETED|Overall Study||6
501713|NCT00280826|1206643|P1|STARTED|Overall Study||6
501714|NCT00280735|1206651|P1|NOT COMPLETED|Overall Study||18
501715|NCT00280735|1206651|P1|COMPLETED|Overall Study||57
501716|NCT00280735|1206651|P1|Received Adequate Exposure|Overall Study||57
501717|NCT00280735|1206651|P1|Received Treatment|Overall Study||72
501718|NCT00280735|1206651|P1|STARTED|Overall Study||75
501719|NCT00280683|1206663|P2|NOT COMPLETED|Overall Study||3
501720|NCT00280683|1206664|P1|NOT COMPLETED|Overall Study||2
501721|NCT00280683|1206663|P2|COMPLETED|Overall Study||7
501722|NCT00280683|1206664|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
501723|NCT00280683|1206663|P2|STARTED|Overall Study||10
501724|NCT00280683|1206664|P1|STARTED|Overall Study||10
501725|NCT00280566|1206674|P3|NOT COMPLETED|Period 2 Double Blind||57
501726|NCT00280566|1206675|P2|NOT COMPLETED|Period 2 Double Blind||43
501727|NCT00280566|1206676|P1|NOT COMPLETED|Period 2 Double Blind||0
501728|NCT00280566|1206674|P3|COMPLETED|Period 2 Double Blind||54
501729|NCT00280566|1206675|P2|COMPLETED|Period 2 Double Blind||84
501730|NCT00280566|1206676|P1|COMPLETED|Period 2 Double Blind||0
501731|NCT00280566|1206674|P3|STARTED|Period 2 Double Blind||111
501732|NCT00280566|1206675|P2|STARTED|Period 2 Double Blind||127
501733|NCT00280566|1206676|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
501734|NCT00280566|1206674|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
501735|NCT00280566|1206675|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
501736|NCT00280566|1206676|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
501737|NCT00280566|1206674|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
501738|NCT00280566|1206675|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
501739|NCT00280566|1206676|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
501740|NCT00280566|1206674|P3|STARTED|Period 1 Open Label Ziprasidone||0
501741|NCT00280566|1206675|P2|STARTED|Period 1 Open Label Ziprasidone||0
501742|NCT00280566|1206676|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
501743|NCT00280397|1206701|P1|NOT COMPLETED|Overall Study||1
501744|NCT00280397|1206701|P1|COMPLETED|Overall Study||26
501745|NCT00280397|1206701|P1|STARTED|Overall Study||27
501746|NCT00280384|1206716|P8|NOT COMPLETED|Overall Study||0
501747|NCT00280384|1206717|P7|NOT COMPLETED|Overall Study||0
501748|NCT00280384|1206718|P6|NOT COMPLETED|Overall Study||0
501749|NCT00280384|1206719|P5|NOT COMPLETED|Overall Study||0
501750|NCT00280384|1206720|P4|NOT COMPLETED|Overall Study||0
501751|NCT00280384|1206721|P3|NOT COMPLETED|Overall Study||0
501752|NCT00280384|1206722|P2|NOT COMPLETED|Overall Study||0
501753|NCT00280384|1206723|P1|NOT COMPLETED|Overall Study||0
501754|NCT00280384|1206716|P8|COMPLETED|Overall Study||6
501755|NCT00280384|1206717|P7|COMPLETED|Overall Study||6
501756|NCT00280384|1206718|P6|COMPLETED|Overall Study||6
501757|NCT00280384|1206719|P5|COMPLETED|Overall Study||6
501758|NCT00280384|1206720|P4|COMPLETED|Overall Study||6
501759|NCT00280384|1206721|P3|COMPLETED|Overall Study||6
501760|NCT00280384|1206722|P2|COMPLETED|Overall Study||6
501761|NCT00280384|1206723|P1|COMPLETED|Overall Study||6
501762|NCT00280384|1206716|P8|STARTED|Overall Study||6
501763|NCT00280384|1206717|P7|STARTED|Overall Study||6
501764|NCT00280384|1206718|P6|STARTED|Overall Study||6
501765|NCT00280384|1206719|P5|STARTED|Overall Study||6
501766|NCT00280384|1206720|P4|STARTED|Overall Study||6
501767|NCT00280384|1206721|P3|STARTED|Overall Study||6
501768|NCT00280384|1206722|P2|STARTED|Overall Study||6
501769|NCT00280384|1206723|P1|STARTED|Overall Study||6
501770|NCT00280293|1206767|P2|NOT COMPLETED|Overall Study||23
501771|NCT00280293|1206768|P1|NOT COMPLETED|Overall Study||26
501772|NCT00280293|1206767|P2|COMPLETED|Overall Study||34
501773|NCT00280293|1206768|P1|COMPLETED|Overall Study||29
501774|NCT00280293|1206767|P2|STARTED|Overall Study||57
501775|NCT00280293|1206768|P1|STARTED|Overall Study||55
501776|NCT00280241|1206780|P1|NOT COMPLETED|Overall Study||10
501777|NCT00280241|1206780|P1|COMPLETED|Overall Study||55
501778|NCT00280241|1206780|P1|STARTED|Overall Study||65
501779|NCT00280059|1206789|P2|NOT COMPLETED|Extension Phase||38
501780|NCT00280059|1206790|P1|NOT COMPLETED|Extension Phase||49
501781|NCT00280059|1206789|P2|COMPLETED|Extension Phase||177
501782|NCT00280059|1206790|P1|COMPLETED|Extension Phase||145
501783|NCT00280059|1206789|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
501870|NCT00279201|1206947|P2|NOT COMPLETED|Initiation||145
501784|NCT00280059|1206790|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
501785|NCT00280059|1206789|P2|NOT COMPLETED|Efficacy Assessment Phase||80
501786|NCT00280059|1206790|P1|NOT COMPLETED|Efficacy Assessment Phase||94
501787|NCT00280059|1206789|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
501788|NCT00280059|1206790|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
501789|NCT00280059|1206789|P2|STARTED|Efficacy Assessment Phase||330
501790|NCT00280059|1206790|P1|STARTED|Efficacy Assessment Phase||330
501791|NCT00279955|1206839|P3|NOT COMPLETED|Overall Study||0
501792|NCT00279955|1206840|P2|NOT COMPLETED|Overall Study||0
501793|NCT00279955|1206841|P1|NOT COMPLETED|Overall Study||0
501794|NCT00279955|1206839|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
501795|NCT00279955|1206840|P2|COMPLETED|Overall Study||486
501796|NCT00279955|1206841|P1|COMPLETED|Overall Study||157
501797|NCT00279955|1206839|P3|STARTED|Overall Study||358
501798|NCT00279955|1206840|P2|STARTED|Overall Study||486
501799|NCT00279955|1206841|P1|STARTED|Overall Study||157
501800|NCT00279916|1206854|P2|NOT COMPLETED|Overall Study||5
501801|NCT00279916|1206855|P1|NOT COMPLETED|Overall Study||7
501802|NCT00279916|1206854|P2|COMPLETED|Overall Study||41
501803|NCT00279916|1206855|P1|COMPLETED|Overall Study||38
501804|NCT00279916|1206854|P2|STARTED|Overall Study||46
501805|NCT00279916|1206855|P1|STARTED|Overall Study||45
501806|NCT00279708|1206877|P2|NOT COMPLETED|Overall Study||4
501807|NCT00279708|1206878|P1|NOT COMPLETED|Overall Study||3
501808|NCT00279708|1206877|P2|COMPLETED|Overall Study||24
501809|NCT00279708|1206878|P1|COMPLETED|Overall Study||24
501810|NCT00279708|1206877|P2|STARTED|Overall Study||28
501811|NCT00279708|1206878|P1|STARTED|Overall Study|"Started meaning randomized"|27
501812|NCT00279591|1206886|P2|NOT COMPLETED|Overall Study||0
501813|NCT00279591|1206887|P1|NOT COMPLETED|Overall Study||0
501814|NCT00279591|1206886|P2|COMPLETED|Overall Study||46
501815|NCT00279591|1206887|P1|COMPLETED|Overall Study||48
501816|NCT00279591|1206886|P2|STARTED|Overall Study||46
501817|NCT00279591|1206887|P1|STARTED|Overall Study||48
501818|NCT00279305|1206903|P2|NOT COMPLETED|Overall Study||1
501819|NCT00279305|1206904|P1|NOT COMPLETED|Overall Study||8
501820|NCT00279305|1206903|P2|COMPLETED|Overall Study||29
501821|NCT00279305|1206904|P1|COMPLETED|Overall Study||49
501822|NCT00279305|1206903|P2|STARTED|Overall Study||30
501823|NCT00279305|1206904|P1|STARTED|Overall Study||57
501824|NCT00279214|1206912|P2|NOT COMPLETED|Overall Study||2
501825|NCT00279214|1206913|P1|NOT COMPLETED|Overall Study||3
501826|NCT00279214|1206912|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
501827|NCT00279214|1206913|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
501828|NCT00279214|1206912|P2|STARTED|Overall Study||21
501829|NCT00279214|1206913|P1|STARTED|Overall Study||22
501830|NCT00279201|1206943|P6|NOT COMPLETED|Intensification Addendum||37
501831|NCT00279201|1206944|P5|NOT COMPLETED|Intensification Addendum||29
501832|NCT00279201|1206945|P4|NOT COMPLETED|Intensification Addendum||28
501833|NCT00279201|1206946|P3|NOT COMPLETED|Intensification Addendum||23
501834|NCT00279201|1206947|P2|NOT COMPLETED|Intensification Addendum||0
501835|NCT00279201|1206948|P1|NOT COMPLETED|Intensification Addendum||0
501836|NCT00279201|1206943|P6|COMPLETED|Intensification Addendum||162
501837|NCT00279201|1206944|P5|COMPLETED|Intensification Addendum||142
501838|NCT00279201|1206945|P4|COMPLETED|Intensification Addendum||172
501839|NCT00279201|1206946|P3|COMPLETED|Intensification Addendum||151
501840|NCT00279201|1206947|P2|COMPLETED|Intensification Addendum||0
501841|NCT00279201|1206948|P1|COMPLETED|Intensification Addendum||0
501842|NCT00279201|1206943|P6|STARTED|Intensification Addendum||199
501843|NCT00279201|1206944|P5|STARTED|Intensification Addendum||171
501844|NCT00279201|1206945|P4|STARTED|Intensification Addendum||200
501845|NCT00279201|1206946|P3|STARTED|Intensification Addendum||174
501846|NCT00279201|1206947|P2|STARTED|Intensification Addendum||0
501847|NCT00279201|1206948|P1|STARTED|Intensification Addendum||0
501848|NCT00279201|1206943|P6|NOT COMPLETED|Maintenance||0
501849|NCT00279201|1206944|P5|NOT COMPLETED|Maintenance||0
501850|NCT00279201|1206945|P4|NOT COMPLETED|Maintenance||0
501851|NCT00279201|1206946|P3|NOT COMPLETED|Maintenance||0
501852|NCT00279201|1206947|P2|NOT COMPLETED|Maintenance||234
501853|NCT00279201|1206948|P1|NOT COMPLETED|Maintenance||231
501854|NCT00279201|1206943|P6|COMPLETED|Maintenance||0
501855|NCT00279201|1206944|P5|COMPLETED|Maintenance||0
501856|NCT00279201|1206945|P4|COMPLETED|Maintenance||0
501857|NCT00279201|1206946|P3|COMPLETED|Maintenance||0
501858|NCT00279201|1206947|P2|COMPLETED|Maintenance||239
501859|NCT00279201|1206948|P1|COMPLETED|Maintenance||188
501860|NCT00279201|1206943|P6|STARTED|Maintenance||0
501861|NCT00279201|1206944|P5|STARTED|Maintenance||0
501862|NCT00279201|1206945|P4|STARTED|Maintenance||0
501863|NCT00279201|1206946|P3|STARTED|Maintenance||0
501864|NCT00279201|1206947|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
501865|NCT00279201|1206948|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
501866|NCT00279201|1206943|P6|NOT COMPLETED|Initiation||0
501867|NCT00279201|1206944|P5|NOT COMPLETED|Initiation||0
501868|NCT00279201|1206945|P4|NOT COMPLETED|Initiation||0
501869|NCT00279201|1206946|P3|NOT COMPLETED|Initiation||0
501871|NCT00279201|1206948|P1|NOT COMPLETED|Initiation||128
501872|NCT00279201|1206943|P6|COMPLETED|Initiation||0
501873|NCT00279201|1206944|P5|COMPLETED|Initiation||0
501874|NCT00279201|1206945|P4|COMPLETED|Initiation||0
501875|NCT00279201|1206946|P3|COMPLETED|Initiation||0
501876|NCT00279201|1206947|P2|COMPLETED|Initiation||900
501877|NCT00279201|1206948|P1|COMPLETED|Initiation||918
501878|NCT00279201|1206943|P6|STARTED|Initiation||0
501879|NCT00279201|1206944|P5|STARTED|Initiation||0
501880|NCT00279201|1206945|P4|STARTED|Initiation||0
501881|NCT00279201|1206946|P3|STARTED|Initiation||0
501882|NCT00279201|1206947|P2|STARTED|Initiation||1045
501883|NCT00279201|1206948|P1|STARTED|Initiation||1046
501884|NCT00278993|1207092|P1|NOT COMPLETED|Overall Study||107
501885|NCT00278993|1207092|P1|COMPLETED|Overall Study||1
501886|NCT00278993|1207092|P1|STARTED|Overall Study||108
501887|NCT00278954|1207100|P1|NOT COMPLETED|Overall Study||5
501888|NCT00278954|1207100|P1|COMPLETED|Overall Study||45
501889|NCT00278954|1207100|P1|STARTED|Overall Study||50
501890|NCT00278915|1207108|P1|NOT COMPLETED|Overall Study||1
501891|NCT00278915|1207108|P1|COMPLETED|Overall Study||29
501892|NCT00278915|1207108|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
501893|NCT00278889|1207144|P3|NOT COMPLETED|Overall Study||20
501894|NCT00278889|1207145|P2|NOT COMPLETED|Overall Study||27
501895|NCT00278889|1207146|P1|NOT COMPLETED|Overall Study||25
501896|NCT00278889|1207144|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
501897|NCT00278889|1207145|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
501898|NCT00278889|1207146|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
501899|NCT00278889|1207144|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
501900|NCT00278889|1207145|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
501901|NCT00278889|1207146|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
501902|NCT00278889|1207144|P3|STARTED|Overall Study|Randomised|68
501903|NCT00278889|1207145|P2|STARTED|Overall Study|Randomised|74
501904|NCT00278889|1207146|P1|STARTED|Overall Study|Randomised|73
501905|NCT00278876|1207172|P1|NOT COMPLETED|Overall Study||9
501906|NCT00278876|1207172|P1|COMPLETED|Overall Study||38
501907|NCT00278876|1207172|P1|STARTED|Overall Study||47
501908|NCT00278863|1207180|P2|NOT COMPLETED|Overall Study||2
501909|NCT00278863|1207181|P1|NOT COMPLETED|Overall Study||5
501910|NCT00278863|1207180|P2|COMPLETED|Overall Study||45
501911|NCT00278863|1207181|P1|COMPLETED|Overall Study||44
501912|NCT00278863|1207180|P2|STARTED|Overall Study||47
501913|NCT00278863|1207181|P1|STARTED|Overall Study||49
501914|NCT00278655|1207189|P1|NOT COMPLETED|Overall Study||0
501915|NCT00278655|1207189|P1|COMPLETED|Overall Study||21
501916|NCT00278655|1207189|P1|STARTED|Overall Study||21
501917|NCT00278525|1207196|P2|NOT COMPLETED|Overall Study||0
501918|NCT00278525|1207197|P1|NOT COMPLETED|Overall Study||0
501919|NCT00278525|1207196|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
501920|NCT00278525|1207197|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
501921|NCT00278525|1207196|P2|STARTED|Overall Study||10
501922|NCT00278525|1207197|P1|STARTED|Overall Study||9
501923|NCT00278473|1207207|P2|NOT COMPLETED|Overall Study||3
501924|NCT00278473|1207208|P1|NOT COMPLETED|Overall Study||4
501925|NCT00278473|1207207|P2|COMPLETED|Overall Study||40
501926|NCT00278473|1207208|P1|COMPLETED|Overall Study||41
501927|NCT00278473|1207207|P2|STARTED|Overall Study||43
501928|NCT00278473|1207208|P1|STARTED|Overall Study||45
501929|NCT00278395|1207224|P1|NOT COMPLETED|Overall Study||3
501930|NCT00278395|1207224|P1|COMPLETED|Overall Study||11
501931|NCT00278395|1207224|P1|STARTED|Overall Study||14
501932|NCT00277524|1207228|P4|NOT COMPLETED|Overall Study||0
501933|NCT00277524|1207229|P3|NOT COMPLETED|Overall Study||0
501934|NCT00277524|1207230|P2|NOT COMPLETED|Overall Study||0
501935|NCT00277524|1207231|P1|NOT COMPLETED|Overall Study||0
501936|NCT00277524|1207228|P4|COMPLETED|Overall Study||850
501937|NCT00277524|1207229|P3|COMPLETED|Overall Study||1088
501938|NCT00277524|1207230|P2|COMPLETED|Overall Study||324
501939|NCT00277524|1207231|P1|COMPLETED|Overall Study||621
501940|NCT00277524|1207228|P4|STARTED|Overall Study||850
501941|NCT00277524|1207229|P3|STARTED|Overall Study||1088
501942|NCT00277524|1207230|P2|STARTED|Overall Study||324
501943|NCT00277524|1207231|P1|STARTED|Overall Study||621
501944|NCT00277446|1207249|P1|NOT COMPLETED|Overall Study||0
501945|NCT00277446|1207249|P1|COMPLETED|Overall Study||13
501946|NCT00277446|1207249|P1|STARTED|Overall Study||13
501947|NCT00277394|1207257|P2|NOT COMPLETED|Overall Study||24
501948|NCT00277394|1207258|P1|NOT COMPLETED|Overall Study||37
501949|NCT00277394|1207257|P2|COMPLETED|Overall Study||246
501950|NCT00277394|1207258|P1|COMPLETED|Overall Study||232
501951|NCT00277394|1207257|P2|STARTED|Overall Study||270
501952|NCT00277394|1207258|P1|STARTED|Overall Study||269
501953|NCT00277355|1207270|P2|NOT COMPLETED|Overall Study||5
501954|NCT00277355|1207271|P1|NOT COMPLETED|Overall Study||14
501955|NCT00277355|1207270|P2|COMPLETED|Overall Study||22
501956|NCT00277355|1207271|P1|COMPLETED|Overall Study||73
501957|NCT00277355|1207270|P2|STARTED|Overall Study||27
501958|NCT00277355|1207271|P1|STARTED|Overall Study||87
501959|NCT00277212|1207279|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
501960|NCT00277212|1207280|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
501961|NCT00277212|1207281|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
501962|NCT00277212|1207279|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
501963|NCT00277212|1207280|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
501964|NCT00277212|1207281|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
501965|NCT00277212|1207279|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
501966|NCT00277212|1207280|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
501967|NCT00277212|1207281|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
501968|NCT00277212|1207279|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
501969|NCT00277212|1207280|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
501970|NCT00277212|1207281|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
501971|NCT00277212|1207279|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
501972|NCT00277212|1207280|P2|STARTED|Phase 2 - Double-Blind Treatment||173
501973|NCT00277212|1207281|P1|STARTED|Phase 2 - Double-Blind Treatment||0
501974|NCT00277212|1207279|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
501975|NCT00277212|1207280|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
501976|NCT00277212|1207281|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
501977|NCT00277212|1207279|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
501978|NCT00277212|1207280|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
501979|NCT00277212|1207281|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
501980|NCT00277212|1207279|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
501981|NCT00277212|1207280|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
501982|NCT00277212|1207281|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
501983|NCT00277212|1207279|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
501984|NCT00277212|1207280|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
501985|NCT00277212|1207281|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
501986|NCT00277212|1207279|P3|STARTED|Phase 1 - Single-Blind Treatment||0
501987|NCT00277212|1207280|P2|STARTED|Phase 1 - Single-Blind Treatment||0
501988|NCT00277212|1207281|P1|STARTED|Phase 1 - Single-Blind Treatment||787
501989|NCT00277095|1207319|P1|NOT COMPLETED|Overall Study||21
501990|NCT00277095|1207319|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
501991|NCT00277095|1207319|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
501992|NCT00276861|1207323|P1|NOT COMPLETED|Overall Study||0
501993|NCT00276861|1207323|P1|COMPLETED|Overall Study||10
501994|NCT00276861|1207323|P1|STARTED|Overall Study||10
501995|NCT00276614|1207328|P1|NOT COMPLETED|Overall Study||3
501996|NCT00276614|1207328|P1|COMPLETED|Overall Study||1
501997|NCT00276614|1207328|P1|STARTED|Overall Study||4
501998|NCT00276549|1207332|P1|NOT COMPLETED|Overall Study||0
501999|NCT00276549|1207332|P1|COMPLETED|Overall Study||35
502000|NCT00276549|1207332|P1|STARTED|Overall Study||35
502001|NCT00276484|1207339|P2|NOT COMPLETED|Overall Study||13
502002|NCT00276484|1207340|P1|NOT COMPLETED|Overall Study||9
502003|NCT00276484|1207339|P2|COMPLETED|Overall Study||278
502004|NCT00276484|1207340|P1|COMPLETED|Overall Study||279
502005|NCT00276484|1207339|P2|STARTED|Overall Study||291
502006|NCT00276484|1207340|P1|STARTED|Overall Study||288
502007|NCT00276458|1207372|P2|NOT COMPLETED|Overall Study||7
502008|NCT00276458|1207373|P1|NOT COMPLETED|Overall Study||6
502009|NCT00276458|1207372|P2|COMPLETED|Overall Study||91
502010|NCT00276458|1207373|P1|COMPLETED|Overall Study||92
502011|NCT00276458|1207372|P2|STARTED|Overall Study||98
502012|NCT00276458|1207373|P1|STARTED|Overall Study||98
502013|NCT00276419|1207407|P2|NOT COMPLETED|Second Intervention||0
502014|NCT00276419|1207408|P1|NOT COMPLETED|Second Intervention||0
502015|NCT00276419|1207407|P2|COMPLETED|Second Intervention||8
502016|NCT00276419|1207408|P1|COMPLETED|Second Intervention||7
502017|NCT00276419|1207407|P2|STARTED|Second Intervention||8
502018|NCT00276419|1207408|P1|STARTED|Second Intervention||7
502019|NCT00276419|1207407|P2|NOT COMPLETED|Wash-out Phase||0
502020|NCT00276419|1207408|P1|NOT COMPLETED|Wash-out Phase||0
502021|NCT00276419|1207407|P2|COMPLETED|Wash-out Phase||8
502022|NCT00276419|1207408|P1|COMPLETED|Wash-out Phase||7
502023|NCT00276419|1207407|P2|STARTED|Wash-out Phase||8
502024|NCT00276419|1207408|P1|STARTED|Wash-out Phase||7
502025|NCT00276419|1207407|P2|NOT COMPLETED|First Intervention||2
502026|NCT00276419|1207408|P1|NOT COMPLETED|First Intervention||1
502027|NCT00276419|1207407|P2|COMPLETED|First Intervention||8
502028|NCT00276419|1207408|P1|COMPLETED|First Intervention||7
502029|NCT00276419|1207407|P2|STARTED|First Intervention||10
502030|NCT00276419|1207408|P1|STARTED|First Intervention||8
502031|NCT00276406|1207420|P2|NOT COMPLETED|Overall Study||0
502032|NCT00276406|1207421|P1|NOT COMPLETED|Overall Study||0
502033|NCT00276406|1207420|P2|COMPLETED|Overall Study||14
502034|NCT00276406|1207421|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
502035|NCT00276406|1207420|P2|STARTED|Overall Study||14
502036|NCT00276406|1207421|P1|STARTED|Overall Study||16
502037|NCT00276250|1207452|P3|NOT COMPLETED|Overall Study||0
502038|NCT00276250|1207453|P2|NOT COMPLETED|Overall Study||0
502039|NCT00276250|1207454|P1|NOT COMPLETED|Overall Study||0
502040|NCT00276250|1207452|P3|COMPLETED|Overall Study||0
502041|NCT00276250|1207453|P2|COMPLETED|Overall Study||1
502042|NCT00276250|1207454|P1|COMPLETED|Overall Study||4
502043|NCT00276250|1207452|P3|STARTED|Overall Study||0
502044|NCT00276250|1207453|P2|STARTED|Overall Study||1
502045|NCT00276250|1207454|P1|STARTED|Overall Study||4
502046|NCT00276159|1207486|P1|NOT COMPLETED|Overall Study||6
502047|NCT00276159|1207486|P1|COMPLETED|Overall Study||0
502048|NCT00276159|1207486|P1|STARTED|Overall Study||6
502049|NCT00276094|1207496|P3|NOT COMPLETED|Overall Study||38
502050|NCT00276094|1207497|P2|NOT COMPLETED|Overall Study||42
502051|NCT00276094|1207498|P1|NOT COMPLETED|Overall Study||57
502052|NCT00276094|1207496|P3|COMPLETED|Overall Study||230
502053|NCT00276094|1207497|P2|COMPLETED|Overall Study||234
502054|NCT00276094|1207498|P1|COMPLETED|Overall Study||225
502055|NCT00276094|1207496|P3|STARTED|Overall Study||268
502056|NCT00276094|1207497|P2|STARTED|Overall Study||276
502057|NCT00276094|1207498|P1|STARTED|Overall Study||282
502058|NCT00276016|1207551|P6|NOT COMPLETED|Intervention 3||0
502059|NCT00276016|1207552|P5|NOT COMPLETED|Intervention 3||0
502060|NCT00276016|1207553|P4|NOT COMPLETED|Intervention 3||0
502061|NCT00276016|1207554|P3|NOT COMPLETED|Intervention 3||0
502062|NCT00276016|1207555|P2|NOT COMPLETED|Intervention 3||0
502063|NCT00276016|1207556|P1|NOT COMPLETED|Intervention 3||0
502064|NCT00276016|1207551|P6|COMPLETED|Intervention 3||6
502065|NCT00276016|1207552|P5|COMPLETED|Intervention 3||6
502066|NCT00276016|1207553|P4|COMPLETED|Intervention 3||6
502067|NCT00276016|1207554|P3|COMPLETED|Intervention 3||7
502068|NCT00276016|1207555|P2|COMPLETED|Intervention 3||6
502069|NCT00276016|1207556|P1|COMPLETED|Intervention 3||7
502070|NCT00276016|1207551|P6|STARTED|Intervention 3||6
502071|NCT00276016|1207552|P5|STARTED|Intervention 3||6
502072|NCT00276016|1207553|P4|STARTED|Intervention 3||6
502073|NCT00276016|1207554|P3|STARTED|Intervention 3||7
502074|NCT00276016|1207555|P2|STARTED|Intervention 3||6
502075|NCT00276016|1207556|P1|STARTED|Intervention 3||7
502076|NCT00276016|1207551|P6|NOT COMPLETED|Wash Out 2||0
502077|NCT00276016|1207552|P5|NOT COMPLETED|Wash Out 2||0
502078|NCT00276016|1207553|P4|NOT COMPLETED|Wash Out 2||0
502079|NCT00276016|1207554|P3|NOT COMPLETED|Wash Out 2||0
502080|NCT00276016|1207555|P2|NOT COMPLETED|Wash Out 2||0
502081|NCT00276016|1207556|P1|NOT COMPLETED|Wash Out 2||0
502082|NCT00276016|1207551|P6|COMPLETED|Wash Out 2||6
502083|NCT00276016|1207552|P5|COMPLETED|Wash Out 2||6
502084|NCT00276016|1207553|P4|COMPLETED|Wash Out 2||6
502085|NCT00276016|1207554|P3|COMPLETED|Wash Out 2||7
502086|NCT00276016|1207555|P2|COMPLETED|Wash Out 2||6
502087|NCT00276016|1207556|P1|COMPLETED|Wash Out 2||7
502088|NCT00276016|1207551|P6|STARTED|Wash Out 2||6
502089|NCT00276016|1207552|P5|STARTED|Wash Out 2||6
502090|NCT00276016|1207553|P4|STARTED|Wash Out 2||6
502091|NCT00276016|1207554|P3|STARTED|Wash Out 2||7
502092|NCT00276016|1207555|P2|STARTED|Wash Out 2||6
502093|NCT00276016|1207556|P1|STARTED|Wash Out 2||7
502094|NCT00276016|1207551|P6|NOT COMPLETED|Intervention 2||0
502095|NCT00276016|1207552|P5|NOT COMPLETED|Intervention 2||0
502096|NCT00276016|1207553|P4|NOT COMPLETED|Intervention 2||0
502097|NCT00276016|1207554|P3|NOT COMPLETED|Intervention 2||0
502098|NCT00276016|1207555|P2|NOT COMPLETED|Intervention 2||0
502099|NCT00276016|1207556|P1|NOT COMPLETED|Intervention 2||0
502100|NCT00276016|1207551|P6|COMPLETED|Intervention 2||6
502101|NCT00276016|1207552|P5|COMPLETED|Intervention 2||6
502102|NCT00276016|1207553|P4|COMPLETED|Intervention 2||6
502103|NCT00276016|1207554|P3|COMPLETED|Intervention 2||7
502104|NCT00276016|1207555|P2|COMPLETED|Intervention 2||6
502105|NCT00276016|1207556|P1|COMPLETED|Intervention 2||7
502106|NCT00276016|1207551|P6|STARTED|Intervention 2||6
502107|NCT00276016|1207552|P5|STARTED|Intervention 2||6
502108|NCT00276016|1207553|P4|STARTED|Intervention 2||6
502109|NCT00276016|1207554|P3|STARTED|Intervention 2||7
502110|NCT00276016|1207555|P2|STARTED|Intervention 2||6
502111|NCT00276016|1207556|P1|STARTED|Intervention 2||7
502112|NCT00276016|1207551|P6|NOT COMPLETED|Wash Out 1||0
502113|NCT00276016|1207552|P5|NOT COMPLETED|Wash Out 1||0
502114|NCT00276016|1207553|P4|NOT COMPLETED|Wash Out 1||0
502115|NCT00276016|1207554|P3|NOT COMPLETED|Wash Out 1||0
502116|NCT00276016|1207555|P2|NOT COMPLETED|Wash Out 1||0
502117|NCT00276016|1207556|P1|NOT COMPLETED|Wash Out 1||0
502118|NCT00276016|1207551|P6|COMPLETED|Wash Out 1||6
502119|NCT00276016|1207552|P5|COMPLETED|Wash Out 1||6
502120|NCT00276016|1207553|P4|COMPLETED|Wash Out 1||6
502121|NCT00276016|1207554|P3|COMPLETED|Wash Out 1||7
502122|NCT00276016|1207555|P2|COMPLETED|Wash Out 1||6
502123|NCT00276016|1207556|P1|COMPLETED|Wash Out 1||7
502124|NCT00276016|1207551|P6|STARTED|Wash Out 1||6
502125|NCT00276016|1207552|P5|STARTED|Wash Out 1||6
502126|NCT00276016|1207553|P4|STARTED|Wash Out 1||6
502127|NCT00276016|1207554|P3|STARTED|Wash Out 1||7
502128|NCT00276016|1207555|P2|STARTED|Wash Out 1||6
502129|NCT00276016|1207556|P1|STARTED|Wash Out 1||7
502130|NCT00276016|1207551|P6|NOT COMPLETED|Intervention 1||0
502131|NCT00276016|1207552|P5|NOT COMPLETED|Intervention 1||0
502132|NCT00276016|1207553|P4|NOT COMPLETED|Intervention 1||0
502133|NCT00276016|1207554|P3|NOT COMPLETED|Intervention 1||0
502134|NCT00276016|1207555|P2|NOT COMPLETED|Intervention 1||1
502135|NCT00276016|1207556|P1|NOT COMPLETED|Intervention 1||0
502136|NCT00276016|1207551|P6|COMPLETED|Intervention 1||6
502137|NCT00276016|1207552|P5|COMPLETED|Intervention 1||6
502138|NCT00276016|1207553|P4|COMPLETED|Intervention 1||6
502139|NCT00276016|1207554|P3|COMPLETED|Intervention 1||7
502140|NCT00276016|1207555|P2|COMPLETED|Intervention 1||6
502141|NCT00276016|1207556|P1|COMPLETED|Intervention 1||7
502142|NCT00276016|1207551|P6|STARTED|Intervention 1||6
502143|NCT00276016|1207552|P5|STARTED|Intervention 1||6
502144|NCT00276016|1207553|P4|STARTED|Intervention 1||6
502145|NCT00276016|1207554|P3|STARTED|Intervention 1||7
502146|NCT00276016|1207555|P2|STARTED|Intervention 1||7
502147|NCT00276016|1207556|P1|STARTED|Intervention 1||7
502148|NCT00275834|1207568|P3|NOT COMPLETED|Overall Study||1
502149|NCT00275834|1207569|P2|NOT COMPLETED|Overall Study||3
502150|NCT00275834|1207570|P1|NOT COMPLETED|Overall Study||3
502151|NCT00275834|1207568|P3|COMPLETED|Overall Study||74
502152|NCT00275834|1207569|P2|COMPLETED|Overall Study||73
502153|NCT00275834|1207570|P1|COMPLETED|Overall Study||71
502154|NCT00275834|1207568|P3|Completed Study While on Study Drug|Overall Study||62
502155|NCT00275834|1207569|P2|Completed Study While on Study Drug|Overall Study||51
502156|NCT00275834|1207570|P1|Completed Study While on Study Drug|Overall Study||54
502157|NCT00275834|1207568|P3|STARTED|Overall Study||75
502158|NCT00275834|1207569|P2|STARTED|Overall Study||76
502159|NCT00275834|1207570|P1|STARTED|Overall Study||74
502160|NCT00275821|1207602|P3|NOT COMPLETED|Overall Study||12
502161|NCT00275821|1207603|P2|NOT COMPLETED|Overall Study||23
502162|NCT00275821|1207604|P1|NOT COMPLETED|Overall Study||14
502163|NCT00275821|1207602|P3|COMPLETED|Overall Study||103
502164|NCT00275821|1207603|P2|COMPLETED|Overall Study||95
502165|NCT00275821|1207604|P1|COMPLETED|Overall Study||106
502166|NCT00275821|1207602|P3|STARTED|Overall Study||115
502167|NCT00275821|1207603|P2|STARTED|Overall Study||118
502168|NCT00275821|1207604|P1|STARTED|Overall Study||120
502169|NCT00275561|1207623|P2|NOT COMPLETED|Overall Study||6
502170|NCT00275561|1207624|P1|NOT COMPLETED|Overall Study||2
502171|NCT00275561|1207623|P2|COMPLETED|Overall Study||15
502172|NCT00275561|1207624|P1|COMPLETED|Overall Study||19
502173|NCT00275561|1207623|P2|STARTED|Overall Study||21
502174|NCT00275561|1207624|P1|STARTED|Overall Study||21
502175|NCT00275392|1207636|P2|NOT COMPLETED|Overall Study||2
502176|NCT00275392|1207637|P1|NOT COMPLETED|Overall Study||0
502177|NCT00275392|1207636|P2|COMPLETED|Overall Study||17
502178|NCT00275392|1207637|P1|COMPLETED|Overall Study||20
502179|NCT00275392|1207636|P2|STARTED|Overall Study||19
502180|NCT00275392|1207637|P1|STARTED|Overall Study||20
502181|NCT00275340|1207647|P2|NOT COMPLETED|Overall Study||4
502182|NCT00275340|1207648|P1|NOT COMPLETED|Overall Study||2
502183|NCT00275340|1207647|P2|COMPLETED|Overall Study||45
502184|NCT00275340|1207648|P1|COMPLETED|Overall Study||50
502185|NCT00275340|1207647|P2|STARTED|Overall Study||49
502186|NCT00275340|1207648|P1|STARTED|Overall Study||52
502187|NCT00275301|1207652|P1|NOT COMPLETED|Overall Study||5
502188|NCT00275301|1207652|P1|COMPLETED|Overall Study||14
502189|NCT00275301|1207652|P1|STARTED|Overall Study||19
502190|NCT00275275|1207659|P3|NOT COMPLETED|Overall Study||6
502191|NCT00275275|1207660|P2|NOT COMPLETED|Overall Study||2
502192|NCT00275275|1207661|P1|NOT COMPLETED|Overall Study||6
502193|NCT00275275|1207659|P3|COMPLETED|Overall Study||15
502194|NCT00275275|1207660|P2|COMPLETED|Overall Study||18
502195|NCT00275275|1207661|P1|COMPLETED|Overall Study||14
502196|NCT00275275|1207659|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
502197|NCT00275275|1207660|P2|STARTED|Overall Study||20
502198|NCT00275275|1207661|P1|STARTED|Overall Study||20
502199|NCT00275262|1207671|P2|NOT COMPLETED|Overall Study||9
502200|NCT00275262|1207672|P1|NOT COMPLETED|Overall Study||6
502201|NCT00275262|1207671|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
502202|NCT00275262|1207672|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
502203|NCT00275262|1207671|P2|STARTED|Overall Study||13
502204|NCT00275262|1207672|P1|STARTED|Overall Study||12
502205|NCT00275028|1207686|P1|NOT COMPLETED|Overall Study||47
502206|NCT00275028|1207686|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
502207|NCT00275028|1207686|P1|STARTED|Overall Study||47
502208|NCT00275002|1207693|P2|NOT COMPLETED|Overall Study||16
502209|NCT00275002|1207694|P1|NOT COMPLETED|Overall Study||22
502210|NCT00275002|1207693|P2|COMPLETED|Overall Study||0
502211|NCT00275002|1207694|P1|COMPLETED|Overall Study||3
502212|NCT00275002|1207693|P2|STARTED|Overall Study||16
502213|NCT00275002|1207694|P1|STARTED|Overall Study||25
502214|NCT00274937|1207702|P1|NOT COMPLETED|Overall Study||20
502215|NCT00274937|1207702|P1|COMPLETED|Overall Study||91
502216|NCT00274937|1207702|P1|STARTED|Overall Study||111
502217|NCT00274924|1207712|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
502218|NCT00274924|1207713|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
502219|NCT00274924|1207714|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
502220|NCT00274924|1207712|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
502221|NCT00274924|1207713|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
502222|NCT00274924|1207714|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
502223|NCT00274924|1207712|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
502224|NCT00274924|1207713|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
502225|NCT00274924|1207714|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
502226|NCT00274924|1207712|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
502316|NCT00274625|1207874|P1|COMPLETED|Overall Study||139
502227|NCT00274924|1207713|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
502228|NCT00274924|1207714|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
502229|NCT00274924|1207712|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
502230|NCT00274924|1207713|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
502231|NCT00274924|1207714|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
502232|NCT00274924|1207712|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
502233|NCT00274924|1207713|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
502234|NCT00274924|1207714|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
502235|NCT00274924|1207712|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
502236|NCT00274924|1207713|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
502237|NCT00274924|1207714|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
502238|NCT00274924|1207712|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
502239|NCT00274924|1207713|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
502240|NCT00274924|1207714|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
502241|NCT00274924|1207712|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
502242|NCT00274924|1207713|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
502243|NCT00274924|1207714|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
502244|NCT00274846|1207723|P1|NOT COMPLETED|Overall Study||1
502245|NCT00274846|1207723|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
502246|NCT00274846|1207723|P1|STARTED|Overall Study||21
502247|NCT00274781|1207731|P1|NOT COMPLETED|Overall Study||0
502248|NCT00274781|1207731|P1|COMPLETED|Overall Study||30
502249|NCT00274781|1207731|P1|STARTED|Overall Study||30
502250|NCT00274768|1207737|P1|NOT COMPLETED|Overall Study||0
502251|NCT00274768|1207737|P1|COMPLETED|Overall Study||26
502252|NCT00274768|1207737|P1|STARTED|Overall Study||26
502253|NCT00274742|1207747|P6|NOT COMPLETED|Overall Study||3
502254|NCT00274742|1207748|P5|NOT COMPLETED|Overall Study||16
502255|NCT00274742|1207749|P4|NOT COMPLETED|Overall Study||5
502256|NCT00274742|1207750|P3|NOT COMPLETED|Overall Study||2
502257|NCT00274742|1207751|P2|NOT COMPLETED|Overall Study||8
502258|NCT00274742|1207752|P1|NOT COMPLETED|Overall Study||0
502259|NCT00274742|1207747|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
502260|NCT00274742|1207748|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
502261|NCT00274742|1207749|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
502262|NCT00274742|1207750|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
502263|NCT00274742|1207751|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
502264|NCT00274742|1207752|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
502265|NCT00274742|1207747|P6|STARTED|Overall Study||4
502266|NCT00274742|1207748|P5|STARTED|Overall Study||32
502267|NCT00274742|1207749|P4|STARTED|Overall Study||9
502268|NCT00274742|1207750|P3|STARTED|Overall Study||6
502269|NCT00274742|1207751|P2|STARTED|Overall Study||13
502270|NCT00274742|1207752|P1|STARTED|Overall Study||12
502271|NCT00274716|1207790|P6|NOT COMPLETED|Phase B||1
502272|NCT00274716|1207791|P5|NOT COMPLETED|Phase B||0
502273|NCT00274716|1207792|P4|NOT COMPLETED|Phase B||1
502274|NCT00274716|1207793|P3|NOT COMPLETED|Phase B||3
502275|NCT00274716|1207794|P2|NOT COMPLETED|Phase B||4
502276|NCT00274716|1207795|P1|NOT COMPLETED|Phase B||1
502277|NCT00274716|1207790|P6|COMPLETED|Phase B||14
502278|NCT00274716|1207791|P5|COMPLETED|Phase B||16
502279|NCT00274716|1207792|P4|COMPLETED|Phase B||41
502280|NCT00274716|1207793|P3|COMPLETED|Phase B||41
502281|NCT00274716|1207794|P2|COMPLETED|Phase B||40
502282|NCT00274716|1207795|P1|COMPLETED|Phase B||42
502283|NCT00274716|1207790|P6|STARTED|Phase B||15
502284|NCT00274716|1207791|P5|STARTED|Phase B||16
502285|NCT00274716|1207792|P4|STARTED|Phase B||42
502286|NCT00274716|1207793|P3|STARTED|Phase B||44
502287|NCT00274716|1207794|P2|STARTED|Phase B||44
502288|NCT00274716|1207795|P1|STARTED|Phase B||43
502289|NCT00274716|1207790|P6|NOT COMPLETED|Phase A||4
502290|NCT00274716|1207791|P5|NOT COMPLETED|Phase A||3
502291|NCT00274716|1207792|P4|NOT COMPLETED|Phase A||9
502292|NCT00274716|1207793|P3|NOT COMPLETED|Phase A||8
502293|NCT00274716|1207794|P2|NOT COMPLETED|Phase A||10
502294|NCT00274716|1207795|P1|NOT COMPLETED|Phase A||11
502295|NCT00274716|1207790|P6|COMPLETED|Phase A||15
502296|NCT00274716|1207791|P5|COMPLETED|Phase A||16
502297|NCT00274716|1207792|P4|COMPLETED|Phase A||42
502298|NCT00274716|1207793|P3|COMPLETED|Phase A||44
502299|NCT00274716|1207794|P2|COMPLETED|Phase A||44
502300|NCT00274716|1207795|P1|COMPLETED|Phase A||43
502301|NCT00274716|1207790|P6|STARTED|Phase A||19
502302|NCT00274716|1207791|P5|STARTED|Phase A||19
502303|NCT00274716|1207792|P4|STARTED|Phase A||51
502304|NCT00274716|1207793|P3|STARTED|Phase A||52
502305|NCT00274716|1207794|P2|STARTED|Phase A||54
502306|NCT00274716|1207795|P1|STARTED|Phase A||54
502307|NCT00274651|1207857|P2|NOT COMPLETED|Overall Study||20
502308|NCT00274651|1207858|P1|NOT COMPLETED|Overall Study||28
502309|NCT00274651|1207857|P2|COMPLETED|Overall Study||4
502310|NCT00274651|1207858|P1|COMPLETED|Overall Study||1
502311|NCT00274651|1207857|P2|STARTED|Overall Study||24
502312|NCT00274651|1207858|P1|STARTED|Overall Study||29
502313|NCT00274625|1207873|P2|NOT COMPLETED|Overall Study||62
502314|NCT00274625|1207874|P1|NOT COMPLETED|Overall Study||60
502315|NCT00274625|1207873|P2|COMPLETED|Overall Study||141
502317|NCT00274625|1207873|P2|STARTED|Overall Study||203
502318|NCT00274625|1207874|P1|STARTED|Overall Study||199
502319|NCT00274469|1207882|P2|NOT COMPLETED|Overall Study||50
502320|NCT00274469|1207883|P1|NOT COMPLETED|Overall Study||38
502321|NCT00274469|1207882|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
502322|NCT00274469|1207883|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
502323|NCT00274469|1207882|P2|STARTED|Overall Study|Number of patients randomized|103
502324|NCT00274469|1207883|P1|STARTED|Overall Study|Number of patients randomized|102
502325|NCT00274456|1207901|P4|NOT COMPLETED|Overall Study||45
502326|NCT00274456|1207902|P3|NOT COMPLETED|Overall Study||35
502327|NCT00274456|1207903|P2|NOT COMPLETED|Overall Study||27
502328|NCT00274456|1207904|P1|NOT COMPLETED|Overall Study||37
502329|NCT00274456|1207901|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
502330|NCT00274456|1207902|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
502331|NCT00274456|1207903|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
502332|NCT00274456|1207904|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
502333|NCT00274456|1207901|P4|At Least One Response Assessment|Overall Study||70
502334|NCT00274456|1207902|P3|At Least One Response Assessment|Overall Study||73
502335|NCT00274456|1207903|P2|At Least One Response Assessment|Overall Study||76
502336|NCT00274456|1207904|P1|At Least One Response Assessment|Overall Study||73
502337|NCT00274456|1207901|P4|STARTED|Overall Study||74
502338|NCT00274456|1207902|P3|STARTED|Overall Study||74
502339|NCT00274456|1207903|P2|STARTED|Overall Study||76
502340|NCT00274456|1207904|P1|STARTED|Overall Study||76
502341|NCT00274287|1207946|P1|NOT COMPLETED|Overall Study||2
502342|NCT00274287|1207946|P1|COMPLETED|Overall Study||13
502343|NCT00274287|1207946|P1|STARTED|Overall Study||15
502344|NCT00274261|1207952|P2|NOT COMPLETED|Overall Study||337
502345|NCT00274261|1207953|P1|NOT COMPLETED|Overall Study||489
502346|NCT00274261|1207952|P2|COMPLETED|Overall Study||296
502347|NCT00274261|1207953|P1|COMPLETED|Overall Study||443
502348|NCT00274261|1207952|P2|STARTED|Overall Study||633
502349|NCT00274261|1207953|P1|STARTED|Overall Study||932
502350|NCT00273910|1207965|P6|NOT COMPLETED|Overall Study||0
502351|NCT00273910|1207966|P5|NOT COMPLETED|Overall Study||0
502352|NCT00273910|1207967|P4|NOT COMPLETED|Overall Study||0
502353|NCT00273910|1207968|P3|NOT COMPLETED|Overall Study||0
502354|NCT00273910|1207969|P2|NOT COMPLETED|Overall Study||0
502355|NCT00273910|1207970|P1|NOT COMPLETED|Overall Study||0
502356|NCT00273910|1207965|P6|COMPLETED|Overall Study||14
502357|NCT00273910|1207966|P5|COMPLETED|Overall Study||15
502358|NCT00273910|1207967|P4|COMPLETED|Overall Study||19
502359|NCT00273910|1207968|P3|COMPLETED|Overall Study||18
502360|NCT00273910|1207969|P2|COMPLETED|Overall Study||19
502361|NCT00273910|1207970|P1|COMPLETED|Overall Study||19
502362|NCT00273910|1207965|P6|STARTED|Overall Study||14
502363|NCT00273910|1207966|P5|STARTED|Overall Study||15
502364|NCT00273910|1207967|P4|STARTED|Overall Study||19
502365|NCT00273910|1207968|P3|STARTED|Overall Study||18
502366|NCT00273910|1207969|P2|STARTED|Overall Study||19
502367|NCT00273910|1207970|P1|STARTED|Overall Study||19
502368|NCT00273858|1207990|P1|NOT COMPLETED|Overall Study||537
502369|NCT00273858|1207990|P1|COMPLETED|Overall Study||343
502370|NCT00273858|1207990|P1|STARTED|Overall Study||880
502371|NCT00273793|1208005|P6|NOT COMPLETED|Overall Study||0
502372|NCT00273793|1208006|P5|NOT COMPLETED|Overall Study||0
502373|NCT00273793|1208007|P4|NOT COMPLETED|Overall Study||0
502374|NCT00273793|1208008|P3|NOT COMPLETED|Overall Study||0
502375|NCT00273793|1208009|P2|NOT COMPLETED|Overall Study||0
502376|NCT00273793|1208010|P1|NOT COMPLETED|Overall Study||0
502377|NCT00273793|1208005|P6|COMPLETED|Overall Study||29
502378|NCT00273793|1208006|P5|COMPLETED|Overall Study||58
502379|NCT00273793|1208007|P4|COMPLETED|Overall Study||60
502380|NCT00273793|1208008|P3|COMPLETED|Overall Study||18
502381|NCT00273793|1208009|P2|COMPLETED|Overall Study||38
502382|NCT00273793|1208010|P1|COMPLETED|Overall Study||36
502383|NCT00273793|1208005|P6|STARTED|Overall Study||29
502384|NCT00273793|1208006|P5|STARTED|Overall Study||58
502385|NCT00273793|1208007|P4|STARTED|Overall Study||60
502386|NCT00273793|1208008|P3|STARTED|Overall Study||18
502387|NCT00273793|1208009|P2|STARTED|Overall Study||38
502388|NCT00273793|1208010|P1|STARTED|Overall Study||36
502389|NCT00273754|1208032|P2|NOT COMPLETED|Overall Study||0
502390|NCT00273754|1208033|P1|NOT COMPLETED|Overall Study||0
502391|NCT00273754|1208032|P2|COMPLETED|Overall Study||36
502392|NCT00273754|1208033|P1|COMPLETED|Overall Study||36
502393|NCT00273754|1208032|P2|STARTED|Overall Study||36
502394|NCT00273754|1208033|P1|STARTED|Overall Study||36
502395|NCT00273182|1208049|P1|NOT COMPLETED|Overall Study||985
502396|NCT00273182|1208049|P1|COMPLETED|Overall Study||1014
502397|NCT00273182|1208049|P1|STARTED|Overall Study||1999
502398|NCT00273052|1208059|P2|NOT COMPLETED|Overall Study||88
502399|NCT00273052|1208060|P1|NOT COMPLETED|Overall Study||69
502400|NCT00273052|1208059|P2|COMPLETED|Overall Study||190
502401|NCT00273052|1208060|P1|COMPLETED|Overall Study||221
502402|NCT00273052|1208059|P2|STARTED|Overall Study||278
502403|NCT00273052|1208060|P1|STARTED|Overall Study||290
502404|NCT00272987|1208095|P3|NOT COMPLETED|Overall Study||19
502405|NCT00272987|1208096|P2|NOT COMPLETED|Overall Study||14
502406|NCT00272987|1208097|P1|NOT COMPLETED|Overall Study||21
502407|NCT00272987|1208095|P3|COMPLETED|Overall Study||1
502408|NCT00272987|1208096|P2|COMPLETED|Overall Study||0
502409|NCT00272987|1208097|P1|COMPLETED|Overall Study||8
502410|NCT00272987|1208095|P3|Ongoing|Overall Study||15
502411|NCT00272987|1208096|P2|Ongoing|Overall Study||14
502412|NCT00272987|1208097|P1|Ongoing|Overall Study||20
502413|NCT00272987|1208095|P3|STARTED|Overall Study||20
502414|NCT00272987|1208096|P2|STARTED|Overall Study||14
502415|NCT00272987|1208097|P1|STARTED|Overall Study||29
502416|NCT00272961|1208161|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
502417|NCT00272961|1208162|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
502418|NCT00272961|1208163|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
502419|NCT00272961|1208164|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
502420|NCT00272961|1208165|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
502421|NCT00272961|1208161|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
502422|NCT00272961|1208162|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
502423|NCT00272961|1208163|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
502424|NCT00272961|1208164|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
502425|NCT00272961|1208165|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
502426|NCT00272961|1208161|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
502427|NCT00272961|1208162|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
502428|NCT00272961|1208163|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
502429|NCT00272961|1208164|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
502430|NCT00272961|1208165|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
502431|NCT00272961|1208161|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502432|NCT00272961|1208162|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502433|NCT00272961|1208163|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502434|NCT00272961|1208164|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502435|NCT00272961|1208165|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
502436|NCT00272961|1208161|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502437|NCT00272961|1208162|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502438|NCT00272961|1208163|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502439|NCT00272961|1208164|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
502440|NCT00272961|1208165|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
502441|NCT00272961|1208161|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
502442|NCT00272961|1208162|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
502443|NCT00272961|1208163|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
502444|NCT00272961|1208164|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
502445|NCT00272961|1208165|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
502446|NCT00272792|1208224|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
502447|NCT00272792|1208225|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
502448|NCT00272792|1208224|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
502449|NCT00272792|1208225|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
502450|NCT00272792|1208224|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
502451|NCT00272792|1208225|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
502452|NCT00272792|1208224|P2|NOT COMPLETED|Part 1: Responsiveness||0
502453|NCT00272792|1208225|P1|NOT COMPLETED|Part 1: Responsiveness||1
502454|NCT00272792|1208224|P2|COMPLETED|Part 1: Responsiveness||0
502455|NCT00272792|1208225|P1|COMPLETED|Part 1: Responsiveness||89
502456|NCT00272792|1208224|P2|STARTED|Part 1: Responsiveness||0
502457|NCT00272792|1208225|P1|STARTED|Part 1: Responsiveness||90
502458|NCT00272779|1208235|P2|NOT COMPLETED|Baseline Through Week 96||136
502459|NCT00272779|1208236|P1|NOT COMPLETED|Baseline Through Week 96||139
502460|NCT00272779|1208235|P2|COMPLETED|Baseline Through Week 96||307
502461|NCT00272779|1208236|P1|COMPLETED|Baseline Through Week 96||301
502462|NCT00272779|1208235|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
502463|NCT00272779|1208236|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
502464|NCT00272779|1208235|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
502465|NCT00272779|1208236|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
502466|NCT00272779|1208235|P2|NOT COMPLETED|Baseline Through Week 48||443
502467|NCT00272779|1208236|P1|NOT COMPLETED|Baseline Through Week 48||440
502468|NCT00272779|1208235|P2|COMPLETED|Baseline Through Week 48||0
502469|NCT00272779|1208236|P1|COMPLETED|Baseline Through Week 48||0
502470|NCT00272779|1208235|P2|STILL ON TREATMENT|Baseline Through Week 48||368
502471|NCT00272779|1208236|P1|STILL ON TREATMENT|Baseline Through Week 48||385
502472|NCT00272779|1208235|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
502473|NCT00272779|1208236|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
502474|NCT00272779|1208235|P2|Discontinued Before Week 48|Baseline Through Week 48||58
502475|NCT00272779|1208236|P1|Discontinued Before Week 48|Baseline Through Week 48||39
502476|NCT00272779|1208235|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
502477|NCT00272779|1208236|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
502478|NCT00272779|1208235|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
502479|NCT00272779|1208236|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
502480|NCT00272779|1208235|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
502481|NCT00272779|1208236|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
502482|NCT00272337|1208420|P5|NOT COMPLETED|Overall Study||0
502483|NCT00272337|1208421|P4|NOT COMPLETED|Overall Study||0
502484|NCT00272337|1208422|P3|NOT COMPLETED|Overall Study||0
502485|NCT00272337|1208423|P2|NOT COMPLETED|Overall Study||0
502486|NCT00272337|1208424|P1|NOT COMPLETED|Overall Study||0
502487|NCT00272337|1208420|P5|COMPLETED|Overall Study||8
502488|NCT00272337|1208421|P4|COMPLETED|Overall Study||7
502489|NCT00272337|1208422|P3|COMPLETED|Overall Study||7
502490|NCT00272337|1208423|P2|COMPLETED|Overall Study||7
502491|NCT00272337|1208424|P1|COMPLETED|Overall Study||8
502492|NCT00272337|1208420|P5|STARTED|Overall Study||8
502493|NCT00272337|1208421|P4|STARTED|Overall Study||7
502494|NCT00272337|1208422|P3|STARTED|Overall Study||7
502495|NCT00272337|1208423|P2|STARTED|Overall Study||7
502496|NCT00272337|1208424|P1|STARTED|Overall Study||8
502497|NCT00272311|1208441|P5|NOT COMPLETED|Overall Study||0
502498|NCT00272311|1208442|P4|NOT COMPLETED|Overall Study||0
502499|NCT00272311|1208443|P3|NOT COMPLETED|Overall Study||0
502500|NCT00272311|1208444|P2|NOT COMPLETED|Overall Study||0
502501|NCT00272311|1208445|P1|NOT COMPLETED|Overall Study||0
502502|NCT00272311|1208441|P5|COMPLETED|Overall Study||14
502503|NCT00272311|1208442|P4|COMPLETED|Overall Study||14
502504|NCT00272311|1208443|P3|COMPLETED|Overall Study||14
502505|NCT00272311|1208444|P2|COMPLETED|Overall Study||14
502506|NCT00272311|1208445|P1|COMPLETED|Overall Study||14
502507|NCT00272311|1208441|P5|STARTED|Overall Study||14
502508|NCT00272311|1208442|P4|STARTED|Overall Study||14
502509|NCT00272311|1208443|P3|STARTED|Overall Study||14
502510|NCT00272311|1208444|P2|STARTED|Overall Study||14
502511|NCT00272311|1208445|P1|STARTED|Overall Study||14
502512|NCT00272168|1208459|P2|NOT COMPLETED|Overall Study||10
502513|NCT00272168|1208460|P1|NOT COMPLETED|Overall Study||10
502514|NCT00272168|1208459|P2|COMPLETED|Overall Study||31
502515|NCT00272168|1208460|P1|COMPLETED|Overall Study||37
502516|NCT00272168|1208459|P2|STARTED|Overall Study||41
502517|NCT00272168|1208460|P1|STARTED|Overall Study||47
502518|NCT00272038|1208476|P1|NOT COMPLETED|Overall Study||7
502519|NCT00272038|1208476|P1|COMPLETED|Overall Study||22
502520|NCT00272038|1208476|P1|STARTED|Overall Study||29
502521|NCT00271947|1208482|P1|NOT COMPLETED|Overall Study||1
502522|NCT00271947|1208482|P1|COMPLETED|Overall Study||0
502523|NCT00271947|1208482|P1|STARTED|Overall Study||1
502524|NCT00271856|1208488|P2|NOT COMPLETED|Overall Study||18
502525|NCT00271856|1208489|P1|NOT COMPLETED|Overall Study||11
502526|NCT00271856|1208488|P2|COMPLETED|Overall Study||70
502527|NCT00271856|1208489|P1|COMPLETED|Overall Study||78
502528|NCT00271856|1208488|P2|STARTED|Overall Study||88
502529|NCT00271856|1208489|P1|STARTED|Overall Study||89
502530|NCT00271817|1208508|P3|NOT COMPLETED|Part 2||84
502531|NCT00271817|1208509|P2|NOT COMPLETED|Part 2||32
502532|NCT00271817|1208510|P1|NOT COMPLETED|Part 2||0
502533|NCT00271817|1208508|P3|COMPLETED|Part 2||401
502534|NCT00271817|1208509|P2|COMPLETED|Part 2||234
502535|NCT00271817|1208510|P1|COMPLETED|Part 2||0
502536|NCT00271817|1208508|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
502537|NCT00271817|1208509|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
502538|NCT00271817|1208510|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
502539|NCT00271817|1208508|P3|NOT COMPLETED|Part 1||285
502540|NCT00271817|1208509|P2|NOT COMPLETED|Part 1||59
502541|NCT00271817|1208510|P1|NOT COMPLETED|Part 1||106
502542|NCT00271817|1208508|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
502543|NCT00271817|1208509|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
502544|NCT00271817|1208510|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
502545|NCT00271817|1208508|P3|STARTED|Part 1||676
502546|NCT00271817|1208509|P2|STARTED|Part 1||272
502547|NCT00271817|1208510|P1|STARTED|Part 1||272
502548|NCT00271739|1208539|P2|NOT COMPLETED|Overall Study||105
502549|NCT00271739|1208540|P1|NOT COMPLETED|Overall Study||115
502550|NCT00271739|1208539|P2|COMPLETED|Overall Study||716
502551|NCT00271739|1208540|P1|COMPLETED|Overall Study||729
502552|NCT00271739|1208539|P2|STARTED|Overall Study||821
502553|NCT00271739|1208540|P1|STARTED|Overall Study||844
502554|NCT00271609|1208552|P2|NOT COMPLETED|Overall Study||3
502555|NCT00271609|1208553|P1|NOT COMPLETED|Overall Study||13
502556|NCT00271609|1208552|P2|COMPLETED|Overall Study||29
502557|NCT00271609|1208553|P1|COMPLETED|Overall Study||43
502558|NCT00271609|1208552|P2|STARTED|Overall Study||32
502559|NCT00271609|1208553|P1|STARTED|Overall Study||56
502560|NCT00271596|1208563|P2|NOT COMPLETED|Overall Study||1
502561|NCT00271596|1208564|P1|NOT COMPLETED|Overall Study||1
502562|NCT00271596|1208563|P2|COMPLETED|Overall Study||15
502563|NCT00271596|1208564|P1|COMPLETED|Overall Study||16
502564|NCT00271596|1208563|P2|STARTED|Overall Study||16
502565|NCT00271596|1208564|P1|STARTED|Overall Study||17
502566|NCT00271570|1208590|P2|NOT COMPLETED|Overall Study||0
502567|NCT00271570|1208591|P1|NOT COMPLETED|Overall Study||0
502568|NCT00271570|1208590|P2|COMPLETED|Overall Study||12
502569|NCT00271570|1208591|P1|COMPLETED|Overall Study||12
502570|NCT00271570|1208590|P2|STARTED|Overall Study||12
502571|NCT00271570|1208591|P1|STARTED|Overall Study||12
502572|NCT00271544|1208599|P1|NOT COMPLETED|Overall Study||20
502573|NCT00271544|1208599|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
502574|NCT00271544|1208599|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
502575|NCT00271544|1208599|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
502576|NCT00271544|1208599|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
502577|NCT00271375|1208623|P3|NOT COMPLETED|Overall Study||0
502578|NCT00271375|1208624|P2|NOT COMPLETED|Overall Study||0
502579|NCT00271375|1208625|P1|NOT COMPLETED|Overall Study||0
502580|NCT00271375|1208623|P3|COMPLETED|Overall Study||57
502581|NCT00271375|1208624|P2|COMPLETED|Overall Study||83
502582|NCT00271375|1208625|P1|COMPLETED|Overall Study||114
502583|NCT00271375|1208623|P3|STARTED|Overall Study||57
502584|NCT00271375|1208624|P2|STARTED|Overall Study||83
502585|NCT00271375|1208625|P1|STARTED|Overall Study||114
502586|NCT00271219|1208663|P2|NOT COMPLETED|Overall Study||28
502587|NCT00271219|1208664|P1|NOT COMPLETED|Overall Study||16
502588|NCT00271219|1208663|P2|COMPLETED|Overall Study||58
502589|NCT00271219|1208664|P1|COMPLETED|Overall Study||73
502590|NCT00271219|1208663|P2|STARTED|Overall Study||86
502591|NCT00271219|1208664|P1|STARTED|Overall Study||89
502592|NCT00271154|1208690|P2|NOT COMPLETED|Overall Study||0
502593|NCT00271154|1208691|P1|NOT COMPLETED|Overall Study||0
502594|NCT00271154|1208690|P2|COMPLETED|Overall Study||419
502595|NCT00271154|1208691|P1|COMPLETED|Overall Study||191
502596|NCT00271154|1208690|P2|STARTED|Overall Study||419
502597|NCT00271154|1208691|P1|STARTED|Overall Study||191
502598|NCT00271024|1208704|P4|NOT COMPLETED|Overall Study||24
502599|NCT00271024|1208705|P3|NOT COMPLETED|Overall Study||23
502600|NCT00271024|1208706|P2|NOT COMPLETED|Overall Study||26
502601|NCT00271024|1208707|P1|NOT COMPLETED|Overall Study||22
502602|NCT00271024|1208704|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
502603|NCT00271024|1208705|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
502604|NCT00271024|1208706|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
502605|NCT00271024|1208707|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
502606|NCT00271024|1208704|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
502607|NCT00271024|1208705|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
502608|NCT00271024|1208706|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
502609|NCT00271024|1208707|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
502610|NCT00271024|1208704|P4|STARTED|Overall Study||88
502611|NCT00271024|1208705|P3|STARTED|Overall Study||88
502612|NCT00271024|1208706|P2|STARTED|Overall Study||77
502613|NCT00271024|1208707|P1|STARTED|Overall Study||80
502614|NCT00271011|1208749|P1|NOT COMPLETED|Overall Study||0
502615|NCT00271011|1208749|P1|COMPLETED|Overall Study||13
502616|NCT00271011|1208749|P1|STARTED|Overall Study||13
502617|NCT00270894|1208754|P1|NOT COMPLETED|Overall Study||2
502618|NCT00270894|1208754|P1|COMPLETED|Overall Study||28
502619|NCT00270894|1208754|P1|STARTED|Overall Study||30
502620|NCT00270842|1208767|P3|NOT COMPLETED|Overall Study||16
502621|NCT00270842|1208768|P2|NOT COMPLETED|Overall Study||16
502622|NCT00270842|1208769|P1|NOT COMPLETED|Overall Study||15
502623|NCT00270842|1208767|P3|COMPLETED|Overall Study||18
502624|NCT00270842|1208768|P2|COMPLETED|Overall Study||18
502625|NCT00270842|1208769|P1|COMPLETED|Overall Study||18
502626|NCT00270842|1208767|P3|STARTED|Overall Study||34
502627|NCT00270842|1208768|P2|STARTED|Overall Study||34
502628|NCT00270842|1208769|P1|STARTED|Overall Study||33
502629|NCT00270790|1208780|P1|NOT COMPLETED|Overall Study||5
502630|NCT00270790|1208780|P1|COMPLETED|Overall Study||16
502631|NCT00270790|1208780|P1|STARTED|Overall Study||21
502632|NCT00270634|1208789|P4|NOT COMPLETED|Overall Study||5
502633|NCT00270634|1208790|P3|NOT COMPLETED|Overall Study||22
502634|NCT00270634|1208791|P2|NOT COMPLETED|Overall Study||13
502635|NCT00270634|1208792|P1|NOT COMPLETED|Overall Study||17
502636|NCT00270634|1208789|P4|COMPLETED|Overall Study||81
502637|NCT00270634|1208790|P3|COMPLETED|Overall Study||62
502638|NCT00270634|1208791|P2|COMPLETED|Overall Study||64
502639|NCT00270634|1208792|P1|COMPLETED|Overall Study||70
502640|NCT00270634|1208789|P4|STARTED|Overall Study||86
502641|NCT00270634|1208790|P3|STARTED|Overall Study||84
502642|NCT00270634|1208791|P2|STARTED|Overall Study||77
502643|NCT00270634|1208792|P1|STARTED|Overall Study||87
502644|NCT00270296|1208829|P3|NOT COMPLETED|Overall Study||61
502645|NCT00270296|1208830|P2|NOT COMPLETED|Overall Study||90
502646|NCT00270296|1208831|P1|NOT COMPLETED|Overall Study||99
502647|NCT00270296|1208829|P3|COMPLETED|Overall Study||109
502648|NCT00270296|1208830|P2|COMPLETED|Overall Study||185
502649|NCT00270296|1208831|P1|COMPLETED|Overall Study||186
502650|NCT00270296|1208829|P3|STARTED|Overall Study||170
502651|NCT00270296|1208830|P2|STARTED|Overall Study||275
502652|NCT00270296|1208831|P1|STARTED|Overall Study||285
502653|NCT00270257|1208844|P2|NOT COMPLETED|Overall Study||424
502654|NCT00270257|1208845|P1|NOT COMPLETED|Overall Study||412
502655|NCT00270257|1208844|P2|COMPLETED|Overall Study||204
502656|NCT00270257|1208845|P1|COMPLETED|Overall Study||211
502657|NCT00270257|1208844|P2|Visit 104|Overall Study||204
502658|NCT00270257|1208845|P1|Visit 104|Overall Study||211
502659|NCT00270257|1208844|P2|Week 78|Overall Study||285
502660|NCT00270257|1208845|P1|Week 78|Overall Study||283
502661|NCT00270257|1208844|P2|Week 52|Overall Study||340
502662|NCT00270257|1208845|P1|Week 52|Overall Study||362
502663|NCT00270257|1208844|P2|Week 26|Overall Study||440
502664|NCT00270257|1208845|P1|Week 26|Overall Study||460
502665|NCT00270257|1208844|P2|Week 8|Overall Study||443
502666|NCT00270257|1208845|P1|Week 8|Overall Study||510
502667|NCT00270257|1208844|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
502668|NCT00270257|1208845|P1|STARTED|Overall Study||623
502669|NCT00270231|1208863|P2|NOT COMPLETED|Second Intervention||1
502670|NCT00270231|1208864|P1|NOT COMPLETED|Second Intervention||0
502671|NCT00270231|1208863|P2|COMPLETED|Second Intervention||30
502672|NCT00270231|1208864|P1|COMPLETED|Second Intervention||30
502673|NCT00270231|1208863|P2|STARTED|Second Intervention||31
502674|NCT00270231|1208864|P1|STARTED|Second Intervention||30
502675|NCT00270231|1208863|P2|NOT COMPLETED|Washout Period||0
502676|NCT00270231|1208864|P1|NOT COMPLETED|Washout Period||1
502677|NCT00270231|1208863|P2|COMPLETED|Washout Period||31
502678|NCT00270231|1208864|P1|COMPLETED|Washout Period||30
502679|NCT00270231|1208863|P2|STARTED|Washout Period||31
502680|NCT00270231|1208864|P1|STARTED|Washout Period||31
502681|NCT00270231|1208863|P2|NOT COMPLETED|First Intervention||1
502682|NCT00270231|1208864|P1|NOT COMPLETED|First Intervention||1
502683|NCT00270231|1208863|P2|COMPLETED|First Intervention||31
502684|NCT00270231|1208864|P1|COMPLETED|First Intervention||31
502685|NCT00270231|1208863|P2|STARTED|First Intervention||32
502686|NCT00270231|1208864|P1|STARTED|First Intervention||32
502687|NCT00270205|1208874|P4|NOT COMPLETED|Overall Study||1
502688|NCT00270205|1208875|P3|NOT COMPLETED|Overall Study||0
502689|NCT00270205|1208876|P2|NOT COMPLETED|Overall Study||0
502690|NCT00270205|1208877|P1|NOT COMPLETED|Overall Study||1
502691|NCT00270205|1208874|P4|COMPLETED|Overall Study||6
502692|NCT00270205|1208875|P3|COMPLETED|Overall Study||6
502693|NCT00270205|1208876|P2|COMPLETED|Overall Study||6
502694|NCT00270205|1208877|P1|COMPLETED|Overall Study||5
502695|NCT00270205|1208874|P4|STARTED|Overall Study||7
502696|NCT00270205|1208875|P3|STARTED|Overall Study||6
502697|NCT00270205|1208876|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
502698|NCT00270205|1208877|P1|STARTED|Overall Study||6
502699|NCT00269919|1208987|P1|NOT COMPLETED|Overall Study||27
502700|NCT00269919|1208987|P1|COMPLETED|Overall Study||13
502701|NCT00269919|1208987|P1|Treated|Overall Study||39
502702|NCT00269919|1208987|P1|STARTED|Overall Study||40
502703|NCT00269633|1209006|P2|NOT COMPLETED|Overall Study||0
502704|NCT00269633|1209007|P1|NOT COMPLETED|Overall Study||1
502705|NCT00269633|1209006|P2|COMPLETED|Overall Study||5
502706|NCT00269633|1209007|P1|COMPLETED|Overall Study||3
502707|NCT00269633|1209006|P2|STARTED|Overall Study||5
502708|NCT00269633|1209007|P1|STARTED|Overall Study||4
502709|NCT00269477|1209017|P4|NOT COMPLETED|Overall Study||0
502710|NCT00269477|1209018|P3|NOT COMPLETED|Overall Study||1
502711|NCT00269477|1209019|P2|NOT COMPLETED|Overall Study||6
502712|NCT00269477|1209020|P1|NOT COMPLETED|Overall Study||5
502713|NCT00269477|1209017|P4|COMPLETED|Overall Study||60
502714|NCT00269477|1209018|P3|COMPLETED|Overall Study||57
502715|NCT00269477|1209019|P2|COMPLETED|Overall Study||12
502716|NCT00269477|1209020|P1|COMPLETED|Overall Study||4
502717|NCT00269477|1209017|P4|STARTED|Overall Study||60
502718|NCT00269477|1209018|P3|STARTED|Overall Study||58
502719|NCT00269477|1209019|P2|STARTED|Overall Study||18
502720|NCT00269477|1209020|P1|STARTED|Overall Study||9
502721|NCT00269152|1209036|P2|NOT COMPLETED|Overall Study||10
502722|NCT00269152|1209037|P1|NOT COMPLETED|Overall Study||18
502723|NCT00269152|1209036|P2|COMPLETED|Overall Study||49
502724|NCT00269152|1209037|P1|COMPLETED|Overall Study||45
502725|NCT00269152|1209036|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
502726|NCT00269152|1209037|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
502727|NCT00269113|1209053|P2|NOT COMPLETED|Overall Study||37
502728|NCT00269113|1209054|P1|NOT COMPLETED|Overall Study||74
502729|NCT00269113|1209053|P2|COMPLETED|Overall Study||146
502730|NCT00269113|1209054|P1|COMPLETED|Overall Study||103
502731|NCT00269113|1209053|P2|STARTED|Overall Study||183
502732|NCT00269113|1209054|P1|STARTED|Overall Study||177
502733|NCT00268983|1209074|P2|NOT COMPLETED|Overall Study||0
502734|NCT00268983|1209075|P1|NOT COMPLETED|Overall Study||3
502735|NCT00268983|1209074|P2|COMPLETED|Overall Study||8
502736|NCT00268983|1209075|P1|COMPLETED|Overall Study||3
502737|NCT00268983|1209074|P2|STARTED|Overall Study||8
502738|NCT00268983|1209075|P1|STARTED|Overall Study||6
502739|NCT00268905|1209118|P3|NOT COMPLETED|Overall Study||12
502740|NCT00268905|1209119|P2|NOT COMPLETED|Overall Study||9
502741|NCT00268905|1209120|P1|NOT COMPLETED|Overall Study||43
502742|NCT00268905|1209118|P3|COMPLETED|Overall Study||0
502743|NCT00268905|1209119|P2|COMPLETED|Overall Study||0
502744|NCT00268905|1209120|P1|COMPLETED|Overall Study||0
502745|NCT00268905|1209118|P3|STARTED|Overall Study||12
502746|NCT00268905|1209119|P2|STARTED|Overall Study||9
502747|NCT00268905|1209120|P1|STARTED|Overall Study||43
502748|NCT00268892|1209137|P3|NOT COMPLETED|Overall Study||39
502749|NCT00268892|1209138|P2|NOT COMPLETED|Overall Study||42
502750|NCT00268892|1209139|P1|NOT COMPLETED|Overall Study||39
502751|NCT00268892|1209137|P3|COMPLETED|Overall Study||54
502752|NCT00268892|1209138|P2|COMPLETED|Overall Study||53
502753|NCT00268892|1209139|P1|COMPLETED|Overall Study||51
502754|NCT00268892|1209137|P3|Switched to Higher Dose|Overall Study||76
502755|NCT00268892|1209138|P2|Switched to Higher Dose|Overall Study||68
502756|NCT00268892|1209139|P1|Switched to Higher Dose|Overall Study||59
502757|NCT00268892|1209137|P3|STARTED|Overall Study||93
502758|NCT00268892|1209138|P2|STARTED|Overall Study||95
502759|NCT00268892|1209139|P1|STARTED|Overall Study||90
502760|NCT00268762|1209150|P1|NOT COMPLETED|Overall Study||0
502761|NCT00268762|1209150|P1|COMPLETED|Overall Study||65
502762|NCT00268762|1209150|P1|STARTED|Overall Study||65
502763|NCT00268463|1209158|P2|NOT COMPLETED|Overall Study||12
502764|NCT00268463|1209159|P1|NOT COMPLETED|Overall Study||10
502765|NCT00268463|1209158|P2|COMPLETED|Overall Study||0
502766|NCT00268463|1209159|P1|COMPLETED|Overall Study||0
502767|NCT00268463|1209158|P2|STARTED|Overall Study||12
502768|NCT00268463|1209159|P1|STARTED|Overall Study||10
502769|NCT00268437|1209165|P1|NOT COMPLETED|Overall Study||1
502770|NCT00268437|1209165|P1|COMPLETED|Overall Study||26
502771|NCT00268437|1209165|P1|STARTED|Overall Study||27
502772|NCT00268346|1209172|P2|NOT COMPLETED|Overall Study||3
502773|NCT00268346|1209173|P1|NOT COMPLETED|Overall Study||0
502774|NCT00268346|1209172|P2|COMPLETED|Overall Study||37
502775|NCT00268346|1209173|P1|COMPLETED|Overall Study||18
502776|NCT00268346|1209172|P2|Started Treatment|Overall Study||40
502777|NCT00268346|1209173|P1|Started Treatment|Overall Study||18
502778|NCT00268346|1209172|P2|STARTED|Overall Study||40
502779|NCT00268346|1209173|P1|STARTED|Overall Study||18
502780|NCT00268242|1209179|P1|NOT COMPLETED|Overall Study||1
502781|NCT00268242|1209179|P1|COMPLETED|Overall Study||23
502782|NCT00268242|1209179|P1|STARTED|Overall Study||24
502783|NCT00268203|1209188|P1|NOT COMPLETED|Overall Study||647
502784|NCT00268203|1209188|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
502785|NCT00268203|1209188|P1|Completed 2 Years of Follow-up|Overall Study||62
502786|NCT00268203|1209188|P1|STARTED|Overall Study||765
502787|NCT00267969|1209202|P7|NOT COMPLETED|After Controlled Period||72
502788|NCT00267969|1209203|P6|NOT COMPLETED|After Controlled Period||82
502789|NCT00267969|1209204|P5|NOT COMPLETED|After Controlled Period||35
502790|NCT00267969|1209205|P4|NOT COMPLETED|After Controlled Period||36
502791|NCT00267969|1209206|P3|NOT COMPLETED|After Controlled Period||0
502792|NCT00267969|1209207|P2|NOT COMPLETED|After Controlled Period||0
502793|NCT00267969|1209208|P1|NOT COMPLETED|After Controlled Period||0
502794|NCT00267969|1209202|P7|COMPLETED|After Controlled Period||173
502795|NCT00267969|1209203|P6|COMPLETED|After Controlled Period||172
502796|NCT00267969|1209204|P5|COMPLETED|After Controlled Period||85
502797|NCT00267969|1209205|P4|COMPLETED|After Controlled Period||87
502798|NCT00267969|1209206|P3|COMPLETED|After Controlled Period||0
502799|NCT00267969|1209207|P2|COMPLETED|After Controlled Period||0
502800|NCT00267969|1209208|P1|COMPLETED|After Controlled Period||0
502801|NCT00267969|1209202|P7|STARTED|After Controlled Period||245
502802|NCT00267969|1209203|P6|STARTED|After Controlled Period||254
502803|NCT00267969|1209204|P5|STARTED|After Controlled Period||120
502804|NCT00267969|1209205|P4|STARTED|After Controlled Period||123
502805|NCT00267969|1209206|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
502806|NCT00267969|1209207|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
502807|NCT00267969|1209208|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
502808|NCT00267969|1209202|P7|NOT COMPLETED|Controlled Period||0
502809|NCT00267969|1209203|P6|NOT COMPLETED|Controlled Period||0
502810|NCT00267969|1209204|P5|NOT COMPLETED|Controlled Period||0
502811|NCT00267969|1209205|P4|NOT COMPLETED|Controlled Period||0
502812|NCT00267969|1209206|P3|NOT COMPLETED|Controlled Period||11
502813|NCT00267969|1209207|P2|NOT COMPLETED|Controlled Period||1
502814|NCT00267969|1209208|P1|NOT COMPLETED|Controlled Period||12
502815|NCT00267969|1209202|P7|COMPLETED|Controlled Period||0
502816|NCT00267969|1209203|P6|COMPLETED|Controlled Period||0
502817|NCT00267969|1209204|P5|COMPLETED|Controlled Period||0
502818|NCT00267969|1209205|P4|COMPLETED|Controlled Period||0
502819|NCT00267969|1209206|P3|COMPLETED|Controlled Period||245
502820|NCT00267969|1209207|P2|COMPLETED|Controlled Period||254
502821|NCT00267969|1209208|P1|COMPLETED|Controlled Period||243
502822|NCT00267969|1209202|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
502823|NCT00267969|1209203|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
502824|NCT00267969|1209204|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
502825|NCT00267969|1209205|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
502826|NCT00267969|1209206|P3|STARTED|Controlled Period|Number of patients randomized|256
502827|NCT00267969|1209207|P2|STARTED|Controlled Period|Number of patients randomized|255
502828|NCT00267969|1209208|P1|STARTED|Controlled Period|Number of patients randomized|255
502829|NCT00267956|1209234|P4|NOT COMPLETED|After Controlled Period||2
502830|NCT00267956|1209235|P3|NOT COMPLETED|After Controlled Period||5
502831|NCT00267956|1209236|P2|NOT COMPLETED|After Controlled Period||0
502832|NCT00267956|1209237|P1|NOT COMPLETED|After Controlled Period||0
502833|NCT00267956|1209234|P4|COMPLETED|After Controlled Period||70
502834|NCT00267956|1209235|P3|COMPLETED|After Controlled Period||52
502835|NCT00267956|1209236|P2|COMPLETED|After Controlled Period||0
502836|NCT00267956|1209237|P1|COMPLETED|After Controlled Period||0
502837|NCT00267956|1209234|P4|STARTED|After Controlled Period||72
502838|NCT00267956|1209235|P3|STARTED|After Controlled Period||57
502839|NCT00267956|1209236|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
502840|NCT00267956|1209237|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
502841|NCT00267956|1209234|P4|NOT COMPLETED|Controlled Period||0
502842|NCT00267956|1209235|P3|NOT COMPLETED|Controlled Period||0
502843|NCT00267956|1209236|P2|NOT COMPLETED|Controlled Period||4
502844|NCT00267956|1209237|P1|NOT COMPLETED|Controlled Period||13
502845|NCT00267956|1209234|P4|COMPLETED|Controlled Period||0
502846|NCT00267956|1209235|P3|COMPLETED|Controlled Period||0
502847|NCT00267956|1209236|P2|COMPLETED|Controlled Period||72
502848|NCT00267956|1209237|P1|COMPLETED|Controlled Period||57
502849|NCT00267956|1209234|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
502850|NCT00267956|1209235|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
502851|NCT00267956|1209236|P2|STARTED|Controlled Period||76
502852|NCT00267956|1209237|P1|STARTED|Controlled Period||70
502853|NCT00267774|1209257|P2|NOT COMPLETED|Overall Study||0
502854|NCT00267774|1209258|P1|NOT COMPLETED|Overall Study||0
502855|NCT00267774|1209257|P2|COMPLETED|Overall Study||496
502856|NCT00267774|1209258|P1|COMPLETED|Overall Study||509
502857|NCT00267774|1209257|P2|STARTED|Overall Study||496
502858|NCT00267774|1209258|P1|STARTED|Overall Study||509
502859|NCT00267748|1209267|P3|NOT COMPLETED|Randomized Period||132
502860|NCT00267748|1209268|P2|NOT COMPLETED|Randomized Period||127
502861|NCT00267748|1209269|P1|NOT COMPLETED|Randomized Period||0
502862|NCT00267748|1209267|P3|COMPLETED|Randomized Period||14
502863|NCT00267748|1209268|P2|COMPLETED|Randomized Period||19
502864|NCT00267748|1209269|P1|COMPLETED|Randomized Period||0
502865|NCT00267748|1209267|P3|Treated|Randomized Period||143
502866|NCT00267748|1209268|P2|Treated|Randomized Period||146
502867|NCT00267748|1209269|P1|Treated|Randomized Period||0
502868|NCT00267748|1209267|P3|STARTED|Randomized Period||146
502869|NCT00267748|1209268|P2|STARTED|Randomized Period||146
502870|NCT00267748|1209269|P1|STARTED|Randomized Period||0
502871|NCT00267748|1209267|P3|NOT COMPLETED|Non-randomized Period||0
502872|NCT00267748|1209268|P2|NOT COMPLETED|Non-randomized Period||0
502873|NCT00267748|1209269|P1|NOT COMPLETED|Non-randomized Period||23
502874|NCT00267748|1209267|P3|COMPLETED|Non-randomized Period||0
502875|NCT00267748|1209268|P2|COMPLETED|Non-randomized Period||0
502876|NCT00267748|1209269|P1|COMPLETED|Non-randomized Period||2
502877|NCT00267748|1209267|P3|STARTED|Non-randomized Period||0
502878|NCT00267748|1209268|P2|STARTED|Non-randomized Period||0
502879|NCT00267748|1209269|P1|STARTED|Non-randomized Period||25
502880|NCT00267696|1209286|P1|NOT COMPLETED|Overall Study||0
502881|NCT00267696|1209286|P1|COMPLETED|Overall Study||45
502882|NCT00267696|1209286|P1|STARTED|Overall Study||45
502883|NCT00267670|1209293|P2|NOT COMPLETED|Overall Study||0
502884|NCT00267670|1209294|P1|NOT COMPLETED|Overall Study||4
502885|NCT00267670|1209293|P2|COMPLETED|Overall Study||7
502886|NCT00267670|1209294|P1|COMPLETED|Overall Study||15
502887|NCT00267670|1209293|P2|STARTED|Overall Study||7
502888|NCT00267670|1209294|P1|STARTED|Overall Study||19
502889|NCT00267644|1209308|P2|NOT COMPLETED|Overall Study||0
502890|NCT00267644|1209309|P1|NOT COMPLETED|Overall Study||0
502891|NCT00267644|1209308|P2|COMPLETED|Overall Study||63
502892|NCT00267644|1209309|P1|COMPLETED|Overall Study||13
502893|NCT00267644|1209308|P2|STARTED|Overall Study||63
502894|NCT00267644|1209309|P1|STARTED|Overall Study||13
502895|NCT00267631|1209319|P2|NOT COMPLETED|Overall Study||0
502896|NCT00267631|1209320|P1|NOT COMPLETED|Overall Study||0
502897|NCT00267631|1209319|P2|COMPLETED|Overall Study||3031
502898|NCT00267631|1209320|P1|COMPLETED|Overall Study||2361
502899|NCT00267631|1209319|P2|STARTED|Overall Study||3031
502900|NCT00267631|1209320|P1|STARTED|Overall Study||2361
502901|NCT00267488|1209326|P1|NOT COMPLETED|Overall Study||11
502902|NCT00267488|1209326|P1|COMPLETED|Overall Study||26
502903|NCT00267488|1209326|P1|STARTED|Overall Study||37
502904|NCT00267293|1209338|P3|NOT COMPLETED|Overall Study||0
502905|NCT00267293|1209339|P2|NOT COMPLETED|Overall Study||0
502906|NCT00267293|1209340|P1|NOT COMPLETED|Overall Study||0
502907|NCT00267293|1209338|P3|COMPLETED|Overall Study||20
502908|NCT00267293|1209339|P2|COMPLETED|Overall Study||20
502909|NCT00267293|1209340|P1|COMPLETED|Overall Study||20
502910|NCT00267293|1209338|P3|STARTED|Overall Study||20
502911|NCT00267293|1209339|P2|STARTED|Overall Study||20
502912|NCT00267293|1209340|P1|STARTED|Overall Study||20
502913|NCT00267202|1209350|P2|NOT COMPLETED|Overall Study||34
502914|NCT00267202|1209351|P1|NOT COMPLETED|Overall Study||53
502915|NCT00267202|1209350|P2|COMPLETED|Overall Study||105
502916|NCT00267202|1209351|P1|COMPLETED|Overall Study||83
502917|NCT00267202|1209350|P2|STARTED|Overall Study||139
502918|NCT00267202|1209351|P1|STARTED|Overall Study||136
502919|NCT00267189|1209372|P2|NOT COMPLETED|Overall Study||1
502920|NCT00267189|1209373|P1|NOT COMPLETED|Overall Study||5
502921|NCT00267189|1209372|P2|COMPLETED|Overall Study||72
502922|NCT00267189|1209373|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
502923|NCT00267189|1209372|P2|Completed Study Medication|Overall Study||72
502924|NCT00267189|1209373|P1|Completed Study Medication|Overall Study||54
502925|NCT00267189|1209372|P2|STARTED|Overall Study||73
502926|NCT00267189|1209373|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
502927|NCT00267150|1209383|P1|NOT COMPLETED|Overall Study||1
502928|NCT00267150|1209383|P1|COMPLETED|Overall Study||30
502929|NCT00267150|1209383|P1|STARTED|Overall Study||31
502930|NCT00267111|1209390|P2|NOT COMPLETED|Overall Study||0
502931|NCT00267111|1209391|P1|NOT COMPLETED|Overall Study||0
502932|NCT00267111|1209390|P2|COMPLETED|Overall Study||55
502933|NCT00267111|1209391|P1|COMPLETED|Overall Study||55
502934|NCT00267111|1209390|P2|STARTED|Overall Study||55
502935|NCT00267111|1209391|P1|STARTED|Overall Study||55
502936|NCT00267098|1209407|P8|NOT COMPLETED|Overall Study||15
502937|NCT00267098|1209408|P7|NOT COMPLETED|Overall Study||46
502938|NCT00267098|1209409|P6|NOT COMPLETED|Overall Study||40
502939|NCT00267098|1209410|P5|NOT COMPLETED|Overall Study||37
502940|NCT00267098|1209411|P4|NOT COMPLETED|Overall Study||106
502941|NCT00267098|1209412|P3|NOT COMPLETED|Overall Study||94
502942|NCT00267098|1209413|P2|NOT COMPLETED|Overall Study||51
502943|NCT00267098|1209414|P1|NOT COMPLETED|Overall Study||109
502944|NCT00267098|1209407|P8|COMPLETED|Overall Study||5
502945|NCT00267098|1209408|P7|COMPLETED|Overall Study||55
502946|NCT00267098|1209409|P6|COMPLETED|Overall Study||66
502947|NCT00267098|1209410|P5|COMPLETED|Overall Study||10
502948|NCT00267098|1209411|P4|COMPLETED|Overall Study||135
502949|NCT00267098|1209412|P3|COMPLETED|Overall Study||149
502950|NCT00267098|1209413|P2|COMPLETED|Overall Study||0
502951|NCT00267098|1209414|P1|COMPLETED|Overall Study||0
502952|NCT00267098|1209407|P8|STARTED|Overall Study||20
502953|NCT00267098|1209408|P7|STARTED|Overall Study||101
502954|NCT00267098|1209409|P6|STARTED|Overall Study||106
502955|NCT00267098|1209410|P5|STARTED|Overall Study||47
502956|NCT00267098|1209411|P4|STARTED|Overall Study||241
502957|NCT00267098|1209412|P3|STARTED|Overall Study||243
502958|NCT00267098|1209413|P2|STARTED|Overall Study||51
502959|NCT00267098|1209414|P1|STARTED|Overall Study||109
502960|NCT00267085|1209547|P1|NOT COMPLETED|Overall Study||0
502961|NCT00267085|1209547|P1|COMPLETED|Overall Study||10
502962|NCT00267085|1209547|P1|STARTED|Overall Study||10
502963|NCT00267059|1209551|P1|NOT COMPLETED|Overall Study||0
502964|NCT00267059|1209551|P1|COMPLETED|Overall Study||44
502965|NCT00267059|1209551|P1|STARTED|Overall Study||44
502966|NCT00267046|1209557|P2|NOT COMPLETED|Overall Study||11
502967|NCT00267046|1209558|P1|NOT COMPLETED|Overall Study||12
502968|NCT00267046|1209557|P2|COMPLETED|Overall Study||5
502969|NCT00267046|1209558|P1|COMPLETED|Overall Study||20
502970|NCT00267046|1209557|P2|STARTED|Overall Study||16
502971|NCT00267046|1209558|P1|STARTED|Overall Study||32
502972|NCT00267007|1209568|P2|NOT COMPLETED|Overall Study||1
502973|NCT00267007|1209569|P1|NOT COMPLETED|Overall Study||8
502974|NCT00267007|1209568|P2|COMPLETED|Overall Study||10
502975|NCT00267007|1209569|P1|COMPLETED|Overall Study||11
502976|NCT00267007|1209568|P2|STARTED|Overall Study||11
502977|NCT00267007|1209569|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
502978|NCT00266864|1209579|P2|NOT COMPLETED|Overall Study||2
502979|NCT00266864|1209580|P1|NOT COMPLETED|Overall Study||5
502980|NCT00266864|1209579|P2|COMPLETED|Overall Study||11
502981|NCT00266864|1209580|P1|COMPLETED|Overall Study||13
502982|NCT00266864|1209579|P2|STARTED|Overall Study||13
502983|NCT00266864|1209580|P1|STARTED|Overall Study||18
502984|NCT00266825|1209589|P2|NOT COMPLETED|Completed Follow-Up||24
502985|NCT00266825|1209590|P1|NOT COMPLETED|Completed Follow-Up||25
502986|NCT00266825|1209589|P2|COMPLETED|Completed Follow-Up||154
502987|NCT00266825|1209590|P1|COMPLETED|Completed Follow-Up||147
502988|NCT00266825|1209589|P2|STARTED|Completed Follow-Up||178
502989|NCT00266825|1209590|P1|STARTED|Completed Follow-Up||172
502990|NCT00266825|1209589|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
502991|NCT00266825|1209590|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
502992|NCT00266825|1209589|P2|COMPLETED|Enrolled and Allocated Intervention||178
502993|NCT00266825|1209590|P1|COMPLETED|Enrolled and Allocated Intervention||172
502994|NCT00266825|1209589|P2|STARTED|Enrolled and Allocated Intervention||178
502995|NCT00266825|1209590|P1|STARTED|Enrolled and Allocated Intervention||172
502996|NCT00266812|1209616|P2|NOT COMPLETED|Overall Study||11
502997|NCT00266812|1209617|P1|NOT COMPLETED|Overall Study||21
502998|NCT00266812|1209616|P2|COMPLETED|Overall Study||2
502999|NCT00266812|1209617|P1|COMPLETED|Overall Study||1
503000|NCT00266812|1209616|P2|STARTED|Overall Study||13
503001|NCT00266812|1209617|P1|STARTED|Overall Study||22
503002|NCT00266799|1209625|P2|NOT COMPLETED|Overall Study||34
503003|NCT00266799|1209626|P1|NOT COMPLETED|Overall Study||36
503004|NCT00266799|1209625|P2|COMPLETED|Overall Study||68
503005|NCT00266799|1209626|P1|COMPLETED|Overall Study||62
503006|NCT00266799|1209625|P2|STARTED|Overall Study||102
503007|NCT00266799|1209626|P1|STARTED|Overall Study||98
503008|NCT00266695|1209640|P1|NOT COMPLETED|Overall Study||29
503009|NCT00266695|1209640|P1|COMPLETED|Overall Study||174
503010|NCT00266695|1209640|P1|STARTED|Overall Study||203
503011|NCT00266656|1209652|P2|NOT COMPLETED|Overall Study||13
503012|NCT00266656|1209653|P1|NOT COMPLETED|Overall Study||14
503013|NCT00266656|1209652|P2|COMPLETED|Overall Study||20
503014|NCT00266656|1209653|P1|COMPLETED|Overall Study||22
503015|NCT00266656|1209652|P2|STARTED|Overall Study||33
503016|NCT00266656|1209653|P1|STARTED|Overall Study||36
503017|NCT00266630|1209677|P2|NOT COMPLETED|Overall Study||28
503018|NCT00266630|1209678|P1|NOT COMPLETED|Overall Study||42
503019|NCT00266630|1209677|P2|COMPLETED|Overall Study||11
503020|NCT00266630|1209678|P1|COMPLETED|Overall Study||58
503021|NCT00266630|1209677|P2|STARTED|Overall Study||39
503022|NCT00266630|1209678|P1|STARTED|Overall Study||100
503023|NCT00266409|1209720|P4|NOT COMPLETED|Overall Study||22
503024|NCT00266409|1209721|P3|NOT COMPLETED|Overall Study||17
503025|NCT00266409|1209722|P2|NOT COMPLETED|Overall Study||46
503026|NCT00266409|1209723|P1|NOT COMPLETED|Overall Study||45
503027|NCT00266409|1209720|P4|COMPLETED|Overall Study||49
503028|NCT00266409|1209721|P3|COMPLETED|Overall Study||55
503029|NCT00266409|1209722|P2|COMPLETED|Overall Study||92
503030|NCT00266409|1209723|P1|COMPLETED|Overall Study||92
503031|NCT00266409|1209720|P4|STARTED|Overall Study||71
503032|NCT00266409|1209721|P3|STARTED|Overall Study||72
503033|NCT00266409|1209722|P2|STARTED|Overall Study||138
503034|NCT00266409|1209723|P1|STARTED|Overall Study||137
503035|NCT00265395|1210007|P2|NOT COMPLETED|Overall Study||17
503036|NCT00265395|1210008|P1|NOT COMPLETED|Overall Study||8
503037|NCT00265395|1210007|P2|COMPLETED|Overall Study||56
503038|NCT00265395|1210008|P1|COMPLETED|Overall Study||78
503039|NCT00265395|1210007|P2|STARTED|Overall Study||73
503040|NCT00265395|1210008|P1|STARTED|Overall Study||86
503041|NCT00265382|1210013|P1|NOT COMPLETED|Overall Study||145
503042|NCT00265382|1210013|P1|COMPLETED|Overall Study||76
503043|NCT00265382|1210013|P1|STARTED|Overall Study||221
503044|NCT00265343|1210033|P2|NOT COMPLETED|Overall Study||19
503045|NCT00265343|1210034|P1|NOT COMPLETED|Overall Study||21
503046|NCT00265343|1210033|P2|COMPLETED|Overall Study||153
503047|NCT00265343|1210034|P1|COMPLETED|Overall Study||113
503048|NCT00265343|1210033|P2|STARTED|Overall Study||172
503049|NCT00265343|1210034|P1|STARTED|Overall Study||134
503050|NCT00265330|1210042|P1|NOT COMPLETED|Overall Study||95
503051|NCT00265330|1210042|P1|COMPLETED|Overall Study||67
503052|NCT00265330|1210042|P1|STARTED|Overall Study||162
503053|NCT00265317|1210068|P4|NOT COMPLETED|Phase 2||65
503054|NCT00265317|1210069|P3|NOT COMPLETED|Phase 2||64
503055|NCT00265317|1210070|P2|NOT COMPLETED|Phase 2||0
503056|NCT00265317|1210071|P1|NOT COMPLETED|Phase 2||0
503057|NCT00265317|1210068|P4|COMPLETED|Phase 2||2
503058|NCT00265317|1210069|P3|COMPLETED|Phase 2||1
503059|NCT00265317|1210070|P2|COMPLETED|Phase 2||0
503060|NCT00265317|1210071|P1|COMPLETED|Phase 2||0
503061|NCT00265317|1210068|P4|STARTED|Phase 2||67
503062|NCT00265317|1210069|P3|STARTED|Phase 2||65
503063|NCT00265317|1210070|P2|STARTED|Phase 2||0
503064|NCT00265317|1210071|P1|STARTED|Phase 2||0
503065|NCT00265317|1210068|P4|NOT COMPLETED|Lead-In||0
503066|NCT00265317|1210069|P3|NOT COMPLETED|Lead-In||0
503067|NCT00265317|1210070|P2|NOT COMPLETED|Lead-In||17
503068|NCT00265317|1210071|P1|NOT COMPLETED|Lead-In||12
503069|NCT00265317|1210068|P4|COMPLETED|Lead-In||0
503070|NCT00265317|1210069|P3|COMPLETED|Lead-In||0
503071|NCT00265317|1210070|P2|COMPLETED|Lead-In||0
503072|NCT00265317|1210071|P1|COMPLETED|Lead-In||1
503073|NCT00265317|1210068|P4|STARTED|Lead-In||0
503074|NCT00265317|1210069|P3|STARTED|Lead-In||0
503075|NCT00265317|1210070|P2|STARTED|Lead-In||17
503076|NCT00265317|1210071|P1|STARTED|Lead-In||13
503077|NCT00266279|1210184|P1|NOT COMPLETED|Overall Study||2
503078|NCT00266279|1210184|P1|COMPLETED|Overall Study||15
503079|NCT00266279|1210184|P1|STARTED|Overall Study||17
503080|NCT00266227|1210190|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
503081|NCT00266227|1210191|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
503082|NCT00266227|1210192|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
503083|NCT00266227|1210190|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
503084|NCT00266227|1210191|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
503085|NCT00266227|1210192|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
503086|NCT00266227|1210190|P3|STARTED|Retreatment: Week 48 to Week 72||0
503087|NCT00266227|1210191|P2|STARTED|Retreatment: Week 48 to Week 72||134
503088|NCT00266227|1210192|P1|STARTED|Retreatment: Week 48 to Week 72||291
503089|NCT00266227|1210190|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
503090|NCT00266227|1210191|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
503091|NCT00266227|1210192|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
503092|NCT00266227|1210190|P3|COMPLETED|Retreatment: Up to Week 48||0
503093|NCT00266227|1210191|P2|COMPLETED|Retreatment: Up to Week 48||134
503094|NCT00266227|1210192|P1|COMPLETED|Retreatment: Up to Week 48||291
503095|NCT00266227|1210190|P3|STARTED|Retreatment: Up to Week 48||0
503096|NCT00266227|1210191|P2|STARTED|Retreatment: Up to Week 48||157
503097|NCT00266227|1210192|P1|STARTED|Retreatment: Up to Week 48||318
503098|NCT00266227|1210190|P3|NOT COMPLETED|Initial Treatment||77
503099|NCT00266227|1210191|P2|NOT COMPLETED|Initial Treatment||0
503100|NCT00266227|1210192|P1|NOT COMPLETED|Initial Treatment||0
503101|NCT00266227|1210190|P3|COMPLETED|Initial Treatment||482
503102|NCT00266227|1210191|P2|COMPLETED|Initial Treatment||0
503103|NCT00266227|1210192|P1|COMPLETED|Initial Treatment||0
503104|NCT00266227|1210190|P3|STARTED|Initial Treatment||559
503105|NCT00266227|1210191|P2|STARTED|Initial Treatment||0
503106|NCT00266227|1210192|P1|STARTED|Initial Treatment||0
503107|NCT00266110|1210237|P1|NOT COMPLETED|Overall Study||7
503108|NCT00266110|1210237|P1|COMPLETED|Overall Study||10
503109|NCT00266110|1210237|P1|STARTED|Overall Study||17
503110|NCT00266032|1210244|P3|NOT COMPLETED|Open-label Safety Extension||25
503111|NCT00266032|1210245|P2|NOT COMPLETED|Open-label Safety Extension||14
503112|NCT00266032|1210246|P1|NOT COMPLETED|Open-label Safety Extension||41
503113|NCT00266032|1210244|P3|COMPLETED|Open-label Safety Extension||140
503114|NCT00266032|1210245|P2|COMPLETED|Open-label Safety Extension||115
503115|NCT00266032|1210246|P1|COMPLETED|Open-label Safety Extension||448
503116|NCT00266032|1210244|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
503117|NCT00266032|1210245|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
503118|NCT00266032|1210246|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
503119|NCT00266032|1210244|P3|NOT COMPLETED|Treatment||47
503120|NCT00266032|1210245|P2|NOT COMPLETED|Treatment||64
503121|NCT00266032|1210246|P1|NOT COMPLETED|Treatment||111
503122|NCT00266032|1210244|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
503123|NCT00266032|1210245|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
503124|NCT00266032|1210246|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
503125|NCT00266032|1210244|P3|Patients Treated and in FAS|Treatment|FAS|216
503126|NCT00266032|1210245|P2|Patients Treated and in FAS|Treatment|FAS|209
503127|NCT00266032|1210246|P1|Patients Treated and in FAS|Treatment|FAS|642
503128|NCT00266032|1210244|P3|Patients Treated|Treatment||229
503129|NCT00266032|1210245|P2|Patients Treated|Treatment||221
503130|NCT00266032|1210246|P1|Patients Treated|Treatment||684
503131|NCT00266032|1210244|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
503132|NCT00266032|1210245|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
503133|NCT00266032|1210246|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
503134|NCT00265889|1210274|P1|NOT COMPLETED|Overall Study||5
503135|NCT00265889|1210274|P1|COMPLETED|Overall Study||37
503136|NCT00265889|1210274|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
503137|NCT00265889|1210274|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
503138|NCT00265889|1210274|P1|STARTED|Overall Study||42
503139|NCT00265850|1210283|P3|NOT COMPLETED|Overall Study||0
503140|NCT00265850|1210284|P2|NOT COMPLETED|Overall Study||0
503141|NCT00265850|1210285|P1|NOT COMPLETED|Overall Study||0
503142|NCT00265850|1210283|P3|COMPLETED|Overall Study||533
503143|NCT00265850|1210284|P2|COMPLETED|Overall Study||902
503144|NCT00265850|1210285|P1|COMPLETED|Overall Study||899
503145|NCT00265850|1210283|P3|STARTED|Overall Study||533
503146|NCT00265850|1210284|P2|STARTED|Overall Study||902
503147|NCT00265850|1210285|P1|STARTED|Overall Study||899
503148|NCT00265798|1210295|P1|NOT COMPLETED|Overall Study||0
503149|NCT00265798|1210295|P1|COMPLETED|Overall Study||38
503150|NCT00265798|1210295|P1|STARTED|Overall Study||38
503151|NCT00265785|1210301|P1|NOT COMPLETED|Overall Study||27
503152|NCT00265785|1210301|P1|COMPLETED|Overall Study||0
503153|NCT00265785|1210301|P1|Eligible and Began Protocol Treatment|Overall Study||24
503154|NCT00265785|1210301|P1|Eligible|Overall Study||26
503155|NCT00265785|1210301|P1|STARTED|Overall Study||27
503156|NCT00265759|1210314|P4|NOT COMPLETED|Overall Study||9
503157|NCT00265759|1210315|P3|NOT COMPLETED|Overall Study||2
503158|NCT00265759|1210316|P2|NOT COMPLETED|Overall Study||1
503159|NCT00265759|1210317|P1|NOT COMPLETED|Overall Study||0
503160|NCT00265759|1210314|P4|COMPLETED|Overall Study||236
503161|NCT00265759|1210315|P3|COMPLETED|Overall Study||123
503162|NCT00265759|1210316|P2|COMPLETED|Overall Study||127
503163|NCT00265759|1210317|P1|COMPLETED|Overall Study||124
503164|NCT00265759|1210314|P4|STARTED|Overall Study||245
503165|NCT00265759|1210315|P3|STARTED|Overall Study||125
503166|NCT00265759|1210316|P2|STARTED|Overall Study||128
503167|NCT00265759|1210317|P1|STARTED|Overall Study||124
503168|NCT00265616|1210348|P2|NOT COMPLETED|Overall Study||0
503169|NCT00265616|1210349|P1|NOT COMPLETED|Overall Study||0
503170|NCT00265616|1210348|P2|COMPLETED|Overall Study||9
503171|NCT00265616|1210349|P1|COMPLETED|Overall Study||14
503172|NCT00265616|1210348|P2|STARTED|Overall Study||9
503173|NCT00265616|1210349|P1|STARTED|Overall Study||14
503174|NCT00265512|1210367|P2|NOT COMPLETED|Overall Study||95
503175|NCT00265512|1210368|P1|NOT COMPLETED|Overall Study||45
503176|NCT00265512|1210367|P2|COMPLETED|Overall Study||359
503177|NCT00265512|1210368|P1|COMPLETED|Overall Study||168
503178|NCT00265512|1210367|P2|STARTED|Overall Study||454
503179|NCT00265512|1210368|P1|STARTED|Overall Study||213
503180|NCT00265473|1210374|P1|NOT COMPLETED|Overall Study||0
503181|NCT00265473|1210374|P1|COMPLETED|Overall Study||5
503182|NCT00265473|1210374|P1|STARTED|Overall Study||5
503183|NCT00265239|1210384|P2|NOT COMPLETED|Overall Study||1
503184|NCT00265239|1210385|P1|NOT COMPLETED|Overall Study||2
503185|NCT00265239|1210384|P2|COMPLETED|Overall Study||51
503186|NCT00265239|1210385|P1|COMPLETED|Overall Study||50
503187|NCT00265239|1210384|P2|STARTED|Overall Study||52
503188|NCT00265239|1210385|P1|STARTED|Overall Study||52
503189|NCT00265200|1210397|P1|NOT COMPLETED|Overall Study||4
503190|NCT00265200|1210397|P1|COMPLETED|Overall Study||24
503191|NCT00265200|1210397|P1|STARTED|Overall Study||28
503192|NCT00265122|1210407|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
503193|NCT00265122|1210408|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
503194|NCT00265122|1210409|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
503195|NCT00265122|1210410|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
503196|NCT00265122|1210411|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
503197|NCT00265122|1210412|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
503198|NCT00265122|1210407|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
503199|NCT00265122|1210408|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
503200|NCT00265122|1210409|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
503201|NCT00265122|1210410|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
503202|NCT00265122|1210411|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
503203|NCT00265122|1210412|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
503204|NCT00265122|1210407|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
503205|NCT00265122|1210408|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
503206|NCT00265122|1210409|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
503207|NCT00265122|1210410|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
503208|NCT00265122|1210411|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
503209|NCT00265122|1210412|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
503210|NCT00265122|1210407|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
503211|NCT00265122|1210408|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
503212|NCT00265122|1210409|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
503213|NCT00265122|1210410|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
503214|NCT00265122|1210411|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
503215|NCT00265122|1210412|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
503216|NCT00265122|1210407|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
503217|NCT00265122|1210408|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
503218|NCT00265122|1210409|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
503219|NCT00265122|1210410|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
503220|NCT00265122|1210411|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
503221|NCT00265122|1210412|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
503222|NCT00265122|1210407|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
503223|NCT00265122|1210408|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
503224|NCT00265122|1210409|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
503225|NCT00265122|1210410|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
503226|NCT00265122|1210411|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
503227|NCT00265122|1210412|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
503228|NCT00265109|1210434|P1|NOT COMPLETED|Overall Study||6
503229|NCT00265109|1210434|P1|COMPLETED|Overall Study||11
503230|NCT00265109|1210434|P1|STARTED|Overall Study||17
503231|NCT00265096|1210441|P3|NOT COMPLETED|Overall Study||39
503232|NCT00265096|1210442|P2|NOT COMPLETED|Overall Study||51
503233|NCT00265096|1210443|P1|NOT COMPLETED|Overall Study||36
503234|NCT00265096|1210441|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
503317|NCT00264550|1210603|P1|COMPLETED|Overall Study||90
503235|NCT00265096|1210442|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
503236|NCT00265096|1210443|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
503237|NCT00265096|1210441|P3|STARTED|Overall Study||146
503238|NCT00265096|1210442|P2|STARTED|Overall Study||146
503239|NCT00265096|1210443|P1|STARTED|Overall Study||113
503240|NCT00265083|1210475|P3|NOT COMPLETED|Overall Study||42
503241|NCT00265083|1210476|P2|NOT COMPLETED|Overall Study||42
503242|NCT00265083|1210477|P1|NOT COMPLETED|Overall Study||17
503243|NCT00265083|1210475|P3|COMPLETED|Overall Study||98
503244|NCT00265083|1210476|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
503245|NCT00265083|1210477|P1|COMPLETED|Overall Study||61
503246|NCT00265083|1210475|P3|STARTED|Overall Study||140
503247|NCT00265083|1210476|P2|STARTED|Overall Study|One patient did not receive study agent.|138
503248|NCT00265083|1210477|P1|STARTED|Overall Study||78
503249|NCT00264875|1210498|P1|NOT COMPLETED|Overall Study||30
503250|NCT00264875|1210498|P1|COMPLETED|Overall Study||190
503251|NCT00264875|1210498|P1|STARTED|Overall Study||220
503252|NCT00264849|1210504|P2|NOT COMPLETED|Overall Study||25
503253|NCT00264849|1210505|P1|NOT COMPLETED|Overall Study||22
503254|NCT00264849|1210504|P2|COMPLETED|Overall Study||106
503255|NCT00264849|1210505|P1|COMPLETED|Overall Study||253
503256|NCT00264849|1210504|P2|STARTED|Overall Study||131
503257|NCT00264849|1210505|P1|STARTED|Overall Study||275
503258|NCT00264810|1210541|P2|NOT COMPLETED|Open Label Evaluation Period||6
503259|NCT00264810|1210542|P1|NOT COMPLETED|Open Label Evaluation Period||6
503260|NCT00264810|1210541|P2|COMPLETED|Open Label Evaluation Period||86
503261|NCT00264810|1210542|P1|COMPLETED|Open Label Evaluation Period||89
503262|NCT00264810|1210541|P2|1-year Post-implant|Open Label Evaluation Period||90
503263|NCT00264810|1210542|P1|1-year Post-implant|Open Label Evaluation Period||92
503264|NCT00264810|1210541|P2|STARTED|Open Label Evaluation Period||92
503265|NCT00264810|1210542|P1|STARTED|Open Label Evaluation Period||95
503266|NCT00264810|1210541|P2|NOT COMPLETED|Blinded Evaluation Period||1
503267|NCT00264810|1210542|P1|NOT COMPLETED|Blinded Evaluation Period||1
503268|NCT00264810|1210541|P2|COMPLETED|Blinded Evaluation Period||92
503269|NCT00264810|1210542|P1|COMPLETED|Blinded Evaluation Period||95
503270|NCT00264810|1210541|P2|STARTED|Blinded Evaluation Period||93
503271|NCT00264810|1210542|P1|STARTED|Blinded Evaluation Period||96
503272|NCT00264810|1210541|P2|NOT COMPLETED|Stimulation Optimization Period||1
503273|NCT00264810|1210542|P1|NOT COMPLETED|Stimulation Optimization Period||1
503274|NCT00264810|1210541|P2|COMPLETED|Stimulation Optimization Period||93
503275|NCT00264810|1210542|P1|COMPLETED|Stimulation Optimization Period||96
503276|NCT00264810|1210541|P2|STARTED|Stimulation Optimization Period||94
503277|NCT00264810|1210542|P1|STARTED|Stimulation Optimization Period||97
503278|NCT00264810|1210541|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
503279|NCT00264810|1210542|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
503280|NCT00264810|1210541|P2|COMPLETED|Post-Operative Stabilization Period||94
503281|NCT00264810|1210542|P1|COMPLETED|Post-Operative Stabilization Period||97
503282|NCT00264810|1210541|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
503283|NCT00264810|1210542|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
503284|NCT00264810|1210541|P2|NOT COMPLETED|Baseline||26
503285|NCT00264810|1210542|P1|NOT COMPLETED|Baseline||23
503286|NCT00264810|1210541|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
503287|NCT00264810|1210542|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
503288|NCT00264810|1210541|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
503289|NCT00264810|1210542|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
503290|NCT00264797|1210552|P2|NOT COMPLETED|Overall Study||43
503291|NCT00264797|1210553|P1|NOT COMPLETED|Overall Study||33
503292|NCT00264797|1210552|P2|COMPLETED|Overall Study||109
503293|NCT00264797|1210553|P1|COMPLETED|Overall Study||118
503294|NCT00264797|1210552|P2|STARTED|Overall Study||152
503295|NCT00264797|1210553|P1|STARTED|Overall Study||151
503296|NCT00264641|1210567|P2|NOT COMPLETED|Overall Study||0
503297|NCT00264641|1210568|P1|NOT COMPLETED|Overall Study||0
503298|NCT00264641|1210567|P2|COMPLETED|Overall Study||10
503299|NCT00264641|1210568|P1|COMPLETED|Overall Study||10
503300|NCT00264641|1210567|P2|Initiation of the Study|Overall Study||10
503301|NCT00264641|1210568|P1|Initiation of the Study|Overall Study||10
503302|NCT00264641|1210567|P2|STARTED|Overall Study||10
503303|NCT00264641|1210568|P1|STARTED|Overall Study||10
503304|NCT00264576|1210575|P2|NOT COMPLETED|Overall Study||1
503305|NCT00264576|1210576|P1|NOT COMPLETED|Overall Study||1
503306|NCT00264576|1210575|P2|COMPLETED|Overall Study||304
503307|NCT00264576|1210576|P1|COMPLETED|Overall Study||307
503308|NCT00264576|1210575|P2|STARTED|Overall Study||305
503309|NCT00264576|1210576|P1|STARTED|Overall Study||308
503310|NCT00264550|1210600|P4|NOT COMPLETED|Overall Study||30
503311|NCT00264550|1210601|P3|NOT COMPLETED|Overall Study||17
503312|NCT00264550|1210602|P2|NOT COMPLETED|Overall Study||41
503313|NCT00264550|1210603|P1|NOT COMPLETED|Overall Study||43
503314|NCT00264550|1210600|P4|COMPLETED|Overall Study||59
503315|NCT00264550|1210601|P3|COMPLETED|Overall Study||72
503316|NCT00264550|1210602|P2|COMPLETED|Overall Study||92
503318|NCT00264550|1210600|P4|STARTED|Overall Study||89
503319|NCT00264550|1210601|P3|STARTED|Overall Study||89
503320|NCT00264550|1210602|P2|STARTED|Overall Study||133
503321|NCT00264550|1210603|P1|STARTED|Overall Study||133
503322|NCT00264537|1210642|P4|NOT COMPLETED|Overall Study||60
503323|NCT00264537|1210643|P3|NOT COMPLETED|Overall Study||50
503324|NCT00264537|1210644|P2|NOT COMPLETED|Overall Study||58
503325|NCT00264537|1210645|P1|NOT COMPLETED|Overall Study||50
503326|NCT00264537|1210642|P4|COMPLETED|Overall Study||99
503327|NCT00264537|1210643|P3|COMPLETED|Overall Study||109
503328|NCT00264537|1210644|P2|COMPLETED|Overall Study||101
503329|NCT00264537|1210645|P1|COMPLETED|Overall Study||110
503330|NCT00264537|1210642|P4|STARTED|Overall Study||159
503331|NCT00264537|1210643|P3|STARTED|Overall Study||159
503332|NCT00264537|1210644|P2|STARTED|Overall Study||159
503333|NCT00264537|1210645|P1|STARTED|Overall Study||160
503334|NCT00264498|1210677|P2|NOT COMPLETED|Crossover Treatment||9
503335|NCT00264498|1210678|P1|NOT COMPLETED|Crossover Treatment||6
503336|NCT00264498|1210677|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
503337|NCT00264498|1210678|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
503338|NCT00264498|1210677|P2|STARTED|Crossover Treatment||9
503339|NCT00264498|1210678|P1|STARTED|Crossover Treatment||6
503340|NCT00264498|1210677|P2|NOT COMPLETED|Randomized Treatment||18
503341|NCT00264498|1210678|P1|NOT COMPLETED|Randomized Treatment||17
503342|NCT00264498|1210677|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
503343|NCT00264498|1210678|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
503344|NCT00264498|1210677|P2|STARTED|Randomized Treatment||18
503345|NCT00264498|1210678|P1|STARTED|Randomized Treatment||17
503346|NCT00264381|1210686|P2|NOT COMPLETED|Overall Study||0
503347|NCT00264381|1210687|P1|NOT COMPLETED|Overall Study||0
503348|NCT00264381|1210686|P2|COMPLETED|Overall Study||37
503349|NCT00264381|1210687|P1|COMPLETED|Overall Study||35
503350|NCT00264381|1210686|P2|STARTED|Overall Study||37
503351|NCT00264381|1210687|P1|STARTED|Overall Study||35
503352|NCT00264303|1210701|P2|NOT COMPLETED|Overall Study||29
503353|NCT00264303|1210702|P1|NOT COMPLETED|Overall Study||25
503354|NCT00264303|1210701|P2|COMPLETED|Overall Study||419
503355|NCT00264303|1210702|P1|COMPLETED|Overall Study||413
503356|NCT00264303|1210701|P2|STARTED|Overall Study||448
503357|NCT00264303|1210702|P1|STARTED|Overall Study||438
503358|NCT00264290|1210720|P2|NOT COMPLETED|Observation (4 Weeks)||0
503359|NCT00264290|1210721|P1|NOT COMPLETED|Observation (4 Weeks)||0
503360|NCT00264290|1210720|P2|COMPLETED|Observation (4 Weeks)||14
503361|NCT00264290|1210721|P1|COMPLETED|Observation (4 Weeks)||15
503362|NCT00264290|1210720|P2|STARTED|Observation (4 Weeks)||14
503363|NCT00264290|1210721|P1|STARTED|Observation (4 Weeks)||15
503364|NCT00264290|1210720|P2|NOT COMPLETED|Intervention (8 Weeks)||0
503365|NCT00264290|1210721|P1|NOT COMPLETED|Intervention (8 Weeks)||1
503366|NCT00264290|1210720|P2|COMPLETED|Intervention (8 Weeks)||14
503367|NCT00264290|1210721|P1|COMPLETED|Intervention (8 Weeks)||15
503368|NCT00264290|1210720|P2|STARTED|Intervention (8 Weeks)||14
503369|NCT00264290|1210721|P1|STARTED|Intervention (8 Weeks)||16
503370|NCT00264238|1210727|P1|NOT COMPLETED|Overall Study||1
503371|NCT00264238|1210727|P1|COMPLETED|Overall Study||14
503372|NCT00264238|1210727|P1|STARTED|Overall Study||15
503373|NCT00264147|1210739|P6|NOT COMPLETED|Treatment II Period||33
503374|NCT00264147|1210740|P5|NOT COMPLETED|Treatment II Period||33
503375|NCT00264147|1210741|P4|NOT COMPLETED|Treatment II Period||0
503376|NCT00264147|1210742|P3|NOT COMPLETED|Treatment II Period||0
503377|NCT00264147|1210743|P2|NOT COMPLETED|Treatment II Period||0
503378|NCT00264147|1210744|P1|NOT COMPLETED|Treatment II Period||0
503379|NCT00264147|1210739|P6|COMPLETED|Treatment II Period||116
503380|NCT00264147|1210740|P5|COMPLETED|Treatment II Period||147
503381|NCT00264147|1210741|P4|COMPLETED|Treatment II Period||0
503382|NCT00264147|1210742|P3|COMPLETED|Treatment II Period||0
503383|NCT00264147|1210743|P2|COMPLETED|Treatment II Period||0
503384|NCT00264147|1210744|P1|COMPLETED|Treatment II Period||0
503385|NCT00264147|1210739|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
503386|NCT00264147|1210740|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
503387|NCT00264147|1210741|P4|STARTED|Treatment II Period||0
503388|NCT00264147|1210742|P3|STARTED|Treatment II Period||0
503389|NCT00264147|1210743|P2|STARTED|Treatment II Period||0
503390|NCT00264147|1210744|P1|STARTED|Treatment II Period||0
503391|NCT00264147|1210739|P6|NOT COMPLETED|Treatment I Period||0
503392|NCT00264147|1210740|P5|NOT COMPLETED|Treatment I Period||56
503393|NCT00264147|1210741|P4|NOT COMPLETED|Treatment I Period||72
503394|NCT00264147|1210742|P3|NOT COMPLETED|Treatment I Period||77
503395|NCT00264147|1210743|P2|NOT COMPLETED|Treatment I Period||83
503396|NCT00264147|1210744|P1|NOT COMPLETED|Treatment I Period||98
503397|NCT00264147|1210739|P6|COMPLETED|Treatment I Period||0
503398|NCT00264147|1210740|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
503399|NCT00264147|1210741|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
503400|NCT00264147|1210742|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
503401|NCT00264147|1210743|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
503402|NCT00264147|1210744|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
503403|NCT00264147|1210739|P6|STARTED|Treatment I Period||0
503404|NCT00264147|1210740|P5|STARTED|Treatment I Period||155
503405|NCT00264147|1210741|P4|STARTED|Treatment I Period||140
503406|NCT00264147|1210742|P3|STARTED|Treatment I Period||151
503407|NCT00264147|1210743|P2|STARTED|Treatment I Period||154
503408|NCT00264147|1210744|P1|STARTED|Treatment I Period||161
503409|NCT00264004|1210787|P4|NOT COMPLETED|Overall Study||15
503410|NCT00264004|1210788|P3|NOT COMPLETED|Overall Study||14
503411|NCT00264004|1210789|P2|NOT COMPLETED|Overall Study||11
503412|NCT00264004|1210790|P1|NOT COMPLETED|Overall Study||17
503413|NCT00264004|1210787|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
503414|NCT00264004|1210788|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
503415|NCT00264004|1210789|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
503416|NCT00264004|1210790|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
503417|NCT00264004|1210787|P4|STARTED|Overall Study|Randomised|34
503418|NCT00264004|1210788|P3|STARTED|Overall Study|Randomised|30
503419|NCT00264004|1210789|P2|STARTED|Overall Study|Randomised|32
503420|NCT00264004|1210790|P1|STARTED|Overall Study|Randomised|30
503421|NCT00263887|1210818|P2|NOT COMPLETED|Overall Study||7
503422|NCT00263887|1210819|P1|NOT COMPLETED|Overall Study||3
503423|NCT00263887|1210818|P2|COMPLETED|Overall Study||32
503424|NCT00263887|1210819|P1|COMPLETED|Overall Study||35
503425|NCT00263887|1210818|P2|STARTED|Overall Study||39
503426|NCT00263887|1210819|P1|STARTED|Overall Study||38
503427|NCT00263757|1210827|P2|NOT COMPLETED|Overall Study||8
503428|NCT00263757|1210828|P1|NOT COMPLETED|Overall Study||8
503429|NCT00263757|1210827|P2|COMPLETED|Overall Study||5
503430|NCT00263757|1210828|P1|COMPLETED|Overall Study||4
503431|NCT00263757|1210827|P2|STARTED|Overall Study||13
503432|NCT00263757|1210828|P1|STARTED|Overall Study||12
503433|NCT00263666|1210840|P2|NOT COMPLETED|Overall Study||11
503434|NCT00263666|1210841|P1|NOT COMPLETED|Overall Study||7
503435|NCT00263666|1210840|P2|COMPLETED|Overall Study||39
503436|NCT00263666|1210841|P1|COMPLETED|Overall Study||43
503437|NCT00263666|1210840|P2|STARTED|Overall Study||50
503438|NCT00263666|1210841|P1|STARTED|Overall Study||50
503439|NCT00263328|1210895|P3|NOT COMPLETED|Overall Study||7
503440|NCT00263328|1210896|P2|NOT COMPLETED|Overall Study||2
503441|NCT00263328|1210897|P1|NOT COMPLETED|Overall Study||8
503442|NCT00263328|1210895|P3|COMPLETED|Overall Study||6
503443|NCT00263328|1210896|P2|COMPLETED|Overall Study||12
503444|NCT00263328|1210897|P1|COMPLETED|Overall Study||10
503445|NCT00263328|1210895|P3|STARTED|Overall Study||13
503446|NCT00263328|1210896|P2|STARTED|Overall Study||14
503447|NCT00263328|1210897|P1|STARTED|Overall Study||18
503448|NCT00263211|1211055|P2|NOT COMPLETED|Overall Study||1
503449|NCT00263211|1211056|P1|NOT COMPLETED|Overall Study||5
503450|NCT00263211|1211055|P2|COMPLETED|Overall Study||23
503451|NCT00263211|1211056|P1|COMPLETED|Overall Study||19
503452|NCT00263211|1211055|P2|STARTED|Overall Study||24
503453|NCT00263211|1211056|P1|STARTED|Overall Study||24
503454|NCT00262964|1211074|P4|NOT COMPLETED|Overall Study||0
503455|NCT00262964|1211075|P3|NOT COMPLETED|Overall Study||0
503456|NCT00262964|1211076|P2|NOT COMPLETED|Overall Study||0
503457|NCT00262964|1211077|P1|NOT COMPLETED|Overall Study||0
503458|NCT00262964|1211074|P4|COMPLETED|Overall Study||12
503459|NCT00262964|1211075|P3|COMPLETED|Overall Study||17
503460|NCT00262964|1211076|P2|COMPLETED|Overall Study||11
503461|NCT00262964|1211077|P1|COMPLETED|Overall Study||11
503462|NCT00262964|1211074|P4|STARTED|Overall Study||12
503463|NCT00262964|1211075|P3|STARTED|Overall Study||17
503464|NCT00262964|1211076|P2|STARTED|Overall Study||11
503465|NCT00262964|1211077|P1|STARTED|Overall Study||11
503466|NCT00262951|1211107|P1|NOT COMPLETED|Overall Study||16
503467|NCT00262951|1211107|P1|COMPLETED|Overall Study||7
503468|NCT00262951|1211107|P1|STARTED|Overall Study||23
503469|NCT00262925|1211112|P1|NOT COMPLETED|Overall Study||11
503470|NCT00262925|1211112|P1|COMPLETED|Overall Study||1
503471|NCT00262925|1211112|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
503472|NCT00262873|1211118|P1|NOT COMPLETED|Overall Study||8
503473|NCT00262873|1211118|P1|COMPLETED|Overall Study||0
503474|NCT00262873|1211118|P1|STARTED|Overall Study||8
503475|NCT00262860|1211129|P1|NOT COMPLETED|Overall Study||2
503476|NCT00262860|1211129|P1|COMPLETED|Overall Study||16
503477|NCT00262860|1211129|P1|STARTED|Overall Study||18
503478|NCT00262847|1211138|P3|NOT COMPLETED|Overall Study||396
503479|NCT00262847|1211139|P2|NOT COMPLETED|Overall Study||513
503480|NCT00262847|1211140|P1|NOT COMPLETED|Overall Study||518
503481|NCT00262847|1211138|P3|COMPLETED|Overall Study||227
503482|NCT00262847|1211139|P2|COMPLETED|Overall Study||112
503483|NCT00262847|1211140|P1|COMPLETED|Overall Study||107
503484|NCT00262847|1211138|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
503485|NCT00262847|1211139|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
503486|NCT00262847|1211140|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
503487|NCT00262834|1211156|P2|NOT COMPLETED|Overall Study||4
503488|NCT00262834|1211157|P1|NOT COMPLETED|Overall Study||1
503489|NCT00262834|1211156|P2|COMPLETED|Overall Study||25
503490|NCT00262834|1211157|P1|COMPLETED|Overall Study||24
503491|NCT00262834|1211156|P2|STARTED|Overall Study||29
503492|NCT00262834|1211157|P1|STARTED|Overall Study||25
503493|NCT00262743|1211167|P2|NOT COMPLETED|Overall Study||12
503494|NCT00262743|1211168|P1|NOT COMPLETED|Overall Study||0
503495|NCT00262743|1211167|P2|COMPLETED|Overall Study||30
503496|NCT00262743|1211168|P1|COMPLETED|Overall Study||27
503497|NCT00262743|1211167|P2|STARTED|Overall Study||42
503498|NCT00262743|1211168|P1|STARTED|Overall Study||27
503499|NCT00262730|1211175|P1|NOT COMPLETED|Overall Study||0
503500|NCT00262730|1211175|P1|COMPLETED|Overall Study||97
503501|NCT00262730|1211175|P1|STARTED|Overall Study||97
503502|NCT00262639|1211183|P4|NOT COMPLETED|Overall Study||0
503503|NCT00262639|1211184|P3|NOT COMPLETED|Overall Study||0
503504|NCT00262639|1211185|P2|NOT COMPLETED|Overall Study||0
503505|NCT00262639|1211186|P1|NOT COMPLETED|Overall Study||0
503506|NCT00262639|1211183|P4|COMPLETED|Overall Study||7
503507|NCT00262639|1211184|P3|COMPLETED|Overall Study||9
503508|NCT00262639|1211185|P2|COMPLETED|Overall Study||26
503509|NCT00262639|1211186|P1|COMPLETED|Overall Study||18
503510|NCT00262639|1211183|P4|STARTED|Overall Study||7
503511|NCT00262639|1211184|P3|STARTED|Overall Study||9
503512|NCT00262639|1211185|P2|STARTED|Overall Study||26
503513|NCT00262639|1211186|P1|STARTED|Overall Study||18
503514|NCT00262600|1211203|P3|NOT COMPLETED|Overall Study||266
503515|NCT00262600|1211204|P2|NOT COMPLETED|Overall Study||252
503516|NCT00262600|1211205|P1|NOT COMPLETED|Overall Study||235
503517|NCT00262600|1211203|P3|COMPLETED|Overall Study||5756
503518|NCT00262600|1211204|P2|COMPLETED|Overall Study||5824
503519|NCT00262600|1211205|P1|COMPLETED|Overall Study||5780
503520|NCT00262600|1211203|P3|STARTED|Overall Study||6022
503521|NCT00262600|1211204|P2|STARTED|Overall Study||6076
503522|NCT00262600|1211205|P1|STARTED|Overall Study||6015
503523|NCT00262522|1211232|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
503524|NCT00262522|1211233|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
503525|NCT00262522|1211234|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
503526|NCT00262522|1211235|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
503527|NCT00262522|1211232|P4|COMPLETED|Study Start Through 96 Weeks||0
503528|NCT00262522|1211233|P3|COMPLETED|Study Start Through 96 Weeks||254
503529|NCT00262522|1211234|P2|COMPLETED|Study Start Through 96 Weeks||0
503530|NCT00262522|1211235|P1|COMPLETED|Study Start Through 96 Weeks||256
503531|NCT00262522|1211232|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
503532|NCT00262522|1211233|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
503533|NCT00262522|1211234|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
503608|NCT00262223|1211297|P2|STARTED|Treatment Phase||37
503534|NCT00262522|1211235|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
503535|NCT00262522|1211232|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
503536|NCT00262522|1211233|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
503537|NCT00262522|1211234|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
503538|NCT00262522|1211235|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
503539|NCT00262522|1211232|P4|COMPLETED|Study Start Through 48 Weeks||0
503540|NCT00262522|1211233|P3|COMPLETED|Study Start Through 48 Weeks||276
503541|NCT00262522|1211234|P2|COMPLETED|Study Start Through 48 Weeks||0
503542|NCT00262522|1211235|P1|COMPLETED|Study Start Through 48 Weeks||284
503543|NCT00262522|1211232|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
503544|NCT00262522|1211233|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
503545|NCT00262522|1211234|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
503546|NCT00262522|1211235|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
503547|NCT00262522|1211232|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
503548|NCT00262522|1211233|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
503549|NCT00262522|1211234|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
503550|NCT00262522|1211235|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
503551|NCT00262522|1211232|P4|COMPLETED|Study Start Through 8 Weeks||160
503552|NCT00262522|1211233|P3|COMPLETED|Study Start Through 8 Weeks||155
503553|NCT00262522|1211234|P2|COMPLETED|Study Start Through 8 Weeks||161
503554|NCT00262522|1211235|P1|COMPLETED|Study Start Through 8 Weeks||163
503555|NCT00262522|1211232|P4|STARTED|Study Start Through 8 Weeks||165
503556|NCT00262522|1211233|P3|STARTED|Study Start Through 8 Weeks||166
503557|NCT00262522|1211234|P2|STARTED|Study Start Through 8 Weeks||166
503558|NCT00262522|1211235|P1|STARTED|Study Start Through 8 Weeks||167
503559|NCT00262509|1211257|P2|NOT COMPLETED|Overall Study||0
503560|NCT00262509|1211258|P1|NOT COMPLETED|Overall Study||0
503561|NCT00262509|1211257|P2|COMPLETED|Overall Study||9
503562|NCT00262509|1211258|P1|COMPLETED|Overall Study||8
503563|NCT00262509|1211257|P2|STARTED|Overall Study||9
503564|NCT00262509|1211258|P1|STARTED|Overall Study||8
503565|NCT00262314|1211264|P1|NOT COMPLETED|Overall Study||337
503566|NCT00262314|1211264|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
503567|NCT00262314|1211264|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
503568|NCT00262301|1211282|P3|NOT COMPLETED|Open-label Phase||0
503569|NCT00262301|1211283|P2|NOT COMPLETED|Open-label Phase||0
503570|NCT00262301|1211284|P1|NOT COMPLETED|Open-label Phase||0
503571|NCT00262301|1211282|P3|COMPLETED|Open-label Phase||57
503572|NCT00262301|1211283|P2|COMPLETED|Open-label Phase||0
503573|NCT00262301|1211284|P1|COMPLETED|Open-label Phase||0
503574|NCT00262301|1211282|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
503575|NCT00262301|1211283|P2|STARTED|Open-label Phase||0
503576|NCT00262301|1211284|P1|STARTED|Open-label Phase||0
503577|NCT00262301|1211282|P3|NOT COMPLETED|Double-blind Phase||0
503578|NCT00262301|1211283|P2|NOT COMPLETED|Double-blind Phase||1
503579|NCT00262301|1211284|P1|NOT COMPLETED|Double-blind Phase||1
503580|NCT00262301|1211282|P3|COMPLETED|Double-blind Phase||0
503581|NCT00262301|1211283|P2|COMPLETED|Double-blind Phase||15
503582|NCT00262301|1211284|P1|COMPLETED|Double-blind Phase||15
503583|NCT00262301|1211282|P3|STARTED|Double-blind Phase||0
503584|NCT00262301|1211283|P2|STARTED|Double-blind Phase||16
503585|NCT00262301|1211284|P1|STARTED|Double-blind Phase||16
503586|NCT00262223|1211297|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
503587|NCT00262223|1211298|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
503588|NCT00262223|1211297|P2|COMPLETED|12-month Post-treatment Follow-up||22
503589|NCT00262223|1211298|P1|COMPLETED|12-month Post-treatment Follow-up||21
503590|NCT00262223|1211297|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
503591|NCT00262223|1211298|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
503592|NCT00262223|1211297|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
503593|NCT00262223|1211298|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
503594|NCT00262223|1211297|P2|COMPLETED|6-month Post-treatment Follow-up||28
503595|NCT00262223|1211298|P1|COMPLETED|6-month Post-treatment Follow-up||22
503596|NCT00262223|1211297|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
503597|NCT00262223|1211298|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
503598|NCT00262223|1211297|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
503599|NCT00262223|1211298|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
503600|NCT00262223|1211297|P2|COMPLETED|1-week Post-treatment Follow-up||25
503601|NCT00262223|1211298|P1|COMPLETED|1-week Post-treatment Follow-up||24
503602|NCT00262223|1211297|P2|STARTED|1-week Post-treatment Follow-up||29
503603|NCT00262223|1211298|P1|STARTED|1-week Post-treatment Follow-up||28
503604|NCT00262223|1211297|P2|NOT COMPLETED|Treatment Phase||8
503605|NCT00262223|1211298|P1|NOT COMPLETED|Treatment Phase||4
503606|NCT00262223|1211297|P2|COMPLETED|Treatment Phase||29
503607|NCT00262223|1211298|P1|COMPLETED|Treatment Phase||28
503609|NCT00262223|1211298|P1|STARTED|Treatment Phase||32
503610|NCT00262119|1211309|P3|NOT COMPLETED|Overall Study||58
503611|NCT00262119|1211310|P2|NOT COMPLETED|Overall Study||70
503612|NCT00262119|1211311|P1|NOT COMPLETED|Overall Study||58
503613|NCT00262119|1211309|P3|COMPLETED|Overall Study||325
503614|NCT00262119|1211310|P2|COMPLETED|Overall Study||328
503615|NCT00262119|1211311|P1|COMPLETED|Overall Study||327
503616|NCT00262119|1211309|P3|STARTED|Overall Study||383
503617|NCT00262119|1211310|P2|STARTED|Overall Study||398
503618|NCT00262119|1211311|P1|STARTED|Overall Study||385
503619|NCT00262080|1211331|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
503620|NCT00262080|1211332|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
503621|NCT00262080|1211333|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
503622|NCT00262080|1211331|P3|COMPLETED|Repeat Dose Treatment Period||14
503623|NCT00262080|1211332|P2|COMPLETED|Repeat Dose Treatment Period||25
503624|NCT00262080|1211333|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
503625|NCT00262080|1211331|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
503626|NCT00262080|1211332|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
503627|NCT00262080|1211333|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
503628|NCT00262080|1211331|P3|NOT COMPLETED|Double Blind Treatment Period||0
503629|NCT00262080|1211332|P2|NOT COMPLETED|Double Blind Treatment Period||0
503630|NCT00262080|1211333|P1|NOT COMPLETED|Double Blind Treatment Period||1
503631|NCT00262080|1211331|P3|COMPLETED|Double Blind Treatment Period||0
503632|NCT00262080|1211332|P2|COMPLETED|Double Blind Treatment Period||36
503633|NCT00262080|1211333|P1|COMPLETED|Double Blind Treatment Period||35
503634|NCT00262080|1211331|P3|STARTED|Double Blind Treatment Period||0
503635|NCT00262080|1211332|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
503636|NCT00262080|1211333|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
503637|NCT00262067|1211353|P4|NOT COMPLETED|Overall Study||113
503638|NCT00262067|1211354|P3|NOT COMPLETED|Overall Study||216
503639|NCT00262067|1211355|P2|NOT COMPLETED|Overall Study||100
503640|NCT00262067|1211356|P1|NOT COMPLETED|Overall Study||219
503641|NCT00262067|1211353|P4|COMPLETED|Overall Study||93
503642|NCT00262067|1211354|P3|COMPLETED|Overall Study||193
503643|NCT00262067|1211355|P2|COMPLETED|Overall Study||107
503644|NCT00262067|1211356|P1|COMPLETED|Overall Study||196
503645|NCT00262067|1211353|P4|STARTED|Overall Study||206
503646|NCT00262067|1211354|P3|STARTED|Overall Study||409
503647|NCT00262067|1211355|P2|STARTED|Overall Study||207
503648|NCT00262067|1211356|P1|STARTED|Overall Study||415
503649|NCT00262041|1211390|P3|NOT COMPLETED|Overall Study||6
503650|NCT00262041|1211391|P2|NOT COMPLETED|Overall Study||4
503651|NCT00262041|1211392|P1|NOT COMPLETED|Overall Study||2
503652|NCT00262041|1211390|P3|COMPLETED|Overall Study||203
503653|NCT00262041|1211391|P2|COMPLETED|Overall Study||147
503654|NCT00262041|1211392|P1|COMPLETED|Overall Study||162
503655|NCT00262041|1211390|P3|STARTED|Overall Study||209
503656|NCT00262041|1211391|P2|STARTED|Overall Study||151
503657|NCT00262041|1211392|P1|STARTED|Overall Study||164
503658|NCT00262028|1211421|P9|NOT COMPLETED|Overall Study||19
503659|NCT00262028|1211422|P8|NOT COMPLETED|Overall Study||18
503660|NCT00262028|1211423|P7|NOT COMPLETED|Overall Study||12
503661|NCT00262028|1211424|P6|NOT COMPLETED|Overall Study||13
503662|NCT00262028|1211425|P5|NOT COMPLETED|Overall Study||12
503663|NCT00262028|1211426|P4|NOT COMPLETED|Overall Study||23
503664|NCT00262028|1211427|P3|NOT COMPLETED|Overall Study||20
503665|NCT00262028|1211428|P2|NOT COMPLETED|Overall Study||27
503666|NCT00262028|1211429|P1|NOT COMPLETED|Overall Study||24
503667|NCT00262028|1211421|P9|COMPLETED|Overall Study||81
503668|NCT00262028|1211422|P8|COMPLETED|Overall Study||55
503669|NCT00262028|1211423|P7|COMPLETED|Overall Study||59
503670|NCT00262028|1211424|P6|COMPLETED|Overall Study||60
503671|NCT00262028|1211425|P5|COMPLETED|Overall Study||62
503672|NCT00262028|1211426|P4|COMPLETED|Overall Study||134
503673|NCT00262028|1211427|P3|COMPLETED|Overall Study||137
503674|NCT00262028|1211428|P2|COMPLETED|Overall Study||126
503675|NCT00262028|1211429|P1|COMPLETED|Overall Study||128
503676|NCT00262028|1211421|P9|STARTED|Overall Study||100
503677|NCT00262028|1211422|P8|STARTED|Overall Study||73
503678|NCT00262028|1211423|P7|STARTED|Overall Study||71
503679|NCT00262028|1211424|P6|STARTED|Overall Study||73
503680|NCT00262028|1211425|P5|STARTED|Overall Study||74
503681|NCT00262028|1211426|P4|STARTED|Overall Study||157
503682|NCT00262028|1211427|P3|STARTED|Overall Study||157
503683|NCT00262028|1211428|P2|STARTED|Overall Study||153
503684|NCT00262028|1211429|P1|STARTED|Overall Study||152
503685|NCT00262002|1211491|P7|NOT COMPLETED|Overall Study||6
503686|NCT00262002|1211492|P6|NOT COMPLETED|Overall Study||7
503687|NCT00262002|1211493|P5|NOT COMPLETED|Overall Study||7
503688|NCT00262002|1211494|P4|NOT COMPLETED|Overall Study||5
503689|NCT00262002|1211495|P3|NOT COMPLETED|Overall Study||0
503690|NCT00262002|1211496|P2|NOT COMPLETED|Overall Study||6
503691|NCT00262002|1211497|P1|NOT COMPLETED|Overall Study||11
503692|NCT00262002|1211491|P7|COMPLETED|Overall Study||84
503693|NCT00262002|1211492|P6|COMPLETED|Overall Study||83
503694|NCT00262002|1211493|P5|COMPLETED|Overall Study||91
503695|NCT00262002|1211494|P4|COMPLETED|Overall Study||93
503696|NCT00262002|1211495|P3|COMPLETED|Overall Study||45
503697|NCT00262002|1211496|P2|COMPLETED|Overall Study||84
503698|NCT00262002|1211497|P1|COMPLETED|Overall Study||79
503699|NCT00262002|1211491|P7|STARTED|Overall Study||90
503700|NCT00262002|1211492|P6|STARTED|Overall Study||90
503701|NCT00262002|1211493|P5|STARTED|Overall Study||98
503702|NCT00262002|1211494|P4|STARTED|Overall Study||98
503703|NCT00262002|1211495|P3|STARTED|Overall Study||45
503704|NCT00262002|1211496|P2|STARTED|Overall Study||90
503705|NCT00262002|1211497|P1|STARTED|Overall Study||90
503706|NCT00261950|1211590|P1|NOT COMPLETED|Overall Study||26
503707|NCT00261950|1211590|P1|COMPLETED|Overall Study||84
503708|NCT00261950|1211590|P1|STARTED|Overall Study||110
503709|NCT00261846|1211617|P14|NOT COMPLETED|Part 2: Efficacy||23
503710|NCT00261846|1211618|P13|NOT COMPLETED|Part 2: Efficacy||26
503711|NCT00261846|1211619|P12|NOT COMPLETED|Part 2: Efficacy||26
503712|NCT00261846|1211620|P11|NOT COMPLETED|Part 2: Efficacy||25
503713|NCT00261846|1211621|P10|NOT COMPLETED|Part 2: Efficacy||42
503714|NCT00261846|1211622|P9|NOT COMPLETED|Part 2: Efficacy||2
503715|NCT00261846|1211623|P8|NOT COMPLETED|Part 2: Efficacy||26
503716|NCT00261846|1211624|P7|NOT COMPLETED|Part 2: Efficacy||33
503717|NCT00261846|1211625|P6|NOT COMPLETED|Part 2: Efficacy||33
503718|NCT00261846|1211626|P5|NOT COMPLETED|Part 2: Efficacy||60
503719|NCT00261846|1211627|P4|NOT COMPLETED|Part 2: Efficacy||162
503720|NCT00261846|1211628|P3|NOT COMPLETED|Part 2: Efficacy||0
503721|NCT00261846|1211629|P2|NOT COMPLETED|Part 2: Efficacy||0
503722|NCT00261846|1211630|P1|NOT COMPLETED|Part 2: Efficacy||0
503723|NCT00261846|1211617|P14|COMPLETED|Part 2: Efficacy||1
503724|NCT00261846|1211618|P13|COMPLETED|Part 2: Efficacy||3
503725|NCT00261846|1211619|P12|COMPLETED|Part 2: Efficacy||9
503726|NCT00261846|1211620|P11|COMPLETED|Part 2: Efficacy||6
503727|NCT00261846|1211621|P10|COMPLETED|Part 2: Efficacy||4
503728|NCT00261846|1211622|P9|COMPLETED|Part 2: Efficacy||2
503729|NCT00261846|1211623|P8|COMPLETED|Part 2: Efficacy||1
503730|NCT00261846|1211624|P7|COMPLETED|Part 2: Efficacy||17
503731|NCT00261846|1211625|P6|COMPLETED|Part 2: Efficacy||4
503732|NCT00261846|1211626|P5|COMPLETED|Part 2: Efficacy||28
503733|NCT00261846|1211627|P4|COMPLETED|Part 2: Efficacy||38
503734|NCT00261846|1211628|P3|COMPLETED|Part 2: Efficacy||0
503735|NCT00261846|1211629|P2|COMPLETED|Part 2: Efficacy||0
503736|NCT00261846|1211630|P1|COMPLETED|Part 2: Efficacy||0
503737|NCT00261846|1211617|P14|STARTED|Part 2: Efficacy||24
503738|NCT00261846|1211618|P13|STARTED|Part 2: Efficacy||29
503739|NCT00261846|1211619|P12|STARTED|Part 2: Efficacy||35
503740|NCT00261846|1211620|P11|STARTED|Part 2: Efficacy||31
503821|NCT00261495|1211902|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
503741|NCT00261846|1211621|P10|STARTED|Part 2: Efficacy|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|46
503742|NCT00261846|1211622|P9|STARTED|Part 2: Efficacy||4
503743|NCT00261846|1211623|P8|STARTED|Part 2: Efficacy||27
503744|NCT00261846|1211624|P7|STARTED|Part 2: Efficacy||50
503745|NCT00261846|1211625|P6|STARTED|Part 2: Efficacy||37
503746|NCT00261846|1211626|P5|STARTED|Part 2: Efficacy||88
503747|NCT00261846|1211627|P4|STARTED|Part 2: Efficacy|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|200
503748|NCT00261846|1211628|P3|STARTED|Part 2: Efficacy||0
503749|NCT00261846|1211629|P2|STARTED|Part 2: Efficacy||0
503750|NCT00261846|1211630|P1|STARTED|Part 2: Efficacy||0
503751|NCT00261846|1211617|P14|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503752|NCT00261846|1211618|P13|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503753|NCT00261846|1211619|P12|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503754|NCT00261846|1211620|P11|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503755|NCT00261846|1211621|P10|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503756|NCT00261846|1211622|P9|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503757|NCT00261846|1211623|P8|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503758|NCT00261846|1211624|P7|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503759|NCT00261846|1211625|P6|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503760|NCT00261846|1211626|P5|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503761|NCT00261846|1211627|P4|NOT COMPLETED|Part 1: Dose-escalation Phase||0
503762|NCT00261846|1211628|P3|NOT COMPLETED|Part 1: Dose-escalation Phase||12
503763|NCT00261846|1211629|P2|NOT COMPLETED|Part 1: Dose-escalation Phase||3
503764|NCT00261846|1211630|P1|NOT COMPLETED|Part 1: Dose-escalation Phase||3
503765|NCT00261846|1211617|P14|COMPLETED|Part 1: Dose-escalation Phase||0
503766|NCT00261846|1211618|P13|COMPLETED|Part 1: Dose-escalation Phase||0
503767|NCT00261846|1211619|P12|COMPLETED|Part 1: Dose-escalation Phase||0
503768|NCT00261846|1211620|P11|COMPLETED|Part 1: Dose-escalation Phase||0
503769|NCT00261846|1211621|P10|COMPLETED|Part 1: Dose-escalation Phase||0
503770|NCT00261846|1211622|P9|COMPLETED|Part 1: Dose-escalation Phase||0
503771|NCT00261846|1211623|P8|COMPLETED|Part 1: Dose-escalation Phase||0
503772|NCT00261846|1211624|P7|COMPLETED|Part 1: Dose-escalation Phase||0
503773|NCT00261846|1211625|P6|COMPLETED|Part 1: Dose-escalation Phase||0
503774|NCT00261846|1211626|P5|COMPLETED|Part 1: Dose-escalation Phase||0
503775|NCT00261846|1211627|P4|COMPLETED|Part 1: Dose-escalation Phase||0
503776|NCT00261846|1211628|P3|COMPLETED|Part 1: Dose-escalation Phase||0
503777|NCT00261846|1211629|P2|COMPLETED|Part 1: Dose-escalation Phase||0
503778|NCT00261846|1211630|P1|COMPLETED|Part 1: Dose-escalation Phase||0
503779|NCT00261846|1211617|P14|STARTED|Part 1: Dose-escalation Phase||0
503780|NCT00261846|1211618|P13|STARTED|Part 1: Dose-escalation Phase||0
503781|NCT00261846|1211619|P12|STARTED|Part 1: Dose-escalation Phase||0
503782|NCT00261846|1211620|P11|STARTED|Part 1: Dose-escalation Phase||0
503783|NCT00261846|1211621|P10|STARTED|Part 1: Dose-escalation Phase||0
503784|NCT00261846|1211622|P9|STARTED|Part 1: Dose-escalation Phase||0
503785|NCT00261846|1211623|P8|STARTED|Part 1: Dose-escalation Phase||0
503786|NCT00261846|1211624|P7|STARTED|Part 1: Dose-escalation Phase||0
503787|NCT00261846|1211625|P6|STARTED|Part 1: Dose-escalation Phase||0
503788|NCT00261846|1211626|P5|STARTED|Part 1: Dose-escalation Phase||0
503789|NCT00261846|1211627|P4|STARTED|Part 1: Dose-escalation Phase||0
503790|NCT00261846|1211628|P3|STARTED|Part 1: Dose-escalation Phase||12
503791|NCT00261846|1211629|P2|STARTED|Part 1: Dose-escalation Phase||3
503792|NCT00261846|1211630|P1|STARTED|Part 1: Dose-escalation Phase||3
503793|NCT00261833|1211846|P2|NOT COMPLETED|Overall Study||18
503794|NCT00261833|1211847|P1|NOT COMPLETED|Overall Study||9
503795|NCT00261833|1211846|P2|COMPLETED|Overall Study||69
503796|NCT00261833|1211847|P1|COMPLETED|Overall Study||84
503797|NCT00261833|1211846|P2|STARTED|Overall Study||87
503798|NCT00261833|1211847|P1|STARTED|Overall Study||93
503799|NCT00261716|1211881|P2|NOT COMPLETED|Overall Study||10
503800|NCT00261716|1211882|P1|NOT COMPLETED|Overall Study||6
503801|NCT00261716|1211881|P2|COMPLETED|Overall Study||11
503802|NCT00261716|1211882|P1|COMPLETED|Overall Study||11
503803|NCT00261716|1211881|P2|STARTED|Overall Study||21
503804|NCT00261716|1211882|P1|STARTED|Overall Study||17
503805|NCT00261495|1211902|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
503806|NCT00261495|1211903|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
503807|NCT00261495|1211902|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
503808|NCT00261495|1211903|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
503809|NCT00261495|1211902|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
503810|NCT00261495|1211903|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
503811|NCT00261495|1211902|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
503812|NCT00261495|1211903|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
503813|NCT00261495|1211902|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
503814|NCT00261495|1211903|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
503815|NCT00261495|1211902|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
503816|NCT00261495|1211903|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
503817|NCT00261495|1211902|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
503818|NCT00261495|1211903|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
503819|NCT00261495|1211902|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
503820|NCT00261495|1211903|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
503822|NCT00261495|1211903|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
503823|NCT00261443|1212067|P3|NOT COMPLETED|4: Extension Phase||2
503824|NCT00261443|1212068|P2|NOT COMPLETED|4: Extension Phase||3
503825|NCT00261443|1212069|P1|NOT COMPLETED|4: Extension Phase||0
503826|NCT00261443|1212067|P3|COMPLETED|4: Extension Phase||21
503827|NCT00261443|1212068|P2|COMPLETED|4: Extension Phase||16
503828|NCT00261443|1212069|P1|COMPLETED|4: Extension Phase||0
503829|NCT00261443|1212067|P3|STARTED|4: Extension Phase||23
503830|NCT00261443|1212068|P2|STARTED|4: Extension Phase||19
503831|NCT00261443|1212069|P1|STARTED|4: Extension Phase||0
503832|NCT00261443|1212067|P3|NOT COMPLETED|3: Assessment of Relapse||65
503833|NCT00261443|1212068|P2|NOT COMPLETED|3: Assessment of Relapse||80
503834|NCT00261443|1212069|P1|NOT COMPLETED|3: Assessment of Relapse||0
503835|NCT00261443|1212067|P3|COMPLETED|3: Assessment of Relapse||103
503836|NCT00261443|1212068|P2|COMPLETED|3: Assessment of Relapse||89
503837|NCT00261443|1212069|P1|COMPLETED|3: Assessment of Relapse||0
503838|NCT00261443|1212067|P3|STARTED|3: Assessment of Relapse||168
503839|NCT00261443|1212068|P2|STARTED|3: Assessment of Relapse||169
503840|NCT00261443|1212069|P1|STARTED|3: Assessment of Relapse||0
503841|NCT00261443|1212067|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
503842|NCT00261443|1212068|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
503843|NCT00261443|1212069|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
503844|NCT00261443|1212067|P3|COMPLETED|2: Stability & Maintenance of Stability||0
503845|NCT00261443|1212068|P2|COMPLETED|2: Stability & Maintenance of Stability||0
503846|NCT00261443|1212069|P1|COMPLETED|2: Stability & Maintenance of Stability||346
503847|NCT00261443|1212067|P3|STARTED|2: Stability & Maintenance of Stability||0
503848|NCT00261443|1212068|P2|STARTED|2: Stability & Maintenance of Stability||0
503849|NCT00261443|1212069|P1|STARTED|2: Stability & Maintenance of Stability||686
503850|NCT00261443|1212067|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
503851|NCT00261443|1212068|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
503852|NCT00261443|1212069|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
503853|NCT00261443|1212067|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
503854|NCT00261443|1212068|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
503855|NCT00261443|1212069|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
503856|NCT00261443|1212067|P3|STARTED|1: Confirmation of Partial Nonresponse||0
503857|NCT00261443|1212068|P2|STARTED|1: Confirmation of Partial Nonresponse||0
503858|NCT00261443|1212069|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
503859|NCT00260962|1212326|P2|NOT COMPLETED|Overall Study||2
503860|NCT00260962|1212327|P1|NOT COMPLETED|Overall Study||4
503861|NCT00260962|1212326|P2|COMPLETED|Overall Study||14
503862|NCT00260962|1212327|P1|COMPLETED|Overall Study||14
503863|NCT00260962|1212326|P2|STARTED|Overall Study||16
503864|NCT00260962|1212327|P1|STARTED|Overall Study||18
503865|NCT00260832|1212337|P2|NOT COMPLETED|Overall Study||211
503866|NCT00260832|1212338|P1|NOT COMPLETED|Overall Study||228
503867|NCT00260832|1212337|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
503868|NCT00260832|1212338|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
503869|NCT00260832|1212337|P2|STARTED|Overall Study||242
503870|NCT00260832|1212338|P1|STARTED|Overall Study||243
503871|NCT00260689|1212347|P3|NOT COMPLETED|Overall Study||15
503872|NCT00260689|1212348|P2|NOT COMPLETED|Overall Study||49
503873|NCT00260689|1212349|P1|NOT COMPLETED|Overall Study||41
503874|NCT00260689|1212347|P3|COMPLETED|Overall Study||1
503875|NCT00260689|1212348|P2|COMPLETED|Overall Study||11
503876|NCT00260689|1212349|P1|COMPLETED|Overall Study||19
503877|NCT00260689|1212347|P3|STARTED|Overall Study||16
503878|NCT00260689|1212348|P2|STARTED|Overall Study||60
503879|NCT00260689|1212349|P1|STARTED|Overall Study||60
503880|NCT00260533|1212365|P2|NOT COMPLETED|Overall Study||3
503881|NCT00260533|1212366|P1|NOT COMPLETED|Overall Study||3
503882|NCT00260533|1212365|P2|COMPLETED|Overall Study||10
503883|NCT00260533|1212366|P1|COMPLETED|Overall Study||11
503884|NCT00260533|1212365|P2|STARTED|Overall Study||13
503885|NCT00260533|1212366|P1|STARTED|Overall Study||14
503886|NCT00260429|1212374|P2|NOT COMPLETED|Overall Study||0
503887|NCT00260429|1212375|P1|NOT COMPLETED|Overall Study||2
503888|NCT00260429|1212374|P2|COMPLETED|Overall Study||12
503889|NCT00260429|1212375|P1|COMPLETED|Overall Study||21
503890|NCT00260429|1212374|P2|STARTED|Overall Study||12
503891|NCT00260429|1212375|P1|STARTED|Overall Study||23
503892|NCT00260208|1212383|P2|NOT COMPLETED|Overall Study||34
503893|NCT00260208|1212384|P1|NOT COMPLETED|Overall Study||47
503894|NCT00260208|1212383|P2|COMPLETED|Overall Study||138
503895|NCT00260208|1212384|P1|COMPLETED|Overall Study||137
503896|NCT00260208|1212383|P2|Modified ITT|Overall Study||96
503897|NCT00260208|1212384|P1|Modified ITT|Overall Study||101
503898|NCT00260208|1212383|P2|Intent to Treat (ITT) Population|Overall Study||169
503899|NCT00260208|1212384|P1|Intent to Treat (ITT) Population|Overall Study||182
503900|NCT00260208|1212383|P2|STARTED|Overall Study||172
503901|NCT00260208|1212384|P1|STARTED|Overall Study|"Started indicates safety population."|184
503902|NCT00260195|1212414|P2|NOT COMPLETED|Overall Study||0
503903|NCT00260195|1212415|P1|NOT COMPLETED|Overall Study||0
503904|NCT00260195|1212414|P2|COMPLETED|Overall Study||37
503905|NCT00260195|1212415|P1|COMPLETED|Overall Study||39
503906|NCT00260195|1212414|P2|STARTED|Overall Study||37
503907|NCT00260195|1212415|P1|STARTED|Overall Study||39
503908|NCT00260065|1212427|P1|NOT COMPLETED|Overall Study||93
503909|NCT00260065|1212427|P1|COMPLETED|Overall Study||6
503910|NCT00260065|1212427|P1|STARTED|Overall Study||99
503911|NCT00259857|1212434|P2|NOT COMPLETED|24 Months Treatment||3
503912|NCT00259857|1212435|P1|NOT COMPLETED|24 Months Treatment||0
503913|NCT00259857|1212434|P2|COMPLETED|24 Months Treatment||6
503914|NCT00259857|1212435|P1|COMPLETED|24 Months Treatment||10
503915|NCT00259857|1212434|P2|STARTED|24 Months Treatment||9
503916|NCT00259857|1212435|P1|STARTED|24 Months Treatment||10
503917|NCT00259857|1212434|P2|NOT COMPLETED|12 Months Treatment||2
503918|NCT00259857|1212435|P1|NOT COMPLETED|12 Months Treatment||1
503919|NCT00259857|1212434|P2|COMPLETED|12 Months Treatment||9
503920|NCT00259857|1212435|P1|COMPLETED|12 Months Treatment||10
503921|NCT00259857|1212434|P2|STARTED|12 Months Treatment||11
503922|NCT00259857|1212435|P1|STARTED|12 Months Treatment||11
503923|NCT00259740|1212453|P2|NOT COMPLETED|Overall Study||53
503924|NCT00259740|1212454|P1|NOT COMPLETED|Overall Study||43
503925|NCT00259740|1212453|P2|COMPLETED|Overall Study||0
503926|NCT00259740|1212454|P1|COMPLETED|Overall Study||0
503927|NCT00259740|1212453|P2|Received Study Medication|Overall Study||53
503928|NCT00259740|1212454|P1|Received Study Medication|Overall Study||42
503929|NCT00259740|1212453|P2|STARTED|Overall Study||53
503930|NCT00259740|1212454|P1|STARTED|Overall Study||43
503931|NCT00259649|1212464|P1|NOT COMPLETED|Overall Study||10
503932|NCT00259649|1212464|P1|COMPLETED|Overall Study||61
503933|NCT00259649|1212464|P1|STARTED|Overall Study||71
503934|NCT00259610|1212472|P4|NOT COMPLETED|Overall Study||43
503935|NCT00259610|1212473|P3|NOT COMPLETED|Overall Study||73
503936|NCT00259610|1212474|P2|NOT COMPLETED|Overall Study||46
503937|NCT00259610|1212475|P1|NOT COMPLETED|Overall Study||76
503938|NCT00259610|1212472|P4|COMPLETED|Overall Study||81
503939|NCT00259610|1212473|P3|COMPLETED|Overall Study||182
503940|NCT00259610|1212474|P2|COMPLETED|Overall Study||86
503941|NCT00259610|1212475|P1|COMPLETED|Overall Study||168
503942|NCT00259610|1212472|P4|STARTED|Overall Study||124
503943|NCT00259610|1212473|P3|STARTED|Overall Study||255
503944|NCT00259610|1212474|P2|STARTED|Overall Study||132
503945|NCT00259610|1212475|P1|STARTED|Overall Study||244
503946|NCT00259298|1212489|P1|NOT COMPLETED|Overall Study||3
503947|NCT00259298|1212489|P1|COMPLETED|Overall Study||9
503948|NCT00259298|1212489|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
503949|NCT00259298|1212489|P1|STARTED|Overall Study||12
503950|NCT00259285|1212497|P1|NOT COMPLETED|Overall Study||0
503951|NCT00259285|1212497|P1|COMPLETED|Overall Study||10
503952|NCT00259285|1212497|P1|STARTED|Overall Study||10
503953|NCT00259272|1212507|P4|NOT COMPLETED|Overall Study||21
503954|NCT00259272|1212508|P3|NOT COMPLETED|Overall Study||5
503955|NCT00259272|1212509|P2|NOT COMPLETED|Overall Study||7
503956|NCT00259272|1212510|P1|NOT COMPLETED|Overall Study||15
503957|NCT00259272|1212507|P4|COMPLETED|Overall Study||27
503958|NCT00259272|1212508|P3|COMPLETED|Overall Study||21
503959|NCT00259272|1212509|P2|COMPLETED|Overall Study||24
503960|NCT00259272|1212510|P1|COMPLETED|Overall Study||21
503961|NCT00259272|1212507|P4|STARTED|Overall Study||48
503962|NCT00259272|1212508|P3|STARTED|Overall Study||26
503963|NCT00259272|1212509|P2|STARTED|Overall Study||31
503964|NCT00259272|1212510|P1|STARTED|Overall Study||36
503965|NCT00259090|1212588|P3|NOT COMPLETED|Overall Study||0
503966|NCT00259090|1212589|P2|NOT COMPLETED|Overall Study||0
503967|NCT00259090|1212590|P1|NOT COMPLETED|Overall Study||0
503968|NCT00259090|1212588|P3|COMPLETED|Overall Study||37
503969|NCT00259090|1212589|P2|COMPLETED|Overall Study||31
503970|NCT00259090|1212590|P1|COMPLETED|Overall Study||35
503971|NCT00259090|1212588|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
503972|NCT00259090|1212589|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
503973|NCT00259090|1212590|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
503974|NCT00259012|1212606|P2|NOT COMPLETED|Overall Study||4
503975|NCT00259012|1212607|P1|NOT COMPLETED|Overall Study||2
503976|NCT00259012|1212606|P2|COMPLETED|Overall Study||30
503977|NCT00259012|1212607|P1|COMPLETED|Overall Study||31
503978|NCT00259012|1212606|P2|STARTED|Overall Study||34
503979|NCT00259012|1212607|P1|STARTED|Overall Study||33
503980|NCT00258908|1212639|P1|NOT COMPLETED|Overall Study||0
503981|NCT00258908|1212639|P1|COMPLETED|Overall Study||112
503982|NCT00258908|1212639|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
503983|NCT00258895|1212647|P2|NOT COMPLETED|Overall Study||3
503984|NCT00258895|1212648|P1|NOT COMPLETED|Overall Study||10
503985|NCT00258895|1212647|P2|COMPLETED|Overall Study||159
503986|NCT00258895|1212648|P1|COMPLETED|Overall Study||477
503987|NCT00258895|1212647|P2|STARTED|Overall Study||162
503988|NCT00258895|1212648|P1|STARTED|Overall Study||487
503989|NCT00258882|1212664|P2|NOT COMPLETED|Pregnancy Surveillance||0
503990|NCT00258882|1212665|P1|NOT COMPLETED|Pregnancy Surveillance||0
503991|NCT00258882|1212664|P2|COMPLETED|Pregnancy Surveillance||675
503992|NCT00258882|1212665|P1|COMPLETED|Pregnancy Surveillance||225
503993|NCT00258882|1212664|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
503994|NCT00258882|1212665|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
503995|NCT00258882|1212664|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
503996|NCT00258882|1212665|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
503997|NCT00258882|1212664|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
503998|NCT00258882|1212665|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
503999|NCT00258882|1212664|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
504000|NCT00258882|1212665|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
504001|NCT00258882|1212664|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
504002|NCT00258882|1212665|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
504003|NCT00258882|1212664|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
504004|NCT00258882|1212665|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
504005|NCT00258882|1212664|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
504006|NCT00258882|1212665|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
504007|NCT00258856|1212684|P4|NOT COMPLETED|Overall Study||1
504008|NCT00258856|1212685|P3|NOT COMPLETED|Overall Study||2
504009|NCT00258856|1212686|P2|NOT COMPLETED|Overall Study||0
504010|NCT00258856|1212687|P1|NOT COMPLETED|Overall Study||3
504011|NCT00258856|1212684|P4|COMPLETED|Overall Study||58
504012|NCT00258856|1212685|P3|COMPLETED|Overall Study||56
504013|NCT00258856|1212686|P2|COMPLETED|Overall Study||58
504014|NCT00258856|1212687|P1|COMPLETED|Overall Study||56
504015|NCT00258856|1212684|P4|STARTED|Overall Study||59
504016|NCT00258856|1212685|P3|STARTED|Overall Study||58
504017|NCT00258856|1212686|P2|STARTED|Overall Study||58
504018|NCT00258856|1212687|P1|STARTED|Overall Study||59
504019|NCT00258830|1212699|P2|NOT COMPLETED|Overall Study||0
504020|NCT00258830|1212700|P1|NOT COMPLETED|Overall Study||0
504021|NCT00258830|1212699|P2|COMPLETED|Overall Study||60
504022|NCT00258830|1212700|P1|COMPLETED|Overall Study||60
504023|NCT00258830|1212699|P2|STARTED|Overall Study||60
504024|NCT00258830|1212700|P1|STARTED|Overall Study||60
504025|NCT00258817|1212714|P2|NOT COMPLETED|Overall Study||0
504026|NCT00258817|1212715|P1|NOT COMPLETED|Overall Study||0
504027|NCT00258817|1212714|P2|COMPLETED|Overall Study||15
504028|NCT00258817|1212715|P1|COMPLETED|Overall Study||15
504029|NCT00258817|1212714|P2|STARTED|Overall Study||15
504030|NCT00258817|1212715|P1|STARTED|Overall Study||15
504031|NCT00258674|1212728|P3|NOT COMPLETED|Overall Study||34
504032|NCT00258674|1212729|P2|NOT COMPLETED|Overall Study||53
504033|NCT00258674|1212730|P1|NOT COMPLETED|Overall Study||32
504034|NCT00258674|1212728|P3|COMPLETED|Overall Study||568
504035|NCT00258674|1212729|P2|COMPLETED|Overall Study||758
504036|NCT00258674|1212730|P1|COMPLETED|Overall Study||565
504037|NCT00258674|1212728|P3|STARTED|Overall Study||602
504038|NCT00258674|1212729|P2|STARTED|Overall Study||811
504039|NCT00258674|1212730|P1|STARTED|Overall Study||597
504040|NCT00258440|1212789|P3|NOT COMPLETED|Overall Study||1
504041|NCT00258440|1212790|P2|NOT COMPLETED|Overall Study||0
504042|NCT00258440|1212791|P1|NOT COMPLETED|Overall Study||0
504043|NCT00258440|1212789|P3|COMPLETED|Overall Study||5
504044|NCT00258440|1212790|P2|COMPLETED|Overall Study||0
504045|NCT00258440|1212791|P1|COMPLETED|Overall Study||1
504046|NCT00258440|1212789|P3|STARTED|Overall Study||6
504047|NCT00258440|1212790|P2|STARTED|Overall Study||0
504048|NCT00258440|1212791|P1|STARTED|Overall Study||1
504049|NCT00258362|1212802|P1|NOT COMPLETED|Overall Study||0
504050|NCT00258362|1212802|P1|COMPLETED|Overall Study||41
504051|NCT00258362|1212802|P1|STARTED|Overall Study||41
504052|NCT00258349|1212807|P1|NOT COMPLETED|Overall Study||0
504053|NCT00258349|1212807|P1|COMPLETED|Overall Study||16
504054|NCT00258349|1212807|P1|HER2-positive by Central Review|Overall Study||10
504055|NCT00258349|1212807|P1|STARTED|Overall Study||16
504056|NCT00258310|1212814|P1|NOT COMPLETED|Overall Study||0
504057|NCT00258310|1212814|P1|COMPLETED|Overall Study||35
504058|NCT00258310|1212814|P1|STARTED|Overall Study||35
504059|NCT00258206|1212818|P1|NOT COMPLETED|Overall Study||0
504060|NCT00258206|1212818|P1|COMPLETED|Overall Study||21
504061|NCT00258206|1212818|P1|STARTED|Overall Study||21
504062|NCT00258154|1212824|P2|NOT COMPLETED|Overall Study||7
504063|NCT00258154|1212825|P1|NOT COMPLETED|Overall Study||9
504064|NCT00258154|1212824|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
504065|NCT00258154|1212825|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
504066|NCT00258154|1212824|P2|Vaccinated at Visit 3|Overall Study||197
504067|NCT00258154|1212825|P1|Vaccinated at Visit 3|Overall Study||195
504068|NCT00258154|1212824|P2|Vaccinated at Visit 2|Overall Study||198
504069|NCT00258154|1212825|P1|Vaccinated at Visit 2|Overall Study||198
504070|NCT00258154|1212824|P2|Vaccinated at Visit 1|Overall Study||202
504071|NCT00258154|1212825|P1|Vaccinated at Visit 1|Overall Study||201
504072|NCT00258154|1212824|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
504073|NCT00258154|1212825|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
504074|NCT00258011|1212893|P1|NOT COMPLETED|Overall Study||0
504075|NCT00258011|1212893|P1|COMPLETED|Overall Study||3
504076|NCT00258011|1212893|P1|STARTED|Overall Study||3
504077|NCT00257933|1212900|P2|NOT COMPLETED|Overall Study||0
504078|NCT00257933|1212901|P1|NOT COMPLETED|Overall Study||0
504079|NCT00257933|1212900|P2|COMPLETED|Overall Study||78
504080|NCT00257933|1212901|P1|COMPLETED|Overall Study||74
504081|NCT00257933|1212900|P2|STARTED|Overall Study||78
504082|NCT00257933|1212901|P1|STARTED|Overall Study||74
504083|NCT00257920|1212909|P2|NOT COMPLETED|Period: Second Intervention||1
504084|NCT00257920|1212910|P1|NOT COMPLETED|Period: Second Intervention||2
504085|NCT00257920|1212909|P2|COMPLETED|Period: Second Intervention||18
504086|NCT00257920|1212910|P1|COMPLETED|Period: Second Intervention||19
504087|NCT00257920|1212909|P2|STARTED|Period: Second Intervention||19
504088|NCT00257920|1212910|P1|STARTED|Period: Second Intervention||21
504089|NCT00257920|1212909|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
504090|NCT00257920|1212910|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
504091|NCT00257920|1212909|P2|COMPLETED|Period: Washout Period of Two Weeks||19
504092|NCT00257920|1212910|P1|COMPLETED|Period: Washout Period of Two Weeks||21
504093|NCT00257920|1212909|P2|STARTED|Period: Washout Period of Two Weeks||20
504094|NCT00257920|1212910|P1|STARTED|Period: Washout Period of Two Weeks||21
504095|NCT00257920|1212909|P2|NOT COMPLETED|Period: First Intervention||0
504096|NCT00257920|1212910|P1|NOT COMPLETED|Period: First Intervention||0
504097|NCT00257920|1212909|P2|COMPLETED|Period: First Intervention||20
504098|NCT00257920|1212910|P1|COMPLETED|Period: First Intervention||21
504099|NCT00257920|1212909|P2|STARTED|Period: First Intervention||20
504100|NCT00257920|1212910|P1|STARTED|Period: First Intervention||21
504101|NCT00257894|1212920|P2|NOT COMPLETED|Overall Study||5
504102|NCT00257894|1212921|P1|NOT COMPLETED|Overall Study||4
504103|NCT00257894|1212920|P2|COMPLETED|Overall Study||15
504104|NCT00257894|1212921|P1|COMPLETED|Overall Study||17
504105|NCT00257894|1212920|P2|STARTED|Overall Study||20
504106|NCT00257894|1212921|P1|STARTED|Overall Study||21
504107|NCT00257686|1212939|P6|NOT COMPLETED|Overall Study||9
504108|NCT00257686|1212940|P5|NOT COMPLETED|Overall Study||22
504109|NCT00257686|1212941|P4|NOT COMPLETED|Overall Study||11
504110|NCT00257686|1212942|P3|NOT COMPLETED|Overall Study||18
504111|NCT00257686|1212943|P2|NOT COMPLETED|Overall Study||19
504112|NCT00257686|1212944|P1|NOT COMPLETED|Overall Study||21
504113|NCT00257686|1212939|P6|COMPLETED|Overall Study||95
504114|NCT00257686|1212940|P5|COMPLETED|Overall Study||194
504115|NCT00257686|1212941|P4|COMPLETED|Overall Study||88
504116|NCT00257686|1212942|P3|COMPLETED|Overall Study||208
504117|NCT00257686|1212943|P2|COMPLETED|Overall Study||89
504118|NCT00257686|1212944|P1|COMPLETED|Overall Study||188
504119|NCT00257686|1212939|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
504120|NCT00257686|1212940|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
504121|NCT00257686|1212941|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
504122|NCT00257686|1212942|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
504123|NCT00257686|1212943|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
504124|NCT00257686|1212944|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
504125|NCT00257686|1212939|P6|STARTED|Overall Study||104
504126|NCT00257686|1212940|P5|STARTED|Overall Study||216
504127|NCT00257686|1212941|P4|STARTED|Overall Study||99
504128|NCT00257686|1212942|P3|STARTED|Overall Study||226
504129|NCT00257686|1212943|P2|STARTED|Overall Study||108
504130|NCT00257686|1212944|P1|STARTED|Overall Study||209
504131|NCT00257660|1212966|P2|NOT COMPLETED|Overall Study||23
504132|NCT00257660|1212967|P1|NOT COMPLETED|Overall Study||10
504133|NCT00257660|1212966|P2|COMPLETED|Overall Study||38
504134|NCT00257660|1212967|P1|COMPLETED|Overall Study||45
504135|NCT00257660|1212966|P2|STARTED|Overall Study||61
504136|NCT00257660|1212967|P1|STARTED|Overall Study||55
504137|NCT00257608|1212997|P3|NOT COMPLETED|Post Chemotherapy Phase||244
504138|NCT00257608|1212998|P2|NOT COMPLETED|Post Chemotherapy Phase||264
504139|NCT00257608|1212999|P1|NOT COMPLETED|Post Chemotherapy Phase||0
504140|NCT00257608|1212997|P3|COMPLETED|Post Chemotherapy Phase||126
504141|NCT00257608|1212998|P2|COMPLETED|Post Chemotherapy Phase||109
504142|NCT00257608|1212999|P1|COMPLETED|Post Chemotherapy Phase||0
504143|NCT00257608|1212997|P3|STARTED|Post Chemotherapy Phase||370
504144|NCT00257608|1212998|P2|STARTED|Post Chemotherapy Phase||373
504145|NCT00257608|1212999|P1|STARTED|Post Chemotherapy Phase||0
504146|NCT00257608|1212997|P3|NOT COMPLETED|Chemotherapy Phase||0
504147|NCT00257608|1212998|P2|NOT COMPLETED|Chemotherapy Phase||0
504148|NCT00257608|1212999|P1|NOT COMPLETED|Chemotherapy Phase||376
504149|NCT00257608|1212997|P3|COMPLETED|Chemotherapy Phase||0
504150|NCT00257608|1212998|P2|COMPLETED|Chemotherapy Phase||0
504151|NCT00257608|1212999|P1|COMPLETED|Chemotherapy Phase||769
504152|NCT00257608|1212997|P3|STARTED|Chemotherapy Phase||0
504153|NCT00257608|1212998|P2|STARTED|Chemotherapy Phase||0
504154|NCT00257608|1212999|P1|STARTED|Chemotherapy Phase||1145
504155|NCT00257556|1213025|P2|NOT COMPLETED|Overall Study||10
504156|NCT00257556|1213026|P1|NOT COMPLETED|Overall Study||14
504157|NCT00257556|1213025|P2|COMPLETED|Overall Study||32
504158|NCT00257556|1213026|P1|COMPLETED|Overall Study||24
504159|NCT00257556|1213025|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
504160|NCT00257556|1213026|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
504161|NCT00257556|1213025|P2|STARTED|Overall Study||42
504162|NCT00257556|1213026|P1|STARTED|Overall Study||38
504163|NCT00257322|1213052|P1|NOT COMPLETED|Overall Study||4
504164|NCT00257322|1213052|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
504165|NCT00257322|1213052|P1|STARTED|Overall Study|20 subjects accrued.|20
504166|NCT00257309|1213059|P2|NOT COMPLETED|Overall Study||2
504167|NCT00257309|1213060|P1|NOT COMPLETED|Overall Study||2
504168|NCT00257309|1213059|P2|COMPLETED|Overall Study||130
504169|NCT00257309|1213060|P1|COMPLETED|Overall Study||132
504170|NCT00257309|1213059|P2|STARTED|Overall Study||132
504171|NCT00257309|1213060|P1|STARTED|Overall Study||134
504172|NCT00257192|1213070|P2|NOT COMPLETED|Overall Study||39
504173|NCT00257192|1213071|P1|NOT COMPLETED|Overall Study||58
504174|NCT00257192|1213070|P2|COMPLETED|Overall Study||52
504175|NCT00257192|1213071|P1|COMPLETED|Overall Study||135
504176|NCT00257192|1213070|P2|Received Study Treatment|Overall Study||90
504177|NCT00257192|1213071|P1|Received Study Treatment|Overall Study||193
504178|NCT00257192|1213070|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
504179|NCT00257192|1213071|P1|STARTED|Overall Study||193
504180|NCT00257166|1213115|P2|NOT COMPLETED|Overall Study||37
504181|NCT00257166|1213116|P1|NOT COMPLETED|Overall Study||53
504182|NCT00257166|1213115|P2|COMPLETED|Overall Study||51
504183|NCT00257166|1213116|P1|COMPLETED|Overall Study||97
504184|NCT00257166|1213115|P2|Treated|Overall Study||88
504185|NCT00257166|1213116|P1|Treated|Overall Study||149
504186|NCT00257166|1213115|P2|STARTED|Overall Study||88
504187|NCT00257166|1213116|P1|STARTED|Overall Study||150
504188|NCT00257010|1213128|P1|NOT COMPLETED|Overall Study||128
504189|NCT00257010|1213128|P1|COMPLETED|Overall Study||319
504190|NCT00257010|1213128|P1|STARTED|Overall Study||447
504191|NCT00256997|1213139|P2|NOT COMPLETED|Overall Study||55
504192|NCT00256997|1213140|P1|NOT COMPLETED|Overall Study||48
504193|NCT00256997|1213139|P2|COMPLETED|Overall Study||31
504194|NCT00256997|1213140|P1|COMPLETED|Overall Study||33
504195|NCT00256997|1213139|P2|Treated|Overall Study||86
504196|NCT00256997|1213140|P1|Treated|Overall Study||79
504197|NCT00256997|1213139|P2|STARTED|Overall Study||86
504198|NCT00256997|1213140|P1|STARTED|Overall Study||81
504199|NCT00256984|1213164|P1|NOT COMPLETED|Overall Study||16
504200|NCT00256984|1213164|P1|COMPLETED|Overall Study||59
504201|NCT00256984|1213164|P1|STARTED|Overall Study||75
504202|NCT00256750|1213177|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
504203|NCT00256750|1213178|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
504204|NCT00256750|1213179|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
504205|NCT00256750|1213177|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
504206|NCT00256750|1213178|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
504207|NCT00256750|1213179|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
504208|NCT00256750|1213177|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
504209|NCT00256750|1213178|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
504210|NCT00256750|1213179|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
504211|NCT00256750|1213177|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
504212|NCT00256750|1213178|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
504213|NCT00256750|1213179|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
504214|NCT00256750|1213177|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
504215|NCT00256750|1213178|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
504216|NCT00256750|1213179|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
504217|NCT00256750|1213177|P3|STARTED|Post-Transplant Treated (36 Months)||164
504218|NCT00256750|1213178|P2|STARTED|Post-Transplant Treated (36 Months)||176
504219|NCT00256750|1213179|P1|STARTED|Post-Transplant Treated (36 Months)||153
504220|NCT00256750|1213177|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
504221|NCT00256750|1213178|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
504222|NCT00256750|1213179|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
504223|NCT00256750|1213177|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
504224|NCT00256750|1213178|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
504225|NCT00256750|1213179|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
504226|NCT00256750|1213177|P3|STARTED|Post-Transplant Treated (24 Months)||173
504227|NCT00256750|1213178|P2|STARTED|Post-Transplant Treated (24 Months)||183
504228|NCT00256750|1213179|P1|STARTED|Post-Transplant Treated (24 Months)||174
504229|NCT00256750|1213177|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
504230|NCT00256750|1213178|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
504231|NCT00256750|1213179|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
504232|NCT00256750|1213177|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
504233|NCT00256750|1213178|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
504234|NCT00256750|1213179|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
504235|NCT00256750|1213177|P3|STARTED|Post-Transplant Treated (12 Months)||219
504236|NCT00256750|1213178|P2|STARTED|Post-Transplant Treated (12 Months)||226
504237|NCT00256750|1213179|P1|STARTED|Post-Transplant Treated (12 Months)||215
504238|NCT00256750|1213177|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
504239|NCT00256750|1213178|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
504240|NCT00256750|1213179|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
504241|NCT00256750|1213177|P3|COMPLETED|Transplanted Pre-Treatment||219
504242|NCT00256750|1213178|P2|COMPLETED|Transplanted Pre-Treatment||226
504243|NCT00256750|1213179|P1|COMPLETED|Transplanted Pre-Treatment||215
504244|NCT00256750|1213177|P3|STARTED|Transplanted Pre-Treatment||219
504245|NCT00256750|1213178|P2|STARTED|Transplanted Pre-Treatment||226
504246|NCT00256750|1213179|P1|STARTED|Transplanted Pre-Treatment||221
504247|NCT00256724|1213315|P2|NOT COMPLETED|Overall Study||8
504248|NCT00256724|1213316|P1|NOT COMPLETED|Overall Study||5
504249|NCT00256724|1213315|P2|COMPLETED|Overall Study||16
504250|NCT00256724|1213316|P1|COMPLETED|Overall Study||18
504251|NCT00256724|1213315|P2|STARTED|Overall Study||24
504252|NCT00256724|1213316|P1|STARTED|Overall Study||23
504253|NCT00256698|1213326|P2|NOT COMPLETED|Overall Study||172
504254|NCT00256698|1213327|P1|NOT COMPLETED|Overall Study||167
504255|NCT00256698|1213326|P2|COMPLETED|Overall Study||84
504256|NCT00256698|1213327|P1|COMPLETED|Overall Study||91
504257|NCT00256698|1213326|P2|STARTED|Overall Study||256
504258|NCT00256698|1213327|P1|STARTED|Overall Study||258
504259|NCT00256295|1213345|P1|NOT COMPLETED|Overall Study||4
504260|NCT00256295|1213345|P1|COMPLETED|Overall Study||3
504261|NCT00256295|1213345|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
504262|NCT00256243|1213351|P1|NOT COMPLETED|Overall Study||10
504263|NCT00256243|1213351|P1|COMPLETED|Overall Study||38
504264|NCT00256243|1213351|P1|STARTED|Overall Study||48
504265|NCT00256204|1213360|P4|NOT COMPLETED|Overall Study||49
504266|NCT00256204|1213361|P3|NOT COMPLETED|Overall Study||54
504267|NCT00256204|1213362|P2|NOT COMPLETED|Overall Study||50
504268|NCT00256204|1213363|P1|NOT COMPLETED|Overall Study||67
504269|NCT00256204|1213360|P4|COMPLETED|Overall Study||244
504270|NCT00256204|1213361|P3|COMPLETED|Overall Study||241
504271|NCT00256204|1213362|P2|COMPLETED|Overall Study||238
504272|NCT00256204|1213363|P1|COMPLETED|Overall Study||231
504273|NCT00256204|1213360|P4|STARTED|Overall Study||293
504274|NCT00256204|1213361|P3|STARTED|Overall Study||295
504275|NCT00256204|1213362|P2|STARTED|Overall Study||288
504276|NCT00256204|1213363|P1|STARTED|Overall Study||298
504277|NCT00255970|1213378|P2|NOT COMPLETED|Overall Study||0
504278|NCT00255970|1213379|P1|NOT COMPLETED|Overall Study||0
504279|NCT00255970|1213378|P2|COMPLETED|Overall Study||19
504280|NCT00255970|1213379|P1|COMPLETED|Overall Study||21
504281|NCT00255970|1213378|P2|Final Visit Week 24|Overall Study||19
504282|NCT00255970|1213379|P1|Final Visit Week 24|Overall Study||21
504283|NCT00255970|1213378|P2|Screening Visit|Overall Study||19
504284|NCT00255970|1213379|P1|Screening Visit|Overall Study||21
504285|NCT00255970|1213378|P2|STARTED|Overall Study||19
504286|NCT00255970|1213379|P1|STARTED|Overall Study||21
504287|NCT00255840|1213399|P2|NOT COMPLETED|Overall Study||70
504288|NCT00255840|1213400|P1|NOT COMPLETED|Overall Study||63
504289|NCT00255840|1213399|P2|COMPLETED|Overall Study||334
504290|NCT00255840|1213400|P1|COMPLETED|Overall Study||345
504291|NCT00255840|1213399|P2|STARTED|Overall Study||404
504292|NCT00255840|1213400|P1|STARTED|Overall Study||408
504293|NCT00255723|1213408|P2|NOT COMPLETED|Overall Study||2
504294|NCT00255723|1213409|P1|NOT COMPLETED|Overall Study||2
504295|NCT00255723|1213408|P2|COMPLETED|Overall Study||39
504296|NCT00255723|1213409|P1|COMPLETED|Overall Study||54
504297|NCT00255723|1213408|P2|STARTED|Overall Study||41
504298|NCT00255723|1213409|P1|STARTED|Overall Study||56
504299|NCT00255684|1213415|P1|NOT COMPLETED|Overall Study||0
504300|NCT00255684|1213415|P1|COMPLETED|Overall Study||16
504301|NCT00255684|1213415|P1|STARTED|Overall Study||16
504302|NCT00255190|1213422|P2|NOT COMPLETED|Overall Study||157
504303|NCT00255190|1213423|P1|NOT COMPLETED|Overall Study||50
504304|NCT00255190|1213422|P2|COMPLETED|Overall Study||281
504305|NCT00255190|1213423|P1|COMPLETED|Overall Study||103
504306|NCT00255190|1213422|P2|STARTED|Overall Study||438
504307|NCT00255190|1213423|P1|STARTED|Overall Study||153
504308|NCT00255177|1213491|P4|NOT COMPLETED|Overall Study||2
504309|NCT00255177|1213492|P3|NOT COMPLETED|Overall Study||1
504310|NCT00255177|1213493|P2|NOT COMPLETED|Overall Study||1
504311|NCT00255177|1213494|P1|NOT COMPLETED|Overall Study||2
504312|NCT00255177|1213491|P4|COMPLETED|Overall Study||4
504313|NCT00255177|1213492|P3|COMPLETED|Overall Study||12
504314|NCT00255177|1213493|P2|COMPLETED|Overall Study||13
504315|NCT00255177|1213494|P1|COMPLETED|Overall Study||9
504316|NCT00255177|1213491|P4|STARTED|Overall Study||6
504317|NCT00255177|1213492|P3|STARTED|Overall Study||13
504318|NCT00255177|1213493|P2|STARTED|Overall Study||14
504319|NCT00255177|1213494|P1|STARTED|Overall Study||11
504320|NCT00255164|1213507|P3|NOT COMPLETED|Overall Study||49
504321|NCT00255164|1213508|P2|NOT COMPLETED|Overall Study||49
504322|NCT00255164|1213509|P1|NOT COMPLETED|Overall Study||123
504323|NCT00255164|1213507|P3|COMPLETED|Overall Study||103
504324|NCT00255164|1213508|P2|COMPLETED|Overall Study||110
504325|NCT00255164|1213509|P1|COMPLETED|Overall Study||17
504326|NCT00255164|1213507|P3|STARTED|Overall Study||152
504327|NCT00255164|1213508|P2|STARTED|Overall Study||159
504328|NCT00255164|1213509|P1|STARTED|Overall Study||140
504329|NCT00255151|1213535|P3|NOT COMPLETED|Overall Study||49
504330|NCT00255151|1213536|P2|NOT COMPLETED|Overall Study||49
504331|NCT00255151|1213537|P1|NOT COMPLETED|Overall Study||123
504332|NCT00255151|1213535|P3|COMPLETED|Overall Study||103
504333|NCT00255151|1213536|P2|COMPLETED|Overall Study||110
504334|NCT00255151|1213537|P1|COMPLETED|Overall Study||17
504335|NCT00255151|1213535|P3|STARTED|Overall Study||152
504336|NCT00255151|1213536|P2|STARTED|Overall Study||159
504337|NCT00255151|1213537|P1|STARTED|Overall Study||140
504338|NCT00255125|1213562|P2|NOT COMPLETED|Overall Study||0
504339|NCT00255125|1213563|P1|NOT COMPLETED|Overall Study||0
504340|NCT00255125|1213562|P2|COMPLETED|Overall Study||42
504341|NCT00255125|1213563|P1|COMPLETED|Overall Study||44
504342|NCT00255125|1213562|P2|STARTED|Overall Study||42
504343|NCT00255125|1213563|P1|STARTED|Overall Study||44
504344|NCT00255086|1213571|P2|NOT COMPLETED|Overall Study||2
504345|NCT00255086|1213572|P1|NOT COMPLETED|Overall Study||2
504346|NCT00255086|1213571|P2|COMPLETED|Overall Study||6
504347|NCT00255086|1213572|P1|COMPLETED|Overall Study||7
504348|NCT00255086|1213571|P2|STARTED|Overall Study||8
504349|NCT00255086|1213572|P1|STARTED|Overall Study||9
504350|NCT00255047|1213584|P4|NOT COMPLETED|Overall Study||46
504351|NCT00255047|1213585|P3|NOT COMPLETED|Overall Study||50
504352|NCT00255047|1213586|P2|NOT COMPLETED|Overall Study||48
504353|NCT00255047|1213587|P1|NOT COMPLETED|Overall Study||48
504354|NCT00255047|1213584|P4|COMPLETED|Overall Study||502
504355|NCT00255047|1213585|P3|COMPLETED|Overall Study||496
504356|NCT00255047|1213586|P2|COMPLETED|Overall Study||487
504357|NCT00255047|1213587|P1|COMPLETED|Overall Study||490
504358|NCT00255047|1213584|P4|STARTED|Overall Study||548
504359|NCT00255047|1213585|P3|STARTED|Overall Study||546
504360|NCT00255047|1213586|P2|STARTED|Overall Study||535
504361|NCT00255047|1213587|P1|STARTED|Overall Study||538
504362|NCT00255034|1213611|P2|NOT COMPLETED|Overall Study||38
504363|NCT00255034|1213612|P1|NOT COMPLETED|Overall Study||15
504364|NCT00255034|1213611|P2|COMPLETED|Overall Study||26
504365|NCT00255034|1213612|P1|COMPLETED|Overall Study||64
504366|NCT00255034|1213611|P2|STARTED|Overall Study||64
504367|NCT00255034|1213612|P1|STARTED|Overall Study||79
504368|NCT00255008|1213622|P4|NOT COMPLETED|Overall Study||22
504369|NCT00255008|1213623|P3|NOT COMPLETED|Overall Study||16
504370|NCT00255008|1213624|P2|NOT COMPLETED|Overall Study||9
504371|NCT00255008|1213625|P1|NOT COMPLETED|Overall Study||32
504372|NCT00255008|1213622|P4|COMPLETED|Overall Study||12
504373|NCT00255008|1213623|P3|COMPLETED|Overall Study||17
504374|NCT00255008|1213624|P2|COMPLETED|Overall Study||0
504375|NCT00255008|1213625|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
504376|NCT00255008|1213622|P4|STARTED|Overall Study||34
504377|NCT00255008|1213623|P3|STARTED|Overall Study||33
504378|NCT00255008|1213624|P2|STARTED|Overall Study||9
504379|NCT00255008|1213625|P1|STARTED|Overall Study||45
504380|NCT00254995|1213637|P2|NOT COMPLETED|Overall Study||0
504381|NCT00254995|1213638|P1|NOT COMPLETED|Overall Study||0
504382|NCT00254995|1213637|P2|COMPLETED|Overall Study||31065
504383|NCT00254995|1213638|P1|COMPLETED|Overall Study||31561
504384|NCT00254995|1213637|P2|STARTED|Overall Study||31065
504385|NCT00254995|1213638|P1|STARTED|Overall Study||31561
504386|NCT00254982|1213661|P2|NOT COMPLETED|Overall Study||31
504387|NCT00254982|1213662|P1|NOT COMPLETED|Overall Study||36
504388|NCT00254982|1213661|P2|COMPLETED|Overall Study||265
504389|NCT00254982|1213662|P1|COMPLETED|Overall Study||261
504390|NCT00254982|1213661|P2|STARTED|Overall Study||296
504391|NCT00254982|1213662|P1|STARTED|Overall Study||297
504392|NCT00254592|1213668|P1|NOT COMPLETED|Overall Study||2
504393|NCT00254592|1213668|P1|COMPLETED|Overall Study||41
504394|NCT00254592|1213668|P1|STARTED|Overall Study||43
504395|NCT00254566|1213674|P2|NOT COMPLETED|Overall Study||26
504396|NCT00254566|1213675|P1|NOT COMPLETED|Overall Study||31
504397|NCT00254566|1213674|P2|COMPLETED|Overall Study||172
504398|NCT00254566|1213675|P1|COMPLETED|Overall Study||167
504399|NCT00254566|1213674|P2|STARTED|Overall Study||198
504400|NCT00254566|1213675|P1|STARTED|Overall Study||198
504401|NCT00254540|1213699|P2|NOT COMPLETED|Overall Study||22
504402|NCT00254540|1213700|P1|NOT COMPLETED|Overall Study||19
504403|NCT00254540|1213699|P2|COMPLETED|Overall Study||4
504404|NCT00254540|1213700|P1|COMPLETED|Overall Study||6
504405|NCT00254540|1213699|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
504406|NCT00254540|1213700|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
504407|NCT00254501|1213729|P2|NOT COMPLETED|Overall Study||1
504408|NCT00254501|1213730|P1|NOT COMPLETED|Overall Study||1
504409|NCT00254501|1213729|P2|COMPLETED|Overall Study||36
504410|NCT00254501|1213730|P1|COMPLETED|Overall Study||31
504411|NCT00254501|1213729|P2|STARTED|Overall Study||37
504412|NCT00254501|1213730|P1|STARTED|Overall Study||32
504413|NCT00254462|1213744|P2|NOT COMPLETED|Overall Study||10
504414|NCT00254462|1213745|P1|NOT COMPLETED|Overall Study||8
504415|NCT00254462|1213744|P2|COMPLETED|Overall Study||39
504416|NCT00254462|1213745|P1|COMPLETED|Overall Study||36
504417|NCT00254462|1213744|P2|STARTED|Overall Study||49
504418|NCT00254462|1213745|P1|STARTED|Overall Study||44
504419|NCT00254293|1213759|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
504420|NCT00254293|1213760|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
504421|NCT00254293|1213761|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
504422|NCT00254293|1213762|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
504423|NCT00254293|1213763|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
504424|NCT00254293|1213764|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
504425|NCT00254293|1213765|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
504426|NCT00254293|1213759|P7|COMPLETED|LTE Open Label Fixed Dosing||35
504427|NCT00254293|1213760|P6|COMPLETED|LTE Open Label Fixed Dosing||0
504428|NCT00254293|1213761|P5|COMPLETED|LTE Open Label Fixed Dosing||0
504429|NCT00254293|1213762|P4|COMPLETED|LTE Open Label Fixed Dosing||0
504430|NCT00254293|1213763|P3|COMPLETED|LTE Open Label Fixed Dosing||0
504431|NCT00254293|1213764|P2|COMPLETED|LTE Open Label Fixed Dosing||0
504432|NCT00254293|1213765|P1|COMPLETED|LTE Open Label Fixed Dosing||0
504433|NCT00254293|1213759|P7|STARTED|LTE Open Label Fixed Dosing||48
504434|NCT00254293|1213760|P6|STARTED|LTE Open Label Fixed Dosing||0
504435|NCT00254293|1213761|P5|STARTED|LTE Open Label Fixed Dosing||0
504436|NCT00254293|1213762|P4|STARTED|LTE Open Label Fixed Dosing||0
504437|NCT00254293|1213763|P3|STARTED|LTE Open Label Fixed Dosing||0
504438|NCT00254293|1213764|P2|STARTED|LTE Open Label Fixed Dosing||0
504439|NCT00254293|1213765|P1|STARTED|LTE Open Label Fixed Dosing||0
504440|NCT00254293|1213759|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
504441|NCT00254293|1213760|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
504442|NCT00254293|1213761|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
504443|NCT00254293|1213762|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
504444|NCT00254293|1213763|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
504445|NCT00254293|1213764|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
504446|NCT00254293|1213765|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
504447|NCT00254293|1213759|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
504448|NCT00254293|1213760|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
504449|NCT00254293|1213761|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
504450|NCT00254293|1213762|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
504451|NCT00254293|1213763|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
504452|NCT00254293|1213764|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
504453|NCT00254293|1213765|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
504454|NCT00254293|1213759|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
504455|NCT00254293|1213760|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
504456|NCT00254293|1213761|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
504457|NCT00254293|1213762|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
504458|NCT00254293|1213763|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
504459|NCT00254293|1213764|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
504460|NCT00254293|1213765|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
504461|NCT00254293|1213759|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
504462|NCT00254293|1213760|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
504463|NCT00254293|1213761|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
504464|NCT00254293|1213762|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
504465|NCT00254293|1213763|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
504466|NCT00254293|1213764|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
504467|NCT00254293|1213765|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
504468|NCT00254293|1213759|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
504469|NCT00254293|1213760|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
504470|NCT00254293|1213761|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
504555|NCT00251862|1214006|P2|COMPLETED|Overall Study||269
504471|NCT00254293|1213762|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
504472|NCT00254293|1213763|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
504473|NCT00254293|1213764|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
504474|NCT00254293|1213765|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
504475|NCT00254293|1213759|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
504476|NCT00254293|1213760|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
504477|NCT00254293|1213761|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
504478|NCT00254293|1213762|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
504479|NCT00254293|1213763|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
504480|NCT00254293|1213764|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
504481|NCT00254293|1213765|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
504482|NCT00254163|1213848|P2|NOT COMPLETED|Overall Study||46
504483|NCT00254163|1213849|P1|NOT COMPLETED|Overall Study||45
504484|NCT00254163|1213848|P2|COMPLETED|Overall Study||46
504485|NCT00254163|1213849|P1|COMPLETED|Overall Study||47
504486|NCT00254163|1213848|P2|STARTED|Overall Study||92
504487|NCT00254163|1213849|P1|STARTED|Overall Study||92
504488|NCT00254072|1213873|P2|NOT COMPLETED|Overall Study||0
504489|NCT00254072|1213874|P1|NOT COMPLETED|Overall Study||0
504490|NCT00254072|1213873|P2|COMPLETED|Overall Study||175
504491|NCT00254072|1213874|P1|COMPLETED|Overall Study||180
504492|NCT00254072|1213873|P2|STARTED|Overall Study||175
504493|NCT00254072|1213874|P1|STARTED|Overall Study||180
504494|NCT00253981|1213882|P2|NOT COMPLETED|Overall Study||0
504495|NCT00253981|1213883|P1|NOT COMPLETED|Overall Study||0
504496|NCT00253981|1213882|P2|COMPLETED|Overall Study||14
504497|NCT00253981|1213883|P1|COMPLETED|Overall Study||16
504498|NCT00253981|1213882|P2|STARTED|Overall Study||14
504499|NCT00253981|1213883|P1|STARTED|Overall Study||16
504500|NCT00253890|1213891|P2|NOT COMPLETED|Overall Study||7
504501|NCT00253890|1213892|P1|NOT COMPLETED|Overall Study||7
504502|NCT00253890|1213891|P2|COMPLETED|Overall Study||61
504503|NCT00253890|1213892|P1|COMPLETED|Overall Study||62
504504|NCT00253890|1213891|P2|STARTED|Overall Study||68
504505|NCT00253890|1213892|P1|STARTED|Overall Study||69
504506|NCT00253747|1213900|P2|NOT COMPLETED|Overall Study||27
504507|NCT00253747|1213901|P1|NOT COMPLETED|Overall Study||24
504508|NCT00253747|1213900|P2|COMPLETED|Overall Study||101
504509|NCT00253747|1213901|P1|COMPLETED|Overall Study||103
504510|NCT00253747|1213900|P2|STARTED|Overall Study||128
504511|NCT00253747|1213901|P1|STARTED|Overall Study||127
504512|NCT00253643|1213923|P4|NOT COMPLETED|Overall Study||3
504513|NCT00253643|1213924|P3|NOT COMPLETED|Overall Study||1
504514|NCT00253643|1213925|P2|NOT COMPLETED|Overall Study||0
504515|NCT00253643|1213926|P1|NOT COMPLETED|Overall Study||0
504516|NCT00253643|1213923|P4|COMPLETED|Overall Study||28
504517|NCT00253643|1213924|P3|COMPLETED|Overall Study||28
504518|NCT00253643|1213925|P2|COMPLETED|Overall Study||15
504519|NCT00253643|1213926|P1|COMPLETED|Overall Study||14
504520|NCT00253643|1213923|P4|STARTED|Overall Study||31
504521|NCT00253643|1213924|P3|STARTED|Overall Study||29
504522|NCT00253643|1213925|P2|STARTED|Overall Study||15
504523|NCT00253643|1213926|P1|STARTED|Overall Study||14
504524|NCT00253513|1213940|P1|NOT COMPLETED|Overall Study||0
504525|NCT00253513|1213940|P1|COMPLETED|Overall Study||60
504526|NCT00253513|1213940|P1|STARTED|Overall Study||60
504527|NCT00253448|1213947|P1|NOT COMPLETED|Overall Study||1
504528|NCT00253448|1213947|P1|COMPLETED|Overall Study||34
504529|NCT00253448|1213947|P1|STARTED|Overall Study||35
504530|NCT00253435|1213953|P2|NOT COMPLETED|Overall Study||0
504531|NCT00253435|1213954|P1|NOT COMPLETED|Overall Study||0
504532|NCT00253435|1213953|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
504533|NCT00253435|1213954|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
504534|NCT00253435|1213953|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
504535|NCT00253435|1213954|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
504536|NCT00253435|1213953|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
504537|NCT00253435|1213954|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
504538|NCT00253435|1213953|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
504539|NCT00253435|1213954|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
504540|NCT00253435|1213953|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
504541|NCT00253435|1213954|P1|STARTED|Overall Study|Total number is 42|42
504542|NCT00253370|1213966|P1|NOT COMPLETED|Overall Study||43
504543|NCT00253370|1213966|P1|COMPLETED|Overall Study||1
504544|NCT00253370|1213966|P1|STARTED|Overall Study||44
504545|NCT00251927|1213974|P2|NOT COMPLETED|Overall Study||74
504546|NCT00251927|1213975|P1|NOT COMPLETED|Overall Study||108
504547|NCT00251927|1213974|P2|COMPLETED|Overall Study|Completed 5 year visit|192
504548|NCT00251927|1213975|P1|COMPLETED|Overall Study|Completed 5 year visit|180
504549|NCT00251927|1213974|P2|STARTED|Overall Study|Randomised|266
504550|NCT00251927|1213975|P1|STARTED|Overall Study|Randomised|288
504551|NCT00251862|1214005|P3|NOT COMPLETED|Overall Study||0
504552|NCT00251862|1214006|P2|NOT COMPLETED|Overall Study||0
504553|NCT00251862|1214007|P1|NOT COMPLETED|Overall Study||0
504554|NCT00251862|1214005|P3|COMPLETED|Overall Study||276
504556|NCT00251862|1214007|P1|COMPLETED|Overall Study||280
504557|NCT00251862|1214005|P3|STARTED|Overall Study||276
504558|NCT00251862|1214006|P2|STARTED|Overall Study||269
504559|NCT00251862|1214007|P1|STARTED|Overall Study||280
504560|NCT00253019|1214027|P3|NOT COMPLETED|Overall Study||18
504561|NCT00253019|1214028|P2|NOT COMPLETED|Overall Study||31
504562|NCT00253019|1214029|P1|NOT COMPLETED|Overall Study||29
504563|NCT00253019|1214027|P3|COMPLETED|Overall Study||83
504564|NCT00253019|1214028|P2|COMPLETED|Overall Study||78
504565|NCT00253019|1214029|P1|COMPLETED|Overall Study||82
504566|NCT00253019|1214027|P3|STARTED|Overall Study||101
504567|NCT00253019|1214028|P2|STARTED|Overall Study||109
504568|NCT00253019|1214029|P1|STARTED|Overall Study||111
504569|NCT00252967|1214039|P2|NOT COMPLETED|Overall Study||0
504570|NCT00252967|1214040|P1|NOT COMPLETED|Overall Study||0
504571|NCT00252967|1214039|P2|COMPLETED|Overall Study||33
504572|NCT00252967|1214040|P1|COMPLETED|Overall Study||31
504573|NCT00252967|1214039|P2|STARTED|Overall Study||33
504574|NCT00252967|1214040|P1|STARTED|Overall Study||31
504575|NCT00252733|1214064|P2|NOT COMPLETED|Overall Study||92
504576|NCT00252733|1214065|P1|NOT COMPLETED|Overall Study||106
504577|NCT00252733|1214064|P2|COMPLETED|Overall Study||618
504578|NCT00252733|1214065|P1|COMPLETED|Overall Study||605
504579|NCT00252733|1214064|P2|STARTED|Overall Study||710
504580|NCT00252733|1214065|P1|STARTED|Overall Study||711
504581|NCT00252720|1214075|P2|NOT COMPLETED|Overall Study||165
504582|NCT00252720|1214076|P1|NOT COMPLETED|Overall Study||132
504583|NCT00252720|1214075|P2|COMPLETED|Overall Study||789
504584|NCT00252720|1214076|P1|COMPLETED|Overall Study||819
504585|NCT00252720|1214075|P2|STARTED|Overall Study||954
504586|NCT00252720|1214076|P1|STARTED|Overall Study||951
504587|NCT00252694|1214090|P2|NOT COMPLETED|Overall Study||154
504588|NCT00252694|1214091|P1|NOT COMPLETED|Overall Study||144
504589|NCT00252694|1214090|P2|COMPLETED|Overall Study||800
504590|NCT00252694|1214091|P1|COMPLETED|Overall Study||807
504591|NCT00252694|1214090|P2|STARTED|Overall Study||954
504592|NCT00252694|1214091|P1|STARTED|Overall Study||951
504593|NCT00252629|1214106|P3|NOT COMPLETED|Overall Study||0
504594|NCT00252629|1214107|P2|NOT COMPLETED|Overall Study||0
504595|NCT00252629|1214108|P1|NOT COMPLETED|Overall Study||1
504596|NCT00252629|1214106|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
504597|NCT00252629|1214107|P2|COMPLETED|Overall Study||9
504598|NCT00252629|1214108|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
504690|NCT00251758|1214321|P2|NOT COMPLETED|Overall Study||27
504599|NCT00252629|1214106|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
504600|NCT00252629|1214107|P2|STARTED|Overall Study||9
504601|NCT00252629|1214108|P1|STARTED|Overall Study||9
504602|NCT00252590|1214124|P3|NOT COMPLETED|Overall Study||3
504603|NCT00252590|1214125|P2|NOT COMPLETED|Overall Study||2
504604|NCT00252590|1214126|P1|NOT COMPLETED|Overall Study||2
504605|NCT00252590|1214124|P3|COMPLETED|Overall Study||31
504606|NCT00252590|1214125|P2|COMPLETED|Overall Study||28
504607|NCT00252590|1214126|P1|COMPLETED|Overall Study||33
504608|NCT00252590|1214124|P3|STARTED|Overall Study||34
504609|NCT00252590|1214125|P2|STARTED|Overall Study||30
504610|NCT00252590|1214126|P1|STARTED|Overall Study||35
504611|NCT00252564|1214139|P2|NOT COMPLETED|Overall Study||44
504612|NCT00252564|1214140|P1|NOT COMPLETED|Overall Study||39
504613|NCT00252564|1214139|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
504614|NCT00252564|1214140|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
504615|NCT00252564|1214139|P2|STARTED|Overall Study|From randomization|123
504616|NCT00252564|1214140|P1|STARTED|Overall Study|From randomization|124
504617|NCT00252538|1214152|P2|NOT COMPLETED|Overall Study||0
504618|NCT00252538|1214153|P1|NOT COMPLETED|Overall Study||0
504619|NCT00252538|1214152|P2|COMPLETED|Overall Study||114
504620|NCT00252538|1214153|P1|COMPLETED|Overall Study||19
504621|NCT00252538|1214152|P2|STARTED|Overall Study||114
504622|NCT00252538|1214153|P1|STARTED|Overall Study||19
504623|NCT00252512|1214160|P2|NOT COMPLETED|12 Month Follow up||1
504624|NCT00252512|1214161|P1|NOT COMPLETED|12 Month Follow up||9
504625|NCT00252512|1214160|P2|COMPLETED|12 Month Follow up||121
504626|NCT00252512|1214161|P1|COMPLETED|12 Month Follow up||123
504627|NCT00252512|1214160|P2|STARTED|12 Month Follow up||122
504628|NCT00252512|1214161|P1|STARTED|12 Month Follow up||132
504629|NCT00252512|1214160|P2|NOT COMPLETED|Six Month Follow up||12
504630|NCT00252512|1214161|P1|NOT COMPLETED|Six Month Follow up||4
504631|NCT00252512|1214160|P2|COMPLETED|Six Month Follow up||122
504632|NCT00252512|1214161|P1|COMPLETED|Six Month Follow up||132
504633|NCT00252512|1214160|P2|STARTED|Six Month Follow up||134
504634|NCT00252512|1214161|P1|STARTED|Six Month Follow up||136
504635|NCT00252512|1214160|P2|NOT COMPLETED|Intervention||31
504636|NCT00252512|1214161|P1|NOT COMPLETED|Intervention||29
504637|NCT00252512|1214160|P2|COMPLETED|Intervention||134
504638|NCT00252512|1214161|P1|COMPLETED|Intervention||136
504639|NCT00252512|1214160|P2|STARTED|Intervention||165
504640|NCT00252512|1214161|P1|STARTED|Intervention||165
504641|NCT00252499|1214170|P3|NOT COMPLETED|Overall Study||0
504642|NCT00252499|1214171|P2|NOT COMPLETED|Overall Study||0
504643|NCT00252499|1214172|P1|NOT COMPLETED|Overall Study||1
504644|NCT00252499|1214170|P3|COMPLETED|Overall Study||6
504645|NCT00252499|1214171|P2|COMPLETED|Overall Study||2
504646|NCT00252499|1214172|P1|COMPLETED|Overall Study||4
504647|NCT00252499|1214170|P3|STARTED|Overall Study||6
504648|NCT00252499|1214171|P2|STARTED|Overall Study||2
504649|NCT00252499|1214172|P1|STARTED|Overall Study||5
504650|NCT00252239|1214199|P4|NOT COMPLETED|Overall Study||1
504651|NCT00252239|1214200|P3|NOT COMPLETED|Overall Study||2
504652|NCT00252239|1214201|P2|NOT COMPLETED|Overall Study||0
504653|NCT00252239|1214202|P1|NOT COMPLETED|Overall Study||1
504654|NCT00252239|1214199|P4|COMPLETED|Overall Study||30
504655|NCT00252239|1214200|P3|COMPLETED|Overall Study||17
504656|NCT00252239|1214201|P2|COMPLETED|Overall Study||31
504657|NCT00252239|1214202|P1|COMPLETED|Overall Study||30
504658|NCT00252239|1214199|P4|STARTED|Overall Study||31
504659|NCT00252239|1214200|P3|STARTED|Overall Study||19
504660|NCT00252239|1214201|P2|STARTED|Overall Study||31
504661|NCT00252239|1214202|P1|STARTED|Overall Study||31
504662|NCT00252187|1214214|P2|NOT COMPLETED|Overall Study||1
504663|NCT00252187|1214215|P1|NOT COMPLETED|Overall Study||4
504664|NCT00252187|1214214|P2|COMPLETED|Overall Study||20
504665|NCT00252187|1214215|P1|COMPLETED|Overall Study||20
504666|NCT00252187|1214214|P2|STARTED|Overall Study||21
504667|NCT00252187|1214215|P1|STARTED|Overall Study||24
504668|NCT00252174|1214238|P3|NOT COMPLETED|Overall Study||0
504669|NCT00252174|1214239|P2|NOT COMPLETED|Overall Study||1
504670|NCT00252174|1214240|P1|NOT COMPLETED|Overall Study||0
504671|NCT00252174|1214238|P3|COMPLETED|Overall Study||0
504672|NCT00252174|1214239|P2|COMPLETED|Overall Study||1
504673|NCT00252174|1214240|P1|COMPLETED|Overall Study||0
504674|NCT00252174|1214238|P3|STARTED|Overall Study|No subjects entered Stage 2|0
504675|NCT00252174|1214239|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
504676|NCT00252174|1214240|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
504677|NCT00252057|1214277|P2|NOT COMPLETED|Overall Study||8
504678|NCT00252057|1214278|P1|NOT COMPLETED|Overall Study||3
504679|NCT00252057|1214277|P2|COMPLETED|Overall Study||368
504680|NCT00252057|1214278|P1|COMPLETED|Overall Study||370
504681|NCT00252057|1214277|P2|STARTED|Overall Study||376
504682|NCT00252057|1214278|P1|STARTED|Overall Study||373
504683|NCT00251979|1214286|P2|NOT COMPLETED|Overall Study||40
504684|NCT00251979|1214287|P1|NOT COMPLETED|Overall Study||38
504685|NCT00251979|1214286|P2|COMPLETED|Overall Study||349
504686|NCT00251979|1214287|P1|COMPLETED|Overall Study||337
504687|NCT00251979|1214286|P2|STARTED|Overall Study|ITT population|389
504688|NCT00251979|1214287|P1|STARTED|Overall Study|ITT population|375
504689|NCT00251758|1214320|P3|NOT COMPLETED|Overall Study||27
504691|NCT00251758|1214322|P1|NOT COMPLETED|Overall Study||28
504692|NCT00251758|1214320|P3|COMPLETED|Overall Study||277
504693|NCT00251758|1214321|P2|COMPLETED|Overall Study||285
504694|NCT00251758|1214322|P1|COMPLETED|Overall Study||264
504695|NCT00251758|1214320|P3|STARTED|Overall Study||304
504696|NCT00251758|1214321|P2|STARTED|Overall Study||312
504697|NCT00251758|1214322|P1|STARTED|Overall Study||292
504698|NCT00251745|1214342|P3|NOT COMPLETED|Overall Study||27
504699|NCT00251745|1214343|P2|NOT COMPLETED|Overall Study||27
504700|NCT00251745|1214344|P1|NOT COMPLETED|Overall Study||28
504701|NCT00251745|1214342|P3|COMPLETED|Overall Study||277
504702|NCT00251745|1214343|P2|COMPLETED|Overall Study||285
504703|NCT00251745|1214344|P1|COMPLETED|Overall Study||264
504704|NCT00251745|1214342|P3|STARTED|Overall Study||304
504705|NCT00251745|1214343|P2|STARTED|Overall Study||312
504706|NCT00251745|1214344|P1|STARTED|Overall Study||292
504707|NCT00251719|1214364|P3|NOT COMPLETED|Overall Study||30
504708|NCT00251719|1214365|P2|NOT COMPLETED|Overall Study||45
504709|NCT00251719|1214366|P1|NOT COMPLETED|Overall Study||53
504710|NCT00251719|1214364|P3|COMPLETED|Overall Study||643
504711|NCT00251719|1214365|P2|COMPLETED|Overall Study||642
504712|NCT00251719|1214366|P1|COMPLETED|Overall Study||641
504713|NCT00251719|1214364|P3|STARTED|Overall Study||673
504714|NCT00251719|1214365|P2|STARTED|Overall Study||687
504715|NCT00251719|1214366|P1|STARTED|Overall Study||694
504716|NCT00251693|1214392|P3|NOT COMPLETED|Overall Study||46
504717|NCT00251693|1214393|P2|NOT COMPLETED|Overall Study||44
504718|NCT00251693|1214394|P1|NOT COMPLETED|Overall Study||51
504719|NCT00251693|1214392|P3|COMPLETED|Overall Study||644
504720|NCT00251693|1214393|P2|COMPLETED|Overall Study||624
504721|NCT00251693|1214394|P1|COMPLETED|Overall Study||629
504722|NCT00251693|1214392|P3|STARTED|Overall Study||690
504723|NCT00251693|1214393|P2|STARTED|Overall Study||668
504724|NCT00251693|1214394|P1|STARTED|Overall Study||680
504725|NCT00251641|1214419|P2|NOT COMPLETED|Overall Study||88
504726|NCT00251641|1214420|P1|NOT COMPLETED|Overall Study||112
504727|NCT00251641|1214419|P2|COMPLETED|Overall Study||127
504728|NCT00251641|1214420|P1|COMPLETED|Overall Study||541
504729|NCT00251641|1214419|P2|STARTED|Overall Study||215
504730|NCT00251641|1214420|P1|STARTED|Overall Study||653
504731|NCT00251589|1214438|P4|NOT COMPLETED|Overall Study||2
504732|NCT00251589|1214439|P3|NOT COMPLETED|Overall Study||2
504733|NCT00251589|1214440|P2|NOT COMPLETED|Overall Study||3
504734|NCT00251589|1214441|P1|NOT COMPLETED|Overall Study||15
504735|NCT00251589|1214438|P4|COMPLETED|Overall Study||0
504736|NCT00251589|1214439|P3|COMPLETED|Overall Study||0
504737|NCT00251589|1214440|P2|COMPLETED|Overall Study||0
504738|NCT00251589|1214441|P1|COMPLETED|Overall Study||1
504739|NCT00251589|1214438|P4|STARTED|Overall Study||2
504740|NCT00251589|1214439|P3|STARTED|Overall Study||2
504741|NCT00251589|1214440|P2|STARTED|Overall Study||3
504742|NCT00251589|1214441|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
504743|NCT00251316|1214478|P2|NOT COMPLETED|Overall Study||3
504744|NCT00251316|1214479|P1|NOT COMPLETED|Overall Study||2
504745|NCT00251316|1214478|P2|COMPLETED|Overall Study||14
504746|NCT00251316|1214479|P1|COMPLETED|Overall Study||15
504747|NCT00251316|1214478|P2|STARTED|Overall Study||17
504748|NCT00251316|1214479|P1|STARTED|Overall Study||17
504749|NCT00251303|1214487|P2|NOT COMPLETED|Overall Study||1
504750|NCT00251303|1214488|P1|NOT COMPLETED|Overall Study||8
504751|NCT00251303|1214487|P2|COMPLETED|Overall Study||29
504752|NCT00251303|1214488|P1|COMPLETED|Overall Study||22
504753|NCT00251303|1214487|P2|STARTED|Overall Study||30
504754|NCT00251303|1214488|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
504755|NCT00251238|1214498|P2|NOT COMPLETED|Overall Study||0
504756|NCT00251238|1214499|P1|NOT COMPLETED|Overall Study||0
504757|NCT00251238|1214498|P2|COMPLETED|Overall Study||20
504758|NCT00251238|1214499|P1|COMPLETED|Overall Study||21
504759|NCT00251238|1214498|P2|STARTED|Overall Study||20
504760|NCT00251238|1214499|P1|STARTED|Overall Study||21
504761|NCT00251004|1214512|P3|NOT COMPLETED|Overall Study||31
504762|NCT00251004|1214513|P2|NOT COMPLETED|Overall Study||41
504763|NCT00251004|1214514|P1|NOT COMPLETED|Overall Study||45
504764|NCT00251004|1214512|P3|COMPLETED|Overall Study||246
504765|NCT00251004|1214513|P2|COMPLETED|Overall Study||238
504766|NCT00251004|1214514|P1|COMPLETED|Overall Study||232
504767|NCT00251004|1214512|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
504768|NCT00251004|1214513|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
504769|NCT00251004|1214514|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
504770|NCT00251004|1214512|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
504771|NCT00251004|1214513|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
504772|NCT00251004|1214514|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
504773|NCT00251004|1214512|P3|STARTED|Overall Study||277
504774|NCT00251004|1214513|P2|STARTED|Overall Study||279
504775|NCT00251004|1214514|P1|STARTED|Overall Study||277
504776|NCT00250926|1214531|P1|NOT COMPLETED|Overall Study||0
504777|NCT00250926|1214531|P1|COMPLETED|Overall Study||23
504778|NCT00250926|1214531|P1|STARTED|Overall Study||23
504779|NCT00250835|1214538|P1|NOT COMPLETED|Overall Study||1
504780|NCT00250835|1214538|P1|COMPLETED|Overall Study||37
504781|NCT00250835|1214538|P1|STARTED|Overall Study||38
504782|NCT00250718|1214547|P1|NOT COMPLETED|Overall Study||3
504783|NCT00250718|1214547|P1|COMPLETED|Overall Study||14
504784|NCT00250718|1214547|P1|Received Treatment|Overall Study||16
504785|NCT00250718|1214547|P1|STARTED|Overall Study||17
504786|NCT00250679|1214555|P3|NOT COMPLETED|Overall Study||44
504787|NCT00250679|1214556|P2|NOT COMPLETED|Overall Study||49
504788|NCT00250679|1214557|P1|NOT COMPLETED|Overall Study||39
504789|NCT00250679|1214555|P3|COMPLETED|Overall Study||103
504790|NCT00250679|1214556|P2|COMPLETED|Overall Study||100
504791|NCT00250679|1214557|P1|COMPLETED|Overall Study||108
504792|NCT00250679|1214555|P3|STARTED|Overall Study||147
504793|NCT00250679|1214556|P2|STARTED|Overall Study||149
504794|NCT00250679|1214557|P1|STARTED|Overall Study||147
504795|NCT00250588|1214658|P3|NOT COMPLETED|Overall Study||13
504796|NCT00250588|1214659|P2|NOT COMPLETED|Overall Study||19
504797|NCT00250588|1214660|P1|NOT COMPLETED|Overall Study||9
504798|NCT00250588|1214658|P3|COMPLETED|Overall Study||74
504799|NCT00250588|1214659|P2|COMPLETED|Overall Study||65
504800|NCT00250588|1214660|P1|COMPLETED|Overall Study||72
504801|NCT00250588|1214658|P3|STARTED|Overall Study||87
504802|NCT00250588|1214659|P2|STARTED|Overall Study||84
504803|NCT00250588|1214660|P1|STARTED|Overall Study||81
504804|NCT00250497|1214676|P2|NOT COMPLETED|Overall Study||15
504805|NCT00250497|1214677|P1|NOT COMPLETED|Overall Study||5
504806|NCT00250497|1214676|P2|COMPLETED|Overall Study||159
504807|NCT00250497|1214677|P1|COMPLETED|Overall Study||177
504808|NCT00250497|1214676|P2|STARTED|Overall Study||174
504809|NCT00250497|1214677|P1|STARTED|Overall Study||182
504810|NCT00250484|1214695|P2|NOT COMPLETED|Overall Study||0
504811|NCT00250484|1214696|P1|NOT COMPLETED|Overall Study||0
504812|NCT00250484|1214695|P2|COMPLETED|Overall Study||8
504813|NCT00250484|1214696|P1|COMPLETED|Overall Study||9
504814|NCT00250484|1214695|P2|STARTED|Overall Study||8
504815|NCT00250484|1214696|P1|STARTED|Overall Study||9
504816|NCT00250458|1214706|P2|NOT COMPLETED|Overall Study||17
504817|NCT00250458|1214707|P1|NOT COMPLETED|Overall Study||32
504818|NCT00250458|1214706|P2|COMPLETED|Overall Study||97
504819|NCT00250458|1214707|P1|COMPLETED|Overall Study||200
504820|NCT00250458|1214706|P2|STARTED|Overall Study||114
504821|NCT00250458|1214707|P1|STARTED|Overall Study||232
504822|NCT00250432|1214717|P2|NOT COMPLETED|Overall Study||47
504823|NCT00250432|1214718|P1|NOT COMPLETED|Overall Study||45
504824|NCT00250432|1214717|P2|COMPLETED|Overall Study||53
504825|NCT00250432|1214718|P1|COMPLETED|Overall Study||59
504826|NCT00250432|1214717|P2|STARTED|Overall Study||100
504827|NCT00250432|1214718|P1|STARTED|Overall Study||104
504828|NCT00249288|1214728|P2|NOT COMPLETED|Overall Study||5
504829|NCT00249288|1214729|P1|NOT COMPLETED|Overall Study||5
504830|NCT00249288|1214728|P2|COMPLETED|Overall Study||14
504831|NCT00249288|1214729|P1|COMPLETED|Overall Study||14
504832|NCT00249288|1214728|P2|Initiated Treatment|Overall Study||15
504833|NCT00249288|1214729|P1|Initiated Treatment|Overall Study||17
504834|NCT00249288|1214728|P2|STARTED|Overall Study||19
504835|NCT00249288|1214729|P1|STARTED|Overall Study||19
504836|NCT00249249|1214739|P4|NOT COMPLETED|Overall Study||3
504837|NCT00249249|1214740|P3|NOT COMPLETED|Overall Study||15
504838|NCT00249249|1214741|P2|NOT COMPLETED|Overall Study||5
504839|NCT00249249|1214742|P1|NOT COMPLETED|Overall Study||20
504840|NCT00249249|1214739|P4|COMPLETED|Overall Study||100
504841|NCT00249249|1214740|P3|COMPLETED|Overall Study||288
504842|NCT00249249|1214741|P2|COMPLETED|Overall Study||98
504843|NCT00249249|1214742|P1|COMPLETED|Overall Study||301
504844|NCT00249249|1214739|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
504845|NCT00249249|1214740|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
504846|NCT00249249|1214741|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
504847|NCT00249249|1214742|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
504848|NCT00249249|1214739|P4|STARTED|Overall Study||103
504849|NCT00249249|1214740|P3|STARTED|Overall Study||303
504850|NCT00249249|1214741|P2|STARTED|Overall Study||103
504851|NCT00249249|1214742|P1|STARTED|Overall Study||321
504852|NCT00250276|1214800|P4|NOT COMPLETED|Overall Study||19
504853|NCT00250276|1214801|P3|NOT COMPLETED|Overall Study||19
504854|NCT00250276|1214802|P2|NOT COMPLETED|Overall Study||21
504855|NCT00250276|1214803|P1|NOT COMPLETED|Overall Study||17
504856|NCT00250276|1214800|P4|COMPLETED|Overall Study||181
504857|NCT00250276|1214801|P3|COMPLETED|Overall Study||182
504858|NCT00250276|1214802|P2|COMPLETED|Overall Study||177
504859|NCT00250276|1214803|P1|COMPLETED|Overall Study||182
504860|NCT00250276|1214800|P4|STARTED|Overall Study||200
504861|NCT00250276|1214801|P3|STARTED|Overall Study||201
504862|NCT00250276|1214802|P2|STARTED|Overall Study||198
504863|NCT00250276|1214803|P1|STARTED|Overall Study||199
504864|NCT00249873|1214883|P2|NOT COMPLETED|Overall Study||1254
504865|NCT00249873|1214884|P1|NOT COMPLETED|Overall Study||1330
504866|NCT00249873|1214883|P2|COMPLETED|Overall Study|started and completed study drug|2528
504867|NCT00249873|1214884|P1|COMPLETED|Overall Study|started and completed study drug|2442
504868|NCT00249873|1214883|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
504869|NCT00249873|1214884|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
504870|NCT00249821|1214898|P2|NOT COMPLETED|Overall Study||1
504871|NCT00249821|1214899|P1|NOT COMPLETED|Overall Study||0
504872|NCT00249821|1214898|P2|COMPLETED|Overall Study||11
504873|NCT00249821|1214899|P1|COMPLETED|Overall Study||10
504874|NCT00249821|1214898|P2|STARTED|Overall Study||12
504875|NCT00249821|1214899|P1|STARTED|Overall Study||10
504876|NCT00249795|1214921|P2|NOT COMPLETED|Overall Study||1390
504877|NCT00249795|1214922|P1|NOT COMPLETED|Overall Study||1394
504878|NCT00249795|1214921|P2|COMPLETED|Overall Study|started and completed study drug|3108
504879|NCT00249795|1214922|P1|COMPLETED|Overall Study|started and completed study drug|3124
504880|NCT00249795|1214921|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
504881|NCT00249795|1214922|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
504882|NCT00249613|1214942|P2|NOT COMPLETED|12 Month Follow-up||15
504883|NCT00249613|1214943|P1|NOT COMPLETED|12 Month Follow-up||17
504884|NCT00249613|1214942|P2|COMPLETED|12 Month Follow-up||124
504885|NCT00249613|1214943|P1|COMPLETED|12 Month Follow-up||135
504886|NCT00249613|1214942|P2|STARTED|12 Month Follow-up||139
504887|NCT00249613|1214943|P1|STARTED|12 Month Follow-up||152
504888|NCT00249613|1214942|P2|NOT COMPLETED|Baseline||0
504889|NCT00249613|1214943|P1|NOT COMPLETED|Baseline||0
504890|NCT00249613|1214942|P2|COMPLETED|Baseline||139
504891|NCT00249613|1214943|P1|COMPLETED|Baseline||152
504892|NCT00249613|1214942|P2|STARTED|Baseline||139
504893|NCT00249613|1214943|P1|STARTED|Baseline||152
504894|NCT00249496|1214954|P2|NOT COMPLETED|Overall Study||1
504895|NCT00249496|1214955|P1|NOT COMPLETED|Overall Study||0
504896|NCT00249496|1214954|P2|COMPLETED|Overall Study||26
504897|NCT00249496|1214955|P1|COMPLETED|Overall Study||24
504898|NCT00249496|1214954|P2|STARTED|Overall Study||27
504899|NCT00249496|1214955|P1|STARTED|Overall Study||24
504900|NCT00249470|1214963|P2|NOT COMPLETED|Overall Study||0
504901|NCT00249470|1214964|P1|NOT COMPLETED|Overall Study||0
504902|NCT00249470|1214963|P2|COMPLETED|Overall Study||28
504903|NCT00249470|1214964|P1|COMPLETED|Overall Study||28
504904|NCT00249470|1214963|P2|STARTED|Overall Study||28
504905|NCT00249470|1214964|P1|STARTED|Overall Study||28
504906|NCT00249379|1214972|P2|NOT COMPLETED|Overall Study||8
504907|NCT00249379|1214973|P1|NOT COMPLETED|Overall Study||8
504908|NCT00249379|1214972|P2|COMPLETED|Overall Study||4
504909|NCT00249379|1214973|P1|COMPLETED|Overall Study||6
504910|NCT00249379|1214972|P2|STARTED|Overall Study||12
504911|NCT00249379|1214973|P1|STARTED|Overall Study||14
504912|NCT00249002|1214985|P1|NOT COMPLETED|Overall Study||7
504913|NCT00249002|1214985|P1|COMPLETED|Overall Study||2
504914|NCT00249002|1214985|P1|STARTED|Overall Study||9
504915|NCT00248807|1215003|P2|NOT COMPLETED|Overall Study||0
504916|NCT00248807|1215004|P1|NOT COMPLETED|Overall Study||0
504917|NCT00248807|1215003|P2|COMPLETED|Overall Study||11
504918|NCT00248807|1215004|P1|COMPLETED|Overall Study||19
504919|NCT00248807|1215003|P2|STARTED|Overall Study||11
504920|NCT00248807|1215004|P1|STARTED|Overall Study||19
504921|NCT00248794|1215021|P3|NOT COMPLETED|Overall Study||3
504922|NCT00248794|1215022|P2|NOT COMPLETED|Overall Study||8
504923|NCT00248794|1215023|P1|NOT COMPLETED|Overall Study||6
504924|NCT00248794|1215021|P3|COMPLETED|Overall Study||7
504925|NCT00248794|1215022|P2|COMPLETED|Overall Study||16
504926|NCT00248794|1215023|P1|COMPLETED|Overall Study||19
504927|NCT00248794|1215021|P3|STARTED|Overall Study||10
504928|NCT00248794|1215022|P2|STARTED|Overall Study||24
504929|NCT00248794|1215023|P1|STARTED|Overall Study||25
504930|NCT00248781|1215045|P2|NOT COMPLETED|Overall Study||4
504931|NCT00248781|1215046|P1|NOT COMPLETED|Overall Study||10
504932|NCT00248781|1215045|P2|COMPLETED|Overall Study||47
504933|NCT00248781|1215046|P1|COMPLETED|Overall Study||42
504934|NCT00248781|1215045|P2|STARTED|Overall Study||51
504935|NCT00248781|1215046|P1|STARTED|Overall Study||52
504936|NCT00248651|1215073|P3|NOT COMPLETED|Overall Study||32
504937|NCT00248651|1215074|P2|NOT COMPLETED|Overall Study||40
504938|NCT00248651|1215075|P1|NOT COMPLETED|Overall Study||28
504939|NCT00248651|1215073|P3|COMPLETED|Overall Study||65
504940|NCT00248651|1215074|P2|COMPLETED|Overall Study||58
504941|NCT00248651|1215075|P1|COMPLETED|Overall Study||69
504942|NCT00248651|1215073|P3|Completed 12 Weeks of Treatment|Overall Study||75
504943|NCT00248651|1215074|P2|Completed 12 Weeks of Treatment|Overall Study||66
504944|NCT00248651|1215075|P1|Completed 12 Weeks of Treatment|Overall Study||78
504945|NCT00248651|1215073|P3|STARTED|Overall Study||97
504946|NCT00248651|1215074|P2|STARTED|Overall Study||98
504947|NCT00248651|1215075|P1|STARTED|Overall Study||97
504948|NCT00248638|1215094|P2|NOT COMPLETED|Overall Study||0
504949|NCT00248638|1215095|P1|NOT COMPLETED|Overall Study||0
504950|NCT00248638|1215094|P2|COMPLETED|Overall Study||75
504951|NCT00248638|1215095|P1|COMPLETED|Overall Study||75
504952|NCT00248638|1215094|P2|STARTED|Overall Study||75
504953|NCT00248638|1215095|P1|STARTED|Overall Study||75
504954|NCT00248625|1215105|P2|NOT COMPLETED|Overall Study||2
504955|NCT00248625|1215106|P1|NOT COMPLETED|Overall Study||0
504956|NCT00248625|1215105|P2|COMPLETED|Overall Study||90
504957|NCT00248625|1215106|P1|COMPLETED|Overall Study||92
504958|NCT00248625|1215105|P2|STARTED|Overall Study||92
504959|NCT00248625|1215106|P1|STARTED|Overall Study||92
504960|NCT00248560|1215126|P1|NOT COMPLETED|Overall Study||0
504961|NCT00248560|1215126|P1|COMPLETED|Overall Study||36
504962|NCT00248560|1215126|P1|STARTED|Overall Study||36
504963|NCT00248547|1215132|P2|NOT COMPLETED|Overall Study||0
504964|NCT00248547|1215133|P1|NOT COMPLETED|Overall Study||0
504965|NCT00248547|1215132|P2|COMPLETED|Overall Study||20
504966|NCT00248547|1215133|P1|COMPLETED|Overall Study||20
504967|NCT00248547|1215132|P2|STARTED|Overall Study||20
504968|NCT00248547|1215133|P1|STARTED|Overall Study||20
504969|NCT00248495|1215139|P1|NOT COMPLETED|Overall Study||1
504970|NCT00248495|1215139|P1|COMPLETED|Overall Study||37
504971|NCT00248495|1215139|P1|STARTED|Overall Study||38
504972|NCT00248287|1215150|P2|NOT COMPLETED|Overall Study||19
504973|NCT00248287|1215151|P1|NOT COMPLETED|Overall Study||24
504974|NCT00248287|1215150|P2|COMPLETED|Overall Study||60
504975|NCT00248287|1215151|P1|COMPLETED|Overall Study||51
504976|NCT00248287|1215150|P2|STARTED|Overall Study||79
504977|NCT00248287|1215151|P1|STARTED|Overall Study||75
504978|NCT00248170|1215165|P2|NOT COMPLETED|Overall Study||808
504979|NCT00248170|1215166|P1|NOT COMPLETED|Overall Study||761
504980|NCT00248170|1215165|P2|COMPLETED|Overall Study||1286
504981|NCT00248170|1215166|P1|COMPLETED|Overall Study||1317
504982|NCT00248170|1215165|P2|Safety Set|Overall Study||2062
504983|NCT00248170|1215166|P1|Safety Set|Overall Study||2049
504984|NCT00248170|1215165|P2|Intent-to-treat (ITT)|Overall Study||2075
504985|NCT00248170|1215166|P1|Intent-to-treat (ITT)|Overall Study||2061
504986|NCT00248170|1215165|P2|STARTED|Overall Study||2094
504987|NCT00248170|1215166|P1|STARTED|Overall Study||2078
504988|NCT00247962|1215188|P2|NOT COMPLETED|Overall Study||19
504989|NCT00247962|1215189|P1|NOT COMPLETED|Overall Study||26
504990|NCT00247962|1215188|P2|COMPLETED|Overall Study||168
504991|NCT00247962|1215189|P1|COMPLETED|Overall Study||353
504992|NCT00247962|1215188|P2|STARTED|Overall Study||187
504993|NCT00247962|1215189|P1|STARTED|Overall Study||379
504994|NCT00247676|1215197|P1|NOT COMPLETED|Overall Study||36
504995|NCT00247676|1215197|P1|COMPLETED|Overall Study||1
504996|NCT00247676|1215197|P1|STARTED|Overall Study||37
504997|NCT00247611|1215227|P2|NOT COMPLETED|On Protocol Sample||125
504998|NCT00247611|1215228|P1|NOT COMPLETED|On Protocol Sample||111
504999|NCT00247611|1215227|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
505000|NCT00247611|1215228|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
505001|NCT00247611|1215227|P2|STARTED|On Protocol Sample|ITT sample participants|277
505002|NCT00247611|1215228|P1|STARTED|On Protocol Sample|ITT sample participants|287
505003|NCT00247611|1215227|P2|NOT COMPLETED|Intention to Treat Sample||13
505004|NCT00247611|1215228|P1|NOT COMPLETED|Intention to Treat Sample||17
505005|NCT00247611|1215227|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
505006|NCT00247611|1215228|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
505007|NCT00247611|1215227|P2|STARTED|Intention to Treat Sample|Participants randomized|290
505008|NCT00247611|1215228|P1|STARTED|Intention to Treat Sample|Participants randomized|304
505009|NCT00247611|1215227|P2|NOT COMPLETED|Baselined||13
505010|NCT00247611|1215228|P1|NOT COMPLETED|Baselined||17
505011|NCT00247611|1215227|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
505012|NCT00247611|1215228|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
505013|NCT00247611|1215227|P2|STARTED|Baselined|Participants randomized|290
505014|NCT00247611|1215228|P1|STARTED|Baselined|Participants randomized|304
505015|NCT00247416|1215246|P2|NOT COMPLETED|Overall Study||2
505016|NCT00247416|1215247|P1|NOT COMPLETED|Overall Study||1
505017|NCT00247416|1215246|P2|COMPLETED|Overall Study||31
505018|NCT00247416|1215247|P1|COMPLETED|Overall Study||25
505019|NCT00247416|1215246|P2|STARTED|Overall Study||33
505020|NCT00247416|1215247|P1|STARTED|Overall Study||26
505021|NCT00247377|1215261|P2|NOT COMPLETED|Overall Study||0
505022|NCT00247377|1215262|P1|NOT COMPLETED|Overall Study||0
505023|NCT00247377|1215261|P2|COMPLETED|Overall Study||86
505024|NCT00247377|1215262|P1|COMPLETED|Overall Study||111
505025|NCT00247377|1215261|P2|STARTED|Overall Study||86
505026|NCT00247377|1215262|P1|STARTED|Overall Study||111
505027|NCT00247273|1215288|P2|NOT COMPLETED|Overall Study||137
505028|NCT00247273|1215289|P1|NOT COMPLETED|Overall Study||146
505029|NCT00247273|1215288|P2|COMPLETED|Overall Study||513
505030|NCT00247273|1215289|P1|COMPLETED|Overall Study||498
505031|NCT00247273|1215288|P2|Intent to Treat Population|Overall Study||650
505032|NCT00247273|1215289|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
505033|NCT00247273|1215288|P2|STARTED|Overall Study||650
505034|NCT00247273|1215289|P1|STARTED|Overall Study||644
505035|NCT00246805|1215335|P2|NOT COMPLETED|Phase 2||0
505036|NCT00246805|1215336|P1|NOT COMPLETED|Phase 2||0
505037|NCT00246805|1215335|P2|COMPLETED|Phase 2||33
505038|NCT00246805|1215336|P1|COMPLETED|Phase 2||33
505039|NCT00246805|1215335|P2|STARTED|Phase 2||33
505040|NCT00246805|1215336|P1|STARTED|Phase 2||33
505041|NCT00246805|1215335|P2|NOT COMPLETED|Phase 1||0
505042|NCT00246805|1215336|P1|NOT COMPLETED|Phase 1||1
505043|NCT00246805|1215335|P2|COMPLETED|Phase 1||33
505044|NCT00246805|1215336|P1|COMPLETED|Phase 1||33
505045|NCT00246805|1215335|P2|STARTED|Phase 1||33
505046|NCT00246805|1215336|P1|STARTED|Phase 1||34
505047|NCT00246571|1215344|P2|NOT COMPLETED|Overall Study||104
505048|NCT00246571|1215345|P1|NOT COMPLETED|Overall Study||113
505049|NCT00246571|1215344|P2|COMPLETED|Overall Study||0
505050|NCT00246571|1215345|P1|COMPLETED|Overall Study||0
505051|NCT00246571|1215344|P2|Randomized But Not Treated|Overall Study||1
505052|NCT00246571|1215345|P1|Randomized But Not Treated|Overall Study||3
505053|NCT00246571|1215344|P2|STARTED|Overall Study||104
505054|NCT00246571|1215345|P1|STARTED|Overall Study||113
505055|NCT00246519|1215385|P2|NOT COMPLETED|Overall Study||64
505056|NCT00246519|1215386|P1|NOT COMPLETED|Overall Study||56
505057|NCT00246519|1215385|P2|COMPLETED|Overall Study||382
505058|NCT00246519|1215386|P1|COMPLETED|Overall Study||386
505059|NCT00246519|1215385|P2|STARTED|Overall Study||446
505060|NCT00246519|1215386|P1|STARTED|Overall Study||442
505061|NCT00246376|1215397|P5|NOT COMPLETED|Overall Study||17
505062|NCT00246376|1215398|P4|NOT COMPLETED|Overall Study||26
505063|NCT00246376|1215399|P3|NOT COMPLETED|Overall Study||16
505064|NCT00246376|1215400|P2|NOT COMPLETED|Overall Study||19
505065|NCT00246376|1215401|P1|NOT COMPLETED|Overall Study||15
505066|NCT00246376|1215397|P5|COMPLETED|Overall Study||28
505067|NCT00246376|1215398|P4|COMPLETED|Overall Study||21
505068|NCT00246376|1215399|P3|COMPLETED|Overall Study||29
505069|NCT00246376|1215400|P2|COMPLETED|Overall Study||24
505070|NCT00246376|1215401|P1|COMPLETED|Overall Study||26
505071|NCT00246376|1215397|P5|After Dietary run-in at Two Weeks|Overall Study||42
505072|NCT00246376|1215398|P4|After Dietary run-in at Two Weeks|Overall Study||40
505073|NCT00246376|1215399|P3|After Dietary run-in at Two Weeks|Overall Study||41
505074|NCT00246376|1215400|P2|After Dietary run-in at Two Weeks|Overall Study||38
505075|NCT00246376|1215401|P1|After Dietary run-in at Two Weeks|Overall Study||30
505076|NCT00246376|1215397|P5|STARTED|Overall Study||45
505077|NCT00246376|1215398|P4|STARTED|Overall Study||47
505078|NCT00246376|1215399|P3|STARTED|Overall Study||45
505079|NCT00246376|1215400|P2|STARTED|Overall Study||43
505080|NCT00246376|1215401|P1|STARTED|Overall Study||41
505081|NCT00246337|1215452|P9|NOT COMPLETED|Overall Study||11
505082|NCT00246337|1215453|P8|NOT COMPLETED|Overall Study||13
505083|NCT00246337|1215454|P7|NOT COMPLETED|Overall Study||9
505084|NCT00246337|1215455|P6|NOT COMPLETED|Overall Study||15
505085|NCT00246337|1215456|P5|NOT COMPLETED|Overall Study||4
505086|NCT00246337|1215457|P4|NOT COMPLETED|Overall Study||1
505087|NCT00246337|1215458|P3|NOT COMPLETED|Overall Study||3
505088|NCT00246337|1215459|P2|NOT COMPLETED|Overall Study||2
505089|NCT00246337|1215460|P1|NOT COMPLETED|Overall Study||32
505090|NCT00246337|1215452|P9|COMPLETED|Overall Study||34
505091|NCT00246337|1215453|P8|COMPLETED|Overall Study||40
505092|NCT00246337|1215454|P7|COMPLETED|Overall Study||45
505093|NCT00246337|1215455|P6|COMPLETED|Overall Study||39
505094|NCT00246337|1215456|P5|COMPLETED|Overall Study||12
505095|NCT00246337|1215457|P4|COMPLETED|Overall Study||16
505096|NCT00246337|1215458|P3|COMPLETED|Overall Study||15
505097|NCT00246337|1215459|P2|COMPLETED|Overall Study||14
505098|NCT00246337|1215460|P1|COMPLETED|Overall Study||115
505099|NCT00246337|1215452|P9|Completed Period (Both Doses)|Overall Study||15
505100|NCT00246337|1215453|P8|Completed Period (Both Doses)|Overall Study||13
505101|NCT00246337|1215454|P7|Completed Period (Both Doses)|Overall Study||16
505102|NCT00246337|1215455|P6|Completed Period (Both Doses)|Overall Study||10
505103|NCT00246337|1215456|P5|Completed Period (Both Doses)|Overall Study||4
505104|NCT00246337|1215457|P4|Completed Period (Both Doses)|Overall Study||11
505105|NCT00246337|1215458|P3|Completed Period (Both Doses)|Overall Study||6
505106|NCT00246337|1215459|P2|Completed Period (Both Doses)|Overall Study||10
505107|NCT00246337|1215460|P1|Completed Period (Both Doses)|Overall Study||69
505108|NCT00246337|1215452|P9|Completed Period (Initial Dose)|Overall Study||19
505109|NCT00246337|1215453|P8|Completed Period (Initial Dose)|Overall Study||27
505110|NCT00246337|1215454|P7|Completed Period (Initial Dose)|Overall Study||29
505111|NCT00246337|1215455|P6|Completed Period (Initial Dose)|Overall Study||29
505112|NCT00246337|1215456|P5|Completed Period (Initial Dose)|Overall Study||8
505113|NCT00246337|1215457|P4|Completed Period (Initial Dose)|Overall Study||5
505114|NCT00246337|1215458|P3|Completed Period (Initial Dose)|Overall Study||9
505115|NCT00246337|1215459|P2|Completed Period (Initial Dose)|Overall Study||4
505116|NCT00246337|1215460|P1|Completed Period (Initial Dose)|Overall Study||46
505117|NCT00246337|1215452|P9|STARTED|Overall Study||45
505118|NCT00246337|1215453|P8|STARTED|Overall Study||53
505119|NCT00246337|1215454|P7|STARTED|Overall Study||54
505120|NCT00246337|1215455|P6|STARTED|Overall Study||54
505121|NCT00246337|1215456|P5|STARTED|Overall Study||16
505122|NCT00246337|1215457|P4|STARTED|Overall Study||17
505123|NCT00246337|1215458|P3|STARTED|Overall Study||18
505124|NCT00246337|1215459|P2|STARTED|Overall Study||16
505125|NCT00246337|1215460|P1|STARTED|Overall Study||147
505126|NCT00246324|1215507|P1|NOT COMPLETED|Overall Study||1
505127|NCT00246324|1215507|P1|COMPLETED|Overall Study||15
505128|NCT00246324|1215507|P1|STARTED|Overall Study||16
505129|NCT00246259|1215514|P2|NOT COMPLETED|Overall Study||26
505130|NCT00246259|1215515|P1|NOT COMPLETED|Overall Study||28
505131|NCT00246259|1215514|P2|COMPLETED|Overall Study||15
505132|NCT00246259|1215515|P1|COMPLETED|Overall Study||16
505133|NCT00246259|1215514|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
505134|NCT00246259|1215515|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
505135|NCT00246259|1215514|P2|STARTED|Overall Study||41
505136|NCT00246259|1215515|P1|STARTED|Overall Study||44
505137|NCT00246090|1215549|P1|NOT COMPLETED|Overall Study||295
505138|NCT00246090|1215549|P1|COMPLETED|Overall Study||3
505139|NCT00246090|1215549|P1|STARTED|Overall Study||298
505140|NCT00246025|1215558|P4|NOT COMPLETED|Overall Study||13
505141|NCT00246025|1215559|P3|NOT COMPLETED|Overall Study||10
505142|NCT00246025|1215560|P2|NOT COMPLETED|Overall Study||9
505143|NCT00246025|1215561|P1|NOT COMPLETED|Overall Study||10
505144|NCT00246025|1215558|P4|COMPLETED|Overall Study||116
505145|NCT00246025|1215559|P3|COMPLETED|Overall Study||116
505146|NCT00246025|1215560|P2|COMPLETED|Overall Study||124
505147|NCT00246025|1215561|P1|COMPLETED|Overall Study||114
505148|NCT00246025|1215558|P4|STARTED|Overall Study||129
505149|NCT00246025|1215559|P3|STARTED|Overall Study||126
505150|NCT00246025|1215560|P2|STARTED|Overall Study||133
505151|NCT00246025|1215561|P1|STARTED|Overall Study||124
505152|NCT00246012|1215620|P9|NOT COMPLETED|Overall Study||28
505153|NCT00246012|1215621|P8|NOT COMPLETED|Overall Study||28
505154|NCT00246012|1215622|P7|NOT COMPLETED|Overall Study||31
505155|NCT00246012|1215623|P6|NOT COMPLETED|Overall Study||28
505156|NCT00246012|1215624|P5|NOT COMPLETED|Overall Study||3
505157|NCT00246012|1215625|P4|NOT COMPLETED|Overall Study||3
505158|NCT00246012|1215626|P3|NOT COMPLETED|Overall Study||2
505159|NCT00246012|1215627|P2|NOT COMPLETED|Overall Study||1
505160|NCT00246012|1215628|P1|NOT COMPLETED|Overall Study||3
505161|NCT00246012|1215620|P9|COMPLETED|Overall Study||4
505162|NCT00246012|1215621|P8|COMPLETED|Overall Study||5
505163|NCT00246012|1215622|P7|COMPLETED|Overall Study||1
505164|NCT00246012|1215623|P6|COMPLETED|Overall Study||4
505165|NCT00246012|1215624|P5|COMPLETED|Overall Study||0
505166|NCT00246012|1215625|P4|COMPLETED|Overall Study||0
505167|NCT00246012|1215626|P3|COMPLETED|Overall Study||1
505168|NCT00246012|1215627|P2|COMPLETED|Overall Study||2
505169|NCT00246012|1215628|P1|COMPLETED|Overall Study||0
505170|NCT00246012|1215620|P9|Treated|Overall Study||32
505171|NCT00246012|1215621|P8|Treated|Overall Study||33
505172|NCT00246012|1215622|P7|Treated|Overall Study||31
505173|NCT00246012|1215623|P6|Treated|Overall Study||31
505174|NCT00246012|1215624|P5|Treated|Overall Study||3
505175|NCT00246012|1215625|P4|Treated|Overall Study||3
505176|NCT00246012|1215626|P3|Treated|Overall Study||3
505177|NCT00246012|1215627|P2|Treated|Overall Study||3
505178|NCT00246012|1215628|P1|Treated|Overall Study||3
505179|NCT00246012|1215620|P9|STARTED|Overall Study||32
505180|NCT00246012|1215621|P8|STARTED|Overall Study||33
505181|NCT00246012|1215622|P7|STARTED|Overall Study||32
505182|NCT00246012|1215623|P6|STARTED|Overall Study||32
505183|NCT00246012|1215624|P5|STARTED|Overall Study||3
505184|NCT00246012|1215625|P4|STARTED|Overall Study||3
505185|NCT00246012|1215626|P3|STARTED|Overall Study||3
505186|NCT00246012|1215627|P2|STARTED|Overall Study||3
505187|NCT00246012|1215628|P1|STARTED|Overall Study||3
505188|NCT00245960|1215723|P2|NOT COMPLETED|Overall Study||28
505189|NCT00245960|1215724|P1|NOT COMPLETED|Overall Study||29
505190|NCT00245960|1215723|P2|COMPLETED|Overall Study||345
505191|NCT00245960|1215724|P1|COMPLETED|Overall Study||350
505192|NCT00245960|1215723|P2|STARTED|Overall Study||373
505193|NCT00245960|1215724|P1|STARTED|Overall Study||379
505194|NCT00245856|1215732|P2|NOT COMPLETED|Period Two||1
505195|NCT00245856|1215733|P1|NOT COMPLETED|Period Two||0
505196|NCT00245856|1215732|P2|COMPLETED|Period Two||38
505197|NCT00245856|1215733|P1|COMPLETED|Period Two||0
505198|NCT00245856|1215732|P2|STARTED|Period Two||39
505199|NCT00245856|1215733|P1|STARTED|Period Two||0
505200|NCT00245856|1215732|P2|NOT COMPLETED|Period One||0
505201|NCT00245856|1215733|P1|NOT COMPLETED|Period One||0
505202|NCT00245856|1215732|P2|COMPLETED|Period One||0
505203|NCT00245856|1215733|P1|COMPLETED|Period One||28
505204|NCT00245856|1215732|P2|STARTED|Period One||0
505205|NCT00245856|1215733|P1|STARTED|Period One||28
505206|NCT00245102|1215746|P6|NOT COMPLETED|Overall Study||4
505207|NCT00245102|1215747|P5|NOT COMPLETED|Overall Study||0
505208|NCT00245102|1215748|P4|NOT COMPLETED|Overall Study||3
505209|NCT00245102|1215749|P3|NOT COMPLETED|Overall Study||7
505210|NCT00245102|1215750|P2|NOT COMPLETED|Overall Study||4
505211|NCT00245102|1215751|P1|NOT COMPLETED|Overall Study||7
505212|NCT00245102|1215746|P6|COMPLETED|Overall Study||19
505213|NCT00245102|1215747|P5|COMPLETED|Overall Study||5
505214|NCT00245102|1215748|P4|COMPLETED|Overall Study||10
505215|NCT00245102|1215749|P3|COMPLETED|Overall Study||39
505216|NCT00245102|1215750|P2|COMPLETED|Overall Study||12
505217|NCT00245102|1215751|P1|COMPLETED|Overall Study||37
505218|NCT00245102|1215746|P6|STARTED|Overall Study||23
505219|NCT00245102|1215747|P5|STARTED|Overall Study||5
505220|NCT00245102|1215748|P4|STARTED|Overall Study||13
505221|NCT00245102|1215749|P3|STARTED|Overall Study||46
505222|NCT00245102|1215750|P2|STARTED|Overall Study||16
505223|NCT00245102|1215751|P1|STARTED|Overall Study||44
505224|NCT00245063|1215767|P2|NOT COMPLETED|Overall Study||5
505225|NCT00245063|1215768|P1|NOT COMPLETED|Overall Study||7
505226|NCT00245063|1215767|P2|COMPLETED|Overall Study||8
505227|NCT00245063|1215768|P1|COMPLETED|Overall Study||5
505228|NCT00245063|1215767|P2|STARTED|Overall Study||13
505229|NCT00245063|1215768|P1|STARTED|Overall Study||12
505230|NCT00245050|1215776|P2|NOT COMPLETED|Overall Study||2
505231|NCT00245050|1215777|P1|NOT COMPLETED|Overall Study||3
505232|NCT00245050|1215776|P2|COMPLETED|Overall Study||14
505233|NCT00245050|1215777|P1|COMPLETED|Overall Study||15
505234|NCT00245050|1215776|P2|STARTED|Overall Study||16
505235|NCT00245050|1215777|P1|STARTED|Overall Study||18
505236|NCT00245011|1215785|P1|NOT COMPLETED|Overall Study||1
505321|NCT00245570|1215823|P2|COMPLETED|Washout Between Periods II and III||8
505237|NCT00245011|1215785|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
505238|NCT00245011|1215785|P1|STARTED|Overall Study||11
505239|NCT00244933|1215789|P1|NOT COMPLETED|Overall Study||2
505240|NCT00244933|1215789|P1|COMPLETED|Overall Study||17
505241|NCT00244933|1215789|P1|STARTED|Overall Study||19
505242|NCT00244881|1215793|P1|NOT COMPLETED|Overall Study||3
505243|NCT00244881|1215793|P1|COMPLETED|Overall Study||23
505244|NCT00244881|1215793|P1|STARTED|Overall Study||26
505245|NCT00244855|1215801|P2|NOT COMPLETED|Overall Study||1
505246|NCT00244855|1215802|P1|NOT COMPLETED|Overall Study||0
505247|NCT00244855|1215801|P2|COMPLETED|Overall Study||24
505248|NCT00244855|1215802|P1|COMPLETED|Overall Study||7
505249|NCT00244855|1215801|P2|STARTED|Overall Study||25
505250|NCT00244855|1215802|P1|STARTED|Overall Study||7
505251|NCT00245635|1215812|P2|NOT COMPLETED|Overall Study||0
505252|NCT00245635|1215813|P1|NOT COMPLETED|Overall Study||0
505253|NCT00245635|1215812|P2|COMPLETED|Overall Study||18
505254|NCT00245635|1215813|P1|COMPLETED|Overall Study||25
505255|NCT00245635|1215812|P2|STARTED|Overall Study||18
505256|NCT00245635|1215813|P1|STARTED|Overall Study||25
505257|NCT00245570|1215819|P6|NOT COMPLETED|Treatment Period IV||0
505258|NCT00245570|1215820|P5|NOT COMPLETED|Treatment Period IV||0
505259|NCT00245570|1215821|P4|NOT COMPLETED|Treatment Period IV||0
505260|NCT00245570|1215822|P3|NOT COMPLETED|Treatment Period IV||0
505261|NCT00245570|1215823|P2|NOT COMPLETED|Treatment Period IV||0
505262|NCT00245570|1215824|P1|NOT COMPLETED|Treatment Period IV||0
505263|NCT00245570|1215819|P6|COMPLETED|Treatment Period IV||8
505264|NCT00245570|1215820|P5|COMPLETED|Treatment Period IV||8
505265|NCT00245570|1215821|P4|COMPLETED|Treatment Period IV||8
505266|NCT00245570|1215822|P3|COMPLETED|Treatment Period IV||8
505267|NCT00245570|1215823|P2|COMPLETED|Treatment Period IV||7
505268|NCT00245570|1215824|P1|COMPLETED|Treatment Period IV||7
505269|NCT00245570|1215819|P6|STARTED|Treatment Period IV||8
505270|NCT00245570|1215820|P5|STARTED|Treatment Period IV||8
505271|NCT00245570|1215821|P4|STARTED|Treatment Period IV||8
505272|NCT00245570|1215822|P3|STARTED|Treatment Period IV||8
505273|NCT00245570|1215823|P2|STARTED|Treatment Period IV||7
505274|NCT00245570|1215824|P1|STARTED|Treatment Period IV||7
505275|NCT00245570|1215819|P6|NOT COMPLETED|Washout Between Periods III and IV||0
505276|NCT00245570|1215820|P5|NOT COMPLETED|Washout Between Periods III and IV||0
505277|NCT00245570|1215821|P4|NOT COMPLETED|Washout Between Periods III and IV||0
505278|NCT00245570|1215822|P3|NOT COMPLETED|Washout Between Periods III and IV||0
505279|NCT00245570|1215823|P2|NOT COMPLETED|Washout Between Periods III and IV||1
505280|NCT00245570|1215824|P1|NOT COMPLETED|Washout Between Periods III and IV||0
505281|NCT00245570|1215819|P6|COMPLETED|Washout Between Periods III and IV||8
505282|NCT00245570|1215820|P5|COMPLETED|Washout Between Periods III and IV||8
505369|NCT00245219|1215905|P2|COMPLETED|Overall Study||88
505283|NCT00245570|1215821|P4|COMPLETED|Washout Between Periods III and IV||8
505284|NCT00245570|1215822|P3|COMPLETED|Washout Between Periods III and IV||8
505285|NCT00245570|1215823|P2|COMPLETED|Washout Between Periods III and IV||7
505286|NCT00245570|1215824|P1|COMPLETED|Washout Between Periods III and IV||7
505287|NCT00245570|1215819|P6|STARTED|Washout Between Periods III and IV||8
505288|NCT00245570|1215820|P5|STARTED|Washout Between Periods III and IV||8
505289|NCT00245570|1215821|P4|STARTED|Washout Between Periods III and IV||8
505290|NCT00245570|1215822|P3|STARTED|Washout Between Periods III and IV||8
505291|NCT00245570|1215823|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
505292|NCT00245570|1215824|P1|STARTED|Washout Between Periods III and IV||7
505293|NCT00245570|1215819|P6|NOT COMPLETED|Treatment Period III||0
505294|NCT00245570|1215820|P5|NOT COMPLETED|Treatment Period III||0
505295|NCT00245570|1215821|P4|NOT COMPLETED|Treatment Period III||0
505296|NCT00245570|1215822|P3|NOT COMPLETED|Treatment Period III||0
505297|NCT00245570|1215823|P2|NOT COMPLETED|Treatment Period III||0
505298|NCT00245570|1215824|P1|NOT COMPLETED|Treatment Period III||0
505299|NCT00245570|1215819|P6|COMPLETED|Treatment Period III||8
505300|NCT00245570|1215820|P5|COMPLETED|Treatment Period III||8
505301|NCT00245570|1215821|P4|COMPLETED|Treatment Period III||8
505302|NCT00245570|1215822|P3|COMPLETED|Treatment Period III||8
505303|NCT00245570|1215823|P2|COMPLETED|Treatment Period III||8
505304|NCT00245570|1215824|P1|COMPLETED|Treatment Period III||7
505305|NCT00245570|1215819|P6|STARTED|Treatment Period III||8
505306|NCT00245570|1215820|P5|STARTED|Treatment Period III||8
505307|NCT00245570|1215821|P4|STARTED|Treatment Period III||8
505308|NCT00245570|1215822|P3|STARTED|Treatment Period III||8
505309|NCT00245570|1215823|P2|STARTED|Treatment Period III||8
505310|NCT00245570|1215824|P1|STARTED|Treatment Period III||7
505311|NCT00245570|1215819|P6|NOT COMPLETED|Washout Between Periods II and III||0
505312|NCT00245570|1215820|P5|NOT COMPLETED|Washout Between Periods II and III||0
505313|NCT00245570|1215821|P4|NOT COMPLETED|Washout Between Periods II and III||0
505314|NCT00245570|1215822|P3|NOT COMPLETED|Washout Between Periods II and III||0
505315|NCT00245570|1215823|P2|NOT COMPLETED|Washout Between Periods II and III||0
505316|NCT00245570|1215824|P1|NOT COMPLETED|Washout Between Periods II and III||0
505317|NCT00245570|1215819|P6|COMPLETED|Washout Between Periods II and III||8
505318|NCT00245570|1215820|P5|COMPLETED|Washout Between Periods II and III||8
505319|NCT00245570|1215821|P4|COMPLETED|Washout Between Periods II and III||8
505320|NCT00245570|1215822|P3|COMPLETED|Washout Between Periods II and III||8
505322|NCT00245570|1215824|P1|COMPLETED|Washout Between Periods II and III||7
505323|NCT00245570|1215819|P6|STARTED|Washout Between Periods II and III||8
505324|NCT00245570|1215820|P5|STARTED|Washout Between Periods II and III||8
505325|NCT00245570|1215821|P4|STARTED|Washout Between Periods II and III||8
505326|NCT00245570|1215822|P3|STARTED|Washout Between Periods II and III||8
505327|NCT00245570|1215823|P2|STARTED|Washout Between Periods II and III||8
505328|NCT00245570|1215824|P1|STARTED|Washout Between Periods II and III||7
505329|NCT00245570|1215819|P6|NOT COMPLETED|Treatment Period II||0
505330|NCT00245570|1215820|P5|NOT COMPLETED|Treatment Period II||0
505331|NCT00245570|1215821|P4|NOT COMPLETED|Treatment Period II||0
505332|NCT00245570|1215822|P3|NOT COMPLETED|Treatment Period II||0
505333|NCT00245570|1215823|P2|NOT COMPLETED|Treatment Period II||0
505334|NCT00245570|1215824|P1|NOT COMPLETED|Treatment Period II||0
505335|NCT00245570|1215819|P6|COMPLETED|Treatment Period II||8
505336|NCT00245570|1215820|P5|COMPLETED|Treatment Period II||8
505337|NCT00245570|1215821|P4|COMPLETED|Treatment Period II||8
505338|NCT00245570|1215822|P3|COMPLETED|Treatment Period II||8
505339|NCT00245570|1215823|P2|COMPLETED|Treatment Period II||8
505340|NCT00245570|1215824|P1|COMPLETED|Treatment Period II||7
505341|NCT00245570|1215819|P6|STARTED|Treatment Period II||8
505342|NCT00245570|1215820|P5|STARTED|Treatment Period II||8
505343|NCT00245570|1215821|P4|STARTED|Treatment Period II||8
505344|NCT00245570|1215822|P3|STARTED|Treatment Period II||8
505345|NCT00245570|1215823|P2|STARTED|Treatment Period II||8
505346|NCT00245570|1215824|P1|STARTED|Treatment Period II||7
505347|NCT00245557|1215870|P2|NOT COMPLETED|Overall Study||16
505348|NCT00245557|1215871|P1|NOT COMPLETED|Overall Study||6
505349|NCT00245557|1215870|P2|COMPLETED|Overall Study||10
505350|NCT00245557|1215871|P1|COMPLETED|Overall Study||11
505351|NCT00245557|1215870|P2|STARTED|Overall Study||26
505352|NCT00245557|1215871|P1|STARTED|Overall Study||17
505353|NCT00245466|1215885|P3|NOT COMPLETED|Overall Study||37
505354|NCT00245466|1215886|P2|NOT COMPLETED|Overall Study||44
505355|NCT00245466|1215887|P1|NOT COMPLETED|Overall Study||36
505356|NCT00245466|1215885|P3|COMPLETED|Overall Study||3
505357|NCT00245466|1215886|P2|COMPLETED|Overall Study||2
505358|NCT00245466|1215887|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
505359|NCT00245466|1215885|P3|Started FE200486 CS02A|Overall Study||26
505360|NCT00245466|1215886|P2|Started FE200486 CS02A|Overall Study||30
505361|NCT00245466|1215887|P1|Started FE200486 CS02A|Overall Study||32
505362|NCT00245466|1215885|P3|STARTED|Overall Study||40
505363|NCT00245466|1215886|P2|STARTED|Overall Study||46
505364|NCT00245466|1215887|P1|STARTED|Overall Study||43
505365|NCT00245219|1215904|P3|NOT COMPLETED|Overall Study||2
505366|NCT00245219|1215905|P2|NOT COMPLETED|Overall Study||6
505367|NCT00245219|1215906|P1|NOT COMPLETED|Overall Study||6
505368|NCT00245219|1215904|P3|COMPLETED|Overall Study||58
505370|NCT00245219|1215906|P1|COMPLETED|Overall Study||85
505371|NCT00245219|1215904|P3|STARTED|Overall Study||60
505372|NCT00245219|1215905|P2|STARTED|Overall Study||94
505373|NCT00245219|1215906|P1|STARTED|Overall Study||91
505374|NCT00245128|1215920|P1|NOT COMPLETED|Overall Study||10
505375|NCT00245128|1215920|P1|COMPLETED|Overall Study||0
505376|NCT00245128|1215920|P1|STARTED|Overall Study||10
505377|NCT00244764|1215924|P1|NOT COMPLETED|Overall Study||96
505378|NCT00244764|1215924|P1|COMPLETED|Overall Study||129
505379|NCT00244764|1215924|P1|STARTED|Overall Study||225
505380|NCT00244725|1215935|P4|NOT COMPLETED|Overall Study||21
505381|NCT00244725|1215936|P3|NOT COMPLETED|Overall Study||24
505382|NCT00244725|1215937|P2|NOT COMPLETED|Overall Study||19
505383|NCT00244725|1215938|P1|NOT COMPLETED|Overall Study||23
505384|NCT00244725|1215935|P4|COMPLETED|Overall Study||216
505385|NCT00244725|1215936|P3|COMPLETED|Overall Study||215
505386|NCT00244725|1215937|P2|COMPLETED|Overall Study||226
505387|NCT00244725|1215938|P1|COMPLETED|Overall Study||214
505388|NCT00244725|1215935|P4|STARTED|Overall Study||237
505389|NCT00244725|1215936|P3|STARTED|Overall Study||239
505390|NCT00244725|1215937|P2|STARTED|Overall Study||245
505391|NCT00244725|1215938|P1|STARTED|Overall Study||237
505392|NCT00244712|1215994|P2|NOT COMPLETED|Overall Study||124
505393|NCT00244712|1215995|P1|NOT COMPLETED|Overall Study||109
505394|NCT00244712|1215994|P2|COMPLETED|Overall Study||221
505395|NCT00244712|1215995|P1|COMPLETED|Overall Study||234
505396|NCT00244712|1215994|P2|STARTED|Overall Study||345
505397|NCT00244712|1215995|P1|STARTED|Overall Study||343
505398|NCT00244621|1216030|P3|NOT COMPLETED|Open-label Treatment Period||2
505399|NCT00244621|1216031|P2|NOT COMPLETED|Open-label Treatment Period||1
505400|NCT00244621|1216032|P1|NOT COMPLETED|Open-label Treatment Period||1
505401|NCT00244621|1216030|P3|COMPLETED|Open-label Treatment Period||28
505402|NCT00244621|1216031|P2|COMPLETED|Open-label Treatment Period||28
505403|NCT00244621|1216032|P1|COMPLETED|Open-label Treatment Period||25
505404|NCT00244621|1216030|P3|STARTED|Open-label Treatment Period||30
505405|NCT00244621|1216031|P2|STARTED|Open-label Treatment Period||29
505406|NCT00244621|1216032|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
505407|NCT00244621|1216030|P3|NOT COMPLETED|Double-blind Treatment Period||2
505408|NCT00244621|1216031|P2|NOT COMPLETED|Double-blind Treatment Period||3
505409|NCT00244621|1216032|P1|NOT COMPLETED|Double-blind Treatment Period||2
505410|NCT00244621|1216030|P3|COMPLETED|Double-blind Treatment Period||30
505411|NCT00244621|1216031|P2|COMPLETED|Double-blind Treatment Period||29
505412|NCT00244621|1216032|P1|COMPLETED|Double-blind Treatment Period||27
505413|NCT00244621|1216030|P3|STARTED|Double-blind Treatment Period||32
505414|NCT00244621|1216031|P2|STARTED|Double-blind Treatment Period||32
505415|NCT00244621|1216032|P1|STARTED|Double-blind Treatment Period||29
505416|NCT00244374|1216049|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
505417|NCT00244374|1216050|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
505418|NCT00244374|1216051|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
505419|NCT00244374|1216052|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
505420|NCT00244374|1216053|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
505421|NCT00244374|1216049|P5|COMPLETED|Vaccine Adherence Cohort||41
505422|NCT00244374|1216050|P4|COMPLETED|Vaccine Adherence Cohort||36
505423|NCT00244374|1216051|P3|COMPLETED|Vaccine Adherence Cohort||43
505424|NCT00244374|1216052|P2|COMPLETED|Vaccine Adherence Cohort||47
505425|NCT00244374|1216053|P1|COMPLETED|Vaccine Adherence Cohort||0
505426|NCT00244374|1216049|P5|STARTED|Vaccine Adherence Cohort||41
505427|NCT00244374|1216050|P4|STARTED|Vaccine Adherence Cohort||36
505428|NCT00244374|1216051|P3|STARTED|Vaccine Adherence Cohort||43
505429|NCT00244374|1216052|P2|STARTED|Vaccine Adherence Cohort||47
505430|NCT00244374|1216053|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
505431|NCT00244374|1216049|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505432|NCT00244374|1216050|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505433|NCT00244374|1216051|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505434|NCT00244374|1216052|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505435|NCT00244374|1216053|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
505436|NCT00244374|1216049|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505437|NCT00244374|1216050|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505438|NCT00244374|1216051|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505439|NCT00244374|1216052|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
505440|NCT00244374|1216053|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
505441|NCT00244374|1216049|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
505442|NCT00244374|1216050|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
505443|NCT00244374|1216051|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
505444|NCT00244374|1216052|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
505445|NCT00244374|1216053|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
505446|NCT00244374|1216049|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
505447|NCT00244374|1216050|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
505448|NCT00244374|1216051|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
505449|NCT00244374|1216052|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
505534|NCT00243386|1216220|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
505450|NCT00244374|1216053|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
505451|NCT00244374|1216049|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
505452|NCT00244374|1216050|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
505453|NCT00244374|1216051|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
505454|NCT00244374|1216052|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
505455|NCT00244374|1216053|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
505456|NCT00244374|1216049|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
505457|NCT00244374|1216050|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
505458|NCT00244374|1216051|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
505459|NCT00244374|1216052|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
505460|NCT00244374|1216053|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
505461|NCT00244374|1216049|P5|STARTED|Pre-Randomization Cross-sectional Study||0
505462|NCT00244374|1216050|P4|STARTED|Pre-Randomization Cross-sectional Study||0
505463|NCT00244374|1216051|P3|STARTED|Pre-Randomization Cross-sectional Study||0
505464|NCT00244374|1216052|P2|STARTED|Pre-Randomization Cross-sectional Study||0
505465|NCT00244374|1216053|P1|STARTED|Pre-Randomization Cross-sectional Study||546
505466|NCT00244140|1216071|P2|NOT COMPLETED|Overall Study||0
505467|NCT00244140|1216072|P1|NOT COMPLETED|Overall Study||0
505468|NCT00244140|1216071|P2|COMPLETED|Overall Study||22
505469|NCT00244140|1216072|P1|COMPLETED|Overall Study||412
505470|NCT00244140|1216071|P2|STARTED|Overall Study||22
505471|NCT00244140|1216072|P1|STARTED|Overall Study||412
505472|NCT00244101|1216087|P3|NOT COMPLETED|Overall Study||0
505473|NCT00244101|1216088|P2|NOT COMPLETED|Overall Study||0
505474|NCT00244101|1216089|P1|NOT COMPLETED|Overall Study||0
505475|NCT00244101|1216087|P3|COMPLETED|Overall Study||216
505476|NCT00244101|1216088|P2|COMPLETED|Overall Study||223
505477|NCT00244101|1216089|P1|COMPLETED|Overall Study||209
505478|NCT00244101|1216087|P3|STARTED|Overall Study||216
505479|NCT00244101|1216088|P2|STARTED|Overall Study||223
505480|NCT00244101|1216089|P1|STARTED|Overall Study||209
505481|NCT00244010|1216099|P2|NOT COMPLETED|Overall Study||0
505482|NCT00244010|1216100|P1|NOT COMPLETED|Overall Study||0
505483|NCT00244010|1216099|P2|COMPLETED|Overall Study||2
505484|NCT00244010|1216100|P1|COMPLETED|Overall Study||2
505485|NCT00244010|1216099|P2|STARTED|Overall Study||2
505486|NCT00244010|1216100|P1|STARTED|Overall Study||2
505487|NCT00243932|1216109|P3|NOT COMPLETED|Stage 2: Efficacy||0
505488|NCT00243932|1216110|P2|NOT COMPLETED|Stage 2: Efficacy||0
505489|NCT00243932|1216111|P1|NOT COMPLETED|Stage 2: Efficacy||0
505490|NCT00243932|1216109|P3|COMPLETED|Stage 2: Efficacy||0
505491|NCT00243932|1216110|P2|COMPLETED|Stage 2: Efficacy||40
505492|NCT00243932|1216111|P1|COMPLETED|Stage 2: Efficacy||40
505493|NCT00243932|1216109|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
505494|NCT00243932|1216110|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
505495|NCT00243932|1216111|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
505496|NCT00243932|1216109|P3|NOT COMPLETED|Stage 1: Dose Selection||0
505497|NCT00243932|1216110|P2|NOT COMPLETED|Stage 1: Dose Selection||0
505498|NCT00243932|1216111|P1|NOT COMPLETED|Stage 1: Dose Selection||2
505499|NCT00243932|1216109|P3|COMPLETED|Stage 1: Dose Selection||35
505500|NCT00243932|1216110|P2|COMPLETED|Stage 1: Dose Selection||35
505501|NCT00243932|1216111|P1|COMPLETED|Stage 1: Dose Selection||33
505502|NCT00243932|1216109|P3|STARTED|Stage 1: Dose Selection||35
505503|NCT00243932|1216110|P2|STARTED|Stage 1: Dose Selection||35
505504|NCT00243932|1216111|P1|STARTED|Stage 1: Dose Selection||35
505505|NCT00243919|1216122|P3|NOT COMPLETED|Overall Study||11
505506|NCT00243919|1216123|P2|NOT COMPLETED|Overall Study||18
505507|NCT00243919|1216124|P1|NOT COMPLETED|Overall Study||17
505508|NCT00243919|1216122|P3|COMPLETED|Overall Study||115
505509|NCT00243919|1216123|P2|COMPLETED|Overall Study||125
505510|NCT00243919|1216124|P1|COMPLETED|Overall Study||122
505511|NCT00243919|1216122|P3|STARTED|Overall Study||126
505512|NCT00243919|1216123|P2|STARTED|Overall Study||143
505513|NCT00243919|1216124|P1|STARTED|Overall Study||139
505514|NCT00243659|1216167|P2|NOT COMPLETED|Overall Study||3
505515|NCT00243659|1216168|P1|NOT COMPLETED|Overall Study||2
505516|NCT00243659|1216167|P2|COMPLETED|Overall Study||5
505517|NCT00243659|1216168|P1|COMPLETED|Overall Study||20
505518|NCT00243659|1216167|P2|STARTED|Overall Study||8
505519|NCT00243659|1216168|P1|STARTED|Overall Study||22
505520|NCT00243503|1216176|P1|NOT COMPLETED|Overall Study||58
505521|NCT00243503|1216176|P1|COMPLETED|Overall Study||2
505522|NCT00243503|1216176|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
505523|NCT00243412|1216193|P2|NOT COMPLETED|Overall Study||11
505524|NCT00243412|1216194|P1|NOT COMPLETED|Overall Study||10
505525|NCT00243412|1216193|P2|COMPLETED|Overall Study|Completed Week 104|10
505526|NCT00243412|1216194|P1|COMPLETED|Overall Study|Completed Week 104|11
505527|NCT00243412|1216193|P2|Safety Evaluable|Overall Study||20
505528|NCT00243412|1216194|P1|Safety Evaluable|Overall Study||21
505529|NCT00243412|1216193|P2|STARTED|Overall Study|Intent to treat|21
505530|NCT00243412|1216194|P1|STARTED|Overall Study|Intent to treat|21
505531|NCT00243386|1216220|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
505532|NCT00243386|1216221|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
505533|NCT00243386|1216222|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
505535|NCT00243386|1216221|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
505536|NCT00243386|1216222|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
505537|NCT00243386|1216220|P3|STARTED|PK-Driven or Standard Prophylaxis||32
505538|NCT00243386|1216221|P2|STARTED|PK-Driven or Standard Prophylaxis||34
505539|NCT00243386|1216222|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
505540|NCT00243386|1216220|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
505541|NCT00243386|1216221|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
505542|NCT00243386|1216222|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
505543|NCT00243386|1216220|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
505544|NCT00243386|1216221|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
505545|NCT00243386|1216222|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
505546|NCT00243386|1216220|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
505547|NCT00243386|1216221|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
505548|NCT00243386|1216222|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
505549|NCT00243386|1216220|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
505550|NCT00243386|1216221|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
505551|NCT00243386|1216222|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
505552|NCT00243386|1216220|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
505553|NCT00243386|1216221|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
505554|NCT00243386|1216222|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
505555|NCT00243386|1216220|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
505556|NCT00243386|1216221|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
505557|NCT00243386|1216222|P1|STARTED|On-Demand Regimen (Study Part 1)||73
505558|NCT00243347|1216287|P1|NOT COMPLETED|Overall Study||19
505559|NCT00243347|1216287|P1|COMPLETED|Overall Study|Completed study|0
505560|NCT00243347|1216287|P1|STARTED|Overall Study|Treated|19
505561|NCT00243269|1216296|P4|NOT COMPLETED|Overall Study||4
505562|NCT00243269|1216297|P3|NOT COMPLETED|Overall Study||1
505563|NCT00243269|1216298|P2|NOT COMPLETED|Overall Study||1
505564|NCT00243269|1216299|P1|NOT COMPLETED|Overall Study||3
505565|NCT00243269|1216296|P4|COMPLETED|Overall Study||25
505566|NCT00243269|1216297|P3|COMPLETED|Overall Study||11
505567|NCT00243269|1216298|P2|COMPLETED|Overall Study||10
505568|NCT00243269|1216299|P1|COMPLETED|Overall Study||28
505569|NCT00243269|1216296|P4|STARTED|Overall Study||29
505570|NCT00243269|1216297|P3|STARTED|Overall Study||12
505571|NCT00243269|1216298|P2|STARTED|Overall Study||11
505572|NCT00243269|1216299|P1|STARTED|Overall Study||31
505573|NCT00243243|1216315|P2|NOT COMPLETED|Overall Study||0
505574|NCT00243243|1216316|P1|NOT COMPLETED|Overall Study||0
505575|NCT00243243|1216315|P2|COMPLETED|Overall Study||10
505576|NCT00243243|1216316|P1|COMPLETED|Overall Study||10
505577|NCT00243243|1216315|P2|STARTED|Overall Study||10
505578|NCT00243243|1216316|P1|STARTED|Overall Study||10
505579|NCT00243191|1216322|P1|NOT COMPLETED|Overall Study||0
505580|NCT00243191|1216322|P1|COMPLETED|Overall Study||18
505581|NCT00243191|1216322|P1|STARTED|Overall Study||18
505582|NCT00243074|1216326|P1|NOT COMPLETED|Overall Study||54
505583|NCT00243074|1216326|P1|COMPLETED|Overall Study||0
505584|NCT00243074|1216326|P1|STARTED|Overall Study||54
505585|NCT00243061|1216335|P1|NOT COMPLETED|Overall Study||0
505586|NCT00243061|1216335|P1|COMPLETED|Overall Study||24
505587|NCT00243061|1216335|P1|STARTED|Overall Study||24
505588|NCT00243022|1216346|P2|NOT COMPLETED|Overall Study||1
505589|NCT00243022|1216347|P1|NOT COMPLETED|Overall Study||2
505590|NCT00243022|1216346|P2|COMPLETED|Overall Study||4
505591|NCT00243022|1216347|P1|COMPLETED|Overall Study||5
505592|NCT00243022|1216346|P2|STARTED|Overall Study||5
505593|NCT00243022|1216347|P1|STARTED|Overall Study||7
505594|NCT00242710|1216369|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
505595|NCT00242710|1216370|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
505596|NCT00242710|1216371|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
505597|NCT00242710|1216372|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
505598|NCT00242710|1216369|P4|COMPLETED|Study Extension (up to Year 2)||84
505599|NCT00242710|1216370|P3|COMPLETED|Study Extension (up to Year 2)||69
505600|NCT00242710|1216371|P2|COMPLETED|Study Extension (up to Year 2)||148
505601|NCT00242710|1216372|P1|COMPLETED|Study Extension (up to Year 2)||141
505602|NCT00242710|1216369|P4|STARTED|Study Extension (up to Year 2)||94
505603|NCT00242710|1216370|P3|STARTED|Study Extension (up to Year 2)||84
505604|NCT00242710|1216371|P2|STARTED|Study Extension (up to Year 2)||177
505605|NCT00242710|1216372|P1|STARTED|Study Extension (up to Year 2)||168
505606|NCT00242710|1216369|P4|NOT COMPLETED|Period Between Core Study and Extension||49
505607|NCT00242710|1216370|P3|NOT COMPLETED|Period Between Core Study and Extension||48
505608|NCT00242710|1216371|P2|NOT COMPLETED|Period Between Core Study and Extension||112
505609|NCT00242710|1216372|P1|NOT COMPLETED|Period Between Core Study and Extension||119
505610|NCT00242710|1216369|P4|COMPLETED|Period Between Core Study and Extension||94
505611|NCT00242710|1216370|P3|COMPLETED|Period Between Core Study and Extension||84
505612|NCT00242710|1216371|P2|COMPLETED|Period Between Core Study and Extension||177
505613|NCT00242710|1216372|P1|COMPLETED|Period Between Core Study and Extension||168
505614|NCT00242710|1216369|P4|STARTED|Period Between Core Study and Extension||143
505615|NCT00242710|1216370|P3|STARTED|Period Between Core Study and Extension||132
505616|NCT00242710|1216371|P2|STARTED|Period Between Core Study and Extension||289
505617|NCT00242710|1216372|P1|STARTED|Period Between Core Study and Extension||287
505618|NCT00242710|1216369|P4|NOT COMPLETED|Core Study (up to Year 1)||31
505619|NCT00242710|1216370|P3|NOT COMPLETED|Core Study (up to Year 1)||51
505620|NCT00242710|1216371|P2|NOT COMPLETED|Core Study (up to Year 1)||64
505621|NCT00242710|1216372|P1|NOT COMPLETED|Core Study (up to Year 1)||86
505622|NCT00242710|1216369|P4|COMPLETED|Core Study (up to Year 1)||143
505623|NCT00242710|1216370|P3|COMPLETED|Core Study (up to Year 1)||132
505624|NCT00242710|1216371|P2|COMPLETED|Core Study (up to Year 1)||289
505625|NCT00242710|1216372|P1|COMPLETED|Core Study (up to Year 1)||287
505626|NCT00242710|1216369|P4|Treated|Core Study (up to Year 1)||172
505627|NCT00242710|1216370|P3|Treated|Core Study (up to Year 1)||179
505628|NCT00242710|1216371|P2|Treated|Core Study (up to Year 1)||349
505629|NCT00242710|1216372|P1|Treated|Core Study (up to Year 1)||361
505630|NCT00242710|1216369|P4|STARTED|Core Study (up to Year 1)||174
505631|NCT00242710|1216370|P3|STARTED|Core Study (up to Year 1)||183
505632|NCT00242710|1216371|P2|STARTED|Core Study (up to Year 1)||353
505633|NCT00242710|1216372|P1|STARTED|Core Study (up to Year 1)||373
505634|NCT00242684|1216422|P1|NOT COMPLETED|Overall Study||0
505635|NCT00242684|1216422|P1|COMPLETED|Overall Study||446
505636|NCT00242684|1216422|P1|STARTED|Overall Study||446
505637|NCT00242658|1216429|P2|NOT COMPLETED|Overall Study||19
505638|NCT00242658|1216430|P1|NOT COMPLETED|Overall Study||22
505639|NCT00242658|1216429|P2|COMPLETED|Overall Study||188
505640|NCT00242658|1216430|P1|COMPLETED|Overall Study||165
505641|NCT00242658|1216429|P2|STARTED|Overall Study||207
505642|NCT00242658|1216430|P1|STARTED|Overall Study||187
505643|NCT00242632|1216440|P2|NOT COMPLETED|Overall Study||0
505644|NCT00242632|1216441|P1|NOT COMPLETED|Overall Study||0
505645|NCT00242632|1216440|P2|COMPLETED|Overall Study||11
505646|NCT00242632|1216441|P1|COMPLETED|Overall Study||11
505647|NCT00242632|1216440|P2|STARTED|Overall Study||11
505648|NCT00242632|1216441|P1|STARTED|Overall Study||11
505649|NCT00242619|1216449|P2|NOT COMPLETED|Overall Study||0
505650|NCT00242619|1216450|P1|NOT COMPLETED|Overall Study||0
505651|NCT00242619|1216449|P2|COMPLETED|Overall Study||4
505652|NCT00242619|1216450|P1|COMPLETED|Overall Study||8
505653|NCT00242619|1216449|P2|STARTED|Overall Study||4
505654|NCT00242619|1216450|P1|STARTED|Overall Study||8
505655|NCT00242580|1216461|P3|NOT COMPLETED|Overall Study||14
505656|NCT00242580|1216462|P2|NOT COMPLETED|Overall Study||12
505657|NCT00242580|1216463|P1|NOT COMPLETED|Overall Study||10
505658|NCT00242580|1216461|P3|COMPLETED|Overall Study||24
505659|NCT00242580|1216462|P2|COMPLETED|Overall Study||29
505660|NCT00242580|1216463|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
505661|NCT00242580|1216461|P3|STARTED|Overall Study||38
505662|NCT00242580|1216462|P2|STARTED|Overall Study||41
505663|NCT00242580|1216463|P1|STARTED|Overall Study||32
505664|NCT00242567|1216488|P2|NOT COMPLETED|Overall Study||140
505665|NCT00242567|1216489|P1|NOT COMPLETED|Overall Study||166
505666|NCT00242567|1216488|P2|COMPLETED|Overall Study||123
505667|NCT00242567|1216489|P1|COMPLETED|Overall Study||93
505668|NCT00242567|1216488|P2|Never Received Study Drug|Overall Study||191
505669|NCT00242567|1216489|P1|Never Received Study Drug|Overall Study||0
505670|NCT00242567|1216488|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
505671|NCT00242567|1216489|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
505672|NCT00242567|1216488|P2|STARTED|Overall Study||263
505673|NCT00242567|1216489|P1|STARTED|Overall Study||259
505674|NCT00242502|1216505|P1|NOT COMPLETED|Overall Study||0
505675|NCT00242502|1216505|P1|COMPLETED|Overall Study||59
505676|NCT00242502|1216505|P1|STARTED|Overall Study||59
505677|NCT00242385|1216509|P2|NOT COMPLETED|Period 2||0
505678|NCT00242385|1216510|P1|NOT COMPLETED|Period 2||0
505679|NCT00242385|1216509|P2|COMPLETED|Period 2||11
505680|NCT00242385|1216510|P1|COMPLETED|Period 2||14
505681|NCT00242385|1216509|P2|STARTED|Period 2||11
505682|NCT00242385|1216510|P1|STARTED|Period 2||14
505683|NCT00242385|1216509|P2|NOT COMPLETED|Period 1||0
505684|NCT00242385|1216510|P1|NOT COMPLETED|Period 1||0
505685|NCT00242385|1216509|P2|COMPLETED|Period 1||11
505686|NCT00242385|1216510|P1|COMPLETED|Period 1||14
505687|NCT00242385|1216509|P2|STARTED|Period 1||11
505688|NCT00242385|1216510|P1|STARTED|Period 1||14
505689|NCT00242216|1216536|P2|NOT COMPLETED|Overall Study||22
505690|NCT00242216|1216537|P1|NOT COMPLETED|Overall Study||18
505691|NCT00242216|1216536|P2|COMPLETED|Overall Study||15
505692|NCT00242216|1216537|P1|COMPLETED|Overall Study||21
505693|NCT00242216|1216536|P2|STARTED|Overall Study||37
505694|NCT00242216|1216537|P1|STARTED|Overall Study||39
505695|NCT00241839|1216547|P2|NOT COMPLETED|Overall Study||18
505696|NCT00241839|1216548|P1|NOT COMPLETED|Overall Study||19
505697|NCT00241839|1216547|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
505698|NCT00241839|1216548|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
505699|NCT00241839|1216547|P2|STARTED|Overall Study||71
505700|NCT00241839|1216548|P1|STARTED|Overall Study||71
505701|NCT00241644|1216564|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
505702|NCT00241644|1216565|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
505703|NCT00241644|1216566|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
505704|NCT00241644|1216567|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
505705|NCT00241644|1216564|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
505706|NCT00241644|1216565|P3|COMPLETED|Second Efficacy Period (Year 2)||682
505707|NCT00241644|1216566|P2|COMPLETED|Second Efficacy Period (Year 2)||697
505708|NCT00241644|1216567|P1|COMPLETED|Second Efficacy Period (Year 2)||710
505709|NCT00241644|1216564|P4|STARTED|Second Efficacy Period (Year 2)||1525
505710|NCT00241644|1216565|P3|STARTED|Second Efficacy Period (Year 2)||746
505711|NCT00241644|1216566|P2|STARTED|Second Efficacy Period (Year 2)||754
505712|NCT00241644|1216567|P1|STARTED|Second Efficacy Period (Year 2)||771
505713|NCT00241644|1216564|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
505714|NCT00241644|1216565|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
505715|NCT00241644|1216566|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
505716|NCT00241644|1216567|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
505717|NCT00241644|1216564|P4|COMPLETED|First Efficacy Period (Year 1)||2803
505718|NCT00241644|1216565|P3|COMPLETED|First Efficacy Period (Year 1)||1392
505719|NCT00241644|1216566|P2|COMPLETED|First Efficacy Period (Year 1)||1383
505720|NCT00241644|1216567|P1|COMPLETED|First Efficacy Period (Year 1)||1420
505721|NCT00241644|1216564|P4|STARTED|First Efficacy Period (Year 1)||3298
505722|NCT00241644|1216565|P3|STARTED|First Efficacy Period (Year 1)||1641
505723|NCT00241644|1216566|P2|STARTED|First Efficacy Period (Year 1)||1651
505724|NCT00241644|1216567|P1|STARTED|First Efficacy Period (Year 1)||1647
505725|NCT00241358|1216652|P3|NOT COMPLETED|Overall Study||1
505726|NCT00241358|1216653|P2|NOT COMPLETED|Overall Study||1
505727|NCT00241358|1216654|P1|NOT COMPLETED|Overall Study||0
505728|NCT00241358|1216652|P3|COMPLETED|Overall Study||20
505729|NCT00241358|1216653|P2|COMPLETED|Overall Study||45
505730|NCT00241358|1216654|P1|COMPLETED|Overall Study||25
505731|NCT00241358|1216652|P3|STARTED|Overall Study||21
505732|NCT00241358|1216653|P2|STARTED|Overall Study||46
505733|NCT00241358|1216654|P1|STARTED|Overall Study||25
505734|NCT00241280|1216687|P2|NOT COMPLETED|Overall Study||68
505735|NCT00241280|1216688|P1|NOT COMPLETED|Overall Study||48
505736|NCT00241280|1216687|P2|COMPLETED|Overall Study||186
505737|NCT00241280|1216688|P1|COMPLETED|Overall Study||199
505738|NCT00241280|1216687|P2|STARTED|Overall Study||254
505739|NCT00241280|1216688|P1|STARTED|Overall Study||247
505740|NCT00241176|1216696|P1|NOT COMPLETED|Overall Study||0
505741|NCT00241176|1216696|P1|COMPLETED|Overall Study||11
505742|NCT00241176|1216696|P1|STARTED|Overall Study||11
505743|NCT00240994|1216703|P1|NOT COMPLETED|Overall Study||3
505744|NCT00240994|1216703|P1|COMPLETED|Overall Study||32
505745|NCT00240994|1216703|P1|STARTED|Overall Study||35
505746|NCT00240981|1216709|P2|NOT COMPLETED|Overall Study||33
505747|NCT00240981|1216710|P1|NOT COMPLETED|Overall Study||38
505748|NCT00240981|1216709|P2|COMPLETED|Overall Study||70
505749|NCT00240981|1216710|P1|COMPLETED|Overall Study||68
505750|NCT00240981|1216709|P2|Intent to Treat Sample|Overall Study||83
505751|NCT00240981|1216710|P1|Intent to Treat Sample|Overall Study||82
505752|NCT00240981|1216709|P2|STARTED|Overall Study||103
505753|NCT00240981|1216710|P1|STARTED|Overall Study||106
505754|NCT00240539|1216738|P4|NOT COMPLETED|Overall Study||0
505755|NCT00240539|1216739|P3|NOT COMPLETED|Overall Study||0
505756|NCT00240539|1216740|P2|NOT COMPLETED|Overall Study||0
505757|NCT00240539|1216741|P1|NOT COMPLETED|Overall Study||0
505758|NCT00240539|1216738|P4|COMPLETED|Overall Study||1
505759|NCT00240539|1216739|P3|COMPLETED|Overall Study||31
505760|NCT00240539|1216740|P2|COMPLETED|Overall Study||2
505761|NCT00240539|1216741|P1|COMPLETED|Overall Study||2
505762|NCT00240539|1216738|P4|STARTED|Overall Study||1
505763|NCT00240539|1216739|P3|STARTED|Overall Study||31
505764|NCT00240539|1216740|P2|STARTED|Overall Study||2
505765|NCT00240539|1216741|P1|STARTED|Overall Study||2
505766|NCT00240526|1216763|P4|NOT COMPLETED|Year 20||0
505767|NCT00240526|1216764|P3|NOT COMPLETED|Year 20||0
505768|NCT00240526|1216765|P2|NOT COMPLETED|Year 20||0
505769|NCT00240526|1216766|P1|NOT COMPLETED|Year 20||0
505770|NCT00240526|1216763|P4|COMPLETED|Year 20||20
505771|NCT00240526|1216764|P3|COMPLETED|Year 20||13
505772|NCT00240526|1216765|P2|COMPLETED|Year 20||17
505773|NCT00240526|1216766|P1|COMPLETED|Year 20||19
505774|NCT00240526|1216763|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
505775|NCT00240526|1216764|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
505776|NCT00240526|1216765|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
505777|NCT00240526|1216766|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
505778|NCT00240526|1216763|P4|NOT COMPLETED|Year 19||0
505779|NCT00240526|1216764|P3|NOT COMPLETED|Year 19||0
505780|NCT00240526|1216765|P2|NOT COMPLETED|Year 19||0
505781|NCT00240526|1216766|P1|NOT COMPLETED|Year 19||0
505782|NCT00240526|1216763|P4|COMPLETED|Year 19||18
505783|NCT00240526|1216764|P3|COMPLETED|Year 19||12
505784|NCT00240526|1216765|P2|COMPLETED|Year 19||16
505785|NCT00240526|1216766|P1|COMPLETED|Year 19||17
505786|NCT00240526|1216763|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
505787|NCT00240526|1216764|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
505788|NCT00240526|1216765|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
505789|NCT00240526|1216766|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
505790|NCT00240526|1216763|P4|NOT COMPLETED|Year 18||0
505791|NCT00240526|1216764|P3|NOT COMPLETED|Year 18||0
505792|NCT00240526|1216765|P2|NOT COMPLETED|Year 18||0
505793|NCT00240526|1216766|P1|NOT COMPLETED|Year 18||0
505794|NCT00240526|1216763|P4|COMPLETED|Year 18||20
505795|NCT00240526|1216764|P3|COMPLETED|Year 18||14
505796|NCT00240526|1216765|P2|COMPLETED|Year 18||17
505797|NCT00240526|1216766|P1|COMPLETED|Year 18||16
505798|NCT00240526|1216763|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
505799|NCT00240526|1216764|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
505800|NCT00240526|1216765|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
505801|NCT00240526|1216766|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
505802|NCT00240526|1216763|P4|NOT COMPLETED|Year 17||0
505803|NCT00240526|1216764|P3|NOT COMPLETED|Year 17||0
505804|NCT00240526|1216765|P2|NOT COMPLETED|Year 17||0
505805|NCT00240526|1216766|P1|NOT COMPLETED|Year 17||0
505806|NCT00240526|1216763|P4|COMPLETED|Year 17||20
505807|NCT00240526|1216764|P3|COMPLETED|Year 17||13
505808|NCT00240526|1216765|P2|COMPLETED|Year 17||17
505809|NCT00240526|1216766|P1|COMPLETED|Year 17||19
505810|NCT00240526|1216763|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
505811|NCT00240526|1216764|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
505812|NCT00240526|1216765|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
505813|NCT00240526|1216766|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
505814|NCT00240526|1216763|P4|NOT COMPLETED|Year 16||0
505815|NCT00240526|1216764|P3|NOT COMPLETED|Year 16||0
505816|NCT00240526|1216765|P2|NOT COMPLETED|Year 16||0
505817|NCT00240526|1216766|P1|NOT COMPLETED|Year 16||0
505818|NCT00240526|1216763|P4|COMPLETED|Year 16||22
505819|NCT00240526|1216764|P3|COMPLETED|Year 16||16
505820|NCT00240526|1216765|P2|COMPLETED|Year 16||19
505821|NCT00240526|1216766|P1|COMPLETED|Year 16||17
505822|NCT00240526|1216763|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
505823|NCT00240526|1216764|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
505824|NCT00240526|1216765|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
505825|NCT00240526|1216766|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
505826|NCT00240526|1216763|P4|NOT COMPLETED|Year 15||0
505827|NCT00240526|1216764|P3|NOT COMPLETED|Year 15||0
505828|NCT00240526|1216765|P2|NOT COMPLETED|Year 15||0
505829|NCT00240526|1216766|P1|NOT COMPLETED|Year 15||0
505830|NCT00240526|1216763|P4|COMPLETED|Year 15||21
505831|NCT00240526|1216764|P3|COMPLETED|Year 15||14
505832|NCT00240526|1216765|P2|COMPLETED|Year 15||19
505833|NCT00240526|1216766|P1|COMPLETED|Year 15||19
505834|NCT00240526|1216763|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
505835|NCT00240526|1216764|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
505836|NCT00240526|1216765|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
505837|NCT00240526|1216766|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
505838|NCT00240500|1216802|P6|NOT COMPLETED|Overall Study||1
505839|NCT00240500|1216803|P5|NOT COMPLETED|Overall Study||3
505840|NCT00240500|1216804|P4|NOT COMPLETED|Overall Study||4
505841|NCT00240500|1216805|P3|NOT COMPLETED|Overall Study||3
505842|NCT00240500|1216806|P2|NOT COMPLETED|Overall Study||3
505843|NCT00240500|1216807|P1|NOT COMPLETED|Overall Study||1
505844|NCT00240500|1216802|P6|COMPLETED|Overall Study||2
505845|NCT00240500|1216803|P5|COMPLETED|Overall Study||26
505846|NCT00240500|1216804|P4|COMPLETED|Overall Study||19
505847|NCT00240500|1216805|P3|COMPLETED|Overall Study||14
505848|NCT00240500|1216806|P2|COMPLETED|Overall Study||17
505849|NCT00240500|1216807|P1|COMPLETED|Overall Study||16
505850|NCT00240500|1216802|P6|STARTED|Overall Study||3
505851|NCT00240500|1216803|P5|STARTED|Overall Study||29
505852|NCT00240500|1216804|P4|STARTED|Overall Study||23
505853|NCT00240500|1216805|P3|STARTED|Overall Study||17
505854|NCT00240500|1216806|P2|STARTED|Overall Study||20
505855|NCT00240500|1216807|P1|STARTED|Overall Study||17
505856|NCT00240487|1216829|P2|NOT COMPLETED|Overall Study||0
505857|NCT00240487|1216830|P1|NOT COMPLETED|Overall Study||0
505858|NCT00240487|1216829|P2|COMPLETED|Overall Study||28
505859|NCT00240487|1216830|P1|COMPLETED|Overall Study||24
505860|NCT00240487|1216829|P2|STARTED|Overall Study||28
505861|NCT00240487|1216830|P1|STARTED|Overall Study||24
505862|NCT00240331|1216838|P2|NOT COMPLETED|Overall Study||134
505863|NCT00240331|1216839|P1|NOT COMPLETED|Overall Study||126
505864|NCT00240331|1216838|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
505865|NCT00240331|1216839|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
505866|NCT00240331|1216838|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
505867|NCT00240331|1216839|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
505868|NCT00240227|1216857|P1|NOT COMPLETED|Overall Study||0
505869|NCT00240227|1216857|P1|COMPLETED|Overall Study||8
505870|NCT00240227|1216857|P1|STARTED|Overall Study||8
505871|NCT00240162|1216863|P1|NOT COMPLETED|Overall Study||0
505872|NCT00240162|1216863|P1|COMPLETED|Overall Study||21
505873|NCT00240162|1216863|P1|STARTED|Overall Study||21
505874|NCT00240110|1216872|P2|NOT COMPLETED|Overall Study||7
505875|NCT00240110|1216873|P1|NOT COMPLETED|Overall Study||6
505876|NCT00240110|1216872|P2|COMPLETED|Overall Study||6
505877|NCT00240110|1216873|P1|COMPLETED|Overall Study||7
505878|NCT00240110|1216872|P2|STARTED|Overall Study||13
505879|NCT00240110|1216873|P1|STARTED|Overall Study||13
505880|NCT00240097|1216881|P1|NOT COMPLETED|Part II||23
505881|NCT00240097|1216881|P1|COMPLETED|Part II||3
505882|NCT00240097|1216881|P1|STARTED|Part II||26
505883|NCT00240097|1216881|P1|NOT COMPLETED|Part I||4
505884|NCT00240097|1216881|P1|COMPLETED|Part I||26
505885|NCT00240097|1216881|P1|STARTED|Part I||30
505886|NCT00240071|1216891|P1|NOT COMPLETED|Overall Study||3
505887|NCT00240071|1216891|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
505888|NCT00240071|1216891|P1|STARTED|Overall Study||30
505889|NCT00239928|1216895|P1|NOT COMPLETED|Overall Study||10
505890|NCT00239928|1216895|P1|COMPLETED|Overall Study||51
505891|NCT00239928|1216895|P1|STARTED|Overall Study||61
505892|NCT00239837|1216907|P2|NOT COMPLETED|Overall Study||7
505893|NCT00239837|1216908|P1|NOT COMPLETED|Overall Study||3
505894|NCT00239837|1216907|P2|COMPLETED|Overall Study|3-year follow-up|45
505895|NCT00239837|1216908|P1|COMPLETED|Overall Study|3-year follow-up|45
505896|NCT00239837|1216907|P2|6 Months|Overall Study||50
505897|NCT00239837|1216908|P1|6 Months|Overall Study||48
505898|NCT00239837|1216907|P2|STARTED|Overall Study||52
505899|NCT00239837|1216908|P1|STARTED|Overall Study||48
505900|NCT00239733|1216928|P1|NOT COMPLETED|Overall Study||0
505901|NCT00239733|1216928|P1|COMPLETED|Overall Study||6
505902|NCT00239733|1216928|P1|STARTED|Overall Study||6
505903|NCT00239720|1216935|P2|NOT COMPLETED|Overall Study||1
505904|NCT00239720|1216936|P1|NOT COMPLETED|Overall Study||1
505905|NCT00239720|1216935|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
505906|NCT00239720|1216936|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
505907|NCT00239720|1216935|P2|STARTED|Overall Study||1
505908|NCT00239720|1216936|P1|STARTED|Overall Study||3
505909|NCT00239681|1216944|P2|NOT COMPLETED|Overall Study||715
505910|NCT00239681|1216945|P1|NOT COMPLETED|Overall Study||693
505911|NCT00239681|1216944|P2|COMPLETED|Overall Study||8186
505912|NCT00239681|1216945|P1|COMPLETED|Overall Study||8208
505913|NCT00239681|1216944|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
505914|NCT00239681|1216945|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
505915|NCT00239681|1216944|P2|STARTED|Overall Study||8901
505916|NCT00239681|1216945|P1|STARTED|Overall Study||8901
505917|NCT00239642|1216964|P3|NOT COMPLETED|Overall Study||2
505918|NCT00239642|1216965|P2|NOT COMPLETED|Overall Study||0
505919|NCT00239642|1216966|P1|NOT COMPLETED|Overall Study||2
505920|NCT00239642|1216964|P3|COMPLETED|Overall Study||47
505921|NCT00239642|1216965|P2|COMPLETED|Overall Study||47
505922|NCT00239642|1216966|P1|COMPLETED|Overall Study||47
505923|NCT00239642|1216964|P3|STARTED|Overall Study||49
505924|NCT00239642|1216965|P2|STARTED|Overall Study||47
505925|NCT00239642|1216966|P1|STARTED|Overall Study||49
505926|NCT00239356|1217000|P2|NOT COMPLETED|Overall Study||9
505927|NCT00239356|1217001|P1|NOT COMPLETED|Overall Study||39
505928|NCT00239356|1217000|P2|COMPLETED|Overall Study||11
505929|NCT00239356|1217001|P1|COMPLETED|Overall Study||58
505930|NCT00239356|1217000|P2|STARTED|Overall Study||20
505931|NCT00239356|1217001|P1|STARTED|Overall Study||97
505932|NCT00239226|1217023|P4|NOT COMPLETED|Overall Study||3
505933|NCT00239226|1217024|P3|NOT COMPLETED|Overall Study||1
505934|NCT00239226|1217025|P2|NOT COMPLETED|Overall Study||0
505935|NCT00239226|1217026|P1|NOT COMPLETED|Overall Study||1
505936|NCT00239226|1217023|P4|COMPLETED|Overall Study||14
505937|NCT00239226|1217024|P3|COMPLETED|Overall Study||36
505938|NCT00239226|1217025|P2|COMPLETED|Overall Study||18
505939|NCT00239226|1217026|P1|COMPLETED|Overall Study||29
505940|NCT00239226|1217023|P4|STARTED|Overall Study||17
505941|NCT00239226|1217024|P3|STARTED|Overall Study||37
505942|NCT00239226|1217025|P2|STARTED|Overall Study||18
505943|NCT00239226|1217026|P1|STARTED|Overall Study||30
505944|NCT00239005|1217038|P2|NOT COMPLETED|Overall Study||12
505945|NCT00239005|1217039|P1|NOT COMPLETED|Overall Study||12
505946|NCT00239005|1217038|P2|COMPLETED|Overall Study||53
505947|NCT00239005|1217039|P1|COMPLETED|Overall Study||57
505948|NCT00239005|1217038|P2|Intention-to-treat Population (ITT)|Overall Study||61
505949|NCT00239005|1217039|P1|Intention-to-treat Population (ITT)|Overall Study||68
505950|NCT00239005|1217038|P2|STARTED|Overall Study||65
505951|NCT00239005|1217039|P1|STARTED|Overall Study||69
505952|NCT00238615|1217049|P1|NOT COMPLETED|Overall Study||0
505953|NCT00238615|1217049|P1|COMPLETED|Overall Study||13
505954|NCT00238615|1217049|P1|STARTED|Overall Study||13
505955|NCT00238433|1217055|P1|NOT COMPLETED|Overall Study||3
505956|NCT00238433|1217055|P1|COMPLETED|Overall Study||34
505957|NCT00238433|1217055|P1|STARTED|Overall Study||37
505958|NCT00238420|1217062|P2|NOT COMPLETED|Overall Study||1
505959|NCT00238420|1217063|P1|NOT COMPLETED|Overall Study||1
505960|NCT00238420|1217062|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
505961|NCT00238420|1217063|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
505962|NCT00238420|1217062|P2|STARTED|Overall Study||48
505963|NCT00238420|1217063|P1|STARTED|Overall Study||22
505964|NCT00238355|1217073|P1|NOT COMPLETED|Overall Study||3
505965|NCT00238355|1217073|P1|COMPLETED|Overall Study||10
505966|NCT00238355|1217073|P1|STARTED|Overall Study||13
505967|NCT00238303|1217080|P3|NOT COMPLETED|Overall Study||9
505968|NCT00238303|1217081|P2|NOT COMPLETED|Overall Study||2
505969|NCT00238303|1217082|P1|NOT COMPLETED|Overall Study||15
505970|NCT00238303|1217080|P3|COMPLETED|Overall Study||11
505971|NCT00238303|1217081|P2|COMPLETED|Overall Study||13
505972|NCT00238303|1217082|P1|COMPLETED|Overall Study||53
505973|NCT00238303|1217080|P3|STARTED|Overall Study||20
505974|NCT00238303|1217081|P2|STARTED|Overall Study||15
505975|NCT00238303|1217082|P1|STARTED|Overall Study||68
505976|NCT00238264|1217099|P1|NOT COMPLETED|Overall Study||36
505977|NCT00238264|1217099|P1|COMPLETED|Overall Study||56
505978|NCT00238264|1217099|P1|STARTED|Overall Study||92
505979|NCT00238238|1217112|P3|NOT COMPLETED|Overall Study||0
505980|NCT00238238|1217113|P2|NOT COMPLETED|Overall Study||3
505981|NCT00238238|1217114|P1|NOT COMPLETED|Overall Study||0
505982|NCT00238238|1217112|P3|COMPLETED|Overall Study||46
505983|NCT00238238|1217113|P2|COMPLETED|Overall Study||45
505984|NCT00238238|1217114|P1|COMPLETED|Overall Study||3
505985|NCT00238238|1217112|P3|STARTED|Overall Study||46
505986|NCT00238238|1217113|P2|STARTED|Overall Study||48
505987|NCT00238238|1217114|P1|STARTED|Overall Study||3
505988|NCT00238121|1217127|P2|NOT COMPLETED|Overall Study||2
505989|NCT00238121|1217128|P1|NOT COMPLETED|Overall Study||3
505990|NCT00238121|1217127|P2|COMPLETED|Overall Study||14
505991|NCT00238121|1217128|P1|COMPLETED|Overall Study||37
505992|NCT00238121|1217127|P2|STARTED|Overall Study||16
505993|NCT00238121|1217128|P1|STARTED|Overall Study||40
505994|NCT00238108|1217141|P2|NOT COMPLETED|Overall Study||0
505995|NCT00238108|1217142|P1|NOT COMPLETED|Overall Study||0
505996|NCT00238108|1217141|P2|COMPLETED|Overall Study||8
505997|NCT00238108|1217142|P1|COMPLETED|Overall Study||8
505998|NCT00238108|1217141|P2|STARTED|Overall Study||8
505999|NCT00238108|1217142|P1|STARTED|Overall Study||8
506000|NCT00237809|1217152|P4|NOT COMPLETED|Overall Study||9
506001|NCT00237809|1217153|P3|NOT COMPLETED|Overall Study||9
506002|NCT00237809|1217154|P2|NOT COMPLETED|Overall Study||10
506003|NCT00237809|1217155|P1|NOT COMPLETED|Overall Study||11
506004|NCT00237809|1217152|P4|COMPLETED|Overall Study||17
506005|NCT00237809|1217153|P3|COMPLETED|Overall Study||15
506006|NCT00237809|1217154|P2|COMPLETED|Overall Study||17
506007|NCT00237809|1217155|P1|COMPLETED|Overall Study||16
506008|NCT00237809|1217152|P4|STARTED|Overall Study||26
506009|NCT00237809|1217153|P3|STARTED|Overall Study||24
506010|NCT00237809|1217154|P2|STARTED|Overall Study||27
506011|NCT00237809|1217155|P1|STARTED|Overall Study||27
506012|NCT00237796|1217191|P2|NOT COMPLETED|Overall Study||5
506013|NCT00237796|1217192|P1|NOT COMPLETED|Overall Study||10
506014|NCT00237796|1217191|P2|COMPLETED|Overall Study||33
506015|NCT00237796|1217192|P1|COMPLETED|Overall Study||31
506016|NCT00237796|1217191|P2|STARTED|Overall Study||38
506017|NCT00237796|1217192|P1|STARTED|Overall Study||41
506018|NCT00237770|1217212|P2|NOT COMPLETED|Overall Study||0
506019|NCT00237770|1217213|P1|NOT COMPLETED|Overall Study||0
506020|NCT00237770|1217212|P2|COMPLETED|Overall Study||7
506021|NCT00237770|1217213|P1|COMPLETED|Overall Study||9
506022|NCT00237770|1217212|P2|STARTED|Overall Study||7
506023|NCT00237770|1217213|P1|STARTED|Overall Study||9
506024|NCT00237744|1217226|P3|NOT COMPLETED|Overall Study||0
506025|NCT00237744|1217227|P2|NOT COMPLETED|Overall Study||1
506026|NCT00237744|1217228|P1|NOT COMPLETED|Overall Study||3
506027|NCT00237744|1217226|P3|COMPLETED|Overall Study||18
506028|NCT00237744|1217227|P2|COMPLETED|Overall Study||10
506029|NCT00237744|1217228|P1|COMPLETED|Overall Study||8
506030|NCT00237744|1217226|P3|STARTED|Overall Study||18
506031|NCT00237744|1217227|P2|STARTED|Overall Study||11
506032|NCT00237744|1217228|P1|STARTED|Overall Study||11
506033|NCT00237718|1217241|P2|NOT COMPLETED|Overall Study||41
506034|NCT00237718|1217242|P1|NOT COMPLETED|Overall Study||46
506035|NCT00237718|1217241|P2|COMPLETED|Overall Study||124
506036|NCT00237718|1217242|P1|COMPLETED|Overall Study||114
506037|NCT00237718|1217241|P2|STARTED|Overall Study||165
506038|NCT00237718|1217242|P1|STARTED|Overall Study||160
506039|NCT00237692|1217254|P4|NOT COMPLETED|Overall Study||19
506040|NCT00237692|1217255|P3|NOT COMPLETED|Overall Study||22
506041|NCT00237692|1217256|P2|NOT COMPLETED|Overall Study||14
506042|NCT00237692|1217257|P1|NOT COMPLETED|Overall Study||18
506043|NCT00237692|1217254|P4|COMPLETED|Overall Study||128
506044|NCT00237692|1217255|P3|COMPLETED|Overall Study||127
506045|NCT00237692|1217256|P2|COMPLETED|Overall Study||134
506046|NCT00237692|1217257|P1|COMPLETED|Overall Study||129
506047|NCT00237692|1217254|P4|18 Month f/u|Overall Study||122
506048|NCT00237692|1217255|P3|18 Month f/u|Overall Study||126
506049|NCT00237692|1217256|P2|18 Month f/u|Overall Study||131
506050|NCT00237692|1217257|P1|18 Month f/u|Overall Study||124
506051|NCT00237692|1217254|P4|12 Month f/u|Overall Study||127
506052|NCT00237692|1217255|P3|12 Month f/u|Overall Study||132
506053|NCT00237692|1217256|P2|12 Month f/u|Overall Study||127
506054|NCT00237692|1217257|P1|12 Month f/u|Overall Study||137
506055|NCT00237692|1217254|P4|6 Month f/u|Overall Study||134
506056|NCT00237692|1217255|P3|6 Month f/u|Overall Study||135
506057|NCT00237692|1217256|P2|6 Month f/u|Overall Study||134
506058|NCT00237692|1217257|P1|6 Month f/u|Overall Study||132
506059|NCT00237692|1217254|P4|STARTED|Overall Study||147
506060|NCT00237692|1217255|P3|STARTED|Overall Study||149
506061|NCT00237692|1217256|P2|STARTED|Overall Study||148
506062|NCT00237692|1217257|P1|STARTED|Overall Study||147
506063|NCT00237666|1217287|P1|NOT COMPLETED|Overall Study||6
506064|NCT00237666|1217287|P1|COMPLETED|Overall Study||24
506065|NCT00237666|1217287|P1|STARTED|Overall Study||30
506066|NCT00237458|1217297|P1|NOT COMPLETED|Overall Study||3
506067|NCT00237458|1217297|P1|COMPLETED|Overall Study||4
506068|NCT00237458|1217297|P1|STARTED|Overall Study||7
506069|NCT00237185|1217315|P2|NOT COMPLETED|Extension||19
506070|NCT00237185|1217316|P1|NOT COMPLETED|Extension||16
506071|NCT00237185|1217315|P2|COMPLETED|Extension||13
506072|NCT00237185|1217316|P1|COMPLETED|Extension||8
506073|NCT00237185|1217315|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
506074|NCT00237185|1217316|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
506075|NCT00237185|1217315|P2|NOT COMPLETED|Core||37
506076|NCT00237185|1217316|P1|NOT COMPLETED|Core||44
506077|NCT00237185|1217315|P2|COMPLETED|Core||37
506078|NCT00237185|1217316|P1|COMPLETED|Core||30
506079|NCT00237185|1217315|P2|Treated Participants|Core||74
506080|NCT00237185|1217316|P1|Treated Participants|Core||73
506081|NCT00237185|1217315|P2|STARTED|Core||74
506082|NCT00237185|1217316|P1|STARTED|Core||74
506083|NCT00237042|1217347|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
506084|NCT00237042|1217348|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
506085|NCT00237042|1217349|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
506086|NCT00237042|1217347|P3|COMPLETED|Long Term (12 Month) Follow up||48
506087|NCT00237042|1217348|P2|COMPLETED|Long Term (12 Month) Follow up||46
506088|NCT00237042|1217349|P1|COMPLETED|Long Term (12 Month) Follow up||48
506089|NCT00237042|1217347|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
506090|NCT00237042|1217348|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
506091|NCT00237042|1217349|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
506092|NCT00237042|1217347|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
506093|NCT00237042|1217348|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
506094|NCT00237042|1217349|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
506095|NCT00237042|1217347|P3|COMPLETED|Short Term (6 Month) Follow up||46
506096|NCT00237042|1217348|P2|COMPLETED|Short Term (6 Month) Follow up||47
506097|NCT00237042|1217349|P1|COMPLETED|Short Term (6 Month) Follow up||50
506098|NCT00237042|1217347|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
506099|NCT00237042|1217348|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
506100|NCT00237042|1217349|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
506101|NCT00237042|1217347|P3|NOT COMPLETED|Treatment||38
506102|NCT00237042|1217348|P2|NOT COMPLETED|Treatment||7
506103|NCT00237042|1217349|P1|NOT COMPLETED|Treatment||6
506104|NCT00237042|1217347|P3|COMPLETED|Treatment||36
506105|NCT00237042|1217348|P2|COMPLETED|Treatment||50
506106|NCT00237042|1217349|P1|COMPLETED|Treatment||54
506107|NCT00237042|1217347|P3|STARTED|Treatment||74
506108|NCT00237042|1217348|P2|STARTED|Treatment||57
506109|NCT00237042|1217349|P1|STARTED|Treatment||60
506110|NCT00236977|1217368|P2|NOT COMPLETED|Overall Study||19
506111|NCT00236977|1217369|P1|NOT COMPLETED|Overall Study||21
506112|NCT00236977|1217368|P2|COMPLETED|Overall Study||72
506113|NCT00236977|1217369|P1|COMPLETED|Overall Study||70
506114|NCT00236977|1217368|P2|STARTED|Overall Study||91
506115|NCT00236977|1217369|P1|STARTED|Overall Study||91
506116|NCT00236951|1217391|P4|NOT COMPLETED|Overall Study||31
506117|NCT00236951|1217392|P3|NOT COMPLETED|Overall Study||19
506118|NCT00236951|1217393|P2|NOT COMPLETED|Overall Study||31
506119|NCT00236951|1217394|P1|NOT COMPLETED|Overall Study||26
506120|NCT00236951|1217391|P4|COMPLETED|Overall Study||17
506121|NCT00236951|1217392|P3|COMPLETED|Overall Study||21
506122|NCT00236951|1217393|P2|COMPLETED|Overall Study||46
506123|NCT00236951|1217394|P1|COMPLETED|Overall Study||33
506124|NCT00236951|1217391|P4|STARTED|Overall Study||48
506125|NCT00236951|1217392|P3|STARTED|Overall Study||40
506126|NCT00236951|1217393|P2|STARTED|Overall Study||77
506127|NCT00236951|1217394|P1|STARTED|Overall Study||59
506128|NCT00236938|1217406|P2|NOT COMPLETED|Overall Study||20
506129|NCT00236938|1217407|P1|NOT COMPLETED|Overall Study||13
506130|NCT00236938|1217406|P2|COMPLETED|Overall Study||26
506131|NCT00236938|1217407|P1|COMPLETED|Overall Study||62
506132|NCT00236938|1217406|P2|STARTED|Overall Study||46
506133|NCT00236938|1217407|P1|STARTED|Overall Study||75
506134|NCT00236899|1217423|P4|NOT COMPLETED|Overall Study||40
506135|NCT00236899|1217424|P3|NOT COMPLETED|Overall Study||44
506136|NCT00236899|1217425|P2|NOT COMPLETED|Overall Study||40
506137|NCT00236899|1217426|P1|NOT COMPLETED|Overall Study||42
506138|NCT00236899|1217423|P4|COMPLETED|Overall Study||19
506139|NCT00236899|1217424|P3|COMPLETED|Overall Study||14
506140|NCT00236899|1217425|P2|COMPLETED|Overall Study||24
506141|NCT00236899|1217426|P1|COMPLETED|Overall Study||18
506142|NCT00236899|1217423|P4|STARTED|Overall Study||59
506143|NCT00236899|1217424|P3|STARTED|Overall Study||58
506144|NCT00236899|1217425|P2|STARTED|Overall Study||64
506145|NCT00236899|1217426|P1|STARTED|Overall Study||60
506146|NCT00236197|1217458|P2|NOT COMPLETED|Overall Study||14
506147|NCT00236197|1217459|P1|NOT COMPLETED|Overall Study||5
506148|NCT00236197|1217458|P2|COMPLETED|Overall Study||293
506149|NCT00236197|1217459|P1|COMPLETED|Overall Study||307
506150|NCT00236197|1217458|P2|STARTED|Overall Study||307
506151|NCT00236197|1217459|P1|STARTED|Overall Study||312
506152|NCT00236184|1217467|P2|NOT COMPLETED|Overall Study||11
506153|NCT00236184|1217468|P1|NOT COMPLETED|Overall Study||18
506154|NCT00236184|1217467|P2|COMPLETED|Overall Study||308
506155|NCT00236184|1217468|P1|COMPLETED|Overall Study||292
506156|NCT00236184|1217467|P2|STARTED|Overall Study||319
506157|NCT00236184|1217468|P1|STARTED|Overall Study||310
506158|NCT00236080|1217479|P5|NOT COMPLETED|Overall Study||1
506159|NCT00236080|1217480|P4|NOT COMPLETED|Overall Study||2
506160|NCT00236080|1217481|P3|NOT COMPLETED|Overall Study||5
506161|NCT00236080|1217482|P2|NOT COMPLETED|Overall Study||1
506162|NCT00236080|1217483|P1|NOT COMPLETED|Overall Study||2
506163|NCT00236080|1217479|P5|COMPLETED|Overall Study||26
506164|NCT00236080|1217480|P4|COMPLETED|Overall Study||23
506165|NCT00236080|1217481|P3|COMPLETED|Overall Study||22
506166|NCT00236080|1217482|P2|COMPLETED|Overall Study||27
506167|NCT00236080|1217483|P1|COMPLETED|Overall Study||27
506168|NCT00236080|1217479|P5|STARTED|Overall Study||27
506169|NCT00236080|1217480|P4|STARTED|Overall Study||25
506170|NCT00236080|1217481|P3|STARTED|Overall Study||27
506171|NCT00236080|1217482|P2|STARTED|Overall Study||28
506172|NCT00236080|1217483|P1|STARTED|Overall Study||29
506173|NCT00235989|1217504|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
506174|NCT00235989|1217505|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
506175|NCT00235989|1217506|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
506176|NCT00235989|1217507|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
506177|NCT00235989|1217508|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
506178|NCT00235989|1217509|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
506179|NCT00235989|1217504|P6|COMPLETED|Extension Treatment Period (ET)||0
506180|NCT00235989|1217505|P5|COMPLETED|Extension Treatment Period (ET)||0
506181|NCT00235989|1217506|P4|COMPLETED|Extension Treatment Period (ET)||14
506182|NCT00235989|1217507|P3|COMPLETED|Extension Treatment Period (ET)||14
506183|NCT00235989|1217508|P2|COMPLETED|Extension Treatment Period (ET)||2
506184|NCT00235989|1217509|P1|COMPLETED|Extension Treatment Period (ET)||8
506185|NCT00235989|1217504|P6|STARTED|Extension Treatment Period (ET)||0
506186|NCT00235989|1217505|P5|STARTED|Extension Treatment Period (ET)||0
506187|NCT00235989|1217506|P4|STARTED|Extension Treatment Period (ET)||20
506188|NCT00235989|1217507|P3|STARTED|Extension Treatment Period (ET)||19
506189|NCT00235989|1217508|P2|STARTED|Extension Treatment Period (ET)||6
506190|NCT00235989|1217509|P1|STARTED|Extension Treatment Period (ET)||16
506191|NCT00235989|1217504|P6|NOT COMPLETED|Core Treatment Period (CT)||2
506192|NCT00235989|1217505|P5|NOT COMPLETED|Core Treatment Period (CT)||0
506193|NCT00235989|1217506|P4|NOT COMPLETED|Core Treatment Period (CT)||0
506194|NCT00235989|1217507|P3|NOT COMPLETED|Core Treatment Period (CT)||0
506195|NCT00235989|1217508|P2|NOT COMPLETED|Core Treatment Period (CT)||0
506196|NCT00235989|1217509|P1|NOT COMPLETED|Core Treatment Period (CT)||0
506197|NCT00235989|1217504|P6|COMPLETED|Core Treatment Period (CT)||25
506198|NCT00235989|1217505|P5|COMPLETED|Core Treatment Period (CT)||36
506199|NCT00235989|1217506|P4|COMPLETED|Core Treatment Period (CT)||0
506200|NCT00235989|1217507|P3|COMPLETED|Core Treatment Period (CT)||0
506201|NCT00235989|1217508|P2|COMPLETED|Core Treatment Period (CT)||0
506202|NCT00235989|1217509|P1|COMPLETED|Core Treatment Period (CT)||0
506203|NCT00235989|1217504|P6|STARTED|Core Treatment Period (CT)||27
506204|NCT00235989|1217505|P5|STARTED|Core Treatment Period (CT)||36
506205|NCT00235989|1217506|P4|STARTED|Core Treatment Period (CT)||0
506206|NCT00235989|1217507|P3|STARTED|Core Treatment Period (CT)||0
506207|NCT00235989|1217508|P2|STARTED|Core Treatment Period (CT)||0
506208|NCT00235989|1217509|P1|STARTED|Core Treatment Period (CT)||0
506209|NCT00235872|1217523|P1|NOT COMPLETED|Overall Study||147
506210|NCT00235872|1217523|P1|COMPLETED|Overall Study||162
506211|NCT00235872|1217523|P1|STARTED|Overall Study||309
506212|NCT00235833|1217538|P1|NOT COMPLETED|Overall Study||16
506213|NCT00235833|1217538|P1|COMPLETED|Overall Study||9
506214|NCT00235833|1217538|P1|STARTED|Overall Study||25
506215|NCT00235755|1217554|P3|NOT COMPLETED|12-Week Maintenance Phase||31
506216|NCT00235755|1217555|P2|NOT COMPLETED|12-Week Maintenance Phase||27
506217|NCT00235755|1217556|P1|NOT COMPLETED|12-Week Maintenance Phase||16
506218|NCT00235755|1217554|P3|COMPLETED|12-Week Maintenance Phase||122
506219|NCT00235755|1217555|P2|COMPLETED|12-Week Maintenance Phase||135
506220|NCT00235755|1217556|P1|COMPLETED|12-Week Maintenance Phase||152
506221|NCT00235755|1217554|P3|STARTED|12-Week Maintenance Phase||153
506222|NCT00235755|1217555|P2|STARTED|12-Week Maintenance Phase||162
506223|NCT00235755|1217556|P1|STARTED|12-Week Maintenance Phase||168
506224|NCT00235755|1217554|P3|NOT COMPLETED|4-Week Titration Phase||26
506225|NCT00235755|1217555|P2|NOT COMPLETED|4-Week Titration Phase||19
506226|NCT00235755|1217556|P1|NOT COMPLETED|4-Week Titration Phase||11
506227|NCT00235755|1217554|P3|COMPLETED|4-Week Titration Phase||153
506228|NCT00235755|1217555|P2|COMPLETED|4-Week Titration Phase||162
506229|NCT00235755|1217556|P1|COMPLETED|4-Week Titration Phase||168
506230|NCT00235755|1217554|P3|STARTED|4-Week Titration Phase||179
506231|NCT00235755|1217555|P2|STARTED|4-Week Titration Phase||181
506232|NCT00235755|1217556|P1|STARTED|4-Week Titration Phase||179
506233|NCT00235716|1217634|P4|NOT COMPLETED|Overall Study||62
506234|NCT00235716|1217635|P3|NOT COMPLETED|Overall Study||65
506235|NCT00235716|1217636|P2|NOT COMPLETED|Overall Study||67
506236|NCT00235716|1217637|P1|NOT COMPLETED|Overall Study||62
506237|NCT00235716|1217634|P4|COMPLETED|Overall Study||90
506238|NCT00235716|1217635|P3|COMPLETED|Overall Study||89
506239|NCT00235716|1217636|P2|COMPLETED|Overall Study||88
506240|NCT00235716|1217637|P1|COMPLETED|Overall Study||90
506241|NCT00235716|1217634|P4|STARTED|Overall Study||152
506242|NCT00235716|1217635|P3|STARTED|Overall Study||154
506243|NCT00235716|1217636|P2|STARTED|Overall Study||155
506244|NCT00235716|1217637|P1|STARTED|Overall Study||152
506245|NCT00235573|1217671|P1|NOT COMPLETED|Overall Study||0
506246|NCT00235573|1217671|P1|COMPLETED|Overall Study||21
506247|NCT00235573|1217671|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
506248|NCT00235456|1217677|P2|NOT COMPLETED|Overall Study||7
506249|NCT00235456|1217678|P1|NOT COMPLETED|Overall Study||2
506250|NCT00235456|1217677|P2|COMPLETED|Overall Study||143
506251|NCT00235456|1217678|P1|COMPLETED|Overall Study||148
506252|NCT00235456|1217677|P2|STARTED|Overall Study||150
506253|NCT00235456|1217678|P1|STARTED|Overall Study||150
506254|NCT00235443|1217700|P6|NOT COMPLETED|Overall Study||45
506255|NCT00235443|1217701|P5|NOT COMPLETED|Overall Study||30
506256|NCT00235443|1217702|P4|NOT COMPLETED|Overall Study||97
506257|NCT00235443|1217703|P3|NOT COMPLETED|Overall Study||62
506258|NCT00235443|1217704|P2|NOT COMPLETED|Overall Study||38
506259|NCT00235443|1217705|P1|NOT COMPLETED|Overall Study||8
506260|NCT00235443|1217700|P6|COMPLETED|Overall Study||9
506261|NCT00235443|1217701|P5|COMPLETED|Overall Study||9
506262|NCT00235443|1217702|P4|COMPLETED|Overall Study||108
506263|NCT00235443|1217703|P3|COMPLETED|Overall Study||23
506264|NCT00235443|1217704|P2|COMPLETED|Overall Study||19
506265|NCT00235443|1217705|P1|COMPLETED|Overall Study||3
506266|NCT00235443|1217700|P6|STARTED|Overall Study||54
506267|NCT00235443|1217701|P5|STARTED|Overall Study||39
506268|NCT00235443|1217702|P4|STARTED|Overall Study||205
506269|NCT00235443|1217703|P3|STARTED|Overall Study||85
506270|NCT00235443|1217704|P2|STARTED|Overall Study||57
506271|NCT00235443|1217705|P1|STARTED|Overall Study||11
506272|NCT00235391|1217846|P6|NOT COMPLETED|Overall Study||4
506273|NCT00235391|1217847|P5|NOT COMPLETED|Overall Study||12
506274|NCT00235391|1217848|P4|NOT COMPLETED|Overall Study||220
506275|NCT00235391|1217849|P3|NOT COMPLETED|Overall Study||24
506276|NCT00235391|1217850|P2|NOT COMPLETED|Overall Study||18
506277|NCT00235391|1217851|P1|NOT COMPLETED|Overall Study||12
506278|NCT00235391|1217846|P6|COMPLETED|Overall Study||3
506279|NCT00235391|1217847|P5|COMPLETED|Overall Study||31
506280|NCT00235391|1217848|P4|COMPLETED|Overall Study||944
506281|NCT00235391|1217849|P3|COMPLETED|Overall Study||148
506282|NCT00235391|1217850|P2|COMPLETED|Overall Study||182
506283|NCT00235391|1217851|P1|COMPLETED|Overall Study||85
506284|NCT00235391|1217846|P6|Deferasirox Treatment|Overall Study||7
506285|NCT00235391|1217847|P5|Deferasirox Treatment|Overall Study||43
506286|NCT00235391|1217848|P4|Deferasirox Treatment|Overall Study||1164
506287|NCT00235391|1217849|P3|Deferasirox Treatment|Overall Study||172
506288|NCT00235391|1217850|P2|Deferasirox Treatment|Overall Study||200
506289|NCT00235391|1217851|P1|Deferasirox Treatment|Overall Study||97
506290|NCT00235391|1217846|P6|STARTED|Overall Study||7
506291|NCT00235391|1217847|P5|STARTED|Overall Study||43
506292|NCT00235391|1217848|P4|STARTED|Overall Study||1164
506293|NCT00235391|1217849|P3|STARTED|Overall Study||172
506294|NCT00235391|1217850|P2|STARTED|Overall Study||200
506295|NCT00235391|1217851|P1|STARTED|Overall Study||97
506296|NCT00235326|1217868|P2|NOT COMPLETED|Overall Study||1400
506297|NCT00235326|1217869|P1|NOT COMPLETED|Overall Study||746
506298|NCT00235326|1217868|P2|COMPLETED|Overall Study||1586
506299|NCT00235326|1217869|P1|COMPLETED|Overall Study||829
506300|NCT00235326|1217868|P2|STARTED|Overall Study||2986
506301|NCT00235326|1217869|P1|STARTED|Overall Study||1575
506302|NCT00234884|1217873|P1|NOT COMPLETED|Overall Study||1630
506303|NCT00234884|1217873|P1|COMPLETED|Overall Study||1805
506304|NCT00234884|1217873|P1|STARTED|Overall Study||3435
506305|NCT00234832|1217883|P2|NOT COMPLETED|Overall Study||996
506306|NCT00234832|1217884|P1|NOT COMPLETED|Overall Study||1016
506307|NCT00234832|1217883|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
506308|NCT00234832|1217884|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
506309|NCT00234832|1217883|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
506310|NCT00234832|1217884|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
506311|NCT00234494|1217909|P1|NOT COMPLETED|Overall Study||2
506312|NCT00234494|1217909|P1|COMPLETED|Overall Study||43
506313|NCT00234494|1217909|P1|STARTED|Overall Study||45
506314|NCT00233519|1217918|P2|NOT COMPLETED|Overall Study||1
506315|NCT00233519|1217919|P1|NOT COMPLETED|Overall Study||1
506316|NCT00233519|1217918|P2|COMPLETED|Overall Study||9
506317|NCT00233519|1217919|P1|COMPLETED|Overall Study||6
506318|NCT00233519|1217918|P2|STARTED|Overall Study||10
506319|NCT00233519|1217919|P1|STARTED|Overall Study||7
506320|NCT00233454|1217925|P1|NOT COMPLETED|Overall Study||6
506321|NCT00233454|1217925|P1|COMPLETED|Overall Study||20
506322|NCT00233454|1217925|P1|2 Months (for Response Rate)|Overall Study||26
506323|NCT00233454|1217925|P1|STARTED|Overall Study||26
506324|NCT00233402|1217932|P2|NOT COMPLETED|Overall Study||124
506325|NCT00233402|1217933|P1|NOT COMPLETED|Overall Study||104
506326|NCT00233402|1217932|P2|COMPLETED|Overall Study||271
506327|NCT00233402|1217933|P1|COMPLETED|Overall Study||280
506328|NCT00233402|1217932|P2|STARTED|Overall Study||395
506329|NCT00233402|1217933|P1|STARTED|Overall Study||384
506330|NCT00234286|1217944|P1|NOT COMPLETED|Overall Study||0
506422|NCT00233090|1218119|P1|NOT COMPLETED|Overall Study||0
506331|NCT00234286|1217944|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
506332|NCT00234286|1217944|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
506333|NCT00234104|1217983|P4|NOT COMPLETED|Overall Study||8
506334|NCT00234104|1217984|P3|NOT COMPLETED|Overall Study||5
506335|NCT00234104|1217985|P2|NOT COMPLETED|Overall Study||1
506336|NCT00234104|1217986|P1|NOT COMPLETED|Overall Study||4
506337|NCT00234104|1217983|P4|COMPLETED|Overall Study||21
506338|NCT00234104|1217984|P3|COMPLETED|Overall Study||29
506339|NCT00234104|1217985|P2|COMPLETED|Overall Study||28
506340|NCT00234104|1217986|P1|COMPLETED|Overall Study||26
506341|NCT00234104|1217983|P4|STARTED|Overall Study||29
506342|NCT00234104|1217984|P3|STARTED|Overall Study||34
506343|NCT00234104|1217985|P2|STARTED|Overall Study||29
506344|NCT00234104|1217986|P1|STARTED|Overall Study||30
506345|NCT00234078|1218000|P4|NOT COMPLETED|Overall Study||4
506346|NCT00234078|1218001|P3|NOT COMPLETED|Overall Study||10
506347|NCT00234078|1218002|P2|NOT COMPLETED|Overall Study||9
506348|NCT00234078|1218003|P1|NOT COMPLETED|Overall Study||6
506349|NCT00234078|1218000|P4|COMPLETED|Overall Study||68
506350|NCT00234078|1218001|P3|COMPLETED|Overall Study||64
506351|NCT00234078|1218002|P2|COMPLETED|Overall Study||63
506352|NCT00234078|1218003|P1|COMPLETED|Overall Study||66
506353|NCT00234078|1218000|P4|STARTED|Overall Study||72
506354|NCT00234078|1218001|P3|STARTED|Overall Study||74
506355|NCT00234078|1218002|P2|STARTED|Overall Study||72
506356|NCT00234078|1218003|P1|STARTED|Overall Study||72
506357|NCT00234065|1218027|P2|NOT COMPLETED|Overall Study||356
506358|NCT00234065|1218028|P1|NOT COMPLETED|Overall Study||475
506359|NCT00234065|1218027|P2|COMPLETED|Overall Study||1004
506360|NCT00234065|1218028|P1|COMPLETED|Overall Study||881
506361|NCT00234065|1218027|P2|STARTED|Overall Study||1360
506362|NCT00234065|1218028|P1|STARTED|Overall Study||1356
506363|NCT00234039|1218044|P1|NOT COMPLETED|Overall Study||50
506364|NCT00234039|1218044|P1|COMPLETED|Overall Study||8
506365|NCT00234039|1218044|P1|Eligible and Began Protocol Therapy|Overall Study||47
506366|NCT00234039|1218044|P1|Eligible|Overall Study||49
506367|NCT00234039|1218044|P1|STARTED|Overall Study||58
506368|NCT00233987|1218051|P1|NOT COMPLETED|Overall Study||15
506369|NCT00233987|1218051|P1|COMPLETED|Overall Study||83
506370|NCT00233987|1218051|P1|Eligible and Treated|Overall Study||92
506371|NCT00233987|1218051|P1|Eligible|Overall Study||94
506372|NCT00233987|1218051|P1|STARTED|Overall Study||98
506373|NCT00233948|1218060|P6|NOT COMPLETED|Overall Study||0
506374|NCT00233948|1218061|P5|NOT COMPLETED|Overall Study||0
506375|NCT00233948|1218062|P4|NOT COMPLETED|Overall Study||0
506376|NCT00233948|1218063|P3|NOT COMPLETED|Overall Study||0
506377|NCT00233948|1218064|P2|NOT COMPLETED|Overall Study||0
506378|NCT00233948|1218065|P1|NOT COMPLETED|Overall Study||1
506379|NCT00233948|1218060|P6|COMPLETED|Overall Study||12
506380|NCT00233948|1218061|P5|COMPLETED|Overall Study||4
506381|NCT00233948|1218062|P4|COMPLETED|Overall Study||3
506382|NCT00233948|1218063|P3|COMPLETED|Overall Study||3
506383|NCT00233948|1218064|P2|COMPLETED|Overall Study||3
506384|NCT00233948|1218065|P1|COMPLETED|Overall Study||3
506385|NCT00233948|1218060|P6|STARTED|Overall Study||12
506386|NCT00233948|1218061|P5|STARTED|Overall Study||4
506387|NCT00233948|1218062|P4|STARTED|Overall Study||3
506388|NCT00233948|1218063|P3|STARTED|Overall Study||3
506389|NCT00233948|1218064|P2|STARTED|Overall Study||3
506390|NCT00233948|1218065|P1|STARTED|Overall Study||4
506391|NCT00233324|1218084|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
506392|NCT00233324|1218085|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
506393|NCT00233324|1218086|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
506394|NCT00233324|1218087|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
506395|NCT00233324|1218084|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
506396|NCT00233324|1218085|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
506397|NCT00233324|1218086|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
506398|NCT00233324|1218087|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
506399|NCT00233324|1218084|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
506400|NCT00233324|1218085|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
506401|NCT00233324|1218086|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
506402|NCT00233324|1218087|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
506403|NCT00233324|1218084|P4|NOT COMPLETED|Main Study||47
506404|NCT00233324|1218085|P3|NOT COMPLETED|Main Study||62
506405|NCT00233324|1218086|P2|NOT COMPLETED|Main Study||60
506406|NCT00233324|1218087|P1|NOT COMPLETED|Main Study||68
506407|NCT00233324|1218084|P4|COMPLETED|Main Study||280
506408|NCT00233324|1218085|P3|COMPLETED|Main Study||274
506409|NCT00233324|1218086|P2|COMPLETED|Main Study||275
506410|NCT00233324|1218087|P1|COMPLETED|Main Study||250
506411|NCT00233324|1218084|P4|STARTED|Main Study||327
506412|NCT00233324|1218085|P3|STARTED|Main Study||336
506413|NCT00233324|1218086|P2|STARTED|Main Study||335
506414|NCT00233324|1218087|P1|STARTED|Main Study||318
506415|NCT00233103|1218103|P2|NOT COMPLETED|Overall Study||6
506416|NCT00233103|1218104|P1|NOT COMPLETED|Overall Study||5
506417|NCT00233103|1218103|P2|COMPLETED|Overall Study||19
506418|NCT00233103|1218104|P1|COMPLETED|Overall Study||22
506419|NCT00233103|1218103|P2|STARTED|Overall Study||25
506420|NCT00233103|1218104|P1|STARTED|Overall Study||27
506421|NCT00233090|1218118|P2|NOT COMPLETED|Overall Study||0
506423|NCT00233090|1218118|P2|COMPLETED|Overall Study||9
506424|NCT00233090|1218119|P1|COMPLETED|Overall Study||12
506425|NCT00233090|1218118|P2|STARTED|Overall Study||9
506426|NCT00233090|1218119|P1|STARTED|Overall Study||12
506427|NCT00233064|1218141|P2|NOT COMPLETED|Overall Study||12
506428|NCT00233064|1218142|P1|NOT COMPLETED|Overall Study||14
506429|NCT00233064|1218141|P2|COMPLETED|Overall Study||190
506430|NCT00233064|1218142|P1|COMPLETED|Overall Study||197
506431|NCT00233064|1218141|P2|STARTED|Overall Study||202
506432|NCT00233064|1218142|P1|STARTED|Overall Study||211
506433|NCT00232739|1218149|P1|NOT COMPLETED|Overall Study||9
506434|NCT00232739|1218149|P1|COMPLETED|Overall Study||91
506435|NCT00232739|1218149|P1|STARTED|Overall Study||100
506436|NCT00232596|1218168|P2|NOT COMPLETED|12-Week Maintenance Phase||28
506437|NCT00232596|1218169|P1|NOT COMPLETED|12-Week Maintenance Phase||12
506438|NCT00232596|1218168|P2|COMPLETED|12-Week Maintenance Phase||97
506439|NCT00232596|1218169|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
506440|NCT00232596|1218168|P2|STARTED|12-Week Maintenance Phase||125
506441|NCT00232596|1218169|P1|STARTED|12-Week Maintenance Phase||138
506442|NCT00232596|1218168|P2|NOT COMPLETED|6-Week Titration Phase||29
506443|NCT00232596|1218169|P1|NOT COMPLETED|6-Week Titration Phase||14
506444|NCT00232596|1218168|P2|COMPLETED|6-Week Titration Phase||125
506445|NCT00232596|1218169|P1|COMPLETED|6-Week Titration Phase||138
506446|NCT00232596|1218168|P2|STARTED|6-Week Titration Phase||154
506447|NCT00232596|1218169|P1|STARTED|6-Week Titration Phase||152
506448|NCT00232583|1218221|P2|NOT COMPLETED|Overall Study||13
506449|NCT00232583|1218222|P1|NOT COMPLETED|Overall Study||10
506450|NCT00232583|1218221|P2|COMPLETED|Overall Study||16
506451|NCT00232583|1218222|P1|COMPLETED|Overall Study||19
506452|NCT00232583|1218221|P2|STARTED|Overall Study||29
506453|NCT00232583|1218222|P1|STARTED|Overall Study||29
506454|NCT00232557|1218230|P2|NOT COMPLETED|Overall Study||5
506455|NCT00232557|1218231|P1|NOT COMPLETED|Overall Study||3
506456|NCT00232557|1218230|P2|COMPLETED|Overall Study||60
506457|NCT00232557|1218231|P1|COMPLETED|Overall Study||68
506458|NCT00232557|1218230|P2|STARTED|Overall Study||65
506459|NCT00232557|1218231|P1|STARTED|Overall Study||71
506460|NCT00232544|1218241|P2|NOT COMPLETED|Overall Study||15
506461|NCT00232544|1218242|P1|NOT COMPLETED|Overall Study||20
506462|NCT00232544|1218241|P2|COMPLETED|Overall Study||111
506463|NCT00232544|1218242|P1|COMPLETED|Overall Study||104
506464|NCT00232544|1218241|P2|STARTED|Overall Study||126
506465|NCT00232544|1218242|P1|STARTED|Overall Study||124
506466|NCT00232479|1218250|P1|NOT COMPLETED|Overall Study||0
506467|NCT00232479|1218250|P1|COMPLETED|Overall Study||44
506468|NCT00232479|1218250|P1|STARTED|Overall Study||44
506469|NCT00232180|1218257|P3|NOT COMPLETED|Open Label Phase||148
506470|NCT00232180|1218258|P2|NOT COMPLETED|Open Label Phase||0
506471|NCT00232180|1218259|P1|NOT COMPLETED|Open Label Phase||0
506472|NCT00232180|1218257|P3|COMPLETED|Open Label Phase||1098
506473|NCT00232180|1218258|P2|COMPLETED|Open Label Phase||0
506474|NCT00232180|1218259|P1|COMPLETED|Open Label Phase||0
506475|NCT00232180|1218257|P3|Treated|Open Label Phase||1245
506476|NCT00232180|1218258|P2|Treated|Open Label Phase||0
506477|NCT00232180|1218259|P1|Treated|Open Label Phase||0
506478|NCT00232180|1218257|P3|STARTED|Open Label Phase||1246
506479|NCT00232180|1218258|P2|STARTED|Open Label Phase||0
506480|NCT00232180|1218259|P1|STARTED|Open Label Phase||0
506481|NCT00232180|1218257|P3|NOT COMPLETED|Double-blind (DB) Phase||0
506482|NCT00232180|1218258|P2|NOT COMPLETED|Double-blind (DB) Phase||605
506483|NCT00232180|1218259|P1|NOT COMPLETED|Double-blind (DB) Phase||541
506484|NCT00232180|1218257|P3|COMPLETED|Double-blind (DB) Phase||0
506485|NCT00232180|1218258|P2|COMPLETED|Double-blind (DB) Phase||771
506486|NCT00232180|1218259|P1|COMPLETED|Double-blind (DB) Phase||826
506487|NCT00232180|1218257|P3|Treated|Double-blind (DB) Phase||0
506488|NCT00232180|1218258|P2|Treated|Double-blind (DB) Phase||1372
506489|NCT00232180|1218259|P1|Treated|Double-blind (DB) Phase||1364
506490|NCT00232180|1218257|P3|STARTED|Double-blind (DB) Phase||0
506491|NCT00232180|1218258|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
506492|NCT00232180|1218259|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
506493|NCT00232141|1218304|P2|NOT COMPLETED|Overall Study||26
506494|NCT00232141|1218305|P1|NOT COMPLETED|Overall Study||31
506495|NCT00232141|1218304|P2|COMPLETED|Overall Study||125
506496|NCT00232141|1218305|P1|COMPLETED|Overall Study||120
506497|NCT00232141|1218304|P2|STARTED|Overall Study||151
506498|NCT00232141|1218305|P1|STARTED|Overall Study||151
506499|NCT00231816|1218375|P2|NOT COMPLETED|Overall Study||12
506500|NCT00231816|1218376|P1|NOT COMPLETED|Overall Study||16
506501|NCT00231816|1218375|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
506502|NCT00231816|1218376|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
506503|NCT00231816|1218375|P2|Vaccinated at Visit 2|Overall Study||371
506504|NCT00231816|1218376|P1|Vaccinated at Visit 2|Overall Study||369
506505|NCT00231816|1218375|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
506506|NCT00231816|1218376|P1|Vaccinated at Visit 1|Overall Study||382
506507|NCT00231816|1218375|P2|STARTED|Overall Study||381
506508|NCT00231816|1218376|P1|STARTED|Overall Study||382
506509|NCT00231777|1218391|P2|NOT COMPLETED|Overall Study||2
506510|NCT00231777|1218392|P1|NOT COMPLETED|Overall Study||6
506511|NCT00231777|1218391|P2|COMPLETED|Overall Study||44
506512|NCT00231777|1218392|P1|COMPLETED|Overall Study||164
506513|NCT00231777|1218391|P2|STARTED|Overall Study||46
506514|NCT00231777|1218392|P1|STARTED|Overall Study||170
506515|NCT00231478|1218406|P2|NOT COMPLETED|Overall Study||6
506516|NCT00231478|1218407|P1|NOT COMPLETED|Overall Study||8
506517|NCT00231478|1218406|P2|COMPLETED|Overall Study||78
506518|NCT00231478|1218407|P1|COMPLETED|Overall Study||79
506519|NCT00231478|1218406|P2|STARTED|Overall Study||84
506520|NCT00231478|1218407|P1|STARTED|Overall Study||87
506521|NCT00231465|1218419|P1|NOT COMPLETED|Overall Study||2
506522|NCT00231465|1218419|P1|COMPLETED|Overall Study||42
506523|NCT00231465|1218419|P1|STARTED|Overall Study||44
506524|NCT00231309|1218425|P1|NOT COMPLETED|Overall Study||0
506525|NCT00231309|1218425|P1|COMPLETED|Overall Study||10
506526|NCT00231309|1218425|P1|STARTED|Overall Study||10
506527|NCT00231283|1218430|P1|NOT COMPLETED|Overall Study||5
506528|NCT00231283|1218430|P1|COMPLETED|Overall Study||95
506529|NCT00231283|1218430|P1|STARTED|Overall Study||100
506530|NCT00231179|1218439|P2|NOT COMPLETED|Overall Study||24
506531|NCT00231179|1218440|P1|NOT COMPLETED|Overall Study||24
506532|NCT00231179|1218439|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
506533|NCT00231179|1218440|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
506534|NCT00231179|1218439|P2|STARTED|Overall Study||150
506535|NCT00231179|1218440|P1|STARTED|Overall Study||152
506536|NCT00231153|1218456|P2|NOT COMPLETED|Overall Study||188
506537|NCT00231153|1218457|P1|NOT COMPLETED|Overall Study||217
506538|NCT00231153|1218456|P2|COMPLETED|Overall Study||720
506539|NCT00231153|1218457|P1|COMPLETED|Overall Study||690
506540|NCT00231153|1218456|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
506541|NCT00231153|1218457|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
506542|NCT00231114|1218467|P2|NOT COMPLETED|Post-Treatment Period||1
506543|NCT00231114|1218468|P1|NOT COMPLETED|Post-Treatment Period||8
506544|NCT00231114|1218467|P2|COMPLETED|Post-Treatment Period||97
506545|NCT00231114|1218468|P1|COMPLETED|Post-Treatment Period||181
506546|NCT00231114|1218467|P2|STARTED|Post-Treatment Period||98
506547|NCT00231114|1218468|P1|STARTED|Post-Treatment Period||189
506548|NCT00231114|1218467|P2|NOT COMPLETED|Treatment Period||0
506549|NCT00231114|1218468|P1|NOT COMPLETED|Treatment Period||1
506550|NCT00231114|1218467|P2|COMPLETED|Treatment Period||98
506551|NCT00231114|1218468|P1|COMPLETED|Treatment Period||189
506552|NCT00231114|1218467|P2|STARTED|Treatment Period||98
506553|NCT00231114|1218468|P1|STARTED|Treatment Period||190
506554|NCT00231114|1218467|P2|NOT COMPLETED|Randomized||3
506555|NCT00231114|1218468|P1|NOT COMPLETED|Randomized||6
506556|NCT00231114|1218467|P2|COMPLETED|Randomized||98
506557|NCT00231114|1218468|P1|COMPLETED|Randomized||190
506558|NCT00231114|1218467|P2|STARTED|Randomized||101
506559|NCT00231114|1218468|P1|STARTED|Randomized||196
506560|NCT00231062|1218504|P1|NOT COMPLETED|Overall Study||6
506561|NCT00231062|1218504|P1|COMPLETED|Overall Study||109
506562|NCT00231062|1218504|P1|STARTED|Overall Study||115
506563|NCT00230971|1218512|P2|NOT COMPLETED|Baseline Participants||19
506564|NCT00230971|1218513|P1|NOT COMPLETED|Baseline Participants||22
506565|NCT00230971|1218512|P2|COMPLETED|Baseline Participants||216
506566|NCT00230971|1218513|P1|COMPLETED|Baseline Participants||210
506567|NCT00230971|1218512|P2|STARTED|Baseline Participants||235
506568|NCT00230971|1218513|P1|STARTED|Baseline Participants||232
506569|NCT00230971|1218512|P2|NOT COMPLETED|Randomization||3
506570|NCT00230971|1218513|P1|NOT COMPLETED|Randomization||3
506571|NCT00230971|1218512|P2|COMPLETED|Randomization||235
506572|NCT00230971|1218513|P1|COMPLETED|Randomization||232
506573|NCT00230971|1218512|P2|STARTED|Randomization||238
506574|NCT00230971|1218513|P1|STARTED|Randomization||235
506575|NCT00230802|1218527|P2|NOT COMPLETED|Overall Study||0
506576|NCT00230802|1218528|P1|NOT COMPLETED|Overall Study||0
506577|NCT00230802|1218527|P2|COMPLETED|Overall Study||23
506578|NCT00230802|1218528|P1|COMPLETED|Overall Study||25
506579|NCT00230802|1218527|P2|STARTED|Overall Study||23
506580|NCT00230802|1218528|P1|STARTED|Overall Study||25
506581|NCT00230737|1218541|P3|NOT COMPLETED|Overall Study||0
506582|NCT00230737|1218542|P2|NOT COMPLETED|Overall Study||0
506583|NCT00230737|1218543|P1|NOT COMPLETED|Overall Study||0
506584|NCT00230737|1218541|P3|COMPLETED|Overall Study||8
506585|NCT00230737|1218542|P2|COMPLETED|Overall Study||10
506586|NCT00230737|1218543|P1|COMPLETED|Overall Study||9
506587|NCT00230737|1218541|P3|STARTED|Overall Study||8
506588|NCT00230737|1218542|P2|STARTED|Overall Study||10
506589|NCT00230737|1218543|P1|STARTED|Overall Study||9
506590|NCT00230282|1218551|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
506591|NCT00230282|1218551|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
506592|NCT00230282|1218551|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
506593|NCT00230282|1218551|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
506594|NCT00230282|1218551|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
506595|NCT00230282|1218551|P1|STARTED|Fludarabine + Cyclophosphamide||25
506596|NCT00228813|1218556|P1|NOT COMPLETED|Overall Study||4
506597|NCT00228813|1218556|P1|COMPLETED|Overall Study||4
506598|NCT00228813|1218556|P1|STARTED|Overall Study||8
506599|NCT00230178|1218565|P3|NOT COMPLETED|Overall Study||7
506600|NCT00230178|1218566|P2|NOT COMPLETED|Overall Study||7
506601|NCT00230178|1218567|P1|NOT COMPLETED|Overall Study||4
506602|NCT00230178|1218565|P3|COMPLETED|Overall Study||86
506603|NCT00230178|1218566|P2|COMPLETED|Overall Study||86
506604|NCT00230178|1218567|P1|COMPLETED|Overall Study||90
506605|NCT00230178|1218565|P3|Treated|Overall Study||91
506606|NCT00230178|1218566|P2|Treated|Overall Study||92
506607|NCT00230178|1218567|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
506608|NCT00230178|1218565|P3|STARTED|Overall Study||93
506609|NCT00230178|1218566|P2|STARTED|Overall Study||93
506610|NCT00230178|1218567|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
506611|NCT00230126|1218583|P2|NOT COMPLETED|Overall Study||1
506612|NCT00230126|1218584|P1|NOT COMPLETED|Overall Study||2
506613|NCT00230126|1218583|P2|COMPLETED|Overall Study||27
506614|NCT00230126|1218584|P1|COMPLETED|Overall Study||28
506615|NCT00230126|1218583|P2|STARTED|Overall Study||28
506616|NCT00230126|1218584|P1|STARTED|Overall Study||30
506617|NCT00230100|1218596|P2|NOT COMPLETED|Overall Study||0
506618|NCT00230100|1218597|P1|NOT COMPLETED|Overall Study||0
506619|NCT00230100|1218596|P2|COMPLETED|Overall Study||17
506620|NCT00230100|1218597|P1|COMPLETED|Overall Study||29
506621|NCT00230100|1218596|P2|STARTED|Overall Study||17
506622|NCT00230100|1218597|P1|STARTED|Overall Study||29
506623|NCT00230048|1218619|P2|NOT COMPLETED|Overall Study||18
506624|NCT00230048|1218620|P1|NOT COMPLETED|Overall Study||13
506625|NCT00230048|1218619|P2|COMPLETED|Overall Study||37
506626|NCT00230048|1218620|P1|COMPLETED|Overall Study||39
506627|NCT00230048|1218619|P2|Completed Intervention/Control Session|Overall Study||55
506628|NCT00230048|1218620|P1|Completed Intervention/Control Session|Overall Study||52
506629|NCT00230048|1218619|P2|STARTED|Overall Study||55
506630|NCT00230048|1218620|P1|STARTED|Overall Study||52
506631|NCT00230022|1218630|P2|NOT COMPLETED|Overall Study||0
506632|NCT00230022|1218631|P1|NOT COMPLETED|Overall Study||0
506633|NCT00230022|1218630|P2|COMPLETED|Overall Study||15
506634|NCT00230022|1218631|P1|COMPLETED|Overall Study||15
506635|NCT00230022|1218630|P2|STARTED|Overall Study||15
506636|NCT00230022|1218631|P1|STARTED|Overall Study||15
506637|NCT00230009|1218639|P2|NOT COMPLETED|Follow-up||26
506638|NCT00230009|1218640|P1|NOT COMPLETED|Follow-up||31
506639|NCT00230009|1218639|P2|COMPLETED|Follow-up||24
506640|NCT00230009|1218640|P1|COMPLETED|Follow-up||19
506641|NCT00230009|1218639|P2|STARTED|Follow-up||50
506642|NCT00230009|1218640|P1|STARTED|Follow-up||50
506643|NCT00230009|1218639|P2|NOT COMPLETED|Single Session Intervention/Control||0
506644|NCT00230009|1218640|P1|NOT COMPLETED|Single Session Intervention/Control||0
506645|NCT00230009|1218639|P2|COMPLETED|Single Session Intervention/Control||50
506646|NCT00230009|1218640|P1|COMPLETED|Single Session Intervention/Control||50
506647|NCT00230009|1218639|P2|STARTED|Single Session Intervention/Control||50
506648|NCT00230009|1218640|P1|STARTED|Single Session Intervention/Control||50
506649|NCT00229970|1218657|P3|NOT COMPLETED|Overall Study||0
506650|NCT00229970|1218658|P2|NOT COMPLETED|Overall Study||0
506651|NCT00229970|1218659|P1|NOT COMPLETED|Overall Study||0
506652|NCT00229970|1218657|P3|COMPLETED|Overall Study||75
506653|NCT00229970|1218658|P2|COMPLETED|Overall Study||72
506654|NCT00229970|1218659|P1|COMPLETED|Overall Study||78
506655|NCT00229970|1218657|P3|STARTED|Overall Study||75
506656|NCT00229970|1218658|P2|STARTED|Overall Study||72
506657|NCT00229970|1218659|P1|STARTED|Overall Study||78
506658|NCT00229957|1218669|P2|NOT COMPLETED|Overall Study||12
506659|NCT00229957|1218670|P1|NOT COMPLETED|Overall Study||20
506660|NCT00229957|1218669|P2|COMPLETED|Overall Study||139
506661|NCT00229957|1218670|P1|COMPLETED|Overall Study||132
506662|NCT00229957|1218669|P2|STARTED|Overall Study||151
506663|NCT00229957|1218670|P1|STARTED|Overall Study||152
506664|NCT00229723|1218683|P7|NOT COMPLETED|Maintenance Phase||10
506665|NCT00229723|1218684|P6|NOT COMPLETED|Maintenance Phase||19
506666|NCT00229723|1218685|P5|NOT COMPLETED|Maintenance Phase||15
506667|NCT00229723|1218686|P4|NOT COMPLETED|Maintenance Phase||17
506668|NCT00229723|1218687|P3|NOT COMPLETED|Maintenance Phase||9
506669|NCT00229723|1218688|P2|NOT COMPLETED|Maintenance Phase||14
506670|NCT00229723|1218689|P1|NOT COMPLETED|Maintenance Phase||25
506671|NCT00229723|1218683|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
506672|NCT00229723|1218684|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
506673|NCT00229723|1218685|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
506674|NCT00229723|1218686|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
506675|NCT00229723|1218687|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
506676|NCT00229723|1218688|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
506677|NCT00229723|1218689|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
506678|NCT00229723|1218683|P7|STARTED|Maintenance Phase||19
506679|NCT00229723|1218684|P6|STARTED|Maintenance Phase||31
506680|NCT00229723|1218685|P5|STARTED|Maintenance Phase||22
506681|NCT00229723|1218686|P4|STARTED|Maintenance Phase||26
506682|NCT00229723|1218687|P3|STARTED|Maintenance Phase||25
506683|NCT00229723|1218688|P2|STARTED|Maintenance Phase||19
506684|NCT00229723|1218689|P1|STARTED|Maintenance Phase||50
506685|NCT00229723|1218683|P7|NOT COMPLETED|Concomitant Phase||3
506686|NCT00229723|1218684|P6|NOT COMPLETED|Concomitant Phase||3
506687|NCT00229723|1218685|P5|NOT COMPLETED|Concomitant Phase||2
506688|NCT00229723|1218686|P4|NOT COMPLETED|Concomitant Phase||5
506689|NCT00229723|1218687|P3|NOT COMPLETED|Concomitant Phase||6
506690|NCT00229723|1218688|P2|NOT COMPLETED|Concomitant Phase||5
506691|NCT00229723|1218689|P1|NOT COMPLETED|Concomitant Phase||10
506692|NCT00229723|1218683|P7|COMPLETED|Concomitant Phase||19
506693|NCT00229723|1218684|P6|COMPLETED|Concomitant Phase||31
506694|NCT00229723|1218685|P5|COMPLETED|Concomitant Phase||22
506695|NCT00229723|1218686|P4|COMPLETED|Concomitant Phase||26
506696|NCT00229723|1218687|P3|COMPLETED|Concomitant Phase||25
506697|NCT00229723|1218688|P2|COMPLETED|Concomitant Phase||19
506698|NCT00229723|1218689|P1|COMPLETED|Concomitant Phase||50
506699|NCT00229723|1218683|P7|STARTED|Concomitant Phase|Received randomized treatment|22
506700|NCT00229723|1218684|P6|STARTED|Concomitant Phase|Received randomized treatment|34
506701|NCT00229723|1218685|P5|STARTED|Concomitant Phase|Received randomized treatment|24
506702|NCT00229723|1218686|P4|STARTED|Concomitant Phase|Received randomized treatment|31
506703|NCT00229723|1218687|P3|STARTED|Concomitant Phase|Received randomized treatment|31
506704|NCT00229723|1218688|P2|STARTED|Concomitant Phase|Received randomized treatment|24
506705|NCT00229723|1218689|P1|STARTED|Concomitant Phase|Received randomized treatment|60
506706|NCT00229658|1218742|P2|NOT COMPLETED|Overall Study||167
506707|NCT00229658|1218743|P1|NOT COMPLETED|Overall Study||225
506708|NCT00229658|1218742|P2|COMPLETED|Overall Study||364
506709|NCT00229658|1218743|P1|COMPLETED|Overall Study||541
506710|NCT00229658|1218742|P2|STARTED|Overall Study||531
506711|NCT00229658|1218743|P1|STARTED|Overall Study||766
506712|NCT00229619|1218771|P1|NOT COMPLETED|Overall Study||0
506713|NCT00229619|1218771|P1|COMPLETED|Overall Study||11
506714|NCT00229619|1218771|P1|STARTED|Overall Study||11
506715|NCT00228566|1218775|P1|NOT COMPLETED|Overall Study||71
506716|NCT00228566|1218775|P1|COMPLETED|Overall Study||176
506717|NCT00228566|1218775|P1|STARTED|Overall Study||247
506718|NCT00228553|1218779|P1|NOT COMPLETED|Overall Study||430
506719|NCT00228553|1218779|P1|COMPLETED|Overall Study||313
506720|NCT00228553|1218779|P1|STARTED|Overall Study||743
506721|NCT00229203|1218785|P2|NOT COMPLETED|Overall Study||19
506722|NCT00229203|1218786|P1|NOT COMPLETED|Overall Study||32
506723|NCT00229203|1218785|P2|COMPLETED|Overall Study||0
506724|NCT00229203|1218786|P1|COMPLETED|Overall Study||0
506725|NCT00229203|1218785|P2|STARTED|Overall Study||19
506726|NCT00229203|1218786|P1|STARTED|Overall Study||32
506727|NCT00228943|1218798|P1|NOT COMPLETED|Week 2||1
506728|NCT00228943|1218798|P1|COMPLETED|Week 2||27
506729|NCT00228943|1218798|P1|STARTED|Week 2||28
506730|NCT00228943|1218798|P1|NOT COMPLETED|Week 1||0
506731|NCT00228943|1218798|P1|COMPLETED|Week 1||28
506732|NCT00228943|1218798|P1|STARTED|Week 1||28
506733|NCT00228917|1218810|P4|NOT COMPLETED|Overall Study||0
506734|NCT00228917|1218811|P3|NOT COMPLETED|Overall Study||0
506735|NCT00228917|1218812|P2|NOT COMPLETED|Overall Study||3
506736|NCT00228917|1218813|P1|NOT COMPLETED|Overall Study||1
506737|NCT00228917|1218810|P4|COMPLETED|Overall Study||107
506738|NCT00228917|1218811|P3|COMPLETED|Overall Study||213
506739|NCT00228917|1218812|P2|COMPLETED|Overall Study||320
506740|NCT00228917|1218813|P1|COMPLETED|Overall Study||646
506741|NCT00228917|1218810|P4|STARTED|Overall Study||107
506742|NCT00228917|1218811|P3|STARTED|Overall Study||213
506743|NCT00228917|1218812|P2|STARTED|Overall Study||323
506744|NCT00228917|1218813|P1|STARTED|Overall Study||647
506745|NCT00228384|1218841|P2|NOT COMPLETED|Overall Study||29
506746|NCT00228384|1218842|P1|NOT COMPLETED|Overall Study||29
506747|NCT00228384|1218841|P2|COMPLETED|Overall Study||47
506748|NCT00228384|1218842|P1|COMPLETED|Overall Study||43
506749|NCT00228384|1218841|P2|Three Year Follow-up (Final)|Overall Study||47
506750|NCT00228384|1218842|P1|Three Year Follow-up (Final)|Overall Study||43
506751|NCT00228384|1218841|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
506752|NCT00228384|1218842|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
506753|NCT00228384|1218841|P2|Baseline|Overall Study||76
506754|NCT00228384|1218842|P1|Baseline|Overall Study||72
506755|NCT00228384|1218841|P2|STARTED|Overall Study||76
506756|NCT00228384|1218842|P1|STARTED|Overall Study||72
506757|NCT00227994|1218882|P2|NOT COMPLETED|Overall Study||7
506758|NCT00227994|1218883|P1|NOT COMPLETED|Overall Study||7
506759|NCT00227994|1218882|P2|COMPLETED|Overall Study||13
506760|NCT00227994|1218883|P1|COMPLETED|Overall Study||13
506761|NCT00227994|1218882|P2|STARTED|Overall Study||20
506762|NCT00227994|1218883|P1|STARTED|Overall Study||20
506763|NCT00227903|1218893|P2|NOT COMPLETED|Overall Study||10
506764|NCT00227903|1218894|P1|NOT COMPLETED|Overall Study||5
506765|NCT00227903|1218893|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
506766|NCT00227903|1218894|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
506767|NCT00227903|1218893|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
506768|NCT00227903|1218894|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
506769|NCT00227903|1218893|P2|STARTED|Overall Study||92
506770|NCT00227903|1218894|P1|STARTED|Overall Study||91
506771|NCT00227760|1218954|P1|NOT COMPLETED|Overall Study||0
506772|NCT00227760|1218954|P1|COMPLETED|Overall Study||44
506773|NCT00227760|1218954|P1|STARTED|Overall Study||44
506774|NCT00227721|1218960|P1|NOT COMPLETED|Overall Study||1
506775|NCT00227721|1218960|P1|COMPLETED|Overall Study||29
506776|NCT00227721|1218960|P1|STARTED|Overall Study||30
506777|NCT00227591|1218964|P1|NOT COMPLETED|Overall Study||1
506778|NCT00227591|1218964|P1|COMPLETED|Overall Study||47
506779|NCT00227591|1218964|P1|Began Treatment|Overall Study||47
506780|NCT00227591|1218964|P1|STARTED|Overall Study|48 pts registered to the study|48
506781|NCT00227539|1218968|P1|NOT COMPLETED|Overall Study||1
506782|NCT00227539|1218968|P1|COMPLETED|Overall Study||24
506783|NCT00227539|1218968|P1|STARTED|Overall Study||25
506784|NCT00227370|1218976|P2|NOT COMPLETED|Overall Study||24
506785|NCT00227370|1218977|P1|NOT COMPLETED|Overall Study||21
506786|NCT00227370|1218976|P2|COMPLETED|Overall Study||46
506787|NCT00227370|1218977|P1|COMPLETED|Overall Study||45
506788|NCT00227370|1218976|P2|STARTED|Overall Study|Treatment Group|70
506789|NCT00227370|1218977|P1|STARTED|Overall Study|Placebo Group|66
506790|NCT00227344|1218997|P2|NOT COMPLETED|Overall Study||5
506791|NCT00227344|1218998|P1|NOT COMPLETED|Overall Study||12
506792|NCT00227344|1218997|P2|COMPLETED|Overall Study||37
506793|NCT00227344|1218998|P1|COMPLETED|Overall Study||75
506794|NCT00227344|1218997|P2|STARTED|Overall Study||42
506795|NCT00227344|1218998|P1|STARTED|Overall Study||87
506796|NCT00227305|1219018|P1|NOT COMPLETED|Overall Study||144
506797|NCT00227305|1219018|P1|COMPLETED|Overall Study|Completed 26 weeks|237
506798|NCT00227305|1219018|P1|Drug Received|Overall Study|safety population|380
506799|NCT00227305|1219018|P1|STARTED|Overall Study|enrolled|381
506800|NCT00227266|1219035|P3|NOT COMPLETED|Overall Study||4
506801|NCT00227266|1219036|P2|NOT COMPLETED|Overall Study||0
506802|NCT00227266|1219037|P1|NOT COMPLETED|Overall Study||1
506803|NCT00227266|1219035|P3|COMPLETED|Overall Study||29
506804|NCT00227266|1219036|P2|COMPLETED|Overall Study||30
506805|NCT00227266|1219037|P1|COMPLETED|Overall Study||30
506806|NCT00227266|1219035|P3|STARTED|Overall Study||33
506807|NCT00227266|1219036|P2|STARTED|Overall Study||30
506808|NCT00227266|1219037|P1|STARTED|Overall Study||31
506809|NCT00227019|1219057|P1|NOT COMPLETED|Overall Study||0
506810|NCT00227019|1219057|P1|COMPLETED|Overall Study||16
506811|NCT00227019|1219057|P1|STARTED|Overall Study||16
506812|NCT00226811|1219063|P1|NOT COMPLETED|Overall Study||76
506813|NCT00226811|1219063|P1|COMPLETED|Overall Study||2
506814|NCT00226811|1219063|P1|STARTED|Overall Study||78
506815|NCT00226655|1219073|P1|NOT COMPLETED|Overall Study||79
506816|NCT00226655|1219073|P1|COMPLETED|Overall Study||33
506817|NCT00226655|1219073|P1|STARTED|Overall Study||112
506818|NCT00226590|1219077|P1|NOT COMPLETED|Overall Study||0
506819|NCT00226590|1219077|P1|COMPLETED|Overall Study||39
506820|NCT00226590|1219077|P1|STARTED|Overall Study||39
506821|NCT00226577|1219084|P1|NOT COMPLETED|Overall Study||0
506822|NCT00226577|1219084|P1|COMPLETED|Overall Study||52
506823|NCT00226577|1219084|P1|STARTED|Overall Study||52
506824|NCT00225784|1219092|P1|NOT COMPLETED|Overall Study||4
506825|NCT00225784|1219092|P1|COMPLETED|Overall Study||33
506826|NCT00225784|1219092|P1|STARTED|Overall Study||37
506827|NCT00225732|1219105|P2|NOT COMPLETED|Overall Study||0
506828|NCT00225732|1219106|P1|NOT COMPLETED|Overall Study||0
506829|NCT00225732|1219105|P2|COMPLETED|Overall Study||166
506830|NCT00225732|1219106|P1|COMPLETED|Overall Study||153
506831|NCT00225732|1219105|P2|STARTED|Overall Study||166
506832|NCT00225732|1219106|P1|STARTED|Overall Study||153
506833|NCT00225498|1219112|P1|NOT COMPLETED|Overall Study||0
506834|NCT00225498|1219112|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
506835|NCT00225498|1219112|P1|STARTED|Overall Study||10
506836|NCT00225420|1219116|P3|NOT COMPLETED|Overall Study||0
506837|NCT00225420|1219117|P2|NOT COMPLETED|Overall Study||0
506838|NCT00225420|1219118|P1|NOT COMPLETED|Overall Study||0
506839|NCT00225420|1219116|P3|COMPLETED|Overall Study||3
506840|NCT00225420|1219117|P2|COMPLETED|Overall Study||6
506841|NCT00225420|1219118|P1|COMPLETED|Overall Study||9
506842|NCT00225420|1219116|P3|STARTED|Overall Study||3
506843|NCT00225420|1219117|P2|STARTED|Overall Study||6
506844|NCT00225420|1219118|P1|STARTED|Overall Study||9
506845|NCT00225277|1219127|P2|NOT COMPLETED|Overall Study||95
506846|NCT00225277|1219128|P1|NOT COMPLETED|Overall Study||97
506847|NCT00225277|1219127|P2|COMPLETED|Overall Study||178
506848|NCT00225277|1219128|P1|COMPLETED|Overall Study||177
506849|NCT00225277|1219127|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
506850|NCT00225277|1219128|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
506851|NCT00225251|1219146|P2|NOT COMPLETED|Overall Study||1
506852|NCT00225251|1219147|P1|NOT COMPLETED|Overall Study||1
506853|NCT00225251|1219146|P2|COMPLETED|Overall Study||6
506854|NCT00225251|1219147|P1|COMPLETED|Overall Study||10
506855|NCT00225251|1219146|P2|STARTED|Overall Study||7
506856|NCT00225251|1219147|P1|STARTED|Overall Study||11
506857|NCT00225212|1219161|P1|NOT COMPLETED|Overall Study||6
506858|NCT00225212|1219161|P1|COMPLETED|Overall Study||29
506859|NCT00225212|1219161|P1|STARTED|Overall Study||35
506860|NCT00225147|1219170|P4|NOT COMPLETED|Open-label Phase||10
506861|NCT00225147|1219171|P3|NOT COMPLETED|Open-label Phase||0
506862|NCT00225147|1219172|P2|NOT COMPLETED|Open-label Phase||0
506863|NCT00225147|1219173|P1|NOT COMPLETED|Open-label Phase||0
506864|NCT00225147|1219170|P4|COMPLETED|Open-label Phase||52
506865|NCT00225147|1219171|P3|COMPLETED|Open-label Phase||0
506866|NCT00225147|1219172|P2|COMPLETED|Open-label Phase||0
506867|NCT00225147|1219173|P1|COMPLETED|Open-label Phase||0
506868|NCT00225147|1219170|P4|STARTED|Open-label Phase||62
506869|NCT00225147|1219171|P3|STARTED|Open-label Phase||0
506870|NCT00225147|1219172|P2|STARTED|Open-label Phase||0
506871|NCT00225147|1219173|P1|STARTED|Open-label Phase||0
506872|NCT00225147|1219170|P4|NOT COMPLETED|Double-blind Phase||0
506873|NCT00225147|1219171|P3|NOT COMPLETED|Double-blind Phase||0
506874|NCT00225147|1219172|P2|NOT COMPLETED|Double-blind Phase||0
506875|NCT00225147|1219173|P1|NOT COMPLETED|Double-blind Phase||0
506876|NCT00225147|1219170|P4|COMPLETED|Double-blind Phase||0
506877|NCT00225147|1219171|P3|COMPLETED|Double-blind Phase||13
506878|NCT00225147|1219172|P2|COMPLETED|Double-blind Phase||12
506879|NCT00225147|1219173|P1|COMPLETED|Double-blind Phase||13
506880|NCT00225147|1219170|P4|STARTED|Double-blind Phase||0
506881|NCT00225147|1219171|P3|STARTED|Double-blind Phase||13
506882|NCT00225147|1219172|P2|STARTED|Double-blind Phase||12
506883|NCT00225147|1219173|P1|STARTED|Double-blind Phase||13
506884|NCT00225017|1219189|P2|NOT COMPLETED|Overall Study||1
506885|NCT00225017|1219190|P1|NOT COMPLETED|Overall Study||0
506886|NCT00225017|1219189|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
506887|NCT00225017|1219190|P1|COMPLETED|Overall Study||26
506888|NCT00225017|1219189|P2|STARTED|Overall Study||24
506889|NCT00225017|1219190|P1|STARTED|Overall Study||26
506890|NCT00224874|1219204|P4|NOT COMPLETED|Overall Study||0
506891|NCT00224874|1219205|P3|NOT COMPLETED|Overall Study||1
506892|NCT00224874|1219206|P2|NOT COMPLETED|Overall Study||0
506893|NCT00224874|1219207|P1|NOT COMPLETED|Overall Study||0
506894|NCT00224874|1219204|P4|COMPLETED|Overall Study||42
506895|NCT00224874|1219205|P3|COMPLETED|Overall Study||46
506896|NCT00224874|1219206|P2|COMPLETED|Overall Study||45
506897|NCT00224874|1219207|P1|COMPLETED|Overall Study||46
506898|NCT00224874|1219204|P4|STARTED|Overall Study||42
506899|NCT00224874|1219205|P3|STARTED|Overall Study||47
506900|NCT00224874|1219206|P2|STARTED|Overall Study||45
506901|NCT00224874|1219207|P1|STARTED|Overall Study||46
506902|NCT00224770|1219252|P3|NOT COMPLETED|Overall Study||0
506903|NCT00224770|1219253|P2|NOT COMPLETED|Overall Study||2
506904|NCT00224770|1219254|P1|NOT COMPLETED|Overall Study||4
506905|NCT00224770|1219252|P3|COMPLETED|Overall Study||14
506906|NCT00224770|1219253|P2|COMPLETED|Overall Study||52
506907|NCT00224770|1219254|P1|COMPLETED|Overall Study||38
506908|NCT00224770|1219252|P3|STARTED|Overall Study||14
506909|NCT00224770|1219253|P2|STARTED|Overall Study||54
506910|NCT00224770|1219254|P1|STARTED|Overall Study||42
506911|NCT00224484|1219289|P3|NOT COMPLETED|Overall Study||62
506912|NCT00224484|1219290|P2|NOT COMPLETED|Overall Study||65
506913|NCT00224484|1219291|P1|NOT COMPLETED|Overall Study||146
506914|NCT00224484|1219289|P3|COMPLETED|Overall Study||1425
506915|NCT00224484|1219290|P2|COMPLETED|Overall Study||1426
506916|NCT00224484|1219291|P1|COMPLETED|Overall Study||2831
506917|NCT00224484|1219289|P3|STARTED|Overall Study||1487
506918|NCT00224484|1219290|P2|STARTED|Overall Study||1491
506919|NCT00224484|1219291|P1|STARTED|Overall Study||2977
506920|NCT00224289|1219350|P1|NOT COMPLETED|Overall Study||0
506921|NCT00224289|1219350|P1|COMPLETED|Overall Study||17
506922|NCT00224289|1219350|P1|STARTED|Overall Study||17
506923|NCT00224133|1219355|P1|NOT COMPLETED|Overall Study||226
506924|NCT00224133|1219355|P1|COMPLETED|Overall Study||435
506925|NCT00224133|1219355|P1|STARTED|Overall Study||661
506926|NCT00224120|1219361|P2|NOT COMPLETED|Overall Study||24
506927|NCT00224120|1219362|P1|NOT COMPLETED|Overall Study||22
506928|NCT00224120|1219361|P2|COMPLETED|Overall Study||205
506929|NCT00224120|1219362|P1|COMPLETED|Overall Study||211
506930|NCT00224120|1219361|P2|STARTED|Overall Study||229
506931|NCT00224120|1219362|P1|STARTED|Overall Study||233
506932|NCT00224107|1219372|P2|NOT COMPLETED|Overall Study||14
506933|NCT00224107|1219373|P1|NOT COMPLETED|Overall Study||31
506934|NCT00224107|1219372|P2|COMPLETED|Overall Study||214
506935|NCT00224107|1219373|P1|COMPLETED|Overall Study||202
506936|NCT00224107|1219372|P2|STARTED|Overall Study||228
506937|NCT00224107|1219373|P1|STARTED|Overall Study||233
506938|NCT00224055|1219383|P2|NOT COMPLETED|Overall Study||14
506939|NCT00224055|1219384|P1|NOT COMPLETED|Overall Study||15
506940|NCT00224055|1219383|P2|COMPLETED|Overall Study||31
506941|NCT00224055|1219384|P1|COMPLETED|Overall Study||29
506942|NCT00224055|1219383|P2|STARTED|Overall Study||45
506943|NCT00224055|1219384|P1|STARTED|Overall Study||44
506944|NCT00224042|1219394|P2|NOT COMPLETED|Overall Study||6
506945|NCT00224042|1219395|P1|NOT COMPLETED|Overall Study||6
506946|NCT00224042|1219394|P2|COMPLETED|Overall Study||20
506947|NCT00224042|1219395|P1|COMPLETED|Overall Study||20
506948|NCT00224042|1219394|P2|STARTED|Overall Study||26
506949|NCT00224042|1219395|P1|STARTED|Overall Study||26
506950|NCT00224029|1219407|P1|NOT COMPLETED|Overall Study||6
506951|NCT00224029|1219407|P1|COMPLETED|Overall Study||18
506952|NCT00224029|1219407|P1|STARTED|Overall Study||24
506953|NCT00224016|1219413|P2|NOT COMPLETED|Follow-Up Period||0
506954|NCT00224016|1219414|P1|NOT COMPLETED|Follow-Up Period||0
506955|NCT00224016|1219413|P2|COMPLETED|Follow-Up Period||0
506956|NCT00224016|1219414|P1|COMPLETED|Follow-Up Period||35
506957|NCT00224016|1219413|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
506958|NCT00224016|1219414|P1|STARTED|Follow-Up Period||35
506959|NCT00224016|1219413|P2|NOT COMPLETED|Maintenance Period||1
506960|NCT00224016|1219414|P1|NOT COMPLETED|Maintenance Period||2
506961|NCT00224016|1219413|P2|COMPLETED|Maintenance Period||14
506962|NCT00224016|1219414|P1|COMPLETED|Maintenance Period||36
506963|NCT00224016|1219413|P2|STARTED|Maintenance Period||15
506964|NCT00224016|1219414|P1|STARTED|Maintenance Period||38
506965|NCT00224016|1219413|P2|NOT COMPLETED|Titration Period||1
506966|NCT00224016|1219414|P1|NOT COMPLETED|Titration Period||1
506967|NCT00224016|1219413|P2|COMPLETED|Titration Period||15
506968|NCT00224016|1219414|P1|COMPLETED|Titration Period||38
506969|NCT00224016|1219413|P2|STARTED|Titration Period||16
506970|NCT00224016|1219414|P1|STARTED|Titration Period||39
506971|NCT00224003|1219422|P1|NOT COMPLETED|Overall Study||7
506972|NCT00224003|1219422|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
506973|NCT00224003|1219422|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
506974|NCT00223977|1219429|P3|NOT COMPLETED|Overall Study||3
506975|NCT00223977|1219430|P2|NOT COMPLETED|Overall Study||11
506976|NCT00223977|1219431|P1|NOT COMPLETED|Overall Study||9
506977|NCT00223977|1219429|P3|COMPLETED|Overall Study||39
506978|NCT00223977|1219430|P2|COMPLETED|Overall Study||47
506979|NCT00223977|1219431|P1|COMPLETED|Overall Study||37
506980|NCT00223977|1219429|P3|STARTED|Overall Study||42
506981|NCT00223977|1219430|P2|STARTED|Overall Study||58
506982|NCT00223977|1219431|P1|STARTED|Overall Study||46
506983|NCT00223821|1219453|P2|NOT COMPLETED|Overall Study||10
506984|NCT00223821|1219454|P1|NOT COMPLETED|Overall Study||4
506985|NCT00223821|1219453|P2|COMPLETED|Overall Study||22
506986|NCT00223821|1219454|P1|COMPLETED|Overall Study||28
506987|NCT00223821|1219453|P2|Completed 6-month Follow-up|Overall Study||25
506988|NCT00223821|1219454|P1|Completed 6-month Follow-up|Overall Study||28
506989|NCT00223821|1219453|P2|Completed Post-treatment Assessment|Overall Study||27
506990|NCT00223821|1219454|P1|Completed Post-treatment Assessment|Overall Study||31
506991|NCT00223821|1219453|P2|Completed Therapy|Overall Study||28
506992|NCT00223821|1219454|P1|Completed Therapy|Overall Study||31
506993|NCT00223821|1219453|P2|STARTED|Overall Study||32
506994|NCT00223821|1219454|P1|STARTED|Overall Study||32
506995|NCT00223808|1219465|P3|NOT COMPLETED|Overall Study||5
506996|NCT00223808|1219466|P2|NOT COMPLETED|Overall Study||5
506997|NCT00223808|1219467|P1|NOT COMPLETED|Overall Study||3
506998|NCT00223808|1219465|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
506999|NCT00223808|1219466|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
507000|NCT00223808|1219467|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
507001|NCT00223808|1219465|P3|STARTED|Overall Study||23
507002|NCT00223808|1219466|P2|STARTED|Overall Study||22
507003|NCT00223808|1219467|P1|STARTED|Overall Study||22
507004|NCT00223795|1219484|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
507005|NCT00223795|1219485|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
507006|NCT00223795|1219484|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
507007|NCT00223795|1219485|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
507008|NCT00223795|1219484|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
507009|NCT00223795|1219485|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
507010|NCT00223795|1219484|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
507011|NCT00223795|1219485|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
507012|NCT00223795|1219484|P2|COMPLETED|First Intervention - Eight Weeks||18
507013|NCT00223795|1219485|P1|COMPLETED|First Intervention - Eight Weeks||19
507014|NCT00223795|1219484|P2|STARTED|First Intervention - Eight Weeks||27
507015|NCT00223795|1219485|P1|STARTED|First Intervention - Eight Weeks||26
507016|NCT00223704|1219495|P3|NOT COMPLETED|Overall Study||0
507017|NCT00223704|1219496|P2|NOT COMPLETED|Overall Study||0
507018|NCT00223704|1219497|P1|NOT COMPLETED|Overall Study||0
507019|NCT00223704|1219495|P3|COMPLETED|Overall Study||40
507020|NCT00223704|1219496|P2|COMPLETED|Overall Study||37
507021|NCT00223704|1219497|P1|COMPLETED|Overall Study||38
507022|NCT00223704|1219495|P3|STARTED|Overall Study||40
507023|NCT00223704|1219496|P2|STARTED|Overall Study||37
507024|NCT00223704|1219497|P1|STARTED|Overall Study||38
507025|NCT00223678|1219519|P2|NOT COMPLETED|Overall Study||0
507026|NCT00223678|1219520|P1|NOT COMPLETED|Overall Study||0
507027|NCT00223678|1219519|P2|COMPLETED|Overall Study||7
507028|NCT00223678|1219520|P1|COMPLETED|Overall Study||13
507029|NCT00223678|1219519|P2|STARTED|Overall Study||7
507030|NCT00223678|1219520|P1|STARTED|Overall Study||13
507031|NCT00223652|1219528|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
507032|NCT00223652|1219529|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
507033|NCT00223652|1219528|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
507034|NCT00223652|1219529|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
507035|NCT00223652|1219528|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
507036|NCT00223652|1219529|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
507037|NCT00223652|1219528|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
507038|NCT00223652|1219529|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
507039|NCT00223652|1219528|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
507040|NCT00223652|1219529|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
507041|NCT00223652|1219528|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
507042|NCT00223652|1219529|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
507043|NCT00223652|1219528|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
507044|NCT00223652|1219529|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
507045|NCT00223652|1219528|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
507046|NCT00223652|1219529|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
507047|NCT00223652|1219528|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
507048|NCT00223652|1219529|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
507049|NCT00223496|1219545|P1|NOT COMPLETED|Overall Study||22
507050|NCT00223496|1219545|P1|COMPLETED|Overall Study||10
507051|NCT00223496|1219545|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
507052|NCT00223236|1219551|P2|NOT COMPLETED|Overall Study||14
507053|NCT00223236|1219552|P1|NOT COMPLETED|Overall Study||7
507054|NCT00223236|1219551|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
507055|NCT00223236|1219552|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
507056|NCT00223236|1219551|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
507057|NCT00223236|1219552|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
507058|NCT00222729|1219564|P1|NOT COMPLETED|Overall Study||3
507059|NCT00222729|1219564|P1|COMPLETED|Overall Study||37
507060|NCT00222729|1219564|P1|STARTED|Overall Study||40
507061|NCT00222105|1219571|P1|NOT COMPLETED|Overall Study||14
507062|NCT00222105|1219571|P1|COMPLETED|Overall Study||11
507063|NCT00222105|1219571|P1|STARTED|Overall Study||25
507064|NCT00221299|1219579|P4|NOT COMPLETED|Overall Study||1
507065|NCT00221299|1219580|P3|NOT COMPLETED|Overall Study||0
507066|NCT00221299|1219581|P2|NOT COMPLETED|Overall Study||2
507067|NCT00221299|1219582|P1|NOT COMPLETED|Overall Study||1
507068|NCT00221299|1219579|P4|COMPLETED|Overall Study||10
507069|NCT00221299|1219580|P3|COMPLETED|Overall Study||14
507070|NCT00221299|1219581|P2|COMPLETED|Overall Study||11
507071|NCT00221299|1219582|P1|COMPLETED|Overall Study||10
507072|NCT00221299|1219579|P4|STARTED|Overall Study||11
507073|NCT00221299|1219580|P3|STARTED|Overall Study||14
507074|NCT00221299|1219581|P2|STARTED|Overall Study||13
507075|NCT00221299|1219582|P1|STARTED|Overall Study||11
507076|NCT00221195|1219592|P2|NOT COMPLETED|Overall Study||3
507077|NCT00221195|1219593|P1|NOT COMPLETED|Overall Study||5
507078|NCT00221195|1219592|P2|COMPLETED|Overall Study||14
507079|NCT00221195|1219593|P1|COMPLETED|Overall Study||12
507080|NCT00221195|1219592|P2|STARTED|Overall Study||17
507081|NCT00221195|1219593|P1|STARTED|Overall Study||17
507082|NCT00220961|1219602|P2|NOT COMPLETED|Overall Study||90
507083|NCT00220961|1219603|P1|NOT COMPLETED|Overall Study||71
507084|NCT00220961|1219602|P2|COMPLETED|Overall Study||213
507085|NCT00220961|1219603|P1|COMPLETED|Overall Study||228
507086|NCT00220961|1219602|P2|STARTED|Overall Study||303
507087|NCT00220961|1219603|P1|STARTED|Overall Study||299
507088|NCT00220805|1219619|P2|NOT COMPLETED|Overall Study||11
507089|NCT00220805|1219620|P1|NOT COMPLETED|Overall Study||8
507090|NCT00220805|1219619|P2|COMPLETED|Overall Study||16
507091|NCT00220805|1219620|P1|COMPLETED|Overall Study||22
507092|NCT00220805|1219619|P2|STARTED|Overall Study||27
507093|NCT00220805|1219620|P1|STARTED|Overall Study||30
507094|NCT00220779|1219641|P3|NOT COMPLETED|Overall Study||4
507095|NCT00220779|1219642|P2|NOT COMPLETED|Overall Study||4
507096|NCT00220779|1219643|P1|NOT COMPLETED|Overall Study||7
507097|NCT00220779|1219641|P3|COMPLETED|Overall Study||37
507098|NCT00220779|1219642|P2|COMPLETED|Overall Study||38
507099|NCT00220779|1219643|P1|COMPLETED|Overall Study||38
507100|NCT00220779|1219641|P3|STARTED|Overall Study||41
507101|NCT00220779|1219642|P2|STARTED|Overall Study||42
507102|NCT00220779|1219643|P1|STARTED|Overall Study||45
507103|NCT00220740|1219653|P2|NOT COMPLETED|Withdrawal Period||15
507104|NCT00220740|1219654|P1|NOT COMPLETED|Withdrawal Period||6
507105|NCT00220740|1219653|P2|COMPLETED|Withdrawal Period||16
507106|NCT00220740|1219654|P1|COMPLETED|Withdrawal Period||37
507107|NCT00220740|1219653|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
507108|NCT00220740|1219654|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
507109|NCT00220740|1219653|P2|NOT COMPLETED|Rescue Treatment||18
507110|NCT00220740|1219654|P1|NOT COMPLETED|Rescue Treatment||19
507111|NCT00220740|1219653|P2|COMPLETED|Rescue Treatment||5
507112|NCT00220740|1219654|P1|COMPLETED|Rescue Treatment||26
507113|NCT00220740|1219653|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
507114|NCT00220740|1219654|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
507115|NCT00220740|1219653|P2|NOT COMPLETED|Efficacy Period||46
507116|NCT00220740|1219654|P1|NOT COMPLETED|Efficacy Period||26
507117|NCT00220740|1219653|P2|COMPLETED|Efficacy Period||12
507118|NCT00220740|1219654|P1|COMPLETED|Efficacy Period||33
507119|NCT00220740|1219653|P2|STARTED|Efficacy Period||58
507120|NCT00220740|1219654|P1|STARTED|Efficacy Period||59
507121|NCT00220727|1219668|P2|NOT COMPLETED|Second Infusion (Week <6)||0
507122|NCT00220727|1219669|P1|NOT COMPLETED|Second Infusion (Week <6)||1
507123|NCT00220727|1219668|P2|COMPLETED|Second Infusion (Week <6)||4
507124|NCT00220727|1219669|P1|COMPLETED|Second Infusion (Week <6)||3
507125|NCT00220727|1219668|P2|STARTED|Second Infusion (Week <6)||4
507126|NCT00220727|1219669|P1|STARTED|Second Infusion (Week <6)||4
507127|NCT00220727|1219668|P2|NOT COMPLETED|First Infusion (Week 0)||0
507128|NCT00220727|1219669|P1|NOT COMPLETED|First Infusion (Week 0)||0
507129|NCT00220727|1219668|P2|COMPLETED|First Infusion (Week 0)||4
507130|NCT00220727|1219669|P1|COMPLETED|First Infusion (Week 0)||4
507131|NCT00220727|1219668|P2|STARTED|First Infusion (Week 0)||4
507132|NCT00220727|1219669|P1|STARTED|First Infusion (Week 0)||4
507133|NCT00220701|1219685|P2|NOT COMPLETED|Overall Study||4
507134|NCT00220701|1219686|P1|NOT COMPLETED|Overall Study||5
507135|NCT00220701|1219685|P2|COMPLETED|Overall Study||13
507136|NCT00220701|1219686|P1|COMPLETED|Overall Study||12
507137|NCT00220701|1219685|P2|STARTED|Overall Study||17
507138|NCT00220701|1219686|P1|STARTED|Overall Study||17
507139|NCT00220636|1219702|P1|NOT COMPLETED|Overall Study||4
507140|NCT00220636|1219702|P1|COMPLETED|Overall Study||11
507141|NCT00220636|1219702|P1|STARTED|Overall Study||15
507142|NCT00219557|1219712|P3|NOT COMPLETED|Phase 2||33
507143|NCT00219557|1219713|P2|NOT COMPLETED|Phase 2||69
507144|NCT00219557|1219714|P1|NOT COMPLETED|Phase 2||0
507145|NCT00219557|1219712|P3|COMPLETED|Phase 2||1
507146|NCT00219557|1219713|P2|COMPLETED|Phase 2||0
507147|NCT00219557|1219714|P1|COMPLETED|Phase 2||0
507148|NCT00219557|1219712|P3|Treated|Phase 2||31
507149|NCT00219557|1219713|P2|Treated|Phase 2||68
507150|NCT00219557|1219714|P1|Treated|Phase 2||0
507151|NCT00219557|1219712|P3|STARTED|Phase 2||34
507152|NCT00219557|1219713|P2|STARTED|Phase 2||69
507153|NCT00219557|1219714|P1|STARTED|Phase 2||0
507154|NCT00219557|1219712|P3|NOT COMPLETED|Phase 1||0
507155|NCT00219557|1219713|P2|NOT COMPLETED|Phase 1||0
507156|NCT00219557|1219714|P1|NOT COMPLETED|Phase 1||7
507157|NCT00219557|1219712|P3|COMPLETED|Phase 1||0
507158|NCT00219557|1219713|P2|COMPLETED|Phase 1||0
507159|NCT00219557|1219714|P1|COMPLETED|Phase 1||1
507160|NCT00219557|1219712|P3|STARTED|Phase 1||0
507161|NCT00219557|1219713|P2|STARTED|Phase 1||0
507162|NCT00219557|1219714|P1|STARTED|Phase 1||8
507163|NCT00219544|1219742|P2|NOT COMPLETED|Double Blind Treatment Period||0
507164|NCT00219544|1219743|P1|NOT COMPLETED|Double Blind Treatment Period||0
507165|NCT00219544|1219742|P2|COMPLETED|Double Blind Treatment Period||77
507166|NCT00219544|1219743|P1|COMPLETED|Double Blind Treatment Period||80
507167|NCT00219544|1219742|P2|STARTED|Double Blind Treatment Period||77
507168|NCT00219544|1219743|P1|STARTED|Double Blind Treatment Period||80
507169|NCT00219544|1219742|P2|NOT COMPLETED|Single Blind Treatment Period||0
507170|NCT00219544|1219743|P1|NOT COMPLETED|Single Blind Treatment Period||22
507171|NCT00219544|1219742|P2|COMPLETED|Single Blind Treatment Period||0
507172|NCT00219544|1219743|P1|COMPLETED|Single Blind Treatment Period||234
507173|NCT00219544|1219742|P2|STARTED|Single Blind Treatment Period||0
507174|NCT00219544|1219743|P1|STARTED|Single Blind Treatment Period||256
507175|NCT00219349|1219781|P1|NOT COMPLETED|Escitalopram Phase||11
507176|NCT00219349|1219781|P1|COMPLETED|Escitalopram Phase||4
507177|NCT00219349|1219781|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|15
507178|NCT00219349|1219781|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
507179|NCT00219349|1219781|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
507180|NCT00219349|1219781|P1|STARTED|Cognitive Behavioral Therapy Phase||25
507181|NCT00219284|1219787|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
507182|NCT00219284|1219788|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
507183|NCT00219284|1219787|P2|COMPLETED|Extension Phase - 8 Weeks||99
507184|NCT00219284|1219788|P1|COMPLETED|Extension Phase - 8 Weeks||112
507185|NCT00219284|1219787|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
507186|NCT00219284|1219788|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
507187|NCT00219284|1219787|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
507188|NCT00219284|1219788|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
507189|NCT00219284|1219787|P2|COMPLETED|Treatment Phase - 16 Weeks||128
507190|NCT00219284|1219788|P1|COMPLETED|Treatment Phase - 16 Weeks||136
507191|NCT00219284|1219787|P2|STARTED|Treatment Phase - 16 Weeks||179
507192|NCT00219284|1219788|P1|STARTED|Treatment Phase - 16 Weeks||180
507193|NCT00219141|1219813|P3|NOT COMPLETED|Overall Study||12
507194|NCT00219141|1219814|P2|NOT COMPLETED|Overall Study||21
507195|NCT00219141|1219815|P1|NOT COMPLETED|Overall Study||14
507196|NCT00219141|1219813|P3|COMPLETED|Overall Study||142
507197|NCT00219141|1219814|P2|COMPLETED|Overall Study||131
507198|NCT00219141|1219815|P1|COMPLETED|Overall Study||140
507199|NCT00219141|1219813|P3|STARTED|Overall Study||154
507200|NCT00219141|1219814|P2|STARTED|Overall Study||152
507201|NCT00219141|1219815|P1|STARTED|Overall Study||154
507202|NCT00218634|1219861|P2|NOT COMPLETED|Overall Study||15
507203|NCT00218634|1219862|P1|NOT COMPLETED|Overall Study||8
507204|NCT00218634|1219861|P2|COMPLETED|Overall Study||30
507205|NCT00218634|1219862|P1|COMPLETED|Overall Study||36
507206|NCT00218634|1219861|P2|STARTED|Overall Study||45
507207|NCT00218634|1219862|P1|STARTED|Overall Study||44
507208|NCT00218543|1219882|P1|NOT COMPLETED|Overall Study||15
507209|NCT00218543|1219882|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
507210|NCT00218543|1219882|P1|STARTED|Overall Study||20
507211|NCT00218465|1219889|P2|NOT COMPLETED|Overall Study||18
507212|NCT00218465|1219890|P1|NOT COMPLETED|Overall Study||17
507213|NCT00218465|1219889|P2|COMPLETED|Overall Study||30
507214|NCT00218465|1219890|P1|COMPLETED|Overall Study||33
507215|NCT00218465|1219889|P2|STARTED|Overall Study||48
507216|NCT00218465|1219890|P1|STARTED|Overall Study||50
507217|NCT00218439|1219902|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
507218|NCT00218439|1219903|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
507219|NCT00218439|1219902|P2|COMPLETED|Second Intervention (4 Weeks)||30
507220|NCT00218439|1219903|P1|COMPLETED|Second Intervention (4 Weeks)||33
507221|NCT00218439|1219902|P2|STARTED|Second Intervention (4 Weeks)||35
507222|NCT00218439|1219903|P1|STARTED|Second Intervention (4 Weeks)||40
507223|NCT00218439|1219902|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
507224|NCT00218439|1219903|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
507225|NCT00218439|1219902|P2|COMPLETED|First Intervention (4 Weeks)||35
507226|NCT00218439|1219903|P1|COMPLETED|First Intervention (4 Weeks)||40
507227|NCT00218439|1219902|P2|STARTED|First Intervention (4 Weeks)||47
507228|NCT00218439|1219903|P1|STARTED|First Intervention (4 Weeks)||58
507229|NCT00218335|1219921|P4|NOT COMPLETED|Overall Study||36
507230|NCT00218335|1219922|P3|NOT COMPLETED|Overall Study||54
507231|NCT00218335|1219923|P2|NOT COMPLETED|Overall Study||3
507232|NCT00218335|1219924|P1|NOT COMPLETED|Overall Study||6
507233|NCT00218335|1219921|P4|COMPLETED|Overall Study||388
507234|NCT00218335|1219922|P3|COMPLETED|Overall Study||319
507235|NCT00218335|1219923|P2|COMPLETED|Overall Study||110
507236|NCT00218335|1219924|P1|COMPLETED|Overall Study||108
507237|NCT00218335|1219921|P4|18 Month Follow-up|Overall Study||368
507238|NCT00218335|1219922|P3|18 Month Follow-up|Overall Study||296
507239|NCT00218335|1219923|P2|18 Month Follow-up|Overall Study||108
507240|NCT00218335|1219924|P1|18 Month Follow-up|Overall Study||101
507241|NCT00218335|1219921|P4|12 Month Follow-up|Overall Study||303
507242|NCT00218335|1219922|P3|12 Month Follow-up|Overall Study||244
507243|NCT00218335|1219923|P2|12 Month Follow-up|Overall Study||102
507244|NCT00218335|1219924|P1|12 Month Follow-up|Overall Study||95
507245|NCT00218335|1219921|P4|6 Month Follow-up|Overall Study||301
507246|NCT00218335|1219922|P3|6 Month Follow-up|Overall Study||219
507247|NCT00218335|1219923|P2|6 Month Follow-up|Overall Study||99
507248|NCT00218335|1219924|P1|6 Month Follow-up|Overall Study||103
507249|NCT00218335|1219921|P4|STARTED|Overall Study||424
507250|NCT00218335|1219922|P3|STARTED|Overall Study||373
507251|NCT00218335|1219923|P2|STARTED|Overall Study||113
507252|NCT00218335|1219924|P1|STARTED|Overall Study||114
507253|NCT00218296|1219988|P2|NOT COMPLETED|Overall Study||121
507254|NCT00218296|1219989|P1|NOT COMPLETED|Overall Study||111
507255|NCT00218296|1219988|P2|COMPLETED|Overall Study||48
507256|NCT00218296|1219989|P1|COMPLETED|Overall Study||52
507257|NCT00218296|1219988|P2|STARTED|Overall Study||169
507258|NCT00218296|1219989|P1|STARTED|Overall Study||163
507259|NCT00218023|1220009|P4|NOT COMPLETED|Overall Study||7
507260|NCT00218023|1220010|P3|NOT COMPLETED|Overall Study||10
507261|NCT00218023|1220011|P2|NOT COMPLETED|Overall Study||15
507262|NCT00218023|1220012|P1|NOT COMPLETED|Overall Study||13
507263|NCT00218023|1220009|P4|COMPLETED|Overall Study||11
507264|NCT00218023|1220010|P3|COMPLETED|Overall Study||6
507265|NCT00218023|1220011|P2|COMPLETED|Overall Study||10
507266|NCT00218023|1220012|P1|COMPLETED|Overall Study||9
507267|NCT00218023|1220009|P4|Received Drug or Placebo in Phase II|Overall Study||18
507268|NCT00218023|1220010|P3|Received Drug or Placebo in Phase II|Overall Study||15
507269|NCT00218023|1220011|P2|Received Drug or Placebo in Phase II|Overall Study||24
507270|NCT00218023|1220012|P1|Received Drug or Placebo in Phase II|Overall Study||18
507271|NCT00218023|1220009|P4|STARTED|Overall Study||18
507272|NCT00218023|1220010|P3|STARTED|Overall Study||16
507273|NCT00218023|1220011|P2|STARTED|Overall Study||25
507274|NCT00218023|1220012|P1|STARTED|Overall Study||22
507275|NCT00217971|1220028|P2|NOT COMPLETED|Overall Study||33
507276|NCT00217971|1220029|P1|NOT COMPLETED|Overall Study||24
507277|NCT00217971|1220028|P2|COMPLETED|Overall Study||44
507278|NCT00217971|1220029|P1|COMPLETED|Overall Study||55
507279|NCT00217971|1220028|P2|STARTED|Overall Study||77
507280|NCT00217971|1220029|P1|STARTED|Overall Study||79
507281|NCT00217724|1220035|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
507282|NCT00217724|1220036|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
507283|NCT00217724|1220035|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
507284|NCT00217724|1220036|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
507285|NCT00217724|1220035|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
507286|NCT00217724|1220036|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
507287|NCT00217724|1220035|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
507288|NCT00217724|1220036|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
507289|NCT00217724|1220035|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
507290|NCT00217724|1220036|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
507291|NCT00217724|1220035|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
507292|NCT00217724|1220036|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
507293|NCT00217672|1220044|P2|NOT COMPLETED|Follow-up||0
507294|NCT00217672|1220045|P1|NOT COMPLETED|Follow-up||5
507295|NCT00217672|1220044|P2|COMPLETED|Follow-up||0
507296|NCT00217672|1220045|P1|COMPLETED|Follow-up||69
507297|NCT00217672|1220044|P2|STARTED|Follow-up||0
507298|NCT00217672|1220045|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
507299|NCT00217672|1220044|P2|NOT COMPLETED|Treatment||7
507300|NCT00217672|1220045|P1|NOT COMPLETED|Treatment||67
507301|NCT00217672|1220044|P2|COMPLETED|Treatment||0
507302|NCT00217672|1220045|P1|COMPLETED|Treatment||0
507303|NCT00217672|1220044|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
507304|NCT00217672|1220045|P1|STARTED|Treatment||67
507305|NCT00217672|1220044|P2|NOT COMPLETED|Allocation||0
507306|NCT00217672|1220045|P1|NOT COMPLETED|Allocation||2
507307|NCT00217672|1220044|P2|COMPLETED|Allocation||7
507308|NCT00217672|1220045|P1|COMPLETED|Allocation||67
507309|NCT00217672|1220044|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
507310|NCT00217672|1220045|P1|STARTED|Allocation||69
507311|NCT00217620|1220051|P1|NOT COMPLETED|Overall Study||51
507312|NCT00217620|1220051|P1|COMPLETED|Overall Study||0
507313|NCT00217620|1220051|P1|Eligible and Began Protocol Therapy|Overall Study||37
507314|NCT00217620|1220051|P1|Eligible|Overall Study||38
507315|NCT00217620|1220051|P1|STARTED|Overall Study||51
507316|NCT00217581|1220062|P1|NOT COMPLETED|Overall Study||1
507317|NCT00217581|1220062|P1|COMPLETED|Overall Study||38
507318|NCT00217581|1220062|P1|STARTED|Overall Study||39
507319|NCT00217490|1220070|P4|NOT COMPLETED|Overall Study||23
507320|NCT00217490|1220071|P3|NOT COMPLETED|Overall Study||24
507321|NCT00217490|1220072|P2|NOT COMPLETED|Overall Study||25
507322|NCT00217490|1220073|P1|NOT COMPLETED|Overall Study||17
507323|NCT00217490|1220070|P4|COMPLETED|Overall Study||130
507324|NCT00217490|1220071|P3|COMPLETED|Overall Study||131
507325|NCT00217490|1220072|P2|COMPLETED|Overall Study||128
507326|NCT00217490|1220073|P1|COMPLETED|Overall Study||137
507327|NCT00217490|1220070|P4|STARTED|Overall Study||153
507328|NCT00217490|1220071|P3|STARTED|Overall Study||155
507329|NCT00217490|1220072|P2|STARTED|Overall Study||153
507330|NCT00217490|1220073|P1|STARTED|Overall Study||154
507331|NCT00217464|1220087|P1|NOT COMPLETED|Overall Study||17
507332|NCT00217464|1220087|P1|COMPLETED|Overall Study||0
507333|NCT00217464|1220087|P1|STARTED|Overall Study||17
507334|NCT00217438|1220094|P2|NOT COMPLETED|Overall Study||1
507335|NCT00217438|1220095|P1|NOT COMPLETED|Overall Study||0
507336|NCT00217438|1220094|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
507337|NCT00217438|1220095|P1|COMPLETED|Overall Study||66
507338|NCT00217438|1220094|P2|STARTED|Overall Study||64
507339|NCT00217438|1220095|P1|STARTED|Overall Study||66
507340|NCT00217425|1220103|P1|NOT COMPLETED|Overall Study||37
507341|NCT00217425|1220103|P1|COMPLETED|Overall Study||9
507342|NCT00217425|1220103|P1|Eligible and Treated|Overall Study||39
507343|NCT00217425|1220103|P1|Treated|Overall Study||44
507344|NCT00217425|1220103|P1|STARTED|Overall Study||46
507345|NCT00217399|1220109|P1|NOT COMPLETED|Overall Study||0
507346|NCT00217399|1220109|P1|COMPLETED|Overall Study||35
507347|NCT00217399|1220109|P1|STARTED|Overall Study||35
507348|NCT00217087|1220117|P2|NOT COMPLETED|Overall Study||20
507349|NCT00217087|1220118|P1|NOT COMPLETED|Overall Study||11
507350|NCT00217087|1220117|P2|COMPLETED|Overall Study||17
507351|NCT00217087|1220118|P1|COMPLETED|Overall Study||25
507352|NCT00217087|1220117|P2|STARTED|Overall Study||37
507353|NCT00217087|1220118|P1|STARTED|Overall Study||36
507354|NCT00216099|1220130|P1|NOT COMPLETED|Overall Study||1
507355|NCT00216099|1220130|P1|COMPLETED|Overall Study||48
507356|NCT00216099|1220130|P1|Response Analysis|Overall Study||48
507357|NCT00216099|1220130|P1|Toxicity Analysis|Overall Study||49
507358|NCT00216099|1220130|P1|STARTED|Overall Study||49
507359|NCT00216086|1220141|P1|NOT COMPLETED|Overall Study||4
507360|NCT00216086|1220141|P1|COMPLETED|Overall Study||18
507361|NCT00216086|1220141|P1|STARTED|Overall Study||22
507362|NCT00216060|1220150|P2|NOT COMPLETED|Overall Study||0
507363|NCT00216060|1220151|P1|NOT COMPLETED|Overall Study||0
507364|NCT00216060|1220150|P2|COMPLETED|Overall Study||31
507365|NCT00216060|1220151|P1|COMPLETED|Overall Study||32
507366|NCT00216060|1220150|P2|STARTED|Overall Study||31
507367|NCT00216060|1220151|P1|STARTED|Overall Study||32
507368|NCT00215943|1220173|P2|NOT COMPLETED|Overall Study||14
507369|NCT00215943|1220174|P1|NOT COMPLETED|Overall Study||9
507370|NCT00215943|1220173|P2|COMPLETED|Overall Study||23
507371|NCT00215943|1220174|P1|COMPLETED|Overall Study||27
507372|NCT00215943|1220173|P2|STARTED|Overall Study||37
507373|NCT00215943|1220174|P1|STARTED|Overall Study||36
507374|NCT00215930|1220186|P1|NOT COMPLETED|Overall Study||0
507375|NCT00215930|1220186|P1|COMPLETED|Overall Study||53
507376|NCT00215930|1220186|P1|STARTED|Overall Study||53
507377|NCT00217022|1220194|P2|NOT COMPLETED|Overall Study||1
507378|NCT00217022|1220195|P1|NOT COMPLETED|Overall Study||1
507379|NCT00217022|1220194|P2|COMPLETED|Overall Study||3
507380|NCT00217022|1220195|P1|COMPLETED|Overall Study||11
507381|NCT00217022|1220194|P2|STARTED|Overall Study||4
507382|NCT00217022|1220195|P1|STARTED|Overall Study||12
507383|NCT00216736|1220205|P2|NOT COMPLETED|Overall Study||1
507384|NCT00216736|1220206|P1|NOT COMPLETED|Overall Study||1
507385|NCT00216736|1220205|P2|COMPLETED|Overall Study||30
507386|NCT00216736|1220206|P1|COMPLETED|Overall Study||31
507387|NCT00216736|1220205|P2|STARTED|Overall Study||31
507388|NCT00216736|1220206|P1|STARTED|Overall Study||32
507389|NCT00216671|1220220|P2|NOT COMPLETED|Overall Study||50
507390|NCT00216671|1220221|P1|NOT COMPLETED|Overall Study||35
507391|NCT00216671|1220220|P2|COMPLETED|Overall Study||60
507392|NCT00216671|1220221|P1|COMPLETED|Overall Study||75
507393|NCT00216671|1220220|P2|STARTED|Overall Study||110
507394|NCT00216671|1220221|P1|STARTED|Overall Study||110
507395|NCT00216476|1220239|P3|NOT COMPLETED|Overall Study||17
507396|NCT00216476|1220240|P2|NOT COMPLETED|Overall Study||107
507397|NCT00216476|1220241|P1|NOT COMPLETED|Overall Study||105
507398|NCT00216476|1220239|P3|COMPLETED|Overall Study||28
507399|NCT00216476|1220240|P2|COMPLETED|Overall Study||230
507400|NCT00216476|1220241|P1|COMPLETED|Overall Study||224
507401|NCT00216476|1220239|P3|STARTED|Overall Study||45
507402|NCT00216476|1220240|P2|STARTED|Overall Study||337
507403|NCT00216476|1220241|P1|STARTED|Overall Study||329
507404|NCT00216320|1220261|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
507405|NCT00216320|1220262|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
507406|NCT00216320|1220263|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
507407|NCT00216320|1220261|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
507408|NCT00216320|1220262|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
507409|NCT00216320|1220263|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
507410|NCT00216320|1220261|P3|STARTED|Phase 2 (Weeks 6 -12)||25
507411|NCT00216320|1220262|P2|STARTED|Phase 2 (Weeks 6 -12)||35
507412|NCT00216320|1220263|P1|STARTED|Phase 2 (Weeks 6 -12)||43
507413|NCT00216320|1220261|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
507414|NCT00216320|1220262|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
507415|NCT00216320|1220263|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
507416|NCT00216320|1220261|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
507417|NCT00216320|1220262|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
507418|NCT00216320|1220263|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
507419|NCT00216320|1220261|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
507420|NCT00216320|1220262|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
507421|NCT00216320|1220263|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
507422|NCT00216203|1220278|P1|NOT COMPLETED|Overall Study||2
507423|NCT00216203|1220278|P1|COMPLETED|Overall Study||34
507424|NCT00216203|1220278|P1|STARTED|Overall Study||36
507425|NCT00216125|1220286|P3|NOT COMPLETED|Randomization Phase||8
507426|NCT00216125|1220287|P2|NOT COMPLETED|Randomization Phase||11
507427|NCT00216125|1220288|P1|NOT COMPLETED|Randomization Phase||0
507428|NCT00216125|1220286|P3|COMPLETED|Randomization Phase||74
507429|NCT00216125|1220287|P2|COMPLETED|Randomization Phase||73
507430|NCT00216125|1220288|P1|COMPLETED|Randomization Phase||0
507431|NCT00216125|1220286|P3|DSMB Cohort for Futility|Randomization Phase||74
507432|NCT00216125|1220287|P2|DSMB Cohort for Futility|Randomization Phase||73
507433|NCT00216125|1220288|P1|DSMB Cohort for Futility|Randomization Phase||0
507434|NCT00216125|1220286|P3|STARTED|Randomization Phase||82
507435|NCT00216125|1220287|P2|STARTED|Randomization Phase||84
507436|NCT00216125|1220288|P1|STARTED|Randomization Phase||0
507437|NCT00216125|1220286|P3|NOT COMPLETED|Pre-Randomization Phase||0
507438|NCT00216125|1220287|P2|NOT COMPLETED|Pre-Randomization Phase||0
507439|NCT00216125|1220288|P1|NOT COMPLETED|Pre-Randomization Phase||77
507440|NCT00216125|1220286|P3|COMPLETED|Pre-Randomization Phase||0
507441|NCT00216125|1220287|P2|COMPLETED|Pre-Randomization Phase||0
507442|NCT00216125|1220288|P1|COMPLETED|Pre-Randomization Phase||166
507443|NCT00216125|1220286|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
507444|NCT00216125|1220287|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
507445|NCT00216125|1220288|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
507446|NCT00216125|1220286|P3|STARTED|Pre-Randomization Phase||0
507447|NCT00216125|1220287|P2|STARTED|Pre-Randomization Phase||0
507448|NCT00216125|1220288|P1|STARTED|Pre-Randomization Phase||243
507449|NCT00215787|1220297|P1|NOT COMPLETED|Overall Study||0
507450|NCT00215787|1220297|P1|COMPLETED|Overall Study||20
507451|NCT00215787|1220297|P1|STARTED|Overall Study||20
507452|NCT00215683|1220304|P3|NOT COMPLETED|Overall Study||32
507453|NCT00215683|1220305|P2|NOT COMPLETED|Overall Study||26
507454|NCT00215683|1220306|P1|NOT COMPLETED|Overall Study||29
507455|NCT00215683|1220304|P3|COMPLETED|Overall Study||12
507456|NCT00215683|1220305|P2|COMPLETED|Overall Study||22
507457|NCT00215683|1220306|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
507458|NCT00215683|1220304|P3|Switched to 160 mg|Overall Study||36
507459|NCT00215683|1220305|P2|Switched to 160 mg|Overall Study||41
507460|NCT00215683|1220306|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
507461|NCT00215683|1220304|P3|STARTED|Overall Study||44
507462|NCT00215683|1220305|P2|STARTED|Overall Study||48
507463|NCT00215683|1220306|P1|STARTED|Overall Study|Safety analysis set|45
507464|NCT00215657|1220325|P8|NOT COMPLETED|Overall Study||16
507465|NCT00215657|1220326|P7|NOT COMPLETED|Overall Study||23
507466|NCT00215657|1220327|P6|NOT COMPLETED|Overall Study||20
507467|NCT00215657|1220328|P5|NOT COMPLETED|Overall Study||23
507468|NCT00215657|1220329|P4|NOT COMPLETED|Overall Study||18
507469|NCT00215657|1220330|P3|NOT COMPLETED|Overall Study||11
507470|NCT00215657|1220331|P2|NOT COMPLETED|Overall Study||11
507471|NCT00215657|1220332|P1|NOT COMPLETED|Overall Study||22
507472|NCT00215657|1220325|P8|COMPLETED|Overall Study||11
507473|NCT00215657|1220326|P7|COMPLETED|Overall Study||4
507474|NCT00215657|1220327|P6|COMPLETED|Overall Study||4
507475|NCT00215657|1220328|P5|COMPLETED|Overall Study||4
507476|NCT00215657|1220329|P4|COMPLETED|Overall Study||6
507477|NCT00215657|1220330|P3|COMPLETED|Overall Study||2
507478|NCT00215657|1220331|P2|COMPLETED|Overall Study||1
507479|NCT00215657|1220332|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
507480|NCT00215657|1220325|P8|Started FE200486 CS07A|Overall Study||23
507481|NCT00215657|1220326|P7|Started FE200486 CS07A|Overall Study||14
507482|NCT00215657|1220327|P6|Started FE200486 CS07A|Overall Study||20
507483|NCT00215657|1220328|P5|Started FE200486 CS07A|Overall Study||17
507484|NCT00215657|1220329|P4|Started FE200486 CS07A|Overall Study||24
507485|NCT00215657|1220330|P3|Started FE200486 CS07A|Overall Study||7
507486|NCT00215657|1220331|P2|Started FE200486 CS07A|Overall Study||6
507487|NCT00215657|1220332|P1|Started FE200486 CS07A|Overall Study||20
507488|NCT00215657|1220325|P8|Intention-to-treat Population|Overall Study||27
507489|NCT00215657|1220326|P7|Intention-to-treat Population|Overall Study||24
507490|NCT00215657|1220327|P6|Intention-to-treat Population|Overall Study||24
507491|NCT00215657|1220328|P5|Intention-to-treat Population|Overall Study||24
507492|NCT00215657|1220329|P4|Intention-to-treat Population|Overall Study||24
507493|NCT00215657|1220330|P3|Intention-to-treat Population|Overall Study||12
507494|NCT00215657|1220331|P2|Intention-to-treat Population|Overall Study||12
507495|NCT00215657|1220332|P1|Intention-to-treat Population|Overall Study||25
507496|NCT00215657|1220325|P8|STARTED|Overall Study||27
507497|NCT00215657|1220326|P7|STARTED|Overall Study||27
507498|NCT00215657|1220327|P6|STARTED|Overall Study||24
507499|NCT00215657|1220328|P5|STARTED|Overall Study||27
507500|NCT00215657|1220329|P4|STARTED|Overall Study||24
507501|NCT00215657|1220330|P3|STARTED|Overall Study||13
507502|NCT00215657|1220331|P2|STARTED|Overall Study||12
507503|NCT00215657|1220332|P1|STARTED|Overall Study||26
507504|NCT00215553|1220365|P7|NOT COMPLETED|Overall Study||0
507505|NCT00215553|1220366|P6|NOT COMPLETED|Overall Study||6
507506|NCT00215553|1220367|P5|NOT COMPLETED|Overall Study||2
507507|NCT00215553|1220368|P4|NOT COMPLETED|Overall Study||1
507508|NCT00215553|1220369|P3|NOT COMPLETED|Overall Study||2
507509|NCT00215553|1220370|P2|NOT COMPLETED|Overall Study||1
507510|NCT00215553|1220371|P1|NOT COMPLETED|Overall Study||0
507511|NCT00215553|1220365|P7|COMPLETED|Overall Study||36
507512|NCT00215553|1220366|P6|COMPLETED|Overall Study|6 Subjects discontinued due to AE|32
507513|NCT00215553|1220367|P5|COMPLETED|Overall Study|2 Subjects discontinued due to AE|26
507514|NCT00215553|1220368|P4|COMPLETED|Overall Study|1 Subject discontinued due to AE|4
507515|NCT00215553|1220369|P3|COMPLETED|Overall Study|2 Subjects discontinued due to AE|4
507516|NCT00215553|1220370|P2|COMPLETED|Overall Study|1 Subject discontinued due to AE|5
507517|NCT00215553|1220371|P1|COMPLETED|Overall Study||5
507518|NCT00215553|1220365|P7|STARTED|Overall Study||36
507519|NCT00215553|1220366|P6|STARTED|Overall Study||38
507520|NCT00215553|1220367|P5|STARTED|Overall Study||28
507521|NCT00215553|1220368|P4|STARTED|Overall Study||5
507522|NCT00215553|1220369|P3|STARTED|Overall Study||6
507523|NCT00215553|1220370|P2|STARTED|Overall Study||6
507524|NCT00215553|1220371|P1|STARTED|Overall Study||5
507525|NCT00215540|1220404|P3|NOT COMPLETED|Overall Study||0
507526|NCT00215540|1220405|P2|NOT COMPLETED|Overall Study||0
507527|NCT00215540|1220406|P1|NOT COMPLETED|Overall Study||1
507528|NCT00215540|1220404|P3|COMPLETED|Overall Study||44
507529|NCT00215540|1220405|P2|COMPLETED|Overall Study||47
507530|NCT00215540|1220406|P1|COMPLETED|Overall Study||44
507531|NCT00215540|1220404|P3|STARTED|Overall Study||44
507532|NCT00215540|1220405|P2|STARTED|Overall Study||47
507533|NCT00215540|1220406|P1|STARTED|Overall Study||45
507534|NCT00215150|1220441|P1|NOT COMPLETED|Randomization Phase Placebo||1
507535|NCT00215150|1220441|P1|COMPLETED|Randomization Phase Placebo||10
507536|NCT00215150|1220441|P1|STARTED|Randomization Phase Placebo||11
507537|NCT00215150|1220441|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
507538|NCT00215150|1220441|P1|COMPLETED|Randomization Phase Ziprasidone||7
507539|NCT00215150|1220441|P1|STARTED|Randomization Phase Ziprasidone||10
507540|NCT00215150|1220441|P1|NOT COMPLETED|Open Label Phase||30
507541|NCT00215150|1220441|P1|COMPLETED|Open Label Phase||21
507542|NCT00215150|1220441|P1|STARTED|Open Label Phase|Number of subjects consented|51
507543|NCT00215137|1220449|P3|NOT COMPLETED|Randomization Period||0
507544|NCT00215137|1220450|P2|NOT COMPLETED|Randomization Period||2
507545|NCT00215137|1220451|P1|NOT COMPLETED|Randomization Period||0
507546|NCT00215137|1220449|P3|COMPLETED|Randomization Period||5
507547|NCT00215137|1220450|P2|COMPLETED|Randomization Period||5
507548|NCT00215137|1220451|P1|COMPLETED|Randomization Period||0
507549|NCT00215137|1220449|P3|STARTED|Randomization Period||5
507550|NCT00215137|1220450|P2|STARTED|Randomization Period||7
507551|NCT00215137|1220451|P1|STARTED|Randomization Period||0
507552|NCT00215137|1220449|P3|NOT COMPLETED|Open Label Escitalopram||0
507553|NCT00215137|1220450|P2|NOT COMPLETED|Open Label Escitalopram||0
507554|NCT00215137|1220451|P1|NOT COMPLETED|Open Label Escitalopram||1
507555|NCT00215137|1220449|P3|COMPLETED|Open Label Escitalopram||0
507556|NCT00215137|1220450|P2|COMPLETED|Open Label Escitalopram||0
507557|NCT00215137|1220451|P1|COMPLETED|Open Label Escitalopram||13
507558|NCT00215137|1220449|P3|STARTED|Open Label Escitalopram||0
507559|NCT00215137|1220450|P2|STARTED|Open Label Escitalopram||0
507560|NCT00215137|1220451|P1|STARTED|Open Label Escitalopram||14
507561|NCT00214903|1220463|P4|NOT COMPLETED|Overall Study||0
507562|NCT00214903|1220464|P3|NOT COMPLETED|Overall Study||0
507563|NCT00214903|1220465|P2|NOT COMPLETED|Overall Study||0
507564|NCT00214903|1220466|P1|NOT COMPLETED|Overall Study||0
507565|NCT00214903|1220463|P4|COMPLETED|Overall Study||3057
507566|NCT00214903|1220464|P3|COMPLETED|Overall Study||4113
507567|NCT00214903|1220465|P2|COMPLETED|Overall Study||13384
507568|NCT00214903|1220466|P1|COMPLETED|Overall Study||10043
507569|NCT00214903|1220463|P4|STARTED|Overall Study||3057
507570|NCT00214903|1220464|P3|STARTED|Overall Study||4113
507571|NCT00214903|1220465|P2|STARTED|Overall Study||13384
507572|NCT00214903|1220466|P1|STARTED|Overall Study||10043
507573|NCT00214786|1220480|P1|NOT COMPLETED|Overall Study||3
507574|NCT00214786|1220480|P1|COMPLETED|Overall Study||1
507575|NCT00214786|1220480|P1|STARTED|Overall Study||4
507576|NCT00214539|1220495|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
507577|NCT00214539|1220496|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
507578|NCT00214539|1220495|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
507579|NCT00214539|1220496|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
507580|NCT00214539|1220495|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
507581|NCT00214539|1220496|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
507582|NCT00214539|1220495|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
507583|NCT00214539|1220496|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
507584|NCT00214539|1220495|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
507585|NCT00214539|1220496|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
507586|NCT00214539|1220495|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
507587|NCT00214539|1220496|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
507588|NCT00214539|1220495|P2|NOT COMPLETED|Treatment Period||0
507589|NCT00214539|1220496|P1|NOT COMPLETED|Treatment Period||0
507590|NCT00214539|1220495|P2|COMPLETED|Treatment Period||17
507591|NCT00214539|1220496|P1|COMPLETED|Treatment Period||15
507592|NCT00214539|1220495|P2|STARTED|Treatment Period||17
507593|NCT00214539|1220496|P1|STARTED|Treatment Period||15
507594|NCT00214539|1220495|P2|NOT COMPLETED|Randomized||0
507595|NCT00214539|1220496|P1|NOT COMPLETED|Randomized||2
507596|NCT00214539|1220495|P2|COMPLETED|Randomized||17
507597|NCT00214539|1220496|P1|COMPLETED|Randomized||15
507598|NCT00214539|1220495|P2|STARTED|Randomized||17
507599|NCT00214539|1220496|P1|STARTED|Randomized||17
507600|NCT00214526|1220522|P2|NOT COMPLETED|Post-Treatment Period||0
507601|NCT00214526|1220523|P1|NOT COMPLETED|Post-Treatment Period||1
507602|NCT00214526|1220522|P2|COMPLETED|Post-Treatment Period||49
507603|NCT00214526|1220523|P1|COMPLETED|Post-Treatment Period||52
507604|NCT00214526|1220522|P2|STARTED|Post-Treatment Period||49
507605|NCT00214526|1220523|P1|STARTED|Post-Treatment Period||53
507606|NCT00214526|1220522|P2|NOT COMPLETED|Treatment Period||5
507607|NCT00214526|1220523|P1|NOT COMPLETED|Treatment Period||2
507608|NCT00214526|1220522|P2|COMPLETED|Treatment Period||49
507609|NCT00214526|1220523|P1|COMPLETED|Treatment Period||53
507610|NCT00214526|1220522|P2|STARTED|Treatment Period||54
507611|NCT00214526|1220523|P1|STARTED|Treatment Period||55
507612|NCT00214526|1220522|P2|NOT COMPLETED|Randomized||2
507613|NCT00214526|1220523|P1|NOT COMPLETED|Randomized||1
507614|NCT00214526|1220522|P2|COMPLETED|Randomized||54
507615|NCT00214526|1220523|P1|COMPLETED|Randomized||55
507616|NCT00214526|1220522|P2|STARTED|Randomized||56
507617|NCT00214526|1220523|P1|STARTED|Randomized||56
507618|NCT00214487|1220551|P2|NOT COMPLETED|Overall Study||3
507619|NCT00214487|1220552|P1|NOT COMPLETED|Overall Study||5
507620|NCT00214487|1220551|P2|COMPLETED|Overall Study||40
507621|NCT00214487|1220552|P1|COMPLETED|Overall Study||38
507622|NCT00214487|1220551|P2|STARTED|Overall Study||43
507623|NCT00214487|1220552|P1|STARTED|Overall Study||43
507624|NCT00214461|1220562|P4|NOT COMPLETED|Overall Study||1
507625|NCT00214461|1220563|P3|NOT COMPLETED|Overall Study||2
507626|NCT00214461|1220564|P2|NOT COMPLETED|Overall Study||0
507627|NCT00214461|1220565|P1|NOT COMPLETED|Overall Study||0
507628|NCT00214461|1220562|P4|COMPLETED|Overall Study||11
507629|NCT00214461|1220563|P3|COMPLETED|Overall Study||10
507630|NCT00214461|1220564|P2|COMPLETED|Overall Study||12
507631|NCT00214461|1220565|P1|COMPLETED|Overall Study||12
507632|NCT00214461|1220562|P4|STARTED|Overall Study||12
507633|NCT00214461|1220563|P3|STARTED|Overall Study||12
507634|NCT00214461|1220564|P2|STARTED|Overall Study||12
507635|NCT00214461|1220565|P1|STARTED|Overall Study||12
507636|NCT00214383|1220581|P2|NOT COMPLETED|Overall Study||26
507637|NCT00214383|1220582|P1|NOT COMPLETED|Overall Study||16
507638|NCT00214383|1220581|P2|COMPLETED|Overall Study||127
507639|NCT00214383|1220582|P1|COMPLETED|Overall Study||132
507640|NCT00214383|1220581|P2|STARTED|Overall Study||153
507641|NCT00214383|1220582|P1|STARTED|Overall Study||148
507642|NCT00214201|1220594|P2|NOT COMPLETED|Overall Study||2
507643|NCT00214201|1220595|P1|NOT COMPLETED|Overall Study||2
507644|NCT00214201|1220594|P2|COMPLETED|Overall Study||18
507645|NCT00214201|1220595|P1|COMPLETED|Overall Study||18
507646|NCT00214201|1220594|P2|STARTED|Overall Study||20
507647|NCT00214201|1220595|P1|STARTED|Overall Study||20
507648|NCT00214019|1220605|P1|NOT COMPLETED|Overall Study||30
507649|NCT00214019|1220605|P1|COMPLETED|Overall Study||6
507650|NCT00214019|1220605|P1|Fluticasone/Salmeterol Arm|Overall Study||6
507651|NCT00214019|1220605|P1|Fluticasone/Placebo Arm|Overall Study||6
507652|NCT00214019|1220605|P1|Placebo/Salmeterol Arm|Overall Study||6
507653|NCT00214019|1220605|P1|Placebo/Placebo Arm|Overall Study||6
507654|NCT00214019|1220605|P1|STARTED|Overall Study||36
507655|NCT00213135|1220615|P3|NOT COMPLETED|Overall Study||57
507656|NCT00213135|1220616|P2|NOT COMPLETED|Overall Study||35
507657|NCT00213135|1220617|P1|NOT COMPLETED|Overall Study||50
507658|NCT00213135|1220615|P3|COMPLETED|Overall Study||380
507659|NCT00213135|1220616|P2|COMPLETED|Overall Study||398
507660|NCT00213135|1220617|P1|COMPLETED|Overall Study||406
507661|NCT00213135|1220615|P3|STARTED|Overall Study||437
507662|NCT00213135|1220616|P2|STARTED|Overall Study||433
507663|NCT00213135|1220617|P1|STARTED|Overall Study||456
507664|NCT00210639|1220636|P2|NOT COMPLETED|Overall Study||42
507665|NCT00210639|1220637|P1|NOT COMPLETED|Overall Study||63
507666|NCT00210639|1220636|P2|COMPLETED|Overall Study||41
507667|NCT00210639|1220637|P1|COMPLETED|Overall Study||61
507668|NCT00210639|1220636|P2|STARTED|Overall Study||83
507669|NCT00210639|1220637|P1|STARTED|Overall Study||124
507670|NCT00210626|1220645|P2|NOT COMPLETED|Overall Study||45
507671|NCT00210626|1220646|P1|NOT COMPLETED|Overall Study||48
507672|NCT00210626|1220645|P2|COMPLETED|Overall Study||50
507673|NCT00210626|1220646|P1|COMPLETED|Overall Study||49
507674|NCT00210626|1220645|P2|STARTED|Overall Study||95
507675|NCT00210626|1220646|P1|STARTED|Overall Study||97
507676|NCT00212758|1220654|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
507677|NCT00212758|1220655|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
507678|NCT00212758|1220654|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
507679|NCT00212758|1220655|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
507680|NCT00212758|1220654|P2|STARTED|Standard Therapy of GH (12 Months)||9
507681|NCT00212758|1220655|P1|STARTED|Standard Therapy of GH (12 Months)||8
507682|NCT00212758|1220654|P2|NOT COMPLETED|Second Intervention (7 Days)||0
507683|NCT00212758|1220655|P1|NOT COMPLETED|Second Intervention (7 Days)||0
507684|NCT00212758|1220654|P2|COMPLETED|Second Intervention (7 Days)||9
507685|NCT00212758|1220655|P1|COMPLETED|Second Intervention (7 Days)||8
507686|NCT00212758|1220654|P2|STARTED|Second Intervention (7 Days)||9
507687|NCT00212758|1220655|P1|STARTED|Second Intervention (7 Days)||8
507688|NCT00212758|1220654|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
507689|NCT00212758|1220655|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
507690|NCT00212758|1220654|P2|COMPLETED|Wash Out Period (2 Weeks)||9
507691|NCT00212758|1220655|P1|COMPLETED|Wash Out Period (2 Weeks)||8
507692|NCT00212758|1220654|P2|STARTED|Wash Out Period (2 Weeks)||9
507693|NCT00212758|1220655|P1|STARTED|Wash Out Period (2 Weeks)||8
507694|NCT00212758|1220654|P2|NOT COMPLETED|First Intervention (7 Days)||0
507695|NCT00212758|1220655|P1|NOT COMPLETED|First Intervention (7 Days)||0
507696|NCT00212758|1220654|P2|COMPLETED|First Intervention (7 Days)||9
507697|NCT00212758|1220655|P1|COMPLETED|First Intervention (7 Days)||8
507698|NCT00212758|1220654|P2|STARTED|First Intervention (7 Days)||9
507699|NCT00212758|1220655|P1|STARTED|First Intervention (7 Days)||8
507700|NCT00212355|1220661|P1|NOT COMPLETED|Overall Study||3
507701|NCT00212355|1220661|P1|COMPLETED|Overall Study||34
507702|NCT00212355|1220661|P1|STARTED|Overall Study||37
507703|NCT00212264|1220668|P3|NOT COMPLETED|Overall Study||4
507704|NCT00212264|1220669|P2|NOT COMPLETED|Overall Study||16
507705|NCT00212264|1220670|P1|NOT COMPLETED|Overall Study||12
507706|NCT00212264|1220668|P3|COMPLETED|Overall Study||64
507707|NCT00212264|1220669|P2|COMPLETED|Overall Study||54
507708|NCT00212264|1220670|P1|COMPLETED|Overall Study||58
507709|NCT00212264|1220668|P3|STARTED|Overall Study||68
507710|NCT00212264|1220669|P2|STARTED|Overall Study||70
507711|NCT00212264|1220670|P1|STARTED|Overall Study||70
507712|NCT00212134|1220682|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
507713|NCT00212134|1220683|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
507714|NCT00212134|1220682|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
507715|NCT00212134|1220683|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
507802|NCT00209339|1220832|P1|STARTED|At 12 Months Follow-up||55
507716|NCT00212134|1220682|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
507717|NCT00212134|1220683|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
507718|NCT00212134|1220682|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
507719|NCT00212134|1220683|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
507720|NCT00212134|1220682|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
507721|NCT00212134|1220683|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
507722|NCT00212134|1220682|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
507723|NCT00212134|1220683|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
507724|NCT00212134|1220682|P2|STARTED|Phase 1 (to Age 1 Year)||57
507725|NCT00212134|1220683|P1|STARTED|Phase 1 (to Age 1 Year)||57
507726|NCT00211887|1220704|P3|NOT COMPLETED|Overall Study||36
507727|NCT00211887|1220705|P2|NOT COMPLETED|Overall Study||56
507728|NCT00211887|1220706|P1|NOT COMPLETED|Overall Study||102
507729|NCT00211887|1220704|P3|COMPLETED|Overall Study||223
507730|NCT00211887|1220705|P2|COMPLETED|Overall Study||194
507731|NCT00211887|1220706|P1|COMPLETED|Overall Study||397
507732|NCT00211887|1220704|P3|STARTED|Overall Study||259
507733|NCT00211887|1220705|P2|STARTED|Overall Study||250
507734|NCT00211887|1220706|P1|STARTED|Overall Study||499
507735|NCT00211809|1220723|P1|NOT COMPLETED|Overall Study||6
507736|NCT00211809|1220723|P1|COMPLETED|Overall Study||11
507737|NCT00211809|1220723|P1|STARTED|Overall Study||17
507738|NCT00211692|1220739|P2|NOT COMPLETED|Overall Study||0
507739|NCT00211692|1220740|P1|NOT COMPLETED|Overall Study||0
507740|NCT00211692|1220739|P2|COMPLETED|Overall Study||31
507741|NCT00211692|1220740|P1|COMPLETED|Overall Study||33
507742|NCT00211692|1220739|P2|STARTED|Overall Study||31
507743|NCT00211692|1220740|P1|STARTED|Overall Study||33
507744|NCT00211536|1220750|P2|NOT COMPLETED|Overall Study||7
507745|NCT00211536|1220751|P1|NOT COMPLETED|Overall Study||4
507746|NCT00211536|1220750|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
507747|NCT00211536|1220751|P1|COMPLETED|Overall Study||49
507748|NCT00211536|1220750|P2|As Treated Data Analysis Set|Overall Study||48
507749|NCT00211536|1220751|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
507750|NCT00211536|1220750|P2|STARTED|Overall Study||54
507751|NCT00211536|1220751|P1|STARTED|Overall Study||53
507752|NCT00211510|1220767|P2|NOT COMPLETED|Overall Study||2
507753|NCT00211510|1220768|P1|NOT COMPLETED|Overall Study||6
507754|NCT00211510|1220767|P2|COMPLETED|Overall Study||72
507755|NCT00211510|1220768|P1|COMPLETED|Overall Study||66
507756|NCT00211510|1220767|P2|STARTED|Overall Study||74
507757|NCT00211510|1220768|P1|STARTED|Overall Study||72
507758|NCT00211237|1220786|P2|NOT COMPLETED|Overall Study||30
507759|NCT00211237|1220787|P1|NOT COMPLETED|Overall Study||30
507760|NCT00211237|1220786|P2|COMPLETED|Overall Study||34
507761|NCT00211237|1220787|P1|COMPLETED|Overall Study||40
507762|NCT00211237|1220786|P2|STARTED|Overall Study||64
507763|NCT00211237|1220787|P1|STARTED|Overall Study||70
507764|NCT00211172|1220795|P2|NOT COMPLETED|Overall Study||32
507765|NCT00211172|1220796|P1|NOT COMPLETED|Overall Study||39
507766|NCT00211172|1220795|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
507767|NCT00211172|1220796|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
507768|NCT00211172|1220795|P2|STARTED|Overall Study||458
507769|NCT00211172|1220796|P1|STARTED|Overall Study||449
507770|NCT00211081|1220802|P1|NOT COMPLETED|Overall Study||2
507771|NCT00211081|1220802|P1|COMPLETED|Overall Study|Study completed in 2008|10
507772|NCT00211081|1220802|P1|STARTED|Overall Study|Study started in 2006|12
507773|NCT00210470|1220806|P1|NOT COMPLETED|Overall Study||1
507774|NCT00210470|1220806|P1|COMPLETED|Overall Study||26
507775|NCT00210470|1220806|P1|STARTED|Overall Study||27
507776|NCT00209560|1220812|P2|NOT COMPLETED|Overall Study||0
507777|NCT00209560|1220813|P1|NOT COMPLETED|Overall Study||1
507778|NCT00209560|1220812|P2|COMPLETED|Overall Study||42
507779|NCT00209560|1220813|P1|COMPLETED|Overall Study||120
507780|NCT00209560|1220812|P2|STARTED|Overall Study||42
507781|NCT00209560|1220813|P1|STARTED|Overall Study||121
507782|NCT00209417|1220823|P2|NOT COMPLETED|Overall Study||0
507783|NCT00209417|1220824|P1|NOT COMPLETED|Overall Study||0
507784|NCT00209417|1220823|P2|COMPLETED|Overall Study||327
507785|NCT00209417|1220824|P1|COMPLETED|Overall Study||321
507786|NCT00209417|1220823|P2|STARTED|Overall Study||327
507787|NCT00209417|1220824|P1|STARTED|Overall Study||321
507788|NCT00209339|1220832|P1|NOT COMPLETED|At 5 Years Follow-up||8
507789|NCT00209339|1220832|P1|COMPLETED|At 5 Years Follow-up||15
507790|NCT00209339|1220832|P1|STARTED|At 5 Years Follow-up||23
507791|NCT00209339|1220832|P1|NOT COMPLETED|At 4 Years Follow-up||5
507792|NCT00209339|1220832|P1|COMPLETED|At 4 Years Follow-up||23
507793|NCT00209339|1220832|P1|STARTED|At 4 Years Follow-up||28
507794|NCT00209339|1220832|P1|NOT COMPLETED|At 3 Years Follow-up||1
507795|NCT00209339|1220832|P1|COMPLETED|At 3 Years Follow-up||28
507796|NCT00209339|1220832|P1|STARTED|At 3 Years Follow-up||29
507797|NCT00209339|1220832|P1|NOT COMPLETED|At 24 Months Follow-up||11
507798|NCT00209339|1220832|P1|COMPLETED|At 24 Months Follow-up||29
507799|NCT00209339|1220832|P1|STARTED|At 24 Months Follow-up||40
507800|NCT00209339|1220832|P1|NOT COMPLETED|At 12 Months Follow-up||15
507801|NCT00209339|1220832|P1|COMPLETED|At 12 Months Follow-up||40
507803|NCT00209170|1220916|P2|NOT COMPLETED|Overall Study||3
507804|NCT00209170|1220917|P1|NOT COMPLETED|Overall Study||2
507805|NCT00209170|1220916|P2|COMPLETED|Overall Study||4
507806|NCT00209170|1220917|P1|COMPLETED|Overall Study||5
507807|NCT00209170|1220916|P2|STARTED|Overall Study||7
507808|NCT00209170|1220917|P1|STARTED|Overall Study||7
507809|NCT00209131|1220925|P2|NOT COMPLETED|Overall Study||11
507810|NCT00209131|1220926|P1|NOT COMPLETED|Overall Study||15
507811|NCT00209131|1220925|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
507812|NCT00209131|1220926|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
507813|NCT00209131|1220925|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
507814|NCT00209131|1220926|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
507815|NCT00209092|1220936|P2|NOT COMPLETED|Overall Study||2
507816|NCT00209092|1220937|P1|NOT COMPLETED|Overall Study||8
507817|NCT00209092|1220936|P2|COMPLETED|Overall Study||24
507818|NCT00209092|1220937|P1|COMPLETED|Overall Study||17
507819|NCT00209092|1220936|P2|STARTED|Overall Study||26
507820|NCT00209092|1220937|P1|STARTED|Overall Study||25
507821|NCT00209027|1220947|P2|NOT COMPLETED|Overall Study||0
507822|NCT00209027|1220948|P1|NOT COMPLETED|Overall Study||10
507823|NCT00209027|1220947|P2|COMPLETED|Overall Study||10
507824|NCT00209027|1220948|P1|COMPLETED|Overall Study||0
507825|NCT00209027|1220947|P2|STARTED|Overall Study||10
507826|NCT00209027|1220948|P1|STARTED|Overall Study||10
507827|NCT00208975|1220954|P1|NOT COMPLETED|Overall Study||0
507828|NCT00208975|1220954|P1|COMPLETED|Overall Study||15
507829|NCT00208975|1220954|P1|STARTED|Overall Study||15
507830|NCT00208949|1220961|P2|NOT COMPLETED|Overall Study||0
507831|NCT00208949|1220962|P1|NOT COMPLETED|Overall Study||0
507832|NCT00208949|1220961|P2|COMPLETED|Overall Study||25
507833|NCT00208949|1220962|P1|COMPLETED|Overall Study||25
507834|NCT00208949|1220961|P2|STARTED|Overall Study||25
507835|NCT00208949|1220962|P1|STARTED|Overall Study||25
507836|NCT00208767|1220972|P2|NOT COMPLETED|Overall Study||7
507837|NCT00208767|1220973|P1|NOT COMPLETED|Overall Study||27
507838|NCT00208767|1220972|P2|COMPLETED|Overall Study||33
507839|NCT00208767|1220973|P1|COMPLETED|Overall Study||53
507840|NCT00208767|1220972|P2|STARTED|Overall Study||40
507841|NCT00208767|1220973|P1|STARTED|Overall Study||80
507842|NCT00208507|1220981|P2|NOT COMPLETED|Overall Study||8
507843|NCT00208507|1220982|P1|NOT COMPLETED|Overall Study||14
507844|NCT00208507|1220981|P2|COMPLETED|Overall Study||79
507845|NCT00208507|1220982|P1|COMPLETED|Overall Study||163
507846|NCT00208507|1220981|P2|STARTED|Overall Study||87
507847|NCT00208507|1220982|P1|STARTED|Overall Study||177
507848|NCT00208494|1220990|P2|NOT COMPLETED|Overall Study||34
507849|NCT00208494|1220991|P1|NOT COMPLETED|Overall Study||30
507850|NCT00208494|1220990|P2|COMPLETED|Overall Study||162
507851|NCT00208494|1220991|P1|COMPLETED|Overall Study||164
507852|NCT00208494|1220990|P2|STARTED|Overall Study||196
507853|NCT00208494|1220991|P1|STARTED|Overall Study||194
507854|NCT00208325|1221001|P4|NOT COMPLETED|Overall Study||14
507855|NCT00208325|1221002|P3|NOT COMPLETED|Overall Study||14
507856|NCT00208325|1221003|P2|NOT COMPLETED|Overall Study||54
507857|NCT00208325|1221004|P1|NOT COMPLETED|Overall Study||51
507858|NCT00208325|1221001|P4|COMPLETED|Overall Study||147
507859|NCT00208325|1221002|P3|COMPLETED|Overall Study||156
507860|NCT00208325|1221003|P2|COMPLETED|Overall Study||142
507861|NCT00208325|1221004|P1|COMPLETED|Overall Study||142
507862|NCT00208325|1221001|P4|STARTED|Overall Study||161
507863|NCT00208325|1221002|P3|STARTED|Overall Study||170
507864|NCT00208325|1221003|P2|STARTED|Overall Study||196
507865|NCT00208325|1221004|P1|STARTED|Overall Study||193
507866|NCT00208091|1221112|P1|NOT COMPLETED|Overall Study||0
507867|NCT00208091|1221112|P1|COMPLETED|Overall Study||16
507868|NCT00208091|1221112|P1|STARTED|Overall Study||16
507869|NCT00208026|1221120|P1|NOT COMPLETED|Overall Study||0
507870|NCT00208026|1221120|P1|COMPLETED|Overall Study||3
507871|NCT00208026|1221120|P1|STARTED|Overall Study||3
507872|NCT00207883|1221126|P2|NOT COMPLETED|Overall Study||0
507873|NCT00207883|1221127|P1|NOT COMPLETED|Overall Study||0
507874|NCT00207883|1221126|P2|COMPLETED|Overall Study||119
507875|NCT00207883|1221127|P1|COMPLETED|Overall Study||93
507876|NCT00207883|1221126|P2|STARTED|Overall Study||119
507877|NCT00207883|1221127|P1|STARTED|Overall Study||93
507878|NCT00207740|1221139|P4|NOT COMPLETED|Overall Study||43
507879|NCT00207740|1221140|P3|NOT COMPLETED|Overall Study||40
507880|NCT00207740|1221141|P2|NOT COMPLETED|Overall Study||41
507881|NCT00207740|1221142|P1|NOT COMPLETED|Overall Study||29
507882|NCT00207740|1221139|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
507883|NCT00207740|1221140|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
507884|NCT00207740|1221141|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
507885|NCT00207740|1221142|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
507886|NCT00207740|1221139|P4|STARTED|Overall Study||78
507887|NCT00207740|1221140|P3|STARTED|Overall Study||76
507888|NCT00207740|1221141|P2|STARTED|Overall Study||77
507889|NCT00207740|1221142|P1|STARTED|Overall Study||78
507890|NCT00207727|1221188|P5|NOT COMPLETED|Overall Study||34
507891|NCT00207727|1221189|P4|NOT COMPLETED|Overall Study||37
507892|NCT00207727|1221190|P3|NOT COMPLETED|Overall Study||41
507893|NCT00207727|1221191|P2|NOT COMPLETED|Overall Study||42
507894|NCT00207727|1221192|P1|NOT COMPLETED|Overall Study||38
507895|NCT00207727|1221188|P5|COMPLETED|Overall Study||16
507896|NCT00207727|1221189|P4|COMPLETED|Overall Study||13
507897|NCT00207727|1221190|P3|COMPLETED|Overall Study||9
507898|NCT00207727|1221191|P2|COMPLETED|Overall Study||8
507899|NCT00207727|1221192|P1|COMPLETED|Overall Study||11
507900|NCT00207727|1221188|P5|STARTED|Overall Study||50
507901|NCT00207727|1221189|P4|STARTED|Overall Study||50
507902|NCT00207727|1221190|P3|STARTED|Overall Study||50
507903|NCT00207727|1221191|P2|STARTED|Overall Study||50
507904|NCT00207727|1221192|P1|STARTED|Overall Study||49
507905|NCT00207714|1221219|P5|NOT COMPLETED|Overall Study||5
507906|NCT00207714|1221220|P4|NOT COMPLETED|Overall Study||8
507907|NCT00207714|1221221|P3|NOT COMPLETED|Overall Study||10
507908|NCT00207714|1221222|P2|NOT COMPLETED|Overall Study||7
507909|NCT00207714|1221223|P1|NOT COMPLETED|Overall Study||14
507910|NCT00207714|1221219|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
507911|NCT00207714|1221220|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
507912|NCT00207714|1221221|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
507913|NCT00207714|1221222|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
507914|NCT00207714|1221223|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
507915|NCT00207714|1221219|P5|STARTED|Overall Study||34
507916|NCT00207714|1221220|P4|STARTED|Overall Study||34
507917|NCT00207714|1221221|P3|STARTED|Overall Study||34
507918|NCT00207714|1221222|P2|STARTED|Overall Study||35
507919|NCT00207714|1221223|P1|STARTED|Overall Study||35
507920|NCT00207142|1221245|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
507921|NCT00207142|1221246|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
507922|NCT00207142|1221247|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
507923|NCT00207142|1221248|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
507924|NCT00207142|1221245|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
507925|NCT00207142|1221246|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
507926|NCT00207142|1221247|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
507927|NCT00207142|1221248|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
507928|NCT00207142|1221245|P4|STARTED|Maintenance Phase/Rescue Phase||50
507929|NCT00207142|1221246|P3|STARTED|Maintenance Phase/Rescue Phase||85
507930|NCT00207142|1221247|P2|STARTED|Maintenance Phase/Rescue Phase||87
507931|NCT00207142|1221248|P1|STARTED|Maintenance Phase/Rescue Phase||0
507932|NCT00207142|1221245|P4|NOT COMPLETED|Induction Phase||0
507933|NCT00207142|1221246|P3|NOT COMPLETED|Induction Phase||0
507934|NCT00207142|1221247|P2|NOT COMPLETED|Induction Phase||0
507935|NCT00207142|1221248|P1|NOT COMPLETED|Induction Phase||30
507936|NCT00207142|1221245|P4|COMPLETED|Induction Phase||0
507937|NCT00207142|1221246|P3|COMPLETED|Induction Phase||0
507938|NCT00207142|1221247|P2|COMPLETED|Induction Phase||0
507939|NCT00207142|1221248|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
507940|NCT00207142|1221245|P4|STARTED|Induction Phase||0
507941|NCT00207142|1221246|P3|STARTED|Induction Phase||0
507942|NCT00207142|1221247|P2|STARTED|Induction Phase||0
507943|NCT00207142|1221248|P1|STARTED|Induction Phase||252
507944|NCT00207090|1221285|P1|NOT COMPLETED|Overall Study||7
507945|NCT00207090|1221285|P1|COMPLETED|Overall Study||8
507946|NCT00207090|1221285|P1|STARTED|Overall Study|Number of participants treated|15
507947|NCT00206726|1221314|P1|NOT COMPLETED|Overall Study||51
507948|NCT00206726|1221314|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
507949|NCT00206726|1221314|P1|4 Cycles Completed|Overall Study|per protocol population|41
507950|NCT00206726|1221314|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
507951|NCT00206726|1221314|P1|STARTED|Overall Study||60
507952|NCT00206518|1221325|P2|NOT COMPLETED|Overall Study||6
507953|NCT00206518|1221326|P1|NOT COMPLETED|Overall Study||10
507954|NCT00206518|1221325|P2|COMPLETED|Overall Study||78
507955|NCT00206518|1221326|P1|COMPLETED|Overall Study||73
507956|NCT00206518|1221325|P2|STARTED|Overall Study||84
507957|NCT00206518|1221326|P1|STARTED|Overall Study||83
507958|NCT00206440|1221338|P2|NOT COMPLETED|Overall Study||4
507959|NCT00206440|1221339|P1|NOT COMPLETED|Overall Study||5
507960|NCT00206440|1221338|P2|COMPLETED|Overall Study||18
507961|NCT00206440|1221339|P1|COMPLETED|Overall Study||16
507962|NCT00206440|1221338|P2|STARTED|Overall Study||22
507963|NCT00206440|1221339|P1|STARTED|Overall Study||21
507964|NCT00206427|1221345|P1|NOT COMPLETED|Overall Study||2
507965|NCT00206427|1221345|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
507966|NCT00206427|1221345|P1|STARTED|Overall Study|Received First Dose|49
507967|NCT00206102|1221351|P2|NOT COMPLETED|Overall Study||315
507968|NCT00206102|1221352|P1|NOT COMPLETED|Overall Study||408
507969|NCT00206102|1221351|P2|COMPLETED|Overall Study||187
507970|NCT00206102|1221352|P1|COMPLETED|Overall Study||188
507971|NCT00206102|1221351|P2|STARTED|Overall Study||502
507972|NCT00206102|1221352|P1|STARTED|Overall Study||596
507973|NCT00206076|1221388|P2|NOT COMPLETED|Overall Study||1
507974|NCT00206076|1221389|P1|NOT COMPLETED|Overall Study||3
507975|NCT00206076|1221388|P2|COMPLETED|Overall Study||9
507976|NCT00206076|1221389|P1|COMPLETED|Overall Study||6
507977|NCT00206076|1221388|P2|STARTED|Overall Study||10
507978|NCT00206076|1221389|P1|STARTED|Overall Study||9
507979|NCT00205881|1221399|P1|NOT COMPLETED|Overall Study||16
507980|NCT00205881|1221399|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
507981|NCT00205881|1221399|P1|STARTED|Overall Study||32
507982|NCT00205855|1221404|P1|NOT COMPLETED|Overall Study||21
507983|NCT00205855|1221404|P1|COMPLETED|Overall Study||44
507984|NCT00205855|1221404|P1|STARTED|Overall Study||65
507985|NCT00205803|1221410|P2|NOT COMPLETED|Toddler Dose||3
507986|NCT00205803|1221411|P1|NOT COMPLETED|Toddler Dose||2
507987|NCT00205803|1221410|P2|COMPLETED|Toddler Dose||100
507988|NCT00205803|1221411|P1|COMPLETED|Toddler Dose||84
507989|NCT00205803|1221410|P2|STARTED|Toddler Dose||103
507990|NCT00205803|1221411|P1|STARTED|Toddler Dose||86
507991|NCT00205803|1221410|P2|NOT COMPLETED|After Infant Series||13
507992|NCT00205803|1221411|P1|NOT COMPLETED|After Infant Series||18
507993|NCT00205803|1221410|P2|COMPLETED|After Infant Series||103
507994|NCT00205803|1221411|P1|COMPLETED|After Infant Series||86
507995|NCT00205803|1221410|P2|STARTED|After Infant Series||116
507996|NCT00205803|1221411|P1|STARTED|After Infant Series||104
507997|NCT00205803|1221410|P2|NOT COMPLETED|Infant Series||11
507998|NCT00205803|1221411|P1|NOT COMPLETED|Infant Series||18
507999|NCT00205803|1221410|P2|COMPLETED|Infant Series||116
508000|NCT00205803|1221411|P1|COMPLETED|Infant Series||104
508001|NCT00205803|1221410|P2|Vaccinated Dose 3|Infant Series||118
508002|NCT00205803|1221411|P1|Vaccinated Dose 3|Infant Series||110
508003|NCT00205803|1221410|P2|Vaccinated Dose 2|Infant Series||122
508004|NCT00205803|1221411|P1|Vaccinated Dose 2|Infant Series||115
508005|NCT00205803|1221410|P2|Vaccinated Dose 1|Infant Series||126
508006|NCT00205803|1221411|P1|Vaccinated Dose 1|Infant Series||121
508007|NCT00205803|1221410|P2|STARTED|Infant Series||127
508008|NCT00205803|1221411|P1|STARTED|Infant Series||122
508009|NCT00205777|1221467|P6|NOT COMPLETED|Study Extension II||282
508010|NCT00205777|1221468|P5|NOT COMPLETED|Study Extension II||0
508011|NCT00205777|1221469|P4|NOT COMPLETED|Study Extension II||149
508012|NCT00205777|1221470|P3|NOT COMPLETED|Study Extension II||0
508013|NCT00205777|1221471|P2|NOT COMPLETED|Study Extension II||0
508014|NCT00205777|1221472|P1|NOT COMPLETED|Study Extension II||0
508015|NCT00205777|1221467|P6|COMPLETED|Study Extension II||860
508016|NCT00205777|1221468|P5|COMPLETED|Study Extension II||0
508017|NCT00205777|1221469|P4|COMPLETED|Study Extension II||441
508018|NCT00205777|1221470|P3|COMPLETED|Study Extension II||0
508019|NCT00205777|1221471|P2|COMPLETED|Study Extension II||0
508020|NCT00205777|1221472|P1|COMPLETED|Study Extension II||0
508021|NCT00205777|1221467|P6|TREATED|Study Extension II||1011
508022|NCT00205777|1221468|P5|TREATED|Study Extension II||0
508023|NCT00205777|1221469|P4|TREATED|Study Extension II||519
508024|NCT00205777|1221470|P3|TREATED|Study Extension II||0
508025|NCT00205777|1221471|P2|TREATED|Study Extension II||0
508026|NCT00205777|1221472|P1|TREATED|Study Extension II||0
508027|NCT00205777|1221467|P6|STARTED|Study Extension II||1142
508028|NCT00205777|1221468|P5|STARTED|Study Extension II||0
508029|NCT00205777|1221469|P4|STARTED|Study Extension II||590
508030|NCT00205777|1221470|P3|STARTED|Study Extension II||0
508031|NCT00205777|1221471|P2|STARTED|Study Extension II||0
508032|NCT00205777|1221472|P1|STARTED|Study Extension II||0
508033|NCT00205777|1221467|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
508034|NCT00205777|1221468|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
508035|NCT00205777|1221469|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
508036|NCT00205777|1221470|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
508037|NCT00205777|1221471|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
508038|NCT00205777|1221472|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
508039|NCT00205777|1221467|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
508040|NCT00205777|1221468|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
508041|NCT00205777|1221469|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
508042|NCT00205777|1221470|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
508043|NCT00205777|1221471|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
508044|NCT00205777|1221472|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
508045|NCT00205777|1221467|P6|STARTED|Completed SE I, Entered Extension SE II||0
508046|NCT00205777|1221468|P5|STARTED|Completed SE I, Entered Extension SE II||840
508047|NCT00205777|1221469|P4|STARTED|Completed SE I, Entered Extension SE II||830
508048|NCT00205777|1221470|P3|STARTED|Completed SE I, Entered Extension SE II||0
508049|NCT00205777|1221471|P2|STARTED|Completed SE I, Entered Extension SE II||0
508050|NCT00205777|1221472|P1|STARTED|Completed SE I, Entered Extension SE II||833
508051|NCT00205777|1221467|P6|NOT COMPLETED|Study Extension I||0
508052|NCT00205777|1221468|P5|NOT COMPLETED|Study Extension I||201
508053|NCT00205777|1221469|P4|NOT COMPLETED|Study Extension I||228
508054|NCT00205777|1221470|P3|NOT COMPLETED|Study Extension I||1070
508055|NCT00205777|1221471|P2|NOT COMPLETED|Study Extension I||0
508056|NCT00205777|1221472|P1|NOT COMPLETED|Study Extension I||214
508057|NCT00205777|1221467|P6|COMPLETED|Study Extension I||0
508058|NCT00205777|1221468|P5|COMPLETED|Study Extension I||840
508059|NCT00205777|1221469|P4|COMPLETED|Study Extension I||830
508060|NCT00205777|1221470|P3|COMPLETED|Study Extension I||0
508061|NCT00205777|1221471|P2|COMPLETED|Study Extension I||0
508062|NCT00205777|1221472|P1|COMPLETED|Study Extension I||833
508063|NCT00205777|1221467|P6|STARTED|Study Extension I||0
508064|NCT00205777|1221468|P5|STARTED|Study Extension I||1041
508065|NCT00205777|1221469|P4|STARTED|Study Extension I||1058
508066|NCT00205777|1221470|P3|STARTED|Study Extension I||1070
508067|NCT00205777|1221471|P2|STARTED|Study Extension I||0
508068|NCT00205777|1221472|P1|STARTED|Study Extension I||1047
508069|NCT00205777|1221467|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
508070|NCT00205777|1221468|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
508071|NCT00205777|1221469|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
508072|NCT00205777|1221470|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
508073|NCT00205777|1221471|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
508074|NCT00205777|1221472|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
508075|NCT00205777|1221467|P6|COMPLETED|Completed Core Study, Entered SE I||0
508076|NCT00205777|1221468|P5|COMPLETED|Completed Core Study, Entered SE I||0
508077|NCT00205777|1221469|P4|COMPLETED|Completed Core Study, Entered SE I||1058
508078|NCT00205777|1221470|P3|COMPLETED|Completed Core Study, Entered SE I||1070
508079|NCT00205777|1221471|P2|COMPLETED|Completed Core Study, Entered SE I||1041
508080|NCT00205777|1221472|P1|COMPLETED|Completed Core Study, Entered SE I||1047
508081|NCT00205777|1221467|P6|STARTED|Completed Core Study, Entered SE I||0
508082|NCT00205777|1221468|P5|STARTED|Completed Core Study, Entered SE I||0
508083|NCT00205777|1221469|P4|STARTED|Completed Core Study, Entered SE I||1282
508084|NCT00205777|1221470|P3|STARTED|Completed Core Study, Entered SE I||1277
508085|NCT00205777|1221471|P2|STARTED|Completed Core Study, Entered SE I||1245
508086|NCT00205777|1221472|P1|STARTED|Completed Core Study, Entered SE I||1279
508087|NCT00205777|1221467|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
508088|NCT00205777|1221468|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
508089|NCT00205777|1221469|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
508090|NCT00205777|1221470|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
508091|NCT00205777|1221471|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
508092|NCT00205777|1221472|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
508093|NCT00205777|1221467|P6|COMPLETED|Core Study (Up to 3 Years)||0
508094|NCT00205777|1221468|P5|COMPLETED|Core Study (Up to 3 Years)||0
508095|NCT00205777|1221469|P4|COMPLETED|Core Study (Up to 3 Years)||1282
508096|NCT00205777|1221470|P3|COMPLETED|Core Study (Up to 3 Years)||1277
508097|NCT00205777|1221471|P2|COMPLETED|Core Study (Up to 3 Years)||1245
508098|NCT00205777|1221472|P1|COMPLETED|Core Study (Up to 3 Years)||1279
508099|NCT00205777|1221467|P6|TREATED|Core Study (Up to 3 Years)||0
508100|NCT00205777|1221468|P5|TREATED|Core Study (Up to 3 Years)||0
508101|NCT00205777|1221469|P4|TREATED|Core Study (Up to 3 Years)||1885
508102|NCT00205777|1221470|P3|TREATED|Core Study (Up to 3 Years)||1849
508103|NCT00205777|1221471|P2|TREATED|Core Study (Up to 3 Years)||1872
508104|NCT00205777|1221472|P1|TREATED|Core Study (Up to 3 Years)||1886
508105|NCT00205777|1221467|P6|STARTED|Core Study (Up to 3 Years)||0
508106|NCT00205777|1221468|P5|STARTED|Core Study (Up to 3 Years)||0
508107|NCT00205777|1221469|P4|STARTED|Core Study (Up to 3 Years)||1914
508108|NCT00205777|1221470|P3|STARTED|Core Study (Up to 3 Years)||1884
508109|NCT00205777|1221471|P2|STARTED|Core Study (Up to 3 Years)||1904
508110|NCT00205777|1221472|P1|STARTED|Core Study (Up to 3 Years)||1907
508111|NCT00205712|1221681|P2|NOT COMPLETED|Overall Study||1
508112|NCT00205712|1221682|P1|NOT COMPLETED|Overall Study||0
508113|NCT00205712|1221681|P2|COMPLETED|Overall Study||19
508114|NCT00205712|1221682|P1|COMPLETED|Overall Study||20
508115|NCT00205712|1221681|P2|STARTED|Overall Study||20
508116|NCT00205712|1221682|P1|STARTED|Overall Study||20
508117|NCT00205504|1221694|P2|NOT COMPLETED|Overall Study||0
508118|NCT00205504|1221695|P1|NOT COMPLETED|Overall Study||7
508119|NCT00205504|1221694|P2|COMPLETED|Overall Study||15
508120|NCT00205504|1221695|P1|COMPLETED|Overall Study||14
508121|NCT00205504|1221694|P2|STARTED|Overall Study||15
508122|NCT00205504|1221695|P1|STARTED|Overall Study||21
508123|NCT00205049|1221721|P2|NOT COMPLETED|Overall Study||0
508124|NCT00205049|1221722|P1|NOT COMPLETED|Overall Study||0
508125|NCT00205049|1221721|P2|COMPLETED|Overall Study||0
508126|NCT00205049|1221722|P1|COMPLETED|Overall Study||0
508127|NCT00205049|1221721|P2|STARTED|Overall Study||0
508128|NCT00205049|1221722|P1|STARTED|Overall Study||0
508129|NCT00204932|1221730|P2|NOT COMPLETED|Overall Study||6
508130|NCT00204932|1221731|P1|NOT COMPLETED|Overall Study||2
508131|NCT00204932|1221730|P2|COMPLETED|Overall Study||18
508132|NCT00204932|1221731|P1|COMPLETED|Overall Study||22
508133|NCT00204932|1221730|P2|STARTED|Overall Study||24
508134|NCT00204932|1221731|P1|STARTED|Overall Study||24
508135|NCT00204373|1221737|P1|NOT COMPLETED|Overall Study||0
508136|NCT00204373|1221737|P1|COMPLETED|Overall Study||72
508137|NCT00204373|1221737|P1|STARTED|Overall Study||72
508138|NCT00203996|1221748|P10|NOT COMPLETED|Overall Study||1
508139|NCT00203996|1221749|P9|NOT COMPLETED|Overall Study||0
508140|NCT00203996|1221750|P8|NOT COMPLETED|Overall Study||2
508141|NCT00203996|1221751|P7|NOT COMPLETED|Overall Study||0
508142|NCT00203996|1221752|P6|NOT COMPLETED|Overall Study||0
508143|NCT00203996|1221753|P5|NOT COMPLETED|Overall Study||1
508144|NCT00203996|1221754|P4|NOT COMPLETED|Overall Study||10
508145|NCT00203996|1221755|P3|NOT COMPLETED|Overall Study||0
508146|NCT00203996|1221756|P2|NOT COMPLETED|Overall Study||0
508147|NCT00203996|1221757|P1|NOT COMPLETED|Overall Study||0
508148|NCT00203996|1221748|P10|COMPLETED|Overall Study||2
508149|NCT00203996|1221749|P9|COMPLETED|Overall Study||2
508150|NCT00203996|1221750|P8|COMPLETED|Overall Study||2
508151|NCT00203996|1221751|P7|COMPLETED|Overall Study||2
508152|NCT00203996|1221752|P6|COMPLETED|Overall Study||3
508153|NCT00203996|1221753|P5|COMPLETED|Overall Study||3
508154|NCT00203996|1221754|P4|COMPLETED|Overall Study||9
508155|NCT00203996|1221755|P3|COMPLETED|Overall Study||0
508156|NCT00203996|1221756|P2|COMPLETED|Overall Study||0
508157|NCT00203996|1221757|P1|COMPLETED|Overall Study||0
508158|NCT00203996|1221748|P10|Aim 3 Only: Third Intervention|Overall Study||2
508159|NCT00203996|1221749|P9|Aim 3 Only: Third Intervention|Overall Study||2
508160|NCT00203996|1221750|P8|Aim 3 Only: Third Intervention|Overall Study||2
508161|NCT00203996|1221751|P7|Aim 3 Only: Third Intervention|Overall Study||2
508162|NCT00203996|1221752|P6|Aim 3 Only: Third Intervention|Overall Study||3
508163|NCT00203996|1221753|P5|Aim 3 Only: Third Intervention|Overall Study||0
508164|NCT00203996|1221754|P4|Aim 3 Only: Third Intervention|Overall Study||0
508165|NCT00203996|1221755|P3|Aim 3 Only: Third Intervention|Overall Study||0
508166|NCT00203996|1221756|P2|Aim 3 Only: Third Intervention|Overall Study||0
508167|NCT00203996|1221757|P1|Aim 3 Only: Third Intervention|Overall Study||0
508168|NCT00203996|1221748|P10|Aim 3 Only: Second Washout|Overall Study||2
508169|NCT00203996|1221749|P9|Aim 3 Only: Second Washout|Overall Study||2
508170|NCT00203996|1221750|P8|Aim 3 Only: Second Washout|Overall Study||2
508171|NCT00203996|1221751|P7|Aim 3 Only: Second Washout|Overall Study||2
508172|NCT00203996|1221752|P6|Aim 3 Only: Second Washout|Overall Study||3
508173|NCT00203996|1221753|P5|Aim 3 Only: Second Washout|Overall Study||0
508174|NCT00203996|1221754|P4|Aim 3 Only: Second Washout|Overall Study||0
508175|NCT00203996|1221755|P3|Aim 3 Only: Second Washout|Overall Study||0
508176|NCT00203996|1221756|P2|Aim 3 Only: Second Washout|Overall Study||0
508177|NCT00203996|1221757|P1|Aim 3 Only: Second Washout|Overall Study||0
508178|NCT00203996|1221748|P10|Aim 3 Only: Second Intervention|Overall Study||2
508179|NCT00203996|1221749|P9|Aim 3 Only: Second Intervention|Overall Study||2
508180|NCT00203996|1221750|P8|Aim 3 Only: Second Intervention|Overall Study||2
508181|NCT00203996|1221751|P7|Aim 3 Only: Second Intervention|Overall Study||2
508182|NCT00203996|1221752|P6|Aim 3 Only: Second Intervention|Overall Study||3
508183|NCT00203996|1221753|P5|Aim 3 Only: Second Intervention|Overall Study||0
508184|NCT00203996|1221754|P4|Aim 3 Only: Second Intervention|Overall Study||0
508185|NCT00203996|1221755|P3|Aim 3 Only: Second Intervention|Overall Study||0
508186|NCT00203996|1221756|P2|Aim 3 Only: Second Intervention|Overall Study||0
508187|NCT00203996|1221757|P1|Aim 3 Only: Second Intervention|Overall Study||0
508188|NCT00203996|1221748|P10|Aim 3 Only: Washout|Overall Study||2
508189|NCT00203996|1221749|P9|Aim 3 Only: Washout|Overall Study||2
508190|NCT00203996|1221750|P8|Aim 3 Only: Washout|Overall Study||2
508191|NCT00203996|1221751|P7|Aim 3 Only: Washout|Overall Study||2
508192|NCT00203996|1221752|P6|Aim 3 Only: Washout|Overall Study||3
508193|NCT00203996|1221753|P5|Aim 3 Only: Washout|Overall Study||0
508194|NCT00203996|1221754|P4|Aim 3 Only: Washout|Overall Study||0
508195|NCT00203996|1221755|P3|Aim 3 Only: Washout|Overall Study||0
508196|NCT00203996|1221756|P2|Aim 3 Only: Washout|Overall Study||0
508197|NCT00203996|1221757|P1|Aim 3 Only: Washout|Overall Study||0
508198|NCT00203996|1221748|P10|Aim 3 Only: First Intervention|Overall Study||3
508199|NCT00203996|1221749|P9|Aim 3 Only: First Intervention|Overall Study||2
508200|NCT00203996|1221750|P8|Aim 3 Only: First Intervention|Overall Study||4
508201|NCT00203996|1221751|P7|Aim 3 Only: First Intervention|Overall Study||2
508202|NCT00203996|1221752|P6|Aim 3 Only: First Intervention|Overall Study||3
508203|NCT00203996|1221753|P5|Aim 3 Only: First Intervention|Overall Study||0
508204|NCT00203996|1221754|P4|Aim 3 Only: First Intervention|Overall Study||0
508205|NCT00203996|1221755|P3|Aim 3 Only: First Intervention|Overall Study||0
508206|NCT00203996|1221756|P2|Aim 3 Only: First Intervention|Overall Study||0
508207|NCT00203996|1221757|P1|Aim 3 Only: First Intervention|Overall Study||0
508208|NCT00203996|1221748|P10|STARTED|Overall Study||3
508209|NCT00203996|1221749|P9|STARTED|Overall Study||2
508210|NCT00203996|1221750|P8|STARTED|Overall Study||4
508211|NCT00203996|1221751|P7|STARTED|Overall Study||2
508212|NCT00203996|1221752|P6|STARTED|Overall Study||3
508213|NCT00203996|1221753|P5|STARTED|Overall Study||4
508214|NCT00203996|1221754|P4|STARTED|Overall Study||19
508215|NCT00203996|1221755|P3|STARTED|Overall Study||0
508216|NCT00203996|1221756|P2|STARTED|Overall Study||0
508217|NCT00203996|1221757|P1|STARTED|Overall Study||0
508218|NCT00203931|1221806|P2|NOT COMPLETED|Overall Study||5
508219|NCT00203931|1221807|P1|NOT COMPLETED|Overall Study||7
508220|NCT00203931|1221806|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
508221|NCT00203931|1221807|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
508222|NCT00203931|1221806|P2|STARTED|Overall Study||28
508223|NCT00203931|1221807|P1|STARTED|Overall Study||27
508224|NCT00203892|1221824|P3|NOT COMPLETED|Overall Study||0
508225|NCT00203892|1221825|P2|NOT COMPLETED|Overall Study||2
508226|NCT00203892|1221826|P1|NOT COMPLETED|Overall Study||2
508227|NCT00203892|1221824|P3|COMPLETED|Overall Study||6
508228|NCT00203892|1221825|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
508229|NCT00203892|1221826|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
508230|NCT00203892|1221824|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
508231|NCT00203892|1221825|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
508232|NCT00203892|1221826|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
508233|NCT00203892|1221824|P3|STARTED|Overall Study||6
508234|NCT00203892|1221825|P2|STARTED|Overall Study||10
508235|NCT00203892|1221826|P1|STARTED|Overall Study||7
508236|NCT00203502|1221837|P1|NOT COMPLETED|Overall Study||1
508237|NCT00203502|1221837|P1|COMPLETED|Overall Study||39
508238|NCT00203502|1221837|P1|STARTED|Overall Study||40
508239|NCT00203476|1221848|P3|NOT COMPLETED|Overall Study||0
508240|NCT00203476|1221849|P2|NOT COMPLETED|Overall Study||1
508241|NCT00203476|1221850|P1|NOT COMPLETED|Overall Study||1
508242|NCT00203476|1221848|P3|COMPLETED|Overall Study||10
508243|NCT00203476|1221849|P2|COMPLETED|Overall Study||9
508244|NCT00203476|1221850|P1|COMPLETED|Overall Study||9
508245|NCT00203476|1221848|P3|STARTED|Overall Study||10
508246|NCT00203476|1221849|P2|STARTED|Overall Study||10
508247|NCT00203476|1221850|P1|STARTED|Overall Study||10
508248|NCT00203424|1221867|P1|NOT COMPLETED|Follow-up Period||6
508249|NCT00203424|1221867|P1|COMPLETED|Follow-up Period||10
508250|NCT00203424|1221867|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
508251|NCT00203424|1221867|P1|NOT COMPLETED|Treatment Period||11
508252|NCT00203424|1221867|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
508253|NCT00203424|1221867|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
508254|NCT00203411|1221874|P1|NOT COMPLETED|Follow-up||4
508255|NCT00203411|1221874|P1|COMPLETED|Follow-up||41
508256|NCT00203411|1221874|P1|STARTED|Follow-up||45
508257|NCT00203411|1221874|P1|NOT COMPLETED|Treatment Period||0
508258|NCT00203411|1221874|P1|COMPLETED|Treatment Period||45
508259|NCT00203411|1221874|P1|STARTED|Treatment Period||45
508260|NCT00203307|1221883|P2|NOT COMPLETED|Second Intervention||0
508261|NCT00203307|1221884|P1|NOT COMPLETED|Second Intervention||0
508262|NCT00203307|1221883|P2|COMPLETED|Second Intervention||0
508263|NCT00203307|1221884|P1|COMPLETED|Second Intervention||1
508264|NCT00203307|1221883|P2|STARTED|Second Intervention||0
508265|NCT00203307|1221884|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
508266|NCT00203307|1221883|P2|NOT COMPLETED|First Intervention||0
508267|NCT00203307|1221884|P1|NOT COMPLETED|First Intervention||2
508268|NCT00203307|1221883|P2|COMPLETED|First Intervention||0
508269|NCT00203307|1221884|P1|COMPLETED|First Intervention||1
508270|NCT00203307|1221883|P2|STARTED|First Intervention||0
508271|NCT00203307|1221884|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
508272|NCT00203294|1221892|P2|NOT COMPLETED|Overall Study||13
508273|NCT00203294|1221893|P1|NOT COMPLETED|Overall Study||8
508274|NCT00203294|1221892|P2|COMPLETED|Overall Study||10
508275|NCT00203294|1221893|P1|COMPLETED|Overall Study||14
508276|NCT00203294|1221892|P2|STARTED|Overall Study||23
508277|NCT00203294|1221893|P1|STARTED|Overall Study||22
508278|NCT00203268|1221899|P1|NOT COMPLETED|Late Treatment||0
508279|NCT00203268|1221899|P1|COMPLETED|Late Treatment||9
508280|NCT00203268|1221899|P1|STARTED|Late Treatment||9
508281|NCT00203268|1221899|P1|NOT COMPLETED|Early Treatment||4
508282|NCT00203268|1221899|P1|COMPLETED|Early Treatment||9
508283|NCT00203268|1221899|P1|STARTED|Early Treatment||13
508284|NCT00203242|1221905|P1|NOT COMPLETED|Overall Study||1
508285|NCT00203242|1221905|P1|COMPLETED|Overall Study||14
508286|NCT00203242|1221905|P1|STARTED|Overall Study||15
508287|NCT00203229|1221911|P2|NOT COMPLETED|Overall Study||3
508288|NCT00203229|1221912|P1|NOT COMPLETED|Overall Study||3
508289|NCT00203229|1221911|P2|COMPLETED|Overall Study||7
508290|NCT00203229|1221912|P1|COMPLETED|Overall Study||7
508291|NCT00203229|1221911|P2|STARTED|Overall Study||10
508292|NCT00203229|1221912|P1|STARTED|Overall Study||10
508293|NCT00203216|1221918|P1|NOT COMPLETED|Overall Study||4
508294|NCT00203216|1221918|P1|COMPLETED|Overall Study||27
508295|NCT00203216|1221918|P1|STARTED|Overall Study||31
508296|NCT00203203|1221924|P2|NOT COMPLETED|Overall Study||0
508297|NCT00203203|1221925|P1|NOT COMPLETED|Overall Study||1
508298|NCT00203203|1221924|P2|COMPLETED|Overall Study||20
508299|NCT00203203|1221925|P1|COMPLETED|Overall Study||9
508300|NCT00203203|1221924|P2|STARTED|Overall Study||20
508301|NCT00203203|1221925|P1|STARTED|Overall Study||10
508302|NCT00203047|1221957|P2|NOT COMPLETED|Overall Study||203
508303|NCT00203047|1221958|P1|NOT COMPLETED|Overall Study||191
508304|NCT00203047|1221957|P2|COMPLETED|Overall Study||7
508305|NCT00203047|1221958|P1|COMPLETED|Overall Study||13
508306|NCT00203047|1221957|P2|In Database as of January 29, 2009|Overall Study||209
508307|NCT00203047|1221958|P1|In Database as of January 29, 2009|Overall Study||199
508308|NCT00203047|1221957|P2|STARTED|Overall Study||210
508309|NCT00203047|1221958|P1|STARTED|Overall Study||204
508310|NCT00202878|1221972|P2|NOT COMPLETED|Overall Study||2217
508311|NCT00202878|1221973|P1|NOT COMPLETED|Overall Study||2199
508312|NCT00202878|1221972|P2|COMPLETED|Overall Study||6860
508313|NCT00202878|1221973|P1|COMPLETED|Overall Study||6868
508314|NCT00202878|1221972|P2|STARTED|Overall Study||9077
508315|NCT00202878|1221973|P1|STARTED|Overall Study||9067
508316|NCT00202839|1221987|P2|NOT COMPLETED|Overall Study||10
508317|NCT00202839|1221988|P1|NOT COMPLETED|Overall Study||24
508318|NCT00202839|1221987|P2|COMPLETED|Overall Study||72
508319|NCT00202839|1221988|P1|COMPLETED|Overall Study||54
508320|NCT00202839|1221987|P2|STARTED|Overall Study||82
508321|NCT00202839|1221988|P1|STARTED|Overall Study||78
508322|NCT00202722|1221996|P1|NOT COMPLETED|Overall Study||0
508323|NCT00202722|1221996|P1|COMPLETED|Overall Study||41
508324|NCT00202722|1221996|P1|STARTED|Overall Study||41
508325|NCT00202449|1222004|P3|NOT COMPLETED|Overall Study||12
508326|NCT00202449|1222005|P2|NOT COMPLETED|Overall Study||11
508327|NCT00202449|1222006|P1|NOT COMPLETED|Overall Study||11
508328|NCT00202449|1222004|P3|COMPLETED|Overall Study||9
508329|NCT00202449|1222005|P2|COMPLETED|Overall Study||9
508330|NCT00202449|1222006|P1|COMPLETED|Overall Study||7
508331|NCT00202449|1222004|P3|STARTED|Overall Study||21
508332|NCT00202449|1222005|P2|STARTED|Overall Study||20
508333|NCT00202449|1222006|P1|STARTED|Overall Study||18
508334|NCT00201877|1222020|P1|NOT COMPLETED|Overall Study||0
508335|NCT00201877|1222020|P1|COMPLETED|Overall Study||25
508336|NCT00201877|1222020|P1|STARTED|Overall Study||25
508337|NCT00201864|1222026|P1|NOT COMPLETED|Overall Study||0
508338|NCT00201864|1222026|P1|COMPLETED|Overall Study||40
508339|NCT00201864|1222026|P1|STARTED|Overall Study||40
508340|NCT00201851|1222037|P3|NOT COMPLETED|Overall Study||1
508341|NCT00201851|1222038|P2|NOT COMPLETED|Overall Study||2
508342|NCT00201851|1222039|P1|NOT COMPLETED|Overall Study||8
508343|NCT00201851|1222037|P3|COMPLETED|Overall Study||230
508344|NCT00201851|1222038|P2|COMPLETED|Overall Study||255
508345|NCT00201851|1222039|P1|COMPLETED|Overall Study||244
508346|NCT00201851|1222037|P3|STARTED|Overall Study||231
508347|NCT00201851|1222038|P2|STARTED|Overall Study||257
508348|NCT00201851|1222039|P1|STARTED|Overall Study||252
508349|NCT00201838|1222049|P2|NOT COMPLETED|Overall Study||0
508350|NCT00201838|1222050|P1|NOT COMPLETED|Overall Study||0
508351|NCT00201838|1222049|P2|COMPLETED|Overall Study||8
508352|NCT00201838|1222050|P1|COMPLETED|Overall Study||30
508353|NCT00201838|1222049|P2|Treatment Cohort|Overall Study||8
508354|NCT00201838|1222050|P1|Treatment Cohort|Overall Study||30
508355|NCT00201838|1222049|P2|STARTED|Overall Study||8
508356|NCT00201838|1222050|P1|STARTED|Overall Study||30
508357|NCT00201825|1222064|P1|NOT COMPLETED|Overall Study||0
508358|NCT00201825|1222064|P1|COMPLETED|Overall Study||29
508359|NCT00201825|1222064|P1|STARTED|Overall Study||29
508360|NCT00201773|1222071|P1|NOT COMPLETED|Overall Study||6
508361|NCT00201773|1222071|P1|COMPLETED|Overall Study||16
508362|NCT00201773|1222071|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
508363|NCT00201773|1222071|P1|Received All Exemestane Therapy|Overall Study||5
508364|NCT00201773|1222071|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
508365|NCT00201773|1222071|P1|STARTED|Overall Study||22
508366|NCT00201734|1222080|P2|NOT COMPLETED|Overall Study||0
508367|NCT00201734|1222081|P1|NOT COMPLETED|Overall Study||3
508368|NCT00201734|1222080|P2|COMPLETED|Overall Study||25
508369|NCT00201734|1222081|P1|COMPLETED|Overall Study||29
508370|NCT00201734|1222080|P2|Patients Not Evaluable|Overall Study||0
508371|NCT00201734|1222081|P1|Patients Not Evaluable|Overall Study||3
508372|NCT00201734|1222080|P2|STARTED|Overall Study||25
508373|NCT00201734|1222081|P1|STARTED|Overall Study||32
508374|NCT00201643|1222098|P2|NOT COMPLETED|Overall Study||4
508375|NCT00201643|1222099|P1|NOT COMPLETED|Overall Study||5
508376|NCT00201643|1222098|P2|COMPLETED|Overall Study||210
508377|NCT00201643|1222099|P1|COMPLETED|Overall Study||218
508378|NCT00201643|1222098|P2|STARTED|Overall Study||214
508379|NCT00201643|1222099|P1|STARTED|Overall Study||223
508380|NCT00201448|1222123|P2|NOT COMPLETED|Overall Study||0
508381|NCT00201448|1222124|P1|NOT COMPLETED|Overall Study||0
508382|NCT00201448|1222123|P2|COMPLETED|Overall Study||40
508383|NCT00201448|1222124|P1|COMPLETED|Overall Study||42
508384|NCT00201448|1222123|P2|STARTED|Overall Study||40
508385|NCT00201448|1222124|P1|STARTED|Overall Study||42
508386|NCT00201409|1222134|P2|NOT COMPLETED|Overall Study||1
508387|NCT00201409|1222135|P1|NOT COMPLETED|Overall Study||1
508388|NCT00201409|1222134|P2|COMPLETED|Overall Study||66
508389|NCT00201409|1222135|P1|COMPLETED|Overall Study||64
508390|NCT00201409|1222134|P2|STARTED|Overall Study||67
508391|NCT00201409|1222135|P1|STARTED|Overall Study||65
508392|NCT00201240|1222145|P1|NOT COMPLETED|Overall Study||3
508393|NCT00201240|1222145|P1|COMPLETED|Overall Study||44
508394|NCT00201240|1222145|P1|STARTED|Overall Study||47
508395|NCT00201201|1222163|P2|NOT COMPLETED|Overall Study||7
508396|NCT00201201|1222164|P1|NOT COMPLETED|Overall Study||5
508397|NCT00201201|1222163|P2|COMPLETED|Overall Study||66
508398|NCT00201201|1222164|P1|COMPLETED|Overall Study||82
508399|NCT00201201|1222163|P2|STARTED|Overall Study||73
508400|NCT00201201|1222164|P1|STARTED|Overall Study||87
508401|NCT00201123|1222183|P3|NOT COMPLETED|Overall Study||9
508402|NCT00201123|1222184|P2|NOT COMPLETED|Overall Study||4
508403|NCT00201123|1222185|P1|NOT COMPLETED|Overall Study||6
508404|NCT00201123|1222183|P3|COMPLETED|Overall Study||23
508405|NCT00201123|1222184|P2|COMPLETED|Overall Study||28
508406|NCT00201123|1222185|P1|COMPLETED|Overall Study||26
508407|NCT00201123|1222183|P3|Did Not Meet Continuation Criteria|Overall Study||5
508408|NCT00201123|1222184|P2|Did Not Meet Continuation Criteria|Overall Study||0
508409|NCT00201123|1222185|P1|Did Not Meet Continuation Criteria|Overall Study||2
508410|NCT00201123|1222183|P3|STARTED|Overall Study||32
508411|NCT00201123|1222184|P2|STARTED|Overall Study||32
508412|NCT00201123|1222185|P1|STARTED|Overall Study||32
508413|NCT00201006|1222202|P3|NOT COMPLETED|Overall Study||4
508414|NCT00201006|1222203|P2|NOT COMPLETED|Overall Study||2
508415|NCT00201006|1222204|P1|NOT COMPLETED|Overall Study||8
508416|NCT00201006|1222202|P3|COMPLETED|Overall Study||75
508417|NCT00201006|1222203|P2|COMPLETED|Overall Study||70
508418|NCT00201006|1222204|P1|COMPLETED|Overall Study||75
508419|NCT00201006|1222202|P3|STARTED|Overall Study||79
508420|NCT00201006|1222203|P2|STARTED|Overall Study||72
508421|NCT00201006|1222204|P1|STARTED|Overall Study||83
508422|NCT00200967|1222214|P2|NOT COMPLETED|Run-out Period||0
508423|NCT00200967|1222215|P1|NOT COMPLETED|Run-out Period||1
508424|NCT00200967|1222214|P2|COMPLETED|Run-out Period||41
508425|NCT00200967|1222215|P1|COMPLETED|Run-out Period||34
508426|NCT00200967|1222214|P2|STARTED|Run-out Period||41
508427|NCT00200967|1222215|P1|STARTED|Run-out Period||35
508428|NCT00200967|1222214|P2|NOT COMPLETED|Second Treatment Period||2
508429|NCT00200967|1222215|P1|NOT COMPLETED|Second Treatment Period||1
508430|NCT00200967|1222214|P2|COMPLETED|Second Treatment Period||41
508431|NCT00200967|1222215|P1|COMPLETED|Second Treatment Period||35
508432|NCT00200967|1222214|P2|STARTED|Second Treatment Period||43
508433|NCT00200967|1222215|P1|STARTED|Second Treatment Period||36
508434|NCT00200967|1222214|P2|NOT COMPLETED|Wash-out Period||1
508435|NCT00200967|1222215|P1|NOT COMPLETED|Wash-out Period||0
508436|NCT00200967|1222214|P2|COMPLETED|Wash-out Period||43
508437|NCT00200967|1222215|P1|COMPLETED|Wash-out Period||36
508438|NCT00200967|1222214|P2|STARTED|Wash-out Period||44
508439|NCT00200967|1222215|P1|STARTED|Wash-out Period||36
508440|NCT00200967|1222214|P2|NOT COMPLETED|First Treatment Period||1
508441|NCT00200967|1222215|P1|NOT COMPLETED|First Treatment Period||6
508442|NCT00200967|1222214|P2|COMPLETED|First Treatment Period||44
508443|NCT00200967|1222215|P1|COMPLETED|First Treatment Period||36
508444|NCT00200967|1222214|P2|First Treatment Period|First Treatment Period||45
508445|NCT00200967|1222215|P1|First Treatment Period|First Treatment Period||42
508446|NCT00200967|1222214|P2|STARTED|First Treatment Period||45
508447|NCT00200967|1222215|P1|STARTED|First Treatment Period||42
508448|NCT00200785|1222245|P2|NOT COMPLETED|Second Intervention||0
508449|NCT00200785|1222246|P1|NOT COMPLETED|Second Intervention||0
508450|NCT00200785|1222245|P2|COMPLETED|Second Intervention||6
508451|NCT00200785|1222246|P1|COMPLETED|Second Intervention||9
508452|NCT00200785|1222245|P2|STARTED|Second Intervention||6
508453|NCT00200785|1222246|P1|STARTED|Second Intervention||9
508454|NCT00200785|1222245|P2|NOT COMPLETED|Washout Period of 1 Week||0
508455|NCT00200785|1222246|P1|NOT COMPLETED|Washout Period of 1 Week||0
508456|NCT00200785|1222245|P2|COMPLETED|Washout Period of 1 Week||6
508457|NCT00200785|1222246|P1|COMPLETED|Washout Period of 1 Week||9
508458|NCT00200785|1222245|P2|STARTED|Washout Period of 1 Week||6
508459|NCT00200785|1222246|P1|STARTED|Washout Period of 1 Week||9
508460|NCT00200785|1222245|P2|NOT COMPLETED|First Intervention||0
508461|NCT00200785|1222246|P1|NOT COMPLETED|First Intervention||0
508462|NCT00200785|1222245|P2|COMPLETED|First Intervention||6
508463|NCT00200785|1222246|P1|COMPLETED|First Intervention||9
508464|NCT00200785|1222245|P2|STARTED|First Intervention||6
508465|NCT00200785|1222246|P1|STARTED|First Intervention||9
508466|NCT00200356|1222256|P2|NOT COMPLETED|Overall Study||7
508467|NCT00200356|1222257|P1|NOT COMPLETED|Overall Study||8
508468|NCT00200356|1222256|P2|COMPLETED|Overall Study||195
508469|NCT00200356|1222257|P1|COMPLETED|Overall Study||191
508470|NCT00200356|1222256|P2|Safety Analysis Set|Overall Study||198
508471|NCT00200356|1222257|P1|Safety Analysis Set|Overall Study||194
508472|NCT00200356|1222256|P2|STARTED|Overall Study||202
508473|NCT00200356|1222257|P1|STARTED|Overall Study||199
508474|NCT00200343|1222284|P3|NOT COMPLETED|Overall Study||13
508475|NCT00200343|1222285|P2|NOT COMPLETED|Overall Study||8
508476|NCT00200343|1222286|P1|NOT COMPLETED|Overall Study||16
508477|NCT00200343|1222284|P3|COMPLETED|Overall Study||184
508478|NCT00200343|1222285|P2|COMPLETED|Overall Study||192
508479|NCT00200343|1222286|P1|COMPLETED|Overall Study||183
508480|NCT00200343|1222284|P3|STARTED|Overall Study||197
508481|NCT00200343|1222285|P2|STARTED|Overall Study||200
508482|NCT00200343|1222286|P1|STARTED|Overall Study||199
508483|NCT00200057|1222309|P1|NOT COMPLETED|Overall Study||9
508484|NCT00200057|1222309|P1|COMPLETED|Overall Study||111
508485|NCT00200057|1222309|P1|12 Month Follow-up|Overall Study||111
508486|NCT00200057|1222309|P1|6 Month Follow-up|Overall Study||114
508487|NCT00200057|1222309|P1|3 Month Follow-up|Overall Study||116
508488|NCT00200057|1222309|P1|1 Month Follow-up|Overall Study||117
508489|NCT00200057|1222309|P1|STARTED|Overall Study||120
508490|NCT00199914|1222321|P2|NOT COMPLETED|Overall Study||6
508491|NCT00199914|1222322|P1|NOT COMPLETED|Overall Study||3
508492|NCT00199914|1222321|P2|COMPLETED|Overall Study||54
508493|NCT00199914|1222322|P1|COMPLETED|Overall Study||50
508494|NCT00199914|1222321|P2|STARTED|Overall Study||60
508495|NCT00199914|1222322|P1|STARTED|Overall Study||53
508496|NCT00199381|1222328|P1|NOT COMPLETED|Overall Study||504
508497|NCT00199381|1222328|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
508498|NCT00199381|1222328|P1|STARTED|Overall Study||504
508499|NCT00198822|1222335|P3|NOT COMPLETED|Overall Study||21
508500|NCT00198822|1222336|P2|NOT COMPLETED|Overall Study||20
508501|NCT00198822|1222337|P1|NOT COMPLETED|Overall Study||14
508502|NCT00198822|1222335|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
508503|NCT00198822|1222336|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
508504|NCT00198822|1222337|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
508505|NCT00198822|1222335|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
508506|NCT00198822|1222336|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
508507|NCT00198822|1222337|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
508508|NCT00197119|1222356|P2|NOT COMPLETED|Year 10||0
508509|NCT00197119|1222357|P1|NOT COMPLETED|Year 10||0
508510|NCT00197119|1222356|P2|COMPLETED|Year 10||108
508511|NCT00197119|1222357|P1|COMPLETED|Year 10||120
508512|NCT00197119|1222356|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
508513|NCT00197119|1222357|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
508514|NCT00197119|1222356|P2|NOT COMPLETED|Year 9||0
508515|NCT00197119|1222357|P1|NOT COMPLETED|Year 9||0
508516|NCT00197119|1222356|P2|COMPLETED|Year 9||114
508517|NCT00197119|1222357|P1|COMPLETED|Year 9||121
508518|NCT00197119|1222356|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
508519|NCT00197119|1222357|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
508520|NCT00197119|1222356|P2|NOT COMPLETED|Year 8||0
508521|NCT00197119|1222357|P1|NOT COMPLETED|Year 8||0
508522|NCT00197119|1222356|P2|COMPLETED|Year 8||115
508523|NCT00197119|1222357|P1|COMPLETED|Year 8||122
508524|NCT00197119|1222356|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
508525|NCT00197119|1222357|P1|STARTED|Year 8||122
508526|NCT00197119|1222356|P2|NOT COMPLETED|Year 7||0
508527|NCT00197119|1222357|P1|NOT COMPLETED|Year 7||0
508528|NCT00197119|1222356|P2|COMPLETED|Year 7||114
508529|NCT00197119|1222357|P1|COMPLETED|Year 7||122
508530|NCT00197119|1222356|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
508531|NCT00197119|1222357|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
508532|NCT00197119|1222356|P2|NOT COMPLETED|Year 6||0
508533|NCT00197119|1222357|P1|NOT COMPLETED|Year 6||0
508534|NCT00197119|1222356|P2|COMPLETED|Year 6||118
508535|NCT00197119|1222357|P1|COMPLETED|Year 6||126
508536|NCT00197119|1222356|P2|STARTED|Year 6||118
508537|NCT00197119|1222357|P1|STARTED|Year 6||126
508538|NCT00198133|1222369|P2|NOT COMPLETED|Overall Study||8
508539|NCT00198133|1222370|P1|NOT COMPLETED|Overall Study||5
508540|NCT00198133|1222369|P2|COMPLETED|Overall Study||3
508541|NCT00198133|1222370|P1|COMPLETED|Overall Study||11
508542|NCT00198133|1222369|P2|STARTED|Overall Study||11
508543|NCT00198133|1222370|P1|STARTED|Overall Study||16
508544|NCT00198081|1222382|P2|NOT COMPLETED|Overall Study||0
508545|NCT00198081|1222383|P1|NOT COMPLETED|Overall Study||1
508546|NCT00198081|1222382|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
508547|NCT00198081|1222383|P1|COMPLETED|Overall Study||4
508548|NCT00198081|1222382|P2|STARTED|Overall Study|No enrollment on this arm.|0
508549|NCT00198081|1222383|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
508550|NCT00198042|1222409|P1|NOT COMPLETED|Overall Study||0
508551|NCT00198042|1222409|P1|COMPLETED|Overall Study||18
508552|NCT00198042|1222409|P1|STARTED|Overall Study||18
508553|NCT00198029|1222413|P1|NOT COMPLETED|Overall Study||4
508554|NCT00198029|1222413|P1|COMPLETED|Overall Study||28
508555|NCT00198029|1222413|P1|STARTED|Overall Study||32
508556|NCT00197106|1222420|P3|NOT COMPLETED|Overall Treatment Period||6
508557|NCT00197106|1222421|P2|NOT COMPLETED|Overall Treatment Period||1
508558|NCT00197106|1222422|P1|NOT COMPLETED|Overall Treatment Period||0
508559|NCT00197106|1222420|P3|COMPLETED|Overall Treatment Period||74
508560|NCT00197106|1222421|P2|COMPLETED|Overall Treatment Period||77
508561|NCT00197106|1222422|P1|COMPLETED|Overall Treatment Period||0
508562|NCT00197106|1222420|P3|STARTED|Overall Treatment Period||80
508563|NCT00197106|1222421|P2|STARTED|Overall Treatment Period||78
508564|NCT00197106|1222422|P1|STARTED|Overall Treatment Period||0
508565|NCT00197106|1222420|P3|NOT COMPLETED|4-Week Run-In Period||0
508566|NCT00197106|1222421|P2|NOT COMPLETED|4-Week Run-In Period||0
508567|NCT00197106|1222422|P1|NOT COMPLETED|4-Week Run-In Period||99
508568|NCT00197106|1222420|P3|COMPLETED|4-Week Run-In Period||0
508569|NCT00197106|1222421|P2|COMPLETED|4-Week Run-In Period||0
508570|NCT00197106|1222422|P1|COMPLETED|4-Week Run-In Period||158
508571|NCT00197106|1222420|P3|STARTED|4-Week Run-In Period||0
508572|NCT00197106|1222421|P2|STARTED|4-Week Run-In Period||0
508573|NCT00197106|1222422|P1|STARTED|4-Week Run-In Period||257
508574|NCT00197028|1222458|P2|NOT COMPLETED|Overall Study||21
508575|NCT00197028|1222459|P1|NOT COMPLETED|Overall Study||16
508576|NCT00197028|1222458|P2|COMPLETED|Overall Study||86
508577|NCT00197028|1222459|P1|COMPLETED|Overall Study||91
508578|NCT00197028|1222458|P2|STARTED|Overall Study||107
508579|NCT00197028|1222459|P1|STARTED|Overall Study||107
508580|NCT00197015|1222502|P3|NOT COMPLETED|Overall Study||77
508581|NCT00197015|1222503|P2|NOT COMPLETED|Overall Study||89
508582|NCT00197015|1222504|P1|NOT COMPLETED|Overall Study||50
508583|NCT00197015|1222502|P3|COMPLETED|Overall Study||385
508584|NCT00197015|1222503|P2|COMPLETED|Overall Study||366
508585|NCT00197015|1222504|P1|COMPLETED|Overall Study||274
508586|NCT00197015|1222502|P3|STARTED|Overall Study||462
508587|NCT00197015|1222503|P2|STARTED|Overall Study||455
508588|NCT00197015|1222504|P1|STARTED|Overall Study||324
508589|NCT00197002|1222563|P3|NOT COMPLETED|Overall Study||17
508590|NCT00197002|1222564|P2|NOT COMPLETED|Overall Study||18
508591|NCT00197002|1222565|P1|NOT COMPLETED|Overall Study||22
508592|NCT00197002|1222563|P3|COMPLETED|Overall Study||132
508593|NCT00197002|1222564|P2|COMPLETED|Overall Study||119
508594|NCT00197002|1222565|P1|COMPLETED|Overall Study||125
508595|NCT00197002|1222563|P3|STARTED|Overall Study||149
508596|NCT00197002|1222564|P2|STARTED|Overall Study||137
508597|NCT00197002|1222565|P1|STARTED|Overall Study||147
508598|NCT00196976|1222616|P14|NOT COMPLETED|Booster Study||0
508599|NCT00196976|1222617|P13|NOT COMPLETED|Booster Study||0
508600|NCT00196976|1222618|P12|NOT COMPLETED|Booster Study||2
508601|NCT00196976|1222619|P11|NOT COMPLETED|Booster Study||2
508602|NCT00196976|1222620|P10|NOT COMPLETED|Booster Study||0
508603|NCT00196976|1222621|P9|NOT COMPLETED|Booster Study||0
508604|NCT00196976|1222622|P8|NOT COMPLETED|Booster Study||0
508605|NCT00196976|1222623|P7|NOT COMPLETED|Booster Study||0
508606|NCT00196976|1222624|P6|NOT COMPLETED|Booster Study||0
508607|NCT00196976|1222625|P5|NOT COMPLETED|Booster Study||0
508608|NCT00196976|1222626|P4|NOT COMPLETED|Booster Study||0
508609|NCT00196976|1222627|P3|NOT COMPLETED|Booster Study||0
508610|NCT00196976|1222628|P2|NOT COMPLETED|Booster Study||0
508611|NCT00196976|1222629|P1|NOT COMPLETED|Booster Study||0
508612|NCT00196976|1222616|P14|COMPLETED|Booster Study||43
508613|NCT00196976|1222617|P13|COMPLETED|Booster Study||45
508614|NCT00196976|1222618|P12|COMPLETED|Booster Study||30
508615|NCT00196976|1222619|P11|COMPLETED|Booster Study||31
508616|NCT00196976|1222620|P10|COMPLETED|Booster Study||0
508617|NCT00196976|1222621|P9|COMPLETED|Booster Study||0
508618|NCT00196976|1222622|P8|COMPLETED|Booster Study||0
508619|NCT00196976|1222623|P7|COMPLETED|Booster Study||0
508620|NCT00196976|1222624|P6|COMPLETED|Booster Study||0
508621|NCT00196976|1222625|P5|COMPLETED|Booster Study||0
508622|NCT00196976|1222626|P4|COMPLETED|Booster Study||0
508623|NCT00196976|1222627|P3|COMPLETED|Booster Study||0
508624|NCT00196976|1222628|P2|COMPLETED|Booster Study||0
508625|NCT00196976|1222629|P1|COMPLETED|Booster Study||0
508626|NCT00196976|1222616|P14|STARTED|Booster Study||43
508627|NCT00196976|1222617|P13|STARTED|Booster Study||45
508628|NCT00196976|1222618|P12|STARTED|Booster Study||32
508629|NCT00196976|1222619|P11|STARTED|Booster Study||33
508630|NCT00196976|1222620|P10|STARTED|Booster Study||0
508631|NCT00196976|1222621|P9|STARTED|Booster Study||0
508632|NCT00196976|1222622|P8|STARTED|Booster Study||0
508633|NCT00196976|1222623|P7|STARTED|Booster Study||0
508634|NCT00196976|1222624|P6|STARTED|Booster Study||0
508635|NCT00196976|1222625|P5|STARTED|Booster Study||0
508636|NCT00196976|1222626|P4|STARTED|Booster Study||0
508637|NCT00196976|1222627|P3|STARTED|Booster Study||0
508638|NCT00196976|1222628|P2|STARTED|Booster Study||0
508639|NCT00196976|1222629|P1|STARTED|Booster Study||0
508640|NCT00196976|1222616|P14|NOT COMPLETED|Primary Study||0
508641|NCT00196976|1222617|P13|NOT COMPLETED|Primary Study||0
508642|NCT00196976|1222618|P12|NOT COMPLETED|Primary Study||0
508643|NCT00196976|1222619|P11|NOT COMPLETED|Primary Study||0
508644|NCT00196976|1222620|P10|NOT COMPLETED|Primary Study||1
508645|NCT00196976|1222621|P9|NOT COMPLETED|Primary Study||0
508646|NCT00196976|1222622|P8|NOT COMPLETED|Primary Study||3
508647|NCT00196976|1222623|P7|NOT COMPLETED|Primary Study||0
508648|NCT00196976|1222624|P6|NOT COMPLETED|Primary Study||2
508649|NCT00196976|1222625|P5|NOT COMPLETED|Primary Study||3
508650|NCT00196976|1222626|P4|NOT COMPLETED|Primary Study||1
508651|NCT00196976|1222627|P3|NOT COMPLETED|Primary Study||4
508652|NCT00196976|1222628|P2|NOT COMPLETED|Primary Study||1
508653|NCT00196976|1222629|P1|NOT COMPLETED|Primary Study||1
508654|NCT00196976|1222616|P14|COMPLETED|Primary Study||0
508655|NCT00196976|1222617|P13|COMPLETED|Primary Study||0
508656|NCT00196976|1222618|P12|COMPLETED|Primary Study||0
508657|NCT00196976|1222619|P11|COMPLETED|Primary Study||0
508658|NCT00196976|1222620|P10|COMPLETED|Primary Study||51
508659|NCT00196976|1222621|P9|COMPLETED|Primary Study||52
508660|NCT00196976|1222622|P8|COMPLETED|Primary Study||49
508661|NCT00196976|1222623|P7|COMPLETED|Primary Study||50
508662|NCT00196976|1222624|P6|COMPLETED|Primary Study||52
508663|NCT00196976|1222625|P5|COMPLETED|Primary Study||37
508664|NCT00196976|1222626|P4|COMPLETED|Primary Study||39
508665|NCT00196976|1222627|P3|COMPLETED|Primary Study||37
508666|NCT00196976|1222628|P2|COMPLETED|Primary Study||40
508667|NCT00196976|1222629|P1|COMPLETED|Primary Study||38
508668|NCT00196976|1222616|P14|STARTED|Primary Study||0
508669|NCT00196976|1222617|P13|STARTED|Primary Study||0
508670|NCT00196976|1222618|P12|STARTED|Primary Study||0
508671|NCT00196976|1222619|P11|STARTED|Primary Study||0
508672|NCT00196976|1222620|P10|STARTED|Primary Study||52
508673|NCT00196976|1222621|P9|STARTED|Primary Study||52
508674|NCT00196976|1222622|P8|STARTED|Primary Study||52
508675|NCT00196976|1222623|P7|STARTED|Primary Study||50
508676|NCT00196976|1222624|P6|STARTED|Primary Study||54
508677|NCT00196976|1222625|P5|STARTED|Primary Study||40
508678|NCT00196976|1222626|P4|STARTED|Primary Study||40
508679|NCT00196976|1222627|P3|STARTED|Primary Study||41
508680|NCT00196976|1222628|P2|STARTED|Primary Study||41
508681|NCT00196976|1222629|P1|STARTED|Primary Study||39
508682|NCT00196937|1222825|P3|NOT COMPLETED|Overall Study||7
508683|NCT00196937|1222826|P2|NOT COMPLETED|Overall Study||5
508684|NCT00196937|1222827|P1|NOT COMPLETED|Overall Study||9
508685|NCT00196937|1222825|P3|COMPLETED|Overall Study||204
508686|NCT00196937|1222826|P2|COMPLETED|Overall Study||221
508687|NCT00196937|1222827|P1|COMPLETED|Overall Study||220
508688|NCT00196937|1222825|P3|STARTED|Overall Study||211
508689|NCT00196937|1222826|P2|STARTED|Overall Study||226
508690|NCT00196937|1222827|P1|STARTED|Overall Study||229
508691|NCT00197496|1222867|P2|NOT COMPLETED|Follow-up||1
508692|NCT00197496|1222868|P1|NOT COMPLETED|Follow-up||2
508693|NCT00197496|1222867|P2|COMPLETED|Follow-up||4
508694|NCT00197496|1222868|P1|COMPLETED|Follow-up||10
508695|NCT00197496|1222867|P2|STARTED|Follow-up||5
508696|NCT00197496|1222868|P1|STARTED|Follow-up||12
508697|NCT00197496|1222867|P2|NOT COMPLETED|Baseline to Discharge||2
508698|NCT00197496|1222868|P1|NOT COMPLETED|Baseline to Discharge||2
508699|NCT00197496|1222867|P2|COMPLETED|Baseline to Discharge||5
508700|NCT00197496|1222868|P1|COMPLETED|Baseline to Discharge||12
508701|NCT00197496|1222867|P2|STARTED|Baseline to Discharge||7
508702|NCT00197496|1222868|P1|STARTED|Baseline to Discharge||14
508703|NCT00197392|1222883|P2|NOT COMPLETED|Overall Study||86
508704|NCT00197392|1222884|P1|NOT COMPLETED|Overall Study||88
508705|NCT00197392|1222883|P2|COMPLETED|Overall Study||134
508706|NCT00197392|1222884|P1|COMPLETED|Overall Study||126
508707|NCT00197392|1222883|P2|Per Protocol|Overall Study||134
508708|NCT00197392|1222884|P1|Per Protocol|Overall Study||126
508709|NCT00197392|1222883|P2|Evaluable|Overall Study||181
508710|NCT00197392|1222884|P1|Evaluable|Overall Study||176
508711|NCT00197392|1222883|P2|Modified Intent to Treat|Overall Study||210
508712|NCT00197392|1222884|P1|Modified Intent to Treat|Overall Study||209
508713|NCT00197392|1222883|P2|Safety Population|Overall Study||220
508714|NCT00197392|1222884|P1|Safety Population|Overall Study||214
508715|NCT00197392|1222883|P2|STARTED|Overall Study||220
508716|NCT00197392|1222884|P1|STARTED|Overall Study||214
508717|NCT00197236|1222916|P3|NOT COMPLETED|Overall Study||23
508718|NCT00197236|1222917|P2|NOT COMPLETED|Overall Study||17
508719|NCT00197236|1222918|P1|NOT COMPLETED|Overall Study||14
508720|NCT00197236|1222916|P3|COMPLETED|Overall Study||109
508721|NCT00197236|1222917|P2|COMPLETED|Overall Study||110
508722|NCT00197236|1222918|P1|COMPLETED|Overall Study||121
508723|NCT00197236|1222916|P3|STARTED|Overall Study||132
508724|NCT00197236|1222917|P2|STARTED|Overall Study||127
508725|NCT00197236|1222918|P1|STARTED|Overall Study||135
508726|NCT00197184|1222967|P2|NOT COMPLETED|Overall Study||0
508727|NCT00197184|1222968|P1|NOT COMPLETED|Overall Study||0
508728|NCT00197184|1222967|P2|COMPLETED|Overall Study||137
508729|NCT00197184|1222968|P1|COMPLETED|Overall Study||139
508730|NCT00197184|1222967|P2|STARTED|Overall Study||137
508731|NCT00197184|1222968|P1|STARTED|Overall Study||139
508732|NCT00196716|1222990|P1|NOT COMPLETED|0.3 mg/kg Period||0
508733|NCT00196716|1222990|P1|COMPLETED|0.3 mg/kg Period||21
508734|NCT00196716|1222990|P1|STARTED|0.3 mg/kg Period||21
508735|NCT00196716|1222990|P1|NOT COMPLETED|1.0 mg/kg Period||0
508736|NCT00196716|1222990|P1|COMPLETED|1.0 mg/kg Period||21
508737|NCT00196716|1222990|P1|STARTED|1.0 mg/kg Period||21
508738|NCT00196326|1223000|P1|NOT COMPLETED|Overall Study||986
508739|NCT00196326|1223000|P1|COMPLETED|Overall Study||1249
508740|NCT00196326|1223000|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
508741|NCT00196326|1223000|P1|Safety Population|Overall Study|Treated participants|2185
508742|NCT00196326|1223000|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
508743|NCT00196313|1223008|P2|NOT COMPLETED|Overall Study||8
508744|NCT00196313|1223009|P1|NOT COMPLETED|Overall Study||11
508745|NCT00196313|1223008|P2|COMPLETED|Overall Study||40
508746|NCT00196313|1223009|P1|COMPLETED|Overall Study||36
508747|NCT00196313|1223008|P2|STARTED|Overall Study||48
508748|NCT00196313|1223009|P1|STARTED|Overall Study||47
508749|NCT00196196|1223023|P1|NOT COMPLETED|Overall Study||7
508750|NCT00196196|1223023|P1|COMPLETED|Overall Study||267
508751|NCT00196196|1223023|P1|STARTED|Overall Study||274
508752|NCT00196105|1223031|P3|NOT COMPLETED|Overall Study||7
508753|NCT00196105|1223032|P2|NOT COMPLETED|Overall Study||5
508754|NCT00196105|1223033|P1|NOT COMPLETED|Overall Study||4
508755|NCT00196105|1223031|P3|COMPLETED|Overall Study||82
508756|NCT00196105|1223032|P2|COMPLETED|Overall Study||83
508757|NCT00196105|1223033|P1|COMPLETED|Overall Study||60
508758|NCT00196105|1223031|P3|STARTED|Overall Study||89
508759|NCT00196105|1223032|P2|STARTED|Overall Study||88
508760|NCT00196105|1223033|P1|STARTED|Overall Study||64
508761|NCT00195819|1223053|P2|NOT COMPLETED|Open-label||20
508762|NCT00195819|1223054|P1|NOT COMPLETED|Open-label||0
508763|NCT00195819|1223053|P2|COMPLETED|Open-label||62
508764|NCT00195819|1223054|P1|COMPLETED|Open-label||0
508765|NCT00195819|1223053|P2|STARTED|Open-label||82
508766|NCT00195819|1223054|P1|STARTED|Open-label||0
508767|NCT00195819|1223053|P2|NOT COMPLETED|Double-Blind||0
508768|NCT00195819|1223054|P1|NOT COMPLETED|Double-Blind||2
508769|NCT00195819|1223053|P2|COMPLETED|Double-Blind||38
508770|NCT00195819|1223054|P1|COMPLETED|Double-Blind||42
508771|NCT00195819|1223053|P2|STARTED|Double-Blind||38
508772|NCT00195819|1223054|P1|STARTED|Double-Blind||44
508773|NCT00195715|1223104|P1|NOT COMPLETED|Overall Study||377
508774|NCT00195715|1223104|P1|COMPLETED|Overall Study||400
508775|NCT00195715|1223104|P1|STARTED|Overall Study||777
508776|NCT00195702|1223135|P6|NOT COMPLETED|Open-label Extension Phase||78
508777|NCT00195702|1223136|P5|NOT COMPLETED|Open-label Extension Phase||78
508778|NCT00195702|1223137|P4|NOT COMPLETED|Open-label Extension Phase||99
508779|NCT00195702|1223138|P3|NOT COMPLETED|Open-label Extension Phase||0
508780|NCT00195702|1223139|P2|NOT COMPLETED|Open-label Extension Phase||0
508781|NCT00195702|1223140|P1|NOT COMPLETED|Open-label Extension Phase||0
508782|NCT00195702|1223135|P6|COMPLETED|Open-label Extension Phase||56
508783|NCT00195702|1223136|P5|COMPLETED|Open-label Extension Phase||80
508784|NCT00195702|1223137|P4|COMPLETED|Open-label Extension Phase||66
508785|NCT00195702|1223138|P3|COMPLETED|Open-label Extension Phase||0
508786|NCT00195702|1223139|P2|COMPLETED|Open-label Extension Phase||0
508787|NCT00195702|1223140|P1|COMPLETED|Open-label Extension Phase||0
508788|NCT00195702|1223135|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
508789|NCT00195702|1223136|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
508790|NCT00195702|1223137|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
508791|NCT00195702|1223138|P3|STARTED|Open-label Extension Phase||0
508792|NCT00195702|1223139|P2|STARTED|Open-label Extension Phase||0
508793|NCT00195702|1223140|P1|STARTED|Open-label Extension Phase||0
508794|NCT00195702|1223135|P6|NOT COMPLETED|Double-blind Phase||0
508795|NCT00195702|1223136|P5|NOT COMPLETED|Double-blind Phase||0
508796|NCT00195702|1223137|P4|NOT COMPLETED|Double-blind Phase||0
508797|NCT00195702|1223138|P3|NOT COMPLETED|Double-blind Phase||60
508798|NCT00195702|1223139|P2|NOT COMPLETED|Double-blind Phase||48
508799|NCT00195702|1223140|P1|NOT COMPLETED|Double-blind Phase||44
508800|NCT00195702|1223135|P6|COMPLETED|Double-blind Phase||0
508801|NCT00195702|1223136|P5|COMPLETED|Double-blind Phase||0
508802|NCT00195702|1223137|P4|COMPLETED|Double-blind Phase||0
508803|NCT00195702|1223138|P3|COMPLETED|Double-blind Phase||140
508804|NCT00195702|1223139|P2|COMPLETED|Double-blind Phase||159
508805|NCT00195702|1223140|P1|COMPLETED|Double-blind Phase||168
508806|NCT00195702|1223135|P6|STARTED|Double-blind Phase||0
508807|NCT00195702|1223136|P5|STARTED|Double-blind Phase||0
508808|NCT00195702|1223137|P4|STARTED|Double-blind Phase||0
508809|NCT00195702|1223138|P3|STARTED|Double-blind Phase||200
508810|NCT00195702|1223139|P2|STARTED|Double-blind Phase||207
508811|NCT00195702|1223140|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
508812|NCT00195676|1223204|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
508813|NCT00195676|1223204|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
508814|NCT00195676|1223204|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
508815|NCT00195676|1223204|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
508816|NCT00195676|1223204|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
508817|NCT00195676|1223204|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
508818|NCT00195676|1223204|P1|NOT COMPLETED|Period O - Open-label Treatment||606
508908|NCT00195273|1223426|P1|COMPLETED|Overall Study||10
508819|NCT00195676|1223204|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
508820|NCT00195676|1223204|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
508821|NCT00195663|1223218|P3|NOT COMPLETED|Open-Label Extension Period||97
508822|NCT00195663|1223219|P2|NOT COMPLETED|Open-Label Extension Period||74
508823|NCT00195663|1223220|P1|NOT COMPLETED|Open-Label Extension Period||76
508824|NCT00195663|1223218|P3|COMPLETED|Open-Label Extension Period||86
508825|NCT00195663|1223219|P2|COMPLETED|Open-Label Extension Period||85
508826|NCT00195663|1223220|P1|COMPLETED|Open-Label Extension Period||79
508827|NCT00195663|1223218|P3|STARTED|Open-Label Extension Period||183
508828|NCT00195663|1223219|P2|STARTED|Open-Label Extension Period||159
508829|NCT00195663|1223220|P1|STARTED|Open-Label Extension Period||155
508830|NCT00195663|1223218|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
508831|NCT00195663|1223219|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
508832|NCT00195663|1223220|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
508833|NCT00195663|1223218|P3|COMPLETED|2-year Double-blind Treatment Period||196
508834|NCT00195663|1223219|P2|COMPLETED|2-year Double-blind Treatment Period||166
508835|NCT00195663|1223220|P1|COMPLETED|2-year Double-blind Treatment Period||164
508836|NCT00195663|1223218|P3|STARTED|2-year Double-blind Treatment Period||268
508837|NCT00195663|1223219|P2|STARTED|2-year Double-blind Treatment Period||274
508838|NCT00195663|1223220|P1|STARTED|2-year Double-blind Treatment Period||257
508839|NCT00195650|1223314|P1|NOT COMPLETED|Overall Study||525
508840|NCT00195650|1223314|P1|COMPLETED|Overall Study||321
508841|NCT00195650|1223314|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
508842|NCT00195507|1223330|P2|NOT COMPLETED|Overall Study||118
508843|NCT00195507|1223331|P1|NOT COMPLETED|Overall Study||99
508844|NCT00195507|1223330|P2|COMPLETED|Overall Study||245
508845|NCT00195507|1223331|P1|COMPLETED|Overall Study||258
508846|NCT00195507|1223330|P2|STARTED|Overall Study||363
508847|NCT00195507|1223331|P1|STARTED|Overall Study||357
508848|NCT00195494|1223345|P6|NOT COMPLETED|Year 2||0
508849|NCT00195494|1223346|P5|NOT COMPLETED|Year 2||0
508850|NCT00195494|1223347|P4|NOT COMPLETED|Year 2||23
508851|NCT00195494|1223348|P3|NOT COMPLETED|Year 2||18
508852|NCT00195494|1223349|P2|NOT COMPLETED|Year 2||16
508853|NCT00195494|1223350|P1|NOT COMPLETED|Year 2||7
508854|NCT00195494|1223345|P6|COMPLETED|Year 2||0
508855|NCT00195494|1223346|P5|COMPLETED|Year 2||0
508856|NCT00195494|1223347|P4|COMPLETED|Year 2||76
508857|NCT00195494|1223348|P3|COMPLETED|Year 2||93
508858|NCT00195494|1223349|P2|COMPLETED|Year 2||74
508859|NCT00195494|1223350|P1|COMPLETED|Year 2||104
508860|NCT00195494|1223345|P6|STARTED|Year 2||0
508861|NCT00195494|1223346|P5|STARTED|Year 2||0
508862|NCT00195494|1223347|P4|STARTED|Year 2||99
508863|NCT00195494|1223348|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
508864|NCT00195494|1223349|P2|STARTED|Year 2||90
508865|NCT00195494|1223350|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
508866|NCT00195494|1223345|P6|NOT COMPLETED|Year 1||53
508867|NCT00195494|1223346|P5|NOT COMPLETED|Year 1||79
508868|NCT00195494|1223347|P4|NOT COMPLETED|Year 1||0
508869|NCT00195494|1223348|P3|NOT COMPLETED|Year 1||0
508870|NCT00195494|1223349|P2|NOT COMPLETED|Year 1||0
508871|NCT00195494|1223350|P1|NOT COMPLETED|Year 1||0
508872|NCT00195494|1223345|P6|COMPLETED|Year 1||221
508873|NCT00195494|1223346|P5|COMPLETED|Year 1||189
508874|NCT00195494|1223347|P4|COMPLETED|Year 1||0
508875|NCT00195494|1223348|P3|COMPLETED|Year 1||0
508876|NCT00195494|1223349|P2|COMPLETED|Year 1||0
508877|NCT00195494|1223350|P1|COMPLETED|Year 1||0
508878|NCT00195494|1223345|P6|STARTED|Year 1||274
508879|NCT00195494|1223346|P5|STARTED|Year 1||268
508880|NCT00195494|1223347|P4|STARTED|Year 1||0
508881|NCT00195494|1223348|P3|STARTED|Year 1||0
508882|NCT00195494|1223349|P2|STARTED|Year 1||0
508883|NCT00195494|1223350|P1|STARTED|Year 1||0
508884|NCT00195442|1223368|P1|NOT COMPLETED|Overall Study||136
508885|NCT00195442|1223368|P1|COMPLETED|Overall Study||152
508886|NCT00195442|1223368|P1|STARTED|Overall Study||288
508887|NCT00195429|1223387|P2|NOT COMPLETED|Overall Study||5
508888|NCT00195429|1223388|P1|NOT COMPLETED|Overall Study||5
508889|NCT00195429|1223387|P2|COMPLETED|Overall Study||18
508890|NCT00195429|1223388|P1|COMPLETED|Overall Study||19
508891|NCT00195429|1223387|P2|STARTED|Overall Study||23
508892|NCT00195429|1223388|P1|STARTED|Overall Study||24
508893|NCT00195403|1223396|P1|NOT COMPLETED|Overall Study||0
508894|NCT00195403|1223396|P1|COMPLETED|Overall Study||1014
508895|NCT00195403|1223396|P1|STARTED|Overall Study||1014
508896|NCT00195351|1223404|P2|NOT COMPLETED|Overall Study||16
508897|NCT00195351|1223405|P1|NOT COMPLETED|Overall Study||21
508898|NCT00195351|1223404|P2|COMPLETED|Overall Study||215
508899|NCT00195351|1223405|P1|COMPLETED|Overall Study||215
508900|NCT00195351|1223404|P2|STARTED|Overall Study||231
508901|NCT00195351|1223405|P1|STARTED|Overall Study||236
508902|NCT00195338|1223415|P1|NOT COMPLETED|Overall Study||12
508903|NCT00195338|1223415|P1|COMPLETED|Overall Study||13
508904|NCT00195338|1223415|P1|STARTED|Overall Study||25
508905|NCT00195273|1223425|P2|NOT COMPLETED|Overall Study||14
508906|NCT00195273|1223426|P1|NOT COMPLETED|Overall Study||21
508907|NCT00195273|1223425|P2|COMPLETED|Overall Study||16
508909|NCT00195273|1223425|P2|STARTED|Overall Study||30
508910|NCT00195273|1223426|P1|STARTED|Overall Study||31
508911|NCT00195260|1223440|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
508912|NCT00195260|1223441|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
508913|NCT00195260|1223442|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
508914|NCT00195260|1223443|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508915|NCT00195260|1223444|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508916|NCT00195260|1223445|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508917|NCT00195260|1223446|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508918|NCT00195260|1223447|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508919|NCT00195260|1223448|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508920|NCT00195260|1223449|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508921|NCT00195260|1223450|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508922|NCT00195260|1223440|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
508923|NCT00195260|1223441|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508924|NCT00195260|1223442|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
508925|NCT00195260|1223443|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508926|NCT00195260|1223444|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508927|NCT00195260|1223445|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508928|NCT00195260|1223446|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508929|NCT00195260|1223447|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508930|NCT00195260|1223448|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508931|NCT00195260|1223449|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508932|NCT00195260|1223450|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508933|NCT00195260|1223440|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
508934|NCT00195260|1223441|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
508935|NCT00195260|1223442|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
508936|NCT00195260|1223443|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508937|NCT00195260|1223444|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508938|NCT00195260|1223445|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508939|NCT00195260|1223446|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508940|NCT00195260|1223447|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508941|NCT00195260|1223448|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508942|NCT00195260|1223449|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508943|NCT00195260|1223450|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
508944|NCT00195260|1223440|P11|NOT COMPLETED|Part 1: Dose Escalation||0
508945|NCT00195260|1223441|P10|NOT COMPLETED|Part 1: Dose Escalation||0
508946|NCT00195260|1223442|P9|NOT COMPLETED|Part 1: Dose Escalation||0
508947|NCT00195260|1223443|P8|NOT COMPLETED|Part 1: Dose Escalation||6
508948|NCT00195260|1223444|P7|NOT COMPLETED|Part 1: Dose Escalation||10
508949|NCT00195260|1223445|P6|NOT COMPLETED|Part 1: Dose Escalation||7
508950|NCT00195260|1223446|P5|NOT COMPLETED|Part 1: Dose Escalation||7
508951|NCT00195260|1223447|P4|NOT COMPLETED|Part 1: Dose Escalation||7
508952|NCT00195260|1223448|P3|NOT COMPLETED|Part 1: Dose Escalation||6
508953|NCT00195260|1223449|P2|NOT COMPLETED|Part 1: Dose Escalation||4
508954|NCT00195260|1223450|P1|NOT COMPLETED|Part 1: Dose Escalation||4
508955|NCT00195260|1223440|P11|COMPLETED|Part 1: Dose Escalation||0
508956|NCT00195260|1223441|P10|COMPLETED|Part 1: Dose Escalation||0
508957|NCT00195260|1223442|P9|COMPLETED|Part 1: Dose Escalation||0
508958|NCT00195260|1223443|P8|COMPLETED|Part 1: Dose Escalation||0
508959|NCT00195260|1223444|P7|COMPLETED|Part 1: Dose Escalation||0
508960|NCT00195260|1223445|P6|COMPLETED|Part 1: Dose Escalation||0
508961|NCT00195260|1223446|P5|COMPLETED|Part 1: Dose Escalation||0
508962|NCT00195260|1223447|P4|COMPLETED|Part 1: Dose Escalation||0
508963|NCT00195260|1223448|P3|COMPLETED|Part 1: Dose Escalation||0
508964|NCT00195260|1223449|P2|COMPLETED|Part 1: Dose Escalation||0
508965|NCT00195260|1223450|P1|COMPLETED|Part 1: Dose Escalation||0
508966|NCT00195260|1223440|P11|STARTED|Part 1: Dose Escalation||0
508967|NCT00195260|1223441|P10|STARTED|Part 1: Dose Escalation||0
508968|NCT00195260|1223442|P9|STARTED|Part 1: Dose Escalation||0
508969|NCT00195260|1223443|P8|STARTED|Part 1: Dose Escalation||6
508970|NCT00195260|1223444|P7|STARTED|Part 1: Dose Escalation||10
508971|NCT00195260|1223445|P6|STARTED|Part 1: Dose Escalation||7
508972|NCT00195260|1223446|P5|STARTED|Part 1: Dose Escalation||7
508973|NCT00195260|1223447|P4|STARTED|Part 1: Dose Escalation||7
508974|NCT00195260|1223448|P3|STARTED|Part 1: Dose Escalation||6
508975|NCT00195260|1223449|P2|STARTED|Part 1: Dose Escalation||4
508976|NCT00195260|1223450|P1|STARTED|Part 1: Dose Escalation||4
508977|NCT00194896|1223600|P4|NOT COMPLETED|Overall Study||12
508978|NCT00194896|1223601|P3|NOT COMPLETED|Overall Study||6
508979|NCT00194896|1223602|P2|NOT COMPLETED|Overall Study||5
508980|NCT00194896|1223603|P1|NOT COMPLETED|Overall Study||11
508981|NCT00194896|1223600|P4|COMPLETED|Overall Study||9
508982|NCT00194896|1223601|P3|COMPLETED|Overall Study||7
508983|NCT00194896|1223602|P2|COMPLETED|Overall Study||10
508984|NCT00194896|1223603|P1|COMPLETED|Overall Study||4
508985|NCT00194896|1223600|P4|STARTED|Overall Study||21
508986|NCT00194896|1223601|P3|STARTED|Overall Study||13
508987|NCT00194896|1223602|P2|STARTED|Overall Study||15
508988|NCT00194896|1223603|P1|STARTED|Overall Study||15
508989|NCT00194792|1223617|P1|NOT COMPLETED|Overall Study||1
508990|NCT00194792|1223617|P1|COMPLETED|Overall Study||27
508991|NCT00194792|1223617|P1|STARTED|Overall Study||28
508992|NCT00194675|1223629|P2|NOT COMPLETED|Overall Study||2
508993|NCT00194675|1223630|P1|NOT COMPLETED|Overall Study||5
508994|NCT00194675|1223629|P2|COMPLETED|Overall Study||24
508995|NCT00194675|1223630|P1|COMPLETED|Overall Study||22
508996|NCT00194675|1223629|P2|STARTED|Overall Study||26
508997|NCT00194675|1223630|P1|STARTED|Overall Study||27
508998|NCT00194610|1223648|P2|NOT COMPLETED|Overall Study||0
508999|NCT00194610|1223649|P1|NOT COMPLETED|Overall Study||0
509000|NCT00194610|1223648|P2|COMPLETED|Overall Study||9
509001|NCT00194610|1223649|P1|COMPLETED|Overall Study||11
509002|NCT00194610|1223648|P2|STARTED|Overall Study||9
509003|NCT00194610|1223649|P1|STARTED|Overall Study||11
509004|NCT00194532|1223657|P2|NOT COMPLETED|Overall Study||0
509005|NCT00194532|1223658|P1|NOT COMPLETED|Overall Study||0
509006|NCT00194532|1223657|P2|COMPLETED|Overall Study||150
509007|NCT00194532|1223658|P1|COMPLETED|Overall Study||150
509008|NCT00194532|1223657|P2|STARTED|Overall Study||150
509009|NCT00194532|1223658|P1|STARTED|Overall Study||150
509010|NCT00194129|1223668|P2|NOT COMPLETED|Overall Study||13
509011|NCT00194129|1223669|P1|NOT COMPLETED|Overall Study||10
509012|NCT00194129|1223668|P2|COMPLETED|Overall Study||3
509013|NCT00194129|1223669|P1|COMPLETED|Overall Study||5
509014|NCT00194129|1223668|P2|STARTED|Overall Study||16
509015|NCT00194129|1223669|P1|STARTED|Overall Study||15
509016|NCT00194077|1223677|P2|NOT COMPLETED|Overall Study||30
509017|NCT00194077|1223678|P1|NOT COMPLETED|Overall Study||24
509018|NCT00194077|1223677|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
509019|NCT00194077|1223678|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
509020|NCT00194077|1223677|P2|STARTED|Overall Study||30
509021|NCT00194077|1223678|P1|STARTED|Overall Study||30
509022|NCT00194025|1223684|P1|NOT COMPLETED|Overall Study||5
509023|NCT00194025|1223684|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
509024|NCT00194025|1223684|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
509025|NCT00194012|1223699|P2|NOT COMPLETED|Open Label Extension||7
509026|NCT00194012|1223700|P1|NOT COMPLETED|Open Label Extension||6
509027|NCT00194012|1223699|P2|COMPLETED|Open Label Extension||14
509028|NCT00194012|1223700|P1|COMPLETED|Open Label Extension||17
509120|NCT00192296|1223822|P2|NOT COMPLETED|Overall Study||1
509029|NCT00194012|1223699|P2|STARTED|Open Label Extension|Participants not completing randomized phase could enroll in open-label ext. Thus the differences.|21
509030|NCT00194012|1223700|P1|STARTED|Open Label Extension|Participants not completing randomized phase could enroll in open-label ext. Thus the differences.|23
509031|NCT00194012|1223699|P2|NOT COMPLETED|Randomized Phase||23
509032|NCT00194012|1223700|P1|NOT COMPLETED|Randomized Phase||15
509033|NCT00194012|1223699|P2|COMPLETED|Randomized Phase||6
509034|NCT00194012|1223700|P1|COMPLETED|Randomized Phase||15
509035|NCT00194012|1223699|P2|STARTED|Randomized Phase||29
509036|NCT00194012|1223700|P1|STARTED|Randomized Phase||30
509037|NCT00193609|1223708|P1|NOT COMPLETED|Overall Study||4
509038|NCT00193609|1223708|P1|COMPLETED|Overall Study||44
509039|NCT00193609|1223708|P1|STARTED|Overall Study||48
509040|NCT00193596|1223715|P2|NOT COMPLETED|Overall Study||66
509041|NCT00193596|1223716|P1|NOT COMPLETED|Overall Study||56
509042|NCT00193596|1223715|P2|COMPLETED|Overall Study||39
509043|NCT00193596|1223716|P1|COMPLETED|Overall Study||37
509044|NCT00193596|1223715|P2|STARTED|Overall Study||105
509045|NCT00193596|1223716|P1|STARTED|Overall Study||93
509046|NCT00193492|1223726|P2|NOT COMPLETED|Overall Study||15
509047|NCT00193492|1223727|P1|NOT COMPLETED|Overall Study||17
509048|NCT00193492|1223726|P2|COMPLETED|Overall Study||14
509049|NCT00193492|1223727|P1|COMPLETED|Overall Study||14
509050|NCT00193492|1223726|P2|STARTED|Overall Study||29
509051|NCT00193492|1223727|P1|STARTED|Overall Study||31
509052|NCT00193479|1223735|P1|NOT COMPLETED|Maintenance Rituximab||0
509053|NCT00193479|1223735|P1|COMPLETED|Maintenance Rituximab||44
509054|NCT00193479|1223735|P1|STARTED|Maintenance Rituximab||44
509055|NCT00193479|1223735|P1|NOT COMPLETED|Induction Chemotherapy||3
509056|NCT00193479|1223735|P1|COMPLETED|Induction Chemotherapy||48
509057|NCT00193479|1223735|P1|STARTED|Induction Chemotherapy||51
509058|NCT00193453|1223739|P1|NOT COMPLETED|Overall Study||48
509059|NCT00193453|1223739|P1|COMPLETED|Overall Study||21
509060|NCT00193453|1223739|P1|STARTED|Overall Study||69
509061|NCT00193427|1223745|P1|NOT COMPLETED|Overall Study||49
509062|NCT00193427|1223745|P1|COMPLETED|Overall Study||26
509063|NCT00193427|1223745|P1|STARTED|Overall Study||75
509064|NCT00193414|1223752|P1|NOT COMPLETED|Overall Study||58
509065|NCT00193414|1223752|P1|COMPLETED|Overall Study||14
509066|NCT00193414|1223752|P1|STARTED|Overall Study||72
509067|NCT00193375|1223758|P1|NOT COMPLETED|Overall Study||19
509068|NCT00193375|1223758|P1|COMPLETED|Overall Study||41
509069|NCT00193375|1223758|P1|STARTED|Overall Study||60
509070|NCT00193258|1223764|P1|NOT COMPLETED|Overall Study||0
509071|NCT00193258|1223764|P1|COMPLETED|Overall Study||94
509072|NCT00193258|1223764|P1|STARTED|Overall Study||94
509073|NCT00193219|1223770|P1|NOT COMPLETED|Overall Study||30
509074|NCT00193219|1223770|P1|COMPLETED|Overall Study||6
509075|NCT00193219|1223770|P1|STARTED|Overall Study||36
509076|NCT00193206|1223776|P1|NOT COMPLETED|Postoperative Therapy||14
509077|NCT00193206|1223776|P1|COMPLETED|Postoperative Therapy||102
509078|NCT00193206|1223776|P1|STARTED|Postoperative Therapy||116
509079|NCT00193206|1223776|P1|NOT COMPLETED|Surgery||0
509080|NCT00193206|1223776|P1|COMPLETED|Surgery||116
509081|NCT00193206|1223776|P1|STARTED|Surgery||116
509082|NCT00193206|1223776|P1|NOT COMPLETED|Preoperative Therapy||7
509083|NCT00193206|1223776|P1|COMPLETED|Preoperative Therapy||116
509084|NCT00193206|1223776|P1|STARTED|Preoperative Therapy||123
509085|NCT00193180|1223780|P1|NOT COMPLETED|Overall Study||10
509086|NCT00193180|1223780|P1|COMPLETED|Overall Study||27
509087|NCT00193180|1223780|P1|STARTED|Overall Study||37
509088|NCT00193128|1223788|P2|NOT COMPLETED|Overall Study||10
509089|NCT00193128|1223789|P1|NOT COMPLETED|Overall Study||0
509090|NCT00193128|1223788|P2|COMPLETED|Overall Study||39
509091|NCT00193128|1223789|P1|COMPLETED|Overall Study||10
509092|NCT00193128|1223788|P2|STARTED|Overall Study||49
509093|NCT00193128|1223789|P1|STARTED|Overall Study||10
509094|NCT00193063|1223795|P1|NOT COMPLETED|Overall Study||4
509095|NCT00193063|1223795|P1|COMPLETED|Overall Study||37
509096|NCT00193063|1223795|P1|STARTED|Overall Study||41
509097|NCT00193050|1223801|P1|NOT COMPLETED|Adjuvant||10
509098|NCT00193050|1223801|P1|COMPLETED|Adjuvant||77
509099|NCT00193050|1223801|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
509100|NCT00193050|1223801|P1|NOT COMPLETED|Surgery||0
509101|NCT00193050|1223801|P1|COMPLETED|Surgery||103
509102|NCT00193050|1223801|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
509103|NCT00193050|1223801|P1|NOT COMPLETED|Neoadjuvant Treatment||9
509104|NCT00193050|1223801|P1|COMPLETED|Neoadjuvant Treatment||101
509105|NCT00193050|1223801|P1|STARTED|Neoadjuvant Treatment||110
509106|NCT00193037|1223807|P2|NOT COMPLETED|Crossover Treatment||0
509107|NCT00193037|1223808|P1|NOT COMPLETED|Crossover Treatment||0
509108|NCT00193037|1223807|P2|COMPLETED|Crossover Treatment||24
509109|NCT00193037|1223808|P1|COMPLETED|Crossover Treatment||32
509110|NCT00193037|1223807|P2|STARTED|Crossover Treatment||24
509111|NCT00193037|1223808|P1|STARTED|Crossover Treatment||32
509112|NCT00193037|1223807|P2|NOT COMPLETED|Randomized Treatment||28
509113|NCT00193037|1223808|P1|NOT COMPLETED|Randomized Treatment||18
509114|NCT00193037|1223807|P2|COMPLETED|Randomized Treatment||24
509115|NCT00193037|1223808|P1|COMPLETED|Randomized Treatment||32
509116|NCT00193037|1223807|P2|STARTED|Randomized Treatment||52
509117|NCT00193037|1223808|P1|STARTED|Randomized Treatment||50
509118|NCT00192296|1223820|P4|NOT COMPLETED|Overall Study||0
509119|NCT00192296|1223821|P3|NOT COMPLETED|Overall Study||0
509121|NCT00192296|1223823|P1|NOT COMPLETED|Overall Study||0
509122|NCT00192296|1223820|P4|COMPLETED|Overall Study||6
509123|NCT00192296|1223821|P3|COMPLETED|Overall Study||6
509124|NCT00192296|1223822|P2|COMPLETED|Overall Study||5
509125|NCT00192296|1223823|P1|COMPLETED|Overall Study||6
509126|NCT00192296|1223820|P4|STARTED|Overall Study||6
509127|NCT00192296|1223821|P3|STARTED|Overall Study||6
509128|NCT00192296|1223822|P2|STARTED|Overall Study||6
509129|NCT00192296|1223823|P1|STARTED|Overall Study||6
509130|NCT00192647|1223879|P2|NOT COMPLETED|Overall Study||146
509131|NCT00192647|1223880|P1|NOT COMPLETED|Overall Study||128
509132|NCT00192647|1223879|P2|COMPLETED|Overall Study||302
509133|NCT00192647|1223880|P1|COMPLETED|Overall Study||320
509134|NCT00192647|1223879|P2|Treated|Overall Study||438
509135|NCT00192647|1223880|P1|Treated|Overall Study||433
509136|NCT00192647|1223879|P2|STARTED|Overall Study||448
509137|NCT00192647|1223880|P1|STARTED|Overall Study||448
509138|NCT00192075|1223898|P2|NOT COMPLETED|Overall Study||19
509139|NCT00192075|1223899|P1|NOT COMPLETED|Overall Study||39
509140|NCT00192075|1223898|P2|COMPLETED|Overall Study||23
509141|NCT00192075|1223899|P1|COMPLETED|Overall Study||3
509142|NCT00192075|1223898|P2|STARTED|Overall Study||42
509143|NCT00192075|1223899|P1|STARTED|Overall Study||42
509144|NCT00192036|1223924|P1|NOT COMPLETED|Overall Study||21
509145|NCT00192036|1223924|P1|COMPLETED|Overall Study||28
509146|NCT00192036|1223924|P1|STARTED|Overall Study||49
509147|NCT00192023|1223934|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
509148|NCT00192023|1223935|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
509149|NCT00192023|1223934|P2|COMPLETED|Period IV - Optional Open-Label||0
509150|NCT00192023|1223935|P1|COMPLETED|Period IV - Optional Open-Label||49
509151|NCT00192023|1223934|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
509152|NCT00192023|1223935|P1|STARTED|Period IV - Optional Open-Label||124
509153|NCT00192023|1223934|P2|NOT COMPLETED|Period III - Double-Blind||0
509154|NCT00192023|1223935|P1|NOT COMPLETED|Period III - Double-Blind||7
509155|NCT00192023|1223934|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
509156|NCT00192023|1223935|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
509157|NCT00192023|1223934|P2|STARTED|Period III - Double-Blind||32
509158|NCT00192023|1223935|P1|STARTED|Period III - Double-Blind||107
509159|NCT00191984|1223957|P1|NOT COMPLETED|Overall Study||39
509160|NCT00191984|1223957|P1|COMPLETED|Overall Study||7
509161|NCT00191984|1223957|P1|STARTED|Overall Study||46
509162|NCT00191945|1223967|P2|NOT COMPLETED|Open-Label Treatment Extension||0
509163|NCT00191945|1223968|P1|NOT COMPLETED|Open-Label Treatment Extension||0
509164|NCT00191945|1223967|P2|COMPLETED|Open-Label Treatment Extension||48
509165|NCT00191945|1223968|P1|COMPLETED|Open-Label Treatment Extension||94
509166|NCT00191945|1223967|P2|STARTED|Open-Label Treatment Extension||48
509167|NCT00191945|1223968|P1|STARTED|Open-Label Treatment Extension||94
509168|NCT00191945|1223967|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
509169|NCT00191945|1223968|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
509170|NCT00191945|1223967|P2|COMPLETED|Double-Blind Acute Treatment||48
509171|NCT00191945|1223968|P1|COMPLETED|Double-Blind Acute Treatment||94
509172|NCT00191945|1223967|P2|STARTED|Double-Blind Acute Treatment||51
509173|NCT00191945|1223968|P1|STARTED|Double-Blind Acute Treatment||100
509174|NCT00191906|1224004|P4|NOT COMPLETED|Study Period III||0
509175|NCT00191906|1224005|P3|NOT COMPLETED|Study Period III||0
509176|NCT00191906|1224006|P2|NOT COMPLETED|Study Period III||4
509177|NCT00191906|1224007|P1|NOT COMPLETED|Study Period III||5
509178|NCT00191906|1224004|P4|COMPLETED|Study Period III||0
509179|NCT00191906|1224005|P3|COMPLETED|Study Period III||0
509180|NCT00191906|1224006|P2|COMPLETED|Study Period III||7
509181|NCT00191906|1224007|P1|COMPLETED|Study Period III||9
509182|NCT00191906|1224004|P4|STARTED|Study Period III||0
509183|NCT00191906|1224005|P3|STARTED|Study Period III||0
509184|NCT00191906|1224006|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
509185|NCT00191906|1224007|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
509186|NCT00191906|1224004|P4|NOT COMPLETED|Study Period II||0
509187|NCT00191906|1224005|P3|NOT COMPLETED|Study Period II||1
509188|NCT00191906|1224006|P2|NOT COMPLETED|Study Period II||5
509189|NCT00191906|1224007|P1|NOT COMPLETED|Study Period II||0
509190|NCT00191906|1224004|P4|COMPLETED|Study Period II||18
509191|NCT00191906|1224005|P3|COMPLETED|Study Period II||26
509192|NCT00191906|1224006|P2|COMPLETED|Study Period II||32
509193|NCT00191906|1224007|P1|COMPLETED|Study Period II||39
509194|NCT00191906|1224004|P4|STARTED|Study Period II||18
509195|NCT00191906|1224005|P3|STARTED|Study Period II||27
509196|NCT00191906|1224006|P2|STARTED|Study Period II||37
509197|NCT00191906|1224007|P1|STARTED|Study Period II||39
509198|NCT00191854|1224050|P3|NOT COMPLETED|Overall Study||39
509199|NCT00191854|1224051|P2|NOT COMPLETED|Overall Study||30
509200|NCT00191854|1224052|P1|NOT COMPLETED|Overall Study||37
509201|NCT00191854|1224050|P3|COMPLETED|Overall Study||12
509202|NCT00191854|1224051|P2|COMPLETED|Overall Study||17
509203|NCT00191854|1224052|P1|COMPLETED|Overall Study||12
509204|NCT00191854|1224050|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
509205|NCT00191854|1224051|P2|Received at Least One Dose of Study Drug|Overall Study||47
509206|NCT00191854|1224052|P1|Received at Least One Dose of Study Drug|Overall Study||49
509207|NCT00191854|1224050|P3|STARTED|Overall Study||51
509208|NCT00191854|1224051|P2|STARTED|Overall Study||47
509209|NCT00191854|1224052|P1|STARTED|Overall Study||49
509210|NCT00191815|1224072|P1|NOT COMPLETED|Overall Study||40
509211|NCT00191815|1224072|P1|COMPLETED|Overall Study||30
509212|NCT00191815|1224072|P1|Treated|Overall Study||67
509213|NCT00191815|1224072|P1|STARTED|Overall Study||70
509214|NCT00191789|1224084|P1|NOT COMPLETED|Overall Study||25
509215|NCT00191789|1224084|P1|COMPLETED|Overall Study||40
509216|NCT00191789|1224084|P1|STARTED|Overall Study||65
509217|NCT00191724|1224101|P5|NOT COMPLETED|Overall Study||3
509218|NCT00191724|1224102|P4|NOT COMPLETED|Overall Study||3
509219|NCT00191724|1224103|P3|NOT COMPLETED|Overall Study||1
509220|NCT00191724|1224104|P2|NOT COMPLETED|Overall Study||1
509221|NCT00191724|1224105|P1|NOT COMPLETED|Overall Study||1
509222|NCT00191724|1224101|P5|COMPLETED|Overall Study||12
509223|NCT00191724|1224102|P4|COMPLETED|Overall Study||5
509224|NCT00191724|1224103|P3|COMPLETED|Overall Study||8
509225|NCT00191724|1224104|P2|COMPLETED|Overall Study||8
509226|NCT00191724|1224105|P1|COMPLETED|Overall Study||5
509227|NCT00191724|1224101|P5|STARTED|Overall Study||15
509228|NCT00191724|1224102|P4|STARTED|Overall Study||8
509229|NCT00191724|1224103|P3|STARTED|Overall Study||9
509230|NCT00191724|1224104|P2|STARTED|Overall Study||9
509231|NCT00191724|1224105|P1|STARTED|Overall Study||6
509232|NCT00191646|1224134|P2|NOT COMPLETED|Overall Study||153
509233|NCT00191646|1224135|P1|NOT COMPLETED|Overall Study||171
509234|NCT00191646|1224134|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
509235|NCT00191646|1224135|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
509236|NCT00191646|1224134|P2|Received Crossover Therapy|Overall Study||78
509237|NCT00191646|1224135|P1|Received Crossover Therapy|Overall Study||77
509238|NCT00191646|1224134|P2|Received Consolidation Therapy|Overall Study||183
509239|NCT00191646|1224135|P1|Received Consolidation Therapy|Overall Study||169
509240|NCT00191646|1224134|P2|Received Induction Therapy|Overall Study||409
509241|NCT00191646|1224135|P1|Received Induction Therapy|Overall Study||411
509242|NCT00191646|1224134|P2|STARTED|Overall Study||414
509243|NCT00191646|1224135|P1|STARTED|Overall Study||417
509244|NCT00191477|1224155|P2|NOT COMPLETED|Overall Study||129
509245|NCT00191477|1224156|P1|NOT COMPLETED|Overall Study||138
509246|NCT00191477|1224155|P2|COMPLETED|Overall Study||47
509247|NCT00191477|1224156|P1|COMPLETED|Overall Study||41
509248|NCT00191477|1224155|P2|Received Study Drug|Overall Study||162
509249|NCT00191477|1224156|P1|Received Study Drug|Overall Study||166
509250|NCT00191477|1224155|P2|STARTED|Overall Study||176
509251|NCT00191477|1224156|P1|STARTED|Overall Study||179
509252|NCT00191451|1224175|P3|NOT COMPLETED|Overall Study||14
509253|NCT00191451|1224176|P2|NOT COMPLETED|Overall Study||14
509254|NCT00191451|1224177|P1|NOT COMPLETED|Overall Study||7
509255|NCT00191451|1224175|P3|COMPLETED|Overall Study||35
509256|NCT00191451|1224176|P2|COMPLETED|Overall Study||37
509257|NCT00191451|1224177|P1|COMPLETED|Overall Study||43
509258|NCT00191451|1224175|P3|Received at Least One Dose of Study Drug|Overall Study||47
509259|NCT00191451|1224176|P2|Received at Least One Dose of Study Drug|Overall Study||48
509260|NCT00191451|1224177|P1|Received at Least One Dose of Study Drug|Overall Study||50
509261|NCT00191451|1224175|P3|STARTED|Overall Study||49
509262|NCT00191451|1224176|P2|STARTED|Overall Study||51
509263|NCT00191451|1224177|P1|STARTED|Overall Study||50
509264|NCT00191386|1224197|P1|NOT COMPLETED|Overall Study||160
509265|NCT00191386|1224197|P1|COMPLETED|Overall Study||68
509266|NCT00191386|1224197|P1|3 Years|Overall Study||65
509267|NCT00191386|1224197|P1|2 Years|Overall Study||105
509268|NCT00191386|1224197|P1|12 Months|Overall Study||149
509269|NCT00191386|1224197|P1|6 Months|Overall Study||183
509270|NCT00191386|1224197|P1|STARTED|Overall Study||228
509271|NCT00191334|1224204|P1|NOT COMPLETED|Overall Study||17
509272|NCT00191334|1224204|P1|COMPLETED|Overall Study||33
509273|NCT00191334|1224204|P1|STARTED|Overall Study||50
509274|NCT00191308|1224212|P1|NOT COMPLETED|Overall Study||1
509275|NCT00191308|1224212|P1|COMPLETED|Overall Study||29
509276|NCT00191308|1224212|P1|STARTED|Overall Study||30
509277|NCT00191282|1224222|P2|NOT COMPLETED|Overall Study||212
509278|NCT00191282|1224223|P1|NOT COMPLETED|Overall Study||220
509279|NCT00191282|1224222|P2|COMPLETED|Overall Study||346
509280|NCT00191282|1224223|P1|COMPLETED|Overall Study||338
509281|NCT00191282|1224222|P2|STARTED|Overall Study||558
509282|NCT00191282|1224223|P1|STARTED|Overall Study||558
509283|NCT00191269|1224283|P2|NOT COMPLETED|Overall Study||58
509284|NCT00191269|1224284|P1|NOT COMPLETED|Overall Study||6
509285|NCT00191269|1224283|P2|COMPLETED|Overall Study||4
509286|NCT00191269|1224284|P1|COMPLETED|Overall Study||0
509287|NCT00191269|1224283|P2|STARTED|Overall Study||62
509288|NCT00191269|1224284|P1|STARTED|Overall Study||6
509289|NCT00191191|1224300|P2|NOT COMPLETED|Overall Study||112
509290|NCT00191191|1224301|P1|NOT COMPLETED|Overall Study||114
509291|NCT00191191|1224300|P2|COMPLETED|Overall Study||0
509292|NCT00191191|1224301|P1|COMPLETED|Overall Study||0
509293|NCT00191191|1224300|P2|Full Analysis Set Population|Overall Study||108
509294|NCT00191191|1224301|P1|Full Analysis Set Population|Overall Study||108
509295|NCT00191191|1224300|P2|Safety Analysis Population|Overall Study||111
509296|NCT00191191|1224301|P1|Safety Analysis Population|Overall Study||114
509297|NCT00191191|1224300|P2|STARTED|Overall Study||112
509298|NCT00191191|1224301|P1|STARTED|Overall Study||114
509299|NCT00191165|1224317|P2|NOT COMPLETED|Overall Study||2
509300|NCT00191165|1224318|P1|NOT COMPLETED|Overall Study||2
509301|NCT00191165|1224317|P2|COMPLETED|Overall Study||11
509302|NCT00191165|1224318|P1|COMPLETED|Overall Study||12
509303|NCT00191165|1224317|P2|STARTED|Overall Study||13
509304|NCT00191165|1224318|P1|STARTED|Overall Study||14
509305|NCT00191152|1224330|P2|NOT COMPLETED|Crossover Treatment||28
509306|NCT00191152|1224331|P1|NOT COMPLETED|Crossover Treatment||27
509307|NCT00191152|1224330|P2|COMPLETED|Crossover Treatment||53
509308|NCT00191152|1224331|P1|COMPLETED|Crossover Treatment||50
509309|NCT00191152|1224330|P2|Received Treatment|Crossover Treatment||80
509310|NCT00191152|1224331|P1|Received Treatment|Crossover Treatment||76
509311|NCT00191152|1224330|P2|STARTED|Crossover Treatment||81
509312|NCT00191152|1224331|P1|STARTED|Crossover Treatment||77
509313|NCT00191152|1224330|P2|NOT COMPLETED|Initial Treatment||153
509314|NCT00191152|1224331|P1|NOT COMPLETED|Initial Treatment||141
509315|NCT00191152|1224330|P2|COMPLETED|Initial Treatment||83
509316|NCT00191152|1224331|P1|COMPLETED|Initial Treatment||98
509317|NCT00191152|1224330|P2|Received Initial Treatment|Initial Treatment||227
509318|NCT00191152|1224331|P1|Received Initial Treatment|Initial Treatment||236
509319|NCT00191152|1224330|P2|STARTED|Initial Treatment||236
509320|NCT00191152|1224331|P1|STARTED|Initial Treatment||239
509321|NCT00191139|1224363|P2|NOT COMPLETED|Overall Study||12
509322|NCT00191139|1224364|P1|NOT COMPLETED|Overall Study||5
509323|NCT00191139|1224363|P2|COMPLETED|Overall Study||20
509324|NCT00191139|1224364|P1|COMPLETED|Overall Study||27
509325|NCT00191139|1224363|P2|STARTED|Overall Study||32
509326|NCT00191139|1224364|P1|STARTED|Overall Study||32
509327|NCT00191113|1224380|P2|NOT COMPLETED|Addendum 3||0
509328|NCT00191113|1224381|P1|NOT COMPLETED|Addendum 3||0
509329|NCT00191113|1224380|P2|COMPLETED|Addendum 3||37
509330|NCT00191113|1224381|P1|COMPLETED|Addendum 3||20
509331|NCT00191113|1224380|P2|STARTED|Addendum 3||37
509332|NCT00191113|1224381|P1|STARTED|Addendum 3||20
509333|NCT00191113|1224380|P2|NOT COMPLETED|Addendum 2||17
509334|NCT00191113|1224381|P1|NOT COMPLETED|Addendum 2||10
509335|NCT00191113|1224380|P2|COMPLETED|Addendum 2||31
509336|NCT00191113|1224381|P1|COMPLETED|Addendum 2||18
509337|NCT00191113|1224380|P2|STARTED|Addendum 2||48
509338|NCT00191113|1224381|P1|STARTED|Addendum 2||28
509339|NCT00191113|1224380|P2|NOT COMPLETED|Addendum 1||0
509340|NCT00191113|1224381|P1|NOT COMPLETED|Addendum 1||0
509341|NCT00191113|1224380|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
509342|NCT00191113|1224381|P1|COMPLETED|Addendum 1||2
509343|NCT00191113|1224380|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
509344|NCT00191113|1224381|P1|STARTED|Addendum 1||2
509345|NCT00191113|1224380|P2|NOT COMPLETED|Core Study||15
509346|NCT00191113|1224381|P1|NOT COMPLETED|Core Study||35
509347|NCT00191113|1224380|P2|COMPLETED|Core Study||61
509348|NCT00191113|1224381|P1|COMPLETED|Core Study||43
509349|NCT00191113|1224380|P2|STARTED|Core Study||76
509350|NCT00191113|1224381|P1|STARTED|Core Study||78
509351|NCT00191100|1224423|P2|NOT COMPLETED|Overall Study||12
509352|NCT00191100|1224424|P1|NOT COMPLETED|Overall Study||42
509353|NCT00191100|1224423|P2|COMPLETED|Overall Study||244
509354|NCT00191100|1224424|P1|COMPLETED|Overall Study||217
509355|NCT00191100|1224423|P2|STARTED|Overall Study||256
509356|NCT00191100|1224424|P1|STARTED|Overall Study||259
509357|NCT00190983|1224440|P1|NOT COMPLETED|Overall Study||2
509358|NCT00190983|1224440|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
509359|NCT00190983|1224440|P1|STARTED|Overall Study||29
509360|NCT00190775|1224449|P2|NOT COMPLETED|Overall Study||100
509361|NCT00190775|1224450|P1|NOT COMPLETED|Overall Study||149
509362|NCT00190775|1224449|P2|COMPLETED|Overall Study||134
509363|NCT00190775|1224450|P1|COMPLETED|Overall Study||119
509364|NCT00190775|1224449|P2|Received Study Drug|Overall Study||234
509365|NCT00190775|1224450|P1|Received Study Drug|Overall Study||266
509366|NCT00190775|1224449|P2|STARTED|Overall Study||234
509367|NCT00190775|1224450|P1|STARTED|Overall Study||268
509368|NCT00190749|1224521|P2|NOT COMPLETED|Overall Study||31
509369|NCT00190749|1224522|P1|NOT COMPLETED|Overall Study||26
509370|NCT00190749|1224521|P2|COMPLETED|Overall Study||31
509371|NCT00190749|1224522|P1|COMPLETED|Overall Study||42
509372|NCT00190749|1224521|P2|STARTED|Overall Study||62
509373|NCT00190749|1224522|P1|STARTED|Overall Study||68
509374|NCT00190684|1224586|P1|NOT COMPLETED|Overall Study||1489
509375|NCT00190684|1224586|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
509376|NCT00190684|1224586|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
509377|NCT00190684|1224586|P1|STARTED|Overall Study||1553
509378|NCT00190671|1224607|P2|NOT COMPLETED|Overall Study||42
509379|NCT00190671|1224608|P1|NOT COMPLETED|Overall Study||27
509380|NCT00190671|1224607|P2|COMPLETED|Overall Study||19
509381|NCT00190671|1224608|P1|COMPLETED|Overall Study||15
509382|NCT00190671|1224607|P2|STARTED|Overall Study||61
509383|NCT00190671|1224608|P1|STARTED|Overall Study||42
509384|NCT00189540|1224628|P2|NOT COMPLETED|Overall Study||1
509385|NCT00189540|1224629|P1|NOT COMPLETED|Overall Study||7
509386|NCT00189540|1224628|P2|COMPLETED|Overall Study||5
509387|NCT00189540|1224629|P1|COMPLETED|Overall Study||14
509388|NCT00189540|1224628|P2|STARTED|Overall Study||6
509389|NCT00189540|1224629|P1|STARTED|Overall Study||21
509390|NCT00189488|1224647|P2|NOT COMPLETED|Overall Study||22
509391|NCT00189488|1224648|P1|NOT COMPLETED|Overall Study||15
509392|NCT00189488|1224647|P2|COMPLETED|Overall Study||55
509393|NCT00189488|1224648|P1|COMPLETED|Overall Study||63
509394|NCT00189488|1224647|P2|Received Palifermin/Placebo|Overall Study||76
509395|NCT00189488|1224648|P1|Received Palifermin/Placebo|Overall Study||75
509396|NCT00189488|1224647|P2|STARTED|Overall Study||77
509397|NCT00189488|1224648|P1|STARTED|Overall Study||78
509398|NCT00189475|1224670|P2|NOT COMPLETED|Overall Study||0
509399|NCT00189475|1224671|P1|NOT COMPLETED|Overall Study||0
509400|NCT00189475|1224670|P2|COMPLETED|Overall Study||42
509401|NCT00189475|1224671|P1|COMPLETED|Overall Study||42
509402|NCT00189475|1224670|P2|STARTED|Overall Study||42
509403|NCT00189475|1224671|P1|STARTED|Overall Study||42
509404|NCT00189462|1224679|P2|NOT COMPLETED|Overall Study||21
509405|NCT00189462|1224680|P1|NOT COMPLETED|Overall Study||23
509406|NCT00189462|1224679|P2|COMPLETED|Overall Study||28
509407|NCT00189462|1224680|P1|COMPLETED|Overall Study||27
509408|NCT00189462|1224679|P2|STARTED|Overall Study||49
509409|NCT00189462|1224680|P1|STARTED|Overall Study||50
509410|NCT00189436|1224688|P2|NOT COMPLETED|Overall Study||5
509411|NCT00189436|1224689|P1|NOT COMPLETED|Overall Study||8
509412|NCT00189436|1224688|P2|COMPLETED|Overall Study||25
509413|NCT00189436|1224689|P1|COMPLETED|Overall Study||23
509414|NCT00189436|1224688|P2|STARTED|Overall Study||30
509415|NCT00189436|1224689|P1|STARTED|Overall Study||31
509416|NCT00189423|1224697|P2|NOT COMPLETED|Overall Study||766
509417|NCT00189423|1224698|P1|NOT COMPLETED|Overall Study||765
509418|NCT00189423|1224697|P2|COMPLETED|Overall Study||74
509419|NCT00189423|1224698|P1|COMPLETED|Overall Study||48
509420|NCT00189423|1224697|P2|STARTED|Overall Study||840
509421|NCT00189423|1224698|P1|STARTED|Overall Study||813
509422|NCT00189306|1224718|P1|NOT COMPLETED|Long-Term Follow-up||38
509423|NCT00189306|1224718|P1|COMPLETED|Long-Term Follow-up||119
509424|NCT00189306|1224718|P1|STARTED|Long-Term Follow-up||157
509425|NCT00189306|1224718|P1|NOT COMPLETED|Posttreatment Period||12
509426|NCT00189306|1224718|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
509427|NCT00189306|1224718|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
509428|NCT00189306|1224718|P1|NOT COMPLETED|Treatment Period||5
509429|NCT00189306|1224718|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
509430|NCT00189306|1224718|P1|STARTED|Treatment Period||169
509431|NCT00189202|1224723|P1|NOT COMPLETED|Overall Study||5
509432|NCT00189202|1224723|P1|COMPLETED|Overall Study||44
509433|NCT00189202|1224723|P1|STARTED|Overall Study||49
509434|NCT00189137|1224734|P2|NOT COMPLETED|Overall Study||0
509435|NCT00189137|1224735|P1|NOT COMPLETED|Overall Study||0
509436|NCT00189137|1224734|P2|COMPLETED|Overall Study||43
509437|NCT00189137|1224735|P1|COMPLETED|Overall Study||37
509438|NCT00189137|1224734|P2|STARTED|Overall Study||43
509439|NCT00189137|1224735|P1|STARTED|Overall Study||37
509440|NCT00189098|1224745|P2|NOT COMPLETED|Overall Study||6
509441|NCT00189098|1224746|P1|NOT COMPLETED|Overall Study||5
509442|NCT00189098|1224745|P2|COMPLETED|Overall Study||44
509443|NCT00189098|1224746|P1|COMPLETED|Overall Study||46
509444|NCT00189098|1224745|P2|STARTED|Overall Study||50
509445|NCT00189098|1224746|P1|STARTED|Overall Study||51
509446|NCT00187889|1224764|P2|NOT COMPLETED|Overall Study||4
509447|NCT00187889|1224765|P1|NOT COMPLETED|Overall Study||6
509448|NCT00187889|1224764|P2|COMPLETED|Overall Study||22
509449|NCT00187889|1224765|P1|COMPLETED|Overall Study||19
509450|NCT00187889|1224764|P2|STARTED|Overall Study||26
509451|NCT00187889|1224765|P1|STARTED|Overall Study||25
509452|NCT00187876|1224775|P2|NOT COMPLETED|Overall Study||0
509453|NCT00187876|1224776|P1|NOT COMPLETED|Overall Study||0
509454|NCT00187876|1224775|P2|COMPLETED|Overall Study||43
509455|NCT00187876|1224776|P1|COMPLETED|Overall Study||24
509456|NCT00187876|1224775|P2|STARTED|Overall Study||43
509457|NCT00187876|1224776|P1|STARTED|Overall Study||24
509458|NCT00187720|1224784|P2|NOT COMPLETED|Overall Study||0
509459|NCT00187720|1224785|P1|NOT COMPLETED|Overall Study||0
509460|NCT00187720|1224784|P2|COMPLETED|Overall Study||14
509461|NCT00187720|1224785|P1|COMPLETED|Overall Study||9
509462|NCT00187720|1224784|P2|STARTED|Overall Study||14
509463|NCT00187720|1224785|P1|STARTED|Overall Study||9
509464|NCT00187681|1224793|P2|NOT COMPLETED|Overall Study||0
509465|NCT00187681|1224794|P1|NOT COMPLETED|Overall Study||0
509466|NCT00187681|1224793|P2|COMPLETED|Overall Study||8
509467|NCT00187681|1224794|P1|COMPLETED|Overall Study||12
509468|NCT00187681|1224793|P2|STARTED|Overall Study||8
509469|NCT00187681|1224794|P1|STARTED|Overall Study||12
509470|NCT00187655|1224802|P1|NOT COMPLETED|Overall Study||0
509471|NCT00187655|1224802|P1|COMPLETED|Overall Study||24
509472|NCT00187655|1224802|P1|STARTED|Overall Study||24
509473|NCT00187486|1224807|P1|NOT COMPLETED|Overall Study||1
509474|NCT00187486|1224807|P1|COMPLETED|Overall Study||65
509475|NCT00187486|1224807|P1|STARTED|Overall Study||66
509476|NCT00187226|1224818|P6|NOT COMPLETED|Overall Study||0
509477|NCT00187226|1224819|P5|NOT COMPLETED|Overall Study||0
509478|NCT00187226|1224820|P4|NOT COMPLETED|Overall Study||0
509479|NCT00187226|1224821|P3|NOT COMPLETED|Overall Study||0
509480|NCT00187226|1224822|P2|NOT COMPLETED|Overall Study||0
509481|NCT00187226|1224823|P1|NOT COMPLETED|Overall Study||0
509482|NCT00187226|1224818|P6|COMPLETED|Overall Study||1
509483|NCT00187226|1224819|P5|COMPLETED|Overall Study||34
509484|NCT00187226|1224820|P4|COMPLETED|Overall Study||2
509485|NCT00187226|1224821|P3|COMPLETED|Overall Study||28
509486|NCT00187226|1224822|P2|COMPLETED|Overall Study||49
509487|NCT00187226|1224823|P1|COMPLETED|Overall Study||88
509488|NCT00187226|1224818|P6|STARTED|Overall Study||1
509489|NCT00187226|1224819|P5|STARTED|Overall Study||34
509490|NCT00187226|1224820|P4|STARTED|Overall Study||2
509491|NCT00187226|1224821|P3|STARTED|Overall Study||28
509492|NCT00187226|1224822|P2|STARTED|Overall Study||49
509493|NCT00187226|1224823|P1|STARTED|Overall Study||88
509494|NCT00187200|1224839|P2|NOT COMPLETED|Overall Study||18
509495|NCT00187200|1224840|P1|NOT COMPLETED|Overall Study||18
509496|NCT00187200|1224839|P2|COMPLETED|Overall Study||26
509497|NCT00187200|1224840|P1|COMPLETED|Overall Study||31
509498|NCT00187200|1224839|P2|STARTED|Overall Study||44
509499|NCT00187200|1224840|P1|STARTED|Overall Study||49
509500|NCT00187135|1224858|P6|NOT COMPLETED|Visit Three||6
509501|NCT00187135|1224859|P5|NOT COMPLETED|Visit Three||8
509502|NCT00187135|1224860|P4|NOT COMPLETED|Visit Three||9
509503|NCT00187135|1224861|P3|NOT COMPLETED|Visit Three||9
509504|NCT00187135|1224862|P2|NOT COMPLETED|Visit Three||7
509505|NCT00187135|1224863|P1|NOT COMPLETED|Visit Three||7
509506|NCT00187135|1224858|P6|COMPLETED|Visit Three||12
509507|NCT00187135|1224859|P5|COMPLETED|Visit Three||11
509508|NCT00187135|1224860|P4|COMPLETED|Visit Three||9
509509|NCT00187135|1224861|P3|COMPLETED|Visit Three||14
509510|NCT00187135|1224862|P2|COMPLETED|Visit Three||17
509511|NCT00187135|1224863|P1|COMPLETED|Visit Three||14
509512|NCT00187135|1224858|P6|STARTED|Visit Three||18
509513|NCT00187135|1224859|P5|STARTED|Visit Three||19
509514|NCT00187135|1224860|P4|STARTED|Visit Three||18
509515|NCT00187135|1224861|P3|STARTED|Visit Three||23
509516|NCT00187135|1224862|P2|STARTED|Visit Three||24
509517|NCT00187135|1224863|P1|STARTED|Visit Three||21
509518|NCT00187135|1224858|P6|NOT COMPLETED|Visit Two||8
509519|NCT00187135|1224859|P5|NOT COMPLETED|Visit Two||6
509520|NCT00187135|1224860|P4|NOT COMPLETED|Visit Two||8
509521|NCT00187135|1224861|P3|NOT COMPLETED|Visit Two||2
509522|NCT00187135|1224862|P2|NOT COMPLETED|Visit Two||3
509523|NCT00187135|1224863|P1|NOT COMPLETED|Visit Two||5
509524|NCT00187135|1224858|P6|COMPLETED|Visit Two||18
509525|NCT00187135|1224859|P5|COMPLETED|Visit Two||19
509526|NCT00187135|1224860|P4|COMPLETED|Visit Two||18
509527|NCT00187135|1224861|P3|COMPLETED|Visit Two||23
509528|NCT00187135|1224862|P2|COMPLETED|Visit Two||24
509529|NCT00187135|1224863|P1|COMPLETED|Visit Two||21
509530|NCT00187135|1224858|P6|STARTED|Visit Two||26
509531|NCT00187135|1224859|P5|STARTED|Visit Two||25
509532|NCT00187135|1224860|P4|STARTED|Visit Two||26
509533|NCT00187135|1224861|P3|STARTED|Visit Two||25
509534|NCT00187135|1224862|P2|STARTED|Visit Two||27
509535|NCT00187135|1224863|P1|STARTED|Visit Two||26
509536|NCT00187135|1224858|P6|NOT COMPLETED|Visit One||2
509537|NCT00187135|1224859|P5|NOT COMPLETED|Visit One||0
509538|NCT00187135|1224860|P4|NOT COMPLETED|Visit One||0
509539|NCT00187135|1224861|P3|NOT COMPLETED|Visit One||0
509540|NCT00187135|1224862|P2|NOT COMPLETED|Visit One||1
509541|NCT00187135|1224863|P1|NOT COMPLETED|Visit One||4
509542|NCT00187135|1224858|P6|COMPLETED|Visit One||26
509543|NCT00187135|1224859|P5|COMPLETED|Visit One||25
509544|NCT00187135|1224860|P4|COMPLETED|Visit One||26
509545|NCT00187135|1224861|P3|COMPLETED|Visit One||25
509546|NCT00187135|1224862|P2|COMPLETED|Visit One||27
509547|NCT00187135|1224863|P1|COMPLETED|Visit One||26
509548|NCT00187135|1224858|P6|STARTED|Visit One||28
509549|NCT00187135|1224859|P5|STARTED|Visit One||25
509550|NCT00187135|1224860|P4|STARTED|Visit One||26
509551|NCT00187135|1224861|P3|STARTED|Visit One||25
509552|NCT00187135|1224862|P2|STARTED|Visit One||28
509553|NCT00187135|1224863|P1|STARTED|Visit One||30
509554|NCT00187096|1224886|P3|NOT COMPLETED|Overall Study||1
509555|NCT00187096|1224887|P2|NOT COMPLETED|Overall Study||0
509556|NCT00187096|1224888|P1|NOT COMPLETED|Overall Study||0
509557|NCT00187096|1224886|P3|COMPLETED|Overall Study||11
509558|NCT00187096|1224887|P2|COMPLETED|Overall Study||3
509559|NCT00187096|1224888|P1|COMPLETED|Overall Study||10
509560|NCT00187096|1224886|P3|STARTED|Overall Study||12
509561|NCT00187096|1224887|P2|STARTED|Overall Study||3
509562|NCT00187096|1224888|P1|STARTED|Overall Study||10
509563|NCT00186901|1224926|P3|NOT COMPLETED|Overall Study||149
509564|NCT00186901|1224927|P2|NOT COMPLETED|Overall Study||45
509565|NCT00186901|1224928|P1|NOT COMPLETED|Overall Study||49
509566|NCT00186901|1224926|P3|COMPLETED|Overall Study||0
509567|NCT00186901|1224927|P2|COMPLETED|Overall Study||96
509568|NCT00186901|1224928|P1|COMPLETED|Overall Study||85
509569|NCT00186901|1224926|P3|24 Month Follow-up|Overall Study||0
509570|NCT00186901|1224927|P2|24 Month Follow-up|Overall Study||107
509571|NCT00186901|1224928|P1|24 Month Follow-up|Overall Study||106
509572|NCT00186901|1224926|P3|12 Month Follow-up|Overall Study||0
509573|NCT00186901|1224927|P2|12 Month Follow-up|Overall Study||122
509574|NCT00186901|1224928|P1|12 Month Follow-up|Overall Study||117
509575|NCT00186901|1224926|P3|Baseline|Overall Study||0
509576|NCT00186901|1224927|P2|Baseline|Overall Study||141
509577|NCT00186901|1224928|P1|Baseline|Overall Study||134
509578|NCT00186901|1224926|P3|STARTED|Overall Study||149
509579|NCT00186901|1224927|P2|STARTED|Overall Study||141
509580|NCT00186901|1224928|P1|STARTED|Overall Study||134
509581|NCT00186888|1224968|P3|NOT COMPLETED|Overall Study||0
509582|NCT00186888|1224969|P2|NOT COMPLETED|Overall Study||3
509583|NCT00186888|1224970|P1|NOT COMPLETED|Overall Study||4
509584|NCT00186888|1224968|P3|COMPLETED|Overall Study||55
509585|NCT00186888|1224969|P2|COMPLETED|Overall Study||24
509586|NCT00186888|1224970|P1|COMPLETED|Overall Study||19
509587|NCT00186888|1224968|P3|Window Therapy|Overall Study||0
509588|NCT00186888|1224969|P2|Window Therapy|Overall Study||27
509589|NCT00186888|1224970|P1|Window Therapy|Overall Study||0
509590|NCT00186888|1224968|P3|STARTED|Overall Study||55
509591|NCT00186888|1224969|P2|STARTED|Overall Study||27
509592|NCT00186888|1224970|P1|STARTED|Overall Study||23
509593|NCT00186875|1225036|P2|NOT COMPLETED|Overall Study||0
509594|NCT00186875|1225037|P1|NOT COMPLETED|Overall Study||0
509595|NCT00186875|1225036|P2|COMPLETED|Overall Study||14
509596|NCT00186875|1225037|P1|COMPLETED|Overall Study||26
509597|NCT00186875|1225036|P2|STARTED|Overall Study||14
509598|NCT00186875|1225037|P1|STARTED|Overall Study||26
509599|NCT00186537|1225046|P3|NOT COMPLETED|Overall Study||3
509600|NCT00186537|1225047|P2|NOT COMPLETED|Overall Study||0
509601|NCT00186537|1225048|P1|NOT COMPLETED|Overall Study||7
509602|NCT00186537|1225046|P3|COMPLETED|Overall Study||13
509603|NCT00186537|1225047|P2|COMPLETED|Overall Study||12
509604|NCT00186537|1225048|P1|COMPLETED|Overall Study||12
509605|NCT00186537|1225046|P3|STARTED|Overall Study||16
509606|NCT00186537|1225047|P2|STARTED|Overall Study||12
509607|NCT00186537|1225048|P1|STARTED|Overall Study||19
509608|NCT00186485|1225062|P1|NOT COMPLETED|Overall Study||3
509609|NCT00186485|1225062|P1|COMPLETED|Overall Study||25
509610|NCT00186485|1225062|P1|STARTED|Overall Study||28
509611|NCT00186446|1225068|P1|NOT COMPLETED|Overall Study||9
509612|NCT00186446|1225068|P1|COMPLETED|Overall Study||11
509613|NCT00186446|1225068|P1|STARTED|Overall Study||20
509614|NCT00186186|1225074|P1|NOT COMPLETED|Overall Study||8
509615|NCT00186186|1225074|P1|COMPLETED|Overall Study||20
509616|NCT00186186|1225074|P1|STARTED|Overall Study||28
509617|NCT00186069|1225081|P2|NOT COMPLETED|Overall Study||0
509618|NCT00186069|1225082|P1|NOT COMPLETED|Overall Study||0
509619|NCT00186069|1225081|P2|COMPLETED|Overall Study||15
509620|NCT00186069|1225082|P1|COMPLETED|Overall Study||15
509621|NCT00186069|1225081|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
509622|NCT00186069|1225082|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
509623|NCT00186056|1225094|P2|NOT COMPLETED|Overall Study||1
509624|NCT00186056|1225095|P1|NOT COMPLETED|Overall Study||2
509625|NCT00186056|1225094|P2|COMPLETED|Overall Study||16
509626|NCT00186056|1225095|P1|COMPLETED|Overall Study||12
509627|NCT00186056|1225094|P2|STARTED|Overall Study||17
509628|NCT00186056|1225095|P1|STARTED|Overall Study||14
509629|NCT00186017|1225103|P2|NOT COMPLETED|Overall Study||3
509630|NCT00186017|1225104|P1|NOT COMPLETED|Overall Study||2
509631|NCT00186017|1225103|P2|COMPLETED|Overall Study||22
509632|NCT00186017|1225104|P1|COMPLETED|Overall Study||23
509633|NCT00186017|1225103|P2|STARTED|Overall Study||25
509634|NCT00186017|1225104|P1|STARTED|Overall Study||25
509635|NCT00185965|1225118|P2|NOT COMPLETED|Overall Study||1
509636|NCT00185965|1225119|P1|NOT COMPLETED|Overall Study||0
509637|NCT00185965|1225118|P2|COMPLETED|Overall Study||14
509638|NCT00185965|1225119|P1|COMPLETED|Overall Study||15
509639|NCT00185965|1225118|P2|STARTED|Overall Study||15
509640|NCT00185965|1225119|P1|STARTED|Overall Study||15
509641|NCT00185692|1225125|P1|NOT COMPLETED|Overall Study||16
509642|NCT00185692|1225125|P1|COMPLETED|Overall Study||0
509643|NCT00185692|1225125|P1|STARTED|Overall Study||16
509644|NCT00185679|1225130|P1|NOT COMPLETED|Overall Study||0
509645|NCT00185679|1225130|P1|COMPLETED|Overall Study||13
509646|NCT00185679|1225130|P1|STARTED|Overall Study||13
509647|NCT00185588|1225140|P4|NOT COMPLETED|Overall Study||4
509648|NCT00185588|1225141|P3|NOT COMPLETED|Overall Study||6
509649|NCT00185588|1225142|P2|NOT COMPLETED|Overall Study||2
509650|NCT00185588|1225143|P1|NOT COMPLETED|Overall Study||3
509651|NCT00185588|1225140|P4|COMPLETED|Overall Study||13
509652|NCT00185588|1225141|P3|COMPLETED|Overall Study||0
509653|NCT00185588|1225142|P2|COMPLETED|Overall Study||2
509654|NCT00185588|1225143|P1|COMPLETED|Overall Study||3
509655|NCT00185588|1225140|P4|STARTED|Overall Study||17
509656|NCT00185588|1225141|P3|STARTED|Overall Study||6
509657|NCT00185588|1225142|P2|STARTED|Overall Study||4
509658|NCT00185588|1225143|P1|STARTED|Overall Study||6
509659|NCT00185458|1225157|P1|NOT COMPLETED|HRT Phase||27
509660|NCT00185458|1225157|P1|COMPLETED|HRT Phase||141
509661|NCT00185458|1225157|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
509662|NCT00185458|1225157|P1|NOT COMPLETED|Contraception Phase||58
509663|NCT00185458|1225157|P1|COMPLETED|Contraception Phase||336
509664|NCT00185458|1225157|P1|STARTED|Contraception Phase||394
509665|NCT00185380|1225220|P3|NOT COMPLETED|Overall Study||74
509666|NCT00185380|1225221|P2|NOT COMPLETED|Overall Study||72
509667|NCT00185380|1225222|P1|NOT COMPLETED|Overall Study||66
509668|NCT00185380|1225220|P3|COMPLETED|Overall Study||182
509669|NCT00185380|1225221|P2|COMPLETED|Overall Study||174
509670|NCT00185380|1225222|P1|COMPLETED|Overall Study||174
509671|NCT00185380|1225220|P3|Subjects Received Treatment|Overall Study||254
509672|NCT00185380|1225221|P2|Subjects Received Treatment|Overall Study||245
509673|NCT00185380|1225222|P1|Subjects Received Treatment|Overall Study||239
509674|NCT00185380|1225220|P3|STARTED|Overall Study||256
509675|NCT00185380|1225221|P2|STARTED|Overall Study||246
509676|NCT00185380|1225222|P1|STARTED|Overall Study||240
509677|NCT00185211|1225250|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
509678|NCT00185211|1225251|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
509679|NCT00185211|1225250|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
509680|NCT00185211|1225251|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
509681|NCT00185211|1225250|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
509682|NCT00185211|1225251|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
509683|NCT00185211|1225250|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
509684|NCT00185211|1225251|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
509685|NCT00185211|1225250|P2|COMPLETED|Placebo-controlled Study (92012)||166
509686|NCT00185211|1225251|P1|COMPLETED|Placebo-controlled Study (92012)||271
509687|NCT00185211|1225250|P2|STARTED|Placebo-controlled Study (92012)||176
509688|NCT00185211|1225251|P1|STARTED|Placebo-controlled Study (92012)||292
509689|NCT00184717|1225279|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
509690|NCT00184717|1225280|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
509691|NCT00184717|1225281|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
509692|NCT00184717|1225282|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
509693|NCT00184717|1225283|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
509694|NCT00184717|1225279|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
509695|NCT00184717|1225280|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
509696|NCT00184717|1225281|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
509697|NCT00184717|1225282|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
509698|NCT00184717|1225283|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
509699|NCT00184717|1225279|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
509700|NCT00184717|1225280|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
509701|NCT00184717|1225281|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
509702|NCT00184717|1225282|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
509703|NCT00184717|1225283|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
509704|NCT00184717|1225279|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
509705|NCT00184717|1225280|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
509706|NCT00184717|1225281|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
509707|NCT00184717|1225282|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
509708|NCT00184717|1225283|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
509709|NCT00184717|1225279|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
509710|NCT00184717|1225280|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
509711|NCT00184717|1225281|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
509712|NCT00184717|1225282|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
509713|NCT00184717|1225283|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
509714|NCT00184717|1225279|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
509715|NCT00184717|1225280|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
509716|NCT00184717|1225281|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
509717|NCT00184717|1225282|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
509718|NCT00184717|1225283|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
509719|NCT00184717|1225279|P5|STARTED|Main Period (GHLIQUID-1516)||0
509720|NCT00184717|1225280|P4|STARTED|Main Period (GHLIQUID-1516)||0
509721|NCT00184717|1225281|P3|STARTED|Main Period (GHLIQUID-1516)||21
509722|NCT00184717|1225282|P2|STARTED|Main Period (GHLIQUID-1516)||38
509723|NCT00184717|1225283|P1|STARTED|Main Period (GHLIQUID-1516)||39
509724|NCT00184600|1225324|P3|NOT COMPLETED|Overall Study||34
509725|NCT00184600|1225325|P2|NOT COMPLETED|Overall Study||51
509726|NCT00184600|1225326|P1|NOT COMPLETED|Overall Study||45
509727|NCT00184600|1225324|P3|COMPLETED|Overall Study||201
509728|NCT00184600|1225325|P2|COMPLETED|Overall Study||188
509729|NCT00184600|1225326|P1|COMPLETED|Overall Study||189
509730|NCT00184600|1225324|P3|STARTED|Overall Study||235
509731|NCT00184600|1225325|P2|STARTED|Overall Study||239
509732|NCT00184600|1225326|P1|STARTED|Overall Study||234
509733|NCT00184548|1225380|P4|NOT COMPLETED|Overall Study||7
509734|NCT00184548|1225381|P3|NOT COMPLETED|Overall Study||3
509735|NCT00184548|1225382|P2|NOT COMPLETED|Overall Study||13
509736|NCT00184548|1225383|P1|NOT COMPLETED|Overall Study||8
509737|NCT00184548|1225380|P4|COMPLETED|Overall Study||38
509738|NCT00184548|1225381|P3|COMPLETED|Overall Study||44
509739|NCT00184548|1225382|P2|COMPLETED|Overall Study||242
509740|NCT00184548|1225383|P1|COMPLETED|Overall Study||218
509741|NCT00184548|1225380|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
509742|NCT00184548|1225381|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
509743|NCT00184548|1225382|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
509744|NCT00184548|1225383|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
509745|NCT00184548|1225380|P4|STARTED|Overall Study||45
509746|NCT00184548|1225381|P3|STARTED|Overall Study||47
509747|NCT00184548|1225382|P2|STARTED|Overall Study||255
509748|NCT00184548|1225383|P1|STARTED|Overall Study||226
509749|NCT00184054|1225417|P1|NOT COMPLETED|Overall Study||1
509750|NCT00184054|1225417|P1|COMPLETED|Overall Study||10
509751|NCT00184054|1225417|P1|STARTED|Overall Study||11
509752|NCT00184028|1225422|P1|NOT COMPLETED|Overall Study||10
509753|NCT00184028|1225422|P1|COMPLETED|Overall Study||2
509754|NCT00184028|1225422|P1|STARTED|Overall Study||12
509755|NCT00183963|1225431|P4|NOT COMPLETED|Overall Study||1
509756|NCT00183963|1225432|P3|NOT COMPLETED|Overall Study||1
509757|NCT00183963|1225433|P2|NOT COMPLETED|Overall Study||1
509758|NCT00183963|1225434|P1|NOT COMPLETED|Overall Study||1
509759|NCT00183963|1225431|P4|COMPLETED|Overall Study||0
509760|NCT00183963|1225432|P3|COMPLETED|Overall Study||0
509761|NCT00183963|1225433|P2|COMPLETED|Overall Study||0
509762|NCT00183963|1225434|P1|COMPLETED|Overall Study||0
509763|NCT00183963|1225431|P4|STARTED|Overall Study||1
509764|NCT00183963|1225432|P3|STARTED|Overall Study||1
509765|NCT00183963|1225433|P2|STARTED|Overall Study||1
509766|NCT00183963|1225434|P1|STARTED|Overall Study||1
509767|NCT00183794|1225448|P1|NOT COMPLETED|Overall Study||0
509768|NCT00183794|1225448|P1|COMPLETED|Overall Study||20
509769|NCT00183794|1225448|P1|STARTED|Overall Study||20
509770|NCT00183729|1225455|P2|NOT COMPLETED|Overall Study||5
509771|NCT00183729|1225456|P1|NOT COMPLETED|Overall Study||3
509772|NCT00183729|1225455|P2|COMPLETED|Overall Study||13
509773|NCT00183729|1225456|P1|COMPLETED|Overall Study||14
509774|NCT00183729|1225455|P2|STARTED|Overall Study||18
509775|NCT00183729|1225456|P1|STARTED|Overall Study||17
509776|NCT00183677|1225462|P1|NOT COMPLETED|Overall Study||44
509777|NCT00183677|1225462|P1|COMPLETED|Overall Study||53
509778|NCT00183677|1225462|P1|STARTED|Overall Study||97
509779|NCT00183625|1225468|P4|NOT COMPLETED|Overall Study||14
509780|NCT00183625|1225469|P3|NOT COMPLETED|Overall Study||19
509781|NCT00183625|1225470|P2|NOT COMPLETED|Overall Study||18
509782|NCT00183625|1225471|P1|NOT COMPLETED|Overall Study||18
509783|NCT00183625|1225468|P4|COMPLETED|Overall Study||10
509784|NCT00183625|1225469|P3|COMPLETED|Overall Study||9
509785|NCT00183625|1225470|P2|COMPLETED|Overall Study||10
509786|NCT00183625|1225471|P1|COMPLETED|Overall Study||9
509787|NCT00183625|1225468|P4|Obtained Employment|Overall Study||14
509788|NCT00183625|1225469|P3|Obtained Employment|Overall Study||14
509789|NCT00183625|1225470|P2|Obtained Employment|Overall Study||18
509790|NCT00183625|1225471|P1|Obtained Employment|Overall Study||21
509791|NCT00183625|1225468|P4|STARTED|Overall Study||24
509792|NCT00183625|1225469|P3|STARTED|Overall Study||28
509793|NCT00183625|1225470|P2|STARTED|Overall Study||28
509794|NCT00183625|1225471|P1|STARTED|Overall Study||27
509795|NCT00183469|1225481|P2|NOT COMPLETED|Overall Study||29
509796|NCT00183469|1225482|P1|NOT COMPLETED|Overall Study||28
509797|NCT00183469|1225481|P2|COMPLETED|Overall Study||16
509798|NCT00183469|1225482|P1|COMPLETED|Overall Study||13
509799|NCT00183469|1225481|P2|STARTED|Overall Study||45
509800|NCT00183469|1225482|P1|STARTED|Overall Study||41
509801|NCT00183456|1225492|P4|NOT COMPLETED|Overall Study||28
509802|NCT00183456|1225493|P3|NOT COMPLETED|Overall Study||16
509803|NCT00183456|1225494|P2|NOT COMPLETED|Overall Study||1
509804|NCT00183456|1225495|P1|NOT COMPLETED|Overall Study||3
509805|NCT00183456|1225492|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
509806|NCT00183456|1225493|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
509807|NCT00183456|1225494|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
509808|NCT00183456|1225495|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
509809|NCT00183456|1225492|P4|18 Month Follow-up|Overall Study||207
509810|NCT00183456|1225493|P3|18 Month Follow-up|Overall Study||303
509811|NCT00183456|1225494|P2|18 Month Follow-up|Overall Study||81
509812|NCT00183456|1225495|P1|18 Month Follow-up|Overall Study||80
509813|NCT00183456|1225492|P4|12 Month Follow-up|Overall Study||186
509814|NCT00183456|1225493|P3|12 Month Follow-up|Overall Study||267
509815|NCT00183456|1225494|P2|12 Month Follow-up|Overall Study||74
509816|NCT00183456|1225495|P1|12 Month Follow-up|Overall Study||76
509817|NCT00183456|1225492|P4|6 Month Follow-up|Overall Study||175
509818|NCT00183456|1225493|P3|6 Month Follow-up|Overall Study||278
509819|NCT00183456|1225494|P2|6 Month Follow-up|Overall Study||77
509820|NCT00183456|1225495|P1|6 Month Follow-up|Overall Study||74
509821|NCT00183456|1225492|P4|STARTED|Overall Study||248
509822|NCT00183456|1225493|P3|STARTED|Overall Study||329
509823|NCT00183456|1225494|P2|STARTED|Overall Study||84
509824|NCT00183456|1225495|P1|STARTED|Overall Study||85
509825|NCT00183430|1225543|P2|NOT COMPLETED|Overall Study||0
509826|NCT00183430|1225544|P1|NOT COMPLETED|Overall Study||6
509827|NCT00183430|1225543|P2|COMPLETED|Overall Study||11
509828|NCT00183430|1225544|P1|COMPLETED|Overall Study||3
509829|NCT00183430|1225543|P2|STARTED|Overall Study||11
509830|NCT00183430|1225544|P1|STARTED|Overall Study||9
509831|NCT00183339|1225556|P2|NOT COMPLETED|Overall Study||4
509832|NCT00183339|1225557|P1|NOT COMPLETED|Overall Study||6
509833|NCT00183339|1225556|P2|COMPLETED|Overall Study||4
509834|NCT00183339|1225557|P1|COMPLETED|Overall Study||4
509835|NCT00183339|1225556|P2|STARTED|Overall Study||8
509836|NCT00183339|1225557|P1|STARTED|Overall Study||10
509837|NCT00183274|1225569|P6|NOT COMPLETED|Phase 3: Double-Blind||4
509838|NCT00183274|1225570|P5|NOT COMPLETED|Phase 3: Double-Blind||20
509839|NCT00183274|1225571|P4|NOT COMPLETED|Phase 3: Double-Blind||2
509840|NCT00183274|1225572|P3|NOT COMPLETED|Phase 3: Double-Blind||0
509841|NCT00183274|1225573|P2|NOT COMPLETED|Phase 3: Double-Blind||0
509842|NCT00183274|1225574|P1|NOT COMPLETED|Phase 3: Double-Blind||0
509843|NCT00183274|1225569|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
509844|NCT00183274|1225570|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
509845|NCT00183274|1225571|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
509846|NCT00183274|1225572|P3|COMPLETED|Phase 3: Double-Blind||0
509847|NCT00183274|1225573|P2|COMPLETED|Phase 3: Double-Blind||0
509848|NCT00183274|1225574|P1|COMPLETED|Phase 3: Double-Blind||0
509849|NCT00183274|1225569|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
509850|NCT00183274|1225570|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
509851|NCT00183274|1225571|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
509852|NCT00183274|1225572|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
509853|NCT00183274|1225573|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
509854|NCT00183274|1225574|P1|STARTED|Phase 3: Double-Blind||0
509855|NCT00183274|1225569|P6|NOT COMPLETED|Phase 2: Double-Blind||0
509856|NCT00183274|1225570|P5|NOT COMPLETED|Phase 2: Double-Blind||0
509857|NCT00183274|1225571|P4|NOT COMPLETED|Phase 2: Double-Blind||0
509858|NCT00183274|1225572|P3|NOT COMPLETED|Phase 2: Double-Blind||43
509859|NCT00183274|1225573|P2|NOT COMPLETED|Phase 2: Double-Blind||26
509860|NCT00183274|1225574|P1|NOT COMPLETED|Phase 2: Double-Blind||0
509861|NCT00183274|1225569|P6|COMPLETED|Phase 2: Double-Blind||0
509862|NCT00183274|1225570|P5|COMPLETED|Phase 2: Double-Blind||0
509863|NCT00183274|1225571|P4|COMPLETED|Phase 2: Double-Blind||0
509864|NCT00183274|1225572|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
509865|NCT00183274|1225573|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
509866|NCT00183274|1225574|P1|COMPLETED|Phase 2: Double-Blind||0
509867|NCT00183274|1225569|P6|STARTED|Phase 2: Double-Blind||0
509868|NCT00183274|1225570|P5|STARTED|Phase 2: Double-Blind||0
509869|NCT00183274|1225571|P4|STARTED|Phase 2: Double-Blind||0
509870|NCT00183274|1225572|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
509871|NCT00183274|1225573|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
509872|NCT00183274|1225574|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
509873|NCT00183274|1225569|P6|NOT COMPLETED|Phase 1: Open-Label||0
509874|NCT00183274|1225570|P5|NOT COMPLETED|Phase 1: Open-Label||0
509875|NCT00183274|1225571|P4|NOT COMPLETED|Phase 1: Open-Label||0
509876|NCT00183274|1225572|P3|NOT COMPLETED|Phase 1: Open-Label||0
509877|NCT00183274|1225573|P2|NOT COMPLETED|Phase 1: Open-Label||0
509878|NCT00183274|1225574|P1|NOT COMPLETED|Phase 1: Open-Label||110
509879|NCT00183274|1225569|P6|COMPLETED|Phase 1: Open-Label||0
509880|NCT00183274|1225570|P5|COMPLETED|Phase 1: Open-Label||0
509881|NCT00183274|1225571|P4|COMPLETED|Phase 1: Open-Label||0
509882|NCT00183274|1225572|P3|COMPLETED|Phase 1: Open-Label||0
509883|NCT00183274|1225573|P2|COMPLETED|Phase 1: Open-Label||0
509884|NCT00183274|1225574|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
509885|NCT00183274|1225569|P6|STARTED|Phase 1: Open-Label||0
509886|NCT00183274|1225570|P5|STARTED|Phase 1: Open-Label||0
509887|NCT00183274|1225571|P4|STARTED|Phase 1: Open-Label||0
509888|NCT00183274|1225572|P3|STARTED|Phase 1: Open-Label||0
509889|NCT00183274|1225573|P2|STARTED|Phase 1: Open-Label||0
509890|NCT00183274|1225574|P1|STARTED|Phase 1: Open-Label||268
509891|NCT00183248|1225591|P2|NOT COMPLETED|Overall Study||1
509892|NCT00183248|1225592|P1|NOT COMPLETED|Overall Study||1
509893|NCT00183248|1225591|P2|COMPLETED|Overall Study||4
509894|NCT00183248|1225592|P1|COMPLETED|Overall Study||3
509895|NCT00183248|1225591|P2|STARTED|Overall Study||5
509896|NCT00183248|1225592|P1|STARTED|Overall Study||4
509897|NCT00183196|1225613|P3|NOT COMPLETED|Overall Study||18
509898|NCT00183196|1225614|P2|NOT COMPLETED|Overall Study||15
509899|NCT00183196|1225615|P1|NOT COMPLETED|Overall Study||20
509900|NCT00183196|1225613|P3|COMPLETED|Overall Study||32
509901|NCT00183196|1225614|P2|COMPLETED|Overall Study||35
509902|NCT00183196|1225615|P1|COMPLETED|Overall Study||30
509903|NCT00183196|1225613|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
509904|NCT00183196|1225614|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
509905|NCT00183196|1225615|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
509906|NCT00183092|1225625|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
509907|NCT00183092|1225626|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
509908|NCT00183092|1225627|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
509909|NCT00183092|1225628|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
509910|NCT00183092|1225625|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
509911|NCT00183092|1225626|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
509912|NCT00183092|1225627|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
509913|NCT00183092|1225628|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
509914|NCT00183092|1225625|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
509915|NCT00183092|1225626|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
509916|NCT00183092|1225627|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
510006|NCT00181844|1225762|P1|COMPLETED|Exposed to Study Medication||22
509917|NCT00183092|1225628|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
509918|NCT00183092|1225625|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
509919|NCT00183092|1225626|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
509920|NCT00183092|1225627|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
509921|NCT00183092|1225628|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
509922|NCT00183092|1225625|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
509923|NCT00183092|1225626|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
509924|NCT00183092|1225627|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
509925|NCT00183092|1225628|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
509926|NCT00183092|1225625|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
509927|NCT00183092|1225626|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
509928|NCT00183092|1225627|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
509929|NCT00183092|1225628|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
509930|NCT00183092|1225625|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
509931|NCT00183092|1225626|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
509932|NCT00183092|1225627|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
509933|NCT00183092|1225628|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
509934|NCT00183092|1225625|P4|STARTED|Double-blind (Baseline - Month 2)||0
509935|NCT00183092|1225626|P3|STARTED|Double-blind (Baseline - Month 2)||0
509936|NCT00183092|1225627|P2|STARTED|Double-blind (Baseline - Month 2)||28
509937|NCT00183092|1225628|P1|STARTED|Double-blind (Baseline - Month 2)||23
509938|NCT00182793|1225649|P1|NOT COMPLETED|Overall Study||0
509939|NCT00182793|1225649|P1|COMPLETED|Overall Study||32
509940|NCT00182793|1225649|P1|STARTED|Overall Study||32
509941|NCT00182767|1225654|P5|NOT COMPLETED|Overall Study||0
509942|NCT00182767|1225655|P4|NOT COMPLETED|Overall Study||0
509943|NCT00182767|1225656|P3|NOT COMPLETED|Overall Study||0
509944|NCT00182767|1225657|P2|NOT COMPLETED|Overall Study||0
509945|NCT00182767|1225658|P1|NOT COMPLETED|Overall Study||0
509946|NCT00182767|1225654|P5|COMPLETED|Overall Study||24
509947|NCT00182767|1225655|P4|COMPLETED|Overall Study||3
509948|NCT00182767|1225656|P3|COMPLETED|Overall Study||6
509949|NCT00182767|1225657|P2|COMPLETED|Overall Study||6
509950|NCT00182767|1225658|P1|COMPLETED|Overall Study||6
509951|NCT00182767|1225654|P5|STARTED|Overall Study||24
509952|NCT00182767|1225655|P4|STARTED|Overall Study||3
509953|NCT00182767|1225656|P3|STARTED|Overall Study||6
509954|NCT00182767|1225657|P2|STARTED|Overall Study||6
509955|NCT00182767|1225658|P1|STARTED|Overall Study||6
509956|NCT00182754|1225675|P2|NOT COMPLETED|Overall Study||0
509957|NCT00182754|1225676|P1|NOT COMPLETED|Overall Study||0
509958|NCT00182754|1225675|P2|COMPLETED|Overall Study||17
509959|NCT00182754|1225676|P1|COMPLETED|Overall Study||16
509960|NCT00182754|1225675|P2|STARTED|Overall Study||17
509961|NCT00182754|1225676|P1|STARTED|Overall Study||16
509962|NCT00182728|1225686|P1|NOT COMPLETED|Overall Study||0
509963|NCT00182728|1225686|P1|COMPLETED|Overall Study||71
509964|NCT00182728|1225686|P1|STARTED|Overall Study||71
509965|NCT00182689|1225698|P2|NOT COMPLETED|Overall Study||49
509966|NCT00182689|1225699|P1|NOT COMPLETED|Overall Study||40
509967|NCT00182689|1225698|P2|COMPLETED|Overall Study||0
509968|NCT00182689|1225699|P1|COMPLETED|Overall Study||0
509969|NCT00182689|1225698|P2|Eligible and Began Protocol Therapy|Overall Study||45
509970|NCT00182689|1225699|P1|Eligible and Began Protocol Therapy|Overall Study||38
509971|NCT00182689|1225698|P2|Eligible|Overall Study||45
509972|NCT00182689|1225699|P1|Eligible|Overall Study||39
509973|NCT00182689|1225698|P2|STARTED|Overall Study||49
509974|NCT00182689|1225699|P1|STARTED|Overall Study||40
509975|NCT00182637|1225709|P1|NOT COMPLETED|Overall Study||3
509976|NCT00182637|1225709|P1|COMPLETED|Overall Study|off study date|2
509977|NCT00182637|1225709|P1|STARTED|Overall Study|active/on treatment date|5
509978|NCT00182091|1225719|P4|NOT COMPLETED|Overall Study||0
509979|NCT00182091|1225720|P3|NOT COMPLETED|Overall Study||0
509980|NCT00182091|1225721|P2|NOT COMPLETED|Overall Study||0
509981|NCT00182091|1225722|P1|NOT COMPLETED|Overall Study||1
509982|NCT00182091|1225719|P4|COMPLETED|Overall Study||20
509983|NCT00182091|1225720|P3|COMPLETED|Overall Study||25
509984|NCT00182091|1225721|P2|COMPLETED|Overall Study||15
509985|NCT00182091|1225722|P1|COMPLETED|Overall Study||14
509986|NCT00182091|1225719|P4|STARTED|Overall Study||20
509987|NCT00182091|1225720|P3|STARTED|Overall Study||25
509988|NCT00182091|1225721|P2|STARTED|Overall Study||15
509989|NCT00182091|1225722|P1|STARTED|Overall Study||15
509990|NCT00182078|1225738|P2|NOT COMPLETED|Overall Study||0
509991|NCT00182078|1225739|P1|NOT COMPLETED|Overall Study||1
509992|NCT00182078|1225738|P2|COMPLETED|Overall Study||17
509993|NCT00182078|1225739|P1|COMPLETED|Overall Study||8
509994|NCT00182078|1225738|P2|STARTED|Overall Study||17
509995|NCT00182078|1225739|P1|STARTED|Overall Study||9
509996|NCT00182000|1225751|P2|NOT COMPLETED|Overall Study||2
509997|NCT00182000|1225752|P1|NOT COMPLETED|Overall Study||5
509998|NCT00182000|1225751|P2|COMPLETED|Overall Study||13
509999|NCT00182000|1225752|P1|COMPLETED|Overall Study||9
510000|NCT00182000|1225751|P2|STARTED|Overall Study||15
510001|NCT00182000|1225752|P1|STARTED|Overall Study||14
510002|NCT00181883|1225758|P1|NOT COMPLETED|Overall Study||10
510003|NCT00181883|1225758|P1|COMPLETED|Overall Study||20
510004|NCT00181883|1225758|P1|STARTED|Overall Study||30
510005|NCT00181844|1225762|P1|NOT COMPLETED|Exposed to Study Medication||17
510007|NCT00181844|1225762|P1|STARTED|Exposed to Study Medication||39
510008|NCT00181844|1225762|P1|NOT COMPLETED|Signed Consent||12
510009|NCT00181844|1225762|P1|COMPLETED|Signed Consent||39
510010|NCT00181844|1225762|P1|STARTED|Signed Consent||51
510011|NCT00181766|1225766|P1|NOT COMPLETED|Overall Study||12
510012|NCT00181766|1225766|P1|COMPLETED|Overall Study|Completed the trial.|33
510013|NCT00181766|1225766|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
510014|NCT00181714|1225771|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
510015|NCT00181714|1225771|P1|COMPLETED|Began Treatment With OROS-MPH||30
510016|NCT00181714|1225771|P1|STARTED|Began Treatment With OROS-MPH||154
510017|NCT00181714|1225771|P1|NOT COMPLETED|Signed Consent/Enrolled||49
510018|NCT00181714|1225771|P1|COMPLETED|Signed Consent/Enrolled||154
510019|NCT00181714|1225771|P1|STARTED|Signed Consent/Enrolled||203
510020|NCT00181623|1225775|P1|NOT COMPLETED|Overall Study||1
510021|NCT00181623|1225775|P1|COMPLETED|Overall Study||5
510022|NCT00181623|1225775|P1|STARTED|Overall Study||6
510023|NCT00181610|1225782|P3|NOT COMPLETED|Overall Study||0
510024|NCT00181610|1225783|P2|NOT COMPLETED|Overall Study||1
510025|NCT00181610|1225784|P1|NOT COMPLETED|Overall Study||0
510026|NCT00181610|1225782|P3|COMPLETED|Overall Study||3
510027|NCT00181610|1225783|P2|COMPLETED|Overall Study||3
510028|NCT00181610|1225784|P1|COMPLETED|Overall Study||4
510029|NCT00181610|1225782|P3|STARTED|Overall Study||3
510030|NCT00181610|1225783|P2|STARTED|Overall Study||4
510031|NCT00181610|1225784|P1|STARTED|Overall Study||4
510032|NCT00181155|1225792|P2|NOT COMPLETED|Overall Study||0
510033|NCT00181155|1225793|P1|NOT COMPLETED|Overall Study||2
510034|NCT00181155|1225792|P2|COMPLETED|Overall Study||3
510035|NCT00181155|1225793|P1|COMPLETED|Overall Study||13
510036|NCT00181155|1225792|P2|STARTED|Overall Study||3
510037|NCT00181155|1225793|P1|STARTED|Overall Study||15
510038|NCT00180687|1225805|P4|NOT COMPLETED|Overall Study||0
510039|NCT00180687|1225806|P3|NOT COMPLETED|Overall Study||0
510040|NCT00180687|1225807|P2|NOT COMPLETED|Overall Study||0
510041|NCT00180687|1225808|P1|NOT COMPLETED|Overall Study||0
510042|NCT00180687|1225805|P4|COMPLETED|Overall Study||20
510043|NCT00180687|1225806|P3|COMPLETED|Overall Study||20
510044|NCT00180687|1225807|P2|COMPLETED|Overall Study||20
510045|NCT00180687|1225808|P1|COMPLETED|Overall Study||20
510046|NCT00180687|1225805|P4|STARTED|Overall Study||20
510047|NCT00180687|1225806|P3|STARTED|Overall Study||20
510048|NCT00180687|1225807|P2|STARTED|Overall Study||20
510049|NCT00180687|1225808|P1|STARTED|Overall Study||20
510050|NCT00180479|1225832|P2|NOT COMPLETED|Overall Study||13
510051|NCT00180479|1225833|P1|NOT COMPLETED|Overall Study||16
510052|NCT00180479|1225832|P2|COMPLETED|Overall Study||320
510053|NCT00180479|1225833|P1|COMPLETED|Overall Study||653
510054|NCT00180479|1225832|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
510055|NCT00180479|1225833|P1|STARTED|Overall Study||669
510056|NCT00180323|1225925|P1|NOT COMPLETED|Overall Study||0
510057|NCT00180323|1225925|P1|COMPLETED|Overall Study||43
510058|NCT00180323|1225925|P1|STARTED|Overall Study||43
510059|NCT00180271|1225934|P2|NOT COMPLETED|Overall Study||0
510060|NCT00180271|1225935|P1|NOT COMPLETED|Overall Study||0
510061|NCT00180271|1225934|P2|COMPLETED|Overall Study||731
510062|NCT00180271|1225935|P1|COMPLETED|Overall Study||1089
510063|NCT00180271|1225934|P2|STARTED|Overall Study||731
510064|NCT00180271|1225935|P1|STARTED|Overall Study||1089
510065|NCT00179959|1225943|P2|NOT COMPLETED|Overall Study||3
510066|NCT00179959|1225944|P1|NOT COMPLETED|Overall Study||6
510067|NCT00179959|1225943|P2|COMPLETED|Overall Study||13
510068|NCT00179959|1225944|P1|COMPLETED|Overall Study||9
510069|NCT00179959|1225943|P2|STARTED|Overall Study||16
510070|NCT00179959|1225944|P1|STARTED|Overall Study||15
510071|NCT00179673|1225950|P1|NOT COMPLETED|Overall Study||43
510072|NCT00179673|1225950|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
510073|NCT00179673|1225950|P1|Received Study Drug|Overall Study||43
510074|NCT00179673|1225950|P1|STARTED|Overall Study||43
510075|NCT00179660|1225958|P1|NOT COMPLETED|Overall Study||50
510076|NCT00179660|1225958|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
510077|NCT00179660|1225958|P1|Completed 12 Cycles of Treatment|Overall Study||12
510078|NCT00179660|1225958|P1|Received Study Drug|Overall Study||49
510079|NCT00179660|1225958|P1|STARTED|Overall Study||50
510080|NCT00179647|1225967|P1|NOT COMPLETED|Overall Study||1913
510081|NCT00179647|1225967|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
510082|NCT00179647|1225967|P1|STARTED|Overall Study||1913
510083|NCT00179621|1225974|P4|NOT COMPLETED|Open-Label Period||43
510084|NCT00179621|1225975|P3|NOT COMPLETED|Open-Label Period||28
510085|NCT00179621|1225976|P2|NOT COMPLETED|Open-Label Period||28
510086|NCT00179621|1225977|P1|NOT COMPLETED|Open-Label Period||0
510087|NCT00179621|1225974|P4|COMPLETED|Open-Label Period||13
510088|NCT00179621|1225975|P3|COMPLETED|Open-Label Period||19
510089|NCT00179621|1225976|P2|COMPLETED|Open-Label Period||14
510090|NCT00179621|1225977|P1|COMPLETED|Open-Label Period||0
510091|NCT00179621|1225974|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
510092|NCT00179621|1225975|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
510187|NCT00177164|1226160|P2|COMPLETED|Overall Study||9
510188|NCT00177164|1226161|P1|COMPLETED|Overall Study||14
510093|NCT00179621|1225976|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
510094|NCT00179621|1225977|P1|STARTED|Open-Label Period||0
510095|NCT00179621|1225974|P4|NOT COMPLETED|Double-Blind Period||0
510096|NCT00179621|1225975|P3|NOT COMPLETED|Double-Blind Period||30
510097|NCT00179621|1225976|P2|NOT COMPLETED|Double-Blind Period||46
510098|NCT00179621|1225977|P1|NOT COMPLETED|Double-Blind Period||64
510099|NCT00179621|1225974|P4|COMPLETED|Double-Blind Period||0
510100|NCT00179621|1225975|P3|COMPLETED|Double-Blind Period||39
510101|NCT00179621|1225976|P2|COMPLETED|Double-Blind Period||23
510102|NCT00179621|1225977|P1|COMPLETED|Double-Blind Period||3
510103|NCT00179621|1225974|P4|STARTED|Double-Blind Period||0
510104|NCT00179621|1225975|P3|STARTED|Double-Blind Period||69
510105|NCT00179621|1225976|P2|STARTED|Double-Blind Period||69
510106|NCT00179621|1225977|P1|STARTED|Double-Blind Period||67
510107|NCT00179309|1226030|P2|NOT COMPLETED|Crossover||0
510108|NCT00179309|1226031|P1|NOT COMPLETED|Crossover||0
510109|NCT00179309|1226030|P2|COMPLETED|Crossover||3
510110|NCT00179309|1226031|P1|COMPLETED|Crossover||0
510111|NCT00179309|1226030|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
510112|NCT00179309|1226031|P1|STARTED|Crossover||0
510113|NCT00179309|1226030|P2|NOT COMPLETED|Treatment||5
510114|NCT00179309|1226031|P1|NOT COMPLETED|Treatment||4
510115|NCT00179309|1226030|P2|COMPLETED|Treatment||18
510116|NCT00179309|1226031|P1|COMPLETED|Treatment||21
510117|NCT00179309|1226030|P2|STARTED|Treatment||23
510118|NCT00179309|1226031|P1|STARTED|Treatment||25
510119|NCT00178919|1226041|P2|NOT COMPLETED|Overall Study||25
510120|NCT00178919|1226042|P1|NOT COMPLETED|Overall Study||0
510121|NCT00178919|1226041|P2|COMPLETED|Overall Study||68
510122|NCT00178919|1226042|P1|COMPLETED|Overall Study||19
510123|NCT00178919|1226041|P2|STARTED|Overall Study||93
510124|NCT00178919|1226042|P1|STARTED|Overall Study||19
510125|NCT00178841|1226050|P1|NOT COMPLETED|Overall Study||0
510126|NCT00178841|1226050|P1|COMPLETED|Overall Study||4
510127|NCT00178841|1226050|P1|STARTED|Overall Study||4
510128|NCT00178711|1226058|P2|NOT COMPLETED|Overall Study||0
510129|NCT00178711|1226059|P1|NOT COMPLETED|Overall Study||0
510130|NCT00178711|1226058|P2|COMPLETED|Overall Study||45
510131|NCT00178711|1226059|P1|COMPLETED|Overall Study||52
510132|NCT00178711|1226058|P2|STARTED|Overall Study||45
510133|NCT00178711|1226059|P1|STARTED|Overall Study||52
510134|NCT00178685|1226070|P3|NOT COMPLETED|Overall Study||196
510135|NCT00178685|1226071|P2|NOT COMPLETED|Overall Study||204
510136|NCT00178685|1226072|P1|NOT COMPLETED|Overall Study||111
510137|NCT00178685|1226070|P3|COMPLETED|Overall Study||128
510138|NCT00178685|1226071|P2|COMPLETED|Overall Study||120
510139|NCT00178685|1226072|P1|COMPLETED|Overall Study||61
510140|NCT00178685|1226070|P3|STARTED|Overall Study||324
510141|NCT00178685|1226071|P2|STARTED|Overall Study||324
510142|NCT00178685|1226072|P1|STARTED|Overall Study||172
510143|NCT00178633|1226083|P1|NOT COMPLETED|Overall Study||6
510144|NCT00178633|1226083|P1|COMPLETED|Overall Study||37
510145|NCT00178633|1226083|P1|STARTED|Overall Study||43
510146|NCT00178503|1226091|P1|NOT COMPLETED|MPH Trial: High Dose||0
510147|NCT00178503|1226091|P1|COMPLETED|MPH Trial: High Dose||24
510148|NCT00178503|1226091|P1|STARTED|MPH Trial: High Dose||24
510149|NCT00178503|1226091|P1|NOT COMPLETED|MPH Trial: Med Dose||0
510150|NCT00178503|1226091|P1|COMPLETED|MPH Trial: Med Dose||24
510151|NCT00178503|1226091|P1|STARTED|MPH Trial: Med Dose||24
510152|NCT00178503|1226091|P1|NOT COMPLETED|MPH Trial: Low Dose||0
510153|NCT00178503|1226091|P1|COMPLETED|MPH Trial: Low Dose||24
510154|NCT00178503|1226091|P1|STARTED|MPH Trial: Low Dose||24
510155|NCT00178503|1226091|P1|NOT COMPLETED|MPH Trial: Placebo||0
510156|NCT00178503|1226091|P1|COMPLETED|MPH Trial: Placebo||24
510157|NCT00178503|1226091|P1|STARTED|MPH Trial: Placebo||24
510158|NCT00178477|1226109|P1|NOT COMPLETED|Overall Study||5
510159|NCT00178477|1226109|P1|COMPLETED|Overall Study||5
510160|NCT00178477|1226109|P1|STARTED|Overall Study||10
510161|NCT00178464|1226113|P1|NOT COMPLETED|Overall Study||2
510162|NCT00178464|1226113|P1|COMPLETED|Overall Study||9
510163|NCT00178464|1226113|P1|STARTED|Overall Study||11
510164|NCT00177307|1226118|P1|NOT COMPLETED|Overall Study||1
510165|NCT00177307|1226118|P1|COMPLETED|Overall Study||39
510166|NCT00177307|1226118|P1|STARTED|Overall Study||40
510167|NCT00177294|1226127|P2|NOT COMPLETED|Overall Study||5
510168|NCT00177294|1226128|P1|NOT COMPLETED|Overall Study||7
510169|NCT00177294|1226127|P2|COMPLETED|Overall Study||59
510170|NCT00177294|1226128|P1|COMPLETED|Overall Study||53
510171|NCT00177294|1226127|P2|STARTED|Overall Study||64
510172|NCT00177294|1226128|P1|STARTED|Overall Study||60
510173|NCT00177255|1226134|P1|NOT COMPLETED|Overall Study||0
510174|NCT00177255|1226134|P1|COMPLETED|Overall Study||39
510175|NCT00177255|1226134|P1|STARTED|Overall Study||39
510176|NCT00177216|1226142|P3|NOT COMPLETED|Overall Study||1
510177|NCT00177216|1226143|P2|NOT COMPLETED|Overall Study||3
510178|NCT00177216|1226144|P1|NOT COMPLETED|Overall Study||6
510179|NCT00177216|1226142|P3|COMPLETED|Overall Study||19
510180|NCT00177216|1226143|P2|COMPLETED|Overall Study||20
510181|NCT00177216|1226144|P1|COMPLETED|Overall Study||20
510182|NCT00177216|1226142|P3|STARTED|Overall Study||20
510183|NCT00177216|1226143|P2|STARTED|Overall Study||23
510184|NCT00177216|1226144|P1|STARTED|Overall Study||26
510185|NCT00177164|1226160|P2|NOT COMPLETED|Overall Study||16
510186|NCT00177164|1226161|P1|NOT COMPLETED|Overall Study||9
510189|NCT00177164|1226160|P2|STARTED|Overall Study||25
510190|NCT00177164|1226161|P1|STARTED|Overall Study||23
510191|NCT00178256|1226173|P4|NOT COMPLETED|Overall Study||2
510192|NCT00178256|1226174|P3|NOT COMPLETED|Overall Study||0
510193|NCT00178256|1226175|P2|NOT COMPLETED|Overall Study||1
510194|NCT00178256|1226176|P1|NOT COMPLETED|Overall Study||4
510195|NCT00178256|1226173|P4|COMPLETED|Overall Study||16
510196|NCT00178256|1226174|P3|COMPLETED|Overall Study||6
510197|NCT00178256|1226175|P2|COMPLETED|Overall Study||6
510198|NCT00178256|1226176|P1|COMPLETED|Overall Study||6
510199|NCT00178256|1226173|P4|STARTED|Overall Study||18
510200|NCT00178256|1226174|P3|STARTED|Overall Study||6
510201|NCT00178256|1226175|P2|STARTED|Overall Study||7
510202|NCT00178256|1226176|P1|STARTED|Overall Study||10
510203|NCT00178191|1226186|P3|NOT COMPLETED|Overall Study||0
510204|NCT00178191|1226187|P2|NOT COMPLETED|Overall Study||0
510205|NCT00178191|1226188|P1|NOT COMPLETED|Overall Study||0
510206|NCT00178191|1226186|P3|COMPLETED|Overall Study||7
510207|NCT00178191|1226187|P2|COMPLETED|Overall Study||10
510208|NCT00178191|1226188|P1|COMPLETED|Overall Study||11
510209|NCT00178191|1226186|P3|STARTED|Overall Study||7
510210|NCT00178191|1226187|P2|STARTED|Overall Study||10
510211|NCT00178191|1226188|P1|STARTED|Overall Study||11
510212|NCT00178178|1226200|P4|NOT COMPLETED|Overall Study||0
510213|NCT00178178|1226201|P3|NOT COMPLETED|Overall Study||0
510214|NCT00178178|1226202|P2|NOT COMPLETED|Overall Study||0
510215|NCT00178178|1226203|P1|NOT COMPLETED|Overall Study||0
510216|NCT00178178|1226200|P4|COMPLETED|Overall Study||24
510217|NCT00178178|1226201|P3|COMPLETED|Overall Study||24
510218|NCT00178178|1226202|P2|COMPLETED|Overall Study||24
510219|NCT00178178|1226203|P1|COMPLETED|Overall Study||24
510220|NCT00178178|1226200|P4|STARTED|Overall Study||24
510221|NCT00178178|1226201|P3|STARTED|Overall Study||24
510222|NCT00178178|1226202|P2|STARTED|Overall Study||24
510223|NCT00178178|1226203|P1|STARTED|Overall Study||24
510224|NCT00178126|1226215|P2|NOT COMPLETED|Overall Study||27
510225|NCT00178126|1226216|P1|NOT COMPLETED|Overall Study||25
510226|NCT00178126|1226215|P2|COMPLETED|Overall Study||86
510227|NCT00178126|1226216|P1|COMPLETED|Overall Study||94
510228|NCT00178126|1226215|P2|STARTED|Overall Study||113
510229|NCT00178126|1226216|P1|STARTED|Overall Study||119
510230|NCT00177970|1226224|P2|NOT COMPLETED|Overall Study||0
510231|NCT00177970|1226225|P1|NOT COMPLETED|Overall Study||0
510232|NCT00177970|1226224|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
510233|NCT00177970|1226225|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
510234|NCT00177970|1226224|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
510235|NCT00177970|1226225|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
510236|NCT00177866|1226247|P2|NOT COMPLETED|Overall Study||0
510237|NCT00177866|1226248|P1|NOT COMPLETED|Overall Study||0
510238|NCT00177866|1226247|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
510239|NCT00177866|1226248|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
510240|NCT00177866|1226247|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
510241|NCT00177866|1226248|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
510242|NCT00177671|1226258|P2|NOT COMPLETED|Overall Study||14
510243|NCT00177671|1226259|P1|NOT COMPLETED|Overall Study||25
510244|NCT00177671|1226258|P2|COMPLETED|Overall Study||49
510245|NCT00177671|1226259|P1|COMPLETED|Overall Study||42
510246|NCT00177671|1226258|P2|Month 24|Overall Study||49
510247|NCT00177671|1226259|P1|Month 24|Overall Study||42
510248|NCT00177671|1226258|P2|Month 12|Overall Study||57
510249|NCT00177671|1226259|P1|Month 12|Overall Study||45
510250|NCT00177671|1226258|P2|STARTED|Overall Study||63
510251|NCT00177671|1226259|P1|STARTED|Overall Study||67
510252|NCT00176917|1226271|P1|NOT COMPLETED|Overall Study||0
510253|NCT00176917|1226271|P1|COMPLETED|Overall Study||41
510254|NCT00176917|1226271|P1|STARTED|Overall Study||41
510255|NCT00176904|1226278|P1|NOT COMPLETED|Overall Study||0
510256|NCT00176904|1226278|P1|COMPLETED|Overall Study||135
510257|NCT00176904|1226278|P1|STARTED|Overall Study||135
510258|NCT00176878|1226286|P1|NOT COMPLETED|Overall Study||0
510259|NCT00176878|1226286|P1|COMPLETED|Overall Study||10
510260|NCT00176878|1226286|P1|STARTED|Overall Study||10
510261|NCT00176865|1226298|P3|NOT COMPLETED|Overall Study||0
510262|NCT00176865|1226299|P2|NOT COMPLETED|Overall Study||0
510263|NCT00176865|1226300|P1|NOT COMPLETED|Overall Study||0
510264|NCT00176865|1226298|P3|COMPLETED|Overall Study||6
510265|NCT00176865|1226299|P2|COMPLETED|Overall Study||10
510266|NCT00176865|1226300|P1|COMPLETED|Overall Study||3
510267|NCT00176865|1226298|P3|STARTED|Overall Study||6
510268|NCT00176865|1226299|P2|STARTED|Overall Study||10
510269|NCT00176865|1226300|P1|STARTED|Overall Study||3
510270|NCT00176852|1226338|P3|NOT COMPLETED|Overall Study||0
510271|NCT00176852|1226339|P2|NOT COMPLETED|Overall Study||0
510272|NCT00176852|1226340|P1|NOT COMPLETED|Overall Study||0
510273|NCT00176852|1226338|P3|COMPLETED|Overall Study||14
510274|NCT00176852|1226339|P2|COMPLETED|Overall Study||5
510275|NCT00176852|1226340|P1|COMPLETED|Overall Study||3
510276|NCT00176852|1226338|P3|STARTED|Overall Study||14
510277|NCT00176852|1226339|P2|STARTED|Overall Study||5
510278|NCT00176852|1226340|P1|STARTED|Overall Study||3
510279|NCT00176839|1226399|P1|NOT COMPLETED|Overall Study||0
510280|NCT00176839|1226399|P1|COMPLETED|Overall Study||11
510281|NCT00176839|1226399|P1|STARTED|Overall Study||11
510282|NCT00176826|1226408|P1|NOT COMPLETED|Overall Study||0
510283|NCT00176826|1226408|P1|COMPLETED|Overall Study||22
510284|NCT00176826|1226408|P1|STARTED|Overall Study||22
510285|NCT00176800|1226418|P1|NOT COMPLETED|Overall Study||0
510286|NCT00176800|1226418|P1|COMPLETED|Overall Study||69
510287|NCT00176800|1226418|P1|STARTED|Overall Study||69
510288|NCT00176644|1226424|P1|NOT COMPLETED|Overall Study||1
510289|NCT00176644|1226424|P1|COMPLETED|Overall Study||22
510290|NCT00176644|1226424|P1|STARTED|Overall Study||23
510291|NCT00176631|1226432|P1|NOT COMPLETED|Overall Study||0
510292|NCT00176631|1226432|P1|COMPLETED|Overall Study||10
510293|NCT00176631|1226432|P1|STARTED|Overall Study||10
510294|NCT00176605|1226437|P1|NOT COMPLETED|Overall Study||2
510295|NCT00176605|1226437|P1|COMPLETED|Overall Study||13
510296|NCT00176605|1226437|P1|STARTED|Overall Study||15
510297|NCT00176501|1226442|P1|NOT COMPLETED|Overall Study||0
510298|NCT00176501|1226442|P1|COMPLETED|Overall Study||3
510299|NCT00176501|1226442|P1|STARTED|Overall Study||3
510300|NCT00176488|1226448|P1|NOT COMPLETED|Overall Study||1
510301|NCT00176488|1226448|P1|COMPLETED|Overall Study||30
510302|NCT00176488|1226448|P1|STARTED|Overall Study||31
510303|NCT00176462|1226456|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
510304|NCT00176462|1226457|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
510305|NCT00176462|1226456|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
510306|NCT00176462|1226457|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
510307|NCT00176462|1226456|P2|STARTED|Continuation -up to 30mos Post Remission||26
510308|NCT00176462|1226457|P1|STARTED|Continuation -up to 30mos Post Remission||19
510309|NCT00176462|1226456|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
510310|NCT00176462|1226457|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
510311|NCT00176462|1226456|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
510312|NCT00176462|1226457|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
510313|NCT00176462|1226456|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
510314|NCT00176462|1226457|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
510315|NCT00176462|1226456|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
510316|NCT00176462|1226457|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
510317|NCT00176462|1226456|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
510318|NCT00176462|1226457|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
510319|NCT00176462|1226456|P2|STARTED|Delayed Intensification (8 Weeks)||29
510320|NCT00176462|1226457|P1|STARTED|Delayed Intensification (8 Weeks)||20
510321|NCT00176462|1226456|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
510322|NCT00176462|1226457|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
510323|NCT00176462|1226456|P2|COMPLETED|Consolidation (12 Weeks)||29
510324|NCT00176462|1226457|P1|COMPLETED|Consolidation (12 Weeks)||20
510325|NCT00176462|1226456|P2|STARTED|Consolidation (12 Weeks)||34
510326|NCT00176462|1226457|P1|STARTED|Consolidation (12 Weeks)||20
510327|NCT00176462|1226456|P2|NOT COMPLETED|Induction (4 Weeks)||5
510328|NCT00176462|1226457|P1|NOT COMPLETED|Induction (4 Weeks)||1
510329|NCT00176462|1226456|P2|COMPLETED|Induction (4 Weeks)||34
510330|NCT00176462|1226457|P1|COMPLETED|Induction (4 Weeks)||20
510331|NCT00176462|1226456|P2|STARTED|Induction (4 Weeks)||39
510332|NCT00176462|1226457|P1|STARTED|Induction (4 Weeks)||21
510333|NCT00176436|1226466|P2|NOT COMPLETED|Overall Study||5
510334|NCT00176436|1226467|P1|NOT COMPLETED|Overall Study||6
510335|NCT00176436|1226466|P2|COMPLETED|Overall Study||12
510336|NCT00176436|1226467|P1|COMPLETED|Overall Study||14
510337|NCT00176436|1226466|P2|STARTED|Overall Study||17
510338|NCT00176436|1226467|P1|STARTED|Overall Study||20
510339|NCT00176306|1226473|P1|NOT COMPLETED|Overall Study||0
510340|NCT00176306|1226473|P1|COMPLETED|Overall Study||15
510341|NCT00176306|1226473|P1|STARTED|Overall Study||15
510342|NCT00176254|1226477|P1|NOT COMPLETED|Overall Study||1
510343|NCT00176254|1226477|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
510344|NCT00176254|1226477|P1|STARTED|Overall Study||40
510345|NCT00176228|1226485|P1|NOT COMPLETED|Overall Study||2
510346|NCT00176228|1226485|P1|COMPLETED|Overall Study|Study ended|46
510347|NCT00176228|1226485|P1|STARTED|Overall Study|When study began|48
510348|NCT00176202|1226492|P2|NOT COMPLETED|Overall Study||16
510349|NCT00176202|1226493|P1|NOT COMPLETED|Overall Study||5
510350|NCT00176202|1226492|P2|COMPLETED|Overall Study||17
510351|NCT00176202|1226493|P1|COMPLETED|Overall Study||27
510352|NCT00176202|1226492|P2|STARTED|Overall Study||33
510353|NCT00176202|1226493|P1|STARTED|Overall Study||32
510354|NCT00175877|1226505|P1|NOT COMPLETED|Overall Study||349
510355|NCT00175877|1226505|P1|COMPLETED|Overall Study||497
510356|NCT00175877|1226505|P1|STARTED|Overall Study||846
510357|NCT00175019|1226539|P3|NOT COMPLETED|Overall Study||57
510358|NCT00175019|1226540|P2|NOT COMPLETED|Overall Study||171
510359|NCT00175019|1226541|P1|NOT COMPLETED|Overall Study||194
510360|NCT00175019|1226539|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
510361|NCT00175019|1226540|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
510362|NCT00175019|1226541|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
510363|NCT00175019|1226539|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
510364|NCT00175019|1226540|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
510365|NCT00175019|1226541|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
510366|NCT00175006|1226585|P1|NOT COMPLETED|Overall Study||0
510367|NCT00175006|1226585|P1|COMPLETED|Overall Study||13
510368|NCT00175006|1226585|P1|STARTED|Overall Study||13
510369|NCT00174967|1226594|P4|NOT COMPLETED|Overall Study||2
510370|NCT00174967|1226595|P3|NOT COMPLETED|Overall Study||2
510371|NCT00174967|1226596|P2|NOT COMPLETED|Overall Study||3
510372|NCT00174967|1226597|P1|NOT COMPLETED|Overall Study||1
510373|NCT00174967|1226594|P4|COMPLETED|Overall Study||36
510374|NCT00174967|1226595|P3|COMPLETED|Overall Study||36
510375|NCT00174967|1226596|P2|COMPLETED|Overall Study||37
510376|NCT00174967|1226597|P1|COMPLETED|Overall Study||36
510377|NCT00174967|1226594|P4|STARTED|Overall Study||38
510378|NCT00174967|1226595|P3|STARTED|Overall Study||38
510379|NCT00174967|1226596|P2|STARTED|Overall Study||40
510380|NCT00174967|1226597|P1|STARTED|Overall Study||37
510381|NCT00174954|1226643|P1|NOT COMPLETED|Overall Study||4
510382|NCT00174954|1226643|P1|COMPLETED|Overall Study||28
510383|NCT00174954|1226643|P1|STARTED|Overall Study||32
510384|NCT00174941|1226651|P4|NOT COMPLETED|Overall Study||58
510385|NCT00174941|1226652|P3|NOT COMPLETED|Overall Study||18
510386|NCT00174941|1226653|P2|NOT COMPLETED|Overall Study||38
510387|NCT00174941|1226654|P1|NOT COMPLETED|Overall Study||2
510388|NCT00174941|1226651|P4|COMPLETED|Overall Study||58
510389|NCT00174941|1226652|P3|COMPLETED|Overall Study||11
510390|NCT00174941|1226653|P2|COMPLETED|Overall Study||41
510391|NCT00174941|1226654|P1|COMPLETED|Overall Study||6
510392|NCT00174941|1226651|P4|STARTED|Overall Study||116
510393|NCT00174941|1226652|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
510394|NCT00174941|1226653|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
510395|NCT00174941|1226654|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
510396|NCT00174915|1226729|P5|NOT COMPLETED|Overall Study||33
510397|NCT00174915|1226730|P4|NOT COMPLETED|Overall Study||57
510398|NCT00174915|1226731|P3|NOT COMPLETED|Overall Study||48
510399|NCT00174915|1226732|P2|NOT COMPLETED|Overall Study||69
510400|NCT00174915|1226733|P1|NOT COMPLETED|Overall Study||93
510401|NCT00174915|1226729|P5|COMPLETED|Overall Study||101
510402|NCT00174915|1226730|P4|COMPLETED|Overall Study||211
510403|NCT00174915|1226731|P3|COMPLETED|Overall Study||86
510404|NCT00174915|1226732|P2|COMPLETED|Overall Study||200
510405|NCT00174915|1226733|P1|COMPLETED|Overall Study||174
510406|NCT00174915|1226729|P5|STARTED|Overall Study||134
510407|NCT00174915|1226730|P4|STARTED|Overall Study||268
510408|NCT00174915|1226731|P3|STARTED|Overall Study||134
510409|NCT00174915|1226732|P2|STARTED|Overall Study||269
510410|NCT00174915|1226733|P1|STARTED|Overall Study||267
510411|NCT00174785|1226792|P2|NOT COMPLETED|Overall Study||716
510412|NCT00174785|1226793|P1|NOT COMPLETED|Overall Study||696
510413|NCT00174785|1226792|P2|COMPLETED|Overall Study|completed study drug|1611
510414|NCT00174785|1226793|P1|COMPLETED|Overall Study|completed study drug|1605
510415|NCT00174785|1226792|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
510416|NCT00174785|1226793|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
510417|NCT00174460|1226809|P2|NOT COMPLETED|Overall Study||1
510418|NCT00174460|1226810|P1|NOT COMPLETED|Overall Study||0
510419|NCT00174460|1226809|P2|COMPLETED|Overall Study||14
510420|NCT00174460|1226810|P1|COMPLETED|Overall Study||18
510421|NCT00174460|1226809|P2|Received Study Treatment|Overall Study||14
510422|NCT00174460|1226810|P1|Received Study Treatment|Overall Study||18
510423|NCT00174460|1226809|P2|STARTED|Overall Study||15
510424|NCT00174460|1226810|P1|STARTED|Overall Study||18
510425|NCT00174447|1226856|P1|NOT COMPLETED|Overall Study||38
510426|NCT00174447|1226856|P1|COMPLETED|Overall Study||5
510427|NCT00174447|1226856|P1|STARTED|Overall Study||43
510428|NCT00174382|1226865|P1|NOT COMPLETED|Overall Study||33
510429|NCT00174382|1226865|P1|COMPLETED|Overall Study||116
510430|NCT00174382|1226865|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
510431|NCT00174291|1226884|P2|NOT COMPLETED|Overall Study||6
510432|NCT00174291|1226885|P1|NOT COMPLETED|Overall Study||5
510433|NCT00174291|1226884|P2|COMPLETED|Overall Study||4
510434|NCT00174291|1226885|P1|COMPLETED|Overall Study||6
510435|NCT00174291|1226884|P2|STARTED|Overall Study||10
510436|NCT00174291|1226885|P1|STARTED|Overall Study||11
510437|NCT00174265|1226915|P2|NOT COMPLETED|Overall Study||21
510438|NCT00174265|1226916|P1|NOT COMPLETED|Overall Study||29
510439|NCT00174265|1226915|P2|COMPLETED|Overall Study||89
510440|NCT00174265|1226916|P1|COMPLETED|Overall Study||57
510441|NCT00174265|1226915|P2|STARTED|Overall Study||110
510442|NCT00174265|1226916|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
510443|NCT00174252|1226924|P1|NOT COMPLETED|Overall Study||2
510444|NCT00174252|1226924|P1|COMPLETED|Overall Study||55
510445|NCT00174252|1226924|P1|STARTED|Overall Study||57
510446|NCT00174187|1226959|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
510447|NCT00174187|1226960|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
510448|NCT00174187|1226961|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
510449|NCT00174187|1226959|P3|COMPLETED|Period 2 (After 3 Years)||13
510450|NCT00174187|1226960|P2|COMPLETED|Period 2 (After 3 Years)||0
510451|NCT00174187|1226961|P1|COMPLETED|Period 2 (After 3 Years)||0
510452|NCT00174187|1226959|P3|STARTED|Period 2 (After 3 Years)||21
510453|NCT00174187|1226960|P2|STARTED|Period 2 (After 3 Years)||0
510454|NCT00174187|1226961|P1|STARTED|Period 2 (After 3 Years)||0
510455|NCT00174187|1226959|P3|NOT COMPLETED|Between Period 1 and Period 2||5
510456|NCT00174187|1226960|P2|NOT COMPLETED|Between Period 1 and Period 2||0
510457|NCT00174187|1226961|P1|NOT COMPLETED|Between Period 1 and Period 2||0
510458|NCT00174187|1226959|P3|COMPLETED|Between Period 1 and Period 2||21
510459|NCT00174187|1226960|P2|COMPLETED|Between Period 1 and Period 2||0
510460|NCT00174187|1226961|P1|COMPLETED|Between Period 1 and Period 2||0
510461|NCT00174187|1226959|P3|Consented|Between Period 1 and Period 2||24
510462|NCT00174187|1226960|P2|Consented|Between Period 1 and Period 2||0
510463|NCT00174187|1226961|P1|Consented|Between Period 1 and Period 2||0
510464|NCT00174187|1226959|P3|STARTED|Between Period 1 and Period 2||26
510465|NCT00174187|1226960|P2|STARTED|Between Period 1 and Period 2||0
510466|NCT00174187|1226961|P1|STARTED|Between Period 1 and Period 2||0
510467|NCT00174187|1226959|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
510468|NCT00174187|1226960|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
510469|NCT00174187|1226961|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
510470|NCT00174187|1226959|P3|COMPLETED|Period 1 (up to 3 Years)||0
510471|NCT00174187|1226960|P2|COMPLETED|Period 1 (up to 3 Years)||11
510472|NCT00174187|1226961|P1|COMPLETED|Period 1 (up to 3 Years)||15
510473|NCT00174187|1226959|P3|STARTED|Period 1 (up to 3 Years)||0
510474|NCT00174187|1226960|P2|STARTED|Period 1 (up to 3 Years)||15
510475|NCT00174187|1226961|P1|STARTED|Period 1 (up to 3 Years)||15
510476|NCT00171704|1227024|P2|NOT COMPLETED|Overall Study||49
510477|NCT00171704|1227025|P1|NOT COMPLETED|Overall Study||44
510478|NCT00171704|1227024|P2|COMPLETED|Overall Study||81
510479|NCT00171704|1227025|P1|COMPLETED|Overall Study||89
510480|NCT00171704|1227024|P2|STARTED|Overall Study||130
510481|NCT00171704|1227025|P1|STARTED|Overall Study||133
510482|NCT00171340|1227047|P2|NOT COMPLETED|Overall Study||135
510483|NCT00171340|1227048|P1|NOT COMPLETED|Overall Study||124
510484|NCT00171340|1227047|P2|COMPLETED|Overall Study||398
510485|NCT00171340|1227048|P1|COMPLETED|Overall Study||408
510486|NCT00171340|1227047|P2|STARTED|Overall Study||533
510487|NCT00171340|1227048|P1|STARTED|Overall Study||532
510488|NCT00171314|1227064|P2|NOT COMPLETED|Overall Study||78
510489|NCT00171314|1227065|P1|NOT COMPLETED|Overall Study||91
510490|NCT00171314|1227064|P2|COMPLETED|Overall Study||186
510491|NCT00171314|1227065|P1|COMPLETED|Overall Study||172
510492|NCT00171314|1227064|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
510493|NCT00171314|1227065|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
510494|NCT00171314|1227064|P2|STARTED|Overall Study||264
510495|NCT00171314|1227065|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
510496|NCT00171301|1227081|P2|NOT COMPLETED|Overall Study||9
510497|NCT00171301|1227082|P1|NOT COMPLETED|Overall Study||8
510498|NCT00171301|1227081|P2|COMPLETED|Overall Study||62
510499|NCT00171301|1227082|P1|COMPLETED|Overall Study||154
510500|NCT00171301|1227081|P2|Received Deferasirox|Overall Study||69
510501|NCT00171301|1227082|P1|Received Deferasirox|Overall Study||162
510502|NCT00171301|1227081|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
510503|NCT00171301|1227082|P1|STARTED|Overall Study||162
510504|NCT00172185|1227097|P4|NOT COMPLETED|Overall Study||4
510505|NCT00172185|1227098|P3|NOT COMPLETED|Overall Study||5
510506|NCT00172185|1227099|P2|NOT COMPLETED|Overall Study||2
510507|NCT00172185|1227100|P1|NOT COMPLETED|Overall Study||0
510508|NCT00172185|1227097|P4|COMPLETED|Overall Study||23
510509|NCT00172185|1227098|P3|COMPLETED|Overall Study||20
510510|NCT00172185|1227099|P2|COMPLETED|Overall Study||5
510511|NCT00172185|1227100|P1|COMPLETED|Overall Study||6
510512|NCT00172185|1227097|P4|STARTED|Overall Study||27
510513|NCT00172185|1227098|P3|STARTED|Overall Study||25
510514|NCT00172185|1227099|P2|STARTED|Overall Study||7
510515|NCT00172185|1227100|P1|STARTED|Overall Study||6
510516|NCT00172042|1227116|P2|NOT COMPLETED|Overall Study||125
510517|NCT00172042|1227117|P1|NOT COMPLETED|Overall Study||158
510518|NCT00172042|1227116|P2|COMPLETED|Overall Study||86
510519|NCT00172042|1227117|P1|COMPLETED|Overall Study||68
510520|NCT00172042|1227116|P2|STARTED|Overall Study||211
510521|NCT00172042|1227117|P1|STARTED|Overall Study||226
510522|NCT00171925|1227139|P2|NOT COMPLETED|Overall Study||31
510523|NCT00171925|1227140|P1|NOT COMPLETED|Overall Study||30
510524|NCT00171925|1227139|P2|COMPLETED|Overall Study||40
510525|NCT00171925|1227140|P1|COMPLETED|Overall Study||42
510526|NCT00171925|1227139|P2|STARTED|Overall Study||71
510527|NCT00171925|1227140|P1|STARTED|Overall Study||72
510528|NCT00171873|1227152|P2|NOT COMPLETED|Overall Study||3
510529|NCT00171873|1227153|P1|NOT COMPLETED|Overall Study||9
510530|NCT00171873|1227152|P2|COMPLETED|Overall Study||40
510531|NCT00171873|1227153|P1|COMPLETED|Overall Study||33
510532|NCT00171873|1227152|P2|STARTED|Overall Study||43
510533|NCT00171873|1227153|P1|STARTED|Overall Study||42
510534|NCT00171834|1227166|P7|NOT COMPLETED|Overall Study||4
510535|NCT00171834|1227167|P6|NOT COMPLETED|Overall Study||35
510536|NCT00171834|1227168|P5|NOT COMPLETED|Overall Study||8
510537|NCT00171834|1227169|P4|NOT COMPLETED|Overall Study||12
510538|NCT00171834|1227170|P3|NOT COMPLETED|Overall Study||12
510539|NCT00171834|1227171|P2|NOT COMPLETED|Overall Study||12
510540|NCT00171834|1227172|P1|NOT COMPLETED|Overall Study||6
510541|NCT00171834|1227166|P7|COMPLETED|Overall Study||0
510542|NCT00171834|1227167|P6|COMPLETED|Overall Study||0
510543|NCT00171834|1227168|P5|COMPLETED|Overall Study||0
510544|NCT00171834|1227169|P4|COMPLETED|Overall Study||0
510545|NCT00171834|1227170|P3|COMPLETED|Overall Study||0
510546|NCT00171834|1227171|P2|COMPLETED|Overall Study||0
510547|NCT00171834|1227172|P1|COMPLETED|Overall Study||0
510548|NCT00171834|1227166|P7|Completed 6 Cycles of Treatment|Overall Study||0
510549|NCT00171834|1227167|P6|Completed 6 Cycles of Treatment|Overall Study||1
510550|NCT00171834|1227168|P5|Completed 6 Cycles of Treatment|Overall Study||2
510551|NCT00171834|1227169|P4|Completed 6 Cycles of Treatment|Overall Study||0
510552|NCT00171834|1227170|P3|Completed 6 Cycles of Treatment|Overall Study||1
510553|NCT00171834|1227171|P2|Completed 6 Cycles of Treatment|Overall Study||0
510554|NCT00171834|1227172|P1|Completed 6 Cycles of Treatment|Overall Study||0
510555|NCT00171834|1227166|P7|STARTED|Overall Study||4
510556|NCT00171834|1227167|P6|STARTED|Overall Study||35
510557|NCT00171834|1227168|P5|STARTED|Overall Study||8
510558|NCT00171834|1227169|P4|STARTED|Overall Study||12
510559|NCT00171834|1227170|P3|STARTED|Overall Study||12
510560|NCT00171834|1227171|P2|STARTED|Overall Study||12
510561|NCT00171834|1227172|P1|STARTED|Overall Study||6
510562|NCT00171210|1227212|P2|NOT COMPLETED|Overall Study||115
510563|NCT00171210|1227213|P1|NOT COMPLETED|Overall Study||69
510564|NCT00171210|1227212|P2|COMPLETED|Overall Study||181
510565|NCT00171210|1227213|P1|COMPLETED|Overall Study||190
510566|NCT00171210|1227212|P2|STARTED EXTENSION STUDY|Overall Study||247
510567|NCT00171210|1227213|P1|STARTED EXTENSION STUDY|Overall Study||259
510568|NCT00171210|1227212|P2|STARTED|Overall Study||296
510569|NCT00171210|1227213|P1|STARTED|Overall Study||259
510570|NCT00171054|1227243|P2|NOT COMPLETED|Overall Study||12
510571|NCT00171054|1227244|P1|NOT COMPLETED|Overall Study||10
510572|NCT00171054|1227243|P2|COMPLETED|Overall Study||50
510573|NCT00171054|1227244|P1|COMPLETED|Overall Study||53
510574|NCT00171054|1227243|P2|STARTED|Overall Study||62
510575|NCT00171054|1227244|P1|STARTED|Overall Study||63
510576|NCT00170950|1227276|P2|NOT COMPLETED|Overall Study||910
510577|NCT00170950|1227277|P1|NOT COMPLETED|Overall Study||885
510578|NCT00170950|1227276|P2|COMPLETED|Overall Study||4852
510579|NCT00170950|1227277|P1|COMPLETED|Overall Study||4859
510580|NCT00170950|1227276|P2|STARTED|Overall Study||5762
510581|NCT00170950|1227277|P1|STARTED|Overall Study||5744
510582|NCT00170846|1227290|P3|NOT COMPLETED|Overall Study||13
510583|NCT00170846|1227291|P2|NOT COMPLETED|Overall Study||19
510584|NCT00170846|1227292|P1|NOT COMPLETED|Overall Study||11
510585|NCT00170846|1227290|P3|COMPLETED|Overall Study||131
510586|NCT00170846|1227291|P2|COMPLETED|Overall Study||108
510587|NCT00170846|1227292|P1|COMPLETED|Overall Study||112
510588|NCT00170846|1227290|P3|STARTED|Overall Study||144
510589|NCT00170846|1227291|P2|STARTED|Overall Study||127
510590|NCT00170846|1227292|P1|STARTED|Overall Study||123
510591|NCT00170625|1227306|P1|NOT COMPLETED|Overall Study||0
510592|NCT00170625|1227306|P1|COMPLETED|Overall Study||26
510593|NCT00170625|1227306|P1|STARTED|Overall Study||26
510594|NCT00170157|1227311|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
510595|NCT00170157|1227312|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
510596|NCT00170157|1227311|P2|COMPLETED|Treatment Period 2 Crossover||41
510597|NCT00170157|1227312|P1|COMPLETED|Treatment Period 2 Crossover||0
510598|NCT00170157|1227311|P2|STARTED|Treatment Period 2 Crossover||41
510599|NCT00170157|1227312|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
510600|NCT00170157|1227311|P2|NOT COMPLETED|Washout Period of 14 Days||17
510601|NCT00170157|1227312|P1|NOT COMPLETED|Washout Period of 14 Days||0
510602|NCT00170157|1227311|P2|COMPLETED|Washout Period of 14 Days||41
510603|NCT00170157|1227312|P1|COMPLETED|Washout Period of 14 Days||0
510604|NCT00170157|1227311|P2|STARTED|Washout Period of 14 Days||58
510605|NCT00170157|1227312|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
510606|NCT00170157|1227311|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
510607|NCT00170157|1227312|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
510608|NCT00170157|1227311|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
510609|NCT00170157|1227312|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
510610|NCT00170157|1227311|P2|STARTED|Treatment Period 1 Initial Randomization||58
510611|NCT00170157|1227312|P1|STARTED|Treatment Period 1 Initial Randomization||54
510612|NCT00169442|1227324|P6|NOT COMPLETED|Overall Study||2
510613|NCT00169442|1227325|P5|NOT COMPLETED|Overall Study||1
510614|NCT00169442|1227326|P4|NOT COMPLETED|Overall Study||0
510615|NCT00169442|1227327|P3|NOT COMPLETED|Overall Study||1
510616|NCT00169442|1227328|P2|NOT COMPLETED|Overall Study||1
510617|NCT00169442|1227329|P1|NOT COMPLETED|Overall Study||0
510618|NCT00169442|1227324|P6|COMPLETED|Overall Study||41
510619|NCT00169442|1227325|P5|COMPLETED|Overall Study||41
510620|NCT00169442|1227326|P4|COMPLETED|Overall Study||250
510621|NCT00169442|1227327|P3|COMPLETED|Overall Study||166
510622|NCT00169442|1227328|P2|COMPLETED|Overall Study||123
510623|NCT00169442|1227329|P1|COMPLETED|Overall Study||119
510624|NCT00169442|1227324|P6|STARTED|Overall Study||43
510625|NCT00169442|1227325|P5|STARTED|Overall Study||42
510626|NCT00169442|1227326|P4|STARTED|Overall Study||250
510627|NCT00169442|1227327|P3|STARTED|Overall Study||167
510628|NCT00169442|1227328|P2|STARTED|Overall Study||124
510629|NCT00169442|1227329|P1|STARTED|Overall Study||119
510630|NCT00168844|1227439|P3|NOT COMPLETED|Overall Study||91
510631|NCT00168844|1227440|P2|NOT COMPLETED|Overall Study||55
510632|NCT00168844|1227441|P1|NOT COMPLETED|Overall Study||55
510633|NCT00168844|1227439|P3|COMPLETED|Overall Study||228
510634|NCT00168844|1227440|P2|COMPLETED|Overall Study||277
510635|NCT00168844|1227441|P1|COMPLETED|Overall Study||277
510636|NCT00168844|1227439|P3|STARTED|Overall Study||319
510637|NCT00168844|1227440|P2|STARTED|Overall Study||332
510638|NCT00168844|1227441|P1|STARTED|Overall Study||332
510639|NCT00168831|1227623|P3|NOT COMPLETED|Overall Study||114
510640|NCT00168831|1227624|P2|NOT COMPLETED|Overall Study||81
510641|NCT00168831|1227625|P1|NOT COMPLETED|Overall Study||60
510642|NCT00168831|1227623|P3|COMPLETED|Overall Study||220
510643|NCT00168831|1227624|P2|COMPLETED|Overall Study||254
510644|NCT00168831|1227625|P1|COMPLETED|Overall Study||278
510645|NCT00168831|1227623|P3|STARTED|Overall Study||334
510646|NCT00168831|1227624|P2|STARTED|Overall Study||335
510647|NCT00168831|1227625|P1|STARTED|Overall Study||338
510648|NCT00168818|1227807|P3|NOT COMPLETED|Treatment||133
510649|NCT00168818|1227808|P2|NOT COMPLETED|Treatment||151
510650|NCT00168818|1227809|P1|NOT COMPLETED|Treatment||133
510651|NCT00168818|1227807|P3|COMPLETED|Treatment||1021
510652|NCT00168818|1227808|P2|COMPLETED|Treatment||1012
510653|NCT00168818|1227809|P1|COMPLETED|Treatment||1013
510654|NCT00168818|1227807|P3|STARTED|Treatment||1154
510655|NCT00168818|1227808|P2|STARTED|Treatment||1163
510656|NCT00168818|1227809|P1|STARTED|Treatment||1146
510657|NCT00168818|1227807|P3|NOT COMPLETED|Overall Study||124
510658|NCT00168818|1227808|P2|NOT COMPLETED|Overall Study||109
510659|NCT00168818|1227809|P1|NOT COMPLETED|Overall Study||117
510660|NCT00168818|1227807|P3|COMPLETED|Overall Study||1030
510661|NCT00168818|1227808|P2|COMPLETED|Overall Study||1054
510662|NCT00168818|1227809|P1|COMPLETED|Overall Study||1029
510663|NCT00168818|1227807|P3|STARTED|Overall Study||1154
510664|NCT00168818|1227808|P2|STARTED|Overall Study||1163
510665|NCT00168818|1227809|P1|STARTED|Overall Study||1146
510666|NCT00168805|1227853|P3|NOT COMPLETED|Treatment||62
510667|NCT00168805|1227854|P2|NOT COMPLETED|Treatment||56
510668|NCT00168805|1227855|P1|NOT COMPLETED|Treatment||49
510669|NCT00168805|1227853|P3|COMPLETED|Treatment||632
510670|NCT00168805|1227854|P2|COMPLETED|Treatment||647
510671|NCT00168805|1227855|P1|COMPLETED|Treatment||630
510672|NCT00168805|1227853|P3|STARTED|Treatment||694
510673|NCT00168805|1227854|P2|STARTED|Treatment||703
510674|NCT00168805|1227855|P1|STARTED|Treatment||679
510675|NCT00168805|1227853|P3|NOT COMPLETED|Overall Study||78
510676|NCT00168805|1227854|P2|NOT COMPLETED|Overall Study||78
510677|NCT00168805|1227855|P1|NOT COMPLETED|Overall Study||71
510678|NCT00168805|1227853|P3|COMPLETED|Overall Study||616
510679|NCT00168805|1227854|P2|COMPLETED|Overall Study||625
510680|NCT00168805|1227855|P1|COMPLETED|Overall Study||608
510681|NCT00168805|1227853|P3|STARTED|Overall Study||694
510682|NCT00168805|1227854|P2|STARTED|Overall Study||703
510683|NCT00168805|1227855|P1|STARTED|Overall Study||679
510684|NCT00168454|1227902|P6|NOT COMPLETED|Overall Study||6
510685|NCT00168454|1227903|P5|NOT COMPLETED|Overall Study||6
510686|NCT00168454|1227904|P4|NOT COMPLETED|Overall Study||9
510687|NCT00168454|1227905|P3|NOT COMPLETED|Overall Study||6
510688|NCT00168454|1227906|P2|NOT COMPLETED|Overall Study||7
510689|NCT00168454|1227907|P1|NOT COMPLETED|Overall Study||7
510690|NCT00168454|1227902|P6|COMPLETED|Overall Study||50
510691|NCT00168454|1227903|P5|COMPLETED|Overall Study||47
510692|NCT00168454|1227904|P4|COMPLETED|Overall Study||40
510693|NCT00168454|1227905|P3|COMPLETED|Overall Study||48
510694|NCT00168454|1227906|P2|COMPLETED|Overall Study||50
510695|NCT00168454|1227907|P1|COMPLETED|Overall Study||37
510696|NCT00168454|1227902|P6|STARTED|Overall Study||56
510697|NCT00168454|1227903|P5|STARTED|Overall Study||53
510698|NCT00168454|1227904|P4|STARTED|Overall Study||49
510699|NCT00168454|1227905|P3|STARTED|Overall Study||54
510700|NCT00168454|1227906|P2|STARTED|Overall Study||57
510701|NCT00168454|1227907|P1|STARTED|Overall Study||44
510702|NCT00168428|1227953|P2|NOT COMPLETED|Open-Label Phase (OL)||68
510703|NCT00168428|1227954|P1|NOT COMPLETED|Open-Label Phase (OL)||44
510704|NCT00168428|1227953|P2|COMPLETED|Open-Label Phase (OL)||261
510705|NCT00168428|1227954|P1|COMPLETED|Open-Label Phase (OL)||261
510706|NCT00168428|1227953|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
510707|NCT00168428|1227954|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
510708|NCT00168428|1227953|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
510709|NCT00168428|1227954|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
510710|NCT00168428|1227953|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
510711|NCT00168428|1227954|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
510712|NCT00168428|1227953|P2|STARTED|Double-Blind Phase (DB)||358
510713|NCT00168428|1227954|P1|STARTED|Double-Blind Phase (DB)||347
510714|NCT00167310|1227972|P2|NOT COMPLETED|Overall Study||10
510715|NCT00167310|1227973|P1|NOT COMPLETED|Overall Study||8
510716|NCT00167310|1227972|P2|COMPLETED|Overall Study||18
510717|NCT00167310|1227973|P1|COMPLETED|Overall Study||21
510718|NCT00167310|1227972|P2|STARTED|Overall Study||28
510719|NCT00167310|1227973|P1|STARTED|Overall Study||29
510720|NCT00167245|1227983|P2|NOT COMPLETED|Overall Study||41
510721|NCT00167245|1227984|P1|NOT COMPLETED|Overall Study||29
510722|NCT00167245|1227983|P2|COMPLETED|Overall Study||46
510723|NCT00167245|1227984|P1|COMPLETED|Overall Study||54
510724|NCT00167245|1227983|P2|STARTED|Overall Study||87
510725|NCT00167245|1227984|P1|STARTED|Overall Study||83
510726|NCT00167206|1227992|P1|NOT COMPLETED|Overall Study||0
510727|NCT00167206|1227992|P1|COMPLETED|Overall Study||16
510728|NCT00167206|1227992|P1|STARTED|Overall Study||16
510729|NCT00168389|1228007|P3|NOT COMPLETED|Overall Study||95
510730|NCT00168389|1228008|P2|NOT COMPLETED|Overall Study||48
510731|NCT00168389|1228009|P1|NOT COMPLETED|Overall Study||56
510732|NCT00168389|1228007|P3|COMPLETED|Overall Study||70
510733|NCT00168389|1228008|P2|COMPLETED|Overall Study||118
510734|NCT00168389|1228009|P1|COMPLETED|Overall Study||107
510735|NCT00168389|1228007|P3|STARTED|Overall Study||165
510736|NCT00168389|1228008|P2|STARTED|Overall Study||166
510737|NCT00168389|1228009|P1|STARTED|Overall Study||163
510738|NCT00168337|1228038|P3|NOT COMPLETED|Overall Study||103
510739|NCT00168337|1228039|P2|NOT COMPLETED|Overall Study||69
510740|NCT00168337|1228040|P1|NOT COMPLETED|Overall Study||70
510741|NCT00168337|1228038|P3|COMPLETED|Overall Study||82
510742|NCT00168337|1228039|P2|COMPLETED|Overall Study||112
510743|NCT00168337|1228040|P1|COMPLETED|Overall Study||118
510744|NCT00168337|1228038|P3|STARTED|Overall Study||185
510745|NCT00168337|1228039|P2|STARTED|Overall Study||181
510746|NCT00168337|1228040|P1|STARTED|Overall Study||188
510747|NCT00168324|1228069|P3|NOT COMPLETED|Open-Label Period||6
510748|NCT00168324|1228070|P2|NOT COMPLETED|Open-Label Period||8
510749|NCT00168324|1228071|P1|NOT COMPLETED|Open-Label Period||4
510750|NCT00168324|1228069|P3|COMPLETED|Open-Label Period||152
510751|NCT00168324|1228070|P2|COMPLETED|Open-Label Period||147
510752|NCT00168324|1228071|P1|COMPLETED|Open-Label Period||160
510753|NCT00168324|1228069|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
510754|NCT00168324|1228070|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
510755|NCT00168324|1228071|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
510756|NCT00168324|1228069|P3|NOT COMPLETED|Double-Blind Period||13
510757|NCT00168324|1228070|P2|NOT COMPLETED|Double-Blind Period||7
510758|NCT00168324|1228071|P1|NOT COMPLETED|Double-Blind Period||12
510759|NCT00168324|1228069|P3|COMPLETED|Double-Blind Period||189
510760|NCT00168324|1228070|P2|COMPLETED|Double-Blind Period||189
510761|NCT00168324|1228071|P1|COMPLETED|Double-Blind Period||189
510762|NCT00168324|1228069|P3|STARTED|Double-Blind Period||202
510763|NCT00168324|1228070|P2|STARTED|Double-Blind Period||196
510764|NCT00168324|1228071|P1|STARTED|Double-Blind Period||201
510765|NCT00168311|1228093|P2|NOT COMPLETED|Overall Study||2
510766|NCT00168311|1228094|P1|NOT COMPLETED|Overall Study||0
510767|NCT00168311|1228093|P2|COMPLETED|Overall Study||8
510768|NCT00168311|1228094|P1|COMPLETED|Overall Study||12
510769|NCT00168311|1228093|P2|STARTED|Overall Study||10
510770|NCT00168311|1228094|P1|STARTED|Overall Study||12
510771|NCT00168298|1228103|P3|NOT COMPLETED|Open-Label Period||8
510772|NCT00168298|1228104|P2|NOT COMPLETED|Open-Label Period||5
510773|NCT00168298|1228105|P1|NOT COMPLETED|Open-Label Period||7
510774|NCT00168298|1228103|P3|COMPLETED|Open-Label Period||160
510775|NCT00168298|1228104|P2|COMPLETED|Open-Label Period||168
510776|NCT00168298|1228105|P1|COMPLETED|Open-Label Period||172
510777|NCT00168298|1228103|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
510778|NCT00168298|1228104|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
510779|NCT00168298|1228105|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
510780|NCT00168298|1228103|P3|NOT COMPLETED|Double-Blind Period||15
510781|NCT00168298|1228104|P2|NOT COMPLETED|Double-Blind Period||12
510782|NCT00168298|1228105|P1|NOT COMPLETED|Double-Blind Period||12
510783|NCT00168298|1228103|P3|COMPLETED|Double-Blind Period||209
510784|NCT00168298|1228104|P2|COMPLETED|Double-Blind Period||206
510785|NCT00168298|1228105|P1|COMPLETED|Double-Blind Period||214
510786|NCT00168298|1228103|P3|STARTED|Double-Blind Period||224
510787|NCT00168298|1228104|P2|STARTED|Double-Blind Period||218
510788|NCT00168298|1228105|P1|STARTED|Double-Blind Period||226
510789|NCT00167102|1228124|P2|NOT COMPLETED|Overall Study||0
510790|NCT00167102|1228125|P1|NOT COMPLETED|Overall Study||0
510791|NCT00167102|1228124|P2|COMPLETED|Overall Study||22
510792|NCT00167102|1228125|P1|COMPLETED|Overall Study||23
510793|NCT00167102|1228124|P2|STARTED|Overall Study||22
510794|NCT00167102|1228125|P1|STARTED|Overall Study||23
510795|NCT00166036|1228135|P2|NOT COMPLETED|Overall Study||0
510796|NCT00166036|1228136|P1|NOT COMPLETED|Overall Study||0
510797|NCT00166036|1228135|P2|COMPLETED|Overall Study||19
510798|NCT00166036|1228136|P1|COMPLETED|Overall Study||17
510799|NCT00166036|1228135|P2|STARTED|Overall Study||19
510800|NCT00166036|1228136|P1|STARTED|Overall Study||17
510801|NCT00168103|1228147|P4|NOT COMPLETED|Overall Study||0
510802|NCT00168103|1228148|P3|NOT COMPLETED|Overall Study||1
510803|NCT00168103|1228149|P2|NOT COMPLETED|Overall Study||5
510804|NCT00168103|1228150|P1|NOT COMPLETED|Overall Study||2
510805|NCT00168103|1228147|P4|COMPLETED|Overall Study||1
510806|NCT00168103|1228148|P3|COMPLETED|Overall Study||41
510807|NCT00168103|1228149|P2|COMPLETED|Overall Study||38
510808|NCT00168103|1228150|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
510809|NCT00168103|1228147|P4|STARTED|Overall Study||1
510810|NCT00168103|1228148|P3|STARTED|Overall Study||42
510811|NCT00168103|1228149|P2|STARTED|Overall Study||43
510812|NCT00168103|1228150|P1|STARTED|Overall Study||40
510813|NCT00168064|1228172|P2|NOT COMPLETED|Overall Study||44
510814|NCT00168064|1228173|P1|NOT COMPLETED|Overall Study||49
510815|NCT00168064|1228172|P2|COMPLETED|Overall Study||86
510816|NCT00168064|1228173|P1|COMPLETED|Overall Study||81
510817|NCT00168064|1228172|P2|STARTED|Overall Study|127 participants received AP formulation|130
510818|NCT00168064|1228173|P1|STARTED|Overall Study|128 participants received PG formulation|130
510819|NCT00168038|1228181|P1|NOT COMPLETED|Overall Study||2
510820|NCT00168038|1228181|P1|COMPLETED|Overall Study||55
510821|NCT00168038|1228181|P1|STARTED|Overall Study||57
510822|NCT00167778|1228193|P1|NOT COMPLETED|Overall Study||1
510823|NCT00167778|1228193|P1|COMPLETED|Overall Study||10
510824|NCT00167778|1228193|P1|STARTED|Overall Study||11
510825|NCT00167544|1228244|P2|NOT COMPLETED|Overall Study||0
510826|NCT00167544|1228245|P1|NOT COMPLETED|Overall Study||1
510827|NCT00167544|1228244|P2|COMPLETED|Overall Study||33
510828|NCT00167544|1228245|P1|COMPLETED|Overall Study||30
510829|NCT00167544|1228244|P2|STARTED|Overall Study||33
510830|NCT00167544|1228245|P1|STARTED|Overall Study||31
510831|NCT00166712|1228261|P2|NOT COMPLETED|Overall Study||5
510832|NCT00166712|1228262|P1|NOT COMPLETED|Overall Study||2
510833|NCT00166712|1228261|P2|COMPLETED|Overall Study|Completed study participation.|11
510834|NCT00166712|1228262|P1|COMPLETED|Overall Study|Completed study participation.|22
510835|NCT00166712|1228261|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
510836|NCT00166712|1228262|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
510837|NCT00166712|1228261|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
510838|NCT00166712|1228262|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
510839|NCT00166712|1228261|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
510840|NCT00166712|1228262|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
510841|NCT00166712|1228261|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
510842|NCT00166712|1228262|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
510843|NCT00166712|1228261|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
510844|NCT00166712|1228262|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
510845|NCT00166517|1228279|P2|NOT COMPLETED|Overall Study||2
510846|NCT00166517|1228280|P1|NOT COMPLETED|Overall Study||5
510847|NCT00166517|1228279|P2|COMPLETED|Overall Study||61
510848|NCT00166517|1228280|P1|COMPLETED|Overall Study||110
510849|NCT00166517|1228279|P2|Vaccinated at Visit 3|Overall Study||61
510850|NCT00166517|1228280|P1|Vaccinated at Visit 3|Overall Study||110
510851|NCT00166517|1228279|P2|Vaccinated at Visit 2|Overall Study||61
510852|NCT00166517|1228280|P1|Vaccinated at Visit 2|Overall Study||112
510853|NCT00166517|1228279|P2|Vaccinated at Visit 1|Overall Study||63
510854|NCT00166517|1228280|P1|Vaccinated at Visit 1|Overall Study||115
510855|NCT00166517|1228279|P2|STARTED|Overall Study||63
510856|NCT00166517|1228280|P1|STARTED|Overall Study||115
510857|NCT00166504|1228290|P2|NOT COMPLETED|Overall Study||4
510858|NCT00166504|1228291|P1|NOT COMPLETED|Overall Study||5
510859|NCT00166504|1228290|P2|COMPLETED|Overall Study||91
510860|NCT00166504|1228291|P1|COMPLETED|Overall Study||103
510861|NCT00166504|1228290|P2|STARTED|Overall Study||95
510862|NCT00166504|1228291|P1|STARTED|Overall Study||108
510863|NCT00166361|1228299|P2|NOT COMPLETED|Overall Study||0
510864|NCT00166361|1228300|P1|NOT COMPLETED|Overall Study||0
510865|NCT00166361|1228299|P2|COMPLETED|Overall Study||10
510866|NCT00166361|1228300|P1|COMPLETED|Overall Study||14
510867|NCT00166361|1228299|P2|STARTED|Overall Study||10
510868|NCT00166361|1228300|P1|STARTED|Overall Study||14
510869|NCT00166296|1228308|P2|NOT COMPLETED|Overall Study||9
510870|NCT00166296|1228309|P1|NOT COMPLETED|Overall Study||7
510871|NCT00166296|1228308|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
510872|NCT00166296|1228309|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
510873|NCT00166296|1228308|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
510874|NCT00166296|1228309|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
510875|NCT00166296|1228308|P2|STARTED|Overall Study|Randomized patients|66
510876|NCT00166296|1228309|P1|STARTED|Overall Study|Randomized patients|67
510877|NCT00166205|1228321|P1|NOT COMPLETED|Overall Study||48
510878|NCT00166205|1228321|P1|COMPLETED|Overall Study||228
510879|NCT00166205|1228321|P1|Intervention - SAGB Surgery|Overall Study||276
510880|NCT00166205|1228321|P1|STARTED|Overall Study||276
510881|NCT00166166|1228337|P2|NOT COMPLETED|Overall Study||0
510882|NCT00166166|1228338|P1|NOT COMPLETED|Overall Study||0
510883|NCT00166166|1228337|P2|COMPLETED|Overall Study||71
510884|NCT00166166|1228338|P1|COMPLETED|Overall Study||103
510885|NCT00166166|1228337|P2|STARTED|Overall Study||71
510886|NCT00166166|1228338|P1|STARTED|Overall Study||103
510887|NCT00166114|1228361|P2|NOT COMPLETED|Overall Study||6
510888|NCT00166114|1228362|P1|NOT COMPLETED|Overall Study||14
510889|NCT00166114|1228361|P2|COMPLETED|Overall Study||13
510890|NCT00166114|1228362|P1|COMPLETED|Overall Study||7
510891|NCT00166114|1228361|P2|STARTED|Overall Study||19
510892|NCT00166114|1228362|P1|STARTED|Overall Study||21
510893|NCT00165984|1228368|P1|NOT COMPLETED|Overall Study||15
510894|NCT00165984|1228368|P1|COMPLETED|Overall Study||150
510895|NCT00165984|1228368|P1|STARTED|Overall Study||165
510896|NCT00165958|1228377|P2|NOT COMPLETED|Overall Study||2
510897|NCT00165958|1228378|P1|NOT COMPLETED|Overall Study||1
510898|NCT00165958|1228377|P2|COMPLETED|Overall Study||19
510899|NCT00165958|1228378|P1|COMPLETED|Overall Study||18
510900|NCT00165958|1228377|P2|STARTED|Overall Study||21
510901|NCT00165958|1228378|P1|STARTED|Overall Study||19
510902|NCT00165841|1228386|P2|NOT COMPLETED|Overall Study||62
510903|NCT00165841|1228387|P1|NOT COMPLETED|Overall Study||30
510904|NCT00165841|1228386|P2|COMPLETED|Overall Study||35
510905|NCT00165841|1228387|P1|COMPLETED|Overall Study||73
510906|NCT00165841|1228386|P2|STARTED|Overall Study||97
510907|NCT00165841|1228387|P1|STARTED|Overall Study||103
510908|NCT00165789|1228397|P4|NOT COMPLETED|Overall Study||14
510909|NCT00165789|1228398|P3|NOT COMPLETED|Overall Study||1
510910|NCT00165789|1228399|P2|NOT COMPLETED|Overall Study||4
510911|NCT00165789|1228400|P1|NOT COMPLETED|Overall Study||0
510912|NCT00165789|1228397|P4|COMPLETED|Overall Study||21
510913|NCT00165789|1228398|P3|COMPLETED|Overall Study||11
510914|NCT00165789|1228399|P2|COMPLETED|Overall Study||16
510915|NCT00165789|1228400|P1|COMPLETED|Overall Study||8
510916|NCT00165789|1228397|P4|STARTED|Overall Study||35
510917|NCT00165789|1228398|P3|STARTED|Overall Study||12
510918|NCT00165789|1228399|P2|STARTED|Overall Study||20
510919|NCT00165789|1228400|P1|STARTED|Overall Study||8
510920|NCT00165776|1228454|P4|NOT COMPLETED|Overall Study||2
510921|NCT00165776|1228455|P3|NOT COMPLETED|Overall Study||2
510922|NCT00165776|1228456|P2|NOT COMPLETED|Overall Study||1
510923|NCT00165776|1228457|P1|NOT COMPLETED|Overall Study||4
510924|NCT00165776|1228454|P4|COMPLETED|Overall Study||29
510925|NCT00165776|1228455|P3|COMPLETED|Overall Study||31
510926|NCT00165776|1228456|P2|COMPLETED|Overall Study||33
510927|NCT00165776|1228457|P1|COMPLETED|Overall Study||31
510928|NCT00165776|1228454|P4|STARTED|Overall Study||31
510929|NCT00165776|1228455|P3|STARTED|Overall Study||33
510930|NCT00165776|1228456|P2|STARTED|Overall Study||34
510931|NCT00165776|1228457|P1|STARTED|Overall Study||35
510932|NCT00165698|1228493|P2|NOT COMPLETED|Overall Study||15
510933|NCT00165698|1228494|P1|NOT COMPLETED|Overall Study||8
510934|NCT00165698|1228493|P2|COMPLETED|Overall Study||105
510935|NCT00165698|1228494|P1|COMPLETED|Overall Study||112
510936|NCT00165698|1228493|P2|STARTED|Overall Study||120
510937|NCT00165698|1228494|P1|STARTED|Overall Study||120
510938|NCT00165672|1228520|P2|NOT COMPLETED|Overall Study||1
510939|NCT00165672|1228521|P1|NOT COMPLETED|Overall Study||0
510940|NCT00165672|1228520|P2|COMPLETED|Overall Study||12
510941|NCT00165672|1228521|P1|COMPLETED|Overall Study||13
510942|NCT00165672|1228520|P2|STARTED|Overall Study||13
510943|NCT00165672|1228521|P1|STARTED|Overall Study||13
510944|NCT00165646|1228530|P3|NOT COMPLETED|Overall Study||4
510945|NCT00165646|1228531|P2|NOT COMPLETED|Overall Study||5
510946|NCT00165646|1228532|P1|NOT COMPLETED|Overall Study||5
510947|NCT00165646|1228530|P3|COMPLETED|Overall Study||98
510948|NCT00165646|1228531|P2|COMPLETED|Overall Study||88
510949|NCT00165646|1228532|P1|COMPLETED|Overall Study||88
510950|NCT00165646|1228530|P3|STARTED|Overall Study||102
510951|NCT00165646|1228531|P2|STARTED|Overall Study||93
510952|NCT00165646|1228532|P1|STARTED|Overall Study||93
510953|NCT00165503|1228540|P1|NOT COMPLETED|Overall Study||16
510954|NCT00165503|1228540|P1|COMPLETED|Overall Study||0
510955|NCT00165503|1228540|P1|STARTED|Overall Study||16
510956|NCT00163657|1228547|P3|NOT COMPLETED|Overall Study||37
510957|NCT00163657|1228548|P2|NOT COMPLETED|Overall Study||23
510958|NCT00163657|1228549|P1|NOT COMPLETED|Overall Study||20
510959|NCT00163657|1228547|P3|COMPLETED|Overall Study||116
510960|NCT00163657|1228548|P2|COMPLETED|Overall Study||56
510961|NCT00163657|1228549|P1|COMPLETED|Overall Study||60
510962|NCT00163657|1228547|P3|STARTED|Overall Study||153
510963|NCT00163657|1228548|P2|STARTED|Overall Study||79
510964|NCT00163657|1228549|P1|STARTED|Overall Study||80
510965|NCT00163293|1228563|P3|NOT COMPLETED|Overall Study||19
510966|NCT00163293|1228564|P2|NOT COMPLETED|Overall Study||7
510967|NCT00163293|1228565|P1|NOT COMPLETED|Overall Study||13
510968|NCT00163293|1228563|P3|COMPLETED|Overall Study||66
510969|NCT00163293|1228564|P2|COMPLETED|Overall Study||69
510970|NCT00163293|1228565|P1|COMPLETED|Overall Study||66
510971|NCT00163293|1228563|P3|STARTED|Overall Study||85
510972|NCT00163293|1228564|P2|STARTED|Overall Study||76
510973|NCT00163293|1228565|P1|STARTED|Overall Study||79
510974|NCT00163215|1228639|P1|NOT COMPLETED|Overall Study||15
510975|NCT00163215|1228639|P1|COMPLETED|Overall Study||31
510976|NCT00163215|1228639|P1|STARTED|Overall Study||46
510977|NCT00163189|1228659|P1|NOT COMPLETED|Overall Study||63
510978|NCT00163189|1228659|P1|COMPLETED|Overall Study||35
510979|NCT00163189|1228659|P1|STARTED|Overall Study||98
510980|NCT00163020|1228683|P2|NOT COMPLETED|Overall Study||2
510981|NCT00163020|1228684|P1|NOT COMPLETED|Overall Study||0
510982|NCT00163020|1228683|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
510983|NCT00163020|1228684|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
510984|NCT00163020|1228683|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
510985|NCT00163020|1228684|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
510986|NCT00162981|1228724|P2|NOT COMPLETED|Overall Study||6
510987|NCT00162981|1228725|P1|NOT COMPLETED|Overall Study||4
510988|NCT00162981|1228724|P2|COMPLETED|Overall Study||30
510989|NCT00162981|1228725|P1|COMPLETED|Overall Study||28
510990|NCT00162981|1228724|P2|STARTED|Overall Study||36
510991|NCT00162981|1228725|P1|STARTED|Overall Study||32
510992|NCT00162942|1228741|P2|NOT COMPLETED|Overall Study||52
510993|NCT00162942|1228742|P1|NOT COMPLETED|Overall Study||106
510994|NCT00162942|1228741|P2|COMPLETED|Overall Study||26
510995|NCT00162942|1228742|P1|COMPLETED|Overall Study||51
510996|NCT00162942|1228741|P2|Week 12|Overall Study||61
510997|NCT00162942|1228742|P1|Week 12|Overall Study||127
510998|NCT00162942|1228741|P2|STARTED|Overall Study||78
510999|NCT00162942|1228742|P1|STARTED|Overall Study||157
511000|NCT00162370|1228790|P1|NOT COMPLETED|Efficacy Population||51
511001|NCT00162370|1228790|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
511002|NCT00162370|1228790|P1|STARTED|Efficacy Population||366
511003|NCT00162370|1228790|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
511004|NCT00162370|1228790|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
511005|NCT00162370|1228790|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
511006|NCT00162266|1228798|P4|NOT COMPLETED|Open-Label Period||137
511007|NCT00162266|1228799|P3|NOT COMPLETED|Open-Label Period||0
511008|NCT00162266|1228800|P2|NOT COMPLETED|Open-Label Period||0
511009|NCT00162266|1228801|P1|NOT COMPLETED|Open-Label Period||0
511010|NCT00162266|1228798|P4|COMPLETED|Open-Label Period||82
511011|NCT00162266|1228799|P3|COMPLETED|Open-Label Period||0
511012|NCT00162266|1228800|P2|COMPLETED|Open-Label Period||0
511013|NCT00162266|1228801|P1|COMPLETED|Open-Label Period||0
511014|NCT00162266|1228798|P4|STARTED|Open-Label Period||219
511015|NCT00162266|1228799|P3|STARTED|Open-Label Period||0
511016|NCT00162266|1228800|P2|STARTED|Open-Label Period||0
511017|NCT00162266|1228801|P1|STARTED|Open-Label Period||0
511018|NCT00162266|1228798|P4|NOT COMPLETED|Double-Blind Period||0
511019|NCT00162266|1228799|P3|NOT COMPLETED|Double-Blind Period||48
511020|NCT00162266|1228800|P2|NOT COMPLETED|Double-Blind Period||31
511021|NCT00162266|1228801|P1|NOT COMPLETED|Double-Blind Period||25
511022|NCT00162266|1228798|P4|COMPLETED|Double-Blind Period||0
511023|NCT00162266|1228799|P3|COMPLETED|Double-Blind Period||71
511024|NCT00162266|1228800|P2|COMPLETED|Double-Blind Period||74
511025|NCT00162266|1228801|P1|COMPLETED|Double-Blind Period||90
511026|NCT00162266|1228798|P4|Completed Day 1 to Day 181|Double-Blind Period||0
511027|NCT00162266|1228799|P3|Completed Day 1 to Day 181|Double-Blind Period||78
511028|NCT00162266|1228800|P2|Completed Day 1 to Day 181|Double-Blind Period||80
511029|NCT00162266|1228801|P1|Completed Day 1 to Day 181|Double-Blind Period||98
511030|NCT00162266|1228798|P4|STARTED|Double-Blind Period||0
511031|NCT00162266|1228799|P3|STARTED|Double-Blind Period||119
511032|NCT00162266|1228800|P2|STARTED|Double-Blind Period||105
511033|NCT00162266|1228801|P1|STARTED|Double-Blind Period||115
511034|NCT00162136|1229002|P1|NOT COMPLETED|Overall Study||35
511035|NCT00162136|1229002|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
511036|NCT00162136|1229002|P1|STARTED|Overall Study||35
511037|NCT00162123|1229034|P8|NOT COMPLETED|Overall Study||58
511038|NCT00162123|1229035|P7|NOT COMPLETED|Overall Study||4
511039|NCT00162123|1229036|P6|NOT COMPLETED|Overall Study||9
511040|NCT00162123|1229037|P5|NOT COMPLETED|Overall Study||31
511041|NCT00162123|1229038|P4|NOT COMPLETED|Overall Study||8
511042|NCT00162123|1229039|P3|NOT COMPLETED|Overall Study||21
511043|NCT00162123|1229040|P2|NOT COMPLETED|Overall Study||29
511044|NCT00162123|1229041|P1|NOT COMPLETED|Overall Study||44
511045|NCT00162123|1229034|P8|COMPLETED|Overall Study|Still on treatment|0
511046|NCT00162123|1229035|P7|COMPLETED|Overall Study|Still on treatment|0
511047|NCT00162123|1229036|P6|COMPLETED|Overall Study|Still on treatment|4
511048|NCT00162123|1229037|P5|COMPLETED|Overall Study|Still on treatment|14
511049|NCT00162123|1229038|P4|COMPLETED|Overall Study|Still on treatment|3
511050|NCT00162123|1229039|P3|COMPLETED|Overall Study|Still on treatment|3
511051|NCT00162123|1229040|P2|COMPLETED|Overall Study|Still on treatment|5
511052|NCT00162123|1229041|P1|COMPLETED|Overall Study|Still on treatment|9
511053|NCT00162123|1229034|P8|Received Treatment|Overall Study||0
511054|NCT00162123|1229035|P7|Received Treatment|Overall Study||4
511055|NCT00162123|1229036|P6|Received Treatment|Overall Study||12
511056|NCT00162123|1229037|P5|Received Treatment|Overall Study||33
511057|NCT00162123|1229038|P4|Received Treatment|Overall Study||11
511058|NCT00162123|1229039|P3|Received Treatment|Overall Study||24
511059|NCT00162123|1229040|P2|Received Treatment|Overall Study||34
511060|NCT00162123|1229041|P1|Received Treatment|Overall Study||53
511061|NCT00162123|1229034|P8|STARTED|Overall Study|Enrolled|58
511062|NCT00162123|1229035|P7|STARTED|Overall Study|Enrolled|4
511063|NCT00162123|1229036|P6|STARTED|Overall Study|Enrolled|13
511064|NCT00162123|1229037|P5|STARTED|Overall Study|Enrolled|45
511065|NCT00162123|1229038|P4|STARTED|Overall Study|Enrolled|11
511066|NCT00162123|1229039|P3|STARTED|Overall Study|Enrolled|24
511067|NCT00162123|1229040|P2|STARTED|Overall Study|Enrolled|34
511068|NCT00162123|1229041|P1|STARTED|Overall Study|Enrolled|53
511069|NCT00162097|1229074|P4|NOT COMPLETED|Overall Study||1
511070|NCT00162097|1229075|P3|NOT COMPLETED|Overall Study||0
511071|NCT00162097|1229076|P2|NOT COMPLETED|Overall Study||0
511072|NCT00162097|1229077|P1|NOT COMPLETED|Overall Study||0
511073|NCT00162097|1229074|P4|COMPLETED|Overall Study||6
511074|NCT00162097|1229075|P3|COMPLETED|Overall Study||1
511075|NCT00162097|1229076|P2|COMPLETED|Overall Study||2
511076|NCT00162097|1229077|P1|COMPLETED|Overall Study||6
511077|NCT00162097|1229074|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
511078|NCT00162097|1229075|P3|STARTED|Overall Study|Treated on Day 1|1
511079|NCT00162097|1229076|P2|STARTED|Overall Study|Treated on Day 1|2
511080|NCT00162097|1229077|P1|STARTED|Overall Study|Treated on Day 1|6
511081|NCT00162032|1229139|P2|NOT COMPLETED|Overall Study||2
511082|NCT00162032|1229140|P1|NOT COMPLETED|Overall Study||5
511083|NCT00162032|1229139|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
511084|NCT00162032|1229140|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
511085|NCT00162032|1229139|P2|STARTED|Overall Study||116
511086|NCT00162032|1229140|P1|STARTED|Overall Study||329
511087|NCT00161616|1229150|P2|NOT COMPLETED|Overall Study||19
511088|NCT00161616|1229151|P1|NOT COMPLETED|Overall Study||26
511089|NCT00161616|1229150|P2|COMPLETED|Overall Study||119
511090|NCT00161616|1229151|P1|COMPLETED|Overall Study||113
511091|NCT00161616|1229150|P2|STARTED|Overall Study||138
511092|NCT00161616|1229151|P1|STARTED|Overall Study||139
511093|NCT00161473|1229161|P2|NOT COMPLETED|Overall Study||6
511094|NCT00161473|1229162|P1|NOT COMPLETED|Overall Study||5
511095|NCT00161473|1229161|P2|COMPLETED|Overall Study||6
511096|NCT00161473|1229162|P1|COMPLETED|Overall Study||7
511097|NCT00161473|1229161|P2|STARTED|Overall Study||12
511098|NCT00161473|1229162|P1|STARTED|Overall Study||12
511099|NCT00161382|1229176|P2|NOT COMPLETED|Overall Study||289
511100|NCT00161382|1229177|P1|NOT COMPLETED|Overall Study||249
511101|NCT00161382|1229176|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
511102|NCT00161382|1229177|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
511103|NCT00161382|1229176|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
511104|NCT00161382|1229177|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
511105|NCT00161213|1229183|P1|NOT COMPLETED|Overall Study||2
511106|NCT00161213|1229183|P1|COMPLETED|Overall Study||42
511107|NCT00161213|1229183|P1|STARTED|Overall Study||44
511108|NCT00160706|1229190|P1|NOT COMPLETED|Overall Study||286
511109|NCT00160706|1229190|P1|COMPLETED|Overall Study||24
511110|NCT00160706|1229190|P1|STARTED|Overall Study||310
511111|NCT00160693|1229202|P1|NOT COMPLETED|Overall Study||235
511112|NCT00160693|1229202|P1|COMPLETED|Overall Study||167
511113|NCT00160693|1229202|P1|STARTED|Overall Study||402
511114|NCT00160641|1229219|P1|NOT COMPLETED|Overall Study||221
511115|NCT00160641|1229219|P1|COMPLETED|Overall Study||346
511116|NCT00160641|1229219|P1|STARTED|Overall Study||567
511117|NCT00160563|1229253|P3|NOT COMPLETED|Overall Study||90
511118|NCT00160563|1229254|P2|NOT COMPLETED|Overall Study||45
511119|NCT00160563|1229255|P1|NOT COMPLETED|Overall Study||51
511120|NCT00160563|1229253|P3|COMPLETED|Overall Study||11
511121|NCT00160563|1229254|P2|COMPLETED|Overall Study||2
511122|NCT00160563|1229255|P1|COMPLETED|Overall Study||8
511123|NCT00160563|1229253|P3|STARTED|Overall Study||101
511124|NCT00160563|1229254|P2|STARTED|Overall Study||47
511125|NCT00160563|1229255|P1|STARTED|Overall Study||59
511126|NCT00160524|1229267|P1|NOT COMPLETED|Overall Study||478
511127|NCT00160524|1229267|P1|COMPLETED|Overall Study||117
511128|NCT00160524|1229267|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
511129|NCT00160251|1229284|P8|NOT COMPLETED|Post-amendment 2||55
511130|NCT00160251|1229285|P7|NOT COMPLETED|Post-amendment 2||0
511131|NCT00160251|1229286|P6|NOT COMPLETED|Post-amendment 2||0
511132|NCT00160251|1229287|P5|NOT COMPLETED|Post-amendment 2||0
511133|NCT00160251|1229288|P4|NOT COMPLETED|Post-amendment 2||0
511134|NCT00160251|1229289|P3|NOT COMPLETED|Post-amendment 2||0
511135|NCT00160251|1229290|P2|NOT COMPLETED|Post-amendment 2||0
511136|NCT00160251|1229291|P1|NOT COMPLETED|Post-amendment 2||0
511137|NCT00160251|1229284|P8|COMPLETED|Post-amendment 2||88
511138|NCT00160251|1229285|P7|COMPLETED|Post-amendment 2||0
511139|NCT00160251|1229286|P6|COMPLETED|Post-amendment 2||0
511140|NCT00160251|1229287|P5|COMPLETED|Post-amendment 2||0
511141|NCT00160251|1229288|P4|COMPLETED|Post-amendment 2||0
511142|NCT00160251|1229289|P3|COMPLETED|Post-amendment 2||0
511143|NCT00160251|1229290|P2|COMPLETED|Post-amendment 2||0
511144|NCT00160251|1229291|P1|COMPLETED|Post-amendment 2||0
511145|NCT00160251|1229284|P8|STARTED|Post-amendment 2||143
511146|NCT00160251|1229285|P7|STARTED|Post-amendment 2||0
511147|NCT00160251|1229286|P6|STARTED|Post-amendment 2||0
511148|NCT00160251|1229287|P5|STARTED|Post-amendment 2||0
511149|NCT00160251|1229288|P4|STARTED|Post-amendment 2||0
511150|NCT00160251|1229289|P3|STARTED|Post-amendment 2||0
511151|NCT00160251|1229290|P2|STARTED|Post-amendment 2||0
511152|NCT00160251|1229291|P1|STARTED|Post-amendment 2||0
511153|NCT00160251|1229284|P8|NOT COMPLETED|Prior to Amendment 2||0
511154|NCT00160251|1229285|P7|NOT COMPLETED|Prior to Amendment 2||4
511155|NCT00160251|1229286|P6|NOT COMPLETED|Prior to Amendment 2||83
511156|NCT00160251|1229287|P5|NOT COMPLETED|Prior to Amendment 2||28
511157|NCT00160251|1229288|P4|NOT COMPLETED|Prior to Amendment 2||40
511158|NCT00160251|1229289|P3|NOT COMPLETED|Prior to Amendment 2||44
511159|NCT00160251|1229290|P2|NOT COMPLETED|Prior to Amendment 2||6
511160|NCT00160251|1229291|P1|NOT COMPLETED|Prior to Amendment 2||9
511161|NCT00160251|1229284|P8|COMPLETED|Prior to Amendment 2||0
511162|NCT00160251|1229285|P7|COMPLETED|Prior to Amendment 2||61
511163|NCT00160251|1229286|P6|COMPLETED|Prior to Amendment 2||14
511164|NCT00160251|1229287|P5|COMPLETED|Prior to Amendment 2||21
511165|NCT00160251|1229288|P4|COMPLETED|Prior to Amendment 2||9
511166|NCT00160251|1229289|P3|COMPLETED|Prior to Amendment 2||4
511167|NCT00160251|1229290|P2|COMPLETED|Prior to Amendment 2||28
511168|NCT00160251|1229291|P1|COMPLETED|Prior to Amendment 2||6
511169|NCT00160251|1229284|P8|STARTED|Prior to Amendment 2||0
511170|NCT00160251|1229285|P7|STARTED|Prior to Amendment 2||65
511171|NCT00160251|1229286|P6|STARTED|Prior to Amendment 2||97
511172|NCT00160251|1229287|P5|STARTED|Prior to Amendment 2||49
511173|NCT00160251|1229288|P4|STARTED|Prior to Amendment 2||49
511174|NCT00160251|1229289|P3|STARTED|Prior to Amendment 2||48
511175|NCT00160251|1229290|P2|STARTED|Prior to Amendment 2||34
511176|NCT00160251|1229291|P1|STARTED|Prior to Amendment 2||15
511177|NCT00160199|1229367|P2|NOT COMPLETED|Overall Study||37
511178|NCT00160199|1229368|P1|NOT COMPLETED|Overall Study||24
511179|NCT00160199|1229367|P2|COMPLETED|Overall Study||81
511180|NCT00160199|1229368|P1|COMPLETED|Overall Study||98
511181|NCT00160199|1229367|P2|STARTED|Overall Study||118
511182|NCT00160199|1229368|P1|STARTED|Overall Study||122
511183|NCT00159965|1229388|P2|NOT COMPLETED|Overall Study||5
511184|NCT00159965|1229389|P1|NOT COMPLETED|Overall Study||7
511185|NCT00159965|1229388|P2|COMPLETED|Overall Study||14
511186|NCT00159965|1229389|P1|COMPLETED|Overall Study||12
511187|NCT00159965|1229388|P2|STARTED|Overall Study||19
511188|NCT00159965|1229389|P1|STARTED|Overall Study||19
511189|NCT00159913|1229425|P4|NOT COMPLETED|Overall Study||2
511190|NCT00159913|1229426|P3|NOT COMPLETED|Overall Study||2
511191|NCT00159913|1229427|P2|NOT COMPLETED|Overall Study||0
511192|NCT00159913|1229428|P1|NOT COMPLETED|Overall Study||2
511193|NCT00159913|1229425|P4|COMPLETED|Overall Study||58
511194|NCT00159913|1229426|P3|COMPLETED|Overall Study||75
511195|NCT00159913|1229427|P2|COMPLETED|Overall Study||55
511196|NCT00159913|1229428|P1|COMPLETED|Overall Study||40
511197|NCT00159913|1229425|P4|STARTED|Overall Study||60
511198|NCT00159913|1229426|P3|STARTED|Overall Study||77
511199|NCT00159913|1229427|P2|STARTED|Overall Study||55
511200|NCT00159913|1229428|P1|STARTED|Overall Study||42
511201|NCT00159874|1229502|P7|NOT COMPLETED|Overall Study||5
511202|NCT00159874|1229503|P6|NOT COMPLETED|Overall Study||12
511203|NCT00159874|1229504|P5|NOT COMPLETED|Overall Study||8
511204|NCT00159874|1229505|P4|NOT COMPLETED|Overall Study||6
511205|NCT00159874|1229506|P3|NOT COMPLETED|Overall Study||43
511206|NCT00159874|1229507|P2|NOT COMPLETED|Overall Study||30
511207|NCT00159874|1229508|P1|NOT COMPLETED|Overall Study||20
511208|NCT00159874|1229502|P7|COMPLETED|Overall Study||0
511209|NCT00159874|1229503|P6|COMPLETED|Overall Study||11
511210|NCT00159874|1229504|P5|COMPLETED|Overall Study||11
511211|NCT00159874|1229505|P4|COMPLETED|Overall Study||7
511212|NCT00159874|1229506|P3|COMPLETED|Overall Study||34
511213|NCT00159874|1229507|P2|COMPLETED|Overall Study||25
511214|NCT00159874|1229508|P1|COMPLETED|Overall Study||22
511215|NCT00159874|1229502|P7|Treated|Overall Study||5
511216|NCT00159874|1229503|P6|Treated|Overall Study||23
511217|NCT00159874|1229504|P5|Treated|Overall Study||19
511218|NCT00159874|1229505|P4|Treated|Overall Study||13
511219|NCT00159874|1229506|P3|Treated|Overall Study||77
511220|NCT00159874|1229507|P2|Treated|Overall Study||55
511221|NCT00159874|1229508|P1|Treated|Overall Study||42
511222|NCT00159874|1229502|P7|STARTED|Overall Study||5
511223|NCT00159874|1229503|P6|STARTED|Overall Study||23
511224|NCT00159874|1229504|P5|STARTED|Overall Study||19
511225|NCT00159874|1229505|P4|STARTED|Overall Study||13
511226|NCT00159874|1229506|P3|STARTED|Overall Study||77
511227|NCT00159874|1229507|P2|STARTED|Overall Study||55
511228|NCT00159874|1229508|P1|STARTED|Overall Study||42
511229|NCT00159861|1229678|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
511230|NCT00159861|1229679|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
511231|NCT00159861|1229678|P2|COMPLETED|Extension Study - up to 3 Years||56
511232|NCT00159861|1229679|P1|COMPLETED|Extension Study - up to 3 Years||53
511233|NCT00159861|1229678|P2|Treated|Extension Study - up to 3 Years||127
511234|NCT00159861|1229679|P1|Treated|Extension Study - up to 3 Years||115
511235|NCT00159861|1229678|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
511236|NCT00159861|1229679|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
511237|NCT00159861|1229678|P2|NOT COMPLETED|Core Study - 16 Weeks||12
511238|NCT00159861|1229679|P1|NOT COMPLETED|Core Study - 16 Weeks||25
511239|NCT00159861|1229678|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
511240|NCT00159861|1229679|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
511241|NCT00159861|1229678|P2|Treated|Core Study - 16 Weeks||134
511242|NCT00159861|1229679|P1|Treated|Core Study - 16 Weeks||131
511243|NCT00159861|1229678|P2|STARTED|Core Study - 16 Weeks||134
511244|NCT00159861|1229679|P1|STARTED|Core Study - 16 Weeks||133
511245|NCT00159822|1229700|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
511246|NCT00159822|1229700|P1|COMPLETED|Post-treatment Follow-up Period||23
511247|NCT00159822|1229700|P1|STARTED|Post-treatment Follow-up Period||26
511248|NCT00159822|1229700|P1|NOT COMPLETED|Voriconazole Treatment Period||22
511249|NCT00159822|1229700|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
511250|NCT00159822|1229700|P1|STARTED|Voriconazole Treatment Period||48
511251|NCT00159783|1229718|P3|NOT COMPLETED|Overall Study||39
511252|NCT00159783|1229719|P2|NOT COMPLETED|Overall Study||27
511253|NCT00159783|1229720|P1|NOT COMPLETED|Overall Study||19
511254|NCT00159783|1229718|P3|COMPLETED|Overall Study||68
511255|NCT00159783|1229719|P2|COMPLETED|Overall Study||52
511256|NCT00159783|1229720|P1|COMPLETED|Overall Study||13
511257|NCT00159783|1229718|P3|STARTED|Overall Study||107
511258|NCT00159783|1229719|P2|STARTED|Overall Study||79
511259|NCT00159783|1229720|P1|STARTED|Overall Study||32
511260|NCT00159432|1229750|P1|NOT COMPLETED|Overall Study||10
511261|NCT00159432|1229750|P1|COMPLETED|Overall Study||53
511262|NCT00159432|1229750|P1|STARTED|Overall Study||63
511263|NCT00159419|1229757|P2|NOT COMPLETED|Overall Study||0
511264|NCT00159419|1229758|P1|NOT COMPLETED|Overall Study||0
511265|NCT00159419|1229757|P2|COMPLETED|Overall Study||9
511266|NCT00159419|1229758|P1|COMPLETED|Overall Study||9
511267|NCT00159419|1229757|P2|STARTED|Overall Study||9
511268|NCT00159419|1229758|P1|STARTED|Overall Study||9
511269|NCT00158925|1229764|P1|NOT COMPLETED|Overall Study||12
511270|NCT00158925|1229764|P1|COMPLETED|Overall Study||84
511271|NCT00158925|1229764|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
511272|NCT00158743|1229774|P2|NOT COMPLETED|Overall Study||7
511273|NCT00158743|1229775|P1|NOT COMPLETED|Overall Study||9
511274|NCT00158743|1229774|P2|COMPLETED|Overall Study||20
511275|NCT00158743|1229775|P1|COMPLETED|Overall Study||15
511276|NCT00158743|1229774|P2|STARTED|Overall Study||27
511277|NCT00158743|1229775|P1|STARTED|Overall Study||24
511278|NCT00158600|1229783|P2|NOT COMPLETED|Overall Study||4
511279|NCT00158600|1229784|P1|NOT COMPLETED|Overall Study||5
511280|NCT00158600|1229783|P2|COMPLETED|Overall Study||26
511281|NCT00158600|1229784|P1|COMPLETED|Overall Study||55
511282|NCT00158600|1229783|P2|STARTED|Overall Study||30
511283|NCT00158600|1229784|P1|STARTED|Overall Study||60
511284|NCT00158379|1229802|P1|NOT COMPLETED|Overall Study||0
511285|NCT00158379|1229802|P1|COMPLETED|Overall Study||105
511286|NCT00158379|1229802|P1|STARTED|Overall Study||105
511287|NCT00158262|1229809|P2|NOT COMPLETED|Overall Study||1
511288|NCT00158262|1229810|P1|NOT COMPLETED|Overall Study||1
511289|NCT00158262|1229809|P2|COMPLETED|Overall Study||21
511290|NCT00158262|1229810|P1|COMPLETED|Overall Study||20
511291|NCT00158262|1229809|P2|STARTED|Overall Study||22
511292|NCT00158262|1229810|P1|STARTED|Overall Study||21
511293|NCT00158249|1229822|P2|NOT COMPLETED|Overall Study||0
511294|NCT00158249|1229823|P1|NOT COMPLETED|Overall Study||2
511295|NCT00158249|1229822|P2|COMPLETED|Overall Study||10
511296|NCT00158249|1229823|P1|COMPLETED|Overall Study||9
511297|NCT00158249|1229822|P2|STARTED|Overall Study||10
511298|NCT00158249|1229823|P1|STARTED|Overall Study||11
511299|NCT00158223|1229833|P2|NOT COMPLETED|Overall Study||3
511300|NCT00158223|1229834|P1|NOT COMPLETED|Overall Study||5
511301|NCT00158223|1229833|P2|COMPLETED|Overall Study||22
511302|NCT00158223|1229834|P1|COMPLETED|Overall Study||23
511303|NCT00158223|1229833|P2|STARTED|Overall Study||25
511304|NCT00158223|1229834|P1|STARTED|Overall Study||28
511305|NCT00158197|1229848|P4|NOT COMPLETED|Overall Study||0
511306|NCT00158197|1229849|P3|NOT COMPLETED|Overall Study||0
511307|NCT00158197|1229850|P2|NOT COMPLETED|Overall Study||0
511308|NCT00158197|1229851|P1|NOT COMPLETED|Overall Study||0
511309|NCT00158197|1229848|P4|COMPLETED|Overall Study||29
511310|NCT00158197|1229849|P3|COMPLETED|Overall Study||28
511311|NCT00158197|1229850|P2|COMPLETED|Overall Study||30
511312|NCT00158197|1229851|P1|COMPLETED|Overall Study||32
511313|NCT00158197|1229848|P4|STARTED|Overall Study||29
511314|NCT00158197|1229849|P3|STARTED|Overall Study||28
511315|NCT00158197|1229850|P2|STARTED|Overall Study||30
511316|NCT00158197|1229851|P1|STARTED|Overall Study||32
511317|NCT00158054|1229871|P2|NOT COMPLETED|Overall Study||3
511318|NCT00158054|1229872|P1|NOT COMPLETED|Overall Study||10
511319|NCT00158054|1229871|P2|COMPLETED|Overall Study||74
511320|NCT00158054|1229872|P1|COMPLETED|Overall Study||70
511321|NCT00158054|1229871|P2|STARTED|Overall Study||77
511322|NCT00158054|1229872|P1|STARTED|Overall Study||80
511323|NCT00157950|1229886|P2|NOT COMPLETED|Overall Study||0
511324|NCT00157950|1229887|P1|NOT COMPLETED|Overall Study||1
511325|NCT00157950|1229886|P2|COMPLETED|Overall Study||59
511326|NCT00157950|1229887|P1|COMPLETED|Overall Study||116
511327|NCT00157950|1229886|P2|Vaccinated at Dose 3|Overall Study||59
511328|NCT00157950|1229887|P1|Vaccinated at Dose 3|Overall Study||116
511329|NCT00157950|1229886|P2|Vaccinated at Dose 2|Overall Study||59
511330|NCT00157950|1229887|P1|Vaccinated at Dose 2|Overall Study||117
511331|NCT00157950|1229886|P2|Vaccinated at Dose 1|Overall Study||59
511332|NCT00157950|1229887|P1|Vaccinated at Dose 1|Overall Study||117
511333|NCT00157950|1229886|P2|STARTED|Overall Study||59
511334|NCT00157950|1229887|P1|STARTED|Overall Study||117
511335|NCT00157820|1229904|P3|NOT COMPLETED|2nd 8 Months||14
511336|NCT00157820|1229905|P2|NOT COMPLETED|2nd 8 Months||13
511337|NCT00157820|1229906|P1|NOT COMPLETED|2nd 8 Months||5
511338|NCT00157820|1229904|P3|COMPLETED|2nd 8 Months||94
511339|NCT00157820|1229905|P2|COMPLETED|2nd 8 Months||88
511340|NCT00157820|1229906|P1|COMPLETED|2nd 8 Months||98
511341|NCT00157820|1229904|P3|STARTED|2nd 8 Months||108
511342|NCT00157820|1229905|P2|STARTED|2nd 8 Months||101
511343|NCT00157820|1229906|P1|STARTED|2nd 8 Months||103
511344|NCT00157820|1229904|P3|NOT COMPLETED|1 Month Wash Out Period||0
511345|NCT00157820|1229905|P2|NOT COMPLETED|1 Month Wash Out Period||0
511346|NCT00157820|1229906|P1|NOT COMPLETED|1 Month Wash Out Period||0
511347|NCT00157820|1229904|P3|COMPLETED|1 Month Wash Out Period||108
511348|NCT00157820|1229905|P2|COMPLETED|1 Month Wash Out Period||101
511349|NCT00157820|1229906|P1|COMPLETED|1 Month Wash Out Period||103
511350|NCT00157820|1229904|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
511351|NCT00157820|1229905|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
511352|NCT00157820|1229906|P1|STARTED|1 Month Wash Out Period||103
511353|NCT00157820|1229904|P3|NOT COMPLETED|1st 8 Month||6
511354|NCT00157820|1229905|P2|NOT COMPLETED|1st 8 Month||12
511355|NCT00157820|1229906|P1|NOT COMPLETED|1st 8 Month||8
511356|NCT00157820|1229904|P3|COMPLETED|1st 8 Month||106
511357|NCT00157820|1229905|P2|COMPLETED|1st 8 Month||99
511358|NCT00157820|1229906|P1|COMPLETED|1st 8 Month||103
511359|NCT00157820|1229904|P3|STARTED|1st 8 Month||112
511360|NCT00157820|1229905|P2|STARTED|1st 8 Month||111
511361|NCT00157820|1229906|P1|STARTED|1st 8 Month||111
511362|NCT00157820|1229904|P3|NOT COMPLETED|Randomized||8
511363|NCT00157820|1229905|P2|NOT COMPLETED|Randomized||5
511364|NCT00157820|1229906|P1|NOT COMPLETED|Randomized||7
511365|NCT00157820|1229904|P3|COMPLETED|Randomized||112
511366|NCT00157820|1229905|P2|COMPLETED|Randomized||111
511367|NCT00157820|1229906|P1|COMPLETED|Randomized||111
511368|NCT00157820|1229904|P3|STARTED|Randomized||120
511369|NCT00157820|1229905|P2|STARTED|Randomized||116
511370|NCT00157820|1229906|P1|STARTED|Randomized||118
511371|NCT00157755|1229919|P6|NOT COMPLETED|Overall Study||5
511372|NCT00157755|1229920|P5|NOT COMPLETED|Overall Study||2
511373|NCT00157755|1229921|P4|NOT COMPLETED|Overall Study||4
511374|NCT00157755|1229922|P3|NOT COMPLETED|Overall Study||7
511375|NCT00157755|1229923|P2|NOT COMPLETED|Overall Study||4
511376|NCT00157755|1229924|P1|NOT COMPLETED|Overall Study||2
511377|NCT00157755|1229919|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
511378|NCT00157755|1229920|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
511379|NCT00157755|1229921|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
511380|NCT00157755|1229922|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
511381|NCT00157755|1229923|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
511382|NCT00157755|1229924|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
511383|NCT00157755|1229919|P6|STARTED|Overall Study||5
511384|NCT00157755|1229920|P5|STARTED|Overall Study||12
511385|NCT00157755|1229921|P4|STARTED|Overall Study||15
511386|NCT00157755|1229922|P3|STARTED|Overall Study||10
511387|NCT00157755|1229923|P2|STARTED|Overall Study||19
511388|NCT00157755|1229924|P1|STARTED|Overall Study||26
511389|NCT00157573|1229946|P2|NOT COMPLETED|Overall Study||0
511390|NCT00157573|1229947|P1|NOT COMPLETED|Overall Study||0
511391|NCT00157573|1229946|P2|COMPLETED|Overall Study||37
511392|NCT00157573|1229947|P1|COMPLETED|Overall Study||35
511393|NCT00157573|1229946|P2|STARTED|Overall Study||37
511394|NCT00157573|1229947|P1|STARTED|Overall Study||35
511395|NCT00157248|1229960|P4|NOT COMPLETED|Overall Study||47
511396|NCT00157248|1229961|P3|NOT COMPLETED|Overall Study||21
511397|NCT00157248|1229962|P2|NOT COMPLETED|Overall Study||37
511398|NCT00157248|1229963|P1|NOT COMPLETED|Overall Study||48
511399|NCT00157248|1229960|P4|COMPLETED|Overall Study||77
511400|NCT00157248|1229961|P3|COMPLETED|Overall Study||29
511401|NCT00157248|1229962|P2|COMPLETED|Overall Study||52
511402|NCT00157248|1229963|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
511403|NCT00157248|1229960|P4|STARTED|Overall Study||124
511404|NCT00157248|1229961|P3|STARTED|Overall Study||50
511405|NCT00157248|1229962|P2|STARTED|Overall Study||89
511406|NCT00157248|1229963|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
511407|NCT00157209|1230069|P2|NOT COMPLETED|Overall Study||0
511408|NCT00157209|1230070|P1|NOT COMPLETED|Overall Study||10
511409|NCT00157209|1230069|P2|COMPLETED|Overall Study||83
511410|NCT00157209|1230070|P1|COMPLETED|Overall Study||78
511411|NCT00157209|1230069|P2|STARTED|Overall Study||83
511412|NCT00157209|1230070|P1|STARTED|Overall Study||88
511413|NCT00157196|1230084|P1|NOT COMPLETED|Overall Study||9
511414|NCT00157196|1230084|P1|COMPLETED|Overall Study||13
511415|NCT00157196|1230084|P1|STARTED|Overall Study||22
511416|NCT00157157|1230090|P1|NOT COMPLETED|Overall Study||11
511417|NCT00157157|1230090|P1|COMPLETED|Overall Study||44
511418|NCT00157157|1230090|P1|STARTED|Overall Study||55
511419|NCT00157014|1230117|P4|NOT COMPLETED|Overall Study||1
511420|NCT00157014|1230118|P3|NOT COMPLETED|Overall Study||1
511421|NCT00157014|1230119|P2|NOT COMPLETED|Overall Study||5
511422|NCT00157014|1230120|P1|NOT COMPLETED|Overall Study||7
511423|NCT00157014|1230117|P4|COMPLETED|Overall Study||5
511424|NCT00157014|1230118|P3|COMPLETED|Overall Study||4
511425|NCT00157014|1230119|P2|COMPLETED|Overall Study||41
511426|NCT00157014|1230120|P1|COMPLETED|Overall Study||45
511427|NCT00157014|1230117|P4|STARTED|Overall Study||6
511428|NCT00157014|1230118|P3|STARTED|Overall Study||5
511429|NCT00157014|1230119|P2|STARTED|Overall Study||46
511430|NCT00157014|1230120|P1|STARTED|Overall Study||52
511431|NCT00156936|1230200|P2|NOT COMPLETED|Overall Study||11
511432|NCT00156936|1230201|P1|NOT COMPLETED|Overall Study||72
511433|NCT00156936|1230200|P2|COMPLETED|Overall Study||5
511434|NCT00156936|1230201|P1|COMPLETED|Overall Study||20
511435|NCT00156936|1230200|P2|STARTED|Overall Study||16
511436|NCT00156936|1230201|P1|STARTED|Overall Study||92
511437|NCT00156923|1230209|P2|NOT COMPLETED|Overall Study||32
511438|NCT00156923|1230210|P1|NOT COMPLETED|Overall Study||34
511439|NCT00156923|1230209|P2|COMPLETED|Overall Study||20
511440|NCT00156923|1230210|P1|COMPLETED|Overall Study||22
511441|NCT00156923|1230209|P2|STARTED|Overall Study||52
511442|NCT00156923|1230210|P1|STARTED|Overall Study||56
511443|NCT00156910|1230218|P2|NOT COMPLETED|Open-Label Phase (OL)||55
511444|NCT00156910|1230219|P1|NOT COMPLETED|Open-Label Phase (OL)||33
511445|NCT00156910|1230218|P2|COMPLETED|Open-Label Phase (OL)||231
511446|NCT00156910|1230219|P1|COMPLETED|Open-Label Phase (OL)||252
511447|NCT00156910|1230218|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
511448|NCT00156910|1230219|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
511449|NCT00156910|1230218|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
511450|NCT00156910|1230219|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
511451|NCT00156910|1230218|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
511452|NCT00156910|1230219|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
511453|NCT00156910|1230218|P2|STARTED|Double-Blind Phase (DB)||338
511454|NCT00156910|1230219|P1|STARTED|Double-Blind Phase (DB)||341
511455|NCT00156819|1230236|P3|NOT COMPLETED|Overall Study||3
511456|NCT00156819|1230237|P2|NOT COMPLETED|Overall Study||1
511457|NCT00156819|1230238|P1|NOT COMPLETED|Overall Study||1
511458|NCT00156819|1230236|P3|COMPLETED|Overall Study||162
511459|NCT00156819|1230237|P2|COMPLETED|Overall Study||165
511460|NCT00156819|1230238|P1|COMPLETED|Overall Study||168
511461|NCT00156819|1230236|P3|STARTED|Overall Study||165
511462|NCT00156819|1230237|P2|STARTED|Overall Study||166
511463|NCT00156819|1230238|P1|STARTED|Overall Study||169
511464|NCT00156715|1230246|P1|NOT COMPLETED|Overall Study||7
511465|NCT00156715|1230246|P1|COMPLETED|Overall Study||16
511466|NCT00156715|1230246|P1|STARTED|Overall Study||23
511467|NCT00156533|1230255|P4|NOT COMPLETED|Overall Study||2
511468|NCT00156533|1230256|P3|NOT COMPLETED|Overall Study||2
511469|NCT00156533|1230257|P2|NOT COMPLETED|Overall Study||2
511470|NCT00156533|1230258|P1|NOT COMPLETED|Overall Study||2
511471|NCT00156533|1230255|P4|COMPLETED|Overall Study||3
511472|NCT00156533|1230256|P3|COMPLETED|Overall Study||3
511473|NCT00156533|1230257|P2|COMPLETED|Overall Study||3
511474|NCT00156533|1230258|P1|COMPLETED|Overall Study||3
511475|NCT00156533|1230255|P4|STARTED|Overall Study||5
511476|NCT00156533|1230256|P3|STARTED|Overall Study||5
511477|NCT00156533|1230257|P2|STARTED|Overall Study||5
511478|NCT00156533|1230258|P1|STARTED|Overall Study||5
511479|NCT00156390|1230274|P2|NOT COMPLETED|Overall Study||8
511480|NCT00156390|1230275|P1|NOT COMPLETED|Overall Study||14
511481|NCT00156390|1230274|P2|COMPLETED|Overall Study||69
511482|NCT00156390|1230275|P1|COMPLETED|Overall Study||96
511483|NCT00156390|1230274|P2|STARTED|Overall Study||77
511484|NCT00156390|1230275|P1|STARTED|Overall Study||110
511485|NCT00156247|1230281|P1|NOT COMPLETED|Overall Study||4
511486|NCT00156247|1230281|P1|COMPLETED|Overall Study||5
511487|NCT00156247|1230281|P1|STARTED|Overall Study||9
511488|NCT00156065|1230290|P3|NOT COMPLETED|Overall Study||27
511489|NCT00156065|1230291|P2|NOT COMPLETED|Overall Study||63
511490|NCT00156065|1230292|P1|NOT COMPLETED|Overall Study||31
511491|NCT00156065|1230290|P3|COMPLETED|Overall Study||16
511492|NCT00156065|1230291|P2|COMPLETED|Overall Study||30
511493|NCT00156065|1230292|P1|COMPLETED|Overall Study||20
511494|NCT00156065|1230290|P3|STARTED|Overall Study||43
511495|NCT00156065|1230291|P2|STARTED|Overall Study||93
511496|NCT00156065|1230292|P1|STARTED|Overall Study||51
511497|NCT00156013|1230303|P1|NOT COMPLETED|Overall Study||2
511498|NCT00156013|1230303|P1|COMPLETED|Overall Study||31
511499|NCT00156013|1230303|P1|STARTED|Overall Study||33
511500|NCT00154466|1230310|P3|NOT COMPLETED|Overall Study||0
511501|NCT00154466|1230311|P2|NOT COMPLETED|Overall Study||0
511502|NCT00154466|1230312|P1|NOT COMPLETED|Overall Study||0
511503|NCT00154466|1230310|P3|COMPLETED|Overall Study||19
511504|NCT00154466|1230311|P2|COMPLETED|Overall Study||19
511505|NCT00154466|1230312|P1|COMPLETED|Overall Study||20
511506|NCT00154466|1230310|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
511507|NCT00154466|1230311|P2|STARTED|Overall Study||19
511508|NCT00154466|1230312|P1|STARTED|Overall Study||20
511509|NCT00154375|1230324|P2|NOT COMPLETED|Overall Study||106
511510|NCT00154375|1230325|P1|NOT COMPLETED|Overall Study||113
511511|NCT00154375|1230324|P2|COMPLETED|Overall Study||14
511512|NCT00154375|1230325|P1|COMPLETED|Overall Study||7
511513|NCT00154375|1230324|P2|Not Exposed to Study Treatment|Overall Study||2
511514|NCT00154375|1230325|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
511515|NCT00154375|1230324|P2|Discontinued Study Treatment|Overall Study||104
511516|NCT00154375|1230325|P1|Discontinued Study Treatment|Overall Study||111
511517|NCT00154375|1230324|P2|STARTED|Overall Study||120
511518|NCT00154375|1230325|P1|STARTED|Overall Study||120
511519|NCT00154310|1230336|P2|NOT COMPLETED|Overall Study||28
511520|NCT00154310|1230337|P1|NOT COMPLETED|Overall Study||37
511521|NCT00154310|1230336|P2|COMPLETED|Overall Study||117
511522|NCT00154310|1230337|P1|COMPLETED|Overall Study||118
511523|NCT00154310|1230336|P2|STARTED|Overall Study||145
511524|NCT00154310|1230337|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
511525|NCT00154297|1230353|P2|NOT COMPLETED|Overall Study||7
511526|NCT00154297|1230354|P1|NOT COMPLETED|Overall Study||8
511527|NCT00154297|1230353|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
511528|NCT00154297|1230354|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
511529|NCT00154297|1230353|P2|STARTED|Overall Study|Randomized population.|74
511530|NCT00154297|1230354|P1|STARTED|Overall Study|Randomized population.|65
511531|NCT00154284|1230372|P2|NOT COMPLETED|Overall Study||13
511532|NCT00154284|1230373|P1|NOT COMPLETED|Overall Study||7
511533|NCT00154284|1230372|P2|COMPLETED|Overall Study||42
511534|NCT00154284|1230373|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
511535|NCT00154284|1230372|P2|Intent to Treat (ITT) Population|Overall Study||53
511536|NCT00154284|1230373|P1|Intent to Treat (ITT) Population|Overall Study||57
511537|NCT00154284|1230372|P2|STARTED|Overall Study||55
511538|NCT00154284|1230373|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
511539|NCT00154102|1230387|P2|NOT COMPLETED|Overall Study||2
511540|NCT00154102|1230388|P1|NOT COMPLETED|Overall Study||7
511541|NCT00154102|1230387|P2|COMPLETED|Overall Study||597
511542|NCT00154102|1230388|P1|COMPLETED|Overall Study||592
511543|NCT00154102|1230387|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
511544|NCT00154102|1230388|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
511545|NCT00154063|1230424|P2|NOT COMPLETED|Overall Study||22
511546|NCT00154063|1230425|P1|NOT COMPLETED|Overall Study||12
511547|NCT00154063|1230424|P2|COMPLETED|Overall Study||80
511548|NCT00154063|1230425|P1|COMPLETED|Overall Study||92
511549|NCT00154063|1230424|P2|STARTED|Overall Study||102
511550|NCT00154063|1230425|P1|STARTED|Overall Study||104
511551|NCT00153985|1230481|P1|NOT COMPLETED|Overall Study||0
511552|NCT00153985|1230481|P1|COMPLETED|Overall Study||2
511553|NCT00153985|1230481|P1|STARTED|Overall Study||2
511554|NCT00153920|1230487|P1|NOT COMPLETED|Overall Study||30
511555|NCT00153920|1230487|P1|COMPLETED|Overall Study||36
511556|NCT00153920|1230487|P1|Eligible and Treated|Overall Study||64
511557|NCT00153920|1230487|P1|STARTED|Overall Study||66
511558|NCT00153816|1230502|P6|NOT COMPLETED|Overall Study||27
511559|NCT00153816|1230503|P5|NOT COMPLETED|Overall Study||17
511560|NCT00153816|1230504|P4|NOT COMPLETED|Overall Study||31
511561|NCT00153816|1230505|P3|NOT COMPLETED|Overall Study||32
511562|NCT00153816|1230506|P2|NOT COMPLETED|Overall Study||32
511563|NCT00153816|1230507|P1|NOT COMPLETED|Overall Study||32
511564|NCT00153816|1230502|P6|COMPLETED|Overall Study||262
511565|NCT00153816|1230503|P5|COMPLETED|Overall Study||278
511566|NCT00153816|1230504|P4|COMPLETED|Overall Study||390
511567|NCT00153816|1230505|P3|COMPLETED|Overall Study||388
511568|NCT00153816|1230506|P2|COMPLETED|Overall Study||387
511569|NCT00153816|1230507|P1|COMPLETED|Overall Study||383
511570|NCT00153816|1230502|P6|STARTED|Overall Study||289
511571|NCT00153816|1230503|P5|STARTED|Overall Study||295
511572|NCT00153816|1230504|P4|STARTED|Overall Study||421
511573|NCT00153816|1230505|P3|STARTED|Overall Study||420
511574|NCT00153816|1230506|P2|STARTED|Overall Study||419
511575|NCT00153816|1230507|P1|STARTED|Overall Study||415
511576|NCT00153179|1230529|P4|NOT COMPLETED|Study Visit Day 2||0
511577|NCT00153179|1230530|P3|NOT COMPLETED|Study Visit Day 2||0
511578|NCT00153179|1230531|P2|NOT COMPLETED|Study Visit Day 2||0
511579|NCT00153179|1230532|P1|NOT COMPLETED|Study Visit Day 2||0
511580|NCT00153179|1230529|P4|COMPLETED|Study Visit Day 2||7
511581|NCT00153179|1230530|P3|COMPLETED|Study Visit Day 2||11
511582|NCT00153179|1230531|P2|COMPLETED|Study Visit Day 2||8
511583|NCT00153179|1230532|P1|COMPLETED|Study Visit Day 2||9
511584|NCT00153179|1230529|P4|STARTED|Study Visit Day 2||7
511585|NCT00153179|1230530|P3|STARTED|Study Visit Day 2||11
511586|NCT00153179|1230531|P2|STARTED|Study Visit Day 2||8
511587|NCT00153179|1230532|P1|STARTED|Study Visit Day 2||9
511588|NCT00153179|1230529|P4|NOT COMPLETED|Study Visit Day 1||0
511589|NCT00153179|1230530|P3|NOT COMPLETED|Study Visit Day 1||0
511590|NCT00153179|1230531|P2|NOT COMPLETED|Study Visit Day 1||0
511591|NCT00153179|1230532|P1|NOT COMPLETED|Study Visit Day 1||0
511592|NCT00153179|1230529|P4|COMPLETED|Study Visit Day 1||9
511593|NCT00153179|1230530|P3|COMPLETED|Study Visit Day 1||13
511594|NCT00153179|1230531|P2|COMPLETED|Study Visit Day 1||8
511595|NCT00153179|1230532|P1|COMPLETED|Study Visit Day 1||10
511596|NCT00153179|1230529|P4|STARTED|Study Visit Day 1||9
511597|NCT00153179|1230530|P3|STARTED|Study Visit Day 1||13
511598|NCT00153179|1230531|P2|STARTED|Study Visit Day 1||8
511599|NCT00153179|1230532|P1|STARTED|Study Visit Day 1||10
511600|NCT00153166|1230543|P3|NOT COMPLETED|Overall Study||0
511601|NCT00153166|1230544|P2|NOT COMPLETED|Overall Study||0
511602|NCT00153166|1230545|P1|NOT COMPLETED|Overall Study||0
511603|NCT00153166|1230543|P3|COMPLETED|Overall Study||28
511604|NCT00153166|1230544|P2|COMPLETED|Overall Study||37
511605|NCT00153166|1230545|P1|COMPLETED|Overall Study||11
511606|NCT00153166|1230543|P3|Received Placebo and Placebo|Overall Study||7
511607|NCT00153166|1230544|P2|Received Placebo and Placebo|Overall Study||9
511608|NCT00153166|1230545|P1|Received Placebo and Placebo|Overall Study||3
511609|NCT00153166|1230543|P3|Received Placebo and Pioglitazone|Overall Study||7
511610|NCT00153166|1230544|P2|Received Placebo and Pioglitazone|Overall Study||10
511611|NCT00153166|1230545|P1|Received Placebo and Pioglitazone|Overall Study||3
511612|NCT00153166|1230543|P3|Received Atorvastatin and Placebo|Overall Study||7
511613|NCT00153166|1230544|P2|Received Atorvastatin and Placebo|Overall Study||9
511614|NCT00153166|1230545|P1|Received Atorvastatin and Placebo|Overall Study||2
511615|NCT00153166|1230543|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
511616|NCT00153166|1230544|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
511617|NCT00153166|1230545|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
511618|NCT00153166|1230543|P3|STARTED|Overall Study||28
511619|NCT00153166|1230544|P2|STARTED|Overall Study||37
511620|NCT00153166|1230545|P1|STARTED|Overall Study||11
511621|NCT00153101|1230562|P5|NOT COMPLETED|Overall Study||10
511622|NCT00153101|1230563|P4|NOT COMPLETED|Overall Study||8
511623|NCT00153101|1230564|P3|NOT COMPLETED|Overall Study||15
511624|NCT00153101|1230565|P2|NOT COMPLETED|Overall Study||18
511625|NCT00153101|1230566|P1|NOT COMPLETED|Overall Study||17
511626|NCT00153101|1230562|P5|COMPLETED|Overall Study||2962
511627|NCT00153101|1230563|P4|COMPLETED|Overall Study||2946
511628|NCT00153101|1230564|P3|COMPLETED|Overall Study||8561
511629|NCT00153101|1230565|P2|COMPLETED|Overall Study||8524
511630|NCT00153101|1230566|P1|COMPLETED|Overall Study||8485
511631|NCT00153101|1230562|P5|STARTED|Overall Study||2972
511632|NCT00153101|1230563|P4|STARTED|Overall Study||2954
511633|NCT00153101|1230564|P3|STARTED|Overall Study||8576
511634|NCT00153101|1230565|P2|STARTED|Overall Study||8542
511635|NCT00153101|1230566|P1|STARTED|Overall Study||8502
511636|NCT00153062|1230674|P4|NOT COMPLETED|Overall Study||411
511637|NCT00153062|1230675|P3|NOT COMPLETED|Overall Study||415
511638|NCT00153062|1230676|P2|NOT COMPLETED|Overall Study||406
511639|NCT00153062|1230677|P1|NOT COMPLETED|Overall Study||387
511640|NCT00153062|1230674|P4|COMPLETED|Overall Study||4680
511641|NCT00153062|1230675|P3|COMPLETED|Overall Study||4645
511642|NCT00153062|1230676|P2|COMPLETED|Overall Study||4689
511643|NCT00153062|1230677|P1|COMPLETED|Overall Study||4699
511644|NCT00153062|1230674|P4|STARTED|Overall Study||5091
511645|NCT00153062|1230675|P3|STARTED|Overall Study||5060
511646|NCT00153062|1230676|P2|STARTED|Overall Study||5095
511647|NCT00153062|1230677|P1|STARTED|Overall Study||5086
511648|NCT00152971|1230696|P3|NOT COMPLETED|Treatment||80
511649|NCT00152971|1230697|P2|NOT COMPLETED|Treatment||63
511650|NCT00152971|1230698|P1|NOT COMPLETED|Treatment||71
511651|NCT00152971|1230696|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
511652|NCT00152971|1230697|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
511653|NCT00152971|1230698|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
511654|NCT00152971|1230696|P3|STARTED|Treatment||868
511655|NCT00152971|1230697|P2|STARTED|Treatment||871
511656|NCT00152971|1230698|P1|STARTED|Treatment||857
511657|NCT00152971|1230696|P3|NOT COMPLETED|Overall Study||49
511658|NCT00152971|1230697|P2|NOT COMPLETED|Overall Study||48
511659|NCT00152971|1230698|P1|NOT COMPLETED|Overall Study||51
511660|NCT00152971|1230696|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
511661|NCT00152971|1230697|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
511662|NCT00152971|1230698|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
511663|NCT00152971|1230696|P3|STARTED|Overall Study||868
511664|NCT00152971|1230697|P2|STARTED|Overall Study||871
511665|NCT00152971|1230698|P1|STARTED|Overall Study||857
511666|NCT00152763|1230734|P4|NOT COMPLETED|Overall Study||14
511667|NCT00152763|1230735|P3|NOT COMPLETED|Overall Study||4
511668|NCT00152763|1230736|P2|NOT COMPLETED|Overall Study||5
511669|NCT00152763|1230737|P1|NOT COMPLETED|Overall Study||10
511670|NCT00152763|1230734|P4|COMPLETED|Overall Study||63
511671|NCT00152763|1230735|P3|COMPLETED|Overall Study||16
511672|NCT00152763|1230736|P2|COMPLETED|Overall Study||14
511673|NCT00152763|1230737|P1|COMPLETED|Overall Study||67
511674|NCT00152763|1230734|P4|STARTED|Overall Study||77
511675|NCT00152763|1230735|P3|STARTED|Overall Study||20
511676|NCT00152763|1230736|P2|STARTED|Overall Study||19
511677|NCT00152763|1230737|P1|STARTED|Overall Study||77
511678|NCT00152516|1230853|P1|NOT COMPLETED|Overall Study||75
511679|NCT00152516|1230853|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
511680|NCT00152516|1230853|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
511681|NCT00152009|1230881|P4|NOT COMPLETED|Overall Study||33
511682|NCT00152009|1230882|P3|NOT COMPLETED|Overall Study||37
511683|NCT00152009|1230883|P2|NOT COMPLETED|Overall Study||31
511684|NCT00152009|1230884|P1|NOT COMPLETED|Overall Study||29
511685|NCT00152009|1230881|P4|COMPLETED|Overall Study||53
511686|NCT00152009|1230882|P3|COMPLETED|Overall Study||49
511687|NCT00152009|1230883|P2|COMPLETED|Overall Study||55
511688|NCT00152009|1230884|P1|COMPLETED|Overall Study||58
511689|NCT00152009|1230881|P4|STARTED|Overall Study||86
511690|NCT00152009|1230882|P3|STARTED|Overall Study||86
511691|NCT00152009|1230883|P2|STARTED|Overall Study||86
511692|NCT00152009|1230884|P1|STARTED|Overall Study||87
511693|NCT00151996|1230916|P2|NOT COMPLETED|Overall Study||7
511694|NCT00151996|1230917|P1|NOT COMPLETED|Overall Study||5
511695|NCT00151996|1230916|P2|COMPLETED|Overall Study||26
511696|NCT00151996|1230917|P1|COMPLETED|Overall Study||37
511697|NCT00151996|1230916|P2|STARTED|Overall Study||33
511698|NCT00151996|1230917|P1|STARTED|Overall Study||42
511699|NCT00151892|1230933|P2|NOT COMPLETED|Overall Study||83
511700|NCT00151892|1230934|P1|NOT COMPLETED|Overall Study||76
511701|NCT00151892|1230933|P2|COMPLETED|Overall Study||330
511702|NCT00151892|1230934|P1|COMPLETED|Overall Study||340
511703|NCT00151892|1230933|P2|STARTED|Overall Study||413
511704|NCT00151892|1230934|P1|STARTED|Overall Study||416
511705|NCT00151814|1230951|P3|NOT COMPLETED|Overall Study||0
511706|NCT00151814|1230952|P2|NOT COMPLETED|Overall Study||0
511707|NCT00151814|1230953|P1|NOT COMPLETED|Overall Study||0
511708|NCT00151814|1230951|P3|COMPLETED|Overall Study||10
511709|NCT00151814|1230952|P2|COMPLETED|Overall Study||10
511710|NCT00151814|1230953|P1|COMPLETED|Overall Study||4
511711|NCT00151814|1230951|P3|STARTED|Overall Study||10
511712|NCT00151814|1230952|P2|STARTED|Overall Study||10
511713|NCT00151814|1230953|P1|STARTED|Overall Study||4
511714|NCT00151775|1230979|P12|NOT COMPLETED|Period 4: Open Label||0
511715|NCT00151775|1230980|P11|NOT COMPLETED|Period 4: Open Label||0
511716|NCT00151775|1230981|P10|NOT COMPLETED|Period 4: Open Label||21
511717|NCT00151775|1230982|P9|NOT COMPLETED|Period 4: Open Label||0
511718|NCT00151775|1230983|P8|NOT COMPLETED|Period 4: Open Label||0
511719|NCT00151775|1230984|P7|NOT COMPLETED|Period 4: Open Label||0
511720|NCT00151775|1230985|P6|NOT COMPLETED|Period 4: Open Label||0
511721|NCT00151775|1230986|P5|NOT COMPLETED|Period 4: Open Label||30
511722|NCT00151775|1230987|P4|NOT COMPLETED|Period 4: Open Label||0
511723|NCT00151775|1230988|P3|NOT COMPLETED|Period 4: Open Label||0
511724|NCT00151775|1230989|P2|NOT COMPLETED|Period 4: Open Label||0
511725|NCT00151775|1230990|P1|NOT COMPLETED|Period 4: Open Label||0
511726|NCT00151775|1230979|P12|COMPLETED|Period 4: Open Label||0
511727|NCT00151775|1230980|P11|COMPLETED|Period 4: Open Label||57
511728|NCT00151775|1230981|P10|COMPLETED|Period 4: Open Label||83
511729|NCT00151775|1230982|P9|COMPLETED|Period 4: Open Label||0
511730|NCT00151775|1230983|P8|COMPLETED|Period 4: Open Label||0
511731|NCT00151775|1230984|P7|COMPLETED|Period 4: Open Label||0
511732|NCT00151775|1230985|P6|COMPLETED|Period 4: Open Label||0
511733|NCT00151775|1230986|P5|COMPLETED|Period 4: Open Label||149
511734|NCT00151775|1230987|P4|COMPLETED|Period 4: Open Label||0
511735|NCT00151775|1230988|P3|COMPLETED|Period 4: Open Label||0
511736|NCT00151775|1230989|P2|COMPLETED|Period 4: Open Label||0
511737|NCT00151775|1230990|P1|COMPLETED|Period 4: Open Label||0
511738|NCT00151775|1230979|P12|STARTED|Period 4: Open Label||0
511739|NCT00151775|1230980|P11|STARTED|Period 4: Open Label||57
511740|NCT00151775|1230981|P10|STARTED|Period 4: Open Label||104
511741|NCT00151775|1230982|P9|STARTED|Period 4: Open Label||0
511742|NCT00151775|1230983|P8|STARTED|Period 4: Open Label||0
511743|NCT00151775|1230984|P7|STARTED|Period 4: Open Label||0
511744|NCT00151775|1230985|P6|STARTED|Period 4: Open Label||0
511745|NCT00151775|1230986|P5|STARTED|Period 4: Open Label||179
511746|NCT00151775|1230987|P4|STARTED|Period 4: Open Label||0
511747|NCT00151775|1230988|P3|STARTED|Period 4: Open Label||0
511748|NCT00151775|1230989|P2|STARTED|Period 4: Open Label||0
511749|NCT00151775|1230990|P1|STARTED|Period 4: Open Label||0
511750|NCT00151775|1230979|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
511751|NCT00151775|1230980|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511752|NCT00151775|1230981|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511753|NCT00151775|1230982|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511754|NCT00151775|1230983|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
511755|NCT00151775|1230984|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
511756|NCT00151775|1230985|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
511757|NCT00151775|1230986|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511758|NCT00151775|1230987|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511759|NCT00151775|1230988|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
511760|NCT00151775|1230989|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511761|NCT00151775|1230990|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
511762|NCT00151775|1230979|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
511763|NCT00151775|1230980|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
511764|NCT00151775|1230981|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
511765|NCT00151775|1230982|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
511766|NCT00151775|1230983|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
511767|NCT00151775|1230984|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
511768|NCT00151775|1230985|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
511769|NCT00151775|1230986|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
511770|NCT00151775|1230987|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
511771|NCT00151775|1230988|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
511772|NCT00151775|1230989|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
511773|NCT00151775|1230990|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
511774|NCT00151775|1230979|P12|STARTED|Period 3: Double-blind, Withdrawal||29
511775|NCT00151775|1230980|P11|STARTED|Period 3: Double-blind, Withdrawal||29
511776|NCT00151775|1230981|P10|STARTED|Period 3: Double-blind, Withdrawal||0
511777|NCT00151775|1230982|P9|STARTED|Period 3: Double-blind, Withdrawal||26
511778|NCT00151775|1230983|P8|STARTED|Period 3: Double-blind, Withdrawal||28
511779|NCT00151775|1230984|P7|STARTED|Period 3: Double-blind, Withdrawal||27
511780|NCT00151775|1230985|P6|STARTED|Period 3: Double-blind, Withdrawal||26
511781|NCT00151775|1230986|P5|STARTED|Period 3: Double-blind, Withdrawal||0
511782|NCT00151775|1230987|P4|STARTED|Period 3: Double-blind, Withdrawal||44
511783|NCT00151775|1230988|P3|STARTED|Period 3: Double-blind, Withdrawal||45
511784|NCT00151775|1230989|P2|STARTED|Period 3: Double-blind, Withdrawal||45
511785|NCT00151775|1230990|P1|STARTED|Period 3: Double-blind, Withdrawal||48
511786|NCT00151775|1230979|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511787|NCT00151775|1230980|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
511788|NCT00151775|1230981|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511789|NCT00151775|1230982|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511790|NCT00151775|1230983|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511791|NCT00151775|1230984|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
511792|NCT00151775|1230985|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
511793|NCT00151775|1230986|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511794|NCT00151775|1230987|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511795|NCT00151775|1230988|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
511796|NCT00151775|1230989|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
511797|NCT00151775|1230990|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
511798|NCT00151775|1230979|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
511799|NCT00151775|1230980|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
511800|NCT00151775|1230981|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
511801|NCT00151775|1230982|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
511802|NCT00151775|1230983|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
511803|NCT00151775|1230984|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
511804|NCT00151775|1230985|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
511805|NCT00151775|1230986|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
511806|NCT00151775|1230987|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
511807|NCT00151775|1230988|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
511808|NCT00151775|1230989|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
511809|NCT00151775|1230990|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
511810|NCT00151775|1230979|P12|STARTED|Period 2 - Double-Blind Dose Response||0
511811|NCT00151775|1230980|P11|STARTED|Period 2 - Double-Blind Dose Response||60
511812|NCT00151775|1230981|P10|STARTED|Period 2 - Double-Blind Dose Response||0
511813|NCT00151775|1230982|P9|STARTED|Period 2 - Double-Blind Dose Response||0
511814|NCT00151775|1230983|P8|STARTED|Period 2 - Double-Blind Dose Response||0
511815|NCT00151775|1230984|P7|STARTED|Period 2 - Double-Blind Dose Response||56
511816|NCT00151775|1230985|P6|STARTED|Period 2 - Double-Blind Dose Response||56
511817|NCT00151775|1230986|P5|STARTED|Period 2 - Double-Blind Dose Response||0
511818|NCT00151775|1230987|P4|STARTED|Period 2 - Double-Blind Dose Response||0
511819|NCT00151775|1230988|P3|STARTED|Period 2 - Double-Blind Dose Response||0
511820|NCT00151775|1230989|P2|STARTED|Period 2 - Double-Blind Dose Response||95
511821|NCT00151775|1230990|P1|STARTED|Period 2 - Double-Blind Dose Response||95
511822|NCT00151476|1231034|P2|NOT COMPLETED|FAP Analyzed Subjects||3
511823|NCT00151476|1231035|P1|NOT COMPLETED|FAP Analyzed Subjects||0
511824|NCT00151476|1231034|P2|COMPLETED|FAP Analyzed Subjects||51
511825|NCT00151476|1231035|P1|COMPLETED|FAP Analyzed Subjects||13
511826|NCT00151476|1231034|P2|STARTED|FAP Analyzed Subjects||54
511827|NCT00151476|1231035|P1|STARTED|FAP Analyzed Subjects||13
511828|NCT00151476|1231034|P2|NOT COMPLETED|FAP Identified Subjects||1
511829|NCT00151476|1231035|P1|NOT COMPLETED|FAP Identified Subjects||0
511830|NCT00151476|1231034|P2|COMPLETED|FAP Identified Subjects||54
511831|NCT00151476|1231035|P1|COMPLETED|FAP Identified Subjects||13
511832|NCT00151476|1231034|P2|STARTED|FAP Identified Subjects||55
511833|NCT00151476|1231035|P1|STARTED|FAP Identified Subjects||13
511834|NCT00151411|1231092|P2|NOT COMPLETED|Overall Study||43
511835|NCT00151411|1231093|P1|NOT COMPLETED|Overall Study||33
511836|NCT00151411|1231092|P2|COMPLETED|Overall Study||16
511837|NCT00151411|1231093|P1|COMPLETED|Overall Study||22
511838|NCT00151411|1231092|P2|STARTED|Overall Study||59
511839|NCT00151411|1231093|P1|STARTED|Overall Study||55
511840|NCT00151372|1231101|P2|NOT COMPLETED|Overall Study||29
511841|NCT00151372|1231102|P1|NOT COMPLETED|Overall Study||29
511842|NCT00151372|1231101|P2|COMPLETED|Overall Study||45
511843|NCT00151372|1231102|P1|COMPLETED|Overall Study||38
511844|NCT00151372|1231101|P2|STARTED|Overall Study||74
511845|NCT00151372|1231102|P1|STARTED|Overall Study||67
511846|NCT00151320|1231112|P1|NOT COMPLETED|Overall Study||0
511847|NCT00151320|1231112|P1|COMPLETED|Overall Study||76
511848|NCT00151320|1231112|P1|STARTED|Overall Study||76
511849|NCT00150969|1231119|P2|NOT COMPLETED|24-48 Month Extension||100
511850|NCT00150969|1231120|P1|NOT COMPLETED|24-48 Month Extension||88
511851|NCT00150969|1231119|P2|COMPLETED|24-48 Month Extension||40
511852|NCT00150969|1231120|P1|COMPLETED|24-48 Month Extension||33
511853|NCT00150969|1231119|P2|STARTED|24-48 Month Extension||140
511854|NCT00150969|1231120|P1|STARTED|24-48 Month Extension||121
511855|NCT00150969|1231119|P2|NOT COMPLETED|24 Month Main Study||21
511856|NCT00150969|1231120|P1|NOT COMPLETED|24 Month Main Study||19
511857|NCT00150969|1231119|P2|COMPLETED|24 Month Main Study||202
511858|NCT00150969|1231120|P1|COMPLETED|24 Month Main Study||198
511859|NCT00150969|1231119|P2|STARTED|24 Month Main Study||223
511860|NCT00150969|1231120|P1|STARTED|24 Month Main Study||217
511861|NCT00150618|1231157|P5|NOT COMPLETED|Overall Study||25
511862|NCT00150618|1231158|P4|NOT COMPLETED|Overall Study||26
511863|NCT00150618|1231159|P3|NOT COMPLETED|Overall Study||27
511864|NCT00150618|1231160|P2|NOT COMPLETED|Overall Study||18
511865|NCT00150618|1231161|P1|NOT COMPLETED|Overall Study||17
511866|NCT00150618|1231157|P5|COMPLETED|Overall Study||41
511867|NCT00150618|1231158|P4|COMPLETED|Overall Study||40
511868|NCT00150618|1231159|P3|COMPLETED|Overall Study||38
511869|NCT00150618|1231160|P2|COMPLETED|Overall Study||47
511870|NCT00150618|1231161|P1|COMPLETED|Overall Study||45
511871|NCT00150618|1231157|P5|STARTED|Overall Study||66
511872|NCT00150618|1231158|P4|STARTED|Overall Study||66
511873|NCT00150618|1231159|P3|STARTED|Overall Study||65
511874|NCT00150618|1231160|P2|STARTED|Overall Study||65
511875|NCT00150618|1231161|P1|STARTED|Overall Study||62
511876|NCT00150592|1231195|P2|NOT COMPLETED|Overall Study||3
511877|NCT00150592|1231196|P1|NOT COMPLETED|Overall Study||7
511878|NCT00150592|1231195|P2|COMPLETED|Overall Study||54
511879|NCT00150592|1231196|P1|COMPLETED|Overall Study||114
511880|NCT00150592|1231195|P2|STARTED|Overall Study||57
511881|NCT00150592|1231196|P1|STARTED|Overall Study||121
511882|NCT00150462|1231227|P11|NOT COMPLETED|Overall Study||3
511883|NCT00150462|1231228|P10|NOT COMPLETED|Overall Study||6
511884|NCT00150462|1231229|P9|NOT COMPLETED|Overall Study||6
511885|NCT00150462|1231230|P8|NOT COMPLETED|Overall Study||8
511886|NCT00150462|1231231|P7|NOT COMPLETED|Overall Study||3
511887|NCT00150462|1231232|P6|NOT COMPLETED|Overall Study||4
511888|NCT00150462|1231233|P5|NOT COMPLETED|Overall Study||3
511889|NCT00150462|1231234|P4|NOT COMPLETED|Overall Study||3
511890|NCT00150462|1231235|P3|NOT COMPLETED|Overall Study||4
511891|NCT00150462|1231236|P2|NOT COMPLETED|Overall Study||3
511892|NCT00150462|1231237|P1|NOT COMPLETED|Overall Study||3
511893|NCT00150462|1231227|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
511894|NCT00150462|1231228|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
511895|NCT00150462|1231229|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511896|NCT00150462|1231230|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511897|NCT00150462|1231231|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511898|NCT00150462|1231232|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511899|NCT00150462|1231233|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511900|NCT00150462|1231234|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511901|NCT00150462|1231235|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511902|NCT00150462|1231236|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511903|NCT00150462|1231237|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
511904|NCT00150462|1231227|P11|STARTED|Overall Study||4
511905|NCT00150462|1231228|P10|STARTED|Overall Study||7
511906|NCT00150462|1231229|P9|STARTED|Overall Study||6
511907|NCT00150462|1231230|P8|STARTED|Overall Study||8
511908|NCT00150462|1231231|P7|STARTED|Overall Study||3
511909|NCT00150462|1231232|P6|STARTED|Overall Study||4
511910|NCT00150462|1231233|P5|STARTED|Overall Study||3
511911|NCT00150462|1231234|P4|STARTED|Overall Study||3
511912|NCT00150462|1231235|P3|STARTED|Overall Study||4
511913|NCT00150462|1231236|P2|STARTED|Overall Study||3
511914|NCT00150462|1231237|P1|STARTED|Overall Study||3
511915|NCT00150345|1231347|P2|NOT COMPLETED|Overall Study||32
511916|NCT00150345|1231348|P1|NOT COMPLETED|Overall Study||34
511917|NCT00150345|1231347|P2|COMPLETED|Overall Study||34
511918|NCT00150345|1231348|P1|COMPLETED|Overall Study||47
511919|NCT00150345|1231347|P2|STARTED|Overall Study||66
511920|NCT00150345|1231348|P1|STARTED|Overall Study||81
511921|NCT00150176|1231412|P2|NOT COMPLETED|Overall Study||120
511922|NCT00150176|1231413|P1|NOT COMPLETED|Overall Study||59
511923|NCT00150176|1231412|P2|COMPLETED|Overall Study||72
511924|NCT00150176|1231413|P1|COMPLETED|Overall Study||135
511925|NCT00150176|1231412|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
511926|NCT00150176|1231413|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
511927|NCT00149994|1231424|P2|NOT COMPLETED|Overall Study||1
511928|NCT00149994|1231425|P1|NOT COMPLETED|Overall Study||1
511929|NCT00149994|1231424|P2|COMPLETED|Overall Study||85
511930|NCT00149994|1231425|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
511931|NCT00149994|1231424|P2|STARTED|Overall Study||86
511932|NCT00149994|1231425|P1|STARTED|Overall Study|"Started indicates Safety population."|85
511933|NCT00149890|1231433|P2|NOT COMPLETED|Overall Study||18
511934|NCT00149890|1231434|P1|NOT COMPLETED|Overall Study||13
511935|NCT00149890|1231433|P2|COMPLETED|Overall Study||20
511936|NCT00149890|1231434|P1|COMPLETED|Overall Study||26
511937|NCT00149890|1231433|P2|STARTED|Overall Study||38
511938|NCT00149890|1231434|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
511939|NCT00149825|1231454|P2|NOT COMPLETED|Overall Study||3
511940|NCT00149825|1231455|P1|NOT COMPLETED|Overall Study||5
511941|NCT00149825|1231454|P2|COMPLETED|Overall Study||12
511942|NCT00149825|1231455|P1|COMPLETED|Overall Study||10
511943|NCT00149825|1231454|P2|STARTED|Overall Study||15
511944|NCT00149825|1231455|P1|STARTED|Overall Study||15
511945|NCT00149799|1231465|P3|NOT COMPLETED|Discontinuation (Phase II)||9
511946|NCT00149799|1231466|P2|NOT COMPLETED|Discontinuation (Phase II)||3
511947|NCT00149799|1231467|P1|NOT COMPLETED|Discontinuation (Phase II)||0
511948|NCT00149799|1231465|P3|COMPLETED|Discontinuation (Phase II)||21
511949|NCT00149799|1231466|P2|COMPLETED|Discontinuation (Phase II)||25
511950|NCT00149799|1231467|P1|COMPLETED|Discontinuation (Phase II)||0
511951|NCT00149799|1231465|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|30
512043|NCT00147199|1231628|P1|STARTED|Overall Study||115
511952|NCT00149799|1231466|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|28
511953|NCT00149799|1231467|P1|STARTED|Discontinuation (Phase II)||0
511954|NCT00149799|1231465|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
511955|NCT00149799|1231466|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
511956|NCT00149799|1231467|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
511957|NCT00149799|1231465|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
511958|NCT00149799|1231466|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
511959|NCT00149799|1231467|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
511960|NCT00149799|1231465|P3|STARTED|Open Label Escitalopram (Phase I)||0
511961|NCT00149799|1231466|P2|STARTED|Open Label Escitalopram (Phase I)||0
511962|NCT00149799|1231467|P1|STARTED|Open Label Escitalopram (Phase I)||100
511963|NCT00149747|1231477|P2|NOT COMPLETED|Overall Study||3
511964|NCT00149747|1231478|P1|NOT COMPLETED|Overall Study||4
511965|NCT00149747|1231477|P2|COMPLETED|Overall Study||27
511966|NCT00149747|1231478|P1|COMPLETED|Overall Study||32
511967|NCT00149747|1231477|P2|STARTED|Overall Study||30
511968|NCT00149747|1231478|P1|STARTED|Overall Study||36
511969|NCT00149643|1231490|P2|NOT COMPLETED|Overall Study||36
511970|NCT00149643|1231491|P1|NOT COMPLETED|Overall Study||34
511971|NCT00149643|1231490|P2|COMPLETED|Overall Study||0
511972|NCT00149643|1231491|P1|COMPLETED|Overall Study||0
511973|NCT00149643|1231490|P2|STARTED|Overall Study||36
511974|NCT00149643|1231491|P1|STARTED|Overall Study||34
511975|NCT00149630|1231503|P2|NOT COMPLETED|Overall Study||5
511976|NCT00149630|1231504|P1|NOT COMPLETED|Overall Study||8
511977|NCT00149630|1231503|P2|COMPLETED|Overall Study||35
511978|NCT00149630|1231504|P1|COMPLETED|Overall Study||26
511979|NCT00149630|1231503|P2|STARTED|Overall Study||40
511980|NCT00149630|1231504|P1|STARTED|Overall Study||34
511981|NCT00149227|1231516|P2|NOT COMPLETED|Overall Study||0
511982|NCT00149227|1231517|P1|NOT COMPLETED|Overall Study||0
511983|NCT00149227|1231516|P2|COMPLETED|Overall Study||1514
511984|NCT00149227|1231517|P1|COMPLETED|Overall Study||1517
511985|NCT00149227|1231516|P2|STARTED|Overall Study||1514
511986|NCT00149227|1231517|P1|STARTED|Overall Study||1517
511987|NCT00149214|1231543|P2|NOT COMPLETED|Overall Study||17
511988|NCT00149214|1231544|P1|NOT COMPLETED|Overall Study||26
511989|NCT00149214|1231543|P2|COMPLETED|Overall Study||105
511990|NCT00149214|1231544|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
511991|NCT00149214|1231543|P2|STARTED|Overall Study||122
511992|NCT00149214|1231544|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
511993|NCT00148954|1231560|P2|NOT COMPLETED|Overall Study||300
511994|NCT00148954|1231561|P1|NOT COMPLETED|Overall Study||307
511995|NCT00148954|1231560|P2|COMPLETED|Overall Study||677
511996|NCT00148954|1231561|P1|COMPLETED|Overall Study||678
511997|NCT00148954|1231560|P2|STARTED|Overall Study||977
511998|NCT00148954|1231561|P1|STARTED|Overall Study||985
511999|NCT00147316|1231567|P1|NOT COMPLETED|Overall Study||0
512000|NCT00147316|1231567|P1|COMPLETED|Overall Study||103
512001|NCT00147316|1231567|P1|STARTED|Overall Study||103
512002|NCT00147290|1231574|P2|NOT COMPLETED|Overall Study||0
512003|NCT00147290|1231575|P1|NOT COMPLETED|Overall Study||0
512004|NCT00147290|1231574|P2|COMPLETED|Overall Study||260
512005|NCT00147290|1231575|P1|COMPLETED|Overall Study||266
512006|NCT00147290|1231574|P2|STARTED|Overall Study||260
512007|NCT00147290|1231575|P1|STARTED|Overall Study||266
512008|NCT00147277|1231581|P2|NOT COMPLETED|Overall Study||0
512009|NCT00147277|1231582|P1|NOT COMPLETED|Overall Study||0
512010|NCT00147277|1231581|P2|COMPLETED|Overall Study||450
512011|NCT00147277|1231582|P1|COMPLETED|Overall Study||475
512012|NCT00147277|1231581|P2|STARTED|Overall Study||450
512013|NCT00147277|1231582|P1|STARTED|Overall Study||475
512014|NCT00147238|1231586|P1|NOT COMPLETED|Overall Study||8
512015|NCT00147238|1231586|P1|COMPLETED|Overall Study||2
512016|NCT00147238|1231586|P1|STARTED|Overall Study||10
512017|NCT00147225|1231596|P6|NOT COMPLETED|Overall Study||2
512018|NCT00147225|1231597|P5|NOT COMPLETED|Overall Study||1
512019|NCT00147225|1231598|P4|NOT COMPLETED|Overall Study||1
512020|NCT00147225|1231599|P3|NOT COMPLETED|Overall Study||2
512021|NCT00147225|1231600|P2|NOT COMPLETED|Overall Study||0
512022|NCT00147225|1231601|P1|NOT COMPLETED|Overall Study||1
512023|NCT00147225|1231596|P6|COMPLETED|Overall Study||10
512024|NCT00147225|1231597|P5|COMPLETED|Overall Study||10
512025|NCT00147225|1231598|P4|COMPLETED|Overall Study||10
512026|NCT00147225|1231599|P3|COMPLETED|Overall Study||6
512027|NCT00147225|1231600|P2|COMPLETED|Overall Study||6
512028|NCT00147225|1231601|P1|COMPLETED|Overall Study||6
512029|NCT00147225|1231596|P6|STARTED|Overall Study||12
512030|NCT00147225|1231597|P5|STARTED|Overall Study||11
512031|NCT00147225|1231598|P4|STARTED|Overall Study||11
512032|NCT00147225|1231599|P3|STARTED|Overall Study||8
512033|NCT00147225|1231600|P2|STARTED|Overall Study||6
512034|NCT00147225|1231601|P1|STARTED|Overall Study||7
512035|NCT00147212|1231621|P1|NOT COMPLETED|Overall Study||0
512036|NCT00147212|1231621|P1|COMPLETED|Overall Study||50
512037|NCT00147212|1231621|P1|STARTED|Overall Study||50
512038|NCT00147199|1231627|P2|NOT COMPLETED|Overall Study||10
512039|NCT00147199|1231628|P1|NOT COMPLETED|Overall Study||13
512040|NCT00147199|1231627|P2|COMPLETED|Overall Study||110
512041|NCT00147199|1231628|P1|COMPLETED|Overall Study||102
512042|NCT00147199|1231627|P2|STARTED|Overall Study||120
512044|NCT00148798|1231652|P2|NOT COMPLETED|Overall Study||0
512045|NCT00148798|1231653|P1|NOT COMPLETED|Overall Study||0
512046|NCT00148798|1231652|P2|COMPLETED|Overall Study||568
512047|NCT00148798|1231653|P1|COMPLETED|Overall Study||557
512048|NCT00148798|1231652|P2|STARTED|Overall Study|ITT Population|568
512049|NCT00148798|1231653|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
512050|NCT00148759|1231675|P2|NOT COMPLETED|Overall Study||1
512051|NCT00148759|1231676|P1|NOT COMPLETED|Overall Study||2
512052|NCT00148759|1231675|P2|COMPLETED|Overall Study||11
512053|NCT00148759|1231676|P1|COMPLETED|Overall Study||9
512054|NCT00148759|1231675|P2|24-hr PK Sampling|Overall Study||11
512055|NCT00148759|1231676|P1|24-hr PK Sampling|Overall Study||9
512056|NCT00148759|1231675|P2|STARTED|Overall Study||12
512057|NCT00148759|1231676|P1|STARTED|Overall Study||11
512058|NCT00148733|1231686|P2|NOT COMPLETED|Overall Study||15
512059|NCT00148733|1231687|P1|NOT COMPLETED|Overall Study||14
512060|NCT00148733|1231686|P2|COMPLETED|Overall Study||1299
512061|NCT00148733|1231687|P1|COMPLETED|Overall Study||1300
512062|NCT00148733|1231686|P2|STARTED|Overall Study||1314
512063|NCT00148733|1231687|P1|STARTED|Overall Study||1314
512064|NCT00148668|1231695|P2|NOT COMPLETED|Overall Study||0
512065|NCT00148668|1231696|P1|NOT COMPLETED|Overall Study||0
512066|NCT00148668|1231695|P2|COMPLETED|Overall Study||40
512067|NCT00148668|1231696|P1|COMPLETED|Overall Study||41
512068|NCT00148668|1231695|P2|STARTED|Overall Study||40
512069|NCT00148668|1231696|P1|STARTED|Overall Study||41
512070|NCT00148122|1231702|P1|NOT COMPLETED|Overall Study||2
512071|NCT00148122|1231702|P1|COMPLETED|Overall Study||38
512072|NCT00148122|1231702|P1|STARTED|Overall Study||40
512073|NCT00148109|1231710|P2|NOT COMPLETED|Overall Study||20
512074|NCT00148109|1231711|P1|NOT COMPLETED|Overall Study||12
512075|NCT00148109|1231710|P2|COMPLETED|Overall Study||1
512076|NCT00148109|1231711|P1|COMPLETED|Overall Study||3
512077|NCT00148109|1231710|P2|STARTED|Overall Study||21
512078|NCT00148109|1231711|P1|STARTED|Overall Study||15
512079|NCT00147030|1231723|P2|NOT COMPLETED|Overall Study||0
512080|NCT00147030|1231724|P1|NOT COMPLETED|Overall Study||0
512081|NCT00147030|1231723|P2|COMPLETED|Overall Study||162
512082|NCT00147030|1231724|P1|COMPLETED|Overall Study||163
512083|NCT00147030|1231723|P2|STARTED|Overall Study||162
512084|NCT00147030|1231724|P1|STARTED|Overall Study||163
512085|NCT00147966|1231772|P1|NOT COMPLETED|Overall Study||0
512086|NCT00147966|1231772|P1|COMPLETED|Overall Study||24
512087|NCT00147966|1231772|P1|STARTED|Overall Study||24
512088|NCT00147823|1231778|P2|NOT COMPLETED|Overall Study||15
512089|NCT00147823|1231779|P1|NOT COMPLETED|Overall Study||13
512090|NCT00147823|1231778|P2|COMPLETED|Overall Study||16
512091|NCT00147823|1231779|P1|COMPLETED|Overall Study||19
512092|NCT00147823|1231778|P2|Month 24 Visit|Overall Study||18
512093|NCT00147823|1231779|P1|Month 24 Visit|Overall Study||21
512094|NCT00147823|1231778|P2|Month 18 Visit|Overall Study||20
512095|NCT00147823|1231779|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
512096|NCT00147823|1231778|P2|Month 12 CT Scan|Overall Study||25
512097|NCT00147823|1231779|P1|Month 12 CT Scan|Overall Study||20
512098|NCT00147823|1231778|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
512099|NCT00147823|1231779|P1|Month 12 Visit|Overall Study||21
512100|NCT00147823|1231778|P2|Month 6 Visit|Overall Study||21
512101|NCT00147823|1231779|P1|Month 6 Visit|Overall Study||25
512102|NCT00147823|1231778|P2|Month 3 Visit|Overall Study||24
512103|NCT00147823|1231779|P1|Month 3 Visit|Overall Study||25
512104|NCT00147823|1231778|P2|Week 6 Visit|Overall Study||28
512105|NCT00147823|1231779|P1|Week 6 Visit|Overall Study||26
512106|NCT00147823|1231778|P2|STARTED|Overall Study||31
512107|NCT00147823|1231779|P1|STARTED|Overall Study||32
512108|NCT00147745|1231810|P3|NOT COMPLETED|Overall Study||0
512109|NCT00147745|1231811|P2|NOT COMPLETED|Overall Study||0
512110|NCT00147745|1231812|P1|NOT COMPLETED|Overall Study||1
512111|NCT00147745|1231810|P3|COMPLETED|Overall Study||6
512112|NCT00147745|1231811|P2|COMPLETED|Overall Study||14
512113|NCT00147745|1231812|P1|COMPLETED|Overall Study||15
512114|NCT00147745|1231810|P3|STARTED|Overall Study||6
512115|NCT00147745|1231811|P2|STARTED|Overall Study||14
512116|NCT00147745|1231812|P1|STARTED|Overall Study||16
512117|NCT00147537|1231834|P11|NOT COMPLETED|Phase 2||52
512118|NCT00147537|1231835|P10|NOT COMPLETED|Phase 2||161
512119|NCT00147537|1231836|P9|NOT COMPLETED|Phase 2||0
512120|NCT00147537|1231837|P8|NOT COMPLETED|Phase 2||0
512121|NCT00147537|1231838|P7|NOT COMPLETED|Phase 2||0
512122|NCT00147537|1231839|P6|NOT COMPLETED|Phase 2||0
512123|NCT00147537|1231840|P5|NOT COMPLETED|Phase 2||0
512124|NCT00147537|1231841|P4|NOT COMPLETED|Phase 2||0
512125|NCT00147537|1231842|P3|NOT COMPLETED|Phase 2||0
512126|NCT00147537|1231843|P2|NOT COMPLETED|Phase 2||0
512127|NCT00147537|1231844|P1|NOT COMPLETED|Phase 2||0
512128|NCT00147537|1231834|P11|COMPLETED|Phase 2||3
512129|NCT00147537|1231835|P10|COMPLETED|Phase 2||5
512130|NCT00147537|1231836|P9|COMPLETED|Phase 2||0
512131|NCT00147537|1231837|P8|COMPLETED|Phase 2||0
512132|NCT00147537|1231838|P7|COMPLETED|Phase 2||0
512133|NCT00147537|1231839|P6|COMPLETED|Phase 2||0
512134|NCT00147537|1231840|P5|COMPLETED|Phase 2||0
512135|NCT00147537|1231841|P4|COMPLETED|Phase 2||0
512136|NCT00147537|1231842|P3|COMPLETED|Phase 2||0
512137|NCT00147537|1231843|P2|COMPLETED|Phase 2||0
512138|NCT00147537|1231844|P1|COMPLETED|Phase 2||0
512139|NCT00147537|1231834|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
512140|NCT00147537|1231835|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
512141|NCT00147537|1231836|P9|STARTED|Phase 2||0
512142|NCT00147537|1231837|P8|STARTED|Phase 2||0
512143|NCT00147537|1231838|P7|STARTED|Phase 2||0
512144|NCT00147537|1231839|P6|STARTED|Phase 2||0
512145|NCT00147537|1231840|P5|STARTED|Phase 2||0
512146|NCT00147537|1231841|P4|STARTED|Phase 2||0
512147|NCT00147537|1231842|P3|STARTED|Phase 2||0
512148|NCT00147537|1231843|P2|STARTED|Phase 2||0
512149|NCT00147537|1231844|P1|STARTED|Phase 2||0
512150|NCT00147537|1231834|P11|NOT COMPLETED|Phase 1b||0
512151|NCT00147537|1231835|P10|NOT COMPLETED|Phase 1b||0
512152|NCT00147537|1231836|P9|NOT COMPLETED|Phase 1b||17
512153|NCT00147537|1231837|P8|NOT COMPLETED|Phase 1b||7
512154|NCT00147537|1231838|P7|NOT COMPLETED|Phase 1b||18
512155|NCT00147537|1231839|P6|NOT COMPLETED|Phase 1b||3
512156|NCT00147537|1231840|P5|NOT COMPLETED|Phase 1b||3
512157|NCT00147537|1231841|P4|NOT COMPLETED|Phase 1b||2
512158|NCT00147537|1231842|P3|NOT COMPLETED|Phase 1b||4
512159|NCT00147537|1231843|P2|NOT COMPLETED|Phase 1b||2
512160|NCT00147537|1231844|P1|NOT COMPLETED|Phase 1b||2
512161|NCT00147537|1231834|P11|COMPLETED|Phase 1b||0
512162|NCT00147537|1231835|P10|COMPLETED|Phase 1b||0
512163|NCT00147537|1231836|P9|COMPLETED|Phase 1b||1
512164|NCT00147537|1231837|P8|COMPLETED|Phase 1b||0
512165|NCT00147537|1231838|P7|COMPLETED|Phase 1b||0
512166|NCT00147537|1231839|P6|COMPLETED|Phase 1b||0
512167|NCT00147537|1231840|P5|COMPLETED|Phase 1b||0
512168|NCT00147537|1231841|P4|COMPLETED|Phase 1b||1
512169|NCT00147537|1231842|P3|COMPLETED|Phase 1b||0
512170|NCT00147537|1231843|P2|COMPLETED|Phase 1b||0
512171|NCT00147537|1231844|P1|COMPLETED|Phase 1b||1
512172|NCT00147537|1231834|P11|STARTED|Phase 1b||0
512173|NCT00147537|1231835|P10|STARTED|Phase 1b||0
512174|NCT00147537|1231836|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
512175|NCT00147537|1231837|P8|STARTED|Phase 1b||7
512176|NCT00147537|1231838|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
512177|NCT00147537|1231839|P6|STARTED|Phase 1b||3
512178|NCT00147537|1231840|P5|STARTED|Phase 1b||3
512179|NCT00147537|1231841|P4|STARTED|Phase 1b||3
512180|NCT00147537|1231842|P3|STARTED|Phase 1b||4
512181|NCT00147537|1231843|P2|STARTED|Phase 1b||2
512182|NCT00147537|1231844|P1|STARTED|Phase 1b||3
512183|NCT00147498|1232027|P4|NOT COMPLETED|Overall Study||17
512184|NCT00147498|1232028|P3|NOT COMPLETED|Overall Study||17
512185|NCT00147498|1232029|P2|NOT COMPLETED|Overall Study||9
512186|NCT00147498|1232030|P1|NOT COMPLETED|Overall Study||3
512187|NCT00147498|1232027|P4|COMPLETED|Overall Study||48
512188|NCT00147498|1232028|P3|COMPLETED|Overall Study||52
512189|NCT00147498|1232029|P2|COMPLETED|Overall Study||60
512190|NCT00147498|1232030|P1|COMPLETED|Overall Study||58
512191|NCT00147498|1232027|P4|STARTED|Overall Study||65
512192|NCT00147498|1232028|P3|STARTED|Overall Study||69
512193|NCT00147498|1232029|P2|STARTED|Overall Study||69
512194|NCT00147498|1232030|P1|STARTED|Overall Study||61
512195|NCT00147446|1232126|P2|NOT COMPLETED|Overall Study||0
512196|NCT00147446|1232127|P1|NOT COMPLETED|Overall Study||0
512197|NCT00147446|1232126|P2|COMPLETED|Overall Study||61
512198|NCT00147446|1232127|P1|COMPLETED|Overall Study||60
512199|NCT00147446|1232126|P2|STARTED|Overall Study||61
512200|NCT00147446|1232127|P1|STARTED|Overall Study||60
512201|NCT00146848|1232138|P3|NOT COMPLETED|Post-randomization||39
512202|NCT00146848|1232139|P2|NOT COMPLETED|Post-randomization||47
512203|NCT00146848|1232140|P1|NOT COMPLETED|Post-randomization||38
512204|NCT00146848|1232138|P3|COMPLETED|Post-randomization||431
512205|NCT00146848|1232139|P2|COMPLETED|Post-randomization||441
512206|NCT00146848|1232140|P1|COMPLETED|Post-randomization||437
512207|NCT00146848|1232138|P3|STARTED|Post-randomization||470
512208|NCT00146848|1232139|P2|STARTED|Post-randomization||488
512209|NCT00146848|1232140|P1|STARTED|Post-randomization||475
512210|NCT00146848|1232138|P3|NOT COMPLETED|Pre-randomization||0
512211|NCT00146848|1232139|P2|NOT COMPLETED|Pre-randomization||0
512212|NCT00146848|1232140|P1|NOT COMPLETED|Pre-randomization||309
512213|NCT00146848|1232138|P3|COMPLETED|Pre-randomization||0
512214|NCT00146848|1232139|P2|COMPLETED|Pre-randomization||0
512215|NCT00146848|1232140|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
512216|NCT00146848|1232138|P3|STARTED|Pre-randomization||0
512217|NCT00146848|1232139|P2|STARTED|Pre-randomization||0
512218|NCT00146848|1232140|P1|STARTED|Pre-randomization|Registered|1742
512219|NCT00146770|1232156|P2|NOT COMPLETED|Overall Study||0
512220|NCT00146770|1232157|P1|NOT COMPLETED|Overall Study||5
512221|NCT00146770|1232156|P2|COMPLETED|Overall Study||22
512222|NCT00146770|1232157|P1|COMPLETED|Overall Study||18
512223|NCT00146770|1232156|P2|STARTED|Overall Study||22
512224|NCT00146770|1232157|P1|STARTED|Overall Study||23
512225|NCT00146757|1232175|P2|NOT COMPLETED|Overall Study||0
512226|NCT00146757|1232176|P1|NOT COMPLETED|Overall Study||2
512227|NCT00146757|1232175|P2|COMPLETED|Overall Study||4
512228|NCT00146757|1232176|P1|COMPLETED|Overall Study||14
512229|NCT00146757|1232175|P2|STARTED|Overall Study||4
512230|NCT00146757|1232176|P1|STARTED|Overall Study||16
512231|NCT00146328|1232196|P3|NOT COMPLETED|Overall Study||291
512232|NCT00146328|1232197|P2|NOT COMPLETED|Overall Study||154
512233|NCT00146328|1232198|P1|NOT COMPLETED|Overall Study||141
512234|NCT00146328|1232196|P3|COMPLETED|Overall Study||158
512235|NCT00146328|1232197|P2|COMPLETED|Overall Study||101
512236|NCT00146328|1232198|P1|COMPLETED|Overall Study||150
512237|NCT00146328|1232196|P3|STARTED|Overall Study||449
512238|NCT00146328|1232197|P2|STARTED|Overall Study||255
512239|NCT00146328|1232198|P1|STARTED|Overall Study||291
512240|NCT00145795|1232283|P2|NOT COMPLETED|Overall Study||0
512241|NCT00145795|1232284|P1|NOT COMPLETED|Overall Study||1
512242|NCT00145795|1232283|P2|COMPLETED|Overall Study||10
512243|NCT00145795|1232284|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
512244|NCT00145795|1232283|P2|STARTED|Overall Study||10
512245|NCT00145795|1232284|P1|STARTED|Overall Study||10
512246|NCT00145704|1232310|P2|NOT COMPLETED|Overall Study||3
512247|NCT00145704|1232311|P1|NOT COMPLETED|Overall Study||3
512248|NCT00145704|1232310|P2|COMPLETED|Overall Study||0
512249|NCT00145704|1232311|P1|COMPLETED|Overall Study||0
512250|NCT00145704|1232310|P2|STARTED|Overall Study||3
512251|NCT00145704|1232311|P1|STARTED|Overall Study||3
512252|NCT00145626|1232319|P1|NOT COMPLETED|Overall Study||5
512253|NCT00145626|1232319|P1|COMPLETED|Overall Study||14
512254|NCT00145626|1232319|P1|STARTED|Overall Study||19
512255|NCT00145600|1232351|P4|NOT COMPLETED|Overall Study||16
512256|NCT00145600|1232352|P3|NOT COMPLETED|Overall Study||5
512257|NCT00145600|1232353|P2|NOT COMPLETED|Overall Study||10
512258|NCT00145600|1232354|P1|NOT COMPLETED|Overall Study||8
512259|NCT00145600|1232351|P4|COMPLETED|Overall Study||130
512260|NCT00145600|1232352|P3|COMPLETED|Overall Study||8
512261|NCT00145600|1232353|P2|COMPLETED|Overall Study||36
512262|NCT00145600|1232354|P1|COMPLETED|Overall Study||83
512263|NCT00145600|1232351|P4|STARTED|Overall Study||146
512264|NCT00145600|1232352|P3|STARTED|Overall Study||13
512265|NCT00145600|1232353|P2|STARTED|Overall Study||46
512266|NCT00145600|1232354|P1|STARTED|Overall Study||91
512267|NCT00145587|1232468|P2|NOT COMPLETED|Overall Study||0
512268|NCT00145587|1232469|P1|NOT COMPLETED|Overall Study||0
512269|NCT00145587|1232468|P2|COMPLETED|Overall Study||1
512270|NCT00145587|1232469|P1|COMPLETED|Overall Study||5
512271|NCT00145587|1232468|P2|STARTED|Overall Study||1
512272|NCT00145587|1232469|P1|STARTED|Overall Study||5
512273|NCT00145574|1232478|P3|NOT COMPLETED|Open Label Long-term Extension||11
512274|NCT00145574|1232479|P2|NOT COMPLETED|Open Label Long-term Extension||0
512275|NCT00145574|1232480|P1|NOT COMPLETED|Open Label Long-term Extension||0
512276|NCT00145574|1232478|P3|COMPLETED|Open Label Long-term Extension||173
512277|NCT00145574|1232479|P2|COMPLETED|Open Label Long-term Extension||0
512278|NCT00145574|1232480|P1|COMPLETED|Open Label Long-term Extension||0
512279|NCT00145574|1232478|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
512280|NCT00145574|1232479|P2|STARTED|Open Label Long-term Extension||0
512281|NCT00145574|1232480|P1|STARTED|Open Label Long-term Extension||0
512282|NCT00145574|1232478|P3|NOT COMPLETED|Double Blind||2
512283|NCT00145574|1232479|P2|NOT COMPLETED|Double Blind||5
512284|NCT00145574|1232480|P1|NOT COMPLETED|Double Blind||1
512285|NCT00145574|1232478|P3|COMPLETED|Double Blind||62
512286|NCT00145574|1232479|P2|COMPLETED|Double Blind||60
512287|NCT00145574|1232480|P1|COMPLETED|Double Blind||64
512288|NCT00145574|1232478|P3|STARTED|Double Blind||64
512289|NCT00145574|1232479|P2|STARTED|Double Blind||65
512290|NCT00145574|1232480|P1|STARTED|Double Blind||65
512291|NCT00145509|1232537|P2|NOT COMPLETED|Overall Study||21
512292|NCT00145509|1232538|P1|NOT COMPLETED|Overall Study||22
512293|NCT00145509|1232537|P2|COMPLETED|Overall Study||15
512294|NCT00145509|1232538|P1|COMPLETED|Overall Study||19
512295|NCT00145509|1232537|P2|STARTED|Overall Study||36
512296|NCT00145509|1232538|P1|STARTED|Overall Study||41
512297|NCT00145496|1232552|P2|NOT COMPLETED|Overall Study||81
512298|NCT00145496|1232553|P1|NOT COMPLETED|Overall Study||123
512299|NCT00145496|1232552|P2|COMPLETED|Overall Study||143
512300|NCT00145496|1232553|P1|COMPLETED|Overall Study||121
512301|NCT00145496|1232552|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
512302|NCT00145496|1232553|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
512303|NCT00145418|1232563|P1|NOT COMPLETED|Overall Study||0
512304|NCT00145418|1232563|P1|COMPLETED|Overall Study||15
512305|NCT00145418|1232563|P1|STARTED|Overall Study||15
512306|NCT00145327|1232573|P3|NOT COMPLETED|Overall Study||248
512307|NCT00145327|1232574|P2|NOT COMPLETED|Overall Study||124
512308|NCT00145327|1232575|P1|NOT COMPLETED|Overall Study||142
512309|NCT00145327|1232573|P3|COMPLETED|Overall Study||975
512310|NCT00145327|1232574|P2|COMPLETED|Overall Study||493
512311|NCT00145327|1232575|P1|COMPLETED|Overall Study||474
512312|NCT00145327|1232573|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
512313|NCT00145327|1232574|P2|STARTED|Overall Study||617
512314|NCT00145327|1232575|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
512315|NCT00145249|1232631|P3|NOT COMPLETED|Overall Study||17
512316|NCT00145249|1232632|P2|NOT COMPLETED|Overall Study||15
512317|NCT00145249|1232633|P1|NOT COMPLETED|Overall Study||11
512318|NCT00145249|1232631|P3|COMPLETED|Overall Study||31
512319|NCT00145249|1232632|P2|COMPLETED|Overall Study||33
512320|NCT00145249|1232633|P1|COMPLETED|Overall Study||36
512321|NCT00145249|1232631|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
512322|NCT00145249|1232632|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
512323|NCT00145249|1232633|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
512324|NCT00145119|1232674|P1|NOT COMPLETED|Overall Study||45
512325|NCT00145119|1232674|P1|COMPLETED|Overall Study||267
512326|NCT00145119|1232674|P1|STARTED|Overall Study||312
512327|NCT00144339|1232680|P2|NOT COMPLETED|Overall Study||1099
512328|NCT00144339|1232681|P1|NOT COMPLETED|Overall Study||1358
512329|NCT00144339|1232680|P2|COMPLETED|Overall Study||1887
512330|NCT00144339|1232681|P1|COMPLETED|Overall Study||1648
512331|NCT00144339|1232680|P2|STARTED|Overall Study||2986
512332|NCT00144339|1232681|P1|STARTED|Overall Study||3006
512333|NCT00144300|1232889|P2|NOT COMPLETED|Overall Study||28
512334|NCT00144300|1232890|P1|NOT COMPLETED|Overall Study||29
512335|NCT00144300|1232889|P2|COMPLETED|Overall Study||97
512336|NCT00144300|1232890|P1|COMPLETED|Overall Study||92
512337|NCT00144300|1232889|P2|STARTED|Overall Study||125
512338|NCT00144300|1232890|P1|STARTED|Overall Study||121
512339|NCT00145041|1232936|P1|NOT COMPLETED|Overall Study||0
512340|NCT00145041|1232936|P1|COMPLETED|Overall Study||7
512341|NCT00145041|1232936|P1|STARTED|Overall Study||7
512342|NCT00144963|1232942|P1|NOT COMPLETED|Overall Study||0
512343|NCT00144963|1232942|P1|COMPLETED|Overall Study||36
512344|NCT00144963|1232942|P1|STARTED|Overall Study||36
512345|NCT00144781|1232950|P4|NOT COMPLETED|Overall Study||0
512346|NCT00144781|1232951|P3|NOT COMPLETED|Overall Study||0
512347|NCT00144781|1232952|P2|NOT COMPLETED|Overall Study||2
512348|NCT00144781|1232953|P1|NOT COMPLETED|Overall Study||0
512349|NCT00144781|1232950|P4|COMPLETED|Overall Study||9
512350|NCT00144781|1232951|P3|COMPLETED|Overall Study||8
512351|NCT00144781|1232952|P2|COMPLETED|Overall Study||7
512352|NCT00144781|1232953|P1|COMPLETED|Overall Study||8
512353|NCT00144781|1232950|P4|STARTED|Overall Study||9
512354|NCT00144781|1232951|P3|STARTED|Overall Study||8
512355|NCT00144781|1232952|P2|STARTED|Overall Study||9
512356|NCT00144781|1232953|P1|STARTED|Overall Study||8
512357|NCT00144170|1232973|P2|NOT COMPLETED|Overall Study||396
512358|NCT00144170|1232974|P1|NOT COMPLETED|Overall Study||352
512359|NCT00144170|1232973|P2|COMPLETED|Overall Study||32
512360|NCT00144170|1232974|P1|COMPLETED|Overall Study||86
512361|NCT00144170|1232973|P2|STARTED|Overall Study||428
512362|NCT00144170|1232974|P1|STARTED|Overall Study||438
512363|NCT00144027|1233164|P2|NOT COMPLETED|Overall Study||11
512364|NCT00144027|1233165|P1|NOT COMPLETED|Overall Study||3
512365|NCT00144027|1233164|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
512366|NCT00144027|1233165|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
512367|NCT00144027|1233164|P2|Completed 6 Month Assessment|Overall Study||24
512368|NCT00144027|1233165|P1|Completed 6 Month Assessment|Overall Study||37
512369|NCT00144027|1233164|P2|Completed Baseline Assessment|Overall Study||29
512370|NCT00144027|1233165|P1|Completed Baseline Assessment|Overall Study||39
512371|NCT00144027|1233164|P2|STARTED|Overall Study|participants who consented|36
512372|NCT00144027|1233165|P1|STARTED|Overall Study|participants who consented|39
512373|NCT00143845|1233171|P1|NOT COMPLETED|Overall Study||0
512374|NCT00143845|1233171|P1|COMPLETED|Overall Study||54
512375|NCT00143845|1233171|P1|STARTED|Overall Study||54
512376|NCT00143819|1233179|P2|NOT COMPLETED|Overall Study||3
512377|NCT00143819|1233180|P1|NOT COMPLETED|Overall Study||2
512378|NCT00143819|1233179|P2|COMPLETED|Overall Study||5
512379|NCT00143819|1233180|P1|COMPLETED|Overall Study||3
512380|NCT00143819|1233179|P2|STARTED|Overall Study||8
512381|NCT00143819|1233180|P1|STARTED|Overall Study||5
512382|NCT00143598|1233195|P2|NOT COMPLETED|Overall Study||94
512383|NCT00143598|1233196|P1|NOT COMPLETED|Overall Study||92
512384|NCT00143598|1233195|P2|COMPLETED|Overall Study||302
512385|NCT00143598|1233196|P1|COMPLETED|Overall Study||318
512386|NCT00143598|1233195|P2|STARTED|Overall Study||396
512387|NCT00143598|1233196|P1|STARTED|Overall Study||410
512388|NCT00143507|1233210|P2|NOT COMPLETED|Overall Study||652
512389|NCT00143507|1233211|P1|NOT COMPLETED|Overall Study||687
512390|NCT00143507|1233210|P2|COMPLETED|Overall Study||4786
512391|NCT00143507|1233211|P1|COMPLETED|Overall Study||4792
512392|NCT00143507|1233210|P2|STARTED|Overall Study||5438
512393|NCT00143507|1233211|P1|STARTED|Overall Study||5479
512394|NCT00143455|1233245|P4|NOT COMPLETED|Cohort 2||93
512395|NCT00143455|1233246|P3|NOT COMPLETED|Cohort 2||106
512396|NCT00143455|1233247|P2|NOT COMPLETED|Cohort 2||0
512397|NCT00143455|1233248|P1|NOT COMPLETED|Cohort 2||0
512398|NCT00143455|1233245|P4|COMPLETED|Cohort 2||111
512399|NCT00143455|1233246|P3|COMPLETED|Cohort 2||97
512400|NCT00143455|1233247|P2|COMPLETED|Cohort 2||0
512401|NCT00143455|1233248|P1|COMPLETED|Cohort 2||0
512402|NCT00143455|1233245|P4|Received Treatment|Cohort 2||203
512403|NCT00143455|1233246|P3|Received Treatment|Cohort 2||202
512404|NCT00143455|1233247|P2|Received Treatment|Cohort 2||0
512405|NCT00143455|1233248|P1|Received Treatment|Cohort 2||0
512406|NCT00143455|1233245|P4|STARTED|Cohort 2||204
512407|NCT00143455|1233246|P3|STARTED|Cohort 2||203
512408|NCT00143455|1233247|P2|STARTED|Cohort 2||0
512409|NCT00143455|1233248|P1|STARTED|Cohort 2||0
512410|NCT00143455|1233245|P4|NOT COMPLETED|Cohort 1||0
512411|NCT00143455|1233246|P3|NOT COMPLETED|Cohort 1||0
512412|NCT00143455|1233247|P2|NOT COMPLETED|Cohort 1||17
512413|NCT00143455|1233248|P1|NOT COMPLETED|Cohort 1||14
512414|NCT00143455|1233245|P4|COMPLETED|Cohort 1||0
512415|NCT00143455|1233246|P3|COMPLETED|Cohort 1||0
512416|NCT00143455|1233247|P2|COMPLETED|Cohort 1||22
512417|NCT00143455|1233248|P1|COMPLETED|Cohort 1||25
512418|NCT00143455|1233245|P4|Received Treatment|Cohort 1||0
512419|NCT00143455|1233246|P3|Received Treatment|Cohort 1||0
512420|NCT00143455|1233247|P2|Received Treatment|Cohort 1||38
512421|NCT00143455|1233248|P1|Received Treatment|Cohort 1||39
512422|NCT00143455|1233245|P4|STARTED|Cohort 1||0
512423|NCT00143455|1233246|P3|STARTED|Cohort 1||0
512424|NCT00143455|1233247|P2|STARTED|Cohort 1||39
512425|NCT00143455|1233248|P1|STARTED|Cohort 1||39
512426|NCT00142415|1233286|P6|NOT COMPLETED|Overall Study||2
512427|NCT00142415|1233287|P5|NOT COMPLETED|Overall Study||1
512428|NCT00142415|1233288|P4|NOT COMPLETED|Overall Study||0
512429|NCT00142415|1233289|P3|NOT COMPLETED|Overall Study||0
512430|NCT00142415|1233290|P2|NOT COMPLETED|Overall Study||0
512431|NCT00142415|1233291|P1|NOT COMPLETED|Overall Study||0
512432|NCT00142415|1233286|P6|COMPLETED|Overall Study||6
512433|NCT00142415|1233287|P5|COMPLETED|Overall Study||2
512434|NCT00142415|1233288|P4|COMPLETED|Overall Study||3
512435|NCT00142415|1233289|P3|COMPLETED|Overall Study||6
512436|NCT00142415|1233290|P2|COMPLETED|Overall Study||3
512437|NCT00142415|1233291|P1|COMPLETED|Overall Study||3
512438|NCT00142415|1233286|P6|STARTED|Overall Study||8
512439|NCT00142415|1233287|P5|STARTED|Overall Study||3
512440|NCT00142415|1233288|P4|STARTED|Overall Study||3
512441|NCT00142415|1233289|P3|STARTED|Overall Study||6
512442|NCT00142415|1233290|P2|STARTED|Overall Study||3
512443|NCT00142415|1233291|P1|STARTED|Overall Study||3
512444|NCT00142298|1233329|P10|NOT COMPLETED|Overall Study||0
512445|NCT00142298|1233330|P9|NOT COMPLETED|Overall Study||5
512446|NCT00142298|1233331|P8|NOT COMPLETED|Overall Study||8
512447|NCT00142298|1233332|P7|NOT COMPLETED|Overall Study||8
512448|NCT00142298|1233333|P6|NOT COMPLETED|Overall Study||16
512449|NCT00142298|1233334|P5|NOT COMPLETED|Overall Study||10
512450|NCT00142298|1233335|P4|NOT COMPLETED|Overall Study||85
512451|NCT00142298|1233336|P3|NOT COMPLETED|Overall Study||33
512452|NCT00142298|1233337|P2|NOT COMPLETED|Overall Study||176
512453|NCT00142298|1233338|P1|NOT COMPLETED|Overall Study||160
512454|NCT00142298|1233329|P10|COMPLETED|Overall Study||13
512455|NCT00142298|1233330|P9|COMPLETED|Overall Study||52
512456|NCT00142298|1233331|P8|COMPLETED|Overall Study||58
512457|NCT00142298|1233332|P7|COMPLETED|Overall Study||15
512458|NCT00142298|1233333|P6|COMPLETED|Overall Study||10
512459|NCT00142298|1233334|P5|COMPLETED|Overall Study||46
512460|NCT00142298|1233335|P4|COMPLETED|Overall Study||121
512461|NCT00142298|1233336|P3|COMPLETED|Overall Study||90
512462|NCT00142298|1233337|P2|COMPLETED|Overall Study||456
512463|NCT00142298|1233338|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
512464|NCT00142298|1233329|P10|Per Protocol Population|Overall Study||13
512465|NCT00142298|1233330|P9|Per Protocol Population|Overall Study||56
512466|NCT00142298|1233331|P8|Per Protocol Population|Overall Study||64
512467|NCT00142298|1233332|P7|Per Protocol Population|Overall Study||19
512468|NCT00142298|1233333|P6|Per Protocol Population|Overall Study||25
512469|NCT00142298|1233334|P5|Per Protocol Population|Overall Study||50
512470|NCT00142298|1233335|P4|Per Protocol Population|Overall Study||202
512471|NCT00142298|1233336|P3|Per Protocol Population|Overall Study||120
512472|NCT00142298|1233337|P2|Per Protocol Population|Overall Study||606
512473|NCT00142298|1233338|P1|Per Protocol Population|Overall Study||635
512474|NCT00142298|1233329|P10|Safety Population|Overall Study||13
512475|NCT00142298|1233330|P9|Safety Population|Overall Study||57
512476|NCT00142298|1233331|P8|Safety Population|Overall Study||66
512477|NCT00142298|1233332|P7|Safety Population|Overall Study||23
512478|NCT00142298|1233333|P6|Safety Population|Overall Study||26
512479|NCT00142298|1233334|P5|Safety Population|Overall Study||50
512480|NCT00142298|1233335|P4|Safety Population|Overall Study||206
512481|NCT00142298|1233336|P3|Safety Population|Overall Study||122
512482|NCT00142298|1233337|P2|Safety Population|Overall Study||626
512483|NCT00142298|1233338|P1|Safety Population|Overall Study||655
512484|NCT00142298|1233329|P10|STARTED|Overall Study||13
512485|NCT00142298|1233330|P9|STARTED|Overall Study||57
512486|NCT00142298|1233331|P8|STARTED|Overall Study||66
512487|NCT00142298|1233332|P7|STARTED|Overall Study||23
512488|NCT00142298|1233333|P6|STARTED|Overall Study||26
512489|NCT00142298|1233334|P5|STARTED|Overall Study||56
512490|NCT00142298|1233335|P4|STARTED|Overall Study||206
512491|NCT00142298|1233336|P3|STARTED|Overall Study||123
512492|NCT00142298|1233337|P2|STARTED|Overall Study||632
512493|NCT00142298|1233338|P1|STARTED|Overall Study||667
512494|NCT00143403|1233362|P2|NOT COMPLETED|Overall Study||46
512495|NCT00143403|1233363|P1|NOT COMPLETED|Overall Study||35
512496|NCT00143403|1233362|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
512497|NCT00143403|1233363|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
512498|NCT00143403|1233362|P2|Treated|Overall Study||153
512499|NCT00143403|1233363|P1|Treated|Overall Study||153
512500|NCT00143403|1233362|P2|STARTED|Overall Study||161
512501|NCT00143403|1233363|P1|STARTED|Overall Study||160
512502|NCT00143390|1233373|P2|NOT COMPLETED|Overall Study||149
512503|NCT00143390|1233374|P1|NOT COMPLETED|Overall Study||149
512504|NCT00143390|1233373|P2|COMPLETED|Overall Study||0
512505|NCT00143390|1233374|P1|COMPLETED|Overall Study||0
512506|NCT00143390|1233373|P2|STARTED|Overall Study||149
512507|NCT00143390|1233374|P1|STARTED|Overall Study||149
512508|NCT00143312|1233390|P1|NOT COMPLETED|Overall Study||16
512509|NCT00143312|1233390|P1|COMPLETED|Overall Study||29
512510|NCT00143312|1233390|P1|STARTED|Overall Study||45
512511|NCT00143247|1233400|P1|NOT COMPLETED|Overall Study||156
512512|NCT00143247|1233400|P1|COMPLETED|Overall Study||17
512513|NCT00143247|1233400|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
512514|NCT00142935|1233417|P3|NOT COMPLETED|Overall Study||7
512515|NCT00142935|1233418|P2|NOT COMPLETED|Overall Study||8
512516|NCT00142935|1233419|P1|NOT COMPLETED|Overall Study||3
512517|NCT00142935|1233417|P3|COMPLETED|Overall Study||23
512518|NCT00142935|1233418|P2|COMPLETED|Overall Study||20
512519|NCT00142935|1233419|P1|COMPLETED|Overall Study||26
512520|NCT00142935|1233417|P3|STARTED|Overall Study||30
512521|NCT00142935|1233418|P2|STARTED|Overall Study||28
512522|NCT00142935|1233419|P1|STARTED|Overall Study||29
512523|NCT00142909|1233444|P2|NOT COMPLETED|Medications Begin||3
512524|NCT00142909|1233445|P1|NOT COMPLETED|Medications Begin||9
512525|NCT00142909|1233444|P2|COMPLETED|Medications Begin||31
512526|NCT00142909|1233445|P1|COMPLETED|Medications Begin||26
512527|NCT00142909|1233444|P2|STARTED|Medications Begin||34
512528|NCT00142909|1233445|P1|STARTED|Medications Begin||35
512529|NCT00142909|1233444|P2|NOT COMPLETED|Randomization||10
512530|NCT00142909|1233445|P1|NOT COMPLETED|Randomization||7
512531|NCT00142909|1233444|P2|COMPLETED|Randomization||34
512532|NCT00142909|1233445|P1|COMPLETED|Randomization||35
512533|NCT00142909|1233444|P2|STARTED|Randomization||44
512534|NCT00142909|1233445|P1|STARTED|Randomization||42
512535|NCT00142818|1233465|P4|NOT COMPLETED|Overall Study||22
512536|NCT00142818|1233466|P3|NOT COMPLETED|Overall Study||13
512537|NCT00142818|1233467|P2|NOT COMPLETED|Overall Study||21
512538|NCT00142818|1233468|P1|NOT COMPLETED|Overall Study||17
512539|NCT00142818|1233465|P4|COMPLETED|Overall Study||20
512540|NCT00142818|1233466|P3|COMPLETED|Overall Study||24
512541|NCT00142818|1233467|P2|COMPLETED|Overall Study||19
512542|NCT00142818|1233468|P1|COMPLETED|Overall Study||28
512543|NCT00142818|1233465|P4|STARTED|Overall Study||42
512544|NCT00142818|1233466|P3|STARTED|Overall Study||37
512545|NCT00142818|1233467|P2|STARTED|Overall Study||40
512546|NCT00142818|1233468|P1|STARTED|Overall Study||45
512547|NCT00142597|1233480|P2|NOT COMPLETED|Overall Study||1
512548|NCT00142597|1233481|P1|NOT COMPLETED|Overall Study||3
512549|NCT00142597|1233480|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
512550|NCT00142597|1233481|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
512551|NCT00142597|1233480|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
512552|NCT00142597|1233481|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
512553|NCT00142168|1233487|P1|NOT COMPLETED|Overall Study||0
512554|NCT00142168|1233487|P1|COMPLETED|Overall Study||16
512555|NCT00142168|1233487|P1|STARTED|Overall Study||16
512556|NCT00142116|1233494|P1|NOT COMPLETED|Overall Study||0
512557|NCT00142116|1233494|P1|COMPLETED|Overall Study||25
512558|NCT00142116|1233494|P1|STARTED|Overall Study||25
512563|NCT00141817|1233525|P4|NOT COMPLETED|Overall Study||0
512564|NCT00141817|1233526|P3|NOT COMPLETED|Overall Study||1
512565|NCT00141817|1233527|P2|NOT COMPLETED|Overall Study||0
512566|NCT00141817|1233528|P1|NOT COMPLETED|Overall Study||1
512567|NCT00141817|1233525|P4|COMPLETED|Overall Study||13
512568|NCT00141817|1233526|P3|COMPLETED|Overall Study||10
512569|NCT00141817|1233527|P2|COMPLETED|Overall Study||10
512570|NCT00141817|1233528|P1|COMPLETED|Overall Study||6
512571|NCT00141817|1233525|P4|STARTED|Overall Study||13
512572|NCT00141817|1233526|P3|STARTED|Overall Study||11
512573|NCT00141817|1233527|P2|STARTED|Overall Study||10
512574|NCT00141817|1233528|P1|STARTED|Overall Study||7
512575|NCT00141778|1233569|P3|NOT COMPLETED|Started Study Medication||4
512576|NCT00141778|1233570|P2|NOT COMPLETED|Started Study Medication||7
512577|NCT00141778|1233571|P1|NOT COMPLETED|Started Study Medication||2
512578|NCT00141778|1233569|P3|COMPLETED|Started Study Medication||143
512579|NCT00141778|1233570|P2|COMPLETED|Started Study Medication||144
512580|NCT00141778|1233571|P1|COMPLETED|Started Study Medication||145
512581|NCT00141778|1233569|P3|STARTED|Started Study Medication||147
512582|NCT00141778|1233570|P2|STARTED|Started Study Medication||151
512583|NCT00141778|1233571|P1|STARTED|Started Study Medication||147
512584|NCT00141778|1233569|P3|NOT COMPLETED|Randomization Prior to Study Med||6
512585|NCT00141778|1233570|P2|NOT COMPLETED|Randomization Prior to Study Med||2
512586|NCT00141778|1233571|P1|NOT COMPLETED|Randomization Prior to Study Med||5
512587|NCT00141778|1233569|P3|COMPLETED|Randomization Prior to Study Med||147
512588|NCT00141778|1233570|P2|COMPLETED|Randomization Prior to Study Med||151
512589|NCT00141778|1233571|P1|COMPLETED|Randomization Prior to Study Med||147
512590|NCT00141778|1233569|P3|STARTED|Randomization Prior to Study Med||153
512591|NCT00141778|1233570|P2|STARTED|Randomization Prior to Study Med||153
512592|NCT00141778|1233571|P1|STARTED|Randomization Prior to Study Med||152
512593|NCT00141765|1233609|P1|NOT COMPLETED|Overall Study||0
512594|NCT00141765|1233609|P1|COMPLETED|Overall Study||25
512595|NCT00141765|1233609|P1|STARTED|Overall Study||25
512596|NCT00141739|1233613|P1|NOT COMPLETED|Overall Study||0
512597|NCT00141739|1233613|P1|COMPLETED|Overall Study||100
512598|NCT00141739|1233613|P1|STARTED|Overall Study|Number of evaluable patients|100
512599|NCT00141726|1233624|P1|NOT COMPLETED|Overall Study||3
512600|NCT00141726|1233624|P1|COMPLETED|Overall Study||31
512601|NCT00141726|1233624|P1|STARTED|Overall Study||34
512602|NCT00141518|1233632|P3|NOT COMPLETED|Overall Study||6
512603|NCT00141518|1233633|P2|NOT COMPLETED|Overall Study||6
512604|NCT00141518|1233634|P1|NOT COMPLETED|Overall Study||16
512605|NCT00141518|1233632|P3|COMPLETED|Overall Study||12
512606|NCT00141518|1233633|P2|COMPLETED|Overall Study||16
512607|NCT00141518|1233634|P1|COMPLETED|Overall Study||21
512608|NCT00141518|1233632|P3|Full Analysis Sample|Overall Study||18
512609|NCT00141518|1233633|P2|Full Analysis Sample|Overall Study||22
512610|NCT00141518|1233634|P1|Full Analysis Sample|Overall Study||27
512611|NCT00141518|1233632|P3|Safety Sample|Overall Study||18
512612|NCT00141518|1233633|P2|Safety Sample|Overall Study||22
512613|NCT00141518|1233634|P1|Safety Sample|Overall Study||36
512614|NCT00141518|1233632|P3|STARTED|Overall Study||18
512615|NCT00141518|1233633|P2|STARTED|Overall Study||22
512616|NCT00141518|1233634|P1|STARTED|Overall Study||37
512617|NCT00141453|1233823|P2|NOT COMPLETED|Overall Study||5
512618|NCT00141453|1233824|P1|NOT COMPLETED|Overall Study||6
512619|NCT00141453|1233823|P2|COMPLETED|Overall Study||284
512620|NCT00141453|1233824|P1|COMPLETED|Overall Study||282
512621|NCT00141453|1233823|P2|STARTED|Overall Study||289
512622|NCT00141453|1233824|P1|STARTED|Overall Study||288
512623|NCT00141297|1233838|P10|NOT COMPLETED|Overall Study||6
512624|NCT00141297|1233839|P9|NOT COMPLETED|Overall Study||20
512625|NCT00141297|1233840|P8|NOT COMPLETED|Overall Study||4
512626|NCT00141297|1233841|P7|NOT COMPLETED|Overall Study||3
512627|NCT00141297|1233842|P6|NOT COMPLETED|Overall Study||3
512628|NCT00141297|1233843|P5|NOT COMPLETED|Overall Study||22
512629|NCT00141297|1233844|P4|NOT COMPLETED|Overall Study||3
512630|NCT00141297|1233845|P3|NOT COMPLETED|Overall Study||7
512631|NCT00141297|1233846|P2|NOT COMPLETED|Overall Study||3
512632|NCT00141297|1233847|P1|NOT COMPLETED|Overall Study||3
512633|NCT00141297|1233838|P10|COMPLETED|Overall Study||0
512634|NCT00141297|1233839|P9|COMPLETED|Overall Study||0
512635|NCT00141297|1233840|P8|COMPLETED|Overall Study||0
512636|NCT00141297|1233841|P7|COMPLETED|Overall Study||0
512637|NCT00141297|1233842|P6|COMPLETED|Overall Study||0
512638|NCT00141297|1233843|P5|COMPLETED|Overall Study||0
512639|NCT00141297|1233844|P4|COMPLETED|Overall Study||0
512640|NCT00141297|1233845|P3|COMPLETED|Overall Study||0
512641|NCT00141297|1233846|P2|COMPLETED|Overall Study||0
512642|NCT00141297|1233847|P1|COMPLETED|Overall Study||0
512643|NCT00141297|1233838|P10|STARTED|Overall Study||6
512644|NCT00141297|1233839|P9|STARTED|Overall Study||20
512645|NCT00141297|1233840|P8|STARTED|Overall Study||4
512646|NCT00141297|1233841|P7|STARTED|Overall Study||3
512647|NCT00141297|1233842|P6|STARTED|Overall Study||3
512648|NCT00141297|1233843|P5|STARTED|Overall Study||22
512649|NCT00141297|1233844|P4|STARTED|Overall Study||3
512650|NCT00141297|1233845|P3|STARTED|Overall Study||7
512651|NCT00141297|1233846|P2|STARTED|Overall Study||3
512652|NCT00141297|1233847|P1|STARTED|Overall Study||3
512653|NCT00141271|1234125|P3|NOT COMPLETED|Overall Study||57
512654|NCT00141271|1234126|P2|NOT COMPLETED|Overall Study||63
512655|NCT00141271|1234127|P1|NOT COMPLETED|Overall Study||80
512656|NCT00141271|1234125|P3|COMPLETED|Overall Study||111
512657|NCT00141271|1234126|P2|COMPLETED|Overall Study||102
512658|NCT00141271|1234127|P1|COMPLETED|Overall Study||91
512659|NCT00141271|1234125|P3|STARTED|Overall Study||168
512660|NCT00141271|1234126|P2|STARTED|Overall Study||165
512661|NCT00141271|1234127|P1|STARTED|Overall Study||171
512662|NCT00141219|1234248|P2|NOT COMPLETED|Overall Study||16
512663|NCT00141219|1234249|P1|NOT COMPLETED|Overall Study||24
512664|NCT00141219|1234248|P2|COMPLETED|Overall Study||62
512665|NCT00141219|1234249|P1|COMPLETED|Overall Study||138
512666|NCT00141219|1234248|P2|STARTED|Overall Study||78
512667|NCT00141219|1234249|P1|STARTED|Overall Study||162
512668|NCT00141102|1234301|P2|NOT COMPLETED|Overall Study||625
512669|NCT00141102|1234302|P1|NOT COMPLETED|Overall Study||508
512670|NCT00141102|1234301|P2|COMPLETED|Overall Study||1621
512671|NCT00141102|1234302|P1|COMPLETED|Overall Study||1730
512672|NCT00141102|1234301|P2|Received Treatment|Overall Study||2237
512673|NCT00141102|1234302|P1|Received Treatment|Overall Study||2223
512674|NCT00141102|1234301|P2|STARTED|Overall Study||2246
512675|NCT00141102|1234302|P1|STARTED|Overall Study||2238
512676|NCT00141037|1234342|P2|NOT COMPLETED|Overall Study||18
512677|NCT00141037|1234343|P1|NOT COMPLETED|Overall Study||10
512678|NCT00141037|1234342|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
512679|NCT00141037|1234343|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
512680|NCT00141037|1234342|P2|STARTED|Overall Study||70
512681|NCT00141037|1234343|P1|STARTED|Overall Study||60
512682|NCT00140842|1234353|P2|NOT COMPLETED|Overall Study||0
512683|NCT00140842|1234354|P1|NOT COMPLETED|Overall Study||0
512684|NCT00140842|1234353|P2|COMPLETED|Overall Study||15
512685|NCT00140842|1234354|P1|COMPLETED|Overall Study||15
512686|NCT00140842|1234353|P2|STARTED|Overall Study||15
512687|NCT00140842|1234354|P1|STARTED|Overall Study||15
512688|NCT00140621|1234362|P1|NOT COMPLETED|Overall Study||0
512689|NCT00140621|1234362|P1|COMPLETED|Overall Study||6
512690|NCT00140621|1234362|P1|STARTED|Overall Study||6
512691|NCT00140556|1234372|P1|NOT COMPLETED|Chemoradiotherapy Period||0
512692|NCT00140556|1234372|P1|COMPLETED|Chemoradiotherapy Period||28
512693|NCT00140556|1234372|P1|STARTED|Chemoradiotherapy Period||28
512694|NCT00140556|1234372|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
512695|NCT00140556|1234372|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
512696|NCT00140556|1234372|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
512697|NCT00140426|1234378|P2|NOT COMPLETED|Overall Study||3
512698|NCT00140426|1234379|P1|NOT COMPLETED|Overall Study||0
512699|NCT00140426|1234378|P2|COMPLETED|Overall Study||16
512700|NCT00140426|1234379|P1|COMPLETED|Overall Study||22
512701|NCT00140426|1234378|P2|STARTED|Overall Study||19
512702|NCT00140426|1234379|P1|STARTED|Overall Study||22
512703|NCT00140413|1234412|P2|NOT COMPLETED|Overall Study||0
512704|NCT00140413|1234413|P1|NOT COMPLETED|Overall Study||3
512705|NCT00140413|1234412|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
512706|NCT00140413|1234413|P1|COMPLETED|Overall Study||10
512707|NCT00140413|1234412|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
512708|NCT00140413|1234413|P1|Received at Least One Dose of GH|Overall Study||13
512709|NCT00140413|1234412|P2|STARTED|Overall Study||7
512710|NCT00140413|1234413|P1|STARTED|Overall Study||13
512711|NCT00140244|1234420|P2|NOT COMPLETED|Intervention 2||2
512712|NCT00140244|1234421|P1|NOT COMPLETED|Intervention 2||0
512713|NCT00140244|1234420|P2|COMPLETED|Intervention 2||2
512714|NCT00140244|1234421|P1|COMPLETED|Intervention 2||3
512715|NCT00140244|1234420|P2|STARTED|Intervention 2||4
512716|NCT00140244|1234421|P1|STARTED|Intervention 2||3
512717|NCT00140244|1234420|P2|NOT COMPLETED|Washout||0
512718|NCT00140244|1234421|P1|NOT COMPLETED|Washout||0
512719|NCT00140244|1234420|P2|COMPLETED|Washout||4
512720|NCT00140244|1234421|P1|COMPLETED|Washout||3
512721|NCT00140244|1234420|P2|STARTED|Washout||4
512722|NCT00140244|1234421|P1|STARTED|Washout||3
512723|NCT00140244|1234420|P2|NOT COMPLETED|Intervention 1||0
512724|NCT00140244|1234421|P1|NOT COMPLETED|Intervention 1||0
512725|NCT00140244|1234420|P2|COMPLETED|Intervention 1||4
512726|NCT00140244|1234421|P1|COMPLETED|Intervention 1||3
512727|NCT00140244|1234420|P2|STARTED|Intervention 1||4
512728|NCT00140244|1234421|P1|STARTED|Intervention 1||3
512729|NCT00140231|1234453|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
512730|NCT00140231|1234454|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
512731|NCT00140231|1234453|P2|COMPLETED|Fasting State With Leptin and Crossover||6
512732|NCT00140231|1234454|P1|COMPLETED|Fasting State With Leptin and Crossover||7
512733|NCT00140231|1234453|P2|STARTED|Fasting State With Leptin and Crossover||6
512734|NCT00140231|1234454|P1|STARTED|Fasting State With Leptin and Crossover||7
512735|NCT00140231|1234453|P2|NOT COMPLETED|Washout 8 Weeks||0
512736|NCT00140231|1234454|P1|NOT COMPLETED|Washout 8 Weeks||0
512737|NCT00140231|1234453|P2|COMPLETED|Washout 8 Weeks||6
512738|NCT00140231|1234454|P1|COMPLETED|Washout 8 Weeks||7
512739|NCT00140231|1234453|P2|STARTED|Washout 8 Weeks||6
512740|NCT00140231|1234454|P1|STARTED|Washout 8 Weeks||7
512741|NCT00140231|1234453|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
512742|NCT00140231|1234454|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
512743|NCT00140231|1234453|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
512744|NCT00140231|1234454|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
512745|NCT00140231|1234453|P2|STARTED|First Fasting State 3 Days With Placebo||6
512746|NCT00140231|1234454|P1|STARTED|First Fasting State 3 Days With Placebo||7
512747|NCT00140231|1234453|P2|NOT COMPLETED|Washout 8weeks||0
512748|NCT00140231|1234454|P1|NOT COMPLETED|Washout 8weeks||0
512749|NCT00140231|1234453|P2|COMPLETED|Washout 8weeks||6
512750|NCT00140231|1234454|P1|COMPLETED|Washout 8weeks||7
512751|NCT00140231|1234453|P2|STARTED|Washout 8weeks||6
512752|NCT00140231|1234454|P1|STARTED|Washout 8weeks||7
512753|NCT00140231|1234453|P2|NOT COMPLETED|Fed State 1 Day- day5||0
512754|NCT00140231|1234454|P1|NOT COMPLETED|Fed State 1 Day- day5||0
512755|NCT00140231|1234453|P2|COMPLETED|Fed State 1 Day- day5||6
512756|NCT00140231|1234454|P1|COMPLETED|Fed State 1 Day- day5||7
512757|NCT00140231|1234453|P2|STARTED|Fed State 1 Day- day5||6
512758|NCT00140231|1234454|P1|STARTED|Fed State 1 Day- day5||7
512759|NCT00140140|1234473|P3|NOT COMPLETED|Overall Study||2
512760|NCT00140140|1234474|P2|NOT COMPLETED|Overall Study||2
512761|NCT00140140|1234475|P1|NOT COMPLETED|Overall Study||2
512762|NCT00140140|1234473|P3|COMPLETED|Overall Study|Progressive disease|4
512763|NCT00140140|1234474|P2|COMPLETED|Overall Study|Progressive disease|4
512764|NCT00140140|1234475|P1|COMPLETED|Overall Study|Progressive disease|2
512765|NCT00140140|1234473|P3|STARTED|Overall Study||6
512766|NCT00140140|1234474|P2|STARTED|Overall Study||6
512767|NCT00140140|1234475|P1|STARTED|Overall Study||4
512768|NCT00139997|1234514|P2|NOT COMPLETED|Overall Study||2
512769|NCT00139997|1234515|P1|NOT COMPLETED|Overall Study||1
512770|NCT00139997|1234514|P2|COMPLETED|Overall Study||9
512771|NCT00139997|1234515|P1|COMPLETED|Overall Study||14
512772|NCT00139997|1234514|P2|STARTED|Overall Study||11
512773|NCT00139997|1234515|P1|STARTED|Overall Study||15
512774|NCT00139776|1234525|P4|NOT COMPLETED|Period III||106
512775|NCT00139776|1234526|P3|NOT COMPLETED|Period III||76
512776|NCT00139776|1234527|P2|NOT COMPLETED|Period III||0
512777|NCT00139776|1234528|P1|NOT COMPLETED|Period III||0
512778|NCT00139776|1234525|P4|COMPLETED|Period III||321
512779|NCT00139776|1234526|P3|COMPLETED|Period III||355
512780|NCT00139776|1234527|P2|COMPLETED|Period III||0
512781|NCT00139776|1234528|P1|COMPLETED|Period III||0
512782|NCT00139776|1234525|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
512783|NCT00139776|1234526|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
512784|NCT00139776|1234527|P2|STARTED|Period III||0
512785|NCT00139776|1234528|P1|STARTED|Period III||0
512786|NCT00139776|1234525|P4|NOT COMPLETED|Period II||0
512787|NCT00139776|1234526|P3|NOT COMPLETED|Period II||0
512788|NCT00139776|1234527|P2|NOT COMPLETED|Period II||322
512789|NCT00139776|1234528|P1|NOT COMPLETED|Period II||0
512790|NCT00139776|1234525|P4|COMPLETED|Period II||0
512791|NCT00139776|1234526|P3|COMPLETED|Period II||0
512792|NCT00139776|1234527|P2|COMPLETED|Period II||875
512793|NCT00139776|1234528|P1|COMPLETED|Period II||0
512794|NCT00139776|1234525|P4|STARTED|Period II||0
512795|NCT00139776|1234526|P3|STARTED|Period II||0
512796|NCT00139776|1234527|P2|STARTED|Period II||1197
512797|NCT00139776|1234528|P1|STARTED|Period II||0
512798|NCT00139776|1234525|P4|NOT COMPLETED|Period I||0
512799|NCT00139776|1234526|P3|NOT COMPLETED|Period I||0
512800|NCT00139776|1234527|P2|NOT COMPLETED|Period I||0
512801|NCT00139776|1234528|P1|NOT COMPLETED|Period I||575
512802|NCT00139776|1234525|P4|COMPLETED|Period I||0
512803|NCT00139776|1234526|P3|COMPLETED|Period I||0
512804|NCT00139776|1234527|P2|COMPLETED|Period I||0
512805|NCT00139776|1234528|P1|COMPLETED|Period I||1197
512806|NCT00139776|1234525|P4|STARTED|Period I||0
512807|NCT00139776|1234526|P3|STARTED|Period I||0
512808|NCT00139776|1234527|P2|STARTED|Period I||0
512809|NCT00139776|1234528|P1|STARTED|Period I||1772
512810|NCT00139737|1234563|P1|NOT COMPLETED|Overall Study||341
512811|NCT00139737|1234563|P1|COMPLETED|Overall Study||3
512812|NCT00139737|1234563|P1|Received Treatment|Overall Study||331
512813|NCT00139737|1234563|P1|STARTED|Overall Study||344
512814|NCT00139659|1234569|P2|NOT COMPLETED|Overall Study||18
512815|NCT00139659|1234570|P1|NOT COMPLETED|Overall Study||40
512816|NCT00139659|1234569|P2|COMPLETED|Overall Study||123
512817|NCT00139659|1234570|P1|COMPLETED|Overall Study||106
512818|NCT00139659|1234569|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
512819|NCT00139659|1234570|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
512820|NCT00139477|1234648|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
512821|NCT00139477|1234649|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
512822|NCT00139477|1234648|P2|COMPLETED|Second Intervention -6Months to 12Months||18
512823|NCT00139477|1234649|P1|COMPLETED|Second Intervention -6Months to 12Months||14
512824|NCT00139477|1234648|P2|STARTED|Second Intervention -6Months to 12Months||23
512825|NCT00139477|1234649|P1|STARTED|Second Intervention -6Months to 12Months||19
512826|NCT00139477|1234648|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
512827|NCT00139477|1234649|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
512828|NCT00139477|1234648|P2|COMPLETED|First Intervention -Baseline to 6Months||23
512829|NCT00139477|1234649|P1|COMPLETED|First Intervention -Baseline to 6Months||19
512830|NCT00139477|1234648|P2|STARTED|First Intervention -Baseline to 6Months||35
512831|NCT00139477|1234649|P1|STARTED|First Intervention -Baseline to 6Months||31
512832|NCT00138671|1234671|P2|NOT COMPLETED|Overall Study||16
512833|NCT00138671|1234672|P1|NOT COMPLETED|Overall Study||13
512834|NCT00138671|1234671|P2|COMPLETED|Overall Study||30
512835|NCT00138671|1234672|P1|COMPLETED|Overall Study||46
512836|NCT00138671|1234671|P2|STARTED|Overall Study||46
512837|NCT00138671|1234672|P1|STARTED|Overall Study||59
512838|NCT00138658|1234722|P1|NOT COMPLETED|Overall Study||61
512839|NCT00138658|1234722|P1|COMPLETED|Overall Study||20
512840|NCT00138658|1234722|P1|STARTED|Overall Study||81
512841|NCT00138645|1234734|P2|NOT COMPLETED|Overall Study||7
512842|NCT00138645|1234735|P1|NOT COMPLETED|Overall Study||6
512843|NCT00138645|1234734|P2|COMPLETED|Overall Study||23
512844|NCT00138645|1234735|P1|COMPLETED|Overall Study||24
512845|NCT00138645|1234734|P2|STARTED|Overall Study||30
512846|NCT00138645|1234735|P1|STARTED|Overall Study||30
512847|NCT00138424|1234745|P4|NOT COMPLETED|Overall Study||0
512848|NCT00138424|1234746|P3|NOT COMPLETED|Overall Study||0
512849|NCT00138424|1234747|P2|NOT COMPLETED|Overall Study||1
512850|NCT00138424|1234748|P1|NOT COMPLETED|Overall Study||0
512851|NCT00138424|1234745|P4|COMPLETED|Overall Study||3
512852|NCT00138424|1234746|P3|COMPLETED|Overall Study||5
512853|NCT00138424|1234747|P2|COMPLETED|Overall Study||4
512854|NCT00138424|1234748|P1|COMPLETED|Overall Study||9
512855|NCT00138424|1234745|P4|STARTED|Overall Study||3
512856|NCT00138424|1234746|P3|STARTED|Overall Study||5
512857|NCT00138424|1234747|P2|STARTED|Overall Study||5
512858|NCT00138424|1234748|P1|STARTED|Overall Study||9
512859|NCT00138294|1234814|P1|NOT COMPLETED|Overall Study||0
512860|NCT00138294|1234814|P1|COMPLETED|Overall Study||29255
512861|NCT00138294|1234814|P1|STARTED|Overall Study||29255
512862|NCT00138203|1234824|P1|NOT COMPLETED|Overall Study||0
512863|NCT00138203|1234824|P1|COMPLETED|Overall Study||16
512864|NCT00138203|1234824|P1|STARTED|Overall Study||16
512865|NCT00138151|1234830|P1|NOT COMPLETED|Overall Study||4
512866|NCT00138151|1234830|P1|COMPLETED|Overall Study||29
512867|NCT00138151|1234830|P1|STARTED|Overall Study||33
512868|NCT00138125|1234836|P1|NOT COMPLETED|Overall Study||0
512869|NCT00138125|1234836|P1|COMPLETED|Overall Study||2
512870|NCT00138125|1234836|P1|STARTED|Overall Study||2
512871|NCT00138073|1234840|P1|NOT COMPLETED|Overall Study||55
512872|NCT00138073|1234840|P1|COMPLETED|Overall Study||0
512873|NCT00138073|1234840|P1|Pre-intervention Testing|Overall Study||55
512874|NCT00138073|1234840|P1|STARTED|Overall Study||55
512875|NCT00138034|1234847|P2|NOT COMPLETED|Overall Study||3
512876|NCT00138034|1234848|P1|NOT COMPLETED|Overall Study||3
512877|NCT00138034|1234847|P2|COMPLETED|Overall Study||20
512878|NCT00138034|1234848|P1|COMPLETED|Overall Study||23
512879|NCT00138034|1234847|P2|STARTED|Overall Study||23
512880|NCT00138034|1234848|P1|STARTED|Overall Study||26
512881|NCT00137969|1234858|P2|NOT COMPLETED|Overall Study||21
512882|NCT00137969|1234859|P1|NOT COMPLETED|Overall Study||67
512883|NCT00137969|1234858|P2|COMPLETED|Overall Study||67
512884|NCT00137969|1234859|P1|COMPLETED|Overall Study||107
512885|NCT00137969|1234858|P2|Received Study Drug|Overall Study||88
512886|NCT00137969|1234859|P1|Received Study Drug|Overall Study||169
512887|NCT00137969|1234858|P2|STARTED|Overall Study||88
512888|NCT00137969|1234859|P1|STARTED|Overall Study||174
512889|NCT00137631|1234881|P2|NOT COMPLETED|Overall Study||41
512890|NCT00137631|1234882|P1|NOT COMPLETED|Overall Study||37
512891|NCT00137631|1234881|P2|COMPLETED|Overall Study||133
512892|NCT00137631|1234882|P1|COMPLETED|Overall Study||127
512893|NCT00137631|1234881|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
512894|NCT00137631|1234882|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
512895|NCT00137631|1234881|P2|Complete 3-month Follow-up|Overall Study||125
512896|NCT00137631|1234882|P1|Complete 3-month Follow-up|Overall Study||120
512897|NCT00137631|1234881|P2|STARTED|Overall Study||174
512898|NCT00137631|1234882|P1|STARTED|Overall Study||164
512899|NCT00137449|1234898|P2|NOT COMPLETED|Overall Study||18
512900|NCT00137449|1234899|P1|NOT COMPLETED|Overall Study||16
512901|NCT00137449|1234898|P2|COMPLETED|Overall Study||12
512902|NCT00137449|1234899|P1|COMPLETED|Overall Study||14
512903|NCT00137449|1234898|P2|STARTED|Overall Study||30
512904|NCT00137449|1234899|P1|STARTED|Overall Study||30
512905|NCT00137436|1234936|P1|NOT COMPLETED|Overall Study||43
512906|NCT00137436|1234936|P1|COMPLETED|Overall Study||12
512907|NCT00137436|1234936|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
512908|NCT00137423|1234955|P2|NOT COMPLETED|Overall Study||44
512909|NCT00137423|1234956|P1|NOT COMPLETED|Overall Study||39
512910|NCT00137423|1234955|P2|COMPLETED|Overall Study||9
512911|NCT00137423|1234956|P1|COMPLETED|Overall Study||15
512912|NCT00137423|1234955|P2|STARTED|Overall Study||53
512913|NCT00137423|1234956|P1|STARTED|Overall Study||54
512914|NCT00137280|1234978|P2|NOT COMPLETED|Overall Study||55
512915|NCT00137280|1234979|P1|NOT COMPLETED|Overall Study||84
512916|NCT00137280|1234978|P2|COMPLETED|Overall Study||357
512917|NCT00137280|1234979|P1|COMPLETED|Overall Study||305
512918|NCT00137280|1234978|P2|STARTED|Overall Study||412
512919|NCT00137280|1234979|P1|STARTED|Overall Study||389
512920|NCT00137267|1234993|P2|NOT COMPLETED|Overall Study||21
512921|NCT00137267|1234994|P1|NOT COMPLETED|Overall Study||15
512922|NCT00137267|1234993|P2|COMPLETED|Overall Study||26
512923|NCT00137267|1234994|P1|COMPLETED|Overall Study||40
512924|NCT00137267|1234993|P2|STARTED|Overall Study||47
512925|NCT00137267|1234994|P1|STARTED|Overall Study||55
512926|NCT00137111|1235006|P4|NOT COMPLETED|Total Therapy||0
512927|NCT00137111|1235007|P3|NOT COMPLETED|Total Therapy||0
512928|NCT00137111|1235008|P2|NOT COMPLETED|Total Therapy||0
512929|NCT00137111|1235009|P1|NOT COMPLETED|Total Therapy||40
512930|NCT00137111|1235006|P4|COMPLETED|Total Therapy||0
512931|NCT00137111|1235007|P3|COMPLETED|Total Therapy||0
512932|NCT00137111|1235008|P2|COMPLETED|Total Therapy||0
512933|NCT00137111|1235009|P1|COMPLETED|Total Therapy||458
512934|NCT00137111|1235006|P4|STARTED|Total Therapy||0
512935|NCT00137111|1235007|P3|STARTED|Total Therapy||0
512936|NCT00137111|1235008|P2|STARTED|Total Therapy||0
512937|NCT00137111|1235009|P1|STARTED|Total Therapy||498
512938|NCT00137111|1235006|P4|NOT COMPLETED|Window Therapy||0
512939|NCT00137111|1235007|P3|NOT COMPLETED|Window Therapy||0
512940|NCT00137111|1235008|P2|NOT COMPLETED|Window Therapy||0
512941|NCT00137111|1235009|P1|NOT COMPLETED|Window Therapy||0
512942|NCT00137111|1235006|P4|COMPLETED|Window Therapy||142
512943|NCT00137111|1235007|P3|COMPLETED|Window Therapy||180
512944|NCT00137111|1235008|P2|COMPLETED|Window Therapy||176
512945|NCT00137111|1235009|P1|COMPLETED|Window Therapy||0
512946|NCT00137111|1235006|P4|STARTED|Window Therapy||142
512947|NCT00137111|1235007|P3|STARTED|Window Therapy||180
512948|NCT00137111|1235008|P2|STARTED|Window Therapy||176
512949|NCT00137111|1235009|P1|STARTED|Window Therapy||0
512950|NCT00137046|1235023|P2|NOT COMPLETED|Overall Study||93
512951|NCT00137046|1235024|P1|NOT COMPLETED|Overall Study||99
512952|NCT00137046|1235023|P2|COMPLETED|Overall Study||198
512953|NCT00137046|1235024|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
512954|NCT00137046|1235023|P2|Received Study Treatment|Overall Study||290
512955|NCT00137046|1235024|P1|Received Study Treatment|Overall Study||290
512956|NCT00137046|1235023|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
512957|NCT00137046|1235024|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
512958|NCT00136955|1235072|P1|NOT COMPLETED|Overall Study||23
512959|NCT00136955|1235072|P1|COMPLETED|Overall Study||18
512960|NCT00136955|1235072|P1|STARTED|Overall Study||41
512961|NCT00136916|1235081|P2|NOT COMPLETED|Overall Study||104
512962|NCT00136916|1235082|P1|NOT COMPLETED|Overall Study||125
512963|NCT00136916|1235081|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
512964|NCT00136916|1235082|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
512965|NCT00136916|1235081|P2|Received Treatment|Overall Study||311
512966|NCT00136916|1235082|P1|Received Treatment|Overall Study||316
512967|NCT00136916|1235081|P2|STARTED|Overall Study||316
512968|NCT00136916|1235082|P1|STARTED|Overall Study||319
512969|NCT00136838|1235136|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
512970|NCT00136838|1235137|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
512971|NCT00136838|1235136|P2|COMPLETED|Second Intervention ( 5 Days)||6
512972|NCT00136838|1235137|P1|COMPLETED|Second Intervention ( 5 Days)||6
512973|NCT00136838|1235136|P2|STARTED|Second Intervention ( 5 Days)||6
512974|NCT00136838|1235137|P1|STARTED|Second Intervention ( 5 Days)||6
512975|NCT00136838|1235136|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
512976|NCT00136838|1235137|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
512977|NCT00136838|1235136|P2|COMPLETED|First Intervention ( 5 Days)||6
512978|NCT00136838|1235137|P1|COMPLETED|First Intervention ( 5 Days)||6
512979|NCT00136838|1235136|P2|STARTED|First Intervention ( 5 Days)||6
512980|NCT00136838|1235137|P1|STARTED|First Intervention ( 5 Days)||6
512981|NCT00136812|1235147|P2|NOT COMPLETED|Overall Study||0
512982|NCT00136812|1235148|P1|NOT COMPLETED|Overall Study||0
512983|NCT00136812|1235147|P2|COMPLETED|Overall Study||113
512984|NCT00136812|1235148|P1|COMPLETED|Overall Study||111
512985|NCT00136812|1235147|P2|STARTED|Overall Study||113
512986|NCT00136812|1235148|P1|STARTED|Overall Study||111
512987|NCT00136760|1235158|P4|NOT COMPLETED|Overall Study||0
512988|NCT00136760|1235159|P3|NOT COMPLETED|Overall Study||0
512989|NCT00136760|1235160|P2|NOT COMPLETED|Overall Study||0
512990|NCT00136760|1235161|P1|NOT COMPLETED|Overall Study||0
512991|NCT00136760|1235158|P4|COMPLETED|Overall Study||13
512992|NCT00136760|1235159|P3|COMPLETED|Overall Study||11
512993|NCT00136760|1235160|P2|COMPLETED|Overall Study||16
512994|NCT00136760|1235161|P1|COMPLETED|Overall Study||12
512995|NCT00136760|1235158|P4|STARTED|Overall Study||13
512996|NCT00136760|1235159|P3|STARTED|Overall Study||11
512997|NCT00136760|1235160|P2|STARTED|Overall Study||16
512998|NCT00136760|1235161|P1|STARTED|Overall Study||12
512999|NCT00136695|1235177|P2|NOT COMPLETED|Overall Study||8
513000|NCT00136695|1235178|P1|NOT COMPLETED|Overall Study||11
513001|NCT00136695|1235177|P2|COMPLETED|Overall Study||35
513002|NCT00136695|1235178|P1|COMPLETED|Overall Study||34
513003|NCT00136695|1235177|P2|STARTED|Overall Study||43
513004|NCT00136695|1235178|P1|STARTED|Overall Study||45
513005|NCT00136357|1235186|P2|NOT COMPLETED|Overall Study||2
513006|NCT00136357|1235187|P1|NOT COMPLETED|Overall Study||3
513007|NCT00136357|1235186|P2|COMPLETED|Overall Study||39
513008|NCT00136357|1235187|P1|COMPLETED|Overall Study||38
513009|NCT00136357|1235186|P2|STARTED|Overall Study||41
513010|NCT00136357|1235187|P1|STARTED|Overall Study||41
513011|NCT00136318|1235195|P2|NOT COMPLETED|Overall Study||7
513012|NCT00136318|1235196|P1|NOT COMPLETED|Overall Study||7
513013|NCT00136318|1235195|P2|COMPLETED|Overall Study||84
513014|NCT00136318|1235196|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
513015|NCT00136318|1235195|P2|STARTED|Overall Study|Took first dose of study medication|91
513016|NCT00136318|1235196|P1|STARTED|Overall Study|Took first dose of study medication|90
513017|NCT00136084|1235212|P2|NOT COMPLETED|Overall Study||42
513018|NCT00136084|1235213|P1|NOT COMPLETED|Overall Study||48
513019|NCT00136084|1235212|P2|COMPLETED|Overall Study||72
513020|NCT00136084|1235213|P1|COMPLETED|Overall Study||61
513021|NCT00136084|1235212|P2|STARTED|Overall Study||114
513022|NCT00136084|1235213|P1|STARTED|Overall Study||109
513023|NCT00135798|1235229|P3|NOT COMPLETED|Overall Study||0
513024|NCT00135798|1235230|P2|NOT COMPLETED|Overall Study||0
513025|NCT00135798|1235231|P1|NOT COMPLETED|Overall Study||0
513026|NCT00135798|1235229|P3|COMPLETED|Overall Study||32
513027|NCT00135798|1235230|P2|COMPLETED|Overall Study||31
513028|NCT00135798|1235231|P1|COMPLETED|Overall Study||16
513029|NCT00135798|1235229|P3|STARTED|Overall Study||32
513030|NCT00135798|1235230|P2|STARTED|Overall Study||31
513031|NCT00135798|1235231|P1|STARTED|Overall Study||16
513032|NCT00135694|1235250|P3|NOT COMPLETED|Overall Study||7
513033|NCT00135694|1235251|P2|NOT COMPLETED|Overall Study||21
513034|NCT00135694|1235252|P1|NOT COMPLETED|Overall Study||180
513035|NCT00135694|1235250|P3|COMPLETED|Overall Study||11
513036|NCT00135694|1235251|P2|COMPLETED|Overall Study||56
513037|NCT00135694|1235252|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
513038|NCT00135694|1235250|P3|STARTED|Overall Study||18
513039|NCT00135694|1235251|P2|STARTED|Overall Study||77
513040|NCT00135694|1235252|P1|STARTED|Overall Study||180
513041|NCT00135356|1235272|P2|NOT COMPLETED|Overall Study||9
513042|NCT00135356|1235273|P1|NOT COMPLETED|Overall Study||17
513043|NCT00135356|1235272|P2|COMPLETED|Overall Study||60
513044|NCT00135356|1235273|P1|COMPLETED|Overall Study||114
513045|NCT00135356|1235272|P2|Discontinued on or After Week 96 Visit|Overall Study||0
513046|NCT00135356|1235273|P1|Discontinued on or After Week 96 Visit|Overall Study||1
513047|NCT00135356|1235272|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
513048|NCT00135356|1235273|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
513049|NCT00135356|1235272|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
513050|NCT00135356|1235273|P1|STARTED|Overall Study|Number randomized and treated|131
513051|NCT00135330|1235316|P3|NOT COMPLETED|Overall Study||11
513052|NCT00135330|1235317|P2|NOT COMPLETED|Overall Study||13
513053|NCT00135330|1235318|P1|NOT COMPLETED|Overall Study||12
513054|NCT00135330|1235316|P3|COMPLETED|Overall Study||34
513055|NCT00135330|1235317|P2|COMPLETED|Overall Study||34
513056|NCT00135330|1235318|P1|COMPLETED|Overall Study||33
513057|NCT00135330|1235316|P3|STARTED|Overall Study||45
513058|NCT00135330|1235317|P2|STARTED|Overall Study||47
513059|NCT00135330|1235318|P1|STARTED|Overall Study||45
513060|NCT00135200|1235410|P1|NOT COMPLETED|Overall Study||0
513061|NCT00135200|1235410|P1|COMPLETED|Overall Study||16
513062|NCT00135200|1235410|P1|STARTED|Overall Study||16
513063|NCT00134901|1235417|P2|NOT COMPLETED|Overall Study||15
513064|NCT00134901|1235418|P1|NOT COMPLETED|Overall Study||17
513065|NCT00134901|1235417|P2|COMPLETED|Overall Study||27
513066|NCT00134901|1235418|P1|COMPLETED|Overall Study||22
513067|NCT00134901|1235417|P2|STARTED|Overall Study||42
513068|NCT00134901|1235418|P1|STARTED|Overall Study||39
513069|NCT00134784|1235430|P4|NOT COMPLETED|Overall Study||1
513070|NCT00134784|1235431|P3|NOT COMPLETED|Overall Study||2
513071|NCT00134784|1235432|P2|NOT COMPLETED|Overall Study||2
513072|NCT00134784|1235433|P1|NOT COMPLETED|Overall Study||2
513073|NCT00134784|1235430|P4|COMPLETED|Overall Study||37
513074|NCT00134784|1235431|P3|COMPLETED|Overall Study||35
513075|NCT00134784|1235432|P2|COMPLETED|Overall Study||36
513076|NCT00134784|1235433|P1|COMPLETED|Overall Study||27
513077|NCT00134784|1235430|P4|STARTED|Overall Study||38
513078|NCT00134784|1235431|P3|STARTED|Overall Study||37
513079|NCT00134784|1235432|P2|STARTED|Overall Study||38
513080|NCT00134784|1235433|P1|STARTED|Overall Study||29
513081|NCT00134719|1235443|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
513082|NCT00134719|1235444|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
513083|NCT00134719|1235445|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
513084|NCT00134719|1235443|P3|COMPLETED|Fourth Dose Vaccination Phase||203
513085|NCT00134719|1235444|P2|COMPLETED|Fourth Dose Vaccination Phase||203
513086|NCT00134719|1235445|P1|COMPLETED|Fourth Dose Vaccination Phase||623
513087|NCT00134719|1235443|P3|STARTED|Fourth Dose Vaccination Phase||204
513088|NCT00134719|1235444|P2|STARTED|Fourth Dose Vaccination Phase||206
513089|NCT00134719|1235445|P1|STARTED|Fourth Dose Vaccination Phase||625
513090|NCT00134719|1235443|P3|NOT COMPLETED|Primary Vaccination Phase||5
513091|NCT00134719|1235444|P2|NOT COMPLETED|Primary Vaccination Phase||6
513092|NCT00134719|1235445|P1|NOT COMPLETED|Primary Vaccination Phase||14
513093|NCT00134719|1235443|P3|COMPLETED|Primary Vaccination Phase||216
513094|NCT00134719|1235444|P2|COMPLETED|Primary Vaccination Phase||215
513095|NCT00134719|1235445|P1|COMPLETED|Primary Vaccination Phase||647
513096|NCT00134719|1235443|P3|STARTED|Primary Vaccination Phase||221
513097|NCT00134719|1235444|P2|STARTED|Primary Vaccination Phase||221
513098|NCT00134719|1235445|P1|STARTED|Primary Vaccination Phase||661
513099|NCT00134563|1235576|P3|NOT COMPLETED|Overall Study||96
513100|NCT00134563|1235577|P2|NOT COMPLETED|Overall Study||92
513101|NCT00134563|1235578|P1|NOT COMPLETED|Overall Study||104
513194|NCT00132808|1235838|P3|NOT COMPLETED|Stratum I||5
513102|NCT00134563|1235576|P3|COMPLETED|Overall Study|completed treatment period|263
513103|NCT00134563|1235577|P2|COMPLETED|Overall Study|completed treatment period|274
513104|NCT00134563|1235578|P1|COMPLETED|Overall Study|completed treatment period|259
513105|NCT00134563|1235576|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
513106|NCT00134563|1235577|P2|Treated|Overall Study||365
513107|NCT00134563|1235578|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
513108|NCT00134563|1235576|P3|STARTED|Overall Study|Randomized|359
513109|NCT00134563|1235577|P2|STARTED|Overall Study|Randomized|366
513110|NCT00134563|1235578|P1|STARTED|Overall Study|Randomized|363
513111|NCT00134056|1235603|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
513112|NCT00134056|1235604|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
513113|NCT00134056|1235603|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
513114|NCT00134056|1235604|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
513115|NCT00134056|1235603|P2|STARTED|Eligible for Protocol Assigned Treatment||500
513116|NCT00134056|1235604|P1|STARTED|Eligible for Protocol Assigned Treatment||496
513117|NCT00134056|1235603|P2|NOT COMPLETED|Randomization||20
513118|NCT00134056|1235604|P1|NOT COMPLETED|Randomization||22
513119|NCT00134056|1235603|P2|COMPLETED|Randomization||500
513120|NCT00134056|1235604|P1|COMPLETED|Randomization||496
513121|NCT00134056|1235603|P2|STARTED|Randomization||520
513122|NCT00134056|1235604|P1|STARTED|Randomization||518
513123|NCT00134043|1235626|P2|NOT COMPLETED|Overall Study||0
513124|NCT00134043|1235627|P1|NOT COMPLETED|Overall Study||0
513125|NCT00134043|1235626|P2|COMPLETED|Overall Study||3
513126|NCT00134043|1235627|P1|COMPLETED|Overall Study||16
513127|NCT00134043|1235626|P2|STARTED|Overall Study||3
513128|NCT00134043|1235627|P1|STARTED|Overall Study||16
513129|NCT00134004|1235632|P1|NOT COMPLETED|Overall Study||0
513130|NCT00134004|1235632|P1|COMPLETED|Overall Study||210
513131|NCT00134004|1235632|P1|STARTED|Overall Study||210
513132|NCT00133978|1235644|P4|NOT COMPLETED|Overall Study||2
513133|NCT00133978|1235645|P3|NOT COMPLETED|Overall Study||0
513134|NCT00133978|1235646|P2|NOT COMPLETED|Overall Study||1
513135|NCT00133978|1235647|P1|NOT COMPLETED|Overall Study||2
513136|NCT00133978|1235644|P4|COMPLETED|Overall Study||300
513137|NCT00133978|1235645|P3|COMPLETED|Overall Study||310
513138|NCT00133978|1235646|P2|COMPLETED|Overall Study||307
513139|NCT00133978|1235647|P1|COMPLETED|Overall Study||301
513140|NCT00133978|1235644|P4|STARTED|Overall Study||302
513141|NCT00133978|1235645|P3|STARTED|Overall Study||310
513142|NCT00133978|1235646|P2|STARTED|Overall Study||308
513143|NCT00133978|1235647|P1|STARTED|Overall Study||303
513144|NCT00133952|1235671|P2|NOT COMPLETED|Overall Study||28
513145|NCT00133952|1235672|P1|NOT COMPLETED|Overall Study||42
513146|NCT00133952|1235671|P2|COMPLETED|Overall Study||124
513147|NCT00133952|1235672|P1|COMPLETED|Overall Study||115
513148|NCT00133952|1235671|P2|Received at Least One Dose of Study Drug|Overall Study||149
513149|NCT00133952|1235672|P1|Received at Least One Dose of Study Drug|Overall Study||153
513150|NCT00133952|1235671|P2|STARTED|Overall Study||152
513151|NCT00133952|1235672|P1|STARTED|Overall Study||157
513152|NCT00133809|1235694|P1|NOT COMPLETED|Overall Study||0
513153|NCT00133809|1235694|P1|COMPLETED|Overall Study||8
513154|NCT00133809|1235694|P1|STARTED|Overall Study||8
513155|NCT00133705|1235703|P2|NOT COMPLETED|Overall Study||3
513156|NCT00133705|1235704|P1|NOT COMPLETED|Overall Study||2
513157|NCT00133705|1235703|P2|COMPLETED|Overall Study||17
513158|NCT00133705|1235704|P1|COMPLETED|Overall Study||20
513159|NCT00133705|1235703|P2|STARTED|Overall Study||20
513160|NCT00133705|1235704|P1|STARTED|Overall Study||22
513161|NCT00133575|1235717|P7|NOT COMPLETED|Overall Study||3
513162|NCT00133575|1235718|P6|NOT COMPLETED|Overall Study||1
513163|NCT00133575|1235719|P5|NOT COMPLETED|Overall Study||4
513164|NCT00133575|1235720|P4|NOT COMPLETED|Overall Study||1
513165|NCT00133575|1235721|P3|NOT COMPLETED|Overall Study||2
513166|NCT00133575|1235722|P2|NOT COMPLETED|Overall Study||0
513167|NCT00133575|1235723|P1|NOT COMPLETED|Overall Study||0
513168|NCT00133575|1235717|P7|COMPLETED|Overall Study||9
513169|NCT00133575|1235718|P6|COMPLETED|Overall Study||9
513170|NCT00133575|1235719|P5|COMPLETED|Overall Study||6
513171|NCT00133575|1235720|P4|COMPLETED|Overall Study||9
513172|NCT00133575|1235721|P3|COMPLETED|Overall Study||8
513173|NCT00133575|1235722|P2|COMPLETED|Overall Study||10
513174|NCT00133575|1235723|P1|COMPLETED|Overall Study||10
513175|NCT00133575|1235717|P7|STARTED|Overall Study||12
513176|NCT00133575|1235718|P6|STARTED|Overall Study||10
513177|NCT00133575|1235719|P5|STARTED|Overall Study||10
513178|NCT00133575|1235720|P4|STARTED|Overall Study||10
513179|NCT00133575|1235721|P3|STARTED|Overall Study||10
513180|NCT00133575|1235722|P2|STARTED|Overall Study||10
513181|NCT00133575|1235723|P1|STARTED|Overall Study||10
513182|NCT00132873|1235830|P1|NOT COMPLETED|Overall Study||9
513183|NCT00132873|1235830|P1|COMPLETED|Overall Study||50
513184|NCT00132873|1235830|P1|STARTED|Overall Study||59
513185|NCT00132808|1235838|P3|NOT COMPLETED|Stratum II||9
513186|NCT00132808|1235839|P2|NOT COMPLETED|Stratum II||15
513187|NCT00132808|1235840|P1|NOT COMPLETED|Stratum II||8
513188|NCT00132808|1235838|P3|COMPLETED|Stratum II||116
513189|NCT00132808|1235839|P2|COMPLETED|Stratum II||96
513190|NCT00132808|1235840|P1|COMPLETED|Stratum II||113
513191|NCT00132808|1235838|P3|STARTED|Stratum II||125
513192|NCT00132808|1235839|P2|STARTED|Stratum II||111
513193|NCT00132808|1235840|P1|STARTED|Stratum II||121
513195|NCT00132808|1235839|P2|NOT COMPLETED|Stratum I||12
513196|NCT00132808|1235840|P1|NOT COMPLETED|Stratum I||9
513197|NCT00132808|1235838|P3|COMPLETED|Stratum I||72
513198|NCT00132808|1235839|P2|COMPLETED|Stratum I||58
513199|NCT00132808|1235840|P1|COMPLETED|Stratum I||68
513200|NCT00132808|1235838|P3|STARTED|Stratum I||77
513201|NCT00132808|1235839|P2|STARTED|Stratum I||70
513202|NCT00132808|1235840|P1|STARTED|Stratum I||77
513203|NCT00132769|1235865|P2|NOT COMPLETED|Overall Study||11
513204|NCT00132769|1235866|P1|NOT COMPLETED|Overall Study||11
513205|NCT00132769|1235865|P2|COMPLETED|Overall Study||42
513206|NCT00132769|1235866|P1|COMPLETED|Overall Study||42
513207|NCT00132769|1235865|P2|STARTED|Overall Study||53
513208|NCT00132769|1235866|P1|STARTED|Overall Study||53
513209|NCT00132730|1235892|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
513210|NCT00132730|1235893|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
513211|NCT00132730|1235894|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
513212|NCT00132730|1235895|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
513213|NCT00132730|1235896|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
513214|NCT00132730|1235897|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
513215|NCT00132730|1235892|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
513216|NCT00132730|1235893|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
513217|NCT00132730|1235894|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
513218|NCT00132730|1235895|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
513219|NCT00132730|1235896|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
513220|NCT00132730|1235897|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
513221|NCT00132730|1235892|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
513222|NCT00132730|1235893|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
513223|NCT00132730|1235894|P4|STARTED|Period V - Open-label Extension (EXT2)||0
513224|NCT00132730|1235895|P3|STARTED|Period V - Open-label Extension (EXT2)||0
513225|NCT00132730|1235896|P2|STARTED|Period V - Open-label Extension (EXT2)||0
513226|NCT00132730|1235897|P1|STARTED|Period V - Open-label Extension (EXT2)||0
513227|NCT00132730|1235892|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
513228|NCT00132730|1235893|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
513229|NCT00132730|1235894|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
513230|NCT00132730|1235895|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
513231|NCT00132730|1235896|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
513232|NCT00132730|1235897|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
513233|NCT00132730|1235892|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
513234|NCT00132730|1235893|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
513235|NCT00132730|1235894|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
513236|NCT00132730|1235895|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
513237|NCT00132730|1235896|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
513238|NCT00132730|1235897|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
513239|NCT00132730|1235892|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
513240|NCT00132730|1235893|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
513241|NCT00132730|1235894|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
513242|NCT00132730|1235895|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
513243|NCT00132730|1235896|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
513244|NCT00132730|1235897|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
513245|NCT00132730|1235892|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
513246|NCT00132730|1235893|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
513247|NCT00132730|1235894|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
513248|NCT00132730|1235895|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
513249|NCT00132730|1235896|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
513250|NCT00132730|1235897|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
513251|NCT00132730|1235892|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
513252|NCT00132730|1235893|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
513253|NCT00132730|1235894|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
513254|NCT00132730|1235895|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
513255|NCT00132730|1235896|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
513256|NCT00132730|1235897|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
513257|NCT00132730|1235892|P6|STARTED|Period III - Blinded Extension (EXT1)||0
513258|NCT00132730|1235893|P5|STARTED|Period III - Blinded Extension (EXT1)||0
513259|NCT00132730|1235894|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
513260|NCT00132730|1235895|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
513261|NCT00132730|1235896|P2|STARTED|Period III - Blinded Extension (EXT1)||0
513262|NCT00132730|1235897|P1|STARTED|Period III - Blinded Extension (EXT1)||0
513263|NCT00132730|1235892|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
513264|NCT00132730|1235893|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
513265|NCT00132730|1235894|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
513266|NCT00132730|1235895|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
513267|NCT00132730|1235896|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
513268|NCT00132730|1235897|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
513269|NCT00132730|1235892|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
513270|NCT00132730|1235893|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
513271|NCT00132730|1235894|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
513272|NCT00132730|1235895|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
513273|NCT00132730|1235896|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
513274|NCT00132730|1235897|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
513275|NCT00132730|1235892|P6|STARTED|Period II - 12-week Treatment (Base)||0
513276|NCT00132730|1235893|P5|STARTED|Period II - 12-week Treatment (Base)||0
513277|NCT00132730|1235894|P4|STARTED|Period II - 12-week Treatment (Base)||153
513278|NCT00132730|1235895|P3|STARTED|Period II - 12-week Treatment (Base)||153
513279|NCT00132730|1235896|P2|STARTED|Period II - 12-week Treatment (Base)||148
513280|NCT00132730|1235897|P1|STARTED|Period II - 12-week Treatment (Base)||150
513281|NCT00132730|1235892|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
513282|NCT00132730|1235893|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
513283|NCT00132730|1235894|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
513284|NCT00132730|1235895|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
513285|NCT00132730|1235896|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
513286|NCT00132730|1235897|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
513287|NCT00132730|1235892|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
513288|NCT00132730|1235893|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
513289|NCT00132730|1235894|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
513290|NCT00132730|1235895|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
513291|NCT00132730|1235896|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
513292|NCT00132730|1235897|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
513293|NCT00132730|1235892|P6|STARTED|Period I - Placebo Run-in (Base)||0
513294|NCT00132730|1235893|P5|STARTED|Period I - Placebo Run-in (Base)||0
513295|NCT00132730|1235894|P4|STARTED|Period I - Placebo Run-in (Base)||153
513296|NCT00132730|1235895|P3|STARTED|Period I - Placebo Run-in (Base)||153
513297|NCT00132730|1235896|P2|STARTED|Period I - Placebo Run-in (Base)||148
513298|NCT00132730|1235897|P1|STARTED|Period I - Placebo Run-in (Base)||150
513299|NCT00132691|1235941|P2|NOT COMPLETED|Overall Study||12
513300|NCT00132691|1235942|P1|NOT COMPLETED|Overall Study||11
513301|NCT00132691|1235941|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
513302|NCT00132691|1235942|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
513303|NCT00132691|1235941|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
513304|NCT00132691|1235942|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
513305|NCT00132678|1235982|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
513306|NCT00132678|1235983|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
513307|NCT00132678|1235984|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
513308|NCT00132678|1235982|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
513309|NCT00132678|1235983|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
513310|NCT00132678|1235984|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
513311|NCT00132678|1235982|P3|STARTED|Period IV (Double-Blind Treatment)||0
513312|NCT00132678|1235983|P2|STARTED|Period IV (Double-Blind Treatment)||149
513313|NCT00132678|1235984|P1|STARTED|Period IV (Double-Blind Treatment)||154
513314|NCT00132678|1235982|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
513315|NCT00132678|1235983|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
513316|NCT00132678|1235984|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
513317|NCT00132678|1235982|P3|COMPLETED|Period III (Open-Label Stabilization)||0
513318|NCT00132678|1235983|P2|COMPLETED|Period III (Open-Label Stabilization)||0
513319|NCT00132678|1235984|P1|COMPLETED|Period III (Open-Label Stabilization)||303
513320|NCT00132678|1235982|P3|STARTED|Period III (Open-Label Stabilization)||0
513321|NCT00132678|1235983|P2|STARTED|Period III (Open-Label Stabilization)||0
513322|NCT00132678|1235984|P1|STARTED|Period III (Open-Label Stabilization)||501
513323|NCT00132678|1235982|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
513324|NCT00132678|1235983|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
513325|NCT00132678|1235984|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
513326|NCT00132678|1235982|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
513327|NCT00132678|1235983|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
513328|NCT00132678|1235984|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
513329|NCT00132678|1235982|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
513330|NCT00132678|1235983|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
513331|NCT00132678|1235984|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
513332|NCT00132496|1235998|P2|NOT COMPLETED|Overall Study||2
513333|NCT00132496|1235999|P1|NOT COMPLETED|Overall Study||2
513334|NCT00132496|1235998|P2|COMPLETED|Overall Study||55
513335|NCT00132496|1235999|P1|COMPLETED|Overall Study||52
513336|NCT00132496|1235998|P2|STARTED|Overall Study||57
513337|NCT00132496|1235999|P1|STARTED|Overall Study||54
513338|NCT00132314|1236007|P2|NOT COMPLETED|Overall Study||72
513339|NCT00132314|1236008|P1|NOT COMPLETED|Overall Study||73
513340|NCT00132314|1236007|P2|COMPLETED|Overall Study||120
513341|NCT00132314|1236008|P1|COMPLETED|Overall Study||117
513342|NCT00132314|1236007|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
513343|NCT00132314|1236008|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
513344|NCT00132314|1236007|P2|Received Treatment|Overall Study||185
513345|NCT00132314|1236008|P1|Received Treatment|Overall Study||188
513346|NCT00132314|1236007|P2|STARTED|Overall Study||192
513347|NCT00132314|1236008|P1|STARTED|Overall Study||190
513348|NCT00132132|1236018|P2|NOT COMPLETED|Overall Study||2
513349|NCT00132132|1236019|P1|NOT COMPLETED|Overall Study||7
513350|NCT00132132|1236018|P2|COMPLETED|Overall Study||13
513351|NCT00132132|1236019|P1|COMPLETED|Overall Study||8
513352|NCT00132132|1236018|P2|STARTED|Overall Study||15
513353|NCT00132132|1236019|P1|STARTED|Overall Study||15
513354|NCT00132028|1236027|P1|NOT COMPLETED|Overall Study||27
513355|NCT00132028|1236027|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
513356|NCT00132028|1236027|P1|Eligible and Began Protocol Therapy|Overall Study||25
513357|NCT00132028|1236027|P1|Eligible|Overall Study||25
513358|NCT00132028|1236027|P1|STARTED|Overall Study||27
513359|NCT00132002|1236033|P1|NOT COMPLETED|Overall Study||0
513360|NCT00132002|1236033|P1|COMPLETED|Overall Study||14
513361|NCT00132002|1236033|P1|STARTED|Overall Study||14
513362|NCT00131937|1236039|P1|NOT COMPLETED|Overall Study||14
513363|NCT00131937|1236039|P1|COMPLETED|Overall Study||0
513364|NCT00131937|1236039|P1|STARTED|Overall Study||14
513365|NCT00131911|1236047|P2|NOT COMPLETED|Overall Study||0
513366|NCT00131911|1236048|P1|NOT COMPLETED|Overall Study||1
513367|NCT00131911|1236047|P2|COMPLETED|Overall Study||42
513368|NCT00131911|1236048|P1|COMPLETED|Overall Study||50
513369|NCT00131911|1236047|P2|STARTED|Overall Study||42
513370|NCT00131911|1236048|P1|STARTED|Overall Study||51
513371|NCT00131885|1236065|P4|NOT COMPLETED|Time 2: Second Intervention||0
513372|NCT00131885|1236066|P3|NOT COMPLETED|Time 2: Second Intervention||0
513373|NCT00131885|1236067|P2|NOT COMPLETED|Time 2: Second Intervention||0
513374|NCT00131885|1236068|P1|NOT COMPLETED|Time 2: Second Intervention||0
513375|NCT00131885|1236065|P4|COMPLETED|Time 2: Second Intervention||9
513376|NCT00131885|1236066|P3|COMPLETED|Time 2: Second Intervention||9
513377|NCT00131885|1236067|P2|COMPLETED|Time 2: Second Intervention||9
513378|NCT00131885|1236068|P1|COMPLETED|Time 2: Second Intervention||9
513379|NCT00131885|1236065|P4|STARTED|Time 2: Second Intervention||9
513380|NCT00131885|1236066|P3|STARTED|Time 2: Second Intervention||9
513381|NCT00131885|1236067|P2|STARTED|Time 2: Second Intervention||9
513382|NCT00131885|1236068|P1|STARTED|Time 2: Second Intervention||9
513383|NCT00131885|1236065|P4|NOT COMPLETED|Time 1: First Intervention||0
513384|NCT00131885|1236066|P3|NOT COMPLETED|Time 1: First Intervention||0
513385|NCT00131885|1236067|P2|NOT COMPLETED|Time 1: First Intervention||0
513386|NCT00131885|1236068|P1|NOT COMPLETED|Time 1: First Intervention||0
513387|NCT00131885|1236065|P4|COMPLETED|Time 1: First Intervention||9
513388|NCT00131885|1236066|P3|COMPLETED|Time 1: First Intervention||9
513389|NCT00131885|1236067|P2|COMPLETED|Time 1: First Intervention||9
513390|NCT00131885|1236068|P1|COMPLETED|Time 1: First Intervention||9
513391|NCT00131885|1236065|P4|STARTED|Time 1: First Intervention||9
513392|NCT00131885|1236066|P3|STARTED|Time 1: First Intervention||9
513393|NCT00131885|1236067|P2|STARTED|Time 1: First Intervention||9
513394|NCT00131885|1236068|P1|STARTED|Time 1: First Intervention||9
513395|NCT00131677|1236100|P2|NOT COMPLETED|Overall Study||39
513396|NCT00131677|1236101|P1|NOT COMPLETED|Overall Study||30
513397|NCT00131677|1236100|P2|COMPLETED|Overall Study||160
513398|NCT00131677|1236101|P1|COMPLETED|Overall Study||171
513399|NCT00131677|1236100|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
513400|NCT00131677|1236101|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
513401|NCT00131664|1236118|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
513402|NCT00131664|1236119|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
513403|NCT00131664|1236120|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
513404|NCT00131664|1236121|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
513405|NCT00131664|1236122|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
513406|NCT00131664|1236123|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
513407|NCT00131664|1236118|P6|COMPLETED|Second Period (Additional Drug Added)||22
513408|NCT00131664|1236119|P5|COMPLETED|Second Period (Additional Drug Added)||15
513409|NCT00131664|1236120|P4|COMPLETED|Second Period (Additional Drug Added)||19
513410|NCT00131664|1236121|P3|COMPLETED|Second Period (Additional Drug Added)||76
513411|NCT00131664|1236122|P2|COMPLETED|Second Period (Additional Drug Added)||97
513412|NCT00131664|1236123|P1|COMPLETED|Second Period (Additional Drug Added)||81
513413|NCT00131664|1236118|P6|STARTED|Second Period (Additional Drug Added)||25
513414|NCT00131664|1236119|P5|STARTED|Second Period (Additional Drug Added)||16
513415|NCT00131664|1236120|P4|STARTED|Second Period (Additional Drug Added)||21
513416|NCT00131664|1236121|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
513417|NCT00131664|1236122|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
513418|NCT00131664|1236123|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
513419|NCT00131664|1236118|P6|NOT COMPLETED|First Period (First 6 Months)||0
513420|NCT00131664|1236119|P5|NOT COMPLETED|First Period (First 6 Months)||0
513421|NCT00131664|1236120|P4|NOT COMPLETED|First Period (First 6 Months)||0
513422|NCT00131664|1236121|P3|NOT COMPLETED|First Period (First 6 Months)||16
513423|NCT00131664|1236122|P2|NOT COMPLETED|First Period (First 6 Months)||18
513424|NCT00131664|1236123|P1|NOT COMPLETED|First Period (First 6 Months)||25
513425|NCT00131664|1236118|P6|COMPLETED|First Period (First 6 Months)||0
513426|NCT00131664|1236119|P5|COMPLETED|First Period (First 6 Months)||0
513427|NCT00131664|1236120|P4|COMPLETED|First Period (First 6 Months)||0
513428|NCT00131664|1236121|P3|COMPLETED|First Period (First 6 Months)||104
513429|NCT00131664|1236122|P2|COMPLETED|First Period (First 6 Months)||117
513430|NCT00131664|1236123|P1|COMPLETED|First Period (First 6 Months)||111
513431|NCT00131664|1236118|P6|STARTED|First Period (First 6 Months)||0
513432|NCT00131664|1236119|P5|STARTED|First Period (First 6 Months)||0
513433|NCT00131664|1236120|P4|STARTED|First Period (First 6 Months)||0
513434|NCT00131664|1236121|P3|STARTED|First Period (First 6 Months)||120
513435|NCT00131664|1236122|P2|STARTED|First Period (First 6 Months)||135
513436|NCT00131664|1236123|P1|STARTED|First Period (First 6 Months)||136
513437|NCT00131573|1236184|P2|NOT COMPLETED|Overall Study||26
513438|NCT00131573|1236185|P1|NOT COMPLETED|Overall Study||33
513439|NCT00131573|1236184|P2|COMPLETED|Overall Study||13
513440|NCT00131573|1236185|P1|COMPLETED|Overall Study||13
513441|NCT00131573|1236184|P2|STARTED|Overall Study||39
513442|NCT00131573|1236185|P1|STARTED|Overall Study||46
513443|NCT00131508|1236195|P2|NOT COMPLETED|Overall Study||8
513444|NCT00131508|1236196|P1|NOT COMPLETED|Overall Study||3
513445|NCT00131508|1236195|P2|COMPLETED|Overall Study||5
513446|NCT00131508|1236196|P1|COMPLETED|Overall Study||9
513447|NCT00131508|1236195|P2|STARTED|Overall Study||13
513448|NCT00131508|1236196|P1|STARTED|Overall Study||12
513449|NCT00131456|1236220|P2|NOT COMPLETED|Overall Study||20
513450|NCT00131456|1236221|P1|NOT COMPLETED|Overall Study||19
513451|NCT00131456|1236220|P2|COMPLETED|Overall Study||31
513452|NCT00131456|1236221|P1|COMPLETED|Overall Study||33
513453|NCT00131456|1236220|P2|STARTED|Overall Study||51
513454|NCT00131456|1236221|P1|STARTED|Overall Study||52
513455|NCT00131378|1236231|P4|NOT COMPLETED|Overall Study||9
513456|NCT00131378|1236232|P3|NOT COMPLETED|Overall Study||10
513457|NCT00131378|1236233|P2|NOT COMPLETED|Overall Study||18
513458|NCT00131378|1236234|P1|NOT COMPLETED|Overall Study||11
513459|NCT00131378|1236231|P4|COMPLETED|Overall Study||21
513460|NCT00131378|1236232|P3|COMPLETED|Overall Study||22
513461|NCT00131378|1236233|P2|COMPLETED|Overall Study||22
513462|NCT00131378|1236234|P1|COMPLETED|Overall Study||29
513463|NCT00131378|1236231|P4|STARTED|Overall Study||30
513464|NCT00131378|1236232|P3|STARTED|Overall Study||32
513465|NCT00131378|1236233|P2|STARTED|Overall Study||40
513466|NCT00131378|1236234|P1|STARTED|Overall Study||40
513467|NCT00131352|1236258|P2|NOT COMPLETED|Repeat Treatment Period||0
513468|NCT00131352|1236259|P1|NOT COMPLETED|Repeat Treatment Period||2
513469|NCT00131352|1236258|P2|COMPLETED|Repeat Treatment Period||0
513470|NCT00131352|1236259|P1|COMPLETED|Repeat Treatment Period||158
513471|NCT00131352|1236258|P2|STARTED|Repeat Treatment Period||0
513472|NCT00131352|1236259|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
513473|NCT00131352|1236258|P2|NOT COMPLETED|Initial Treatment Period||12
513474|NCT00131352|1236259|P1|NOT COMPLETED|Initial Treatment Period||9
513475|NCT00131352|1236258|P2|COMPLETED|Initial Treatment Period||118
513476|NCT00131352|1236259|P1|COMPLETED|Initial Treatment Period||114
513477|NCT00131352|1236258|P2|Intent to Treat Population|Initial Treatment Period||129
513478|NCT00131352|1236259|P1|Intent to Treat Population|Initial Treatment Period||124
513479|NCT00131352|1236258|P2|STARTED|Initial Treatment Period|Safety population|130
513480|NCT00131352|1236259|P1|STARTED|Initial Treatment Period|Safety population|123
513481|NCT00131248|1236281|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
513482|NCT00131248|1236282|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
513483|NCT00131248|1236281|P2|COMPLETED|Intervention 3 (4-day Course)||9
513484|NCT00131248|1236282|P1|COMPLETED|Intervention 3 (4-day Course)||8
513485|NCT00131248|1236281|P2|STARTED|Intervention 3 (4-day Course)||9
513486|NCT00131248|1236282|P1|STARTED|Intervention 3 (4-day Course)||8
513487|NCT00131248|1236281|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
513488|NCT00131248|1236282|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
513489|NCT00131248|1236281|P2|COMPLETED|Washout 2 (24 Hours)||9
513490|NCT00131248|1236282|P1|COMPLETED|Washout 2 (24 Hours)||8
513491|NCT00131248|1236281|P2|STARTED|Washout 2 (24 Hours)||9
513492|NCT00131248|1236282|P1|STARTED|Washout 2 (24 Hours)||8
513493|NCT00131248|1236281|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
513494|NCT00131248|1236282|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
513495|NCT00131248|1236281|P2|COMPLETED|Intervention 2 (7-day Course)||9
513496|NCT00131248|1236282|P1|COMPLETED|Intervention 2 (7-day Course)||8
513497|NCT00131248|1236281|P2|STARTED|Intervention 2 (7-day Course)||9
513498|NCT00131248|1236282|P1|STARTED|Intervention 2 (7-day Course)||8
513499|NCT00131248|1236281|P2|NOT COMPLETED|Washout (24 Hour)||0
513500|NCT00131248|1236282|P1|NOT COMPLETED|Washout (24 Hour)||0
513501|NCT00131248|1236281|P2|COMPLETED|Washout (24 Hour)||9
513502|NCT00131248|1236282|P1|COMPLETED|Washout (24 Hour)||8
513503|NCT00131248|1236281|P2|STARTED|Washout (24 Hour)||9
513504|NCT00131248|1236282|P1|STARTED|Washout (24 Hour)||8
513505|NCT00131248|1236281|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
513506|NCT00131248|1236282|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
513507|NCT00131248|1236281|P2|COMPLETED|Intervention 1 (3-day Course)||9
513508|NCT00131248|1236282|P1|COMPLETED|Intervention 1 (3-day Course)||8
513509|NCT00131248|1236281|P2|STARTED|Intervention 1 (3-day Course)||9
513510|NCT00131248|1236282|P1|STARTED|Intervention 1 (3-day Course)||9
513511|NCT00130923|1236290|P2|NOT COMPLETED|Overall Study||14
513512|NCT00130923|1236291|P1|NOT COMPLETED|Overall Study||13
513513|NCT00130923|1236290|P2|COMPLETED|Overall Study||32
513514|NCT00130923|1236291|P1|COMPLETED|Overall Study||36
513515|NCT00130923|1236290|P2|STARTED|Overall Study||46
513516|NCT00130923|1236291|P1|STARTED|Overall Study||49
513517|NCT00130832|1236299|P2|NOT COMPLETED|Overall Study||17
513518|NCT00130832|1236300|P1|NOT COMPLETED|Overall Study||16
513519|NCT00130832|1236299|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
513520|NCT00130832|1236300|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
513521|NCT00130832|1236299|P2|STARTED|Overall Study||363
513522|NCT00130832|1236300|P1|STARTED|Overall Study||372
513523|NCT00130793|1236312|P2|NOT COMPLETED|Overall Study||4
513524|NCT00130793|1236313|P1|NOT COMPLETED|Overall Study||3
513525|NCT00130793|1236312|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
513526|NCT00130793|1236313|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
513527|NCT00130793|1236312|P2|Vaccinated|Overall Study||185
513528|NCT00130793|1236313|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
513529|NCT00130793|1236312|P2|STARTED|Overall Study||185
513530|NCT00130793|1236313|P1|STARTED|Overall Study||183
513531|NCT00130780|1236325|P2|NOT COMPLETED|Overall Study||0
513532|NCT00130780|1236326|P1|NOT COMPLETED|Overall Study||0
513533|NCT00130780|1236325|P2|COMPLETED|Overall Study||20
513534|NCT00130780|1236326|P1|COMPLETED|Overall Study||51
513535|NCT00130780|1236325|P2|STARTED|Overall Study||20
513536|NCT00130780|1236326|P1|STARTED|Overall Study||51
513537|NCT00130728|1236334|P2|NOT COMPLETED|Overall Study||213
513538|NCT00130728|1236335|P1|NOT COMPLETED|Overall Study||211
513539|NCT00130728|1236334|P2|COMPLETED|Overall Study||104
513540|NCT00130728|1236335|P1|COMPLETED|Overall Study||108
513541|NCT00130728|1236334|P2|Received Study Drug (Safety Population)|Overall Study||313
513542|NCT00130728|1236335|P1|Received Study Drug (Safety Population)|Overall Study||313
513543|NCT00130728|1236334|P2|STARTED|Overall Study||317
513544|NCT00130728|1236335|P1|STARTED|Overall Study||319
513545|NCT00130689|1236347|P1|NOT COMPLETED|Overall Study||43
513546|NCT00130689|1236347|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
513547|NCT00130689|1236347|P1|Treated|Overall Study||35
513548|NCT00130689|1236347|P1|Eligible|Overall Study||37
513549|NCT00130689|1236347|P1|STARTED|Overall Study||43
513550|NCT00130637|1236351|P1|NOT COMPLETED|Overall Study||3
513551|NCT00130637|1236351|P1|COMPLETED|Overall Study||3
513552|NCT00130637|1236351|P1|STARTED|Overall Study||6
513553|NCT00130520|1236356|P1|NOT COMPLETED|Overall Study||39
513554|NCT00130520|1236356|P1|COMPLETED|Overall Study||1
513555|NCT00130520|1236356|P1|Completion of at Least One Cycle|Overall Study||39
513556|NCT00130520|1236356|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
513557|NCT00130286|1236366|P4|NOT COMPLETED|Overall Study||2
513558|NCT00130286|1236367|P3|NOT COMPLETED|Overall Study||4
513559|NCT00130286|1236368|P2|NOT COMPLETED|Overall Study||3
513560|NCT00130286|1236369|P1|NOT COMPLETED|Overall Study||0
513561|NCT00130286|1236366|P4|COMPLETED|Overall Study||17
513562|NCT00130286|1236367|P3|COMPLETED|Overall Study||13
513563|NCT00130286|1236368|P2|COMPLETED|Overall Study||16
513564|NCT00130286|1236369|P1|COMPLETED|Overall Study||22
513565|NCT00130286|1236366|P4|STARTED|Overall Study||19
513566|NCT00130286|1236367|P3|STARTED|Overall Study||17
513567|NCT00130286|1236368|P2|STARTED|Overall Study||19
513568|NCT00130286|1236369|P1|STARTED|Overall Study||22
513569|NCT00130247|1236389|P2|NOT COMPLETED|Overall Study||4
513570|NCT00130247|1236390|P1|NOT COMPLETED|Overall Study||2
513571|NCT00130247|1236389|P2|COMPLETED|Overall Study||194
513572|NCT00130247|1236390|P1|COMPLETED|Overall Study||194
513573|NCT00130247|1236389|P2|STARTED|Overall Study||198
513574|NCT00130247|1236390|P1|STARTED|Overall Study||196
513575|NCT00130117|1236408|P2|NOT COMPLETED|Overall Study||3
513576|NCT00130117|1236409|P1|NOT COMPLETED|Overall Study||4
513577|NCT00130117|1236408|P2|COMPLETED|Overall Study||6
513578|NCT00130117|1236409|P1|COMPLETED|Overall Study||7
513579|NCT00130117|1236408|P2|STARTED|Overall Study||9
513580|NCT00130117|1236409|P1|STARTED|Overall Study||11
513581|NCT00130039|1236432|P2|NOT COMPLETED|Overall Study||18
513582|NCT00130039|1236433|P1|NOT COMPLETED|Overall Study||30
513583|NCT00130039|1236432|P2|COMPLETED|Overall Study|full analysis set|207
513584|NCT00130039|1236433|P1|COMPLETED|Overall Study|full analysis set|202
513585|NCT00130039|1236432|P2|STARTED|Overall Study||225
513586|NCT00130039|1236433|P1|STARTED|Overall Study||232
513587|NCT00129974|1236449|P1|NOT COMPLETED|Overall Study||1
513588|NCT00129974|1236449|P1|COMPLETED|Overall Study||0
513589|NCT00129974|1236449|P1|STARTED|Overall Study||1
513590|NCT00129961|1236456|P2|NOT COMPLETED|Overall Study||23
513591|NCT00129961|1236457|P1|NOT COMPLETED|Overall Study||19
513592|NCT00129961|1236456|P2|COMPLETED|Overall Study||24
513593|NCT00129961|1236457|P1|COMPLETED|Overall Study||20
513594|NCT00129961|1236456|P2|STARTED|Overall Study||47
513595|NCT00129961|1236457|P1|STARTED|Overall Study||39
513596|NCT00129766|1236493|P2|NOT COMPLETED|Overall Study||59
513597|NCT00129766|1236494|P1|NOT COMPLETED|Overall Study||60
513598|NCT00129766|1236493|P2|COMPLETED|Overall Study||3270
513599|NCT00129766|1236494|P1|COMPLETED|Overall Study||3246
513600|NCT00129766|1236493|P2|STARTED|Overall Study||3329
513601|NCT00129766|1236494|P1|STARTED|Overall Study||3306
513602|NCT00129727|1236532|P1|NOT COMPLETED|Overall Study||5
513603|NCT00129727|1236532|P1|COMPLETED|Overall Study||57
513604|NCT00129727|1236532|P1|STARTED|Overall Study||62
513605|NCT00129623|1236540|P2|NOT COMPLETED|Overall Study||12
513606|NCT00129623|1236541|P1|NOT COMPLETED|Overall Study||10
513607|NCT00129623|1236540|P2|COMPLETED|Overall Study||65
513608|NCT00129623|1236541|P1|COMPLETED|Overall Study||73
513609|NCT00129623|1236540|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
513610|NCT00129623|1236541|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
513611|NCT00129623|1236540|P2|STARTED|Overall Study||77
513612|NCT00129623|1236541|P1|STARTED|Overall Study||83
513613|NCT00129545|1236566|P3|NOT COMPLETED|Overall Study||111
513614|NCT00129545|1236567|P2|NOT COMPLETED|Overall Study||164
513615|NCT00129545|1236568|P1|NOT COMPLETED|Overall Study||26
513616|NCT00129545|1236566|P3|COMPLETED|Overall Study||133
513617|NCT00129545|1236567|P2|COMPLETED|Overall Study||299
513618|NCT00129545|1236568|P1|COMPLETED|Overall Study||67
513619|NCT00129545|1236566|P3|STARTED|Overall Study||244
513620|NCT00129545|1236567|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
513621|NCT00129545|1236568|P1|STARTED|Overall Study||93
513622|NCT00129480|1236580|P2|NOT COMPLETED|Overall Study||0
513623|NCT00129480|1236581|P1|NOT COMPLETED|Overall Study||0
513624|NCT00129480|1236580|P2|COMPLETED|Overall Study||214
513625|NCT00129480|1236581|P1|COMPLETED|Overall Study||187
513626|NCT00129480|1236580|P2|STARTED|Overall Study||214
513627|NCT00129480|1236581|P1|STARTED|Overall Study||187
513628|NCT00129467|1236589|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
513629|NCT00129467|1236590|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
513630|NCT00129467|1236589|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
513631|NCT00129467|1236590|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
513632|NCT00129467|1236589|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
513633|NCT00129467|1236590|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
513634|NCT00129467|1236589|P2|NOT COMPLETED|Received Intervention||4
513635|NCT00129467|1236590|P1|NOT COMPLETED|Received Intervention||6
513636|NCT00129467|1236589|P2|COMPLETED|Received Intervention||13
513637|NCT00129467|1236590|P1|COMPLETED|Received Intervention||9
513638|NCT00129467|1236589|P2|STARTED|Received Intervention||17
513639|NCT00129467|1236590|P1|STARTED|Received Intervention||15
513640|NCT00129441|1236598|P2|NOT COMPLETED|Overall Study||0
513641|NCT00129441|1236599|P1|NOT COMPLETED|Overall Study||0
513642|NCT00129441|1236598|P2|COMPLETED|Overall Study||6
513643|NCT00129441|1236599|P1|COMPLETED|Overall Study||9
513644|NCT00129441|1236598|P2|Year 1, Visit 8|Overall Study||6
513645|NCT00129441|1236599|P1|Year 1, Visit 8|Overall Study||9
513646|NCT00129441|1236598|P2|Week 26, Visit 7|Overall Study||6
513647|NCT00129441|1236599|P1|Week 26, Visit 7|Overall Study||9
513648|NCT00129441|1236598|P2|Week 5, Visit 6|Overall Study||6
513649|NCT00129441|1236599|P1|Week 5, Visit 6|Overall Study||9
513650|NCT00129441|1236598|P2|Week 4, Visit 5|Overall Study||6
513651|NCT00129441|1236599|P1|Week 4, Visit 5|Overall Study||9
513652|NCT00129441|1236598|P2|Week 3, Visit 4|Overall Study||6
513653|NCT00129441|1236599|P1|Week 3, Visit 4|Overall Study||9
513654|NCT00129441|1236598|P2|Week 2, Visit 3|Overall Study||6
513655|NCT00129441|1236599|P1|Week 2, Visit 3|Overall Study||9
513656|NCT00129441|1236598|P2|Week 1, Visit 2|Overall Study||6
513657|NCT00129441|1236599|P1|Week 1, Visit 2|Overall Study||9
513658|NCT00129441|1236598|P2|Baseline, Visit 1|Overall Study||6
513659|NCT00129441|1236599|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
513660|NCT00129441|1236598|P2|STARTED|Overall Study||6
513661|NCT00129441|1236599|P1|STARTED|Overall Study||9
513662|NCT00129402|1236621|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
513663|NCT00129402|1236622|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513664|NCT00129402|1236623|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513665|NCT00129402|1236624|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513666|NCT00129402|1236625|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513667|NCT00129402|1236626|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513668|NCT00129402|1236627|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513669|NCT00129402|1236621|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
513670|NCT00129402|1236622|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513671|NCT00129402|1236623|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513672|NCT00129402|1236624|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513673|NCT00129402|1236625|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513674|NCT00129402|1236626|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513675|NCT00129402|1236627|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
513676|NCT00129402|1236621|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
513677|NCT00129402|1236622|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
513678|NCT00129402|1236623|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
513679|NCT00129402|1236624|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
513680|NCT00129402|1236625|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
513681|NCT00129402|1236626|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
513682|NCT00129402|1236627|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
513683|NCT00129402|1236621|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513684|NCT00129402|1236622|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
513685|NCT00129402|1236623|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513686|NCT00129402|1236624|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513687|NCT00129402|1236625|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
513688|NCT00129402|1236626|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513689|NCT00129402|1236627|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513690|NCT00129402|1236621|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513691|NCT00129402|1236622|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
513692|NCT00129402|1236623|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513693|NCT00129402|1236624|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513694|NCT00129402|1236625|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
513695|NCT00129402|1236626|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513696|NCT00129402|1236627|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
513697|NCT00129402|1236621|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
513698|NCT00129402|1236622|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
513699|NCT00129402|1236623|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
513700|NCT00129402|1236624|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
513701|NCT00129402|1236625|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
513702|NCT00129402|1236626|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
513703|NCT00129402|1236627|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
513704|NCT00129402|1236621|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
513705|NCT00129402|1236622|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
513706|NCT00129402|1236623|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
513707|NCT00129402|1236624|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
513708|NCT00129402|1236625|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
513709|NCT00129402|1236626|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
513710|NCT00129402|1236627|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
513711|NCT00129402|1236621|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
513712|NCT00129402|1236622|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
513713|NCT00129402|1236623|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
513714|NCT00129402|1236624|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
513715|NCT00129402|1236625|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
513716|NCT00129402|1236626|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
513717|NCT00129402|1236627|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
513718|NCT00129402|1236621|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
513719|NCT00129402|1236622|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
513720|NCT00129402|1236623|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
513721|NCT00129402|1236624|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
513722|NCT00129402|1236625|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
513723|NCT00129402|1236626|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
513724|NCT00129402|1236627|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
513725|NCT00129311|1236646|P2|NOT COMPLETED|Overall Study||19
513726|NCT00129311|1236647|P1|NOT COMPLETED|Overall Study||12
513727|NCT00129311|1236646|P2|COMPLETED|Overall Study||31
513728|NCT00129311|1236647|P1|COMPLETED|Overall Study||39
513729|NCT00129311|1236646|P2|STARTED|Overall Study||50
513730|NCT00129311|1236647|P1|STARTED|Overall Study||51
513731|NCT00129272|1236657|P2|NOT COMPLETED|Overall Study||22
513732|NCT00129272|1236658|P1|NOT COMPLETED|Overall Study||17
513733|NCT00129272|1236657|P2|COMPLETED|Overall Study||51
513734|NCT00129272|1236658|P1|COMPLETED|Overall Study||54
513735|NCT00129272|1236657|P2|STARTED|Overall Study||73
513736|NCT00129272|1236658|P1|STARTED|Overall Study||71
513737|NCT00129259|1236668|P2|NOT COMPLETED|Overall Study||3
513738|NCT00129259|1236669|P1|NOT COMPLETED|Overall Study||3
513739|NCT00129259|1236668|P2|COMPLETED|Overall Study||22
513740|NCT00129259|1236669|P1|COMPLETED|Overall Study||49
513741|NCT00129259|1236668|P2|Received All or Part of Cycle 2|Overall Study||0
513742|NCT00129259|1236669|P1|Received All or Part of Cycle 2|Overall Study||40
513743|NCT00129259|1236668|P2|Received All or Part of Cycle 1|Overall Study||0
513744|NCT00129259|1236669|P1|Received All or Part of Cycle 1|Overall Study||52
513745|NCT00129259|1236668|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
513746|NCT00129259|1236669|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
513747|NCT00129246|1236681|P2|NOT COMPLETED|Overall Study||0
513748|NCT00129246|1236682|P1|NOT COMPLETED|Overall Study||0
513749|NCT00129246|1236681|P2|COMPLETED|Overall Study||20
513750|NCT00129246|1236682|P1|COMPLETED|Overall Study||20
513751|NCT00129246|1236681|P2|STARTED|Overall Study||20
513752|NCT00129246|1236682|P1|STARTED|Overall Study||20
513753|NCT00129220|1236697|P3|NOT COMPLETED|Study Period III||10
513754|NCT00129220|1236698|P2|NOT COMPLETED|Study Period III||1
513755|NCT00129220|1236699|P1|NOT COMPLETED|Study Period III||13
513756|NCT00129220|1236697|P3|COMPLETED|Study Period III||42
513757|NCT00129220|1236698|P2|COMPLETED|Study Period III||7
513758|NCT00129220|1236699|P1|COMPLETED|Study Period III||59
513759|NCT00129220|1236697|P3|STARTED|Study Period III||52
513760|NCT00129220|1236698|P2|STARTED|Study Period III||8
513761|NCT00129220|1236699|P1|STARTED|Study Period III||72
513762|NCT00129220|1236697|P3|NOT COMPLETED|Study Period II||47
513763|NCT00129220|1236698|P2|NOT COMPLETED|Study Period II||12
513764|NCT00129220|1236699|P1|NOT COMPLETED|Study Period II||33
513765|NCT00129220|1236697|P3|COMPLETED|Study Period II||52
513766|NCT00129220|1236698|P2|COMPLETED|Study Period II||8
513767|NCT00129220|1236699|P1|COMPLETED|Study Period II||72
513768|NCT00129220|1236697|P3|Received at Least One Dose of Study Drug|Study Period II||97
513769|NCT00129220|1236698|P2|Received at Least One Dose of Study Drug|Study Period II||20
513770|NCT00129220|1236699|P1|Received at Least One Dose of Study Drug|Study Period II||104
513771|NCT00129220|1236697|P3|STARTED|Study Period II||99
513772|NCT00129220|1236698|P2|STARTED|Study Period II||20
513773|NCT00129220|1236699|P1|STARTED|Study Period II||105
513774|NCT00129129|1236739|P5|NOT COMPLETED|Fourth Dose Phase||6
513775|NCT00129129|1236740|P4|NOT COMPLETED|Fourth Dose Phase||4
513776|NCT00129129|1236741|P3|NOT COMPLETED|Fourth Dose Phase||0
513777|NCT00129129|1236742|P2|NOT COMPLETED|Fourth Dose Phase||0
513778|NCT00129129|1236743|P1|NOT COMPLETED|Fourth Dose Phase||4
513779|NCT00129129|1236739|P5|COMPLETED|Fourth Dose Phase||124
513780|NCT00129129|1236740|P4|COMPLETED|Fourth Dose Phase||128
513781|NCT00129129|1236741|P3|COMPLETED|Fourth Dose Phase||0
513782|NCT00129129|1236742|P2|COMPLETED|Fourth Dose Phase||0
513783|NCT00129129|1236743|P1|COMPLETED|Fourth Dose Phase||232
513784|NCT00129129|1236739|P5|STARTED|Fourth Dose Phase||130
513785|NCT00129129|1236740|P4|STARTED|Fourth Dose Phase||132
513786|NCT00129129|1236741|P3|STARTED|Fourth Dose Phase||0
513787|NCT00129129|1236742|P2|STARTED|Fourth Dose Phase||0
513788|NCT00129129|1236743|P1|STARTED|Fourth Dose Phase||236
513789|NCT00129129|1236739|P5|NOT COMPLETED|Primary Phase||0
513790|NCT00129129|1236740|P4|NOT COMPLETED|Primary Phase||0
513791|NCT00129129|1236741|P3|NOT COMPLETED|Primary Phase||0
513792|NCT00129129|1236742|P2|NOT COMPLETED|Primary Phase||25
513793|NCT00129129|1236743|P1|NOT COMPLETED|Primary Phase||25
513794|NCT00129129|1236739|P5|COMPLETED|Primary Phase||0
513795|NCT00129129|1236740|P4|COMPLETED|Primary Phase||0
513796|NCT00129129|1236741|P3|COMPLETED|Primary Phase||150
513797|NCT00129129|1236742|P2|COMPLETED|Primary Phase||294
513798|NCT00129129|1236743|P1|COMPLETED|Primary Phase||262
513799|NCT00129129|1236739|P5|STARTED|Primary Phase||0
513800|NCT00129129|1236740|P4|STARTED|Primary Phase||0
513801|NCT00129129|1236741|P3|STARTED|Primary Phase||150
513802|NCT00129129|1236742|P2|STARTED|Primary Phase||319
513803|NCT00129129|1236743|P1|STARTED|Primary Phase||287
513804|NCT00129116|1236950|P5|NOT COMPLETED|Booster Phase||1
513805|NCT00129116|1236951|P4|NOT COMPLETED|Booster Phase||0
513806|NCT00129116|1236952|P3|NOT COMPLETED|Booster Phase||0
513807|NCT00129116|1236953|P2|NOT COMPLETED|Booster Phase||0
513808|NCT00129116|1236954|P1|NOT COMPLETED|Booster Phase||2
513809|NCT00129116|1236950|P5|COMPLETED|Booster Phase||43
513810|NCT00129116|1236951|P4|COMPLETED|Booster Phase||44
513811|NCT00129116|1236952|P3|COMPLETED|Booster Phase||44
513812|NCT00129116|1236953|P2|COMPLETED|Booster Phase||42
513813|NCT00129116|1236954|P1|COMPLETED|Booster Phase||45
513814|NCT00129116|1236950|P5|STARTED|Booster Phase||44
513815|NCT00129116|1236951|P4|STARTED|Booster Phase||44
513816|NCT00129116|1236952|P3|STARTED|Booster Phase||44
513817|NCT00129116|1236953|P2|STARTED|Booster Phase||42
513818|NCT00129116|1236954|P1|STARTED|Booster Phase||47
513819|NCT00129116|1236950|P5|NOT COMPLETED|Primary Phase||1
513820|NCT00129116|1236951|P4|NOT COMPLETED|Primary Phase||1
513821|NCT00129116|1236952|P3|NOT COMPLETED|Primary Phase||1
513822|NCT00129116|1236953|P2|NOT COMPLETED|Primary Phase||4
513823|NCT00129116|1236954|P1|NOT COMPLETED|Primary Phase||2
513824|NCT00129116|1236950|P5|COMPLETED|Primary Phase||76
513825|NCT00129116|1236951|P4|COMPLETED|Primary Phase||77
513826|NCT00129116|1236952|P3|COMPLETED|Primary Phase||77
513827|NCT00129116|1236953|P2|COMPLETED|Primary Phase||73
513828|NCT00129116|1236954|P1|COMPLETED|Primary Phase||76
513829|NCT00129116|1236950|P5|STARTED|Primary Phase||77
513830|NCT00129116|1236951|P4|STARTED|Primary Phase||78
513831|NCT00129116|1236952|P3|STARTED|Primary Phase||78
513832|NCT00129116|1236953|P2|STARTED|Primary Phase||77
513833|NCT00129116|1236954|P1|STARTED|Primary Phase||78
513834|NCT00128921|1237219|P3|NOT COMPLETED|Overall Study||0
513835|NCT00128921|1237220|P2|NOT COMPLETED|Overall Study||5
513836|NCT00128921|1237221|P1|NOT COMPLETED|Overall Study||5
513837|NCT00128921|1237219|P3|COMPLETED|Overall Study||0
513838|NCT00128921|1237220|P2|COMPLETED|Overall Study||3
513839|NCT00128921|1237221|P1|COMPLETED|Overall Study||5
513840|NCT00128921|1237219|P3|Received Bortezomib|Overall Study||0
513841|NCT00128921|1237220|P2|Received Bortezomib|Overall Study||6
513842|NCT00128921|1237221|P1|Received Bortezomib|Overall Study||10
513843|NCT00128921|1237219|P3|STARTED|Overall Study||0
513844|NCT00128921|1237220|P2|STARTED|Overall Study||8
513845|NCT00128921|1237221|P1|STARTED|Overall Study||10
513846|NCT00128830|1237238|P1|NOT COMPLETED|Overall Study||72
513847|NCT00128830|1237238|P1|COMPLETED|Overall Study||139
513848|NCT00128830|1237238|P1|STARTED|Overall Study||211
513849|NCT00128713|1237256|P3|NOT COMPLETED|Overall Study||0
513850|NCT00128713|1237257|P2|NOT COMPLETED|Overall Study||0
513851|NCT00128713|1237258|P1|NOT COMPLETED|Overall Study||0
513852|NCT00128713|1237256|P3|COMPLETED|Overall Study||449
513853|NCT00128713|1237257|P2|COMPLETED|Overall Study||449
513854|NCT00128713|1237258|P1|COMPLETED|Overall Study||453
513855|NCT00128713|1237256|P3|STARTED|Overall Study||449
513856|NCT00128713|1237257|P2|STARTED|Overall Study||449
513857|NCT00128713|1237258|P1|STARTED|Overall Study||453
513858|NCT00128661|1237280|P2|NOT COMPLETED|Overall Study||258
513859|NCT00128661|1237281|P1|NOT COMPLETED|Overall Study||274
513860|NCT00128661|1237280|P2|COMPLETED|Overall Study||3481
513861|NCT00128661|1237281|P1|COMPLETED|Overall Study||3453
513862|NCT00128661|1237280|P2|STARTED|Overall Study||3739
513863|NCT00128661|1237281|P1|STARTED|Overall Study||3727
513864|NCT00128492|1237327|P2|NOT COMPLETED|Overall Study||59
513865|NCT00128492|1237328|P1|NOT COMPLETED|Overall Study||20
513866|NCT00128492|1237327|P2|COMPLETED|Overall Study||130
513867|NCT00128492|1237328|P1|COMPLETED|Overall Study||65
513868|NCT00128492|1237327|P2|STARTED|Overall Study||189
513869|NCT00128492|1237328|P1|STARTED|Overall Study||85
513870|NCT00128401|1237388|P2|NOT COMPLETED|Overall Study||4
513871|NCT00128401|1237389|P1|NOT COMPLETED|Overall Study||6
513872|NCT00128401|1237388|P2|COMPLETED|Overall Study||15
513873|NCT00128401|1237389|P1|COMPLETED|Overall Study||14
513874|NCT00128401|1237388|P2|STARTED|Overall Study||19
513875|NCT00128401|1237389|P1|STARTED|Overall Study||20
513876|NCT00128219|1237400|P2|NOT COMPLETED|Overall Study||71
513877|NCT00128219|1237401|P1|NOT COMPLETED|Overall Study||69
513878|NCT00128219|1237400|P2|COMPLETED|Overall Study||263
513879|NCT00128219|1237401|P1|COMPLETED|Overall Study||264
513880|NCT00128219|1237400|P2|STARTED|Overall Study||334
513881|NCT00128219|1237401|P1|STARTED|Overall Study||333
513882|NCT00128206|1237485|P2|NOT COMPLETED|Overall Study||120
513883|NCT00128206|1237486|P1|NOT COMPLETED|Overall Study||137
513884|NCT00128206|1237485|P2|COMPLETED|Overall Study||60
513885|NCT00128206|1237486|P1|COMPLETED|Overall Study||47
513886|NCT00128206|1237485|P2|STARTED|Overall Study||180
513887|NCT00128206|1237486|P1|STARTED|Overall Study||184
513888|NCT00128193|1237504|P12|NOT COMPLETED|Overall Study||2
513889|NCT00128193|1237505|P11|NOT COMPLETED|Overall Study||3
513890|NCT00128193|1237506|P10|NOT COMPLETED|Overall Study||2
513891|NCT00128193|1237507|P9|NOT COMPLETED|Overall Study||2
513892|NCT00128193|1237508|P8|NOT COMPLETED|Overall Study||0
513893|NCT00128193|1237509|P7|NOT COMPLETED|Overall Study||4
513894|NCT00128193|1237510|P6|NOT COMPLETED|Overall Study||3
513895|NCT00128193|1237511|P5|NOT COMPLETED|Overall Study||2
513896|NCT00128193|1237512|P4|NOT COMPLETED|Overall Study||1
513897|NCT00128193|1237513|P3|NOT COMPLETED|Overall Study||3
513898|NCT00128193|1237514|P2|NOT COMPLETED|Overall Study||0
513899|NCT00128193|1237515|P1|NOT COMPLETED|Overall Study||0
513900|NCT00128193|1237504|P12|COMPLETED|Overall Study||18
513901|NCT00128193|1237505|P11|COMPLETED|Overall Study||17
513902|NCT00128193|1237506|P10|COMPLETED|Overall Study||18
513903|NCT00128193|1237507|P9|COMPLETED|Overall Study||18
513904|NCT00128193|1237508|P8|COMPLETED|Overall Study||20
513905|NCT00128193|1237509|P7|COMPLETED|Overall Study||16
513906|NCT00128193|1237510|P6|COMPLETED|Overall Study||17
513907|NCT00128193|1237511|P5|COMPLETED|Overall Study||18
513908|NCT00128193|1237512|P4|COMPLETED|Overall Study||44
513909|NCT00128193|1237513|P3|COMPLETED|Overall Study||42
513910|NCT00128193|1237514|P2|COMPLETED|Overall Study||5
513911|NCT00128193|1237515|P1|COMPLETED|Overall Study||5
513912|NCT00128193|1237504|P12|STARTED|Overall Study||20
513913|NCT00128193|1237505|P11|STARTED|Overall Study||20
513914|NCT00128193|1237506|P10|STARTED|Overall Study||20
513915|NCT00128193|1237507|P9|STARTED|Overall Study||20
513916|NCT00128193|1237508|P8|STARTED|Overall Study||20
513917|NCT00128193|1237509|P7|STARTED|Overall Study||20
513918|NCT00128193|1237510|P6|STARTED|Overall Study||20
513919|NCT00128193|1237511|P5|STARTED|Overall Study||20
513920|NCT00128193|1237512|P4|STARTED|Overall Study||45
513921|NCT00128193|1237513|P3|STARTED|Overall Study||45
513922|NCT00128193|1237514|P2|STARTED|Overall Study||5
513923|NCT00128193|1237515|P1|STARTED|Overall Study||5
513924|NCT00128180|1237751|P2|NOT COMPLETED|Overall Study||0
513925|NCT00128180|1237752|P1|NOT COMPLETED|Overall Study||0
513926|NCT00128180|1237751|P2|COMPLETED|Overall Study||34
513927|NCT00128180|1237752|P1|COMPLETED|Overall Study||32
513928|NCT00128180|1237751|P2|STARTED|Overall Study||34
513929|NCT00128180|1237752|P1|STARTED|Overall Study||32
513930|NCT00127933|1237778|P2|NOT COMPLETED|Overall Study||0
513931|NCT00127933|1237779|P1|NOT COMPLETED|Overall Study||1
513932|NCT00127933|1237778|P2|COMPLETED|Overall Study||34
513933|NCT00127933|1237779|P1|COMPLETED|Overall Study||122
513934|NCT00127933|1237778|P2|Postoperative|Overall Study||27
513935|NCT00127933|1237779|P1|Postoperative|Overall Study||98
513936|NCT00127933|1237778|P2|Quality of Life Population|Overall Study||33
513937|NCT00127933|1237779|P1|Quality of Life Population|Overall Study||118
513938|NCT00127933|1237778|P2|Safety Population|Overall Study||34
513939|NCT00127933|1237779|P1|Safety Population|Overall Study||122
513940|NCT00127933|1237778|P2|Clinical Response|Overall Study||34
513941|NCT00127933|1237779|P1|Clinical Response|Overall Study||122
513942|NCT00127933|1237778|P2|Pathological Response|Overall Study||28
513943|NCT00127933|1237779|P1|Pathological Response|Overall Study||101
513944|NCT00127933|1237778|P2|STARTED|Overall Study||34
513945|NCT00127933|1237779|P1|STARTED|Overall Study||123
513946|NCT00127855|1237800|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
513947|NCT00127855|1237801|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
513948|NCT00127855|1237802|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
513949|NCT00127855|1237803|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
513950|NCT00127855|1237804|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
513951|NCT00127855|1237800|P5|COMPLETED|Polysaccharide Challenge Dose||77
513952|NCT00127855|1237801|P4|COMPLETED|Polysaccharide Challenge Dose||81
513953|NCT00127855|1237802|P3|COMPLETED|Polysaccharide Challenge Dose||77
513954|NCT00127855|1237803|P2|COMPLETED|Polysaccharide Challenge Dose||79
513955|NCT00127855|1237804|P1|COMPLETED|Polysaccharide Challenge Dose||80
513956|NCT00127855|1237800|P5|STARTED|Polysaccharide Challenge Dose||77
513957|NCT00127855|1237801|P4|STARTED|Polysaccharide Challenge Dose||81
513958|NCT00127855|1237802|P3|STARTED|Polysaccharide Challenge Dose||77
513959|NCT00127855|1237803|P2|STARTED|Polysaccharide Challenge Dose||79
513960|NCT00127855|1237804|P1|STARTED|Polysaccharide Challenge Dose||80
513961|NCT00127855|1237800|P5|NOT COMPLETED|Primary Vaccination Course||4
513962|NCT00127855|1237801|P4|NOT COMPLETED|Primary Vaccination Course||0
513963|NCT00127855|1237802|P3|NOT COMPLETED|Primary Vaccination Course||2
513964|NCT00127855|1237803|P2|NOT COMPLETED|Primary Vaccination Course||1
513965|NCT00127855|1237804|P1|NOT COMPLETED|Primary Vaccination Course||2
513966|NCT00127855|1237800|P5|COMPLETED|Primary Vaccination Course||78
513967|NCT00127855|1237801|P4|COMPLETED|Primary Vaccination Course||81
513968|NCT00127855|1237802|P3|COMPLETED|Primary Vaccination Course||78
513969|NCT00127855|1237803|P2|COMPLETED|Primary Vaccination Course||81
513970|NCT00127855|1237804|P1|COMPLETED|Primary Vaccination Course||80
513971|NCT00127855|1237800|P5|STARTED|Primary Vaccination Course||82
513972|NCT00127855|1237801|P4|STARTED|Primary Vaccination Course||81
513973|NCT00127855|1237802|P3|STARTED|Primary Vaccination Course||80
513974|NCT00127855|1237803|P2|STARTED|Primary Vaccination Course||82
513975|NCT00127855|1237804|P1|STARTED|Primary Vaccination Course||82
513976|NCT00127842|1237986|P1|NOT COMPLETED|Overall Study||39
513977|NCT00127842|1237986|P1|COMPLETED|Overall Study||71
513978|NCT00127842|1237986|P1|STARTED|Overall Study||110
513979|NCT00127803|1238004|P4|NOT COMPLETED|Overall Study||1
513980|NCT00127803|1238005|P3|NOT COMPLETED|Overall Study||0
513981|NCT00127803|1238006|P2|NOT COMPLETED|Overall Study||0
513982|NCT00127803|1238007|P1|NOT COMPLETED|Overall Study||3
513983|NCT00127803|1238004|P4|COMPLETED|Overall Study||11
513984|NCT00127803|1238005|P3|COMPLETED|Overall Study||12
513985|NCT00127803|1238006|P2|COMPLETED|Overall Study||13
513986|NCT00127803|1238007|P1|COMPLETED|Overall Study||10
513987|NCT00127803|1238004|P4|STARTED|Overall Study||12
513988|NCT00127803|1238005|P3|STARTED|Overall Study||12
513989|NCT00127803|1238006|P2|STARTED|Overall Study||13
513990|NCT00127803|1238007|P1|STARTED|Overall Study||13
513991|NCT00127790|1238029|P4|NOT COMPLETED|Post-Treatment||0
513992|NCT00127790|1238030|P3|NOT COMPLETED|Post-Treatment||0
513993|NCT00127790|1238031|P2|NOT COMPLETED|Post-Treatment||0
513994|NCT00127790|1238032|P1|NOT COMPLETED|Post-Treatment||0
513995|NCT00127790|1238029|P4|COMPLETED|Post-Treatment||4
513996|NCT00127790|1238030|P3|COMPLETED|Post-Treatment||6
513997|NCT00127790|1238031|P2|COMPLETED|Post-Treatment||5
513998|NCT00127790|1238032|P1|COMPLETED|Post-Treatment||6
513999|NCT00127790|1238029|P4|STARTED|Post-Treatment||4
514000|NCT00127790|1238030|P3|STARTED|Post-Treatment||6
514001|NCT00127790|1238031|P2|STARTED|Post-Treatment||5
514002|NCT00127790|1238032|P1|STARTED|Post-Treatment||6
514003|NCT00127790|1238029|P4|NOT COMPLETED|Pre-Treatment||0
514004|NCT00127790|1238030|P3|NOT COMPLETED|Pre-Treatment||0
514005|NCT00127790|1238031|P2|NOT COMPLETED|Pre-Treatment||0
514006|NCT00127790|1238032|P1|NOT COMPLETED|Pre-Treatment||0
514007|NCT00127790|1238029|P4|COMPLETED|Pre-Treatment||4
514008|NCT00127790|1238030|P3|COMPLETED|Pre-Treatment||6
514009|NCT00127790|1238031|P2|COMPLETED|Pre-Treatment||5
514010|NCT00127790|1238032|P1|COMPLETED|Pre-Treatment||6
514011|NCT00127790|1238029|P4|STARTED|Pre-Treatment||4
514012|NCT00127790|1238030|P3|STARTED|Pre-Treatment||6
514013|NCT00127790|1238031|P2|STARTED|Pre-Treatment||5
514014|NCT00127790|1238032|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
514015|NCT00127712|1238056|P2|NOT COMPLETED|Overall Study||0
514016|NCT00127712|1238057|P1|NOT COMPLETED|Overall Study||5
514017|NCT00127712|1238056|P2|COMPLETED|Overall Study||65
514018|NCT00127712|1238057|P1|COMPLETED|Overall Study||60
514019|NCT00127712|1238056|P2|STARTED|Overall Study||65
514020|NCT00127712|1238057|P1|STARTED|Overall Study||65
514021|NCT00127530|1238071|P2|NOT COMPLETED|Overall Study||21
514022|NCT00127530|1238072|P1|NOT COMPLETED|Overall Study||1
514023|NCT00127530|1238071|P2|COMPLETED|Overall Study||207
514024|NCT00127530|1238072|P1|COMPLETED|Overall Study||71
514025|NCT00127530|1238071|P2|STARTED|Overall Study||228
514026|NCT00127530|1238072|P1|STARTED|Overall Study||72
514027|NCT00127413|1238082|P4|NOT COMPLETED|Overall Study||2
514028|NCT00127413|1238083|P3|NOT COMPLETED|Overall Study||8
514029|NCT00127413|1238084|P2|NOT COMPLETED|Overall Study||4
514030|NCT00127413|1238085|P1|NOT COMPLETED|Overall Study||6
514031|NCT00127413|1238082|P4|COMPLETED|Overall Study||5
514032|NCT00127413|1238083|P3|COMPLETED|Overall Study||5
514033|NCT00127413|1238084|P2|COMPLETED|Overall Study||6
514034|NCT00127413|1238085|P1|COMPLETED|Overall Study||6
514035|NCT00127413|1238082|P4|STARTED|Overall Study||7
514036|NCT00127413|1238083|P3|STARTED|Overall Study||13
514037|NCT00127413|1238084|P2|STARTED|Overall Study||10
514038|NCT00127413|1238085|P1|STARTED|Overall Study||12
514039|NCT00127218|1238097|P2|NOT COMPLETED|Overall Study||15
514040|NCT00127218|1238098|P1|NOT COMPLETED|Overall Study||13
514041|NCT00127218|1238097|P2|COMPLETED|Overall Study||58
514042|NCT00127218|1238098|P1|COMPLETED|Overall Study||59
514043|NCT00127218|1238097|P2|STARTED|Overall Study||73
514044|NCT00127218|1238098|P1|STARTED|Overall Study||72
514045|NCT00127192|1238109|P5|NOT COMPLETED|Overall Study||5
514046|NCT00127192|1238110|P4|NOT COMPLETED|Overall Study||1
514047|NCT00127192|1238111|P3|NOT COMPLETED|Overall Study||2
514048|NCT00127192|1238112|P2|NOT COMPLETED|Overall Study||1
514049|NCT00127192|1238113|P1|NOT COMPLETED|Overall Study||3
514050|NCT00127192|1238109|P5|COMPLETED|Overall Study||68
514051|NCT00127192|1238110|P4|COMPLETED|Overall Study||67
514052|NCT00127192|1238111|P3|COMPLETED|Overall Study||68
514053|NCT00127192|1238112|P2|COMPLETED|Overall Study||71
514054|NCT00127192|1238113|P1|COMPLETED|Overall Study||77
514055|NCT00127192|1238109|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
514056|NCT00127192|1238110|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
514057|NCT00127192|1238111|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
514058|NCT00127192|1238112|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
514059|NCT00127192|1238113|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
514060|NCT00127166|1238137|P2|NOT COMPLETED|Period II||0
514061|NCT00127166|1238138|P1|NOT COMPLETED|Period II||3
514062|NCT00127166|1238137|P2|COMPLETED|Period II||73
514063|NCT00127166|1238138|P1|COMPLETED|Period II||72
514064|NCT00127166|1238137|P2|STARTED|Period II||73
514065|NCT00127166|1238138|P1|STARTED|Period II||75
514066|NCT00127166|1238137|P2|NOT COMPLETED|Washout Period||1
514067|NCT00127166|1238138|P1|NOT COMPLETED|Washout Period||0
514068|NCT00127166|1238137|P2|COMPLETED|Washout Period||73
514069|NCT00127166|1238138|P1|COMPLETED|Washout Period||75
514070|NCT00127166|1238137|P2|STARTED|Washout Period||74
514071|NCT00127166|1238138|P1|STARTED|Washout Period||75
514072|NCT00127166|1238137|P2|NOT COMPLETED|Period I||2
514073|NCT00127166|1238138|P1|NOT COMPLETED|Period I||3
514074|NCT00127166|1238137|P2|COMPLETED|Period I||74
514075|NCT00127166|1238138|P1|COMPLETED|Period I||75
514076|NCT00127166|1238137|P2|STARTED|Period I||76
514077|NCT00127166|1238138|P1|STARTED|Period I||78
514078|NCT00127101|1238158|P6|NOT COMPLETED|Continuation Phase||3
514079|NCT00127101|1238159|P5|NOT COMPLETED|Continuation Phase||3
514080|NCT00127101|1238160|P4|NOT COMPLETED|Continuation Phase||0
514081|NCT00127101|1238161|P3|NOT COMPLETED|Continuation Phase||1
514082|NCT00127101|1238162|P2|NOT COMPLETED|Continuation Phase||0
514083|NCT00127101|1238163|P1|NOT COMPLETED|Continuation Phase||0
514084|NCT00127101|1238158|P6|COMPLETED|Continuation Phase||0
514085|NCT00127101|1238159|P5|COMPLETED|Continuation Phase||0
514086|NCT00127101|1238160|P4|COMPLETED|Continuation Phase||0
514087|NCT00127101|1238161|P3|COMPLETED|Continuation Phase||0
514088|NCT00127101|1238162|P2|COMPLETED|Continuation Phase||0
514089|NCT00127101|1238163|P1|COMPLETED|Continuation Phase||0
514090|NCT00127101|1238158|P6|STARTED|Continuation Phase||3
514091|NCT00127101|1238159|P5|STARTED|Continuation Phase||3
514092|NCT00127101|1238160|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
514093|NCT00127101|1238161|P3|STARTED|Continuation Phase||1
514094|NCT00127101|1238162|P2|STARTED|Continuation Phase||0
514095|NCT00127101|1238163|P1|STARTED|Continuation Phase||0
514096|NCT00127101|1238158|P6|NOT COMPLETED|Base Protocol||1
514097|NCT00127101|1238159|P5|NOT COMPLETED|Base Protocol||2
514098|NCT00127101|1238160|P4|NOT COMPLETED|Base Protocol||0
514099|NCT00127101|1238161|P3|NOT COMPLETED|Base Protocol||2
514100|NCT00127101|1238162|P2|NOT COMPLETED|Base Protocol||4
514101|NCT00127101|1238163|P1|NOT COMPLETED|Base Protocol||2
514102|NCT00127101|1238158|P6|COMPLETED|Base Protocol||3
514103|NCT00127101|1238159|P5|COMPLETED|Base Protocol||3
514104|NCT00127101|1238160|P4|COMPLETED|Base Protocol||3
514105|NCT00127101|1238161|P3|COMPLETED|Base Protocol||1
514106|NCT00127101|1238162|P2|COMPLETED|Base Protocol||1
514107|NCT00127101|1238163|P1|COMPLETED|Base Protocol||1
514108|NCT00127101|1238158|P6|STARTED|Base Protocol||4
514109|NCT00127101|1238159|P5|STARTED|Base Protocol||5
514110|NCT00127101|1238160|P4|STARTED|Base Protocol||3
514111|NCT00127101|1238161|P3|STARTED|Base Protocol||3
514112|NCT00127101|1238162|P2|STARTED|Base Protocol||5
514113|NCT00127101|1238163|P1|STARTED|Base Protocol||3
514114|NCT00127036|1238185|P2|NOT COMPLETED|Overall Study||11
514115|NCT00127036|1238186|P1|NOT COMPLETED|Overall Study||8
514116|NCT00127036|1238185|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
514117|NCT00127036|1238186|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
514118|NCT00127036|1238185|P2|STARTED|Overall Study||31
514119|NCT00127036|1238186|P1|STARTED|Overall Study||34
514120|NCT00126776|1238198|P2|NOT COMPLETED|Overall Study||0
514121|NCT00126776|1238199|P1|NOT COMPLETED|Overall Study||0
514122|NCT00126776|1238198|P2|COMPLETED|Overall Study||371
514123|NCT00126776|1238199|P1|COMPLETED|Overall Study||372
514124|NCT00126776|1238198|P2|STARTED|Overall Study||371
514125|NCT00126776|1238199|P1|STARTED|Overall Study||372
514126|NCT00126750|1238205|P2|NOT COMPLETED|Overall Study||266
514127|NCT00126750|1238206|P1|NOT COMPLETED|Overall Study||180
514128|NCT00126750|1238205|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
514129|NCT00126750|1238206|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
514130|NCT00126750|1238205|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
514131|NCT00126750|1238206|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
514132|NCT00126737|1238216|P4|NOT COMPLETED|Overall Study||7
514133|NCT00126737|1238217|P3|NOT COMPLETED|Overall Study||6
514134|NCT00126737|1238218|P2|NOT COMPLETED|Overall Study||3
514135|NCT00126737|1238219|P1|NOT COMPLETED|Overall Study||6
514136|NCT00126737|1238216|P4|COMPLETED|Overall Study||18
514137|NCT00126737|1238217|P3|COMPLETED|Overall Study||24
514138|NCT00126737|1238218|P2|COMPLETED|Overall Study||24
514139|NCT00126737|1238219|P1|COMPLETED|Overall Study||22
514140|NCT00126737|1238216|P4|STARTED|Overall Study||25
514141|NCT00126737|1238217|P3|STARTED|Overall Study||30
514142|NCT00126737|1238218|P2|STARTED|Overall Study||27
514143|NCT00126737|1238219|P1|STARTED|Overall Study||28
514144|NCT00126659|1238248|P3|NOT COMPLETED|Overall Study||2
514145|NCT00126659|1238249|P2|NOT COMPLETED|Overall Study||0
514146|NCT00126659|1238250|P1|NOT COMPLETED|Overall Study||0
514147|NCT00126659|1238248|P3|COMPLETED|Overall Study||2
514148|NCT00126659|1238249|P2|COMPLETED|Overall Study||3
514149|NCT00126659|1238250|P1|COMPLETED|Overall Study||3
514150|NCT00126659|1238248|P3|STARTED|Overall Study||4
514151|NCT00126659|1238249|P2|STARTED|Overall Study||3
514152|NCT00126659|1238250|P1|STARTED|Overall Study||3
514153|NCT00126594|1238258|P2|NOT COMPLETED|Overall Study||37
514154|NCT00126594|1238259|P1|NOT COMPLETED|Overall Study||39
514155|NCT00126594|1238258|P2|COMPLETED|Overall Study||3
514156|NCT00126594|1238259|P1|COMPLETED|Overall Study||1
514157|NCT00126594|1238258|P2|STARTED|Overall Study||40
514158|NCT00126594|1238259|P1|STARTED|Overall Study||40
514159|NCT00126581|1238276|P2|NOT COMPLETED|Overall Study||20
514160|NCT00126581|1238277|P1|NOT COMPLETED|Overall Study||13
514161|NCT00126581|1238276|P2|COMPLETED|Overall Study||80
514162|NCT00126581|1238277|P1|COMPLETED|Overall Study||68
514163|NCT00126581|1238276|P2|STARTED|Overall Study||100
514164|NCT00126581|1238277|P1|STARTED|Overall Study||81
514165|NCT00126568|1238297|P1|NOT COMPLETED|Overall Study||2
514166|NCT00126568|1238297|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
514167|NCT00126568|1238297|P1|STARTED|Overall Study||20
514168|NCT00126555|1238303|P1|NOT COMPLETED|Overall Study||6
514169|NCT00126555|1238303|P1|COMPLETED|Overall Study||17
514170|NCT00126555|1238303|P1|STARTED|Overall Study||23
514171|NCT00126503|1238319|P2|NOT COMPLETED|Overall Study||21
514172|NCT00126503|1238320|P1|NOT COMPLETED|Overall Study||47
514173|NCT00126503|1238319|P2|COMPLETED|Overall Study||0
514174|NCT00126503|1238320|P1|COMPLETED|Overall Study||1
514175|NCT00126503|1238319|P2|STARTED|Overall Study||21
514176|NCT00126503|1238320|P1|STARTED|Overall Study||48
514177|NCT00126490|1238332|P1|NOT COMPLETED|Overall Study||1
514178|NCT00126490|1238332|P1|COMPLETED|Overall Study||18
514179|NCT00126490|1238332|P1|STARTED|Overall Study||19
514180|NCT00126438|1238342|P2|NOT COMPLETED|Overall Study||10
514181|NCT00126438|1238343|P1|NOT COMPLETED|Overall Study||34
514182|NCT00126438|1238342|P2|COMPLETED|Overall Study||52
514183|NCT00126438|1238343|P1|COMPLETED|Overall Study||419
514184|NCT00126438|1238342|P2|STARTED|Overall Study||62
514185|NCT00126438|1238343|P1|STARTED|Overall Study||453
514186|NCT00126425|1238351|P2|NOT COMPLETED|Overall Study||11
514187|NCT00126425|1238352|P1|NOT COMPLETED|Overall Study||41
514188|NCT00126425|1238351|P2|COMPLETED|Overall Study||37
514189|NCT00126425|1238352|P1|COMPLETED|Overall Study||498
514190|NCT00126425|1238351|P2|STARTED|Overall Study||48
514191|NCT00126425|1238352|P1|STARTED|Overall Study||539
514192|NCT00126191|1238360|P2|NOT COMPLETED|Overall Study||2
514193|NCT00126191|1238361|P1|NOT COMPLETED|Overall Study||0
514194|NCT00126191|1238360|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
514195|NCT00126191|1238361|P1|COMPLETED|Overall Study||2
514196|NCT00126191|1238360|P2|STARTED|Overall Study||8
514197|NCT00126191|1238361|P1|STARTED|Overall Study||2
514198|NCT00126126|1238371|P2|NOT COMPLETED|Overall Study||2
514199|NCT00126126|1238372|P1|NOT COMPLETED|Overall Study||0
514200|NCT00126126|1238371|P2|COMPLETED|Overall Study||7
514201|NCT00126126|1238372|P1|COMPLETED|Overall Study||9
514202|NCT00126126|1238371|P2|STARTED|Overall Study||9
514203|NCT00126126|1238372|P1|STARTED|Overall Study||9
514204|NCT00126113|1238382|P2|NOT COMPLETED|Overall Study||2
514205|NCT00126113|1238383|P1|NOT COMPLETED|Overall Study||3
514206|NCT00126113|1238382|P2|COMPLETED|Overall Study||35
514207|NCT00126113|1238383|P1|COMPLETED|Overall Study||34
514208|NCT00126113|1238382|P2|STARTED|Overall Study||37
514209|NCT00126113|1238383|P1|STARTED|Overall Study||37
514210|NCT00125957|1238397|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
514211|NCT00125957|1238398|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
514212|NCT00125957|1238397|P2|COMPLETED|Second Intervention (3 Weeks)||17
514213|NCT00125957|1238398|P1|COMPLETED|Second Intervention (3 Weeks)||15
514214|NCT00125957|1238397|P2|STARTED|Second Intervention (3 Weeks)||17
514215|NCT00125957|1238398|P1|STARTED|Second Intervention (3 Weeks)||15
514216|NCT00125957|1238397|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
514217|NCT00125957|1238398|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
514218|NCT00125957|1238397|P2|COMPLETED|First Intervention (3 Weeks)||17
514219|NCT00125957|1238398|P1|COMPLETED|First Intervention (3 Weeks)||15
514220|NCT00125957|1238397|P2|STARTED|First Intervention (3 Weeks)||17
514221|NCT00125957|1238398|P1|STARTED|First Intervention (3 Weeks)||15
514222|NCT00125931|1238406|P1|NOT COMPLETED|Overall Study||0
514223|NCT00125931|1238406|P1|COMPLETED|Overall Study||10
514224|NCT00125931|1238406|P1|STARTED|Overall Study||10
514225|NCT00125619|1238413|P2|NOT COMPLETED|Overall Study||0
514226|NCT00125619|1238414|P1|NOT COMPLETED|Overall Study||0
514227|NCT00125619|1238413|P2|COMPLETED|Overall Study||8
514228|NCT00125619|1238414|P1|COMPLETED|Overall Study||8
514229|NCT00125619|1238413|P2|STARTED|Overall Study||8
514230|NCT00125619|1238414|P1|STARTED|Overall Study||8
514231|NCT00125593|1238434|P2|NOT COMPLETED|Overall Study||103
514232|NCT00125593|1238435|P1|NOT COMPLETED|Overall Study||101
514233|NCT00125593|1238434|P2|COMPLETED|Overall Study||4517
514234|NCT00125593|1238435|P1|COMPLETED|Overall Study||4549
514235|NCT00125593|1238434|P2|STARTED|Overall Study||4620
514236|NCT00125593|1238435|P1|STARTED|Overall Study||4650
514237|NCT00125528|1238455|P2|NOT COMPLETED|Overall Study||1
514238|NCT00125528|1238456|P1|NOT COMPLETED|Overall Study||2
514239|NCT00125528|1238455|P2|COMPLETED|Overall Study||20
514240|NCT00125528|1238456|P1|COMPLETED|Overall Study||18
514241|NCT00125528|1238455|P2|STARTED|Overall Study||21
514242|NCT00125528|1238456|P1|STARTED|Overall Study||20
514243|NCT00125515|1238467|P3|NOT COMPLETED|Overall Study||21
514244|NCT00125515|1238468|P2|NOT COMPLETED|Overall Study||20
514245|NCT00125515|1238469|P1|NOT COMPLETED|Overall Study||20
514246|NCT00125515|1238467|P3|COMPLETED|Overall Study||6
514247|NCT00125515|1238468|P2|COMPLETED|Overall Study||7
514248|NCT00125515|1238469|P1|COMPLETED|Overall Study||7
514249|NCT00125515|1238467|P3|STARTED|Overall Study||27
514250|NCT00125515|1238468|P2|STARTED|Overall Study||27
514251|NCT00125515|1238469|P1|STARTED|Overall Study||27
514252|NCT00125268|1238479|P2|NOT COMPLETED|Overall Study||1
514253|NCT00125268|1238480|P1|NOT COMPLETED|Overall Study||1
514254|NCT00125268|1238479|P2|COMPLETED|Overall Study||13
514255|NCT00125268|1238480|P1|COMPLETED|Overall Study||15
514256|NCT00125268|1238479|P2|STARTED|Overall Study||14
514257|NCT00125268|1238480|P1|STARTED|Overall Study||16
514258|NCT00125242|1238492|P2|NOT COMPLETED|Overall Study||2
514259|NCT00125242|1238493|P1|NOT COMPLETED|Overall Study||7
514260|NCT00125242|1238492|P2|COMPLETED|Overall Study||14
514261|NCT00125242|1238493|P1|COMPLETED|Overall Study||87
514262|NCT00125242|1238492|P2|STARTED|Overall Study||16
514263|NCT00125242|1238493|P1|STARTED|Overall Study||94
514264|NCT00125190|1238498|P1|NOT COMPLETED|Overall Study||15
514265|NCT00125190|1238498|P1|COMPLETED|Overall Study||30
514266|NCT00125190|1238498|P1|STARTED|Overall Study||45
514267|NCT00125164|1238516|P4|NOT COMPLETED|Overall Study||6
514268|NCT00125164|1238517|P3|NOT COMPLETED|Overall Study||4
514269|NCT00125164|1238518|P2|NOT COMPLETED|Overall Study||0
514270|NCT00125164|1238519|P1|NOT COMPLETED|Overall Study||2
514271|NCT00125164|1238516|P4|COMPLETED|Overall Study||45
514272|NCT00125164|1238517|P3|COMPLETED|Overall Study||40
514273|NCT00125164|1238518|P2|COMPLETED|Overall Study||16
514274|NCT00125164|1238519|P1|COMPLETED|Overall Study||23
514275|NCT00125164|1238516|P4|STARTED|Overall Study||51
514276|NCT00125164|1238517|P3|STARTED|Overall Study||44
514277|NCT00125164|1238518|P2|STARTED|Overall Study||16
514278|NCT00125164|1238519|P1|STARTED|Overall Study||25
514279|NCT00125138|1238573|P4|NOT COMPLETED|Overall Study||5
514280|NCT00125138|1238574|P3|NOT COMPLETED|Overall Study||4
514281|NCT00125138|1238575|P2|NOT COMPLETED|Overall Study||3
514282|NCT00125138|1238576|P1|NOT COMPLETED|Overall Study||3
514283|NCT00125138|1238573|P4|COMPLETED|Overall Study||25
514284|NCT00125138|1238574|P3|COMPLETED|Overall Study||21
514285|NCT00125138|1238575|P2|COMPLETED|Overall Study||17
514286|NCT00125138|1238576|P1|COMPLETED|Overall Study||12
514287|NCT00125138|1238573|P4|STARTED|Overall Study||30
514288|NCT00125138|1238574|P3|STARTED|Overall Study||25
514289|NCT00125138|1238575|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
514290|NCT00125138|1238576|P1|STARTED|Overall Study||15
514291|NCT00125034|1238592|P2|NOT COMPLETED|Overall Study||0
514292|NCT00125034|1238593|P1|NOT COMPLETED|Overall Study||0
514293|NCT00125034|1238592|P2|COMPLETED|Overall Study||168
514294|NCT00125034|1238593|P1|COMPLETED|Overall Study||170
514295|NCT00125034|1238592|P2|STARTED|Overall Study|Randomized & treated|168
514296|NCT00125034|1238593|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
514297|NCT00124982|1238625|P3|NOT COMPLETED|Long-term Period||89
514298|NCT00124982|1238626|P2|NOT COMPLETED|Long-term Period||0
514299|NCT00124982|1238627|P1|NOT COMPLETED|Long-term Period||0
514300|NCT00124982|1238625|P3|COMPLETED|Long-term Period||441
514301|NCT00124982|1238626|P2|COMPLETED|Long-term Period||0
514302|NCT00124982|1238627|P1|COMPLETED|Long-term Period||0
514303|NCT00124982|1238625|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
514304|NCT00124982|1238626|P2|STARTED|Long-term Period||0
514305|NCT00124982|1238627|P1|STARTED|Long-term Period||0
514306|NCT00124982|1238625|P3|NOT COMPLETED|Short-term Period||0
514307|NCT00124982|1238626|P2|NOT COMPLETED|Short-term Period||114
514308|NCT00124982|1238627|P1|NOT COMPLETED|Short-term Period||72
514309|NCT00124982|1238625|P3|COMPLETED|Short-term Period||0
514310|NCT00124982|1238626|P2|COMPLETED|Short-term Period||483
514311|NCT00124982|1238627|P1|COMPLETED|Short-term Period||377
514312|NCT00124982|1238625|P3|STARTED|Short-term Period||0
514313|NCT00124982|1238626|P2|STARTED|Short-term Period||597
514314|NCT00124982|1238627|P1|STARTED|Short-term Period||449
514315|NCT00124943|1238709|P4|NOT COMPLETED|Phase II||5
514316|NCT00124943|1238710|P3|NOT COMPLETED|Phase II||0
514317|NCT00124943|1238711|P2|NOT COMPLETED|Phase II||2
514318|NCT00124943|1238712|P1|NOT COMPLETED|Phase II||0
514319|NCT00124943|1238709|P4|COMPLETED|Phase II||50
514320|NCT00124943|1238710|P3|COMPLETED|Phase II||3
514321|NCT00124943|1238711|P2|COMPLETED|Phase II||49
514322|NCT00124943|1238712|P1|COMPLETED|Phase II||3
514323|NCT00124943|1238709|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
514324|NCT00124943|1238710|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
514325|NCT00124943|1238711|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
514326|NCT00124943|1238712|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
514327|NCT00124943|1238709|P4|NOT COMPLETED|Phase I||0
514328|NCT00124943|1238710|P3|NOT COMPLETED|Phase I||0
514329|NCT00124943|1238711|P2|NOT COMPLETED|Phase I||0
514330|NCT00124943|1238712|P1|NOT COMPLETED|Phase I||0
514331|NCT00124943|1238709|P4|COMPLETED|Phase I||3
514332|NCT00124943|1238710|P3|COMPLETED|Phase I||3
514333|NCT00124943|1238711|P2|COMPLETED|Phase I||3
514334|NCT00124943|1238712|P1|COMPLETED|Phase I||3
514335|NCT00124943|1238709|P4|STARTED|Phase I||3
514336|NCT00124943|1238710|P3|STARTED|Phase I||3
514337|NCT00124943|1238711|P2|STARTED|Phase I||3
514338|NCT00124943|1238712|P1|STARTED|Phase I||3
514339|NCT00124748|1238752|P2|NOT COMPLETED|Overall Study||284
514340|NCT00124748|1238753|P1|NOT COMPLETED|Overall Study||143
514341|NCT00124748|1238752|P2|COMPLETED|Overall Study||35
514342|NCT00124748|1238753|P1|COMPLETED|Overall Study||14
514343|NCT00124748|1238752|P2|Safety Population|Overall Study||316
514344|NCT00124748|1238753|P1|Safety Population|Overall Study||157
514345|NCT00124748|1238752|P2|STARTED|Overall Study||319
514346|NCT00124748|1238753|P1|STARTED|Overall Study||157
514347|NCT00124735|1238805|P10|NOT COMPLETED|Overall Study||2
514348|NCT00124735|1238806|P9|NOT COMPLETED|Overall Study||3
514349|NCT00124735|1238807|P8|NOT COMPLETED|Overall Study||1
514350|NCT00124735|1238808|P7|NOT COMPLETED|Overall Study||0
514351|NCT00124735|1238809|P6|NOT COMPLETED|Overall Study||2
514352|NCT00124735|1238810|P5|NOT COMPLETED|Overall Study||2
514353|NCT00124735|1238811|P4|NOT COMPLETED|Overall Study||3
514354|NCT00124735|1238812|P3|NOT COMPLETED|Overall Study||0
514355|NCT00124735|1238813|P2|NOT COMPLETED|Overall Study||2
514356|NCT00124735|1238814|P1|NOT COMPLETED|Overall Study||1
514357|NCT00124735|1238805|P10|COMPLETED|Overall Study||18
514358|NCT00124735|1238806|P9|COMPLETED|Overall Study||22
514359|NCT00124735|1238807|P8|COMPLETED|Overall Study||19
514360|NCT00124735|1238808|P7|COMPLETED|Overall Study||6
514361|NCT00124735|1238809|P6|COMPLETED|Overall Study||5
514362|NCT00124735|1238810|P5|COMPLETED|Overall Study||17
514363|NCT00124735|1238811|P4|COMPLETED|Overall Study||18
514364|NCT00124735|1238812|P3|COMPLETED|Overall Study||18
514365|NCT00124735|1238813|P2|COMPLETED|Overall Study||6
514366|NCT00124735|1238814|P1|COMPLETED|Overall Study||4
514367|NCT00124735|1238805|P10|STARTED|Overall Study||20
514368|NCT00124735|1238806|P9|STARTED|Overall Study||25
514369|NCT00124735|1238807|P8|STARTED|Overall Study||20
514370|NCT00124735|1238808|P7|STARTED|Overall Study||6
514371|NCT00124735|1238809|P6|STARTED|Overall Study||7
514372|NCT00124735|1238810|P5|STARTED|Overall Study||19
514373|NCT00124735|1238811|P4|STARTED|Overall Study||21
514374|NCT00124735|1238812|P3|STARTED|Overall Study||18
514375|NCT00124735|1238813|P2|STARTED|Overall Study||8
514376|NCT00124735|1238814|P1|STARTED|Overall Study||5
514377|NCT00124709|1238860|P2|NOT COMPLETED|Overall Study||272
514378|NCT00124709|1238861|P1|NOT COMPLETED|Overall Study||255
514379|NCT00124709|1238860|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
514380|NCT00124709|1238861|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
514381|NCT00124709|1238860|P2|Patients Who Received Study Medication|Overall Study||544
514382|NCT00124709|1238861|P1|Patients Who Received Study Medication|Overall Study||543
514383|NCT00124709|1238860|P2|STARTED|Overall Study||545
514384|NCT00124709|1238861|P1|STARTED|Overall Study||546
514385|NCT00124657|1238878|P3|NOT COMPLETED|Overall Study||32
514386|NCT00124657|1238879|P2|NOT COMPLETED|Overall Study||5
514387|NCT00124657|1238880|P1|NOT COMPLETED|Overall Study||16
514388|NCT00124657|1238878|P3|COMPLETED|Overall Study||7
514389|NCT00124657|1238879|P2|COMPLETED|Overall Study||0
514390|NCT00124657|1238880|P1|COMPLETED|Overall Study||2
514391|NCT00124657|1238878|P3|STARTED|Overall Study||39
514392|NCT00124657|1238879|P2|STARTED|Overall Study||5
514393|NCT00124657|1238880|P1|STARTED|Overall Study||18
514394|NCT00124618|1238915|P1|NOT COMPLETED|Overall Study||1
514395|NCT00124618|1238915|P1|COMPLETED|Overall Study||57
514396|NCT00124618|1238915|P1|STARTED|Overall Study||58
514397|NCT00124579|1238922|P1|NOT COMPLETED|Maintenance||2
514398|NCT00124579|1238922|P1|COMPLETED|Maintenance||0
514399|NCT00124579|1238922|P1|STARTED|Maintenance||2
514400|NCT00124579|1238922|P1|NOT COMPLETED|Induction||5
514401|NCT00124579|1238922|P1|COMPLETED|Induction||2
514402|NCT00124579|1238922|P1|STARTED|Induction||7
514403|NCT00124449|1238930|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
514404|NCT00124449|1238931|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
514405|NCT00124449|1238930|P2|COMPLETED|18-Month Untreated Observation Period||4
514406|NCT00124449|1238931|P1|COMPLETED|18-Month Untreated Observation Period||7
514407|NCT00124449|1238930|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
514408|NCT00124449|1238931|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
514409|NCT00124449|1238930|P2|STARTED|18-Month Untreated Observation Period||17
514410|NCT00124449|1238931|P1|STARTED|18-Month Untreated Observation Period||22
514411|NCT00124449|1238930|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
514412|NCT00124449|1238931|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
514413|NCT00124449|1238930|P2|COMPLETED|6-month Double-Blind Treatment Period||17
514414|NCT00124449|1238931|P1|COMPLETED|6-month Double-Blind Treatment Period||22
514415|NCT00124449|1238930|P2|STARTED|6-month Double-Blind Treatment Period||28
514416|NCT00124449|1238931|P1|STARTED|6-month Double-Blind Treatment Period||28
514417|NCT00124176|1238966|P2|NOT COMPLETED|Overall Study||0
514418|NCT00124176|1238967|P1|NOT COMPLETED|Overall Study||0
514419|NCT00124176|1238966|P2|COMPLETED|Overall Study||41
514420|NCT00124176|1238967|P1|COMPLETED|Overall Study||40
514421|NCT00124176|1238966|P2|Received Study Drug|Overall Study||41
514422|NCT00124176|1238967|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
514423|NCT00124176|1238966|P2|STARTED|Overall Study||41
514424|NCT00124176|1238967|P1|STARTED|Overall Study||40
514425|NCT00124072|1238985|P4|NOT COMPLETED|Overall Study||500
514426|NCT00124072|1238986|P3|NOT COMPLETED|Overall Study||492
514427|NCT00124072|1238987|P2|NOT COMPLETED|Overall Study||512
514428|NCT00124072|1238988|P1|NOT COMPLETED|Overall Study||514
514429|NCT00124072|1238985|P4|COMPLETED|Overall Study||2515
514430|NCT00124072|1238986|P3|COMPLETED|Overall Study||2524
514431|NCT00124072|1238987|P2|COMPLETED|Overall Study||2504
514432|NCT00124072|1238988|P1|COMPLETED|Overall Study||2503
514433|NCT00124072|1238985|P4|STARTED|Overall Study||3015
514434|NCT00124072|1238986|P3|STARTED|Overall Study||3016
514435|NCT00124072|1238987|P2|STARTED|Overall Study||3016
514436|NCT00124072|1238988|P1|STARTED|Overall Study||3017
514437|NCT00124020|1239000|P2|NOT COMPLETED|Overall Study||91
514438|NCT00124020|1239001|P1|NOT COMPLETED|Overall Study||88
514439|NCT00124020|1239000|P2|COMPLETED|Overall Study||289
514440|NCT00124020|1239001|P1|COMPLETED|Overall Study||289
514441|NCT00124020|1239000|P2|STARTED|Overall Study||380
514442|NCT00124020|1239001|P1|STARTED|Overall Study||377
514443|NCT00123955|1239009|P2|NOT COMPLETED|Overall Study||4
514444|NCT00123955|1239010|P1|NOT COMPLETED|Overall Study||5
514445|NCT00123955|1239009|P2|COMPLETED|Overall Study||34
514446|NCT00123955|1239010|P1|COMPLETED|Overall Study||37
514447|NCT00123955|1239009|P2|STARTED|Overall Study||38
514448|NCT00123955|1239010|P1|STARTED|Overall Study||42
514449|NCT00123734|1239016|P1|NOT COMPLETED|Overall Study||8
514450|NCT00123734|1239016|P1|COMPLETED|Overall Study||74
514451|NCT00123734|1239016|P1|STARTED|Overall Study||82
514452|NCT00123682|1239051|P4|NOT COMPLETED|Overall Study||95
514453|NCT00123682|1239052|P3|NOT COMPLETED|Overall Study||154
514454|NCT00123682|1239053|P2|NOT COMPLETED|Overall Study||203
514455|NCT00123682|1239054|P1|NOT COMPLETED|Overall Study||320
514456|NCT00123682|1239051|P4|COMPLETED|Overall Study||430
514457|NCT00123682|1239052|P3|COMPLETED|Overall Study||438
514458|NCT00123682|1239053|P2|COMPLETED|Overall Study||731
514459|NCT00123682|1239054|P1|COMPLETED|Overall Study||749
514460|NCT00123682|1239051|P4|STARTED|Overall Study||525
514461|NCT00123682|1239052|P3|STARTED|Overall Study||592
514462|NCT00123682|1239053|P2|STARTED|Overall Study||934
514463|NCT00123682|1239054|P1|STARTED|Overall Study||1069
514464|NCT00123643|1239074|P2|NOT COMPLETED|Overall Study||0
514465|NCT00123643|1239075|P1|NOT COMPLETED|Overall Study||0
514466|NCT00123643|1239074|P2|COMPLETED|Overall Study||16
514467|NCT00123643|1239075|P1|COMPLETED|Overall Study||20
514468|NCT00123643|1239074|P2|STARTED|Overall Study||16
514469|NCT00123643|1239075|P1|STARTED|Overall Study||20
514470|NCT00123630|1239083|P2|NOT COMPLETED|Overall Study||0
514471|NCT00123630|1239084|P1|NOT COMPLETED|Overall Study||0
514472|NCT00123630|1239083|P2|COMPLETED|Overall Study||15
514473|NCT00123630|1239084|P1|COMPLETED|Overall Study||15
514474|NCT00123630|1239083|P2|STARTED|Overall Study||15
514475|NCT00123630|1239084|P1|STARTED|Overall Study||15
514476|NCT00123604|1239092|P2|NOT COMPLETED|Overall Study||1
514477|NCT00123604|1239093|P1|NOT COMPLETED|Overall Study||1
514478|NCT00123604|1239092|P2|COMPLETED|Overall Study||16
514479|NCT00123604|1239093|P1|COMPLETED|Overall Study||18
514480|NCT00123604|1239092|P2|STARTED|Overall Study||17
514481|NCT00123604|1239093|P1|STARTED|Overall Study||19
514482|NCT00123487|1239101|P2|NOT COMPLETED|Treated With Study Drug||305
514483|NCT00123487|1239102|P1|NOT COMPLETED|Treated With Study Drug||304
514484|NCT00123487|1239101|P2|COMPLETED|Treated With Study Drug||0
514485|NCT00123487|1239102|P1|COMPLETED|Treated With Study Drug||0
514486|NCT00123487|1239101|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
514487|NCT00123487|1239102|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
514488|NCT00123487|1239101|P2|NOT COMPLETED|Randomized||1
514489|NCT00123487|1239102|P1|NOT COMPLETED|Randomized||1
514490|NCT00123487|1239101|P2|COMPLETED|Randomized||304
514491|NCT00123487|1239102|P1|COMPLETED|Randomized||305
514492|NCT00123487|1239101|P2|STARTED|Randomized||305
514493|NCT00123487|1239102|P1|STARTED|Randomized||306
514494|NCT00123474|1239146|P4|NOT COMPLETED|As Treated at Study Closure||167
514495|NCT00123474|1239147|P3|NOT COMPLETED|As Treated at Study Closure||167
514496|NCT00123474|1239148|P2|NOT COMPLETED|As Treated at Study Closure||163
514497|NCT00123474|1239149|P1|NOT COMPLETED|As Treated at Study Closure||165
514498|NCT00123474|1239146|P4|COMPLETED|As Treated at Study Closure||0
514499|NCT00123474|1239147|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
514500|NCT00123474|1239148|P2|COMPLETED|As Treated at Study Closure||0
514501|NCT00123474|1239149|P1|COMPLETED|As Treated at Study Closure||0
514502|NCT00123474|1239146|P4|STARTED|As Treated at Study Closure||167
514503|NCT00123474|1239147|P3|STARTED|As Treated at Study Closure||167
514504|NCT00123474|1239148|P2|STARTED|As Treated at Study Closure||163
514505|NCT00123474|1239149|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
514506|NCT00123474|1239146|P4|NOT COMPLETED|Randomized to Treatment||1
514507|NCT00123474|1239147|P3|NOT COMPLETED|Randomized to Treatment||2
514508|NCT00123474|1239148|P2|NOT COMPLETED|Randomized to Treatment||4
514509|NCT00123474|1239149|P1|NOT COMPLETED|Randomized to Treatment||1
514510|NCT00123474|1239146|P4|COMPLETED|Randomized to Treatment||167
514511|NCT00123474|1239147|P3|COMPLETED|Randomized to Treatment||166
514512|NCT00123474|1239148|P2|COMPLETED|Randomized to Treatment||163
514513|NCT00123474|1239149|P1|COMPLETED|Randomized to Treatment||166
514514|NCT00123474|1239146|P4|STARTED|Randomized to Treatment||168
514515|NCT00123474|1239147|P3|STARTED|Randomized to Treatment||168
514516|NCT00123474|1239148|P2|STARTED|Randomized to Treatment||167
514517|NCT00123474|1239149|P1|STARTED|Randomized to Treatment||167
514518|NCT00123422|1239243|P3|NOT COMPLETED|Overall Study||10
514519|NCT00123422|1239244|P2|NOT COMPLETED|Overall Study||6
514520|NCT00123422|1239245|P1|NOT COMPLETED|Overall Study||4
514521|NCT00123422|1239243|P3|COMPLETED|Overall Study||25
514522|NCT00123422|1239244|P2|COMPLETED|Overall Study||27
514523|NCT00123422|1239245|P1|COMPLETED|Overall Study||31
514524|NCT00123422|1239243|P3|8-week Testing|Overall Study||27
514525|NCT00123422|1239244|P2|8-week Testing|Overall Study||30
514526|NCT00123422|1239245|P1|8-week Testing|Overall Study||32
514527|NCT00123422|1239243|P3|STARTED|Overall Study||35
514528|NCT00123422|1239244|P2|STARTED|Overall Study||33
514529|NCT00123422|1239245|P1|STARTED|Overall Study||35
514530|NCT00123409|1239258|P2|NOT COMPLETED|Overall Study||3
514531|NCT00123409|1239259|P1|NOT COMPLETED|Overall Study||4
514532|NCT00123409|1239258|P2|COMPLETED|Overall Study||71
514533|NCT00123409|1239259|P1|COMPLETED|Overall Study||68
514534|NCT00123409|1239258|P2|STARTED|Overall Study||74
514535|NCT00123409|1239259|P1|STARTED|Overall Study||72
514536|NCT00123162|1239269|P2|NOT COMPLETED|Overall Study||0
514537|NCT00123162|1239270|P1|NOT COMPLETED|Overall Study||0
514538|NCT00123162|1239269|P2|COMPLETED|Overall Study||12
514539|NCT00123162|1239270|P1|COMPLETED|Overall Study||13
514540|NCT00123162|1239269|P2|STARTED|Overall Study||12
514541|NCT00123162|1239270|P1|STARTED|Overall Study||13
514542|NCT00123123|1239281|P3|NOT COMPLETED|Overall Study||0
514543|NCT00123123|1239282|P2|NOT COMPLETED|Overall Study||0
514544|NCT00123123|1239283|P1|NOT COMPLETED|Overall Study||0
514545|NCT00123123|1239281|P3|COMPLETED|Overall Study||58
514546|NCT00123123|1239282|P2|COMPLETED|Overall Study||58
514547|NCT00123123|1239283|P1|COMPLETED|Overall Study||59
514548|NCT00123123|1239281|P3|STARTED|Overall Study||58
514549|NCT00123123|1239282|P2|STARTED|Overall Study||58
514550|NCT00123123|1239283|P1|STARTED|Overall Study||59
514551|NCT00122980|1239296|P2|NOT COMPLETED|Overall Study||40
514552|NCT00122980|1239297|P1|NOT COMPLETED|Overall Study||43
514553|NCT00122980|1239296|P2|COMPLETED|Overall Study|Study terminated early|26
514554|NCT00122980|1239297|P1|COMPLETED|Overall Study|Study terminated early|24
514555|NCT00122980|1239296|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
514556|NCT00122980|1239297|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
514557|NCT00122954|1239321|P2|NOT COMPLETED|Overall Study||3
514558|NCT00122954|1239322|P1|NOT COMPLETED|Overall Study||2
514559|NCT00122954|1239321|P2|COMPLETED|Overall Study||18
514560|NCT00122954|1239322|P1|COMPLETED|Overall Study||16
514561|NCT00122954|1239321|P2|STARTED|Overall Study||21
514562|NCT00122954|1239322|P1|STARTED|Overall Study||18
514563|NCT00122681|1239332|P2|NOT COMPLETED|Overall Study||1521
514564|NCT00122681|1239333|P1|NOT COMPLETED|Overall Study||1514
514565|NCT00122681|1239332|P2|COMPLETED|Overall Study||7798
514566|NCT00122681|1239333|P1|COMPLETED|Overall Study||7811
514567|NCT00122681|1239332|P2|STARTED|Overall Study||9319
514568|NCT00122681|1239333|P1|STARTED|Overall Study||9325
514569|NCT00122460|1239399|P2|NOT COMPLETED|Overall Study||1
514570|NCT00122460|1239400|P1|NOT COMPLETED|Overall Study||7
514571|NCT00122460|1239399|P2|COMPLETED|Overall Study||219
514572|NCT00122460|1239400|P1|COMPLETED|Overall Study||215
514573|NCT00122460|1239399|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
514574|NCT00122460|1239400|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
514575|NCT00122447|1239426|P4|NOT COMPLETED|Overall Study||3
514576|NCT00122447|1239427|P3|NOT COMPLETED|Overall Study||1
514577|NCT00122447|1239428|P2|NOT COMPLETED|Overall Study||5
514578|NCT00122447|1239429|P1|NOT COMPLETED|Overall Study||1
514579|NCT00122447|1239426|P4|COMPLETED|Overall Study||14
514580|NCT00122447|1239427|P3|COMPLETED|Overall Study||16
514581|NCT00122447|1239428|P2|COMPLETED|Overall Study||13
514582|NCT00122447|1239429|P1|COMPLETED|Overall Study||17
514583|NCT00122447|1239426|P4|STARTED|Overall Study||17
514584|NCT00122447|1239427|P3|STARTED|Overall Study||17
514585|NCT00122447|1239428|P2|STARTED|Overall Study||18
514586|NCT00122447|1239429|P1|STARTED|Overall Study||18
514587|NCT00122382|1239449|P3|NOT COMPLETED|Open-Label Study||26
514588|NCT00122382|1239450|P2|NOT COMPLETED|Open-Label Study||0
514589|NCT00122382|1239451|P1|NOT COMPLETED|Open-Label Study||0
514590|NCT00122382|1239449|P3|COMPLETED|Open-Label Study||433
514591|NCT00122382|1239450|P2|COMPLETED|Open-Label Study||0
514592|NCT00122382|1239451|P1|COMPLETED|Open-Label Study||0
514593|NCT00122382|1239449|P3|STARTED|Open-Label Study||459
514594|NCT00122382|1239450|P2|STARTED|Open-Label Study||0
514595|NCT00122382|1239451|P1|STARTED|Open-Label Study||0
514596|NCT00122382|1239449|P3|NOT COMPLETED|Double-Blind Study||0
514597|NCT00122382|1239450|P2|NOT COMPLETED|Double-Blind Study||28
514598|NCT00122382|1239451|P1|NOT COMPLETED|Double-Blind Study||24
514599|NCT00122382|1239449|P3|COMPLETED|Double-Blind Study||0
514600|NCT00122382|1239450|P2|COMPLETED|Double-Blind Study||227
514601|NCT00122382|1239451|P1|COMPLETED|Double-Blind Study||232
514602|NCT00122382|1239449|P3|Treated|Double-Blind Study||0
514603|NCT00122382|1239450|P2|Treated|Double-Blind Study||253
514604|NCT00122382|1239451|P1|Treated|Double-Blind Study||256
514605|NCT00122382|1239449|P3|STARTED|Double-Blind Study||0
514606|NCT00122382|1239450|P2|STARTED|Double-Blind Study|participants randomized|255
514607|NCT00122382|1239451|P1|STARTED|Double-Blind Study|participants randomized|256
514608|NCT00122369|1239504|P3|NOT COMPLETED|Overall Study||0
514609|NCT00122369|1239505|P2|NOT COMPLETED|Overall Study||0
514610|NCT00122369|1239506|P1|NOT COMPLETED|Overall Study||0
514611|NCT00122369|1239504|P3|COMPLETED|Overall Study||78
514612|NCT00122369|1239505|P2|COMPLETED|Overall Study||82
514613|NCT00122369|1239506|P1|COMPLETED|Overall Study||76
514614|NCT00122369|1239504|P3|STARTED|Overall Study||78
514615|NCT00122369|1239505|P2|STARTED|Overall Study||82
514616|NCT00122369|1239506|P1|STARTED|Overall Study||76
514617|NCT00122317|1239595|P1|NOT COMPLETED|Overall Study||11
514618|NCT00122317|1239595|P1|COMPLETED|Overall Study||176
514619|NCT00122317|1239595|P1|STARTED|Overall Study||187
514620|NCT00122187|1239601|P2|NOT COMPLETED|Overall Study||2
514621|NCT00122187|1239602|P1|NOT COMPLETED|Overall Study||2
514622|NCT00122187|1239601|P2|COMPLETED|Overall Study||2
514623|NCT00122187|1239602|P1|COMPLETED|Overall Study||2
514624|NCT00122187|1239601|P2|Post-intervention Data Collection|Overall Study||2
514625|NCT00122187|1239602|P1|Post-intervention Data Collection|Overall Study||2
514626|NCT00122187|1239601|P2|Intervention Implemented|Overall Study||4
514627|NCT00122187|1239602|P1|Intervention Implemented|Overall Study||3
514628|NCT00122187|1239601|P2|Randomized to Intervention or Usual Care|Overall Study||4
514629|NCT00122187|1239602|P1|Randomized to Intervention or Usual Care|Overall Study||4
514630|NCT00122187|1239601|P2|Matched by Colonoscopy Volume|Overall Study||4
514631|NCT00122187|1239602|P1|Matched by Colonoscopy Volume|Overall Study||4
514632|NCT00122187|1239601|P2|STARTED|Overall Study||4
514633|NCT00122187|1239602|P1|STARTED|Overall Study||4
514634|NCT00122135|1239616|P2|NOT COMPLETED|Overall Study||0
514635|NCT00122135|1239617|P1|NOT COMPLETED|Overall Study||3
514636|NCT00122135|1239616|P2|COMPLETED|Overall Study||60
514637|NCT00122135|1239617|P1|COMPLETED|Overall Study||57
514638|NCT00122135|1239616|P2|STARTED|Overall Study||60
514639|NCT00122135|1239617|P1|STARTED|Overall Study||60
514640|NCT00122109|1239625|P2|NOT COMPLETED|Overall Study||7
514641|NCT00122109|1239626|P1|NOT COMPLETED|Overall Study||6
514642|NCT00122109|1239625|P2|COMPLETED|Overall Study||57
514643|NCT00122109|1239626|P1|COMPLETED|Overall Study||55
514644|NCT00122109|1239625|P2|STARTED|Overall Study|ITT|64
514645|NCT00122109|1239626|P1|STARTED|Overall Study|ITT|61
514646|NCT00121836|1239650|P1|NOT COMPLETED|Overall Study||55
514647|NCT00121836|1239650|P1|COMPLETED|Overall Study||54
514648|NCT00121836|1239650|P1|STARTED|Overall Study||109
514649|NCT00121810|1239661|P2|NOT COMPLETED|Overall Study||39
514650|NCT00121810|1239662|P1|NOT COMPLETED|Overall Study||30
514651|NCT00121810|1239661|P2|COMPLETED|Overall Study||115
514652|NCT00121810|1239662|P1|COMPLETED|Overall Study||121
514653|NCT00121810|1239661|P2|Intent-to-Treat (ITT) Population|Overall Study||151
514654|NCT00121810|1239662|P1|Intent-to-Treat (ITT) Population|Overall Study||148
514655|NCT00121810|1239661|P2|Safety Population|Overall Study||153
514656|NCT00121810|1239662|P1|Safety Population|Overall Study||148
514657|NCT00121810|1239661|P2|STARTED|Overall Study||154
514658|NCT00121810|1239662|P1|STARTED|Overall Study||151
514659|NCT00121719|1239690|P14|NOT COMPLETED|Overall Study||7
514660|NCT00121719|1239691|P13|NOT COMPLETED|Overall Study||24
514661|NCT00121719|1239692|P12|NOT COMPLETED|Overall Study||5
514662|NCT00121719|1239693|P11|NOT COMPLETED|Overall Study||6
514663|NCT00121719|1239694|P10|NOT COMPLETED|Overall Study||3
514664|NCT00121719|1239695|P9|NOT COMPLETED|Overall Study||6
514665|NCT00121719|1239696|P8|NOT COMPLETED|Overall Study||9
514666|NCT00121719|1239697|P7|NOT COMPLETED|Overall Study||12
514667|NCT00121719|1239698|P6|NOT COMPLETED|Overall Study||3
514668|NCT00121719|1239699|P5|NOT COMPLETED|Overall Study||3
514669|NCT00121719|1239700|P4|NOT COMPLETED|Overall Study||3
514670|NCT00121719|1239701|P3|NOT COMPLETED|Overall Study||4
514671|NCT00121719|1239702|P2|NOT COMPLETED|Overall Study||4
514672|NCT00121719|1239703|P1|NOT COMPLETED|Overall Study||4
514673|NCT00121719|1239690|P14|COMPLETED|Overall Study||0
514674|NCT00121719|1239691|P13|COMPLETED|Overall Study||0
514675|NCT00121719|1239692|P12|COMPLETED|Overall Study||0
514676|NCT00121719|1239693|P11|COMPLETED|Overall Study||0
514677|NCT00121719|1239694|P10|COMPLETED|Overall Study||0
514678|NCT00121719|1239695|P9|COMPLETED|Overall Study||0
514679|NCT00121719|1239696|P8|COMPLETED|Overall Study||0
514680|NCT00121719|1239697|P7|COMPLETED|Overall Study||0
514681|NCT00121719|1239698|P6|COMPLETED|Overall Study||0
514682|NCT00121719|1239699|P5|COMPLETED|Overall Study||0
514683|NCT00121719|1239700|P4|COMPLETED|Overall Study||0
514684|NCT00121719|1239701|P3|COMPLETED|Overall Study||0
514685|NCT00121719|1239702|P2|COMPLETED|Overall Study||0
514686|NCT00121719|1239703|P1|COMPLETED|Overall Study||0
514687|NCT00121719|1239690|P14|STARTED|Overall Study||7
514688|NCT00121719|1239691|P13|STARTED|Overall Study||24
514689|NCT00121719|1239692|P12|STARTED|Overall Study||5
514690|NCT00121719|1239693|P11|STARTED|Overall Study||6
514691|NCT00121719|1239694|P10|STARTED|Overall Study||3
514692|NCT00121719|1239695|P9|STARTED|Overall Study||6
514693|NCT00121719|1239696|P8|STARTED|Overall Study||9
514694|NCT00121719|1239697|P7|STARTED|Overall Study||12
514695|NCT00121719|1239698|P6|STARTED|Overall Study||3
514696|NCT00121719|1239699|P5|STARTED|Overall Study||3
514697|NCT00121719|1239700|P4|STARTED|Overall Study||3
514698|NCT00121719|1239701|P3|STARTED|Overall Study||4
514699|NCT00121719|1239702|P2|STARTED|Overall Study||4
514700|NCT00121719|1239703|P1|STARTED|Overall Study||4
514701|NCT00121667|1239880|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
514702|NCT00121667|1239881|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
514703|NCT00121667|1239882|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
514704|NCT00121667|1239883|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
514705|NCT00121667|1239880|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
514706|NCT00121667|1239881|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
514707|NCT00121667|1239882|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
514708|NCT00121667|1239883|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
514709|NCT00121667|1239880|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
514710|NCT00121667|1239881|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
514711|NCT00121667|1239882|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
514712|NCT00121667|1239883|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
514713|NCT00121667|1239880|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
514714|NCT00121667|1239881|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
514715|NCT00121667|1239882|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
514716|NCT00121667|1239883|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
514717|NCT00121667|1239880|P4|NOT COMPLETED|Short Term (ST) Period||67
514718|NCT00121667|1239881|P3|NOT COMPLETED|Short Term (ST) Period||41
514719|NCT00121667|1239882|P2|NOT COMPLETED|Short Term (ST) Period||48
514720|NCT00121667|1239883|P1|NOT COMPLETED|Short Term (ST) Period||44
514721|NCT00121667|1239880|P4|COMPLETED|Short Term (ST) Period||112
514722|NCT00121667|1239881|P3|COMPLETED|Short Term (ST) Period||140
514723|NCT00121667|1239882|P2|COMPLETED|Short Term (ST) Period||143
514724|NCT00121667|1239883|P1|COMPLETED|Short Term (ST) Period||148
514725|NCT00121667|1239880|P4|STARTED|Short Term (ST) Period||179
514726|NCT00121667|1239881|P3|STARTED|Short Term (ST) Period||181
514727|NCT00121667|1239882|P2|STARTED|Short Term (ST) Period||191
514728|NCT00121667|1239883|P1|STARTED|Short Term (ST) Period||192
514729|NCT00121641|1239981|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
514730|NCT00121641|1239982|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
514731|NCT00121641|1239983|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
514732|NCT00121641|1239984|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
514733|NCT00121641|1239985|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
514734|NCT00121641|1239981|P5|COMPLETED|48-month Short Term + Long Term Period||8
514735|NCT00121641|1239982|P4|COMPLETED|48-month Short Term + Long Term Period||24
514736|NCT00121641|1239983|P3|COMPLETED|48-month Short Term + Long Term Period||28
514737|NCT00121641|1239984|P2|COMPLETED|48-month Short Term + Long Term Period||24
514738|NCT00121641|1239985|P1|COMPLETED|48-month Short Term + Long Term Period||23
514739|NCT00121641|1239981|P5|STARTED|48-month Short Term + Long Term Period||66
514740|NCT00121641|1239982|P4|STARTED|48-month Short Term + Long Term Period||95
514741|NCT00121641|1239983|P3|STARTED|48-month Short Term + Long Term Period||98
514742|NCT00121641|1239984|P2|STARTED|48-month Short Term + Long Term Period||106
514743|NCT00121641|1239985|P1|STARTED|48-month Short Term + Long Term Period||102
514744|NCT00121641|1239981|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
514745|NCT00121641|1239982|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
514746|NCT00121641|1239983|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
514747|NCT00121641|1239984|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
514748|NCT00121641|1239985|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
514749|NCT00121641|1239981|P5|COMPLETED|24-week Short-term Treatment Period||25
514750|NCT00121641|1239982|P4|COMPLETED|24-week Short-term Treatment Period||55
514751|NCT00121641|1239983|P3|COMPLETED|24-week Short-term Treatment Period||69
514752|NCT00121641|1239984|P2|COMPLETED|24-week Short-term Treatment Period||68
514753|NCT00121641|1239985|P1|COMPLETED|24-week Short-term Treatment Period||73
514754|NCT00121641|1239981|P5|STARTED|24-week Short-term Treatment Period||66
514755|NCT00121641|1239982|P4|STARTED|24-week Short-term Treatment Period||95
514756|NCT00121641|1239983|P3|STARTED|24-week Short-term Treatment Period||98
514757|NCT00121641|1239984|P2|STARTED|24-week Short-term Treatment Period||106
514758|NCT00121641|1239985|P1|STARTED|24-week Short-term Treatment Period||102
514759|NCT00121485|1240098|P2|NOT COMPLETED|Overall Study||7
514760|NCT00121485|1240099|P1|NOT COMPLETED|Overall Study||1
514761|NCT00121485|1240098|P2|COMPLETED|Overall Study||59
514762|NCT00121485|1240099|P1|COMPLETED|Overall Study||133
514763|NCT00121485|1240098|P2|STARTED|Overall Study||66
514764|NCT00121485|1240099|P1|STARTED|Overall Study||134
514765|NCT00121472|1240133|P1|NOT COMPLETED|Overall Study||0
514766|NCT00121472|1240133|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
514767|NCT00121472|1240133|P1|STARTED|Overall Study||194
514768|NCT00121238|1240144|P1|NOT COMPLETED|Overall Study||3
514769|NCT00121238|1240144|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
514770|NCT00121238|1240144|P1|STARTED|Overall Study||16
514771|NCT00121225|1240152|P1|NOT COMPLETED|Overall Study||0
514772|NCT00121225|1240152|P1|COMPLETED|Overall Study||32
514773|NCT00121225|1240152|P1|STARTED|Overall Study||32
514774|NCT00121199|1240156|P1|NOT COMPLETED|Overall Study||28
514775|NCT00121199|1240156|P1|COMPLETED|Overall Study||45
514776|NCT00121199|1240156|P1|Eligible and Began Protocol Therapy|Overall Study||64
514777|NCT00121199|1240156|P1|Eligible|Overall Study||64
514778|NCT00121199|1240156|P1|STARTED|Overall Study||73
514779|NCT00121186|1240163|P1|NOT COMPLETED|Overall Study||0
514780|NCT00121186|1240163|P1|COMPLETED|Overall Study||1
514781|NCT00121186|1240163|P1|STARTED|Overall Study||1
514782|NCT00121134|1240172|P4|NOT COMPLETED|Overall Study||9
514783|NCT00121134|1240173|P3|NOT COMPLETED|Overall Study||21
514784|NCT00121134|1240174|P2|NOT COMPLETED|Overall Study||15
514785|NCT00121134|1240175|P1|NOT COMPLETED|Overall Study||16
514786|NCT00121134|1240172|P4|COMPLETED|Overall Study||31
514787|NCT00121134|1240173|P3|COMPLETED|Overall Study||20
514788|NCT00121134|1240174|P2|COMPLETED|Overall Study||26
514789|NCT00121134|1240175|P1|COMPLETED|Overall Study||24
514790|NCT00121134|1240172|P4|STARTED|Overall Study||40
514791|NCT00121134|1240173|P3|STARTED|Overall Study||41
514792|NCT00121134|1240174|P2|STARTED|Overall Study||41
514793|NCT00121134|1240175|P1|STARTED|Overall Study||40
514794|NCT00120874|1240187|P2|NOT COMPLETED|Overall Study||1
514795|NCT00120874|1240188|P1|NOT COMPLETED|Overall Study||0
514796|NCT00120874|1240187|P2|COMPLETED|Overall Study||9
514797|NCT00120874|1240188|P1|COMPLETED|Overall Study||10
514798|NCT00120874|1240187|P2|Completed Study; Started Extension Study|Overall Study||10
514799|NCT00120874|1240188|P1|Completed Study; Started Extension Study|Overall Study||10
514800|NCT00120874|1240187|P2|STARTED|Overall Study||10
514801|NCT00120874|1240188|P1|STARTED|Overall Study||10
514802|NCT00120627|1240226|P2|NOT COMPLETED|Overall Study||5
514803|NCT00120627|1240227|P1|NOT COMPLETED|Overall Study||5
514804|NCT00120627|1240226|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
514805|NCT00120627|1240227|P1|COMPLETED|Overall Study||66
514806|NCT00120627|1240226|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
514807|NCT00120627|1240227|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
514808|NCT00120627|1240226|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
514809|NCT00120627|1240227|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
514810|NCT00120627|1240226|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
514811|NCT00120627|1240227|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
514812|NCT00120523|1240253|P2|NOT COMPLETED|Follow-Up Period||24
514813|NCT00120523|1240254|P1|NOT COMPLETED|Follow-Up Period||30
514814|NCT00120523|1240253|P2|COMPLETED|Follow-Up Period||46
514815|NCT00120523|1240254|P1|COMPLETED|Follow-Up Period||90
514816|NCT00120523|1240253|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
514817|NCT00120523|1240254|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
514818|NCT00120523|1240253|P2|NOT COMPLETED|Treatment Period||339
514819|NCT00120523|1240254|P1|NOT COMPLETED|Treatment Period||369
514820|NCT00120523|1240253|P2|COMPLETED|Treatment Period||874
514821|NCT00120523|1240254|P1|COMPLETED|Treatment Period||836
514822|NCT00120523|1240253|P2|STARTED|Treatment Period||1213
514823|NCT00120523|1240254|P1|STARTED|Treatment Period||1205
514824|NCT00120406|1240278|P2|NOT COMPLETED|Overall Study||16
514825|NCT00120406|1240279|P1|NOT COMPLETED|Overall Study||19
514826|NCT00120406|1240278|P2|COMPLETED|Overall Study||222
514827|NCT00120406|1240279|P1|COMPLETED|Overall Study||217
514828|NCT00120406|1240278|P2|STARTED|Overall Study||238
514829|NCT00120406|1240279|P1|STARTED|Overall Study||236
514830|NCT00120289|1240289|P2|NOT COMPLETED|Overall Study||109
514831|NCT00120289|1240290|P1|NOT COMPLETED|Overall Study||121
514832|NCT00120289|1240289|P2|COMPLETED|Overall Study||1587
514833|NCT00120289|1240290|P1|COMPLETED|Overall Study||1597
514834|NCT00120289|1240289|P2|STARTED|Overall Study||1696
514835|NCT00120289|1240290|P1|STARTED|Overall Study||1718
514836|NCT00120250|1240302|P2|NOT COMPLETED|Overall Study||2
514837|NCT00120250|1240303|P1|NOT COMPLETED|Overall Study||1
514838|NCT00120250|1240302|P2|COMPLETED|Overall Study||12
514839|NCT00120250|1240303|P1|COMPLETED|Overall Study||12
514840|NCT00120250|1240302|P2|STARTED|Overall Study||14
514841|NCT00120250|1240303|P1|STARTED|Overall Study||13
514842|NCT00120042|1240319|P3|NOT COMPLETED|Overall Study||0
514843|NCT00120042|1240320|P2|NOT COMPLETED|Overall Study||0
514844|NCT00120042|1240321|P1|NOT COMPLETED|Overall Study||0
514845|NCT00120042|1240319|P3|COMPLETED|Overall Study||83
514846|NCT00120042|1240320|P2|COMPLETED|Overall Study||83
514847|NCT00120042|1240321|P1|COMPLETED|Overall Study||85
514848|NCT00120042|1240319|P3|STARTED|Overall Study||83
514849|NCT00120042|1240320|P2|STARTED|Overall Study||83
514850|NCT00120042|1240321|P1|STARTED|Overall Study||85
514851|NCT00119678|1240331|P2|NOT COMPLETED|Open-label Treatment Period||0
514852|NCT00119678|1240332|P1|NOT COMPLETED|Open-label Treatment Period||110
514853|NCT00119678|1240331|P2|COMPLETED|Open-label Treatment Period||0
514854|NCT00119678|1240332|P1|COMPLETED|Open-label Treatment Period||0
514855|NCT00119678|1240331|P2|STARTED|Open-label Treatment Period||0
514856|NCT00119678|1240332|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
514857|NCT00119678|1240331|P2|NOT COMPLETED|Double-blind Treatment Period||26
514858|NCT00119678|1240332|P1|NOT COMPLETED|Double-blind Treatment Period||41
514859|NCT00119678|1240331|P2|COMPLETED|Double-blind Treatment Period||35
514860|NCT00119678|1240332|P1|COMPLETED|Double-blind Treatment Period||81
514861|NCT00119678|1240331|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
514862|NCT00119678|1240332|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
514863|NCT00119678|1240331|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
514864|NCT00119678|1240332|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
514865|NCT00119678|1240331|P2|STARTED|Double-blind Treatment Period||61
514866|NCT00119678|1240332|P1|STARTED|Double-blind Treatment Period||122
514867|NCT00119405|1240378|P1|NOT COMPLETED|Overall Study||1
514868|NCT00119405|1240378|P1|COMPLETED|Overall Study||17
514869|NCT00119405|1240378|P1|STARTED|Overall Study||18
514870|NCT00119392|1240382|P1|NOT COMPLETED|Overall Study||5
514871|NCT00119392|1240382|P1|COMPLETED|Overall Study||40
514872|NCT00119392|1240382|P1|STARTED|Overall Study||45
514873|NCT00119379|1240392|P2|NOT COMPLETED|Overall Study||1
514874|NCT00119379|1240393|P1|NOT COMPLETED|Overall Study||4
514875|NCT00119379|1240392|P2|COMPLETED|Overall Study||23
514876|NCT00119379|1240393|P1|COMPLETED|Overall Study||22
514877|NCT00119379|1240392|P2|STARTED|Overall Study||24
514878|NCT00119379|1240393|P1|STARTED|Overall Study||26
514879|NCT00119262|1240411|P2|NOT COMPLETED|Overall Study||58
514880|NCT00119262|1240412|P1|NOT COMPLETED|Overall Study||46
514881|NCT00119262|1240411|P2|COMPLETED|Overall Study||64
514882|NCT00119262|1240412|P1|COMPLETED|Overall Study||58
514883|NCT00119262|1240411|P2|Eligible and Treated|Overall Study||119
514884|NCT00119262|1240412|P1|Eligible and Treated|Overall Study||102
514885|NCT00119262|1240411|P2|Treated|Overall Study||120
514886|NCT00119262|1240412|P1|Treated|Overall Study||103
514887|NCT00119262|1240411|P2|Eligible|Overall Study||120
514888|NCT00119262|1240412|P1|Eligible|Overall Study||103
514889|NCT00119262|1240411|P2|STARTED|Overall Study||122
514890|NCT00119262|1240412|P1|STARTED|Overall Study||104
514891|NCT00119158|1240424|P2|NOT COMPLETED|Placebo Treatment||0
514892|NCT00119158|1240425|P1|NOT COMPLETED|Placebo Treatment||0
514893|NCT00119158|1240424|P2|COMPLETED|Placebo Treatment||45
514894|NCT00119158|1240425|P1|COMPLETED|Placebo Treatment||45
514895|NCT00119158|1240424|P2|STARTED|Placebo Treatment||45
514896|NCT00119158|1240425|P1|STARTED|Placebo Treatment||45
514897|NCT00119158|1240424|P2|NOT COMPLETED|Active Treatment||0
514898|NCT00119158|1240425|P1|NOT COMPLETED|Active Treatment||0
514899|NCT00119158|1240424|P2|COMPLETED|Active Treatment||45
514900|NCT00119158|1240425|P1|COMPLETED|Active Treatment||45
514901|NCT00119158|1240424|P2|STARTED|Active Treatment||45
514902|NCT00119158|1240425|P1|STARTED|Active Treatment|patients are self controls|45
514903|NCT00119041|1240436|P3|NOT COMPLETED|Overall Study||0
514904|NCT00119041|1240437|P2|NOT COMPLETED|Overall Study||0
514905|NCT00119041|1240438|P1|NOT COMPLETED|Overall Study||0
514906|NCT00119041|1240436|P3|COMPLETED|Overall Study||22
514907|NCT00119041|1240437|P2|COMPLETED|Overall Study||83
514908|NCT00119041|1240438|P1|COMPLETED|Overall Study||199
514909|NCT00119041|1240436|P3|STARTED|Overall Study||22
514910|NCT00119041|1240437|P2|STARTED|Overall Study||83
514911|NCT00119041|1240438|P1|STARTED|Overall Study||199
514912|NCT00119015|1240449|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
514913|NCT00119015|1240450|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
514914|NCT00119015|1240451|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
514915|NCT00119015|1240449|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
514916|NCT00119015|1240450|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
514917|NCT00119015|1240451|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
514918|NCT00119015|1240449|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
514919|NCT00119015|1240450|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
514920|NCT00119015|1240451|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
514921|NCT00119015|1240449|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
514922|NCT00119015|1240450|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
514923|NCT00119015|1240451|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
514924|NCT00119015|1240449|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
514925|NCT00119015|1240450|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
514926|NCT00119015|1240451|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
514927|NCT00119015|1240449|P3|STARTED|Open-Label Phase (2 Weeks)||0
514928|NCT00119015|1240450|P2|STARTED|Open-Label Phase (2 Weeks)||0
514929|NCT00119015|1240451|P1|STARTED|Open-Label Phase (2 Weeks)||102
514930|NCT00118911|1240467|P2|NOT COMPLETED|Overall Study||5
514931|NCT00118911|1240468|P1|NOT COMPLETED|Overall Study||2
514932|NCT00118911|1240467|P2|COMPLETED|Overall Study||38
514933|NCT00118911|1240468|P1|COMPLETED|Overall Study||41
514934|NCT00118911|1240467|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
514935|NCT00118911|1240468|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
514936|NCT00118911|1240467|P2|6 Month Follow-up|Overall Study||30
514937|NCT00118911|1240468|P1|6 Month Follow-up|Overall Study||37
514938|NCT00118911|1240467|P2|Completed Post-Treatment Assessment|Overall Study||37
514939|NCT00118911|1240468|P1|Completed Post-Treatment Assessment|Overall Study||41
514940|NCT00118911|1240467|P2|Received Intervention as Assigned|Overall Study||38
514941|NCT00118911|1240468|P1|Received Intervention as Assigned|Overall Study||41
514942|NCT00118911|1240467|P2|STARTED|Overall Study||43
514943|NCT00118911|1240468|P1|STARTED|Overall Study||43
514944|NCT00118898|1240480|P4|NOT COMPLETED|Overall Study||141
514945|NCT00118898|1240481|P3|NOT COMPLETED|Overall Study||123
514946|NCT00118898|1240482|P2|NOT COMPLETED|Overall Study||141
514947|NCT00118898|1240483|P1|NOT COMPLETED|Overall Study||121
514948|NCT00118898|1240480|P4|COMPLETED|Overall Study||322
514949|NCT00118898|1240481|P3|COMPLETED|Overall Study||342
514950|NCT00118898|1240482|P2|COMPLETED|Overall Study||324
514951|NCT00118898|1240483|P1|COMPLETED|Overall Study||343
514952|NCT00118898|1240480|P4|Initiated Treatment|Overall Study||462
514953|NCT00118898|1240481|P3|Initiated Treatment|Overall Study||464
514954|NCT00118898|1240482|P2|Initiated Treatment|Overall Study||461
514955|NCT00118898|1240483|P1|Initiated Treatment|Overall Study||461
514956|NCT00118898|1240480|P4|STARTED|Overall Study||463
514957|NCT00118898|1240481|P3|STARTED|Overall Study||465
514958|NCT00118898|1240482|P2|STARTED|Overall Study||465
514959|NCT00118898|1240483|P1|STARTED|Overall Study||464
514960|NCT00118755|1240579|P2|NOT COMPLETED|Overall Study||215
514961|NCT00118755|1240580|P1|NOT COMPLETED|Overall Study||210
514962|NCT00118755|1240579|P2|COMPLETED|Overall Study||3
514963|NCT00118755|1240580|P1|COMPLETED|Overall Study||7
514964|NCT00118755|1240579|P2|Safety Population|Overall Study||211
514965|NCT00118755|1240580|P1|Safety Population|Overall Study||208
514966|NCT00118755|1240579|P2|STARTED|Overall Study||218
514967|NCT00118755|1240580|P1|STARTED|Overall Study||217
514968|NCT00118742|1240594|P2|NOT COMPLETED|Overall Study||66
514969|NCT00118742|1240595|P1|NOT COMPLETED|Overall Study||49
514970|NCT00118742|1240594|P2|COMPLETED|Overall Study||82
514971|NCT00118742|1240595|P1|COMPLETED|Overall Study||96
514972|NCT00118742|1240594|P2|STARTED|Overall Study||148
514973|NCT00118742|1240595|P1|STARTED|Overall Study||145
514974|NCT00118703|1240609|P2|NOT COMPLETED|Overall Study||9
514975|NCT00118703|1240610|P1|NOT COMPLETED|Overall Study||5
514976|NCT00118703|1240609|P2|COMPLETED|Overall Study||165
514977|NCT00118703|1240610|P1|COMPLETED|Overall Study||168
514978|NCT00118703|1240609|P2|STARTED|Overall Study||174
514979|NCT00118703|1240610|P1|STARTED|Overall Study||173
514980|NCT00118534|1240622|P2|NOT COMPLETED|Overall Study||0
514981|NCT00118534|1240623|P1|NOT COMPLETED|Overall Study||0
514982|NCT00118534|1240622|P2|COMPLETED|Overall Study||471
514983|NCT00118534|1240623|P1|COMPLETED|Overall Study||472
514984|NCT00118534|1240622|P2|STARTED|Overall Study||471
514985|NCT00118534|1240623|P1|STARTED|Overall Study||472
514986|NCT00118430|1240708|P3|NOT COMPLETED|Overall Study||28
514987|NCT00118430|1240709|P2|NOT COMPLETED|Overall Study||24
514988|NCT00118430|1240710|P1|NOT COMPLETED|Overall Study||21
514989|NCT00118430|1240708|P3|COMPLETED|Overall Study||222
514990|NCT00118430|1240709|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
514991|NCT00118430|1240710|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
514992|NCT00118430|1240708|P3|STARTED|Overall Study||250
514993|NCT00118430|1240709|P2|STARTED|Overall Study||127
514994|NCT00118430|1240710|P1|STARTED|Overall Study||123
514995|NCT00118417|1240725|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
514996|NCT00118417|1240726|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
514997|NCT00118417|1240725|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
514998|NCT00118417|1240726|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
514999|NCT00118417|1240725|P2|STARTED|Phase III (Weeks 12 to 24)||10
515000|NCT00118417|1240726|P1|STARTED|Phase III (Weeks 12 to 24)||9
515001|NCT00118417|1240725|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
515002|NCT00118417|1240726|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
515003|NCT00118417|1240725|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
515004|NCT00118417|1240726|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
515005|NCT00118417|1240725|P2|STARTED|Phase II (Weeks 6 to 12)||13
515006|NCT00118417|1240726|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
515007|NCT00118417|1240725|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
515008|NCT00118417|1240726|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
515009|NCT00118417|1240725|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
515010|NCT00118417|1240726|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
515011|NCT00118417|1240725|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
515012|NCT00118417|1240726|P1|STARTED|Phase I (Weeks 0 to 6)||39
515013|NCT00118404|1240739|P3|NOT COMPLETED|Overall Study||20
515014|NCT00118404|1240740|P2|NOT COMPLETED|Overall Study||16
515015|NCT00118404|1240741|P1|NOT COMPLETED|Overall Study||24
515016|NCT00118404|1240739|P3|COMPLETED|Overall Study||49
515017|NCT00118404|1240740|P2|COMPLETED|Overall Study||70
515018|NCT00118404|1240741|P1|COMPLETED|Overall Study||62
515019|NCT00118404|1240739|P3|STARTED|Overall Study||69
515020|NCT00118404|1240740|P2|STARTED|Overall Study||86
515021|NCT00118404|1240741|P1|STARTED|Overall Study||86
515022|NCT00118378|1240757|P2|NOT COMPLETED|Overall Study||8
515023|NCT00118378|1240758|P1|NOT COMPLETED|Overall Study||2
515024|NCT00118378|1240757|P2|COMPLETED|Overall Study||45
515025|NCT00118378|1240758|P1|COMPLETED|Overall Study||60
515026|NCT00118378|1240757|P2|STARTED|Overall Study||53
515027|NCT00118378|1240758|P1|STARTED|Overall Study||62
515028|NCT00118365|1240772|P2|NOT COMPLETED|Overall Study||60
515029|NCT00118365|1240773|P1|NOT COMPLETED|Overall Study||59
515030|NCT00118365|1240772|P2|COMPLETED|Overall Study||124
515031|NCT00118365|1240773|P1|COMPLETED|Overall Study||132
515032|NCT00118365|1240772|P2|STARTED|Overall Study||184
515033|NCT00118365|1240773|P1|STARTED|Overall Study||191
515034|NCT00118352|1240842|P3|NOT COMPLETED|Overall Study||0
515035|NCT00118352|1240843|P2|NOT COMPLETED|Overall Study||0
515036|NCT00118352|1240844|P1|NOT COMPLETED|Overall Study||0
515037|NCT00118352|1240842|P3|COMPLETED|Overall Study||0
515038|NCT00118352|1240843|P2|COMPLETED|Overall Study||0
515039|NCT00118352|1240844|P1|COMPLETED|Overall Study||12
515040|NCT00118352|1240842|P3|STARTED|Overall Study||0
515041|NCT00118352|1240843|P2|STARTED|Overall Study||0
515042|NCT00118352|1240844|P1|STARTED|Overall Study||12
515043|NCT00118287|1240870|P1|NOT COMPLETED|Overall Study||2
515044|NCT00118287|1240870|P1|COMPLETED|Overall Study||30
515045|NCT00118287|1240870|P1|STARTED|Overall Study||32
515046|NCT00118248|1240876|P2|NOT COMPLETED|Overall Study||0
515047|NCT00118248|1240877|P1|NOT COMPLETED|Overall Study||0
515048|NCT00118248|1240876|P2|COMPLETED|Overall Study||24
515049|NCT00118248|1240877|P1|COMPLETED|Overall Study||17
515050|NCT00118248|1240876|P2|STARTED|Overall Study||24
515051|NCT00118248|1240877|P1|STARTED|Overall Study||17
515052|NCT00118157|1240890|P1|NOT COMPLETED|Overall Study||12
515053|NCT00118157|1240890|P1|COMPLETED|Overall Study||7
515054|NCT00118157|1240890|P1|STARTED|Overall Study||19
515055|NCT00118144|1240894|P1|NOT COMPLETED|Overall Study||1
515056|NCT00118144|1240894|P1|COMPLETED|Overall Study||41
515057|NCT00118144|1240894|P1|STARTED|Overall Study||42
515058|NCT00118131|1240900|P1|NOT COMPLETED|Overall Study||0
515059|NCT00118131|1240900|P1|COMPLETED|Overall Study||49
515060|NCT00118131|1240900|P1|STARTED|Overall Study||49
515061|NCT00118092|1240907|P1|NOT COMPLETED|Overall Study||2
515062|NCT00118092|1240907|P1|COMPLETED|Overall Study||15
515063|NCT00118092|1240907|P1|STARTED|Overall Study||17
515064|NCT00118053|1240915|P1|NOT COMPLETED|Overall Study||0
515065|NCT00118053|1240915|P1|COMPLETED|Overall Study||5
515066|NCT00118053|1240915|P1|STARTED|Overall Study||5
515067|NCT00118040|1240925|P3|NOT COMPLETED|Overall Study||6
515068|NCT00118040|1240926|P2|NOT COMPLETED|Overall Study||2
515069|NCT00118040|1240927|P1|NOT COMPLETED|Overall Study||1
515070|NCT00118040|1240925|P3|COMPLETED|Overall Study||14
515071|NCT00118040|1240926|P2|COMPLETED|Overall Study||18
515072|NCT00118040|1240927|P1|COMPLETED|Overall Study||19
515073|NCT00118040|1240925|P3|STARTED|Overall Study||20
515074|NCT00118040|1240926|P2|STARTED|Overall Study||20
515075|NCT00118040|1240927|P1|STARTED|Overall Study||20
515076|NCT00117988|1240988|P1|NOT COMPLETED|Overall Study||4
515077|NCT00117988|1240988|P1|COMPLETED|Overall Study||18
515078|NCT00117988|1240988|P1|STARTED|Overall Study||22
515079|NCT00117962|1240994|P2|NOT COMPLETED|Overall Study||25
515080|NCT00117962|1240995|P1|NOT COMPLETED|Overall Study||22
515081|NCT00117962|1240994|P2|COMPLETED|Overall Study||28
515082|NCT00117962|1240995|P1|COMPLETED|Overall Study||26
515083|NCT00117962|1240994|P2|STARTED|Overall Study||53
515084|NCT00117962|1240995|P1|STARTED|Overall Study||48
515085|NCT00117949|1241011|P4|NOT COMPLETED|Overall Study||24
515086|NCT00117949|1241012|P3|NOT COMPLETED|Overall Study||24
515087|NCT00117949|1241013|P2|NOT COMPLETED|Overall Study||24
515088|NCT00117949|1241014|P1|NOT COMPLETED|Overall Study||10
515089|NCT00117949|1241011|P4|COMPLETED|Overall Study||0
515090|NCT00117949|1241012|P3|COMPLETED|Overall Study||0
515091|NCT00117949|1241013|P2|COMPLETED|Overall Study||0
515092|NCT00117949|1241014|P1|COMPLETED|Overall Study||0
515093|NCT00117949|1241011|P4|STARTED|Overall Study||24
515094|NCT00117949|1241012|P3|STARTED|Overall Study||24
515095|NCT00117949|1241013|P2|STARTED|Overall Study||24
515096|NCT00117949|1241014|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
515097|NCT00117845|1241048|P1|NOT COMPLETED|Overall Study||1
515098|NCT00117845|1241048|P1|COMPLETED|Overall Study||16
515099|NCT00117845|1241048|P1|STARTED|Overall Study||17
515100|NCT00117806|1241055|P2|NOT COMPLETED|Overall Study||16
515101|NCT00117806|1241056|P1|NOT COMPLETED|Overall Study||38
515102|NCT00117806|1241055|P2|COMPLETED|Overall Study||60
515103|NCT00117806|1241056|P1|COMPLETED|Overall Study||43
515104|NCT00117806|1241055|P2|STARTED|Overall Study||76
515105|NCT00117806|1241056|P1|STARTED|Overall Study||81
515106|NCT00117793|1241066|P1|NOT COMPLETED|Overall Study||12
515107|NCT00117793|1241066|P1|COMPLETED|Overall Study||5
515108|NCT00117793|1241066|P1|STARTED|Overall Study||17
515109|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
515110|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
515111|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
515112|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
515113|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
515114|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 433 - 480||82
515115|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
515116|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
515117|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
515118|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
515119|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
515120|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
515121|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
515122|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
515123|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
515124|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
515125|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 337 - 384||93
515126|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 337 - 384||183
515127|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
515128|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
515129|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
515130|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
515131|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 289 - 336||100
515132|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 289 - 336||192
515133|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
515134|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
515135|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
515136|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
515137|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 241 - 288||103
515138|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 241 - 288||202
515139|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
515140|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
515141|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
515142|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
515143|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 193 - 240||106
515144|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 193 - 240||209
515145|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
515146|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
515147|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
515148|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
515149|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 145 - 192||109
515150|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 145 - 192||219
515151|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
515152|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
515153|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
515154|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
515155|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 97 - 144||110
515156|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 97 - 144||225
515157|NCT00117676|1241083|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
515158|NCT00117676|1241084|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
515159|NCT00117676|1241083|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
515160|NCT00117676|1241084|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
515161|NCT00117676|1241083|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
515162|NCT00117676|1241084|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
515163|NCT00117676|1241083|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
515164|NCT00117676|1241084|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
515165|NCT00117676|1241083|P2|COMPLETED|Double-blind Period Through Week 48||121
515166|NCT00117676|1241084|P1|COMPLETED|Double-blind Period Through Week 48||244
515167|NCT00117676|1241083|P2|STARTED|Double-blind Period Through Week 48||128
515168|NCT00117676|1241084|P1|STARTED|Double-blind Period Through Week 48||254
515169|NCT00117637|1241173|P2|NOT COMPLETED|Second Intervention (Period 2)||22
515170|NCT00117637|1241174|P1|NOT COMPLETED|Second Intervention (Period 2)||10
515171|NCT00117637|1241173|P2|COMPLETED|Second Intervention (Period 2)||39
515172|NCT00117637|1241174|P1|COMPLETED|Second Intervention (Period 2)||39
515173|NCT00117637|1241173|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
515174|NCT00117637|1241174|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
515175|NCT00117637|1241173|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
515176|NCT00117637|1241174|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
515177|NCT00117637|1241173|P2|NOT COMPLETED|First Intervention (Period 1)||25
515178|NCT00117637|1241174|P1|NOT COMPLETED|First Intervention (Period 1)||18
515179|NCT00117637|1241173|P2|COMPLETED|First Intervention (Period 1)||67
515180|NCT00117637|1241174|P1|COMPLETED|First Intervention (Period 1)||79
515181|NCT00117637|1241173|P2|Subjects Received Treatment|First Intervention (Period 1)||90
515182|NCT00117637|1241174|P1|Subjects Received Treatment|First Intervention (Period 1)||97
515183|NCT00117637|1241173|P2|STARTED|First Intervention (Period 1)||92
515184|NCT00117637|1241174|P1|STARTED|First Intervention (Period 1)||97
515185|NCT00117598|1241249|P5|NOT COMPLETED|After Treament Cross Over||4
515186|NCT00117598|1241250|P4|NOT COMPLETED|After Treament Cross Over||3
515187|NCT00117598|1241251|P3|NOT COMPLETED|After Treament Cross Over||0
515188|NCT00117598|1241252|P2|NOT COMPLETED|After Treament Cross Over||0
515189|NCT00117598|1241253|P1|NOT COMPLETED|After Treament Cross Over||0
515190|NCT00117598|1241249|P5|COMPLETED|After Treament Cross Over||0
515191|NCT00117598|1241250|P4|COMPLETED|After Treament Cross Over||0
515192|NCT00117598|1241251|P3|COMPLETED|After Treament Cross Over||0
515193|NCT00117598|1241252|P2|COMPLETED|After Treament Cross Over||0
515194|NCT00117598|1241253|P1|COMPLETED|After Treament Cross Over||0
515195|NCT00117598|1241249|P5|STARTED|After Treament Cross Over||4
515196|NCT00117598|1241250|P4|STARTED|After Treament Cross Over||3
515197|NCT00117598|1241251|P3|STARTED|After Treament Cross Over||0
515198|NCT00117598|1241252|P2|STARTED|After Treament Cross Over||0
515199|NCT00117598|1241253|P1|STARTED|After Treament Cross Over||0
515200|NCT00117598|1241249|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
515201|NCT00117598|1241250|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
515202|NCT00117598|1241251|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
515203|NCT00117598|1241252|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
515204|NCT00117598|1241253|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
515205|NCT00117598|1241249|P5|COMPLETED|Prior to Treatment Cross Over||0
515206|NCT00117598|1241250|P4|COMPLETED|Prior to Treatment Cross Over||0
515207|NCT00117598|1241251|P3|COMPLETED|Prior to Treatment Cross Over||4
515208|NCT00117598|1241252|P2|COMPLETED|Prior to Treatment Cross Over||3
515209|NCT00117598|1241253|P1|COMPLETED|Prior to Treatment Cross Over||0
515210|NCT00117598|1241249|P5|STARTED|Prior to Treatment Cross Over||0
515211|NCT00117598|1241250|P4|STARTED|Prior to Treatment Cross Over||0
515212|NCT00117598|1241251|P3|STARTED|Prior to Treatment Cross Over||56
515213|NCT00117598|1241252|P2|STARTED|Prior to Treatment Cross Over||56
515214|NCT00117598|1241253|P1|STARTED|Prior to Treatment Cross Over||57
515215|NCT00117585|1241281|P1|NOT COMPLETED|Overall Study||0
515216|NCT00117585|1241281|P1|COMPLETED|Overall Study||341
515217|NCT00117585|1241281|P1|STARTED|Overall Study||341
515218|NCT00117559|1241287|P2|NOT COMPLETED|Overall Study||1
515219|NCT00117559|1241288|P1|NOT COMPLETED|Overall Study||1
515220|NCT00117559|1241287|P2|COMPLETED|Overall Study||9
515221|NCT00117559|1241288|P1|COMPLETED|Overall Study||8
515222|NCT00117559|1241287|P2|STARTED|Overall Study||10
515223|NCT00117559|1241288|P1|STARTED|Overall Study||9
515224|NCT00117338|1241296|P2|NOT COMPLETED|Overall Study||4
515225|NCT00117338|1241297|P1|NOT COMPLETED|Overall Study||5
515226|NCT00117338|1241296|P2|COMPLETED|Overall Study||127
515227|NCT00117338|1241297|P1|COMPLETED|Overall Study||140
515228|NCT00117338|1241296|P2|STARTED|Overall Study||131
515229|NCT00117338|1241297|P1|STARTED|Overall Study||145
515230|NCT00117312|1241319|P4|NOT COMPLETED|Overall Study||21
515231|NCT00117312|1241320|P3|NOT COMPLETED|Overall Study||24
515232|NCT00117312|1241321|P2|NOT COMPLETED|Overall Study||20
515233|NCT00117312|1241322|P1|NOT COMPLETED|Overall Study||10
515234|NCT00117312|1241319|P4|COMPLETED|Overall Study||3
515235|NCT00117312|1241320|P3|COMPLETED|Overall Study||0
515236|NCT00117312|1241321|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
515237|NCT00117312|1241322|P1|COMPLETED|Overall Study||0
515238|NCT00117312|1241319|P4|Started FE200486 CS06A|Overall Study||9
515239|NCT00117312|1241320|P3|Started FE200486 CS06A|Overall Study||16
515240|NCT00117312|1241321|P2|Started FE200486 CS06A|Overall Study||11
515241|NCT00117312|1241322|P1|Started FE200486 CS06A|Overall Study||1
515242|NCT00117312|1241319|P4|STARTED|Overall Study||24
515243|NCT00117312|1241320|P3|STARTED|Overall Study||24
515244|NCT00117312|1241321|P2|STARTED|Overall Study||24
515245|NCT00117312|1241322|P1|STARTED|Overall Study||10
515246|NCT00117286|1241338|P2|NOT COMPLETED|Overall Study||21
515247|NCT00117286|1241339|P1|NOT COMPLETED|Overall Study||28
515248|NCT00117286|1241338|P2|COMPLETED|Overall Study||6
515249|NCT00117286|1241339|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
515250|NCT00117286|1241338|P2|Switched to Higher Dose|Overall Study||17
515251|NCT00117286|1241339|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
515252|NCT00117286|1241338|P2|STARTED|Overall Study||27
515253|NCT00117286|1241339|P1|STARTED|Overall Study|Safety analysis set|30
515254|NCT00117156|1241347|P1|NOT COMPLETED|Overall Study||11
515255|NCT00117156|1241347|P1|COMPLETED|Overall Study||15
515256|NCT00117156|1241347|P1|STARTED|Overall Study||26
515257|NCT00116857|1241357|P2|NOT COMPLETED|Overall Study||4
515258|NCT00116857|1241358|P1|NOT COMPLETED|Overall Study||3
515259|NCT00116857|1241357|P2|COMPLETED|Overall Study||56
515260|NCT00116857|1241358|P1|COMPLETED|Overall Study||59
515261|NCT00116857|1241357|P2|STARTED|Overall Study||60
515262|NCT00116857|1241358|P1|STARTED|Overall Study||62
515263|NCT00116831|1241366|P2|NOT COMPLETED|Overall Study||72
515264|NCT00116831|1241367|P1|NOT COMPLETED|Overall Study||73
515265|NCT00116831|1241366|P2|COMPLETED|Overall Study||259
515266|NCT00116831|1241367|P1|COMPLETED|Overall Study||264
515267|NCT00116831|1241366|P2|STARTED|Overall Study||331
515268|NCT00116831|1241367|P1|STARTED|Overall Study||337
515269|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
515270|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
515271|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
515272|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
515273|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
515274|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 433 - 480||57
515275|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
515276|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
515277|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
515278|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
515279|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
515280|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
515281|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
515282|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
515283|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
515284|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
515285|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 337 - 384||57
515286|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 337 - 384||98
515287|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
515288|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
515289|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
515290|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
515291|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 289 - 336||64
515292|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 289 - 336||104
515293|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
515294|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
515295|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
515296|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
515297|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 241 - 288||64
515298|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 241 - 288||110
515299|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
515300|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
515301|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
515302|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
515303|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 193 - 240||68
515304|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 193 - 240||123
515305|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
515306|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
515307|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
515308|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
515309|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 145 - 192||74
515310|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 145 - 192||133
515311|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
515312|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
515313|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
515314|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
515315|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 97 - 144||83
515316|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 97 - 144||144
515317|NCT00116805|1241445|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
515318|NCT00116805|1241446|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
515319|NCT00116805|1241445|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
515320|NCT00116805|1241446|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
515321|NCT00116805|1241445|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
515322|NCT00116805|1241446|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
515323|NCT00116805|1241445|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
515324|NCT00116805|1241446|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
515325|NCT00116805|1241445|P2|COMPLETED|Double-blind Period Through Week 48||85
515326|NCT00116805|1241446|P1|COMPLETED|Double-blind Period Through Week 48||165
515327|NCT00116805|1241445|P2|STARTED|Double-blind Period Through Week 48||90
515328|NCT00116805|1241446|P1|STARTED|Double-blind Period Through Week 48||176
515329|NCT00116779|1241539|P2|NOT COMPLETED|Overall Study||19
515330|NCT00116779|1241540|P1|NOT COMPLETED|Overall Study||21
515331|NCT00116779|1241539|P2|COMPLETED|Overall Study||45
515332|NCT00116779|1241540|P1|COMPLETED|Overall Study||42
515333|NCT00116779|1241539|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
515334|NCT00116779|1241540|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
515335|NCT00116753|1241573|P3|NOT COMPLETED|Overall Study||24
515336|NCT00116753|1241574|P2|NOT COMPLETED|Overall Study||30
515337|NCT00116753|1241575|P1|NOT COMPLETED|Overall Study||32
515338|NCT00116753|1241573|P3|COMPLETED|Overall Study||128
515339|NCT00116753|1241574|P2|COMPLETED|Overall Study||125
515340|NCT00116753|1241575|P1|COMPLETED|Overall Study||121
515341|NCT00116753|1241573|P3|ITT Population|Overall Study||147
515342|NCT00116753|1241574|P2|ITT Population|Overall Study||150
515343|NCT00116753|1241575|P1|ITT Population|Overall Study||150
515344|NCT00116753|1241573|P3|STARTED|Overall Study||152
515345|NCT00116753|1241574|P2|STARTED|Overall Study||155
515346|NCT00116753|1241575|P1|STARTED|Overall Study|Randomised.|153
515347|NCT00116688|1241597|P2|NOT COMPLETED|Overall Study||4
515348|NCT00116688|1241598|P1|NOT COMPLETED|Overall Study||92
515349|NCT00116688|1241597|P2|COMPLETED|Overall Study||17
515350|NCT00116688|1241598|P1|COMPLETED|Overall Study||200
515351|NCT00116688|1241597|P2|Received Study Medication|Overall Study||20
515352|NCT00116688|1241598|P1|Received Study Medication|Overall Study||291
515353|NCT00116688|1241597|P2|STARTED|Overall Study||21
515354|NCT00116688|1241598|P1|STARTED|Overall Study||292
515355|NCT00116649|1241613|P1|NOT COMPLETED|Overall Study||155
515356|NCT00116649|1241613|P1|COMPLETED|Overall Study||396
515357|NCT00116649|1241613|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
515358|NCT00116428|1241620|P2|NOT COMPLETED|Overall Study||5
515359|NCT00116428|1241621|P1|NOT COMPLETED|Overall Study||3
515360|NCT00116428|1241620|P2|COMPLETED|Overall Study||56
515361|NCT00116428|1241621|P1|COMPLETED|Overall Study||103
515362|NCT00116428|1241620|P2|STARTED|Overall Study||61
515363|NCT00116428|1241621|P1|STARTED|Overall Study||106
515364|NCT00116272|1241639|P2|NOT COMPLETED|Overall Study||6
515365|NCT00116272|1241640|P1|NOT COMPLETED|Overall Study||11
515366|NCT00116272|1241639|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
515367|NCT00116272|1241640|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
515368|NCT00116272|1241639|P2|STARTED|Overall Study||164
515369|NCT00116272|1241640|P1|STARTED|Overall Study||370
515370|NCT00116207|1241692|P2|NOT COMPLETED|Overall Study||4
515371|NCT00116207|1241693|P1|NOT COMPLETED|Overall Study||9
515372|NCT00116207|1241692|P2|COMPLETED|Overall Study||18
515373|NCT00116207|1241693|P1|COMPLETED|Overall Study||13
515374|NCT00116207|1241692|P2|STARTED|Overall Study||22
515375|NCT00116207|1241693|P1|STARTED|Overall Study||22
515376|NCT00116168|1241709|P4|NOT COMPLETED|Overall Study||0
515377|NCT00116168|1241710|P3|NOT COMPLETED|Overall Study||0
515378|NCT00116168|1241711|P2|NOT COMPLETED|Overall Study||5
515379|NCT00116168|1241712|P1|NOT COMPLETED|Overall Study||6
515380|NCT00116168|1241709|P4|COMPLETED|Overall Study||6
515381|NCT00116168|1241710|P3|COMPLETED|Overall Study||6
515382|NCT00116168|1241711|P2|COMPLETED|Overall Study||6
515383|NCT00116168|1241712|P1|COMPLETED|Overall Study||0
515384|NCT00116168|1241709|P4|STARTED|Overall Study||6
515385|NCT00116168|1241710|P3|STARTED|Overall Study||6
515386|NCT00116168|1241711|P2|STARTED|Overall Study||11
515387|NCT00116168|1241712|P1|STARTED|Overall Study||6
515388|NCT00115934|1241776|P2|NOT COMPLETED|Overall Study||2
515389|NCT00115934|1241777|P1|NOT COMPLETED|Overall Study||4
515390|NCT00115934|1241776|P2|COMPLETED|Overall Study||274
515391|NCT00115934|1241777|P1|COMPLETED|Overall Study||275
515392|NCT00115934|1241776|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
515393|NCT00115934|1241777|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
515394|NCT00115869|1241817|P2|NOT COMPLETED|Overall Study||296
515395|NCT00115869|1241818|P1|NOT COMPLETED|Overall Study||317
515396|NCT00115869|1241817|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
515397|NCT00115869|1241818|P1|COMPLETED|Overall Study||3894
515398|NCT00115869|1241817|P2|Completed Data Collection at 12th Grade|Overall Study||3847
515399|NCT00115869|1241818|P1|Completed Data Collection at 12th Grade|Overall Study||3876
515400|NCT00115869|1241817|P2|STARTED|Overall Study||4177
515401|NCT00115869|1241818|P1|STARTED|Overall Study||4211
515402|NCT00115804|1241826|P1|NOT COMPLETED|Overall Study||2
515403|NCT00115804|1241826|P1|COMPLETED|Overall Study||4
515404|NCT00115804|1241826|P1|STARTED|Overall Study||6
515405|NCT00115765|1241841|P4|NOT COMPLETED|Overall Study||31
515406|NCT00115765|1241842|P3|NOT COMPLETED|Overall Study||121
515407|NCT00115765|1241843|P2|NOT COMPLETED|Overall Study||100
515408|NCT00115765|1241844|P1|NOT COMPLETED|Overall Study||35
515409|NCT00115765|1241841|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
515410|NCT00115765|1241842|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
515411|NCT00115765|1241843|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
515412|NCT00115765|1241844|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
515413|NCT00115765|1241841|P4|STARTED|Overall Study||115
515414|NCT00115765|1241842|P3|STARTED|Overall Study||410
515415|NCT00115765|1241843|P2|STARTED|Overall Study||413
515416|NCT00115765|1241844|P1|STARTED|Overall Study||115
515417|NCT00115739|1241882|P1|NOT COMPLETED|Overall Study||3
515418|NCT00115739|1241882|P1|COMPLETED|Overall Study||8
515419|NCT00115739|1241882|P1|STARTED|Overall Study||11
515420|NCT00115349|1241891|P2|NOT COMPLETED|Overall Study||9
515421|NCT00115349|1241892|P1|NOT COMPLETED|Overall Study||11
515422|NCT00115349|1241891|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
515423|NCT00115349|1241892|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
515424|NCT00115349|1241891|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
515425|NCT00115349|1241892|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
515426|NCT00115297|1241900|P2|NOT COMPLETED|Overall Study||0
515427|NCT00115297|1241901|P1|NOT COMPLETED|Overall Study||0
515428|NCT00115297|1241900|P2|COMPLETED|Overall Study||32
515429|NCT00115297|1241901|P1|COMPLETED|Overall Study||30
515430|NCT00115297|1241900|P2|STARTED|Overall Study||32
515431|NCT00115297|1241901|P1|STARTED|Overall Study||30
515432|NCT00115063|1241913|P2|NOT COMPLETED|Overall Study||104
515433|NCT00115063|1241914|P1|NOT COMPLETED|Overall Study||99
515434|NCT00115063|1241913|P2|COMPLETED|Overall Study||86
515435|NCT00115063|1241914|P1|COMPLETED|Overall Study||101
515436|NCT00115063|1241913|P2|STARTED|Overall Study||190
515437|NCT00115063|1241914|P1|STARTED|Overall Study||200
515438|NCT00114972|1241932|P2|NOT COMPLETED|Overall Study||12
515439|NCT00114972|1241933|P1|NOT COMPLETED|Overall Study||48
515440|NCT00114972|1241932|P2|COMPLETED|Overall Study||891
515441|NCT00114972|1241933|P1|COMPLETED|Overall Study||849
515442|NCT00114972|1241932|P2|STARTED|Overall Study||903
515443|NCT00114972|1241933|P1|STARTED|Overall Study||897
515444|NCT00114959|1241953|P1|NOT COMPLETED|Overall Study||8
515445|NCT00114959|1241953|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
515446|NCT00114959|1241953|P1|STARTED|Overall Study||15
515447|NCT00114634|1241960|P1|NOT COMPLETED|Overall Study||3
515448|NCT00114634|1241960|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
515449|NCT00114634|1241960|P1|STARTED|Overall Study||13
515450|NCT00114517|1241978|P4|NOT COMPLETED|Overall Study||10
515451|NCT00114517|1241979|P3|NOT COMPLETED|Overall Study||14
515452|NCT00114517|1241980|P2|NOT COMPLETED|Overall Study||11
515453|NCT00114517|1241981|P1|NOT COMPLETED|Overall Study||12
515454|NCT00114517|1241978|P4|COMPLETED|Overall Study||176
515455|NCT00114517|1241979|P3|COMPLETED|Overall Study||172
515456|NCT00114517|1241980|P2|COMPLETED|Overall Study||123
515457|NCT00114517|1241981|P1|COMPLETED|Overall Study||125
515458|NCT00114517|1241978|P4|STARTED|Overall Study||186
515459|NCT00114517|1241979|P3|STARTED|Overall Study||186
515460|NCT00114517|1241980|P2|STARTED|Overall Study||134
515461|NCT00114517|1241981|P1|STARTED|Overall Study||137
515462|NCT00114504|1241993|P2|NOT COMPLETED|Overall Study||0
515463|NCT00114504|1241994|P1|NOT COMPLETED|Overall Study||0
515464|NCT00114504|1241993|P2|COMPLETED|Overall Study||22
515465|NCT00114504|1241994|P1|COMPLETED|Overall Study||21
515466|NCT00114504|1241993|P2|STARTED|Overall Study||22
515467|NCT00114504|1241994|P1|STARTED|Overall Study||21
515468|NCT00114244|1242006|P2|NOT COMPLETED|Overall Study||7
515469|NCT00114244|1242007|P1|NOT COMPLETED|Overall Study||2
515470|NCT00114244|1242006|P2|COMPLETED|Overall Study||30
515471|NCT00114244|1242007|P1|COMPLETED|Overall Study||13
515472|NCT00114244|1242006|P2|STARTED|Overall Study||37
515473|NCT00114244|1242007|P1|STARTED|Overall Study||15
515474|NCT00114166|1242017|P1|NOT COMPLETED|Overall Study||1
515475|NCT00114166|1242017|P1|COMPLETED|Overall Study|total numbers of eligible and evaluable participants|80
515476|NCT00114166|1242017|P1|Registered to Regimen II|Overall Study||65
515477|NCT00114166|1242017|P1|Registered to Regimen I|Overall Study||15
515478|NCT00114166|1242017|P1|STARTED|Overall Study|total number of participants enrolled|81
515479|NCT00114127|1242025|P2|NOT COMPLETED|Overall Study||4
515480|NCT00114127|1242026|P1|NOT COMPLETED|Overall Study||4
515481|NCT00114127|1242025|P2|COMPLETED|Overall Study||11
515482|NCT00114127|1242026|P1|COMPLETED|Overall Study||9
515483|NCT00114127|1242025|P2|STARTED|Overall Study||15
515484|NCT00114127|1242026|P1|STARTED|Overall Study||13
515485|NCT00114101|1242036|P2|NOT COMPLETED|Overall Study||0
515486|NCT00114101|1242037|P1|NOT COMPLETED|Overall Study||0
515487|NCT00114101|1242036|P2|COMPLETED|Overall Study||229
515488|NCT00114101|1242037|P1|COMPLETED|Overall Study||231
515489|NCT00114101|1242036|P2|STARTED|Overall Study||229
515490|NCT00114101|1242037|P1|STARTED|Overall Study||231
515491|NCT00113919|1242049|P1|NOT COMPLETED|Overall Study||14
515492|NCT00113919|1242049|P1|COMPLETED|Overall Study||0
515493|NCT00113919|1242049|P1|STARTED|Overall Study||14
515494|NCT00113880|1242056|P3|NOT COMPLETED|Overall Study||0
515495|NCT00113880|1242057|P2|NOT COMPLETED|Overall Study||0
515496|NCT00113880|1242058|P1|NOT COMPLETED|Overall Study||0
515497|NCT00113880|1242056|P3|COMPLETED|Overall Study||62492
515498|NCT00113880|1242057|P2|COMPLETED|Overall Study||71949
515499|NCT00113880|1242058|P1|COMPLETED|Overall Study||63061
515500|NCT00113880|1242056|P3|STARTED|Overall Study||62492
515501|NCT00113880|1242057|P2|STARTED|Overall Study||71949
515502|NCT00113880|1242058|P1|STARTED|Overall Study||63061
515503|NCT00113841|1242117|P2|NOT COMPLETED|Overall Study||2
515504|NCT00113841|1242118|P1|NOT COMPLETED|Overall Study||1
515505|NCT00113841|1242117|P2|COMPLETED|Overall Study||15
515506|NCT00113841|1242118|P1|COMPLETED|Overall Study||15
515507|NCT00113841|1242117|P2|STARTED|Overall Study||17
515508|NCT00113841|1242118|P1|STARTED|Overall Study||16
515509|NCT00113763|1242126|P2|NOT COMPLETED|Overall Study||26
515510|NCT00113763|1242127|P1|NOT COMPLETED|Overall Study||73
515511|NCT00113763|1242126|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
515512|NCT00113763|1242127|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
515513|NCT00113763|1242126|P2|Received Study Drug|Overall Study||0
515514|NCT00113763|1242127|P1|Received Study Drug|Overall Study||229
515515|NCT00113763|1242126|P2|STARTED|Overall Study||232
515516|NCT00113763|1242127|P1|STARTED|Overall Study||231
515517|NCT00113607|1242153|P2|NOT COMPLETED|Overall Study||337
515518|NCT00113607|1242154|P1|NOT COMPLETED|Overall Study||335
515519|NCT00113607|1242153|P2|COMPLETED|Overall Study||0
515520|NCT00113607|1242154|P1|COMPLETED|Overall Study||0
515614|NCT00113022|1242476|P1|STARTED|Overall Study||5
515521|NCT00113607|1242153|P2|STARTED|Overall Study|Number of randomized participants|337
515522|NCT00113607|1242154|P1|STARTED|Overall Study|Number of randomized participants|335
515523|NCT00113568|1242168|P1|NOT COMPLETED|Overall Study||545
515524|NCT00113568|1242168|P1|COMPLETED|Overall Study||239
515525|NCT00113568|1242168|P1|Intent to Treat Population|Overall Study||723
515526|NCT00113568|1242168|P1|STARTED|Overall Study||784
515527|NCT00113529|1242180|P1|NOT COMPLETED|Overall Study||34
515528|NCT00113529|1242180|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
515529|NCT00113529|1242180|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
515530|NCT00113516|1242213|P2|NOT COMPLETED|Part 2||66
515531|NCT00113516|1242214|P1|NOT COMPLETED|Part 2||0
515532|NCT00113516|1242213|P2|COMPLETED|Part 2||0
515533|NCT00113516|1242214|P1|COMPLETED|Part 2||0
515534|NCT00113516|1242213|P2|STARTED|Part 2||66
515535|NCT00113516|1242214|P1|STARTED|Part 2||0
515536|NCT00113516|1242213|P2|NOT COMPLETED|Part 1||0
515537|NCT00113516|1242214|P1|NOT COMPLETED|Part 1||84
515538|NCT00113516|1242213|P2|COMPLETED|Part 1||0
515539|NCT00113516|1242214|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
515540|NCT00113516|1242213|P2|STARTED|Part 1||0
515541|NCT00113516|1242214|P1|STARTED|Part 1||84
515542|NCT00113490|1242257|P2|NOT COMPLETED|Overall Study||3
515543|NCT00113490|1242258|P1|NOT COMPLETED|Overall Study||2
515544|NCT00113490|1242257|P2|COMPLETED|Overall Study||67
515545|NCT00113490|1242258|P1|COMPLETED|Overall Study||64
515546|NCT00113490|1242257|P2|STARTED|Overall Study||70
515547|NCT00113490|1242258|P1|STARTED|Overall Study||66
515548|NCT00113425|1242271|P1|NOT COMPLETED|Overall Study||15
515549|NCT00113425|1242271|P1|COMPLETED|Overall Study||29
515550|NCT00113425|1242271|P1|STARTED|Overall Study||44
515551|NCT00113399|1242291|P2|NOT COMPLETED|Overall Study||5
515552|NCT00113399|1242292|P1|NOT COMPLETED|Overall Study||2
515553|NCT00113399|1242291|P2|COMPLETED|Overall Study||3
515554|NCT00113399|1242292|P1|COMPLETED|Overall Study||5
515555|NCT00113399|1242291|P2|STARTED|Overall Study||8
515556|NCT00113399|1242292|P1|STARTED|Overall Study||7
515557|NCT00113386|1242300|P2|NOT COMPLETED|Overall Study||4
515558|NCT00113386|1242301|P1|NOT COMPLETED|Overall Study||7
515559|NCT00113386|1242300|P2|COMPLETED|Overall Study||5
515560|NCT00113386|1242301|P1|COMPLETED|Overall Study||3
515561|NCT00113386|1242300|P2|STARTED|Overall Study||9
515562|NCT00113386|1242301|P1|STARTED|Overall Study||10
515563|NCT00113373|1242307|P1|NOT COMPLETED|Overall Study||3
515564|NCT00113373|1242307|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
515565|NCT00113373|1242307|P1|STARTED|Overall Study||28
515566|NCT00113360|1242313|P1|NOT COMPLETED|Overall Study||7
515567|NCT00113360|1242313|P1|COMPLETED|Overall Study||60
515568|NCT00113360|1242313|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
515569|NCT00113334|1242317|P1|NOT COMPLETED|Overall Study||0
515570|NCT00113334|1242317|P1|COMPLETED|Overall Study||6
515571|NCT00113334|1242317|P1|STARTED|Overall Study||6
515572|NCT00113321|1242321|P1|NOT COMPLETED|Overall Study||0
515573|NCT00113321|1242321|P1|COMPLETED|Overall Study||16
515574|NCT00113321|1242321|P1|STARTED|Overall Study||16
515575|NCT00113295|1242327|P2|NOT COMPLETED|Overall Study||1
515576|NCT00113295|1242328|P1|NOT COMPLETED|Overall Study||5
515577|NCT00113295|1242327|P2|COMPLETED|Overall Study||10
515578|NCT00113295|1242328|P1|COMPLETED|Overall Study||6
515579|NCT00113295|1242327|P2|STARTED|Overall Study||11
515580|NCT00113295|1242328|P1|STARTED|Overall Study||11
515581|NCT00113269|1242347|P4|NOT COMPLETED|Overall Study||40
515582|NCT00113269|1242348|P3|NOT COMPLETED|Overall Study||41
515583|NCT00113269|1242349|P2|NOT COMPLETED|Overall Study||22
515584|NCT00113269|1242350|P1|NOT COMPLETED|Overall Study||25
515585|NCT00113269|1242347|P4|COMPLETED|Overall Study||140
515586|NCT00113269|1242348|P3|COMPLETED|Overall Study||134
515587|NCT00113269|1242349|P2|COMPLETED|Overall Study||48
515588|NCT00113269|1242350|P1|COMPLETED|Overall Study||51
515589|NCT00113269|1242347|P4|Received Treatment|Overall Study||171
515590|NCT00113269|1242348|P3|Received Treatment|Overall Study||164
515591|NCT00113269|1242349|P2|Received Treatment|Overall Study||69
515592|NCT00113269|1242350|P1|Received Treatment|Overall Study||70
515593|NCT00113269|1242347|P4|STARTED|Overall Study||180
515594|NCT00113269|1242348|P3|STARTED|Overall Study||175
515595|NCT00113269|1242349|P2|STARTED|Overall Study||70
515596|NCT00113269|1242350|P1|STARTED|Overall Study||76
515597|NCT00113230|1242400|P1|NOT COMPLETED|Overall Study||0
515598|NCT00113230|1242400|P1|COMPLETED|Overall Study||25
515599|NCT00113230|1242400|P1|STARTED|Overall Study||25
515600|NCT00113217|1242404|P1|NOT COMPLETED|Overall Study||0
515601|NCT00113217|1242404|P1|COMPLETED|Overall Study||50
515602|NCT00113217|1242404|P1|STARTED|Overall Study||50
515603|NCT00113087|1242410|P2|NOT COMPLETED|Overall Study||21
515604|NCT00113087|1242411|P1|NOT COMPLETED|Overall Study||24
515605|NCT00113087|1242410|P2|COMPLETED|Overall Study||94
515606|NCT00113087|1242411|P1|COMPLETED|Overall Study||91
515607|NCT00113087|1242410|P2|STARTED|Overall Study||115
515608|NCT00113087|1242411|P1|STARTED|Overall Study||115
515609|NCT00113022|1242475|P2|NOT COMPLETED|Overall Study||2
515610|NCT00113022|1242476|P1|NOT COMPLETED|Overall Study||3
515611|NCT00113022|1242475|P2|COMPLETED|Overall Study||2
515612|NCT00113022|1242476|P1|COMPLETED|Overall Study||2
515613|NCT00113022|1242475|P2|STARTED|Overall Study||4
515615|NCT00112918|1242485|P3|NOT COMPLETED|Overall Study||299
515616|NCT00112918|1242486|P2|NOT COMPLETED|Overall Study||345
515617|NCT00112918|1242487|P1|NOT COMPLETED|Overall Study||297
515618|NCT00112918|1242485|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
515619|NCT00112918|1242486|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
515620|NCT00112918|1242487|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
515621|NCT00112918|1242485|P3|Stage III Disease Population|Overall Study||952
515622|NCT00112918|1242486|P2|Stage III Disease Population|Overall Study||960
515623|NCT00112918|1242487|P1|Stage III Disease Population|Overall Study||955
515624|NCT00112918|1242485|P3|Received Treatment|Overall Study||1135
515625|NCT00112918|1242486|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
515626|NCT00112918|1242487|P1|Received Treatment|Overall Study||1126
515627|NCT00112918|1242485|P3|STARTED|Overall Study||1145
515628|NCT00112918|1242486|P2|STARTED|Overall Study||1155
515629|NCT00112918|1242487|P1|STARTED|Overall Study||1151
515630|NCT00112905|1242510|P1|NOT COMPLETED|Overall Study||12
515631|NCT00112905|1242510|P1|COMPLETED|Overall Study||15
515632|NCT00112905|1242510|P1|Eligible and Treated|Overall Study||22
515633|NCT00112905|1242510|P1|STARTED|Overall Study||27
515634|NCT00112866|1242519|P2|NOT COMPLETED|Overall Study||2
515635|NCT00112866|1242520|P1|NOT COMPLETED|Overall Study||2
515636|NCT00112866|1242519|P2|COMPLETED|Overall Study||13
515637|NCT00112866|1242520|P1|COMPLETED|Overall Study||13
515638|NCT00112866|1242519|P2|STARTED|Overall Study||15
515639|NCT00112866|1242520|P1|STARTED|Overall Study||15
515640|NCT00112840|1242542|P3|NOT COMPLETED|Overall Study||6
515641|NCT00112840|1242543|P2|NOT COMPLETED|Overall Study||0
515642|NCT00112840|1242544|P1|NOT COMPLETED|Overall Study||2
515643|NCT00112840|1242542|P3|COMPLETED|Overall Study||40
515644|NCT00112840|1242543|P2|COMPLETED|Overall Study||6
515645|NCT00112840|1242544|P1|COMPLETED|Overall Study||6
515646|NCT00112840|1242542|P3|STARTED|Overall Study||46
515647|NCT00112840|1242543|P2|STARTED|Overall Study||6
515648|NCT00112840|1242544|P1|STARTED|Overall Study||8
515649|NCT00112736|1242563|P2|NOT COMPLETED|Overall Study||0
515650|NCT00112736|1242564|P1|NOT COMPLETED|Overall Study||1
515651|NCT00112736|1242563|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
515737|NCT00112437|1242648|P2|NOT COMPLETED|12 Month Extension||9
515652|NCT00112736|1242564|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
515653|NCT00112736|1242563|P2|STARTED|Overall Study||47
515654|NCT00112736|1242564|P1|STARTED|Overall Study||22
515655|NCT00112723|1242577|P3|NOT COMPLETED|Overall Study||2
515656|NCT00112723|1242578|P2|NOT COMPLETED|Overall Study||7
515657|NCT00112723|1242579|P1|NOT COMPLETED|Overall Study||2
515658|NCT00112723|1242577|P3|COMPLETED|Overall Study||12
515659|NCT00112723|1242578|P2|COMPLETED|Overall Study||12
515660|NCT00112723|1242579|P1|COMPLETED|Overall Study||11
515661|NCT00112723|1242577|P3|Patients Evaluable for Toxicity|Overall Study||12
515662|NCT00112723|1242578|P2|Patients Evaluable for Toxicity|Overall Study||12
515663|NCT00112723|1242579|P1|Patients Evaluable for Toxicity|Overall Study||11
515664|NCT00112723|1242577|P3|STARTED|Overall Study||14
515665|NCT00112723|1242578|P2|STARTED|Overall Study||19
515666|NCT00112723|1242579|P1|STARTED|Overall Study||13
515667|NCT00112671|1242604|P1|NOT COMPLETED|Overall Study||0
515668|NCT00112671|1242604|P1|COMPLETED|Overall Study||17
515669|NCT00112671|1242604|P1|STARTED|Overall Study||17
515670|NCT00112593|1242610|P1|NOT COMPLETED|Overall Study||0
515671|NCT00112593|1242610|P1|COMPLETED|Overall Study||5
515672|NCT00112593|1242610|P1|STARTED|Overall Study||5
515673|NCT00112489|1242619|P1|NOT COMPLETED|Overall Study||40
515674|NCT00112489|1242619|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
515675|NCT00112489|1242619|P1|STARTED|Overall Study|All patients enrolled on study|55
515676|NCT00112463|1242623|P1|NOT COMPLETED|Overall Study||39
515677|NCT00112463|1242623|P1|COMPLETED|Overall Study||1
515678|NCT00112463|1242623|P1|STARTED|Overall Study||40
515679|NCT00112437|1242635|P15|NOT COMPLETED|12 Month Extension (Year 3)||1
515680|NCT00112437|1242636|P14|NOT COMPLETED|12 Month Extension (Year 3)||2
515681|NCT00112437|1242637|P13|NOT COMPLETED|12 Month Extension (Year 3)||1
515682|NCT00112437|1242638|P12|NOT COMPLETED|12 Month Extension (Year 3)||3
515683|NCT00112437|1242639|P11|NOT COMPLETED|12 Month Extension (Year 3)||4
515684|NCT00112437|1242640|P10|NOT COMPLETED|12 Month Extension (Year 3)||1
515685|NCT00112437|1242641|P9|NOT COMPLETED|12 Month Extension (Year 3)||1
515686|NCT00112437|1242642|P8|NOT COMPLETED|12 Month Extension (Year 3)||0
515687|NCT00112437|1242643|P7|NOT COMPLETED|12 Month Extension (Year 3)||5
515688|NCT00112437|1242644|P6|NOT COMPLETED|12 Month Extension (Year 3)||2
515689|NCT00112437|1242645|P5|NOT COMPLETED|12 Month Extension (Year 3)||0
515690|NCT00112437|1242646|P4|NOT COMPLETED|12 Month Extension (Year 3)||0
515691|NCT00112437|1242647|P3|NOT COMPLETED|12 Month Extension (Year 3)||0
515692|NCT00112437|1242648|P2|NOT COMPLETED|12 Month Extension (Year 3)||0
515693|NCT00112437|1242649|P1|NOT COMPLETED|12 Month Extension (Year 3)||0
515694|NCT00112437|1242635|P15|COMPLETED|12 Month Extension (Year 3)||19
515695|NCT00112437|1242636|P14|COMPLETED|12 Month Extension (Year 3)||16
515696|NCT00112437|1242637|P13|COMPLETED|12 Month Extension (Year 3)||20
515697|NCT00112437|1242638|P12|COMPLETED|12 Month Extension (Year 3)||16
515698|NCT00112437|1242639|P11|COMPLETED|12 Month Extension (Year 3)||13
515699|NCT00112437|1242640|P10|COMPLETED|12 Month Extension (Year 3)||17
515700|NCT00112437|1242641|P9|COMPLETED|12 Month Extension (Year 3)||16
515701|NCT00112437|1242642|P8|COMPLETED|12 Month Extension (Year 3)||18
515702|NCT00112437|1242643|P7|COMPLETED|12 Month Extension (Year 3)||17
515703|NCT00112437|1242644|P6|COMPLETED|12 Month Extension (Year 3)||17
515704|NCT00112437|1242645|P5|COMPLETED|12 Month Extension (Year 3)||0
515705|NCT00112437|1242646|P4|COMPLETED|12 Month Extension (Year 3)||0
515706|NCT00112437|1242647|P3|COMPLETED|12 Month Extension (Year 3)||0
515707|NCT00112437|1242648|P2|COMPLETED|12 Month Extension (Year 3)||0
515708|NCT00112437|1242649|P1|COMPLETED|12 Month Extension (Year 3)||0
515709|NCT00112437|1242635|P15|STARTED|12 Month Extension (Year 3)||20
515710|NCT00112437|1242636|P14|STARTED|12 Month Extension (Year 3)||18
515711|NCT00112437|1242637|P13|STARTED|12 Month Extension (Year 3)||21
515712|NCT00112437|1242638|P12|STARTED|12 Month Extension (Year 3)||19
515713|NCT00112437|1242639|P11|STARTED|12 Month Extension (Year 3)||17
515714|NCT00112437|1242640|P10|STARTED|12 Month Extension (Year 3)||18
515715|NCT00112437|1242641|P9|STARTED|12 Month Extension (Year 3)||17
515716|NCT00112437|1242642|P8|STARTED|12 Month Extension (Year 3)||18
515717|NCT00112437|1242643|P7|STARTED|12 Month Extension (Year 3)||22
515718|NCT00112437|1242644|P6|STARTED|12 Month Extension (Year 3)||19
515719|NCT00112437|1242645|P5|STARTED|12 Month Extension (Year 3)||0
515720|NCT00112437|1242646|P4|STARTED|12 Month Extension (Year 3)||0
515721|NCT00112437|1242647|P3|STARTED|12 Month Extension (Year 3)||0
515722|NCT00112437|1242648|P2|STARTED|12 Month Extension (Year 3)||0
515723|NCT00112437|1242649|P1|STARTED|12 Month Extension (Year 3)||0
515724|NCT00112437|1242635|P15|NOT COMPLETED|12 Month Extension||0
515725|NCT00112437|1242636|P14|NOT COMPLETED|12 Month Extension||0
515726|NCT00112437|1242637|P13|NOT COMPLETED|12 Month Extension||0
515727|NCT00112437|1242638|P12|NOT COMPLETED|12 Month Extension||0
515728|NCT00112437|1242639|P11|NOT COMPLETED|12 Month Extension||0
515729|NCT00112437|1242640|P10|NOT COMPLETED|12 Month Extension||0
515730|NCT00112437|1242641|P9|NOT COMPLETED|12 Month Extension||0
515731|NCT00112437|1242642|P8|NOT COMPLETED|12 Month Extension||0
515732|NCT00112437|1242643|P7|NOT COMPLETED|12 Month Extension||0
515733|NCT00112437|1242644|P6|NOT COMPLETED|12 Month Extension||0
515734|NCT00112437|1242645|P5|NOT COMPLETED|12 Month Extension||13
515735|NCT00112437|1242646|P4|NOT COMPLETED|12 Month Extension||7
515736|NCT00112437|1242647|P3|NOT COMPLETED|12 Month Extension||8
515738|NCT00112437|1242649|P1|NOT COMPLETED|12 Month Extension||3
515739|NCT00112437|1242635|P15|COMPLETED|12 Month Extension||0
515740|NCT00112437|1242636|P14|COMPLETED|12 Month Extension||0
515741|NCT00112437|1242637|P13|COMPLETED|12 Month Extension||0
515742|NCT00112437|1242638|P12|COMPLETED|12 Month Extension||0
515743|NCT00112437|1242639|P11|COMPLETED|12 Month Extension||0
515744|NCT00112437|1242640|P10|COMPLETED|12 Month Extension||0
515745|NCT00112437|1242641|P9|COMPLETED|12 Month Extension||0
515746|NCT00112437|1242642|P8|COMPLETED|12 Month Extension||0
515747|NCT00112437|1242643|P7|COMPLETED|12 Month Extension||0
515748|NCT00112437|1242644|P6|COMPLETED|12 Month Extension||0
515749|NCT00112437|1242645|P5|COMPLETED|12 Month Extension||50
515750|NCT00112437|1242646|P4|COMPLETED|12 Month Extension||62
515751|NCT00112437|1242647|P3|COMPLETED|12 Month Extension||55
515752|NCT00112437|1242648|P2|COMPLETED|12 Month Extension||53
515753|NCT00112437|1242649|P1|COMPLETED|12 Month Extension||60
515754|NCT00112437|1242635|P15|STARTED|12 Month Extension||0
515755|NCT00112437|1242636|P14|STARTED|12 Month Extension||0
515756|NCT00112437|1242637|P13|STARTED|12 Month Extension||0
515757|NCT00112437|1242638|P12|STARTED|12 Month Extension||0
515758|NCT00112437|1242639|P11|STARTED|12 Month Extension||0
515759|NCT00112437|1242640|P10|STARTED|12 Month Extension||0
515760|NCT00112437|1242641|P9|STARTED|12 Month Extension||0
515761|NCT00112437|1242642|P8|STARTED|12 Month Extension||0
515762|NCT00112437|1242643|P7|STARTED|12 Month Extension||0
515763|NCT00112437|1242644|P6|STARTED|12 Month Extension||0
515764|NCT00112437|1242645|P5|STARTED|12 Month Extension||63
515765|NCT00112437|1242646|P4|STARTED|12 Month Extension||69
515766|NCT00112437|1242647|P3|STARTED|12 Month Extension||63
515767|NCT00112437|1242648|P2|STARTED|12 Month Extension||62
515768|NCT00112437|1242649|P1|STARTED|12 Month Extension||63
515769|NCT00112437|1242635|P15|NOT COMPLETED|12 Month Base Study||0
515770|NCT00112437|1242636|P14|NOT COMPLETED|12 Month Base Study||0
515771|NCT00112437|1242637|P13|NOT COMPLETED|12 Month Base Study||0
515772|NCT00112437|1242638|P12|NOT COMPLETED|12 Month Base Study||0
515773|NCT00112437|1242639|P11|NOT COMPLETED|12 Month Base Study||0
515774|NCT00112437|1242640|P10|NOT COMPLETED|12 Month Base Study||0
515775|NCT00112437|1242641|P9|NOT COMPLETED|12 Month Base Study||0
515776|NCT00112437|1242642|P8|NOT COMPLETED|12 Month Base Study||0
515777|NCT00112437|1242643|P7|NOT COMPLETED|12 Month Base Study||0
515778|NCT00112437|1242644|P6|NOT COMPLETED|12 Month Base Study||0
515779|NCT00112437|1242645|P5|NOT COMPLETED|12 Month Base Study||12
515780|NCT00112437|1242646|P4|NOT COMPLETED|12 Month Base Study||8
515781|NCT00112437|1242647|P3|NOT COMPLETED|12 Month Base Study||12
515782|NCT00112437|1242648|P2|NOT COMPLETED|12 Month Base Study||18
515783|NCT00112437|1242649|P1|NOT COMPLETED|12 Month Base Study||15
515784|NCT00112437|1242635|P15|COMPLETED|12 Month Base Study||0
515785|NCT00112437|1242636|P14|COMPLETED|12 Month Base Study||0
515786|NCT00112437|1242637|P13|COMPLETED|12 Month Base Study||0
515787|NCT00112437|1242638|P12|COMPLETED|12 Month Base Study||0
515788|NCT00112437|1242639|P11|COMPLETED|12 Month Base Study||0
515789|NCT00112437|1242640|P10|COMPLETED|12 Month Base Study||0
515790|NCT00112437|1242641|P9|COMPLETED|12 Month Base Study||0
515791|NCT00112437|1242642|P8|COMPLETED|12 Month Base Study||0
515792|NCT00112437|1242643|P7|COMPLETED|12 Month Base Study||0
515793|NCT00112437|1242644|P6|COMPLETED|12 Month Base Study||0
515794|NCT00112437|1242645|P5|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|66
515795|NCT00112437|1242646|P4|COMPLETED|12 Month Base Study||71
515796|NCT00112437|1242647|P3|COMPLETED|12 Month Base Study||65
515797|NCT00112437|1242648|P2|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|64
515798|NCT00112437|1242649|P1|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|68
515799|NCT00112437|1242635|P15|STARTED|12 Month Base Study||0
515800|NCT00112437|1242636|P14|STARTED|12 Month Base Study||0
515801|NCT00112437|1242637|P13|STARTED|12 Month Base Study||0
515802|NCT00112437|1242638|P12|STARTED|12 Month Base Study||0
515803|NCT00112437|1242639|P11|STARTED|12 Month Base Study||0
515804|NCT00112437|1242640|P10|STARTED|12 Month Base Study||0
515805|NCT00112437|1242641|P9|STARTED|12 Month Base Study||0
515806|NCT00112437|1242642|P8|STARTED|12 Month Base Study||0
515807|NCT00112437|1242643|P7|STARTED|12 Month Base Study||0
515808|NCT00112437|1242644|P6|STARTED|12 Month Base Study||0
515809|NCT00112437|1242645|P5|STARTED|12 Month Base Study||78
515810|NCT00112437|1242646|P4|STARTED|12 Month Base Study||79
515811|NCT00112437|1242647|P3|STARTED|12 Month Base Study||77
515812|NCT00112437|1242648|P2|STARTED|12 Month Base Study||82
515813|NCT00112437|1242649|P1|STARTED|12 Month Base Study||83
515814|NCT00112385|1242908|P2|NOT COMPLETED|Overall Study||1
515815|NCT00112385|1242909|P1|NOT COMPLETED|Overall Study||1
515816|NCT00112385|1242908|P2|COMPLETED|Overall Study||4
515817|NCT00112385|1242909|P1|COMPLETED|Overall Study||10
515818|NCT00112385|1242908|P2|STARTED|Overall Study||5
515819|NCT00112385|1242909|P1|STARTED|Overall Study||11
515820|NCT00112359|1242999|P2|NOT COMPLETED|Overall Study||13
515821|NCT00112359|1243000|P1|NOT COMPLETED|Overall Study||27
515822|NCT00112359|1242999|P2|COMPLETED|Overall Study||67
515823|NCT00112359|1243000|P1|COMPLETED|Overall Study||57
515824|NCT00112359|1242999|P2|STARTED|Overall Study||80
515825|NCT00112359|1243000|P1|STARTED|Overall Study||84
515826|NCT00112294|1243026|P2|NOT COMPLETED|Overall Study||0
515827|NCT00112294|1243027|P1|NOT COMPLETED|Overall Study||5
515828|NCT00112294|1243026|P2|COMPLETED|Overall Study|Off all study therapies.|320
515829|NCT00112294|1243027|P1|COMPLETED|Overall Study|Off all study therapies.|320
515830|NCT00112294|1243026|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
515831|NCT00112294|1243027|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
515832|NCT00112294|1243026|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
515833|NCT00112294|1243027|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
515834|NCT00112151|1243071|P6|NOT COMPLETED|Overall Study||3
515835|NCT00112151|1243072|P5|NOT COMPLETED|Overall Study||6
515836|NCT00112151|1243073|P4|NOT COMPLETED|Overall Study||3
515837|NCT00112151|1243074|P3|NOT COMPLETED|Overall Study||3
515838|NCT00112151|1243075|P2|NOT COMPLETED|Overall Study||5
515839|NCT00112151|1243076|P1|NOT COMPLETED|Overall Study||4
515840|NCT00112151|1243071|P6|COMPLETED|Overall Study||25
515841|NCT00112151|1243072|P5|COMPLETED|Overall Study||22
515842|NCT00112151|1243073|P4|COMPLETED|Overall Study||24
515843|NCT00112151|1243074|P3|COMPLETED|Overall Study||25
515844|NCT00112151|1243075|P2|COMPLETED|Overall Study||23
515845|NCT00112151|1243076|P1|COMPLETED|Overall Study||24
515846|NCT00112151|1243071|P6|STARTED|Overall Study||28
515847|NCT00112151|1243072|P5|STARTED|Overall Study||28
515848|NCT00112151|1243073|P4|STARTED|Overall Study||27
515849|NCT00112151|1243074|P3|STARTED|Overall Study||28
515850|NCT00112151|1243075|P2|STARTED|Overall Study||28
515851|NCT00112151|1243076|P1|STARTED|Overall Study||28
515852|NCT00112112|1243107|P2|NOT COMPLETED|Overall Study||0
515853|NCT00112112|1243108|P1|NOT COMPLETED|Overall Study||0
515854|NCT00112112|1243107|P2|COMPLETED|Overall Study||10
515855|NCT00112112|1243108|P1|COMPLETED|Overall Study||10
515856|NCT00112112|1243107|P2|STARTED|Overall Study||10
515857|NCT00112112|1243108|P1|STARTED|Overall Study||10
515858|NCT00112047|1243208|P2|NOT COMPLETED|Atripla Phase||20
515859|NCT00112047|1243209|P1|NOT COMPLETED|Atripla Phase||18
515860|NCT00112047|1243208|P2|COMPLETED|Atripla Phase||106
515861|NCT00112047|1243209|P1|COMPLETED|Atripla Phase||142
515862|NCT00112047|1243208|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
515863|NCT00112047|1243209|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
515864|NCT00112047|1243208|P2|NOT COMPLETED|Randomized Phase||88
515865|NCT00112047|1243209|P1|NOT COMPLETED|Randomized Phase||70
515866|NCT00112047|1243208|P2|COMPLETED|Randomized Phase||166
515867|NCT00112047|1243209|P1|COMPLETED|Randomized Phase||187
515868|NCT00112047|1243208|P2|STARTED|Randomized Phase|ITT analysis population|254
515869|NCT00112047|1243209|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
515870|NCT00111917|1243309|P2|NOT COMPLETED|Overall Study||1
515871|NCT00111917|1243310|P1|NOT COMPLETED|Overall Study||1
515872|NCT00111917|1243309|P2|COMPLETED|Overall Study||3
515873|NCT00111917|1243310|P1|COMPLETED|Overall Study||8
515874|NCT00111917|1243309|P2|STARTED|Overall Study||4
515875|NCT00111917|1243310|P1|STARTED|Overall Study||9
515876|NCT00111813|1243322|P6|NOT COMPLETED|Overall Study||6
515877|NCT00111813|1243323|P5|NOT COMPLETED|Overall Study||6
515878|NCT00111813|1243324|P4|NOT COMPLETED|Overall Study||5
515879|NCT00111813|1243325|P3|NOT COMPLETED|Overall Study||10
515880|NCT00111813|1243326|P2|NOT COMPLETED|Overall Study||3
515881|NCT00111813|1243327|P1|NOT COMPLETED|Overall Study||3
515882|NCT00111813|1243322|P6|COMPLETED|Overall Study||0
515883|NCT00111813|1243323|P5|COMPLETED|Overall Study||0
515884|NCT00111813|1243324|P4|COMPLETED|Overall Study||1
515885|NCT00111813|1243325|P3|COMPLETED|Overall Study||0
515886|NCT00111813|1243326|P2|COMPLETED|Overall Study||0
515887|NCT00111813|1243327|P1|COMPLETED|Overall Study||0
515888|NCT00111813|1243322|P6|STARTED|Overall Study||6
515889|NCT00111813|1243323|P5|STARTED|Overall Study||6
515890|NCT00111813|1243324|P4|STARTED|Overall Study||6
515891|NCT00111813|1243325|P3|STARTED|Overall Study||10
515892|NCT00111813|1243326|P2|STARTED|Overall Study||3
515893|NCT00111813|1243327|P1|STARTED|Overall Study||3
515894|NCT00111761|1243362|P2|NOT COMPLETED|Part 2||0
515895|NCT00111761|1243363|P1|NOT COMPLETED|Part 2||8
515896|NCT00111761|1243362|P2|COMPLETED|Part 2||0
515897|NCT00111761|1243363|P1|COMPLETED|Part 2||16
515898|NCT00111761|1243362|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
515899|NCT00111761|1243363|P1|STARTED|Part 2||24
515900|NCT00111761|1243362|P2|NOT COMPLETED|Part 1||5
515901|NCT00111761|1243363|P1|NOT COMPLETED|Part 1||0
515902|NCT00111761|1243362|P2|COMPLETED|Part 1|Completed through safety followup|14
515903|NCT00111761|1243363|P1|COMPLETED|Part 1||0
515904|NCT00111761|1243362|P2|STARTED|Part 1||19
515905|NCT00111761|1243363|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
515906|NCT00111657|1243380|P1|NOT COMPLETED|Overall Study||16
515907|NCT00111657|1243380|P1|COMPLETED|Overall Study|Completed all intended doses.|21
515908|NCT00111657|1243380|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
515909|NCT00111007|1243392|P2|NOT COMPLETED|Long Term Follow-up||45
515910|NCT00111007|1243393|P1|NOT COMPLETED|Long Term Follow-up||47
515911|NCT00111007|1243392|P2|COMPLETED|Long Term Follow-up||62
515912|NCT00111007|1243393|P1|COMPLETED|Long Term Follow-up||54
515913|NCT00111007|1243392|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
515914|NCT00111007|1243393|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
515915|NCT00111007|1243392|P2|NOT COMPLETED|Active Follow-up||2
515916|NCT00111007|1243393|P1|NOT COMPLETED|Active Follow-up||6
515917|NCT00111007|1243392|P2|COMPLETED|Active Follow-up||2
515918|NCT00111007|1243393|P1|COMPLETED|Active Follow-up||0
515919|NCT00111007|1243392|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
515920|NCT00111007|1243393|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
515921|NCT00111007|1243392|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
515922|NCT00111007|1243393|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
515923|NCT00111007|1243392|P2|COMPLETED|Double-blind (DB) Treatment||24
515924|NCT00111007|1243393|P1|COMPLETED|Double-blind (DB) Treatment||27
515925|NCT00111007|1243392|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
515926|NCT00111007|1243393|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
515927|NCT00111007|1243392|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
515928|NCT00111007|1243393|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
515929|NCT00110994|1243409|P2|NOT COMPLETED|Long Term Follow-up||17
515930|NCT00110994|1243410|P1|NOT COMPLETED|Long Term Follow-up||19
515931|NCT00110994|1243409|P2|COMPLETED|Long Term Follow-up||30
515932|NCT00110994|1243410|P1|COMPLETED|Long Term Follow-up||22
515933|NCT00110994|1243409|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
515934|NCT00110994|1243410|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
515935|NCT00110994|1243409|P2|NOT COMPLETED|Active Follow-up||2
515936|NCT00110994|1243410|P1|NOT COMPLETED|Active Follow-up||1
515937|NCT00110994|1243409|P2|COMPLETED|Active Follow-up||0
515938|NCT00110994|1243410|P1|COMPLETED|Active Follow-up||0
515939|NCT00110994|1243409|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
515940|NCT00110994|1243410|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
515941|NCT00110994|1243409|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
515942|NCT00110994|1243410|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
515943|NCT00110994|1243409|P2|COMPLETED|Double-blind (DB) Treatment||3
515944|NCT00110994|1243410|P1|COMPLETED|Double-blind (DB) Treatment||9
515945|NCT00110994|1243409|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
515946|NCT00110994|1243410|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
515947|NCT00110994|1243409|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
515948|NCT00110994|1243410|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
515949|NCT00110890|1243436|P2|NOT COMPLETED|Overall Study||179
515950|NCT00110890|1243437|P1|NOT COMPLETED|Overall Study||361
515951|NCT00110890|1243436|P2|COMPLETED|Overall Study|Follow-up Phase|5
515952|NCT00110890|1243437|P1|COMPLETED|Overall Study|Follow-up Phase|7
515953|NCT00110890|1243436|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
515954|NCT00110890|1243437|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
515955|NCT00110890|1243436|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
515956|NCT00110890|1243437|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
515957|NCT00110890|1243436|P2|STARTED|Overall Study||184
515958|NCT00110890|1243437|P1|STARTED|Overall Study||368
515959|NCT00110812|1243454|P3|NOT COMPLETED|Extended Follow-up||4
515960|NCT00110812|1243455|P2|NOT COMPLETED|Extended Follow-up||4
515961|NCT00110812|1243456|P1|NOT COMPLETED|Extended Follow-up||2
515962|NCT00110812|1243454|P3|COMPLETED|Extended Follow-up||69
515963|NCT00110812|1243455|P2|COMPLETED|Extended Follow-up||65
515964|NCT00110812|1243456|P1|COMPLETED|Extended Follow-up||78
515965|NCT00110812|1243454|P3|STARTED|Extended Follow-up||73
515966|NCT00110812|1243455|P2|STARTED|Extended Follow-up||69
515967|NCT00110812|1243456|P1|STARTED|Extended Follow-up||80
515968|NCT00110812|1243454|P3|NOT COMPLETED|Main Study||13
515969|NCT00110812|1243455|P2|NOT COMPLETED|Main Study||11
515970|NCT00110812|1243456|P1|NOT COMPLETED|Main Study||8
515971|NCT00110812|1243454|P3|COMPLETED|Main Study||74
515972|NCT00110812|1243455|P2|COMPLETED|Main Study||78
515973|NCT00110812|1243456|P1|COMPLETED|Main Study||83
515974|NCT00110812|1243454|P3|STARTED|Main Study||87
515975|NCT00110812|1243455|P2|STARTED|Main Study||89
515976|NCT00110812|1243456|P1|STARTED|Main Study||91
515977|NCT00110617|1243501|P2|NOT COMPLETED|Overall Study||29
515978|NCT00110617|1243502|P1|NOT COMPLETED|Overall Study||39
515979|NCT00110617|1243501|P2|COMPLETED|Overall Study||39
515980|NCT00110617|1243502|P1|COMPLETED|Overall Study||96
515981|NCT00110617|1243501|P2|On Going at Week 24|Overall Study||53
515982|NCT00110617|1243502|P1|On Going at Week 24|Overall Study||126
515983|NCT00110617|1243501|P2|Full Analysis 2; Received ICL670|Overall Study||53
515984|NCT00110617|1243502|P1|Full Analysis 2; Received ICL670|Overall Study||135
515985|NCT00110617|1243501|P2|Safety Set 1; Received Study Drug|Overall Study||56
515986|NCT00110617|1243502|P1|Safety Set 1; Received Study Drug|Overall Study||135
515987|NCT00110617|1243501|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
515988|NCT00110617|1243502|P1|STARTED|Overall Study||135
515989|NCT00110513|1243515|P1|NOT COMPLETED|Overall Study||0
515990|NCT00110513|1243515|P1|COMPLETED|Overall Study||18
515991|NCT00110513|1243515|P1|STARTED|Overall Study||18
515992|NCT00110461|1243522|P3|NOT COMPLETED|Acute Phase||23
515993|NCT00110461|1243523|P2|NOT COMPLETED|Acute Phase||22
515994|NCT00110461|1243524|P1|NOT COMPLETED|Acute Phase||14
515995|NCT00110461|1243522|P3|COMPLETED|Acute Phase||76
515996|NCT00110461|1243523|P2|COMPLETED|Acute Phase||77
515997|NCT00110461|1243524|P1|COMPLETED|Acute Phase||84
515998|NCT00110461|1243522|P3|STARTED|Acute Phase||99
515999|NCT00110461|1243523|P2|STARTED|Acute Phase||99
516000|NCT00110461|1243524|P1|STARTED|Acute Phase||98
516001|NCT00110461|1243522|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
516002|NCT00110461|1243523|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
516003|NCT00110461|1243524|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
516004|NCT00110461|1243522|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
516005|NCT00110461|1243523|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
516006|NCT00110461|1243524|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
516007|NCT00110461|1243522|P3|STARTED|30-Week, Double-blind Treatment Phase||99
516008|NCT00110461|1243523|P2|STARTED|30-Week, Double-blind Treatment Phase||99
516009|NCT00110461|1243524|P1|STARTED|30-Week, Double-blind Treatment Phase||98
516010|NCT00110396|1243619|P1|NOT COMPLETED|Overall Study||36
516011|NCT00110396|1243619|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
516012|NCT00110396|1243619|P1|STARTED|Overall Study||260
516013|NCT00110357|1243627|P2|NOT COMPLETED|Overall Study||19
516014|NCT00110357|1243628|P1|NOT COMPLETED|Overall Study||27
516015|NCT00110357|1243627|P2|COMPLETED|Overall Study|Number Still on Study|0
516016|NCT00110357|1243628|P1|COMPLETED|Overall Study|Number Still on Study|0
516017|NCT00110357|1243627|P2|STARTED|Overall Study||19
516018|NCT00110357|1243628|P1|STARTED|Overall Study||27
516019|NCT00110305|1243716|P2|NOT COMPLETED|Overall Study||32
516020|NCT00110305|1243717|P1|NOT COMPLETED|Overall Study||114
516021|NCT00110305|1243716|P2|COMPLETED|Overall Study||57
516022|NCT00110305|1243717|P1|COMPLETED|Overall Study||165
516023|NCT00110305|1243716|P2|STARTED|Overall Study||89
516024|NCT00110305|1243717|P1|STARTED|Overall Study||279
516025|NCT00110214|1243770|P2|NOT COMPLETED|Overall Study||503
516026|NCT00110214|1243771|P1|NOT COMPLETED|Overall Study||509
516027|NCT00110214|1243770|P2|COMPLETED|Overall Study||21
516028|NCT00110214|1243771|P1|COMPLETED|Overall Study||17
516029|NCT00110214|1243770|P2|STARTED|Overall Study||524
516030|NCT00110214|1243771|P1|STARTED|Overall Study||526
516031|NCT00110136|1243783|P1|NOT COMPLETED|Overall Study||0
516032|NCT00110136|1243783|P1|COMPLETED|Overall Study||9
516033|NCT00110136|1243783|P1|STARTED|Overall Study||9
516034|NCT00110084|1243792|P1|NOT COMPLETED|Overall Study||28
516035|NCT00110084|1243792|P1|COMPLETED|Overall Study||22
516036|NCT00110084|1243792|P1|STARTED|Overall Study||50
516037|NCT00110019|1243801|P2|NOT COMPLETED|Overall Study||413
516038|NCT00110019|1243802|P1|NOT COMPLETED|Overall Study||406
516039|NCT00110019|1243801|P2|COMPLETED|Overall Study||0
516040|NCT00110019|1243802|P1|COMPLETED|Overall Study||4
516041|NCT00110019|1243801|P2|Treated|Overall Study||397
516042|NCT00110019|1243802|P1|Treated|Overall Study||393
516043|NCT00110019|1243801|P2|Eligible|Overall Study||398
516044|NCT00110019|1243802|P1|Eligible|Overall Study||395
516045|NCT00110019|1243801|P2|STARTED|Overall Study||413
516046|NCT00110019|1243802|P1|STARTED|Overall Study||410
516047|NCT00109967|1243814|P2|NOT COMPLETED|Overall Study||6
516048|NCT00109967|1243815|P1|NOT COMPLETED|Overall Study||20
516049|NCT00109967|1243814|P2|COMPLETED|Overall Study||15
516050|NCT00109967|1243815|P1|COMPLETED|Overall Study||30
516051|NCT00109967|1243814|P2|STARTED|Overall Study||21
516052|NCT00109967|1243815|P1|STARTED|Overall Study||50
516053|NCT00109928|1243829|P1|NOT COMPLETED|Overall Study||13
516054|NCT00109928|1243829|P1|COMPLETED|Overall Study||21
516055|NCT00109928|1243829|P1|Eligible and Began Protocol Therapy|Overall Study||33
516056|NCT00109928|1243829|P1|Eligible|Overall Study||33
516057|NCT00109928|1243829|P1|STARTED|Overall Study||34
516058|NCT00109876|1243836|P1|NOT COMPLETED|Overall Study||0
516059|NCT00109876|1243836|P1|COMPLETED|Overall Study||51
516060|NCT00109876|1243836|P1|STARTED|Overall Study||51
516061|NCT00109850|1243846|P1|NOT COMPLETED|Overall Study||4
516062|NCT00109850|1243846|P1|COMPLETED|Overall Study||18
516063|NCT00109850|1243846|P1|Eligible and Began Protocol Therapy|Overall Study||21
516064|NCT00109850|1243846|P1|Eligible|Overall Study||21
516065|NCT00109850|1243846|P1|STARTED|Overall Study||22
516066|NCT00109837|1243853|P1|NOT COMPLETED|Overall Study||23
516067|NCT00109837|1243853|P1|COMPLETED|Overall Study||56
516068|NCT00109837|1243853|P1|Eligible and Ph- and Treated|Overall Study||60
516069|NCT00109837|1243853|P1|Eligible and Ph-|Overall Study||61
516070|NCT00109837|1243853|P1|Eligible|Overall Study||78
516071|NCT00109837|1243853|P1|STARTED|Overall Study||79
516072|NCT00109772|1243863|P2|NOT COMPLETED|Open-label Extension||49
516073|NCT00109772|1243864|P1|NOT COMPLETED|Open-label Extension||45
516074|NCT00109772|1243863|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
516075|NCT00109772|1243864|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
516076|NCT00109772|1243863|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
516077|NCT00109772|1243864|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
516078|NCT00109772|1243863|P2|NOT COMPLETED|Double-blind Treatment||15
516079|NCT00109772|1243864|P1|NOT COMPLETED|Double-blind Treatment||22
516080|NCT00109772|1243863|P2|COMPLETED|Double-blind Treatment||79
516081|NCT00109772|1243864|P1|COMPLETED|Double-blind Treatment||68
516082|NCT00109772|1243863|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
516083|NCT00109772|1243864|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
516084|NCT00109772|1243863|P2|STARTED|Double-blind Treatment||94
516085|NCT00109772|1243864|P1|STARTED|Double-blind Treatment||90
516086|NCT00109733|1243904|P2|NOT COMPLETED|Overall Study||4
516087|NCT00109733|1243905|P1|NOT COMPLETED|Overall Study||2
516088|NCT00109733|1243904|P2|COMPLETED|Overall Study||12
516089|NCT00109733|1243905|P1|COMPLETED|Overall Study||13
516090|NCT00109733|1243904|P2|STARTED|Overall Study||16
516091|NCT00109733|1243905|P1|STARTED|Overall Study||15
516092|NCT00109590|1243922|P3|NOT COMPLETED|Overall Study||4
516093|NCT00109590|1243923|P2|NOT COMPLETED|Overall Study||2
516094|NCT00109590|1243924|P1|NOT COMPLETED|Overall Study||2
516095|NCT00109590|1243922|P3|COMPLETED|Overall Study||56
516096|NCT00109590|1243923|P2|COMPLETED|Overall Study||56
516097|NCT00109590|1243924|P1|COMPLETED|Overall Study||55
516098|NCT00109590|1243922|P3|RECEIVED TREATMENT|Overall Study||57
516099|NCT00109590|1243923|P2|RECEIVED TREATMENT|Overall Study||56
516100|NCT00109590|1243924|P1|RECEIVED TREATMENT|Overall Study||56
516101|NCT00109590|1243922|P3|STARTED|Overall Study||60
516102|NCT00109590|1243923|P2|STARTED|Overall Study||58
516103|NCT00109590|1243924|P1|STARTED|Overall Study||57
516104|NCT00109577|1243966|P2|NOT COMPLETED|Overall Study||3
516105|NCT00109577|1243967|P1|NOT COMPLETED|Overall Study||3
516106|NCT00109577|1243966|P2|COMPLETED|Overall Study||17
516107|NCT00109577|1243967|P1|COMPLETED|Overall Study||17
516108|NCT00109577|1243966|P2|STARTED|Overall Study||20
516109|NCT00109577|1243967|P1|STARTED|Overall Study||20
516110|NCT00109473|1243975|P2|NOT COMPLETED|52 Week Extension Phase||5
516111|NCT00109473|1243976|P1|NOT COMPLETED|52 Week Extension Phase||4
516112|NCT00109473|1243975|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
516113|NCT00109473|1243976|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
516114|NCT00109473|1243975|P2|Analyzed|52 Week Extension Phase||8
516115|NCT00109473|1243976|P1|Analyzed|52 Week Extension Phase||9
516116|NCT00109473|1243975|P2|STARTED|52 Week Extension Phase||8
516117|NCT00109473|1243976|P1|STARTED|52 Week Extension Phase||9
516118|NCT00109473|1243975|P2|NOT COMPLETED|Week 12 to Week 24||0
516119|NCT00109473|1243976|P1|NOT COMPLETED|Week 12 to Week 24||1
516120|NCT00109473|1243975|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
516121|NCT00109473|1243976|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
516122|NCT00109473|1243975|P2|Analyzed|Week 12 to Week 24||9
516123|NCT00109473|1243976|P1|Analyzed|Week 12 to Week 24||9
516124|NCT00109473|1243975|P2|STARTED|Week 12 to Week 24||9
516125|NCT00109473|1243976|P1|STARTED|Week 12 to Week 24||10
516126|NCT00109473|1243975|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
516127|NCT00109473|1243976|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
516128|NCT00109473|1243975|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
516129|NCT00109473|1243976|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
516130|NCT00109473|1243975|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
516131|NCT00109473|1243976|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
516132|NCT00109473|1243975|P2|STARTED|Baseline (0 Through 12 Weeks)||10
516133|NCT00109473|1243976|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
516134|NCT00109343|1243998|P3|NOT COMPLETED|Overall Study||30
516135|NCT00109343|1243999|P2|NOT COMPLETED|Overall Study||37
516136|NCT00109343|1244000|P1|NOT COMPLETED|Overall Study||64
516137|NCT00109343|1243998|P3|COMPLETED|Overall Study||229
516138|NCT00109343|1243999|P2|COMPLETED|Overall Study||221
516139|NCT00109343|1244000|P1|COMPLETED|Overall Study||446
516140|NCT00109343|1243998|P3|Vaccinated at Visit 4|Overall Study||240
516141|NCT00109343|1243999|P2|Vaccinated at Visit 4|Overall Study||235
516142|NCT00109343|1244000|P1|Vaccinated at Visit 4|Overall Study||466
516143|NCT00109343|1243998|P3|Vaccinated at Visit 2|Overall Study||246
516144|NCT00109343|1243999|P2|Vaccinated at Visit 2|Overall Study||246
516145|NCT00109343|1244000|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
516146|NCT00109343|1243998|P3|Vaccinated at Visit 1|Overall Study||259
516147|NCT00109343|1243999|P2|Vaccinated at Visit 1|Overall Study||258
516148|NCT00109343|1244000|P1|Vaccinated at Visit 1|Overall Study||510
516149|NCT00109343|1243998|P3|STARTED|Overall Study||259
516150|NCT00109343|1243999|P2|STARTED|Overall Study||258
516151|NCT00109343|1244000|P1|STARTED|Overall Study||510
516152|NCT00109031|1244045|P4|NOT COMPLETED|Overall Study||0
516153|NCT00109031|1244046|P3|NOT COMPLETED|Overall Study||2
516154|NCT00109031|1244047|P2|NOT COMPLETED|Overall Study||2
516155|NCT00109031|1244048|P1|NOT COMPLETED|Overall Study||0
516156|NCT00109031|1244045|P4|COMPLETED|Overall Study||12
516157|NCT00109031|1244046|P3|COMPLETED|Overall Study||12
516158|NCT00109031|1244047|P2|COMPLETED|Overall Study||8
516159|NCT00109031|1244048|P1|COMPLETED|Overall Study||11
516160|NCT00109031|1244045|P4|STARTED|Overall Study||12
516161|NCT00109031|1244046|P3|STARTED|Overall Study||14
516162|NCT00109031|1244047|P2|STARTED|Overall Study||10
516163|NCT00109031|1244048|P1|STARTED|Overall Study||11
516164|NCT00109005|1244084|P2|NOT COMPLETED|Overall Study||0
516165|NCT00109005|1244085|P1|NOT COMPLETED|Overall Study||0
516166|NCT00109005|1244084|P2|COMPLETED|Overall Study||9
516167|NCT00109005|1244085|P1|COMPLETED|Overall Study||8
516168|NCT00109005|1244084|P2|STARTED|Overall Study||9
516169|NCT00109005|1244085|P1|STARTED|Overall Study||8
516170|NCT00108953|1244099|P2|NOT COMPLETED|Follow-up||33
516171|NCT00108953|1244100|P1|NOT COMPLETED|Follow-up||29
516172|NCT00108953|1244099|P2|COMPLETED|Follow-up||12
516173|NCT00108953|1244100|P1|COMPLETED|Follow-up||11
516174|NCT00108953|1244099|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
516175|NCT00108953|1244100|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
516176|NCT00108953|1244099|P2|NOT COMPLETED|Treatment Period||0
516177|NCT00108953|1244100|P1|NOT COMPLETED|Treatment Period||0
516178|NCT00108953|1244099|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
516179|NCT00108953|1244100|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
516180|NCT00108953|1244099|P2|STARTED|Treatment Period|ITT population|49
516181|NCT00108953|1244100|P1|STARTED|Treatment Period|ITT population|47
516182|NCT00108862|1244122|P2|NOT COMPLETED|Overall Study||62
516183|NCT00108862|1244123|P1|NOT COMPLETED|Overall Study||68
516184|NCT00108862|1244122|P2|COMPLETED|Overall Study||339
516185|NCT00108862|1244123|P1|COMPLETED|Overall Study||337
516186|NCT00108862|1244122|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
516187|NCT00108862|1244123|P1|STARTED|Overall Study||405
516188|NCT00108732|1244151|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
516189|NCT00108732|1244151|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
516190|NCT00108732|1244151|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
516191|NCT00108732|1244151|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
516192|NCT00108732|1244151|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
516193|NCT00108732|1244151|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
516194|NCT00108732|1244151|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
516195|NCT00108628|1244160|P2|NOT COMPLETED|Overall Study||10
516196|NCT00108628|1244161|P1|NOT COMPLETED|Overall Study||20
516197|NCT00108628|1244160|P2|COMPLETED|Overall Study||53
516198|NCT00108628|1244161|P1|COMPLETED|Overall Study||41
516199|NCT00108628|1244160|P2|Completed Treatment|Overall Study||57
516200|NCT00108628|1244161|P1|Completed Treatment|Overall Study||42
516201|NCT00108628|1244160|P2|Received One or More Sessions|Overall Study||58
516202|NCT00108628|1244161|P1|Received One or More Sessions|Overall Study||53
516203|NCT00108628|1244160|P2|STARTED|Overall Study||63
516204|NCT00108628|1244161|P1|STARTED|Overall Study||61
516205|NCT00108550|1244187|P2|NOT COMPLETED|Overall Study||16
516206|NCT00108550|1244188|P1|NOT COMPLETED|Overall Study||16
516207|NCT00108550|1244187|P2|COMPLETED|Overall Study||37
516208|NCT00108550|1244188|P1|COMPLETED|Overall Study||39
516209|NCT00108550|1244187|P2|STARTED|Overall Study||53
516210|NCT00108550|1244188|P1|STARTED|Overall Study||55
516211|NCT00108524|1244198|P2|NOT COMPLETED|Overall Study||18
516212|NCT00108524|1244199|P1|NOT COMPLETED|Overall Study||29
516213|NCT00108524|1244198|P2|COMPLETED|Overall Study||61
516214|NCT00108524|1244199|P1|COMPLETED|Overall Study||52
516215|NCT00108524|1244198|P2|STARTED|Overall Study||79
516216|NCT00108524|1244199|P1|STARTED|Overall Study||81
516217|NCT00108485|1244211|P2|NOT COMPLETED|Overall Study||2
516218|NCT00108485|1244212|P1|NOT COMPLETED|Overall Study||3
516219|NCT00108485|1244211|P2|COMPLETED|Overall Study||2
516220|NCT00108485|1244212|P1|COMPLETED|Overall Study||2
516221|NCT00108485|1244211|P2|STARTED|Overall Study||4
516222|NCT00108485|1244212|P1|STARTED|Overall Study||5
516223|NCT00108433|1244220|P2|NOT COMPLETED|Overall Study||17
516224|NCT00108433|1244221|P1|NOT COMPLETED|Overall Study||21
516225|NCT00108433|1244220|P2|COMPLETED|Overall Study||14
516226|NCT00108433|1244221|P1|COMPLETED|Overall Study||9
516227|NCT00108433|1244220|P2|STARTED|Overall Study||31
516228|NCT00108433|1244221|P1|STARTED|Overall Study||30
516229|NCT00108355|1244237|P2|NOT COMPLETED|Overall Study||2
516230|NCT00108355|1244238|P1|NOT COMPLETED|Overall Study||2
516231|NCT00108355|1244237|P2|COMPLETED|Overall Study||12
516232|NCT00108355|1244238|P1|COMPLETED|Overall Study||13
516233|NCT00108355|1244237|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
516234|NCT00108355|1244238|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
516235|NCT00108342|1244248|P2|NOT COMPLETED|Overall Study||0
516236|NCT00108342|1244249|P1|NOT COMPLETED|Overall Study||1
516237|NCT00108342|1244248|P2|COMPLETED|Overall Study||9
516238|NCT00108342|1244249|P1|COMPLETED|Overall Study||7
516239|NCT00108342|1244248|P2|STARTED|Overall Study||9
516240|NCT00108342|1244249|P1|STARTED|Overall Study||8
516241|NCT00108303|1244258|P3|NOT COMPLETED|Overall Study||0
516242|NCT00108303|1244259|P2|NOT COMPLETED|Overall Study||0
516243|NCT00108303|1244260|P1|NOT COMPLETED|Overall Study||0
516244|NCT00108303|1244258|P3|COMPLETED|Overall Study||180
516245|NCT00108303|1244259|P2|COMPLETED|Overall Study||179
516246|NCT00108303|1244260|P1|COMPLETED|Overall Study||179
516247|NCT00108303|1244258|P3|STARTED|Overall Study||180
516248|NCT00108303|1244259|P2|STARTED|Overall Study||179
516249|NCT00108303|1244260|P1|STARTED|Overall Study||179
516250|NCT00108277|1244275|P3|NOT COMPLETED|Overall Study||16
516251|NCT00108277|1244276|P2|NOT COMPLETED|Overall Study||12
516252|NCT00108277|1244277|P1|NOT COMPLETED|Overall Study||10
516253|NCT00108277|1244275|P3|COMPLETED|Overall Study||19
516254|NCT00108277|1244276|P2|COMPLETED|Overall Study||16
516255|NCT00108277|1244277|P1|COMPLETED|Overall Study||19
516256|NCT00108277|1244275|P3|STARTED|Overall Study||35
516257|NCT00108277|1244276|P2|STARTED|Overall Study||28
516258|NCT00108277|1244277|P1|STARTED|Overall Study||29
516259|NCT00107172|1244287|P2|NOT COMPLETED|Overall Study||5
516260|NCT00107172|1244288|P1|NOT COMPLETED|Overall Study||5
516261|NCT00107172|1244287|P2|COMPLETED|Overall Study||103
516262|NCT00107172|1244288|P1|COMPLETED|Overall Study||109
516263|NCT00107172|1244287|P2|STARTED|Overall Study||108
516264|NCT00107172|1244288|P1|STARTED|Overall Study||114
516265|NCT00107120|1244318|P2|NOT COMPLETED|Overall Study||24
516266|NCT00107120|1244319|P1|NOT COMPLETED|Overall Study||29
516267|NCT00107120|1244318|P2|COMPLETED|Overall Study||133
516268|NCT00107120|1244319|P1|COMPLETED|Overall Study||126
516269|NCT00107120|1244318|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
516270|NCT00107120|1244319|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
516271|NCT00107042|1244331|P2|NOT COMPLETED|Overall Study||16
516272|NCT00107042|1244332|P1|NOT COMPLETED|Overall Study||22
516273|NCT00107042|1244331|P2|COMPLETED|Overall Study||47
516274|NCT00107042|1244332|P1|COMPLETED|Overall Study||38
516275|NCT00107042|1244331|P2|STARTED|Overall Study||63
516276|NCT00107042|1244332|P1|STARTED|Overall Study||60
516277|NCT00106964|1244398|P3|NOT COMPLETED|Overall Study||7
516278|NCT00106964|1244399|P2|NOT COMPLETED|Overall Study||15
516279|NCT00106964|1244400|P1|NOT COMPLETED|Overall Study||13
516280|NCT00106964|1244398|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
516281|NCT00106964|1244399|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
516282|NCT00106964|1244400|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
516283|NCT00106964|1244398|P3|STARTED|Overall Study||127
516284|NCT00106964|1244399|P2|STARTED|Overall Study||126
516285|NCT00106964|1244400|P1|STARTED|Overall Study||118
516286|NCT00106938|1244425|P2|NOT COMPLETED|Overall Study||71
516287|NCT00106938|1244426|P1|NOT COMPLETED|Overall Study||176
516288|NCT00106938|1244425|P2|COMPLETED|Overall Study||293
516289|NCT00106938|1244426|P1|COMPLETED|Overall Study||913
516290|NCT00106938|1244425|P2|STARTED|Overall Study||364
516291|NCT00106938|1244426|P1|STARTED|Overall Study||1089
516292|NCT00108160|1244473|P2|NOT COMPLETED|Overall Study||21
516293|NCT00108160|1244474|P1|NOT COMPLETED|Overall Study||39
516294|NCT00108160|1244473|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
516295|NCT00108160|1244474|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
516296|NCT00108160|1244473|P2|Completed Visit 7 (18 mo)|Overall Study||31
516297|NCT00108160|1244474|P1|Completed Visit 7 (18 mo)|Overall Study||34
516298|NCT00108160|1244473|P2|Completed Visit 6 (15 mo)|Overall Study||33
516299|NCT00108160|1244474|P1|Completed Visit 6 (15 mo)|Overall Study||36
516300|NCT00108160|1244473|P2|Completed Visit 5 (12 mo)|Overall Study||37
516301|NCT00108160|1244474|P1|Completed Visit 5 (12 mo)|Overall Study||37
516302|NCT00108160|1244473|P2|Completed Visit 4 (9 mo)|Overall Study||37
516303|NCT00108160|1244474|P1|Completed Visit 4 (9 mo)|Overall Study||38
516304|NCT00108160|1244473|P2|Completed Visit 3 (6 mo)|Overall Study||38
516305|NCT00108160|1244474|P1|Completed Visit 3 (6 mo)|Overall Study||44
516306|NCT00108160|1244473|P2|Completed Visit 2 (3 mo)|Overall Study||46
516307|NCT00108160|1244474|P1|Completed Visit 2 (3 mo)|Overall Study||54
516308|NCT00108160|1244473|P2|Completed Visit 1 (2 Wks)|Overall Study||54
516309|NCT00108160|1244474|P1|Completed Visit 1 (2 Wks)|Overall Study||72
516310|NCT00108160|1244473|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
516311|NCT00108160|1244474|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
516312|NCT00108160|1244473|P2|STARTED|Overall Study||63
516313|NCT00108160|1244474|P1|STARTED|Overall Study||83
516314|NCT00108082|1244487|P3|NOT COMPLETED|Overall Study||43
516315|NCT00108082|1244488|P2|NOT COMPLETED|Overall Study||32
516316|NCT00108082|1244489|P1|NOT COMPLETED|Overall Study||38
516317|NCT00108082|1244487|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
516318|NCT00108082|1244488|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
516319|NCT00108082|1244489|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
516320|NCT00108082|1244487|P3|STARTED|Overall Study||96
516321|NCT00108082|1244488|P2|STARTED|Overall Study||100
516322|NCT00108082|1244489|P1|STARTED|Overall Study||91
516323|NCT00108069|1244538|P2|NOT COMPLETED|Overall Study||13
516324|NCT00108069|1244539|P1|NOT COMPLETED|Overall Study||30
516325|NCT00108069|1244538|P2|COMPLETED|Overall Study||0
516326|NCT00108069|1244539|P1|COMPLETED|Overall Study||0
516327|NCT00108069|1244538|P2|STARTED|Overall Study||13
516328|NCT00108069|1244539|P1|STARTED|Overall Study||30
516329|NCT00107991|1244553|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
516330|NCT00107991|1244553|P1|COMPLETED|18-Week Post Treatment Assessment||8
516331|NCT00107991|1244553|P1|STARTED|18-Week Post Treatment Assessment||10
516332|NCT00107991|1244553|P1|NOT COMPLETED|12 Week Treatment Period||5
516333|NCT00107991|1244553|P1|COMPLETED|12 Week Treatment Period||10
516334|NCT00107991|1244553|P1|STARTED|12 Week Treatment Period||15
516335|NCT00107991|1244553|P1|NOT COMPLETED|Eligibility Assessment||23
516336|NCT00107991|1244553|P1|COMPLETED|Eligibility Assessment||15
516337|NCT00107991|1244553|P1|STARTED|Eligibility Assessment||38
516338|NCT00107978|1244563|P2|NOT COMPLETED|Overall Study||50
516339|NCT00107978|1244564|P1|NOT COMPLETED|Overall Study||33
516340|NCT00107978|1244563|P2|COMPLETED|Overall Study||431
516341|NCT00107978|1244564|P1|COMPLETED|Overall Study||425
516342|NCT00107978|1244563|P2|STARTED|Overall Study||481
516343|NCT00107978|1244564|P1|STARTED|Overall Study||458
516344|NCT00107952|1244572|P2|NOT COMPLETED|Overall Study||81
516345|NCT00107952|1244573|P1|NOT COMPLETED|Overall Study||95
516346|NCT00107952|1244572|P2|COMPLETED|Overall Study||299
516347|NCT00107952|1244573|P1|COMPLETED|Overall Study||286
516348|NCT00107952|1244572|P2|STARTED|Overall Study||380
516349|NCT00107952|1244573|P1|STARTED|Overall Study||381
516350|NCT00107900|1244585|P6|NOT COMPLETED|Overall Study||9
516351|NCT00107900|1244586|P5|NOT COMPLETED|Overall Study||21
516352|NCT00107900|1244587|P4|NOT COMPLETED|Overall Study||12
516353|NCT00107900|1244588|P3|NOT COMPLETED|Overall Study||25
516354|NCT00107900|1244589|P2|NOT COMPLETED|Overall Study||3
516355|NCT00107900|1244590|P1|NOT COMPLETED|Overall Study||10
516356|NCT00107900|1244585|P6|COMPLETED|Overall Study||94
516357|NCT00107900|1244586|P5|COMPLETED|Overall Study||94
516358|NCT00107900|1244587|P4|COMPLETED|Overall Study||87
516359|NCT00107900|1244588|P3|COMPLETED|Overall Study||104
516360|NCT00107900|1244589|P2|COMPLETED|Overall Study||72
516361|NCT00107900|1244590|P1|COMPLETED|Overall Study||75
516362|NCT00107900|1244585|P6|STARTED|Overall Study||103
516363|NCT00107900|1244586|P5|STARTED|Overall Study||115
516364|NCT00107900|1244587|P4|STARTED|Overall Study||99
516365|NCT00107900|1244588|P3|STARTED|Overall Study||129
516366|NCT00107900|1244589|P2|STARTED|Overall Study||75
516367|NCT00107900|1244590|P1|STARTED|Overall Study||85
516368|NCT00107783|1244624|P2|NOT COMPLETED|Overall Study||4
516369|NCT00107783|1244625|P1|NOT COMPLETED|Overall Study||3
516370|NCT00107783|1244624|P2|COMPLETED|Overall Study||16
516371|NCT00107783|1244625|P1|COMPLETED|Overall Study||17
516372|NCT00107783|1244624|P2|STARTED|Overall Study||20
516373|NCT00107783|1244625|P1|STARTED|Overall Study||20
516374|NCT00107653|1244641|P2|NOT COMPLETED|Overall Study||76
516375|NCT00107653|1244642|P1|NOT COMPLETED|Overall Study||79
516376|NCT00107653|1244641|P2|COMPLETED|Overall Study||224
516377|NCT00107653|1244642|P1|COMPLETED|Overall Study||190
516378|NCT00107653|1244641|P2|STARTED|Overall Study||300
516379|NCT00107653|1244642|P1|STARTED|Overall Study||269
516380|NCT00107614|1244688|P1|NOT COMPLETED|Overall Study||12
516381|NCT00107614|1244688|P1|COMPLETED|Overall Study||0
516382|NCT00107614|1244688|P1|STARTED|Overall Study||12
516383|NCT00107575|1244694|P2|NOT COMPLETED|Overall Study||10
516384|NCT00107575|1244695|P1|NOT COMPLETED|Overall Study||11
516385|NCT00107575|1244694|P2|COMPLETED|Overall Study||107
516386|NCT00107575|1244695|P1|COMPLETED|Overall Study||108
516387|NCT00107575|1244694|P2|STARTED|Overall Study||117
516388|NCT00107575|1244695|P1|STARTED|Overall Study||119
516389|NCT00107536|1244709|P1|NOT COMPLETED|Overall Study||0
516390|NCT00107536|1244709|P1|COMPLETED|Overall Study||26
516391|NCT00107536|1244709|P1|STARTED|Overall Study||26
516392|NCT00107380|1244719|P1|NOT COMPLETED|Overall Study||30
516393|NCT00107380|1244719|P1|COMPLETED|Overall Study||56
516394|NCT00107380|1244719|P1|Eligible|Overall Study||84
516395|NCT00107380|1244719|P1|STARTED|Overall Study||86
516396|NCT00107315|1244725|P1|NOT COMPLETED|Overall Study||15
516397|NCT00107315|1244725|P1|COMPLETED|Overall Study||1
516398|NCT00107315|1244725|P1|STARTED|Overall Study||16
516399|NCT00107276|1244732|P1|NOT COMPLETED|Overall Study||72
516400|NCT00107276|1244732|P1|COMPLETED|Overall Study||40
516401|NCT00107276|1244732|P1|Eligible|Overall Study||96
516402|NCT00107276|1244732|P1|STARTED|Overall Study||112
516403|NCT00107198|1244738|P1|NOT COMPLETED|Overall Study||52
516404|NCT00107198|1244738|P1|COMPLETED|Overall Study||136
516405|NCT00107198|1244738|P1|STARTED|Overall Study||188
516406|NCT00106704|1244748|P2|NOT COMPLETED|Overall Study||151
516407|NCT00106704|1244749|P1|NOT COMPLETED|Overall Study||131
516408|NCT00106704|1244748|P2|COMPLETED|Overall Study||68
516409|NCT00106704|1244749|P1|COMPLETED|Overall Study||91
516410|NCT00106704|1244748|P2|STARTED|Overall Study||219
516411|NCT00106704|1244749|P1|STARTED|Overall Study||222
516412|NCT00106639|1244760|P3|NOT COMPLETED|Overall Study||2
516413|NCT00106639|1244761|P2|NOT COMPLETED|Overall Study||7
516414|NCT00106639|1244762|P1|NOT COMPLETED|Overall Study||3
516415|NCT00106639|1244760|P3|COMPLETED|Overall Study||19
516416|NCT00106639|1244761|P2|COMPLETED|Overall Study||13
516417|NCT00106639|1244762|P1|COMPLETED|Overall Study||17
516418|NCT00106639|1244760|P3|STARTED|Overall Study||21
516419|NCT00106639|1244761|P2|STARTED|Overall Study||20
516420|NCT00106639|1244762|P1|STARTED|Overall Study||20
516421|NCT00106626|1244889|P4|NOT COMPLETED|Overall Study||13
516422|NCT00106626|1244890|P3|NOT COMPLETED|Overall Study||12
516423|NCT00106626|1244891|P2|NOT COMPLETED|Overall Study||6
516424|NCT00106626|1244892|P1|NOT COMPLETED|Overall Study||10
516425|NCT00106626|1244889|P4|COMPLETED|Overall Study||3
516426|NCT00106626|1244890|P3|COMPLETED|Overall Study||2
516427|NCT00106626|1244891|P2|COMPLETED|Overall Study||3
516428|NCT00106626|1244892|P1|COMPLETED|Overall Study||3
516429|NCT00106626|1244889|P4|STARTED|Overall Study||16
516430|NCT00106626|1244890|P3|STARTED|Overall Study||14
516431|NCT00106626|1244891|P2|STARTED|Overall Study||9
516432|NCT00106626|1244892|P1|STARTED|Overall Study||13
516433|NCT00106535|1244910|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
516434|NCT00106535|1244911|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
516435|NCT00106535|1244912|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
516436|NCT00106535|1244913|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
516437|NCT00106535|1244910|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
516438|NCT00106535|1244911|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
516439|NCT00106535|1244912|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
516440|NCT00106535|1244913|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
516441|NCT00106535|1244910|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
516442|NCT00106535|1244911|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
516443|NCT00106535|1244912|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
516444|NCT00106535|1244913|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
516445|NCT00106535|1244910|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
516446|NCT00106535|1244911|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
516447|NCT00106535|1244912|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
516448|NCT00106535|1244913|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
516449|NCT00106535|1244910|P4|COMPLETED|2-year Placebo Controlled Period||0
516450|NCT00106535|1244911|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
516451|NCT00106535|1244912|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
516452|NCT00106535|1244913|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
516453|NCT00106535|1244910|P4|Completed Week 52|2-year Placebo Controlled Period||0
516454|NCT00106535|1244911|P3|Completed Week 52|2-year Placebo Controlled Period||338
516455|NCT00106535|1244912|P2|Completed Week 52|2-year Placebo Controlled Period||342
516456|NCT00106535|1244913|P1|Completed Week 52|2-year Placebo Controlled Period||326
516457|NCT00106535|1244910|P4|Completed Week 24|2-year Placebo Controlled Period||0
516458|NCT00106535|1244911|P3|Completed Week 24|2-year Placebo Controlled Period||366
516459|NCT00106535|1244912|P2|Completed Week 24|2-year Placebo Controlled Period||373
516460|NCT00106535|1244913|P1|Completed Week 24|2-year Placebo Controlled Period||356
516461|NCT00106535|1244910|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
516462|NCT00106535|1244911|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
516463|NCT00106535|1244912|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
516464|NCT00106535|1244913|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
516465|NCT00106535|1244910|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
516466|NCT00106535|1244911|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
516467|NCT00106535|1244912|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
516468|NCT00106535|1244913|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
516469|NCT00106535|1244910|P4|STARTED|2-year Placebo Controlled Period||0
516470|NCT00106535|1244911|P3|STARTED|2-year Placebo Controlled Period||401
516471|NCT00106535|1244912|P2|STARTED|2-year Placebo Controlled Period||401
516472|NCT00106535|1244913|P1|STARTED|2-year Placebo Controlled Period||394
516473|NCT00106431|1245206|P1|NOT COMPLETED|Overall Study||65
516474|NCT00106431|1245206|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
516475|NCT00106431|1245206|P1|STARTED|Overall Study||102
516476|NCT00106392|1245218|P2|NOT COMPLETED|Overall Study||27
516477|NCT00106392|1245219|P1|NOT COMPLETED|Overall Study||26
516478|NCT00106392|1245218|P2|COMPLETED|Overall Study||42
516479|NCT00106392|1245219|P1|COMPLETED|Overall Study||36
516480|NCT00106392|1245218|P2|Full Analysis Set (FAS)|Overall Study||61
516481|NCT00106392|1245219|P1|Full Analysis Set (FAS)|Overall Study||53
516482|NCT00106392|1245218|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
516483|NCT00106392|1245219|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
516484|NCT00106392|1245218|P2|STARTED|Overall Study||69
516485|NCT00106392|1245219|P1|STARTED|Overall Study||62
516486|NCT00106353|1245237|P7|NOT COMPLETED|Part 2||16
516487|NCT00106353|1245238|P6|NOT COMPLETED|Part 2||18
516488|NCT00106353|1245239|P5|NOT COMPLETED|Part 2||16
516489|NCT00106353|1245240|P4|NOT COMPLETED|Part 2||0
516490|NCT00106353|1245241|P3|NOT COMPLETED|Part 2||0
516491|NCT00106353|1245242|P2|NOT COMPLETED|Part 2||0
516492|NCT00106353|1245243|P1|NOT COMPLETED|Part 2||0
516493|NCT00106353|1245237|P7|COMPLETED|Part 2||0
516494|NCT00106353|1245238|P6|COMPLETED|Part 2||1
516495|NCT00106353|1245239|P5|COMPLETED|Part 2||1
516496|NCT00106353|1245240|P4|COMPLETED|Part 2||0
516497|NCT00106353|1245241|P3|COMPLETED|Part 2||0
516498|NCT00106353|1245242|P2|COMPLETED|Part 2||0
516499|NCT00106353|1245243|P1|COMPLETED|Part 2||0
516500|NCT00106353|1245237|P7|STARTED|Part 2||16
516501|NCT00106353|1245238|P6|STARTED|Part 2||19
516502|NCT00106353|1245239|P5|STARTED|Part 2||17
516503|NCT00106353|1245240|P4|STARTED|Part 2||0
516504|NCT00106353|1245241|P3|STARTED|Part 2||0
516505|NCT00106353|1245242|P2|STARTED|Part 2||0
516506|NCT00106353|1245243|P1|STARTED|Part 2||0
516507|NCT00106353|1245237|P7|NOT COMPLETED|Part 1||0
516508|NCT00106353|1245238|P6|NOT COMPLETED|Part 1||0
516509|NCT00106353|1245239|P5|NOT COMPLETED|Part 1||0
516510|NCT00106353|1245240|P4|NOT COMPLETED|Part 1||7
516511|NCT00106353|1245241|P3|NOT COMPLETED|Part 1||3
516512|NCT00106353|1245242|P2|NOT COMPLETED|Part 1||5
516513|NCT00106353|1245243|P1|NOT COMPLETED|Part 1||4
516514|NCT00106353|1245237|P7|COMPLETED|Part 1||0
516515|NCT00106353|1245238|P6|COMPLETED|Part 1||0
516516|NCT00106353|1245239|P5|COMPLETED|Part 1||0
516517|NCT00106353|1245240|P4|COMPLETED|Part 1||0
516518|NCT00106353|1245241|P3|COMPLETED|Part 1||0
516519|NCT00106353|1245242|P2|COMPLETED|Part 1||0
516520|NCT00106353|1245243|P1|COMPLETED|Part 1||0
516521|NCT00106353|1245237|P7|STARTED|Part 1||0
516522|NCT00106353|1245238|P6|STARTED|Part 1||0
516523|NCT00106353|1245239|P5|STARTED|Part 1||0
516524|NCT00106353|1245240|P4|STARTED|Part 1||7
516525|NCT00106353|1245241|P3|STARTED|Part 1||3
516526|NCT00106353|1245242|P2|STARTED|Part 1||5
516527|NCT00106353|1245243|P1|STARTED|Part 1||4
516528|NCT00106249|1245370|P2|NOT COMPLETED|Overall Study||2
516529|NCT00106249|1245371|P1|NOT COMPLETED|Overall Study||3
516530|NCT00106249|1245370|P2|COMPLETED|Overall Study||11
516531|NCT00106249|1245371|P1|COMPLETED|Overall Study||11
516532|NCT00106249|1245370|P2|STARTED|Overall Study||13
516533|NCT00106249|1245371|P1|STARTED|Overall Study||14
516534|NCT00106184|1245383|P2|NOT COMPLETED|Overall Study||2
516535|NCT00106184|1245384|P1|NOT COMPLETED|Overall Study||3
516536|NCT00106184|1245383|P2|COMPLETED|Overall Study||102
516537|NCT00106184|1245384|P1|COMPLETED|Overall Study||93
516538|NCT00106184|1245383|P2|Treated|Overall Study|104 subjects were randomized.|102
516539|NCT00106184|1245384|P1|Treated|Overall Study|96 subjects were randomized.|93
516540|NCT00106184|1245383|P2|STARTED|Overall Study||104
516541|NCT00106184|1245384|P1|STARTED|Overall Study||96
516542|NCT00106119|1245394|P2|NOT COMPLETED|Second Intervention||0
516543|NCT00106119|1245395|P1|NOT COMPLETED|Second Intervention||0
516544|NCT00106119|1245394|P2|COMPLETED|Second Intervention||7
516545|NCT00106119|1245395|P1|COMPLETED|Second Intervention||7
516546|NCT00106119|1245394|P2|STARTED|Second Intervention||7
516547|NCT00106119|1245395|P1|STARTED|Second Intervention||7
516548|NCT00106119|1245394|P2|NOT COMPLETED|Washout Period of 30 Days||0
516549|NCT00106119|1245395|P1|NOT COMPLETED|Washout Period of 30 Days||0
516550|NCT00106119|1245394|P2|COMPLETED|Washout Period of 30 Days||7
516551|NCT00106119|1245395|P1|COMPLETED|Washout Period of 30 Days||7
516552|NCT00106119|1245394|P2|STARTED|Washout Period of 30 Days||7
516553|NCT00106119|1245395|P1|STARTED|Washout Period of 30 Days||7
516554|NCT00106119|1245394|P2|NOT COMPLETED|First Intervention||0
516555|NCT00106119|1245395|P1|NOT COMPLETED|First Intervention||0
516556|NCT00106119|1245394|P2|COMPLETED|First Intervention||7
516557|NCT00106119|1245395|P1|COMPLETED|First Intervention||7
516558|NCT00106119|1245394|P2|STARTED|First Intervention||7
516559|NCT00106119|1245395|P1|STARTED|First Intervention||7
516560|NCT00106106|1245415|P2|NOT COMPLETED|Overall Study||4
516561|NCT00106106|1245416|P1|NOT COMPLETED|Overall Study||4
516562|NCT00106106|1245415|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
516563|NCT00106106|1245416|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
516564|NCT00106106|1245415|P2|Completed Both MRS Scans|Overall Study||15
516565|NCT00106106|1245416|P1|Completed Both MRS Scans|Overall Study||18
516566|NCT00106106|1245415|P2|STARTED|Overall Study||23
516567|NCT00106106|1245416|P1|STARTED|Overall Study||26
516568|NCT00106080|1245426|P2|NOT COMPLETED|Overall Study||27
516569|NCT00106080|1245427|P1|NOT COMPLETED|Overall Study||43
516570|NCT00106080|1245426|P2|COMPLETED|Overall Study||155
516571|NCT00106080|1245427|P1|COMPLETED|Overall Study||151
516572|NCT00106080|1245426|P2|STARTED|Overall Study||182
516573|NCT00106080|1245427|P1|STARTED|Overall Study||194
516574|NCT00106028|1245437|P2|NOT COMPLETED|Overall Study||12
516575|NCT00106028|1245438|P1|NOT COMPLETED|Overall Study||6
516576|NCT00106028|1245437|P2|COMPLETED|Overall Study|Completed Month 36|82
516577|NCT00106028|1245438|P1|COMPLETED|Overall Study|Completed Month 36|43
516578|NCT00106028|1245437|P2|Month 12 Completed/Started Open Label|Overall Study||87
516579|NCT00106028|1245438|P1|Month 12 Completed/Started Open Label|Overall Study||49
516580|NCT00106028|1245437|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
516581|NCT00106028|1245438|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
516582|NCT00106002|1245532|P1|NOT COMPLETED|Overall Study||2
516583|NCT00106002|1245532|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
516584|NCT00106002|1245532|P1|STARTED|Overall Study||37
516585|NCT00105989|1245540|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
516586|NCT00105989|1245541|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
516587|NCT00105989|1245540|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
516588|NCT00105989|1245541|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
516589|NCT00105989|1245540|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
516590|NCT00105989|1245541|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
516591|NCT00105989|1245540|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
516592|NCT00105989|1245541|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
516593|NCT00105989|1245540|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
516594|NCT00105989|1245541|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
516595|NCT00105989|1245540|P2|STARTED|Continuation - Open Label:Week 10-34||0
516596|NCT00105989|1245541|P1|STARTED|Continuation - Open Label:Week 10-34||413
516597|NCT00105989|1245540|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
516598|NCT00105989|1245541|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
516599|NCT00105989|1245540|P2|COMPLETED|Acute - Open Label: Week 0-10||0
516600|NCT00105989|1245541|P1|COMPLETED|Acute - Open Label: Week 0-10||413
516601|NCT00105989|1245540|P2|STARTED|Acute - Open Label: Week 0-10||0
516602|NCT00105989|1245541|P1|STARTED|Acute - Open Label: Week 0-10||514
516603|NCT00105586|1245657|P2|NOT COMPLETED|Overall Study||16
516604|NCT00105586|1245658|P1|NOT COMPLETED|Overall Study||17
516605|NCT00105586|1245657|P2|COMPLETED|Overall Study||69
516606|NCT00105586|1245658|P1|COMPLETED|Overall Study||75
516607|NCT00105586|1245657|P2|STARTED|Overall Study||85
516608|NCT00105586|1245658|P1|STARTED|Overall Study||92
516609|NCT00105534|1245668|P2|NOT COMPLETED|Overall Study||33
516610|NCT00105534|1245669|P1|NOT COMPLETED|Overall Study||22
516611|NCT00105534|1245668|P2|COMPLETED|Overall Study||317
516612|NCT00105534|1245669|P1|COMPLETED|Overall Study||313
516613|NCT00105534|1245668|P2|STARTED|Overall Study||350
516614|NCT00105534|1245669|P1|STARTED|Overall Study||335
516615|NCT00105482|1245679|P2|NOT COMPLETED|Overall Study||55
516616|NCT00105482|1245680|P1|NOT COMPLETED|Overall Study||59
516617|NCT00105482|1245679|P2|COMPLETED|Overall Study||30
516618|NCT00105482|1245680|P1|COMPLETED|Overall Study||28
516619|NCT00105482|1245679|P2|STARTED|Overall Study||85
516620|NCT00105482|1245680|P1|STARTED|Overall Study||87
516621|NCT00105469|1245696|P2|NOT COMPLETED|Overall Study||11
516622|NCT00105469|1245697|P1|NOT COMPLETED|Overall Study||22
516623|NCT00105469|1245696|P2|COMPLETED|Overall Study||367
516624|NCT00105469|1245697|P1|COMPLETED|Overall Study||343
516625|NCT00105469|1245696|P2|STARTED|Overall Study||378
516626|NCT00105469|1245697|P1|STARTED|Overall Study||365
516627|NCT00105443|1245707|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
516628|NCT00105443|1245708|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
516629|NCT00105443|1245709|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
516630|NCT00105443|1245710|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
516631|NCT00105443|1245707|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
516632|NCT00105443|1245708|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
516633|NCT00105443|1245709|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
516634|NCT00105443|1245710|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
516635|NCT00105443|1245707|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
516699|NCT00105157|1245814|P2|NOT COMPLETED|Open-Label Continuation of DB||10
516636|NCT00105443|1245708|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
516637|NCT00105443|1245709|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
516638|NCT00105443|1245710|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
516639|NCT00105443|1245707|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
516640|NCT00105443|1245708|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
516641|NCT00105443|1245709|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
516642|NCT00105443|1245710|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
516643|NCT00105443|1245707|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
516644|NCT00105443|1245708|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
516645|NCT00105443|1245709|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
516646|NCT00105443|1245710|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
516647|NCT00105443|1245707|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
516648|NCT00105443|1245708|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
516649|NCT00105443|1245709|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
516650|NCT00105443|1245710|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
516651|NCT00105443|1245707|P4|NOT COMPLETED|Double-Blind Treatment||0
516652|NCT00105443|1245708|P3|NOT COMPLETED|Double-Blind Treatment||11
516653|NCT00105443|1245709|P2|NOT COMPLETED|Double-Blind Treatment||0
516654|NCT00105443|1245710|P1|NOT COMPLETED|Double-Blind Treatment||14
516655|NCT00105443|1245707|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
516656|NCT00105443|1245708|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
516657|NCT00105443|1245709|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
516658|NCT00105443|1245710|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
516659|NCT00105443|1245707|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
516660|NCT00105443|1245708|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
516661|NCT00105443|1245709|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
516662|NCT00105443|1245710|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
516663|NCT00105443|1245707|P4|STARTED|Double-Blind Treatment||47
516664|NCT00105443|1245708|P3|STARTED|Double-Blind Treatment||256
516665|NCT00105443|1245709|P2|STARTED|Double-Blind Treatment||57
516666|NCT00105443|1245710|P1|STARTED|Double-Blind Treatment||242
516667|NCT00105235|1245737|P1|NOT COMPLETED|Overall Study||7
516668|NCT00105235|1245737|P1|COMPLETED|Overall Study||20
516669|NCT00105235|1245737|P1|STARTED|Overall Study||27
516670|NCT00105196|1245750|P2|NOT COMPLETED|Overall Study||23
516671|NCT00105196|1245751|P1|NOT COMPLETED|Overall Study||30
516672|NCT00105196|1245750|P2|COMPLETED|Overall Study||149
516673|NCT00105196|1245751|P1|COMPLETED|Overall Study||147
516674|NCT00105196|1245750|P2|STARTED|Overall Study||172
516675|NCT00105196|1245751|P1|STARTED|Overall Study||177
516676|NCT00105183|1245774|P3|NOT COMPLETED|Overall Study||23
516677|NCT00105183|1245775|P2|NOT COMPLETED|Overall Study||19
516678|NCT00105183|1245776|P1|NOT COMPLETED|Overall Study||22
516679|NCT00105183|1245774|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
516680|NCT00105183|1245775|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
516681|NCT00105183|1245776|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
516682|NCT00105183|1245774|P3|STARTED|Overall Study|Randomized|62
516683|NCT00105183|1245775|P2|STARTED|Overall Study|Randomized|79
516684|NCT00105183|1245776|P1|STARTED|Overall Study|Randomized|82
516685|NCT00105157|1245812|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
516686|NCT00105157|1245813|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
516687|NCT00105157|1245814|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
516688|NCT00105157|1245815|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
516689|NCT00105157|1245812|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
516690|NCT00105157|1245813|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
516691|NCT00105157|1245814|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
516692|NCT00105157|1245815|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
516693|NCT00105157|1245812|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
516694|NCT00105157|1245813|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
516695|NCT00105157|1245814|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
516696|NCT00105157|1245815|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
516697|NCT00105157|1245812|P4|NOT COMPLETED|Open-Label Continuation of DB||1
516698|NCT00105157|1245813|P3|NOT COMPLETED|Open-Label Continuation of DB||9
516700|NCT00105157|1245815|P1|NOT COMPLETED|Open-Label Continuation of DB||7
516701|NCT00105157|1245812|P4|COMPLETED|Open-Label Continuation of DB||5
516702|NCT00105157|1245813|P3|COMPLETED|Open-Label Continuation of DB||24
516703|NCT00105157|1245814|P2|COMPLETED|Open-Label Continuation of DB||21
516704|NCT00105157|1245815|P1|COMPLETED|Open-Label Continuation of DB||23
516705|NCT00105157|1245812|P4|STARTED|Open-Label Continuation of DB||6
516706|NCT00105157|1245813|P3|STARTED|Open-Label Continuation of DB||33
516707|NCT00105157|1245814|P2|STARTED|Open-Label Continuation of DB||31
516708|NCT00105157|1245815|P1|STARTED|Open-Label Continuation of DB||30
516709|NCT00105157|1245812|P4|NOT COMPLETED|Double-Blind (DB)||39
516710|NCT00105157|1245813|P3|NOT COMPLETED|Double-Blind (DB)||12
516711|NCT00105157|1245814|P2|NOT COMPLETED|Double-Blind (DB)||14
516712|NCT00105157|1245815|P1|NOT COMPLETED|Double-Blind (DB)||14
516713|NCT00105157|1245812|P4|COMPLETED|Double-Blind (DB)||6
516714|NCT00105157|1245813|P3|COMPLETED|Double-Blind (DB)||33
516715|NCT00105157|1245814|P2|COMPLETED|Double-Blind (DB)||31
516716|NCT00105157|1245815|P1|COMPLETED|Double-Blind (DB)||30
516717|NCT00105157|1245812|P4|Treated|Double-Blind (DB)||45
516718|NCT00105157|1245813|P3|Treated|Double-Blind (DB)||45
516719|NCT00105157|1245814|P2|Treated|Double-Blind (DB)||45
516720|NCT00105157|1245815|P1|Treated|Double-Blind (DB)||43
516721|NCT00105157|1245812|P4|STARTED|Double-Blind (DB)||45
516722|NCT00105157|1245813|P3|STARTED|Double-Blind (DB)||45
516723|NCT00105157|1245814|P2|STARTED|Double-Blind (DB)||45
516724|NCT00105157|1245815|P1|STARTED|Double-Blind (DB)||44
516725|NCT00105079|1246009|P2|NOT COMPLETED|Overall Study||35
516726|NCT00105079|1246010|P1|NOT COMPLETED|Overall Study||39
516727|NCT00105079|1246009|P2|COMPLETED|Overall Study||135
516728|NCT00105079|1246010|P1|COMPLETED|Overall Study||128
516729|NCT00105079|1246009|P2|Safety Population|Overall Study||168
516730|NCT00105079|1246010|P1|Safety Population|Overall Study||163
516731|NCT00105079|1246009|P2|STARTED|Overall Study||170
516732|NCT00105079|1246010|P1|STARTED|Overall Study||167
516733|NCT00105066|1246028|P2|NOT COMPLETED|Overall Study||5
516734|NCT00105066|1246029|P1|NOT COMPLETED|Overall Study||2
516735|NCT00105066|1246028|P2|COMPLETED|Overall Study||45
516736|NCT00105066|1246029|P1|COMPLETED|Overall Study||25
516737|NCT00105066|1246028|P2|STARTED|Overall Study||50
516738|NCT00105066|1246029|P1|STARTED|Overall Study||27
516739|NCT00105027|1246045|P6|NOT COMPLETED|Overall Study||13
516740|NCT00105027|1246046|P5|NOT COMPLETED|Overall Study||15
516741|NCT00105027|1246047|P4|NOT COMPLETED|Overall Study||16
516742|NCT00105027|1246048|P3|NOT COMPLETED|Overall Study||9
516743|NCT00105027|1246049|P2|NOT COMPLETED|Overall Study||9
516744|NCT00105027|1246050|P1|NOT COMPLETED|Overall Study||15
516745|NCT00105027|1246045|P6|COMPLETED|Overall Study||125
516746|NCT00105027|1246046|P5|COMPLETED|Overall Study||121
516747|NCT00105027|1246047|P4|COMPLETED|Overall Study||121
516748|NCT00105027|1246048|P3|COMPLETED|Overall Study||82
516749|NCT00105027|1246049|P2|COMPLETED|Overall Study||83
516750|NCT00105027|1246050|P1|COMPLETED|Overall Study||73
516751|NCT00105027|1246045|P6|STARTED|Overall Study||138
516752|NCT00105027|1246046|P5|STARTED|Overall Study||136
516753|NCT00105027|1246047|P4|STARTED|Overall Study||137
516754|NCT00105027|1246048|P3|STARTED|Overall Study||91
516755|NCT00105027|1246049|P2|STARTED|Overall Study||92
516756|NCT00105027|1246050|P1|STARTED|Overall Study||88
516757|NCT00105001|1246067|P3|NOT COMPLETED|Overall Study||0
516758|NCT00105001|1246068|P2|NOT COMPLETED|Overall Study||0
516759|NCT00105001|1246069|P1|NOT COMPLETED|Overall Study||0
516760|NCT00105001|1246067|P3|COMPLETED|Overall Study||69
516761|NCT00105001|1246068|P2|COMPLETED|Overall Study||71
516762|NCT00105001|1246069|P1|COMPLETED|Overall Study||70
516763|NCT00105001|1246067|P3|STARTED|Overall Study||69
516764|NCT00105001|1246068|P2|STARTED|Overall Study||71
516765|NCT00105001|1246069|P1|STARTED|Overall Study||70
516766|NCT00104884|1246089|P1|NOT COMPLETED|Overall Study||4
516767|NCT00104884|1246089|P1|COMPLETED|Overall Study||0
516768|NCT00104884|1246089|P1|STARTED|Overall Study||4
516769|NCT00104871|1246093|P1|NOT COMPLETED|Overall Study||1
516770|NCT00104871|1246093|P1|COMPLETED|Overall Study||21
516771|NCT00104871|1246093|P1|STARTED|Overall Study||22
516772|NCT00104728|1246098|P1|NOT COMPLETED|Overall Study||19
516773|NCT00104728|1246098|P1|COMPLETED|Overall Study||23
516774|NCT00104728|1246098|P1|STARTED|Overall Study|42 consented on study|42
516775|NCT00104650|1246106|P3|NOT COMPLETED|Follow-up Period||10
516776|NCT00104650|1246107|P2|NOT COMPLETED|Follow-up Period||13
516777|NCT00104650|1246108|P1|NOT COMPLETED|Follow-up Period||11
516778|NCT00104650|1246106|P3|COMPLETED|Follow-up Period||18
516779|NCT00104650|1246107|P2|COMPLETED|Follow-up Period||12
516780|NCT00104650|1246108|P1|COMPLETED|Follow-up Period||14
516781|NCT00104650|1246106|P3|STARTED|Follow-up Period||28
516782|NCT00104650|1246107|P2|STARTED|Follow-up Period||25
516783|NCT00104650|1246108|P1|STARTED|Follow-up Period||25
516784|NCT00104650|1246106|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
516785|NCT00104650|1246107|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
516786|NCT00104650|1246108|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
516787|NCT00104650|1246106|P3|COMPLETED|Treatment Period (25 Weeks)||28
516788|NCT00104650|1246107|P2|COMPLETED|Treatment Period (25 Weeks)||25
516789|NCT00104650|1246108|P1|COMPLETED|Treatment Period (25 Weeks)||25
516790|NCT00104650|1246106|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
516791|NCT00104650|1246107|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
516792|NCT00104650|1246108|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
516793|NCT00104650|1246106|P3|STARTED|Treatment Period (25 Weeks)||38
516794|NCT00104650|1246107|P2|STARTED|Treatment Period (25 Weeks)||36
516795|NCT00104650|1246108|P1|STARTED|Treatment Period (25 Weeks)||37
516796|NCT00104637|1246140|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
516797|NCT00104637|1246141|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
516798|NCT00104637|1246140|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
516799|NCT00104637|1246141|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
516800|NCT00104637|1246140|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
516801|NCT00104637|1246141|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
516802|NCT00104637|1246140|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
516803|NCT00104637|1246141|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
516804|NCT00104637|1246140|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
516805|NCT00104637|1246141|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
516806|NCT00104637|1246140|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
516807|NCT00104637|1246141|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
516808|NCT00104637|1246140|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
516809|NCT00104637|1246141|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
516810|NCT00104637|1246140|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
516811|NCT00104637|1246141|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
516812|NCT00104637|1246140|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
516813|NCT00104637|1246141|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
516814|NCT00104572|1246170|P3|NOT COMPLETED|Overall Study||0
516815|NCT00104572|1246171|P2|NOT COMPLETED|Overall Study||3
516816|NCT00104572|1246172|P1|NOT COMPLETED|Overall Study||3
516817|NCT00104572|1246170|P3|COMPLETED|Overall Study||9
516818|NCT00104572|1246171|P2|COMPLETED|Overall Study||10
516819|NCT00104572|1246172|P1|COMPLETED|Overall Study||10
516820|NCT00104572|1246170|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
516821|NCT00104572|1246171|P2|STARTED|Overall Study|These are the analysed subjects|13
516822|NCT00104572|1246172|P1|STARTED|Overall Study|These are the analysed subjects|13
516823|NCT00104520|1246182|P2|NOT COMPLETED|Overall Study||71
516824|NCT00104520|1246183|P1|NOT COMPLETED|Overall Study||50
516825|NCT00104520|1246182|P2|COMPLETED|Overall Study||64
516826|NCT00104520|1246183|P1|COMPLETED|Overall Study||26
516827|NCT00104520|1246182|P2|STARTED|Overall Study||135
516828|NCT00104520|1246183|P1|STARTED|Overall Study||76
516829|NCT00104416|1246203|P5|NOT COMPLETED|Continuation Phase||5
516830|NCT00104416|1246204|P4|NOT COMPLETED|Continuation Phase||2
516831|NCT00104416|1246205|P3|NOT COMPLETED|Continuation Phase||6
516832|NCT00104416|1246206|P2|NOT COMPLETED|Continuation Phase||0
516833|NCT00104416|1246207|P1|NOT COMPLETED|Continuation Phase||0
516834|NCT00104416|1246203|P5|COMPLETED|Continuation Phase||27
516835|NCT00104416|1246204|P4|COMPLETED|Continuation Phase||65
516836|NCT00104416|1246205|P3|COMPLETED|Continuation Phase||63
516837|NCT00104416|1246206|P2|COMPLETED|Continuation Phase||0
516838|NCT00104416|1246207|P1|COMPLETED|Continuation Phase||0
516839|NCT00104416|1246203|P5|STARTED|Continuation Phase||32
516840|NCT00104416|1246204|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
516841|NCT00104416|1246205|P3|STARTED|Continuation Phase||69
516842|NCT00104416|1246206|P2|STARTED|Continuation Phase||0
516843|NCT00104416|1246207|P1|STARTED|Continuation Phase||0
516844|NCT00104416|1246203|P5|NOT COMPLETED|Double-Blind Phase||0
516845|NCT00104416|1246204|P4|NOT COMPLETED|Double-Blind Phase||0
516846|NCT00104416|1246205|P3|NOT COMPLETED|Double-Blind Phase||0
516847|NCT00104416|1246206|P2|NOT COMPLETED|Double-Blind Phase||10
516848|NCT00104416|1246207|P1|NOT COMPLETED|Double-Blind Phase||8
516849|NCT00104416|1246203|P5|COMPLETED|Double-Blind Phase||0
516850|NCT00104416|1246204|P4|COMPLETED|Double-Blind Phase||0
516851|NCT00104416|1246205|P3|COMPLETED|Double-Blind Phase||0
516852|NCT00104416|1246206|P2|COMPLETED|Double-Blind Phase||66
516853|NCT00104416|1246207|P1|COMPLETED|Double-Blind Phase||69
516854|NCT00104416|1246203|P5|STARTED|Double-Blind Phase||0
516855|NCT00104416|1246204|P4|STARTED|Double-Blind Phase||0
516856|NCT00104416|1246205|P3|STARTED|Double-Blind Phase||0
516857|NCT00104416|1246206|P2|STARTED|Double-Blind Phase||76
516858|NCT00104416|1246207|P1|STARTED|Double-Blind Phase||77
516859|NCT00104299|1246252|P2|NOT COMPLETED|Overall Study||10
516860|NCT00104299|1246253|P1|NOT COMPLETED|Overall Study||9
516861|NCT00104299|1246252|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
516862|NCT00104299|1246253|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
516863|NCT00104299|1246252|P2|STARTED|Overall Study||98
516864|NCT00104299|1246253|P1|STARTED|Overall Study||99
516865|NCT00104247|1246275|P2|NOT COMPLETED|Overall Study||1
516866|NCT00104247|1246276|P1|NOT COMPLETED|Overall Study||1
516867|NCT00104247|1246275|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
516868|NCT00104247|1246276|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
516869|NCT00104247|1246275|P2|STARTED|Overall Study||47
516870|NCT00104247|1246276|P1|STARTED|Overall Study||42
516871|NCT00104234|1246284|P2|NOT COMPLETED|Overall Study||1
516872|NCT00104234|1246285|P1|NOT COMPLETED|Overall Study||0
516873|NCT00104234|1246284|P2|COMPLETED|Overall Study||19
516874|NCT00104234|1246285|P1|COMPLETED|Overall Study||19
516875|NCT00104234|1246284|P2|STARTED|Overall Study||20
516876|NCT00104234|1246285|P1|STARTED|Overall Study||19
516877|NCT00104104|1246295|P2|NOT COMPLETED|Overall Study||72
516878|NCT00104104|1246296|P1|NOT COMPLETED|Overall Study||75
516879|NCT00104104|1246295|P2|COMPLETED|Overall Study||17
516880|NCT00104104|1246296|P1|COMPLETED|Overall Study||15
516881|NCT00104104|1246295|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
516882|NCT00104104|1246296|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
516883|NCT00104104|1246295|P2|Safety Population (Including Site 74)|Overall Study||88
516884|NCT00104104|1246296|P1|Safety Population (Including Site 74)|Overall Study||88
516885|NCT00104104|1246295|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
516886|NCT00104104|1246296|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
516887|NCT00104052|1246310|P1|NOT COMPLETED|Overall Study||29
516888|NCT00104052|1246310|P1|COMPLETED|Overall Study||78
516889|NCT00104052|1246310|P1|STARTED|Overall Study||107
516890|NCT00103857|1246321|P7|NOT COMPLETED|50-Week Extension Study||0
516891|NCT00103857|1246322|P6|NOT COMPLETED|50-Week Extension Study||20
516892|NCT00103857|1246323|P5|NOT COMPLETED|50-Week Extension Study||21
516893|NCT00103857|1246324|P4|NOT COMPLETED|50-Week Extension Study||36
516894|NCT00103857|1246325|P3|NOT COMPLETED|50-Week Extension Study||26
516895|NCT00103857|1246326|P2|NOT COMPLETED|50-Week Extension Study||27
516896|NCT00103857|1246327|P1|NOT COMPLETED|50-Week Extension Study||38
516897|NCT00103857|1246321|P7|COMPLETED|50-Week Extension Study||0
516898|NCT00103857|1246322|P6|COMPLETED|50-Week Extension Study||78
516899|NCT00103857|1246323|P5|COMPLETED|50-Week Extension Study||101
516900|NCT00103857|1246324|P4|COMPLETED|50-Week Extension Study||98
516901|NCT00103857|1246325|P3|COMPLETED|50-Week Extension Study||95
516902|NCT00103857|1246326|P2|COMPLETED|50-Week Extension Study||80
516903|NCT00103857|1246327|P1|COMPLETED|50-Week Extension Study||65
516904|NCT00103857|1246321|P7|STARTED|50-Week Extension Study||0
516905|NCT00103857|1246322|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
516906|NCT00103857|1246323|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
516907|NCT00103857|1246324|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
516908|NCT00103857|1246325|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
516987|NCT00103259|1246534|P1|Treated|Overall Study||23
516909|NCT00103857|1246326|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
516910|NCT00103857|1246327|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
516911|NCT00103857|1246321|P7|NOT COMPLETED|54-Week Base Study||38
516912|NCT00103857|1246322|P6|NOT COMPLETED|54-Week Base Study||61
516913|NCT00103857|1246323|P5|NOT COMPLETED|54-Week Base Study||41
516914|NCT00103857|1246324|P4|NOT COMPLETED|54-Week Base Study||42
516915|NCT00103857|1246325|P3|NOT COMPLETED|54-Week Base Study||47
516916|NCT00103857|1246326|P2|NOT COMPLETED|54-Week Base Study||56
516917|NCT00103857|1246327|P1|NOT COMPLETED|54-Week Base Study||57
516918|NCT00103857|1246321|P7|COMPLETED|54-Week Base Study||79
516919|NCT00103857|1246322|P6|COMPLETED|54-Week Base Study||115
516920|NCT00103857|1246323|P5|COMPLETED|54-Week Base Study||141
516921|NCT00103857|1246324|P4|COMPLETED|54-Week Base Study||148
516922|NCT00103857|1246325|P3|COMPLETED|54-Week Base Study||135
516923|NCT00103857|1246326|P2|COMPLETED|54-Week Base Study||126
516924|NCT00103857|1246327|P1|COMPLETED|54-Week Base Study||122
516925|NCT00103857|1246321|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
516926|NCT00103857|1246322|P6|STARTED|54-Week Base Study||176
516927|NCT00103857|1246323|P5|STARTED|54-Week Base Study||182
516928|NCT00103857|1246324|P4|STARTED|54-Week Base Study||190
516929|NCT00103857|1246325|P3|STARTED|54-Week Base Study||182
516930|NCT00103857|1246326|P2|STARTED|54-Week Base Study||182
516931|NCT00103857|1246327|P1|STARTED|54-Week Base Study||179
516932|NCT00103844|1246392|P2|NOT COMPLETED|Overall Study||0
516933|NCT00103844|1246393|P1|NOT COMPLETED|Overall Study||0
516934|NCT00103844|1246392|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
516935|NCT00103844|1246393|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
516936|NCT00103844|1246392|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
516937|NCT00103844|1246393|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
516938|NCT00103844|1246392|P2|STARTED|Overall Study||49
516939|NCT00103844|1246393|P1|STARTED|Overall Study||101
516940|NCT00103740|1246426|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
516941|NCT00103740|1246427|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
516942|NCT00103740|1246426|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
516943|NCT00103740|1246427|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
516944|NCT00103740|1246426|P2|STARTED|Period 2 - Extended Observation Period||63
516945|NCT00103740|1246427|P1|STARTED|Period 2 - Extended Observation Period||78
516946|NCT00103740|1246426|P2|NOT COMPLETED|Period 1 - Core||4
516947|NCT00103740|1246427|P1|NOT COMPLETED|Period 1 - Core||7
516948|NCT00103740|1246426|P2|COMPLETED|Period 1 - Core||89
516949|NCT00103740|1246427|P1|COMPLETED|Period 1 - Core||85
516950|NCT00103740|1246426|P2|STARTED|Period 1 - Core||93
516951|NCT00103740|1246427|P1|STARTED|Period 1 - Core||92
516952|NCT00103662|1246455|P2|NOT COMPLETED|Overall Study||33
516953|NCT00103662|1246456|P1|NOT COMPLETED|Overall Study||19
516954|NCT00103662|1246455|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
516955|NCT00103662|1246456|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
516956|NCT00103662|1246455|P2|STARTED|Overall Study||154
516957|NCT00103662|1246456|P1|STARTED|Overall Study||148
516958|NCT00103610|1246482|P2|NOT COMPLETED|Overall Study||80
516959|NCT00103610|1246483|P1|NOT COMPLETED|Overall Study||38
516960|NCT00103610|1246482|P2|COMPLETED|Overall Study||68
516961|NCT00103610|1246483|P1|COMPLETED|Overall Study||112
516962|NCT00103610|1246482|P2|STARTED|Overall Study||148
516963|NCT00103610|1246483|P1|STARTED|Overall Study||150
516964|NCT00103506|1246507|P2|NOT COMPLETED|Overall Study||324
516965|NCT00103506|1246508|P1|NOT COMPLETED|Overall Study||322
516966|NCT00103506|1246507|P2|COMPLETED|Overall Study||0
516967|NCT00103506|1246508|P1|COMPLETED|Overall Study||0
516968|NCT00103506|1246507|P2|STARTED|Overall Study||324
516969|NCT00103506|1246508|P1|STARTED|Overall Study||322
516970|NCT00103311|1246520|P2|NOT COMPLETED|Overall Study||1
516971|NCT00103311|1246521|P1|NOT COMPLETED|Overall Study||4
516972|NCT00103311|1246520|P2|COMPLETED|Overall Study||30
516973|NCT00103311|1246521|P1|COMPLETED|Overall Study||29
516974|NCT00103311|1246520|P2|STARTED|Overall Study||31
516975|NCT00103311|1246521|P1|STARTED|Overall Study||33
516976|NCT00103259|1246533|P2|NOT COMPLETED|Overall Study||12
516977|NCT00103259|1246534|P1|NOT COMPLETED|Overall Study||12
516978|NCT00103259|1246533|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
516979|NCT00103259|1246534|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
516980|NCT00103259|1246533|P2|Eligible Patients Who Cross Over|Overall Study||10
516981|NCT00103259|1246534|P1|Eligible Patients Who Cross Over|Overall Study||0
516982|NCT00103259|1246533|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
516983|NCT00103259|1246534|P1|Cross Over to the Other Arm|Overall Study||0
516984|NCT00103259|1246533|P2|Eligible and Treated|Overall Study||38
516985|NCT00103259|1246534|P1|Eligible and Treated|Overall Study||23
516986|NCT00103259|1246533|P2|Treated|Overall Study||41
516988|NCT00103259|1246533|P2|Eligible|Overall Study||41
516989|NCT00103259|1246534|P1|Eligible|Overall Study||27
516990|NCT00103259|1246533|P2|STARTED|Overall Study||44
516991|NCT00103259|1246534|P1|STARTED|Overall Study||27
516992|NCT00103207|1246546|P1|NOT COMPLETED|Overall Study||38
516993|NCT00103207|1246546|P1|COMPLETED|Overall Study||34
516994|NCT00103207|1246546|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
516995|NCT00103207|1246546|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
516996|NCT00103207|1246546|P1|STARTED|Overall Study||72
516997|NCT00103194|1246556|P1|NOT COMPLETED|Overall Study||31
516998|NCT00103194|1246556|P1|COMPLETED|Overall Study||18
516999|NCT00103194|1246556|P1|Eligible and Treated|Overall Study||35
517000|NCT00103194|1246556|P1|Eligible|Overall Study||35
517001|NCT00103194|1246556|P1|Treated|Overall Study||49
517002|NCT00103194|1246556|P1|STARTED|Overall Study||49
517003|NCT00103142|1246565|P2|NOT COMPLETED|Overall Study||1
517004|NCT00103142|1246566|P1|NOT COMPLETED|Overall Study||3
517005|NCT00103142|1246565|P2|COMPLETED|Overall Study||36
517006|NCT00103142|1246566|P1|COMPLETED|Overall Study||33
517007|NCT00103142|1246565|P2|STARTED|Overall Study||37
517008|NCT00103142|1246566|P1|STARTED|Overall Study||36
517009|NCT00103116|1246574|P1|NOT COMPLETED|Overall Study||0
517010|NCT00103116|1246574|P1|COMPLETED|Overall Study||32
517011|NCT00103116|1246574|P1|STARTED|Overall Study||32
517012|NCT00103012|1246582|P3|NOT COMPLETED|Overall Study||4
517013|NCT00103012|1246583|P2|NOT COMPLETED|Overall Study||1
517014|NCT00103012|1246584|P1|NOT COMPLETED|Overall Study||3
517015|NCT00103012|1246582|P3|COMPLETED|Overall Study||12
517016|NCT00103012|1246583|P2|COMPLETED|Overall Study||13
517017|NCT00103012|1246584|P1|COMPLETED|Overall Study||14
517018|NCT00103012|1246582|P3|STARTED|Overall Study||16
517019|NCT00103012|1246583|P2|STARTED|Overall Study||14
517020|NCT00103012|1246584|P1|STARTED|Overall Study||17
517021|NCT00102804|1246594|P2|NOT COMPLETED|Overall Study||222
517022|NCT00102804|1246595|P1|NOT COMPLETED|Overall Study||441
517023|NCT00102804|1246594|P2|COMPLETED|Overall Study||0
517024|NCT00102804|1246595|P1|COMPLETED|Overall Study||0
517025|NCT00102804|1246594|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
517026|NCT00102804|1246595|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
517027|NCT00102804|1246594|P2|STARTED|Overall Study||222
517028|NCT00102804|1246595|P1|STARTED|Overall Study||441
517029|NCT00102687|1246616|P5|NOT COMPLETED|Maintenance Period||13
517030|NCT00102687|1246617|P4|NOT COMPLETED|Maintenance Period||10
517031|NCT00102687|1246618|P3|NOT COMPLETED|Maintenance Period||6
517032|NCT00102687|1246619|P2|NOT COMPLETED|Maintenance Period||4
517033|NCT00102687|1246620|P1|NOT COMPLETED|Maintenance Period||7
517034|NCT00102687|1246616|P5|COMPLETED|Maintenance Period||8
517035|NCT00102687|1246617|P4|COMPLETED|Maintenance Period||12
517036|NCT00102687|1246618|P3|COMPLETED|Maintenance Period||2
517037|NCT00102687|1246619|P2|COMPLETED|Maintenance Period||2
517038|NCT00102687|1246620|P1|COMPLETED|Maintenance Period||6
517039|NCT00102687|1246616|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
517040|NCT00102687|1246617|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
517041|NCT00102687|1246618|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
517042|NCT00102687|1246619|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
517043|NCT00102687|1246620|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
517044|NCT00102687|1246616|P5|NOT COMPLETED|Initial Period||0
517045|NCT00102687|1246617|P4|NOT COMPLETED|Initial Period||0
517046|NCT00102687|1246618|P3|NOT COMPLETED|Initial Period||26
517047|NCT00102687|1246619|P2|NOT COMPLETED|Initial Period||28
517048|NCT00102687|1246620|P1|NOT COMPLETED|Initial Period||18
517049|NCT00102687|1246616|P5|COMPLETED|Initial Period||0
517050|NCT00102687|1246617|P4|COMPLETED|Initial Period||0
517051|NCT00102687|1246618|P3|COMPLETED|Initial Period||25
517052|NCT00102687|1246619|P2|COMPLETED|Initial Period||22
517053|NCT00102687|1246620|P1|COMPLETED|Initial Period||32
517054|NCT00102687|1246616|P5|STARTED|Initial Period||0
517055|NCT00102687|1246617|P4|STARTED|Initial Period||0
517056|NCT00102687|1246618|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
517057|NCT00102687|1246619|P2|STARTED|Initial Period||50
517058|NCT00102687|1246620|P1|STARTED|Initial Period||50
517059|NCT00102596|1246684|P2|NOT COMPLETED|Part C||0
517060|NCT00102596|1246685|P1|NOT COMPLETED|Part C||0
517061|NCT00102596|1246684|P2|COMPLETED|Part C||2
517062|NCT00102596|1246685|P1|COMPLETED|Part C||0
517063|NCT00102596|1246684|P2|STARTED|Part C|Only 2 patients participated in Part C|2
517064|NCT00102596|1246685|P1|STARTED|Part C||0
517065|NCT00102596|1246684|P2|NOT COMPLETED|Part B||0
517066|NCT00102596|1246685|P1|NOT COMPLETED|Part B||0
517067|NCT00102596|1246684|P2|COMPLETED|Part B||10
517068|NCT00102596|1246685|P1|COMPLETED|Part B||0
517069|NCT00102596|1246684|P2|STARTED|Part B||10
517070|NCT00102596|1246685|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
517071|NCT00102596|1246684|P2|NOT COMPLETED|Part A||0
517072|NCT00102596|1246685|P1|NOT COMPLETED|Part A||7
517073|NCT00102596|1246684|P2|COMPLETED|Part A||0
517074|NCT00102596|1246685|P1|COMPLETED|Part A||4
517075|NCT00102596|1246684|P2|Participants Assigned Treatment|Part A||0
517076|NCT00102596|1246685|P1|Participants Assigned Treatment|Part A||5
517077|NCT00102596|1246684|P2|STARTED|Part A||0
517078|NCT00102596|1246685|P1|STARTED|Part A||11
517079|NCT00102518|1246694|P1|NOT COMPLETED|Overall Study||87
517080|NCT00102518|1246694|P1|COMPLETED|Overall Study||238
517081|NCT00102518|1246694|P1|STARTED|Overall Study||325
517082|NCT00102440|1246703|P3|NOT COMPLETED|Overall Study||66
517083|NCT00102440|1246704|P2|NOT COMPLETED|Overall Study||98
517084|NCT00102440|1246705|P1|NOT COMPLETED|Overall Study||88
517085|NCT00102440|1246703|P3|COMPLETED|Overall Study||187
517086|NCT00102440|1246704|P2|COMPLETED|Overall Study||153
517087|NCT00102440|1246705|P1|COMPLETED|Overall Study||168
517088|NCT00102440|1246703|P3|STARTED|Overall Study||253
517089|NCT00102440|1246704|P2|STARTED|Overall Study||251
517090|NCT00102440|1246705|P1|STARTED|Overall Study||256
517091|NCT00102063|1246755|P3|NOT COMPLETED|Overall Study||10
517092|NCT00102063|1246756|P2|NOT COMPLETED|Overall Study||18
517093|NCT00102063|1246757|P1|NOT COMPLETED|Overall Study||16
517094|NCT00102063|1246755|P3|COMPLETED|Overall Study||90
517095|NCT00102063|1246756|P2|COMPLETED|Overall Study||84
517096|NCT00102063|1246757|P1|COMPLETED|Overall Study||84
517097|NCT00102063|1246755|P3|STARTED|Overall Study||100
517098|NCT00102063|1246756|P2|STARTED|Overall Study||102
517099|NCT00102063|1246757|P1|STARTED|Overall Study||100
517100|NCT00101933|1246788|P2|NOT COMPLETED|Overall Study||0
517101|NCT00101933|1246789|P1|NOT COMPLETED|Overall Study||0
517102|NCT00101933|1246788|P2|COMPLETED|Overall Study||55
517103|NCT00101933|1246789|P1|COMPLETED|Overall Study||54
517104|NCT00101933|1246788|P2|STARTED|Overall Study||55
517105|NCT00101933|1246789|P1|STARTED|Overall Study||54
517106|NCT00101907|1246815|P6|NOT COMPLETED|Overall Study||0
517107|NCT00101907|1246816|P5|NOT COMPLETED|Overall Study||5
517108|NCT00101907|1246817|P4|NOT COMPLETED|Overall Study||1
517109|NCT00101907|1246818|P3|NOT COMPLETED|Overall Study||1
517110|NCT00101907|1246819|P2|NOT COMPLETED|Overall Study||1
517111|NCT00101907|1246820|P1|NOT COMPLETED|Overall Study||2
517112|NCT00101907|1246815|P6|COMPLETED|Overall Study||2
517113|NCT00101907|1246816|P5|COMPLETED|Overall Study||6
517114|NCT00101907|1246817|P4|COMPLETED|Overall Study||5
517115|NCT00101907|1246818|P3|COMPLETED|Overall Study||5
517116|NCT00101907|1246819|P2|COMPLETED|Overall Study||7
517117|NCT00101907|1246820|P1|COMPLETED|Overall Study||6
517118|NCT00101907|1246815|P6|STARTED|Overall Study||2
517119|NCT00101907|1246816|P5|STARTED|Overall Study||11
517120|NCT00101907|1246817|P4|STARTED|Overall Study||6
517121|NCT00101907|1246818|P3|STARTED|Overall Study||6
517122|NCT00101907|1246819|P2|STARTED|Overall Study||8
517123|NCT00101907|1246820|P1|STARTED|Overall Study||8
517124|NCT00101868|1246862|P2|NOT COMPLETED|Overall Study||32
517125|NCT00101868|1246863|P1|NOT COMPLETED|Overall Study||29
517126|NCT00101868|1246862|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
517127|NCT00101868|1246863|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
517128|NCT00101868|1246862|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
517129|NCT00101868|1246863|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
517130|NCT00101816|1246875|P2|NOT COMPLETED|Overall Study||0
517131|NCT00101816|1246876|P1|NOT COMPLETED|Overall Study||0
517132|NCT00101816|1246875|P2|COMPLETED|Overall Study||99
517133|NCT00101816|1246876|P1|COMPLETED|Overall Study||10
517134|NCT00101816|1246875|P2|STARTED|Overall Study||99
517135|NCT00101816|1246876|P1|STARTED|Overall Study||10
517136|NCT00101686|1246933|P10|NOT COMPLETED|Overall Study||30
517137|NCT00101686|1246934|P9|NOT COMPLETED|Overall Study||30
517138|NCT00101686|1246935|P8|NOT COMPLETED|Overall Study||30
517139|NCT00101686|1246936|P7|NOT COMPLETED|Overall Study||27
517140|NCT00101686|1246937|P6|NOT COMPLETED|Overall Study||72
517141|NCT00101686|1246938|P5|NOT COMPLETED|Overall Study||73
517142|NCT00101686|1246939|P4|NOT COMPLETED|Overall Study||72
517143|NCT00101686|1246940|P3|NOT COMPLETED|Overall Study||69
517144|NCT00101686|1246941|P2|NOT COMPLETED|Overall Study||73
517145|NCT00101686|1246942|P1|NOT COMPLETED|Overall Study||71
517146|NCT00101686|1246933|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
517147|NCT00101686|1246934|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
517148|NCT00101686|1246935|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
517149|NCT00101686|1246936|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
517150|NCT00101686|1246937|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
517151|NCT00101686|1246938|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
517152|NCT00101686|1246939|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
517153|NCT00101686|1246940|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
517154|NCT00101686|1246941|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
517155|NCT00101686|1246942|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
517156|NCT00101686|1246933|P10|Received Treatment|Overall Study||29
517157|NCT00101686|1246934|P9|Received Treatment|Overall Study||30
517158|NCT00101686|1246935|P8|Received Treatment|Overall Study||29
517159|NCT00101686|1246936|P7|Received Treatment|Overall Study||27
517160|NCT00101686|1246937|P6|Received Treatment|Overall Study||70
517161|NCT00101686|1246938|P5|Received Treatment|Overall Study||71
517162|NCT00101686|1246939|P4|Received Treatment|Overall Study||70
517163|NCT00101686|1246940|P3|Received Treatment|Overall Study||67
517164|NCT00101686|1246941|P2|Received Treatment|Overall Study||67
517165|NCT00101686|1246942|P1|Received Treatment|Overall Study||70
517166|NCT00101686|1246933|P10|STARTED|Overall Study||30
517167|NCT00101686|1246934|P9|STARTED|Overall Study||30
517168|NCT00101686|1246935|P8|STARTED|Overall Study||30
517169|NCT00101686|1246936|P7|STARTED|Overall Study||27
517170|NCT00101686|1246937|P6|STARTED|Overall Study||72
517171|NCT00101686|1246938|P5|STARTED|Overall Study||73
517172|NCT00101686|1246939|P4|STARTED|Overall Study||72
517173|NCT00101686|1246940|P3|STARTED|Overall Study||69
517174|NCT00101686|1246941|P2|STARTED|Overall Study||73
517175|NCT00101686|1246942|P1|STARTED|Overall Study||71
517176|NCT00101660|1246989|P2|NOT COMPLETED|Overall Study||0
517177|NCT00101660|1246990|P1|NOT COMPLETED|Overall Study||0
517178|NCT00101660|1246989|P2|COMPLETED|Overall Study||288
517179|NCT00101660|1246990|P1|COMPLETED|Overall Study||99
517180|NCT00101660|1246989|P2|STARTED|Overall Study||288
517181|NCT00101660|1246990|P1|STARTED|Overall Study||99
517182|NCT00101647|1247008|P2|NOT COMPLETED|Overall Study||0
517183|NCT00101647|1247009|P1|NOT COMPLETED|Overall Study||0
517184|NCT00101647|1247008|P2|COMPLETED|Overall Study||161
517185|NCT00101647|1247009|P1|COMPLETED|Overall Study||13
517186|NCT00101647|1247008|P2|STARTED|Overall Study|Randomized|161
517187|NCT00101647|1247009|P1|STARTED|Overall Study|Randomized|13
517188|NCT00101582|1247059|P2|NOT COMPLETED|Overall Study||15
517189|NCT00101582|1247060|P1|NOT COMPLETED|Overall Study||11
517190|NCT00101582|1247059|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
517191|NCT00101582|1247060|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
517192|NCT00101582|1247059|P2|Received Study Drug|Overall Study||94
517193|NCT00101582|1247060|P1|Received Study Drug|Overall Study||91
517194|NCT00101582|1247059|P2|STARTED|Overall Study||94
517195|NCT00101582|1247060|P1|STARTED|Overall Study||94
517196|NCT00101452|1247083|P3|NOT COMPLETED|Overall Study||43
517197|NCT00101452|1247084|P2|NOT COMPLETED|Overall Study||43
517198|NCT00101452|1247085|P1|NOT COMPLETED|Overall Study||44
517199|NCT00101452|1247083|P3|COMPLETED|Overall Study||22
517200|NCT00101452|1247084|P2|COMPLETED|Overall Study||26
517201|NCT00101452|1247085|P1|COMPLETED|Overall Study||21
517202|NCT00101452|1247083|P3|STARTED|Overall Study||65
517203|NCT00101452|1247084|P2|STARTED|Overall Study||69
517204|NCT00101452|1247085|P1|STARTED|Overall Study||65
517205|NCT00101439|1247099|P2|NOT COMPLETED|Period 2||2
517206|NCT00101439|1247100|P1|NOT COMPLETED|Period 2||0
517207|NCT00101439|1247099|P2|COMPLETED|Period 2||28
517208|NCT00101439|1247100|P1|COMPLETED|Period 2||28
517209|NCT00101439|1247099|P2|STARTED|Period 2||30
517210|NCT00101439|1247100|P1|STARTED|Period 2||28
517211|NCT00101439|1247099|P2|NOT COMPLETED|Period 1||0
517212|NCT00101439|1247100|P1|NOT COMPLETED|Period 1||0
517213|NCT00101439|1247099|P2|COMPLETED|Period 1||30
517214|NCT00101439|1247100|P1|COMPLETED|Period 1||28
517215|NCT00101439|1247099|P2|STARTED|Period 1||30
517216|NCT00101439|1247100|P1|STARTED|Period 1||28
517217|NCT00101413|1247108|P1|NOT COMPLETED|Overall Study||0
517218|NCT00101413|1247108|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
517219|NCT00101413|1247108|P1|STARTED|Overall Study||52
517220|NCT00101400|1247116|P1|NOT COMPLETED|Survival Follow-Up||7
517221|NCT00101400|1247116|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
517222|NCT00101400|1247116|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
517223|NCT00101400|1247116|P1|NOT COMPLETED|Treatment||0
517224|NCT00101400|1247116|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
517225|NCT00101400|1247116|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
517226|NCT00101361|1247127|P2|NOT COMPLETED|Overall Study||0
517227|NCT00101361|1247128|P1|NOT COMPLETED|Overall Study||0
517228|NCT00101361|1247127|P2|COMPLETED|Overall Study||104
517229|NCT00101361|1247128|P1|COMPLETED|Overall Study||108
517230|NCT00101361|1247127|P2|STARTED|Overall Study||104
517231|NCT00101361|1247128|P1|STARTED|Overall Study||108
517232|NCT00101283|1247136|P2|NOT COMPLETED|Overall Study||3
517233|NCT00101283|1247137|P1|NOT COMPLETED|Overall Study||0
517234|NCT00101283|1247136|P2|COMPLETED|Overall Study||13
517235|NCT00101283|1247137|P1|COMPLETED|Overall Study||16
517236|NCT00101283|1247136|P2|Began Treatment|Overall Study||13
517237|NCT00101283|1247137|P1|Began Treatment|Overall Study||16
517238|NCT00101283|1247136|P2|STARTED|Overall Study||16
517239|NCT00101283|1247137|P1|STARTED|Overall Study||16
517240|NCT00101192|1247147|P1|NOT COMPLETED|Overall Study||7
517241|NCT00101192|1247147|P1|COMPLETED|Overall Study||69
517242|NCT00101192|1247147|P1|STARTED|Overall Study||76
517243|NCT00101166|1247151|P1|NOT COMPLETED|Overall Study||10
517244|NCT00101166|1247151|P1|COMPLETED|Overall Study||18
517245|NCT00101166|1247151|P1|STARTED|Overall Study||28
517246|NCT00101101|1247159|P1|NOT COMPLETED|Overall Study||20
517247|NCT00101101|1247159|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
517248|NCT00101101|1247159|P1|STARTED|Overall Study||43
517249|NCT00101036|1247167|P2|NOT COMPLETED|Overall Study||0
517250|NCT00101036|1247168|P1|NOT COMPLETED|Overall Study||0
517251|NCT00101036|1247167|P2|COMPLETED|Overall Study||40
517252|NCT00101036|1247168|P1|COMPLETED|Overall Study||17
517253|NCT00101036|1247167|P2|STARTED|Overall Study||40
517254|NCT00101036|1247168|P1|STARTED|Overall Study||17
517255|NCT00100932|1247180|P2|NOT COMPLETED|Overall Study||27
517256|NCT00100932|1247181|P1|NOT COMPLETED|Overall Study||73
517257|NCT00100932|1247180|P2|COMPLETED|Overall Study||1
517258|NCT00100932|1247181|P1|COMPLETED|Overall Study||5
517259|NCT00100932|1247180|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
517260|NCT00100932|1247181|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
517261|NCT00100841|1247191|P1|NOT COMPLETED|Overall Study||0
517262|NCT00100841|1247191|P1|COMPLETED|Overall Study||66
517263|NCT00100841|1247191|P1|STARTED|Overall Study||66
517264|NCT00100815|1247196|P1|NOT COMPLETED|Overall Study||49
517265|NCT00100815|1247196|P1|COMPLETED|Overall Study||1
517266|NCT00100815|1247196|P1|STARTED|Overall Study||50
517267|NCT00100802|1247204|P1|NOT COMPLETED|Overall Study||80
517268|NCT00100802|1247204|P1|COMPLETED|Overall Study||38
517269|NCT00100802|1247204|P1|STARTED|Overall Study||118
517270|NCT00100789|1247209|P1|NOT COMPLETED|Overall Study||64
517271|NCT00100789|1247209|P1|COMPLETED|Overall Study||3
517272|NCT00100789|1247209|P1|Eligible and Began Protocol Therapy|Overall Study||63
517273|NCT00100789|1247209|P1|Eligible|Overall Study||64
517274|NCT00100789|1247209|P1|STARTED|Overall Study||67
517275|NCT00100698|1247218|P2|NOT COMPLETED|Overall Study||2
517276|NCT00100698|1247219|P1|NOT COMPLETED|Overall Study||6
517277|NCT00100698|1247218|P2|COMPLETED|Overall Study||27
517278|NCT00100698|1247219|P1|COMPLETED|Overall Study||21
517279|NCT00100698|1247218|P2|STARTED|Overall Study||29
517280|NCT00100698|1247219|P1|STARTED|Overall Study||27
517281|NCT00100659|1247261|P2|NOT COMPLETED|Overall Study||2
517282|NCT00100659|1247262|P1|NOT COMPLETED|Overall Study||3
517283|NCT00100659|1247261|P2|COMPLETED|Overall Study||57
517284|NCT00100659|1247262|P1|COMPLETED|Overall Study||52
517285|NCT00100659|1247261|P2|STARTED|Overall Study||59
517286|NCT00100659|1247262|P1|STARTED|Overall Study||55
517287|NCT00100230|1247270|P2|NOT COMPLETED|Overall Study||15
517288|NCT00100230|1247271|P1|NOT COMPLETED|Overall Study||12
517289|NCT00100230|1247270|P2|COMPLETED|Overall Study||22
517290|NCT00100230|1247271|P1|COMPLETED|Overall Study||29
517291|NCT00100230|1247270|P2|STARTED|Overall Study||37
517292|NCT00100230|1247271|P1|STARTED|Overall Study||41
517293|NCT00100178|1247284|P3|NOT COMPLETED|Overall Study||10
517294|NCT00100178|1247285|P2|NOT COMPLETED|Overall Study||10
517295|NCT00100178|1247286|P1|NOT COMPLETED|Overall Study||9
517296|NCT00100178|1247284|P3|COMPLETED|Overall Study||32
517297|NCT00100178|1247285|P2|COMPLETED|Overall Study||21
517298|NCT00100178|1247286|P1|COMPLETED|Overall Study||32
517299|NCT00100178|1247284|P3|STARTED|Overall Study||42
517300|NCT00100178|1247285|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
517301|NCT00100178|1247286|P1|STARTED|Overall Study||41
517302|NCT00100048|1247299|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
517303|NCT00100048|1247300|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
517304|NCT00100048|1247301|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
517305|NCT00100048|1247302|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
517306|NCT00100048|1247303|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
517307|NCT00100048|1247304|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
517308|NCT00100048|1247299|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
517309|NCT00100048|1247300|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
517310|NCT00100048|1247301|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
517311|NCT00100048|1247302|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
517312|NCT00100048|1247303|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
517313|NCT00100048|1247304|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
517314|NCT00100048|1247299|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
517315|NCT00100048|1247300|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
517316|NCT00100048|1247301|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
517317|NCT00100048|1247302|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
517318|NCT00100048|1247303|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
517319|NCT00100048|1247304|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
517320|NCT00100048|1247299|P6|Treated|Cohort I & II-Combination Therapy Phase||38
517321|NCT00100048|1247300|P5|Treated|Cohort I & II-Combination Therapy Phase||0
517322|NCT00100048|1247301|P4|Treated|Cohort I & II-Combination Therapy Phase||40
517323|NCT00100048|1247302|P3|Treated|Cohort I & II-Combination Therapy Phase||41
517324|NCT00100048|1247303|P2|Treated|Cohort I & II-Combination Therapy Phase||40
517325|NCT00100048|1247304|P1|Treated|Cohort I & II-Combination Therapy Phase||39
517326|NCT00100048|1247299|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
517327|NCT00100048|1247300|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
517328|NCT00100048|1247301|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
517329|NCT00100048|1247302|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
517330|NCT00100048|1247303|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
517331|NCT00100048|1247304|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
517332|NCT00100048|1247299|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517333|NCT00100048|1247300|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517334|NCT00100048|1247301|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517335|NCT00100048|1247302|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517336|NCT00100048|1247303|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517337|NCT00100048|1247304|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517338|NCT00100048|1247299|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
517339|NCT00100048|1247300|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
517340|NCT00100048|1247301|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
517341|NCT00100048|1247302|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
517342|NCT00100048|1247303|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
517343|NCT00100048|1247304|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
517344|NCT00100048|1247299|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
517345|NCT00100048|1247300|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
517346|NCT00100048|1247301|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
517347|NCT00100048|1247302|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
517348|NCT00100048|1247303|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
517349|NCT00100048|1247304|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
517350|NCT00100048|1247299|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
517351|NCT00100048|1247300|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
517352|NCT00100048|1247301|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
517353|NCT00100048|1247302|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
517354|NCT00100048|1247303|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
517355|NCT00100048|1247304|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
517356|NCT00099983|1247413|P2|NOT COMPLETED|Overall Study||25
517357|NCT00099983|1247414|P1|NOT COMPLETED|Overall Study||24
517358|NCT00099983|1247413|P2|COMPLETED|Overall Study||124
517359|NCT00099983|1247414|P1|COMPLETED|Overall Study||123
517360|NCT00099983|1247413|P2|STARTED|Overall Study||149
517361|NCT00099983|1247414|P1|STARTED|Overall Study||147
517362|NCT00099632|1247426|P6|NOT COMPLETED|Overall Study||2
517363|NCT00099632|1247427|P5|NOT COMPLETED|Overall Study||1
517364|NCT00099632|1247428|P4|NOT COMPLETED|Overall Study||1
517365|NCT00099632|1247429|P3|NOT COMPLETED|Overall Study||3
517366|NCT00099632|1247430|P2|NOT COMPLETED|Overall Study||1
517367|NCT00099632|1247431|P1|NOT COMPLETED|Overall Study||1
517368|NCT00099632|1247426|P6|COMPLETED|Overall Study||66
517369|NCT00099632|1247427|P5|COMPLETED|Overall Study||70
517370|NCT00099632|1247428|P4|COMPLETED|Overall Study||66
517371|NCT00099632|1247429|P3|COMPLETED|Overall Study||72
517372|NCT00099632|1247430|P2|COMPLETED|Overall Study||67
517373|NCT00099632|1247431|P1|COMPLETED|Overall Study||72
517374|NCT00099632|1247426|P6|STARTED|Overall Study||68
517375|NCT00099632|1247427|P5|STARTED|Overall Study||71
517376|NCT00099632|1247428|P4|STARTED|Overall Study||67
517377|NCT00099632|1247429|P3|STARTED|Overall Study||75
517378|NCT00099632|1247430|P2|STARTED|Overall Study||68
517379|NCT00099632|1247431|P1|STARTED|Overall Study||73
517380|NCT00099437|1247471|P2|NOT COMPLETED|Overall Study||349
517381|NCT00099437|1247472|P1|NOT COMPLETED|Overall Study||366
517382|NCT00099437|1247471|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
517383|NCT00099437|1247472|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
517384|NCT00099437|1247471|P2|STARTED|Overall Study|randomised patients|362
517385|NCT00099437|1247472|P1|STARTED|Overall Study|randomised patients|374
517386|NCT00099359|1247495|P3|NOT COMPLETED|Overall Study||68
517387|NCT00099359|1247496|P2|NOT COMPLETED|Overall Study||65
517388|NCT00099359|1247497|P1|NOT COMPLETED|Overall Study||54
517389|NCT00099359|1247495|P3|COMPLETED|Overall Study||506
517390|NCT00099359|1247496|P2|COMPLETED|Overall Study||515
517391|NCT00099359|1247497|P1|COMPLETED|Overall Study||527
517392|NCT00099359|1247495|P3|STARTED|Overall Study||574
517393|NCT00099359|1247496|P2|STARTED|Overall Study||580
517394|NCT00099359|1247497|P1|STARTED|Overall Study||581
517395|NCT00099268|1247520|P2|NOT COMPLETED|Overall Study||82
517396|NCT00099268|1247521|P1|NOT COMPLETED|Overall Study||92
517397|NCT00099268|1247520|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
517398|NCT00099268|1247521|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
517399|NCT00099268|1247520|P2|Intent-to-Treat|Overall Study||372
517400|NCT00099268|1247521|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
517401|NCT00099268|1247520|P2|STARTED|Overall Study||373
517402|NCT00099268|1247521|P1|STARTED|Overall Study||374
517403|NCT00099047|1247539|P2|NOT COMPLETED|Overall Study||0
517404|NCT00099047|1247540|P1|NOT COMPLETED|Overall Study||0
517405|NCT00099047|1247539|P2|COMPLETED|Overall Study||12
517406|NCT00099047|1247540|P1|COMPLETED|Overall Study||11
517407|NCT00099047|1247539|P2|STARTED|Overall Study||12
517408|NCT00099047|1247540|P1|STARTED|Overall Study||11
517409|NCT00099021|1247546|P1|NOT COMPLETED|Overall Study||0
517410|NCT00099021|1247546|P1|COMPLETED|Overall Study||21
517411|NCT00099021|1247546|P1|STARTED|Overall Study||21
517412|NCT00098956|1247552|P1|NOT COMPLETED|Overall Study||0
517413|NCT00098956|1247552|P1|COMPLETED|Overall Study||19
517414|NCT00098956|1247552|P1|STARTED|Overall Study||19
517415|NCT00098865|1247557|P1|NOT COMPLETED|Overall Study||9
517416|NCT00098865|1247557|P1|COMPLETED|Overall Study||6
517417|NCT00098865|1247557|P1|STARTED|Overall Study||15
517418|NCT00098839|1247565|P2|NOT COMPLETED|Overall Study||33
517419|NCT00098839|1247566|P1|NOT COMPLETED|Overall Study||32
517420|NCT00098839|1247565|P2|COMPLETED|Overall Study||27
517421|NCT00098839|1247566|P1|COMPLETED|Overall Study||24
517422|NCT00098839|1247565|P2|STARTED|Overall Study||60
517423|NCT00098839|1247566|P1|STARTED|Overall Study||56
517424|NCT00098813|1247576|P1|NOT COMPLETED|Overall Study||19
517425|NCT00098813|1247576|P1|COMPLETED|Overall Study||1
517426|NCT00098813|1247576|P1|STARTED|Overall Study||20
517427|NCT00098787|1247583|P3|NOT COMPLETED|Overall Study||63
517428|NCT00098787|1247584|P2|NOT COMPLETED|Overall Study||75
517429|NCT00098787|1247585|P1|NOT COMPLETED|Overall Study||73
517430|NCT00098787|1247583|P3|COMPLETED|Overall Study||0
517431|NCT00098787|1247584|P2|COMPLETED|Overall Study||0
517432|NCT00098787|1247585|P1|COMPLETED|Overall Study||0
517433|NCT00098787|1247583|P3|Eligible and Treated|Overall Study||59
517434|NCT00098787|1247584|P2|Eligible and Treated|Overall Study||66
517435|NCT00098787|1247585|P1|Eligible and Treated|Overall Study||61
517436|NCT00098787|1247583|P3|Treated|Overall Study||62
517437|NCT00098787|1247584|P2|Treated|Overall Study||73
517438|NCT00098787|1247585|P1|Treated|Overall Study||70
517439|NCT00098787|1247583|P3|STARTED|Overall Study||63
517440|NCT00098787|1247584|P2|STARTED|Overall Study||75
517441|NCT00098787|1247585|P1|STARTED|Overall Study||73
517442|NCT00098774|1247599|P1|NOT COMPLETED|Overall Study||18
517443|NCT00098774|1247599|P1|COMPLETED|Overall Study||26
517444|NCT00098774|1247599|P1|STARTED|Overall Study||44
517445|NCT00098748|1247609|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
517446|NCT00098748|1247610|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
517447|NCT00098748|1247611|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
517448|NCT00098748|1247609|P3|COMPLETED|Continued on Open-Label Treatment||0
517449|NCT00098748|1247610|P2|COMPLETED|Continued on Open-Label Treatment||10
517450|NCT00098748|1247611|P1|COMPLETED|Continued on Open-Label Treatment||7
517451|NCT00098748|1247609|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
517452|NCT00098748|1247610|P2|STARTED|Continued on Open-Label Treatment||25
517453|NCT00098748|1247611|P1|STARTED|Continued on Open-Label Treatment||15
517454|NCT00098748|1247609|P3|NOT COMPLETED|Received Study Treatment||44
517455|NCT00098748|1247610|P2|NOT COMPLETED|Received Study Treatment||36
517456|NCT00098748|1247611|P1|NOT COMPLETED|Received Study Treatment||48
517457|NCT00098748|1247609|P3|COMPLETED|Received Study Treatment||18
517458|NCT00098748|1247610|P2|COMPLETED|Received Study Treatment||25
517459|NCT00098748|1247611|P1|COMPLETED|Received Study Treatment||15
517460|NCT00098748|1247609|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
517461|NCT00098748|1247610|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
517462|NCT00098748|1247611|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
517463|NCT00098748|1247609|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
517464|NCT00098748|1247610|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
517465|NCT00098748|1247611|P1|STARTED|Received Study Treatment||63
517466|NCT00098748|1247609|P3|NOT COMPLETED|Assigned to Study Treatment||2
517467|NCT00098748|1247610|P2|NOT COMPLETED|Assigned to Study Treatment||2
517468|NCT00098748|1247611|P1|NOT COMPLETED|Assigned to Study Treatment||0
517469|NCT00098748|1247609|P3|COMPLETED|Assigned to Study Treatment||62
517470|NCT00098748|1247610|P2|COMPLETED|Assigned to Study Treatment||61
517471|NCT00098748|1247611|P1|COMPLETED|Assigned to Study Treatment||63
517472|NCT00098748|1247609|P3|STARTED|Assigned to Study Treatment||64
517473|NCT00098748|1247610|P2|STARTED|Assigned to Study Treatment||63
517474|NCT00098748|1247611|P1|STARTED|Assigned to Study Treatment||63
517475|NCT00098722|1247667|P7|NOT COMPLETED|Observation Phase||17
517476|NCT00098722|1247668|P6|NOT COMPLETED|Observation Phase||45
517477|NCT00098722|1247669|P5|NOT COMPLETED|Observation Phase||0
517478|NCT00098722|1247670|P4|NOT COMPLETED|Observation Phase||0
517479|NCT00098722|1247671|P3|NOT COMPLETED|Observation Phase||0
517480|NCT00098722|1247672|P2|NOT COMPLETED|Observation Phase||0
517481|NCT00098722|1247673|P1|NOT COMPLETED|Observation Phase||0
517482|NCT00098722|1247667|P7|COMPLETED|Observation Phase||48
517483|NCT00098722|1247668|P6|COMPLETED|Observation Phase||160
517484|NCT00098722|1247669|P5|COMPLETED|Observation Phase||0
517485|NCT00098722|1247670|P4|COMPLETED|Observation Phase||0
517486|NCT00098722|1247671|P3|COMPLETED|Observation Phase||0
517487|NCT00098722|1247672|P2|COMPLETED|Observation Phase||0
517488|NCT00098722|1247673|P1|COMPLETED|Observation Phase||0
517489|NCT00098722|1247667|P7|STARTED|Observation Phase||65
517490|NCT00098722|1247668|P6|STARTED|Observation Phase||205
517491|NCT00098722|1247669|P5|STARTED|Observation Phase||0
517492|NCT00098722|1247670|P4|STARTED|Observation Phase||0
517493|NCT00098722|1247671|P3|STARTED|Observation Phase||0
517494|NCT00098722|1247672|P2|STARTED|Observation Phase||0
517495|NCT00098722|1247673|P1|STARTED|Observation Phase||0
517496|NCT00098722|1247667|P7|NOT COMPLETED|Open Label Phase||0
517497|NCT00098722|1247668|P6|NOT COMPLETED|Open Label Phase||0
517498|NCT00098722|1247669|P5|NOT COMPLETED|Open Label Phase||50
517499|NCT00098722|1247670|P4|NOT COMPLETED|Open Label Phase||272
517500|NCT00098722|1247671|P3|NOT COMPLETED|Open Label Phase||0
517501|NCT00098722|1247672|P2|NOT COMPLETED|Open Label Phase||0
517502|NCT00098722|1247673|P1|NOT COMPLETED|Open Label Phase||0
517503|NCT00098722|1247667|P7|COMPLETED|Open Label Phase||0
517504|NCT00098722|1247668|P6|COMPLETED|Open Label Phase||0
517505|NCT00098722|1247669|P5|COMPLETED|Open Label Phase||0
517506|NCT00098722|1247670|P4|COMPLETED|Open Label Phase||0
517507|NCT00098722|1247671|P3|COMPLETED|Open Label Phase||0
517508|NCT00098722|1247672|P2|COMPLETED|Open Label Phase||0
517509|NCT00098722|1247673|P1|COMPLETED|Open Label Phase||0
517510|NCT00098722|1247667|P7|STARTED|Open Label Phase||0
517511|NCT00098722|1247668|P6|STARTED|Open Label Phase||0
517512|NCT00098722|1247669|P5|STARTED|Open Label Phase||50
517513|NCT00098722|1247670|P4|STARTED|Open Label Phase||272
517514|NCT00098722|1247671|P3|STARTED|Open Label Phase||0
517515|NCT00098722|1247672|P2|STARTED|Open Label Phase||0
517516|NCT00098722|1247673|P1|STARTED|Open Label Phase||0
517517|NCT00098722|1247667|P7|NOT COMPLETED|Double Blind Phase||0
517518|NCT00098722|1247668|P6|NOT COMPLETED|Double Blind Phase||0
517519|NCT00098722|1247669|P5|NOT COMPLETED|Double Blind Phase||0
517520|NCT00098722|1247670|P4|NOT COMPLETED|Double Blind Phase||0
517521|NCT00098722|1247671|P3|NOT COMPLETED|Double Blind Phase||94
517522|NCT00098722|1247672|P2|NOT COMPLETED|Double Blind Phase||194
517523|NCT00098722|1247673|P1|NOT COMPLETED|Double Blind Phase||186
517524|NCT00098722|1247667|P7|COMPLETED|Double Blind Phase||0
517525|NCT00098722|1247668|P6|COMPLETED|Double Blind Phase||0
517526|NCT00098722|1247669|P5|COMPLETED|Double Blind Phase||0
517527|NCT00098722|1247670|P4|COMPLETED|Double Blind Phase||0
517528|NCT00098722|1247671|P3|COMPLETED|Double Blind Phase||0
517529|NCT00098722|1247672|P2|COMPLETED|Double Blind Phase||0
517530|NCT00098722|1247673|P1|COMPLETED|Double Blind Phase||0
517531|NCT00098722|1247667|P7|Treated|Double Blind Phase||0
517532|NCT00098722|1247668|P6|Treated|Double Blind Phase||0
517533|NCT00098722|1247669|P5|Treated|Double Blind Phase||0
517534|NCT00098722|1247670|P4|Treated|Double Blind Phase||0
517535|NCT00098722|1247671|P3|Treated|Double Blind Phase||91
517536|NCT00098722|1247672|P2|Treated|Double Blind Phase||191
517537|NCT00098722|1247673|P1|Treated|Double Blind Phase||182
517538|NCT00098722|1247667|P7|STARTED|Double Blind Phase||0
517539|NCT00098722|1247668|P6|STARTED|Double Blind Phase||0
517540|NCT00098722|1247669|P5|STARTED|Double Blind Phase||0
517541|NCT00098722|1247670|P4|STARTED|Double Blind Phase||0
517542|NCT00098722|1247671|P3|STARTED|Double Blind Phase||94
517543|NCT00098722|1247672|P2|STARTED|Double Blind Phase||194
517544|NCT00098722|1247673|P1|STARTED|Double Blind Phase||186
517545|NCT00098670|1247736|P1|NOT COMPLETED|Overall Study||0
517546|NCT00098670|1247736|P1|COMPLETED|Overall Study||102
517547|NCT00098670|1247736|P1|STARTED|Overall Study||102
517548|NCT00098475|1247747|P4|NOT COMPLETED|Step 2||0
517549|NCT00098475|1247748|P3|NOT COMPLETED|Step 2||0
517550|NCT00098475|1247749|P2|NOT COMPLETED|Step 2||10
517551|NCT00098475|1247750|P1|NOT COMPLETED|Step 2||5
517552|NCT00098475|1247747|P4|COMPLETED|Step 2||0
517553|NCT00098475|1247748|P3|COMPLETED|Step 2||0
517554|NCT00098475|1247749|P2|COMPLETED|Step 2||5
517555|NCT00098475|1247750|P1|COMPLETED|Step 2||0
517556|NCT00098475|1247747|P4|Eligible|Step 2||0
517557|NCT00098475|1247748|P3|Eligible|Step 2||0
517558|NCT00098475|1247749|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
517559|NCT00098475|1247750|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
517560|NCT00098475|1247747|P4|Treated|Step 2||0
517561|NCT00098475|1247748|P3|Treated|Step 2||0
517562|NCT00098475|1247749|P2|Treated|Step 2||14
517563|NCT00098475|1247750|P1|Treated|Step 2||4
517564|NCT00098475|1247747|P4|STARTED|Step 2||0
517565|NCT00098475|1247748|P3|STARTED|Step 2||0
517566|NCT00098475|1247749|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
517567|NCT00098475|1247750|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
517568|NCT00098475|1247747|P4|NOT COMPLETED|Step 1||3
517569|NCT00098475|1247748|P3|NOT COMPLETED|Step 1||4
517570|NCT00098475|1247749|P2|NOT COMPLETED|Step 1||173
517571|NCT00098475|1247750|P1|NOT COMPLETED|Step 1||171
517572|NCT00098475|1247747|P4|COMPLETED|Step 1||0
517573|NCT00098475|1247748|P3|COMPLETED|Step 1||0
517574|NCT00098475|1247749|P2|COMPLETED|Step 1||49
517575|NCT00098475|1247750|P1|COMPLETED|Step 1||52
517576|NCT00098475|1247747|P4|Eligible|Step 1||3
517577|NCT00098475|1247748|P3|Eligible|Step 1||4
517578|NCT00098475|1247749|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
517579|NCT00098475|1247750|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
517580|NCT00098475|1247747|P4|Treated|Step 1||3
517581|NCT00098475|1247748|P3|Treated|Step 1||4
517582|NCT00098475|1247749|P2|Treated|Step 1||220
517583|NCT00098475|1247750|P1|Treated|Step 1||223
517584|NCT00098475|1247747|P4|STARTED|Step 1||3
517585|NCT00098475|1247748|P3|STARTED|Step 1||4
517586|NCT00098475|1247749|P2|STARTED|Step 1||222
517587|NCT00098475|1247750|P1|STARTED|Step 1||223
517588|NCT00098371|1247762|P1|NOT COMPLETED|Overall Study||0
517589|NCT00098371|1247762|P1|COMPLETED|Overall Study||64
517590|NCT00098371|1247762|P1|STARTED|Overall Study||64
517591|NCT00098345|1247787|P1|NOT COMPLETED|Overall Study||13
517592|NCT00098345|1247787|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
517593|NCT00098345|1247787|P1|STARTED|Overall Study||30
517594|NCT00098306|1247800|P7|NOT COMPLETED|Observational Phase||26
517595|NCT00098306|1247801|P6|NOT COMPLETED|Observational Phase||46
517596|NCT00098306|1247802|P5|NOT COMPLETED|Observational Phase||0
517597|NCT00098306|1247803|P4|NOT COMPLETED|Observational Phase||0
517598|NCT00098306|1247804|P3|NOT COMPLETED|Observational Phase||0
517599|NCT00098306|1247805|P2|NOT COMPLETED|Observational Phase||0
517600|NCT00098306|1247806|P1|NOT COMPLETED|Observational Phase||0
517601|NCT00098306|1247800|P7|COMPLETED|Observational Phase||55
517602|NCT00098306|1247801|P6|COMPLETED|Observational Phase||204
517603|NCT00098306|1247802|P5|COMPLETED|Observational Phase||0
517604|NCT00098306|1247803|P4|COMPLETED|Observational Phase||0
517605|NCT00098306|1247804|P3|COMPLETED|Observational Phase||0
517606|NCT00098306|1247805|P2|COMPLETED|Observational Phase||0
517607|NCT00098306|1247806|P1|COMPLETED|Observational Phase||0
517608|NCT00098306|1247800|P7|STARTED|Observational Phase||81
517609|NCT00098306|1247801|P6|STARTED|Observational Phase||250
517610|NCT00098306|1247802|P5|STARTED|Observational Phase||0
517611|NCT00098306|1247803|P4|STARTED|Observational Phase||0
517612|NCT00098306|1247804|P3|STARTED|Observational Phase||0
517613|NCT00098306|1247805|P2|STARTED|Observational Phase||0
517614|NCT00098306|1247806|P1|STARTED|Observational Phase||0
517615|NCT00098306|1247800|P7|NOT COMPLETED|Open Label||0
517616|NCT00098306|1247801|P6|NOT COMPLETED|Open Label||0
517617|NCT00098306|1247802|P5|NOT COMPLETED|Open Label||62
517618|NCT00098306|1247803|P4|NOT COMPLETED|Open Label||327
517619|NCT00098306|1247804|P3|NOT COMPLETED|Open Label||0
517620|NCT00098306|1247805|P2|NOT COMPLETED|Open Label||0
517621|NCT00098306|1247806|P1|NOT COMPLETED|Open Label||0
517622|NCT00098306|1247800|P7|COMPLETED|Open Label||0
517623|NCT00098306|1247801|P6|COMPLETED|Open Label||0
517624|NCT00098306|1247802|P5|COMPLETED|Open Label||0
517625|NCT00098306|1247803|P4|COMPLETED|Open Label||0
517626|NCT00098306|1247804|P3|COMPLETED|Open Label||0
517627|NCT00098306|1247805|P2|COMPLETED|Open Label||0
517628|NCT00098306|1247806|P1|COMPLETED|Open Label||0
517629|NCT00098306|1247800|P7|STARTED|Open Label||0
517630|NCT00098306|1247801|P6|STARTED|Open Label||0
517631|NCT00098306|1247802|P5|STARTED|Open Label||62
517632|NCT00098306|1247803|P4|STARTED|Open Label||327
517633|NCT00098306|1247804|P3|STARTED|Open Label||0
517634|NCT00098306|1247805|P2|STARTED|Open Label||0
517635|NCT00098306|1247806|P1|STARTED|Open Label||0
517636|NCT00098306|1247800|P7|NOT COMPLETED|Double Blind||0
517637|NCT00098306|1247801|P6|NOT COMPLETED|Double Blind||0
517638|NCT00098306|1247802|P5|NOT COMPLETED|Double Blind||0
517639|NCT00098306|1247803|P4|NOT COMPLETED|Double Blind||0
517640|NCT00098306|1247804|P3|NOT COMPLETED|Double Blind||120
517641|NCT00098306|1247805|P2|NOT COMPLETED|Double Blind||240
517642|NCT00098306|1247806|P1|NOT COMPLETED|Double Blind||241
517643|NCT00098306|1247800|P7|COMPLETED|Double Blind||0
517644|NCT00098306|1247801|P6|COMPLETED|Double Blind||0
517645|NCT00098306|1247802|P5|COMPLETED|Double Blind||0
517646|NCT00098306|1247803|P4|COMPLETED|Double Blind||0
517647|NCT00098306|1247804|P3|COMPLETED|Double Blind||0
517648|NCT00098306|1247805|P2|COMPLETED|Double Blind||0
517649|NCT00098306|1247806|P1|COMPLETED|Double Blind||0
517650|NCT00098306|1247800|P7|Treated|Double Blind||0
517651|NCT00098306|1247801|P6|Treated|Double Blind||0
517652|NCT00098306|1247802|P5|Treated|Double Blind||0
517653|NCT00098306|1247803|P4|Treated|Double Blind||0
517654|NCT00098306|1247804|P3|Treated|Double Blind||118
517655|NCT00098306|1247805|P2|Treated|Double Blind||235
517656|NCT00098306|1247806|P1|Treated|Double Blind||232
517657|NCT00098306|1247800|P7|STARTED|Double Blind||0
517658|NCT00098306|1247801|P6|STARTED|Double Blind||0
517659|NCT00098306|1247802|P5|STARTED|Double Blind||0
517660|NCT00098306|1247803|P4|STARTED|Double Blind||0
517661|NCT00098306|1247804|P3|STARTED|Double Blind||120
517662|NCT00098306|1247805|P2|STARTED|Double Blind||240
517663|NCT00098306|1247806|P1|STARTED|Double Blind||241
517664|NCT00098293|1247872|P5|NOT COMPLETED|Supplemental Phase (SP)||33
517665|NCT00098293|1247873|P4|NOT COMPLETED|Supplemental Phase (SP)||0
517666|NCT00098293|1247874|P3|NOT COMPLETED|Supplemental Phase (SP)||0
517667|NCT00098293|1247875|P2|NOT COMPLETED|Supplemental Phase (SP)||0
517668|NCT00098293|1247876|P1|NOT COMPLETED|Supplemental Phase (SP)||0
517669|NCT00098293|1247872|P5|COMPLETED|Supplemental Phase (SP)||94
517670|NCT00098293|1247873|P4|COMPLETED|Supplemental Phase (SP)||0
517671|NCT00098293|1247874|P3|COMPLETED|Supplemental Phase (SP)||0
517672|NCT00098293|1247875|P2|COMPLETED|Supplemental Phase (SP)||0
517673|NCT00098293|1247876|P1|COMPLETED|Supplemental Phase (SP)||0
517674|NCT00098293|1247872|P5|STARTED|Supplemental Phase (SP)||127
517675|NCT00098293|1247873|P4|STARTED|Supplemental Phase (SP)||0
517676|NCT00098293|1247874|P3|STARTED|Supplemental Phase (SP)||0
517677|NCT00098293|1247875|P2|STARTED|Supplemental Phase (SP)||0
517678|NCT00098293|1247876|P1|STARTED|Supplemental Phase (SP)||0
517679|NCT00098293|1247872|P5|NOT COMPLETED|Open-label (OL) Phase||0
517680|NCT00098293|1247873|P4|NOT COMPLETED|Open-label (OL) Phase||65
517681|NCT00098293|1247874|P3|NOT COMPLETED|Open-label (OL) Phase||41
517682|NCT00098293|1247875|P2|NOT COMPLETED|Open-label (OL) Phase||25
517683|NCT00098293|1247876|P1|NOT COMPLETED|Open-label (OL) Phase||0
517684|NCT00098293|1247872|P5|COMPLETED|Open-label (OL) Phase||0
517685|NCT00098293|1247873|P4|COMPLETED|Open-label (OL) Phase||65
517686|NCT00098293|1247874|P3|COMPLETED|Open-label (OL) Phase||158
517687|NCT00098293|1247875|P2|COMPLETED|Open-label (OL) Phase||177
517688|NCT00098293|1247876|P1|COMPLETED|Open-label (OL) Phase||0
517689|NCT00098293|1247872|P5|STARTED|Open-label (OL) Phase||0
517690|NCT00098293|1247873|P4|STARTED|Open-label (OL) Phase||130
517691|NCT00098293|1247874|P3|STARTED|Open-label (OL) Phase||199
517692|NCT00098293|1247875|P2|STARTED|Open-label (OL) Phase||202
517693|NCT00098293|1247876|P1|STARTED|Open-label (OL) Phase||0
517694|NCT00098293|1247872|P5|NOT COMPLETED|Between DB and OL Phase||0
517695|NCT00098293|1247873|P4|NOT COMPLETED|Between DB and OL Phase||0
517696|NCT00098293|1247874|P3|NOT COMPLETED|Between DB and OL Phase||3
517697|NCT00098293|1247875|P2|NOT COMPLETED|Between DB and OL Phase||0
517698|NCT00098293|1247876|P1|NOT COMPLETED|Between DB and OL Phase||0
517699|NCT00098293|1247872|P5|COMPLETED|Between DB and OL Phase||0
517700|NCT00098293|1247873|P4|COMPLETED|Between DB and OL Phase||0
517701|NCT00098293|1247874|P3|COMPLETED|Between DB and OL Phase||199
517702|NCT00098293|1247875|P2|COMPLETED|Between DB and OL Phase||202
517703|NCT00098293|1247876|P1|COMPLETED|Between DB and OL Phase||0
517704|NCT00098293|1247872|P5|STARTED|Between DB and OL Phase||0
517705|NCT00098293|1247873|P4|STARTED|Between DB and OL Phase||0
517706|NCT00098293|1247874|P3|STARTED|Between DB and OL Phase||202
517707|NCT00098293|1247875|P2|STARTED|Between DB and OL Phase||202
517708|NCT00098293|1247876|P1|STARTED|Between DB and OL Phase||0
517709|NCT00098293|1247872|P5|NOT COMPLETED|Double-blind (DB) Phase||0
517710|NCT00098293|1247873|P4|NOT COMPLETED|Double-blind (DB) Phase||0
517711|NCT00098293|1247874|P3|NOT COMPLETED|Double-blind (DB) Phase||170
517712|NCT00098293|1247875|P2|NOT COMPLETED|Double-blind (DB) Phase||166
517713|NCT00098293|1247876|P1|NOT COMPLETED|Double-blind (DB) Phase||177
517714|NCT00098293|1247872|P5|COMPLETED|Double-blind (DB) Phase||0
517715|NCT00098293|1247873|P4|COMPLETED|Double-blind (DB) Phase||0
517716|NCT00098293|1247874|P3|COMPLETED|Double-blind (DB) Phase||202
517717|NCT00098293|1247875|P2|COMPLETED|Double-blind (DB) Phase||202
517718|NCT00098293|1247876|P1|COMPLETED|Double-blind (DB) Phase||0
517719|NCT00098293|1247872|P5|Treated|Double-blind (DB) Phase||0
517720|NCT00098293|1247873|P4|Treated|Double-blind (DB) Phase||0
517721|NCT00098293|1247874|P3|Treated|Double-blind (DB) Phase||361
517722|NCT00098293|1247875|P2|Treated|Double-blind (DB) Phase||360
517723|NCT00098293|1247876|P1|Treated|Double-blind (DB) Phase||174
517724|NCT00098293|1247872|P5|STARTED|Double-blind (DB) Phase||0
517725|NCT00098293|1247873|P4|STARTED|Double-blind (DB) Phase||0
517726|NCT00098293|1247874|P3|STARTED|Double-blind (DB) Phase||372
517727|NCT00098293|1247875|P2|STARTED|Double-blind (DB) Phase||368
517728|NCT00098293|1247876|P1|STARTED|Double-blind (DB) Phase||177
517729|NCT00098254|1247929|P1|NOT COMPLETED|Overall Study||3
517730|NCT00098254|1247929|P1|COMPLETED|Overall Study||34
517731|NCT00098254|1247929|P1|STARTED|Overall Study||37
517732|NCT00098059|1247950|P2|NOT COMPLETED|Overall Study||1
517733|NCT00098059|1247951|P1|NOT COMPLETED|Overall Study||0
517734|NCT00098059|1247950|P2|COMPLETED|Overall Study||46
517735|NCT00098059|1247951|P1|COMPLETED|Overall Study||27
517736|NCT00098059|1247950|P2|STARTED|Overall Study||47
517737|NCT00098059|1247951|P1|STARTED|Overall Study||27
517738|NCT00097981|1247997|P2|NOT COMPLETED|Overall Study||100
517739|NCT00097981|1247998|P1|NOT COMPLETED|Overall Study||106
517740|NCT00097981|1247997|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
517741|NCT00097981|1247998|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
517742|NCT00097981|1247997|P2|Received Study Medication|Overall Study||106
517743|NCT00097981|1247998|P1|Received Study Medication|Overall Study||110
517744|NCT00097981|1247997|P2|STARTED|Overall Study|Enrollment at randomization|112
517745|NCT00097981|1247998|P1|STARTED|Overall Study|Enrollment at randomization|113
517746|NCT00097786|1248020|P4|NOT COMPLETED|Overall Study||310
517747|NCT00097786|1248021|P3|NOT COMPLETED|Overall Study||313
517748|NCT00097786|1248022|P2|NOT COMPLETED|Overall Study||292
517749|NCT00097786|1248023|P1|NOT COMPLETED|Overall Study||296
517750|NCT00097786|1248020|P4|COMPLETED|Overall Study||2036
517751|NCT00097786|1248021|P3|COMPLETED|Overall Study||2016
517752|NCT00097786|1248022|P2|COMPLETED|Overall Study||2023
517753|NCT00097786|1248023|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
517754|NCT00097786|1248020|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
517755|NCT00097786|1248021|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
517756|NCT00097786|1248022|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
517757|NCT00097786|1248023|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
517758|NCT00097786|1248020|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
517759|NCT00097786|1248021|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
517760|NCT00097786|1248022|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
517761|NCT00097786|1248023|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
517762|NCT00097786|1248020|P4|Complete FU for Progression to Diabetes|Overall Study||1762
517763|NCT00097786|1248021|P3|Complete FU for Progression to Diabetes|Overall Study||1734
517764|NCT00097786|1248022|P2|Complete FU for Progression to Diabetes|Overall Study||1712
517765|NCT00097786|1248023|P1|Complete FU for Progression to Diabetes|Overall Study||1709
517766|NCT00097786|1248020|P4|STARTED|Overall Study||2346
517767|NCT00097786|1248021|P3|STARTED|Overall Study||2329
517768|NCT00097786|1248022|P2|STARTED|Overall Study||2315
517769|NCT00097786|1248023|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
517770|NCT00097773|1248045|P4|NOT COMPLETED|Overall Study||3
517771|NCT00097773|1248046|P3|NOT COMPLETED|Overall Study||8
517772|NCT00097773|1248047|P2|NOT COMPLETED|Overall Study||8
517773|NCT00097773|1248048|P1|NOT COMPLETED|Overall Study||8
517774|NCT00097773|1248045|P4|COMPLETED|Overall Study||73
517775|NCT00097773|1248046|P3|COMPLETED|Overall Study||68
517776|NCT00097773|1248047|P2|COMPLETED|Overall Study||68
517777|NCT00097773|1248048|P1|COMPLETED|Overall Study||68
517778|NCT00097773|1248045|P4|STARTED|Overall Study||76
517779|NCT00097773|1248046|P3|STARTED|Overall Study||76
517780|NCT00097773|1248047|P2|STARTED|Overall Study||76
517781|NCT00097773|1248048|P1|STARTED|Overall Study||76
517782|NCT00097721|1248068|P2|NOT COMPLETED|Overall Study||33
517783|NCT00097721|1248069|P1|NOT COMPLETED|Overall Study||71
517784|NCT00097721|1248068|P2|COMPLETED|Overall Study||0
517785|NCT00097721|1248069|P1|COMPLETED|Overall Study||0
517786|NCT00097721|1248068|P2|STARTED|Overall Study||33
517787|NCT00097721|1248069|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
517788|NCT00097708|1248086|P3|NOT COMPLETED|Overall Study||65
517789|NCT00097708|1248087|P2|NOT COMPLETED|Overall Study||56
517790|NCT00097708|1248088|P1|NOT COMPLETED|Overall Study||64
517791|NCT00097708|1248086|P3|COMPLETED|Overall Study||97
517792|NCT00097708|1248087|P2|COMPLETED|Overall Study||120
517793|NCT00097708|1248088|P1|COMPLETED|Overall Study||109
517794|NCT00097708|1248086|P3|Treated|Overall Study||160
517795|NCT00097708|1248087|P2|Treated|Overall Study||176
517796|NCT00097708|1248088|P1|Treated|Overall Study||171
517797|NCT00097708|1248086|P3|Intent-to-Treat (ITT)|Overall Study||149
517798|NCT00097708|1248087|P2|Intent-to-Treat (ITT)|Overall Study||169
517799|NCT00097708|1248088|P1|Intent-to-Treat (ITT)|Overall Study||165
517800|NCT00097708|1248086|P3|STARTED|Overall Study||162
517801|NCT00097708|1248087|P2|STARTED|Overall Study||176
517802|NCT00097708|1248088|P1|STARTED|Overall Study||173
517803|NCT00097695|1248100|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
517804|NCT00097695|1248101|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
517805|NCT00097695|1248102|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
517806|NCT00097695|1248103|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
517807|NCT00097695|1248100|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
517808|NCT00097695|1248101|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
517809|NCT00097695|1248102|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
517810|NCT00097695|1248103|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
517811|NCT00097695|1248100|P4|STARTED|The Open Label Extension (OLE) Phase||20
517812|NCT00097695|1248101|P3|STARTED|The Open Label Extension (OLE) Phase||3
517813|NCT00097695|1248102|P2|STARTED|The Open Label Extension (OLE) Phase||26
517814|NCT00097695|1248103|P1|STARTED|The Open Label Extension (OLE) Phase||23
517815|NCT00097695|1248100|P4|NOT COMPLETED|The Controlled Phase||20
517816|NCT00097695|1248101|P3|NOT COMPLETED|The Controlled Phase||5
517817|NCT00097695|1248102|P2|NOT COMPLETED|The Controlled Phase||3
517818|NCT00097695|1248103|P1|NOT COMPLETED|The Controlled Phase||4
517819|NCT00097695|1248100|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
517820|NCT00097695|1248101|P3|COMPLETED|The Controlled Phase||3
517821|NCT00097695|1248102|P2|COMPLETED|The Controlled Phase||26
517822|NCT00097695|1248103|P1|COMPLETED|The Controlled Phase||23
517823|NCT00097695|1248100|P4|STARTED|The Controlled Phase||20
517824|NCT00097695|1248101|P3|STARTED|The Controlled Phase||8
517825|NCT00097695|1248102|P2|STARTED|The Controlled Phase||29
517826|NCT00097695|1248103|P1|STARTED|The Controlled Phase||27
517827|NCT00097591|1248119|P2|NOT COMPLETED|Overall Study||394
517828|NCT00097591|1248120|P1|NOT COMPLETED|Overall Study||410
517829|NCT00097591|1248119|P2|COMPLETED|Overall Study||6401
517830|NCT00097591|1248120|P1|COMPLETED|Overall Study||6403
517831|NCT00097591|1248119|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
517832|NCT00097591|1248120|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
517833|NCT00097539|1248143|P7|NOT COMPLETED|Overall Study||171
517834|NCT00097539|1248144|P6|NOT COMPLETED|Overall Study||5892
517835|NCT00097539|1248145|P5|NOT COMPLETED|Overall Study||1758
517836|NCT00097539|1248146|P4|NOT COMPLETED|Overall Study||3585
517837|NCT00097539|1248147|P3|NOT COMPLETED|Overall Study||9108
517838|NCT00097539|1248148|P2|NOT COMPLETED|Overall Study||6531
517839|NCT00097539|1248149|P1|NOT COMPLETED|Overall Study||19066
517840|NCT00097539|1248143|P7|COMPLETED|Overall Study||68
517841|NCT00097539|1248144|P6|COMPLETED|Overall Study||2118
517842|NCT00097539|1248145|P5|COMPLETED|Overall Study||386
517843|NCT00097539|1248146|P4|COMPLETED|Overall Study||2066
517844|NCT00097539|1248147|P3|COMPLETED|Overall Study||3411
517845|NCT00097539|1248148|P2|COMPLETED|Overall Study||2825
517846|NCT00097539|1248149|P1|COMPLETED|Overall Study||8220
517847|NCT00097539|1248143|P7|STARTED|Overall Study||239
517848|NCT00097539|1248144|P6|STARTED|Overall Study||8010
517849|NCT00097539|1248145|P5|STARTED|Overall Study||2144
517850|NCT00097539|1248146|P4|STARTED|Overall Study||5651
517851|NCT00097539|1248147|P3|STARTED|Overall Study||12519
517852|NCT00097539|1248148|P2|STARTED|Overall Study||9356
517853|NCT00097539|1248149|P1|STARTED|Overall Study||27286
517854|NCT00097500|1248195|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
517855|NCT00097500|1248196|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
517856|NCT00097500|1248195|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
517857|NCT00097500|1248196|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
517858|NCT00097500|1248195|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
517859|NCT00097500|1248196|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
517860|NCT00097500|1248195|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
517861|NCT00097500|1248196|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
517862|NCT00097500|1248195|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
517863|NCT00097500|1248196|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
517864|NCT00097500|1248195|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
517865|NCT00097500|1248196|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
517866|NCT00097448|1248220|P2|NOT COMPLETED|Overall Study||1
517867|NCT00097448|1248221|P1|NOT COMPLETED|Overall Study||4
517868|NCT00097448|1248220|P2|COMPLETED|Overall Study||129
517869|NCT00097448|1248221|P1|COMPLETED|Overall Study||121
517870|NCT00097448|1248220|P2|STARTED|Overall Study||130
517871|NCT00097448|1248221|P1|STARTED|Overall Study||125
517872|NCT00097370|1248227|P1|NOT COMPLETED|Stage 3||59
517873|NCT00097370|1248227|P1|COMPLETED|Stage 3||0
517874|NCT00097370|1248227|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
517875|NCT00097370|1248227|P1|NOT COMPLETED|Stage 2||13
517876|NCT00097370|1248227|P1|COMPLETED|Stage 2||59
517877|NCT00097370|1248227|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
517878|NCT00097370|1248227|P1|NOT COMPLETED|Stage 1||6
517879|NCT00097370|1248227|P1|COMPLETED|Stage 1||31
517880|NCT00097370|1248227|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
517881|NCT00097253|1248244|P1|NOT COMPLETED|Water (Control)||0
517882|NCT00097253|1248244|P1|COMPLETED|Water (Control)||56
517883|NCT00097253|1248244|P1|STARTED|Water (Control)||56
517884|NCT00097253|1248244|P1|NOT COMPLETED|Lemon||0
517885|NCT00097253|1248244|P1|COMPLETED|Lemon||56
517886|NCT00097253|1248244|P1|STARTED|Lemon||56
517887|NCT00097253|1248244|P1|NOT COMPLETED|Lavender||0
517888|NCT00097253|1248244|P1|COMPLETED|Lavender||56
517889|NCT00097253|1248244|P1|STARTED|Lavender||56
517890|NCT00096993|1248261|P2|NOT COMPLETED|Overall Study||65
517891|NCT00096993|1248262|P1|NOT COMPLETED|Overall Study||65
517892|NCT00096993|1248261|P2|COMPLETED|Overall Study||0
517893|NCT00096993|1248262|P1|COMPLETED|Overall Study||1
517894|NCT00096993|1248261|P2|STARTED|Overall Study||65
517895|NCT00096993|1248262|P1|STARTED|Overall Study||66
517896|NCT00096954|1248278|P2|NOT COMPLETED|Overall Study||20
517897|NCT00096954|1248279|P1|NOT COMPLETED|Overall Study||24
517898|NCT00096954|1248278|P2|COMPLETED|Overall Study||154
517899|NCT00096954|1248279|P1|COMPLETED|Overall Study||135
517900|NCT00096954|1248278|P2|Received Study Drug|Overall Study||171
517901|NCT00096954|1248279|P1|Received Study Drug|Overall Study||157
517902|NCT00096954|1248278|P2|STARTED|Overall Study||174
517903|NCT00096954|1248279|P1|STARTED|Overall Study||159
517904|NCT00096941|1248291|P1|NOT COMPLETED|Overall Study||3
517905|NCT00096941|1248291|P1|COMPLETED|Overall Study||0
517906|NCT00096941|1248291|P1|STARTED|Overall Study||3
517907|NCT00096785|1248298|P2|NOT COMPLETED|Overall Study||1
517908|NCT00096785|1248299|P1|NOT COMPLETED|Overall Study||2
517909|NCT00096785|1248298|P2|COMPLETED|Overall Study|As randomized cohort|33
517910|NCT00096785|1248299|P1|COMPLETED|Overall Study|As randomized cohort|33
517911|NCT00096785|1248298|P2|As-Treated Population|Overall Study||33
517912|NCT00096785|1248299|P1|As-Treated Population|Overall Study||36
517913|NCT00096785|1248298|P2|As-Randomized Population|Overall Study||34
517914|NCT00096785|1248299|P1|As-Randomized Population|Overall Study||35
517915|NCT00096785|1248298|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
517916|NCT00096785|1248299|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
517917|NCT00096681|1248323|P1|NOT COMPLETED|Overall Study||0
517918|NCT00096681|1248323|P1|COMPLETED|Overall Study||762
517919|NCT00096681|1248323|P1|STARTED|Overall Study||762
517920|NCT00095563|1248328|P1|NOT COMPLETED|Overall Study||0
517921|NCT00095563|1248328|P1|COMPLETED|Overall Study||39
517922|NCT00095563|1248328|P1|STARTED|Overall Study||39
517923|NCT00095498|1248340|P3|NOT COMPLETED|Overall Study||39
517924|NCT00095498|1248341|P2|NOT COMPLETED|Overall Study||35
517925|NCT00095498|1248342|P1|NOT COMPLETED|Overall Study||37
517926|NCT00095498|1248340|P3|COMPLETED|Overall Study||39
517927|NCT00095498|1248341|P2|COMPLETED|Overall Study||38
517928|NCT00095498|1248342|P1|COMPLETED|Overall Study||39
517929|NCT00095498|1248340|P3|Received Investigational Product|Overall Study||75
517930|NCT00095498|1248341|P2|Received Investigational Product|Overall Study||71
517931|NCT00095498|1248342|P1|Received Investigational Product|Overall Study||72
517932|NCT00095498|1248340|P3|STARTED|Overall Study||78
517933|NCT00095498|1248341|P2|STARTED|Overall Study||73
517934|NCT00095498|1248342|P1|STARTED|Overall Study||76
517935|NCT00095303|1248769|P2|NOT COMPLETED|Follow Up Study||58
517936|NCT00095303|1248770|P1|NOT COMPLETED|Follow Up Study||59
517937|NCT00095303|1248769|P2|COMPLETED|Follow Up Study||121
517938|NCT00095303|1248770|P1|COMPLETED|Follow Up Study||140
518030|NCT00096135|1248981|P1|COMPLETED|Overall Study||63
517939|NCT00095303|1248769|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
517940|NCT00095303|1248770|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
517941|NCT00095303|1248769|P2|NOT COMPLETED|Main Study||87
517942|NCT00095303|1248770|P1|NOT COMPLETED|Main Study||91
517943|NCT00095303|1248769|P2|COMPLETED|Main Study||148
517944|NCT00095303|1248770|P1|COMPLETED|Main Study||154
517945|NCT00095303|1248769|P2|STARTED|Main Study||235
517946|NCT00095303|1248770|P1|STARTED|Main Study||245
517947|NCT00096538|1248836|P1|NOT COMPLETED|Overall Study||1
517948|NCT00096538|1248836|P1|COMPLETED|Overall Study||5
517949|NCT00096538|1248836|P1|STARTED|Overall Study||6
517950|NCT00096486|1248844|P4|NOT COMPLETED|Overall Study||2
517951|NCT00096486|1248845|P3|NOT COMPLETED|Overall Study||2
517952|NCT00096486|1248846|P2|NOT COMPLETED|Overall Study||0
517953|NCT00096486|1248847|P1|NOT COMPLETED|Overall Study||0
517954|NCT00096486|1248844|P4|COMPLETED|Overall Study||36
517955|NCT00096486|1248845|P3|COMPLETED|Overall Study||24
517956|NCT00096486|1248846|P2|COMPLETED|Overall Study||6
517957|NCT00096486|1248847|P1|COMPLETED|Overall Study||4
517958|NCT00096486|1248844|P4|STARTED|Overall Study||38
517959|NCT00096486|1248845|P3|STARTED|Overall Study||26
517960|NCT00096486|1248846|P2|STARTED|Overall Study||6
517961|NCT00096486|1248847|P1|STARTED|Overall Study||4
517962|NCT00096460|1248859|P2|NOT COMPLETED|Overall Study||1
517963|NCT00096460|1248860|P1|NOT COMPLETED|Overall Study||7
517964|NCT00096460|1248859|P2|COMPLETED|Overall Study||7
517965|NCT00096460|1248860|P1|COMPLETED|Overall Study||15
517966|NCT00096460|1248859|P2|STARTED|Overall Study||8
517967|NCT00096460|1248860|P1|STARTED|Overall Study||22
517968|NCT00096447|1248866|P1|NOT COMPLETED|Overall Study||1
517969|NCT00096447|1248866|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
517970|NCT00096447|1248866|P1|STARTED|Overall Study||31
517971|NCT00096382|1248874|P2|NOT COMPLETED|Overall Study||0
517972|NCT00096382|1248875|P1|NOT COMPLETED|Overall Study||2
517973|NCT00096382|1248874|P2|COMPLETED|Overall Study||3
517974|NCT00096382|1248875|P1|COMPLETED|Overall Study||21
517975|NCT00096382|1248874|P2|STARTED|Overall Study||3
517976|NCT00096382|1248875|P1|STARTED|Overall Study||23
517977|NCT00096356|1248885|P2|NOT COMPLETED|Overall Study||53
517978|NCT00096356|1248886|P1|NOT COMPLETED|Overall Study||44
517979|NCT00096356|1248885|P2|COMPLETED|Overall Study||61
517980|NCT00096356|1248886|P1|COMPLETED|Overall Study||78
517981|NCT00096356|1248885|P2|STARTED|Overall Study||114
517982|NCT00096356|1248886|P1|STARTED|Overall Study||122
517983|NCT00096278|1248898|P2|NOT COMPLETED|Overall Study||20
517984|NCT00096278|1248899|P1|NOT COMPLETED|Overall Study||18
517985|NCT00096278|1248898|P2|COMPLETED|Overall Study||1334
517986|NCT00096278|1248899|P1|COMPLETED|Overall Study||1338
517987|NCT00096278|1248898|P2|STARTED|Overall Study||1354
517988|NCT00096278|1248899|P1|STARTED|Overall Study||1356
517989|NCT00096265|1248908|P3|NOT COMPLETED|Overall Study||0
517990|NCT00096265|1248909|P2|NOT COMPLETED|Overall Study||0
517991|NCT00096265|1248910|P1|NOT COMPLETED|Overall Study||1
517992|NCT00096265|1248908|P3|COMPLETED|Overall Study||41
517993|NCT00096265|1248909|P2|COMPLETED|Overall Study||40
517994|NCT00096265|1248910|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
517995|NCT00096265|1248908|P3|STARTED|Overall Study||41
517996|NCT00096265|1248909|P2|STARTED|Overall Study||40
517997|NCT00096265|1248910|P1|STARTED|Overall Study||45
517998|NCT00096226|1248918|P1|NOT COMPLETED|Overall Study||17
517999|NCT00096226|1248918|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
518000|NCT00096226|1248918|P1|STARTED|Overall Study||60
518001|NCT00096200|1248925|P3|NOT COMPLETED|Overall Study||0
518002|NCT00096200|1248926|P2|NOT COMPLETED|Overall Study||7
518003|NCT00096200|1248927|P1|NOT COMPLETED|Overall Study||1
518004|NCT00096200|1248925|P3|COMPLETED|Overall Study||5
518005|NCT00096200|1248926|P2|COMPLETED|Overall Study||23
518006|NCT00096200|1248927|P1|COMPLETED|Overall Study||8
518007|NCT00096200|1248925|P3|STARTED|Overall Study||5
518008|NCT00096200|1248926|P2|STARTED|Overall Study||30
518009|NCT00096200|1248927|P1|STARTED|Overall Study||9
518010|NCT00096174|1248935|P1|NOT COMPLETED|Overall Study||62
518011|NCT00096174|1248935|P1|COMPLETED|Overall Study||7
518012|NCT00096174|1248935|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
518013|NCT00096174|1248935|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
518014|NCT00096174|1248935|P1|STARTED|Overall Study||69
518015|NCT00096161|1248945|P4|NOT COMPLETED|Overall Study||0
518016|NCT00096161|1248946|P3|NOT COMPLETED|Overall Study||0
518017|NCT00096161|1248947|P2|NOT COMPLETED|Overall Study||0
518018|NCT00096161|1248948|P1|NOT COMPLETED|Overall Study||0
518019|NCT00096161|1248945|P4|COMPLETED|Overall Study||0
518020|NCT00096161|1248946|P3|COMPLETED|Overall Study||6
518021|NCT00096161|1248947|P2|COMPLETED|Overall Study||10
518022|NCT00096161|1248948|P1|COMPLETED|Overall Study||20
518023|NCT00096161|1248945|P4|STARTED|Overall Study||0
518024|NCT00096161|1248946|P3|STARTED|Overall Study||6
518025|NCT00096161|1248947|P2|STARTED|Overall Study||10
518026|NCT00096161|1248948|P1|STARTED|Overall Study||20
518027|NCT00096135|1248980|P2|NOT COMPLETED|Overall Study||15
518028|NCT00096135|1248981|P1|NOT COMPLETED|Overall Study||63
518029|NCT00096135|1248980|P2|COMPLETED|Overall Study||27
518031|NCT00096135|1248980|P2|STARTED|Overall Study||42
518032|NCT00096135|1248981|P1|STARTED|Overall Study||126
518033|NCT00096122|1248987|P1|NOT COMPLETED|Overall Study||0
518034|NCT00096122|1248987|P1|COMPLETED|Overall Study||95
518035|NCT00096122|1248987|P1|STARTED|Overall Study||95
518036|NCT00096109|1248991|P1|NOT COMPLETED|Overall Study||0
518037|NCT00096109|1248991|P1|COMPLETED|Overall Study||11
518038|NCT00096109|1248991|P1|STARTED|Overall Study||11
518039|NCT00096031|1248997|P1|NOT COMPLETED|Overall Study||63
518040|NCT00096031|1248997|P1|COMPLETED|Overall Study||0
518041|NCT00096031|1248997|P1|Eligible and Began Protocol Therapy|Overall Study||55
518042|NCT00096031|1248997|P1|Eligible|Overall Study||57
518043|NCT00096031|1248997|P1|STARTED|Overall Study||63
518044|NCT00096018|1249005|P2|NOT COMPLETED|Overall Study||14
518045|NCT00096018|1249006|P1|NOT COMPLETED|Overall Study||2
518046|NCT00096018|1249005|P2|COMPLETED|Overall Study||16
518047|NCT00096018|1249006|P1|COMPLETED|Overall Study||11
518048|NCT00096018|1249005|P2|Treated With Study Therapy|Overall Study||25
518049|NCT00096018|1249006|P1|Treated With Study Therapy|Overall Study||13
518050|NCT00096018|1249005|P2|STARTED|Overall Study||30
518051|NCT00096018|1249006|P1|STARTED|Overall Study||13
518052|NCT00095979|1249014|P1|NOT COMPLETED|Overall Study||2
518053|NCT00095979|1249014|P1|COMPLETED|Overall Study||50
518054|NCT00095979|1249014|P1|STARTED|Overall Study||52
518055|NCT00095940|1249027|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
518056|NCT00095940|1249028|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
518057|NCT00095940|1249029|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
518058|NCT00095940|1249030|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
518059|NCT00095940|1249031|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
518060|NCT00095940|1249032|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
518061|NCT00095940|1249033|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
518062|NCT00095940|1249034|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
518063|NCT00095940|1249035|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
518064|NCT00095940|1249027|P9|COMPLETED|Lapatinib Continuation/Phase II||1
518065|NCT00095940|1249028|P8|COMPLETED|Lapatinib Continuation/Phase II||0
518066|NCT00095940|1249029|P7|COMPLETED|Lapatinib Continuation/Phase II||0
518067|NCT00095940|1249030|P6|COMPLETED|Lapatinib Continuation/Phase II||0
518068|NCT00095940|1249031|P5|COMPLETED|Lapatinib Continuation/Phase II||0
518069|NCT00095940|1249032|P4|COMPLETED|Lapatinib Continuation/Phase II||0
518070|NCT00095940|1249033|P3|COMPLETED|Lapatinib Continuation/Phase II||1
518071|NCT00095940|1249034|P2|COMPLETED|Lapatinib Continuation/Phase II||0
518072|NCT00095940|1249035|P1|COMPLETED|Lapatinib Continuation/Phase II||0
518073|NCT00095940|1249027|P9|STARTED|Lapatinib Continuation/Phase II||14
518074|NCT00095940|1249028|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
518075|NCT00095940|1249029|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
518076|NCT00095940|1249030|P6|STARTED|Lapatinib Continuation/Phase II||13
518077|NCT00095940|1249031|P5|STARTED|Lapatinib Continuation/Phase II||0
518078|NCT00095940|1249032|P4|STARTED|Lapatinib Continuation/Phase II||0
518079|NCT00095940|1249033|P3|STARTED|Lapatinib Continuation/Phase II||17
518080|NCT00095940|1249034|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
518081|NCT00095940|1249035|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
518082|NCT00095940|1249027|P9|NOT COMPLETED|Molecular Biology Phase||0
518083|NCT00095940|1249028|P8|NOT COMPLETED|Molecular Biology Phase||0
518084|NCT00095940|1249029|P7|NOT COMPLETED|Molecular Biology Phase||0
518085|NCT00095940|1249030|P6|NOT COMPLETED|Molecular Biology Phase||0
518086|NCT00095940|1249031|P5|NOT COMPLETED|Molecular Biology Phase||0
518087|NCT00095940|1249032|P4|NOT COMPLETED|Molecular Biology Phase||0
518088|NCT00095940|1249033|P3|NOT COMPLETED|Molecular Biology Phase||0
518089|NCT00095940|1249034|P2|NOT COMPLETED|Molecular Biology Phase||0
518090|NCT00095940|1249035|P1|NOT COMPLETED|Molecular Biology Phase||0
518091|NCT00095940|1249027|P9|COMPLETED|Molecular Biology Phase||0
518092|NCT00095940|1249028|P8|COMPLETED|Molecular Biology Phase||2
518093|NCT00095940|1249029|P7|COMPLETED|Molecular Biology Phase||2
518094|NCT00095940|1249030|P6|COMPLETED|Molecular Biology Phase||0
518095|NCT00095940|1249031|P5|COMPLETED|Molecular Biology Phase||0
518096|NCT00095940|1249032|P4|COMPLETED|Molecular Biology Phase||0
518097|NCT00095940|1249033|P3|COMPLETED|Molecular Biology Phase||0
518098|NCT00095940|1249034|P2|COMPLETED|Molecular Biology Phase||2
518099|NCT00095940|1249035|P1|COMPLETED|Molecular Biology Phase||2
518100|NCT00095940|1249027|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
518101|NCT00095940|1249028|P8|STARTED|Molecular Biology Phase||2
518102|NCT00095940|1249029|P7|STARTED|Molecular Biology Phase||2
518103|NCT00095940|1249030|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
518104|NCT00095940|1249031|P5|STARTED|Molecular Biology Phase||0
518105|NCT00095940|1249032|P4|STARTED|Molecular Biology Phase||0
518106|NCT00095940|1249033|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
518107|NCT00095940|1249034|P2|STARTED|Molecular Biology Phase||2
518108|NCT00095940|1249035|P1|STARTED|Molecular Biology Phase||2
518109|NCT00095875|1249059|P2|NOT COMPLETED|Overall Study||9
518110|NCT00095875|1249060|P1|NOT COMPLETED|Overall Study||14
518111|NCT00095875|1249059|P2|COMPLETED|Overall Study||66
518112|NCT00095875|1249060|P1|COMPLETED|Overall Study||56
518113|NCT00095875|1249059|P2|STARTED|Overall Study||75
518114|NCT00095875|1249060|P1|STARTED|Overall Study||70
518115|NCT00095836|1249068|P1|NOT COMPLETED|Overall Study||4
518116|NCT00095836|1249068|P1|COMPLETED|Overall Study||23
518117|NCT00095836|1249068|P1|STARTED|Overall Study||27
518118|NCT00095784|1249075|P1|NOT COMPLETED|Overall Study||0
518119|NCT00095784|1249075|P1|COMPLETED|Overall Study||21
518120|NCT00095784|1249075|P1|STARTED|Overall Study||21
518121|NCT00095628|1249098|P1|NOT COMPLETED|Overall Study||1
518122|NCT00095628|1249098|P1|COMPLETED|Overall Study||20
518123|NCT00095628|1249098|P1|STARTED|Overall Study||21
518124|NCT00095576|1249109|P2|NOT COMPLETED|Overall Study||1481
518125|NCT00095576|1249110|P1|NOT COMPLETED|Overall Study||1475
518126|NCT00095576|1249109|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
518127|NCT00095576|1249110|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
518128|NCT00095576|1249109|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
518129|NCT00095576|1249110|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
518130|NCT00095576|1249109|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
518131|NCT00095576|1249110|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
518132|NCT00095576|1249109|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
518133|NCT00095576|1249110|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
518134|NCT00095576|1249109|P2|STARTED|Overall Study||1495
518135|NCT00095576|1249110|P1|STARTED|Overall Study||1484
518136|NCT00095238|1249124|P2|NOT COMPLETED|Overall Study||852
518137|NCT00095238|1249125|P1|NOT COMPLETED|Overall Study||857
518138|NCT00095238|1249124|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
518139|NCT00095238|1249125|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
518140|NCT00095238|1249124|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
518141|NCT00095238|1249125|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
518142|NCT00095238|1249124|P2|STARTED|Overall Study|number randomized|2061
518143|NCT00095238|1249125|P1|STARTED|Overall Study|number randomized|2067
518144|NCT00095212|1249187|P2|NOT COMPLETED|Overall Study||3
518145|NCT00095212|1249188|P1|NOT COMPLETED|Overall Study||1
518146|NCT00095212|1249187|P2|COMPLETED|Overall Study||9
518147|NCT00095212|1249188|P1|COMPLETED|Overall Study||12
518148|NCT00095212|1249187|P2|STARTED|Overall Study||12
518149|NCT00095212|1249188|P1|STARTED|Overall Study||13
518150|NCT00095199|1249218|P4|NOT COMPLETED|Overall Study||143
518151|NCT00095199|1249219|P3|NOT COMPLETED|Overall Study||160
518152|NCT00095199|1249220|P2|NOT COMPLETED|Overall Study||242
518153|NCT00095199|1249221|P1|NOT COMPLETED|Overall Study||296
518154|NCT00095199|1249218|P4|COMPLETED|Overall Study||23
518155|NCT00095199|1249219|P3|COMPLETED|Overall Study||7
518156|NCT00095199|1249220|P2|COMPLETED|Overall Study||62
518157|NCT00095199|1249221|P1|COMPLETED|Overall Study||6
518158|NCT00095199|1249218|P4|STARTED|Overall Study||166
518159|NCT00095199|1249219|P3|STARTED|Overall Study||167
518160|NCT00095199|1249220|P2|STARTED|Overall Study||304
518161|NCT00095199|1249221|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
518162|NCT00095173|1249259|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
518163|NCT00095173|1249260|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
518164|NCT00095173|1249261|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
518165|NCT00095173|1249262|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
518166|NCT00095173|1249263|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
518167|NCT00095173|1249264|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
518168|NCT00095173|1249259|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
518169|NCT00095173|1249260|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
518170|NCT00095173|1249261|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
518171|NCT00095173|1249262|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
518172|NCT00095173|1249263|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
518173|NCT00095173|1249264|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
518174|NCT00095173|1249259|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
518175|NCT00095173|1249260|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
518176|NCT00095173|1249261|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
518177|NCT00095173|1249262|P3|STARTED|Open-Label Extension Phase (Period C)||0
518178|NCT00095173|1249263|P2|STARTED|Open-Label Extension Phase (Period C)||0
518179|NCT00095173|1249264|P1|STARTED|Open-Label Extension Phase (Period C)||0
518180|NCT00095173|1249259|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
518181|NCT00095173|1249260|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
518182|NCT00095173|1249261|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
518183|NCT00095173|1249262|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
518184|NCT00095173|1249263|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
518185|NCT00095173|1249264|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
518186|NCT00095173|1249259|P6|COMPLETED|Double-Blind Phase (Period B)||0
518187|NCT00095173|1249260|P5|COMPLETED|Double-Blind Phase (Period B)||0
518188|NCT00095173|1249261|P4|COMPLETED|Double-Blind Phase (Period B)||0
518189|NCT00095173|1249262|P3|COMPLETED|Double-Blind Phase (Period B)||31
518190|NCT00095173|1249263|P2|COMPLETED|Double-Blind Phase (Period B)||49
518191|NCT00095173|1249264|P1|COMPLETED|Double-Blind Phase (Period B)||0
518192|NCT00095173|1249259|P6|STARTED|Double-Blind Phase (Period B)||0
518193|NCT00095173|1249260|P5|STARTED|Double-Blind Phase (Period B)||0
518194|NCT00095173|1249261|P4|STARTED|Double-Blind Phase (Period B)||0
518195|NCT00095173|1249262|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
518196|NCT00095173|1249263|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
518197|NCT00095173|1249264|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
518198|NCT00095173|1249259|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
518199|NCT00095173|1249260|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
518200|NCT00095173|1249261|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
518201|NCT00095173|1249262|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
518202|NCT00095173|1249263|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
518203|NCT00095173|1249264|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
518204|NCT00095173|1249259|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
518205|NCT00095173|1249260|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
518206|NCT00095173|1249261|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
518207|NCT00095173|1249262|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
518208|NCT00095173|1249263|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
518209|NCT00095173|1249264|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
518210|NCT00095173|1249259|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
518211|NCT00095173|1249260|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
518212|NCT00095173|1249261|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
518213|NCT00095173|1249262|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
518214|NCT00095173|1249263|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
518215|NCT00095173|1249264|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
518216|NCT00095147|1249302|P5|NOT COMPLETED|Long-term Extension Period||45
518217|NCT00095147|1249303|P4|NOT COMPLETED|Long-term Extension Period||0
518218|NCT00095147|1249304|P3|NOT COMPLETED|Long-term Extension Period||0
518219|NCT00095147|1249305|P2|NOT COMPLETED|Long-term Extension Period||0
518220|NCT00095147|1249306|P1|NOT COMPLETED|Long-term Extension Period||0
518221|NCT00095147|1249302|P5|COMPLETED|Long-term Extension Period||327
518222|NCT00095147|1249303|P4|COMPLETED|Long-term Extension Period||0
518223|NCT00095147|1249304|P3|COMPLETED|Long-term Extension Period||0
518224|NCT00095147|1249305|P2|COMPLETED|Long-term Extension Period||0
518225|NCT00095147|1249306|P1|COMPLETED|Long-term Extension Period||0
518226|NCT00095147|1249302|P5|STARTED|Long-term Extension Period||372
518227|NCT00095147|1249303|P4|STARTED|Long-term Extension Period||0
518228|NCT00095147|1249304|P3|STARTED|Long-term Extension Period||0
518229|NCT00095147|1249305|P2|STARTED|Long-term Extension Period||0
518230|NCT00095147|1249306|P1|STARTED|Long-term Extension Period||0
518231|NCT00095147|1249302|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
518232|NCT00095147|1249303|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
518233|NCT00095147|1249304|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
518234|NCT00095147|1249305|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
518235|NCT00095147|1249306|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
518236|NCT00095147|1249302|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
518237|NCT00095147|1249303|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
518238|NCT00095147|1249304|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
518239|NCT00095147|1249305|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
518240|NCT00095147|1249306|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
518241|NCT00095147|1249302|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
518242|NCT00095147|1249303|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
518243|NCT00095147|1249304|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
518244|NCT00095147|1249305|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
518245|NCT00095147|1249306|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
518246|NCT00095147|1249302|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
518247|NCT00095147|1249303|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
518248|NCT00095147|1249304|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
518249|NCT00095147|1249305|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
518250|NCT00095147|1249306|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
518251|NCT00095147|1249302|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
518252|NCT00095147|1249303|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
518253|NCT00095147|1249304|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
518254|NCT00095147|1249305|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
518255|NCT00095147|1249306|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
518256|NCT00095147|1249302|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
518257|NCT00095147|1249303|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
518258|NCT00095147|1249304|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
518259|NCT00095147|1249305|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
518260|NCT00095147|1249306|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
518261|NCT00095121|1249501|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
518262|NCT00095121|1249502|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
518263|NCT00095121|1249501|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
518264|NCT00095121|1249502|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
518265|NCT00095121|1249501|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
518266|NCT00095121|1249502|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
518267|NCT00095121|1249501|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
518268|NCT00095121|1249502|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
518269|NCT00095121|1249501|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
518270|NCT00095121|1249502|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
518271|NCT00095121|1249501|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
518272|NCT00095121|1249502|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
518273|NCT00095121|1249501|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
518274|NCT00095121|1249502|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
518275|NCT00095056|1249548|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
518276|NCT00095056|1249549|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
518277|NCT00095056|1249548|P2|COMPLETED|Phase B (Weeks 12-54)||20
518278|NCT00095056|1249549|P1|COMPLETED|Phase B (Weeks 12-54)||46
518279|NCT00095056|1249548|P2|STARTED|Phase B (Weeks 12-54)||25
518280|NCT00095056|1249549|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
518281|NCT00095056|1249548|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
518282|NCT00095056|1249549|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
518283|NCT00095056|1249548|P2|COMPLETED|Phase A (Weeks 0-12)||25
518284|NCT00095056|1249549|P1|COMPLETED|Phase A (Weeks 0-12)||58
518285|NCT00095056|1249548|P2|STARTED|Phase A (Weeks 0-12)||26
518286|NCT00095056|1249549|P1|STARTED|Phase A (Weeks 0-12)||65
518287|NCT00094900|1249557|P1|NOT COMPLETED|Overall Study||1
518288|NCT00094900|1249557|P1|COMPLETED|Overall Study||10
518289|NCT00094900|1249557|P1|STARTED|Overall Study||11
518290|NCT00094887|1249659|P2|NOT COMPLETED|Overall Study||6
518291|NCT00094887|1249660|P1|NOT COMPLETED|Overall Study||5
518292|NCT00094887|1249659|P2|COMPLETED|Overall Study||69
518293|NCT00094887|1249660|P1|COMPLETED|Overall Study||70
518294|NCT00094887|1249659|P2|STARTED|Overall Study|75|75
518295|NCT00094887|1249660|P1|STARTED|Overall Study|75|75
518296|NCT00094861|1249668|P2|NOT COMPLETED|Overall Study||9
518297|NCT00094861|1249669|P1|NOT COMPLETED|Overall Study||18
518298|NCT00094861|1249668|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
518299|NCT00094861|1249669|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
518300|NCT00094861|1249668|P2|Participants Treated|Overall Study||48
518301|NCT00094861|1249669|P1|Participants Treated|Overall Study||46
518302|NCT00094861|1249668|P2|STARTED|Overall Study||49
518303|NCT00094861|1249669|P1|STARTED|Overall Study||46
518304|NCT00094835|1249696|P7|NOT COMPLETED|Overall Study||2
518305|NCT00094835|1249697|P6|NOT COMPLETED|Overall Study||3
518306|NCT00094835|1249698|P5|NOT COMPLETED|Overall Study||4
518307|NCT00094835|1249699|P4|NOT COMPLETED|Overall Study||1
518308|NCT00094835|1249700|P3|NOT COMPLETED|Overall Study||3
518309|NCT00094835|1249701|P2|NOT COMPLETED|Overall Study||3
518310|NCT00094835|1249702|P1|NOT COMPLETED|Overall Study||4
518311|NCT00094835|1249696|P7|COMPLETED|Overall Study||4
518312|NCT00094835|1249697|P6|COMPLETED|Overall Study||3
518313|NCT00094835|1249698|P5|COMPLETED|Overall Study||3
518314|NCT00094835|1249699|P4|COMPLETED|Overall Study||4
518315|NCT00094835|1249700|P3|COMPLETED|Overall Study||4
518316|NCT00094835|1249701|P2|COMPLETED|Overall Study||8
518317|NCT00094835|1249702|P1|COMPLETED|Overall Study||5
518318|NCT00094835|1249696|P7|Treated With Motesanib|Overall Study||6
518319|NCT00094835|1249697|P6|Treated With Motesanib|Overall Study||5
518320|NCT00094835|1249698|P5|Treated With Motesanib|Overall Study||7
518321|NCT00094835|1249699|P4|Treated With Motesanib|Overall Study||4
518322|NCT00094835|1249700|P3|Treated With Motesanib|Overall Study||6
518323|NCT00094835|1249701|P2|Treated With Motesanib|Overall Study||11
518324|NCT00094835|1249702|P1|Treated With Motesanib|Overall Study||6
518325|NCT00094835|1249696|P7|STARTED|Overall Study||6
518326|NCT00094835|1249697|P6|STARTED|Overall Study||6
518327|NCT00094835|1249698|P5|STARTED|Overall Study||7
518328|NCT00094835|1249699|P4|STARTED|Overall Study||5
518329|NCT00094835|1249700|P3|STARTED|Overall Study||7
518330|NCT00094835|1249701|P2|STARTED|Overall Study||11
518331|NCT00094835|1249702|P1|STARTED|Overall Study||9
518332|NCT00094809|1249780|P2|NOT COMPLETED|Overall Study||65
518333|NCT00094809|1249781|P1|NOT COMPLETED|Overall Study||52
518334|NCT00094809|1249780|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
518335|NCT00094809|1249781|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
518336|NCT00094809|1249780|P2|Completed All 4 Cycles of Treatment|Overall Study||90
518337|NCT00094809|1249781|P1|Completed All 4 Cycles of Treatment|Overall Study||98
518338|NCT00094809|1249780|P2|Properly Consented; Received Study Drug|Overall Study||118
518339|NCT00094809|1249781|P1|Properly Consented; Received Study Drug|Overall Study||123
518340|NCT00094809|1249780|P2|Received Study Drug|Overall Study||118
518341|NCT00094809|1249781|P1|Received Study Drug|Overall Study||124
518342|NCT00094809|1249780|P2|STARTED|Overall Study||126
518343|NCT00094809|1249781|P1|STARTED|Overall Study||126
518344|NCT00094770|1249807|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
518345|NCT00094770|1249808|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
518346|NCT00094770|1249807|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
518347|NCT00094770|1249808|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
518348|NCT00094770|1249807|P2|STARTED|Year 2 (Week 0 to Week 104)||584
518349|NCT00094770|1249808|P1|STARTED|Year 2 (Week 0 to Week 104)||588
518350|NCT00094770|1249807|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
518351|NCT00094770|1249808|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
518352|NCT00094770|1249807|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
518353|NCT00094770|1249808|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
518354|NCT00094770|1249807|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
518355|NCT00094770|1249808|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
518356|NCT00094757|1249839|P3|NOT COMPLETED|Overall Study||30
518357|NCT00094757|1249840|P2|NOT COMPLETED|Overall Study||62
518358|NCT00094757|1249841|P1|NOT COMPLETED|Overall Study||53
518359|NCT00094757|1249839|P3|COMPLETED|Overall Study||80
518360|NCT00094757|1249840|P2|COMPLETED|Overall Study||144
518361|NCT00094757|1249841|P1|COMPLETED|Overall Study||152
518362|NCT00094757|1249839|P3|STARTED|Overall Study||110
518363|NCT00094757|1249840|P2|STARTED|Overall Study||206
518364|NCT00094757|1249841|P1|STARTED|Overall Study||205
518365|NCT00094653|1249861|P3|NOT COMPLETED|Overall Study||126
518366|NCT00094653|1249862|P2|NOT COMPLETED|Overall Study||106
518367|NCT00094653|1249863|P1|NOT COMPLETED|Overall Study||321
518368|NCT00094653|1249861|P3|COMPLETED|Overall Study||10
518369|NCT00094653|1249862|P2|COMPLETED|Overall Study||31
518370|NCT00094653|1249863|P1|COMPLETED|Overall Study||82
518371|NCT00094653|1249861|P3|Treated|Overall Study||131
518372|NCT00094653|1249862|P2|Treated|Overall Study||131
518373|NCT00094653|1249863|P1|Treated|Overall Study||381
518374|NCT00094653|1249861|P3|STARTED|Overall Study||136
518375|NCT00094653|1249862|P2|STARTED|Overall Study||137
518376|NCT00094653|1249863|P1|STARTED|Overall Study||403
518377|NCT00094575|1249926|P2|NOT COMPLETED|Overall Study||146
518378|NCT00094575|1249927|P1|NOT COMPLETED|Overall Study||146
518379|NCT00094575|1249926|P2|COMPLETED|Overall Study||291
518380|NCT00094575|1249927|P1|COMPLETED|Overall Study||298
518381|NCT00094575|1249926|P2|STARTED|Overall Study||437
518382|NCT00094575|1249927|P1|STARTED|Overall Study||444
518383|NCT00094536|1249947|P1|NOT COMPLETED|Treatment and Follow-up||31
518384|NCT00094536|1249947|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
518385|NCT00094536|1249947|P1|36 Month Follow-up|Treatment and Follow-up||51
518386|NCT00094536|1249947|P1|24 Month Follow-up|Treatment and Follow-up||53
518387|NCT00094536|1249947|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
518388|NCT00094536|1249947|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
518389|NCT00094536|1249947|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
518390|NCT00094536|1249947|P1|COMPLETED|Inclusion Exclusion Evaluation||82
518391|NCT00094536|1249947|P1|STARTED|Inclusion Exclusion Evaluation||106
518392|NCT00094497|1249953|P2|NOT COMPLETED|Overall Study||0
518393|NCT00094497|1249954|P1|NOT COMPLETED|Overall Study||0
518394|NCT00094497|1249953|P2|COMPLETED|Overall Study||153
518395|NCT00094497|1249954|P1|COMPLETED|Overall Study||151
518396|NCT00094497|1249953|P2|Received Second Line Therapy|Overall Study||101
518397|NCT00094497|1249954|P1|Received Second Line Therapy|Overall Study||84
518398|NCT00094497|1249953|P2|Treated|Overall Study||149
518399|NCT00094497|1249954|P1|Treated|Overall Study||148
518400|NCT00094497|1249953|P2|STARTED|Overall Study||153
518401|NCT00094497|1249954|P1|STARTED|Overall Study||151
518402|NCT00094458|1249971|P6|NOT COMPLETED|OLE: Open-Label Extension||4
518403|NCT00094458|1249972|P5|NOT COMPLETED|OLE: Open-Label Extension||5
518404|NCT00094458|1249973|P4|NOT COMPLETED|OLE: Open-Label Extension||1
518405|NCT00094458|1249974|P3|NOT COMPLETED|OLE: Open-Label Extension||0
518406|NCT00094458|1249975|P2|NOT COMPLETED|OLE: Open-Label Extension||0
518407|NCT00094458|1249976|P1|NOT COMPLETED|OLE: Open-Label Extension||0
518408|NCT00094458|1249971|P6|COMPLETED|OLE: Open-Label Extension||13
518409|NCT00094458|1249972|P5|COMPLETED|OLE: Open-Label Extension||13
518410|NCT00094458|1249973|P4|COMPLETED|OLE: Open-Label Extension||7
518411|NCT00094458|1249974|P3|COMPLETED|OLE: Open-Label Extension||0
518412|NCT00094458|1249975|P2|COMPLETED|OLE: Open-Label Extension||0
518413|NCT00094458|1249976|P1|COMPLETED|OLE: Open-Label Extension||0
518414|NCT00094458|1249971|P6|STARTED|OLE: Open-Label Extension||17
518415|NCT00094458|1249972|P5|STARTED|OLE: Open-Label Extension||18
518416|NCT00094458|1249973|P4|STARTED|OLE: Open-Label Extension||8
518417|NCT00094458|1249974|P3|STARTED|OLE: Open-Label Extension||0
518418|NCT00094458|1249975|P2|STARTED|OLE: Open-Label Extension||0
518419|NCT00094458|1249976|P1|STARTED|OLE: Open-Label Extension||0
518420|NCT00094458|1249971|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
518421|NCT00094458|1249972|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
518422|NCT00094458|1249973|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
518423|NCT00094458|1249974|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
518424|NCT00094458|1249975|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
518425|NCT00094458|1249976|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
518426|NCT00094458|1249971|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
518427|NCT00094458|1249972|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
518428|NCT00094458|1249973|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
518429|NCT00094458|1249974|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
518430|NCT00094458|1249975|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
518431|NCT00094458|1249976|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
518432|NCT00094458|1249971|P6|STARTED|Study Extension: Week 30 Through Week 50||0
518433|NCT00094458|1249972|P5|STARTED|Study Extension: Week 30 Through Week 50||0
518434|NCT00094458|1249973|P4|STARTED|Study Extension: Week 30 Through Week 50||0
518435|NCT00094458|1249974|P3|STARTED|Study Extension: Week 30 Through Week 50||108
518436|NCT00094458|1249975|P2|STARTED|Study Extension: Week 30 Through Week 50||97
518437|NCT00094458|1249976|P1|STARTED|Study Extension: Week 30 Through Week 50||75
518438|NCT00094458|1249971|P6|NOT COMPLETED|Main Study: Through Week 30||0
518439|NCT00094458|1249972|P5|NOT COMPLETED|Main Study: Through Week 30||0
518440|NCT00094458|1249973|P4|NOT COMPLETED|Main Study: Through Week 30||0
518441|NCT00094458|1249974|P3|NOT COMPLETED|Main Study: Through Week 30||48
518442|NCT00094458|1249975|P2|NOT COMPLETED|Main Study: Through Week 30||58
518443|NCT00094458|1249976|P1|NOT COMPLETED|Main Study: Through Week 30||84
518444|NCT00094458|1249971|P6|COMPLETED|Main Study: Through Week 30||0
518445|NCT00094458|1249972|P5|COMPLETED|Main Study: Through Week 30||0
518446|NCT00094458|1249973|P4|COMPLETED|Main Study: Through Week 30||0
518447|NCT00094458|1249974|P3|COMPLETED|Main Study: Through Week 30||121
518448|NCT00094458|1249975|P2|COMPLETED|Main Study: Through Week 30||111
518449|NCT00094458|1249976|P1|COMPLETED|Main Study: Through Week 30||86
518450|NCT00094458|1249971|P6|STARTED|Main Study: Through Week 30||0
518451|NCT00094458|1249972|P5|STARTED|Main Study: Through Week 30||0
518452|NCT00094458|1249973|P4|STARTED|Main Study: Through Week 30||0
518453|NCT00094458|1249974|P3|STARTED|Main Study: Through Week 30||169
518454|NCT00094458|1249975|P2|STARTED|Main Study: Through Week 30||169
518455|NCT00094458|1249976|P1|STARTED|Main Study: Through Week 30||170
518456|NCT00094328|1250014|P1|NOT COMPLETED|Overall Study||1
518457|NCT00094328|1250014|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
518458|NCT00094328|1250014|P1|STARTED|Overall Study|Received treatment|14
518459|NCT00094302|1250024|P2|NOT COMPLETED|Overall Study||406
518460|NCT00094302|1250025|P1|NOT COMPLETED|Overall Study||417
518461|NCT00094302|1250024|P2|COMPLETED|Overall Study||1316
518462|NCT00094302|1250025|P1|COMPLETED|Overall Study||1306
518463|NCT00094302|1250024|P2|STARTED|Overall Study||1722
518464|NCT00094302|1250025|P1|STARTED|Overall Study||1723
518465|NCT00094172|1250081|P2|NOT COMPLETED|Overall Study||7
518466|NCT00094172|1250082|P1|NOT COMPLETED|Overall Study||14
518467|NCT00094172|1250081|P2|COMPLETED|Overall Study||25
518468|NCT00094172|1250082|P1|COMPLETED|Overall Study||36
518469|NCT00094172|1250081|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
518470|NCT00094172|1250082|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
518471|NCT00094107|1250092|P1|NOT COMPLETED|Overall Study||32
518472|NCT00094107|1250092|P1|COMPLETED|Overall Study||0
518473|NCT00094107|1250092|P1|STARTED|Overall Study||32
518474|NCT00094094|1250101|P1|NOT COMPLETED|Overall Study||32
518475|NCT00094094|1250101|P1|COMPLETED|Overall Study||0
518476|NCT00094094|1250101|P1|STARTED|Overall Study||32
518477|NCT00094055|1250110|P1|NOT COMPLETED|Overall Study||60
518478|NCT00094055|1250110|P1|COMPLETED|Overall Study||0
518479|NCT00094055|1250110|P1|STARTED|Overall Study||60
518480|NCT00093847|1250121|P2|NOT COMPLETED|Overall Study||10
518481|NCT00093847|1250122|P1|NOT COMPLETED|Overall Study||8
518482|NCT00093847|1250121|P2|COMPLETED|Overall Study||24
518483|NCT00093847|1250122|P1|COMPLETED|Overall Study||31
518484|NCT00093847|1250121|P2|STARTED|Overall Study||34
518485|NCT00093847|1250122|P1|STARTED|Overall Study||39
518486|NCT00093808|1250130|P1|NOT COMPLETED|Overall Study||2
518487|NCT00093808|1250130|P1|COMPLETED|Overall Study||45
518488|NCT00093808|1250130|P1|STARTED|Overall Study||47
518489|NCT00093782|1250137|P1|NOT COMPLETED|Overall Study||0
518490|NCT00093782|1250137|P1|COMPLETED|Overall Study||36
518491|NCT00093782|1250137|P1|STARTED|Overall Study||36
518492|NCT00093756|1250149|P2|NOT COMPLETED|Overall Study||0
518493|NCT00093756|1250150|P1|NOT COMPLETED|Overall Study||0
518494|NCT00093756|1250149|P2|COMPLETED|Overall Study||27
518495|NCT00093756|1250150|P1|COMPLETED|Overall Study||21
518496|NCT00093756|1250149|P2|STARTED|Overall Study||27
518497|NCT00093756|1250150|P1|STARTED|Overall Study||21
518498|NCT00093496|1250157|P2|NOT COMPLETED|Overall Study||3
518499|NCT00093496|1250158|P1|NOT COMPLETED|Overall Study||1
518500|NCT00093496|1250157|P2|COMPLETED|Overall Study||11
518501|NCT00093496|1250158|P1|COMPLETED|Overall Study||14
518502|NCT00093496|1250157|P2|STARTED|Overall Study||14
518503|NCT00093496|1250158|P1|STARTED|Overall Study||15
518504|NCT00093470|1250171|P2|NOT COMPLETED|Overall Study||0
518505|NCT00093470|1250172|P1|NOT COMPLETED|Overall Study||73
518506|NCT00093470|1250171|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
518507|NCT00093470|1250172|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
518508|NCT00093470|1250171|P2|Patients With Toxicity Assessment|Overall Study||69
518509|NCT00093470|1250172|P1|Patients With Toxicity Assessment|Overall Study||72
518510|NCT00093470|1250171|P2|Treated|Overall Study||71
518511|NCT00093470|1250172|P1|Treated|Overall Study||72
518512|NCT00093470|1250171|P2|STARTED|Overall Study||71
518513|NCT00093470|1250172|P1|STARTED|Overall Study||73
518514|NCT00093379|1250180|P1|NOT COMPLETED|Overall Study||0
518515|NCT00093379|1250180|P1|COMPLETED|Overall Study||20
518516|NCT00093379|1250180|P1|STARTED|Overall Study||20
518517|NCT00093145|1250186|P1|NOT COMPLETED|Overall Study||17
518518|NCT00093145|1250186|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
518519|NCT00093145|1250186|P1|At Least One Response Assessment|Overall Study||31
518520|NCT00093145|1250186|P1|STARTED|Overall Study||32
518521|NCT00093041|1250201|P6|NOT COMPLETED|Overall Study||3
518522|NCT00093041|1250202|P5|NOT COMPLETED|Overall Study||1
518523|NCT00093041|1250203|P4|NOT COMPLETED|Overall Study||1
518524|NCT00093041|1250204|P3|NOT COMPLETED|Overall Study||2
518525|NCT00093041|1250205|P2|NOT COMPLETED|Overall Study||3
518526|NCT00093041|1250206|P1|NOT COMPLETED|Overall Study||2
518527|NCT00093041|1250201|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
518528|NCT00093041|1250202|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
518529|NCT00093041|1250203|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
518530|NCT00093041|1250204|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
518531|NCT00093041|1250205|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
518532|NCT00093041|1250206|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
518533|NCT00093041|1250201|P6|STARTED|Overall Study||7
518534|NCT00093041|1250202|P5|STARTED|Overall Study||4
518535|NCT00093041|1250203|P4|STARTED|Overall Study||4
518536|NCT00093041|1250204|P3|STARTED|Overall Study||5
518537|NCT00093041|1250205|P2|STARTED|Overall Study||4
518538|NCT00093041|1250206|P1|STARTED|Overall Study||4
518539|NCT00093015|1250228|P2|NOT COMPLETED|Overall Study||664
518540|NCT00093015|1250229|P1|NOT COMPLETED|Overall Study||665
518541|NCT00093015|1250228|P2|COMPLETED|Overall Study||1348
518542|NCT00093015|1250229|P1|COMPLETED|Overall Study||1361
518543|NCT00093015|1250228|P2|Received Study Medication|Overall Study||2004
518544|NCT00093015|1250229|P1|Received Study Medication|Overall Study||2019
518545|NCT00093015|1250228|P2|STARTED|Overall Study||2012
518546|NCT00093015|1250229|P1|STARTED|Overall Study||2026
518547|NCT00091832|1250261|P6|NOT COMPLETED|Overall Study||11
518548|NCT00091832|1250262|P5|NOT COMPLETED|Overall Study||15
518549|NCT00091832|1250263|P4|NOT COMPLETED|Overall Study||14
518550|NCT00091832|1250264|P3|NOT COMPLETED|Overall Study||12
518551|NCT00091832|1250265|P2|NOT COMPLETED|Overall Study||11
518552|NCT00091832|1250266|P1|NOT COMPLETED|Overall Study||14
518553|NCT00091832|1250261|P6|COMPLETED|Overall Study||32
518554|NCT00091832|1250262|P5|COMPLETED|Overall Study||27
518555|NCT00091832|1250263|P4|COMPLETED|Overall Study||29
518556|NCT00091832|1250264|P3|COMPLETED|Overall Study||30
518557|NCT00091832|1250265|P2|COMPLETED|Overall Study||31
518558|NCT00091832|1250266|P1|COMPLETED|Overall Study||29
518559|NCT00091832|1250261|P6|Received Study Medication|Overall Study||43
518560|NCT00091832|1250262|P5|Received Study Medication|Overall Study||42
518561|NCT00091832|1250263|P4|Received Study Medication|Overall Study||43
518562|NCT00091832|1250264|P3|Received Study Medication|Overall Study||41
518563|NCT00091832|1250265|P2|Received Study Medication|Overall Study||42
518564|NCT00091832|1250266|P1|Received Study Medication|Overall Study||43
518565|NCT00091832|1250261|P6|STARTED|Overall Study||43
518566|NCT00091832|1250262|P5|STARTED|Overall Study||42
518567|NCT00091832|1250263|P4|STARTED|Overall Study||43
518568|NCT00091832|1250264|P3|STARTED|Overall Study||42
518569|NCT00091832|1250265|P2|STARTED|Overall Study||42
518570|NCT00091832|1250266|P1|STARTED|Overall Study||43
518571|NCT00091819|1250384|P2|NOT COMPLETED|Overall Study||46
518572|NCT00091819|1250385|P1|NOT COMPLETED|Overall Study||42
518573|NCT00091819|1250384|P2|COMPLETED|Overall Study||387
518574|NCT00091819|1250385|P1|COMPLETED|Overall Study||387
518575|NCT00091819|1250384|P2|STARTED|Overall Study||433
518576|NCT00091819|1250385|P1|STARTED|Overall Study||429
518577|NCT00091793|1250393|P2|NOT COMPLETED|Overall Study||22
518578|NCT00091793|1250394|P1|NOT COMPLETED|Overall Study||24
518579|NCT00091793|1250393|P2|COMPLETED|Overall Study||144
518580|NCT00091793|1250394|P1|COMPLETED|Overall Study||142
518581|NCT00091793|1250393|P2|STARTED|Overall Study||166
518582|NCT00091793|1250394|P1|STARTED|Overall Study||166
518583|NCT00092677|1250418|P2|NOT COMPLETED|Overall Study||11
518584|NCT00092677|1250419|P1|NOT COMPLETED|Overall Study||5
518585|NCT00092677|1250418|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
518586|NCT00092677|1250419|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
518587|NCT00092677|1250418|P2|STARTED|Overall Study||929
518588|NCT00092677|1250419|P1|STARTED|Overall Study||944
518589|NCT00092547|1250463|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
518590|NCT00092547|1250464|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
518591|NCT00092547|1250465|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
518592|NCT00092547|1250463|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
518593|NCT00092547|1250464|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
518594|NCT00092547|1250465|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
518595|NCT00092547|1250463|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
518596|NCT00092547|1250464|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
518597|NCT00092547|1250465|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
518598|NCT00092547|1250463|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
518599|NCT00092547|1250464|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
518600|NCT00092547|1250465|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
518601|NCT00092547|1250463|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
518602|NCT00092547|1250464|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
518603|NCT00092547|1250465|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
518669|NCT00092534|1250511|P1|NOT COMPLETED|Extension Study||0
518604|NCT00092547|1250463|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
518605|NCT00092547|1250464|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
518606|NCT00092547|1250465|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
518607|NCT00092547|1250463|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
518608|NCT00092547|1250464|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
518609|NCT00092547|1250465|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
518610|NCT00092547|1250463|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
518611|NCT00092547|1250464|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
518612|NCT00092547|1250465|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
518613|NCT00092547|1250463|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
518614|NCT00092547|1250464|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
518615|NCT00092547|1250465|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
518616|NCT00092547|1250463|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
518617|NCT00092547|1250464|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
518618|NCT00092547|1250465|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
518619|NCT00092547|1250463|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
518620|NCT00092547|1250464|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
518621|NCT00092547|1250465|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
518622|NCT00092547|1250463|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
518623|NCT00092547|1250464|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
518624|NCT00092547|1250465|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
518625|NCT00092547|1250463|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
518626|NCT00092547|1250464|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
518627|NCT00092547|1250465|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
518628|NCT00092547|1250463|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
518629|NCT00092547|1250464|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
518630|NCT00092547|1250465|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
518631|NCT00092547|1250463|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
518632|NCT00092547|1250464|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
518633|NCT00092547|1250465|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
518634|NCT00092547|1250463|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
518635|NCT00092547|1250464|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
518710|NCT00092521|1250529|P4|STARTED|Extension Study (Group 4)||844
518636|NCT00092547|1250465|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
518637|NCT00092547|1250463|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
518638|NCT00092547|1250464|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
518639|NCT00092547|1250465|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
518640|NCT00092547|1250463|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
518641|NCT00092547|1250464|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
518642|NCT00092547|1250465|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
518643|NCT00092547|1250463|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
518644|NCT00092547|1250464|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
518645|NCT00092547|1250465|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
518646|NCT00092547|1250463|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
518647|NCT00092547|1250464|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
518648|NCT00092547|1250465|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
518649|NCT00092547|1250463|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
518650|NCT00092547|1250464|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
518651|NCT00092547|1250465|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
518652|NCT00092547|1250463|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
518653|NCT00092547|1250464|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
518654|NCT00092547|1250465|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
518655|NCT00092547|1250463|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
518656|NCT00092547|1250464|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
518657|NCT00092547|1250465|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
518658|NCT00092547|1250463|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
518659|NCT00092547|1250464|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
518660|NCT00092547|1250465|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
518661|NCT00092547|1250463|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
518662|NCT00092547|1250464|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
518663|NCT00092547|1250465|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
518664|NCT00092547|1250463|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
518665|NCT00092547|1250464|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
518666|NCT00092547|1250465|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
518667|NCT00092534|1250509|P3|NOT COMPLETED|Extension Study||145
518668|NCT00092534|1250510|P2|NOT COMPLETED|Extension Study||0
518670|NCT00092534|1250509|P3|COMPLETED|Extension Study||449
518671|NCT00092534|1250510|P2|COMPLETED|Extension Study||0
518672|NCT00092534|1250511|P1|COMPLETED|Extension Study||0
518673|NCT00092534|1250509|P3|STARTED|Extension Study||594
518674|NCT00092534|1250510|P2|STARTED|Extension Study||0
518675|NCT00092534|1250511|P1|STARTED|Extension Study||0
518676|NCT00092534|1250509|P3|NOT COMPLETED|Base Study Follow Up Period||0
518677|NCT00092534|1250510|P2|NOT COMPLETED|Base Study Follow Up Period||694
518678|NCT00092534|1250511|P1|NOT COMPLETED|Base Study Follow Up Period||316
518679|NCT00092534|1250509|P3|COMPLETED|Base Study Follow Up Period||0
518680|NCT00092534|1250510|P2|COMPLETED|Base Study Follow Up Period||5277
518681|NCT00092534|1250511|P1|COMPLETED|Base Study Follow Up Period||5626
518682|NCT00092534|1250509|P3|STARTED|Base Study Follow Up Period||0
518683|NCT00092534|1250510|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
518684|NCT00092534|1250511|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
518685|NCT00092534|1250509|P3|NOT COMPLETED|Base Study Vaccination Period||0
518686|NCT00092534|1250510|P2|NOT COMPLETED|Base Study Vaccination Period||126
518687|NCT00092534|1250511|P1|NOT COMPLETED|Base Study Vaccination Period||171
518688|NCT00092534|1250509|P3|COMPLETED|Base Study Vaccination Period||0
518689|NCT00092534|1250510|P2|COMPLETED|Base Study Vaccination Period||5954
518690|NCT00092534|1250511|P1|COMPLETED|Base Study Vaccination Period||5916
518691|NCT00092534|1250509|P3|STARTED|Base Study Vaccination Period||0
518692|NCT00092534|1250510|P2|STARTED|Base Study Vaccination Period||6080
518693|NCT00092534|1250511|P1|STARTED|Base Study Vaccination Period||6087
518694|NCT00092521|1250529|P4|NOT COMPLETED|Extension Study (Group 4)||209
518695|NCT00092521|1250530|P3|NOT COMPLETED|Extension Study (Group 4)||0
518696|NCT00092521|1250531|P2|NOT COMPLETED|Extension Study (Group 4)||0
518697|NCT00092521|1250532|P1|NOT COMPLETED|Extension Study (Group 4)||0
518698|NCT00092521|1250529|P4|COMPLETED|Extension Study (Group 4)||635
518699|NCT00092521|1250530|P3|COMPLETED|Extension Study (Group 4)||0
518700|NCT00092521|1250531|P2|COMPLETED|Extension Study (Group 4)||0
518701|NCT00092521|1250532|P1|COMPLETED|Extension Study (Group 4)||0
518702|NCT00092521|1250529|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
518703|NCT00092521|1250530|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
518704|NCT00092521|1250531|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
518705|NCT00092521|1250532|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
518706|NCT00092521|1250529|P4|Initiated Extension Study|Extension Study (Group 4)||829
518707|NCT00092521|1250530|P3|Initiated Extension Study|Extension Study (Group 4)||0
518708|NCT00092521|1250531|P2|Initiated Extension Study|Extension Study (Group 4)||0
518709|NCT00092521|1250532|P1|Initiated Extension Study|Extension Study (Group 4)||0
518711|NCT00092521|1250530|P3|STARTED|Extension Study (Group 4)||0
518712|NCT00092521|1250531|P2|STARTED|Extension Study (Group 4)||0
518713|NCT00092521|1250532|P1|STARTED|Extension Study (Group 4)||0
518714|NCT00092521|1250529|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
518715|NCT00092521|1250530|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
518716|NCT00092521|1250531|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
518717|NCT00092521|1250532|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
518718|NCT00092521|1250529|P4|COMPLETED|Follow-Up (After Month 7)||0
518719|NCT00092521|1250530|P3|COMPLETED|Follow-Up (After Month 7)||1959
518720|NCT00092521|1250531|P2|COMPLETED|Follow-Up (After Month 7)||155
518721|NCT00092521|1250532|P1|COMPLETED|Follow-Up (After Month 7)||2353
518722|NCT00092521|1250529|P4|STARTED|Follow-Up (After Month 7)||0
518723|NCT00092521|1250530|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
518724|NCT00092521|1250531|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
518725|NCT00092521|1250532|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
518726|NCT00092521|1250529|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
518727|NCT00092521|1250530|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
518728|NCT00092521|1250531|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
518729|NCT00092521|1250532|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
518730|NCT00092521|1250529|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
518731|NCT00092521|1250530|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
518732|NCT00092521|1250531|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
518733|NCT00092521|1250532|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
518734|NCT00092521|1250529|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
518735|NCT00092521|1250530|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
518736|NCT00092521|1250531|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
518737|NCT00092521|1250532|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
518738|NCT00092495|1250546|P5|NOT COMPLETED|Extension Study||0
518739|NCT00092495|1250547|P4|NOT COMPLETED|Extension Study||0
518740|NCT00092495|1250548|P3|NOT COMPLETED|Extension Study||0
518741|NCT00092495|1250549|P2|NOT COMPLETED|Extension Study||0
518742|NCT00092495|1250550|P1|NOT COMPLETED|Extension Study||0
518743|NCT00092495|1250546|P5|COMPLETED|Extension Study||12
518744|NCT00092495|1250547|P4|COMPLETED|Extension Study||0
518745|NCT00092495|1250548|P3|COMPLETED|Extension Study||0
518746|NCT00092495|1250549|P2|COMPLETED|Extension Study||0
518747|NCT00092495|1250550|P1|COMPLETED|Extension Study||0
518748|NCT00092495|1250546|P5|STARTED|Extension Study||12
518749|NCT00092495|1250547|P4|STARTED|Extension Study||0
518750|NCT00092495|1250548|P3|STARTED|Extension Study||0
518751|NCT00092495|1250549|P2|STARTED|Extension Study||0
518752|NCT00092495|1250550|P1|STARTED|Extension Study||0
518753|NCT00092495|1250546|P5|NOT COMPLETED|Base Study Follow-up Period||0
518754|NCT00092495|1250547|P4|NOT COMPLETED|Base Study Follow-up Period||14
518755|NCT00092495|1250548|P3|NOT COMPLETED|Base Study Follow-up Period||4
518756|NCT00092495|1250549|P2|NOT COMPLETED|Base Study Follow-up Period||3
518757|NCT00092495|1250550|P1|NOT COMPLETED|Base Study Follow-up Period||3
518758|NCT00092495|1250546|P5|COMPLETED|Base Study Follow-up Period||0
518759|NCT00092495|1250547|P4|COMPLETED|Base Study Follow-up Period||446
518760|NCT00092495|1250548|P3|COMPLETED|Base Study Follow-up Period||126
518761|NCT00092495|1250549|P2|COMPLETED|Base Study Follow-up Period||122
518762|NCT00092495|1250550|P1|COMPLETED|Base Study Follow-up Period||112
518763|NCT00092495|1250546|P5|STARTED|Base Study Follow-up Period||0
518764|NCT00092495|1250547|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
518765|NCT00092495|1250548|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
518766|NCT00092495|1250549|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
518767|NCT00092495|1250550|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
518768|NCT00092495|1250546|P5|NOT COMPLETED|Base Study Vaccination Period||0
518769|NCT00092495|1250547|P4|NOT COMPLETED|Base Study Vaccination Period||88
518770|NCT00092495|1250548|P3|NOT COMPLETED|Base Study Vaccination Period||34
518771|NCT00092495|1250549|P2|NOT COMPLETED|Base Study Vaccination Period||22
518772|NCT00092495|1250550|P1|NOT COMPLETED|Base Study Vaccination Period||37
518773|NCT00092495|1250546|P5|COMPLETED|Base Study Vaccination Period||0
518774|NCT00092495|1250547|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
518775|NCT00092495|1250548|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
518776|NCT00092495|1250549|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
518777|NCT00092495|1250550|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
518778|NCT00092495|1250546|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
518779|NCT00092495|1250547|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
518780|NCT00092495|1250548|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
519020|NCT00090285|1251107|P1|COMPLETED|Extension 1||0
518781|NCT00092495|1250549|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
518782|NCT00092495|1250550|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
518783|NCT00092495|1250546|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
518784|NCT00092495|1250547|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
518785|NCT00092495|1250548|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
518786|NCT00092495|1250549|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
518787|NCT00092495|1250550|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
518788|NCT00092495|1250546|P5|STARTED|Base Study Vaccination Period||0
518789|NCT00092495|1250547|P4|STARTED|Base Study Vaccination Period||1529
518790|NCT00092495|1250548|P3|STARTED|Base Study Vaccination Period||508
518791|NCT00092495|1250549|P2|STARTED|Base Study Vaccination Period||514
518792|NCT00092495|1250550|P1|STARTED|Base Study Vaccination Period||504
518793|NCT00092456|1250616|P4|NOT COMPLETED|Overall Study||16
518794|NCT00092456|1250617|P3|NOT COMPLETED|Overall Study||29
518795|NCT00092456|1250618|P2|NOT COMPLETED|Overall Study||17
518796|NCT00092456|1250619|P1|NOT COMPLETED|Overall Study||25
518797|NCT00092456|1250616|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
518798|NCT00092456|1250617|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
518799|NCT00092456|1250618|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
518800|NCT00092456|1250619|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
518801|NCT00092456|1250616|P4|Vaccinated at Visit 3|Overall Study||98
518802|NCT00092456|1250617|P3|Vaccinated at Visit 3|Overall Study||200
518803|NCT00092456|1250618|P2|Vaccinated at Visit 3|Overall Study||210
518804|NCT00092456|1250619|P1|Vaccinated at Visit 3|Overall Study||202
518805|NCT00092456|1250616|P4|Vaccinated at Visit 2|Overall Study||104
518806|NCT00092456|1250617|P3|Vaccinated at Visit 2|Overall Study||210
518807|NCT00092456|1250618|P2|Vaccinated at Visit 2|Overall Study||217
518808|NCT00092456|1250619|P1|Vaccinated at Visit 2|Overall Study||208
518809|NCT00092456|1250616|P4|Vaccinated at Visit 1|Overall Study||113
518810|NCT00092456|1250617|P3|Vaccinated at Visit 1|Overall Study||229
518811|NCT00092456|1250618|P2|Vaccinated at Visit 1|Overall Study||225
518812|NCT00092456|1250619|P1|Vaccinated at Visit 1|Overall Study||226
518813|NCT00092456|1250616|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
518814|NCT00092456|1250617|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
518815|NCT00092456|1250618|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
518816|NCT00092456|1250619|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
518817|NCT00092443|1250667|P2|NOT COMPLETED|Overall Study||54
518818|NCT00092443|1250668|P1|NOT COMPLETED|Overall Study||58
518819|NCT00092443|1250667|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
518820|NCT00092443|1250668|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
518821|NCT00092443|1250667|P2|Vaccinated at Visit 3|Overall Study||608
518822|NCT00092443|1250668|P1|Vaccinated at Visit 3|Overall Study||593
518823|NCT00092443|1250667|P2|Vaccinated at Visit 2|Overall Study||627
518824|NCT00092443|1250668|P1|Vaccinated at Visit 2|Overall Study||618
518825|NCT00092443|1250667|P2|Vaccinated at Visit 1|Overall Study||660
518826|NCT00092443|1250668|P1|Vaccinated at Visit 1|Overall Study||650
518827|NCT00092443|1250667|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
518828|NCT00092443|1250668|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
518829|NCT00092417|1250686|P2|NOT COMPLETED|Overall Study||1
518830|NCT00092417|1250687|P1|NOT COMPLETED|Overall Study||5
518831|NCT00092417|1250686|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
518832|NCT00092417|1250687|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
518833|NCT00092417|1250686|P2|Vaccinated|Overall Study||234
518834|NCT00092417|1250687|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
518835|NCT00092417|1250686|P2|STARTED|Overall Study|Started Period Group 2|234
518836|NCT00092417|1250687|P1|STARTED|Overall Study|Started Period Group 1|464
518837|NCT00092131|1250701|P2|NOT COMPLETED|Treatment Period II||1
518838|NCT00092131|1250702|P1|NOT COMPLETED|Treatment Period II||0
518839|NCT00092131|1250701|P2|COMPLETED|Treatment Period II||25
518840|NCT00092131|1250702|P1|COMPLETED|Treatment Period II||24
518841|NCT00092131|1250701|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
518842|NCT00092131|1250702|P1|STARTED|Treatment Period II||24
518843|NCT00092131|1250701|P2|NOT COMPLETED|Treatment Period I||0
518844|NCT00092131|1250702|P1|NOT COMPLETED|Treatment Period I||1
518845|NCT00092131|1250701|P2|COMPLETED|Treatment Period I||26
518846|NCT00092131|1250702|P1|COMPLETED|Treatment Period I||24
518847|NCT00092131|1250701|P2|STARTED|Treatment Period I||26
519095|NCT00090220|1251168|P6|COMPLETED|Extension 1 (EXT1)||0
518848|NCT00092131|1250702|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
518849|NCT00092118|1250732|P2|NOT COMPLETED|Overall Study||89
518850|NCT00092118|1250733|P1|NOT COMPLETED|Overall Study||84
518851|NCT00092118|1250732|P2|COMPLETED|Overall Study||913
518852|NCT00092118|1250733|P1|COMPLETED|Overall Study||906
518853|NCT00092118|1250732|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
518854|NCT00092118|1250733|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
518855|NCT00091962|1250746|P3|NOT COMPLETED|Overall Study||0
518856|NCT00091962|1250747|P2|NOT COMPLETED|Overall Study||0
518857|NCT00091962|1250748|P1|NOT COMPLETED|Overall Study||0
518858|NCT00091962|1250746|P3|COMPLETED|Overall Study||151
518859|NCT00091962|1250747|P2|COMPLETED|Overall Study||152
518860|NCT00091962|1250748|P1|COMPLETED|Overall Study||150
518861|NCT00091962|1250746|P3|STARTED|Overall Study||151
518862|NCT00091962|1250747|P2|STARTED|Overall Study||152
518863|NCT00091962|1250748|P1|STARTED|Overall Study||150
518864|NCT00091949|1250767|P2|NOT COMPLETED|Overall Study||151
518865|NCT00091949|1250768|P1|NOT COMPLETED|Overall Study||175
518866|NCT00091949|1250767|P2|COMPLETED|Overall Study||1786
518867|NCT00091949|1250768|P1|COMPLETED|Overall Study||1764
518868|NCT00091949|1250767|P2|STARTED|Overall Study||1937
518869|NCT00091949|1250768|P1|STARTED|Overall Study||1939
518870|NCT00091572|1250788|P2|NOT COMPLETED|Overall Study||82
518871|NCT00091572|1250789|P1|NOT COMPLETED|Overall Study||95
518872|NCT00091572|1250788|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
518873|NCT00091572|1250789|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
518874|NCT00091572|1250788|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
518875|NCT00091572|1250789|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
518876|NCT00091507|1250803|P2|NOT COMPLETED|Overall Study||19
518877|NCT00091507|1250804|P1|NOT COMPLETED|Overall Study||21
518878|NCT00091507|1250803|P2|COMPLETED|Overall Study||460
518879|NCT00091507|1250804|P1|COMPLETED|Overall Study||411
518880|NCT00091507|1250803|P2|STARTED|Overall Study||479
518881|NCT00091507|1250804|P1|STARTED|Overall Study||432
518882|NCT00091442|1250820|P2|NOT COMPLETED|Overall Study||373
518883|NCT00091442|1250821|P1|NOT COMPLETED|Overall Study||369
518884|NCT00091442|1250820|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
518885|NCT00091442|1250821|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
518886|NCT00091442|1250820|P2|STARTED|Overall Study||378
518887|NCT00091442|1250821|P1|STARTED|Overall Study||373
518888|NCT00091390|1250831|P1|NOT COMPLETED|Overall Study||4
518889|NCT00091390|1250831|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
518890|NCT00091390|1250831|P1|STARTED|Overall Study||129
518891|NCT00091273|1250835|P1|NOT COMPLETED|Overall Study||0
518892|NCT00091273|1250835|P1|COMPLETED|Overall Study||9
518893|NCT00091273|1250835|P1|STARTED|Overall Study||9
518894|NCT00091260|1250841|P1|NOT COMPLETED|Overall Study||0
518895|NCT00091260|1250841|P1|COMPLETED|Overall Study||82
518896|NCT00091260|1250841|P1|STARTED|Overall Study||82
518897|NCT00091169|1250849|P2|NOT COMPLETED|Overall Study||53
518898|NCT00091169|1250850|P1|NOT COMPLETED|Overall Study||57
518899|NCT00091169|1250849|P2|COMPLETED|Overall Study||134
518900|NCT00091169|1250850|P1|COMPLETED|Overall Study||132
518901|NCT00091169|1250849|P2|Treated|Overall Study||170
518902|NCT00091169|1250850|P1|Treated|Overall Study||163
518903|NCT00091169|1250849|P2|STARTED|Overall Study||187
518904|NCT00091169|1250850|P1|STARTED|Overall Study||189
518905|NCT00091026|1250868|P2|NOT COMPLETED|Overall Study||3
518906|NCT00091026|1250869|P1|NOT COMPLETED|Overall Study||1
518907|NCT00091026|1250868|P2|COMPLETED|Overall Study||68
518908|NCT00091026|1250869|P1|COMPLETED|Overall Study||71
518909|NCT00091026|1250868|P2|STARTED|Overall Study||71
518910|NCT00091026|1250869|P1|STARTED|Overall Study||72
518911|NCT00090987|1250879|P1|NOT COMPLETED|Overall Study||21
518912|NCT00090987|1250879|P1|COMPLETED|Overall Study||9
518913|NCT00090987|1250879|P1|STARTED|Overall Study||30
518914|NCT00090844|1250885|P2|NOT COMPLETED|Overall Study||1
518915|NCT00090844|1250886|P1|NOT COMPLETED|Overall Study||1
518916|NCT00090844|1250885|P2|COMPLETED|Overall Study||21
518917|NCT00090844|1250886|P1|COMPLETED|Overall Study||26
518918|NCT00090844|1250885|P2|STARTED|Overall Study||22
518919|NCT00090844|1250886|P1|STARTED|Overall Study||27
518920|NCT00090779|1250894|P2|NOT COMPLETED|Step 3||5
518921|NCT00090779|1250895|P1|NOT COMPLETED|Step 3||7
518922|NCT00090779|1250894|P2|COMPLETED|Step 3||0
518923|NCT00090779|1250895|P1|COMPLETED|Step 3||0
518924|NCT00090779|1250894|P2|STARTED|Step 3||5
518925|NCT00090779|1250895|P1|STARTED|Step 3||7
518926|NCT00090779|1250894|P2|NOT COMPLETED|Step 2||18
518927|NCT00090779|1250895|P1|NOT COMPLETED|Step 2||6
518928|NCT00090779|1250894|P2|COMPLETED|Step 2||1
518929|NCT00090779|1250895|P1|COMPLETED|Step 2||0
518930|NCT00090779|1250894|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
518931|NCT00090779|1250895|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
518932|NCT00090779|1250894|P2|NOT COMPLETED|Step 1||15
518933|NCT00090779|1250895|P1|NOT COMPLETED|Step 1||11
518934|NCT00090779|1250894|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
518935|NCT00090779|1250895|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
518936|NCT00090779|1250894|P2|STARTED|Step 1||64
518937|NCT00090779|1250895|P1|STARTED|Step 1||66
518938|NCT00090766|1250919|P3|NOT COMPLETED|Overall Study||3
518939|NCT00090766|1250920|P2|NOT COMPLETED|Overall Study||2
518940|NCT00090766|1250921|P1|NOT COMPLETED|Overall Study||3
518941|NCT00090766|1250919|P3|COMPLETED|Overall Study||22
518942|NCT00090766|1250920|P2|COMPLETED|Overall Study||19
518943|NCT00090766|1250921|P1|COMPLETED|Overall Study||14
518944|NCT00090766|1250919|P3|STARTED|Overall Study||25
518945|NCT00090766|1250920|P2|STARTED|Overall Study||21
518946|NCT00090766|1250921|P1|STARTED|Overall Study||17
518947|NCT00090753|1250963|P2|NOT COMPLETED|Extended Treatment Period||191
518948|NCT00090753|1250964|P1|NOT COMPLETED|Extended Treatment Period||359
518949|NCT00090753|1250963|P2|COMPLETED|Extended Treatment Period||59
518950|NCT00090753|1250964|P1|COMPLETED|Extended Treatment Period||94
518951|NCT00090753|1250963|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
518952|NCT00090753|1250964|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
518953|NCT00090753|1250963|P2|NOT COMPLETED|First Treatment Period||178
518954|NCT00090753|1250964|P1|NOT COMPLETED|First Treatment Period||256
518955|NCT00090753|1250963|P2|COMPLETED|First Treatment Period||302
518956|NCT00090753|1250964|P1|COMPLETED|First Treatment Period||492
518957|NCT00090753|1250963|P2|STARTED|First Treatment Period||480
518958|NCT00090753|1250964|P1|STARTED|First Treatment Period||748
518959|NCT00090610|1250974|P2|NOT COMPLETED|Overall Study||1
518960|NCT00090610|1250975|P1|NOT COMPLETED|Overall Study||1
518961|NCT00090610|1250974|P2|COMPLETED|Overall Study||74
518962|NCT00090610|1250975|P1|COMPLETED|Overall Study||74
518963|NCT00090610|1250974|P2|STARTED|Overall Study||75
518964|NCT00090610|1250975|P1|STARTED|Overall Study||75
518965|NCT00090584|1250991|P2|NOT COMPLETED|Baseline to 8 Months||41
518966|NCT00090584|1250992|P1|NOT COMPLETED|Baseline to 8 Months||44
518967|NCT00090584|1250991|P2|COMPLETED|Baseline to 8 Months||112
518968|NCT00090584|1250992|P1|COMPLETED|Baseline to 8 Months||110
518969|NCT00090584|1250991|P2|STARTED|Baseline to 8 Months||153
518970|NCT00090584|1250992|P1|STARTED|Baseline to 8 Months||154
518971|NCT00090584|1250991|P2|NOT COMPLETED|Baseline to 10 Weeks||12
518972|NCT00090584|1250992|P1|NOT COMPLETED|Baseline to 10 Weeks||15
518973|NCT00090584|1250991|P2|COMPLETED|Baseline to 10 Weeks||141
518974|NCT00090584|1250992|P1|COMPLETED|Baseline to 10 Weeks||139
518975|NCT00090584|1250991|P2|STARTED|Baseline to 10 Weeks||153
518976|NCT00090584|1250992|P1|STARTED|Baseline to 10 Weeks||154
518977|NCT00090545|1251024|P2|NOT COMPLETED|Overall Study||24
518978|NCT00090545|1251025|P1|NOT COMPLETED|Overall Study||22
518979|NCT00090545|1251024|P2|COMPLETED|Overall Study||0
518980|NCT00090545|1251025|P1|COMPLETED|Overall Study||0
518981|NCT00090545|1251024|P2|STARTED|Overall Study||24
518982|NCT00090545|1251025|P1|STARTED|Overall Study||22
518983|NCT00090519|1251035|P2|NOT COMPLETED|Overall Study||75
518984|NCT00090519|1251036|P1|NOT COMPLETED|Overall Study||73
518985|NCT00090519|1251035|P2|COMPLETED|Overall Study||285
518986|NCT00090519|1251036|P1|COMPLETED|Overall Study||298
518987|NCT00090519|1251035|P2|STARTED|Overall Study||360
518988|NCT00090519|1251036|P1|STARTED|Overall Study||371
518989|NCT00090493|1251060|P1|NOT COMPLETED|Overall Study||2
518990|NCT00090493|1251060|P1|COMPLETED|Overall Study||2
518991|NCT00090493|1251060|P1|STARTED|Overall Study||4
518992|NCT00090402|1251067|P3|NOT COMPLETED|Overall Study||1
518993|NCT00090402|1251068|P2|NOT COMPLETED|Overall Study||2
518994|NCT00090402|1251069|P1|NOT COMPLETED|Overall Study||2
518995|NCT00090402|1251067|P3|COMPLETED|Overall Study||12
518996|NCT00090402|1251068|P2|COMPLETED|Overall Study||11
518997|NCT00090402|1251069|P1|COMPLETED|Overall Study||11
518998|NCT00090402|1251067|P3|STARTED|Overall Study||13
518999|NCT00090402|1251068|P2|STARTED|Overall Study||13
519000|NCT00090402|1251069|P1|STARTED|Overall Study||13
519001|NCT00090363|1251080|P3|NOT COMPLETED|Overall Study||96
519002|NCT00090363|1251081|P2|NOT COMPLETED|Overall Study||107
519003|NCT00090363|1251082|P1|NOT COMPLETED|Overall Study||106
519004|NCT00090363|1251080|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
519005|NCT00090363|1251081|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
519006|NCT00090363|1251082|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
519007|NCT00090363|1251080|P3|Received Study Treatment.|Overall Study||98
519008|NCT00090363|1251081|P2|Received Study Treatment.|Overall Study||107
519009|NCT00090363|1251082|P1|Received Study Treatment.|Overall Study||107
519010|NCT00090363|1251080|P3|STARTED|Overall Study||98
519011|NCT00090363|1251081|P2|STARTED|Overall Study||107
519012|NCT00090363|1251082|P1|STARTED|Overall Study||107
519013|NCT00090285|1251104|P4|NOT COMPLETED|Extension 1||1
519014|NCT00090285|1251105|P3|NOT COMPLETED|Extension 1||57
519015|NCT00090285|1251106|P2|NOT COMPLETED|Extension 1||0
519016|NCT00090285|1251107|P1|NOT COMPLETED|Extension 1||0
519017|NCT00090285|1251104|P4|COMPLETED|Extension 1||15
519018|NCT00090285|1251105|P3|COMPLETED|Extension 1||1041
519019|NCT00090285|1251106|P2|COMPLETED|Extension 1||0
519021|NCT00090285|1251104|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
519022|NCT00090285|1251105|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
519023|NCT00090285|1251106|P2|STARTED|Extension 1||0
519024|NCT00090285|1251107|P1|STARTED|Extension 1||0
519025|NCT00090285|1251104|P4|NOT COMPLETED|Base Study Follow-up Period||0
519026|NCT00090285|1251105|P3|NOT COMPLETED|Base Study Follow-up Period||0
519027|NCT00090285|1251106|P2|NOT COMPLETED|Base Study Follow-up Period||342
519028|NCT00090285|1251107|P1|NOT COMPLETED|Base Study Follow-up Period||335
519029|NCT00090285|1251104|P4|COMPLETED|Base Study Follow-up Period||0
519030|NCT00090285|1251105|P3|COMPLETED|Base Study Follow-up Period||0
519031|NCT00090285|1251106|P2|COMPLETED|Base Study Follow-up Period||1479
519032|NCT00090285|1251107|P1|COMPLETED|Base Study Follow-up Period||1487
519033|NCT00090285|1251104|P4|STARTED|Base Study Follow-up Period||0
519034|NCT00090285|1251105|P3|STARTED|Base Study Follow-up Period||0
519035|NCT00090285|1251106|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
519036|NCT00090285|1251107|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
519037|NCT00090285|1251104|P4|NOT COMPLETED|Base Study Vaccination Period||0
519038|NCT00090285|1251105|P3|NOT COMPLETED|Base Study Vaccination Period||0
519039|NCT00090285|1251106|P2|NOT COMPLETED|Base Study Vaccination Period||219
519040|NCT00090285|1251107|P1|NOT COMPLETED|Base Study Vaccination Period||214
519041|NCT00090285|1251104|P4|COMPLETED|Base Study Vaccination Period||0
519042|NCT00090285|1251105|P3|COMPLETED|Base Study Vaccination Period||0
519043|NCT00090285|1251106|P2|COMPLETED|Base Study Vaccination Period||1814
519044|NCT00090285|1251107|P1|COMPLETED|Base Study Vaccination Period||1818
519045|NCT00090285|1251104|P4|Vaccinated|Base Study Vaccination Period||0
519046|NCT00090285|1251105|P3|Vaccinated|Base Study Vaccination Period||0
519047|NCT00090285|1251106|P2|Vaccinated|Base Study Vaccination Period||2030
519048|NCT00090285|1251107|P1|Vaccinated|Base Study Vaccination Period||2025
519049|NCT00090285|1251104|P4|STARTED|Base Study Vaccination Period||0
519050|NCT00090285|1251105|P3|STARTED|Base Study Vaccination Period||0
519051|NCT00090285|1251106|P2|STARTED|Base Study Vaccination Period||2033
519052|NCT00090285|1251107|P1|STARTED|Base Study Vaccination Period||2032
519053|NCT00090259|1251126|P2|NOT COMPLETED|Overall Study||48
519054|NCT00090259|1251127|P1|NOT COMPLETED|Overall Study||62
519055|NCT00090259|1251126|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
519056|NCT00090259|1251127|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
519057|NCT00090259|1251126|P2|STARTED|Overall Study||1921
519058|NCT00090259|1251127|P1|STARTED|Overall Study||1913
519059|NCT00090233|1251143|P2|NOT COMPLETED|Overall Study||5065
519060|NCT00090233|1251144|P1|NOT COMPLETED|Overall Study||4999
519061|NCT00090233|1251143|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
519062|NCT00090233|1251144|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
519063|NCT00090233|1251143|P2|Vaccinated at Visit 3|Overall Study||29598
519064|NCT00090233|1251144|P1|Vaccinated at Visit 3|Overall Study||29667
519065|NCT00090233|1251143|P2|Vaccinated at Visit 2|Overall Study||31066
519066|NCT00090233|1251144|P1|Vaccinated at Visit 2|Overall Study||31052
519067|NCT00090233|1251143|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
519068|NCT00090233|1251144|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
519069|NCT00090233|1251143|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
519070|NCT00090233|1251144|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
519071|NCT00090220|1251168|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
519072|NCT00090220|1251169|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
519073|NCT00090220|1251170|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
519074|NCT00090220|1251171|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
519075|NCT00090220|1251172|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
519076|NCT00090220|1251173|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
519077|NCT00090220|1251168|P6|COMPLETED|Long-term Follow-up (EXT2)||623
519078|NCT00090220|1251169|P5|COMPLETED|Long-term Follow-up (EXT2)||641
519079|NCT00090220|1251170|P4|COMPLETED|Long-term Follow-up (EXT2)||0
519080|NCT00090220|1251171|P3|COMPLETED|Long-term Follow-up (EXT2)||0
519081|NCT00090220|1251172|P2|COMPLETED|Long-term Follow-up (EXT2)||0
519082|NCT00090220|1251173|P1|COMPLETED|Long-term Follow-up (EXT2)||0
519083|NCT00090220|1251168|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
519084|NCT00090220|1251169|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
519085|NCT00090220|1251170|P4|STARTED|Long-term Follow-up (EXT2)||0
519086|NCT00090220|1251171|P3|STARTED|Long-term Follow-up (EXT2)||0
519087|NCT00090220|1251172|P2|STARTED|Long-term Follow-up (EXT2)||0
519088|NCT00090220|1251173|P1|STARTED|Long-term Follow-up (EXT2)||0
519089|NCT00090220|1251168|P6|NOT COMPLETED|Extension 1 (EXT1)||0
519090|NCT00090220|1251169|P5|NOT COMPLETED|Extension 1 (EXT1)||0
519091|NCT00090220|1251170|P4|NOT COMPLETED|Extension 1 (EXT1)||2
519092|NCT00090220|1251171|P3|NOT COMPLETED|Extension 1 (EXT1)||55
519093|NCT00090220|1251172|P2|NOT COMPLETED|Extension 1 (EXT1)||0
519094|NCT00090220|1251173|P1|NOT COMPLETED|Extension 1 (EXT1)||0
519096|NCT00090220|1251169|P5|COMPLETED|Extension 1 (EXT1)||0
519097|NCT00090220|1251170|P4|COMPLETED|Extension 1 (EXT1)||5
519098|NCT00090220|1251171|P3|COMPLETED|Extension 1 (EXT1)||1267
519099|NCT00090220|1251172|P2|COMPLETED|Extension 1 (EXT1)||0
519100|NCT00090220|1251173|P1|COMPLETED|Extension 1 (EXT1)||0
519101|NCT00090220|1251168|P6|Vaccinated|Extension 1 (EXT1)||0
519102|NCT00090220|1251169|P5|Vaccinated|Extension 1 (EXT1)||0
519103|NCT00090220|1251170|P4|Vaccinated|Extension 1 (EXT1)||7
519104|NCT00090220|1251171|P3|Vaccinated|Extension 1 (EXT1)||1321
519105|NCT00090220|1251172|P2|Vaccinated|Extension 1 (EXT1)||0
519106|NCT00090220|1251173|P1|Vaccinated|Extension 1 (EXT1)||0
519107|NCT00090220|1251168|P6|STARTED|Extension 1 (EXT1)||0
519108|NCT00090220|1251169|P5|STARTED|Extension 1 (EXT1)||0
519109|NCT00090220|1251170|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
519110|NCT00090220|1251171|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
519111|NCT00090220|1251172|P2|STARTED|Extension 1 (EXT1)||0
519112|NCT00090220|1251173|P1|STARTED|Extension 1 (EXT1)||0
519113|NCT00090220|1251168|P6|NOT COMPLETED|Base Study Follow-up Period||0
519114|NCT00090220|1251169|P5|NOT COMPLETED|Base Study Follow-up Period||0
519115|NCT00090220|1251170|P4|NOT COMPLETED|Base Study Follow-up Period||0
519116|NCT00090220|1251171|P3|NOT COMPLETED|Base Study Follow-up Period||0
519117|NCT00090220|1251172|P2|NOT COMPLETED|Base Study Follow-up Period||164
519118|NCT00090220|1251173|P1|NOT COMPLETED|Base Study Follow-up Period||160
519119|NCT00090220|1251168|P6|COMPLETED|Base Study Follow-up Period||0
519120|NCT00090220|1251169|P5|COMPLETED|Base Study Follow-up Period||0
519121|NCT00090220|1251170|P4|COMPLETED|Base Study Follow-up Period||0
519122|NCT00090220|1251171|P3|COMPLETED|Base Study Follow-up Period||0
519123|NCT00090220|1251172|P2|COMPLETED|Base Study Follow-up Period||1687
519124|NCT00090220|1251173|P1|COMPLETED|Base Study Follow-up Period||1695
519125|NCT00090220|1251168|P6|STARTED|Base Study Follow-up Period||0
519126|NCT00090220|1251169|P5|STARTED|Base Study Follow-up Period||0
519127|NCT00090220|1251170|P4|STARTED|Base Study Follow-up Period||0
519128|NCT00090220|1251171|P3|STARTED|Base Study Follow-up Period||0
519129|NCT00090220|1251172|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
519130|NCT00090220|1251173|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
519131|NCT00090220|1251168|P6|NOT COMPLETED|Base Study Vaccination Period||0
519132|NCT00090220|1251169|P5|NOT COMPLETED|Base Study Vaccination Period||0
519133|NCT00090220|1251170|P4|NOT COMPLETED|Base Study Vaccination Period||0
519134|NCT00090220|1251171|P3|NOT COMPLETED|Base Study Vaccination Period||0
519135|NCT00090220|1251172|P2|NOT COMPLETED|Base Study Vaccination Period||63
519136|NCT00090220|1251173|P1|NOT COMPLETED|Base Study Vaccination Period||64
519137|NCT00090220|1251168|P6|COMPLETED|Base Study Vaccination Period||0
519138|NCT00090220|1251169|P5|COMPLETED|Base Study Vaccination Period||0
519139|NCT00090220|1251170|P4|COMPLETED|Base Study Vaccination Period||0
519140|NCT00090220|1251171|P3|COMPLETED|Base Study Vaccination Period||0
519141|NCT00090220|1251172|P2|COMPLETED|Base Study Vaccination Period||1845
519142|NCT00090220|1251173|P1|COMPLETED|Base Study Vaccination Period||1847
519143|NCT00090220|1251168|P6|Vaccinated|Base Study Vaccination Period||0
519144|NCT00090220|1251169|P5|Vaccinated|Base Study Vaccination Period||0
519145|NCT00090220|1251170|P4|Vaccinated|Base Study Vaccination Period||0
519146|NCT00090220|1251171|P3|Vaccinated|Base Study Vaccination Period||0
519147|NCT00090220|1251172|P2|Vaccinated|Base Study Vaccination Period||1907
519148|NCT00090220|1251173|P1|Vaccinated|Base Study Vaccination Period||1910
519149|NCT00090220|1251168|P6|STARTED|Base Study Vaccination Period||0
519150|NCT00090220|1251169|P5|STARTED|Base Study Vaccination Period||0
519151|NCT00090220|1251170|P4|STARTED|Base Study Vaccination Period||0
519152|NCT00090220|1251171|P3|STARTED|Base Study Vaccination Period||0
519153|NCT00090220|1251172|P2|STARTED|Base Study Vaccination Period||1908
519154|NCT00090220|1251173|P1|STARTED|Base Study Vaccination Period||1911
519155|NCT00090142|1251265|P2|NOT COMPLETED|Treatment Period II||0
519156|NCT00090142|1251266|P1|NOT COMPLETED|Treatment Period II||1
519157|NCT00090142|1251265|P2|COMPLETED|Treatment Period II||28
519158|NCT00090142|1251266|P1|COMPLETED|Treatment Period II||25
519159|NCT00090142|1251265|P2|STARTED|Treatment Period II||28
519160|NCT00090142|1251266|P1|STARTED|Treatment Period II||26
519161|NCT00090142|1251265|P2|NOT COMPLETED|Treatment Period I||3
519162|NCT00090142|1251266|P1|NOT COMPLETED|Treatment Period I||5
519163|NCT00090142|1251265|P2|COMPLETED|Treatment Period I||28
519164|NCT00090142|1251266|P1|COMPLETED|Treatment Period I||26
519165|NCT00090142|1251265|P2|STARTED|Treatment Period I||31
519166|NCT00090142|1251266|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
519167|NCT00090103|1251297|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
519168|NCT00090103|1251298|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
519169|NCT00090103|1251299|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
519170|NCT00090103|1251297|P3|COMPLETED|16-Week Safety Follow-up Period||1143
519171|NCT00090103|1251298|P2|COMPLETED|16-Week Safety Follow-up Period||1205
519172|NCT00090103|1251299|P1|COMPLETED|16-Week Safety Follow-up Period||1224
519173|NCT00090103|1251297|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
519259|NCT00089648|1251582|P1|NOT COMPLETED|Overall Study||41
519260|NCT00089648|1251582|P1|COMPLETED|Overall Study||20
519174|NCT00090103|1251298|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
519175|NCT00090103|1251299|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
519176|NCT00090103|1251297|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
519177|NCT00090103|1251298|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
519178|NCT00090103|1251299|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
519179|NCT00090103|1251297|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
519180|NCT00090103|1251298|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
519181|NCT00090103|1251299|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
519182|NCT00090103|1251297|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
519183|NCT00090103|1251298|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
519184|NCT00090103|1251299|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
519185|NCT00090051|1251399|P2|NOT COMPLETED|Overall Study||95
519186|NCT00090051|1251400|P1|NOT COMPLETED|Overall Study||109
519187|NCT00090051|1251399|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
519188|NCT00090051|1251400|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
519189|NCT00090051|1251399|P2|Safety Population; Received Study Drug|Overall Study||274
519190|NCT00090051|1251400|P1|Safety Population; Received Study Drug|Overall Study||272
519191|NCT00090051|1251399|P2|STARTED|Overall Study||276
519192|NCT00090051|1251400|P1|STARTED|Overall Study||276
519193|NCT00089999|1251436|P2|NOT COMPLETED|Overall Study||69
519194|NCT00089999|1251437|P1|NOT COMPLETED|Overall Study||69
519195|NCT00089999|1251436|P2|COMPLETED|Overall Study||0
519196|NCT00089999|1251437|P1|COMPLETED|Overall Study||0
519197|NCT00089999|1251436|P2|STARTED|Overall Study||69
519198|NCT00089999|1251437|P1|STARTED|Overall Study||69
519199|NCT00089986|1251460|P3|NOT COMPLETED|Overall Study||10
519200|NCT00089986|1251461|P2|NOT COMPLETED|Overall Study||24
519201|NCT00089986|1251462|P1|NOT COMPLETED|Overall Study||15
519202|NCT00089986|1251460|P3|COMPLETED|Overall Study||172
519203|NCT00089986|1251461|P2|COMPLETED|Overall Study||574
519204|NCT00089986|1251462|P1|COMPLETED|Overall Study||584
519205|NCT00089986|1251460|P3|STARTED|Overall Study||182
519206|NCT00089986|1251461|P2|STARTED|Overall Study||598
519207|NCT00089986|1251462|P1|STARTED|Overall Study||599
519208|NCT00089895|1251481|P2|NOT COMPLETED|Overall Study||42
519209|NCT00089895|1251482|P1|NOT COMPLETED|Overall Study||35
519210|NCT00089895|1251481|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
519211|NCT00089895|1251482|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
519212|NCT00089895|1251481|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
519383|NCT00088595|1251954|P1|STARTED|Overall Study||45
519213|NCT00089895|1251482|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
519214|NCT00089843|1251494|P4|NOT COMPLETED|Overall Study||7
519215|NCT00089843|1251495|P3|NOT COMPLETED|Overall Study||5
519216|NCT00089843|1251496|P2|NOT COMPLETED|Overall Study||4
519217|NCT00089843|1251497|P1|NOT COMPLETED|Overall Study||2
519218|NCT00089843|1251494|P4|COMPLETED|Overall Study||11
519219|NCT00089843|1251495|P3|COMPLETED|Overall Study||15
519220|NCT00089843|1251496|P2|COMPLETED|Overall Study||16
519221|NCT00089843|1251497|P1|COMPLETED|Overall Study||17
519222|NCT00089843|1251494|P4|STARTED|Overall Study||18
519223|NCT00089843|1251495|P3|STARTED|Overall Study||20
519224|NCT00089843|1251496|P2|STARTED|Overall Study||20
519225|NCT00089843|1251497|P1|STARTED|Overall Study||19
519226|NCT00089791|1251509|P2|NOT COMPLETED|Overall Study||630
519227|NCT00089791|1251510|P1|NOT COMPLETED|Overall Study||700
519228|NCT00089791|1251509|P2|COMPLETED|Overall Study||3272
519229|NCT00089791|1251510|P1|COMPLETED|Overall Study||3206
519230|NCT00089791|1251509|P2|Safety Analysis Set|Overall Study||3886
519231|NCT00089791|1251510|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
519232|NCT00089791|1251509|P2|Received Study Medication|Overall Study||3879
519233|NCT00089791|1251510|P1|Received Study Medication|Overall Study||3883
519234|NCT00089791|1251509|P2|STARTED|Overall Study||3902
519235|NCT00089791|1251510|P1|STARTED|Overall Study||3906
519236|NCT00089778|1251523|P3|NOT COMPLETED|Overall Study||1
519237|NCT00089778|1251524|P2|NOT COMPLETED|Overall Study||0
519238|NCT00089778|1251525|P1|NOT COMPLETED|Overall Study||0
519239|NCT00089778|1251523|P3|COMPLETED|Overall Study||7
519240|NCT00089778|1251524|P2|COMPLETED|Overall Study||1
519241|NCT00089778|1251525|P1|COMPLETED|Overall Study||2
519242|NCT00089778|1251523|P3|STARTED|Overall Study||8
519243|NCT00089778|1251524|P2|STARTED|Overall Study||1
519244|NCT00089778|1251525|P1|STARTED|Overall Study||2
519245|NCT00089674|1251538|P2|NOT COMPLETED|Overall Study||267
519246|NCT00089674|1251539|P1|NOT COMPLETED|Overall Study||289
519247|NCT00089674|1251538|P2|COMPLETED|Overall Study||467
519248|NCT00089674|1251539|P1|COMPLETED|Overall Study||445
519249|NCT00089674|1251538|P2|Received Study Drug|Overall Study||726
519250|NCT00089674|1251539|P1|Received Study Drug|Overall Study||730
519251|NCT00089674|1251538|P2|STARTED|Overall Study||734
519252|NCT00089674|1251539|P1|STARTED|Overall Study||734
519253|NCT00089661|1251565|P2|NOT COMPLETED|Overall Study||26
519254|NCT00089661|1251566|P1|NOT COMPLETED|Overall Study||21
519255|NCT00089661|1251565|P2|COMPLETED|Overall Study||99
519256|NCT00089661|1251566|P1|COMPLETED|Overall Study||106
519257|NCT00089661|1251565|P2|STARTED|Overall Study||125
519258|NCT00089661|1251566|P1|STARTED|Overall Study||127
519261|NCT00089648|1251582|P1|STARTED|Overall Study||61
519262|NCT00089635|1251598|P1|NOT COMPLETED|Overall Study||43
519263|NCT00089635|1251598|P1|COMPLETED|Overall Study||160
519264|NCT00089635|1251598|P1|STARTED|Overall Study||203
519265|NCT00089609|1251612|P2|NOT COMPLETED|Overall Study||1
519266|NCT00089609|1251613|P1|NOT COMPLETED|Overall Study||3
519267|NCT00089609|1251612|P2|COMPLETED|Overall Study||12
519268|NCT00089609|1251613|P1|COMPLETED|Overall Study||57
519269|NCT00089609|1251612|P2|STARTED|Overall Study||13
519270|NCT00089609|1251613|P1|STARTED|Overall Study||60
519271|NCT00089583|1251632|P2|NOT COMPLETED|Overall Study||38
519272|NCT00089583|1251633|P1|NOT COMPLETED|Overall Study||7
519273|NCT00089583|1251632|P2|COMPLETED|Overall Study||51
519274|NCT00089583|1251633|P1|COMPLETED|Overall Study||13
519275|NCT00089583|1251632|P2|STARTED|Overall Study||89
519276|NCT00089583|1251633|P1|STARTED|Overall Study||20
519277|NCT00089544|1251727|P2|NOT COMPLETED|Overall Study||0
519278|NCT00089544|1251728|P1|NOT COMPLETED|Overall Study||1
519279|NCT00089544|1251727|P2|COMPLETED|Overall Study||7
519280|NCT00089544|1251728|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
519281|NCT00089544|1251727|P2|STARTED|Overall Study||7
519282|NCT00089544|1251728|P1|STARTED|Overall Study||16
519283|NCT00089505|1251742|P4|NOT COMPLETED|Overall Study||21
519284|NCT00089505|1251743|P3|NOT COMPLETED|Overall Study||21
519285|NCT00089505|1251744|P2|NOT COMPLETED|Overall Study||2
519286|NCT00089505|1251745|P1|NOT COMPLETED|Overall Study||9
519287|NCT00089505|1251742|P4|COMPLETED|Overall Study||230
519288|NCT00089505|1251743|P3|COMPLETED|Overall Study||228
519289|NCT00089505|1251744|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
519290|NCT00089505|1251745|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
519291|NCT00089505|1251742|P4|STARTED|Overall Study||251
519292|NCT00089505|1251743|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
519293|NCT00089505|1251744|P2|STARTED|Overall Study||120
519294|NCT00089505|1251745|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
519295|NCT00089479|1251789|P2|NOT COMPLETED|Overall Study||289
519296|NCT00089479|1251790|P1|NOT COMPLETED|Overall Study||331
519297|NCT00089479|1251789|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
519298|NCT00089479|1251790|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
519384|NCT00088530|1251972|P2|NOT COMPLETED|Overall Study||54
519385|NCT00088530|1251973|P1|NOT COMPLETED|Overall Study||50
519299|NCT00089479|1251789|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
519300|NCT00089479|1251790|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
519301|NCT00089479|1251789|P2|STARTED|Overall Study||1307
519302|NCT00089479|1251790|P1|STARTED|Overall Study||1304
519303|NCT00089414|1251817|P3|NOT COMPLETED|Overall Study||0
519304|NCT00089414|1251818|P2|NOT COMPLETED|Overall Study||0
519305|NCT00089414|1251819|P1|NOT COMPLETED|Overall Study||0
519306|NCT00089414|1251817|P3|COMPLETED|Overall Study||2
519307|NCT00089414|1251818|P2|COMPLETED|Overall Study||1
519308|NCT00089414|1251819|P1|COMPLETED|Overall Study||2
519309|NCT00089414|1251817|P3|STARTED|Overall Study||2
519310|NCT00089414|1251818|P2|STARTED|Overall Study||1
519311|NCT00089414|1251819|P1|STARTED|Overall Study||2
519312|NCT00089297|1251833|P1|NOT COMPLETED|Overall Study||38
519313|NCT00089297|1251833|P1|COMPLETED|Overall Study||36
519314|NCT00089297|1251833|P1|Eligible|Overall Study||63
519315|NCT00089297|1251833|P1|Treated|Overall Study||70
519316|NCT00089297|1251833|P1|STARTED|Overall Study||74
519317|NCT00089141|1251842|P2|NOT COMPLETED|Overall Study||24
519318|NCT00089141|1251843|P1|NOT COMPLETED|Overall Study||18
519319|NCT00089141|1251842|P2|COMPLETED|Overall Study||53
519320|NCT00089141|1251843|P1|COMPLETED|Overall Study||56
519321|NCT00089141|1251842|P2|STARTED|Overall Study||77
519322|NCT00089141|1251843|P1|STARTED|Overall Study||74
519323|NCT00089076|1251865|P1|NOT COMPLETED|Overall Study||10
519324|NCT00089076|1251865|P1|COMPLETED|Overall Study||8
519325|NCT00089076|1251865|P1|STARTED|Overall Study||18
519326|NCT00089011|1251878|P2|NOT COMPLETED|Overall Study||0
519327|NCT00089011|1251879|P1|NOT COMPLETED|Overall Study||0
519328|NCT00089011|1251878|P2|COMPLETED|Overall Study||50
519329|NCT00089011|1251879|P1|COMPLETED|Overall Study||100
519330|NCT00089011|1251878|P2|STARTED|Overall Study||50
519331|NCT00089011|1251879|P1|STARTED|Overall Study||100
519332|NCT00088985|1251899|P1|NOT COMPLETED|Overall Study||3
519333|NCT00088985|1251899|P1|COMPLETED|Overall Study||4
519334|NCT00088985|1251899|P1|STARTED|Overall Study||7
519335|NCT00088972|1251905|P2|NOT COMPLETED|Overall Study||4
519336|NCT00088972|1251906|P1|NOT COMPLETED|Overall Study||2
519337|NCT00088972|1251905|P2|COMPLETED|Overall Study||1
519338|NCT00088972|1251906|P1|COMPLETED|Overall Study||1
519339|NCT00088972|1251905|P2|STARTED|Overall Study||5
519340|NCT00088972|1251906|P1|STARTED|Overall Study||3
519341|NCT00088907|1251914|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
519342|NCT00088907|1251915|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
519343|NCT00088907|1251914|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
519344|NCT00088907|1251915|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
519345|NCT00088907|1251914|P2|Treated|Single Gefitinib Treatment (Step 2)||0
519346|NCT00088907|1251915|P1|Treated|Single Gefitinib Treatment (Step 2)||19
519347|NCT00088907|1251914|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
519348|NCT00088907|1251915|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
519349|NCT00088907|1251914|P2|NOT COMPLETED|Randomized Study (Step 1)||134
519350|NCT00088907|1251915|P1|NOT COMPLETED|Randomized Study (Step 1)||136
519351|NCT00088907|1251914|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
519352|NCT00088907|1251915|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
519353|NCT00088907|1251914|P2|Eligible and Treated|Randomized Study (Step 1)||122
519354|NCT00088907|1251915|P1|Eligible and Treated|Randomized Study (Step 1)||117
519355|NCT00088907|1251914|P2|Eligible|Randomized Study (Step 1)||122
519356|NCT00088907|1251915|P1|Eligible|Randomized Study (Step 1)||117
519357|NCT00088907|1251914|P2|Treated|Randomized Study (Step 1)||124
519358|NCT00088907|1251915|P1|Treated|Randomized Study (Step 1)||129
519359|NCT00088907|1251914|P2|STARTED|Randomized Study (Step 1)||134
519360|NCT00088907|1251915|P1|STARTED|Randomized Study (Step 1)||136
519361|NCT00088881|1251926|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
519362|NCT00088881|1251926|P1|COMPLETED|Step 3 - Radiation Therapy||1
519363|NCT00088881|1251926|P1|STARTED|Step 3 - Radiation Therapy||1
519364|NCT00088881|1251926|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
519365|NCT00088881|1251926|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
519366|NCT00088881|1251926|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
519367|NCT00088881|1251926|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
519368|NCT00088881|1251926|P1|NOT COMPLETED|Step 1 - R-CHOP||14
519369|NCT00088881|1251926|P1|COMPLETED|Step 1 - R-CHOP||48
519370|NCT00088881|1251926|P1|Eligible and Treated|Step 1 - R-CHOP||53
519371|NCT00088881|1251926|P1|STARTED|Step 1 - R-CHOP||62
519372|NCT00088634|1251937|P2|NOT COMPLETED|Overall Study||43
519373|NCT00088634|1251938|P1|NOT COMPLETED|Overall Study||38
519374|NCT00088634|1251937|P2|COMPLETED|Overall Study||47
519375|NCT00088634|1251938|P1|COMPLETED|Overall Study||52
519376|NCT00088634|1251937|P2|STARTED|Overall Study||90
519377|NCT00088634|1251938|P1|STARTED|Overall Study||90
519378|NCT00088621|1251950|P1|NOT COMPLETED|Overall Study||54
519379|NCT00088621|1251950|P1|COMPLETED|Overall Study||7
519380|NCT00088621|1251950|P1|STARTED|Overall Study||61
519381|NCT00088595|1251954|P1|NOT COMPLETED|Overall Study||28
519382|NCT00088595|1251954|P1|COMPLETED|Overall Study||17
519386|NCT00088530|1251972|P2|COMPLETED|Overall Study||16
519387|NCT00088530|1251973|P1|COMPLETED|Overall Study||20
519388|NCT00088530|1251972|P2|STARTED|Overall Study||70
519389|NCT00088530|1251973|P1|STARTED|Overall Study||70
519390|NCT00088465|1251985|P1|NOT COMPLETED|Overall Study||561
519391|NCT00088465|1251985|P1|COMPLETED|Overall Study||370
519392|NCT00088465|1251985|P1|STARTED|Overall Study||931
519393|NCT00088374|1252008|P1|NOT COMPLETED|Overall Study||2
519394|NCT00088374|1252008|P1|COMPLETED|Overall Study||7
519395|NCT00088374|1252008|P1|STARTED|Overall Study||9
519396|NCT00088218|1252019|P2|NOT COMPLETED|Overall Study||0
519397|NCT00088218|1252020|P1|NOT COMPLETED|Overall Study||0
519398|NCT00088218|1252019|P2|COMPLETED|Overall Study||79
519399|NCT00088218|1252020|P1|COMPLETED|Overall Study||16
519400|NCT00088218|1252019|P2|STARTED|Overall Study||79
519401|NCT00088218|1252020|P1|STARTED|Overall Study||16
519402|NCT00088166|1252028|P2|NOT COMPLETED|Overall Study||61
519403|NCT00088166|1252029|P1|NOT COMPLETED|Overall Study||53
519404|NCT00088166|1252028|P2|COMPLETED|Overall Study||39
519405|NCT00088166|1252029|P1|COMPLETED|Overall Study||47
519406|NCT00088166|1252028|P2|STARTED|Overall Study||100
519407|NCT00088166|1252029|P1|STARTED|Overall Study||100
519408|NCT00088153|1252053|P2|NOT COMPLETED|Overall Study||25
519409|NCT00088153|1252054|P1|NOT COMPLETED|Overall Study||24
519410|NCT00088153|1252053|P2|COMPLETED|Overall Study||30
519411|NCT00088153|1252054|P1|COMPLETED|Overall Study||31
519412|NCT00088153|1252053|P2|STARTED|Overall Study||55
519413|NCT00088153|1252054|P1|STARTED|Overall Study||55
519414|NCT00087698|1252064|P1|NOT COMPLETED|Overall Study||36
519415|NCT00087698|1252064|P1|COMPLETED|Overall Study||41
519416|NCT00087698|1252064|P1|STARTED|Overall Study||77
519417|NCT00087685|1252073|P1|NOT COMPLETED|Overall Study||14
519418|NCT00087685|1252073|P1|COMPLETED|Overall Study||21
519419|NCT00087685|1252073|P1|STARTED|Overall Study||35
519420|NCT00087672|1252078|P1|NOT COMPLETED|Overall Study||0
519421|NCT00087672|1252078|P1|COMPLETED|Overall Study||41
519422|NCT00087672|1252078|P1|STARTED|Overall Study||41
519423|NCT00087646|1252086|P4|NOT COMPLETED|Overall Study||84
519424|NCT00087646|1252087|P3|NOT COMPLETED|Overall Study||65
519425|NCT00087646|1252088|P2|NOT COMPLETED|Overall Study||42
519426|NCT00087646|1252089|P1|NOT COMPLETED|Overall Study||135
519427|NCT00087646|1252086|P4|COMPLETED|Overall Study||229
519428|NCT00087646|1252087|P3|COMPLETED|Overall Study||91
519429|NCT00087646|1252088|P2|COMPLETED|Overall Study||114
519430|NCT00087646|1252089|P1|COMPLETED|Overall Study||182
519431|NCT00087646|1252086|P4|STARTED|Overall Study||313
519432|NCT00087646|1252087|P3|STARTED|Overall Study||156
519433|NCT00087646|1252088|P2|STARTED|Overall Study||156
519434|NCT00087646|1252089|P1|STARTED|Overall Study||317
519435|NCT00087633|1252117|P2|NOT COMPLETED|Overall Study||17
519436|NCT00087633|1252118|P1|NOT COMPLETED|Overall Study||24
519437|NCT00087633|1252117|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
519438|NCT00087633|1252118|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
519439|NCT00087633|1252117|P2|STARTED|Overall Study|Randomized|60
519440|NCT00087633|1252118|P1|STARTED|Overall Study|Randomized|55
519441|NCT00087607|1252128|P2|NOT COMPLETED|Overall Study||122
519442|NCT00087607|1252129|P1|NOT COMPLETED|Overall Study||122
519443|NCT00087607|1252128|P2|COMPLETED|Overall Study||71
519444|NCT00087607|1252129|P1|COMPLETED|Overall Study||70
519445|NCT00087607|1252128|P2|STARTED|Overall Study||193
519446|NCT00087607|1252129|P1|STARTED|Overall Study||192
519447|NCT00087594|1252169|P2|NOT COMPLETED|Overall Study||12
519448|NCT00087594|1252170|P1|NOT COMPLETED|Overall Study||8
519449|NCT00087594|1252169|P2|COMPLETED|Overall Study||12
519450|NCT00087594|1252170|P1|COMPLETED|Overall Study||16
519451|NCT00087594|1252169|P2|STARTED|Overall Study||24
519452|NCT00087594|1252170|P1|STARTED|Overall Study||24
519453|NCT00087568|1252204|P2|NOT COMPLETED|Overall Study||2
519454|NCT00087568|1252205|P1|NOT COMPLETED|Overall Study||30
519455|NCT00087568|1252204|P2|COMPLETED|Overall Study||23
519456|NCT00087568|1252205|P1|COMPLETED|Overall Study||2
519457|NCT00087568|1252204|P2|STARTED|Overall Study||25
519458|NCT00087568|1252205|P1|STARTED|Overall Study||32
519459|NCT00087555|1252232|P3|NOT COMPLETED|Overall Study||21
519460|NCT00087555|1252233|P2|NOT COMPLETED|Overall Study||11
519461|NCT00087555|1252234|P1|NOT COMPLETED|Overall Study||12
519462|NCT00087555|1252232|P3|COMPLETED|Overall Study||46
519463|NCT00087555|1252233|P2|COMPLETED|Overall Study||51
519464|NCT00087555|1252234|P1|COMPLETED|Overall Study||54
519465|NCT00087555|1252232|P3|Treated|Overall Study||67
519466|NCT00087555|1252233|P2|Treated|Overall Study||60
519467|NCT00087555|1252234|P1|Treated|Overall Study||65
519468|NCT00087555|1252232|P3|STARTED|Overall Study||67
519469|NCT00087555|1252233|P2|STARTED|Overall Study||62
519470|NCT00087555|1252234|P1|STARTED|Overall Study||66
519471|NCT00087529|1252244|P2|NOT COMPLETED|Overall Study||68
519472|NCT00087529|1252245|P1|NOT COMPLETED|Overall Study||31
519473|NCT00087529|1252244|P2|COMPLETED|Overall Study||224
519474|NCT00087529|1252245|P1|COMPLETED|Overall Study||116
519475|NCT00087529|1252244|P2|STARTED|Overall Study||292
519476|NCT00087529|1252245|P1|STARTED|Overall Study||147
519477|NCT00087516|1252260|P4|NOT COMPLETED|Overall Study||85
519478|NCT00087516|1252261|P3|NOT COMPLETED|Overall Study||97
519479|NCT00087516|1252262|P2|NOT COMPLETED|Overall Study||169
519480|NCT00087516|1252263|P1|NOT COMPLETED|Overall Study||161
519481|NCT00087516|1252260|P4|COMPLETED|Overall Study||38
519482|NCT00087516|1252261|P3|COMPLETED|Overall Study||33
519483|NCT00087516|1252262|P2|COMPLETED|Overall Study||81
519484|NCT00087516|1252263|P1|COMPLETED|Overall Study||77
519485|NCT00087516|1252260|P4|STARTED|Overall Study||123
519486|NCT00087516|1252261|P3|STARTED|Overall Study||130
519487|NCT00087516|1252262|P2|STARTED|Overall Study||250
519488|NCT00087516|1252263|P1|STARTED|Overall Study||238
519489|NCT00087490|1252292|P2|NOT COMPLETED|Overall Study||269
519490|NCT00087490|1252293|P1|NOT COMPLETED|Overall Study||258
519491|NCT00087490|1252292|P2|COMPLETED|Overall Study||264
519492|NCT00087490|1252293|P1|COMPLETED|Overall Study||286
519493|NCT00087490|1252292|P2|Treated|Overall Study||515
519494|NCT00087490|1252293|P1|Treated|Overall Study||537
519495|NCT00087490|1252292|P2|STARTED|Overall Study||533
519496|NCT00087490|1252293|P1|STARTED|Overall Study||544
519497|NCT00087438|1252327|P1|NOT COMPLETED|Overall Study||4
519498|NCT00087438|1252327|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
519499|NCT00087438|1252327|P1|STARTED|Overall Study||59
519500|NCT00087152|1252331|P1|NOT COMPLETED|Overall Study||6
519501|NCT00087152|1252331|P1|COMPLETED|Overall Study||21
519502|NCT00087152|1252331|P1|STARTED|Overall Study||27
519503|NCT00087139|1252340|P3|NOT COMPLETED|Overall Study||36
519504|NCT00087139|1252341|P2|NOT COMPLETED|Overall Study||49
519505|NCT00087139|1252342|P1|NOT COMPLETED|Overall Study||39
519506|NCT00087139|1252340|P3|COMPLETED|Overall Study||0
519507|NCT00087139|1252341|P2|COMPLETED|Overall Study||0
519508|NCT00087139|1252342|P1|COMPLETED|Overall Study||0
519509|NCT00087139|1252340|P3|Patients w/ Measurable Disease Response|Overall Study||0
519510|NCT00087139|1252341|P2|Patients w/ Measurable Disease Response|Overall Study||2
519511|NCT00087139|1252342|P1|Patients w/ Measurable Disease Response|Overall Study||5
519512|NCT00087139|1252340|P3|Patients With PSA Response|Overall Study||4
519513|NCT00087139|1252341|P2|Patients With PSA Response|Overall Study||8
519514|NCT00087139|1252342|P1|Patients With PSA Response|Overall Study||10
519515|NCT00087139|1252340|P3|Patients With Measurable Disease|Overall Study||24
519516|NCT00087139|1252341|P2|Patients With Measurable Disease|Overall Study||25
519517|NCT00087139|1252342|P1|Patients With Measurable Disease|Overall Study||22
519518|NCT00087139|1252340|P3|Patients for the Analysis of PSA Respons|Overall Study||22
519519|NCT00087139|1252341|P2|Patients for the Analysis of PSA Respons|Overall Study||34
519520|NCT00087139|1252342|P1|Patients for the Analysis of PSA Respons|Overall Study||30
519521|NCT00087139|1252340|P3|Eligible and Treated|Overall Study||32
519522|NCT00087139|1252341|P2|Eligible and Treated|Overall Study||42
519523|NCT00087139|1252342|P1|Eligible and Treated|Overall Study||35
519524|NCT00087139|1252340|P3|Treated|Overall Study||36
519525|NCT00087139|1252341|P2|Treated|Overall Study||48
519526|NCT00087139|1252342|P1|Treated|Overall Study||39
519527|NCT00087139|1252340|P3|STARTED|Overall Study||36
519528|NCT00087139|1252341|P2|STARTED|Overall Study||49
519529|NCT00087139|1252342|P1|STARTED|Overall Study||39
519530|NCT00086996|1252357|P1|NOT COMPLETED|Overall Study||64
519531|NCT00086996|1252357|P1|COMPLETED|Overall Study||34
519532|NCT00086996|1252357|P1|Eligible and Began Protocol Therapy|Overall Study||93
519533|NCT00086996|1252357|P1|Eligible|Overall Study||93
519534|NCT00086996|1252357|P1|STARTED|Overall Study||98
519535|NCT00086957|1252364|P3|NOT COMPLETED|Overall Study||0
519536|NCT00086957|1252365|P2|NOT COMPLETED|Overall Study||0
519537|NCT00086957|1252366|P1|NOT COMPLETED|Overall Study||0
519538|NCT00086957|1252364|P3|COMPLETED|Overall Study||22
519539|NCT00086957|1252365|P2|COMPLETED|Overall Study||7
519540|NCT00086957|1252366|P1|COMPLETED|Overall Study||2
519541|NCT00086957|1252364|P3|STARTED|Overall Study||22
519542|NCT00086957|1252365|P2|STARTED|Overall Study||7
519543|NCT00086957|1252366|P1|STARTED|Overall Study||2
519544|NCT00086684|1252379|P3|NOT COMPLETED|Overall Study||53
519545|NCT00086684|1252380|P2|NOT COMPLETED|Overall Study||55
519546|NCT00086684|1252381|P1|NOT COMPLETED|Overall Study||55
519547|NCT00086684|1252379|P3|COMPLETED|Overall Study||69
519548|NCT00086684|1252380|P2|COMPLETED|Overall Study||74
519549|NCT00086684|1252381|P1|COMPLETED|Overall Study||63
519550|NCT00086684|1252379|P3|STARTED|Overall Study||122
519551|NCT00086684|1252380|P2|STARTED|Overall Study||129
519552|NCT00086684|1252381|P1|STARTED|Overall Study||118
519553|NCT00086619|1252394|P2|NOT COMPLETED|Overall Study||17
519554|NCT00086619|1252395|P1|NOT COMPLETED|Overall Study||15
519555|NCT00086619|1252394|P2|COMPLETED|Overall Study||23
519556|NCT00086619|1252395|P1|COMPLETED|Overall Study||25
519557|NCT00086619|1252394|P2|Completed 12 Month Visit|Overall Study||26
519558|NCT00086619|1252395|P1|Completed 12 Month Visit|Overall Study||26
519559|NCT00086619|1252394|P2|Completed Baseline Visit|Overall Study||36
519560|NCT00086619|1252395|P1|Completed Baseline Visit|Overall Study||34
519561|NCT00086619|1252394|P2|STARTED|Overall Study||40
519562|NCT00086619|1252395|P1|STARTED|Overall Study||40
519563|NCT00086580|1252405|P2|NOT COMPLETED|Observation Period||65
519564|NCT00086580|1252406|P1|NOT COMPLETED|Observation Period||46
519565|NCT00086580|1252405|P2|COMPLETED|Observation Period||56
519566|NCT00086580|1252406|P1|COMPLETED|Observation Period||49
519567|NCT00086580|1252405|P2|STARTED|Observation Period||121
519568|NCT00086580|1252406|P1|STARTED|Observation Period||95
519569|NCT00086580|1252405|P2|NOT COMPLETED|Follow-up Period||119
519570|NCT00086580|1252406|P1|NOT COMPLETED|Follow-up Period||104
519571|NCT00086580|1252405|P2|COMPLETED|Follow-up Period||18
519572|NCT00086580|1252406|P1|COMPLETED|Follow-up Period||37
519573|NCT00086580|1252405|P2|STARTED|Follow-up Period||137
519574|NCT00086580|1252406|P1|STARTED|Follow-up Period||141
519575|NCT00086580|1252405|P2|NOT COMPLETED|Treatment Period||60
519576|NCT00086580|1252406|P1|NOT COMPLETED|Treatment Period||65
519577|NCT00086580|1252405|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
519578|NCT00086580|1252406|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
519579|NCT00086580|1252405|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
519580|NCT00086580|1252406|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
519581|NCT00086580|1252405|P2|STARTED|Treatment Period||167
519582|NCT00086580|1252406|P1|STARTED|Treatment Period||168
519583|NCT00086515|1252452|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
519584|NCT00086515|1252453|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
519585|NCT00086515|1252452|P2|COMPLETED|Phase B (Weeks 24-104)||109
519586|NCT00086515|1252453|P1|COMPLETED|Phase B (Weeks 24-104)||201
519587|NCT00086515|1252452|P2|STARTED|Phase B (Weeks 24-104)||164
519588|NCT00086515|1252453|P1|STARTED|Phase B (Weeks 24-104)||391
519589|NCT00086515|1252452|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
519590|NCT00086515|1252453|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
519591|NCT00086515|1252452|P2|COMPLETED|Phase A to Phase B Transition Period||164
519592|NCT00086515|1252453|P1|COMPLETED|Phase A to Phase B Transition Period||391
519593|NCT00086515|1252452|P2|STARTED|Phase A to Phase B Transition Period||192
519594|NCT00086515|1252453|P1|STARTED|Phase A to Phase B Transition Period||415
519595|NCT00086515|1252452|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
519596|NCT00086515|1252453|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
519597|NCT00086515|1252452|P2|COMPLETED|Phase A (Weeks 0-24)||192
519598|NCT00086515|1252453|P1|COMPLETED|Phase A (Weeks 0-24)||415
519599|NCT00086515|1252452|P2|STARTED|Phase A (Weeks 0-24)||237
519600|NCT00086515|1252453|P1|STARTED|Phase A (Weeks 0-24)||464
519601|NCT00086502|1252465|P2|NOT COMPLETED|Overall Study||20
519602|NCT00086502|1252466|P1|NOT COMPLETED|Overall Study||26
519603|NCT00086502|1252465|P2|COMPLETED|Overall Study||158
519604|NCT00086502|1252466|P1|COMPLETED|Overall Study||149
519605|NCT00086502|1252465|P2|STARTED|Overall Study||178
519606|NCT00086502|1252466|P1|STARTED|Overall Study||175
519607|NCT00086450|1252476|P2|NOT COMPLETED|Overall Study||0
519608|NCT00086450|1252477|P1|NOT COMPLETED|Overall Study||0
519609|NCT00086450|1252476|P2|COMPLETED|Overall Study||947
519610|NCT00086450|1252477|P1|COMPLETED|Overall Study||953
519611|NCT00086450|1252476|P2|STARTED|Overall Study||947
519612|NCT00086450|1252477|P1|STARTED|Overall Study||953
519613|NCT00086411|1252493|P4|NOT COMPLETED|Overall Study||12
519614|NCT00086411|1252494|P3|NOT COMPLETED|Overall Study||13
519615|NCT00086411|1252495|P2|NOT COMPLETED|Overall Study||11
519616|NCT00086411|1252496|P1|NOT COMPLETED|Overall Study||11
519617|NCT00086411|1252493|P4|COMPLETED|Overall Study||53
519618|NCT00086411|1252494|P3|COMPLETED|Overall Study||49
519619|NCT00086411|1252495|P2|COMPLETED|Overall Study||52
519620|NCT00086411|1252496|P1|COMPLETED|Overall Study||59
519621|NCT00086411|1252493|P4|STARTED|Overall Study||65
519622|NCT00086411|1252494|P3|STARTED|Overall Study||62
519623|NCT00086411|1252495|P2|STARTED|Overall Study||63
519624|NCT00086411|1252496|P1|STARTED|Overall Study||70
519625|NCT00086385|1252510|P4|NOT COMPLETED|Overall Study||1
519626|NCT00086385|1252511|P3|NOT COMPLETED|Overall Study||1
519627|NCT00086385|1252512|P2|NOT COMPLETED|Overall Study||2
519628|NCT00086385|1252513|P1|NOT COMPLETED|Overall Study||2
519629|NCT00086385|1252510|P4|COMPLETED|Overall Study||98
519630|NCT00086385|1252511|P3|COMPLETED|Overall Study||103
519631|NCT00086385|1252512|P2|COMPLETED|Overall Study||97
519632|NCT00086385|1252513|P1|COMPLETED|Overall Study||98
519633|NCT00086385|1252510|P4|STARTED|Overall Study||99
519634|NCT00086385|1252511|P3|STARTED|Overall Study||104
519635|NCT00086385|1252512|P2|STARTED|Overall Study||99
519636|NCT00086385|1252513|P1|STARTED|Overall Study||100
519637|NCT00086346|1252525|P2|NOT COMPLETED|Patients Dosed With Test Article||23
519638|NCT00086346|1252526|P1|NOT COMPLETED|Patients Dosed With Test Article||140
519639|NCT00086346|1252525|P2|COMPLETED|Patients Dosed With Test Article||187
519640|NCT00086346|1252526|P1|COMPLETED|Patients Dosed With Test Article||249
519641|NCT00086346|1252525|P2|STARTED|Patients Dosed With Test Article||210
519642|NCT00086346|1252526|P1|STARTED|Patients Dosed With Test Article||389
519643|NCT00086346|1252525|P2|NOT COMPLETED|Randomization||4
519644|NCT00086346|1252526|P1|NOT COMPLETED|Randomization||4
519645|NCT00086346|1252525|P2|COMPLETED|Randomization||210
519646|NCT00086346|1252526|P1|COMPLETED|Randomization||389
519647|NCT00086346|1252525|P2|STARTED|Randomization||214
519648|NCT00086346|1252526|P1|STARTED|Randomization||393
519649|NCT00086307|1252541|P3|NOT COMPLETED|Overall Study||8
519650|NCT00086307|1252542|P2|NOT COMPLETED|Overall Study||1
519651|NCT00086307|1252543|P1|NOT COMPLETED|Overall Study||2
519652|NCT00086307|1252541|P3|COMPLETED|Overall Study||5
519653|NCT00086307|1252542|P2|COMPLETED|Overall Study||12
519654|NCT00086307|1252543|P1|COMPLETED|Overall Study||11
519655|NCT00086307|1252541|P3|STARTED|Overall Study||13
519656|NCT00086307|1252542|P2|STARTED|Overall Study||13
519657|NCT00086307|1252543|P1|STARTED|Overall Study||13
519658|NCT00086281|1252566|P15|NOT COMPLETED|Phase 2||0
519659|NCT00086281|1252567|P14|NOT COMPLETED|Phase 2||1
519660|NCT00086281|1252568|P13|NOT COMPLETED|Phase 2||1
519661|NCT00086281|1252569|P12|NOT COMPLETED|Phase 2||0
519662|NCT00086281|1252570|P11|NOT COMPLETED|Phase 2||0
519663|NCT00086281|1252571|P10|NOT COMPLETED|Phase 2||0
519664|NCT00086281|1252572|P9|NOT COMPLETED|Phase 2||0
519665|NCT00086281|1252573|P8|NOT COMPLETED|Phase 2||0
519666|NCT00086281|1252574|P7|NOT COMPLETED|Phase 2||0
519667|NCT00086281|1252575|P6|NOT COMPLETED|Phase 2||0
519668|NCT00086281|1252576|P5|NOT COMPLETED|Phase 2||0
519669|NCT00086281|1252577|P4|NOT COMPLETED|Phase 2||0
519670|NCT00086281|1252578|P3|NOT COMPLETED|Phase 2||0
519671|NCT00086281|1252579|P2|NOT COMPLETED|Phase 2||0
519672|NCT00086281|1252580|P1|NOT COMPLETED|Phase 2||0
519673|NCT00086281|1252566|P15|COMPLETED|Phase 2||0
519674|NCT00086281|1252567|P14|COMPLETED|Phase 2||26
519675|NCT00086281|1252568|P13|COMPLETED|Phase 2||22
519676|NCT00086281|1252569|P12|COMPLETED|Phase 2||0
519677|NCT00086281|1252570|P11|COMPLETED|Phase 2||0
519678|NCT00086281|1252571|P10|COMPLETED|Phase 2||0
519679|NCT00086281|1252572|P9|COMPLETED|Phase 2||0
519680|NCT00086281|1252573|P8|COMPLETED|Phase 2||0
519681|NCT00086281|1252574|P7|COMPLETED|Phase 2||0
519682|NCT00086281|1252575|P6|COMPLETED|Phase 2||0
519683|NCT00086281|1252576|P5|COMPLETED|Phase 2||0
519684|NCT00086281|1252577|P4|COMPLETED|Phase 2||0
519685|NCT00086281|1252578|P3|COMPLETED|Phase 2||0
519686|NCT00086281|1252579|P2|COMPLETED|Phase 2||0
519687|NCT00086281|1252580|P1|COMPLETED|Phase 2||0
519688|NCT00086281|1252566|P15|STARTED|Phase 2||0
519689|NCT00086281|1252567|P14|STARTED|Phase 2||27
519690|NCT00086281|1252568|P13|STARTED|Phase 2||23
519691|NCT00086281|1252569|P12|STARTED|Phase 2||0
519692|NCT00086281|1252570|P11|STARTED|Phase 2||0
519693|NCT00086281|1252571|P10|STARTED|Phase 2||0
519694|NCT00086281|1252572|P9|STARTED|Phase 2||0
519695|NCT00086281|1252573|P8|STARTED|Phase 2||0
519696|NCT00086281|1252574|P7|STARTED|Phase 2||0
519697|NCT00086281|1252575|P6|STARTED|Phase 2||0
519698|NCT00086281|1252576|P5|STARTED|Phase 2||0
519699|NCT00086281|1252577|P4|STARTED|Phase 2||0
519700|NCT00086281|1252578|P3|STARTED|Phase 2||0
519701|NCT00086281|1252579|P2|STARTED|Phase 2||0
519702|NCT00086281|1252580|P1|STARTED|Phase 2||0
519703|NCT00086281|1252566|P15|NOT COMPLETED|Phase 1||3
519704|NCT00086281|1252567|P14|NOT COMPLETED|Phase 1||1
519705|NCT00086281|1252568|P13|NOT COMPLETED|Phase 1||1
519706|NCT00086281|1252569|P12|NOT COMPLETED|Phase 1||1
519707|NCT00086281|1252570|P11|NOT COMPLETED|Phase 1||3
519708|NCT00086281|1252571|P10|NOT COMPLETED|Phase 1||1
519709|NCT00086281|1252572|P9|NOT COMPLETED|Phase 1||0
519710|NCT00086281|1252573|P8|NOT COMPLETED|Phase 1||0
519711|NCT00086281|1252574|P7|NOT COMPLETED|Phase 1||0
519712|NCT00086281|1252575|P6|NOT COMPLETED|Phase 1||0
519713|NCT00086281|1252576|P5|NOT COMPLETED|Phase 1||0
519714|NCT00086281|1252577|P4|NOT COMPLETED|Phase 1||0
519715|NCT00086281|1252578|P3|NOT COMPLETED|Phase 1||0
519716|NCT00086281|1252579|P2|NOT COMPLETED|Phase 1||0
519717|NCT00086281|1252580|P1|NOT COMPLETED|Phase 1||0
519718|NCT00086281|1252566|P15|COMPLETED|Phase 1||0
519719|NCT00086281|1252567|P14|COMPLETED|Phase 1||0
519720|NCT00086281|1252568|P13|COMPLETED|Phase 1||0
519721|NCT00086281|1252569|P12|COMPLETED|Phase 1||0
519722|NCT00086281|1252570|P11|COMPLETED|Phase 1||0
519723|NCT00086281|1252571|P10|COMPLETED|Phase 1||0
519724|NCT00086281|1252572|P9|COMPLETED|Phase 1||2
519725|NCT00086281|1252573|P8|COMPLETED|Phase 1||1
519726|NCT00086281|1252574|P7|COMPLETED|Phase 1||1
519727|NCT00086281|1252575|P6|COMPLETED|Phase 1||3
519728|NCT00086281|1252576|P5|COMPLETED|Phase 1||1
519729|NCT00086281|1252577|P4|COMPLETED|Phase 1||11
519730|NCT00086281|1252578|P3|COMPLETED|Phase 1||8
519731|NCT00086281|1252579|P2|COMPLETED|Phase 1||12
519732|NCT00086281|1252580|P1|COMPLETED|Phase 1||11
519733|NCT00086281|1252566|P15|STARTED|Phase 1||3
519734|NCT00086281|1252567|P14|STARTED|Phase 1||1
519735|NCT00086281|1252568|P13|STARTED|Phase 1||1
519736|NCT00086281|1252569|P12|STARTED|Phase 1||1
519737|NCT00086281|1252570|P11|STARTED|Phase 1||3
519738|NCT00086281|1252571|P10|STARTED|Phase 1||1
519739|NCT00086281|1252572|P9|STARTED|Phase 1||2
519740|NCT00086281|1252573|P8|STARTED|Phase 1||1
519741|NCT00086281|1252574|P7|STARTED|Phase 1||1
519742|NCT00086281|1252575|P6|STARTED|Phase 1||3
519743|NCT00086281|1252576|P5|STARTED|Phase 1||1
519744|NCT00086281|1252577|P4|STARTED|Phase 1||11
519745|NCT00086281|1252578|P3|STARTED|Phase 1||8
519746|NCT00086281|1252579|P2|STARTED|Phase 1||12
519747|NCT00086281|1252580|P1|STARTED|Phase 1||11
519748|NCT00086190|1252593|P3|NOT COMPLETED|Overall Study||6
519749|NCT00086190|1252594|P2|NOT COMPLETED|Overall Study||4
519750|NCT00086190|1252595|P1|NOT COMPLETED|Overall Study||8
519751|NCT00086190|1252593|P3|COMPLETED|Overall Study||33
519752|NCT00086190|1252594|P2|COMPLETED|Overall Study||30
519753|NCT00086190|1252595|P1|COMPLETED|Overall Study||34
519754|NCT00086190|1252593|P3|STARTED|Overall Study||39
519755|NCT00086190|1252594|P2|STARTED|Overall Study||34
519756|NCT00086190|1252595|P1|STARTED|Overall Study||42
519757|NCT00086138|1252653|P2|NOT COMPLETED|Overall Study||3
519758|NCT00086138|1252654|P1|NOT COMPLETED|Overall Study||4
519759|NCT00086138|1252653|P2|COMPLETED|Overall Study||64
519760|NCT00086138|1252654|P1|COMPLETED|Overall Study||60
519761|NCT00086138|1252653|P2|STARTED|Overall Study||67
519762|NCT00086138|1252654|P1|STARTED|Overall Study||64
519763|NCT00086047|1252664|P2|NOT COMPLETED|Overall Study||7
519764|NCT00086047|1252665|P1|NOT COMPLETED|Overall Study||7
519765|NCT00086047|1252664|P2|COMPLETED|Overall Study||50
519766|NCT00086047|1252665|P1|COMPLETED|Overall Study||50
519767|NCT00086047|1252664|P2|STARTED|Overall Study||57
519768|NCT00086047|1252665|P1|STARTED|Overall Study||57
519769|NCT00085917|1252673|P2|NOT COMPLETED|Overall Study||3
519770|NCT00085917|1252674|P1|NOT COMPLETED|Overall Study||4
519771|NCT00085917|1252673|P2|COMPLETED|Overall Study||11
519772|NCT00085917|1252674|P1|COMPLETED|Overall Study||11
519773|NCT00085917|1252673|P2|STARTED|Overall Study||14
519774|NCT00085917|1252674|P1|STARTED|Overall Study||15
519775|NCT00085839|1252686|P2|NOT COMPLETED|Overall Study||0
519776|NCT00085839|1252687|P1|NOT COMPLETED|Overall Study||0
519777|NCT00085839|1252686|P2|COMPLETED|Overall Study||51
519778|NCT00085839|1252687|P1|COMPLETED|Overall Study||52
519779|NCT00085839|1252686|P2|STARTED|Overall Study||51
519780|NCT00085839|1252687|P1|STARTED|Overall Study||52
519781|NCT00085735|1252703|P6|NOT COMPLETED|Overall Study||31
519782|NCT00085735|1252704|P5|NOT COMPLETED|Overall Study||42
519783|NCT00085735|1252705|P4|NOT COMPLETED|Overall Study||19
519784|NCT00085735|1252706|P3|NOT COMPLETED|Overall Study||17
519785|NCT00085735|1252707|P2|NOT COMPLETED|Overall Study||10
519786|NCT00085735|1252708|P1|NOT COMPLETED|Overall Study||12
519787|NCT00085735|1252703|P6|COMPLETED|Overall Study||115
519788|NCT00085735|1252704|P5|COMPLETED|Overall Study||105
519789|NCT00085735|1252705|P4|COMPLETED|Overall Study||46
519790|NCT00085735|1252706|P3|COMPLETED|Overall Study||46
519791|NCT00085735|1252707|P2|COMPLETED|Overall Study||54
519792|NCT00085735|1252708|P1|COMPLETED|Overall Study||52
519793|NCT00085735|1252703|P6|STARTED|Overall Study||146
519794|NCT00085735|1252704|P5|STARTED|Overall Study||147
519795|NCT00085735|1252705|P4|STARTED|Overall Study||65
519796|NCT00085735|1252706|P3|STARTED|Overall Study||63
519797|NCT00085735|1252707|P2|STARTED|Overall Study||64
519798|NCT00085735|1252708|P1|STARTED|Overall Study||64
519799|NCT00085709|1252736|P2|NOT COMPLETED|Overall Study||50
519800|NCT00085709|1252737|P1|NOT COMPLETED|Overall Study||53
519801|NCT00085709|1252736|P2|COMPLETED|Overall Study||270
519802|NCT00085709|1252737|P1|COMPLETED|Overall Study||264
519803|NCT00085709|1252736|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
519804|NCT00085709|1252737|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
519805|NCT00085709|1252736|P2|Eligible|Overall Study||301
519806|NCT00085709|1252737|P1|Eligible|Overall Study||298
519807|NCT00085709|1252736|P2|STARTED|Overall Study||320
519808|NCT00085709|1252737|P1|STARTED|Overall Study||317
519809|NCT00085644|1252753|P3|NOT COMPLETED|Open-Label Period||109
519810|NCT00085644|1252754|P2|NOT COMPLETED|Open-Label Period||0
519811|NCT00085644|1252755|P1|NOT COMPLETED|Open-Label Period||0
519812|NCT00085644|1252753|P3|COMPLETED|Open-Label Period||202
519813|NCT00085644|1252754|P2|COMPLETED|Open-Label Period||0
519814|NCT00085644|1252755|P1|COMPLETED|Open-Label Period||0
519815|NCT00085644|1252753|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
519816|NCT00085644|1252754|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
519817|NCT00085644|1252755|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
519818|NCT00085644|1252753|P3|NOT COMPLETED|Double-Blind Period||0
519819|NCT00085644|1252754|P2|NOT COMPLETED|Double-Blind Period||6
519820|NCT00085644|1252755|P1|NOT COMPLETED|Double-Blind Period||13
519821|NCT00085644|1252753|P3|COMPLETED|Double-Blind Period||0
519822|NCT00085644|1252754|P2|COMPLETED|Double-Blind Period||101
519823|NCT00085644|1252755|P1|COMPLETED|Double-Blind Period||195
519824|NCT00085644|1252753|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
519825|NCT00085644|1252754|P2|STARTED|Double-Blind Period||107
519826|NCT00085644|1252755|P1|STARTED|Double-Blind Period||208
519827|NCT00085631|1252796|P3|NOT COMPLETED|Overall Study||7
519828|NCT00085631|1252797|P2|NOT COMPLETED|Overall Study||11
519829|NCT00085631|1252798|P1|NOT COMPLETED|Overall Study||4
519830|NCT00085631|1252796|P3|COMPLETED|Overall Study||32
519831|NCT00085631|1252797|P2|COMPLETED|Overall Study||38
519832|NCT00085631|1252798|P1|COMPLETED|Overall Study||9
519833|NCT00085631|1252796|P3|STARTED|Overall Study||39
519834|NCT00085631|1252797|P2|STARTED|Overall Study||49
519835|NCT00085631|1252798|P1|STARTED|Overall Study||13
519836|NCT00085566|1252808|P3|NOT COMPLETED|Overall Study||14
519837|NCT00085566|1252809|P2|NOT COMPLETED|Overall Study||0
519838|NCT00085566|1252810|P1|NOT COMPLETED|Overall Study||0
519839|NCT00085566|1252808|P3|COMPLETED|Overall Study||43
519840|NCT00085566|1252809|P2|COMPLETED|Overall Study||3
519841|NCT00085566|1252810|P1|COMPLETED|Overall Study||3
519842|NCT00085566|1252808|P3|STARTED|Overall Study||57
519843|NCT00085566|1252809|P2|STARTED|Overall Study||3
519844|NCT00085566|1252810|P1|STARTED|Overall Study||3
519845|NCT00085540|1252820|P2|NOT COMPLETED|Overall Study||2
519846|NCT00085540|1252821|P1|NOT COMPLETED|Overall Study||0
519847|NCT00085540|1252820|P2|COMPLETED|Overall Study||40
519848|NCT00085540|1252821|P1|COMPLETED|Overall Study||8
519849|NCT00085540|1252820|P2|STARTED|Overall Study||42
519850|NCT00085540|1252821|P1|STARTED|Overall Study||8
519851|NCT00085436|1252828|P1|NOT COMPLETED|Overall Study||0
519852|NCT00085436|1252828|P1|COMPLETED|Overall Study||18
519853|NCT00085436|1252828|P1|STARTED|Overall Study||18
519854|NCT00085423|1252832|P1|NOT COMPLETED|Overall Study||2
519855|NCT00085423|1252832|P1|COMPLETED|Overall Study||18
519856|NCT00085423|1252832|P1|STARTED|Overall Study||20
519857|NCT00085410|1252838|P1|NOT COMPLETED|Overall Study||0
519858|NCT00085410|1252838|P1|COMPLETED|Overall Study||20
519859|NCT00085410|1252838|P1|STARTED|Overall Study||20
519860|NCT00085293|1252852|P1|NOT COMPLETED|Overall Study||0
519861|NCT00085293|1252852|P1|COMPLETED|Overall Study||12
519862|NCT00085293|1252852|P1|STARTED|Overall Study||12
519863|NCT00085254|1252860|P3|NOT COMPLETED|Overall Study||0
519864|NCT00085254|1252861|P2|NOT COMPLETED|Overall Study||0
519865|NCT00085254|1252862|P1|NOT COMPLETED|Overall Study||0
519866|NCT00085254|1252860|P3|COMPLETED|Overall Study||48
519867|NCT00085254|1252861|P2|COMPLETED|Overall Study||46
519868|NCT00085254|1252862|P1|COMPLETED|Overall Study||18
519869|NCT00085254|1252860|P3|STARTED|Overall Study||48
519870|NCT00085254|1252861|P2|STARTED|Overall Study||46
519871|NCT00085254|1252862|P1|STARTED|Overall Study||18
519872|NCT00085202|1252878|P2|NOT COMPLETED|Overall Study||24
519873|NCT00085202|1252879|P1|NOT COMPLETED|Overall Study||18
519874|NCT00085202|1252878|P2|COMPLETED|Overall Study||120
519875|NCT00085202|1252879|P1|COMPLETED|Overall Study||251
519876|NCT00085202|1252878|P2|STARTED|Overall Study||144
519877|NCT00085202|1252879|P1|STARTED|Overall Study||269
519878|NCT00085098|1252892|P2|NOT COMPLETED|Overall Study||2
519879|NCT00085098|1252893|P1|NOT COMPLETED|Overall Study||1
519880|NCT00085098|1252892|P2|COMPLETED|Overall Study||11
519881|NCT00085098|1252893|P1|COMPLETED|Overall Study||10
519882|NCT00085098|1252892|P2|STARTED|Overall Study||13
519883|NCT00085098|1252893|P1|STARTED|Overall Study||11
519884|NCT00084864|1252903|P4|NOT COMPLETED|Overall Study||0
519885|NCT00084864|1252904|P3|NOT COMPLETED|Overall Study||0
519886|NCT00084864|1252905|P2|NOT COMPLETED|Overall Study||0
519887|NCT00084864|1252906|P1|NOT COMPLETED|Overall Study||1
519888|NCT00084864|1252903|P4|COMPLETED|Overall Study||4
519889|NCT00084864|1252904|P3|COMPLETED|Overall Study||4
519890|NCT00084864|1252905|P2|COMPLETED|Overall Study||7
519891|NCT00084864|1252906|P1|COMPLETED|Overall Study||9
519892|NCT00084864|1252903|P4|STARTED|Overall Study||4
519893|NCT00084864|1252904|P3|STARTED|Overall Study||4
519894|NCT00084864|1252905|P2|STARTED|Overall Study||7
519895|NCT00084864|1252906|P1|STARTED|Overall Study||10
519896|NCT00084838|1252932|P1|NOT COMPLETED|Overall Study||13
519897|NCT00084838|1252932|P1|COMPLETED|Overall Study||12
519898|NCT00084838|1252932|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
519899|NCT00084838|1252932|P1|STARTED|Overall Study||25
519900|NCT00084747|1252954|P1|NOT COMPLETED|Overall Study||13
519901|NCT00084747|1252954|P1|COMPLETED|Overall Study||17
519902|NCT00084747|1252954|P1|STARTED|Overall Study||30
519903|NCT00084682|1252959|P1|NOT COMPLETED|Overall Study||1
519904|NCT00084682|1252959|P1|COMPLETED|Overall Study||13
519905|NCT00084682|1252959|P1|STARTED|Overall Study||14
519906|NCT00084617|1252963|P1|NOT COMPLETED|Overall Study||9
519907|NCT00084617|1252963|P1|COMPLETED|Overall Study||30
519908|NCT00084617|1252963|P1|STARTED|Overall Study||39
519909|NCT00084487|1252969|P1|NOT COMPLETED|Overall Study||1
519910|NCT00084487|1252969|P1|COMPLETED|Overall Study||20
519911|NCT00084487|1252969|P1|STARTED|Overall Study||21
519912|NCT00084409|1252979|P2|NOT COMPLETED|Overall Study||12
519913|NCT00084409|1252980|P1|NOT COMPLETED|Overall Study||15
519914|NCT00084409|1252979|P2|COMPLETED|Overall Study|4 Current, 8 former|65
519915|NCT00084409|1252980|P1|COMPLETED|Overall Study|9 current, 6 former|60
519916|NCT00084409|1252979|P2|STARTED|Overall Study|41 current, 36 former|77
519917|NCT00084409|1252980|P1|STARTED|Overall Study|40 Current, 35 former|75
519918|NCT00084383|1253008|P1|NOT COMPLETED|Overall Study||47
519919|NCT00084383|1253008|P1|COMPLETED|Overall Study||13
519920|NCT00084383|1253008|P1|STARTED|Overall Study||60
519921|NCT00084318|1253015|P2|NOT COMPLETED|Overall Study||13
519922|NCT00084318|1253016|P1|NOT COMPLETED|Overall Study||22
519923|NCT00084318|1253015|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
519924|NCT00084318|1253016|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
519925|NCT00084318|1253015|P2|STARTED|Overall Study||119
519926|NCT00084318|1253016|P1|STARTED|Overall Study||119
519927|NCT00084266|1253034|P2|NOT COMPLETED|Overall Study||423
519928|NCT00084266|1253035|P1|NOT COMPLETED|Overall Study||441
519929|NCT00084266|1253034|P2|COMPLETED|Overall Study||184
519930|NCT00084266|1253035|P1|COMPLETED|Overall Study||177
519931|NCT00084266|1253034|P2|Treated|Overall Study||587
519932|NCT00084266|1253035|P1|Treated|Overall Study||597
519933|NCT00084266|1253034|P2|STARTED|Overall Study||607
519934|NCT00084266|1253035|P1|STARTED|Overall Study||618
519935|NCT00084136|1253072|P3|NOT COMPLETED|NRTI Comparison||82
519936|NCT00084136|1253073|P2|NOT COMPLETED|NRTI Comparison||0
519937|NCT00084136|1253074|P1|NOT COMPLETED|NRTI Comparison||101
519938|NCT00084136|1253072|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
519939|NCT00084136|1253073|P2|COMPLETED|NRTI Comparison||0
519940|NCT00084136|1253074|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
519941|NCT00084136|1253072|P3|STARTED|NRTI Comparison||526
519942|NCT00084136|1253073|P2|STARTED|NRTI Comparison||0
519943|NCT00084136|1253074|P1|STARTED|NRTI Comparison||519
519944|NCT00084136|1253072|P3|NOT COMPLETED|PI Comparison||0
519945|NCT00084136|1253073|P2|NOT COMPLETED|PI Comparison||47
519946|NCT00084136|1253074|P1|NOT COMPLETED|PI Comparison||55
519947|NCT00084136|1253072|P3|COMPLETED|PI Comparison||0
519948|NCT00084136|1253073|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
519949|NCT00084136|1253074|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
519950|NCT00084136|1253072|P3|STARTED|PI Comparison||0
519951|NCT00084136|1253073|P2|STARTED|PI Comparison||526
519952|NCT00084136|1253074|P1|STARTED|PI Comparison||519
519953|NCT00084084|1253133|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
519954|NCT00084084|1253133|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
519955|NCT00084084|1253133|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
519956|NCT00084084|1253133|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
519957|NCT00084084|1253133|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
519958|NCT00084084|1253133|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
519959|NCT00083915|1253143|P2|NOT COMPLETED|Overall Study||37
519960|NCT00083915|1253144|P1|NOT COMPLETED|Overall Study||50
519961|NCT00083915|1253143|P2|COMPLETED|Overall Study||8
519962|NCT00083915|1253144|P1|COMPLETED|Overall Study||2
519963|NCT00083915|1253143|P2|STARTED|Overall Study||45
519964|NCT00083915|1253144|P1|STARTED|Overall Study||52
519965|NCT00083889|1253152|P2|NOT COMPLETED|Overall Study||375
519966|NCT00083889|1253153|P1|NOT COMPLETED|Overall Study||375
519967|NCT00083889|1253152|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
519968|NCT00083889|1253153|P1|COMPLETED|Overall Study||0
519969|NCT00083889|1253152|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
519970|NCT00083889|1253153|P1|Received Treatment|Overall Study||375
519971|NCT00083889|1253152|P2|STARTED|Overall Study||375
519972|NCT00083889|1253153|P1|STARTED|Overall Study||375
519973|NCT00083759|1253204|P2|NOT COMPLETED|Overall Study||83
519974|NCT00083759|1253205|P1|NOT COMPLETED|Overall Study||84
519975|NCT00083759|1253204|P2|COMPLETED|Overall Study||66
519976|NCT00083759|1253205|P1|COMPLETED|Overall Study||66
519977|NCT00083759|1253204|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
519978|NCT00083759|1253205|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
519979|NCT00083720|1253213|P1|NOT COMPLETED|Overall Study||0
519980|NCT00083720|1253213|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
519981|NCT00083720|1253213|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
519982|NCT00083616|1253223|P1|NOT COMPLETED|Overall Study||31
520071|NCT00082017|1253422|P2|NOT COMPLETED|Overall Study||0
519983|NCT00083616|1253223|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
519984|NCT00083616|1253223|P1|Received Study Medication|Overall Study||182
519985|NCT00083616|1253223|P1|STARTED|Overall Study||185
519986|NCT00083551|1253237|P2|NOT COMPLETED|Overall Study||0
519987|NCT00083551|1253238|P1|NOT COMPLETED|Overall Study||0
519988|NCT00083551|1253237|P2|COMPLETED|Overall Study||345
519989|NCT00083551|1253238|P1|COMPLETED|Overall Study||323
519990|NCT00083551|1253237|P2|STARTED|Overall Study||345
519991|NCT00083551|1253238|P1|STARTED|Overall Study||323
519992|NCT00083382|1253244|P1|NOT COMPLETED|Overall Study||0
519993|NCT00083382|1253244|P1|COMPLETED|Overall Study||83
519994|NCT00083382|1253244|P1|STARTED|Overall Study||83
519995|NCT00083226|1253248|P1|NOT COMPLETED|Overall Study||42
519996|NCT00083226|1253248|P1|COMPLETED|Overall Study||0
519997|NCT00083226|1253248|P1|STARTED|Overall Study||42
519998|NCT00083174|1253256|P2|NOT COMPLETED|Overall Study||0
519999|NCT00083174|1253257|P1|NOT COMPLETED|Overall Study||0
520000|NCT00083174|1253256|P2|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2275
520001|NCT00083174|1253257|P1|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2285
520002|NCT00083174|1253256|P2|STARTED|Overall Study||2275
520003|NCT00083174|1253257|P1|STARTED|Overall Study||2285
520004|NCT00083122|1253277|P2|NOT COMPLETED|Overall Study||0
520005|NCT00083122|1253278|P1|NOT COMPLETED|Overall Study||0
520006|NCT00083122|1253277|P2|COMPLETED|Overall Study||5
520007|NCT00083122|1253278|P1|COMPLETED|Overall Study||40
520008|NCT00083122|1253277|P2|STARTED|Overall Study||5
520009|NCT00083122|1253278|P1|STARTED|Overall Study||40
520010|NCT00082888|1253287|P1|NOT COMPLETED|Overall Study||22
520011|NCT00082888|1253287|P1|COMPLETED|Overall Study||71
520012|NCT00082888|1253287|P1|STARTED|Overall Study||93
520013|NCT00082810|1253291|P1|NOT COMPLETED|Overall Study||31
520014|NCT00082810|1253291|P1|COMPLETED|Overall Study||2
520015|NCT00082810|1253291|P1|STARTED|Overall Study||33
520016|NCT00082758|1253301|P3|NOT COMPLETED|Overall Study||0
520017|NCT00082758|1253302|P2|NOT COMPLETED|Overall Study||17
520018|NCT00082758|1253303|P1|NOT COMPLETED|Overall Study||15
520019|NCT00082758|1253301|P3|COMPLETED|Overall Study||0
520020|NCT00082758|1253302|P2|COMPLETED|Overall Study||7
520021|NCT00082758|1253303|P1|COMPLETED|Overall Study||0
520022|NCT00082758|1253301|P3|STARTED|Overall Study||0
520023|NCT00082758|1253302|P2|STARTED|Overall Study||24
520024|NCT00082758|1253303|P1|STARTED|Overall Study||15
520025|NCT00082433|1253313|P2|NOT COMPLETED|Overall Study||597
520026|NCT00082433|1253314|P1|NOT COMPLETED|Overall Study||594
520112|NCT00081458|1253532|P1|NOT COMPLETED|Overall Study||1
520027|NCT00082433|1253313|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
520028|NCT00082433|1253314|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
520029|NCT00082433|1253313|P2|STARTED|Overall Study||612
520030|NCT00082433|1253314|P1|STARTED|Overall Study||609
520031|NCT00082407|1253334|P2|NOT COMPLETED|Overall Study||27
520032|NCT00082407|1253335|P1|NOT COMPLETED|Overall Study||56
520033|NCT00082407|1253334|P2|COMPLETED|Overall Study||223
520034|NCT00082407|1253335|P1|COMPLETED|Overall Study||199
520035|NCT00082407|1253334|P2|Received Treatment (Intent to Treat)|Overall Study||248
520036|NCT00082407|1253335|P1|Received Treatment (Intent to Treat)|Overall Study||253
520037|NCT00082407|1253334|P2|STARTED|Overall Study||250
520038|NCT00082407|1253335|P1|STARTED|Overall Study||255
520039|NCT00082381|1253355|P2|NOT COMPLETED|Overall Study||26
520040|NCT00082381|1253356|P1|NOT COMPLETED|Overall Study||55
520041|NCT00082381|1253355|P2|COMPLETED|Overall Study||242
520042|NCT00082381|1253356|P1|COMPLETED|Overall Study||228
520043|NCT00082381|1253355|P2|Received Treatment (Intent to Treat)|Overall Study||267
520044|NCT00082381|1253356|P1|Received Treatment (Intent to Treat)|Overall Study||282
520045|NCT00082381|1253355|P2|STARTED|Overall Study||268
520046|NCT00082381|1253356|P1|STARTED|Overall Study||283
520047|NCT00082368|1253374|P1|NOT COMPLETED|Overall Study||1
520048|NCT00082368|1253374|P1|COMPLETED|Overall Study||11
520049|NCT00082368|1253374|P1|STARTED|Overall Study||12
520050|NCT00082355|1253379|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
520051|NCT00082355|1253379|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
520052|NCT00082355|1253379|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
520053|NCT00082355|1253379|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
520054|NCT00082355|1253379|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
520055|NCT00082355|1253379|P1|STARTED|Initial Results of Thrombolytic Therapy||30
520056|NCT00082342|1253386|P2|NOT COMPLETED|Overall Study||0
520057|NCT00082342|1253387|P1|NOT COMPLETED|Overall Study||0
520058|NCT00082342|1253386|P2|COMPLETED|Overall Study||12
520059|NCT00082342|1253387|P1|COMPLETED|Overall Study||13
520060|NCT00082342|1253386|P2|STARTED|Overall Study||12
520061|NCT00082342|1253387|P1|STARTED|Overall Study||13
520062|NCT00082329|1253407|P1|NOT COMPLETED|Overall Study||0
520063|NCT00082329|1253407|P1|COMPLETED|Overall Study||9
520064|NCT00082329|1253407|P1|STARTED|Overall Study||9
520065|NCT00082173|1253413|P2|NOT COMPLETED|Overall Study||11
520066|NCT00082173|1253414|P1|NOT COMPLETED|Overall Study||10
520067|NCT00082173|1253413|P2|COMPLETED|Overall Study||61
520068|NCT00082173|1253414|P1|COMPLETED|Overall Study||64
520069|NCT00082173|1253413|P2|STARTED|Overall Study||72
520070|NCT00082173|1253414|P1|STARTED|Overall Study||74
520072|NCT00082017|1253423|P1|NOT COMPLETED|Overall Study||0
520073|NCT00082017|1253422|P2|COMPLETED|Overall Study||9
520074|NCT00082017|1253423|P1|COMPLETED|Overall Study||11
520075|NCT00082017|1253422|P2|STARTED|Overall Study||9
520076|NCT00082017|1253423|P1|STARTED|Overall Study||11
520077|NCT00081939|1253439|P1|NOT COMPLETED|Overall Study||0
520078|NCT00081939|1253439|P1|COMPLETED|Overall Study||303
520079|NCT00081939|1253439|P1|STARTED|Overall Study||303
520080|NCT00081861|1253443|P1|NOT COMPLETED|Overall Study||0
520081|NCT00081861|1253443|P1|COMPLETED|Overall Study||13
520082|NCT00081861|1253443|P1|STARTED|Overall Study||13
520083|NCT00081770|1253450|P3|NOT COMPLETED|Overall Study||456
520084|NCT00081770|1253451|P2|NOT COMPLETED|Overall Study||546
520085|NCT00081770|1253452|P1|NOT COMPLETED|Overall Study||502
520086|NCT00081770|1253450|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
520087|NCT00081770|1253451|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
520088|NCT00081770|1253452|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
520089|NCT00081770|1253450|P3|STARTED|Overall Study||1035
520090|NCT00081770|1253451|P2|STARTED|Overall Study||1016
520091|NCT00081770|1253452|P1|STARTED|Overall Study||1019
520092|NCT00081731|1253471|P2|NOT COMPLETED|Overall Study||8
520093|NCT00081731|1253472|P1|NOT COMPLETED|Overall Study||8
520094|NCT00081731|1253471|P2|COMPLETED|Overall Study||459
520095|NCT00081731|1253472|P1|COMPLETED|Overall Study||472
520096|NCT00081731|1253471|P2|STARTED|Overall Study||467
520097|NCT00081731|1253472|P1|STARTED|Overall Study||480
520098|NCT00081653|1253492|P2|NOT COMPLETED|Overall Study||37
520099|NCT00081653|1253493|P1|NOT COMPLETED|Overall Study||47
520100|NCT00081653|1253492|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
520101|NCT00081653|1253493|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
520102|NCT00081653|1253492|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
520103|NCT00081653|1253493|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
520104|NCT00081497|1253511|P2|NOT COMPLETED|Overall Study||2
520105|NCT00081497|1253512|P1|NOT COMPLETED|Overall Study||3
520106|NCT00081497|1253511|P2|COMPLETED|Overall Study||37
520107|NCT00081497|1253512|P1|COMPLETED|Overall Study||25
520108|NCT00081497|1253511|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
520109|NCT00081497|1253512|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
520110|NCT00081458|1253530|P3|NOT COMPLETED|Overall Study||4
520111|NCT00081458|1253531|P2|NOT COMPLETED|Overall Study||8
520113|NCT00081458|1253530|P3|COMPLETED|Overall Study||29
520114|NCT00081458|1253531|P2|COMPLETED|Overall Study||27
520115|NCT00081458|1253532|P1|COMPLETED|Overall Study||15
520116|NCT00081458|1253530|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
520117|NCT00081458|1253531|P2|Received Treatment|Overall Study||35
520118|NCT00081458|1253532|P1|Received Treatment|Overall Study||16
520119|NCT00081458|1253530|P3|STARTED|Overall Study||33
520120|NCT00081458|1253531|P2|STARTED|Overall Study||35
520121|NCT00081458|1253532|P1|STARTED|Overall Study||16
520122|NCT00081328|1253546|P3|NOT COMPLETED|Overall Study||0
520123|NCT00081328|1253547|P2|NOT COMPLETED|Overall Study||0
520124|NCT00081328|1253548|P1|NOT COMPLETED|Overall Study||0
520125|NCT00081328|1253546|P3|COMPLETED|Overall Study||234
520126|NCT00081328|1253547|P2|COMPLETED|Overall Study||233
520127|NCT00081328|1253548|P1|COMPLETED|Overall Study||232
520128|NCT00081328|1253546|P3|STARTED|Overall Study||234
520129|NCT00081328|1253547|P2|STARTED|Overall Study||233
520130|NCT00081328|1253548|P1|STARTED|Overall Study||232
520131|NCT00081289|1253588|P2|NOT COMPLETED|Overall Study||21
520132|NCT00081289|1253589|P1|NOT COMPLETED|Overall Study||21
520133|NCT00081289|1253588|P2|COMPLETED|Overall Study||52
520134|NCT00081289|1253589|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
520135|NCT00081289|1253588|P2|STARTED|Overall Study||73
520136|NCT00081289|1253589|P1|STARTED|Overall Study||73
520137|NCT00081159|1253597|P2|NOT COMPLETED|Overall Study||5
520138|NCT00081159|1253598|P1|NOT COMPLETED|Overall Study||2
520139|NCT00081159|1253597|P2|COMPLETED|Overall Study||35
520140|NCT00081159|1253598|P1|COMPLETED|Overall Study||37
520141|NCT00081159|1253597|P2|STARTED|Overall Study||40
520142|NCT00081159|1253598|P1|STARTED|Overall Study||39
520143|NCT00080938|1253608|P1|NOT COMPLETED|Overall Study||24
520144|NCT00080938|1253608|P1|COMPLETED|Overall Study||2
520145|NCT00080938|1253608|P1|Eligible and Treated|Overall Study||21
520146|NCT00080938|1253608|P1|Began Protocol Therapy|Overall Study||25
520147|NCT00080938|1253608|P1|STARTED|Overall Study||26
520148|NCT00080912|1253617|P2|NOT COMPLETED|Overall Study||0
520149|NCT00080912|1253618|P1|NOT COMPLETED|Overall Study||0
520150|NCT00080912|1253617|P2|COMPLETED|Overall Study||425
520151|NCT00080912|1253618|P1|COMPLETED|Overall Study||425
520152|NCT00080912|1253617|P2|STARTED|Overall Study||425
520153|NCT00080912|1253618|P1|STARTED|Overall Study||425
520154|NCT00080899|1253624|P1|NOT COMPLETED|Overall Study||1
520155|NCT00080899|1253624|P1|COMPLETED|Overall Study||22
520156|NCT00080899|1253624|P1|STARTED|Overall Study||23
520157|NCT00080535|1253629|P1|NOT COMPLETED|Overall Study||0
520158|NCT00080535|1253629|P1|COMPLETED|Overall Study||10
520159|NCT00080535|1253629|P1|STARTED|Overall Study||10
520160|NCT00080483|1253636|P2|NOT COMPLETED|Overall Study||2
520161|NCT00080483|1253637|P1|NOT COMPLETED|Overall Study||2
520162|NCT00080483|1253636|P2|COMPLETED|Overall Study||16
520163|NCT00080483|1253637|P1|COMPLETED|Overall Study||15
520164|NCT00080483|1253636|P2|STARTED|Overall Study||18
520165|NCT00080483|1253637|P1|STARTED|Overall Study||17
520166|NCT00080470|1253645|P2|NOT COMPLETED|Overall Study||28
520167|NCT00080470|1253646|P1|NOT COMPLETED|Overall Study||34
520168|NCT00080470|1253645|P2|COMPLETED|Overall Study||14
520169|NCT00080470|1253646|P1|COMPLETED|Overall Study||11
520170|NCT00080470|1253645|P2|STARTED|Overall Study||42
520171|NCT00080470|1253646|P1|STARTED|Overall Study||45
520172|NCT00080301|1253656|P2|NOT COMPLETED|Overall Study||11
520173|NCT00080301|1253657|P1|NOT COMPLETED|Overall Study||5
520174|NCT00080301|1253656|P2|COMPLETED|Overall Study|Participants who are off treatment|366
520175|NCT00080301|1253657|P1|COMPLETED|Overall Study|Participants who are off treatment|370
520176|NCT00080301|1253656|P2|Still on Treatment|Overall Study||1
520177|NCT00080301|1253657|P1|Still on Treatment|Overall Study||0
520178|NCT00080301|1253656|P2|Never Treated|Overall Study||10
520179|NCT00080301|1253657|P1|Never Treated|Overall Study||5
520180|NCT00080301|1253656|P2|STARTED|Overall Study||377
520181|NCT00080301|1253657|P1|STARTED|Overall Study||375
520182|NCT00080288|1253677|P2|NOT COMPLETED|Overall Study||38
520183|NCT00080288|1253678|P1|NOT COMPLETED|Overall Study||30
520184|NCT00080288|1253677|P2|COMPLETED|Overall Study||89
520185|NCT00080288|1253678|P1|COMPLETED|Overall Study||97
520186|NCT00080288|1253677|P2|STARTED|Overall Study||127
520187|NCT00080288|1253678|P1|STARTED|Overall Study||127
520188|NCT00080223|1253686|P1|NOT COMPLETED|Overall Study||76
520189|NCT00080223|1253686|P1|COMPLETED|Overall Study||7
520190|NCT00080223|1253686|P1|STARTED|Overall Study||83
520191|NCT00080119|1253698|P4|NOT COMPLETED|Overall Study||163
520192|NCT00080119|1253699|P3|NOT COMPLETED|Overall Study||165
520193|NCT00080119|1253700|P2|NOT COMPLETED|Overall Study||62
520194|NCT00080119|1253701|P1|NOT COMPLETED|Overall Study||56
520195|NCT00080119|1253698|P4|COMPLETED|Overall Study||111
520196|NCT00080119|1253699|P3|COMPLETED|Overall Study||108
520197|NCT00080119|1253700|P2|COMPLETED|Overall Study||339
520198|NCT00080119|1253701|P1|COMPLETED|Overall Study||347
520199|NCT00080119|1253698|P4|STARTED|Overall Study||274
520200|NCT00080119|1253699|P3|STARTED|Overall Study||273
520201|NCT00080119|1253700|P2|STARTED|Overall Study||401
520202|NCT00080119|1253701|P1|STARTED|Overall Study||403
520203|NCT00079937|1253735|P2|NOT COMPLETED|Overall Study||32
520204|NCT00079937|1253736|P1|NOT COMPLETED|Overall Study||69
520205|NCT00079937|1253735|P2|COMPLETED|Overall Study||175
520206|NCT00079937|1253736|P1|COMPLETED|Overall Study||352
520207|NCT00079937|1253735|P2|STARTED|Overall Study||207
520208|NCT00079937|1253736|P1|STARTED|Overall Study||421
520209|NCT00079781|1253755|P3|NOT COMPLETED|Follow-up Period||2
520210|NCT00079781|1253756|P2|NOT COMPLETED|Follow-up Period||0
520211|NCT00079781|1253757|P1|NOT COMPLETED|Follow-up Period||4
520212|NCT00079781|1253755|P3|COMPLETED|Follow-up Period||12
520213|NCT00079781|1253756|P2|COMPLETED|Follow-up Period||9
520214|NCT00079781|1253757|P1|COMPLETED|Follow-up Period||38
520215|NCT00079781|1253755|P3|STARTED|Follow-up Period||14
520216|NCT00079781|1253756|P2|STARTED|Follow-up Period||9
520217|NCT00079781|1253757|P1|STARTED|Follow-up Period||42
520218|NCT00079781|1253755|P3|NOT COMPLETED|Evaluation Period||0
520219|NCT00079781|1253756|P2|NOT COMPLETED|Evaluation Period||0
520220|NCT00079781|1253757|P1|NOT COMPLETED|Evaluation Period||0
520221|NCT00079781|1253755|P3|COMPLETED|Evaluation Period||14
520222|NCT00079781|1253756|P2|COMPLETED|Evaluation Period||9
520223|NCT00079781|1253757|P1|COMPLETED|Evaluation Period||42
520224|NCT00079781|1253755|P3|STARTED|Evaluation Period||14
520225|NCT00079781|1253756|P2|STARTED|Evaluation Period||9
520226|NCT00079781|1253757|P1|STARTED|Evaluation Period||42
520227|NCT00079781|1253755|P3|NOT COMPLETED|Pre-implant Period||1
520228|NCT00079781|1253756|P2|NOT COMPLETED|Pre-implant Period||1
520229|NCT00079781|1253757|P1|NOT COMPLETED|Pre-implant Period||3
520230|NCT00079781|1253755|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
520231|NCT00079781|1253756|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
520232|NCT00079781|1253757|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
520233|NCT00079781|1253755|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
520234|NCT00079781|1253756|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
520235|NCT00079781|1253757|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
520236|NCT00079677|1253766|P2|NOT COMPLETED|Overall Study||14
520237|NCT00079677|1253767|P1|NOT COMPLETED|Overall Study||20
520238|NCT00079677|1253766|P2|COMPLETED|Overall Study||118
520239|NCT00079677|1253767|P1|COMPLETED|Overall Study||111
520240|NCT00079677|1253766|P2|STARTED|Overall Study||132
520241|NCT00079677|1253767|P1|STARTED|Overall Study||131
520242|NCT00079417|1253775|P1|NOT COMPLETED|Overall Study||9
520243|NCT00079417|1253775|P1|COMPLETED|Overall Study||19
520244|NCT00079417|1253775|P1|STARTED|Overall Study||28
520245|NCT00079391|1253779|P1|NOT COMPLETED|Overall Study||1
520246|NCT00079391|1253779|P1|COMPLETED|Overall Study||49
520247|NCT00079391|1253779|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
520248|NCT00079339|1253791|P3|NOT COMPLETED|Overall Study||6
520249|NCT00079339|1253792|P2|NOT COMPLETED|Overall Study||39
520250|NCT00079339|1253793|P1|NOT COMPLETED|Overall Study||5
520251|NCT00079339|1253791|P3|COMPLETED|Overall Study||0
520252|NCT00079339|1253792|P2|COMPLETED|Overall Study||1
520253|NCT00079339|1253793|P1|COMPLETED|Overall Study||0
520254|NCT00079339|1253791|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
520255|NCT00079339|1253792|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
520256|NCT00079339|1253793|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
520257|NCT00079339|1253791|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
520258|NCT00079339|1253792|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
520259|NCT00079339|1253793|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
520260|NCT00079339|1253791|P3|Enrolled in Phase I|Overall Study||6
520261|NCT00079339|1253792|P2|Enrolled in Phase I|Overall Study||6
520262|NCT00079339|1253793|P1|Enrolled in Phase I|Overall Study||5
520263|NCT00079339|1253791|P3|STARTED|Overall Study||6
520264|NCT00079339|1253792|P2|STARTED|Overall Study||40
520265|NCT00079339|1253793|P1|STARTED|Overall Study||5
520266|NCT00079326|1253809|P2|NOT COMPLETED|Overall Study||0
520267|NCT00079326|1253810|P1|NOT COMPLETED|Overall Study||0
520268|NCT00079326|1253809|P2|COMPLETED|Overall Study||24
520269|NCT00079326|1253810|P1|COMPLETED|Overall Study||15
520270|NCT00079326|1253809|P2|STARTED|Overall Study||24
520271|NCT00079326|1253810|P1|STARTED|Overall Study||15
520272|NCT00079274|1253824|P7|NOT COMPLETED|Overall Study||0
520273|NCT00079274|1253825|P6|NOT COMPLETED|Overall Study||20
520274|NCT00079274|1253826|P5|NOT COMPLETED|Overall Study||15
520275|NCT00079274|1253827|P4|NOT COMPLETED|Overall Study||444
520276|NCT00079274|1253828|P3|NOT COMPLETED|Overall Study||27
520277|NCT00079274|1253829|P2|NOT COMPLETED|Overall Study||27
520278|NCT00079274|1253830|P1|NOT COMPLETED|Overall Study||321
520279|NCT00079274|1253824|P7|COMPLETED|Overall Study||332
520280|NCT00079274|1253825|P6|COMPLETED|Overall Study||26
520281|NCT00079274|1253826|P5|COMPLETED|Overall Study||30
520282|NCT00079274|1253827|P4|COMPLETED|Overall Study||906
520283|NCT00079274|1253828|P3|COMPLETED|Overall Study||84
520284|NCT00079274|1253829|P2|COMPLETED|Overall Study||84
520285|NCT00079274|1253830|P1|COMPLETED|Overall Study||1081
520286|NCT00079274|1253824|P7|STARTED|Overall Study||332
520287|NCT00079274|1253825|P6|STARTED|Overall Study||46
520288|NCT00079274|1253826|P5|STARTED|Overall Study||45
520289|NCT00079274|1253827|P4|STARTED|Overall Study||1350
520290|NCT00079274|1253828|P3|STARTED|Overall Study||111
520291|NCT00079274|1253829|P2|STARTED|Overall Study||111
520292|NCT00079274|1253830|P1|STARTED|Overall Study||1402
520293|NCT00079183|1253843|P1|NOT COMPLETED|Overall Study||7
520294|NCT00079183|1253843|P1|COMPLETED|Overall Study||37
520295|NCT00079183|1253843|P1|Drop Outs|Overall Study||7
520296|NCT00079183|1253843|P1|STARTED|Overall Study||44
520297|NCT00079040|1253858|P1|NOT COMPLETED|Overall Study||2
520298|NCT00079040|1253858|P1|COMPLETED|Overall Study||63
520299|NCT00079040|1253858|P1|STARTED|Overall Study||65
520300|NCT00079001|1253866|P2|NOT COMPLETED|Overall Study||0
520301|NCT00079001|1253867|P1|NOT COMPLETED|Overall Study||0
520302|NCT00079001|1253866|P2|COMPLETED|Overall Study||322
520303|NCT00079001|1253867|P1|COMPLETED|Overall Study||323
520304|NCT00079001|1253866|P2|STARTED|Overall Study||322
520305|NCT00079001|1253867|P1|STARTED|Overall Study||323
520306|NCT00078949|1253881|P4|NOT COMPLETED|Maintenance||3
520307|NCT00078949|1253882|P3|NOT COMPLETED|Maintenance||3
520308|NCT00078949|1253883|P2|NOT COMPLETED|Maintenance||0
520309|NCT00078949|1253884|P1|NOT COMPLETED|Maintenance||0
520310|NCT00078949|1253881|P4|COMPLETED|Maintenance||112
520311|NCT00078949|1253882|P3|COMPLETED|Maintenance||112
520312|NCT00078949|1253883|P2|COMPLETED|Maintenance||0
520313|NCT00078949|1253884|P1|COMPLETED|Maintenance||0
520314|NCT00078949|1253881|P4|STARTED|Maintenance||115
520315|NCT00078949|1253882|P3|STARTED|Maintenance||115
520316|NCT00078949|1253883|P2|STARTED|Maintenance||0
520317|NCT00078949|1253884|P1|STARTED|Maintenance||0
520318|NCT00078949|1253881|P4|NOT COMPLETED|Salvage||0
520319|NCT00078949|1253882|P3|NOT COMPLETED|Salvage||0
520320|NCT00078949|1253883|P2|NOT COMPLETED|Salvage||5
520321|NCT00078949|1253884|P1|NOT COMPLETED|Salvage||4
520322|NCT00078949|1253881|P4|COMPLETED|Salvage||0
520323|NCT00078949|1253882|P3|COMPLETED|Salvage||0
520324|NCT00078949|1253883|P2|COMPLETED|Salvage||304
520325|NCT00078949|1253884|P1|COMPLETED|Salvage||306
520326|NCT00078949|1253881|P4|STARTED|Salvage||0
520327|NCT00078949|1253882|P3|STARTED|Salvage||0
520328|NCT00078949|1253883|P2|STARTED|Salvage||309
520329|NCT00078949|1253884|P1|STARTED|Salvage||310
520330|NCT00078767|1253898|P2|NOT COMPLETED|Overall Study||1
520331|NCT00078767|1253899|P1|NOT COMPLETED|Overall Study||1
520332|NCT00078767|1253898|P2|COMPLETED|Overall Study||11
520333|NCT00078767|1253899|P1|COMPLETED|Overall Study||11
520334|NCT00078767|1253898|P2|STARTED|Overall Study||12
520335|NCT00078767|1253899|P1|STARTED|Overall Study||12
520336|NCT00078754|1253916|P3|NOT COMPLETED|Overall Study||15
520337|NCT00078754|1253917|P2|NOT COMPLETED|Overall Study||19
520338|NCT00078754|1253918|P1|NOT COMPLETED|Overall Study||15
520339|NCT00078754|1253916|P3|COMPLETED|Overall Study||16
520340|NCT00078754|1253917|P2|COMPLETED|Overall Study||11
520341|NCT00078754|1253918|P1|COMPLETED|Overall Study||14
520342|NCT00078754|1253916|P3|STARTED|Overall Study||31
520343|NCT00078754|1253917|P2|STARTED|Overall Study||30
520344|NCT00078754|1253918|P1|STARTED|Overall Study||29
520345|NCT00078728|1253928|P2|NOT COMPLETED|Overall Study||3
520346|NCT00078728|1253929|P1|NOT COMPLETED|Overall Study||4
520347|NCT00078728|1253928|P2|COMPLETED|Overall Study||17
520348|NCT00078728|1253929|P1|COMPLETED|Overall Study||16
520349|NCT00078728|1253928|P2|STARTED|Overall Study||20
520350|NCT00078728|1253929|P1|STARTED|Overall Study||20
520351|NCT00078715|1253935|P2|NOT COMPLETED|Second Intervention||0
520352|NCT00078715|1253936|P1|NOT COMPLETED|Second Intervention||0
520353|NCT00078715|1253935|P2|COMPLETED|Second Intervention||4
520354|NCT00078715|1253936|P1|COMPLETED|Second Intervention||2
520355|NCT00078715|1253935|P2|STARTED|Second Intervention||4
520356|NCT00078715|1253936|P1|STARTED|Second Intervention||2
520357|NCT00078715|1253935|P2|NOT COMPLETED|First Intervention||0
520358|NCT00078715|1253936|P1|NOT COMPLETED|First Intervention||0
520359|NCT00078715|1253935|P2|COMPLETED|First Intervention||4
520360|NCT00078715|1253936|P1|COMPLETED|First Intervention||2
520361|NCT00078715|1253935|P2|STARTED|First Intervention||4
520362|NCT00078715|1253936|P1|STARTED|First Intervention||2
520363|NCT00078559|1253942|P1|NOT COMPLETED|Overall Study||0
520364|NCT00078559|1253942|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
520365|NCT00078559|1253942|P1|STARTED|Overall Study||10
520366|NCT00078403|1253971|P3|NOT COMPLETED|Overall Study||28
520367|NCT00078403|1253972|P2|NOT COMPLETED|Overall Study||16
520368|NCT00078403|1253973|P1|NOT COMPLETED|Overall Study||18
520369|NCT00078403|1253971|P3|COMPLETED|Overall Study||141
520370|NCT00078403|1253972|P2|COMPLETED|Overall Study||26
520371|NCT00078403|1253973|P1|COMPLETED|Overall Study||26
520372|NCT00078403|1253971|P3|STARTED|Overall Study||169
520373|NCT00078403|1253972|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
520374|NCT00078403|1253973|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
520375|NCT00078377|1254033|P3|NOT COMPLETED|Overall Study||9
520376|NCT00078377|1254034|P2|NOT COMPLETED|Overall Study||16
520377|NCT00078377|1254035|P1|NOT COMPLETED|Overall Study||11
520378|NCT00078377|1254033|P3|COMPLETED|Overall Study||55
520379|NCT00078377|1254034|P2|COMPLETED|Overall Study||49
520380|NCT00078377|1254035|P1|COMPLETED|Overall Study||56
520381|NCT00078377|1254033|P3|STARTED|Overall Study||64
520382|NCT00078377|1254034|P2|STARTED|Overall Study||65
520383|NCT00078377|1254035|P1|STARTED|Overall Study||67
520384|NCT00078325|1254051|P3|NOT COMPLETED|Overall Study||11
520385|NCT00078325|1254052|P2|NOT COMPLETED|Overall Study||19
520386|NCT00078325|1254053|P1|NOT COMPLETED|Overall Study||21
520387|NCT00078325|1254051|P3|COMPLETED|Overall Study||120
520388|NCT00078325|1254052|P2|COMPLETED|Overall Study||114
520389|NCT00078325|1254053|P1|COMPLETED|Overall Study||110
520390|NCT00078325|1254051|P3|STARTED|Overall Study||131
520391|NCT00078325|1254052|P2|STARTED|Overall Study||133
520392|NCT00078325|1254053|P1|STARTED|Overall Study||131
520393|NCT00078312|1254064|P1|NOT COMPLETED|Overall Study||177
520394|NCT00078312|1254064|P1|COMPLETED|Overall Study||151
520395|NCT00078312|1254064|P1|STARTED|Overall Study||328
520396|NCT00078286|1254070|P2|NOT COMPLETED|Overall Study||83
520397|NCT00078286|1254071|P1|NOT COMPLETED|Overall Study||96
520398|NCT00078286|1254070|P2|COMPLETED|Overall Study||152
520399|NCT00078286|1254071|P1|COMPLETED|Overall Study||138
520400|NCT00078286|1254070|P2|STARTED|Overall Study||235
520401|NCT00078286|1254071|P1|STARTED|Overall Study||234
520402|NCT00077974|1254079|P1|NOT COMPLETED|Overall Study||104
520403|NCT00077974|1254079|P1|COMPLETED|Overall Study||2
520404|NCT00077974|1254079|P1|STARTED|Overall Study||106
520405|NCT00077922|1254094|P1|NOT COMPLETED|Overall Study||0
520406|NCT00077922|1254094|P1|COMPLETED|Overall Study||15
520407|NCT00077922|1254094|P1|STARTED|Overall Study||15
520408|NCT00077857|1254101|P2|NOT COMPLETED|Overall Study||204
520409|NCT00077857|1254102|P1|NOT COMPLETED|Overall Study||201
520410|NCT00077857|1254101|P2|COMPLETED|Overall Study||31
520411|NCT00077857|1254102|P1|COMPLETED|Overall Study||34
520412|NCT00077857|1254101|P2|Safety Population: Actual Dose Received|Overall Study||248
520413|NCT00077857|1254102|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
520414|NCT00077857|1254101|P2|Received Study Drug|Overall Study||234
520415|NCT00077857|1254102|P1|Received Study Drug|Overall Study||231
520416|NCT00077857|1254101|P2|STARTED|Overall Study||235
520417|NCT00077857|1254102|P1|STARTED|Overall Study||235
520418|NCT00077766|1254122|P2|NOT COMPLETED|Overall Study||25
520419|NCT00077766|1254123|P1|NOT COMPLETED|Overall Study||39
520420|NCT00077766|1254122|P2|COMPLETED|Overall Study||131
520421|NCT00077766|1254123|P1|COMPLETED|Overall Study||118
520422|NCT00077766|1254122|P2|STARTED|Overall Study||156
520423|NCT00077766|1254123|P1|STARTED|Overall Study||157
520424|NCT00077675|1254143|P2|NOT COMPLETED|Overall Study||9
520425|NCT00077675|1254144|P1|NOT COMPLETED|Overall Study||11
520426|NCT00077675|1254143|P2|COMPLETED|Overall Study||89
520427|NCT00077675|1254144|P1|COMPLETED|Overall Study||92
520428|NCT00077675|1254143|P2|STARTED|Overall Study||98
520429|NCT00077675|1254144|P1|STARTED|Overall Study||103
520430|NCT00077649|1254154|P4|NOT COMPLETED|Overall Study||17
520431|NCT00077649|1254155|P3|NOT COMPLETED|Overall Study||15
520432|NCT00077649|1254156|P2|NOT COMPLETED|Overall Study||9
520433|NCT00077649|1254157|P1|NOT COMPLETED|Overall Study||14
520434|NCT00077649|1254154|P4|COMPLETED|Overall Study||30
520435|NCT00077649|1254155|P3|COMPLETED|Overall Study||32
520436|NCT00077649|1254156|P2|COMPLETED|Overall Study||38
520437|NCT00077649|1254157|P1|COMPLETED|Overall Study||33
520438|NCT00077649|1254154|P4|Completed 24 Weeks of Follow-up|Overall Study||31
520439|NCT00077649|1254155|P3|Completed 24 Weeks of Follow-up|Overall Study||36
520440|NCT00077649|1254156|P2|Completed 24 Weeks of Follow-up|Overall Study||40
520441|NCT00077649|1254157|P1|Completed 24 Weeks of Follow-up|Overall Study||36
520442|NCT00077649|1254154|P4|STARTED|Overall Study||47
520443|NCT00077649|1254155|P3|STARTED|Overall Study||47
520444|NCT00077649|1254156|P2|STARTED|Overall Study||47
520445|NCT00077649|1254157|P1|STARTED|Overall Study||47
520446|NCT00077636|1254205|P2|NOT COMPLETED|Overall Study||92
520447|NCT00077636|1254206|P1|NOT COMPLETED|Overall Study||44
520448|NCT00077636|1254205|P2|COMPLETED|Overall Study||641
520449|NCT00077636|1254206|P1|COMPLETED|Overall Study||692
520450|NCT00077636|1254205|P2|STARTED|Overall Study||733
520451|NCT00077636|1254206|P1|STARTED|Overall Study||736
520452|NCT00077623|1254227|P3|NOT COMPLETED|Overall Study||32
520453|NCT00077623|1254228|P2|NOT COMPLETED|Overall Study||43
520454|NCT00077623|1254229|P1|NOT COMPLETED|Overall Study||36
520455|NCT00077623|1254227|P3|COMPLETED|Overall Study||159
520456|NCT00077623|1254228|P2|COMPLETED|Overall Study||148
520457|NCT00077623|1254229|P1|COMPLETED|Overall Study||154
520458|NCT00077623|1254227|P3|STARTED|Overall Study||191
520459|NCT00077623|1254228|P2|STARTED|Overall Study||191
520460|NCT00077623|1254229|P1|STARTED|Overall Study||190
520461|NCT00077610|1254264|P3|NOT COMPLETED|Overall Study||46
520462|NCT00077610|1254265|P2|NOT COMPLETED|Overall Study||56
520463|NCT00077610|1254266|P1|NOT COMPLETED|Overall Study||54
520464|NCT00077610|1254264|P3|COMPLETED|Overall Study||180
520465|NCT00077610|1254265|P2|COMPLETED|Overall Study||168
520466|NCT00077610|1254266|P1|COMPLETED|Overall Study||169
520467|NCT00077610|1254264|P3|Started Treatment|Overall Study||225
520468|NCT00077610|1254265|P2|Started Treatment|Overall Study||220
520469|NCT00077610|1254266|P1|Started Treatment|Overall Study||221
520470|NCT00077610|1254264|P3|STARTED|Overall Study||226
520471|NCT00077610|1254265|P2|STARTED|Overall Study||224
520472|NCT00077610|1254266|P1|STARTED|Overall Study||223
520473|NCT00077376|1254295|P1|NOT COMPLETED|Overall Study||22
520474|NCT00077376|1254295|P1|COMPLETED|Overall Study||39
520475|NCT00077376|1254295|P1|HER2+ in Central Testing|Overall Study||39
520476|NCT00077376|1254295|P1|Treated|Overall Study||59
520477|NCT00077376|1254295|P1|STARTED|Overall Study||61
520478|NCT00077207|1254306|P1|NOT COMPLETED|Overall Study||30
520479|NCT00077207|1254306|P1|COMPLETED|Overall Study||36
520480|NCT00077207|1254306|P1|STARTED|Overall Study||66
520481|NCT00076999|1254315|P5|NOT COMPLETED|Overall Study||25
520482|NCT00076999|1254316|P4|NOT COMPLETED|Overall Study||1
520483|NCT00076999|1254317|P3|NOT COMPLETED|Overall Study||17
520484|NCT00076999|1254318|P2|NOT COMPLETED|Overall Study||24
520485|NCT00076999|1254319|P1|NOT COMPLETED|Overall Study||12
520486|NCT00076999|1254315|P5|COMPLETED|Overall Study||9
520487|NCT00076999|1254316|P4|COMPLETED|Overall Study||5
520488|NCT00076999|1254317|P3|COMPLETED|Overall Study||2
520489|NCT00076999|1254318|P2|COMPLETED|Overall Study||7
520490|NCT00076999|1254319|P1|COMPLETED|Overall Study||13
520491|NCT00076999|1254315|P5|STARTED|Overall Study||34
520492|NCT00076999|1254316|P4|STARTED|Overall Study||6
520493|NCT00076999|1254317|P3|STARTED|Overall Study||19
520494|NCT00076999|1254318|P2|STARTED|Overall Study||31
520495|NCT00076999|1254319|P1|STARTED|Overall Study||25
520496|NCT00076804|1254438|P2|NOT COMPLETED|Overall Study||69
520497|NCT00076804|1254439|P1|NOT COMPLETED|Overall Study||60
520498|NCT00076804|1254438|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
520499|NCT00076804|1254439|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
520500|NCT00076804|1254438|P2|STARTED|Overall Study||137
520501|NCT00076804|1254439|P1|STARTED|Overall Study||137
520502|NCT00076752|1254451|P1|NOT COMPLETED|Overall Study||3
520503|NCT00076752|1254451|P1|COMPLETED|Overall Study||6
520504|NCT00076752|1254451|P1|STARTED|Overall Study||9
520505|NCT00076687|1254473|P3|NOT COMPLETED|Overall Study||4
520506|NCT00076687|1254474|P2|NOT COMPLETED|Overall Study||5
520507|NCT00076687|1254475|P1|NOT COMPLETED|Overall Study||6
520508|NCT00076687|1254473|P3|COMPLETED|Overall Study||51
520509|NCT00076687|1254474|P2|COMPLETED|Overall Study||47
520510|NCT00076687|1254475|P1|COMPLETED|Overall Study||42
520511|NCT00076687|1254473|P3|STARTED|Overall Study||55
520512|NCT00076687|1254474|P2|STARTED|Overall Study||52
520513|NCT00076687|1254475|P1|STARTED|Overall Study||48
520514|NCT00076570|1254494|P2|NOT COMPLETED|Overall Study||8
520515|NCT00076570|1254495|P1|NOT COMPLETED|Overall Study||8
520516|NCT00076570|1254494|P2|COMPLETED|Overall Study||8
520517|NCT00076570|1254495|P1|COMPLETED|Overall Study||7
520518|NCT00076570|1254494|P2|STARTED|Overall Study||16
520519|NCT00076570|1254495|P1|STARTED|Overall Study||15
520520|NCT00076336|1254505|P2|NOT COMPLETED|Overall Study||56
520521|NCT00076336|1254506|P1|NOT COMPLETED|Overall Study||52
520522|NCT00076336|1254505|P2|COMPLETED|Overall Study||60
520523|NCT00076336|1254506|P1|COMPLETED|Overall Study||64
520524|NCT00076336|1254505|P2|Completed Week 104|Overall Study||62
520525|NCT00076336|1254506|P1|Completed Week 104|Overall Study||70
520526|NCT00076336|1254505|P2|Completed Week 52|Overall Study||94
520527|NCT00076336|1254506|P1|Completed Week 52|Overall Study||97
520528|NCT00076336|1254505|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
520529|NCT00076336|1254506|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
520530|NCT00076336|1254505|P2|Safety Population|Overall Study||116
520531|NCT00076336|1254506|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
520532|NCT00076336|1254505|P2|STARTED|Overall Study||116
520533|NCT00076336|1254506|P1|STARTED|Overall Study||116
520534|NCT00076258|1254522|P2|NOT COMPLETED|Overall Study||3
520535|NCT00076258|1254523|P1|NOT COMPLETED|Overall Study||1
520536|NCT00076258|1254522|P2|COMPLETED|Overall Study||61
520537|NCT00076258|1254523|P1|COMPLETED|Overall Study||61
520538|NCT00076258|1254522|P2|STARTED|Overall Study||64
520539|NCT00076258|1254523|P1|STARTED|Overall Study||62
520540|NCT00076245|1254533|P4|NOT COMPLETED|Overall Study||1
520541|NCT00076245|1254534|P3|NOT COMPLETED|Overall Study||0
520542|NCT00076245|1254535|P2|NOT COMPLETED|Overall Study||0
520543|NCT00076245|1254536|P1|NOT COMPLETED|Overall Study||0
520544|NCT00076245|1254533|P4|COMPLETED|Overall Study||14
520545|NCT00076245|1254534|P3|COMPLETED|Overall Study||15
520546|NCT00076245|1254535|P2|COMPLETED|Overall Study||15
520547|NCT00076245|1254536|P1|COMPLETED|Overall Study||16
520548|NCT00076245|1254533|P4|STARTED|Overall Study||15
520549|NCT00076245|1254534|P3|STARTED|Overall Study||15
520550|NCT00076245|1254535|P2|STARTED|Overall Study||15
520551|NCT00076245|1254536|P1|STARTED|Overall Study||16
520552|NCT00076219|1254552|P2|NOT COMPLETED|Overall Study||11
520553|NCT00076219|1254553|P1|NOT COMPLETED|Overall Study||18
520554|NCT00076219|1254552|P2|COMPLETED|Overall Study||550
520555|NCT00076219|1254553|P1|COMPLETED|Overall Study||545
520556|NCT00076219|1254552|P2|STARTED|Overall Study||561
520557|NCT00076219|1254553|P1|STARTED|Overall Study||563
520558|NCT00076102|1254559|P1|NOT COMPLETED|Overall Study||0
520559|NCT00076102|1254559|P1|COMPLETED|Overall Study||36
520560|NCT00076102|1254559|P1|STARTED|Overall Study||36
520561|NCT00076050|1254566|P2|NOT COMPLETED|Overall Study||43
520562|NCT00076050|1254567|P1|NOT COMPLETED|Overall Study||23
520563|NCT00076050|1254566|P2|COMPLETED|Overall Study||83
520564|NCT00076050|1254567|P1|COMPLETED|Overall Study||99
520565|NCT00076050|1254566|P2|STARTED|Overall Study||126
520566|NCT00076050|1254567|P1|STARTED|Overall Study||122
520567|NCT00076024|1254580|P4|NOT COMPLETED|Phase 2, Open-label||16
520568|NCT00076024|1254581|P3|NOT COMPLETED|Phase 2, Open-label||0
520569|NCT00076024|1254582|P2|NOT COMPLETED|Phase 2, Open-label||0
520570|NCT00076024|1254583|P1|NOT COMPLETED|Phase 2, Open-label||0
520571|NCT00076024|1254580|P4|COMPLETED|Phase 2, Open-label||0
520572|NCT00076024|1254581|P3|COMPLETED|Phase 2, Open-label||0
520573|NCT00076024|1254582|P2|COMPLETED|Phase 2, Open-label||0
520574|NCT00076024|1254583|P1|COMPLETED|Phase 2, Open-label||0
520575|NCT00076024|1254580|P4|STARTED|Phase 2, Open-label||16
520576|NCT00076024|1254581|P3|STARTED|Phase 2, Open-label||0
520577|NCT00076024|1254582|P2|STARTED|Phase 2, Open-label||0
520578|NCT00076024|1254583|P1|STARTED|Phase 2, Open-label||0
520579|NCT00076024|1254580|P4|NOT COMPLETED|Phase 2, Double-blind||0
520580|NCT00076024|1254581|P3|NOT COMPLETED|Phase 2, Double-blind||56
520581|NCT00076024|1254582|P2|NOT COMPLETED|Phase 2, Double-blind||112
520582|NCT00076024|1254583|P1|NOT COMPLETED|Phase 2, Double-blind||0
520583|NCT00076024|1254580|P4|COMPLETED|Phase 2, Double-blind||0
520584|NCT00076024|1254581|P3|COMPLETED|Phase 2, Double-blind||0
520585|NCT00076024|1254582|P2|COMPLETED|Phase 2, Double-blind||0
520586|NCT00076024|1254583|P1|COMPLETED|Phase 2, Double-blind||0
520587|NCT00076024|1254580|P4|Treated|Phase 2, Double-blind||0
520588|NCT00076024|1254581|P3|Treated|Phase 2, Double-blind||56
520589|NCT00076024|1254582|P2|Treated|Phase 2, Double-blind||111
520590|NCT00076024|1254583|P1|Treated|Phase 2, Double-blind||0
520591|NCT00076024|1254580|P4|STARTED|Phase 2, Double-blind||0
520592|NCT00076024|1254581|P3|STARTED|Phase 2, Double-blind||56
520593|NCT00076024|1254582|P2|STARTED|Phase 2, Double-blind||112
520594|NCT00076024|1254583|P1|STARTED|Phase 2, Double-blind||0
520595|NCT00076024|1254580|P4|NOT COMPLETED|Phase 1, Lead-in||0
520596|NCT00076024|1254581|P3|NOT COMPLETED|Phase 1, Lead-in||0
520597|NCT00076024|1254582|P2|NOT COMPLETED|Phase 1, Lead-in||0
520598|NCT00076024|1254583|P1|NOT COMPLETED|Phase 1, Lead-in||6
520599|NCT00076024|1254580|P4|COMPLETED|Phase 1, Lead-in||0
520600|NCT00076024|1254581|P3|COMPLETED|Phase 1, Lead-in||0
520601|NCT00076024|1254582|P2|COMPLETED|Phase 1, Lead-in||0
520602|NCT00076024|1254583|P1|COMPLETED|Phase 1, Lead-in||0
520603|NCT00076024|1254580|P4|STARTED|Phase 1, Lead-in||0
520604|NCT00076024|1254581|P3|STARTED|Phase 1, Lead-in||0
520605|NCT00076024|1254582|P2|STARTED|Phase 1, Lead-in||0
520606|NCT00076024|1254583|P1|STARTED|Phase 1, Lead-in||6
520607|NCT00076011|1254597|P1|NOT COMPLETED|Overall Study||52
520608|NCT00076011|1254597|P1|COMPLETED|Overall Study||0
520609|NCT00076011|1254597|P1|STARTED|Overall Study||52
520610|NCT00075946|1254609|P5|NOT COMPLETED|Overall Study||188
520611|NCT00075946|1254610|P4|NOT COMPLETED|Overall Study||30
520612|NCT00075946|1254611|P3|NOT COMPLETED|Overall Study||28
520613|NCT00075946|1254612|P2|NOT COMPLETED|Overall Study||151
520614|NCT00075946|1254613|P1|NOT COMPLETED|Overall Study||148
520615|NCT00075946|1254609|P5|COMPLETED|Overall Study||0
520616|NCT00075946|1254610|P4|COMPLETED|Overall Study||0
520617|NCT00075946|1254611|P3|COMPLETED|Overall Study||0
520618|NCT00075946|1254612|P2|COMPLETED|Overall Study||0
520619|NCT00075946|1254613|P1|COMPLETED|Overall Study||0
520620|NCT00075946|1254609|P5|Included in Primary Analysis|Overall Study||0
520621|NCT00075946|1254610|P4|Included in Primary Analysis|Overall Study||29
520622|NCT00075946|1254611|P3|Included in Primary Analysis|Overall Study||23
520623|NCT00075946|1254612|P2|Included in Primary Analysis|Overall Study||146
520624|NCT00075946|1254613|P1|Included in Primary Analysis|Overall Study||143
520625|NCT00075946|1254609|P5|Treated and With Toxicity Data Available|Overall Study||154
520626|NCT00075946|1254610|P4|Treated and With Toxicity Data Available|Overall Study||29
520627|NCT00075946|1254611|P3|Treated and With Toxicity Data Available|Overall Study||27
520628|NCT00075946|1254612|P2|Treated and With Toxicity Data Available|Overall Study||148
520629|NCT00075946|1254613|P1|Treated and With Toxicity Data Available|Overall Study||142
520630|NCT00075946|1254609|P5|STARTED|Overall Study||188
520631|NCT00075946|1254610|P4|STARTED|Overall Study||30
520632|NCT00075946|1254611|P3|STARTED|Overall Study||28
520633|NCT00075946|1254612|P2|STARTED|Overall Study||151
520634|NCT00075946|1254613|P1|STARTED|Overall Study||148
520635|NCT00075881|1254628|P1|NOT COMPLETED|Overall Study||43
520636|NCT00075881|1254628|P1|COMPLETED|Overall Study||1
520637|NCT00075881|1254628|P1|Reinduction Treatment|Overall Study||7
520638|NCT00075881|1254628|P1|Maintenance Treatment|Overall Study||15
520639|NCT00075881|1254628|P1|Induction Treatment|Overall Study||42
520640|NCT00075881|1254628|P1|Treated|Overall Study||42
520641|NCT00075881|1254628|P1|Eligible|Overall Study||43
520642|NCT00075881|1254628|P1|STARTED|Overall Study||44
520643|NCT00075829|1254639|P4|NOT COMPLETED|Overall Study||24
520644|NCT00075829|1254640|P3|NOT COMPLETED|Overall Study||34
520645|NCT00075829|1254641|P2|NOT COMPLETED|Overall Study||118
520646|NCT00075829|1254642|P1|NOT COMPLETED|Overall Study||258
520647|NCT00075829|1254639|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
520648|NCT00075829|1254640|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
520649|NCT00075829|1254641|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
520650|NCT00075829|1254642|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
520651|NCT00075829|1254639|P4|STARTED|Overall Study||37
520652|NCT00075829|1254640|P3|STARTED|Overall Study||48
520653|NCT00075829|1254641|P2|STARTED|Overall Study||189
520654|NCT00075829|1254642|P1|STARTED|Overall Study||436
520655|NCT00075816|1254672|P2|NOT COMPLETED|Overall Study||11
520656|NCT00075816|1254673|P1|NOT COMPLETED|Overall Study||14
520657|NCT00075816|1254672|P2|COMPLETED|Overall Study||262
520658|NCT00075816|1254673|P1|COMPLETED|Overall Study||264
520659|NCT00075816|1254672|P2|STARTED|Overall Study||273
520660|NCT00075816|1254673|P1|STARTED|Overall Study||278
520661|NCT00075803|1254713|P2|NOT COMPLETED|Overall Study||0
520662|NCT00075803|1254714|P1|NOT COMPLETED|Overall Study||0
520663|NCT00075803|1254713|P2|COMPLETED|Overall Study||305
520664|NCT00075803|1254714|P1|COMPLETED|Overall Study||295
520665|NCT00075803|1254713|P2|STARTED|Overall Study||305
520666|NCT00075803|1254714|P1|STARTED|Overall Study||295
520667|NCT00075764|1254742|P2|NOT COMPLETED|Overall Study||349
520668|NCT00075764|1254743|P1|NOT COMPLETED|Overall Study||345
520669|NCT00075764|1254742|P2|COMPLETED|Overall Study||0
520670|NCT00075764|1254743|P1|COMPLETED|Overall Study||0
520671|NCT00075764|1254742|P2|STARTED|Overall Study||349
520672|NCT00075764|1254743|P1|STARTED|Overall Study||345
520673|NCT00075725|1254767|P12|NOT COMPLETED|Overall Study||18
520674|NCT00075725|1254768|P11|NOT COMPLETED|Overall Study||9
520675|NCT00075725|1254769|P10|NOT COMPLETED|Overall Study||18
520676|NCT00075725|1254770|P9|NOT COMPLETED|Overall Study||117
520677|NCT00075725|1254771|P8|NOT COMPLETED|Overall Study||295
520678|NCT00075725|1254772|P7|NOT COMPLETED|Overall Study||75
520679|NCT00075725|1254773|P6|NOT COMPLETED|Overall Study||313
520680|NCT00075725|1254774|P5|NOT COMPLETED|Overall Study||66
520681|NCT00075725|1254775|P4|NOT COMPLETED|Overall Study||78
520682|NCT00075725|1254776|P3|NOT COMPLETED|Overall Study||121
520683|NCT00075725|1254777|P2|NOT COMPLETED|Overall Study||49
520684|NCT00075725|1254778|P1|NOT COMPLETED|Overall Study||74
520685|NCT00075725|1254767|P12|COMPLETED|Overall Study||10
520686|NCT00075725|1254768|P11|COMPLETED|Overall Study||3
520687|NCT00075725|1254769|P10|COMPLETED|Overall Study||16
520688|NCT00075725|1254770|P9|COMPLETED|Overall Study||185
520689|NCT00075725|1254771|P8|COMPLETED|Overall Study||401
520690|NCT00075725|1254772|P7|COMPLETED|Overall Study||171
520691|NCT00075725|1254773|P6|COMPLETED|Overall Study||397
520692|NCT00075725|1254774|P5|COMPLETED|Overall Study||166
520693|NCT00075725|1254775|P4|COMPLETED|Overall Study||168
520694|NCT00075725|1254776|P3|COMPLETED|Overall Study||175
520695|NCT00075725|1254777|P2|COMPLETED|Overall Study||57
520696|NCT00075725|1254778|P1|COMPLETED|Overall Study||172
520697|NCT00075725|1254767|P12|STARTED|Overall Study||28
520698|NCT00075725|1254768|P11|STARTED|Overall Study||12
520699|NCT00075725|1254769|P10|STARTED|Overall Study||34
520700|NCT00075725|1254770|P9|STARTED|Overall Study||302
520701|NCT00075725|1254771|P8|STARTED|Overall Study||696
520702|NCT00075725|1254772|P7|STARTED|Overall Study||246
520703|NCT00075725|1254773|P6|STARTED|Overall Study||710
520704|NCT00075725|1254774|P5|STARTED|Overall Study||232
520705|NCT00075725|1254775|P4|STARTED|Overall Study||246
520706|NCT00075725|1254776|P3|STARTED|Overall Study||296
520707|NCT00075725|1254777|P2|STARTED|Overall Study||106
520708|NCT00075725|1254778|P1|STARTED|Overall Study||246
520709|NCT00075608|1254867|P1|NOT COMPLETED|Overall Study||0
520710|NCT00075608|1254867|P1|COMPLETED|Overall Study||12
520711|NCT00075608|1254867|P1|STARTED|Overall Study||12
520712|NCT00075582|1254875|P2|NOT COMPLETED|Overall Study||35
520713|NCT00075582|1254876|P1|NOT COMPLETED|Overall Study||50
520714|NCT00075582|1254875|P2|COMPLETED|Overall Study||50
520715|NCT00075582|1254876|P1|COMPLETED|Overall Study||255
520716|NCT00075582|1254875|P2|STARTED|Overall Study||85
520717|NCT00075582|1254876|P1|STARTED|Overall Study||305
520718|NCT00075504|1254886|P2|NOT COMPLETED|Overall Study||7
520719|NCT00075504|1254887|P1|NOT COMPLETED|Overall Study||9
520720|NCT00075504|1254886|P2|COMPLETED|Overall Study||3
520721|NCT00075504|1254887|P1|COMPLETED|Overall Study||14
520722|NCT00075504|1254886|P2|STARTED|Overall Study||10
520723|NCT00075504|1254887|P1|STARTED|Overall Study||23
520724|NCT00075478|1254899|P2|NOT COMPLETED|Overall Study||1
520725|NCT00075478|1254900|P1|NOT COMPLETED|Overall Study||1
520726|NCT00075478|1254899|P2|COMPLETED|Overall Study||44
520727|NCT00075478|1254900|P1|COMPLETED|Overall Study||41
520728|NCT00075478|1254899|P2|STARTED|Overall Study||45
520729|NCT00075478|1254900|P1|STARTED|Overall Study||42
520730|NCT00075400|1254920|P1|NOT COMPLETED|Overall Study||3
520731|NCT00075400|1254920|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
520732|NCT00075400|1254920|P1|STARTED|Overall Study||26
520733|NCT00075270|1254928|P2|NOT COMPLETED|Overall Study||284
520734|NCT00075270|1254929|P1|NOT COMPLETED|Overall Study||286
520735|NCT00075270|1254928|P2|COMPLETED|Overall Study||4
520736|NCT00075270|1254929|P1|COMPLETED|Overall Study||5
520737|NCT00075270|1254928|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
520738|NCT00075270|1254929|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
520739|NCT00075270|1254928|P2|STARTED|Overall Study||288
520740|NCT00075270|1254929|P1|STARTED|Overall Study||291
520741|NCT00075218|1254975|P3|NOT COMPLETED|Open-Label Treatment||255
520742|NCT00075218|1254976|P2|NOT COMPLETED|Open-Label Treatment||0
520743|NCT00075218|1254977|P1|NOT COMPLETED|Open-Label Treatment||0
520744|NCT00075218|1254975|P3|COMPLETED|Open-Label Treatment||0
520745|NCT00075218|1254976|P2|COMPLETED|Open-Label Treatment||0
520746|NCT00075218|1254977|P1|COMPLETED|Open-Label Treatment||0
520747|NCT00075218|1254975|P3|STARTED|Open-Label Treatment||255
520748|NCT00075218|1254976|P2|STARTED|Open-Label Treatment||0
520749|NCT00075218|1254977|P1|STARTED|Open-Label Treatment||0
520750|NCT00075218|1254975|P3|NOT COMPLETED|Double-Blind Treatment||0
520751|NCT00075218|1254976|P2|NOT COMPLETED|Double-Blind Treatment||15
520752|NCT00075218|1254977|P1|NOT COMPLETED|Double-Blind Treatment||91
520753|NCT00075218|1254975|P3|COMPLETED|Double-Blind Treatment||0
520754|NCT00075218|1254976|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
520755|NCT00075218|1254977|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
520756|NCT00075218|1254975|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
520757|NCT00075218|1254976|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
520758|NCT00075218|1254977|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
520759|NCT00075218|1254975|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
520760|NCT00075218|1254976|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
520761|NCT00075218|1254977|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
520762|NCT00075218|1254975|P3|STARTED|Double-Blind Treatment||0
520763|NCT00075218|1254976|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
520764|NCT00075218|1254977|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
520765|NCT00075088|1255012|P2|NOT COMPLETED|Overall Study||0
520766|NCT00075088|1255013|P1|NOT COMPLETED|Overall Study||0
520767|NCT00075088|1255012|P2|COMPLETED|Overall Study||391
520768|NCT00075088|1255013|P1|COMPLETED|Overall Study||403
520769|NCT00075088|1255012|P2|STARTED|Overall Study||391
520770|NCT00075088|1255013|P1|STARTED|Overall Study||403
520771|NCT00075023|1255026|P2|NOT COMPLETED|Part Two||0
520772|NCT00075023|1255027|P1|NOT COMPLETED|Part Two||0
520773|NCT00075023|1255026|P2|COMPLETED|Part Two||0
520774|NCT00075023|1255027|P1|COMPLETED|Part Two||0
520775|NCT00075023|1255026|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
520776|NCT00075023|1255027|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
520777|NCT00075023|1255026|P2|NOT COMPLETED|Pilot Study||2
520778|NCT00075023|1255027|P1|NOT COMPLETED|Pilot Study||2
520779|NCT00075023|1255026|P2|COMPLETED|Pilot Study||3
520780|NCT00075023|1255027|P1|COMPLETED|Pilot Study||3
520781|NCT00075023|1255026|P2|STARTED|Pilot Study||5
520782|NCT00075023|1255027|P1|STARTED|Pilot Study||5
520783|NCT00074984|1255036|P2|NOT COMPLETED|Overall Study||8
520784|NCT00074984|1255037|P1|NOT COMPLETED|Overall Study||3
520785|NCT00074984|1255036|P2|COMPLETED|Overall Study||43
520786|NCT00074984|1255037|P1|COMPLETED|Overall Study||28
520787|NCT00074984|1255036|P2|STARTED|Overall Study||51
520788|NCT00074984|1255037|P1|STARTED|Overall Study||31
520789|NCT00074958|1255052|P1|NOT COMPLETED|Overall Study||1
520790|NCT00074958|1255052|P1|COMPLETED|Overall Study||15
520791|NCT00074958|1255052|P1|STARTED|Overall Study||16
520792|NCT00074815|1255060|P3|NOT COMPLETED|Overall Study||12
520793|NCT00074815|1255061|P2|NOT COMPLETED|Overall Study||6
520794|NCT00074815|1255062|P1|NOT COMPLETED|Overall Study||5
520795|NCT00074815|1255060|P3|COMPLETED|Overall Study||30
520796|NCT00074815|1255061|P2|COMPLETED|Overall Study||34
520797|NCT00074815|1255062|P1|COMPLETED|Overall Study||37
520798|NCT00074815|1255060|P3|STARTED|Overall Study||42
520799|NCT00074815|1255061|P2|STARTED|Overall Study||40
520800|NCT00074815|1255062|P1|STARTED|Overall Study||42
520801|NCT00074802|1255072|P2|NOT COMPLETED|Overall Study||7
520802|NCT00074802|1255073|P1|NOT COMPLETED|Overall Study||9
520803|NCT00074802|1255072|P2|COMPLETED|Overall Study||25
520804|NCT00074802|1255073|P1|COMPLETED|Overall Study||20
520805|NCT00074802|1255072|P2|STARTED|Overall Study||32
520806|NCT00074802|1255073|P1|STARTED|Overall Study||29
520807|NCT00074711|1255093|P2|NOT COMPLETED|Overall Study||15
520808|NCT00074711|1255094|P1|NOT COMPLETED|Overall Study||15
520809|NCT00074711|1255093|P2|COMPLETED|Overall Study||106
520810|NCT00074711|1255094|P1|COMPLETED|Overall Study||105
520811|NCT00074711|1255093|P2|STARTED|Overall Study||121
520812|NCT00074711|1255094|P1|STARTED|Overall Study||120
520813|NCT00074581|1255112|P2|NOT COMPLETED|Overall Study||226
520814|NCT00074581|1255113|P1|NOT COMPLETED|Overall Study||244
520815|NCT00074581|1255112|P2|COMPLETED|Overall Study||1541
520816|NCT00074581|1255113|P1|COMPLETED|Overall Study||1545
520817|NCT00074581|1255112|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
520818|NCT00074581|1255113|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
520819|NCT00074412|1255123|P2|NOT COMPLETED|Overall Study||84
520820|NCT00074412|1255124|P1|NOT COMPLETED|Overall Study||82
520821|NCT00074412|1255123|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
520822|NCT00074412|1255124|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
520823|NCT00074412|1255123|P2|Month 12 Visit|Overall Study||735
520824|NCT00074412|1255124|P1|Month 12 Visit|Overall Study||733
520825|NCT00074412|1255123|P2|Month 9 Visit|Overall Study||741
520826|NCT00074412|1255124|P1|Month 9 Visit|Overall Study||741
520827|NCT00074412|1255123|P2|Month 6 Visit|Overall Study||748
520828|NCT00074412|1255124|P1|Month 6 Visit|Overall Study||748
520829|NCT00074412|1255123|P2|Month 5 Visit|Overall Study||750
520830|NCT00074412|1255124|P1|Month 5 Visit|Overall Study||756
520831|NCT00074412|1255123|P2|Month 4 Visit|Overall Study||752
520832|NCT00074412|1255124|P1|Month 4 Visit|Overall Study||758
520833|NCT00074412|1255123|P2|Month 3 Visit|Overall Study||755
520834|NCT00074412|1255124|P1|Month 3 Visit|Overall Study||759
520835|NCT00074412|1255123|P2|Week 8 Visit|Overall Study||759
520836|NCT00074412|1255124|P1|Week 8 Visit|Overall Study||759
520837|NCT00074412|1255123|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
520838|NCT00074412|1255124|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
520839|NCT00074269|1255138|P1|NOT COMPLETED|Overall Study||0
520840|NCT00074269|1255138|P1|COMPLETED|Overall Study||5
520841|NCT00074269|1255138|P1|STARTED|Overall Study||5
520842|NCT00074165|1255142|P1|NOT COMPLETED|Overall Study||0
520843|NCT00074165|1255142|P1|COMPLETED|Overall Study||17
520844|NCT00074165|1255142|P1|STARTED|Overall Study||17
520845|NCT00074152|1255149|P2|NOT COMPLETED|Overall Study||33
520846|NCT00074152|1255150|P1|NOT COMPLETED|Overall Study||55
520847|NCT00074152|1255149|P2|COMPLETED|Overall Study||52
520848|NCT00074152|1255150|P1|COMPLETED|Overall Study||22
520849|NCT00074152|1255149|P2|STARTED|Overall Study||85
520850|NCT00074152|1255150|P1|STARTED|Overall Study||77
520851|NCT00074035|1255160|P1|NOT COMPLETED|Overall Study||0
520852|NCT00074035|1255160|P1|COMPLETED|Overall Study||38
520853|NCT00074035|1255160|P1|STARTED|Overall Study||38
520854|NCT00073983|1255167|P1|NOT COMPLETED|Overall Study||1
520855|NCT00073983|1255167|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
520856|NCT00073983|1255167|P1|STARTED|Overall Study||54
520857|NCT00073918|1255182|P1|NOT COMPLETED|Overall Study||4
520858|NCT00073918|1255182|P1|COMPLETED|Overall Study||107
520859|NCT00073918|1255182|P1|STARTED|Overall Study||111
520860|NCT00073528|1255189|P2|NOT COMPLETED|Overall Study||642
520861|NCT00073528|1255190|P1|NOT COMPLETED|Overall Study||644
520862|NCT00073528|1255189|P2|COMPLETED|Overall Study||0
520863|NCT00073528|1255190|P1|COMPLETED|Overall Study||0
520864|NCT00073528|1255189|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
520865|NCT00073528|1255190|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
520866|NCT00073528|1255189|P2|STARTED|Overall Study||642
520867|NCT00073528|1255190|P1|STARTED|Overall Study||644
520868|NCT00073333|1255267|P3|NOT COMPLETED|Overall Study||0
520869|NCT00073333|1255268|P2|NOT COMPLETED|Overall Study||14
520870|NCT00073333|1255269|P1|NOT COMPLETED|Overall Study||14
520871|NCT00073333|1255267|P3|COMPLETED|Overall Study||19
520872|NCT00073333|1255268|P2|COMPLETED|Overall Study||27
520873|NCT00073333|1255269|P1|COMPLETED|Overall Study||32
520874|NCT00073333|1255267|P3|STARTED|Overall Study||19
520875|NCT00073333|1255268|P2|STARTED|Overall Study||41
520876|NCT00073333|1255269|P1|STARTED|Overall Study||46
520877|NCT00073307|1255279|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
520878|NCT00073307|1255280|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
520879|NCT00073307|1255281|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
520880|NCT00073307|1255279|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
520881|NCT00073307|1255280|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
520882|NCT00073307|1255281|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
520883|NCT00073307|1255279|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
520884|NCT00073307|1255280|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
520885|NCT00073307|1255281|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
520886|NCT00073307|1255279|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
520887|NCT00073307|1255280|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
520888|NCT00073307|1255281|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
520889|NCT00073307|1255279|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
520890|NCT00073307|1255280|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
520891|NCT00073307|1255281|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
520892|NCT00073307|1255279|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
520893|NCT00073307|1255280|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
520894|NCT00073307|1255281|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
520895|NCT00073307|1255279|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
520896|NCT00073307|1255280|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
520897|NCT00073307|1255281|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
520898|NCT00073307|1255279|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
520899|NCT00073307|1255280|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
520900|NCT00073307|1255281|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
520901|NCT00073073|1255299|P1|NOT COMPLETED|Overall Study||4
520902|NCT00073073|1255299|P1|COMPLETED|Overall Study||42
520903|NCT00073073|1255299|P1|STARTED|Overall Study||46
520904|NCT00073021|1255312|P2|NOT COMPLETED|Overall Study||16
520905|NCT00073021|1255313|P1|NOT COMPLETED|Overall Study||26
520906|NCT00073021|1255312|P2|COMPLETED|Overall Study||113
520907|NCT00073021|1255313|P1|COMPLETED|Overall Study||113
520908|NCT00073021|1255312|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
520909|NCT00073021|1255313|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
520910|NCT00073008|1255343|P2|NOT COMPLETED|Overall Study||63
520911|NCT00073008|1255344|P1|NOT COMPLETED|Overall Study||62
520912|NCT00073008|1255343|P2|COMPLETED|Overall Study||3
520913|NCT00073008|1255344|P1|COMPLETED|Overall Study||3
520914|NCT00073008|1255343|P2|STARTED|Overall Study||66
520915|NCT00073008|1255344|P1|STARTED|Overall Study||65
520916|NCT00072761|1255376|P2|NOT COMPLETED|Overall Study||2
520917|NCT00072761|1255377|P1|NOT COMPLETED|Overall Study||9
520918|NCT00072761|1255376|P2|COMPLETED|Overall Study||95
520919|NCT00072761|1255377|P1|COMPLETED|Overall Study||90
520920|NCT00072761|1255376|P2|STARTED|Overall Study||97
520921|NCT00072761|1255377|P1|STARTED|Overall Study||99
520922|NCT00072566|1255383|P1|NOT COMPLETED|Overall Study||0
520923|NCT00072566|1255383|P1|COMPLETED|Overall Study||70
520924|NCT00072566|1255383|P1|STARTED|Overall Study||70
520925|NCT00072475|1255389|P1|NOT COMPLETED|Overall Study||97
520926|NCT00072475|1255389|P1|COMPLETED|Overall Study||45
520927|NCT00072475|1255389|P1|STARTED|Overall Study||142
520928|NCT00072449|1255397|P1|NOT COMPLETED|Overall Study||0
520929|NCT00072449|1255397|P1|COMPLETED|Overall Study||12
520930|NCT00072449|1255397|P1|STARTED|Overall Study||12
520931|NCT00072293|1255406|P2|NOT COMPLETED|Overall Study||2
520932|NCT00072293|1255407|P1|NOT COMPLETED|Overall Study||1
520933|NCT00072293|1255406|P2|COMPLETED|Overall Study||467
520934|NCT00072293|1255407|P1|COMPLETED|Overall Study||464
520935|NCT00072293|1255406|P2|STARTED|Overall Study||469
520936|NCT00072293|1255407|P1|STARTED|Overall Study||465
520937|NCT00072280|1255419|P2|NOT COMPLETED|Follow-up||2
520938|NCT00072280|1255420|P1|NOT COMPLETED|Follow-up||2
520939|NCT00072280|1255419|P2|COMPLETED|Follow-up||0
520940|NCT00072280|1255420|P1|COMPLETED|Follow-up||0
520941|NCT00072280|1255419|P2|STARTED|Follow-up||2
520942|NCT00072280|1255420|P1|STARTED|Follow-up||2
520943|NCT00072280|1255419|P2|NOT COMPLETED|Treatment||2
520944|NCT00072280|1255420|P1|NOT COMPLETED|Treatment||1
520945|NCT00072280|1255419|P2|COMPLETED|Treatment||2
520946|NCT00072280|1255420|P1|COMPLETED|Treatment||2
520947|NCT00072280|1255419|P2|STARTED|Treatment||4
520948|NCT00072280|1255420|P1|STARTED|Treatment||3
520949|NCT00072189|1255425|P1|NOT COMPLETED|Overall Study||1
520950|NCT00072189|1255425|P1|COMPLETED|Overall Study||16
520951|NCT00072189|1255425|P1|STARTED|Overall Study||17
520952|NCT00072176|1255433|P2|NOT COMPLETED|Overall Study||1
520953|NCT00072176|1255434|P1|NOT COMPLETED|Overall Study||1
520954|NCT00072176|1255433|P2|COMPLETED|Overall Study||27
520955|NCT00072176|1255434|P1|COMPLETED|Overall Study||33
520956|NCT00072176|1255433|P2|STARTED|Overall Study||28
520957|NCT00072176|1255434|P1|STARTED|Overall Study||34
520958|NCT00071981|1255446|P4|NOT COMPLETED|Overall Study||45
520959|NCT00071981|1255447|P3|NOT COMPLETED|Overall Study||37
520960|NCT00071981|1255448|P2|NOT COMPLETED|Overall Study||41
520961|NCT00071981|1255449|P1|NOT COMPLETED|Overall Study||46
520962|NCT00071981|1255446|P4|COMPLETED|Overall Study||3
520963|NCT00071981|1255447|P3|COMPLETED|Overall Study||0
520964|NCT00071981|1255448|P2|COMPLETED|Overall Study||2
520965|NCT00071981|1255449|P1|COMPLETED|Overall Study||1
520966|NCT00071981|1255446|P4|Have Helper T Cell Response Data|Overall Study||39
520967|NCT00071981|1255447|P3|Have Helper T Cell Response Data|Overall Study||25
520968|NCT00071981|1255448|P2|Have Helper T Cell Response Data|Overall Study||27
520969|NCT00071981|1255449|P1|Have Helper T Cell Response Data|Overall Study||37
520970|NCT00071981|1255446|P4|Have CTL Response Data|Overall Study||41
520971|NCT00071981|1255447|P3|Have CTL Response Data|Overall Study||29
520972|NCT00071981|1255448|P2|Have CTL Response Data|Overall Study||30
520973|NCT00071981|1255449|P1|Have CTL Response Data|Overall Study||40
520974|NCT00071981|1255446|P4|Eligible and Treated|Overall Study||42
520975|NCT00071981|1255447|P3|Eligible and Treated|Overall Study||32
520976|NCT00071981|1255448|P2|Eligible and Treated|Overall Study||33
520977|NCT00071981|1255449|P1|Eligible and Treated|Overall Study||41
520978|NCT00071981|1255446|P4|Treated|Overall Study||48
520979|NCT00071981|1255447|P3|Treated|Overall Study||36
520980|NCT00071981|1255448|P2|Treated|Overall Study||38
520981|NCT00071981|1255449|P1|Treated|Overall Study||45
520982|NCT00071981|1255446|P4|Eligible|Overall Study||42
520983|NCT00071981|1255447|P3|Eligible|Overall Study||33
520984|NCT00071981|1255448|P2|Eligible|Overall Study||36
520985|NCT00071981|1255449|P1|Eligible|Overall Study||43
520986|NCT00071981|1255446|P4|STARTED|Overall Study||48
520987|NCT00071981|1255447|P3|STARTED|Overall Study||37
520988|NCT00071981|1255448|P2|STARTED|Overall Study||43
520989|NCT00071981|1255449|P1|STARTED|Overall Study||47
520990|NCT00071890|1255477|P2|NOT COMPLETED|Overall Study||0
520991|NCT00071890|1255478|P1|NOT COMPLETED|Overall Study||0
520992|NCT00071890|1255477|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
520993|NCT00071890|1255478|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
520994|NCT00071890|1255477|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
520995|NCT00071890|1255478|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
520996|NCT00071812|1255492|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
520997|NCT00071812|1255493|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
520998|NCT00071812|1255494|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
520999|NCT00071812|1255495|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
521000|NCT00071812|1255492|P4|COMPLETED|24-Week Open-Label Extension Period||178
521001|NCT00071812|1255493|P3|COMPLETED|24-Week Open-Label Extension Period||7
521002|NCT00071812|1255494|P2|COMPLETED|24-Week Open-Label Extension Period||11
521003|NCT00071812|1255495|P1|COMPLETED|24-Week Open-Label Extension Period||0
521004|NCT00071812|1255492|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
521005|NCT00071812|1255493|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
521006|NCT00071812|1255494|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
521007|NCT00071812|1255495|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
521008|NCT00071812|1255492|P4|NOT COMPLETED|24-Week Double-Blind Period||11
521009|NCT00071812|1255493|P3|NOT COMPLETED|24-Week Double-Blind Period||8
521010|NCT00071812|1255494|P2|NOT COMPLETED|24-Week Double-Blind Period||6
521011|NCT00071812|1255495|P1|NOT COMPLETED|24-Week Double-Blind Period||10
521012|NCT00071812|1255492|P4|COMPLETED|24-Week Double-Blind Period||60
521013|NCT00071812|1255493|P3|COMPLETED|24-Week Double-Blind Period||63
521014|NCT00071812|1255494|P2|COMPLETED|24-Week Double-Blind Period||66
521015|NCT00071812|1255495|P1|COMPLETED|24-Week Double-Blind Period||59
521016|NCT00071812|1255492|P4|STARTED|24-Week Double-Blind Period||71
521017|NCT00071812|1255493|P3|STARTED|24-Week Double-Blind Period||71
521018|NCT00071812|1255494|P2|STARTED|24-Week Double-Blind Period||72
521019|NCT00071812|1255495|P1|STARTED|24-Week Double-Blind Period||69
521020|NCT00071799|1255537|P2|NOT COMPLETED|Overall Study||98
521021|NCT00071799|1255538|P1|NOT COMPLETED|Overall Study||70
521022|NCT00071799|1255537|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
521023|NCT00071799|1255538|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
521024|NCT00071799|1255537|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
521025|NCT00071799|1255538|P1|STARTED|Overall Study||179
521026|NCT00071760|1255578|P1|NOT COMPLETED|Overall Study||54
521027|NCT00071760|1255578|P1|COMPLETED|Overall Study||0
521028|NCT00071760|1255578|P1|Ongoing|Overall Study||25
521029|NCT00071760|1255578|P1|STARTED|Overall Study||54
521030|NCT00071721|1255639|P2|NOT COMPLETED|Overall Study||91
521031|NCT00071721|1255640|P1|NOT COMPLETED|Overall Study||72
521032|NCT00071721|1255639|P2|COMPLETED|Overall Study||69
521033|NCT00071721|1255640|P1|COMPLETED|Overall Study||81
521034|NCT00071721|1255639|P2|STARTED|Overall Study||160
521035|NCT00071721|1255640|P1|STARTED|Overall Study||153
521036|NCT00071513|1255658|P2|NOT COMPLETED|Follow-up Assessment||6
521037|NCT00071513|1255659|P1|NOT COMPLETED|Follow-up Assessment||6
521038|NCT00071513|1255658|P2|COMPLETED|Follow-up Assessment||247
521039|NCT00071513|1255659|P1|COMPLETED|Follow-up Assessment||233
521040|NCT00071513|1255658|P2|STARTED|Follow-up Assessment||253
521041|NCT00071513|1255659|P1|STARTED|Follow-up Assessment||239
521042|NCT00071513|1255658|P2|NOT COMPLETED|Intervention Component||3
521043|NCT00071513|1255659|P1|NOT COMPLETED|Intervention Component||2
521044|NCT00071513|1255658|P2|COMPLETED|Intervention Component||253
521045|NCT00071513|1255659|P1|COMPLETED|Intervention Component||239
521046|NCT00071513|1255658|P2|STARTED|Intervention Component||256
521047|NCT00071513|1255659|P1|STARTED|Intervention Component||241
521048|NCT00071487|1255671|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
521049|NCT00071487|1255672|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
521050|NCT00071487|1255673|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
521051|NCT00071487|1255674|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
521052|NCT00071487|1255671|P4|COMPLETED|24-Week Open-Label Extension Period||279
521053|NCT00071487|1255672|P3|COMPLETED|24-Week Open-Label Extension Period||23
521054|NCT00071487|1255673|P2|COMPLETED|24-Week Open-Label Extension Period||19
521055|NCT00071487|1255674|P1|COMPLETED|24-Week Open-Label Extension Period||0
521056|NCT00071487|1255671|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
521057|NCT00071487|1255672|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
521058|NCT00071487|1255673|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
521059|NCT00071487|1255674|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
521060|NCT00071487|1255671|P4|NOT COMPLETED|52-Week Double-Blind Period||21
521061|NCT00071487|1255672|P3|NOT COMPLETED|52-Week Double-Blind Period||17
521062|NCT00071487|1255673|P2|NOT COMPLETED|52-Week Double-Blind Period||27
521063|NCT00071487|1255674|P1|NOT COMPLETED|52-Week Double-Blind Period||20
521064|NCT00071487|1255671|P4|COMPLETED|52-Week Double-Blind Period||90
521065|NCT00071487|1255672|P3|COMPLETED|52-Week Double-Blind Period||94
521066|NCT00071487|1255673|P2|COMPLETED|52-Week Double-Blind Period||87
521067|NCT00071487|1255674|P1|COMPLETED|52-Week Double-Blind Period||93
521068|NCT00071487|1255671|P4|STARTED|52-Week Double-Blind Period||111
521069|NCT00071487|1255672|P3|STARTED|52-Week Double-Blind Period||111
521070|NCT00071487|1255673|P2|STARTED|52-Week Double-Blind Period||114
521071|NCT00071487|1255674|P1|STARTED|52-Week Double-Blind Period||113
521072|NCT00071396|1255718|P1|NOT COMPLETED|Overall Study||3
521073|NCT00071396|1255718|P1|COMPLETED|Overall Study|Evaluable for response.|41
521074|NCT00071396|1255718|P1|STARTED|Overall Study||44
521075|NCT00071110|1255724|P2|NOT COMPLETED|Overall Study||4
521076|NCT00071110|1255725|P1|NOT COMPLETED|Overall Study||0
521077|NCT00071110|1255724|P2|COMPLETED|Overall Study||25
521078|NCT00071110|1255725|P1|COMPLETED|Overall Study||28
521079|NCT00071110|1255724|P2|STARTED|Overall Study||29
521080|NCT00071110|1255725|P1|STARTED|Overall Study||28
521081|NCT00071058|1255737|P1|NOT COMPLETED|Overall Study||1
521082|NCT00071058|1255737|P1|COMPLETED|Overall Study||49
521083|NCT00071058|1255737|P1|STARTED|Overall Study||50
521084|NCT00071032|1255744|P2|NOT COMPLETED|Overall Study||8
521085|NCT00071032|1255745|P1|NOT COMPLETED|Overall Study||9
521086|NCT00071032|1255744|P2|COMPLETED|Overall Study||1001
521087|NCT00071032|1255745|P1|COMPLETED|Overall Study||998
521088|NCT00071032|1255744|P2|STARTED|Overall Study||1009
521089|NCT00071032|1255745|P1|STARTED|Overall Study||1007
521090|NCT00071006|1255753|P1|NOT COMPLETED|Overall Study||12
521091|NCT00071006|1255753|P1|COMPLETED|Overall Study||0
521092|NCT00071006|1255753|P1|STARTED|Overall Study||12
521093|NCT00070941|1255766|P3|NOT COMPLETED|Overall Study||4
521094|NCT00070941|1255767|P2|NOT COMPLETED|Overall Study||8
521095|NCT00070941|1255768|P1|NOT COMPLETED|Overall Study||10
521096|NCT00070941|1255766|P3|COMPLETED|Overall Study||2
521097|NCT00070941|1255767|P2|COMPLETED|Overall Study||3
521098|NCT00070941|1255768|P1|COMPLETED|Overall Study||2
521099|NCT00070941|1255766|P3|STARTED|Overall Study||6
521100|NCT00070941|1255767|P2|STARTED|Overall Study||11
521101|NCT00070941|1255768|P1|STARTED|Overall Study||12
521102|NCT00070564|1255780|P6|NOT COMPLETED|Overall Study||52
521103|NCT00070564|1255781|P5|NOT COMPLETED|Overall Study||79
521104|NCT00070564|1255782|P4|NOT COMPLETED|Overall Study||167
521105|NCT00070564|1255783|P3|NOT COMPLETED|Overall Study||171
521106|NCT00070564|1255784|P2|NOT COMPLETED|Overall Study||203
521107|NCT00070564|1255785|P1|NOT COMPLETED|Overall Study||200
521108|NCT00070564|1255780|P6|COMPLETED|Overall Study||244
521109|NCT00070564|1255781|P5|COMPLETED|Overall Study||203
521110|NCT00070564|1255782|P4|COMPLETED|Overall Study||481
521111|NCT00070564|1255783|P3|COMPLETED|Overall Study||526
521112|NCT00070564|1255784|P2|COMPLETED|Overall Study||490
521113|NCT00070564|1255785|P1|COMPLETED|Overall Study||478
521114|NCT00070564|1255780|P6|STARTED|Overall Study||296
521115|NCT00070564|1255781|P5|STARTED|Overall Study||282
521116|NCT00070564|1255782|P4|STARTED|Overall Study||648
521117|NCT00070564|1255783|P3|STARTED|Overall Study||697
521118|NCT00070564|1255784|P2|STARTED|Overall Study||693
521119|NCT00070564|1255785|P1|STARTED|Overall Study||678
521120|NCT00070499|1255831|P4|NOT COMPLETED|Overall Study||110
521121|NCT00070499|1255832|P3|NOT COMPLETED|Overall Study||120
521122|NCT00070499|1255833|P2|NOT COMPLETED|Overall Study||26
521123|NCT00070499|1255834|P1|NOT COMPLETED|Overall Study||38
521124|NCT00070499|1255831|P4|COMPLETED|Overall Study||17
521125|NCT00070499|1255832|P3|COMPLETED|Overall Study||6
521126|NCT00070499|1255833|P2|COMPLETED|Overall Study||52
521127|NCT00070499|1255834|P1|COMPLETED|Overall Study||37
521128|NCT00070499|1255831|P4|Eligible and Treated|Overall Study||123
521129|NCT00070499|1255832|P3|Eligible and Treated|Overall Study||123
521130|NCT00070499|1255833|P2|Eligible and Treated|Overall Study||73
521131|NCT00070499|1255834|P1|Eligible and Treated|Overall Study||72
521132|NCT00070499|1255831|P4|Eligible|Overall Study||125
521133|NCT00070499|1255832|P3|Eligible|Overall Study||123
521134|NCT00070499|1255833|P2|Eligible|Overall Study||73
521135|NCT00070499|1255834|P1|Eligible|Overall Study||73
521136|NCT00070499|1255831|P4|STARTED|Overall Study||127
521137|NCT00070499|1255832|P3|STARTED|Overall Study||126
521138|NCT00070499|1255833|P2|STARTED|Overall Study||78
521139|NCT00070499|1255834|P1|STARTED|Overall Study||75
521140|NCT00070291|1255860|P1|NOT COMPLETED|Step 2||1
521141|NCT00070291|1255860|P1|COMPLETED|Step 2||0
521142|NCT00070291|1255860|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
521143|NCT00070291|1255860|P1|NOT COMPLETED|Step 1||2
521144|NCT00070291|1255860|P1|COMPLETED|Step 1||2
521145|NCT00070291|1255860|P1|Treated|Step 1||3
521146|NCT00070291|1255860|P1|STARTED|Step 1||4
521147|NCT00070135|1255865|P1|NOT COMPLETED|Overall Study||0
521148|NCT00070135|1255865|P1|COMPLETED|Overall Study||114
521149|NCT00070135|1255865|P1|STARTED|Overall Study||114
521150|NCT00070109|1255876|P5|NOT COMPLETED|Overall Study||8
521151|NCT00070109|1255877|P4|NOT COMPLETED|Overall Study||20
521152|NCT00070109|1255878|P3|NOT COMPLETED|Overall Study||8
521153|NCT00070109|1255879|P2|NOT COMPLETED|Overall Study||6
521154|NCT00070109|1255880|P1|NOT COMPLETED|Overall Study||8
521155|NCT00070109|1255876|P5|COMPLETED|Overall Study||0
521156|NCT00070109|1255877|P4|COMPLETED|Overall Study||0
521157|NCT00070109|1255878|P3|COMPLETED|Overall Study||0
521158|NCT00070109|1255879|P2|COMPLETED|Overall Study||0
521159|NCT00070109|1255880|P1|COMPLETED|Overall Study||0
521160|NCT00070109|1255876|P5|STARTED|Overall Study||8
521161|NCT00070109|1255877|P4|STARTED|Overall Study||20
521162|NCT00070109|1255878|P3|STARTED|Overall Study||8
521163|NCT00070109|1255879|P2|STARTED|Overall Study||6
521164|NCT00070109|1255880|P1|STARTED|Overall Study||8
521165|NCT00070018|1255893|P1|NOT COMPLETED|Overall Study||4
521166|NCT00070018|1255893|P1|COMPLETED|Overall Study||42
521167|NCT00070018|1255893|P1|Eligible and Began Protocol Therapy|Overall Study||46
521168|NCT00070018|1255893|P1|Eligible|Overall Study||46
521169|NCT00070018|1255893|P1|STARTED|Overall Study||46
521170|NCT00069953|1255897|P1|NOT COMPLETED|Overall Study||2
521171|NCT00069953|1255897|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
521172|NCT00069953|1255897|P1|STARTED|Overall Study||43
521173|NCT00069823|1255903|P2|NOT COMPLETED|Overall Study||3
521174|NCT00069823|1255904|P1|NOT COMPLETED|Overall Study||6
521175|NCT00069823|1255903|P2|COMPLETED|Overall Study||200
521176|NCT00069823|1255904|P1|COMPLETED|Overall Study||193
521177|NCT00069823|1255903|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
521178|NCT00069823|1255904|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
521179|NCT00069784|1255946|P2|NOT COMPLETED|Overall Study||0
521180|NCT00069784|1255947|P1|NOT COMPLETED|Overall Study||1212
521181|NCT00069784|1255946|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
521182|NCT00069784|1255947|P1|COMPLETED|Overall Study|completed study treatment|5052
521183|NCT00069784|1255946|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
521184|NCT00069784|1255947|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
521185|NCT00069784|1255946|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
521186|NCT00069784|1255947|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
521187|NCT00069641|1255968|P3|NOT COMPLETED|Overall Study||1
521188|NCT00069641|1255969|P2|NOT COMPLETED|Overall Study||0
521189|NCT00069641|1255970|P1|NOT COMPLETED|Overall Study||1
521190|NCT00069641|1255968|P3|COMPLETED|Overall Study||31
521191|NCT00069641|1255969|P2|COMPLETED|Overall Study||32
521192|NCT00069641|1255970|P1|COMPLETED|Overall Study||31
521193|NCT00069641|1255968|P3|STARTED|Overall Study||32
521194|NCT00069641|1255969|P2|STARTED|Overall Study||32
521195|NCT00069641|1255970|P1|STARTED|Overall Study||32
521196|NCT00069329|1255995|P1|NOT COMPLETED|Overall Study||2
521197|NCT00069329|1255995|P1|COMPLETED|Overall Study||41
521198|NCT00069329|1255995|P1|STARTED|Overall Study||43
521199|NCT00069277|1256019|P1|NOT COMPLETED|Overall Study||21
521200|NCT00069277|1256019|P1|COMPLETED|Overall Study||0
521201|NCT00069277|1256019|P1|STARTED|Overall Study||21
521202|NCT00069264|1256023|P1|NOT COMPLETED|Overall Study||32
521203|NCT00069264|1256023|P1|COMPLETED|Overall Study||0
521204|NCT00069264|1256023|P1|STARTED|Overall Study||32
521205|NCT00069238|1256027|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
521206|NCT00069238|1256028|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
521207|NCT00069238|1256029|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
521208|NCT00069238|1256027|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
521209|NCT00069238|1256028|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
521210|NCT00069238|1256029|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
521211|NCT00069238|1256027|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
521212|NCT00069238|1256028|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
521213|NCT00069238|1256029|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
521214|NCT00069238|1256027|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
521215|NCT00069238|1256028|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
521216|NCT00069238|1256029|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
521217|NCT00069238|1256027|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
521218|NCT00069238|1256028|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
521219|NCT00069238|1256029|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
521220|NCT00069238|1256027|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
521221|NCT00069238|1256028|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
521222|NCT00069238|1256029|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
521223|NCT00069238|1256027|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
521224|NCT00069238|1256028|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
521225|NCT00069238|1256029|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
521226|NCT00069238|1256027|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
521227|NCT00069238|1256028|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
521228|NCT00069238|1256029|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
521229|NCT00069238|1256027|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
521230|NCT00069238|1256028|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
521231|NCT00069238|1256029|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
521232|NCT00069160|1256036|P2|NOT COMPLETED|Overall Study||0
521233|NCT00069160|1256037|P1|NOT COMPLETED|Overall Study||0
521234|NCT00069160|1256036|P2|COMPLETED|Overall Study||25
521235|NCT00069160|1256037|P1|COMPLETED|Overall Study||23
521236|NCT00069160|1256036|P2|STARTED|Overall Study||25
521237|NCT00069160|1256037|P1|STARTED|Overall Study||23
521238|NCT00069121|1256052|P2|NOT COMPLETED|Overall Study||276
521239|NCT00069121|1256053|P1|NOT COMPLETED|Overall Study||302
521240|NCT00069121|1256052|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
521241|NCT00069121|1256053|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
521242|NCT00069121|1256052|P2|Received Treatment|Overall Study|Safety Population|938
521243|NCT00069121|1256053|P1|Received Treatment|Overall Study|Safety Population|926
521244|NCT00069121|1256052|P2|STARTED|Overall Study||944
521245|NCT00069121|1256053|P1|STARTED|Overall Study||942
521246|NCT00069108|1256075|P2|NOT COMPLETED|Overall Study||219
521247|NCT00069108|1256076|P1|NOT COMPLETED|Overall Study||213
521248|NCT00069108|1256075|P2|COMPLETED|Overall Study||95
521249|NCT00069108|1256076|P1|COMPLETED|Overall Study||100
521250|NCT00069108|1256075|P2|STARTED|Overall Study||314
521251|NCT00069108|1256076|P1|STARTED|Overall Study||313
521252|NCT00069095|1256108|P6|NOT COMPLETED|Follow-up Phase||101
521253|NCT00069095|1256109|P5|NOT COMPLETED|Follow-up Phase||92
521254|NCT00069095|1256110|P4|NOT COMPLETED|Follow-up Phase||112
521255|NCT00069095|1256111|P3|NOT COMPLETED|Follow-up Phase||120
521256|NCT00069095|1256112|P2|NOT COMPLETED|Follow-up Phase||206
521257|NCT00069095|1256113|P1|NOT COMPLETED|Follow-up Phase||174
521258|NCT00069095|1256108|P6|COMPLETED|Follow-up Phase||171
521259|NCT00069095|1256109|P5|COMPLETED|Follow-up Phase||186
521260|NCT00069095|1256110|P4|COMPLETED|Follow-up Phase||187
521261|NCT00069095|1256111|P3|COMPLETED|Follow-up Phase||178
521262|NCT00069095|1256112|P2|COMPLETED|Follow-up Phase||93
521263|NCT00069095|1256113|P1|COMPLETED|Follow-up Phase||110
521264|NCT00069095|1256108|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
521265|NCT00069095|1256109|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
521266|NCT00069095|1256110|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
521267|NCT00069095|1256111|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
521268|NCT00069095|1256112|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
521269|NCT00069095|1256113|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
521270|NCT00069095|1256108|P6|NOT COMPLETED|Post-study Treatment Phase||29
521271|NCT00069095|1256109|P5|NOT COMPLETED|Post-study Treatment Phase||36
521272|NCT00069095|1256110|P4|NOT COMPLETED|Post-study Treatment Phase||17
521273|NCT00069095|1256111|P3|NOT COMPLETED|Post-study Treatment Phase||21
521274|NCT00069095|1256112|P2|NOT COMPLETED|Post-study Treatment Phase||13
521275|NCT00069095|1256113|P1|NOT COMPLETED|Post-study Treatment Phase||8
521276|NCT00069095|1256108|P6|COMPLETED|Post-study Treatment Phase||0
521277|NCT00069095|1256109|P5|COMPLETED|Post-study Treatment Phase||0
521278|NCT00069095|1256110|P4|COMPLETED|Post-study Treatment Phase||0
521279|NCT00069095|1256111|P3|COMPLETED|Post-study Treatment Phase||0
521280|NCT00069095|1256112|P2|COMPLETED|Post-study Treatment Phase||0
521281|NCT00069095|1256113|P1|COMPLETED|Post-study Treatment Phase||0
521282|NCT00069095|1256108|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
521283|NCT00069095|1256109|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
521284|NCT00069095|1256110|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
521285|NCT00069095|1256111|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
521286|NCT00069095|1256112|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
521287|NCT00069095|1256113|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
521288|NCT00069095|1256108|P6|NOT COMPLETED|Primary Treatment Phase||301
521289|NCT00069095|1256109|P5|NOT COMPLETED|Primary Treatment Phase||302
521290|NCT00069095|1256110|P4|NOT COMPLETED|Primary Treatment Phase||320
521291|NCT00069095|1256111|P3|NOT COMPLETED|Primary Treatment Phase||314
521292|NCT00069095|1256112|P2|NOT COMPLETED|Primary Treatment Phase||302
521293|NCT00069095|1256113|P1|NOT COMPLETED|Primary Treatment Phase||295
521294|NCT00069095|1256108|P6|COMPLETED|Primary Treatment Phase||48
521295|NCT00069095|1256109|P5|COMPLETED|Primary Treatment Phase||48
521296|NCT00069095|1256110|P4|COMPLETED|Primary Treatment Phase||31
521297|NCT00069095|1256111|P3|COMPLETED|Primary Treatment Phase||36
521298|NCT00069095|1256112|P2|COMPLETED|Primary Treatment Phase||15
521299|NCT00069095|1256113|P1|COMPLETED|Primary Treatment Phase||22
521300|NCT00069095|1256108|P6|STARTED|Primary Treatment Phase||349
521301|NCT00069095|1256109|P5|STARTED|Primary Treatment Phase||350
521302|NCT00069095|1256110|P4|STARTED|Primary Treatment Phase||351
521303|NCT00069095|1256111|P3|STARTED|Primary Treatment Phase||350
521304|NCT00069095|1256112|P2|STARTED|Primary Treatment Phase||317
521305|NCT00069095|1256113|P1|STARTED|Primary Treatment Phase||317
521306|NCT00068822|1256167|P2|NOT COMPLETED|Optional Crossover Intervention||0
521307|NCT00068822|1256168|P1|NOT COMPLETED|Optional Crossover Intervention||0
521308|NCT00068822|1256167|P2|COMPLETED|Optional Crossover Intervention||29
521309|NCT00068822|1256168|P1|COMPLETED|Optional Crossover Intervention||9
521310|NCT00068822|1256167|P2|Crossover at Month 3|Optional Crossover Intervention||27
521311|NCT00068822|1256168|P1|Crossover at Month 3|Optional Crossover Intervention||8
521312|NCT00068822|1256167|P2|Crossover at Month 1|Optional Crossover Intervention||2
521313|NCT00068822|1256168|P1|Crossover at Month 1|Optional Crossover Intervention||1
521314|NCT00068822|1256167|P2|STARTED|Optional Crossover Intervention||29
521315|NCT00068822|1256168|P1|STARTED|Optional Crossover Intervention||9
521316|NCT00068822|1256167|P2|NOT COMPLETED|First Randomized Intervention||2
521317|NCT00068822|1256168|P1|NOT COMPLETED|First Randomized Intervention||1
521318|NCT00068822|1256167|P2|COMPLETED|First Randomized Intervention||61
521319|NCT00068822|1256168|P1|COMPLETED|First Randomized Intervention||67
521320|NCT00068822|1256167|P2|STARTED|First Randomized Intervention||63
521321|NCT00068822|1256168|P1|STARTED|First Randomized Intervention||68
521322|NCT00068770|1256180|P2|NOT COMPLETED|Overall Study||0
521323|NCT00068770|1256181|P1|NOT COMPLETED|Overall Study||0
521324|NCT00068770|1256180|P2|COMPLETED|Overall Study||22
521325|NCT00068770|1256181|P1|COMPLETED|Overall Study||13
521326|NCT00068770|1256180|P2|STARTED|Overall Study||22
521327|NCT00068770|1256181|P1|STARTED|Overall Study||13
521328|NCT00068718|1256189|P1|NOT COMPLETED|Overall Study||0
521329|NCT00068718|1256189|P1|COMPLETED|Overall Study||35
521330|NCT00068718|1256189|P1|STARTED|Overall Study||35
521331|NCT00068601|1256201|P2|NOT COMPLETED|Overall Study||60
521332|NCT00068601|1256202|P1|NOT COMPLETED|Overall Study||62
521333|NCT00068601|1256201|P2|COMPLETED|Overall Study||66
521334|NCT00068601|1256202|P1|COMPLETED|Overall Study||69
521335|NCT00068601|1256201|P2|STARTED|Overall Study||126
521336|NCT00068601|1256202|P1|STARTED|Overall Study||131
521337|NCT00068588|1256215|P3|NOT COMPLETED|Overall Study||4
521338|NCT00068588|1256216|P2|NOT COMPLETED|Overall Study||0
521339|NCT00068588|1256217|P1|NOT COMPLETED|Overall Study||0
521340|NCT00068588|1256215|P3|COMPLETED|Overall Study||17
521341|NCT00068588|1256216|P2|COMPLETED|Overall Study||3
521342|NCT00068588|1256217|P1|COMPLETED|Overall Study||0
521343|NCT00068588|1256215|P3|STARTED|Overall Study||21
521344|NCT00068588|1256216|P2|STARTED|Overall Study||3
521345|NCT00068588|1256217|P1|STARTED|Overall Study||0
521346|NCT00068575|1256227|P1|NOT COMPLETED|Overall Study||0
521347|NCT00068575|1256227|P1|COMPLETED|Overall Study||28
521348|NCT00068575|1256227|P1|STARTED|Overall Study||28
521349|NCT00068419|1256231|P1|NOT COMPLETED|Overall Study||60
521350|NCT00068419|1256231|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
521351|NCT00068419|1256231|P1|STARTED|Overall Study||70
521352|NCT00068393|1256235|P1|NOT COMPLETED|Overall Study||10
521353|NCT00068393|1256235|P1|COMPLETED|Overall Study||29
521354|NCT00068393|1256235|P1|Eligible and Treated|Overall Study||38
521355|NCT00068393|1256235|P1|STARTED|Overall Study||39
521356|NCT00068380|1256241|P1|NOT COMPLETED|Overall Study||5
521357|NCT00068380|1256241|P1|COMPLETED|Overall Study||12
521358|NCT00068380|1256241|P1|STARTED|Overall Study||17
521359|NCT00068341|1256248|P3|NOT COMPLETED|Overall Study||0
521360|NCT00068341|1256249|P2|NOT COMPLETED|Overall Study||0
521361|NCT00068341|1256250|P1|NOT COMPLETED|Overall Study||0
521362|NCT00068341|1256248|P3|COMPLETED|Overall Study||44
521363|NCT00068341|1256249|P2|COMPLETED|Overall Study||15
521364|NCT00068341|1256250|P1|COMPLETED|Overall Study||15
521365|NCT00068341|1256248|P3|STARTED|Overall Study||44
521366|NCT00068341|1256249|P2|STARTED|Overall Study||15
521367|NCT00068341|1256250|P1|STARTED|Overall Study||15
521368|NCT00068237|1256271|P1|NOT COMPLETED|Overall Study||5
521369|NCT00068237|1256271|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
521370|NCT00068237|1256271|P1|STARTED|Overall Study||49
521371|NCT00068107|1256275|P1|NOT COMPLETED|Overall Study||9
521372|NCT00068107|1256275|P1|COMPLETED|Overall Study||3
521373|NCT00068107|1256275|P1|STARTED|Overall Study||12
521374|NCT00067808|1256289|P3|NOT COMPLETED|Overall Study||0
521375|NCT00067808|1256290|P2|NOT COMPLETED|Overall Study||0
521376|NCT00067808|1256291|P1|NOT COMPLETED|Overall Study||0
521377|NCT00067808|1256289|P3|COMPLETED|Overall Study||14
521378|NCT00067808|1256290|P2|COMPLETED|Overall Study||93
521379|NCT00067808|1256291|P1|COMPLETED|Overall Study||17
521380|NCT00067808|1256289|P3|STARTED|Overall Study||14
521381|NCT00067808|1256290|P2|STARTED|Overall Study||93
521382|NCT00067808|1256291|P1|STARTED|Overall Study||17
521383|NCT00067470|1256301|P2|NOT COMPLETED|Overall Study||1
521384|NCT00067470|1256302|P1|NOT COMPLETED|Overall Study||0
521385|NCT00067470|1256301|P2|COMPLETED|Overall Study||19
521386|NCT00067470|1256302|P1|COMPLETED|Overall Study||19
521387|NCT00067470|1256301|P2|STARTED|Overall Study||20
521388|NCT00067470|1256302|P1|STARTED|Overall Study||19
521389|NCT00067236|1256314|P2|NOT COMPLETED|Overall Study||26
521390|NCT00067236|1256315|P1|NOT COMPLETED|Overall Study||20
521391|NCT00067236|1256314|P2|COMPLETED|Overall Study||99
521392|NCT00067236|1256315|P1|COMPLETED|Overall Study||108
521393|NCT00067236|1256314|P2|STARTED|Overall Study||125
521394|NCT00067236|1256315|P1|STARTED|Overall Study||128
521395|NCT00066963|1256324|P3|NOT COMPLETED|Overall Study||39
521396|NCT00066963|1256325|P2|NOT COMPLETED|Overall Study||31
521397|NCT00066963|1256326|P1|NOT COMPLETED|Overall Study||26
521398|NCT00066963|1256324|P3|COMPLETED|Overall Study||87
521399|NCT00066963|1256325|P2|COMPLETED|Overall Study||93
521400|NCT00066963|1256326|P1|COMPLETED|Overall Study|any follow-up|100
521401|NCT00066963|1256324|P3|STARTED|Overall Study||126
521402|NCT00066963|1256325|P2|STARTED|Overall Study||124
521403|NCT00066963|1256326|P1|STARTED|Overall Study||126
521404|NCT00066807|1256336|P2|NOT COMPLETED|Overall Study||15
521405|NCT00066807|1256337|P1|NOT COMPLETED|Overall Study||14
521406|NCT00066807|1256336|P2|COMPLETED|Overall Study||0
521407|NCT00066807|1256337|P1|COMPLETED|Overall Study||0
521408|NCT00066807|1256336|P2|STARTED|Overall Study||15
521409|NCT00066807|1256337|P1|STARTED|Overall Study||14
521410|NCT00066781|1256351|P2|NOT COMPLETED|Overall Study||0
521411|NCT00066781|1256352|P1|NOT COMPLETED|Overall Study||0
521412|NCT00066781|1256351|P2|COMPLETED|Overall Study||17
521413|NCT00066781|1256352|P1|COMPLETED|Overall Study||14
521414|NCT00066781|1256351|P2|STARTED|Overall Study||17
521415|NCT00066781|1256352|P1|STARTED|Overall Study||14
521416|NCT00066742|1256362|P1|NOT COMPLETED|Consolidation Chemotherapy||3
521417|NCT00066742|1256362|P1|COMPLETED|Consolidation Chemotherapy||39
521418|NCT00066742|1256362|P1|Eligible|Consolidation Chemotherapy||40
521419|NCT00066742|1256362|P1|STARTED|Consolidation Chemotherapy||42
521420|NCT00066742|1256362|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
521421|NCT00066742|1256362|P1|COMPLETED|Induction Chemoradiotherapy||43
521422|NCT00066742|1256362|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
521423|NCT00066742|1256362|P1|Eligible|Induction Chemoradiotherapy||69
521424|NCT00066742|1256362|P1|STARTED|Induction Chemoradiotherapy||72
521425|NCT00066703|1256371|P2|NOT COMPLETED|Overall Study||582
521426|NCT00066703|1256372|P1|NOT COMPLETED|Overall Study||612
521427|NCT00066703|1256371|P2|COMPLETED|Overall Study||756
521428|NCT00066703|1256372|P1|COMPLETED|Overall Study||722
521429|NCT00066703|1256371|P2|STARTED|Overall Study||1338
521430|NCT00066703|1256372|P1|STARTED|Overall Study||1334
521431|NCT00066690|1256385|P3|NOT COMPLETED|Overall Study||564
521432|NCT00066690|1256386|P2|NOT COMPLETED|Overall Study||522
521433|NCT00066690|1256387|P1|NOT COMPLETED|Overall Study||598
521434|NCT00066690|1256385|P3|COMPLETED|Overall Study||457
521435|NCT00066690|1256386|P2|COMPLETED|Overall Study||502
521436|NCT00066690|1256387|P1|COMPLETED|Overall Study||423
521437|NCT00066690|1256385|P3|STARTED|Overall Study||1021
521438|NCT00066690|1256386|P2|STARTED|Overall Study||1024
521439|NCT00066690|1256387|P1|STARTED|Overall Study||1021
521440|NCT00066573|1256403|P2|NOT COMPLETED|Overall Study||28
521441|NCT00066573|1256404|P1|NOT COMPLETED|Overall Study||28
521442|NCT00066573|1256403|P2|COMPLETED|Overall Study||3759
521443|NCT00066573|1256404|P1|COMPLETED|Overall Study||3761
521444|NCT00066573|1256403|P2|STARTED|Overall Study||3787
521445|NCT00066573|1256404|P1|STARTED|Overall Study||3789
521446|NCT00066469|1256410|P1|NOT COMPLETED|Overall Study||16
521447|NCT00066469|1256410|P1|COMPLETED|Overall Study||39
521448|NCT00066469|1256410|P1|STARTED|Overall Study||55
521449|NCT00066365|1256416|P2|NOT COMPLETED|Overall Study||14
521450|NCT00066365|1256417|P1|NOT COMPLETED|Overall Study||23
521451|NCT00066365|1256416|P2|COMPLETED|Overall Study||4
521452|NCT00066365|1256417|P1|COMPLETED|Overall Study||8
521453|NCT00066365|1256416|P2|STARTED|Overall Study||18
521454|NCT00066365|1256417|P1|STARTED|Overall Study||31
521455|NCT00066222|1256445|P1|NOT COMPLETED|Overall Study||1
521456|NCT00066222|1256445|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
521457|NCT00066222|1256445|P1|STARTED|Overall Study||72
521458|NCT00066170|1256453|P4|NOT COMPLETED|Overall Study||9
521459|NCT00066170|1256454|P3|NOT COMPLETED|Overall Study||4
521460|NCT00066170|1256455|P2|NOT COMPLETED|Overall Study||10
521461|NCT00066170|1256456|P1|NOT COMPLETED|Overall Study||7
521462|NCT00066170|1256453|P4|COMPLETED|Overall Study||48
521463|NCT00066170|1256454|P3|COMPLETED|Overall Study||59
521464|NCT00066170|1256455|P2|COMPLETED|Overall Study||45
521465|NCT00066170|1256456|P1|COMPLETED|Overall Study||49
521466|NCT00066170|1256453|P4|Intent to Treat|Overall Study||54
521467|NCT00066170|1256454|P3|Intent to Treat|Overall Study||63
521468|NCT00066170|1256455|P2|Intent to Treat|Overall Study||50
521469|NCT00066170|1256456|P1|Intent to Treat|Overall Study||55
521470|NCT00066170|1256453|P4|STARTED|Overall Study||57
521471|NCT00066170|1256454|P3|STARTED|Overall Study||63
521472|NCT00066170|1256455|P2|STARTED|Overall Study||55
521473|NCT00066170|1256456|P1|STARTED|Overall Study||56
521474|NCT00066066|1256469|P6|NOT COMPLETED|Overall Study||5
521475|NCT00066066|1256470|P5|NOT COMPLETED|Overall Study||3
521476|NCT00066066|1256471|P4|NOT COMPLETED|Overall Study||4
521477|NCT00066066|1256472|P3|NOT COMPLETED|Overall Study||7
521478|NCT00066066|1256473|P2|NOT COMPLETED|Overall Study||4
521479|NCT00066066|1256474|P1|NOT COMPLETED|Overall Study||6
521480|NCT00066066|1256469|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
521481|NCT00066066|1256470|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
521482|NCT00066066|1256471|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
521483|NCT00066066|1256472|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
521484|NCT00066066|1256473|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
521485|NCT00066066|1256474|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
521486|NCT00066066|1256469|P6|12 Month|Overall Study||9
521487|NCT00066066|1256470|P5|12 Month|Overall Study||19
521488|NCT00066066|1256471|P4|12 Month|Overall Study||11
521489|NCT00066066|1256472|P3|12 Month|Overall Study||21
521490|NCT00066066|1256473|P2|12 Month|Overall Study||11
521491|NCT00066066|1256474|P1|12 Month|Overall Study||18
521492|NCT00066066|1256469|P6|6 Month|Overall Study||14
521493|NCT00066066|1256470|P5|6 Month|Overall Study||21
521494|NCT00066066|1256471|P4|6 Month|Overall Study||13
521495|NCT00066066|1256472|P3|6 Month|Overall Study||23
521496|NCT00066066|1256473|P2|6 Month|Overall Study||13
521497|NCT00066066|1256474|P1|6 Month|Overall Study||19
521498|NCT00066066|1256469|P6|3 Month|Overall Study||15
521499|NCT00066066|1256470|P5|3 Month|Overall Study||22
521500|NCT00066066|1256471|P4|3 Month|Overall Study||16
521501|NCT00066066|1256472|P3|3 Month|Overall Study||23
521502|NCT00066066|1256473|P2|3 Month|Overall Study||17
521503|NCT00066066|1256474|P1|3 Month|Overall Study||21
521504|NCT00066066|1256469|P6|Baseline|Overall Study||20
521505|NCT00066066|1256470|P5|Baseline|Overall Study||27
521506|NCT00066066|1256471|P4|Baseline|Overall Study||20
521507|NCT00066066|1256472|P3|Baseline|Overall Study||30
521508|NCT00066066|1256473|P2|Baseline|Overall Study||22
521509|NCT00066066|1256474|P1|Baseline|Overall Study||27
521510|NCT00066066|1256469|P6|STARTED|Overall Study||20
521511|NCT00066066|1256470|P5|STARTED|Overall Study||27
521512|NCT00066066|1256471|P4|STARTED|Overall Study||20
521513|NCT00066066|1256472|P3|STARTED|Overall Study||30
521514|NCT00066066|1256473|P2|STARTED|Overall Study||22
521515|NCT00066066|1256474|P1|STARTED|Overall Study||27
521516|NCT00065806|1256490|P2|NOT COMPLETED|Overall Study||19
521517|NCT00065806|1256491|P1|NOT COMPLETED|Overall Study||20
521518|NCT00065806|1256490|P2|COMPLETED|Overall Study||89
521519|NCT00065806|1256491|P1|COMPLETED|Overall Study||93
521520|NCT00065806|1256490|P2|STARTED|Overall Study||108
521521|NCT00065806|1256491|P1|STARTED|Overall Study||113
521522|NCT00065611|1256535|P2|NOT COMPLETED|Overall Study||1
521523|NCT00065611|1256536|P1|NOT COMPLETED|Overall Study||0
521524|NCT00065611|1256535|P2|COMPLETED|Overall Study||3
521525|NCT00065611|1256536|P1|COMPLETED|Overall Study||4
521526|NCT00065611|1256535|P2|STARTED|Overall Study||4
521527|NCT00065611|1256536|P1|STARTED|Overall Study||4
521528|NCT00065507|1256548|P2|NOT COMPLETED|Overall Study||29
521529|NCT00065507|1256549|P1|NOT COMPLETED|Overall Study||29
521530|NCT00065507|1256548|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
521531|NCT00065507|1256549|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
521532|NCT00065507|1256548|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
521533|NCT00065507|1256549|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
521534|NCT00065507|1256548|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
521535|NCT00065507|1256549|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
521536|NCT00065507|1256548|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
521537|NCT00065507|1256549|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
521538|NCT00065507|1256548|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
521539|NCT00065507|1256549|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
521540|NCT00065507|1256548|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
521541|NCT00065507|1256549|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
521542|NCT00065468|1256614|P3|NOT COMPLETED|Overall Study||210
521543|NCT00065468|1256615|P2|NOT COMPLETED|Overall Study||209
521544|NCT00065468|1256616|P1|NOT COMPLETED|Overall Study||207
521545|NCT00065468|1256614|P3|COMPLETED|Overall Study||0
521546|NCT00065468|1256615|P2|COMPLETED|Overall Study||0
521547|NCT00065468|1256616|P1|COMPLETED|Overall Study||0
521548|NCT00065468|1256614|P3|Received Treatment|Overall Study||208
521549|NCT00065468|1256615|P2|Received Treatment|Overall Study||208
521550|NCT00065468|1256616|P1|Received Treatment|Overall Study||200
521551|NCT00065468|1256614|P3|STARTED|Overall Study||210
521552|NCT00065468|1256615|P2|STARTED|Overall Study||209
521553|NCT00065468|1256616|P1|STARTED|Overall Study||207
521554|NCT00065442|1256647|P2|NOT COMPLETED|Overall Study||220
521555|NCT00065442|1256648|P1|NOT COMPLETED|Overall Study||125
521556|NCT00065442|1256647|P2|COMPLETED|Overall Study||121
521557|NCT00065442|1256648|P1|COMPLETED|Overall Study||46
521558|NCT00065442|1256647|P2|STARTED|Overall Study||341
521559|NCT00065442|1256648|P1|STARTED|Overall Study||171
521560|NCT00065429|1256663|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521561|NCT00065429|1256664|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521562|NCT00065429|1256665|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
521563|NCT00065429|1256666|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521564|NCT00065429|1256667|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521565|NCT00065429|1256668|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521566|NCT00065429|1256669|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521567|NCT00065429|1256663|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521568|NCT00065429|1256664|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521569|NCT00065429|1256665|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
521570|NCT00065429|1256666|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521571|NCT00065429|1256667|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521572|NCT00065429|1256668|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521573|NCT00065429|1256669|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
521574|NCT00065429|1256663|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
521575|NCT00065429|1256664|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
521576|NCT00065429|1256665|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
521577|NCT00065429|1256666|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
521578|NCT00065429|1256667|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
521579|NCT00065429|1256668|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
521580|NCT00065429|1256669|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
521581|NCT00065429|1256663|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
521582|NCT00065429|1256664|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
521583|NCT00065429|1256665|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
521584|NCT00065429|1256666|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
521585|NCT00065429|1256667|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
521586|NCT00065429|1256668|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
521587|NCT00065429|1256669|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
521588|NCT00065429|1256663|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
521589|NCT00065429|1256664|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
521590|NCT00065429|1256665|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
521591|NCT00065429|1256666|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
521592|NCT00065429|1256667|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
521593|NCT00065429|1256668|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
521594|NCT00065429|1256669|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
521595|NCT00065429|1256663|P7|STARTED|Phase I - May 2001 - Oct 2002||4
521596|NCT00065429|1256664|P6|STARTED|Phase I - May 2001 - Oct 2002||4
521597|NCT00065429|1256665|P5|STARTED|Phase I - May 2001 - Oct 2002||9
521598|NCT00065429|1256666|P4|STARTED|Phase I - May 2001 - Oct 2002||4
521599|NCT00065429|1256667|P3|STARTED|Phase I - May 2001 - Oct 2002||4
521600|NCT00065429|1256668|P2|STARTED|Phase I - May 2001 - Oct 2002||3
521601|NCT00065429|1256669|P1|STARTED|Phase I - May 2001 - Oct 2002||4
521602|NCT00065260|1256683|P2|NOT COMPLETED|Overall Study||1
521603|NCT00065260|1256684|P1|NOT COMPLETED|Overall Study||0
521604|NCT00065260|1256683|P2|COMPLETED|Overall Study||26
521605|NCT00065260|1256684|P1|COMPLETED|Overall Study||27
521606|NCT00065260|1256683|P2|STARTED|Overall Study||27
521607|NCT00065260|1256684|P1|STARTED|Overall Study||27
521608|NCT00065156|1256690|P1|NOT COMPLETED|Overall Study||124
521609|NCT00065156|1256690|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
521610|NCT00065156|1256690|P1|Modified Intent to Treat Population|Overall Study||94
521611|NCT00065156|1256690|P1|STARTED|Overall Study||148
521612|NCT00065065|1256707|P2|NOT COMPLETED|Overall Study||20
521613|NCT00065065|1256708|P1|NOT COMPLETED|Overall Study||10
521614|NCT00065065|1256707|P2|COMPLETED|Overall Study||33
521615|NCT00065065|1256708|P1|COMPLETED|Overall Study||42
521616|NCT00065065|1256707|P2|STARTED|Overall Study||53
521617|NCT00065065|1256708|P1|STARTED|Overall Study||52
521618|NCT00064259|1256716|P4|NOT COMPLETED|Overall Study||1
521619|NCT00064259|1256717|P3|NOT COMPLETED|Overall Study||0
521620|NCT00064259|1256718|P2|NOT COMPLETED|Overall Study||0
521621|NCT00064259|1256719|P1|NOT COMPLETED|Overall Study||1
521622|NCT00064259|1256716|P4|COMPLETED|Overall Study||0
521623|NCT00064259|1256717|P3|COMPLETED|Overall Study||6
521624|NCT00064259|1256718|P2|COMPLETED|Overall Study||4
521625|NCT00064259|1256719|P1|COMPLETED|Overall Study||3
521626|NCT00064259|1256716|P4|STARTED|Overall Study||1
521627|NCT00064259|1256717|P3|STARTED|Overall Study||6
521628|NCT00064259|1256718|P2|STARTED|Overall Study||4
521629|NCT00064259|1256719|P1|STARTED|Overall Study||4
521630|NCT00064844|1256725|P2|NOT COMPLETED|Overall Study||19
521631|NCT00064844|1256726|P1|NOT COMPLETED|Overall Study||8
521632|NCT00064844|1256725|P2|COMPLETED|Overall Study||32
521633|NCT00064844|1256726|P1|COMPLETED|Overall Study||37
521634|NCT00064844|1256725|P2|12 Month Follow-up|Overall Study||32
521635|NCT00064844|1256726|P1|12 Month Follow-up|Overall Study||37
521636|NCT00064844|1256725|P2|6 Month Follow-up|Overall Study||40
521637|NCT00064844|1256726|P1|6 Month Follow-up|Overall Study||39
521638|NCT00064844|1256725|P2|3 Month Follow-up|Overall Study||47
521639|NCT00064844|1256726|P1|3 Month Follow-up|Overall Study||40
521640|NCT00064844|1256725|P2|2 Week Follow-up|Overall Study||51
521641|NCT00064844|1256726|P1|2 Week Follow-up|Overall Study||45
521642|NCT00064844|1256725|P2|STARTED|Overall Study||51
521643|NCT00064844|1256726|P1|STARTED|Overall Study||45
521644|NCT00064792|1256736|P2|NOT COMPLETED|Overall Study||0
521645|NCT00064792|1256737|P1|NOT COMPLETED|Overall Study||5
521646|NCT00064792|1256736|P2|COMPLETED|Overall Study||10
521647|NCT00064792|1256737|P1|COMPLETED|Overall Study||8
521648|NCT00064792|1256736|P2|STARTED|Overall Study||10
521649|NCT00064792|1256737|P1|STARTED|Overall Study||13
521650|NCT00064753|1256747|P2|NOT COMPLETED|Overall Study||648
521651|NCT00064753|1256748|P1|NOT COMPLETED|Overall Study||674
521652|NCT00064753|1256747|P2|COMPLETED|Overall Study||1406
521653|NCT00064753|1256748|P1|COMPLETED|Overall Study||1382
521654|NCT00064753|1256747|P2|STARTED|Overall Study||2054
521655|NCT00064753|1256748|P1|STARTED|Overall Study||2056
521656|NCT00064701|1256779|P3|NOT COMPLETED|Clinical Continuation Phase||140
521657|NCT00064701|1256780|P2|NOT COMPLETED|Clinical Continuation Phase||178
521658|NCT00064701|1256781|P1|NOT COMPLETED|Clinical Continuation Phase||170
521659|NCT00064701|1256779|P3|COMPLETED|Clinical Continuation Phase||11
521660|NCT00064701|1256780|P2|COMPLETED|Clinical Continuation Phase||4
521661|NCT00064701|1256781|P1|COMPLETED|Clinical Continuation Phase||9
521662|NCT00064701|1256779|P3|STARTED|Clinical Continuation Phase||151
521663|NCT00064701|1256780|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
521664|NCT00064701|1256781|P1|STARTED|Clinical Continuation Phase||179
521665|NCT00064701|1256779|P3|NOT COMPLETED|One Year Post-transplant||72
521666|NCT00064701|1256780|P2|NOT COMPLETED|One Year Post-transplant||43
521667|NCT00064701|1256781|P1|NOT COMPLETED|One Year Post-transplant||40
521668|NCT00064701|1256779|P3|COMPLETED|One Year Post-transplant||151
521669|NCT00064701|1256780|P2|COMPLETED|One Year Post-transplant||183
521670|NCT00064701|1256781|P1|COMPLETED|One Year Post-transplant||179
521671|NCT00064701|1256779|P3|Received Study Drug|One Year Post-transplant||212
521672|NCT00064701|1256780|P2|Received Study Drug|One Year Post-transplant||214
521673|NCT00064701|1256781|P1|Received Study Drug|One Year Post-transplant||212
521674|NCT00064701|1256779|P3|STARTED|One Year Post-transplant||223
521675|NCT00064701|1256780|P2|STARTED|One Year Post-transplant||226
521676|NCT00064701|1256781|P1|STARTED|One Year Post-transplant||219
521677|NCT00064662|1256833|P2|NOT COMPLETED|Overall Study||61
521678|NCT00064662|1256834|P1|NOT COMPLETED|Overall Study||74
521679|NCT00064662|1256833|P2|COMPLETED|Overall Study||265
521680|NCT00064662|1256834|P1|COMPLETED|Overall Study||255
521681|NCT00064662|1256833|P2|STARTED|Overall Study||326
521682|NCT00064662|1256834|P1|STARTED|Overall Study||329
521683|NCT00064350|1256845|P3|NOT COMPLETED|Cross-Over||0
521684|NCT00064350|1256846|P2|NOT COMPLETED|Cross-Over||14
521685|NCT00064350|1256847|P1|NOT COMPLETED|Cross-Over||6
521686|NCT00064350|1256845|P3|COMPLETED|Cross-Over||0
521687|NCT00064350|1256846|P2|COMPLETED|Cross-Over||13
521688|NCT00064350|1256847|P1|COMPLETED|Cross-Over||4
521689|NCT00064350|1256845|P3|Eligible and Treated|Cross-Over||0
521690|NCT00064350|1256846|P2|Eligible and Treated|Cross-Over||21
521691|NCT00064350|1256847|P1|Eligible and Treated|Cross-Over||7
521692|NCT00064350|1256845|P3|Treated|Cross-Over||0
521693|NCT00064350|1256846|P2|Treated|Cross-Over||26
521694|NCT00064350|1256847|P1|Treated|Cross-Over||9
521695|NCT00064350|1256845|P3|STARTED|Cross-Over||0
521696|NCT00064350|1256846|P2|STARTED|Cross-Over||27
521697|NCT00064350|1256847|P1|STARTED|Cross-Over||10
521698|NCT00064350|1256845|P3|NOT COMPLETED|Randomization||0
521699|NCT00064350|1256846|P2|NOT COMPLETED|Randomization||18
521700|NCT00064350|1256847|P1|NOT COMPLETED|Randomization||26
521701|NCT00064350|1256845|P3|COMPLETED|Randomization||0
521702|NCT00064350|1256846|P2|COMPLETED|Randomization||28
521703|NCT00064350|1256847|P1|COMPLETED|Randomization||33
521704|NCT00064350|1256845|P3|Eligible and Treated|Randomization||0
521705|NCT00064350|1256846|P2|Eligible and Treated|Randomization||31
521706|NCT00064350|1256847|P1|Eligible and Treated|Randomization||50
521707|NCT00064350|1256845|P3|Treated|Randomization||0
521708|NCT00064350|1256846|P2|Treated|Randomization||40
521709|NCT00064350|1256847|P1|Treated|Randomization||55
521710|NCT00064350|1256845|P3|STARTED|Randomization||0
521711|NCT00064350|1256846|P2|STARTED|Randomization||46
521712|NCT00064350|1256847|P1|STARTED|Randomization||59
521713|NCT00064350|1256845|P3|NOT COMPLETED|Induction Treatment||236
521714|NCT00064350|1256846|P2|NOT COMPLETED|Induction Treatment||9
521715|NCT00064350|1256847|P1|NOT COMPLETED|Induction Treatment||8
521716|NCT00064350|1256845|P3|COMPLETED|Induction Treatment||1
521717|NCT00064350|1256846|P2|COMPLETED|Induction Treatment||37
521718|NCT00064350|1256847|P1|COMPLETED|Induction Treatment||51
521719|NCT00064350|1256845|P3|Eligible and Treated|Induction Treatment||194
521720|NCT00064350|1256846|P2|Eligible and Treated|Induction Treatment||46
521721|NCT00064350|1256847|P1|Eligible and Treated|Induction Treatment||59
521722|NCT00064350|1256845|P3|Treated|Induction Treatment||228
521723|NCT00064350|1256846|P2|Treated|Induction Treatment||46
521724|NCT00064350|1256847|P1|Treated|Induction Treatment||59
521725|NCT00064350|1256845|P3|STARTED|Induction Treatment||237
521726|NCT00064350|1256846|P2|STARTED|Induction Treatment||46
521727|NCT00064350|1256847|P1|STARTED|Induction Treatment||59
521728|NCT00064038|1256864|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
521729|NCT00064038|1256865|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
521730|NCT00064038|1256866|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
521731|NCT00064038|1256864|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
521732|NCT00064038|1256865|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
521733|NCT00064038|1256866|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
521734|NCT00064038|1256864|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
521735|NCT00064038|1256865|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
521736|NCT00064038|1256866|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
521737|NCT00064038|1256864|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
521738|NCT00064038|1256865|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
521739|NCT00064038|1256866|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
521740|NCT00064038|1256864|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
521741|NCT00064038|1256865|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
521742|NCT00064038|1256866|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
521743|NCT00064038|1256864|P3|NOT COMPLETED|Initial Randomization||0
521744|NCT00064038|1256865|P2|NOT COMPLETED|Initial Randomization||98
521745|NCT00064038|1256866|P1|NOT COMPLETED|Initial Randomization||100
521746|NCT00064038|1256864|P3|COMPLETED|Initial Randomization||0
521747|NCT00064038|1256865|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
521748|NCT00064038|1256866|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
521749|NCT00064038|1256864|P3|Safety Population|Initial Randomization||0
521750|NCT00064038|1256865|P2|Safety Population|Initial Randomization||94
521751|NCT00064038|1256866|P1|Safety Population|Initial Randomization||96
521752|NCT00064038|1256864|P3|Eligible and Analyzable|Initial Randomization||0
521753|NCT00064038|1256865|P2|Eligible and Analyzable|Initial Randomization||95
521754|NCT00064038|1256866|P1|Eligible and Analyzable|Initial Randomization||97
521755|NCT00064038|1256864|P3|STARTED|Initial Randomization||0
521756|NCT00064038|1256865|P2|STARTED|Initial Randomization||98
521757|NCT00064038|1256866|P1|STARTED|Initial Randomization||100
521758|NCT00064025|1256876|P1|NOT COMPLETED|Overall Study||7
521759|NCT00064025|1256876|P1|COMPLETED|Overall Study||68
521760|NCT00064025|1256876|P1|STARTED|Overall Study||75
521761|NCT00063986|1256883|P1|NOT COMPLETED|Overall Study||6
521762|NCT00063986|1256883|P1|COMPLETED|Overall Study||104
521763|NCT00063986|1256883|P1|Eligible and Treated|Overall Study||104
521764|NCT00063986|1256883|P1|Treated|Overall Study||105
521765|NCT00063986|1256883|P1|STARTED|Overall Study||110
521766|NCT00063934|1256895|P1|NOT COMPLETED|Overall Study||1
521767|NCT00063934|1256895|P1|COMPLETED|Overall Study||30
521768|NCT00063934|1256895|P1|STARTED|Overall Study||31
521769|NCT00063635|1256904|P3|NOT COMPLETED|Overall Study||9
521770|NCT00063635|1256905|P2|NOT COMPLETED|Overall Study||8
521771|NCT00063635|1256906|P1|NOT COMPLETED|Overall Study||6
521772|NCT00063635|1256904|P3|COMPLETED|Overall Study||49
521773|NCT00063635|1256905|P2|COMPLETED|Overall Study||50
521774|NCT00063635|1256906|P1|COMPLETED|Overall Study||51
521775|NCT00063635|1256904|P3|STARTED|Overall Study||58
521776|NCT00063635|1256905|P2|STARTED|Overall Study||58
521777|NCT00063635|1256906|P1|STARTED|Overall Study||57
521778|NCT00063622|1256947|P3|NOT COMPLETED|Overall Study||11
521779|NCT00063622|1256948|P2|NOT COMPLETED|Overall Study||4
521780|NCT00063622|1256949|P1|NOT COMPLETED|Overall Study||10
521781|NCT00063622|1256947|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
521782|NCT00063622|1256948|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
521783|NCT00063622|1256949|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
521784|NCT00063622|1256947|P3|STARTED|Overall Study||83
521785|NCT00063622|1256948|P2|STARTED|Overall Study||84
521786|NCT00063622|1256949|P1|STARTED|Overall Study||80
521787|NCT00063570|1256974|P2|NOT COMPLETED|Overall Study||0
521788|NCT00063570|1256975|P1|NOT COMPLETED|Overall Study||0
521789|NCT00063570|1256974|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
521790|NCT00063570|1256975|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
521791|NCT00063570|1256974|P2|STARTED|Overall Study||21
521792|NCT00063570|1256975|P1|STARTED|Overall Study||52
521793|NCT00063362|1256991|P2|NOT COMPLETED|Overall Study||4
521794|NCT00063362|1256992|P1|NOT COMPLETED|Overall Study||4
521795|NCT00063362|1256991|P2|COMPLETED|Overall Study||22
521796|NCT00063362|1256992|P1|COMPLETED|Overall Study||19
521797|NCT00063362|1256991|P2|STARTED|Overall Study||26
521798|NCT00063362|1256992|P1|STARTED|Overall Study||23
521799|NCT00063258|1257000|P2|NOT COMPLETED|Overall Study||0
521800|NCT00063258|1257001|P1|NOT COMPLETED|Overall Study||4
521801|NCT00063258|1257000|P2|COMPLETED|Overall Study||0
521802|NCT00063258|1257001|P1|COMPLETED|Overall Study||1
521803|NCT00063258|1257000|P2|STARTED|Overall Study||0
521804|NCT00063258|1257001|P1|STARTED|Overall Study||5
521805|NCT00063232|1257007|P1|NOT COMPLETED|Overall Study||0
521806|NCT00063232|1257007|P1|COMPLETED|Overall Study||26
521807|NCT00063232|1257007|P1|STARTED|Overall Study||26
521808|NCT00063154|1257013|P1|NOT COMPLETED|Overall Study||51
521809|NCT00063154|1257013|P1|COMPLETED|Overall Study||0
521810|NCT00063154|1257013|P1|STARTED|Overall Study||51
521811|NCT00062764|1257020|P1|NOT COMPLETED|Overall Study||0
521812|NCT00062764|1257020|P1|COMPLETED|Overall Study||18
521813|NCT00062764|1257020|P1|STARTED|Overall Study||18
521814|NCT00062751|1257033|P5|NOT COMPLETED|Overall Study||6
521815|NCT00062751|1257034|P4|NOT COMPLETED|Overall Study||5
521816|NCT00062751|1257035|P3|NOT COMPLETED|Overall Study||30
521817|NCT00062751|1257036|P2|NOT COMPLETED|Overall Study||30
521818|NCT00062751|1257037|P1|NOT COMPLETED|Overall Study||33
521819|NCT00062751|1257033|P5|COMPLETED|Overall Study||0
521820|NCT00062751|1257034|P4|COMPLETED|Overall Study||1
521821|NCT00062751|1257035|P3|COMPLETED|Overall Study||3
521822|NCT00062751|1257036|P2|COMPLETED|Overall Study||0
521823|NCT00062751|1257037|P1|COMPLETED|Overall Study||0
521824|NCT00062751|1257033|P5|STARTED|Overall Study||6
521825|NCT00062751|1257034|P4|STARTED|Overall Study||6
521826|NCT00062751|1257035|P3|STARTED|Overall Study||33
521827|NCT00062751|1257036|P2|STARTED|Overall Study||30
521828|NCT00062751|1257037|P1|STARTED|Overall Study||33
521829|NCT00062738|1257108|P3|NOT COMPLETED|Overall Study||0
521830|NCT00062738|1257109|P2|NOT COMPLETED|Overall Study||0
521831|NCT00062738|1257110|P1|NOT COMPLETED|Overall Study||0
521832|NCT00062738|1257108|P3|COMPLETED|Overall Study||17
521833|NCT00062738|1257109|P2|COMPLETED|Overall Study||18
521834|NCT00062738|1257110|P1|COMPLETED|Overall Study||17
521835|NCT00062738|1257108|P3|STARTED|Overall Study||17
521836|NCT00062738|1257109|P2|STARTED|Overall Study||18
521837|NCT00062738|1257110|P1|STARTED|Overall Study||17
521838|NCT00062647|1257123|P2|NOT COMPLETED|Overall Study||13
521839|NCT00062647|1257124|P1|NOT COMPLETED|Overall Study||16
521840|NCT00062647|1257123|P2|COMPLETED|Overall Study||17
521841|NCT00062647|1257124|P1|COMPLETED|Overall Study||14
521842|NCT00062647|1257123|P2|STARTED|Overall Study||30
521843|NCT00062647|1257124|P1|STARTED|Overall Study||30
521844|NCT00062439|1257130|P1|NOT COMPLETED|Consolidation Chemotherapy||2
521845|NCT00062439|1257130|P1|COMPLETED|Consolidation Chemotherapy||20
521846|NCT00062439|1257130|P1|STARTED|Consolidation Chemotherapy||22
521847|NCT00062439|1257130|P1|NOT COMPLETED|Surgery||7
521848|NCT00062439|1257130|P1|COMPLETED|Surgery||22
521849|NCT00062439|1257130|P1|STARTED|Surgery||29
521850|NCT00062439|1257130|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
521851|NCT00062439|1257130|P1|COMPLETED|Post Chemoradiation Assessment||29
521852|NCT00062439|1257130|P1|STARTED|Post Chemoradiation Assessment||38
521853|NCT00062439|1257130|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
521854|NCT00062439|1257130|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
521855|NCT00062439|1257130|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
521856|NCT00062010|1257142|P1|NOT COMPLETED|Overall Study||3
521857|NCT00062010|1257142|P1|COMPLETED|Overall Study||34
521858|NCT00062010|1257142|P1|Eligible and Treated|Overall Study||34
521859|NCT00062010|1257142|P1|STARTED|Overall Study||37
521860|NCT00061945|1257150|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
521861|NCT00061945|1257151|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
521862|NCT00061945|1257150|P2|COMPLETED|Course IV: Alemtuzumab||50
521863|NCT00061945|1257151|P1|COMPLETED|Course IV: Alemtuzumab||18
521864|NCT00061945|1257150|P2|STARTED|Course IV: Alemtuzumab||66
521865|NCT00061945|1257151|P1|STARTED|Course IV: Alemtuzumab||25
521866|NCT00061945|1257150|P2|NOT COMPLETED|Registration Through Course 3||115
521867|NCT00061945|1257151|P1|NOT COMPLETED|Registration Through Course 3||94
521868|NCT00061945|1257150|P2|COMPLETED|Registration Through Course 3||66
521869|NCT00061945|1257151|P1|COMPLETED|Registration Through Course 3||25
521870|NCT00061945|1257150|P2|STARTED|Registration Through Course 3||181
521871|NCT00061945|1257151|P1|STARTED|Registration Through Course 3||119
521872|NCT00061932|1257161|P2|NOT COMPLETED|Overall Study||4
521873|NCT00061932|1257162|P1|NOT COMPLETED|Overall Study||13
521874|NCT00061932|1257161|P2|COMPLETED|Overall Study||8
521875|NCT00061932|1257162|P1|COMPLETED|Overall Study||16
521876|NCT00061932|1257161|P2|STARTED|Overall Study||12
521877|NCT00061932|1257162|P1|STARTED|Overall Study||29
521878|NCT00061893|1257168|P1|NOT COMPLETED|Overall Study||18
521879|NCT00061893|1257168|P1|COMPLETED|Overall Study||20
521880|NCT00061893|1257168|P1|STARTED|Overall Study||38
521881|NCT00061633|1257175|P2|NOT COMPLETED|Overall Study||11
521882|NCT00061633|1257176|P1|NOT COMPLETED|Overall Study||5
521883|NCT00061633|1257175|P2|COMPLETED|Overall Study||74
521884|NCT00061633|1257176|P1|COMPLETED|Overall Study||79
521885|NCT00061633|1257175|P2|STARTED|Overall Study||85
521886|NCT00061633|1257176|P1|STARTED|Overall Study||84
521887|NCT00061373|1257184|P2|NOT COMPLETED|Overall Study||0
521888|NCT00061373|1257185|P1|NOT COMPLETED|Overall Study||0
521889|NCT00061373|1257184|P2|COMPLETED|Overall Study||3
521890|NCT00061373|1257185|P1|COMPLETED|Overall Study||15
521891|NCT00061373|1257184|P2|Aspirin and Tinzaparin|Overall Study||3
521892|NCT00061373|1257185|P1|Aspirin and Tinzaparin|Overall Study||15
521893|NCT00061373|1257184|P2|STARTED|Overall Study||3
521894|NCT00061373|1257185|P1|STARTED|Overall Study||15
521895|NCT00061048|1257201|P1|NOT COMPLETED|Overall Study||22
521896|NCT00061048|1257201|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
521897|NCT00061048|1257201|P1|STARTED|Overall Study||29
521898|NCT00060944|1257211|P2|NOT COMPLETED|Overall Study||134
521899|NCT00060944|1257212|P1|NOT COMPLETED|Overall Study||136
521900|NCT00060944|1257211|P2|COMPLETED|Overall Study||0
521901|NCT00060944|1257212|P1|COMPLETED|Overall Study||0
521902|NCT00060944|1257211|P2|Treated|Overall Study||130
521903|NCT00060944|1257212|P1|Treated|Overall Study||130
521904|NCT00060944|1257211|P2|STARTED|Overall Study||134
521905|NCT00060944|1257212|P1|STARTED|Overall Study||136
521906|NCT00060840|1257228|P2|NOT COMPLETED|Overall Study||9
521907|NCT00060840|1257229|P1|NOT COMPLETED|Overall Study||4
521908|NCT00060840|1257228|P2|COMPLETED|Overall Study||68
521909|NCT00060840|1257229|P1|COMPLETED|Overall Study||69
521910|NCT00060840|1257228|P2|STARTED|Overall Study||77
521911|NCT00060840|1257229|P1|STARTED|Overall Study||73
521912|NCT00060528|1257235|P4|NOT COMPLETED|Overall Study||0
521913|NCT00060528|1257236|P3|NOT COMPLETED|Overall Study||0
521914|NCT00060528|1257237|P2|NOT COMPLETED|Overall Study||0
521915|NCT00060528|1257238|P1|NOT COMPLETED|Overall Study||0
521916|NCT00060528|1257235|P4|COMPLETED|Overall Study||8
521917|NCT00060528|1257236|P3|COMPLETED|Overall Study||7
521918|NCT00060528|1257237|P2|COMPLETED|Overall Study||9
521919|NCT00060528|1257238|P1|COMPLETED|Overall Study||8
521920|NCT00060528|1257235|P4|STARTED|Overall Study||8
521921|NCT00060528|1257236|P3|STARTED|Overall Study||7
521922|NCT00060528|1257237|P2|STARTED|Overall Study||9
521923|NCT00060528|1257238|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
521924|NCT00060346|1257252|P1|NOT COMPLETED|Overall Study||0
521925|NCT00060346|1257252|P1|COMPLETED|Overall Study||16
521926|NCT00060346|1257252|P1|Eligible and Treated|Overall Study||16
521927|NCT00060346|1257252|P1|STARTED|Overall Study||16
521928|NCT00060333|1257256|P1|NOT COMPLETED|Overall Study||0
521929|NCT00060333|1257256|P1|COMPLETED|Overall Study||20
521930|NCT00060333|1257256|P1|STARTED|Overall Study||20
521931|NCT00060008|1257267|P1|NOT COMPLETED|Overall Study||0
521932|NCT00060008|1257267|P1|COMPLETED|Overall Study||18
521933|NCT00060008|1257267|P1|STARTED|Overall Study||18
521934|NCT00059839|1257274|P2|NOT COMPLETED|Overall Study||17
521935|NCT00059839|1257275|P1|NOT COMPLETED|Overall Study||12
521936|NCT00059839|1257274|P2|COMPLETED|Overall Study||47
521937|NCT00059839|1257275|P1|COMPLETED|Overall Study||53
521938|NCT00059839|1257274|P2|STARTED|Overall Study||64
521939|NCT00059839|1257275|P1|STARTED|Overall Study||65
521940|NCT00059787|1257281|P1|NOT COMPLETED|Overall Study||20
521941|NCT00059787|1257281|P1|COMPLETED|Overall Study||36
521942|NCT00059787|1257281|P1|STARTED|Overall Study||56
521943|NCT00059475|1257297|P8|NOT COMPLETED|Overall Study||0
521944|NCT00059475|1257298|P7|NOT COMPLETED|Overall Study||0
521945|NCT00059475|1257299|P6|NOT COMPLETED|Overall Study||0
521946|NCT00059475|1257300|P5|NOT COMPLETED|Overall Study||0
521947|NCT00059475|1257301|P4|NOT COMPLETED|Overall Study||0
521948|NCT00059475|1257302|P3|NOT COMPLETED|Overall Study||0
521949|NCT00059475|1257303|P2|NOT COMPLETED|Overall Study||0
521950|NCT00059475|1257304|P1|NOT COMPLETED|Overall Study||0
521951|NCT00059475|1257297|P8|COMPLETED|Overall Study||7
521952|NCT00059475|1257298|P7|COMPLETED|Overall Study||34
521953|NCT00059475|1257299|P6|COMPLETED|Overall Study||2
521954|NCT00059475|1257300|P5|COMPLETED|Overall Study||33
521955|NCT00059475|1257301|P4|COMPLETED|Overall Study||3
521956|NCT00059475|1257302|P3|COMPLETED|Overall Study||24
521957|NCT00059475|1257303|P2|COMPLETED|Overall Study||2
521958|NCT00059475|1257304|P1|COMPLETED|Overall Study||33
521959|NCT00059475|1257297|P8|STARTED|Overall Study||7
521960|NCT00059475|1257298|P7|STARTED|Overall Study||34
521961|NCT00059475|1257299|P6|STARTED|Overall Study||2
521962|NCT00059475|1257300|P5|STARTED|Overall Study||33
521963|NCT00059475|1257301|P4|STARTED|Overall Study||3
521964|NCT00059475|1257302|P3|STARTED|Overall Study||24
521965|NCT00059475|1257303|P2|STARTED|Overall Study||2
521966|NCT00059475|1257304|P1|STARTED|Overall Study||33
521967|NCT00059332|1257332|P2|NOT COMPLETED|Overall Study||2
521968|NCT00059332|1257333|P1|NOT COMPLETED|Overall Study||3
521969|NCT00059332|1257332|P2|COMPLETED|Overall Study||855
521970|NCT00059332|1257333|P1|COMPLETED|Overall Study||840
521971|NCT00059332|1257332|P2|STARTED|Overall Study||857
521972|NCT00059332|1257333|P1|STARTED|Overall Study||843
521973|NCT00059215|1257359|P4|NOT COMPLETED|Overall Study||15
521974|NCT00059215|1257360|P3|NOT COMPLETED|Overall Study||15
521975|NCT00059215|1257361|P2|NOT COMPLETED|Overall Study||14
521976|NCT00059215|1257362|P1|NOT COMPLETED|Overall Study||13
521977|NCT00059215|1257359|P4|COMPLETED|Overall Study||239
521978|NCT00059215|1257360|P3|COMPLETED|Overall Study||236
521979|NCT00059215|1257361|P2|COMPLETED|Overall Study||186
521980|NCT00059215|1257362|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
521981|NCT00059215|1257359|P4|STARTED|Overall Study||254
521982|NCT00059215|1257360|P3|STARTED|Overall Study||251
521983|NCT00059215|1257361|P2|STARTED|Overall Study||200
521984|NCT00059215|1257362|P1|STARTED|Overall Study||200
521985|NCT00058825|1257388|P1|NOT COMPLETED|Overall Study||22
521986|NCT00058825|1257388|P1|COMPLETED|Overall Study||5
521987|NCT00058825|1257388|P1|STARTED|Overall Study||27
521988|NCT00058552|1257404|P2|NOT COMPLETED|Overall Study||62
521989|NCT00058552|1257405|P1|NOT COMPLETED|Overall Study||65
521990|NCT00058552|1257404|P2|COMPLETED|Overall Study||2
521991|NCT00058552|1257405|P1|COMPLETED|Overall Study||0
521992|NCT00058552|1257404|P2|STARTED|Overall Study||64
521993|NCT00058552|1257405|P1|STARTED|Overall Study||65
521994|NCT00058539|1257423|P1|NOT COMPLETED|Overall Study||42
521995|NCT00058539|1257423|P1|COMPLETED|Overall Study||0
521996|NCT00058539|1257423|P1|STARTED|Overall Study||42
521997|NCT00058240|1257437|P4|NOT COMPLETED|Second Dose Level||0
521998|NCT00058240|1257438|P3|NOT COMPLETED|Second Dose Level||0
521999|NCT00058240|1257439|P2|NOT COMPLETED|Second Dose Level||0
522000|NCT00058240|1257440|P1|NOT COMPLETED|Second Dose Level||0
522001|NCT00058240|1257437|P4|COMPLETED|Second Dose Level||4
522002|NCT00058240|1257438|P3|COMPLETED|Second Dose Level||2
522003|NCT00058240|1257439|P2|COMPLETED|Second Dose Level||0
522004|NCT00058240|1257440|P1|COMPLETED|Second Dose Level||0
522005|NCT00058240|1257437|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
522006|NCT00058240|1257438|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
522007|NCT00058240|1257439|P2|STARTED|Second Dose Level||0
522008|NCT00058240|1257440|P1|STARTED|Second Dose Level||0
522009|NCT00058240|1257437|P4|NOT COMPLETED|First Dose Level||0
522010|NCT00058240|1257438|P3|NOT COMPLETED|First Dose Level||0
522011|NCT00058240|1257439|P2|NOT COMPLETED|First Dose Level||0
522012|NCT00058240|1257440|P1|NOT COMPLETED|First Dose Level||0
522013|NCT00058240|1257437|P4|COMPLETED|First Dose Level||12
522014|NCT00058240|1257438|P3|COMPLETED|First Dose Level||17
522015|NCT00058240|1257439|P2|COMPLETED|First Dose Level||3
522016|NCT00058240|1257440|P1|COMPLETED|First Dose Level||20
522017|NCT00058240|1257437|P4|Treated|First Dose Level||12
522018|NCT00058240|1257438|P3|Treated|First Dose Level||17
522019|NCT00058240|1257439|P2|Treated|First Dose Level||3
522020|NCT00058240|1257440|P1|Treated|First Dose Level||20
522021|NCT00058240|1257437|P4|STARTED|First Dose Level||12
522022|NCT00058240|1257438|P3|STARTED|First Dose Level||17
522023|NCT00058240|1257439|P2|STARTED|First Dose Level||3
522024|NCT00058240|1257440|P1|STARTED|First Dose Level||20
522025|NCT00058214|1257450|P1|NOT COMPLETED|Overall Study||1
522026|NCT00058214|1257450|P1|COMPLETED|Overall Study||24
522027|NCT00058214|1257450|P1|STARTED|Overall Study||25
522028|NCT00058019|1257457|P2|NOT COMPLETED|Overall Study||0
522029|NCT00058019|1257458|P1|NOT COMPLETED|Overall Study||0
522030|NCT00058019|1257457|P2|COMPLETED|Overall Study||12
522031|NCT00058019|1257458|P1|COMPLETED|Overall Study||39
522032|NCT00058019|1257457|P2|STARTED|Overall Study||12
522033|NCT00058019|1257458|P1|STARTED|Overall Study||39
522034|NCT00057954|1257471|P1|NOT COMPLETED|Overall Study||2
522035|NCT00057954|1257471|P1|COMPLETED|Overall Study||4
522036|NCT00057954|1257471|P1|STARTED|Overall Study||6
522037|NCT00057941|1257479|P2|NOT COMPLETED|Overall Study||74
522038|NCT00057941|1257480|P1|NOT COMPLETED|Overall Study||74
522039|NCT00057941|1257479|P2|COMPLETED|Overall Study||0
522040|NCT00057941|1257480|P1|COMPLETED|Overall Study||0
522041|NCT00057941|1257479|P2|Eligible|Overall Study||69
522042|NCT00057941|1257480|P1|Eligible|Overall Study||72
522043|NCT00057941|1257479|P2|Treated|Overall Study||74
522044|NCT00057941|1257480|P1|Treated|Overall Study||74
522045|NCT00057941|1257479|P2|STARTED|Overall Study||74
522046|NCT00057941|1257480|P1|STARTED|Overall Study||74
522047|NCT00057876|1257488|P2|NOT COMPLETED|Overall Study||27
522048|NCT00057876|1257489|P1|NOT COMPLETED|Overall Study||29
522049|NCT00057876|1257488|P2|COMPLETED|Overall Study||9
522050|NCT00057876|1257489|P1|COMPLETED|Overall Study||9
522051|NCT00057876|1257488|P2|Eligible and Treated|Overall Study||34
522052|NCT00057876|1257489|P1|Eligible and Treated|Overall Study||34
522053|NCT00057876|1257488|P2|Began Protocol Therapy|Overall Study||34
522054|NCT00057876|1257489|P1|Began Protocol Therapy|Overall Study||35
522055|NCT00057876|1257488|P2|Eligible|Overall Study||34
522056|NCT00057876|1257489|P1|Eligible|Overall Study||37
522057|NCT00057876|1257488|P2|STARTED|Overall Study||36
522058|NCT00057876|1257489|P1|STARTED|Overall Study||38
522059|NCT00057863|1257499|P1|NOT COMPLETED|Overall Study||3
522060|NCT00057863|1257499|P1|COMPLETED|Overall Study||32
522061|NCT00057863|1257499|P1|STARTED|Overall Study||35
522062|NCT00057837|1257508|P2|NOT COMPLETED|Overall Study||39
522063|NCT00057837|1257509|P1|NOT COMPLETED|Overall Study||31
522064|NCT00057837|1257508|P2|COMPLETED|Overall Study||31
522065|NCT00057837|1257509|P1|COMPLETED|Overall Study||39
522066|NCT00057837|1257508|P2|Patients With Response|Overall Study||38
522067|NCT00057837|1257509|P1|Patients With Response|Overall Study||46
522068|NCT00057837|1257508|P2|Eligible and Treated|Overall Study||66
522069|NCT00057837|1257509|P1|Eligible and Treated|Overall Study||66
522070|NCT00057837|1257508|P2|Treated|Overall Study||68
522071|NCT00057837|1257509|P1|Treated|Overall Study||69
522072|NCT00057837|1257508|P2|STARTED|Overall Study||70
522073|NCT00057837|1257509|P1|STARTED|Overall Study||70
522074|NCT00057811|1257521|P2|NOT COMPLETED|Overall Study||12
522075|NCT00057811|1257522|P1|NOT COMPLETED|Overall Study||10
522076|NCT00057811|1257521|P2|COMPLETED|Overall Study||34
522077|NCT00057811|1257522|P1|COMPLETED|Overall Study||41
522078|NCT00057811|1257521|P2|STARTED|Overall Study||46
522079|NCT00057811|1257522|P1|STARTED|Overall Study||51
522080|NCT00057785|1257534|P1|NOT COMPLETED|Overall Study||0
522174|NCT00056160|1257763|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
522081|NCT00057785|1257534|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
522082|NCT00057785|1257534|P1|STARTED|Overall Study||68
522083|NCT00057746|1257541|P3|NOT COMPLETED|Overall Study||1
522084|NCT00057746|1257542|P2|NOT COMPLETED|Overall Study||0
522085|NCT00057746|1257543|P1|NOT COMPLETED|Overall Study||0
522086|NCT00057746|1257541|P3|COMPLETED|Overall Study||66
522087|NCT00057746|1257542|P2|COMPLETED|Overall Study||67
522088|NCT00057746|1257543|P1|COMPLETED|Overall Study||131
522089|NCT00057746|1257541|P3|STARTED|Overall Study||67
522090|NCT00057746|1257542|P2|STARTED|Overall Study||67
522091|NCT00057746|1257543|P1|STARTED|Overall Study||131
522092|NCT00057681|1257554|P3|NOT COMPLETED|Overall Study||34
522093|NCT00057681|1257555|P2|NOT COMPLETED|Overall Study||72
522094|NCT00057681|1257556|P1|NOT COMPLETED|Overall Study||65
522095|NCT00057681|1257554|P3|COMPLETED|Overall Study||69
522096|NCT00057681|1257555|P2|COMPLETED|Overall Study||67
522097|NCT00057681|1257556|P1|COMPLETED|Overall Study||72
522098|NCT00057681|1257554|P3|STARTED|Overall Study||103
522099|NCT00057681|1257555|P2|STARTED|Overall Study||139
522100|NCT00057681|1257556|P1|STARTED|Overall Study||137
522101|NCT00057577|1257572|P2|NOT COMPLETED|Overall Study||0
522102|NCT00057577|1257573|P1|NOT COMPLETED|Overall Study||0
522103|NCT00057577|1257572|P2|COMPLETED|Overall Study||225
522104|NCT00057577|1257573|P1|COMPLETED|Overall Study||227
522105|NCT00057577|1257572|P2|STARTED|Overall Study||225
522106|NCT00057577|1257573|P1|STARTED|Overall Study||227
522107|NCT00057551|1257590|P3|NOT COMPLETED|Overall Study||16
522108|NCT00057551|1257591|P2|NOT COMPLETED|Overall Study||27
522109|NCT00057551|1257592|P1|NOT COMPLETED|Overall Study||25
522110|NCT00057551|1257590|P3|COMPLETED|Overall Study||80
522111|NCT00057551|1257591|P2|COMPLETED|Overall Study||168
522112|NCT00057551|1257592|P1|COMPLETED|Overall Study||175
522113|NCT00057551|1257590|P3|STARTED|Overall Study||96
522114|NCT00057551|1257591|P2|STARTED|Overall Study||195
522115|NCT00057551|1257592|P1|STARTED|Overall Study||200
522116|NCT00057330|1257602|P2|NOT COMPLETED|Overall Study||920
522117|NCT00057330|1257603|P1|NOT COMPLETED|Overall Study||1132
522118|NCT00057330|1257602|P2|COMPLETED|Overall Study||2826
522119|NCT00057330|1257603|P1|COMPLETED|Overall Study||3445
522120|NCT00057330|1257602|P2|STARTED|Overall Study||3746
522121|NCT00057330|1257603|P1|STARTED|Overall Study||4577
522122|NCT00056862|1257633|P2|NOT COMPLETED|Overall Study||0
522123|NCT00056862|1257634|P1|NOT COMPLETED|Overall Study||1
522124|NCT00056862|1257633|P2|COMPLETED|Overall Study||27
522125|NCT00056862|1257634|P1|COMPLETED|Overall Study||30
522126|NCT00056862|1257633|P2|STARTED|Overall Study||27
522127|NCT00056862|1257634|P1|STARTED|Overall Study||31
522128|NCT00056563|1257650|P2|NOT COMPLETED|Overall Study||0
522129|NCT00056563|1257651|P1|NOT COMPLETED|Overall Study||0
522130|NCT00056563|1257650|P2|COMPLETED|Overall Study||134
522131|NCT00056563|1257651|P1|COMPLETED|Overall Study||121
522132|NCT00056563|1257650|P2|STARTED|Overall Study||134
522133|NCT00056563|1257651|P1|STARTED|Overall Study||121
522134|NCT00056550|1257659|P1|NOT COMPLETED|Overall Study||0
522135|NCT00056550|1257659|P1|COMPLETED|Overall Study||14
522136|NCT00056550|1257659|P1|STARTED|Overall Study||14
522137|NCT00056498|1257666|P2|NOT COMPLETED|Overall Study||7
522138|NCT00056498|1257667|P1|NOT COMPLETED|Overall Study||5
522139|NCT00056498|1257666|P2|COMPLETED|Overall Study||28
522140|NCT00056498|1257667|P1|COMPLETED|Overall Study||25
522141|NCT00056498|1257666|P2|STARTED|Overall Study||35
522142|NCT00056498|1257667|P1|STARTED|Overall Study||30
522143|NCT00056472|1257675|P2|NOT COMPLETED|Overall Study||69
522144|NCT00056472|1257676|P1|NOT COMPLETED|Overall Study||48
522145|NCT00056472|1257675|P2|COMPLETED|Overall Study||61
522146|NCT00056472|1257676|P1|COMPLETED|Overall Study||81
522147|NCT00056472|1257675|P2|STARTED|Overall Study||130
522148|NCT00056472|1257676|P1|STARTED|Overall Study||129
522149|NCT00056407|1257688|P2|NOT COMPLETED|Overall Study||1193
522150|NCT00056407|1257689|P1|NOT COMPLETED|Overall Study||1211
522151|NCT00056407|1257688|P2|COMPLETED|Overall Study||2912
522152|NCT00056407|1257689|P1|COMPLETED|Overall Study||2915
522153|NCT00056407|1257688|P2|STARTED|Overall Study||4105
522154|NCT00056407|1257689|P1|STARTED|Overall Study||4126
522155|NCT00056316|1257747|P2|NOT COMPLETED|Overall Study||3
522156|NCT00056316|1257748|P1|NOT COMPLETED|Overall Study||3
522157|NCT00056316|1257747|P2|COMPLETED|Overall Study||38
522158|NCT00056316|1257748|P1|COMPLETED|Overall Study||30
522159|NCT00056316|1257747|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
522160|NCT00056316|1257748|P1|STARTED|Overall Study||33
522161|NCT00056160|1257762|P2|NOT COMPLETED|Final Follow-up||0
522162|NCT00056160|1257763|P1|NOT COMPLETED|Final Follow-up||6
522163|NCT00056160|1257762|P2|COMPLETED|Final Follow-up||0
522164|NCT00056160|1257763|P1|COMPLETED|Final Follow-up||0
522165|NCT00056160|1257762|P2|STARTED|Final Follow-up||0
522166|NCT00056160|1257763|P1|STARTED|Final Follow-up||6
522167|NCT00056160|1257762|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
522168|NCT00056160|1257763|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
522169|NCT00056160|1257762|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
522170|NCT00056160|1257763|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
522171|NCT00056160|1257762|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
522172|NCT00056160|1257763|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
522173|NCT00056160|1257762|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
522175|NCT00056160|1257762|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
522176|NCT00056160|1257763|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
522177|NCT00056160|1257762|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
522178|NCT00056160|1257763|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
522179|NCT00055692|1257775|P1|NOT COMPLETED|Overall Study||0
522180|NCT00055692|1257775|P1|COMPLETED|Overall Study||46
522181|NCT00055692|1257775|P1|STARTED|Overall Study||46
522182|NCT00055601|1257786|P2|NOT COMPLETED|Overall Study||2
522183|NCT00055601|1257787|P1|NOT COMPLETED|Overall Study||2
522184|NCT00055601|1257786|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
522185|NCT00055601|1257787|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
522186|NCT00055601|1257786|P2|STARTED|Overall Study||49
522187|NCT00055601|1257787|P1|STARTED|Overall Study||48
522188|NCT00055497|1257801|P4|NOT COMPLETED|Overall Study||90
522189|NCT00055497|1257802|P3|NOT COMPLETED|Overall Study||2
522190|NCT00055497|1257803|P2|NOT COMPLETED|Overall Study||3
522191|NCT00055497|1257804|P1|NOT COMPLETED|Overall Study||5
522192|NCT00055497|1257801|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
522193|NCT00055497|1257802|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
522194|NCT00055497|1257803|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
522195|NCT00055497|1257804|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
522196|NCT00055497|1257801|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
522197|NCT00055497|1257802|P3|STARTED|Overall Study||18
522198|NCT00055497|1257803|P2|STARTED|Overall Study||19
522199|NCT00055497|1257804|P1|STARTED|Overall Study||18
522200|NCT00055471|1257849|P3|NOT COMPLETED|Period 2: Extension Period||0
522201|NCT00055471|1257850|P2|NOT COMPLETED|Period 2: Extension Period||0
522202|NCT00055471|1257851|P1|NOT COMPLETED|Period 2: Extension Period||0
522203|NCT00055471|1257849|P3|COMPLETED|Period 2: Extension Period||0
522204|NCT00055471|1257850|P2|COMPLETED|Period 2: Extension Period||6
522205|NCT00055471|1257851|P1|COMPLETED|Period 2: Extension Period||3
522206|NCT00055471|1257849|P3|STARTED|Period 2: Extension Period||0
522207|NCT00055471|1257850|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
522208|NCT00055471|1257851|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
522209|NCT00055471|1257849|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
522210|NCT00055471|1257850|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
522211|NCT00055471|1257851|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
522212|NCT00055471|1257849|P3|COMPLETED|Period 1: Dose Escalation Period||0
522213|NCT00055471|1257850|P2|COMPLETED|Period 1: Dose Escalation Period||8
522214|NCT00055471|1257851|P1|COMPLETED|Period 1: Dose Escalation Period||3
522215|NCT00055471|1257849|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
522216|NCT00055471|1257850|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
522217|NCT00055471|1257851|P1|STARTED|Period 1: Dose Escalation Period||3
522218|NCT00055237|1257879|P2|NOT COMPLETED|Overall Study||0
522219|NCT00055237|1257880|P1|NOT COMPLETED|Overall Study||0
522220|NCT00055237|1257879|P2|COMPLETED|Overall Study||2
522221|NCT00055237|1257880|P1|COMPLETED|Overall Study||17
522222|NCT00055237|1257879|P2|STARTED|Overall Study||2
522223|NCT00055237|1257880|P1|STARTED|Overall Study||17
522224|NCT00054847|1257887|P2|NOT COMPLETED|Overall Study||100
522225|NCT00054847|1257888|P1|NOT COMPLETED|Overall Study||98
522226|NCT00054847|1257887|P2|COMPLETED|Overall Study||266
522227|NCT00054847|1257888|P1|COMPLETED|Overall Study||269
522228|NCT00054847|1257887|P2|STARTED|Overall Study||366
522229|NCT00054847|1257888|P1|STARTED|Overall Study||367
522230|NCT00054717|1257902|P2|NOT COMPLETED|Overall Study||299
522231|NCT00054717|1257903|P1|NOT COMPLETED|Overall Study||262
522232|NCT00054717|1257902|P2|COMPLETED|Overall Study||18
522233|NCT00054717|1257903|P1|COMPLETED|Overall Study||51
522234|NCT00054717|1257902|P2|STARTED|Overall Study||317
522235|NCT00054717|1257903|P1|STARTED|Overall Study||313
522236|NCT00054704|1258091|P2|NOT COMPLETED|Overall Study||5
522237|NCT00054704|1258092|P1|NOT COMPLETED|Overall Study||5
522238|NCT00054704|1258091|P2|COMPLETED|Overall Study||6
522239|NCT00054704|1258092|P1|COMPLETED|Overall Study||4
522240|NCT00054704|1258091|P2|STARTED|Overall Study||11
522241|NCT00054704|1258092|P1|STARTED|Overall Study||9
522242|NCT00054691|1258098|P1|NOT COMPLETED|Overall Study||3
522243|NCT00054691|1258098|P1|COMPLETED|Overall Study||37
522244|NCT00054691|1258098|P1|STARTED|Overall Study||40
522245|NCT00054665|1258103|P2|NOT COMPLETED|Part B||0
522246|NCT00054665|1258104|P1|NOT COMPLETED|Part B||0
522247|NCT00054665|1258103|P2|COMPLETED|Part B||44
522248|NCT00054665|1258104|P1|COMPLETED|Part B||0
522249|NCT00054665|1258103|P2|STARTED|Part B|26 participants received only Part B|44
522250|NCT00054665|1258104|P1|STARTED|Part B||0
522251|NCT00054665|1258103|P2|NOT COMPLETED|Part A||0
522252|NCT00054665|1258104|P1|NOT COMPLETED|Part A||0
522253|NCT00054665|1258103|P2|COMPLETED|Part A||0
522254|NCT00054665|1258104|P1|COMPLETED|Part A||23
522255|NCT00054665|1258103|P2|STARTED|Part A||0
522256|NCT00054665|1258104|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
522257|NCT00054639|1258112|P1|NOT COMPLETED|Overall Study||2
522258|NCT00054639|1258112|P1|COMPLETED|Overall Study||46
522259|NCT00054639|1258112|P1|STARTED|Overall Study||48
522260|NCT00054327|1258122|P6|NOT COMPLETED|Overall Study||0
522261|NCT00054327|1258123|P5|NOT COMPLETED|Overall Study||0
522262|NCT00054327|1258124|P4|NOT COMPLETED|Overall Study||0
522263|NCT00054327|1258125|P3|NOT COMPLETED|Overall Study||0
522264|NCT00054327|1258126|P2|NOT COMPLETED|Overall Study||0
522265|NCT00054327|1258127|P1|NOT COMPLETED|Overall Study||1
522266|NCT00054327|1258122|P6|COMPLETED|Overall Study||2
522267|NCT00054327|1258123|P5|COMPLETED|Overall Study||10
522268|NCT00054327|1258124|P4|COMPLETED|Overall Study||4
522269|NCT00054327|1258125|P3|COMPLETED|Overall Study||3
522270|NCT00054327|1258126|P2|COMPLETED|Overall Study||4
522271|NCT00054327|1258127|P1|COMPLETED|Overall Study||10
522272|NCT00054327|1258122|P6|STARTED|Overall Study||2
522273|NCT00054327|1258123|P5|STARTED|Overall Study||10
522274|NCT00054327|1258124|P4|STARTED|Overall Study||4
522275|NCT00054327|1258125|P3|STARTED|Overall Study||3
522276|NCT00054327|1258126|P2|STARTED|Overall Study||4
522277|NCT00054327|1258127|P1|STARTED|Overall Study||11
522278|NCT00054275|1258165|P1|NOT COMPLETED|Overall Study||11
522279|NCT00054275|1258165|P1|COMPLETED|Overall Study||28
522280|NCT00054275|1258165|P1|STARTED|Overall Study||39
522281|NCT00054028|1258173|P1|NOT COMPLETED|Overall Study||0
522282|NCT00054028|1258173|P1|COMPLETED|Overall Study||31
522283|NCT00054028|1258173|P1|Phase II|Overall Study||22
522284|NCT00054028|1258173|P1|Phase I|Overall Study||9
522285|NCT00054028|1258173|P1|STARTED|Overall Study||31
522286|NCT00053846|1258181|P2|NOT COMPLETED|Overall Study||27
522287|NCT00053846|1258182|P1|NOT COMPLETED|Overall Study||26
522288|NCT00053846|1258181|P2|COMPLETED|Overall Study||192
522289|NCT00053846|1258182|P1|COMPLETED|Overall Study||187
522290|NCT00053846|1258181|P2|STARTED|Overall Study||219
522291|NCT00053846|1258182|P1|STARTED|Overall Study||213
522292|NCT00053703|1258191|P3|NOT COMPLETED|Overall Study||15
522293|NCT00053703|1258192|P2|NOT COMPLETED|Overall Study||13
522294|NCT00053703|1258193|P1|NOT COMPLETED|Overall Study||18
522295|NCT00053703|1258191|P3|COMPLETED|Overall Study||25
522296|NCT00053703|1258192|P2|COMPLETED|Overall Study||28
522297|NCT00053703|1258193|P1|COMPLETED|Overall Study||17
522298|NCT00053703|1258191|P3|STARTED|Overall Study||40
522299|NCT00053703|1258192|P2|STARTED|Overall Study||41
522300|NCT00053703|1258193|P1|STARTED|Overall Study||35
522301|NCT00053495|1258221|P5|NOT COMPLETED|Overall Study||0
522302|NCT00053495|1258222|P4|NOT COMPLETED|Overall Study||0
522303|NCT00053495|1258223|P3|NOT COMPLETED|Overall Study||0
522304|NCT00053495|1258224|P2|NOT COMPLETED|Overall Study||0
522305|NCT00053495|1258225|P1|NOT COMPLETED|Overall Study||0
522306|NCT00053495|1258221|P5|COMPLETED|Overall Study||49
522307|NCT00053495|1258222|P4|COMPLETED|Overall Study||51
522308|NCT00053495|1258223|P3|COMPLETED|Overall Study||101
522309|NCT00053495|1258224|P2|COMPLETED|Overall Study||101
522310|NCT00053495|1258225|P1|COMPLETED|Overall Study||51
522311|NCT00053495|1258221|P5|STARTED|Overall Study||49
522312|NCT00053495|1258222|P4|STARTED|Overall Study||51
522313|NCT00053495|1258223|P3|STARTED|Overall Study||101
522314|NCT00053495|1258224|P2|STARTED|Overall Study||101
522315|NCT00053495|1258225|P1|STARTED|Overall Study||51
522316|NCT00053482|1258277|P5|NOT COMPLETED|Overall Study||0
522317|NCT00053482|1258278|P4|NOT COMPLETED|Overall Study||0
522318|NCT00053482|1258279|P3|NOT COMPLETED|Overall Study||0
522319|NCT00053482|1258280|P2|NOT COMPLETED|Overall Study||0
522320|NCT00053482|1258281|P1|NOT COMPLETED|Overall Study||0
522321|NCT00053482|1258277|P5|COMPLETED|Overall Study||52
522322|NCT00053482|1258278|P4|COMPLETED|Overall Study||50
522323|NCT00053482|1258279|P3|COMPLETED|Overall Study||102
522324|NCT00053482|1258280|P2|COMPLETED|Overall Study||102
522325|NCT00053482|1258281|P1|COMPLETED|Overall Study||51
522326|NCT00053482|1258277|P5|STARTED|Overall Study||52
522327|NCT00053482|1258278|P4|STARTED|Overall Study||50
522328|NCT00053482|1258279|P3|STARTED|Overall Study||102
522329|NCT00053482|1258280|P2|STARTED|Overall Study||102
522330|NCT00053482|1258281|P1|STARTED|Overall Study||51
522331|NCT00053417|1258332|P4|NOT COMPLETED|Overall Study||6
522332|NCT00053417|1258333|P3|NOT COMPLETED|Overall Study||1
522333|NCT00053417|1258334|P2|NOT COMPLETED|Overall Study||2
522334|NCT00053417|1258335|P1|NOT COMPLETED|Overall Study||2
522335|NCT00053417|1258332|P4|COMPLETED|Overall Study||51
522336|NCT00053417|1258333|P3|COMPLETED|Overall Study||49
522337|NCT00053417|1258334|P2|COMPLETED|Overall Study||50
522338|NCT00053417|1258335|P1|COMPLETED|Overall Study||45
522339|NCT00053417|1258332|P4|STARTED|Overall Study||57
522340|NCT00053417|1258333|P3|STARTED|Overall Study||50
522341|NCT00053417|1258334|P2|STARTED|Overall Study||52
522342|NCT00053417|1258335|P1|STARTED|Overall Study||47
522343|NCT00053365|1258345|P1|NOT COMPLETED|Overall Study||6
522344|NCT00053365|1258345|P1|COMPLETED|Overall Study||55
522345|NCT00053365|1258345|P1|STARTED|Overall Study||61
522346|NCT00053014|1258350|P1|NOT COMPLETED|Overall Study||0
522347|NCT00053014|1258350|P1|COMPLETED|Overall Study||5
522348|NCT00053014|1258350|P1|STARTED|Overall Study||5
522349|NCT00052962|1258357|P2|NOT COMPLETED|Overall Study||2
522350|NCT00052962|1258358|P1|NOT COMPLETED|Overall Study||1
522351|NCT00052962|1258357|P2|COMPLETED|Overall Study||15
522352|NCT00052962|1258358|P1|COMPLETED|Overall Study||12
522353|NCT00052962|1258357|P2|STARTED|Overall Study||17
522354|NCT00052962|1258358|P1|STARTED|Overall Study||13
522355|NCT00052715|1258366|P1|NOT COMPLETED|Overall Study||1
522356|NCT00052715|1258366|P1|COMPLETED|Overall Study||30
522357|NCT00052715|1258366|P1|STARTED|Overall Study||31
522358|NCT00052429|1258373|P1|NOT COMPLETED|Overall Study||0
522359|NCT00052429|1258373|P1|COMPLETED|Overall Study||25
522360|NCT00052429|1258373|P1|STARTED|Overall Study||25
522361|NCT00052078|1258382|P4|NOT COMPLETED|Overall Study||15
522362|NCT00052078|1258383|P3|NOT COMPLETED|Overall Study||13
522363|NCT00052078|1258384|P2|NOT COMPLETED|Overall Study||6
522364|NCT00052078|1258385|P1|NOT COMPLETED|Overall Study||23
522365|NCT00052078|1258382|P4|COMPLETED|Overall Study||61
522366|NCT00052078|1258383|P3|COMPLETED|Overall Study||127
522367|NCT00052078|1258384|P2|COMPLETED|Overall Study||133
522368|NCT00052078|1258385|P1|COMPLETED|Overall Study||110
522369|NCT00052078|1258382|P4|STARTED|Overall Study||76
522370|NCT00052078|1258383|P3|STARTED|Overall Study||140
522371|NCT00052078|1258384|P2|STARTED|Overall Study||139
522372|NCT00052078|1258385|P1|STARTED|Overall Study||133
522373|NCT00051636|1258397|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
522374|NCT00051636|1258398|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
522375|NCT00051636|1258397|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
522376|NCT00051636|1258398|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
522377|NCT00051636|1258397|P2|STARTED|Period 2- Extended Observation Period||52
522378|NCT00051636|1258398|P1|STARTED|Period 2- Extended Observation Period||75
522379|NCT00051636|1258397|P2|NOT COMPLETED|Period 1 - Core||6
522380|NCT00051636|1258398|P1|NOT COMPLETED|Period 1 - Core||4
522381|NCT00051636|1258397|P2|COMPLETED|Period 1 - Core||76
522382|NCT00051636|1258398|P1|COMPLETED|Period 1 - Core||86
522383|NCT00051636|1258397|P2|STARTED|Period 1 - Core||82
522384|NCT00051636|1258398|P1|STARTED|Period 1 - Core||90
522385|NCT00051558|1258426|P2|NOT COMPLETED|Overall Study||96
522386|NCT00051558|1258427|P1|NOT COMPLETED|Overall Study||91
522387|NCT00051558|1258426|P2|COMPLETED|Overall Study||118
522388|NCT00051558|1258427|P1|COMPLETED|Overall Study||123
522389|NCT00051558|1258426|P2|STARTED|Overall Study||214
522390|NCT00051558|1258427|P1|STARTED|Overall Study||214
522391|NCT00051363|1258463|P2|NOT COMPLETED|Overall Study||144
522392|NCT00051363|1258464|P1|NOT COMPLETED|Overall Study||115
522393|NCT00051363|1258463|P2|COMPLETED|Overall Study||403
522394|NCT00051363|1258464|P1|COMPLETED|Overall Study||443
522395|NCT00051363|1258463|P2|Completed 6M Vist On-Study|Overall Study||403
522396|NCT00051363|1258464|P1|Completed 6M Vist On-Study|Overall Study||443
522397|NCT00051363|1258463|P2|Completed 6M Visit On-Treatment|Overall Study||372
522398|NCT00051363|1258464|P1|Completed 6M Visit On-Treatment|Overall Study||427
522399|NCT00051363|1258463|P2|Completed 2M Visit On-Study|Overall Study||432
522400|NCT00051363|1258464|P1|Completed 2M Visit On-Study|Overall Study||468
522401|NCT00051363|1258463|P2|Completed 2M Visit On-Treatment|Overall Study||417
522402|NCT00051363|1258464|P1|Completed 2M Visit On-Treatment|Overall Study||456
522403|NCT00051363|1258463|P2|Randomized & Analyzed|Overall Study||542
522404|NCT00051363|1258464|P1|Randomized & Analyzed|Overall Study||556
522405|NCT00051363|1258463|P2|STARTED|Overall Study||547
522406|NCT00051363|1258464|P1|STARTED|Overall Study||558
522407|NCT00050778|1258501|P3|NOT COMPLETED|Overall Study||18
522408|NCT00050778|1258502|P2|NOT COMPLETED|Overall Study||21
522409|NCT00050778|1258503|P1|NOT COMPLETED|Overall Study||45
522410|NCT00050778|1258501|P3|COMPLETED|Overall Study||92
522411|NCT00050778|1258502|P2|COMPLETED|Overall Study||92
522412|NCT00050778|1258503|P1|COMPLETED|Overall Study||66
522413|NCT00050778|1258501|P3|Treated|Overall Study||108
522414|NCT00050778|1258502|P2|Treated|Overall Study||108
522415|NCT00050778|1258503|P1|Treated|Overall Study||107
522416|NCT00050778|1258501|P3|STARTED|Overall Study||110
522417|NCT00050778|1258502|P2|STARTED|Overall Study||113
522418|NCT00050778|1258503|P1|STARTED|Overall Study|Randomized.|111
522419|NCT00050622|1258529|P1|NOT COMPLETED|Overall Study||1
522420|NCT00050622|1258529|P1|COMPLETED|Overall Study||153
522421|NCT00050622|1258529|P1|STARTED|Overall Study||154
522422|NCT00051168|1258565|P1|NOT COMPLETED|Overall Study||135
522423|NCT00051168|1258565|P1|COMPLETED|Overall Study||367
522424|NCT00051168|1258565|P1|STARTED|Overall Study||502
522425|NCT00051025|1258571|P2|NOT COMPLETED|Overall Study||4
522426|NCT00051025|1258572|P1|NOT COMPLETED|Overall Study||2
522427|NCT00051025|1258571|P2|COMPLETED|Overall Study||0
522428|NCT00051025|1258572|P1|COMPLETED|Overall Study||3
522429|NCT00051025|1258571|P2|STARTED|Overall Study||4
522430|NCT00051025|1258572|P1|STARTED|Overall Study||5
522431|NCT00050986|1258580|P1|NOT COMPLETED|Overall Study||2
522432|NCT00050986|1258580|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
522433|NCT00050986|1258580|P1|STARTED|Overall Study||55
522434|NCT00050960|1258586|P2|NOT COMPLETED|Overall Study||304
522435|NCT00050960|1258587|P1|NOT COMPLETED|Overall Study||302
522436|NCT00050960|1258586|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
522437|NCT00050960|1258587|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
522438|NCT00050960|1258586|P2|STARTED|Overall Study||306
522439|NCT00050960|1258587|P1|STARTED|Overall Study||306
522440|NCT00050167|1258595|P2|NOT COMPLETED|Overall Study||1
522441|NCT00050167|1258596|P1|NOT COMPLETED|Overall Study||1
522442|NCT00050167|1258595|P2|COMPLETED|Overall Study||300
522443|NCT00050167|1258596|P1|COMPLETED|Overall Study||301
522444|NCT00050167|1258595|P2|STARTED|Overall Study||301
522445|NCT00050167|1258596|P1|STARTED|Overall Study||302
522446|NCT00050089|1258606|P4|NOT COMPLETED|Overall Study||0
522447|NCT00050089|1258607|P3|NOT COMPLETED|Overall Study||0
522448|NCT00050089|1258608|P2|NOT COMPLETED|Overall Study||0
522449|NCT00050089|1258609|P1|NOT COMPLETED|Overall Study||0
522450|NCT00050089|1258606|P4|COMPLETED|Overall Study|For primary outcome assessment|78
522451|NCT00050089|1258607|P3|COMPLETED|Overall Study|For primary outcome assessment|86
522452|NCT00050089|1258608|P2|COMPLETED|Overall Study|For primary outcome assessment|98
522453|NCT00050089|1258609|P1|COMPLETED|Overall Study|For primary outcome assessment|106
522454|NCT00050089|1258606|P4|Baseline|Overall Study||78
522455|NCT00050089|1258607|P3|Baseline|Overall Study||86
522456|NCT00050089|1258608|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
522457|NCT00050089|1258609|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
522458|NCT00050089|1258606|P4|STARTED|Overall Study||78
522459|NCT00050089|1258607|P3|STARTED|Overall Study||86
522460|NCT00050089|1258608|P2|STARTED|Overall Study||98
522461|NCT00050089|1258609|P1|STARTED|Overall Study||106
522462|NCT00050011|1258629|P2|NOT COMPLETED|Overall Study||126
522463|NCT00050011|1258630|P1|NOT COMPLETED|Overall Study||121
522464|NCT00050011|1258629|P2|COMPLETED|Overall Study||175
522465|NCT00050011|1258630|P1|COMPLETED|Overall Study||180
522466|NCT00050011|1258629|P2|Intent-to-treat Population|Overall Study||300
522467|NCT00050011|1258630|P1|Intent-to-treat Population|Overall Study||300
522468|NCT00050011|1258629|P2|STARTED|Overall Study||301
522469|NCT00050011|1258630|P1|STARTED|Overall Study||301
522470|NCT00049842|1258652|P2|NOT COMPLETED|Follow-up Phase||5
522471|NCT00049842|1258653|P1|NOT COMPLETED|Follow-up Phase||7
522472|NCT00049842|1258652|P2|COMPLETED|Follow-up Phase||189
522473|NCT00049842|1258653|P1|COMPLETED|Follow-up Phase||211
522474|NCT00049842|1258652|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
522475|NCT00049842|1258653|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
522476|NCT00049842|1258652|P2|NOT COMPLETED|Treatment Phase||78
522477|NCT00049842|1258653|P1|NOT COMPLETED|Treatment Phase||93
522478|NCT00049842|1258652|P2|COMPLETED|Treatment Phase||192
522479|NCT00049842|1258653|P1|COMPLETED|Treatment Phase||177
522480|NCT00049842|1258652|P2|STARTED|Treatment Phase||270
522481|NCT00049842|1258653|P1|STARTED|Treatment Phase||270
522482|NCT00049543|1258671|P2|NOT COMPLETED|Overall Study||9
522483|NCT00049543|1258672|P1|NOT COMPLETED|Overall Study||2
522484|NCT00049543|1258671|P2|COMPLETED|Overall Study||243
522485|NCT00049543|1258672|P1|COMPLETED|Overall Study||249
522486|NCT00049543|1258671|P2|STARTED|Overall Study||252
522487|NCT00049543|1258672|P1|STARTED|Overall Study||251
522488|NCT00049530|1258682|P1|NOT COMPLETED|Overall Study||32
522489|NCT00049530|1258682|P1|COMPLETED|Overall Study||0
522490|NCT00049530|1258682|P1|Eligible and Treated|Overall Study||29
522491|NCT00049530|1258682|P1|STARTED|Overall Study||32
522492|NCT00049517|1258691|P6|NOT COMPLETED|Conditioning/Transplant||6
522493|NCT00049517|1258692|P5|NOT COMPLETED|Conditioning/Transplant||6
522494|NCT00049517|1258693|P4|NOT COMPLETED|Conditioning/Transplant||43
522495|NCT00049517|1258694|P3|NOT COMPLETED|Conditioning/Transplant||38
522496|NCT00049517|1258695|P2|NOT COMPLETED|Conditioning/Transplant||50
522497|NCT00049517|1258696|P1|NOT COMPLETED|Conditioning/Transplant||52
522498|NCT00049517|1258691|P6|COMPLETED|Conditioning/Transplant||18
522499|NCT00049517|1258692|P5|COMPLETED|Conditioning/Transplant||15
522500|NCT00049517|1258693|P4|COMPLETED|Conditioning/Transplant||32
522501|NCT00049517|1258694|P3|COMPLETED|Conditioning/Transplant||25
522502|NCT00049517|1258695|P2|COMPLETED|Conditioning/Transplant||40
522503|NCT00049517|1258696|P1|COMPLETED|Conditioning/Transplant||27
522504|NCT00049517|1258691|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
522505|NCT00049517|1258692|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
522506|NCT00049517|1258693|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
522507|NCT00049517|1258694|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
522508|NCT00049517|1258695|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
522509|NCT00049517|1258696|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
522510|NCT00049517|1258691|P6|STARTED|Conditioning/Transplant||24
522511|NCT00049517|1258692|P5|STARTED|Conditioning/Transplant||21
522512|NCT00049517|1258693|P4|STARTED|Conditioning/Transplant||75
522513|NCT00049517|1258694|P3|STARTED|Conditioning/Transplant||63
522514|NCT00049517|1258695|P2|STARTED|Conditioning/Transplant||90
522515|NCT00049517|1258696|P1|STARTED|Conditioning/Transplant||79
522516|NCT00049517|1258691|P6|NOT COMPLETED|Induction||54
522517|NCT00049517|1258692|P5|NOT COMPLETED|Induction||60
522518|NCT00049517|1258693|P4|NOT COMPLETED|Induction||0
522519|NCT00049517|1258694|P3|NOT COMPLETED|Induction||0
522520|NCT00049517|1258695|P2|NOT COMPLETED|Induction||0
522521|NCT00049517|1258696|P1|NOT COMPLETED|Induction||0
522522|NCT00049517|1258691|P6|COMPLETED|Induction||108
522523|NCT00049517|1258692|P5|COMPLETED|Induction||128
522524|NCT00049517|1258693|P4|COMPLETED|Induction||75
522525|NCT00049517|1258694|P3|COMPLETED|Induction||63
522526|NCT00049517|1258695|P2|COMPLETED|Induction||90
522527|NCT00049517|1258696|P1|COMPLETED|Induction||79
522528|NCT00049517|1258691|P6|Treated|Induction||160
522529|NCT00049517|1258692|P5|Treated|Induction||186
522530|NCT00049517|1258693|P4|Treated|Induction||75
522531|NCT00049517|1258694|P3|Treated|Induction||63
522532|NCT00049517|1258695|P2|Treated|Induction||90
522533|NCT00049517|1258696|P1|Treated|Induction||79
522534|NCT00049517|1258691|P6|STARTED|Induction||162
522535|NCT00049517|1258692|P5|STARTED|Induction||188
522536|NCT00049517|1258693|P4|STARTED|Induction||75
522537|NCT00049517|1258694|P3|STARTED|Induction||63
522538|NCT00049517|1258695|P2|STARTED|Induction||90
522539|NCT00049517|1258696|P1|STARTED|Induction||79
522540|NCT00049504|1258706|P1|NOT COMPLETED|Overall Study||0
522541|NCT00049504|1258706|P1|COMPLETED|Overall Study||55
522542|NCT00049504|1258706|P1|STARTED|Overall Study||55
522543|NCT00049322|1258714|P2|NOT COMPLETED|Overall Study||6
522544|NCT00049322|1258715|P1|NOT COMPLETED|Overall Study||1
522545|NCT00049322|1258714|P2|COMPLETED|Overall Study||9
522546|NCT00049322|1258715|P1|COMPLETED|Overall Study||14
522547|NCT00049322|1258714|P2|STARTED|Overall Study||15
522548|NCT00049322|1258715|P1|STARTED|Overall Study||15
522549|NCT00049257|1258727|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
522550|NCT00049257|1258727|P1|COMPLETED|Follow-up Period for Survival Status||41
522551|NCT00049257|1258727|P1|STARTED|Follow-up Period for Survival Status||45
522552|NCT00049257|1258727|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
522553|NCT00049257|1258727|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
522554|NCT00049257|1258727|P1|STARTED|Carboplatin, Paclitaxel||58
522555|NCT00049127|1258739|P5|NOT COMPLETED|Overall Study||0
522556|NCT00049127|1258740|P4|NOT COMPLETED|Overall Study||0
522557|NCT00049127|1258741|P3|NOT COMPLETED|Overall Study||1
522558|NCT00049127|1258742|P2|NOT COMPLETED|Overall Study||0
522559|NCT00049127|1258743|P1|NOT COMPLETED|Overall Study||0
522560|NCT00049127|1258739|P5|COMPLETED|Overall Study||12
522561|NCT00049127|1258740|P4|COMPLETED|Overall Study||0
522562|NCT00049127|1258741|P3|COMPLETED|Overall Study||39
522563|NCT00049127|1258742|P2|COMPLETED|Overall Study||0
522564|NCT00049127|1258743|P1|COMPLETED|Overall Study||12
522565|NCT00049127|1258739|P5|STARTED|Overall Study||12
522566|NCT00049127|1258740|P4|STARTED|Overall Study||0
522567|NCT00049127|1258741|P3|STARTED|Overall Study||40
522568|NCT00049127|1258742|P2|STARTED|Overall Study||0
522569|NCT00049127|1258743|P1|STARTED|Overall Study||12
522570|NCT00049036|1258772|P2|NOT COMPLETED|Overall Study||0
522571|NCT00049036|1258773|P1|NOT COMPLETED|Overall Study||0
522572|NCT00049036|1258772|P2|COMPLETED|Overall Study||55
522573|NCT00049036|1258773|P1|COMPLETED|Overall Study||51
522574|NCT00049036|1258772|P2|STARTED|Overall Study||55
522575|NCT00049036|1258773|P1|STARTED|Overall Study||51
522576|NCT00048997|1258781|P2|NOT COMPLETED|Overall Study||3
522577|NCT00048997|1258782|P1|NOT COMPLETED|Overall Study||13
522578|NCT00048997|1258781|P2|COMPLETED|Overall Study||177
522579|NCT00048997|1258782|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
522580|NCT00048997|1258781|P2|STARTED|Overall Study||180
522581|NCT00048997|1258782|P1|STARTED|Overall Study||176
522582|NCT00048932|1258789|P3|NOT COMPLETED|Open Label Period (OL)||441
522583|NCT00048932|1258790|P2|NOT COMPLETED|Open Label Period (OL)||0
522584|NCT00048932|1258791|P1|NOT COMPLETED|Open Label Period (OL)||0
522585|NCT00048932|1258789|P3|COMPLETED|Open Label Period (OL)||743
522586|NCT00048932|1258790|P2|COMPLETED|Open Label Period (OL)||0
522587|NCT00048932|1258791|P1|COMPLETED|Open Label Period (OL)||0
522588|NCT00048932|1258789|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
522589|NCT00048932|1258790|P2|STARTED|Open Label Period (OL)||0
522590|NCT00048932|1258791|P1|STARTED|Open Label Period (OL)||0
522591|NCT00048932|1258789|P3|NOT COMPLETED|Double Blind Period (DB)||0
522592|NCT00048932|1258790|P2|NOT COMPLETED|Double Blind Period (DB)||87
522593|NCT00048932|1258791|P1|NOT COMPLETED|Double Blind Period (DB)||123
522594|NCT00048932|1258789|P3|COMPLETED|Double Blind Period (DB)||0
522595|NCT00048932|1258790|P2|COMPLETED|Double Blind Period (DB)||395
522596|NCT00048932|1258791|P1|COMPLETED|Double Blind Period (DB)||836
522597|NCT00048932|1258789|P3|STARTED|Double Blind Period (DB)||0
522598|NCT00048932|1258790|P2|STARTED|Double Blind Period (DB)|Number Treated|482
522599|NCT00048932|1258791|P1|STARTED|Double Blind Period (DB)|Number Treated|959
522600|NCT00048893|1258815|P1|NOT COMPLETED|Overall Study||0
522601|NCT00048893|1258815|P1|COMPLETED|Overall Study||37
522602|NCT00048893|1258815|P1|STARTED|Overall Study||37
522603|NCT00048737|1258826|P1|NOT COMPLETED|Overall Study||0
522604|NCT00048737|1258826|P1|COMPLETED|Overall Study||70
522605|NCT00048737|1258826|P1|STARTED|Overall Study||70
522606|NCT00048724|1258832|P2|NOT COMPLETED|Overall Study||118
522607|NCT00048724|1258833|P1|NOT COMPLETED|Overall Study||116
522608|NCT00048724|1258832|P2|COMPLETED|Overall Study||197
522609|NCT00048724|1258833|P1|COMPLETED|Overall Study||195
522610|NCT00048724|1258832|P2|STARTED|Overall Study||315
522611|NCT00048724|1258833|P1|STARTED|Overall Study||311
522612|NCT00048581|1258843|P3|NOT COMPLETED|Open-Label Period||167
522613|NCT00048581|1258844|P2|NOT COMPLETED|Open-Label Period||0
522614|NCT00048581|1258845|P1|NOT COMPLETED|Open-Label Period||0
522615|NCT00048581|1258843|P3|COMPLETED|Open-Label Period||150
522616|NCT00048581|1258844|P2|COMPLETED|Open-Label Period||0
522617|NCT00048581|1258845|P1|COMPLETED|Open-Label Period||0
522618|NCT00048581|1258843|P3|STARTED|Open-Label Period||317
522619|NCT00048581|1258844|P2|STARTED|Open-Label Period||0
522620|NCT00048581|1258845|P1|STARTED|Open-Label Period||0
522621|NCT00048581|1258843|P3|NOT COMPLETED|Double-Blind Period||0
522622|NCT00048581|1258844|P2|NOT COMPLETED|Double-Blind Period||34
522623|NCT00048581|1258845|P1|NOT COMPLETED|Double-Blind Period||35
522624|NCT00048581|1258843|P3|COMPLETED|Double-Blind Period||0
522625|NCT00048581|1258844|P2|COMPLETED|Double-Blind Period||99
522626|NCT00048581|1258845|P1|COMPLETED|Double-Blind Period||223
522627|NCT00048581|1258843|P3|STARTED|Double-Blind Period||0
522628|NCT00048581|1258844|P2|STARTED|Double-Blind Period||133
522629|NCT00048581|1258845|P1|STARTED|Double-Blind Period||258
522630|NCT00048568|1259012|P3|NOT COMPLETED|Open-Label Period||160
522631|NCT00048568|1259013|P2|NOT COMPLETED|Open-Label Period||0
522632|NCT00048568|1259014|P1|NOT COMPLETED|Open-Label Period||0
522633|NCT00048568|1259012|P3|COMPLETED|Open-Label Period||379
522634|NCT00048568|1259013|P2|COMPLETED|Open-Label Period||0
522635|NCT00048568|1259014|P1|COMPLETED|Open-Label Period||0
522636|NCT00048568|1259012|P3|STARTED|Open-Label Period||539
522637|NCT00048568|1259013|P2|STARTED|Open-Label Period||0
522638|NCT00048568|1259014|P1|STARTED|Open-Label Period||0
522639|NCT00048568|1259012|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
522640|NCT00048568|1259013|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
522641|NCT00048568|1259014|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
522642|NCT00048568|1259012|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
522643|NCT00048568|1259013|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
522644|NCT00048568|1259014|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
522645|NCT00048568|1259012|P3|STARTED|Double-Blind Period Days 170 to 365||0
522646|NCT00048568|1259013|P2|STARTED|Double-Blind Period Days 170 to 365||174
522647|NCT00048568|1259014|P1|STARTED|Double-Blind Period Days 170 to 365||401
522648|NCT00048568|1259012|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
522649|NCT00048568|1259013|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
522650|NCT00048568|1259014|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
522651|NCT00048568|1259012|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
522652|NCT00048568|1259013|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
522653|NCT00048568|1259014|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
522654|NCT00048568|1259012|P3|STARTED|Double-Blind Period Days 1 to 169||0
522655|NCT00048568|1259013|P2|STARTED|Double-Blind Period Days 1 to 169||219
522656|NCT00048568|1259014|P1|STARTED|Double-Blind Period Days 1 to 169||433
522657|NCT00048542|1259306|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
522658|NCT00048542|1259307|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
522659|NCT00048542|1259308|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
522660|NCT00048542|1259309|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
522661|NCT00048542|1259310|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
522662|NCT00048542|1259311|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
522663|NCT00048542|1259312|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
522664|NCT00048542|1259313|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
522665|NCT00048542|1259306|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
522666|NCT00048542|1259307|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
522667|NCT00048542|1259308|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
522668|NCT00048542|1259309|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
522669|NCT00048542|1259310|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
522670|NCT00048542|1259311|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
522671|NCT00048542|1259312|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
522672|NCT00048542|1259313|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
522673|NCT00048542|1259306|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
522674|NCT00048542|1259307|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
522675|NCT00048542|1259308|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
522676|NCT00048542|1259309|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
522677|NCT00048542|1259310|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
522678|NCT00048542|1259311|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
522679|NCT00048542|1259312|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
522680|NCT00048542|1259313|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
522681|NCT00048542|1259306|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
522682|NCT00048542|1259307|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
522683|NCT00048542|1259308|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
522684|NCT00048542|1259309|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
522685|NCT00048542|1259310|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
522686|NCT00048542|1259311|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
522687|NCT00048542|1259312|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
522688|NCT00048542|1259313|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
522689|NCT00048542|1259306|P8|COMPLETED|Open-Label Extension BSA Phase||0
522690|NCT00048542|1259307|P7|COMPLETED|Open-Label Extension BSA Phase||0
522691|NCT00048542|1259308|P6|COMPLETED|Open-Label Extension BSA Phase||47
522692|NCT00048542|1259309|P5|COMPLETED|Open-Label Extension BSA Phase||59
522693|NCT00048542|1259310|P4|COMPLETED|Open-Label Extension BSA Phase||0
522694|NCT00048542|1259311|P3|COMPLETED|Open-Label Extension BSA Phase||0
522695|NCT00048542|1259312|P2|COMPLETED|Open-Label Extension BSA Phase||0
522696|NCT00048542|1259313|P1|COMPLETED|Open-Label Extension BSA Phase||0
522697|NCT00048542|1259306|P8|STARTED|Open-Label Extension BSA Phase||0
522698|NCT00048542|1259307|P7|STARTED|Open-Label Extension BSA Phase||0
522699|NCT00048542|1259308|P6|STARTED|Open-Label Extension BSA Phase||57
522700|NCT00048542|1259309|P5|STARTED|Open-Label Extension BSA Phase||71
522701|NCT00048542|1259310|P4|STARTED|Open-Label Extension BSA Phase||0
522702|NCT00048542|1259311|P3|STARTED|Open-Label Extension BSA Phase||0
522703|NCT00048542|1259312|P2|STARTED|Open-Label Extension BSA Phase||0
522704|NCT00048542|1259313|P1|STARTED|Open-Label Extension BSA Phase||0
522705|NCT00048542|1259306|P8|NOT COMPLETED|Double-Blind Phase||0
522706|NCT00048542|1259307|P7|NOT COMPLETED|Double-Blind Phase||0
522707|NCT00048542|1259308|P6|NOT COMPLETED|Double-Blind Phase||0
522708|NCT00048542|1259309|P5|NOT COMPLETED|Double-Blind Phase||0
522709|NCT00048542|1259310|P4|NOT COMPLETED|Double-Blind Phase||0
522710|NCT00048542|1259311|P3|NOT COMPLETED|Double-Blind Phase||1
522711|NCT00048542|1259312|P2|NOT COMPLETED|Double-Blind Phase||1
522712|NCT00048542|1259313|P1|NOT COMPLETED|Double-Blind Phase||3
522713|NCT00048542|1259306|P8|COMPLETED|Double-Blind Phase||0
522714|NCT00048542|1259307|P7|COMPLETED|Double-Blind Phase||0
522715|NCT00048542|1259308|P6|COMPLETED|Double-Blind Phase||0
522716|NCT00048542|1259309|P5|COMPLETED|Double-Blind Phase||0
522717|NCT00048542|1259310|P4|COMPLETED|Double-Blind Phase||28
522718|NCT00048542|1259311|P3|COMPLETED|Double-Blind Phase||29
522719|NCT00048542|1259312|P2|COMPLETED|Double-Blind Phase||36
522720|NCT00048542|1259313|P1|COMPLETED|Double-Blind Phase||35
522721|NCT00048542|1259306|P8|STARTED|Double-Blind Phase||0
522722|NCT00048542|1259307|P7|STARTED|Double-Blind Phase||0
522723|NCT00048542|1259308|P6|STARTED|Double-Blind Phase||0
522724|NCT00048542|1259309|P5|STARTED|Double-Blind Phase||0
522725|NCT00048542|1259310|P4|STARTED|Double-Blind Phase||28
522726|NCT00048542|1259311|P3|STARTED|Double-Blind Phase||30
522727|NCT00048542|1259312|P2|STARTED|Double-Blind Phase||37
522728|NCT00048542|1259313|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
522729|NCT00048347|1259379|P1|NOT COMPLETED|Overall Study||2
522730|NCT00048347|1259379|P1|COMPLETED|Overall Study||16
522731|NCT00048347|1259379|P1|STARTED|Overall Study||18
522732|NCT00048165|1259385|P2|NOT COMPLETED|Completed 12 Months Study||3
522733|NCT00048165|1259386|P1|NOT COMPLETED|Completed 12 Months Study||3
522734|NCT00048165|1259385|P2|COMPLETED|Completed 12 Months Study||167
522735|NCT00048165|1259386|P1|COMPLETED|Completed 12 Months Study||162
522736|NCT00048165|1259385|P2|STARTED|Completed 12 Months Study||170
522737|NCT00048165|1259386|P1|STARTED|Completed 12 Months Study||165
522738|NCT00048165|1259385|P2|NOT COMPLETED|Completed 6 Months Study||48
522739|NCT00048165|1259386|P1|NOT COMPLETED|Completed 6 Months Study||51
522740|NCT00048165|1259385|P2|COMPLETED|Completed 6 Months Study||170
522741|NCT00048165|1259386|P1|COMPLETED|Completed 6 Months Study||165
522742|NCT00048165|1259385|P2|STARTED|Completed 6 Months Study||218
522743|NCT00048165|1259386|P1|STARTED|Completed 6 Months Study||216
522744|NCT00048074|1259421|P3|NOT COMPLETED|Overall Study||97
522745|NCT00048074|1259422|P2|NOT COMPLETED|Overall Study||87
522746|NCT00048074|1259423|P1|NOT COMPLETED|Overall Study||81
522747|NCT00048074|1259421|P3|COMPLETED|Overall Study||372
522748|NCT00048074|1259422|P2|COMPLETED|Overall Study||361
522749|NCT00048074|1259423|P1|COMPLETED|Overall Study||384
522750|NCT00048074|1259421|P3|STARTED|Overall Study||469
522751|NCT00048074|1259422|P2|STARTED|Overall Study||448
522752|NCT00048074|1259423|P1|STARTED|Overall Study||465
522753|NCT00048061|1259480|P4|NOT COMPLETED|Overall Study||79
522754|NCT00048061|1259481|P3|NOT COMPLETED|Overall Study||84
522755|NCT00048061|1259482|P2|NOT COMPLETED|Overall Study||73
522756|NCT00048061|1259483|P1|NOT COMPLETED|Overall Study||75
522757|NCT00048061|1259480|P4|COMPLETED|Overall Study||322
522758|NCT00048061|1259481|P3|COMPLETED|Overall Study||316
522759|NCT00048061|1259482|P2|COMPLETED|Overall Study||328
522760|NCT00048061|1259483|P1|COMPLETED|Overall Study||325
522761|NCT00048061|1259480|P4|STARTED|Overall Study||401
522762|NCT00048061|1259481|P3|STARTED|Overall Study||400
522763|NCT00048061|1259482|P2|STARTED|Overall Study||401
522764|NCT00048061|1259483|P1|STARTED|Overall Study||400
522765|NCT00048035|1259559|P8|NOT COMPLETED|Extension Year 2||3
522766|NCT00048035|1259560|P7|NOT COMPLETED|Extension Year 2||3
522767|NCT00048035|1259561|P6|NOT COMPLETED|Extension Year 2||0
522768|NCT00048035|1259562|P5|NOT COMPLETED|Extension Year 2||0
522769|NCT00048035|1259563|P4|NOT COMPLETED|Extension Year 2||0
522770|NCT00048035|1259564|P3|NOT COMPLETED|Extension Year 2||0
522771|NCT00048035|1259565|P2|NOT COMPLETED|Extension Year 2||0
522772|NCT00048035|1259566|P1|NOT COMPLETED|Extension Year 2||0
522773|NCT00048035|1259559|P8|COMPLETED|Extension Year 2||10
522774|NCT00048035|1259560|P7|COMPLETED|Extension Year 2||11
522775|NCT00048035|1259561|P6|COMPLETED|Extension Year 2||0
522776|NCT00048035|1259562|P5|COMPLETED|Extension Year 2||0
522777|NCT00048035|1259563|P4|COMPLETED|Extension Year 2||0
522778|NCT00048035|1259564|P3|COMPLETED|Extension Year 2||0
522779|NCT00048035|1259565|P2|COMPLETED|Extension Year 2||0
522780|NCT00048035|1259566|P1|COMPLETED|Extension Year 2||0
522781|NCT00048035|1259559|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
522782|NCT00048035|1259560|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
522783|NCT00048035|1259561|P6|STARTED|Extension Year 2||0
522784|NCT00048035|1259562|P5|STARTED|Extension Year 2||0
522785|NCT00048035|1259563|P4|STARTED|Extension Year 2||0
522786|NCT00048035|1259564|P3|STARTED|Extension Year 2||0
522787|NCT00048035|1259565|P2|STARTED|Extension Year 2||0
522788|NCT00048035|1259566|P1|STARTED|Extension Year 2||0
522789|NCT00048035|1259559|P8|NOT COMPLETED|Extension Year 1||11
522790|NCT00048035|1259560|P7|NOT COMPLETED|Extension Year 1||11
522791|NCT00048035|1259561|P6|NOT COMPLETED|Extension Year 1||0
522792|NCT00048035|1259562|P5|NOT COMPLETED|Extension Year 1||0
522793|NCT00048035|1259563|P4|NOT COMPLETED|Extension Year 1||0
522794|NCT00048035|1259564|P3|NOT COMPLETED|Extension Year 1||0
522795|NCT00048035|1259565|P2|NOT COMPLETED|Extension Year 1||0
522796|NCT00048035|1259566|P1|NOT COMPLETED|Extension Year 1||0
522797|NCT00048035|1259559|P8|COMPLETED|Extension Year 1||15
522798|NCT00048035|1259560|P7|COMPLETED|Extension Year 1||16
522799|NCT00048035|1259561|P6|COMPLETED|Extension Year 1||0
522800|NCT00048035|1259562|P5|COMPLETED|Extension Year 1||0
522801|NCT00048035|1259563|P4|COMPLETED|Extension Year 1||0
522802|NCT00048035|1259564|P3|COMPLETED|Extension Year 1||0
522803|NCT00048035|1259565|P2|COMPLETED|Extension Year 1||0
522804|NCT00048035|1259566|P1|COMPLETED|Extension Year 1||0
522805|NCT00048035|1259559|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
522806|NCT00048035|1259560|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
522807|NCT00048035|1259561|P6|STARTED|Extension Year 1||0
522808|NCT00048035|1259562|P5|STARTED|Extension Year 1||0
522809|NCT00048035|1259563|P4|STARTED|Extension Year 1||0
522810|NCT00048035|1259564|P3|STARTED|Extension Year 1||0
522811|NCT00048035|1259565|P2|STARTED|Extension Year 1||0
522812|NCT00048035|1259566|P1|STARTED|Extension Year 1||0
522813|NCT00048035|1259559|P8|NOT COMPLETED|Core Period||0
522814|NCT00048035|1259560|P7|NOT COMPLETED|Core Period||0
522815|NCT00048035|1259561|P6|NOT COMPLETED|Core Period||1
522816|NCT00048035|1259562|P5|NOT COMPLETED|Core Period||1
522817|NCT00048035|1259563|P4|NOT COMPLETED|Core Period||1
522818|NCT00048035|1259564|P3|NOT COMPLETED|Core Period||1
522819|NCT00048035|1259565|P2|NOT COMPLETED|Core Period||2
522820|NCT00048035|1259566|P1|NOT COMPLETED|Core Period||4
522821|NCT00048035|1259559|P8|COMPLETED|Core Period||0
522822|NCT00048035|1259560|P7|COMPLETED|Core Period||0
522823|NCT00048035|1259561|P6|COMPLETED|Core Period||14
522824|NCT00048035|1259562|P5|COMPLETED|Core Period||15
522825|NCT00048035|1259563|P4|COMPLETED|Core Period||14
522826|NCT00048035|1259564|P3|COMPLETED|Core Period||14
522827|NCT00048035|1259565|P2|COMPLETED|Core Period||13
522828|NCT00048035|1259566|P1|COMPLETED|Core Period||11
522829|NCT00048035|1259559|P8|STARTED|Core Period||0
522830|NCT00048035|1259560|P7|STARTED|Core Period||0
522831|NCT00048035|1259561|P6|STARTED|Core Period||15
522832|NCT00048035|1259562|P5|STARTED|Core Period||16
522833|NCT00048035|1259563|P4|STARTED|Core Period||15
522834|NCT00048035|1259564|P3|STARTED|Core Period||15
522835|NCT00048035|1259565|P2|STARTED|Core Period||15
522836|NCT00048035|1259566|P1|STARTED|Core Period||15
522837|NCT00047879|1259604|P2|NOT COMPLETED|Overall Study||3
522838|NCT00047879|1259605|P1|NOT COMPLETED|Overall Study||4
522839|NCT00047879|1259604|P2|COMPLETED|Overall Study||0
522840|NCT00047879|1259605|P1|COMPLETED|Overall Study||0
522841|NCT00047879|1259604|P2|STARTED|Overall Study||3
522842|NCT00047879|1259605|P1|STARTED|Overall Study||4
522843|NCT00047619|1259617|P2|NOT COMPLETED|Overall Study||0
522844|NCT00047619|1259618|P1|NOT COMPLETED|Overall Study||0
522845|NCT00047619|1259617|P2|COMPLETED|Overall Study||14
522846|NCT00047619|1259618|P1|COMPLETED|Overall Study||14
522847|NCT00047619|1259617|P2|STARTED|Overall Study||14
522848|NCT00047619|1259618|P1|STARTED|Overall Study||14
522849|NCT00046228|1259629|P3|NOT COMPLETED|1 Year||12
522850|NCT00046228|1259630|P2|NOT COMPLETED|1 Year||14
522851|NCT00046228|1259631|P1|NOT COMPLETED|1 Year||19
522852|NCT00046228|1259629|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
522853|NCT00046228|1259630|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
522854|NCT00046228|1259631|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
522855|NCT00046228|1259629|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
522856|NCT00046228|1259630|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
522857|NCT00046228|1259631|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
522858|NCT00046228|1259629|P3|NOT COMPLETED|90 Days||15
522859|NCT00046228|1259630|P2|NOT COMPLETED|90 Days||8
522860|NCT00046228|1259631|P1|NOT COMPLETED|90 Days||13
522861|NCT00046228|1259629|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
522862|NCT00046228|1259630|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
522863|NCT00046228|1259631|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
522864|NCT00046228|1259629|P3|STARTED|90 Days||828
522865|NCT00046228|1259630|P2|STARTED|90 Days||818
522866|NCT00046228|1259631|P1|STARTED|90 Days||806
522867|NCT00047463|1259668|P2|NOT COMPLETED|Overall Study||3
522868|NCT00047463|1259669|P1|NOT COMPLETED|Overall Study||0
522869|NCT00047463|1259668|P2|COMPLETED|Overall Study||19
522870|NCT00047463|1259669|P1|COMPLETED|Overall Study||13
522871|NCT00047463|1259668|P2|STARTED|Overall Study||22
522872|NCT00047463|1259669|P1|STARTED|Overall Study||13
522873|NCT00047385|1259680|P2|NOT COMPLETED|Overall Study||500
522874|NCT00047385|1259681|P1|NOT COMPLETED|Overall Study||267
522875|NCT00047385|1259680|P2|COMPLETED|Overall Study||26232
522876|NCT00047385|1259681|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
522877|NCT00047385|1259680|P2|STARTED|Overall Study||26732
522878|NCT00047385|1259681|P1|STARTED|Overall Study||26722
522879|NCT00047320|1259699|P1|NOT COMPLETED|Overall Study||28
522880|NCT00047320|1259699|P1|COMPLETED|Overall Study||76
522881|NCT00047320|1259699|P1|STARTED|Overall Study||104
522882|NCT00047008|1259705|P2|NOT COMPLETED|Overall Study||11
522883|NCT00047008|1259706|P1|NOT COMPLETED|Overall Study||11
522884|NCT00047008|1259705|P2|COMPLETED|Overall Study||360
522885|NCT00047008|1259706|P1|COMPLETED|Overall Study||361
522886|NCT00047008|1259705|P2|STARTED|Overall Study||371
522887|NCT00047008|1259706|P1|STARTED|Overall Study||372
522888|NCT00046930|1259714|P2|NOT COMPLETED|Overall Study||4
522889|NCT00046930|1259715|P1|NOT COMPLETED|Overall Study||12
522890|NCT00046930|1259714|P2|COMPLETED|Overall Study||221
522891|NCT00046930|1259715|P1|COMPLETED|Overall Study||212
522892|NCT00046930|1259714|P2|STARTED|Overall Study||225
522893|NCT00046930|1259715|P1|STARTED|Overall Study||224
522894|NCT00046891|1259730|P2|NOT COMPLETED|Overall Study||30
522895|NCT00046891|1259731|P1|NOT COMPLETED|Overall Study||29
522896|NCT00046891|1259730|P2|COMPLETED|Overall Study||83
522897|NCT00046891|1259731|P1|COMPLETED|Overall Study||84
522898|NCT00046891|1259730|P2|STARTED|Overall Study||113
522899|NCT00046891|1259731|P1|STARTED|Overall Study||113
522900|NCT00046839|1259751|P2|NOT COMPLETED|Overall Study||2
522901|NCT00046839|1259752|P1|NOT COMPLETED|Overall Study||1
522902|NCT00046839|1259751|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
522903|NCT00046839|1259752|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
522904|NCT00046839|1259751|P2|STARTED|Overall Study||13
522905|NCT00046839|1259752|P1|STARTED|Overall Study||8
522906|NCT00046475|1259761|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
522907|NCT00046475|1259762|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
522908|NCT00046475|1259763|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
522909|NCT00046475|1259761|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
522910|NCT00046475|1259762|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
522911|NCT00046475|1259763|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
522912|NCT00046475|1259761|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
522913|NCT00046475|1259762|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
522914|NCT00046475|1259763|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
522915|NCT00046475|1259761|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
522916|NCT00046475|1259762|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
522917|NCT00046475|1259763|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
522918|NCT00046475|1259761|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
522919|NCT00046475|1259762|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
522920|NCT00046475|1259763|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
522921|NCT00046475|1259761|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
522922|NCT00046475|1259762|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
522923|NCT00046475|1259763|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
522924|NCT00046475|1259761|P3|NOT COMPLETED|Titration (1 Week)||0
522925|NCT00046475|1259762|P2|NOT COMPLETED|Titration (1 Week)||0
522926|NCT00046475|1259763|P1|NOT COMPLETED|Titration (1 Week)||0
522927|NCT00046475|1259761|P3|COMPLETED|Titration (1 Week)||0
522928|NCT00046475|1259762|P2|COMPLETED|Titration (1 Week)||0
522929|NCT00046475|1259763|P1|COMPLETED|Titration (1 Week)||136
522930|NCT00046475|1259761|P3|STARTED|Titration (1 Week)||0
522931|NCT00046475|1259762|P2|STARTED|Titration (1 Week)||0
522932|NCT00046475|1259763|P1|STARTED|Titration (1 Week)||136
522933|NCT00046475|1259761|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
522934|NCT00046475|1259762|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
522935|NCT00046475|1259763|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
522936|NCT00046475|1259761|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
522937|NCT00046475|1259762|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
522938|NCT00046475|1259763|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
522939|NCT00046475|1259761|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
522940|NCT00046475|1259762|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
522941|NCT00046475|1259763|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
522942|NCT00045734|1259799|P1|NOT COMPLETED|Overall Study||1
522943|NCT00045734|1259799|P1|COMPLETED|Overall Study||22
522944|NCT00045734|1259799|P1|STARTED|Overall Study||23
522945|NCT00045708|1259814|P3|NOT COMPLETED|Phase 2||0
522946|NCT00045708|1259815|P2|NOT COMPLETED|Phase 2||0
522947|NCT00045708|1259816|P1|NOT COMPLETED|Phase 2||0
522948|NCT00045708|1259814|P3|COMPLETED|Phase 2||19
522949|NCT00045708|1259815|P2|COMPLETED|Phase 2||0
522950|NCT00045708|1259816|P1|COMPLETED|Phase 2||0
522951|NCT00045708|1259814|P3|STARTED|Phase 2||19
522952|NCT00045708|1259815|P2|STARTED|Phase 2||0
522953|NCT00045708|1259816|P1|STARTED|Phase 2||0
522954|NCT00045708|1259814|P3|NOT COMPLETED|Phase 1||0
522955|NCT00045708|1259815|P2|NOT COMPLETED|Phase 1||1
522956|NCT00045708|1259816|P1|NOT COMPLETED|Phase 1||0
522957|NCT00045708|1259814|P3|COMPLETED|Phase 1||0
522958|NCT00045708|1259815|P2|COMPLETED|Phase 1||16
522959|NCT00045708|1259816|P1|COMPLETED|Phase 1||21
522960|NCT00045708|1259814|P3|STARTED|Phase 1||0
522961|NCT00045708|1259815|P2|STARTED|Phase 1||17
522962|NCT00045708|1259816|P1|STARTED|Phase 1||21
522963|NCT00045630|1259839|P1|NOT COMPLETED|Overall Study||6
522964|NCT00045630|1259839|P1|COMPLETED|Overall Study||71
522965|NCT00045630|1259839|P1|Eligible and Began Protocol Therapy|Overall Study||74
522966|NCT00045630|1259839|P1|Eligible|Overall Study||75
522967|NCT00045630|1259839|P1|STARTED|Overall Study||77
522968|NCT00045487|1259845|P1|NOT COMPLETED|Overall Study||11
522969|NCT00045487|1259845|P1|COMPLETED|Overall Study||30
522970|NCT00045487|1259845|P1|STARTED|Overall Study||41
522971|NCT00045435|1259849|P1|NOT COMPLETED|Overall Study||0
522972|NCT00045435|1259849|P1|COMPLETED|Overall Study||17
522973|NCT00045435|1259849|P1|STARTED|Overall Study||17
522974|NCT00045305|1259858|P1|NOT COMPLETED|Overall Study||14
522975|NCT00045305|1259858|P1|COMPLETED|Overall Study||3
522976|NCT00045305|1259858|P1|Eligible and Treated|Overall Study||17
522977|NCT00045305|1259858|P1|STARTED|Overall Study||17
522978|NCT00045162|1259869|P2|NOT COMPLETED|Overall Study||118
522979|NCT00045162|1259870|P1|NOT COMPLETED|Overall Study||142
522980|NCT00045162|1259869|P2|COMPLETED|Overall Study||217
522981|NCT00045162|1259870|P1|COMPLETED|Overall Study||194
522982|NCT00045162|1259869|P2|STARTED|Overall Study||335
522983|NCT00045162|1259870|P1|STARTED|Overall Study||336
522984|NCT00045032|1259885|P3|NOT COMPLETED|Overall Study||726
522985|NCT00045032|1259886|P2|NOT COMPLETED|Overall Study||708
522986|NCT00045032|1259887|P1|NOT COMPLETED|Overall Study||863
522987|NCT00045032|1259885|P3|COMPLETED|Overall Study||974
522988|NCT00045032|1259886|P2|COMPLETED|Overall Study||994
522989|NCT00045032|1259887|P1|COMPLETED|Overall Study||834
522990|NCT00045032|1259885|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
522991|NCT00045032|1259886|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
522992|NCT00045032|1259887|P1|Crossover to Adjuvant Herceptin|Overall Study||888
523084|NCT00044213|1260454|P2|NOT COMPLETED|Overall Study||112
522993|NCT00045032|1259885|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
522994|NCT00045032|1259886|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
522995|NCT00045032|1259887|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
522996|NCT00043186|1260023|P9|NOT COMPLETED|Overall Study||17
522997|NCT00043186|1260024|P8|NOT COMPLETED|Overall Study||16
522998|NCT00043186|1260025|P7|NOT COMPLETED|Overall Study||17
522999|NCT00043186|1260026|P6|NOT COMPLETED|Overall Study||8
523000|NCT00043186|1260027|P5|NOT COMPLETED|Overall Study||18
523001|NCT00043186|1260028|P4|NOT COMPLETED|Overall Study||22
523002|NCT00043186|1260029|P3|NOT COMPLETED|Overall Study||20
523003|NCT00043186|1260030|P2|NOT COMPLETED|Overall Study||15
523004|NCT00043186|1260031|P1|NOT COMPLETED|Overall Study||17
523005|NCT00043186|1260023|P9|COMPLETED|Overall Study||30
523006|NCT00043186|1260024|P8|COMPLETED|Overall Study||31
523007|NCT00043186|1260025|P7|COMPLETED|Overall Study||25
523008|NCT00043186|1260026|P6|COMPLETED|Overall Study||39
523009|NCT00043186|1260027|P5|COMPLETED|Overall Study||36
523010|NCT00043186|1260028|P4|COMPLETED|Overall Study||19
523011|NCT00043186|1260029|P3|COMPLETED|Overall Study||24
523012|NCT00043186|1260030|P2|COMPLETED|Overall Study||29
523013|NCT00043186|1260031|P1|COMPLETED|Overall Study||29
523014|NCT00043186|1260023|P9|STARTED|Overall Study||47
523015|NCT00043186|1260024|P8|STARTED|Overall Study||47
523016|NCT00043186|1260025|P7|STARTED|Overall Study||42
523017|NCT00043186|1260026|P6|STARTED|Overall Study||47
523018|NCT00043186|1260027|P5|STARTED|Overall Study||54
523019|NCT00043186|1260028|P4|STARTED|Overall Study||41
523020|NCT00043186|1260029|P3|STARTED|Overall Study||44
523021|NCT00043186|1260030|P2|STARTED|Overall Study||44
523022|NCT00043186|1260031|P1|STARTED|Overall Study||46
523023|NCT00044655|1260359|P2|NOT COMPLETED|Overall Study||38
523024|NCT00044655|1260360|P1|NOT COMPLETED|Overall Study||20
523025|NCT00044655|1260359|P2|COMPLETED|Overall Study||79
523026|NCT00044655|1260360|P1|COMPLETED|Overall Study||82
523027|NCT00044655|1260359|P2|STARTED|Overall Study||117
523028|NCT00044655|1260360|P1|STARTED|Overall Study||102
523029|NCT00044512|1260366|P1|NOT COMPLETED|Follow Up||2
523030|NCT00044512|1260366|P1|COMPLETED|Follow Up||135
523031|NCT00044512|1260366|P1|STARTED|Follow Up||137
523032|NCT00044512|1260366|P1|NOT COMPLETED|Treatment||0
523033|NCT00044512|1260366|P1|COMPLETED|Treatment||137
523034|NCT00044512|1260366|P1|STARTED|Treatment||137
523035|NCT00042991|1260384|P7|NOT COMPLETED|Overall Study||2
523036|NCT00042991|1260385|P6|NOT COMPLETED|Overall Study||5
523037|NCT00042991|1260386|P5|NOT COMPLETED|Overall Study||3
523038|NCT00042991|1260387|P4|NOT COMPLETED|Overall Study||2
523039|NCT00042991|1260388|P3|NOT COMPLETED|Overall Study||6
523040|NCT00042991|1260389|P2|NOT COMPLETED|Overall Study||40
523041|NCT00042991|1260390|P1|NOT COMPLETED|Overall Study||6
523042|NCT00042991|1260384|P7|COMPLETED|Overall Study||1
523043|NCT00042991|1260385|P6|COMPLETED|Overall Study||0
523044|NCT00042991|1260386|P5|COMPLETED|Overall Study||0
523045|NCT00042991|1260387|P4|COMPLETED|Overall Study||0
523046|NCT00042991|1260388|P3|COMPLETED|Overall Study||1
523047|NCT00042991|1260389|P2|COMPLETED|Overall Study||3
523048|NCT00042991|1260390|P1|COMPLETED|Overall Study||0
523049|NCT00042991|1260384|P7|Phase-II Trial|Overall Study||0
523050|NCT00042991|1260385|P6|Phase-II Trial|Overall Study||0
523051|NCT00042991|1260386|P5|Phase-II Trial|Overall Study||0
523052|NCT00042991|1260387|P4|Phase-II Trial|Overall Study||0
523053|NCT00042991|1260388|P3|Phase-II Trial|Overall Study||0
523054|NCT00042991|1260389|P2|Phase-II Trial|Overall Study||36
523055|NCT00042991|1260390|P1|Phase-II Trial|Overall Study||0
523056|NCT00042991|1260384|P7|Phase-I Trial|Overall Study||3
523057|NCT00042991|1260385|P6|Phase-I Trial|Overall Study||5
523058|NCT00042991|1260386|P5|Phase-I Trial|Overall Study||3
523059|NCT00042991|1260387|P4|Phase-I Trial|Overall Study||2
523060|NCT00042991|1260388|P3|Phase-I Trial|Overall Study||7
523061|NCT00042991|1260389|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
523062|NCT00042991|1260390|P1|Phase-I Trial|Overall Study||6
523063|NCT00042991|1260384|P7|STARTED|Overall Study||3
523064|NCT00042991|1260385|P6|STARTED|Overall Study||5
523065|NCT00042991|1260386|P5|STARTED|Overall Study||3
523066|NCT00042991|1260387|P4|STARTED|Overall Study||2
523067|NCT00042991|1260388|P3|STARTED|Overall Study||7
523068|NCT00042991|1260389|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
523069|NCT00042991|1260390|P1|STARTED|Overall Study||6
523070|NCT00042939|1260433|P2|NOT COMPLETED|Overall Study||21
523071|NCT00042939|1260434|P1|NOT COMPLETED|Overall Study||24
523072|NCT00042939|1260433|P2|COMPLETED|Overall Study||25
523073|NCT00042939|1260434|P1|COMPLETED|Overall Study||24
523074|NCT00042939|1260433|P2|Patients With EGFR Results Available|Overall Study||31
523075|NCT00042939|1260434|P1|Patients With EGFR Results Available|Overall Study||30
523076|NCT00042939|1260433|P2|Eligible and Began Protocol Therapy|Overall Study||43
523077|NCT00042939|1260434|P1|Eligible and Began Protocol Therapy|Overall Study||44
523078|NCT00042939|1260433|P2|Treated|Overall Study||45
523079|NCT00042939|1260434|P1|Treated|Overall Study||46
523080|NCT00042939|1260433|P2|STARTED|Overall Study||46
523081|NCT00042939|1260434|P1|STARTED|Overall Study||48
523082|NCT00044213|1260452|P4|NOT COMPLETED|Overall Study||136
523083|NCT00044213|1260453|P3|NOT COMPLETED|Overall Study||138
523085|NCT00044213|1260455|P1|NOT COMPLETED|Overall Study||100
523086|NCT00044213|1260452|P4|COMPLETED|Overall Study||301
523087|NCT00044213|1260453|P3|COMPLETED|Overall Study||294
523088|NCT00044213|1260454|P2|COMPLETED|Overall Study||306
523089|NCT00044213|1260455|P1|COMPLETED|Overall Study||321
523090|NCT00044213|1260452|P4|STARTED|Overall Study||437
523091|NCT00044213|1260453|P3|STARTED|Overall Study||432
523092|NCT00044213|1260454|P2|STARTED|Overall Study||418
523093|NCT00044213|1260455|P1|STARTED|Overall Study||421
523094|NCT00044044|1260474|P5|NOT COMPLETED|Overall Study||36
523095|NCT00044044|1260475|P4|NOT COMPLETED|Overall Study||44
523096|NCT00044044|1260476|P3|NOT COMPLETED|Overall Study||40
523097|NCT00044044|1260477|P2|NOT COMPLETED|Overall Study||41
523098|NCT00044044|1260478|P1|NOT COMPLETED|Overall Study||44
523099|NCT00044044|1260474|P5|COMPLETED|Overall Study||36
523100|NCT00044044|1260475|P4|COMPLETED|Overall Study||29
523101|NCT00044044|1260476|P3|COMPLETED|Overall Study||31
523102|NCT00044044|1260477|P2|COMPLETED|Overall Study||28
523103|NCT00044044|1260478|P1|COMPLETED|Overall Study||27
523104|NCT00044044|1260474|P5|STARTED|Overall Study||72
523105|NCT00044044|1260475|P4|STARTED|Overall Study||73
523106|NCT00044044|1260476|P3|STARTED|Overall Study||71
523107|NCT00044044|1260477|P2|STARTED|Overall Study||69
523108|NCT00044044|1260478|P1|STARTED|Overall Study||71
523109|NCT00044005|1260508|P3|NOT COMPLETED|Overall Study||22
523110|NCT00044005|1260509|P2|NOT COMPLETED|Overall Study||14
523111|NCT00044005|1260510|P1|NOT COMPLETED|Overall Study||19
523112|NCT00044005|1260508|P3|COMPLETED|Overall Study||11
523113|NCT00044005|1260509|P2|COMPLETED|Overall Study||19
523114|NCT00044005|1260510|P1|COMPLETED|Overall Study||13
523115|NCT00044005|1260508|P3|STARTED|Overall Study||33
523116|NCT00044005|1260509|P2|STARTED|Overall Study||33
523117|NCT00044005|1260510|P1|STARTED|Overall Study||32
523118|NCT00043979|1260520|P3|NOT COMPLETED|Period 2||0
523119|NCT00043979|1260521|P2|NOT COMPLETED|Period 2||0
523120|NCT00043979|1260522|P1|NOT COMPLETED|Period 2||0
523121|NCT00043979|1260520|P3|COMPLETED|Period 2||10
523122|NCT00043979|1260521|P2|COMPLETED|Period 2||13
523123|NCT00043979|1260522|P1|COMPLETED|Period 2||0
523124|NCT00043979|1260520|P3|STARTED|Period 2||10
523125|NCT00043979|1260521|P2|STARTED|Period 2||13
523126|NCT00043979|1260522|P1|STARTED|Period 2||0
523127|NCT00043979|1260520|P3|NOT COMPLETED|Period 1||3
523128|NCT00043979|1260521|P2|NOT COMPLETED|Period 1||4
523129|NCT00043979|1260522|P1|NOT COMPLETED|Period 1||7
523130|NCT00043979|1260520|P3|COMPLETED|Period 1||10
523131|NCT00043979|1260521|P2|COMPLETED|Period 1||13
523132|NCT00043979|1260522|P1|COMPLETED|Period 1||23
523133|NCT00043979|1260520|P3|STARTED|Period 1||13
523134|NCT00043979|1260521|P2|STARTED|Period 1||17
523135|NCT00043979|1260522|P1|STARTED|Period 1||30
523136|NCT00043550|1260543|P3|NOT COMPLETED|Overall Study||20
523137|NCT00043550|1260544|P2|NOT COMPLETED|Overall Study||12
523138|NCT00043550|1260545|P1|NOT COMPLETED|Overall Study||22
523139|NCT00043550|1260543|P3|COMPLETED|Overall Study||30
523140|NCT00043550|1260544|P2|COMPLETED|Overall Study||39
523141|NCT00043550|1260545|P1|COMPLETED|Overall Study||33
523142|NCT00043550|1260543|P3|Week 8 Completed|Overall Study||35
523143|NCT00043550|1260544|P2|Week 8 Completed|Overall Study||40
523144|NCT00043550|1260545|P1|Week 8 Completed|Overall Study||35
523145|NCT00043550|1260543|P3|STARTED|Overall Study||50
523146|NCT00043550|1260544|P2|STARTED|Overall Study||51
523147|NCT00043550|1260545|P1|STARTED|Overall Study||55
523148|NCT00042432|1260555|P2|NOT COMPLETED|Overall Study||7
523149|NCT00042432|1260556|P1|NOT COMPLETED|Overall Study||9
523150|NCT00042432|1260555|P2|COMPLETED|Overall Study||20
523151|NCT00042432|1260556|P1|COMPLETED|Overall Study||18
523152|NCT00042432|1260555|P2|STARTED|Overall Study||27
523153|NCT00042432|1260556|P1|STARTED|Overall Study||27
523154|NCT00040365|1260564|P1|NOT COMPLETED|Overall Study||11
523155|NCT00040365|1260564|P1|COMPLETED|Overall Study||19
523156|NCT00040365|1260564|P1|Completed Follow Up Phase|Overall Study||19
523157|NCT00040365|1260564|P1|STARTED|Overall Study||30
523158|NCT00042224|1260575|P2|NOT COMPLETED|Overall Study||3
523159|NCT00042224|1260576|P1|NOT COMPLETED|Overall Study||3
523160|NCT00042224|1260575|P2|COMPLETED|Overall Study||16
523161|NCT00042224|1260576|P1|COMPLETED|Overall Study||17
523162|NCT00042224|1260575|P2|STARTED|Overall Study||19
523163|NCT00042224|1260576|P1|STARTED|Overall Study||20
523164|NCT00041938|1260584|P2|NOT COMPLETED|Overall Study||31
523165|NCT00041938|1260585|P1|NOT COMPLETED|Overall Study||38
523166|NCT00041938|1260584|P2|COMPLETED|Overall Study||1111
523167|NCT00041938|1260585|P1|COMPLETED|Overall Study||1125
523168|NCT00041938|1260584|P2|Withdrew Consent|Overall Study||14
523169|NCT00041938|1260585|P1|Withdrew Consent|Overall Study||20
523170|NCT00041938|1260584|P2|Lost to Follow-up|Overall Study||17
523171|NCT00041938|1260585|P1|Lost to Follow-up|Overall Study||18
523172|NCT00041938|1260584|P2|Only Vital Status Known|Overall Study||46
523173|NCT00041938|1260585|P1|Only Vital Status Known|Overall Study||44
523174|NCT00041938|1260584|P2|Primary Endpoint|Overall Study||302
523175|NCT00041938|1260585|P1|Primary Endpoint|Overall Study||320
523176|NCT00041938|1260584|P2|Completed Follow-up|Overall Study||745
523177|NCT00041938|1260585|P1|Completed Follow-up|Overall Study||761
523178|NCT00041938|1260584|P2|STARTED|Overall Study||1142
523179|NCT00041938|1260585|P1|STARTED|Overall Study||1163
523180|NCT00041756|1260618|P5|NOT COMPLETED|Overall Study||60
523181|NCT00041756|1260619|P4|NOT COMPLETED|Overall Study||16
523182|NCT00041756|1260620|P3|NOT COMPLETED|Overall Study||13
523183|NCT00041756|1260621|P2|NOT COMPLETED|Overall Study||15
523184|NCT00041756|1260622|P1|NOT COMPLETED|Overall Study||8
523185|NCT00041756|1260618|P5|COMPLETED|Overall Study||19
523186|NCT00041756|1260619|P4|COMPLETED|Overall Study||64
523187|NCT00041756|1260620|P3|COMPLETED|Overall Study||66
523188|NCT00041756|1260621|P2|COMPLETED|Overall Study||65
523189|NCT00041756|1260622|P1|COMPLETED|Overall Study||69
523190|NCT00041756|1260618|P5|STARTED|Overall Study||79
523191|NCT00041756|1260619|P4|STARTED|Overall Study||80
523192|NCT00041756|1260620|P3|STARTED|Overall Study||79
523193|NCT00041756|1260621|P2|STARTED|Overall Study||80
523194|NCT00041756|1260622|P1|STARTED|Overall Study||77
523195|NCT00041717|1260641|P2|NOT COMPLETED|Overall Study||12
523196|NCT00041717|1260642|P1|NOT COMPLETED|Overall Study||33
523197|NCT00041717|1260641|P2|COMPLETED|Overall Study||86
523198|NCT00041717|1260642|P1|COMPLETED|Overall Study||81
523199|NCT00041717|1260641|P2|STARTED|Overall Study||98
523200|NCT00041717|1260642|P1|STARTED|Overall Study||114
523201|NCT00039871|1260650|P1|NOT COMPLETED|Overall Study||1384
523202|NCT00039871|1260650|P1|COMPLETED|Overall Study||928
523203|NCT00039871|1260650|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
523204|NCT00041470|1260656|P1|NOT COMPLETED|Overall Study||40
523205|NCT00041470|1260656|P1|COMPLETED|Overall Study||0
523206|NCT00041470|1260656|P1|STARTED|Overall Study||40
523207|NCT00041392|1260663|P2|NOT COMPLETED|Overall Study||0
523208|NCT00041392|1260664|P1|NOT COMPLETED|Overall Study||0
523209|NCT00041392|1260663|P2|COMPLETED|Overall Study||191
523210|NCT00041392|1260664|P1|COMPLETED|Overall Study||198
523211|NCT00041392|1260663|P2|STARTED|Overall Study||191
523212|NCT00041392|1260664|P1|STARTED|Overall Study||198
523213|NCT00041132|1260670|P1|NOT COMPLETED|Overall Study||30
523214|NCT00041132|1260670|P1|COMPLETED|Overall Study||26
523215|NCT00041132|1260670|P1|Eligible and Began Protocol Therapy|Overall Study||49
523216|NCT00041132|1260670|P1|Eligible|Overall Study||49
523217|NCT00041132|1260670|P1|STARTED|Overall Study||56
523218|NCT00041119|1260680|P4|NOT COMPLETED|Overall Study||0
523219|NCT00041119|1260681|P3|NOT COMPLETED|Overall Study||0
523220|NCT00041119|1260682|P2|NOT COMPLETED|Overall Study||0
523221|NCT00041119|1260683|P1|NOT COMPLETED|Overall Study||0
523222|NCT00041119|1260680|P4|COMPLETED|Overall Study||789
523223|NCT00041119|1260681|P3|COMPLETED|Overall Study||1151
523224|NCT00041119|1260682|P2|COMPLETED|Overall Study||789
523225|NCT00041119|1260683|P1|COMPLETED|Overall Study||1142
523226|NCT00041119|1260680|P4|STARTED|Overall Study||789
523227|NCT00041119|1260681|P3|STARTED|Overall Study||1151
523228|NCT00041119|1260682|P2|STARTED|Overall Study||789
523229|NCT00041119|1260683|P1|STARTED|Overall Study||1142
523230|NCT00041080|1260705|P2|NOT COMPLETED|Overall Study||10
523231|NCT00041080|1260706|P1|NOT COMPLETED|Overall Study||30
523232|NCT00041080|1260705|P2|COMPLETED|Overall Study||60
523233|NCT00041080|1260706|P1|COMPLETED|Overall Study||39
523234|NCT00041080|1260705|P2|STARTED|Overall Study|number patients enrolled on study|70
523235|NCT00041080|1260706|P1|STARTED|Overall Study|number patients enrolled on study|69
523236|NCT00041067|1260712|P1|NOT COMPLETED|Overall Study||76
523237|NCT00041067|1260712|P1|COMPLETED|Overall Study||0
523238|NCT00041067|1260712|P1|Eligible|Overall Study||74
523239|NCT00041067|1260712|P1|STARTED|Overall Study||76
523240|NCT00040937|1260719|P1|NOT COMPLETED|Maintenance||0
523241|NCT00040937|1260719|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
523242|NCT00040937|1260719|P1|STARTED|Maintenance||76
523243|NCT00040937|1260719|P1|NOT COMPLETED|Autologous PBSCT||31
523244|NCT00040937|1260719|P1|COMPLETED|Autologous PBSCT||77
523245|NCT00040937|1260719|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
523246|NCT00040937|1260719|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
523247|NCT00040937|1260719|P1|COMPLETED|Induction/PBSC Mobilization||110
523248|NCT00040937|1260719|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
523249|NCT00040846|1260732|P6|NOT COMPLETED|Overall Study||0
523250|NCT00040846|1260733|P5|NOT COMPLETED|Overall Study||0
523251|NCT00040846|1260734|P4|NOT COMPLETED|Overall Study||0
523252|NCT00040846|1260735|P3|NOT COMPLETED|Overall Study||0
523253|NCT00040846|1260736|P2|NOT COMPLETED|Overall Study||0
523254|NCT00040846|1260737|P1|NOT COMPLETED|Overall Study||0
523255|NCT00040846|1260732|P6|COMPLETED|Overall Study||0
523256|NCT00040846|1260733|P5|COMPLETED|Overall Study||0
523257|NCT00040846|1260734|P4|COMPLETED|Overall Study||0
523258|NCT00040846|1260735|P3|COMPLETED|Overall Study||0
523259|NCT00040846|1260736|P2|COMPLETED|Overall Study||0
523260|NCT00040846|1260737|P1|COMPLETED|Overall Study||60
523261|NCT00040846|1260732|P6|STARTED|Overall Study||0
523262|NCT00040846|1260733|P5|STARTED|Overall Study||0
523263|NCT00040846|1260734|P4|STARTED|Overall Study||0
523264|NCT00040846|1260735|P3|STARTED|Overall Study||0
523265|NCT00040846|1260736|P2|STARTED|Overall Study||0
523266|NCT00040846|1260737|P1|STARTED|Overall Study||60
523267|NCT00040742|1260779|P4|NOT COMPLETED|Overall Study||34
523268|NCT00040742|1260780|P3|NOT COMPLETED|Overall Study||46
523269|NCT00040742|1260781|P2|NOT COMPLETED|Overall Study||49
523270|NCT00040742|1260782|P1|NOT COMPLETED|Overall Study||39
523271|NCT00040742|1260779|P4|COMPLETED|Overall Study||152
523272|NCT00040742|1260780|P3|COMPLETED|Overall Study||141
523273|NCT00040742|1260781|P2|COMPLETED|Overall Study||134
523274|NCT00040742|1260782|P1|COMPLETED|Overall Study||149
523275|NCT00040742|1260779|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
523276|NCT00040742|1260780|P3|STARTED|Overall Study||187
523277|NCT00040742|1260781|P2|STARTED|Overall Study||183
523278|NCT00040742|1260782|P1|STARTED|Overall Study||188
523279|NCT00040664|1260796|P4|NOT COMPLETED|Overall Study||27
523280|NCT00040664|1260797|P3|NOT COMPLETED|Overall Study||13
523281|NCT00040664|1260798|P2|NOT COMPLETED|Overall Study||13
523282|NCT00040664|1260799|P1|NOT COMPLETED|Overall Study||53
523283|NCT00040664|1260796|P4|COMPLETED|Overall Study||8
523284|NCT00040664|1260797|P3|COMPLETED|Overall Study||4
523285|NCT00040664|1260798|P2|COMPLETED|Overall Study||4
523286|NCT00040664|1260799|P1|COMPLETED|Overall Study||16
523287|NCT00040664|1260796|P4|STARTED|Overall Study||35
523288|NCT00040664|1260797|P3|STARTED|Overall Study||17
523289|NCT00040664|1260798|P2|STARTED|Overall Study||17
523290|NCT00040664|1260799|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
523291|NCT00039741|1260851|P4|NOT COMPLETED|Overall Study||14
523292|NCT00039741|1260852|P3|NOT COMPLETED|Overall Study||11
523293|NCT00039741|1260853|P2|NOT COMPLETED|Overall Study||12
523294|NCT00039741|1260854|P1|NOT COMPLETED|Overall Study||15
523295|NCT00039741|1260851|P4|COMPLETED|Overall Study||50
523296|NCT00039741|1260852|P3|COMPLETED|Overall Study||54
523297|NCT00039741|1260853|P2|COMPLETED|Overall Study||56
523298|NCT00039741|1260854|P1|COMPLETED|Overall Study||51
523299|NCT00039741|1260851|P4|Death|Overall Study||0
523300|NCT00039741|1260852|P3|Death|Overall Study||0
523301|NCT00039741|1260853|P2|Death|Overall Study||1
523302|NCT00039741|1260854|P1|Death|Overall Study||0
523303|NCT00039741|1260851|P4|STARTED|Overall Study||64
523304|NCT00039741|1260852|P3|STARTED|Overall Study||65
523305|NCT00039741|1260853|P2|STARTED|Overall Study||68
523306|NCT00039741|1260854|P1|STARTED|Overall Study||66
523307|NCT00039377|1260896|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
523308|NCT00039377|1260897|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
523309|NCT00039377|1260898|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
523310|NCT00039377|1260899|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
523311|NCT00039377|1260896|P4|COMPLETED|Course 5 (Transplant Assignments)||1
523312|NCT00039377|1260897|P3|COMPLETED|Course 5 (Transplant Assignments)||19
523313|NCT00039377|1260898|P2|COMPLETED|Course 5 (Transplant Assignments)||15
523314|NCT00039377|1260899|P1|COMPLETED|Course 5 (Transplant Assignments)||0
523315|NCT00039377|1260896|P4|STARTED|Course 5 (Transplant Assignments)||1
523316|NCT00039377|1260897|P3|STARTED|Course 5 (Transplant Assignments)||19
523317|NCT00039377|1260898|P2|STARTED|Course 5 (Transplant Assignments)||15
523318|NCT00039377|1260899|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
523319|NCT00039377|1260896|P4|NOT COMPLETED|Initial Registration||0
523320|NCT00039377|1260897|P3|NOT COMPLETED|Initial Registration||0
523321|NCT00039377|1260898|P2|NOT COMPLETED|Initial Registration||0
523322|NCT00039377|1260899|P1|NOT COMPLETED|Initial Registration||22
523323|NCT00039377|1260896|P4|COMPLETED|Initial Registration||0
523324|NCT00039377|1260897|P3|COMPLETED|Initial Registration||0
523325|NCT00039377|1260898|P2|COMPLETED|Initial Registration||0
523326|NCT00039377|1260899|P1|COMPLETED|Initial Registration||35
523327|NCT00039377|1260896|P4|STARTED|Initial Registration||0
523328|NCT00039377|1260897|P3|STARTED|Initial Registration||0
523329|NCT00039377|1260898|P2|STARTED|Initial Registration||0
523330|NCT00039377|1260899|P1|STARTED|Initial Registration||57
523331|NCT00039195|1260911|P1|NOT COMPLETED|Overall Study||0
523332|NCT00039195|1260911|P1|COMPLETED|Overall Study||98
523333|NCT00039195|1260911|P1|STARTED|Overall Study||98
523334|NCT00039130|1260915|P1|NOT COMPLETED|Overall Study||30
523335|NCT00039130|1260915|P1|COMPLETED|Overall Study||75
523336|NCT00039130|1260915|P1|STARTED|Overall Study||105
523337|NCT00038948|1260923|P2|NOT COMPLETED|Overall Study||77
523338|NCT00038948|1260924|P1|NOT COMPLETED|Overall Study||169
523339|NCT00038948|1260923|P2|COMPLETED|Overall Study||198
523340|NCT00038948|1260924|P1|COMPLETED|Overall Study||386
523341|NCT00038948|1260923|P2|STARTED|Overall Study||275
523342|NCT00038948|1260924|P1|STARTED|Overall Study||555
523343|NCT00038857|1260936|P1|NOT COMPLETED|Overall Study||1
523344|NCT00038857|1260936|P1|COMPLETED|Overall Study||28
523345|NCT00038857|1260936|P1|STARTED|Overall Study||29
523346|NCT00038610|1260940|P1|NOT COMPLETED|Overall Study||0
523347|NCT00038610|1260940|P1|COMPLETED|Overall Study||54
523348|NCT00038610|1260940|P1|STARTED|Overall Study||54
523349|NCT00038467|1260948|P2|NOT COMPLETED|Overall Study||542
523350|NCT00038467|1260949|P1|NOT COMPLETED|Overall Study||542
523351|NCT00038467|1260948|P2|COMPLETED|Overall Study||1830
523352|NCT00038467|1260949|P1|COMPLETED|Overall Study||1810
523353|NCT00038467|1260948|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
523354|NCT00038467|1260949|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
523355|NCT00038467|1260948|P2|STARTED|Overall Study||2372
523356|NCT00038467|1260949|P1|STARTED|Overall Study||2352
523357|NCT00038103|1261011|P2|NOT COMPLETED|Overall Study||56
523358|NCT00038103|1261012|P1|NOT COMPLETED|Overall Study||55
523359|NCT00038103|1261011|P2|COMPLETED|Overall Study||0
523360|NCT00038103|1261012|P1|COMPLETED|Overall Study||0
523361|NCT00038103|1261011|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
523362|NCT00038103|1261012|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
523363|NCT00038103|1261011|P2|STARTED|Overall Study||56
523364|NCT00038103|1261012|P1|STARTED|Overall Study||55
523365|NCT00037830|1261035|P3|NOT COMPLETED|Overall Study||1
523366|NCT00037830|1261036|P2|NOT COMPLETED|Overall Study||7
523367|NCT00037830|1261037|P1|NOT COMPLETED|Overall Study||10
523368|NCT00037830|1261035|P3|COMPLETED|Overall Study||16
523369|NCT00037830|1261036|P2|COMPLETED|Overall Study||31
523370|NCT00037830|1261037|P1|COMPLETED|Overall Study||29
523371|NCT00037830|1261035|P3|STARTED|Overall Study||17
523372|NCT00037830|1261036|P2|STARTED|Overall Study||38
523373|NCT00037830|1261037|P1|STARTED|Overall Study||39
523374|NCT00036569|1261058|P1|NOT COMPLETED|Overall Study||0
523375|NCT00036569|1261058|P1|COMPLETED|Overall Study||32
523376|NCT00036569|1261058|P1|STARTED|Overall Study||32
523377|NCT00036270|1261069|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
523378|NCT00036270|1261070|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
523379|NCT00036270|1261069|P2|COMPLETED|Study Treatment to 5 Year Report||1380
523380|NCT00036270|1261070|P1|COMPLETED|Study Treatment to 5 Year Report||2333
523381|NCT00036270|1261069|P2|Treated|Study Treatment to 5 Year Report||4814
523382|NCT00036270|1261070|P1|Treated|Study Treatment to 5 Year Report||4852
523383|NCT00036270|1261069|P2|STARTED|Study Treatment to 5 Year Report||4868
523384|NCT00036270|1261070|P1|STARTED|Study Treatment to 5 Year Report||4898
523385|NCT00036270|1261069|P2|NOT COMPLETED|Randomized to Study Treatment||7
523386|NCT00036270|1261070|P1|NOT COMPLETED|Randomized to Study Treatment||6
523387|NCT00036270|1261069|P2|COMPLETED|Randomized to Study Treatment||4868
523388|NCT00036270|1261070|P1|COMPLETED|Randomized to Study Treatment||4898
523389|NCT00036270|1261069|P2|STARTED|Randomized to Study Treatment||4875
523390|NCT00036270|1261070|P1|STARTED|Randomized to Study Treatment||4904
523391|NCT00035932|1261089|P3|NOT COMPLETED|Overall Study||49
523392|NCT00035932|1261090|P2|NOT COMPLETED|Overall Study||60
523393|NCT00035932|1261091|P1|NOT COMPLETED|Overall Study||56
523394|NCT00035932|1261089|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
523395|NCT00035932|1261090|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
523396|NCT00035932|1261091|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
523397|NCT00035932|1261089|P3|Discontinued on or After Week 96|Overall Study||6
523398|NCT00035932|1261090|P2|Discontinued on or After Week 96|Overall Study||4
523399|NCT00035932|1261091|P1|Discontinued on or After Week 96|Overall Study||4
523400|NCT00035932|1261089|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
523401|NCT00035932|1261090|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
523402|NCT00035932|1261091|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
523403|NCT00035932|1261089|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
523404|NCT00035932|1261090|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
523405|NCT00035932|1261091|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
523406|NCT00035932|1261089|P3|STARTED|Overall Study|123 randomized, 118 treated|118
523407|NCT00035932|1261090|P2|STARTED|Overall Study|115 randomized, 110 treated|110
523408|NCT00035932|1261091|P1|STARTED|Overall Study|120 randomized, 119 treated|119
523409|NCT00035815|1261217|P2|NOT COMPLETED|Overall Study||11
523410|NCT00035815|1261218|P1|NOT COMPLETED|Overall Study||17
523411|NCT00035815|1261217|P2|COMPLETED|Overall Study||152
523412|NCT00035815|1261218|P1|COMPLETED|Overall Study||150
523413|NCT00035815|1261217|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
523414|NCT00035815|1261218|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
523415|NCT00035555|1261231|P3|NOT COMPLETED|Overall Study||22
523416|NCT00035555|1261232|P2|NOT COMPLETED|Overall Study||16
523417|NCT00035555|1261233|P1|NOT COMPLETED|Overall Study||16
523418|NCT00035555|1261231|P3|COMPLETED|Overall Study||51
523419|NCT00035555|1261232|P2|COMPLETED|Overall Study||55
523420|NCT00035555|1261233|P1|COMPLETED|Overall Study||58
523421|NCT00035555|1261231|P3|Number Who Received Study Drug|Overall Study||71
523422|NCT00035555|1261232|P2|Number Who Received Study Drug|Overall Study||71
523423|NCT00035555|1261233|P1|Number Who Received Study Drug|Overall Study||74
523424|NCT00035555|1261231|P3|Number Who Had Undergone Transplantation|Overall Study||73
523425|NCT00035555|1261232|P2|Number Who Had Undergone Transplantation|Overall Study||71
523426|NCT00035555|1261233|P1|Number Who Had Undergone Transplantation|Overall Study||74
523427|NCT00035555|1261231|P3|STARTED|Overall Study|Randomized patients|73
523428|NCT00035555|1261232|P2|STARTED|Overall Study|Randomized patients|71
523429|NCT00035555|1261233|P1|STARTED|Overall Study|Randomized patients|74
523430|NCT00033917|1261276|P2|NOT COMPLETED|Overall Study||0
523431|NCT00033917|1261277|P1|NOT COMPLETED|Overall Study||0
523432|NCT00033917|1261276|P2|COMPLETED|Overall Study||222
523433|NCT00033917|1261277|P1|COMPLETED|Overall Study||209
523434|NCT00033917|1261276|P2|STARTED|Overall Study||222
523435|NCT00033917|1261277|P1|STARTED|Overall Study||209
523436|NCT00033657|1261289|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
523437|NCT00033657|1261290|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
523438|NCT00033657|1261289|P2|COMPLETED|Adjuvant Chemotherapy||16
523439|NCT00033657|1261290|P1|COMPLETED|Adjuvant Chemotherapy||18
523440|NCT00033657|1261289|P2|STARTED|Adjuvant Chemotherapy||33
523441|NCT00033657|1261290|P1|STARTED|Adjuvant Chemotherapy||36
523442|NCT00033657|1261289|P2|NOT COMPLETED|Surgical Resection||3
523443|NCT00033657|1261290|P1|NOT COMPLETED|Surgical Resection||0
523444|NCT00033657|1261289|P2|COMPLETED|Surgical Resection||33
523445|NCT00033657|1261290|P1|COMPLETED|Surgical Resection||36
523446|NCT00033657|1261289|P2|STARTED|Surgical Resection||36
523447|NCT00033657|1261290|P1|STARTED|Surgical Resection||36
523448|NCT00033657|1261289|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
523449|NCT00033657|1261290|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
523450|NCT00033657|1261289|P2|COMPLETED|Neoadjuvant Chemotherapy||36
523451|NCT00033657|1261290|P1|COMPLETED|Neoadjuvant Chemotherapy||36
523452|NCT00033657|1261289|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
523453|NCT00033657|1261290|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
523454|NCT00033657|1261289|P2|Eligible|Neoadjuvant Chemotherapy||43
523455|NCT00033657|1261290|P1|Eligible|Neoadjuvant Chemotherapy||42
523456|NCT00033657|1261289|P2|STARTED|Neoadjuvant Chemotherapy||47
523457|NCT00033657|1261290|P1|STARTED|Neoadjuvant Chemotherapy||50
523458|NCT00033631|1261304|P2|NOT COMPLETED|Overall Study||15
523459|NCT00033631|1261305|P1|NOT COMPLETED|Overall Study||18
523460|NCT00033631|1261304|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
523461|NCT00033631|1261305|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
523462|NCT00033631|1261304|P2|STARTED|Overall Study||763
523463|NCT00033631|1261305|P1|STARTED|Overall Study||769
523464|NCT00033540|1261323|P1|NOT COMPLETED|Overall Study||57
523465|NCT00033540|1261323|P1|COMPLETED|Overall Study||0
523466|NCT00033540|1261323|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
523467|NCT00033540|1261323|P1|Eligible|Overall Study||54
523468|NCT00033540|1261323|P1|STARTED|Overall Study||57
523469|NCT00033514|1261333|P2|NOT COMPLETED|Overall Study||4
523470|NCT00033514|1261334|P1|NOT COMPLETED|Overall Study||1
523471|NCT00033514|1261333|P2|COMPLETED|Overall Study||7
523472|NCT00033514|1261334|P1|COMPLETED|Overall Study||15
523473|NCT00033514|1261333|P2|STARTED|Overall Study||11
523474|NCT00033514|1261334|P1|STARTED|Overall Study||16
523475|NCT00033371|1261344|P2|NOT COMPLETED|Overall Study||10
523476|NCT00033371|1261345|P1|NOT COMPLETED|Overall Study||6
523477|NCT00033371|1261344|P2|COMPLETED|Overall Study||47
523478|NCT00033371|1261345|P1|COMPLETED|Overall Study||49
523479|NCT00033371|1261344|P2|STARTED|Overall Study||57
523480|NCT00033371|1261345|P1|STARTED|Overall Study||55
523481|NCT00033293|1261353|P2|NOT COMPLETED|Overall Study||18
523482|NCT00033293|1261354|P1|NOT COMPLETED|Overall Study||10
523483|NCT00033293|1261353|P2|COMPLETED|Overall Study||9
523484|NCT00033293|1261354|P1|COMPLETED|Overall Study||16
523485|NCT00033293|1261353|P2|STARTED|Overall Study||27
523486|NCT00033293|1261354|P1|STARTED|Overall Study||26
523487|NCT00032630|1261374|P2|NOT COMPLETED|Overall Study||43
523488|NCT00032630|1261375|P1|NOT COMPLETED|Overall Study||49
523489|NCT00032630|1261374|P2|COMPLETED|Overall Study||1061
523490|NCT00032630|1261375|P1|COMPLETED|Overall Study||1050
523491|NCT00032630|1261374|P2|STARTED|Overall Study||1104
523492|NCT00032630|1261375|P1|STARTED|Overall Study||1099
523493|NCT00032591|1261385|P2|NOT COMPLETED|Follow-up||5
523494|NCT00032591|1261386|P1|NOT COMPLETED|Follow-up||2
523495|NCT00032591|1261385|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
523496|NCT00032591|1261386|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
523497|NCT00032591|1261385|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
523498|NCT00032591|1261386|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
523499|NCT00032591|1261385|P2|NOT COMPLETED|Randomization||0
523500|NCT00032591|1261386|P1|NOT COMPLETED|Randomization||0
523501|NCT00032591|1261385|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
523502|NCT00032591|1261386|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
523503|NCT00032591|1261385|P2|STARTED|Randomization||1457
523504|NCT00032591|1261386|P1|STARTED|Randomization|2922 underwent randomization|1465
523505|NCT00032591|1261385|P2|NOT COMPLETED|Screening||415
523506|NCT00032591|1261386|P1|NOT COMPLETED|Screening||408
523507|NCT00032591|1261385|P2|COMPLETED|Screening||1457
523508|NCT00032591|1261386|P1|COMPLETED|Screening|823 were excluded from the study|1465
523509|NCT00032591|1261385|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
523510|NCT00032591|1261386|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
523511|NCT00032487|1261402|P2|NOT COMPLETED|Overall Study||120
523512|NCT00032487|1261403|P1|NOT COMPLETED|Overall Study||139
523513|NCT00032487|1261402|P2|COMPLETED|Overall Study||772
523514|NCT00032487|1261403|P1|COMPLETED|Overall Study||760
523515|NCT00032487|1261402|P2|STARTED|Overall Study||892
523516|NCT00032487|1261403|P1|STARTED|Overall Study||899
523517|NCT00031694|1261411|P1|NOT COMPLETED|Overall Study||19
523518|NCT00031694|1261411|P1|COMPLETED|Overall Study||0
523519|NCT00031694|1261411|P1|STARTED|Overall Study||19
523520|NCT00031551|1261417|P2|NOT COMPLETED|Overall Study||0
523521|NCT00031551|1261418|P1|NOT COMPLETED|Overall Study||2
523522|NCT00031551|1261417|P2|COMPLETED|Overall Study||25
523523|NCT00031551|1261418|P1|COMPLETED|Overall Study||0
523524|NCT00031551|1261417|P2|STARTED|Overall Study||25
523525|NCT00031551|1261418|P1|STARTED|Overall Study||2
523526|NCT00031486|1261430|P2|NOT COMPLETED|Overall Study||12
523527|NCT00031486|1261431|P1|NOT COMPLETED|Overall Study||7
523528|NCT00031486|1261430|P2|COMPLETED|Overall Study||35
523529|NCT00031486|1261431|P1|COMPLETED|Overall Study||33
523530|NCT00031486|1261430|P2|STARTED|Overall Study||47
523531|NCT00031486|1261431|P1|STARTED|Overall Study||40
523532|NCT00031460|1261457|P2|NOT COMPLETED|Overall Study||14
523533|NCT00031460|1261458|P1|NOT COMPLETED|Overall Study||9
523534|NCT00031460|1261457|P2|COMPLETED|Overall Study||8
523535|NCT00031460|1261458|P1|COMPLETED|Overall Study||15
523536|NCT00031460|1261457|P2|STARTED|Overall Study||22
523537|NCT00031460|1261458|P1|STARTED|Overall Study||24
523538|NCT00031447|1261472|P2|NOT COMPLETED|Overall Study||7
523539|NCT00031447|1261473|P1|NOT COMPLETED|Overall Study||10
523540|NCT00031447|1261472|P2|COMPLETED|Overall Study||8
523541|NCT00031447|1261473|P1|COMPLETED|Overall Study||4
523542|NCT00031447|1261472|P2|STARTED|Overall Study||15
523543|NCT00031447|1261473|P1|STARTED|Overall Study||14
523544|NCT00030992|1261485|P1|NOT COMPLETED|Overall Study||0
523545|NCT00030992|1261485|P1|COMPLETED|Overall Study||102
523546|NCT00030992|1261485|P1|STARTED|Overall Study||102
523547|NCT00030901|1261492|P3|NOT COMPLETED|Randomization||88
523548|NCT00030901|1261493|P2|NOT COMPLETED|Randomization||101
523549|NCT00030901|1261494|P1|NOT COMPLETED|Randomization||0
523550|NCT00030901|1261492|P3|COMPLETED|Randomization||137
523551|NCT00030901|1261493|P2|COMPLETED|Randomization||126
523552|NCT00030901|1261494|P1|COMPLETED|Randomization||0
523553|NCT00030901|1261492|P3|Eligible|Randomization||211
523554|NCT00030901|1261493|P2|Eligible|Randomization||212
523555|NCT00030901|1261494|P1|Eligible|Randomization||0
523556|NCT00030901|1261492|P3|STARTED|Randomization||225
523557|NCT00030901|1261493|P2|STARTED|Randomization||227
523558|NCT00030901|1261494|P1|STARTED|Randomization||0
523559|NCT00030901|1261492|P3|NOT COMPLETED|Initial Registration||0
523560|NCT00030901|1261493|P2|NOT COMPLETED|Initial Registration||0
523561|NCT00030901|1261494|P1|NOT COMPLETED|Initial Registration||167
523562|NCT00030901|1261492|P3|COMPLETED|Initial Registration||0
523563|NCT00030901|1261493|P2|COMPLETED|Initial Registration||0
523564|NCT00030901|1261494|P1|COMPLETED|Initial Registration||452
523565|NCT00030901|1261492|P3|STARTED|Initial Registration||0
523566|NCT00030901|1261493|P2|STARTED|Initial Registration||0
523567|NCT00030901|1261494|P1|STARTED|Initial Registration||619
523568|NCT00030823|1261502|P1|NOT COMPLETED|Overall Study||1
523569|NCT00030823|1261502|P1|COMPLETED|Overall Study||13
523570|NCT00030823|1261502|P1|STARTED|Overall Study||14
523571|NCT00030147|1261510|P4|NOT COMPLETED|Overall Study||0
523572|NCT00030147|1261511|P3|NOT COMPLETED|Overall Study||0
523573|NCT00030147|1261512|P2|NOT COMPLETED|Overall Study||1
523574|NCT00030147|1261513|P1|NOT COMPLETED|Overall Study||0
523575|NCT00030147|1261510|P4|COMPLETED|Overall Study||11
523576|NCT00030147|1261511|P3|COMPLETED|Overall Study||16
523577|NCT00030147|1261512|P2|COMPLETED|Overall Study||18
523578|NCT00030147|1261513|P1|COMPLETED|Overall Study||17
523579|NCT00030147|1261510|P4|STARTED|Overall Study||11
523580|NCT00030147|1261511|P3|STARTED|Overall Study||16
523581|NCT00030147|1261512|P2|STARTED|Overall Study||19
523582|NCT00030147|1261513|P1|STARTED|Overall Study||17
523583|NCT00029536|1261531|P4|NOT COMPLETED|Overall Study||0
523584|NCT00029536|1261532|P3|NOT COMPLETED|Overall Study||0
523585|NCT00029536|1261533|P2|NOT COMPLETED|Overall Study||0
523586|NCT00029536|1261534|P1|NOT COMPLETED|Overall Study||0
523587|NCT00029536|1261531|P4|COMPLETED|Overall Study||59
523588|NCT00029536|1261532|P3|COMPLETED|Overall Study||105
523589|NCT00029536|1261533|P2|COMPLETED|Overall Study||45
523590|NCT00029536|1261534|P1|COMPLETED|Overall Study||85
523591|NCT00029536|1261531|P4|STARTED|Overall Study||59
523592|NCT00029536|1261532|P3|STARTED|Overall Study||105
523593|NCT00029536|1261533|P2|STARTED|Overall Study||45
523594|NCT00029536|1261534|P1|STARTED|Overall Study||85
523595|NCT00029172|1261558|P1|NOT COMPLETED|Overall Study||6
523596|NCT00029172|1261558|P1|COMPLETED|Overall Study||182
523597|NCT00029172|1261558|P1|STARTED|Overall Study||188
523598|NCT00029146|1261564|P2|NOT COMPLETED|Overall Study||1
523599|NCT00029146|1261565|P1|NOT COMPLETED|Overall Study||2
523600|NCT00029146|1261564|P2|COMPLETED|Overall Study||97
523601|NCT00029146|1261565|P1|COMPLETED|Overall Study||95
523602|NCT00029146|1261564|P2|STARTED|Overall Study||98
523603|NCT00029146|1261565|P1|STARTED|Overall Study||97
523604|NCT00029107|1261594|P2|NOT COMPLETED|Overall Study||0
523605|NCT00029107|1261595|P1|NOT COMPLETED|Overall Study||0
523606|NCT00029107|1261594|P2|COMPLETED|Overall Study||12
523607|NCT00029107|1261595|P1|COMPLETED|Overall Study||12
523608|NCT00029107|1261594|P2|STARTED|Overall Study||12
523609|NCT00029107|1261595|P1|STARTED|Overall Study||12
523610|NCT00028769|1261601|P1|NOT COMPLETED|Overall Study||41
523611|NCT00028769|1261601|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
523612|NCT00028769|1261601|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
523613|NCT00028769|1261601|P1|Eligible|Overall Study||36
523614|NCT00028769|1261601|P1|STARTED|Overall Study||41
523615|NCT00028262|1261607|P1|NOT COMPLETED|Overall Study||1
523616|NCT00028262|1261607|P1|COMPLETED|Overall Study||9
523617|NCT00028262|1261607|P1|STARTED|Overall Study||10
523618|NCT00028093|1261613|P2|NOT COMPLETED|Overall Study||0
523619|NCT00028093|1261614|P1|NOT COMPLETED|Overall Study||0
523620|NCT00028093|1261613|P2|COMPLETED|Overall Study||25
523621|NCT00028093|1261614|P1|COMPLETED|Overall Study||25
523622|NCT00028093|1261613|P2|STARTED|Overall Study||25
523623|NCT00028093|1261614|P1|STARTED|Overall Study||25
523624|NCT00028002|1261620|P1|NOT COMPLETED|Overall Study||11
523625|NCT00028002|1261620|P1|COMPLETED|Overall Study|Subjects comtributing data to the primary analysis are considered to have completed the study.|52
523626|NCT00028002|1261620|P1|STARTED|Overall Study||63
523627|NCT00027846|1261627|P3|NOT COMPLETED|Overall Study||37
523628|NCT00027846|1261628|P2|NOT COMPLETED|Overall Study||68
523629|NCT00027846|1261629|P1|NOT COMPLETED|Overall Study||2
523630|NCT00027846|1261627|P3|COMPLETED|Overall Study||41
523631|NCT00027846|1261628|P2|COMPLETED|Overall Study||219
523632|NCT00027846|1261629|P1|COMPLETED|Overall Study||11
523633|NCT00027846|1261627|P3|STARTED|Overall Study||78
523634|NCT00027846|1261628|P2|STARTED|Overall Study||287
523635|NCT00027846|1261629|P1|STARTED|Overall Study||13
523636|NCT00027560|1261647|P1|NOT COMPLETED|Overall Study||1
523637|NCT00027560|1261647|P1|COMPLETED|Overall Study||50
523638|NCT00027560|1261647|P1|STARTED|Overall Study||51
523639|NCT00027378|1261658|P2|NOT COMPLETED|Overall Study||3
523640|NCT00027378|1261659|P1|NOT COMPLETED|Overall Study||0
523641|NCT00027378|1261658|P2|COMPLETED|Overall Study||23
523642|NCT00027378|1261659|P1|COMPLETED|Overall Study||24
523643|NCT00027378|1261658|P2|STARTED|Overall Study||26
523644|NCT00027378|1261659|P1|STARTED|Overall Study||24
523645|NCT00027027|1261672|P5|NOT COMPLETED|Overall Study||8
523646|NCT00027027|1261673|P4|NOT COMPLETED|Overall Study||3
523647|NCT00027027|1261674|P3|NOT COMPLETED|Overall Study||4
523648|NCT00027027|1261675|P2|NOT COMPLETED|Overall Study||3
523649|NCT00027027|1261676|P1|NOT COMPLETED|Overall Study||3
523650|NCT00027027|1261672|P5|COMPLETED|Overall Study||0
523651|NCT00027027|1261673|P4|COMPLETED|Overall Study||0
523652|NCT00027027|1261674|P3|COMPLETED|Overall Study||0
523653|NCT00027027|1261675|P2|COMPLETED|Overall Study||0
523654|NCT00027027|1261676|P1|COMPLETED|Overall Study||0
523655|NCT00027027|1261672|P5|Treated Beyond Cycle 2|Overall Study||4
523656|NCT00027027|1261673|P4|Treated Beyond Cycle 2|Overall Study||2
523657|NCT00027027|1261674|P3|Treated Beyond Cycle 2|Overall Study||2
523658|NCT00027027|1261675|P2|Treated Beyond Cycle 2|Overall Study||1
523659|NCT00027027|1261676|P1|Treated Beyond Cycle 2|Overall Study||1
523660|NCT00027027|1261672|P5|Discontinued at Cycle 2|Overall Study||3
523661|NCT00027027|1261673|P4|Discontinued at Cycle 2|Overall Study||1
523662|NCT00027027|1261674|P3|Discontinued at Cycle 2|Overall Study||1
523663|NCT00027027|1261675|P2|Discontinued at Cycle 2|Overall Study||2
523664|NCT00027027|1261676|P1|Discontinued at Cycle 2|Overall Study||2
523665|NCT00027027|1261672|P5|Completed 2 Cycles of Treatment|Overall Study||7
523666|NCT00027027|1261673|P4|Completed 2 Cycles of Treatment|Overall Study||3
523667|NCT00027027|1261674|P3|Completed 2 Cycles of Treatment|Overall Study||3
523668|NCT00027027|1261675|P2|Completed 2 Cycles of Treatment|Overall Study||3
523669|NCT00027027|1261676|P1|Completed 2 Cycles of Treatment|Overall Study||3
523670|NCT00027027|1261672|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
523671|NCT00027027|1261673|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
523672|NCT00027027|1261674|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
523673|NCT00027027|1261675|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
523674|NCT00027027|1261676|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
523675|NCT00027027|1261672|P5|STARTED|Overall Study||8
523676|NCT00027027|1261673|P4|STARTED|Overall Study||3
523677|NCT00027027|1261674|P3|STARTED|Overall Study||4
523678|NCT00027027|1261675|P2|STARTED|Overall Study||3
523679|NCT00027027|1261676|P1|STARTED|Overall Study||3
523680|NCT00026494|1261725|P4|NOT COMPLETED|Overall Study||0
523681|NCT00026494|1261726|P3|NOT COMPLETED|Overall Study||6
523682|NCT00026494|1261727|P2|NOT COMPLETED|Overall Study||0
523683|NCT00026494|1261728|P1|NOT COMPLETED|Overall Study||2
523684|NCT00026494|1261725|P4|COMPLETED|Overall Study||16
523685|NCT00026494|1261726|P3|COMPLETED|Overall Study||16
523686|NCT00026494|1261727|P2|COMPLETED|Overall Study||4
523687|NCT00026494|1261728|P1|COMPLETED|Overall Study||5
523688|NCT00026494|1261725|P4|STARTED|Overall Study||16
523689|NCT00026494|1261726|P3|STARTED|Overall Study||22
523690|NCT00026494|1261727|P2|STARTED|Overall Study||4
523691|NCT00026494|1261728|P1|STARTED|Overall Study||7
523692|NCT00026312|1261740|P2|NOT COMPLETED|Overall Study||269
523693|NCT00026312|1261741|P1|NOT COMPLETED|Overall Study||34
523694|NCT00026312|1261740|P2|COMPLETED|Overall Study||1064
523695|NCT00026312|1261741|P1|COMPLETED|Overall Study||82
523696|NCT00026312|1261740|P2|STARTED|Overall Study||1333
523697|NCT00026312|1261741|P1|STARTED|Overall Study||116
523698|NCT00026221|1261759|P3|NOT COMPLETED|Overall Study||0
523699|NCT00026221|1261760|P2|NOT COMPLETED|Overall Study||0
523700|NCT00026221|1261761|P1|NOT COMPLETED|Overall Study||0
523701|NCT00026221|1261759|P3|COMPLETED|Overall Study||25
523702|NCT00026221|1261760|P2|COMPLETED|Overall Study||16
523703|NCT00026221|1261761|P1|COMPLETED|Overall Study||16
523704|NCT00026221|1261759|P3|STARTED|Overall Study||25
523705|NCT00026221|1261760|P2|STARTED|Overall Study||16
523706|NCT00026221|1261761|P1|STARTED|Overall Study||16
523707|NCT00025883|1261780|P1|NOT COMPLETED|Overall Study||17
523708|NCT00025883|1261780|P1|COMPLETED|Overall Study||86
523709|NCT00025883|1261780|P1|Partial Lipodystrophy|Overall Study||40
523710|NCT00025883|1261780|P1|Generalized Lipodystrophy|Overall Study||63
523711|NCT00025883|1261780|P1|STARTED|Overall Study||103
523712|NCT00025662|1261787|P1|NOT COMPLETED|Overall Study||3
523713|NCT00025662|1261787|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
523714|NCT00025662|1261787|P1|STARTED|Overall Study||25
523715|NCT00025506|1261795|P1|NOT COMPLETED|Overall Study||10
523716|NCT00025506|1261795|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
523717|NCT00025506|1261795|P1|STARTED|Overall Study||55
523718|NCT00025259|1261808|P7|NOT COMPLETED|Overall Study||51
523719|NCT00025259|1261809|P6|NOT COMPLETED|Overall Study||52
523720|NCT00025259|1261810|P5|NOT COMPLETED|Overall Study||36
523721|NCT00025259|1261811|P4|NOT COMPLETED|Overall Study||114
523722|NCT00025259|1261812|P3|NOT COMPLETED|Overall Study||81
523723|NCT00025259|1261813|P2|NOT COMPLETED|Overall Study||89
523724|NCT00025259|1261814|P1|NOT COMPLETED|Overall Study||45
523725|NCT00025259|1261808|P7|COMPLETED|Overall Study||102
523726|NCT00025259|1261809|P6|COMPLETED|Overall Study||101
523727|NCT00025259|1261810|P5|COMPLETED|Overall Study||6
523728|NCT00025259|1261811|P4|COMPLETED|Overall Study||457
523729|NCT00025259|1261812|P3|COMPLETED|Overall Study||301
523730|NCT00025259|1261813|P2|COMPLETED|Overall Study||292
523731|NCT00025259|1261814|P1|COMPLETED|Overall Study||7
523732|NCT00025259|1261808|P7|STARTED|Overall Study||153
523733|NCT00025259|1261809|P6|STARTED|Overall Study||153
523734|NCT00025259|1261810|P5|STARTED|Overall Study||42
523735|NCT00025259|1261811|P4|STARTED|Overall Study||571
523736|NCT00025259|1261812|P3|STARTED|Overall Study||382
523737|NCT00025259|1261813|P2|STARTED|Overall Study||381
523738|NCT00025259|1261814|P1|STARTED|Overall Study||52
523739|NCT00025233|1261850|P1|NOT COMPLETED|Overall Study||4
523740|NCT00025233|1261850|P1|COMPLETED|Overall Study||46
523741|NCT00025233|1261850|P1|STARTED|Overall Study||50
523742|NCT00025155|1261856|P1|NOT COMPLETED|Overall Study||2
523743|NCT00025155|1261856|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
523744|NCT00025155|1261856|P1|STARTED|Overall Study||51
523745|NCT00024258|1261862|P1|NOT COMPLETED|Overall Study||9
523746|NCT00024258|1261862|P1|COMPLETED|Overall Study||13
523747|NCT00024258|1261862|P1|STARTED|Overall Study||22
523748|NCT00024167|1261869|P2|NOT COMPLETED|Overall Study||47
523749|NCT00024167|1261870|P1|NOT COMPLETED|Overall Study||53
523750|NCT00024167|1261869|P2|COMPLETED|Overall Study||15
523751|NCT00024167|1261870|P1|COMPLETED|Overall Study||12
523752|NCT00024167|1261869|P2|Induction Treatment Option 2 Completed|Overall Study||41
523753|NCT00024167|1261870|P1|Induction Treatment Option 2 Completed|Overall Study||43
523754|NCT00024167|1261869|P2|Induction Treatment Option 1 Completed|Overall Study||21
523755|NCT00024167|1261870|P1|Induction Treatment Option 1 Completed|Overall Study||22
523756|NCT00024167|1261869|P2|STARTED|Overall Study||62
523757|NCT00024167|1261870|P1|STARTED|Overall Study||65
523758|NCT00024102|1261881|P2|NOT COMPLETED|Overall Study||0
523759|NCT00024102|1261882|P1|NOT COMPLETED|Overall Study||0
523760|NCT00024102|1261881|P2|COMPLETED|Overall Study||307
523761|NCT00024102|1261882|P1|COMPLETED|Overall Study||326
523762|NCT00024102|1261881|P2|STARTED|Overall Study||307
523763|NCT00024102|1261882|P1|STARTED|Overall Study||326
523764|NCT00023764|1261894|P1|NOT COMPLETED|Overall Study||14
523765|NCT00023764|1261894|P1|COMPLETED|Overall Study||89
523766|NCT00023764|1261894|P1|STARTED|Overall Study||103
523767|NCT00023712|1261901|P2|NOT COMPLETED|Overall Study||1
523768|NCT00023712|1261902|P1|NOT COMPLETED|Overall Study||2
523769|NCT00023712|1261901|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
523770|NCT00023712|1261902|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
523771|NCT00023712|1261901|P2|STARTED|Overall Study|total number of participants enrolled on study|30
523772|NCT00023712|1261902|P1|STARTED|Overall Study|total number of participants enrolled on study|28
523773|NCT00023673|1261917|P4|NOT COMPLETED|Overall Study||2
523774|NCT00023673|1261918|P3|NOT COMPLETED|Overall Study||0
523775|NCT00023673|1261919|P2|NOT COMPLETED|Overall Study||0
523776|NCT00023673|1261920|P1|NOT COMPLETED|Overall Study||0
523777|NCT00023673|1261917|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
523778|NCT00023673|1261918|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
523779|NCT00023673|1261919|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
523780|NCT00023673|1261920|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
523781|NCT00023673|1261917|P4|STARTED|Overall Study||46
523782|NCT00023673|1261918|P3|STARTED|Overall Study||0
523783|NCT00023673|1261919|P2|STARTED|Overall Study||9
523784|NCT00023673|1261920|P1|STARTED|Overall Study||8
523785|NCT00023452|1261929|P2|NOT COMPLETED|Overall Study||872
523786|NCT00023452|1261930|P1|NOT COMPLETED|Overall Study||1323
523787|NCT00023452|1261929|P2|COMPLETED|Overall Study||3273
523788|NCT00023452|1261930|P1|COMPLETED|Overall Study||2585
523789|NCT00023452|1261929|P2|Completed Study|Overall Study||3475
523790|NCT00023452|1261930|P1|Completed Study|Overall Study||3174
523791|NCT00023452|1261929|P2|Not Treated|Overall Study||105
523792|NCT00023452|1261930|P1|Not Treated|Overall Study||149
523793|NCT00023452|1261929|P2|Completed Treatment|Overall Study||3273
523794|NCT00023452|1261930|P1|Completed Treatment|Overall Study||2585
523795|NCT00023452|1261929|P2|Enrolled as Part of a Cluster|Overall Study||971
523796|NCT00023452|1261930|P1|Enrolled as Part of a Cluster|Overall Study||718
523797|NCT00023452|1261929|P2|Randomized|Overall Study||3174
523798|NCT00023452|1261930|P1|Randomized|Overall Study||3190
523799|NCT00023452|1261929|P2|STARTED|Overall Study||4145
523800|NCT00023452|1261930|P1|STARTED|Overall Study||3908
523801|NCT00023322|1261954|P1|NOT COMPLETED|Overall Study||1
523802|NCT00023322|1261954|P1|COMPLETED|Overall Study||12
523803|NCT00023322|1261954|P1|STARTED|Overall Study||13
523804|NCT00023309|1261961|P2|NOT COMPLETED|Overall Study||0
523805|NCT00023309|1261962|P1|NOT COMPLETED|Overall Study||0
523806|NCT00023309|1261961|P2|COMPLETED|Overall Study||19
523807|NCT00023309|1261962|P1|COMPLETED|Overall Study||22
523808|NCT00023309|1261961|P2|STARTED|Overall Study||19
523809|NCT00023309|1261962|P1|STARTED|Overall Study||22
523810|NCT00022763|1261978|P2|NOT COMPLETED|Overall Study||17
523811|NCT00022763|1261979|P1|NOT COMPLETED|Overall Study||9
523812|NCT00022763|1261978|P2|COMPLETED|Overall Study||11
523813|NCT00022763|1261979|P1|COMPLETED|Overall Study||15
523814|NCT00022763|1261978|P2|STARTED|Overall Study||28
523815|NCT00022763|1261979|P1|STARTED|Overall Study||24
523816|NCT00022698|1262004|P2|NOT COMPLETED|Overall Study||35
523817|NCT00022698|1262005|P1|NOT COMPLETED|Overall Study||8
523818|NCT00022698|1262004|P2|COMPLETED|Overall Study||17
523819|NCT00022698|1262005|P1|COMPLETED|Overall Study||7
523820|NCT00022698|1262004|P2|STARTED|Overall Study||52
523821|NCT00022698|1262005|P1|STARTED|Overall Study||15
523822|NCT00022672|1262030|P2|NOT COMPLETED|Extension Phase||51
523823|NCT00022672|1262031|P1|NOT COMPLETED|Extension Phase||3
523824|NCT00022672|1262030|P2|COMPLETED|Extension Phase||7
523825|NCT00022672|1262031|P1|COMPLETED|Extension Phase||11
523826|NCT00022672|1262030|P2|Safety Set: Received Study Drug|Extension Phase||58
523827|NCT00022672|1262031|P1|Safety Set: Received Study Drug|Extension Phase||14
523828|NCT00022672|1262030|P2|STARTED|Extension Phase||58
523829|NCT00022672|1262031|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
523830|NCT00022672|1262030|P2|NOT COMPLETED|Main Phase: 24 Months||100
523831|NCT00022672|1262031|P1|NOT COMPLETED|Main Phase: 24 Months||87
523832|NCT00022672|1262030|P2|COMPLETED|Main Phase: 24 Months||4
523833|NCT00022672|1262031|P1|COMPLETED|Main Phase: 24 Months||16
523834|NCT00022672|1262030|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
523835|NCT00022672|1262031|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
523836|NCT00022672|1262030|P2|STARTED|Main Phase: 24 Months||104
523837|NCT00022672|1262031|P1|STARTED|Main Phase: 24 Months||103
523838|NCT00022659|1262064|P1|NOT COMPLETED|Overall Study||2
523839|NCT00022659|1262064|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
523840|NCT00022659|1262064|P1|STARTED|Overall Study||64
523841|NCT00022633|1262072|P2|NOT COMPLETED|Overall Study||5
523842|NCT00022633|1262073|P1|NOT COMPLETED|Overall Study||32
523843|NCT00022633|1262072|P2|COMPLETED|Overall Study||5
523844|NCT00022633|1262073|P1|COMPLETED|Overall Study||23
523845|NCT00022633|1262072|P2|Eligible|Overall Study||10
523846|NCT00022633|1262073|P1|Eligible|Overall Study||51
523847|NCT00022633|1262072|P2|STARTED|Overall Study||10
523848|NCT00022633|1262073|P1|STARTED|Overall Study||55
523849|NCT00022516|1262086|P2|NOT COMPLETED|Overall Study||230
523850|NCT00022516|1262087|P1|NOT COMPLETED|Overall Study||3
523851|NCT00022516|1262086|P2|COMPLETED|Overall Study||314
523852|NCT00022516|1262087|P1|COMPLETED|Overall Study||539
523853|NCT00022516|1262086|P2|STARTED|Overall Study||544
523854|NCT00022516|1262087|P1|STARTED|Overall Study||542
523855|NCT00022490|1262099|P1|NOT COMPLETED|Overall Study||0
523856|NCT00022490|1262099|P1|COMPLETED|Overall Study||24
523857|NCT00022490|1262099|P1|STARTED|Overall Study||24
523858|NCT00021541|1262105|P2|NOT COMPLETED|Period 2-crossover||11
523859|NCT00021541|1262106|P1|NOT COMPLETED|Period 2-crossover||10
523860|NCT00021541|1262105|P2|COMPLETED|Period 2-crossover||12
523861|NCT00021541|1262106|P1|COMPLETED|Period 2-crossover||10
523862|NCT00021541|1262105|P2|STARTED|Period 2-crossover||23
523863|NCT00021541|1262106|P1|STARTED|Period 2-crossover||20
523864|NCT00021541|1262105|P2|NOT COMPLETED|Period 1-First Treatment||8
523865|NCT00021541|1262106|P1|NOT COMPLETED|Period 1-First Treatment||11
523866|NCT00021541|1262105|P2|COMPLETED|Period 1-First Treatment||23
523867|NCT00021541|1262106|P1|COMPLETED|Period 1-First Treatment||20
523868|NCT00021541|1262105|P2|Ineligible Patients|Period 1-First Treatment||2
523869|NCT00021541|1262106|P1|Ineligible Patients|Period 1-First Treatment||0
523870|NCT00021541|1262105|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
523871|NCT00021541|1262106|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
523872|NCT00021541|1262105|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
523873|NCT00021541|1262106|P1|STARTED|Period 1-First Treatment||31
523874|NCT00021255|1262115|P3|NOT COMPLETED|Overall Study||149
523875|NCT00021255|1262116|P2|NOT COMPLETED|Overall Study||270
523876|NCT00021255|1262117|P1|NOT COMPLETED|Overall Study||121
523877|NCT00021255|1262115|P3|COMPLETED|Overall Study||926
523878|NCT00021255|1262116|P2|COMPLETED|Overall Study||804
523879|NCT00021255|1262117|P1|COMPLETED|Overall Study||952
523880|NCT00021255|1262115|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
523881|NCT00021255|1262116|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
523882|NCT00021255|1262117|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
523883|NCT00021255|1262115|P3|Treated|Overall Study||1057
523884|NCT00021255|1262116|P2|Treated|Overall Study||1072
523885|NCT00021255|1262117|P1|Treated|Overall Study||1045
523886|NCT00021255|1262115|P3|STARTED|Overall Study|Randomized|1075
523887|NCT00021255|1262116|P2|STARTED|Overall Study|Randomized|1074
523888|NCT00021255|1262117|P1|STARTED|Overall Study|Randomized|1073
523889|NCT00021229|1262134|P3|NOT COMPLETED|Overall Study||16
523890|NCT00021229|1262135|P2|NOT COMPLETED|Overall Study||33
523891|NCT00021229|1262136|P1|NOT COMPLETED|Overall Study||35
523892|NCT00021229|1262134|P3|COMPLETED|Overall Study||0
523893|NCT00021229|1262135|P2|COMPLETED|Overall Study||0
523894|NCT00021229|1262136|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
523895|NCT00021229|1262134|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
523896|NCT00021229|1262135|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
523897|NCT00021229|1262136|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
523898|NCT00021229|1262134|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
523899|NCT00021229|1262135|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
523900|NCT00021229|1262136|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
523901|NCT00021229|1262134|P3|Enrolled in Phase I|Overall Study||16
523902|NCT00021229|1262135|P2|Enrolled in Phase I|Overall Study||33
523903|NCT00021229|1262136|P1|Enrolled in Phase I|Overall Study||35
523904|NCT00021229|1262134|P3|STARTED|Overall Study||16
523905|NCT00021229|1262135|P2|STARTED|Overall Study||33
523906|NCT00021229|1262136|P1|STARTED|Overall Study||36
523907|NCT00020722|1262162|P1|NOT COMPLETED|Overall Study||0
523908|NCT00020722|1262162|P1|COMPLETED|Overall Study||7
523909|NCT00020722|1262162|P1|STARTED|Overall Study||7
523910|NCT00019747|1262169|P2|NOT COMPLETED|Overall Study||0
523911|NCT00019747|1262170|P1|NOT COMPLETED|Overall Study||0
523912|NCT00019747|1262169|P2|COMPLETED|Overall Study||16
523913|NCT00019747|1262170|P1|COMPLETED|Overall Study||23
523914|NCT00019747|1262169|P2|STARTED|Overall Study||16
523915|NCT00019747|1262170|P1|STARTED|Overall Study||23
523916|NCT00019604|1262176|P1|NOT COMPLETED|Overall Study||39
523917|NCT00019604|1262176|P1|COMPLETED|Overall Study||5
523918|NCT00019604|1262176|P1|STARTED|Overall Study||44
523919|NCT00018031|1262189|P1|NOT COMPLETED|Overall Study||0
523920|NCT00018031|1262189|P1|COMPLETED|Overall Study||36
523921|NCT00018031|1262189|P1|STARTED|Overall Study||36
523922|NCT00017563|1262193|P1|NOT COMPLETED|Overall Study||1
523923|NCT00017563|1262193|P1|COMPLETED|Overall Study||56
523924|NCT00017563|1262193|P1|STARTED|Overall Study||57
523925|NCT00016913|1262197|P1|NOT COMPLETED|Overall Study||0
523926|NCT00016913|1262197|P1|COMPLETED|Overall Study||27
523927|NCT00016913|1262197|P1|STARTED|Overall Study||27
523928|NCT00016354|1262203|P8|NOT COMPLETED|Overall Study||1
523929|NCT00016354|1262204|P7|NOT COMPLETED|Overall Study||0
523930|NCT00016354|1262205|P6|NOT COMPLETED|Overall Study||0
523931|NCT00016354|1262206|P5|NOT COMPLETED|Overall Study||0
523932|NCT00016354|1262207|P4|NOT COMPLETED|Overall Study||0
523933|NCT00016354|1262208|P3|NOT COMPLETED|Overall Study||0
523934|NCT00016354|1262209|P2|NOT COMPLETED|Overall Study||0
523935|NCT00016354|1262210|P1|NOT COMPLETED|Overall Study||0
523936|NCT00016354|1262203|P8|COMPLETED|Overall Study||6
523937|NCT00016354|1262204|P7|COMPLETED|Overall Study||6
523938|NCT00016354|1262205|P6|COMPLETED|Overall Study||1
523939|NCT00016354|1262206|P5|COMPLETED|Overall Study||1
523940|NCT00016354|1262207|P4|COMPLETED|Overall Study||1
523941|NCT00016354|1262208|P3|COMPLETED|Overall Study||1
523942|NCT00016354|1262209|P2|COMPLETED|Overall Study||1
523943|NCT00016354|1262210|P1|COMPLETED|Overall Study||1
523944|NCT00016354|1262203|P8|STARTED|Overall Study||7
523945|NCT00016354|1262204|P7|STARTED|Overall Study||6
523946|NCT00016354|1262205|P6|STARTED|Overall Study||1
523947|NCT00016354|1262206|P5|STARTED|Overall Study||1
523948|NCT00016354|1262207|P4|STARTED|Overall Study||1
523949|NCT00016354|1262208|P3|STARTED|Overall Study||1
523950|NCT00016354|1262209|P2|STARTED|Overall Study||1
523951|NCT00016354|1262210|P1|STARTED|Overall Study||1
523952|NCT00015847|1262214|P1|NOT COMPLETED|Overall Study||0
523953|NCT00015847|1262214|P1|COMPLETED|Overall Study||25
523954|NCT00015847|1262214|P1|STARTED|Overall Study||25
523955|NCT00015457|1262220|P2|NOT COMPLETED|Second Intervention||0
523956|NCT00015457|1262221|P1|NOT COMPLETED|Second Intervention||1
523957|NCT00015457|1262220|P2|COMPLETED|Second Intervention||5
523958|NCT00015457|1262221|P1|COMPLETED|Second Intervention||7
523959|NCT00015457|1262220|P2|STARTED|Second Intervention||5
523960|NCT00015457|1262221|P1|STARTED|Second Intervention||8
523961|NCT00015457|1262220|P2|NOT COMPLETED|First Intervention||3
523962|NCT00015457|1262221|P1|NOT COMPLETED|First Intervention||0
523963|NCT00015457|1262220|P2|COMPLETED|First Intervention||5
523964|NCT00015457|1262221|P1|COMPLETED|First Intervention||8
523965|NCT00015457|1262220|P2|STARTED|First Intervention||8
523966|NCT00015457|1262221|P1|STARTED|First Intervention||8
523967|NCT00014911|1262229|P1|NOT COMPLETED|Overall Study||11
523968|NCT00014911|1262229|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
523969|NCT00014911|1262229|P1|STARTED|Overall Study||36
523970|NCT00014560|1262238|P1|NOT COMPLETED|Overall Study||3
523971|NCT00014560|1262238|P1|COMPLETED|Overall Study||0
523972|NCT00014560|1262238|P1|STARTED|Overall Study||3
523973|NCT00014495|1262246|P4|NOT COMPLETED|Overall Study||1
523974|NCT00014495|1262247|P3|NOT COMPLETED|Overall Study||1
523975|NCT00014495|1262248|P2|NOT COMPLETED|Overall Study||0
523976|NCT00014495|1262249|P1|NOT COMPLETED|Overall Study||0
523977|NCT00014495|1262246|P4|COMPLETED|Overall Study||5
523978|NCT00014495|1262247|P3|COMPLETED|Overall Study||19
523979|NCT00014495|1262248|P2|COMPLETED|Overall Study||3
523980|NCT00014495|1262249|P1|COMPLETED|Overall Study||3
523981|NCT00014495|1262246|P4|STARTED|Overall Study||6
523982|NCT00014495|1262247|P3|STARTED|Overall Study||20
523983|NCT00014495|1262248|P2|STARTED|Overall Study||3
523984|NCT00014495|1262249|P1|STARTED|Overall Study||3
523985|NCT00013611|1262258|P2|NOT COMPLETED|Overall Study||100
523986|NCT00013611|1262259|P1|NOT COMPLETED|Overall Study||91
523987|NCT00013611|1262258|P2|COMPLETED|Overall Study||746
523988|NCT00013611|1262259|P1|COMPLETED|Overall Study||758
523989|NCT00013611|1262258|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
523990|NCT00013611|1262259|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
523991|NCT00012298|1262282|P7|NOT COMPLETED|Overall Study||0
523992|NCT00012298|1262283|P6|NOT COMPLETED|Overall Study||0
523993|NCT00012298|1262284|P5|NOT COMPLETED|Overall Study||0
523994|NCT00012298|1262285|P4|NOT COMPLETED|Overall Study||0
523995|NCT00012298|1262286|P3|NOT COMPLETED|Overall Study||0
523996|NCT00012298|1262287|P2|NOT COMPLETED|Overall Study||0
523997|NCT00012298|1262288|P1|NOT COMPLETED|Overall Study||0
523998|NCT00012298|1262282|P7|COMPLETED|Overall Study||39
523999|NCT00012298|1262283|P6|COMPLETED|Overall Study||6
524000|NCT00012298|1262284|P5|COMPLETED|Overall Study||5
524001|NCT00012298|1262285|P4|COMPLETED|Overall Study||4
524002|NCT00012298|1262286|P3|COMPLETED|Overall Study||9
524003|NCT00012298|1262287|P2|COMPLETED|Overall Study||7
524004|NCT00012298|1262288|P1|COMPLETED|Overall Study||11
524005|NCT00012298|1262282|P7|STARTED|Overall Study||39
524006|NCT00012298|1262283|P6|STARTED|Overall Study||6
524007|NCT00012298|1262284|P5|STARTED|Overall Study||5
524008|NCT00012298|1262285|P4|STARTED|Overall Study||4
524009|NCT00012298|1262286|P3|STARTED|Overall Study||9
524010|NCT00012298|1262287|P2|STARTED|Overall Study||7
524011|NCT00012298|1262288|P1|STARTED|Overall Study||11
524012|NCT00012012|1262312|P2|NOT COMPLETED|Overall Study||3
524013|NCT00012012|1262313|P1|NOT COMPLETED|Overall Study||1
524014|NCT00012012|1262312|P2|COMPLETED|Overall Study||15
524015|NCT00012012|1262313|P1|COMPLETED|Overall Study||26
524016|NCT00012012|1262312|P2|STARTED|Overall Study||18
524017|NCT00012012|1262313|P1|STARTED|Overall Study||27
524018|NCT00011986|1262324|P5|NOT COMPLETED|Overall Study||0
524019|NCT00011986|1262325|P4|NOT COMPLETED|Overall Study||0
524020|NCT00011986|1262326|P3|NOT COMPLETED|Overall Study||0
524021|NCT00011986|1262327|P2|NOT COMPLETED|Overall Study||0
524022|NCT00011986|1262328|P1|NOT COMPLETED|Overall Study||0
524023|NCT00011986|1262324|P5|COMPLETED|Overall Study||861
524024|NCT00011986|1262325|P4|COMPLETED|Overall Study||861
524025|NCT00011986|1262326|P3|COMPLETED|Overall Study||862
524026|NCT00011986|1262327|P2|COMPLETED|Overall Study||864
524027|NCT00011986|1262328|P1|COMPLETED|Overall Study||864
524028|NCT00011986|1262324|P5|Initiated Treatment|Overall Study||851
524029|NCT00011986|1262325|P4|Initiated Treatment|Overall Study||846
524030|NCT00011986|1262326|P3|Initiated Treatment|Overall Study||854
524031|NCT00011986|1262327|P2|Initiated Treatment|Overall Study||860
524032|NCT00011986|1262328|P1|Initiated Treatment|Overall Study||862
524033|NCT00011986|1262324|P5|STARTED|Overall Study||861
524034|NCT00011986|1262325|P4|STARTED|Overall Study||861
524035|NCT00011986|1262326|P3|STARTED|Overall Study||862
524036|NCT00011986|1262327|P2|STARTED|Overall Study||864
524037|NCT00011986|1262328|P1|STARTED|Overall Study||864
524038|NCT00010803|1262342|P2|NOT COMPLETED|Overall Study||98
524039|NCT00010803|1262343|P1|NOT COMPLETED|Overall Study||97
524040|NCT00010803|1262342|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
524041|NCT00010803|1262343|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
524042|NCT00010803|1262342|P2|STARTED|Overall Study|Randomized|1524
524043|NCT00010803|1262343|P1|STARTED|Overall Study|Randomized|1545
524044|NCT00010439|1262353|P1|NOT COMPLETED|Overall Study||0
524045|NCT00010439|1262353|P1|COMPLETED|Overall Study||10
524046|NCT00010439|1262353|P1|6 Months|Overall Study||10
524047|NCT00010439|1262353|P1|STARTED|Overall Study||10
524048|NCT00010257|1262360|P2|NOT COMPLETED|Overall Study||0
524049|NCT00010257|1262361|P1|NOT COMPLETED|Overall Study||1
524050|NCT00010257|1262360|P2|COMPLETED|Overall Study||21
524051|NCT00010257|1262361|P1|COMPLETED|Overall Study||24
524052|NCT00010257|1262360|P2|STARTED|Overall Study||21
524053|NCT00010257|1262361|P1|STARTED|Overall Study||25
524054|NCT00009737|1262371|P2|NOT COMPLETED|Overall Study||123
524055|NCT00009737|1262372|P1|NOT COMPLETED|Overall Study||170
524056|NCT00009737|1262371|P2|COMPLETED|Overall Study||860
524057|NCT00009737|1262372|P1|COMPLETED|Overall Study||834
524058|NCT00009737|1262371|P2|STARTED|Overall Study||983
524059|NCT00009737|1262372|P1|STARTED|Overall Study||1004
524060|NCT00008385|1262390|P2|NOT COMPLETED|Overall Study||802
524061|NCT00008385|1262391|P1|NOT COMPLETED|Overall Study||387
524062|NCT00008385|1262390|P2|COMPLETED|Overall Study||238
524063|NCT00008385|1262391|P1|COMPLETED|Overall Study||134
524064|NCT00008385|1262390|P2|Off Treatment Reasons Reported|Overall Study||795
524065|NCT00008385|1262391|P1|Off Treatment Reasons Reported|Overall Study||398
524066|NCT00008385|1262390|P2|Treated|Overall Study||865
524067|NCT00008385|1262391|P1|Treated|Overall Study||477
524068|NCT00008385|1262390|P2|STARTED|Overall Study||1040
524069|NCT00008385|1262391|P1|STARTED|Overall Study||521
524070|NCT00008138|1262401|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
524071|NCT00008138|1262401|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
524072|NCT00008138|1262401|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
524073|NCT00008138|1262401|P1|NOT COMPLETED|Interval Debulking||2
524074|NCT00008138|1262401|P1|COMPLETED|Interval Debulking||36
524075|NCT00008138|1262401|P1|Received Protocol Surgery|Interval Debulking||36
524076|NCT00008138|1262401|P1|STARTED|Interval Debulking||38
524077|NCT00008138|1262401|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
524078|NCT00008138|1262401|P1|COMPLETED|Neoadjuvant Chemotherapy||38
524079|NCT00008138|1262401|P1|Eligible|Neoadjuvant Chemotherapy||58
524080|NCT00008138|1262401|P1|STARTED|Neoadjuvant Chemotherapy||58
524081|NCT00007644|1262409|P2|NOT COMPLETED|Overall Study||0
524082|NCT00007644|1262410|P1|NOT COMPLETED|Overall Study||0
524083|NCT00007644|1262409|P2|COMPLETED|Overall Study||367
524084|NCT00007644|1262410|P1|COMPLETED|Overall Study||364
524085|NCT00007644|1262409|P2|STARTED|Overall Study||367
524086|NCT00007644|1262410|P1|STARTED|Overall Study||364
524087|NCT00007475|1262419|P4|NOT COMPLETED|Overall Study||0
524088|NCT00007475|1262420|P3|NOT COMPLETED|Overall Study||0
524089|NCT00007475|1262421|P2|NOT COMPLETED|Overall Study||0
524090|NCT00007475|1262422|P1|NOT COMPLETED|Overall Study||4
524091|NCT00007475|1262419|P4|COMPLETED|Overall Study||0
524092|NCT00007475|1262420|P3|COMPLETED|Overall Study||2
524093|NCT00007475|1262421|P2|COMPLETED|Overall Study||1
524094|NCT00007475|1262422|P1|COMPLETED|Overall Study||8
524095|NCT00007475|1262419|P4|Initiate Cyclophosphamide|Overall Study||0
524096|NCT00007475|1262420|P3|Initiate Cyclophosphamide|Overall Study||2
524097|NCT00007475|1262421|P2|Initiate Cyclophosphamide|Overall Study||1
524098|NCT00007475|1262422|P1|Initiate Cyclophosphamide|Overall Study||12
524099|NCT00007475|1262419|P4|Initial Plasma Exchange|Overall Study||0
524100|NCT00007475|1262420|P3|Initial Plasma Exchange|Overall Study||2
524101|NCT00007475|1262421|P2|Initial Plasma Exchange|Overall Study||1
524102|NCT00007475|1262422|P1|Initial Plasma Exchange|Overall Study||12
524103|NCT00007475|1262419|P4|Post-initial Transplant Proteinuria|Overall Study||0
524104|NCT00007475|1262420|P3|Post-initial Transplant Proteinuria|Overall Study||2
524105|NCT00007475|1262421|P2|Post-initial Transplant Proteinuria|Overall Study||1
524106|NCT00007475|1262422|P1|Post-initial Transplant Proteinuria|Overall Study||12
524107|NCT00007475|1262419|P4|Initial Transplant|Overall Study||0
524108|NCT00007475|1262420|P3|Initial Transplant|Overall Study||2
524109|NCT00007475|1262421|P2|Initial Transplant|Overall Study||1
524110|NCT00007475|1262422|P1|Initial Transplant|Overall Study||12
524111|NCT00007475|1262419|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
524112|NCT00007475|1262420|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
524113|NCT00007475|1262421|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
524114|NCT00007475|1262422|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
524115|NCT00007475|1262419|P4|STARTED|Overall Study||0
524116|NCT00007475|1262420|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
524117|NCT00007475|1262421|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
524118|NCT00007475|1262422|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
524119|NCT00007345|1262444|P2|NOT COMPLETED|Overall Study||11
524120|NCT00007345|1262445|P1|NOT COMPLETED|Overall Study||2
524121|NCT00007345|1262444|P2|COMPLETED|Overall Study||73
524122|NCT00007345|1262445|P1|COMPLETED|Overall Study||45
524123|NCT00007345|1262444|P2|STARTED|Overall Study||84
524124|NCT00007345|1262445|P1|STARTED|Overall Study||47
524125|NCT00006916|1262463|P1|NOT COMPLETED|Overall Study||5
524126|NCT00006916|1262463|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
524127|NCT00006916|1262463|P1|STARTED|Overall Study||19
524128|NCT00006903|1262469|P3|NOT COMPLETED|Overall Study||6
524129|NCT00006903|1262470|P2|NOT COMPLETED|Overall Study||4
524130|NCT00006903|1262471|P1|NOT COMPLETED|Overall Study||10
524131|NCT00006903|1262469|P3|COMPLETED|Overall Study||27
524132|NCT00006903|1262470|P2|COMPLETED|Overall Study||20
524133|NCT00006903|1262471|P1|COMPLETED|Overall Study||0
524134|NCT00006903|1262469|P3|STARTED|Overall Study||33
524135|NCT00006903|1262470|P2|STARTED|Overall Study||24
524136|NCT00006903|1262471|P1|STARTED|Overall Study||10
524137|NCT00006721|1262479|P3|NOT COMPLETED|Overall Study||33
524138|NCT00006721|1262480|P2|NOT COMPLETED|Overall Study||25
524139|NCT00006721|1262481|P1|NOT COMPLETED|Overall Study||4
524140|NCT00006721|1262479|P3|COMPLETED|Overall Study||242
524141|NCT00006721|1262480|P2|COMPLETED|Overall Study||254
524142|NCT00006721|1262481|P1|COMPLETED|Overall Study||13
524143|NCT00006721|1262479|P3|Eligible and Began Protocol Therapy|Overall Study||265
524144|NCT00006721|1262480|P2|Eligible and Began Protocol Therapy|Overall Study||267
524145|NCT00006721|1262481|P1|Eligible and Began Protocol Therapy|Overall Study||14
524146|NCT00006721|1262479|P3|Eligible|Overall Study||265
524147|NCT00006721|1262480|P2|Eligible|Overall Study||267
524148|NCT00006721|1262481|P1|Eligible|Overall Study||15
524149|NCT00006721|1262479|P3|STARTED|Overall Study||275
524150|NCT00006721|1262480|P2|STARTED|Overall Study||279
524151|NCT00006721|1262481|P1|STARTED|Overall Study||17
524152|NCT00006604|1262506|P17|NOT COMPLETED|Overall Study||9
524153|NCT00006604|1262507|P16|NOT COMPLETED|Overall Study||5
524154|NCT00006604|1262508|P15|NOT COMPLETED|Overall Study||10
524155|NCT00006604|1262509|P14|NOT COMPLETED|Overall Study||6
524156|NCT00006604|1262510|P13|NOT COMPLETED|Overall Study||4
524157|NCT00006604|1262511|P12|NOT COMPLETED|Overall Study||6
524158|NCT00006604|1262512|P11|NOT COMPLETED|Overall Study||8
524159|NCT00006604|1262513|P10|NOT COMPLETED|Overall Study||19
524160|NCT00006604|1262514|P9|NOT COMPLETED|Overall Study||1
524161|NCT00006604|1262515|P8|NOT COMPLETED|Overall Study||3
524162|NCT00006604|1262516|P7|NOT COMPLETED|Overall Study||9
524163|NCT00006604|1262517|P6|NOT COMPLETED|Overall Study||3
524164|NCT00006604|1262518|P5|NOT COMPLETED|Overall Study||2
524165|NCT00006604|1262519|P4|NOT COMPLETED|Overall Study||5
524166|NCT00006604|1262520|P3|NOT COMPLETED|Overall Study||4
524167|NCT00006604|1262521|P2|NOT COMPLETED|Overall Study||0
524168|NCT00006604|1262522|P1|NOT COMPLETED|Overall Study||2
524169|NCT00006604|1262506|P17|COMPLETED|Overall Study||6
524170|NCT00006604|1262507|P16|COMPLETED|Overall Study||1
524171|NCT00006604|1262508|P15|COMPLETED|Overall Study||14
524172|NCT00006604|1262509|P14|COMPLETED|Overall Study||0
524173|NCT00006604|1262510|P13|COMPLETED|Overall Study||22
524174|NCT00006604|1262511|P12|COMPLETED|Overall Study||6
524175|NCT00006604|1262512|P11|COMPLETED|Overall Study||13
524176|NCT00006604|1262513|P10|COMPLETED|Overall Study||6
524177|NCT00006604|1262514|P9|COMPLETED|Overall Study||4
524178|NCT00006604|1262515|P8|COMPLETED|Overall Study||2
524179|NCT00006604|1262516|P7|COMPLETED|Overall Study||12
524180|NCT00006604|1262517|P6|COMPLETED|Overall Study||2
524181|NCT00006604|1262518|P5|COMPLETED|Overall Study||3
524182|NCT00006604|1262519|P4|COMPLETED|Overall Study||1
524183|NCT00006604|1262520|P3|COMPLETED|Overall Study||1
524184|NCT00006604|1262521|P2|COMPLETED|Overall Study||2
524185|NCT00006604|1262522|P1|COMPLETED|Overall Study||4
524186|NCT00006604|1262506|P17|STARTED|Overall Study||15
524187|NCT00006604|1262507|P16|STARTED|Overall Study||6
524188|NCT00006604|1262508|P15|STARTED|Overall Study||24
524189|NCT00006604|1262509|P14|STARTED|Overall Study||6
524190|NCT00006604|1262510|P13|STARTED|Overall Study||26
524191|NCT00006604|1262511|P12|STARTED|Overall Study||12
524192|NCT00006604|1262512|P11|STARTED|Overall Study||21
524193|NCT00006604|1262513|P10|STARTED|Overall Study||25
524194|NCT00006604|1262514|P9|STARTED|Overall Study||5
524195|NCT00006604|1262515|P8|STARTED|Overall Study||5
524196|NCT00006604|1262516|P7|STARTED|Overall Study||21
524197|NCT00006604|1262517|P6|STARTED|Overall Study||5
524198|NCT00006604|1262518|P5|STARTED|Overall Study||5
524199|NCT00006604|1262519|P4|STARTED|Overall Study||6
524200|NCT00006604|1262520|P3|STARTED|Overall Study||5
524201|NCT00006604|1262521|P2|STARTED|Overall Study||2
524202|NCT00006604|1262522|P1|STARTED|Overall Study||6
524203|NCT00006489|1262640|P4|NOT COMPLETED|Overall Study||11
524204|NCT00006489|1262641|P3|NOT COMPLETED|Overall Study||15
524205|NCT00006489|1262642|P2|NOT COMPLETED|Overall Study||14
524206|NCT00006489|1262643|P1|NOT COMPLETED|Overall Study||13
524207|NCT00006489|1262640|P4|COMPLETED|Overall Study||32
524208|NCT00006489|1262641|P3|COMPLETED|Overall Study||25
524209|NCT00006489|1262642|P2|COMPLETED|Overall Study||26
524210|NCT00006489|1262643|P1|COMPLETED|Overall Study||29
524211|NCT00006489|1262640|P4|STARTED|Overall Study||43
524212|NCT00006489|1262641|P3|STARTED|Overall Study||40
524213|NCT00006489|1262642|P2|STARTED|Overall Study||40
524214|NCT00006489|1262643|P1|STARTED|Overall Study||42
524215|NCT00006478|1262661|P1|NOT COMPLETED|Overall Study||7
524216|NCT00006478|1262661|P1|COMPLETED|Overall Study||12
524217|NCT00006478|1262661|P1|STARTED|Overall Study||19
524218|NCT00006409|1262671|P6|NOT COMPLETED|Post-3 Year Intervention||62
524219|NCT00006409|1262672|P5|NOT COMPLETED|Post-3 Year Intervention||62
524220|NCT00006409|1262673|P4|NOT COMPLETED|Post-3 Year Intervention||0
524221|NCT00006409|1262674|P3|NOT COMPLETED|Post-3 Year Intervention||0
524222|NCT00006409|1262675|P2|NOT COMPLETED|Post-3 Year Intervention||0
524223|NCT00006409|1262676|P1|NOT COMPLETED|Post-3 Year Intervention||0
524224|NCT00006409|1262671|P6|COMPLETED|Post-3 Year Intervention||1714
524225|NCT00006409|1262672|P5|COMPLETED|Post-3 Year Intervention||1664
524226|NCT00006409|1262673|P4|COMPLETED|Post-3 Year Intervention||0
524227|NCT00006409|1262674|P3|COMPLETED|Post-3 Year Intervention||0
524228|NCT00006409|1262675|P2|COMPLETED|Post-3 Year Intervention||0
524229|NCT00006409|1262676|P1|COMPLETED|Post-3 Year Intervention||0
524230|NCT00006409|1262671|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
524231|NCT00006409|1262672|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
524232|NCT00006409|1262673|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
524233|NCT00006409|1262674|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
524234|NCT00006409|1262675|P2|STARTED|Post-3 Year Intervention||0
524235|NCT00006409|1262676|P1|STARTED|Post-3 Year Intervention||0
524236|NCT00006409|1262671|P6|NOT COMPLETED|Post-2 Year Intervention||0
524237|NCT00006409|1262672|P5|NOT COMPLETED|Post-2 Year Intervention||0
524238|NCT00006409|1262673|P4|NOT COMPLETED|Post-2 Year Intervention||168
524239|NCT00006409|1262674|P3|NOT COMPLETED|Post-2 Year Intervention||251
524240|NCT00006409|1262675|P2|NOT COMPLETED|Post-2 Year Intervention||0
524241|NCT00006409|1262676|P1|NOT COMPLETED|Post-2 Year Intervention||0
524242|NCT00006409|1262671|P6|COMPLETED|Post-2 Year Intervention||0
524243|NCT00006409|1262672|P5|COMPLETED|Post-2 Year Intervention||0
524244|NCT00006409|1262673|P4|COMPLETED|Post-2 Year Intervention||1545
524245|NCT00006409|1262674|P3|COMPLETED|Post-2 Year Intervention||1540
524246|NCT00006409|1262675|P2|COMPLETED|Post-2 Year Intervention||0
524247|NCT00006409|1262676|P1|COMPLETED|Post-2 Year Intervention||0
524248|NCT00006409|1262671|P6|STARTED|Post-2 Year Intervention||0
524249|NCT00006409|1262672|P5|STARTED|Post-2 Year Intervention||0
524250|NCT00006409|1262673|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
524251|NCT00006409|1262674|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
524252|NCT00006409|1262675|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
524253|NCT00006409|1262676|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
524254|NCT00006409|1262671|P6|NOT COMPLETED|Baseline||0
524255|NCT00006409|1262672|P5|NOT COMPLETED|Baseline||0
524256|NCT00006409|1262673|P4|NOT COMPLETED|Baseline||0
524257|NCT00006409|1262674|P3|NOT COMPLETED|Baseline||0
524258|NCT00006409|1262675|P2|NOT COMPLETED|Baseline||70
524259|NCT00006409|1262676|P1|NOT COMPLETED|Baseline||48
524260|NCT00006409|1262671|P6|COMPLETED|Baseline||0
524261|NCT00006409|1262672|P5|COMPLETED|Baseline||0
524262|NCT00006409|1262673|P4|COMPLETED|Baseline||0
524263|NCT00006409|1262674|P3|COMPLETED|Baseline||0
524264|NCT00006409|1262675|P2|COMPLETED|Baseline||786
524265|NCT00006409|1262676|P1|COMPLETED|Baseline||817
524266|NCT00006409|1262671|P6|STARTED|Baseline||0
524267|NCT00006409|1262672|P5|STARTED|Baseline||0
524268|NCT00006409|1262673|P4|STARTED|Baseline||0
524269|NCT00006409|1262674|P3|STARTED|Baseline||0
524270|NCT00006409|1262675|P2|STARTED|Baseline||856
524271|NCT00006409|1262676|P1|STARTED|Baseline||865
524272|NCT00006392|1262700|P4|NOT COMPLETED|Overall Study||160
524273|NCT00006392|1262701|P3|NOT COMPLETED|Overall Study||160
524274|NCT00006392|1262702|P2|NOT COMPLETED|Overall Study||158
524275|NCT00006392|1262703|P1|NOT COMPLETED|Overall Study||167
524276|NCT00006392|1262700|P4|COMPLETED|Overall Study||8696
524277|NCT00006392|1262701|P3|COMPLETED|Overall Study||8703
524278|NCT00006392|1262702|P2|COMPLETED|Overall Study||8752
524279|NCT00006392|1262703|P1|COMPLETED|Overall Study||8737
524280|NCT00006392|1262700|P4|STARTED|Overall Study||8856
524281|NCT00006392|1262701|P3|STARTED|Overall Study||8863
524282|NCT00006392|1262702|P2|STARTED|Overall Study||8910
524283|NCT00006392|1262703|P1|STARTED|Overall Study||8904
524284|NCT00006389|1262733|P1|NOT COMPLETED|Overall Study||1
524285|NCT00006389|1262733|P1|COMPLETED|Overall Study||11
524286|NCT00006389|1262733|P1|STARTED|Overall Study||12
524287|NCT00006305|1262743|P4|NOT COMPLETED|Overall Study||14
524288|NCT00006305|1262744|P3|NOT COMPLETED|Overall Study||15
524289|NCT00006305|1262745|P2|NOT COMPLETED|Overall Study||10
524290|NCT00006305|1262746|P1|NOT COMPLETED|Overall Study||17
524291|NCT00006305|1262743|P4|COMPLETED|Overall Study||585
524292|NCT00006305|1262744|P3|COMPLETED|Overall Study||578
524293|NCT00006305|1262745|P2|COMPLETED|Overall Study||574
524294|NCT00006305|1262746|P1|COMPLETED|Overall Study||575
524295|NCT00006305|1262743|P4|STARTED|Overall Study||599
524296|NCT00006305|1262744|P3|STARTED|Overall Study||593
524297|NCT00006305|1262745|P2|STARTED|Overall Study||584
524298|NCT00006305|1262746|P1|STARTED|Overall Study||592
524299|NCT00006289|1262762|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
524300|NCT00006289|1262763|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
524301|NCT00006289|1262762|P2|COMPLETED|Second Intervention (5 Weeks)||9
524302|NCT00006289|1262763|P1|COMPLETED|Second Intervention (5 Weeks)||9
524303|NCT00006289|1262762|P2|STARTED|Second Intervention (5 Weeks)||10
524304|NCT00006289|1262763|P1|STARTED|Second Intervention (5 Weeks)||10
524305|NCT00006289|1262762|P2|NOT COMPLETED|Washout (>= 1 Week)||0
524306|NCT00006289|1262763|P1|NOT COMPLETED|Washout (>= 1 Week)||0
524307|NCT00006289|1262762|P2|COMPLETED|Washout (>= 1 Week)||10
524308|NCT00006289|1262763|P1|COMPLETED|Washout (>= 1 Week)||10
524309|NCT00006289|1262762|P2|STARTED|Washout (>= 1 Week)||10
524310|NCT00006289|1262763|P1|STARTED|Washout (>= 1 Week)||10
524311|NCT00006289|1262762|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
524312|NCT00006289|1262763|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
524313|NCT00006289|1262762|P2|COMPLETED|First Intervention (5 Weeks)||10
524314|NCT00006289|1262763|P1|COMPLETED|First Intervention (5 Weeks)||10
524315|NCT00006289|1262762|P2|STARTED|First Intervention (5 Weeks)||10
524316|NCT00006289|1262763|P1|STARTED|First Intervention (5 Weeks)||11
524317|NCT00006244|1262779|P1|NOT COMPLETED|Overall Study||0
524318|NCT00006244|1262779|P1|COMPLETED|Overall Study||36
524319|NCT00006244|1262779|P1|STARTED|Overall Study||36
524320|NCT00006237|1262790|P2|NOT COMPLETED|Overall Study||61
524321|NCT00006237|1262791|P1|NOT COMPLETED|Overall Study||125
524322|NCT00006237|1262790|P2|COMPLETED|Overall Study||159
524323|NCT00006237|1262791|P1|COMPLETED|Overall Study||87
524324|NCT00006237|1262790|P2|Eligible and Treated|Overall Study||199
524325|NCT00006237|1262791|P1|Eligible and Treated|Overall Study||203
524326|NCT00006237|1262790|P2|Eligible|Overall Study||200
524327|NCT00006237|1262791|P1|Eligible|Overall Study||203
524328|NCT00006237|1262790|P2|STARTED|Overall Study||220
524329|NCT00006237|1262791|P1|STARTED|Overall Study||212
524330|NCT00006184|1262803|P2|NOT COMPLETED|Overall Study||0
524331|NCT00006184|1262804|P1|NOT COMPLETED|Overall Study||1
524332|NCT00006184|1262803|P2|COMPLETED|Overall Study||10
524333|NCT00006184|1262804|P1|COMPLETED|Overall Study||9
524334|NCT00006184|1262803|P2|STARTED|Overall Study||10
524335|NCT00006184|1262804|P1|STARTED|Overall Study||10
524336|NCT00006178|1262811|P1|NOT COMPLETED|Overall Study||0
524337|NCT00006178|1262811|P1|COMPLETED|Overall Study||12
524338|NCT00006178|1262811|P1|STARTED|Overall Study||12
524339|NCT00006170|1262822|P4|NOT COMPLETED|Overall Study||39
524340|NCT00006170|1262823|P3|NOT COMPLETED|Overall Study||43
524341|NCT00006170|1262824|P2|NOT COMPLETED|Overall Study||50
524342|NCT00006170|1262825|P1|NOT COMPLETED|Overall Study||49
524343|NCT00006170|1262822|P4|COMPLETED|Overall Study||28
524344|NCT00006170|1262823|P3|COMPLETED|Overall Study||46
524345|NCT00006170|1262824|P2|COMPLETED|Overall Study||37
524346|NCT00006170|1262825|P1|COMPLETED|Overall Study||57
524347|NCT00006170|1262822|P4|STARTED|Overall Study||67
524348|NCT00006170|1262823|P3|STARTED|Overall Study||89
524349|NCT00006170|1262824|P2|STARTED|Overall Study||87
524350|NCT00006170|1262825|P1|STARTED|Overall Study||106
524351|NCT00006164|1262845|P2|NOT COMPLETED|Overall Study||81
524352|NCT00006164|1262846|P1|NOT COMPLETED|Overall Study||70
524353|NCT00006164|1262845|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
524354|NCT00006164|1262846|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
524355|NCT00006164|1262845|P2|STARTED|Overall Study||533
524356|NCT00006164|1262846|P1|STARTED|Overall Study||517
524357|NCT00006156|1262872|P2|NOT COMPLETED|Overall Study||0
524358|NCT00006156|1262873|P1|NOT COMPLETED|Overall Study||0
524359|NCT00006156|1262872|P2|COMPLETED|Overall Study||7
524360|NCT00006156|1262873|P1|COMPLETED|Overall Study||42
524361|NCT00006156|1262872|P2|STARTED|Overall Study||7
524362|NCT00006156|1262873|P1|STARTED|Overall Study||42
524363|NCT00006151|1262882|P2|NOT COMPLETED|Overall Study||14
524364|NCT00006151|1262883|P1|NOT COMPLETED|Overall Study||13
524365|NCT00006151|1262882|P2|COMPLETED|Overall Study||16
524366|NCT00006151|1262883|P1|COMPLETED|Overall Study||17
524367|NCT00006151|1262882|P2|STARTED|Overall Study||30
524368|NCT00006151|1262883|P1|STARTED|Overall Study||30
524369|NCT00006011|1262892|P3|NOT COMPLETED|Overall Study||73
524370|NCT00006011|1262893|P2|NOT COMPLETED|Overall Study||77
524371|NCT00006011|1262894|P1|NOT COMPLETED|Overall Study||65
524372|NCT00006011|1262892|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
524373|NCT00006011|1262893|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
524374|NCT00006011|1262894|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
524375|NCT00006011|1262892|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
524376|NCT00006011|1262893|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
524377|NCT00006011|1262894|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
524378|NCT00005957|1262902|P2|NOT COMPLETED|Overall Study||28
524379|NCT00005957|1262903|P1|NOT COMPLETED|Overall Study||8
524380|NCT00005957|1262902|P2|COMPLETED|Overall Study||888
524381|NCT00005957|1262903|P1|COMPLETED|Overall Study||908
524382|NCT00005957|1262902|P2|STARTED|Overall Study||916
524383|NCT00005957|1262903|P1|STARTED|Overall Study||916
524384|NCT00005947|1262913|P2|NOT COMPLETED|Overall Study||41
524385|NCT00005947|1262914|P1|NOT COMPLETED|Overall Study||57
524386|NCT00005947|1262913|P2|COMPLETED|Overall Study||4
524387|NCT00005947|1262914|P1|COMPLETED|Overall Study||25
524388|NCT00005947|1262913|P2|STARTED|Overall Study||45
524389|NCT00005947|1262914|P1|STARTED|Overall Study||82
524390|NCT00005937|1262922|P1|NOT COMPLETED|Overall Study||5
524391|NCT00005937|1262922|P1|COMPLETED|Overall Study||37
524392|NCT00005937|1262922|P1|STARTED|Overall Study||42
524393|NCT00005908|1262926|P2|NOT COMPLETED|Overall Study||0
524394|NCT00005908|1262927|P1|NOT COMPLETED|Overall Study||1
524395|NCT00005908|1262926|P2|COMPLETED|Overall Study||20
524396|NCT00005908|1262927|P1|COMPLETED|Overall Study||9
524397|NCT00005908|1262926|P2|STARTED|Overall Study||20
524398|NCT00005908|1262927|P1|STARTED|Overall Study||10
524399|NCT00005906|1262936|P1|NOT COMPLETED|Overall Study||3
524400|NCT00005906|1262936|P1|COMPLETED|Overall Study||1
524401|NCT00005906|1262936|P1|STARTED|Overall Study||4
524402|NCT00005901|1262944|P2|NOT COMPLETED|Overall Study||0
524403|NCT00005901|1262945|P1|NOT COMPLETED|Overall Study||0
524404|NCT00005901|1262944|P2|COMPLETED|Overall Study||15
524405|NCT00005901|1262945|P1|COMPLETED|Overall Study||19
524406|NCT00005901|1262944|P2|STARTED|Overall Study||15
524407|NCT00005901|1262945|P1|STARTED|Overall Study||19
524408|NCT00005879|1262963|P2|NOT COMPLETED|Overall Study||10
524409|NCT00005879|1262964|P1|NOT COMPLETED|Overall Study||8
524410|NCT00005879|1262963|P2|COMPLETED|Overall Study||88
524411|NCT00005879|1262964|P1|COMPLETED|Overall Study||93
524412|NCT00005879|1262963|P2|STARTED|Overall Study||98
524413|NCT00005879|1262964|P1|STARTED|Overall Study||101
524414|NCT00005669|1262974|P2|NOT COMPLETED|Overall Study||7
524415|NCT00005669|1262975|P1|NOT COMPLETED|Overall Study||8
524416|NCT00005669|1262974|P2|COMPLETED|Overall Study||40
524417|NCT00005669|1262975|P1|COMPLETED|Overall Study||45
524418|NCT00005669|1262974|P2|STARTED|Overall Study||47
524419|NCT00005669|1262975|P1|STARTED|Overall Study||53
524420|NCT00005047|1262993|P4|NOT COMPLETED|Overall Study||0
524421|NCT00005047|1262994|P3|NOT COMPLETED|Overall Study||0
524422|NCT00005047|1262995|P2|NOT COMPLETED|Overall Study||0
524423|NCT00005047|1262996|P1|NOT COMPLETED|Overall Study||19
524424|NCT00005047|1262993|P4|COMPLETED|Overall Study||158
524425|NCT00005047|1262994|P3|COMPLETED|Overall Study||227
524426|NCT00005047|1262995|P2|COMPLETED|Overall Study||56
524427|NCT00005047|1262996|P1|COMPLETED|Overall Study||39
524428|NCT00005047|1262993|P4|STARTED|Overall Study||158
524429|NCT00005047|1262994|P3|STARTED|Overall Study||227
524430|NCT00005047|1262995|P2|STARTED|Overall Study||56
524431|NCT00005047|1262996|P1|STARTED|Overall Study||58
524432|NCT00004980|1263012|P2|NOT COMPLETED|Overall Study||2
524433|NCT00004980|1263013|P1|NOT COMPLETED|Overall Study||2
524434|NCT00004980|1263012|P2|COMPLETED|Overall Study||21
524435|NCT00004980|1263013|P1|COMPLETED|Overall Study||25
524436|NCT00004980|1263012|P2|STARTED|Overall Study||23
524437|NCT00004980|1263013|P1|STARTED|Overall Study||27
524438|NCT00004978|1263027|P2|NOT COMPLETED|Overall Study||270
524439|NCT00004978|1263028|P1|NOT COMPLETED|Overall Study||244
524440|NCT00004978|1263027|P2|COMPLETED|Overall Study||1790
524441|NCT00004978|1263028|P1|COMPLETED|Overall Study||1846
524442|NCT00004978|1263027|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
524443|NCT00004978|1263028|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
524444|NCT00004888|1263054|P2|NOT COMPLETED|Overall Study||24
524445|NCT00004888|1263055|P1|NOT COMPLETED|Overall Study||11
524446|NCT00004888|1263054|P2|COMPLETED|Overall Study||22
524447|NCT00004888|1263055|P1|COMPLETED|Overall Study||27
524448|NCT00004888|1263054|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
524449|NCT00004888|1263055|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
524450|NCT00004859|1263073|P2|NOT COMPLETED|Overall Study||282
524451|NCT00004859|1263074|P1|NOT COMPLETED|Overall Study||118
524452|NCT00004859|1263073|P2|COMPLETED|Overall Study||12
524453|NCT00004859|1263074|P1|COMPLETED|Overall Study||177
524454|NCT00004859|1263073|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
524455|NCT00004859|1263074|P1|Treated and Having Toxicity Data|Overall Study||289
524456|NCT00004859|1263073|P2|Treated|Overall Study||289
524457|NCT00004859|1263074|P1|Treated|Overall Study||289
524458|NCT00004859|1263073|P2|Eligible|Overall Study||271
524459|NCT00004859|1263074|P1|Eligible|Overall Study||275
524460|NCT00004859|1263073|P2|STARTED|Overall Study||294
524461|NCT00004859|1263074|P1|STARTED|Overall Study||295
524462|NCT00004732|1263086|P2|NOT COMPLETED|Overall Study||111
524463|NCT00004732|1263087|P1|NOT COMPLETED|Overall Study||69
524464|NCT00004732|1263086|P2|COMPLETED|Overall Study||1129
524465|NCT00004732|1263087|P1|COMPLETED|Overall Study||1193
524466|NCT00004732|1263086|P2|STARTED|Overall Study||1240
524467|NCT00004732|1263087|P1|STARTED|Overall Study||1262
524468|NCT00004635|1263097|P2|NOT COMPLETED|Period Two||9
524469|NCT00004635|1263098|P1|NOT COMPLETED|Period Two||6
524470|NCT00004635|1263097|P2|COMPLETED|Period Two||50
524471|NCT00004635|1263098|P1|COMPLETED|Period Two||38
524472|NCT00004635|1263097|P2|STARTED|Period Two||59
524473|NCT00004635|1263098|P1|STARTED|Period Two||44
524474|NCT00004635|1263097|P2|NOT COMPLETED|Period One||6
524475|NCT00004635|1263098|P1|NOT COMPLETED|Period One||6
524476|NCT00004635|1263097|P2|COMPLETED|Period One||74
524477|NCT00004635|1263098|P1|COMPLETED|Period One||73
524478|NCT00004635|1263097|P2|Received Treatment|Period One||75
524479|NCT00004635|1263098|P1|Received Treatment|Period One||73
524480|NCT00004635|1263097|P2|STARTED|Period One||80
524481|NCT00004635|1263098|P1|STARTED|Period One||79
524482|NCT00004563|1263110|P2|NOT COMPLETED|Overall Study||24
524483|NCT00004563|1263111|P1|NOT COMPLETED|Overall Study||25
524484|NCT00004563|1263110|P2|COMPLETED|Overall Study||55
524485|NCT00004563|1263111|P1|COMPLETED|Overall Study||54
524486|NCT00004563|1263110|P2|STARTED|Overall Study||79
524487|NCT00004563|1263111|P1|STARTED|Overall Study||79
524488|NCT00004562|1263123|P2|NOT COMPLETED|Overall Study||91
524489|NCT00004562|1263124|P1|NOT COMPLETED|Overall Study||102
524490|NCT00004562|1263123|P2|COMPLETED|Overall Study||1009
524491|NCT00004562|1263124|P1|COMPLETED|Overall Study||999
524492|NCT00004562|1263123|P2|STARTED|Overall Study||1100
524493|NCT00004562|1263124|P1|STARTED|Overall Study||1101
524494|NCT00004547|1263135|P3|NOT COMPLETED|Overall Study||22
524495|NCT00004547|1263136|P2|NOT COMPLETED|Overall Study||9
524496|NCT00004547|1263137|P1|NOT COMPLETED|Overall Study||22
524497|NCT00004547|1263135|P3|COMPLETED|Overall Study||35
524498|NCT00004547|1263136|P2|COMPLETED|Overall Study||39
524499|NCT00004547|1263137|P1|COMPLETED|Overall Study||61
524500|NCT00004547|1263135|P3|Not Evaluable|Overall Study||23
524501|NCT00004547|1263136|P2|Not Evaluable|Overall Study||9
524502|NCT00004547|1263137|P1|Not Evaluable|Overall Study||21
524503|NCT00004547|1263135|P3|STARTED|Overall Study||57
524504|NCT00004547|1263136|P2|STARTED|Overall Study||48
524505|NCT00004547|1263137|P1|STARTED|Overall Study||83
524506|NCT00004500|1263157|P2|NOT COMPLETED|Overall Study||0
524507|NCT00004500|1263158|P1|NOT COMPLETED|Overall Study||0
524508|NCT00004500|1263157|P2|COMPLETED|Overall Study||31
524509|NCT00004500|1263158|P1|COMPLETED|Overall Study||38
524510|NCT00004500|1263157|P2|1 Year Follow-Up|Overall Study||24
524511|NCT00004500|1263158|P1|1 Year Follow-Up|Overall Study||24
524512|NCT00004500|1263157|P2|STARTED|Overall Study||31
524513|NCT00004500|1263158|P1|STARTED|Overall Study||38
524514|NCT00004412|1263171|P3|NOT COMPLETED|Crossover Period||0
524515|NCT00004412|1263172|P2|NOT COMPLETED|Crossover Period||0
524516|NCT00004412|1263173|P1|NOT COMPLETED|Crossover Period||0
524517|NCT00004412|1263171|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
524518|NCT00004412|1263172|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
524519|NCT00004412|1263173|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
524520|NCT00004412|1263171|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
524521|NCT00004412|1263172|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
524522|NCT00004412|1263173|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
524523|NCT00004412|1263171|P3|NOT COMPLETED|Randomized Period||0
524524|NCT00004412|1263172|P2|NOT COMPLETED|Randomized Period||0
524525|NCT00004412|1263173|P1|NOT COMPLETED|Randomized Period||3
524526|NCT00004412|1263171|P3|COMPLETED|Randomized Period||0
524527|NCT00004412|1263172|P2|COMPLETED|Randomized Period||12
524528|NCT00004412|1263173|P1|COMPLETED|Randomized Period||8
524529|NCT00004412|1263171|P3|STARTED|Randomized Period||0
524530|NCT00004412|1263172|P2|STARTED|Randomized Period||12
524531|NCT00004412|1263173|P1|STARTED|Randomized Period||11
524532|NCT00004228|1263188|P7|NOT COMPLETED|Overall Study||12
524533|NCT00004228|1263189|P6|NOT COMPLETED|Overall Study||14
524534|NCT00004228|1263190|P5|NOT COMPLETED|Overall Study||16
524535|NCT00004228|1263191|P4|NOT COMPLETED|Overall Study||7
524536|NCT00004228|1263192|P3|NOT COMPLETED|Overall Study||19
524537|NCT00004228|1263193|P2|NOT COMPLETED|Overall Study||15
524538|NCT00004228|1263194|P1|NOT COMPLETED|Overall Study||9
524539|NCT00004228|1263188|P7|COMPLETED|Overall Study||45
524540|NCT00004228|1263189|P6|COMPLETED|Overall Study||51
524541|NCT00004228|1263190|P5|COMPLETED|Overall Study||51
524542|NCT00004228|1263191|P4|COMPLETED|Overall Study||6
524543|NCT00004228|1263192|P3|COMPLETED|Overall Study||46
524544|NCT00004228|1263193|P2|COMPLETED|Overall Study||51
524545|NCT00004228|1263194|P1|COMPLETED|Overall Study||51
524546|NCT00004228|1263188|P7|STARTED|Overall Study||57
524547|NCT00004228|1263189|P6|STARTED|Overall Study||65
524548|NCT00004228|1263190|P5|STARTED|Overall Study||67
524549|NCT00004228|1263191|P4|STARTED|Overall Study||13
524550|NCT00004228|1263192|P3|STARTED|Overall Study||65
524551|NCT00004228|1263193|P2|STARTED|Overall Study||66
524552|NCT00004228|1263194|P1|STARTED|Overall Study||60
524553|NCT00004146|1263217|P1|NOT COMPLETED|Overall Study||0
524554|NCT00004146|1263217|P1|COMPLETED|Overall Study||55
524555|NCT00004146|1263217|P1|STARTED|Overall Study||55
524556|NCT00004143|1263224|P1|NOT COMPLETED|Overall Study||0
524557|NCT00004143|1263224|P1|COMPLETED|Overall Study||2
524558|NCT00004143|1263224|P1|STARTED|Overall Study||2
524559|NCT00004092|1263235|P2|NOT COMPLETED|Overall Study||0
524560|NCT00004092|1263236|P1|NOT COMPLETED|Overall Study||0
524561|NCT00004092|1263235|P2|COMPLETED|Overall Study||51
524562|NCT00004092|1263236|P1|COMPLETED|Overall Study||21
524563|NCT00004092|1263235|P2|STARTED|Overall Study||51
524564|NCT00004092|1263236|P1|STARTED|Overall Study||21
524565|NCT00004054|1263246|P2|NOT COMPLETED|Overall Study||0
524566|NCT00004054|1263247|P1|NOT COMPLETED|Overall Study||0
524567|NCT00004054|1263246|P2|COMPLETED|Overall Study||200
524568|NCT00004054|1263247|P1|COMPLETED|Overall Study||197
524569|NCT00004054|1263246|P2|STARTED|Overall Study||200
524570|NCT00004054|1263247|P1|STARTED|Overall Study||197
524571|NCT00003910|1263253|P2|NOT COMPLETED|Step 2||0
524572|NCT00003910|1263254|P1|NOT COMPLETED|Step 2||0
524573|NCT00003910|1263253|P2|COMPLETED|Step 2||16
524574|NCT00003910|1263254|P1|COMPLETED|Step 2||0
524575|NCT00003910|1263253|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
524576|NCT00003910|1263254|P1|STARTED|Step 2||0
524577|NCT00003910|1263253|P2|NOT COMPLETED|Step 1||0
524578|NCT00003910|1263254|P1|NOT COMPLETED|Step 1||0
524579|NCT00003910|1263253|P2|COMPLETED|Step 1||0
524580|NCT00003910|1263254|P1|COMPLETED|Step 1||55
524581|NCT00003910|1263253|P2|STARTED|Step 1||0
524582|NCT00003910|1263254|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
524583|NCT00003907|1263261|P2|NOT COMPLETED|Overall Study||23
524584|NCT00003907|1263262|P1|NOT COMPLETED|Overall Study||13
524585|NCT00003907|1263261|P2|COMPLETED|Overall Study||8
524586|NCT00003907|1263262|P1|COMPLETED|Overall Study||6
524587|NCT00003907|1263261|P2|Eligible and Treated|Overall Study||29
524588|NCT00003907|1263262|P1|Eligible and Treated|Overall Study||17
524589|NCT00003907|1263261|P2|Received Protocol Therapy (Treated)|Overall Study||31
524590|NCT00003907|1263262|P1|Received Protocol Therapy (Treated)|Overall Study||18
524591|NCT00003907|1263261|P2|Eligible|Overall Study||29
524592|NCT00003907|1263262|P1|Eligible|Overall Study||18
524593|NCT00003907|1263261|P2|STARTED|Overall Study||31
524594|NCT00003907|1263262|P1|STARTED|Overall Study||19
524595|NCT00003901|1263272|P1|NOT COMPLETED|Overall Study||17
524596|NCT00003901|1263272|P1|COMPLETED|Overall Study||1030
524597|NCT00003901|1263272|P1|STARTED|Overall Study||1047
524598|NCT00003896|1263283|P1|NOT COMPLETED|Overall Study||29
524599|NCT00003896|1263283|P1|COMPLETED|Overall Study||39
524600|NCT00003896|1263283|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
524601|NCT00003896|1263283|P1|STARTED|Overall Study||68
524602|NCT00003895|1263291|P2|NOT COMPLETED|Overall Study||4
524603|NCT00003895|1263292|P1|NOT COMPLETED|Overall Study||7
524604|NCT00003895|1263291|P2|COMPLETED|Overall Study||14
524605|NCT00003895|1263292|P1|COMPLETED|Overall Study||11
524606|NCT00003895|1263291|P2|STARTED|Overall Study||18
524607|NCT00003895|1263292|P1|STARTED|Overall Study||18
524608|NCT00003875|1263298|P1|NOT COMPLETED|Overall Study||1
524609|NCT00003875|1263298|P1|COMPLETED|Overall Study||29
524610|NCT00003875|1263298|P1|STARTED|Overall Study||30
524611|NCT00003869|1263307|P2|NOT COMPLETED|Overall Study||12
524612|NCT00003869|1263308|P1|NOT COMPLETED|Overall Study||41
524613|NCT00003869|1263307|P2|COMPLETED|Overall Study||80
524614|NCT00003869|1263308|P1|COMPLETED|Overall Study||53
524615|NCT00003869|1263307|P2|STARTED|Overall Study||92
524616|NCT00003869|1263308|P1|STARTED|Overall Study||94
524617|NCT00003820|1263324|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
524618|NCT00003820|1263325|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
524619|NCT00003820|1263324|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
524620|NCT00003820|1263325|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
524621|NCT00003820|1263324|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
524622|NCT00003820|1263325|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
524623|NCT00003820|1263324|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
524624|NCT00003820|1263325|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
524625|NCT00003820|1263324|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
524626|NCT00003820|1263325|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
524627|NCT00003820|1263324|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
524628|NCT00003820|1263325|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
524629|NCT00003820|1263324|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
524630|NCT00003820|1263325|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
524631|NCT00003820|1263324|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
524632|NCT00003820|1263325|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
524633|NCT00003820|1263324|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
524634|NCT00003820|1263325|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
524635|NCT00003820|1263324|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
524636|NCT00003820|1263325|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
524637|NCT00003820|1263324|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
524638|NCT00003820|1263325|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
524639|NCT00003820|1263324|P2|STARTED|Cycle 1 (Initial Treatment)||16
524640|NCT00003820|1263325|P1|STARTED|Cycle 1 (Initial Treatment)||23
524641|NCT00003782|1263334|P3|NOT COMPLETED|Overall Study||26
524642|NCT00003782|1263335|P2|NOT COMPLETED|Overall Study||31
524643|NCT00003782|1263336|P1|NOT COMPLETED|Overall Study||30
524644|NCT00003782|1263334|P3|COMPLETED|Overall Study||1758
524645|NCT00003782|1263335|P2|COMPLETED|Overall Study||1753
524646|NCT00003782|1263336|P1|COMPLETED|Overall Study||1753
524647|NCT00003782|1263334|P3|STARTED|Overall Study||1784
524648|NCT00003782|1263335|P2|STARTED|Overall Study||1784
524649|NCT00003782|1263336|P1|STARTED|Overall Study||1783
524650|NCT00003726|1263344|P1|NOT COMPLETED|Overall Study||1
524651|NCT00003726|1263344|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
524652|NCT00003726|1263344|P1|STARTED|Overall Study||1
524653|NCT00003659|1263348|P1|NOT COMPLETED|Overall Study||3
524654|NCT00003659|1263348|P1|COMPLETED|Overall Study||36
524655|NCT00003659|1263348|P1|STARTED|Overall Study||39
524656|NCT00003641|1263356|P2|NOT COMPLETED|Overall Study||174
524657|NCT00003641|1263357|P1|NOT COMPLETED|Overall Study||569
524658|NCT00003641|1263356|P2|COMPLETED|Overall Study||407
524659|NCT00003641|1263357|P1|COMPLETED|Overall Study||0
524660|NCT00003641|1263356|P2|Toxicity Assessed|Overall Study||568
524661|NCT00003641|1263357|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
524662|NCT00003641|1263356|P2|Treated|Overall Study||569
524663|NCT00003641|1263357|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
524664|NCT00003641|1263356|P2|STARTED|Overall Study||581
524665|NCT00003641|1263357|P1|STARTED|Overall Study||569
524666|NCT00003631|1263368|P3|NOT COMPLETED|Overall Study||9
524667|NCT00003631|1263369|P2|NOT COMPLETED|Overall Study||1
524668|NCT00003631|1263370|P1|NOT COMPLETED|Overall Study||3
524669|NCT00003631|1263368|P3|COMPLETED|Overall Study||15
524670|NCT00003631|1263369|P2|COMPLETED|Overall Study||43
524671|NCT00003631|1263370|P1|COMPLETED|Overall Study||47
524672|NCT00003631|1263368|P3|STARTED|Overall Study||24
524673|NCT00003631|1263369|P2|STARTED|Overall Study||44
524674|NCT00003631|1263370|P1|STARTED|Overall Study||50
524675|NCT00003590|1263378|P1|NOT COMPLETED|Overall Study||22
524676|NCT00003590|1263378|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
524677|NCT00003590|1263378|P1|Eligible and Began Protocol Therapy|Overall Study||28
524678|NCT00003590|1263378|P1|Eligible|Overall Study||28
524679|NCT00003590|1263378|P1|STARTED|Overall Study||29
524680|NCT00003537|1263383|P1|NOT COMPLETED|Overall Study||1
524681|NCT00003537|1263383|P1|COMPLETED|Overall Study||18
524682|NCT00003537|1263383|P1|STARTED|Overall Study||19
524683|NCT00003483|1263388|P1|NOT COMPLETED|Overall Study||1
524684|NCT00003483|1263388|P1|COMPLETED|Overall Study||2
524685|NCT00003483|1263388|P1|STARTED|Overall Study||3
524686|NCT00003479|1263393|P1|NOT COMPLETED|Overall Study||3
524687|NCT00003479|1263393|P1|COMPLETED|Overall Study||6
524688|NCT00003479|1263393|P1|STARTED|Overall Study||9
524689|NCT00003477|1263398|P1|NOT COMPLETED|Overall Study||4
524690|NCT00003477|1263398|P1|COMPLETED|Overall Study||8
524691|NCT00003477|1263398|P1|STARTED|Overall Study||12
524692|NCT00003476|1263403|P1|NOT COMPLETED|Overall Study||1
524693|NCT00003476|1263403|P1|COMPLETED|Overall Study||7
524694|NCT00003476|1263403|P1|STARTED|Overall Study||8
524695|NCT00003475|1263408|P1|NOT COMPLETED|Overall Study||13
524696|NCT00003475|1263408|P1|COMPLETED|Overall Study||27
524697|NCT00003475|1263408|P1|STARTED|Overall Study||40
524698|NCT00003473|1263413|P1|NOT COMPLETED|Overall Study||3
524699|NCT00003473|1263413|P1|COMPLETED|Overall Study||17
524700|NCT00003473|1263413|P1|STARTED|Overall Study||20
524701|NCT00003470|1263418|P1|NOT COMPLETED|Overall Study||6
524702|NCT00003470|1263418|P1|COMPLETED|Overall Study||21
524703|NCT00003470|1263418|P1|STARTED|Overall Study||27
524704|NCT00003469|1263423|P1|NOT COMPLETED|Overall Study||0
524705|NCT00003469|1263423|P1|COMPLETED|Overall Study||4
524706|NCT00003469|1263423|P1|STARTED|Overall Study||4
524707|NCT00003468|1263428|P1|NOT COMPLETED|Overall Study||2
524708|NCT00003468|1263428|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
524709|NCT00003468|1263428|P1|STARTED|Overall Study||11
524710|NCT00003460|1263433|P1|NOT COMPLETED|Overall Study||1
524711|NCT00003460|1263433|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
524712|NCT00003460|1263433|P1|STARTED|Overall Study||13
524713|NCT00003459|1263438|P1|NOT COMPLETED|Overall Study||9
524714|NCT00003459|1263438|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
524715|NCT00003459|1263438|P1|STARTED|Overall Study||40
524716|NCT00003458|1263443|P1|NOT COMPLETED|Overall Study||4
524717|NCT00003458|1263443|P1|COMPLETED|Overall Study||30
524718|NCT00003458|1263443|P1|STARTED|Overall Study||34
524719|NCT00003457|1263448|P1|NOT COMPLETED|Overall Study||9
524720|NCT00003457|1263448|P1|COMPLETED|Overall Study||31
524721|NCT00003457|1263448|P1|STARTED|Overall Study||40
524722|NCT00003389|1263455|P2|NOT COMPLETED|Overall Study||60
524723|NCT00003389|1263456|P1|NOT COMPLETED|Overall Study||98
524724|NCT00003389|1263455|P2|COMPLETED|Overall Study||366
524725|NCT00003389|1263456|P1|COMPLETED|Overall Study||330
524726|NCT00003389|1263455|P2|Eligible Patients|Overall Study||399
524727|NCT00003389|1263456|P1|Eligible Patients|Overall Study||395
524728|NCT00003389|1263455|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
524729|NCT00003389|1263456|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
524730|NCT00003389|1263455|P2|STARTED|Overall Study||426
524731|NCT00003389|1263456|P1|STARTED|Overall Study||428
524732|NCT00003377|1263471|P5|NOT COMPLETED|Period II||1
524733|NCT00003377|1263472|P4|NOT COMPLETED|Period II||0
524734|NCT00003377|1263473|P3|NOT COMPLETED|Period II||0
524735|NCT00003377|1263474|P2|NOT COMPLETED|Period II||0
524736|NCT00003377|1263475|P1|NOT COMPLETED|Period II||0
524737|NCT00003377|1263471|P5|COMPLETED|Period II||16
524738|NCT00003377|1263472|P4|COMPLETED|Period II||0
524739|NCT00003377|1263473|P3|COMPLETED|Period II||0
524740|NCT00003377|1263474|P2|COMPLETED|Period II||0
524741|NCT00003377|1263475|P1|COMPLETED|Period II||0
524742|NCT00003377|1263471|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
524743|NCT00003377|1263472|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
524744|NCT00003377|1263473|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
524745|NCT00003377|1263474|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
524746|NCT00003377|1263475|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
524747|NCT00003377|1263471|P5|NOT COMPLETED|Period I||0
524748|NCT00003377|1263472|P4|NOT COMPLETED|Period I||1
524749|NCT00003377|1263473|P3|NOT COMPLETED|Period I||1
524750|NCT00003377|1263474|P2|NOT COMPLETED|Period I||0
524751|NCT00003377|1263475|P1|NOT COMPLETED|Period I||0
524752|NCT00003377|1263471|P5|COMPLETED|Period I||0
524753|NCT00003377|1263472|P4|COMPLETED|Period I||2
524754|NCT00003377|1263473|P3|COMPLETED|Period I||2
524755|NCT00003377|1263474|P2|COMPLETED|Period I||3
524756|NCT00003377|1263475|P1|COMPLETED|Period I||3
524757|NCT00003377|1263471|P5|STARTED|Period I||0
524758|NCT00003377|1263472|P4|STARTED|Period I||3
524759|NCT00003377|1263473|P3|STARTED|Period I||3
524760|NCT00003377|1263474|P2|STARTED|Period I||3
524761|NCT00003377|1263475|P1|STARTED|Period I||3
524762|NCT00003298|1263489|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
524763|NCT00003298|1263489|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
524764|NCT00003298|1263489|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
524765|NCT00003298|1263489|P1|STARTED|Step 2 (Adjuvant Therapy)||10
524766|NCT00003298|1263489|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
524767|NCT00003298|1263489|P1|COMPLETED|Re-register to Step 2 After Surgery||10
524768|NCT00003298|1263489|P1|STARTED|Re-register to Step 2 After Surgery||28
524769|NCT00003298|1263489|P1|NOT COMPLETED|Surgery||7
524858|NCT00002842|1263584|P1|STARTED|Overall Study||49
524770|NCT00003298|1263489|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
524771|NCT00003298|1263489|P1|STARTED|Surgery||35
524772|NCT00003298|1263489|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
524773|NCT00003298|1263489|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
524774|NCT00003298|1263489|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
524775|NCT00003298|1263489|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
524776|NCT00003298|1263489|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
524777|NCT00003224|1263503|P6|NOT COMPLETED|Overall Study||0
524778|NCT00003224|1263504|P5|NOT COMPLETED|Overall Study||0
524779|NCT00003224|1263505|P4|NOT COMPLETED|Overall Study||0
524780|NCT00003224|1263506|P3|NOT COMPLETED|Overall Study||0
524781|NCT00003224|1263507|P2|NOT COMPLETED|Overall Study||0
524782|NCT00003224|1263508|P1|NOT COMPLETED|Overall Study||0
524783|NCT00003224|1263503|P6|COMPLETED|Overall Study||3
524784|NCT00003224|1263504|P5|COMPLETED|Overall Study||4
524785|NCT00003224|1263505|P4|COMPLETED|Overall Study||2
524786|NCT00003224|1263506|P3|COMPLETED|Overall Study||4
524787|NCT00003224|1263507|P2|COMPLETED|Overall Study||5
524788|NCT00003224|1263508|P1|COMPLETED|Overall Study||4
524789|NCT00003224|1263503|P6|STARTED|Overall Study||3
524790|NCT00003224|1263504|P5|STARTED|Overall Study||4
524791|NCT00003224|1263505|P4|STARTED|Overall Study||2
524792|NCT00003224|1263506|P3|STARTED|Overall Study||4
524793|NCT00003224|1263507|P2|STARTED|Overall Study||5
524794|NCT00003224|1263508|P1|STARTED|Overall Study||4
524795|NCT00003222|1263528|P2|NOT COMPLETED|Overall Study||1
524796|NCT00003222|1263529|P1|NOT COMPLETED|Overall Study||0
524797|NCT00003222|1263528|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
524798|NCT00003222|1263529|P1|COMPLETED|Overall Study||13
524799|NCT00003222|1263528|P2|STARTED|Overall Study||28
524800|NCT00003222|1263529|P1|STARTED|Overall Study||13
524801|NCT00003199|1263539|P1|NOT COMPLETED|Overall Study||22
524802|NCT00003199|1263539|P1|COMPLETED|Overall Study||28
524803|NCT00003199|1263539|P1|STARTED|Overall Study||50
524804|NCT00003138|1263547|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
524805|NCT00003138|1263548|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
524806|NCT00003138|1263547|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
524807|NCT00003138|1263548|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
524808|NCT00003138|1263547|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
524809|NCT00003138|1263548|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
524810|NCT00003138|1263547|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
524811|NCT00003138|1263548|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
524812|NCT00003138|1263547|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
524813|NCT00003138|1263548|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
524814|NCT00003138|1263547|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
524815|NCT00003138|1263548|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
524816|NCT00003138|1263547|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
524817|NCT00003138|1263548|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
524818|NCT00003138|1263547|P2|NOT COMPLETED|Step 2 (Cross Over)||0
524819|NCT00003138|1263548|P1|NOT COMPLETED|Step 2 (Cross Over)||26
524820|NCT00003138|1263547|P2|COMPLETED|Step 2 (Cross Over)||0
524821|NCT00003138|1263548|P1|COMPLETED|Step 2 (Cross Over)||0
524822|NCT00003138|1263547|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
524823|NCT00003138|1263548|P1|STARTED|Step 2 (Cross Over)||26
524824|NCT00003138|1263547|P2|NOT COMPLETED|Step 1||57
524825|NCT00003138|1263548|P1|NOT COMPLETED|Step 1||61
524826|NCT00003138|1263547|P2|COMPLETED|Step 1||0
524827|NCT00003138|1263548|P1|COMPLETED|Step 1||0
524828|NCT00003138|1263547|P2|Patients With Transfusion Data|Step 1||42
524829|NCT00003138|1263548|P1|Patients With Transfusion Data|Step 1||37
524830|NCT00003138|1263547|P2|Patients With QOL Data at 4 Months|Step 1||42
524831|NCT00003138|1263548|P1|Patients With QOL Data at 4 Months|Step 1||42
524832|NCT00003138|1263547|P2|Eligible and Treated|Step 1||50
524833|NCT00003138|1263548|P1|Eligible and Treated|Step 1||52
524834|NCT00003138|1263547|P2|Treated|Step 1||53
524835|NCT00003138|1263548|P1|Treated|Step 1||56
524836|NCT00003138|1263547|P2|Patients With Complete Data|Step 1||53
524837|NCT00003138|1263548|P1|Patients With Complete Data|Step 1||57
524838|NCT00003138|1263547|P2|STARTED|Step 1||57
524839|NCT00003138|1263548|P1|STARTED|Step 1||61
524840|NCT00002975|1263561|P1|NOT COMPLETED|Overall Study||5
524841|NCT00002975|1263561|P1|COMPLETED|Overall Study||175
524842|NCT00002975|1263561|P1|Treated With Study Therapy|Overall Study||175
524843|NCT00002975|1263561|P1|STARTED|Overall Study||180
524844|NCT00002931|1263565|P1|NOT COMPLETED|Overall Study||2
524845|NCT00002931|1263565|P1|COMPLETED|Overall Study||46
524846|NCT00002931|1263565|P1|STARTED|Overall Study||48
524847|NCT00002850|1263574|P3|NOT COMPLETED|Overall Study||4
524848|NCT00002850|1263575|P2|NOT COMPLETED|Overall Study||2
524849|NCT00002850|1263576|P1|NOT COMPLETED|Overall Study||5
524850|NCT00002850|1263574|P3|COMPLETED|Overall Study||63
524851|NCT00002850|1263575|P2|COMPLETED|Overall Study||74
524852|NCT00002850|1263576|P1|COMPLETED|Overall Study||64
524853|NCT00002850|1263574|P3|STARTED|Overall Study||67
524854|NCT00002850|1263575|P2|STARTED|Overall Study||76
524855|NCT00002850|1263576|P1|STARTED|Overall Study||69
524856|NCT00002842|1263584|P1|NOT COMPLETED|Overall Study||27
524857|NCT00002842|1263584|P1|COMPLETED|Overall Study||22
524859|NCT00002766|1263590|P2|NOT COMPLETED|Overall Study||4
524860|NCT00002766|1263591|P1|NOT COMPLETED|Overall Study||3
524861|NCT00002766|1263590|P2|COMPLETED|Overall Study||85
524862|NCT00002766|1263591|P1|COMPLETED|Overall Study||78
524863|NCT00002766|1263590|P2|STARTED|Overall Study||89
524864|NCT00002766|1263591|P1|STARTED|Overall Study||81
524865|NCT00002651|1263599|P3|NOT COMPLETED|Consolidation and Randomization||860
524866|NCT00002651|1263600|P2|NOT COMPLETED|Consolidation and Randomization||838
524867|NCT00002651|1263601|P1|NOT COMPLETED|Consolidation and Randomization||0
524868|NCT00002651|1263599|P3|COMPLETED|Consolidation and Randomization||22
524869|NCT00002651|1263600|P2|COMPLETED|Consolidation and Randomization||29
524870|NCT00002651|1263601|P1|COMPLETED|Consolidation and Randomization||0
524871|NCT00002651|1263599|P3|Assessable for Toxicity|Consolidation and Randomization||702
524872|NCT00002651|1263600|P2|Assessable for Toxicity|Consolidation and Randomization||732
524873|NCT00002651|1263601|P1|Assessable for Toxicity|Consolidation and Randomization||0
524874|NCT00002651|1263599|P3|Eligible|Consolidation and Randomization||770
524875|NCT00002651|1263600|P2|Eligible|Consolidation and Randomization||765
524876|NCT00002651|1263601|P1|Eligible|Consolidation and Randomization||0
524877|NCT00002651|1263599|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
524878|NCT00002651|1263600|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
524879|NCT00002651|1263601|P1|STARTED|Consolidation and Randomization||0
524880|NCT00002651|1263599|P3|NOT COMPLETED|Induction||0
524881|NCT00002651|1263600|P2|NOT COMPLETED|Induction||0
524882|NCT00002651|1263601|P1|NOT COMPLETED|Induction||1343
524883|NCT00002651|1263599|P3|COMPLETED|Induction||0
524884|NCT00002651|1263600|P2|COMPLETED|Induction||0
524885|NCT00002651|1263601|P1|COMPLETED|Induction||1697
524886|NCT00002651|1263599|P3|Eligible and Began Protocol Therapy|Induction||0
524887|NCT00002651|1263600|P2|Eligible and Began Protocol Therapy|Induction||0
524888|NCT00002651|1263601|P1|Eligible and Began Protocol Therapy|Induction||2950
524889|NCT00002651|1263599|P3|Eligible|Induction||0
524890|NCT00002651|1263600|P2|Eligible|Induction||0
524891|NCT00002651|1263601|P1|Eligible|Induction||2950
524892|NCT00002651|1263599|P3|STARTED|Induction||0
524893|NCT00002651|1263600|P2|STARTED|Induction||0
524894|NCT00002651|1263601|P1|STARTED|Induction||3040
524895|NCT00002601|1263617|P1|NOT COMPLETED|Overall Study||0
524896|NCT00002601|1263617|P1|COMPLETED|Overall Study||13
524897|NCT00002601|1263617|P1|STARTED|Overall Study||13
524898|NCT00002597|1263627|P2|NOT COMPLETED|Overall Study||23
524899|NCT00002597|1263628|P1|NOT COMPLETED|Overall Study||26
524900|NCT00002597|1263627|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
524901|NCT00002597|1263628|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
524902|NCT00002597|1263627|P2|STARTED|Overall Study||1015
524903|NCT00002597|1263628|P1|STARTED|Overall Study||1013
524904|NCT00002558|1263652|P2|NOT COMPLETED|Overall Study||1
524905|NCT00002558|1263653|P1|NOT COMPLETED|Overall Study||0
524906|NCT00002558|1263652|P2|COMPLETED|Overall Study||15
524907|NCT00002558|1263653|P1|COMPLETED|Overall Study||92
524908|NCT00002558|1263652|P2|STARTED|Overall Study||16
524909|NCT00002558|1263653|P1|STARTED|Overall Study||92
524910|NCT00002540|1263661|P2|NOT COMPLETED|Overall Study||2464
524911|NCT00002540|1263662|P1|NOT COMPLETED|Overall Study||801
524912|NCT00002540|1263661|P2|COMPLETED|Overall Study||35876
524913|NCT00002540|1263662|P1|COMPLETED|Overall Study||37544
524914|NCT00002540|1263661|P2|STARTED|Overall Study||38340
524915|NCT00002540|1263662|P1|STARTED|Overall Study||38345
524916|NCT00002525|1263690|P2|NOT COMPLETED|Overall Study||0
524917|NCT00002525|1263691|P1|NOT COMPLETED|Overall Study||186
524918|NCT00002525|1263690|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
524919|NCT00002525|1263691|P1|COMPLETED|Overall Study||241
524920|NCT00002525|1263690|P2|Dukes' B2 Stage|Overall Study||139
524921|NCT00002525|1263691|P1|Dukes' B2 Stage|Overall Study||150
524922|NCT00002525|1263690|P2|Dukes' B3 or C Stage|Overall Study||158
524923|NCT00002525|1263691|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
524924|NCT00002525|1263690|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
524925|NCT00002525|1263691|P1|Treated|Overall Study||419
524926|NCT00002525|1263690|P2|STARTED|Overall Study||428
524927|NCT00002525|1263691|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
524928|NCT00001984|1263705|P1|NOT COMPLETED|Overall Study||0
524929|NCT00001984|1263705|P1|COMPLETED|Overall Study||5
524930|NCT00001984|1263705|P1|STARTED|Overall Study||5
524931|NCT00001962|1263715|P1|NOT COMPLETED|Overall Study||28
524932|NCT00001962|1263715|P1|COMPLETED|Overall Study||72
524933|NCT00001962|1263715|P1|STARTED|Overall Study||100
524934|NCT00001959|1263719|P1|NOT COMPLETED|Overall Study||3
524935|NCT00001959|1263719|P1|COMPLETED|Overall Study||18
524936|NCT00001959|1263719|P1|STARTED|Overall Study||21
524937|NCT00001941|1263725|P5|NOT COMPLETED|Overall Study||1
524938|NCT00001941|1263726|P4|NOT COMPLETED|Overall Study||0
524939|NCT00001941|1263727|P3|NOT COMPLETED|Overall Study||0
524940|NCT00001941|1263728|P2|NOT COMPLETED|Overall Study||0
524941|NCT00001941|1263729|P1|NOT COMPLETED|Overall Study||0
524942|NCT00001941|1263725|P5|COMPLETED|Overall Study||19
524943|NCT00001941|1263726|P4|COMPLETED|Overall Study||3
524944|NCT00001941|1263727|P3|COMPLETED|Overall Study||3
524945|NCT00001941|1263728|P2|COMPLETED|Overall Study||5
524946|NCT00001941|1263729|P1|COMPLETED|Overall Study||3
524947|NCT00001941|1263725|P5|STARTED|Overall Study||20
524948|NCT00001941|1263726|P4|STARTED|Overall Study||3
524949|NCT00001941|1263727|P3|STARTED|Overall Study||3
524950|NCT00001941|1263728|P2|STARTED|Overall Study||5
524951|NCT00001941|1263729|P1|STARTED|Overall Study||3
524952|NCT00001832|1263750|P15|NOT COMPLETED|Treatment Period||0
524953|NCT00001832|1263751|P14|NOT COMPLETED|Treatment Period||0
524954|NCT00001832|1263752|P13|NOT COMPLETED|Treatment Period||0
524955|NCT00001832|1263753|P12|NOT COMPLETED|Treatment Period||0
524956|NCT00001832|1263754|P11|NOT COMPLETED|Treatment Period||0
524957|NCT00001832|1263755|P10|NOT COMPLETED|Treatment Period||0
524958|NCT00001832|1263756|P9|NOT COMPLETED|Treatment Period||0
524959|NCT00001832|1263757|P8|NOT COMPLETED|Treatment Period||1
524960|NCT00001832|1263758|P7|NOT COMPLETED|Treatment Period||0
524961|NCT00001832|1263759|P6|NOT COMPLETED|Treatment Period||1
524962|NCT00001832|1263760|P5|NOT COMPLETED|Treatment Period||0
524963|NCT00001832|1263761|P4|NOT COMPLETED|Treatment Period||0
524964|NCT00001832|1263762|P3|NOT COMPLETED|Treatment Period||0
524965|NCT00001832|1263763|P2|NOT COMPLETED|Treatment Period||0
524966|NCT00001832|1263764|P1|NOT COMPLETED|Treatment Period||0
524967|NCT00001832|1263750|P15|COMPLETED|Treatment Period||2
524968|NCT00001832|1263751|P14|COMPLETED|Treatment Period||3
524969|NCT00001832|1263752|P13|COMPLETED|Treatment Period||6
524970|NCT00001832|1263753|P12|COMPLETED|Treatment Period||7
524971|NCT00001832|1263754|P11|COMPLETED|Treatment Period||1
524972|NCT00001832|1263755|P10|COMPLETED|Treatment Period||6
524973|NCT00001832|1263756|P9|COMPLETED|Treatment Period||8
524974|NCT00001832|1263757|P8|COMPLETED|Treatment Period||6
524975|NCT00001832|1263758|P7|COMPLETED|Treatment Period||4
524976|NCT00001832|1263759|P6|COMPLETED|Treatment Period||50
524977|NCT00001832|1263760|P5|COMPLETED|Treatment Period||6
524978|NCT00001832|1263761|P4|COMPLETED|Treatment Period||3
524979|NCT00001832|1263762|P3|COMPLETED|Treatment Period||3
524980|NCT00001832|1263763|P2|COMPLETED|Treatment Period||3
524981|NCT00001832|1263764|P1|COMPLETED|Treatment Period||0
524982|NCT00001832|1263750|P15|STARTED|Treatment Period||2
524983|NCT00001832|1263751|P14|STARTED|Treatment Period||3
524984|NCT00001832|1263752|P13|STARTED|Treatment Period||6
524985|NCT00001832|1263753|P12|STARTED|Treatment Period||7
524986|NCT00001832|1263754|P11|STARTED|Treatment Period||1
524987|NCT00001832|1263755|P10|STARTED|Treatment Period||6
524988|NCT00001832|1263756|P9|STARTED|Treatment Period||8
524989|NCT00001832|1263757|P8|STARTED|Treatment Period||7
524990|NCT00001832|1263758|P7|STARTED|Treatment Period||4
524991|NCT00001832|1263759|P6|STARTED|Treatment Period||51
524992|NCT00001832|1263760|P5|STARTED|Treatment Period||6
524993|NCT00001832|1263761|P4|STARTED|Treatment Period||3
524994|NCT00001832|1263762|P3|STARTED|Treatment Period||3
524995|NCT00001832|1263763|P2|STARTED|Treatment Period||3
524996|NCT00001832|1263764|P1|STARTED|Treatment Period||0
524997|NCT00001832|1263750|P15|NOT COMPLETED|Apheresis Period||0
524998|NCT00001832|1263751|P14|NOT COMPLETED|Apheresis Period||0
524999|NCT00001832|1263752|P13|NOT COMPLETED|Apheresis Period||0
525000|NCT00001832|1263753|P12|NOT COMPLETED|Apheresis Period||0
525001|NCT00001832|1263754|P11|NOT COMPLETED|Apheresis Period||0
525002|NCT00001832|1263755|P10|NOT COMPLETED|Apheresis Period||0
525003|NCT00001832|1263756|P9|NOT COMPLETED|Apheresis Period||0
525004|NCT00001832|1263757|P8|NOT COMPLETED|Apheresis Period||0
525005|NCT00001832|1263758|P7|NOT COMPLETED|Apheresis Period||0
525006|NCT00001832|1263759|P6|NOT COMPLETED|Apheresis Period||0
525007|NCT00001832|1263760|P5|NOT COMPLETED|Apheresis Period||0
525008|NCT00001832|1263761|P4|NOT COMPLETED|Apheresis Period||0
525009|NCT00001832|1263762|P3|NOT COMPLETED|Apheresis Period||0
525010|NCT00001832|1263763|P2|NOT COMPLETED|Apheresis Period||0
525011|NCT00001832|1263764|P1|NOT COMPLETED|Apheresis Period||60
525012|NCT00001832|1263750|P15|COMPLETED|Apheresis Period||0
525013|NCT00001832|1263751|P14|COMPLETED|Apheresis Period||0
525014|NCT00001832|1263752|P13|COMPLETED|Apheresis Period||0
525015|NCT00001832|1263753|P12|COMPLETED|Apheresis Period||0
525016|NCT00001832|1263754|P11|COMPLETED|Apheresis Period||0
525017|NCT00001832|1263755|P10|COMPLETED|Apheresis Period||0
525018|NCT00001832|1263756|P9|COMPLETED|Apheresis Period||0
525019|NCT00001832|1263757|P8|COMPLETED|Apheresis Period||0
525020|NCT00001832|1263758|P7|COMPLETED|Apheresis Period||0
525021|NCT00001832|1263759|P6|COMPLETED|Apheresis Period||0
525022|NCT00001832|1263760|P5|COMPLETED|Apheresis Period||0
525023|NCT00001832|1263761|P4|COMPLETED|Apheresis Period||0
525024|NCT00001832|1263762|P3|COMPLETED|Apheresis Period||0
525025|NCT00001832|1263763|P2|COMPLETED|Apheresis Period||0
525026|NCT00001832|1263764|P1|COMPLETED|Apheresis Period||110
525027|NCT00001832|1263750|P15|STARTED|Apheresis Period||0
525028|NCT00001832|1263751|P14|STARTED|Apheresis Period||0
525029|NCT00001832|1263752|P13|STARTED|Apheresis Period||0
525030|NCT00001832|1263753|P12|STARTED|Apheresis Period||0
525031|NCT00001832|1263754|P11|STARTED|Apheresis Period||0
525032|NCT00001832|1263755|P10|STARTED|Apheresis Period||0
525033|NCT00001832|1263756|P9|STARTED|Apheresis Period||0
525034|NCT00001832|1263757|P8|STARTED|Apheresis Period||0
525035|NCT00001832|1263758|P7|STARTED|Apheresis Period||0
525036|NCT00001832|1263759|P6|STARTED|Apheresis Period||0
525037|NCT00001832|1263760|P5|STARTED|Apheresis Period||0
525038|NCT00001832|1263761|P4|STARTED|Apheresis Period||0
525039|NCT00001832|1263762|P3|STARTED|Apheresis Period||0
525040|NCT00001832|1263763|P2|STARTED|Apheresis Period||0
525041|NCT00001832|1263764|P1|STARTED|Apheresis Period||170
525042|NCT00001723|1263810|P2|NOT COMPLETED|Overall Study||16
525043|NCT00001723|1263811|P1|NOT COMPLETED|Overall Study||13
525044|NCT00001723|1263810|P2|COMPLETED|Overall Study||84
525045|NCT00001723|1263811|P1|COMPLETED|Overall Study||87
525046|NCT00001723|1263810|P2|STARTED|Overall Study||100
525047|NCT00001723|1263811|P1|STARTED|Overall Study||100
525048|NCT00001703|1263827|P1|NOT COMPLETED|Overall Study||5
525049|NCT00001703|1263827|P1|COMPLETED|Overall Study||1
525050|NCT00001703|1263827|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
525051|NCT00001703|1263827|P1|STARTED|Overall Study||6
525052|NCT00001656|1263834|P2|NOT COMPLETED|Overall Study||0
525053|NCT00001656|1263835|P1|NOT COMPLETED|Overall Study||1
525054|NCT00001656|1263834|P2|COMPLETED|Overall Study||12
525055|NCT00001656|1263835|P1|COMPLETED|Overall Study||12
525056|NCT00001656|1263834|P2|STARTED|Overall Study||12
525057|NCT00001656|1263835|P1|STARTED|Overall Study||13
525058|NCT00001596|1263865|P2|NOT COMPLETED|Overall Study||10
525059|NCT00001596|1263866|P1|NOT COMPLETED|Overall Study||17
525060|NCT00001596|1263865|P2|COMPLETED|Overall Study||2
525061|NCT00001596|1263866|P1|COMPLETED|Overall Study||6
525062|NCT00001596|1263865|P2|STARTED|Overall Study||12
525063|NCT00001596|1263866|P1|STARTED|Overall Study||23
525064|NCT00001586|1263888|P2|NOT COMPLETED|Overall Study||0
525065|NCT00001586|1263889|P1|NOT COMPLETED|Overall Study||0
525066|NCT00001586|1263888|P2|COMPLETED|Overall Study||56
525067|NCT00001586|1263889|P1|COMPLETED|Overall Study||49
525068|NCT00001586|1263888|P2|STARTED|Overall Study||56
525069|NCT00001586|1263889|P1|STARTED|Overall Study||49
525070|NCT00001575|1263897|P1|NOT COMPLETED|Overall Study||45
525071|NCT00001575|1263897|P1|COMPLETED|Overall Study||42
525072|NCT00001575|1263897|P1|Treated|Overall Study||65
525073|NCT00001575|1263897|P1|STARTED|Overall Study||87
525074|NCT00001566|1263903|P1|NOT COMPLETED|Overall Study||19
525075|NCT00001566|1263903|P1|COMPLETED|Overall Study||23
525076|NCT00001566|1263903|P1|Completed Immunotherapy|Overall Study||23
525077|NCT00001566|1263903|P1|STARTED|Overall Study||42
525078|NCT00001304|1263917|P2|NOT COMPLETED|Overall Study||0
525079|NCT00001304|1263918|P1|NOT COMPLETED|Overall Study||0
525080|NCT00001304|1263917|P2|COMPLETED|Overall Study||14
525081|NCT00001304|1263918|P1|COMPLETED|Overall Study||13
525082|NCT00001304|1263917|P2|STARTED|Overall Study||14
525083|NCT00001304|1263918|P1|STARTED|Overall Study||13
525084|NCT00001262|1263939|P3|NOT COMPLETED|Overall Study||0
525085|NCT00001262|1263940|P2|NOT COMPLETED|Overall Study||14
525086|NCT00001262|1263941|P1|NOT COMPLETED|Overall Study||10
525087|NCT00001262|1263939|P3|COMPLETED|Overall Study||3
525088|NCT00001262|1263940|P2|COMPLETED|Overall Study||8
525089|NCT00001262|1263941|P1|COMPLETED|Overall Study||25
525090|NCT00001262|1263939|P3|STARTED|Overall Study||3
525091|NCT00001262|1263940|P2|STARTED|Overall Study||22
525092|NCT00001262|1263941|P1|STARTED|Overall Study||35
525093|NCT00001213|1263967|P1|NOT COMPLETED|Overall Study||18
525094|NCT00001213|1263967|P1|COMPLETED|Overall Study||310
525095|NCT00001213|1263967|P1|STARTED|Overall Study||328
525096|NCT00001151|1263972|P1|NOT COMPLETED|Overall Study||5
525097|NCT00001151|1263972|P1|COMPLETED|Overall Study||1
525098|NCT00001151|1263972|P1|STARTED|Overall Study||6
525099|NCT00000620|1263978|P8|NOT COMPLETED|Overall Study||146
525100|NCT00000620|1263979|P7|NOT COMPLETED|Overall Study||149
525101|NCT00000620|1263980|P6|NOT COMPLETED|Overall Study||152
525102|NCT00000620|1263981|P5|NOT COMPLETED|Overall Study||135
525103|NCT00000620|1263982|P4|NOT COMPLETED|Overall Study||178
525104|NCT00000620|1263983|P3|NOT COMPLETED|Overall Study||170
525105|NCT00000620|1263984|P2|NOT COMPLETED|Overall Study||136
525106|NCT00000620|1263985|P1|NOT COMPLETED|Overall Study||162
525107|NCT00000620|1263978|P8|COMPLETED|Overall Study||1224
525108|NCT00000620|1263979|P7|COMPLETED|Overall Study||1242
525109|NCT00000620|1263980|P6|COMPLETED|Overall Study||1026
525110|NCT00000620|1263981|P5|COMPLETED|Overall Study||1049
525111|NCT00000620|1263982|P4|COMPLETED|Overall Study||1205
525112|NCT00000620|1263983|P3|COMPLETED|Overall Study||1204
525113|NCT00000620|1263984|P2|COMPLETED|Overall Study||1057
525114|NCT00000620|1263985|P1|COMPLETED|Overall Study||1016
525115|NCT00000620|1263978|P8|STARTED|Overall Study||1370
525116|NCT00000620|1263979|P7|STARTED|Overall Study||1391
525117|NCT00000620|1263980|P6|STARTED|Overall Study||1178
525118|NCT00000620|1263981|P5|STARTED|Overall Study||1184
525119|NCT00000620|1263982|P4|STARTED|Overall Study||1383
525120|NCT00000620|1263983|P3|STARTED|Overall Study||1374
525121|NCT00000620|1263984|P2|STARTED|Overall Study||1193
525122|NCT00000620|1263985|P1|STARTED|Overall Study||1178
525123|NCT00000575|1264004|P3|NOT COMPLETED|Overall Study||0
525124|NCT00000575|1264005|P2|NOT COMPLETED|Overall Study||0
525125|NCT00000575|1264006|P1|NOT COMPLETED|Overall Study||0
525126|NCT00000575|1264004|P3|COMPLETED|Overall Study||418
525127|NCT00000575|1264005|P2|COMPLETED|Overall Study||312
525128|NCT00000575|1264006|P1|COMPLETED|Overall Study||311
525129|NCT00000575|1264004|P3|STARTED|Overall Study||418
525130|NCT00000575|1264005|P2|STARTED|Overall Study||312
525131|NCT00000575|1264006|P1|STARTED|Overall Study||311
525132|NCT00000479|1264036|P4|NOT COMPLETED|Overall Study||0
525133|NCT00000479|1264037|P3|NOT COMPLETED|Overall Study||0
525134|NCT00000479|1264038|P2|NOT COMPLETED|Overall Study||0
525135|NCT00000479|1264039|P1|NOT COMPLETED|Overall Study||0
525136|NCT00000479|1264036|P4|COMPLETED|Overall Study||9971
525137|NCT00000479|1264037|P3|COMPLETED|Overall Study||9966
525138|NCT00000479|1264038|P2|COMPLETED|Overall Study||9971
525139|NCT00000479|1264039|P1|COMPLETED|Overall Study||9968
525140|NCT00000479|1264036|P4|STARTED|Overall Study||9971
525141|NCT00000479|1264037|P3|STARTED|Overall Study||9966
525142|NCT00000479|1264038|P2|STARTED|Overall Study||9971
525143|NCT00000479|1264039|P1|STARTED|Overall Study||9968
525144|NCT00000392|1264055|P2|NOT COMPLETED|Overall Study||32
525145|NCT00000392|1264056|P1|NOT COMPLETED|Overall Study||40
525146|NCT00000392|1264055|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
525147|NCT00000392|1264056|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
525148|NCT00000392|1264055|P2|STARTED|Overall Study||109
525149|NCT00000392|1264056|P1|STARTED|Overall Study||106
525150|NCT00000378|1264066|P2|NOT COMPLETED|Overall Study||14
525151|NCT00000378|1264067|P1|NOT COMPLETED|Overall Study||16
525152|NCT00000378|1264066|P2|COMPLETED|Overall Study||38
525153|NCT00000378|1264067|P1|COMPLETED|Overall Study||42
525154|NCT00000378|1264066|P2|STARTED|Overall Study||52
525155|NCT00000378|1264067|P1|STARTED|Overall Study||58
525156|NCT00000371|1264075|P2|NOT COMPLETED|Overall Study||16
525157|NCT00000371|1264076|P1|NOT COMPLETED|Overall Study||13
525158|NCT00000371|1264075|P2|COMPLETED|Overall Study||12
525159|NCT00000371|1264076|P1|COMPLETED|Overall Study||14
525160|NCT00000371|1264075|P2|STARTED|Overall Study||28
525161|NCT00000371|1264076|P1|STARTED|Overall Study||27
525162|NCT00000143|1264084|P2|NOT COMPLETED|Overall Study||0
525163|NCT00000143|1264085|P1|NOT COMPLETED|Overall Study||0
525164|NCT00000143|1264084|P2|COMPLETED|Overall Study||30
525165|NCT00000143|1264085|P1|COMPLETED|Overall Study||31
525166|NCT00000143|1264084|P2|STARTED|Overall Study||30
525167|NCT00000143|1264085|P1|STARTED|Overall Study||31
525168|NCT00000142|1264094|P3|NOT COMPLETED|Overall Study||0
525169|NCT00000142|1264095|P2|NOT COMPLETED|Overall Study||0
525170|NCT00000142|1264096|P1|NOT COMPLETED|Overall Study||0
525171|NCT00000142|1264094|P3|COMPLETED|Overall Study||12
525172|NCT00000142|1264095|P2|COMPLETED|Overall Study||26
525173|NCT00000142|1264096|P1|COMPLETED|Overall Study||26
525174|NCT00000142|1264094|P3|STARTED|Overall Study||12
525175|NCT00000142|1264095|P2|STARTED|Overall Study||26
525176|NCT00000142|1264096|P1|STARTED|Overall Study||26
525177|NCT00000136|1264106|P2|NOT COMPLETED|Overall Study||0
525178|NCT00000136|1264107|P1|NOT COMPLETED|Overall Study||0
525179|NCT00000136|1264106|P2|COMPLETED|Overall Study||127
525180|NCT00000136|1264107|P1|COMPLETED|Overall Study||107
525181|NCT00000136|1264106|P2|STARTED|Overall Study||127
525182|NCT00000136|1264107|P1|STARTED|Overall Study||107
525183|NCT00000135|1264115|P2|NOT COMPLETED|Overall Study||14
525184|NCT00000135|1264116|P1|NOT COMPLETED|Overall Study||27
525185|NCT00000135|1264115|P2|COMPLETED|Overall Study||91
525186|NCT00000135|1264116|P1|COMPLETED|Overall Study||77
525187|NCT00000135|1264115|P2|STARTED|Overall Study||105
525188|NCT00000135|1264116|P1|STARTED|Overall Study||104
525189|NCT00000134|1264125|P3|NOT COMPLETED|Overall Study||0
525190|NCT00000134|1264126|P2|NOT COMPLETED|Overall Study||0
525191|NCT00000134|1264127|P1|NOT COMPLETED|Overall Study||0
525192|NCT00000134|1264125|P3|COMPLETED|Overall Study||96
525193|NCT00000134|1264126|P2|COMPLETED|Overall Study||94
525194|NCT00000134|1264127|P1|COMPLETED|Overall Study||89
525195|NCT00000134|1264125|P3|STARTED|Overall Study||96
525196|NCT00000134|1264126|P2|STARTED|Overall Study||94
525197|NCT00000134|1264127|P1|STARTED|Overall Study||89
525198|NCT00000125|1264137|P2|NOT COMPLETED|Overall Study||238
525199|NCT00000125|1264138|P1|NOT COMPLETED|Overall Study||239
525200|NCT00000125|1264137|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
525201|NCT00000125|1264138|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
525202|NCT00000125|1264137|P2|Completed OHTS Phase I, June 2002|Overall Study||702
525203|NCT00000125|1264138|P1|Completed OHTS Phase I, June 2002|Overall Study||706
525204|NCT00000125|1264137|P2|STARTED|Overall Study||817
525205|NCT00000125|1264138|P1|STARTED|Overall Study||819
525219|NCT00586170|1264163|P2|NOT COMPLETED|Overall Study||0
525220|NCT00586170|1264164|P1|NOT COMPLETED|Overall Study||0
525221|NCT00586170|1264163|P2|COMPLETED|Overall Study||3
525222|NCT00586170|1264164|P1|COMPLETED|Overall Study||5
525223|NCT00586170|1264163|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
525224|NCT00586170|1264164|P1|STARTED|Overall Study||5
525225|NCT02784925|1264172|P1|NOT COMPLETED|Overall Study||0
525226|NCT02784925|1264172|P1|COMPLETED|Overall Study||30
525227|NCT02784925|1264172|P1|STARTED|Overall Study||30
525228|NCT02388191|1264178|P2|NOT COMPLETED|Overall Study||0
525229|NCT02388191|1264179|P1|NOT COMPLETED|Overall Study||1
525230|NCT02388191|1264178|P2|COMPLETED|Overall Study||60
525231|NCT02388191|1264179|P1|COMPLETED|Overall Study||58
525232|NCT02388191|1264178|P2|STARTED|Overall Study||60
525233|NCT02388191|1264179|P1|STARTED|Overall Study||59
525234|NCT02357342|1264195|P2|NOT COMPLETED|Extension Study||0
525235|NCT02357342|1264196|P1|NOT COMPLETED|Extension Study||0
525236|NCT02357342|1264195|P2|COMPLETED|Extension Study||9
525237|NCT02357342|1264196|P1|COMPLETED|Extension Study||4
525238|NCT02357342|1264195|P2|STARTED|Extension Study||9
525239|NCT02357342|1264196|P1|STARTED|Extension Study||4
525240|NCT02357342|1264195|P2|NOT COMPLETED|First 6 Months||0
525241|NCT02357342|1264196|P1|NOT COMPLETED|First 6 Months||2
525242|NCT02357342|1264195|P2|COMPLETED|First 6 Months||20
525243|NCT02357342|1264196|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
525244|NCT02357342|1264195|P2|STARTED|First 6 Months||20
525245|NCT02357342|1264196|P1|STARTED|First 6 Months||20
525246|NCT01893359|1264209|P3|NOT COMPLETED|Overall Study||0
525247|NCT01893359|1264210|P2|NOT COMPLETED|Overall Study||0
525248|NCT01893359|1264211|P1|NOT COMPLETED|Overall Study||0
525249|NCT01893359|1264209|P3|COMPLETED|Overall Study||0
525250|NCT01893359|1264210|P2|COMPLETED|Overall Study||2
525251|NCT01893359|1264211|P1|COMPLETED|Overall Study||0
525252|NCT01893359|1264209|P3|STARTED|Overall Study||0
525253|NCT01893359|1264210|P2|STARTED|Overall Study||2
525254|NCT01893359|1264211|P1|STARTED|Overall Study||0
525255|NCT01851720|1264224|P2|NOT COMPLETED|Overall Study||1
525256|NCT01851720|1264225|P1|NOT COMPLETED|Overall Study||0
525257|NCT01851720|1264224|P2|COMPLETED|Overall Study||0
525258|NCT01851720|1264225|P1|COMPLETED|Overall Study||0
525259|NCT01851720|1264224|P2|STARTED|Overall Study||1
525260|NCT01851720|1264225|P1|STARTED|Overall Study||0
525261|NCT01849458|1264231|P1|NOT COMPLETED|Overall Study||4
525262|NCT01849458|1264231|P1|COMPLETED|Overall Study||46
525263|NCT01849458|1264231|P1|6 Months Follow-up|Overall Study||50
525264|NCT01849458|1264231|P1|STARTED|Overall Study||50
525265|NCT01762761|1264243|P2|NOT COMPLETED|Overall Study||4
525266|NCT01762761|1264244|P1|NOT COMPLETED|Overall Study||2
525267|NCT01762761|1264243|P2|COMPLETED|Overall Study||100
525268|NCT01762761|1264244|P1|COMPLETED|Overall Study||49
525269|NCT01762761|1264243|P2|STARTED|Overall Study||104
525270|NCT01762761|1264244|P1|STARTED|Overall Study||51
525271|NCT01253317|1264296|P1|NOT COMPLETED|Overall Study||2
525272|NCT01253317|1264296|P1|COMPLETED|Overall Study||10
525273|NCT01253317|1264296|P1|STARTED|Overall Study||12
525274|NCT01233687|1264304|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
525275|NCT01233687|1264304|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
525276|NCT01233687|1264304|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
525277|NCT01233687|1264304|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
525278|NCT01233687|1264304|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
525279|NCT01233687|1264304|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
525280|NCT01233687|1264304|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
525300|NCT00956085|1264342|P1|NOT COMPLETED|Overall Study||0
525301|NCT00956085|1264342|P1|COMPLETED|Overall Study||12
525302|NCT00956085|1264342|P1|STARTED|Overall Study||12
525303|NCT00610857|1264346|P1|NOT COMPLETED|Overall Study||2
525304|NCT00610857|1264346|P1|COMPLETED|Overall Study||35
525305|NCT00610857|1264346|P1|STARTED|Overall Study||37
525306|NCT00483327|1264353|P1|NOT COMPLETED|Overall Study||10
525307|NCT00483327|1264353|P1|COMPLETED|Overall Study||20
525308|NCT00483327|1264353|P1|STARTED|Overall Study||30
525350|NCT01894230|1264441|P2|NOT COMPLETED|Overall Study||7
525351|NCT01894230|1264442|P1|NOT COMPLETED|Overall Study||7
525352|NCT01894230|1264441|P2|COMPLETED|Overall Study||69
525353|NCT01894230|1264442|P1|COMPLETED|Overall Study||76
525354|NCT01894230|1264441|P2|STARTED|Overall Study||76
525355|NCT01894230|1264442|P1|STARTED|Overall Study||83
525371|NCT01229943|1264514|P2|NOT COMPLETED|Overall Study||17
525372|NCT01229943|1264515|P1|NOT COMPLETED|Overall Study||18
525373|NCT01229943|1264514|P2|COMPLETED|Overall Study||58
525374|NCT01229943|1264515|P1|COMPLETED|Overall Study||57
525375|NCT01229943|1264514|P2|STARTED|Overall Study||75
525376|NCT01229943|1264515|P1|STARTED|Overall Study||75
525390|NCT01016483|1264552|P4|NOT COMPLETED|Phase II||0
525391|NCT01016483|1264553|P3|NOT COMPLETED|Phase II||0
525392|NCT01016483|1264554|P2|NOT COMPLETED|Phase II||0
525393|NCT01016483|1264555|P1|NOT COMPLETED|Phase II||0
525394|NCT01016483|1264552|P4|COMPLETED|Phase II||44
525395|NCT01016483|1264553|P3|COMPLETED|Phase II||44
525396|NCT01016483|1264554|P2|COMPLETED|Phase II||0
525397|NCT01016483|1264555|P1|COMPLETED|Phase II||0
525398|NCT01016483|1264552|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
525399|NCT01016483|1264553|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
525400|NCT01016483|1264554|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
525401|NCT01016483|1264555|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
525402|NCT01016483|1264552|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
525403|NCT01016483|1264553|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
525404|NCT01016483|1264554|P2|STARTED|Phase II||0
525405|NCT01016483|1264555|P1|STARTED|Phase II||0
525406|NCT01016483|1264552|P4|NOT COMPLETED|Safety Run-in Part||0
525407|NCT01016483|1264553|P3|NOT COMPLETED|Safety Run-in Part||0
525408|NCT01016483|1264554|P2|NOT COMPLETED|Safety Run-in Part||0
525409|NCT01016483|1264555|P1|NOT COMPLETED|Safety Run-in Part||0
525410|NCT01016483|1264552|P4|COMPLETED|Safety Run-in Part||0
525411|NCT01016483|1264553|P3|COMPLETED|Safety Run-in Part||0
525412|NCT01016483|1264554|P2|COMPLETED|Safety Run-in Part||26
525413|NCT01016483|1264555|P1|COMPLETED|Safety Run-in Part||27
525414|NCT01016483|1264552|P4|STARTED|Safety Run-in Part||0
525415|NCT01016483|1264553|P3|STARTED|Safety Run-in Part||0
525416|NCT01016483|1264554|P2|STARTED|Safety Run-in Part||26
525417|NCT01016483|1264555|P1|STARTED|Safety Run-in Part||27
525418|NCT01012999|1264661|P1|NOT COMPLETED|Overall Study||1
525419|NCT01012999|1264661|P1|COMPLETED|Overall Study||15
525420|NCT01012999|1264661|P1|STARTED|Overall Study||16
525421|NCT00390455|1264667|P2|NOT COMPLETED|Overall Study||23
525422|NCT00390455|1264668|P1|NOT COMPLETED|Overall Study||32
525423|NCT00390455|1264667|P2|COMPLETED|Overall Study||124
525424|NCT00390455|1264668|P1|COMPLETED|Overall Study||116
525425|NCT00390455|1264667|P2|STARTED|Overall Study||147
525426|NCT00390455|1264668|P1|STARTED|Overall Study||148
525450|NCT00141921|1264725|P1|NOT COMPLETED|Overall Study||141
525451|NCT00141921|1264725|P1|COMPLETED|Overall Study||41
525452|NCT00141921|1264725|P1|Received Treatment|Overall Study||181
525453|NCT00141921|1264725|P1|STARTED|Overall Study||182
525454|NCT00125658|1264749|P2|NOT COMPLETED|Overall Study||0
525455|NCT00125658|1264750|P1|NOT COMPLETED|Overall Study||0
525456|NCT00125658|1264749|P2|COMPLETED|Overall Study||6
525457|NCT00125658|1264750|P1|COMPLETED|Overall Study||8
525458|NCT00125658|1264749|P2|STARTED|Overall Study||6
525459|NCT00125658|1264750|P1|STARTED|Overall Study||8
525460|NCT02482428|1264773|P5|NOT COMPLETED|Overall Study||7
525461|NCT02482428|1264774|P4|NOT COMPLETED|Overall Study||2
525462|NCT02482428|1264775|P3|NOT COMPLETED|Overall Study||1
525463|NCT02482428|1264776|P2|NOT COMPLETED|Overall Study||12
525464|NCT02482428|1264777|P1|NOT COMPLETED|Overall Study||9
525465|NCT02482428|1264773|P5|COMPLETED|Overall Study||15
525466|NCT02482428|1264774|P4|COMPLETED|Overall Study||8
525467|NCT02482428|1264775|P3|COMPLETED|Overall Study||9
525468|NCT02482428|1264776|P2|COMPLETED|Overall Study||10
525469|NCT02482428|1264777|P1|COMPLETED|Overall Study||15
525470|NCT02482428|1264773|P5|STARTED|Overall Study||22
525471|NCT02482428|1264774|P4|STARTED|Overall Study||10
525472|NCT02482428|1264775|P3|STARTED|Overall Study||10
525473|NCT02482428|1264776|P2|STARTED|Overall Study||22
525474|NCT02482428|1264777|P1|STARTED|Overall Study||24
525475|NCT01639469|1264799|P2|NOT COMPLETED|Overall Study||3
525476|NCT01639469|1264800|P1|NOT COMPLETED|Overall Study||5
525477|NCT01639469|1264799|P2|COMPLETED|Overall Study||77
525478|NCT01639469|1264800|P1|COMPLETED|Overall Study||84
525479|NCT01639469|1264799|P2|STARTED|Overall Study||80
525480|NCT01639469|1264800|P1|STARTED|Overall Study||89
525481|NCT01261325|1264809|P3|NOT COMPLETED|Overall Study||26
525482|NCT01261325|1264810|P2|NOT COMPLETED|Overall Study||29
525483|NCT01261325|1264811|P1|NOT COMPLETED|Overall Study||17
525484|NCT01261325|1264809|P3|COMPLETED|Overall Study||225
525485|NCT01261325|1264810|P2|COMPLETED|Overall Study||225
525486|NCT01261325|1264811|P1|COMPLETED|Overall Study||246
525487|NCT01261325|1264809|P3|STARTED|Overall Study||251
525488|NCT01261325|1264810|P2|STARTED|Overall Study||254
525489|NCT01261325|1264811|P1|STARTED|Overall Study||263
525490|NCT01161121|1264843|P1|NOT COMPLETED|Overall Study||0
525491|NCT01161121|1264843|P1|COMPLETED|Overall Study||46
525492|NCT01161121|1264843|P1|STARTED|Overall Study||46
525493|NCT01134614|1264855|P2|NOT COMPLETED|Overall Study||122
525494|NCT01134614|1264856|P1|NOT COMPLETED|Overall Study||123
525495|NCT01134614|1264855|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
525496|NCT01134614|1264856|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
525497|NCT01134614|1264855|P2|Treated and Toxicity Assessed|Overall Study||120
525498|NCT01134614|1264856|P1|Treated and Toxicity Assessed|Overall Study||118
525499|NCT01134614|1264855|P2|Treated|Overall Study||121
525500|NCT01134614|1264856|P1|Treated|Overall Study||119
525501|NCT01134614|1264855|P2|STARTED|Overall Study||122
525502|NCT01134614|1264856|P1|STARTED|Overall Study||123
525503|NCT00378703|1264870|P4|NOT COMPLETED|Overall Study||91
525504|NCT00378703|1264871|P3|NOT COMPLETED|Overall Study||90
525505|NCT00378703|1264872|P2|NOT COMPLETED|Overall Study||91
525506|NCT00378703|1264873|P1|NOT COMPLETED|Overall Study||89
525507|NCT00378703|1264870|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
525508|NCT00378703|1264871|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
525509|NCT00378703|1264872|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
525510|NCT00378703|1264873|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
525511|NCT00378703|1264870|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
525512|NCT00378703|1264871|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
525513|NCT00378703|1264872|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
525514|NCT00378703|1264873|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
525515|NCT00378703|1264870|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
525516|NCT00378703|1264871|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
525517|NCT00378703|1264872|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
525518|NCT00378703|1264873|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
525519|NCT00378703|1264870|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
525520|NCT00378703|1264871|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
525521|NCT00378703|1264872|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
525522|NCT00378703|1264873|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
525523|NCT00280748|1264895|P1|NOT COMPLETED|Overall Study||4
525524|NCT00280748|1264895|P1|COMPLETED|Overall Study||6
525525|NCT00280748|1264895|P1|STARTED|Overall Study||10
525526|NCT02234362|1264905|P1|NOT COMPLETED|Overall Study||26
525527|NCT02234362|1264905|P1|COMPLETED|Overall Study||21
525528|NCT02234362|1264905|P1|Received at Least One Dose of Medication|Overall Study||27
525529|NCT02234362|1264905|P1|STARTED|Overall Study||47
525530|NCT01681849|1264925|P3|NOT COMPLETED|Overall Study||39
525531|NCT01681849|1264926|P2|NOT COMPLETED|Overall Study||7
525532|NCT01681849|1264927|P1|NOT COMPLETED|Overall Study||8
525533|NCT01681849|1264925|P3|COMPLETED|Overall Study||17
525534|NCT01681849|1264926|P2|COMPLETED|Overall Study||6
525535|NCT01681849|1264927|P1|COMPLETED|Overall Study||7
525536|NCT01681849|1264925|P3|STARTED|Overall Study||56
525537|NCT01681849|1264926|P2|STARTED|Overall Study||13
525538|NCT01681849|1264927|P1|STARTED|Overall Study||15
525539|NCT01656252|1264936|P1|NOT COMPLETED|Phase II||0
525540|NCT01656252|1264936|P1|COMPLETED|Phase II||0
525541|NCT01656252|1264936|P1|STARTED|Phase II||0
525542|NCT01656252|1264936|P1|NOT COMPLETED|Phase I||0
525543|NCT01656252|1264936|P1|COMPLETED|Phase I||14
525544|NCT01656252|1264936|P1|STARTED|Phase I||14
525545|NCT01317901|1264970|P2|NOT COMPLETED|Overall Study||0
525546|NCT01317901|1264971|P1|NOT COMPLETED|Overall Study||0
525547|NCT01317901|1264970|P2|COMPLETED|Overall Study||6
525548|NCT01317901|1264971|P1|COMPLETED|Overall Study||6
525549|NCT01317901|1264970|P2|STARTED|Overall Study||6
525550|NCT01317901|1264971|P1|STARTED|Overall Study||6
525551|NCT01188681|1264981|P4|NOT COMPLETED|Overall Study||1
525552|NCT01188681|1264982|P3|NOT COMPLETED|Overall Study||1
525553|NCT01188681|1264983|P2|NOT COMPLETED|Overall Study||0
525554|NCT01188681|1264984|P1|NOT COMPLETED|Overall Study||0
525555|NCT01188681|1264981|P4|COMPLETED|Overall Study||33
525556|NCT01188681|1264982|P3|COMPLETED|Overall Study||32
525557|NCT01188681|1264983|P2|COMPLETED|Overall Study||6
525558|NCT01188681|1264984|P1|COMPLETED|Overall Study||6
525559|NCT01188681|1264981|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
525560|NCT01188681|1264982|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
525561|NCT01188681|1264983|P2|STARTED|Overall Study||6
525562|NCT01188681|1264984|P1|STARTED|Overall Study||6
525563|NCT01153815|1265000|P2|NOT COMPLETED|Overall Study||5
525564|NCT01153815|1265001|P1|NOT COMPLETED|Overall Study||9
525565|NCT01153815|1265000|P2|COMPLETED|Overall Study||82
525566|NCT01153815|1265001|P1|COMPLETED|Overall Study||74
525567|NCT01153815|1265000|P2|STARTED|Overall Study||87
525568|NCT01153815|1265001|P1|STARTED|Overall Study||83
525569|NCT01076270|1265023|P1|NOT COMPLETED|Overall Study||0
525570|NCT01076270|1265023|P1|COMPLETED|Overall Study||1
525571|NCT01076270|1265023|P1|STARTED|Overall Study||1
525572|NCT01061736|1265038|P10|NOT COMPLETED|Overall Study||74
525573|NCT01061736|1265039|P9|NOT COMPLETED|Overall Study||97
525574|NCT01061736|1265040|P8|NOT COMPLETED|Overall Study||94
525575|NCT01061736|1265041|P7|NOT COMPLETED|Overall Study||84
525576|NCT01061736|1265042|P6|NOT COMPLETED|Overall Study||3
525577|NCT01061736|1265043|P5|NOT COMPLETED|Overall Study||7
525578|NCT01061736|1265044|P4|NOT COMPLETED|Overall Study||3
525579|NCT01061736|1265045|P3|NOT COMPLETED|Overall Study||6
525580|NCT01061736|1265046|P2|NOT COMPLETED|Overall Study||4
525581|NCT01061736|1265047|P1|NOT COMPLETED|Overall Study||13
525582|NCT01061736|1265038|P10|COMPLETED|Overall Study||354
525583|NCT01061736|1265039|P9|COMPLETED|Overall Study||330
525584|NCT01061736|1265040|P8|COMPLETED|Overall Study||336
525585|NCT01061736|1265041|P7|COMPLETED|Overall Study||0
525586|NCT01061736|1265042|P6|COMPLETED|Overall Study||49
525587|NCT01061736|1265043|P5|COMPLETED|Overall Study||45
525588|NCT01061736|1265044|P4|COMPLETED|Overall Study||48
525589|NCT01061736|1265045|P3|COMPLETED|Overall Study||45
525590|NCT01061736|1265046|P2|COMPLETED|Overall Study||46
525591|NCT01061736|1265047|P1|COMPLETED|Overall Study||37
525592|NCT01061736|1265038|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
525593|NCT01061736|1265039|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
525594|NCT01061736|1265040|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
525595|NCT01061736|1265041|P7|Rescued|Overall Study||0
525596|NCT01061736|1265042|P6|Rescued|Overall Study||0
525597|NCT01061736|1265043|P5|Rescued|Overall Study||0
525598|NCT01061736|1265044|P4|Rescued|Overall Study||0
525599|NCT01061736|1265045|P3|Rescued|Overall Study||0
525600|NCT01061736|1265046|P2|Rescued|Overall Study||0
525601|NCT01061736|1265047|P1|Rescued|Overall Study||0
525602|NCT01061736|1265038|P10|Treated|Overall Study||428
525603|NCT01061736|1265039|P9|Treated|Overall Study||426
525604|NCT01061736|1265040|P8|Treated|Overall Study||428
525605|NCT01061736|1265041|P7|Treated|Overall Study||84
525606|NCT01061736|1265042|P6|Treated|Overall Study||52
525607|NCT01061736|1265043|P5|Treated|Overall Study||51
525608|NCT01061736|1265044|P4|Treated|Overall Study||51
525609|NCT01061736|1265045|P3|Treated|Overall Study||51
525610|NCT01061736|1265046|P2|Treated|Overall Study||50
525611|NCT01061736|1265047|P1|Treated|Overall Study||50
525612|NCT01061736|1265038|P10|STARTED|Overall Study||428
525613|NCT01061736|1265039|P9|STARTED|Overall Study||427
525614|NCT01061736|1265040|P8|STARTED|Overall Study||430
525615|NCT01061736|1265041|P7|STARTED|Overall Study||84
525616|NCT01061736|1265042|P6|STARTED|Overall Study||52
525617|NCT01061736|1265043|P5|STARTED|Overall Study||52
525618|NCT01061736|1265044|P4|STARTED|Overall Study||51
525619|NCT01061736|1265045|P3|STARTED|Overall Study||51
525620|NCT01061736|1265046|P2|STARTED|Overall Study||50
525621|NCT01061736|1265047|P1|STARTED|Overall Study||50
